PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Herpin, A; Englberger, E; Zehner, M; Wacker, R; Gessler, M; Schartl, M				Herpin, Amaury; Englberger, Eva; Zehner, Mario; Wacker, Robin; Gessler, Manfred; Schartl, Manfred			Defective autophagy through epg5 mutation results in failure to reduce germ plasm and mitochondria	FASEB JOURNAL			English	Article						gonad development; medaka; primordial germ cell	MEDAKA ORYZIAS-LATIPES; P GRANULE COMPONENTS; C. ELEGANS; CAENORHABDITIS-ELEGANS; PATERNAL MITOCHONDRIA; GONAD DEVELOPMENT; DEGRADATION; CELLS; EXPRESSION; DROSOPHILA	Autophagy is an evolutionarily conserved catabolic process that transports cytoplasmic components to lysosomes for degradation. In addition to the canonical view of strict stress-response-induced autophagy, selectively programmed autophagy was recently reported in the context of gonad development of flies and worms, where autophagy seems to be necessary for clearance of germ plasm components. Similar functions have not been described in vertebrates. We used the medaka fish to study the role of autophagy in gonad formation and gametogenesis for the first time in a vertebrate organism for which thegermline is specifiedby germplasm. Using a transgenic line deficient in the Ol-epg5 gene-a new critical component of the autophagy pathway-we show that such deficiency leads to an impaired autophagic flux, possibly attributed to compromised maturation or processing of the autophagosomes. Ol-epg5 deficiency correlates with selectively impaired spermatogenesis and low allele transmission rates of the mutant allele caused by failure of germ plasm and mitochondria clearance during the process of germ cell specification and in the adult gonads. The mouse epg-5 homolog is similarly expressed in the maturating and adult testes, suggesting an at least partially conserved function of this process during spermatogenesis in vertebrates.	[Herpin, Amaury; Zehner, Mario; Wacker, Robin; Schartl, Manfred] Univ Wurzburg, Physiol Chem, Bioctr, D-97074 Wurzburg, Germany; [Englberger, Eva; Gessler, Manfred] Univ Wurzburg, Dev Biochem, Bioctr, D-97074 Wurzburg, Germany; [Herpin, Amaury] INRA, Fish Physiol & Genom, Unit Rech 1037, F-35042 Rennes, France; [Schartl, Manfred] Univ Clin Wurzburg, Ctr Comprehens Canc, Wurzburg, Germany	University of Wurzburg; University of Wurzburg; INRAE; University of Wurzburg	Herpin, A (corresponding author), Univ Wurzburg, Physiol Chem, Bioctr, D-97074 Wurzburg, Germany.	amaury.herpin@biozentrum.uni-wurzburg.de	Herpin, Amaury/B-8950-2011	Herpin, Amaury/0000-0002-0630-4027; Schartl, Manfred/0000-0001-9882-5948; Gessler, Manfred/0000-0002-7915-6045	Deutsche Forschungsgemeinschaft (DFG) [HE 7135/2-1, SCHA 408/12-1, SFB 688]; DFG Graduate Training Program [GK 1048]; U.S. National Institutes of Health [1R01GM085318-01A2, 212791A]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085318] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); DFG Graduate Training Program; U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank the National Institute for Basic Biology, Japan (NRBP Medaka) for providing genomic resources and BAC clones; the fish facilities at the University of Wurzburg and at the INRA Rennes (F. Borel, C. Duret); and S. Bertho for technical assistance in performing the immunohistochemistry. This work was supported in part by the Deutsche Forschungsgemeinschaft (DFG) through Grants HE 7135/2-1 (to A.H.), SCHA 408/12-1 (to M.S.), and SFB 688 (TP A16) (to M.G.); the DFG Graduate Training Program Grant GK 1048, "Molecular basis of organ development in vertebrates"; and U.S. National Institutes of Health Grant 1R01GM085318-01A2, subaward No. 212791A, "Mechanisms of sex determination in zebrafish." A.H. and M.S designed the experiments and wrote the manuscript. A.H., E.E., M.Z., and R.W. performed the experiments. A.H., M.G., and M.S. discussed/commented on the results and edited the manuscript. All authors approved the manuscript. The authors declare no conflicts of interest.	Al Rawi S, 2011, SCIENCE, V334, P1144, DOI 10.1126/science.1211878; Barth JMI, 2011, CELL DEATH DIFFER, V18, P915, DOI 10.1038/cdd.2010.157; Berekelya LA, 2005, MOL BIOL+, V39, P664; Carew Jennifer S, 2012, Cancer Manag Res, V4, P357, DOI 10.2147/CMAR.S26133; Cullup T, 2013, NAT GENET, V45, P83, DOI 10.1038/ng.2497; Di Bartolomeo S, 2010, TRAFFIC, V11, P1280, DOI 10.1111/j.1600-0854.2010.01103.x; Ding WX, 2012, BIOL CHEM, V393, P547, DOI 10.1515/hsz-2012-0119; Extavour CG, 2003, DEVELOPMENT, V130, P5869, DOI 10.1242/dev.00804; FURUKAWA K, 1994, EXP CELL RES, V212, P426, DOI 10.1006/excr.1994.1164; Gottlieb R. A., 2013, HEART FAIL REV; HAY B, 1988, CELL, V55, P577, DOI 10.1016/0092-8674(88)90216-4; Herpin A, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-99; Herpin A, 2008, DEV BIOL, V320, P319, DOI 10.1016/j.ydbio.2008.03.030; Herpin A, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-3; Herpin A, 2013, MOL BIOL EVOL, V30, P2328, DOI 10.1093/molbev/mst130; Herpin A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000844; Herpin A, 2009, NUCLEIC ACIDS RES, V37, P1510, DOI 10.1093/nar/gkn1065; Hornung U, 2007, SEX DEV, V1, P197, DOI 10.1159/000102108; Johnson AD, 2011, REPRODUCTION, V141, P291, DOI 10.1530/REP-10-0474; Johnson CW, 2012, FUTURE MED CHEM, V4, P1715, DOI [10.4155/FMC.12.112, 10.4155/fmc.12.112]; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Kluver N, 2009, DEV BIOL, V325, P179, DOI 10.1016/j.ydbio.2008.10.009; LASKO PF, 1988, NATURE, V335, P611, DOI 10.1038/335611a0; Leimeister C, 1998, MECH DEVELOP, V75, P29, DOI 10.1016/S0925-4773(98)00072-0; Luo SM, 2013, AUTOPHAGY, V9, P2156, DOI 10.4161/auto.26302; Luo SM, 2013, P NATL ACAD SCI USA, V110, P13038, DOI 10.1073/pnas.1303231110; Mizushima N, 2007, GENE DEV, V21, P2861, DOI 10.1101/gad.1599207; Nakamura S, 2008, DEV GROWTH DIFFER, V50, P415, DOI [10.1111/j.1440-169X.2008.01027.x, 10.1111/j.1440-169x.2008.01027.x]; Nakamura S, 2008, MOL REPROD DEV, V75, P472, DOI 10.1002/mrd.20764; Nezis IP, 2010, J CELL BIOL, V190, P523, DOI 10.1083/jcb.201002035; Nishimura Y, 2006, P NATL ACAD SCI USA, V103, P1382, DOI 10.1073/pnas.0506911103; Politi Y, 2014, DEV CELL, V29, P305, DOI 10.1016/j.devcel.2014.04.005; Sato M, 2011, SCIENCE, V334, P1141, DOI 10.1126/science.1210333; Strome S, 2007, SCIENCE, V316, P392, DOI 10.1126/science.1140846; Tanaka M, 2001, P NATL ACAD SCI USA, V98, P2544, DOI 10.1073/pnas.041315498; Thome RG, 2009, AUTOPHAGY, V5, P117, DOI 10.4161/auto.5.1.7302; Tian Y, 2010, CELL, V141, P1042, DOI 10.1016/j.cell.2010.04.034; Voronina E, 2013, MOL REPROD DEV, V80, P624, DOI 10.1002/mrd.22136; WOLF N, 1983, J EMBRYOL EXP MORPH, V73, P297; Xie ZP, 2007, NAT CELL BIOL, V9, P1102, DOI 10.1038/ncb1007-1102; Yang ZF, 2010, CURR OPIN CELL BIOL, V22, P124, DOI 10.1016/j.ceb.2009.11.014; Yang ZF, 2009, CURR TOP MICROBIOL, V335, P1, DOI 10.1007/978-3-642-00302-8_1; Yordy B, 2011, CURR OPIN VIROL, V1, P196, DOI 10.1016/j.coviro.2011.05.016; Zhang YX, 2009, CELL, V136, P308, DOI 10.1016/j.cell.2008.12.022; Zhao HY, 2013, J CELL BIOL, V200, P731, DOI 10.1083/jcb.201211014; Zhao Y, 2009, AUTOPHAGY, V5, P717, DOI 10.4161/auto.5.5.8552; Zhou QH, 2011, CELL RES, V21, P1662, DOI 10.1038/cr.2011.182; Zhou Y, 2004, IUBMB LIFE, V56, P19, DOI 10.1080/15216540310001658886	48	25	25	0	16	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2015	29	10					4145	4161		10.1096/fj.14-265462	http://dx.doi.org/10.1096/fj.14-265462			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CR5FY	26183773	Green Published			2022-12-26	WOS:000361367300006
J	Ruben, K; Wurzlbauer, A; Walte, A; Sippl, W; Bracher, F; Becker, W				Rueben, Katharina; Wurzlbauer, Anne; Walte, Agnes; Sippl, Wolfgang; Bracher, Franz; Becker, Walter			Selectivity Profiling and Biological Activity of Novel beta-Carbolines as Potent and Selective DYRK1 Kinase Inhibitors	PLOS ONE			English	Article							DOWN-SYNDROME; PROTEIN-KINASES; ALZHEIMERS-DISEASE; DRUG DISCOVERY; MOUSE MODEL; CYCLIN D1; SPECIFICITY; FAMILY; PHOSPHORYLATION; HASPIN	DYRK1A is a pleiotropic protein kinase with diverse functions in cellular regulation, including cell cycle control, neuronal differentiation, and synaptic transmission. Enhanced activity and overexpression of DYRK1A have been linked to altered brain development and function in Down syndrome and neurodegenerative diseases such as Alzheimer's disease. The beta-carboline alkaloid harmine is a high affinity inhibitor of DYRK1A but suffers from the drawback of inhibiting monoamine oxidase A (MAO-A) with even higher potency. Here we characterized a series of novel harmine analogs with minimal or absent MAO-A inhibitory activity. We identified several inhibitors with submicromolar potencies for DYRK1A and selectivity for DYRK1A and DYRK1B over the related kinases DYRK2 and HIPK2. An optimized inhibitor, AnnH75, inhibited CLK1, CLK4, and haspin/GSG2 as the only off-targets in a panel of 300 protein kinases. In cellular assays, AnnH75 dose-dependently reduced the phosphorylation of three known DYRK1A substrates (SF3B1, SEPT4, and tau) without negative effects on cell viability. AnnH75 inhibited the cotranslational tyrosine autophosphorylation of DYRK1A and threonine phosphorylation of an exogenous substrate protein with similar potency. In conclusion, we have characterized an optimized beta-carboline inhibitor as a highly selective chemical probe that complies with desirable properties of drug-like molecules and is suitable to interrogate the function of DYRK1A in biological studies.	[Rueben, Katharina; Walte, Agnes; Becker, Walter] Rhein Westfal TH Aachen, Inst Pharmacol & Toxicol, Aachen, Germany; [Wurzlbauer, Anne; Bracher, Franz] Univ Munich, Ctr Drug Res, Dept Pharm, Munich, Germany; [Sippl, Wolfgang] Univ Halle Wittenberg, Inst Pharm, D-06108 Halle, Germany	RWTH Aachen University; University of Munich; Martin Luther University Halle Wittenberg	Becker, W (corresponding author), Rhein Westfal TH Aachen, Inst Pharmacol & Toxicol, Aachen, Germany.	wbecker@ukaachen.de	Sippl, Wolfgang/P-5944-2014; Becker, Walter/B-8889-2008	Sippl, Wolfgang/0000-0002-5985-9261; Becker, Walter/0000-0002-0347-4768	German Research Foundation (DFG) [BE 1967/3-1, BR 1034/6-1]	German Research Foundation (DFG)(German Research Foundation (DFG))	This work was supported by the German Research Foundation (DFG grants BE 1967/3-1 to WB and BR 1034/6-1 to FB; www.dfg.de).	Adayev T, 2011, ARCH BIOCHEM BIOPHYS, V507, P212, DOI 10.1016/j.abb.2010.12.024; Altafaj X, 2013, NEUROBIOL DIS, V52, P117, DOI 10.1016/j.nbd.2012.11.017; Aranda S, 2011, FASEB J, V25, P449, DOI 10.1096/fj.10-165837; Ashford AL, 2014, BIOCHEM J, V457, P43, DOI 10.1042/BJ20130461; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Becker W, 1998, J BIOL CHEM, V273, P25893, DOI 10.1074/jbc.273.40.25893; Becker W, 2014, CNS NEUROL DISORD-DR, V13, P26, DOI 10.2174/18715273113126660186; Becker W, 2012, CELL CYCLE, V11, P3389, DOI 10.4161/cc.21404; Becker W, 2011, FEBS J, V278, P246, DOI 10.1111/j.1742-4658.2010.07956.x; Cohen P, 2013, ACS CHEM BIOL, V8, P96, DOI 10.1021/cb300610s; Cohen P, 2010, BIOCHEM J, V425, P53, DOI 10.1042/BJ20091428; Coutadeur S, 2015, J NEUROCHEM, V133, P440, DOI 10.1111/jnc.13018; Cozza G, 2013, BBA-PROTEINS PROTEOM, V1834, P1402, DOI 10.1016/j.bbapap.2013.01.018; Cuny GD, 2012, BIOORG MED CHEM LETT, V22, P2015, DOI 10.1016/j.bmcl.2012.01.028; Cuny GD, 2010, BIOORG MED CHEM LETT, V20, P3491, DOI 10.1016/j.bmcl.2010.04.150; Dai J, 2005, GENE DEV, V19, P472, DOI 10.1101/gad.1267105; de Graaf Katrin, 2006, BMC Biochemistry, V7, DOI 10.1186/1471-2091-7-7; De la Torre R, 2014, MOL NUTR FOOD RES, V58, P278, DOI 10.1002/mnfr.201300325; Di Vona C, 2015, MOL CELL, V57, P506, DOI 10.1016/j.molcel.2014.12.026; Dierssen M, 2012, NAT REV NEUROSCI, V13, P844, DOI 10.1038/nrn3314; Drung B, 2014, BIOORG MED CHEM LETT, V24, P4854, DOI 10.1016/j.bmcl.2014.08.054; Eswaran J, 2010, BBA-PROTEINS PROTEOM, V1804, P429, DOI 10.1016/j.bbapap.2009.10.013; Falke H, 2015, J MED CHEM, V58, P3131, DOI 10.1021/jm501994d; Friedman E, 2007, J CELL BIOCHEM, V102, P274, DOI 10.1002/jcb.21451; Frye SV, 2010, NAT CHEM BIOL, V6, P159, DOI 10.1038/nchembio.296; Gao YH, 2013, BIOCHEM J, V451, P313, DOI 10.1042/BJ20121418; Garcia-Cerro S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106572; Ginovart N, 2006, J CEREBR BLOOD F MET, V26, P330, DOI 10.1038/sj.jcbfm.9600197; Gockler N, 2009, FEBS J, V276, P6324, DOI 10.1111/j.1742-4658.2009.07346.x; Graczyk PP, 2007, J MED CHEM, V50, P5773, DOI 10.1021/jm070562u; Hasegawa K, 2012, STEM CELL TRANSL MED, V1, P18, DOI 10.5966/sctm.2011-0033; Hastie CJ, 2006, NAT PROTOC, V1, P968, DOI 10.1038/nprot.2006.149; Higgins JMG, 2010, CHROMOSOMA, V119, P137, DOI 10.1007/s00412-009-0250-4; Himpel S, 2000, J BIOL CHEM, V275, P2431, DOI 10.1074/jbc.275.4.2431; Huertas D, 2012, ONCOGENE, V31, P1408, DOI 10.1038/onc.2011.335; Ionescu A, 2012, MINI-REV MED CHEM, V12, P1315; Keramati AR, 2014, NEW ENGL J MED, V370, P1909, DOI 10.1056/NEJMoa1301824; Knapp S, 2013, NAT CHEM BIOL, V9, P3, DOI 10.1038/nchembio.1113; Knight ZA, 2005, CHEM BIOL, V12, P621, DOI 10.1016/j.chembiol.2005.04.011; Lipinski CA, 1997, ADV DRUG DELIVER REV, V23, P3, DOI 10.1016/S0169-409X(96)00423-1; Lochhead PA, 2005, CELL, V121, P925, DOI 10.1016/j.cell.2005.03.034; Mariano M, 2014, ACS CHEM NEUROSCI, V5, P1198, DOI 10.1021/cn5001815; Ogawa Y, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1090; Ortiz-Abalia J, 2008, AM J HUM GENET, V83, P479, DOI 10.1016/j.ajhg.2008.09.010; Park Joongkyu, 2013, Exp Neurobiol, V22, P244, DOI 10.5607/en.2013.22.4.244; Schmitt C, 2014, ACS MED CHEM LETT, V5, P963, DOI 10.1021/ml500059y; Schmitt C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087851; Sitz JH, 2008, NEUROSCIENCE, V157, P596, DOI 10.1016/j.neuroscience.2008.09.034; Smith B, 2012, ACS CHEM NEUROSCI, V3, P857, DOI 10.1021/cn300094k; Smyth Lynette A, 2009, J Chem Biol, V2, P131, DOI 10.1007/s12154-009-0023-9; Soppa U, 2014, CELL CYCLE, V13, P2084, DOI 10.4161/cc.29104; Stefos GC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067470; Tahtouh T, 2012, J MED CHEM, V55, P9312, DOI 10.1021/jm301034u; Tejedor FJ, 2011, FEBS J, V278, P223, DOI 10.1111/j.1742-4658.2010.07954.x; Walte A, 2013, FEBS J, V280, P4495, DOI 10.1111/febs.12411; Wegiel J, 2011, FEBS J, V278, P236, DOI 10.1111/j.1742-4658.2010.07955.x; Workman P, 2010, CHEM BIOL, V17, P561, DOI 10.1016/j.chembiol.2010.05.013	57	46	46	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2015	10	7							e0132453	10.1371/journal.pone.0132453	http://dx.doi.org/10.1371/journal.pone.0132453			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LN	26192590	Green Published, gold, Green Submitted			2022-12-26	WOS:000358546400026
J	Wu, WT; Lin, YJ; Li, CY; Tsai, PJ; Yang, CY; Liou, SH; Wu, TN				Wu, Wei-Te; Lin, Yu-Jen; Li, Chung-Yi; Tsai, Perng-Jy; Yang, Chun-Yuh; Liou, Saou-Hsing; Wu, Trong-Neng			Cancer Attributable to Asbestos Exposure in Shipbreaking Workers: A Matched-Cohort Study	PLOS ONE			English	Article							SHIPYARD WORKERS; MORTALITY; WELDERS	Purpose Long-term follow-up studies of asbestos-related cancer in shipbreaking workers are lacking. This study examines the relationship between cancer incidence and asbestos exposure among former Taiwan shipbreaking workers. Methods A total of 4,427 shipbreaking workers and 22,135 population-based matched controls were successfully followed in this study. The study cohort was linked to the Taiwan Cancer Registry for new cancer cases. The adjusted hazard ratio (aHR) for cancer was calculated for the shipbreaking workers with Total Exposure Potential Scores (TEP) for asbestos. Results Follow-up generated 109,932 person-years, with 940 deaths and 436 cancer cases, among 4,427 shipbreaking workers from 1985 to 2008. The high asbestos exposure group also had a statistically significant increase in the risk of overall cancer (aHR= 1.71; 95% CI: 1.42-2.05), esophagus cancer (aHR= 2.31; 95% CI: 1.00-5.41), liver and intrahepatic bile duct cancer (aHR= 1.60; 95% CI: 1.08-2.36), and trachea, bronchus, and lung cancer (aHR= 3.08; 95% CI: 1.80-5.25). Mesothelioma cases were found in the high asbestos exposure group. Moreover, overall cancer, esophagus cancer, and trachea, bronchus, and lung cancer were seen in a dose-dependent relationship with asbestos exposure. Conclusions This study presented the elevated trend of asbestos exposure with cancer incidence for overall cancer, esophagus cancer, and trachea, bronchus, and lung cancer among shipbreaking workers. Those workers previously exposed to asbestos should receive persistent monitoring in order to early detect adverse health outcomes.	[Wu, Wei-Te; Yang, Chun-Yuh; Liou, Saou-Hsing; Wu, Trong-Neng] Natl Hlth Res Inst, Natl Inst Environm Hlth Sci, Miaoli, Taiwan; [Lin, Yu-Jen] Natl Taiwan Univ, Inst Occupat Med & Ind Hyg, Taipei 10764, Taiwan; [Li, Chung-Yi] Natl Cheng Kung Univ, Coll Med, Dept Publ Hlth, Tainan 70101, Taiwan; [Tsai, Perng-Jy] Natl Cheng Kung Univ, Coll Med, Dept Environm & Occupat Hlth, Tainan 70101, Taiwan; [Yang, Chun-Yuh] Kaohsiung Med Univ, Inst Publ Hlth, Kaohsiung, Taiwan; [Wu, Trong-Neng] HungKuang Univ, Dept Nursing, Taichung, Taiwan	National Health Research Institutes - Taiwan; National Taiwan University; National Cheng Kung University; National Cheng Kung University; Kaohsiung Medical University; Hungkuang University	Wu, TN (corresponding author), Natl Hlth Res Inst, Natl Inst Environm Hlth Sci, Miaoli, Taiwan.	tnwu@hk.edu.tw	LI, CHUNG-YI/ABI-1419-2020; Wu, Wei-Te/S-8189-2019	LI, CHUNG-YI/0000-0002-0321-8908; 	National Health Research Institutes [EO-101-PP-07]; Institute of Occupational Safety and Health (IOSH), Taiwan, ROC [98-M-507]	National Health Research Institutes(National Health Research Institutes, Japan); Institute of Occupational Safety and Health (IOSH), Taiwan, ROC	This study was partly supported by National Health Research Institutes (EO-101-PP-07) and Institute of Occupational Safety and Health (IOSH 98-M-507), Taiwan, ROC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartrip PWJ, 2004, POSTGRAD MED J, V80, P72, DOI 10.1136/pmj.2003.012526; Beckett WS, 2007, OCCUP ENVIRON MED, V64, DOI 10.1136/oem.2006.032284; Berry G, 2000, OCCUP ENVIRON MED, V57, P782, DOI 10.1136/oem.57.11.782; Bray F, 2009, EUR J CANCER, V45, P747, DOI 10.1016/j.ejca.2008.11.032; Bureau of Health Promotion Ministry of Health and Welfare the Executive Yuan Taiwan, CANC REG ANN REP; Coleman M P, 1993, IARC Sci Publ, P1; dos Santos Silva I, 1999, CANC EPIDEMIOLOGY PR; Hein MJ, 2007, OCCUP ENVIRON MED, V64, P616, DOI 10.1136/oem.2006.031005; Kirkeleit J, 2013, AM J EPIDEMIOL; Krstev S, 2007, OCCUP ENVIRON MED, V64, P651, DOI 10.1136/oem.2006.029652; Ladou J, 2010, ENVIRON HEALTH PERSP, V118, P897, DOI 10.1289/ehp.1002285; Liu YK, 2003, J OCCUP HEALTH, V45, P36, DOI 10.1539/joh.45.36; MELKILD A, 1989, SCAND J WORK ENV HEA, V15, P387, DOI 10.5271/sjweh.1834; Musk AW, 2008, OCCUP ENVIRON MED, V65, P541, DOI 10.1136/oem.2007.034280; PETO J, 1985, ANN OCCUP HYG, V29, P305, DOI 10.1093/annhyg/29.3.305; Puntoni R, 2001, AM J IND MED, V40, P363, DOI 10.1002/ajim.1110; Rushworth DH, 2005, NAV ENG J, V117, P35, DOI 10.1111/j.1559-3584.2005.tb00336.x; SANDEN A, 1987, INT ARCH OCC ENV HEA, V59, P455, DOI 10.1007/BF00377839; Sarraf M., 2010, SHIP BREAKING RECYCL; SELIKOFF IJ, 1991, ANN NY ACAD SCI, V643, P1, DOI 10.1111/j.1749-6632.1991.tb24439.x; Shin Hai-Rim, 2008, J Prev Med Public Health, V41, P84; Shipbuilders Association of Japan, 2012, SHIPB STAT; Straif K, 2009, LANCET ONCOL, V10, P453, DOI 10.1016/S1470-2045(09)70134-2; TOLA S, 1988, BRIT J IND MED, V45, P209; Tsai SP, 2005, TOB CONTROL, V14, pI33, DOI 10.1136/tc.2003.005561; W.H.O. IARC, 2012, IARC MONOGRAPHS EVAL, P219; WHO (World Health Organization), 2006, ASB HIST; Wu WT, 2014, ENVIRON RES, V132, P370, DOI 10.1016/j.envres.2014.04.026; Wu WT, 2013, AM J IND MED, V56, P701, DOI 10.1002/ajim.22135	29	23	23	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2015	10	7							e0133128	10.1371/journal.pone.0133128	http://dx.doi.org/10.1371/journal.pone.0133128			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LN	26192180	gold, Green Published			2022-12-26	WOS:000358546400059
J	Yu, PT; Wang, YH; Coles, N; Xiong, W; Xu, LH				Yu, Pengtao; Wang, Yanhui; Coles, Neil; Xiong, Wei; Xu, Lihong			Simulation of Runoff Changes Caused by Cropland to Forest Conversion in the Upper Yangtze River Region, SW China	PLOS ONE			English	Article							WATER YIELD; CATCHMENT; EVAPOTRANSPIRATION; REDUCTION	The "Grain for Green Project" is a country-wide ecological program to converse marginal cropland to forest, which has been implemented in China since 2002. To quantify influence of this significant vegetation change, Guanslhe Hydrological (GSH) Model, a validated physically-based distributed hydrological model, was applied to simulate runoff responses to land use change in the Guansihe watershed that is located in the upper reaches of the Yangtze River basin in Southwestern China with an area of only 21.1 km2. Runoff responses to two single rainfall events, 90 mm and 206 mm respectively, were simulated for 16 scenarios of cropland to forest conversion. The model simulations indicated that the total runoff generated after conversion to forest was strongly dependent on whether the land was initially used for dry croplands without standing water in fields or constructed (or walled) paddy fields. The simulated total runoff generated from the two rainfall events displayed limited variation for the conversion of dry croplands to forest, while it strongly decreased after paddy fields were converted to forest. The effect of paddy terraces on runoff generation was dependent on the rainfall characteristics and antecedent moisture (or saturation) conditions in the fields. The reduction in simulated runoff generated from intense rainfall events suggested that afforestation and terracing might be effective in managing runoff and had the potential to mitigate flooding in southwestern China.	[Yu, Pengtao; Wang, Yanhui; Xiong, Wei; Xu, Lihong] Chinese Acad Forestry, Res Inst Forest Ecol Environm & Protect, Beijing 100091, Peoples R China; [Coles, Neil] Univ Western Australia, Sch Environm Syst Engn, Ctr Excellence Ecohydrol, Perth, WA 6009, Australia	Chinese Academy of Forestry; Research Institute of Forest Ecology, Environment and Protection, CAF; University of Western Australia	Yu, PT (corresponding author), Chinese Acad Forestry, Res Inst Forest Ecol Environm & Protect, Beijing 100091, Peoples R China.	yupt@caf.ac.cn	xu, li/GNH-3667-2022; Coles, Neil/ABI-2884-2020; Coles, Neil/C-1669-2018; Coles, Neil/D-4027-2011	Coles, Neil/0000-0003-0289-4098; Coles, Neil/0000-0003-0289-4098; Coles, Neil/0000-0003-0289-4098	National Science Foundation of China (NSFC) [91225302]	National Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	The National Science Foundation of China (NSFC #91225302 to P.Y.) granted this work (www.nsfc.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beven K, 1985, HYDROLOGICAL FORECAS, P405; BOSCH JM, 1982, J HYDROL, V55, P3, DOI 10.1016/0022-1694(82)90117-2; Brooks RH, 1964, HYDROLOGY PAPERS COL, V3, DOI DOI 10.13031/2013.40684; Brown AE, 2005, J HYDROL, V310, P28, DOI 10.1016/j.jhydrol.2004.12.010; Calder IR, 2006, WATER INT, V31, P87, DOI 10.1080/02508060608691918; D'Odorico P, 2006, DRYLAND ECOHYDROLOGY, P31, DOI 10.1007/1-4020-4260-4_3; Dye P, 2007, FOREST ECOL MANAG, V251, P121, DOI 10.1016/j.foreco.2007.06.013; FAO, 2000, GLOB FOR RES ASS 200, P140; FAO, 2011, CLIM CHANG WAT FOOD; FAO and CIFOR, 2005, FOR FLOODS DROWN FIC, V2; Farley KA, 2005, GLOBAL CHANGE BIOL, V11, P1565, DOI 10.1111/j.1365-2486.2005.01011.x; Foresight, 2011, FUT FOOD FARM 2011; Gao JX, 2002, THESIS NW AGR FOREST; Hofer T, 2006, FLOODS BANGLADESH HI, P252; Hoffmann WA, 2000, J CLIMATE, V13, P1593, DOI 10.1175/1520-0442(2000)013<1593:VCFITC>2.0.CO;2; Hu ZY, 2003, J SICHUAN FORESTRY S, V24, P17; Jackson RB, 2005, SCIENCE, V310, P1944, DOI 10.1126/science.1119282; Jiao JuYing, 1999, Transactions of the Chinese Society of Agricultural Engineering, V15, P59; Jiao JY, 1999, TERR DEVEL MANAG, V9, P52; Kang LL, 2005, SCI SOIL WATER CONSE, V3, P51; Laurance WF, 2007, NATURE, V449, P409, DOI 10.1038/449409a; Lei XiaoZhang, 2005, Journal of Beijing Forestry University, V27, P20; Lei XZ, 2008, SCI SOIL WATER CONS, V6, P24; Li CZ, 2001, J SOIL WATER CONSERV, V15, P36; Li FuCheng, 2009, Research of Agricultural Modernization, V30, P727; Li YC, 2009, FORESTRY EC, V9, P4; Luo ZS, 2007, ACTA ECOLOGICA SINIC, V27, P1772; McCuen RH, 2006, J HYDROL ENG, V11, P597, DOI 10.1061/(ASCE)1084-0699(2006)11:6(597); PHILIP J. R., 1957, SOIL SCI, V83, P345, DOI 10.1097/00010694-195705000-00002; Qiu GY, 2011, J HYDROL, V411, P120, DOI 10.1016/j.jhydrol.2011.09.040; Roberts S, 2001, FOREST ECOL MANAG, V143, P153, DOI 10.1016/S0378-1127(00)00514-4; Robinson M, 2003, FOREST ECOL MANAG, V186, P85, DOI 10.1016/S0378-1127(03)00238-X; Sun G, 2005, J HYDROL, V308, P258, DOI 10.1016/j.jhydrol.2004.11.021; Sun G, 2008, J AM WATER RESOUR AS, V44, P1164, DOI 10.1111/j.1752-1688.2008.00241.x; Sun G, 2006, J HYDROL, V328, P548, DOI 10.1016/j.jhydrol.2005.12.013; TRIMBLE SW, 1987, WATER RESOUR RES, V23, P425, DOI 10.1029/WR023i003p00425; Vertessy RA, 2001, FOREST ECOL MANAG, V143, P13, DOI 10.1016/S0378-1127(00)00501-6; Wang GY, 2007, SCIENCE, V318, P1556, DOI 10.1126/science.1147247; Wang YH, 2010, EXPLORATION MULTIFUN; Wei XH, 2008, J AM WATER RESOUR AS, V44, P1076, DOI 10.1111/j.1752-1688.2008.00237.x; WHITEHEAD PG, 1993, J HYDROL, V145, P217, DOI 10.1016/0022-1694(93)90055-E; Wilcox BP, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2009GL041929; Wu XX, 2010, J SICHUAN FORESTRY S, V31, P15; WWF (World Wide Fund for Nature), 2003, REP SUGG CHIN GRAIN; Yang JX, 2008, SCI SOIL WATER CONS, V6, P30; Yu PengTao, 2003, Scientia Silvae Sinicae, V39, P1; Yu PT, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2008GL036744; Zhao RJ, 1984, HYDROLOGICAL SIMULAT; Zheng SW, 2009, J SICHUAN FORESTRY S, V30, P50; Zheng SW, 2010, J SICHUAN FORESTRY S, V31, P60	50	18	19	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2015	10	7							e0132395	10.1371/journal.pone.0132395	http://dx.doi.org/10.1371/journal.pone.0132395			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LN	26192181	Green Published, gold, Green Submitted			2022-12-26	WOS:000358546400023
J	de Coul, ELMO; Schreuder, I; Conti, S; van Sighem, A; Xiridou, M; Van Veen, MG; Heijne, JCM				de Coul, Eline L. M. Op; Schreuder, Imke; Conti, Stefano; van Sighem, Ard; Xiridou, Maria; Van Veen, Maaike G.; Heijne, Janneke C. M.			Changing Patterns of Undiagnosed HIV Infection in the Netherlands: Who Benefits Most from Intensified HIV Test and Treat Policies?	PLOS ONE			English	Article							MULTIPARAMETER EVIDENCE SYNTHESIS; PARTNER NOTIFICATION; DRUG-USERS; TRANSMISSION; VIRUS; PREVALENCE; EPIDEMIC; UNAWARE; DECLINE; AWARE	Objectives To estimate HIV prevalence, the number of people living with HIV/AIDS (PLWHA) and the undiagnosed proportion in the Netherlands for 2012, and to compare these with published 2007 estimates. Design Synthesis of all available data sources. Methods Multi-Parameter Evidence Synthesis (MPES) was used to obtain estimates in mutually exclusive key populations at higher risk in three geographical regions (Amsterdam, Rotterdam, rest of the Netherlands). Data sources included HIV prevalence surveys, diagnoses at STI clinics, and registered cases in HIV care. Group specific estimates were reported as Bayesian posterior medians and 95% credible intervals (CrI). Results The 2012 model estimated 24,350 PLWHA (95% CrI 20,420-31,280) aged 15-70 years; 2,906 (+14%) more than in 2007. The estimated population HIV prevalence was 0.20% (95% CrI 0.17-0.26%). The overall proportion of undiagnosed HIV was lower in 2012 (34%, 95% CrI 22-49%) compared to 2007 (40%, 95% CrI 25-55%). After MSM, migrants from sub-Saharan Africa and the Caribbean formed the largest groups of PLWHA, but proportions of undiagnosed HIV remained high in these groups, 48% and 44% respectively. Amsterdam had lowest proportions undiagnosed for most key populations at higher risk, including MSM and migrants. Conclusions In 2012, the number of PLWHA was higher compared to 2007, while the proportion of undiagnosed HIV was lower, especially among MSM. Higher HIV testing rates, earlier treatment, and an improved life expectancy may explain these differences. HIV interventions need to be expanded in all key populations at higher risk, with special focus on migrants and key populationsliving outside of Amsterdam.	[de Coul, Eline L. M. Op; Schreuder, Imke; Xiridou, Maria; Heijne, Janneke C. M.] Natl Inst Publ Hlth & Environm, Ctr Infect Dis Control, NL-3720 BA Bilthoven, Netherlands; [Schreuder, Imke] Erasmus MC, Dept ViroSci, Rotterdam, Netherlands; [Conti, Stefano] Publ Hlth England, Stat Modelling & Econ Dept, London, England; [van Sighem, Ard] Stichting HIV Monitoring, Amsterdam, Netherlands; [Van Veen, Maaike G.] Amsterdam Hlth Serv, STI Clin Dept, Cluster Infect Dis, Amsterdam, Netherlands	Netherlands National Institute for Public Health & the Environment; Erasmus University Rotterdam; Erasmus MC; Public Health England	Heijne, JCM (corresponding author), Natl Inst Publ Hlth & Environm, Ctr Infect Dis Control, NL-3720 BA Bilthoven, Netherlands.	janneke.heijne@rivm.nl			Netherlands Ministry of Health, Welfare and Sport; Gilead Sciences; ViiV Healthcare; Bristol-Myers Squibb	Netherlands Ministry of Health, Welfare and Sport; Gilead Sciences(Gilead Sciences); ViiV Healthcare; Bristol-Myers Squibb(Bristol-Myers Squibb)	Stichting HIV Monitoring is supported by a grant of the Netherlands Ministry of Health, Welfare and Sport. Ard van Sighem has received travel grants and honoraria to his institution from Gilead Sciences, ViiV Healthcare, and Bristol-Myers Squibb. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ades AE, 2006, J R STAT SOC A STAT, V169, P5, DOI 10.1111/j.1467-985X.2005.00377.x; [Anonymous], 2012, GLOB REP UNAIDS REP; [Anonymous], 2013, UNAIDS REP GLOB AIDS; Bezemer D, 2008, AIDS, V22, P1071, DOI 10.1097/QAD.0b013e3282fd167c; Brenner BG, 2007, J INFECT DIS, V195, P951, DOI 10.1086/512088; Centers for Disease Control and Prevention, 2012, HIV SURVEILLANCE R S, V17; Conti S, 2011, ANN APPL STAT, V5, P2359, DOI 10.1214/11-AOAS488; de Vos AS, 2013, ADDICTION, V108, P1070, DOI 10.1111/add.12125; Dukers-Muijrers NHTM, 2009, SEX TRANSM INFECT, V85, P226, DOI 10.1136/sti.2008.033191; Dutch Association of HIV-treating physicians, START TREATM; EMCDDA, 2013, EUR DRUG REP TRENDS; Gotz HM, 2014, SEX TRANSM INFECT, V90, P195, DOI 10.1136/sextrans-2013-051254; Guy RJ, 2008, SEX HEALTH, V5, P91, DOI 10.1071/SH07070; Haasnoot A, 2012, EPIDEMIOL INFECT, V140, P951, DOI 10.1017/S0950268811001336; Hall HI, 2012, AIDS, V26, P893, DOI 10.1097/QAD.0b013e328351f73f; Heijman RLJ, 2009, SEX TRANSM INFECT, V85, P249, DOI 10.1136/sti.2008.033258; Heijnen A, 2013, SEKSHAG EXPERTGROUP; Hospers HJ, 2006, SCHORER MONITOR 2006; Lange JMA, 2013, CLIN INFECT DIS, V57, P1048, DOI 10.1093/cid/cit425; Lunn DJ, 2000, STAT COMPUT, V10, P325, DOI 10.1023/A:1008929526011; Marks G, 2006, AIDS, V20, P1447, DOI 10.1097/01.aids.0000233579.79714.8d; Mocroft A, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001510; Op de Coul ELM, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-185; Op de Coul ELM, 2014, 8 NETH C HIV PATH EP; Presanis AM, 2010, AIDS, V24, P2849, DOI 10.1097/QAD.0b013e32834021ed; Sanquin, SANQ ANN REP 2012; SOA AIDS Nederland, 2013, STRAT AANP SOAS HIV; Soetens LC, 2013, SEXUALLY TRANSMITTED; Van Aar F, 2014, SEXUALLY TRANSMITTED; van Aar F, 2014, 8 NETH C HIV PATH EP; van Aar F, 2015, INT J STD AIDS, V26, P565, DOI 10.1177/0956462414547398; van Aar F, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-114; van Beek P, 2013, PROGRAMMA BERICHT EX; van den Berg CHSB, 2007, EUR J EPIDEMIOL, V22, P183, DOI 10.1007/s10654-006-9089-7; van empelen P, 2011, SCHORER MONITOR 2011; van Sighem A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044819; van Veen MG, 2011, AIDS, V25, P229, DOI 10.1097/QAD.0b013e32834171bc; van-Sighem A, 2013, MONITORING REPORT 20; Walker N, 2004, SEX TRANSM INFECT, V80, DOI 10.1136/sti.2004.010207; Zuilhof W, 2009, SEKSOA MAGAZINE	40	23	23	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0133232	10.1371/journal.pone.0133232	http://dx.doi.org/10.1371/journal.pone.0133232			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RV	26185998	Green Published, Green Submitted, gold			2022-12-26	WOS:000358198700113
J	Zhao, L; Liu, S; Wang, Y; Zhang, QY; Zhao, WJ; Wang, ZJ; Yin, M				Zhao, Lu; Liu, Sha; Wang, Yin; Zhang, Qiaoyan; Zhao, Wenjuan; Wang, Zejian; Yin, Ming			Effects of Curculigoside on Memory Impairment and Bone Loss via Anti-Oxidative Character in APP/PS1 Mutated Transgenic Mice	PLOS ONE			English	Article							NF-KAPPA-B; ALZHEIMERS-DISEASE; OXIDATIVE STRESS; AMYLOID-BETA; POSTMENOPAUSAL OSTEOPOROSIS; LIPID-PEROXIDATION; NITRIC-OXIDE; DIFFERENTIATION; ORCHIOIDES; OSTEOBLASTS	Alzheimer's disease (AD) and osteoporosis are two closely related multifactorial progressively degenerative diseases that predominantly affect aged people. These two diseases share many common risk factors, including old age, being female, smoking, excessive drinking, low estrogen, and vitamin D3 levels. Additionally, oxidative damage and the dysfunction of the antioxidant system play important roles in the pathogenesis of osteoporosis and AD. A beta not only leads to impaired memory but also plays a crucial role in the demineralization process of bone tissues of older people and women with menopause. Curculigoside can promote calcium deposition and increase the levels of ALP and Runx2 in osteoblasts under oxidative stress via anti-oxidative character. Therefore, we investigated the effects of CUR on the spatial learning and memory by the Morris water maze and brain immunohistochemistry, and bone microstructure and material properties of femurs by micro-computed tomography and mechanical testing in APP/PS1 mutated transgenic mice. Oral administration of CUR can significantly enhance learning performance and ameliorate bone loss in APP/PS1 mutated transgenic mice, and the mechanism may be related to its antioxidant effect. Based on these results, CUR has real potential as a new natural resource for developing medicines or dietary supplements for the prevention and treatment of the two closely linked multifactorial progressive degenerative disorders, AD and osteoporosis.	[Zhao, Lu; Zhao, Wenjuan; Wang, Zejian; Yin, Ming] Shanghai Jiao Tong Univ, Sch Pharm, Shanghai 200030, Peoples R China; [Wang, Yin] PLA 455 Hosp, Shanghai, Peoples R China; [Liu, Sha] Chengdu Med Coll, Sch Pharm, Dept Pharmacol, Chengdu, Sichuan, Peoples R China; [Zhang, Qiaoyan] Second Mil Med Univ, Sch Pharm, Shanghai, Peoples R China	Shanghai Jiao Tong University; Chengdu Medical College; Naval Medical University	Wang, ZJ (corresponding author), Shanghai Jiao Tong Univ, Sch Pharm, Shanghai 200030, Peoples R China.	wangzejian@sjtu.edu.cn; myin@sjtu.edu.cn			National Natural Science Foundation of China [81274152]; natural science foundation of Shanghai science and Technology Commission, China [13ZR1449600]; scientific research fund of Shanghai City Health Planning Commission, China [2013299]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); natural science foundation of Shanghai science and Technology Commission, China; scientific research fund of Shanghai City Health Planning Commission, China	This study was supported by the grants from the National Natural Science Foundation of China (Grant No. 81274152), the natural science foundation of Shanghai science and Technology Commission, China (Grant No. 13ZR1449600), and the scientific research fund of Shanghai City Health Planning Commission, China (Grant No. 2013299).	Almeida M, 2007, J BIOL CHEM, V282, P27285, DOI 10.1074/jbc.M702810200; Bai XC, 2004, BIOCHEM BIOPH RES CO, V314, P197, DOI 10.1016/j.bbrc.2003.12.073; Belkacemi A, 2012, FREE RADICAL BIO MED, V52, P593, DOI 10.1016/j.freeradbiomed.2011.11.020; Tung BT, 2015, EXP GERONTOL, V64, P1, DOI 10.1016/j.exger.2015.02.004; CALABRESE V, 2014, EXPT PHARM DRUG DISC, V5, P120; Cao Q, 2014, BIOMATERIALS, V35, P8273, DOI 10.1016/j.biomaterials.2014.06.020; Chen G, 2015, BIOL PHARM B; Garnero P, 1996, J BONE MINER RES, V11, P337, DOI 10.1002/jbmr.5650110307; Garnero P, 2014, BONE, V66, P46, DOI 10.1016/j.bone.2014.05.016; Gouras GK, 2014, NEUROTHERAPEUTICS, P1; Jagger CJ, 2005, ENDOCRINOLOGY, V146, P113, DOI 10.1210/en.2004-1058; Jia P, 2012, J ORTHOP RES, V30, P1843, DOI 10.1002/jor.22133; Jiao L, 2009, PHYTOMEDICINE, V16, P874, DOI 10.1016/j.phymed.2009.01.005; Kang Z, 2014, NEUROSCIENCE, V267, P232, DOI 10.1016/j.neuroscience.2014.02.050; Lakshmi V, 2003, J ETHNOPHARMACOL, V89, P181, DOI 10.1016/S0378-8741(03)00160-0; Lalonde R, 2012, REV NEUROSCIENCE, V23, P363, DOI 10.1515/revneuro-2012-0041; LENARDO MJ, 1989, CELL, V58, P227, DOI 10.1016/0092-8674(89)90833-7; Li SF, 2014, BONE, V61, P164, DOI 10.1016/j.bone.2014.01.010; Lin TW, 2015, NEUROBIOL LEARN MEM, V118, P189, DOI 10.1016/j.nlm.2014.12.005; Liraz O, 2013, MOL NEURODEGENER, V8, DOI 10.1186/1750-1326-8-16; Liu Lei, 2012, Zhong Xi Yi Jie He Xue Bao, V10, P1419, DOI 10.3736/jcim20121214; Liu MM, 2014, STEM CELLS DEV, V23, P146, DOI 10.1089/scd.2013.0261; Manolagas SC, 2010, ENDOCR REV, V31, P266, DOI 10.1210/er.2009-0024; Melville KM, 2014, J BONE MINER RES, V29, P370, DOI 10.1002/jbmr.2082; Mlakar SJ, 2012, MENOPAUSE, V19, P368, DOI 10.1097/gme.0b013e31822d5b10; Morley JE, 2014, BIOCHEM PHARMACOL, V88, P479, DOI 10.1016/j.bcp.2013.12.018; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; Ozgocmen S, 2007, ARCH MED RES, V38, P196, DOI 10.1016/j.arcmed.2006.09.010; Ozgocmen S, 2007, MOL CELL BIOCHEM, V295, P45, DOI 10.1007/s11010-006-9270-z; PECK WA, 1993, AM J MED, V94, P646; Salminen A, 2008, AGEING RES REV, V7, P83, DOI 10.1016/j.arr.2007.09.002; Sato Y, 2004, J NEUROL SCI, V223, P107, DOI 10.1016/j.jns.2004.03.033; Shen GS, 2014, CALCIFIED TISSUE INT, V94, P632, DOI 10.1007/s00223-014-9845-8; Steeve KT, 2004, CYTOKINE GROWTH F R, V15, P49, DOI 10.1016/j.cytogfr.2003.10.005; Tian Z, 2012, FOOD CHEM TOXICOL, V50, P4010, DOI 10.1016/j.fct.2012.08.006; Toth P., 2015, AGING CELL; Wang Y, 2012, ACTA BIOCH BIOPH SIN, V44, P431, DOI 10.1093/abbs/gms014; Wang YK, 2010, J ETHNOPHARMACOL, V132, P233, DOI 10.1016/j.jep.2010.08.008; [吴琼 WU Qiong], 2007, [中国现代应用药学, Chinese Journal of Modern Applied Pharmacy], V24, P6; Wu XY, 2012, MOLECULES, V17, P10108, DOI 10.3390/molecules170910108; Xia WF, 2013, J BONE MINER RES, V28, P2122, DOI 10.1002/jbmr.1954; Zhao Y, 2013, OXIDATIVE STRESS AND, V2013	42	17	24	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0133289	10.1371/journal.pone.0133289	http://dx.doi.org/10.1371/journal.pone.0133289			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RV	26186010	Green Submitted, gold, Green Published			2022-12-26	WOS:000358198700121
J	Lopper, ME; Boone, J; Morrow, C				Lopper, Matthew E.; Boone, Jacob; Morrow, Christopher			Deinococcus radiodurans PriA is a Pseudohelicase	PLOS ONE			English	Article							SINGLE-STRANDED-DNA; STALLED REPLICATION FORKS; PHI X174-TYPE PRIMOSOME; ESCHERICHIA-COLI K-12; FACTOR-Y; PROTEIN; HELICASE; BINDING; RESTART; REPAIR	Reactivation of repaired DNA replication forks in bacteria is catalyzed by PriA helicase. This broadly-conserved bacterial enzyme can remodel the structure of DNA at a repaired DNA replication fork by unwinding small portions of duplex DNA to prepare the fork for replisome reloading. While PriA's helicase activity is not strictly required for cell viability in E. coli, the sequence motifs that confer helicase activity upon PriA are well-conserved among sequenced bacterial priA genes, suggesting that PriA's duplex DNA unwinding activity confers a selective advantage upon cells. However, these helicase sequence motifs are not well-conserved among priA genes from the Deinococcus-Thermus phylum. Here, we show that PriA from a highly radiation-resistant member of that phylum, Deinococcus radiodurans, lacks the ability to hydrolyze ATP and unwind duplex DNA, thus qualifying D. radiodurans PriA as a pseudohelicase. Despite the lack of helicase activity, D. radiodurans PriA has retained the DNA binding activity expected of a typical PriA helicase, and we present evidence for a physical interaction between D. radiodurans PriA and its cognate replicative helicase, DnaB. This suggests that PriA has retained a role in replisome reloading onto repaired DNA replication forks in D. radiodurans despite its lack of helicase activity.	[Lopper, Matthew E.; Boone, Jacob; Morrow, Christopher] Univ Dayton, Dept Chem, Dayton, OH 45469 USA	University of Dayton	Lopper, ME (corresponding author), Univ Dayton, Dept Chem, Dayton, OH 45469 USA.	mlopper1@udayton.edu		Morrow, Christopher/0000-0002-9208-2511	University of Dayton Honors Program	University of Dayton Honors Program	JB and CM were supported by the University of Dayton Honors Program.	BROSH RM, 1995, J BACTERIOL, V177, P5612, DOI 10.1128/jb.177.19.5612-5621.1995; Cox MM, 2001, ANNU REV GENET, V35, P53, DOI 10.1146/annurev.genet.35.102401.090016; Cox MM, 2000, NATURE, V404, P37, DOI 10.1038/35003501; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Feng C, 2011, BMC MICROBIOL, V11, DOI [10.1186/1471-2180-11-189, 10.1186/1471-2229-11-136]; Galletto R, 2004, BIOCHEMISTRY-US, V43, P11002, DOI 10.1021/bi049378q; GORBALENYA AE, 1993, CURR OPIN STRUC BIOL, V3, P419, DOI 10.1016/S0959-440X(05)80116-2; Heller RC, 2005, MOL CELL, V17, P733, DOI 10.1016/j.molcel.2005.01.019; Heller RC, 2006, NAT REV MOL CELL BIO, V7, P932, DOI 10.1038/nrm2058; Jezewska MJ, 2000, J BIOL CHEM, V275, P27865; Jezewska MJ, 2000, BIOCHEMISTRY-US, V39, P10454, DOI 10.1021/bi001113y; Kogoma T, 1996, J BACTERIOL, V178, P1258, DOI 10.1128/jb.178.5.1258-1264.1996; LEE MS, 1987, P NATL ACAD SCI USA, V84, P8345, DOI 10.1073/pnas.84.23.8345; LINDER P, 1989, NATURE, V337, P121, DOI 10.1038/337121a0; Liu J, 1996, J BIOL CHEM, V271, P15656, DOI 10.1074/jbc.271.26.15656; Lopper M, 2007, MOL CELL, V26, P781, DOI 10.1016/j.molcel.2007.05.012; MORRICAL SW, 1986, BIOCHEMISTRY-US, V25, P1482, DOI 10.1021/bi00355a003; Ng JY, 1996, J BIOL CHEM, V271, P15642, DOI 10.1074/jbc.271.26.15642; NURSE P, 1990, P NATL ACAD SCI USA, V87, P4615, DOI 10.1073/pnas.87.12.4615; Pace C N, 1986, Methods Enzymol, V131, P266; Sandler SJ, 2000, GENETICS, V155, P487; Sandler SJ, 1996, GENETICS, V143, P5; SCHEKMAN R, 1975, J BIOL CHEM, V250, P5859; SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x; WICKNER S, 1974, P NATL ACAD SCI USA, V71, P4120, DOI 10.1073/pnas.71.10.4120; WICKNER S, 1975, P NATL ACAD SCI USA, V72, P3342, DOI 10.1073/pnas.72.9.3342; ZAVITZ KH, 1992, J BIOL CHEM, V267, P6933	28	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2015	10	7							e0133419	10.1371/journal.pone.0133419	http://dx.doi.org/10.1371/journal.pone.0133419			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RQ	26182205	gold, Green Submitted, Green Published			2022-12-26	WOS:000358198200064
J	Moreno-Garcia, M; Vargas, V; Ramirez-Bello, I; Hernandez-Martinez, G; Lanz-Mendoza, H				Moreno-Garcia, Miguel; Vargas, Valeria; Ramirez-Bello, Inci; Hernandez-Martinez, Guadalupe; Lanz-Mendoza, Humberto			Bacterial Exposure at the Larval Stage Induced Sexual Immune Dimorphism and Priming in Adult Aedes aegypti Mosquitoes	PLOS ONE			English	Article							MESSENGER-RNA EXPRESSION; YELLOW-FEVER MOSQUITO; ESCHERICHIA-COLI; NITRIC-OXIDE; TRADE-OFFS; ANTIBACTERIAL DEFENSE; BATEMANS PRINCIPLE; INFECTION; SYSTEM; INSECT	Gender differences in the immune response of insects are driven by natural selection for females and sexual selection for males. These natural forces entail a multitude of extrinsic and intrinsic factors involved in a genotype-environment interaction that results in sex-biased expression of the genes shared by males and females. However, little is known about how an infection at a particular ontogenetic stage may influence later stages, or how it may impact sexual immune dimorphism. Using Aedes aegypti mosquitoes, the aim of the present study was to analyze the effect of a bacterial exposure at the larval stage on adult immunity in males and females. The parameters measured were phenoloxidase activity, nitric oxide production, antimicrobial activity, and the antimicrobial peptide transcript response. As a measure of the immune response success, the persistence of injected bacteria was also evaluated. The results show that males, as well as females, were able to enhance survival in the adult stage as a result of being exposed at the larval stage, which indicates a priming effect. Moreover, there was a differential gender immune response, evidenced by higher PO activity in males as well as higher NO production and greater antimicrobial activity in females. The greater bacterial persistence in females suggests a gender-specific strategy for protection after a previous experience with an elicitor. Hence, this study provides a primary characterization of the complex and gender-specific immune response of male and female adults against a bacterial challenge in mosquitoes primed at an early ontogenetic stage.	[Moreno-Garcia, Miguel; Vargas, Valeria; Ramirez-Bello, Inci; Hernandez-Martinez, Guadalupe; Lanz-Mendoza, Humberto] Inst Nacl Salud Publ, Ctr Invest Enfermedades Infecciosas, Cuernavaca 62100, Morelos, Mexico; [Vargas, Valeria] Univ Nacl Autonoma Mexico, Ciencias Biol, Mexico City 04510, DF, Mexico	Instituto Nacional de Salud Publica; Universidad Nacional Autonoma de Mexico	Moreno-Garcia, M (corresponding author), Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA.	miguelmoga2000@yahoo.com.mx; humberto@insp.mx	Lanz-Mendoza, Humberto/GLV-1737-2022	MORENO-GARCIA, MIGUEL/0000-0001-6733-9007; Vargas, Valeria/0000-0003-3657-2708	Programa Nacional de Posgrado de Calidad, SEP-CONACYT [290662 INSP]; Fondo Sectorial de Investigacion para la Educacion SEP-CONACYT [Proyect: 183027]; Posgrado en Ciencias Biologicas (CONACYT) [269766]; Comision Coordinadora de Institutos Nacionales de Salud y Hospitales de Alta Especialidad, Secretaria de Salud, Mexico (Programas de Becas de Inicio a la Investigacion grant)	Programa Nacional de Posgrado de Calidad, SEP-CONACYT; Fondo Sectorial de Investigacion para la Educacion SEP-CONACYT; Posgrado en Ciencias Biologicas (CONACYT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Comision Coordinadora de Institutos Nacionales de Salud y Hospitales de Alta Especialidad, Secretaria de Salud, Mexico (Programas de Becas de Inicio a la Investigacion grant)	MM-G received a posdoctoral fellowship (Programa Nacional de Posgrado de Calidad, SEP-CONACYT; 290662 INSP) and Fondo Sectorial de Investigacion para la Educacion SEP-CONACYT (Proyect: 183027). VV received Posgrado en Ciencias Biologicas (CONACYT MsC grant No. 269766. IR-B received Comision Coordinadora de Institutos Nacionales de Salud y Hospitales de Alta Especialidad, Secretaria de Salud, Mexico (Programas de Becas de Inicio a la Investigacion grant). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamo SA, 2004, ANIM BEHAV, V68, P1443, DOI 10.1016/j.anbehav.2004.05.005; Adamo SA, 2001, ANIM BEHAV, V62, P417, DOI 10.1006/anbe.2001.1786; Altincicek B, 2011, DEV COMP IMMUNOL, V35, P1089, DOI 10.1016/j.dci.2011.03.017; Arbeitman MN, 2002, SCIENCE, V297, P2270, DOI 10.1126/science.1072152; Bartholomay LC, 2007, INSECT MOL BIOL, V16, P761, DOI 10.1111/j.1365-2583.2007.00773.x; Bartholomay LC, 2004, INSECT MOL BIOL, V13, P125, DOI 10.1111/j.0962-1075.2004.00467.x; BOMAN HG, 1972, NATURE, V237, P232, DOI 10.1038/237232a0; Bulet P, 2004, IMMUNOL REV, V198, P169, DOI 10.1111/j.0105-2896.2004.0124.x; Castillo J, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002274; Choi YJ, 2012, INSECT BIOCHEM MOLEC, V42, P729, DOI 10.1016/j.ibmb.2012.06.005; Clements AN., 1992, BIOL MOSQUITOES DEV; Coggins SA, 2012, DEV COMP IMMUNOL, V37, P390, DOI 10.1016/j.dci.2012.01.005; Contreras-Garduno J, 2014, MICROBES INFECT, V16, P261, DOI 10.1016/j.micinf.2013.11.010; Contreras-Garduno J, 2015, DEV COMP IMMUNOL, V52, P172, DOI 10.1016/j.dci.2015.05.004; Cotter SC, 2004, J EVOLUTION BIOL, V17, P421, DOI 10.1046/j.1420-9101.2003.00655.x; Dada N, 2013, ACTA TROP, V126, P177, DOI 10.1016/j.actatropica.2013.02.023; Dong YM, 2006, PLOS BIOL, V4, P1137, DOI 10.1371/journal.pbio.0040229; Dubovskiy IM, 2008, J INVERTEBR PATHOL, V98, P360, DOI 10.1016/j.jip.2008.03.011; DYE C, 1992, ANNU REV ENTOMOL, V37, P1, DOI 10.1146/annurev.en.37.010192.000245; Eleftherianos I, 2006, INSECT BIOCHEM MOLEC, V36, P517, DOI 10.1016/j.ibmb.2006.04.001; Fellowes MDE, 1998, P ROY SOC B-BIOL SCI, V265, P1553, DOI 10.1098/rspb.1998.0471; Ferguson HM, 2005, TRENDS ECOL EVOL, V20, P202, DOI 10.1016/j.tree.2005.02.003; Freitak D, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-56; Gonzalez-Santoyo I, 2012, ENTOMOL EXP APPL, V142, P1, DOI 10.1111/j.1570-7458.2011.01187.x; Haine ER, 2008, SCIENCE, V322, P1257, DOI 10.1126/science.1165265; Hernandez-Martinez S, 2002, J MED ENTOMOL, V39, P61, DOI 10.1603/0022-2585-39.1.61; Hillyer JF, 2004, MICROBES INFECT, V6, P448, DOI 10.1016/j.micinf.2004.01.005; Hillyer JF, 2005, CELL MICROBIOL, V7, P39, DOI 10.1111/j.1462-5822.2004.00430.x; Hillyer JF, 2010, DEV COMP IMMUNOL, V34, P141, DOI 10.1016/j.dci.2009.08.014; Jacot A, 2005, P ROY SOC B-BIOL SCI, V272, P63, DOI 10.1098/rspb.2004.2919; King JG, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-55; Lazzaro BP, 2001, GENETICS, V159, P659; LECLAIRE M, 1994, OECOLOGIA, V100, P379, DOI 10.1007/BF00317858; Lowenberger C, 1999, J BIOL CHEM, V274, P20092, DOI 10.1074/jbc.274.29.20092; Lowenberger C, 2001, INSECT BIOCHEM MOLEC, V31, P219, DOI 10.1016/S0965-1748(00)00141-7; Luplertlop N, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001252; McKean KA, 2005, EVOLUTION, V59, P1510; MERRITT RW, 1992, ANNU REV ENTOMOL, V37, P349, DOI 10.1146/annurev.en.37.010192.002025; Metcalfe NB, 2001, TRENDS ECOL EVOL, V16, P254, DOI 10.1016/S0169-5347(01)02124-3; Moreno-Garcia M, 2013, B ENTOMOL RES, V103, P127, DOI 10.1017/S000748531200048X; Moreno-Garcia M, 2010, J MED ENTOMOL, V47, P111, DOI 10.1603/ME08267; Moret Y, 2006, P R SOC B, V273, P1399, DOI 10.1098/rspb.2006.3465; Muller U, 1997, PROG NEUROBIOL, V51, P363, DOI 10.1016/S0301-0082(96)00067-6; Natori Shunji, 1998, P245; Ottaviani E, 2015, ISJ-INVERT SURVIV J, V12, P1; Pham LN, 2007, PLOS PATHOG, V3, DOI 10.1371/journal.ppat.0030026; Ponlawat A, 2009, AM J TROP MED HYG, V80, P395, DOI 10.4269/ajtmh.2009.80.395; Ramirez JL, 2014, J INNATE IMMUN, V6, P119, DOI 10.1159/000353765; Ramirez JL, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001561; Ramos-Castaneda J, 2008, INTERVIROLOGY, V51, P335, DOI 10.1159/000175639; Rances E, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002548; Rantala MJ, 2006, J EVOLUTION BIOL, V19, P834, DOI 10.1111/j.1420-9101.2005.01048.x; Rice WR, 2001, J EVOLUTION BIOL, V14, P685, DOI 10.1046/j.1420-9101.2001.00319.x; Rivero A, 2006, TRENDS PARASITOL, V22, P219, DOI 10.1016/j.pt.2006.02.014; Rodrigues J, 2010, SCIENCE, V329, P1353, DOI 10.1126/science.1190689; Rolff J, 2002, P ROY SOC B-BIOL SCI, V269, P867, DOI 10.1098/rspb.2002.1959; Rolff J, 2004, P ROY SOC B-BIOL SCI, V271, P2157, DOI 10.1098/rspb.2004.2859; Sadd B, 2006, J EVOLUTION BIOL, V19, P321, DOI 10.1111/j.1420-9101.2005.01062.x; Schmid-Hempel P, 2003, TRENDS ECOL EVOL, V18, P27, DOI 10.1016/S0169-5347(02)00013-7; Schulenburg H, 2009, PHILOS T R SOC B, V364, P3, DOI 10.1098/rstb.2008.0249; Schwartz A, 2004, J EVOLUTION BIOL, V17, P834, DOI 10.1111/j.1420-9101.2004.00720.x; Siva-Jothy MT, 2002, PHYSIOL ENTOMOL, V27, P206, DOI 10.1046/j.1365-3032.2002.00286.x; Soderhall K, 1998, CURR OPIN IMMUNOL, V10, P23, DOI 10.1016/S0952-7915(98)80026-5; Srygley RB, 2012, J INSECT PHYSIOL, V58, P342, DOI 10.1016/j.jinsphys.2011.12.005; Tate AT, 2012, OIKOS, V121, P1083, DOI 10.1111/j.1600-0706.2011.19725.x; Thomas AM, 2010, ECOL ENTOMOL, V35, P200, DOI 10.1111/j.1365-2311.2009.01169.x; Tidbury HJ, 2011, P ROY SOC B-BIOL SCI, V278, P871, DOI 10.1098/rspb.2010.1517; Voordouw MJ, 2008, OIKOS, V117, P1269, DOI 10.1111/j.0030-1299.2008.16741.x; WALKER ED, 1991, ECOLOGY, V72, P1529, DOI 10.2307/1940953; Wang JJ, 2013, DEV COMP IMMUNOL, V40, P142, DOI 10.1016/j.dci.2013.02.003; Zuk M, 1996, INT J PARASITOL, V26, P1009, DOI [10.1016/S0020-7519(96)00086-0, 10.1016/S0020-7519(96)80001-4]	73	34	36	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2015	10	7							e0133240	10.1371/journal.pone.0133240	http://dx.doi.org/10.1371/journal.pone.0133240			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RQ	26181517	gold, Green Published, Green Submitted			2022-12-26	WOS:000358198200060
J	Ratliff, EP; Mauntz, RE; Kotzebue, RW; Gonzalez, A; Achal, M; Barekat, A; Finley, KA; Sparhawk, JM; Robinson, JE; Herr, DR; Harris, GL; Joiner, WJ; Finley, KD				Ratliff, Eric P.; Mauntz, Ruth E.; Kotzebue, Roxanne W.; Gonzalez, Arysa; Achal, Madhulika; Barekat, Ayeh; Finley, Kaelyn A.; Sparhawk, Jonathan M.; Robinson, James E.; Herr, Deron R.; Harris, Greg L.; Joiner, William J.; Finley, Kim D.			Aging and Autophagic Function Influences the Progressive Decline of Adult Drosophila Behaviors	PLOS ONE			English	Article							BINDING-PROTEIN GENES; CIRCADIAN-RHYTHMS; SLEEP; MELANOGASTER; SYSTEM; MEMORY; MODEL; NEURODEGENERATION; DISSATISFACTION; HEALTHSPAN	Multiple neurological disorders are characterized by the abnormal accumulation of protein aggregates and the progressive impairment of complex behaviors. Our Drosophila studies demonstrate that middle-aged wild-type flies (WT, similar to 4-weeks) exhibit a marked accumulation of neural aggregates that is commensurate with the decline of the autophagy pathway. However, enhancing autophagy via neuronal over-expression of Atg8a (Atg8a-OE) reduces the age-dependent accumulation of aggregates. Here we assess basal locomotor activity profiles for single- and group-housed male and female WT flies and observed that only modest behavioral changes occurred by 4-weeks of age, with the noted exception of group-housed male flies. Male flies in same-sex social groups exhibit a progressive increase in nighttime activity. Infrared videos show aged group-housed males (4-weeks) are engaged in extensive bouts of courtship during periods of darkness, which is partly repressed during lighted conditions. Together, these nighttime courtship behaviors were nearly absent in young WT flies and aged Atg8a-OE flies. Previous studies have indicated a regulatory role for olfaction in male courtship partner choice. Coincidently, the mRNA expression profiles of several olfactory genes decline with age in WT flies; however, they are maintained in age-matched Atg8a-OE flies. Together, these results suggest that middle-aged male flies develop impairments in olfaction, which could contribute to the dysregulation of courtship behaviors during dark time periods. Combined, our results demonstrate that as Drosophila age, they develop early behavior defects that are coordinate with protein aggregate accumulation in the nervous system. In addition, the nighttime activity behavior is preserved when neuronal autophagy is maintained (Atg8a-OE flies). Thus, environmental or genetic factors that modify autophagic capacity could have a positive impact on neuronal aging and complex behaviors.	[Ratliff, Eric P.; Mauntz, Ruth E.; Kotzebue, Roxanne W.; Gonzalez, Arysa; Achal, Madhulika; Barekat, Ayeh; Finley, Kaelyn A.; Sparhawk, Jonathan M.; Finley, Kim D.] San Diego State Univ, Donald P Shiley BioSci Ctr, San Diego, CA 92182 USA; [Ratliff, Eric P.; Mauntz, Ruth E.; Kotzebue, Roxanne W.; Gonzalez, Arysa; Finley, Kaelyn A.; Herr, Deron R.; Harris, Greg L.; Finley, Kim D.] Express Drug Designs LLC, San Diego, CA USA; [Ratliff, Eric P.; Kotzebue, Roxanne W.; Gonzalez, Arysa; Achal, Madhulika; Barekat, Ayeh; Sparhawk, Jonathan M.; Herr, Deron R.; Harris, Greg L.; Finley, Kim D.] San Diego State Univ, Dept Biol, San Diego, CA 92182 USA; [Robinson, James E.; Joiner, William J.] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; [Robinson, James E.] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [Herr, Deron R.] Natl Univ Singapore, Dept Pharmacol, Singapore 117548, Singapore	California State University System; San Diego State University; California State University System; San Diego State University; University of California System; University of California San Diego; University of California System; University of California San Diego; National University of Singapore	Finley, KD (corresponding author), San Diego State Univ, Donald P Shiley BioSci Ctr, San Diego, CA 92182 USA.	kfinley@mail.sdsu.edu	Herr, Deron/AAB-7380-2020	Herr, Deron/0000-0001-5755-0896; Mauntz, Ruth/0000-0003-0376-3313	National Institutes of Health/National Institute of Aging [R44AG033427, R01AG039628]; National Science Foundation [DGE-1144086]; University of California San Diego Graduate Cellular and Molecular Pharmacology [T32 GM007752]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007752] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R44AG033427, R01AG039628] Funding Source: NIH RePORTER	National Institutes of Health/National Institute of Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Science Foundation(National Science Foundation (NSF)); University of California San Diego Graduate Cellular and Molecular Pharmacology; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the National Institutes of Health/National Institute of Aging (http://www.nia.nih.gov): R44AG033427 and R01AG039628; the National Science Foundation (https://www.nsfgrfp.org): DGE-1144086; University of California San Diego Graduate Cellular and Molecular Pharmacology (http://biomedsci.ucsd.edu/): T32 GM007752. Expression Drug Designs, LLC provided support in the form of salaries for co-authors (Kim Finley, Eric Ratliff, Ruth Mauntz, Arysa Gonzalez, Kaelyn Finley, Deron Herr, and Greg Harris) but did not have any additional role in the study design, data collection and analysis or in the decision to publish or prepare the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Agrawal S, 2014, J EXP BIOL, V217, P2796, DOI 10.1242/jeb.105817; Andretic R, 2005, CURR BIOL, V15, P1165, DOI 10.1016/j.cub.2005.05.025; Andretic R, 2008, P NATL ACAD SCI USA, V105, P20392, DOI 10.1073/pnas.0806776105; Arya GH, 2010, GENETICS, V186, P1475, DOI 10.1534/genetics.110.123166; Bartlett BJ, 2011, AUTOPHAGY, V7, P572, DOI 10.4161/auto.7.6.14943; Beaver LM, 2004, CURR BIOL, V14, P1492, DOI 10.1016/j.cub.2004.08.022; Bishop NA, 2010, NATURE, V464, P529, DOI 10.1038/nature08983; Chen AY, 2014, GENES BRAIN BEHAV, V13, P812, DOI 10.1111/gbb.12172; Chen AY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097758; Chiu Joanna C, 2010, J Vis Exp, DOI 10.3791/2157; Clausen TH, 2010, AUTOPHAGY, V6, P330, DOI 10.4161/auto.6.3.11226; Cuervo AM, 2005, AUTOPHAGY, V1, P131, DOI 10.4161/auto.1.3.2017; Cumming RC, 2008, METHOD ENZYMOL, V451, P639, DOI 10.1016/S0076-6879(08)03235-7; de Castro IP, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.394; Dean T, 2011, J NEUROSCI, V31, P11387, DOI 10.1523/JNEUROSCI.0502-11.2011; Diaper DC, 2013, HUM MOL GENET, V22, P3883, DOI 10.1093/hmg/ddt243; Diaper DC, 2013, HUM MOL GENET, V22, P1539, DOI 10.1093/hmg/ddt005; Ehrnhoefer DE, 2006, HUM MOL GENET, V15, P2743, DOI 10.1093/hmg/ddl210; Fedina TY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049799; Filimonenko M, 2010, MOL CELL, V38, P265, DOI 10.1016/j.molcel.2010.04.007; Finley KD, 2003, J NEUROSCI, V23, P1254, DOI 10.1523/JNEUROSCI.23-04-01254.2003; Finley KD, 1997, P NATL ACAD SCI USA, V94, P913, DOI 10.1073/pnas.94.3.913; Finley KD, 1998, NEURON, V21, P1363, DOI 10.1016/S0896-6273(00)80655-8; Gargano JW, 2005, EXP GERONTOL, V40, P386, DOI 10.1016/j.exger.2005.02.005; Giebultowicz J, 2010, CURR BIOL, V20, pR608, DOI 10.1016/j.cub.2010.05.052; Gilestro GF, 2012, NAT PROTOC, V7, P995, DOI 10.1038/nprot.2012.041; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; Harada E, 2008, GENES GENET SYST, V83, P257, DOI 10.1266/ggs.83.257; Heinrichsen ET, 2014, MOL METAB, V3, P42, DOI 10.1016/j.molmet.2013.10.003; Joiner MA, 2000, LEARN MEMORY, V7, P32, DOI 10.1101/lm.7.1.32; Joiner WJ, 2006, NATURE, V441, P757, DOI 10.1038/nature04811; Joiner WJ, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003605; Juhasz G, 2008, AUTOPHAGY, V4, P357, DOI 10.4161/auto.5572; Juhasz G, 2007, GENE DEV, V21, P3061, DOI 10.1101/gad.1600707; Koh K, 2006, P NATL ACAD SCI USA, V103, P13843, DOI 10.1073/pnas.0605903103; Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723; Krishnan N, 2009, AGING-US, V1, P937, DOI 10.18632/aging.100103; Kuo TH, 2012, J EXP BIOL, V215, P814, DOI 10.1242/jeb.064980; Lindmo K, 2008, AUTOPHAGY, V4, P500, DOI 10.4161/auto.5829; Lindmo K, 2006, EXP CELL RES, V312, P2018, DOI 10.1016/j.yexcr.2006.03.002; Linford NJ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002668; Liu HJ, 2005, P NATL ACAD SCI USA, V102, P10522, DOI 10.1073/pnas.0500945102; Liu WJ, 2008, BIOCHEM BIOPH RES CO, V372, P798, DOI 10.1016/j.bbrc.2008.05.119; Marcora MS, 2014, MOL NEURODEGENER, V9, DOI 10.1186/1750-1326-9-5; Nezis IP, 2008, J CELL BIOL, V180, P1065, DOI 10.1083/jcb.200711108; Nixon RA, 2007, J CELL SCI, V120, P4081, DOI 10.1242/jcs.019265; Piazza N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005886; Rakshit K, 2013, EXP GERONTOL, V48, P1260, DOI 10.1016/j.exger.2013.07.013; Rakshit K, 2013, AGING CELL, V12, P752, DOI 10.1111/acel.12100; Rakshit K, 2012, CHRONOBIOL INT, V29, P5, DOI 10.3109/07420528.2011.635237; Reggiori Fulvio, 2012, Int J Cell Biol, V2012, P219625, DOI 10.1155/2012/219625; Rogers I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040569; Rusten TE, 2008, CELL CYCLE, V7, P1166, DOI 10.4161/cc.7.9.5784; Seelaar H, 2010, J NEUROL, V257, P747, DOI 10.1007/s00415-009-5404-z; Sehgal A, 2007, Cold Spring Harb Symp Quant Biol, V72, P557, DOI 10.1101/sqb.2007.72.018; Simon AF, 2006, MECH AGEING DEV, V127, P647, DOI 10.1016/j.mad.2006.02.006; Simonsen A, 2008, AUTOPHAGY, V4, P176, DOI 10.4161/auto.5269; Simonsen A, 2007, GENETICS, V176, P1283, DOI 10.1534/genetics.106.065011; STRAUSS R, 1993, J NEUROSCI, V13, P1852, DOI 10.1523/jneurosci.13-05-01852.1993; Tamura T, 2003, NEURON, V40, P1003, DOI 10.1016/S0896-6273(03)00732-3; Tsai HY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034784; van Alphen B, 2013, J NEUROSCI, V33, P6917, DOI 10.1523/JNEUROSCI.0061-13.2013; van Swinderen B, 2007, SCIENCE, V315, P1590, DOI 10.1126/science.1137931; Vieira FG, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r235; Vosshall LB, 2005, NEURON, V45, P179, DOI 10.1016/j.neuron.2005.01.001; White KE, 2010, FRONT NEUROSCI-SWITZ, V4, DOI 10.3389/fnins.2010.00205; Wu MN, 2008, SLEEP, V31, P465, DOI 10.1093/sleep/31.4.465; Wu MN, 2010, NAT NEUROSCI, V13, P69, DOI 10.1038/nn.2454; Yamazaki D, 2007, NAT NEUROSCI, V10, P478, DOI 10.1038/nn1863; Yang DS, 2014, BRAIN, V137, P3300, DOI 10.1093/brain/awu278; Zatloukal K, 2002, AM J PATHOL, V160, P255, DOI 10.1016/S0002-9440(10)64369-6; Ziegler AB, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00072	72	22	22	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2015	10	7							e0132768	10.1371/journal.pone.0132768	http://dx.doi.org/10.1371/journal.pone.0132768			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RQ	26182057	Green Submitted, Green Published, gold			2022-12-26	WOS:000358198200033
J	Rohner, NA; McClain, J; Tuell, SL; Warner, A; Smith, B; Yun, Y; Mohan, A; Sushnitha, M; Thomas, SN				Rohner, Nathan Andrew; McClain, Jacob; Tuell, Sara Lydia; Warner, Alex; Smith, Blair; Yun, Youngho; Mohan, Abhinav; Sushnitha, Manuela; Thomas, Susan Napier			Lymph node biophysical remodeling is associated with melanoma lymphatic drainage	FASEB JOURNAL			English	Article						sentinel lymph node; cancer; tissue mechanical properties	INTERSTITIAL FLUID PRESSURE; ENDOTHELIAL GROWTH-FACTOR; TUMOR MICROENVIRONMENT; SOLID STRESS; HYALURONIC-ACID; CELL; COLLAGEN; FLOW; LYMPHANGIOGENESIS; METASTASIS	Tissue remodeling is a characteristic of many solid tumor malignancies including melanoma. By virtue of tumor lymphatic transport, remodeling pathways active within the local tumor microenvironment have the potential to be operational within lymph nodes (LNs) draining the tumor interstitium. Here, we show that lymphatic drainage from murine B16 melanomas in syngeneic, immune-competent C57Bl/6 mice is associated with LN enlargement as well as nonuniform increases in bulk tissue elasticity and viscoelasticity, as measured by the response of whole LNs to compression. These remodeling responses, which quickly manifest in tumor-draining lymph nodes (TDLNs) after tumor inoculation and before apparent metastasis, were accompanied by changes in matrix composition, including up to 3-fold increases in the abundance of soluble collagen and hyaluronic acid. Intranodal pressures were also significantly increased in TDLNs (+1 cmH(2)O) relative to both non-tumor-draining LNs (-1 cmH(2)O) and LNs from naive animals (-1 to 2 cmH(2)O). These data suggest that the reorganization of matrix structure, composition, and fluid microenvironment within LNs associated with tumor lymphatic drainage parallels remodeling seen in primary malignancies and has the potential to regulate the adhesion, proliferation, and signaling function of LN-resident cells involved in directing melanoma disease progression.	Georgia Inst Technol, George W Woodruff Sch Mech Engn, Parker H Petit Inst Bioengn & Biosci, Atlanta, GA 30332 USA; Emory Univ, Winship Canc Inst, Atlanta, GA 30322 USA	University System of Georgia; Georgia Institute of Technology; Emory University	Thomas, SN (corresponding author), Georgia Inst Technol, George W Woodruff Sch Mech Engn, 315 Ferst Dr NW, Atlanta, GA 30332 USA.	susan.thomas@gatech.edu	Thomas, Susan/B-4592-2016		Georgia Institute of Technology; U.S. National Institutes of Health Cell and Tissue Engineering Training Grant [T32 GM-008433]; U.S. National Science Foundation Award [1342194]; Georgia Institute of Technology Undergraduate Research Opportunities Office, Air Products; U.S. National Science Foundation Summer Undergraduate Research in Engineering/Science Program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008433] Funding Source: NIH RePORTER	Georgia Institute of Technology; U.S. National Institutes of Health Cell and Tissue Engineering Training Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. National Science Foundation Award(National Science Foundation (NSF)); Georgia Institute of Technology Undergraduate Research Opportunities Office, Air Products; U.S. National Science Foundation Summer Undergraduate Research in Engineering/Science Program(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank Alex Schudel, Caitlin Powell, Monica McNerney, Karan Khendry, and Rahul Rege for technical assistance as well as Sha'aqua T. Asberry and Andrew Shaw for technical advice. This work was supported by institutional funds from the Georgia Institute of Technology; U.S. National Institutes of Health Cell and Tissue Engineering Training Grant T32 GM-008433; U.S. National Science Foundation Award 1342194; Georgia Institute of Technology Undergraduate Research Opportunities Office, Air Products; and U.S. National Science Foundation Summer Undergraduate Research in Engineering/Science Program.	Angeli V, 2006, IMMUNITY, V24, P203, DOI 10.1016/j.immuni.2006.01.003; AUKLAND K, 1993, PHYSIOL REV, V73, P1, DOI 10.1152/physrev.1993.73.1.1; Badwe RA, 2003, NEW ENGL J MED, V349, P1968; Barcus CE, 2013, J BIOL CHEM, V288, P12722, DOI 10.1074/jbc.M112.447631; Bastiaannet E, 2009, J CLIN ONCOL, V27, P4774, DOI 10.1200/JCO.2008.20.1822; Bobek V, 2010, ANTICANCER RES, V30, P4799; Boucher Y, 1996, CANCER RES, V56, P4264; Chung MK, 2012, ANN SURG ONCOL, V19, P1595, DOI 10.1245/s10434-011-2154-9; Deed R, 1997, INT J CANCER, V71, P251, DOI 10.1002/(SICI)1097-0215(19970410)71:2<251::AID-IJC21>3.0.CO;2-J; DuFort CC, 2011, NAT REV MOL CELL BIO, V12, P308, DOI 10.1038/nrm3112; DUNN MG, 1983, CONNECT TISSUE RES, V12, P59, DOI 10.3109/03008208309005612; Egger ME, 2014, J AM COLL SURGEONS, V218, P519, DOI 10.1016/j.jamcollsurg.2013.12.014; Faffe DS, 2009, PHYSIOL REV, V89, P759, DOI 10.1152/physrev.00019.2007; FIDLER IJ, 1973, NATURE-NEW BIOL, V242, P148, DOI 10.1038/newbio242148a0; Fieber C, 2004, J CELL SCI, V117, P359, DOI 10.1242/jcs.00831; Fukumura D, 2001, P NATL ACAD SCI USA, V98, P2604, DOI 10.1073/pnas.041359198; Fung Y.C., 1993, BIOMECHANICS MECH PR; Goel S, 2011, PHYSIOL REV, V91, P1071, DOI 10.1152/physrev.00038.2010; GUTMANN R, 1992, CANCER RES, V52, P1993; Hagendoorn J, 2006, CANCER RES, V66, P3360, DOI 10.1158/0008-5472.CAN-05-2655; Harrell MI, 2007, AM J PATHOL, V170, P774, DOI 10.2353/ajpath.2007.060761; Hautmann SH, 2001, J UROLOGY, V165, P2068, DOI 10.1016/S0022-5347(05)66296-9; Helmlinger G, 1997, NAT BIOTECHNOL, V15, P778, DOI 10.1038/nbt0897-778; Ichikawa T, 1999, J INVEST DERMATOL, V113, P935, DOI 10.1046/j.1523-1747.1999.00804.x; Insana MF, 2004, J MAMMARY GLAND BIOL, V9, P393, DOI 10.1007/s10911-004-1409-5; Johnson K. L., 1985, CONTACT MECH, DOI 10.1201/b17110-2; Jung JI, 2015, INT J CANCER, V136, P258, DOI 10.1002/ijc.28983; Koh YX, 2014, EJSO-EUR J SURG ONC, V40, P1263, DOI 10.1016/j.ejso.2014.05.008; Korhonen RK, 2003, J BIOMECH, V36, P1373, DOI 10.1016/S0021-9290(03)00069-1; Kornuta JA, 2014, ANN BIOMED ENG, V42, P1691, DOI 10.1007/s10439-014-1024-6; Kosaki R, 1999, CANCER RES, V59, P1141; Kumar S, 2009, CANCER METAST REV, V28, P113, DOI 10.1007/s10555-008-9173-4; Levental KR, 2009, CELL, V139, P891, DOI 10.1016/j.cell.2009.10.027; LEVICK JR, 1987, Q J EXP PHYSIOL CMS, V72, P409, DOI 10.1113/expphysiol.1987.sp003085; Lokeshwar VB, 2001, J BIOL CHEM, V276, P11922, DOI 10.1074/jbc.M008432200; Lu PF, 2012, J CELL BIOL, V196, P395, DOI 10.1083/jcb.201102147; Lund AW, 2012, CELL REP, V1, P191, DOI 10.1016/j.celrep.2012.01.005; MAROUDAS A, 1975, BIORHEOLOGY, V12, P233; Marzo AL, 1999, J IMMUNOL, V162, P5838; Minamiya Yoshihiro, 2006, Ann Thorac Cardiovasc Surg, V12, P381; Miserocchi G, 2001, NEWS PHYSIOL SCI, V16, P66; Miteva DO, 2010, CIRC RES, V106, P920, DOI 10.1161/CIRCRESAHA.109.207274; Miyaji K., 1997, CANCER, V80, P1920; Mu W, 2013, NEOPLASIA, V15, P875, DOI 10.1593/neo.13786; Mummert ME, 2003, MOL CANCER THER, V2, P295; Nathanson SD, 2015, SEMIN CELL DEV BIOL, V38, P106, DOI 10.1016/j.semcdb.2014.10.002; Nathanson SD, 2014, ANN SURG ONCOL, V21, P81, DOI 10.1245/s10434-013-3249-2; Nathanson SD, 2011, ANN SURG ONCOL, V18, P3791, DOI 10.1245/s10434-011-1796-y; O'Connor RS, 2012, J IMMUNOL, V189, P1330, DOI 10.4049/jimmunol.1102757; Paszek MJ, 2005, CANCER CELL, V8, P241, DOI 10.1016/j.ccr.2005.08.010; Peinado H, 2011, SEMIN CANCER BIOL, V21, P139, DOI 10.1016/j.semcancer.2011.01.002; Phan GQ, 2009, CANCER CONTROL, V16, P234, DOI 10.1177/107327480901600305; Provenzano PP, 2008, BMC MED, V6, DOI 10.1186/1741-7015-6-11; Qian CN, 2006, CANCER RES, V66, P10365, DOI 10.1158/0008-5472.CAN-06-2977; Reintgen M, 2013, ANN SURG ONCOL, V20, P668, DOI 10.1245/s10434-012-2652-4; Rudrabhatla SR, 2006, J INVEST DERMATOL, V126, P1378, DOI 10.1038/sj.jid.5700255; Rutkowski JM, 2006, MICROVASC RES, V72, P161, DOI 10.1016/j.mvr.2006.05.009; Rutkowski JM, 2010, AM J PATHOL, V176, P1122, DOI 10.2353/ajpath.2010.090733; Savani RC, 2001, J BIOL CHEM, V276, P36770, DOI 10.1074/jbc.M102273200; Shieh AC, 2011, ANN BIOMED ENG, V39, P1379, DOI 10.1007/s10439-011-0252-2; Shieh AC, 2011, CANCER RES, V71, P790, DOI 10.1158/0008-5472.CAN-10-1513; Shields JD, 2007, CANCER CELL, V11, P526, DOI 10.1016/j.ccr.2007.04.020; Shrestha B, 2010, J IMMUNOL, V184, P4819, DOI 10.4049/jimmunol.0903063; Sloothaak DAM, 2014, BRIT J SURG, V101, P701, DOI 10.1002/bjs.9451; Stylianopoulos T, 2013, P NATL ACAD SCI USA, V110, P18632, DOI 10.1073/pnas.1318415110; Stylianopoulos T, 2013, CANCER RES, V73, P3833, DOI 10.1158/0008-5472.CAN-12-4521; Stylianopoulos T, 2012, P NATL ACAD SCI USA, V109, P15101, DOI 10.1073/pnas.1213353109; Swartz MA, 2012, NAT REV CANCER, V12, P210, DOI 10.1038/nrc3186; Tanter M, 2008, ULTRASOUND MED BIOL, V34, P1373, DOI 10.1016/j.ultrasmedbio.2008.02.002; Thomas SN, 2015, CURR OPIN CHEM ENG, V7, P65, DOI 10.1016/j.coche.2014.11.003; Thomas SN, 2014, BIOMATERIALS, V35, P814, DOI 10.1016/j.biomaterials.2013.10.003; Thomas SN, 2012, J IMMUNOL, V189, P2181, DOI 10.4049/jimmunol.1103545; Thomas SN, 2011, BIOMATERIALS, V32, P2194, DOI 10.1016/j.biomaterials.2010.11.037; Tilghman RW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037231; Tomei AA, 2009, J IMMUNOL, V183, P4273, DOI 10.4049/jimmunol.0900835; Trochon V, 1997, FEBS LETT, V418, P6, DOI 10.1016/S0014-5793(97)01337-9; Veronesi U, 2003, NEW ENGL J MED, V349, P546, DOI 10.1056/NEJMoa012782; Voutouri C, 2014, J BIOMECH, V47, P3441, DOI 10.1016/j.jbiomech.2014.09.019; Webster B, 2006, J EXP MED, V203, P1903, DOI 10.1084/jem.20052272; Weiler M, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00215; Wiig H, 2003, ACTA ANAESTH SCAND, V47, P111, DOI 10.1034/j.1399-6576.2003.00050.x; Wiig H, 2012, PHYSIOL REV, V92, P1005, DOI 10.1152/physrev.00037.2011; Winkelmann CT, 2006, MOL IMAGING, V5, P105, DOI 10.2310/7290.2006.00011; Xu XM, 2003, CANCER RES, V63, P5685; Yang BG, 2007, J IMMUNOL, V179, P4376, DOI 10.4049/jimmunol.179.7.4376; Yang M, 2000, P NATL ACAD SCI USA, V97, P1206, DOI 10.1073/pnas.97.3.1206; Yi M, 2008, CANCER-AM CANCER SOC, V113, P30, DOI 10.1002/cncr.23514	87	29	30	0	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2015	29	11					4512	4522		10.1096/fj.15-274761	http://dx.doi.org/10.1096/fj.15-274761			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CV8EZ	26178165	Green Published			2022-12-26	WOS:000364514700011
J	Yao, JW; Dodson, VJ; Frank, MW; Rock, CO				Yao, Jiangwei; Dodson, V. Joshua; Frank, Matthew W.; Rock, Charles O.			Chlamydia trachomatis Scavenges Host Fatty Acids for Phospholipid Synthesis via an Acyl-Acyl Carrier Protein Synthetase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GRAM-POSITIVE PATHOGENS; ESCHERICHIA-COLI; ENZYMATIC-SYNTHESIS; BINDING PROTEIN; ACYLTRANSFERASE; PURIFICATION; LIPOPROTEIN; PROLIPOPROTEIN; CHROMATOGRAPHY; QUANTITATION	The obligate intracellular parasite Chlamydia trachomatis has a reduced genome but relies on de novo fatty acid and phospholipid biosynthesis to produce its membrane phospholipids. Lipidomic analyses showed that 8% of the phospholipid molecular species synthesized by C. trachomatis contained oleic acid, an abundant host fatty acid that cannot be made by the bacterium. Mass tracing experiments showed that isotopically labeled palmitic, myristic, and lauric acids added to the medium were incorporated into C. trachomatis-derived phospholipid molecular species. HeLa cells did not elongate lauric acid, but infected HeLa cell cultures elongated laurate to myristate and palmitate. The elongated fatty acids were incorporated exclusively into C. trachomatis-produced phospholipid molecular species. C. trachomatis has adjacent genes encoding the separate domains of the bifunctional acyl-acyl carrier protein (ACP) synthetase/2-acylglycerolphosphoethanolamine acyltransferase gene (aas) of Escherichia coli. The CT775 gene encodes an acyltransferase (LpaT) that selectively transfers fatty acids from acyl-ACP to the 1-position of 2-acyl-glycerophospholipids. The CT776 gene encodes an acyl-ACP synthetase (AasC) with a substrate preference for palmitic compared with oleic acid in vitro. Exogenous fatty acids were elongated and incorporated into phospholipids by Escherichia coli-expressing AasC, illustrating its function as an acyl-ACP synthetase in vivo. These data point to an AasC-dependent pathway in C. trachomatis that selectively scavenges host saturated fatty acids to be used for the de novo synthesis of its membrane constituents.	[Yao, Jiangwei; Dodson, V. Joshua; Frank, Matthew W.; Rock, Charles O.] St Jude Childrens Res Hosp, Dept Infect Dis, Memphis, TN 38105 USA	St Jude Children's Research Hospital	Rock, CO (corresponding author), St Jude Childrens Res Hosp, Dept Infect Dis, 262 Danny Thomas Pl, Memphis, TN 38105 USA.	charles.rock@stjude.org	Regan, Clinton/E-6250-2012	Yao, Jiangwei/0000-0001-7088-3468	National Institutes of Health [GM034496]; Cancer Center Support Grant [CA21765]; American Lebanese Syrian Associated Charities; NATIONAL CANCER INSTITUTE [P30CA021765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM034496, R37GM034496] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Center Support Grant; American Lebanese Syrian Associated Charities(American Lebanese Syrian Associated Charities (ALSAC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM034496 (to C. O. R.). This work was also supported by Cancer Center Support Grant CA21765 and the American Lebanese Syrian Associated Charities. The authors declare that they have no conflicts of interest with the contents of this article.	Bastidas RJ, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a010256; BECKER Y, 1978, MICROBIOL REV, V42, P274, DOI 10.1128/MMBR.42.2.274-306.1978; BIDAWID S, 1989, A VAN LEEUW J MICROB, V55, P123, DOI 10.1007/BF00404752; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; COOPER CL, 1989, J BIOL CHEM, V264, P7384; Dumoux M, 2015, CURR OPIN MICROBIOL, V23, P1, DOI 10.1016/j.mib.2014.09.019; Dumoux M, 2012, TRAFFIC, V13, P1612, DOI 10.1111/tra.12002; EVERETT KDE, 1994, J BACTERIOL, V176, P6082, DOI 10.1128/jb.176.19.6082-6087.1994; Harvat EM, 2005, J BIOL CHEM, V280, P12028, DOI 10.1074/jbc.M414368200; Hillmann F, 2011, J BIOL CHEM, V286, P27936, DOI 10.1074/jbc.M111.243519; HSU L, 1991, J BIOL CHEM, V266, P13783; Ivanova PT, 2007, METHOD ENZYMOL, V432, P21, DOI 10.1016/S0076-6879(07)32002-8; JACKOWSKI S, 1986, J BIOL CHEM, V261, P1328; JACKOWSKI S, 1994, J BIOL CHEM, V269, P2921; Jiang YF, 2006, BIOCHEMISTRY-US, V45, P10008, DOI 10.1021/bi060842w; KAMEDA K, 1981, J BIOL CHEM, V256, P5702; Kokes M, 2015, CELL HOST MICROBE, V17, P716, DOI 10.1016/j.chom.2015.03.014; Krank J, 2007, METHOD ENZYMOL, V432, P1, DOI 10.1016/S0076-6879(07)32001-6; Lu YJ, 2006, MOL CELL, V23, P765, DOI 10.1016/j.molcel.2006.06.030; MUNOA FJ, 1991, J BIOL CHEM, V266, P17667; Neff L, 2007, J BACTERIOL, V189, P4739, DOI 10.1128/JB.01889-06; Parsons JB, 2015, ANTIMICROB AGENTS CH, V59, P849, DOI 10.1128/AAC.04179-14; Parsons JB, 2013, PROG LIPID RES, V52, P249, DOI 10.1016/j.plipres.2013.02.002; Parsons JB, 2011, P NATL ACAD SCI USA, V108, P15378, DOI 10.1073/pnas.1109208108; PLUCKTHUN A, 1982, BIOCHEMISTRY-US, V21, P1743; RAY TK, 1976, P NATL ACAD SCI USA, V73, P4374, DOI 10.1073/pnas.73.12.4374; Rock C O, 1981, Methods Enzymol, V72, P397; ROCK CO, 1979, J BIOL CHEM, V254, P7123; ROCK CO, 1979, J BIOL CHEM, V254, P7116; Rund S, 1999, J BIOL CHEM, V274, P16819, DOI 10.1074/jbc.274.24.16819; SANKARAN K, 1994, J BIOL CHEM, V269, P19701; Scidmore Marci A, 2005, Curr Protoc Microbiol, VChapter 11, DOI 10.1002/9780471729259.mc11a01s00; Soupene E, 2015, MICROBIOLOGYOPEN, V4, P235, DOI 10.1002/mbo3.234; SPENCER AK, 1979, FEBS LETT, V101, P253, DOI 10.1016/0014-5793(79)81019-4; Stephens RS, 1998, SCIENCE, V282, P754, DOI 10.1126/science.282.5389.754; Wang GQ, 2007, MICROBIOL-SGM, V153, P1935, DOI 10.1099/mic.0.2006/003491-0; Wylie JL, 1997, J BACTERIOL, V179, P7233, DOI 10.1128/jb.179.23.7233-7242.1997; Yao JW, 2015, J BIOL CHEM, V290, P18874, DOI 10.1074/jbc.M115.657148; Yao JW, 2015, J BIOL CHEM, V290, P5940, DOI 10.1074/jbc.R114.636241; Yao JW, 2014, J BIOL CHEM, V289, P22365, DOI 10.1074/jbc.M114.584185	41	30	30	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	2015	290	36					22163	22173		10.1074/jbc.M115.671008	http://dx.doi.org/10.1074/jbc.M115.671008			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CQ9XI	26195634	hybrid, Green Published			2022-12-26	WOS:000360968500033
J	Dorantes-Aranda, JJ; Seger, A; Mardones, JI; Nichols, PD; Hallegraeff, GM				Dorantes-Aranda, Juan Jose; Seger, Andreas; Mardones, Jorge I.; Nichols, Peter D.; Hallegraeff, Gustaaf M.			Progress in Understanding Algal Bloom-Mediated Fish Kills: The Role of Superoxide Radicals, Phycotoxins and Fatty Acids	PLOS ONE			English	Article							GYMNODINIOID DINOFLAGELLATES KARENIACEAE; CHATTONELLA-MARINA RAPHIDOPHYCEAE; RAINBOW-TROUT; HETEROSIGMA-AKASHIWO; HYDROGEN-PEROXIDE; CHEMICAL DEFENSE; RED TIDES; ICHTHYOTOXICITY; ASSAY; TOXICITY	Quantification of the role of reactive oxygen species, phycotoxins and fatty acids in fish toxicity by harmful marine microalgae remains inconclusive. An in vitro fish gill (from rainbow trout Oncorhynchus mykiss) assay was used to simultaneously assess the effect in superoxide dismutase, catalase and lactate dehydrogenase enzymatic activities caused by seven species of ichthyotoxic microalgae (Chattonella marina, Fibrocapsa japonica, Heterosigma akashiwo, Karenia mikimotoi, Alexandrium catenella, Karlodinium veneficum, Prymnesium parvum). Quantification of superoxide production by these algae was also performed. The effect of purified phycotoxins and crude extracts was compared, and the effect of fatty acids is discussed. The raphidophyte Chattonella was the most ichthyotoxic (gill cell viability down to 35%) and also the major producer of superoxide radicals (14 pmol cell(-1) hr(-1)) especially after cell lysis. The raphidophyte Heterosigmaand dinoflagellate Alexandrium were the least toxic and had low superoxide production, except when A. catenella was lysed (5.6 pmol cell(-1) hr(-1)). Catalase showed no changes in activity in all the treatments. Superoxide dismutase (SOD) and lactate dehydrogenase exhibited significant activity increases of <= 23% and 51.2% TCC (total cellular content), respectively, after exposure to C. marina, but SOD showed insignificant changes with remaining algal species. A strong relationship between gill cell viability and superoxide production or superoxide dismutase was not observed. Purified brevetoxins PbTx-2 and -3 (from Karenia brevis, LC50 of 22.1 versus 35.2 mu g mL(-1)) and karlotoxin KmTx-2 (from Karlodinium; LC50 = 380 ng mL(-1)) could almost entirely account for the fish killing activity by those two dinoflagellates. However, the paralytic shellfish toxins (PST) GTX1&4, C1&C2, and STX did not account for Alexandriu-michthyotoxicity. Only aqueous extracts of Alexandrium were cytotoxic (<= 65% decrease of viability), whereas crude methanol and acetone extracts of Chattonella, Fibrocapsa, Heterosigma, Karlodinium and Prymnesium decreased cell viability down to 0%. These and our previous findings involving the role of fatty acids confirm that superoxide radicals are only partially involved in ichthyotoxicity and point to a highly variable contribution by other compounds such as lipid peroxidation products (e.g. aldehydes).	[Dorantes-Aranda, Juan Jose; Seger, Andreas; Mardones, Jorge I.; Nichols, Peter D.; Hallegraeff, Gustaaf M.] Univ Tasmania, Inst Marine & Antarct Studies, Hobart, Tas, Australia; [Nichols, Peter D.] CSIRO, Oceans & Atmosphere Flagship, Hobart, Tas, Australia	University of Tasmania; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Dorantes-Aranda, JJ (corresponding author), Univ Tasmania, Inst Marine & Antarct Studies, Hobart, Tas, Australia.	Juan.DorantesAranda@utas.edu.au	Seger, Andreas/AAH-4093-2019; Nichols, Peter D/C-5128-2011; Hallegraeff, Gustaaf/C-8351-2013	Seger, Andreas/0000-0001-7018-0455; Hallegraeff, Gustaaf/0000-0001-8464-7343; Dorantes-Aranda, Juan Jose/0000-0003-1513-6501	Australian Research Council [DP130102859]	Australian Research Council(Australian Research Council)	This work was supported by the Australian Research Council, Grant DP130102859 to GMH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aebi H, 1984, Methods Enzymol, V105, P121; Aguilera-Belmonte A, 2013, HARMFUL ALGAE, V23, P55, DOI 10.1016/j.hal.2012.12.006; Alexander B, 1999, J PHARMACOL TOXICOL, V41, P55, DOI 10.1016/S1056-8719(98)00038-0; Anderson DM, 2000, ESTIMATED ANNUAL ECO; Bachvaroff TR, 2008, HARMFUL ALGAE, V7, P473, DOI 10.1016/j.hal.2007.10.003; BADEN DG, 1989, FASEB J, V3, P1807, DOI 10.1096/fasebj.3.7.2565840; Bertin MJ, 2014, AQUAT TOXICOL, V146, P1, DOI 10.1016/j.aquatox.2013.09.026; BLACKBURN SI, 1989, J PHYCOL, V25, P577, DOI 10.1111/j.1529-8817.1989.tb00264.x; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BOLS NC, 1994, J FISH DIS, V17, P601, DOI 10.1111/j.1365-2761.1994.tb00258.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Burns JM, 2012, AQUAT SCI, V74, P683, DOI 10.1007/s00027-012-0251-x; Dayeh VR, 2005, SMALL -SCALE FRESHWATER TOXICITY INVESTIGATIONS, VOL 1 - TOXICITY TEST METHODS, P473, DOI 10.1007/1-4020-3120-3_16; de Boer MK, 2009, HARMFUL ALGAE, V8, P699, DOI 10.1016/j.hal.2009.02.001; Deeds JR, 2006, J AQUAT ANIM HEALTH, V18, P136, DOI 10.1577/H05-027.1; Dorantes-Aranda JJ, 2011, HARMFUL ALGAE, V10, P366, DOI 10.1016/j.hal.2011.01.002; Fossat B, 1999, J APPL TOXICOL, V19, P275, DOI 10.1002/(SICI)1099-1263(199907/08)19:4<275::AID-JAT578>3.0.CO;2-B; Fu M, 2004, TOXICON, V43, P355, DOI 10.1016/j.toxicon.2003.09.012; Godrant A, 2009, LIMNOL OCEANOGR-METH, V7, P682, DOI 10.4319/lom.2009.7.682; HALLIWELL B, 1984, BIOCHEM J, V219, P1, DOI 10.1042/bj2190001; Hansen E, 2004, TOXICOLOGY, V199, P207, DOI 10.1016/j.tox.2004.02.026; Henrikson JC, 2010, TOXICON, V55, P1396, DOI 10.1016/j.toxicon.2010.02.017; Hillebrand H, 1999, J PHYCOL, V35, P403, DOI 10.1046/j.1529-8817.1999.3520403.x; Hoagland P, 2002, ESTUARIES, V25, P819, DOI 10.1007/BF02804908; Imai Ichiro, 2006, Plankton & Benthos Research, V1, P71; Ishimatsu A, 1996, FISHERIES SCI, V62, P50, DOI 10.2331/fishsci.62.50; Itakura S., 2014, PICES SCI REP, V47, P17; Dorantes-Aranda JJ, 2013, J PHYCOL, V49, P427, DOI 10.1111/jpy.12053; Juttner F, 2005, AQUAT ECOL, V39, P271, DOI 10.1007/s10452-005-3419-9; Kim CS, 1999, J PLANKTON RES, V21, P2105, DOI 10.1093/plankt/21.11.2105; Kim Daekyung, 2010, P245; Kim HakGyoon, 2010, P121; Landsberg JH, 2002, REV FISH SCI, V10, P113, DOI 10.1080/20026491051695; LEE TY, 1995, ANAL CHEM, V67, P225, DOI 10.1021/ac00097a034; Lewis T, 2000, J MICROBIOL METH, V43, P107, DOI 10.1016/S0167-7012(00)00217-7; Lush G, 2001, HARMFUL ALGAL BLOOMS, P268; Ma HY, 2009, MAR DRUGS, V7, P497, DOI 10.3390/md7040497; Makri A, 2011, ENG LIFE SCI, V11, P52, DOI 10.1002/elsc.201000086; Marshall JA, 2005, MAR BIOL, V147, P533, DOI 10.1007/s00227-005-1596-7; Marshall JA, 2003, HARMFUL ALGAE, V2, P273, DOI 10.1016/S1568-9883(03)00046-5; Marshall JA, 2002, J APPL PHYCOL, V14, P255, DOI 10.1023/A:1021101203543; Marshall JA, 2002, J PLANKTON RES, V24, P1231, DOI 10.1093/plankt/24.11.1231; MCCORD JM, 1969, J BIOL CHEM, V244, P6049; Miller CJ, 2011, ANAL CHEM, V83, P261, DOI 10.1021/ac1022748; Mooney BD, 2007, J PHYCOL, V43, P101, DOI 10.1111/j.1529-8817.2006.00312.x; Mooney BD, 2011, MAR ECOL PROG SER, V426, P213, DOI 10.3354/meps09036; Mooney BD, 2010, HARMFUL ALGAE, V9, P557, DOI 10.1016/j.hal.2010.04.005; Mooney BD, 2009, J PHYCOL, V45, P164, DOI 10.1111/j.1529-8817.2008.00630.x; Nakayama GR, 1997, J IMMUNOL METHODS, V204, P205, DOI 10.1016/S0022-1759(97)00043-4; Oda T, 1997, BIOSCI BIOTECH BIOCH, V61, P1658, DOI 10.1271/bbb.61.1658; PAGE B, 1993, INT J ONCOL, V3, P473; Park TG, 2013, HARMFUL ALGAE, V30, pS131, DOI 10.1016/j.hal.2013.10.012; Place AR, 2012, HARMFUL ALGAE, V14, P179, DOI 10.1016/j.hal.2011.10.021; Pohnert G, 2002, MAR ECOL PROG SER, V245, P33, DOI 10.3354/meps245033; Pohnert G, 2000, ANGEW CHEM INT EDIT, V39, P4352, DOI 10.1002/1521-3773(20001201)39:23<4352::AID-ANIE4352>3.0.CO;2-U; Riso RD, 2006, ANAL BIOANAL CHEM, V385, P76, DOI 10.1007/s00216-006-0393-6; Scandalios John G., 2002, Trends in Biochemical Sciences, V27, P483, DOI 10.1016/S0968-0004(02)02170-9; Schirmer K, 1997, TOXICOL IN VITRO, V11, P107, DOI 10.1016/S0887-2333(97)00002-7; SHILO M, 1960, ANN NY ACAD SCI, V90, P866, DOI 10.1111/j.1749-6632.1960.tb26429.x; SHILO M, 1953, J GEN MICROBIOL, V8, P333, DOI 10.1099/00221287-8-3-333; Smedes F, 1999, MAR POLLUT BULL, V38, P193, DOI 10.1016/S0025-326X(98)00170-2; Tang JYM, 2005, AQUAT TOXICOL, V72, P351, DOI 10.1016/j.aquatox.2005.01.007; Tang YZ, 2009, HARMFUL ALGAE, V8, P454, DOI 10.1016/j.hal.2008.10.001; Twiner MJ, 2005, HARMFUL ALGAE, V4, P789, DOI 10.1016/j.hal.2004.12.006; Twiner MJ, 2001, LIMNOL OCEANOGR, V46, P1400, DOI 10.4319/lo.2001.46.6.1400; ULITZUF S, 1964, J GEN MICROBIOL, V36, P161, DOI 10.1099/00221287-36-2-161; Valavanidis A, 2006, ECOTOX ENVIRON SAFE, V64, P178, DOI 10.1016/j.ecoenv.2005.03.013; van Deventer M, 2012, BOT MAR, V55, P31, DOI [10.1515/BOT.2011.122, 10.1515/bot.2011.122]; VOLKMAN JK, 1989, J EXP MAR BIOL ECOL, V128, P219, DOI 10.1016/0022-0981(89)90029-4; WINSTON GW, 1991, AQUAT TOXICOL, V19, P137, DOI 10.1016/0166-445X(91)90033-6; Woo SPS, 2006, J EXP MAR BIOL ECOL, V336, P230, DOI 10.1016/j.jembe.2006.05.013; YANG CZ, 1995, DIS AQUAT ORGAN, V23, P101, DOI 10.3354/dao023101; Zou YN, 2013, BIOSCI BIOTECH BIOCH, V77, P345, DOI 10.1271/bbb.120764	73	84	86	4	111	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0133549	10.1371/journal.pone.0133549	http://dx.doi.org/10.1371/journal.pone.0133549			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LZ	26197230	gold, Green Published			2022-12-26	WOS:000358547600112
J	Wang, Z; Zhao, F; Gao, Q; Liu, ZL; Zhang, YX; Li, XY; Li, YH; Ma, WL; Deng, T; Zhang, ZZ; Cen, S				Wang, Zhen; Zhao, Fei; Gao, Qian; Liu, Zhenlong; Zhang, Yongxin; Li, Xiaoyu; Li, Yuhuan; Ma, Weilie; Deng, Tao; Zhang, Zhizhen; Cen, Shan			Establishment of a High-Throughput Assay to Monitor Influenza A Virus RNA Transcription and Replication	PLOS ONE			English	Article							HOST FACTORS; ANTIVIRAL ACTIVITY; PA SUBUNIT; POLYMERASE; IDENTIFICATION; PROTEIN; GENOME; INTERACTS; NUCLEOPROTEIN; GENERATION	Influenza A virus (IAV) poses significant threats to public health because of the recent emergence of highly pathogenic strains and wide-spread resistance to available anti-influenza drugs. Therefore, new antiviral targets and new drugs to fight influenza virus infections are needed. Although IAV RNA transcription/replication represents a promising target for antiviral drug development, no assay ideal for high-throughput screening (HTS) application is currently available to identify inhibitors targeting these processes. In this work, we developed a novel HTS assay to analyze the transcription and replication of IAV RNA using an A549 cell line stably expressing IAV RNA-dependent RNA polymerase (RdRp) complex, NP and a viral minigenomic RNA. Both secreted Gaussia luciferase (Gluc) and blasticidin resistance gene (Bsd) were encoded in the viral minigenome and expressed under the control of IAV RdRp. Gluc serves as a reporter to monitor the activity of IAV RdRp, and Bsd is used to maintain the expression of all foreign genes. Biochemical studies and the statistical analysis presented herein demonstrate the high specificity, sensitivity and reproducibility of the assay. This work provides an ideal HTS assay for the identification of inhibitors targeting the function of IAV RdRp and a convenient reporting system for mechanism study of IAV RNA transcription / replication.	[Wang, Zhen; Zhao, Fei; Gao, Qian; Liu, Zhenlong; Zhang, Yongxin; Li, Xiaoyu; Li, Yuhuan; Cen, Shan] Chinese Acad Med Sci, Inst Med Biotechnol, Beijing 100730, Peoples R China; [Wang, Zhen; Zhao, Fei; Gao, Qian; Liu, Zhenlong; Zhang, Yongxin; Li, Xiaoyu; Li, Yuhuan; Deng, Tao; Cen, Shan] Pekin Union Med Coll, Beijing, Peoples R China; [Ma, Weilie; Zhang, Zhizhen] Guangdong Med Coll, Dept Biochem, Zhanjiang, Guangdong, Peoples R China; [Deng, Tao] Chinese Acad Med Sci, Inst Pathogen Biol, Beijing 100730, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Medicinal Biotechnology - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Guangdong Medical University; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Pathogen Biology - CAMS	Zhang, ZZ (corresponding author), Guangdong Med Coll, Dept Biochem, Zhanjiang, Guangdong, Peoples R China.	zzzhang@gdmc.edu.cn; shancen@imb.pumc.edu.cn	Liu, Zhenlong/AAE-7581-2021; ZHANG, ZHIZHEN/GYA-3230-2022	Liu, Zhenlong/0000-0001-9149-7179	China 973 programs [2012CB911102]; China Mega-Project for Infectious Disease [2013ZX10004601-002]; National S&T Major Special Project on Major New Drug Innovation [2012ZX09301-002-004]	China 973 programs(National Basic Research Program of China); China Mega-Project for Infectious Disease; National S&T Major Special Project on Major New Drug Innovation	This work was supported by China 973 programs 2012CB911102 (SC), China Mega-Project for Infectious Disease 2013ZX10004601-002 (SC), The National S&T Major Special Project on Major New Drug Innovation 2012ZX09301-002-004 (SC), and the Xiehe Scholar (SC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bortz E, 2011, MBIO, V2, DOI 10.1128/mBio.00151-11; Chase G, 2011, METHODS, V55, P188, DOI 10.1016/j.ymeth.2011.08.007; de Jong MD, 2005, NEW ENGL J MED, V353, P2667, DOI 10.1056/NEJMoa054512; de Vries E, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001329; de Wit E, 2004, VIRUS RES, V103, P155, DOI 10.1016/j.virusres.2004.02.028; Deyde VM, 2007, J INFECT DIS, V196, P249, DOI 10.1086/518936; Fodor E, 2004, J VIROL, V78, P9144, DOI 10.1128/JVI.78.17.9144-9153.2004; Fodor E, 2013, ACTA VIROL, V57, P113, DOI 10.4149/av_2013_02_113; Furuta Y, 2002, ANTIMICROB AGENTS CH, V46, P977, DOI 10.1128/AAC.46.4.977-981.2002; Hayden F, 2009, CLIN INFECT DIS, V48, pS3, DOI 10.1086/591851; Hsu JTA, 2012, ANTIMICROB AGENTS CH, V56, P647, DOI 10.1128/AAC.00125-11; Hsu WB, 2013, J VIROL, V87, P110, DOI 10.1128/JVI.00939-12; HUANG TS, 1990, J VIROL, V64, P5669, DOI 10.1128/JVI.64.11.5669-5673.1990; Iversen PW, 2006, J BIOMOL SCREEN, V11, P247, DOI 10.1177/1087057105285610; Kakugawa S, 2009, J VIROL, V83, P6429, DOI 10.1128/JVI.00293-09; Kao RY, 2010, NAT BIOTECHNOL, V28, P600, DOI 10.1038/nbt.1638; Karlas A, 2010, NATURE, V463, P818, DOI 10.1038/nature08760; Kawaguchi A, 2011, J VIROL, V85, P6197, DOI 10.1128/JVI.00277-11; Kim CU, 1998, J MED CHEM, V41, P2451, DOI 10.1021/jm980162u; Konig R, 2010, NATURE, V463, P813, DOI 10.1038/nature08699; Lackenby A, 2008, EURO SURVEILLANCE B, V13; Li L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035234; LI R, 1989, VIRUS RES, V12, P97, DOI 10.1016/0168-1702(89)90057-9; Lutz A, 2005, J VIROL METHODS, V126, P13, DOI 10.1016/j.jviromet.2005.01.016; Mayer D, 2007, J PROTEOME RES, V6, P672, DOI 10.1021/pr060432u; Mullin AE, 2004, J GEN VIROL, V85, P3689, DOI 10.1099/vir.0.80518-0; Nagata K, 2008, REV MED VIROL, V18, P247, DOI 10.1002/rmv.575; Naito T, 2007, P NATL ACAD SCI USA, V104, P18235, DOI 10.1073/pnas.0705856104; Ortigoza MB, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002668; Ozawa M, 2013, SCI REP-UK, V3, DOI 10.1038/srep01106; Rodriguez A, 2011, J VIROL, V85, P12062, DOI 10.1128/JVI.00684-11; Samji Tasleem, 2009, Yale Journal of Biology and Medicine, V82, P153; Satterly N, 2007, P NATL ACAD SCI USA, V104, P1853, DOI 10.1073/pnas.0610977104; Schickli JH, 2001, PHILOS T ROY SOC B, V356, P1965, DOI 10.1098/rstb.2001.0979; Shapira SD, 2009, CELL, V139, P1255, DOI 10.1016/j.cell.2009.12.018; SIDWELL RW, 1972, SCIENCE, V177, P705, DOI 10.1126/science.177.4050.705; Su CY, 2010, P NATL ACAD SCI USA, V107, P19151, DOI 10.1073/pnas.1013592107; Tafforeau L, 2011, J VIROL, V85, P13010, DOI 10.1128/JVI.02651-10; Tannous BA, 2009, NAT PROTOC, V4, P582, DOI 10.1038/nprot.2009.28; WANG C, 1993, J VIROL, V67, P5585, DOI 10.1128/JVI.67.9.5585-5594.1993; Watanabe T, 2010, CELL HOST MICROBE, V7, P427, DOI 10.1016/j.chom.2010.05.008; Yamada K, 2012, MICROBES INFECT, V14, P740, DOI 10.1016/j.micinf.2012.02.012; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206; Zhang JJ, 2010, J VIROL, V84, P12619, DOI 10.1128/JVI.01696-10	44	9	9	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0133558	10.1371/journal.pone.0133558	http://dx.doi.org/10.1371/journal.pone.0133558			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LZ	26196128	Green Published, Green Submitted, gold			2022-12-26	WOS:000358547600115
J	Wills, BD; Chong, CD; Wilder, SM; Eubanks, MD; Holway, DA; Suarez, AV				Wills, Bill D.; Chong, Cody D.; Wilder, Shawn M.; Eubanks, Micky D.; Holway, David A.; Suarez, Andrew V.			Effect of Carbohydrate Supplementation on Investment into Offspring Number, Size, and Condition in a Social Insect	PLOS ONE			English	Article							ANT SOLENOPSIS-INVICTA; FIRE ANT; COLONY GROWTH; WORKER CASTE; GRAIN HYPOTHESIS; TROPHIC ECOLOGY; HARVESTER ANT; INVASIVE ANT; BUILDING ANT; RESOURCE USE	Resource availability can determine an organism's investment strategies for growth and reproduction. When nutrients are limited, there are potential tradeoffs between investing into offspring number versus individual offspring size. In social insects, colony investment in offspring size and number may shift in response to colony needs and the availability of food resources. We experimentally manipulated the diet of a polymorphic ant species (Solenopsis invicta) to test how access to the carbohydrate and amino acid components of nectar resources affect colony investment in worker number, body size, size distributions, and individual percent fat mass. We reared field-collected colonies on one of four macronutrient treatment supplements: water, amino acids, carbohydrates, and amino acid and carbohydrates. Having access to carbohydrates nearly doubled colony biomass after 60 days. This increase in biomass resulted from an increase in worker number and mean worker size. Access to carbohydrates also altered worker body size distributions. Finally, we found a negative relationship between worker number and size, suggesting a tradeoff in colony investment strategies. This tradeoff was more pronounced for colonies without access to carbohydrate resources. The monopolization of plant-based resources has been implicated in the ecological success of ants. Our results shed light on a possible mechanism for this success, and also have implications for the success of introduced species. In addition to increases in colony size, our results suggest that having access to plant-based carbohydrates can also result in larger workers that may have better individual fighting ability, and that can withstand greater temperature fluctuations and periods of food deprivation.	[Wills, Bill D.; Suarez, Andrew V.] Univ Illinois, Dept Anim Biol, Urbana, IL 61801 USA; [Chong, Cody D.] Univ Illinois, Sch Integrat Biol, Urbana, IL 61801 USA; [Wilder, Shawn M.; Eubanks, Micky D.] Texas A&M Univ, Dept Entomol, College Stn, TX 77843 USA; [Holway, David A.] Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA; [Suarez, Andrew V.] Univ Illinois, Dept Entomol, Program Ecol Evolut & Conservat Biol, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; Texas A&M University System; Texas A&M University College Station; University of California System; University of California San Diego; University of Illinois System; University of Illinois Urbana-Champaign	Wills, BD (corresponding author), Michigan State Univ, Dept Entomol, E Lansing, MI 48824 USA.	willsbd@gmail.com		Wilder, Shawn/0000-0003-0359-7220	National Science Foundation, Division of Environmental Biology [0716983, 0717054, 0716966]; University of Illinois, Department of Animal Biology	National Science Foundation, Division of Environmental Biology(National Science Foundation (NSF)); University of Illinois, Department of Animal Biology	National Science Foundation, Division of Environmental Biology (http://www.nsf.gov/dir/index.jsp?org=BIO) 0716983 to MDE, National Science Foundation, Division of Environmental Biology (http://www.nsf.gov/dir/index.jsp?org=BIO) 0717054 to DAH, National Science Foundation, Division of Environmental Biology (http://www.nsf.gov/dir/index.jsp?org=BIO) 0716966 to AVS, and the University of Illinois, Department of Animal Biology to BDW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araujo MB, 2010, J INSECT SCI, V10, DOI 10.1673/031.010.9401; BESHERS SN, 1994, ECOLOGY, V75, P763, DOI 10.2307/1941733; Blanchard GB, 2000, ANIM BEHAV, V59, P723, DOI 10.1006/anbe.1999.1374; Bluthgen N, 2004, AUSTRAL ECOL, V29, P418, DOI 10.1111/j.1442-9993.2004.01380.x; Brown WD, 2006, BEHAV ECOL SOCIOBIOL, V60, P612, DOI 10.1007/s00265-006-0204-2; CALABI P, 1989, J INSECT PHYSIOL, V35, P643, DOI 10.1016/0022-1910(89)90127-3; Calder WA., 1984, SIZE FUNCTION LIFE H; Clark RE, 2012, ENVIRON ENTOMOL, V41, P1405, DOI 10.1603/EN12131; DAVIDSON DW, 1978, AM NAT, V112, P523, DOI 10.1086/283294; Davidson DW, 1997, BIOL J LINN SOC, V61, P153, DOI 10.1006/bijl.1996.0128; Davidson DW, 2003, SCIENCE, V300, P969, DOI 10.1126/science.1082074; Davidson DW, 1998, ECOL ENTOMOL, V23, P484, DOI 10.1046/j.1365-2311.1998.00145.x; Dussutour A, 2008, J EXP BIOL, V211, P2224, DOI 10.1242/jeb.017509; Dussutour A, 2012, P ROY SOC B-BIOL SCI, V279, P2402, DOI 10.1098/rspb.2012.0051; Dussutour A, 2009, CURR BIOL, V19, P740, DOI 10.1016/j.cub.2009.03.015; Evans AR, 2012, P NATL ACAD SCI USA, V109, P4187, DOI 10.1073/pnas.1120774109; Fjerdingstad EJ, 2006, AM NAT, V167, P390, DOI 10.1086/499545; FRANCKE OF, 1985, SOUTHWEST NAT, V30, P59, DOI 10.2307/3670657; FRANKS NR, 1993, ANIM BEHAV, V45, P197, DOI 10.1006/anbe.1993.1021; Grover CD, 2007, P ROY SOC B-BIOL SCI, V274, P2951, DOI 10.1098/rspb.2007.1065; Hahn DA, 2006, PHYSIOL BIOCHEM ZOOL, V79, P847, DOI 10.1086/505995; Hart LM, 2012, INSECT SOC, V59, P45, DOI 10.1007/s00040-011-0186-6; Helms KR, 2008, ENVIRON ENTOMOL, V37, P487, DOI 10.1603/0046-225X(2008)37[487:PRACGI]2.0.CO;2; Helms KR, 2013, MYRMECOL NEWS, V18, P61; Helms KR, 2011, BIOL INVASIONS, V13, P67, DOI 10.1007/s10530-010-9790-z; Helms KR, 2002, ECOLOGY, V83, P2425, DOI 10.1890/0012-9658(2002)083[2425:WAOTIA]2.0.CO;2; Hou C, 2010, P NATL ACAD SCI USA, V107, P3534; KASPARI M, 1995, AM NAT, V145, P610, DOI 10.1086/285758; Kaspari M, 1999, FUNCT ECOL, V13, P530, DOI 10.1046/j.1365-2435.1999.00343.x; Kaspari M, 2007, ECOL ENTOMOL, V32, P279, DOI 10.1111/j.1365-2311.2007.00870.x; Kay AD, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2374; Kay AD, 2010, ECOLOGY, V91, P57, DOI 10.1890/09-0908.1; LANZA J, 1991, ECOL ENTOMOL, V16, P203, DOI 10.1111/j.1365-2311.1991.tb00210.x; McGlynn TP, 2002, INSECT SOC, V49, P8, DOI 10.1007/s00040-002-8270-6; Moczek AP, 1998, BEHAV ECOL, V9, P636, DOI 10.1093/beheco/9.6.636; NIJHOUT HF, 1974, J EXP BIOL, V61, P481; Oster FG, 1978, CASTE ECOLOGY SOCIAL; Passera L, 1996, NATURE, V379, P630, DOI 10.1038/379630a0; PASSERA L, 1974, INSECT SOC, V21, P71, DOI 10.1007/BF02222980; Portner HO, 2008, SCIENCE, V322, P690, DOI 10.1126/science.1163156; PORTER SD, 1981, BEHAV ECOL SOCIOBIOL, V9, P247, DOI 10.1007/BF00299879; PORTER SD, 1985, BEHAV ECOL SOCIOBIOL, V16, P323, DOI 10.1007/BF00295545; PORTER SD, 1989, J KANSAS ENTOMOL SOC, V62, P288; Powell S, 2005, P ROY SOC B-BIOL SCI, V272, P2173, DOI 10.1098/rspb.2005.3196; Powell S, 2009, J EVOLUTION BIOL, V22, P1004, DOI 10.1111/j.1420-9101.2009.01710.x; Reznick D, 2000, TRENDS ECOL EVOL, V15, P421, DOI 10.1016/S0169-5347(00)01941-8; REZNICK D, 1985, OIKOS, V44, P257, DOI 10.2307/3544698; RISSING SW, 1984, BEHAV ECOL SOCIOBIOL, V15, P121, DOI 10.1007/BF00299379; Roff DA, 2007, J EVOLUTION BIOL, V20, P433, DOI 10.1111/j.1420-9101.2006.01255.x; Rowles AD, 2009, OECOLOGIA, V161, P161, DOI 10.1007/s00442-009-1368-z; SCHLUTER D, 1994, SCIENCE, V266, P798, DOI 10.1126/science.266.5186.798; Schoener TW, 2011, SCIENCE, V331, P426, DOI 10.1126/science.1193954; Shik JZ, 2014, ANIM BEHAV, V95, P33, DOI 10.1016/j.anbehav.2014.06.008; Shik JZ, 2013, BIOL INVASIONS, V15, P829, DOI 10.1007/s10530-012-0330-x; Shik JZ, 2010, BEHAV ECOL SOCIOBIOL, V64, P1981, DOI 10.1007/s00265-010-1009-x; Silva RR, 2010, ECOL MONOGR, V80, P107, DOI 10.1890/08-1298.1; Simmons LW, 2006, P NATL ACAD SCI USA, V103, P16346, DOI 10.1073/pnas.0603474103; SMITH CC, 1974, AM NAT, V108, P499, DOI 10.1086/282929; Smith Chris R, 2009, Cold Spring Harb Protoc, V2009, DOI 10.1101/pdb.prot5243; Smith CR, 2010, FUNCT ECOL, V24, P122, DOI 10.1111/j.1365-2435.2009.01604.x; Stearns S.C., 1992, pi; Styrsky JD, 2007, P ROY SOC B-BIOL SCI, V274, P151, DOI 10.1098/rspb.2006.3701; TENNANT LE, 1991, J ENTOMOL SCI, V26, P450, DOI 10.18474/0749-8004-26.4.450; Tillberg CV, 2007, P NATL ACAD SCI USA, V104, P20856, DOI 10.1073/pnas.0706903105; TRANIELLO JFA, 1989, ANNU REV ENTOMOL, V34, P191, DOI 10.1146/annurev.en.34.010189.001203; TSCHINKEL WR, 1988, BEHAV ECOL SOCIOBIOL, V22, P103, DOI 10.1007/BF00303545; TSCHINKEL WR, 1993, ECOL MONOGR, V63, P425, DOI 10.2307/2937154; Tschinkel WR, 2006, FIRE ANTS; VINSON SB, 1983, FLA ENTOMOL, V66, P126, DOI 10.2307/3494559; Vogt JT, 2002, ENVIRON ENTOMOL, V31, P47, DOI 10.1603/0046-225X-31.1.47; WHEELER DE, 1991, AM NAT, V138, P1218, DOI 10.1086/285279; Whitehouse MEA, 1996, ANIM BEHAV, V51, P1207, DOI 10.1006/anbe.1996.0126; Wiescher PT, 2012, OECOLOGIA, V169, P1063, DOI 10.1007/s00442-012-2262-7; Wilder SM, 2013, OECOLOGIA, V172, P197, DOI 10.1007/s00442-012-2477-7; Wilder SM, 2011, P NATL ACAD SCI USA, V108, P20639, DOI 10.1073/pnas.1115263108; Wilder SM, 2011, ECOLOGY, V92, P325, DOI 10.1890/10-0623.1; Wilder SM, 2010, ECOL MODEL, V221, P1505, DOI 10.1016/j.ecolmodel.2010.03.010; WILSON EO, 1953, Q REV BIOL, V28, P136, DOI 10.1086/399512; Wolf M, 2007, NATURE, V447, P581, DOI 10.1038/nature05835; Yang AS, 2004, CURR BIOL, V14, P514, DOI 10.1016/j.cub.2004.03.005	80	24	24	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0132440	10.1371/journal.pone.0132440	http://dx.doi.org/10.1371/journal.pone.0132440			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LZ	26196147	gold, Green Published, Green Submitted			2022-12-26	WOS:000358547600035
J	Meijering, RAM; Wiersma, M; van Marion, DMS; Zhang, D; Hoogstra-Berends, F; Dijkhuis, AJ; Schmidt, M; Wieland, T; Kampinga, HH; Henning, RH; Brundel, BJJM				Meijering, Roelien A. M.; Wiersma, Marit; van Marion, Denise M. S.; Zhang, Deli; Hoogstra-Berends, Femke; Dijkhuis, Anne-Jan; Schmidt, Martina; Wieland, Thomas; Kampinga, Harm H.; Henning, Robert H.; Brundel, Bianca J. J. M.			RhoA Activation Sensitizes Cells to Proteotoxic Stimuli by Abrogating the HSF1-Dependent Heat Shock Response	PLOS ONE			English	Article							STRESS; CALPAIN; GTPASES; PHOSPHORYLATION; PROTECTS; COMPLEX; KINASE	Background The heat shock response (HSR) is an ancient and highly conserved program of stress-induced gene expression, aimed at reestablishing protein homeostasis to preserve cellular fitness. Cells that fail to activate or maintain this protective response are hypersensitive to proteotoxic stress. The HSR is mediated by the heat shock transcription factor 1 (HSF1), which binds to conserved heat shock elements (HSE) in the promoter region of heat shock genes, resulting in the expression of heat shock proteins (HSP). Recently, we observed that hyperactivation of RhoA conditions cardiomyocytes for the cardiac arrhythmia atrial fibrillation. Also, the HSR is annihilated in atrial fibrillation, and induction of HSR mitigates sensitization of cells to this disease. Therefore, we hypothesized active RhoA to suppress the HSR resulting in sensitization of cells for proteotoxic stimuli. Methods and Results Stimulation of RhoA activity significantly suppressed the proteotoxic stress-induced HSR in HL-1 atrial cardiomyocytes as determined with a luciferase reporter construct driven by the HSF1 regulated human HSP70 (HSPA1A) promoter and HSP protein expression by Western Blot analysis. Inversely, RhoA inhibition boosted the proteotoxic stress-induced HSR. While active RhoA did not preclude HSF1 nuclear accumulation, phosphorylation, acetylation, or sumoylation, it did impair binding of HSF1 to the hsp genes promoter element HSE. Impaired binding results in suppression of HSP expression and sensitized cells to proteotoxic stress. Conclusion These results reveal that active RhoA negatively regulates the HSR via attenuation of the HSF1-HSE binding and thus may play a role in sensitizing cells to proteotoxic stimuli.	[Meijering, Roelien A. M.; Wiersma, Marit; van Marion, Denise M. S.; Zhang, Deli; Hoogstra-Berends, Femke; Henning, Robert H.; Brundel, Bianca J. J. M.] Univ Groningen, Univ Med Ctr Groningen, Dept Clin Pharm & Pharmacol, Groningen, Netherlands; [Dijkhuis, Anne-Jan; Kampinga, Harm H.] Univ Groningen, Univ Med Ctr Groningen, Dept Cell Biol, Groningen, Netherlands; [Schmidt, Martina] Univ Groningen, Univ Med Ctr Groningen, Dept Cell Biol, Groningen, Netherlands; [Wieland, Thomas] Heidelberg Univ, Mannheim Med Fac, Inst Expt & Clin Pharmacol & Toxicol, Mannheim, Germany; [Brundel, Bianca J. J. M.] Vrije Univ Amsterdam, Med Ctr, Inst Cardiovasc Res, Dept Physiol, Amsterdam, Netherlands	University of Groningen; University of Groningen; University of Groningen; Ruprecht Karls University Heidelberg; Vrije Universiteit Amsterdam	Brundel, BJJM (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Clin Pharm & Pharmacol, Groningen, Netherlands.	B.J.J.M.Brundel@umcg.nl	Wieland, Thomas/G-1772-2012; Wieland, Thomas/Q-1506-2019; Zhang, Deli/ABE-5166-2020; Henning, Robert H/AAY-5222-2020; Schmidt, Martina/C-5339-2018	Wieland, Thomas/0000-0001-8262-8261; Wieland, Thomas/0000-0001-8262-8261; Zhang, Deli/0000-0002-8891-9665; Schmidt, Martina/0000-0003-3075-0630; Henning, Robert/0000-0002-5135-4621; Kampinga, Harm/0000-0002-8966-8466	Dutch Heart Foundation [2007B217, 2009B024, 2013T096, 2013T088, 2013T144]; EFRO grant (Operationeel Programma Noord-Nederland (OP-EFRO)); LSH-Impulse grant [40-43100-98-008]	Dutch Heart Foundation(Netherlands Heart Foundation); EFRO grant (Operationeel Programma Noord-Nederland (OP-EFRO)); LSH-Impulse grant	This study was supported by the Dutch Heart Foundation (2007B217, 2009B024, 2013T096, 2013T088 and 2013T144), EFRO grant (Operationeel Programma Noord-Nederland 2007-2013 (OP-EFRO)), Drug delivery and targeting cluster) and LSH-Impulse grant (40-43100-98-008).	Aarti I, 2010, APOPTOSIS, V15, P679, DOI 10.1007/s10495-010-0474-z; Adam O, 2007, J AM COLL CARDIOL, V50, P359, DOI 10.1016/j.jacc.2007.03.041; Akerfelt M, 2010, NAT REV MOL CELL BIO, V11, P545, DOI 10.1038/nrm2938; Anckar J, 2011, ANNU REV BIOCHEM, V80, P1089, DOI 10.1146/annurev-biochem-060809-095203; Appert-Collin A, 2007, P NATL ACAD SCI USA, V104, P10140, DOI 10.1073/pnas.0701099104; Bevilacqua E, 2010, J BIOL CHEM, V285, P17098, DOI 10.1074/jbc.M110.109439; Brundel BJJM, 2006, CIRC RES, V99, P1394, DOI 10.1161/01.RES.0000252323.83137.fe; Brundel BJJM, 2006, J MOL CELL CARDIOL, V41, P555, DOI 10.1016/j.yjmcc.2006.06.068; Claycomb WC, 1998, P NATL ACAD SCI USA, V95, P2979, DOI 10.1073/pnas.95.6.2979; Coleman ML, 2004, NAT REV MOL CELL BIO, V5, P355, DOI 10.1038/nrm1365; FIGUEIREDOPEREIRA ME, 1994, J NEUROCHEM, V62, P1989; Giguere CJ, 2008, BIOCHEM BIOPH RES CO, V371, P578, DOI 10.1016/j.bbrc.2008.04.133; Hageman J, 2011, BIOCHEM J, V435, P127, DOI 10.1042/BJ20101247; Heldens L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023512; Hietakangas V, 2003, MOL CELL BIOL, V23, P2953, DOI 10.1128/MCB.23.8.2953-2968.2003; Hietakangas V, 2006, P NATL ACAD SCI USA, V103, P45, DOI 10.1073/pnas.0503698102; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Kampinga HH, 2010, NAT REV MOL CELL BIO, V11, P579, DOI 10.1038/nrm2941; Ke L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020395; Kim DH, 2012, INTEGR BIOL-UK, V4, P1019, DOI 10.1039/c2ib20067h; Li Y, 2009, CARDIOVASC DRUG THER, V23, P361, DOI 10.1007/s10557-009-6199-y; Moepps B, 2008, CELL SIGNAL, V20, P1528, DOI 10.1016/j.cellsig.2008.04.010; Morimoto RI, 2008, GENE DEV, V22, P1427, DOI 10.1101/gad.1657108; Morimoto RI, 2011, COLD SH Q B, V76, P91, DOI 10.1101/sqb.2012.76.010637; Morimoto RI, 2014, J GERONTOL A-BIOL, V69, pS33, DOI 10.1093/gerona/glu049; Neef DW, 2014, CELL REP, V9, P955, DOI 10.1016/j.celrep.2014.09.056; PINTER M, 1994, NEUROSCI LETT, V170, P91, DOI 10.1016/0304-3940(94)90246-1; Sah VP, 1999, J CLIN INVEST, V103, P1627, DOI 10.1172/JCI6842; Schinzel R, 2015, CURR OPIN CELL BIOL, V33, P102, DOI 10.1016/j.ceb.2015.01.006; Schmidt M, 1999, J BIOL CHEM, V274, P14648, DOI 10.1074/jbc.274.21.14648; Stankiewicz TR, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00314; Tatum MC, 2015, CURR BIOL, V25, P163, DOI 10.1016/j.cub.2014.11.040; van Oosten-Hawle P, 2014, J EXP BIOL, V217, P129, DOI 10.1242/jeb.091249; Vogt A, 2007, CELL SIGNAL, V19, P1229, DOI 10.1016/j.cellsig.2007.01.003; Westerheide SD, 2009, SCIENCE, V323, P1063, DOI 10.1126/science.1165946; Westerheide SD, 2004, J BIOL CHEM, V279, P56053, DOI 10.1074/jbc.M409267200; Xu GJ, 2013, EXP THER MED, V5, P723, DOI 10.3892/etm.2013.899	37	7	7	5	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2015	10	7							e0133553	10.1371/journal.pone.0133553	http://dx.doi.org/10.1371/journal.pone.0133553			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LN	26193369	Green Published, gold, Green Submitted			2022-12-26	WOS:000358546400102
J	Chao, CH; Su, YF; Chan, HM; Huang, SL; Lin, CL; Kwan, AL; Lou, YT; Chen, CW				Chao, Chia-Hung; Su, Yu-Feng; Chan, Hon-Man; Huang, Shiuh-Lin; Lin, Chih-Lung; Kwan, Aij-Lie; Lou, Yun-Ting; Chen, Chao-Wen			Osteoporosis Self-Assessment Tool for Asians Can Predict Neurologic Prognosis in Patients with Isolated Moderate Traumatic Brain Injury	PLOS ONE			English	Article							BONE-MINERAL DENSITY; PLACEBO-CONTROLLED TRIAL; VITAMIN-D HORMONE; POSTMENOPAUSAL WOMEN; INCREASED RISK; MULTIPLE TRAUMA; IDENTIFY WOMEN; HEAD-INJURY; MRC CRASH; VALIDATION	Objectives Osteoporosis Self-Assessment Tool for Asians (OSTA) has been proved to be a simple and effective tool for recognizing osteoporosis risk. Our previous study has demonstrated that the preoperative OSTA index was a good prognostic predictor for stage II and III colon cancer patients after surgery. We aim to evaluate the value of OSTA index in prognostication of isolated traumatic brain injury with moderate severity (GCS 9-13). Methods We retrospectively reviewed all patients visiting Kaohsiung Medical University Hospital emergency department due to isolated moderate traumatic brain injury from Jan. 2010 to Dec. 2012. Background data (including the OSTA index), clinical presentations, management and outcomes (ICU admission days, total admission days, complications, Glasgow outcome score (GOS) at discharge, mortality) of the patients were recorded for further analysis. Our major outcome was good neurologic recovery defined as GOS of 5. Pearson chisquare test and the Mann-Whitney U test were used to compare demographic features. Multiple logistic regression was used to identify independent risk factors. Results 107 isolated moderate TBI patients were studied. 40 patients (37.4%) showed good recovery and 10 (9.3%) died at discharge. The univariate analysis revealed that younger age, higher OSTA index, lower ISS, lower AIS-H, and avoidance to neurosurgery were associated with better neurologic outcome for all moderate TBI patients. Multivariate analysis revealed that lower ISS, higher OSTA, and the avoidance of neurosurgery were independent risk factors predicting good neurologic recovery. Conclusion Higher ISS, lower OSTA index and exposure to neurosurgery were the independent risk factors for poorer recovery from isolated moderate TBI. In addition to labeling the cohort harboring osteoporotic risk, OSTA index could predict neurologic prognosis in patients with isolated moderate traumatic brain injury.	[Chao, Chia-Hung; Su, Yu-Feng; Huang, Shiuh-Lin; Lin, Chih-Lung; Kwan, Aij-Lie] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Div Neurosurg, Dept Surg, Kaohsiung, Taiwan; [Chao, Chia-Hung] Kaohsiung Med Univ, Coll Med, Grad Inst Med, Kaohsiung, Taiwan; [Chan, Hon-Man; Huang, Shiuh-Lin; Lin, Chih-Lung; Kwan, Aij-Lie] Kaohsiung Med Univ, Dept Surg, Coll Med, Fac Med, Kaohsiung, Taiwan; [Lou, Yun-Ting] I Shou Univ, E DA Hosp, Dept Ophthalmol, Kaohsiung, Taiwan; [Chen, Chao-Wen] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Surg, Div Traumatol, Kaohsiung, Taiwan; [Chen, Chao-Wen] Kaohsiung Med Univ, Dept Emergency Med, Coll Med, Fac Med, Kaohsiung, Taiwan	Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University; E-Da Hospital; I Shou University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University	Chen, CW (corresponding author), Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Surg, Div Traumatol, Kaohsiung, Taiwan.	cwchen@kmu.edu.tw		Su, Yu-feng/0000-0003-0355-3981; Chen, Chao Wen/0000-0002-8405-342X	Ministry of Science and Technology of Taiwan [MOST 102-2314-B-037-045, 103-2627-M-037 -005]; Kaohsiung Medical University [KMU-0M- 17]; National Sun Yat-sen University [NSYSUKMU103-P022]	Ministry of Science and Technology of Taiwan(Ministry of Science and Technology, Taiwan); Kaohsiung Medical University; National Sun Yat-sen University	CWC received the grant from Ministry of Science and Technology of Taiwan (MOST 102-2314-B-037-045 and 103-2627-M-037 -005; http://www.most.gov.tw/), Kaohsiung Medical University (KMU-0M- 17; http://www.kmuh.org.tw/) as well as National Sun Yat-sen University (NSYSUKMU103-P022; www.nsysu.edu.tw/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akbari GA, 2012, ACTA CHIR ORTHOP TR, V79, P535; Bazarian JJ, 2010, J NEUROTRAUM, V27, P527, DOI 10.1089/neu.2009.1068; Blake GM, 2010, SEMIN NUCL MED, V40, P62, DOI 10.1053/j.semnuclmed.2009.08.001; Burge R, 2007, J BONE MINER RES, V22, P465, DOI [10.1359/jbmr.061113, 10.1359/JBMR.061113]; Cekic M, 2010, NEUROTHERAPEUTICS, V7, P81, DOI 10.1016/j.nurt.2009.10.017; Chabas JF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065034; Chaiyakunapruk N, 2006, J AM PHARM ASSOC, V46, P391, DOI 10.1331/154434506777069624; Chawda MN, 2004, INJURY, V35, P347, DOI 10.1016/S0020-1383(03)00140-2; Chen CW, 2013, J SURG RES, V181, P242, DOI 10.1016/j.jss.2012.06.062; Dimai HP, 2012, HEALTH ECON REV, V2, DOI 10.1186/2191-1991-2-12; Edwards P, 2005, LANCET, V365, P1957; Fransiska Y, 2012, J ORTHOP SURG-HONG K, V20, P205, DOI 10.1177/230949901202000214; Gan BK, 2004, ANN ACAD MED SINGAP, V33, P63; Geater Sarayut, 2004, Journal of the Medical Association of Thailand, V87, P1286; Hang NP, 2004, J FORMOS MED ASSOC, V103, P130; Imai Yuuki, 2013, Clin Calcium, V23, P1621, DOI CliCa131116211626; JENNETT B, 1975, LANCET, V1, P480; Koh LKH, 2001, OSTEOPOROSIS INT, V12, P699, DOI 10.1007/s001980170070; Lane NE, 2006, AM J OBSTET GYNECOL, V194, pS3, DOI 10.1016/j.ajog.2005.08.047; Leitgeb J, 2013, ARCH ORTHOP TRAUM SU, V133, P659, DOI 10.1007/s00402-013-1710-0; Li-Yu JT, 2005, OSTEOPOROSIS INT, V16, P1789, DOI 10.1007/s00198-005-1929-x; Liu Min-yan, 2011, Zhonghua Yi Xue Za Zhi, V91, P2112; Marmarou A, 2007, J NEUROTRAUM, V24, P239, DOI 10.1089/neu.2006.0036; Muzha I, 2004, LANCET, V364, P1321, DOI 10.1016/S0140-6736(04)17188-2; Norouzi V, 2013, ARCH TRAUMA RES, V2, P30, DOI [10.5812/atr.9411, 10.5812/atr.940]; Park HM, 2003, J CLIN DENSITOM, V6, P247, DOI 10.1385/JCD:6:3:247; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Reid IR, 2014, LANCET, V383, P146, DOI 10.1016/S0140-6736(13)61647-5; Richy F, 2004, QJM-INT J MED, V97, P39, DOI 10.1093/qjmed/hch002; Rubin KH, 2013, J BONE MINER RES, V28, P1701, DOI 10.1002/jbmr.1956; Rud B, 2007, OSTEOPOROSIS INT, V18, P1177, DOI 10.1007/s00198-006-0319-3; Rud B, 2009, OSTEOPOROSIS INT, V20, P599, DOI 10.1007/s00198-008-0713-0; Sanders S, 2013, SOUTH MED J, V106, P698, DOI 10.1097/SMJ.0b013e3182a0df8b; Simpkins JW, 2010, BBA-GEN SUBJECTS, V1800, P1113, DOI 10.1016/j.bbagen.2009.11.013; Stein DG, 2011, PM&R, V3, pS100, DOI 10.1016/j.pmrj.2011.03.010; Thomas T, 2013, PRESSE MED, V42, P1351, DOI 10.1016/j.lpm.2013.07.008; Wehren LE, 2004, J INTERN MED, V256, P375, DOI 10.1111/j.1365-2796.2004.01397.x; Wolf R L, 2000, Curr Rheumatol Rep, V2, P74, DOI 10.1007/s11926-996-0072-9; Yang Y, 2013, BMC MUSCULOSKEL DIS, V14, DOI 10.1186/1471-2474-14-271	39	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0132685	10.1371/journal.pone.0132685	http://dx.doi.org/10.1371/journal.pone.0132685			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RV	26186582	Green Published, Green Submitted, gold			2022-12-26	WOS:000358198700054
J	Guez, J; Saar-Ashkenazy, R; Mualem, L; Efrati, M; Keha, E				Guez, Jonathan; Saar-Ashkenazy, Rotem; Mualem, Liran; Efrati, Matan; Keha, Eldad			Negative Emotional Arousal Impairs Associative Memory Performance for Emotionally Neutral Content in Healthy Participants	PLOS ONE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; ELDERLY SUBJECTS; CONSOLIDATION; RECOLLECTION; ENHANCEMENT; FAMILIARITY; RESPONSES; PICTURES	The effect of emotional arousal on memory presents a complex pattern with previous studies reporting conflicting results of both improved and reduced memory performance following arousal manipulations. In this study we further tested the effect of negative emotional arousal (NEA) on individual-item recognition and associative recognition of neutral stimuli in healthy participants, and hypothesized that NEA will particularly impair associative memory performance. The current study consists of two experiments; in both, participants studied a list of word-pairs and were then tested for items (items recognition test), and for associations (associative recognition test). In the first experiment, the arousal manipulation was induced by flashing emotionally-negative or neutral pictures between study-pairs while in the second experiment arousal was induced by presenting emotionally-negative or neutral pictures between lists. The results of the two experiments converged and supported an associative memory deficit observed under NEA conditions. We suggest that NEA is associated with an altered ability to bind one stimulus to another as a result of impaired recollection, resulting in poorer associative memory performance. The current study findings may contribute to the understanding of the mechanism underlying memory impairments reported in disorders associated with traumatic stress.	[Guez, Jonathan] Beer Sheva Mental Hlth Ctr, Beer Sheva, Israel; [Guez, Jonathan; Mualem, Liran; Efrati, Matan; Keha, Eldad] Achva Acad Coll, Dept Psychol, Beer Tuvia, Israel; [Saar-Ashkenazy, Rotem] Ben Gurion Univ Negev, Dept Cognit Neurosci, IL-84105 Beer Sheva, Israel; [Saar-Ashkenazy, Rotem] Ben Gurion Univ Negev, Zlotowski Ctr Neurosci, IL-84105 Beer Sheva, Israel; [Saar-Ashkenazy, Rotem] Ashkelon Acad Coll, Dept Psychol, Ashqelon, Israel; [Saar-Ashkenazy, Rotem] Ashkelon Acad Coll, Sch Social Work, Ashqelon, Israel; [Keha, Eldad] Tel Aviv Univ, Dept Psychol, IL-69978 Tel Aviv, Israel	Ben Gurion University; Ben Gurion University; Tel Aviv University	Guez, J (corresponding author), Beer Sheva Mental Hlth Ctr, Beer Sheva, Israel.	jonjon@bgu.ac.il	Guez, Jonathan/M-1620-2019	Guez, Jonathan/0000-0002-4964-7206				American psychiatric association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; Bob P, 2008, MED SCI MONITOR, V14, pCR499; Bremner JD, 2000, PSYCHOL SCI, V11, P333, DOI 10.1111/1467-9280.00266; Brewin CR, 2007, J ABNORM PSYCHOL, V116, P448, DOI 10.1037/0021-843X.116.3.448; Brewin CR, 2011, ANNU REV CLIN PSYCHO, V7, P203, DOI 10.1146/annurev-clinpsy-032210-104544; Danckwerts A, 2003, NEUROPSYCHOL REV, V13, P221, DOI 10.1023/B:NERV.0000009485.76839.b7; Diamond David M., 2007, Neural Plasticity, V2007, P1, DOI 10.1155/2007/60803; Doerksen S, 2001, EMOTION, V1, P5, DOI 10.1037/1528-3542.1.1.5; Ehlers A, 2000, BEHAV RES THER, V38, P319, DOI 10.1016/S0005-7967(99)00123-0; Ehlers A, 2010, INT J PSYCHOPHYSIOL, V78, P27, DOI 10.1016/j.ijpsycho.2010.04.009; Eichenbaum H, 2007, ANNU REV NEUROSCI, V30, P123, DOI 10.1146/annurev.neuro.30.051606.094328; Golier JA, 2002, AM J PSYCHIAT, V159, P1682, DOI 10.1176/appi.ajp.159.10.1682; Greve A, 2011, NEUROPSYCHOLOGIA, V49, P2746, DOI 10.1016/j.neuropsychologia.2011.06.002; Guez J, 2013, PSYCHIAT RES, V209, P479, DOI 10.1016/j.psychres.2012.12.013; Guez J, 2011, J TRAUMA STRESS, V24, P260, DOI 10.1002/jts.20635; Isaac CL, 2006, CLIN PSYCHOL REV, V26, P939, DOI 10.1016/j.cpr.2005.12.004; JACOBY LL, 1991, J MEM LANG, V30, P513, DOI 10.1016/0749-596X(91)90025-F; Karl A, 2006, NEUROSCI BIOBEHAV R, V30, P1004, DOI 10.1016/j.neubiorev.2006.03.004; Kensinger EA, 2003, MEM COGNITION, V31, P1169, DOI 10.3758/BF03195800; Kudielka BM, 1998, J CLIN ENDOCR METAB, V83, P1756, DOI 10.1210/jc.83.5.1756; LANG PJ, 1993, PSYCHOPHYSIOLOGY, V30, P261, DOI 10.1111/j.1469-8986.1993.tb03352.x; Lang PJ, 1999, A4 U FLOR CTR RES PS, DOI DOI 10.1016/J.BIOPSYCH.2010.04.020; Mather M, 2008, J MEM LANG, V58, P449, DOI 10.1016/j.jml.2007.01.004; Mather M, 2009, AM J PSYCHOL, V122, P349; Mather M, 2009, EMOT REV, V1, P118, DOI 10.1177/1754073908100435; MCEWEN BS, 1968, NATURE, V220, P911, DOI 10.1038/220911a0; Nadel L, 1997, CURR OPIN NEUROBIOL, V7, P217, DOI 10.1016/S0959-4388(97)80010-4; Nashiro K, 2011, AM J PSYCHOL, V124, P301, DOI 10.5406/amerjpsyc.124.3.0301; Nashiro K, 2011, EXP AGING RES, V37, P108, DOI 10.1080/0361073X.2011.536746; O'Keane V, 2005, BIOL PSYCHIAT, V58, P963, DOI 10.1016/j.biopsych.2005.04.049; Old SR, 2008, PSYCHOL AGING, V23, P104, DOI 10.1037/0882-7974.23.1.104; Orr SP, 2000, J ABNORM PSYCHOL, V109, P290, DOI 10.1037//0021-843X.109.2.290; ROSNOW RL, 1995, PSYCHOL SCI, V6, P3, DOI 10.1111/j.1467-9280.1995.tb00297.x; Rubinstein O, 2005, WORD ASS NORMS DISCR; Saar-Ashkenazy R, 2014, J TRAUMA STRESS, V27, P18, DOI 10.1002/jts.21887; Samuelson Kristin W, 2011, Dialogues Clin Neurosci, V13, P346; Savic Miroslav M., 2005, Neural Plasticity, V12, P289, DOI 10.1155/NP.2005.289; Schwarze U, 2012, J NEUROSCI, V32, P1481, DOI 10.1523/JNEUROSCI.4497-11.2012; Spielberger C.D., 1983, MANUAL STATE TRAIT A, DOI DOI 10.1002/9780470479216.CORPSY0943; Squire LR, 2007, CURR OPIN NEUROBIOL, V17, P185, DOI 10.1016/j.conb.2007.02.006; Suendermann O, 2010, PSYCHOSOM MED, V72, P301, DOI 10.1097/PSY.0b013e3181d07db8; Wolf OT, 1998, PSYCHONEUROENDOCRINO, V23, P617; Yonelinas AP, 2002, J MEM LANG, V46, P441, DOI 10.1006/jmla.2002.2864; Yonelinas AP, 2005, J NEUROSCI, V25, P3002, DOI 10.1523/JNEUROSCI.5295-04.2005; Zoellner LA, 2000, J ABNORM PSYCHOL, V109, P517, DOI 10.1037//0021-843X.109.3.517	45	4	5	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0132405	10.1371/journal.pone.0132405	http://dx.doi.org/10.1371/journal.pone.0132405			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN1RV	26186001	Green Published, Green Submitted, gold			2022-12-26	WOS:000358198700041
J	Husslik, F; Hanschmann, KM; Kramer, A; von Loetzen, CS; Schweimer, K; Bellinghausen, I; Treudler, R; Simon, JC; Vogel, L; Volker, E; Randow, S; Reuter, A; Rosch, P; Vieths, S; Holzhauser, T; Schiller, D				Husslik, Felix; Hanschmann, Kay-Martin; Kraemer, Ariane; von Loetzen, Christian Seutter; Schweimer, Kristian; Bellinghausen, Iris; Treudler, Regina; Simon, Jan C.; Vogel, Lothar; Voelker, Elke; Randow, Stefanie; Reuter, Andreas; Roesch, Paul; Vieths, Stefan; Holzhauser, Thomas; Schiller, Dirk			Folded or Not? Tracking Bet v 1 Conformation in Recombinant Allergen Preparations	PLOS ONE			English	Article							BIRCH POLLEN ALLERGEN; HIGH-LEVEL EXPRESSION; IMMUNE-RESPONSES; CIRCULAR-DICHROISM; CROSS-REACTIVITY; CELL RESPONSES; APPLE ALLERGEN; POTENTIAL USE; IGE BINDING; IN-VITRO	Background Recombinant Bet v 1a (rBet v 1a) has been used in allergy research for more than three decades, including clinical application of so-called hypoallergens. Quantitative IgE binding to rBet v 1a depends on its native protein conformation, which might be compromised upon heterologous expression, purification, or mutational engineering of rBet v 1a. Objective To correlate experimental/theoretical comparisons of IgE binding of defined molar ratios of folded/misfolded recombinant Bet v 1a variants and to determine accuracy and precision of immuno-and physicochemical assays routinely used to assess the quality of recombinant allergen preparations. Methods rBet v 1a and its misfolded variant rBet v 1a(S112P/R145P) were heterologously expressed and purified from Escherichia coli. Structural integrities and oligomerisation of the recombinant allergens were evaluated by H-1-nuclear magnetic resonance (H-1-NMR), circular dichroism (CD) spectroscopy, and dynamic light scattering (DLS). IgE binding of defined combinations of rBet v 1a and rBet v 1a(S112P/R145P) was assessed using immunoblotting (IB), enzyme-linked immunosorbent assay (ELISA) and mediator release (MR) of humanized rat basophilic leukemia cells sensitized with serum IgE of subjects allergic to birch pollen. Experimental and theoretically expected results of the analyses were compared. Results H-1-NMR spectra of rBet v 1a and rBet v 1a(S112P/R145P) demonstrate a native and highly disordered protein conformations, respectively. The CD spectra suggested typical alpha-helical and beta-sheet secondary structure content of rBet v 1a and random coil for rBet v 1a(S112P/R145P). The hydrodynamic radii (R-H) of 2.49 +/- 0.39 nm (rBet v 1a) and 3.1 +/- 0.56 nm (rBet v 1a(S112P/R145P)) showed monomeric dispersion of both allergens in solution. Serum IgE of birch pollen allergic subjects bound to 0.1% rBet v 1a in the presence of 99.9% of non-IgE binding rBet v 1aS112P/R145P. Immunoblot analysis overestimated, whereas ELISA and mediator release assay underestimated the actual quantity of IgE-reactive rBet v 1a in mixtures of rBet v 1a/rBet v 1aS112P/R145P with a molar ratio of rBet v 1a <= 10%. Conclusion Valid conclusions on quantitative IgE binding of recombinant Bet v 1a preparations depend on the accuracy and precision of physico-and immunochemical assays with which natively folded allergen is detected.	[Husslik, Felix; Kraemer, Ariane; Vogel, Lothar; Voelker, Elke; Randow, Stefanie; Reuter, Andreas; Vieths, Stefan; Holzhauser, Thomas; Schiller, Dirk] Paul Ehrlich Inst, Div Allergol, Langen, Hesse, Germany; [Hanschmann, Kay-Martin] Paul Ehrlich Inst, Biostat Sect, Div EU Cooperat Microbiol, Langen, Hesse, Germany; [von Loetzen, Christian Seutter; Schweimer, Kristian; Roesch, Paul] Univ Bayreuth, Dept Biopolymers, Bayreuth, Bavaria, Germany; [Bellinghausen, Iris] Univ Med Ctr, Dept Dermatol, Mainz, Rhineland Palat, Germany; [Treudler, Regina; Simon, Jan C.] Univ Leipzig, Dept Dermatol Venerol & Allergol, Leipzig, Saxony, Germany	Paul Ehrlich Institute; Paul Ehrlich Institute; University of Bayreuth; Johannes Gutenberg University of Mainz; Leipzig University	Schiller, D (corresponding author), Paul Ehrlich Inst, Div Allergol, Langen, Hesse, Germany.	Dirk.Schiller@pei.de	Holzhauser, Thomas/ABD-5038-2020	Schweimer, Kristian/0000-0002-3837-8442; Reuter, Andreas/0000-0002-6082-9000; Holzhauser, Thomas/0000-0002-7818-7261				Albrecht M, 2008, MOL NUTR FOOD RES, V52, pS186, DOI 10.1002/mnfr.200700424; Berkner H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111691; Bohle B, 2004, J IMMUNOL, V172, P6642, DOI 10.4049/jimmunol.172.11.6642; BRAUN D, 1994, J AM CHEM SOC, V116, P8466, DOI 10.1021/ja00098a005; Ciprandi G, 2012, J Biol Regul Homeost Agents, V26, pS113; D'Amato G, 2007, ALLERGY, V62, P976, DOI 10.1111/j.1398-9995.2007.01393.x; Daniel C, 2006, ALLERGY, V61, P812, DOI 10.1111/j.1398-9995.2006.01071.x; De Amici M, 2003, ANN ALLERG ASTHMA IM, V91, P490, DOI 10.1016/S1081-1206(10)61519-0; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Ferreira F, 1998, FASEB J, V12, P231, DOI 10.1096/fasebj.12.2.231; Ferreira F, 1996, J EXP MED, V183, P599, DOI 10.1084/jem.183.2.599; Fiebig Helmut, 2009, Arb Paul Ehrlich Inst Bundesinstitut Impfstoffe Biomed Arzneim Langen Hess, V96, P71; Gafvelin G, 2005, INT ARCH ALLERGY IMM, V138, P59, DOI 10.1159/000087358; Gajhede M, 1996, NAT STRUCT BIOL, V3, P1040, DOI 10.1038/nsb1296-1040; Gepp B, 2014, J ALLERGY CLIN IMMUN, V134, P188, DOI 10.1016/j.jaci.2013.12.1073; GodnicCvar J, 1997, J ALLERGY CLIN IMMUN, V99, P354, DOI 10.1016/S0091-6749(97)70053-8; GREENFIE.N, 1969, BIOCHEMISTRY-US, V8, P4108, DOI 10.1021/bi00838a031; Gronlund H, 2010, HUM VACCINES, V6, P970, DOI 10.4161/hv.6.12.13348; Hecker J, 2012, ALLERGY, V67, P1530, DOI 10.1111/all.12045; Himly M, 2009, ALLERGY, V64, P1038, DOI 10.1111/j.1398-9995.2009.01957.x; HoffmannSommergruber K, 1997, PROTEIN EXPRES PURIF, V9, P33, DOI 10.1006/prep.1996.0671; Holm J, 2004, J IMMUNOL, V173, P5258, DOI 10.4049/jimmunol.173.8.5258; Holm J, 2011, J BIOL CHEM, V286, P17569, DOI 10.1074/jbc.M110.194878; HOLZWARTH G, 1965, J AM CHEM SOC, V87, P218, DOI 10.1021/ja01080a015; Jahn-Schmid B, 2005, J ALLERGY CLIN IMMUN, V116, P213, DOI 10.1016/j.jaci.2005.04.019; Kahlert H, 2008, INT ARCH ALLERGY IMM, V145, P193, DOI 10.1159/000109288; Kitzmuller C, 2012, ALLERGY, V67, P1375, DOI 10.1111/all.12016; Klinglmayr E, 2009, ALLERGY, V64, P647, DOI 10.1111/j.1398-9995.2008.01844.x; Kofler S, 2014, J BIOL CHEM, V289, P540, DOI 10.1074/jbc.M113.518795; KYHSEANDERSEN J, 1984, J BIOCHEM BIOPH METH, V10, P203, DOI 10.1016/0165-022X(84)90040-X; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Mahler V, 2004, CLIN EXP ALLERGY, V34, P115, DOI 10.1111/j.1365-2222.2004.01857.x; Markovic-Housley Z, 2003, J MOL BIOL, V325, P123, DOI 10.1016/S0022-2836(02)01197-X; MERUTKA G, 1995, J BIOMOL NMR, V5, P14, DOI 10.1007/BF00227466; Meyer W, 2013, ALLERGY, V68, P724, DOI 10.1111/all.12148; Pichler U, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/832404; PIOTTO M, 1992, J BIOMOL NMR, V2, P661, DOI 10.1007/BF02192855; Pree I, 2007, J IMMUNOL, V179, P5309, DOI 10.4049/jimmunol.179.8.5309; Purohit A, 2008, CLIN EXP ALLERGY, V38, P1514, DOI 10.1111/j.1365-2222.2008.03042.x; Schwarzinger S, 2001, J AM CHEM SOC, V123, P2970, DOI 10.1021/ja003760i; Seutter von Loetzen C, 2014, BIOCHEM J, V457, P379, DOI 10.1042/BJ20130413; Siebeneicher S, 2014, ALLERGY, V69, P328, DOI 10.1111/all.12326; Smole U, 2010, IMMUNOBIOLOGY, V215, P903, DOI 10.1016/j.imbio.2009.11.003; Son DY, 1999, EUR J NUTR, V38, P201, DOI 10.1007/s003940050063; Tresch S, 2003, CLIN EXP ALLERGY, V33, P1153, DOI 10.1046/j.1365-2222.2003.01717.x; van Hage-Hamsten M, 2002, CLIN EXP ALLERGY, V32, P1448, DOI 10.1046/j.1365-2745.2002.01495.x; VENYAMINOV SY, 1993, ANAL BIOCHEM, V214, P17, DOI 10.1006/abio.1993.1450; Vieths S, 2012, Pharmeur Bio Sci Notes, V2012, P118; Vogel L, 2005, ALLERGY, V60, P1021, DOI 10.1111/j.1398-9995.2005.00803.x; Wallner M, 2011, J ALLERGY CLIN IMMUN, V127, P1571, DOI 10.1016/j.jaci.2011.01.064; Wiedermann U, 1999, J ALLERGY CLIN IMMUN, V103, P1202, DOI 10.1016/S0091-6749(99)70200-9; WILLIAMSON MP, 1990, BIOPOLYMERS, V29, P1428; Winkler B, 2002, CLIN EXP ALLERGY, V32, P30, DOI 10.1046/j.0022-0477.2001.01214.x; WISHART DS, 1991, J MOL BIOL, V222, P311, DOI 10.1016/0022-2836(91)90214-Q	55	5	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0132956	10.1371/journal.pone.0132956	http://dx.doi.org/10.1371/journal.pone.0132956			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RV	26186356	Green Published, Green Submitted, gold			2022-12-26	WOS:000358198700075
J	Ren, XN; Yang, ZY; Shao, B; Yin, SA; Yang, XG				Ren, Xiangnan; Yang, Zhenyu; Shao, Bing; Yin, Shi-an; Yang, Xiaoguang			B-Vitamin Levels in Human Milk among Different Lactation Stages and Areas in China	PLOS ONE			English	Article							PERFORMANCE LIQUID-CHROMATOGRAPHY; BREAST-MILK; RIBOFLAVIN SUPPLEMENTATION; JAPANESE WOMEN; FOLIC-ACID; THIAMIN; PREGNANCY; PRETERM; MOTHERS; TERM	To determine the contents of B-vitamins in human milk in China, we analyzed 1778 human milk samples from the sample bank of the National High Technique R & D Program (863 Projects) which was a cross-sectional survey and covered 6419 human milk samples from healthy lactating mothers who were at different stages of lactation (0-330 days postpartum) in 11 provinces of China. The contents of free forms of six B-vitamins in these human milk samples were analyzed by using UPLC-MS/MS. The median concentrations of free form of 6 B-vitamins in colostrums, transitional milk, 15-180 d mature milk and 181-330 d mature milk were respectively as follows: thiamin 5.0 mu g/L, 6.7 mu g/L, 21.1 mu g/L and 40.7 mu g/L; riboflavin 29.3 mu g/L, 40.6 mu g/L, 33.6 mu g/L and 29.6 mu g/L; niacin 470.7 mu g/L, 661.3 mu g/L, 687.0 mu g/L and 571.3 mu g/L; vitamin B-6 4.6 mu g/L, 16.1 mu g/L, 62.7 mu g/L and 80.7 mu g/L; flavin adenine dinucleotide (FAD) 808.7 mu g/L, 1162.8 mu g/L, 1023.9 mu g/L and 1057.2 mu g/L; pantothenic acid 1770.9 mu g/L, 2626.8 mu g/L, 2213.0 mu g/L and 1895.5 mu g/L. The contents of 6 B-vitamins varied significantly among the different lactation stages and different areas (coastal area vs inland area, rural area vs urban area). The present study indicated that the concentrations of B-vitamins in colostrum were generally much lower than those in transitional milk and mature milk. Further studies are warranted for their roles and significance on B-vitamins in colostrum in nutrition and metabolism of neonates.	[Ren, Xiangnan; Yang, Zhenyu; Yin, Shi-an; Yang, Xiaoguang] Chinese Ctr Dis Control & Prevent, Natl Inst Nutr & Hlth, Beijing 100050, Peoples R China; [Shao, Bing] Beijing Res Ctr Prevent Med, Beijing Key Lab Diagnost & Traceabil Technol Food, Beijing 100013, Peoples R China	Chinese Center for Disease Control & Prevention	Yin, SA (corresponding author), Chinese Ctr Dis Control & Prevent, Natl Inst Nutr & Hlth, 29 Nan Wei Rd, Beijing 100050, Peoples R China.	shianyin@126.com; xgyangcdc@vip.sina.com	shao, bing/L-8793-2019		National High Technology Research and Development Program of China (863 Program) [2010AA023004]	National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China)	This work was supported by the National High Technology Research and Development Program of China (863 Program) (No. 2010AA023004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Backes JM, 2011, POSTGRAD MED, V123, P70, DOI 10.3810/pgm.2011.03.2265; Blum JW, 1997, J NUTR, V127, P2024, DOI 10.1093/jn/127.10.2024; Bohm V, 1997, Z ERNAHRUNGSWISS, V36, P214, DOI 10.1007/BF01623366; Bowman BA, 1998, PRESENT KNOWLEDGE NU; Boylan LM, 2002, J AM DIET ASSOC, V102, P1433, DOI 10.1016/S0002-8223(02)90317-2; Boylan S, 2011, PUBLIC HEALTH NUTR, V14, P678, DOI 10.1017/S1368980010002570; Chinese Nutrition Society, 2013, CHIN DIET REF INT; Draper CE, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-398; Dror DK, 2012, PAEDIATR PERINAT EP, V26, P55, DOI 10.1111/j.1365-3016.2012.01277.x; Elmadfa I, 2012, INT J VITAM NUTR RES, V82, P342, DOI 10.1024/0300-9831/a000129; FORD JE, 1983, ARCH DIS CHILD, V58, P367, DOI 10.1136/adc.58.5.367; Goedhart Annemiek C., 1994, Nutrition Research Reviews, V7, P1, DOI 10.1079/NRR19940004; Halvin K, 2013, ANAL BIOANAL CHEM, V405, P1213, DOI 10.1007/s00216-012-6538-x; HAMAKER B, 1985, AM J CLIN NUTR, V42, P650, DOI 10.1093/ajcn/42.4.650; Hampel D, 2012, J CHROMATOGR B, V903, P7, DOI 10.1016/j.jchromb.2012.06.024; KARRA MV, 1986, AM J CLIN NUTR, V43, P495, DOI 10.1093/ajcn/43.4.495; Liu HH, 2014, CHINESE J FOOD NUTR, V20, P77; Liu Huihui, 2014, Wei Sheng Yan Jiu, V43, P409; Liu XF, 2007, CHINESE J MODERN PRE, V34, P3321; Ma WJ, 2002, DESCRIPTION GUANGDON; MCCULLOUGH AL, 1990, AM J CLIN NUTR, V51, P1067, DOI 10.1093/ajcn/51.6.1067; McGready R, 2001, AM J CLIN NUTR, V74, P808; NAIL PA, 1980, AM J CLIN NUTR, V33, P198, DOI 10.1093/ajcn/33.2.198; Oguz SS, 2011, J PEDIATR ENDOCR MET, V24, P843, DOI 10.1515/JPEM.2011.318; Ornoy A, 2013, PEDIATR RES, V73, P111, DOI 10.1038/pr.2012.140; Ortega RM, 2004, BRIT J NUTR, V92, P129, DOI 10.1079/BJN20041153; Powers HJ, 2003, AM J CLIN NUTR, V77, P1352; RONNHOLM KA, 1986, AM J CLIN NUTR, V43, P1; ROUGHEAD ZK, 1990, AM J CLIN NUTR, V52, P854, DOI 10.1093/ajcn/52.5.854; Sakurai T, 2005, J NUTR SCI VITAMINOL, V51, P239, DOI 10.3177/jnsv.51.239; Shi YD, 2011, FOOD CHEM, V127, P1193, DOI 10.1016/j.foodchem.2011.01.123; SNEED SM, 1981, AM J CLIN NUTR, V34, P1338, DOI 10.1093/ajcn/34.7.1338; SONG WO, 1984, AM J CLIN NUTR, V40, P317, DOI 10.1093/ajcn/40.2.317; Stamm RA, 2013, NUTRIENTS, V5, P3920, DOI 10.3390/nu5103920; Stelmach W, 2005, PUBLIC HEALTH, V119, P498, DOI 10.1016/j.puhe.2004.09.006; Stuetz W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036280; Stuetz W, 2012, EUR J NUTR, V51, P425, DOI 10.1007/s00394-011-0226-z; THOMAS MR, 1980, AM J CLIN NUTR, V33, P2151, DOI 10.1093/ajcn/33.10.2151; UDIPI SA, 1985, AM J CLIN NUTR, V42, P522, DOI 10.1093/ajcn/42.3.522; Wang DK, 1986, CHINESE J ACTA NUTR, P81; Wang LD, 2002, DESCRIPTION CHINESE, P19; Yagi T, 2013, J NUTR SCI VITAMINOL, V59, P9, DOI 10.3177/jnsv.59.9; Yang YX., 2009, CHINA FOOD COMPOSITI; Yin T, 1989, Ying Yang Xue Bao, V11, P233; Zhai FengYing, 2005, Acta Nutrimenta Sinica, V27, P181; Zhai FY, 2002, DESCRIPTION CHINESE; Zhang L, 2014, VARIATIONS CHEM COMP, P55; Zhao XH, 2011, CORRELATION ANAL LAC, P317	48	11	12	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0133285	10.1371/journal.pone.0133285	http://dx.doi.org/10.1371/journal.pone.0133285			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RV	26186707	Green Submitted, Green Published, gold			2022-12-26	WOS:000358198700120
J	Wang, C; Zhang, J; Deng, WJ; Gong, WY; Liu, X; Ye, ZC; Peng, H; Lou, TQ				Wang, Cheng; Zhang, Jun; Deng, Wenjie; Gong, Wenyu; Liu, Xun; Ye, Zengchun; Peng, Hui; Lou, Tanqi			Nighttime Systolic Blood-Pressure Load Is Correlated with Target-Organ Damage Independent of Ambulatory Blood-Pressure Level in Patients with Non-Diabetic Chronic Kidney Disease	PLOS ONE			English	Article							VENTRICULAR MASS INDEX; DIABETIC-NEPHROPATHY; PRACTICE GUIDELINES; HYPERTENSION; CHILDREN; STRATIFICATION; VARIABILITY; HYPERTROPHY; RISK	Background The impacts of blood pressure (BP) load on target-organ damage in patients with chronic kidney disease (CKD) are largely unclear. We examined whether BP load is correlated with target-organ damage (TOD) in Chinese CKD patients independent of BP level. Methods We recruited 1219 CKD patients admitted to our hospital division in this cross-sectional study. The TOD were measured by estimated glomerular filtration rate (eGFR), proteinuria, left ventricular mass index (LVMI) and carotid intima-media thickness (cIMT) in this study. Univariate and multivariate linear analyses were used to evaluate the relationship between systolic blood pressure (SBP) load, diastolic blood pressure (DBP) load and these renal, cardiovascular parameters. Results In multivariable-adjusted models, BP load and ambulatory BP levels both independently correlated with LVMI, eGFR and proteinuria in all groups of CKD patients (p<0.05), 24-h SBP correlated with cIMT only in non-diabetic CKD patients without hypertension (p<0.05), while nighttime SBP load was associated with cIMT only in non-diabetic CKD patients (p<0.05). Furthermore, nighttime SBP load additionally increased coefficient of determination (R-2) and correlated with LVMI, proteinuria in non-diabetic CKD patients without hypertension (R-2 = 0.034, P<0.001 and R-2 = 0.012, P = 0.006 respectively) and LVMI, cIMT, eGFR in non-diabetic CKD patients with hypertension (R-2>0.008, P<0.05) in multivariable-adjusted model which already including the 24-h BP. BP load did not refine this correlation based on the 24-h BP level in diabetic CKD patients. Conclusion Night-time SBP load was correlated with TOD in patients with non-diabetic chronic kidney disease independent of BP level.	[Wang, Cheng; Zhang, Jun; Deng, Wenjie; Gong, Wenyu; Liu, Xun; Ye, Zengchun; Peng, Hui; Lou, Tanqi] Sun Yat Sen Univ, Affiliated Hosp 3, Dept Med, Div Nephrol, Guangzhou 510630, Guangdong, Peoples R China	Sun Yat Sen University	Lou, TQ (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 3, Dept Med, Div Nephrol, Guangzhou 510630, Guangdong, Peoples R China.	lou.tq@163.com	wang, cheng/A-4225-2017		National Natural Science Foundation of China [81300595]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This project was supported by the National Natural Science Foundation of China (No.81300595). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakris GL, 2009, J CLIN HYPERTENS GRE, P11144; Bidani AK, 2012, AM J MED, V125, P1057, DOI 10.1016/j.amjmed.2012.04.008; Bidani AK, 2009, HYPERTENSION, V54, P393, DOI 10.1161/HYPERTENSIONAHA.109.133777; Bliziotis IA, 2012, J HYPERTENS, V30, P1289, DOI 10.1097/HJH.0b013e3283531eaf; Bostanci BK, 2012, PEDIATR NEPHROL, V27, P1929, DOI 10.1007/s00467-012-2187-8; DEVEREUX RB, 1986, AM J CARDIOL, V57, P450, DOI 10.1016/0002-9149(86)90771-X; Drawz PE, 2010, RENAL FAILURE, V32, P1036, DOI 10.3109/0886022X.2010.510615; Fabbian F, 2013, CHRONOBIOL INT, V30, P17, DOI 10.3109/07420528.2012.715872; Levey AS, 2003, ANN INTERN MED, V139, P137, DOI 10.7326/0003-4819-139-2-200307150-00013; Li JH, 2013, CLIN NEPHROL, V79, P199, DOI 10.5414/CN107401; Li Y, 2014, HYPERTENSION, V63, P925, DOI 10.1161/HYPERTENSIONAHA.113.02780; Liu M, 2013, J HYPERTENS, V31, P1812, DOI 10.1097/HJH.0b013e3283624f9b; Ma YC, 2006, J AM SOC NEPHROL, V17, P2937, DOI 10.1681/ASN.2006040368; Mancia G, 2003, J HYPERTENS, V21, P1011, DOI 10.1097/01.hjh.0000059051.65882.32; O'Brien E, 2005, J HYPERTENS, V23, P697, DOI 10.1097/01.hjh.0000163132.84890.c4; Ptinopoulou AG, 2013, HYPERTENS RES, V36, P91, DOI 10.1038/hr.2012.157; Sarnak MJ, 2003, CIRCULATION; Sarwar N, 2010, LANCET, V375, P2215, DOI 10.1016/S0140-6736(10)60484-9; Sharma AP, 2013, PEDIATR NEPHROL, V28, P1275, DOI 10.1007/s00467-013-2468-x; Sorof JM, 2002, HYPERTENSION, V39, P903, DOI 10.1161/01.HYP.0000013266.40320.3B; Tamura K, 2008, CLIN EXP HYPERTENS, V30, P33, DOI 10.1080/10641960701813890; Tatasciore A, 2007, HYPERTENSION, V50, P325, DOI 10.1161/HYPERTENSIONAHA.107.090084; The Department of Disease Control Ministry of Health China the Chinese Diabetes Society, 2004, CHIN J PREV CONTROL, P12283; Urbina E, 2008, HYPERTENSION, V52, P433, DOI 10.1161/HYPERTENSIONAHA.108.190329; van der Meer IM, 2010, J RENAL CARE, V36, P34, DOI 10.1111/j.1755-6686.2010.00165.x; Wang C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055419; WHITE WB, 1991, J HYPERTENS, V9, pS39; ZACHARIAH PK, 1991, JAMA-J AM MED ASSOC, V265, P1414, DOI 10.1001/jama.265.11.1414; Zhang LX, 2012, LANCET, V379, P815, DOI 10.1016/S0140-6736(12)60033-6	29	17	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0131546	10.1371/journal.pone.0131546	http://dx.doi.org/10.1371/journal.pone.0131546			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RV	26186336	gold, Green Published, Green Submitted			2022-12-26	WOS:000358198700019
J	Chavoshi, SH; De Baets, B; Neutens, T; De Tre, G; Van de Weghe, N				Chavoshi, Seyed Hossein; De Baets, Bernard; Neutens, Tijs; De Tre, Guy; Van de Weghe, Nico			Exploring Dance Movement Data Using Sequence Alignment Methods	PLOS ONE			English	Article							QUALITATIVE TRAJECTORY CALCULUS; REPRESENTING MOVING-OBJECTS; ACTIVITY PATTERNS; SIMILARITY; BLUETOOTH; INFORMATION; DIAGRAMS; SEARCH; SPACE; TIME	Despite the abundance of research on knowledge discovery from moving object databases, only a limited number of studies have examined the interaction between moving point objects in space over time. This paper describes a novel approach for measuring similarity in the interaction between moving objects. The proposed approach consists of three steps. First, we transform movement data into sequences of successive qualitative relations based on the Qualitative Trajectory Calculus (QTC). Second, sequence alignment methods are applied to measure the similarity between movement sequences. Finally, movement sequences are grouped based on similarity by means of an agglomerative hierarchical clustering method. The applicability of this approach is tested using movement data from samba and tango dancers.	[Chavoshi, Seyed Hossein; Neutens, Tijs; Van de Weghe, Nico] Univ Ghent, Dept Geog, B-9000 Ghent, Belgium; [De Baets, Bernard] Univ Ghent, KERMIT, Dept Math Modelling Stat & Bioinformat, B-9000 Ghent, Belgium; [De Tre, Guy] Univ Ghent, Dept Telecommun & Informat Proc, B-9000 Ghent, Belgium	Ghent University; Ghent University; Ghent University	Chavoshi, SH (corresponding author), Univ Ghent, Dept Geog, B-9000 Ghent, Belgium.	seyedhossein.chavoshi@ugent.be	Van de Weghe, Nico/B-7680-2011; De Tre, Guy/C-6374-2014; Neutens, Tijs/A-8623-2015; Van de Weghe, Nico/N-4214-2019; De Baets, Bernard/E-8877-2010	Van de Weghe, Nico/0000-0002-5327-4000; Van de Weghe, Nico/0000-0002-5327-4000; De Baets, Bernard/0000-0002-3876-620X; De Tre, Guy/0000-0002-1283-1915	Special Research Fund of Ghent University (BOF)	Special Research Fund of Ghent University (BOF)(Ghent University)	The authors would like to thank the Special Research Fund of Ghent University (BOF) for supporting the research.	ABBOTT A, 1995, ANNU REV SOCIOL, V21, P93, DOI 10.1146/annurev.so.21.080195.000521; ALLEN JF, 1983, COMMUN ACM, V26, P832, DOI 10.1145/182.358434; [Anonymous], P 31 INT C VER LARG; Bogaert P, 2007, LECT NOTES ARTIF INT, V4387, P20; Brodie M., 2008, SPORTS TECHNOL, V1, P17, DOI [10.1080/19346182.2008.9648447, DOI 10.1080/19346182.2008.9648447, DOI 10.1002/JST.6]; Buchin K., 2009, P 17 ACM SIGSPATIAL, P296, DOI [10.1145/1653771.1653813, DOI 10.1145/1653771.1653813]; Chavoshi SH, 2014, APPL GEOGR, V47, P111, DOI 10.1016/j.apgeog.2013.12.007; Chen L., 2005, P 2005 ACM SIGMOD IN, P491, DOI DOI 10.1145/1066157.1066213; Colombo G, 2013, COMPUT AIDED DESIGN, V10, P671; DeCesare NJ, 2005, WILDLIFE SOC B, V33, P935, DOI 10.2193/0091-7648(2005)33[935:EOFCOG]2.0.CO;2; Delafontaine M., 2012, QUALITATIVE TRAJECTO, P147; Delafontaine M, 2012, APPL GEOGR, V34, P659, DOI 10.1016/j.apgeog.2012.04.003; Delafontaine M, 2011, INFORM SCIENCES, V181, P1573, DOI 10.1016/j.ins.2010.12.021; Delafontaine M, 2011, EXPERT SYST APPL, V38, P5187, DOI 10.1016/j.eswa.2010.10.042; Dodge S, 2011, THESIS U ZURICH ZURI, P160; Dodge S, 2012, INT J GEOGR INF SCI, V26, P1563, DOI 10.1080/13658816.2011.630003; Fabrikant SI, 2008, CARTOGR J, V45, P201, DOI 10.1179/000870408X311396; Faloutsos C, 1998, COMPRESSION AND COMPLEXITY OF SEQUENCES 1997 - PROCEEDINGS, P2, DOI 10.1109/SEQUEN.1997.666899; Frank AU, 1996, INT J GEOGR INF SYST, V10, P269, DOI 10.1080/026937996138043; FREKSA C, 1992, LECT NOTES COMPUT SC, V639, P162; Frentzos E, ICDE 2007 IEEE 23 IN, P816; Gagliardo A, 2007, J EXP BIOL, V210, P1132, DOI 10.1242/jeb.003244; Galton A, 2001, FUND INFORM, V46, P55; Gau RJ, 2004, WILDLIFE SOC B, V32, P693, DOI 10.2193/0091-7648(2004)032[0693:UFPOTG]2.0.CO;2; Giannotti, 2008, MOBILITY DATA MINING, DOI 10.1007/978-3-540-75177-9; Guerra-Salcedo CM, 2005, WMSCI 2005: 9th World Multi-Conference on Systemics, Cybernetics and Informatics, Vol 3, P146; Hornsby K, 2002, ANN MATH ARTIF INTEL, V36, P177, DOI 10.1023/A:1015812206586; Hvidberg M, 2006, EPIDEMIOLOGY, V17, pS38, DOI 10.1097/00001648-200611001-00059; Joh CH, 2002, TRANSPORT RES B-METH, V36, P385, DOI 10.1016/S0191-2615(01)00009-1; Laube P, 2005, INT J GEOGR INF SCI, V19, P639, DOI 10.1080/13658810500105572; Lin B, 2005, P 13 ANN ACM INT WOR, P21; Michael K, 2006, INT SYMP TECHNOL SOC, P97; Miller HJ, 2009, CH CRC DATA MIN KNOW, P1; Mirabella O, 4 INT C HUM SYST INT, P52; Morrison DA., 2010, SYST BIOL, V59, P363; Mount DW, 2007, CSH PROTOCOLS, V2007; Muller M., 2007, INFORM RETRIEVAL MUS, DOI [10.1007/978-3-540- 74048-3_4, DOI 10.1007/978-3-540-74048-3]; NEEDLEMAN SB, 1970, J MOL BIOL, V48, P443, DOI 10.1016/0022-2836(70)90057-4; Ong R, 2011, LECT NOTES ARTIF INT, V6913, P650, DOI 10.1007/978-3-642-23808-6_49; Orellana D, 2012, TOURISM MANAGE, V33, P672, DOI 10.1016/j.tourman.2011.07.010; Pan XS, 2007, AI SOC, V22, P113, DOI 10.1007/s00146-007-0126-1; Pelekis N, 2007, INT WORKSHOP TEMPORA, P129; Randell D. A., 1992, Principles of Knowledge Representation and Reasoning: Proceedings of the Third International Conference (KR '92), P165; Rosenberg MS, 2009, SEQUENCE ALIGNMENT: METHODS, MODELS, CONCEPTS, AND STRATEGIES, P1; Shoval N, 2007, ANN ASSOC AM GEOGR, V97, P282, DOI 10.1111/j.1467-8306.2007.00536.x; Shoval N, 2007, ANN TOURISM RES, V34, P141, DOI 10.1016/j.annals.2006.07.007; Sinha G., 2005, J GEOGRAPHICAL SYSTE, V7, P115, DOI DOI 10.1007/S10109-005-0153-8; Van de Weghe N, 2005, LECT NOTES COMPUT SC, V3770, P228, DOI 10.1007/11568346_25; Van de Weghe N, 2005, LECT NOTES COMPUT SC, V3762, P1087; Van de Weghe N, 2004, INT GEOSCI REMOTE SE, P4157; Van de Weghe N, 2005, EXPERT SYST APPL, V29, P977, DOI 10.1016/j.eswa.2005.06.022; Van de Weghe N, P WORKSH BEH MON INT, P91; Van de Weghe N, 2004, THESIS GHENT U BELG, P268; Van de Weghe N, 2006, CONTROL CYBERN, V35, P97; van Kreveld M., 2007, P 15 ANN ACM INT S A, P1, DOI [10.1145/1341012.1341068, DOI 10.1145/1341012.1341068]; Van Shaick J, 2008, URBANISM TRACK APPL; Versichele M, 2012, SENSORS-BASEL, V12, P14196, DOI 10.3390/s121014196; Versichele M, 2012, APPL GEOGR, V32, P208, DOI 10.1016/j.apgeog.2011.05.011; Vlachos M, 2002, PROC INT CONF DATA, P673, DOI 10.1109/ICDE.2002.994784; Wang LA, 2003, PATTERN RECOGN, V36, P585, DOI 10.1016/S0031-3203(02)00100-0; Wilson C, 2006, ENVIRON PLANN A, V38, P187, DOI 10.1068/a3722; Wilson C, 2001, TRANSPORT RES REC, P55; Wilson C, 2008, TRANSPORTATION, V35, P485, DOI 10.1007/s11116-008-9162-z; Yanagisawa Y, 2003, LECT NOTES COMPUT SC, V2574, P63; Yuan YH, 2014, INT J GEOGR INF SCI, V28, P496, DOI 10.1080/13658816.2013.854369	65	11	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2015	10	7							e0132452	10.1371/journal.pone.0132452	http://dx.doi.org/10.1371/journal.pone.0132452			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RQ	26181435	Green Submitted, gold, Green Published			2022-12-26	WOS:000358198200019
J	Hashimoto, A; Tanaka, M; Takeda, S; Ito, H; Nagano, K				Hashimoto, Ayako; Tanaka, Michinori; Takeda, Satoshi; Ito, Hideki; Nagano, Keisuke			Cilostazol Induces PGI(2) Production via Activation of the Downstream Epac-1/Rap1 Signaling Cascade to Increase Intracellular Calcium by PLC epsilon and to Activate p44/42 MAPK in Human Aortic Endothelial Cells	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; PROSTACYCLIN; ADENOSINE; KINASE; PHOSPHORYLATION; COMBINATION; PROTECTION; MECHANISM; RELEASE; AGENT	Background Cilostazol, a selective phosphodiesterase 3 (PDE3) inhibitor, is known as an anti-platelet drug and acts directly on platelets. Cilostazol has been shown to exhibit vascular protection in ischemic diseases. Although vascular endothelium-derived prostaglandin I-2 (PGI(2)) plays an important role in vascular protection, it is unknown whether cilostazol directly stimulates PGI(2) synthesis in endothelial cells. Here, we elucidate the mechanism of cilostazol-induced PGI(2) stimulation in endothelial cells. Methods and Results Human aortic endothelial cells (HAECs) were stimulated with cilostazol and PGI(2) accumulation in the culture media was measured. Cilostazol increased PGI(2) synthesis via the arachidonic acid pathway. Cilostazol-induced intracellular calcium also promoted PGI(2) synthesis via the inositol 1,4,5-trisphosphate receptor. Using RNAi, silencing of PDE3B abolished the induction effect of cilostazol on PGI(2) synthesis and intracellular cAMP accumulation. Inhibition of the exchange protein, which was directly activated by cyclic AMP 1 (Epac-1) and its downstream signal the Ras-like small GTPase (Rap-1), abolished cilostazol-induced PGI(2) synthesis, but this did not take place via protein kinase A (PKA). Inhibition of downstream signaling, such as mitogen-activated protein kinase (MAPK), phosphoinositide 3-kinase (PI3K) gamma, and phospholipase C (PLC) epsilon, suppressed cilostazol-induced PGI(2) synthesis. Conclusions The PDE3/Epac-1/Rap-1 signaling pathway plays an important role in cilostazol-induced PGI(2) synthesis. Namely, stimulation of HAECs with cilostazol induces intracellular calcium elevation via the Rap-1/PLC epsilon/IP3 pathway, along with MAPK activation via direct activation by Epac-1/Rap-1 and indirect activation by Epac-1/Rap-1/PI3K gamma, resulting in synergistically induced PGI(2) synthesis.	[Hashimoto, Ayako; Ito, Hideki; Nagano, Keisuke] Otsuka Pharmaceut Co Ltd, Inst New Drug Discovery 1, Tokushima, Tokushima 77101, Japan; [Tanaka, Michinori] Otsuka Pharmaceut Co Ltd, Med Chem Res Inst, Tokushima, Tokushima 77101, Japan; [Takeda, Satoshi] Otsuka Pharmaceut Co Ltd, Qs Res Inst, Tokushima, Tokushima 77101, Japan	Otsuka Pharmaceutical; Otsuka Pharmaceutical; Otsuka Pharmaceutical	Hashimoto, A (corresponding author), Otsuka Pharmaceut Co Ltd, Inst New Drug Discovery 1, Tokushima, Tokushima 77101, Japan.	Hashimoto.Ayako@ostuka.jp			Otsuka Pharmaceutical Co., Ltd.	Otsuka Pharmaceutical Co., Ltd.(Otsuka Pharmaceutical)	This study is financially supported by Otsuka Pharmaceutical Co., Ltd. The funder provided support in the form of salaries for all authors, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Blanco FJ, 1999, J RHEUMATOL, V26, P1366; Bonetti PO, 2003, ARTERIOSCL THROM VAS, V23, P168, DOI 10.1161/01.ATV.0000051384.43104.FC; BROTHERTON AFA, 1982, THROMB RES, V28, P637, DOI 10.1016/0049-3848(82)90155-4; Cone J, 1999, J CARDIOVASC PHARM, V34, P497, DOI 10.1097/00005344-199910000-00004; Funk CD, 2007, J CARDIOVASC PHARM, V50, P470, DOI 10.1097/FJC.0b013e318157f72d; Gloerich M, 2010, ANNU REV PHARMACOL, V50, P355, DOI 10.1146/annurev.pharmtox.010909.105714; Hashimoto A, 2006, ATHEROSCLEROSIS, V189, P350, DOI 10.1016/j.atherosclerosis.2006.01.022; Holz GG, 2006, J PHYSIOL-LONDON, V577, P5, DOI 10.1113/jphysiol.2006.119644; IGAWA T, 1990, THROMB RES, V57, P617, DOI 10.1016/0049-3848(90)90079-R; Kambayashi J, 2003, CURR PHARM DESIGN, V9, P2289, DOI 10.2174/1381612033453910; Khazaei M, 2008, Pathophysiology, V15, P49, DOI 10.1016/j.pathophys.2008.02.002; LIN LL, 1993, CELL, V72, P269, DOI 10.1016/0092-8674(93)90666-E; Lugnier C, 2006, PHARMACOL THERAPEUT, V109, P366, DOI 10.1016/j.pharmthera.2005.07.003; Manickavasagam S, 2007, CARDIOVASC DRUG THER, V21, P321, DOI 10.1007/s10557-007-6036-0; Mayati A, 2012, J BIOL CHEM, V287, P4041, DOI 10.1074/jbc.M111.319970; Mitchell JA, 2008, EXP PHYSIOL, V93, P141, DOI 10.1113/expphysiol.2007.038588; NEMENOFF RA, 1993, J BIOL CHEM, V268, P1960; Oyama N, 2011, STROKE, V42, P2571, DOI 10.1161/STROKEAHA.110.609834; Packer M., 1998, FOOD DRUG ADM CARD R, P1; PARSONS WJ, 1988, MOL PHARMACOL, V33, P441; Porto I, 2012, CURR VASC PHARMACOL, V10, P468, DOI 10.2174/157016112800812854; Qiu ZH, 1998, J BIOL CHEM, V273, P8203, DOI 10.1074/jbc.273.14.8203; Ray CJ, 2006, J PHYSIOL-LONDON, V570, P85, DOI 10.1113/jphysiol.2005.099390; Ray CJ, 2002, J PHYSIOL-LONDON, V544, P195, DOI 10.1113/jphysiol.2002.023440; Sheu JJ, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-164; Sudano I, 2006, J CARDIOVASC PHARM, V47, pS136, DOI 10.1097/00005344-200606001-00008; Sudo T, 2000, BIOCHEM PHARMACOL, V59, P347, DOI 10.1016/S0006-2952(99)00346-9; WHITE DG, 1989, BRIT J PHARMACOL, V97, P683, DOI 10.1111/j.1476-5381.1989.tb12004.x; Wilson LS, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.217026; Zhang QH, 2012, BIOCHEM BIOPH RES CO, V420, P17, DOI 10.1016/j.bbrc.2012.02.103	30	17	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2015	10	7							e0132835	10.1371/journal.pone.0132835	http://dx.doi.org/10.1371/journal.pone.0132835			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RQ	26181635	gold, Green Published, Green Submitted			2022-12-26	WOS:000358198200040
J	Solomou, A; Meur, G; Bellomo, E; Hodson, DJ; Tomas, A; Li, SM; Philippe, E; Herrera, PL; Magnan, C; Rutter, GA				Solomou, Antonia; Meur, Gargi; Bellomo, Elisa; Hodson, David J.; Tomas, Alejandra; Li, Stephanie Migrenne; Philippe, Erwann; Herrera, Pedro L.; Magnan, Christophe; Rutter, Guy A.			The Zinc Transporter Slc30a8/ZnT8 Is Required in a Subpopulation of Pancreatic alpha-Cells for Hypoglycemia-induced Glucagon Secretion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						calcium; diabetes; glucagon; secretion; zinc	GENOME-WIDE ASSOCIATION; FREE CYTOSOLIC ZN2+; GLUCOSE-HOMEOSTASIS; INSULIN-RELEASE; RISK LOCI; ISLETS; EXPRESSION; MOUSE; MUTATIONS; RESPONSES	Background: The role of the type 2 diabetes risk gene SLC30A8, encoding ZnT8, in the control of glucagon secretion is not clearly established. Results: Inactivation of ZnT8 in a subset of -cells leads to increased glucagon secretion in vivo and in vitro. Conclusion: ZnT8 is involved in normal glucagon release. Significance:SLC30A8 diabetes risk alleles may influence glucagon secretion. SLC30A8 encodes a zinc transporter ZnT8 largely restricted to pancreatic islet - and -cells, and responsible for zinc accumulation into secretory granules. Although common SLC30A8 variants, believed to reduce ZnT8 activity, increase type 2 diabetes risk in humans, rare inactivating mutations are protective. To investigate the role of Slc30a8 in the control of glucagon secretion, Slc30a8 was inactivated selectively in -cells by crossing mice with alleles floxed at exon 1 to animals expressing Cre recombinase under the pre-proglucagon promoter. Further crossing to Rosa26:tdRFP mice, and sorting of RFP+: glucagon(+) cells from KO mice, revealed recombination in approximate to 30% of -cells, of which approximate to 50% were ZnT8-negative (14 +/- 1.8% of all -cells). Although glucose and insulin tolerance were normal, female ZnT8KO mice required lower glucose infusion rates during hypoglycemic clamps and displayed enhanced glucagon release (p < 0.001) versus WT mice. Correspondingly, islets isolated from ZnT8KO mice secreted more glucagon at 1 mm glucose, but not 17 mm glucose, than WT controls (n = 5; p = 0.008). Although the expression of other ZnT family members was unchanged, cytoplasmic (n = 4 mice per genotype; p < 0.0001) and granular (n = 3, p < 0.01) free Zn2+ levels were significantly lower in KO -cells versus control cells. In response to low glucose, the amplitude and frequency of intracellular Ca2+ increases were unchanged in -cells of ZnT8KO KO mice. ZnT8 is thus important in a subset of -cells for normal responses to hypoglycemia and acts via Ca2+-independent mechanisms.	[Solomou, Antonia; Meur, Gargi; Bellomo, Elisa; Hodson, David J.; Tomas, Alejandra; Rutter, Guy A.] Univ London Imperial Coll Sci Technol & Med, Dept Med, Div Diabet Endocrinol & Metab, Sect Cell Biol & Funct Genom, London W12 0NN, England; [Tomas, Alejandra] Univ Coll London, Inst Ophthalmol, Dept Cell Biol, Greater London EC1V 9EL, England; [Li, Stephanie Migrenne; Philippe, Erwann; Magnan, Christophe] Univ Paris 07, Unit Funct & Adapt Biol BFA EAC CNRS 7059, F-75013 Paris, France; [Herrera, Pedro L.] Univ Geneva, Fac Med, Dept Genet Med & Dev, CH-1211 Geneva 4, Switzerland	Imperial College London; University of London; University College London; UDICE-French Research Universities; Universite Paris Cite; University of Geneva	Rutter, GA (corresponding author), Univ London Imperial Coll Sci Technol & Med, Imperial Ctr Translat & Expt Med, Hammersmith Hosp,Sect Cell Biol & Funct Genom, Dept Med,Div Diabet Endocrinol & Metab, Du Cane Rd, London W12 0NN, England.	g.rutter@imperial.ac.uk	magnan, christophe/AAJ-7622-2021	magnan, christophe/0000-0002-7044-2571; Rutter, Guy/0000-0001-6360-0343; Meur, Gargi/0000-0002-8466-2997; Bellomo, Elisa/0000-0003-4823-2209; Herrera Merino, Pedro Luis/0000-0003-0771-9504; Tomas, Alejandra/0000-0002-2290-8453; Hodson, David/0000-0002-8641-8568	Diabetes UK [BDA 11/0004409, BDA 11/0004210]; Wellcome Trust [081958/Z/07/Z, WT098424AIA]; Medical Research Council (MRC) [GO401641, MR/J0003042/1]; Innovative Medicines Initiative Joint Undertaking [155005]; European Union; European Federation of Pharmaceutical Industries and Associations (EFPIA) companies; MRC [MR/K001981/1] Funding Source: UKRI; Diabetes UK [11/0004409] Funding Source: researchfish; Medical Research Council [MR/K001981/1] Funding Source: researchfish	Diabetes UK(Diabetes UK); Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Innovative Medicines Initiative Joint Undertaking; European Union(European Commission); European Federation of Pharmaceutical Industries and Associations (EFPIA) companies; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Diabetes UK(Diabetes UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by grants from Diabetes UK (Ph.D. studentship BDA 11/0004409 and Project BDA 11/0004210), the Wellcome Trust (Programme 081958/Z/07/Z; Senior Investigator Award WT098424AIA), and the Medical Research Council (MRC) (Project GO401641; Programme MR/J0003042/1) (to G. A. R.). This work was also supported by the Innovative Medicines Initiative Joint Undertaking under Grant Agreement 155005 (IMIDIA), resources of which are composed of financial contribution from the European Union's Seventh Framework Programme (FP7/2007-2013) and European Federation of Pharmaceutical Industries and Associations (EFPIA) companies. The authors declare that they have no conflicts of interest with the contents of this article.	Bellomo EA, 2011, J BIOL CHEM, V286, P25778, DOI 10.1074/jbc.M111.246082; Burgess A, 2010, P NATL ACAD SCI USA, V107, P12564, DOI 10.1073/pnas.0914191107; Cox RD, 2011, DIS MODEL MECH, V4, P155, DOI 10.1242/dmm.000414; Cryer PE, 2002, DIABETOLOGIA, V45, P937, DOI 10.1007/s00125-002-0822-9; Diraison F, 2004, BIOCHEM J, V378, P769, DOI 10.1042/BJ20031277; ELAYAT AA, 1995, J ANAT, V186, P629; Fadista J, 2014, P NATL ACAD SCI USA, V111, P13924, DOI 10.1073/pnas.1402665111; Flannick J, 2014, NAT GENET, V46, P357, DOI 10.1038/ng.2915; Franklin I, 2005, DIABETES, V54, P1808, DOI 10.2337/diabetes.54.6.1808; GEELEN MJH, 1978, FEBS LETT, V90, P57, DOI 10.1016/0014-5793(78)80297-X; Gerber PA, 2014, DIABETOLOGIA, V57, P1635, DOI 10.1007/s00125-014-3266-0; Gyulkhandanyan AV, 2006, J BIOL CHEM, V281, P9361, DOI 10.1074/jbc.M508542200; Haase H, 2005, BIOMETALS, V18, P333, DOI 10.1007/s10534-005-3707-9; Herrera PL, 2000, DEVELOPMENT, V127, P2317; Ishihara H, 2003, NAT CELL BIOL, V5, P330, DOI 10.1038/ncb951; Kawamori D, 2009, CELL METAB, V9, P350, DOI 10.1016/j.cmet.2009.02.007; Kim I, 2011, PHARMACOGENOMICS J, V11, P191, DOI 10.1038/tpj.2010.22; Lee Y, 2011, DIABETES, V60, P391, DOI 10.2337/db10-0426; Lemaire K, 2009, P NATL ACAD SCI USA, V106, P14872, DOI 10.1073/pnas.0906587106; Leung YM, 2006, ENDOCRINOLOGY, V147, P2155, DOI 10.1210/en.2005-1249; Maret W, 2013, ADV NUTR, V4, P82, DOI 10.3945/an.112.003038; Martinez-Sanchez A, 2015, MOL ENDOCRINOL, V29, P1067, DOI 10.1210/me.2015; Nicolson TJ, 2009, DIABETES, V58, P2070, DOI 10.2337/db09-0551; Pound LD, 2009, BIOCHEM J, V421, P371, DOI 10.1042/BJ20090530; Quoix N, 2007, FEBS LETT, V581, P4235, DOI 10.1016/j.febslet.2007.07.068; Ravier MA, 2005, DIABETES, V54, P1789, DOI 10.2337/diabetes.54.6.1789; Ravier MA, 2010, METHODS MOL BIOL, V633, P171, DOI 10.1007/978-1-59745-019-5_12; Rutter GA, 2006, BIOCHEM SOC T, V34, P675, DOI 10.1042/BST0340675; Rutter GA, 2014, DIABETIC MED, V31, P1480, DOI 10.1111/dme.12579; Rutter GA, 2004, NEUROREPORT, V15, P79, DOI 10.1097/00001756-200401190-00016; Rutter GA, 2015, CELL MOL LIFE SCI, V72, P453, DOI 10.1007/s00018-014-1755-4; Rutter GA, 2015, DIABETOLOGIA, V58, P31, DOI 10.1007/s00125-014-3405-7; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Scully Tony, 2012, Nature, V485, pS2; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Stalmans W., 1983, GLUCAGON 1, V66/1, P291; Sun G, 2015, MOL METAB, V4, P277, DOI 10.1016/j.molmet.2015.01.006; Taborsky GJ, 1998, DIABETES, V47, P995, DOI 10.2337/diabetes.47.7.995; Tamaki M, 2013, J CLIN INVEST, V123, P4513, DOI 10.1172/JCI68807; UNGER RH, 1985, DIABETOLOGIA, V28, P574, DOI 10.1007/BF00281991; Vinkenborg JL, 2009, NAT METHODS, V6, P737, DOI [10.1038/NMETH.1368, 10.1038/nmeth.1368]; Voight BF, 2010, NAT GENET, V42, P579, DOI 10.1038/ng.609; Wideman RD, 2006, P NATL ACAD SCI USA, V103, P13468, DOI 10.1073/pnas.0600655103; Wijesekara N, 2010, DIABETOLOGIA, V53, P1656, DOI 10.1007/s00125-010-1733-9; WITTERS LA, 1979, AM J PHYSIOL, V237, pE23, DOI 10.1152/ajpendo.1979.237.1.E23; Woodroofe CC, 2004, CHEM BIOL, V11, P1659, DOI 10.1016/j.chembiol.2004.09.013; Xavier GD, 2009, DIABETES, V58, P894, DOI 10.2337/db08-1187; Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364; Zhou YD, 2014, HUM MOL GENET, V23, P6419, DOI 10.1093/hmg/ddu359	49	33	35	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	2015	290	35					21432	21442		10.1074/jbc.M115.645291	http://dx.doi.org/10.1074/jbc.M115.645291			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CQ5IS	26178371	Green Published, hybrid			2022-12-26	WOS:000360637600020
J	Vanheule, V; Janssens, R; Boff, D; Kitic, N; Berghmans, N; Ronsse, I; Kungl, AJ; Amaral, FA; Teixeira, MM; Van Damme, J; Proost, P; Mortier, A				Vanheule, Vincent; Janssens, Rik; Boff, Daiane; Kitic, Nikola; Berghmans, Nele; Ronsse, Isabelle; Kungl, Andreas J.; Amaral, Flavio Almeida; Teixeira, Mauro Martins; Van Damme, Jo; Proost, Paul; Mortier, Anneleen			The Positively Charged COOH-terminal Glycosaminoglycan-binding CXCL9(74-103) Peptide Inhibits CXCL8-induced Neutrophil Extravasation and Monosodium Urate Crystal-induced Gout in Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						chemokine; glycosaminoglycan; inflammation; migration; neutrophil	IN-VIVO ACTIVITY; HEPARAN-SULFATE; POSTTRANSLATIONAL MODIFICATION; BIOLOGICAL-ACTIVITY; CHEMOKINE ACTIVITY; CXCR3 LIGANDS; ENDOTHELIAL-CELLS; C-TERMINUS; CYTOKINES; IDENTIFICATION	Background: Chemokines, such as CXCL8 and CXCL9, drive leukocyte migration to an inflammation site. Results: CXCL9(74-103), derived from CXCL9, lacks leukocyte-attracting activity but competes with CXCL8 for GAG binding and inhibits neutrophil migration in two murine acute inflammation models. Conclusion: Through inhibition of chemokine-GAG interaction, CXCL9(74-103) blocks neutrophil migration. Significance: CXCL9(74-103) may be a lead molecule for development of anti-inflammatory agents. The ELR-CXC chemokine CXCL9 is characterized by a long, highly positively charged COOH-terminal region, absent in most other chemokines. Several natural leukocyte- and fibroblast-derived COOH-terminally truncated CXCL9 forms missing up to 30 amino acids were identified. To investigate the role of the COOH-terminal region of CXCL9, several COOH-terminal peptides were chemically synthesized. These peptides display high affinity for glycosaminoglycans (GAGs) and compete with functional intact chemokines for GAG binding, the longest peptide (CXCL9(74-103)) being the most potent. The COOH-terminal peptide CXCL9(74-103) does not signal through or act as an antagonist for CXCR3, the G protein-coupled CXCL9 receptor, and does not influence neutrophil chemotactic activity of CXCL8 in vitro. Based on the GAG binding data, an anti-inflammatory role for CXCL9(74-103) was further evidenced in vivo. Simultaneous intravenous injection of CXCL9(74-103) with CXCL8 injection in the joint diminished CXCL8-induced neutrophil extravasation. Analogously, monosodium urate crystal-induced neutrophil migration to the tibiofemural articulation, a murine model of gout, is highly reduced by intravenous injection of CXCL9(74-103). These data show that chemokine-derived peptides with high affinity for GAGs may be used as anti-inflammatory peptides; by competing with active chemokines for binding and immobilization on GAGs, these peptides may lower chemokine presentation on the endothelium and disrupt the generation of a chemokine gradient, thereby preventing a chemokine from properly performing its chemotactic function. The CXCL9 peptide may serve as a lead molecule for further development of inhibitors of inflammation based on interference with chemokine-GAG interactions.	[Vanheule, Vincent; Janssens, Rik; Berghmans, Nele; Ronsse, Isabelle; Van Damme, Jo; Proost, Paul; Mortier, Anneleen] Katholieke Univ Leuven, Rega Inst, Dept Microbiol & Immunol, Lab Mol Immunol, B-3000 Louvain, Belgium; [Boff, Daiane; Amaral, Flavio Almeida; Teixeira, Mauro Martins] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Fisiol & Biofis, BR-31270901 Belo Horizonte, MG, Brazil; [Kitic, Nikola; Kungl, Andreas J.] Karl Franzens Univ Graz, Inst Pharmaceut Sci, Dept Pharmaceut Chem, A-8010 Graz, Austria	KU Leuven; Universidade Federal de Minas Gerais; University of Graz	Proost, P (corresponding author), Katholieke Univ Leuven, Rega Inst, Lab Mol Immunol, Minderbroedersstr 10, B-3000 Louvain, Belgium.	paul.proost@rega.kuleuven.be	Amaral, Flávio Almeida/C-3768-2018; Boff, Daiane/AAU-2149-2021; Proost, Paul/V-3052-2017; Janssens, Rik/S-7744-2017; Teixeira, Mauro M/A-4587-2008	Amaral, Flávio Almeida/0000-0002-1695-0612; Proost, Paul/0000-0002-0133-5545; Janssens, Rik/0000-0003-1428-3921; Teixeira, Mauro M/0000-0002-6944-3008; Boff, Daiane/0000-0001-8127-916X; Mortier, Anneleen/0000-0002-9662-674X; Kungl, Andreas/0000-0003-3362-797X; Van Damme, Jo/0000-0002-6707-1167	Interuniversity Attraction Poles Programme (I.A.P. Project) [7/40]; Fund for Scientific Research of Flanders (FWO-Vlaanderen Projects) [G.0764.14, G.0773.13, G.0D66.13]; Brazilian National Council for Scientific and Technological Development (CNPq); Concerted Research Actions of the Regional Government of Flanders [GOA/12/017]; Hercules foundation of the Flemish government [AKUL/11/31]	Interuniversity Attraction Poles Programme (I.A.P. Project); Fund for Scientific Research of Flanders (FWO-Vlaanderen Projects)(FWO); Brazilian National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Concerted Research Actions of the Regional Government of Flanders; Hercules foundation of the Flemish government	This research was supported by the Interuniversity Attraction Poles Programme initiated by the Belgian Science Policy Office (I.A.P. Project 7/40), the Fund for Scientific Research of Flanders (FWO-Vlaanderen Projects G.0764.14, G.0773.13, and G.0D66.13), the Brazilian National Council for Scientific and Technological Development (CNPq), and the Concerted Research Actions of the Regional Government of Flanders (GOA/12/017). The Hercules foundation of the Flemish government provided funding to purchase LC-MS/MS equipment (Contract AKUL/11/31). The authors declare that they have no conflicts of interest with the contents of this article.	Adage T, 2012, BRIT J PHARMACOL, V167, P1195, DOI 10.1111/j.1476-5381.2012.02089.x; Alcami A, 2010, CURR OPIN IMMUNOL, V22, P482, DOI 10.1016/j.coi.2010.06.004; Ali S, 2000, J BIOL CHEM, V275, P11721, DOI 10.1074/jbc.275.16.11721; Allegretti M, 2012, IMMUNOL LETT, V145, P68, DOI 10.1016/j.imlet.2012.04.003; Amaral FA, 2012, ARTHRITIS RHEUM-US, V64, P474, DOI 10.1002/art.33355; Bao XF, 2010, IMMUNITY, V33, P817, DOI 10.1016/j.immuni.2010.10.018; Bedke J, 2010, MOL IMMUNOL, V47, P1047, DOI 10.1016/j.molimm.2009.11.012; Blackhall FH, 2001, BRIT J CANCER, V85, P1094, DOI 10.1054/bjoc.2001.2054; BRANDT E, 1993, MOL IMMUNOL, V30, P979, DOI 10.1016/0161-5890(93)90123-S; Campanella GSV, 2006, J IMMUNOL, V177, P6991, DOI 10.4049/jimmunol.177.10.6991; Clark-Lewis I, 2003, J BIOL CHEM, V278, P289, DOI 10.1074/jbc.M209470200; Cox JH, 2008, J BIOL CHEM, V283, P19389, DOI 10.1074/jbc.M800266200; Denis C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034199; Dyer DP, 2014, J IMMUNOL, V192, P2177, DOI 10.4049/jimmunol.1300194; EHLERT JE, 1995, J BIOL CHEM, V270, P6338, DOI 10.1074/jbc.270.11.6338; Ehlert JE, 1998, J IMMUNOL, V161, P4975; Ellyard JI, 2007, J BIOL CHEM, V282, P15238, DOI 10.1074/jbc.M608046200; Falsone A., 2013, BIOSCIENCE REP, P33; FARBER JM, 1993, BIOCHEM BIOPH RES CO, V192, P223, DOI 10.1006/bbrc.1993.1403; Feldmann M, 1996, ANNU REV IMMUNOL, V14, P397, DOI 10.1146/annurev.immunol.14.1.397; Gerlza T, 2014, MOLECULES, V19, P10618, DOI 10.3390/molecules190710618; Gouwy M, 2008, MOL PHARMACOL, V74, P485, DOI 10.1124/mol.108.045146; Groom JR, 2011, IMMUNOL CELL BIOL, V89, P207, DOI 10.1038/icb.2010.158; Handel TM, 2005, ANNU REV BIOCHEM, V74, P385, DOI 10.1146/annurev.biochem.72.121801.161747; Hensbergen PJ, 2004, J BIOL CHEM, V279, P13402, DOI 10.1074/jbc.M312814200; Hensbergen PJ, 2001, EUR J BIOCHEM, V268, P4992, DOI 10.1046/j.0014-2956.2001.02433.x; Hileman RE, 1998, BIOESSAYS, V20, P156, DOI 10.1002/(SICI)1521-1878(199802)20:2<156::AID-BIES8>3.3.CO;2-#; Johnson Z, 2005, CYTOKINE GROWTH F R, V16, P625, DOI 10.1016/j.cytogfr.2005.04.006; Keeley EC, 2011, EXP CELL RES, V317, P685, DOI 10.1016/j.yexcr.2010.10.020; Kiefer F, 2011, CELL MOL LIFE SCI, V68, P2811, DOI 10.1007/s00018-011-0677-7; Krijgsveld J, 2000, J BIOL CHEM, V275, P20374, DOI 10.1074/jbc.275.27.20374; Kumar A.V., 2015, CURR PROTEIN PEPT SC, V16, P77; Kuschert GSV, 1998, BIOCHEMISTRY-US, V37, P11193, DOI 10.1021/bi972867o; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; LIAO F, 1995, J EXP MED, V182, P1301, DOI 10.1084/jem.182.5.1301; Liehn EA, 2010, J AM COLL CARDIOL, V56, P1847, DOI 10.1016/j.jacc.2010.04.066; Loos T, 2006, LAB INVEST, V86, P902, DOI 10.1038/labinvest.3700453; Loos T, 2009, METHOD ENZYMOL, V461, P3, DOI 10.1016/S0076-6879(09)05401-9; Mantovani A, 2010, CYTOKINE GROWTH F R, V21, P27, DOI 10.1016/j.cytogfr.2009.11.007; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Massena S, 2010, BLOOD, V116, P1924, DOI 10.1182/blood-2010-01-266072; Middleton J, 1997, CELL, V91, P385, DOI 10.1016/S0092-8674(00)80422-5; Middleton J, 2002, BLOOD, V100, P3853, DOI 10.1182/blood.V100.12.3853; Moelants EAV, 2014, INFECT IMMUN, V82, P2511, DOI 10.1128/IAI.01624-14; Moelants EAV, 2013, IMMUNOL CELL BIOL, V91, P402, DOI 10.1038/icb.2013.16; Mortier A, 2012, IMMUNOL LETT, V145, P2, DOI 10.1016/j.imlet.2012.04.015; Mortier A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023913; Mortier A, 2011, EXP CELL RES, V317, P642, DOI 10.1016/j.yexcr.2010.11.016; Mortier A, 2010, J BIOL CHEM, V285, P29750, DOI 10.1074/jbc.M110.119388; Mortier A, 2008, PHARMACOL THERAPEUT, V120, P197, DOI 10.1016/j.pharmthera.2008.08.006; Murphy PM, 2000, PHARMACOL REV, V52, P145; Nesmelova IV, 2005, J BIOL CHEM, V280, P4948, DOI 10.1074/jbc.M405364200; Nibbs RJB, 2013, NAT REV IMMUNOL, V13, P815, DOI 10.1038/nri3544; Piccinini AM, 2010, J BIOL CHEM, V285, P8782, DOI 10.1074/jbc.M109.043299; Proost P, 2004, J LEUKOCYTE BIOL, V75, P777, DOI 10.1189/jlb.1003524; Proost P, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1997; Proudfoot AEI, 2003, P NATL ACAD SCI USA, V100, P1885, DOI 10.1073/pnas.0334864100; Rot A, 2004, ANNU REV IMMUNOL, V22, P891, DOI 10.1146/annurev.immunol.22.012703.104543; Sadir R, 2004, J BIOL CHEM, V279, P43854, DOI 10.1074/jbc.M405392200; Salanga CL, 2011, EXP CELL RES, V317, P590, DOI 10.1016/j.yexcr.2011.01.004; Sarris M, 2012, CURR BIOL, V22, P2375, DOI 10.1016/j.cub.2012.11.018; Schuh JM, 2003, CYTOKINE GROWTH F R, V14, P503, DOI 10.1016/S1359-6101(03)00057-1; Selvan RS, 1996, ANN NY ACAD SCI, V797, P127, DOI 10.1111/j.1749-6632.1996.tb52955.x; Severin IC, 2010, J BIOL CHEM, V285, P17713, DOI 10.1074/jbc.M109.082552; Struyf S, 2011, BLOOD, V117, P480, DOI 10.1182/blood-2009-11-253591; Szekanecz Zoltan, 2010, Front Biosci (Schol Ed), V2, P153; THOMPSON LD, 1994, BIOCHEMISTRY-US, V33, P3831, DOI 10.1021/bi00179a006; Van den Steen PE, 2003, BIOCHEM BIOPH RES CO, V310, P889, DOI 10.1016/j.bbrc.2003.09.098; Van Raemdonck K, 2014, ONCOTARGET, V5, P10916; Vandercappellen J, 2011, CYTOKINE GROWTH F R, V22, P1, DOI 10.1016/j.cytogfr.2010.10.011; Wang LC, 2005, NAT IMMUNOL, V6, P902, DOI 10.1038/ni1233; Weber M, 2013, SCIENCE, V339, P328, DOI 10.1126/science.1228456	72	43	43	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	2015	290	35					21292	21304		10.1074/jbc.M115.649855	http://dx.doi.org/10.1074/jbc.M115.649855			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CQ5IS	26183778	Green Published, hybrid			2022-12-26	WOS:000360637600009
J	Chung, SA; Nititham, J; Elboudwarej, E; Quach, HL; Taylor, KE; Barcellos, LF; Criswell, LA				Chung, Sharon A.; Nititham, Joanne; Elboudwarej, Emon; Quach, Hong L.; Taylor, Kimberly E.; Barcellos, Lisa F.; Criswell, Lindsey A.			Genome-Wide Assessment of Differential DNA Methylation Associated with Autoantibody Production in Systemic Lupus Erythematosus	PLOS ONE			English	Article							CLINICAL-MANIFESTATIONS; REVISED CRITERIA; HUMAN-DISEASE; I INTERFERON; T-CELLS; RISK; GENE; CLASSIFICATION; PROCAINAMIDE; VARIANTS	Systemic lupus erythematosus (SLE) is characterized by the development of autoantibodies associated with specific clinical manifestations. Previous studies have shown an association between differential DNA methylation and SLE susceptibility, but have not investigated SLE-related autoantibodies. Our goal was to determine whether DNA methylation is associated with production of clinically relevant SLE-related autoantibodies, with an emphasis on the anti-dsDNA autoantibody. In this study, we characterized the methylation status of 467,314 CpG sites in 326 women with SLE. Using a discovery and replication study design, we identified and replicated significant associations between anti-dsDNA autoantibody production and the methylation status of 16 CpG sites (P-discovery<1.07E-07 and P-replication<0.0029) in 11 genes. Associations were further investigated using multivariable regression to adjust for estimated leukocyte cell proportions and population substructure. The adjusted mean DNA methylation difference between anti-dsDNA positive and negative cases ranged from 1.2% to 19%, and the adjusted odds ratio for anti-dsDNA autoantibody production comparing the lowest and highest methylation tertiles ranged from 6.8 to 18.2. Differential methylation for these CpG sites was also associated with anti-SSA, anti-Sm, and anti-RNP autoantibody production. Overall, associated CpG sites were hypomethylated in autoantibody positive compared to autoantibody negative cases. Differential methylation of CpG sites within the major histocompatibility region was not strongly associated with autoantibody production. Genes with differentially methylated CpG sites represent multiple biologic pathways, and have not been associated with autoantibody production in genetic association studies. In conclusion, hypomethylation of CpG sites within genes from different pathways is associated with anti-dsDNA, anti-SSA, anti-Sm, and anti-RNP production in SLE, and these associations are not explained by genetic variation. Thus, studies of epigenetic mechanisms such as DNA methylation represent a complementary method to genetic association studies to identify biologic pathways that may contribute to the clinical heterogeneity of autoimmune diseases.	[Chung, Sharon A.; Nititham, Joanne; Taylor, Kimberly E.; Criswell, Lindsey A.] Univ Calif San Francisco, Rosalind Russell Ephraim P Engleman Rheumatol Re, San Francisco, CA 94143 USA; [Elboudwarej, Emon; Quach, Hong L.; Barcellos, Lisa F.] Univ Calif Berkeley, Sch Publ Hlth, Div Epidemiol, Genet Epidemiol & Genom Lab, Berkeley, CA 94720 USA	University of California System; University of California San Francisco; University of California System; University of California Berkeley	Chung, SA (corresponding author), Univ Calif San Francisco, Rosalind Russell Ephraim P Engleman Rheumatol Re, San Francisco, CA 94143 USA.	sharon.chung@ucsf.edu			National Institutes of Health [5R01-AR052300, 5K24-AR02175, 5P60-AR053308, UCSF-CTSI KL2 RR024130, UCSF-CTSI UL1 TR000004]; Alliance for Lupus Research; Mary Kirkland Scholar Award; Russell/Engleman Medical Research Center for Arthritis; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000004] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR052300, K24AR002175, P60AR053308, K23AR063126] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alliance for Lupus Research; Mary Kirkland Scholar Award; Russell/Engleman Medical Research Center for Arthritis; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	The work was supported by the following: National Institutes of Health (www.nih.gov) grants 5R01-AR052300 (LAC), 5K24-AR02175 (LAC), 5P60-AR053308 (LAC), UCSF-CTSI KL2 RR024130 (SAC), and UCSF-CTSI UL1 TR000004 (SAC); Alliance for Lupus Research (www.lupusresearch.org); Mary Kirkland Scholar Award (http://www.hss.edu/mary-kirkland-scholar-program.asp, LAC); and the Russell/Engleman Medical Research Center for Arthritis (http://www.rosalindrussellcenter.ucsf.edu/, LAC, SAC). The contents of this publication are solely the responsibility of the authors and do not necessarily represent the official views of the NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Absher DM, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003678; Aguiar RCT, 2000, BLOOD, V96, P4328, DOI 10.1182/blood.V96.13.4328.h8004328_4328_4334; Baechler EC, 2003, P NATL ACAD SCI USA, V100, P2610, DOI 10.1073/pnas.0337679100; Barbarulo A, 2013, ONCOGENE, V32, P4231, DOI 10.1038/onc.2012.448; Bell JT, 2012, PLOS GENET, V8, P189, DOI 10.1371/journal.pgen.1002629; Bell JT, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-1-r10; Bronson PG, 2012, CURR OPIN IMMUNOL, V24, P530, DOI 10.1016/j.coi.2012.07.008; Buyon J, 2008, PRIMER RHEUMATIC DIS, P303; Chung SA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001323; Coit P, 2013, J AUTOIMMUN, V43, P78, DOI 10.1016/j.jaut.2013.04.003; CORNACCHIA E, 1988, J IMMUNOL, V140, P2197; Dall'Era MC, 2005, ANN RHEUM DIS, V64, P1692, DOI 10.1136/ard.2004.033753; Dedeurwaerder S, 2011, EPIGENOMICS-UK, V3, P771, DOI [10.2217/EPI.11.105, 10.2217/epi.11.105]; Egger G, 2004, NATURE, V429, P457, DOI 10.1038/nature02625; Fraser HB, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-2-r8; Harley JB, 2008, NAT GENET, V40, P204, DOI 10.1038/ng.81; Hochberg MC, 1997, ARTHRITIS RHEUM, V40, P1725, DOI 10.1002/art.1780400928; Hom G, 2008, NEW ENGL J MED, V358, P900, DOI 10.1056/NEJMoa0707865; Houseman EA, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-86; Isenberg DA, 2007, RHEUMATOLOGY, V46, P1052, DOI 10.1093/rheumatology/kem112; Javierre BM, 2010, GENOME RES, V20, P170, DOI 10.1101/gr.100289.109; Kim JH, 2013, ARTHRITIS RHEUM-US, V65, P1055, DOI 10.1002/art.37854; Kirou KA, 2005, ARTHRITIS RHEUM-US, V52, P1491, DOI 10.1002/art.21031; Liu Y, 2013, NAT BIOTECHNOL, V31, P142, DOI 10.1038/nbt.2487; Morris DL, 2014, GENES IMMUN; NYCE J, 1989, CANCER RES, V49, P5829; Plant D, 2014, NAT REV RHEUMATOL; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; QUDDUS J, 1993, J CLIN INVEST, V92, P38, DOI 10.1172/JCI116576; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Reinius LE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041361; Roberti MC, 2009, VIRCHOWS ARCH, V454, P311, DOI 10.1007/s00428-009-0732-z; Robertson KD, 2005, NAT REV GENET, V6, P597, DOI 10.1038/nrg1655; TAN EM, 1982, ARTHRITIS RHEUM, V25, P1271, DOI 10.1002/art.1780251101; Thorburn CM, 2007, GENES IMMUN, V8, P279, DOI 10.1038/sj.gene.6364383; Touleimat N, 2012, EPIGENOMICS-UK, V4, P325, DOI [10.2217/epi.12.21, 10.2217/EPI.12.21]; Wang D, 2012, BIOINFORMATICS, V28, P729, DOI 10.1093/bioinformatics/bts013; Weckerle CE, 2011, ARTHRITIS RHEUM-US, V63, P1044, DOI 10.1002/art.30187; Yan QS, 2009, MOL CELL, V36, P110, DOI 10.1016/j.molcel.2009.08.019; Zhou Y, 2008, AUTOIMMUN REV, V7, P376, DOI 10.1016/j.autrev.2008.03.003	41	41	41	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2015	10	7							e0129813	10.1371/journal.pone.0129813	http://dx.doi.org/10.1371/journal.pone.0129813			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LN	26192630	Green Submitted, Green Published, gold			2022-12-26	WOS:000358546400004
J	Donaldsson, S; Falk, M; Jonsson, B; Drevhammar, T				Donaldsson, Snorri; Falk, Markus; Jonsson, Baldvin; Drevhammar, Thomas			Imposed Work of Breathing for Flow Meters with In-Line versus Flow-Through Technique during Simulated Neonatal Breathing	PLOS ONE			English	Article							PRETERM INFANTS; NEWBORNS; VENTILATION; PRESSURE; BIRTH; CPAP; PARAMETERS; SYSTEMS; TERM	Background The ability to determine airflow during nasal CPAP (NCPAP) treatment without adding dead space or resistance would be useful when investigating the physiologic effects of different NCPAP systems on breathing. The aim of this study was to investigate the effect on pressure stability of different flow measuring devices at the in-line and flow-through position, using simulated neonatal breathing. Methods Six different flow measure devices were evaluated by recording pressure changes and imposed work of breathing for breaths with 16 and 32 ml tidal volumes. The tests were performed initially with the devices in an in line position and with 5 and 10 L/min using flow through technique, without CPAP. The flow meters were then subsequently tested with an Infant Flow CPAP system at 3, 5 and 8 cm H2O pressure using flow through technique. The quality of the recorded signals was compared graphically. Results The resistance of the measuring devices generated pressure swings and imposed work of breathing. With bias flow, the resistance also generated CPAP pressure. Three of the devices had low resistance and generated no changes in pressure stability or CPAP pressure. The two devices intended for neonatal use had the highest measured resistance. Conclusion The importance of pressure stability and increased work of breathing during non-invasive respiratory support are insufficiently studied. Clinical trials using flow-through technique have not focused on pressure stability. Our results indicate that a flow-through technique might be a way forward in obtaining a sufficiently high signal quality without the added effects of rebreathing and increased work of breathing. The results should stimulate further research and the development of equipment for dynamic flow measurements in neonates.	[Donaldsson, Snorri; Jonsson, Baldvin; Drevhammar, Thomas] Karolinska Inst, Dept Womens & Childrens Hlth, Stockholm, Sweden; [Falk, Markus; Drevhammar, Thomas] Ostersund Hosp, Dept Anaesthesiol, Ostersund, Sweden	Karolinska Institutet	Drevhammar, T (corresponding author), Karolinska Inst, Dept Womens & Childrens Hlth, Stockholm, Sweden.	thomas.drevhammar@regionjh.se	Donaldsson, Snorri/K-6410-2019; Drevhammar, Thomas/ABA-6177-2020	Drevhammar, Thomas/0000-0002-4038-2221; Falk, Markus/0000-0002-4318-5039; Jonsson, Baldvin/0000-0002-9812-732X; Njafloo, Zahra/0000-0003-3151-9625	Research and Development Unit, Jamtland County Council, Sweden [8250]	Research and Development Unit, Jamtland County Council, Sweden	Funding was provided by The Research and Development Unit, Jamtland County Council, Sweden, Grant no 8250 to TD. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDREASSON B, 1988, PEDIATR PULM, V4, P213, DOI 10.1002/ppul.1950040405; Drevhammar T, 2013, PEDIATR CRIT CARE ME, V14, pE196, DOI 10.1097/PCC.0b013e31827212e4; Drevhammar T, 2012, PEDIATR CRIT CARE ME, V13, pE113, DOI 10.1097/PCC.0b013e31822f1b79; Foitzik B, 1998, J APPL PHYSIOL, V85, P1187, DOI 10.1152/jappl.1998.85.3.1187; Foitzik B, 2001, CRIT CARE MED, V29, P413, DOI 10.1097/00003246-200102000-00036; Fouzas S, 2014, J PEDIATR-US, V164, P283, DOI 10.1016/j.jpeds.2013.09.034; Frey U, 2000, EUR RESPIR J, V16, P731, DOI 10.1034/j.1399-3003.2000.16d28.x; Huckstadt T, 2003, INTENS CARE MED, V29, P1134, DOI 10.1007/s00134-003-1785-0; LAHIRI S, 1978, J APPL PHYSIOL, V44, P673, DOI 10.1152/jappl.1978.44.5.673; RIGATTO H, 1972, J APPL PHYSIOL, V32, P423, DOI 10.1152/jappl.1972.32.3.423; RUTTIMANN UE, 1981, CRIT CARE MED, V9, P801, DOI 10.1097/00003246-198111000-00011; Sandberg KL, 2012, NEONATOLOGY, V102, P282, DOI 10.1159/000341765; Schilleman K, 2013, J PEDIATR-US, V162, P457, DOI 10.1016/j.jpeds.2012.09.036; Schmalisch G, 2001, EUR RESPIR J, V17, P108, DOI 10.1183/09031936.01.17101080; te Pas AB, 2009, PEDIATR RES, V65, P352, DOI 10.1203/PDR.0b013e318193f117; THOMSON A, 1983, ARCH DIS CHILD, V58, P891, DOI 10.1136/adc.58.11.891; Vogt B, 2014, PHYSIOL MEAS, V35, pR59, DOI 10.1088/0967-3334/35/3/R59	17	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2015	10	7							e0133432	10.1371/journal.pone.0133432	http://dx.doi.org/10.1371/journal.pone.0133432			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LN	26192188	Green Published, Green Submitted, gold			2022-12-26	WOS:000358546400083
J	Kifle, YW; Goeyvaerts, N; Van Kerckhove, K; Willem, L; Faes, C; Leirs, H; Hens, N; Beutels, P				Kifle, Yimer Wasihun; Goeyvaerts, Nele; Van Kerckhove, Kim; Willem, Lander; Faes, Christel; Leirs, Herwig; Hens, Niel; Beutels, Philippe			Animal Ownership and Touching Enrich the Context of Social Contacts Relevant to the Spread of Human Infectious Diseases	PLOS ONE			English	Article							MIXING PATTERNS; PET OWNERSHIP; HOST-RANGE; TRANSMISSION; PARAMETERS; EMERGENCE; HEALTH; RISK; DOGS	Many human infectious diseases originate from animals or are transmitted through animal vectors. We aimed to identify factors that are predictive of ownership and touching of animals, assess whether animal ownership influences social contact behavior, and estimate the probability of a major zoonotic outbreak should a transmissible influenza-like pathogen be present in animals, all in the setting of a densely populated European country. A diary-based social contact survey (n = 1768) was conducted in Flanders, Belgium, from September 2010 until February 2011. Many participants touched pets (46%), poultry (2%) or livestock (2%) on a randomly assigned day, and a large proportion of participants owned such animals (51%, 15% and 5%, respectively). Logistic regression models indicated that larger households are more likely to own an animal and, unsurprisingly, that animal owners are more likely to touch animals. We observed a significant effect of age on animal ownership and touching. The total number of social contacts during a randomly assigned day was modeled using weighted-negative binomial regression. Apart from age, household size and day type (weekend versus weekday and regular versus holiday period), animal ownership was positively associated with the total number of social contacts during the weekend. Assuming that animal ownership and/or touching are at-risk events, we demonstrate a method to estimate the outbreak potential of zoonoses. We show that in Belgium animal-human interactions involving young children (0-9 years) and adults (25-54 years) have the highest potential to cause a major zoonotic outbreak.	[Kifle, Yimer Wasihun; Goeyvaerts, Nele; Willem, Lander; Hens, Niel; Beutels, Philippe] Univ Antwerp, Vaccine & Infect Dis Inst, CHERMID, B-2020 Antwerp, Belgium; [Kifle, Yimer Wasihun; Goeyvaerts, Nele; Van Kerckhove, Kim; Willem, Lander; Faes, Christel; Hens, Niel] Hasselt Univ, Interuniv Inst Biostat & Stat Bioinformat I BioSt, Diepenbeek, Belgium; [Willem, Lander] Univ Antwerp, Dept Math & Comp Sci, B-2020 Antwerp, Belgium; [Leirs, Herwig] Univ Antwerp, Evolutionary Ecol Grp, B-2020 Antwerp, Belgium; [Beutels, Philippe] Univ New S Wales, Sch Publ Hlth & Community Med, Sydney, NSW, Australia	University of Antwerp; Hasselt University; University of Antwerp; University of Antwerp; University of New South Wales Sydney	Beutels, P (corresponding author), Univ Antwerp, Vaccine & Infect Dis Inst, CHERMID, B-2020 Antwerp, Belgium.	philippe.beutels@uantwerpen.be	Willem, Lander/AAC-4658-2019; Faes, Christel/E-1384-2017; Hens, Niel/M-4445-2017; Beutels, Philippe/A-1919-2010; Leirs, Herwig/B-8197-2008	Willem, Lander/0000-0002-9210-1196; Faes, Christel/0000-0002-1878-9869; Hens, Niel/0000-0003-1881-0637; Beutels, Philippe/0000-0001-5034-3595; Leirs, Herwig/0000-0002-7612-5024; Goeyvaerts, Nele/0000-0003-0526-5318	Concerted Research Action (Geconcerteerde Onderzoeksacties) (GOA) of the University of Antwerp; IAP Research Network of the Belgian State (Belgian Science Policy) [P7/06]; Special Research Fund (Bijzonder Onderzoeksfonds [BOF]) of the University of Antwerp; AXA Research Fund; University of Antwerp scientific chair in Evidence-Based Vaccinology, by a gift from Pfizer	Concerted Research Action (Geconcerteerde Onderzoeksacties) (GOA) of the University of Antwerp; IAP Research Network of the Belgian State (Belgian Science Policy)(Belgian Federal Science Policy Office); Special Research Fund (Bijzonder Onderzoeksfonds [BOF]) of the University of Antwerp; AXA Research Fund(AXA Research Fund); University of Antwerp scientific chair in Evidence-Based Vaccinology, by a gift from Pfizer	This study was financed as part of a Concerted Research Action (Geconcerteerde Onderzoeksacties) (GOA) of the University of Antwerp. Support from the IAP Research Network P7/06 of the Belgian State (Belgian Science Policy) is gratefully acknowledged. LW is supported by an interdisciplinary PhD grant of the Special Research Fund (Bijzonder Onderzoeksfonds [BOF]) of the University of Antwerp. NG is beneficiary of a postdoctoral grant from the AXA Research Fund. NH gratefully acknowledges support from the University of Antwerp scientific chair in Evidence-Based Vaccinology, financed in 2009-2014 by a gift from Pfizer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agresti A., 2013, CATEGORICAL DATA ANA, V3rd ed.; ALBERT A, 1988, J MARRIAGE FAM, V50, P543, DOI 10.2307/352019; Beutels P, 2006, EPIDEMIOL INFECT, V134, P1158, DOI 10.1017/S0950268806006418; Cleaveland S, 2001, PHILOS T R SOC B, V356, P991, DOI 10.1098/rstb.2001.0889; Friedmann E, 1995, THE WALTHAM BOOK OF, P33; Goeyvaerts N, 2010, J R STAT SOC C-APPL, V59, P255, DOI 10.1111/j.1467-9876.2009.00693.x; Greene CE, 2006, INFECT DIS DOG CAT, P1051; Headey B, 2003, MED J AUSTRALIA, V179, P460, DOI 10.5694/j.1326-5377.2003.tb05646.x; Hens N, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-187; Hilbe JM, 2007, NEGATIVE BINOMIAL RE; Horby P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016965; Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536; Katcher A. H., 1982, California Veterinarian, V36, P9; Katcher AH, 1981, INTERRELATIONS PEOPL, P41; McNicholas J, 2005, BMJ-BRIT MED J, V331, P1252, DOI 10.1136/bmj.331.7527.1252; McNicholas J, 2000, BRIT J PSYCHOL, V91, P61, DOI 10.1348/000712600161673; Melegaro A, 2011, EPIDEMICS-NETH, V3, P143, DOI 10.1016/j.epidem.2011.04.001; Mossong J, 2008, PLOS MED, V5, P381, DOI 10.1371/journal.pmed.0050074; Ogunjimi B, 2009, MATH BIOSCI, V218, P80, DOI 10.1016/j.mbs.2008.12.009; Read JM, 2012, EPIDEMIOL INFECT, V140, P2117, DOI 10.1017/S0950268812000842; ROBINS DM, 1991, J CONTEMP ETHNOGR, V20, P3, DOI 10.1177/089124191020001001; Sakamoto Y, 1986, AKAIKE INFORMATION C; Singh S, 2013, ARXIV PREPRINT; Taylor LH, 2001, PHILOS T R SOC B, V356, P983, DOI 10.1098/rstb.2001.0888; Voith VL, 2009, VET CLIN N AM-SMALL, V39, P327, DOI 10.1016/j.cvsm.2008.10.014; Wallinga J, 2006, AM J EPIDEMIOL, V164, P936, DOI 10.1093/aje/kwj317; Westgarth Carri, 2007, BMC Vet Res, V3, P5, DOI 10.1186/1746-6148-3-5; Willem L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048695; Woolhouse MEJ, 2005, EMERG INFECT DIS, V11, P1842, DOI 10.3201/eid1112.050997	29	10	10	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2015	10	7							e0133461	10.1371/journal.pone.0133461	http://dx.doi.org/10.1371/journal.pone.0133461			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LN	26193480	Green Submitted, Green Published, gold			2022-12-26	WOS:000358546400091
J	Malaponte, G; Signorelli, SS; Bevelacqua, V; Polesel, J; Taborelli, M; Guarneri, C; Fenga, C; Umezawa, K; Libra, M				Malaponte, Grazia; Signorelli, Salvatore S.; Bevelacqua, Valentina; Polesel, Jerry; Taborelli, Martina; Guarneri, Claudio; Fenga, Concettina; Umezawa, Kazou; Libra, Massimo			Increased Levels of NF-kappa B-Dependent Markers in Cancer-Associated Deep Venous Thrombosis	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; ENDOTHELIAL GROWTH-FACTOR; TISSUE FACTOR EXPRESSION; PROINFLAMMATORY CYTOKINE EXPRESSION; PERIPHERAL ARTERIAL-DISEASE; BLOOD MONONUCLEAR-CELLS; FACTOR-ALPHA; PROCOAGULANT ACTIVITY; INFLAMMATORY STIMULI; PLASMA-LEVELS	Several studies highlight the role of inflammatory markers in thrombosis as well as in cancer. However, their combined role in cancer-associated deep vein thrombosis (DVT) and the molecular mechanisms, involved in its pathophysiology, needs further investigations. In the present study, C-reactive protein, interleukin-6 (IL-6), tumor necrosis factor-alpha (TNF-alpha), interleukin-1 (IL-1 beta), matrix metalloproteases-9 (MMP-9), vascular endothelial growth factor (VEGF), tissue factor (TF), fibrinogen and soluble P-selectin, were analyzed in plasma and in monocyte samples from 385 cancer patients, of whom 64 were concomitantly affected by DVT (+). All these markers were higher in cancer patients DVT+ than in those DVT-. Accordingly, significantly higher NF-kappa B activity was observed in cancer patients DVT + than DVT-. Significant correlation between data obtained in plasma and monocyte samples was observed. NF-kappa B inhibition was associated with decreased levels of all molecules in both cancer DVT+ and DVT-. To further demonstrate the involvement of NF-kappa B activation by the above mentioned molecules, we treated monocyte derived from healthy donors with a pool of sera from cancer patients with and without DVT. These set of experiments further suggest the significant role played by some molecules, regulated by NF-kappa B , and detected in cancer patients with DVT. Our data support the notion that NF-kappa B may be considered as a therapeutic target for cancer patients, especially those complicated by DVT. Treatment with NF-kappa B inhibitors may represent a possible strategy to prevent or reduce the risk of DVT in cancer patients.	[Malaponte, Grazia; Bevelacqua, Valentina; Libra, Massimo] Univ Catania, Dept Biomed & Biotechnol Sci, Sect Gen & Clin Pathol & Oncol, Catania, Italy; [Signorelli, Salvatore S.] Univ Catania, Garibaldi Hosp, Dept Clin & Expt Med, Med Angiol Unit, Catania, Italy; [Polesel, Jerry; Taborelli, Martina] Natl Canc Inst, Ctr Riferimento Oncol, Epidemiol & Biostat Unit, Aviano, Italy; [Guarneri, Claudio] Univ Messina, Dept Clin & Expt Med, Dermatol Sect, Messina, Italy; [Fenga, Concettina] Univ Messina, SASATAS, Dept Environm & Hlth Sci, Messina, Italy; [Umezawa, Kazou] Aichi Med Univ, Dept Mol Target Med Screening, Nagakute, Aichi 48011, Japan	University of Catania; University of Catania; IRCCS Aviano (CRO); University of Messina; University of Messina; Aichi Medical University	Signorelli, SS (corresponding author), Univ Catania, Garibaldi Hosp, Dept Clin & Expt Med, Med Angiol Unit, Catania, Italy.	ssignore@unict.it	Libra, Massimo/L-8241-2018; Taborelli, Martina/J-3595-2018; Libra, Massimo/ABF-6654-2020; Polesel, Jerry/AAA-5750-2019; Fenga, Concettina/AAC-2150-2019	Libra, Massimo/0000-0002-7232-7737; Taborelli, Martina/0000-0002-6731-7569; Libra, Massimo/0000-0002-7232-7737; Polesel, Jerry/0000-0001-9381-1520; Fenga, Concettina/0000-0001-6369-2700; MALAPONTE, Grazia/0000-0001-6595-1198; SIGNORELLI, Salvatore Santo/0000-0001-9264-0061				Adzic M, 2006, REDOX REP, V11, P38, DOI 10.1179/135100006X101002; Aggarwal BB, 2009, CURR OPIN PHARMACOL, V9, P351, DOI 10.1016/j.coph.2009.06.020; Ariga A, 2002, J BIOL CHEM, V277, P24625, DOI 10.1074/jbc.M112063200; Ay C, 2008, BLOOD, V112, P2703, DOI 10.1182/blood-2008-02-142422; Balkwill F, 2001, LANCET, V357, P539, DOI 10.1016/S0140-6736(00)04046-0; Cardile V, 2010, CELL PHYSIOL BIOCHEM, V25, P543, DOI 10.1159/000303058; Castellano G, 2008, CLIN CANCER RES, V14, P7470, DOI 10.1158/1078-0432.CCR-08-0870; CELI A, 1994, P NATL ACAD SCI USA, V91, P8767, DOI 10.1073/pnas.91.19.8767; CERMAK J, 1993, BLOOD, V82, P513, DOI 10.1182/blood.V82.2.513.513; Chen Z, 1999, CLIN CANCER RES, V5, P1369; Christiansen SC, 2006, PLOS MED, V3, P1414, DOI 10.1371/journal.pmed.0030334; Cohen T, 1996, J BIOL CHEM, V271, P736, DOI 10.1074/jbc.271.2.736; CONKLING PR, 1988, BLOOD, V72, P128; Costa Carla, 2007, Angiogenesis, V10, P149, DOI 10.1007/s10456-007-9074-0; Culig Z, 2011, BBA-MOL CELL RES, V1813, P308, DOI 10.1016/j.bbamcr.2010.12.010; Dima SO, 2012, PANCREAS, V41, P1001, DOI 10.1097/MPA.0b013e3182546e13; Dong G, 1999, CANCER RES, V59, P3495; Duffey DC, 1999, CANCER RES, V59, P3468; ECONOMOU JS, 1988, INT J CANCER, V42, P712, DOI 10.1002/ijc.2910420514; EDWARDS RL, 1979, BLOOD, V54, P359; Esmon CT, 2000, HAEMOSTASIS, V30, P34; Falanga A, 2001, INT J HEMATOL, V73, P137, DOI 10.1007/BF02981929; Forster Y, 2003, CANCER LETT, V193, P65, DOI 10.1016/S0304-3835(02)00687-0; Goldberg JE, 2010, CURR DRUG TARGETS, V11, P1133; Goldenberg N, 2003, J CLIN ONCOL, V21, P4194, DOI 10.1200/JCO.2003.05.165; Grignani G, 2000, HAEMATOLOGICA, V85, P967; Grignani G, 1998, HAEMATOLOGICA, V83, pS20; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Haddad TC, 2006, THROMB RES, V118, P555, DOI 10.1016/j.thromres.2005.10.015; Han X, 2014, J HEMATOL ONCOL, V7, DOI 10.1186/s13045-014-0054-8; Hopkins MH, 2012, BIOMARK INSIGHTS, V7, P143, DOI 10.4137/BMI.S10092; HU TF, 1994, ONCOL RES, V6, P321; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; Khorana AA, 2007, J THROMB HAEMOST, V5, P632, DOI 10.1111/j.1538-7836.2007.02374.x; Khorana AA, 2012, HEMATOL-AM SOC HEMAT, P626, DOI 10.1182/asheducation-2012.1.626; Kimura YN, 2007, CANCER SCI, V98, P2009, DOI 10.1111/j.1349-7006.2007.00633.x; Kwon KA, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-203; Lampiasi N, 2009, MOL PHARMACOL, V76, P290, DOI 10.1124/mol.109.055418; Lwaleed BA, 2000, SAUDI MED J, V21, P722; Lwaleed BA, 1999, BRIT J CANCER, V80, P279, DOI 10.1038/sj.bjc.6690352; Macri A, 2006, BIOMARKERS, V11, P184, DOI 10.1080/13547500600565677; Maeda S, 2008, CANCER SCI, V99, P836, DOI 10.1111/j.1349-7006.2008.00763.x; Makin AJ, 2003, CLIN SCI, V104, P397, DOI 10.1042/CS20020182; Malaponte G, 2013, CYTOKINE, V62, P64, DOI 10.1016/j.cyto.2013.02.017; Matsumoto G, 2005, CLIN CANCER RES, V11, P1287; Matsumoto N, 2000, BIOORG MED CHEM LETT, V10, P865, DOI 10.1016/S0960-894X(00)00114-1; Mechtcheriakova D, 1999, BLOOD, V93, P3811, DOI 10.1182/blood.V93.11.3811.411k40_3811_3823; Mercurio F, 1999, CURR OPIN CELL BIOL, V11, P226, DOI 10.1016/S0955-0674(99)80030-1; Merogi AJ, 1997, HUM PATHOL, V28, P321, DOI 10.1016/S0046-8177(97)90131-3; MORGAN D, 1988, HAEMOSTASIS, V18, P55; Moses AGW, 2009, ONCOL REP, V21, P1091, DOI 10.3892/or_00000328; NAKASHIMA J, 1995, CANCER RES, V55, P4881; Nowak M, 2010, SCAND J IMMUNOL, V71, P91, DOI 10.1111/j.1365-3083.2009.02350.x; Ono M, 2008, CANCER SCI, V99, P1501, DOI 10.1111/j.1349-7006.2008.00853.x; Osterud B, 1998, BLOOD COAGUL FIBRIN, V9, pS9; Pikarsky E, 2004, NATURE, V431, P461, DOI 10.1038/nature02924; Pollard JW, 2004, NAT REV CANCER, V4, P71, DOI 10.1038/nrc1256; Rak J, 2006, SEMIN THROMB HEMOST, V32, P54, DOI 10.1055/s-2006-933341; RICKLES FR, 1995, THROMB HAEMOSTASIS, V74, P391; RICKLES FR, 1983, BLOOD, V62, P14; Rickles FR, 2001, THROMB RES, V102, pV215, DOI 10.1016/S0049-3848(01)00285-7; Roselli M, 2003, THROMB HAEMOSTASIS, V89, P177; Ryuto M, 1996, J BIOL CHEM, V271, P28220, DOI 10.1074/jbc.271.45.28220; Sallah S, 2002, THROMB HAEMOSTASIS, V87, P575; Schauer IG, 2013, NEOPLASIA, V15, P409, DOI 10.1593/neo.121228; Setia S, 2014, BIOMED PHARMACOTHER, V68, P119, DOI 10.1016/j.biopha.2013.09.003; Signorelli SS, 2014, INT J MOL MED, V33, P777, DOI 10.3892/ijmm.2014.1657; Signorelli SS, 2003, VASC MED, V8, P15, DOI 10.1191/1358863x03vm466oa; Song CJ, 2006, J THROMB HAEMOST, V4, P98, DOI 10.1111/j.1538-7836.2005.01705.x; Sorensen HT, 1998, NEW ENGL J MED, V338, P1169, DOI 10.1056/NEJM199804233381701; Suzuki E, 2006, BIOMED PHARMACOTHER, V60, P578, DOI 10.1016/j.biopha.2006.07.089; Szaba FM, 2002, BLOOD, V99, P1053, DOI 10.1182/blood.V99.3.1053; Szotowski B, 2005, CIRC RES, V96, P1233, DOI 10.1161/01.RES.0000171805.24799.fa; tenCate JW, 1997, THROMB HAEMOSTASIS, V78, P415; Umezawa K, 2002, MOL CELLS, V14, P163; Vieira LM, 2007, THROMB RES, V119, P157, DOI 10.1016/j.thromres.2006.01.005; Wun T, 2009, CANCER INVEST, V27, P63, DOI 10.1080/07357900802656681; Yoshida N, 2002, BRIT J CANCER, V86, P1396, DOI 10.1038/sj.bjc.6600257	78	36	39	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2015	10	7							e0132496	10.1371/journal.pone.0132496	http://dx.doi.org/10.1371/journal.pone.0132496			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LN	26192925	Green Published, gold, Green Submitted			2022-12-26	WOS:000358546400028
J	Ramadan, KSE; Evoy, S				Ramadan, Khaled Sayed Elbadawi; Evoy, Stephane			Low Temperature Reactive Sputtering of Thin Aluminum Nitride Films on Metallic Nanocomposites	PLOS ONE			English	Article							SURFACE-PLASMON RESONANCE; MAGNETIC-FIELD; COLI; BIOSENSORS; PROTEINS; PROBES; PHAGE; ORIENTATION; DEPOSITION; SYSTEM	Piezoelectric aluminum nitride thin films were deposited on aluminum-molybdenum (AlMo) metallic nanocomposites using reactive DC sputtering at room temperature. The effect of sputtering parameters on film properties was assessed. A comparative study between AlN grown on AlMo and pure aluminum showed an equivalent (002) crystallographic texture. The piezoelectric coefficients were measured to be 0.5 +/- 0.1 C m(-2) and 0.9 +/- 0.1 C m(-2), for AlN deposited on Al/0.32Mo and pure Al, respectively. Films grown onto Al/0.32Mo however featured improved surface roughness. Roughness values were measured to be 1.3nm and 5.4 nm for AlN films grown on AlMo and on Al, respectively. In turn, the dielectric constant was measured to be 8.9 +/- 0.7 for AlN deposited on Al/0.32Mo seed layer, and 8.7 +/- 0.7 for AlN deposited on aluminum; thus, equivalent within experimental error. Compatibility of this room temperature process with the lift-off patterning of the deposited AlN is also reported.	[Ramadan, Khaled Sayed Elbadawi; Evoy, Stephane] Univ Alberta, Dept Elect & Comp Engn, Edmonton, AB T6G 2V4, Canada	University of Alberta	Evoy, S (corresponding author), Univ Alberta, Dept Elect & Comp Engn, 9211-116th St, Edmonton, AB T6G 2V4, Canada.	sevoy@uaberta.ca			Natural Sciences and Engineering Research Council of Canada, through its Discovery Grant Program	Natural Sciences and Engineering Research Council of Canada, through its Discovery Grant Program(Natural Sciences and Engineering Research Council of Canada (NSERC))	The work was funded by the Natural Sciences and Engineering Research Council of Canada, through its Discovery Grant Program. The funding agency had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ababneh A, 2010, MATER SCI ENG B-ADV, V172, P253, DOI 10.1016/j.mseb.2010.05.026; Abdel-Hamid I, 1999, BIOSENS BIOELECTRON, V14, P309, DOI 10.1016/S0956-5663(99)00004-4; Abdel-Hamid I, 1998, SENSOR ACTUAT B-CHEM, V49, P202, DOI 10.1016/S0925-4005(98)00125-7; Amiri-Jami M, 2006, BIOTECHNOL LETT, V28, P1187, DOI 10.1007/s10529-006-9077-8; Arya SK, 2011, ANALYST, V136, P486, DOI 10.1039/c0an00697a; Assouar MB, 2007, J APPL PHYS, V101, DOI 10.1063/1.2739218; Balasubramanian S, 2007, BIOSENS BIOELECTRON, V22, P948, DOI 10.1016/j.bios.2006.04.003; Caliendo C, 2003, THIN SOLID FILMS, V441, P32, DOI 10.1016/S0040-6090(03)00911-8; Campbell GA, 2007, SENSOR ACTUAT B-CHEM, V126, P354, DOI 10.1016/j.snb.2007.03.021; Chibli H, 2014, ANALYST, V139, P179, DOI 10.1039/c3an01608k; Cole M, 2015, SENSOR ACTUAT B-CHEM, V207, P1147, DOI 10.1016/j.snb.2014.09.029; Cooper MA, 2002, NAT REV DRUG DISCOV, V1, P515, DOI 10.1038/nrd838; Ekinci KL, 2002, APPL PHYS LETT, V81, P2253, DOI 10.1063/1.1507833; Feng XL, 2008, NAT NANOTECHNOL, V3, P342, DOI 10.1038/nnano.2008.125; Fischer LM, 2008, SENSOR ACTUAT B-CHEM, V134, P613, DOI 10.1016/j.snb.2008.06.003; Fung YS, 2001, ANAL CHEM, V73, P5302, DOI 10.1021/ac010655y; Galca AC, 2012, THIN SOLID FILMS, V524, P328, DOI 10.1016/j.tsf.2012.10.015; Gartia MR, 2012, J ENVIRON MONITOR, V14, P3068, DOI 10.1039/c2em30380a; Gau JJ, 2001, BIOSENS BIOELECTRON, V16, P745, DOI 10.1016/S0956-5663(01)00216-0; Gervals L, 2007, SENSOR ACTUAT B-CHEM, V125, P615, DOI 10.1016/j.snb.2007.03.007; Giuliano KA, 1998, TRENDS BIOTECHNOL, V16, P135, DOI 10.1016/S0167-7799(97)01166-9; Guthy C, 2013, SENSOR ACTUAT B-CHEM, V187, P111, DOI 10.1016/j.snb.2012.09.070; Haes AJ, 2005, J AM CHEM SOC, V127, P2264, DOI 10.1021/ja044087q; Ilic B, 2001, J VAC SCI TECHNOL B, V19, P2825, DOI 10.1116/1.1421572; Ilic B, 2004, APPL PHYS LETT, V85, P2604, DOI 10.1063/1.1794378; Ivaldi P, 2011, J MICROMECH MICROENG, V21, DOI 10.1088/0960-1317/21/8/085023; Jaber B, 1997, SENSOR ACTUAT A-PHYS, V63, P91, DOI 10.1016/S0924-4247(97)01530-6; Jin H, 2012, THIN SOLID FILMS, V520, P4863, DOI 10.1016/j.tsf.2012.03.015; Joung HA, 2008, ANAL CHIM ACTA, V630, P168, DOI 10.1016/j.aca.2008.10.001; Keusgen M, 2002, NATURWISSENSCHAFTEN, V89, P433, DOI 10.1007/s00114-002-0358-3; Khatir NM, 2014, SENSORS-BASEL, V14, P19229, DOI 10.3390/s141019229; Khatir NM, 2012, SENSORS-BASEL, V12, P3578, DOI 10.3390/s120303578; Lee Z, 2006, NANOTECHNOLOGY, V17, P3063, DOI 10.1088/0957-4484/17/12/042; Li M, 2007, NAT NANOTECHNOL, V2, P114, DOI 10.1038/nnano.2006.208; Liao JC, 2006, J CLIN MICROBIOL, V44, P561, DOI 10.1128/JCM.44.2.561-570.2006; Liao WC, 2009, ANAL CHEM, V81, P2470, DOI 10.1021/ac8020517; Liu HY, 2013, J CRYST GROWTH, V363, P80, DOI 10.1016/j.jcrysgro.2012.10.008; Luber E, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/12/125705; Marauska S, 2012, MICROSYST TECHNOL, V18, P787, DOI 10.1007/s00542-012-1493-1; Martin F, 2004, J VAC SCI TECHNOL A, V22, P361, DOI 10.1116/1.1649343; Medjani F, 2006, THIN SOLID FILMS, V515, P260, DOI 10.1016/j.tsf.2005.12.145; Nelson-Fitzpatrick N, 2011, J MICROMECH MICROENG, V21, DOI 10.1088/0960-1317/21/11/115022; Oh BK, 2005, BIOSENS BIOELECTRON, V20, P1847, DOI 10.1016/j.bios.2004.05.010; Ophus C, 2009, ACTA MATER, V57, P4296, DOI 10.1016/j.actamat.2009.05.029; Pelegrini MV, 2014, CAN J PHYS, V92, P940, DOI 10.1139/cjp-2013-0556; Poshtiban S, 2013, SENSOR ACTUAT B-CHEM, V181, P410, DOI 10.1016/j.snb.2012.12.082; Singh A, 2012, ANALYST, V137, P3405, DOI 10.1039/c2an35371g; Singh A, 2011, ANALYST, V136, P4780, DOI 10.1039/c1an15547d; Singh A, 2010, BIOSENS BIOELECTRON, V26, P131, DOI 10.1016/j.bios.2010.05.024; Singh AV, 2011, THIN SOLID FILMS, V519, P5846, DOI 10.1016/j.tsf.2011.02.074; Sinha N, 2009, APPL PHYS LETT, V95, DOI 10.1063/1.3194148; Stoeckel C, 2014, J APPL PHYS, V116, DOI 10.1063/1.4887799; Tadigadapa S, 2009, MEAS SCI TECHNOL, V20; Tawil N, 2012, BIOSENS BIOELECTRON, V37, P24, DOI 10.1016/j.bios.2012.04.048; Taylor AD, 2005, SENSOR ACTUAT B-CHEM, V107, P202, DOI 10.1016/j.snb.2004.11.097; Taylor AD, 2006, BIOSENS BIOELECTRON, V22, P752, DOI 10.1016/j.bios.2006.03.012; Tothill IE, 2009, SEMINARS IN CELL DEV; van den Hurk R, 2013, SENSOR ACTUAT B-CHEM, V176, P960, DOI 10.1016/j.snb.2012.09.023; Villanueva LG, 2011, NANO LETT, V11, P5054, DOI 10.1021/nl2031162; Wan JH, 2007, SENSOR ACTUAT B-CHEM, V127, P559, DOI 10.1016/j.snb.2007.05.017; Xu XH, 2001, THIN SOLID FILMS, V388, P62, DOI 10.1016/S0040-6090(00)01914-3; Zimmermann M, 2008, SENSOR ACTUAT B-CHEM, V131, P254, DOI 10.1016/j.snb.2007.11.016; Zuniga C, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3151919	63	4	4	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2015	10	7							e0133479	10.1371/journal.pone.0133479	http://dx.doi.org/10.1371/journal.pone.0133479			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LN	26193701	gold, Green Published, Green Submitted			2022-12-26	WOS:000358546400093
J	Salaun, M; Peng, J; Hensley, HH; Roder, N; Flieder, DB; Houlle-Crepin, S; Abramovici-Roels, O; Sabourin, JC; Thiberville, L; Clapper, ML				Salauen, Mathieu; Peng, Jing; Hensley, Harvey H.; Roder, Navid; Flieder, Douglas B.; Houlle-Crepin, Solene; Abramovici-Roels, Olivia; Sabourin, Jean-Christophe; Thiberville, Luc; Clapper, Margie L.			MMP-13 In-Vivo Molecular Imaging Reveals Early Expression in Lung Adenocarcinoma	PLOS ONE			English	Article							COLLAGENASE-3 MATRIX METALLOPROTEINASE-13; SQUAMOUS-CELL CARCINOMAS; GENE-EXPRESSION; FLUORESCENT PROTEINS; BREAST CARCINOMAS; MOUSE MODEL; CANCER; TISSUE; CLASSIFICATION; INHIBITORS	Introduction Several matrix metalloproteinases (MMPs) are overexpressed in lung cancer and may serve as potential targets for the development of bioactivable probes for molecular imaging. Objective To characterize and monitor the activity of MMPs during the progression of lung adenocarcinoma. Methods K-ras(LSL-G12D) mice were imaged serially during the development of adenocarcinomas using fluorescence molecular tomography (FMT) and a probe specific for MMP-2, -3, -9 and -13. Lung tumors were identified using FMT and MRI co-registration, and the probe concentration in each tumor was assessed at each time-point. The expression of Mmp2, -3, -9, -13 was quantified by qRT-PCR using RNA isolated from microdissected tumor cells. Immunohistochemical staining of overexpressed MMPs in animals was assessed on human lung tumors. Results In mice, 7 adenomas and 5 adenocarcinomas showed an increase in fluorescent signal on successive FMT scans, starting between weeks 4 and 8. qRT-PCR assays revealed significant overexpression of only Mmp-13 in mice lung tumors. In human tumors, a high MMP-13 immunostaining index was found in tumor cells from invasive lesions (24/27), but in none of the non-invasive (0/4) (p=0.001). Conclusion MMP-13 is detected in early pulmonary invasive adenocarcinomas and may be a potential target for molecular imaging of lung cancer.	[Salauen, Mathieu; Peng, Jing; Roder, Navid; Clapper, Margie L.] Fox Chase Canc Ctr, Prevent & Control Program, Philadelphia, PA 19111 USA; [Salauen, Mathieu; Thiberville, Luc] Univ Rouen, Lab Quant IF LITIS, EA 4108, Rouen, France; [Salauen, Mathieu; Thiberville, Luc] Rouen Univ Hosp, Clin Pneumol, Rouen, France; [Salauen, Mathieu; Thiberville, Luc] Rouen Univ Hosp, CIC INSERM U1404, Rouen, France; [Hensley, Harvey H.] Fox Chase Canc Ctr, Biol Imaging Facil, Philadelphia, PA 19111 USA; [Flieder, Douglas B.] Fox Chase Canc Ctr, Dept Pathol, Philadelphia, PA 19111 USA; [Houlle-Crepin, Solene; Abramovici-Roels, Olivia; Sabourin, Jean-Christophe] Rouen Univ Hosp, Dept Pathol, Rouen, France	Fox Chase Cancer Center; Universite de Rouen Normandie; CHU de Rouen; CHU de Rouen; Institut National de la Sante et de la Recherche Medicale (Inserm); Fox Chase Cancer Center; Fox Chase Cancer Center; CHU de Rouen	Salaun, M (corresponding author), Fox Chase Canc Ctr, Prevent & Control Program, 7701 Burholme Ave, Philadelphia, PA 19111 USA.	Mathieu.Salaun@univ-rouen.fr	SALAUN, Mathieu/M-3914-2019	SALAUN, Mathieu/0000-0003-1430-6396	ADIR (Aide a Domicile aux Insuffisants Respiratoires - Association) Association, Bois-Guillaume, France; Fondation ARC pour la Recherche sur le Cancer, Villejuif, France; Keystone Program in Personalized Risk and Prevention, Fox Chase Cancer Center, Philadelphia, PA, USA; National Cancer Institute [CA006927]; NATIONAL CANCER INSTITUTE [P30CA006927] Funding Source: NIH RePORTER	ADIR (Aide a Domicile aux Insuffisants Respiratoires - Association) Association, Bois-Guillaume, France; Fondation ARC pour la Recherche sur le Cancer, Villejuif, France; Keystone Program in Personalized Risk and Prevention, Fox Chase Cancer Center, Philadelphia, PA, USA; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	MS received grants from ADIR (Aide a Domicile aux Insuffisants Respiratoires - Association) Association, Bois-Guillaume, France (www.adirassistance.com/fr/accueil) and from Fondation ARC pour la Recherche sur le Cancer, Villejuif, France (www.fondation-arc.org), this work (MLC) was supported by the Keystone Program in Personalized Risk and Prevention, Fox Chase Cancer Center, Philadelphia, PA, USA (www.fccc.edu), a Grant CA006927 from the National Cancer Institute (www.cancer.gov/), and by an appropriation from the Commonwealth of Pennsylvania. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberle DR, 2011, NEW ENGL J MED, V365, P395, DOI 10.1056/NEJMoa1102873; Airola K, 1997, J INVEST DERMATOL, V109, P225, DOI 10.1111/1523-1747.ep12319441; Ala-Aho R, 2005, BIOCHIMIE, V87, P273, DOI 10.1016/j.biochi.2004.12.009; ASTOUL P, 1994, ANTICANCER RES, V14, P85; Atreya R, 2014, NAT MED, V20, P313, DOI 10.1038/nm.3462; Beasley MB, 2005, SEMIN ROENTGENOL, V40, P90, DOI 10.1053/j.ro.2005.01.001; Bostrom PJ, 2000, INT J CANCER, V88, P417, DOI 10.1002/1097-0215(20001101)88:3<417::AID-IJC14>3.3.CO;2-7; Cazorla M, 1998, J PATHOL, V186, P144, DOI 10.1002/(SICI)1096-9896(1998100)186:2<144::AID-PATH147>3.0.CO;2-#; Clapper ML, 2011, NEOPLASIA, V13, P685, DOI 10.1593/neo.11400; Connolly DC, 2009, CURR PROTOC PHARMACO, V45, p2 1; Deguchi JO, 2005, CIRCULATION, V112, P2708, DOI 10.1161/CIRCULATIONAHA.105.562041; DuPage M, 2009, NAT PROTOC, V4, P1064, DOI 10.1038/nprot.2009.95; Elnemr Ayman, 2003, Gastric Cancer, V6, P30, DOI 10.1007/s101200300004; Etoh T, 2000, GUT, P47; FREIJE JMP, 1994, J BIOL CHEM, V269, P16766; Galateau-Salle FB, 2000, HUM PATHOL, V31, P296, DOI 10.1016/S0046-8177(00)80242-7; Graves EE, 2004, CURR MOL MED, V4, P419, DOI 10.2174/1566524043360555; Grimm J, 2005, P NATL ACAD SCI USA, V102, P14404, DOI 10.1073/pnas.0503920102; Hensley H, 2007, CANCER BIOL THER, V6, P1717, DOI 10.4161/cbt.6.11.4830; Hensley HH, 2012, NEOPLASIA, V14, P451, DOI 10.1596/neo.12480; Hoffman RM, 2005, NAT REV CANCER, V5, P796, DOI 10.1038/nrc1717; Hoffman RM, 2006, NAT PROTOC, V1, P1429, DOI 10.1038/nprot.2006.223; Hoffman RM, 2006, NAT PROTOC, V1, P775, DOI 10.1038/nprot.2006.109; Hoffman RM, 2006, NAT PROTOC, V1, P928, DOI 10.1038/nprot.2006.119; Hoffman RM, 2015, LAB INVEST, V95, P432, DOI 10.1038/labinvest.2014.154; Hsiung PL, 2008, NAT MED, V14, P454, DOI 10.1038/nm1692; Hsu CP, 2006, LUNG CANCER, V52, P349, DOI 10.1016/j.lungcan.2006.01.011; Hu ZB, 2005, CLIN CANCER RES, V11, P5433, DOI 10.1158/1078-0432.CCR-05-0311; Johansson N, 1997, AM J PATHOL, V151, P499; Kanomata N, 2005, MODERN PATHOL, V18, P828, DOI 10.1038/modpathol.3800365; Kitamura H, 1999, HUM PATHOL, V30, P331, DOI 10.1016/S0046-8177(99)90013-8; Knauper V, 1996, J BIOL CHEM, V271, P1544, DOI 10.1074/jbc.271.3.1544; Liotta LA, 2001, NATURE, V411, P375, DOI 10.1038/35077241; Liu DW, 2005, EUR RESPIR J, V26, P1002, DOI 10.1183/09031936.05.00050205; Loening Andreas Markus, 2003, Mol Imaging, V2, P131, DOI 10.1162/153535003322556877; Meireles SI, 2010, CANCER PREV RES, V3, P707, DOI 10.1158/1940-6207.CAPR-09-0162; Mitchell PG, 1996, J CLIN INVEST, V97, P761, DOI 10.1172/JCI118475; Morisse H, 2013, MED MYCOL, V51, P352, DOI 10.3109/13693786.2012.729138; Nikitin AY, 2004, CANCER RES, V64, P2307, DOI 10.1158/0008-5472.CAN-03-3376; Rath T, 2006, INFLAMM BOWEL DIS, V12, P1025, DOI 10.1097/01.mib.0000234133.97594.04; Salaun M, 2010, EUR RESPIR J, V36, P451, DOI 10.1183/09031936.00194509; Salaun M, 2013, EUR RESPIR J, V42, P1646, DOI 10.1183/09031936.00191911; Sweet-Cordero A, 2005, NAT GENET, V37, P48, DOI 10.1038/ng1490; Thiberville L, 2009, EUR RESPIR J, V33, P974, DOI 10.1183/09031936.00083708; Thomas P, 2000, J PATHOL, V190, P150; Travis WD, 2011, J THORAC ONCOL, V6, P244, DOI 10.1097/JTO.0b013e318206a221; Uria JA, 1997, CANCER RES, V57, P4882; WANG XO, 1992, INT J CANCER, V51, P992; Wernicke D, 1996, J RHEUMATOL, V23, P590; Wistuba II, 2002, ONCOGENE, V21, P7298, DOI 10.1038/sj.onc.1205806; Yamada T, 2010, ANTICANCER RES, V30, P2693; Yang M, 1998, CANCER RES, V58, P4217; Zhang B, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-83	53	15	16	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2015	10	7							e0132960	10.1371/journal.pone.0132960	http://dx.doi.org/10.1371/journal.pone.0132960			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LN	26193700	Green Submitted, Green Published, gold			2022-12-26	WOS:000358546400045
J	Yu, JM; Ao, YY; Liu, N; Li, LL; Duan, ZJ				Yu, Jie-mei; Ao, Yuan-yun; Liu, Na; Li, Li-li; Duan, Zhao-jun			Salivirus in Children and Its Association with Childhood Acute Gastroenteritis: A Paired Case-Control Study	PLOS ONE			English	Article							REVERSE TRANSCRIPTION-PCR; VIRAL GASTROENTERITIS; KLASSEVIRUS INFECTION; GENETIC DIVERSITY; STOOL SPECIMENS; RT-PCR; NOROVIRUS; SAPOVIRUS; DIARRHEA; DISEASE	Salivirus was recently discovered in children with gastroenteritis and in sewage. Though a causative role for salivirus in childhood gastroenteritis was suggested in the previous study, the relationship between salivirus and acute gastroenteritis has not yet been clearly clarified. The sewage strain reported by Ng, although represented by incomplete genome sequencing data, was distinct from previously reported saliviruses, and had not previously been detected in humans. A case-control study examining 461 paired stool samples from children with diarrhea and healthy controls (1:1) was conducted in this study. Also, common diarrheal viruses were detected and complete genome of a salivirus was determined. Results showed that salivirus was detected in 16 (3.5%) and 13 (2.8%) of the case and control samples, respectively; no differences in detection rates (p=0.571) or mean values of viral loads (p=0.400) were observed between the groups. Multivariate Cox regression revealed no association between salivirus and gastroenteritis (p=0.774). The data also demonstrated that salivirus infection did not exacerbate clinical symptoms of gastroenteritis in children. Furthermore, complete genome sequence of a salivirus recovered from the feces of a child with diarrhea (i.e., SaliV-FHB) shared a 99% nucleotide identity with the sewage strain. In conclusion, a paired case-control study did not support a causative role for salivirus strains detected in this study with pediatric gastroenteritis. This study also demonstrated that all known saliviruses can be detected in the feces of children with or without gastroenteritis.	[Yu, Jie-mei; Ao, Yuan-yun; Liu, Na; Li, Li-li; Duan, Zhao-jun] China CDC, Inst Viral Dis Control & Prevent, Beijing, Peoples R China	Chinese Center for Disease Control & Prevention	Duan, ZJ (corresponding author), China CDC, Inst Viral Dis Control & Prevent, Beijing, Peoples R China.	zhaojund@126.com	Ao, yuanyun/ABF-9640-2020		National Natural Science Foundation of China [81290345]; Bill Melinda Gates [OPP1016839]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Bill Melinda Gates(Bill & Melinda Gates Foundation)	This work was supported by the National Natural Science Foundation of China (grant no. 81290345), URL: http://www.nsfc.gov.cn/ (JM) and The Bill & Melinda Gates (grant no. OPP1016839), URL: http://www.gatesfoundation.org/ (ZJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambert-Balay K, 2008, J CLIN MICROBIOL, V46, P1252, DOI 10.1128/JCM.02140-07; Baumgarte S, 2008, J CLIN MICROBIOL, V46, P242, DOI 10.1128/JCM.01468-07; Chan MCW, 2006, J VIROL METHODS, V134, P146, DOI 10.1016/j.jviromet.2005.12.013; Chen SY, 2007, J CLIN MICROBIOL, V45, P2054, DOI 10.1128/JCM.01519-06; Cheng WX, 2008, CLIN INFECT DIS, V47, P161, DOI 10.1086/589244; Chhabra P, 2013, J INFECT DIS, V208, P790, DOI 10.1093/infdis/jit254; Colomba C, 2006, EUR J CLIN MICROBIOL, V25, P570, DOI 10.1007/s10096-006-0188-x; Dennehy PH, 2005, INFECT DIS CLIN N AM, V19, P585, DOI 10.1016/j.idc.2005.05.003; Denno Donna M., 2007, Animal Health Research Reviews, V8, P69, DOI 10.1017/S1466252307001302; EHRNST A, 1993, SCAND J INFECT DIS, V25, P275, DOI 10.3109/00365549309008499; Greninger AL, 2010, CLIN VACCINE IMMUNOL, V17, P1584, DOI 10.1128/CVI.00152-10; Greninger AL, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-82; Han TH, 2010, EMERG INFECT DIS, V16, P1623, DOI 10.3201/eid1610.100539; Haramoto E, 2013, APPL ENV MICROBIOL, V79; Holtz LR, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-86; Jin Y, 2009, J CLIN VIROL, V44, P238, DOI 10.1016/j.jcv.2008.12.010; Kageyama T, 2003, J CLIN MICROBIOL, V41, P1548, DOI 10.1128/JCM.41.4.1548-1557.2003; Kirkwood CD, 2005, J MED VIROL, V77, P96, DOI 10.1002/jmv.20419; Li LL, 2009, J VIROL, V83, P12002, DOI 10.1128/JVI.01241-09; Logan C, 2007, J VIROL METHODS, V146, P36, DOI 10.1016/j.jviromet.2007.05.031; Pang XLL, 2004, J MED VIROL, V72, P496, DOI 10.1002/jmv.20009; Patil PR, 2014, J MED VIROLOGY; Pham NTK, 2007, J CLIN MICROBIOL, V45, P2287, DOI 10.1128/JCM.00525-07; Phillips G, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-63; Shan TL, 2010, EMERG INFECT DIS, V16, P1303, DOI 10.3201/eid1608.100087; Terry FFN, 2012, J VIROL, V86, P12161, DOI 10.1128/JVI.00869-12; Wolffs PFG, 2011, J CLIN MICROBIOL, V49, P1926, DOI 10.1128/JCM.01925-10; Wu W, 2014, ARCH VIROL, V159, P1995, DOI 10.1007/s00705-014-1986-6; Xing WJ, 2014, LANCET INFECT DIS, V14, P308, DOI 10.1016/S1473-3099(13)70342-6	29	22	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2015	10	7							e0130977	10.1371/journal.pone.0130977	http://dx.doi.org/10.1371/journal.pone.0130977			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LN	26193371	gold, Green Published, Green Submitted			2022-12-26	WOS:000358546400008
J	Maruyama, K; Akiyama, M; Kokame, K; Sekiya, A; Morishita, E; Miyata, T				Maruyama, Keiko; Akiyama, Masashi; Kokame, Koichi; Sekiya, Akiko; Morishita, Eriko; Miyata, Toshiyuki			ELISA-Based Detection System for Protein S K196E Mutation, a Genetic Risk Factor for Venous Thromboembolism	PLOS ONE			English	Article							DEEP-VEIN THROMBOSIS; JAPANESE PATIENTS; C ANTICOAGULANT; COAGULATION; SUBSTITUTION; INFLAMMATION; DEFICIENCY; DOMAIN; GLU	Protein S (PS) acts as a cofactor for activated protein C in the plasma anticoagulant system. PS Lys196-to-Glu (K196E) mutation is a genetic risk factor for venous thromboembolism in Japanese individuals. Because of the substantial overlap in PS anticoagulant activity between KK (wild-type) and KE (heterozygous) genotypes, it is difficult to identify PS K196E carriers by measuring PS activity. Here, we generated monoclonal antibodies specific to the PS K196E mutant and developed a simple and reliable method for the identification of PS K196E carriers. We immunized mice with a keyhole limpet hemocyanin-conjugated synthetic peptide with Glu196. The hybridoma cells were screened for the binding ability of the produced antibodies to recombinant mutant EGF-like domains of PS (Ile117-Glu283). We obtained three hybridoma cell lines producing PS K196E mutation-specific antibodies. We established a sandwich enzyme-linked immunosorbent assay (ELISA) system in which the PS K196E mutation-specific monoclonal antibody was used as a detection antibody. We measured human plasma samples by using this system and successfully discriminated 11 individuals with the KE genotype from 122 individuals with the KK genotype. The ELISA system using the PS K196E mutation-specific antibody is a useful tool for the rapid identification of PS K196E carriers, who are at a higher risk for venous thromboembolism.	[Maruyama, Keiko; Akiyama, Masashi; Kokame, Koichi; Miyata, Toshiyuki] Natl Cerebral & Cardiovasc Ctr, Dept Mol Pathogenesis, Suita, Osaka, Japan; [Sekiya, Akiko; Morishita, Eriko] Kanazawa Univ, Grad Sch Med Sci, Dept Clin Lab Sci, Kanazawa, Ishikawa, Japan	National Cerebral & Cardiovascular Center - Japan; Kanazawa University	Miyata, T (corresponding author), Natl Cerebral & Cardiovasc Ctr, Dept Mol Pathogenesis, Suita, Osaka, Japan.	miyata@ncvc.go.jp		Kokame, Koichi/0000-0002-9654-6299; Akiyama, Masashi/0000-0001-5863-9315; Maruyama, Keiko/0000-0003-4183-0345	Ministry of Health, Labour and Welfare of Japan; Japan Society for the Promotion of Science; Takeda Science Foundation	Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Takeda Science Foundation(Takeda Science Foundation (TSF))	This work was supported in part by grants-in-aid from the Ministry of Health, Labour and Welfare of Japan, the Japan Society for the Promotion of Science, and the Takeda Science Foundation.	Akiyama M, 2009, P NATL ACAD SCI USA, V106, P19274, DOI 10.1073/pnas.0909755106; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; BERTINA RM, 1994, NATURE, V369, P64, DOI 10.1038/369064a0; Burstyn-Cohen T, 2009, J CLIN INVEST, V119, P2942, DOI 10.1172/JCI39325; Dahlback B, 2007, THROMB HAEMOSTASIS, V98, P90, DOI 10.1160/TH07-04-0269; De Frutos PG, 2007, THROMB HAEMOSTASIS, V98, P543, DOI 10.1160/TH07-03-0199; FUJIMURA H, 1995, THROMB HAEMOSTASIS, V74, P1381; Griffin JH, 2012, INT J HEMATOL, V95, P333, DOI 10.1007/s12185-012-1059-0; Hackeng TM, 2009, ARTERIOSCL THROM VAS, V29, P2015, DOI 10.1161/ATVBAHA.108.177436; HAYASHI T, 1994, BLOOD, V83, P683, DOI 10.1182/blood.V83.3.683.bloodjournal833683; Ikejiri M, 2010, INT J HEMATOL, V92, P302, DOI 10.1007/s12185-010-0671-0; Kimura R, 2006, J THROMB HAEMOST, V4, P2010, DOI 10.1111/j.1538-7836.2006.02071.x; Kimura R, 2006, BLOOD, V107, P1737, DOI 10.1182/blood-2005-09-3892; Kinoshita S, 2005, CLIN BIOCHEM, V38, P908, DOI 10.1016/j.clinbiochem.2005.05.006; Kujovich JL, 2011, GENET MED, V13, P1, DOI 10.1097/GIM.0b013e3181faa0f2; Liu WY, 2013, THROMB RES, V132, P314, DOI 10.1016/j.thromres.2013.05.008; Miyata T, 2012, J THROMB HAEMOST, V10, P319, DOI 10.1111/j.1538-7836.2011.04578.x; Miyata T, 1998, BLOOD COAGUL FIBRIN, V9, P451, DOI 10.1097/00001721-199807000-00011; Miyata T, 2009, THROMB RES, V124, P14, DOI 10.1016/j.thromres.2008.08.020; Sakaguchi N, 2005, J IMMUNOL, V174, P4485, DOI 10.4049/jimmunol.174.8.4485; Saller F, 2009, BLOOD, V114, P2307, DOI 10.1182/blood-2009-03-209031; Suleiman L, 2013, CRIT REV ONCOL HEMAT, V88, P637, DOI 10.1016/j.critrevonc.2013.07.004; Toda S, 2014, BLOOD, V123, P3963, DOI 10.1182/blood-2014-01-547976; Tsuda T, 2012, BLOOD COAGUL FIBRIN, V23, P56, DOI 10.1097/MBC.0b013e32834ddefd; Valentin MA, 2011, J PHARMACEUT BIOMED, V55, P869, DOI 10.1016/j.jpba.2011.03.033; van der Meer JHM, 2014, BLOOD, V123, P2460, DOI 10.1182/blood-2013-09-528752; YAMAZAKI T, 1993, THROMB RES, V70, P395, DOI 10.1016/0049-3848(93)90081-X; Yin T, 2014, J THROMB THROMBOLYS, V37, P56, DOI 10.1007/s11239-013-1005-x	28	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0133196	10.1371/journal.pone.0133196	http://dx.doi.org/10.1371/journal.pone.0133196			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RV	26186226	gold, Green Published, Green Submitted			2022-12-26	WOS:000358198700106
J	Kowalski, T; Grabowski, S; Deorowicz, S				Kowalski, Tomasz; Grabowski, Szymon; Deorowicz, Sebastian			Indexing Arbitrary-Length k-Mers in Sequencing Reads	PLOS ONE			English	Article							ALIGNMENT; VERSATILE; GENOMES; MEMORY; ERRORS	We propose a lightweight data structure for indexing and querying collections of NGS reads data in main memory. The data structure supports the interface proposed in the pioneering work by Philippe et al. for counting and locating k-mers in sequencing reads. Our solution, PgSA (pseudogenome suffix array), based on finding overlapping reads, is competitive to the existing algorithms in the space use, query times, or both. The main applications of our index include variant calling, error correction and analysis of reads from RNA-seq experiments.	[Kowalski, Tomasz; Grabowski, Szymon] Lodz Univ Technol, Inst Appl Comp Sci, PL-90924 Lodz, Poland; [Deorowicz, Sebastian] Silesian Tech Univ, Inst Informat, PL-44100 Gliwice, Poland	Lodz University of Technology; Silesian University of Technology	Deorowicz, S (corresponding author), Silesian Tech Univ, Inst Informat, Akad 16, PL-44100 Gliwice, Poland.	sebastian.deorowicz@polsl.pl	Kowalski, Tomasz M/V-1500-2017; Grabowski, Szymon/AAJ-2398-2021; Deorowicz, Sebastian/F-8386-2014	Kowalski, Tomasz M/0000-0003-0953-3762; Grabowski, Szymon/0000-0003-1714-1224; Deorowicz, Sebastian/0000-0002-9496-733X	Polish National Science Centre [DEC-2012/05/B/ST6/03148]; GeCONiI-Upper Silesian Center for Computational Science and Engineering [POIG.02.03.01-24-099/13]	Polish National Science Centre; GeCONiI-Upper Silesian Center for Computational Science and Engineering	This work was supported by The Polish National Science Centre under the project DEC-2012/05/B/ST6/03148. The infrastructure was supported by POIG.02.03.01-24-099/13 grant "GeCONiI-Upper Silesian Center for Computational Science and Engineering." The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ames SK, 2013, BIOINFORMATICS, V29, P2253, DOI 10.1093/bioinformatics/btt389; Bazinet AL, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-92; Bingmann T., 2013, P ALENEX, P88; Danek A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109384; Deorowicz S, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-160; Ferragina P, 2000, ANN IEEE SYMP FOUND, P390, DOI 10.1109/SFCS.2000.892127; Grabowski S, 2014, SAMPLING SUFFIX ARRA; Grabowski S, 2015, BIOINFORMATICS, V31, P1389, DOI 10.1093/bioinformatics/btu844; Grossi R, 2003, SIAM PROC S, P841; Gusfield D., 1997, ALGORITHMS STRINGS T; Hayden EC, 2014, NATURE NEWS; Heo Y, 2014, BIOINFORMATICS, V30, P1354, DOI 10.1093/bioinformatics/btu030; Ilie L, 2013, BIOINFORMATICS, V29, P2490, DOI 10.1093/bioinformatics/btt407; Karkkainen J., 1996, Computing and Combinatorics. Second Annual International Conference. COCOON '96. Proceedings, P219; Kelly DR, 2010, GENOME BIOL, V11; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Maier D, 1997, NOTE COMPLEXITY SUPE, P233; MANBER U, 1993, SIAM J COMPUT, V22, P935, DOI 10.1137/0222058; Marcais G, 2011, BIOINFORMATICS, V27, P764, DOI 10.1093/bioinformatics/btr011; Molnar M, 2014, BRIEFINGS BIOINFORMA; National Human Genome Research Institute, 2015, DNA SEQ COSTS; Philippe N, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-3-r30; Philippe N, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-242; Rizk G, 2013, BIOINFORMATICS, V29, P652, DOI 10.1093/bioinformatics/btt020; Salmela L, 2010, BIOINFORMATICS, V26, P1284, DOI 10.1093/bioinformatics/btq151; Salzberg SL, 2014, HUM MUTAT, V35, P283, DOI 10.1002/humu.22503; Schroder J, 2009, BIOINFORMATICS, V25, P2157, DOI 10.1093/bioinformatics/btp379; Schulz MH, 2014, BIOINFORMATICS, V30, pI356, DOI 10.1093/bioinformatics/btu440; U S Department of Veteran Affairs, 2015, MILL VET PROGR; Valimaki Niko, 2013, Bioinformatics Research and Applications. 9th International Symposium, ISBRA 2013. Proceedings, P237, DOI 10.1007/978-3-642-38036-5_24; Wood DE, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-3-r46; Zhang JJ, 2014, BIOINFORMATICS, V30, P614, DOI 10.1093/bioinformatics/btt593	34	10	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2015	10	7							e0133198	10.1371/journal.pone.0133198	http://dx.doi.org/10.1371/journal.pone.0133198			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RQ	26182400	gold, Green Published, Green Submitted			2022-12-26	WOS:000358198200055
J	Meireles, DD; Schripsema, J; Arnholdt, ACV; Dagnino, D				Meireles, Diogo de Abreu; Schripsema, Jan; Veto Arnholdt, Andrea Cristina; Dagnino, Denise			Persistence of Only a Minute Viable Population in Chlorotic Microcystis aeruginosa PCC 7806 Cultures Obtained by Nutrient Limitation	PLOS ONE			English	Article							STARVATION-INDUCED CHLOROSIS; CYANOBACTERIUM; ACCLIMATION; PCC-7806; DYNAMICS; BACTERIA; CYCLE; FLOW	Cultures from the cyanobacterial strain Microcystis aeruginosa PCC 7806 submitted to nutrient limitation become chlorotic. When returned to nutrient rich conditions these cultures regain their green colour. The aim of this study was to verify whether the cells in these cultures could be considered resting stages allowing the survival of periods of nutrient starvation as has been reported for Synechococcus PCC 7942. The experiments with Microcystis were carried out in parallel with Synechococcus cultures to rule out the possibility that any results obtained with Microcystis were due to our particular experimental conditions. The results of the experiments with Synechococcus PCC 7942 cultures were comparable to the reported in the literature. For Microcystis PCC 7806 a different response was observed. Analysis of chlorotic Microcystis cultures by flow cytometry showed that the phenotype of the cells in the population was not homogenous: the amount of nucleic acids was about the same in all cells but only around one percent of the population emitted red autofluorescence indicating the presence of chlorophyll. Monitoring of the reversion of chlorosis by flow cytometry showed that the re-greening was most likely the result of the division of the small population of red autofluorescent cells originally present in the chlorotic cultures. This assumption was confirmed by analysing the integrity of the DNA and the membrane permeability of the cells of chlorotic cultures. Most of the DNA of these cultures was degraded and only the autofluorescent population of the chlorotic cultures showed membrane integrity. Thus, contrary to what has been reported for other cyanobacterial genera, most of the cells in chlorotic Microcystis cultures are not resting stages but dead. It is interesting to note that the red autofluorescent cells of green and chlorotic cultures obtained in double strength ASM-1 medium differ with respect to metabolism: levels of emission of red autofluorescence are higher in the cells of green cultures and the ability to convert fluorescein diacetate of these cells are heterogeneous when compared to the autofluorescent cells of chlorotic cultures. Thus, the small population of the red autofluorescent cells of chlorotic cultures are in a differentiated metabolic state that allow them to persist in conditions in which most of the population loses viability; persistent cells can be detected in chlorotic cultures maintained for more than a year.	[Meireles, Diogo de Abreu; Dagnino, Denise] Univ Estadual Norte Fluminense, Lab Biotecnol, Campos Dos Goytacazes, RJ, Brazil; [Schripsema, Jan; Dagnino, Denise] Univ Estadual Norte Fluminense, Lab Ciencias Quim, Grp Metabol, Campos Dos Goytacazes, RJ, Brazil; [Veto Arnholdt, Andrea Cristina] Univ Estadual Norte Fluminense, Lab Biol Reconhecer, Campos Dos Goytacazes, RJ, Brazil	Universidade Estadual do Norte Fluminense; Universidade Estadual do Norte Fluminense; Universidade Estadual do Norte Fluminense	Dagnino, D (corresponding author), Univ Estadual Norte Fluminense, Lab Biotecnol, Campos Dos Goytacazes, RJ, Brazil.	dagnino@uenf.br	Schripsema, Jan/A-6395-2008; Meireles, Diogo/C-4427-2014; de Abreu Meireles, Diogo/AAP-7591-2020	Schripsema, Jan/0000-0002-5362-4074; Meireles, Diogo/0000-0002-8451-2083; de Abreu Meireles, Diogo/0000-0002-8451-2083; Arnholdt, Andrea Cristina Veto/0000-0003-3620-573X	Conselho Nacional de Pesquisa (CNPq); Fundacao de Amparo a Pesquisa do Rio de Janeiro (FAPERJ)	Conselho Nacional de Pesquisa (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ))	The authors thank the Conselho Nacional de Pesquisa (CNPq) and the Fundacao de Amparo a Pesquisa do Rio de Janeiro (FAPERJ) for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN MM, 1969, ARCH MIKROBIOL, V69, P114, DOI 10.1007/BF00409755; BOSTROM B, 1989, AQUAT SCI, V51, P153, DOI 10.1007/BF00879300; Brunberg AK, 2002, J PLANKTON RES, V24, P1247, DOI 10.1093/plankt/24.11.1247; Carmichael WW, 2001, HUM ECOL RISK ASSESS, V7, P1393, DOI 10.1080/20018091095087; Castenholz RW, 2001, BERGEYS MANUAL SYSTE, P473, DOI DOI 10.1007/978-0-387-21609-6_27; CHEN WP, 1993, NUCLEIC ACIDS RES, V21, P2260, DOI 10.1093/nar/21.9.2260; Dagnino D, 2006, ENVIRON MICROBIOL, V8, P30, DOI 10.1111/j.1462-2920.2005.00866.x; Frangeul L, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-274; Gorbushina AA, 2007, ENVIRON MICROBIOL, V9, P1613, DOI 10.1111/j.1462-2920.2007.01301.x; Gorham P.R., 1964, INT VER THEOR ANGEW, V15, P1964, DOI [DOI 10.1080/03680770.1962.11895606, 10.1080/03680770.1962.11895606]; Gorl M, 1998, MICROBIOL-SGM, V144, P2449, DOI 10.1099/00221287-144-9-2449; Ionescu D, 2010, FEMS MICROBIOL ECOL, V72, P103, DOI 10.1111/j.1574-6941.2010.00835.x; Joux F, 2000, MICROBES INFECT, V2, P1523, DOI 10.1016/S1286-4579(00)01307-1; Kadouri D, 2005, CRIT REV MICROBIOL, V31, P55, DOI 10.1080/10408410590899228; Kaprelyants AS, 1996, APPL ENVIRON MICROB, V62, P1311, DOI 10.1128/AEM.62.4.1311-1316.1996; Kell DB, 1998, ANTON LEEUW INT J G, V73, P169, DOI 10.1023/A:1000664013047; Lewis K, 2010, ANNU REV MICROBIOL, V64, P357, DOI 10.1146/annurev.micro.112408.134306; Moezelaar R, 1997, EUR J PHYCOL, V32, P373, DOI 10.1080/09670269710001737309; Moser S, 2009, EUR J ORG CHEM, V2009, P21, DOI 10.1002/ejoc.200800804; Llorens JMN, 2010, FEMS MICROBIOL REV, V34, P476, DOI 10.1111/j.1574-6976.2010.00213.x; O'Neil JM, 2012, HARMFUL ALGAE, V14, P313, DOI 10.1016/j.hal.2011.10.027; Potts M, 2005, INTEGR COMP BIOL, V45, P800, DOI 10.1093/icb/45.5.800; REYNOLDS CS, 1981, PHILOS T ROY SOC B, V293, P419, DOI 10.1098/rstb.1981.0081; Saha SK, 2003, FEMS MICROBIOL ECOL, V45, P263, DOI 10.1016/S0168-6496(03)00162-4; Salomon E, 2013, BBA-BIOENERGETICS, V1827, P340, DOI 10.1016/j.bbabio.2012.11.010; Satoh K, 2002, PLANT CELL PHYSIOL, V43, P170, DOI 10.1093/pcp/pcf020; Sauer J, 2001, PLANT PHYSIOL, V126, P233, DOI 10.1104/pp.126.1.233; Schwarz R, 2005, MICROBIOL-SGM, V151, P2503, DOI 10.1099/mic.0.27883-0; STEVENS SE, 1981, ARCH MICROBIOL, V130, P204, DOI 10.1007/BF00459520; Tonk L, 2009, HARMFUL ALGAE, V8, P219, DOI 10.1016/j.hal.2008.05.005; Veldhuis MJW, 2001, EUR J PHYCOL, V36, P167, DOI 10.1080/09670260110001735318; Verspagen JMH, 2005, FRESHWATER BIOL, V50, P854, DOI 10.1111/j.1365-2427.2005.01368.x; Yoshida T, 2009, J GEN APPL MICROBIOL, V55, P135, DOI 10.2323/jgam.55.135	33	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2015	10	7							e0133075	10.1371/journal.pone.0133075	http://dx.doi.org/10.1371/journal.pone.0133075			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RQ	26181753	Green Published, Green Submitted, gold			2022-12-26	WOS:000358198200051
J	Patel, RR; Barbosa, C; Xiao, YC; Cummins, TR				Patel, Reesha R.; Barbosa, Cindy; Xiao, Yucheng; Cummins, Theodore R.			Human Nav1.6 Channels Generate Larger Resurgent Currents than Human Nav1.1 Channels, but the Nav beta 4 Peptide Does Not Protect Either Isoform from Use-Dependent Reduction	PLOS ONE			English	Article							CEREBELLAR PURKINJE NEURONS; AXON INITIAL SEGMENT; MESENCEPHALIC TRIGEMINAL NEURONS; SUBTHRESHOLD SODIUM CURRENTS; ACTION-POTENTIAL INITIATION; MYELINATED NERVE-FIBERS; SLOW INACTIVATION; NA+ CHANNELS; INCOMPLETE INACTIVATION; FUNCTIONAL-ANALYSIS	Voltage-gated sodium channels are responsible for the initiation and propagation of action potentials (APs). Two brain isoforms, Nav1.1 and Nav1.6, have very distinct cellular and subcellular expression. Specifically, Nav1.1 is predominantly expressed in the soma and proximal axon initial segment of fast-spiking GABAergic neurons, while Nav1.6 is found at the distal axon initial segment and nodes of Ranvier of both fast-spiking GABAergic and excitatory neurons. Interestingly, an auxiliary voltage-gated sodium channel subunit, Nav beta 4, is also enriched in the axon initial segment of fast-spiking GABAergic neurons. The C-terminal tail of Nav beta 4 is thought to mediate resurgent sodium current, an atypical current that occurs immediately following the action potential and is predicted to enhance excitability. To better understand the contribution of Nav1.1, Nav1.6 and Nav beta 4 to high frequency firing, we compared the properties of these two channel isoforms in the presence and absence of a peptide corresponding to part of the C-terminal tail of Nav beta 4. We used whole-cell patch clamp recordings to examine the biophysical properties of these two channel isoforms in HEK293T cells and found several differences between human Nav1.1 and Nav1.6 currents. Nav1.1 channels exhibited slower closed-state inactivation but faster open-state inactivation than Nav1.6 channels. We also observed a greater propensity of Nav1.6 to generate resurgent currents, most likely due to its slower kinetics of open-state inactivation, compared to Nav1.1. These two isoforms also showed differential responses to slow and fast AP waveforms, which were altered by the Nav beta 4 peptide. Although the Nav beta 4 peptide substantially increased the rate of recovery from apparent inactivation, Nav beta 4 peptide did not protect either channel isoform from undergoing use-dependent reduction with 10 Hz step-pulse stimulation or trains of slow or fast AP waveforms. Overall, these two channels have distinct biophysical properties that may differentially contribute to regulating neuronal excitability.	[Patel, Reesha R.; Cummins, Theodore R.] Indiana Univ Sch Med, Program Med Neurosci, Indianapolis, IN 46202 USA; [Patel, Reesha R.; Xiao, Yucheng; Cummins, Theodore R.] Indiana Univ Sch Med, Paul & Carole Stark Neurosci Res Inst, Indianapolis, IN 46202 USA; [Barbosa, Cindy; Xiao, Yucheng; Cummins, Theodore R.] Indiana Univ Sch Med, Dept Pharmacol & Toxicol, Indianapolis, IN 46202 USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington	Cummins, TR (corresponding author), Indiana Univ Sch Med, Program Med Neurosci, Indianapolis, IN 46202 USA.	trcummin@iu.edu			National Institutes of Health [NS053422]; Dravet Syndrome Foundation; Paul and Carole Stark Medical Neuroscience Graduate Student Fellowship; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS090837, R56NS053422, R01NS053422] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dravet Syndrome Foundation; Paul and Carole Stark Medical Neuroscience Graduate Student Fellowship; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The research was supported by a National Institutes of Health grant (NS053422) and a grant from the Dravet Syndrome Foundation to T.R.C. R.R. P. was partially supported by a Paul and Carole Stark Medical Neuroscience Graduate Student Fellowship.	Akemann W, 2006, J NEUROSCI, V26, P4602, DOI 10.1523/JNEUROSCI.5204-05.2006; Aman TK, 2007, BIOPHYS J, V92, P1938, DOI 10.1529/biophysj.106.093500; Aman TK, 2009, J NEUROSCI, V29, P2027, DOI 10.1523/JNEUROSCI.4531-08.2009; Bant JS, 2010, P NATL ACAD SCI USA, V107, P12357, DOI 10.1073/pnas.1005633107; Bean BP, 2007, NAT REV NEUROSCI, V8, P451, DOI 10.1038/nrn2148; BELLUZZI O, 1986, J PHYSIOL-LONDON, V380, P275, DOI 10.1113/jphysiol.1986.sp016285; Buffington SA, 2013, J NEUROSCI, V33, P6191, DOI 10.1523/JNEUROSCI.4051-12.2013; Burbidge SA, 2002, MOL BRAIN RES, V103, P80, DOI 10.1016/S0169-328X(02)00188-2; Carter BC, 2011, J NEUROPHYSIOL, V105, P860, DOI 10.1152/jn.01056.2010; Carter BC, 2009, NEURON, V64, P898, DOI 10.1016/j.neuron.2009.12.011; Castelli L, 2007, J PHYSIOL-LONDON, V582, P1179, DOI 10.1113/jphysiol.2007.135350; Castelli L, 2007, BRAIN RES, V1163, P44, DOI 10.1016/j.brainres.2007.05.065; CONNORS BW, 1990, TRENDS NEUROSCI, V13, P99, DOI 10.1016/0166-2236(90)90185-D; Cummins TR, 1998, J NEUROSCI, V18, P9607; Cummins TR, 2005, FEBS LETT, V579, P2166, DOI 10.1016/j.febslet.2005.03.009; Do MTH, 2003, NEURON, V39, P109, DOI 10.1016/S0896-6273(03)00360-X; Do MTH, 2004, J NEUROPHYSIOL, V92, P726, DOI 10.1152/jn.00186.2004; DUBRIDGE RB, 1987, MOL CELL BIOL, V7, P379, DOI 10.1128/MCB.7.1.379; Ellerkmann RK, 2001, J PHYSIOL-LONDON, V532, P385, DOI 10.1111/j.1469-7793.2001.0385f.x; Enomoto A, 2006, J NEUROSCI, V26, P3412, DOI 10.1523/JNEUROSCI.5274-05.2006; Enomoto A, 2007, J NEUROPHYSIOL, V98, P710, DOI 10.1152/jn.00292.2007; Fleidervish IA, 1996, J NEUROPHYSIOL, V76, P2125, DOI 10.1152/jn.1996.76.3.2125; Fry M, 2006, EUR J NEUROSCI, V24, P2557, DOI 10.1111/j.1460-9568.2006.05139.x; Gittis AH, 2010, J NEUROPHYSIOL, V104, P1625, DOI 10.1152/jn.00378.2010; Grieco TM, 2005, NEURON, V45, P233, DOI 10.1016/j.neuron.2004.12.035; Grieco TM, 2004, J NEUROSCI, V24, P35, DOI 10.1523/JNEUROSCI.3807-03.2004; He BJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085188; Hines ML, 1997, NEURAL COMPUT, V9, P1179, DOI 10.1162/neco.1997.9.6.1179; Hu H, 2014, NAT NEUROSCI, V17, P686, DOI 10.1038/nn.3678; Hu WQ, 2009, NAT NEUROSCI, V12, P996, DOI 10.1038/nn.2359; Khaliq ZM, 2003, J NEUROSCI, V23, P4899, DOI 10.1523/jneurosci.23-12-04899.2003; Kole MHP, 2008, NAT NEUROSCI, V11, P178, DOI 10.1038/nn2040; Lorincz A, 2010, SCIENCE, V328, P906, DOI 10.1126/science.1187958; Lorincz A, 2008, J NEUROSCI, V28, P14329, DOI 10.1523/JNEUROSCI.4833-08.2008; Magistretti J, 2006, J PHYSIOL-LONDON, V573, P83, DOI 10.1113/jphysiol.2006.106682; MCCORMICK DA, 1985, J NEUROPHYSIOL, V54, P782, DOI 10.1152/jn.1985.54.4.782; Miyazaki H, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6525; Ogiwara I, 2007, J NEUROSCI, V27, P5903, DOI 10.1523/JNEUROSCI.5270-06.2007; Pospischil M, 2008, BIOL CYBERN, V99, P427, DOI 10.1007/s00422-008-0263-8; Raman IM, 1997, NEURON, V19, P881, DOI 10.1016/S0896-6273(00)80969-1; Raman IM, 1997, J NEUROSCI, V17, P4517, DOI 10.1523/jneurosci.17-12-04517.1997; Raman IM, 2001, BIOPHYS J, V80, P729, DOI 10.1016/S0006-3495(01)76052-3; Rudy B, 2001, TRENDS NEUROSCI, V24, P517, DOI 10.1016/S0166-2236(00)01892-0; SCHWARZ JR, 1987, PFLUG ARCH EUR J PHY, V409, P569, DOI 10.1007/BF00584655; SCHWARZ JR, 1986, PFLUG ARCH EUR J PHY, V406, P397, DOI 10.1007/BF00590943; Stuart G, 1997, TRENDS NEUROSCI, V20, P125, DOI 10.1016/S0166-2236(96)10075-8; Theile JW, 2011, J PHYSIOL-LONDON, V589, P597, DOI 10.1113/jphysiol.2010.200915; Van Wart A, 2007, J COMP NEUROL, V500, P339, DOI 10.1002/cne.21173; Venkatesan K, 2014, J NEUROSCI, V34, P16126, DOI 10.1523/JNEUROSCI.1271-14.2014; Wang GK, 2006, J GEN PHYSIOL, V127, P277, DOI 10.1085/jgp.200509399; Yan HD, 2014, ELIFE, V3, DOI 10.7554/eLife.04193; Yu FH, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-3-207; Yu FH, 2006, NAT NEUROSCI, V9, P1142, DOI 10.1038/nn1754	53	14	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2015	10	7							e0133485	10.1371/journal.pone.0133485	http://dx.doi.org/10.1371/journal.pone.0133485			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RQ	26182346	Green Published, gold			2022-12-26	WOS:000358198200065
J	Wagner, B; Melzer, H; Freymuller, G; Stumvoll, S; Rendi-Wagner, P; Paulke-Korinek, M; Repa, A; Mooi, FR; Kollaritsch, H; Mittermayer, H; Kessler, HH; Stanek, G; Steinborn, R; Duchene, M; Wiedermann, U				Wagner, Birgit; Melzer, Helen; Freymueller, Georg; Stumvoll, Sabine; Rendi-Wagner, Pamela; Paulke-Korinek, Maria; Repa, Andreas; Mooi, Frits R.; Kollaritsch, Herwig; Mittermayer, Helmut; Kessler, Harald H.; Stanek, Gerold; Steinborn, Ralf; Duchene, Michael; Wiedermann, Ursula			Genetic Variation of Bordetella pertussis in Austria	PLOS ONE			English	Article							FIELD GEL-ELECTROPHORESIS; VIRULENCE FACTORS; ANTIGENIC DIVERGENCE; VACCINATION COVERAGE; COMPARATIVE GENOMICS; MITOCHONDRIAL-DNA; TEMPORAL TRENDS; TOXIN; PERTACTIN; POLYMORPHISM	In Austria, vaccination coverage against Bordetella pertussis infections during infancy is estimated at around 90%. Within the last years, however, the number of pertussis cases has increased steadily, not only in children but also in adolescents and adults, indicating both insufficient herd immunity and vaccine coverage. Waning immunity in the host and/or adaptation of the bacterium to the immunised hosts could contribute to the observed reemergence of pertussis. In this study we therefore addressed the genetic variability in B. pertussis strains from several Austrian cities. Between the years 2002 and 2008, 110 samples were collected from Vienna (n = 32), Linz (n = 63) and Graz (n = 15) by nasopharyngeal swabs. DNA was extracted from the swabs, and bacterial sequence polymorphisms were examined by MLVA (multiple-locus variable number of tandem repeat analysis) (n = 77), by PCR amplification and conventional Sanger sequencing of the polymorphic regions of the prn (pertactin) gene (n = 110), and by amplification refractory mutation system quantitative PCR (ARMS-qPCR) (n = 110) to directly address polymorphisms in the genes encoding two pertussis toxin subunits (ptxA and ptxB), a fimbrial adhesin (fimD), tracheal colonisation factor (tcfA), and the virulence sensor protein (bvgS). Finally, the ptxP promoter region was screened by ARMS-qPCR for the presence of the ptxP3 allele, which has been associated with elevated production of pertussis toxin. The MLVA analysis revealed the highest level of polymorphisms with an absence of MLVA Type 29, which is found outside Austria. Only Prn subtypes Prn1/7, Prn2 and Prn3 were found with a predominance of the non-vaccine type Prn2. The analysis of the ptxA, ptxB, fimD, tcfA and bvgS polymorphisms showed a genotype mixed between the vaccine strain Tohama I and a clinical isolate from 2006 (L517). The major part of the samples (93%) displayed the ptxP3 allele. The consequences for the vaccination strategy are discussed.	[Wagner, Birgit; Melzer, Helen; Rendi-Wagner, Pamela; Paulke-Korinek, Maria; Kollaritsch, Herwig; Duchene, Michael; Wiedermann, Ursula] Med Univ Vienna, Ctr Pathophysiol Infectiol & Immunol, Inst Specif Prophylaxis & Trop Med, Vienna, Austria; [Melzer, Helen] Astellas Pharma, Vienna, Austria; [Freymueller, Georg; Steinborn, Ralf] Univ Vet Med, Genom Core Facil, VetCore, Vienna, Austria; [Stumvoll, Sabine; Mittermayer, Helmut] Elisabethinen Hosp, Dept Hyg Microbiol & Trop Med, Linz, Austria; [Stumvoll, Sabine; Mittermayer, Helmut] Anal BioLab, Linz, Austria; [Rendi-Wagner, Pamela; Paulke-Korinek, Maria] Fed Minist Hlth, Vienna, Austria; [Repa, Andreas] Med Univ Vienna, Dept Pediat & Adolescent Med, Vienna, Austria; [Mooi, Frits R.] Natl Inst Publ Hlth & Environm, Ctr Infect Dis Control, NL-3720 BA Bilthoven, Netherlands; [Kessler, Harald H.] Med Univ Graz, Dept Hyg Microbiol & Environm Med, Graz, Austria; [Stanek, Gerold] Med Univ Vienna, Ctr Pathophysiol Infectiol & Immunol, Inst Hyg & Appl Immunol, Vienna, Austria	Medical University of Vienna; University of Veterinary Medicine Vienna; Ordensklinikum Linz Elisabethinen; Medical University of Vienna; Netherlands National Institute for Public Health & the Environment; Medical University of Graz; Medical University of Vienna	Duchene, M (corresponding author), Med Univ Vienna, Ctr Pathophysiol Infectiol & Immunol, Inst Specif Prophylaxis & Trop Med, Vienna, Austria.	michael.duchene@meduniwien.ac.at	Duchêne, Michael/G-6659-2019	Duchêne, Michael/0000-0003-1232-3600; Wiedermann, Ursula/0000-0002-1302-3223	VARPER from the Austrian endowment "Stiftung zur Forderung der Bekampfung der Tuberkulose und anderer Lungenerkrankungen"; Jubilaumsfonds der Osterreichischen Nationalbank [12226]	VARPER from the Austrian endowment "Stiftung zur Forderung der Bekampfung der Tuberkulose und anderer Lungenerkrankungen"; Jubilaumsfonds der Osterreichischen Nationalbank	This study was supported by a grant entitled VARPER from the Austrian endowment "Stiftung zur Forderung der Bekampfung der Tuberkulose und anderer Lungenerkrankungen", and by Grant 12226 from the "Jubilaumsfonds der Osterreichischen Nationalbank". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bart MJ, 2014, MBIO, V5, DOI 10.1128/mBio.01074-14; Bart MJ, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-627; Black RE, 2010, LANCET, V375, P1969, DOI 10.1016/S0140-6736(10)60549-1; Borisova O, 2007, CLIN VACCINE IMMUNOL, V14, P234, DOI 10.1128/CVI.00294-06; Bottero D, 2007, CLIN VACCINE IMMUNOL, V14, P1490, DOI 10.1128/CVI.00177-07; Byrne S, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-53; Caro V, 2007, VACCINE, V25, P4335, DOI 10.1016/j.vaccine.2006.08.024; Cassiday P, 2000, J INFECT DIS, V182, P1402, DOI 10.1086/315881; Celentano LP, 2005, PEDIATR INFECT DIS J, V24, P761, DOI 10.1097/01.inf.0000177282.53500.77; Crowcroft NS, 2002, BMJ-BRIT MED J, V324, P1537, DOI 10.1136/bmj.324.7353.1537; de Gouw D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084523; ECDC (European Centre for Disease Prevention and Control), 2014, ANN EP REP VACC PREV, P21; Elomaa A, 2007, VACCINE, V25, P918, DOI 10.1016/j.vaccine.2006.09.012; Fry NK, 2001, INFECT IMMUN, V69, P5520, DOI 10.1128/IAI.69.9.5520-5528.2001; Gzyl A, 2004, VACCINE, V22, P2122, DOI 10.1016/j.vaccine.2003.12.006; Halperin SA, 2007, NEW ENGL J MED, V356, P110, DOI 10.1056/NEJMp068288; He Q, 2012, EUROSURVEILLANCE, V9, P17; He QS, 2008, FUTURE MICROBIOL, V3, P329, DOI 10.2217/17460913.3.3.329; Hegerle N, 2012, CLIN MICROBIOL INFEC, V18, pE340, DOI 10.1111/j.1469-0691.2012.03925.x; Heikkinen E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000904; King AJ, 2008, BMC GENOMICS, V9, P1, DOI 10.1186/1471-2164-9-311; Klein NP, 2012, NEW ENGL J MED, V367, P1012, DOI 10.1056/NEJMoa1200850; Kodama A, 2004, J CLIN MICROBIOL, V42, P5453, DOI 10.1128/JCM.42.12.5453-5457.2004; Litt DJ, 2009, J CLIN MICROBIOL, V47, P680, DOI 10.1128/JCM.01838-08; Maharjan RP, 2008, RES MICROBIOL, V159, P602, DOI 10.1016/j.resmic.2008.08.004; Miyaji Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077165; Mooi FR, 1998, INFECT IMMUN, V66, P670, DOI 10.1128/IAI.66.2.670-675.1998; Mooi FR, 2000, EUR J CLIN MICROBIOL, V19, P174, DOI 10.1007/s100960050455; Mooi FR, 2010, INFECT GENET EVOL, V10, P36, DOI 10.1016/j.meegid.2009.10.007; Mooi FR, 2009, EMERG INFECT DIS, V15, P1206, DOI 10.3201/eid1508.081511; NEI M, 1981, GENETICS, V97, P145; Octavia S, 2012, J INFECT DIS, V205, P1220, DOI 10.1093/infdis/jis178; Parkhill J, 2003, NAT GENET, V35, P32, DOI 10.1038/ng1227; Paulke-Korinek M, 2011, VACCINE, V29, P5130, DOI 10.1016/j.vaccine.2011.05.046; Rendi-Wagner P, 2007, PEDIATR INFECT DIS J, V26, P806, DOI 10.1097/INF.0b013e318124a9dd; Schouls LM, 2004, J BACTERIOL, V186, P5496, DOI 10.1128/JB.186.16.5496-5505.2004; Steinborn R, 1998, FEBS LETT, V426, P352, DOI 10.1016/S0014-5793(98)00350-0; Steinborn R, 2000, NAT GENET, V25, P255, DOI 10.1038/77000; Stibitz S, 1997, J BACTERIOL, V179, P5820, DOI 10.1128/jb.179.18.5820-5826.1997; Tartof SY, 2013, PEDIATRICS, V131, pE1047, DOI 10.1542/peds.2012-1928; Thierry-Carstensen B, 2013, VACCINE, V31, P5178, DOI 10.1016/j.vaccine.2013.08.034; van Amersfoorth SCM, 2005, J CLIN MICROBIOL, V43, P2837, DOI 10.1128/JCM.43.6.2837-2843.2005; van der Maas NAT, 2013, VACCINE, V31, P4541, DOI 10.1016/j.vaccine.2013.07.060; van Gent M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046407; van Gent M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020340; van Loo IHM, 1999, J INFECT DIS, V179, P915, DOI 10.1086/314690; WHO, 2010, WEEKLY EPIDEMIOLOGIC; Zhang LJ, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001478.pub5	48	15	19	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2015	10	7							e0132623	10.1371/journal.pone.0132623	http://dx.doi.org/10.1371/journal.pone.0132623			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RQ	26182210	Green Published, Green Submitted, gold			2022-12-26	WOS:000358198200024
J	Yu, SG; Chu, WW; Zhang, LF; Han, HM; Zhao, RX; Wu, W; Zhu, JN; Dodson, MV; Wei, W; Liu, HL; Chen, J				Yu, ShiGang; Chu, WeiWei; Zhang, LiFan; Han, HouMing; Zhao, RongXue; Wu, Wei; Zhu, JiangNing; Dodson, Michael V.; Wei, Wei; Liu, HongLin; Chen, Jie			Identification of Laying-Related SNP Markers in Geese Using RAD Sequencing	PLOS ONE			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; GENOME-WIDE ASSOCIATION; CELL-CELL COMMUNICATION; NEXT-GENERATION; DE-NOVO; DISCOVERY; EXPRESSION; GENE; PROLACTIN; PROTEIN	Laying performance is an important economical trait of goose production. As laying performance is of low heritability, it is of significance to develop a marker-assisted selection (MAS) strategy for this trait. Definition of sequence variation related to the target trait is a prerequisite of quantitating MAS, but little is presently known about the goose genome, which greatly hinders the identification of genetic markers for the laying traits of geese. Recently developed restriction site-associated DNA (RAD) sequencing is a possible approach for discerning large-scale single nucleotide polymorphism (SNP) and reducing the complexity of a genome without having reference genomic information available. In the present study, we developed a pooled RAD sequencing strategy for detecting geese laying-related SNP. Two DNA pools were constructed, each consisting of equal amounts of genomic DNA from 10 individuals with either high estimated breeding value (HEBV) or low estimated breeding value (LEBV). A total of 139,013 SNP were obtained from 42,291,356 sequences, of which 18,771,943 were for LEBV and 23,519,413 were for HEBV cohorts. Fifty-five SNP which had different allelic frequencies in the two DNA pools were further validated by individual-based AS-PCR genotyping in the LEBV and HEBV cohorts. Ten out of 55 SNP exhibited distinct allele distributions in these two cohorts. These 10 SNP were further genotyped in a goose population of 492 geese to verify the association with egg numbers. The result showed that 8 of 10 SNP were associated with egg numbers. Additionally, liner regression analysis revealed that SNP Record-111407, 106975 and 112359 were involved in a multiplegene network affecting laying performance. We used IPCR to extend the unknown regions flanking the candidate RAD tags. The obtained sequences were subjected to BLAST to retrieve the orthologous genes in either ducks or chickens. Five novel genes were cloned for geese which harbored the candidate laying-related SNP, including membrane associated guanylate kinase (MAGI-1), KIAA1462, Rho GTPase activating protein 21 (ARHGAP21), acyl-CoA synthetase family member 2 (ACSF2), astrotactin 2 (ASTN2). Collectively, our data suggests that 8 SNP and 5 genes might be promising candidate markers or targets for marker-assisted selection of egg numbers in geese.	[Yu, ShiGang; Chu, WeiWei; Zhang, LiFan; Wei, Wei; Liu, HongLin; Chen, Jie] Nanjing Agr Univ, Coll Anim Sci & Technol, Nanjing, Jiangsu, Peoples R China; [Han, HouMing; Zhao, RongXue; Wu, Wei; Zhu, JiangNing] Jiangsu Lihua Anim Husb CO LTD, Changzhou, Peoples R China; [Dodson, Michael V.] Washington State Univ, Dept Anim Sci, Pullman, WA 99164 USA	Nanjing Agricultural University; Washington State University	Chen, J (corresponding author), Nanjing Agr Univ, Coll Anim Sci & Technol, Nanjing, Jiangsu, Peoples R China.	jiechen@njau.edu.cn	liu, honglin/HDN-0409-2022; YU, Shigang/HGA-1248-2022	liu, honglin/0000-0002-1254-3163; YU, Shigang/0000-0003-3378-8255; , Lifan/0000-0002-8166-9173	Jiangsu Lihua Animal Husbandry CO. LTD Research Fund; Jiangsu Agriculture Science and Technology Innovation Fund (JASTIF) [CX(14)2071]; Fundamental Research Funds for Central Universities [KYZ201414]	Jiangsu Lihua Animal Husbandry CO. LTD Research Fund; Jiangsu Agriculture Science and Technology Innovation Fund (JASTIF); Fundamental Research Funds for Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by Jiangsu Lihua Animal Husbandry CO. LTD Research Fund to J. Chen. This work was also funded by Jiangsu Agriculture Science and Technology Innovation Fund (JASTIF, CX(14)2071) and the Fundamental Research Funds for the Central Universities (No. KYZ201414). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Jiangsu Lihua Animal Husbandry CO. LTD provided the individual samples and egg performance data.	Ahn HW, 2010, MOL HUM REPROD, V16, P463, DOI 10.1093/molehr/gaq017; Akashi M, 2011, BIOCHEM BIOPH RES CO, V413, P224, DOI 10.1016/j.bbrc.2011.08.073; Akiyama T, 2006, P NATL ACAD SCI USA, V103, P7339, DOI 10.1073/pnas.0510946103; Amish SJ, 2012, MOL ECOL RESOUR, V12, P653, DOI 10.1111/j.1755-0998.2012.03157.x; Baird NA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003376; Barcellos KSA, 2013, J BIOL CHEM, V288, P2179, DOI 10.1074/jbc.M112.432716; Berger J, 2001, NAT GENET, V29, P475, DOI 10.1038/ng773; Bus A, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-281; Carmichael SN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077832; Catchen JM, 2011, G3-GENES GENOM GENET, V1, P171, DOI 10.1534/g3.111.000240; Chaurasia G, 2007, NUCLEIC ACIDS RES, V35, pD590, DOI 10.1093/nar/gkl817; Chen J, 2012, MOL BIOL REP, V39, P475, DOI 10.1007/s11033-011-0761-y; Chen LW, 2013, INT J GYNECOL PATHOL, V32, P156, DOI 10.1097/PGP.0b013e31825a0353; Chowdhury R, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000648; Davey JW, 2011, NAT REV GENET, V12, P499, DOI 10.1038/nrg3012; Ding ST, 2007, POULTRY SCI, V86, P1206, DOI 10.1093/ps/86.6.1206; Eppig John J., 1997, Human Reproduction (Oxford), V12, P127; Erdmann J, 2010, EUROPEAN HEART JOURN; Everett MV, 2011, MOL ECOL RESOUR, V11, P93, DOI 10.1111/j.1755-0998.2010.02969.x; Fujino T, 2001, J BIOL CHEM, V276, P11420, DOI 10.1074/jbc.M008782200; Garner C, 2011, GENET EPIDEMIOL, V35, P261, DOI 10.1002/gepi.20574; Gautier M, 2013, MOL ECOL, V22, P3766, DOI 10.1111/mec.12360; Ghazalpour A, 2006, PLOS GENET, V2, P1182, DOI 10.1371/journal.pgen.0020130; Glessner JT, 2009, NATURE, V459, P569, DOI 10.1038/nature07953; [郭军 Guo Jun], 2011, [畜牧兽医学报, Acta Veterinaria et Zootechnica Sinica], V42, P1477; Hallows WC, 2006, P NATL ACAD SCI USA, V103, P10230, DOI 10.1073/pnas.0604392103; Hayashi K, 2006, THEOR APPL GENET, V113, P251, DOI 10.1007/s00122-006-0290-6; Hou R, 2013, SCI CHINA LIFE SCI, V56, P104, DOI 10.1007/s11427-013-4441-0; Houston RD, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-244; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang YH, 2013, NAT GENET, V45, P776, DOI 10.1038/ng.2657; Ihaka R., 1996, J COMPUT GRAPH STAT, V5, P299, DOI [DOI 10.1080/10618600.1996.10474713, 10.2307/1390807]; Jiang RS, 2009, S AFR J ANIM SCI, V39, P83; Jiang ZH, 2009, INT J BIOL SCI, V5, P528; Johnson RC, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-724; Kang B, 2014, MOLECULAR BIOLOGY RE, P1; Kapun M, 2014, MOL ECOL, V23, P1813, DOI 10.1111/mec.12594; Khongmanee A, 2013, PROTEOMICS, V13, P3157, DOI 10.1002/pmic.201300219; Kranjec C, 2014, J VIROL, V88, P7155, DOI 10.1128/JVI.03247-13; Lancaster OM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001179; Lesch KP, 2008, J NEURAL TRANSM, V115, P1573, DOI 10.1007/s00702-008-0119-3; Liu J, 2012, PLANT METHODS, V8, DOI 10.1186/1746-4811-8-34; Liu KJ, 2005, BIOINFORMATICS, V21, P2128, DOI 10.1093/bioinformatics/bti282; Menetrey J, 2007, EMBO J, V26, P1953, DOI 10.1038/sj.emboj.7601634; Montavon C, 2012, GYNECOL ONCOL, V124, P582, DOI 10.1016/j.ygyno.2011.11.026; Morozova O, 2008, GENOMICS, V92, P255, DOI 10.1016/j.ygeno.2008.07.001; Murdock DG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082194; Ogden R, 2013, MOL ECOL, V22, P3112, DOI 10.1111/mec.12234; Paraguassu-Braga FH, 2003, CELL DEATH DIFFER, V10, P1101, DOI 10.1038/sj.cdd.4401279; Peden JF, 2011, NAT GENET, V43, P339, DOI 10.1038/ng.782; Pegadaraju V, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-556; Pujolar JM, 2013, MOL ECOL RESOUR, V13, P706, DOI 10.1111/1755-0998.12117; Rowe HC, 2011, MOL ECOL, V20, P3499, DOI 10.1111/j.1365-294X.2011.05197.x; Ru hua W, 2009, ANIMAL HUSBANDRY AND, V2; Senn H, 2013, MOL ECOL, V22, P3141, DOI 10.1111/mec.12242; STEIN LS, 1991, CANCER RES, V51, P696; Stickney HL, 2002, GENOME RES, V12, P1929, DOI 10.1101/gr.777302; Suzuki F, 2013, TOHOKU J EXP MED, V231, P193, DOI 10.1620/tjem.231.193; Turner TL, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001336; Vrijenhoek T, 2008, AM J HUM GENET, V83, P504, DOI 10.1016/j.ajhg.2008.09.011; Wakeley J, 1996, TRENDS ECOL EVOL, V11, P158, DOI 10.1016/0169-5347(96)10009-4; Wang LQ, 2012, GYNECOL ENDOCRINOL, V28, P665, DOI 10.3109/09513590.2012.650768; Willing EM, 2011, BIOINFORMATICS, V27, P2187, DOI 10.1093/bioinformatics/btr346; Wilson MR, 2000, EXP CELL RES, V254, P257, DOI 10.1006/excr.1999.4771; Wilson PM, 2010, J NEUROSCI, V30, P8529, DOI 10.1523/JNEUROSCI.0032-10.2010; Xu Q, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055496; Yang ZH, 1999, J MOL EVOL, V48, P274, DOI 10.1007/PL00006470; You FM, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-59; Zhang X, 2013, FOLIA BIOL, V61, P1; Zhang X, 2013, FOLIA BIOL-KRAKOW, V61, P59, DOI 10.3409/fb61_1-2.59; Zhao X, 2011, CHINA POULTRY, V16; Zhu Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041901	73	20	22	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2015	10	7							e0131572	10.1371/journal.pone.0131572	http://dx.doi.org/10.1371/journal.pone.0131572			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RQ	26181055	Green Submitted, Green Published, gold			2022-12-26	WOS:000358198200006
J	Almoguera, B; Li, JK; Jose, PFS; Liu, YC; March, M; Pellegrino, R; Golhar, R; Corton, M; Blanco-Kelly, F; Lopez-Molina, MI; Garcia-Sandoval, B; Guo, YR; Tian, LF; Liu, XZ; Guan, LP; Zhang, JG; Keating, B; Xu, X; Hakonarson, H; Ayuso, C				Almoguera, Berta; Li, Jiankang; Fernandez-San Jose, Patricia; Liu, Yichuan; March, Michael; Pellegrino, Renata; Golhar, Ryan; Corton, Marta; Blanco-Kelly, Fiona; Isabel Lopez-Molina, Maria; Garcia-Sandoval, Blanca; Guo, Yiran; Tian, Lifeng; Liu, Xuanzhu; Guan, Liping; Zhang, Jianguo; Keating, Brendan; Xu, Xun; Hakonarson, Hakon; Ayuso, Carmen			Application of Whole Exome Sequencing in Six Families with an Initial Diagnosis of Autosomal Dominant Retinitis Pigmentosa: Lessons Learned	PLOS ONE			English	Article							ONSET RETINAL DEGENERATION; COPY-NUMBER VARIATION; SPANISH FAMILIES; MUTATION; GENES; RPGR; RP2; PHENOTYPE; IDENTIFICATION; STANDARD	This study aimed to identify the genetics underlying dominant forms of inherited retinal dystrophies using whole exome sequencing (WES) in six families extensively screened for known mutations or genes. Thirty-eight individuals were subjected to WES. Causative variants were searched among single nucleotide variants (SNVs) and insertion/deletion variants (indels) and whenever no potential candidate emerged, copy number variant (CNV) analysis was performed. Variants or regions harboring a candidate variant were prioritized and segregation of the variant with the disease was further assessed using Sanger sequencing in case of SNVs and indels, and quantitative PCR (qPCR) for CNVs. SNV and indel analysis led to the identification of a previously reported mutation in PRPH2. Two additional mutations linked to different forms of retinal dystrophies were identified in two families: a known frameshift deletion in RPGR, a gene responsible for X-linked retinitis pigmentosa and p.Ser163Arg in C1QTNF5 associated with Late-Onset Retinal Degeneration. A novel heterozygous deletion spanning the entire region of PRPF31 was also identified in the affected members of a fourth family, which was confirmed with qPCR. This study allowed the identification of the genetic cause of the retinal dystrophy and the establishment of a correct diagnosis in four families, including a large heterozygous deletion in PRPF31, typically considered one of the pitfalls of this method. Since all findings in this study are restricted to known genes, we propose that targeted sequencing using gene-panel is an optimal first approach for the genetic screening and that once known genetic causes are ruled out, WES might be used to uncover new genes involved in inherited retinal dystrophies.	[Almoguera, Berta; Liu, Yichuan; March, Michael; Pellegrino, Renata; Golhar, Ryan; Guo, Yiran; Tian, Lifeng; Keating, Brendan; Hakonarson, Hakon] Childrens Hosp Philadelphia, Ctr Appl Genom, Philadelphia, PA 19104 USA; [Li, Jiankang; Liu, Xuanzhu; Guan, Liping; Zhang, Jianguo; Xu, Xun] BGI Shenzhen, Shenzhen 518083, Peoples R China; [Fernandez-San Jose, Patricia; Corton, Marta; Blanco-Kelly, Fiona; Ayuso, Carmen] IIS Fdn Jimenez Diaz, Dept Genet & Genom, Madrid 28040, Spain; [Fernandez-San Jose, Patricia; Corton, Marta; Blanco-Kelly, Fiona; Isabel Lopez-Molina, Maria; Garcia-Sandoval, Blanca; Ayuso, Carmen] ISCIII, Ctr Biomed Network Res Rare Dis CIBERER, Madrid, Spain; [Isabel Lopez-Molina, Maria; Garcia-Sandoval, Blanca] Fdn Jimenez Diaz, Dept Ophthalmol, E-28040 Madrid, Spain	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Beijing Genomics Institute (BGI); Fundacion Jimenez Diaz; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Instituto de Salud Carlos III	Ayuso, C (corresponding author), Childrens Hosp Philadelphia, Ctr Appl Genom, Philadelphia, PA 19104 USA.	cayuso@fjd.es	March, Michael/AAB-6502-2019; Liu, Yichuan/AAF-3893-2021; Xu, Xun/AAI-6763-2020; Guo, Yiran/H-4120-2011	March, Michael/0000-0001-9173-6862; Xu, Xun/0000-0002-5338-5173; Corton, Marta/0000-0003-0087-1626; Pellegrino, Renata/0000-0002-2217-7371; LIU, YICHUAN/0000-0003-2023-072X; Ayuso, Carmen/0000-0002-9242-7065; Blanco-Kelly, Fiona/0000-0003-0052-5651	Instituto 429 de Salud Carlos III [CM12/00013, CP/03256]; FJD-Biobank [RD09/0076/00101]; CIBER-ER [06/07/0036]; FIS [PI: 13/00226]; ONCE; Fundaluce [4019-002]; Institution Development Award from The Children's Hospital of Philadelphia [U01-HG006830]; Shenzhen Municipal Government of China [GJHZ20130417140916986]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG006830] Funding Source: NIH RePORTER	Instituto 429 de Salud Carlos III; FJD-Biobank; CIBER-ER; FIS(Instituto de Salud Carlos III); ONCE; Fundaluce; Institution Development Award from The Children's Hospital of Philadelphia; Shenzhen Municipal Government of China; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	Patricia Fernandez San Jose's work is supported by a Rio Hortega grant (CM12/00013) and Marta Corton by a Miguel Servet grant (CP/03256), both from Instituto 429 de Salud Carlos III. This work was funded in part by FJD-Biobank (RD09/0076/00101), CIBER-ER (06/07/0036), FIS (PI: 13/00226), ONCE 2013 and Fundaluce (4019-002); by an Institution Development Award from The Children's Hospital of Philadelphia, and U01-HG006830 (NHGRI433 sponsored eMERGE Network); and by the Shenzhen Municipal Government of China (No GJHZ20130417140916986).	Almoguera B, 2014, ORPHANET J RARE DIS, V9, DOI 10.1186/s13023-014-0190-9; Audo I, 2012, ORPHANET J RARE DIS, V7, DOI 10.1186/1750-1172-7-8; Avila-Fernandez A, 2015, HUM MOL GENET, V24, P4037, DOI 10.1093/hmg/ddv140; AYUSO C, 1995, CLIN GENET, V48, P120; Blanco-Kelly F, 2012, MOL VIS, V18, P1478; Borooah S, 2009, BRIT J OPHTHALMOL, V93, P284, DOI 10.1136/bjo.2008.150151; Borras E, 2013, CLIN GENET, V84, P441, DOI 10.1111/cge.12151; Bowne SJ, 2011, INVEST OPHTH VIS SCI, V52, P494, DOI 10.1167/iovs.10-6180; Branham K, 2012, INVEST OPHTH VIS SCI, V53, P8232, DOI 10.1167/iovs.12-11025; Chassine T, 2015, BRIT J OPHTHALMOL, V99, P1360, DOI 10.1136/bjophthalmol-2014-306224; Churchill JD, 2013, INVEST OPHTH VIS SCI, V54, P1411, DOI 10.1167/iovs.12-11541; Consugar MB, 2015, GENET MED, V17, P253, DOI 10.1038/gim.2014.172; Corton M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065574; Daiger SP, 2013, CLIN GENET, V84, P132, DOI 10.1111/cge.12203; Daiger SP, 2008, ADV EXP MED BIOL, V613, P203, DOI 10.1007/978-0-387-74904-4_23; Edelmann L, 2007, J MED GENET, V44, P136, DOI 10.1136/jmg.2006.044537; Eisenberger T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078496; FISHMAN GA, 1986, ARCH OPHTHALMOL-CHIC, V104, P1329, DOI 10.1001/archopht.1986.01050210083030; Fromer M, 2012, AM J HUM GENET, V91, P597, DOI 10.1016/j.ajhg.2012.08.005; Garcia-Hoyos M, 2006, INVEST OPHTH VIS SCI, V47, P3777, DOI 10.1167/iovs.06-0323; Glessner JT, 2009, NATURE, V459, P569, DOI 10.1038/nature07953; Hamel C, 2006, ORPHANET J RARE DIS, V1, DOI 10.1186/1750-1172-1-40; Hartong DT, 2006, LANCET, V368, P1795, DOI 10.1016/S0140-6736(06)69740-7; Hayward C, 2003, HUM MOL GENET, V12, P2657, DOI 10.1093/hmg/ddg289; Jayasundera T, 2010, ARCH OPHTHALMOL-CHIC, V128, P915, DOI 10.1001/archophthalmol.2010.122; Jose PFS, 2015, INVEST OPHTH VIS SCI, V56, P2173, DOI 10.1167/iovs.14-16178; Kitiratschky VBD, 2011, OPHTHALMIC GENET, V32, P151, DOI 10.3109/13816810.2011.559650; Koenekoop RK, 2003, AM J OPHTHALMOL, V136, P678, DOI 10.1016/S0002-9394(03)00331-3; Kohl S, 2012, ADV EXP MED BIOL, V723, P337, DOI 10.1007/978-1-4614-0631-0_44; Kohn L, 2009, EUR J HUM GENET, V17, P651, DOI 10.1038/ejhg.2008.223; Kuntz CA, 1996, INVEST OPHTH VIS SCI, V37, P1772; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Ma XY, 2015, SCI REP-UK, V5, DOI 10.1038/srep09236; MARMOR MF, 1993, ARCH OPHTHALMOL-CHIC, V111, P601, DOI 10.1001/archopht.1993.01090050035023; Marmor MF, 1999, DOC OPHTHALMOL, V97, P143; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Milam AH, 2000, OPHTHALMOLOGY, V107, P2256, DOI 10.1016/S0161-6420(00)00419-X; Neveling K, 2012, HUM MUTAT, V33, P963, DOI 10.1002/humu.22045; Ng SB, 2010, NAT GENET, V42, P30, DOI 10.1038/ng.499; Nishiguchi KM, 2013, P NATL ACAD SCI USA, V110, P16139, DOI 10.1073/pnas.1308243110; REIG C, 1994, HUM GENET, V94, P283; Rope AF, 2011, AM J HUM GENET, V89, P28, DOI 10.1016/j.ajhg.2011.05.017; Shanks ME, 2013, EUR J HUM GENET, V21, P274, DOI 10.1038/ejhg.2012.172; Sharon D, 2000, INVEST OPHTH VIS SCI, V41, P2712; Soumplis V, 2013, ACTA OPHTHALMOL, V91, pE191, DOI 10.1111/aos.12010; Trujillo MJ, 1998, MED CLIN-BARCELONA, V110, P501; Vervoort R, 2000, NAT GENET, V25, P462, DOI 10.1038/78182; Vincent A, 2012, RETINA-J RET VIT DIS, V32, P1643, DOI 10.1097/IAE.0b013e318240a574; Wang F, 2014, INVEST OPHTH VIS SCI, V55, P7159, DOI 10.1167/iovs.14-15520; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Wu DM, 2010, EYE, V24, P764, DOI 10.1038/eye.2009.270	51	19	21	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0133624	10.1371/journal.pone.0133624	http://dx.doi.org/10.1371/journal.pone.0133624			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LZ	26197217	Green Submitted, Green Published, gold			2022-12-26	WOS:000358547600121
J	Huang, JY; Jian, ZH; Nfor, ON; Jhang, KM; Ku, WY; Ko, PC; Jan, SR; Ho, CC; Lung, CC; Pan, HH; Liang, YC; Liaw, YP				Huang, Jing-Yang; Jian, Zhi-Hong; Nfor, Oswald Ndi; Jhang, Kai-Ming; Ku, Wen-Yuan; Ko, Pei-Chieh; Jan, Shiou-Rung; Ho, Chien-Chang; Lung, Chia-Chi; Pan, Hui-Hsien; Liang, Yu-Chiu; Liaw, Yung-Po			The Impact of Coexisting Asthma, Chronic Obstructive Pulmonary Disease and Tuberculosis on Survival in Patients with Lung Squamous Cell Carcinoma	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; CANCER-RISK; SURGICAL RESECTION; GENDER-DIFFERENCES; ESTROGEN-RECEPTOR; OVERLAP SYNDROME; COPD-ASTHMA; POPULATION; SMOKING; TAIWAN	Background Pulmonary diseases [asthma, chronic obstructive pulmonary disease (COPD), and tuberculosis (TB)] are associated with lung cancer mortality. However, the relationship between coexisting pulmonary diseases and survival in patients with lung squamous cell carcinoma (SqCC) has not been well defined. Methods Patients newly diagnosed with SqCC between 2003 and 2008 were identified by linking the National Health Insurance Research Database and Taiwan Cancer Registry Database. Cases with SqCC were followed up until death, loss to follow-up, or study end in 2010. Information on health status, date of death and the main causes of death was ascertained from the National Death Registry Database. Cox proportional hazard regression was used to calculate the hazard ratio (HR) of coexisting asthma, COPD and/or TB. Results During the study period, a total of 5406 cases with SqCC were enrolled. For all cause-mortality, HRs were 1.08 [95% confidence interval (CI), 0.99-1.18], 1.04 (95% CI, 0.97-1.12), and 1.14 (95% CI, 1.00-1.31) for individuals with asthma, COPD, and TB, respectively. Specifically, among men with coexisting pulmonary diseases, the HRs were 1.56 (95% CI, 1.23-1.97) and 1.11 (95% CI, 1.00-1.24) for individuals with asthma+COPD+TB and asthma+COPD, respectively. Among male patients with stage III SqCC, HRs were 3.41 (95% CI, 1.27-9.17) and 1.65 (95% CI, 1.10-2.47) for individuals with asthma+TB and asthma+COPD+TB, respectively. Among male patients with stage IV SqCC, HRs were 1.40 (95% CI, 1.00-1.97) and 1.25 (95% CI, 1.03-1.52) for individuals with asthma+ COPD +TB and asthma. Among female patients with stage I and II, HR was 0.19 (95% CI, 005-0.77) for individuals with asthma. Conclusions Coexisting pulmonary diseases increased the risk of mortality from SqCC in male patients. For female patients with early stage SqCC, pre-existing asthma decreased mortality. These patients deserve greater attention while undergoing cancer treatment.	[Huang, Jing-Yang; Jian, Zhi-Hong; Nfor, Oswald Ndi; Jhang, Kai-Ming; Ku, Wen-Yuan; Ko, Pei-Chieh; Jan, Shiou-Rung; Lung, Chia-Chi; Liaw, Yung-Po] Chung Shan Med Univ, Dept Publ Hlth, Taichung, Taiwan; [Huang, Jing-Yang; Jian, Zhi-Hong; Nfor, Oswald Ndi; Jhang, Kai-Ming; Ku, Wen-Yuan; Ko, Pei-Chieh; Jan, Shiou-Rung; Lung, Chia-Chi; Liaw, Yung-Po] Chung Shan Med Univ, Inst Publ Hlth, Taichung, Taiwan; [Jhang, Kai-Ming] Changhua Christian Hosp, Dept Neurol, Changhua, Taiwan; [Ho, Chien-Chang] Fu Jen Catholic Univ, Dept Phys Educ, New Taipei City, Taiwan; [Lung, Chia-Chi; Liaw, Yung-Po] Chung Shan Med Univ Hosp, Dept Family & Community Med, Taichung, Taiwan; [Pan, Hui-Hsien] Chung Shan Med Univ Hosp, Dept Pediat, Taichung, Taiwan; [Pan, Hui-Hsien] Chung Shan Med Univ, Sch Med, Taichung, Taiwan; [Liang, Yu-Chiu] Taipei Med Univ, Coll Humanities & Social Sci, Taipei, Taiwan	Chung Shan Medical University; Chung Shan Medical University; Changhua Christian Hospital; Fu Jen Catholic University; Chung Shan Medical University; Chung Shan Medical University Hospital; Chung Shan Medical University; Chung Shan Medical University Hospital; Chung Shan Medical University; Taipei Medical University	Liaw, YP (corresponding author), Chung Shan Med Univ, Dept Publ Hlth, Taichung, Taiwan.	Liawyp@csmu.edu.tw	Liaw, Yung Po/AAV-6746-2021	Huang, Jing-Yang/0000-0002-0794-9388				Ahmad S, 2011, CLIN DEV IMMUNOL, V2011, DOI [10.1155/2011/814943, DOI 10.1155/2011/814943]; [Anonymous], TAIW TUB CONTR REP 2; Ballaz Santiago, 2003, Clin Lung Cancer, V5, P46, DOI 10.3816/CLC.2003.n.021; Brown DW, 2005, J ASTHMA, V42, P597, DOI 10.1080/02770900500216234; Caracta CF, 2003, MT SINAI J MED, V70, P215; de Marco R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062985; Doris K, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-118; El-Zein M, 2014, ANN ALLERG ASTHMA IM, V112, P230, DOI 10.1016/j.anai.2013.12.021; El-Zein M, 2010, ANN ALLERG ASTHMA IM, V104, P378, DOI 10.1016/j.anai.2010.03.003; Federico A, 2007, INT J CANCER, V121, P2381, DOI 10.1002/ijc.23192; Fu JJ, 2014, ALLERGY ASTHMA IMMUN, V6, P316, DOI 10.4168/aair.2014.6.4.316; Hardin M, 2014, EUR RESPIR J, V44, P341, DOI 10.1183/09031936.00216013; Hwang CY, 2010, ACTA DERM-VENEREOL, V90, P589, DOI 10.2340/00015555-0963; Inghammar M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010138; Janssen-Heijnen MLG, 2004, THORAX, V59, P602, DOI 10.1136/thx.2003.018044; Jian ZH, 2014, MEDICINE, V93, DOI 10.1097/MD.0000000000000127; Jonsson F, 2013, BRIT J CANCER, V109, P1921, DOI 10.1038/bjc.2013.411; Kawaguchi T, 2010, J THORAC ONCOL, V5, P620, DOI 10.1097/JTO.0b013e3181d2dcd9; Kiri VA, 2009, RESP MED, V103, P85, DOI 10.1016/j.rmed.2008.07.024; Kuo CH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033226; Lee CH, 2013, RESP MED, V107, P1222, DOI 10.1016/j.rmed.2012.12.002; Leung CC, 2013, INT J TUBERC LUNG D, V17, P687, DOI 10.5588/ijtld.12.0816; Lu JFR, 2003, HEALTH AFFAIR, V22, P77, DOI 10.1377/hlthaff.22.3.77; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Menezes AMB, 2014, CHEST, V145, P297, DOI 10.1378/chest.13-0622; Nielsen SF, 2012, NEW ENGL J MED, V367, P1792, DOI 10.1056/NEJMoa1201735; Oda K, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100014; Pan HH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096190; Parsons A, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.b5569; Rena O, 2013, TUMORI, V99, P661, DOI 10.1700/1390.15453; Rothwell PM, 2012, LANCET, V379, P1591, DOI 10.1016/S0140-6736(12)60209-8; Sekine Y, 2007, ANN THORAC SURG, V84, P946, DOI 10.1016/j.athoracsur.2007.04.038; Sekine Y, 2013, THORAC CARDIOV SURG, V61, P124, DOI 10.1055/s-0032-1304543; Singh S, 2013, WORLD J CLIN ONCOL, V4, P43, DOI 10.5306/wjco.v4.i2.43; SKILLRUD DM, 1986, ANN INTERN MED, V105, P503, DOI 10.7326/0003-4819-105-4-503; Stabile LP, 2005, CANCER RES, V65, P1459, DOI 10.1158/0008-5472.CAN-04-1872; Tammemagi CM, 2003, INT J CANCER, V103, P792, DOI 10.1002/ijc.10882; Thomas L, 2005, CHEST, V128, P370, DOI 10.1378/chest.128.1.370; Tsai YW, 2008, J WOMENS HEALTH, V17, P971, DOI 10.1089/jwh.2007.0621; Tseng CH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109852; VESTERINEN E, 1993, ACTA ONCOL, V32, P517, DOI 10.3109/02841869309096110; Wang YC, 2007, CHEST, V131, P705, DOI 10.1378/chest.06-1829; Wu CT, 2005, J THORAC CARDIOV SUR, V130, P979, DOI 10.1016/j.jtcvs.2005.06.012; Yang TY, 2015, INT J CLIN PRACT, V69, P571, DOI 10.1111/ijcp.12598; Zhai RH, 2014, CHEST, V145, P346, DOI 10.1378/chest.13-1176; Zhou YM, 2013, J CARDIOTHORAC SURG, V8, DOI 10.1186/1749-8090-8-123	46	10	11	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0133367	10.1371/journal.pone.0133367	http://dx.doi.org/10.1371/journal.pone.0133367			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LZ	26196516	Green Submitted, Green Published, gold			2022-12-26	WOS:000358547600088
J	Perez, CT; Hill, RH; Grillner, S				Perez, Carolina Thorn; Hill, Russell H.; Grillner, Sten			Substance P Depolarizes Lamprey Spinal Cord Neurons by Inhibiting Background Potassium Channels	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; DOMAIN K+ CHANNEL; LOCOMOTOR NETWORK; CALCIUM-CHANNELS; TASK-1; MODULATION; RAT; MOTONEURONS; ANANDAMIDE; RECEPTOR	Substance P is endogenously released in the adult lamprey spinal cord and accelerates the burst frequency of fictive locomotion. This is achieved by multiple effects on interneurons and motoneurons, including an attenuation of calcium currents, potentiation of NMDA currents and reduction of the reciprocal inhibition. While substance P also depolarizes spinal cord neurons, the underlying mechanism has not been resolved. Here we show that effects of substance P on background K+ channels are the main source for this depolarization. Hyperpolarizing steps induced inward currents during whole-cell voltage clamp that were reduced by substance P. These background K+ channels are pH sensitive and are selectively blocked by anandamide and AVE1231. These blockers counteracted the effect of substance P on these channels and the resting membrane potential depolarization in spinal cord neurons. Thus, we have shown now that substance P inhibits background K+ channels that in turn induce depolarization, which is likely to contribute to the frequency increase observed with substance P during fictive locomotion.	[Perez, Carolina Thorn; Hill, Russell H.; Grillner, Sten] Karolinska Inst, Nobel Inst Neurophysiol, Dept Neurosci, S-10401 Stockholm, Sweden	Karolinska Institutet	Grillner, S (corresponding author), Karolinska Inst, Nobel Inst Neurophysiol, Dept Neurosci, Box 60400, S-10401 Stockholm, Sweden.	sten.grillner@ki.se		Thorn Perez, Carolina/0000-0003-4309-0969; Thorn Perez, Carolina/0000-0002-3480-8599	Swedish Research Council [VRNG 621-2013-4613]; STG; Karolinska Institutet, STG	Swedish Research Council(Swedish Research CouncilEuropean Commission); STG; Karolinska Institutet, STG	This work was supported by the Swedish Research Council VRNG 621-2013-4613, STG, and Karolinska Institutet, STG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barthe JY, 1997, EXP BRAIN RES, V115, P485, DOI 10.1007/PL00005718; Duprat F, 1997, EMBO J, V16, P5464, DOI 10.1093/emboj/16.17.5464; Ehrlich JR, 2008, J CARDIOVASC PHARM, V51, P380, DOI 10.1097/FJC.0b013e3181669030; Grillner S, 2003, NAT REV NEUROSCI, V4, P573, DOI 10.1038/nrn1137; Hille B., 2001, ION CHANNELS EXCITAB, P813; Kettunen P, 2003, J NEUROPHYSIOL, V90, P2341, DOI 10.1152/jn.01132.2002; KOH DS, 1992, J MEMBRANE BIOL, V130, P149; Leonoudakis D, 1998, J NEUROSCI, V18, P868; Lesage F, 2003, NEUROPHARMACOLOGY, V44, P1, DOI 10.1016/S0028-3908(02)00339-8; Lopes CMB, 2000, J BIOL CHEM, V275, P16969, DOI 10.1074/jbc.M001948200; Lu BX, 2009, NATURE, V457, P741, DOI 10.1038/nature07579; Maggi CA, 1997, TRENDS PHARMACOL SCI, V18, P351, DOI 10.1016/S0165-6147(97)90663-5; Maingret F, 2001, EMBO J, V20, P47, DOI 10.1093/emboj/20.1.47; Medhurst AD, 2001, MOL BRAIN RES, V86, P101, DOI 10.1016/S0169-328X(00)00263-1; NICOLL RA, 1990, PHYSIOL REV, V70, P513, DOI 10.1152/physrev.1990.70.2.513; Parker D, 1999, J NEUROSCI, V19, P1647; Parker D, 1998, J NEUROSCI, V18, P8095; Perez CT, 2007, J NEUROPHYSIOL, V97, P3331, DOI 10.1152/jn.01302.2006; Perez CT, 2009, J NEUROPHYSIOL, V102, P1358, DOI 10.1152/jn.00294.2009; Perrier JF, 2013, CURR PHARM DESIGN, V19, P4371, DOI 10.2174/13816128113199990341; Ren DJ, 2011, NEURON, V72, P899, DOI 10.1016/j.neuron.2011.12.007; Schiekel J, 2013, CARDIOVASC RES, V97, P97, DOI 10.1093/cvr/cvs285; Schneider ER, 2014, CURR TOP MEMBR, V74, P113, DOI 10.1016/B978-0-12-800181-3.00005-1; Talley EM, 2000, NEURON, V25, P399, DOI 10.1016/S0896-6273(00)80903-4; Tegner J, 1997, J NEUROPHYSIOL, V77, P1795, DOI 10.1152/jn.1997.77.4.1795; Thom Perez C, 2012, SUBSTANCE P REDUCES; Wang D, 2013, J PHYSIOL-LONDON, V591, P2509, DOI 10.1113/jphysiol.2012.248526; Zygmunt PM, 1999, NATURE, V400, P452, DOI 10.1038/22761	29	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0133136	10.1371/journal.pone.0133136	http://dx.doi.org/10.1371/journal.pone.0133136			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LZ	26197458	Green Published, Green Submitted, gold			2022-12-26	WOS:000358547600064
J	Pham, QD; Wilson, DP; Kerr, CC; Shattock, AJ; Do, HM; Duong, AT; Nguyen, LT; Zhang, L				Quang Duy Pham; Wilson, David P.; Kerr, Cliff C.; Shattock, Andrew J.; Hoa Mai Do; Anh Thuy Duong; Long Thanh Nguyen; Zhang, Lei			Estimating the Cost-Effectiveness of HIV Prevention Programmes in Vietnam, 2006-2010: A Modelling Study	PLOS ONE			English	Article							INJECTING DRUG-USERS; ANTIRETROVIRAL THERAPY; METHADONE-MAINTENANCE; HARM REDUCTION; DISABILITY WEIGHTS; HEALTH; RISK; SEX; INTERVENTIONS; PREVALENCE	Introduction Vietnam has been largely reliant on international support in its HIV response. Over 20062010, a total of US$480 million was invested in its HIV programmes, more than 70% of which came from international sources. This study investigates the potential epidemiological impacts of these programmes and their cost-effectiveness. Methods We conducted a data synthesis of HIV programming, spending, epidemiological, and clinical outcomes. Counterfactual scenarios were defined based on assumed programme coverage and behaviours had the programmes not been implemented. An epidemiological model, calibrated to reflect the actual epidemiological trends, was used to estimate plausible ranges of programme impacts. The model was then used to estimate the costs per averted infection, death, and disability adjusted life-year (DALY). Results Based on observed prevalence reductions amongst most population groups, and plausible counterfactuals, modelling suggested that antiretroviral therapy (ART) and prevention programmes over 2006-2010 have averted an estimated 50,600 [95% uncertainty bound: 36,300-68,900] new infections and 42,600 [36,100-54,100] deaths, resulting in 401,600 [312,200-496,300] fewer DALYs across all population groups. HIV programmes in Vietnam have cost an estimated US$1,972 [1,447-2,747], US$2,344 [1,843-2,765], and US$248 [201-319] for each averted infection, death, and DALY, respectively. Conclusions Our evaluation suggests that HIV programmes in Vietnam have most likely had benefits that are cost-effective. ART and direct HIV prevention were the most cost-effective interventions in reducing HIV disease burden.	[Quang Duy Pham; Wilson, David P.; Kerr, Cliff C.; Shattock, Andrew J.; Zhang, Lei] Univ New S Wales, Kirby Inst, Sydney, NSW, Australia; [Quang Duy Pham] Inst Pasteur, Dept Dis Control & Prevent, Ho Chi Minh City, Vietnam; [Hoa Mai Do] Hanoi Sch Publ Hlth, Dept Hlth Syst, Hanoi, Vietnam; [Anh Thuy Duong] Vietnam Adm HIV AIDS Control, Dept Planning & Finance, Hanoi, Vietnam; [Long Thanh Nguyen] Minist Heath, Hanoi, Vietnam; [Zhang, Lei] Monash Univ, Fac Med Nursing & Hlth Sci, Sch Publ Hlth & Prevent Med, Melbourne, Vic 3004, Australia; [Zhang, Lei] Alfred Hlth, Melbourne Sexual Hlth Ctr, Melbourne, Vic, Australia	University of New South Wales Sydney; Kirby Institute; Hanoi University of Public Health; Monash University	Zhang, L (corresponding author), Univ New S Wales, Kirby Inst, Sydney, NSW, Australia.	Lzhang@kirby.unsw.edu.au	Duong, Anh/GPW-9558-2022; Zhang, Lei/D-4039-2011	Zhang, Lei/0000-0003-2343-084X; Shattock, Andrew/0000-0002-2285-8425	World Bank [8004397]; AusAID PhD scholarship; Australian National Health and Medical Research Council; Australian Government, Department of Health and Ageing	World Bank(The World Bank India); AusAID PhD scholarship; Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Australian Government, Department of Health and Ageing(Australian GovernmentDepartment of Health & Ageing)	This research was supported by the World Bank under the terms of the contract number: 8004397. QDP is supported by an AusAID PhD scholarship. DPW's work was funded in part by the Australian National Health and Medical Research Council. The Kirby Institute is funded by the Australian Government, Department of Health and Ageing and is affiliated with the UNSW Australia.	Duong AT, 2014, JAIDS-J ACQ IMM DEF, V65, pE1, DOI 10.1097/QAI.0b013e3182a17d15; [Anonymous], 2013, LANCET, DOI DOI 10.1016/S0140-6736(12)61898-4; Aspinall EJ, 2014, INT J EPIDEMIOL, V43, P235, DOI 10.1093/ije/dyt243; Tran BX, 2012, GLOB PUBLIC HEALTH, V7, P1080, DOI 10.1080/17441692.2012.736259; Beyrer C, 2012, LANCET, V380, P367, DOI 10.1016/S0140-6736(12)60821-6; Birungi J, 2012, 19 INT AIDS C WASH U; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Craig AP, 2014, J INT AIDS SOC, V17, DOI 10.7448/IAS.17.1.18822; Tran DA, 2014, AIDS PATIENT CARE ST, V28, P365, DOI 10.1089/apc.2014.0016; Nguyen DB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055750; Easterbrook PJ, 2014, AIDS, V28, pS93, DOI 10.1097/QAD.0000000000000253; Eaton JW, 2014, LANCET GLOB HEALTH, V2, pE23, DOI 10.1016/S2214-109X(13)70172-4; Family Health International, 2012, COST AN SEL USAID SU; Family Health International, 2013, IMPR HIV CASC SERV V; Gilks CF, 2006, LANCET, V368, P505, DOI 10.1016/S0140-6736(06)69158-7; Guinness L, 2010, ADDICTION, V105, P319, DOI 10.1111/j.1360-0443.2009.02755.x; Hien NT, 2004, AIDS EDUC PREV, V16, P137, DOI 10.1521/aeap.16.3.5.137.35527; Hogan DR, 2005, BRIT MED J, V331, P1431, DOI 10.1136/bmj.38643.368692.68; Iversen J., 2014, AUSTR NEEDLE SYRINGE; Kato M, 2013, JAIDS-J ACQ IMM DEF, V63, pE142, DOI 10.1097/QAI.0b013e31829b535b; Kerr CC, 2015, JAIDS-J ACQ IMM DEF, V69, P365, DOI 10.1097/QAI.0000000000000605; Kumaranayake L, 2004, ADDICTION, V99, P1565, DOI 10.1111/j.1360-0443.2004.00899.x; Marsch LA, 1998, ADDICTION, V93, P515, DOI 10.1046/j.1360-0443.1998.9345157.x; Ministry of Health, 2006, RES HIV STI INT BIOL; Ministry of Health, 2011, RES HIV STI INT BIOL; National AIDS Standing Bureau Family Health International United States Agency for International Development, 2001, HIV AIDS BEH SURV SU; Nguyen TTM, 2012, ADV PREV MED; Patel P, 2014, AIDS, V28, P1509, DOI 10.1097/QAD.0000000000000298; Prinja S, 2011, SEX TRANSM INFECT, V87, P354, DOI 10.1136/sti.2010.047829; Public Health Agency of Canada, 2006, I TRACK ENH SURV RIS; Quan VM, 1998, SUBST USE MISUSE, V33, P1055, DOI 10.3109/10826089809062206; Quan VM, 2000, J ACQ IMMUN DEF SYND, V25, P360, DOI 10.1097/00126334-200012010-00011; Pham QD, 2012, SEX TRANSM DIS, V39, P799, DOI 10.1097/OLQ.0b013e318265b180; Rottingen JA, 2002, SEX TRANSM DIS, V29, P818, DOI 10.1097/00007435-200212000-00014; Salomon JA, 2012, LANCET, V380, P2129, DOI 10.1016/S0140-6736(12)61680-8; Shillcutt SD, 2009, PHARMACOECONOMICS, V27, P903, DOI 10.2165/10899580-000000000-00000; Srikantiah P, 2010, AIDS, V24, pS62, DOI 10.1097/01.aids.0000390091.45435.ea; Stouthard MEA, 2000, EUR J PUBLIC HEALTH, V10, P24, DOI 10.1093/eurpub/10.1.24; The Joint United Nations Programme on HIV/AIDS (UNAIDS), 2012, VIETN NAT AIDS SPEND; The Joint United Nations Programme on HIV/AIDS (UNAIDS), 2013, HIV IN ASIA AND THE; Vuong T, 2012, INT J DRUG POLICY, V23, P319, DOI 10.1016/j.drugpo.2011.11.005; Tran BX, 2012, DRUG ALCOHOL DEPEN, V125, P260, DOI 10.1016/j.drugalcdep.2012.02.021; Van den Berg C, 2007, ADDICTION, V102, P1454, DOI 10.1111/j.1360-0443.2007.01912.x; Vassall A, 2014, LANCET GLOB HEALTH, V2, pE531, DOI 10.1016/S2214-109X(14)70277-3; Vickerman P, 2006, SEX TRANSM DIS, V33, pS89, DOI 10.1097/01.olq.0000221335.80508.fa; Wammes JJG, 2012, INT J DRUG POLICY, V23, P358, DOI 10.1016/j.drugpo.2012.06.009; Wilson DP, 2008, LANCET, V372, P314, DOI 10.1016/S0140-6736(08)61115-0; Zhang L, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-250	48	10	10	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0133171	10.1371/journal.pone.0133171	http://dx.doi.org/10.1371/journal.pone.0133171			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN6LZ	26196290	Green Published, Green Submitted, gold			2022-12-26	WOS:000358547600066
J	Sharp, JA; Hair, PS; Pallera, HK; Kumar, PS; Mauriello, CT; Nyalwidhe, JO; Phelps, CA; Park, D; Thielens, NM; Pascal, SM; Chen, W; Duffy, DM; Lattanzio, FA; Cunnion, KM; Krishna, NK				Sharp, Julia A.; Hair, Pamela S.; Pallera, Haree K.; Kumar, Parvathi S.; Mauriello, Clifford T.; Nyalwidhe, Julius O.; Phelps, Cody A.; Park, Dalnam; Thielens, Nicole M.; Pascal, Stephen M.; Chen, Waldon; Duffy, Diane M.; Lattanzio, Frank A.; Cunnion, Kenji M.; Krishna, Neel K.			Peptide Inhibitor of Complement C1 (PIC1) Rapidly Inhibits Complement Activation after Intravascular Injection in Rats	PLOS ONE			English	Article							SERINE PROTEASES; BINDING; IMMUNE; IDENTIFICATION; FICOLINS; PATHWAY	The complement system has been increasingly recognized to play a pivotal role in a variety of inflammatory and autoimmune diseases. Consequently, therapeutic modulators of the classical, lectin and alternative pathways of the complement system are currently in preclinical and clinical development. Our laboratory has identified a peptide that specifically inhibits the classical and lectin pathways of complement and is referred to as Peptide Inhibitor of Complement C1 (PIC1). In this study, we determined that the lead PIC1 variant demonstrates a salt-dependent binding to C1q, the initiator molecule of the classical pathway. Additionally, this peptide bound to the lectin pathway initiator molecule MBL as well as the ficolins H, M and L, suggesting a common mechanism of PIC1 inhibitory activity occurs via binding to the collagen-like tails of these collectin molecules. We further analyzed the effect of arginine and glutamic acid residue substitution on the complement inhibitory activity of our lead derivative in a hemolytic assay and found that the original sequence demonstrated superior inhibitory activity. To improve upon the solubility of the lead derivative, a pegylated, water soluble variant was developed, structurally characterized and demonstrated to inhibit complement activation in mouse plasma, as well as rat, non-human primate and human serum in vitro. After intravenous injection in rats, the pegylated derivative inhibited complement activation in the blood by 90% after 30 seconds, demonstrating extremely rapid function. Additionally, no adverse toxicological effects were observed in limited testing. Together these results show that PIC1 rapidly inhibits classical complement activation in vitro and in vivo and is functional for a variety of animal species, suggesting its utility in animal models of classical complement-mediated diseases.	[Sharp, Julia A.; Pallera, Haree K.; Nyalwidhe, Julius O.; Phelps, Cody A.; Cunnion, Kenji M.; Krishna, Neel K.] Eastern Virginia Med Sch, Dept Microbiol & Mol Cell Biol, Norfolk, VA 23501 USA; [Hair, Pamela S.; Kumar, Parvathi S.; Mauriello, Clifford T.; Park, Dalnam; Cunnion, Kenji M.; Krishna, Neel K.] Eastern Virginia Med Sch, Dept Pediat, Norfolk, VA 23501 USA; [Nyalwidhe, Julius O.] Leroy T Canoles Jr Canc Res Ctr, Norfolk, VA USA; [Thielens, Nicole M.] Univ Grenoble Alpes, IBS, F-38044 Grenoble, France; [Thielens, Nicole M.] CNRS, IBS, F-38044 Grenoble, France; [Thielens, Nicole M.] CEA, IBS, F-38044 Grenoble, France; [Pascal, Stephen M.; Chen, Waldon] Old Dominion Univ, Dept Chem & Biochem, Norfolk, VA USA; [Duffy, Diane M.; Lattanzio, Frank A.] Eastern Virginia Med Sch, Dept Physiol Sci, Norfolk, VA 23501 USA; [Cunnion, Kenji M.] Childrens Specialty Grp, Norfolk, VA USA	Eastern Virginia Medical School; Eastern Virginia Medical School; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); Old Dominion University; Eastern Virginia Medical School	Krishna, NK (corresponding author), Eastern Virginia Med Sch, Dept Microbiol & Mol Cell Biol, Norfolk, VA 23501 USA.	krishnnk@evms.edu	Thielens, Nicole M/F-2512-2013	Thielens, Nicole M/0000-0002-7354-0302; Krishna, Neel/0000-0002-4615-4035; Pallera, Haree/0000-0002-4576-1626	Virginia Innovation Partnership, a US Department of Commerce i6 Challenge grant [GG11598 142515]; Children's Health Foundation, Children's Hospital of The King's Daughters, Norfolk, Virginia	Virginia Innovation Partnership, a US Department of Commerce i6 Challenge grant; Children's Health Foundation, Children's Hospital of The King's Daughters, Norfolk, Virginia	This study was supported by the grant subaward #GG11598 142515. Virginia Innovation Partnership, a US Department of Commerce i6 Challenge grant; http://www.virginia.edu/vpr/i6/ NKK; Children's Health Foundation, Children's Hospital of The King's Daughters, Norfolk, Virginia; www.chkd.org KMC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, ACD ACD NMR PROC AC; Bally I, 2013, P NATL ACAD SCI USA, V110, P8650, DOI 10.1073/pnas.1304894110; Bonaparte RS, 2008, J VIROL, V82, P817, DOI 10.1128/JVI.01847-07; COOPER NR, 1985, ADV IMMUNOL, V37, P151, DOI 10.1016/S0065-2776(08)60340-5; Cunnion KM, 2001, INFECT IMMUN, V69, P6796, DOI 10.1128/IAI.69.11.6796-6803.2001; Gout E, 2010, J BIOL CHEM, V285, P6612, DOI 10.1074/jbc.M109.065854; Gronemus JQ, 2010, MOL IMMUNOL, V48, P305, DOI 10.1016/j.molimm.2010.07.012; Hair PS, 2010, MOL IMMUNOL, V47, P792, DOI 10.1016/j.molimm.2009.10.006; JAFFE CJ, 1976, J CLIN INVEST, V58, P942, DOI 10.1172/JCI108547; Johnson WC, 1999, PROTEINS, V35, P307, DOI 10.1002/(SICI)1097-0134(19990515)35:3<307::AID-PROT4>3.0.CO;2-3; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Lacroix M, 2009, J IMMUNOL, V182, P456, DOI 10.4049/jimmunol.182.1.456; Liu ML, 1998, J MAGN RESON, V132, P125, DOI 10.1006/jmre.1998.1405; Matsushita M, 2013, MOL IMMUNOL, V55, P22, DOI 10.1016/j.molimm.2012.08.017; Mauriello CT, 2013, MOL IMMUNOL, V53, P132, DOI 10.1016/j.molimm.2012.07.012; Phillips AE, 2009, J IMMUNOL, V182, P7708, DOI 10.4049/jimmunol.0900666; Ricklin D, 2013, J IMMUNOL, V190, P3839, DOI 10.4049/jimmunol.1203200; Ricklin D, 2013, J IMMUNOL, V190, P3831, DOI 10.4049/jimmunol.1203487; Ricklin D, 2010, NAT IMMUNOL, V11, P785, DOI 10.1038/ni.1923; Shah TA, 2014, TRANSFUSION, V54, P2892, DOI 10.1111/trf.12695; Sharp JA, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00406; Strobel E, 2008, TRANSFUS MED HEMOTH, V35, P346, DOI 10.1159/000154811; Teillet F, 2007, J IMMUNOL, V178, P5710, DOI 10.4049/jimmunol.178.9.5710; Trau HA, 2015, BIOL REPROD, V92, DOI 10.1095/biolreprod.114.123711; Walport MJ, 2001, NEW ENGL J MED, V344, P1058, DOI 10.1056/NEJM200104053441406; Wasowska BA, 2007, CELL IMMUNOL, V248, P18, DOI 10.1016/j.cellimm.2007.04.009; Zundorf I, 2014, PHARMAZIE, V69, P323, DOI 10.1691/ph.2014.3867	27	25	28	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0132446	10.1371/journal.pone.0132446	http://dx.doi.org/10.1371/journal.pone.0132446			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LZ	26196285	gold, Green Published, Green Submitted			2022-12-26	WOS:000358547600036
J	Thomas, AC; Eijgelaar, WJ; Daemen, MJAP; Newby, AC				Thomas, Anita C.; Eijgelaar, Wouter J.; Daemen, Mat J. A. P.; Newby, Andrew C.			Foam Cell Formation In Vivo Converts Macrophages to a Pro-Fibrotic Phenotype	PLOS ONE			English	Article							HUMAN ATHEROSCLEROTIC LESIONS; SMOOTH-MUSCLE-CELLS; GROWTH-FACTOR-BETA; TGF-BETA; LIPID-METABOLISM; CHOLESTEROL ACCUMULATION; REGULATES EXPRESSION; RECEPTOR; ACTIVATION; DIFFERENTIATION	Formation of foam cell macrophages, which sequester extracellular modified lipids, is a key event in atherosclerosis. How lipid loading affects macrophage phenotype is controversial, with evidence suggesting either pro-or anti-inflammatory consequences. To investigate this further, we compared the transcriptomes of foamy and non-foamy macrophages that accumulate in the subcutaneous granulomas of fed-fat ApoE null mice and normal chow fed wild-type mice in vivo. Consistent with previous studies, LXR/RXR pathway genes were significantly over-represented among the genes up-regulated in foam cell macrophages. Unexpectedly, the hepatic fibrosis pathway, associated with platelet derived growth factor and transforming growth factor-beta action, was also over-represented. Several collagen polypeptides and proteoglycan core proteins as well as connective tissue growth factor and fibrosis-related FOS and JUN transcription factors were up-regulated in foam cell macrophages. Increased expression of several of these genes was confirmed at the protein level in foam cell macrophages from subcutaneous granulomas and in atherosclerotic plaques. Moreover, phosphorylation and nuclear translocation of SMAD2, which is downstream of several transforming growth factor-beta family members, was also detected in foam cell macrophages. We conclude that foam cell formation in vivo leads to a pro-fibrotic macrophage phenotype, which could contribute to plaque stability, especially in early lesions that have few vascular smooth muscle cells.	[Thomas, Anita C.; Newby, Andrew C.] Univ Bristol, Bristol Heart Inst, Bristol, Avon, England; [Eijgelaar, Wouter J.; Daemen, Mat J. A. P.] Cardiovasc Res Inst Maastricht CARIM, Maastricht, Netherlands; [Daemen, Mat J. A. P.] Univ Amsterdam, Acad Med Ctr, NL-1105 AZ Amsterdam, Netherlands	University of Bristol; Maastricht University; University of Amsterdam; Academic Medical Center Amsterdam	Thomas, AC (corresponding author), Univ Bristol, Bristol Heart Inst, Bristol, Avon, England.	a.thomas@bristol.ac.uk	Thomas, Anita C/E-1743-2011	Thomas, Anita C/0000-0002-3792-2653; Daemen, Mat/0000-0003-1076-199X	British Heart Foundation; NIHR Bristol Cardiovascular Biomedical Research Unit; British Heart Foundation [RG/09/006/27918] Funding Source: researchfish	British Heart Foundation(British Heart Foundation); NIHR Bristol Cardiovascular Biomedical Research Unit; British Heart Foundation(British Heart Foundation)	This work was supported by the British Heart Foundation and the NIHR Bristol Cardiovascular Biomedical Research Unit (ACT and ACN). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Adamson S, 2011, CURR OPIN LIPIDOL, V22, P335, DOI 10.1097/MOL.0b013e32834a97e4; Adiguzel E, 2009, VASC MED, V14, P73, DOI 10.1177/1358863X08094801; Allahverdian S, 2014, CIRCULATION, V129, P1551, DOI 10.1161/CIRCULATIONAHA.113.005015; Ambarus CA, 2012, J IMMUNOL METHODS, V375, P196, DOI 10.1016/j.jim.2011.10.013; Berisha SZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065003; Bobik A, 1999, CIRCULATION, V99, P2883, DOI 10.1161/01.CIR.99.22.2883; BORDER WA, 1994, NEW ENGL J MED, V331, P1286; Bouhlel MA, 2007, CELL METAB, V6, P137, DOI 10.1016/j.cmet.2007.06.010; Boyle JJ, 2012, CURR OPIN LIPIDOL, V23, P453, DOI 10.1097/MOL.0b013e328356b145; Chase AJ, 2002, ARTERIOSCL THROM VAS, V22, P765, DOI 10.1161/01.ATV.0000015078.09208.92; Chen G, 2013, J CELL SCI, V126, P3697, DOI 10.1242/jcs.126714; Chinetti-Gbaguidi G, 2011, CIRC RES, V108, P985, DOI 10.1161/CIRCRESAHA.110.233775; Cicha I, 2005, ARTERIOSCL THROM VAS, V25, P1008, DOI 10.1161/01.ATV.0000162173.27682.7b; COOKSON FB, 1971, BRIT J EXP PATHOL, V52, P62; Daley JM, 2010, J LEUKOCYTE BIOL, V87, P59, DOI 10.1189/jlb.0409236; de Winther MPJ, 2005, ARTERIOSCL THROM VAS, V25, P904, DOI 10.1161/01.ATV.0000160340.72641.87; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Draude G, 2000, AM J PHYSIOL-HEART C, V278, pH1042, DOI 10.1152/ajpheart.2000.278.4.H1042; Duewell P, 2010, NATURE, V464, P1357, DOI 10.1038/nature08938; Galis ZS, 2002, CIRC RES, V90, P251, DOI 10.1161/res.90.3.251; Galkina E, 2009, ANNU REV IMMUNOL, V27, P165, DOI 10.1146/annurev.immunol.021908.132620; Gold ES, 2012, J EXP MED, V209, P807, DOI 10.1084/jem.20111202; Grainger DJ, 1996, NAT MED, V2, P381, DOI 10.1038/nm0496-381; Guasch RM, 1998, MOL CELL BIOL, V18, P4761, DOI 10.1128/MCB.18.8.4761; Hackshaw A, 2011, J CLIN ONCOL, V29, P1657, DOI 10.1200/JCO.2010.32.2933; Hayes EM, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00537; Hu YW, 2010, J ATHEROSCLER THROMB, V17, P493, DOI 10.5551/jat.3152; Huang WC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042507; Johnson JL, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/276457; Joseph SB, 2003, NAT MED, V9, P213, DOI 10.1038/nm820; Kadl A, 2010, CIRC RES, V107, P737, DOI 10.1161/CIRCRESAHA.109.215715; Kalinina N, 2004, ARTERIOSCL THROM VAS, V24, P1391, DOI 10.1161/01.ATV.0000133605.89421.79; Karin M, 1997, CURR OPIN CELL BIOL, V9, P240, DOI 10.1016/S0955-0674(97)80068-3; Leask A, 2004, FASEB J, V18, P816, DOI 10.1096/fj.03-1273rev; Ley K, 2011, ARTERIOSCL THROM VAS, V31, P1506, DOI 10.1161/ATVBAHA.110.221127; Li ZY, 2006, J BIOMECH, V39, P2611, DOI 10.1016/j.jbiomech.2005.08.022; Libby P, 2013, J CLIN INVEST, V123, P3201, DOI 10.1172/JCI67526; Lin SM, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkm1075; Liu JA, 2004, ARTERIOSCL THROM VAS, V24, P1359, DOI 10.1161/01.ATV.0000134530.27208.41; Lundberg AM, 2011, CURR OPIN LIPIDOL, V22, P343, DOI 10.1097/MOL.0b013e32834ada80; Martinez FO, 2006, J IMMUNOL, V177, P7303, DOI 10.4049/jimmunol.177.10.7303; Martinez FO, 2011, EUR J IMMUNOL, V41, P1531, DOI 10.1002/eji.201141670; McLaren JE, 2011, PROG LIPID RES, V50, P331, DOI 10.1016/j.plipres.2011.04.002; Merrilees M, 2000, J VASC RES, V37, P50, DOI 10.1159/000025713; Merrilees MJ, 2011, ARTERIOSCL THROM VAS, V31, P1309, DOI 10.1161/ATVBAHA.111.225573; Monaco C, 2009, CIRCULATION, V120, P2462, DOI 10.1161/CIRCULATIONAHA.109.851881; Moritani NH, 2003, J BONE MINER METAB, V21, P205, DOI 10.1007/s00774-003-0410-1; Newby AC, 2014, CURR OPIN LIPIDOL, V25, P358, DOI 10.1097/MOL.0000000000000111; Pourcet B, 2011, CIRC RES, V109, P492, DOI 10.1161/CIRCRESAHA.111.241810; Quillard T, 2014, ARTERIOSCL THROM VAS, V34, P1179, DOI 10.1161/ATVBAHA.114.303326; Rajamaki K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011765; Ramachandran A, 2011, AM J PATHOL, V179, P2977, DOI 10.1016/j.ajpath.2011.08.034; Rekhter MD, 1999, CARDIOVASC RES, V41, P376, DOI 10.1016/S0008-6363(98)00321-6; Rodgers KJ, 2006, ARTERIOSCL THROM VAS, V26, P851, DOI 10.1161/01.ATV.0000203526.75772.4b; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Shashkin P, 2005, CURR PHARM DESIGN, V11, P3061, DOI 10.2174/1381612054865064; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Spann NJ, 2012, CELL, V151, P138, DOI 10.1016/j.cell.2012.06.054; Stoger JL, 2012, ATHEROSCLEROSIS, V225, P461, DOI 10.1016/j.atherosclerosis.2012.09.013; Suwanabol PA, 2011, J SURG RES, V167, P287, DOI 10.1016/j.jss.2010.12.020; Suzuki M, 2012, ARTERIOSCL THROM VAS, V32, P2910, DOI 10.1161/ATVBAHA.112.300383; ten Dijke P, 2007, NAT REV MOL CELL BIO, V8, P857, DOI 10.1038/nrm2262; Thomas AH, 2007, EXP BIOL MED, V232, P406; Thomas AC, 2007, ARTERIOSCL THROM VAS, V27, P571, DOI 10.1161/01.ATV.0000256470.23842.94; Tuomisto TT, 2003, ARTERIOSCL THROM VAS, V23, P2235, DOI 10.1161/01.ATV.0000102551.91154.96; van Tits LJH, 2011, ATHEROSCLEROSIS, V214, P345, DOI 10.1016/j.atherosclerosis.2010.11.018; Weitkamp B, 1999, FASEB J, V13, P1445, DOI 10.1096/fasebj.13.11.1445; Wight TN, 2004, CIRC RES, V94, P1158, DOI 10.1161/01.RES.0000126921.29919.51; Wilson HM, 2005, AM J PATHOL, V167, P27, DOI 10.1016/S0002-9440(10)62950-1; Wolfs IMJ, 2011, THROMB HAEMOSTASIS, V106, P763, DOI 10.1160/TH11-05-0320; Xifteri A, 2011, PNEUMON, V24, P149; Xu W, 2007, EUR J IMMUNOL, V37, P1594, DOI 10.1002/eji.200737042; Xu YJ, 2008, J BIOL CHEM, V283, P1563, DOI 10.1074/jbc.M707997200; Yehualaeshet T, 1999, AM J PATHOL, V155, P841, DOI 10.1016/S0002-9440(10)65183-8; Yu Q, 2000, GENE DEV, V14, P163; Zuckerman SH, 2001, ATHEROSCLEROSIS, V155, P79, DOI 10.1016/S0021-9150(00)00540-2	76	34	35	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0128163	10.1371/journal.pone.0128163	http://dx.doi.org/10.1371/journal.pone.0128163			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LZ	26197235	Green Published, gold, Green Submitted			2022-12-26	WOS:000358547600002
J	Aadland, E; Ylvisaker, E				Aadland, Eivind; Ylvisaker, Einar			Reliability of Objectively Measured Sedentary Time and Physical Activity in Adults	PLOS ONE			English	Article							TEST-RETEST RELIABILITY; GENERALIZABILITY THEORY; CARDIOVASCULAR-DISEASE; METABOLIC SYNDROME; LIFE-STYLE; BEHAVIOR; RISK	Background In adults, a minimum of 3-5 days of accelerometer monitoring is usually considered appropriate to obtain reliable estimates of physical activity (PA). However, a longer period of measurement might be needed to obtain reliable estimates of sedentary behavior (SED). The aim of this study was to determine the reliability of objectively assessed SED and PA in adults. Methods Eighty-seven adult subjects (28 men; mean (standard deviation) age 31.3 (12.2) years; body mass index 23.7 (3.1) kg/m(2)) wore the GT3X+ accelerometer for 21 subsequent days, for which the reliability of different wear time criteria (8 to 12 h/day and 3 to 5 d/week) was explored. Variance partitioning along with the Spearman-Brown prophecy formula was used as the basis for determining intraclass-correlation coefficients (ICC) and the number of monitoring days needed (N) to achieve an ICC = 0.80. Week-by-week reliability was reported using ICC, Bland-Altman plots and absolute measures of agreement. Results Seven-10 days of monitoring was needed to reliably assess overall- (axis 1 and vector magnitude (VM) counts per minute (CPM)) and moderate-to-vigorous PA (MVPA), 3-4 days was needed for light PA (LPA), whereas the number of days needed for SED depended on whether adjustments were made for wear time (6-8 days) or not (13-15 days). The week-by-week ICC was >= 0.70 for all variables, with limits of agreement being +/- 267.8 cpm for CPM, +/- 352.3 cpm for VM CPM, +/- 76.8 min/day for SED, +/- 57.8 min/day for LPA and +/- 43.8 min/day for MVPA, equal to 1.0-1.6 standard deviations, when adjustment was made for wear time. Conclusions For most variables, more than one week of measurement was needed to achieve an ICC = 0.80. Correcting for wear time was crucial to reliably determine SED. Considerable week-by-week variability was found for all variables. Researchers need to be aware of substantial intra-individual variability in accelerometer-measurements.	[Aadland, Eivind; Ylvisaker, Einar] Sogn og Fjordane Univ Coll, Fac Teacher Educ & Sport, Sogndal, Norway	Western Norway University of Applied Sciences	Aadland, E (corresponding author), Sogn og Fjordane Univ Coll, Fac Teacher Educ & Sport, Sogndal, Norway.	eivind.aadland@hisf.no						Aadland E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0085223; Atkin AJ, 2012, INT J EPIDEMIOL, V41, P1460, DOI 10.1093/ije/dys118; Bankoski A, 2011, DIABETES CARE, V34, P497, DOI 10.2337/dc10-0987; Baranowski T, 2008, MED SCI SPORT EXER, V40, pS544, DOI 10.1249/MSS.0b013e31817c6651; Barnes J, 2012, APPL PHYSIOL NUTR ME, V37, P540, DOI [10.1139/H2012-024, 10.1139/h2012-024]; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Celis-Morales CA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036345; Coleman KJ, 1998, RES Q EXERCISE SPORT, V69, P58, DOI 10.1080/02701367.1998.10607667; Colley Rachel, 2010, Health Rep, V21, P63; Edwardson CL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034916; Ekelund U, 2007, DIABETES CARE, V30, P337, DOI 10.2337/dc06-1883; Ford ES, 2012, INT J EPIDEMIOL, V41, P1338, DOI 10.1093/ije/dys078; Green AN, 2014, EUR J APPL PHYSIOL, V114, P907, DOI 10.1007/s00421-014-2822-0; GRETEBECK RJ, 1992, MED SCI SPORT EXER, V24, P1167; Hagstromer M, 2007, MED SCI SPORT EXER, V39, P1502, DOI 10.1249/mss.0b013e3180a76de5; Hansen BH, 2012, MED SCI SPORT EXER, V44, P266, DOI 10.1249/MSS.0b013e31822cb354; Hart TL, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-62; Healy GN, 2008, DIABETES CARE, V31, P369, DOI 10.2337/dc07-1795; Herrmann SD, 2014, BRIT J SPORT MED, V48, P278, DOI 10.1136/bjsports-2012-091410; Hopkins WG, 2000, SPORTS MED, V30, P1, DOI 10.2165/00007256-200030010-00001; Hutcheon JA, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2289; Jerome GJ, 2009, MED SCI SPORT EXER, V41, P110, DOI 10.1249/MSS.0b013e3181846cd8; Kim J, 2013, INT J BEHAV NUTR PHY, V10, DOI 10.1186/1479-5868-10-30; Levin S, 1999, ANN EPIDEMIOL, V9, P481, DOI 10.1016/S1047-2797(99)00022-8; Matthews CE, 2002, MED SCI SPORT EXER, V34, P1376, DOI 10.1097/00005768-200208000-00021; Matthews CE, 2012, MED SCI SPORT EXER, V44, pS68, DOI 10.1249/MSS.0b013e3182399e5b; McGraw KO, 1996, PSYCHOL METHODS, V1, P30, DOI 10.1037/1082-989X.1.1.30; McGuire KA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020503; Metzger JS, 2008, MED SCI SPORT EXER, V40, P630, DOI 10.1249/MSS.0b013e3181620ebc; Scheers T, 2013, MED SCI SPORT EXER, V45, P481, DOI 10.1249/MSS.0b013e31827563ba; Sirard JR, 2011, J PHYS ACT HEALTH, V8, P668, DOI 10.1123/jpah.8.5.668; Troiano RP, 2008, MED SCI SPORT EXER, V40, P181, DOI 10.1249/mss.0b013e31815a51b3; Trost SG, 2005, MED SCI SPORT EXER, V37, pS531, DOI 10.1249/01.mss.0000185657.86065.98; Weir JP, 2005, J STRENGTH COND RES, V19, P231, DOI 10.1519/15184.1; Wickel EE, 2010, MED SCI SPORT EXER, V42, P1528, DOI 10.1249/MSS.0b013e3181d107c4; Wilmot EG, 2012, DIABETOLOGIA, V55, P2895, DOI 10.1007/s00125-012-2677-z	36	60	61	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2015	10	7							e0133296	10.1371/journal.pone.0133296	http://dx.doi.org/10.1371/journal.pone.0133296			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LN	26192184	Green Published, Green Submitted, gold			2022-12-26	WOS:000358546400071
J	Abysique, A; Tardivel, C; Troadec, JD; Felix, B				Abysique, Anne; Tardivel, Catherine; Troadec, Jean-Denis; Felix, Bernadette			The Food Contaminant Mycotoxin Deoxynivalenol Inhibits the Swallowing Reflex in Anaesthetized Rats	PLOS ONE			English	Article							MESSENGER-RNA EXPRESSION; SUPERIOR LARYNGEAL NERVE; TRICHOTHECENE DEOXYNIVALENOL; TISSUE DISTRIBUTION; ORAL-EXPOSURE; GENE-EXPRESSION; BRAIN-STEM; INDUCTION; VOMITOXIN; ACTIVATION	Deoxynivalenol (DON), one of the most abundant mycotoxins found on cereals, is known to be implicated in acute and chronic illnesses in both humans and animals. Among the symptoms, anorexia, reduction of weight gain and decreased nutrition efficiency were described, but the mechanisms underlying these effects on feeding behavior are not yet totally understood. Swallowing is a major motor component of ingestive behavior which allows the propulsion of the alimentary bolus from the mouth to the esophagus. To better understand DON effects on ingestive behaviour, we have studied its effects on rhythmic swallowing in the rat, after intravenous and central administration. Repetitive electrical stimulation of the superior laryngeal nerve or of the tractus solitarius, induces rhythmic swallowing that can be recorded using electromyographic electrodes inserted in sublingual muscles. Here we provide the first demonstration that, after intravenous and central administration, DON strongly inhibits the swallowing reflex with a short latency and in a dose dependent manner. Moreover, using c-Fos staining, a strong neuronal activation was observed in the solitary tract nucleus which contains the central pattern generator of swallowing and in the area postrema after DON intravenous injection. Our data show that DON modifies swallowing and interferes with central neuronal networks dedicated to food intake regulation.	[Abysique, Anne; Tardivel, Catherine; Troadec, Jean-Denis; Felix, Bernadette] Aix Marseille Univ, Lab Physiol & Physiopathol Syst Nerveux Somato Mo, EA 4674, Marseille, France; [Tardivel, Catherine; Felix, Bernadette] INRA, Dept AlimH, U1189, St Genes Champanelle, France	UDICE-French Research Universities; Aix-Marseille Universite; INRAE	Troadec, JD (corresponding author), Aix Marseille Univ, Lab Physiol & Physiopathol Syst Nerveux Somato Mo, EA 4674, Marseille, France.	j-d.troadec@univ-amu.fr; bernadette.felix@univ-amu.fr	troadec, jean denis/V-1412-2017	Troadec, jean denis/0000-0003-0346-6247	Aix-Marseille University (AMU); Institut National de la Recherche Agronomique (INRA)	Aix-Marseille University (AMU); Institut National de la Recherche Agronomique (INRA)	Funding was received from Aix-Marseille University (AMU) for AA, CT, JDT, BF and Institut National de la Recherche Agronomique (INRA) for CT, BF.	ABBAS HK, 1986, APPL ENVIRON MICROB, V51, P841, DOI 10.1128/AEM.51.4.841-843.1986; Amuzie CJ, 2008, TOXICOLOGY, V248, P39, DOI 10.1016/j.tox.2008.03.005; AZCONAOLIVERA JI, 1995, TOXICOL APPL PHARM, V133, P109, DOI 10.1006/taap.1995.1132; Bae HY, 2010, TOXICOL SCI, V115, P444, DOI 10.1093/toxsci/kfq055; Bao L, 2011, J AOAC INT, V94, P1506, DOI 10.5740/jaoacint.10-477; Bariohay B, 2008, AM J PHYSIOL-REG I, V295, pR1050, DOI 10.1152/ajpregu.90407.2008; Bieger Detlef, 1993, Dysphagia, V8, P308, DOI 10.1007/BF01321768; Binder EM, 2007, ANIM FEED SCI TECH, V133, P149, DOI 10.1016/j.anifeedsci.2006.08.008; Bonnet MS, 2012, TOXINS, V4, P1120, DOI 10.3390/toxins4111120; Bryden WL, 2007, ASIA PAC J CLIN NUTR, V16, P95; BUNNER DL, 1988, TOXICOL APPL PHARM, V92, P113, DOI 10.1016/0041-008X(88)90233-5; Felix B, 2006, AM J PHYSIOL-REG I, V291, pR657, DOI 10.1152/ajpregu.00560.2005; Filtenborg O, 1996, INT J FOOD MICROBIOL, V33, P85, DOI 10.1016/0168-1605(96)01153-1; Flannery BM, 2012, TOXICOL SCI, V130, P289, DOI 10.1093/toxsci/kfs255; Flannery BM, 2011, FOOD CHEM TOXICOL, V49, P1863, DOI 10.1016/j.fct.2011.05.004; Gaige S, 2003, J PHYSIOL-LONDON, V546, P267, DOI 10.1113/jphysiol.2002.029462; Girardet C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026134; Harada H, 2005, NEUROSCI RES, V51, P395, DOI 10.1016/j.neures.2004.12.007; He KY, 2012, TOXICOL SCI, V127, P382, DOI 10.1093/toxsci/kfs134; Jean A, 2001, PHYSIOL REV, V81, P929, DOI 10.1152/physrev.2001.81.2.929; Jean A, 1994, NUCL SOLITARY TRACT, P361; KESSLER JP, 1985, EXP BRAIN RES, V57, P256; KESSLER JP, 1990, EXP BRAIN RES, V83, P151; KESSLER JP, 1991, EUR J PHARMACOL, V201, P59, DOI 10.1016/0014-2999(91)90323-I; KESSLER JP, 1985, EUR J PHARMACOL, V118, P77, DOI 10.1016/0014-2999(85)90665-X; Kobashi M, 2014, PHYSIOL BEHAV, V130, P6, DOI 10.1016/j.physbeh.2014.03.009; Kobashi M, 2010, REGUL PEPTIDES, V160, P19, DOI 10.1016/j.regpep.2009.12.014; Lam DD, 2010, PHARMACOL BIOCHEM BE, V97, P84, DOI 10.1016/j.pbb.2010.09.003; Maolood N, 2009, J CHEM NEUROANAT, V37, P182, DOI 10.1016/j.jchemneu.2008.12.007; Maresca M, 2013, TOXINS, V5, P784, DOI 10.3390/toxins5040784; Mikami O, 2010, J VET SCI, V11, P107, DOI 10.4142/jvs.2010.11.2.107; Moon Y, 2002, TOXICOL SCI, V69, P373, DOI 10.1093/toxsci/69.2.373; Mostafeezur RM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050703; Ngampongsa S, 2011, J TOXICOL SCI, V36, P453, DOI 10.2131/jts.36.453; Olsen M, 2001, SAFETY EVALUATION CE, P420; OSSENKOPP KP, 1994, PHARMACOL BIOCHEM BE, V47, P363, DOI 10.1016/0091-3057(94)90024-8; Oswald IP, 2005, FOOD ADDIT CONTAM A, V22, P354, DOI 10.1080/02652030500058320; Paxinos G., 1998, RAT BRAIN STEREOTAXI, Vfourth; Pestka JJ, 2008, FOOD CHEM TOXICOL, V46, P2826, DOI 10.1016/j.fct.2008.05.016; Pestka JJ, 2008, TOXICOL LETT, V178, P83, DOI 10.1016/j.toxlet.2008.02.005; Pestka JJ, 2010, ARCH TOXICOL, V84, P663, DOI 10.1007/s00204-010-0579-8; Pestka JJ, 2005, J TOXICOL ENV HEAL B, V8, P39, DOI 10.1080/10937400590889458; Pinton P, 2012, TOXICOL SCI, V130, P180, DOI 10.1093/toxsci/kfs239; PRELUSKY DB, 1988, FUND APPL TOXICOL, V10, P276, DOI 10.1016/0272-0590(88)90312-0; Reinhold Lilli, 2011, Mycotoxin Res, V27, P137, DOI 10.1007/s12550-011-0086-7; Rodrigues I, 2012, TOXINS, V4, P663, DOI 10.3390/toxins4090663; Sirot V, 2013, FOOD CHEM TOXICOL, V52, P1, DOI 10.1016/j.fct.2012.10.036; TRENHOLM HL, 1984, J AM VET MED ASSOC, V185, P527; Turner PC, 2008, ENVIRON HEALTH PERSP, V116, P21, DOI 10.1289/ehp.10663; WANG YT, 1991, AM J PHYSIOL, V261, pR639, DOI 10.1152/ajpregu.1991.261.3.R639; Willis CL, 2007, NEUROSCIENCE, V150, P498, DOI 10.1016/j.neuroscience.2007.09.023; Wolf-Hall CE, 1999, J FOOD PROTECT, V62, P962, DOI 10.4315/0362-028X-62.8.962; Wu WD, 2013, TOXICOL SCI, V133, P186, DOI 10.1093/toxsci/kft033; Yang GH, 2000, TOXICOL APPL PHARM, V164, P149, DOI 10.1006/taap.1999.8888; Yoshino Naoto, 1996, Natural Toxins, V4, P234, DOI 10.1002/(SICI)(1996)4:5<234::AID-NT6>3.0.CO;2-E; Zhou HR, 2003, TOXICOL SCI, V74, P335, DOI 10.1093/toxsci/kfg148; Zhou HR, 2003, TOXICOL SCI, V72, P130, DOI 10.1093/toxsci/kfg006	57	12	12	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2015	10	7							e0133355	10.1371/journal.pone.0133355	http://dx.doi.org/10.1371/journal.pone.0133355			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LN	26192767	Green Published, gold, Green Submitted			2022-12-26	WOS:000358546400075
J	Clifton, EH; Jaronski, ST; Hodgson, EW; Gassmann, AJ				Clifton, Eric H.; Jaronski, Stefan T.; Hodgson, Erin W.; Gassmann, Aaron J.			Abundance of Soil-Borne Entomopathogenic Fungi in Organic and Conventional Fields in the Midwestern USA with an Emphasis on the Effect of Herbicides and Fungicides on Fungal Persistence	PLOS ONE			English	Article							METARHIZIUM-ANISOPLIAE; BEAUVERIA-BASSIANA; FARMING SYSTEM; MARGINS; INSECT; BIODIVERSITY; AGRICULTURE; ENVIRONMENT; MANAGEMENT; PHYLOGENY	Entomopathogenic fungi (EPF) are widespread in agricultural fields and help suppress crop pests. These natural enemies may be hindered by certain agronomic practices associated with conventional agriculture including the use of pesticides. We tested whether the abundance of EPF differed between organic and conventional fields, and whether specific cropping practices and soil properties were correlated with their abundance. In one year of the survey, soil from organic fields and accompanying margins had significantly more EPF than conventional fields and accompanying margins. Regression analysis revealed that the percentage of silt and the application of organic fertilizer were positively correlated with EPF abundance; but nitrogen concentration, tillage, conventional fields, and margins of conventional fields were negatively correlated with EPF abundance. A greenhouse experiment in which fungicides and herbicides were applied to the soil surface showed no significant effect on EPF. Though organic fields were perceived to be more suitable environments for EPF, abiotic factors and cropping practices such as tillage may have greater impacts on the abundance of EPF. Also, fungicides and herbicides may not be as toxic to soil-borne EPF as originally thought.	[Clifton, Eric H.; Hodgson, Erin W.; Gassmann, Aaron J.] Iowa State Univ, Dept Entomol, Ames, IA 50011 USA; [Jaronski, Stefan T.] USDA, Northern Plains Agr Res Lab, Sidney, MT USA	Iowa State University; United States Department of Agriculture (USDA)	Clifton, EH (corresponding author), Iowa State Univ, Dept Entomol, Ames, IA 50011 USA.	eclifton@iastate.edu	Jaronski, Stefan/AFU-7254-2022; Hodgson, Erin/M-9115-2019	Hodgson, Erin/0000-0003-2492-3558	Leopold Center for Sustainable Agriculture [E2010-18]	Leopold Center for Sustainable Agriculture	This work was supported by Leopold Center for Sustainable Agriculture, Grant: E2010-18 [http://www.leopold.iastate.edu/grants/e2010-18]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Kaisi MM, 2013, J SOIL WATER CONSERV, V68, p19A, DOI 10.2489/jswc.68.1.19A; AMS [Agricultural Marketing Service], 2014, NAT ORG PROGR US; [Anonymous], [No title captured]; Bednarek A, 1997, J NEMATOL, V29, P220; Behie SW, 2012, SCIENCE, V336, P1576, DOI 10.1126/science.1222289; Bengtsson J, 2005, J APPL ECOL, V42, P261, DOI 10.1111/j.1365-2664.2005.01005.x; BING LA, 1993, AGR ECOSYST ENVIRON, V45, P147, DOI 10.1016/0167-8809(93)90065-W; Bischoff JF, 2009, MYCOLOGIA, V101, P512, DOI 10.3852/07-202; Bruck DJ, 2009, BIOCONTROL, V54, P597, DOI 10.1007/s10526-009-9213-1; CHASE AR, 1986, FLA ENTOMOL, V69, P285, DOI 10.2307/3494930; Crowder DW, 2012, ECOLOGY, V93, P2001, DOI 10.1890/12-0110.1; Crowder DW, 2010, NATURE, V466, P109, DOI 10.1038/nature09183; D'Alessandro CP, 2011, BIOCONTROL SCI TECHN, V21, P189, DOI 10.1080/09583157.2010.536200; de Snoo GR, 1999, LANDSCAPE URBAN PLAN, V46, P151, DOI 10.1016/S0169-2046(99)00039-0; Ekesi S, 2003, J INVERTEBR PATHOL, V83, P157, DOI 10.1016/S0022-2011(03)00069-7; Gardner WH, 1986, AM SOC AGRONOMY MONO, V9; Garratt MPD, 2011, AGR ECOSYST ENVIRON, V141, P261, DOI 10.1016/j.agee.2011.03.014; GEE GW, 1986, AM SOC AGRONOMY MONO, V9; Goettel GM, 1997, MANUAL TECHNIQUES IN; HAJEK AE, 1994, ANNU REV ENTOMOL, V39, P293, DOI 10.1146/annurev.en.39.010194.001453; Hummel RL, 2002, ENVIRON ENTOMOL, V31, P84, DOI 10.1603/0046-225X-31.1.84; Imoulan A, 2011, WORLD J MICROB BIOT, V27, P2619, DOI 10.1007/s11274-011-0735-1; Jabbour R, 2009, BIOL CONTROL, V51, P435, DOI 10.1016/j.biocontrol.2009.08.004; Jaronski S. T., 2012, MANUAL TECHNIQUES IN; Jaronski ST, 2010, BIOCONTROL, V55, P159, DOI 10.1007/s10526-009-9248-3; Jaros-Su J, 1999, BIOL CONTROL, V15, P259, DOI 10.1006/bcon.1999.0724; Keyser CA, 2014, J INVERTEBR PATHOL, V120, P67, DOI 10.1016/j.jip.2014.05.008; Klingen I, 2002, AGR ECOSYST ENVIRON, V91, P191, DOI 10.1016/S0167-8809(01)00227-4; LORIA R, 1983, ENVIRON ENTOMOL, V12, P1724, DOI 10.1093/ee/12.6.1724; Marshall EJR, 2002, AGR ECOSYST ENVIRON, V89, P5, DOI 10.1016/S0167-8809(01)00315-2; Meyling NV, 2011, BIOL CONTROL, V59, P180, DOI 10.1016/j.biocontrol.2011.07.017; Meyling NV, 2009, MOL ECOL, V18, P1282, DOI 10.1111/j.1365-294X.2009.04095.x; Mietkiewski RT, 1997, BIOCONTROL SCI TECHN, V7, P565, DOI 10.1080/09583159730622; Mochi DA, 2005, NEOTROP ENTOMOL, V34, P961, DOI 10.1590/S1519-566X2005000600013; National Drought Mitigation Center, 2014, US DROUGHT MON IOW; Quesada-Moraga E, 2007, MYCOL RES, V111, P947, DOI 10.1016/j.mycres.2007.06.006; Quinn GP, 2003, EXPT DESIGN DATA ANA; Rehner SA, 2011, MYCOLOGIA, V103, P1055, DOI 10.3852/10-302; Rudeen ML, 2013, J INVERTEBR PATHOL, V114, P329, DOI 10.1016/j.jip.2013.09.009; Samson PR, 2005, BIOCONTROL, V50, P151, DOI 10.1007/s10526-004-0419-y; SAS Institute Inc., 2012, SAS STAT 9 3 US GUID; Scheepmaker JWA, 2010, BIOCONTROL SCI TECHN, V20, P503, DOI 10.1080/09583150903545035; SOSAGOMEZ DR, 1994, FLA ENTOMOL, V77, P284, DOI 10.2307/3495515; Tarasco E., 2010, IOBC/WPRS Bulletin, V57, P85; Vanninen I, 1996, MYCOL RES, V100, P93, DOI 10.1016/S0953-7562(96)80106-7; Vega FE, 2010, FUNGAL ECOL, V3, P122, DOI [10.1016/j.funeco.2009.05.001, 10.1016/j.funeco.2009.07.002]; Willer H, 2013, BIOFACH C NUR GERM; Wolfinger, 1996, SAS SYSTEM LINEAR MO; Yaginuma K, 2007, JPN J APPL ENTOMOL Z, V51, P213, DOI 10.1303/jjaez.2007.213; Yanez M, 2010, CHIL J AGR RES, V70, P390, DOI 10.4067/S0718-58392010000300006; Zehnder G, 2007, ANNU REV ENTOMOL, V52, P57, DOI 10.1146/annurev.ento.52.110405.091337; Zimmermann G, 2007, BIOCONTROL SCI TECHN, V17, P879, DOI 10.1080/09583150701593963; Zimmermann G, 2007, BIOCONTROL SCI TECHN, V17, P553, DOI 10.1080/09583150701309006	53	33	35	1	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2015	10	7							e0133613	10.1371/journal.pone.0133613	http://dx.doi.org/10.1371/journal.pone.0133613			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LN	26191815	Green Submitted, Green Published, gold			2022-12-26	WOS:000358546400106
J	Johnson, KR; Nicodemus-Johnson, J; Spindler, MJ; Carnegie, GK				Johnson, Keven R.; Nicodemus-Johnson, Jessie; Spindler, Mathew J.; Carnegie, Graeme K.			Genome-Wide Gene Expression Analysis Shows AKAP13-Mediated PKD1 Signaling Regulates the Transcriptional Response to Cardiac Hypertrophy	PLOS ONE			English	Article							AKAP-LBC; HEART-FAILURE; IN-VIVO; FETAL; REQUIREMENT; METABOLISM; MICROARRAY; PATHWAYS	In the heart, scaffolding proteins such as A-Kinase Anchoring Proteins (AKAPs) play a crucial role in normal cellular function by serving as a signaling hub for multiple protein kinases including protein kinase D1 (PKD1). Under cardiac hypertrophic conditions AKAP13 anchored PKD1 activates the transcription factor MEF2 leading to subsequent fetal gene activation and hypertrophic response. We used an expression microarray to identify the global transcriptional response in the hearts of wild-type mice expressing the native form of AKAP13 compared to a gene-trap mouse model expressing a truncated form of AKAP13 that is unable to bind PKD1 (AKAP13-Delta PKD1). Microarray analysis showed that AKAP13-Delta PKD1 mice broadly failed to exhibit the transcriptional profile normally associated with compensatory cardiac hypertrophy following trans-aortic constriction (TAC). The identified differentially expressed genes in WT and AKAP13-Delta PKD1 hearts are vital for the compensatory hypertrophic response to pressure-overload and include myofilament, apoptotic, and cell growth/differentiation genes in addition to genes not previously identified as affected by AKAP13-anchored PKD1. Our results show that AKAP13-PKD1 signaling is critical for transcriptional regulation of key contractile, cell death, and metabolic pathways during the development of compensatory hypertrophy in vivo.	[Johnson, Keven R.; Carnegie, Graeme K.] Univ Illinois, Coll Med, Dept Pharmacol, Chicago, IL 60612 USA; [Nicodemus-Johnson, Jessie] Univ Chicago, Dept Human Genet, Chicago, IL 60612 USA; [Spindler, Mathew J.] Gladstone Inst Cardiovasc Dis, San Francisco, CA 94158 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Chicago; University of California System; University of California San Francisco; The J David Gladstone Institutes	Johnson, KR (corresponding author), Univ Illinois, Coll Med, Dept Pharmacol, Chicago, IL 60612 USA.	kevenj54@gmail.com			American Heart Association SDG [11SDG5230003]; National Center for Advancing Translational Science-University of Illinois at Chicago Center for Clinical and Translational Sciences [UL1TR000050]; American Heart Association postdoctoral fellowship [13POST17000023]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000050] Funding Source: NIH RePORTER	American Heart Association SDG(American Heart Association); National Center for Advancing Translational Science-University of Illinois at Chicago Center for Clinical and Translational Sciences; American Heart Association postdoctoral fellowship(American Heart Association); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was funded by the American Heart Association SDG 11SDG5230003, the National Center for Advancing Translational Science-University of Illinois at Chicago Center for Clinical and Translational Sciences Grant UL1TR000050 to GKC, and the American Heart Association postdoctoral fellowship 13POST17000023 to JNJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bassel-Duby R, 2006, ANNU REV BIOCHEM, V75, P19, DOI 10.1146/annurev.biochem.75.103004.142622; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Carnegie GK, 2004, MOL CELL, V15, P889, DOI 10.1016/j.molcel.2004.09.015; Carnegie GK, 2008, MOL CELL, V32, P169, DOI 10.1016/j.molcel.2008.08.030; Chien KR, 1999, CELL, V98, P555, DOI 10.1016/S0092-8674(00)80043-4; Darwish H, 2007, ONCOGENE, V26, P4319, DOI 10.1038/sj.onc.1210195; Depre C, 1998, NAT MED, V4, P1269, DOI 10.1038/3253; Du P, 2008, BIOINFORMATICS, V24, P1547, DOI 10.1093/bioinformatics/btn224; el Azzouzi H, 2010, EUR J HEART FAIL, V12, P4, DOI 10.1093/eurjhf/hfp165; EVERETT AW, 1986, J MOL CELL CARDIOL, V18, P607, DOI 10.1016/S0022-2828(86)80968-3; Fielitz J, 2008, P NATL ACAD SCI USA, V105, P3059, DOI 10.1073/pnas.0712265105; Goodwin GW, 1998, J BIOL CHEM, V273, P29530, DOI 10.1074/jbc.273.45.29530; Iida K, 1999, TOHOKU J EXP MED, V187, P15, DOI 10.1620/tjem.187.15; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Kim Y, 2008, J CLIN INVEST, V118, P124, DOI 10.1172/JCI33255; Korvald C, 2000, AM J PHYSIOL-HEART C, V278, pH1345, DOI 10.1152/ajpheart.2000.278.4.H1345; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Marks AR, 2003, CIRCULATION, V107, P1456, DOI 10.1161/01.CIR.0000059745.95643.83; Miller MK, 2003, J MOL BIOL, V333, P951, DOI 10.1016/j.jmb.2003.09.012; Olson EN, 2003, GENE DEV, V17, P1937, DOI 10.1101/gad.1110103; Ozgen N, 2008, J BIOL CHEM, V283, P17009, DOI 10.1074/jbc.M709851200; Picard MH, 2011, J AM SOC ECHOCARDIOG, V24, P1, DOI 10.1016/j.echo.2010.11.006; Rajabi M, 2007, HEART FAIL REV, V12, P331, DOI 10.1007/s10741-007-9034-1; Razeghi P, 2001, CIRCULATION, V104, P2923, DOI 10.1161/hc4901.100526; Ryu SJ, 1999, NATURE, V397, P446, DOI 10.1038/17141; SASSOON DA, 1988, DEVELOPMENT, V104, P155; SCHWARTZ K, 1992, SYM SOC EXP BIOL, V46, P265; Spindler MJ, PLOS ONE, V8, DOI [10.1371/journal.pone.0062705PONE-D-10-06029, DOI 10.1371/J0URNAL.P0NE.0062705]; Stevens JL, 2002, SCIENCE, V296, P755, DOI 10.1126/science.1068943; Taglieri DM, 2014, J MOL CELL CARDIOL, V66, P27, DOI 10.1016/j.yjmcc.2013.10.010; Vega RB, 2004, MOL CELL BIOL, V24, P8374, DOI 10.1128/MCB.24.19.8374-8385.2004; Wang G, 2005, MOL CELL, V17, P683, DOI 10.1016/j.molcel.2005.02.010; Yoav B, 1995, J ROY STAT SOC, V57, P289	33	16	17	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2015	10	7							e0132474	10.1371/journal.pone.0132474	http://dx.doi.org/10.1371/journal.pone.0132474			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LN	26192751	Green Submitted, Green Published, gold			2022-12-26	WOS:000358546400027
J	Dong, YJ; Wu, NQ; Li, FJ; Huang, LP; Wen, WW				Dong, Yajie; Wu, Naiqin; Li, Fengjiang; Huang, Linpei; Wen, Wenwen			Time-Transgressive Nature of the Magnetic Susceptibility Record across the Chinese Loess Plateau at the Pleistocene/Holocene Transition	PLOS ONE			English	Article							NORTHERN CHINA; MONSOON PRECIPITATION; CLIMATE CHANGES; DUST ACCUMULATION; HOLOCENE OPTIMUM; MODERN SOILS; DAIHAI LAKE; EAST-ASIA; PALEOSOL; DEPOSITS	The loess stratigraphic boundary at the Pleistocene/Holocene transition defined by the magnetic susceptibility (MS) has previously been assumed to be synchronous with the Marine Isotope Stage (MIS) 2/1 boundary, and approximately time-synchronous at different sections across the Chinese Loess Plateau (CLP). However, although this assumption has been used as a basis for proxy-age model of Chinese loess deposits, it has rarely been tested by using absolute dating methods. In this study, we applied a single-aliquot regenerative-dose (SAR) protocol to the 45-63 mu m quartz grain-size fraction to derive luminescence ages for the last glacial and Holocene sections of three loess sections on a transect from southeast to northwest across the CLP. Based on the 33 closely spaced optically stimulated luminescence (OSL) samples from the three sections, OSL chronologies were established using a polynomial curve fit at each section. Based on the OSL chronology, the timing of the Pleistocene/Holocene boundary, as defined by rapid changes in MS values, is dated at similar to 10.5 ka, 8.5 ka and 7.5 ka in the Yaoxian section, Jingchuan and Huanxian sections respectively. These results are clearly inconsistent with the MIS 2/1 boundary age of 12.05 ka, and therefore we conclude that the automatic correlation of the Pleistocene/Holocene transition, as inferred from the MS record, with the MIS 2/1 boundary is incorrect. The results clearly demonstrate that the marked changes in MS along the southeast to northwest transect are time-transgressive among the different sites, with the timing of significant paleosol development as indicated by the MS record being delayed by 3-4 ka in the northwest compared to the southeast. Our results suggest that this asynchronous paleosol development during the last deglacial was caused by the delayed arrival of the summer monsoon in the northwest CLP compared to the southeast.	[Dong, Yajie; Wu, Naiqin; Li, Fengjiang; Huang, Linpei; Wen, Wenwen] Chinese Acad Sci, Inst Geol & Geophys, Key Lab Cenozo Geol & Environm, Beijing, Peoples R China; [Dong, Yajie] Univ Chinese Acad Sci, Beijing, Peoples R China; [Huang, Linpei; Wen, Wenwen] Yunnan Normal Univ, Coll Tourism & Geog, Key Lab Plateau Lake Ecol & Global Change, Kunming, Peoples R China	Chinese Academy of Sciences; Institute of Geology & Geophysics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Yunnan Normal University	Dong, YJ (corresponding author), Chinese Acad Sci, Inst Geol & Geophys, Key Lab Cenozo Geol & Environm, Beijing, Peoples R China.	dongyajie@mail.iggcas.ac.cn; nqwu@mail.iggcas.ac.cn		Dong, Yajie/0000-0003-3913-2812	Strategic Priority Research Program: Climate Change, Carbon Budget and Relevant Issues [XDA05120203]; National Natural Science Foundation of China [41272205, 41430103, 41372186]	Strategic Priority Research Program: Climate Change, Carbon Budget and Relevant Issues(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study is supported by the Strategic Priority Research Program: Climate Change, Carbon Budget and Relevant Issues (XDA05120203), the National Natural Science Foundation of China (Projects 41272205, 41430103, and 41372186). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitken M.J., 1998, INTRO OPTICAL DATING; AN ZH, 1991, QUATERNARY RES, V36, P29, DOI 10.1016/0033-5894(91)90015-W; An ZS, 2000, QUATERNARY SCI REV, V19, P743, DOI 10.1016/S0277-3791(99)00031-1; Balsam WL, 2011, QUATERNARY SCI REV, V30, P2732, DOI 10.1016/j.quascirev.2011.06.002; Buylaert JP, 2008, QUAT GEOCHRONOL, V3, P99, DOI 10.1016/j.quageo.2007.05.003; Derbyshire E, 1995, QUATERNARY SCI REV, V14, P681, DOI 10.1016/0277-3791(95)00077-1; DING Z, 1994, QUATERNARY SCI REV, V13, P39, DOI 10.1016/S0277-3791(99)00017-7; DING ZL, 1995, QUATERNARY RES, V44, P149, DOI 10.1006/qres.1995.1059; Ding ZL, 2005, EARTH PLANET SC LETT, V237, P45, DOI 10.1016/j.epsl.2005.06.036; DING ZL, 1993, CATENA, V20, P73, DOI 10.1016/0341-8162(93)90030-S; DING ZL, 1990, CHINESE SCI BULL, V34, P1494; Grimm EC, 1992, CLIM DYNAM, V6, P179, DOI 10.1007/BF00193530; Guo ZT, 2000, GEOPHYS RES LETT, V27, P1751, DOI 10.1029/1999GL008419; Han JM, 1996, STUD GEOPHYS GEOD, V40, P262, DOI 10.1007/BF02300742; Hao QZ, 2012, NATURE, V490, P393, DOI 10.1038/nature11493; Hao QZ, 1978, J GEOPHYS RES SOLID, P110; He Y, 2004, QUATERNARY RES, V61, P52, DOI 10.1016/j.yqres.2003.08.004; HELLER F, 1982, NATURE, V300, P431, DOI 10.1038/300431a0; HELLER F, 1984, GEOPHYS J ROY ASTR S, V77, P125, DOI 10.1111/j.1365-246X.1984.tb01928.x; Huang CC, 2003, EARTH SURF PROC LAND, V28, P1259, DOI 10.1002/esp.512; JACOBSON GL, 1986, ECOLOGY, V67, P958, DOI 10.2307/1939818; Jia YF, 2008, J GEOGR SCI, V18, P425, DOI 10.1007/s11442-008-0425-6; Kang SG, 2013, BOREAS, V42, P815, DOI 10.1111/bor.12005; Kang SG, 2011, QUAT GEOCHRONOL, V6, P480, DOI 10.1016/j.quageo.2011.04.004; KUKLA G, 1989, PALAEOGEOGR PALAEOCL, V72, P203, DOI 10.1016/0031-0182(89)90143-0; KUKLA G, 1988, GEOLOGY, V16, P811, DOI 10.1130/0091-7613(1988)016<0811:PCICDB>2.3.CO;2; KUKLA G, 1987, QUATERNARY SCI REV, V6, P191, DOI 10.1016/0277-3791(87)90004-7; Kutzbach J. E., 1993, P24; Lai ZP, 2006, HOLOCENE, V16, P893, DOI 10.1191/0959683606hol980rr; Lai ZP, 2007, PALAEOGEOGR PALAEOCL, V248, P431, DOI 10.1016/j.palaeo.2006.12.013; Li Q, 2014, GLOBAL PLANET CHANGE, V121, P101, DOI 10.1016/j.gloplacha.2014.07.009; LISIECKI LE, 2005, PALEOCEANOGRAPHY, V0020; Liu JQ, 2000, GEOLOGOS, V5, P165; Liu QS, 2004, GEOPHYS J INT, V156, P267, DOI 10.1111/j.1365-246X.2003.02148.x; Liu T.S., 1992, QUAT SCI, V1, P12; Liu TS, 1998, ANNU REV EARTH PL SC, V26, P111, DOI 10.1146/annurev.earth.26.1.111; Liu TS, 1997, QUATERNARY ENV; Liu TS., 1985, LOESS ENV; Lotter AF, 1992, CLIM DYNAM, V6, P233, DOI 10.1007/BF00193536; Lu HY, 2007, QUATERNARY SCI REV, V26, P759, DOI 10.1016/j.quascirev.2006.10.006; Lu HY, 2006, CHINESE SCI BULL, V51, P2253, DOI 10.1007/s11434-006-2097-x; Lu HY, 2013, GEOLOGY, V41, P1023, DOI 10.1130/G34488.1; Lu HY, 2005, GEOPHYS RES LETT, P32; Lu YC, 2007, QUATERNARY RES, V67, P152, DOI 10.1016/j.yqres.2006.08.003; Maher BA, 1995, QUATERNARY RES, V44, P383, DOI 10.1006/qres.1995.1083; Mason JA, 2009, GEOLOGY, V37, P947, DOI 10.1130/G30240A.1; Mix AC, 1986, PALEOCEANOGRAPHY, V1, P43, DOI 10.1029/PA001i001p00043; Murray AS, 2000, RADIAT MEAS, V32, P57, DOI 10.1016/S1350-4487(99)00253-X; Muschitiello F, 2015, QUATERNARY SCI REV, V109, P49, DOI 10.1016/j.quascirev.2014.11.015; Peterse F, 2014, QUATERNARY SCI REV, V83, P76, DOI 10.1016/j.quascirev.2013.11.001; Peterse F, 2011, EARTH PLANET SC LETT, V301, P256, DOI 10.1016/j.epsl.2010.11.010; PISIAS NG, 1984, MAR GEOL, V56, P119, DOI 10.1016/0025-3227(84)90009-4; PORTER SC, 1995, NATURE, V375, P305, DOI 10.1038/375305a0; Prell WL, 1986, PALEOCEANOGRAPHY, V1, P137, DOI 10.1029/PA001i002p00137; Prescott JR, 1997, RADIAT MEAS, V27, P893, DOI 10.1016/S1350-4487(97)00204-7; Qin JT, 2009, RADIAT MEAS, V44, P417, DOI 10.1016/j.radmeas.2009.06.008; [覃金堂 Qin Jintang], 2007, [第四纪研究, Quaternary Sciences], V27, P546; Roberts HM, 2008, BOREAS, V37, P483, DOI 10.1111/j.1502-3885.2008.00057.x; Roberts HM, 2004, RADIAT MEAS, V38, P241, DOI 10.1016/j.radmeas.2003.10.001; Ruddiman WF, 2001, EARTHS CLIMATE FUTUR; RUTTER N, 1991, QUATERNARY SCI REV, V10, P1, DOI 10.1016/0277-3791(91)90028-S; Song Y, 2014, QUATERN INT, V334, P119, DOI 10.1016/j.quaint.2013.12.010; Stevens T, 2008, GEOLOGY, V36, P415, DOI 10.1130/G24524A.1; Stevens T, 2007, EARTH-SCI REV, V80, P111, DOI 10.1016/j.earscirev.2006.09.001; Stevens T, 2006, GEOLOGY, V34, P849, DOI 10.1130/G22472.1; Timar A, 2010, QUAT GEOCHRONOL, V5, P143, DOI 10.1016/j.quageo.2009.03.003; Vriend M, 2011, QUATERN INT, V240, P167, DOI 10.1016/j.quaint.2010.11.009; Walker M, 2009, J QUATERNARY SCI, V24, P3, DOI 10.1002/jqs.1227; Wang YJ, 2001, SCIENCE, V294, P2345, DOI 10.1126/science.1064618; Wen RL, 2010, QUATERNARY RES, V73, P293, DOI 10.1016/j.yqres.2009.10.006; Wu NQ, 2002, BOREAS, V31, P20, DOI 10.1080/03009480210648; Xiao JL, 2004, QUATERNARY SCI REV, V23, P1669, DOI 10.1016/j.quascirev.2004.01.005; Xiao J, 2008, J PALEOLIMNOL, V40, P519, DOI 10.1007/s10933-007-9179-x; Xiao JL, 2006, HOLOCENE, V16, P551, DOI 10.1191/0959683606hl950rp; Yang SL, 2008, EARTH PLANET SC LETT, V274, P499, DOI 10.1016/j.epsl.2008.08.001; Zhai DY, 2011, QUATERNARY RES, V75, P512, DOI 10.1016/j.yqres.2011.02.008; Zhang J., 1992, CLIMATE CHINA; Zhang YZ, 2015, BOREAS, V44, P127, DOI 10.1111/bor.12095; Zhao H, 2007, HOLOCENE, V17, P1015, DOI 10.1177/0959683607080530; ZHOU LP, 1990, NATURE, V346, P737, DOI 10.1038/346737a0; Zhou WJ, 2007, RADIOCARBON, V49, P865, DOI 10.1017/S0033822200042739	81	14	16	3	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0133541	10.1371/journal.pone.0133541	http://dx.doi.org/10.1371/journal.pone.0133541			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RV	26186443	gold, Green Published, Green Submitted			2022-12-26	WOS:000358198700156
J	Bendas, A; Rothe, U; Kiess, W; Kapellen, TM; Stange, T; Manuwald, U; Salzsieder, E; Holl, RW; Schoffer, O; Stahl-Pehe, A; Giani, G; Ehehalt, S; Neu, A; Rosenbauer, J				Bendas, Alexander; Rothe, Ulrike; Kiess, Wieland; Kapellen, Thomas Michael; Stange, Thoralf; Manuwald, Ulf; Salzsieder, Eckhard; Holl, Reinhard Walter; Schoffer, Olaf; Stahl-Pehe, Anna; Giani, Guido; Ehehalt, Stefan; Neu, Andreas; Rosenbauer, Joachim			Trends in Incidence Rates during 1999-2008 and Prevalence in 2008 of Childhood Type 1 Diabetes Mellitus in GERMANY - Model-Based National Estimates	PLOS ONE			English	Article							TIME TRENDS; CHILDREN; AGE; PATHOGENESIS; POPULATION; REGISTRY; OBESITY	Aims To estimate the national incidence rate and trend of type 1 diabetes (T1DM) in Germany from 1999 to 2008 and the national prevalence in 2008 in the age group 0-14 years. Methods Data were taken from a nationwide registry for incident cases of T1DM in the ages 0-4 years and 3 regional registries (North-Rhine-Westphalia, Baden-Wuerttemberg and Saxony) for incident cases of T1DM in the ages 0-14 years covering 41% of the child population in Germany. The degree of ascertainment was >= 97% in all registries. Incident and prevalent cases were grouped by region, sex, age (0-4, 5-9, 10-14 years), and, for incident data, additionally by two 5-year periods (1999-2003, 2004-2008). Poisson regression models were fitted to the data to derive national estimates of incidence rate trends and prevalence in the age groups 5-9, 10-14 and 0-14 years. We used direct age-standardization. Results The estimated national incidence rate in 0-14-year-olds increased significantly by 18.1% (95% CI: 11.6-25.0%, p<0.001) from 1999-2003 to 2004-2008, independent of sex, corresponding to an average annual increase of 3.4% (95%-CI: 2.2-4.6%). The overall incidence rate was estimated at 22.9 per 100,000 person-years and we identified a within-country west-east-gradient previously unknown. The national prevalence in the ages 0-14 years on 31/12/2008 was estimated to be 148.1 per 100,000 persons. Conclusions The national incidence rate of childhood T1DM in Germany is higher than in many other countries around the world. Importantly, the estimated trend of the incidence rate confirms the international data of a global increase of T1DM incidences.	[Bendas, Alexander] Univ Hosp, Dept Otorhinolaryngol, Dresden, Germany; [Rothe, Ulrike; Manuwald, Ulf] Tech Univ Dresden, Fac Med Carl Gustav Carus, Hlth Sci Publ Hlth, Dresden, Germany; [Kiess, Wieland; Kapellen, Thomas Michael] Univ Leipzig, Hosp Children & Adolescents, Ctr Pediat Res, Dept Women & Child Hlth, D-04109 Leipzig, Germany; [Stange, Thoralf] Tech Univ Dresden, Fac Med Carl Gustav Carus, Inst Med Informat & Biometry, Dresden, Germany; [Salzsieder, Eckhard] Inst Diabet Gerhardt Katsch Karlsburg, Karlsburg, Germany; [Holl, Reinhard Walter] Univ Ulm, Inst Epidemiol & Med Biometry, D-89069 Ulm, Germany; [Schoffer, Olaf] Tech Univ Dresden, Fac Med Carl Gustav Carus, Dept Tumorepidemiol, Dresden, Germany; [Stahl-Pehe, Anna; Giani, Guido; Rosenbauer, Joachim] Univ Dusseldorf, Leibniz Inst Diabet Res, German Diabet Ctr, Inst Biometr & Epidemiol, Dusseldorf, Germany; [Ehehalt, Stefan] Publ Hlth Dept Stuttgart, Dept Pediat, Stuttgart, Germany; [Ehehalt, Stefan] Publ Hlth Dept Stuttgart, Dept Dent Hlth Care, Stuttgart, Germany; [Ehehalt, Stefan] Publ Hlth Dept Stuttgart, Dept Hlth Promot & Social Serv, Stuttgart, Germany; [Neu, Andreas] Univ Childrens Hosp Tubingen, Tubingen, Germany	Technische Universitat Dresden; Carl Gustav Carus University Hospital; Technische Universitat Dresden; Leipzig University; Technische Universitat Dresden; Ulm University; Technische Universitat Dresden; Deutsches Diabetes-Zentrum (DDZ); Heinrich Heine University Dusseldorf; Eberhard Karls University of Tubingen; TUBINGEN UNIVERSITY CHILDRENS HOSPITAL	Rothe, U (corresponding author), Tech Univ Dresden, Fac Med Carl Gustav Carus, Hlth Sci Publ Hlth, Dresden, Germany.	ulrike.rothe@tu-dresden.de	Schoffer, Olaf/R-1841-2016	Schoffer, Olaf/0000-0001-6922-7148; Holl, Reinhard/0000-0003-1395-4842; Stahl-Pehe, Anna/0000-0002-5281-6023; Prof. Rothe, Ulrike/0000-0001-9779-7260	German Diabetes Association (DDG); Open Access Publication Funds of the TU Dresden	German Diabetes Association (DDG); Open Access Publication Funds of the TU Dresden	This work was supported by the German Diabetes Association (DDG) in 2010 and the Open Access Publication Funds of the TU Dresden. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berhan Y, 2011, DIABETES, V60, P577, DOI 10.2337/db10-0813; Bessaoud K, 2006, DIABETIC MED, V23, P857, DOI 10.1111/j.1464-5491.2006.01925.x; Bluher S, 2011, INT J PEDIATR OBES, V6, pE199, DOI 10.3109/17477166.2010.526305; Bluestone JA, 2010, NATURE, V464, P1293, DOI 10.1038/nature08933; Breslow NE, 1980, STATISTICAL METHODS, V32, P49; Bruno G, 2010, DIABETES, V59, P2281, DOI 10.2337/db10-0151; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; Dahlquist G, 2006, DIABETOLOGIA, V49, P20, DOI 10.1007/s00125-005-0076-4; Ehehalt S, 2012, PEDIATR DIABETES, V13, P15, DOI 10.1111/j.1399-5448.2011.00799.x; Ehehalt S, 2010, DIABETES CARE, V33, P338, DOI 10.2337/dc09-1503; Ehehalt S, 2009, EUR J PEDIATR, V168, P613, DOI 10.1007/s00431-008-0808-9; Gale EAM, 2001, DIABETOLOGIA, V44, P3, DOI 10.1007/s001250051573; Galler A, 2010, HORM RES PAEDIAT, V74, P285, DOI 10.1159/000303141; Harjutsalo V, 2008, LANCET, V371, P1777, DOI 10.1016/S0140-6736(08)60765-5; Heinzl H, 2003, COMPUT STAT DATA AN, V44, P253, DOI 10.1016/S0167-9473(03)00062-8; International Diabbetes Federation, 2013, DIABETES ATLAS; Junghans C, 2013, EPIDEMIOLGIE DIABETE; Knip M, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a007690; McCullagh P, 1989, MONOGRAPHS STAT APPL, V37, P1, DOI DOI 10.1007/978-1-4899-3242-6; MICHAELIS D, 1993, DIABETES METAB, V19, P110; Moss A, 2012, EUR J PEDIATR, V171, P289, DOI 10.1007/s00431-011-1531-5; Patterson CC, 2007, DIABETOLOGIA, V50, P2439, DOI 10.1007/s00125-007-0824-8; Patterson CC, 2012, DIABETOLOGIA, V55, P2142, DOI 10.1007/s00125-012-2571-8; Patterson CC, 2009, LANCET, V373, P2027, DOI 10.1016/S0140-6736(09)60568-7; Rosenbauer J, 1999, DIABETOLOGIA, V42, P1055, DOI 10.1007/s001250051270; Rosenbauer J, 2002, J PEDIATR ENDOCR MET, V15, P1497; Rosenbauer J, 2002, DIABETOLOGIA, V45, P457; Rosenbauer J, 2012, DIABETES CARE, V35, P80, DOI 10.2337/dc11-0993; Solresz G, 2009, IDF DIABETES ATLAS, P1	29	59	62	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2015	10	7							e0132716	10.1371/journal.pone.0132716	http://dx.doi.org/10.1371/journal.pone.0132716			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RQ	26181330	Green Published, gold, Green Submitted			2022-12-26	WOS:000358198200027
J	Hui, BB; Ryder, N; Su, JY; Ward, J; Chen, MY; Donovan, B; Fairley, CK; Guy, RJ; Lahra, MM; Law, MG; Whiley, DM; Regan, DG				Hui, Ben B.; Ryder, Nathan; Su, Jiunn-Yih; Ward, James; Chen, Marcus Y.; Donovan, Basil; Fairley, Christopher K.; Guy, Rebecca J.; Lahra, Monica M.; Law, Mathew G.; Whiley, David M.; Regan, David G.			Exploring the Benefits of Molecular Testing for Gonorrhoea Antibiotic Resistance Surveillance in Remote Settings	PLOS ONE			English	Article							NEISSERIA-GONORRHOEAE; ANTIMICROBIAL RESISTANCE; PHARYNGEAL GONORRHEA; ACQUIRING GONORRHEA; 500 MG; AUSTRALIA; INFECTION; CEFTRIAXONE; PREVALENCE; RISK	Background Surveillance for gonorrhoea antimicrobial resistance (AMR) is compromised by a move away from culture-based testing in favour of more convenient nucleic acid amplification test (NAAT) tests. We assessed the potential benefit of a molecular resistance test in terms of the timeliness of detection of gonorrhoea AMR. Methods and Findings An individual-based mathematical model was developed to describe the transmission of gonorrhoea in a remote Indigenous population in Australia. We estimated the impact of the molecular test on the time delay between first importation and the first confirmation that the prevalence of gonorrhoea AMR (resistance proportion) has breached the WHO-recommended 5% threshold (when a change in antibiotic should occur). In the remote setting evaluated in this study, the model predicts that when culture is the only available means of testing for AMR, the breach will only be detected when the actual prevalence of AMR in the population has already reached 8 - 18%, with an associated delay of similar to 43 - 69 months between first importation and detection. With the addition of a molecular resistance test, the number of samples for which AMR can be determined increases facilitating earlier detection at a lower resistance proportion. For the best case scenario, where AMR can be determined for all diagnostic samples, the alert would be triggered at least 8 months earlier than using culture alone and the resistance proportion will have only slightly exceeded the 5% notification threshold. Conclusions Molecular tests have the potential to provide more timely warning of the emergence of gonorrhoea AMR. This in turn will facilitate earlier treatment switching and more targeted treatment, which has the potential to reduce the population impact of gonorrhoea AMR.	[Hui, Ben B.; Donovan, Basil; Guy, Rebecca J.; Law, Mathew G.; Regan, David G.] UNSW Australia, Kirby Inst, Sydney, NSW, Australia; [Ryder, Nathan; Su, Jiunn-Yih] Ctr Dis Control, Dept Hlth, Sexual Hlth & Blood Borne Virus Unit, Darwin, NT, Australia; [Ward, James] South Australian Hlth & Med Res Inst, Adelaide, SA, Australia; [Chen, Marcus Y.; Fairley, Christopher K.] Monash Univ, Cent Clin Sch, Melbourne, Vic 3004, Australia; [Chen, Marcus Y.; Fairley, Christopher K.] Alfred Hlth, Melbourne Sexual Hlth Ctr, Carlton, Vic, Australia; [Chen, Marcus Y.; Fairley, Christopher K.] Univ Melbourne, Sch Populat & Global Hlth, Melbourne, Vic, Australia; [Donovan, Basil] Sydney Hosp, Sydney Sexual Hlth Ctr, Sydney, NSW, Australia; [Lahra, Monica M.] Prince Wales Hosp, WHO Collaborating Ctr STD, Dept Microbiol, South Eastern Area Lab Serv, Sydney, NSW, Australia; [Whiley, David M.] Queensland Childrens Hlth Serv, Queensland Paediat Infect Dis Lab, Brisbane, Qld, Australia; [Whiley, David M.] Univ Queensland, Queensland Childrens Med Res Inst, Brisbane, Qld 4072, Australia	University of New South Wales Sydney; Kirby Institute; South Australian Health & Medical Research Institute (SAHMRI); Monash University; University of Melbourne; University of Queensland	Hui, BB (corresponding author), UNSW Australia, Kirby Inst, Sydney, NSW, Australia.	bhui@kirby.unsw.edu.au	Shoushtari, Masoud/AAQ-7317-2020; Whiley, David M/E-8955-2011; Donovan, Basil J/K-1246-2012; Lahra, Monica/AAQ-6548-2020; Ward, James/ABD-1439-2020	Whiley, David M/0000-0001-5969-3161; Donovan, Basil J/0000-0001-8851-4126; Ward, James/0000-0002-2892-4542; Hui, Ben/0000-0002-6567-5821; Regan, David/0000-0002-2893-0969; Law, Matthew/0000-0002-3540-8837; Christopher, Fairley/0000-0001-9081-1664; Guy, Rebecca/0000-0002-2929-4634	National Health and Medical Research Council [APP1025517]; Australian Government Department of Health and Ageing	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Australian Government Department of Health and Ageing(Australian GovernmentDepartment of Health & Ageing)	This work was supported by National Health and Medical Research Council Project Grants (APP1025517). The Kirby Institute is funded by the Australian Government Department of Health and Ageing and is affiliated with the Faculty of Medicine, University of New South Wales. The views expressed in this publication do not necessarily represent the position of the Australian Government.	[Australian Bureau of Statistics Australian Bureau of Statistics], 2011, EST AB TORR STRAIT I; Australian Bureau of Statistics, 2009, EXP EST PROJ AB TORR; Australian Government Department of Health, AUSTR GON SURV PROGR; Biddle N, 2009, J POPUL RES, V26, P305, DOI 10.1007/s12546-010-9026-1; BRUNHAM RC, 1991, P ROY SOC B-BIOL SCI, V246, P173, DOI 10.1098/rspb.1991.0141; Bryant J, 2011, SEX HEALTH, V8, P378, DOI 10.1071/SH10138; Chan CH, 2012, SEX TRANSM INFECT, V88, P200, DOI 10.1136/sextrans-2011-050049; Fagan PS, 2014, COMMUNICABLE DIS INT, V37; Garnett GP, 1999, PHILOS T R SOC B, V354, P787, DOI 10.1098/rstb.1999.0431; Goire N, 2014, NAT REV MICROBIOL, V12, P223, DOI 10.1038/nrmicro3217; Goire N, 2011, J CLIN MICROBIOL, V49, P513, DOI 10.1128/JCM.02024-10; Guy R, 2011, AUSTR SEX HLTH C 26, P139; Guy R, 2012, SEX HEALTH, V9, P205, DOI 10.1071/SH11074; HOLMES KK, 1970, AM J EPIDEMIOL, V91, P170, DOI 10.1093/oxfordjournals.aje.a121125; Hui BB, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-188; Johnson LF, 2010, SEX TRANSM INFECT, V86, P169, DOI 10.1136/sti.2009.037341; Korenromp EL, 2002, INT J STD AIDS, V13, P91, DOI 10.1258/0956462021924712; Lagarias JC, 1998, SIAM J OPTIMIZ, V9, P112, DOI 10.1137/S1052623496303470; Lahra MM, 2013, COMMUN DIS INTELL, V37, pE233; Lahra MM, 2013, SEX TRANSM INFECT, V89, P19, DOI 10.1136/sextrans-2012-050906; Lynn F, 2005, J CLIN MICROBIOL, V43, P368, DOI 10.1128/JCM.43.1.368-375.2005; McDonagh P, 2009, SEX HEALTH, V6, P241, DOI 10.1071/SH09025; Northern Territory Department of Health, 2013, SEX HLTH BLOOD BORN; Pinksky P, 1990, MATH BIOSCI, V98, P103; PLATT R, 1983, JAMA-J AM MED ASSOC, V250, P3205, DOI 10.1001/jama.250.23.3205; POTTERAT JJ, 1987, SEX TRANSM DIS, V14, P107, DOI 10.1097/00007435-198704000-00010; Read PJ, 2013, SEX HEALTH, V10, P460, DOI 10.1071/SH13077; Rissel CE, 2003, AUST NZ J PUBL HEAL, V27, P124, DOI 10.1111/j.1467-842X.2003.tb00799.x; Senior K, 2014, CULT HEALTH SEX, V16, P453, DOI 10.1080/13691058.2014.888096; Speers DJ, 2014, J ANTIMICROB CHEMOTH, V69, P1243, DOI 10.1093/jac/dkt501; Spicknall IH, 2013, AM J EPIDEMIOL, V178, P508, DOI 10.1093/aje/kwt017; Su J-Y, 2009, NO TERRITORY DIS CON, P11; Tabrizi S, 2012, 13 IUSTI WORLD C MEL, P72; Tapsall JW, 2008, J ANTIMICROB CHEMOTH, V61, P150, DOI 10.1093/jac/dkm434; Tapsall J, 2009, J MED MICROBIOL, V58, P683, DOI 10.1099/jmm.0.007641-0; The Kirby Institute, 2013, BLOODB VIR SEX TRANS; Thompson SC, 2008, AUSTR NZ HLTH POLICY, V5; Trembizki E, 2014, J MED MICROBIOL, V63, P45, DOI 10.1099/jmm.0.065094-0; World Health Organization, 2012, GLOB ACT PLAN CONTR; Chen M, 2013, J ANTIMICROB CHEMOTH, V68, P1445, DOI 10.1093/jac/dkt017	40	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2015	10	7							e0133202	10.1371/journal.pone.0133202	http://dx.doi.org/10.1371/journal.pone.0133202			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RQ	26181042	Green Published, gold			2022-12-26	WOS:000358198200056
J	Lareau-Trudel, E; Le Troter, A; Ghattas, B; Pouget, J; Attarian, S; Bendahan, D; Salort-Campana, E				Lareau-Trudel, Emilie; Le Troter, Arnaud; Ghattas, Badih; Pouget, Jean; Attarian, Shahram; Bendahan, David; Salort-Campana, Emmanuelle			Muscle Quantitative MR Imaging and Clustering Analysis in Patients with Facioscapulohumeral Muscular Dystrophy Type 1	PLOS ONE			English	Article							ADIPOSE-TISSUE; SKELETAL-MUSCLE; MOLECULAR DIAGNOSIS; DNA REARRANGEMENTS; FAT INFILTRATION; INVOLVEMENT; QUANTIFICATION; SEGMENTATION; SEPARATION; PHENOTYPE	Background Facioscapulohumeral muscular dystrophy type 1 (FSHD1) is the third most common inherited muscular dystrophy. Considering the highly variable clinical expression and the slow disease progression, sensitive outcome measures would be of interest. Methods and Findings Using muscle MRI, we assessed muscular fatty infiltration in the lower limbs of 35 FSHD1 patients and 22 healthy volunteers by two methods: a quantitative imaging (qMRI) combined with a dedicated automated segmentation method performed on both thighs and a standard T1-weighted four-point visual scale (visual score) on thighs and legs. Each patient had a clinical evaluation including manual muscular testing, Clinical Severity Score (CSS) scale and MFM scale. The intramuscular fat fraction measured using qMRI in the thighs was significantly higher in patients (21.9 +/- 20.4%) than in volunteers (3.6 +/- 2.8%) (p<0.001). In patients, the intramuscular fat fraction was significantly correlated with the muscular fatty infiltration in the thighs evaluated by the mean visual score (p<0.001). However, we observed a ceiling effect of the visual score for patients with a severe fatty infiltration clearly indicating the larger accuracy of the qMRI approach. Mean intramuscular fat fraction was significantly correlated with CSS scale (p <= 0.01) and was inversely correlated with MMT score, MFM subscore D1 (p <= 0.01) further illustrating the sensitivity of the qMRI approach. Overall, a clustering analysis disclosed three different imaging patterns of muscle involvement for the thighs and the legs which could be related to different stages of the disease and put forth muscles which could be of interest for a subtle investigation of the disease progression and/ or the efficiency of any therapeutic strategy. Conclusion The qMRI provides a sensitive measurement of fat fraction which should also be of high interest to assess disease progression and any therapeutic strategy in FSHD1 patients.	[Lareau-Trudel, Emilie; Pouget, Jean; Attarian, Shahram; Salort-Campana, Emmanuelle] Univ Aix Marseille, CHU Timone, Ctr Reference Malad Neuromusculaires & SLA, Marseille, France; [Le Troter, Arnaud; Bendahan, David] Aix Marseille Univ, Ctr Resonance Magnet Biol & Med, UMR CNRS 7339, Marseille, France; [Ghattas, Badih] Aix Marseille Univ, Inst Math Marseille, Marseille, France	UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite	Salort-Campana, E (corresponding author), Univ Aix Marseille, CHU Timone, Ctr Reference Malad Neuromusculaires & SLA, Marseille, France.	emmanuelle.salort-campana@ap-hm.fr	Attarian, Shahram/AAE-6214-2021; Bendahan, David/AAU-1420-2020	le troter, arnaud/0000-0002-7897-9672				Alabousi A, 2011, J MAGN RESON IMAGING, V34, P474, DOI 10.1002/jmri.22603; Berard C, 2005, NEUROMUSCULAR DISORD, V15, P463, DOI 10.1016/j.nmd.2005.03.004; Fischmann A, 2013, J NEUROL, V260, P969, DOI 10.1007/s00415-012-6733-x; Friedman SD, 2014, MUSCLE NERVE, V49, P257, DOI 10.1002/mus.23911; Gloor M, 2011, J MAGN RESON IMAGING, V33, P203, DOI 10.1002/jmri.22431; Janssen BH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085416; Kan HE, 2009, NEUROMUSCULAR DISORD, V19, P357, DOI 10.1016/j.nmd.2009.02.009; Karampinos DC, 2012, J MAGN RESON IMAGING, V35, P899, DOI 10.1002/jmri.23512; Kullberg J, 2010, J MAGN RESON IMAGING, V32, P204, DOI 10.1002/jmri.22193; LAMMINEN AE, 1990, BRIT J RADIOL, V63, P946, DOI 10.1259/0007-1285-63-756-946; Layec G, 2009, MAGN RESON MED, V62, P840, DOI 10.1002/mrm.22085; Lemmers RJLF, 2007, AM J HUM GENET, V81, P884, DOI 10.1086/521986; Lemmers RJFL, 2004, AM J HUM GENET, V75, P1124, DOI 10.1086/426035; Lemmers RJLF, 2002, NAT GENET, V32, P235, DOI 10.1038/ng999; Mattei JP, 2006, MAGN RESON MATER PHY, V19, P275, DOI 10.1007/s10334-006-0051-1; Mercuri E, 2007, J MAGN RESON IMAGING, V25, P433, DOI 10.1002/jmri.20804; Mercuri Eugenio, 2002, Eur J Paediatr Neurol, V6, P305; Mercuri E, 2011, NEUROMUSCULAR DISORD, V21, P16, DOI 10.1016/j.nmd.2010.09.003; Mostacciuolo ML, 2009, CLIN GENET, V75, P550, DOI 10.1111/j.1399-0004.2009.01158.x; Olsen DB, 2006, J NEUROL, V253, P1437, DOI 10.1007/s00415-006-0230-z; PADBERG GW, 1995, MUSCLE NERVE, pS81, DOI 10.1002/mus.880181315; PERSONIUS KE, 1994, PHYS THER, V74, P253, DOI 10.1093/ptj/74.3.253; Positano V, 2009, J MAGN RESON IMAGING, V29, P677, DOI 10.1002/jmri.21699; Ricci E, 1999, ANN NEUROL, V45, P751, DOI 10.1002/1531-8249(199906)45:6<751::AID-ANA9>3.0.CO;2-M; Scionti I, 2012, AM J HUM GENET, V90, P628, DOI 10.1016/j.ajhg.2012.02.019; Sookhoo S, 2007, CLIN RADIOL, V62, P160, DOI 10.1016/j.crad.2006.08.012; Statland JM, 2013, NEUROMUSCULAR DISORD, V23, P306, DOI 10.1016/j.nmd.2013.01.008; Tasca G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100292; Tasca G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038779; Valentinitsch A, 2013, J MAGN RESON IMAGING, V37, P917, DOI 10.1002/jmri.23884; VANDEUTEKOM JCT, 1993, HUM MOL GENET, V2, P2037; Wang CH, 2012, NEUROMUSCULAR DISORD, V22, P331, DOI 10.1016/j.nmd.2011.10.018; WIJMENGA C, 1993, NEUROMUSCULAR DISORD, V3, P487, DOI 10.1016/0960-8966(93)90102-P; WIJMENGA C, 1992, NAT GENET, V2, P26, DOI 10.1038/ng0992-26; Willis TA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070993; Wokke BH, 2013, J MAGN RESON IMAGING, V38, P619, DOI 10.1002/jmri.23998	36	28	29	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2015	10	7							e0132717	10.1371/journal.pone.0132717	http://dx.doi.org/10.1371/journal.pone.0132717			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RQ	26181385	Green Published, Green Submitted, gold			2022-12-26	WOS:000358198200028
J	Kucerova-Levisohn, M; Knirr, S; Mejia, RI; Ortiz, BD				Kucerova-Levisohn, Martina; Knirr, Stefan; Mejia, Rosa I.; Ortiz, Benjamin D.			The 3 '-J alpha Region of the TCR alpha Locus Bears Gene Regulatory Activity in Thymic and Peripheral T Cells	PLOS ONE			English	Article							HEAVY-CHAIN-LOCUS; V(D)J RECOMBINATION; SOMATIC HYPERMUTATION; ENHANCER ELEMENTS; IN-VITRO; C-ALPHA; E-MU; RECEPTOR; BETA; EXPRESSION	Much progress has been made in understanding the important cis-mediated controls on mouse TCR alpha gene function, including identification of the E alpha enhancer and TCR alpha locus control region (LCR). Nevertheless, previous data have suggested that other cis-regulatory elements may reside in the locus outside of the E alpha/LCR. Based on prior findings, we hypothesized the existence of gene regulatory elements in a 3.9-kb region 5' of the C alpha exons. Using DNase hypersensitivity assays and TCR alpha BAC reporter transgenes in mice, we detected gene regulatory activity within this 3.9-kb region. This region is active in both thymic and peripheral T cells, and selectively affects upstream, but not downstream, gene expression. Together, these data indicate the existence of a novel cis-acting regulatory complex that contributes to TCR alpha transgene expression in vivo. The active chromatin sites we discovered within this region would remain in the locus after TCR alpha gene rearrangement, and thus may contribute to endogenous TCR alpha gene activity, particularly in peripheral T cells, where the E alpha element has been found to be inactive.	[Kucerova-Levisohn, Martina; Knirr, Stefan; Mejia, Rosa I.; Ortiz, Benjamin D.] CUNY Hunter Coll, Dept Biol Sci, New York, NY 10021 USA; [Kucerova-Levisohn, Martina; Ortiz, Benjamin D.] CUNY, Grad Ctr, Doctoral Program Biol, New York, NY USA	City University of New York (CUNY) System; Hunter College (CUNY); City University of New York (CUNY) System	Ortiz, BD (corresponding author), CUNY Hunter Coll, Dept Biol Sci, 695 Pk Ave, New York, NY 10021 USA.	Ortiz@genectr.hunter.cuny.edu			National Institutes of Health (NIH) [SC1-GM095402]; Alliance/Merck Ciencia Scholarship; Hunter College Undergraduate Research Initiative Fellowship; Research Centers in Minority Institutions grant from the National Institute on Minority Health and Health Disparities of NIH [G12 MD007599]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [SC1GM095402] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [G12MD007599] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alliance/Merck Ciencia Scholarship; Hunter College Undergraduate Research Initiative Fellowship; Research Centers in Minority Institutions grant from the National Institute on Minority Health and Health Disparities of NIH; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported by National Institutes of Health (NIH) grant SC1-GM095402 (to BDO). RIM was supported by an Alliance/Merck Ciencia Scholarship and a Hunter College Undergraduate Research Initiative Fellowship. The biomedical research infrastructure at Hunter College is supported in part by Research Centers in Minority Institutions grant G12 MD007599 from the National Institute on Minority Health and Health Disparities of NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Birshtein BK, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00163; Deindl E, 2001, BIOTECHNIQUES, V31, P1250, DOI 10.2144/01316bm04; del Blanco B, 2015, P NATL ACAD SCI USA, V112, pE1744, DOI 10.1073/pnas.1406551112; Ghoreschi K, 2010, NATURE, V467, P967, DOI 10.1038/nature09447; Gomos-Klein J, 2007, J IMMUNOL, V179, P1088, DOI 10.4049/jimmunol.179.2.1088; Harrow F, 2005, J IMMUNOL, V175, P6659, DOI 10.4049/jimmunol.175.10.6659; Harrow F, 2004, J BIOL CHEM, V279, P17842, DOI 10.1074/jbc.M401258200; HO IC, 1989, P NATL ACAD SCI USA, V86, P6714, DOI 10.1073/pnas.86.17.6714; Inlay MA, 2006, J IMMUNOL, V177, P1146, DOI 10.4049/jimmunol.177.2.1146; Jung D, 2006, ANNU REV IMMUNOL, V24, P541, DOI 10.1146/annurev.immunol.23.021704.115830; Knirr S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015527; KOOP BF, 1992, GENOMICS, V13, P1209, DOI 10.1016/0888-7543(92)90039-U; Kovalovsky D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008675; Krangel MS, 2004, IMMUNOL REV, V200, P224, DOI 10.1111/j.0105-2896.2004.00155.x; Lahiji A, 2014, J IMMUNOL METHODS, V407, P135, DOI 10.1016/j.jim.2014.03.012; Lahiji A, 2013, J IMMUNOL, V191, P472, DOI 10.4049/jimmunol.1300521; Li FB, 2010, J IMMUNOL, V185, P6049, DOI 10.4049/jimmunol.0902992; Li FB, 2009, J EXP MED, V206, P153, DOI 10.1084/jem.20081202; LURIA S, 1987, EMBO J, V6, P3307, DOI 10.1002/j.1460-2075.1987.tb02650.x; McMurry MT, 2000, SCIENCE, V287, P495, DOI 10.1126/science.287.5452.495; Ortiz BD, 1999, MOL CELL BIOL, V19, P1901; Ortiz BD, 1997, EMBO J, V16, P5037, DOI 10.1093/emboj/16.16.5037; Ortiz BD, 2001, J IMMUNOL, V167, P3836, DOI 10.4049/jimmunol.167.7.3836; Peng C, 2013, J IMMUNOL, V191, P4399, DOI 10.4049/jimmunol.1301858; Santoso B, 2000, J BIOL CHEM, V275, P1952, DOI 10.1074/jbc.275.3.1952; Schlissel MS, 2004, IMMUNOL REV, V200, P215, DOI 10.1111/j.0105-2896.2004.00157.x; Shih HY, 2011, IMMUNOL RES, V49, P192, DOI 10.1007/s12026-010-8181-y; Sleckman BP, 1997, IMMUNITY, V7, P505, DOI 10.1016/S1074-7613(00)80372-6; WINOTO A, 1989, EMBO J, V8, P729, DOI 10.1002/j.1460-2075.1989.tb03432.x; Xiong N, 2002, IMMUNITY, V16, P453, DOI 10.1016/S1074-7613(02)00285-6	31	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0132856	10.1371/journal.pone.0132856	http://dx.doi.org/10.1371/journal.pone.0132856			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26177549	gold, Green Published			2022-12-26	WOS:000358197600169
J	Bostrom, MM; Irjala, H; Mirtti, T; Taimen, P; Kauko, T; Algars, A; Jalkanen, S; Bostrom, PJ				Bostrom, Minna M.; Irjala, Heikki; Mirtti, Tuomas; Taimen, Pekka; Kauko, Tommi; Algars, Annika; Jalkanen, Sirpa; Bostrom, Peter J.			Tumor-Associated Macrophages Provide Significant Prognostic Information in Urothelial Bladder Cancer	PLOS ONE			English	Article							SCAVENGER RECEPTOR; BINDING; MOLECULE; CELLS	Inflammation is an important feature of carcinogenesis. Tumor-associated macrophages (TAMs) can be associated with either poor or improved prognosis, depending on their properties and polarization. Current knowledge of the prognostic significance of TAMs in bladder cancer is limited and was investigated in this study. We analyzed 184 urothelial bladder cancer patients undergoing transurethral resection of a bladder tumor or radical cystectomy. CD68 (pan-macrophage marker), MAC387 (polarized towards type 1 macrophages), and CLEVER-1/Stabilin-1 (type 2 macrophages and lymphatic/blood vessels) were detected immunohistochemically. The median follow-up time was 6.0 years. High macrophage counts associated with a higher pT category and grade. Among patients undergoing transurethral resection, all studied markers apart from CLEVER-1/Stabilin-1 were associated with increased risk of progression and poorer disease-specific and overall survival in univariate analyses. High levels of two macrophage markers (CD68/MAC387(+/+) or CD68/CLEVER-1(+/+) groups) had an independent prognostic role after transurethral resection in multivariate analyses. In the cystectomy cohort, MAC387, alone and in combination with CD68, was associated with poorer survival in univariate analyses, but none of the markers were independent predictors of outcome in multivariate analyses. In conclusion, this study demonstrates that macrophage phenotypes provide significant independent prognostic information, particularly in bladder cancers undergoing transurethral resection.	[Bostrom, Minna M.; Irjala, Heikki; Algars, Annika; Jalkanen, Sirpa] Univ Turku, Dept Med Microbiol & Immunol, MediCity Res Lab, Turku, Finland; [Irjala, Heikki] Turku Univ Hosp, Dept Otorhinolaryngol Head & Neck Surg, FIN-20520 Turku, Finland; [Mirtti, Tuomas] Helsinki Univ Hosp HUSLAB, Dept Pathol, Helsinki, Finland; [Mirtti, Tuomas] Univ Helsinki, Inst Mol Med Finland FIMM, Helsinki, Finland; [Taimen, Pekka] Turku Univ Hosp, Dept Pathol, FIN-20520 Turku, Finland; [Kauko, Tommi] Univ Turku, Dept Biostat, Turku, Finland; [Algars, Annika] Turku Univ Hosp, Dept Radiotherapy & Oncol, FIN-20520 Turku, Finland; [Bostrom, Peter J.] Turku Univ Hosp, Dept Urol, FIN-20520 Turku, Finland	University of Turku; University of Turku; University of Helsinki; University of Turku; University of Turku; University of Turku; University of Turku	Bostrom, MM (corresponding author), Univ Turku, Dept Med Microbiol & Immunol, MediCity Res Lab, Turku, Finland.	mmbost@utu.fi		Kauko, Tommi/0000-0002-7644-3225; Mirtti, Tuomas/0000-0003-0455-9891; Irjala, Heikki/0000-0003-3054-4677; Bostrom, Peter/0000-0003-3647-0015	Juselius Foundation; Cancer Society of Finland; Finnish Medical Foundation; Kirsti and Tor Johanssons Heart and Cancer Foundation; Orion-Farmos; Instrumentariumin tiedesaatio	Juselius Foundation; Cancer Society of Finland; Finnish Medical Foundation; Kirsti and Tor Johanssons Heart and Cancer Foundation; Orion-Farmos; Instrumentariumin tiedesaatio	Peter J. Bostrom received support from the Juselius Foundation (http://www.sigridjuselius.fi/foundation) and Cancer Society of Finland (http://www.cancer.fi/en/). Sirpa Jalkanen received support from the Finnish Medical Foundation (http://www.laaketieteensaatio.fi/fin/in_english/), Kirsti and Tor Johanssons Heart and Cancer Foundation. Minna M. Bostrom received support from the Orion-Farmos (http://www.orion.fi/en/rd/) and Instrumentariumin tiedesaatio (http://www.instrufoundation.fi). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi H, 2002, J BIOL CHEM, V277, P34264, DOI 10.1074/jbc.M204277200; Algars A, 2012, INT J CANCER, V131, P864, DOI 10.1002/ijc.26457; Ayari C, 2009, EUR UROL, V55, P1386, DOI 10.1016/j.eururo.2009.01.040; Botteman MF, 2003, PHARMACOECONOMICS, V21, P1315, DOI 10.1007/BF03262330; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; GOEBELER M, 1994, J LEUKOCYTE BIOL, V55, P259, DOI 10.1002/jlb.55.2.259; Hanada T, 2000, INT J UROL, V7, P263, DOI 10.1046/j.1442-2042.2000.00190.x; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Irjala H, 2003, EUR J IMMUNOL, V33, P815, DOI 10.1002/eji.200323859; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kzhyshkowska J, 2010, THESCIENTIFICWORLDJO, V10, P2039, DOI 10.1100/tsw.2010.189; Lima L, 2012, ADV UROL, V2012, DOI 10.1155/2012/232609; Lopez-Beltran A, 2007, J CLIN PATHOL, V60, P332, DOI 10.1136/jcp.2006.038802; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Mantovani A, 2010, CURR OPIN IMMUNOL, V22, P231, DOI 10.1016/j.coi.2010.01.009; Mukhtar RA, 2012, ANN SURG ONCOL, V19, P3979, DOI 10.1245/s10434-012-2415-2; Palani S, 2011, EUR J IMMUNOL, V41, P2052, DOI 10.1002/eji.201041376; Powles T, 2014, NATURE, V515, P558, DOI 10.1038/nature13904; Rosevear HM, 2009, CANCER METAST REV, V28, P345, DOI 10.1007/s10555-009-9195-6; SALMI M, 1992, SCIENCE, V257, P1407, DOI 10.1126/science.1529341; Sauter G, 2004, WHO CLASSIFICATION C, P29; Shabo I, 2008, INT J CANCER, V123, P780, DOI 10.1002/ijc.23527; Sjodahl G, 2014, UROL ONCOL-SEMIN ORI, V32, P791, DOI 10.1016/j.urolonc.2014.02.007; Sobin LH, 2009, TNM CLASSIFICATION M, P262; Soulas C, 2011, AM J PATHOL, V178, P2121, DOI 10.1016/j.ajpath.2011.01.023; Subimerb C, 2010, MOL MED REP, V3, P597, DOI 10.3892/mmr_00000303; Takayama H, 2009, J UROLOGY, V181, P1894, DOI 10.1016/j.juro.2008.11.090; TUNGEKAR MF, 1991, HISTOPATHOLOGY, V19, P245, DOI 10.1111/j.1365-2559.1991.tb00029.x; Zhang QW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050946	29	44	44	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0133552	10.1371/journal.pone.0133552	http://dx.doi.org/10.1371/journal.pone.0133552			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LZ	26197470	Green Published, Green Submitted, gold			2022-12-26	WOS:000358547600114
J	Lin, N; Jiang, JH; Guo, SC; Xiong, MM				Lin, Nan; Jiang, Junhai; Guo, Shicheng; Xiong, Momiao			Functional Principal Component Analysis and Randomized Sparse Clustering Algorithm for Medical Image Analysis	PLOS ONE			English	Article							FEATURE-SELECTION	Due to the advancement in sensor technology, the growing large medical image data have the ability to visualize the anatomical changes in biological tissues. As a consequence, the medical images have the potential to enhance the diagnosis of disease, the prediction of clinical outcomes and the characterization of disease progression. But in the meantime, the growing data dimensions pose great methodological and computational challenges for the representation and selection of features in image cluster analysis. To address these challenges, we first extend the functional principal component analysis (FPCA) from one dimension to two dimensions to fully capture the space variation of image the signals. The image signals contain a large number of redundant features which provide no additional information for clustering analysis. The widely used methods for removing the irrelevant features are sparse clustering algorithms using a lasso-type penalty to select the features. However, the accuracy of clustering using a lasso-type penalty depends on the selection of the penalty parameters and the threshold value. In practice, they are difficult to determine. Recently, randomized algorithms have received a great deal of attentions in big data analysis. This paper presents a randomized algorithm for accurate feature selection in image clustering analysis. The proposed method is applied to both the liver and kidney cancer histology image data from the TCGA database. The results demonstrate that the randomized feature selection method coupled with functional principal component analysis substantially outperforms the current sparse clustering algorithms in image cluster analysis.	[Lin, Nan; Jiang, Junhai; Guo, Shicheng; Xiong, Momiao] Univ Texas Houston, Ctr Human Genet, Dept Biostat, Sch Publ Hlth,Hlth Sci Ctr, Houston, TX 77030 USA; [Guo, Shicheng] Fudan Univ, State Key Lab Genet Engn, Shanghai 200433, Peoples R China; [Guo, Shicheng] Fudan Univ, Minist Educ, Key Lab Contemporary Anthropol, Sch Life Sci, Shanghai 200433, Peoples R China; [Guo, Shicheng] Fudan Univ, Inst Biomed Sci, Shanghai 200433, Peoples R China	University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health; Fudan University; Fudan University; Fudan University	Xiong, MM (corresponding author), Univ Texas Houston, Ctr Human Genet, Dept Biostat, Sch Publ Hlth,Hlth Sci Ctr, Houston, TX 77030 USA.	Momiao.Xiong@uth.tmc.edu	Guo, Shicheng/A-1204-2016	Guo, Shicheng/0000-0002-7047-9972	National Institutes of Health [1R01AR057120-01]; NHLBI [1R01HL106034-01]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL106034] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR057120] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	The project described was supported by grants 1R01AR057120-01 and 1R01HL106034-01 from the National Institutes of Health and NHLBI, respectively.	[Anonymous], ARXIV12016082; Aroquiaraj I. L., 2013, Proceedings of the 2013 International Conference on Pattern Recognition, Informatics and Mobile Engineering (PRIME), P479, DOI 10.1109/ICPRIME.2013.6496718; Bong CW, 2012, IET IMAGE PROCESS, V6, P1, DOI 10.1049/iet-ipr.2010.0122; Boutsidis C., 2011, ARXIV11102897; Boutsidis C, 2014, SIAM J COMPUT, V43, P687, DOI 10.1137/12086755X; Boutsidis C, 2013, IEEE T INFORM THEORY, V59, P6099, DOI 10.1109/TIT.2013.2255021; Erdogan F, 2004, INT J CLIN PRACT, V58, P333, DOI 10.1111/j.1368-5031.2004.00008.x; Frieze DA, 1999, P 10 ANN ACM SIAM S; Gupta MR, 2006, IEEE IMAGE PROC, P1585; Henderson D, 2006, STOCHASTIC DIFFERENTIAL EQUATIONS IN SCIENCE AND ENGINEERING, P1, DOI 10.1142/9789812774798; Liu H, 2008, CH CRC DATA MIN KNOW, P3; Lowe DG, 2004, INT J COMPUT VISION, V60, P91, DOI 10.1023/B:VISI.0000029664.99615.94; Ramsay J. O, 2006, FUNCTIONAL DATA ANAL; Rudelson M, 2007, J ACM, V54, DOI 10.1145/1255443.1255449; Sagan H., 2012, INTRO CALCULUS VARIA; Samiappan S, 2013, IEEE J-STARS, V6, P792, DOI 10.1109/JSTARS.2013.2237757; Strela V, 1999, IEEE T IMAGE PROCESS, V8, P548, DOI 10.1109/83.753742; Witten DM, 2010, J AM STAT ASSOC, V105, P713, DOI 10.1198/jasa.2010.tm09415; Yang Y, 2010, IEEE T IMAGE PROCESS, V19, P2761, DOI 10.1109/TIP.2010.2049235	19	10	10	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0132945	10.1371/journal.pone.0132945	http://dx.doi.org/10.1371/journal.pone.0132945			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LZ	26196383	Green Published, Green Submitted, gold			2022-12-26	WOS:000358547600057
J	Luo, X; Jellison, KL; Huynh, K; Widmer, G				Luo, Xia; Jellison, Kristen L.; Huynh, Kevin; Widmer, Giovanni			Impact of Bioreactor Environment and Recovery Method on the Profile of Bacterial Populations from Water Distribution Systems	PLOS ONE			English	Article							TAYLOR-COUETTE FLOW; CRYPTOSPORIDIUM-PARVUM; BIOFILM; PATHOGENS; RETENTION; MODEL	Multiple rotating annular reactors were seeded with biofilms flushed from water distribution systems to assess (1) whether biofilms grown in bioreactors are representative of biofilms flushed from the water distribution system in terms of bacterial composition and diversity, and (2) whether the biofilm sampling method affects the population profile of the attached bacterial community. Biofilms were grown in bioreactors until thickness stabilized (9 to 11 weeks) and harvested from reactor coupons by sonication, stomaching, bead-beating, and manual scraping. High-throughput sequencing of 16S rRNA amplicons was used to profile bacterial populations from flushed biofilms seeded into bioreactors as well as biofilms recovered from bioreactor coupons by different methods. beta diversity between flushed and reactor biofilms was compared to beta diversity between (i) biofilms harvested from different reactors and (ii) biofilms harvested by different methods from the same reactor. These analyses showed that average diversity between flushed and bioreactor biofilms was double the diversity between biofilms from different reactors operated in parallel. The diversity between bioreactors was larger than the diversity associated with different biofilm recovery methods. Compared to other experimental variables, the method used to recover biofilms had a negligible impact on the outcome of water biofilm analyses based on 16S amplicon sequencing. Results from this study show that biofilms grown in reactors over 9 to 11 weeks are not representative models of the microbial populations flushed from a distribution system. Furthermore, the bacterial population profile of biofilms grown in replicate reactors from the same flushed water are likely to diverge. However, four common sampling protocols, which differ with respect to disruption of bacterial cells, provide similar information with respect to the 16S rRNA population profile of the biofilm community.	[Luo, Xia; Jellison, Kristen L.] Lehigh Univ, Dept Civil & Environm Engn, Bethlehem, PA 18015 USA; [Huynh, Kevin; Widmer, Giovanni] Tufts Univ, Cummings Sch Vet Med, Dept Infect Dis & Global Hlth, North Grafton, MA 01536 USA	Lehigh University; Tufts University	Widmer, G (corresponding author), Tufts Univ, Cummings Sch Vet Med, Dept Infect Dis & Global Hlth, North Grafton, MA 01536 USA.	giovanni.widmer@tufts.edu			Water Research Foundation [4368]	Water Research Foundation	This study was funded by the Water Research Foundation, project 4368. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BORCARD D, 1992, ECOLOGY, V73, P1045, DOI 10.2307/1940179; Borcard D, 2011, USE R, P1, DOI 10.1007/978-1-4419-7976-6; Camper A, 1999, J APPL MICROBIOL, V85, p1S; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; DiCesare EAW, 2012, APPL ENVIRON MICROB, V78, P4187, DOI 10.1128/AEM.08026-11; Dou HS, 2008, INT J THERM SCI, V47, P1422, DOI 10.1016/j.ijthermalsci.2007.12.012; Dou HS, 2007, INT J THERM SCI, V46, P262, DOI 10.1016/j.ijthermalsci.2006.05.003; Feazel LM, 2009, P NATL ACAD SCI USA, V106, P16393, DOI 10.1073/pnas.0908446106; Gotelli NJ, 2001, ECOL LETT, V4, P379, DOI 10.1046/j.1461-0248.2001.00230.x; Helmi K, 2008, APPL ENVIRON MICROB, V74, P2079, DOI 10.1128/AEM.02495-07; Heydorn A, 2000, MICROBIOL-UK, V146, P2409, DOI 10.1099/00221287-146-10-2409; Lawrence JR, 2000, J MICROBIOL METH, V42, P215, DOI 10.1016/S0167-7012(00)00195-0; Liu G, 2014, ENVIRON SCI TECHNOL, V48, P5467, DOI 10.1021/es5009467; Martiny AC, 2003, APPL ENVIRON MICROB, V69, P6899, DOI 10.1128/AEM.69.11.6899-6907.2003; Searcy KE, 2006, APPL ENVIRON MICROB, V72, P6242, DOI 10.1128/AEM.00344-06; Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60; September SM, 2007, J WATER HEALTH, V5, P219, DOI [10.2166/wh.2007.004b, 10.2166/wh.2007.004]; Servais P., 1995, Aqua (Oxford), V44, P10; ter Braak CJF, 2002, CANOCO REFERENCE MAN; Zhang QS, 2013, GUT MICROBES, V4, P193, DOI 10.4161/gmic.23867	20	8	8	3	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0133427	10.1371/journal.pone.0133427	http://dx.doi.org/10.1371/journal.pone.0133427			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LZ	26196282	Green Published, Green Submitted, gold			2022-12-26	WOS:000358547600096
J	Singh, S; Wu, XY; Ljosa, V; Bray, MA; Piccioni, F; Root, DE; Doench, JG; Boehm, JS; Carpenter, AE				Singh, Shantanu; Wu, Xiaoyun; Ljosa, Vebjorn; Bray, Mark-Anthony; Piccioni, Federica; Root, David E.; Doench, John G.; Boehm, Jesse S.; Carpenter, Anne E.			Morphological Profiles of RNAi-Induced Gene Knockdown Are Highly Reproducible but Dominated by Seed Effects	PLOS ONE			English	Article							MULTIPARAMETRIC PROFILES; TARGET IDENTIFICATION; AUTOMATED MICROSCOPY; INTERFERENCE SCREENS; CELLULAR PHENOTYPES; IMAGE-ANALYSIS; LONG DSRNAS; RESPONSES; CELLS; SUPPRESSION	RNA interference and morphological profiling-the measurement of thousands of phenotypes from individual cells by microscopy and image analysis-are a potentially powerful combination. We show that morphological profiles of RNAi-induced knockdown using the Cell Painting assay are in fact highly sensitive and reproducible. However, we find that the magnitude and prevalence of off-target effects via the RNAi seed-based mechanism make morphological profiles of RNAi reagents targeting the same gene look no more similar than reagents targeting different genes. Pairs of RNAi reagents that share the same seed sequence produce image-based profiles that are much more similar to each other than profiles from pairs designed to target the same gene, a phenomenon previously observed in small-scale gene-expression profiling experiments. Various strategies have been used to enrich on-target versus off-target effects in the context of RNAi screening where a narrow set of phenotypes are measured, mostly based on comparing multiple sequences targeting the same gene; however, new approaches will be needed to make RNAi morphological profiling (that is, comparing multi-dimensional phenotypes) viable. We have shared our raw data and computational pipelines to facilitate research.	[Singh, Shantanu; Wu, Xiaoyun; Ljosa, Vebjorn; Bray, Mark-Anthony; Piccioni, Federica; Root, David E.; Doench, John G.; Boehm, Jesse S.; Carpenter, Anne E.] Broad Inst Harvard & MIT, Cambridge, MA 02142 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Carpenter, AE (corresponding author), Broad Inst Harvard & MIT, Cambridge, MA 02142 USA.	anne@broadinstitute.org	Bray, Mark/C-5973-2008; Singh, Shantanu/GZB-9333-2022; Doench, John G/HCI-9570-2022; Doench, John/ABE-6251-2020; Carpenter, Anne/C-4982-2008	Bray, Mark/0000-0002-9748-3592; Singh, Shantanu/0000-0001-5008-8950; Doench, John G/0000-0002-3707-9889; Doench, John/0000-0002-3707-9889; Carpenter, Anne/0000-0003-1555-8261; Boehm, Jesse/0000-0002-6795-6336	National Science Foundation (NSF CAREER) [DBI 1148823]; National Science Foundation (NSF RIG) [DBI 1119830]; Slim Initiative for Genomic Medicine - Carlos Slim Foundation in Mexico; Direct For Biological Sciences [1148823] Funding Source: National Science Foundation	National Science Foundation (NSF CAREER)(National Science Foundation (NSF)NSF - Office of the Director (OD)); National Science Foundation (NSF RIG); Slim Initiative for Genomic Medicine - Carlos Slim Foundation in Mexico; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	The work was supported by the National Science Foundation (NSF CAREER DBI 1148823, to Anne E. Carpenter; NSF RIG DBI 1119830 to MarkAnthony Bray) and the Slim Initiative for Genomic Medicine, a project funded by the Carlos Slim Foundation in Mexico. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams CL, 2006, METHOD ENZYMOL, V414, P440, DOI 10.1016/S0076-6879(06)14024-0; Birmingham A, 2009, NAT METHODS, V6, P569, DOI 10.1038/nmeth.1351; Bookout Angie L, 2006, Curr Protoc Mol Biol, VChapter 15, DOI 10.1002/0471142727.mb1508s73; Boutros M, 2008, NAT REV GENET, V9, P554, DOI 10.1038/nrg2364; Buehler E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051942; Buehler E, 2012, SCI REP-UK, V2, DOI 10.1038/srep00428; Bushman FD, 2009, SCIENCE, V5, DOI [10.1371/journal.ppat.1000437, DOI 10.1371/JOURNAL.PPAT.1000437]; Chung NJ, 2008, J BIOMOL SCREEN, V13, P149, DOI 10.1177/1087057107312035; Collinet C, 2010, NATURE, V464, P243, DOI 10.1038/nature08779; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Conrad C, 2010, J CELL BIOL, V188, P453, DOI 10.1083/jcb.200910105; Doench JG, 2003, GENE DEV, V17, P438, DOI 10.1101/gad.1064703; Echeverri CJ, 2006, NAT METHODS, V3, P777, DOI 10.1038/nmeth1006-777; Feng Y, 2009, NAT REV DRUG DISCOV, V8, P567, DOI 10.1038/nrd2876; Fischer B, 2015, ELIFE, V4, DOI 10.7554/eLife.05464; Franceschini A, 2014, P NATL ACAD SCI USA, V111, P4548, DOI 10.1073/pnas.1402353111; Fuchs F, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.25; Futamura Y, 2012, CHEM BIOL, V19, P1620, DOI 10.1016/j.chembiol.2012.10.014; Gustafsdottir SM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080999; Hannus M, 2014, NUCLEIC ACIDS RES, V42, P8049, DOI 10.1093/nar/gku480; Held M, 2010, NAT METHODS, V7, P747, DOI 10.1038/nmeth.1486; Horvath P, 2011, J BIOMOL SCREEN, V16, P1059, DOI 10.1177/1087057111414878; Jackson AL, 2006, RNA, V12, P1197, DOI 10.1261/rna.30706; Jackson AL, 2006, RNA, V12, P1179, DOI 10.1261/rna.25706; Jackson AL, 2010, NAT REV DRUG DISCOV, V9, P57, DOI 10.1038/nrd3010; Jackson AL, 2003, NAT BIOTECHNOL, V21, P635, DOI 10.1038/nbt831; Jones TR, 2009, P NATL ACAD SCI USA, V106, P1826, DOI 10.1073/pnas.0808843106; Kamentsky L, 2011, BIOINFORMATICS, V27, P1179, DOI 10.1093/bioinformatics/btr095; Kepp O, 2011, NAT REV DRUG DISCOV, V10, P221, DOI 10.1038/nrd3373; Kittler R, 2007, NAT METHODS, V4, P337, DOI 10.1038/NMETH1025; Kulkarni MM, 2006, NAT METHODS, V3, P833, DOI 10.1038/nmeth935; Laufer C, 2013, NAT METHODS, V10, P427, DOI [10.1038/NMETH.2436, 10.1038/nmeth.2436]; Liberali P, 2014, CELL, V157, P1473, DOI 10.1016/j.cell.2014.04.029; Ljosa V, 2013, J BIOMOL SCREEN, V18, P1321, DOI 10.1177/1087057113503553; Loo LH, 2007, NAT METHODS, V4, P445, DOI 10.1038/NMETH1032; Loo LH, 2009, NAT METHODS, V6, P759, DOI [10.1038/NMETH.1375, 10.1038/nmeth.1375]; Ma Y, 2006, NATURE, V443, P359, DOI 10.1038/nature05179; Misselwitz B, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-30; Moffat J, 2007, TRENDS PHARMACOL SCI, V28, P149, DOI 10.1016/j.tips.2007.02.009; Mohr S, 2010, ANNU REV BIOCHEM, V79, P37, DOI 10.1146/annurev-biochem-060408-092949; Mohr SE, 2014, NAT REV MOL CELL BIO, V15, P591, DOI 10.1038/nrm3860; Panda D, 2012, CURR OPIN VIROL, V2, P784, DOI 10.1016/j.coviro.2012.10.007; Perlman ZE, 2004, SCIENCE, V306, P1194, DOI 10.1126/science.1100709; Ramo P, 2009, BIOINFORMATICS, V25, P3028, DOI 10.1093/bioinformatics/btp524; Schultz Nikolaus, 2011, Silence, V2, P3, DOI 10.1186/1758-907X-2-3; Shao DD, 2013, GENOME RES, V23, P665, DOI 10.1101/gr.143586.112; Sigoillot FD, 2012, NAT METHODS, V9, P363, DOI [10.1038/NMETH.1898, 10.1038/nmeth.1898]; Sigoillot FD, 2011, ACS CHEM BIOL, V6, P47, DOI 10.1021/cb100358f; Simeone A, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003801; Singh S, 2014, J BIOMOL SCREEN, V19, P640, DOI 10.1177/1087057114528537; Slacka MD, 2008, P NATL ACAD SCI USA, V105, P19306, DOI 10.1073/pnas.0807038105; Snijder B, 2013, NAT METHODS, V10, P1089, DOI [10.1038/NMETH.2655, 10.1038/nmeth.2655]; Snijder B, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.9; Sommer C, 2013, J CELL SCI, V126, P5529, DOI 10.1242/jcs.123604; Sundaramurthy V, 2014, NAT PROTOC, V9, P474, DOI 10.1038/nprot.2014.027; Sundaramurthy V, 2013, CELL HOST MICROBE, V13, P129, DOI 10.1016/j.chom.2013.01.008; Wawer MJ, 2014, P NATL ACAD SCI USA, V111, P10911, DOI 10.1073/pnas.1410933111; Yang XP, 2011, NAT METHODS, V8, P659, DOI [10.1038/NMETH.1638, 10.1038/nmeth.1638]; Young DW, 2008, NAT CHEM BIOL, V4, P59, DOI 10.1038/nchembio.2007.53; Zhong R, 2014, NUCLEIC ACIDS RES, V42, P8214, DOI 10.1093/nar/gku306	60	22	23	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0131370	10.1371/journal.pone.0131370	http://dx.doi.org/10.1371/journal.pone.0131370			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LZ	26197079	Green Submitted, gold, Green Published			2022-12-26	WOS:000358547600011
J	Copen, WA; Morais, LT; Wu, O; Schwamm, LH; Schaefer, PW; Gonzalez, RG; Yoo, AJ				Copen, William A.; Morais, Livia T.; Wu, Ona; Schwamm, Lee H.; Schaefer, Pamela W.; Gonzalez, R. Gilberto; Yoo, Albert J.			In Acute Stroke, Can CT Perfusion-Derived Cerebral Blood Volume Maps Substitute for Diffusion-Weighted Imaging in Identifying the Ischemic Core?	PLOS ONE			English	Article							ACUTE HEMISPHERIC STROKE; COMPUTED-TOMOGRAPHY; HYPERACUTE STROKE; INFARCT CORE; MRI; BRAIN; FLOW; REPERFUSION; THRESHOLDS; THROMBOLYSIS	Background and Purpose In the treatment of patients with suspected acute ischemic stroke, increasing evidence suggests the importance of measuring the volume of the irreversibly injured "ischemic core." The gold standard method for doing this in the clinical setting is diffusion-weighted magnetic resonance imaging (DWI), but many authors suggest that maps of regional cerebral blood volume (CBV) derived from computed tomography perfusion imaging (CTP) can substitute for DWI. We sought to determine whether DWI and CTP-derived CBV maps are equivalent in measuring core volume. Methods 58 patients with suspected stroke underwent CTP and DWI within 6 hours of symptom onset. We measured low-CBV lesion volumes using three methods: "objective absolute," i.e. the volume of tissue with CBV below each of six published absolute thresholds (0.9-2.5 mL/100 g), "objective relative," whose six thresholds (51%-60%) were fractions of mean contralateral CBV, and "subjective," in which two radiologists (R1, R2) outlined lesions subjectively. We assessed the sensitivity and specificity of each method, threshold, and radiologist in detecting infarction, and the degree to which each over-or underestimated the DWI core volume. Additionally, in the subset of 32 patients for whom follow-up CT or MRI was available, we measured the proportion of CBV- or DWI-defined core lesions that exceeded the follow-up infarct volume, and the maximum amount by which this occurred. Results DWI was positive in 72% (42/58) of patients. CBV maps' sensitivity/specificity in identifying DWI-positive patients were 100%/0% for both objective methods with all thresholds, 43%/94% for R1, and 83%/44% for R2. Mean core overestimation was 156-699 mL for objective absolute thresholds, and 127-200 mL for objective relative thresholds. For R1 and R2, respectively, mean +/- SD subjective overestimation were -11 +/- 26 mL and -11 +/- 23 mL, but subjective volumes differed from DWI volumes by up to 117 and 124 mL in individual patients. Inter-rater agreement regarding the presence of infarction on CBV maps was poor (kappa = 0.21). Core lesions defined by the six objective absolute CBV thresholds exceeded followup infarct volumes for 81%-100% of patients, by up to 430-1002 mL. Core estimates produced by objective relative thresholds exceeded follow-up volumes in 91% of patients, by up to 210-280 mL. Subjective lesions defined by R1 and R2 exceeded follow-up volumes in 18% and 26% of cases, by up to 71 and 15 mL, respectively. Only 1 of 23 DWI lesions (4%) exceeded final infarct volume, by 3 mL. Conclusion CTP-derived CBV maps cannot reliably substitute for DWI in measuring core volume, or even establish which patients have DWI lesions.	[Copen, William A.; Morais, Livia T.; Wu, Ona; Schaefer, Pamela W.; Gonzalez, R. Gilberto; Yoo, Albert J.] Massachusetts Gen Hosp, Dept Radiol, Div Neuroradiol, Boston, MA 02115 USA; [Schwamm, Lee H.] Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA; [Copen, William A.; Wu, Ona; Schwamm, Lee H.; Schaefer, Pamela W.; Gonzalez, R. Gilberto; Yoo, Albert J.] Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Copen, WA (corresponding author), Massachusetts Gen Hosp, Dept Radiol, Div Neuroradiol, Boston, MA 02115 USA.	wcopen@partners.org	Schaefer, Pamela/AAA-1323-2019	Wu, Ona/0000-0002-5509-9461	National Institutes of Health [R01NS059775]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS059775] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health grant R01NS059775 to OW and WAC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albers GW, 2006, ANN NEUROL, V60, P508, DOI 10.1002/ana.20976; American Association of Physicists in Medicine, 2012, AD BRAIN PERF CT PRO; American College of Radiology American Society for Neuroradiology Society for Pediatric Radiology, 2012, ACR ASNR SPR PRACTIC; Baron JC, 2001, CEREBROVASC DIS, V11, P2, DOI 10.1159/000049119; Bivard A, 2013, RADIOLOGY, V267, P543, DOI 10.1148/radiol.12120971; Bivard A, 2011, BRAIN, V134, P3408, DOI 10.1093/brain/awr257; Bivard A, 2011, CEREBROVASC DIS, V31, P238, DOI 10.1159/000321897; Boutelier T, 2012, IEEE T MED IMAGING, V31, P1381, DOI 10.1109/TMI.2012.2189890; Campbell BCV, 2011, STROKE, V42, P3435, DOI 10.1161/STROKEAHA.111.618355; Chemmanam T, 2010, NEUROLOGY, V75, P1040, DOI 10.1212/WNL.0b013e3181f39ab6; Copen WA, 2015, AM J NEURORADIOL, V36, P638, DOI 10.3174/ajnr.A4186; Delpolyi AR, 2012, J MAGN RESON IMAGING, V36, P1083, DOI 10.1002/jmri.23740; Derdeyn CP, 2002, BRAIN, V125, P595, DOI 10.1093/brain/awf047; Eastwood JD, 2003, AM J NEURORADIOL, V24, P1869; GE Healthcare Publications, 2011, GE HEALTHCARE PUBLIC; Ginde AA, 2008, ACAD EMERG MED, V15, P780, DOI 10.1111/j.1553-2712.2008.00192.x; Grandin CB, 2001, STROKE, V32, P1147, DOI 10.1161/01.STR.32.5.1147; Grant PE, 2001, RADIOLOGY, V221, P43, DOI 10.1148/radiol.2211001523; Jauch EC, 2013, STROKE, V44, P870, DOI 10.1161/STR.0b013e318284056a; JONES TH, 1981, J NEUROSURG, V54, P773, DOI 10.3171/jns.1981.54.6.0773; Kamalian S, 2011, STROKE, V42, P1923, DOI 10.1161/STROKEAHA.110.610618; Karonen JO, 2000, RADIOLOGY, V217, P886, DOI 10.1148/radiology.217.3.r00dc02886; Kudo K, 2013, RADIOLOGY, V267, P201, DOI 10.1148/radiol.12112618; Kudo K, 2010, RADIOLOGY, V254, P200, DOI 10.1148/radiol.254082000; Lansberg MG, 2012, LANCET NEUROL, V11, P860, DOI 10.1016/S1474-4422(12)70203-X; MOSELEY ME, 1990, MAGN RESON MED, V14, P330, DOI 10.1002/mrm.1910140218; Nagar VA, 2009, AM J ROENTGENOL, V193, P1629, DOI 10.2214/AJR.09.2664; Parsons M, 2012, NEW ENGL J MED, V366, P1099, DOI 10.1056/NEJMoa1109842; POWERS WJ, 1991, ANN NEUROL, V29, P231, DOI 10.1002/ana.410290302; Reese TG, 2003, MAGN RESON MED, V49, P177, DOI 10.1002/mrm.10308; Sanak D, 2006, NEURORADIOLOGY, V48, P632, DOI 10.1007/s00234-006-0105-0; Schaefer PW, 2008, STROKE, V39, P2986, DOI 10.1161/STROKEAHA.107.513358; Sorensen AG, 1999, RADIOLOGY, V210, P519, DOI 10.1148/radiology.210.2.r99fe06519; Thomalla G, 2010, ANN NEUROL, V68, P435, DOI 10.1002/ana.22125; Ueda T, 1999, J CEREBR BLOOD F MET, V19, P99, DOI 10.1097/00004647-199901000-00011; WESTGARD JO, 1973, CLIN CHEM, V19, P49; Wintermark M, 2006, STROKE, V37, P979, DOI 10.1161/01.STR.0000209238.61459.39; Wintermark M, 2004, AM J NEURORADIOL, V25, P720; Wintermark M, 2002, STROKE, V33, P2025, DOI 10.1161/01.STR.0000023579.61630.AC; Wintermark M, 2013, J AM COLL RADIOL, V10, P828, DOI [10.1016/j.jacr.2013.06.019, 10.3174/ajnr.A3690]; Yoo AJ, 2009, STROKE, V40, P2046, DOI 10.1161/STROKEAHA.108.541656	41	28	28	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2015	10	7							e0133566	10.1371/journal.pone.0133566	http://dx.doi.org/10.1371/journal.pone.0133566			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LN	26193486	gold, Green Published, Green Submitted			2022-12-26	WOS:000358546400103
J	Glaser, JI; Zamft, BM; Church, GM; Kording, KP				Glaser, Joshua I.; Zamft, Bradley M.; Church, George M.; Kording, Konrad P.			Puzzle Imaging: Using Large-Scale Dimensionality Reduction Algorithms for Localization	PLOS ONE			English	Article							CONNECTIVITY; OPTIMIZATION	Current high-resolution imaging techniques require an intact sample that preserves spatial relationships. We here present a novel approach, "puzzle imaging," that allows imaging a spatially scrambled sample. This technique takes many spatially disordered samples, and then pieces them back together using local properties embedded within the sample. We show that puzzle imaging can efficiently produce high-resolution images using dimensionality reduction algorithms. We demonstrate the theoretical capabilities of puzzle imaging in three biological scenarios, showing that (1) relatively precise 3-dimensional brain imaging is possible; (2) the physical structure of a neural network can often be recovered based only on the neural connectivity matrix; and (3) a chemical map could be reproduced using bacteria with chemosensitive DNA and conjugative transfer. The ability to reconstruct scrambled images promises to enable imaging based on DNA sequencing of homogenized tissue samples.	[Glaser, Joshua I.; Kording, Konrad P.] Northwestern Univ, Dept Phys Med & Rehabil, Chicago, IL 60611 USA; [Glaser, Joshua I.; Kording, Konrad P.] Rehabil Inst Chicago, Chicago, IL 60611 USA; [Zamft, Bradley M.; Church, George M.] Harvard Univ, Sch Med, Dept Genet, Boston, MA USA; [Kording, Konrad P.] Northwestern Univ, Dept Physiol, Chicago, IL 60611 USA; [Kording, Konrad P.] Northwestern Univ, Dept Appl Math, Chicago, IL 60611 USA	Northwestern University; Shirley Ryan AbilityLab; Harvard University; Harvard Medical School; Northwestern University; Northwestern University	Glaser, JI (corresponding author), Northwestern Univ, Dept Phys Med & Rehabil, Chicago, IL 60611 USA.	j-glaser@u.northwestern.edu	; Kording, Konrad/A-1233-2007	church, george/0000-0001-6232-9969; Kording, Konrad/0000-0001-8408-4499	NIH [5R01MH103910, T32 HD057845, 5R01NS063399, P01NS044393, 1R01NS074044]; Office of Naval Research; NIH Centers of Excellence in Genomic Science; Chicago Biomedical Consortium; Searle Funds at The Chicago Community Trust; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD057845] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH103910] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS074044, P01NS044393] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Office of Naval Research(Office of Naval Research); NIH Centers of Excellence in Genomic Science(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Chicago Biomedical Consortium; Searle Funds at The Chicago Community Trust; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Joshua Glaser was supported by NIH grant 5R01MH103910 and NIH grant T32 HD057845. Bradley Zamft was supported by NIH grant 5R01MH103910. George Church acknowledges support from the Office of Naval Research and the NIH Centers of Excellence in Genomic Science. Konrad Kording is funded in part by the Chicago Biomedical Consortium with support from the Searle Funds at The Chicago Community Trust, and is also supported by NIH grants 5R01NS063399, P01NS044393, and 1R01NS074044. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Carr PA, 2009, NAT BIOTECHNOL, V27, P1151, DOI 10.1038/nbt.1590; Chen BL, 2006, P NATL ACAD SCI USA, V103, P4723, DOI 10.1073/pnas.0506806103; Church GM, 2003, US Patent, Patent No. 20030228611; Coifman RR, 2006, APPL COMPUT HARMON A, V21, P5, DOI 10.1016/j.acha.2006.04.006; de Silva V., 2002, ADV NEURAL INFORM PR, V15, P705; De Silva V., 2004, TECHNICAL REPORT; Farzadfard F, 2014, SCIENCE, V346, P825, DOI 10.1126/science.1256272; FREDMAN ML, 1987, J ACM, V34, P596, DOI 10.1145/28869.28874; Friedland AE, 2009, SCIENCE, V324, P1199, DOI 10.1126/science.1172005; Gerlach C, 2013, SCIENCE, V340, P635, DOI 10.1126/science.1235487; Glaser JI, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003145; Golub G. H., 2012, MATRIX COMPUTATIONS, V3; GROSSMAN N, 1982, J BACTERIOL, V152, P35; Hellwig B, 2000, BIOL CYBERN, V82, P111, DOI 10.1007/PL00007964; Kaplan H., 2006, Proceedings of the Twenty-Second Annual Symposium on Computational Geometry (SCG'06), P52, DOI 10.1145/1137856.1137866; Kording KP, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002291; KRUSKAL JB, 1964, PSYCHOMETRIKA, V29, P1, DOI 10.1007/BF02289565; Lee JH, 2014, SCIENCE, V343, P1360, DOI 10.1126/science.1250212; LILEY DTJ, 1994, NETWORK-COMP NEURAL, V5, P175, DOI 10.1088/0954-898X/5/2/004; Marblestone A.H., 2014, ARXIV14045103; Marblestone AH, 2013, CONNECONOMICS EC LAR; Moser F, 2013, ACS SYNTH BIOL, V2, P614, DOI 10.1021/sb400086p; Nakano M, 2003, J BIOTECHNOL, V102, P117, DOI 10.1016/S0168-1656(03)00023-3; Peikon ID, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku604; Perge JA, 2012, J NEUROSCI, V32, P626, DOI 10.1523/JNEUROSCI.4254-11.2012; Ponciano JM, 2007, GENETICS, V176, P957, DOI 10.1534/genetics.106.061937; Tenenbaum JB, 2000, SCIENCE, V290, P2319, DOI 10.1126/science.290.5500.2319; Usoskin D, 2015, NAT NEUROSCI, V18, P145, DOI 10.1038/nn.3881; Van Der Maaten L., 2009, J MACH LEARN RES, V10, P66, DOI DOI 10.1080/13506280444000102; WILLETTS N, 1980, ANNU REV GENET, V14, P41, DOI 10.1146/annurev.ge.14.120180.000353; Yuster R, 2005, ACM T ALGORITHMS, V1, P2, DOI 10.1145/1077464.1077465; Zador AM, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001411; Zamft BM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043876	33	4	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2015	10	7							e0131593	10.1371/journal.pone.0131593	http://dx.doi.org/10.1371/journal.pone.0131593			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LN	26192446	Green Published, Green Submitted, gold			2022-12-26	WOS:000358546400013
J	Morais, ICO; Pereira, GJS; Orzaez, M; Jorge, RJB; Bincoletto, C; Toyama, MH; Monteiro, HSA; Smaili, SS; Perez-Paya, E; Martins, AMC				Morais, Isabel C. O.; Pereira, Gustavo J. S.; Orzaez, M.; Jorge, Roberta J. B.; Bincoletto, Claudia; Toyama, Marcos H.; Monteiro, Helena S. A.; Smaili, Soraya S.; Perez-Paya, Enrique; Martins, Alice M. C.			L-Aminoacid Oxidase from Bothrops leucurus Venom Induces Nephrotoxicity via Apoptosis and Necrosis	PLOS ONE			English	Article							SNAKE-VENOM; CYTOTOXICITY; PURIFICATION; MOOJENI; STRESS; CELLS	Acute renal failure is a common complication caused by Bothrops viper envenomation. In this study, the nefrotoxicity of a main component of B. leucurus venom called L-aminoacid oxidase (LAAO-Bl) was evaluated by using tubular epithelial cell lines MDCK and HK-2 and perfused kidney from rats. LAAO-Bl exhibited cytotoxicity, inducing apoptosis and necrosis in MDCK and HK-2 cell lines in a concentration-dependent manner. MDCK apoptosis induction was accompanied by Ca2+ release from the endoplasmic reticulum, reactive oxygen species (ROS) generation and mitochondrial dysfunction with enhanced expression of Bax protein levels. LAAO-Bl induced caspase-3 and caspase-7 activation in both cell lines. LAAO-Bl (10 mu g/mL) exerts significant effects on the isolated kidney perfusion increasing perfusion pressure and urinary flow and decreasing the glomerular filtration rate and sodium, potassium and chloride tubular transport. Taken together our results suggest that LAAO-Bl is responsible for the nephrotoxicity observed in the envenomation by snakebites. Moreover, the cytotoxic of LAAO-Bl to renal epithelial cells might be responsible, at least in part, for the nephrotoxicity observed in isolated kidney.	[Morais, Isabel C. O.; Jorge, Roberta J. B.; Monteiro, Helena S. A.] Univ Fed Ceara, Fac Med, Dept Physiol & Pharmacol, Fortaleza, Ceara, Brazil; [Pereira, Gustavo J. S.; Bincoletto, Claudia; Smaili, Soraya S.] Univ Fed Sao Paulo, Dept Pharmacol, Sao Paulo, Brazil; [Orzaez, M.; Perez-Paya, Enrique] Ctr Invest Principe Felipe, Dept Med Chem, Valencia, Spain; [Toyama, Marcos H.] Univ Estadual Paulista, Sao Vicente Unit, Sao Paulo, Brazil; [Martins, Alice M. C.] Univ Fed Ceara, Dept Clin & Toxicol Anal, Fortaleza, Ceara, Brazil	Universidade Federal do Ceara; Universidade Federal de Sao Paulo (UNIFESP); Prince Felipe Research Center; Universidade Estadual Paulista; Universidade Federal do Ceara	Martins, AMC (corresponding author), Univ Fed Ceara, Dept Clin & Toxicol Anal, Fortaleza, Ceara, Brazil.	martinsalice@gmail.com	Toyama, Marcos H/P-4673-2017; JORGE, ROBERTA/AAP-5733-2021; Martins, Alice Maria Costa/AAX-3093-2020; Orzaez, Mar/B-4992-2014; Smaili, Soraya/AAH-2129-2019; Pereira, Gustavo José Silva/ABH-1344-2020; Bincoletto, Claudia/H-4936-2012; Pereira, Gustavo/H-4636-2012	Toyama, Marcos H/0000-0001-6836-3084; Orzaez, Mar/0000-0003-3231-5835; Smaili, Soraya/0000-0001-5844-1368; Pereira, Gustavo José Silva/0000-0002-6765-1276; Bincoletto, Claudia/0000-0001-6666-3673; Pereira, Gustavo/0000-0002-1789-3541; Jorge, Roberta/0000-0002-2703-4302	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior By ICOM Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [08/11515-3, 10/51647-6]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), AMCM HSAM; Fundacao de Amparo a Pesquisa do Estado do Ceara (FUNCAP), AMCM HSAM; Centro de Investigacion Principe Felipe, Valencia, Spain, MOC EPP; CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior Brazilian Ministry of Education)	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior By ICOM Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), AMCM HSAM(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado do Ceara (FUNCAP), AMCM HSAM; Centro de Investigacion Principe Felipe, Valencia, Spain, MOC EPP; CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior Brazilian Ministry of Education)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by grants provided by the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior By ICOM Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) (08/11515-3 by SSS; 10/51647-6 by CB), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) by AMCM HSAM, Fundacao de Amparo a Pesquisa do Estado do Ceara (FUNCAP) by AMCM HSAM, Centro de Investigacion Principe Felipe, Valencia, Spain by MOC EPP. Isabel C. O. Morais gratefully acknowledges CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior Brazilian Ministry of Education) for providing a 1-year scholarship to perform this study at Centro de Investigacion Principe Felipe, Valencia, Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Paiva RDA, 2011, BIOCHIMIE, V93, P941, DOI 10.1016/j.biochi.2011.01.009; Alves RM, 2008, COMP BIOCHEM PHYS A, V151, P542, DOI 10.1016/j.cbpa.2008.07.007; Barbosa PSF, 2006, TOXICON, V47, P831, DOI 10.1016/j.toxicon.2006.01.012; Barbosa PS, 2005, TOXICON, V4, P376; BOWMAN RH, 1970, J BIOL CHEM, V245, P1604; Campos LB, 2013, TOXICON, V76, P1, DOI 10.1016/j.toxicon.2013.08.063; Cao SS, 2014, ANTIOXID REDOX SIGN, V21, P396, DOI 10.1089/ars.2014.5851; Ciscotto P, 2009, TOXICON, V53, P330, DOI 10.1016/j.toxicon.2008.12.004; Collares-Buzato CB, 2002, TOXICOL APPL PHARM, V181, P124, DOI 10.1006/taap.2002.9404; de Castroa I, 2004, TOXICON, V43, P833, DOI 10.1016/j.toxicon.2004.03.015; de Moura Andrea A, 2014, Biomed Res Int, V2014, P195356, DOI 10.1155/2014/195356; Deolindo P, 2010, TOXICON, V56, P944, DOI 10.1016/j.toxicon.2010.06.019; Guo CM, 2012, TOXICON, V60, P302, DOI 10.1016/j.toxicon.2012.05.001; Havt A, 2005, INT J BIOCHEM CELL B, V37, P130, DOI 10.1016/j.biocel.2004.06.003; Joo HK, 2014, MITOCHONDRION, V17, P42, DOI 10.1016/j.mito.2014.05.006; Lee ML, 2014, INT J MED SCI, V11, P593, DOI 10.7150/ijms.8096; Lin M, 2014, INT J MOL SCI, V15, P12507, DOI 10.3390/ijms150712507; Liu DM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068770; Braga MDM, 2008, TOXICON, V51, P199, DOI 10.1016/j.toxicon.2007.09.003; Braga MDM, 2007, TOXICON, V49, P329, DOI 10.1016/j.toxicon.2006.10.005; Braga MDM, 2006, TOXICON, V47, P859, DOI 10.1016/j.toxicon.2006.02.016; Marcussi S, 2013, TOXICON, V65, P9, DOI 10.1016/j.toxicon.2012.12.020; Martines MS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086828; Mello CP, 2014, TOXICON, V88, P107, DOI 10.1016/j.toxicon.2014.05.009; Mondragon L, 2008, J MED CHEM, V51, P521, DOI 10.1021/jm701195j; Naumann GB, 2011, BBA-GEN SUBJECTS, V1810, P683, DOI 10.1016/j.bbagen.2011.04.003; de Morais ICO, 2013, TOXICON, V61, P38, DOI 10.1016/j.toxicon.2012.10.005; Samel M, 2006, BBA-PROTEINS PROTEOM, V1764, P707, DOI 10.1016/j.bbapap.2006.01.021; Sitprija V, 2012, TOXICON, V60, P943, DOI 10.1016/j.toxicon.2012.06.012; Smaili SS, 1999, CELL CALCIUM, V26, P121, DOI 10.1054/ceca.1999.0061; Sousa LF, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002442; Stabeli RG, 2007, INT J BIOL MACROMOL, V41, P132, DOI 10.1016/j.ijbiomac.2007.01.006; Sun LK, 2003, TOXICOL IN VITRO, V17, P169, DOI 10.1016/S0887-2333(03)00010-9; Sun MZ, 2010, BIOCHIMIE, V92, P343, DOI 10.1016/j.biochi.2010.01.013; Tan N.H., 2009, HDB VENOMS TOXINS RE, P219; Torii S, 2000, BIOCHEMISTRY-US, V39, P3197, DOI 10.1021/bi992416z; Torres AFC, 2010, J VENOM ANIM TOXINS, V16, P614, DOI 10.1590/S1678-91992010000400012; Toyama MH, 2006, TOXICON, V47, P47, DOI 10.1016/j.toxicon.2005.09.008; Zhang L, 2008, NAT PROD RES, V22, P554, DOI 10.1080/14786410701592679; Zhang L, 2007, LIFE SCI, V80, P1189, DOI 10.1016/j.lfs.2006.12.024	40	19	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2015	10	7							e0132569	10.1371/journal.pone.0132569	http://dx.doi.org/10.1371/journal.pone.0132569			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LN	26193352	Green Submitted, gold, Green Published			2022-12-26	WOS:000358546400030
J	Shiwaku, Y; Neff, L; Nagano, K; Takeyama, KI; de Bruijn, J; Dard, M; Gori, F; Baron, R				Shiwaku, Yukari; Neff, Lynn; Nagano, Kenichi; Takeyama, Ken-Ichi; de Bruijn, Joost; Dard, Michel; Gori, Francesca; Baron, Roland			The Crosstalk between Osteoclasts and Osteoblasts Is Dependent upon the Composition and Structure of Biphasic Calcium Phosphates	PLOS ONE			English	Article							BETA-TRICALCIUM PHOSPHATE; BONE-FORMATION; SPHINGOSINE 1-PHOSPHATE; SEALING ZONE; HYDROXYAPATITE; RESORPTION; ACTIVATION; DIFFERENTIATION; BIOMATERIALS; INHIBITION	Biphasic calcium phosphates (BCPs), consisting of hydroxyapatite (HA) and beta-tricalcium phosphate (beta-TCP), exhibit good biocompatibility and osteoconductivity, maintaining a balance between resorption of the biomaterial and formation of new bone. We tested whether the chemical composition and/or the microstructure of BCPs affect osteoclasts (OCs) differentiation and/or their ability to crosstalk with osteoblasts (OBs). To this aim, OCs were cultured on BCPs with HA content of 5, 20 or 60% and their differentiation and activity were assessed. We found that OC differentiation is partially impaired by increased HA content, but not by the presence of micropores within BCP scaffolds, as indicated by TRAP staining and gene profile expression. We then investigated whether the biomaterial-induced changes in OC differentiation also affect their ability to crosstalk with OBs and regulate OB function. We found that BCPs with low percentage of HA favored the expression of positive coupling factors, including sphingosine-kinase 1 (SPHK1) and collagen triple helix repeat containing 1 (Cthrc1). In turn, the increase of these secreted coupling factors promotes OB differentiation and function. All together our studies suggest that the chemical composition of biomaterials affects not only the differentiation and activity of OCs but also their potential to locally regulate bone formation.	[Shiwaku, Yukari; Neff, Lynn; Nagano, Kenichi; Takeyama, Ken-Ichi; Gori, Francesca; Baron, Roland] Harvard Univ, Sch Dent Med, Dept Oral Med Infect & Immun, Boston, MA 02115 USA; [Baron, Roland] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Med,Endocrine Unit, Boston, MA USA; [de Bruijn, Joost] Xpand Biotechnol BV, Bilthoven, Netherlands; [Dard, Michel] NYU, Coll Dent, Dept Periodontol & Implant Dent, New York, NY 10003 USA	Harvard University; Harvard School of Dental Medicine; Harvard University; Harvard Medical School; Massachusetts General Hospital; New York University	Baron, R (corresponding author), Harvard Univ, Sch Dent Med, Dept Oral Med Infect & Immun, 188 Longwood Ave, Boston, MA 02115 USA.	Roland_Baron@hsdm.harvard.edu	Gori, Francesca/S-9422-2019; Nagano, Kenichi/AAH-3246-2019	Nagano, Kenichi/0000-0003-3145-4841	Straumann	Straumann	This work was supported by Straumann in the form of research support for Dr. Baron's laboratory at Harvard.	Albiges-Rizo C, 2009, J CELL SCI, V122, P3037, DOI 10.1242/jcs.052704; Arinzeh TL, 2005, BIOMATERIALS, V26, P3631, DOI 10.1016/j.biomaterials.2004.09.035; Arnold M, 2004, CHEMPHYSCHEM, V5, P383, DOI 10.1002/cphc.200301014; Benahmed MD, 1996, J HISTOCHEM CYTOCHEM, V44, P1131, DOI 10.1177/44.10.8813078; Bose S, 2012, ACTA BIOMATER, V8, P1401, DOI 10.1016/j.actbio.2011.11.017; Bruzzaniti A, 2009, MOL CELL BIOL, V29, P3644, DOI 10.1128/MCB.00851-08; Cancedda R, 2007, BIOMATERIALS, V28, P4240, DOI 10.1016/j.biomaterials.2007.06.023; Costa-Rodrigues J, 2012, ACTA BIOMATER, V8, P1137, DOI 10.1016/j.actbio.2011.11.032; Davison NL, 2014, BIOMATERIALS, V35, P7441, DOI 10.1016/j.biomaterials.2014.05.048; Doi Y, 1999, J BIOMED MATER RES, V47, P424, DOI 10.1002/(SICI)1097-4636(19991205)47:3<424::AID-JBM19>3.0.CO;2-0; Duong LT, 2001, J BIOL CHEM, V276, P7484, DOI 10.1074/jbc.M008368200; FROST HM, 1969, CALC TISS RES, V3, P211, DOI 10.1007/BF02058664; Geblinger D, 2010, J CELL SCI, V123, P1503, DOI 10.1242/jcs.060954; Ghanaati S, 2012, BIOMED MATER, V7, DOI 10.1088/1748-6041/7/1/015005; GOMI K, 1993, BIOMATERIALS, V14, P91, DOI 10.1016/0142-9612(93)90216-O; Gonda Y, 2009, BIOMATERIALS, V30, P4390, DOI 10.1016/j.biomaterials.2009.05.002; Hannink G, 2011, INJURY, V42, pS22, DOI 10.1016/j.injury.2011.06.008; Henriksen K, 2014, CALCIFIED TISSUE INT, V94, P88, DOI 10.1007/s00223-013-9741-7; Jurdic P, 2006, EUR J CELL BIOL, V85, P195, DOI 10.1016/j.ejcb.2005.09.008; Keller J, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6215; Kim HM, 2001, J BIOMED MATER RES, V56, P250, DOI 10.1002/1097-4636(200108)56:2<250::AID-JBM1092>3.0.CO;2-S; LeGeros RZ, 2008, CHEM REV, V108, P4742, DOI 10.1021/cr800427g; Lotinun S, 2013, J CLIN INVEST, V123, P666, DOI 10.1172/JCI64840; Luxenburg C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000179; Manolagas SC, 2000, ENDOCR REV, V21, P115, DOI 10.1210/er.21.2.115; Martin TJ, 2005, TRENDS MOL MED, V11, P76, DOI 10.1016/j.molmed.2004.12.004; Mastrogiacomo M, 2007, BIOMATERIALS, V28, P1376, DOI 10.1016/j.biomaterials.2006.10.001; Matsuoka K, 2014, J BONE MINER RES, V29, P1522, DOI 10.1002/jbmr.2187; Matsuzaki E, 2013, BONE, V55, P315, DOI 10.1016/j.bone.2013.04.008; Monchau F, 2002, BIOMOL ENG, V19, P143, DOI 10.1016/S1389-0344(02)00023-0; Nakamura M, 2013, J BIOMED MATER RES A, V101, P3141, DOI 10.1002/jbm.a.34621; Negishi-Koga T, 2011, NAT MED, V17, P1473, DOI 10.1038/nm.2489; Okuda T, 2007, BIOMATERIALS, V28, P2612, DOI 10.1016/j.biomaterials.2007.01.040; Pederson L, 2008, P NATL ACAD SCI USA, V105, P20764, DOI 10.1073/pnas.0805133106; Quint P, 2013, J BIOL CHEM, V288, P5398, DOI 10.1074/jbc.M112.413583; Raynaud S, 2002, BIOMATERIALS, V23, P1065, DOI 10.1016/S0142-9612(01)00218-6; Reynolds Mark A, 2003, Ann Periodontol, V8, P227, DOI 10.1902/annals.2003.8.1.227; Ripamonti U, 2010, BIOMATERIALS, V31, P6400, DOI 10.1016/j.biomaterials.2010.04.037; Ryu J, 2006, EMBO J, V25, P5840, DOI 10.1038/sj.emboj.7601430; Saltel F, 2004, MOL BIOL CELL, V15, P5231, DOI 10.1091/mbc.E04-06-0522; Saltel F, 2008, EUR J CELL BIOL, V87, P459, DOI 10.1016/j.ejcb.2008.01.001; Sato C, 2012, BIOCHEM BIOPH RES CO, V423, P200, DOI 10.1016/j.bbrc.2012.05.130; Schilling AF, 2004, BIOMATERIALS, V25, P3963, DOI 10.1016/j.biomaterials.2003.10.079; Sims Natalie A, 2014, Bonekey Rep, V3, P481, DOI 10.1038/bonekey.2013.215; Takeshita S, 2013, J CLIN INVEST, V123, P3914, DOI 10.1172/JCI69493; Tanaka T, 2010, J BIOMED MATER RES A, V93A, P469, DOI 10.1002/jbm.a.32560; Yamada S, 1997, BIOMATERIALS, V18, P1037, DOI 10.1016/S0142-9612(97)00036-7; Zhao C, 2006, CELL METAB, V4, P111, DOI 10.1016/j.cmet.2006.05.012	48	35	37	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2015	10	7							e0132903	10.1371/journal.pone.0132903	http://dx.doi.org/10.1371/journal.pone.0132903			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LN	26193362	gold, Green Published, Green Submitted			2022-12-26	WOS:000358546400042
J	Bozin, I; Ge, YL; Kuchling, J; Dusek, P; Chawla, S; Harms, L; Ruprecht, K; Niendorf, T; Paul, F; Kister, I; Sinnecker, T; Wuerfel, J				Bozin, Ivan; Ge, Yulin; Kuchling, Joseph; Dusek, Petr; Chawla, Sanjeev; Harms, Lutz; Ruprecht, Klemens; Niendorf, Thoralf; Paul, Friedemann; Kister, Ilya; Sinnecker, Tim; Wuerfel, Jens			Magnetic Resonance Phase Alterations in Multiple Sclerosis Patients with Short and Long Disease Duration	PLOS ONE			English	Article							7 TESLA; BIOPHYSICAL MECHANISMS; LESION MORPHOLOGY; IRON DEPOSITION; MRI; MATTER; CONTRAST; DAMAGE	Objective The analysis of the MR phase provides additional information on the tissue microstructure. In multiple sclerosis (MS) lesions phase alterations may reflect different stages of inflammatory activity. Here we investigated lesion morphology in MS patients with short and long disease duration on T2* weighted, phase, magnitude and susceptibility weighted imaging (SWI) at 7 Tesla (T). Methods 17 MS or clinically isolated syndrome patients with short (<60 months) and 11 with long (>60 months) disease duration underwent 7T MRI. Lesions were subsequently analyzed side-by-side with regard to morphology and visibility on T2* weighted, SWI, magnitude and SWI-filtered phase images. Results 126 of 192 T2* weighted lesions (65.6%) were characterized by a phase alteration pattern, and hence could be differentiated on phase images. In detail, a significantly reduced proportion of lesions showing phase alterations was detectable in patients with longer disease duration (mean +/- SD 51 +/- 37%, range 0-100%) compared to patients with short disease duration (mean +/- SD 90 +/- 19.5%, range 50-100%, p = 0.003). Conclusion This cross-sectional study identified different patterns of phase changes in lesions of MS patients with short and long standing disease. Longitudinal studies are warranted to prove that MR phase imaging is useful in determining the activity and the developmental stage of individual MS plaques.	[Bozin, Ivan; Kuchling, Joseph; Paul, Friedemann; Sinnecker, Tim; Wuerfel, Jens] Charite, NeuroCure Clin Res Ctr, D-13353 Berlin, Germany; [Ge, Yulin; Chawla, Sanjeev] NYU, Sch Med, Dept Radiol, New York, NY USA; [Dusek, Petr; Wuerfel, Jens] Univ Med Goettingen, Inst Neuroradiol, Gottingen, Germany; [Dusek, Petr] Charles Univ Prague, Fac Med 1, Dept Neurol, Prague, Czech Republic; [Dusek, Petr] Charles Univ Prague, Fac Med 1, Ctr Clin Neurosci, Prague, Czech Republic; [Dusek, Petr] Gen Univ Hosp, Prague, Czech Republic; [Harms, Lutz; Ruprecht, Klemens; Paul, Friedemann] Charite, Clin & Expt Multiple Sclerosis Res Ctr, D-13353 Berlin, Germany; [Harms, Lutz; Ruprecht, Klemens; Paul, Friedemann] Charite, Dept Neurol, D-13353 Berlin, Germany; [Niendorf, Thoralf; Wuerfel, Jens] Max Delbrueck Ctr Mol Med, Berlin Ultrahigh Field Facil, Berlin, Germany; [Niendorf, Thoralf; Paul, Friedemann; Wuerfel, Jens] Charite, Expt & Clin Res Ctr, D-13353 Berlin, Germany; [Niendorf, Thoralf; Paul, Friedemann; Wuerfel, Jens] Max Delbrueck Ctr Mol Med, Berlin, Germany; [Kister, Ilya] NYU, Sch Med, Dept Neurol, Multiple Sclerosis Care Ctr, New York, NY USA; [Sinnecker, Tim] Asklepios Fachklinikum Teupitz, Dept Neurol, Teupitz, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; New York University; Charles University Prague; Charles University Prague; General University Hospital Prague; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Helmholtz Association; Max Delbruck Center for Molecular Medicine; New York University	Paul, F (corresponding author), Charite, NeuroCure Clin Res Ctr, D-13353 Berlin, Germany.	friedemann.paul@charite.de	Ge, Yulin/L-7052-2019; Ge, Yulin/D-9060-2019; Paul, Friedemann/ABF-9415-2020; Dusek, Petr/F-9084-2017	Ge, Yulin/0000-0002-2320-6031; Dusek, Petr/0000-0003-4877-9642; Kister, Ilya/0000-0003-3549-949X; paul, friedemann/0000-0002-6378-0070; Wuerfel, Jens/0000-0002-0034-8053	German Research Foundation [DFG Exc 257]; German Ministry of Education and Research (Competence Network Multiple Sclerosis KKNMS); Guthy Jackson Charitable Foundation/the National Multiple Sclerosis Society of the USA	German Research Foundation(German Research Foundation (DFG)); German Ministry of Education and Research (Competence Network Multiple Sclerosis KKNMS); Guthy Jackson Charitable Foundation/the National Multiple Sclerosis Society of the USA	This work was supported by the German Research Foundation (DFG Exc 257 to F.P.) and by the German Ministry of Education and Research (Competence Network Multiple Sclerosis KKNMS to F.P. and J.W.) and a research grant from the Guthy Jackson Charitable Foundation/the National Multiple Sclerosis Society of the USA (F.P. and J.W.).	Absinta M, 2013, ANN NEUROL, V74, P669, DOI 10.1002/ana.23959; ADAMS CWM, 1988, J NEUROL NEUROSUR PS, V51, P260, DOI 10.1136/jnnp.51.2.260; Bagnato F, 2011, BRAIN, V134, P3599, DOI 10.1093/brain/awr278; Bakshi R, 2002, ARCH NEUROL-CHICAGO, V59, P62, DOI 10.1001/archneur.59.1.62; Bian W, 2013, MULT SCLER J, V19, P69, DOI 10.1177/1352458512447870; Chen WW, 2014, RADIOLOGY, V271, P183, DOI 10.1148/radiol.13130353; Connor JR, 1996, GLIA, V17, P83, DOI 10.1002/(SICI)1098-1136(199606)17:2<83::AID-GLIA1>3.0.CO;2-7; CRAELIUS W, 1982, ARCH PATHOL LAB MED, V106, P397; de Graaf WL, 2012, EUR RADIOL, V22, P221, DOI 10.1007/s00330-011-2242-z; Dixon JE, 2013, EUR J RADIOL, V82, P719, DOI 10.1016/j.ejrad.2011.09.023; Duyn JH, 2007, P NATL ACAD SCI USA, V104, P11796, DOI 10.1073/pnas.0610821104; Ge YL, 2009, J MAGN RESON IMAGING, V29, P1190, DOI 10.1002/jmri.21758; Grabner G, 2011, J MAGN RESON IMAGING, V33, P543, DOI 10.1002/jmri.22452; Haacke EM, 2009, AM J NEURORADIOL, V30, P19, DOI 10.3174/ajnr.A1400; Haacke EM, 2009, J MAGN RESON IMAGING, V29, P537, DOI 10.1002/jmri.21676; Haacke EM, 2005, MAGN RESON IMAGING, V23, P1, DOI 10.1016/j.mri.2004.10.001; Hametner S, 2013, ANN NEUROL, V74, P848, DOI 10.1002/ana.23974; He X, 2009, P NATL ACAD SCI USA, V106, P13558, DOI 10.1073/pnas.0904899106; Kuchling J, 2014, MULT SCLER J, V20, P1866, DOI 10.1177/1352458514531084; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Li W, 2011, NEUROIMAGE, V55, P1645, DOI 10.1016/j.neuroimage.2010.11.088; Mehta V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057573; Mistry N, 2013, JAMA NEUROL, V70, P623, DOI 10.1001/jamaneurol.2013.1405; Muller K, 2014, J NEUROL, V261, P2032, DOI 10.1007/s00415-014-7460-2; Nielsen AS, 2012, J MAGN RESON IMAGING, V35, P537, DOI 10.1002/jmri.22847; Pitt D, 2010, ARCH NEUROL-CHICAGO, V67, P812, DOI 10.1001/archneurol.2010.148; Polman CH, 2011, ANN NEUROL, V69, P292, DOI 10.1002/ana.22366; Sinnecker T, 2015, EUR RADIOL, V25, P122, DOI 10.1007/s00330-014-3358-8; Sinnecker T, 2013, MULT SCLER J, V19, P316, DOI 10.1177/1352458512451941; Sinnecker T, 2012, NEUROLOGY, V79, P708, DOI 10.1212/WNL.0b013e3182648bc8; Sinnecker T, 2012, ARCH NEUROL-CHICAGO, V69, P739, DOI 10.1001/archneurol.2011.2450; Stephenson E, 2014, NAT REV NEUROL, V10, P459, DOI 10.1038/nrneurol.2014.118; Sukstanskii AL, 2014, MAGN RESON MED, V71, P345, DOI 10.1002/mrm.24629; Tallantyre EC, 2011, NEUROLOGY, V76, P534, DOI 10.1212/WNL.0b013e31820b7630; Wuerfel J, 2008, BRAIN, V131, P2332, DOI 10.1093/brain/awn171; Wuerfel J, 2012, MULT SCLER J, V18, P1592, DOI 10.1177/1352458512441270; Yablonskiy DA, 2012, P NATL ACAD SCI USA, V109, P14212, DOI 10.1073/pnas.1206037109; Yao B, 2012, RADIOLOGY, V262, P206, DOI 10.1148/radiol.11110601	38	16	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0128386	10.1371/journal.pone.0128386	http://dx.doi.org/10.1371/journal.pone.0128386			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RV	26186349	Green Published, Green Submitted, gold, Green Accepted			2022-12-26	WOS:000358198700003
J	Yakovis, E; Artemieva, A				Yakovis, Eugeniy; Artemieva, Anna			Bored to Death: Community-Wide Effect of Predation on a Foundation Species in a Low-Disturbance Arctic Subtidal System	PLOS ONE			English	Article							WHITE SEA; LATITUDINAL VARIATION; BARNACLES; RECRUITMENT; ASCIDIANS; DIET; PREY; COMPETITION; AGGREGATIONS; GASTROPODA	The strength of top-down control by consumers is predicted to decrease with latitude, but most data confirming this assumption come from latitudes <60 degrees, while empirical studies of predation in sub-arctic and arctic marine habitats are few. A barnacle Balanus crenatus is a native foundation species in the shallow subtidal of the White Sea (65 degrees N), hosting a diverse (250+ species) assemblage of macrobenthic organisms. On mixed sediments live barnacles share primary substrates (shells and gravel) with numerous empty barnacle tests, 7% of which had drill holes of an unidentified origin. We manipulated the densities of (i) adult muricid whelks Boreotrophon clathratus (of previously unknown feeding habits), to check if they prey on barnacles, (ii) other predators to reveal their effect on juvenile Boreotrophon, and (iii) empty tests to assess the community-wide effect of predation on barnacles. The abundance of drilled empty tests in the field correlated with that of Boreotrophon. A year-long caging experiment clearly confirmed predation, showing the highest barnacle mortality and proportion of drilled tests in whelk enclosures, and the lowest-in predator exclosure treatments. Boreotrophon preferred the barnacles attached to conspecifics to those from primary substrates. Because of its scarcity Boreotrophon had a minor direct effect on barnacle abundance in the field. Yet, initially defaunated empty tests and live barnacles developed markedly different macrobenthic assemblages, suggesting a strong indirect effect of the predation. Juvenile Boreotrophon were 5-6 times less abundant in open and partial cages than in exclosures and enclosures, which indicates that the recruitment and, consequently, the abundance of Boreotrophon and its predation on Balanus are top-down controlled by apex predators. In contrast, in tropical and temperate intertidal the predation on barnacles is stronger and primarily limited by environmental stress and prey availability.	[Yakovis, Eugeniy; Artemieva, Anna] St Petersburg State Univ, Dept Invertebrate Zool, St Petersburg 199034, Russia	Saint Petersburg State University	Yakovis, E (corresponding author), St Petersburg State Univ, Dept Invertebrate Zool, St Petersburg 199034, Russia.	eugene@yakovis.com	Yakovis, Eugeniy/M-8540-2019; Yakovis, Evgeny L./A-9680-2008; Artemieva, Anna/AAD-9578-2019	Yakovis, Eugeniy/0000-0003-3489-3671; Yakovis, Evgeny L./0000-0003-3489-3671; Artemieva, Anna/0000-0002-1935-7021	Russian Foundation for Basic Research [13-04-10178, 14-04-00972, 14-04-10124]	Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR))	The research was supported by Russian Foundation for Basic Research (http://www.rfbr.ru) grant numbers 13-04-10178, 14-04-00972, and 14-04-10124 received by EY.	AITKEN AE, 1988, LETHAIA, V21, P339, DOI 10.1111/j.1502-3931.1988.tb01762.x; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Aristov D, 2015, J MAR BIOL ASSOC UK, V95, P1601, DOI 10.1017/S0025315415000454; Artemieva A.V., 2004, Vestnik Sankt-Peterburgskogo Universiteta Seriya 3 Biologiya, V4, P5; Barnes H, 1954, J ANIM ECOL, V23, P84; Belogrudov EA., 1973, STUDIES FISH BIOL CO, V4, P84; Bertness MD, 2014, ECOL LETT, V17, P830, DOI 10.1111/ele.12287; BERTNESS MD, 1989, ECOLOGY, V70, P257, DOI 10.2307/1938431; BROS WE, 1987, J EXP MAR BIOL ECOL, V105, P275, DOI 10.1016/0022-0981(87)90176-6; Bruno JF, 2001, MARINE COMMUNITY ECOLOGY, P201; Chiba S, 2014, J SHELLFISH RES, V33, P137, DOI 10.2983/035.033.0113; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Claverie T, 2008, J MAR BIOL ASSOC UK, V88, P157, DOI 10.1017/S0025315408000064; DUDLEY EC, 1978, PALEOBIOLOGY, V4, P436, DOI 10.1017/S0094837300006175; Ellis JC, 2007, ECOLOGY, V88, P853, DOI 10.1890/06-0593; ESTES JA, 1974, SCIENCE, V185, P1058, DOI 10.1126/science.185.4156.1058; FAIRWEATHER PG, 1990, AUST J ECOL, V15, P453, DOI 10.1111/j.1442-9993.1990.tb01470.x; Foster BA., 1987, BARNACLE BIOL, V5, P113; Freestone AL, 2011, ECOLOGY, V92, P983, DOI 10.1890/09-2379.1; Grischankov A.V., 1997, Vestnik Sankt-Peterburgskogo Universiteta Seriya 3 Biologiya, V1, P3; Harley CDG, 2011, OECOLOGIA, V166, P531, DOI 10.1007/s00442-010-1864-1; HIMMELMAN JH, 1993, MAR BIOL, V116, P423, DOI 10.1007/BF00350059; Hjelset AM, 1999, POLAR BIOL, V21, P186, DOI 10.1007/s003000050351; JERNAKOFF P, 1986, MAR ECOL PROG SER, V28, P259, DOI 10.3354/meps028259; KANTOR YI, 1994, VELIGER, V37, P119; Kristjansson TO, 2013, POLAR BIOL, V36, P51, DOI 10.1007/s00300-012-1238-8; MENGE BA, 1972, ECOLOGY, V53, P635, DOI 10.2307/1934777; MENGE BA, 1976, ECOL MONOGR, V46, P355, DOI 10.2307/1942563; MENGE BA, 1978, OECOLOGIA, V34, P17, DOI 10.1007/BF00346238; Merkel FR, 2007, POLAR BIOL, V30, P227, DOI 10.1007/s00300-006-0176-8; Mokievsky VO, 2012, ZOOL ZH, V91, P887; Moles AT, 2003, J BIOGEOGR, V30, P105, DOI 10.1046/j.1365-2699.2003.00781.x; Nadeau M, 2009, J EXP MAR BIOL ECOL, V374, P134, DOI 10.1016/j.jembe.2009.04.014; Peco B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091256; Pennings SC, 2005, ECOLOGY, V86, P2310, DOI 10.1890/04-1022; QIAN PY, 1990, J EXP MAR BIOL ECOL, V142, P63, DOI 10.1016/0022-0981(90)90137-2; Quijon PA, 2005, MAR ECOL PROG SER, V285, P137, DOI 10.3354/meps285137; REAKAKUDLA ML, 1997, BIODIVERSITY, V2, P83; ROBICHAUD DA, 1991, FISH B-NOAA, V89, P669; Roginskaya I.S., 1987, MOLLUSCS WHITE SEA K, V151, P155; ROY K, 1994, PALAIOS, V9, P413, DOI 10.2307/3515059; Sanford E, 2003, SCIENCE, V300, P1135, DOI 10.1126/science.1083437; SCHUBART CD, 1995, J EXP MAR BIOL ECOL, V186, P143, DOI 10.1016/0022-0981(94)00142-Z; SHEILD CJ, 1993, J EXP MAR BIOL ECOL, V166, P107, DOI 10.1016/0022-0981(93)90081-X; SPIGHT TM, 1974, MAR BIOL, V24, P229, DOI 10.1007/BF00391898; TAYLOR JD, 1978, J CONCHOL, V29, P309; Varfolomeeva M, 2008, J EXP MAR BIOL ECOL, V363, P42, DOI 10.1016/j.jembe.2008.06.012; WAHL M, 1989, MAR ECOL PROG SER, V58, P175, DOI 10.3354/meps058175; Wahl M, 1997, HYDROBIOLOGIA, V355, P49, DOI 10.1023/A:1003054802699; Yakovis EL, 2005, J EXP MAR BIOL ECOL, V327, P210, DOI 10.1016/j.jembe.2005.06.015; Yakovis EL, 2004, J EXP MAR BIOL ECOL, V309, P155, DOI 10.1016/j.jembe.2004.03.015; Yakovis EL, 2008, OECOLOGIA, V155, P785, DOI 10.1007/s00442-007-0945-2; Yakovis EL, 2007, MAR ECOL PROG SER, V348, P117, DOI 10.3354/meps07060; Yakovis EL, 2013, HYDROBIOLOGIA, V706, P69, DOI 10.1007/s10750-012-1340-5; Yershov P.N., 2010, VESTNIK SPBGU SER 3, V2, P55	55	4	4	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0132973	10.1371/journal.pone.0132973	http://dx.doi.org/10.1371/journal.pone.0132973			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RV	26186648	Green Published, Green Submitted, gold			2022-12-26	WOS:000358198700079
J	Zavala, K; Opazo, JC				Zavala, Kattina; Opazo, Juan C.			Lineage-Specific Expansion of the Chalcone Synthase Gene Family in Rosids	PLOS ONE			English	Article							DISEASE RESISTANCE GENES; ARABIDOPSIS-THALIANA; POLYKETIDE SYNTHASES; NUCLEOTIDE-SEQUENCES; EVOLUTION; ENZYMES; ISOFLAVONOIDS; SUBSTITUTION; DUPLICATION; PROTEIN	Rosids are a monophyletic group that includes approximately 70,000 species in 140 families, and they are found in a variety of habitats and life forms. Many important crops such as fruit trees and legumes are rosids. The evolutionary success of this group may have been influenced by their ability to produce flavonoids, secondary metabolites that are synthetized through a branch of the phenylpropanoid pathway where chalcone synthase is a key enzyme. In this work, we studied the evolution of the chalcone synthase gene family in 12 species belonging to the rosid clade. Our results show that the last common ancestor of the rosid clade possessed six chalcone synthase gene lineages that were differentially retained during the evolutionary history of the group. In fact, of the six gene lineages that were present in the last common ancestor, 7 species retained 2 of them, whereas the other 5 only retained one gene lineage. We also show that one of the gene lineages was disproportionately expanded in species that belonged to the order Fabales (soybean, barrel medic and Lotus japonicas). Based on the available literature, we suggest that this gene lineage possesses stress-related biological functions (e.g., response to UV light, pathogen defense). We propose that the observed expansion of this clade was a result of a selective pressure to increase the amount of enzymes involved in the production of phenylpropanoid pathway-derived secondary metabolites, which is consistent with the hypothesis that suggested that lineage-specific expansions fuel plant adaptation.	[Zavala, Kattina; Opazo, Juan C.] Univ Austral Chile, Fac Ciencias, Inst Ciencias Ambientales & Evolut, Valdivia, Chile	Universidad Austral de Chile	Opazo, JC (corresponding author), Univ Austral Chile, Fac Ciencias, Inst Ciencias Ambientales & Evolut, Valdivia, Chile.	jopazo@gmail.com		Opazo, Juan C./0000-0001-7938-4083	Fondo Nacional de Desarrollo Cientifico y Tecnologico [FONDECYT 1120032]	Fondo Nacional de Desarrollo Cientifico y Tecnologico(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT)	This work was supported by Fondo Nacional de Desarrollo Cientifico y Tecnologico (FONDECYT 1120032) grant to JCO.	Abascal F, 2010, NUCLEIC ACIDS RES, V38, pW7, DOI 10.1093/nar/gkq291; AKADA S, 1995, PLANT MOL BIOL, V29, P189, DOI 10.1007/BF00043645; AKADA S, 1993, PLANT PHYSIOL, V102, P699, DOI 10.1104/pp.102.2.699; Anisimova M, 2011, SYST BIOL, V60, P685, DOI 10.1093/sysbio/syr041; Baumgarten A, 2003, GENETICS, V165, P309; Cannon Steven B., 2004, BMC Plant Biology, V4, P10, DOI 10.1186/1471-2229-4-10; Dakora FD, 1996, PHYSIOL MOL PLANT P, V49, P1, DOI 10.1006/pmpp.1996.0035; Dixon RA, 1999, TRENDS PLANT SCI, V4, P394, DOI 10.1016/S1360-1385(99)01471-5; Ferreyra MLF, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00222; FEINBAUM RL, 1988, MOL CELL BIOL, V8, P1985, DOI 10.1128/MCB.8.5.1985; Ferrer JL, 1999, NAT STRUCT BIOL, V6, P775, DOI 10.1038/11553; Fischer I, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-151; Flores-Sanchez IJ, 2009, PLANT PHYSIOL BIOCH, V47, P167, DOI 10.1016/j.plaphy.2008.11.005; Force A, 1999, GENETICS, V151, P1531; Forkman G, 1993, FLAVONOIDS ADV RES 1, P583; FukadaTanaka S, 1997, PLANT CELL PHYSIOL, V38, P754, DOI 10.1093/oxfordjournals.pcp.a029232; Gil M, 2013, MOL BIOL EVOL, V30, P1270, DOI 10.1093/molbev/mst034; GOLDMAN N, 1994, MOL BIOL EVOL, V11, P725; Harborne J.B., 1995, J CHEM EDUC, V72, pA73, DOI [10.1021/ED072PA73.11, DOI 10.1021/ED072PA73.11]; Harborne J.B., 2013, FLAVONOIDS ADV RES 1; HELARIUTTA Y, 1995, PLANT MOL BIOL, V28, P47, DOI 10.1007/BF00042037; Jobb G, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-18; Judd WS, PLANT SYSTEMATICS PH; Katoh K, 2009, METHODS MOL BIOL, V537, P39, DOI 10.1007/978-1-59745-251-9_3; LANZ T, 1991, J BIOL CHEM, V266, P9971; Leister D, 2004, TRENDS GENET, V20, P116, DOI 10.1016/j.tig.2004.01.007; Lozovaya VV, 2007, PLANTA, V225, P665, DOI 10.1007/s00425-006-0368-z; Lynch M, 2007, P NATL ACAD SCI USA, V104, P8597, DOI 10.1073/pnas.0702207104; Magallon S, 1999, ANN MISS BOT GAR, P292; McKhann H I, 1994, Curr Top Microbiol Immunol, V192, P139; Meyers BC, 2005, CURR OPIN PLANT BIOL, V8, P129, DOI 10.1016/j.pbi.2005.01.002; Ohno S., 1970, EVOLUTION GENE DUPLI; Shimizu T, 1999, PLANT MOL BIOL, V39, P785, DOI 10.1023/A:1006124219945; Soltis D, 2005, PHYLOGENY EVOLUTION; Tatusova TA, 1999, FEMS MICROBIOL LETT, V174, P247, DOI 10.1016/S0378-1097(99)00149-4; Vanneste K, 2014, GENOME RES, V24, P1334, DOI 10.1101/gr.168997.113; Wang HC, 2009, P NATL ACAD SCI USA, V106, P3853, DOI 10.1073/pnas.0813376106; Wood TE, 2009, P NATL ACAD SCI USA, V106, P13875, DOI 10.1073/pnas.0811575106; Zabala G, 2006, BMC PLANT BIOL, V6, DOI 10.1186/1471-2229-6-26	39	5	5	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2015	10	7							e0133400	10.1371/journal.pone.0133400	http://dx.doi.org/10.1371/journal.pone.0133400			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RQ	26181912	Green Published, gold, Green Submitted			2022-12-26	WOS:000358198200063
J	Verma, D; Das, L; Gambhir, V; Dikshit, KL; Varshney, GC				Verma, Deepshikha; Das, Lahari; Gambhir, Vandana; Dikshit, Kanak Lata; Varshney, Grish C.			Heterogeneity among Homologs of Cutinase-Like Protein Cut5 in Mycobacteria	PLOS ONE			English	Article							PE-PGRS PROTEINS; GENOME EVOLUTION; TUBERCULOSIS; GENES; PURIFICATION; FAMILY; GROWTH; IDENTIFICATION; EXPRESSION; BIOMARKERS	The study of genomic variability within various pathogenic and non-pathogenic strains of mycobacteria provides insight into their evolution and pathogenesis. The mycobacterial genome encodes seven cutinase-like proteins and each one of these exhibit distinct characteristics. We describe the presence of Cut5, a member of the cutinase family, in mycobacteria and the existence of a unique genomic arrangement in the cut5 gene of M. tuberculosis (Mtb) strains. A single nucleotide (T) insertion is observed in the cut5 gene, which is specific for Mtb strains. Using in silico analysis and RT-PCR, we demonstrate the transcription of Rv3724/cut5 as Rv3724a/cut5a and Rv3724b/cut5b in Mtb H37Rv and as full length cut5 in M. bovis. Cut5b protein of Mtb H37Rv (MtbCut5b) was found to be antigenically similar to its homologs in M. bovis and M. smegmatis, without any observed cross-reactivity with other Mtb cutinases. Also, the presence of Cut5b in Mtb and its homologs in M. bovis and M. smegmatis were confirmed by western blotting using antibodies raised against recombinant Cut5b. In Mtb H37Rv, Cut5b was found to be localized in the cell wall, cytosol and membrane fractions. We also report the vast prevalence of Cut5 homologs in pathogenic and non pathogenic species of mycobacteria. In silico analysis revealed that this protein has three possible organizations in mycobacteria. Also, a single nucleotide (T) insertion in Mtb strains and varied genomic arrangements within mycobacterial species make Rv3724/Cut5 a potential candidate that can be exploited as a biomarker in Mtb infection.	[Verma, Deepshikha; Das, Lahari; Gambhir, Vandana; Dikshit, Kanak Lata; Varshney, Grish C.] CSIR, Inst Microbial Technol, Cell Biol & Immunol Div, Chandigarh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Microbial Technology (IMTECH)	Varshney, GC (corresponding author), CSIR, Inst Microbial Technol, Cell Biol & Immunol Div, Chandigarh, India.	grish@imtech.res.in			Council of scientific and industrial research [GENESIS BSC0121, SIP 10, SPLenDID BSC 0104]	Council of scientific and industrial research(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by the GENESIS BSC0121 of Council of scientific and industrial research grant numbers SIP 10, SPLenDID BSC 0104 to DV LD VG GCV. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Banu S, 2002, MOL MICROBIOL, V44, P9, DOI 10.1046/j.1365-2958.2002.02813.x; Bashiri G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045003; Belbahri L, 2008, GENE, V408, P1, DOI 10.1016/j.gene.2007.10.019; Bentrup KHZ, 1999, J BACTERIOL, V181, P7161; Bhaduri A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088090; Brennan MJ, 2001, INFECT IMMUN, V69, P7326, DOI 10.1128/IAI.69.12.7326-7333.2001; Brosch R, 2002, P NATL ACAD SCI USA, V99, P3684, DOI 10.1073/pnas.052548299; Brust B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025078; Chegou NN, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-10; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Daniel J, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002093; Dedieu L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066913; Fukuda Y, 1999, NUCLEIC ACIDS RES, V27, P1847, DOI 10.1093/nar/27.8.1847; Gamieldien J, 2002, TRENDS GENET, V18, P5, DOI 10.1016/S0168-9525(01)02529-X; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Grover A, 2006, PROTEIN EXPRES PURIF, V48, P274, DOI 10.1016/j.pep.2006.03.010; Hu YM, 2006, INFECT IMMUN, V74, P861, DOI 10.1128/IAI.74.2.861-868.2006; Kaur R, 2002, J HISTOCHEM CYTOCHEM, V50, P863, DOI 10.1177/002215540205000612; Krakauer DC, 2000, EVOLUTION, V54, P731, DOI 10.1111/j.0014-3820.2000.tb00075.x; Ocampo M, 2012, AMINO ACIDS, V42, P2067, DOI 10.1007/s00726-011-0938-7; Parker SK, 2007, J BACTERIOL, V189, P4153, DOI 10.1128/JB.01909-06; Parker SK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004281; Pecora ND, 2006, J IMMUNOL, V177, P422, DOI 10.4049/jimmunol.177.1.422; Rosas-Magallanes V, 2006, MOL BIOL EVOL, V23, P1129, DOI 10.1093/molbev/msj120; Sartain MJ, 2006, MOL CELL PROTEOMICS, V5, P2102, DOI 10.1074/mcp.M600089-MCP200; Sassetti CM, 2003, MOL MICROBIOL, V48, P77, DOI 10.1046/j.1365-2958.2003.03425.x; Schuck SD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005590; Schue M, 2010, FASEB J, V24, P1893, DOI 10.1096/fj.09-144766; Skamnioti P, 2008, NEW PHYTOL, V180, P711, DOI 10.1111/j.1469-8137.2008.02598.x; Springer B, 2004, MOL MICROBIOL, V53, P1601, DOI 10.1111/j.1365-2958.2004.04231.x; Sreenu VB, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-78; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Vizcaino C, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000824; WALSH JB, 1987, GENETICS, V117, P543; Walzl G, 2011, NAT REV IMMUNOL, V11, P343, DOI 10.1038/nri2960; Wanner RM, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-249; Weldingh K, 1998, INFECT IMMUN, V66, P3492, DOI 10.1128/IAI.66.8.3492-3500.1998; West NP, 2008, VACCINE, V26, P3853, DOI 10.1016/j.vaccine.2008.05.007; West NP, 2009, FASEB J, V23, P1694, DOI 10.1096/fj.08-114421; Wolf YI, 2000, GENOME BIOL, V1; Yang Y, 2014, CELL HOST MICROBE, V15, P153, DOI 10.1016/j.chom.2014.01.008	42	5	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0133186	10.1371/journal.pone.0133186	http://dx.doi.org/10.1371/journal.pone.0133186			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26177502	Green Published, Green Submitted, gold			2022-12-26	WOS:000358197600228
J	Igoucheva, O; Alexeev, V; Halabi, CM; Adams, SM; Stoilov, I; Sasaki, T; Arita, M; Donahue, A; Mecham, RP; Birk, DE; Chu, ML				Igoucheva, Olga; Alexeev, Vitali; Halabi, Carmen M.; Adams, Sheila M.; Stoilov, Ivan; Sasaki, Takako; Arita, Machiko; Donahue, Adele; Mecham, Robert P.; Birk, David E.; Chu, Mon-Li			Fibulin-4 E57K Knock-in Mice Recapitulate Cutaneous, Vascular and Skeletal Defects of Recessive Cutis Laxa 1B with both Elastic Fiber and Collagen Fibril Abnormalities	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						collagen; connective tissue; elastin; extracellular matrix; lysyl oxidase; skin; tendon; aneurysm; aorta; forelimb	OF-THE-LITERATURE; LATENT TGF-BETA; LYSYL OXIDASE; OSTEOGENESIS IMPERFECTA; ARTERIAL TORTUOSITY; TISSUE LOCALIZATION; GENDER-DIFFERENCES; MATRIX PROTEINS; AORTIC-ANEURYSM; ELASTOGENESIS	Background: Mutations in fibulin-4 cause autosomal recessive cutis laxa 1B, characterized by loose skin with vascular, lung, and skeletal abnormalities. Results: A mouse strain carrying a recurrent fibulin-4 missense mutation was generated and characterized. Conclusion: Mutant mice recapitulate the complete clinical features of the disease. Significance: The study provides the first evidence that fibulin-4 regulates collagen fibrillogenesis. Fibulin-4 is an extracellular matrix protein essential for elastic fiber formation. Frameshift and missense mutations in the fibulin-4 gene (EFEMP2/FBLN4) cause autosomal recessive cutis laxa (ARCL) 1B, characterized by loose skin, aortic aneurysm, arterial tortuosity, lung emphysema, and skeletal abnormalities. Homozygous missense mutations in FBLN4 are a prevalent cause of ARCL 1B. Here we generated a knock-in mouse strain bearing a recurrent fibulin-4 E57K homozygous missense mutation. The mutant mice survived into adulthood and displayed abnormalities in multiple organ systems, including loose skin, bent forelimb, aortic aneurysm, tortuous artery, and pulmonary emphysema. Biochemical studies of dermal fibroblasts showed that fibulin-4 E57K mutant protein was produced but was prone to dimer formation and inefficiently secreted, thereby triggering an endoplasmic reticulum stress response. Immunohistochemistry detected a low level of fibulin-4 E57K protein in the knock-in skin along with altered expression of selected elastic fiber components. Processing of a precursor to mature lysyl oxidase, an enzyme involved in cross-linking of elastin and collagen, was compromised. The knock-in skin had a reduced level of desmosine, an elastin-specific cross-link compound, and ultrastructurally abnormal elastic fibers. Surprisingly, structurally aberrant collagen fibrils and altered organization into fibers were characteristics of the knock-in dermis and forelimb tendons. Type I collagen extracted from the knock-in skin had decreased amounts of covalent intermolecular cross-links, which could contribute to the collagen fibril abnormalities. Our studies provide the first evidence that fibulin-4 plays a role in regulating collagen fibril assembly and offer a preclinical platform for developing treatments for ARCL 1B.	[Igoucheva, Olga; Alexeev, Vitali; Arita, Machiko; Donahue, Adele; Chu, Mon-Li] Thomas Jefferson Univ, Dept Dermatol & Cutaneous Biol, Sidney Kimmel Med Coll, Philadelphia, PA 19107 USA; [Halabi, Carmen M.; Stoilov, Ivan; Mecham, Robert P.] Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA; [Adams, Sheila M.; Birk, David E.] Univ S Florida, Dept Mol Pharmacol & Physiol, Morsani Coll Med, Tampa, FL 33612 USA; [Sasaki, Takako] Oita Univ, Dept Biochem, Fac Med, Yufu, Oita 8795593, Japan	Jefferson University; Washington University (WUSTL); State University System of Florida; University of South Florida; Oita University	Chu, ML (corresponding author), Thomas Jefferson Univ, Dept Dermatol & Cutaneous Biol, 233 South 10th St, Philadelphia, PA 19107 USA.	mon-li.chu@jefferson.edu	Halabi, Carmen/V-5978-2019; Birk, David/I-4072-2012; Regan, Clinton/E-6250-2012	Halabi, Carmen/0000-0003-4889-8131; Birk, David/0000-0002-4865-9088; 	National Institutes of Health [AR056523, HL53325, HL105314, AR044745]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL053325, R37HL053325, R01HL105314] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR044745, R21AR056523] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grants AR056523 (M.-L.C.),HL53325 (R.P.M.), HL105314 (R.P.M.), and AR044745 (D.E.B.). The authors declare that they have no conflicts of interest with the contents of this article.	Acharya M, 2012, MOL VIS, V18, P2182; Al-Hassnan ZN, 2012, AM J CARDIOL, V109, P1677, DOI 10.1016/j.amjcard.2012.01.394; Azzi L, 2005, J INVEST DERMATOL, V124, P22, DOI 10.1111/j.0022-202X.2004.23545.x; Cabral WA, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004465; Cheng JK, 2013, BIOMECH MODEL MECHAN, V12, P497, DOI 10.1007/s10237-012-0420-9; Choi J, 2009, MATRIX BIOL, V28, P211, DOI 10.1016/j.matbio.2009.03.004; Choudhury R, 2009, J BIOL CHEM, V284, P24553, DOI 10.1074/jbc.M109.019364; Dao H, 2007, GENDER MED, V4, P308; Dasouki M, 2007, AM J MED GENET A, V143A, P2635, DOI 10.1002/ajmg.a.31980; El-Hallous E, 2007, J BIOL CHEM, V282, P8935, DOI 10.1074/jbc.M608204200; Erickson LK, 2012, PEDIATR DEVEL PATHOL, V15, P137, DOI 10.2350/11-03-1010-CR.1; Gallagher WM, 2001, FEBS LETT, V489, P59, DOI 10.1016/S0014-5793(00)02389-9; Giltay R, 1999, MATRIX BIOL, V18, P469, DOI 10.1016/S0945-053X(99)00038-4; Grafel I, 2014, NAT MED, V20, P670, DOI 10.1038/nm.3544; Hanada K, 2007, CIRC RES, V100, P738, DOI 10.1161/01.RES.0000260181.19449.95; Hebson C, 2014, EUR J PEDIATR, V173, P671, DOI 10.1007/s00431-013-2217-y; Herchenhan A, 2015, J BIOL CHEM, V290, P16440, DOI 10.1074/jbc.M115.641670; Holmberg J, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-25; Horiguchi M, 2009, P NATL ACAD SCI USA, V106, P19029, DOI 10.1073/pnas.0908268106; Hornstra IK, 2003, J BIOL CHEM, V278, P14387, DOI 10.1074/jbc.M210144200; Hoyer J, 2009, CLIN GENET, V76, P276, DOI 10.1111/j.1399-0004.2009.01204.x; Huang JB, 2010, CIRC RES, V106, P583, DOI 10.1161/CIRCRESAHA.109.207852; Hucthagowder V, 2006, AM J HUM GENET, V78, P1075, DOI 10.1086/504304; Iascone M, 2012, CIRCULATION, V126, P2764, DOI 10.1161/CIRCULATIONAHA.112.119883; Izu Y, 2011, MATRIX BIOL, V30, P53, DOI 10.1016/j.matbio.2010.10.001; Kappanayil M, 2012, ORPHANET J RARE DIS, V7, DOI 10.1186/1750-1172-7-61; Kobayashi N, 2007, J BIOL CHEM, V282, P11805, DOI 10.1074/jbc.M611029200; Lucero HA, 2006, CELL MOL LIFE SCI, V63, P2304, DOI 10.1007/s00018-006-6149-9; Maki JM, 2005, AM J PATHOL, V167, P927, DOI 10.1016/S0002-9440(10)61183-2; Marini JC, 2013, J CLIN ENDOCR METAB, V98, P3095, DOI 10.1210/jc.2013-1505; Massam-Wu T, 2010, J CELL SCI, V123, P3006, DOI 10.1242/jcs.073437; McLaughlin PJ, 2006, MOL CELL BIOL, V26, P1700, DOI 10.1128/MCB.26.5.1700-1709.2006; Nakamura T, 2002, NATURE, V415, P171, DOI 10.1038/415171a; Ni M, 2007, FEBS LETT, V581, P3641, DOI 10.1016/j.febslet.2007.04.045; Noda K, 2013, P NATL ACAD SCI USA, V110, P2852, DOI 10.1073/pnas.1215779110; Ono RN, 2009, J BIOL CHEM, V284, P16872, DOI 10.1074/jbc.M809348200; Panchenko MV, 1996, J BIOL CHEM, V271, P7113, DOI 10.1074/jbc.271.12.7113; Papke CL, 2014, MATRIX BIOL, V37, P142, DOI 10.1016/j.matbio.2014.02.004; Ramirez F, 2009, CURR OPIN CELL BIOL, V21, P616, DOI 10.1016/j.ceb.2009.05.005; Ramnath NWM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106054; Renard M, 2010, EUR J HUM GENET, V18, P895, DOI 10.1038/ejhg.2010.45; Sawyer SL, 2013, AM J MED GENET A, V161A, P1148, DOI 10.1002/ajmg.a.35827; Sicot FX, 2008, MOL CELL BIOL, V28, P1061, DOI 10.1128/MCB.01876-07; Uitto J, 2013, EXP DERMATOL, V22, P88, DOI 10.1111/exd.12025; Urban Z, 2014, MATRIX BIOL, V33, P16, DOI 10.1016/j.matbio.2013.07.006; Wagenseil Jessica E., 2007, Birth Defects Research, V81, P229, DOI 10.1002/bdrc.20111; Xiang Y, 2006, J IMMUNOL, V176, P3196, DOI 10.4049/jimmunol.176.5.3196; Yanagisawa H, 2002, NATURE, V415, P168, DOI 10.1038/415168a; Yanagisawa H, 2010, INT J BIOCHEM CELL B, V42, P1084, DOI 10.1016/j.biocel.2010.03.009	49	27	27	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	2015	290	35					21443	21459		10.1074/jbc.M115.640425	http://dx.doi.org/10.1074/jbc.M115.640425			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CQ5IS	26178373	Green Published, hybrid			2022-12-26	WOS:000360637600021
J	Bourgeois, G; Ney, M; Gaspar, I; Aigueperse, C; Schaefer, M; Kellner, S; Helm, M; Motorin, Y				Bourgeois, Gabrielle; Ney, Michel; Gaspar, Imre; Aigueperse, Christelle; Schaefer, Matthias; Kellner, Stefanie; Helm, Mark; Motorin, Yuri			Eukaryotic rRNA Modification by Yeast 5-Methylcytosine-Methyltransferases and Human Proliferation-Associated Antigen p120	PLOS ONE			English	Article							NUCLEOLAR PROTEIN P120; BOWEN-CONRADI SYNDROME; SACCHAROMYCES-CEREVISIAE; DIMETHYLASE DIM1P; ASSEMBLY FACTOR; NONCODING RNA; MISU NSUN2; NEP1 EMG1; METHYLTRANSFERASE; METHYLATION	Modified nucleotide 5-methylcytosine (m(5)C) is frequently present in various eukaryotic RNAs, including tRNAs, rRNAs and in other non-coding RNAs, as well as in mRNAs. RNA: m(5)C-methyltranferases (MTases) Nop2 from S. cerevisiae and human proliferation-associated nucleolar antigen p120 are both members of a protein family called Nop2/NSUN/NOL1. Protein p120 is well-known as a tumor marker which is over-expressed in various cancer tissues. Using a combination of RNA bisulfite sequencing and HPLC-MS/MS analysis, we demonstrated here that p120 displays an RNA:m(5)C-MTase activity, which restores m(5)C formation at position 2870 in domain V of 25S rRNA in a nop2 Delta yeast strain. We also confirm that yeast proteins Nop2p and Rcm1p catalyze the formation of m(5)C in domains V and IV, respectively. In addition, we do not find any evidence of m(5)C residues in yeast 18S rRNA. We also performed functional complementation of Nop2-deficient yeasts by human p120 and studied the importance of different sequence and structural domains of Nop2 and p120 for yeast growth and m(5)C-MTase activity. Chimeric protein formed by Nop2 and p120 fragments revealed the importance of Nop2 N-terminal domain for correct protein localization and its cellular function. We also validated that the presence of Nop2, rather than the m(5)C modification in rRNA itself, is required for pre-rRNA processing. Our results corroborate that Nop2 belongs to the large family of pre-ribosomal proteins and possesses two related functions in pre-rRNA processing: as an essential factor for cleavages and m(5)C: RNA:modification. These results support the notion of quality control during ribosome synthesis by such modification enzymes.	[Bourgeois, Gabrielle; Ney, Michel; Aigueperse, Christelle; Motorin, Yuri] BioPole UL, CNRS, UMR UL 7365, Lab IMoPA, Vandoeuvre Les Nancy, France; [Gaspar, Imre] EMBL Heidelberg, D-69117 Heidelberg, Germany; [Schaefer, Matthias] German Canc Res Ctr, Div Epigenet, Heidelberg, Germany; [Kellner, Stefanie; Helm, Mark] Johannes Gutenberg Univ Mainz, Inst Pharm & Biochem, D-55122 Mainz, Germany	Centre National de la Recherche Scientifique (CNRS); Universite de Lorraine; European Molecular Biology Laboratory (EMBL); Helmholtz Association; German Cancer Research Center (DKFZ); Johannes Gutenberg University of Mainz	Motorin, Y (corresponding author), BioPole UL, CNRS, UMR UL 7365, Lab IMoPA, Vandoeuvre Les Nancy, France.	Yuri.Motorin@univ-lorraine.fr	Gaspar, Imre/N-6808-2019; Matthias, Schaefer Ronald/E-9157-2015; MOTORIN, Yuri/AAQ-9527-2020; Helm, Mark/AAD-5433-2022	Matthias, Schaefer Ronald/0000-0003-1952-8115; MOTORIN, Yuri/0000-0002-8018-334X; Gaspar, Imre/0000-0002-6527-637X; /0000-0003-3224-7502; NEY, Michel/0000-0002-7214-7744; Helm, Mark/0000-0002-0154-0928; Motorin, Alexandr/0000-0001-9622-4591	Agence Nationale de la Recherche (ANR FR); Deutsche Forschungsgemeinschaft (DFG DE) [FOR1082]; HTRNAMod [ANR-13-ISV8-0001-01]	Agence Nationale de la Recherche (ANR FR)(French National Research Agency (ANR)); Deutsche Forschungsgemeinschaft (DFG DE); HTRNAMod	Funding for this work was supplied by a joint grant from Agence Nationale de la Recherche (ANR FR; www.agence-nationale-recherche.fr/) and Deutsche Forschungsgemeinschaft (DFG DE; www.dfg.de/), HTRNAMod (No ANR-13-ISV8-0001-01) for YM and MH, and by Deutsche Forschungsgemeinschaft (DFG DE; www.dfg.de/) grant FOR1082 for MH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auxilien S, 2012, RNA BIOL, V9, P1331, DOI 10.4161/rna.22180; Blagosklonny MV, 1998, BIOCHEM BIOPH RES CO, V244, P368, DOI 10.1006/bbrc.1998.8278; BRAND RC, 1977, EUR J BIOCHEM, V75, P311, DOI 10.1111/j.1432-1033.1977.tb11531.x; Brzezicha B, 2006, NUCLEIC ACIDS RES, V34, P6034, DOI 10.1093/nar/gkl765; Chi L, 2013, GENE EXPR PATTERNS, V13, P319, DOI 10.1016/j.gep.2013.06.003; DEBEUS E, 1994, J CELL BIOL, V127, P1799, DOI 10.1083/jcb.127.6.1799; Edelheit S, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003602; Ferreira-Cerca S, 2007, MOL CELL, V28, P446, DOI 10.1016/j.molcel.2007.09.029; FONAGY A, 1992, CANCER RES, V52, P5250; FREEMAN JW, 1988, CANCER RES, V48, P5246; FREEMAN JW, 1988, CANCER RES, V48, P1244; Fromont-Racine M, 2003, GENE, V313, P17, DOI 10.1016/S0378-1119(03)00629-2; Frye M, 2006, CURR BIOL, V16, P971, DOI 10.1016/j.cub.2006.04.027; Frye M, 2010, CANCER LETT, V289, P71, DOI 10.1016/j.canlet.2009.08.004; Gigova A, 2014, RNA, V20, P1632, DOI 10.1261/rna.043398.113; GORCZYCA W, 1992, CANCER RES, V52, P3491; Gustafson WC, 1998, BIOCHEM J, V331, P387, DOI 10.1042/bj3310387; Harnpicharnchai P, 2001, MOL CELL, V8, P505, DOI 10.1016/S1097-2765(01)00344-6; Harris T, 2007, BIOL REPROD, V77, P376, DOI 10.1095/biolreprod.106.058669; Hong B, 2001, NUCLEIC ACIDS RES, V29, P2927, DOI 10.1093/nar/29.14.2927; Hong B, 1997, MOL CELL BIOL, V17, P378, DOI 10.1128/MCB.17.1.378; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Hussain S, 2013, CELL REP, V4, P255, DOI 10.1016/j.celrep.2013.06.029; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; JHIANG SM, 1990, CELL GROWTH DIFFER, V1, P319; Kellner S, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku733; Khan MA, 2012, AM J HUM GENET, V90, P856, DOI 10.1016/j.ajhg.2012.03.023; King MY, 2002, BIOCHEMISTRY-US, V41, P11218, DOI 10.1021/bi026055q; KOONIN EV, 1994, NUCLEIC ACIDS RES, V22, P2476, DOI 10.1093/nar/22.13.2476; Kressler D, 1999, NUCLEIC ACIDS RES, V27, P4598, DOI 10.1093/nar/27.23.4598; LAFONTAINE D, 1995, GENE DEV, V9, P2470, DOI 10.1101/gad.9.20.2470; Lafontaine DLJ, 1998, MOL CELL BIOL, V18, P2360, DOI 10.1128/MCB.18.4.2360; Letoquarta J, 2014, P NATL ACAD SCI USA, V111, pE5518, DOI 10.1073/pnas.1413089111; Leulliot N, 2008, NUCLEIC ACIDS RES, V36, P629, DOI 10.1093/nar/gkm1074; Leulliot N, 2008, STRUCTURE, V16, P52, DOI 10.1016/j.str.2007.10.025; MADEN BEH, 1988, J MOL BIOL, V201, P289, DOI 10.1016/0022-2836(88)90139-8; Marchand V, 2011, RNA BIOL, V8, P325, DOI 10.4161/rna.8.2.13984; Metodiev MD, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004110; Meyer B, 2011, NUCLEIC ACIDS RES, V39, P1526, DOI 10.1093/nar/gkq931; Motorin Y, 1999, RNA, V5, P1105, DOI 10.1017/S1355838299982201; Motorin Y, 2011, WIRES RNA, V2, P611, DOI 10.1002/wrna.79; Motorin Y, 2010, NUCLEIC ACIDS RES, V38, P1415, DOI 10.1093/nar/gkp1117; PERLAKY L, 1992, CANCER RES, V52, P428; Reid R, 1999, NUCLEIC ACIDS RES, V27, P3138, DOI 10.1093/nar/27.15.3138; Sakita-Suto S, 2007, MOL BIOL CELL, V18, P1107, DOI 10.1091/mbc.E06-11-1021; Salozhin SV, 2005, BIOCHEMISTRY-MOSCOW+, V70, P525, DOI 10.1007/s10541-005-0146-8; Schaefer M, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkn954; Schilling V, 2012, YEAST, V29, P167, DOI 10.1002/yea.2898; Sharma S, 2013, NUCLEIC ACIDS RES, V41, P9062, DOI 10.1093/nar/gkt679; SMITH JE, 1992, BIOCHEMISTRY-US, V31, P10825, DOI 10.1021/bi00159a025; Spahr H, 2012, P NATL ACAD SCI USA, V109, P15253, DOI 10.1073/pnas.1210688109; Squires JE, 2012, NUCLEIC ACIDS RES, V40, P5023, DOI 10.1093/nar/gks144; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Talkish J, 2012, NUCLEIC ACIDS RES, V40, P8646, DOI 10.1093/nar/gks609; Thomas SR, 2011, NUCLEIC ACIDS RES, V39, P2445, DOI 10.1093/nar/gkq1131; Trere D, 2000, J PATHOL, V192, P216, DOI 10.1002/1096-9896(2000)9999:9999<::AID-PATH695>3.0.CO;2-L; Uchiyama B, 1997, CLIN CANCER RES, V3, P1873; Ueki T, 1997, HUM PATHOL, V28, P74, DOI 10.1016/S0046-8177(97)90282-3; VALDEZ BC, 1992, CANCER RES, V52, P5681; VALDEZ BC, 1994, J BIOL CHEM, V269, P23776; VELDMAN GM, 1981, NUCLEIC ACIDS RES, V9, P6935, DOI 10.1093/nar/9.24.6935; White J, 2008, MOL CELL BIOL, V28, P3151, DOI 10.1128/MCB.01674-07; Wurm JP, 2010, NUCLEIC ACIDS RES, V38, P2387, DOI 10.1093/nar/gkp1189; Yakubovskaya E, 2012, STRUCTURE, V20, P1940, DOI 10.1016/j.str.2012.08.027	64	59	60	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0133321	10.1371/journal.pone.0133321	http://dx.doi.org/10.1371/journal.pone.0133321			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LZ	26196125	Green Published, gold, Green Submitted			2022-12-26	WOS:000358547600085
J	Kreit, M; Vertommen, D; Gillet, L; Michiels, T				Kreit, Marguerite; Vertommen, Didier; Gillet, Laurent; Michiels, Thomas			The Interferon-Inducible Mouse Apolipoprotein L9 and Prohibitins Cooperate to Restrict Theiler's Virus Replication	PLOS ONE			English	Article							GENE-EXPRESSION ANALYSIS; ANTIVIRAL RESPONSE; RECEPTOR PROTEIN; EPITHELIAL-CELLS; L FAMILY; IDENTIFICATION; INFECTION; APOPTOSIS; CLONING; SITES	Apolipoprotein L9b (Apol9b) is an interferon-stimulated gene (ISG) that has antiviral activity and is weakly expressed in primary mouse neurons as compared to other cell types. Here, we show that both Apol9 isoforms (Apol9b and Apol9a) inhibit replication of Theiler's murine encephalomyelitis virus (TMEV) but not replication of vesicular stomatitis virus (VSV), Murid herpesvirus-4 (MuHV-4), or infection by a lentiviral vector. Apol9 genes are strongly expressed in mouse liver and, to a lesser extent, in pancreas, adipose tissue and intestine. Their expression is increased by type I interferon and viral infection. In contrast to genuine apolipoproteins that are involved in lipid transport, ApoL9 has an intracytoplasmic localization and does not seem to be secreted. The cytoplasmic localization of ApoL9 is in line with the observation that ApoL9 inhibits the replication step of TMEV infection. In contrast to human ApoL6, ApoL9 did not sensitize cells to apoptosis, in spite of the presence of a conserved putative BH3 domain, required for antiviral activity. ApoL9a and b isoforms interact with cellular prohibitin 1 (Phb1) and prohibitin 2 (Phb2) and this interaction might contribute to ApoL9 antiviral activity. Knocking down Phb2 slightly increased TMEV replication, irrespective of ApoL9 overexpression. The antiviral activity of prohibitins against TMEV contrasts with the pro-viral activity of prohibitins observed for VSV and reported previously for Dengue 2 (DENV-2), Chikungunya (CHIKV) and influenza H5N1 viruses. ApoL9 is thus an example of ISG displaying a narrow antiviral range, which likely acts in complex with prohibitins to restrict TMEV replication.	[Kreit, Marguerite; Vertommen, Didier; Michiels, Thomas] Catholic Univ Louvain, de Duve Inst, B-1200 Brussels, Belgium; [Gillet, Laurent] Univ Liege, FARAH Res Ctr, Liege, Belgium; [Gillet, Laurent] Fac Med Vet, Liege, Belgium	Universite Catholique Louvain; University of Liege	Michiels, T (corresponding author), Catholic Univ Louvain, de Duve Inst, B-1200 Brussels, Belgium.	thomas.michiels@uclouvain.be	Michiels, Thomas/ABE-3203-2021	Michiels, Thomas/0000-0001-9615-8053; Gillet, Laurent/0000-0002-1047-2525; Vertommen, Didier/0000-0001-7648-8282	FRIA fellowship from the belgian Fund for Scientific research; Faculty of Medicine (Univ. of Louvain); DIANE convention of the belgian walloon region; ARC funding of the (Communaute Francaise de Belgique); Interuniversitary Attraction Poles programme [IAP-P7/45 BELVIR]	FRIA fellowship from the belgian Fund for Scientific research(Fonds de la Recherche Scientifique - FNRS); Faculty of Medicine (Univ. of Louvain); DIANE convention of the belgian walloon region; ARC funding of the (Communaute Francaise de Belgique); Interuniversitary Attraction Poles programme	MK was the recipient of a FRIA fellowship from the belgian Fund for Scientific research and was further supported by a fellowship from the Faculty of Medicine (Univ. of Louvain) and by the following programs which also funded research: the DIANE convention of the belgian walloon region, the ARC funding of the (Communaute Francaise de Belgique) and the Interuniversitary Attraction Poles programme initiated by the Belgian Science Policy Office (IAP-P7/45 BELVIR).	Adler H, 2000, J VIROL, V74, P6964, DOI 10.1128/JVI.74.15.6964-6974.2000; Andersson M, 2000, INVEST OPHTH VIS SCI, V41, P2623; Barrett T, 2013, NUCLEIC ACIDS RES, V41, pD991, DOI 10.1093/nar/gks1193; Bendtsen JD, 2004, PROTEIN ENG DES SEL, V17, P349, DOI 10.1093/protein/gzh037; Coronado MJ, 2012, AM J PHYSIOL-HEART C, V302, pH1726, DOI 10.1152/ajpheart.00783.2011; Day CL, 2008, J MOL BIOL, V380, P958, DOI 10.1016/j.jmb.2008.05.071; Denoncin K, 2010, J BIOL CHEM, V285, P29425, DOI 10.1074/jbc.M110.119321; Donnelly MLL, 2001, J GEN VIROL, V82, P1013, DOI 10.1099/0022-1317-82-5-1013; DUBRIDGE RB, 1987, MOL CELL BIOL, V7, P379, DOI 10.1128/MCB.7.1.379; Duchateau PN, 1997, J BIOL CHEM, V272, P25576, DOI 10.1074/jbc.272.41.25576; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; FIALA M, 1966, J BACTERIOL, V92, P1710, DOI 10.1128/JB.92.6.1710-1715.1966; Flicek P, 2014, NUCLEIC ACIDS RES, V42, pD749, DOI 10.1093/nar/gkt1196; Follenzi A, 2000, NAT GENET, V25, P217, DOI 10.1038/76095; Galindo-Moreno J, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.237; Geer LY, 2010, NUCLEIC ACIDS RES, V38, pD492, DOI 10.1093/nar/gkp858; Go JT, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-627; HAMPARIAN VV, 1964, P SOC EXP BIOL MED, V116, P976, DOI 10.3181/00379727-116-29426; Hermant P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071320; Hoffmann M, 2010, J GEN VIROL, V91, P2782, DOI 10.1099/vir.0.023978-0; HOFMANN K, 1993, BIOL CHEM HOPPESEYLE, V374, P166, DOI DOI 10.1515/BCHM3.1993.374.1-6.143; Hu Y, 2011, J IMMUNOL, V187, P6456, DOI 10.4049/jimmunol.1003691; Jnaoui K, 1998, VIROLOGY, V244, P397, DOI 10.1006/viro.1998.9134; Kedersha N, 2007, METHOD ENZYMOL, V431, P61, DOI 10.1016/S0076-6879(07)31005-7; Kolonin MG, 2004, NAT MED, V10, P625, DOI 10.1038/nm1048; Kreit M, 2014, J VIROL, V88, P3874, DOI 10.1128/JVI.03018-13; Kuadkitkan A, 2010, VIROLOGY, V406, P149, DOI 10.1016/j.virol.2010.07.015; Li J, 2013, MBIO, V4, DOI DOI 10.1128/MBI0.00385-13; Liu C, 2012, J PROTEOME RES, V11, P5396, DOI 10.1021/pr3006342; Liu SY, 2012, P NATL ACAD SCI USA, V109, P4239, DOI 10.1073/pnas.1114981109; Liu ZH, 2005, MOL CANCER RES, V3, P21; Lobert PE, 1999, P NATL ACAD SCI USA, V96, P11560, DOI 10.1073/pnas.96.20.11560; Michiels T, 1997, J VIROL, V71, P9549, DOI 10.1128/JVI.71.12.9549-9556.1997; Mimmack ML, 2002, P NATL ACAD SCI USA, V99, P4680, DOI 10.1073/pnas.032069099; Mitaku S, 1999, PROTEIN ENG, V12, P953, DOI 10.1093/protein/12.11.953; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Page NM, 2001, GENOMICS, V74, P71, DOI 10.1006/geno.2001.6534; Paquette SG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038214; Paul S, 2006, J GEN VIROL, V87, P1237, DOI 10.1099/vir.0.81642-0; Rice AD, 2011, J VIROL, V85, P550, DOI 10.1128/JVI.00254-10; Rusinova I, 2013, NUCLEIC ACIDS RES, V41, pD1040, DOI 10.1093/nar/gks1215; Schoggins JW, 2014, NATURE, V505, P691, DOI 10.1038/nature12862; Schoggins JW, 2011, NATURE, V472, P481, DOI 10.1038/nature09907; Sharma A, 2004, P NATL ACAD SCI USA, V101, P17492, DOI 10.1073/pnas.0407536101; Smith EE, 2009, GENOME RES, V19, P850, DOI 10.1101/gr.085647.108; Sommereyns C, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000017; Sorgeloos F, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003474; Strack RL, 2009, BIOCHEMISTRY-US, V48, P8279, DOI 10.1021/bi900870u; Sugiura N, 2011, JPN J INFECT DIS, V64, P463; Sun LL, 2015, CELL HOST MICROBE, V17, P85, DOI 10.1016/j.chom.2014.11.004; TANGY F, 1989, J VIROL, V63, P1101, DOI 10.1128/JVI.63.3.1101-1106.1989; Thuaud F, 2013, CHEM BIOL, V20, P316, DOI 10.1016/j.chembiol.2013.02.006; van Pesch V, 2004, J VIROL, V78, P8219, DOI 10.1128/JVI.78.15.8219-8228.2004; Vanhamme L, 2003, NATURE, V422, P83, DOI 10.1038/nature01461; Vidick S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083842; Wintachai P, 2012, J MED VIROL, V84, P1757, DOI 10.1002/jmv.23403; Yu CS, 2006, PROTEINS, V64, P643, DOI 10.1002/prot.21018; Zhaorigetu S, 2011, J BIOL CHEM, V286, P27389, DOI 10.1074/jbc.M110.210245	58	19	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0133190	10.1371/journal.pone.0133190	http://dx.doi.org/10.1371/journal.pone.0133190			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LZ	26196674	Green Published, gold, Green Submitted			2022-12-26	WOS:000358547600069
J	O'Hara, NN; Roy, L; O'Hara, LM; Spiegel, JM; Lynd, LD; FitzGerald, JM; Yassi, A; Nophale, LE; Marra, CA				O'Hara, Nathan N.; Roy, Lilla; O'Hara, Lyndsay M.; Spiegel, Jerry M.; Lynd, Larry D.; FitzGerald, J. Mark; Yassi, Annalee; Nophale, Letshego E.; Marra, Carlo A.			Healthcare Worker Preferences for Active Tuberculosis Case Finding Programs in South Africa: A Best-Worst Scaling Choice Experiment	PLOS ONE			English	Article							DRUG-RESISTANT TUBERCULOSIS; INFECTION-CONTROL; SETTINGS	Objective Healthcare workers (HCWs) in South Africa are at a high risk of developing active tuberculosis (TB) due to their occupational exposures. This study aimed to systematically quantify and compare the preferred attributes of an active TB case finding program for HCWs in South Africa. Methods A Best-Worst Scaling choice experiment estimated HCW's preferences using a random-effects conditional logit model. Latent class analysis (LCA) was used to explore heterogeneity in preferences. Results "No cost", "the assurance of confidentiality", "no wait" and testing at the occupational health unit at one's hospital were the most preferred attributes. LCA identified a four class model with consistent differences in preference strength. Sex, occupation, and the time since a previous TB test were statistically significant predictors of class membership. Conclusions The findings support the strengthening of occupational health units in South Africa to offer free and confidential active TB case finding programs for HCWs with minimal wait times. There is considerable variation in active TB case finding preferences amongst HCWs of different gender, occupation, and testing history. Attention to heterogeneity in preferences should optimize screening utilization of target HCW populations.	[O'Hara, Nathan N.; O'Hara, Lyndsay M.; Spiegel, Jerry M.; Yassi, Annalee] Univ British Columbia, Sch Populat & Publ Hlth, Vancouver, BC V5Z 1M9, Canada; [Roy, Lilla; Lynd, Larry D.] Univ British Columbia, Fac Pharmaceut Sci, Collaborat Outcomes Res & Evaluat, Vancouver, BC V5Z 1M9, Canada; [FitzGerald, J. Mark] Univ British Columbia, Inst Heart & Lung Hlth, Vancouver, BC V5Z 1M9, Canada; [Nophale, Letshego E.] Univ Free State, Fac Hlth Sci, Dept Community Hlth, Bloemfontein, South Africa; [Marra, Carlo A.] Mem Univ, Sch Pharm, St John, NF, Canada	University of British Columbia; University of British Columbia; University of British Columbia; University of the Free State; Memorial University Newfoundland	Marra, CA (corresponding author), Mem Univ, Sch Pharm, St John, NF, Canada.	cmarra@mun.ca	O'Hara, Nathan/AAD-2819-2019; O'Hara, Nathan/O-7168-2018; Marra, Carlo/AAE-4904-2021	O'Hara, Nathan/0000-0003-0537-3474; O'Hara, Nathan/0000-0003-0537-3474; Marra, Carlo/0000-0002-2625-2121; Roy, Lilla/0000-0003-1725-9732; Lynd, Larry/0000-0002-7622-3919	Canadian Institutes of Health Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This study was conducted in the context of a collaborative Canadian-South African research program funded by the Canadian Institutes of Health Research [http://www.cihr-irsc.gc.ca/]. The funder had no role in the study design, data collection, analysis, decision to publish or preparation of the manuscript.	[Anonymous], 2014, PERSAL HLTH HU UNPUB; [Anonymous], 2014, TUB NAT MAN GUID; Baussano I, 2011, EMERG INFECT DIS, V17, P488, DOI 10.3201/eid1703.100947; Behr MA, 1999, LANCET, V353, P444, DOI 10.1016/S0140-6736(98)03406-0; Behrman A, 2013, J OCCUP ENVIRON MED, V55, P985, DOI 10.1097/JOM.0b013e3182a0d7cd; Buregyeya E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046069; Cheraghi-Sohi S, 2008, ANN FAM MED, V6, P107, DOI 10.1370/afm.816; Council SANA, 2012, NAT STRAT PLAN HIV S; Engelbrecht MC, 2015, S AFR J INF IN PRESS; Farley JE, 2012, INT J TUBERC LUNG D, V16, P82, DOI 10.5588/ijtld.10.0791; Flynn TN, 2007, J HEALTH ECON, V26, P171, DOI 10.1016/j.jhealeco.2006.04.002; Golub JE, 2013, INT J TUBERC LUNG D, V17, P856, DOI 10.5588/ijtld.13.0059; Hol L, 2010, BRIT J CANCER, V102, P972, DOI 10.1038/sj.bjc.6605566; Hutchinson PL, 2006, AIDS CARE, V18, P446, DOI 10.1080/09540120500213511; Joshi R, 2006, PLOS MED, V3, P2376, DOI 10.1371/journal.pmed.0030494; Khan R, 2015, AIDS CARE, V27, P198, DOI 10.1080/09540121.2014.951308; Kolbe-Alexander T, 2014, J OCCUP ENVIRON MED, V56, P1094, DOI 10.1097/JOM.0000000000000236; LANCASTER KJ, 1966, J POLIT ECON, V74, P132, DOI 10.1086/259131; Lancsar E, 2008, PHARMACOECONOMICS, V26, P661, DOI 10.2165/00019053-200826080-00004; Lancsar E, 2013, SOC SCI MED, V76, P74, DOI 10.1016/j.socscimed.2012.10.007; Lonnroth K, 2013, INT J TUBERC LUNG D, V17, P289, DOI 10.5588/ijtld.12.0797; Mabunda G, 2006, J TRANSCULT NURS, V17, P23, DOI 10.1177/1043659605281978; Marley AAJ, 2005, J MATH PSYCHOL, V49, P464, DOI 10.1016/j.jmp.2005.05.003; Matuka O, 2015, J HOSP INFECT, V89, P192, DOI 10.1016/j.jhin.2014.11.013; McCutcheon AL, 1987, LATENT CLASS ANAL; McFadden D., 1974, FRONTIERS ECONOMETRI; McLellan RK, 2009, J OCCUP ENVIRON MED, V51, P797, DOI 10.1097/JOM.0b013e3181a4b9e8; Menzies D, 2007, INT J TUBERC LUNG D, V11, P593; Naidoo A, 2013, SAMJ S AFR MED J, V103, P176, DOI [10.7196/SAMJ.6266, 10.7196/samj.6266]; Naidoo S, 2006, INT J TUBERC LUNG D, V10, P676; Nyblade L, 2009, J INT AIDS SOC, V12, DOI 10.1186/1758-2652-12-15; O'Donnell MR, 2010, ANN INTERN MED, V153, P516, DOI 10.7326/0003-4819-153-8-201010190-00008; Ryan Mandy, 2003, Appl Health Econ Health Policy, V2, P55; Shisana O, 2004, SAMJ S AFR MED J, V94, P846; The World Bank, 2010, SO AFR HIV AIDS TUB; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; WHO, 2010, SYST EV REV SUPP DEV; World Health Organization, 2008, GLOB TUB CONTR SURV; World Health Organization International Labour Organization Joint United Nations Programme on HIV/AIDS, 2010, JOINT WHO ILO UNAIDS; Yassi A, 2005, J OCCUP ENVIRON MED, V47, P41, DOI 10.1097/01.jom.0000150207.18085.41; Yassi A, 2014, GLOBAL HEALTH ACTION, V7, P1, DOI 10.3402/gha.v7.23594; Yassi A, 2011, BMC INT HEALTH HUM R, V11, DOI 10.1186/1472-698X-11-S2-S8; Yassi A, 2009, INT J OCCUP ENV HEAL, V15, P360, DOI 10.1179/oeh.2009.15.4.360; Zelnick JR, 2013, J PUBLIC HEALTH POL, V34, P388, DOI 10.1057/jphp.2013.20	44	14	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0133304	10.1371/journal.pone.0133304	http://dx.doi.org/10.1371/journal.pone.0133304			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN6LZ	26197344	Green Published, Green Submitted, gold			2022-12-26	WOS:000358547600082
J	Lin, ZL; Green, RS; Chen, SQ; Wu, H; Liu, TT; Li, JY; Wei, J; Lin, J				Lin, Zhenlang; Green, Robert S.; Chen, Shangqin; Wu, Hui; Liu, Tiantian; Li, Jingyang; Wei, Jia; Lin, Jing			Quantification of EUGR as a Measure of the Quality of Nutritional Care of Premature Infants	PLOS ONE			English	Article							POSTNATAL-GROWTH FAILURE; BIRTH-WEIGHT INFANTS; HEALTH-CARE; RETARDATION; PERFORMANCE; PAY; OUTCOMES; UNIT	Objectives To develop an index of the quality of nutritional care of premature infants based on the change in weight Z score from birth to discharge and to illustrate the use of this index in comparing the performance of different NICUs. Methods Retrospective data analysis was performed to compare the growth of premature infants born in three perinatal centers. Infants with gestational age <= 32 weeks who survived to discharge from 2006 to 2010 were included. Weight Z scores at birth and discharge were calculated by the method of Fenton. Using data from one NICU as the reference, a multivariable linear regression model of change in weight Z score from birth to discharge was developed. Employing this model, a benchmark value of change in weight Z score was calculated for each baby. The difference between this calculated benchmark value and the baby's observed change in weight Z score was defined as the performance gap for that infant. The average value of the performance gaps in a NICU serves as its quality care index. Results 1,714 infants were included for analysis. Change in weight Z score is influenced by birth weight Z score and completed weeks of gestation; thus the model for calculating the benchmark change in weight Z score was adjusted for these two variables. We found statistically significant differences in the average performance gaps for the three units. Conclusions A quality care index was developed based on change in weight Z score from birth to discharge adjusted for two initial risk factors. This objective, easily calculated index may be used as a measurement of the quality of nutritional care to rank the performance of different NICUs.	[Lin, Zhenlang; Chen, Shangqin; Li, Jingyang; Wei, Jia; Lin, Jing] Wenzhou Med Univ, Affiliated Hosp 2, Dept Neonatol, Wenzhou 325027, Peoples R China; [Lin, Zhenlang; Chen, Shangqin; Li, Jingyang; Wei, Jia; Lin, Jing] Wenzhou Med Univ, Yuying Childrens Hosp, Wenzhou 325027, Peoples R China; [Green, Robert S.; Lin, Jing] Icahn Sch Med Mt Sinai, Kravis Childrens Hosp, New York, NY 10029 USA; [Green, Robert S.; Lin, Jing] Icahn Sch Med Mt Sinai, Dept Pediat, New York, NY 10029 USA; [Wu, Hui; Liu, Tiantian] Jilin Univ, Hosp 1, Dept Neonatol, Changchun 130021, Peoples R China	Wenzhou Medical University; Wenzhou Medical University; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Jilin University	Lin, J (corresponding author), Wenzhou Med Univ, Affiliated Hosp 2, Dept Neonatol, Wenzhou 325027, Peoples R China.	jing.lin@mssm.edu	Lin, Jing/I-5293-2019	Lin, Jing/0000-0002-4405-134X				Bloom BT, 2003, PEDIATRICS, V112, P8, DOI 10.1542/peds.112.1.8; Clark Reese H, 2003, J Perinatol, V23, P337, DOI 10.1038/sj.jp.7210937; Clark RH, 2003, PEDIATRICS, V111, P986, DOI 10.1542/peds.111.5.986; Cooke RJ, 2004, ARCH DIS CHILD-FETAL, V89, pF428, DOI 10.1136/adc.2001.004044; Ehrenkranz RA, 2006, PEDIATRICS, V117, P1253, DOI 10.1542/peds.2005-1368; Ehrenkranz RA, 1999, PEDIATRICS, V104, P280, DOI 10.1542/peds.104.2.280; Ehrenkranz RA, 2007, SEMIN PERINATOL, V31, P48, DOI 10.1053/j.semperi.2007.02.001; Eijkenaar F, 2012, MED CARE RES REV, V69, P251, DOI 10.1177/1077558711432891; Embleton NE, 2001, PEDIATRICS, V107, P270, DOI 10.1542/peds.107.2.270; Fanaroff Avroy A, 2007, Am J Obstet Gynecol, V196, DOI 10.1016/j.ajog.2006.09.014; Fenton TR, 2007, EUR J CLIN NUTR, V61, P1380, DOI 10.1038/sj.ejcn.1602667; Fenton Tanis R, 2003, BMC Pediatr, V3, P13; Lucas A, 1998, BRIT MED J, V317, P1481, DOI 10.1136/bmj.317.7171.1481; Maas C, 2015, ARCH DIS CHILD-FETAL, V100, pF76, DOI 10.1136/archdischild-2014-306195; Marks KA, 2006, ACTA PAEDIATR, V95, P236, DOI 10.1080/08035250500358315; Moltu SJ, 2014, J PEDIATR GASTR NUTR, V58, P344, DOI 10.1097/MPG.0000000000000220; Olsen IE, 2003, J CLIN EPIDEMIOL, V56, P998, DOI 10.1016/S0895-4356(03)00168-9; Olsen IE, 2002, PEDIATRICS, V110, P1125, DOI 10.1542/peds.110.6.1125; Profit J, 2007, PEDIATRICS, V119, P975, DOI 10.1542/peds.2006-1565; Profit J, 2014, PEDIATRICS, V134, P74, DOI 10.1542/peds.2013-3552; Radmacher Paula G, 2003, J Perinatol, V23, P392, DOI 10.1038/sj.jp.7210947; RICHARDSON DK, 1993, PEDIATRICS, V91, P617; Shan HM, 2009, EUR J PEDIATR, V168, P1055, DOI 10.1007/s00431-008-0885-9; Spitzer AR, 2010, CLIN PERINATOL, V37, P167, DOI 10.1016/j.clp.2010.01.010	24	16	16	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2015	10	7							e0132584	10.1371/journal.pone.0132584	http://dx.doi.org/10.1371/journal.pone.0132584			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LN	26193640	Green Published, gold, Green Submitted			2022-12-26	WOS:000358546400032
J	Oswald, K; Milucka, J; Brand, A; Littmann, S; Wehrli, B; Kuypers, MMM; Schubert, CJ				Oswald, Kirsten; Milucka, Jana; Brand, Andreas; Littmann, Sten; Wehrli, Bernhard; Kuypers, Marcel M. M.; Schubert, Carsten J.			Light-Dependent Aerobic Methane Oxidation Reduces Methane Emissions from Seasonally Stratified Lakes	PLOS ONE			English	Article							ANAEROBIC OXIDATION; WATER COLUMN; SULFUR CYCLE; IRON; SEDIMENTS; BACTERIA; OXYGEN; METHANOTROPHS; REDUCTION; ABUNDANCE	Lakes are a natural source of methane to the atmosphere and contribute significantly to total emissions compared to the oceans. Controls on methane emissions from lake surfaces, particularly biotic processes within anoxic hypolimnia, are only partially understood. Here we investigated biological methane oxidation in the water column of the seasonally stratified Lake Rotsee. A zone of methane oxidation extending from the oxic/anoxic interface into anoxic waters was identified by chemical profiling of oxygen, methane and delta C-13 of methane. Incubation experiments with C-13-methane yielded highest oxidation rates within the oxycline, and comparable rates were measured in anoxic waters. Despite predominantly anoxic conditions within the zone of methane oxidation, known groups of anaerobic methanotrophic archaea were conspicuously absent. Instead, aerobic gammaproteobacterial methanotrophs were identified as the active methane oxidizers. In addition, continuous oxidation and maximum rates always occurred under light conditions. These findings, along with the detection of chlorophyll a, suggest that aerobic methane oxidation is tightly coupled to light-dependent photosynthetic oxygen production both at the oxycline and in the anoxic bottom layer. It is likely that this interaction between oxygenic phototrophs and aerobic methanotrophs represents a widespread mechanism by which methane is oxidized in lake water, thus diminishing its release into the atmosphere.	[Oswald, Kirsten; Brand, Andreas; Wehrli, Bernhard; Schubert, Carsten J.] Eawag, Swiss Fed Inst Aquat Sci & Technol, Dept Surface Waters Res & Management, Kastanienbaum, Switzerland; [Oswald, Kirsten; Brand, Andreas; Wehrli, Bernhard] ETH, Swiss Fed Inst Technol, Inst Biogeochem & Pollutant Dynam, Zurich, Switzerland; [Milucka, Jana; Littmann, Sten; Kuypers, Marcel M. M.] Max Planck Inst Marine Microbiol, Dept Biogeochem, Bremen, Germany	Swiss Federal Institutes of Technology Domain; Swiss Federal Institute of Aquatic Science & Technology (EAWAG); Swiss Federal Institutes of Technology Domain; ETH Zurich; Max Planck Society	Oswald, K (corresponding author), Eawag, Swiss Fed Inst Aquat Sci & Technol, Dept Surface Waters Res & Management, Kastanienbaum, Switzerland.	kirsten.oswald@eawag.ch	Wehrli, Bernhard/A-4406-2013; Wehrli, Bernhard/M-3847-2019; Wehrli, Bernhard/B-4420-2008; Schubert, Carsten/GQQ-1673-2022	Wehrli, Bernhard/0000-0001-7029-1972; Wehrli, Bernhard/0000-0001-7029-1972; Wehrli, Bernhard/0000-0001-7029-1972; Littmann, Sten/0000-0001-8685-5357; Brand, Andreas/0000-0002-3046-037X	Swiss National Science Foundation [135299, 153091, 128707]; Swiss Federal Institute of Aquatic Science and Technology (Eawag); Max-Planck-Gesellschaft	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swiss Federal Institute of Aquatic Science and Technology (Eawag); Max-Planck-Gesellschaft(Max Planck Society)	This study was supported by the Swiss National Science Foundation; grant numbers: 135299, 153091, 128707; http://www.snf.ch/en/Pages/default.aspx; BW CJS; Swiss Federal Institute of Aquatic Science and Technology (Eawag); http://www.eawag.ch; Max-Planck-Gesellschaft; http://www.mpg.de/en.	BARKER JF, 1981, NATURE, V293, P289, DOI 10.1038/293289a0; Bastviken D, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2004GB002238; Beal EJ, 2009, SCIENCE, V325, P184, DOI 10.1126/science.1169984; Blees J, 2014, LIMNOL OCEANOGR, V59, P311, DOI 10.4319/lo.2014.59.2.0311; Blumenberg M, 2007, ORG GEOCHEM, V38, P84, DOI 10.1016/j.orggeochem.2006.08.011; Boehrer B, 2008, REV GEOPHYS, V46, DOI 10.1029/2006RG000210; Bogard MJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6350; Carini S, 2005, ENVIRON MICROBIOL, V7, P1127, DOI 10.1111/j.1462-2920.2005.00786.x; CLINE JD, 1969, LIMNOL OCEANOGR, V14, P454, DOI 10.4319/lo.1969.14.3.0454; Coplen TB, 2002, 014222 US GEOL SURV, P01; Crowe SA, 2011, GEOBIOLOGY, V9, P61, DOI 10.1111/j.1472-4669.2010.00257.x; Crowe SA, 2008, LIMNOL OCEANOGR, V53, P319, DOI 10.4319/lo.2008.53.1.0319; Del Don C, 2001, AQUAT SCI, V63, P70, DOI 10.1007/PL00001345; Deutzmann JS, 2014, P NATL ACAD SCI USA, V111, P18273, DOI 10.1073/pnas.1411617111; Deutzmann JS, 2011, APPL ENVIRON MICROB, V77, P4429, DOI 10.1128/AEM.00340-11; Downing JA, 2006, LIMNOL OCEANOGR, V51, P2388, DOI 10.4319/lo.2006.51.5.2388; Dumestre JF, 1999, APPL ENVIRON MICROB, V65, P534; Durisch-Kaiser E, 2005, APPL ENVIRON MICROB, V71, P8099, DOI 10.1128/AEM.71.12.8099-8106.2005; Durisch-Kaiser E, 2011, J GEOPHYS RES-BIOGEO, V116, DOI 10.1029/2010JG001323; Ehhalt D., 2001, ATMOSPHERIC CHEM GRE; Ettwig KF, 2008, ENVIRON MICROBIOL, V10, P3164, DOI 10.1111/j.1462-2920.2008.01724.x; Ettwig KF, 2010, NATURE, V464, P543, DOI 10.1038/nature08883; Fenchel T., 1979, BACTERIA MINERAL CYC; Griess P., 1879, BER DTSCH CHEM GES, V12, P426, DOI [DOI 10.2147/DDDT.S165440, 10.1002/cber.187901201117., DOI 10.1002/CBER.187901201117]; Hanson RS, 1996, MICROBIOL REV, V60, P439, DOI 10.1128/MMBR.60.2.439-471.1996; Haroon MF, 2013, NATURE, V500, P567, DOI 10.1038/nature12375; Holmkvist L, 2011, GEOCHIM COSMOCHIM AC, V75, P3581, DOI 10.1016/j.gca.2011.03.033; Holtappels M, 2011, METHOD ENZYMOL, V486, P223, DOI [10.1016/S0076-6879(11)86010-6, 10.1016/B978-0-12-381294-0.00010-9]; IMBODEN DM, 1985, CHEM PROCESSES LAKES, P1; JORGENSEN BB, 1982, NATURE, V296, P643, DOI 10.1038/296643a0; KING GM, 1992, ADV MICROB ECOL, V12, P431; Kirf MK, 2014, AQUAT GEOCHEM, V20, P39, DOI 10.1007/s10498-013-9206-7; Knittel K, 2009, ANNU REV MICROBIOL, V63, P311, DOI 10.1146/annurev.micro.61.080706.093130; KOHLER HP, 1984, FEMS MICROBIOL LETT, V21, P279; Kuypers MMM, 2003, NATURE, V422, P608, DOI 10.1038/nature01472; Lavelli A, 2002, NUMERICAL 3D MODELLI; LEAK DJ, 1986, APPL MICROBIOL BIOT, V23, P470, DOI 10.1007/BF02346062; LEGENDRE L, 1983, LIMNOL OCEANOGR, V28, P996, DOI 10.4319/lo.1983.28.5.0996; Liikanen A, 2002, ARCH HYDROBIOL, V154, P585; MCAULLIF C, 1971, CHEM TECHNOL, P46; Milucka J, 2015, ISME J, V9, P1991, DOI 10.1038/ismej.2015.12; Milucka J, 2012, NATURE, V491, P541, DOI 10.1038/nature11656; Murase J, 2005, LIMNOL OCEANOGR, V50, P1339, DOI 10.4319/lo.2005.50.4.1339; Murase J., 2005, FOREST ECOSYSTEMS EN, P143; MURRAY AP, 1986, MAR CHEM, V19, P211, DOI 10.1016/0304-4203(86)90024-1; Musat N, 2008, P NATL ACAD SCI USA, V105, P17861, DOI 10.1073/pnas.0809329105; Neef L, 2010, GLOBAL BIOGEOCHEM CY, V24, DOI 10.1029/2009GB003661; Nordi KA, 2013, LIMNOL OCEANOGR, V58, P546, DOI 10.4319/lo.2013.58.2.0546; Nyerges G, 2010, APPL ENVIRON MICROB, V76, P5648, DOI 10.1128/AEM.00747-10; PANGANIBAN AT, 1979, APPL ENVIRON MICROB, V37, P303, DOI 10.1128/AEM.37.2.303-309.1979; Pernthaler A, 2008, P NATL ACAD SCI USA, V105, P7052, DOI 10.1073/pnas.0711303105; Polerecky L, 2012, ENVIRON MICROBIOL, V14, P1009, DOI 10.1111/j.1462-2920.2011.02681.x; Raghoebarsing AA, 2006, NATURE, V440, P918, DOI 10.1038/nature04617; Reeburgh WS, 2007, CHEM REV, V107, P486, DOI 10.1021/cr050362v; Riedinger N, 2014, GEOBIOLOGY, V12, P172, DOI 10.1111/gbi.12077; Ross JL, 1997, MICROBIAL ECOL, V34, P97, DOI 10.1007/s002489900039; RUDD JWM, 1975, ARCH HYDROBIOL, V75, P522; RUDD JWM, 1976, LIMNOL OCEANOGR, V21, P357, DOI 10.4319/lo.1976.21.3.0357; Schubert CJ, 2010, AQUAT SCI, V72, P455, DOI 10.1007/s00027-010-0148-5; Schubert CJ, 2006, ENVIRON MICROBIOL, V8, P1844, DOI 10.1111/j.1462-2920.2006.01079.x; Schubert CJ, 2011, FEMS MICROBIOL ECOL, V76, P26, DOI 10.1111/j.1574-6941.2010.01036.x; Sivan O, 2011, LIMNOL OCEANOGR, V56, P1536, DOI 10.4319/lo.2011.56.4.1536; Slomp CP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062386; Sundh I, 2005, APPL ENVIRON MICROB, V71, P6746, DOI 10.1128/AEM.71.11.6746-6752.2005; Wankel SD, 2012, ENVIRON MICROBIOL, V14, P2726, DOI 10.1111/j.1462-2920.2012.02825.x; Wetzel R, 2001, LIMNOLOGY 3 E LAKE R; WIESENBURG DA, 1979, J CHEM ENG DATA, V24, P356, DOI 10.1021/je60083a006; WINTERMANS JF, 1965, BIOCHIM BIOPHYS ACTA, V109, P448, DOI 10.1016/0926-6585(65)90170-6; Wise MG, 2001, INT J SYST EVOL MICR, V51, P611, DOI 10.1099/00207713-51-2-611; Wuest A, 2003, ANNU REV FLUID MECH, V35, P373, DOI 10.1146/annurev.fluid.35.101101.161220	70	85	92	5	86	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2015	10	7							e0132574	10.1371/journal.pone.0132574	http://dx.doi.org/10.1371/journal.pone.0132574			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LN	26193458	Green Submitted, Green Published, gold			2022-12-26	WOS:000358546400031
J	Li, XQ; Ye, D; Liang, HW; Zhu, HG; Qin, L; Zhu, YL; Wen, YG				Li, Xiaoqiong; Ye, Duo; Liang, Hongwen; Zhu, Hongguang; Qin, Lin; Zhu, Yuling; Wen, Yuanguang			Effects of Successive Rotation Regimes on Carbon Stocks in Eucalyptus Plantations in Subtropical China Measured over a Full Rotation	PLOS ONE			English	Article							SOIL ORGANIC-CARBON; MECHANICAL SITE PREPARATION; RESIDUE MANAGEMENT; WEED-CONTROL; CUNNINGHAMIA-LANCEOLATA; UNDERSTORY VEGETATION; PINE PLANTATION; CLIMATE-CHANGE; AGE-SEQUENCE; BULK-DENSITY	Plantations play an important role in carbon sequestration and the global carbon cycle. However, there is a dilemma in that most plantations are managed on short rotations, and the carbon sequestration capacities of these short-rotation plantations remain understudied. Eucalyptus has been widely planted in the tropics and subtropics due to its rapid growth, high adaptability, and large economic return. Eucalyptus plantations are primarily planted in successive rotations with a short rotation length of 6 similar to 8 years. In order to estimate the carbon-stock potential of eucalyptus plantations over successive rotations, we chose a first rotation (FR) and a second rotation (SR) stand and monitored the carbon stock dynamics over a full rotation from 1998 to 2005. Our results showed that carbon stock in eucalyptus trees (TC) did not significantly differ between rotations, while understory vegetation (UC) and soil organic matter (SOC) stored less carbon in the SR (1.01 vs. 2.76 Mg.ha(-1) and 70.68 vs. 81.08 Mg.ha(-1), respectively) and forest floor carbon (FFC) conversely stored more (2.80 vs. 2.34 Mg.ha(-1)). The lower UC and SOC stocks in the SR stand resulted in 1.13 times lower overall ecosystem carbon stock. Mineral soils and overstory trees were the two dominant carbon pools in eucalyptus plantations, accounting for 73.77%similar to 75.06% and 20.50%similar to 22.39%, respectively, of the ecosystem carbon pool. However, the relative contribution (to the ecosystem pool) of FFC stocks increased 1.38 times and that of UC decreased 2.30 times in the SR versus FR stand. These carbon pool changes over successive rotations were attributed to intensive successive rotation regimes of eucalyptus plantations. Our eight year study suggests that for the sustainable development of short-rotation plantations, a sound silvicultural strategy is required to achieve the best combination of high wood yield and carbon stock potential.	[Li, Xiaoqiong; Ye, Duo; Liang, Hongwen; Zhu, Hongguang; Qin, Lin; Zhu, Yuling; Wen, Yuanguang] Guangxi Univ, Coll Forestry, State Key Lab Conservat & Utilizat Subtrop Agrobi, Nanning, Guangxi, Peoples R China; [Li, Xiaoqiong; Ye, Duo; Liang, Hongwen; Zhu, Hongguang; Qin, Lin; Zhu, Yuling; Wen, Yuanguang] Guangxi Univ, Guangxi Coll & Univ, Coll Forestry, Key Lab Forestry Sci & Engn, Nanning 530004, Guangxi, Peoples R China	Guangxi University; Guangxi University	Wen, YG (corresponding author), Guangxi Univ, Coll Forestry, State Key Lab Conservat & Utilizat Subtrop Agrobi, Nanning, Guangxi, Peoples R China.	wenyg@263.net			Chinese National Natural Science Foundation [31460121]; Chinese Postdoctoral Science Foundation [2014M552286]; Ministry of Science and Technology [2012BAD22B01]; Chairman Foundation of Guangxi Zhuang Autonomous Region [11166-01]; Natural Science Foundation of Guangxi Zhuang Autonomous Region [1123014, 11199001]; Forestry Bureau of Guangxi Zhuang Autonomous Region	Chinese National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Chinese Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Chairman Foundation of Guangxi Zhuang Autonomous Region; Natural Science Foundation of Guangxi Zhuang Autonomous Region(National Natural Science Foundation of Guangxi Province); Forestry Bureau of Guangxi Zhuang Autonomous Region	This study was funded by the Chinese National Natural Science Foundation (31460121), the Chinese Postdoctoral Science Foundation (2014M552286), the Ministry of Science and Technology (2012BAD22B01), the Chairman Foundation of Guangxi Zhuang Autonomous Region (11166-01), the Natural Science Foundation of Guangxi Zhuang Autonomous Region (1123014 and 11199001) and the Forestry Bureau of Guangxi Zhuang Autonomous Region.	Archibold OW, 2000, FOREST ECOL MANAG, V131, P127, DOI 10.1016/S0378-1127(99)00205-4; Bauhus J, 2001, FOREST ECOL MANAG, V144, P275, DOI 10.1016/S0378-1127(00)00403-5; Bonan GB, 2008, SCIENCE, V320, P1444, DOI 10.1126/science.1155121; Canadell JG, 2008, SCIENCE, V320, P1456, DOI 10.1126/science.1155458; Carneiro A, 2008, FOREST ECOL MANAG, V255, P591, DOI 10.1016/j.foreco.2007.09.028; Chen DM, 2011, AGR FOREST METEOROL, V151, P1214, DOI 10.1016/j.agrformet.2011.04.011; Choi SD, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI 10.1029/2002GB001914; Devine WD, 2007, AGR FOREST METEOROL, V145, P125, DOI 10.1016/j.agrformet.2007.04.009; Fabiao A, 2002, FOREST ECOL MANAG, V171, P87, DOI 10.1016/S0378-1127(02)00463-2; Fernandez C, 2004, FOREST ECOL MANAG, V195, P85, DOI 10.1016/j.foreco.2004.02.052; Fialho RC, 2014, LAND DEGRAD DEV, V25, P428, DOI 10.1002/ldr.2158; Follett RF, 2001, SOIL TILL RES, V61, P77, DOI 10.1016/S0167-1987(01)00180-5; Fonseca F, 2014, FOREST SYST, V23, P84, DOI 10.5424/fs/2014231-04233; Goodale CL, 2002, ECOL APPL, V12, P891, DOI 10.2307/3060997; Grigal DF, 1998, BIOMASS BIOENERG, V14, P371, DOI 10.1016/S0961-9534(97)10073-3; Haeussler S, 1999, CAN J FOREST RES, V29, P1084, DOI 10.1139/cjfr-29-7-1084; [韩艺师 HAN YiShi], 2008, [生态学报, Acta Ecologica Sinica], V28, P4609; Huang XM, 2014, SOIL BIOL BIOCHEM, V73, P42, DOI 10.1016/j.soilbio.2014.01.021; Ibell PT, 2013, PLANT SOIL, V369, P199, DOI 10.1007/s11104-012-1554-3; IUSS-Working-Group-WRB, 2006, WORLD REF BAS SOIL R; Jandl R, 2007, GEODERMA, V137, P253, DOI 10.1016/j.geoderma.2006.09.003; Jouquet P, 2012, BIOL FERT SOILS, V48, P561, DOI 10.1007/s00374-011-0652-3; Keith AM, 2015, GCB BIOENERGY, V7, P541, DOI 10.1111/gcbb.12168; Laclau JP, 2010, FOREST ECOL MANAG, V260, P2148, DOI 10.1016/j.foreco.2010.09.007; Lehmann J, 2011, SOIL BIOL BIOCHEM, V43, P1812, DOI 10.1016/j.soilbio.2011.04.022; Lemma B, 2006, GEODERMA, V136, P886, DOI 10.1016/j.geoderma.2006.06.008; Li X, 2011, J PLANT BIOL, V54, P33, DOI 10.1007/s12374-010-9140-9; Liu SR, 1998, ECOL ENG, V10, P75, DOI 10.1016/S0925-8574(97)10024-6; Liu Wen-fei, 2009, Shengtaixue Zazhi, V28, P1928; Luyssaert S, 2008, NATURE, V455, P213, DOI 10.1038/nature07276; Mendham DS, 2003, FOREST ECOL MANAG, V181, P357, DOI 10.1016/S0378-1127(03)00007-0; Ming AG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109730; da Silva PHM, 2011, FOREST ECOL MANAG, V261, P2075, DOI 10.1016/j.foreco.2011.03.001; Nave LE, 2010, FOREST ECOL MANAG, V259, P857, DOI 10.1016/j.foreco.2009.12.009; NEARY DG, 1990, FOREST ECOL MANAG, V30, P271, DOI 10.1016/0378-1127(90)90142-X; Newmaster SG, 2007, FOREST ECOL MANAG, V246, P196, DOI 10.1016/j.foreco.2007.03.058; O'Connell AM, 2004, SOIL BIOL BIOCHEM, V36, P39, DOI 10.1016/j.soilbio.2003.08.017; Pei SF, 2008, AGR ECOSYST ENVIRON, V124, P33, DOI 10.1016/j.agee.2007.08.008; Peichl M, 2006, AGR FOREST METEOROL, V140, P51, DOI 10.1016/j.agrformet.2006.08.004; Pregitzer KS, 2004, GLOBAL CHANGE BIOL, V10, P2052, DOI 10.1111/j.1365-2486.2004.00866.x; QI SX., 2002, EUCALYPTUS IN CHINA; Ramovs BV, 2003, ECOL APPL, V13, P1682, DOI 10.1890/02-5237; Ranatunga K, 2008, FOREST ECOL MANAG, V255, P2407, DOI 10.1016/j.foreco.2008.01.002; Seiwa K, 2012, FOREST ECOL MANAG, V269, P177, DOI 10.1016/j.foreco.2011.12.014; Subedi P, 2014, SOIL SCI SOC AM J, V78, pS152, DOI 10.2136/sssaj2013.08.0345nafsc; Throop HL, 2012, J ARID ENVIRON, V77, P66, DOI 10.1016/j.jaridenv.2011.08.020; Tian HQ, 1998, NATURE, V396, P664, DOI 10.1038/25328; Turner J, 2000, FOREST ECOL MANAG, V133, P231, DOI 10.1016/S0378-1127(99)00236-4; Wang H, 2013, FOREST ECOL MANAG, V300, P4, DOI 10.1016/j.foreco.2012.04.005; Wang QK, 2008, FOREST ECOL MANAG, V255, P1210, DOI 10.1016/j.foreco.2007.10.026; Wang WJ, 2011, GLOBAL CHANGE BIOL, V17, P2657, DOI 10.1111/j.1365-2486.2011.02447.x; Wang XK, 2001, FOREST ECOL MANAG, V148, P117, DOI 10.1016/S0378-1127(00)00482-5; Wen Y. G., 2005, CHIN J APPL ECOL, V16, P1667; Wen YG, 2006, PLANT DIVERSITY ECOS; Wen YG, 2010, J FOREST RES-JPN, V15, P252, DOI 10.1007/s10310-010-0179-8; Yanai RD, 2003, ECOSYSTEMS, V6, P197, DOI 10.1007/s10021-002-0206-5; Yang M, 2012, J SOIL WATER CONSERV, V2, P035; Zhang JW, 2013, FORESTRY, V86, P3, DOI 10.1093/forestry/cps054; Zhang XQ, 2004, FOREST ECOL MANAG, V202, P131, DOI 10.1016/j.foreco.2004.07.032; Zinn YL, 2011, SOIL RES, V49, P614, DOI 10.1071/SR11264	60	14	17	3	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0132858	10.1371/journal.pone.0132858	http://dx.doi.org/10.1371/journal.pone.0132858			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RV	26186367	Green Published, gold, Green Submitted			2022-12-26	WOS:000358198700067
J	Lavoue, R; Trumel, C; Smets, PMY; Braun, JP; Aresu, L; Daminet, S; Concordet, D; Palanche, F; Peeters, D				Lavoue, Rachel; Trumel, Catherine; Smets, Pascale M. Y.; Braun, Jean-Pierre; Aresu, Luca; Daminet, Sylvie; Concordet, Didier; Palanche, Florence; Peeters, Dominique			Characterization of Proteinuria in Dogue de Bordeaux Dogs, a Breed Predisposed to a Familial Glomerulonephropathy: A Retrospective Study	PLOS ONE			English	Article							RETINOL-BINDING-PROTEIN; FOCAL SEGMENTAL GLOMERULOSCLEROSIS; AGAROSE GEL-ELECTROPHORESIS; TO-CREATININE RATIO; REFERENCE INTERVALS; GLOMERULAR-DISEASE; URINARY PROTEIN; RENAL-DISEASE; CANINE URINE; KIDNEY	Dogue de Bordeaux dog has been reported to be predisposed to a familial glomerulonephropathy that displays some morphological modifications reported in focal and segmental glomerulosclerosis. Prevalence of quantitatively abnormal renal proteinuria was recently reported to be 33% in this breed. The nature of the proteinuria was assessed by sodium dodecyl sulfate-agarose gel electrophoresis and determinations of urinary markers (urinary retinol-binding protein, urinary N-acetyl-beta-glucosaminidase, urinary albumin and urinary immunoglobulin G) on stored specimens. Diagnostic performances of sodium dodecyl sulfate-agarose gel electrophoresis to identify dogs with elevated urinary biomarkers were assessed. Samples from 102 adult Dogue de Bordeaux dogs (47 non-proteinuric [urine protein-to-creatinine ratio <= 0.2], 20 borderline-proteinuric [0.2 < urine protein-to-creatinine ratio <= 0.5] and 35 proteinuric dogs [urine protein-to-creatinine ratio > 0.5]) were used, of which 2 were suffering from familial glomerulonephropathy. The electrophoretic protein patterns, for all but one proteinuric dog, were indicative of a glomerular origin and, in all dogs, the urinary albumin concentration related to creatinine concentration and the urinary immunoglobulin G concentration related to creatinine concentration were above the upper limit of the reference interval established for the breed. Sensitivity and specificity of sodium dodecyl sulfate-agarose gel electrophoresis identifying dogs with elevated urinary albumin concentration were 94% and 92%, respectively, while diagnostic performance of sodium dodecyl sulfate-agarose gel electrophoresis in detecting dogs with elevated urinary immunoglobulin G concentration yielded sensitivity and specificity of 90% and 74%, respectively. These results suggest that all proteinuric and some borderline-proteinuric Dogue de Bordeaux dogs likely have underlying glomerular lesions and that sodium dodecyl sulfate-agarose gel electrophoresis and urinary markers might be useful to screen dogs with borderline-proteinuria. Additional investigations are warranted to assess if these findings are related to the familial glomerulonephropathy.	[Lavoue, Rachel] INP ENVT, Internal Med Unit, Toulouse, France; [Trumel, Catherine; Braun, Jean-Pierre; Palanche, Florence] Univ Toulouse, UPS, INP, ENVT,Lab Cent Biol Med,UMS006, Toulouse, France; [Trumel, Catherine; Braun, Jean-Pierre] INSERM, Lab Cent Biol Med, UMS 006, Toulouse, France; [Smets, Pascale M. Y.; Daminet, Sylvie] Univ Ghent, Fac Vet Med, Dept Med & Clin Biol Small Anim, Merelbeke, Belgium; [Aresu, Luca] Univ Padua, Dept Comparat Biomed & Food Sci, Padua, Italy; [Concordet, Didier] INP ENVT, INRA, UMR Toxalim 1331, Toulouse, France; [Peeters, Dominique] Univ Liege, Fac Vet Med, Dept Compan Anim Clin Sci, Liege, Belgium	Universite de Toulouse; Ecole Nationale Veterinaire de Toulouse; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); Universite de Toulouse; Ecole Nationale Veterinaire de Toulouse; Universite Toulouse III - Paul Sabatier; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National Polytechnique de Toulouse; Institut National de la Sante et de la Recherche Medicale (Inserm); Ghent University; University of Padua; INRAE; Universite de Toulouse; Ecole Nationale Veterinaire de Toulouse; University of Liege	Lavoue, R (corresponding author), INP ENVT, Internal Med Unit, Toulouse, France.	r.lavoue@envt.fr	Concordet, Didier/AAT-1120-2020; Aresu, Luca/J-9788-2018	Concordet, Didier/0000-0003-3916-577X; Daminet, Sylvie/0000-0001-6733-7925; Lavoue, Rachel/0000-0003-3461-5532; Aresu, Luca/0000-0002-7893-1740; trumel, cathy/0000-0001-9717-5808				Amer H, 2013, AM J TRANSPLANT, V13, P676, DOI 10.1111/ajt.12044; Aresu L, 2010, J COMP PATHOL, V143, P190, DOI 10.1016/j.jcpa.2009.12.016; Beaufays F, 2008, THERIOGENOLOGY, V70, P1057, DOI 10.1016/j.theriogenology.2008.06.026; Bourdaud'hui P, 2012, SIMULATION PREDICTIV, P264; BROWN JS, 2010, VET CLIN PATH, V39, P556; CENTER SA, 1985, J AM VET MED ASSOC, V187, P820; Christensen EI, 1999, J AM SOC NEPHROL, V10, P685; Clinical and Laboratory Standards Institute C, 2008, C28A3 I CALS; Costigan MG, 1996, CLIN CHIM ACTA, V255, P133, DOI 10.1016/0009-8981(96)06400-5; D'Amico G, 2003, KIDNEY INT, V63, P809, DOI 10.1046/j.1523-1755.2003.00840.x; de Mik SML, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-74; Friedrichs KR, 2012, VET CLIN PATH, V41, P441, DOI 10.1111/vcp.12006; Geffre A, 2009, VET CLIN PATH, V38, P477, DOI 10.1111/j.1939-165X.2009.00155.x; Geffre A, 2009, VET CLIN PATH, V38, P288, DOI 10.1111/j.1939-165X.2009.00179.x; Giori L, 2011, J VET DIAGN INVEST, V23, P682, DOI 10.1177/1040638711407900; GRAUER GF, 1985, AM J VET RES, V46, P2116; Grauer GF, 2011, TOP COMPANION ANIM M, V26, P121, DOI 10.1053/j.tcam.2011.04.002; Hebert LA, 2000, KIDNEY INT, V57, P1962, DOI 10.1046/j.1523-1755.2000.00045.x; International Renal Interest Society I, 2009, STAGING CKD; Jefferson JA, 2014, ADV CHRONIC KIDNEY D, V21, P398, DOI 10.1053/j.ackd.2014.05.008; Kania K, 2010, ANN CLIN BIOCHEM, V47, P151, DOI 10.1258/acb.2009.009247; Lavoue R, 2014, VET CLIN PATH, V43, P352, DOI 10.1111/vcp.12151; Lavoue R, 2013, VET CLIN PATH, V42, P346, DOI 10.1111/vcp.12067; Lavoue R, 2010, J VET INTERN MED, V24, P314, DOI 10.1111/j.1939-1676.2010.0474.x; Lee RS, 2008, J PROTEOME RES, V7, P4022, DOI 10.1021/pr800301h; Lees GE, 1999, AM J VET RES, V60, P373; Lees GE, 1998, J AM ANIM HOSP ASSOC, V34, P189, DOI 10.5326/15473317-34-3-189; Lees GE, 2005, J VET INTERN MED, V19, P377, DOI 10.1892/0891-6640(2005)19[377:AAMOPI]2.0.CO;2; Lees GE, 2011, TOP COMPANION ANIM M, V26, P143, DOI 10.1053/j.tcam.2011.04.006; Li YH, 2012, BMC NEPHROL, V13, DOI 10.1186/1471-2369-13-29; LILLEHOJ EP, 1986, EXP PATHOL-JENA, V29, P1; Maachi M, 2004, CLIN CHEM, V50, P1834, DOI 10.1373/clinchem.2004.035691; Maddens B, 2011, J VET INTERN MED, V25, P1075, DOI [10.1111/j.1939-1676.2011.0772.x, 10.1111/j.1939-1676.2011.00772.x]; Maddens B, 2010, J VET INTERN MED, V24, P1263, DOI 10.1111/j.1939-1676.2010.0603.x; Maddens BEJ, 2010, VET IMMUNOL IMMUNOP, V134, P259, DOI 10.1016/j.vetimm.2009.09.003; Nabity MB, 2012, J VET INTERN MED, V26, P282, DOI 10.1111/j.1939-1676.2012.00891.x; Nabity MB, 2011, VET CLIN PATH, V40, P222, DOI 10.1111/j.1939-165X.2011.00307.x; Raila J, 2010, AM J VET RES, V71, P1387, DOI 10.2460/ajvr.71.11.1387; SCARPIONI L, 1976, CLIN CHIM ACTA, V68, P107, DOI 10.1016/0009-8981(76)90409-5; Schellenberg S, 2008, J VET INTERN MED, V22, P273, DOI 10.1111/j.1939-1676.2007.0039.x; Schultze A. E., 1989, Veterinary Clinical Pathology, V18, P93, DOI 10.1111/j.1939-165X.1989.tb00527.x; Smets PMY, 2010, J VET INTERN MED, V24, P65, DOI 10.1111/j.1939-1676.2009.0426.x; Smets PMY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031702; Smets PMY, 2010, J VET DIAGN INVEST, V22, P896, DOI 10.1177/104063871002200607; Stokes MB, 2014, ADV CHRONIC KIDNEY D, V21, P400, DOI 10.1053/j.ackd.2014.02.010; Vaden SL, 2011, TOP COMPANION ANIM M, V26, P128, DOI 10.1053/j.tcam.2011.04.003; Vinge L, 2010, NEPHROL DIAL TRANSPL, V25, P2458, DOI 10.1093/ndt/gfq044; WHITE JV, 1984, J AM VET MED ASSOC, V185, P882; Yalcin A, 2004, REV MED VET-TOULOUSE, V155, P104; Yee J, 2014, ADV CHRONIC KIDNEY D, V21, P395, DOI 10.1053/j.ackd.2014.07.001; Zaragoza C, 2004, THERIOGENOLOGY, V61, P1259, DOI 10.1016/j.theriogenology.2003.07.019; Zatelli F, 2002, J VET INTERN MED, V16, P389; Zini E, 2004, AM J VET RES, V65, P964, DOI 10.2460/ajvr.2004.65.964	53	9	9	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2015	10	7							e0133311	10.1371/journal.pone.0133311	http://dx.doi.org/10.1371/journal.pone.0133311			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RQ	26181659	gold, Green Published, Green Submitted			2022-12-26	WOS:000358198200061
J	Sivagnanalingam, U; Balys, M; Eberhardt, A; Wang, N; Myers, JR; Ashton, JM; Becker, MW; Calvi, LM; Mendler, JH				Sivagnanalingam, Umayal; Balys, Marlene; Eberhardt, Allison; Wang, Nancy; Myers, Jason R.; Ashton, John M.; Becker, Michael W.; Calvi, Laura M.; Mendler, Jason H.			Residual Disease in a Novel Xenograft Model of RUNX1-Mutated, Cytogenetically Normal Acute Myeloid Leukemia	PLOS ONE			English	Article							RUNX1 MUTATIONS; OLDER PATIENTS; UP-REGULATION; AML CELLS; BONE	Cytogenetically normal acute myeloid leukemia (CN-AML) patients harboring RUNX1 mutations have a dismal prognosis with anthracycline/cytarabine-based chemotherapy. We aimed to develop an in vivo model of RUNX1-mutated, CN-AML in which the nature of residual disease in this molecular disease subset could be explored. We utilized a well-characterized patient-derived, RUNX1-mutated CN-AML line (CG-SH). Tail vein injection of CG-SH into NOD scid gamma mice led to leukemic engraftment in the bone marrow, spleen, and peripheral blood within 6 weeks. Treatment of leukemic mice with anthracycline/ cytarabine-based chemotherapy resulted in clearance of disease from the spleen and peripheral blood, but persistence of disease in the bone marrow as assessed by flow cytometry and secondary transplantation. Whole exome sequencing of CG-SH revealed mutations in ASXL1, CEBPA, GATA2, and SETBP1, not previously reported. We conclude that CG-SH xenografts are a robust, reproducible in vivo model of CN-AML in which to explore mechanisms of chemotherapy resistance and novel therapeutic approaches.	[Sivagnanalingam, Umayal; Balys, Marlene; Eberhardt, Allison; Becker, Michael W.; Calvi, Laura M.; Mendler, Jason H.] Univ Rochester, Med Ctr, Dept Med, James P Wilmot Canc Inst, Rochester, NY 14642 USA; [Wang, Nancy] Univ Rochester, Med Ctr, Dept Pathol & Lab Med, Rochester, NY 14642 USA; [Myers, Jason R.; Ashton, John M.] Univ Rochester, Med Ctr, Genom Res Ctr, Rochester, NY 14642 USA; [Ashton, John M.] Univ Rochester, Med Ctr, Dept Microbiol & Immunol, James P Wilmot Canc Inst, Rochester, NY 14642 USA	University of Rochester; University of Rochester; University of Rochester; University of Rochester	Mendler, JH (corresponding author), Univ Rochester, Med Ctr, Dept Med, James P Wilmot Canc Inst, Rochester, NY 14642 USA.	jason_mendler@urmc.rochester.edu	Calvi, Laura/P-6988-2019	Calvi, Laura/0000-0001-6969-239X; Ashton, John/0000-0001-9875-5994; Mendler, Jason/0000-0001-5605-5324	Wilmot Cancer Research Fellowship; National Institutes of Health [NCI: CA166280]; Department of Defense [BM110106]; NATIONAL CANCER INSTITUTE [R01CA166280] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000042] Funding Source: NIH RePORTER	Wilmot Cancer Research Fellowship; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	JHM is supported by the Wilmot Cancer Research Fellowship. LMC and MWB are supported by the National Institutes of Health (NCI: CA166280) and the Department of Defense (BM110106). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barabe F, 2007, SCIENCE, V316, P600, DOI 10.1126/science.1139851; Calvi LM, 2001, J CLIN INVEST, V107, P277, DOI 10.1172/JCI11296; Duan CW, 2014, CANCER CELL, V25, P778, DOI 10.1016/j.ccr.2014.04.015; Gaidzik VI, 2011, J CLIN ONCOL, V29, P1364, DOI 10.1200/JCO.2010.30.7926; Greif PA, 2012, HAEMATOL-HEMATOL J, V97, P1909, DOI 10.3324/haematol.2012.064667; Ishikawa F, 2007, NAT BIOTECHNOL, V25, P1315, DOI 10.1038/nbt1350; Jacamo R, 2014, BLOOD, V123, P2691, DOI 10.1182/blood-2013-06-511527; Konopleva M, 2002, LEUKEMIA, V16, P1713, DOI 10.1038/sj.leu.2402608; Ley TJ, 2013, NEW ENGL J MED, V368, P2059, DOI 10.1056/NEJMoa1301689; Matsunaga T, 2003, NAT MED, V9, P1158, DOI 10.1038/nm909; Meads MB, 2009, NAT REV CANCER, V9, P665, DOI 10.1038/nrc2714; Mendler JH, 2012, J CLIN ONCOL, V30, P3109, DOI 10.1200/JCO.2011.40.6652; Metzeler KH, 2011, BLOOD, V118, P6920, DOI 10.1182/blood-2011-08-368225; Munker R, 2009, LEUKEMIA RES, V33, P1405, DOI 10.1016/j.leukres.2009.04.008; Patel JP, 2012, NEW ENGL J MED, V366, P1079, DOI 10.1056/NEJMoa1112304; Schnittger S, 2011, BLOOD, V117, P2348, DOI 10.1182/blood-2009-11-255976; Tang JL, 2009, BLOOD, V114, P5352, DOI 10.1182/blood-2009-05-223784; Wunderlich M, 2013, BLOOD, V121, pE90, DOI 10.1182/blood-2012-10-464677	18	1	1	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0132375	10.1371/journal.pone.0132375	http://dx.doi.org/10.1371/journal.pone.0132375			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26177509	Green Published, Green Submitted, gold			2022-12-26	WOS:000358197600108
J	Yang, SY; Walther, BA; Weng, GJ				Yang, Shu-Yi; Walther, Bruno A.; Weng, Guo-Jing			Stop and Smell the Pollen: The Role of Olfaction and Vision of the Oriental Honey Buzzard in Identifying Food	PLOS ONE			English	Article							RECEPTOR GENE REPERTOIRES; CATHARTES-MELAMBROTUS; ODOR RECOGNITION; BIRDS; COLOR; NAVIGATION; EVOLUTION; SCENT; CUES; AVOIDANCE	The importance of olfaction for various avian behaviors has become increasingly evident. So far, the use of olfaction for food detection among raptors has only been demonstrated for Cathartes vultures. The Oriental honey buzzard (Pernis orientalis) is a resident and migrant in Taiwan and regularly forages in apiaries. One of its foods in apiaries is yellow pollen dough, a softball-sized mixture of pollen, soybeans, and sugar that beekeepers provide as a supplementary food for bees. Given that pollen dough is not similar to any naturally occurring food, we hypothesized that buzzards identify the dough's nutritious contents using olfaction, perhaps in combination with vision. Using a series of choice experiments in which individuals could choose between two doughs, we showed that (1) buzzards almost unerringly chose pollen-containing over pollen lacking doughs when otherwise the doughs were identical in size, shape, and yellow color; (2) buzzards always preferred yellow over black or green doughs if both doughs contained pollen; (3) buzzards still preferred pollen-containing over pollen-lacking doughs when both doughs were black, but at a lower rate than in (1). We statistically excluded the possible influences of the doughs' relative brightness or of repeat visits by the same individuals. Our experiments thus suggest the use of a 'multi-modal foraging strategy' among buzzards whereby olfaction and vision are likely to be both used in identifying food at close distances. We also estimated the olfactory receptor gene repertoire size in the buzzard's genome which is almost five times as large as that of three other raptor species. Therefore, olfaction is likely of far greater ecological importance to this species than to other raptor species. We suggest that olfaction should be considered in the design of behavioral and genetic studies to better understand the use of multiple senses in avian behaviors.	[Yang, Shu-Yi; Weng, Guo-Jing] Natl Pingtung Univ Sci & Technol, Coll Vet Med, Inst Wildlife Conservat, Pingtung, Taiwan; [Walther, Bruno A.] Taipei Med Univ, Coll Publ Hlth & Nutr, Program Global Hlth & Dev, Taipei, Taiwan	National Pingtung University Science & Technology; Taipei Medical University	Weng, GJ (corresponding author), Natl Pingtung Univ Sci & Technol, Coll Vet Med, Inst Wildlife Conservat, Pingtung, Taiwan.	gjw@mail.npust.edu.tw						Almeida-Muradian LB, 2005, J FOOD COMPOS ANAL, V18, P105, DOI 10.1016/j.jfca.2003.10.008; Amo L, 2008, FUNCT ECOL, V22, P289, DOI 10.1111/j.1365-2435.2007.01361.x; Amo L, 2013, ECOL LETT, V16, P1348, DOI 10.1111/ele.12177; Avni D, 2014, J INSECT PHYSIOL, V69, P65, DOI 10.1016/j.jinsphys.2014.07.001; Balthazart J, 2009, BEHAV BRAIN RES, V200, P248, DOI 10.1016/j.bbr.2008.08.036; Bonadonna F, 2004, SCIENCE, V306, P835, DOI 10.1126/science.1103001; Brazil M., 2009, BIRDS E ASIA CHINA T; Caro SP, 2010, J COMP PHYSIOL A, V196, P751, DOI 10.1007/s00359-010-0534-4; Cunningham SJ, 2009, ANIM BEHAV, V78, P899, DOI 10.1016/j.anbehav.2009.07.015; Del Hoyo J, 1994, HDB BIRDS WORLD, V2; Doyle JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095599; Gagliardo A, 2013, J EXP BIOL, V216, P2798, DOI 10.1242/jeb.085738; Gagliardo A, 2013, J EXP BIOL, V216, P2165, DOI 10.1242/jeb.070250; Gess SK, 1996, POLLEN WASPS ECOLOGY, DOI [10.4159/harvard.9780674281684, DOI 10.4159/HARVARD.9780674281684]; GOMEZ LG, 1994, IBIS, V136, P193, DOI 10.1111/j.1474-919X.1994.tb01084.x; GRAVES GR, 1992, J RAPTOR RES, V26, P38; Gwinner H, 2008, ANIM BEHAV, V75, P971, DOI 10.1016/j.anbehav.2007.08.008; Hagelin JC, 2007, AUK, V124, P741, DOI 10.1642/0004-8038(2007)124[741:BOAOCS]2.0.CO;2; Houston DC, 1994, HDB BIRDS WORLD, V2, P24; Huang KY, 2004, J RAPTOR RES, V38, P367; Human H, 2006, PHYTOCHEMISTRY, V67, P1486, DOI 10.1016/j.phytochem.2006.05.023; Hunt JH, 2007, EVOLUTION SOCIAL WAS; Jetz W, 2001, BEHAV ECOL, V12, P134, DOI 10.1093/beheco/12.2.134; Jorge P. E., 2011, BIOL ODORS SOURCES O, P207; Lind O, 2013, J EXP BIOL, V216, P1819, DOI 10.1242/jeb.082834; Lindstrom L, 1999, BEHAV ECOL, V10, P317, DOI 10.1093/beheco/10.3.317; Mardon J, 2010, J EXP BIOL, V213, P558, DOI 10.1242/jeb.032979; MARPLES NM, 1994, ANIM BEHAV, V48, P967, DOI 10.1006/anbe.1994.1322; Marples NM, 1996, ANIM BEHAV, V51, P1417, DOI 10.1006/anbe.1996.0145; Martin GR, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000198; Mihailova M, 2014, ANIM BEHAV, V95, P155, DOI 10.1016/j.anbehav.2014.07.012; Nei M, 2008, NAT REV GENET, V9, P951, DOI 10.1038/nrg2480; Niimura Y, 2006, J HUM GENET, V51, P505, DOI 10.1007/s10038-006-0391-8; Roper TJ, 1997, ANIM BEHAV, V53, P1241, DOI 10.1006/anbe.1996.0384; Roper TJ, 1999, ADV STUD BEHAV, V28, P247, DOI 10.1016/S0065-3454(08)60219-3; Roth TC, 2008, ANIM BEHAV, V76, P2021, DOI 10.1016/j.anbehav.2008.08.022; Rouquier S, 2000, P NATL ACAD SCI USA, V97, P2870, DOI 10.1073/pnas.040580197; Severinghaus L., 2010, AVIFAUNA TAIWAN; Severinghaus LL, 2007, CONSERVATION RES SER, V95-01; Severinghaus LL, 2005, CONSERVATION RES SER, V93-03; Severinghaus LL., 2010, CONSERVATION RES SER, V98-04; Smith HR, 2002, J RAPTOR RES, V36, P144; Steiger SS, 2008, P ROY SOC B-BIOL SCI, V275, P2309, DOI 10.1098/rspb.2008.0607; TROLLE M, 2004, COTINGA, V22, P81; Van Buskirk RW, 2008, J EVOLUTION BIOL, V21, P67, DOI 10.1111/j.1420-9101.2007.01465.x; Wallraff HG, 2004, ANIM BEHAV, V67, P189, DOI 10.1016/j.anbehav.2003.06.007; Warren WC, 2010, NATURE, V464, P757, DOI 10.1038/nature08819; Wenzel BM, 2007, J ORNITHOL, V148, pS191, DOI 10.1007/s10336-007-0147-z; WENZEL BM, 1968, NATURE, V220, P1133, DOI 10.1038/2201133a0; Zhan XJ, 2013, NAT GENET, V45, P563, DOI 10.1038/ng.2588; Zidar J, 2012, ANIM BEHAV, V84, P547, DOI 10.1016/j.anbehav.2012.06.006	51	15	15	0	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0130191	10.1371/journal.pone.0130191	http://dx.doi.org/10.1371/journal.pone.0130191			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26177533	Green Submitted, Green Published, gold			2022-12-26	WOS:000358197600019
J	Bockoven, AA; Wilder, SM; Eubanks, MD				Bockoven, Alison A.; Wilder, Shawn M.; Eubanks, Micky D.			Intraspecific Variation among Social Insect Colonies: Persistent Regional and Colony-Level Differences in Fire Ant Foraging Behavior	PLOS ONE			English	Article							ECOLOGICAL CONSEQUENCES; EVOLUTIONARY ECOLOGY; GENETIC DIVERSITY; HARVESTER ANT; INTERSPECIFIC INTERACTIONS; COLLECTIVE REGULATION; SOLENOPSIS-INVICTA; HYMENOPTERA; SIZE; AGGRESSION	Individuals vary within a species in many ecologically important ways, but the causes and consequences of such variation are often poorly understood. Foraging behavior is among the most profitable and risky activities in which organisms engage and is expected to be under strong selection. Among social insects there is evidence that within-colony variation in traits such as foraging behavior can increase colony fitness, but variation between colonies and the potential consequences of such variation are poorly documented. In this study, we tested natural populations of the red imported fire ant, Solenopsis invicta, for the existence of colony and regional variation in foraging behavior and tested the persistence of this variation over time and across foraging habitats. We also reared single-lineage colonies in standardized environments to explore the contribution of colony lineage. Fire ants from natural populations exhibited significant and persistent colony and regional-level variation in foraging behaviors such as extra-nest activity, exploration, and discovery of and recruitment to resources. Moreover, colony-level variation in extra-nest activity was significantly correlated with colony growth, suggesting that this variation has fitness consequences. Lineage of the colony had a significant effect on extra-nest activity and exploratory activity and explained approximately half of the variation observed in foraging behaviors, suggesting a heritable component to colony-level variation in behavior.	[Bockoven, Alison A.; Wilder, Shawn M.; Eubanks, Micky D.] Texas A&M Univ, Dept Entomol, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station	Bockoven, AA (corresponding author), Texas A&M Univ, Dept Entomol, College Stn, TX 77843 USA.	abockoven@tamu.edu	Bockoven, Alison/L-9807-2016	Bockoven, Alison/0000-0002-2117-1955; Wilder, Shawn/0000-0003-0359-7220	National Science Foundation [DEB 0716983]; Texas Imported Ant Management & Research Program; Texas A&M University Merit Fellowship; Regents' Graduate Fellowship	National Science Foundation(National Science Foundation (NSF)); Texas Imported Ant Management & Research Program; Texas A&M University Merit Fellowship; Regents' Graduate Fellowship	This work was supported by the National Science Foundation (www.nsf.gov)(DEB 0716983 to ME); the Texas Imported Ant Management & Research Program (ME); and the Texas A&M University Merit Fellowship and Regents' Graduate Fellowship (AB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams ES, 2001, J ANIM ECOL, V70, P355, DOI 10.1046/j.1365-2656.2001.00501.x; Ascunce MS, 2011, SCIENCE, V331, P1066, DOI 10.1126/science.1198734; BALL DE, 1983, ENTOMOL EXP APPL, V33, P195, DOI 10.1111/j.1570-7458.1983.tb03256.x; Banks W.A., 1981, TECHNIQUES COLLECTIN; Barber I, 2010, PHILOS T R SOC B, V365, P4077, DOI 10.1098/rstb.2010.0182; Barbosa P., 2005, ECOLOGY PREDATOR PRE; Benedetti-Cecchi L, 2003, ECOLOGY, V84, P2335, DOI 10.1890/02-8011; Bengston SE, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0518; Biro PA, 2006, J ANIM ECOL, V75, P1165, DOI 10.1111/j.1365-2656.2006.01137.x; Blancafort X, 2005, ACTA OECOL, V28, P49, DOI 10.1016/j.actao.2005.02.004; Bolnick DI, 2003, AM NAT, V161, P1, DOI 10.1086/343878; Bolnick DI, 2011, TRENDS ECOLOGY EVOLU; Brown JS, 1999, J MAMMAL, V80, P385, DOI 10.2307/1383287; CALABI P, 1989, J INSECT PHYSIOL, V35, P643, DOI 10.1016/0022-1910(89)90127-3; Callcott AMA, 1996, FLA ENTOMOL, V79, P240, DOI 10.2307/3495821; Chapman BB, 2011, ANIM BEHAV, V82, P391, DOI 10.1016/j.anbehav.2011.05.019; Chapple DG, 2012, TRENDS ECOL EVOL, V27, P57, DOI 10.1016/j.tree.2011.09.010; Cole BJ, 2008, ANN ENTOMOL SOC AM, V101, P272, DOI 10.1603/0013-8746(2008)101[272:DFAAFS]2.0.CO;2; Cole BJ, 2010, BEHAV ECOL, V21, P337, DOI 10.1093/beheco/arp193; Cote J, 2011, P ROY SOC B-BIOL SCI, V278, P1670, DOI 10.1098/rspb.2010.1892; CROSLAND MWJ, 1990, J INSECT BEHAV, V3, P359, DOI 10.1007/BF01052114; CUPP EW, 1973, ANN ENTOMOL SOC AM, V66, P743, DOI 10.1093/aesa/66.4.743; Dall SRX, 2012, ECOL LETT, V15, P1189, DOI 10.1111/j.1461-0248.2012.01846.x; Duffy MA, 2010, FRESHWATER BIOL, V55, P995, DOI 10.1111/j.1365-2427.2009.02336.x; Fjerdingstad EJ, 2005, MOL ECOL, V14, P3123, DOI 10.1111/j.1365-294X.2005.02648.x; Fogarty S, 2011, AM NAT, V177, P273, DOI 10.1086/658174; Folgarait PJ, 1998, BIODIVERS CONSERV, V7, P1221, DOI 10.1023/A:1008891901953; Fox JW, 2008, AM NAT, V172, P667, DOI 10.1086/591689; Gordon DM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063363; Gordon DM, 2013, NATURE, V498, P91, DOI 10.1038/nature12137; Gordon DM, 2011, BEHAV ECOL, V22, P429, DOI 10.1093/beheco/arq218; Grover CD, 2007, P ROY SOC B-BIOL SCI, V274, P2951, DOI 10.1098/rspb.2007.1065; HELLMICH RL, 1985, J HERED, V76, P155, DOI 10.1093/oxfordjournals.jhered.a110056; HOLLDOBLER B, 1980, SCIENCE, V210, P732, DOI 10.1126/science.210.4471.732; HOUSTON A, 1988, AM NAT, V131, P107, DOI 10.1086/284776; Hughes AR, 2008, ECOL LETT, V11, P609, DOI 10.1111/j.1461-0248.2008.01179.x; Hughes WOH, 2008, J EVOLUTION BIOL, V21, P1090, DOI 10.1111/j.1420-9101.2008.01532.x; Hui A, 2014, ANIM BEHAV, V93, P261, DOI 10.1016/j.anbehav.2014.05.006; Hunt GJ, 2007, NATURWISSENSCHAFTEN, V94, P247, DOI 10.1007/s00114-006-0183-1; Jandt JM, 2014, BIOL REV, V89, P48, DOI 10.1111/brv.12042; Kaplan I, 2005, ECOLOGY, V86, P1640, DOI 10.1890/04-0016; Knop E, 2013, ECOSPHERE, V4, DOI 10.1890/ES13-00154.1; Kover PX, 2002, P NATL ACAD SCI USA, V99, P11270, DOI 10.1073/pnas.102288999; Laughlin DC, 2012, ECOL LETT, V15, P1291, DOI 10.1111/j.1461-0248.2012.01852.x; Lawson LP, 2012, P ROY SOC B-BIOL SCI, V279, P3217, DOI 10.1098/rspb.2012.0315; LeBoeuf AC, 2014, CURR OPIN INSECT SCI, V5, P16, DOI 10.1016/j.cois.2014.09.010; LIMA SL, 1990, CAN J ZOOL, V68, P619, DOI 10.1139/z90-092; Linksvayer TA, 2006, EVOLUTION, V60, P2552, DOI 10.1111/j.0014-3820.2006.tb01889.x; Mattila HR, 2007, SCIENCE, V317, P362, DOI 10.1126/science.1143046; Modlmeier AP, 2011, BEHAV ECOL, V22, P1026, DOI 10.1093/beheco/arr086; Ness JH, 2004, OECOLOGIA, V138, P448, DOI 10.1007/s00442-003-1440-z; Oldroyd BP, 2007, TRENDS ECOL EVOL, V22, P408, DOI 10.1016/j.tree.2007.06.001; PAGE RE, 1995, BEHAV ECOL SOCIOBIOL, V36, P135, DOI 10.1007/BF00170718; Pinter-Wollman N, 2012, CURR ZOOL, V58, P580, DOI 10.1093/czoolo/58.4.580; Pintor LM, 2009, ECOLOGY, V90, P581, DOI 10.1890/08-0552.1; Post DM, 2008, ECOLOGY, V89, P2019, DOI 10.1890/07-1216.1; Preisser EL, 2007, ECOLOGY, V88, P2744, DOI 10.1890/07-0260.1; Price P.W., 2011, INSECT ECOLOGY BEHAV; Pruitt JN, 2014, NATURE; Pruitt JN, 2011, ECOLOGY, V92, P1902, DOI 10.1890/11-0701.1; Raine NE, 2006, ENTOMOL GEN, V28, P241; RIECHERT SE, 1991, EVOL ECOL, V5, P327, DOI 10.1007/BF02214236; ROBINSON GE, 1992, ANNU REV ENTOMOL, V37, P637, DOI 10.1146/annurev.en.37.010192.003225; Sanders D, 2011, J ANIM ECOL, V80, P569, DOI 10.1111/j.1365-2656.2010.01796.x; Shine R, 2011, P NATL ACAD SCI USA, V108, P5708, DOI 10.1073/pnas.1018989108; Sih A, 2005, BEHAVIOUR, V142, P1417, DOI 10.1163/156853905774539454; Sih A, 2004, TRENDS ECOL EVOL, V19, P372, DOI 10.1016/j.tree.2004.04.009; Sih A, 2012, ECOL LETT, V15, P278, DOI 10.1111/j.1461-0248.2011.01731.x; Stephens D., 2007, FORAGING BEHAV ECOLO; Styrsky JD, 2007, P ROY SOC B-BIOL SCI, V274, P151, DOI 10.1098/rspb.2006.3701; Styrsky JD, 2010, ECOL ENTOMOL, V35, P190, DOI 10.1111/j.1365-2311.2009.01172.x; Thornton A, 2011, PHILOS T R SOC B, V366, P978, DOI 10.1098/rstb.2010.0312; Tschinkel WR, 1998, BIOSCIENCE, V48, P593, DOI 10.2307/1313419; TSCHINKEL WR, 1995, J ANIM ECOL, V64, P473, DOI 10.2307/5650; Tschinkel WR, 2006, FIRE ANTS; Urban MC, 2008, TRENDS ECOL EVOL, V23, P311, DOI 10.1016/j.tree.2008.02.007; Webster MM, 2009, BEHAV ECOL SOCIOBIOL, V63, P511, DOI 10.1007/s00265-008-0685-2; Wilder SM, 2011, ECOLOGY, V92, P325, DOI 10.1890/10-0623.1; Wilder SM, 2010, BIOL LETTERS, V6, P177, DOI 10.1098/rsbl.2009.0736; Wilder SM, 2011, P NATL ACAD SCI; Wray MK, 2011, BEHAV ECOL SOCIOBIOL, V65, P2061, DOI 10.1007/s00265-011-1215-1	81	19	19	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0133868	10.1371/journal.pone.0133868	http://dx.doi.org/10.1371/journal.pone.0133868			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LZ	26197456	Green Published, gold, Green Submitted			2022-12-26	WOS:000358547600144
J	Coleman, PC; Bale, JS; Hayward, SAL				Coleman, Paul C.; Bale, Jeffrey S.; Hayward, Scott A. L.			Meat Feeding Restricts Rapid Cold Hardening Response and Increases Thermal Activity Thresholds of Adult Blow Flies, Calliphora vicina (Diptera: Calliphoridae)	PLOS ONE			English	Article							BUG NEZARA-VIRIDULA; CHILL COMA RECOVERY; DROSOPHILA-MELANOGASTER; MIGRATORY LOCUST; LOW-TEMPERATURES; ION HOMEOSTASIS; LARVAL DIAPAUSE; CLIMATE-CHANGE; TOLERANCE; MUSCLE	Virtually all temperate insects survive the winter by entering a physiological state of reduced metabolic activity termed diapause. However, there is increasing evidence that climate change is disrupting the diapause response resulting in non-diapause life stages encountering periods of winter cold. This is a significant problem for adult life stages in particular, as they must remain mobile, periodically feed, and potentially initiate reproductive development at a time when resources should be diverted to enhance stress tolerance. Here we present the first evidence of protein/meat feeding restricting rapid cold hardening (RCH) ability and increasing low temperature activity thresholds. No RCH response was noted in adult female blow flies (Calliphora vicina Robineau-Desvoidy) fed a sugar, water and liver (SWL) diet, while a strong RCH response was seen in females fed a diet of sugar and water (SW) only. The RCH response in SW flies was induced at temperatures as high as 10 degrees C, but was strongest following 3h at 0 degrees C. The CTmin (loss of coordinated movement) and chill coma (final appendage twitch) temperature of SWL females (-0.3 +/- 0.5 degrees C and -4.9 +/- 0.5 degrees C, respectively) was significantly higher than for SW females (-3.2 +/- 0.8 degrees C and -8.5 +/- 0.6 degrees C). We confirmed this was not directly the result of altered extracellular K+, as activity thresholds of alanine-fed adults were not significantly different from SW flies. Instead we suggest the loss of cold tolerance is more likely the result of diverting resource allocation to egg development. Between 2009 and 2013 winter air temperatures in Birmingham, UK, fell below the CTmin of SW and SWL flies on 63 and 195 days, respectively, suggesting differential exposure to chill injury depending on whether adults had access to meat or not. We conclude that disruption of diapause could significantly impact on winter survival through loss of synchrony in the timing of active feeding and reproductive development with favourable temperature conditions.	[Coleman, Paul C.; Bale, Jeffrey S.; Hayward, Scott A. L.] Univ Birmingham, Sch Biosci, Birmingham, W Midlands, England	University of Birmingham	Hayward, SAL (corresponding author), Univ Birmingham, Sch Biosci, Birmingham, W Midlands, England.	s.a.hayward@bham.ac.uk		Coleman, Paul/0000-0002-8681-9070; Hayward, Scott/0000-0002-1899-6630	Biotechnology and Biological Sciences Research Council (BBSRC) [BB/F016018/1]	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This study was funded by the Biotechnology and Biological Sciences Research Council (BBSRC) (BB/F016018/1). The University of Birmingham, United Kingdom, covered the publication costs for this article. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altermatt F, 2012, GLOBAL CHANGE BIOL, V18, P2429, DOI 10.1111/j.1365-2486.2012.02727.x; Anagnostou C, 2010, ENTOMOL EXP APPL, V136, P1, DOI 10.1111/j.1570-7458.2010.00997.x; Andersen JL, 2015, FUNCT ECOL, V29, P55, DOI 10.1111/1365-2435.12310; Andersen JL, 2013, J INSECT PHYSIOL, V59, P1041, DOI 10.1016/j.jinsphys.2013.07.008; Andersen LH, 2010, J INSECT PHYSIOL, V56, P336, DOI 10.1016/j.jinsphys.2009.11.006; [Anonymous], 2010, LOW TEMPERATURE BIOL; Bale JS, 2010, J EXP BIOL, V213, P980, DOI 10.1242/jeb.037911; Bale JS, 2002, PHILOS T R SOC B, V357, P849, DOI 10.1098/rstb.2002.1074; BALE JS, 1984, CRYOBIOLOGY, V21, P340, DOI 10.1016/0011-2240(84)90329-8; COHEN BJ, 1990, AM J PHYSIOL, V258, pC24, DOI 10.1152/ajpcell.1990.258.1.C24; Coleman PC, 2014, J EXP BIOL, V217, P1454, DOI 10.1242/jeb.098053; Coleman PC, 2014, PHYSL ECOLOGY DIAPAU; Colinet H, 2014, COMP BIOCHEM PHYS A, V170, P6, DOI 10.1016/j.cbpa.2014.01.004; Colinet H, 2013, METABOLOMICS, V9, P608, DOI 10.1007/s11306-012-0471-z; Coombs MR, 2013, EXP APPL ACAROL, V59, P435, DOI 10.1007/s10493-012-9619-9; CZAJKA MC, 1990, J EXP BIOL, V148, P245; Denlinger DL, 2002, ANNU REV ENTOMOL, V47, P93, DOI 10.1146/annurev.ento.47.091201.145137; Faucherre J, 1999, J INSECT BEHAV, V12, P687, DOI 10.1023/A:1020931804597; Findsen A, 2014, J EXP BIOL, V217, P1297, DOI 10.1242/jeb.098442; Findsen A, 2013, J EXP BIOL, V216, P1630, DOI 10.1242/jeb.081141; Hahn DA, 2011, ANNU REV ENTOMOL, V56, P103, DOI 10.1146/annurev-ento-112408-085436; Hayward SAL, 2007, J EXP BIOL, V210, P836, DOI 10.1242/jeb.02714; Hayward SAL, 2014, J EXP BIOL, V217, P6, DOI 10.1242/jeb.096537; Hazell SP, 2011, J INSECT PHYSIOL, V57, P1085, DOI 10.1016/j.jinsphys.2011.04.004; Hazell SP, 2008, PHYSIOL ENTOMOL, V33, P389, DOI 10.1111/j.1365-3032.2008.00637.x; Hercus MJ, 2000, BIOL J LINN SOC, V71, P403, DOI 10.1111/j.1095-8312.2000.tb01266.x; Hoffmann AA, 2001, EVOLUTION, V55, P436, DOI 10.1111/j.0014-3820.2001.tb01305.x; Hosler JS, 2000, J INSECT PHYSIOL, V46, P621, DOI 10.1016/S0022-1910(99)00148-1; HOYLE G, 1954, J EXP BIOL, V31, P260; Hwang C, 2005, MED VET ENTOMOL, V19, P379, DOI 10.1111/j.1365-2915.2005.00583.x; Ju RT, 2011, J INSECT PHYSIOL, V57, P1577, DOI 10.1016/j.jinsphys.2011.08.012; Kostal V, 2007, COMP BIOCHEM PHYS A, V147, P231, DOI 10.1016/j.cbpa.2006.12.033; Kostal V, 2006, COMP BIOCHEM PHYS B, V143, P171, DOI 10.1016/j.cbpb.2005.11.005; KRUNIC MD, 1971, CAN J ZOOLOG, V49, P863, DOI 10.1139/z71-129; LEE RE, 1987, SCIENCE, V238, P1415, DOI 10.1126/science.238.4832.1415; Lee RE, 2006, J EXP BIOL, V209, P399, DOI 10.1242/jeb.02001; MacMillan HA, 2012, J EXP BIOL, V215, P1366, DOI 10.1242/jeb.066381; MacMillan HA, 2011, J INSECT PHYSIOL, V57, P12, DOI 10.1016/j.jinsphys.2010.10.004; MacMillan HA, 2014, J EXP BIOL, V217, P2930, DOI 10.1242/jeb.107516; Mayntz D, 2005, SCIENCE, V307, P111, DOI 10.1126/science.1105493; McWatters HG, 1998, PHYSIOL ENTOMOL, V23, P369, DOI 10.1046/j.1365-3032.1998.00101.x; MOUSSEAU TA, 1991, ANNU REV ENTOMOL, V36, P511, DOI 10.1146/annurev.en.36.010191.002455; Musolin DL, 2012, PHYSIOL ENTOMOL, V37, P309, DOI 10.1111/j.1365-3032.2012.00846.x; Musolin DL, 2010, GLOBAL CHANGE BIOL, V16, P73, DOI 10.1111/j.1365-2486.2009.01914.x; NUNAMAKER RA, 1993, J MED ENTOMOL, V30, P913, DOI 10.1093/jmedent/30.5.913; NUNES MV, 1989, PHYSIOL ENTOMOL, V14, P471, DOI 10.1111/j.1365-3032.1989.tb01116.x; Olsen TM, 1997, J COMP PHYSIOL B, V167, P105, DOI 10.1007/s003600050053; Owen EL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080061; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Penuelas J, 2001, SCIENCE, V294, P793, DOI 10.1126/science.1066860; Raubenheimer D, 1999, ENTOMOL EXP APPL, V91, P67, DOI 10.1023/A:1003682921131; Rinehart JP, 2000, PHYSIOL ENTOMOL, V25, P330, DOI 10.1046/j.1365-3032.2000.00201.x; Robich RM, 2005, P NATL ACAD SCI USA, V102, P15912, DOI 10.1073/pnas.0507958102; SALT RW, 1961, ANNU REV ENTOMOL, V6, P55, DOI 10.1146/annurev.en.06.010161.000415; Saunders DS, 1998, J INSECT PHYSIOL, V44, P541, DOI 10.1016/S0022-1910(98)00049-3; SAUNDERS DS, 1987, PHYSIOL ENTOMOL, V12, P331, DOI 10.1111/j.1365-3032.1987.tb00758.x; Simmons FH, 1997, J INSECT PHYSIOL, V43, P779, DOI 10.1016/S0022-1910(97)00037-1; Sisodia S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046131; Stelzer RJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009559; Stocker TF, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P1, DOI 10.1017/cbo9781107415324; STOFFOLANO JG, 1974, CAN J ZOOL, V52, P981, DOI 10.1139/z74-130; STRANGWAYSDIXON J, 1961, J EXP BIOL, V38, P225; Tang QH, 2013, ENVIRON RES LETT, V8, DOI 10.1088/1748-9326/8/1/014036; Tauber M.J., 1986, SEASONAL ADAPTATIONS; Teets NM, 2013, PHYSIOL ENTOMOL, V38, P105, DOI 10.1111/phen.12019; Terblanche JS, 2007, J INSECT PHYSIOL, V53, P455, DOI 10.1016/j.jinsphys.2007.01.006; VINOGRADOVA EB, 1972, J INSECT PHYSIOL, V18, P1629, DOI 10.1016/0022-1910(72)90093-5; Vinogradova EB, 2011, ENTOMOL REV, V91, P1; Warbrick-Smith J, 2006, P NATL ACAD SCI USA, V103, P14045, DOI 10.1073/pnas.0605225103; WOOD DW, 1963, COMP BIOCHEM PHYSIOL, V9, P151, DOI 10.1016/0010-406X(63)90018-5; Woollings T, 2014, ENVIRON RES LETT, V9, DOI 10.1088/1748-9326/9/1/014002	71	7	7	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0131301	10.1371/journal.pone.0131301	http://dx.doi.org/10.1371/journal.pone.0131301			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LZ	26196923	Green Published, Green Submitted, gold, Green Accepted			2022-12-26	WOS:000358547600010
J	Whiting, CC; Siebert, J; Newman, AM; Du, HW; Alizadeh, AA; Goronzy, J; Weyand, CM; Krishnan, E; Fathman, CG; Maecker, HT				Whiting, Chan C.; Siebert, Janet; Newman, Aaron M.; Du, Hong-wu; Alizadeh, Ash A.; Goronzy, Jorg; Weyand, Cornelia M.; Krishnan, Eswar; Fathman, C. Garrison; Maecker, Holden T.			Large-Scale and Comprehensive Immune Profiling and Functional Analysis of Normal Human Aging	PLOS ONE			English	Article							HEMATOPOIETIC STEM-CELLS; T-CELLS; GERMINAL-CENTERS; SEX-DIFFERENCES; CYTOMEGALOVIRUS; REPERTOIRE; RESPONSES; HYPERMUTATION; PHENOTYPE; FREQUENCY	While many age-associated immune changes have been reported, a comprehensive set of metrics of immune aging is lacking. Here we report data from 243 healthy adults aged 4097, for whom we measured clinical and functional parameters, serum cytokines, cytokines and gene expression in stimulated and unstimulated PBMC, PBMC phenotypes, and cytokine-stimulated pSTAT signaling in whole blood. Although highly heterogeneous across individuals, many of these assays revealed trends by age, sex, and CMV status, to greater or lesser degrees. Age, then sex and CMV status, showed the greatest impact on the immune system, as measured by the percentage of assay readouts with significant differences. An elastic net regression model could optimally predict age with 14 analytes from different assays. This reinforces the importance of multivariate analysis for defining a healthy immune system. These data provide a reference for others measuring immune parameters in older people.	[Whiting, Chan C.; Du, Hong-wu; Fathman, C. Garrison; Maecker, Holden T.] Stanford Univ, Stanford Sch Med, Inst Immun Transplantat & Infect, Stanford, CA 94305 USA; [Whiting, Chan C.; Du, Hong-wu; Goronzy, Jorg; Weyand, Cornelia M.; Krishnan, Eswar; Fathman, C. Garrison] Stanford Univ, Sch Med, Dept Med, Div Rheumatol & Immunol, Stanford, CA 94305 USA; CytoAnalytics, Denver, CO USA; [Newman, Aaron M.; Alizadeh, Ash A.] Stanford Univ, Sch Med, Dept Med, Div Oncol, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University	Maecker, HT (corresponding author), Stanford Univ, Stanford Sch Med, Inst Immun Transplantat & Infect, Stanford, CA 94305 USA.	Maecker@stanford.edu	Newman, Aaron M/ABE-1620-2021; Weyand, Cornelia/AAH-3343-2021; Alizadeh, Ash A/C-5594-2009; krishnan, Eswar/AAY-1269-2020	Newman, Aaron M/0000-0002-1857-8172; Alizadeh, Ash A/0000-0002-5153-5625; Goronzy, Jorg/0000-0001-7670-1856	National Institute on Aging, National Institutes of Health [1RC4AG039014]; NATIONAL CANCER INSTITUTE [T32CA009302] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL117913] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI108891, U19AI057266, R01AI044142, R01AI108906, R56AI044142] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR042527] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [RC4AG039014, R01AG045779] Funding Source: NIH RePORTER	National Institute on Aging, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by grant 1RC4AG039014 from the National Institute on Aging, National Institutes of Health. JS (CytoAnalytics) performed data analysis as work-for-hire, which was paid for from grant funds. JS did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of all authors are articulated in the 'author contributions' section.	Appay V, 2002, NAT MED, V8, P379, DOI 10.1038/nm0402-379; Beerman I, 2010, P NATL ACAD SCI USA, V107, P5465, DOI 10.1073/pnas.1000834107; Brodin P, 2015, CELL, V160, P37, DOI 10.1016/j.cell.2014.12.020; Cavanagh MM, 2011, AGING DIS, V2, P398; Couillard C, 1997, DIABETOLOGIA, V40, P1178, DOI 10.1007/s001250050804; den Braber I, 2012, IMMUNITY, V36, P288, DOI 10.1016/j.immuni.2012.02.006; Derhovanessian E, 2009, CURR OPIN IMMUNOL, V21, P440, DOI 10.1016/j.coi.2009.05.012; Dunn HS, 2002, J INFECT DIS, V186, P15, DOI 10.1086/341079; Fried LP, 2001, J GERONTOL A-BIOL, V56, pM146, DOI 10.1093/gerona/56.3.M146; FRIES JF, 1980, ARTHRITIS RHEUM, V23, P137, DOI 10.1002/art.1780230202; GODIN G, 1985, Canadian Journal of Applied Sport Sciences, V10, P141; Goronzy JJ, 2013, NAT IMMUNOL, V14, P428, DOI 10.1038/ni.2588; Guerrettaz LM, 2008, P NATL ACAD SCI USA, V105, P11898, DOI 10.1073/pnas.0805498105; Jagannathan P, 2009, J VIROL, V83, P2728, DOI 10.1128/JVI.02128-08; Joosse A, 2013, J CLIN ONCOL, V31, P2337, DOI 10.1200/JCO.2012.44.5031; Khan N, 2002, J IMMUNOL, V169, P1984, DOI 10.4049/jimmunol.169.4.1984; Lang A, 2011, J IMMUNOL, V187, P3759, DOI 10.4049/jimmunol.1100666; Lee SA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089444; Leung J, 2008, GENDER MED, V5, P44, DOI 10.1016/S1550-8579(08)80007-1; Longo DM, 2014, J TRANSL MED, V12, DOI 10.1186/1479-5876-12-178; Mervic L, 2011, MELANOMA RES, V21, P244, DOI 10.1097/CMR.0b013e32834577c8; MILLER C, 1995, J IMMUNOL, V155, P3377; Nomura Laurel E, 2006, AIDS Res Ther, V3, P18, DOI 10.1186/1742-6405-3-18; Pang WW, 2011, P NATL ACAD SCI USA, V108, P20012, DOI 10.1073/pnas.1116110108; Rockwood K, 2005, CAN MED ASSOC J, V173, P489, DOI 10.1503/cmaj.050051; van de Berg PJEJ, 2010, J IMMUNOL, V184, P3417, DOI 10.4049/jimmunol.0903442; Wang C, 2014, J IMMUNOL; Weng NP, 2009, TRENDS IMMUNOL, V30, P306, DOI 10.1016/j.it.2009.03.013; Yang XH, 1996, J EXP MED, V183, P959, DOI 10.1084/jem.183.3.959; Yang Z, 2010, J CLIN ENDOCR METAB, V95, P3926, DOI 10.1210/jc.2009-2194; Yu MC, 2012, P NATL ACAD SCI USA, V109, pE879, DOI 10.1073/pnas.1109797109; Zou H, 2005, J R STAT SOC B, V67, P301, DOI 10.1111/j.1467-9868.2005.00503.x	32	58	59	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0133627	10.1371/journal.pone.0133627	http://dx.doi.org/10.1371/journal.pone.0133627			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LZ	26197454	Green Submitted, Green Published, gold			2022-12-26	WOS:000358547600123
J	Xu, MR; Li, Y; Zheng, Z; Dai, ZH; Tao, Y; Deng, XL				Xu, Meirong; Li, Ya; Zheng, Zheng; Dai, Zehan; Tao, Yang; Deng, Xiaoling			Transcriptional Analyses of Mandarins Seriously Infected by 'Candidatus Liberibacter asiaticus'	PLOS ONE			English	Article							ORANGE CITRUS-SINENSIS; SHOCK PROTEINS DNAK; ARABIDOPSIS-THALIANA; GENE-EXPRESSION; O-METHYLTRANSFERASE; RESPONSIVE ELEMENT; FUNCTIONAL-CHARACTERIZATION; DISEASE RESISTANCE; DEFENSE RESPONSE; ABIOTIC STRESSES	A range of leaf symptoms, including blotchy mottle, yellowing, and small, upright leaves with a variety of chlorotic patterns resembling those induced by zinc deficiencies, are associated with huanglongbing (HLB, yellow shoot disease), a worldwide destructive citrus disease. HLB is presumably caused by the phloem-limited fastidious prokaryotic alpha-proteobacterium 'Candidatus Liberibacter spp.' Previous studies focused on the proteome and transcriptome analyses of citrus 5 to 35 weeks after 'Ca. L. spp.' inoculation. In this study, gene expression profiles were analyzed from mandarin Citrus reticulate Blanco cv. jiaogan leaves after a 2 year infection with 'Ca. L. asiaticus'. The Affymetrix microarray analysis explored 2,017 differentially expressed genes. Of the 1,364 genes had known functions, 938 (46.5%) were up-regulated. Genes related to photosynthesis, carbohydrate metabolic, and structure were mostly down-regulated, with rates of 92.7%, 61.0%, and 80.2%, respectively. Genes associated with oxidation-reduction and transport were mostly up-regulated with the rates of 75.0% and 64.6%, respectively. Our data analyses implied that the infection of 'Ca. L. asiaticus' could alter hormone crosstalk, inducing the jasmine acid pathway and depressing the ethylene and salicylic acid pathways in the citrus host. This study provides an enhanced insight into the host response of citrus to 'Ca. L. asiaticus' infection at a two-years infection stage.	[Xu, Meirong; Li, Ya; Zheng, Zheng; Dai, Zehan; Tao, Yang; Deng, Xiaoling] South China Agr Univ, Citrus Huanglongbing Res Lab, Guangzhou, Guangdong, Peoples R China	South China Agricultural University	Deng, XL (corresponding author), South China Agr Univ, Citrus Huanglongbing Res Lab, Guangzhou, Guangdong, Peoples R China.	xldeng@scau.edu.cn			National Natural Science Fund from National Natural Science Foundation of China [31201480]; Modern Agricultural Industry Technology System from Chinese Ministry of Agriculture [C09058]	National Natural Science Fund from National Natural Science Foundation of China; Modern Agricultural Industry Technology System from Chinese Ministry of Agriculture	The experiment in this study was funded by National Natural Science Fund (Grant No. 31201480) from National Natural Science Foundation of China and Modern Agricultural Industry Technology System (Grant No. C09058) from Chinese Ministry of Agriculture. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS MD, 1995, NATURE, V377, P3; Albrecht U, 2008, PLANT SCI, V175, P291, DOI 10.1016/j.plantsci.2008.05.001; Albrecht U, 2012, PLANT SCI, V185, P118, DOI 10.1016/j.plantsci.2011.09.008; An SH, 2008, PLANTA, V228, P61, DOI 10.1007/s00425-008-0719-z; Aritua V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073742; Bar M, 2010, PLANT J, V63, P791, DOI 10.1111/j.1365-313X.2010.04282.x; Beck G, 2013, PLANT MOL BIOL, V82, P393, DOI 10.1007/s11103-013-0070-z; Bekh-Ochir D, 2013, PLANTA, V237, P1509, DOI 10.1007/s00425-013-1859-3; Bhadauria V, 2012, PLANT SIGNAL BEHAV, V7, P1206, DOI 10.4161/psb.21368; Carmo-Silva AE, 2013, PLANT PHYSIOL, V161, P1645, DOI 10.1104/pp.112.213348; Chen K, 1998, ACTA PHYTOPHYSIOLOGI, V25, P138; Chen W, 2013, PLANT MOL BIOL, V83, P219, DOI 10.1007/s11103-013-0084-6; Cho YS, 2000, CURR MICROBIOL, V41, P33, DOI 10.1007/s002840010087; Choi DS, 2012, PLANT CELL, V24, P1675, DOI 10.1105/tpc.112.095869; Do CT, 2007, PLANTA, V226, P1117, DOI 10.1007/s00425-007-0558-3; Du Z, 2010, NUCLEIC ACIDS RES, V38, pW64, DOI 10.1093/nar/gkq310; Edstam MM, 2013, PLANT MOL BIOL, V83, P625, DOI 10.1007/s11103-013-0113-5; Fan J, 2011, PHYSIOL PLANTARUM, V143, P235, DOI 10.1111/j.1399-3054.2011.01502.x; Fukayama H, 2012, PLANT CELL PHYSIOL, V53, P976, DOI 10.1093/pcp/pcs042; Gao F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015319; Han H, 2010, J PLANT PHYSIOL, V167, P176, DOI 10.1016/j.jplph.2009.08.009; Hong MJ, 2010, GENES GENET SYST, V85, P97, DOI 10.1266/ggs.85.97; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Islam MS, 2009, BMB REP, V42, P611, DOI 10.5483/BMBRep.2009.42.9.611; Itoh H, 2004, PLANT MOL BIOL, V54, P533, DOI 10.1023/B:PLAN.0000038261.21060.47; JAGOUEIX S, 1994, INT J SYST BACTERIOL, V44, P379, DOI 10.1099/00207713-44-3-379; Keith LMW, 1999, MOL PLANT MICROBE IN, V12, P563, DOI 10.1094/MPMI.1999.12.7.563; Kilstrup M, 1997, APPL ENVIRON MICROB, V63, P1826, DOI 10.1128/AEM.63.5.1826-1837.1997; Kim JS, 2009, PHYTOPATHOLOGY, V99, P50, DOI 10.1094/PHYTO-99-1-0050; Lauvergeat V, 2001, PHYTOCHEMISTRY, V57, P1187, DOI 10.1016/S0031-9422(01)00053-X; Liao HL, 2012, J EXP BOT, V63, P3307, DOI 10.1093/jxb/ers070; Liu JZ, 2013, PLANT J, V74, P110, DOI 10.1111/tpj.12108; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Machado CR, 1996, PLANT MOL BIOL, V31, P585, DOI 10.1007/BF00042231; Mafra V, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-247; Mageroy MH, 2012, PLANT J, V69, P1043, DOI 10.1111/j.1365-313X.2011.04854.x; Magnan F, 2008, PLANT J, V56, P575, DOI 10.1111/j.1365-313X.2008.03622.x; Martinelli F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074256; Martinelli F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038039; Mishra P, 2013, BIOMETALS, V26, P97, DOI 10.1007/s10534-012-9597-8; Moriguchi T, 2002, PHYSIOL PLANTARUM, V114, P251, DOI 10.1034/j.1399-3054.2002.1140211.x; Nwugo CC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067442; Nwugo CC, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-59; Park YH, 2012, PLANT CELL REP, V31, P1845, DOI 10.1007/s00299-012-1298-9; Perez-Amador MA, 2000, PLANT PHYSIOL, V122, P169, DOI 10.1104/pp.122.1.169; Pontier D, 2001, PLANT J, V26, P495, DOI 10.1046/j.1365-313x.2001.01049.x; Rejzek M, 2011, MOL BIOSYST, V7, P718, DOI 10.1039/c0mb00204f; Romeis T, 2000, MOL PLANT PATHOL, V1, P3, DOI 10.1046/j.1364-3703.2000.00001.x; Rotblat B, 2002, PLANT J, V32, P1049, DOI 10.1046/j.1365-313X.2002.01490.x; Stracke R, 2009, PLANTA, V229, P427, DOI 10.1007/s00425-008-0841-y; Talon Manuel, 2008, Int J Plant Genomics, V2008, P528361, DOI 10.1155/2008/528361; Tanaka A, 1998, P NATL ACAD SCI USA, V95, P12719, DOI 10.1073/pnas.95.21.12719; Tanaka R, 2010, P NATL ACAD SCI USA, V107, P16721, DOI 10.1073/pnas.1004699107; Thevenin J, 2011, MOL PLANT, V4, P70, DOI 10.1093/mp/ssq045; Trabucco GM, 2013, BMC BIOTECHNOL, V13, DOI 10.1186/1472-6750-13-61; Wenkel S, 2006, PLANT CELL, V18, P2971, DOI 10.1105/tpc.106.043299; Wu AC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100498; Wu ZC, 2004, J EXP BOT, V55, P1483, DOI 10.1093/jxb/erh163; Xu MR, 2013, EUR J PLANT PATHOL, V137, P283, DOI 10.1007/s10658-013-0238-z; Xu Q, 2013, NAT GENET, V45, P59, DOI 10.1038/ng.2472; Zaare-Nahandi F, 2008, BIOCHEM BIOPH RES CO, V371, P59, DOI 10.1016/j.bbrc.2008.03.157; Zhang Mei, 2009, Yichuan, V31, P236, DOI 10.3724/SP.J.1005.2009.00236; Zhu BT, 2002, CURR DRUG METAB, V3, P321, DOI 10.2174/1389200023337586	63	33	36	2	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0133652	10.1371/journal.pone.0133652	http://dx.doi.org/10.1371/journal.pone.0133652			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LZ	26196297	Green Published, gold, Green Submitted			2022-12-26	WOS:000358547600126
J	Zhang, B; Zheng, JC; Peng, Y; Liu, XX; Hoffmann, AA; Ma, CS				Zhang, Bo; Zheng, Jincheng; Peng, Yu; Liu, Xiaoxia; Hoffmann, Ary A.; Ma, Chun-Sen			Stress Responses of Small Heat Shock Protein Genes in Lepidoptera Point to Limited Conservation of Function across Phylogeny	PLOS ONE			English	Article							TEMPORAL EXPRESSION; COMMON CUTWORM; SMALL HSPS; FLESH FLY; EVOLUTION; DIAPAUSE; SILKWORM; PATTERNS; CLONING; GENOME	The small heat shock protein (sHsp) family is thought to play an important role in protein refolding and signal transduction, and thereby protect organisms from stress. However little is known about sHsp function and conservation across phylogenies. In the current study, we provide a comprehensive assessment of small Hsp genes and their stress responses in the oriental fruit moth (OFM), Grapholita molesta. Fourteen small heat shock proteins of OFM clustered with related Hsps in other Lepidoptera despite a high level of variability among them, and in contrast to the highly conserved Hsp11.1. The only known lepidopteran sHsp ortholog (Hsp21.3) was consistently unaffected under thermal stress in Lepidoptera where it has been characterized. However the phylogenetic position of the sHsps within the Lepidoptera was not associated with conservation of induction patterns under thermal extremes or diapause. These findings suggest that the sHsps have evolved rapidly to develop new functions within the Lepidoptera.	[Zhang, Bo; Zheng, Jincheng; Peng, Yu; Ma, Chun-Sen] Chinese Acad Agr Sci, Inst Plant Protect, Grp Climate Change Biol, State Key Lab Biol Plant Dis & Insect Pests, Beijing 100193, Peoples R China; [Liu, Xiaoxia] China Agr Univ, Dept Entomol, Beijing 100094, Peoples R China; [Hoffmann, Ary A.] Univ Melbourne, Sch BioSci, Melbourne, Vic, Australia	Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS; China Agricultural University; University of Melbourne	Ma, CS (corresponding author), Chinese Acad Agr Sci, Inst Plant Protect, Grp Climate Change Biol, State Key Lab Biol Plant Dis & Insect Pests, Beijing 100193, Peoples R China.	machunsen@caas.cn	Hoffmann, Ary/R-2972-2019; Ma, Chun-Sen/K-5414-2019; Hoffmann, Ary/C-2961-2011; peng, yu/GXW-2071-2022	Hoffmann, Ary/0000-0001-9497-7645; Ma, Chun-Sen/0000-0002-3253-6921; 	National Special Fund for Agro-scientific Research in the Public Interest [201103024]; Beijing Natural Science Foundation [5144032]	National Special Fund for Agro-scientific Research in the Public Interest; Beijing Natural Science Foundation(Beijing Natural Science Foundation)	This research was supported by the National Special Fund for Agro-scientific Research in the Public Interest (No. 201103024) and Beijing Natural Science Foundation (5144032). CSM and BZ are the authors who received the fundings respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basha E, 2012, TRENDS BIOCHEM SCI, V37, P106, DOI 10.1016/j.tibs.2011.11.005; Bousquet F, 2012, P NATL ACAD SCI USA, V109, P249, DOI 10.1073/pnas.1109166108; Brocchieri L, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-19; Colinet H, 2012, FUNCT ECOL, V26, P84, DOI 10.1111/j.1365-2435.2011.01898.x; Colinet H, 2010, FEBS J, V277, P174, DOI 10.1111/j.1742-4658.2009.07470.x; Denlinger DL, 2002, ANNU REV ENTOMOL, V47, P93, DOI 10.1146/annurev.ento.47.091201.145137; DICKSON R. C., 1949, ANN ENT SOC AMERICA, V42, P511; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Garczynski SF, 2011, INSECT SCI, V18, P473, DOI 10.1111/j.1744-7917.2010.01401.x; Gkouvitsas T, 2008, J INSECT PHYSIOL, V54, P1503, DOI 10.1016/j.jinsphys.2008.08.009; Gu J, 2012, INSECT MOL BIOL, V21, P535, DOI 10.1111/j.1365-2583.2012.01158.x; Hayward SAL, 2005, J INSECT PHYSIOL, V51, P631, DOI 10.1016/j.jinsphys.2004.11.009; Heckmann LH, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-250; Huang LH, 2008, CELL RES, V18, P1074, DOI 10.1038/cr.2008.283; Huang LH, 2007, INSECT MOL BIOL, V16, P491, DOI 10.1111/j.1365-2583.2007.00744.x; Hull JJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055105; JAKOB U, 1993, J BIOL CHEM, V268, P1517; Jia Haibo, 2011, Int J Biochem Mol Biol, V2, P47; Johnson JL, 2012, BBA-MOL CELL RES, V1823, P607, DOI 10.1016/j.bbamcr.2011.09.020; Jones Michael D., 2010, THESIS; Jones MM, 2010, J ECON ENTOMOL, V103, P1815, DOI 10.1603/EC10029; Kampinga HH, 2009, CELL STRESS CHAPERON, V14, P105, DOI 10.1007/s12192-008-0068-7; Kirk H, 2013, BMC ECOL, V13, DOI 10.1186/1472-6785-13-12; Kriehuber T, 2010, FASEB J, V24, P3633, DOI 10.1096/fj.10-156992; Levine MT, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002729; Li ZW, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-215; Lu MX, 2014, CELL STRESS CHAPERON, V19, P91, DOI 10.1007/s12192-013-0437-8; MADDISON WP, 2006, MESQUITE MODULAR SYS; Mayer MP, 2005, CELL MOL LIFE SCI, V62, P670, DOI 10.1007/s00018-004-4464-6; Mi HY, 2013, NUCLEIC ACIDS RES, V41, pD377, DOI 10.1093/nar/gks1118; Michaud Sebastien, 2003, BMC Dev Biol, V3, P9, DOI 10.1186/1471-213X-3-9; Michaud Sebastien, 2002, Prog Mol Subcell Biol, V28, P79; Morrow G, 2012, INT J BIOCHEM CELL B, V44, P1613, DOI 10.1016/j.biocel.2012.03.009; Mukhopadhyay I, 2003, ENVIRON HEALTH PERSP, V111, P1926, DOI 10.1289/ehp.6339; Mymrikov EV, 2011, PHYSIOL REV, V91, P1123, DOI 10.1152/physrev.00023.2010; Poulain P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009990; Qu ZJ, 2008, BIOCHEM J, V411, P605, DOI 10.1042/BJ20071472; Rinehart JP, 2007, P NATL ACAD SCI USA, V104, P11130, DOI 10.1073/pnas.0703538104; Rinehart JP, 2000, INSECT MOL BIOL, V9, P641, DOI 10.1046/j.1365-2583.2000.00230.x; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; ROTHSCHILD GHL, 1991, TORTRICID PESTS THEI; Russell DA, 1986, THESIS; Sakano D, 2006, BIOSCI BIOTECH BIOCH, V70, P2443, DOI 10.1271/bbb.60176; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Shen Y, 2011, J INSECT PHYSIOL, V57, P908, DOI 10.1016/j.jinsphys.2011.03.026; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; [陶卫军 Tao Weijun], 2011, [吉林农业科学, Journal of Jilin Agricultural Sciences], V36, P43; Taylor RP, 2005, J MOL CELL CARDIOL, V38, P433, DOI 10.1016/j.yjmcc.2004.12.014; Tazir Y, 2009, MOL BIOCHEM PARASIT, V168, P149, DOI 10.1016/j.molbiopara.2009.07.007; WHEELER JC, 1995, P NATL ACAD SCI USA, V92, P10408, DOI 10.1073/pnas.92.22.10408; Zhang QR, 2010, J INSECT PHYSIOL, V56, P138, DOI 10.1016/j.jinsphys.2009.09.013; Zhao LM, 2010, J MED ENTOMOL, V47, P367, DOI 10.1603/ME09232; Zhu JY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032291	53	29	31	4	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0132700	10.1371/journal.pone.0132700	http://dx.doi.org/10.1371/journal.pone.0132700			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LZ	26196395	Green Published, gold			2022-12-26	WOS:000358547600047
J	Li, ZQ; Zhao, YP; Jia, WY; Wang, X; Chen, B; Shahbaz, M; Nie, L; Cheng, L				Li, Ze-qun; Zhao, Yun-peng; Jia, Wen-yu; Wang, Xia; Chen, Bin; Shahbaz, Muhammad; Nie, Lin; Cheng, Lei			Surgical Treatment of Cervical Spondylotic Myelopathy Associated Hypertension-A Retrospective Study of 309 Patients	PLOS ONE			English	Article							JOINT NATIONAL COMMITTEE; BLOOD-PRESSURE; PREOPERATIVE ANXIETY; 7TH REPORT; PATHOGENESIS; PREVENTION; HUMANS	Hypertension is the most prevalent cardiovascular disease, and various risk factors are known to be involved in it. Cervical spondylotic myelopathy (CSM) is the most common non-traumatic cause of myelopathy, which displays neurological symptoms and may induce systemic symptoms. To date, it is still unknown whether CSM is associated with hypertension, and if so, whether the decompression operations can attenuate CSM associated hypertension. Here, a total of 309 patients with CSM who received anterior or posterior decompression surgery were enrolled as subjects. Blood pressure measurements were performed before and within one week after the surgery. Among the 309 subjects, 144 (46.6%) of them exhibited hypertension before surgery, a significantly higher ratio than that of the whole population. One week after surgery, blood pressure of 106 (73.6%) patients turned back to normal. Blood pressure of another 37(25.7%) patients decreased with different degrees, although still higher than normal. Moreover, it appears that both approaches were effective in improving blood pressure, while the posterior approach was more effective in decreasing systolic blood pressure. We speculate this type of hypertension might result from hyperactivity of sympathetic nervous system as the heart rate of these patients decreased after surgery as well. Collectively, compression of spinal cord in CSM patients might be associated with hypertension, and decompression surgery largely attenuated this type of hypertension. These findings prove CSM to be a potential associated factor of high blood pressure and may shed light on therapies of hypertension in clinics.	[Li, Ze-qun; Zhao, Yun-peng; Wang, Xia; Chen, Bin; Nie, Lin; Cheng, Lei] Shandong Univ, Qilu Hosp, Dept Spine Surg, Jinan, Shandong, Peoples R China; [Li, Ze-qun; Shahbaz, Muhammad] Shandong Univ, Qilu Hosp, Dept Gen Surg, Jinan, Shandong, Peoples R China; [Jia, Wen-yu] Shandong Univ, Dept Endocrinol & Metab, Shandong Prov Hosp, Jinan, Shandong, Peoples R China; [Jia, Wen-yu] Shandong Acad Clin Med, Inst Endocrinol, Jinan, Shandong, Peoples R China	Shandong University; Shandong University; Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University	Nie, L (corresponding author), Shandong Univ, Qilu Hosp, Dept Spine Surg, Jinan, Shandong, Peoples R China.	doctor_lizequn@163.com; miraculously2008@163.com			National "973" program of China [2011CB503906]; National Natural Science Foundation of China [81172863, 81128013, 81202069, 81072407]; Natural Science Foundation of Shandong Province [ZR2011CM022]	National "973" program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Shandong Province(Natural Science Foundation of Shandong Province)	This research was supported partially by the National "973" program of China (2011CB503906), the National Natural Science Foundation of China (81172863, 81128013, 81202069 and 81072407) and the Natural Science Foundation of Shandong Province (ZR2011CM022).	Baron EM, 2007, NEUROSURGERY, V60, P35, DOI 10.1227/01.NEU.0000215383.64386.82; Belmonte SL, 2011, CIRC RES, V109, P309, DOI 10.1161/CIRCRESAHA.110.231233; BIANCHI G, 1989, AM J HYPERTENS, V2, pS2, DOI 10.1093/ajh/2.2.2S; Ceravolo GS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111117; Charkoudian N, 2005, J PHYSIOL-LONDON, V568, P315, DOI 10.1113/jphysiol.2005.090076; Chaturvedi S, 2004, NATL MED J INDIA, V17, P227; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Edwards Charles C 2nd, 2003, Spine J, V3, P68, DOI 10.1016/S1529-9430(02)00566-1; Fehlings MG, 2013, SPINE, V38, P2247, DOI 10.1097/BRS.0000000000000047; GUIDETTI B, 1969, Journal of Neurosurgery, V30, P714, DOI 10.3171/jns.1969.30.6.0714; GUYTON AC, 1989, AM J HYPERTENS, V2, P575, DOI 10.1093/ajh/2.7.575; He J, 2009, LANCET, V374, P1765, DOI 10.1016/S0140-6736(09)61199-5; Hsu W, 2009, NEUROSURG QUART, V19, P302, DOI 10.1097/WNQ.0b013e3181bd5f8c; Ishii M, 2000, Nihon Rinsho, V58 Suppl 1, P267; Joyner MJ, 2008, EXP PHYSIOL, V93, P715, DOI 10.1113/expphysiol.2007.039545; Kiray A, 2005, CLIN ANAT, V18, P179, DOI 10.1002/ca.20055; Kohno K, 1997, SURG NEUROL, V48, P237, DOI 10.1016/S0090-3019(97)00166-3; Lebl Darren R, 2011, HSS J, V7, P170, DOI 10.1007/s11420-011-9208-1; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; LUKE RG, 1993, HYPERTENSION, V21, P380, DOI 10.1161/01.HYP.21.3.380; Mancia G, 1999, HYPERTENSION, V34, P724, DOI 10.1161/01.HYP.34.4.724; Mattei Tobias A, 2011, ISRN Neurol, V2011, P463729, DOI 10.5402/2011/463729; Mccormick WE, 2003, CLEV CLIN J MED, V70, P899, DOI 10.3949/ccjm.70.10.899; Morley AP, 2008, ANAESTHESIA, V63, P467, DOI 10.1111/j.1365-2044.2007.05402.x; Muller DN, 2011, CURR OPIN NEPHROL HY, V20, P113, DOI 10.1097/MNH.0b013e3283436f88; Narkiewicz K, 2005, HYPERTENSION, V45, P522, DOI 10.1161/01.HYP.0000160318.46725.46; Nishihara Masaaki, 2014, Nihon Rinsho, V72, P1374; NURICK S, 1972, BRAIN, V95, P87; Panda N, 1996, ANAESTHESIA, V51, P344, DOI 10.1111/j.1365-2044.1996.tb07745.x; Sacco M, 2013, J CLIN HYPERTENS, V15, P600, DOI 10.1111/jch.12145; Savoia C, 2011, EXPERT REV MOL MED, V13, P1, DOI 10.1017/S1462399411001815; Saylam CY, 2009, CLIN ANAT, V22, P324, DOI 10.1002/ca.20764; Singh M, 2010, CARDIOL CLIN, V28, P545, DOI 10.1016/j.ccl.2010.07.001; Skarphedinsson JO, 1997, J PHYSIOL-LONDON, V501, P671, DOI 10.1111/j.1469-7793.1997.671bm.x; Wang JW, 2014, AM J HYPERTENS, V27, P1355, DOI 10.1093/ajh/hpu053; Wang XiaoYan, 2014, Journal of Guangxi Normal University - Natural Science Edition, V32, P32; Weyer C, 2000, HYPERTENSION, V36, P531, DOI 10.1161/01.HYP.36.4.531; Witwer BP, 2007, NEUROSURGERY, V60, P130, DOI 10.1227/01.NEU.0000215351.32372.CE; Yamada H, 2001, J COMP NEUROL, V434, P86, DOI 10.1002/cne.1166	39	12	13	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2015	10	7							e0133828	10.1371/journal.pone.0133828	http://dx.doi.org/10.1371/journal.pone.0133828			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LN	26193469	Green Published, gold, Green Submitted			2022-12-26	WOS:000358546400127
J	Ma, N; Liu, XW; Yang, YJ; Li, JY; Mohamed, I; Liu, GR; Zhang, JY				Ma, Ning; Liu, Xi-Wang; Yang, Ya-Jun; Li, Jian-Yong; Mohamed, Isam; Liu, Guang-Rong; Zhang, Ji-Yu			Preventive Effect of Aspirin Eugenol Ester on Thrombosis in kappa-Carrageenan-Induced Rat Tail Thrombosis Model	PLOS ONE			English	Article							IN-VIVO; ANTIINFLAMMATORY DRUGS; PLATELET; VITRO; AGGREGATION; BIOSYNTHESIS; INFLAMMATION; MECHANISMS; INHIBITORS	Based on the prodrug principle, aspirin eugenol ester (AEE) was synthesized, which can reduce the side effects of aspirin and eugenol. As a good candidate for new antithrombotic and anti-inflammatory medicine, it is essential to evaluate its preventive effect on thrombosis. Preventive effect of AEE was investigated in kappa-carrageenan-induced rat tail thrombosis model. AEE suspension liquids were prepared in 0.5% sodium carboxymethyl cellulose (CMC-Na). AEE was administrated at the dosage of 18, 36 and 72 mg/kg. Aspirin (20 mg/kg), eugenol (18 mg/kg) and 0.5% CMC-Na (30 mg/kg) were used as control drug. In order to compare the effects between AEE and its precursor, integration of aspirin and eugenol group (molar ratio 1:1) was also designed in the experiment. After drugs were administrated intragastrically for seven days, each rat was injected intraperitoneally with 20 mg/kg BW kappa-carrageen dissolved in physiological saline to induce thrombosis. The length of tail-thrombosis was measured at 24 and 48 hours. The blank group just was given physiological saline for seven days without kappa-carrageenan administrated. The results indicated that AEE significantly not only reduced the average length of thrombus, PT values and FIB concentration, but also reduced the red blood cell (RBC), hemoglobin (HGB), hematocrit (HCT) and platelet (PLT). The effects of AEE on platelet aggregation and anticoagulant in vitro showed that AEE could inhibit adenosine diphosphate (ADP)-induced platelet aggregation as dosedependence but no notable effect on blood clotting. From these results, it was concluded that AEE possessed positive effect on thrombosis prevention in vivo through the reduction of FIB, PLT, inhibition of platelet aggregation and the change of TT and PT values.	[Ma, Ning; Liu, Xi-Wang; Yang, Ya-Jun; Li, Jian-Yong; Mohamed, Isam; Liu, Guang-Rong; Zhang, Ji-Yu] CAAS, Lanzhou Inst Husb & Pharmaceut Sci, Key Lab Vet Pharmaceut Dev, Key Lab New Anim Drug Project Gansu Prov,Minist A, Lanzhou 730050, Peoples R China	Chinese Academy of Agricultural Sciences; Lanzhou Institute of Husbandry & Pharmaceutical Sciences, CAAS	Li, JY (corresponding author), CAAS, Lanzhou Inst Husb & Pharmaceut Sci, Key Lab Vet Pharmaceut Dev, Key Lab New Anim Drug Project Gansu Prov,Minist A, Lanzhou 730050, Peoples R China.	lijy1971@163.com		Ning, Ma/0000-0001-6696-0379	science-technology innovation engineering of CAAS (CAAS-ASTIP-LIHPS); National Natural Science Foundation of China [31402254]	science-technology innovation engineering of CAAS (CAAS-ASTIP-LIHPS); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The work was supported by science-technology innovation engineering of CAAS (CAAS-ASTIP-2014-LIHPS) and the National Natural Science Foundation of China (No. 31402254). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anita K, 2014, ORVOSI HETILAP, V155, P851, DOI 10.1556/OH.2014.29899; Arslan R, 2011, THROMB RES, V127, P210, DOI 10.1016/j.thromres.2010.11.028; Baskaran Y, 2010, TOXICOLOGY, V268, P204, DOI 10.1016/j.tox.2009.12.018; Begum R, 2014, PHARM BIOL, P1; BORN GVR, 1962, NATURE, V194, P927, DOI 10.1038/194927b0; Burdan Franciszek, 2006, Postepy Hig Med Dosw (Online), V60, P129; Chami N, 2005, ORAL MICROBIOL IMMUN, V20, P106, DOI 10.1111/j.1399-302X.2004.00202.x; Chesnutt JKW, 2015, COMPUT BIOL MED, V56, P182, DOI 10.1016/j.compbiomed.2014.11.006; DAVIE EW, 1991, BIOCHEMISTRY-US, V30, P10363, DOI 10.1021/bi00107a001; Ema M, 2008, REPROD TOXICOL, V25, P89, DOI 10.1016/j.reprotox.2007.08.003; FERNANDEZ AG, 1995, NAT MED, V1, P602, DOI 10.1038/nm0795-602a; FLOWER R, 1972, NATURE-NEW BIOL, V238, P104, DOI 10.1038/newbio238104a0; Gambero A, 2007, DIGEST DIS SCI, V52, P425, DOI 10.1007/s10620-006-9487-4; Gill AO, 2004, APPL ENVIRON MICROB, V70, P5750, DOI 10.1128/AEM.70.10.5750-5755.2004; Gong Y, 2014, BR J PHARM; Hagimori M, 2009, PHARMACOL RES, V60, P320, DOI 10.1016/j.phrs.2009.04.010; Hsiao G, 2002, BRIT J HAEMATOL, V117, P699, DOI 10.1046/j.1365-2141.2002.03492.x; Hussain M, 2012, INT IMMUNOPHARMACOL, V12, P10, DOI 10.1016/j.intimp.2011.11.021; Jin Z, 2013, CHEM ENG J, V221, P331, DOI 10.1016/j.cej.2013.02.011; Jorgensen L, 2006, J THROMB HAEMOST, V4, P1443, DOI 10.1111/j.1538-7836.2006.02006.x; Li J, 2010, ANIM HUSBAND VET MED, V42, P20; Li JY, 2012, MED CHEM RES, V21, P995, DOI 10.1007/s00044-011-9609-1; Li JY, 2013, FOOD CHEM TOXICOL, V62, P805, DOI 10.1016/j.fct.2013.10.010; Li JY, 2012, FOOD CHEM TOXICOL, V50, P1980, DOI 10.1016/j.fct.2012.03.080; Lim K, 2008, CANCER RES, V68, P553, DOI 10.1158/0008-5472.CAN-07-2295; Liu XJ, 2012, BIOORG MED CHEM LETT, V22, P6591, DOI 10.1016/j.bmcl.2012.09.001; Philippou H, 2014, THROMB RES, V133, P1, DOI 10.1016/j.thromres.2013.10.034; Raghavendra RH, 2009, PROSTAG LEUKOTR ESS, V81, P73, DOI 10.1016/j.plefa.2009.04.009; Sadowski M, 2014, ATHEROSCLEROSIS, V237, P555, DOI 10.1016/j.atherosclerosis.2014.10.020; Schaff M, 2013, CIRCULATION, V128, P541, DOI 10.1161/CIRCULATIONAHA.112.000799; Schoemaker RG, 1998, CARDIOVASC RES, V37, P108, DOI 10.1016/S0008-6363(97)00208-3; Schussheim AE, 1997, PROG CARDIOVASC DIS, V40, P205, DOI 10.1016/S0033-0620(97)80035-7; Shen YM, 2015, BIOMED CHROMATOGR, V29, P129, DOI 10.1002/bmc.3249; STUBBS MT, 1993, THROMB RES, V69, P1, DOI 10.1016/0049-3848(93)90002-6; Sugiyama K, 2014, J BIOL CHEM, V289, P16303, DOI 10.1074/jbc.M114.564526; Sutcliffe P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081970; Tragoolpua Y, 2007, PHYTOTHER RES, V21, P1153, DOI 10.1002/ptr.2226; VANE J, 1987, FASEB J, V1, P89, DOI 10.1096/fasebj.1.2.3111928; Wan QL, 2013, EXP GERONTOL, V48, P499, DOI 10.1016/j.exger.2013.02.020; Wu Z., 2014, PHILOS T A, V6, P372, DOI [10.1098/rsta.2013.038024982253, DOI 10.1098/RSTA.2013.038024982253]; Yan F, 2009, J THROMB THROMBOLYS, V28, P444, DOI 10.1007/s11239-009-0333-3; Ye De-he, 2011, Zhongguo Yaolixue Yu Dulixue Zazhi, V25, P151, DOI 10.3867/j.issn.1000-3002.2011.02.005; Yuan J, 2012, BMC BIOTECHNOL, V12, DOI 10.1186/1472-6750-12-36	43	34	38	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2015	10	7							e0133125	10.1371/journal.pone.0133125	http://dx.doi.org/10.1371/journal.pone.0133125			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LN	26193677	Green Published, Green Submitted, gold			2022-12-26	WOS:000358546400057
J	Al-Daghri, NM; Al-Saleh, Y; Aljohani, N; Alokail, M; Al-Attas, O; Alnaami, AM; Sabico, S; Alsulaimani, M; Al-Harbi, M; Alfawaz, H; Chrousos, GP				Al-Daghri, Nasser M.; Al-Saleh, Yousef; Aljohani, Naji; Alokail, Majed; Al-Attas, Omar; Alnaami, Abdullah M.; Sabico, Shaun; Alsulaimani, Maha; Al-Harbi, Mohammed; Alfawaz, Hanan; Chrousos, George P.			Vitamin D Deficiency and Cardiometabolic Risks: A Juxtaposition of Arab Adolescents and Adults	PLOS ONE			English	Article							CARDIOVASCULAR-DISEASE; METABOLIC SYNDROME; HYPOVITAMINOSIS-D; INSULIN SENSITIVITY; 25-HYDROXYVITAMIN D; D SUPPLEMENTATION; OVERWEIGHT; ASSOCIATIONS; POPULATION; PATTERNS	The recent exponential surge in vitamin D research reflects the global epidemic of vitamin D deficiency and its potential impact on several chronic diseases in both children and adults. Several subpopulations, including Arab adolescent boys and girls, remain understudied. This study aims to fill this gap. A total of 2225 apparently healthy Saudi adolescents (1187 boys and 1038 girls, aged 13-17 years old) and 830 adults (368 men and 462 women, aged 18-50 years old) were respectively recruited from different public schools and medical practices within Riyadh, Saudi Arabia. Anthropometrics were taken and fasting blood samples withdrawn to examine serum glucose and lipid profile by routine analysis and 25-hydroxyvitamin D by ELISA. Almost half of the girls (47.0%) had vitamin D deficiency as compared to only 19.4% of the boys (p<0.001), 36.8% of the adult women and 17.7% of the adult men (p<0.001). Furthermore, in boys there were more significant inverse associations between serum 25(OH) vitamin D levels and cardiometabolic indices than girls, while in contrast women had more significant associations than men. Vitamin D deficiency was significantly associated with diabetes mellitus type 2 (DMT2) [OR 3.47 (CI1.26-5.55); p<0.05] and pre-DM [OR 2.47 (CI 1.48-4.12); p<0.01] in boys. Furthermore, vitamin D insufficiency was significantly associated with abdominal obesity in boys [OR 2.75 (CI 1.1-7.1); p<0.05]. These associations for DMT2 and abdominal obesity were not observed in adult males, girls and adult women. Vitamin D deficiency/insufficiency and hyperglycemia is high among Arab adolescents. Vitamin D deficiency is mostly associated with cardiometabolic risk factors in adolescent Arab boys. This indicates a sex-and age-related disadvantage for boys with low vitamin D status and challenges the extra-skeletal protection of vitamin D correction in adolescent females.	[Al-Daghri, Nasser M.; Alokail, Majed; Al-Attas, Omar; Alnaami, Abdullah M.; Sabico, Shaun; Chrousos, George P.] King Saud Univ, Coll Sci, Dept Biochem, Biomarkers Res Program, Riyadh 11451, Saudi Arabia; [Al-Daghri, Nasser M.; Al-Saleh, Yousef; Aljohani, Naji; Alokail, Majed; Al-Attas, Omar; Alnaami, Abdullah M.; Sabico, Shaun] King Saud Univ, Coll Sci, Dept Biochem, Prince Mutaib Chair Biomarkers Osteoporosis, Riyadh 11451, Saudi Arabia; [Al-Saleh, Yousef] King Saud Bin Abdulaziz Univ Hlth Sci, Coll Med, King Abdulaziz Med City, Riyadh 11426, Saudi Arabia; [Aljohani, Naji] King Saud Bin Abdulaziz Univ Hlth Sci, Fac Med, Specialized Diabet & Endocrine Ctr, King Fahad Med City, Riyadh 11525, Saudi Arabia; [Alsulaimani, Maha] King Saud Univ, Coll Sci, Dept Biochem, Riyadh 11451, Saudi Arabia; [Al-Harbi, Mohammed] Diabet Ctr, Riyadh, Saudi Arabia; [Al-Harbi, Mohammed] Minist Hlth, Unit Adm, Riyadh, Saudi Arabia; [Alfawaz, Hanan] King Saud Univ, Coll Food Sci & Agr, Dept Food Sci & Nutr, Riyadh 11451, Saudi Arabia; [Chrousos, George P.] Univ Athens, Sch Med, Dept Pediat 1, GR-11527 Athens, Greece	King Saud University; King Saud University; King Saud Bin Abdulaziz University for Health Sciences; King Saud Bin Abdulaziz University for Health Sciences; King Saud University; Ministry of Health - Saudi Arabia; King Saud University; Athens Medical School; National & Kapodistrian University of Athens	Al-Daghri, NM (corresponding author), King Saud Univ, Coll Sci, Dept Biochem, Biomarkers Res Program, Riyadh 11451, Saudi Arabia.	aldaghri2011@gmail.com	Al-okail, Majed S/E-5565-2016; Al-Daghri, Nasser/A-8360-2011; Al-Daghri, Nasser/G-7736-2011; Sabico, Shaun/C-9086-2011	Al-okail, Majed S/0000-0001-8147-3499; Al-Daghri, Nasser/0000-0001-5472-1725; Al-Daghri, Nasser/0000-0001-5472-1725; Sabico, Shaun/0000-0002-5248-2350	Deanship of Scientific Research, Prolific Research Group Program, Vice Rectorate for Graduate Studies and Scientific Research in King Saud University (KSU), Riyadh, Saudi Arabia [PRG-1436-15]	Deanship of Scientific Research, Prolific Research Group Program, Vice Rectorate for Graduate Studies and Scientific Research in King Saud University (KSU), Riyadh, Saudi Arabia	The authors thank the Deanship of Scientific Research, Prolific Research Group Program (PRG-1436-15), Vice Rectorate for Graduate Studies and Scientific Research in King Saud University (KSU), Riyadh, Saudi Arabia for funding the study.	Al Mheid I, 2013, EUR HEART J, V34, P3691, DOI 10.1093/eurheartj/eht166; Al-Daghri NM, 2013, J ENDOCRINOL INVEST, V36, P1, DOI 10.3275/8183; Al-Daghri NM, 2014, J PROTEOME RES, V13, P5094, DOI 10.1021/pr5003406; Al-Daghri NM, 2013, MOLECULES, V18, P10671, DOI 10.3390/molecules180910671; Al-Daghri NM, 2012, CARDIOVASC DIABETOL, V11, DOI 10.1186/1475-2840-11-85; Al-Daghri NM, 2012, METABOLISM, V61, P661, DOI 10.1016/j.metabol.2011.09.017; Al-Daghri NM, 2012, CLIN ENDOCRINOL, V76, P346, DOI 10.1111/j.1365-2265.2011.04219.x; Al-Daghri NM, 2010, CENT EUR J MED, V5, P752, DOI 10.2478/s11536-010-0045-2; Al-Hazzaa HM, 2014, J PHYS ACT HEALTH, V11, P1202, DOI 10.1123/jpah.2012-0427; Al-Mogbel ES, 2012, INT J HEALTH SCI-IJH, V6, P116, DOI 10.12816/0005987; Alemzadeh R, 2008, METABOLISM, V57, P183, DOI 10.1016/j.metabol.2007.08.023; Alkharfy KM, 2013, CARDIOVASC DIABETOL, V12, DOI 10.1186/1475-2840-12-113; Ashraf AP, 2011, OBESITY, V19, P2214, DOI 10.1038/oby.2011.110; Bassil D, 2013, DERM-ENDOCRINOL, V5, P274, DOI 10.4161/derm.25111; Beveridge LA, 2013, OSTEOPOROSIS INT, V24, P2167, DOI 10.1007/s00198-013-2281-1; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; de las Heras J, 2013, DIABETES CARE, V36, P2048, DOI 10.2337/dc12-1288; Erdonmez D, 2011, J CLIN RES PEDIATR E, V3, P198, DOI 10.4274/jcrpe.507; Gulseth HL, 2013, CURR VASC PHARMACOL, V11, P968, DOI 10.2174/15701611113119990169; Hughes AM, 2011, PEDIAT ALLERG IMM-UK, V22, P327, DOI 10.1111/j.1399-3038.2010.01099.x; Jang Han Byul, 2013, Osong Public Health Res Perspect, V4, P179, DOI 10.1016/j.phrp.2013.06.004; Kardas F, 2013, INT J ENDOCRINOL, V2013, DOI 10.1155/2013/503270; Kassi E, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-48; Kelishadi R, 2014, NUTRITION, V30, P33, DOI 10.1016/j.nut.2013.05.018; Kim SH, 2013, J CLIN ENDOCR METAB, V98, pE1716, DOI 10.1210/jc.2013-1166; LERNER DJ, 1986, AM HEART J, V111, P383, DOI 10.1016/0002-8703(86)90155-9; Meddeb N, 2005, OSTEOPOROSIS INT, V16, P180, DOI 10.1007/s00198-004-1658-6; Muhairi SJ, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-33; Palacios C, 2014, J STEROID BIOCHEM, V144, P138, DOI 10.1016/j.jsbmb.2013.11.003; Pirgon O, 2013, OBES RES CLIN PRACT, V7, pE275, DOI 10.1016/j.orcp.2012.01.004; Reid IR, 2014, LANCET, V383, P146, DOI 10.1016/S0140-6736(13)61647-5; Rosano GMC, 2007, CLIMACTERIC, V10, P19, DOI 10.1080/13697130601114917; Stanley T, 2013, METAB SYNDR RELAT D, V11, P56, DOI 10.1089/met.2012.0102; Tester J, 2013, DIABETES METAB SYND, V7, P161, DOI 10.1016/j.dsx.2013.06.002; Verdoia M, 2014, EUR J CLIN INVEST, V44, P634, DOI 10.1111/eci.12281; Vitale C, 2009, NAT REV CARDIOL, V6, P532, DOI 10.1038/nrcardio.2009.105; Winzenberg T, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.c7254	37	41	41	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0131315	10.1371/journal.pone.0131315	http://dx.doi.org/10.1371/journal.pone.0131315			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RV	26186591	Green Published, Green Submitted, gold			2022-12-26	WOS:000358198700014
J	Beaulieu, JJ; Golden, HE; Knightes, CD; Mayer, PM; Kaushal, SS; Pennino, MJ; Arango, CP; Balz, DA; Elonen, CM; Fritz, KM; Hill, BH				Beaulieu, Jake J.; Golden, Heather E.; Knightes, Christopher D.; Mayer, Paul M.; Kaushal, Sujay S.; Pennino, Michael J.; Arango, Clay P.; Balz, David A.; Elonen, Colleen M.; Fritz, Ken M.; Hill, Brian H.			Urban Stream Burial Increases Watershed-Scale Nitrate Export	PLOS ONE			English	Article							NITROGEN UPTAKE; TRANSFORMATION; SIZE	Nitrogen (N) uptake in streams is an important ecosystem service that reduces nutrient loading to downstream ecosystems. Here we synthesize studies that investigated the effects of urban stream burial on N-uptake in two metropolitan areas and use simulation modeling to scale our measurements to the broader watershed scale. We report that nitrate travels on average 18 times farther downstream in buried than in open streams before being removed from the water column, indicating that burial substantially reduces N uptake in streams. Simulation modeling suggests that as burial expands throughout a river network, N uptake rates increase in the remaining open reaches which somewhat offsets reduced N uptake in buried reaches. This is particularly true at low levels of stream burial. At higher levels of stream burial, however, open reaches become rare and cumulative N uptake across all open reaches in the watershed rapidly declines. As a result, watershed-scale N export increases slowly at low levels of stream burial, after which increases in export become more pronounced. Stream burial in the lower, more urbanized portions of the watershed had a greater effect on N export than an equivalent amount of stream burial in the upper watershed. We suggest that stream daylighting (i.e., uncovering buried streams) can increase watershed-scale N retention.	[Beaulieu, Jake J.] US EPA, Off Res & Dev, Natl Risk Management Res Lab, Cincinnati, OH 45268 USA; [Golden, Heather E.; Fritz, Ken M.] US EPA, Off Res & Dev, Natl Exposure Res Lab, Cincinnati, OH 45268 USA; [Knightes, Christopher D.] US EPA, Off Res & Dev, Natl Exposure Res Lab, Athens, GA USA; [Mayer, Paul M.] US EPA, Off Res & Dev, Natl Risk Management Res Lab, Ada, OK USA; [Kaushal, Sujay S.; Pennino, Michael J.] Univ Maryland, Dept Geol, College Pk, MD 20742 USA; [Kaushal, Sujay S.; Pennino, Michael J.] Univ Maryland, Earth Syst Interdisciplinary Ctr, College Pk, MD 20742 USA; [Arango, Clay P.] Cent Washington Univ, Dept Biol Sci, Ellensburg, WA USA; [Balz, David A.] Pegasus Tech Serv, Cincinnati, OH USA; [Elonen, Colleen M.; Hill, Brian H.] US EPA, Off Res & Dev, Natl Hlth & Environm Effects Res Lab, Duluth, MN USA	United States Environmental Protection Agency; United States Environmental Protection Agency; United States Environmental Protection Agency; United States Environmental Protection Agency; University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park; Central Washington University; United States Environmental Protection Agency	Beaulieu, JJ (corresponding author), US EPA, Off Res & Dev, Natl Risk Management Res Lab, Cincinnati, OH 45268 USA.	beaulieu.jake@epa.gov		Golden, Heather/0000-0001-5501-9444; Mayer, Paul/0000-0002-8550-1386	Environmental Protection Agency National Network for Environmental Management Studies Award [2010309]; National Science Foundation [DGE-1144243, DBI 0640300, CBET 1058502]; National Aeronautics and Space Administration [NASA NNX11AM28G]; Maryland Sea Grant Awards [SA7528085-U, R/WS-2, NA05OAR4171042]; Baltimore Ecosystem Study LTER project [NSF DEB-0423476]; Pegasus Technical Services; Division Of Environmental Biology [1027188] Funding Source: National Science Foundation; Div Of Chem, Bioeng, Env, & Transp Sys [1058502] Funding Source: National Science Foundation	Environmental Protection Agency National Network for Environmental Management Studies Award; National Science Foundation(National Science Foundation (NSF)); National Aeronautics and Space Administration(National Aeronautics & Space Administration (NASA)); Maryland Sea Grant Awards; Baltimore Ecosystem Study LTER project; Pegasus Technical Services; Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Div Of Chem, Bioeng, Env, & Transp Sys(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	This research was supported by Environmental Protection Agency National Network for Environmental Management Studies Award 2010309, the National Science Foundation Graduate Research Fellowship Program under Grant No. DGE-1144243, National Science Foundation Awards DBI 0640300 and CBET 1058502, National Aeronautics and Space Administration grant NASA NNX11AM28G, Maryland Sea Grant Awards SA7528085-U, R/WS-2 and NA05OAR4171042, and the Baltimore Ecosystem Study LTER project (NSF DEB-0423476). Pegasus Technical Services provided support in the form of salaries for the author DAB, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of the authors are articulated in the 'author contributions' section. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	2000/60/EC Directive 2000/60/EC of the European Parliament and of the Council of 23 October 2000, 2000, OFFICIAL J EUROPEA L, VL 327, P1, DOI DOI 10.1039/ap9842100196; Alexander RB, 2000, NATURE, V403, P758, DOI 10.1038/35001562; Alexander RB, 2007, J AM WATER RESOUR AS, V43, P41, DOI 10.1111/j.1752-1688.2007.00005.x; Anderson WP, 2010, J HYDROL, V393, P309, DOI 10.1016/j.jhydrol.2010.08.030; AUMEN NG, 1990, J N AM BENTHOL SOC, V9, P95; Beaulieu JJ, 2014, BIOGEOCHEMISTRY, V121, P107, DOI 10.1007/s10533-014-9971-4; Conradin F, 2005, NATO SCI SERIES, P277; Diaz RJ, 2008, SCIENCE, V321, P926, DOI 10.1126/science.1156401; Elmore AJ, 2008, FRONT ECOL ENVIRON, V6, P308, DOI 10.1890/070101; Grimm NB, 2005, J N AM BENTHOL SOC, V24, P626, DOI 10.1899/04-027.1; Hall RO, 2003, LIMNOL OCEANOGR, V48, P1120, DOI 10.4319/lo.2003.48.3.1120; Hall RO, 2009, LIMNOL OCEANOGR, V54, P653, DOI 10.4319/lo.2009.54.3.0653; Hietala-Koivu R, 2004, AGR ECOSYST ENVIRON, V103, P75, DOI 10.1016/j.agee.2003.10.015; Hopkins J.N.N., 2007, WATERS ROME, V4, P1; Iversen TM, 1997, RIVER RESTORATION 96; Kaushal SS, 2012, URBAN ECOSYST, V15, P409, DOI 10.1007/s11252-012-0226-7; Kim N.C., 2005, LANDSC ECOL ENG, V1, P77, DOI [10.1007/s11355-005-0011-3, DOI 10.1007/S11355-005-0011-3, DOI 10.1007/s11355-005-0011-3]; Klocker CA, 2009, AQUAT SCI, V71, P411, DOI 10.1007/s00027-009-0118-y; Kummert R, 1992, GEWSSER ALS OKOSYSTE; Meyer J.L., 2005, P 2005 GEORG WAT RES; Meyer JL, 2001, ECOLOGY: ACHIEVEMENT AND CHALLENGE, P295; Montgomery MR, 2008, SCIENCE, V319, P761, DOI 10.1126/science.1153012; Mulholland PJ, 2008, NATURE, V452, P202, DOI 10.1038/nature06686; O'Driscoll M, 2010, WATER-SUI, V2, P605, DOI 10.3390/w2030605; Pennino MJ, 2014, BIOGEOCHEMISTRY, V121, P247, DOI 10.1007/s10533-014-9958-1; Peterson BJ, 2001, SCIENCE, V292, P86, DOI 10.1126/science.1056874; Royer TV, 2006, ENVIRON SCI TECHNOL, V40, P4126, DOI 10.1021/es052573n; Stammler KL, 2013, LANDSCAPE URBAN PLAN, V114, P37, DOI 10.1016/j.landurbplan.2013.02.008; Steele MK, 2014, ECOSYSTEMS, V17, P685, DOI 10.1007/s10021-014-9751-y; Trice A, 2014, DAYLIGHTING STREAMS; Vitousek PM, 1997, ECOL APPL, V7, P737, DOI 10.2307/2269431; Wild TC, 2011, WATER ENVIRON J, V25, P412, DOI 10.1111/j.1747-6593.2010.00236.x; Wollheim WM, 2008, J GEOPHYS RES-BIOGEO, V113, DOI 10.1029/2007JG000660; Wollheim WM, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL025845	34	28	28	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0132256	10.1371/journal.pone.0132256	http://dx.doi.org/10.1371/journal.pone.0132256			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RV	26186731	Green Published, gold, Green Submitted			2022-12-26	WOS:000358198700032
J	Ding, LL; Zhang, XY; Guo, HL; Yuan, JL; Li, SJ; Hu, WL; Golden, T; Wu, N				Ding, Lingling; Zhang, Xiaoyu; Guo, Hongliang; Yuan, Junliang; Li, Shujuan; Hu, Wenli; Golden, Teresa; Wu, Ning			The Functional Study of a Chinese Herbal Compounded Antidepressant Medicine - Jie Yu Chu Fan Capsule on Chronic Unpredictable Mild Stress Mouse Model	PLOS ONE			English	Article							BANXIA-HOUPU DECOCTION; MAJOR DEPRESSIVE DISORDER; EXTRACELLULAR SEROTONIN; GARDENIA-JASMINOIDES; SUCROSE PREFERENCE; OXIDATIVE STRESS; NEUROPEPTIDE-Y; RATS; FLUOXETINE; BRAIN	Jie Yu Chu Fan capsule (JYCF) is a new compounded Chinese herbal medicine for the treatment of depression. The present study was designed to explore the antidepressant effects and the possible mechanisms of JYCF by using chronic unpredictable mild stress (CUMS) mouse model and comparing results to that of fluoxetine. Behavioral tests including an open field test, sucrose preference test and forced swim test were performed to evaluate the antidepressant effects of JYCF. The concentrations of monoamine neurotransmitters and metabolic products including norepinephrine (NE), 5-hydroxytryptamine (5-HT), dopamine (DA), 5-hydroxyindoleacetic acid (5-HIAA), homovanillic acid (HVA) and 3,4dihydroxyphenylacetic acid (DOPAC) in the cerebral cortex and hippocampus of mice were determined by means of high performance liquid chromatography with electrochemical detection (HPLC-EC). The results show that a successful mouse CUMS model was established through 5 weeks of continuous unpredictable stimulation, as indicated by the significant decrease in sucrose preference and locomotor activity and increase in immobility time in the forced swim test. Chronic treatment of JYCF (1.25, 2.5 and 5 g/kg) and fluoxetine (20mg/kg) significantly reversed the CUMS-induced behavioral abnormalities. JYCF (1.25, 2.5 and 5 g/kg) significantly increased NE in CUMS mouse prefrontal cortex (P < 0.01, P < 0.01, P < 0.05 respectively) and 5-HT in hippocampus (P < 0.05). In summary, our findings suggest that JYCF exerts comparable antidepressant-like effects to that of fluoxetine in CUMS mice. Besides, the antidepressant-like effect of JYCF is mediated by the increase of monoaminergic transmitters including 5-HT and NE.	[Ding, Lingling; Zhang, Xiaoyu; Guo, Hongliang; Yuan, Junliang; Li, Shujuan; Hu, Wenli] Capital Med Univ, Beijing Chaoyang Hosp, Dept Neurol, Beijing, Peoples R China; [Golden, Teresa; Wu, Ning] Southeastern Oklahoma State Univ, Dept Biol Sci, Durant, OK USA	Capital Medical University	Hu, WL (corresponding author), Capital Med Univ, Beijing Chaoyang Hosp, Dept Neurol, Beijing, Peoples R China.	huwenli@sina.com	Zhang, xiaoyu/GXA-3206-2022					Becker AE, 2013, NEW ENGL J MED, V369, P66, DOI 10.1056/NEJMra1110827; Brunner E, 2014, NEUROPSYCHOPHARMACOL, V39, P2549, DOI 10.1038/npp.2014.101; Casarotto PC, 2007, EUR NEUROPSYCHOPHARM, V17, P735, DOI 10.1016/j.euroneuro.2007.03.001; D'Aquila PS, 2000, EUR J PHARMACOL, V399, P43, DOI 10.1016/S0014-2999(00)00332-0; Elhwuegi AS, 2004, PROG NEURO-PSYCHOPH, V28, P435, DOI 10.1016/j.pnpbp.2003.11.018; Gao S, 2013, BEHAV BRAIN RES, V238, P79, DOI 10.1016/j.bbr.2012.10.015; Guo YS, 2004, PHYTOTHER RES, V18, P204, DOI 10.1002/ptr.1394; Hou CL, 2006, BRAIN RES, V1095, P154, DOI 10.1016/j.brainres.2006.04.026; Huang CK, 2015, NEUROCHEM RES, V40, P27, DOI 10.1007/s11064-014-1461-5; Iguchi Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114024; Invernizzi R, 1996, PHARMACOL BIOCHEM BE, V54, P143, DOI 10.1016/0091-3057(95)02159-0; Jindal A, 2013, PHARMACOL BIOCHEM BE, V105, P63, DOI 10.1016/j.pbb.2013.01.020; KATZ RJ, 1981, NEUROSCI BIOBEHAV R, V5, P247, DOI 10.1016/0149-7634(81)90005-1; Kim JH, 2012, BIOMOL THER, V20, P214, DOI 10.4062/biomolther.2012.20.2.214; Kupfer DJ, 2012, LANCET, V379, P1045, DOI 10.1016/S0140-6736(11)60602-8; Li JM, 2003, LIFE SCI, V74, P55, DOI 10.1016/j.lfs.2003.06.030; Liu DX, 2014, BEHAV BRAIN RES, V264, P9, DOI 10.1016/j.bbr.2014.01.039; Liu Y, 2013, PHARMACOL BIOCHEM BE, V104, P27, DOI 10.1016/j.pbb.2012.12.024; Lucca G, 2009, NEUROCHEM INT, V54, P358, DOI 10.1016/j.neuint.2009.01.001; Luo DD, 2008, BRAIN RES BULL, V77, P8, DOI 10.1016/j.brainresbull.2008.05.010; Ma XC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020955; Ma ZQ, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/213739; Mahar I, 2014, NEUROSCI BIOBEHAV R, V38, P173, DOI 10.1016/j.neubiorev.2013.11.009; Mao QQ, 2011, PROG NEURO-PSYCHOPH, V35, P1144, DOI 10.1016/j.pnpbp.2011.03.017; Ng F, 2008, INT J NEUROPSYCHOPH, V11, P851, DOI 10.1017/S1461145707008401; Perez-Caballero L, 2014, EXPERT OPIN DRUG DIS, V9, P567, DOI 10.1517/17460441.2014.907790; PORSOLT RD, 1977, ARCH INT PHARMACOD T, V229, P327; Qiu J, 2014, J ETHNOPHARMACOL, V152, P320, DOI 10.1016/j.jep.2014.01.004; Russo E, 2013, NEUROPHARMACOLOGY, V64, P371, DOI 10.1016/j.neuropharm.2012.06.039; RUTTER JJ, 1994, NEUROSCI LETT, V171, P183, DOI 10.1016/0304-3940(94)90635-1; Saenz JCB, 2006, BEHAV BRAIN RES, V169, P57, DOI 10.1016/j.bbr.2005.12.001; Shaft S, 2014, PHARMACOL BIOCHEM BE, V122, P234, DOI 10.1016/j.pbb.2014.03.029; Sun YQ, 2012, PHYTOTHER RES, V26, P67, DOI 10.1002/ptr.3516; Tao WW, 2014, MOLECULES, V19, P19350, DOI 10.3390/molecules191219350; Tian JS, 2010, NEUROSCI LETT, V479, P236, DOI 10.1016/j.neulet.2010.05.069; Walker FR, 2013, NEUROPHARMACOLOGY, V67, P304, DOI 10.1016/j.neuropharm.2012.10.002; Wang YM, 2005, PHYTOTHER RES, V19, P526, DOI 10.1002/ptr.1697; Whiteford HA, 2013, LANCET, V382, P1575, DOI 10.1016/S0140-6736(13)61611-6; Williamson EM, 2001, PHYTOMEDICINE, V8, P401, DOI 10.1078/0944-7113-00060; Willner P, 2005, NEUROPSYCHOBIOLOGY, V52, P90, DOI 10.1159/000087097; WILLNER P, 1987, PSYCHOPHARMACOLOGY, V93, P358; Willner P, 1997, PSYCHOPHARMACOLOGY, V134, P319, DOI 10.1007/s002130050456; Yi LT, 2009, PROG NEURO-PSYCHOPH, V33, P616, DOI 10.1016/j.pnpbp.2009.03.001; Zhang WY, 2004, PHYTOTHER RES, V18, P200, DOI 10.1002/ptr.1391; Zhou XJ, 2012, J ETHNOPHARMACOL, V139, P422, DOI 10.1016/j.jep.2011.11.027	45	18	20	2	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0133405	10.1371/journal.pone.0133405	http://dx.doi.org/10.1371/journal.pone.0133405			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RV	26186537	Green Published, Green Submitted, gold			2022-12-26	WOS:000358198700133
J	Elmore, MT; Brosnan, JT; Armel, GR; Kopsell, DA; Best, MD; Mueller, TC; Sorochan, JC				Elmore, Matthew T.; Brosnan, James T.; Armel, Gregory R.; Kopsell, Dean A.; Best, Michael D.; Mueller, Thomas C.; Sorochan, John C.			Cytochrome P450 Inhibitors Reduce Creeping Bentgrass (Agrostis stolonifera) Tolerance to Topramezone	PLOS ONE			English	Article							SMOOTH CRABGRASS CONTROL; MIXED-FUNCTION OXIDASE; HERBICIDE SAFENERS; CHLOROPHYLL FLUORESCENCE; ECHINOCHLOA-PHYLLOPOGON; PERENNIAL RYEGRASS; RESISTANCE; METABOLISM; CHLORTOLURON; SELECTIVITY	Creeping bentgrass (Agrostis stolonifera L.) is moderately tolerant to the p-hydroxyphenylpyruvate dioxygenase-inhibiting herbicide topramezone. However, the contribution of plant metabolism of topramezone to this tolerance is unknown. Experiments were conducted to determine if known cytochrome P450 monooxygenase inhibitors 1-aminobenzotriazole (ABT) and malathion alone or in combination with the herbicide safener cloquintocet-mexyl influence creeping bentgrass tolerance to topramezone. Creeping bentgrass in hydroponic culture was treated with ABT (70 mu M), malathion (70 mu m and 1000 g ha(-1)), or cloquintocet-mexyl (70 mu M and 1000 g ha(-1)) prior to topramezone (8 g ha(-1)) application. Topramezone-induced injury to creeping bentgrass increased from 22% when applied alone to 79 and 41% when applied with malathion or ABT, respectively. Cloquintocet-mexyl (70 mu M and 1000 g ha(-1)) reduced topramezone injury to 1% and increased creeping bentgrass biomass and PSII quantum yield. Cloquintocet-mexyl mitigated the synergistic effects of ABT more than those of malathion. The effects of malathion on topramezone injury were supported by creeping bentgrass biomass responses. Responses to ABT and malathion suggest that creeping bentgrass tolerance to topramezone is influenced by cytochrome P450-catalyzed metabolism. Future research should elucidate primary topramezone metabolites and determine the contribution of cytochrome P450 monooxygenases and glutathione S-transferases to metabolite formation in safened and non-safened creeping bentgrass.	[Elmore, Matthew T.] Texas A&M AgriLife Extens Serv, Dept Soil & Crop Sci, Dallas, TX 75252 USA; [Brosnan, James T.; Armel, Gregory R.; Kopsell, Dean A.; Mueller, Thomas C.; Sorochan, John C.] Univ Tennessee, Dept Plant Sci, Knoxville, TN 37996 USA; [Best, Michael D.] Univ Tennessee, Dept Chem, Knoxville, TN 37996 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M AgriLife Research; University of Tennessee System; University of Tennessee Knoxville; UT Institute of Agriculture; University of Tennessee System; University of Tennessee Knoxville	Elmore, MT (corresponding author), Texas A&M AgriLife Extens Serv, Dept Soil & Crop Sci, Dallas, TX 75252 USA.	matthew.elmore@ag.tamu.edu		Kopsell, Dean/0000-0002-0299-1624; Elmore, Matthew/0000-0002-3049-3892	Tennessee Agricultural Experiment Station	Tennessee Agricultural Experiment Station	This work was supported by the Tennessee Agricultural Experiment Station. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, PYLEX SPECIMEN LABEL; Beckie HJ, 2012, WEED SCI, V60, P10, DOI 10.1614/WS-D-11-00110.1; Brazier M, 2002, PHYTOCHEMISTRY, V59, P149, DOI 10.1016/S0031-9422(01)00458-7; Brosnan JT, 2013, WEED TECHNOL, V27, P138, DOI 10.1614/WT-D-12-00119.1; BURNET MWM, 1993, PLANTA, V190, P182, DOI 10.1007/BF00196610; CABANNE F, 1987, PESTIC BIOCHEM PHYS, V28, P371, DOI 10.1016/0048-3575(87)90133-7; Chapple C, 1998, ANNU REV PLANT PHYS, V49, P311, DOI 10.1146/annurev.arplant.49.1.311; CHRISTOPHER JT, 1994, PESTIC BIOCHEM PHYS, V49, P172, DOI 10.1006/pest.1994.1045; Davies J, 1999, PESTIC SCI, V55, P1043, DOI 10.1002/(SICI)1096-9063(199911)55:11&lt;1043::AID-PS60&gt;3.0.CO;2-L; deBoer GJ, 2011, PEST MANAG SCI, V67, P279, DOI 10.1002/ps.2062; Dernoeden PH, 2013, CREEPING BENTGRASS MANAGEMENT, 2ND EDITION, P1; Dernoeden PH, 2003, HORTSCIENCE, V38, P607, DOI 10.21273/HORTSCI.38.4.607; DERNOEDEN PH, 1992, HORTSCIENCE, V27, P1001; Elmore MT, 2011, CROP SCI, V51, P2840, DOI 10.2135/cropsci2010.11.0656; Elmore MT, 2012, WEED SCI, V60, P480, DOI 10.1614/WS-D-11-00169.1; Elmore MT, WEED TECHNO IN PRESS; FREAR DS, 1969, PHYTOCHEMISTRY, V8, P2157, DOI 10.1016/S0031-9422(00)88175-3; GAILLARDON P, 1985, WEED RES, V25, P397, DOI 10.1111/j.1365-3180.1985.tb00661.x; Grossmann K, 2007, PEST MANAG SCI, V63, P429, DOI 10.1002/ps.1341; Hart SE, 2004, WEED TECHNOL, V18, P375, DOI 10.1614/WT-03-106R; Hatzios KK, 2004, WEED SCI, V52, P454, DOI 10.1614/P2002-168C; Henry GM, 2004, HORTSCIENCE, V39, P1768, DOI 10.21273/HORTSCI.39.7.1768; Hoagland DR, 1950, CAL AGR EXP STN CIRC, V347, DOI [DOI 10.1016/S0140-6736(00)73482-9, 10.1016/S0140-6736(00)73482-9]; JOHNSON BJ, 1994, HORTSCIENCE, V29, P880, DOI 10.21273/HORTSCI.29.8.880; Kaspar M, 2011, WEED SCI, V59, P232, DOI 10.1614/WS-D-10-00120.1; Kocurek V, 2009, CEREAL RES COMMUN, V37, P289; Kreuz K, 1996, PLANT PHYSIOL, V111, P349, DOI 10.1104/pp.111.2.349; KREUZ K, 1991, Z NATURFORSCH C, V46, P901; Lyman G. T., 2007, Applied Turfgrass Science, P1107; Maxwell K, 2000, J EXP BOT, V51, P659, DOI 10.1093/jexbot/51.345.659; MCINTOSH MS, 1983, AGRON J, V75, P153, DOI 10.2134/agronj1983.00021962007500010041x; Menendez J, 2006, WEED SCI, V54, P237; Mitchell G, 2001, PEST MANAG SCI, V57, P120, DOI 10.1002/1526-4998(200102)57:2<120::AID-PS254>3.0.CO;2-E; Ohba K, 1997, J PESTIC SCI, V22, P277; Osuna MD, 2002, PESTIC BIOCHEM PHYS, V73, P9, DOI 10.1016/S0048-3575(02)00010-X; Preston C, 1996, PESTIC BIOCHEM PHYS, V54, P123, DOI 10.1006/pest.1996.0016; Riechers DE, 1996, PESTIC BIOCHEM PHYS, V56, P88, DOI 10.1006/pest.1996.0063; Riechers DE, 2010, PLANT PHYSIOL, V153, P3, DOI 10.1104/pp.110.153601; SANG RS, 1992, HORTSCIENCE, V27, P237; Siminszky Balazs, 2006, Phytochemistry Reviews, V5, P445, DOI 10.1007/s11101-006-9011-7; Smith A, 2013, P SO WEED SCI SOC, V66, P3; Taylor VL, 2013, ENVIRON EXP BOT, V88, P93, DOI 10.1016/j.envexpbot.2011.12.030; Thies F, 1996, PLANT PHYSIOL, V112, P361, DOI 10.1104/pp.112.1.361; Venner KA, 2014, P NE WEED SCI SOC, P90; Werck-Reichhart D, 2000, TRENDS PLANT SCI, V5, P116, DOI 10.1016/S1360-1385(00)01567-3; Williams MM, 2010, WEED SCI, V58, P289, DOI 10.1614/WS-D-09-00058.1; Yasuor H, 2009, J AGR FOOD CHEM, V57, P3653, DOI 10.1021/jf8039999; Yun MS, 2001, PEST MANAG SCI, V57, P283, DOI 10.1002/ps.298	48	5	6	1	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0130947	10.1371/journal.pone.0130947	http://dx.doi.org/10.1371/journal.pone.0130947			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RV	26186714	Green Published, Green Submitted, gold			2022-12-26	WOS:000358198700008
J	Gasse, B; Liu, X; Corre, E; Sire, JY				Gasse, Barbara; Liu, Xi; Corre, Erwan; Sire, Jean-Yves			Amelotin Gene Structure and Expression during Enamel Formation in the Opossum Monodelphis domestica	PLOS ONE			English	Article							RNA-SEQ DATA; JUNCTIONAL EPITHELIUM; REFERENCE GENOME; MINERALIZATION; EVOLUTION; PROTEIN; ALIGNMENT; TISSUE	Amelotin (AMTN) is an ameloblast-secreted protein that belongs to the secretory calcium-binding phosphoprotein family, which also includes the enamel matrix proteins amelogenin, ameloblastin and enamelin. Although AMTN is supposed to play an important role in enamel formation, data were long limited to the rodents, in which it is expressed during the maturation stage. Recent comparative studies in sauropsids and amphibians revealed that (i) AMTN was expressed earlier, i.e. as soon as ameloblasts are depositing the enamel matrix, and (ii) AMTN structure was different, a change which mostly resulted from an intraexonic splicing in the large exon 8 of an ancestral mammal. The present study was performed to know whether the differences in AMTN structure and expression in rodents compared to non-mammalian tetrapods dated back to an early ancestral mammal or were acquired later in mammalian evolution. We sequenced, assembled and screened the jaw transcriptome of a neonate opossum Monodelphis domestica, a marsupial. We found two AMTN transcripts. Variant 1, representing 70.8% of AMTN transcripts, displayed the structure known in rodents, whereas variant 2 (29.2%) exhibited the nonmammalian tetrapod structure. Then, we studied AMTN expression during amelogenesis in a neonate specimen. We obtained similar data as those reported in rodents. These findings indicate that more than 180 million years ago, before the divergence of marsupials and placentals, changes occurred in AMTN function and structure. The spatiotemporal expression was delayed to the maturation stage of amelogenesis and the intraexonic splicing gave rise to isoform 1, encoded by variant 1 and lacking the RGD motif. The ancestral isoform 2, housing the RGD, was initially conserved, as demonstrated here in a marsupial, then secondarily lost in the placental lineages. These findings bring new elements towards our understanding of the non-prismatic to prismatic enamel transition that occurred at the onset of mammals.	[Gasse, Barbara; Liu, Xi; Sire, Jean-Yves] Univ Paris 06, Sorbonne Univ, IBPS, UMR7138, F-75005 Paris, France; [Gasse, Barbara; Liu, Xi; Sire, Jean-Yves] CNRS, IBPS, UMR7138, F-75005 Paris, France; [Liu, Xi; Corre, Erwan] Univ Paris 06, Sorbonne Univ, Stn Biol Roscoff, Plateforme ABiMS Anal & Bioinformat Marine Sci, F-29680 Roscoff, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite	Sire, JY (corresponding author), Univ Paris 06, Sorbonne Univ, IBPS, UMR7138, F-75005 Paris, France.	jean-yves.sire@upmc.fr	corre, erwan/O-4669-2019	corre, erwan/0000-0001-6354-2278	Centre national de la recherche scientifique, Universite Pierre et Marie Curie; Project "Jaws" [ANR-12-BSV7-020]	Centre national de la recherche scientifique, Universite Pierre et Marie Curie(Centre National de la Recherche Scientifique (CNRS)); Project "Jaws"	This study was financially supported by Centre national de la recherche scientifique, Universite Pierre et Marie Curie, and by the Project "Jaws" (ANR-12-BSV7-020). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbarin N, 2015, J BONE MINER RES, V30, P775, DOI 10.1002/jbmr.2411; Al-Hashimi N, 2010, MOL BIOL EVOL, V27, P2078, DOI 10.1093/molbev/msq098; Gasse B, 2012, J DENT RES, V91, P1085, DOI 10.1177/0022034512460551; Gasse B, 2015, BMC EVOL BIOL, V15, P329; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Iwasaki K, 2005, J DENT RES, V84, P1127, DOI 10.1177/154405910508401207; Kawasaki K, 2003, P NATL ACAD SCI USA, V100, P4060, DOI 10.1073/pnas.0638023100; Kawasaki K, 2007, CELLS TISSUES ORGANS, V186, P7, DOI 10.1159/000102678; Kawasaki K, 2014, J EXP ZOOL PART B, V322, P390, DOI 10.1002/jez.b.22546; Lacruz RS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035200; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Madsen Ole, 2009, P459; Moffatt P, 2006, BIOCHEM J, V399, P37, DOI 10.1042/BJ20060662; Nishio C, 2013, PERIODONTOL 2000, V63, P59, DOI 10.1111/prd.12031; Somogyi-Ganss E, 2012, CELLS TISSUES ORGANS, V195, P535, DOI 10.1159/000329255; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Wood C. B., 1999, Journal of Mammalian Evolution, V6, P177, DOI 10.1023/A:1020624222324	19	39	40	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0133314	10.1371/journal.pone.0133314	http://dx.doi.org/10.1371/journal.pone.0133314			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RV	26186457	Green Published, Green Submitted, gold			2022-12-26	WOS:000358198700124
J	Lang, YH; Fu, FM; Sun, DL; Xi, CH; Chen, FY				Lang, Yuhuang; Fu, Fengming; Sun, Dalong; Xi, Chenhui; Chen, Fengyuan			Labetalol Prevents Intestinal Dysfunction Induced by Traumatic Brain Injury	PLOS ONE			English	Article							SEVERE HEAD-INJURY; TIGHT-JUNCTION; BARRIER FUNCTION; NERVOUS-SYSTEM; MAGUK PROTEIN; NITRIC-OXIDE; X-RECEPTOR; APOPTOSIS; ALPHA; RAT	Background Beta-adrenergic blockade has been hypothesized to have a protective effect on intestinal dysfunction and increased intestinal permeability associated with the epinephrine surge after traumatic brain injury (TBI). Methods Wister rats were subjected to either a weight drop TBI, and intraperitoneally injected or not with labetalol, or a sham procedure (18 rats per group). After 3, 6, or 12h (6 rats per subgroup), intestinal permeability to 4.4 kDa FITC-Dextran and plasma epinephrine levels were measured as was intestinal tight junction protein ZO-1 expression at 12h. Terminal ileum was harvested to measure levels of intestinal tumor necrosis factor (TNF)-alpha and to evaluate histopathology. Results In TBI group vs. sham group, intestinal permeability (P<0.01) was significantly higher at all time-points, and intestinal ZO-1 expression was lower at 12h. In TBI with vs. without labetalol group, 1) intestinal permeability was significantly lower at 6 and 12h (94.31 +/- 7.64 vs. 102.16 +/- 6.40 mu g/mL; 110.21 +/- 7.52 vs. 118.95 +/- 7.11 mu g/mL, respectively); 2) levels of plasma epinephrine and intestinal TNF-alpha were significantly lower at 3, 6 and 12h; and 3) intestinal ZO-1 expression was higher at 3, 6 and 12h (p=0.018). Histopathological evaluation showed that labetalol use preserved intestinal architecture throughout. Conclusion In a rat model of TBI, labetalol reduced TBI-induced sympathetic hyperactivity, and prevented histopathological intestinal injury accompanied by changes in gut permeability and gut TNF-alpha expression.	[Lang, Yuhuang; Xi, Chenhui] Fudan Univ, Shanghai Hosp Affiliated 5, Dept Emergency, Shanghai 200433, Peoples R China; [Fu, Fengming] Fudan Univ, Shanghai Canc Ctr, Intens Care Unit, Shanghai 200433, Peoples R China; [Sun, Dalong; Chen, Fengyuan] Fudan Univ, Shanghai Hosp Affiliated 5, Dept Gastroenterol, Shanghai 200433, Peoples R China	Fudan University; Fudan University; Fudan University	Chen, FY (corresponding author), Fudan Univ, Shanghai Hosp Affiliated 5, Dept Gastroenterol, Shanghai 200433, Peoples R China.	cfy429@163.com			Science and Technology Committee of Minhang District, Shanghai, China [2012MHZ013]	Science and Technology Committee of Minhang District, Shanghai, China	This work has been kindly supported by Grant 2012MHZ013 from the Science and Technology Committee of Minhang District, Shanghai, China.	Adachi M, 2006, MOL CELL BIOL, V26, P9003, DOI 10.1128/MCB.01811-05; Baguley IJ, 2008, NEUROCRIT CARE, V8, P293, DOI 10.1007/s12028-007-9021-3; Bansal V, 2010, J NEUROTRAUM, V27, P2255, DOI 10.1089/neu.2010.1372; Bansal V, 2010, J TRAUMA, V68, P1059, DOI 10.1097/TA.0b013e3181d87373; Bansal V, 2009, J NEUROTRAUM, V26, P1353, DOI [10.1089/neu.2008.0858, 10.1089/neu.2008-0858]; Chavez AM, 1999, CRIT CARE MED, V27, P2246, DOI 10.1097/00003246-199910000-00030; Chen LW, 2003, ARCH SURG-CHICAGO, V138, P1219, DOI 10.1001/archsurg.138.11.1219; CHIU CJ, 1970, ARCH SURG-CHICAGO, V101, P478; CLIFTON GL, 1981, NEUROSURGERY, V8, P10, DOI 10.1227/00006123-198101000-00003; Costantini TW, 2009, SHOCK, V31, P416, DOI 10.1097/SHK.0b013e3181863080; Cotton BA, 2007, J TRAUMA, V62, P26, DOI 10.1097/TA.0b013e31802d02d0; ELENKOV IJ, 1995, J NEUROIMMUNOL, V61, P123, DOI 10.1016/0165-5728(95)00080-L; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; FURUSE M, 1993, J CELL BIOL, V123, P1777, DOI 10.1083/jcb.123.6.1777; Furuse M, 1998, J CELL BIOL, V141, P1539, DOI 10.1083/jcb.141.7.1539; GUMBINER B, 1991, P NATL ACAD SCI USA, V88, P3460, DOI 10.1073/pnas.88.8.3460; Gumbiner BM, 1996, CELL, V84, P345, DOI 10.1016/S0092-8674(00)81279-9; Hang CH, 2005, J SURG RES, V123, P188, DOI 10.1016/j.jss.2004.08.002; Hang CH, 2003, WORLD J GASTROENTERO, V9, P2776; Hang CH, 2007, J SURG RES, V137, P53, DOI 10.1016/j.jss.2006.06.026; Haskins J, 1998, J CELL BIOL, V141, P199, DOI 10.1083/jcb.141.1.199; He Q, 2014, CIRC-HEART FAIL, V7, P1032, DOI 10.1161/CIRCHEARTFAILURE.114.001260; HORTNAGL H, 1980, INTENS CARE MED, V6, P169, DOI 10.1007/BF01757299; Ikenouchi J, 2005, J CELL BIOL, V171, P939, DOI 10.1083/jcb.200510043; Jiang XW, 2011, J CARDIOVASC MED, V12, P732, DOI 10.2459/JCM.0b013e32834a6697; Johnson JD, 2005, J APPL PHYSIOL, V99, P1789, DOI 10.1152/japplphysiol.00390.2005; Lang YH, 2012, J TRAUMA SURG, V14, P51; MACCARTHY EP, 1983, PHARMACOTHERAPY, V3, P193; Maheras KJ, 2013, J NEUROSCI METH, V219, P61, DOI 10.1016/j.jneumeth.2013.07.004; McNeil JJ, 1979, BR J CLIN PHARM, V8, P157; Miele L, 2009, HEPATOLOGY, V49, P1877, DOI 10.1002/hep.22848; MOREL DR, 1984, INTENS CARE MED, V10, P133, DOI 10.1007/BF00265802; Pedersen ME, 2007, CURR HYPERTENS REP, V9, P269, DOI 10.1007/s11906-007-0050-2; PIEK J, 1992, J NEUROSURG, V77, P901, DOI 10.3171/jns.1992.77.6.0901; Prass K, 2003, J EXP MED, V198, P725, DOI 10.1084/jem.20021098; Pu J, 2014, J AM COLL CARDIOL, V63, P2220, DOI 10.1016/j.jacc.2014.02.576; Pu J, 2013, EUR HEART J, V34, P1834, DOI 10.1093/eurheartj/ehs011; Pu J, 2012, EUR HEART J, V33, P372, DOI 10.1093/eurheartj/ehr387; Shan PR, 2008, BIOCHEM BIOPH RES CO, V375, P628, DOI 10.1016/j.bbrc.2008.08.074; STEVENSON BR, 1986, J CELL BIOL, V103, P755, DOI 10.1083/jcb.103.3.755; Tong S, 2014, LAB ANIM SCI, V31, P52; Umeda K, 2006, CELL, V126, P741, DOI 10.1016/j.cell.2006.06.043; Vitarbo EA, 2004, NEUROSURGERY, V55, P416, DOI 10.1227/01.NEU.0000130036.52521.2C; Wang FJ, 2006, GASTROENTEROLOGY, V131, P1153, DOI 10.1053/j.gastro.2006.08.022; Wang YB, 2011, WORLD J GASTROENTERO, V17, P657, DOI 10.3748/wjg.v17.i5.657; Wang Yan-bin, 2010, Zhonghua Nei Ke Za Zhi, V49, P869; Yao TB, 2015, ANTIOXID REDOX SIGN, V22, P633, DOI 10.1089/ars.2014.5887; Zacharia J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065969; Zygun DA, 2005, CRIT CARE MED, V33, P654, DOI 10.1097/01.ccm.0000155911.01844.54	49	11	15	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0133215	10.1371/journal.pone.0133215	http://dx.doi.org/10.1371/journal.pone.0133215			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RV	26186619	Green Published, gold, Green Submitted			2022-12-26	WOS:000358198700110
J	Lee, J; Kagamihara, Y; Kakei, S				Lee, Jongho; Kagamihara, Yasuhiro; Kakei, Shinji			A New Method for Functional Evaluation of Motor Commands in Patients with Cerebellar Ataxia	PLOS ONE			English	Article							MULTIJOINT ARM MOVEMENTS; TRACKING MOVEMENT; MANUAL TRACKING; FREQUENCY-RESPONSE; VOLUNTARY MOVEMENT; KINEMATIC ANALYSIS; ABNORMAL CONTROL; PURKINJE-CELLS; SOLEUS MUSCLE; HUMAN WRIST	Quantitative evaluation of motor functions of patients with cerebellar ataxia is vital for evidence-based treatments and has been a focus in previous investigations of movement kinematics. Due to redundancy of the musculoskeletal system, muscle activities contain more information than the movement kinematics. Therefore, it is preferable to analyze causal anomalies of muscle activities to evaluate motor functions in patients. Here we propose a new method to evaluate the motor functions at the level of muscle activities and movement kinematics. Nineteen patients and 10 control subjects performed two movement tasks of the wrist joint, a step-tracking task and a pursuit task, with a manipulandum. The movements of the wrist joint and activities of the four wrist prime movers were recorded. We developed a linear model for the wrist joint to approximate the causal relationship between muscle activities and movement kinematics in terms of the wrist joint torque. We used a canonical correlation analysis to verify the causality between the muscle activities and the movement kinematics in the model. We found that the activities of the four muscles were related almost entirely to the position and velocity, with negligible correlation with the acceleration of the wrist joint. Moreover, the ratio of the weights for position-and velocity-related torque components characterized the contents of the muscle activities in terms of the movement kinematics. Next, we compared the ratios for the two movement tasks between the controls and patients. In control subjects, the ratios indicated clear task-specific changes that conformed to the functional requirements of the tasks. In contrast, in patients, the task-specific changes diminished highly significantly. The present results indicate that this ability to accommodate motor commands to the task requirements provides a novel quantitative parameter to characterize motor functions in patients with cerebellar ataxia.	[Lee, Jongho; Kakei, Shinji] Tokyo Metropolitan Inst Med Sci, Movement Disorders Project, Tokyo 1568506, Japan; [Kagamihara, Yasuhiro] Tokyo Metropolitan Neurol Hosp, Dept Neurol, Fuchu, Tokyo 1830042, Japan	Tokyo Metropolitan Institute of Medical Science; Tokyo Metropolitan Institute for Neuroscience	Kakei, S (corresponding author), Tokyo Metropolitan Inst Med Sci, Movement Disorders Project, Tokyo 1568506, Japan.	kakei-sj@igakuken.or.jp		Kakei, Shinji/0000-0001-5111-5789	Tokyo Metropolitan Institute of Medical Science; Japan Science and Technology Agency (A-STEP); Ministry of Education, Culture, Sports, Science and Technology in Japan [14580784, 15016008, 16015212, 20033029, 21500319, 21700229, 24650304]	Tokyo Metropolitan Institute of Medical Science; Japan Science and Technology Agency (A-STEP); Ministry of Education, Culture, Sports, Science and Technology in Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This research was supported by the Tokyo Metropolitan Institute of Medical Science and grants-in-aid from the Japan Science and Technology Agency (A-STEP) to SK (http://www.jst.go.jp/), from the Ministry of Education, Culture, Sports, Science and Technology in Japan (http://www.mext.go.jp/) (No. 14580784, No. 15016008, No. 16015212, No. 20033029, No. 21500319) to SK, and (No. 21700229, No. 24650304) to JL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAZAWA K, 1983, J NEUROPHYSIOL, V49, P16, DOI 10.1152/jn.1983.49.1.16; Alciatore DG, 2011, INTRO MECHATRONICS M, P139; Bastian AJ, 1996, J NEUROPHYSIOL, V76, P492, DOI 10.1152/jn.1996.76.1.492; Bastian AJ, 2000, J NEUROPHYSIOL, V83, P3019, DOI 10.1152/jn.2000.83.5.3019; BECKER JD, 1990, J BIOMECH ENG-T ASME, V112, P1, DOI 10.1115/1.2891121; BENNETT DJ, 1992, EXP BRAIN RES, V88, P433, DOI 10.1007/BF02259118; BEPPU H, 1984, BRAIN, V107, P787, DOI 10.1093/brain/107.3.787; Bonnefoi-Kyriacou B, 1998, EXP BRAIN RES, V119, P460, DOI 10.1007/s002210050361; Charles SK, 2011, J BIOMECH, V44, P614, DOI 10.1016/j.jbiomech.2010.11.016; Day BL, 1998, BRAIN, V121, P357, DOI 10.1093/brain/121.2.357; DESERRES SJ, 1991, EXP BRAIN RES, V86, P451, DOI 10.1007/BF00228972; DIENER HC, 1992, MOVEMENT DISORD, V7, P95, DOI 10.1002/mds.870070202; Engel KC, 2000, J NEUROPHYSIOL, V83, P3483, DOI 10.1152/jn.2000.83.6.3483; GIELEN CCAM, 1984, J NEUROPHYSIOL, V52, P553, DOI 10.1152/jn.1984.52.3.553; Grey MJ, 1997, THESIS S FRASER U BU, P51; Halaki M, 2006, J BIOMECH, V39, P2171, DOI 10.1016/j.jbiomech.2005.06.022; HALLETT M, 1975, J NEUROL NEUROSUR PS, V38, P1163, DOI 10.1136/jnnp.38.12.1163; Hardle W. K., 2003, APPL MULTIVARIATE ST, P321; Haruno M, 2005, J NEUROPHYSIOL, V94, P4244, DOI 10.1152/jn.00404.2005; Hewitt AL, 2011, J NEUROPHYSIOL, V106, P2232, DOI 10.1152/jn.00886.2010; HOFFER JA, 1981, J NEUROPHYSIOL, V45, P267, DOI 10.1152/jn.1981.45.2.267; Hoffman DS, 1999, J NEUROPHYSIOL, V81, P319, DOI 10.1152/jn.1999.81.1.319; Holmes G, 1939, BRAIN, V62, P1, DOI 10.1093/brain/62.1.1; Kakei S, 2003, NEUROSCI RES, V46, P1, DOI 10.1016/S0168-0102(03)00031-2; Kakei S, 1999, SCIENCE, V285, P2136, DOI 10.1126/science.285.5436.2136; KOIKE Y, 1995, BIOL CYBERN, V73, P291, DOI 10.1007/BF00199465; Lee J, 2012, CEREBELLUM, V11, P426, DOI 10.1007/s12311-012-0370-x; Lee J, 2008, IEEE ENG MED BIO, P181, DOI 10.1109/IEMBS.2008.4649120; MANNARD A, 1973, J PHYSIOL-LONDON, V229, P275, DOI 10.1113/jphysiol.1973.sp010138; MANO N, 1980, J NEUROPHYSIOL, V43, P713, DOI 10.1152/jn.1980.43.3.713; Manto M, 1996, EUR NEUROL, V36, P333, DOI 10.1159/000117289; Massaquoi S, 1996, CAN J NEUROL SCI, V23, P3, DOI 10.1017/S0317167100039123; Menegoni F, 2009, EUR J NEUROL, V16, P232, DOI 10.1111/j.1468-1331.2008.02396.x; MILNER TE, 1993, EXP BRAIN RES, V94, P522; Milner TE, 1998, EXP BRAIN RES, V122, P309, DOI 10.1007/s002210050519; Nakanishi R, 1992, Rinsho Shinkeigaku, V32, P251; Pasalar S, 2006, NAT NEUROSCI, V9, P1404, DOI 10.1038/nn1783; Rijnveld N, 2007, INT C REHAB ROBOT, P43, DOI 10.1109/ICORR.2007.4428404; Roitman AV, 2005, J NEUROSCI, V25, P9244, DOI 10.1523/JNEUROSCI.1886-05.2005; Roitman AV, 2004, J NEUROPHYSIOL, V91, P901, DOI 10.1152/jn.00261.2003; Sanguineti V, 2003, HUM MOVEMENT SCI, V22, P189, DOI 10.1016/S0167-9457(02)00159-8; Shin D, 2009, J NEUROPHYSIOL, V101, P387, DOI 10.1152/jn.00584.2007; SINKJAER T, 1989, J BIOMECH, V22, P1133, DOI 10.1016/0021-9290(89)90215-7; Staudenmann D, 2010, J ELECTROMYOGR KINES, V20, P375, DOI 10.1016/j.jelekin.2009.08.005; Topka H, 1998, EXP BRAIN RES, V119, P493, DOI 10.1007/s002210050365; Topka H, 1998, EXP BRAIN RES, V119, P483, DOI 10.1007/s002210050364	46	15	15	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0132983	10.1371/journal.pone.0132983	http://dx.doi.org/10.1371/journal.pone.0132983			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RV	26186225	gold, Green Submitted, Green Published			2022-12-26	WOS:000358198700082
J	Gowthaman, R; Lyskov, S; Karanicolas, J				Gowthaman, Ragul; Lyskov, Sergey; Karanicolas, John			DARC 2.0: Improved Docking and Virtual Screening at Protein Interaction Sites	PLOS ONE			English	Article							CONFORMER GENERATION; SWARM OPTIMIZATION; SMALL MOLECULES; DRUG DISCOVERY; BINDING-SITES; TARGETS; INTERFACES; NETWORKS; CHALLENGES; INHIBITORS	Over the past decade, protein-protein interactions have emerged as attractive but challenging targets for therapeutic intervention using small molecules. Due to the relatively flat surfaces that typify protein interaction sites, modern virtual screening tools developed for optimal performance against "traditional" protein targets perform less well when applied instead at protein interaction sites. Previously, we described a docking method specifically catered to the shallow binding modes characteristic of small-molecule inhibitors of protein interaction sites. This method, called DARC (Docking Approach using Ray Casting), operates by comparing the topography of the protein surface when "viewed" from a vantage point inside the protein against the topography of a bound ligand when "viewed" from the same vantage point. Here, we present five key enhancements to DARC. First, we use multiple vantage points to more accurately determine protein-ligand surface complementarity. Second, we describe a new scheme for rapidly determining optimal weights in the DARC scoring function. Third, we incorporate sampling of ligand conformers "on-the-fly" during docking. Fourth, we move beyond simple shape complementarity and introduce a term in the scoring function to capture electrostatic complementarity. Finally, we adjust the control flow in our GPU implementation of DARC to achieve greater speedup of these calculations. At each step of this study, we evaluate the performance of DARC in a "pose recapitulation" experiment: predicting the binding mode of 25 inhibitors each solved in complex with its distinct target protein (a protein interaction site). Whereas the previous version of DARC docked only one of these inhibitors to within 2 angstrom RMSD of its position in the crystal structure, the newer version achieves this level of accuracy for 12 of the 25 complexes, corresponding to a statistically significant performance improvement (p < 0.001). Collectively then, we find that the five enhancements described here - which together make up DARC 2.0 - lead to dramatically improved speed and performance relative to the original DARC method.	[Gowthaman, Ragul; Karanicolas, John] Univ Kansas, Ctr Computat Biol, Lawrence, KS 66045 USA; [Lyskov, Sergey] Johns Hopkins Univ, Dept Chem & Biomol Engn, Baltimore, MD 21218 USA; [Karanicolas, John] Univ Kansas, Dept Mol Biosci, Lawrence, KS 66045 USA	University of Kansas; Johns Hopkins University; University of Kansas	Karanicolas, J (corresponding author), Univ Kansas, Ctr Computat Biol, 2030 Becker Dr, Lawrence, KS 66045 USA.	johnk@ku.edu		Gowthaman, Ragul/0000-0002-0008-6401	National Institute of General Medical Sciences of National Institutes of Health [R01GM099959]; National Science Foundation [MCB130049]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM099959] Funding Source: NIH RePORTER	National Institute of General Medical Sciences of National Institutes of Health; National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a grant from the National Institute of General Medical Sciences of the National Institutes of Health (R01GM099959) and by the National Science Foundation through XSEDE allocation MCB130049. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bourgeas R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009598; Call ST, 2007, J COMPUT CHEM, V28, P1177, DOI 10.1002/jcc.20621; Chen HM, 2007, J COMPUT CHEM, V28, P612, DOI 10.1002/jcc.20542; Coleman RG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075992; Cross JB, 2009, J CHEM INF MODEL, V49, P1455, DOI 10.1021/ci900056c; Damm-Ganamet KL, 2013, J CHEM INF MODEL, V53, P1853, DOI 10.1021/ci400025f; Fuller JC, 2009, DRUG DISCOV TODAY, V14, P155, DOI 10.1016/j.drudis.2008.10.009; Gonzalez MW, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002819; Gordo S, 2009, PROTEIN SCI, V18, P481, DOI 10.1002/pro.43; Gowthaman R, 2015, J MED CHEM FORTHCOMI; Gowthaman R, 2013, J CHEM INF MODEL, V53, P2073, DOI 10.1021/ci4002316; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hawkins PCD, 2012, J CHEM INF MODEL, V52, P2919, DOI 10.1021/ci300314k; Hawkins PCD, 2010, J CHEM INF MODEL, V50, P572, DOI 10.1021/ci100031x; Hendlich M, 1997, J MOL GRAPH MODEL, V15, P359, DOI 10.1016/S1093-3263(98)00002-3; Higueruelo AP, 2009, CHEM BIOL DRUG DES, V74, P457, DOI 10.1111/j.1747-0285.2009.00889.x; Huey R, 2007, J COMPUT CHEM, V28, P1145, DOI 10.1002/jcc.20634; Ideker T, 2008, GENOME RES, V18, P644, DOI 10.1101/gr.071852.107; Imming P, 2006, NAT REV DRUG DISCOV, V5, P821, DOI 10.1038/nrd2132; Irwin JJ, 2012, J CHEM INF MODEL, V52, P1757, DOI 10.1021/ci3001277; Ivanov AA, 2013, TRENDS PHARMACOL SCI, V34, P393, DOI 10.1016/j.tips.2013.04.007; Janin J, 2008, Q REV BIOPHYS, V41, P133, DOI 10.1017/S0033583508004708; Johnson DK, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002951; Kennedy JER, 1995, PROCEEDINGS OF THE I; Khar KR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070661; Lang PT, 2009, RNA, V15, P1219, DOI 10.1261/rna.1563609; Leaver-Fay A, 2011, METHOD ENZYMOL, P545, DOI [10.1016/S0076-6879(11)87019-9, 10.1016/B978-0-12-381270-4.00019-6]; Liu Y, 2013, J COMPUT CHEM, V34, P67, DOI 10.1002/jcc.23108; Lo Conte L, 1999, J MOL BIOL, V285, P2177; Makley LN, 2013, CHEM BIOL DRUG DES, V81, P22, DOI 10.1111/cbdd.12066; McCoy AJ, 1997, J MOL BIOL, V268, P570, DOI 10.1006/jmbi.1997.0987; McGann M, 2011, J CHEM INF MODEL, V51, P578, DOI 10.1021/ci100436p; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Mukherjee S, 2010, J CHEM INF MODEL, V50, P1986, DOI 10.1021/ci1001982; Namasivayam V, 2007, CHEM BIOL DRUG DES, V70, P475, DOI 10.1111/j.1747-0285.2007.00588.x; Nero TL, 2014, NAT REV CANCER, V14, P248, DOI 10.1038/nrc3690; Overington JP, 2006, NAT REV DRUG DISCOV, V5, P993, DOI 10.1038/nrd2199; R Core Team, 2014, R A LANGUAGE AND ENV; Sevimoglu T, 2014, COMPUT STRUCT BIOTEC, V11, P22, DOI 10.1016/j.csbj.2014.08.008; Smith MC, 2012, EXPERT REV MOL MED, V14, DOI 10.1017/erm.2012.10; Stumpf MPH, 2008, P NATL ACAD SCI USA, V105, P6959, DOI 10.1073/pnas.0708078105; Vidal M, 2011, CELL, V144, P986, DOI 10.1016/j.cell.2011.02.016; Villoutreix BO, 2014, MOL INFORM, V33, P414, DOI 10.1002/minf.201400040; Voet A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075762; Wells JA, 2007, NATURE, V450, P1001, DOI 10.1038/nature06526; White Alex W., 2008, Expert Reviews in Molecular Medicine, V10, P1, DOI 10.1017/S1462399408000641; Zinzalla G, 2009, FUTURE MED CHEM, V1, P65, DOI [10.4155/fmc.09.12, 10.4155/FMC.09.12]	47	13	13	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2015	10	7							e0131612	10.1371/journal.pone.0131612	http://dx.doi.org/10.1371/journal.pone.0131612			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RQ	26181386	Green Published, gold, Green Submitted			2022-12-26	WOS:000358198200008
J	Huang, XB; Kanwal, JS; Jiang, TL; Long, ZY; Luo, B; Yue, XK; Gu, YB; Feng, J				Huang, Xiaobin; Kanwal, Jagmeet S.; Jiang, Tinglei; Long, Zhenyu; Luo, Bo; Yue, Xinke; Gu, Yongbo; Feng, Jiang			Situational and Age-Dependent Decision Making during Life Threatening Distress in Myotis macrodactylus	PLOS ONE			English	Article							PREDATION-RISK; ESCAPE BEHAVIOR; MOUSTACHED BAT; DEFENSIVE BEHAVIOR; AUDITORY-CORTEX; CALLS; RESPONSES; ECHOLOCATION; COMMUNICATION; CONSPECIFICS	Echolocation and audiovocal communication have been studied extensively in bats. The manner in which these abilities are incorporated within escape behaviors during life-threatening distress is largely unknown. Here we tested the hypothesis that behavioral response profiles expressed during distress are relatively stereotypic given their evolutionary adaptations to avoid predators. We subjected juvenile and adult big-footed myotis (Myotis macrodactylus) to a sequence of three types of life threatening distress: 1) trapping them in a mist-net (environmental threat), 2) approaching them when trapped (predator threat), and 3) partially restraining their freedom to move (arrest), and recorded their escape behavior in each of the three conditions. Response profiles differed across individuals and with the context in which they were expressed. During environmental and predator threat, bats displayed significantly more biting and wing-flapping behaviors and emitted more echolocation pulses than during arrest. Response profiles also varied with age. During arrest, juveniles were more likely than adults to emit distress calls and vice-versa for biting and wing flapping during environmental and predator threat. Overall, individualized response profiles were classified into ten clusters that were aligned along two divergent response trajectories when viewed within two-dimensional, multifactorial decision space. Juvenile behaviors tended to follow a predominantly "social-dependence" trajectory, whereas adult behaviors were mostly aligned along a "self-reliance" trajectory. We conclude that bats modify their vocal behavior and make age-appropriate and contextually adaptive decisions when distressed. This decision-making ability is consistent with observations in other social species, including humans.	[Huang, Xiaobin; Jiang, Tinglei; Long, Zhenyu; Luo, Bo; Yue, Xinke; Gu, Yongbo; Feng, Jiang] NE Normal Univ, Jilin Prov Key Lab Anim Resource Conservat & Util, Changchun, Peoples R China; [Huang, Xiaobin; Jiang, Tinglei; Long, Zhenyu; Luo, Bo; Yue, Xinke; Gu, Yongbo; Feng, Jiang] NE Normal Univ, Key Lab Wetland Ecol & Vegetat Restorat Natl Envi, Changchun, Peoples R China; [Kanwal, Jagmeet S.] Georgetown Univ, Med Ctr, Dept Neurol, Washington, DC 20007 USA; [Kanwal, Jagmeet S.] Georgetown Univ, Med Ctr, Dept Neurosci, Washington, DC 20007 USA; [Kanwal, Jagmeet S.] Georgetown Univ, Med Ctr, Dept Psychol, Washington, DC 20007 USA	Northeast Normal University - China; Northeast Normal University - China; Georgetown University; Georgetown University; Georgetown University	Jiang, TL (corresponding author), NE Normal Univ, Jilin Prov Key Lab Anim Resource Conservat & Util, Changchun, Peoples R China.	jiangtl730@nenu.edu.cn; fengj@nenu.edu.cn	Jiang, Tinglei/GQQ-9485-2022; Kanwal, Jagmeet S./D-2145-2009	Kanwal, Jagmeet S./0000-0002-4529-3631	National Natural Science Foundation of China [31030011, 31470457, 31100280]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was funded by the National Natural Science Foundation of China (grant no. 31030011, 31470457, 31100280). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya L, 1999, CAN J ZOOL, V77, P27, DOI 10.1139/cjz-77-1-27; AUGUST PV, 1985, SOUTHWEST NAT, V30, P371, DOI 10.2307/3671269; Baxter DJM, 2006, ETHOLOGY, V112, P977, DOI 10.1111/j.1439-0310.2006.01249.x; Bernard JF, 1998, J COMP NEUROL, V401, P429; Boyles JG, 2007, BEHAVIOUR, V144, P1019, DOI 10.1163/156853907781871806; Branch CL, 2012, BEHAV ECOL, V23, P854, DOI 10.1093/beheco/ars041; Branstetter BK, 2010, J ACOUST SOC AM, V128, P2484; Breviglieri CPB, 2013, OECOLOGIA, V173, P905, DOI 10.1007/s00442-013-2677-9; Brunet-Rossinni Anja K., 2009, P315; BURGER J, 1990, J COMP PSYCHOL, V104, P388, DOI 10.1037/0735-7036.104.4.388; Casar C, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2013.0535; Chelini MC, 2009, BEHAV PROCESS, V82, P153, DOI 10.1016/j.beproc.2009.06.001; Conner WE, 2012, ANNU REV ENTOMOL, V57, P21, DOI 10.1146/annurev-ento-121510-133537; CONOVER MR, 1994, BEHAVIOUR, V131, P19, DOI 10.1163/156853994X00190; Cooper WE, 2009, AMPHIBIA-REPTILIA, V30, P99, DOI 10.1163/156853809787392720; Creel S, 2014, BEHAV ECOL, V25, P773, DOI 10.1093/beheco/aru050; de Barros FC, 2010, ANIM BEHAV, V79, P83, DOI 10.1016/j.anbehav.2009.10.006; DEAR SP, 1995, J NEUROPHYSIOL, V73, P1084, DOI 10.1152/jn.1995.73.3.1084; Dechmann DN, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00066; DILL LM, 1990, OECOLOGIA, V83, P473, DOI 10.1007/BF00317197; Edelaar P, 2012, BEHAV ECOL, V23, P619, DOI 10.1093/beheco/ars006; Edut S, 2004, BEHAV BRAIN RES, V155, P207, DOI 10.1016/j.bbr.2004.04.018; Ellis JMS, 2008, ETHOLOGY, V114, P154, DOI 10.1111/j.1439-0310.2007.01439.x; FANSELOW MS, 1994, PSYCHON B REV, V1, P429, DOI 10.3758/BF03210947; Feng AS, 2006, NATURE, V440, P333, DOI 10.1038/nature04416; FENTON MB, 1979, CAN J ZOOL, V57, P1271, DOI 10.1139/z79-163; Ferrara FJ, 2005, J MAMMAL, V86, P729, DOI 10.1644/1545-1542(2005)086[0729:COPSBD]2.0.CO;2; Floresco SB, 2007, CEREB CORTEX, V17, P251, DOI 10.1093/cercor/bhj143; Frid A, 2002, CONSERV ECOL, V6; Ganesh A, 2010, J COMP PHYSIOL A, V196, P155, DOI 10.1007/s00359-009-0502-z; Goerlitz HR, 2010, CURR BIOL, V20, P1568, DOI 10.1016/j.cub.2010.07.046; Gregory PT, 2008, ETHOLOGY, V114, P768, DOI 10.1111/j.1439-0310.2008.01524.x; Gregory PT, 2007, J COMP PSYCHOL, V121, P123, DOI 10.1037/0735-7036.121.2.123; Griesser M, 2008, CURR BIOL, V18, P69, DOI 10.1016/j.cub.2007.11.069; Henderson LE, 2008, J MAMMAL, V89, P952, DOI 10.1644/07-MAMM-A-214.1; Honma A, 2006, P ROY SOC B-BIOL SCI, V273, P1631, DOI 10.1098/rspb.2006.3501; Jiang Ting-Lei, 2008, Acta Zootaxonomica Sinica, V33, P212; Jones G, 2011, J COMP PHYSIOL A, V197, P447, DOI 10.1007/s00359-010-0565-x; KANWAL JS, 1994, J ACOUST SOC AM, V96, P1229, DOI 10.1121/1.410273; KLUMP GM, 1984, Z TIERPSYCHOL, V66, P189; KOENIG WD, 1991, CONDOR, V93, P637, DOI 10.2307/1368195; Krama T, 2005, BEHAV ECOL, V16, P37, DOI 10.1093/beheco/arh116; Kunz TH, 2006, BAT ECOLOGY; Laiolo P, 2004, P ROY SOC B-BIOL SCI, V271, pS513, DOI 10.1098/rsbl.2004.0239; Lamprea MR, 2002, BRAIN RES, V950, P186, DOI 10.1016/S0006-8993(02)03036-6; Landova E, 2013, BEHAV ECOL SOCIOBIOL, V67, P1113, DOI 10.1007/s00265-013-1536-3; LEAL M, 1995, COPEIA, P155; Lienart GDH, 2014, ANIM BEHAV, V89, P199, DOI 10.1016/j.anbehav.2013.12.031; LIMA SL, 1990, CAN J ZOOL, V68, P619, DOI 10.1139/z90-092; Lima SL, 2013, BIOL REV, V88, P626, DOI 10.1111/brv.12021; Liu Y, 2009, ACTA CHIROPTEROL, V11, P105, DOI 10.3161/150811009X465721; Ma J, 2006, J COMP PHYSIOL A, V192, P535, DOI 10.1007/s00359-006-0094-9; Ma J, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00055; Manser MB, 2001, P ROY SOC B-BIOL SCI, V268, P2315, DOI 10.1098/rspb.2001.1773; Marko Gabor, 2013, Ornis Hungarica, V21, P12; Martin J, 2005, CAN J ZOOL, V83, P1189, DOI 10.1139/Z05-114; Michelena P, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0016014, 10.1371/journal.pone.0018631]; Mickleburgh SP, 2002, ORYX, V36, P18, DOI 10.1017/S0030605301000011; Miyatake T, 2004, P ROY SOC B-BIOL SCI, V271, P2293, DOI 10.1098/rspb.2004.2858; NORRIS RA, 1965, BIRD BANDING, V36, P83, DOI 10.2307/4511148; OLSEN JF, 1991, J NEUROPHYSIOL, V65, P1254, DOI 10.1152/jn.1991.65.6.1254; Palmer CR, 2011, CURR OPIN NEUROBIOL, V21, P520, DOI 10.1016/j.conb.2011.05.003; Pascual J, 2014, ANIM BEHAV, V90, P297, DOI 10.1016/j.anbehav.2014.02.002; PERRONE M, 1980, WILSON BULL, V92, P404; Prescott T. J., 2008, SCHOLARPEDIA, V3, P2705, DOI DOI 10.4249/SCHOLARPEDIA.2705; Rajala M, 2012, IBIS, V154, P189, DOI 10.1111/j.1474-919X.2011.01188.x; Ratcliffe JM, 2005, BEHAV ECOL SOCIOBIOL, V58, P157, DOI 10.1007/s00265-005-0912-z; Russ JM, 2004, ANIM BEHAV, V67, P1005, DOI 10.1016/j.anbehav.2003.09.003; Russ JM, 1998, ANIM BEHAV, V55, P705, DOI 10.1006/anbe.1997.0665; Russo D, 2011, MAMM BIOL, V76, P87, DOI 10.1016/j.mambio.2009.08.002; SCHNITZLER HU, 1987, J COMP PHYSIOL A, V161, P267, DOI 10.1007/BF00615246; Segalowitz SJ, 2004, BRAIN COGNITION, V55, P116, DOI 10.1016/s0278-2626(03)00283-5; Stankowich T, 2005, P ROY SOC B-BIOL SCI, V272, P2627, DOI 10.1098/rspb.2005.3251; SUGA N, 1987, J NEUROPHYSIOL, V58, P643, DOI 10.1152/jn.1987.58.4.643; SUGA N, 1986, J NEUROPHYSIOL, V55, P776, DOI 10.1152/jn.1986.55.4.776; Suga N, 1995, HDB BRAIN THEORY NEU, P344; Ulanovsky N, 2008, P NATL ACAD SCI USA, V105, P8491, DOI 10.1073/pnas.0703550105; Wang L, 2014, ACTA THERIOL, V59, P435, DOI 10.1007/s13364-014-0182-0; Wheeler BC, 2008, ANIM BEHAV, V76, P1465, DOI 10.1016/j.anbehav.2008.06.023; Winnie J, 2007, ANIM BEHAV, V73, P215, DOI 10.1016/j.anbehav.2006.07.007; Zimmer C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018977	81	11	13	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2015	10	7							e0132817	10.1371/journal.pone.0132817	http://dx.doi.org/10.1371/journal.pone.0132817			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN1RQ	26181328	Green Published, gold, Green Submitted			2022-12-26	WOS:000358198200037
J	Poria, DK; Guha, A; Nandi, I; Ray, PS				Poria, D. K.; Guha, A.; Nandi, I.; Ray, P. S.			RNA-binding protein HuR sequesters microRNA-21 to prevent translation repression of proinflammatory tumor suppressor gene programmed cell death 4	ONCOGENE			English	Article							MESSENGER-RNA; EXPRESSION; PDCD4; MECHANISMS; STRESS; MIR-21; TARGET; SWITCH; VEGFA; DECOY	Translation control of proinflammatory genes has a crucial role in regulating the inflammatory response and preventing chronic inflammation, including a transition to cancer. The proinflammatory tumor suppressor protein programmed cell death 4 (PDCD4) is important for maintaining the balance between inflammation and tumorigenesis. PDCD4 messenger RNA translation is inhibited by the oncogenic microRNA, miR-21. AU-rich element-binding protein HuR was found to interact with the PDCD4 3'-untranslated region (UTR) and prevent miR-21-mediated repression of PDCD4 translation. Cells stably expressing miR-21 showed higher proliferation and reduced apoptosis, which was reversed by HuR expression. Inflammatory stimulus caused nuclear-cytoplasmic relocalization of HuR, reversing the translation repression of PDCD4. Unprecedentedly, HuR was also found to bind to miR-21 directly, preventing its interaction with the PDCD4 3'-UTR, thereby preventing the translation repression of PDCD4. This suggests that HuR might act as a 'miRNA sponge' to regulate miRNA-mediated translation regulation under conditions of stress-induced nuclear-cytoplasmic translocation of HuR, which would allow fine-tuned gene expression in complex regulatory environments.	[Poria, D. K.; Guha, A.; Nandi, I.; Ray, P. S.] Indian Inst Sci Educ & Res, Dept Biol Sci, Kolkata, India	Indian Institute of Science Education & Research (IISER) - Kolkata	Ray, PS (corresponding author), Indian Inst Sci Educ & Res, Dept Biol Sci, Mohanpur Campus, Nadia 741246, W Bengal, India.	psray@iiserkol.ac.in	Ray, Partho Sarothi/H-3020-2019; Poria, Dipak Kumar/AAM-2084-2021	Ray, Partho Sarothi/0000-0002-8795-3060; Poria, Dipak Kumar/0000-0002-6935-4160; Nandi, Ipsita/0000-0002-4502-2559; Guha, Abhishek/0000-0003-2767-9941	Wellcome Trust-DBT India Alliance intermediate fellowship [WT500139/Z/09/Z]; CSIR senior research fellowship; IISER PBIP fellowship	Wellcome Trust-DBT India Alliance intermediate fellowship(Wellcome Trust DBT India Alliance); CSIR senior research fellowship(Council of Scientific & Industrial Research (CSIR) - India); IISER PBIP fellowship	We acknowledge P L Fox (Cleveland Clinic), S Das (IISc Bangalore), S N Bhattacharyya (IICB, Kolkata), D Chattopadhyay (University of Calcutta) and S Sengupta (University of Calcutta) for providing reagents and laboratory facilities. We are thankful to LRI Molecular Biotechnology Core for services provided. This work was supported by a Wellcome Trust-DBT India Alliance intermediate fellowship (WT500139/Z/09/Z) to PSR, a CSIR senior research fellowship to DKP and IISER PBIP fellowship to AG.	Abdelmohsen K, 2008, BIOL CHEM, V389, P243, DOI 10.1515/BC.2008.022; Abdelmohsen K, 2009, EMBO J, V28, P1271, DOI 10.1038/emboj.2009.67; Anderson P, 2010, NAT REV IMMUNOL, V10, P24, DOI 10.1038/nri2685; Asangani IA, 2008, ONCOGENE, V27, P2128, DOI 10.1038/sj.onc.1210856; Balkhi MY, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004177; Bhattacharyya SN, 2006, CELL, V125, P1111, DOI 10.1016/j.cell.2006.04.031; Biyanee A, 2015, ONCOGENE, V34, P1384, DOI 10.1038/onc.2014.83; Dormoy-Raclet V, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3388; Ebert MS, 2010, CURR BIOL, V20, pR858, DOI 10.1016/j.cub.2010.08.052; Eiring AM, 2010, CELL, V140, P652, DOI 10.1016/j.cell.2010.01.007; Epis MR, 2011, J BIOL CHEM, V286, P41442, DOI 10.1074/jbc.M111.301481; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Frankel LB, 2008, J BIOL CHEM, V283, P1026, DOI 10.1074/jbc.M707224200; Gebauer F, 2004, NAT REV MOL CELL BIO, V5, P827, DOI 10.1038/nrm1488; Hilliard A, 2006, J IMMUNOL, V177, P8095, DOI 10.4049/jimmunol.177.11.8095; Hinman MN, 2008, CELL MOL LIFE SCI, V65, P3168, DOI 10.1007/s00018-008-8252-6; Jafarifar F, 2011, EMBO J, V30, P1324, DOI 10.1038/emboj.2011.38; Kedde M, 2010, NAT CELL BIOL, V12, P1014, DOI 10.1038/ncb2105; Lankat-Buttgereit B, 2009, BIOL CELL, V101, P309, DOI 10.1042/BC20080191; Lebedeva S, 2011, MOL CELL, V43, P340, DOI 10.1016/j.molcel.2011.06.008; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Lu Z, 2008, ONCOGENE, V27, P4373, DOI 10.1038/onc.2008.72; Mukherjee N, 2011, MOL CELL, V43, P327, DOI 10.1016/j.molcel.2011.06.007; Ray PS, 2009, NATURE, V457, P915, DOI 10.1038/nature07598; Ray PS, 2002, NUCLEIC ACIDS RES, V30, P4500, DOI 10.1093/nar/gkf583; Sheedy FJ, 2010, NAT IMMUNOL, V11, P141, DOI 10.1038/ni.1828; Si ML, 2007, ONCOGENE, V26, P2799, DOI 10.1038/sj.onc.1210083; Srikantan S, 2012, CURR PROTEIN PEPT SC, V13, P372, DOI 10.2174/138920312801619394; Srikantan S, 2011, MOL CELL BIOL, V31, P3790, DOI 10.1128/MCB.05639-11; Tominaga K, 2011, MOL CELL BIOL, V31, P4219, DOI 10.1128/MCB.05955-11; Uren PJ, 2011, J BIOL CHEM, V286, P37063, DOI 10.1074/jbc.C111.266882; van Kouwenhove M, 2011, NAT REV CANCER, V11, P644, DOI 10.1038/nrc3107; Wang WG, 2000, MOL CELL BIOL, V20, P760, DOI 10.1128/MCB.20.3.760-769.2000; Yao P, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001635; Young LE, 2012, MOL CANCER RES, V10, P167, DOI 10.1158/1541-7786.MCR-11-0337	35	70	74	3	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 31	2016	35	13					1703	1715		10.1038/onc.2015.235	http://dx.doi.org/10.1038/onc.2015.235			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DH8RP	26189797	Green Published, hybrid			2022-12-26	WOS:000373064200009
J	Kalnins, G; Kuka, J; Grinberga, S; Makrecka-Kuka, M; Liepinsh, E; Dambrova, M; Tars, K				Kalnins, Gints; Kuka, Janis; Grinberga, Solveiga; Makrecka-Kuka, Marina; Liepinsh, Edgars; Dambrova, Maija; Tars, Kaspars			Structure and Function of CutC Choline Lyase from Human Microbiota Bacterium Klebsiella pneumoniae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						choline; conformational change; enzyme catalysis; enzyme structure; radical	TRIMETHYLAMINE-N-OXIDE; PYRUVATE FORMATE-LYASE; FISH ODOR SYNDROME; GUT MICROBIOTA; L-CARNITINE; METABOLISM; MECHANISM; PHOSPHATIDYLCHOLINE; DEGRADATION; CHEMISTRY	Background: The bacterial glycyl radical enzyme CutC converts choline to trimethylamine, a metabolite involved in pathogenesis of several diseases. Results: The structures of substrate-bound and substrate-free CutC revealed significant differences. Conclusion: Choline binding to the active site triggers a conformational change from the open to closed form. Significance: A novel substrate-driven conformational mechanism and a potential target for drug design have been identified. CutC choline trimethylamine-lyase is an anaerobic bacterial glycyl radical enzyme (GRE) that cleaves choline to produce trimethylamine (TMA) and acetaldehyde. In humans, TMA is produced exclusively by the intestinal microbiota, and its metabolite, trimethylamine oxide, has been associated with a higher risk of cardiovascular diseases. Therefore, information about the three-dimensional structures of TMA-producing enzymes is important for microbiota-targeted drug discovery. We have cloned, expressed, and purified the CutC GRE and the activating enzyme CutD from Klebsiella pneumoniae, a representative of the human microbiota. We have determined the first crystal structures of both the choline-bound and choline-free forms of CutC and have discovered that binding of choline at the ligand-binding site triggers conformational changes in the enzyme structure, a feature that has not been observed for any other characterized GRE.	[Kalnins, Gints; Tars, Kaspars] Latvian Biomed Res & Study Ctr, LV-1067 Riga, Latvia; [Kuka, Janis; Grinberga, Solveiga; Makrecka-Kuka, Marina; Liepinsh, Edgars; Dambrova, Maija] Latvian Inst Organ Synth, LV-1006 Riga, Latvia; [Tars, Kaspars] Univ Latvia, LV-1586 Riga, Latvia	Latvian Biomedical Research & Study Centre; Latvian Institute of Organic Synthesis; University of Latvia	Kalnins, G (corresponding author), Latvian Biomed Res & Study Ctr, Ratsupites 1, LV-1067 Riga, Latvia.	gints@biomed.lu.lv	Dambrova, Maija/V-6303-2019	Dambrova, Maija/0000-0002-1739-0928; Kuka, Janis/0000-0002-0411-0229; Tars, Kaspars/0000-0001-8421-9023; Liepinsh, Edgars/0000-0003-2213-8337	State Research Program BIOMEDICINE; Bio-Struct-X Grant [7869]	State Research Program BIOMEDICINE; Bio-Struct-X Grant	This work was supported by State Research Program BIOMEDICINE and Bio-Struct-X Grant Proposal ID 7869. The authors declare that they have no conflicts of interest with the contents of this article.	Becker A, 1999, NAT STRUCT BIOL, V6, P969; Brown JM, 2014, CURR OPIN LIPIDOL, V25, P48, DOI 10.1097/MOL.0000000000000036; Craciun S, 2014, ACS CHEM BIOL, V9, P1408, DOI 10.1021/cb500113p; Craciun S, 2012, P NATL ACAD SCI USA, V109, P21307, DOI 10.1073/pnas.1215689109; Dambrova M, 2002, TRENDS CARDIOVAS MED, V12, P275, DOI 10.1016/S1050-1738(02)00175-5; Dambrova M, 2013, J CLIN PHARMACOL, V53, P1095, DOI 10.1002/jcph.135; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P. R., 1997, JOINT CCP4 ESF EAMCB; Fraser-Andrews EA, 2003, CLIN EXP DERMATOL, V28, P203, DOI 10.1046/j.1365-2230.2003.01230.x; Funk MA, 2014, P NATL ACAD SCI USA, V111, P10161, DOI 10.1073/pnas.1405983111; Gao X, 2014, J BIOSCI BIOENG, V118, P476, DOI 10.1016/j.jbiosc.2014.03.001; HAYWARD HR, 1960, J BIOL CHEM, V235, P538; He CX, 2015, NUTR RES, V35, P361, DOI 10.1016/j.nutres.2015.03.002; Howitt MR, 2012, NAT MED, V18, P1188, DOI 10.1038/nm.2895; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Jernberg C, 2010, MICROBIOL-SGM, V156, P3216, DOI 10.1099/mic.0.040618-0; Koeth RA, 2013, NAT MED, V19, P576, DOI 10.1038/nm.3145; Kuka J, 2014, LIFE SCI, V117, P84, DOI 10.1016/j.lfs.2014.09.028; Leslie A. G. W., 1992, JOINT CCP4 ESF EAMCB; Logan DT, 1999, SCIENCE, V283, P1499, DOI 10.1126/science.283.5407.1499; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; O'Brien JR, 2004, BIOCHEMISTRY-US, V43, P4635, DOI 10.1021/bi035930k; Peng Y, 2010, J BIOL CHEM, V285, P27224, DOI 10.1074/jbc.M109.096875; Romano KA, 2015, MBIO, V6, DOI 10.1128/mBio.02481-14; SANDHU SS, 1986, CAN J MICROBIOL, V32, P743, DOI 10.1139/m86-135; Shisler KA, 2014, ARCH BIOCHEM BIOPHYS, V546, P64, DOI 10.1016/j.abb.2014.01.020; Tang WHW, 2015, CIRC RES, V116, P448, DOI 10.1161/CIRCRESAHA.116.305360; Tang WHW, 2013, NEW ENGL J MED, V368, P1575, DOI 10.1056/NEJMoa1109400; Thibodeaux CJ, 2012, P NATL ACAD SCI USA, V109, P21184, DOI 10.1073/pnas.1219534110; TREACY E, 1995, J INHERIT METAB DIS, V18, P306, DOI 10.1007/BF00710420; Treacy EP, 1998, HUM MOL GENET, V7, P839, DOI 10.1093/hmg/7.5.839; Troseid M, 2015, J INTERN MED, V277, P717, DOI 10.1111/joim.12328; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Vey JL, 2008, P NATL ACAD SCI USA, V105, P16137, DOI 10.1073/pnas.0806640105; Wagner AFV, 2001, BIOCHEM BIOPH RES CO, V285, P456, DOI 10.1006/bbrc.2001.5186; WAGNER AFV, 1992, P NATL ACAD SCI USA, V89, P996, DOI 10.1073/pnas.89.3.996; Walsby CJ, 2005, INORG CHEM, V44, P727, DOI 10.1021/ic0484811; Wang ZN, 2011, NATURE, V472, P57, DOI 10.1038/nature09922; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Zitvogel L, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.3010473	40	55	54	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	2015	290	35					21732	21740		10.1074/jbc.M115.670471	http://dx.doi.org/10.1074/jbc.M115.670471			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CQ5IS	26187464	hybrid, Green Published			2022-12-26	WOS:000360637600044
J	Becking, K; Spijker, AT; Hoencamp, E; Penninx, BWJH; Schoevers, RA; Boschloo, L				Becking, Karlijn; Spijker, Annet T.; Hoencamp, Erik; Penninx, Brenda W. J. H.; Schoevers, Robert A.; Boschloo, Lynn			Disturbances in Hypothalamic-Pituitary-Adrenal Axis and Immunological Activity Differentiating between Unipolar and Bipolar Depressive Episodes	PLOS ONE			English	Article							C-REACTIVE PROTEIN; SPECTRUM DISORDER; HPA AXIS; GENDER-DIFFERENCES; PHYSICAL-ACTIVITY; CHRONIC STRESS; CORTISOL; INFLAMMATION; CYTOKINES; RELIABILITY	Introduction Differentiating bipolar depression (BD) from unipolar depression (UD) is difficult in clinical practice and, consequently, accurate recognition of BD can take as long as nine years. Research has therefore focused on the discriminatory capacities of biomarkers, such as markers of the hypothalamic-pituitary-adrenal (HPA) axis or immunological activity. However, no previous study included assessments of both systems, which is problematic as they may influence each other. Therefore, this study aimed to explore whether cortisol indicators and inflammatory markers were a) independently associated with and/or b) showed effect modification in relation to a lifetime (hypo) manic episode in a large sample of depressed patients. Methods Data were derived from the Netherlands Study of Depression and Anxiety and comprised 764 patients with a DSM-IV depressive disorder at baseline, of which 124 (16.2%) had a lifetime (hypo) manic episode at the 2-year assessment, or a more recent episode at the 4-year or 6-year assessment. Baseline cortisol awakening response, evening cortisol and diurnal cortisol slope were considered as cortisol indicators, while baseline C-reactive Protein (CRP), Interleukin-6 (IL-6), and Tumor Necrosis Factor Alpha (TNF-alpha) were included as inflammatory markers. Results In depressed men and women, none of the cortisol indicators and inflammatory markers were (independently) associated with a (hypo) manic episode. However, effect modification was found of diurnal cortisol slope and CRP in relation to a (hypo) manic episode. Further analyses showed that depressed men with high levels of diurnal cortisol slope and CRP had an increased odds (OR=10.99, p=.001) of having a (hypo) manic episode. No significant differences were found in women. Conclusion Our findings suggest that the combination of high diurnal cortisol slope and high CRP may differentiate between UD and BD. This stresses the importance of considering HPA-axis and immunological activity simultaneously, but more research is needed to unravel their interrelatedness.	[Becking, Karlijn; Penninx, Brenda W. J. H.; Schoevers, Robert A.; Boschloo, Lynn] Univ Groningen, Univ Med Ctr Groningen, Interdisciplinary Ctr Psychopathol & Emot Regulat, Groningen, Netherlands; [Becking, Karlijn; Penninx, Brenda W. J. H.; Schoevers, Robert A.; Boschloo, Lynn] Univ Groningen, Univ Med Ctr Groningen, UCP, Groningen, Netherlands; [Spijker, Annet T.; Hoencamp, Erik] PsyQ Rijnmond, Dept Mood Disorders, Rotterdam, Netherlands; [Hoencamp, Erik] Leiden Univ, Inst Psychol, Leiden, Netherlands; [Penninx, Brenda W. J. H.] Vrije Univ Amsterdam, Med Ctr, Dept Psychiat, Amsterdam, Netherlands; [Penninx, Brenda W. J. H.] EMGO, Inst Hlth & Care Res, Amsterdam, Netherlands; [Penninx, Brenda W. J. H.] Leiden Univ, Med Ctr, Dept Psychiat, Leiden, Netherlands	University of Groningen; University of Groningen; Leiden University; Leiden University - Excl LUMC; Vrije Universiteit Amsterdam; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Becking, K (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Interdisciplinary Ctr Psychopathol & Emot Regulat, Groningen, Netherlands.	k.becking@umcg.nl	Penninx, Brenda WJH/S-7627-2017	Penninx, Brenda WJH/0000-0001-7779-9672; Schoevers, Robert A/0000-0003-0760-9866	Geestkracht program of the Netherlands Organization for Health Research and Development (Zon-Mw) [10-000-1002]; VU University Medical Center; GGZ inGeest; Arkin; Leiden University Medical Center; GGZ Rivierduinen; University Medical Center Groningen; Lentis; GGZ Friesland; GGZ Drenthe; Scientific Institute for Quality of Health Care (IQ Healthcare); Netherlands Institute for Health Services Research (Nivel); Netherlands Institute of Mental Health and Addiction (TRIMBOS); Neuroscience Campus Amsterdam and VIDI grant; Astra Zeneca Nederland; PsyQ Rijnmond	Geestkracht program of the Netherlands Organization for Health Research and Development (Zon-Mw); VU University Medical Center; GGZ inGeest; Arkin; Leiden University Medical Center; GGZ Rivierduinen; University Medical Center Groningen; Lentis; GGZ Friesland; GGZ Drenthe; Scientific Institute for Quality of Health Care (IQ Healthcare); Netherlands Institute for Health Services Research (Nivel); Netherlands Institute of Mental Health and Addiction (TRIMBOS); Neuroscience Campus Amsterdam and VIDI grant; Astra Zeneca Nederland; PsyQ Rijnmond	The infrastructure for the NESDA study (www.nesda.nl) is funded through the Geestkracht program of the Netherlands Organization for Health Research and Development (Zon-Mw, grant number 10-000-1002) and is supported by participating universities and mental health care organizations (VU University Medical Center, GGZ inGeest, Arkin, Leiden University Medical Center, GGZ Rivierduinen, University Medical Center Groningen, Lentis, GGZ Friesland, GGZ Drenthe, Scientific Institute for Quality of Health Care (IQ Healthcare), Netherlands Institute for Health Services Research (Nivel) and the Netherlands Institute of Mental Health and Addiction (TRIMBOS)). Assaying of inflammatory markers was supported by the Neuroscience Campus Amsterdam and VIDI grant (Penninx). Statistical analyses were supported by an unrestricted research grant by Astra Zeneca Nederland (Spijker, Hoencamp, Boschloo). The Netherlands Organization for Health Research and Development had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. PsyQ Rijnmond provided support in the form of salaries for authors AS and EH, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. Astra Zeneca Nederland had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 2001, DIAGN STAT MAN MENT; Anisman H, 2003, ANN MED, V35, P2, DOI 10.1080/07853890310004075; Bai Yanbin, 2014, ASME 2014 33 INT C O, DOI [10.1115/OMAE2014-24678, DOI 10.1115/OMAE2014-24678]; Becking K, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2013.87; Benazzi Franco, 2002, Ann Clin Psychiatry, V14, P97, DOI 10.1023/A:1016854904941; Berk M, 2008, J AFFECT DISORDERS, V110, P126, DOI 10.1016/j.jad.2008.01.018; Berk M, 2007, MED J AUSTRALIA, V187, pS11; Bhagwagar Z, 2005, PSYCHOPHARMACOLOGY, V182, P54, DOI 10.1007/s00213-005-0062-z; Boschloo L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106871; Bremmer MA, 2008, J AFFECT DISORDERS, V106, P249, DOI 10.1016/j.jad.2007.07.002; Cervantes P, 2001, J PSYCHIATR NEUROSCI, V26, P411; Cohen LS, 2006, ARCH GEN PSYCHIAT, V63, P385, DOI 10.1001/archpsyc.63.4.385; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; Daban C, 2005, PSYCHIAT CLIN N AM, V28, P469, DOI 10.1016/j.psc.2005.01.005; De Fruyt J, 2007, PSYCHOTHER PSYCHOSOM, V76, P77, DOI 10.1159/000097966; Deshauer D, 2003, CAN J PSYCHIAT, V48, P462, DOI 10.1177/070674370304800706; Dickerson F, 2007, PROG NEURO-PSYCHOPH, V31, P952, DOI 10.1016/j.pnpbp.2007.02.018; Dunner DL, 2003, BIPOLAR DISORD, V5, P456, DOI 10.1046/j.1399-5618.2003.00073.x; Edwards S, 2001, LIFE SCI, V68, P2093, DOI 10.1016/S0024-3205(01)00996-1; Ghaemi SN, 1999, J AFFECT DISORDERS, V52, P135, DOI 10.1016/S0165-0327(98)00076-7; Ghaemi SN, 2000, J CLIN PSYCHIAT, V61, P804, DOI 10.4088/JCP.v61n1013; Gobinath A, 2014, FRONT NEUROSCI; Goldstein BI, 2009, J CLIN PSYCHIAT, V70, P1078, DOI 10.4088/JCP.08r04505; Grande I, 2012, PHYSIOL BEHAV, V106, P46, DOI 10.1016/j.physbeh.2011.10.029; Haefher S, 2008, J PSYCHIATR RES, V42, P163, DOI 10.1016/j.jpsychires.2007.02.002; HOCHBERG Y, 1990, STAT MED, V9, P811, DOI 10.1002/sim.4780090710; Holsboer F, 2000, NEUROPSYCHOPHARMACOL, V23, P477, DOI 10.1016/S0893-133X(00)00159-7; Horowitz MA, 2013, MOD TR PHARMACOPSYCH, V28, P127, DOI 10.1159/000343980; Howren MB, 2009, PSYCHOSOM MED, V71, P171, DOI 10.1097/PSY.0b013e3181907c1b; Jabben N, 2011, J PSYCHIATR RES, V45, P1208, DOI 10.1016/j.jpsychires.2011.03.010; Kessler RC, 2006, J AFFECT DISORDERS, V96, P259, DOI 10.1016/j.jad.2006.08.018; Kiecolt-Glaser JK, 2003, P NATL ACAD SCI USA, V100, P9090, DOI 10.1073/pnas.1531903100; Kim YK, 2007, J AFFECT DISORDERS, V104, P91, DOI 10.1016/j.jad.2007.02.018; Kudielka BM, 2005, BIOL PSYCHOL, V69, P113, DOI 10.1016/j.biopsycho.2004.11.009; Kuehner C, 2003, ACTA PSYCHIAT SCAND, V108, P163, DOI 10.1034/j.1600-0447.2003.00204.x; Kupfer DJ, 2005, JAMA-J AM MED ASSOC, V293, P2528, DOI 10.1001/jama.293.20.2528; Leboyer M, 2012, J AFFECT DISORDERS, V141, P1, DOI 10.1016/j.jad.2011.12.049; Levine DW, 2003, PSYCHOL ASSESSMENT, V15, P137, DOI 10.1037/1040-3590.15.2.137; McEwen BS, 2003, BIOL PSYCHIAT, V54, P200, DOI 10.1016/S0006-3223(03)00177-X; McEwen BS, 2004, ANN NY ACAD SCI, V1032, P1, DOI 10.1196/annals.1314.001; Miller GE, 2002, HEALTH PSYCHOL, V21, P531, DOI 10.1037//0278-6133.21.6.531; Ng F, 2007, J AFFECT DISORDERS, V101, P259, DOI 10.1016/j.jad.2006.11.014; O'Connor MF, 2009, BRAIN BEHAV IMMUN, V23, P887, DOI 10.1016/j.bbi.2009.04.005; Penninx BWJH, 2008, INT J METH PSYCH RES, V17, P121, DOI 10.1002/mpr.256; Pini S, 2005, EUR NEUROPSYCHOPHARM, V15, P425, DOI 10.1016/j.euroneuro.2005.04.011; Pruessner JC, 2003, PSYCHONEUROENDOCRINO, V28, P916, DOI 10.1016/S0306-4530(02)00108-7; Reed V., 1998, INT J METHODS PSYCHI, V7, P142, DOI [10.1002/mpr.44, DOI 10.1002/MPR.44]; Rybakowski JK, 1999, J PSYCHIAT RES, V33, P363, DOI 10.1016/S0022-3956(99)00014-X; Silverman MN, 2012, ANN NY ACAD SCI, V1261, P55, DOI 10.1111/j.1749-6632.2012.06633.x; Sloan DME, 2003, PSYCHIAT CLIN N AM, V26, P581, DOI 10.1016/S0193-953X(03)00044-3; Stalder T, 2009, PSYCHONEUROENDOCRINO, V34, P607, DOI 10.1016/j.psyneuen.2008.10.023; Su SC, 2011, INT J PSYCHIAT MED, V42, P211, DOI 10.2190/PM.42.3.a; Taylor SE, 2006, BIOL PSYCHIAT, V60, P819, DOI 10.1016/j.biopsych.2006.03.016; Tondo L, 2010, ACTA PSYCHIAT SCAND, V121, P446, DOI 10.1111/j.1600-0447.2009.01523.x; Uceyler N, 2011, BMC MUSCULOSKEL DIS, V12, DOI 10.1186/1471-2474-12-245; Vogelzangs N, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.8; Vogelzangs N, 2010, J AFFECT DISORDERS, V125, P241, DOI 10.1016/j.jad.2010.02.112; Vreeburg SA, 2009, PSYCHONEUROENDOCRINO, V34, P1109, DOI 10.1016/j.psyneuen.2009.04.024; Vreeburg SA, 2009, ARCH GEN PSYCHIAT, V66, P617, DOI 10.1001/archgenpsychiatry.2009.50; WITTCHEN HU, 1991, BRIT J PSYCHIAT, V159, P645, DOI 10.1192/bjp.159.5.645; Woo YS, 2015, J AFFECT DISORDERS, V174, P83, DOI 10.1016/j.jad.2014.11.034; Zunszain PA, 2011, PROG NEURO-PSYCHOPH, V35, P722, DOI 10.1016/j.pnpbp.2010.04.011	62	16	19	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0133898	10.1371/journal.pone.0133898	http://dx.doi.org/10.1371/journal.pone.0133898			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LZ	26196286	gold, Green Published, Green Submitted			2022-12-26	WOS:000358547600146
J	Heinbockel, L; Marwitz, S; Varela, SB; Ferrer-Espada, R; Reiling, N; Goldmann, T; Gutsmann, T; Mier, W; Schuerholz, T; Droemann, D; Brandenburg, K; de Tejada, GM				Heinbockel, Lena; Marwitz, Sebastian; Barcena Varela, Sergio; Ferrer-Espada, Raquel; Reiling, Norbert; Goldmann, Torsten; Gutsmann, Thomas; Mier, Walter; Schuerholz, Tobias; Droemann, Daniel; Brandenburg, Klaus; Martinez de Tejada, Guillermo			Therapeutical Administration of Peptide Pep19-2.5 and Ibuprofen Reduces Inflammation and Prevents Lethal Sepsis	PLOS ONE			English	Article							CATIONIC ANTIMICROBIAL PEPTIDES; SEPTIC SHOCK; LIPOPOLYSACCHARIDE; INTERLEUKIN-18; MACROPHAGES; STRATEGIES; PHYSIOLOGY; IL-1-BETA; MONOCYTES; BACTERIA	Sepsis is still a major cause of death and many efforts have been made to improve the physical condition of sepsis patients and to reduce the high mortality rate associated with this disease. While achievements were implemented in the intensive care treatment, all attempts within the field of novel therapeutics have failed. As a consequence new medications and improved patient stratification as well as a thoughtful management of the support therapies are urgently needed. In this study, we investigated the simultaneous administration of ibuprofen as a commonly used nonsteroidal anti-inflammatory drug (NSAID) and Pep19-2.5 (Aspidasept), a newly developed antimicrobial peptide. Here, we show a synergistic therapeutic effect of combined Pep19-2.5-ibuprofen treatment in an endotoxemia mouse model of sepsis. In vivo protection correlates with a reduction in plasma levels of both tumor necrosis factor a and prostaglandin E, as a likely consequence of Pep19-2.5 and ibuprofen-dependent blockade of TLR4 and COX pro-inflammatory cascades, respectively. This finding is further characterised and confirmed in a transcriptome analysis of LPS-stimulated human monocytes. The transcriptome analyses showed that Pep19-2.5 and ibuprofen exerted a synergistic global effect both on the number of regulated genes as well as on associated gene ontology and pathway expression. Overall, ibuprofen potentiated the anti-inflammatory activity of Pep19-2.5 both in vivo and in vitro, suggesting that NSAIDs could be useful to supplement future anti-sepsis therapies.	[Heinbockel, Lena; Marwitz, Sebastian] Leibniz Ctr Med & Biosci, Res Ctr Borstel, Clin & Expt Pathol, Borstel, Germany; [Barcena Varela, Sergio; Ferrer-Espada, Raquel; Martinez de Tejada, Guillermo] Univ Navarra, Dept Microbiol & Parasitol, E-31080 Pamplona, Spain; [Reiling, Norbert; Brandenburg, Klaus] Leibniz Ctr Med & Biosci, Res Ctr Borstel, Microbial Interface Biol, Borstel, Germany; [Gutsmann, Thomas] Leibniz Ctr Med & Biosci, Res Ctr Borstel, Biophys, Borstel, Germany; [Mier, Walter] Univ Heidelberg Hosp, Dept Nucl Med, Heidelberg, Germany; [Schuerholz, Tobias] Univ Hosp Aachen, Dept Intens Care, Aachen, Germany; [Droemann, Daniel] Univ Schleswig Holstein, Med Clin 3, Lubeck, Germany	Forschungszentrum Borstel; University of Navarra; Forschungszentrum Borstel; Forschungszentrum Borstel; Ruprecht Karls University Heidelberg; RWTH Aachen University; RWTH Aachen University Hospital; University of Kiel; Schleswig Holstein University Hospital	Brandenburg, K (corresponding author), Leibniz Ctr Med & Biosci, Res Ctr Borstel, Microbial Interface Biol, Borstel, Germany.	kbrandenburg@fz-borstel.de	Goldmann, Torsten/E-5906-2010; Martinez-de-Tejada, Guillermo/AAT-8535-2020; Schuerholz, Tobias/E-8071-2011; Martinez-de-Tejada, Guillermo/H-3849-2017; Marwitz, Sebastian/P-5316-2016; Marwitz, Sebastian/P-2900-2019; Gutsmann, Thomas/E-6100-2011; Reiling, Norbert/D-6796-2013	Goldmann, Torsten/0000-0002-1621-560X; Martinez-de-Tejada, Guillermo/0000-0003-3755-451X; Martinez-de-Tejada, Guillermo/0000-0003-3755-451X; Marwitz, Sebastian/0000-0003-4920-5552; Marwitz, Sebastian/0000-0003-4920-5552; Ferrer-Espada, Raquel/0000-0002-5711-5349; Schuerholz, Tobias/0000-0003-3830-3499; Reiling, Norbert/0000-0001-6673-4291; Lazaro-Anton, Leticia/0000-0001-7720-5627	Else-Kroner-Fresenius Stiftung [2011_A140]; Deutsche Forschungsgemeinschaft (DFG) [DR797/3-1 611672]; Proyectos de Investigacion Universidad de Navarra, Spain [PIUNA-P2011-17]; Asociacion de Amigos de la Universidad de Navarra; Gobierno Vasco, Spain	Else-Kroner-Fresenius Stiftung; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Proyectos de Investigacion Universidad de Navarra, Spain; Asociacion de Amigos de la Universidad de Navarra; Gobierno Vasco, Spain(Basque Government)	Research at the laboratories of the authors is supported by the Else-Kroner-Fresenius Stiftung (project 2011_A140), and the Deutsche Forschungsgemeinschaft (DFG, project DR797/3-1 611672). G.M.T. was also funded by a grant from Proyectos de Investigacion Universidad de Navarra (PIUNA-P2011-17), Spain. S.B.V. and R.F.E. were recipients of doctoral fellowships from "Asociacion de Amigos de la Universidad de Navarra" and from Gobierno Vasco, Spain, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angus DC, 2013, NEW ENGL J MED, V369, P840, DOI [10.1056/NEJMc1312359, 10.1056/NEJMra1208623]; Aronoff DM, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/696897; Bernard GR, 1997, NEW ENGL J MED, V336, P912, DOI 10.1056/NEJM199703273361303; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Boyum A, 1968, Scand J Clin Lab Invest Suppl, V97, P77; Bradshaw JP, 2003, BIODRUGS, V17, P233, DOI 10.2165/00063030-200317040-00002; Celik I, 2002, BMC INFECT DIS, V2, DOI 10.1186/1471-2334-2-26; Cohen J, 2009, CLIN MICROBIOL INFEC, V15, P302, DOI 10.1111/j.1469-0691.2009.02753.x; Deitch EA, 1998, SHOCK, V9, P1, DOI 10.1097/00024382-199801000-00001; Eden E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-48; Engel C, 2007, INTENS CARE MED, V33, P606, DOI 10.1007/s00134-006-0517-7; Findlay B, 2010, ANTIMICROB AGENTS CH, V54, P4049, DOI 10.1128/AAC.00530-10; Fink MP, 2014, NAT REV DRUG DISCOV, V13, P741, DOI 10.1038/nrd4368; Fink MP, 2001, AM J PHYSIOL-LUNG C, V281, pL534, DOI 10.1152/ajplung.2001.281.3.L534; Garidel P, 2005, BBA-BIOMEMBRANES, V1715, P122, DOI 10.1016/j.bbamem.2005.07.013; GRAGEGRIEBENOW E, 1993, EUR J IMMUNOL, V23, P3126, DOI 10.1002/eji.1830231213; Hancock REW, 1998, TRENDS BIOTECHNOL, V16, P82, DOI 10.1016/S0167-7799(97)01156-6; Hancock REW, 2000, TRENDS MICROBIOL, V8, P402, DOI 10.1016/S0966-842X(00)01823-0; Heinbockel L, 2013, ANTIMICROB AGENTS CH, V57, P1480, DOI 10.1128/AAC.02066-12; Hirschfeld M, 2000, J IMMUNOL, V165, P618, DOI 10.4049/jimmunol.165.2.618; Kumar A, 2014, VIRULENCE, V5, P80, DOI 10.4161/viru.26913; LEONG D, 1970, Infection and Immunity, V1, P174; Li YK, 2013, J BIOL CHEM, V288, P16225, DOI 10.1074/jbc.M113.454538; LUDERITZ O, 1965, J BACTERIOL, V89, P343; MacKenzie KF, 2013, J IMMUNOL, V190, P565, DOI 10.4049/jimmunol.1202462; MansillaRosello A, 1997, J SURG RES, V67, P199, DOI 10.1006/jsre.1996.4982; Michelucci A, 2013, P NATL ACAD SCI USA, V110, P7820, DOI 10.1073/pnas.1218599110; Nagai M, 2011, THER APHER DIAL, V15, P342, DOI 10.1111/j.1744-9987.2011.00966.x; Nguyen LT, 2011, TRENDS BIOTECHNOL, V29, P464, DOI 10.1016/j.tibtech.2011.05.001; Opal SM, 2014, AM J RESP CRIT CARE, V189, P242, DOI 10.1164/rccm.201312-2292ED; Rubinow KB, 2013, J BIOL CHEM, V288, P9957, DOI 10.1074/jbc.M113.458372; Schuerholz T, 2013, CRIT CARE, V17, DOI 10.1186/cc11920; Snodgrass RG, 2013, J IMMUNOL, V191, P4337, DOI 10.4049/jimmunol.1300298; Tschoeke SK, 2006, CRIT CARE MED, V34, P1225, DOI 10.1097/01.CCM.0000208356.05575.16; Watkins PA, 2008, J BIOL CHEM, V283, P1773, DOI 10.1074/jbc.R700037200; Westphal O., 1965, METHODS CARBOHYDRATE, V5, P83, DOI DOI 10.1016/J.WATRES.2010.04.030	36	10	12	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0133291	10.1371/journal.pone.0133291	http://dx.doi.org/10.1371/journal.pone.0133291			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LZ	26197109	Green Submitted, Green Published, gold			2022-12-26	WOS:000358547600081
J	Suwannarong, K; Chapman, RS; Lantican, C; Michaelides, T; Zimicki, S				Suwannarong, Kanokwan; Chapman, Robert S.; Lantican, Cecile; Michaelides, Tula; Zimicki, Susan			Hunting, Food Preparation, and Consumption of Rodents in Lao PDR	PLOS ONE			English	Article							NORTHEASTERN THAILAND; BORNE DISEASES; SCRUB TYPHUS; RISK-FACTORS; LEPTOSPIROSIS; VIRUS; EPIDEMIOLOGY; TRANSMISSION; POPULATIONS; INFECTION	A cross-sectional study was conducted in 29 villages of Khamkeuth District in Bolikhamxay Province in the Lao PDR during March to May 2013. The study aimed to determine the characteristics associated with rodent consumption and related behaviors among different ethnic groups, ages, and genders. Five-hundred-eighty-four (584) males and females from 18-50 years of age participated in this study. Half of them were Hmong (292, 50%) while 152 respondents were Lao-Tai (26%) or other ethnic groups (140, 24%). Most of the respondents (79.5%) had farming as their main occupation. Prevalences of the studied outcomes were high: 39.9 for hunting or capturing rodents in the previous year, 77.7% for preparing rodents as food, and 86.3% for rodent consumption. Multivariable logistic regression analysis showed that likelihood of these types of rodent contact was more consistently associated with behavioral factors (gathering things from the forest and elsewhere, cultivation-related activities, and taking measures to prevent rodent-borne disease) than with socio-demographic, environmental, or cultural factors. The strongest associations were observed for gathering things; these associations were consistently positive and statistically significant. Although this study did not directly assess rodent-borne zoonosis risk, we believe that study findings raise concern that such risk may be substantial in the study area and other similar areas. Further epidemiological studies on the association between rodent-borne disease infection and rodent hunting, preparation for food, and consumption are recommended. Moreover, further studies are needed on the association between these potential exposure factors (i.e., rodent hunting, preparation for food, and consumption) and rodent-borne infections, especially among ethnic groups like the Hmong in Lao PDR and those in neighboring countries with similar socio-demographic, environmental, behavioral and cultural contexts.	[Suwannarong, Kanokwan] APRO, FHI 360, Bangkok, Thailand; [Suwannarong, Kanokwan; Chapman, Robert S.] Chulalongkorn Univ, Coll Publ Hlth Sci, Bangkok, Thailand; [Lantican, Cecile] Lao PDR Off, FHI 360, Viangchan, Laos; [Michaelides, Tula; Zimicki, Susan] Washington DC Off, FHI 360, Washington, DC USA	Chulalongkorn University	Suwannarong, K (corresponding author), APRO, FHI 360, Bangkok, Thailand.	kanokwan27@yahoo.com			PREVENT Project [GHN-A-00-09-00002-00]; American people through the United States Agency for International Development (USAID)	PREVENT Project; American people through the United States Agency for International Development (USAID)(United States Agency for International Development (USAID))	The EPT/PREVENT Project allowed authors to access, analyze and publish this data. The PREVENT Project was implemented by FHI 360 under USAID Cooperative Agreement GHN-A-00-09-00002-00; this study was made possible by the generous support of the American people through the United States Agency for International Development (USAID). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aplin KP, 2007, RICE LAOS RICE LAOS, P291; Assogbadjo AE, 2005, BELG J ZOOL, V135, P11; Bank W, 2011, LAO PDR EC MONITOR; Bank W, 2010, NATURAL RESOURCE MAN; Blasdell K, 2011, ECOHEALTH, V8, P432, DOI 10.1007/s10393-011-0725-7; Blasdell Kim, 2009, Kasetsart Journal Natural Sciences, V43, P94; Bordes F, 2015, J ANIM ECOL; Bourgeois Luthi N, 2012, DESK REV EXPOSURE HU; Bursac Z, 2008, SOURCE CODE BIOL MED, V3, DOI 10.1186/1751-0473-3-17; Cosson JF, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002902; Davis S, 2005, VECTOR-BORNE ZOONOT, V5, P305, DOI 10.1089/vbz.2005.5.305; de Araujo WN, 2013, AM J TROP MED HYG, V88, P359, DOI 10.4269/ajtmh.2012.12-0245; Duckworth J.W., 1999, WILDLIFE LAO PDR 199; ELBEL RE, 1957, AM J TROP MED HYG, V6, P280, DOI 10.4269/ajtmh.1957.6.280; Fiedler LA., 1990, P 14 VERT PEST C 199; Gamage CD, 2011, JPN J INFECT DIS, V64, P72; GRATZ NG, 1973, ISRAEL J MED SCI, V9, P969; Hugot JP, 2001, INFECT GENET EVOL, V1, P13, DOI 10.1016/S1567-1348(01)00003-X; ICEM, 2003, LAO PDR NAT REP PROT; Kawaguchi L, 2008, AM J TROP MED HYG, V78, P957, DOI 10.4269/ajtmh.2008.78.957; KISH L, 1965, AM SOCIOL REV, V30, P564, DOI 10.2307/2091346; Kunarattanapruk K CJ, 1998, FOOD NUTR BULL, V19; Lerdthusnee K, 2003, ANN NY ACAD SCI, V990, P25, DOI 10.1111/j.1749-6632.2003.tb07333.x; Lerdthusnee K, 2008, INTEGR ZOOL, V3, P267, DOI 10.1111/j.1749-4877.2008.00100.x; LIMPAKARNJANARAT K, 1987, Journal of the Medical Association of Thailand, V70, P243; Meerburg BG, 2006, TIJDSCHR DIERGENEESK, V131, P445; Meerburg BG, 2009, CRIT REV MICROBIOL, V35, P221, DOI 10.1080/10408410902989837; Ministry of Communication T Post and Construction (MoC) and IUCN, 2000, BOL PROV ENV INV, P77; Nitatpattana N, 2002, TROP MED INT HEALTH, V7, P840, DOI 10.1046/j.1365-3156.2002.00830.x; Nitatpattana Narong, 2000, Southeast Asian Journal of Tropical Medicine and Public Health, V31, P277; OOSTEROM J, 1991, INT J FOOD MICROBIOL, V12, P41, DOI 10.1016/0168-1605(91)90046-R; Panaphut Thanachai, 2002, International Journal of Infectious Diseases, V6, P52, DOI 10.1016/S1201-9712(02)90137-2; Parola P, 2003, ANN NY ACAD SCI, V990, P173, DOI 10.1111/j.1749-6632.2003.tb07359.x; Sale JB, 1983, IMPORTANCE VALUES WI, P44; Setalaphruk C, 2007, J ETHNOBIOL ETHNOMED, V3, DOI 10.1186/1746-4269-3-33; Shih CM, 1997, J CLIN MICROBIOL, V35, P450, DOI 10.1128/JCM.35.2.450-454.1997; Somnasang P RP, 1987, RAPID RURAL APPRAISA, P20; Somnasang Prapimporn, 1998, Food and Nutrition Bulletin, V19, P359; Suwannarong K, 2014, J HEALTH RES, V28, P59; Suwannarong K, 2014, SE ASIAN J TROP MED, V45, P1209; Tangkanakul W., 2005, Southeast Asian Journal of Tropical Medicine and Public Health, V36, P281; Tangkanakul W, 2000, AM J TROP MED HYG, V63, P204, DOI 10.4269/ajtmh.2000.63.204; Tangkanakul Waraluk, 2001, Journal of the Medical Association of Thailand, V84, P1674; terMeulen J, 1996, AM J TROP MED HYG, V55, P661; Victoriano AFB, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-147; Vongkhamheng C, 2002, PARTICIPATORY WILDLI; Walker DH, 1996, JAMA-J AM MED ASSOC, V275, P463, DOI 10.1001/jama.275.6.463; Watson DC, 2014, CRIT REV MICROBIOL, V40, P261, DOI 10.3109/1040841X.2013.783555; Woldehanna S, 2011, PREVENT PILOT UNPUB; Wolfe ND, 2005, EMERG INFECT DIS, V11, P1822, DOI 10.3201/eid1112.040789; WWF, 2006, WWF TECHN PAP SER, V8; Yaita K, 2013, INTERNAL MED, V52, P1439, DOI 10.2169/internalmedicine.52.0343	52	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0133150	10.1371/journal.pone.0133150	http://dx.doi.org/10.1371/journal.pone.0133150			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LZ	26196134	Green Published, Green Submitted, gold			2022-12-26	WOS:000358547600065
J	Zhang, N; Liang, HY; Farese, RV; Li, J; Musi, N; Hussey, SE				Zhang, Ning; Liang, Hanyu; Farese, Robert V.; Li, Ji; Musi, Nicolas; Hussey, Sophie E.			Pharmacological TLR4 Inhibition Protects against Acute and Chronic Fat-Induced Insulin Resistance in Rats	PLOS ONE			English	Article							TOLL-LIKE RECEPTOR-4; ADIPOSE-TISSUE; ENDOTOXIN ANTAGONIST; SEVERE SEPSIS; TAK-242; OBESITY; ACID; MICE; MUTATION; INFLAMMATION	Aims To evaluate whether pharmacological TLR4 inhibition protects against acute and chronic fat-induced insulin resistance in rats. Materials and Methods For the acute experiment, rats received a TLR4 inhibitor [TAK-242 or E5564 (2x5 mg/kg i.v. bolus)] or vehicle, and an 8-h Intralipid (20%, 8.5 mg/kg/min) or saline infusion, followed by a two-step hyperinsulinemic-euglycemic clamp. For the chronic experiment, rats were subcutaneously implanted with a slow-release pellet of TAK-242 (1.5 mg/d) or placebo. Rats then received a high fat diet (HFD) or a low fat control diet (LFD) for 10 weeks, followed by a two-step insulin clamp. Results Acute experiment; the lipid-induced reduction (18%) in insulin-stimulated glucose disposal (Rd) was attenuated by TAK-242 and E5564 (the effect of E5564 was more robust), suggesting improved peripheral insulin action. Insulin was able to suppress hepatic glucose production (HGP) in saline-but not lipid-treated rats. TAK-242, but not E5564, partially restored this effect, suggesting improved HGP. Chronic experiment; insulin-stimulated Rd was reduced similar to 30% by the HFD, but completely restored by TAK-242. Insulin could not suppress HGP in rats fed a HFD and TAK-242 had no effect on HGP. Conclusions Pharmacological TLR4 inhibition provides partial protection against acute and chronic fat-induced insulin resistance in vivo.	[Zhang, Ning; Liang, Hanyu; Li, Ji; Musi, Nicolas] Univ Texas Hlth Sci Ctr San Antonio, Barshop Inst Longev & Aging Studies, San Antonio, TX 78229 USA; [Liang, Hanyu; Li, Ji; Musi, Nicolas] Univ Texas Hlth Sci Ctr San Antonio, Dept Med, San Antonio, TX 78229 USA; [Liang, Hanyu; Musi, Nicolas] South Texas Vet Hlth Care Syst, Geriatr Res Educ & Clin Ctr, San Antonio, TX 78229 USA; [Farese, Robert V.; Hussey, Sophie E.] Univ S Florida, Dept Internal Med, Tampa, FL 33620 USA; [Farese, Robert V.; Hussey, Sophie E.] James A Haley Vet Adm Med Ctr, Tampa, FL 33612 USA	University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Audie L. Murphy Memorial Veterans Hospital; State University System of Florida; University of South Florida; US Department of Veterans Affairs; Veterans Health Administration (VHA); James A. Haley Veterans Hospital	Musi, N (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Barshop Inst Longev & Aging Studies, San Antonio, TX 78229 USA.	musi@uthscsa.edu; sophiehussey@icloud.com			NIH [1F32DK095565-01A1, RO1-DK80157, RO1-DK089229]; American Diabetes Association; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F32DK095565, R01DK080157, R01DK089229] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants from the NIH (1F32DK095565-01A1) to S. Hussey, and the NIH (RO1-DK80157 and RO1-DK089229) and American Diabetes Association to N. Musi.	Belfort R, 2005, DIABETES, V54, P1640, DOI 10.2337/diabetes.54.6.1640; Cani PD, 2007, DIABETES, V56, P1761, DOI 10.2337/db06-1491; Creely SJ, 2007, AM J PHYSIOL-ENDOC M, V292, pE740, DOI 10.1152/ajpendo.00302.2006; Dasu MR, 2010, DIABETES CARE, V33, P861, DOI 10.2337/dc09-1799; DEFRONZO RA, 1979, AM J PHYSIOL, V237, pE214; Galbo T, 2013, P NATL ACAD SCI USA, V110, P12780, DOI 10.1073/pnas.1311176110; Holland WL, 2011, J CLIN INVEST, V121, P1858, DOI 10.1172/JCI43378; Hughey CC, 2011, J VISUALIZED EXPT JO; Hussey SE, 2013, DIABETOLOGIA; Jia L, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4878; Kawamoto T, 2008, EUR J PHARMACOL, V584, P40, DOI 10.1016/j.ejphar.2008.01.026; Kim HM, 2007, CELL, V130, P906, DOI 10.1016/j.cell.2007.08.002; Lee JY, 2001, J BIOL CHEM, V276, P16683, DOI 10.1074/jbc.M011695200; Liang CF, 2013, ARTERIOSCL THROM VAS, V33, P777, DOI 10.1161/ATVBAHA.112.301087; Liang HY, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0063983, 10.1371/journal.pone.0074121]; Lynn M, 2003, J INFECT DIS, V187, P631, DOI 10.1086/367990; Matsunaga N, 2011, MOL PHARMACOL, V79, P34, DOI 10.1124/mol.110.068064; Mehta NN, 2010, DIABETES, V59, P172, DOI 10.2337/db09-0367; Mullarkey M, 2003, J PHARMACOL EXP THER, V304, P1093, DOI 10.1124/jpet.102.044487; Opal SM, 2013, JAMA-J AM MED ASSOC, V309, P1154, DOI 10.1001/jama.2013.2194; Phielix E, 2012, DIABETES, V61, P2472, DOI 10.2337/db11-1832; Pierre N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065061; Poggi M, 2007, DIABETOLOGIA, V50, P1267, DOI 10.1007/s00125-007-0654-8; Radin MS, 2008, DIABETOLOGIA, V51, P336, DOI 10.1007/s00125-007-0861-3; REAVEN GM, 1988, AM J MED, V85, P106, DOI 10.1016/0002-9343(88)90402-0; Reyna SM, 2008, DIABETES, V57, P2595, DOI 10.2337/db08-0038; Reyna SM, 2013, J DIABETES RES, V2013, DOI 10.1155/2013/107805; Rice TW, 2010, CRIT CARE MED, V38, P1685, DOI 10.1097/CCM.0b013e3181e7c5c9; Saberi M, 2009, CELL METAB, V10, P419, DOI 10.1016/j.cmet.2009.09.006; Schenk S, 2008, J CLIN INVEST, V118, P2992, DOI 10.1172/JCI34260; Sha T, 2007, EUR J PHARMACOL, V571, P231, DOI 10.1016/j.ejphar.2007.06.027; Shi H, 2006, J CLIN INVEST, V116, P3015, DOI 10.1172/JCI28898; Tsukumo DML, 2007, DIABETES, V56, P1986, DOI 10.2337/db06-1595; Vella A, 2009, DIABETES, V58, P2168, DOI 10.2337/db09-0318; Vijay-Kumar M, 2011, J INFLAMM-LOND, V8, DOI 10.1186/1476-9255-8-2; Wolf R, 1992, RADIOACTIVE STABLE I; Yamada M, 2005, J MED CHEM, V48, P7457, DOI 10.1021/jm050623t	37	20	21	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0132575	10.1371/journal.pone.0132575	http://dx.doi.org/10.1371/journal.pone.0132575			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LZ	26196892	Green Published, Green Submitted, gold			2022-12-26	WOS:000358547600040
J	Leal, MF; Astur, DC; Debieux, P; Arliani, GG; Franciozi, CES; Loyola, LC; Andreoli, CV; Smith, MC; Pochini, AD; Ejnisman, B; Cohen, M				Leal, Mariana Ferreira; Astur, Diego Costa; Debieux, Pedro; Arliani, Gustavo Goncalves; Silveira Franciozi, Carlos Eduardo; Loyola, Leonor Casilla; Andreoli, Carlos Vicente; Smith, Marilia Cardoso; Pochini, Alberto de Castro; Ejnisman, Benno; Cohen, Moises			Identification of Suitable Reference Genes for Investigating Gene Expression in Anterior Cruciate Ligament Injury by Using Reverse Transcription-Quantitative PCR	PLOS ONE			English	Article							REAL-TIME PCR; HOUSEKEEPING GENES; NORMALIZATION; TISSUES; SELECTION; COLLAGEN	The anterior cruciate ligament (ACL) is one of the most frequently injured structures during high-impact sporting activities. Gene expression analysis may be a useful tool for understanding ACL tears and healing failure. Reverse transcription-quantitative polymerase chain reaction (RT-qPCR) has emerged as an effective method for such studies. However, this technique requires the use of suitable reference genes for data normalization. Here, we evaluated the suitability of six reference genes (18S, ACTB, B2M, GAPDH, HPRT1, and TBP) by using ACL samples of 39 individuals with ACL tears (20 with isolated ACL tears and 19 with ACL tear and combined meniscal injury) and of 13 controls. The stability of the candidate reference genes was determined by using the NormFinder, geNorm, BestKeeper DataAssist, and RefFinder software packages and the comparative Delta Ct method. ACTB was the best single reference gene and ACTB+TBP was the best gene pair. The GenEx software showed that the accumulated standard deviation is reduced when a larger number of reference genes is used for gene expression normalization. However, the use of a single reference gene may not be suitable. To identify the optimal combination of reference genes, we evaluated the expression of FN1 and PLOD1. We observed that at least 3 reference genes should be used. ACTB+HPRT1+18S is the best trio for the analyses involving isolated ACL tears and controls. Conversely, ACTB+TBP+18S is the best trio for the analyses involving (1) injured ACL tears and controls, and (2) ACL tears of patients with meniscal tears and controls. Therefore, if the gene expression study aims to compare non-injured ACL, isolated ACL tears and ACL tears from patients with meniscal tear as three independent groups ACTB+TBP+18S+HPRT1 should be used. In conclusion, 3 or more genes should be used as reference genes for analysis of ACL samples of individuals with and without ACL tears.	[Leal, Mariana Ferreira; Astur, Diego Costa; Debieux, Pedro; Arliani, Gustavo Goncalves; Silveira Franciozi, Carlos Eduardo; Loyola, Leonor Casilla; Andreoli, Carlos Vicente; Pochini, Alberto de Castro; Ejnisman, Benno; Cohen, Moises] Univ Fed Sao Paulo, Dept Ortoped & Traumatol, BR-04038032 Sao Paulo, SP, Brazil; [Leal, Mariana Ferreira; Loyola, Leonor Casilla; Smith, Marilia Cardoso] Univ Fed Sao Paulo, Dept Morfol & Genet, Disciplina Genet, BR-04023001 Sao Paulo, SP, Brazil	Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Sao Paulo (UNIFESP)	Leal, MF (corresponding author), Univ Fed Sao Paulo, Dept Ortoped & Traumatol, BR-04038032 Sao Paulo, SP, Brazil.	mariana.morf@epm.br	Debieux, Pedro/AAN-5092-2020; Leal, Mariana/C-4010-2012; Andreoli, Carlos Vicente/AAW-1228-2021; Arliani, Gustavo/O-2722-2013; de A. C. Smith, Marilia/C-4397-2012; franciozi, carlos/C-1284-2015; Ejnisman, Benno/J-1556-2015	Leal, Mariana/0000-0003-4375-2563; Arliani, Gustavo/0000-0003-4371-5041; de A. C. Smith, Marilia/0000-0002-1441-1033; Debieux, Pedro/0000-0003-0015-1223; franciozi, carlos/0000-0002-0932-6870; Ejnisman, Benno/0000-0002-3301-1457	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This study was supported by grants and fellowships from the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ; MC and MCS) and the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP; MC, MFL and LCL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; APLEY AG, 1947, J BONE JOINT SURG, V29, P78; Arliani GG, 2012, REV BRAS ORTOP, V47, P6; Arliani GG, 2012, OPEN ACCESS J SPORTS, V3, P183, DOI 10.2147/OAJSM.S37203; Astur DC, 2012, REV BRAS ORTOP, V47, P5; Astur DC, 2014, BMJ CASE REP, V2014; Astur DC, 2014, KNEE, V21, P911, DOI 10.1016/j.knee.2014.06.003; Astur DC, 2013, ARTHROSCOPY, V29, P913, DOI 10.1016/j.arthro.2013.01.008; Ayers Duncan, 2007, BMC Vet Res, V3, P7; Franciozi CED, 2014, CURR REV MUSCULOSKE, V7, P228, DOI 10.1007/s12178-014-9228-9; de Jonge HJM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000898; Derveaux S, 2010, METHODS, V50, P227, DOI 10.1016/j.ymeth.2009.11.001; EYRE DR, 1984, ANAL BIOCHEM, V137, P380, DOI 10.1016/0003-2697(84)90101-5; Fu J, 2010, ACTA BIOCH BIOPH SIN, V42, P568, DOI 10.1093/abbs/gmq062; Galway R, 1972, J BONE JOINT SURG BR, V54, P2; Huggett J, 2005, GENES IMMUN, V6, P279, DOI 10.1038/sj.gene.6364190; Johnson JS, 2015, J BONE JOINT SURG AM, V97A, P71, DOI 10.2106/JBJS.N.00246; Killian ML, 2010, J SURG RES, V164, P234, DOI 10.1016/j.jss.2009.03.006; Kozera B, 2013, J APPL GENET, V54, P391, DOI 10.1007/s13353-013-0173-x; Leal MF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118821; Leal MF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105002; Li YL, 2009, ANAL BIOCHEM, V394, P110, DOI 10.1016/j.ab.2009.07.022; Llanos A, BMC GENOMICS, V16; Lo IKY, 2003, CLIN ORTHOP RELAT R, P249, DOI 10.1097/01.blo.0000037442.23683.35; Lo IKY, 1998, J ORTHOPAED RES, V16, P421, DOI 10.1002/jor.1100160405; Lyng MB, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-20; Marshall J L, 1975, J Sports Med, V3, P152; McMurray T. P, 1949, BRIT J SURG, V29, P1; Myllyla R, 2007, J CELL PHYSIOL, V212, P323, DOI 10.1002/jcp.21036; Naraoka T, 2012, BONE JOINT RES, V1, P238, DOI 10.1302/2046-3758.110.2000118; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Pombo-Suarez M, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-17; Rubie C, 2005, MOL CELL PROBE, V19, P101, DOI 10.1016/j.mcp.2004.10.001; Silver N, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-33; Speziali A, 2015, MUSCULOSKELET SURG; Spindler KP, 1996, J ORTHOP RES, V14, P857, DOI 10.1002/jor.1100140603; Taylor SC, 2014, J MOL MICROB BIOTECH, V24, P46, DOI 10.1159/000356189; Torg J S, 1976, Am J Sports Med, V4, P84, DOI 10.1177/036354657600400206; Tria A.J, 1992, ILLUSTRATED GUIDE KN; Vakonakis L, 2007, CURR OPIN CELL BIOL, V19, P578, DOI 10.1016/j.ceb.2007.09.005; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wang Q, 2012, INT J LEGAL MED, V126, P943, DOI 10.1007/s00414-012-0774-7; Wisnieski F, 2013, WORLD J GASTROENTERO, V19, P7121, DOI 10.3748/wjg.v19.i41.7121; Yuzbasioglu A, 2010, EXP MOL PATHOL, V88, P326, DOI 10.1016/j.yexmp.2009.12.007; Zhou ZJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088892	45	17	17	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2015	10	7							e0133323	10.1371/journal.pone.0133323	http://dx.doi.org/10.1371/journal.pone.0133323			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LN	26192306	gold, Green Published, Green Submitted			2022-12-26	WOS:000358546400072
J	Mashayak, SY; Jochum, MN; Koschke, K; Aluru, NR; Ruhle, V; Junghans, C				Mashayak, S. Y.; Jochum, Mara N.; Koschke, Konstantin; Aluru, N. R.; Ruehle, Victor; Junghans, Christoph			Relative Entropy and Optimization-Driven Coarse-Graining Methods in VOTCA	PLOS ONE			English	Article							MULTISCALE SIMULATION; MOLECULAR-DYNAMICS; BIOMOLECULAR SYSTEMS; SOFT MATTER; WATER; MODELS; POTENTIALS; PACKAGE; ALGORITHMS	We discuss recent advances of the VOTCA package for systematic coarse-graining. Two methods have been implemented, namely the downhill simplex optimization and the relative entropy minimization. We illustrate the new methods by coarse-graining SPC/E bulk water and more complex water-methanol mixture systems. The CG potentials obtained from both methods are then evaluated by comparing the pair distributions from the coarse-grained to the reference atomistic simulations. In addition to the newly implemented methods, we have also added a parallel analysis framework to improve the computational efficiency of the coarse-graining process.	[Mashayak, S. Y.; Aluru, N. R.] Univ Illinois, Dept Mech Sci & Engn, Beckman Inst Adv Sci & Technol, Urbana, IL 61801 USA; [Jochum, Mara N.; Koschke, Konstantin] Max Planck Inst Polymer Res, D-55128 Mainz, Germany; [Ruehle, Victor] Univ Cambridge, Dept Chem, Cambridge CB2 1EW, England; [Junghans, Christoph] Los Alamos Natl Lab, Comp Computat & Stat Sci Div, Los Alamos, NM 87545 USA	University of Illinois System; University of Illinois Urbana-Champaign; Max Planck Society; University of Cambridge; United States Department of Energy (DOE); Los Alamos National Laboratory	Junghans, C (corresponding author), Los Alamos Natl Lab, Comp Computat & Stat Sci Div, POB 1663, Los Alamos, NM 87545 USA.	junghans@lanl.gov	Junghans, Christoph/G-4238-2010; Mashayak, Sikandar/ABA-4023-2020; Aluru, N/A-4617-2014	Junghans, Christoph/0000-0003-0925-1458; Aluru, N/0000-0002-9622-7837	NSF [480 1264282, 1420882]; AFOSR [11157642]; framework of the multiscale modeling initiative of theMax-Planck Society [SFB 625, M3]; National Science Foundation [NSF PHY11-25915]; LANL; Nestle Research Center; DFG Emmy Noether program [LA-UR-13-26878]; National Nuclear Security Administration of the U.S. DOE [DE-AC52- 06NA25396]	NSF(National Science Foundation (NSF)); AFOSR(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); framework of the multiscale modeling initiative of theMax-Planck Society; National Science Foundation(National Science Foundation (NSF)); LANL(United States Department of Energy (DOE)Los Alamos National Laboratory); Nestle Research Center(Nestle SA); DFG Emmy Noether program(German Research Foundation (DFG)); National Nuclear Security Administration of the U.S. DOE(National Nuclear Security Administration)	SYM and NRA acknowledge financial support by the NSF under grant Nos. 480 1264282 and 1420882 and AFOSR under grant No. 11157642. CJ was financially supported by SFB 625 in the framework of the multiscale modeling initiative of the Max-Planck Society (M3). This research was supported in part by the National Science Foundation under grant number NSF PHY11-25915. CJ thanks LANL for a Director's fellowship and the MPG for hospitality in 2013 at MPI-P. K. Koschke acknowledges funding by the Nestle Research Center. MNJ acknowledges DFG Emmy Noether program for financial support. Assigned: LA-UR-13-26878. LANL is operated by Los Alamos National Security, LLC, for the National Nuclear Security Administration of the U.S. DOE under Contract DE-AC52- 06NA25396. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JA, 2008, J COMPUT PHYS, V227, P5342, DOI 10.1016/j.jcp.2008.01.047; Apol E, 2014, GROMACS USER MANUAL; BERENDSEN HJC, 1987, J PHYS CHEM-US, V91, P6269, DOI 10.1021/j100308a038; Bevc S, 2015, J COMPUT CHEM, V36, P467, DOI 10.1002/jcc.23806; Bezkorovaynaya O, 2012, J COMPUT CHEM, V33, P937, DOI 10.1002/jcc.22915; Chaimovich A, 2011, J CHEM PHYS, V134, DOI 10.1063/1.3557038; Chaimovich A, 2009, PHYS CHEM CHEM PHYS, V11, P1901, DOI 10.1039/b818512c; Cooke IR, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.011506; Fritsch S, 2012, J CHEM THEORY COMPUT, V8, P398, DOI 10.1021/ct200706f; Fritz D, 2011, PHYS CHEM CHEM PHYS, V13, P10412, DOI 10.1039/c1cp20247b; Ganguly P, 2012, J CHEM THEORY COMPUT, V8, P1802, DOI 10.1021/ct3000958; Hadley KR, 2012, MOL SIMULAT, V38, P671, DOI 10.1080/08927022.2012.671942; Halverson JD, 2012, COMPUTER PHYS COMMUN; Hansen N, 1995, ICGA, P57; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Hyeon C, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1481; Izvekov S, 2005, J PHYS CHEM B, V109, P2469, DOI 10.1021/jp044629q; Johnson ME, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2715953; Jones JE, 1924, P R SOC LOND A-CONTA, V106, P463, DOI 10.1098/rspa.1924.0082; Jorgensen WL, 2005, P NATL ACAD SCI USA, V102, P6665, DOI 10.1073/pnas.0408037102; JORGENSEN WL, 1986, J PHYS CHEM-US, V90, P1276, DOI 10.1021/j100398a015; Karimi-Varzaneh HA, 2011, J COMPUT CHEM, V32, P1475, DOI 10.1002/jcc.21717; Laaksonen A, 1997, J PHYS CHEM A, V101, P5910, DOI 10.1021/jp970673c; Limbach HJ, 2006, COMPUT PHYS COMMUN, V174, P704, DOI 10.1016/j.cpc.2005.10.005; Lu JB, 2014, J CHEM THEORY COMPUT, V10, P4104, DOI 10.1021/ct500487h; Lyubartsev A, 2010, FARADAY DISCUSS, V144, P43, DOI 10.1039/b901511f; LYUBARTSEV AP, 1995, PHYS REV E, V52, P3730, DOI 10.1103/PhysRevE.52.3730; Marrink SJ, 2007, J PHYS CHEM B, V111, P7812, DOI 10.1021/jp071097f; Mashayak SY, 2012, J CHEM PHYS, V137, DOI 10.1063/1.4769297; Mirzoev A, 2013, J CHEM THEORY COMPUT, V9, P1512, DOI 10.1021/ct301019v; Molinero V, 2009, J PHYS CHEM B, V113, P4008, DOI 10.1021/jp805227c; Muller-Plathe F, 2002, CHEMPHYSCHEM, V3, P754, DOI 10.1002/1439-7641(20020916)3:9<754::AID-CPHC754>3.0.CO;2-U; Mullinax JW, 2009, J CHEM PHYS, V131, DOI 10.1063/1.3220627; Nagarajan A, 2013, J CHEM THEORY COMPUT, V9, P5168, DOI 10.1021/ct400566j; NELDER JA, 1965, COMPUT J, V7, P308, DOI 10.1093/comjnl/7.4.308; Nezbeda I, 1997, MOL PHYS, V90, P353, DOI 10.1080/00268979709482616; Noid WG, 2013, J CHEM PHYS, V139, DOI 10.1063/1.4818908; NOSE S, 1984, J CHEM PHYS, V81, P511, DOI 10.1063/1.447334; Peter C, 2009, SOFT MATTER, V5, P4357, DOI 10.1039/b912027k; PLIMPTON S, 1995, J COMPUT PHYS, V117, P1, DOI 10.1006/jcph.1995.1039; Poblete S, 2010, J CHEM PHYS, V132, DOI 10.1063/1.3357982; Praprotnik M, 2008, ANNU REV PHYS CHEM, V59, P545, DOI 10.1146/annurev.physchem.59.032607.093707; Reith D, 2003, J COMPUT CHEM, V24, P1624, DOI 10.1002/jcc.10307; Rudzinski JF, 2011, J CHEM PHYS, V135, DOI 10.1063/1.3663709; Ruhle V, 2011, MACROMOL THEOR SIMUL, V20, P472, DOI 10.1002/mats.201100011; Ruhle V, 2009, J CHEM THEORY COMPUT, V5, P3211, DOI 10.1021/ct900369w; Shell MS, 2008, J CHEM PHYS, V129, DOI 10.1063/1.2992060; Smith W, 2006, MOL SIMULAT, V32, P935, DOI 10.1080/08927020600939830; Voth G. A., 2008, COARSE GRAINING COND; Wallqvist A, 2007, MOL MODELS WATER DER, P183; Wang H, 2009, EUR PHYS J E, V28, P221, DOI 10.1140/epje/i2008-10413-5; Wu D, 2005, J CHEM PHYS, V123, DOI 10.1063/1.1992483	52	50	50	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2015	10	7							e0131754	10.1371/journal.pone.0131754	http://dx.doi.org/10.1371/journal.pone.0131754			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LN	26192992	Green Published, Green Submitted, gold			2022-12-26	WOS:000358546400016
J	Rose, JJ; Voora, D; Cyr, DD; Lucas, JE; Zaas, AK; Woods, CW; Newby, LK; Kraus, WE; Ginsburg, GS				Rose, Jason J.; Voora, Deepak; Cyr, Derek D.; Lucas, Joseph E.; Zaas, Aimee K.; Woods, Christopher W.; Newby, L. Kristin; Kraus, William E.; Ginsburg, Geoffrey S.			Gene Expression Profiles Link Respiratory Viral Infection, Platelet Response to Aspirin, and Acute Myocardial Infarction	PLOS ONE			English	Article							INFLUENZA-A VIRUS; CORONARY-ARTERY-DISEASE; CARDIOVASCULAR-DISEASE; RISK; VACCINATION; ACTIVATION; ASSOCIATION; MORTALITY; PROTEINS; GAS6	Background Influenza infection is associated with myocardial infarction (MI), suggesting that respiratory viral infection may induce biologic pathways that contribute to MI. We tested the hypotheses that 1) a validated blood gene expression signature of respiratory viral infection (viral GES) was associated with MI and 2) respiratory viral exposure changes levels of a validated platelet gene expression signature (platelet GES) of platelet function in response to aspirin that is associated with MI. Methods A previously defined viral GES was projected into blood RNA data from 594 patients undergoing elective cardiac catheterization and used to classify patients as having evidence of viral infection or not and tested for association with acute MI using logistic regression. A previously defined platelet GES was projected into blood RNA data from 81 healthy subjects before and after exposure to four respiratory viruses: Respiratory Syncytial Virus (RSV) (n= 20), Human Rhinovirus (HRV) (n= 20), Influenza A virus subtype H1N1 (H1N1) (n= 24), Influenza A Virus subtype H3N2 (H3N2) (n= 17). We tested for the change in platelet GES with viral exposure using linear mixed-effects regression and by symptom status. Results In the catheterization cohort, 32 patients had evidence of viral infection based upon the viral GES, of which 25% (8/32) had MI versus 12.2%(69/567) among those without evidence of viral infection (OR 2.3; CI [1.03-5.5], p= 0.04). In the infection cohorts, only H1N1 exposure increased platelet GES over time (time course p-value = 1e-04). Conclusions A viral GES of non-specific, respiratory viral infection was associated with acute MI; 18% of the top 49 genes in the viral GES are involved with hemostasis and/ or platelet aggregation. Separately, H1N1 exposure, but not exposure to other respiratory viruses, increased a platelet GES previously shown to be associated with MI. Together, these results highlight specific genes and pathways that link viral infection, platelet activation, and MI especially in the case of H1N1 influenza infection.	[Rose, Jason J.; Voora, Deepak; Cyr, Derek D.; Lucas, Joseph E.; Zaas, Aimee K.; Woods, Christopher W.; Ginsburg, Geoffrey S.] Duke Univ, Ctr Appl Genom & Precis Med, Med Ctr, Durham, NC 27708 USA; [Rose, Jason J.; Voora, Deepak; Zaas, Aimee K.; Woods, Christopher W.; Newby, L. Kristin; Kraus, William E.; Ginsburg, Geoffrey S.] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; [Rose, Jason J.] Univ Pittsburgh, Div Pulm Allergy & Crit Care Med, Dept Med, Pittsburgh, PA USA	Duke University; Duke University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Ginsburg, GS (corresponding author), Duke Univ, Ctr Appl Genom & Precis Med, Med Ctr, Durham, NC 27708 USA.	geoffrey.ginsburg@duke.edu	Rose, Jason/AAY-8921-2021		Defense Advanced Research Projects Agency (DARPA) [N66001-09-C-2082]; National Institutes of Health (NIH) [5RC1-GM091083-03]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [RC1GM091083] Funding Source: NIH RePORTER	Defense Advanced Research Projects Agency (DARPA)(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding sources are the following grants: Defense Advanced Research Projects Agency (DARPA)-N66001-09-C-2082 and National Institutes of Health (NIH) 5RC1-GM091083-03.	Angelillo-Scherrer A, 2001, NAT MED, V7, P215, DOI 10.1038/84667; Arbit B, 2011, ACTA CARDIOL, V66, P807, DOI 10.1080/AC.66.6.2136968; Armstrong SM, 2013, VIRULENCE, V4, P537, DOI 10.4161/viru.25779; Barrett B, 2006, EUR RESPIR J, V28, P358, DOI 10.1183/09031936.06.00002606; Berri F, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003229; Bogomol'tsev B P, 2003, Klin Med (Mosk), V81, P9; Brett SJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018120; Bucasas KL, 2011, J INFECT DIS, V203, P921, DOI 10.1093/infdis/jiq156; Coppinger JA, 2004, BLOOD, V103, P2096, DOI 10.1182/blood-2003-08-2804; Dabek J, 2010, INFLAMMATION, V33, P398, DOI 10.1007/s10753-010-9198-z; Davis MM, 2006, CIRCULATION, V114, P1549, DOI 10.1161/CIRCULATIONAHA.106.178242; Erden I, 2011, CARDIOL J, V18, P552, DOI 10.5603/CJ.2011.0012; Eyers S, 2010, J ROY SOC MED, V103, P403, DOI 10.1258/jrsm.2010.090441; Parguina AF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013404; Garcia CC, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001171; Geiler J, 2011, MED MICROBIOL IMMUN, V200, P53, DOI 10.1007/s00430-010-0173-y; Guan XR, 2010, AM J MED SCI, V340, P356, DOI 10.1097/MAJ.0b013e3181eecf29; Guan XR, 2008, INFLAMMATION, V31, P266, DOI 10.1007/s10753-008-9074-2; Guan XR, 2012, INFLAMM RES, V61, P591, DOI 10.1007/s00011-012-0449-3; Han JY, 2009, FASEB J, V23, P4193, DOI 10.1096/fj.09-131862; Hansen GAW, 2009, MOL CELL BIOCHEM, V320, P25, DOI 10.1007/s11010-008-9895-1; Huang YS, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002234; JACKSON GG, 1958, ARCH INTERN MED, V101, P267, DOI 10.1001/archinte.1958.00260140099015; Knapp M, 2012, BASIC RES CARDIOL, V107, DOI 10.1007/s00395-012-0294-0; Kuo RL, 2010, VIROLOGY, V408, P146, DOI 10.1016/j.virol.2010.09.012; Lanza GA, 2011, J INTERN MED, V269, P118, DOI 10.1111/j.1365-2796.2010.02285.x; Laurance S, 2012, ADV NUTR, V3, P196, DOI 10.3945/an.111.001826; Li W, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001985; Liberzon A, 2011, BIOINFORMATICS, V27, P1739, DOI 10.1093/bioinformatics/btr260; Lichenstein R, 2012, J INFECT DIS, V206, P821, DOI 10.1093/infdis/jis435; Link A, 2012, DEUT MED WOCHENSCHR, V137, P1853, DOI 10.1055/s-0032-1305311; Loomba RS, 2012, J CARDIOVASC PHARM T, V17, P277, DOI 10.1177/1074248411429965; Lucas JE, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000920; Maree AO, 2007, CURR PHARM DESIGN, V13, P2656, DOI 10.2174/138161207781662948; MARK DB, 1994, CIRCULATION, V89, P2015, DOI 10.1161/01.CIR.89.5.2015; Mazur I, 2007, CELL MICROBIOL, V9, P1683, DOI 10.1111/j.1462-5822.2007.00902.x; Meier CR, 1998, LANCET, V351, P1467, DOI 10.1016/S0140-6736(97)11084-4; Moscardo A, 2006, PLATELETS, V17, P405, DOI 10.1080/09537100600757869; Mussa T, 2013, VET IMMUNOL IMMUNOP, V154, P25, DOI 10.1016/j.vetimm.2013.04.004; Naghavi M, 2000, CIRCULATION, V102, P3039; Rondina MT, 2012, CHEST, V141, P1490, DOI 10.1378/chest.11-2860; SANO A, 1989, BIOCHEM BIOPH RES CO, V165, P1191, DOI 10.1016/0006-291X(89)92728-9; Schellings MWM, 2009, J EXP MED, V206, P113, DOI 10.1084/jem.20081244; Schremmer Bruno, 2007, V44, P317; Seki M, 2009, JPN J INFECT DIS, V62, P6; Shah SH, 2010, AM HEART J, V160, P371, DOI 10.1016/j.ahj.2010.06.051; Starko KM, 2009, CLIN INFECT DIS, V49, P1405, DOI 10.1086/606060; Tjwa M, 2008, BLOOD, V111, P4096, DOI 10.1182/blood-2007-05-089565; Turner RB, 2001, CLIN INFECT DIS, V33, P1865, DOI 10.1086/324347; Udell JA, 2013, JAMA-J AM MED ASSOC, V310, P1711, DOI 10.1001/jama.2013.279206; Vandermeer ML, 2012, J INFECT DIS, V205, P13, DOI 10.1093/infdis/jir695; Voora D, 2013, J AM COLL CARDIOL, V62, P1267, DOI 10.1016/j.jacc.2013.05.073; Wang LY, 2007, AM J HUM GENET, V80, P650, DOI 10.1086/512981; Warren-Gash C, 2012, J INFECT DIS, V206, P1652, DOI 10.1093/infdis/jis597; Warren-Gash C, 2011, J INFECT DIS, V203, P1710, DOI 10.1093/infdis/jir171; Wiwanitkit V, 2013, ANADOLU KARDIYOL DER, V13, P821, DOI 10.5152/akd.2013.4820; Woods CW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052198; Yamada Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031494; Zaas AK, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006280; Zaas AK, 2009, CELL HOST MICROBE, V6, P207, DOI 10.1016/j.chom.2009.07.006	60	16	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2015	10	7							e0132259	10.1371/journal.pone.0132259	http://dx.doi.org/10.1371/journal.pone.0132259			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LN	26193668	Green Published, Green Accepted, Green Submitted, gold			2022-12-26	WOS:000358546400020
J	Tschirren, B				Tschirren, Barbara			Differential Effects of Maternal Yolk Androgens on Male and Female Offspring: A Role for Sex-Specific Selection?	PLOS ONE			English	Article							TESTOSTERONE LEVELS; IMMUNE FUNCTION; GROWTH; ANDROSTENEDIONE; SUSCEPTIBILITY; CONSEQUENCES; ALLOCATION; PHENOTYPE; SURVIVAL; BEHAVIOR	Maternal hormones are important mediators of prenatal maternal effects in animals. Although their effects on offspring phenotype are often sex-specific, the reason why sometimes sons are more sensitive to prenatal hormone exposure and sometimes daughters is not well understood. Here I combine an experimental manipulation of yolk testosterone concentration in the egg and quantification of selection acting on yolk androgen-sensitive traits in a natural population of great tits (Parus major) with a literature review to test the hypothesis that sex-specific selection on traits affected by yolk androgens determines which sex is more sensitive to prenatal hormone exposure. An experimental increase of the testosterone content in the egg boosted the post-hatching growth of male, but not female great tit nestlings. However, I found no evidence that survival selection on body mass or size is acting differently in the two sexes. A literature review revealed that yolk androgen manipulations affect the growth of males and females differently across species. Interestingly, in studies performed in the wild a significant association between the strength and direction of sexual size dimorphism and sex-specific sensitivities to yolk androgens was observed. In studies performed in captivity, no such relationship was found. Thus, across species there is some evidence that sex-specific selection on body size influences how strongly growth trajectories of males and females are affected by maternally-derived yolk androgens.	Univ Zurich, Inst Evolutionary Biol & Environm Studies, Zurich, Switzerland	University of Zurich	Tschirren, B (corresponding author), Univ Zurich, Inst Evolutionary Biol & Environm Studies, Zurich, Switzerland.	barbara.tschirren@ieu.uzh.ch	Tschirren, Barbara/F-8202-2011	Tschirren, Barbara/0000-0003-4806-4102	Swiss National Science Foundation [PP00P3_128386, PP00P3_157455]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	The study was funded by the Swiss National Science Foundation (http://www.snf.ch) (grant PP00P3_128386 and PP00P3_157455 to BT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2007, CRC HDB AVIAN BODY M, DOI [DOI 10.1201/9781420064452, DOI 10.1080/10888705.2011.527604]; Badyaev AV, 2002, TRENDS ECOL EVOL, V17, P369, DOI 10.1016/S0169-5347(02)02569-7; Balthazart Jacques, 2002, P223; Bates D., 2011, PACKAGE LME4 LINEAR, V1; Benowitz-Fredericks ZM, 2013, GEN COMP ENDOCR, V193, P48, DOI 10.1016/j.ygcen.2013.07.005; Boncoraglio G, 2011, AM NAT, V178, P64, DOI 10.1086/660278; Carere C, 2007, TRENDS ENDOCRIN MET, V18, P73, DOI 10.1016/j.tem.2007.01.003; Gil D, 2008, ADV STUD BEHAV, V38, P337, DOI 10.1016/S0065-3454(08)00007-7; Griffiths R, 1998, MOL ECOL, V7, P1071, DOI 10.1046/j.1365-294x.1998.00389.x; Groothuis TGG, 2005, NEUROSCI BIOBEHAV R, V29, P329, DOI 10.1016/j.neubiorev.2004.12.002; Hines M, 2011, FRONT NEUROENDOCRIN, V32, P170, DOI 10.1016/j.yfrne.2011.02.006; KEMPENAERS B, 1992, NATURE, V357, P494, DOI 10.1038/357494a0; LANDE R, 1983, EVOLUTION, V37, P1210, DOI 10.1111/j.1558-5646.1983.tb00236.x; LOVICH JE, 1992, GROWTH DEVELOP AGING, V56, P269; Mousseau T.A., 1998, MATERNAL EFFECTS ADA; Muller W, 2007, BEHAV ECOL, V18, P929, DOI 10.1093/beheco/arm060; Muller W, 2008, HORM BEHAV, V54, P125, DOI 10.1016/j.yhbeh.2008.02.005; Muller W, 2010, BEHAV ECOL, V21, P493, DOI 10.1093/beheco/arq010; Muller W, 2009, BEHAV ECOL SOCIOBIOL, V63, P809, DOI 10.1007/s00265-009-0714-9; Muriel J, 2013, GEN COMP ENDOCR, V194, P175, DOI 10.1016/j.ygcen.2013.09.013; Pitala N, 2009, J AVIAN BIOL, V40, P225, DOI 10.1111/j.1600-048X.2009.04452.x; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Rice AM, 2013, HORM BEHAV, V63, P813, DOI 10.1016/j.yhbeh.2013.03.019; Rubolini D, 2006, BEHAV ECOL SOCIOBIOL, V59, P344, DOI 10.1007/s00265-005-0057-0; Ruuskanen S, 2012, BEHAV ECOL SOCIOBIOL, V66, P1201, DOI 10.1007/s00265-012-1373-9; Ruuskanen S, 2012, FUNCT ECOL, V26, P884, DOI 10.1111/j.1365-2435.2012.01994.x; Ruuskanen S, 2010, HORM BEHAV, V57, P119, DOI 10.1016/j.yhbeh.2009.09.017; Saino N, 2006, BEHAV ECOL, V17, P172, DOI 10.1093/beheco/arj023; SCHWABL H, 1993, P NATL ACAD SCI USA, V90, P11446, DOI 10.1073/pnas.90.24.11446; Schwabl H, 1996, COMP BIOCHEM PHYS A, V114, P271, DOI 10.1016/0300-9629(96)00009-6; Schwabl H, 2012, AGE, V34, P87, DOI 10.1007/s11357-011-9222-8; Sockman KW, 2008, BEHAV ECOL SOCIOBIOL, V62, P617, DOI 10.1007/s00265-007-0486-z; Stinchcombe JR, 2008, EVOLUTION, V62, P2435, DOI 10.1111/j.1558-5646.2008.00449.x; Tschirren B, 2005, J ANIM ECOL, V74, P675, DOI 10.1111/j.1365-2656.2005.00963.x; Tschirren B, 2003, J ANIM ECOL, V72, P839, DOI 10.1046/j.1365-2656.2003.00755.x; Tschirren B, 2004, P ROY SOC B-BIOL SCI, V271, P1371, DOI 10.1098/rspb.2004.2730; von Engelhardt N, 2006, P ROY SOC B-BIOL SCI, V273, P65, DOI 10.1098/rspb.2005.3274; Weinstock M, 2001, PROG NEUROBIOL, V65, P427, DOI 10.1016/S0301-0082(01)00018-1	38	11	11	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2015	10	7							e0133673	10.1371/journal.pone.0133673	http://dx.doi.org/10.1371/journal.pone.0133673			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LN	26192990	Green Published, Green Accepted, Green Submitted, gold			2022-12-26	WOS:000358546400112
J	Zinicola, M; Higgins, H; Lima, S; Machado, V; Guard, C; Bicalho, R				Zinicola, Martin; Higgins, Hazel; Lima, Svetlana; Machado, Vinicius; Guard, Charles; Bicalho, Rodrigo			Shotgun Metagenomic Sequencing Reveals Functional Genes and Microbiome Associated with Bovine Digital Dermatitis	PLOS ONE			English	Article							ENDOTHELIAL-CELL MONOLAYERS; DAIRY-COWS; BORRELIA-BURGDORFERI; TREPONEMA-DENTICOLA; RHIZOBIUM-LUPINI; IMMUNE-RESPONSE; COPPER-SULFATE; UK CATTLE; LESIONS; PENETRATION	Metagenomic methods amplifying 16S ribosomal RNA genes have been used to describe the microbial diversity of healthy skin and lesion stages of bovine digital dermatitis (DD) and to detect critical pathogens involved with disease pathogenesis. In this study, we characterized the microbiome and for the first time, the composition of functional genes of healthy skin (HS), active (ADD) and inactive (IDD) lesion stages using a whole-genome shotgun approach. Metagenomic sequences were annotated using MG-RAST pipeline. Six phyla were identified as the most abundant. Firmicutes and Actinobacteria were the predominant bacterial phyla in the microbiome of HS, while Spirochetes, Bacteroidetes and Proteobacteria were highly abundant in ADD and IDD. T. denticola-like, T. vincentii-like and T. phagedenis-like constituted the most abundant species in ADD and IDD. Recruitment plots comparing sequences from HS, ADD and IDD samples to the genomes of specific Treponema spp., supported the presence of T. denticola and T. vincentii in ADD and IDD. Comparison of the functional composition of HS to ADD and IDD identified a significant difference in genes associated with motility/chemotaxis and iron acquisition/metabolism. We also provide evidence that the microbiome of ADD and IDD compared to that of HS had significantly higher abundance of genes associated with resistance to copper and zinc, which are commonly used in footbaths to prevent and control DD. In conclusion, the results from this study provide new insights into the HS, ADD and IDD microbiomes, improve our understanding of the disease pathogenesis and generate unprecedented knowledge regarding the functional genetic composition of the digital dermatitis microbiome.	[Zinicola, Martin; Higgins, Hazel; Lima, Svetlana; Machado, Vinicius; Guard, Charles; Bicalho, Rodrigo] Cornell Univ, Dept Populat Med & Diagnost Sci, Ithaca, NY 14850 USA	Cornell University	Bicalho, R (corresponding author), Cornell Univ, Dept Populat Med & Diagnost Sci, Ithaca, NY 14850 USA.	rcb28@cornell.edu			USDA/NIFA Federal Formula Funds [NYC-478438]	USDA/NIFA Federal Formula Funds	Funding was provided for research and publication by the USDA/NIFA Federal Formula Funds project NYC-478438. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berry SL, 2012, VET J, V193, P654, DOI 10.1016/j.tvjl.2012.06.048; BLOWEY RW, 1994, VET REC, V135, P577; Brooks BE, 2008, BBA-BIOMEMBRANES, V1778, P1930, DOI 10.1016/j.bbamem.2007.06.005; Bruijnis MRN, 2012, ANIMAL, V6, P962, DOI 10.1017/S1751731111002606; Cha E, 2010, PREV VET MED, V97, P1, DOI 10.1016/j.prevetmed.2010.07.011; COMSTOCK LE, 1989, INFECT IMMUN, V57, P1626, DOI 10.1128/IAI.57.5.1626-1628.1989; DIGUISEPPI J, 1982, J BIOL CHEM, V257, P4046; Dopfer D, 2012, VET J, V193, P685, DOI 10.1016/j.tvjl.2012.06.054; Dopfer D, 1997, VET REC, V140, P620, DOI 10.1136/vr.140.24.620; Ettema J, 2010, PREV VET MED, V95, P64, DOI 10.1016/j.prevetmed.2010.03.001; Evans NJ, 2008, VET MICROBIOL, V130, P141, DOI 10.1016/j.vetmic.2007.12.019; Garbarino EJ, 2004, J DAIRY SCI, V87, P4123, DOI 10.3168/jds.S0022-0302(04)73555-9; Gomez A, 2014, J DAIRY SCI, V97, P4864, DOI 10.3168/jds.2013-7616; Holzhauer M, 2008, VET REC, V162, P41, DOI 10.1136/vr.162.2.41; Holzhauer M, 2006, J DAIRY SCI, V89, P580, DOI 10.3168/jds.S0022-0302(06)72121-X; Kalyuzhnaya MG, 2008, NAT BIOTECHNOL, V26, P1029, DOI 10.1038/nbt.1488; Kalyuzhnaya MG, 2008, ISME J, V2, P696, DOI 10.1038/ismej.2008.32; Klitgaard K, 2014, APPL ENVIRON MICROB, V80, P4427, DOI 10.1128/AEM.00873-14; Krull AC, 2014, INFECT IMMUN; Laven RA, 2002, VET REC, V151, P144, DOI 10.1136/vr.151.5.144; Li CH, 2000, J MOL MICROB BIOTECH, V2, P345; Li C, 2008, J BACTERIOL, V190, P5607, DOI 10.1128/JB.00319-08; Losinger WC, 2006, J DAIRY RES, V73, P244, DOI 10.1017/S0022029906001798; Lux R, 2001, INFECT IMMUN, V69, P6276, DOI 10.1128/IAI.69.10.6276-6283.2001; Lux R, 2000, J MOL MICROB BIOTECH, V2, P355; MARUYAMA M, 1978, BIOCHIM BIOPHYS ACTA, V535, P110, DOI 10.1016/0005-2795(78)90038-7; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; NEILANDS JB, 1981, J BIOL CHEM, V256, P3831; NEILANDS JB, 1981, ANNU REV BIOCHEM, V50, P715, DOI 10.1146/annurev.bi.50.070181.003435; Peters SR, 1999, ORAL MICROBIOL IMMUN, V14, P379, DOI 10.1034/j.1399-302X.1999.140609.x; Rasmussen M, 2012, VET MICROBIOL, V160, P151, DOI 10.1016/j.vetmic.2012.05.018; Santos TMA, 2012, FEMS MICROBIOL ECOL, V79, P518, DOI 10.1111/j.1574-6941.2011.01234.x; Schlafer S, 2008, VET MICROBIOL, V128, P118, DOI 10.1016/j.vetmic.2007.09.024; Schmitz-Esser S, 2008, APPL ENVIRON MICROB, V74, P5822, DOI 10.1128/AEM.01093-08; Schmitz-Esser S, 2010, J BACTERIOL, V192, P1045, DOI 10.1128/JB.01379-09; Shah N, 2011, BIOCOMPUT-PAC SYM, P165; Sim JH, 2005, MICROBIOL-SGM, V151, P1801, DOI 10.1099/mic.0.27622-0; Speijers MHM, 2010, J DAIRY SCI, V93, P5782, DOI 10.3168/jds.2010-3468; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; Teixeira AGV, 2010, J DAIRY SCI, V93, P3628, DOI 10.3168/jds.2010-3246; THOMAS DD, 1988, P NATL ACAD SCI USA, V85, P3608, DOI 10.1073/pnas.85.10.3608; Thomsen PT, 2015, J DAIRY SCI; TRACHTENBERG S, 1987, J MOL BIOL, V195, P603, DOI 10.1016/0022-2836(87)90185-9; Trott DJ, 2003, J CLIN MICROBIOL, V41, P2522, DOI 10.1128/JCM.41.6.2522-2529.2003; USDA, 2009, DAIR 2007 4; WEINBERG ED, 1978, MICROBIOL REV, V42, P45, DOI 10.1128/MMBR.42.1.45-66.1978; Yano T, 2010, VET MICROBIOL, V143, P352, DOI 10.1016/j.vetmic.2009.12.009; Zinicola M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120504; Zuerner RL, 2007, VET MICROBIOL, V125, P256, DOI 10.1016/j.vetmic.2007.06.001	49	27	27	2	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2015	10	7							e0133674	10.1371/journal.pone.0133674	http://dx.doi.org/10.1371/journal.pone.0133674			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LN	26193110	Green Submitted, Green Published, gold			2022-12-26	WOS:000358546400113
J	Chanzu, NM; Mwanda, W; Oyugi, J; Anzala, O				Chanzu, Nadia Musimbi; Mwanda, Walter; Oyugi, Julius; Anzala, Omu			Mucosal Blood Group Antigen Expression Profiles and HIV Infections: A Study among Female Sex Workers in Kenya	PLOS ONE			English	Article							ECTOCERVICAL MUCOSA; BINDING; ABO; POLYMORPHISM; ACTIVATION; CELLS; FUT2	Background The ABO blood group antigens are carbohydrate moieties expressed on human red blood cells however; these antigens can also be expressed on some other cells particularly the surface of epithelial cells and may be found in mucosal secretions. In many human populations 80% secrete ABO antigens (termed 'secretors') while 20% do not (termed 'non-secretors'). Furthermore, there are disease conditions that are associated with secretor status. Objective To investigate correlations between secretor status and HIV infection among female sex workers in Nairobi, Kenya. Methodology This cross-sectional study recruited 280 female sex workers aged 18-65 years from the Pumwani Majengo cohort, Kenya. Blood typing was determined by serological techniques using monoclonal antibodies to the ABO blood group antigens. Secretor phenotyping was determined using anti-H specific lectins specific to salivary, vaginal and cervical blood group H antigen using the agglutination inhibition technique and correlated to individual HIV sero-status. Participants were additionally screened for Bacterial vaginosis, Neisseria gonorrhoea and Trichomonas vaginalis. Results Out of the 280 participants, 212 (75.7%) were secretors and 68 (24.3%) were non-secretors. The incidence of all infections: HIV, Bacterial vaginosis, Neisseria gonorrhoea and Trichomonas vaginalis was higher among secretors compared to non-secretors. However, this difference was only statistically significant for HIV infection incidence rates: HIV infected secretors (83.7%) versus HIV un-infected secretors (71.8%) (p = 0.029) Based on ABO phenotype stratification, the incidence of HIV infection was higher among blood group A secretors (26/52 = 50%), in comparison to B (12/39 = 33.3%: p = 0.066), AB (3/9 = 33.3%: p = 0.355), and O secretors (36/112 = 32.1%: p = 0.028). Conclusion This is the first report to document the variable expression of the ABH blood group antigens profiling secretor and non-secretor phenotypes in the female genital tract among a high-risk population in a Kenyan population. These findings suggest the non-secretor phenotype may confer a certain degree of protection against HIV infection.	[Chanzu, Nadia Musimbi; Mwanda, Walter] Univ Nairobi, Coll Hlth Sci, Inst Trop & Infect Dis, Nairobi, Kenya; [Oyugi, Julius] Univ Nairobi, Coll Hlth Sci, Dept Med Microbiol, Nairobi, Kenya; [Anzala, Omu] Univ Nairobi, Coll Hlth Sci, KAVI Inst Clin Res, Nairobi, Kenya	University of Nairobi; University of Nairobi; University of Nairobi	Chanzu, NM (corresponding author), Univ Nairobi, Coll Hlth Sci, Inst Trop & Infect Dis, Nairobi, Kenya.	nadiachanzu@gmail.com		Ikumi, Nadia/0000-0002-6096-3533	Global Health Research Initiative under the HIV/AIDS Prevention Trial Capacity Building Grants Program [107005-001]	Global Health Research Initiative under the HIV/AIDS Prevention Trial Capacity Building Grants Program	The study was funded by a grant from the Global Health Research Initiative under the HIV/AIDS Prevention Trial Capacity Building Grants Program (Phase 2) (Project Number: 107005-001). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali S, 2000, J INFECT DIS, V181, P737, DOI 10.1086/315234; [Anonymous], 2013, UNAIDS REP GLOB AIDS; Anstee DJ, 2010, BLOOD, V115, P4635, DOI 10.1182/blood-2010-01-261859; ARENDRUP M, 1991, AIDS, V5, P441, DOI 10.1097/00002030-199104000-00014; Egene J., 2004, NIGER J PHYSL SCI, V19, P7; Ferrer-Admetlla A, 2009, MOL BIOL EVOL, V26, P1993, DOI 10.1093/molbev/msp108; Gelmon L, 2009, KENYA HIV PREVENTION; Gibbs A, 2014, J IMMUNOL, V192, P3947, DOI 10.4049/jimmunol.1302826; Gouws E, 2006, SEX TRANSM INFECT, V82, pIII51, DOI 10.1136/sti.2006.020164; Hayes RJ, 1999, INT J EPIDEMIOL, V28, P319, DOI 10.1093/ije/28.2.319; Higgins MA, 2009, J MOL BIOL, V388, P299, DOI 10.1016/j.jmb.2009.03.012; Hirbod T, 2013, J IMMUNOL, V191, P3948, DOI 10.4049/jimmunol.1301220; Kindberg E, 2006, AIDS, V20, P685, DOI 10.1097/01.aids.0000216368.23325.bc; Koda Y, 2001, GENETICS, V158, P747; Lajoie J, 2014, J INFECT DIS, V210, P319, DOI 10.1093/infdis/jiu023; National AIDS and STI Control Programme, 2013, KEN AIDS IND SURV 20; Neil SJD, 2005, BLOOD, V105, P4693, DOI 10.1182/blood-2004-11-4267; Perry H E, 2007, Immunohematology, V23, P100; Preece AF, 2002, BLOOD, V99, P2477, DOI 10.1182/blood.V99.7.2477; Ruiz-Palacios GM, 2003, J BIOL CHEM, V278, P14112, DOI 10.1074/jbc.M207744200; Sayal S K, 1996, Indian J Dermatol Venereol Leprol, V62, P295; STAPLETON A, 1992, J CLIN INVEST, V90, P965, DOI 10.1172/JCI115973; Storry J R, 2009, Immunohematology, V25, P48; Stowell SR, 2010, NAT MED, V16, P295, DOI 10.1038/nm.2103; Tan M, 2011, TRENDS MICROBIOL, V19, P382, DOI 10.1016/j.tim.2011.05.007; Zhang XF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069379	26	8	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0133049	10.1371/journal.pone.0133049	http://dx.doi.org/10.1371/journal.pone.0133049			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RV	26186209	Green Published, gold			2022-12-26	WOS:000358198700090
J	Leischik, R; Foshag, P; Strauss, M; Littwitz, H; Garg, P; Dworrak, B; Horlitz, M				Leischik, Roman; Foshag, Peter; Strauss, Markus; Littwitz, Henning; Garg, Pankaj; Dworrak, Birgit; Horlitz, Marc			Aerobic Capacity, Physical Activity and Metabolic Risk Factors in Firefighters Compared with Police Officers and Sedentary Clerks	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; BODY-MASS INDEX; CARDIORESPIRATORY FITNESS; CARDIOVASCULAR RISK; LIFE-STYLE; ACTIVITY QUESTIONNAIRE; ANAEROBIC THRESHOLD; CIVIL-SERVANTS; GAS-EXCHANGE; HEALTH	Background This study examined the association between the physical work environment and physiological performance measures, physical activity levels and metabolic parameters among German civil servants. A main focus in this study was to examine the group differences rather than measuring the absolute values in an occupational group. Methods We prospectively examined 198 male German civil servants (97 firefighters [FFs], 55 police officers [POs] and 46 sedentary clerks [SCs]). For each parameter, the groups were compared using a linear regression adjusted for age. Results The 97 FFs showed a similar maximal aerobic power (VO2max l/min) of 3.17 +/- 0.44 l/min compared with the POs, who had a maximal aerobic power of 3.13 +/- 0.62 l/min (estimated difference, POs vs. FFs: 0.05, CI: -0.12-0.23, p=0.553). The maximal aerobic power of the FFs was slightly higher than that of the SCs, who had a maximal aerobic power of 2.85 +/- 0.52 l/min (-0.21, CI: -0.39-0.04, p=0.018 vs. FFs). The average physical activity (in metabolic equivalents [METS]/week) of the FFs was 3818.8 +/- 2843.5, whereas those of the POs and SCs were 2838.2 +/- 2871.9 (-808.2, CI: 1757.6-141.2, p=0.095) and 2212.2 +/- 2292.8 (vs. FFs: -1417.1, CI: -2302-531.88, p=0.002; vs. POs: -2974.4, CI: -1611.2-393.5, p=0.232), respectively. For the FFs, the average body fat percentage was 17.7%+/- 6.2, whereas it was 21.4%+/- 5.6 for the POs (vs. FFs: 2.75, CI: 0.92-4.59, p=0.004) and 20.8%+/- 6.5 for the SCs (vs. FFs: 1.98, CI: -0.28-4.25, p=0.086; vs. POs: -0.77, CI: 3.15-1.61, p=0.523). The average waist circumference was 89.8 cm +/- 10.0 for the FFs, 97.8 cm +/- 12.4 (5.63, CI: 2.10-9.15, p=0.002) for the POs, and 97.3 +/- 11.7 (vs. FFs: -4.89, CI: 1.24-8.55, p=0.009; vs. POs: -0.73, CI: -5.21-3.74, p=0.747) for the SCs. Conclusions The FFs showed significantly higher physical activity levels compared with the SCs. The PO group had the highest cardiovascular risk of all of the groups because it included more participants with metabolic syndrome; furthermore, the POs had an average of 2.75% higher body fat, lower HDL cholesterol values and higher waist circumferences compared with the FFs and higher LDL cholesterol values compared with the SCs. Our data indicate that sedentary occupations appear to be linked to obesity and metabolic syndrome in middle-aged men.	[Leischik, Roman; Foshag, Peter; Strauss, Markus; Littwitz, Henning; Dworrak, Birgit] Univ Witten Herdecke, Fac Hlth, Sch Med, Dept Cardiol, Hagen, Germany; [Garg, Pankaj] Univ Leeds, Leeds Inst Cardiovasc & Metab Med LICAMM, Leeds, W Yorkshire, England; [Horlitz, Marc] Univ Witten Herdecke, Fac Hlth, Sch Med, Dept Cardiol, Cologne, Germany	Witten Herdecke University; University of Leeds; Witten Herdecke University	Leischik, R (corresponding author), Univ Witten Herdecke, Fac Hlth, Sch Med, Dept Cardiol, Hagen, Germany.	info@dr-leischik.de	Leischik, Roman/V-1496-2017; Garg, Pankaj/Q-9987-2016	Garg, Pankaj/0000-0002-5483-169X				Ackland TR, 2012, SPORTS MED, V42, P227, DOI 10.2165/11597140-000000000-00000; Ainsworth BE, 2011, MED SCI SPORT EXER, V43, P1575, DOI 10.1249/MSS.0b013e31821ece12; Ainsworth BE, 2000, MED SCI SPORT EXER, V32, pS498, DOI 10.1097/00005768-200009001-00009; Alberti KGMM, 2006, DIABETIC MED, V23, P469, DOI 10.1111/j.1464-5491.2006.01858.x; Angermayr L, 2010, ANN BEHAV MED, V40, P49, DOI 10.1007/s12160-010-9206-4; Atlantis E, 2006, HEALTH PROMOT INT, V21, P191, DOI 10.1093/heapro/dal012; Baur DM, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-480; Baur DM, 2012, J STRENGTH COND RES, V26, P2331, DOI 10.1519/JSC.0b013e31823e9b19; BEAVER WL, 1986, J APPL PHYSIOL, V60, P2020, DOI 10.1152/jappl.1986.60.6.2020; Bureau of Labor Statistics, 2009, THE EMPLOYMENT SITUA; Clemes SA, 2014, OCCUP MED-OXFORD, V64, P188, DOI 10.1093/occmed/kqt164; Cooper AJM, 2014, DIABETOLOGIA, V57, P73, DOI 10.1007/s00125-013-3069-8; Danaei G, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000058; Sousa ACPD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102299; Drew-Nord DC, 2011, J OCCUP MED TOXICOL,, V6, DOI 10.1186/1745-6673-6-25; Duque I, 2011, EUR SPINE J, V20, P87, DOI 10.1007/s00586-010-1561-0; Durand G, 2011, MED SCI SPORT EXER, V43, P1752, DOI 10.1249/MSS.0b013e318215cf25; Fogelholm M, 2006, MED SCI SPORT EXER, V38, P753, DOI 10.1249/01.mss.0000194075.16960.20; Fong Daniel Y T, 2012, BMJ, V344, pe70, DOI 10.1136/bmj.e70; Gutierrez-Fisac JL, 2002, OBES RES, V10, P270, DOI 10.1038/oby.2002.37; Hallal PC, 2012, LANCET, V380, P247, DOI 10.1016/S0140-6736(12)60646-1; Hartley Tara A, 2011, Int J Emerg Ment Health, V13, P243; Hartley Tara A, 2011, Int J Emerg Ment Health, V13, P211; Hartley TA, 2011, J OCCUP ENVIRON MED, V53, P553, DOI 10.1097/JOM.0b013e3182171995; Haskell WL, 2007, MED SCI SPORT EXER, V39, P1423, DOI [10.1249/mss.0b013e3180616b27, 10.1161/CIRCULATIONAHA.107.185649]; Healy GN, 2011, EUR HEART J, V32, P590, DOI 10.1093/eurheartj/ehq451; Holtermann A, 2012, BRIT J SPORT MED, V46, P291, DOI 10.1136/bjsm.2010.079582; Jackson AS, 2009, ARCH INTERN MED, V169, P1781, DOI 10.1001/archinternmed.2009.312; Kales SN, 2007, NEW ENGL J MED, V356, P1207, DOI 10.1056/NEJMoa060357; Kennedy RA, 2007, J SPORT SCI MED, V6, P448; Kraushaar LE, 2014, PREV SCI, V15, P579, DOI 10.1007/s11121-013-0398-2; Kurtze N, 2008, BMC MED RES METHODOL, V8, DOI 10.1186/1471-2288-8-63; Lagestad P., 2014, INT J POLICE SCI MAN, V16, P76, DOI DOI 10.1350/IJPS.2014.16.1.329; Lakoski SG, 2011, AM J CARDIOL, V108, P34, DOI 10.1016/j.amjcard.2011.02.338; Leischik R, 2005, DEUT MED WOCHENSCHR, V130, P2518, DOI 10.1055/s-2005-918598; Leischik R, 2014, INT J ENV RES PUB HE, V11, P9082, DOI 10.3390/ijerph110909082; Leischik R, 2014, KARDIOL POL, V72, P587, DOI 10.5603/KP.a2014.0089; MACKENBACH JP, 1992, SOC SCI MED, V34, P213, DOI 10.1016/0277-9536(92)90264-Q; Mares N E, 1988, Ned Tijdschr Geneeskd, V132, P1109; MARMOT MG, 1991, LANCET, V337, P1387, DOI 10.1016/0140-6736(91)93068-K; MARMOT MG, 1986, LANCET, V2, P274; MARMOT MG, 1978, J EPIDEMIOL COMMUN H, V32, P244, DOI 10.1136/jech.32.4.244; Meyer T, 2005, INT J SPORTS MED, V26, pS38, DOI 10.1055/s-2004-830514; MORRIS JN, 1953, BRIT J IND MED, V10, P245; Peate WF, 2002, J OCCUP ENVIRON MED, V44, P546, DOI 10.1097/00043764-200206000-00017; POLLOCK ML, 1978, J OCCUP ENVIRON MED, V20, P393; Puder JJ, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d6195; Ramey SL, 2014, J OCCUP ENVIRON MED, V56, P338, DOI 10.1097/JOM.0000000000000108; Ramli A, 2013, MALAYS J MED SCI, V20, P54; RHODES EC, 1992, CAN J SPORT SCI, V17, P228; Chaparro MAS, 2011, NUTR METAB CARDIOVAS, V21, P231, DOI 10.1016/j.numecd.2009.10.001; Shephard RJ, 2003, BRIT J SPORT MED, V37, P197, DOI 10.1136/bjsm.37.3.197; Shiroma EJ, 2010, CIRCULATION, V122, P743, DOI 10.1161/CIRCULATIONAHA.109.914721; SICONOLFI SF, 1985, AM J EPIDEMIOL, V122, P101, DOI 10.1093/oxfordjournals.aje.a114068; Silva-Batista C, 2013, J STRENGTH COND RES, V27, P3481, DOI 10.1519/JSC.0b013e31828f1efa; Simmons RK, 2008, DIABETOLOGIA, V51, P787, DOI 10.1007/s00125-008-0949-4; Sokka T, 2008, CLIN EXP RHEUMATOL, V26, pS35, DOI 10.1161/CIRCULATIONAHA.109.192644; Soteriades ES, 2011, CARDIOL REV, V19, P202, DOI 10.1097/CRD.0b013e318215c105; Soteriades ES, 2005, OBES RES, V13, P1756, DOI 10.1038/oby.2005.214; Spitler D L, 1987, Br J Sports Med, V21, P154; Steding K, 2010, CLIN PHYSIOL FUNCT I, V30, P146, DOI 10.1111/j.1475-097X.2009.00918.x; Tharkar Shabana, 2008, J Assoc Physicians India, V56, P845; Thayyil J, 2012, N AM J MED SCI, V4, P630, DOI 10.4103/1947-2714.104313; van Uffelen JGZ, 2010, AM J PREV MED, V39, P379, DOI 10.1016/j.amepre.2010.05.024; Violanti John M, 2013, Int J Emerg Ment Health, V15, P217; Waldburger R, 2014, EXP CLIN ENDOCR DIAB, V122, P190, DOI 10.1055/s-0034-1367006; Wasserman K, 1997, CHEST, V112, P1091, DOI 10.1378/chest.112.4.1091; WASSERMAN K, 1973, J APPL PHYSIOL, V35, P236, DOI 10.1152/jappl.1973.35.2.236; Wilkinson ML, 2014, PREV CHRONIC DIS, V11, DOI 10.5888/pcd11.140091; Williams-Bell FM, 2009, MED SCI SPORT EXER, V41, P653, DOI 10.1249/MSS.0b013e31818ad117; World Health Organization, 2009, GLOBAL HEALTH RISKS; Yoo C, 2014, J PHYS THER SCI, V26, P1575, DOI 10.1589/jpts.26.1575	73	31	31	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0133113	10.1371/journal.pone.0133113	http://dx.doi.org/10.1371/journal.pone.0133113			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RV	26186442	Green Submitted, gold, Green Published, Green Accepted			2022-12-26	WOS:000358198700092
J	Pearman, JK; Irigoien, X				Pearman, John K.; Irigoien, Xabier			Assessment of Zooplankton Community Composition along a Depth Profile in the Central Red Sea	PLOS ONE			English	Article							VERTICAL-DISTRIBUTION; SURFACE ZOOPLANKTON; EPIPELAGIC ZONE; GULF; AQABA; COPEPODS; MESOZOOPLANKTON; DIVERSITY; SEQUENCES; ABUNDANCE	The composition of zooplankton in the water column has received limited attention in the main body of the Red Sea and this study investigates the change in the community both spatially and temporally across 11 stations in the central Red Sea. Using molecular methods to target the v9 region of the 18S rRNA gene a total of approximately 11.5 million reads were sequenced resulting in 2528 operational taxonomic units (OTUs) at 97% similarity. The phylum Arthropoda dominated in terms of reads accounting for on average 86.2% and 65.3% for neuston nets and vertical multinets respectively. A reduction in the number of OTUs was noticed with depth for both total metazoa and Maxillopoda whilst there was also a significant change in the composition of the Maxillopoda community. The genus Corycaeus had a higher proportion of reads in the epipelagic zone with Pleuromamma becoming increasingly dominant with depth. No significant difference was observed in the community between night and day sampling however there was a significant difference in the zooplankton community between two sampling periods separated by 10 days.	[Pearman, John K.; Irigoien, Xabier] KAUST, Red Sea Res Ctr, Thuwal, Saudi Arabia	King Abdullah University of Science & Technology	Pearman, JK (corresponding author), KAUST, Red Sea Res Ctr, Thuwal, Saudi Arabia.	john.pearman@kaust.edu.sa	Irigoien, Xabier/B-8171-2009	Irigoien, Xabier/0000-0002-5411-6741; Pearman, John Kenneth/0000-0002-2237-9723	King Abdullah University of Science and Technology	King Abdullah University of Science and Technology(King Abdullah University of Science & Technology)	The research was supported by baseline funding provided by King Abdullah University of Science and Technology to Prof. Xabier Irigoien. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Najjar Tariq H., 2008, Jordan Journal of Biological Sciences, V1, P55; Amaral-Zettler LA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006372; [Anonymous], 2007, RES J ENV SCI, DOI DOI 10.3923/RJES.2007.200.210; Beaugrand G, 2003, NATURE, V426, P661, DOI 10.1038/nature02164; Becker RA, 2014, ORIGINAL S CODE R VE; Bottger-Schnack R, 2008, J PLANKTON RES, V30, P529, DOI 10.1093/plankt/fbn018; Bottger R., 1987, Biological Oceanography, V4, P383; BOTTGERSCHNACK R, 1994, HYDROBIOLOGIA, V293, P271; BOTTGERSCHNACK R, 1995, MAR ECOL PROG SER, V118, P81, DOI 10.3354/meps118081; Bucklin A., 2000, P533, DOI 10.1016/B978-012327645-2/50012-8; Bucklin A, 2003, MAR BIOL, V142, P333, DOI 10.1007/s00227-002-0943-1; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Comils A, 2007, J MARINE SYST, V68, P278, DOI 10.1016/j.jmarsys.2007.01.001; Cornils A, 2007, J PLANKTON RES, V29, P57; Cornils A, 2005, J PLANKTON RES, V27, P505, DOI 10.1093/plankt/fbi023; Cornils A, 2010, DEEP-SEA RES PT II, V57, P2076, DOI 10.1016/j.dsr2.2010.09.011; Dorgham MM, 2012, OCEANOLOGIA, V54, P473, DOI 10.5697/oc.54-3.473; ECHELMAN T, 1990, MAR BIOL, V107, P179, DOI 10.1007/BF01313255; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Farstey V, 2002, MAR ECOL PROG SER, V238, P91, DOI 10.3354/meps238091; HAURY LR, 1988, HYDROBIOLOGIA, V167, P335, DOI 10.1007/BF00026322; Hirai J, 2015, MOL ECOL RESOUR, V15, P68, DOI 10.1111/1755-0998.12294; Kelley D., OCE ANAL OCEANOGRAPH; Khalil MT, 1997, J PLANKTON RES, V19, P927, DOI 10.1093/plankt/19.7.927; Kosobokova K, 2000, DEEP-SEA RES PT I, V47, P2029, DOI 10.1016/S0967-0637(00)00015-7; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Lindeque PK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081327; Logares R, 2012, ISME J, V6, P1823, DOI 10.1038/ismej.2012.36; LONGHURST A, 1979, Journal of Plankton Research, V1, P1, DOI 10.1093/plankt/1.1.1; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Machida RJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046180; McMurdie PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061217; Mitra A, 2014, PROG OCEANOGR, V129, P176, DOI 10.1016/j.pocean.2014.04.025; MOORE E, 1976, ESTUAR COAST MAR SCI, V4, P589, DOI 10.1016/0302-3524(76)90068-2; Nishikawa J, 2007, DEEP-SEA RES PT II, V54, P114, DOI 10.1016/j.dsr2.2006.09.005; Oksanen J., **DATA OBJECT**; PANCUCCIPAPADOPOULOU MA, 1992, OCEANOL ACTA, V15, P365; Pearman JK, 2014, FRONT MAR SCI, V1, DOI 10.3389/fmars.2014.00027; Prokopowich CD, 2003, GENOME, V46, P48, DOI 10.1139/G02-103; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Raitsos DE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064909; SCHNEIDER G, 1994, MAR BIOL, V119, P191, DOI 10.1007/BF00349556; Thomsen PF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041732; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; WEIKERT H, 1982, MAR ECOL PROG SER, V8, P129, DOI 10.3354/meps008129	46	19	21	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0133487	10.1371/journal.pone.0133487	http://dx.doi.org/10.1371/journal.pone.0133487			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RV	26186220	Green Published, Green Submitted, gold			2022-12-26	WOS:000358198700146
J	Hu, DN; Mou, CH; Chao, SC; Lin, CY; Nien, CW; Kuan, PT; Jonas, JB; Sung, FC				Hu, Dan-Ning; Mou, Chih-Hsin; Chao, Shih-Chun; Lin, Ching-Yang; Nien, Chan-Wei; Kuan, Pei-Tzu; Jonas, Jost B.; Sung, Fung-Chang			Incidence of Non-Traumatic Subconjunctival Hemorrhage in a Nationwide Study in Taiwan from 2000 to 2011	PLOS ONE			English	Article							RISK; POLYMORPHISM; STROKE	Objective To determine the nationwide incidence of non-traumatic subconjunctival hemorrhage (NTSCH) in Taiwan from 2000-2011 and to analyze the risk factors for NTSCH using a case-control analysis. Methods This is a population-based cohort administrative database study. Randomly selected 1,000,000 residents from the Taiwan National Health Insurance Research Database in 2000 and followed for 12 years to determine the population incidence of NTSCH. Individuals with the first diagnosis of subconjunctival hemorrhage were identified by the corresponding International Classification of Diseases code (ICD) 372.72. Traumatic subconjunctival hemorrhages (ICD-9 codes 921, 871, 850-854 and 959.01) were excluded. The association of NTSCH with various demographic factors, comorbidities and use of medications was studied by a population based case-control analysis using data of 2008-2011. Results A total of 67,720 patients with a first-time diagnosis of NTSCH were identified during the 12 years period. The mean annual incidence was 65 per 10,000 individuals (crude incidence) and 60 per 10,000 individuals (age-and sex-standardized incidence). The incidence rate of NTSCH was higher in women than in men, [men-women ratio: 0.80 (95% confidence interval: 0.78-0.81)]. The age-specific incidence decreased from childhood to the group of teenagers, after which it increased to a maximal value of 136.2 per 10,000 people in the age group of 60-69 years. Case-control analysis showed that comorbidities of hypertension, purpura and thrombocytopenia, and the use of aspirin were significantly associated with the risk of NTSCH. Conclusions This study indicates that NTSCH is a common eye disease that occurs once in 167 individuals in a general East Asian population per year. It occurs more often in women than in men and the age-specific incidence peaked in the age group of 60-69 years. Hypertension, purpura and thrombocytopenia, and the use of aspirin are the major risk factors for NTSCH.	[Hu, Dan-Ning] New York Eye & Ear Infirm Mt Sinai, Dept Ophthalmol, Icahn Sch Med Mt Sinai, New York, NY 10003 USA; [Hu, Dan-Ning; Chao, Shih-Chun; Lin, Ching-Yang; Nien, Chan-Wei; Kuan, Pei-Tzu] Show Chwan Mem Hosp, Dept Ophthalmol, Changhua, Taiwan; [Mou, Chih-Hsin; Sung, Fung-Chang] China Med Univ, Inst Clin & Med Sci, Taichung, Taiwan; [Mou, Chih-Hsin; Sung, Fung-Chang] China Med Univ & Hosp, Management Off Hlth Data, Taichung, Taiwan; [Chao, Shih-Chun] Natl Chiao Tung Univ, Inst Elect & Comp Engn, Hsinchu, Taiwan; [Jonas, Jost B.] Heidelberg Univ, Dept Ophthalmol, Med Fac Mannheim, Heidelberg, Germany	Icahn School of Medicine at Mount Sinai; New York Eye & Ear Infirmary of Mount Sinai; Show Chwan Memorial Hospital; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; National Yang Ming Chiao Tung University; Ruprecht Karls University Heidelberg	Jonas, JB (corresponding author), Heidelberg Univ, Dept Ophthalmol, Med Fac Mannheim, Heidelberg, Germany.	jost.jonas@medma.uni-heidelberg.de; fcsung@mail.cmu.edu.tw			Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence [MOHW103-TDU-B-212-113002]; China Medical University Hospital [1MS1]; National Sciences Council, Executive Yuan [NSC 100-2621-M-039-001]	Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence; China Medical University Hospital; National Sciences Council, Executive Yuan	Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence (MOHW103-TDU-B-212-113002), China Medical University Hospital (grant number 1MS1), National Sciences Council, Executive Yuan (grant number NSC 100-2621-M-039-001).	BLACK RA, 1982, ANN OPHTHALMOL, V14, P1024; Bodack Marie I, 2007, Optometry, V78, P113, DOI 10.1016/j.optm.2006.10.015; Cameron AC., 2013, REGRESSION ANAL COUN, V2nd ed, DOI 10.1017/CBO9781139013567; Chang CH, 2001, CORNEA, V20, P295, DOI 10.1097/00003226-200104000-00011; Chang YS, 2012, AM J OPHTHALMOL, V154, P645, DOI 10.1016/j.ajo.2012.03.046; Duke-Elder S, 1977, SYSTEM OPHTHALMOLO 1, V8, P27; Engin A, 2009, AM J OPHTHALMOL, V147, P634, DOI 10.1016/j.ajo.2008.11.014; FUKUYAMA J, 1990, OPHTHALMOLOGICA, V200, P63, DOI 10.1159/000310079; Hebel JR, 2012, EPIDEMIOLOGY BIOSTAT, P23; Herr S, 2004, PEDIATRICS, V113, P1658, DOI 10.1542/peds.113.6.1658; Incorvaia C, 2002, AM J OPHTHALMOL, V134, P927, DOI 10.1016/S0002-9394(02)01812-3; KATZMAN GH, 1992, CLIN PEDIATR, V31, P149, DOI 10.1177/000992289203100304; Kiratli H, 2012, CAN J OPHTHALMOL, V47, P318, DOI 10.1016/j.jcjo.2012.02.002; Kobayashi H, 2010, J CATARACT REFR SURG, V36, P1115, DOI 10.1016/j.jcrs.2010.01.017; Kumar N, 2006, J CATARACT REFR SURG, V32, P1022, DOI 10.1016/j.jcrs.2006.02.035; Leiker LL, 2009, OPTOMETRY, V80, P227, DOI 10.1016/j.optm.2008.10.018; Mimura T, 2010, OPHTHALMOLOGICA, V224, P133, DOI 10.1159/000236038; Mimura T, 2010, OPHTHALMOLOGICA, V224, P90, DOI 10.1159/000235798; Murthy R, 2009, J HEMATOL ONCOL, V2, DOI 10.1186/1756-8722-2-4; Parmeggiani F, 2004, AM J OPHTHALMOL, V138, P481, DOI 10.1016/j.ajo.2004.03.017; Sodhi PK, 2003, JPN J OPHTHALMOL, V47, P316, DOI 10.1016/S0021-5155(03)00017-0; STUART MJ, 1982, NEW ENGL J MED, V307, P909, DOI 10.1056/NEJM198210073071502; Tarlan B, 2013, CLIN OPHTHALMOL, V7, P1163, DOI 10.2147/OPTH.S35062; Wang TJ, 2013, ACTA OPHTHALMOL, V91, P226, DOI 10.1111/j.1755-3768.2011.02359.x; YANCEY MK, 1991, OBSTET GYNECOL, V78, P646	25	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2015	10	7							e0132762	10.1371/journal.pone.0132762	http://dx.doi.org/10.1371/journal.pone.0132762			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RQ	26181776	Green Published, gold, Green Submitted			2022-12-26	WOS:000358198200032
J	Zhu, XJ; Yang, ZF; Zhou, JY; Liu, L; Sun, XM; Fan, ZF; Hu, SY; Chen, YC; Li, WX; Cao, M; Wang, LX				Zhu, Xue-Jun; Yang, Zhong-Fa; Zhou, Jin-Yong; Liu, Li; Sun, Xue-Mei; Fan, Zhen-Fang; Hu, Shou-You; Chen, Yu-Chao; Li, Wei-Xia; Cao, Meng; Wang, Li-Xin			Progression of Large Lymphoma Is Significantly Impeded with a Combination of Gemcitabine Chemotherapy and Dendritic Cells Intra-Tumor Vaccination	PLOS ONE			English	Article							MYELOID SUPPRESSOR-CELLS; CANCER-IMMUNOTHERAPY; IMMUNE-RESPONSES; NK CELLS; T-CELLS; EXPANSION; MICE; EXPRESSION; CARCINOMA; CD4(+)	Relapsed, refractory lymphoma remains to be a challenge and lacks efficient treatment. Some tumor cells escape from treatment, become resistant to chemotherapeutic agents, and rapidly regenerate into large tumors. Lymphoma cells induce accumulation of Gr-1(+-)CD11b(+) myeloid derived suppressor cells (MDSCs) in lymphatic organs and their vicinity. MDSCs enable tumor cells to escape from immune cells mediated surveillance and attack. Gemcitabine is a chemotherapeutic agent that eliminates both tumor cells and MDSCs, improving the immune environment favorable for subsequent treatment. We evaluated the effects of low dose gemcitabine combined with intra-tumorally delivered dendritic cells (DCs) for the treatment of A20 large-size lymphoma. We showed that MDSCs increased markedly in lymphoma-bearing mice, and that gemcitabine significantly increased the apoptosis of MDSCs. Treatment of lymphoma with either gemcitabine or intra-tumoral DCs alone could not inhibit tumor growth or rescue lymphoma-bearing mice. Treatment of lymphoma with small dose gemcitabine followed by intra-tumorally injected DCs significantly improved the efficacy of either individual treatment by reducing MDSCs, inducing onsite DCs maturation, eliminating tumor cells, inhibiting tumor growth and relapse, and extending the survival of the lymphoma-bearing mice, partly through the induction of the IFN gamma secreting cells and the activation of cytotoxic lymphocytes. We showed that NK cells and CD8(+) T cells were the major effectors to mediate the inhibition of tumor growth. Thus, the observation that gemcitabine synergizes DCs mediated immunotherapy to improve the efficacy of large size lymphoma treatment provides an experimental basis for the combination of chemotherapy and immunotherapy for the efficient treatment of relapsed or refractory lymphoma.	[Zhu, Xue-Jun; Li, Wei-Xia; Cao, Meng; Wang, Li-Xin] Southeast Univ, Sch Med, Dept Microbiol & Immunol, Nanjing, Jiangsu, Peoples R China; [Zhu, Xue-Jun; Zhou, Jin-Yong; Liu, Li; Sun, Xue-Mei; Fan, Zhen-Fang; Hu, Shou-You; Chen, Yu-Chao] Jiangsu Prov Tradit Chinese Med Hosp, Dept Med, Div Hematol, Nanjing, Jiangsu, Peoples R China; [Yang, Zhong-Fa] Univ Massachusetts, Sch Med, Dept Med, Div Hematol Oncol, Worcester, MA 01605 USA	Southeast University - China; University of Massachusetts System; University of Massachusetts Worcester	Zhu, XJ (corresponding author), Southeast Univ, Sch Med, Dept Microbiol & Immunol, Nanjing, Jiangsu, Peoples R China.	Zhuxj2@hotmail.com; lxwang@seu.edu.cn			National Natural Science Foundation of China [31170857, 30972783, 300771999, 81001299]; Top Six Elite Scholar Program of Jiangsu Province China [2010-WS-012]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Top Six Elite Scholar Program of Jiangsu Province China	This work is funded by National Natural Science Foundation of China (31170857, 30972783, 300771999, 81001299) (http://www.nsfc.gov.cn/Portal0/default166.htm) and the Top Six Elite Scholar Program of Jiangsu Province China #2010-WS-012. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam C, 2005, BLOOD, V106, P338, DOI 10.1182/blood-2004-09-3775; Adam C, 2007, J TRANSL MED, V5, DOI 10.1186/1479-5876-5-16; Bauer C, 2007, GUT, V56, P1275, DOI 10.1136/gut.2006.108621; Briones J, 2008, CLIN TRANSL ONCOL, V10, P543, DOI 10.1007/s12094-008-0249-4; Bronte V, 2000, BLOOD, V96, P3838, DOI 10.1182/blood.V96.12.3838.h8003838_3838_3846; Coiffier B, 2002, NEW ENGL J MED, V346, P235, DOI 10.1056/NEJMoa011795; De Velde ALRV, 2008, B CANCER, V95, P320, DOI 10.1684/bdc.2008.0602; Di Nicola M, 2009, BLOOD, V113, P18, DOI 10.1182/blood-2008-06-165654; Donnou Sabrina, 2012, Adv Hematol, V2012, P701704, DOI 10.1155/2012/701704; Gilboa E, 2007, J CLIN INVEST, V117, P1195, DOI 10.1172/JCI31205; Hanson EM, 2009, J IMMUNOL, V183, P937, DOI 10.4049/jimmunol.0804253; Hsu FJ, 1996, NAT MED, V2, P52, DOI 10.1038/nm0196-52; Huang B, 2006, CANCER RES, V66, P1123, DOI 10.1158/0008-5472.CAN-05-1299; Khaled YS, 2013, IMMUNOL CELL BIOL, V91, P493, DOI 10.1038/icb.2013.29; Komaru A, 2009, J IMMUNOL, V183, P4211, DOI 10.4049/jimmunol.0803845; Kusmartsev S, 2003, CANCER RES, V63, P4441; Le HK, 2009, INT IMMUNOPHARMACOL, V9, P900, DOI 10.1016/j.intimp.2009.03.015; Li HQ, 2009, J IMMUNOL, V182, P240, DOI 10.4049/jimmunol.182.1.240; Li YH, 2008, CANCER RES, V68, P6889, DOI 10.1158/0008-5472.CAN-08-0161; Lion E, 2012, ONCOLOGIST, V17, P1256, DOI 10.1634/theoncologist.2011-0122; Liu CR, 2007, BLOOD, V109, P4336, DOI 10.1182/blood-2006-09-046201; Liu L, 2009, LYMPHOMA LEUKEMIA, V18, P502; LYONS AB, 1994, J IMMUNOL METHODS, V171, P131, DOI 10.1016/0022-1759(94)90236-4; Melief CJM, 2008, IMMUNITY, V29, P372, DOI 10.1016/j.immuni.2008.08.004; Nakayama F, 2001, J BIOL CHEM, V276, P16100, DOI 10.1074/jbc.M007272200; Nowak AK, 2002, CANCER RES, V62, P2353; Palucka K, 2011, J INTERN MED, V269, P64, DOI 10.1111/j.1365-2796.2010.02317.x; Rosenberg SA, 2004, NAT MED, V10, P909, DOI 10.1038/nm1100; Serafini P, 2004, CANCER IMMUNOL IMMUN, V53, P64, DOI 10.1007/s00262-003-0443-2; Serafini P, 2006, SEMIN CANCER BIOL, V16, P53, DOI 10.1016/j.semcancer.2005.07.005; Song WR, 2005, CANCER RES, V65, P5958, DOI 10.1158/0008-5472.CAN-05-0406; Steinman RM, 2002, J CLIN INVEST, V109, P1519, DOI 10.1172/JCI200215962; Suzuki E, 2005, CLIN CANCER RES, V11, P6713, DOI 10.1158/1078-0432.CCR-05-0883; Timmerman JM, 2002, BLOOD, V99, P1517, DOI 10.1182/blood.V99.5.1517; Vieweg J, 2007, CLIN CANCER RES, V13, p727S, DOI 10.1158/1078-0432.CCR-06-1924; Wang LX, 2005, CANCER RES, V65, P10569, DOI 10.1158/0008-5472.CAN-05-2117; Watanabe S, 2008, J IMMUNOL, V181, P3291, DOI 10.4049/jimmunol.181.5.3291; Young MRI, 1997, INT J CANCER, V74, P69, DOI 10.1002/(SICI)1097-0215(19970220)74:1<69::AID-IJC12>3.0.CO;2-D; Young MRI, 1996, J IMMUNOL, V156, P1916	39	5	5	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2015	10	7							e0132799	10.1371/journal.pone.0132799	http://dx.doi.org/10.1371/journal.pone.0132799			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RQ	26181041	Green Submitted, Green Published, gold			2022-12-26	WOS:000358198200036
J	Zeitler, M; Steringer, JP; Muller, HM; Mayer, MP; Nickel, W				Zeitler, Marcel; Steringer, Julia P.; Mueller, Hans-Michael; Mayer, Matthias P.; Nickel, Walter			HIV-Tat Protein Forms Phosphoinositide-dependent Membrane Pores Implicated in Unconventional Protein Secretion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR 2; HEPARAN-SULFATE PROTEOGLYCANS; HUMAN-IMMUNODEFICIENCY-VIRUS; PLASMA-MEMBRANE; CELL-SURFACE; MAMMALIAN-CELLS; TRANSLOCATION; MACHINERY; EXPORT; FGF-2	HIV-Tat has been demonstrated to be secreted from cells in a phosphatidylinositol 4,5-bisphosphate (PI(4,5)P-2)-dependent manner. Here we show that HIV-Tat forms membrane-inserted oligomers, a process that is accompanied by changes in secondary structure with a strong increase in antiparallel beta sheet content. Intriguingly, oligomerization of HIV-Tat on membrane surfaces leads to the formation of membrane pores, as demonstrated by physical membrane passage of small fluorescent tracer molecules. Although membrane binding of HIV-Tat did not strictly depend on PI(4,5) P2 but, rather, was mediated by a range of acidic membrane lipids, a functional interaction between PI(4,5) P2 and HIV-Tat was critically required for efficient membrane pore formation by HIV-Tat oligomers. These properties are strikingly similar to what has been reported previously for fibroblast growth factor 2 (FGF2), providing strong evidence of a common core mechanism of unconventional secretion shared by HIV-Tat and fibroblast growth factor 2.	[Zeitler, Marcel; Steringer, Julia P.; Mueller, Hans-Michael; Nickel, Walter] Heidelberg Univ, Biochem Ctr, D-69120 Heidelberg, Germany; [Mayer, Matthias P.] Heidelberg Univ, Zentrum Mol Biol, Deutsch Krebsforschungszentrum, Univ Heidelberg Allianz, D-69120 Heidelberg, Germany	Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg	Nickel, W (corresponding author), Heidelberg Univ, Biochem Ctr, Neuenheimer Feld 328, D-69120 Heidelberg, Germany.	walter.nickel@bzh.uni-heidelberg.de	Mayer, Matthias P./B-9340-2013	Mayer, Matthias P./0000-0002-7859-3112; Muller, Hans-Michael/0000-0002-2384-7285	German Research Council [DFG-SFB 638, DFG-SFB/TRR 83, DFG-GRK1188]; AID-NET program of the Federal Ministry for Education and Research of Germany; cluster of excellence CellNetworks	German Research Council(German Research Foundation (DFG)); AID-NET program of the Federal Ministry for Education and Research of Germany; cluster of excellence CellNetworks	This work was supported by German Research Council Grants DFG-SFB 638, DFG-SFB/TRR 83, and DFG-GRK1188; the AID-NET program of the Federal Ministry for Education and Research of Germany, and the cluster of excellence CellNetworks. The authors declare that they have no conflicts of interest with the contents of this article.	Backhaus R, 2004, J CELL SCI, V117, P1727, DOI 10.1242/jcs.01027; Barth A, 2007, BBA-BIOENERGETICS, V1767, P1073, DOI 10.1016/j.bbabio.2007.06.004; BAYER P, 1995, J MOL BIOL, V247, P529, DOI 10.1016/S0022-2836(05)80133-0; Bellino S, 2014, RETROVIROLOGY, V11, DOI 10.1186/1742-4690-11-49; Campbell GR, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-50; Chang HC, 1997, AIDS, V11, P1421, DOI 10.1097/00002030-199712000-00006; Debaisieux S, 2012, TRAFFIC, V13, P355, DOI 10.1111/j.1600-0854.2011.01286.x; Ebert AD, 2010, TRAFFIC, V11, P813, DOI 10.1111/j.1600-0854.2010.01059.x; Engling A, 2002, J CELL SCI, V115, P3619, DOI 10.1242/jcs.00036; ENSOLI B, 1990, NATURE, V345, P84, DOI 10.1038/345084a0; ENSOLI B, 1993, J VIROL, V67, P277, DOI 10.1128/JVI.67.1.277-287.1993; Ensoli B, 2006, AIDS, V20, P2245, DOI 10.1097/QAD.0b013e3280112cd1; Ensoli F, 2015, RETROVIROLOGY, V12, DOI 10.1186/s12977-015-0151-y; FRANKEL AD, 1988, CELL, V55, P1189, DOI 10.1016/0092-8674(88)90263-2; Malsam J, 2009, P NATL ACAD SCI USA, V106, P2001, DOI 10.1073/pnas.0812813106; Milosevic I, 2005, J NEUROSCI, V25, P2557, DOI 10.1523/JNEUROSCI.3761-04.2005; Muller HM, 2015, J BIOL CHEM, V290, P8925, DOI 10.1074/jbc.M114.622456; Nickel W, 2005, TRAFFIC, V6, P607, DOI 10.1111/j.1600-0854.2005.00302.x; Nickel W, 2008, ANNU REV CELL DEV BI, V24, P287, DOI 10.1146/annurev.cellbio.24.110707.175320; Nickel W, 2007, J CELL SCI, V120, P2295, DOI 10.1242/jcs.011080; Nickel W, 2011, TRAFFIC, V12, P799, DOI 10.1111/j.1600-0854.2011.01187.x; Nickel W, 2009, NAT REV MOL CELL BIO, V10, P148, DOI 10.1038/nrm2617; Peloponese JM, 2000, CR ACAD SCI III-VIE, V323, P883, DOI 10.1016/S0764-4469(00)01228-2; Rabouille C, 2012, J CELL SCI, V125, P5251, DOI 10.1242/jcs.103630; Rayne F, 2010, CELL BIOL INT, V34, P409, DOI 10.1042/CBI20090376; Rayne F, 2010, EMBO J, V29, P1348, DOI 10.1038/emboj.2010.32; Rubartelli A, 1998, IMMUNOL TODAY, V19, P543, DOI 10.1016/S0167-5699(98)01351-6; RUBEN S, 1989, J VIROL, V63, P1; Schafer T, 2004, J BIOL CHEM, V279, P6244, DOI 10.1074/jbc.M310500200; Shi B, 1998, J NEUROVIROL, V4, P281, DOI 10.3109/13550289809114529; Shojania S, 2006, J BIOL CHEM, V281, P8347, DOI 10.1074/jbc.M510748200; Shojania S, 2010, J VIROL METHODS, V164, P35, DOI 10.1016/j.jviromet.2009.11.021; Steringer JP, 2015, J MOL BIOL, V427, P1202, DOI 10.1016/j.jmb.2014.07.012; Steringer JP, 2012, J BIOL CHEM, V287, P27659, DOI 10.1074/jbc.M112.381939; Temmerman K, 2008, TRAFFIC, V9, P1204, DOI 10.1111/j.1600-0854.2008.00749.x; Temmerman K, 2009, J LIPID RES, V50, P1245, DOI 10.1194/jlr.D800043-JLR200; Torrado LC, 2009, J CELL SCI, V122, P3322, DOI 10.1242/jcs.049791; Tyagi M, 2001, J BIOL CHEM, V276, P3254, DOI 10.1074/jbc.M006701200; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X; Xiao H, 2000, P NATL ACAD SCI USA, V97, P11466, DOI 10.1073/pnas.97.21.11466; Zacherl S, 2015, J BIOL CHEM, V290, P3654, DOI 10.1074/jbc.M114.590067; Zehe C, 2006, P NATL ACAD SCI USA, V103, P15479, DOI 10.1073/pnas.0605997103	42	36	37	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	2015	290	36					21976	21984		10.1074/jbc.M115.667097	http://dx.doi.org/10.1074/jbc.M115.667097			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CQ9XI	26183781	Green Published, hybrid			2022-12-26	WOS:000360968500018
J	Anilkumar, NC; Sundaram, MS; Mohan, CD; Rangappa, S; Bulusu, KC; Fuchs, JE; Girish, KS; Bender, A; Basappa; Rangappa, KS				Anilkumar, Nirvanappa C.; Sundaram, Mahalingam S.; Mohan, Chakrabhavi Dhananjaya; Rangappa, Shobith; Bulusu, Krishna C.; Fuchs, Julian E.; Girish, Kesturu S.; Bender, Andreas; Basappa; Rangappa, Kanchugarakoppal S.			A One Pot Synthesis of Novel Bioactive Tri-Substitute-Condensed-Imidazopyridines that Targets Snake Venom Phospholipase A(2)	PLOS ONE			English	Article							CARCINOMA IN-VITRO; DESIGN; SUZUKI; 3-COMPONENT; SONOGASHIRA; INHIBITORS; SPACE; ACID; VIVO	Drugs such as necopidem, saripidem, alpidem, zolpidem, and olprinone contain nitrogen-containing bicyclic, condensed-imidazo[1,2-alpha]pyridines as bioactive scaffolds. In this work, we report a high-yield one pot synthesis of 1-(2-methyl-8-aryl-substitued-imidazo[1,2-alpha]pyridin-3-yl)ethan-1-onefor the first-time. Subsequently, we performed in silico mode-of-action analysis and predicted that the synthesized imidazopyridines targets Phospholipase A(2) (PLA(2)). In vitro analysis confirmed the predicted target PLA(2) for the novel imidazopyridine derivative1-(2-Methyl-8-naphthalen-1-yl-imidazo[1,2-alpha]pyridine-3-yl)-ethanone (compound 3f) showing significant inhibitory activity towards snake venom PLA(2) with an IC50 value of 14.3 mu M. Evidently, the molecular docking analysis suggested that imidazopyridine compound was able to bind to the active site of the PLA(2) with strong affinity, whose affinity values are comparable to nimesulide. Furthermore, we estimated the potential for oral bio-availability by Lipinski's Rule of Five. Hence, it is concluded that the compound 3f could be a lead molecule against snake venom PLA(2).	[Anilkumar, Nirvanappa C.; Basappa] Bangalore Univ, Dept Chem, Biol Chem Lab, Bangalore 560001, Karnataka, India; [Sundaram, Mahalingam S.; Girish, Kesturu S.] Univ Mysore, Dept Studies Biochem, Mysore 570006, Karnataka, India; [Mohan, Chakrabhavi Dhananjaya; Rangappa, Kanchugarakoppal S.] Univ Mysore, Dept Studies Chem, Mysore 570006, Karnataka, India; [Rangappa, Shobith] Hokkaido Univ, Frontier Res Ctr Postgenome Sci & Technol, Sapporo, Hokkaido 0600808, Japan; [Bulusu, Krishna C.; Fuchs, Julian E.; Bender, Andreas] Univ Cambridge, Dept Chem, Ctr Mol Sci Informat, Cambridge CB2 1EW, England; [Girish, Kesturu S.] Tumkur Univ, Dept Studies & Res Biochem, Tumkur 572103, Karnataka, India	Bangalore University; University of Mysore; University of Mysore; Hokkaido University; University of Cambridge; Tumkur University	Basappa (corresponding author), Bangalore Univ, Dept Chem, Biol Chem Lab, Cent Coll Campus,Palace Rd, Bangalore 560001, Karnataka, India.	salundibasappa@gmail.com; rangappaks@gmail.com	Bender, Andreas/C-6942-2009; Rangappa, Shobith/AAI-2169-2020; Mohan, Chakrabhavi Dhananjaya/AGO-1276-2022; KS, Girish/GWZ-7128-2022	Bender, Andreas/0000-0002-6683-7546; Rangappa, Shobith/0000-0002-9800-7192; Mohan, Chakrabhavi Dhananjaya/0000-0002-6810-9219; /0000-0001-6121-0771; KS, Girish/0000-0002-7284-3707; Basappa, Basappa/0000-0002-8844-468X; Bulusu, Krishna/0000-0002-5092-6640	University Grants Commission [41-257-2012-SR]; Vision Group Science and Technology, Department of Science and Technology [SR/FT/LS-142/2012]; DST-JSPS [DST/INT/JAP/P-79/09]; DST Indo-Korea [INT/indo-korea/122/2011-12]; DST-PURSE; European Research Commission (ERC); Unilever; UGC-BSR; Department of Science and Technology	University Grants Commission(University Grants Commission, India); Vision Group Science and Technology, Department of Science and Technology; DST-JSPS; DST Indo-Korea; DST-PURSE; European Research Commission (ERC)(European Research Council (ERC)); Unilever(Unilever); UGC-BSR; Department of Science and Technology(Department of Science & Technology (India))	This research was supported by University Grants Commission (41-257-2012-SR), Vision Group Science and Technology, Department of Science and Technology (NO. SR/FT/LS-142/2012) to Basappa. KSR thanks DST-JSPS (DST/INT/JAP/P-79/09), DST Indo-Korea [INT/indo-korea/122/2011-12] and DST-PURSE for funding. AB thanks Unilever and the European Research Commission (ERC Starting Grant 2013) for funding. MSS thanks UGC-BSR for research fellowship and CDM thanks Department of Science and Technology for INSPIRE fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Tel TH, 2011, EUR J MED CHEM, V46, P1874, DOI 10.1016/j.ejmech.2011.02.051; Martinez-Urbina MA, 2010, EUR J MED CHEM, V45, P1211, DOI 10.1016/j.ejmech.2009.11.049; Anusha S, 2014, RSC ADV, V4, P52181, DOI 10.1039/c4ra07839j; Bakherad M, 2008, TETRAHEDRON LETT, V49, P3819, DOI 10.1016/j.tetlet.2008.03.141; Basappa, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039444; BOMAN HG, 1957, BIOCHIM BIOPHYS ACTA, V24, P619, DOI 10.1016/0006-3002(57)90256-1; Chernyak N, 2010, ANGEW CHEM INT EDIT, V49, P2743, DOI 10.1002/anie.200907291; Chioua M, 2013, EUR J ORG CHEM, V2013, P35, DOI 10.1002/ejoc.201201258; DeLano W.L., PYMOL MOL GRAPHICS S; DiMauro EF, 2006, J ORG CHEM, V71, P3959, DOI 10.1021/jo060218p; El Kazzouli S, 2011, EUR J MED CHEM, V46, P4252, DOI 10.1016/j.ejmech.2011.06.030; Fongmoon D, 2007, J BIOL CHEM, V282, P36895, DOI 10.1074/jbc.M707082200; Frisardi V, 2011, PROG LIPID RES, V50, P313, DOI 10.1016/j.plipres.2011.06.001; Gaulton A, 2012, NUCLEIC ACIDS RES, V40, pD1100, DOI 10.1093/nar/gkr777; JAYANTHI GP, 1989, TOXICON, V27, P875, DOI 10.1016/0041-0101(89)90099-8; Kamal A, 2011, EUR J MED CHEM, V46, P2427, DOI 10.1016/j.ejmech.2011.03.027; Kamal A, 2010, MEDCHEMCOMM, V1, P355, DOI 10.1039/c0md00116c; Keerthy HK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107118; Keerthy HK, 2014, J BIOL CHEM, V289, P31879, DOI 10.1074/jbc.M114.593855; Koutsoukas A, 2013, J CHEM INF MODEL, V53, P1957, DOI 10.1021/ci300435j; Koutsoukas A, 2011, J PROTEOMICS, V74, P2554, DOI 10.1016/j.jprot.2011.05.011; Kumar CA, 2007, INVEST NEW DRUG, V25, P343, DOI 10.1007/s10637-006-9033-4; Lamblin M, 2010, ADV SYNTH CATAL, V352, P33, DOI 10.1002/adsc.200900765; Marcussi S, 2007, CURR TOP MED CHEM, V7, P743, DOI 10.2174/156802607780487614; Mohan CD, 2014, J BIOL CHEM, V289, P34296, DOI 10.1074/jbc.M114.601104; Molecular Operating Environment (MOE), 2013, MOL OP ENV MOE CCGI; Naim M, 2007, J CHEM INF MODEL, V47, P122, DOI 10.1021/ci600406v; Palani T, 2012, EUR J ORG CHEM, V2012, P5038, DOI 10.1002/ejoc.201200679; Penning TD, 2003, BIOORG MED CHEM LETT, V13, P1137, DOI 10.1016/S0960-894X(03)00039-8; Petrovic N, 2001, J LIPID RES, V42, P1706; Rakesh KS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107182; Reddy BVS, 2011, TETRAHEDRON LETT, V52, P5789, DOI 10.1016/j.tetlet.2011.08.110; Sekar K, 2003, J MOL BIOL, V333, P367, DOI 10.1016/j.jmb.2003.08.032; Singh N, 2009, J MOL RECOGNIT, V22, P437, DOI 10.1002/jmr.960; Sunitha K, 2011, BASIC CLIN PHARMACOL, V109, P292, DOI 10.1111/j.1742-7843.2011.00725.x; van der Horst E, 2011, CURR TOP MED CHEM, V11, P1964, DOI 10.2174/156802611796391230	36	23	24	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0131896	10.1371/journal.pone.0131896	http://dx.doi.org/10.1371/journal.pone.0131896			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LZ	26196520	Green Submitted, Green Published, gold			2022-12-26	WOS:000358547600018
J	Setamou, M; Bartels, DW				Setamou, Mamoudou; Bartels, David W.			Living on the Edges: Spatial Niche Occupation of Asian Citrus Psyllid, Diaphorina citri Kuwayama (Hemiptera: Liviidae), in Citrus Groves	PLOS ONE			English	Article							VECTOR; TEMPERATURE; RESPONSES; PATTERNS; BIOLOGY; BEETLE	The spatial niche occupation of the Asian citrus psyllid, Diaphorina citri Kuwayama, 1908, was evaluated to determine its field colonization and food resource exploitation strategies in citrus groves. Mature grapefruit and sweet orange groves were surveyed as part of an areawide program in 2009-2010 to determine D. citri population densities and between-tree distribution. In both cultivars, significantly more psyllids were found on perimeter trees throughout the study period suggesting a strong edge effect in D. citri distribution in the groves. D. citri densities and infestation levels gradually declined from the edge to the center of grove. Higher numbers of D. citri were recorded on trees located on the east and south sides of the groves than those on the west and north sides. Citrus groves located at the outer edge of the study with at least one side non-surrounded to other citrus groves harbored significantly more D. citri than groves located within the block cluster and entirely surrounded by other groves. In detailed field studies during 2012, infestation of D. citri started from border trees in the grove where possibly one generation is completed before inner trees become infested. In addition, psyllid densities decreased significantly with increasing distance from the grove edge. Using the selection index, D citri exhibited a strong niche occupation preference for border trees.	[Setamou, Mamoudou] Texas A&M Univ, Dept Agr Agribusiness & Environm Sci, Kingsville Citrus Ctr, Weslaco, TX 78599 USA; [Bartels, David W.] USDA APHIS, Ctr Plant Hlth Sci Technol, Plant Protect Quarantine Miss Lab, Mission, TX USA	Texas A&M University System; Texas A&M University Kingsville; United States Department of Agriculture (USDA)	Setamou, M (corresponding author), Texas A&M Univ, Dept Agr Agribusiness & Environm Sci, Kingsville Citrus Ctr, Weslaco, TX 78599 USA.	mamoudou.setamou@tamuk.edu			United States Department of Agriculture, Animal and Plant Health Inspection Services, Plant Protection and Quarantine [09-8412-1047CA]	United States Department of Agriculture, Animal and Plant Health Inspection Services, Plant Protection and Quarantine	This study was supported by the United States Department of Agriculture, Animal and Plant Health Inspection Services, Plant Protection and Quarantine (09-8412-1047CA).	Alves GR, 2014, J ECON ENTOMOL, V107, P691, DOI 10.1603/EC13339; Arredondo IMJ, 2009, ABUNDANCE POPULATION; Aubert B., 1990, P 4 FAO UNDP INT AS, P133; Boina DR, 2009, ENVIRON ENTOMOL, V38, P1250, DOI 10.1603/022.038.0436; Bove JM, 2006, J PLANT PATHOL, V88, P7; COURTNEY SP, 1982, ECOL ENTOMOL, V7, P131, DOI 10.1111/j.1365-2311.1982.tb00651.x; Drapela T, 2011, EUR J ENTOMOL, V108, P609, DOI 10.14411/eje.2011.079; Flores D, 2009, SOUTHWEST ENTOMOL, V34, P1, DOI 10.3958/059.034.0101; French J. V., 2001, Subtropical Plant Science, V53, P14; Fung Yun-Chung, 2006, Formosan Entomologist, V26, P109; GOTTWALD TR, 2008, INT RES C HUANGL P O, P305; Grafton-Cardwell EE, 2013, ANNU REV ENTOMOL, V58, P413, DOI 10.1146/annurev-ento-120811-153542; Halbert SE, 2004, FLA ENTOMOL, V87, P330, DOI 10.1653/0015-4040(2004)087[0330:ACPSPA]2.0.CO;2; Hall D. G., 2011, OUTLOOKS PEST MANAG, V22, P189, DOI DOI 10.1564/22AUG11; Hall DG, 2013, ENTOMOL EXP APPL, V146, P207, DOI 10.1111/eea.12025; Hall DG, 2011, J INSECT SCI, V11, DOI 10.1673/031.011.8301; Haynes KJ, 2006, OIKOS, V113, P43, DOI 10.1111/j.0030-1299.2006.13977.x; KREBS CJ, 1999, ECOLOGICAL METHOLOGY; Manly B. F, 2004, RESOURCE SELECTION A; MURCIA C, 1995, TRENDS ECOL EVOL, V10, P58, DOI 10.1016/S0169-5347(00)88977-6; Nansen C, 2006, ENVIRON ENTOMOL, V35, P516, DOI 10.1603/0046-225X-35.2.516; Olson D, 2008, OECOLOGIA, V155, P549, DOI 10.1007/s00442-007-0933-6; Patti JM, 2010, ENVIRON ENTOMOL, V39, P618, DOI 10.1603/EN09216; Porensky LM, 2013, CONSERV BIOL, V27, P509, DOI 10.1111/cobi.12042; Ries L, 2004, ANNU REV ECOL EVOL S, V35, P491, DOI 10.1146/annurev.ecolsys.35.112202.130148; Sara SA, 2013, J INSECT SCI, V13, DOI 10.1673/031.013.3601; SAS, 2008, SAS SAS PROC GUID VE; Savage R. E., 1931, Fisheries Investigations London Ser 2, V12, P1; Setamou M, 2008, J ECON ENTOMOL, V101, P1478, DOI 10.1603/0022-0493(2008)101[1478:DPASPF]2.0.CO;2; Setamou M, 2012, J INSECT BEHAV, V25, P264, DOI 10.1007/s10905-011-9295-3; Thomas CFG, 2001, J APPL ECOL, V38, P100, DOI 10.1046/j.1365-2664.2001.00574.x; Workneh F, 2012, PLANT DIS, V96, P943, DOI 10.1094/PDIS-06-11-0480; Zar J.H., 1999, ZAR KUHR 5 2019, V4th	33	53	54	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2015	10	7							e0131917	10.1371/journal.pone.0131917	http://dx.doi.org/10.1371/journal.pone.0131917			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LN	26193111	Green Submitted, Green Published, gold			2022-12-26	WOS:000358546400017
J	Liu, SH; Chen, R; Hagedorn, CH				Liu, Shuanghu; Chen, Ren; Hagedorn, Curt H.			Tannic Acid Inhibits Hepatitis C Virus Entry into Huh7.5 Cells	PLOS ONE			English	Article							RNA REPLICATION; IN-VITRO; NEUTRALIZING ANTIBODIES; LIVER-TRANSPLANTATION; HYDROLYZABLE TANNINS; VIRAL-HEPATITIS; INFECTION; POLYPHENOLS; EXPRESSION; CULTURE	Chronic infection with the hepatitis C virus (HCV) is a cause of cirrhosis and hepatocellular carcinoma worldwide. Although antiviral therapy has dramatically improved recently, a number of patients remain untreated and some do not clear infection with treatment. Viral entry is an essential step in initiating and maintaining chronic HCV infections. One dramatic example of this is the nearly 100% infection of newly transplanted livers in patients with chronic hepatitis C. HCV entry inhibitors could play a critical role in preventing HCV infection of newly transplanted livers. Tannic acid, a polymer of gallic acid and glucose molecules, is a plant-derived polyphenol that defends some plants from insects and microbial infections. It has been shown to have a variety of biological effects, including antiviral activity, and is used as a flavoring agent in foods and beverages. In this study, we demonstrate that tannic acid is a potent inhibitor of HCV entry into Huh7.5 cells at low concentrations (IC50 5.8 mu M). It also blocks cell-to-cell spread in infectious HCV cell cultures, but does not inhibit HCV replication following infection. Moreover, experimental results indicate that tannic acid inhibits an early step of viral entry, such as the docking of HCV at the cell surface. Gallic acid, tannic acid's structural component, did not show any anti-HCV activity including inhibition of HCV entry or replication at concentrations up to 25 mu M. It is possible the tannin structure is related on the effect on HCV inhibition. Tannic acid, which is widely distributed in plants and foods, has HCV antiviral activity in cell culture at low micromolar concentrations, may provide a relative inexpensive adjuvant to direct-acting HCV antivirals and warrants future investigation.	[Liu, Shuanghu] Univ Utah, Coll Pharm, Dept Med Chem, Salt Lake City, UT 84112 USA; [Liu, Shuanghu; Chen, Ren; Hagedorn, Curt H.] Univ Utah, Dept Med, Salt Lake City, UT 84112 USA; [Hagedorn, Curt H.] Univ Arkansas Med Sci, Dept Med, Little Rock, AR 72205 USA; [Hagedorn, Curt H.] Univ Arkansas Med Sci, Genet Program, Little Rock, AR 72205 USA; [Hagedorn, Curt H.] Cent Arkansas Vet Healthcare Syst, Little Rock, AR USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences; US Department of Veterans Affairs; Veterans Health Administration (VHA); Central Arkansas Veterans Healthcare System	Hagedorn, CH (corresponding author), Univ Utah, Dept Med, Salt Lake City, UT 84112 USA.	chhagedorn@uams.edu			Guangzhou General Hospital, Guangzhou, China; National Institutes of Health [CA148068, CA176130]; NATIONAL CANCER INSTITUTE [R21CA176130, R21CA148068] Funding Source: NIH RePORTER	Guangzhou General Hospital, Guangzhou, China; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	R.C. was supported in part by a fellowship from Guangzhou General Hospital, Guangzhou, China. This work was supported in part by National Institutes of Health Grants CA148068 and CA176130 (CHH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe I, 2001, BIOCHEM BIOPH RES CO, V281, P122, DOI 10.1006/bbrc.2001.4325; Asselah T, 2011, LIVER INT, V31, P68, DOI 10.1111/j.1478-3231.2010.02411.x; Auld DS, 2009, P NATL ACAD SCI USA, V106, P3585, DOI 10.1073/pnas.0813345106; Baldick CJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001086; Bartosch B, 2003, J EXP MED, V197, P633, DOI 10.1084/jem.20021756; Bartosch B, 2010, VIRUSES, V2; Bialek Stephanie R, 2006, Clin Liver Dis, V10, P697, DOI 10.1016/j.cld.2006.08.003; Blanchard E, 2006, J VIROL, V80, P6964, DOI 10.1128/JVI.00024-06; Blight KJ, 2002, J VIROL, V76, P13001, DOI 10.1128/JVI.76.24.13001-13014.2002; Blight KJ, 2000, SCIENCE, V290, P1972, DOI 10.1126/science.290.5498.1972; BRAVO L, 1994, BRIT J NUTR, V71, P933, DOI 10.1079/BJN19940197; Calland N, 2012, HEPATOLOGY, V55, P720, DOI 10.1002/hep.24803; Chung KT, 1998, CRIT REV FOOD SCI, V38, P421, DOI 10.1080/10408699891274273; Ciesek S, 2011, HEPATOLOGY, V54, P1947, DOI 10.1002/hep.24610; Crespo G, 2012, GASTROENTEROLOGY, V142, P1373, DOI 10.1053/j.gastro.2012.02.011; DEVI MA, 1993, CANCER LETT, V69, P191, DOI 10.1016/0304-3835(93)90174-8; Di Pasquale G, 2012, GENE THER, V19, P576, DOI 10.1038/gt.2011.138; Ehrnhoefer DE, 2008, NAT STRUCT MOL BIOL, V15, P558, DOI 10.1038/nsmb.1437; Fafi-Kremer S, 2010, J EXP MED, V207, P2019, DOI 10.1084/jem.20090766; Farquhar MJ, 2011, BIOCHEM SOC T, V39, P532, DOI 10.1042/BST0390532; Fofana I, 2012, GASTROENTEROLOGY, V143, P223, DOI 10.1053/j.gastro.2012.04.006; Gin H, 1999, METABOLISM, V48, P1179, DOI 10.1016/S0026-0495(99)90135-X; GLICK Z, 1970, J NUTR, V100, P509, DOI 10.1093/jn/100.5.509; Hsu M, 2003, P NATL ACAD SCI USA, V100, P7271, DOI 10.1073/pnas.0832180100; Koide T, 1999, CANCER BIOTHER RADIO, V14, P231, DOI 10.1089/cbr.1999.14.231; Koutsoudakis G, 2006, J VIROL, V80, P5308, DOI 10.1128/JVI.02460-05; Krieger N, 2001, J VIROL, V75, P4614, DOI 10.1128/JVI.75.10.4614-4624.2001; Krieger SE, 2010, HEPATOLOGY, V51, P1144, DOI 10.1002/hep.23445; Le Bourvellec C, 2012, CRITICAL REV FOOD SC, V52; Lin LT, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-187; Liu SH, 2014, J GEN VIROL, V95, P423, DOI 10.1099/vir.0.055772-0; Liu SH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044965; Liu XQ, 2005, J NUTR, V135, P165, DOI 10.1093/jn/135.2.165; Manns MP, 2006, GUT, V55, P1350, DOI 10.1136/gut.2005.076646; Meuleman P, 2008, HEPATOLOGY, V48, P1761, DOI 10.1002/hep.22547; Meyer K, 2015, SCI REP-UK, V5, DOI 10.1038/srep09012; Okuda T, 1995, Fortschr Chem Org Naturst, V66, P1; Ono K, 2004, BIOCHIM BIOPHYS ACTA, V1690; Pan MH, 1999, EUR J PHARMACOL, V381, P171, DOI 10.1016/S0014-2999(99)00549-X; Papic N, 2012, VIRUSES-BASEL, V4, P581, DOI 10.3390/v4040581; Poordad F, 2011, NEW ENGL J MED, V364, P1195, DOI 10.1056/NEJMoa1010494; POTTER DK, 1968, J NUTR, V96, P187, DOI 10.1093/jn/96.2.187; Reed KE, 2000, CURR TOP MICROBIOL, V242, P55; SAITO I, 1990, P NATL ACAD SCI USA, V87, P6547, DOI 10.1073/pnas.87.17.6547; Sakagami H, 2000, PHYTOMEDICINE, V7, P39, DOI 10.1016/S0944-7113(00)80020-3; Sarrazin C, 2010, GASTROENTEROLOGY, V138, P447, DOI 10.1053/j.gastro.2009.11.055; SAVOLAINEN H, 1992, J APPL TOXICOL, V12, P191, DOI 10.1002/jat.2550120307; Serrano J, 2009, MOL NUTR FOOD RES, V53, pS310, DOI 10.1002/mnfr.200900039; Shepard CW, 2005, LANCET INFECT DIS, V5, P558, DOI 10.1016/S1473-3099(05)70216-4; Shiina Masaaki, 2006, Hepatology, V43, P1395, DOI 10.1002/hep.21210; TERRILL TH, 1994, BRIT J NUTR, V72, P467, DOI 10.1079/BJN19940048; Theisen LL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088062; Tikoo K, 2008, TOXICOL LETT, V177, P90, DOI 10.1016/j.toxlet.2007.12.012; Timpe JM, 2008, HEPATOLOGY, V47, P17, DOI 10.1002/hep.21959; Tsao R, 2010, NUTRIENTS, V2, P1231, DOI 10.3390/nu2121231; Uchiumi F, 1996, BIOCHEM BIOPH RES CO, V220, P411, DOI 10.1006/bbrc.1996.0419; Uchiumi F, 1998, J BIOL CHEM, V273, P12499, DOI 10.1074/jbc.273.20.12499; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; Wang CC, 2000, CANCER LETT, V149, P77, DOI 10.1016/S0304-3835(99)00344-4; Yi M, 2007, J VIROL, V81; Zeisel MB, 2013, CURR TOP MICROBIOL, V369, P87, DOI 10.1007/978-3-642-27340-7_4; Zeisel MB, 2013, J HEPATOL, V58, P375, DOI 10.1016/j.jhep.2012.09.022; Zeisel MB, 2011, J HEPATOL, V54, P566, DOI 10.1016/j.jhep.2010.10.014; Zhang XF, 2012, BIOORGAN MED CHEM, V20, P1616, DOI 10.1016/j.bmc.2011.11.040; Zhong J, 2005, P NATL ACAD SCI USA, V102, P9294, DOI 10.1073/pnas.0503596102; ZHU J, 1995, VET HUM TOXICOL, V37, P436; Zhu J, 1992, RES VET SCI, V53	67	25	28	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0131358	10.1371/journal.pone.0131358	http://dx.doi.org/10.1371/journal.pone.0131358			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RV	26186636	Green Published, Green Submitted, gold			2022-12-26	WOS:000358198700015
J	Mainka, A; Poznyakovskiy, A; Platzek, I; Fleischer, M; Sundberg, J; Murbe, D				Mainka, Alexander; Poznyakovskiy, Anton; Platzek, Ivan; Fleischer, Mario; Sundberg, Johan; Muerbe, Dirk			Lower Vocal Tract Morphologic Adjustments Are Relevant for Voice Timbre in Singing	PLOS ONE			English	Article							AREA FUNCTIONS; MRI; UPRIGHT; SUPINE; SHAPE	The vocal tract shape is crucial to voice production. Its lower part seems particularly relevant for voice timbre. This study analyzes the detailed morphology of parts of the epilaryngeal tube and the hypopharynx for the sustained German vowels /a/, /e/, /i/, /o/, and /u/ by thirteen male singer subjects who were at the beginning of their academic singing studies. Analysis was based on two different phonatory conditions: a natural, speech-like phonation and a singing phonation, like in classical singing. 3D models of the vocal tract were derived from magnetic resonance imaging and compared with long-term average spectrum analysis of audio recordings from the same subjects. Comparison of singing to the speech-like phonation, which served as reference, showed significant adjustments of the lower vocal tract: an average lowering of the larynx by 8 mm and an increase of the hypopharyngeal cross-sectional area (+21:9%) and volume (+16:8%). Changes in the analyzed epilaryngeal portion of the vocal tract were not significant. Consequently, lower larynx-to-hypopharynx area and volume ratios were found in singing compared to the speech-like phonation. All evaluated measures of the lower vocal tract varied significantly with vowel quality. Acoustically, an increase of high frequency energy in singing correlated with a wider hypopharyngeal area. The findings offer an explanation how classical male singers might succeed in producing a voice timbre with increased high frequency energy, creating a singer's formant cluster.	[Mainka, Alexander; Muerbe, Dirk] Tech Univ Dresden, Univ Hosp Carl Gustav Carus, Dept Otorhinolaryngol, Div Phoniatr & Audiol, D-01062 Dresden, Germany; [Mainka, Alexander; Muerbe, Dirk] Hsch Musik Carl Maria von Weber, Voice Res Lab, Dresden, Germany; [Poznyakovskiy, Anton; Fleischer, Mario] Tech Univ Dresden, Univ Hosp Carl Gustav Carus, Dept Otorhinolaryngol, D-01062 Dresden, Germany; [Platzek, Ivan] Tech Univ Dresden, Univ Hosp Carl Gustav Carus, Dept Radiol, D-01062 Dresden, Germany; [Sundberg, Johan] KTH CSC, Sch Comp Sci & Commun, Dept Speech Mus & Hearing, Stockholm, Sweden	Technische Universitat Dresden; Carl Gustav Carus University Hospital; Technische Universitat Dresden; Carl Gustav Carus University Hospital; Technische Universitat Dresden; Carl Gustav Carus University Hospital; Royal Institute of Technology	Mainka, A (corresponding author), Tech Univ Dresden, Univ Hosp Carl Gustav Carus, Dept Otorhinolaryngol, Div Phoniatr & Audiol, D-01062 Dresden, Germany.	alexander.mainka@uniklinikum-dresden.de	Platzek, Ivan/AAZ-8124-2020	Platzek, Ivan/0000-0002-5933-8108; Fleischer, Mario/0000-0002-6186-8298	German Research Foundation; Open Access Publication Funds of the TU Dresden	German Research Foundation(German Research Foundation (DFG)); Open Access Publication Funds of the TU Dresden	We acknowledge support by the German Research Foundation and the Open Access Publication Funds of the TU Dresden. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrade PA, 2012, J VOICE, V26, DOI 10.1016/j.jvoice.2011.10.006; Bartholomew WT, 1934, J ACOUST SOC AM, V6, P25, DOI 10.1121/1.1915685; Clement P, 2007, J VOICE, V21, P522, DOI 10.1016/j.jvoice.2006.01.005; Demolin D, 2002, CR BIOL, V325, P547, DOI 10.1016/S1631-0691(02)01458-0; DETWEILER RF, 1994, J VOICE, V8, P303, DOI 10.1016/S0892-1997(05)80278-4; Echternach M, 2014, J VOICE, V28; Echternach M, 2011, J ACOUST SOC AM, V129, P3955, DOI 10.1121/1.3589249; Echternach M, 2010, J VOICE, V24, P133, DOI 10.1016/j.jvoice.2008.06.004; Fant G., 1960, ACOUSTIC THEORY SPEE; Fleischer M, 2014, BIOMECH MODEL MECHAN; HAMMARBERG B, 1980, ACTA OTO-LARYNGOL, V90, P441, DOI 10.3109/00016488009131746; Helmholtz H, 1896, LEHRE TONEMPFINDUNGE; INGARD U, 1953, J ACOUST SOC AM, V25, P1037, DOI 10.1121/1.1907235; Kitamura T, 2005, ACOUST SCI TECHNOL, V26, P16, DOI 10.1250/ast.26.16; Kitamura T, 2005, ACOUST SCI TECHNOL, V26, P465, DOI 10.1250/ast.26.465; Nordenberg Maria, 2004, Logoped Phoniatr Vocol, V29, P183, DOI 10.1080/14015430410004689; Omori K, 1996, J VOICE, V10, P228, DOI 10.1016/S0892-1997(96)80003-8; Poznyakovskiy AA, 2008, HEARING RES, V243, P95, DOI 10.1016/j.heares.2008.06.008; Poznyakovskiy AA, 2011, HEARING RES, V282, P25, DOI 10.1016/j.heares.2011.06.009; Roers F, 2009, J VOICE, V23, P408, DOI 10.1016/j.jvoice.2007.12.003; SHIPP T, 1975, J ACOUST SOC AM, V58, P1104, DOI 10.1121/1.380776; Story BH, 1996, J ACOUST SOC AM, V100, P537, DOI 10.1121/1.415960; Story BH, 2001, J ACOUST SOC AM, V109, P1651, DOI 10.1121/1.1352085; SUNDBERG J, 1974, J ACOUST SOC AM, V55, P838, DOI 10.1121/1.1914609; Takemoto H, 2006, J ACOUST SOC AM, V119, P1037, DOI 10.1121/1.2151823; Takemoto H, 2006, J ACOUST SOC AM, V120, P2228, DOI 10.1121/1.2261270; Titze IR, 1997, J ACOUST SOC AM, V101, P2234, DOI 10.1121/1.418246; Traser L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112405; Traser L, 2013, J VOICE, V27, P141, DOI 10.1016/j.jvoice.2012.11.002; Vennard W., 1967, SINGING MECH TECHNIC; [No title captured]	31	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0132241	10.1371/journal.pone.0132241	http://dx.doi.org/10.1371/journal.pone.0132241			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RV	26186691	gold, Green Submitted, Green Published			2022-12-26	WOS:000358198700031
J	Pailler, S; Naidoo, R; Burgess, ND; Freeman, OE; Fisher, B				Pailler, Sharon; Naidoo, Robin; Burgess, Neil D.; Freeman, Olivia E.; Fisher, Brendan			Impacts of Community-Based Natural Resource Management on Wealth, Food Security and Child Health in Tanzania	PLOS ONE			English	Article							PARTICIPATORY FOREST MANAGEMENT; DECENTRALIZATION; POVERTY; LIVELIHOODS; BENEFITS; WILDLIFE; LOCATION; REDD	Community-based natural resource management (CBNRM) is a major global strategy for enhancing conservation outcomes while also seeking to improve rural livelihoods; however, little evidence of socioeconomic outcomes exists. We present a national-level analysis that empirically estimates socioeconomic impacts of CBNRM across Tanzania, while systematically controlling for potential sources of bias. Specifically, we apply a difference-indifferences model to national-scale, cross-sectional data to estimate the impact of three different CBNRM governance regimes on wealth, food security and child health, considering differential impacts of CBNRM on wealthy and poor populations. We also explore whether or not longer-standing CBNRM efforts provide more benefits than recently-established CBNRM areas. Our results show significant improvements in household food security in CBNRM areas compared with non-CBNRM areas, but household wealth and health outcomes in children are generally not significantly different. No one CBNRM governance regime demonstrates consistently different welfare outcomes than the others. Wealthy households benefit more from CBNRM than poor households and CBNRM benefits appear to increase with longer periods of implementation. Perhaps evidence of CBNRM benefits is limited because CBNRM hasn't been around long enough to yield demonstrable outcomes. Nonetheless, achieving demonstrable benefits to rural populations will be crucial for CBNRM's future success in Tanzania.	[Pailler, Sharon] Clark Univ, Dept Econ, Worcester, MA 01610 USA; [Naidoo, Robin; Fisher, Brendan] World Wildlife Fund, Washington, DC 20037 USA; [Burgess, Neil D.] UNEP, World Conservat Monitoring Ctr, Cambridge, England; [Burgess, Neil D.] Nat Hist Museum, Ctr Macroecol Evolut & Climate, Copenhagen, Denmark; [Freeman, Olivia E.] World Agroforestry Ctr, ASB Partnership Trop Forest Margins, Nairobi, Kenya; [Fisher, Brendan] Univ Vermont, Rubenstein Sch Environm & Nat Resources, Gund Inst Ecol Econ, Burlington, VT USA	Clark University; World Wildlife Fund; CGIAR; World Agroforestry (ICRAF); University of Vermont	Pailler, S (corresponding author), Clark Univ, Dept Econ, Worcester, MA 01610 USA.	spailler@clarku.edu						Agrawal A, 2001, POLIT SOC, V29, P485, DOI 10.1177/0032329201029004002; Andam KS, 2008, P NATL ACAD SCI USA, V105, P16089, DOI 10.1073/pnas.0800437105; Andam KS, 2010, P NATL ACAD SCI USA, V107, P9996, DOI 10.1073/pnas.0914177107; Angrist JD, 2009, MOSTLY HARMLESS ECONOMETRICS: AN EMPIRICISTS COMPANION, P1; [Anonymous], TANZANIA DEMOGRAPHIC; Baird TD, 2014, ECOL SOC, V19, DOI 10.5751/ES-06184-190104; Benjaminsen TA, 2013, DEV CHANGE, V44, P1087, DOI 10.1111/dech.12055; Blomley T., 2009, PARTICIPATORY FOREST; Blomley T, 2008, ORYX, V42, P380, DOI 10.1017/S0030605308071433; Bowler DE, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/147-2458-10-456; Burgess ND, 2010, ORYX, V44, P339, DOI 10.1017/S0030605310000554; Chhatre A, 2009, P NATL ACAD SCI USA, V106, P17667, DOI 10.1073/pnas.0905308106; Danielsen F, 2013, ECOL SOC, V18, DOI 10.5751/ES-05464-180341; Ferraro PJ, 2014, P NATL ACAD SCI USA, V111, P4332, DOI 10.1073/pnas.1307712111; IFAD, 2014, INVESTING IN RURAL P; Joppa LN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008273; Kariuki PC, 2007, INTERNATIONAL LIVEST; KENNEDY E, 1992, WORLD DEV, V20, P1077, DOI 10.1016/0305-750X(92)90001-C; Kennedy P., 2003, A GUIDE TO ECONOMETR; Lund JF, 2007, PUBLIC ADMIN DEVELOP, V27, P307, DOI 10.1002/pad.467; Lund JF, 2008, WORLD DEV, V36, P2780, DOI 10.1016/j.worlddev.2008.01.014; Mackenzie CA, 2012, ECOL ECON, V76, P119, DOI 10.1016/j.ecolecon.2012.02.013; Meshack CK, 2006, AFR J ECOL, V44, P468, DOI 10.1111/j.1365-2028.2006.00659.x; Ministry of Natural Resources and Tourism (MNRT), 2012, PARTICIPATORY FOREST; Ministry of Natural Resources and Tourism (MNRT), 2009, SELECTED CASE STUDIE; Mustalahti I, 2010, SOC NATUR RESOUR, V23, P31, DOI 10.1080/08941920802213433; Naidoo R, 2011, ENVIRON RESOUR ECON, V48, P321, DOI 10.1007/s10640-010-9412-3; National Bureau of Statistics (NBS), 2002, TANZANIA POPULATION; National Bureau of Statistics (NBS) [Tanzania] and Macro International Inc, 2000, TANZANIA REPRODUCTIV; Nielsen MR, 2012, WORLD DEV, V40, P1224, DOI 10.1016/j.worlddev.2011.11.009; Ostrom E., 1990, GOVERNING THE COMMON; Persha L, 2011, SCIENCE, V331, P1606, DOI 10.1126/science.1199343; Persha L, 2009, CONSERV BIOL, V23, P1485, DOI 10.1111/j.1523-1739.2009.01276.x; Pfaff A, 2014, WORLD DEV, V55, P7, DOI 10.1016/j.worlddev.2013.01.011; Ribot JC, 2010, ENVIRON CONSERV, V37, P35, DOI 10.1017/S0376892910000329; Robinson EJZ, 2013, NAT RESOUR FORUM, V37, P141, DOI 10.1111/1477-8947.12018; Runsten L., 2013, USING SPATIAL INFORM; Rutstein S., 2004, DHS COMPARATIVE REPO; Schaafsma M., 2012, MAPPING NTFP COLLECT; Schreckenberg K, 2009, INT FOREST REV, V11, P221, DOI 10.1505/ifor.11.2.221; Sims KRE, 2010, J ENVIRON ECON MANAG, V60, P94, DOI 10.1016/j.jeem.2010.05.003; Tanzania Commission for AIDS (TACAIDS), 2005, TANZANIA HIV AIDS IN; Tanzania Commission for AIDS (TACAIDS) Zanzibar AIDS Commission (NBS) National Bureau of Statistics Office of the Chief Government Statistician (OCGS) Inc MI, 2008, TANZANIA HIV AIDS AN; Tanzania Commission for AIDS (TACAIDS) Zanzibar AIDS Commission (NBS) National Bureau of Statistics [Tanzania] Office of the Chief Government Statistician (OCGS) ICF International, 2013, TANZANIA HIV AIDS AN; Trabucco A, 2009, CGIAR CONSORT SPATIA; Treue T, 2014, INT FOREST REV, V16, P23, DOI 10.1505/146554814811031279; Vyamana VG, 2009, INT FOREST REV, V11, P293; WHO Multicentre Growth Reference Study Group, 2006, WHO CHILD GROWTH STA; World Wildlife Fund (WWF), 2014, TANZANIAS WILDLIFE M	49	38	38	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0133252	10.1371/journal.pone.0133252	http://dx.doi.org/10.1371/journal.pone.0133252			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN1RV	26186210	Green Published, Green Submitted, gold			2022-12-26	WOS:000358198700114
J	Park, EM; Lim, YS; Ahn, BY; Hwang, SB				Park, Eun-Mee; Lim, Yun-Sook; Ahn, Byung-Yoon; Hwang, Soon B.			AAM-B Interacts with Nonstructural 4B and Regulates Hepatitis C Virus Propagation	PLOS ONE			English	Article							LIPID DROPLETS; REPLICATION; PROTEIN; ORGANELLE; GENOME; TIP47	Hepatitis C virus (HCV) usurps host cellular lipid metabolism for production of infectious virus particles. Recently, we have screened a siRNA library targeting host factors that control lipid metabolism and lipid droplet (LD) formation in cell culture grown HCV (HCVcc)-infected cells. Of 10 final candidates, we selected the gene encoding AAM-B for further characterization. We showed that siRNA-mediated knockdown of AAM-B impaired HCV propagation in Jc1-infected cells. More precisely, knockdown of AAM-B abrogated production of infectious HCV particles in both Jc1 RNA electroporated cells and Jc1-infected cells. It is worth noting that knockdown of AAM-B exerted no effect on lipid droplet formation. Moreover, AAM-B interacted with nonstructural 4B (NS4B) through the C-terminal region of NS4B. Protein interplay between AAM-B and NS4B was verified in the context of HCV replication. Using either transient or stable expression of AAM-B, we verified that AAM-B colocalized with NS4B in the cytoplasm. Immunofluorescence data further showed that AAM-B might be involved in recruitment of NS4B to sites in close proximity to LDs to facilitate HCV propagation. Collectively, this study provides new insight into how HCV utilizes cellular AAM-B to facilitate viral propagation.	[Park, Eun-Mee; Lim, Yun-Sook; Hwang, Soon B.] Hallym Univ, Natl Res Lab Hepatitis C Virus, Anyang, South Korea; [Park, Eun-Mee; Lim, Yun-Sook; Hwang, Soon B.] Hallym Univ, Ilsong Inst Life Sci, Anyang, South Korea; [Ahn, Byung-Yoon] Korea Univ, Sch Sci & Biotechnol, Seoul, South Korea	Hallym University; Hallym University; Korea University	Hwang, SB (corresponding author), Hallym Univ, Natl Res Lab Hepatitis C Virus, Anyang, South Korea.	sbhwang@hallym.ac.kr			Ministry of Science, ICT and Future Planning, Korea [2012026351]; Korean Health Technology RD Project [HI13C1746]; Ministry of Health and Welfare, Korea	Ministry of Science, ICT and Future Planning, Korea; Korean Health Technology RD Project; Ministry of Health and Welfare, Korea(Ministry of Health & Welfare (MOHW), Republic of Korea)	This work was supported by Basic Science Research Program (2012026351) from the Ministry of Science, ICT and Future Planning, Korea and by the Korean Health Technology R&D Project (HI13C1746), Ministry of Health and Welfare, Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aligo J, 2009, VIROLOGY, V393, P68, DOI 10.1016/j.virol.2009.07.033; Alvisi G, 2011, RNA BIOL, V8, P258, DOI 10.4161/rna.8.2.15011; CHOO QL, 1989, SCIENCE, V244, P359, DOI 10.1126/science.2523562; Fujimoto T, 2008, HISTOCHEM CELL BIOL, V130, P263, DOI 10.1007/s00418-008-0449-0; Gouttenoire J, 2010, REV MED VIROL, V20, P117, DOI 10.1002/rmv.640; Han QX, 2013, J VIROL, V87, P7409, DOI 10.1128/JVI.03523-12; Hanafiah KM, 2013, HEPATOLOGY, V57, P1333, DOI 10.1002/hep.26141; Hugle T, 2001, VIROLOGY, V284, P70, DOI 10.1006/viro.2001.0873; Jones DM, 2009, J VIROL, V83, P2163, DOI 10.1128/JVI.01885-08; Kato T, 2006, NAT PROTOC, V1, P2334, DOI 10.1038/nprot.2006.395; Lindenbach BD, 2005, NATURE, V436, P933, DOI 10.1038/nature04077; Liu PS, 2004, J BIOL CHEM, V279, P3787, DOI 10.1074/jbc.M311945200; Martin S, 2006, NAT REV MOL CELL BIO, V7, P373, DOI 10.1038/nrm1912; Miyanari Y, 2007, NAT CELL BIOL, V9, P1089, DOI 10.1038/ncb1631; Moradpour D, 2007, NAT REV MICROBIOL, V5, P453, DOI 10.1038/nrmicro1645; Ngo HTT, 2013, J VIROL, V87, P5718, DOI 10.1128/JVI.03353-12; Nguyen LN, 2014, J VIROL, V88, P12311, DOI 10.1128/JVI.01678-14; Park CY, 2009, J BIOL CHEM, V284, P9237, DOI 10.1074/jbc.M808773200; Park EM, 2014, FEBS LETT, V588, P1813, DOI 10.1016/j.febslet.2014.03.043; Paul D, 2011, J VIROL, V85, P6963, DOI 10.1128/JVI.00502-11; Ploen D, 2013, EUR J CELL BIOL, V92, P374, DOI 10.1016/j.ejcb.2013.12.003; Ploen D, 2013, J HEPATOL, V58, P1081, DOI 10.1016/j.jhep.2013.01.022; Salloum S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003513; Vogt DA, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003302; Zehmer JK, 2008, J CELL SCI, V121, P1852, DOI 10.1242/jcs.012013; Zehmer JK, 2009, J CELL SCI, V122, P3694, DOI 10.1242/jcs.054700	26	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0132839	10.1371/journal.pone.0132839	http://dx.doi.org/10.1371/journal.pone.0132839			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RV	26185986	gold, Green Submitted, Green Published			2022-12-26	WOS:000358198700065
J	Stewart-Malone, A; Misamore, M; Wilmoth, S; Reyes, A; Wong, WH; Gross, J				Stewart-Malone, Alecia; Misamore, Michael; Wilmoth, Siri; Reyes, Alejandro; Wong, Wai Hing; Gross, Jackson			The Effect of UV-C Exposure on Larval Survival of the Dreissenid Quagga Mussel	PLOS ONE			English	Article							WESTERN UNITED-STATES; INDUCED DNA-DAMAGE; ROSTRIFORMIS-BUGENSIS; ULTRAVIOLET-RADIATION; POPULATION-STRUCTURE; GREAT-LAKES; WATER; COLONIZATION; TEMPERATURE; POLYMORPHA	The rapid spread of quagga mussels (Dreissena rostriformis bugensis) has lead to their invasion of Lake Mead, Nevada, the largest reservoir in North America and partially responsible for providing water to millions of people in the southwest. Current strategies for mitigating the growth and spread of quagga mussels primarily include physical and chemical means of removing adults within water treatment, delivery, and hydropower facilities. In the present study, germicidal ultraviolet light (UV-C) was used to target the larval stage of wild-caught quagga mussel. The lethal effect of UV-C was evaluated at four different doses, 0.0, 13.1, 26.2, and 79.6 mJ/cm(2). Tested doses were determined based on results from preliminary trials. The results demonstrate that germicidal UV-C is effective in controlling the free-swimming life history stages of larval quagga mussels.	[Stewart-Malone, Alecia; Reyes, Alejandro; Gross, Jackson] US Geol Survey, Northern Rocky Mt Sci Ctr, Bozeman, MT USA; [Misamore, Michael] Texas Christian Univ, Ft Worth, TX 76129 USA; [Wilmoth, Siri] Wilmoth Stat Consulting, Bozeman, MT USA; [Wong, Wai Hing] Univ Nevada, Las Vegas, NV 89154 USA	United States Department of the Interior; United States Geological Survey; Texas Christian University; Nevada System of Higher Education (NSHE); University of Nevada Las Vegas	Stewart-Malone, A (corresponding author), Smith Root Inc, 14014 NE Salmon Creek Ave, Vancouver, WA 98686 USA.	amalone@smith-root.com			US Bureau of Reclamation [R11PG80895]	US Bureau of Reclamation	This work was supported by the US Bureau of Reclamation (http://www.usbr.gov/) under Agreement number R11PG80895. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Wilmoth Statistical Consulting provided consultancy support and salary for authors [SW], who had a role in the study design, statistical analysis, and manuscript writing.	ASTM, 2013, E2455062013 ASTM INT, P52, DOI [10.1520/E2455-06R13, DOI 10.1520/E2455-06R13]; Benson A.J., 2013, QUAGGA ZEBRA MUSSELS, P9, DOI DOI 10.1201/B15437-6; Bolton JR, 2005, J ENVIRON ENG SCI, V4, pS27, DOI 10.1139/S04-041; Chalker-Scott L, 1994, P 4 INT ZEBR MUSS C, P162; Choi Wook Jin, 2013, Management of Biological Invasions, V4, P61, DOI 10.3391/mbi.2013.4.1.08; Claudi R, 2007, ASSESSMENT POTENTIAL; Craft CD, 2011, CSU1003 COL DIV WILD, P21; Daniels D, 2007, POWER           0915; Hader DP, 2005, MUTAT RES-FUND MOL M, V571, P221, DOI 10.1016/j.mrfmmm.2004.11.017; Heering W, 2004, IUVA NEWS, V6, P7; LaBounty JF, 2007, LAKELINE, V27, P17; Lewis DP, 1997, METHOD APPARATUS CON; Lupal M, 1993, UV OFFERS RELIABLE D; Matthews J, 2012, REPORTS ENV SCI RADB; Matthews MA, 1999, J MOLLUS STUD, V65, P317, DOI 10.1093/mollus/65.3.317; McFadden D., 1973, FRONTIERS ECONOMETRI, P105, DOI DOI 10.1108/EB028592; McMahon RF, 2011, AQUAT INVASIONS, V6, P131, DOI 10.3391/ai.2011.6.2.02; Meesters KPH, 2003, WATER RES, V37, P525, DOI 10.1016/S0043-1354(02)00354-8; MILLS EL, 1993, CAN J FISH AQUAT SCI, V50, P2305, DOI 10.1139/f93-255; Mills EL, 1996, AM ZOOL, V36, P271; Peyer SM, 2010, J EXP BIOL, V213, P2602, DOI 10.1242/jeb.042549; Peyer SM, 2009, J EXP BIOL, V212, P2026, DOI 10.1242/jeb.028688; Pimentel D, 2005, ECOL ECON, V52, P273, DOI 10.1016/j.ecolecon.2004.10.002; Prescott TH, 2014, QUAGGA ZEBRA MUSSELS, V2nd, P243; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Reef R, 2009, J EXP BIOL, V212, P2760, DOI 10.1242/jeb.031286; Rogers JD, 2010, CIVIL ENG, V80, P52, DOI 10.1061/ciegag.0000325; Rozema J, 2002, J PHOTOCH PHOTOBIO B, V66, P2, DOI 10.1016/S1011-1344(01)00269-X; Schalk S., 2005, TECHNOL APPL SVEN, V8, P32; Seaver RW, 2009, J SHELLFISH RES, V28, P625, DOI 10.2983/035.028.0327; Vanderploeg HA, 2010, J GREAT LAKES RES, V36, P50, DOI 10.1016/j.jglr.2010.04.005; Watters A, 2013, BIOFOULING, V29, P21, DOI 10.1080/08927014.2012.744825; Wong WH, 2011, AQUAT INVASIONS, V6, P125, DOI 10.3391/ai.2011.6.2.01; Wright DA, 1997, ZEBRA MUSSELS AND AQUATIC NUISANCE SPECIES, P467	34	5	5	2	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0133039	10.1371/journal.pone.0133039	http://dx.doi.org/10.1371/journal.pone.0133039			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RV	26186734	Green Submitted, Green Published, gold			2022-12-26	WOS:000358198700088
J	Bray, DJ; Walsh, TR; Noro, MG; Notman, R				Bray, David J.; Walsh, Tiffany R.; Noro, Massimo G.; Notman, Rebecca			Complete Structure of an Epithelial Keratin Dimer: Implications for Intermediate Filament Assembly	PLOS ONE			English	Article							MOLECULAR-DYNAMICS; MECHANICAL-PROPERTIES; COILED-COIL; TAIL DOMAIN; VIMENTIN; ORGANIZATION; PROTEINS; KERATODERMA; SEGMENTS; MUTATION	Keratins are cytoskeletal proteins that hierarchically arrange into filaments, starting with the dimer sub-unit. They are integral to the structural support of cells, in skin, hair and nails. In skin, keratin is thought to play a critical role in conferring the barrier properties and elasticity of skin. In general, the keratin dimer is broadly described by a tri-domain structure: a head, a central rod and a tail. As yet, no atomistic-scale picture of the entire dimer structure exists; this information is pivotal for establishing molecular-level connections between structure and function in intermediate filament proteins. The roles of the head and tail domains in facilitating keratin filament assembly and function remain as open questions. To address these, we report results of molecular dynamics simulations of the entire epithelial human K1/K10 keratin dimer. Our findings comprise: (1) the first three-dimensional structural models of the complete dimer unit, comprising of the head, rod and tail domains; (2) new insights into the chirality of the rod-domain twist gained from analysis of the full domain structure; (3) evidence for tri-subdomain partitioning in the head and tail domains; and, (4) identification of the residue characteristics that mediate non-covalent contact between the chains in the dimer. Our findings are immediately applicable to other epithelial keratins, such as K8/K18 and K5/K14, and to intermediate filament proteins in general.	[Bray, David J.; Notman, Rebecca] Univ Warwick, Dept Chem, Coventry CV4 7AL, W Midlands, England; [Bray, David J.; Notman, Rebecca] Univ Warwick, Ctr Comp Sci, Coventry CV4 7AL, W Midlands, England; [Walsh, Tiffany R.] Deakin Univ, Inst Frontier Mat, Geelong, Vic 3217, Australia; [Noro, Massimo G.] Unilever R&D Port Sunlight, Wirral, Merseyside, England	University of Warwick; University of Warwick; Deakin University; Unilever	Walsh, TR (corresponding author), Deakin Univ, Inst Frontier Mat, Geelong, Vic 3217, Australia.	tiffany.walsh@deakin.edu.au; r.notman@warwick.ac.uk	Walsh, Tiffany R/C-2667-2009; Walsh, Tiffany/ABB-9072-2020; Notman, Rebecca/C-2066-2009	Walsh, Tiffany R/0000-0002-0233-9484; Notman, Rebecca/0000-0002-9721-0375; Bray, David/0000-0002-6107-0091	Unilever RD; Royal Society University Research Fellowship; veski Innovation Fellowship	Unilever RD(Unilever); Royal Society University Research Fellowship(Royal Society of London); veski Innovation Fellowship	This work was funded by Unilever R&D. The authors gratefully acknowledge computing resource from the Centre for Scientific Computing, University of Warwick. RN was supported by a Royal Society University Research Fellowship. TRW was supported by a veski Innovation Fellowship. The Royal Society and veski had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Co-author Massimo G. Noro is employed by Unilever R&D. Unilever R&D provided support in the form of salary for author MGN, and MGN played an additional role in the study design, decision to publish and preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Aziz A, 2010, J BIOL CHEM, V285, P15278, DOI 10.1074/jbc.M109.075598; Azoia NG, 2012, PROTEINS, V80, P1409, DOI 10.1002/prot.24037; Bousquet O, 2001, J CELL BIOL, V155, P747, DOI 10.1083/jcb.200104063; Chamcheu JC, 2011, ARCH BIOCHEM BIOPHYS, V508, P123, DOI 10.1016/j.abb.2010.12.019; Chernyatina AA, 2012, J STRUCT BIOL, V177, P46, DOI 10.1016/j.jsb.2011.11.014; Chou CC, 2012, BIOMACROMOLECULES, V13, P3522, DOI 10.1021/bm301254u; Coulombe PA, 2000, TRENDS CELL BIOL, V10, P420, DOI 10.1016/S0962-8924(00)01828-6; Guharoy M, 2013, CYTOSKELETON, V70, P550, DOI 10.1002/cm.21118; HATZFELD M, 1994, J CELL SCI, V107, P1959; Hess JF, 2013, PROTEIN SCI, V22, P47, DOI 10.1002/pro.2182; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; JOKURA Y, 1995, J INVEST DERMATOL, V104, P806, DOI 10.1111/1523-1747.ep12607005; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; KIMONIS V, 1994, J INVEST DERMATOL, V103, P764, DOI 10.1111/1523-1747.ep12412771; Kirfel J, 2003, CELL MOL LIFE SCI, V60, P56, DOI 10.1007/s000180300004; Kreplak L, 2004, EXP CELL RES, V301, P77, DOI 10.1016/j.yexcr.2004.08.021; Lee CH, 2012, NAT STRUCT MOL BIOL, V19, P707, DOI 10.1038/nsmb.2330; Lee CH, 2009, J CELL BIOL, V186, P409, DOI 10.1083/jcb.200810196; Mackerell AD, 2004, J COMPUT CHEM, V25, P1400, DOI 10.1002/jcc.20065; Meier M, 2009, J MOL BIOL, V390, P245, DOI 10.1016/j.jmb.2009.04.067; Neukirch S, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.038105; Nicolet S, 2010, J STRUCT BIOL, V170, P369, DOI 10.1016/j.jsb.2010.02.012; Norlen L, 2007, EXP CELL RES, V313, P2217, DOI 10.1016/j.yexcr.2007.03.037; Pan XO, 2013, CURR OPIN CELL BIOL, V25, P47, DOI 10.1016/j.ceb.2012.10.018; Parry DAD, 2001, J BIOL CHEM, V276, P39253, DOI 10.1074/jbc.M104604200; Parry DAD, 2007, EXP CELL RES, V313, P2204, DOI 10.1016/j.yexcr.2007.04.009; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Qin Z., 2011, ADV CELL MECH, P117, DOI 10.1007/978-3-642-17590-9_4; Qin Z, 2011, J MOL MODEL, V17, P37, DOI 10.1007/s00894-010-0696-6; Qin Z, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/42/425101; Qin Z, 2010, J BIOMECH, V43, P15, DOI 10.1016/j.jbiomech.2009.09.004; Qin Z, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007294; Richardson ES, 2006, J INVEST DERMATOL, V126, P79, DOI 10.1038/sj.jid.5700025; Smith TA, 2008, J STRUCT BIOL, V162, P139, DOI 10.1016/j.jsb.2007.11.005; STEINERT PM, 1985, J BIOL CHEM, V260, P7142; STEINERT PM, 1993, J BIOL CHEM, V268, P2878; STEINERT PM, 1991, INT J BIOL MACROMOL, V13, P130, DOI 10.1016/0141-8130(91)90037-U; Straussman R, 2007, J MOL BIOL, V366, P1232, DOI 10.1016/j.jmb.2006.11.083; Strelkov SV, 2002, EMBO J, V21, P1255, DOI 10.1093/emboj/21.6.1255; Strelkov SV, 2003, BIOESSAYS, V25, P243, DOI 10.1002/bies.10246; Strelkov SV, 2002, J STRUCT BIOL, V137, P54, DOI 10.1006/jsbi.2002.4454; Strelkov SV, 2001, J MOL BIOL, V306, P773, DOI 10.1006/jmbi.2001.4442; Strnad P, 2011, J CELL SCI, V124, P4221, DOI 10.1242/jcs.089516; Szeverenyi I, 2008, HUM MUTAT, V29, P351, DOI 10.1002/humu.20652; Tanner DE, 2011, J CHEM THEORY COMPUT, V7, P3635, DOI 10.1021/ct200563j; Utiu L, 2011, CHEM PHYS LETT, V517, P86, DOI 10.1016/j.cplett.2011.10.036; Wallace L, 2012, J CELL SCI, V125, P1750, DOI 10.1242/jcs.097139	47	19	21	5	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2015	10	7							e0132706	10.1371/journal.pone.0132706	http://dx.doi.org/10.1371/journal.pone.0132706			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RQ	26181054	Green Submitted, Green Published, gold			2022-12-26	WOS:000358198200026
J	Le, QT; Blanchet, M; Seidah, NG; Labonte, P				Le, Quoc-Tuan; Blanchet, Matthieu; Seidah, Nabil G.; Labonte, Patrick			Plasma Membrane Tetraspanin CD81 Complexes with Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) and Low Density Lipoprotein Receptor (LDLR), and Its Levels Are Reduced by PCSK9	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPATITIS-C VIRUS; AUTOSOMAL-DOMINANT HYPERCHOLESTEROLEMIA; FAMILIAL HYPERCHOLESTEROLEMIA; PROXIMITY LIGATION; LIVER-REGENERATION; IN-SITU; DEGRADATION; MUTATIONS; CHOLESTEROL; MUTANTS	Proprotein convertase subtilisin/kexin type 9 (PCSK9) is an important factor in plasma cholesterol regulation through modulation of low density lipoprotein receptor (LDLR) levels. Naturally occurring mutations can lead to hyper-or hypocholesterolemia in human. Recently, we reported that PCSK9 was also able to modulate CD81 in Huh7 cells. In the present study, several gain-of-function and loss-of-function mutants as well as engineered mutants of PCSK9 were compared for their ability to modulate the cell surface expression of LDLR and CD81. Although PCSK9 gain-of-function D374Y enhanced the degradation both receptors, D374H and D129N seemed to only reduce LDLR levels. In contrast, mutations in the C-terminal hinge-cysteine-histidine-rich domain segment primarily affected the PCSK9-induced CD81 degradation. Furthermore, when C-terminally fused to an ACE2 transmembrane anchor, the secretory N-terminal catalytic or hinge-cysteine-histidine-rich domain domains of PCSK9 were able to reduce CD81 and LDLR levels. These data confirm that PCSK9 reduces CD81 levels via an intracellular pathway as reported for LDLR. Using immunocytochemistry, a proximity ligation assay, and co-immunoprecipitation, we found that the cell surface level of PCSK9 was enhanced upon overexpression of CD81 and that both PCSK9 and LDLR interact with this tetraspanin protein. Interestingly, using CHO-A7 cells lacking LDLR expression, we revealed that LDLR was not required for the degradation of CD81 by PCSK9, but its presence strengthened the PCSK9 effect.	[Le, Quoc-Tuan; Blanchet, Matthieu; Labonte, Patrick] Inst Natl Rech Sci, Inst Armand Frappier, Laval, PQ H7V 1B7, Canada; [Le, Quoc-Tuan] Vietnam Mil Med Univ, Dept Malaria Parasitol & Entomol, Hanoi 151000, Vietnam; [Seidah, Nabil G.] Clin Res Inst Montreal, Biochem Neuroendocrinol Lab, Montreal, PQ H2W 1R7, Canada	University of Quebec; Institut national de la recherche scientifique (INRS); Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal	Labonte, P (corresponding author), Inst Natl Rech Sci, Inst Armand Frappier, 531 Blvd Prairies, Laval, PQ H7V 1B7, Canada.	patrick.labonte@iaf.inrs.ca	Seidah, Nabil/I-3596-2013	Seidah, Nabil/0000-0001-6503-9342	Canadian Institutes of Health Research Operating [93792]; Leducq Foundation [13 CVD-03]	Canadian Institutes of Health Research Operating(Canadian Institutes of Health Research (CIHR)); Leducq Foundation(Leducq Foundation)	This work was supported by Canadian Institutes of Health Research Operating Grant 93792 (to P. L.) and by Leducq Foundation Grant 13 CVD-03 (to N. G. S.). The authors declare that they have no conflicts of interest with the contents of this article.	Abifadel M, 2003, NAT GENET, V34, P154, DOI 10.1038/ng1161; Abifadel M, 2012, ATHEROSCLEROSIS, V223, P394, DOI 10.1016/j.atherosclerosis.2012.04.006; Abifadel M, 2009, HUM MUTAT, V30, P520, DOI 10.1002/humu.20882; Akazawa D, 2007, J VIROL, V81, P5036, DOI 10.1128/JVI.01573-06; Albecka A, 2012, HEPATOLOGY, V55, P998, DOI 10.1002/hep.25501; Allard Delphine, 2005, Hum Mutat, V26, P497, DOI 10.1002/humu.9383; Benjannet S, 2004, J BIOL CHEM, V279, P48865, DOI 10.1074/jbc.M409699200; Benjannet S, 2006, J BIOL CHEM, V281, P30561, DOI 10.1074/jbc.M606495200; Blokzijl A, 2014, BBA-PROTEINS PROTEOM, V1844, P933, DOI 10.1016/j.bbapap.2013.07.016; Bottomley MJ, 2009, J BIOL CHEM, V284, P1313, DOI 10.1074/jbc.M808363200; Bourbon M, 2008, ATHEROSCLEROSIS, V196, P633, DOI 10.1016/j.atherosclerosis.2007.07.019; Butkinaree C, 2015, J BIOL CHEM, V290, P18609, DOI 10.1074/jbc.M115.647180; Cameron J, 2008, J INTERN MED, V263, P420, DOI 10.1111/j.1365-2796.2007.01915.x; Cameron J, 2009, ATHEROSCLEROSIS, V203, P161, DOI 10.1016/j.atherosclerosis.2008.10.007; Canuel M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064145; Cunningham D, 2007, NAT STRUCT MOL BIOL, V14, P413, DOI 10.1038/nsmb1235; Dubuc G, 2010, J LIPID RES, V51, P140, DOI 10.1194/jlr.M900273-JLR200; Evans MJ, 2007, NATURE, V446, P801, DOI 10.1038/nature05654; Fasano T, 2007, ARTERIOSCL THROM VAS, V27, P677, DOI 10.1161/01.ATV.0000255311.26383.2f; Fasano T, 2009, ATHEROSCLEROSIS, V203, P166, DOI 10.1016/j.atherosclerosis.2008.10.027; Feneant L, 2014, VIRUSES-BASEL, V6, P535, DOI 10.3390/v6020535; Fisher TS, 2007, J BIOL CHEM, V282, P20502, DOI 10.1074/jbc.M701634200; Harris HJ, 2010, J BIOL CHEM, V285, P21092, DOI 10.1074/jbc.M110.104836; Hemler ME, 2005, NAT REV MOL CELL BIO, V6, P801, DOI 10.1038/nrm1736; Homer VM, 2008, ATHEROSCLEROSIS, V196, P659, DOI 10.1016/j.atherosclerosis.2007.07.022; Horvath G, 1998, J BIOL CHEM, V273, P30537, DOI 10.1074/jbc.273.46.30537; Huang WX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029092; Kotowski IK, 2006, AM J HUM GENET, V78, P410, DOI 10.1086/500615; KRIEGER M, 1981, J MOL BIOL, V150, P167, DOI 10.1016/0022-2836(81)90447-2; Kwon HJ, 2008, P NATL ACAD SCI USA, V105, P1820, DOI 10.1073/pnas.0712064105; Labonte P, 2009, HEPATOLOGY, V50, P17, DOI 10.1002/hep.22911; Lagace TA, 2006, J CLIN INVEST, V116, P2995, DOI 10.1172/JCI29383; Leren TP, 2004, CLIN GENET, V65, P419, DOI 10.1111/j.0009-9163.2004.0238.x; LIPPINCOTTSCHWARTZ J, 1987, CELL, V49, P669, DOI 10.1016/0092-8674(87)90543-5; Lo Surdo P, 2011, EMBO REP, V12, P1300, DOI 10.1038/embor.2011.205; Maxwell KN, 2004, P NATL ACAD SCI USA, V101, P7100, DOI 10.1073/pnas.0402133101; Mayer G, 2008, J BIOL CHEM, V283, P31791, DOI 10.1074/jbc.M805971200; Miyake Y, 2008, ATHEROSCLEROSIS, V196, P29, DOI 10.1016/j.atherosclerosis.2006.12.035; Nassoury N, 2007, TRAFFIC, V8, P718, DOI 10.1111/j.1600-0854.2007.00562.x; Noguchi T, 2010, ATHEROSCLEROSIS, V210, P166, DOI 10.1016/j.atherosclerosis.2009.11.018; Pileri P, 1998, SCIENCE, V282, P938, DOI 10.1126/science.282.5390.938; Pisciotta L, 2006, ATHEROSCLEROSIS, V186, P433, DOI 10.1016/j.atherosclerosis.2005.08.015; Poirier S, 2008, J BIOL CHEM, V283, P2363, DOI 10.1074/jbc.M708098200; Poirier S, 2009, J BIOL CHEM, V284, P28856, DOI 10.1074/jbc.M109.037085; Roubtsova A, 2011, ARTERIOSCL THROM VAS, V31, P785, DOI 10.1161/ATVBAHA.110.220988; Saavedra YGL, 2012, J BIOL CHEM, V287, P43492, DOI 10.1074/jbc.M112.394023; Seidah NG, 2014, CIRC RES, V114, P1022, DOI 10.1161/CIRCRESAHA.114.301621; Seidah NG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041865; Seidah NG, 2012, NAT REV DRUG DISCOV, V11, P367, DOI 10.1038/nrd3699; Seidah NG, 2003, P NATL ACAD SCI USA, V100, P928, DOI 10.1073/pnas.0335507100; Soderberg O, 2008, METHODS, V45, P227, DOI 10.1016/j.ymeth.2008.06.014; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Strom TB, 2010, MOL GENET METAB, V101, P76, DOI 10.1016/j.ymgme.2010.05.003; Sun H, 2012, ARTERIOSCL THROM VAS, V32, P1585, DOI 10.1161/ATVBAHA.112.250043; Urban D, 2013, J AM COLL CARDIOL, V62, P1401, DOI 10.1016/j.jacc.2013.07.056; Yamamoto T, 2011, J BIOL CHEM, V286, P5464, DOI 10.1074/jbc.M110.199042; Zaid A, 2008, HEPATOLOGY, V48, P646, DOI 10.1002/hep.22354; Zhang DW, 2008, P NATL ACAD SCI USA, V105, P13045, DOI 10.1073/pnas.0806312105; Zhang DW, 2007, J BIOL CHEM, V282, P18602, DOI 10.1074/jbc.M702027200	59	17	17	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2015	290	38					23385	23400		10.1074/jbc.M115.642991	http://dx.doi.org/10.1074/jbc.M115.642991			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CR9OE	26195630	Green Published, hybrid			2022-12-26	WOS:000361685500044
J	Borschitz, T; Schlicht, S; Siegel, E; Hanke, E; von Stebut, E				Borschitz, Thomas; Schlicht, Svenja; Siegel, Ekkehard; Hanke, Eric; von Stebut, Esther			Improvement of a Clinical Score for Necrotizing Fasciitis: 'Pain Out of Proportion' and High CRP Levels Aid the Diagnosis	PLOS ONE			English	Article							LABORATORY RISK INDICATOR; SOFT-TISSUE INFECTIONS; CELL DISTRIBUTION WIDTH; INTENSIVE-CARE; LRINEC SCORE; MANAGEMENT; POPULATION; OUTCOMES; UNIT	Necrotizing fasciitis (NF) is a rare mono-/polymicrobial skin infection that spreads to underlying tissues. NF is quickly progressing and leads to life threatening situations. Immediate surgical debridement together with i.v. antibiotic administration is required to avoid fatal outcome. Early diagnosis is often delayed due to underestimation or confusion with cellulitis. We now compared the initial clinical and laboratory presentation of NF and cellulitis in detail to assess if a typical pattern can be identified that aids timely diagnosis of NF and avoidance of fatal outcome. 138 different clinical and laboratory features of 29 NF patients were compared to those of 59 age-and gender matched patients with severe erysipelas requiring a subsequent hospitalization time of >= 10 days. Differences in clinical presentation were not obvious; however, NF patients suffered significantly more often from strong pain. NF patients exhibited dramatically elevated CRP levels (5-fold, p>0.001). The overall laboratory risk indicator for necrotizing fasciitis (LRINEC) score was significantly higher in NF patients as compared to cellulitis. However, a modification of the score (alteration of laboratory parameters, addition of clinical parameters) led to a clear improvement of the score with a higher positive predictive value without losing specificity. In summary, clinical differentiation of NF from cellulitis appears to be hard. 'Pain out of proportion' may be an early sign for NF. An improvement of the LRINEC score emphasizing only relevant laboratory and clinical findings as suggested may aid the early diagnosis of NF in the future leading to improvement of disease outcome by enabling rapid adequate therapy.	[Borschitz, Thomas] Ctr Coloproctol Surg, Mainz, Germany; [Schlicht, Svenja; von Stebut, Esther] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Dermatol, D-55122 Mainz, Germany; [Siegel, Ekkehard] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Inst Med Microbiol, D-55122 Mainz, Germany; [Hanke, Eric] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Traumatol Orthoped, D-55122 Mainz, Germany	Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz	von Stebut, E (corresponding author), Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Dermatol, D-55122 Mainz, Germany.	vonstebu@mail.uni-mainz.de						[Anonymous], 2014, CURR PROB SURG, V51, P344, DOI 10.1067/j.cpsurg.2014.06.001; Bennett M, 2008, ANZ J SURG, V78, P947, DOI 10.1111/j.1445-2197.2008.04710.x; Bozkurt O, 2015, INT UROL NEPHROL, V47, P243, DOI 10.1007/s11255-014-0897-5; Bucca K, 2013, ANZ J SURG, V83, P365, DOI 10.1111/j.1445-2197.2012.06251.x; Corbin V, 2010, ANN DERMATOL VENER, V137, P5, DOI 10.1016/j.annder.2009.12.002; Glass GE, 2015, ANN ROY COLL SURG, V97, P46, DOI 10.1308/003588414X14055925058553; Goh T, 2014, BRIT J SURG, V101, pE119, DOI 10.1002/bjs.9371; Gundeslioglu AO, 2014, ANN PLAS SURG, V73, P202, DOI 10.1097/SAP.0b013e31826cadb7; Hodgins N, 2015, J PLAST RECONSTR AES, V68, P304, DOI 10.1016/j.bjps.2014.11.003; Holland MJ, 2009, ANAESTH INTENS CARE, V37, P588, DOI 10.1177/0310057X0903700416; Kaul R, 1997, AM J MED, V103, P18, DOI 10.1016/S0002-9343(97)00160-5; Lancerotto L, 2012, J TRAUMA ACUTE CARE, V72, P560, DOI 10.1097/TA.0b013e318232a6b3; Magala John, 2014, BMC Res Notes, V7, P476, DOI 10.1186/1756-0500-7-476; Marks C, 2012, HAUTARZT, V63, P727, DOI 10.1007/s00105-012-2421-0; Murphy G, 2013, J PLAST RECONSTR AES, V66, P1712, DOI [10.1016/j.bjps.2013.07.008, 10.1016/j.bjps.013.07.008]; Pakula AM, 2012, AM SURGEON, V78, P1059; Ryssel H, 2010, ARCH ORTHOP TRAUM SU, V130, P1515, DOI 10.1007/s00402-010-1101-8; Sertoglu E, 2015, AM J EMERG MED, V33, P301, DOI 10.1016/j.ajem.2014.11.021; Shimizu T, 2010, INTERNAL MED, V49, P1051, DOI 10.2169/internalmedicine.49.2964; Stevens DL, 2014, CLIN INFECT DIS, V59, pE10, DOI [10.1093/cid/ciu296, 10.1093/cid/ciu444]; Sturgeon JP, 2014, PEDIAT EMERG CARE, DOI 10.1097; Su YC, 2008, ANZ J SURG, V78, P968, DOI 10.1111/j.1445-2197.2008.04713.x; Sugihara T, 2012, BJU INT, V110, pE1096, DOI 10.1111/j.1464-410X.2012.11291.x; Thomas AJ, 2012, LARYNGOSCOPE, V122, P2683, DOI 10.1002/lary.23680; Tsitsilonis S, 2013, LANGENBECK ARCH SURG, V398, P153, DOI 10.1007/s00423-012-0983-z; Waldron C, 2014, SURGEON, DOI 10.1016; Weng CL, 2014, AM J EMERG MED, V32, P1259, DOI 10.1016/j.ajem.2014.08.001; Wong CH, 2004, CRIT CARE MED, V32, P1535, DOI 10.1097/01.CCM.0000129486.35458.7D; Yahav D, 2014, INT J INFECT DIS, V28, P13, DOI 10.1016/j.ijid.2014.05.024	29	49	56	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0132775	10.1371/journal.pone.0132775	http://dx.doi.org/10.1371/journal.pone.0132775			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LZ	26196941	gold, Green Submitted, Green Published			2022-12-26	WOS:000358547600050
J	Ryu, S; Han, HM; Song, PI; Armstrong, CA; Park, Y				Ryu, Sunhyo; Han, Hyo Mi; Song, Peter I.; Armstrong, Cheryl A.; Park, Yoonkyung			Suppression of Propionibacterium acnes Infection and the Associated Inflammatory Response by the Antimicrobial Peptide P5 in Mice	PLOS ONE			English	Article							FACTOR-KAPPA-B; IN-VITRO; HUMAN KERATINOCYTES; CYTOKINE PRODUCTION; VULGARIS; SKIN; CELLS; PATHOGENESIS; ACTIVATION; EXPRESSION	The cutaneous inflammation associated with acne vulgaris is caused by the anaerobic bacterium Propionibacterium acnes through activation of the innate immune system in the skin. Current standard treatments for acne have limitations that include adverse effects and poor efficacy in many patients, making development of a more effective therapy highly desirable. In the present study, we demonstrate the protective effects of a novel customized alpha-helical cationic peptide, P5, against P. acnes-induced inflammatory responses in vitro and in vivo. Application of P5 significantly reduced expression of two inflammatory cytokines IL-8 and TNF-alpha in P. acnes-treated primary human keratinocytes, where P5 appeared to act in part by binding to bacterial lipoteichoic acid, thereby suppressing TLR2-to-NF-kappa B signaling. In addition, in a mouse model of acne vulgaris, P5 exerted both anti-inflammatory and antimicrobial effects against P. acnes, but exerted no cytotoxic effects against skin cells. These results demonstrate that P5, and perhaps other cationic antimicrobial peptides, offer the unique ability to reduce numbers P. acnes cells in the skin and to inhibit the inflammation they trigger. This suggests these peptides could potentially be used to effectively treat acne without adversely affecting the skin.	[Ryu, Sunhyo; Han, Hyo Mi; Park, Yoonkyung] Chosun Univ, Dept Biomed Sci, Gwangju, South Korea; [Song, Peter I.; Armstrong, Cheryl A.] Univ Colorado Denver, Dept Dermatol, Aurora, CO 80045 USA; [Park, Yoonkyung] Chosun Univ, Res Ctr Proteineous Mat, Gwangju, South Korea	Chosun University; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Chosun University	Armstrong, CA (corresponding author), Univ Colorado Denver, Dept Dermatol, Anschutz Med Campus, Aurora, CO 80045 USA.	Cheryl.armstrong@dhha.org; y_k_park@chosun.ac.kr			National Research Foundation of Korea (NRF) grant - Korean Government (MEST) [2011-0017532]; Global Research Laboratory (GRL) Grant [NRF-2014K1A1A2064460]	National Research Foundation of Korea (NRF) grant - Korean Government (MEST); Global Research Laboratory (GRL) Grant	This work was supported by a National Research Foundation of Korea (NRF) grant funded by the Korean Government (MEST; No. 2011-0017532) and Global Research Laboratory (GRL) Grant (NRF-2014K1A1A2064460). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aki D, 2008, GENES CELLS, V13, P199, DOI 10.1111/j.1365-2443.2007.01159.x; An HJ, 2014, INT J MOL MED, V34, P1341, DOI 10.3892/ijmm.2014.1933; Bakry OA, 2014, ANAL QUANT CYTOPATHO, V36, P100; Berridge MJ, 1998, NATURE, V395, P645, DOI 10.1038/27094; Bogdanov M, 2014, BBA-MOL CELL RES, V1843, P1475, DOI 10.1016/j.bbamcr.2013.12.007; Burkhart CG, 1999, POSTGRAD MED J, V75, P328, DOI 10.1136/pgmj.75.884.328; Charakida A, 2004, Expert Opin Drug Saf, V3, P119, DOI 10.1517/14740338.3.2.119; Chun J, 2006, J IMMUNOL, V177, P1330, DOI 10.4049/jimmunol.177.2.1330; Del Rosso JQ, 2008, J DRUGS DERMATOL, V7, pS2; Denda S, 2012, EXP DERMATOL, V21, P535, DOI 10.1111/j.1600-0625.2012.01507.x; Dhawan SS, 2009, CUTIS, V83, P265; Dispenza MC, 2012, J INVEST DERMATOL, V132, P2198, DOI 10.1038/jid.2012.111; Dreno B, 2014, EUR J DERMATOL, V24, P330, DOI 10.1684/ejd.2014.2309; Fejer G, 2013, P NATL ACAD SCI USA, V110, pE2191, DOI 10.1073/pnas.1302877110; Grange PA, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000527; Guarna MM, 2006, FEMS MICROBIOL LETT, V257, P1, DOI 10.1111/j.1574-6968.2006.00156.x; Hilchie AL, 2013, NAT CHEM BIOL, V9, P761, DOI [10.1038/NCHEMBIO.1393, 10.1038/nchembio.1393]; Holland DB, 2008, FEMS MICROBIOL LETT, V279, P110, DOI 10.1111/j.1574-6968.2007.01021.x; Itoh T, 2014, ANAEROBE, V27, P56, DOI 10.1016/j.anaerobe.2014.03.006; Jeong MS, 2014, ANN DERMATOL, V26, P296, DOI 10.5021/ad.2014.26.3.296; Jeong N, 2010, BIOCHEM BIOPH RES CO, V399, P581, DOI 10.1016/j.bbrc.2010.07.118; Kang S, 2005, AM J PATHOL, V166, P1691, DOI 10.1016/S0002-9440(10)62479-0; Koreck A, 2003, DERMATOLOGY, V206, P96, DOI 10.1159/000068476; Koziel J, 2014, J IMMUNOL, V192, P5363, DOI 10.4049/jimmunol.1303062; Kurokawa I, 2009, EXP DERMATOL, V18, P821, DOI 10.1111/j.1600-0625.2009.00890.x; Lee DJ, 2003, CURR OPIN PEDIATR, V15, P405, DOI 10.1097/00008480-200308000-00009; Lee WR, 2014, J INVEST DERMATOL, V134, P1922, DOI 10.1038/jid.2014.75; Liu J, 2014, GENOME ANNOUNCEMENTS, V2, DOI 10.1128/genomeA.00740-14; Liu X, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003480; Masera RG, 1996, REGUL PEPTIDES, V62, P13, DOI 10.1016/0167-0115(95)00150-6; Miller CM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002212; Murillo N, 2013, FUTURE MICROBIOL, V8, P209, DOI [10.2217/FMB.12.141, 10.2217/fmb.12.141]; Nagaoka I, 2001, J IMMUNOL, V167, P3329, DOI 10.4049/jimmunol.167.6.3329; Nakase K, 2014, J MED MICROBIOL, V63, P721, DOI 10.1099/jmm.0.067611-0; Nguyen LT, 2011, TRENDS BIOTECHNOL, V29, P464, DOI 10.1016/j.tibtech.2011.05.001; Niyonsaba F, 2013, J LEUKOCYTE BIOL, V94, P159, DOI 10.1189/jlb.1012497; Park Y, 2006, BBA-PROTEINS PROTEOM, V1764, P24, DOI 10.1016/j.bbapap.2005.10.019; Park Y, 2003, BBA-PROTEINS PROTEOM, V1645, P172, DOI 10.1016/S1570-9639(02)00541-1; Pickert A, 2009, EXPERT OPIN PHARMACO, V10, P1515, DOI 10.1517/14656560903002097; Pretsch A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097929; Ryu S, 2014, BRIT J DERMATOL, V171, P1358, DOI 10.1111/bjd.13480; Ryu S, 2011, J INVEST DERMATOL, V131, P1677, DOI 10.1038/jid.2011.112; Song PI, 2002, J INVEST DERMATOL, V119, P424, DOI 10.1046/j.1523-1747.2002.01847.x; STEINER H, 1981, NATURE, V292, P246, DOI 10.1038/292246a0; Stotland M, 2009, AM J CLIN DERMATOL, V10, P221, DOI 10.2165/00128071-200910040-00002; Thiboutot DM, 2014, J INVEST DERMATOL, V134, P595, DOI 10.1038/jid.2013.528; TORCZYNSKI RM, 1985, DNA-J MOLEC CELL BIO, V4, P283, DOI 10.1089/dna.1985.4.283; Toyoda Masahiko, 2001, Medical Electron Microscopy, V34, P29, DOI 10.1007/s007950100002; de Sousa ICVD, 2014, EXPERT OPIN INV DRUG, V23, P1389, DOI 10.1517/13543784.2014.923401; Yang DR, 2009, BIOMATERIALS, V30, P6035, DOI 10.1016/j.biomaterials.2009.07.033; ZASLOFF M, 1987, P NATL ACAD SCI USA, V84, P5449, DOI 10.1073/pnas.84.15.5449; Zhou XY, 2006, J BIOL CHEM, V281, P31337, DOI 10.1074/jbc.M602739200	52	30	32	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0132619	10.1371/journal.pone.0132619	http://dx.doi.org/10.1371/journal.pone.0132619			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LZ	26197393	Green Published, Green Submitted, gold			2022-12-26	WOS:000358547600043
J	Vallez, N; Deniz, O; Bueno, G				Vallez, Noelia; Deniz, Oscar; Bueno, Gloria			Sample Selection for Training Cascade Detectors	PLOS ONE			English	Article							DENSITY CLASSIFICATION; PARTIAL AREA; RECOGNITION	Automatic detection systems usually require large and representative training datasets in order to obtain good detection and false positive rates. Training datasets are such that the positive set has few samples and/or the negative set should represent anything except the object of interest. In this respect, the negative set typically contains orders of magnitude more images than the positive set. However, imbalanced training databases lead to biased classifiers. In this paper, we focus our attention on a negative sample selection method to properly balance the training data for cascade detectors. The method is based on the selection of the most informative false positive samples generated in one stage to feed the next stage. The results show that the proposed cascade detector with sample selection obtains on average better partial AUC and smaller standard deviation than the other compared cascade detectors.	[Vallez, Noelia; Deniz, Oscar; Bueno, Gloria] Univ Castilla La Mancha, ETSI Ind, VISILAB Grp, E-13071 Ciudad Real, Spain	Universidad de Castilla-La Mancha	Vallez, N (corresponding author), Univ Castilla La Mancha, ETSI Ind, VISILAB Grp, E-13071 Ciudad Real, Spain.	Noelia.Vallez@uclm.es	Vallez, Noelia/L-3106-2015; Bueno, Gloria/K-6286-2014	Vallez, Noelia/0000-0002-5092-8275; Bueno, Gloria/0000-0002-7345-4869; Deniz, Oscar/0000-0002-0841-4131	Spanish Ministry for Economy and Competitiveness/European Regional Development Fund [TIN2011-24367]; European Union's Horizon Research and Innovation Programme [643924]	Spanish Ministry for Economy and Competitiveness/European Regional Development Fund; European Union's Horizon Research and Innovation Programme	This work was supported by Spanish Ministry for Economy and Competitiveness/European Regional Development Fund through project TIN2011-24367 and European Union's Horizon 2020 Research and Innovation Programme under grant agreement No. 643924. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bourdev L, 2005, PROC CVPR IEEE, P236, DOI 10.1109/cvpr.2005.310; Bueno G, 2011, INT J COMPUT ASS RAD, V6, P309, DOI 10.1007/s11548-010-0510-z; CARPENTER SE, 1991, ANAL CHIM ACTA, V249, P305, DOI 10.1016/S0003-2670(00)83002-0; Chen YT, 2007, LECT NOTES COMPUT SC, V4843, P905; Cheng WC, 2011, IEEE SYS MAN CYBERN, P1430, DOI 10.1109/ICSMC.2011.6083870; Dalal N, 2005, PROC CVPR IEEE, P886, DOI 10.1109/cvpr.2005.177; Deng Y, 2006, INT J INFORM TECHNOL, P108; Dodd LE, 2003, BIOMETRICS, V59, P614, DOI 10.1111/1541-0420.00071; Dundar M., 2007, P IEEE C COMP VIS PA, P1; Eberhart R., 1995, P 6 INT S MICR MACH, P39; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; Gan B, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/420856; Ganganwar V, 2012, INT J EMERGING TECHN, V2, P2250; Grossmann E, 2004, LECT NOTES COMPUT SC, V3138, P983; HARALICK RM, 1987, IEEE T PATTERN ANAL, V9, P532, DOI 10.1109/TPAMI.1987.4767941; Ji RR, 2014, IEEE T IMAGE PROCESS, V23, P3099, DOI 10.1109/TIP.2014.2324291; Ji RR, 2014, IEEE T GEOSCI REMOTE, V52, P1811, DOI 10.1109/TGRS.2013.2255297; Korting TS, 2014, REMOTE SENS-BASEL, V6, P7580, DOI 10.3390/rs6087580; Li SZ, 2015, NEUROCOMPUTING, V151, P565, DOI 10.1016/j.neucom.2014.06.086; Lienhart R, 2002, IEEE IMAGE PROC, P900; Lin C, 2014, NEUROCOMPUTING, V123, P424, DOI 10.1016/j.neucom.2013.08.004; Espinosa-Aranda JL, 2013, LECT NOTES COMPUT SC, V7824, P80, DOI 10.1007/978-3-642-37213-1_9; Ma H, 2013, STAT MED, V32, P3449, DOI 10.1002/sim.5777; Oliveira LS, 2005, INT C DOC AN REC, P570; Papageorgiou CP, 1998, SIXTH INTERNATIONAL CONFERENCE ON COMPUTER VISION, P555, DOI 10.1109/ICCV.1998.710772; Pujara J., 2011, P 8 ANN COLLABORATIO, P55, DOI [10.1145/2030376.2030383, DOI 10.1145/2030376.2030383]; Raykar V. C., 2010, P 16 ACM SIGKDD INT, P853; Saberian M, 2014, J MACH LEARN RES, V15, P2569; Schapire RE, 1999, IJCAI-99: PROCEEDINGS OF THE SIXTEENTH INTERNATIONAL JOINT CONFERENCE ON ARTIFICIAL INTELLIGENCE, VOLS 1 & 2, P1401; Schapire RE, 1998, P 21 ANN INT C RES D, V14, P771; Serrano I, 2015, PLOS ONE, V10; Sochman J, 2004, INT C PATT RECOG, P236, DOI 10.1109/ICPR.2004.1334067; Su SZ, 2015, SIGNAL PROCESS, V112, P43, DOI 10.1016/j.sigpro.2014.11.003; Vallez N, 2014, COMPUT METH PROG BIO, V113, P569, DOI 10.1016/j.cmpb.2013.10.004; Viola P, 2001, PROC CVPR IEEE, P511, DOI 10.1109/cvpr.2001.990517; Walter SD, 2005, STAT MED, V24, P2025, DOI 10.1002/sim.2103; Webb G., 2011, ENCY MACHINE LEARNIN, P262, DOI [10.1007/978-0-387-30164-8_202, DOI 10.1007/978-0-387-30164-8_202]; Wei LY, 2014, IEEE ACM T COMPUT BI, V11, P192, DOI 10.1109/TCBB.2013.146; Zhang C, 2010, BOOSTING BASED FACE; Zhang LM, 2014, IEEE T MULTIMEDIA, V16, P470, DOI 10.1109/TMM.2013.2293424; Zhang Y., 2015, NEURAL PROCESS LETT, P1; Zou Q, 2013, BIOMED RES INT, V2013, DOI [10.1155/2013/686090, 10.1155/2013/608430]	42	7	7	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0133059	10.1371/journal.pone.0133059	http://dx.doi.org/10.1371/journal.pone.0133059			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LZ	26197221	Green Published, gold, Green Submitted			2022-12-26	WOS:000358547600062
J	Crisponi, G; Nurchi, VM; Crespo-Alonso, M; Sanna, G; Zoroddu, MA; Alberti, G; Biesuz, R				Crisponi, Guido; Nurchi, Valeria Marina; Crespo-Alonso, Miriam; Sanna, Gavino; Zoroddu, Maria Antonietta; Alberti, Giancarla; Biesuz, Raffaela			A Speciation Study on the Perturbing Effects of Iron Chelators on the Homeostasis of Essential Metal Ions	PLOS ONE			English	Article							DESFERRIOXAMINE B; COMPLEX-FORMATION; ZINC; DEFERIPRONE; THALASSEMIA; EQUILIBRIA; COPPER(II); IRON(III); ELEMENTS; THERAPY	A number of reports have appeared in literature calling attention to the depletion of essential metal ions during chelation therapy on beta-thalassaemia patients. We present a speciation study to determine how the iron chelators used in therapy interfere with the homeostatic equilibria of essential metal ions. This work includes a thorough analysis of the pharmacokinetic properties of the chelating agents currently in clinical use, of the amounts of iron, copper and zinc available in plasma for chelation, and of all the implied complex formation constants. The results of the study show that a significant amount of essential metal ions is complexed whenever the chelating agent concentration exceeds the amount necessary to coordinate all disposable iron-a frequently occurring situation during chelation therapy. On the contrary, copper and zinc do not interfere with iron chelation, except for a possible influence of copper on iron speciation during deferiprone treatment.	[Crisponi, Guido; Nurchi, Valeria Marina; Crespo-Alonso, Miriam] Univ Cagliari, Dipartimento Sci Chim & Geol, Cagliari, Italy; [Sanna, Gavino; Zoroddu, Maria Antonietta] Univ Sassari, Dipartimento Chim & Farm, I-07100 Sassari, Italy; [Alberti, Giancarla; Biesuz, Raffaela] Univ Pavia, Dipartmento Chim, I-27100 Pavia, Italy	University of Cagliari; University of Sassari; University of Pavia	Crisponi, G (corresponding author), Univ Cagliari, Dipartimento Sci Chim & Geol, Cagliari, Italy.	crisponi@unica.it	Sanna, Gavino/C-8787-2011; Crisponi, Guido/AAM-5076-2021; Alberti, Giancarla/P-5736-2018; Nurchi, Valeria Marina/E-6216-2013	Sanna, Gavino/0000-0001-9572-4041; Crisponi, Guido/0000-0002-3902-0231; Alberti, Giancarla/0000-0003-4106-2219; Nurchi, Valeria Marina/0000-0002-4004-1988; Biesuz, Raffaela/0000-0002-2192-5032	Regione Sardegna "Integrated approach in the design of metal chelators for human diseases";  [CRP-26712]	Regione Sardegna "Integrated approach in the design of metal chelators for human diseases"; 	This study was supported by the Regione Sardegna "Integrated approach in the design of metal chelators for human diseases" and by VMN and MAZ for the project "CRP-26712".	Alderighi L, 1999, COORDIN CHEM REV, V184, P311, DOI 10.1016/S0010-8545(98)00260-4; ALLAIN P, 1991, BRIT J CLIN PHARMACO, V31, P347, DOI 10.1111/j.1365-2125.1991.tb05541.x; ALREFAIE FN, 1994, J CLIN PATHOL, V47, P657, DOI 10.1136/jcp.47.7.657; Alshatwi AA, 2006, PAKISTAN J NUTR, V5, P429; [Anonymous], 1994, ICRP PUBL, V23; Beardmore J, 2009, J INORG BIOCHEM, V103, P205, DOI 10.1016/j.jinorgbio.2008.10.003; Cappellini M.D., 2014, TIF PUBLICATION, V20; CHISOLM JJ, 1985, J PHARMACOL EXP THER, V235, P665; Cooper GJS, 2005, DIABETES, V54, P1468, DOI 10.2337/diabetes.54.5.1468; Crisponi G, 2012, CURR MED CHEM, V19, P2794, DOI 10.2174/092986712800609742; Crisponi G, 2014, THALASS REP, V4, P13, DOI 10.4081/thal.2014.2046; Crisponi G, 2011, MONATSH CHEM, V142, P331, DOI 10.1007/s00706-011-0474-x; Erdogan E, 2013, J TRACE ELEM MED BIO, V27, P109, DOI 10.1016/j.jtemb.2012.10.002; Evans RW, 2012, BBA-GEN SUBJECTS, V1820, P282, DOI 10.1016/j.bbagen.2011.11.007; Farkas E, 1997, J INORG BIOCHEM, V65, P281, DOI 10.1016/S0162-0134(96)00144-4; Farkas E, 1999, POLYHEDRON, V18, P2391, DOI 10.1016/S0277-5387(99)00144-8; Galanello Renzo, 2007, Ther Clin Risk Manag, V3, P795; Galanello Renzo, 2008, Expert Rev Clin Pharmacol, V1, P231, DOI 10.1586/17512433.1.2.231; Gibbs RR, 1986, ORPHAN DIS ORPHAN DR; Heinz U, 1999, ANGEW CHEM INT EDIT, V38, P2568, DOI 10.1002/(SICI)1521-3773(19990903)38:17<2568::AID-ANIE2568>3.0.CO;2-C; Hider RC, 2010, ANN NY ACAD SCI, V1202, P94, DOI 10.1111/j.1749-6632.2010.05573.x; Hider RC, 1983, U.K. Patent, Patent No. [B2118176, 2118176]; Hider RC, 2010, AM J KIDNEY DIS, V55, P614, DOI 10.1053/j.ajkd.2009.10.065; Hyun TH, 2004, AM J CLIN NUTR, V80, P715; Jakusch T, 2006, J INORG BIOCHEM, V100, P1521, DOI 10.1016/j.jinorgbio.2006.05.003; Jamuar SS, 2012, THER ADV HEMATOL, V3, P299, DOI 10.1177/2040620712450252; KEBERLE H, 1964, ANN NY ACAD SCI, V119, P758; Linder MC, 1998, AM J CLIN NUTR, V67, p965S, DOI 10.1093/ajcn/67.5.965S; Lipinski CA, 2012, ADV DRUG DELIVER REV, V64, P4, DOI 10.1016/j.addr.2012.09.019; Maclean KH, 2001, BLOOD, V98, P3831, DOI 10.1182/blood.V98.13.3831; Nick H, 2003, CURR MED CHEM, V10, P1065, DOI 10.2174/0929867033457610; Nisbet-Brown E, 2003, LANCET, V361, P1597, DOI 10.1016/S0140-6736(03)13309-0; Nurchi VM, 2008, J INORG BIOCHEM, V102, P684, DOI 10.1016/j.jinorgbio.2007.10.012; Nurchi VM, 2014, J INORG BIOCHEM, V141, P132, DOI 10.1016/j.jinorgbio.2014.09.002; Nurchi VM, 2013, DALTON T, V42, P6161, DOI 10.1039/c2dt32252h; Origa R, 2005, HAEMATOLOGICA, V90, P1309; Pashalidis I., 2000, Transfusion Science, V23, P259, DOI 10.1016/S0955-3886(00)00102-8; Pettit LD, 2006, IUPAC STABILITY CONS; Powell JJ, 1999, J INORG BIOCHEM, V75, P159, DOI 10.1016/S0162-0134(99)00054-9; Steinhauser S, 2004, EUR J INORG CHEM, P4177, DOI 10.1002/ejic.200400363; Thuma PE, 1998, AM J TROP MED HYG, V58, P358, DOI 10.4269/ajtmh.1998.58.358	41	32	32	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2015	10	7							e0133050	10.1371/journal.pone.0133050	http://dx.doi.org/10.1371/journal.pone.0133050			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LN	26192307	Green Published, gold			2022-12-26	WOS:000358546400048
J	Hartman, W; Helan, M; Smelter, D; Sathish, V; Thompson, M; Pabelick, CM; Johnson, B; Prakash, YS				Hartman, William; Helan, Martin; Smelter, Dan; Sathish, Venkatachalem; Thompson, Michael; Pabelick, Christina M.; Johnson, Bruce; Prakash, Y. S.			Role of Hypoxia-Induced Brain Derived Neurotrophic Factor in Human Pulmonary Artery Smooth Muscle	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; ENDOTHELIAL-CELLS; INDUCED PROLIFERATION; INTRACELLULAR CA2+; PROTEIN EXPRESSION; TRPC EXPRESSION; FACTOR BDNF; HYPERTENSION; RECEPTOR; ACTIVATION	Background Hypoxia effects on pulmonary artery structure and function are key to diseases such as pulmonary hypertension. Recent studies suggest that growth factors called neurotrophins, particularly brain-derived neurotrophic factor (BDNF), can influence lung structure and function, and their role in the pulmonary artery warrants further investigation. In this study, we examined the effect of hypoxia on BDNF in humans, and the influence of hypoxia-enhanced BDNF expression and signaling in human pulmonary artery smooth muscle cells (PASMCs). Methods and Results 48h of 1% hypoxia enhanced BDNF and TrkB expression, as well as release of BDNF. In arteries of patients with pulmonary hypertension, BDNF expression and release was higher at baseline. In isolated PASMCs, hypoxia-induced BDNF increased intracellular Ca2+ responses to serotonin: an effect altered by HIF1 alpha inhibition or by neutralization of extracellular BDNF via chimeric TrkB-Fc. Enhanced BDNF/TrkB signaling increased PASMC survival and proliferation, and decreased apoptosis following hypoxia. Conclusions Enhanced expression and signaling of the BDNF-TrkB system in PASMCs is a potential mechanism by which hypoxia can promote changes in pulmonary artery structure and function. Accordingly, the BDNF-TrkB system could be a key player in the pathogenesis of hypoxia-induced pulmonary vascular diseases, and thus a potential target for therapy.	[Hartman, William; Smelter, Dan; Sathish, Venkatachalem; Thompson, Michael; Pabelick, Christina M.; Prakash, Y. S.] Mayo Clin, Dept Anesthesiol, Rochester, MN 55905 USA; [Sathish, Venkatachalem; Pabelick, Christina M.; Johnson, Bruce; Prakash, Y. S.] Mayo Clin, Dept Physiol & Biomed Engn, Rochester, MN 55905 USA; [Helan, Martin] St Annes Univ Hosp, Int Clin Res Ctr, Dept Cardiovasc Dis, Brno, Czech Republic; [Helan, Martin] Masaryk Univ, St Annes Univ Hosp, Dept Anesthesiol & Intens Care, Brno, Czech Republic; [Johnson, Bruce] Mayo Clin, Dept Internal Med, Div Cardiovasc Med, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic; St Anne's University Hospital Brno (FNUSA-ICRC); Masaryk University Brno; St Anne's University Hospital Brno (FNUSA-ICRC); Mayo Clinic	Hartman, W (corresponding author), Mayo Clin, Dept Anesthesiol, Rochester, MN 55905 USA.	hartman.william@mayo.edu	Helan, Martin/A-4159-2018	Helan, Martin/0000-0002-9021-4947; Prakash, Y S/0000-0002-2968-224X; venkatachalem, sathish/0000-0001-9770-8299	Foundation of Anesthesia Education and Research (FAER); American Heart Association; Flight Attendants Medical Research Institute (FAMRI); National Heart Lung and Blood Institute of the National Institutes of Health [R01 HL056470, HL088029]; European Regional Development Fund-Project FNUSA-ICRC [CZ.1.05/1.1.00/02.0123]; ICRC Human Bridge - Support of Study Stays of Czech Researchers Abroad: "Young Talent Incubator" - European Social Fund [CZ.1.07/2.3.00/20.0022]; state budget of the Czech Republic; National Science Foundation [B-179-M]; Mayo Clinic Center for Translational Science; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL088029, R01HL056470] Funding Source: NIH RePORTER	Foundation of Anesthesia Education and Research (FAER); American Heart Association(American Heart Association); Flight Attendants Medical Research Institute (FAMRI); National Heart Lung and Blood Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); European Regional Development Fund-Project FNUSA-ICRC; ICRC Human Bridge - Support of Study Stays of Czech Researchers Abroad: "Young Talent Incubator" - European Social Fund; state budget of the Czech Republic; National Science Foundation(National Science Foundation (NSF)); Mayo Clinic Center for Translational Science; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the Foundation of Anesthesia Education and Research (FAER) and an American Heart Association Grant in Aid (Hartman), the Flight Attendants Medical Research Institute (FAMRI; Sathish), the National Heart Lung and Blood Institute of the National Institutes of Health (R01 HL056470 and HL088029, Prakash), and the European Regional Development Fund-Project FNUSA-ICRC (No. CZ.1.05/1.1.00/02.0123) and ICRC Human Bridge - Support of Study Stays of Czech Researchers Abroad: "Young Talent Incubator" (reg. n. CZ.1.07/2.3.00/20.0022), which is financed by the European Social Fund and the state budget of the Czech Republic through The Education for Competitiveness Operational Program (Helan). Support for the human studies was from the National Science Foundation, B-179-M, as well as funding through the Mayo Clinic Center for Translational Science (Johnson). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abcejo AJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044343; Aravamudan B, 2012, J CELL MOL MED, V16, P812, DOI 10.1111/j.1582-4934.2011.01356.x; Araya AV, 2013, EFFECT EXERCISE CIRC; Archer SL, 2008, AM J PHYSIOL-HEART C, V294, pH570, DOI 10.1152/ajpheart.01324.2007; BARBACID M, 1995, CURR OPIN CELL BIOL, V7, P148, DOI 10.1016/0955-0674(95)80022-0; Behrens MM, 1999, MICROSC RES TECHNIQ, V45, P276, DOI 10.1002/(SICI)1097-0029(19990515/01)45:4/5<276::AID-JEMT11>3.0.CO;2-4; Bejot Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029405; Bhang SY, 2012, NEUROSCI LETT, V512, P72, DOI 10.1016/j.neulet.2012.01.012; Blum R, 2005, PHYSIOLOGY, V20, P70, DOI 10.1152/physiol.00042.2004; Cao XL, 2011, BRAIN RES, V1385, P263, DOI 10.1016/j.brainres.2011.02.016; Caporali A, 2009, PHYSIOL REV, V89, P279, DOI 10.1152/physrev.00007.2008; Chao MV, 2006, CLIN SCI, V110, P167, DOI 10.1042/CS20050163; Cho HC, 2012, NEUROSCI LETT, V519, P78, DOI 10.1016/j.neulet.2012.05.025; Costello CM, 2008, AM J PHYSIOL-LUNG C, V295, pL272, DOI 10.1152/ajplung.00358.2007; Cotman CW, 2002, EXERC SPORT SCI REV, V30, P75, DOI 10.1097/00003677-200204000-00006; Davie NJ, 2004, AM J PHYSIOL-LUNG C, V286, pL668, DOI 10.1152/ajplung.00108.2003; Frumkin LR, 2012, PHARMACOL REV, V64, P583, DOI 10.1124/pr.111.005587; Fuchs B, 2010, ADV EXP MED BIOL, V661, P187, DOI 10.1007/978-1-60761-500-2_12; Gronli J, 2006, PHARMACOL BIOCHEM BE, V85, P842, DOI 10.1016/j.pbb.2006.11.021; Helan M, 2014, J MOL CELL CARDIOL, V68, P89, DOI 10.1016/j.yjmcc.2014.01.006; Hetman M, 1999, J BIOL CHEM, V274, P22569, DOI 10.1074/jbc.274.32.22569; IP NY, 1994, ANN NEUROL, V35, pS13, DOI 10.1002/ana.410350706; Karczewska-Kupczewska M, 2012, DIABETES CARE, V35, P358, DOI 10.2337/dc11-1295; Kim H, 2004, J BIOL CHEM, V279, P33538, DOI 10.1074/jbc.M404115200; Kuhr FK, 2012, AM J PHYSIOL-HEART C, V302, pH1546, DOI 10.1152/ajpheart.00944.2011; Kwapiszewska G, 2012, AM J PATHOL, V181, P2018, DOI 10.1016/j.ajpath.2012.08.028; Liu ZH, 2007, J HUAZHONG U SCI-MED, V27, P233, DOI 10.1007/s11596-007-0304-x; Lommatzsch M, 2005, NEUROBIOL AGING, V26, P115, DOI 10.1016/j.neurobiolaging.2004.03.002; Lu WJ, 2008, AM J PHYSIOL-LUNG C, V295, pL104, DOI 10.1152/ajplung.00058.2008; Luo CX, 2010, BIOCHEM BIOPH RES CO, V397, P486, DOI 10.1016/j.bbrc.2010.05.140; Martens LK, 2007, J BIOL CHEM, V282, P14379, DOI 10.1074/jbc.M609857200; McGlothlin D, 2012, HEART FAIL CLIN, V8, P301, DOI 10.1016/j.hfc.2012.04.013; McGoon MD, 2012, EUR RESPIR REV, V21, P8, DOI 10.1183/09059180.00008211; Meuchel LW, 2011, CARDIOVASC RES, V91, P668, DOI 10.1093/cvr/cvr107; Meuchel LW, 2011, AM J PHYSIOL-LUNG C, V301, pL91, DOI 10.1152/ajplung.00320.2010; Morrell NW, 2009, J AM COLL CARDIOL, V54, pS20, DOI 10.1016/j.jacc.2009.04.018; Nakamura K, 2006, CANCER RES, V66, P4249, DOI 10.1158/0008-5472.CAN-05-2789; Okada S, 2012, ARTERIOSCL THROM VAS, V32, P1902, DOI 10.1161/ATVBAHA.112.248930; Pak O, 2007, EUR RESPIR J, V30, P364, DOI 10.1183/09031936.00128706; Pardridge William M, 2002, Curr Opin Investig Drugs, V3, P1753; Prakash YS, 2006, AM J PHYSIOL-LUNG C, V291, pL447, DOI 10.1152/ajplung.00501.2005; Prakash YS, 2009, AM J RESP CELL MOL, V41, P603, DOI 10.1165/rcmb.2008-0151OC; Prakash Ys, 2010, Expert Rev Respir Med, V4, P395, DOI 10.1586/ers.10.29; Rey S, 2010, CARDIOVASC RES, V86, P236, DOI 10.1093/cvr/cvq045; Ricci A, 2004, AM J RESP CELL MOL, V30, P12, DOI 10.1165/rcmb.2002-0110OC; Ricci A, 2000, J VASC RES, V37, P355, DOI 10.1159/000025751; Sakao S, 2010, AM J RESP CELL MOL, V43, P629, DOI 10.1165/rcmb.2009-0389TR; Sciesielski LK, 2009, ACTA PHYSIOL, V197, P253, DOI 10.1111/j.1748-1716.2009.02016.x; Shimoda LA, 2006, AM J PHYSIOL-LUNG C, V291, pL941, DOI 10.1152/ajplung.00528.2005; Shimoda LA, 2011, AM J RESP CRIT CARE, V183, P152, DOI 10.1164/rccm.201009-1393PP; Slack SE, 2005, J COMP NEUROL, V489, P59, DOI 10.1002/cne.20606; Stenmark KR, 2006, CIRC RES, V99, P675, DOI 10.1161/01.RES.0000243584.45145.3f; Stenmark KR, 2010, PEDIATR CRIT CARE ME, V11, pS85, DOI 10.1097/PCC.0b013e3181c76db3; Tajsic T, 2011, COMPR PHYSIOL, V1, P295, DOI 10.1002/cphy.c100026; Wang H, 2006, J NEUROCHEM, V96, P694, DOI 10.1111/j.1471-4159.2005.03572.x; Wang J, 2006, CIRC RES, V98, P1528, DOI 10.1161/01.RES.0000227551.68124.98; Whitman EM, 2008, AM J PHYSIOL-LUNG C, V294, pL309, DOI 10.1152/ajplung.00091.2007; Xu M, 2008, AM J PHYSIOL-HEART C, V295, pH1529, DOI 10.1152/ajpheart.00115.2008; Yi B, 2012, GENE, V492, P354, DOI 10.1016/j.gene.2011.11.010; Zhang JM, 2003, EXP NEUROL, V183, P469, DOI 10.1016/S0014-4886(03)00222-X; Zhang WM, 2003, AM J PHYSIOL-LUNG C, V285, pL680, DOI 10.1152/ajplung.00067.2003	61	13	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2015	10	7							e0129489	10.1371/journal.pone.0129489	http://dx.doi.org/10.1371/journal.pone.0129489			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LN	26192455	Green Submitted, Green Published, gold			2022-12-26	WOS:000358546400003
J	Kalvelage, T; Lavik, G; Jensen, MM; Revsbech, NP; Loscher, C; Schunck, H; Desai, DK; Hauss, H; Kiko, R; Holtappels, M; LaRoche, J; Schmitz, RA; Graco, MI; Kuypers, MMM				Kalvelage, Tim; Lavik, Gaute; Jensen, Marlene M.; Revsbech, Niels Peter; Loescher, Carolin; Schunck, Harald; Desai, Dhwani K.; Hauss, Helena; Kiko, Rainer; Holtappels, Moritz; LaRoche, Julie; Schmitz, Ruth A.; Graco, Michelle I.; Kuypers, Marcel M. M.			Aerobic Microbial Respiration In Oceanic Oxygen Minimum Zones	PLOS ONE			English	Article							ANAEROBIC AMMONIUM OXIDATION; NITROGEN LOSS; DEFICIENT CONDITIONS; NITRITE OXIDATION; ORGANIC-CARBON; WATER COLUMN; TIME-SERIES; IN-VIVO; MARINE; ANAMMOX	Oxygen minimum zones are major sites of fixed nitrogen loss in the ocean. Recent studies have highlighted the importance of anaerobic ammonium oxidation, anammox, in pelagic nitrogen removal. Sources of ammonium for the anammox reaction, however, remain controversial, as heterotrophic denitrification and alternative anaerobic pathways of organic matter remineralization cannot account for the ammonium requirements of reported anammox rates. Here, we explore the significance of microaerobic respiration as a source of ammonium during organic matter degradation in the oxygen-deficient waters off Namibia and Peru. Experiments with additions of double-labelled oxygen revealed high aerobic activity in the upper OMZs, likely controlled by surface organic matter export. Consistently observed oxygen consumption in samples retrieved throughout the lower OMZs hints at efficient exploitation of vertically and laterally advected, oxygenated waters in this zone by aerobic microorganisms. In accordance, metagenomic and metatranscriptomic analyses identified genes encoding for aerobic terminal oxidases and demonstrated their expression by diverse microbial communities, even in virtually anoxic waters. Our results suggest that microaerobic respiration is a major mode of organic matter remineralization and source of ammonium (similar to 45-100%) in the upper oxygen minimum zones, and reconcile hitherto observed mismatches between ammonium producing and consuming processes therein.	[Kalvelage, Tim; Lavik, Gaute; Jensen, Marlene M.; Holtappels, Moritz; Kuypers, Marcel M. M.] Max Planck Inst Marine Mikrobiol, Biogeochem Dept, D-28359 Bremen, Germany; [Revsbech, Niels Peter] Univ Aarhus, Dept Biol Sci, Aarhus, Denmark; [Loescher, Carolin; Schunck, Harald] Univ Kiel, Inst Gen Microbiol, Kiel, Germany; [Schunck, Harald; Desai, Dhwani K.; Hauss, Helena; Kiko, Rainer; LaRoche, Julie] GEOMAR Helmholtz Ctr Ocean Res Kiel, Kiel, Germany; [Graco, Michelle I.] Inst Mar Peru, Direcc Invest Oceanog, Lima, Peru	Max Planck Society; Aarhus University; University of Kiel; Helmholtz Association; GEOMAR Helmholtz Center for Ocean Research Kiel; Instituto del Mar del Peru	Kalvelage, T (corresponding author), Max Planck Inst Marine Mikrobiol, Biogeochem Dept, D-28359 Bremen, Germany.	tim.kalvelage@usys.ethz.ch	Löscher, Carolin/AAB-3701-2019; Hauss, Helena M/S-1718-2018; Desai, Dhwani/AAA-4237-2020; Holtappels, Moritz/ABC-7901-2020; Revsbech, Niels P/I-8040-2013	Hauss, Helena M/0000-0002-0754-3388; Desai, Dhwani/0000-0002-1447-5360; Kiko, Rainer/0000-0002-7851-9107; Jensen, Marlene Mark/0000-0002-9711-763X; Holtappels, Moritz/0000-0003-3682-1903; Loscher, Carolin/0000-0002-2044-6849; Revsbech, Niels Peter/0000-0002-2193-262X; Graco, Michelle Ivette/0000-0002-6193-3256; LaRoche, Julie/0000-0003-4809-6411; Schmitz-Streit, Ruth Anne/0000-0002-6788-0829	DFG [Sonderforschungsbereich 754]; Climate-Biogeochemistry Interactions in the Tropical Ocean; Max Planck Society; Canada Excellence Research Chair in Ocean Science and Technology; European Research Council [267233]; Danish Council for Independent Research: Natural Sciences [10-083140, 272-07-0057]	DFG(German Research Foundation (DFG)); Climate-Biogeochemistry Interactions in the Tropical Ocean; Max Planck Society(Max Planck SocietyFoundation CELLEX); Canada Excellence Research Chair in Ocean Science and Technology; European Research Council(European Research Council (ERC)European Commission); Danish Council for Independent Research: Natural Sciences(Det Frie Forskningsrad (DFF))	The authors were supported by the following funders: TK, GL, CL, HS, DKD, HH, RK, JLR, RS, MIG, MMK: DFG-funded Sonderforschungsbereich 754 "Climate-Biogeochemistry Interactions in the Tropical Ocean" (www.sfb754.de); TK, GL, MMJ, MH, MMMK: Max Planck Society (www.mpg.de); TK: Canada Excellence Research Chair in Ocean Science and Technology (http://www.cerc.gc.ca/chairholders-titulaires/wallace-eng.aspx); NPR: European Research Council (http://erc.europa.eu), grant 267233, and Danish Council for Independent Research: Natural Sciences (http://ufm.dk/en/research-and-innovation/councils-and-commissions/ the-danish-council-for-independent-research/thecouncil-1/the-danish-council-for-independentresearch- natural-sciences), grants 10-083140 and 272-07-0057. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLDREDGE AL, 1987, SCIENCE, V235, P689, DOI 10.1126/science.235.4789.689; Babbin AR, 2014, SCIENCE, V344, P406, DOI 10.1126/science.1248364; Belmar L, 2011, FEMS MICROBIOL ECOL, V78, P314, DOI 10.1111/j.1574-6941.2011.01159.x; Beman JM, 2013, ISME J, V7, P2192, DOI 10.1038/ismej.2013.96; Bertrand A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010330; Canfield DE, 2013, ENVIRON MICROBIOL, P1462; Canfield DE, 2010, SCIENCE, V330, P1375, DOI 10.1126/science.1196889; CLINE JD, 1972, LIMNOL OCEANOGR, V17, P885, DOI 10.4319/lo.1972.17.6.0885; CODISPOTI LA, 1980, J MAR RES, V38, P453; Dalsgaard T, 2003, NATURE, V422, P606, DOI 10.1038/nature01526; Dalsgaard T, 2014, MBIO, V5, DOI 10.1128/mBio.01966-14; Dalsgaard T, 2012, LIMNOL OCEANOGR, V57, P1331, DOI 10.4319/lo.2012.57.5.1331; Das A, 2005, J BACTERIOL, V187, P2020, DOI 10.1128/JB.187.6.2020-2029.2005; Dmello R, 1996, MICROBIOL-UK, V142, P755, DOI 10.1099/00221287-142-4-755; Franz J, 2012, DEEP-SEA RES PT I, V62, P20, DOI 10.1016/j.dsr.2011.12.004; Fussel J, 2012, ISME J, V6, P1200, DOI 10.1038/ismej.2011.178; Fukuda R, 1998, APPL ENVIRON MICROB, V64, P3352; Ganesh S, 2014, ISME J, V8, P187, DOI 10.1038/ismej.2013.144; Goericke R, 2000, DEEP-SEA RES PT I, V47, P1183, DOI 10.1016/S0967-0637(99)00108-9; Gruber N., 2004, OCEAN CARBON CYCLE C, VIV, P97, DOI [10.1007/978-1-4020-2087-2_4, DOI 10.1007/978-1-4020-2087-2_4]; Gundersen K, 2002, LIMNOL OCEANOGR, V47, P1525, DOI 10.4319/lo.2002.47.5.1525; Hamersley MR, 2007, LIMNOL OCEANOGR, V52, P923, DOI 10.4319/lo.2007.52.3.0923; Helly JJ, 2004, DEEP-SEA RES PT I, V51, P1159, DOI 10.1016/j.dsr.2004.03.009; Holmes RM, 1999, CAN J FISH AQUAT SCI, V56, P1801, DOI 10.1139/cjfas-56-10-1801; Holtappels M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089369; Holtappels M, 2011, LIMNOL OCEANOGR-METH, V9, P1, DOI 10.4319/lom.2011.9.1; Jensen MM, 2011, ISME J, V5, P1660, DOI 10.1038/ismej.2011.44; Kalvelage T, 2013, NAT GEOSCI, V6, P228, DOI [10.1038/ngeo1739, 10.1038/NGEO1739]; Kalvelage T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029299; Karstensen J, 2008, PROG OCEANOGR, V77, P331, DOI 10.1016/j.pocean.2007.05.009; Klawonn I, 2015, ISME J, V9, P1456, DOI 10.1038/ismej.2014.232; Kuypers MMM, 2005, P NATL ACAD SCI USA, V102, P6478, DOI 10.1073/pnas.0502088102; Lam P, 2011, BIOGEOSCIENCES, V8, P1565, DOI 10.5194/bg-8-1565-2011; Lam P, 2011, ANNU REV MAR SCI, V3, P317, DOI 10.1146/annurev-marine-120709-142814; Lam P, 2009, P NATL ACAD SCI USA, V106, P4752, DOI 10.1073/pnas.0812444106; Landolfi A, 2013, BIOGEOSCIENCES, V10, P1351, DOI 10.5194/bg-10-1351-2013; Lavin P, 2010, ENV MICROBIOL REP, V2, P728, DOI 10.1111/j.1758-2229.2010.00167.x; Levipan HA, 2007, PROG OCEANOGR, V75, P531, DOI 10.1016/j.pocean.2007.08.029; LIPSCHULTZ F, 1990, DEEP-SEA RES, V37, P1513, DOI 10.1016/0198-0149(90)90060-9; Loscher CR, 2012, BIOGEOSCIENCES, V9, P2419, DOI 10.5194/bg-9-2419-2012; Moore CM, 2013, NAT GEOSCI, V6, P701, DOI [10.1038/ngeo1765, 10.1038/NGEO1765]; Morris RL, 2013, NAT REV MICROBIOL, V11, P205, DOI 10.1038/nrmicro2970; NAQVI SWA, 1987, J MAR RES, V45, P1049, DOI 10.1357/002224087788327118; Paulmier A, 2009, BIOGEOSCIENCES, V6, P923, DOI 10.5194/bg-6-923-2009; Picheral M, 2010, LIMNOL OCEANOGR-METH, V8, P462, DOI 10.4319/lom.2010.8.462; Ploug H, 1997, AQUAT MICROB ECOL, V13, P285, DOI 10.3354/ame013285; Ploug H, 2001, LIMNOL OCEANOGR, V46, P1624, DOI 10.4319/lo.2001.46.7.1624; Preisig O, 1996, J BACTERIOL, V178, P1532, DOI 10.1128/JB.178.6.1532-1538.1996; Revsbech NP, 2009, LIMNOL OCEANOGR-METH, V7, P371, DOI 10.4319/lom.2009.7.371; Schunck H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068661; SHANKS AL, 1993, MAR ECOL PROG SER, V96, P43, DOI 10.3354/meps096043; Stewart FJ, 2012, ENVIRON MICROBIOL, V14, P23, DOI 10.1111/j.1462-2920.2010.02400.x; Stocker R, 2012, SCIENCE, V338, P628, DOI 10.1126/science.1208929; Stolper DA, 2010, P NATL ACAD SCI USA, V107, P18755, DOI 10.1073/pnas.1013435107; Strous M, 1997, APPL ENVIRON MICROB, V63, P2446, DOI 10.1128/AEM.63.6.2446-2448.1997; Su B, 2015, BIOGEOSCIENCES, V12, P1113, DOI 10.5194/bg-12-1113-2015; SUESS E, 1980, NATURE, V288, P260, DOI 10.1038/288260a0; Thamdrup B, 2012, DEEP RES 1, P65; Thamdrup B, 2006, LIMNOL OCEANOGR, V51, P2145, DOI 10.4319/lo.2006.51.5.2145; Tiano L, 2014, DEEP-SEA RES PT I, V94, P173, DOI 10.1016/j.dsr.2014.10.001; Tseng CP, 1996, J BACTERIOL, V178, P1094, DOI 10.1128/jb.178.4.1094-1098.1996; WARD BB, 1989, DEEP-SEA RES, V36, P1031, DOI 10.1016/0198-0149(89)90076-9; Ward BB, 2013, SCIENCE, V341, P352, DOI 10.1126/science.1240314; Ward BB, 2008, DEEP-SEA RES PT I, V55, P1672, DOI 10.1016/j.dsr.2008.07.005; Weiland N, 2010, METHODS MOL BIOL, V668, P51, DOI 10.1007/978-1-60761-823-2_3; Whitmire AL, 2009, OPT EXPRESS, V17, P21992, DOI 10.1364/OE.17.021992; Woebken D, 2007, APPL ENVIRON MICROB, V73, P4648, DOI 10.1128/AEM.02774-06; Wright JJ, 2012, NAT REV MICROBIOL, V10, P381, DOI 10.1038/nrmicro2778; Zumft WG, 1997, MICROBIOL MOL BIOL R, V61, P533, DOI 10.1128/.61.4.533-616.1997	69	78	79	5	84	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2015	10	7							e0133526	10.1371/journal.pone.0133526	http://dx.doi.org/10.1371/journal.pone.0133526			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LN	26192623	Green Published, Green Accepted, gold, Green Submitted			2022-12-26	WOS:000358546400098
J	Lei, WJ; Long, YJ; Li, S; Liu, Z; Zhu, FX; Hou, FF; Nie, J				Lei, Wenjing; Long, Yanjun; Li, Shuang; Liu, Ze; Zhu, Fengxin; Hou, Fan Fan; Nie, Jing			Homocysteine Induces Collagen I Expression by Downregulating Histone Methyltransferase G9a	PLOS ONE			English	Article							ENDOTHELIAL-CELL GROWTH; DNA METHYLATION; PLASMA HOMOCYSTEINE; HEMATOPOIETIC STEM; OXIDATIVE STRESS; LIVER; BETA; TRANSCRIPTION; STEATOSIS; REPRESSOR	Hyperhomocysteinemia (HHcy) leads to several clinical manifestations including hepatic fibrosis. Excess deposition of extracellular matrix (ECM) components including collagen is the eponymous lesion of liver fibrosis. In this study, we demonstrated that elevated concentration of Hcy induced the expression of collagen type I in cultured human liver cells as well as in liver tissue of HHcy mice. Meanwhile, Hcy inhibited the expression of histone methyltransferase G9a. Mechanistically, silencing endogenous G9a by siRNA enhanced the promoter activity of COL1A1 in LO2 cells. Conversely, overexpressing G9a inhibited the promoter activity of COL1A1. CHIP assay demonstrated that G9a binds to the neuron-restrictive silencer element (NRSE) on the promoter of COL1A1. Hcy treatment decreased the binding of G9a on NRSE, which in turn decreased the level of H3K9me2 on the promoter of COL1A1, led to upregulation of COL1A1. Taken together, these results provide a novel mechanism on explaining how HHcy promotes ECM production.	[Lei, Wenjing; Long, Yanjun; Li, Shuang; Liu, Ze; Zhu, Fengxin; Hou, Fan Fan; Nie, Jing] Southern Med Univ, Nanfang Hosp, Natl Clin Res Ctr Kidney Dis, Div Nephrol,State Key Lab Organ Failure Res, Guangzhou, Guangdong, Peoples R China	Southern Medical University - China	Nie, J (corresponding author), Southern Med Univ, Nanfang Hosp, Natl Clin Res Ctr Kidney Dis, Div Nephrol,State Key Lab Organ Failure Res, Guangzhou, Guangdong, Peoples R China.	niejing@smu.edu.cn			National 973 Program [2012CB517700]; Nature and Science Foundation of China [81288001]; Natural Science Foundation of Guangdong province [S2013020012748]	National 973 Program(National Basic Research Program of China); Nature and Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangdong province(National Natural Science Foundation of Guangdong Province)	National 973 Program (2012CB517700) JN. Nature and Science Foundation of China (81288001) JN. Natural Science Foundation of Guangdong province (S2013020012748) JN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bosy-Westphal A, 2001, HEPATOL RES, V20, P28, DOI 10.1016/S1386-6346(00)00119-4; Bruce AW, 2004, P NATL ACAD SCI USA, V101, P10458, DOI 10.1073/pnas.0401827101; Castro R, 2003, CLIN CHEM, V49, P1292, DOI 10.1373/49.8.1292; Chen XJ, 2012, GENE DEV, V26, P2499, DOI 10.1101/gad.200329.112; Cho MK, 2004, BIOCHEM PHARMACOL, V67, P2239, DOI 10.1016/j.bcp.2004.02.024; Covington HE, 2011, NEURON, V71, P656, DOI 10.1016/j.neuron.2011.06.007; Davison JM, 2009, J BIOL CHEM, V284, P1982, DOI 10.1074/jbc.M807651200; Diao JS, 2011, ARCH DERMATOL RES, V303, P573, DOI 10.1007/s00403-011-1140-1; Dong CF, 2012, J CLIN INVEST, V122, P1469, DOI 10.1172/JCI57349; Ebert A, 2006, CHROMOSOME RES, V14, P377, DOI 10.1007/s10577-006-1066-1; Eskeland R, 2007, MOL CELL BIOL, V27, P453, DOI 10.1128/MCB.01576-06; Fahrner JA, 2003, GENE DEV, V17, P1805, DOI 10.1101/gad.1123303; Faraci FM, 2003, ARTERIOSCL THROM VAS, V23, P371, DOI 10.1161/01.ATV.0000063607.56590.7F; Finkelstein JD, 2000, SEMIN THROMB HEMOST, V26, P219, DOI 10.1055/s-2000-8466; Garcia-Tevijano ER, 2001, HYPERTENSION, V38, P1217, DOI 10.1161/hy1101.099499; Gellekink Henkjan, 2005, Semin Vasc Med, V5, P98, DOI 10.1055/s-2005-872396; Glenisson W, 2007, BBA-MOL CELL RES, V1773, P1572, DOI 10.1016/j.bbamcr.2007.05.016; Heil SG, 2007, MOL GENET METAB, V91, P55, DOI 10.1016/j.ymgme.2007.01.008; Jakubowski H, 2000, CIRC RES, V87, P45, DOI 10.1161/01.RES.87.1.45; Jamaluddin MS, 2007, BLOOD, V110, P3648, DOI 10.1182/blood-2007-06-096701; Ji C, 2006, J HEPATOL, V45, P321, DOI 10.1016/j.jhep.2006.06.004; Keum YS, 2013, ONCOGENE, V32, P444, DOI 10.1038/onc.2012.71; Li SF, 2013, AM J PHYSIOL-ENDOC M, V304, pE990, DOI 10.1152/ajpendo.00608.2012; Liu QH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032009; Liu S, 2013, BIOL REV, V88, P40, DOI 10.1111/j.1469-185X.2012.00237.x; Liu XH, 2015, J HEMATOL ONCOL, V8, DOI 10.1186/s13045-015-0115-7; Maclean KN, 2010, MOL GENET METAB, V101, P153, DOI 10.1016/j.ymgme.2010.06.010; Maclean KN, 2010, MOL GENET METAB, V101, P163, DOI 10.1016/j.ymgme.2010.06.007; Maze I, 2010, SCIENCE, V327, P213, DOI 10.1126/science.1179438; Michalopolous G, 2015, HEPATOLOGY, V61, P32, DOI 10.1002/hep.27329; Qu Y, 2015, INT J CLIN EXP PATHO, V8, P1292; Robert K, 2005, GASTROENTEROLOGY, V128, P1405, DOI 10.1053/j.gastro.2005.02.034; Roblin X, 2007, GASTROEN CLIN BIOL, V31, P415, DOI 10.1016/S0399-8320(07)89402-4; Roopra A, 2004, MOL CELL, V14, P727, DOI 10.1016/j.molcel.2004.05.026; SCHOENHERR CJ, 1995, SCIENCE, V267, P1360, DOI 10.1126/science.7871435; Sibani S, 2002, CARCINOGENESIS, V23, P61, DOI 10.1093/carcin/23.1.61; St-Germain ME, 2004, MOL CANCER, V3, DOI 10.1186/1476-4598-3-7; Sun GD, 2010, J AM SOC NEPHROL, V21, P2069, DOI 10.1681/ASN.2010060633; Tachibana M, 2005, GENE DEV, V19, P815, DOI 10.1101/gad.1284005; Tyagi N, 2009, ANTIOXID REDOX SIGN, V11, P25, DOI 10.1089/ars.2008.2073; Wang H, 2002, BLOOD, V99, P939; Waterland RA, 2006, J NUTR, V136, p1706S, DOI 10.1093/jn/136.6.1706S; Yoshida K, 2014, INT J ONCOL, V45, P1363, DOI 10.3892/ijo.2014.2552; Yoshikawa M, 2007, J AM SOC NEPHROL, V18, P58, DOI 10.1681/ASN.2005111187; Zuccato C, 2003, NAT GENET, V35, P76, DOI 10.1038/ng1219; Zuccato C, 2007, J NEUROSCI, V27, P6972, DOI 10.1523/JNEUROSCI.4278-06.2007	46	12	15	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2015	10	7							e0130421	10.1371/journal.pone.0130421	http://dx.doi.org/10.1371/journal.pone.0130421			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LN	26192994	gold, Green Published, Green Submitted			2022-12-26	WOS:000358546400006
J	Niegowska, M; Paccagnini, D; Burrai, C; Palermo, M; Sechi, LA				Niegowska, Magdalena; Paccagnini, Daniela; Burrai, Carlo; Palermo, Mario; Sechi, Leonardo A.			Antibodies against Proinsulin and Homologous MAP Epitopes Are Detectable in Hashimoto's Thyroiditis Sardinian Patients, an Additional Link of Association	PLOS ONE			English	Article							COMPETITIVE INSULIN AUTOANTIBODIES; GLUTAMIC-ACID DECARBOXYLASE; AUTOIMMUNE-DISEASES; TRANSPORTER ZNT8; CHILDREN; EPIDEMIOLOGY; PREVALENCE; SENSITIVITY; ADOLESCENTS; DISORDERS	Hashimoto's thyroiditis (HT) is the prevailing organ-specific autoimmune disease in Sardinia, often complicated with other autoimmune disorders, most commonly type 1 diabetes (T1D). While numerous studies describe levels of anty-thyroid antibodies (Abs) in T1D patients, few papers evaluate the status of anti-islet autoimmunity in subjects affected by HT. Previously, we portrayed Mycobacteriumavium subspecies paratuberculosis (MAP) as an environmental factor strongly associated with both diseases. In this study, we analyzed plasma of Sardinian HT patients (n=177) and healthy controls (HCs; n=175) for the presence of Abs against proinsulin and MAP-derived homologous epitopes: MAP1,4 alpha gbp(157-173)/PI64-80 were recognized by 5,08% and 18,64% of HT vs 0,57% and 7,43% of HCs (AUC=0,6 for both; p<0,0003 and 0,002, respectively), whereas the prevalence of Abs against MAP2404c(70-85)/PI46-61 peptides was higher but not significant in patients when compared to HCs. In women (n=152), Abs against MAP1,4 alpha gbp(157-173) were detected in 12,50% of HT vs 2,75% of HCs (AUC=0,63; p<0,0002), while positivity to its human homolog PI64-80 was observed in 16,42% of HT vs 6,42% of HCs (AUC=0,61; p<0,001). In men (n=25), a significant anti-PI46-61 Abs levels were detected in 4% of HT vs none of the HCs (AUC=0,7; p<0,003). Age-related analyses revealed the highest prevalence between 31-40 years old (45,83%) in the total study population and among males (33,33%); in contrast, women had a higher seroreactivity between 51-60 years (42,11%). A further follow-up and determination of anti-islet Abs levels is needed to evaluate the association of immune responses directed against the MAP/PI homologous peptides with progression to overt diabetes in HT subjects.	[Niegowska, Magdalena; Paccagnini, Daniela; Sechi, Leonardo A.] Univ Sassari, Dipartimento Sci Biomed, Sez Microbiol & Virol, I-07100 Sassari, Italy; [Burrai, Carlo; Palermo, Mario] ASL 1, Dept Endocrinol, Sassari, Italy	University of Sassari	Sechi, LA (corresponding author), Univ Sassari, Dipartimento Sci Biomed, Sez Microbiol & Virol, I-07100 Sassari, Italy.	sechila@uniss.it	Sechi, Leonardo Antonio/Y-3109-2018	sechi, leonardo antonio/0000-0003-0566-2049	Sardinian Region [L.R.7 2010]; Fondazione Banco di Sardegna	Sardinian Region(Regione Sardegna); Fondazione Banco di Sardegna(Fondazione Banco di Sardegna)	This research was supported by the Sardinian Region L.R.7 2010 and Fondazione Banco di Sardegna 2014 both to LAS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aksoy DY, 2006, EXP CLIN ENDOCR DIAB, V114, P412, DOI 10.1055/s-2006-924153; BRIGHT GM, 1982, J PEDIATR-US, V100, P8, DOI 10.1016/S0022-3476(82)80227-8; Chimienti F, 2006, J CELL SCI, V119, P4199, DOI 10.1242/jcs.03164; Cooper GS, 2009, J AUTOIMMUN, V33, P197, DOI 10.1016/j.jaut.2009.09.008; Cooper GS, 2003, AUTOIMMUN REV, V2, P119, DOI 10.1016/S1568-9972(03)00006-5; Culina S, 2013, EUR J ENDOCRINOL, V168, pR19, DOI 10.1530/EJE-12-0693; DIMARIO U, 1990, ACTA ENDOCRINOL-COP, V122, P303, DOI 10.1530/acta.0.1220303; Eaton WW, 2007, J AUTOIMMUN, V29, P1, DOI 10.1016/j.jaut.2007.05.002; Fairweather D, 2008, AM J PATHOL, V173, P600, DOI 10.2353/ajpath.2008.071008; Good M, 2009, IRISH VET J, V62, P597, DOI 10.1186/2046-0481-62-9-597; HEGEWALD MJ, 1992, J IMMUNOL METHODS, V154, P61, DOI 10.1016/0022-1759(92)90213-D; HENKIN RI, 1976, MED CLIN N AM, V60, P779, DOI 10.1016/S0025-7125(16)31861-2; KAWASAKI E, 1995, J AUTOIMMUN, V8, P633, DOI 10.1006/jaut.1995.0047; Kawasaki Eiji, 2014, Clin Pediatr Endocrinol, V23, P99, DOI 10.1297/cpe.23.99; Kordonouri O, 2005, ARCH DIS CHILD, V90, P411, DOI 10.1136/adc.2004.056424; Kordonouri O, 2002, DIABETES CARE, V25, P1346, DOI 10.2337/diacare.25.8.1346; Mantovani RM, 2007, J PEDIATR ENDOCR MET, V20, P669; Masala S, 2015, PEDIATR DIABETES, V16, P189, DOI 10.1111/pedi.12269; Masala S, 2014, ACTA DIABETOL, V51, P577, DOI 10.1007/s00592-014-0558-2; Masala S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097621; Masala S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063371; Masala S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026931; Moriguchi M, 2011, METABOLISM, V60, P761, DOI 10.1016/j.metabol.2010.07.025; NUOVO JA, 1988, DIABETES, V37, P317, DOI 10.2337/diabetes.37.3.317; Rogowicz-Frontczak A, 2014, EUR J ENDOCRINOL, V170, P651, DOI 10.1530/EJE-13-0901; Rosu Valentina, 2008, Ann Clin Microbiol Antimicrob, V7, P9, DOI 10.1186/1476-0711-7-9; Sardu C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032487; Severinski S, 2009, COLLEGIUM ANTROPOL, V33, P273; Somers EC, 2006, EPIDEMIOLOGY, V17, P202, DOI 10.1097/01.ede.0000193605.93416.df; VANDERPUMP MPJ, 1995, CLIN ENDOCRINOL, V43, P55, DOI 10.1111/j.1365-2265.1995.tb01894.x; VARDI P, 1993, DIABETES RES CLIN PR, V21, P161, DOI 10.1016/0168-8227(93)90064-C; Wenzlau JM, 2007, P NATL ACAD SCI USA, V104, P17040, DOI 10.1073/pnas.0705894104; Wndell PE, 2013, CURR DIABETES REV, V9, P342, DOI 10.2174/15733998113099990064; Ziegler AG, 2012, DIABETOLOGIA, V55, P1937, DOI 10.1007/s00125-012-2472-x	34	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2015	10	7							e0133497	10.1371/journal.pone.0133497	http://dx.doi.org/10.1371/journal.pone.0133497			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LN	26192189	gold, Green Submitted, Green Published			2022-12-26	WOS:000358546400095
J	Zhang, GD; Wang, MQ; Duan, F; Yuan, K; Li, K; Yan, JY; Chang, ZF; Wang, Y				Zhang, Guodong; Wang, Maoqiang; Duan, Feng; Yuan, Kai; Li, Kai; Yan, Jieyu; Chang, Zhongfei; Wang, Yan			Radiological Findings of Prostatic Arterial Anatomy for Prostatic Arterial Embolization: Preliminary Study in 55 Chinese Patients with Benign Prostatic Hyperplasia	PLOS ONE			English	Article							CONE-BEAM CT	Objective To describe the prostatic arterial supply using Cone-beam computed tomography (CT) and digital subtraction angiography (DSA) before prostatic arterial embolization (PAE) for benign prostatic hyperplasia (BPH). Methods In a retrospective study from January 2012 to January 2014, 55 male patients (110 hemipelves) with BPH who underwent PAE were evaluated by Cone-beam CT in addition to pelvic DSA during embolization planning. Each hemipelvis was evaluated regarding the number of prostatic arteries (PA) and their origins, diameters, territorial perfusion, and anastomoses with adjacent arteries. Results A total of 114 PAs were identified in 110 hemipelves. There was one PA in 96.4% of the hemipelves (n=106), and two independent PAs in the other 3.6% (n=4). The PA was found to originate from the anterior trunk of the internal iliac artery in 39.5% of cases (n=45), from the superior vesical artery in 32.6%(n=37), and from the internal pudendal artery in 27.9% of cases (n=32). Extra-prostatic anastomoses between PA and adjacent arteries were found in 39.1% of hemipelves (n=43). Intra-prostatic anastomoses between PAs and contra- lateral prostatic branches were found in 61.8% of hemipelves (n=68). In 67.3% of our study population (n=37), the prostate was dominantly supplied via a unilateral PA. Conclusion The prostatic vascularization is complex with frequent anatomic variations. Knowledge of the vascular anatomy of the prostate may provide indications for planning PAE and avoiding nontarget embolization.	[Zhang, Guodong; Wang, Maoqiang; Duan, Feng; Yuan, Kai; Li, Kai; Yan, Jieyu; Chang, Zhongfei; Wang, Yan] Chinese Peoples Liberat Army Gen Hosp, Dept Intervent Radiol, Beijing, Peoples R China	Chinese People's Liberation Army General Hospital	Wang, MQ (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Dept Intervent Radiol, Beijing, Peoples R China.	wangmq@vip.sina.com			fifth central health research projects in China	fifth central health research projects in China	This work was supported by the fifth central health research projects in China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antunes AA, 2013, CARDIOVASC INTER RAD, V36, P978, DOI 10.1007/s00270-013-0611-5; Bagla S, 2013, J VASC INTERV RADIOL, V24, P1603, DOI 10.1016/j.jvir.2013.06.024; Bilhim T, 2012, TECH VASC INTERV RAD, V15, P276, DOI 10.1053/j.tvir.2012.09.006; Bilhim T, 2012, J VASC INTERV RADIOL, V23, P1403, DOI 10.1016/j.jvir.2012.07.028; Bilhim T, 2011, EUR RADIOL, V21, P1119, DOI 10.1007/s00330-010-2015-0; BOUISSOU H, 1959, Ann Anat Pathol (Paris), V4, P63; CLEGG EJ, 1955, J ANAT, V89, P209; Ding HM, 2008, SURG RADIOL ANAT, V30, P437, DOI 10.1007/s00276-008-0348-z; Garcia-Monaco R, 2014, J VASC INTERV RADIOL, V25, P315, DOI 10.1016/j.jvir.2013.10.026; Kakeda S, 2007, J VASC INTERV RADIOL, V18, P1508, DOI 10.1016/j.jvir.2007.08.003; Louie JD, 2009, J VASC INTERV RADIOL, V20, P606, DOI 10.1016/j.jvir.2009.01.021; Moreira AM, 2013, CARDIOVASC INTER RAD, V36, P1690, DOI 10.1007/s00270-013-0739-3; Pisco J, 2013, RADIOLOGY, V266, P668, DOI 10.1148/radiol.12111601; Pisco JM, 2011, J VASC INTERV RADIOL, V22, P11, DOI 10.1016/j.jvir.2010.09.030; Venuti JM, 2004, CLIN ANAT, V17, P261, DOI 10.1002/ca.10233; Wallace MJ, 2007, J VASC INTERV RADIOL, V18, P1500, DOI 10.1016/j.jvir.2007.07.021; Wallace MJ, 2009, J VASC INTERV RADIOL, V20, pS523, DOI 10.1016/j.jvir.2009.04.059	17	18	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2015	10	7							e0132678	10.1371/journal.pone.0132678	http://dx.doi.org/10.1371/journal.pone.0132678			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LN	26191796	gold, Green Published, Green Submitted			2022-12-26	WOS:000358546400034
J	Bolotin, S; Deeks, SL; Marchand-Austin, A; Rilkoff, H; Dang, V; Walton, R; Hashim, A; Farrell, D; Crowcroft, NS				Bolotin, Shelly; Deeks, Shelley L.; Marchand-Austin, Alex; Rilkoff, Heather; Dang, Vica; Walton, Ryan; Hashim, Ahmed; Farrell, David; Crowcroft, Natasha S.			Correlation of Real Time PCR Cycle Threshold Cut-Off with Bordetella pertussis Clinical Severity	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; OUTBREAK; EPIDEMIOLOGY; ADOLESCENTS; DIAGNOSIS; CHILDREN; ADULTS; ASSAY; DNA	Bordetella pertussis testing performed using real-time polymerase chain reaction (RT-PCR) is interpreted based on a cycle threshold (Ct) value. At Public Health Ontario Laboratories (PHOL), a Ct value <36 is reported as positive, and Ct values >= 36 and <40 are reported as indeterminate. PHOL reported indeterminate results to physicians and public health units until May 2012, after which these results were only reported to physicians. We investigated the association between Ct value and disease symptom and severity to examine the significance of indeterminate results clinically, epidemiologically and for public health reporting. B. pertussis positive and indeterminate RT-PCR results were linked to pertussis cases reported in the provincial Integrated Public Health Information System (iPHIS), using deterministic linkage. Patients with positive RT-PCR results had a lower median age of 10.8 years compared to 12.0 years for patients with indeterminate results (p = 0.24). Hospitalized patients had significantly lower Ct values than non-hospitalized patients (median Ct values of 20.7 vs. 31.6, p<0.001). The proportion of patients reporting the most indicative symptoms of pertussis did not differ between patients with positive vs. indeterminate RT-PCR results. Taking the most indicative symptoms of pertussis as the gold-standard, the positive predictive value of the RT-PCR test was 68.1%. RT-PCR test results should be interpreted in the context of the clinical symptoms, age, vaccination status, prevalence, and other factors. Further information on interpretation of indeterminate RT-PCR results may be needed, and the utility of reporting to public health practitioners should be re-evaluated.	[Bolotin, Shelly; Deeks, Shelley L.; Marchand-Austin, Alex; Rilkoff, Heather; Dang, Vica; Walton, Ryan; Hashim, Ahmed; Farrell, David; Crowcroft, Natasha S.] Publ Hlth Ontario, Toronto, ON, Canada; [Bolotin, Shelly; Deeks, Shelley L.; Crowcroft, Natasha S.] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Marchand-Austin, Alex; Farrell, David; Crowcroft, Natasha S.] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada	University of Toronto; University of Toronto	Crowcroft, NS (corresponding author), Publ Hlth Ontario, Toronto, ON, Canada.	natasha.crowcroft@oahpp.ca		Marchand-Austin, Alex/0000-0001-5932-2037				Aickin M, 1996, AM J PUBLIC HEALTH, V86, P726, DOI 10.2105/AJPH.86.5.726; Bidet P, 2008, J CLIN MICROBIOL, V46, P3636, DOI 10.1128/JCM.01308-08; Centers for Disease Control and Prevention, 2013, PERT WHOOP COUGH SUR; Cherry JD, 2012, NEW ENGL J MED, V367, P785, DOI 10.1056/NEJMp1209051; Crowcroft NS, 2006, LANCET, V367, P1926, DOI 10.1016/S0140-6736(06)68848-X; DeVincenzo JP, 2013, DIAGN MICR INFEC DIS, V76, P10, DOI 10.1016/j.diagmicrobio.2012.12.015; Gao FX, 2014, J CLIN MICROBIOL, V52, P302, DOI 10.1128/JCM.01656-13; Guris D, 1999, CLIN INFECT DIS, V28, P1230, DOI 10.1086/514776; Guthrie JL, 2008, J CLIN MICROBIOL, V46, P3798, DOI 10.1128/JCM.01551-08; Guthrie JL, 2010, J CLIN MICROBIOL, V48, P1435, DOI 10.1128/JCM.02417-09; He QS, 1996, J INFECT DIS, V174, P1288, DOI 10.1093/infdis/174.6.1288; Health Protection Agency, 2013, HLTH PROTECTION REPO, V7; Horby P, 2005, EPIDEMIOL INFECT, V133, P229, DOI 10.1017/S0950268804003401; McIntyre PB, 2013, CLIN INFECT DIS, V56, P332, DOI 10.1093/cid/cis897; Nakamura Y, 2011, CLIN MICROBIOL INFEC, V17, P365, DOI 10.1111/j.1469-0691.2010.03255.x; Ontario Ministry of Health and Long Term Care, 2013, INF DIS PROT 2013 AP; Papenburg J, 2009, PEDIATR INFECT DIS J, V28, P1143, DOI 10.1097/INF.0b013e3181bd4e1f; Parkhill J, 2003, NAT GENET, V35, P32, DOI 10.1038/ng1227; Riffelmann M, 2005, J CLIN MICROBIOL, V43, P4925, DOI 10.1128/JCM.43.10.4925-4929.2005; Riffelmann M, 2013, EUR J CLIN MICROBIOL; Tatti KM, 2008, DIAGN MICR INFEC DIS, V61, P264, DOI 10.1016/j.diagmicrobio.2008.02.017; Tizolova A, 2013, EUR J CLIN MICROBIOL, V32, P89, DOI 10.1007/s10096-012-1718-3; Vestrheim DF, 2012, J CLIN MICROBIOL, V50, P4114, DOI 10.1128/JCM.01553-12; Waters V, 2009, PEDIATR INFECT DIS J, V28, P582, DOI 10.1097/INF.0b013e318197fac1; Wood N, 2008, PAEDIATR RESPIR REV, V9, P201, DOI 10.1016/j.prrv.2008.05.010; World Health Organization, 2010, WHO REC SURV STAND P; ZANARDI L, 1997, MMWR-MORBID MORTAL W, V51, P73	27	18	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0133209	10.1371/journal.pone.0133209	http://dx.doi.org/10.1371/journal.pone.0133209			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RV	26186564	gold, Green Published, Green Submitted			2022-12-26	WOS:000358198700109
J	Nakajima, K; Fujita, J; Matsui, M; Tohyama, S; Tamura, N; Kanazawa, H; Seki, T; Kishino, Y; Hirano, A; Okada, M; Tabei, R; Sano, M; Goto, S; Tabata, Y; Fukuda, K				Nakajima, Kazuaki; Fujita, Jun; Matsui, Makoto; Tohyama, Shugo; Tamura, Noriko; Kanazawa, Hideaki; Seki, Tomohisa; Kishino, Yoshikazu; Hirano, Akinori; Okada, Marina; Tabei, Ryota; Sano, Motoaki; Goto, Shinya; Tabata, Yasuhiko; Fukuda, Keiichi			Gelatin Hydrogel Enhances the Engraftment of Transplanted Cardiomyocytes and Angiogenesis to Ameliorate Cardiac Function after Myocardial Infarction	PLOS ONE			English	Article							FIBROBLAST-GROWTH-FACTOR; STEM-CELLS; ISCHEMIC CARDIOMYOPATHY; HEART; THERAPY; INTRACORONARY; BIOMATERIALS; REGENERATION; MYOCYTES; TRIAL	Cell transplantation therapy will mean a breakthrough in resolving the donor shortage in cardiac transplantation. Cardiomyocyte (CM) transplantation, however, has been relatively inefficient in restoring cardiac function after myocardial infarction (MI) due to low engraftment of transplanted CM. In order to ameliorate engraftment of CM, the novel transplantation strategy must be invented. Gelatin hydrogel (GH) is a biodegradable water-soluble polymer gel. Gelatin is made of collagen. Although we observed that collagen strongly induced the aggregation of platelets to potentially cause coronary microembolization, GH did not enhance thrombogenicity. Therefore, GH is a suitable biomaterial in the cell therapy after heart failure. To assess the effect of GH on the improvement of cardiac function, fetal rat CM (5x10(6) or 1x10(6) cells) were transplanted with GH (10 mg/ml) to infarcted hearts. We compared this group with sham operated rats, CM in phosphate buffered saline (PBS), only PBS, and only GH-transplanted groups. Three weeks after transplantation, cardiac function was evaluated by echocardiography. The echocardiography confirmed that transplantation of 5x10(6) CM with GH significantly improved cardiac systolic function, compared with the CM+PBS group (fractional area change: 75.1 +/- 3.4% vs. 60.7 +/- 5.9%, p<0.05), only PBS, and only GH groups (60.1 +/- 6.5%, 65.0 +/- 2.8%, p<0.05). Pathological analyses demonstrated that in the CM+GH group, CM were efficiently engrafted in infarcted myocardium (p<0.01) and angiogenesis was significantly enhanced (p<0.05) in both central and peripheral areas of the scar. Moreover, quantitative RT-PCR revealed that angiogenic cytokines, such as basic fibroblast growth factor, vascular endothelial growth factor, and hepatocyte growth factor, were significantly enriched in the CM+GH group (p<0.05). Here, we report that GH confined the CM effectively in infarcted myocardium after transplantation, and that CM transplanted with GH improved cardiac function with a direct contraction effect and enhanced angiogenesis.	[Nakajima, Kazuaki; Fujita, Jun; Tohyama, Shugo; Kanazawa, Hideaki; Seki, Tomohisa; Kishino, Yoshikazu; Okada, Marina; Tabei, Ryota; Sano, Motoaki; Fukuda, Keiichi] Keio Univ, Sch Med, Dept Cardiol, Shinjuku Ku, Tokyo, Japan; [Hirano, Akinori] Keio Univ, Sch Med, Dept Cardiovasc Surg, Shinjuku Ku, Tokyo, Japan; [Matsui, Makoto; Tabata, Yasuhiko] Kyoto Univ, Dept Biomat, Inst Frontier Med Sci, Field Tissue Engn,Sakyo Ku, Kyoto, Japan; [Tamura, Noriko; Goto, Shinya] Tokai Univ, Sch Med, Dept Med Cardiol, Isehara, Kanagawa 25911, Japan; [Tohyama, Shugo] Japan Soc Promot Sci, Tokyo, Japan	Keio University; Keio University; Kyoto University; Tokai University; Japan Society for the Promotion of Science	Fujita, J (corresponding author), Keio Univ, Sch Med, Dept Cardiol, Shinjuku Ku, 35 Shinanomachi, Tokyo, Japan.	jfujita@a6.keio.jp	Goto, Shinya/AAU-6045-2020; Fukuda, Keiichi/L-3777-2013; Seki, Tomohisa/L-3524-2013; Sano, Motoaki/L-3405-2013	Goto, Shinya/0000-0002-6821-1504; Kishino, Yoshikazu/0000-0003-3291-2795; Seki, Tomohisa/0000-0002-4281-135X	Highway Program for Realization of Regenerative Medicine from Japan Science and Technology Agency	Highway Program for Realization of Regenerative Medicine from Japan Science and Technology Agency	The present work was supported by the Highway Program for Realization of Regenerative Medicine from Japan Science and Technology Agency (to KF, http://www.jst.go.jp/saisei-nw/highway/research/b.html).	Bui AL, 2011, NAT REV CARDIOL, V8, P30, DOI 10.1038/nrcardio.2010.165; Christman KL, 2006, J AM COLL CARDIOL, V48, P907, DOI 10.1016/j.jacc.2006.06.005; Fujita J, 2012, AM J PHYSIOL-HEART C, V303, pH1169, DOI 10.1152/ajpheart.00376.2012; Giordano FJ, 2001, P NATL ACAD SCI USA, V98, P5780, DOI 10.1073/pnas.091415198; Goto SY, 2002, CIRCULATION, V106, P266, DOI 10.1161/01.CIR.0000021427.87256.7E; Hato N, 2012, OTOLARYNG HEAD NECK, V146, P641, DOI 10.1177/0194599811431661; Hattan N, 2005, CARDIOVASC RES, V65, P334, DOI 10.1016/j.cardiores.2004.10.004; Hayashi K, 2011, ACTA BIOMATER, V7, P2797, DOI 10.1016/j.actbio.2011.04.013; Hemmi N, 2014, STEM CELL TRANSL MED, V3, P1473, DOI 10.5966/sctm.2014-0072; Kardami E, 2007, HEART FAIL REV, V12, P267, DOI 10.1007/s10741-007-9027-0; Kehat I, 2001, J CLIN INVEST, V108, P407, DOI 10.1172/JCI12131; Lund LH, 2013, J HEART LUNG TRANSPL, V32, P951, DOI 10.1016/j.healun.2013.08.006; Makkar RR, 2012, LANCET, V379, P895, DOI 10.1016/S0140-6736(12)60195-0; Marui A, 2007, CIRC J, V71, P1181, DOI 10.1253/circj.71.1181; Menasche P, 2008, CIRCULATION, V117, P1189, DOI 10.1161/CIRCULATIONAHA.107.734103; Olivetti G, 1996, J MOL CELL CARDIOL, V28, P1463, DOI 10.1006/jmcc.1996.0137; Ono K, 1997, CIRCULATION, V95, P2552, DOI 10.1161/01.CIR.95.11.2552; Ptaszek LM, 2012, LANCET, V379, P933, DOI 10.1016/S0140-6736(12)60075-0; Rane AA, 2011, J AM COLL CARDIOL, V58, P2615, DOI 10.1016/j.jacc.2011.11.001; Strauer BE, 2011, J AM COLL CARDIOL, V58, P1095, DOI 10.1016/j.jacc.2011.06.016; Tabata Y, 1998, BIOMATERIALS, V19, P807, DOI 10.1016/S0142-9612(98)00233-6; Tabata Y, 1999, BIOMATERIALS, V20, P2169, DOI 10.1016/S0142-9612(99)00121-0; Tabata Y, 2009, J R SOC INTERFACE, V6, pS311, DOI 10.1098/rsif.2008.0448.focus; Van Belle E, 1998, CIRCULATION, V97, P381; van Laake LW, 2007, STEM CELL RES, V1, P9, DOI 10.1016/j.scr.2007.06.001; YANAGISAWAMIWA A, 1992, SCIENCE, V257, P1401, DOI 10.1126/science.1382313; Zhang JH, 2009, CIRC RES, V104, pE30, DOI 10.1161/CIRCRESAHA.108.192237	27	32	33	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0133308	10.1371/journal.pone.0133308	http://dx.doi.org/10.1371/journal.pone.0133308			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RV	26186362	Green Published, Green Submitted, gold			2022-12-26	WOS:000358198700123
J	Spithoven, AWM; Bijttebier, P; Van den Noortgate, W; Colpin, H; Verschueren, K; Van Leeuwen, K; Claes, S; Goossens, L				Spithoven, Annette W. M.; Bijttebier, Patricia; Van den Noortgate, Wim; Colpin, Hilde; Verschueren, Karine; Van Leeuwen, Karla; Claes, Stephan; Goossens, Luc			Adolescent Loneliness and the Interaction between the Serotonin Transporter Gene (5-HTTLPR) and Parental Support: A Replication Study	PLOS ONE			English	Article							ENVIRONMENT INTERACTION RESEARCH; BEHAVIOR; HEALTH; TRAJECTORIES; PERCEPTIONS; ADJUSTMENT; DEPRESSION; ADULTS; RISK	Gene-by-environment interaction (GxEs) studies have gained popularity over the last decade, but the robustness of such observed interactions has been questioned. The current study contributes to this debate by replicating the only study on the interaction between the serotonin transporter gene (5-HTTLPR) and perceived parental support on adolescents' peer-related loneliness. A total of 1,111 adolescents (51% boys) with an average age of 13.70 years (SD = 0.93) participated and three annual waves of data were collected. At baseline, adolescent-reported parental support and peer-related loneliness were assessed and genetic information was collected. Assessment of peer-related loneliness was repeated at Waves 2 and 3. Using a cohort-sequential design, a Latent Growth Curve Model was estimated. Overall, a slight increase of loneliness over time was found. However, the development of loneliness over time was found to be different for boys and girls: girls' levels of loneliness increased over time, whereas boys' levels of loneliness decreased. Parental support was inversely related to baseline levels of loneliness, but unrelated to change of loneliness over time. We were unable to replicate the main effect of 5-HTTLPR or the 5-HTTLPR x Support interaction effect. In the Discussion, we examine the implications of our non-replication.	[Spithoven, Annette W. M.; Bijttebier, Patricia; Colpin, Hilde; Verschueren, Karine; Goossens, Luc] Katholieke Univ Leuven, Dept Sch Psychol & Child & Adolescent Dev, Leuven, Belgium; [Van den Noortgate, Wim] Katholieke Univ Leuven, Dept Methodol Educ Sci, Leuven, Belgium; [Van Leeuwen, Karla] Katholieke Univ Leuven, Dept Parenting & Special Educ, Leuven, Belgium; [Claes, Stephan] Katholieke Univ Leuven, Dept Neurosci, Leuven, Belgium	KU Leuven; KU Leuven; KU Leuven; KU Leuven	Spithoven, AWM (corresponding author), Katholieke Univ Leuven, Dept Sch Psychol & Child & Adolescent Dev, Leuven, Belgium.	Annette.Spithoven@ppw.kuleuven.be	Van Leeuwen, Karla/AAF-6095-2020; Van den Noortgate, Wim/AAB-5969-2020	Van Leeuwen, Karla/0000-0002-6628-3483; Van den Noortgate, Wim/0000-0003-4011-219X; /0000-0002-5173-1917; Bijttebier, Patricia/0000-0002-0648-7388; Claes, Stephan/0000-0002-1175-492X; Goossens, Luc/0000-0003-3851-0412; Verschueren, Karine/0000-0003-2172-1424	KU Leuven Research Fund [GOA/12/009]	KU Leuven Research Fund(KU Leuven)	The authors received a Concerted Research Action grant from the KU Leuven Research Fund (GOA/12/009 - http://www.kuleuven.be/research/researchdatabase/project/3H11/3H110263.htm). The authors who received the funding are LG WVDN HC KV KVL and SC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belsky DW, 2014, BIODEMOGR SOC BIOL, V60, P137, DOI 10.1080/19485565.2014.946591; Boomsma DI, 2005, BEHAV GENET, V35, P745, DOI 10.1007/s10519-005-6040-8; Corsano P, 2006, ADOLESCENCE, V41, P341; Delhaye M, 2012, PSYCHOL BELG, V52, P289, DOI 10.5334/pb-52-4-289; Dick DM, 2015, PERSPECT PSYCHOL SCI, V10, P37, DOI 10.1177/1745691614556682; Distel MA, 2010, BEHAV GENET, V40, P480, DOI 10.1007/s10519-010-9341-5; Domitrovich CE, 2001, MERRILL PALMER QUART, V47, P235, DOI 10.1353/mpq.2001.0010; Duncan LE, 2014, AM PSYCHOL, V69, P249, DOI 10.1037/a0036320; Duncan LE, 2011, AM J PSYCHIAT, V168, P1041, DOI 10.1176/appi.ajp.2011.11020191; Eisenberger NI, 2012, NAT NEUROSCI, V15, P669, DOI 10.1038/nn.3086; Galambos NL, 2003, CHILD DEV, V74, P578, DOI 10.1111/1467-8624.7402017; Gaylord NK, 2003, PARENT-SCI PRACT, V3, P23, DOI 10.1207/S15327922PAR0301_02; Goosby BJ, 2013, SOCIOL INQ, V83, P505, DOI 10.1111/soin.12018; Goossens L, 2015, PERSPECT PSYCHOL SCI, V10, P213, DOI 10.1177/1745691614564878; Hariri AR, 2006, TRENDS COGN SCI, V10, P182, DOI 10.1016/j.tics.2006.02.011; Hawkley LC, 2010, ANN BEHAV MED, V40, P218, DOI 10.1007/s12160-010-9210-8; Heinrich LA, 2006, CLIN PSYCHOL REV, V26, P695, DOI 10.1016/j.cpr.2006.04.002; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Karg K, 2011, ARCH GEN PSYCHIAT, V68, P444, DOI 10.1001/archgenpsychiatry.2010.189; Koenig L. J., 1999, LONELINESS CHILDHOOD, P296, DOI [10.1017/CBO9780511551888.015, DOI 10.1017/CBO9780511551888.015]; Mahon NE, 2006, NURS RES, V55, P308, DOI 10.1097/00006199-200609000-00003; Manuck SB, 2014, ANNU REV PSYCHOL, V65, P41, DOI 10.1146/annurev-psych-010213-115100; MARCOEN A, 1987, J YOUTH ADOLESCENCE, V16, P561, DOI 10.1007/BF02138821; Maurizi LK, 2012, J YOUTH ADOLESCENCE, V41, P1035, DOI 10.1007/s10964-011-9741-8; McGuire S, 2000, PSYCHOL SCI, V11, P487, DOI 10.1111/1467-9280.00293; Moffitt TE, 2006, PERSPECT PSYCHOL SCI, V1, P5, DOI 10.1111/j.1745-6916.2006.00002.x; Munafo MR, 2014, J CHILD PSYCHOL PSYC, V55, P1092, DOI 10.1111/jcpp.12261; Munafo MR, 2009, BIOL PSYCHIAT, V65, P211, DOI 10.1016/j.biopsych.2008.06.009; Muthen L. K., 2017, MPLUS USERS GUIDE, DOI DOI 10.1111/J.1600-0447.2011.01711.X; Nelson D. A., 2002, INTRUSIVE PARENTING, P161, DOI DOI 10.1037/10422-006; Nulty DD, 2008, ASSESS EVAL HIGH EDU, V33, P301, DOI 10.1080/02602930701293231; Pluess M, 2012, AM J PSYCHIAT, V169, P222, DOI 10.1176/appi.ajp.2011.11111614; Research Department of the Flemish Government, 2011, SCHOL BEV 25 64 JAAR; Risch N, 2009, JAMA-J AM MED ASSOC, V301, P2462, DOI 10.1001/jama.2009.878; Rotenberg K.J., 1999, LONELINESS CHILDHOOD, P176, DOI 10.1017/CBO9780511551888; Scharf M, 2011, INT J PSYCHOL, V46, P177, DOI 10.1080/00207594.2010.528424; Schinka KC, 2013, J ADOLESCENCE, V36, P1251, DOI 10.1016/j.adolescence.2013.08.002; Shanahan MJ, 2011, DYNAMIC GENOME MENTA, P58; SoftGenetics, 2010, GENEMARKER; Stanley DJ, 2014, PERSPECT PSYCHOL SCI, V9, P305, DOI 10.1177/1745691614528518; Van Leeuwen KG, 2004, DEV PSYCHOL, V40, P1028, DOI 10.1037/0012-1649.40.6.1028; van Roekel E, 2011, J CHILD PSYCHOL PSYC, V52, P1044, DOI 10.1111/j.1469-7610.2011.02424.x; van Roekel E, 2010, J CHILD PSYCHOL PSYC, V51, P747, DOI 10.1111/j.1469-7610.2010.02225.x; Vanhalst J, 2012, J YOUTH ADOLESCENCE, V41, P776, DOI 10.1007/s10964-011-9726-7; Verhagen M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092768; Victor CR, 2012, J PSYCHOL, V146, P85, DOI 10.1080/00223980.2011.613875	46	5	5	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0133430	10.1371/journal.pone.0133430	http://dx.doi.org/10.1371/journal.pone.0133430			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RV	26186217	Green Published, Green Submitted, gold			2022-12-26	WOS:000358198700138
J	Suslak, TJ; Watson, S; Thompson, KJ; Shenton, FC; Bewick, GS; Armstrong, JD; Jarman, AP				Suslak, Thomas J.; Watson, Sonia; Thompson, Karen J.; Shenton, Fiona C.; Bewick, Guy S.; Armstrong, J. Douglas; Jarman, Andrew P.			Piezo Is Essential for Amiloride-Sensitive Stretch-Activated Mechanotransduction in Larval Drosophila Dorsal Bipolar Dendritic Sensory Neurons	PLOS ONE			English	Article							MAMMALIAN MUSCLE-SPINDLES; NEUROMUSCULAR-JUNCTION; MATHEMATICAL-MODEL; MANDUCA-SEXTA; RECEPTOR; CHANNELS; ADAPTATION; PICKPOCKET; TRANSDUCER; GLUTAMATE	Stretch-activated afferent neurons, such as those of mammalian muscle spindles, are essential for proprioception and motor co-ordination, but the underlying mechanisms of mechanotransduction are poorly understood. The dorsal bipolar dendritic (dbd) sensory neurons are putative stretch receptors in the Drosophila larval body wall. We have developed an in vivo protocol to obtain receptor potential recordings from intact dbd neurons in response to stretch. Receptor potential changes in dbd neurons in response to stretch showed a complex, dynamic profile with similar characteristics to those previously observed for mammalian muscle spindles. These profiles were reproduced by a general in silico model of stretch-activated neurons. This in silico model predicts an essential role for a mechanosensory cation channel (MSC) in all aspects of receptor potential generation. Using pharmacological and genetic techniques, we identified the mechanosensory channel, DmPiezo, in this functional role in dbd neurons, with TRPA1 playing a subsidiary role. We also show that rat muscle spindles exhibit a ruthenium red-sensitive current, but found no expression evidence to suggest that this corresponds to Piezo activity. In summary, we show that the dbd neuron is a stretch receptor and demonstrate that this neuron is a tractable model for investigating mechanisms of mechanotransduction.	[Suslak, Thomas J.; Armstrong, J. Douglas] Univ Edinburgh, Doctoral Training Ctr Neuroinformat & Neural Comp, Edinburgh, Midlothian, Scotland; [Suslak, Thomas J.; Armstrong, J. Douglas; Jarman, Andrew P.] Univ Edinburgh, Ctr Integrat Physiol, Edinburgh, Midlothian, Scotland; [Armstrong, J. Douglas] Univ Edinburgh, Inst Adapt & Neural Computat, Edinburgh, Midlothian, Scotland; [Watson, Sonia; Thompson, Karen J.; Bewick, Guy S.] Univ Aberdeen, Inst Med Sci, Aberdeen, Scotland; [Shenton, Fiona C.] Univ Newcastle, Inst Ageing, Newcastle Upon Tyne, Tyne & Wear, England	University of Edinburgh; University of Edinburgh; University of Edinburgh; University of Aberdeen; Newcastle University - UK	Suslak, TJ (corresponding author), Univ Edinburgh, Doctoral Training Ctr Neuroinformat & Neural Comp, Edinburgh, Midlothian, Scotland.	thomas.suslak@gmail.com; andrew.jarman@ed.ac.uk	Suslak, Thomas/GYA-1309-2022; Bewick, Guy/AAL-8214-2021	Bewick, Guy/0000-0001-8266-7797; Armstrong, Douglas/0000-0002-5397-3864; Jarman, Andrew/0000-0003-4036-5701	UK Engineering and Physical Sciences Research Council (EPSRC) [EP/F500385/1, BB/F529254/1]; UK Biotechnology and Biological Sciences Research Council (BBSRC); UK Medical Research Council (MRC); Tenovus Scotland Moulton-Barrett Research Scholarship [OL-532, G13/08]; Scottish Universities Life Sciences Alliance (SULSA) BioSkape grant; Eli Lilly	UK Engineering and Physical Sciences Research Council (EPSRC)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); UK Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); UK Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Tenovus Scotland Moulton-Barrett Research Scholarship; Scottish Universities Life Sciences Alliance (SULSA) BioSkape grant; Eli Lilly(Eli Lilly)	TJS supported in part by grants EP/F500385/1 and BB/F529254/1 for the University of Edinburgh School of Informatics Doctoral Training Centre in Neuroinformatics and Computational Neuroscience (http://www.anc.ed.ac.uk/dtc/) from the UK Engineering and Physical Sciences Research Council (EPSRC), UK Biotechnology and Biological Sciences Research Council (BBSRC), and the UK Medical Research Council (MRC). KJT is supported by a Tenovus Scotland Moulton-Barrett Research Scholarship (OL-532) and Research Grant (G13/08). SW is supported by a Scottish Universities Life Sciences Alliance (SULSA) BioSkape grant in collaboration with Eli Lilly. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams CM, 1998, J CELL BIOL, V140, P143, DOI 10.1083/jcb.140.1.143; Baines RA, 1998, J NEUROSCI, V18, P4673; Banke TG, 2011, BRAIN RES, V1381, P21, DOI 10.1016/j.brainres.2011.01.021; Bewick GS, 2005, J PHYSIOL-LONDON, V562, P381, DOI 10.1113/jphysiol.2004.074799; Bewick GS, 2014, EUR J PHYSL, P1; Bobkov YV, 2011, BBA-BIOMEMBRANES, V1808, P1120, DOI 10.1016/j.bbamem.2010.12.024; CAMPBELL DL, 1988, J PHYSIOL-LONDON, V403, P267, DOI 10.1113/jphysiol.1988.sp017249; Carr MJ, 2001, BRIT J PHARMACOL, V133, P1255, DOI 10.1038/sj.bjp.0704197; Coste B, 2012, NATURE, V483, P176, DOI 10.1038/nature10812; Coste B, 2010, SCIENCE, V330, P55, DOI 10.1126/science.1193270; Delmas P, 2011, NAT REV NEUROSCI, V12, P139, DOI 10.1038/nrn2993; Faucherre A, 2013, J NEUROSCI, V 33, P17089, DOI 10.1523/JNEUROSCI.0522-13.2013; FINLAYSON LH, 1958, PROC R SOC SER B-BIO, V148, P433, DOI 10.1098/rspb.1958.0037; Hu J, 2006, J PHYSIOL-LONDON, V577, P815, DOI 10.1113/jphysiol.2006.117648; HUNT CC, 1978, J GEN PHYSIOL, V71, P683, DOI 10.1085/jgp.71.6.683; JAN LY, 1976, J PHYSIOL-LONDON, V262, P215, DOI 10.1113/jphysiol.1976.sp011593; Kim SH, 2010, P NATL ACAD SCI USA, V107, P8440, DOI 10.1073/pnas.1001425107; Kim SE, 2012, NATURE, V483, P209, DOI 10.1038/nature10801; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LANE JW, 1991, J PHYSIOL-LONDON, V441, P347, DOI 10.1113/jphysiol.1991.sp018755; Lennartson B., 1988, J ANAT, V130, P279; LILEY AW, 1956, J PHYSIOL-LONDON, V132, P650, DOI 10.1113/jphysiol.1956.sp005555; Liu L, 2003, P NATL ACAD SCI USA, V100, P2128, DOI 10.1073/pnas.252785099; Maksimovic S, 2014, NATURE, V509, P617, DOI 10.1038/nature13250; Nair Amit, 2010, BMC Res Notes, V3, P154, DOI 10.1186/1756-0500-3-154; OTTOSON D, 1982, BRAIN RES, V244, P337, DOI 10.1016/0006-8993(82)90093-2; OTTOSON D, 1985, BRAIN RES, V336, P1, DOI 10.1016/0006-8993(85)90409-3; Peyronnet R, 2013, EMBO REP, V14, P1143, DOI 10.1038/embor.2013.170; Proske U, 2012, PHYSIOL REV, V92, P1651, DOI 10.1152/physrev.00048.2011; Ranade SS, 2014, NATURE, V516, P121, DOI 10.1038/nature13980; RYDQVIST B, 1993, J PHYSIOL-LONDON, V469, P193, DOI 10.1113/jphysiol.1993.sp019811; Schrader S, 2007, ARTHROPOD STRUCT DEV, V36, P157, DOI 10.1016/j.asd.2006.08.014; Shen WL, 2011, SCIENCE, V331, P1333, DOI 10.1126/science.1198904; Simon A, 2010, J PHYSIOL-LONDON, V588, P171, DOI 10.1113/jphysiol.2009.182683; Simon MA, 2009, J EXP BIOL, V212, P1021, DOI 10.1242/jeb.023507; Staruschenko A, 2010, J BIOL CHEM, V285, P15167, DOI 10.1074/jbc.M110.106153; STEWART BA, 1994, J COMP PHYSIOL A, V175, P179, DOI 10.1007/BF00215114; Suslak TJ, 2011, NETWORK-COMP NEURAL, V22, P133, DOI 10.3109/0954898X.2011.638967; Swerup C, 1996, J NEUROPHYSIOL, V76, P2211, DOI 10.1152/jn.1996.76.4.2211; Tamarkin DA, 1996, J NEUROPHYSIOL, V76, P1597, DOI 10.1152/jn.1996.76.3.1597; Woo SH, 2014, NATURE, V509, P622, DOI 10.1038/nature13251	41	21	23	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0130969	10.1371/journal.pone.0130969	http://dx.doi.org/10.1371/journal.pone.0130969			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RV	26186008	Green Submitted, Green Published, Green Accepted, gold			2022-12-26	WOS:000358198700009
J	Buck, JC; Hua, J; Brogan, WR; Dang, TD; Urbina, J; Bendis, RJ; Stoler, AB; Blaustein, AR; Relyea, RA				Buck, Julia C.; Hua, Jessica; Brogan, William R., III; Dang, Trang D.; Urbina, Jenny; Bendis, Randall J.; Stoler, Aaron B.; Blaustein, Andrew R.; Relyea, Rick A.			Effects of Pesticide Mixtures on Host-Pathogen Dynamics of the Amphibian Chytrid Fungus	PLOS ONE			English	Article							BATRACHOCHYTRIUM-DENDROBATIDIS INFECTION; ANTIMICROBIAL PEPTIDE DEFENSES; GLOBAL DECLINE; CHYTRIDIOMYCOSIS IMPACTS; IMMUNE DEFENSES; EXPOSURE; EXTINCTION; DISEASE; GROWTH; SUSCEPTIBILITY	Anthropogenic and natural stressors often interact to affect organisms. Amphibian populations are undergoing unprecedented declines and extinctions with pesticides and emerging infectious diseases implicated as causal factors. Although these factors often co-occur, their effects on amphibians are usually examined in isolation. We hypothesized that exposure of larval and metamorphic amphibians to ecologically relevant concentrations of pesticide mixtures would increase their post-metamorphic susceptibility to the fungus Batrachochytrium dendrobatidis (Bd), a pathogen that has contributed to amphibian population declines worldwide. We exposed five anuran species (Pacific treefrog, Pseudacris regilla; spring peeper, Pseudacris crucifer; Cascades frog, Rana cascadae; northern leopard frog, Lithobates pipiens; and western toad, Anaxyrus boreas) from three families to mixtures of four common insecticides (chlorpyrifos, carbaryl, permethrin, and endosulfan) or herbicides (glyphosate, acetochlor, atrazine, and 2,4-D) or a control treatment, either as tadpoles or as newly metamorphic individuals (metamorphs). Subsequently, we exposed animals to Bd or a control inoculate after metamorphosis and compared survival and Bd load. Bd exposure significantly increased mortality in Pacific treefrogs, spring peepers, and western toads, but not in Cascades frogs or northern leopard frogs. However, the effects of pesticide exposure on mortality were negligible, regardless of the timing of exposure. Bd load varied considerably across species; Pacific treefrogs, spring peepers, and western toads had the highest loads, whereas Cascades frogs and northern leopard frogs had the lowest loads. The influence of pesticide exposure on Bd load depended on the amphibian species, timing of pesticide exposure, and the particular pesticide treatment. Our results suggest that exposure to realistic pesticide concentrations has minimal effects on Bd-induced mortality, but can alter Bd load. This result could have broad implications for risk assessment of amphibians; the outcome of exposure to multiple stressors may be unpredictable and can differ between species and life stages.	[Buck, Julia C.] Sam Houston State Univ, Texas Res Inst Environm Studies, Huntsville, TX 77340 USA; [Buck, Julia C.; Dang, Trang D.; Blaustein, Andrew R.] Oregon State Univ, Dept Integrat Biol, Corvallis, OR 97331 USA; [Hua, Jessica; Brogan, William R., III; Bendis, Randall J.; Stoler, Aaron B.; Relyea, Rick A.] Univ Pittsburgh, Dept Biol Sci, Pittsburgh, PA 15260 USA; [Urbina, Jenny; Blaustein, Andrew R.] Oregon State Univ, Environm Sci Grad Program, Corvallis, OR 97331 USA	Texas State University System; Sam Houston State University; Oregon State University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Oregon State University	Buck, JC (corresponding author), Sam Houston State Univ, Texas Res Inst Environm Studies, Huntsville, TX 77340 USA.	julia.buck@gmail.com		Weitemier, Trang/0000-0002-9567-3771; Buck, Julia/0000-0003-3202-7665; Hua, Jessica/0000-0002-9553-902X; Urbina, Jenny/0000-0003-2461-9572	National Science Foundation [DEB 11-19430]	National Science Foundation(National Science Foundation (NSF))	This material is based on work supported under a National Science Foundation grant to R.A.R. and A.R.B. (DEB 11-19430). URL of funder's website: nsf.gov. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALFORD RA, 1988, AM NAT, V131, P91, DOI 10.1086/284775; Bancroft BA, 2011, BIODIVERS CONSERV, V20, P1911, DOI 10.1007/s10531-011-0066-4; Berger L, 2005, DIS AQUAT ORGAN, V68, P47, DOI 10.3354/dao068047; Blaustein AR, 2005, CONSERV BIOL, V19, P1460, DOI 10.1111/j.1523-1739.2005.00195.x; Blaustein AR, 2002, ECOL LETT, V5, P597, DOI 10.1046/j.1461-0248.2002.00352.x; Boone MD, 2013, AQUAT TOXICOL, V130, P139, DOI 10.1016/j.aquatox.2012.12.022; Boyle DG, 2004, DIS AQUAT ORGAN, V60, P141, DOI 10.3354/dao060141; Bradford DF, 2011, ENVIRON TOXICOL CHEM, V30, P682, DOI 10.1002/etc.425; Buck JC, 2012, FRESHWATER BIOL, V57, P61, DOI 10.1111/j.1365-2427.2011.02695.x; Carey C, 1999, DEV COMP IMMUNOL, V23, P459, DOI 10.1016/S0145-305X(99)00028-2; Daszak P, 1999, EMERG INFECT DIS, V5, P735, DOI 10.3201/eid0506.990601; Daszak P, 2000, SCIENCE, V287, P443, DOI 10.1126/science.287.5452.443; Davidson C, 2004, ECOL APPL, V14, P1892, DOI 10.1890/03-5224; Davidson C, 2007, ENVIRON SCI TECHNOL, V41, P1771, DOI 10.1021/es0611947; Egea-Serrano A, 2012, ECOL EVOL, V2, P1382, DOI 10.1002/ece3.249; Environmental Protection Agency, 2010, EPAHQOPP20020262; Gahl MK, 2011, ECOL APPL, V21, P2521, DOI 10.1890/10-2319.1; Garner TWJ, 2009, OIKOS, V118, P783, DOI 10.1111/j.1600-0706.2008.17202.x; Gervasi S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054490; Gilliom RJ, 2007, ENVIRON SCI TECHNOL, V41, P3407; Gosner K. L., 1960, Herpetologica, V16, P183; Groner ML, 2013, ECOL APPL, V23, P1443, DOI 10.1890/12-1572.1; Grube A, 2011, PESTICIDE IND SALES; Hammond JI, 2012, EVOL APPL, V5, P593, DOI 10.1111/j.1752-4571.2011.00237.x; Hanlon SM, 2014, ENVIRON TOXICOL CHEM, V33, P216, DOI 10.1002/etc.2419; Hanlon SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043573; Hanlon SM, 2012, ARCH ENVIRON CON TOX, V63, P137, DOI 10.1007/s00244-011-9744-1; Hayes TB, 2010, J EXP BIOL, V213, P921, DOI 10.1242/jeb.040865; Hayes TB, 2006, ENVIRON HEALTH PERSP, V114, P40, DOI 10.1289/ehp.8051; Holmstrup M, 2010, SCI TOTAL ENVIRON, V408, P3746, DOI 10.1016/j.scitotenv.2009.10.067; Howe GE, 1998, ENVIRON TOXICOL CHEM, V17, P519, DOI [10.1002/etc.5620170324, 10.1897/1551-5028(1998)017&lt;0519:EOCSAL&gt;2.3.CO;2]; Johnson PTJ, 2011, FUNCT ECOL, V25, P726, DOI 10.1111/j.1365-2435.2010.01830.x; Kiesecker JM, 2011, ECOL RES, V26, P897, DOI 10.1007/s11284-010-0702-6; Kleinhenz P, 2012, J HERPETOL, V46, P625, DOI 10.1670/11-070; Kohler HR, 2013, SCIENCE, V341, P759, DOI 10.1126/science.1237591; Kriger KM, 2007, CONSERV BIOL, V21, P1280, DOI 10.1111/j.1523-1739.2007.00777.x; KURIS AM, 1980, AM NAT, V116, P570, DOI 10.1086/283647; Lafferty KD, 2003, ECOL LETT, V6, P654, DOI 10.1046/j.1461-0248.2003.00480.x; Laskowski R, 2010, SCI TOTAL ENVIRON, V408, P3763, DOI 10.1016/j.scitotenv.2010.01.043; Longcore JE, 1999, MYCOLOGIA, V91, P219, DOI 10.2307/3761366; Mann RM, 2009, ENVIRON POLLUT, V157, P2903, DOI 10.1016/j.envpol.2009.05.015; Marcogliese DJ, 2011, TRENDS PARASITOL, V27, P123, DOI 10.1016/j.pt.2010.11.002; McCallum ML, 2007, J HERPETOL, V41, P483, DOI 10.1670/0022-1511(2007)41[483:ADOECD]2.0.CO;2; McMahon TA, 2013, ENVIRON SCI TECHNOL, V47, P7958, DOI 10.1021/es401725s; Metcalfe NB, 2001, TRENDS ECOL EVOL, V16, P254, DOI 10.1016/S0169-5347(01)02124-3; Newman M.C., 2009, FUNDAMENTALS ECOTOXI; Olson DH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056802; Paetow LJ, 2012, ECOTOX ENVIRON SAFE, V80, P372, DOI 10.1016/j.ecoenv.2012.04.006; Parris MJ, 2004, OECOLOGIA, V140, P626, DOI 10.1007/s00442-004-1631-2; Pesticide Management Education Program, 2008, EXT TOX NETW PEST IN; Raberg L, 2009, PHILOS T R SOC B, V364, P37, DOI 10.1098/rstb.2008.0184; Rachowicz LJ, 2004, DIS AQUAT ORGAN, V61, P75, DOI 10.3354/dao061075; Ramsey JP, 2010, INFECT IMMUN, V78, P3981, DOI 10.1128/IAI.00402-10; Relyea RA, 2004, ENVIRON TOXICOL CHEM, V23, P1737, DOI 10.1897/03-493; Relyea RA, 2009, OECOLOGIA, V159, P363, DOI [10.1007/s00442-008-1141-8, 10.1007/s00442-008-1213-9]; Rohr JR, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1502; Rollins-Smith LA, 2005, INTEGR COMP BIOL, V45, P137, DOI 10.1093/icb/45.1.137; Rollins-Smith LA, 2005, DEV COMP IMMUNOL, V29, P589, DOI 10.1016/j.dci.2004.11.004; Rollins-Smith LA, 2001, IMMUNOL RES, V23, P273, DOI 10.1385/IR:23:2-3:273; Rollins-Smith LA, 2011, INTEGR COMP BIOL, V51, P552, DOI 10.1093/icb/icr095; Schneider DS, 2008, NAT REV IMMUNOL, V8, P889, DOI 10.1038/nri2432; Searle CL, 2011, CONSERV BIOL, V25, P965, DOI 10.1111/j.1523-1739.2011.01708.x; Skerratt LF, 2007, ECOHEALTH, V4, P125, DOI 10.1007/s10393-007-0093-5; Smith KF, 2006, CONSERV BIOL, V20, P1349, DOI 10.1111/j.1523-1739.2006.00524.x; Smith KG, 2007, DIS AQUAT ORGAN, V74, P159, DOI 10.3354/dao074159; Stuart SN, 2004, SCIENCE, V306, P1783, DOI 10.1126/science.1103538; Symonds EP, 2007, J WILDLIFE DIS, V43, P48, DOI 10.7589/0090-3558-43.1.48; Venesky MD, 2009, ECOHEALTH, V6, P565, DOI 10.1007/s10393-009-0272-7; Venesky MD, 2010, J PARASITOL, V96, P552, DOI 10.1645/GE-2353.1; Voyles J, 2009, SCIENCE, V326, P582, DOI 10.1126/science.1176765; Vredenburg VT, 2010, P NATL ACAD SCI USA, V107, P9689, DOI 10.1073/pnas.0914111107; Wake DB, 2008, P NATL ACAD SCI USA, V105, P11466, DOI 10.1073/pnas.0801921105	72	22	22	0	85	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2015	10	7							e0132832	10.1371/journal.pone.0132832	http://dx.doi.org/10.1371/journal.pone.0132832			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RQ	26181492	Green Published, gold, Green Submitted, Green Accepted			2022-12-26	WOS:000358198200039
J	Senechal, F; L'Enfant, M; Domon, JM; Rosiau, E; Crepeau, MJ; Surcouf, O; Esquivel-Rodriguez, J; Marcelo, P; Mareck, A; Guerineau, F; Kim, HR; Mravec, J; Bonnin, E; Jamet, E; Kihara, D; Lerouge, P; Ralet, MC; Pelloux, J; Rayon, C				Senechal, Fabien; L'Enfant, Melanie; Domon, Jean-Marc; Rosiau, Emeline; Crepeau, Marie-Jeanne; Surcouf, Ogier; Esquivel-Rodriguez, Juan; Marcelo, Paulo; Mareck, Alain; Guerineau, Francois; Kim, Hyung-Rae; Mravec, Jozef; Bonnin, Estelle; Jamet, Elisabeth; Kihara, Daisuke; Lerouge, Patrice; Ralet, Marie-Christine; Pelloux, Jerome; Rayon, Catherine			Tuning of Pectin Methylesterification PECTIN METHYLESTERASE INHIBITOR 7 MODULATES THE PROCESSIVE ACTIVITY OF CO-EXPRESSED PECTIN METHYLESTERASE 3 IN A pH-DEPENDENT MANNER	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-WALL PECTINS; METHYL ESTERASE; METHYLESTERASE INHIBITORS; STRUCTURAL INSIGHTS; ALCOHOL OXIDASE; ARABIDOPSIS; EXPRESSION; PH; GENES; IDENTIFICATION	Pectin methylesterases (PMEs) catalyze the demethylesterification of homogalacturonan domains of pectin in plant cell walls and are regulated by endogenous pectin methylesterase inhibitors (PMEIs). In Arabidopsis dark-grown hypocotyls, one PME (AtPME3) and one PMEI (AtPMEI7) were identified as potential interacting proteins. Using RT-quantitative PCR analysis and gene promoter:: GUS fusions, we first showed that AtPME3 and AtPMEI7 genes had overlapping patterns of expression in etiolated hypocotyls. The two proteins were identified in hypocotyl cell wall extracts by proteomics. To investigate the potential interaction between AtPME3 and AtPMEI7, both proteins were expressed in a heterologous system and purified by affinity chromatography. The activity of recombinant AtPME3 was characterized on homogalacturonans (HGs) with distinct degrees/patterns of methylesterification. AtPME3 showed the highest activity at pH 7.5 on HG substrates with a degree of methylesterification between 60 and 80% and a random distribution of methyl esters. On the best HG substrate, AtPME3 generates long non-methylesterified stretches and leaves short highly methylesterified zones, indicating that it acts as a processive enzyme. The recombinant AtPMEI7 and AtPME3 interaction reduces the level of demethylesterification of the HG substrate but does not inhibit the processivity of the enzyme. These data suggest that the AtPME3.AtPMEI7 complex is not covalently linked and could, depending on the pH, be alternately formed and dissociated. Docking analysis indicated that the inhibition of AtPME3 could occur via the interaction of AtPMEI7 with aPMEligand-binding cleft structure. All of these data indicate that AtPME3 and AtPMEI7 could be partners involved in the fine tuning of HG methylesterification during plant development.	[Senechal, Fabien; L'Enfant, Melanie; Domon, Jean-Marc; Rosiau, Emeline; Guerineau, Francois; Pelloux, Jerome; Rayon, Catherine] Univ Picardie Jules Verne, Biol Plantes & Innovat, BIOPI EA3900, F-80039 Amiens, France; [Marcelo, Paulo] Univ Picardie Jules Verne, Plateforme Ingn Cellulaire & Anal Prot ICAP, F-80039 Amiens, France; [Crepeau, Marie-Jeanne; Bonnin, Estelle; Ralet, Marie-Christine] INRA, UMR 1268, Biopolymeres Interact Assemblages, F-44316 Nantes, France; [Surcouf, Ogier; Mareck, Alain; Lerouge, Patrice] Univ Rouen, Lab Glycobiol & Matrice Extracellulaire Vegetale, UPRES EA 4358,Inst Rech & Innovat Biomed,Normandi, Grand Reseau Rech Vegetal,Agron,Sol,Innovat,UFR S, F-76821 Mont St Aignan 1, France; [Esquivel-Rodriguez, Juan; Kihara, Daisuke] Purdue Univ, Dept Comp Sci, W Lafayette, IN 47907 USA; [Kim, Hyung-Rae; Kihara, Daisuke] Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA; [Mravec, Jozef] Univ Copenhagen, Dept Plant & Environm Sci, DK-1871 Frederiksberg, Denmark; [Jamet, Elisabeth] Univ Toulouse 3, LRSV, UMR 5546, CNRS, F-31326 Castanet Tolosan, France	Picardie Universites; Universite de Picardie Jules Verne (UPJV); Picardie Universites; Universite de Picardie Jules Verne (UPJV); INRAE; Universite de Rouen Normandie; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; University of Copenhagen; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Rayon, C (corresponding author), Univ Picardie Jules Verne, Biol Plantes & Innovat, BIOPI EA3900, F-80039 Amiens, France.	catherine.rayon@u-picardie.fr	Sénéchal, Fabien/AAR-8411-2021; Sénéchal, Fabien/K-4551-2016; Jamet, Elisabeth/Z-2476-2019; Regan, Clinton/E-6250-2012; Mravec, Jozef/J-7370-2016	Sénéchal, Fabien/0000-0002-4145-7205; Mravec, Jozef/0000-0003-0331-3304; Marcelo, Paulo/0000-0002-2586-8119; Bonnin, Estelle/0000-0002-8268-9408; Esquivel-Rodriguez, Juan/0000-0003-0638-1687; Ralet, Marie-Christine/0000-0002-0292-5272; Pelloux, Jerome/0000-0002-9371-1711; Guerineau, Francois/0000-0003-1383-0348	Agence Nationale de la Recherche [ANR-09-BLANC-0007-01 GROWPEC, ANR-12-BSV5-0001 GALAPAGOS]; Conseil Regional de Picardie; "Trans Channel Wallnet" project; National Institutes of Health [R01GM097528]; National Science Foundation [IIS1319551, DBI1262189, IOS1127027]; National Research Foundation of Korea [NRF-2011-220-C00004]; Institut Universitaire de France; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM097528] Funding Source: NIH RePORTER	Agence Nationale de la Recherche(French National Research Agency (ANR)); Conseil Regional de Picardie(Region Hauts-de-France); "Trans Channel Wallnet" project; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); National Research Foundation of Korea(National Research Foundation of Korea); Institut Universitaire de France; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by Agence Nationale de la Recherche Grants ANR-09-BLANC-0007-01 GROWPEC and ANR-12-BSV5-0001 GALAPAGOS and by the Conseil Regional de Picardie through a Ph.D. studentship (to F. S.). Work was also supported in part by the "Trans Channel Wallnet" project, which was selected by the INTERREG IVA program France (Channel)-England European cross-border cooperation program and National Institutes of Health Grant R01GM097528 (to D. K.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported in part by National Science Foundation Grants IIS1319551, DBI1262189, and IOS1127027 and National Research Foundation of Korea Grant NRF-2011-220-C00004.; Supported by the Institut Universitaire de France.	Agoda-Tandjawa G, 2012, CARBOHYD POLYM, V90, P1081, DOI 10.1016/j.carbpol.2012.06.047; Al-Qsous S, 2004, PLANTA, V219, P369, DOI 10.1007/s00425-004-1246-1; Anthon GE, 2004, J AGR FOOD CHEM, V52, P3749, DOI 10.1021/jf035284w; Baldwin L, 2014, PHYTOCHEMISTRY, V104, P37, DOI 10.1016/j.phytochem.2014.04.011; BALESTRIERI C, 1990, EUR J BIOCHEM, V193, P183, DOI 10.1111/j.1432-1033.1990.tb19321.x; Benhamed M, 2008, PLANT J, V56, P493, DOI 10.1111/j.1365-313X.2008.03606.x; Bourgault R, 2002, ANAL BIOCHEM, V300, P87, DOI 10.1006/abio.2001.5450; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Caffall KH, 2009, CARBOHYD RES, V344, P1879, DOI 10.1016/j.carres.2009.05.021; Cameron RG, 2008, CARBOHYD POLYM, V71, P287, DOI 10.1016/j.carbpol.2007.07.007; CARPITA NC, 1993, PLANT J, V3, P1, DOI 10.1111/j.1365-313X.1993.tb00007.x; Castro SM, 2004, J AGR FOOD CHEM, V52, P5724, DOI 10.1021/jf0352071; Christgau S, 1996, BIOCHEM J, V319, P705, DOI 10.1042/bj3190705; Ciardiello MA, 2008, PROTEINS, V71, P195, DOI 10.1002/prot.21681; Ciardiello MA, 2004, J AGR FOOD CHEM, V52, P7700, DOI 10.1021/jf0491963; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; D'Avino R, 2003, PROTEINS, V53, P830, DOI 10.1002/prot.10487; Daas PJH, 2001, BIOPOLYMERS, V58, P195, DOI 10.1002/1097-0282(200102)58:2<195::AID-BIP80>3.0.CO;2-C; Denes JM, 2000, CARBOHYD RES, V327, P385, DOI 10.1016/S0008-6215(00)00070-7; Di Matteo A, 2005, PLANT CELL, V17, P849, DOI 10.1105/tpc.104.028886; Downie B, 1998, ANAL BIOCHEM, V264, P149, DOI 10.1006/abio.1998.2847; Duvetter T, 2006, J AGR FOOD CHEM, V54, P7825, DOI 10.1021/jf060013h; Esquivel-Rodriguez J, 2014, METHODS MOL BIOL, V1137, P209, DOI 10.1007/978-1-4939-0366-5_15; Futamura N, 2000, PLANT CELL PHYSIOL, V41, P16, DOI 10.1093/pcp/41.1.16; Gonzalez SL, 2011, CIENCIA TECNOL ALIME, V31, P412, DOI 10.1590/S0101-20612011000200020; Grsic-Rausch S, 2004, ANAL BIOCHEM, V333, P14, DOI 10.1016/j.ab.2004.04.042; Guenin S, 2011, NEW PHYTOL, V192, P114, DOI 10.1111/j.1469-8137.2011.03797.x; Gutierrez L, 2009, PLANT CELL, V21, P3119, DOI 10.1105/tpc.108.064758; Hothorn M, 2004, PLANT CELL, V16, P3437, DOI 10.1105/tpc.104.025684; Hothorn M, 2010, P NATL ACAD SCI USA, V107, P17427, DOI 10.1073/pnas.1004481107; Irshad M, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-94; Jerabek-Willemsen M, 2014, J MOL STRUCT, V1077, P101, DOI 10.1016/j.molstruc.2014.03.009; Johansson K, 2002, FEBS LETT, V514, P243, DOI 10.1016/S0014-5793(02)02372-4; Jolie RP, 2010, CARBOHYD RES, V345, P2583, DOI 10.1016/j.carres.2010.10.002; Jolie RP, 2009, INNOV FOOD SCI EMERG, V10, P601, DOI 10.1016/j.ifset.2009.02.003; KLAVONS JA, 1986, J AGR FOOD CHEM, V34, P597, DOI 10.1021/jf00070a004; Lionetti V, 2007, PLANT PHYSIOL, V143, P1871, DOI 10.1104/pp.106.090803; Lionetti V, 2012, J PLANT PHYSIOL, V169, P1623, DOI 10.1016/j.jplph.2012.05.006; Louvet R, 2006, PLANTA, V224, P782, DOI 10.1007/s00425-006-0261-9; Muller K, 2013, PLANT PHYSIOL, V161, P305, DOI 10.1104/pp.112.205724; Nakagawa T, 2007, J BIOSCI BIOENG, V104, P34, DOI 10.1263/jbb.104.34; Nguyen BL, 2002, BIOTECHNOL BIOENG, V78, P683, DOI 10.1002/bit.10249; Peaucelle A, 2008, CURR BIOL, V18, P1943, DOI 10.1016/j.cub.2008.10.065; Pelletier S, 2010, NEW PHYTOL, V188, P726, DOI 10.1111/j.1469-8137.2010.03409.x; Pelloux J, 2007, TRENDS PLANT SCI, V12, P267, DOI 10.1016/j.tplants.2007.04.001; Pilling J, 2000, PLANTA, V210, P391, DOI 10.1007/PL00008147; Raiola A, 2004, FEBS LETT, V557, P199, DOI 10.1016/S0014-5793(03)01491-1; Ralet MC, 2012, BIOMACROMOLECULES, V13, P1615, DOI 10.1021/bm300329r; Ralet MC, 2001, CARBOHYD RES, V336, P117, DOI 10.1016/S0008-6215(01)00248-8; Ralet MC, 2005, PHYTOCHEMISTRY, V66, P1832, DOI 10.1016/j.phytochem.2005.06.003; Ren CW, 2000, PLANT PHYSIOL, V124, P231, DOI 10.1104/pp.124.1.231; RESTREPO MA, 1990, PLANT CELL, V2, P987, DOI 10.1105/tpc.2.10.987; Rockel N, 2008, PLANT J, V53, P133, DOI 10.1111/j.1365-313X.2007.03325.x; Saez-Aguayo S, 2013, PLANT CELL, V25, P308, DOI 10.1105/tpc.112.106575; Senechal F, 2014, ANN BOT-LONDON, V114, P1161, DOI 10.1093/aob/mcu035; Sexton TR, 2012, PLANT PHYSIOL, V158, P531, DOI 10.1104/pp.111.181602; Sterling JD, 2001, PLANT PHYSIOL, V127, P360, DOI 10.1104/pp.127.1.360; Tanhatan-Nasseri A, 2011, CARBOHYD POLYM, V86, P1236, DOI 10.1016/j.carbpol.2011.06.019; Thonar C, 2006, J EXP BOT, V57, P81, DOI 10.1093/jxb/erj006; van Alebeek GJWM, 2003, BIOCHEM J, V372, P211, DOI 10.1042/BJ20021471; Venkatraman V, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-407; VERWOERD TC, 1989, NUCLEIC ACIDS RES, V17, P2362, DOI 10.1093/nar/17.6.2362; Weber M, 2013, PLANT J, V76, P151, DOI 10.1111/tpj.12279; Wienken CJ, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1093; Wolf S, 2003, FEBS LETT, V555, P551, DOI 10.1016/S0014-5793(03)01344-9; Wolf S, 2009, PLANT J, V58, P361, DOI 10.1111/j.1365-313X.2009.03784.x; Yoo SH, 2006, FOOD HYDROCOLLOID, V20, P62, DOI 10.1016/j.foodhyd.2005.03.003	67	33	36	1	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2015	290	38					23320	23335		10.1074/jbc.M115.639534	http://dx.doi.org/10.1074/jbc.M115.639534			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CR9OE	26183897	hybrid, Green Published			2022-12-26	WOS:000361685500039
J	Andreotti, G; Hoppin, JA; Hou, LF; Koutros, S; Gadalla, SM; Savage, SA; Lubin, J; Blair, A; Hoxha, M; Baccarelli, A; Sandler, D; Alavanja, M; Freeman, LEB				Andreotti, Gabriella; Hoppin, Jane A.; Hou, Lifang; Koutros, Stella; Gadalla, Shahinaz M.; Savage, Sharon A.; Lubin, Jay; Blair, Aaron; Hoxha, Mirjam; Baccarelli, Andrea; Sandler, Dale; Alavanja, Michael; Freeman, Laura E. Beane			Pesticide Use and Relative Leukocyte Telomere Length in the Agricultural Health Study	PLOS ONE			English	Article							OCCUPATIONAL-EXPOSURE; OXIDATIVE STRESS; INSECTICIDE USE; APPLICATORS; LYMPHOCYTES; WORKERS; CANCER	Some studies suggest that telomere length (TL) may be influenced by environmental exposures, including pesticides. We examined associations between occupational pesticide use reported at three time points and relative telomere length (RTL) in the Agricultural Health Study (AHS), a prospective cohort study of pesticide applicators in Iowa and North Carolina. RTL was measured by qPCR using leukocyte DNA from 568 cancer-free male AHS participants aged 31-94 years with blood samples collected between 2006 and 2008. Self-reported information, including pesticide use, was collected at three time points: enrollment (1993-1997) and two follow-up questionnaires (1998-2003, 2005-2008). For each pesticide, we evaluated cumulative use (using data from all three questionnaires), and more recent use (using data from the last follow-up questionnaire). Multivariable linear regression was used to examine the associations between pesticide use (ever, lifetime days, intensity-weighted lifetime days (lifetime days*intensity score)) and RTL, adjusting for age at blood draw and use of other pesticides. Of the 57 pesticides evaluated with cumulative use, increasing lifetime days of 2,4-D (p-trend=0.001), diazinon (p-trend=0.002), and butylate (p-trend=0.01) were significantly associated with shorter RTL, while increasing lifetime days of alachlor was significantly associated with longer RTL (p-trend=0.03). Only the association with 2,4-D was significant after adjustment for multiple comparisons. Of the 40 pesticides evaluated for recent use, malathion was associated with shorter RTL (p=0.03), and alachlor with longer RTL (p=0.03). Our findings suggest that leukocyte TL may be impacted by cumulative use and recent use of certain pesticides.	[Andreotti, Gabriella; Koutros, Stella; Gadalla, Shahinaz M.; Savage, Sharon A.; Lubin, Jay; Blair, Aaron; Alavanja, Michael; Freeman, Laura E. Beane] NCI, Div Canc Epidemiol & Genet, NIH, Dept Hlth & Human Serv, Bethesda, MD 20892 USA; [Hoppin, Jane A.] N Carolina State Univ, Dept Biol Sci, Raleigh, NC 27695 USA; [Hou, Lifang] Northwestern Univ, Feinberg Sch Med, Dept Prevent Med, Chicago, IL 60611 USA; [Hou, Lifang] Northwestern Univ, Feinberg Sch Med, Robert H Lurie Comprehens Canc Ctr, Chicago, IL 60611 USA; [Hoxha, Mirjam] Univ Milan, Dept Clin Sci & Community Hlth, Ctr Mol & Genet Epidemiol, Milan, Italy; [Baccarelli, Andrea] Harvard Univ, Sch Publ Hlth, Exposure Epidemiol & Risk Program, Lab Environm Epigenet,Dept Environm Hlth, Boston, MA 02115 USA; [Sandler, Dale] NIEHS, Epidemiol Branch, NIH DHHS, Res Triangle Pk, NC 27709 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of North Carolina; North Carolina State University; Northwestern University; Feinberg School of Medicine; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Feinberg School of Medicine; Robert H. Lurie Comprehensive Cancer Center; University of Milan; Harvard University; Harvard T.H. Chan School of Public Health; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Andreotti, G (corresponding author), NCI, Div Canc Epidemiol & Genet, NIH, Dept Hlth & Human Serv, Bethesda, MD 20892 USA.	andreotg@mail.nih.gov	Savage, Sharon A/B-9747-2015; Savage, Sharon/AAB-5160-2019; Koutros, Stella/W-5788-2019; Gadalla, Shahinaz/U-2848-2019; Gadalla, Shahinaz M/C-4005-2015; Freeman, Laura E. Beane/C-4468-2015	Savage, Sharon A/0000-0001-6006-0740; Savage, Sharon/0000-0001-6006-0740; Koutros, Stella/0000-0001-5294-5485; Gadalla, Shahinaz M/0000-0002-3255-8143; Freeman, Laura E. Beane/0000-0003-1294-4124; Baccarelli, Andrea/0000-0002-3436-0640	Intramural Department of National Institutes of Health; NATIONAL CANCER INSTITUTE [ZIACP010119] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES049030, ZIAES049028] Funding Source: NIH RePORTER	Intramural Department of National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was funded by the Intramural Department of the National Institutes of Health.	Alavanja MCR, 1996, ENVIRON HEALTH PERSP, V104, P362, DOI 10.2307/3432672; Appendix B, 2004, INT HUMAN DOSING STU; Banerjee B D, 2001, Rev Environ Health, V16, P1; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blair A, 2002, EPIDEMIOLOGY, V13, P94, DOI 10.1097/00001648-200201000-00015; Boulay JL, 1999, BIOTECHNIQUES, V27, P228, DOI 10.2144/99272bm03; Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47; Coble J, 2011, INT J ENV RES PUB HE, V8, P4608, DOI 10.3390/ijerph8124608; Coluzzi E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110963; Daniali L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2602; Dioni L, 2011, ENVIRON HEALTH PERSP, V119, P622, DOI 10.1289/ehp.1002486; Figgs LW, 2000, CANCER CAUSE CONTROL, V11, P373, DOI 10.1023/A:1008925824242; Gadalla SM, 2010, AGING-US, V2, P867, DOI 10.18632/aging.100235; Holland NT, 2002, MUTAT RES-GEN TOX EN, V521, P165, DOI 10.1016/S1383-5718(02)00237-1; Hoppin JA, 2002, J EXPO ANAL ENV EPID, V12, P313, DOI 10.1038/sj.jea.7500232; Hoppin JA, 2012, J EXPO SCI ENV EPID, V22, P584, DOI 10.1038/jes.2012.79; Hou LF, 2013, ENVIRON HEALTH PERSP, V121, P919, DOI 10.1289/ehp.1206432; Hou LF, 2012, CANCER LETT, V319, P130, DOI 10.1016/j.canlet.2012.01.028; Lin JG, 2014, DNA REPAIR, V20, P142, DOI 10.1016/j.dnarep.2014.01.012; Ma HX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020466; Muniz JF, 2008, TOXICOL APPL PHARM, V227, P97, DOI 10.1016/j.taap.2007.10.027; Passos JF, 2005, EXP GERONTOL, V40, P466, DOI 10.1016/j.exger.2005.04.006; Rigolin GM, 2004, EUR J HAEMATOL, V73, P351, DOI 10.1111/j.1600-0609.2004.00305.x; Rollison DE, 2011, LEUKEMIA LYMPHOMA, V52, P1528, DOI 10.3109/10428194.2011.568648; Schinasi L, 2014, INT J ENV RES PUB HE, V11, P4449, DOI 10.3390/ijerph110404449; Schreinemachers DM, 2010, ENVIRON HEALTH-GLOB, V9, DOI 10.1186/1476-069X-9-11; Shin JY, 2010, MUTAGENESIS, V25, P511, DOI 10.1093/mutage/geq035; Starks SE, 2012, NEUROTOXICOL TERATOL, V34, P168, DOI 10.1016/j.ntt.2011.08.014; US EPA, 2005, 738R05002 USEPA; von Zglinicki T, 2002, TRENDS BIOCHEM SCI, V27, P339, DOI 10.1016/S0968-0004(02)02110-2; WENG NP, 1995, P NATL ACAD SCI USA, V92, P11091, DOI 10.1073/pnas.92.24.11091; Wentzensen IM, 2011, CANCER EPIDEM BIOMAR, V20, P1238, DOI 10.1158/1055-9965.EPI-11-0005; Wong JYY, 2014, J TOXICOL ENV HEAL A, V77, P441, DOI 10.1080/15287394.2013.875497; Zhang X, 2013, OCCUP ENVIRON MED, V70, P743, DOI 10.1136/oemed-2012-101350	34	27	27	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0133382	10.1371/journal.pone.0133382	http://dx.doi.org/10.1371/journal.pone.0133382			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LZ	26196902	gold, Green Published, Green Submitted			2022-12-26	WOS:000358547600090
J	Depraetere, O; Deschoenmaeker, F; Badri, H; Monsieurs, P; Foubert, I; Leys, N; Wattiez, R; Muylaert, K				Depraetere, Orily; Deschoenmaeker, Frederic; Badri, Hanene; Monsieurs, Pieter; Foubert, Imogen; Leys, Natalie; Wattiez, Ruddy; Muylaert, Koenraad			Trade-Off between Growth and Carbohydrate Accumulation in Nutrient-Limited Arthrospira sp PCC 8005 Studied by Integrating Transcriptomic and Proteomic Approaches	PLOS ONE			English	Article							POLY-BETA-HYDROXYBUTYRATE; NITROGEN STARVATION; GENE-EXPRESSION; GENOME SEQUENCE; LIGHT-INTENSITY; CYANOBACTERIUM; MICROALGAE; PLATENSIS; GLYCOGEN; POLYHYDROXYBUTYRATE	Cyanobacteria have a strong potential for biofuel production due to their ability to accumulate large amounts of carbohydrates. Nitrogen (N) stress can be used to increase the content of carbohydrates in the biomass, but it is expected to reduce biomass productivity. To study this trade-off between carbohydrate accumulation and biomass productivity, we characterized the biomass productivity, biomass composition as well as the transcriptome and proteome of the cyanobacterium Arthrospira sp. PCC 8005 cultured under N-limiting and N-replete conditions. N limitation resulted in a large increase in the carbohydrate content of the biomass (from 14 to 74%) and a decrease in the protein content (from 37 to 10%). Analyses of fatty acids indicated that no lipids were accumulated under N-limited conditions. Nevertheless, it did not affect the biomass productivity of the culture up to five days after N was depleted from the culture medium. Transcriptomic and proteomic analysis indicated that de novo protein synthesis was down-regulated in the N-limited culture. Proteins were degraded and partly converted into carbohydrates through gluconeogenesis. Cellular N derived from protein degradation was recycled through the TCA and GS-GOGAT cycles. In addition, photosynthetic energy production and carbon fixation were both down-regulated, while glycogen synthesis was up-regulated. Our results suggested that N limitation resulted in a redirection of photosynthetic energy from protein synthesis to glycogen synthesis. The fact that glycogen synthesis has a lower energy demand than protein synthesis might explain why Arthrospira is able to achieve a similar biomass productivity under N-limited as under N-replete conditions despite the fact that photosynthetic energy production was impaired by N limitation.	[Depraetere, Orily; Muylaert, Koenraad] KU Leuven Campus Kortrijk, Lab Aquat Biol, B-8500 Kortrijk, Belgium; [Deschoenmaeker, Frederic; Wattiez, Ruddy] Univ Mons, Res Inst Biosci, Dept Prote & Microbiol, B-7000 Mons, Belgium; [Badri, Hanene; Monsieurs, Pieter; Leys, Natalie] Belgian Nucl Res Ctr SCK CEN, Expert Grp Mol & Cellular Biol MCB, B-2400 Mol, Belgium; [Foubert, Imogen] KU Leuven Campus Kortrijk, Dept Mol & Microbial Syst Kulak, Res Unit Food & Lipids, B-8500 Kortrijk, Belgium	KU Leuven; University of Mons; Belgian Nuclear Research Centre (SCK-CEN); KU Leuven	Depraetere, O (corresponding author), KU Leuven Campus Kortrijk, Lab Aquat Biol, E Sabbelaan 53, B-8500 Kortrijk, Belgium.	Orily.Depraetere@kuleuven-kortrijk.be	Leys, Natalie M.E.J./P-2761-2017; Monsieurs, Pieter/A-2917-2009; Monsieurs, Pieter/W-3916-2019	Monsieurs, Pieter/0000-0003-2214-6652; Foubert, Imogen/0000-0001-8735-8926; wattiez, ruddy/0000-0003-2071-4310; Muylaert, Koenraad/0000-0001-9645-4063	innovation by science and technology (IWT) grant [111275]; fund for research training in industry and agriculture (FRIA) [2877824]; FWO project [1509513N]; KU Leuven OT project [14/065]	innovation by science and technology (IWT) grant(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); fund for research training in industry and agriculture (FRIA)(Fonds de la Recherche Scientifique - FNRS); FWO project(FWO); KU Leuven OT project	The innovation by science and technology (IWT) grant 111275 was awarded to Depraetere O. and the fund for research training in industry and agriculture (FRIA) 2877824 was awarded to Deschoenmaeker F. Depraetere O. is an IWT PhD student and Deschoenmaeker is an FRIA PhD student. Additionally, financial support was provided by FWO project 1509513N and KU Leuven OT project 14/065. Deschoenmaeker F., Wattiez R., Monsieurs P., Badri H. and Leys N. are partners of MELiSSA project from European Space Agency. Thanks to the IRBB team (Institute for Research of Biomedicines in Barcelona) for the cDNA library preparation and amplification.	Aguirre von Wobeser E, 2011, PLANT PHYSIOL, V155, P1445, DOI 10.1104/pp.110.165837; Aikawa S, 2012, BIORESOURCE TECHNOL, V108, P211, DOI 10.1016/j.biortech.2012.01.004; Badri H, 2015, MICROBIOLOGYOPEN, V4, P187, DOI 10.1002/mbo3.229; BALL SG, 1990, PLANT SCI, V66, P1, DOI 10.1016/0168-9452(90)90162-H; Becker EW, 2007, BIOTECHNOL ADV, V25, P207, DOI 10.1016/j.biotechadv.2006.11.002; Benemann J, 2013, ENERGIES, V6, P5869, DOI 10.3390/en6115869; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Borowitzka MA, 2013, MITIG ADAPT STRAT GL, V18, P13, DOI 10.1007/s11027-010-9271-9; Branyikova I, 2011, BIOTECHNOL BIOENG, V108, P766, DOI 10.1002/bit.23016; Bryant DA, 2006, THE MOLECULAR BIOLOG; CAMPBELL J, 1982, J BACTERIOL, V149, P361, DOI 10.1128/JB.149.1.361-363.1982; Cheevadhanarak S, 2012, STAND GENOMIC SCI, V6, P43, DOI 10.4056/sigs.2525955; Cho S, 2013, BIORESOURCE TECHNOL, V131, P515, DOI 10.1016/j.biortech.2012.12.176; Cogne G, 2003, BIOTECHNOL BIOENG, V81, P588, DOI 10.1002/bit.10504; DEPHILIPPIS R, 1992, J GEN MICROBIOL, V138, P1623, DOI 10.1099/00221287-138-8-1623; Depraetere O, 2015, BIORESOURCE TECHNOL, V180, P16, DOI 10.1016/j.biortech.2014.12.084; Deschoenmaeker F, 2014, MICROBIOL-SGM, V160, P1224, DOI 10.1099/mic.0.074641-0; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; Eaton A.D., 2005, STANDARD METHODS FOR; Ehira S, 2006, MOL MICROBIOL, V59, P1692, DOI 10.1111/j.1365-2958.2006.05049.x; Forchhammer K, 2008, TRENDS MICROBIOL, V16, P65, DOI 10.1016/j.tim.2007.11.004; Fujisawa T, 2010, DNA RES, V17, P85, DOI 10.1093/dnares/dsq004; Gonzalez-Fernandez C, 2012, BIOTECHNOL ADV, V30, P1655, DOI 10.1016/j.biotechadv.2012.07.003; Gordillo FJL, 1998, J APPL PHYCOL, V10, P461, DOI 10.1023/A:1008090402847; Griffiths MJ, 2009, J APPL PHYCOL, V21, P493, DOI 10.1007/s10811-008-9392-7; Harke MJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069834; Hasunuma T, 2013, J EXP BOT, V64, P2943, DOI 10.1093/jxb/ert134; Huang SQ, 2013, MOL BIOSYST, V9, P2565, DOI 10.1039/c3mb70188c; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Janssen PJ, 2010, J BACTERIOL, V192, P2465, DOI 10.1128/JB.00116-10; Kolodny NH, 2006, J BACTERIOL, V188, P934, DOI 10.1128/JB.188.3.934-940.2006; Krasikov V, 2012, PHYSIOL PLANTARUM, V145, P426, DOI 10.1111/j.1399-3054.2012.01585.x; Lam MK, 2012, BIOTECHNOL ADV, V30, P673, DOI 10.1016/j.biotechadv.2011.11.008; Lefort F, 2014, GENOME ANNOUNC, V2, P4, DOI [10.1128/genomeA.00751-14, DOI 10.1128/GENOMEA.00751-14.COPYRIGHT]; LEPAGE G, 1984, J LIPID RES, V25, P1391; Li X, 2010, BIORESOURCE TECHNOL, V101, P5494, DOI 10.1016/j.biortech.2010.02.016; Lichtenthaler H.K., 2001, CURR PROTOC FOOD ANA, V1, pF4.3.1, DOI [10.1002/0471142913.faf0403s01, DOI 10.1002/0471142913.FAF0403S01]; Luddecke J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083181; MacLean B, 2010, BIOINFORMATICS, V26, P966, DOI 10.1093/bioinformatics/btq054; Markou G, 2012, WORLD J MICROB BIOT, V28, P2661, DOI 10.1007/s11274-012-1076-4; Mata TM, 2010, RENEW SUST ENERG REV, V14, P217, DOI 10.1016/j.rser.2009.07.020; Matallana-Surget S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099076; Monshupanee T, 2014, J APPL MICROBIOL, V116, P830, DOI 10.1111/jam.12409; Nagase H, 2001, BIOCHEM ENG J, V7, P241, DOI 10.1016/S1369-703X(00)00122-4; Osanai T, 2006, DNA RES, V13, P185, DOI 10.1093/dnares/dsl010; PENNINGDEVRIES FW, 1974, J THEOR BIOL, V45, P339; Pienkos PT, 2009, BIOFUEL BIOPROD BIOR, V3, P431, DOI 10.1002/bbb.159; Poorter Hendrik, 1994, P111; Qualls RG, 1989, DETERMINATION OF TOT; Quintana N, 2011, APPL MICROBIOL BIOT, V91, P471, DOI 10.1007/s00253-011-3394-0; Radakovits R, 2010, EUKARYOT CELL, V9, P486, DOI 10.1128/EC.00364-09; Reijnders MJMF, 2014, TRENDS BIOTECHNOL, V32, P617, DOI 10.1016/j.tibtech.2014.10.003; Sassano CEN, 2010, BIOMASS BIOENERG, V34, P1732, DOI 10.1016/j.biombioe.2010.07.002; Sauer J, 2001, PLANT PHYSIOL, V126, P233, DOI 10.1104/pp.126.1.233; Schilling B, 2012, MOL CELL PROTEOMICS, V11, P202, DOI 10.1074/mcp.M112.017707; Schlebusch M, 2010, APPL ENVIRON MICROB, V76, P6101, DOI 10.1128/AEM.00484-10; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Subramanian S, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-150; Tolonen AC, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100087; VANVELDHOVEN PP, 1987, ANAL BIOCHEM, V161, P45, DOI 10.1016/0003-2697(87)90649-X; Wang HL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083485; Wang HL, 2013, PROTEOME SCI, V11, DOI 10.1186/1477-5956-11-6; Wegener KM, 2010, MOL CELL PROTEOMICS, V9, DOI 10.1074/mcp.M110.000109; Yoshikawa N, 2008, J AOAC INT, V91, P524	65	35	36	2	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0132461	10.1371/journal.pone.0132461	http://dx.doi.org/10.1371/journal.pone.0132461			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LZ	26196510	Green Published, Green Submitted, gold			2022-12-26	WOS:000358547600038
J	Lemarie, F; Beauchamp, E; Dayot, S; Duby, C; Legrand, P; Rioux, V				Lemarie, Fanny; Beauchamp, Erwan; Dayot, Stephanie; Duby, Cecile; Legrand, Philippe; Rioux, Vincent			Dietary Caprylic Acid (C8:0) Does Not Increase Plasma Acylated Ghrelin but Decreases Plasma Unacylated Ghrelin in the Rat	PLOS ONE			English	Article							MEDIUM-CHAIN TRIGLYCERIDES; O-ACYLTRANSFERASE GOAT; FATTY-ACIDS; GASTRIC ABSORPTION; ADIPOSE-TISSUE; WEIGHT CONTROL; MYRISTIC ACID; BODY-WEIGHT; FOOD-INTAKE; IN-VIVO	Focusing on the caprylic acid (C8:0), this study aimed at investigating the discrepancy between the formerly described beneficial effects of dietary medium chain fatty acids on body weight loss and the C8:0 newly reported effect on food intake via ghrelin octanoylation. During 6 weeks, Sprague-Dawley male rats were fed with three dietary C8:0 levels (0, 8 and 21% of fatty acids) in three experimental conditions (moderate fat, caloric restriction and high fat). A specific dose-response enrichment of the stomach tissue C8:0 was observed as a function of dietary C8:0, supporting the hypothesis of an early preduodenal hydrolysis of medium chain triglycerides and a direct absorption at the gastric level. However, the octanoylated ghrelin concentration in the plasma was unchanged in spite of the increased C8:0 availability. A reproducible decrease in the plasma concentration of unacylated ghrelin was observed, which was consistent with a decrease in the stomach preproghrelin mRNA and stomach ghrelin expression. The concomitant decrease of the plasma unacylated ghrelin and the stability of its acylated form resulted in a significant increase in the acylated/total ghrelin ratio which had no effect on body weight gain or total dietary consumption. This enhanced ratio measured in rats consuming C8:0 was however suspected to increase (i) growth hormone (GH) secretion as an increase in the GH-dependent mRNA expression of the insulin like growth Factor 1 (IGF-1) was measured (ii) adipocyte diameters in subcutaneous adipose tissue without an increase in the fat pad mass. Altogether, these results show that daily feeding with diets containing C8:0 increased the C8:0 level in the stomach more than all the other tissues, affecting the acylated/total ghrelin plasma ratio by decreasing the concentration of circulating unacylated ghrelin. However, these modifications were not associated with increased body weight or food consumption.	[Lemarie, Fanny; Beauchamp, Erwan; Dayot, Stephanie; Duby, Cecile; Legrand, Philippe; Rioux, Vincent] INRA, Agrocampus Ouest, Lab Biochem & Human Nutr, USC 1378, Rennes, France	INRAE; Institut Agro; Agrocampus Ouest	Rioux, V (corresponding author), INRA, Agrocampus Ouest, Lab Biochem & Human Nutr, USC 1378, Rennes, France.	Vincent.Rioux@agrocampus-ouest.fr	Legrand, Philippe/AAM-6060-2020; Rioux, Vincent/Y-8845-2019; Rioux, Vincent/AAY-4077-2020	Rioux, Vincent/0000-0001-9837-1675; Rioux, Vincent/0000-0001-9837-1675; Legrand, Philippe/0000-0001-5763-4854	CNIEL (Comite National Interprofessionnel de l'Economie Laitiere)	CNIEL (Comite National Interprofessionnel de l'Economie Laitiere)	This work was supported by grants from the CNIEL (Comite National Interprofessionnel de l'Economie Laitiere). The funders had no role in data collection and analysis, decision to publish, or preparation of the manuscript.	Albarran-Zeckler RG, 2011, PEPTIDES, V32, P2229, DOI 10.1016/j.peptides.2011.07.003; Astrup A, 2011, AM J CLIN NUTR, V93, P684, DOI 10.3945/ajcn.110.004622; BABA N, 1987, LIPIDS, V22, P442, DOI 10.1007/BF02537276; Bach AC, 1996, J LIPID RES, V37, P708; BACH AC, 1982, AM J CLIN NUTR, V36, P950, DOI 10.1093/ajcn/36.5.950; Barnett BP, 2010, SCIENCE, V330, P1689, DOI 10.1126/science.1196154; Bays Harold E, 2008, Expert Rev Cardiovasc Ther, V6, P343, DOI 10.1586/14779072.6.3.343; Briggs DI, 2011, CURR DIABETES REV, V7, P201, DOI 10.2174/157339911795843140; CARRIERE F, 1993, GASTROENTEROLOGY, V105, P876, DOI 10.1016/0016-5085(93)90908-U; Castaneda TR, 2010, FRONT NEUROENDOCRIN, V31, P44, DOI 10.1016/j.yfrne.2009.10.008; Chen CY, 2012, MOL MED REP, V6, P191, DOI 10.3892/mmr.2012.901; Chen W, 2014, TRANSL GASTROINTEST, V4, P14; Chia DJ, 2014, MOL ENDOCRINOL, V28, P1012, DOI 10.1210/me.2014-1099; CLARK SB, 1969, GASTROENTEROLOGY, V56, P214; CROZIER G, 1987, METABOLISM, V36, P807, DOI 10.1016/0026-0495(87)90122-3; Cummings DE, 2005, CURR DRUG TARGETS, V6, P153, DOI 10.2174/1389450053174569; Delhanty PJD, 2015, CLIN ENDOCRINOL, V82, P142, DOI 10.1111/cen.12489; Delporte C., 2013, SCIENTIFICA, V2013, DOI DOI 10.1155/2013/518909; EGELRUD T, 1971, SCAND J GASTROENTERO, V6, P329, DOI 10.3109/00365527109181129; Ezanno H, 2015, EUR J LIPID SCI TECH, V117, P281, DOI 10.1002/ejlt.201400304; Ferreira L, 2014, J ANIM PHYSIOL AN N, V98, P1, DOI 10.1111/jpn.12030; Fukumori R, 2013, DOMEST ANIM ENDOCRIN, V45, P216, DOI 10.1016/j.domaniend.2013.09.005; GARGOURI Y, 1986, BIOCHIM BIOPHYS ACTA, V879, P419, DOI 10.1016/0005-2760(86)90234-1; GELIEBTER A, 1983, AM J CLIN NUTR, V37, P1; Goebel-Stengel M, 2013, PEPTIDES, V43, P13, DOI 10.1016/j.peptides.2013.02.011; Gong Z, 2014, AM J PHYSIOL-ENDOC M, V306, pE28, DOI 10.1152/ajpendo.00306.2013; Guillou H, 2002, LIPIDS, V37, P981, DOI 10.1007/s11745-006-0990-3; Gutierrez JA, 2008, P NATL ACAD SCI USA, V105, P6320, DOI 10.1073/pnas.0800708105; Han JR, 2003, OBES RES, V11, P734, DOI 10.1038/oby.2003.103; Han JR, 2002, J NUTR, V132, P904, DOI 10.1093/jn/132.5.904; Hosoda H, 2000, BIOCHEM BIOPH RES CO, V279, P909, DOI 10.1006/bbrc.2000.4039; Hosoda H, 2012, METHOD ENZYMOL, V514, P113, DOI 10.1016/B978-0-12-381272-8.00008-8; Howard AD, 1996, SCIENCE, V273, P974, DOI 10.1126/science.273.5277.974; Hu FB, 1999, AM J CLIN NUTR, V70, P1001; Inhoff T, 2008, PEPTIDES, V29, P2159, DOI 10.1016/j.peptides.2008.09.014; Janssen S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040168; JENSEN RG, 1990, J DAIRY SCI, V73, P223, DOI 10.3168/jds.S0022-0302(90)78666-3; Kamegai J, 2001, DIABETES, V50, P2438, DOI 10.2337/diabetes.50.11.2438; Kirchner H, 2009, NAT MED, V15, P741, DOI 10.1038/nm.1997; Knockaert L, 2012, LAB INVEST, V92, P396, DOI 10.1038/labinvest.2011.193; Kojima M, 1999, NATURE, V402, P656, DOI 10.1038/45230; Kubota N, 1999, MOL CELL, V4, P597, DOI 10.1016/S1097-2765(00)80210-5; Kumar R, 2010, REGUL PEPTIDES, V164, P65, DOI 10.1016/j.regpep.2010.06.005; Lai HC, 1998, J NUTR, V128, P2403, DOI 10.1093/jn/128.12.2403; Lee HM, 2002, ENDOCRINOLOGY, V143, P185, DOI 10.1210/en.143.1.185; Legrand P, 2011, WORLD REV NUTR DIET, V102, P137, DOI 10.1159/000327800; Legrand P, 2010, LIPIDS, V45, P975, DOI 10.1007/s11745-010-3481-5; Leidy HJ, 2007, OBESITY, V15, P446, DOI 10.1038/oby.2007.542; Nagao K, 2010, PHARMACOL RES, V61, P208, DOI 10.1016/j.phrs.2009.11.007; Nishi Y, 2005, ENDOCRINOLOGY, V146, P2709, DOI 10.1210/en.2004-0645; Nishi Y, 2005, ENDOCRINOLOGY, V146, P2255, DOI 10.1210/en.2004-0695; Nishi Yoshihiro, 2013, Front Endocrinol (Lausanne), V4, P84, DOI 10.3389/fendo.2013.00084; Nishi Y, 2012, METHOD ENZYMOL, V514, P303, DOI 10.1016/B978-0-12-381272-8.00019-2; Ooyama K, 2009, J NUTR SCI VITAMINOL, V55, P423, DOI 10.3177/jnsv.55.423; Papamandjaris AA, 1998, LIFE SCI, V62, P1203, DOI 10.1016/S0024-3205(97)01143-0; Patterson M, 2005, J CLIN ENDOCR METAB, V90, P2205, DOI 10.1210/jc.2004-1641; PERRET JP, 1980, J PHYSIOL-PARIS, V76, P159; Rioux V, 2007, ANIMAL, V1, P820, DOI 10.1017/S1751731107000122; Rioux V, 2005, REPROD NUTR DEV, V45, P599, DOI 10.1051/rnd:2005048; Rioux V, 2013, J LIPID RES, V54, P3438, DOI 10.1194/jlr.M042572; SARDA P, 1987, AM J CLIN NUTR, V45, P399, DOI 10.1093/ajcn/45.2.399; St-Onge MP, 2008, J AM COLL NUTR, V27, P547, DOI 10.1080/07315724.2008.10719737; St-Onge MP, 2002, J NUTR, V132, P329; Sun Y, 2006, CELL METAB, V3, P379, DOI 10.1016/j.cmet.2006.04.004; Takagi K, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3685; Takeuchi H, 2008, ASIA PAC J CLIN NUTR, V17, P320; Thompson NM, 2004, ENDOCRINOLOGY, V145, P234, DOI 10.1210/en.2003-0899; Toshinai K, 2006, ENDOCRINOLOGY, V147, P2306, DOI 10.1210/en.2005-1357; Tschop M, 2000, NATURE, V407, P908, DOI 10.1038/35038090; Tsuji H, 2001, J NUTR, V131, P2853, DOI 10.1093/jn/131.11.2853; Wang Q, 2014, MOL METAB, V3, P64, DOI 10.1016/j.molmet.2013.10.001; Yamauchi T, 2001, J CLIN INVEST, V108, P1001, DOI 10.1172/JCI12864; Yang J, 2008, CELL, V132, P387, DOI 10.1016/j.cell.2008.01.017; Yi CX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032100; You YQN, 2008, JPEN-PARENTER ENTER, V32, P169, DOI 10.1177/0148607108314758; ZAMMIT VA, 1984, PROG LIPID RES, V23, P39, DOI 10.1016/0163-7827(84)90005-5; Zhang YY, 2015, P NATL ACAD SCI USA, V112, P1226, DOI 10.1073/pnas.1423643112; Zhao TJ, 2010, P NATL ACAD SCI USA, V107, P7467, DOI 10.1073/pnas.1002271107	78	19	19	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0133600	10.1371/journal.pone.0133600	http://dx.doi.org/10.1371/journal.pone.0133600			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LZ	26196391	Green Published, Green Submitted, gold			2022-12-26	WOS:000358547600117
J	Luo, M; Zhou, XH; Ji, HH; Ma, WJ; Liu, GL; Dai, DJ; Li, JY; Chang, L; Xu, L; Jiang, LT; Duan, SW; Wang, QW				Luo, Mei; Zhou, Xiaohui; Ji, Huihui; Ma, Wenjuan; Liu, Guili; Dai, Dongjun; Li, Jingyun; Chang, Lan; Xu, Lei; Jiang, Liting; Duan, Shiwei; Wang, Qinwen			Population Difference in the Associations of KLOTH Promoter Methylation with Mild Cognitive Impairment in Xinjiang Uygur and Han Populations	PLOS ONE			English	Article							VASCULAR RISK-FACTORS; WORKING-MEMORY; DNA-REPAIR; ALPHA; CHOLESTEROL; AMERICANS; PROTEIN	Background Mild cognitive impairment (MCI) is the intermediate stage of the cognitive changes between normal aging and dementia. KLOTH is an age-related gene that may contribute to the risk of MCI. The aim of our study was to explore the association between KLOTHO promoter methylation and MCI in Xinjiang Uygur and Han populations. Methods DNA methylation assay was performed using the bisulphite pyrosequencing technology among 96 Uygur (48 MCI and 48 controls) and 96 Han (48 MCI and 48 controls) Chinese individuals from Xinjiang province of China. Results We found significant association between KLOTHO promoter methylation and MCI in the Han Chinese (CpG1: p = 3.77E-06; CpG2: p = 1.91E-07; CpG3: p = 5.83E-07; CpG4: p = 2.23E-05; CpG5: p = 3.03E-06) but not in the Uygur Chinese. Higher KLOTHO promoter methylation levels were found in Han MCI patients than Uygur MCI patients for all the five CpGs (adjusted p values by age < 0.02). Conclusion Our results showed that KLOTHO promoter hypermethylation contributed to the MCI risk in Xinjiang Han Chinese but not in Xinjiang Uygur Chinese. The population difference of KLOTHO methylation in the risk of MCI required further investigation in the future.	[Luo, Mei; Zhou, Xiaohui; Ma, Wenjuan] Xinjiang Med Univ, Affiliated Hosp 1, Dept Internal Med Cadres, Urumqi 830000, Peoples R China; [Ji, Huihui; Liu, Guili; Dai, Dongjun; Li, Jingyun; Chang, Lan; Xu, Lei; Jiang, Liting; Duan, Shiwei; Wang, Qinwen] Ningbo Univ, Sch Med, Ningbo Key Lab Behav Neurosci, Zhejiang Prov Key Lab Pathophysiol, Ningbo 315211, Zhejiang, Peoples R China	Xinjiang Medical University; Ningbo University	Zhou, XH (corresponding author), Xinjiang Med Univ, Affiliated Hosp 1, Dept Internal Med Cadres, Urumqi 830000, Peoples R China.	zhouxiaohui858@sina.com; duanshiwei@nbu.edu.cn; wangqinwen@nbu.edu.cn	Duan, Shiwei/AAA-4782-2022	Duan, Shiwei/0000-0001-7682-2877	National Natural Science Foundation of China [81471398, 81070873, 31100919, 81371469]; Ministry of Science and Technology of China [2013CB835100]; Natural Science Foundation of Zhejiang Province [LR13H020003]; Disciplinary Project of Ningbo University [B01350104900]; K. C. Wong Magna Fund in Ningbo University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China); Natural Science Foundation of Zhejiang Province(Natural Science Foundation of Zhejiang Province); Disciplinary Project of Ningbo University; K. C. Wong Magna Fund in Ningbo University	The research was supported by the grants from the National Natural Science Foundation of China (81471398, 81070873, 31100919 and 81371469), the 973 Program from the Ministry of Science and Technology of China (2013CB835100), the Natural Science Foundation of Zhejiang Province (LR13H020003), the Disciplinary Project of Ningbo University (B01350104900), and the3 K. C. Wong Magna Fund in Ningbo University.	Alvarez A, 2007, NEUROBIOL AGING, V28, P533, DOI 10.1016/j.neurobiolaging.2006.02.012; Blasko I, 2011, J NEURAL TRANSM, V118, P663, DOI 10.1007/s00702-011-0599-4; Brobey R. GD, KLOTHO ACTIVATION NE; Caselli RJ, 2012, ALZHEIMERS RES THER, V4, DOI 10.1186/alzrt123; Chang L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110773; Chang XY, 2014, J DIABETES RES, V2014, DOI 10.1155/2014/761938; Chen CD, 2014, BIOCHEMISTRY-US, V53, P5579, DOI 10.1021/bi500409n; Cheng Yan, 2014, Shanghai Arch Psychiatry, V26, P4, DOI 10.3969/j.issn.1002-0829.2014.01.002; Cherubini A, 2010, NEUROSCI LETT, V469, P214, DOI 10.1016/j.neulet.2009.11.077; Christa Maree Stephan B, 2013, BMJ OPEN, V3, DOI [10.1136/bmjopen-2012-001909, DOI 10.1136/BMJ0PEN-2012-001909]; Coppede F, 2010, J ALZHEIMERS DIS, V20, P953, DOI 10.3233/JAD-2010-1415; Dai DJ, 2014, PSYCHIAT RES, V220, P772, DOI 10.1016/j.psychres.2014.08.032; Dohnel K, 2008, NEUROPSYCHOLOGIA, V46, P37, DOI 10.1016/j.neuropsychologia.2007.08.012; Gupta R, 2009, BMC CARDIOVASC DISOR, V9, DOI 10.1186/1471-2261-9-28; Hahn D, 1997, EUR J BIOCHEM, V247, P933, DOI 10.1111/j.1432-1033.1997.00933.x; Hanninen T, 2002, ACTA NEUROL SCAND, V106, P148, DOI 10.1034/j.1600-0404.2002.01225.x; Jiang DJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059752; Johnson LA, 2014, AGE AGEING, V43, P364, DOI 10.1093/ageing/aft189; Kalkonde YV, 2009, DEMENT GERIATR COGN, V28, P145, DOI 10.1159/000235577; Kuro-O M, 2008, BIOL CHEM, V389, P233, DOI 10.1515/BC.2008.028; Kuroo M, 1997, NATURE, V390, P45, DOI 10.1038/36285; Kurosu H, 2005, SCIENCE, V309, P1829, DOI 10.1126/science.1112766; Larrieu S, 2002, NEUROLOGY, V59, P1594, DOI 10.1212/01.WNL.0000034176.07159.F8; Lee HB, 2012, AGING MENT HEALTH, V16, P372, DOI 10.1080/13607863.2011.609533; Lin HC, 2009, NEUROTOXICOLOGY, V30, P622, DOI 10.1016/j.neuro.2009.03.011; Lou Zhongzhang, 2012, Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi, V26, P795; Low LF, 2012, AM J GERIAT PSYCHIAT, V20, P866, DOI 10.1097/JGP.0b013e31823e31e2; Luchsinger JA, 2005, NEUROLOGY, V65, P545, DOI 10.1212/01.wnl.0000172914.08967.dc; Luchsinger JA, 2007, ARCH NEUROL-CHICAGO, V64, P570, DOI 10.1001/archneur.64.4.570; Manly J., 2004, CRIT PERSPECT; McDougall GJ, 2007, ETHNIC DIS, V17, P381; Merkin SS, 2009, INT J PUBLIC HEALTH, V54, P166, DOI 10.1007/s00038-008-7030-4; Nagai Taku, 2003, FASEB Journal, V17, P50; Niu MJ, 2013, J DIABETES COMPLICAT, V27, P443, DOI 10.1016/j.jdiacomp.2013.06.001; O'Bryant SE, 2013, J ALZHEIMERS DIS, V33, P373, DOI 10.3233/JAD-2012-121420; Parnowski T, 2013, PSYCHIATR POL, V47, P1087; Petersen RC, 2001, ARCH NEUROL-CHICAGO, V58, P1985, DOI 10.1001/archneur.58.12.1985; RAZIN A, 1991, MICROBIOL REV, V55, P451, DOI 10.1128/MMBR.55.3.451-458.1991; Semba RD, 2014, NEUROSCI LETT, V558, P37, DOI 10.1016/j.neulet.2013.10.058; Shan MH, 2014, INT J CLIN EXP MED, V7, P3482; Takahashi G, 2004, ANN THORAC SURG, V78, P602, DOI 10.1016/j.athoracsur.2004.02.133; Toro P, 2014, EUR ARCH PSY CLIN N, V264, P485, DOI 10.1007/s00406-013-0468-2; Triebel KL, 2010, ALZ DIS ASSOC DIS, V24, P365, DOI 10.1097/WAD.0b013e3181e7cb05; Wang ZhiZhong, 2014, Int J Alzheimers Dis, V2014, P150628, DOI 10.1155/2014/150628; Xiaohui Zhou ZY, 2014, CHIN J PSYCHIAT, V47, P4; Xie BA, 2013, HUM PATHOL, V44, P795, DOI 10.1016/j.humpath.2012.07.023; Xu LM, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/151723; Young JW, 2009, NEUROBIOL AGING, V30, P1430, DOI 10.1016/j.neurobiolaging.2007.11.018; Yu ZY, 2013, AM J PHYSIOL-RENAL, V305, pF1006, DOI 10.1152/ajprenal.00407.2013; Zeldich E, 2014, J BIOL CHEM, V289, P24700, DOI 10.1074/jbc.M114.567321; Zhang JP, 2006, CLIN CHIM ACTA, V365, P337, DOI 10.1016/j.cca.2005.09.005; Zhang LN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063455; Zou Y, 2014, AM J ALZHEIMERS DIS, V29, P242, DOI 10.1177/1533317513517042	53	13	13	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0132156	10.1371/journal.pone.0132156	http://dx.doi.org/10.1371/journal.pone.0132156			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LZ	26197428	Green Published, gold, Green Submitted			2022-12-26	WOS:000358547600023
J	Revah, O; Libman, L; Fleidervish, IA; Gutnick, MJ				Revah, Omer; Libman, Lior; Fleidervish, Ilya A.; Gutnick, Michael J.			The Outwardly Rectifying Current of Layer 5 Neocortical Neurons that was Originally Identified as "Non-Specific Cationic" Is Essentially a Potassium Current	PLOS ONE			English	Article							DELAYED RECTIFIER CURRENT; TRPM7 CHANNELS; MOUSE; PROTEIN; SLICES; TRPC1; ADAPTATION; EXPRESSION; PERSISTENT; RECEPTORS	In whole-cell patch clamp recordings from layer 5 neocortical neurons, blockade of voltage gated sodium and calcium channels leaves a cesium current that is outward rectifying. This current was originally identified as a "non-specific cationic current", and subsequently it was hypothesized that it is mediated by TRP channels. In order to test this hypothesis, we used fluorescence imaging of intracellular sodium and calcium indicators, and found no evidence to suggest that it is associated with influx of either of these ions to the cell body or dendrites. Moreover, the current is still prominent in neurons from TRPC1(-/-) and TRPC5(-/-) mice. The effects on the current of various blocking agents, and especially its sensitivity to intracellular tetraethylammonium, suggest that it is not a non-specific cationic current, but rather that it is generated by cesium-permeable delayed rectifier potassium channels.	[Revah, Omer; Libman, Lior; Gutnick, Michael J.] Hebrew Univ Jerusalem, Koret Sch Vet Med, Robert H Smith Fac Agr Food & Environm, IL-76100 Rehovot, Israel; [Fleidervish, Ilya A.] Ben Gurion Univ Negev, Dept Physiol & Cell Biol, Fac Hlth Sci, IL-84105 Beer Sheva, Israel; [Fleidervish, Ilya A.] Ben Gurion Univ Negev, Zlotowski Ctr Neurosci, IL-84105 Beer Sheva, Israel	Hebrew University of Jerusalem; Ben Gurion University; Ben Gurion University	Gutnick, MJ (corresponding author), Hebrew Univ Jerusalem, Koret Sch Vet Med, Robert H Smith Fac Agr Food & Environm, IL-76100 Rehovot, Israel.	michael.gutnick@mail.huji.ac.il	Gutnick, Michael/P-7910-2019; Revah, Omer/AAW-4048-2021	Revah, Omer/0000-0002-4002-5689; Fleidervish, Ilya/0000-0002-5501-726X; Gutnick, Michael/0000-0003-2564-5094	Israel Science Foundation [1593/10]	Israel Science Foundation(Israel Science Foundation)	This research was supported by the Israel Science Foundation (grant No. 1593/10)	Aarts M, 2003, CELL, V115, P863, DOI 10.1016/S0092-8674(03)01017-1; ALZHEIMER C, 1994, J PHYSIOL-LONDON, V479, P199, DOI 10.1113/jphysiol.1994.sp020288; Astman N, 2006, J NEUROSCI, V26, P3465, DOI 10.1523/JNEUROSCI.4907-05.2006; BLANTON MG, 1989, J NEUROSCI METH, V30, P203, DOI 10.1016/0165-0270(89)90131-3; Block BM, 1997, J PHYSIOL-LONDON, V499, P403, DOI 10.1113/jphysiol.1997.sp021937; Boisseau S, 2009, HISTOCHEM CELL BIOL, V131, P355, DOI 10.1007/s00418-008-0532-6; Briand LA, 2014, NEUROPSYCHOPHARMACOL, V39, P759, DOI 10.1038/npp.2013.265; Cristino L, 2006, NEUROSCIENCE, V139, P1405, DOI 10.1016/j.neuroscience.2006.02.074; Delmas P, 2002, NEURON, V34, P209, DOI 10.1016/S0896-6273(02)00641-4; Fleidervish IA, 1996, J PHYSIOL-LONDON, V493, P83, DOI 10.1113/jphysiol.1996.sp021366; Fleidervish IA, 2010, NAT NEUROSCI, V13, P852, DOI 10.1038/nn.2574; Grienberger C, 2012, NEURON, V73, P862, DOI 10.1016/j.neuron.2012.02.011; HAAS HL, 1979, J NEUROSCI METH, V1, P323, DOI 10.1016/0165-0270(79)90021-9; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HARDIE RC, 1992, NEURON, V8, P643, DOI 10.1016/0896-6273(92)90086-S; HILLE B, 1967, J GEN PHYSIOL, V50, P1287, DOI 10.1085/jgp.50.5.1287; Kiselyov K, 1998, NATURE, V396, P478, DOI 10.1038/24890; Klemic KG, 1998, J NEUROPHYSIOL, V79, P2345, DOI 10.1152/jn.1998.79.5.2345; Kunert-Keil C, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-159; Liapi A, 2005, EUR J NEUROSCI, V22, P825, DOI 10.1111/j.1460-9568.2005.04270.x; MERRITT JE, 1990, BIOCHEM J, V271, P515, DOI 10.1042/bj2710515; Minke B, 2002, PHYSIOL REV, V82, P429, DOI 10.1152/physrev.00001.2002; Parnas M, 2011, COMPREHENSIVE BIOPHYSICS, VOL 6: CHANNELS, P68, DOI 10.1016/B978-0-12-374920-8.00617-2; Peters M, 2012, J NEUROTRAUM, V29, P2831, DOI 10.1089/neu.2012.2575; Phelan KD, 2013, MOL PHARMACOL, V83, P429, DOI 10.1124/mol.112.082271; Ramsey IS, 2006, ANNU REV PHYSIOL, V68, P619, DOI 10.1146/annurev.physiol.68.040204.100431; RENNIE KJ, 1994, J NEUROPHYSIOL, V71, P317, DOI 10.1152/jn.1994.71.1.317; Rennie KJ, 2000, J MEMBRANE BIOL, V173, P139, DOI 10.1007/s002320001015; Riccio A, 2002, MOL BRAIN RES, V109, P95, DOI 10.1016/S0169-328X(02)00527-2; Rusch A, 1996, J NEUROPHYSIOL, V76, P995, DOI 10.1152/jn.1996.76.2.995; Rychkov G., 2007, V179, P23; SANGUINETTI MC, 1990, AM J PHYSIOL, V259, pH1881, DOI 10.1152/ajpheart.1990.259.6.H1881; Strubing C, 2001, NEURON, V29, P645, DOI 10.1016/S0896-6273(01)00240-9; STUART GJ, 1993, PFLUG ARCH EUR J PHY, V423, P511, DOI 10.1007/BF00374949; Sun HS, 2009, NAT NEUROSCI, V12, P1300, DOI 10.1038/nn.2395; Trequattrini C, 1996, J MEMBRANE BIOL, V154, P143, DOI 10.1007/s002329900139; Tytgat J, 1997, BRAIN RES, V749, P232, DOI 10.1016/S0006-8993(96)01171-7; Voronova IP, 2013, J THERM BIOL, V38, P300, DOI 10.1016/j.jtherbio.2013.03.009; Wei WL, 2007, P NATL ACAD SCI USA, V104, P16323, DOI 10.1073/pnas.0701149104; Wigmore MA, 2000, J PHYSIOL-LONDON, V527, P493, DOI 10.1111/j.1469-7793.2000.t01-1-00493.x; Zechel S, 2007, CELL TISSUE RES, V328, P651, DOI 10.1007/s00441-007-0388-4	41	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0132108	10.1371/journal.pone.0132108	http://dx.doi.org/10.1371/journal.pone.0132108			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LZ	26197082	Green Submitted, Green Published, gold			2022-12-26	WOS:000358547600021
J	Guo, JY; Li, W; Liu, X; Kong, QL; Zhao, CM; Guo, B				Guo, Jinyun; Li, Wang; Liu, Xin; Kong, Qiaoli; Zhao, Chunmei; Guo, Bin			Temporal-Spatial Variation of Global GPS-Derived Total Electron Content, 1999-2013	PLOS ONE			English	Article							POSITIONING SYSTEM; TEC; IONOSPHERE; DENSITY; THERMOSPHERE; PREDICTION	To investigate the temporal-spatial distribution and evolutions of global Total Electron Content (TEC), we estimate the global TEC data from 1999 to 2013 by processing the GPS data collected by the International Global Navigation Satellite System (GNSS) Service (IGS) stations, and robustly constructed the TEC time series at each of the global 5 degrees x2.5 degrees grids. We found that the spatial distribution of the global TEC has a pattern where the number of TECs diminishes gradually from a low-latitude region to high-latitude region, and anomalies appear in the equatorial crest and Greenland. Temporal variations show that the peak TEC appears in equinoctial months, and this corresponds to the semiannual variation of TEC. Furthermore, the winter anomaly is also observed in the equatorial area of the northern hemisphere and high latitudes of the southern hemisphere. Morlet wavelet analysis is used to determine periods of TEC variations and results indicate that the 1-day, 26.5-day, semiannual and annual cycles are the major significant periods. The fitting results of a quadratic polynomial show that the effect of solar activity on TEC is stronger in low latitudes than in mid-high latitudes, and stronger in the southern hemisphere than in the northern hemisphere. But the effect in low latitudes in the northern hemisphere is stronger than that in low latitudes in the southern hemisphere. The effect of solar activity on TECs was analyzed with the cross wavelet analysis and the wavelet coherence transformation, and we found that there appears to be a strong coherence in the period of about 27 days. So the sunspot as one index of solar activity seriously affects the TEC variations with the sun's rotation. We fit the TEC data with the least squares spectral analysis to study the periodic variations of TEC. The changing trend of TEC is generally -0.08 TECu per year from 1999 to 2013. So TECs decrease over most areas year by year, but TECs over the Arctic around Greenland maintained a rising trend during these 15 years.	[Guo, Jinyun; Li, Wang; Liu, Xin; Kong, Qiaoli; Guo, Bin] Shandong Univ Sci & Technol, Coll Geodesy & Geomat, Qingdao 266590, Peoples R China; [Guo, Jinyun; Kong, Qiaoli; Guo, Bin] Shandong Univ Sci & Technol, State Key Lab Min Disaster Prevent & Control Cofo, Qingdao 266590, Peoples R China; [Guo, Jinyun; Kong, Qiaoli; Guo, Bin] Shandong Univ Sci & Technol, Minist Sci & Technol, Qingdao 266590, Peoples R China; [Zhao, Chunmei] Chinese Acad Surveying & Mapping, Beijing 100830, Peoples R China	Shandong University of Science & Technology; Shandong University of Science & Technology; Shandong University of Science & Technology; Chinese Academy of Surveying & Mapping	Guo, JY (corresponding author), Shandong Univ Sci & Technol, Coll Geodesy & Geomat, Qingdao 266590, Peoples R China.	jinyunguo1@126.com		guo, jinyun/0000-0003-1817-1505; Guo, Bin/0000-0001-7886-0172	National Natural Science Foundation of China [41374009]; National Basic Research Program of China [2013CB7333 02]; Public Benefit Scientific Research Project of China [201412001]; Shandong Natural Science Foundation of China [ZR2013DM009]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); Public Benefit Scientific Research Project of China; Shandong Natural Science Foundation of China(Natural Science Foundation of Shandong Province)	The National Natural Science Foundation of China (41374009) and the National Basic Research Program of China (2013CB7333 02) fund to estimate TEC data, the Public Benefit Scientific Research Project of China (201412001) and the Shandong Natural Science Foundation of China (ZR2013DM009) fund to buy software to analyze data.	An Yu-zhu, 2012, Journal of PLA University of Science and Technology (Natural Science Edition), V13, P571; Anderson D, 1999, SPACE ENV TOPICS; ANDERSON DN, 1973, PLANET SPACE SCI, V21, P409, DOI 10.1016/0032-0633(73)90040-8; Bernhardt PA, 1998, PHYS PLASMAS, V5, P2010, DOI 10.1063/1.872872; Dach R, 2009, J GEODESY, V83, P353, DOI 10.1007/s00190-008-0281-2; Fuller-Rowell TJ, 1998, J GEOPHYS RES-SPACE, V103, P3951, DOI 10.1029/97JA03335; FULLERROWELL TJ, 1988, PURE APPL GEOPHYS, V127, P189, DOI 10.1007/BF00879811; FULLERROWELL TJ, 1994, J GEOPHYS RES-SPACE, V99, P3893, DOI 10.1029/93JA02015; Galav P, 2010, J ATMOS SOL-TERR PHY, V72, P1309, DOI 10.1016/j.jastp.2010.09.017; Guo JY, 2015, GEOSCI J, V19, P721, DOI 10.1007/s12303-015-0005-6; Guo JY, 2012, SCI CHINA EARTH SCI, V55, P2068, DOI 10.1007/s11430-012-4524-y; Hajj GA, 1998, RADIO SCI, V33, P175, DOI 10.1029/97RS03183; HANSON WB, 1966, J GEOPHYS RES, V71, P5559, DOI 10.1029/JZ071i023p05559; Kenpankho P, 2011, EARTH PLANETS SPACE, V63, P365, DOI 10.5047/eps.2011.01.010; Kiang CH, 1996, PHYS REV LETT, V76, P2515, DOI 10.1103/PhysRevLett.76.2515; LANYI GE, 1988, RADIO SCI, V23, P483, DOI 10.1029/RS023i004p00483; Li ZG, 2007, CHINESE J GEOPHYS-CH, V50, P327; Liu L, 2007, J GEOPHYS RES-SPACE, V112, DOI 10.1029/2007JA012283; Liu Libo, 2012, [空间科学学报, Chinese Journal of Space Science], V32, P665; Liu LB, 2011, CHINESE SCI BULL, V56, P1202, DOI 10.1007/s11434-010-4226-9; Liu LB, 2009, J GEOPHYS RES-SPACE, V114, DOI 10.1029/2009JA014533; Liu LB, 2009, J GEOPHYS RES-SPACE, V114, DOI 10.1029/2009JA014244; MALLIS M, 1993, J ATMOS TERR PHYS, V55, P1021, DOI 10.1016/0021-9169(93)90095-G; Mannucci AJ, 1998, RADIO SCI, V33, P565, DOI 10.1029/97RS02707; [孟泱 Meng Yang], 2011, [测绘学报, Acta Geodetica et Cartographica Sinica], V40, P37; Mikhailov A.V., 2004, INT J GEOMAGN AERON, V5, pGI1006, DOI [10.1029/2003GI000058, DOI 10.1029/2003GI000058]; Millward GH, 1996, J GEOPHYS RES-SPACE, V101, P5149, DOI 10.1029/95JA03343; Moussas X, 2005, ADV SPACE RES-SERIES, V35, P725, DOI 10.1016/j.asr.2005.03.148; Prasad R, 2001, ACTA ASTRONAUT, V48, P579; Prikryl P, 2010, ANN GEOPHYS-GERMANY, V28, P1307, DOI 10.5194/angeo-28-1307-2010; Richard B.L., 2000, GPS WORLD, V11, P44; Rishbeth H, 1998, J ATMOS SOL-TERR PHY, V60, P1385, DOI 10.1016/S1364-6826(98)00062-5; Saito A, 1998, GEOPHYS RES LETT, V25, P3079, DOI 10.1029/98GL52361; SCHUNK RW, 1975, J GEOPHYS RES-SPACE, V80, P3121, DOI 10.1029/JA080i022p03121; STENING RJ, 1992, J ATMOS TERR PHYS, V54, P1387, DOI 10.1016/0021-9169(92)90147-D; [万卫星 WAN Weixing], 2007, [地球物理学进展, Progress in Geophysiscs], V22, P1040; Wang L, 2014, GEOD GEODYN, V5, P54, DOI 10.3724/SP.J.1246.2014.02054; Wang Weimin, 2012, Chinese Journal of Space Science, V32, P40; Wei Na, 2009, Geomatics and Information Science of Wuhan University, V34, P1363; Wielgosz P, 2004, ANN GEOPHYS-GERMANY, V22, P405, DOI 10.5194/angeo-22-405-2004; Xu JS, 2013, CHINESE J GEOPHYS-CH, V56, P1425, DOI 10.6038/cjg20130501; Yu T, 2006, CHINESE J GEOPHYS-CH, V49, P943; [余涛 YU Tao], 2008, [科技导报, Science & Technology Review], V26, P25; Zhao BQ, 2006, THESIS CHINESE ACAD; Zhu AQ, 2008, THESIS XI DIAN U	45	37	43	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2015	10	7							e0133378	10.1371/journal.pone.0133378	http://dx.doi.org/10.1371/journal.pone.0133378			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LN	26193101	Green Published, Green Submitted, gold			2022-12-26	WOS:000358546400077
J	Han, B; Chen, L; Wang, J; Wu, ZL; Yan, LF; Hou, SW				Han, Bing; Chen, Liang; Wang, Jing; Wu, Zhongliang; Yan, Longfeng; Hou, Suiwen			Constitutive Expresser of Pathogenesis Related Genes 1 Is Required for Pavement Cell Morphogenesis in Arabidopsis	PLOS ONE			English	Article							GENOME-WIDE ANALYSIS; PROTEIN-DEGRADATION; EPIDERMAL-CELLS; E3 LIGASE; GROWTH; SHAPE; CYTOSKELETON; ACTIN; UBIQUITINATION; PATHWAYS	For over 50 years, researchers have focused on the mechanisms underlying the important roles of the cytoskeleton in controlling the cell growth direction and cell expansion. In our study, we performed ethyl methane sulfonate mutagenesis on Col-0 background and identified two new CONSTITUTIVE EXPRESSER OF PATHOGENESIS RELATED GENES 1 (CPR1) alleles with pavement cell (PC) morphogenetic defects. Morphological characterizations showed that polar growth initiation and expansion of PCs are seriously suppressed in cpr1. Closer cytoskeleton investigation showed that the directional arrangement of microtubules (MTs) during PC development is defective and the cortical fine actin filaments cannot be aggregated effectively to form actin cable networks in cpr1 mutants. These results suggest that the abnormal PC morphogenesis in cpr1 is accompanying with the aberrant arrangement of cytoskeleton. Site-directed mutagenesis and knockout within the F-box-associated (FBA) domain, which is reported to be a motif for recognizing particular substrates of CPR1, proved that the FBA domain is indispensable for normal CPR1 regulation of the PC morphogenesis. Further genetic analysis indicated that the defects on PC morphogenesis of cpr1 depend on two lipase-like proteins, ENHANCED DISEASE SUSCEPTIBILITY 1 and PHYTOALEXIN DEFICIENT 4. Our results provide further insights into the relationship between the cytoskeleton and PC morphogenesis, and suggest that the cytoskeleton-mediated PC morphogenesis control might be tightly linked to plant defense responses.	[Han, Bing; Chen, Liang; Wang, Jing; Wu, Zhongliang; Yan, Longfeng; Hou, Suiwen] Lanzhou Univ, Minist Educ, Key Lab Cell Act & Stress Adaptat, Sch Life Sci, Lanzhou 730000, Peoples R China	Lanzhou University	Hou, SW (corresponding author), Lanzhou Univ, Minist Educ, Key Lab Cell Act & Stress Adaptat, Sch Life Sci, Lanzhou 730000, Peoples R China.	housw@lzu.edu.cn		Wang, Jing/0000-0001-6381-1239	Ministry of Agriculture of the People's Republic of China [2014ZX08009-003-002]; National Basic Research Program of China [2011CB915401]; Natural Science Foundation of China (NSFC) [31470372, 31271460]; foundation of Ministry of Education Key Laboratory of Cell Activities and Stress Adaptations [lzujbky-2014-bt05]	Ministry of Agriculture of the People's Republic of China(Ministry of Agriculture & Rural Affairs); National Basic Research Program of China(National Basic Research Program of China); Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); foundation of Ministry of Education Key Laboratory of Cell Activities and Stress Adaptations	This work was supported by the Ministry of Agriculture of the People's Republic of China (Grant NO. 2014ZX08009-003-002) the National Basic Research Program of China (Grant NO. 2011CB915401), the Natural Science Foundation of China (NSFC) (Grant NO. 31470372, 31271460) and the foundation of the Ministry of Education Key Laboratory of Cell Activities and Stress Adaptations (lzujbky-2014-bt05).	Aarts N, 1998, P NATL ACAD SCI USA, V95, P10306, DOI 10.1073/pnas.95.17.10306; Bibikova TN, 1999, PLANT J, V17, P657, DOI 10.1046/j.1365-313X.1999.00415.x; Cadart C, 2014, DEV CELL, V29, P159, DOI 10.1016/j.devcel.2014.04.009; Cheng YT, 2011, P NATL ACAD SCI USA, V108, P14694, DOI 10.1073/pnas.1105685108; Dangl JL, 2001, NATURE, V411, P826, DOI 10.1038/35081161; Deeks MJ, 2003, CURR OPIN PLANT BIOL, V6, P561, DOI 10.1016/j.pbi.2003.09.013; del Pozo JC, 2000, PLANT MOL BIOL, V44, P123, DOI 10.1023/A:1006413007456; Dong S, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-76; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Frank MJ, 2002, CURR BIOL, V12, P849, DOI 10.1016/S0960-9822(02)00819-9; Fu Y, 2005, CELL, V120, P687, DOI 10.1016/j.cell.2004.12.026; Fu Y, 2002, PLANT CELL, V14, P777, DOI 10.1105/tpc.001537; Fu Y, 2009, CURR BIOL, V19, P1827, DOI 10.1016/j.cub.2009.08.052; Glazebrook J, 1996, GENETICS, V143, P973; Gou MY, 2012, PLANT J, V69, P411, DOI 10.1111/j.1365-313X.2011.04799.x; Gou MY, 2009, PLANT J, V60, P757, DOI 10.1111/j.1365-313X.2009.03995.x; Guimil S, 2007, J EXP BOT, V58, P3829, DOI 10.1093/jxb/erm253; Hou XH, 2010, PLANT J, V63, P880, DOI 10.1111/j.1365-313X.2010.04277.x; Hussey PJ, 2006, ANNU REV PLANT BIOL, V57, P109, DOI 10.1146/annurev.arplant.57.032905.105206; Ivakov A, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00439; Kobayashi I, 2003, PLANTA, V217, P340, DOI 10.1007/s00425-003-1042-3; Le J, 2006, CURR BIOL, V16, P895, DOI 10.1016/j.cub.2006.03.061; Lin DS, 2013, CURR BIOL, V23, P290, DOI 10.1016/j.cub.2013.01.022; Mathur J, 2006, CURR OPIN CELL BIOL, V18, P40, DOI 10.1016/j.ceb.2005.12.002; Mathur J, 2004, TRENDS PLANT SCI, V9, P583, DOI 10.1016/j.tplants.2004.10.006; Mathur J, 2002, CURR BIOL, V12, pR669, DOI 10.1016/S0960-9822(02)01164-8; Poraty-Gavra L, 2013, PLANT PHYSIOL, V161, P1172, DOI 10.1104/pp.112.213165; Qiu JL, 2002, PLANT CELL, V14, P101, DOI 10.1105/tpc.010346; Sampathkumar A, 2011, PLANT CELL, V23, P2302, DOI 10.1105/tpc.111.087940; Schmidt SM, 2007, PHYSIOL MOL PLANT P, V71, P135, DOI 10.1016/j.pmpp.2008.01.001; Smith LG, 2003, CURR OPIN PLANT BIOL, V6, P63, DOI 10.1016/S1369-5266(02)00012-2; Sorek N, 2011, PLANT PHYSIOL, V155, P706, DOI 10.1104/pp.110.166850; Wang L, 2004, PLANT MOL BIOL, V56, P929, DOI 10.1007/s11103-004-6236-y; Wasteneys GO, 2003, ANNU REV PLANT BIOL, V54, P691, DOI 10.1146/annurev.arplant.54.031902.134818; Wei JX, 2013, BBA-MOL CELL RES, V1833, P2757, DOI 10.1016/j.bbamcr.2013.07.005; Wu G, 2001, PLANT CELL, V13, P2841, DOI 10.1105/tpc.13.12.2841; Yang SH, 2004, PLANT CELL, V16, P1060, DOI 10.1105/tpc.020479; Yang ZB, 2002, PLANT CELL, V14, pS375, DOI 10.1105/tpc.001065; Zhang CH, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-27; Zhao J, 2013, FASEB J, V27, P2611, DOI 10.1096/fj.12-223099; Zhu Y, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000844	41	4	4	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2015	10	7							e0133249	10.1371/journal.pone.0133249	http://dx.doi.org/10.1371/journal.pone.0133249			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LN	26193674	Green Published, Green Submitted, gold			2022-12-26	WOS:000358546400069
J	Hu, GQ; Liu, X; He, HB; Zhang, W; Xie, HT; Wu, YY; Cui, JH; Sun, C; Zhang, XD				Hu, Guoqing; Liu, Xiao; He, Hongbo; Zhang, Wei; Xie, Hongtu; Wu, Yeye; Cui, Jiehua; Sun, Ci; Zhang, Xudong			Multi-Seasonal Nitrogen Recoveries from Crop Residue in Soil and Crop in a Temperate Agro-Ecosystem	PLOS ONE			English	Article							MANAGEMENT-PRACTICES; FERTILIZER; TILLAGE; DECOMPOSITION; QUALITY; STRAW; CORN; DYNAMICS; CARBON; INPUTS	In conservation tillage systems, at least 30% of the soil surface was covered by crop residues which generally contain significant amounts of nitrogen (N). However, little is known about the multi-seasonal recoveries of the N derived from these crop residues in soil-crop systems, notably in northeastern China. In a temperate agro-ecosystem, N-15-labeled maize residue was applied to field surfaces in the 1st year (2009). From the 2nd to 4th year (2010-2012), one treatment halted the application of maize residue, whereas the soil in the second treatment was re-applied with unlabeled maize residue. Crop and soil samples were collected after each harvest, and their N-15 enrichments were determined on an isotope ratio mass spectrometer to trace the allocation of N derived from the initially applied maize residue in the soil-crop systems. On average, 8.4% of the maize residue N was recovered in the soil-crop in the 1st year, and the vastmajority (61.9%-91.9%) was recovered during subsequent years. Throughout the experiment, the cumulative recovery of the residue N in the crop increased gradually (18.2%-20.9%), but most of the residue N was retained in the soil, notably in the 0-10 cm soil layer. Compared to the single application, the sequential residue application significantly increased the recovery of the residue N in the soil profile (73.8% vs. 40.9%) and remarkably decreased the total and the initially applied residue derived mineral N along the soil profile. Our results suggested that the residue N was actively involved in N cycling, and its release and recovery in crop and soil profile were controlled by the decomposition process. Sequential residue application significantly enhanced the retention and stabilization of the initially applied residue N in the soil and retarded its translocation along the soil profile.	[Hu, Guoqing; Liu, Xiao; He, Hongbo; Zhang, Wei; Xie, Hongtu; Wu, Yeye; Cui, Jiehua; Sun, Ci; Zhang, Xudong] Chinese Acad Sci, Inst Appl Ecol, State Key Lab Forest & Soil Ecol, Shenyang 110164, Peoples R China; [Hu, Guoqing; Liu, Xiao] Univ Chinese Acad Sci, Beijing 100049, Peoples R China; [Wu, Yeye; Zhang, Xudong] Natl Field Observat & Res Stn Shenyang Agroecosys, Shenyang 110016, Peoples R China	Chinese Academy of Sciences; Shenyang Institute of Applied Ecology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	He, HB (corresponding author), Chinese Acad Sci, Inst Appl Ecol, State Key Lab Forest & Soil Ecol, Shenyang 110164, Peoples R China.	hehongbo@iae.ac.cn; xdzhang@iae.ac.cn		Xie, Hongtu/0000-0002-8640-828X	Natural Science Foundation of China [41135024, 41271251]; "Strategic Priority Research Program-Climate Change: Carbon Budget and Related Issues" of the Chinese Academy of Sciences [XDA05050501]; State Key Laboratory of Forest and Soil Ecology [LFSE2013-14]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); "Strategic Priority Research Program-Climate Change: Carbon Budget and Related Issues" of the Chinese Academy of Sciences(Chinese Academy of Sciences); State Key Laboratory of Forest and Soil Ecology	This work was financially supported by the Natural Science Foundation of China (Nos. 41135024 and 41271251), "Strategic Priority Research Program-Climate Change: Carbon Budget and Related Issues" of the Chinese Academy of Sciences (No. XDA05050501), and State Key Laboratory of Forest and Soil Ecology (No. LFSE2013-14). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akkal-Corfini N, 2010, PLANT SOIL, V328, P17, DOI 10.1007/s11104-009-0104-0; Alijani K, 2012, SOIL TILL RES, V124, P78, DOI 10.1016/j.still.2012.05.005; Alvarez CR, 2008, COMMUN SOIL SCI PLAN, V39, P574, DOI 10.1080/00103620701826886; Bending GD, 1998, SOIL BIOL BIOCHEM, V30, P2055, DOI 10.1016/S0038-0717(98)00081-9; Burgess MS, 2002, SOIL SCI SOC AM J, V66, P1350, DOI 10.2136/sssaj2002.1350; Burgess MS, 2002, CAN J SOIL SCI, V82, P127, DOI 10.4141/S01-013; Chen Y, 2010, PEDOSPHERE, V20, P198, DOI 10.1016/S1002-0160(10)60007-0; Coppens F, 2006, EUR J SOIL SCI, V57, P570, DOI 10.1111/j.1365-2389.2006.00825.x; Coppens F, 2007, SOIL BIOL BIOCHEM, V39, P2339, DOI 10.1016/j.soilbio.2007.04.005; Damon PM, 2014, SOIL BIOL BIOCHEM, V74, P127, DOI 10.1016/j.soilbio.2014.03.003; Dourado Neto D, 2010, SOIL SCI SOC AM J, V74, P139, DOI 10.2136/sssaj2009.0192; Douxchamps S, 2011, PLANT SOIL, V341, P179, DOI 10.1007/s11104-010-0633-6; Fosu M, 2003, BIOL FERT SOILS, V39, P117, DOI 10.1007/s00374-003-0677-3; Fowler R, 2001, SOIL TILL RES, V61, P93, DOI 10.1016/S0167-1987(01)00181-7; Geisseler D, 2012, EUR J SOIL BIOL, V53, P107, DOI 10.1016/j.ejsobi.2012.09.006; Gentile R, 2008, SOIL BIOL BIOCHEM, V40, P2375, DOI 10.1016/j.soilbio.2008.05.018; Halpern MT, 2010, SOIL SCI SOC AM J, V74, P1211, DOI 10.2136/sssaj2009.0406; HAUCK RD, 1976, ADV AGRON, V28, P219, DOI 10.1016/S0065-2113(08)60556-8; Huang Y, 2006, CHINESE SCI BULL, V51, P1785, DOI 10.1007/s11434-006-2056-6; Hubbard VC, 1996, SOIL SCI SOC AM J, V60, P1405, DOI 10.2136/sssaj1996.03615995006000050016x; Ibewiro B, 2000, BIOL FERT SOILS, V31, P261, DOI 10.1007/s003740050655; Kumar K, 2000, ADV AGRON, V68, P197; Kumar K, 2001, J AGR SCI-CAMBRIDGE, V136, P35, DOI 10.1017/S0021859600008522; Lu HJ, 2013, PLANT SOIL, V373, P595, DOI 10.1007/s11104-013-1824-8; Lupwayi NZ, 2006, CAN J SOIL SCI, V86, P11, DOI 10.4141/S05-015; Luxhoi J, 2007, SOIL USE MANAGE, V23, P368, DOI 10.1111/j.1475-2743.2007.00126.x; Malhi SS, 2007, SOIL TILL RES, V96, P269, DOI 10.1016/j.still.2007.06.011; Malhi SS, 2011, FIELD CROP RES, V124, P378, DOI 10.1016/j.fcr.2011.07.009; Mubarak AR, 2003, COMMUN SOIL SCI PLAN, V34, P2375, DOI 10.1081/CSS-120024774; Palm CA, 2001, AGR ECOSYST ENVIRON, V83, P27, DOI 10.1016/S0167-8809(00)00267-X; Pittelkow CM, 2015, NATURE, V517, P365, DOI 10.1038/nature13809; Powlson DS, 2011, AGRON J, V103, P279, DOI 10.2134/agronj2010.0146s; POWLSON DS, 1985, J SCI FOOD AGR, V36, P26, DOI 10.1002/jsfa.2740360105; Redin M, 2014, SOIL BIOL BIOCHEM, V78, P65, DOI 10.1016/j.soilbio.2014.07.014; Scopel E, 2013, AGRON SUSTAIN DEV, V33, P113, DOI 10.1007/s13593-012-0106-9; Soil Survey Staff, 2003, KEYS TO SOIL TAXONOM; Zhang JB, 2012, EUR J SOIL SCI, V63, P75, DOI 10.1111/j.1365-2389.2011.01410.x	37	12	12	2	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2015	10	7							e0133437	10.1371/journal.pone.0133437	http://dx.doi.org/10.1371/journal.pone.0133437			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LN	26192436	Green Submitted, Green Published, gold			2022-12-26	WOS:000358546400085
J	Jansen, SW; Roelfsema, F; Akintola, AA; Oei, NY; Cobbaert, CM; Ballieux, BE; van der Grond, J; Westendorp, RG; Pijl, H; van Heemst, D				Jansen, Steffy W.; Roelfsema, Ferdinand; Akintola, Abimbola A.; Oei, Nicole Y.; Cobbaert, Christa M.; Ballieux, Bart E.; van der Grond, Jeroen; Westendorp, Rudi G.; Pijl, Hanno; van Heemst, Diana			Characterization of the Hypothalamic-Pituitary-Adrenal-Axis in Familial Longevity under Resting Conditions	PLOS ONE			English	Article							GLUCOCORTICOID-RECEPTOR GENE; CORTISOL DOSE RESPONSIVENESS; CARDIOVASCULAR RISK-FACTORS; OBESE PREMENOPAUSAL WOMEN; BROWN-NORWAY RAT; BODY-MASS INDEX; LEIDEN LONGEVITY; PLASMA-CORTISOL; ADRENOCORTICOTROPIC HORMONE; NONAGENARIAN SIBLINGS	Objective The hypothalamic-pituitary-adrenal (HPA)-axis is the most important neuro-endocrine stress response system of our body which is of critical importance for survival. Disturbances in HPA-axis activity have been associated with adverse metabolic and cognitive changes. Humans enriched for longevity have less metabolic and cognitive disturbances and therefore diminished activity of the HPA axis may be a potential candidate mechanism underlying healthy familial longevity. Here, we compared 24-h plasma ACTH and serum cortisol concentration profiles and different aspects of the regulation of the HPA-axis in offspring from long-lived siblings, who are enriched for familial longevity and age-matched controls. Design Case-control study within the Leiden Longevity study cohort consisting of 20 middle-aged offspring of nonagenarian siblings (offspring) together with 18 partners (controls). Methods During 24 h, venous blood was sampled every 10 minutes for determination of circulatory ACTH and cortisol concentrations. Deconvolution analysis, cross approximate entropy analysis and ACTH-cortisol-dose response modeling were used to assess, respectively, ACTH and cortisol secretion parameters, feedforward and feedback synchrony and adrenal gland ACTH responsivity. Results Mean (95% Confidence Interval) basal ACTH secretion was higher in male offspring compared to male controls (645 (324-1286) ngl/L/24 h versus 240 (120-477) ng/L/24 h, P = 0.05). Other ACTH and cortisol secretion parameters did not differ between offspring and controls. In addition, no significant differences in feedforward and feedback synchrony and adrenal gland ACTH responsivity were observed between groups. Conclusions These results suggest that familial longevity is not associated with major differences in HPA-axis activity under resting conditions, although modest, sex-specific differences may exist between groups that might be clinically relevant.	[Jansen, Steffy W.; Akintola, Abimbola A.; Westendorp, Rudi G.; van Heemst, Diana] Leiden Univ, Med Ctr, Dept Gerontol & Geriatr, Leiden, Netherlands; [Roelfsema, Ferdinand; Pijl, Hanno] Leiden Univ, Med Ctr, Dept Endocrinol & Metab, Leiden, Netherlands; [Oei, Nicole Y.] Univ Amsterdam, Dev Psychol ADAPT Lab, Amsterdam, Netherlands; [Oei, Nicole Y.] Univ Amsterdam, ABC, Amsterdam, Netherlands; [Oei, Nicole Y.; van der Grond, Jeroen] Leiden Univ, Med Ctr, Dept Radiol, Leiden, Netherlands; [Cobbaert, Christa M.; Ballieux, Bart E.] Leiden Univ, Med Ctr, Dept Clin Chem & Lab Med, Leiden, Netherlands; [van der Grond, Jeroen] Leiden Univ, LIBC, Leiden, Netherlands; [Westendorp, Rudi G.] Univ Copenhagen, Dept Publ Hlth, Copenhagen, Denmark	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Amsterdam; University of Amsterdam; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University - Excl LUMC; University of Copenhagen	van Heemst, D (corresponding author), Leiden Univ, Med Ctr, Dept Gerontol & Geriatr, Leiden, Netherlands.	D.van_Heemst@lumc.nl	Oei, Nicole/T-1219-2019; Akintola, Abi/T-5361-2019; Pijl, Hanno/W-8719-2018	Cobbaert, Christa/0000-0003-3565-1404; Pijl, Hanno/0000-0002-3076-1551	European Commission Project Switchbox (FP7) [Health-F2-2010-2597772]	European Commission Project Switchbox (FP7)	This work was supported by the European Commission Project Switchbox (FP7, Health-F2-2010-2597772).	Bowers J, 2013, ENDOCR REV, V34, P556, DOI 10.1210/er.2012-1056; Bruehl H, 2009, PSYCHONEUROENDOCRINO, V34, P815, DOI 10.1016/j.psyneuen.2008.12.010; Deuschle M, 1997, LIFE SCI, V61, P2239, DOI 10.1016/S0024-3205(97)00926-0; FERRARI E, 1995, NEUROENDOCRINOLOGY, V61, P464, DOI 10.1159/000126869; Fraser CG, 2001, BIOL VARIATION PRINC; HALBREICH U, 1984, PSYCHIAT RES, V13, P221, DOI 10.1016/0165-1781(84)90037-4; Jansen SW, 2015, SCI REP-UK, V5, DOI 10.1038/srep11525; Keenan DM, 2010, AM J PHYSIOL-REG I, V299, pR11, DOI 10.1152/ajpregu.00201.2010; Keenan DM, 2009, AM J PHYSIOL-REG I, V297, pR515, DOI 10.1152/ajpregu.00200.2009; Keenan DM, 2005, J THEOR BIOL, V236, P242, DOI 10.1016/j.jtbi.2005.03.008; Keenan DM, 2001, P NATL ACAD SCI USA, V98, P4028, DOI 10.1073/pnas.051624198; Keenan DM, 2003, AM J PHYSIOL-REG I, V285, pR664, DOI 10.1152/ajpregu.00195.2003; Kok P, 2009, J CLIN ENDOCR METAB, V94, P1176, DOI 10.1210/jc.2008-2303; Kuningas M, 2006, BIOGERONTOLOGY, V7, P231, DOI 10.1007/s10522-006-9021-2; Liu PY, 2009, AM J PHYSIOL-ENDOC M, V297, pE538, DOI 10.1152/ajpendo.00071.2009; Marissal-Arvy N, 2004, J BIOL CHEM, V279, P39232, DOI 10.1074/jbc.M407436200; McEwen BS, 1998, NEW ENGL J MED, V338, P171, DOI 10.1056/NEJM199801153380307; MOS J, 1987, MECH AGEING DEV, V38, P89, DOI 10.1016/0047-6374(87)90113-8; Noordam R, 2012, PSYCHONEUROENDOCRINO, V37, P1669, DOI 10.1016/j.psyneuen.2012.02.013; Noordam R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031166; Phillips DIW, 1998, J CLIN ENDOCR METAB, V83, P757, DOI 10.1210/jc.83.3.757; Pincus S, 1996, P NATL ACAD SCI USA, V93, P2083, DOI 10.1073/pnas.93.5.2083; Pincus SM, 2000, METHOD ENZYMOL, V321, P149; Purnell JQ, 2004, J CLIN ENDOCR METAB, V89, P281, DOI 10.1210/jc.2003-030440; Roelfsema F, 2012, EUR J ENDOCRINOL, V167, P633, DOI 10.1530/EJE-12-0592; Roelfsema F, 2009, J CLIN ENDOCR METAB, V94, P2991, DOI 10.1210/jc.2009-0350; Rozing MP, 2010, J AM GERIATR SOC, V58, P564, DOI 10.1111/j.1532-5415.2010.02725.x; SAPOLSKY RM, 1986, ENDOCR REV, V7, P284, DOI 10.1210/edrv-7-3-284; Schoenmaker M, 2006, EUR J HUM GENET, V14, P79, DOI 10.1038/sj.ejhg.5201508; Seeman T, 2010, ANN NY ACAD SCI, V1186, P223, DOI 10.1111/j.1749-6632.2009.05341.x; SHARMA M, 1989, BIOL PSYCHIAT, V25, P305, DOI 10.1016/0006-3223(89)90178-9; SHERMAN B, 1985, J CLIN ENDOCR METAB, V61, P439, DOI 10.1210/jcem-61-3-439; Stijntjes M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057962; TIZABI Y, 1992, NEUROBIOL AGING, V13, P227, DOI 10.1016/0197-4580(92)90034-U; TOUITOU Y, 1983, J ENDOCRINOL, V96, P53, DOI 10.1677/joe.0.0960053; van den Beukel JC, 2014, FASEB J, V28, P4857, DOI 10.1096/fj.14-254839; van Rossum EFC, 2002, DIABETES, V51, P3128, DOI 10.2337/diabetes.51.10.3128; van Rossum EFC, 2004, AM J MED, V117, P158, DOI 10.1016/j.amjmed.2004.01.027; VanCauter E, 1996, J CLIN ENDOCR METAB, V81, P2468, DOI 10.1210/jc.81.7.2468; VANEEKELEN JAM, 1992, NEUROBIOL AGING, V13, P159, DOI 10.1016/0197-4580(92)90024-R; Veldhuis JD, 2001, AM J PHYSIOL-REG I, V280, pR721; Veldhuis JD, 2013, ENDOCRIN METAB CLIN, V42, P201, DOI 10.1016/j.ecl.2013.02.002; Veldhuis JD, 2011, J CLIN ENDOCR METAB, V96, P2874, DOI 10.1210/jc.2011-0084; Veldhuis JD, 2009, J CLIN ENDOCR METAB, V94, P4045, DOI 10.1210/jc.2009-1143; Veldhuis JD, 2008, ENDOCR REV, V29, P823, DOI 10.1210/er.2008-0005; Vierhapper H, 2004, METABOLISM, V53, P1174, DOI 10.1016/j.metabol.2004.02.021; Walker BR, 2000, J INTERN MED, V247, P198, DOI 10.1046/j.1365-2796.2000.00609.x; Walker BR, 1998, HYPERTENSION, V31, P891, DOI 10.1161/01.HYP.31.4.891; WALTMAN C, 1991, J CLIN ENDOCR METAB, V73, P495, DOI 10.1210/jcem-73-3-495; Westendorp RGJ, 2009, J AM GERIATR SOC, V57, P1634, DOI 10.1111/j.1532-5415.2009.02381.x; Wijsman CA, 2011, AGING CELL, V10, P114, DOI 10.1111/j.1474-9726.2010.00650.x; Wirtz PH, 2007, PSYCHONEUROENDOCRINO, V32, P430, DOI 10.1016/j.psyneuen.2007.02.006	52	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2015	10	7							e0133119	10.1371/journal.pone.0133119	http://dx.doi.org/10.1371/journal.pone.0133119			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LN	26193655	Green Published, Green Submitted, gold			2022-12-26	WOS:000358546400056
J	Lamoury, FMJ; Jacka, B; Bartlett, S; Bull, RA; Wong, A; Amin, J; Schinkel, J; Poon, AF; Matthews, GV; Grebely, J; Dore, GJ; Applegate, TL				Lamoury, Francois M. J.; Jacka, Brendan; Bartlett, Sofia; Bull, Rowena A.; Wong, Arthur; Amin, Janaki; Schinkel, Janke; Poon, Art F.; Matthews, Gail V.; Grebely, Jason; Dore, Gregory J.; Applegate, Tanya L.			The Influence of Hepatitis C Virus Genetic Region on Phylogenetic Clustering Analysis	PLOS ONE			English	Article							SEQUENCE-ANALYSIS; MOLECULAR EVOLUTION; TRANSMISSION; GENOTYPES; HCV; CLASSIFICATION; DIVERGENCE; DIVERSITY; ACCURATE; SUBTYPES	Sequencing is important for understanding the molecular epidemiology and viral evolution of hepatitis C virus (HCV) infection. To date, there is little standardisation among sequencing protocols, in-part due to the high genetic diversity that is observed within HCV. This study aimed to develop a novel, practical sequencing protocol that covered both conserved and variable regions of the viral genome and assess the influence of each subregion, sequence concatenation and unrelated reference sequences on phylogenetic clustering analysis. The Core to the hypervariable region 1 (HVR1) of envelope-2 (E2) and non-structural-5B (NS5B) regions of the HCV genome were amplified and sequenced from participants from the Australian Trial in Acute Hepatitis C (ATAHC), a prospective study of the natural history and treatment of recent HCV infection. Phylogenetic trees were constructed using a general time-reversible substitution model and sensitivity analyses were completed for every subregion. Pairwise distance, genetic distance and bootstrap support were computed to assess the impact of HCV region on clustering results as measured by the identification and percentage of participants falling within all clusters, cluster size, average patristic distance, and bootstrap value. The Robinson-Foulds metrics was also used to compare phylogenetic trees among the different HCV regions. Our results demonstrated that the genomic region of HCV analysed influenced phylogenetic tree topology and clustering results. The HCV Core region alone was not suitable for clustering analysis; NS5B concatenation, the inclusion of reference sequences and removal of HVR1 all influenced clustering outcome. The Core-E2 region, which represented the highest genetic diversity and longest sequence length in this study, provides an ideal method for clustering analysis to address a range of molecular epidemiological questions.	[Lamoury, Francois M. J.; Jacka, Brendan; Bartlett, Sofia; Wong, Arthur; Amin, Janaki; Matthews, Gail V.; Grebely, Jason; Dore, Gregory J.; Applegate, Tanya L.] Univ New South Wales Australia, Kirby Inst, Sydney, NSW, Australia; [Bull, Rowena A.] Univ New South Wales Australia, Sch Med Sci, Inflammat & Infect Res Ctr, Sydney, NSW, Australia; [Schinkel, Janke] Univ Amsterdam, Acad Med Ctr, Dept Med Microbiol, Sect Clin Virol, NL-1105 AZ Amsterdam, Netherlands; [Poon, Art F.] BC Ctr Excellence HIV AIDS, Vancouver, BC, Canada; [Poon, Art F.] Univ British Columbia, Dept Med, Vancouver, BC, Canada; [Dore, Gregory J.] St Vincents Hosp, HIV Immunol Infect Dis Clin Serv Unit, Sydney, NSW 2010, Australia	University of New South Wales Sydney; Kirby Institute; University of New South Wales Sydney; University of Amsterdam; Academic Medical Center Amsterdam; B.C. Centre for Excellence in HIV/AIDS; University of British Columbia; St Vincents Hospital Sydney	Lamoury, FMJ (corresponding author), Univ New South Wales Australia, Kirby Inst, Sydney, NSW, Australia.	flamoury@kirby.unsw.edu.au	Dore, Gregory John/ABD-5665-2021; matthews, gail/AFL-8501-2022; Bartlett, Sofia/U-3708-2018; Jacka, Brendan/T-3553-2018; Schinkel, Janke/I-3099-2012; Poon, Art/W-9811-2019; matthews, gail/AAG-8626-2022	Dore, Gregory John/0000-0002-4741-2622; Bartlett, Sofia/0000-0003-0699-2250; Jacka, Brendan/0000-0002-5910-853X; Schinkel, Janke/0000-0002-1112-0644; Poon, Art/0000-0003-3779-154X; Amin, Janaki/0000-0003-2161-9366; Bull, Rowena/0000-0002-9844-3744; Matthews, Gail/0000-0002-1048-6396; Applegate, Tanya/0000-0002-8657-4261	National Health and Medical Research Council (NHMRC) grant HIV and HCV vaccines and immunopathogenesis [510448]; NHMRC grant Hepatitis C infection: epidemiology, pathogenesis, and treatment, Australia [1053206]; National Institutes of Health [R01 DA 15999-01]	National Health and Medical Research Council (NHMRC) grant HIV and HCV vaccines and immunopathogenesis(National Health and Medical Research Council (NHMRC) of Australia); NHMRC grant Hepatitis C infection: epidemiology, pathogenesis, and treatment, Australia(National Health and Medical Research Council (NHMRC) of Australia); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This research was supported by National Health and Medical Research Council (NHMRC) grant HIV and HCV vaccines and immunopathogenesis (#510448) and NHMRC grant Hepatitis C infection: epidemiology, pathogenesis, and treatment (#1053206), Australia. http://www.nhmrc.gov.au/. The ATAHC study was funded by the National Institutes of Health grant R01 DA 15999-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avo AP, 2013, J MED VIROL, V85, P815, DOI 10.1002/jmv.23545; Bartenschlager R, 2000, J GEN VIROL, V81, P1631, DOI 10.1099/0022-1317-81-7-1631; Brocchieri L, 2001, THEOR POPUL BIOL, V59, P27, DOI 10.1006/tpbi.2000.1485; BUKH J, 1993, P NATL ACAD SCI USA, V90, P8234, DOI 10.1073/pnas.90.17.8234; BUKH J, 1995, SEMIN LIVER DIS, V15, P41, DOI 10.1055/s-2007-1007262; Cai QX, 2013, INT J MOL MED, V31, P347, DOI 10.3892/ijmm.2012.1209; Cantarel BL, 2006, MOL BIOL EVOL, V23, P2090, DOI 10.1093/molbev/msl080; Ciccozzi M, 2011, J MED VIROL, V83, P1565, DOI 10.1002/jmv.22154; Cruz-Rivera M, 2013, J CLIN MICROBIOL, V51, P629, DOI 10.1128/JCM.03042-12; Danielsson Axel, 2014, Infection Ecology & Epidemiology, V4, P22251, DOI 10.3402/iee.v4.22251; DAY WHE, 1985, J CLASSIF, V2, P7, DOI 10.1007/BF01908061; de Bruijne J, 2009, J CLIN MICROBIOL, V47, P3832, DOI 10.1128/JCM.01146-09; Dore GJ, 2010, GASTROENTEROLOGY, V138, P123, DOI 10.1053/j.gastro.2009.09.019; Duffy S, 2008, NAT REV GENET, V9, P267, DOI 10.1038/nrg2323; Escobar-Gutierrez A, 2012, J CLIN MICROBIOL, V50, P1461, DOI 10.1128/JCM.00005-12; Feray C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086098; Fourment M, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-1; Gadagkar SR, 2005, J EXP ZOOL PART B, V304B, P64, DOI 10.1002/jez.b.21026; Galli A, 2014, TRENDS MICROBIOL, V22, P354, DOI 10.1016/j.tim.2014.02.005; Gonzalez-Candelas F, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-76; Gray RR, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-131; Jacka B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067073; Jackowiak P, 2014, INFECT GENET EVOL, V21, P67, DOI 10.1016/j.meegid.2013.10.021; Alcantara LCJ, 2009, NUCLEIC ACIDS RES, V37, pW634, DOI 10.1093/nar/gkp455; Lampe E, 2013, ANTIVIR THER, V18, P435, DOI 10.3851/IMP2606; Leache AD, 2011, SYST BIOL, V60, P126, DOI 10.1093/sysbio/syq073; Matthews GV, 2009, CLIN INFECT DIS, V48, P650, DOI 10.1086/596770; Murphy DG, 2007, J CLIN MICROBIOL, V45, P1102, DOI 10.1128/JCM.02366-06; Nei M., MOL EVOLUTION PHYLOG; Philippe H, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000602; Pybus OG, 2009, J VIROL, V83, P1071, DOI 10.1128/JVI.01501-08; Ragonnet-Cronin M, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-317; ROBINSON DF, 1981, MATH BIOSCI, V53, P131, DOI 10.1016/0025-5564(81)90043-2; Sacks-Davis R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047335; Saludes V, 2013, J CLIN VIROL, V57, P263, DOI 10.1016/j.jcv.2013.03.007; Samimi-Rad K, 2013, HEPAT MON, V13, DOI [10.5812/hepatmon.7699, 10.5812/hepatmon.76]; Simmonds P, 2005, HEPATOLOGY, V42, P962, DOI 10.1002/hep.20819; Simmonds P, 2004, J GEN VIROL, V85, P3173, DOI 10.1099/vir.0.80401-0; SIMMONDS P, 1993, J GEN VIROL, V74, P2391, DOI 10.1099/0022-1317-74-11-2391; Smith DB, 2014, HEPATOLOGY, V59, P318, DOI 10.1002/hep.26744; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Sulbaran MZ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014315; Sultana C, 2011, J GASTROINTEST LIVER, V20, P261; Sunbul M, 2013, INTERVIROLOGY, V56, P201, DOI 10.1159/000346775; Svennblad B, 2007, STAT APPL GENET MOL, V6, DOI 10.2202/1544-6115.1313; Talavera G, 2007, SYST BIOL, V56, P564, DOI 10.1080/10635150701472164; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Urbanus AT, 2009, AIDS, V23, pF1, DOI 10.1097/QAD.0b013e32832e5631; Vanhommerig JW, 2014, CLIN INFECT DIS, V59, P1678, DOI 10.1093/cid/ciu695; Zhang EZ, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-53	50	42	41	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2015	10	7							e0131437	10.1371/journal.pone.0131437	http://dx.doi.org/10.1371/journal.pone.0131437			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LN	26192190	gold, Green Submitted, Green Published			2022-12-26	WOS:000358546400011
J	Liu, B; Chen, S; Guan, YJ; Chen, LM				Liu, Bing; Chen, Shan; Guan, Yujuan; Chen, Limin			Type III Interferon Induces Distinct SOCS1 Expression Pattern that Contributes to Delayed but Prolonged Activation of Jak/STAT Signaling Pathway: Implications for Treatment Non-Response in HCV Patients	PLOS ONE			English	Article							CHRONIC HEPATITIS-C; SUSTAINED VIROLOGICAL RESPONSE; PEGINTERFERON LAMBDA-1A; VIRUS-INFECTION; THERAPY; ALPHA; LIVER; SUPPRESSOR; RESISTANCE; DERIVATION	Suppressor of cytokine signaling 1 (SOCS1) has long been thought to block type I interferon signaling. However, IFN-lambda, a type III IFN with limited receptor expression in hepatic cells, efficiently inhibits HCV (Hepatitis C virus) replication in vivo with potentially less side effects than IFN-alpha. Previous studies demonstrated that type I and type III activated Janus kinase/signal transducer and activator of transcription (Jak/STAT) signaling pathway differently, with delayed but prolonged activation by IFN-lambda stimulation compared to IFN alpha/beta. However, the molecular mechanisms underlying this observation is not well understood. Here, we found that there are distinct differences in SOCS1 expression patterns in Huh-7.5.1 cells following stimulation with IFN-alpha and IFN-lambda. IFN-lambda induced a faster but shorter expression of SOCS1. Furthermore, we confirmed that SOCS1 over-expression abrogates anti-HCV effect of both IFN-alpha and IFN-lambda, leading to increased HCV RNA replication in both HCV replicon cells and JFH1 HCV culture system. In line with this, SOCS1 over-expression inhibited STAT1 phosphorylation, attenuated IFN-stimulated response elements (ISRE) reporter activity, and blocked IFN-stimulated genes (ISGs) expression. Finally, we measured SOCS1 mRNA expression levels in peripheral blood mononuclear cells (PBMCs) with or without IFN-alpha treatment from 48 chronic hepatitis C patients and we found the baseline SOCS1 expression levels are higher in treatment non-responders than in responders before IFN-alpha treatment. Taken together, SOCS1 acts as a suppressor for both type I and type III IFNs and is negatively associated with sustained virological response (SVR) to IFN-based therapy in patients with HCV. More importantly, faster but shorter induction of SOCS1 by IFN-lambda may contribute to delayed but prolonged activation of IFN signaling and ISG expression kinetics by type III IFN.	[Liu, Bing; Chen, Shan; Chen, Limin] Chinese Acad Med Sci, Inst Blood Transfus, Chengdu, Sichuan, Peoples R China; [Liu, Bing; Chen, Shan; Chen, Limin] Peking Union Med Coll, Chengdu, Sichuan, Peoples R China; [Guan, Yujuan] Guangzhou 8 Peoples Hosp, Guangzhou, Guangdong, Peoples R China; [Chen, Limin] Univ Toronto, Toronto Gen Res Inst, Univ Hlth Network, Toronto, ON, Canada	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Blood Transfusion - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital	Chen, LM (corresponding author), Chinese Acad Med Sci, Inst Blood Transfus, Chengdu, Sichuan, Peoples R China.	limin_chen_99@yahoo.com	Chen, Limin/A-8813-2012		Natural Science Foundation of China (NSFC) [81471956, 91442128]	Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	Natural Science Foundation of China (NSFC, 81471956, 91442128), (http://www.amazon.com/gp/product/B00C4OE79K?tag = topone03-20). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bolen CR, 2014, HEPATOLOGY, V59, P1262, DOI 10.1002/hep.26657; Chen LM, 2011, INT J BIOCHEM CELL B, V43, P1427, DOI 10.1016/j.biocel.2011.06.006; Chen LM, 2010, GASTROENTEROLOGY, V138, P1123, DOI 10.1053/j.gastro.2009.10.046; Chen LM, 2005, GASTROENTEROLOGY, V128, P1437, DOI 10.1053/j.gastro.2005.01.059; Dill MT, 2011, GASTROENTEROLOGY, V140, P1021, DOI 10.1053/j.gastro.2010.11.039; Donnelly RP, 2010, J INTERF CYTOK RES, V30, P555, DOI 10.1089/jir.2010.0078; Feld JJ, 2014, ANTIVIR RES, V105, P32, DOI 10.1016/j.antiviral.2014.02.005; Francois-Newton V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022200; Friborg J, 2013, ANTIMICROB AGENTS CH, V57, P1312, DOI 10.1128/AAC.02239-12; Fujimoto M, 2010, THERMODYNAMICS OF CRYSTALLINE STATES, P1, DOI 10.1007/978-1-4419-6688-9_1; Horner SM, 2013, NAT MED, V19, P879, DOI 10.1038/nm.3253; Hruska M, 2015, J CLIN PHARMACOL, V55, P73, DOI 10.1002/jcph.361; Iijima S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118000; Imanaka K, 2005, J VIRAL HEPATITIS, V12, P130, DOI 10.1111/j.1365-2893.2005.00576.x; Jaroszewicz J, 2014, LIVER INT, V34, P6, DOI 10.1111/liv.12294; Jilg N, 2014, HEPATOLOGY, V59, P1250, DOI 10.1002/hep.26653; Koh C, 2014, ANTIVIR RES, V104, P34, DOI 10.1016/j.antiviral.2014.01.005; Kohli A, 2012, J VIRAL HEPATITIS, V19, P843, DOI 10.1111/j.1365-2893.2012.01610.x; Li S, 2014, J VIRAL HEPATITIS, V21, P121, DOI 10.1111/jvh.12131; Li YJ, 2014, REV MED VIROL, V24, P332, DOI 10.1002/rmv.1795; Lin WY, 2005, GASTROENTEROLOGY, V128, P1034, DOI 10.1053/j.gastro.2005.02.006; Malakhova OA, 2006, EMBO J, V25, P2358, DOI 10.1038/sj.emboj.7601149; Manns MP, 2013, NAT REV DRUG DISCOV, V12, P595, DOI 10.1038/nrd4050; Muir AJ, 2010, HEPATOLOGY, V52, P822, DOI 10.1002/hep.23743; Olagnier D, 2014, HEPATOLOGY, V59, P1225, DOI 10.1002/hep.26959; Pascarella S, 2013, LIVER INT, V33, P94, DOI 10.1111/liv.12031; Pearlman BL, 2011, CLIN INFECT DIS, V52, P889, DOI 10.1093/cid/cir076; Pfeffer LM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104202; Piganis RAR, 2011, J BIOL CHEM, V286, P33811, DOI 10.1074/jbc.M111.270207; Pott J, 2011, P NATL ACAD SCI USA, V108, P7944, DOI 10.1073/pnas.1100552108; Randall G, 2006, GASTROENTEROLOGY, V131, P1584, DOI 10.1053/j.gastro.2006.08.043; Sarrazin C, 2012, J HEPATOL, V56, pS88, DOI 10.1016/S0168-8278(12)60010-5; Shao RX, 2013, ANTIVIR RES, V97, P101, DOI 10.1016/j.antiviral.2012.12.001; Shao RX, 2010, J VIROL, V84, P6060, DOI 10.1128/JVI.02484-09; Sommereyns C, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000017; Sorrell MF, 2009, HEPATOLOGY, V49, pS4, DOI 10.1002/hep.22946; Wang XD, 2015, J CLIN PHARMACOL, V55, P63, DOI 10.1002/jcph.363; Yoshimura A, 2007, NAT REV IMMUNOL, V7, P454, DOI 10.1038/nri2093; Zhao C, 2013, TRENDS MICROBIOL, V21, P181, DOI 10.1016/j.tim.2013.01.005; Zhou ZL, 2007, J VIROL, V81, P7749, DOI 10.1128/JVI.02438-06	40	13	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2015	10	7							e0133800	10.1371/journal.pone.0133800	http://dx.doi.org/10.1371/journal.pone.0133800			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LN	26193702	Green Published, gold, Green Submitted			2022-12-26	WOS:000358546400117
J	Park, Y; Shin, JA; Yang, SW; Yim, HW; Kim, HS; Park, YH				Park, Yuli; Shin, Jeong Ah; Yang, Suk Woo; Yim, Hyeon Woo; Kim, Hyun Seung; Park, Young-Hoon		Korean Ophthalmologic Soc	The Relationship between Visual Impairment and Health-Related Quality of Life in Korean Adults: The Korea National Health and Nutrition Examination Survey (2008-2012)	PLOS ONE			English	Article							DIABETIC-RETINOPATHY; COST-EFFECTIVENESS; INSTRUMENT; ORDER; EUROQOL; INDEX; EQ-5D	Introduction To evaluate health-related quality of life (HRQoL) in Korean adults with visual impairment (VI) using various measures based on a nationally distributed sample. Methods Using the Korea National Health and Nutrition Examination Survey (KNHANES, 20082012) data, we compared EuroQol five-dimensional questionnaire (EQ-5D) and EQ-visual analogue scale (VAS) scores after adjusting for socio-demographic and psychosocial factors as well as for comorbidities with VI. Logistic regressions were used to elucidate determinants for the lowest quintile HRQoL scales according to VI severity. Uncorrected visual acuity (VA) which implies vision of ordinary life was measured using an international standard vision chart based on Snellen scale. Results 28,825 participants (sum of weights; 37,562,376) were included in the analysis. The mean EQ-5D and EQ-VAS scores were significantly lower in the VI groups than in the normal vision (defined as VA 20/20-20/25) group based on the better or worse seeing eye (P<.0001 and P<.0001, respectively). Participants with moderate (VA 20/80-20/160) and severe VI (VA <= 20/200) had higher scores of multivariate-adjusted odd ratios (aORs) for the lowest quintile than did the normal vision group which was particularly evident in the results from EQ-5D, whereas the results of the mild VI (VA 20/32-20/63) group did not identify significant differences from the normal vision group independent of classification according to the better or the worse seeing eye. Conversely, EQ-VAS revealed significantly higher score of multivariate-aORs for the lowest quintile in participants with mild VI either for the better or worse seeing eye. Conclusions The severity of VI was definitely associated with impaired HRQoL compared with the normal vision population. The analyses presented here elicited even mild VI could potentially deteriorate the health-related quality of life (or subjective perception of health quality) and therefore, therapeutic approaches should also focus on the subjective perception and better management of health condition.	[Park, Yuli; Kim, Hyun Seung] Catholic Univ Korea, Yeouido St Marys Hosp, Coll Med, Dept Ophthalmol & Visual Sci, Seoul, South Korea; [Shin, Jeong Ah; Yang, Suk Woo; Park, Young-Hoon] Catholic Univ Korea, Seoul St Marys Hosp, Coll Med, Dept Ophthalmol & Visual Sci, Seoul, South Korea; [Yim, Hyeon Woo] Catholic Univ Korea, Coll Med, Dept Prevent Med, Seoul, South Korea	Catholic University of Korea; Catholic University of Korea; Seoul St. Mary's Hospital; Catholic University of Korea	Park, YH (corresponding author), Catholic Univ Korea, Seoul St Marys Hosp, Coll Med, Dept Ophthalmol & Visual Sci, Seoul, South Korea.	parkyh@catholic.ac.kr		Kim, Hyun Seung/0000-0001-6825-8612	Catholic Medical Center Research Foundation	Catholic Medical Center Research Foundation	The authors acknowledge the financial support of the Catholic Medical Center Research Foundation made in the program year of 2012.	Aoki N, 2004, DIABETES CARE, V27, P1095, DOI 10.2337/diacare.27.5.1095; Brandle M, 2004, CURR MED RES OPIN, V20, pS1, DOI 10.1185/030079904X1962; Brazier J, 2007, MEASURING VALUING HL; Brooks R, 1996, HEALTH POLICY, V37, P53, DOI 10.1016/0168-8510(96)00822-6; Childs A, 2005, QUAL LIFE RES, V14, P493, DOI 10.1007/s11136-004-0727-9; *CONST WHO, 1952, HDB BAS DOC, P3; Feeny D, 2002, MED CARE, V40, P113, DOI 10.1097/00005650-200202000-00006; Glasziou P, 2007, HEALTH QUAL LIFE OUT, V5, DOI 10.1186/1477-7525-5-21; Javitt JC, 1996, ANN INTERN MED, V124, P164, DOI 10.7326/0003-4819-124-1_Part_2-199601011-00017; Kontodimopoulos N, 2009, QUAL LIFE RES, V18, P87, DOI 10.1007/s11136-008-9420-8; Kopec JA, 2003, J CLIN EPIDEMIOL, V56, P317, DOI 10.1016/S0895-4356(02)00609-1; Longworth L, 2003, HEALTH ECON, V12, P1061, DOI 10.1002/hec.787; McColl E, 2003, MED CARE, V41, P777, DOI 10.1097/00005650-200307000-00002; McPhail S, 2009, HEALTH QUAL LIFE OUT, V7, DOI 10.1186/1477-7525-7-48; Nam HS., 2007, EQ 5D KOREAN VALUATI; Patrick D L, 1973, Health Serv Res, V8, P228; Rat AC, 2008, OSTEOARTHR CARTILAGE, V16, P429, DOI 10.1016/j.joca.2007.07.011; Rubin RR, 1999, DIABETES-METAB RES, V15, P205, DOI 10.1002/(SICI)1520-7560(199905/06)15:3<205::AID-DMRR29>3.0.CO;2-O; Saito I, 2006, DIABETES RES CLIN PR, V73, P51, DOI 10.1016/j.diabres.2005.11.015; Sintonen H, 2001, ANN MED, V33, P328, DOI 10.3109/07853890109002086; Smith DW, 2004, QUAL LIFE RES, V13, P1391, DOI 10.1023/B:QURE.0000040785.59444.7c; Squirrell DM, 2003, J ROY SOC MED, V96, P273, DOI 10.1258/jrsm.96.6.273; Torrance G W, 1989, Int J Technol Assess Health Care, V5, P559; Torrance G W, 1972, Health Serv Res, V7, P118; Van Wijck EEE, 1998, MED DECIS MAKING, V18, P400, DOI 10.1177/0272989X9801800407; VICKREY BG, 1994, EPILEPSIA, V35, P597, DOI 10.1111/j.1528-1157.1994.tb02480.x; Vijan S, 2000, JAMA-J AM MED ASSOC, V283, P889, DOI 10.1001/jama.283.7.889; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; WILLIAMS A, 1990, HEALTH POLICY, V16, P199; Wu AW, 1997, QUAL LIFE RES, V6, P3, DOI 10.1023/A:1026471020698; Zhou H, 2005, DIABETES CARE, V28, P2856, DOI 10.2337/diacare.28.12.2856	31	14	14	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2015	10	7							e0132779	10.1371/journal.pone.0132779	http://dx.doi.org/10.1371/journal.pone.0132779			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN6LN	26192763	gold, Green Submitted, Green Published			2022-12-26	WOS:000358546400039
J	Ahmad, K; Zwi, AB; Tarantola, DJM; Soomro, AQ; Baig, R; Azam, SI				Ahmad, Khabir; Zwi, Anthony B.; Tarantola, Daniel J. M.; Soomro, Abdul Qadeem; Baig, Rashid; Azam, Syed Iqbal			Gendered Disparities in Quality of Cataract Surgery in a Marginalised Population in Pakistan: The Karachi Marine Fishing Communities Eye and General Health Survey	PLOS ONE			English	Article							NATIONAL BLINDNESS; VISUAL IMPAIRMENT; OUTCOMES	Background Marine fishing communities are among the most marginalised and hard-to-reach groups and have been largely neglected in health research. We examined the quality of cataract surgery and its determinants, with an emphasis on gender, in marine fishing communities in Karachi, Pakistan, using multiple indicators of performance. Methods and Findings The Karachi Marine Fishing Communities Eye and General Health Survey was a door-to-door, cross-sectional study conducted between March 2009 and April 2010 in fishing communities living on 7 islands and in coastal areas in Keamari, Karachi, located on the Arabian Sea. A population-based sample of 638 adults, aged >= 50 years, was studied. A total of 145 eyes (of 97 persons) had undergone cataract surgery in this sample. Cataract surgical outcomes assessed included vision (presenting and best-corrected with a reduced logMAR chart), satisfaction with surgery, astigmatism, and pupil shape. Overall, 65.5% of the operated eyes had some form of visual loss (presenting visual acuity [PVA] < 6/12). 55.2%, 29.0%, and 15.9% of these had good, borderline, and poor visual outcomes based on presenting vision; with best correction, these values were: 68.3 %, 18.6%, and 13.1%, respectively. Of 7 covariates evaluated in the multivariable generalized estimating equations (GEE) analyses, gender was the only significant independent predictor of visual outcome. Women's eyes were nearly 4.38 times more likely to have suboptimal visual outcome (PVA<6/18) compared with men's eyes (adjusted odds ratio 4.38, 95% CI 1.96-9.79; P<0.001) after adjusting for the effect of household financial status. A higher proportion of women's than men's eyes had an irregular pupil (26.5% vs. 14.8%) or severe/very severe astigmatism (27.5% vs. 18.2%). However, these differences did not reach statistical significance. Overall, more than one fourth (44/144) of cataract surgeries resulted in dissatisfaction. The only significant predictor of satisfaction was visual outcome (P <0.001). Conclusions The quality of cataract surgery in this marginalised population, especially among women, falls well below the WHO recommended standards. Gender disparities, in particular, deserve proactive attention in policy, service delivery, research and evaluation.	[Ahmad, Khabir; Zwi, Anthony B.] Univ New S Wales, Fac Arts & Social Sci, Sch Social Sci, Sydney, NSW, Australia; [Ahmad, Khabir; Baig, Rashid] Aga Khan Univ, Dept Surg, Sect Ophthalmol, Karachi, Pakistan; [Ahmad, Khabir] Aga Khan Univ, Dept Surg, Off Surg Res, Karachi, Pakistan; [Tarantola, Daniel J. M.] Univ New S Wales, Fac Med, Sch Publ Hlth & Community Med, Sydney, NSW, Australia; [Soomro, Abdul Qadeem] Al Ibrahim Eye Hosp, Isra Postgrad Inst Ophthalmol, Karachi, Pakistan; [Azam, Syed Iqbal] Aga Khan Univ, Dept Community Hlth Sci, Karachi, Pakistan	University of New South Wales Sydney; Aga Khan University; Aga Khan University; University of New South Wales Sydney; Aga Khan University	Ahmad, K (corresponding author), Univ New S Wales, Fac Arts & Social Sci, Sch Social Sci, Sydney, NSW, Australia.	khabir.ahmad@aku.edu	Zwi, Anthony/AAP-7026-2021; Zwi, Anthony/AAP-8731-2020	Zwi, Anthony/0000-0001-6902-6602; 	Fred Hollows Foundation, Australia	Fred Hollows Foundation, Australia	The Fred Hollows Foundation, Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas Z, A TURBULENT YEAR; Ahmad K, 2015, OPHTHAL EPIDEMIOL, V22, P370, DOI 10.3109/09286586.2015.1012592; Ahmad K, 2015, INVEST OPHTH VIS SCI, V56, P1023, DOI 10.1167/iovs.14-16019; [Anonymous], 2002, Community Eye Health, V15, P49; [Anonymous], HLTH ACT CRIS; Bene C, 2011, PROG DEV STUD, V11, P119, DOI 10.1177/146499341001100203; Bourne R, 2007, BRIT J OPHTHALMOL, V91, P420, DOI 10.1136/bjo.2006.106724; Congdon N, 2013, LANCET GLOB HEALTH, V1, pE37, DOI 10.1016/S2214-109X(13)70003-2; Dineen B, 2007, BRIT J OPHTHALMOL, V91, P1005, DOI 10.1136/bjo.2006.108035; Gruskin S, 2007, LANCET, V370, P449, DOI 10.1016/S0140-6736(07)61200-8; Khanna R, 2011, CURR OPIN OPHTHALMOL, V22, P10, DOI 10.1097/ICU.0b013e3283414f50; Khanna RC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035701; Pascolini D, 2012, BRIT J OPHTHALMOL, V96, P614, DOI 10.1136/bjophthalmol-2011-300539; Tabin G, 2008, CURR OPIN OPHTHALMOL, V19, P55, DOI 10.1097/ICU.0b013e3282f154bd; West S, 2007, OPHTHAL EPIDEMIOL, V14, P173, DOI 10.1080/09286580701423151; Yorston D, 2005, EYE, V19, P1083, DOI 10.1038/sj.eye.6701966; Yorston D, 2002, BRIT J OPHTHALMOL, V86, P543, DOI 10.1136/bjo.86.5.543	17	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0131774	10.1371/journal.pone.0131774	http://dx.doi.org/10.1371/journal.pone.0131774			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RV	26186605	gold, Green Published, Green Submitted			2022-12-26	WOS:000358198700022
J	Choi, E; Lee, YY; Yoon, HJ; Lee, S; Suh, M; Park, B; Jun, JK; Kim, Y; Choi, KS				Choi, Eunji; Lee, Yoon Young; Yoon, Hyo Joong; Lee, Sangeun; Suh, Mina; Park, Boyoung; Jun, Jae Kwan; Kim, Yeol; Choi, Kui Son			Relationship between Cancer Worry and Stages of Adoption for Breast Cancer Screening among Korean Women	PLOS ONE			English	Article							TRANSTHEORETICAL MODEL; PERCEIVED RISK; GASTRIC-CANCER; MAMMOGRAPHY; POPULATION; BEHAVIOR; MORTALITY	Background The possibility of developing breast cancer is a concern for all women; however, few studies have examined the relationship between cancer worry and the stages of adoption for breast cancer screening in Korea. Here, we investigated the associations between cancer worry, the stages of adopting breast cancer screening, and socio-demographic factors known to influence screening behaviors. Methods This study was based on the 2013 Korean National Cancer Screening Survey, an annual cross-sectional survey that utilized nationally representative random sampling to investigate cancer screening rates. Data were analyzed from 1,773 randomly selected women aged 40-74 years. Chi-squared tests and multinomial logistic analyses were conducted to determine the associations between cancer worry and the stages of adoption for breast cancer screening and to outline the factors associated with each stage. Results Korean women were classified into the following stages of adoption for breast cancer screening: pre-contemplation (24.7%), contemplation (13.0%), action/maintenance (50.8%), relapse risk (8.9%), and relapse (2.6%). Women in the action/maintenance stages reported more moderate to higher levels of worry about getting cancer than those in the pre-contemplation stage. Further, age of 40-49 years and having private cancer insurance were associated with women in the action/maintenance stages. Conclusion Interventions to address breast cancer worry may play an important role in increasing participation and equity in breast cancer screening.	[Choi, Eunji; Lee, Sangeun; Jun, Jae Kwan; Choi, Kui Son] Natl Canc Ctr, Grad Sch Canc Sci & Policy, Goyang, Gyeonggi Do, South Korea; [Lee, Yoon Young; Yoon, Hyo Joong; Suh, Mina; Park, Boyoung; Jun, Jae Kwan; Kim, Yeol; Choi, Kui Son] Natl Canc Ctr, Natl Canc Control Inst, Goyang, Gyeonggi Do, South Korea	National Cancer Center - Korea (NCC); National Cancer Center - Korea (NCC)	Choi, KS (corresponding author), Natl Canc Ctr, Grad Sch Canc Sci & Policy, Goyang, Gyeonggi Do, South Korea.	kschoi@ncc.re.kr			National Cancer Center of Korea [1310232]	National Cancer Center of Korea	This study was supported by a Grant-in-Aid for Cancer Research and Control from the National Cancer Center of Korea (http://www.ncc.re.kr) (#1310232). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen MR, 2003, CANCER EPIDEM BIOMAR, V12, P314; Bowen DJ, 2003, J SOC CLIN PSYCHOL, V22, P213, DOI 10.1521/jscp.22.2.213.22875; Cameron LD, 2001, J HEALTH PSYCHOL, V6, P47, DOI 10.1177/135910530100600104; Chamot E, 2001, EUR J CANCER, V37, P1869, DOI 10.1016/S0959-8049(01)00234-9; Consedine NS, 2004, CANCER EPIDEM BIOMAR, V13, P501; Diefenbach MA, 1996, J SOC DISTRESS HOMEL, V5, P11, DOI 10.1007/BF02090456; Hay JL, 2005, PSYCHO-ONCOLOGY, V14, P517, DOI 10.1002/pon.864; Hirai K, 2013, PSYCHO-ONCOLOGY, V22, P2339, DOI 10.1002/pon.3293; Ho SSM, 2014, PUBLIC HEALTH, V128, P1009, DOI 10.1016/j.puhe.2014.09.001; JANI S, 1962, J ABNORM PSYCHOL, V65, P403; Jung KW, 2013, CANCER RES TREAT, V45, P1, DOI 10.4143/crt.2013.45.1.1; Jung KW, 2014, CANCER RES TREAT, V46, P109, DOI 10.4143/crt.2014.46.2.109; Kiin SE, 2008, ARCH INTERN MED, V168, P728, DOI 10.1001/archinte.168.7.728; Kwak MS, 2009, PSYCHO-ONCOLOGY, V18, P708, DOI 10.1002/pon.1458; Kwak MS, 2009, PREV MED, V49, P48, DOI 10.1016/j.ypmed.2009.05.007; Lee MH, 2013, ASIAN PAC J CANCER P, V14, P6095, DOI 10.7314/APJCP.2013.14.10.6095; LERMAN C, 1991, ANN INTERN MED, V114, P657, DOI 10.7326/0003-4819-114-8-657; LERMAN C, 1991, HEALTH PSYCHOL, V10, P259, DOI 10.1037/0278-6133.10.4.259; LEVENTHAL H, 1987, PATIENT EDUC COUNS, V10, P117, DOI 10.1016/0738-3991(87)90093-0; McCaul KD, 1998, J BEHAV MED, V21, P565, DOI 10.1023/A:1018748712987; McCaul KD, 1996, HEALTH PSYCHOL, V15, P430, DOI 10.1037/0278-6133.15.6.430; Miller AM, 1997, WOMEN HEALTH, V26, P41, DOI 10.1300/J013v26n01_04; Moser K, 2009, BMJ, V338; O'Sullivan I, 2001, J MED SCREEN, V8, P145, DOI 10.1136/jms.8.3.145; Oh D, 2011, ASIAN PAC J CANCER P, V12, P2865; PROCHASKA JO, 1983, J CONSULT CLIN PSYCH, V51, P390, DOI 10.1037//0022-006X.51.3.390; Rakowski W, 1996, ANN BEHAV MED, V18, P91, DOI 10.1007/BF02909581; Robb KA, 2004, CANCER EPIDEM BIOMAR, V13, P366; Shin DW, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-133; Shiryazdi SM, 2014, ASIAN PAC J CANCER P, V15, P9817, DOI 10.7314/APJCP.2014.15.22.9817; Skinner CS, 1998, AM J PREV MED, V14, P54, DOI 10.1016/S0749-3797(97)00008-1; Suh M, 2013, ASIAN PAC J CANCER P, V14, P6459, DOI 10.7314/APJCP.2013.14.11.6459; Trauth JM, 2003, HEALTH EDUC BEHAV, V30, P322, DOI 10.1177/1090198103030003007; Vernon SW, 1997, CANCER EPIDEM BIOMAR, V6, P825; Youlden Danny R., 2014, Cancer Biology Medicine, V11, P101, DOI 10.7497/j.issn.2095-3941.2014.02.005	35	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0132351	10.1371/journal.pone.0132351	http://dx.doi.org/10.1371/journal.pone.0132351			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN1RV	26186652	Green Published, gold, Green Submitted			2022-12-26	WOS:000358198700039
J	Feng, J; Mertz, B				Feng, Jun; Mertz, Blake			Novel Phosphotidylinositol 4,5-Bisphosphate Binding Sites on Focal Adhesion Kinase	PLOS ONE			English	Article							DOMAIN; PIP2; FAK	Focal adhesion kinase (FAK) is a protein tyrosine kinase that is ubiquitously expressed, recruited to focal adhesions, and engages in a variety of cellular signaling pathways. Diverse cellular responses, such as cell migration, proliferation, and survival, are regulated by FAK. Prior to activation, FAK adopts an autoinhibited conformation in which the FERM domain binds the kinase domain, blocking access to the activation loop and substrate binding site. Activation of FAK occurs through conformational change, and acidic phospholipids such as phosphatidylinositol 4,5-bisphosphate (PIP2) are known to facilitate this process. PIP2 binding alters the autoinhibited conformation of the FERM and kinase domains and subsequently exposes the activation loop to phosphorylation. However, the detailed molecular mechanism of PIP2 binding and its role in FAK activation remain unclear. In this study, we conducted coarse-grained molecular dynamics simulations to investigate the binding of FAK to PIP2. Our simulations identified novel areas of basic residues in the kinase domain of FAK that potentially undergo transient binding to PIP2 through electrostatic attractions. Our investigation provides a molecular picture of PIP2-initiated FAK activation and introduces promising new pathways for future studies of FAK regulation.	[Feng, Jun; Mertz, Blake] W Virginia Univ, C Eugene Bennett Dept Chem, Morgantown, WV 26506 USA	West Virginia University	Mertz, B (corresponding author), W Virginia Univ, C Eugene Bennett Dept Chem, Morgantown, WV 26506 USA.	blake.mertz@mail.wvu.edu			West Virginia University	West Virginia University	West Virginia University provided startup funds to conduct this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 2005, FEBS J, V272, P5101, DOI 10.1111/j.1742-4658.2005.04945.x; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Baron R, 2007, CHEMPHYSCHEM, V8, P452, DOI 10.1002/cphc.200600658; BRETSCHER MS, 1972, NATURE-NEW BIOL, V236, P11, DOI 10.1038/newbio236011a0; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; BURRIDGE K, 1988, ANNU REV CELL BIOL, V4, P487, DOI 10.1146/annurev.cb.04.110188.002415; Burridge K, 1996, ANNU REV CELL DEV BI, V12, P463, DOI 10.1146/annurev.cellbio.12.1.463; Cai XM, 2008, MOL CELL BIOL, V28, P201, DOI 10.1128/MCB.01324-07; CALALB MB, 1995, MOL CELL BIOL, V15, P954; Cooper LA, 2003, MOL CELL BIOL, V23, P8030, DOI 10.1128/MCB.23.22.8030-8041.2003; de Jong DH, 2013, J CHEM THEORY COMPUT, V9, P687, DOI 10.1021/ct300646g; Dunty JM, 2004, MOL CELL BIOL, V24, P5353, DOI 10.1128/MCB.24.12.5353-5368.2004; Ellenbroek WG, 2011, BIOPHYS J, V101, P2178, DOI 10.1016/j.bpj.2011.09.039; Frame MC, 2010, NAT REV MOL CELL BIO, V11, P802, DOI 10.1038/nrm2996; Gabarra-Niecko V, 2002, BIOCHEM J, V365, P591, DOI 10.1042/BJ20020065; Girault JA, 1999, TRENDS NEUROSCI, V22, P257, DOI 10.1016/S0166-2236(98)01358-7; Goni GM, 2014, P NATL ACAD SCI USA, V111, pE3177, DOI 10.1073/pnas.1317022111; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Irino Y, 2012, J LIPID RES, V53, P810, DOI 10.1194/jlr.D019547; Lietha D, 2007, CELL, V129, P1177, DOI 10.1016/j.cell.2007.05.041; Marrink SJ, 2007, J PHYS CHEM B, V111, P7812, DOI 10.1021/jp071097f; Marrink SJ, 2004, J PHYS CHEM B, V108, P750, DOI 10.1021/jp036508g; McLean GW, 2005, NAT REV CANCER, V5, P505, DOI 10.1038/nrc1647; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; Periole Xavier, 2013, Methods Mol Biol, V924, P533, DOI 10.1007/978-1-62703-017-5_20; Periole X, 2009, J CHEM THEORY COMPUT, V5, P2531, DOI 10.1021/ct9002114; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; SCHALLER MD, 1994, MOL CELL BIOL, V14, P1680, DOI 10.1128/MCB.14.3.1680; Schlaepfer DD, 1999, PROG BIOPHYS MOL BIO, V71, P435, DOI 10.1016/S0079-6107(98)00052-2; Sievers F, 2014, METHODS MOL BIOL, V1079, P105, DOI 10.1007/978-1-62703-646-7_6; Vadali K, 2007, IUBMB LIFE, V59, P709, DOI 10.1080/15216540701694245; Valdar WSJ, 2002, PROTEINS, V48, P227, DOI 10.1002/prot.10146; van den Bogaart G, 2011, NATURE, V479, P552, DOI 10.1038/nature10545; Watt SA, 2002, BIOCHEM J, V363, P657, DOI 10.1042/0264-6021:3630657; Zhou J, 2015, BIOPHYS J, V108, P698, DOI 10.1016/j.bpj.2014.11.3454	37	10	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0132833	10.1371/journal.pone.0132833	http://dx.doi.org/10.1371/journal.pone.0132833			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RV	26186725	Green Published, gold, Green Submitted			2022-12-26	WOS:000358198700064
J	Oliveira, HC; Stolf-Moreira, R; Martinez, CBR; Grillo, R; de Jesus, MB; Fraceto, LF				Oliveira, Halley Caixeta; Stolf-Moreira, Renata; Reis Martinez, Claudia Bueno; Grillo, Renato; de Jesus, Marcelo Bispo; Fraceto, Leonardo Fernandes			Nanoencapsulation Enhances the Post-Emergence Herbicidal Activity of Atrazine against Mustard Plants	PLOS ONE			English	Article							NANOPARTICLES; PROTECTION; RELEASE; DAMAGE	Poly(epsilon-caprolactone) (PCL) nanocapsules have been recently developed as a modified release system for atrazine, an herbicide that can have harmful effects in the environment. Here, the post-emergence herbicidal activity of PCL nanocapsules containing atrazine was evaluated using mustard (Brassica juncea) as target plant species model. Characterization of atrazine-loaded PCL nanocapsules by nanoparticle tracking analysis indicated a concentration of 7.5 x 10(12) particles mL(-1) and an average size distribution of 240.7 nm. The treatment of mustard plants with nanocapsules carrying atrazine at 1 mg mL(-1) resulted in a decrease of net photosynthesis and PSII maximum quantum yield, and an increase of leaf lipid peroxidation, leading to shoot growth inhibition and the development of severe symptoms. Time course analysis until 72 h after treatments showed that nanoencapsulation of atrazine enhanced the herbicidal activity in comparison with a commercial atrazine formulation. In contrast to the commercial formulation, ten-fold dilution of the atrazine-containing nanocapsules did not compromise the herbicidal activity. No effects were observed when plants were treated with nanocapsules without herbicide compared to control leaves sprayed with water. Overall, these results demonstrated that atrazine-containing PCL nanocapsules provide very effective post-emergence herbicidal activity. More importantly, the use of nanoencapsulated atrazine enables the application of lower dosages of the herbicide, without any loss of efficiency, which could provide environmental benefits.	[Oliveira, Halley Caixeta; Stolf-Moreira, Renata] UEL Univ Londrina, Dept Anim & Plant Biol, Londrina, Parana, Brazil; [Reis Martinez, Claudia Bueno] UEL Univ Londrina, Dept Physiol Sci, Londrina, Parana, Brazil; [Grillo, Renato; Fraceto, Leonardo Fernandes] Univ Estadual Campinas, UNICAMP, Inst Biol, Dept Biochem, Campinas, SP, Brazil; [Grillo, Renato; Fraceto, Leonardo Fernandes] Univ Estadual Paulista, UNESP, Dept Environm Engn, Sorocaba, SP, Brazil; [de Jesus, Marcelo Bispo] Univ Estadual Campinas, UNICAMP, Inst Biol, Nanocell Interact Lab, Campinas, SP, Brazil	Universidade de Sao Paulo; Universidade Estadual de Campinas; Universidade Estadual Paulista; Universidade de Sao Paulo; Universidade Estadual de Campinas	Oliveira, HC (corresponding author), UEL Univ Londrina, Dept Anim & Plant Biol, Londrina, Parana, Brazil.	halley@uel.br; leonardo@sorocaba.unesp.br	Grillo, Renato/H-6532-2013; Fraceto, Leonardo/C-4468-2012; Oliveira, Halley C/I-8539-2012; de Jesus, Marcelo Bispo/C-6736-2013; Fraceto, Leonardo Fernandes/ABF-2797-2021; Moreira, Renata Stolf/Q-4776-2019	Grillo, Renato/0000-0002-0284-5782; Oliveira, Halley C/0000-0002-5487-4964; de Jesus, Marcelo Bispo/0000-0003-0812-1491; Fraceto, Leonardo Fernandes/0000-0002-2827-2038; Moreira, Renata Stolf/0000-0002-3146-7848	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [2013/12322-2, 2011/01872-6]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico; Fundunesp; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior; CBRM: INCT-TA/CNPq [573949/2008-5]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundunesp; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CBRM: INCT-TA/CNPq	This work was supported by the following sources of funding. LFF: Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (2013/12322-2), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Fundunesp and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior. RG: Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (2011/01872-6), CBRM: INCT-TA/CNPq (573949/2008-5). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bortoluzzi Edson C., 2006, Rev. bras. eng. agríc. ambient., V10, P881, DOI 10.1590/S1415-43662006000400015; Brain RA, 2012, ECOTOX ENVIRON SAFE, V79, P55, DOI 10.1016/j.ecoenv.2011.12.001; Camejo G, 1998, Methods Mol Biol, V108, P377; CAMPOS EVR, 2014, ADV SCI ENG MED, V6, P1, DOI DOI 10.1166/ASEM.2014.1538; Chen HD, 2011, TRENDS FOOD SCI TECH, V22, P585, DOI 10.1016/j.tifs.2011.09.004; Clemente Z, 2014, J NANOSCI NANOTECHNO, V14, P4911, DOI 10.1166/jnn.2014.8681; Dalton RL, 2010, ENVIRON TOXICOL CHEM, V29, P2304, DOI 10.1002/etc.277; de Oliveira JL, 2015, J AGR FOOD CHEM, V63, P422, DOI 10.1021/jf5059045; Gammon DW, 2005, PEST MANAG SCI, V61, P331, DOI 10.1002/ps.1000; Ghormade V, 2011, BIOTECHNOL ADV, V29, P792, DOI 10.1016/j.biotechadv.2011.06.007; Graymore M, 2001, ENVIRON INT, V26, P483, DOI 10.1016/S0160-4120(01)00031-9; Grillo R, 2014, J HAZARD MATER, V278, P163, DOI 10.1016/j.jhazmat.2014.05.079; Grillo R, 2012, J HAZARD MATER, V231, P1, DOI 10.1016/j.jhazmat.2012.06.019; Grillo R, 2010, J POLYM ENVIRON, V18, P26, DOI 10.1007/s10924-009-0153-8; Guillette LJ, 2012, SCIENCE, V337, P1614, DOI 10.1126/science.1226985; Hess FD, 2000, WEED SCI, V48, P160, DOI 10.1614/0043-1745(2000)048[0160:LDHAO]2.0.CO;2; Hoagland D. R., 1950, CALIFORNIA AGR EXPT, P347; Kah M, 2013, CRIT REV ENV SCI TEC, V43, P1823, DOI 10.1080/10643389.2012.671750; Kah M, 2014, ENVIRON INT, V63, P224, DOI 10.1016/j.envint.2013.11.015; Khot LR, 2012, CROP PROT, V35, P64, DOI 10.1016/j.cropro.2012.01.007; Kumar S, 2014, CARBOHYD POLYM, V101, P1061, DOI 10.1016/j.carbpol.2013.10.025; Rondina ABL, 2014, J TROP ECOL, V30, P599, DOI 10.1017/S0266467414000509; Murchie EH, 2013, J EXP BOT, V64, P3983, DOI 10.1093/jxb/ert208; Namasivayam SKR, 2014, RES J BIOTECHNOL, V9, P19; Pereira AES, 2014, J HAZARD MATER, V268, P207, DOI 10.1016/j.jhazmat.2014.01.025; Quina FH, 2004, QUIM NOVA, V27, P1028, DOI 10.1590/S0100-40422004000600031; RODRIGUES BN, 2011, GUIA HERBICIDAS; Roy A, 2014, CENT EUR J CHEM, V12, P453, DOI 10.2478/s11532-013-0405-2; Santos TG, 2012, CHEMOSPHERE, V89, P1118, DOI 10.1016/j.chemosphere.2012.05.096; Vitor SC, 2013, PLANTA, V238, P475, DOI 10.1007/s00425-013-1906-0; Woodruff MA, 2010, PROG POLYM SCI, V35, P1217, DOI 10.1016/j.progpolymsci.2010.04.002	31	40	40	3	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0132971	10.1371/journal.pone.0132971	http://dx.doi.org/10.1371/journal.pone.0132971			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RV	26186597	Green Published, Green Submitted, gold			2022-12-26	WOS:000358198700078
J	Kolko, M; Horwitz, A; Thygesen, J; Jeppesen, J; Torp-Pedersen, C				Kolko, Miriam; Horwitz, Anna; Thygesen, John; Jeppesen, Jorgen; Torp-Pedersen, Christian			The Prevalence and Incidence of Glaucoma in Denmark in a Fifteen Year Period: A Nationwide Study	PLOS ONE			English	Article							OPEN-ANGLE GLAUCOMA; INTRAOCULAR-PRESSURE; EYE; TRENDS; TRIAL	Purpose The purpose of the present study was to describe the prevalence, incidence and geographic variation of glaucoma in Denmark in the period from 1996 to 2011. Moreover, the aim was to identify the treatment patterns of glaucoma within the studied period. Methods All Danish citizens were included throughout the study period. The National Prescription Registry was used to identify all claimed prescriptions for glaucoma medication. Results A total of 116,592 incident glaucoma patients were identified. Average age at onset was 66 years (range: 0-105 years), 55% were women. The prevalence of glaucoma increased from 0.79% to 1.72% during the investigated period. In 2011 glaucoma affected 3.76% of the population above 50 years and 10% in patients above 80 years. The age-specific incidence rate of glaucoma seemed to be constant and the increasing prevalence was primarily attributed to an aging population. We found the highest prevalence of glaucoma in the capital region of Denmark. Within the studied period the use of prostaglandin analogs and combination drugs increased, whereas the use of beta-blockers, carbon anhydrase inhibitors and parasympathomimetic drugs decreased (p<0.001). Finally, the use of alpha 2-adrenergic agonists remained unchanged. A total of 75% of the patients were treated with two or more glaucoma medications. Conclusions Over all, the present study is the first to assess the frequency and the development of glaucoma in Denmark over a 15-year period. We find that glaucoma affects a little less than 2% of the total population and increases with age to reach a prevalence of more than 10% amongst people above 80 years. Generally, the present study is the largest nation-wide study ever made and must be a close-to-real-life-picture of the utilization of glaucoma medication on a national scale. Our findings confirm other recent estimations on an increasing burden of glaucoma globally.	[Kolko, Miriam] Univ Copenhagen, Dept Neurosci & Pharmacol, Copenhagen, Denmark; [Kolko, Miriam; Horwitz, Anna] Roskilde Univ Hosp, Dept Ophthalmol, Roskilde, Denmark; [Kolko, Miriam] Univ Copenhagen, Ctr Hlth Aging, Copenhagen, Denmark; [Thygesen, John] Univ Copenhagen, Glostrup Hosp, Dept Ophthalmol, Glostrup, Denmark; [Jeppesen, Jorgen] Univ Copenhagen, Glostrup Hosp, Dept Cardiol, Glostrup, Denmark; [Torp-Pedersen, Christian] Aalborg Univ Hosp, Dept Hlth Sci & Technol, Aalborg, Denmark	University of Copenhagen; University of Copenhagen; University of Copenhagen; University of Copenhagen; Aalborg University; Aalborg University Hospital	Kolko, M (corresponding author), Univ Copenhagen, Dept Neurosci & Pharmacol, Copenhagen, Denmark.	mkolko@dadlnet.dk	Thygesen, John/AAG-8403-2020	Kolko, Miriam/0000-0001-8697-0734				Blumenthal D, 2003, NEW ENGL J MED, V349, P2452, DOI 10.1056/NEJMhpr035460; CAIRNS JE, 1968, AM J OPHTHALMOL, V66, P673, DOI 10.1016/0002-9394(68)91288-9; Casson RJ, 2012, CLIN EXP OPHTHALMOL, V40, P350, DOI 10.1111/j.1442-9071.2011.02563.x; Connor AJ, 2014, EYE, V28, P863, DOI 10.1038/eye.2014.114; GOLDSCHMIDT E, 1989, ACTA OPHTHALMOL, V67, P204; Heijl A, 2002, ARCH OPHTHALMOL-CHIC, V120, P1268, DOI 10.1001/archopht.120.10.1268; Heijl A, 2013, OPHTHALMOLOGY, V120, P1541, DOI 10.1016/j.ophtha.2013.01.043; Heijl A, 2009, OPHTHALMOLOGY, V116, P2271, DOI 10.1016/j.ophtha.2009.06.042; KATZ J, 1991, ARCH OPHTHALMOL-CHIC, V109, P1684, DOI 10.1001/archopht.1991.01080120068028; Lam BL, 2011, ARCH OPHTHALMOL-CHIC, V129, P1345, DOI 10.1001/archophthalmol.2011.142; LESKE MC, 1994, ARCH OPHTHALMOL-CHIC, V112, P821, DOI 10.1001/archopht.1994.01090180121046; Lundberg L U, 2000, Ugeskr Laeger, V162, P3028; Mitchell P, 1996, OPHTHALMOLOGY, V103, P1661, DOI 10.1016/S0161-6420(96)30449-1; Olsen J, 2013, ACTA OPHTHALMOL, V91, P25, DOI 10.1111/j.1755-3768.2011.02212.x; Razeghinejad MR, 2011, OPTOMETRY VISION SCI, V88, pE39, DOI 10.1097/OPX.0b013e3181fe2226; Realini T, 2011, OPTOMETRY VISION SCI, V88, P36, DOI 10.1097/OPX.0b013e3182058ead; SOMMER A, 1991, ARCH OPHTHALMOL-CHIC, V109, P1090, DOI 10.1001/archopht.1991.01080080050026; Tham YC, 2014, OPHTHALMOLOGY, V121, P2081, DOI 10.1016/j.ophtha.2014.05.013; Topouzis F, 2007, AM J OPHTHALMOL, V144, P511, DOI 10.1016/j.ajo.2007.06.029; van der Valk R, 2005, OPHTHALMOLOGY, V112, P1177, DOI 10.1016/j.ophtha.2005.01.042	20	35	37	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2015	10	7							e0132048	10.1371/journal.pone.0132048	http://dx.doi.org/10.1371/journal.pone.0132048			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RQ	26182236	Green Published, gold, Green Submitted			2022-12-26	WOS:000358198200014
J	Wang, GJ; Sun, Y; Zhang, K; Jia, TT; Hao, MJ; Zhang, D; Chang, L; Zhang, L; Zhang, R; Lin, GG; Peng, RX; Li, JM				Wang, Guojing; Sun, Yu; Zhang, Kuo; Jia, Tingting; Hao, Mingju; Zhang, Dong; Chang, Le; Zhang, Lei; Zhang, Rui; Lin, Guigao; Peng, Rongxue; Li, Jinming			External Quality Assessment of Molecular Detection of Ebola Virus in China	PLOS ONE			English	Article							SIERRA-LEONE; ARMORED RNA; WEST-AFRICA; EPIDEMIC	In 2014, Ebola hemorrhagic fever broke out in West Africa. As contact between China and West Africa is frequent, the possibility that Ebola virus would enter China was high. Thus, an external assessment of the quality of Ebola virus detection was organized by the National Center for Clinical Laboratories in China. Virus-like particles encapsulating known sequences of epidemic strains of Ebola virus from 2014 were prepared as positive quality controls. The sample panel, which was composed of seven positive and three negative samples, was dispatched to 19 laboratories participating in this assessment of Ebola virus detection. Accurate detection was reported at 14 of the 19 participating laboratories, with a sensitivity of 91.43% and a specificity of 100%. Four participants (21.05%) reported false-negative results and were classified as "acceptable." One participant (5.26%) did not detect any positive samples and was thus classified as "improvable." Based on the results returned, the ability to detect weakly positive Ebola specimens should be improved. Furthermore, commercial assays and the standard primers offered by the Chinese Centers for Disease Control and Prevention were found to be most accurate and dependable for Ebola detection. A two-target detection approach is recommended for Ebola screening; this approach could reduce the probability of false-negative results. Additionally, standardization of operations and punctual adjustment of instruments are necessary for the control and prevention of Ebola virus.	[Wang, Guojing; Sun, Yu; Zhang, Kuo; Jia, Tingting; Hao, Mingju; Zhang, Dong; Chang, Le; Zhang, Lei; Zhang, Rui; Lin, Guigao; Peng, Rongxue; Li, Jinming] Natl Hlth & Family Planning Commiss, Beijing Hosp, Natl Ctr Clin Labs, Beijing, Peoples R China; [Wang, Guojing; Jia, Tingting; Hao, Mingju; Zhang, Dong; Chang, Le; Peng, Rongxue] Chinese Acad Med Sci, Peking Union Med Coll, Grad Sch, Beijing 100730, Peoples R China; [Zhang, Lei] Peking Univ, Sch Clin Med 5, Beijing 100871, Peoples R China	Beijing Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Peking University	Li, JM (corresponding author), Natl Hlth & Family Planning Commiss, Beijing Hosp, Natl Ctr Clin Labs, Beijing, Peoples R China.	jmli@nccl.org.cn	Chang, Le/AAO-2318-2020; Chang, Le/GWU-9821-2022	Chang, Le/0000-0002-6154-7304; Chang, Le/0000-0002-6154-7304; Hao, Mingju/0000-0002-2714-3998	National High Technology Research and Development Program of China 863 program [2011AA02A116]; "AIDS and hepatitis, and other major infectious disease control and prevention" Program of China [2013ZX10004805]	National High Technology Research and Development Program of China 863 program; "AIDS and hepatitis, and other major infectious disease control and prevention" Program of China	This work was supported by the National High Technology Research and Development Program of China 863 program (grant No. 2011AA02A116) and "AIDS and hepatitis, and other major infectious disease control and prevention" Program of China (No. 2013ZX10004805). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aylward B, 2014, NEW ENGL J MED, V371, P1481, DOI 10.1056/NEJMoa1411100; Baize S, 2014, NEW ENGL J MED, V371, P1418, DOI 10.1056/NEJMoa1404505; Briand S, 2014, NEW ENGL J MED, V371, P1180, DOI 10.1056/NEJMp1409858; Chinese Center for disease control and prevention, LAB DET SCHEM EB HAE; Dhillon RS, 2015, LANCET INFECT DIS, V15, P147, DOI 10.1016/S1473-3099(14)71035-7; Drazen JM, 2015, NEW ENGL J MED, V372, P563, DOI 10.1056/NEJMe1415398; Drazen JM, 2014, NEW ENGL J MED, V371, P2029, DOI 10.1056/NEJMe1413139; Fan HJ, 2015, DISASTER MED PUBLIC, V9, P64, DOI 10.1017/dmp.2014.152; Feldmann H, 2014, NEW ENGL J MED, V371, P1375, DOI 10.1056/NEJMp1405314; Frieden TR, 2014, NEW ENGL J MED, V371, P1177, DOI 10.1056/NEJMp1409903; Gao GF, 2014, SCIENCE, V346, P666, DOI 10.1126/science.346.6209.666; Goodman JL, 2014, NEW ENGL J MED, V371, P1086, DOI 10.1056/NEJMp1409817; Leroy EM, 2002, J GEN VIROL, V83, P67, DOI 10.1099/0022-1317-83-1-67; Schieffelin JS, 2014, NEW ENGL J MED, V371, P2092, DOI 10.1056/NEJMoa1411680; Song LQ, 2011, J CLIN MICROBIOL, V49, P3591, DOI 10.1128/JCM.00686-11; Sun Y, 2013, J CLIN MICROBIOL, V51, P4055, DOI 10.1128/JCM.02018-13; World Health Organization, 2015, EB RESP ROADM SIT RE; Zhang BK, 2015, SCI CHINA LIFE SCI, V58, P114, DOI 10.1007/s11427-014-4787-y	18	9	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0132659	10.1371/journal.pone.0132659	http://dx.doi.org/10.1371/journal.pone.0132659			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26177537	Green Submitted, Green Published, gold			2022-12-26	WOS:000358197600139
J	Torihashi, S; Ho, M; Kawakubo, Y; Komatsu, K; Nagai, M; Hirayama, Y; Kawabata, Y; Takenaka-Ninagawa, N; Wanachewin, O; Zhuo, L; Kimata, K				Torihashi, Shigeko; Ho, Mioko; Kawakubo, Yuji; Komatsu, Kazumi; Nagai, Masataka; Hirayama, Yuri; Kawabata, Yuka; Takenaka-Ninagawa, Nana; Wanachewin, Orawan; Zhuo, Lisheng; Kimata, Koji			Acute and Temporal Expression of Tumor Necrosis Factor (TNF)-alpha-stimulated Gene 6 Product, TSG6, in Mesenchymal Stem Cells Creates Microenvironments Required for Their Successful Transplantation into Muscle Tissue	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTER-ALPHA-INHIBITOR; HEAVY-CHAINS; CONSTITUTIVE EXPRESSION; HYALURONAN-SYNTHESIS; CHONDROITIN SULFATE; TRYPSIN INHIBITOR; PROTEIN; DOMAIN; BINDING; PTX3	Previously, we demonstrated that when mesenchymal stem cells (MSCs) from mouse ES cells were transplanted into skeletal muscle, more than 60% of them differentiated into muscles in the crush-injured tibialis anterior muscle in vivo, although MSCs neither differentiated nor settled in the intact muscle. Microenvironments, including the extracellular matrix between the injured and intact muscle, were quite different. In the injured muscle, hyaluronan (HA), heavy chains of inter-alpha-inhibitor (I alpha I), CD44, and TNF-alpha-stimulated gene 6 product (TSG-6) increased 24-48 h after injury, although basement membrane components of differentiated muscle such as perlecan, laminin, and type IV collagen increased gradually 4 days after the crush. We then investigated the microenvironments crucial for cell transplantation, using the lysate of C2C12 myotubules for mimicking injured circumstances in vivo. MSCs settled in the intact muscle when they were transplanted together with the C2C12 lysate or TSG6. MSCs produced and released TSG6 when they were cultured with C2C12 lysates in vitro. MSCs pretreated with the lysate also settled in the intact muscle. Furthermore, MSCs whose TSG6 was knocked down by shRNA, even if transplanted or pretreated with the lysate, could not settle in the muscle. Immunofluorescent staining showed that HA and I alpha I always co-localized or were distributed closely, suggesting formation of covalent complexes, i.e. the SHAP-HA complex in the presence of TSG6. Thus, TSG6, HA, and I alpha I were crucial factors for the settlement and probably the subsequent differentiation of MSCs.	[Torihashi, Shigeko; Kawabata, Yuka; Takenaka-Ninagawa, Nana] Nagoya Univ, Grad Sch Med, Dept Rehabil Sci, Nagoya, Aichi 4619673, Japan; [Ho, Mioko; Kawakubo, Yuji; Komatsu, Kazumi; Nagai, Masataka; Hirayama, Yuri] Nagoya Univ, Sch Hlth Sci, Dept Phys Therapy, Nagoya, Aichi 4618673, Japan; [Wanachewin, Orawan; Zhuo, Lisheng; Kimata, Koji] Aichi Med Univ, Adv Med Res Ctr, Nagakute, Aichi 4801195, Japan; [Wanachewin, Orawan; Zhuo, Lisheng; Kimata, Koji] Aichi Med Univ, Ctr Multidisciplinary Pain, Nagakute, Aichi 4801195, Japan; [Takenaka-Ninagawa, Nana] Kyoto Univ, Dept Clin Applicat, Ctr iPS Cell Res & Applicat, Kyoto 6068507, Japan; [Wanachewin, Orawan] Chiang Mai Univ, Fac Med, Dept Biochem, Chiang Mai 50200, Thailand	Nagoya University; Nagoya University; Aichi Medical University; Aichi Medical University; Kyoto University; Chiang Mai University	Kimata, K (corresponding author), Aichi Med Univ, Adv Med Res Ctr, 1-1 Yazakokarimata, Nagakute, Aichi 4801195, Japan.	kimata@aichi-med-u.ac.jp			Japanese Government [22300185, 24650313, 23570148]	Japanese Government	This work was supported in part by Japanese Government Grants-in-aid for Scientific Research (B) 22300185, Challenging Exploratory Research Grant 24650313 (to S.T.), and Scientific Research (C) Grant 23570148 (to K.K.).	Awaya T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051638; Baranova NS, 2013, J BIOL CHEM, V288, P29642, DOI 10.1074/jbc.M113.477422; Baranova NS, 2011, J BIOL CHEM, V286, P25675, DOI 10.1074/jbc.M111.247395; Calve S, 2012, FASEB J, V26, P2538, DOI 10.1096/fj.11-200162; Calve S, 2010, DEV BIOL, V344, P259, DOI 10.1016/j.ydbio.2010.05.007; Casar JC, 2004, J CELL SCI, V117, P73, DOI 10.1242/jcs.00828; Choi H, 2011, BLOOD, V118, P330, DOI 10.1182/blood-2010-12-327353; Coulson-Thomas VJ, 2014, J BIOL CHEM, V289, P23465, DOI 10.1074/jbc.M114.557447; de la Garza-Rodea AS, 2012, CELL TRANSPLANT, V21, P153, DOI 10.3727/096368911X580554; Di Battista AP, 2013, CELL STRESS CHAPERON, V18, P675, DOI 10.1007/s12192-013-0418-y; Evanko SP, 2007, ADV DRUG DELIVER REV, V59, P1351, DOI 10.1016/j.addr.2007.08.008; Goudenege S, 2012, MOL THER, V20, P2153, DOI 10.1038/mt.2012.188; He H, 2009, J BIOL CHEM, V284, P20136, DOI 10.1074/jbc.M109.021881; Heng BC, 2008, J BIOL CHEM, V283, P32294, DOI 10.1074/jbc.M804155200; Hunt LC, 2013, J BIOL CHEM, V288, P13006, DOI 10.1074/jbc.M113.453209; Hwang YS, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0072023, 10.1371/annotation/b02313dc-840f-4f03-91a2-77cb55a3a4c9]; Ievoli E, 2011, MATRIX BIOL, V30, P330, DOI 10.1016/j.matbio.2011.05.002; Krysko DV, 2012, NAT REV CANCER, V12, P860, DOI 10.1038/nrc3380; Kuraitis D, 2012, BIOMATERIALS, V33, P428, DOI 10.1016/j.biomaterials.2011.09.078; Kuznetsova SA, 2005, J BIOL CHEM, V280, P30899, DOI 10.1074/jbc.M500701200; Kuznetsova SA, 2008, MATRIX BIOL, V27, P201, DOI 10.1016/j.matbio.2007.10.003; Kvezereli M, 2008, J MOL HISTOL, V39, P585, DOI 10.1007/s10735-008-9199-5; Lauer ME, 2013, J BIOL CHEM, V288, P205, DOI 10.1074/jbc.M112.403998; Lauer ME, 2013, J BIOL CHEM, V288, P423, DOI 10.1074/jbc.M112.389882; Lee JL, 2009, J CELL BIOL, V185, P949, DOI 10.1083/jcb.200812060; Lesley J, 2004, J BIOL CHEM, V279, P25745, DOI 10.1074/jbc.M313319200; Maina V, 2009, J LEUKOCYTE BIOL, V86, P123, DOI 10.1189/jlb.0608345; McDonald B, 2013, AM J PHYSIOL-GASTR L, V305, pG797, DOI 10.1152/ajpgi.00058.2013; Mikami T, 2012, J BIOL CHEM, V287, P38531, DOI 10.1074/jbc.M111.336925; Milner CM, 2006, BIOCHEM SOC T, V34, P446, DOI 10.1042/BST0340446; Milner CM, 2003, J CELL SCI, V116, P1863, DOI 10.1242/jcs.00407; Ninagawa N, 2011, DIFFERENTIATION, V82, P153, DOI 10.1016/j.diff.2011.07.001; Ninagawa NT, 2013, BIORESEARCH OPEN ACC, V2, P295, DOI 10.1089/biores.2013.0012; Price FD, 2014, NAT MED, V20, P1174, DOI 10.1038/nm.3655; Rugg MS, 2005, J BIOL CHEM, V280, P25674, DOI 10.1074/jbc.M501332200; Santa Maria L, 2004, EXP CELL RES, V300, P418, DOI 10.1016/j.yexcr.2004.07.017; Swaidani S, 2013, J BIOL CHEM, V288, P412, DOI 10.1074/jbc.M112.389874; Tan KT, 2011, AESTHET SURG J, V31, P47, DOI 10.1177/1090820X10391778; Tran T, 2013, INT REV CEL MOL BIO, V300, P51, DOI 10.1016/B978-0-12-405210-9.00002-3; Tran TH, 2012, J BIOL CHEM, V287, P32651, DOI 10.1074/jbc.M112.353243; Trzeciak P, 2012, POSTEP HIG MED DOSW, V66, P543, DOI 10.5604/17322693.1006408; Tsukahara S, 2006, BIOCHEM J, V398, P595, DOI 10.1042/BJ20060027; UJITA M, 1994, J BIOL CHEM, V269, P27603; Yingsung W, 2003, J BIOL CHEM, V278, P32710, DOI 10.1074/jbc.M303658200; Zhang Q, 2010, NATURE, V464, P104, DOI 10.1038/nature08780; Zhang SZ, 2014, J BIOL CHEM, V289, P13531, DOI 10.1074/jbc.M113.525287; Zhang SZ, 2012, J BIOL CHEM, V287, P12433, DOI 10.1074/jbc.M112.342873; Zhuo LS, 2006, J BIOL CHEM, V281, P20303, DOI 10.1074/jbc.M506703200; Zhuo L, 2008, CONNECT TISSUE RES, V49, P311, DOI 10.1080/03008200802325458; Zhuo LS, 2004, J BIOL CHEM, V279, P38079, DOI 10.1074/jbc.R300039200	50	18	18	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	2015	290	37					22771	22781		10.1074/jbc.M114.629774	http://dx.doi.org/10.1074/jbc.M114.629774			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CR2PB	26178374	Green Published, hybrid			2022-12-26	WOS:000361171500040
J	Sorensen, TH; Cruys-Bagger, N; Windahl, MS; Badino, SF; Borch, K; Westh, P				Sorensen, Trine Holst; Cruys-Bagger, Nicolaj; Windahl, Michael Skovbo; Badino, Silke Flindt; Borch, Kim; Westh, Peter			Temperature Effects on Kinetic Parameters and Substrate Affinity of Cel7A Cellobiohydrolases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARBOHYDRATE-BINDING MODULES; TRICHODERMA-REESEI; CELLULOSE HYDROLYSIS; ENZYMATIC-HYDROLYSIS; SACCHAROMYCES-CEREVISIAE; TALAROMYCES-EMERSONII; PROCESSIVE CELLULASES; INSOLUBLE CELLULOSE; PRODUCT INHIBITION; ETHANOL-PRODUCTION	We measured hydrolytic rates of four purified cellulases in small increments of temperature (10-50 degrees C) and substrate loads (0-100 g/liter) and analyzed the data by a steady state kinetic model that accounts for the processive mechanism. We used wild type cellobiohydrolases (Cel7A) from mesophilic Hypocrea jecorina and thermophilic Rasamsonia emersonii and two variants of these enzymes designed to elucidate the role of the carbohydrate binding module (CBM). We consistently found that the maximal rate increased strongly with temperature, whereas the affinity for the insoluble substrate decreased, and as a result, the effect of temperature depended strongly on the substrate load. Thus, temperature had little or no effect on the hydrolytic rate in dilute substrate suspensions, whereas strong temperature activation (Q(10) values up to 2.6) was observed at saturating substrate loads. The CBM had a dual effect on the activity. On one hand, it diminished the tendency of heat-induced desorption, but on the other hand, it had a pronounced negative effect on the maximal rate, which was 2-fold larger in variants without CBM throughout the investigated temperature range. We conclude that although the CBM is beneficial for affinity it slows down the catalytic process. Cel7A from the thermophilic organism was moderately more activated by temperature than the mesophilic analog. This is in accord with general theories on enzyme temperature adaptation and possibly relevant information for the selection of technical cellulases.	[Sorensen, Trine Holst; Cruys-Bagger, Nicolaj; Windahl, Michael Skovbo; Badino, Silke Flindt; Westh, Peter] Roskilde Univ, Nat Syst & Models, Res Unit Funct Biomat, DK-4000 Roskilde, Denmark; [Windahl, Michael Skovbo; Badino, Silke Flindt; Borch, Kim] Novozymes AS, DK-2880 Bagsvaerd, Denmark	Roskilde University; Novozymes	Westh, P (corresponding author), Roskilde Univ, Nat Syst & Models, Res Unit Funct Biomat, 1 Univ Svej,Bldg 28, DK-4000 Roskilde, Denmark.	pwesth@ruc.dk	Westh, Peter/AAR-9731-2021	Windahl, Michael Skovbo/0000-0002-0572-3115; Sorensen, Trine Holst/0000-0002-2045-7580; Westh, Peter/0000-0002-6185-0637	Danish Council for Strategic Research, Program Commission on Sustainable Energy and Environment [2104-07-0028, 11-116772]; Carlsberg Foundation [2013-01-0208]	Danish Council for Strategic Research, Program Commission on Sustainable Energy and Environment; Carlsberg Foundation(Carlsberg Foundation)	This work was supported by Danish Council for Strategic Research, Program Commission on Sustainable Energy and Environment Grants 2104-07-0028 and 11-116772 (to P. W.) and by Carlsberg Foundation Grant 2013-01-0208 (to P. W.). Novozymes is a major enzyme-producing company.	Alasepp K, 2014, LANGMUIR, V30, P7134, DOI 10.1021/la500161e; Borch K., 2014, WIPO patent, Patent No. 2014138672; Brown RF, 2010, BIOTECHNOL BIOFUELS, V3, DOI 10.1186/1754-6834-3-6; Cherry J, 2009, Variants of glycoside hydrolases, Patent No. [WO2005030926 A3, 2005030926]; Colussi F, 2015, J BIOL CHEM, V290, P2444, DOI 10.1074/jbc.M114.624163; Cruys-Bagger N, 2013, FEBS J, V280, P3952, DOI 10.1111/febs.12397; Cruys-Bagger N, 2012, J BIOL CHEM, V287, P18451, DOI 10.1074/jbc.M111.334946; Davidson EA, 2006, NATURE, V440, P165, DOI 10.1038/nature04514; Day AG, 2004, Novel variant Hypocrea jecorina VBH1 cellulases, Patent No. [WO2004/016760, 2004016760]; DENG SP, 1994, SOIL BIOL BIOCHEM, V26, P1347, DOI 10.1016/0038-0717(94)90216-X; DIVNE C, 1994, SCIENCE, V265, P524, DOI 10.1126/science.8036495; Drissen RET, 2007, BIOCATAL BIOTRANSFOR, V25, P419, DOI 10.1080/10242420701510668; Eriksson T, 2002, APPL BIOCHEM BIOTECH, V101, P41, DOI 10.1385/ABAB:101:1:41; Fersht A., 1999, STRUCTURE MECH PROTE; Garsoux G, 2004, BIOCHEM J, V384, P247, DOI 10.1042/BJ20040325; Gasteiger E., 2005, PROTEOMICS PROTOC HD, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; German DP, 2012, GLOBAL CHANGE BIOL, V18, P1468, DOI 10.1111/j.1365-2486.2011.02615.x; Grassick A, 2004, EUR J BIOCHEM, V271, P4495, DOI 10.1111/j.1432-1033.2004.04409.x; Gruno M, 2004, BIOTECHNOL BIOENG, V86, P503, DOI 10.1002/bit.10838; Heinzelman P, 2009, P NATL ACAD SCI USA, V106, P5610, DOI 10.1073/pnas.0901417106; Horn SJ, 2006, P NATL ACAD SCI USA, V103, P18089, DOI 10.1073/pnas.0608909103; Horn SJ, 2012, METHOD ENZYMOL, V510, P69, DOI 10.1016/B978-0-12-415931-0.00005-7; Houbraken J, 2012, ANTON LEEUW INT J G, V101, P403, DOI 10.1007/s10482-011-9647-1; Hu G, 2009, J PHYS CHEM B, V113, P14761, DOI 10.1021/jp907155v; Jalak J, 2010, BIOTECHNOL BIOENG, V106, P871, DOI 10.1002/bit.22779; Jorgensen H, 2007, BIOFUEL BIOPROD BIOR, V1, P119, DOI 10.1002/bbb.4; Kari J, 2014, J BIOL CHEM, V289, DOI 10.1074/jbc.M114.604264; Laidler K J, 1979, Methods Enzymol, V63, P234; Larsen J, 2008, CHEM ENG TECHNOL, V31, P765, DOI 10.1002/ceat.200800048; Le Costaouec T, 2013, BIORESOURCE TECHNOL, V143, P196, DOI 10.1016/j.biortech.2013.05.079; LEVER M, 1972, ANAL BIOCHEM, V47, P273, DOI 10.1016/0003-2697(72)90301-6; Linder M, 1996, P NATL ACAD SCI USA, V93, P12251, DOI 10.1073/pnas.93.22.12251; Lonhienne T, 2000, BBA-PROTEIN STRUCT M, V1543, P1, DOI 10.1016/S0167-4838(00)00210-7; Moran-Mirabal JM, 2011, BIOPHYS CHEM, V155, P20, DOI 10.1016/j.bpc.2011.02.003; Murphy L, 2013, ENZYME MICROB TECH, V52, P163, DOI 10.1016/j.enzmictec.2013.01.002; NG TK, 1981, APPL ENVIRON MICROB, V42, P231, DOI 10.1128/AEM.42.2.231-240.1981; OOSHIMA H, 1983, BIOTECHNOL BIOENG, V25, P3103, DOI 10.1002/bit.260251223; Pakarinen A, 2014, BIOTECHNOL BIOFUELS, V7, DOI 10.1186/1754-6834-7-27; Palonen H, 1999, APPL ENVIRON MICROB, V65, P5229; Payne CM, 2015, CHEM REV, V115, P1308, DOI 10.1021/cr500351c; Praestgaard E, 2011, FEBS J, V278, P1547, DOI 10.1111/j.1742-4658.2011.08078.x; Somero GN, 2004, COMP BIOCHEM PHYS B, V139, P321, DOI 10.1016/j.cbpc.2004.05.003; Sorensen TH, 2015, J BIOL CHEM, V290, P22203, DOI 10.1074/jbc.M115.659656; Stone MM, 2012, GLOBAL CHANGE BIOL, V18, P1173, DOI 10.1111/j.1365-2486.2011.02545.x; Subhedar PB, 2014, J MOL CATAL B-ENZYM, V101, P108, DOI 10.1016/j.molcatb.2014.01.002; Teugjas H, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-104; TOMME P, 1988, EUR J BIOCHEM, V170, P575, DOI 10.1111/j.1432-1033.1988.tb13736.x; Varnai A, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-30; Vasquez MP, 2007, APPL BIOCHEM BIOTECH, V137, P141, DOI 10.1007/s12010-007-9046-2; Viikari L, 2007, ADV BIOCHEM ENG BIOT, V108, P121, DOI 10.1007/10_2007_065; Voutilainen SP, 2008, BIOTECHNOL BIOENG, V101, P515, DOI 10.1002/bit.21940; Voutilainen SP, 2014, APPL MICROBIOL BIOT, V98, P2991, DOI 10.1007/s00253-013-5177-2; Voutilainen SP, 2010, PROTEIN ENG DES SEL, V23, P69, DOI 10.1093/protein/gzp072; Watanabe A, 2006, APPL SPECTROSC, V60, P611, DOI 10.1366/000370206777670549; Wilson DB, 2009, CURR OPIN BIOTECH, V20, P295, DOI 10.1016/j.copbio.2009.05.007; Wolfenden R, 2001, ACCOUNTS CHEM RES, V34, P938, DOI 10.1021/ar000058i; Wolfenden R, 1998, J AM CHEM SOC, V120, P6814, DOI 10.1021/ja9813055; Wu I, 2013, BIOTECHNOL BIOENG, V110, P1874, DOI 10.1002/bit.24864; Ye ZL, 2014, BIORESOURCE TECHNOL, V167, P582, DOI 10.1016/j.biortech.2014.06.070; Zhang S, 1999, BIOTECHNOL BIOENG, V66, P35, DOI 10.1002/(SICI)1097-0290(1999)66:1&lt;35::AID-BIT3&gt;3.0.CO;2-G; Zhang Y, 2012, APPL BIOCHEM BIOTECH, V168, P144, DOI 10.1007/s12010-011-9362-4; Zhou WL, 2004, BIOCHEMISTRY-US, V43, P9655, DOI 10.1021/bi049394n	62	44	44	3	35	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	2015	290	36					22193	22202		10.1074/jbc.M115.658930	http://dx.doi.org/10.1074/jbc.M115.658930			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CQ9XI	26183777	hybrid, Green Published			2022-12-26	WOS:000360968500036
J	Cabanel, M; Brand, C; Oliveira-Nunes, MC; Cabral-Piccin, MP; Lopes, MF; Brito, JM; de Oliveira, FL; El-Cheikh, MC; Carneiro, K				Cabanel, Mariana; Brand, Camila; Oliveira-Nunes, Maria Cecilia; Cabral-Piccin, Mariela Pires; Lopes, Marcela Freitas; Brito, Jose Marques; de Oliveira, Felipe Leite; El-Cheikh, Marcia Cury; Carneiro, Katia			Epigenetic Control of Macrophage Shape Transition towards an Atypical Elongated Phenotype by Histone Deacetylase Activity	PLOS ONE			English	Article							TRICHOSTATIN-A; ACTIVATION; PU.1; CELL; DIFFERENTIATION; PROLIFERATION; PROGENITORS; INHIBITION	Inflammatory chronic pathologies are complex processes characterized by an imbalance between the resolution of the inflammatory phase and the establishment of tissue repair. The main players in these inflammatory pathologies are bone marrow derived monocytes (BMDMs). However, how monocyte differentiation is modulated to give rise to specific macrophage subpopulations (M1 or M2) that may either maintain the chronic inflammatory process or lead to wound healing is still unclear. Considering that inhibitors of Histone Deacetylase (HDAC) have an anti-inflammatory activity, we asked whether this enzyme would play a role on monocyte differentiation into M1 or M2 phenotype and in the cell shape transition that follows. We then induced murine bone marrow progenitors into monocyte/macrophage differentiation pathway using media containing GM-CSF and the HDAC blocker, Trichostatin A (TSA). We found that the pharmacological inhibition of HDAC activity led to a shape transition from the typical macrophage pancake-like shape into an elongated morphology, which was correlated to a mixed M1/M2 profile of cytokine and chemokine secretion. Our results present, for the first time, that HDAC activity acts as a regulator of macrophage differentiation in the absence of lymphocyte stimuli. We propose that HDAC activity down regulates macrophage plasticity favoring the pro-inflammatory phenotype.	[Cabanel, Mariana; Brand, Camila; Oliveira-Nunes, Maria Cecilia; Brito, Jose Marques; de Oliveira, Felipe Leite; El-Cheikh, Marcia Cury; Carneiro, Katia] Univ Fed Rio de Janeiro, Inst Biomed Sci, Rio De Janeiro, Brazil; [Cabral-Piccin, Mariela Pires; Lopes, Marcela Freitas] Univ Fed Rio de Janeiro, Carlos Chagas Filho Inst Biophys, Rio De Janeiro, Brazil	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro	Carneiro, K (corresponding author), Univ Fed Rio de Janeiro, Inst Biomed Sci, Rio De Janeiro, Brazil.	kcarneiro@histo.ufrj.br	Carneiro, Katia/I-6014-2015; Oliveira, Felipe L/H-9902-2012; Lopes, Marcela Freitas/E-2201-2012; Carneiro, Katia/AAQ-3415-2020; Brand, Camila/D-8873-2014	Lopes, Marcela Freitas/0000-0002-4508-0505; Carneiro, Katia/0000-0001-5915-5486; Leite de Oliveira, Felipe/0000-0001-6193-1616	Brazilian Federal Agency for the Support and Evaluation of Graduate Education (CAPES) from the Ministry of Education for Fellowship; National Council for Technological and Scientific Development (CNPq) [474076/2013-0]; Rio de Janeiro State Research Foundation (FAPERJ) [E-26-110.812-2013]; PEW Foundation [2008-000746-012]	Brazilian Federal Agency for the Support and Evaluation of Graduate Education (CAPES) from the Ministry of Education for Fellowship; National Council for Technological and Scientific Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Rio de Janeiro State Research Foundation (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); PEW Foundation	This work was supported by Brazilian Federal Agency for the Support and Evaluation of Graduate Education (CAPES) from the Ministry of Education for Fellowship to MC; National Council for Technological and Scientific Development (CNPq 474076/2013-0; www.cnpq.br) to KC; Rio de Janeiro State Research Foundation (FAPERJ E-26-110.812-2013, www.faperj.br) to KC; and PEW Foundation (2008-000746-012; www.pewtrusts.org) to KC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Carneiro K, 2011, BMC DEV BIOL, V11, DOI 10.1186/1471-213X-11-29; Chen XF, 2012, P NATL ACAD SCI USA, V109, pE2865, DOI 10.1073/pnas.1121131109; DeKoter RP, 1998, EMBO J, V17, P4456, DOI 10.1093/emboj/17.15.4456; Drummond DC, 2005, ANNU REV PHARMACOL, V45, P495, DOI 10.1146/annurev.pharmtox.45.120403.095825; ELCHEIKH MC, 1990, INFECT IMMUN, V58, P816, DOI 10.1128/IAI.58.3.816-821.1990; Green L.C., 1982, BIOCHEMISTRY-US, V126, P131, DOI DOI 10.1016/0003-2697(82)90118-X; Gregoretti IV, 2004, J MOL BIOL, V338, P17, DOI 10.1016/j.jmb.2004.02.006; Haberland M, 2009, NAT REV GENET, V10, P32, DOI 10.1038/nrg2485; Han SB, 2009, ARCH PHARM RES, V32, P613, DOI 10.1007/s12272-009-1418-4; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Karpurapu M, 2011, BLOOD, V118, P5255, DOI 10.1182/blood-2011-03-341123; Kawamoto H, 2010, IMMUNOL REV, V238, P23, DOI 10.1111/j.1600-065X.2010.00959.x; Kittan NA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078045; KRAAL G, 1987, SCAND J IMMUNOL, V26, P653, DOI 10.1111/j.1365-3083.1987.tb02301.x; Laribee RN, 2001, J IMMUNOL, V167, P5160, DOI 10.4049/jimmunol.167.9.5160; McWhorter FY, 2013, P NATL ACAD SCI USA, V110, P17253, DOI 10.1073/pnas.1308887110; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Mullican SE, 2011, GENE DEV, V25, P2480, DOI 10.1101/gad.175950.111; Odegaard JI, 2011, ANNU REV PATHOL-MECH, V6, P275, DOI 10.1146/annurev-pathol-011110-130138; Rahman MM, 2003, BLOOD, V101, P3451, DOI 10.1182/blood-2002-08-2622; Shivdasani RA, 1997, BLOOD, V90, P1821, DOI 10.1182/blood.V90.5.1821; Shivdasani RA, 1997, EMBO J, V16, P3965, DOI 10.1093/emboj/16.13.3965; Shivdasani RA, 1997, HEMATOL ONCOL CLIN N, V11, P1199, DOI 10.1016/S0889-8588(05)70489-5; Tabas I, 2010, NAT REV IMMUNOL, V10, P36, DOI 10.1038/nri2675; Tseng AS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026382; YOSHIDA M, 1990, J BIOL CHEM, V265, P17174	26	31	31	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0132984	10.1371/journal.pone.0132984	http://dx.doi.org/10.1371/journal.pone.0132984			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LZ	26196676	Green Submitted, Green Published, gold			2022-12-26	WOS:000358547600059
J	Jin, ZN; Wang, WQ; Jiang, N; Zhang, L; Li, YM; Xu, XY; Cai, SL; Wei, L; Liu, XH; Chen, GL; Zhou, YZ; Liu, C; Li, Z; Jin, F; Chen, B				Jin, Zining; Wang, Wenqian; Jiang, Nan; Zhang, Lei; Li, Yiming; Xu, Xiaoyin; Cai, Shouliang; Wei, Liang; Liu, Xuhong; Chen, Guanglei; Zhou, Yizhen; Liu, Cheng; Li, Zhan; Jin, Feng; Chen, Bo			Clinical Implications of iNOS Levels in Triple-Negative Breast Cancer Responding to Neoadjuvant Chemotherapy	PLOS ONE			English	Article							NITRIC-OXIDE; THERAPEUTIC OPPORTUNITIES; PREDICTS POOR; CISPLATIN; SURVIVAL; ANGIOGENESIS; EXPRESSION; RESISTANCE; APOPTOSIS; ANALOGS	Triple-negative breast cancer is a high-risk breast cancer with poor survival rate. To date, there is a lack of targeted therapy for this type of cancer. One unique phenomenon is that inflammatory breast cancer is frequently triple negative. However, it is still ambiguous how inflammation influences triple-negative breast cancer growth and responding to chemotherapy. Herein, we investigated the levels of inflammation-associated enzyme, iNOS, in 20 triple-negative breast cancer patients' tumors, and examined its correlation with patients' responses to platinum-based neoadjuvant chemotherapy. Our studies showed that triple-negative breast cancer patients with attenuated iNOS levels in tumor cells after treatment showed better responses to platinum-based neoadjuvant chemotherapy than other triple-negative breast cancer patients. Our further in vitro studies confirmed that induction of proper levels of NO increased the resistance to cisplatin in triple-negative MDA-MB-231 cells. Our data suggest that aberrant high level of iNOS/NO are associated with less effectiveness of platinum-based neoadjuvant chemotherapy in triple-negative breast cancer. Therefore, we propose to monitor iNOS levels as a new predictor for triple-negative breast cancer patient's response to platinum-based neoadjuvant chemotherapy. Moreover, iNOS/NO is considered as a potential target for combination therapy with platinum drugs for triple-negative breast cancer.	[Jin, Zining; Wang, Wenqian; Jiang, Nan; Zhang, Lei; Li, Yiming; Xu, Xiaoyin; Cai, Shouliang; Wei, Liang; Liu, Xuhong; Chen, Guanglei; Zhou, Yizhen; Liu, Cheng; Li, Zhan; Jin, Feng; Chen, Bo] China Med Univ, Hosp 1, Dept Breast Surg, Shenyang, Liaoning, Peoples R China	China Medical University	Chen, B (corresponding author), China Med Univ, Hosp 1, Dept Breast Surg, Shenyang, Liaoning, Peoples R China.	chbyxl@163.com	JIANG, NAN/AHB-1945-2022	Wang, Wenqian/0000-0003-2925-4306	National Natural Science Foundation of China [81372811]; Science and Technology Agency of Liaoning Province [2013225049]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Agency of Liaoning Province	Dr. Chen Bo received funding from the National Natural Science Foundation of China (No. 81372811, http://www.nsfc.gov.cn/publish/portal1/) and the Science and Technology Agency of Liaoning Province (No. 2013225049, http://www.lninfo.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambs S, 1998, CANCER RES, V58, P334; Belotte J, 2014, REPROD SCI, V21, P503, DOI 10.1177/1933719113503403; Bhattacharyya A, 2000, J BIOL CHEM, V275, P23899, DOI 10.1074/jbc.C000276200; Chaher N, 2012, BREAST CANCER RES TR, V131, P437, DOI 10.1007/s10549-011-1422-5; DAWOOD S, 2010, CANCER, V117, P1819, DOI DOI 10.1002/CNCR.25682; Dent R, 2007, CLIN CANCER RES, V13, P4429, DOI 10.1158/1078-0432.CCR-06-3045; Glynn SA, 2010, J CLIN INVEST, V120, P3843, DOI 10.1172/JCI42059; Godoy LC, 2012, P NATL ACAD SCI USA, V109, P20373, DOI 10.1073/pnas.1218938109; Kilburn LS, 2008, CLIN ONCOL-UK, V20, P35, DOI 10.1016/j.clon.2007.09.010; KOLARIC K, 1983, CANCER CHEMOTH PHARM, V11, P108, DOI 10.1007/BF00254257; Lechner M, 2005, SEMIN CANCER BIOL, V15, P277, DOI 10.1016/j.semcancer.2005.04.004; Li J, 2011, ONCOLOGIST, V16, P1675, DOI 10.1634/theoncologist.2011-0196; Mocellin S, 2007, MED RES REV, V27, P317, DOI 10.1002/med.20092; Moynahan ME, 2001, CANCER RES, V61, P4842; Pance Alena, 2006, Future Oncol, V2, P275, DOI 10.2217/14796694.2.2.275; Rakha EA, 2007, CANCER-AM CANCER SOC, V109, P25, DOI 10.1002/cncr.22381; Ray GN, 2001, BRIT J BIOMED SCI, V58, P169; Seitz S, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-847; SLEDGE GW, 1988, J CLIN ONCOL, V6, P1811, DOI 10.1200/JCO.1988.6.12.1811; SMITH IE, 1992, BRIT J CANCER, V65, P787, DOI 10.1038/bjc.1992.169; Switzer CH, 2011, TRENDS PHARMACOL SCI, V32, P644, DOI 10.1016/j.tips.2011.07.001; Tang CH, 2004, J BIOL CHEM, V279, P288, DOI 10.1074/jbc.M310821200; Turner N, 2004, NAT REV CANCER, V4, P814, DOI 10.1038/nrc1457; Vakkala M, 2000, CLIN CANCER RES, V6, P2408; Yadav BS, 2014, WORLD J CLIN ONCOL, V5, P125, DOI 10.5306/wjco.v5.i2.125	25	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0130286	10.1371/journal.pone.0130286	http://dx.doi.org/10.1371/journal.pone.0130286			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LZ	26196284	Green Published, gold, Green Submitted			2022-12-26	WOS:000358547600006
J	Yu, GQ; Fadrosh, D; Goedert, JJ; Ravel, J; Goldstein, AM				Yu, Guoqin; Fadrosh, Doug; Goedert, James J.; Ravel, Jacques; Goldstein, Alisa M.			Nested PCR Biases in Interpreting Microbial Community Structure in 16S rRNA Gene Sequence Datasets	PLOS ONE			English	Article								Background Sequencing of the PCR-amplified 16S rRNA gene has become a common approach to microbial community investigations in the fields of human health and environmental sciences. This approach, however, is difficult when the amount of DNA is too low to be amplified by standard PCR. Nested PCR can be employed as it can amplify samples with DNA concentration several-fold lower than standard PCR. However, potential biases with nested PCRs that could affect measurement of community structure have received little attention. Results In this study, we used 17 DNAs extracted from vaginal swabs and 12 DNAs extracted from stool samples to study the influence of nested PCR amplification of the 16S rRNA gene on the estimation of microbial community structure using Illumina MiSeq sequencing. Nested and standard PCR methods were compared on alpha-and beta-diversity metrics and relative abundances of bacterial genera. The effects of number of cycles in the first round of PCR (10 vs. 20) and microbial diversity (relatively low in vagina vs. high in stool) were also investigated. Vaginal swab samples showed no significant difference in alpha diversity or community structure between nested PCR and standard PCR (one round of 40 cycles). Stool samples showed significant differences in alpha diversity (except Shannon's index) and relative abundance of 13 genera between nested PCR with 20 cycles in the first round and standard PCR (P<0.01), but not between nested PCR with 10 cycles in the first round and standard PCR. Operational taxonomic units (OTUs) that had low relative abundance (sum of relative abundance <0.167) accounted for most of the distortion (>27% of total OTUs in stool). Conclusions Nested PCR introduced bias in estimated diversity and community structure. The bias was more significant for communities with relatively higher diversity and when more cycles were applied in the first round of PCR. We conclude that nested PCR could be used when standard PCR does not work. However, rare taxa detected by nested PCR should be validated by other technologies.	[Yu, Guoqin; Goedert, James J.; Goldstein, Alisa M.] NCI, Div Canc Epidemiol & Genet, NIH, Bethesda, MD 20892 USA; [Fadrosh, Doug; Ravel, Jacques] Univ Maryland, Sch Med, Inst Genom Sci, Baltimore, MD 21201 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University System of Maryland; University of Maryland Baltimore	Yu, GQ (corresponding author), NCI, Div Canc Epidemiol & Genet, NIH, Bethesda, MD 20892 USA.	yug3@mail.nih.gov	Ravel, Jacques/D-2530-2009	Ravel, Jacques/0000-0002-0851-2233	Intramural Research Program of the NIH, National Cancer Institute	Intramural Research Program of the NIH, National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by the Intramural Research Program of the NIH, National Cancer Institute.	Bai GY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036934; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; CHAO A, 1987, BIOMETRICS, V43, P783, DOI 10.2307/2531532; Coldham T, 2013, VET MICROBIOL, V166, P429, DOI 10.1016/j.vetmic.2013.06.026; Delgado S, 2013, MICROB ECOL, V65, P763, DOI 10.1007/s00248-013-0192-5; Fadrosh DW, 2014, MICROBIOME, V2, DOI 10.1186/2049-2618-2-6; Faith DP, 2006, EVOL BIOINFORM, V2, P121; Fan ZY, 2009, WORLD J MICROB BIOT, V25, P1447, DOI 10.1007/s11274-009-0033-3; Flores R, 2012, EUR J CLIN INVEST, V42, P855, DOI 10.1111/j.1365-2362.2012.02659.x; Kau AL, 2011, NATURE, V474, P327, DOI 10.1038/nature10213; Koido S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086702; Li W, 2014, MICROB ECOL, V67, P679, DOI 10.1007/s00248-013-0345-6; Lozupone C, 2011, ISME J, V5, P169, DOI 10.1038/ismej.2010.133; Ravel J, 2011, P NATL ACAD SCI USA, V108, P4680, DOI 10.1073/pnas.1002611107; Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60; Shannon CE, 1997, M D COMPUT, V14, P306; SIEGEL S., 1956, NONPARAMETRIC STAT B; Stearns JC, 2011, SCI REP-UK, V1, DOI 10.1038/srep00170; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Zarco MF, 2012, ORAL DIS, V18, P109, DOI 10.1111/j.1601-0825.2011.01851.x	20	45	48	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0132253	10.1371/journal.pone.0132253	http://dx.doi.org/10.1371/journal.pone.0132253			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LZ	26196512	gold, Green Published, Green Submitted			2022-12-26	WOS:000358547600028
J	Arshad, A; Yang, B; Bienemann, AS; Barua, NU; Wyatt, MJ; Woolley, M; Johnson, DE; Edler, KJ; Gill, SS				Arshad, Azeem; Yang, Bin; Bienemann, Alison S.; Barua, Neil U.; Wyatt, Marcella J.; Woolley, Max; Johnson, Dave E.; Edler, Karen J.; Gill, Steven S.			Convection-Enhanced Delivery of Carboplatin PLGA Nanoparticles for the Treatment of Glioblastoma	PLOS ONE			English	Article							MALIGNANT GLIOMA; GLIADEL WAFERS; BRAIN; DRUG; RELEASE; TRIAL; FLOW	We currently use Convection-Enhanced Delivery (CED) of the platinum-based drug, carboplatin as a novel treatment strategy for high grade glioblastoma in adults and children. Although initial results show promise, carboplatin is not specifically toxic to tumour cells and has been associated with neurotoxicity at high infused concentrations in pre-clinical studies. Our treatment strategy requires intermittent infusions due to rapid clearance of carboplatin from the brain. In this study, carboplatin was encapsulated in lactic acid-glycolic acid copolymer (PLGA) to develop a novel drug delivery system. Neuronal and tumour cytotoxicity were assessed in primary neuronal and glioblastoma cell cultures. Distribution, tissue clearance and toxicity of carboplatin nanoparticles following CED was assessed in rat and porcine models. Carboplatin nanoparticles conferred greater tumour cytotoxicity, reduced neuronal toxicity and prolonged tissue half-life. In conclusion, this drug delivery system has the potential to improve the prognosis for patients with glioblastomas.	[Arshad, Azeem; Bienemann, Alison S.; Barua, Neil U.; Wyatt, Marcella J.; Gill, Steven S.] Univ Bristol, Sch Clin Sci, Funct Neurosurg Res Grp, Bristol, Avon, England; [Woolley, Max; Johnson, Dave E.] Renishaw Plc, Neurol Applicat Div, London, Glos, England; [Yang, Bin; Edler, Karen J.] Univ Bath, Dept Chem, Bath BA2 7AY, Avon, England	University of Bristol; Renishaw plc; University of Bath	Gill, SS (corresponding author), Univ Bristol, Sch Clin Sci, Funct Neurosurg Res Grp, Bristol, Avon, England.	steven.gill@nbt.nhs.uk	Edler, Karen/A-7324-2011	Edler, Karen/0000-0001-5822-0127; Yang, Bin/0000-0002-6810-9585	Medical Research Council [MR/J005134/1]; MRC [MR/J005134/1] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The study was funded by the Medical Research Council (http://www.mrc.ac.uk) Ref number: MR/J005134/1. Co-authors M. Woolley and D.E. Johnson are employed by Renishaw Plc. Renishaw Plc., were involved in the Medical Research Council grant application where they provided 'in kind contribution' support for the grant application MR/J005134/1 and provided support in the form of salaries for authors M. Woolley and D.E. Johnson, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Barua NU, 2013, ACTA NEUROCHIR, V155, P1459, DOI 10.1007/s00701-013-1700-6; Barua NU, 2013, J NEUROSCI METH, V214, P223, DOI 10.1016/j.jneumeth.2013.02.007; Barua NU, 2012, FLUIDS BARRIERS CNS, V9, DOI 10.1186/2045-8118-9-2; Barua NU, 2014, DRUG DELIVERY; Barua NU, 2013, ACTA NEUROCHIR WIEN; Bienemann A, 2012, J NEUROSCI METH, V203, P284, DOI 10.1016/j.jneumeth.2011.10.002; Birks SM, 2011, NEURO-ONCOLOGY, V13, P950, DOI 10.1093/neuonc/nor108; BOBO RH, 1994, P NATL ACAD SCI USA, V91, P2076, DOI 10.1073/pnas.91.6.2076; Bogdahn U, 2011, NEURO-ONCOLOGY, V13, P132, DOI 10.1093/neuonc/noq142; Bregy A, 2013, EXPERT REV ANTICANC, V13, P1453, DOI 10.1586/14737140.2013.840090; Bruce JN, 2011, NEUROSURGERY; Danhier F, 2012, J CONTROL RELEASE, V161, P505, DOI 10.1016/j.jconrel.2012.01.043; Fleming AB, 2002, CLIN PHARMACOKINET, V41, P403, DOI 10.2165/00003088-200241060-00002; Govender T, 1999, J CONTROL RELEASE, V57, P171, DOI 10.1016/S0168-3659(98)00116-3; Groothuis DR, 2007, J CEREBR BLOOD F MET, V27, P43, DOI 10.1038/sj.jcbfm.9600315; MacKay JA, 2005, BRAIN RES, V1035, P139, DOI 10.1016/j.brainres.2004.12.007; Mehta Ankit I, 2012, Curr Drug Discov Technol, V9, P305; Nance EA, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003594; PARDRIDGE WM, 1989, NEUROBIOL AGING, V10, P636, DOI 10.1016/0197-4580(89)90160-7; Parker KA, 2006, APOPTOSIS OF HUMAN M; PAXINOS G, 1985, J NEUROSCI METH, V13, P139, DOI 10.1016/0165-0270(85)90026-3; Saito R, 2006, J NEUROSCI METH, V154, P225, DOI 10.1016/j.jneumeth.2005.12.027; Sawyer AJ, 2011, DRUG DELIV TRANSL RE, V1, P34, DOI 10.1007/s13346-010-0001-3; Skinner EK, 2012, CHEM COMMUN, V48, P9260, DOI 10.1039/c2cc34926d; Song XR, 2010, J PHARM SCI-US, V99, P4874, DOI 10.1002/jps.22200; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Stupp R, 2007, J CLIN ONCOL, V25, P4127, DOI 10.1200/JCO.2007.11.8554; WALLNER KE, 1989, INT J RADIAT ONCOL, V16, P1405, DOI 10.1016/0360-3016(89)90941-3; Westphal M, 2003, NEURO-ONCOLOGY, V5, P79, DOI 10.1215/15228517-5-2-79; White E, 2012, J NEURO-ONCOL, V108, P77, DOI 10.1007/s11060-012-0833-4; White E, 2012, CONTEMP CLIN TRIALS, V33, P320, DOI 10.1016/j.cct.2011.10.010; White E, 2011, J NEUROSCI METH, V199, P87, DOI 10.1016/j.jneumeth.2011.04.027; Whittle IR, 1999, BRIT J NEUROSURG, V13, P132, DOI 10.1080/02688699943871; Yanamandra N, 2004, ONCOGENE, V23, P2339, DOI 10.1038/sj.onc.1207406; Zhang ZP, 2008, PHARM RES-DORDR, V25, P1925, DOI 10.1007/s11095-008-9611-6; Zhou JB, 2013, P NATL ACAD SCI USA, V110, P11751, DOI 10.1073/pnas.1304504110	36	54	54	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0132266	10.1371/journal.pone.0132266	http://dx.doi.org/10.1371/journal.pone.0132266			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RV	26186224	Green Published, Green Submitted, gold			2022-12-26	WOS:000358198700034
J	Bodi, Z; Bottley, A; Archer, N; May, ST; Fray, RG				Bodi, Zsuzsanna; Bottley, Andrew; Archer, Nathan; May, Sean T.; Fray, Rupert G.			Yeast m(6)A Methylated mRNAs Are Enriched on Translating Ribosomes during Meiosis, and under Rapamycin Treatment	PLOS ONE			English	Article							REVEALS; N-6-METHYLADENOSINE; N6-METHYLADENOSINE; SPORULATION; SUBUNIT; PROGRAM; IME4; M6A	Interest in mRNA methylation has exploded in recent years. The sudden interest in a 40 year old discovery was due in part to the finding of FTO's (Fat Mass Obesity) N6-methyl-adenosine (m(6)A) deaminase activity, thus suggesting a link between obesity-associated diseases and the presence of m(6)A in mRNA. Another catalyst of the sudden rise in mRNA methylation research was the release of mRNA methylomes for human, mouse and Saccharomyces cerevisiae. However, the molecular function, or functions of this mRNA 'epimark' remain to be discovered. There is supportive evidence that m(6)A could be a mark for mRNA degradation due to its binding to YTH domain proteins, and consequently being chaperoned to P bodies. Nonetheless, only a subpopulation of the methylome was found binding to YTHDF2 in HeLa cells. The model organism Saccharomyces cerevisiae, has only one YTH domain protein (Pho92, Mrb1), which targets PHO4 transcripts for degradation under phosphate starvation. However, mRNA methylation is only found under meiosis inducing conditions, and PHO4 transcripts are apparently non-methylated. In this paper we set out to investigate if m(6)A could function alternatively to being a degradation mark in S. cerevisiae; we also sought to test whether it can be induced under non-standard sporulation conditions. We find a positive association between the presence of m(6)A and message translatability. We also find m(6)A induction following prolonged rapamycin treatment.	[Bodi, Zsuzsanna; Bottley, Andrew; Archer, Nathan; Fray, Rupert G.] Univ Nottingham, Sch Biosci, Loughborough LE12 5RD, Leics, England; [May, Sean T.] Univ Nottingham, NASC, Loughborough LE12 5RD, Leics, England	University of Nottingham; University of Nottingham	Fray, RG (corresponding author), Univ Nottingham, Sch Biosci, Sutton Bonington Campus, Loughborough LE12 5RD, Leics, England.	rupert.fray@nottingham.ac.uk	Archer, Nathan/T-7120-2019; may, sean t/B-6838-2012; Fray, Rupert G/A-9059-2016	Archer, Nathan/0000-0002-3356-6161; may, sean t/0000-0001-5282-3250; Fray, Rupert G/0000-0002-3935-8945; Bodi, Zsuzsa/0000-0002-3219-9224	Biotechnology and Biological Sciences Research Council [BB/K013637/1]; BBSRC [BB/M008606/1]; University of Nottingham; BBSRC [BB/L010100/1, BB/E022758/1, BB/E01772X/1, BB/K013637/1, BB/I001271/1, BB/J018961/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/E022758/1, BB/L010100/1, 976176, BB/M008606/1, BB/J018961/1, G17764, G18881, BB/E01772X/1, BB/I001271/1, BBS/B/1356X] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); University of Nottingham; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported in part by a Biotechnology and Biological Sciences Research Council (http://www.bbsrc.co.uk) grant for RNA methylation work in Rupert Fray's lab BB/K013637/1, and is currently supported by BBSRC grant BB/M008606/1. Additional support was provided by the University of Nottingham.	Agarwala SD, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002732; Bodi Z, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00048; Bodi Z, 2010, NUCLEIC ACIDS RES, V38, P5327, DOI 10.1093/nar/gkq266; Bokar JA, 1997, RNA, V3, P1233; Brar GA, 2012, SCIENCE, V335, P552, DOI 10.1126/science.1215110; Clancy MJ, 2002, NUCLEIC ACIDS RES, V30, P4509, DOI 10.1093/nar/gkf573; DESROSIERS R, 1974, P NATL ACAD SCI USA, V71, P3971, DOI 10.1073/pnas.71.10.3971; Dominissini D, 2012, NATURE, V485, P201, DOI 10.1038/nature11112; Hongay CF, 2011, P NATL ACAD SCI USA, V108, P14855, DOI 10.1073/pnas.1111577108; HOROWITZ S, 1984, P NATL ACAD SCI-BIOL, V81, P5667, DOI 10.1073/pnas.81.18.5667; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Hulsen T, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-488; Jia GF, 2011, NAT CHEM BIOL, V7, P885, DOI [10.1038/NCHEMBIO.687, 10.1038/nchembio.687]; KANE SE, 1985, MOL CELL BIOL, V5, P2298, DOI 10.1128/MCB.5.9.2298; Kang HJ, 2014, BIOCHEM J, V457, P391, DOI 10.1042/BJ20130862; KASSIR Y, 1991, METHOD ENZYMOL, V194, P94; Kruse S, 2011, SCI REP-UK, V1, DOI 10.1038/srep00126; Liu JZ, 2014, NAT CHEM BIOL, V10, P93, DOI 10.1038/nchembio.1432; Luo GZ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6630; Meyer KD, 2012, CELL, V149, P1635, DOI 10.1016/j.cell.2012.05.003; Nakazawa N, 2012, J BIOSCI BIOENG, V113, P491, DOI 10.1016/j.jbiosc.2011.11.026; NICHOLS JL, 1981, PLANT SCI LETT, V21, P75, DOI 10.1016/0304-4211(81)90071-7; PERRY RP, 1974, CELL, V1, P37, DOI 10.1016/0092-8674(74)90153-6; Ping XL, 2014, CELL RES, V24, P177, DOI 10.1038/cr.2014.3; Sambrook J., 2001, MOL CLONING LAB MANU; SCHMITT ME, 1990, NUCLEIC ACIDS RES, V18, P3091, DOI 10.1093/nar/18.10.3091; Schwartz S, 2014, CELL REP, V8, P284, DOI 10.1016/j.celrep.2014.05.048; Schwartz S, 2013, CELL, V155, P1409, DOI 10.1016/j.cell.2013.10.047; Tomoo K, 2002, BIOCHEM J, V362, P539, DOI 10.1042/0264-6021:3620539; Wang X, 2014, NATURE, V505, P117, DOI 10.1038/nature12730; Wang Y, 2014, NAT CELL BIOL, V16, P191, DOI 10.1038/ncb2902; WEI CM, 1976, BIOCHEMISTRY-US, V15, P397, DOI 10.1021/bi00647a024; Zheng XF, 1997, P NATL ACAD SCI USA, V94, P3070, DOI 10.1073/pnas.94.7.3070; Zhong SL, 2008, PLANT CELL, V20, P1278, DOI 10.1105/tpc.108.058883	35	50	56	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0132090	10.1371/journal.pone.0132090	http://dx.doi.org/10.1371/journal.pone.0132090			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RV	26186436	gold, Green Submitted, Green Published			2022-12-26	WOS:000358198700028
J	Fisher-Hoch, SP; Vatcheva, KP; Rahbar, MH; McCormick, JB				Fisher-Hoch, Susan P.; Vatcheva, Kristina P.; Rahbar, Mohammad H.; McCormick, Joseph B.			Undiagnosed Diabetes and Pre-Diabetes in Health Disparities	PLOS ONE			English	Article							INSULIN-RESISTANCE; UNITED-STATES; SOCIOECONOMIC-STATUS; HIP RATIO; POPULATION; PREVALENCE; GLUCOSE; RISK; RACE/ETHNICITY; REGRESSION	Globally half of all diabetes mellitus is undiagnosed. We sought to determine the extent and characteristics of undiagnosed type 2 diabetes mellitus and pre-diabetes in Mexican Americans residing in the United States. This disadvantaged population with 50% lifetime risk of diabetes is a microcosm of the current pandemic. We accessed baseline data between 2004 and 2014 from 2,838 adults recruited to our Cameron County Hispanic Cohort (CCHC); a two-stage randomly selected 'Framingham-like' cohort of Mexican Americans on the US Mexico border with severe health disparities. We examined prevalence, risk factors and metabolic health in diagnosed and undiagnosed diabetes and pre-diabetes. Two thirds of this Mexican American population has diabetes or pre-diabetes. Diabetes prevalence was 28.0%, nearly half undiagnosed, and pre-diabetes 31.6%. Mean BMI among those with diabetes was 33.5 kg/m(2) compared with 29.0 kg/m(2) for those without diabetes. Significant risk factors were low income and educational levels. Most with diabetes had increased waist/hip ratio. Lack of insurance and access to health services played a decisive role in failure to have diabetes diagnosed. Participants with undiagnosed diabetes and pre-diabetes had similar measures of poor metabolic health similar but generally not as severe as those with diagnosed diabetes. More than 50% of a minority Mexican American population in South Texas has diabetes or pre-diabetes and is metabolically unhealthy. Only a third of diabetes cases were diagnosed. Sustained efforts are imperative to identify, diagnose and treat individuals in underserved communities.	[Fisher-Hoch, Susan P.; Vatcheva, Kristina P.; McCormick, Joseph B.] Univ Texas Hlth Sci Ctr Houston, Sch Publ Hlth, Div Epidemiol, Brownsville, TX 77030 USA; [Rahbar, Mohammad H.] Univ Texas Houston, Sch Publ Hlth, Sch Med, Dept Internal Med,Div Clin & Translat Sci,Div Epi, Houston, TX 77030 USA; [Rahbar, Mohammad H.] Univ Texas Hlth Sci Ctr Houston, Ctr Clin & Translat Sci, Houston, TX 77030 USA	University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health; University of Texas System; University of Texas Health Science Center Houston	Fisher-Hoch, SP (corresponding author), Univ Texas Hlth Sci Ctr Houston, Sch Publ Hlth, Div Epidemiol, Brownsville Campus, Brownsville, TX 77030 USA.	susan.p.fisher-hoch@uth.tmc.edu		Vatcheva, Kristina/0000-0002-7260-2524; McCormick, Joseph/0000-0002-5844-8102	National Institute on Minority Health and Health Disparities [MD000170 P2]; National Center for Advancing Translational Science [CTSA UL1 TR000371]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000371, UL1TR001120] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [P20MD000170] Funding Source: NIH RePORTER	National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); National Center for Advancing Translational Science; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported by the National Institute on Minority Health and Health Disparities (http://www.nimhd.nih.gov/), Grant # MD000170 P2 and the National Center for Advancing Translational Science (http://www.ncats.nih.gov/), Grant # CTSA UL1 TR000371. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amer Diabet Assoc, 2010, DIABETES CARE, V33, pS11, DOI 10.2337/dc10-S011; Balluz LS, 2008, ETHNIC DIS, V18, P450; Borrell LN, 2006, AM J PUBLIC HEALTH, V96, P1637, DOI 10.2105/AJPH.2005.072884; Boyle JP, 2001, DIABETES CARE, V24, P1936, DOI 10.2337/diacare.24.11.1936; Brancati FL, 1996, ANN EPIDEMIOL, V6, P67, DOI 10.1016/1047-2797(95)00095-X; Danaei Goodarz, 2009, Popul Health Metr, V7, P16, DOI 10.1186/1478-7954-7-16; Davis K, 2014, NEW ENGL J MED, V371, P1567, DOI 10.1056/NEJMp1406707; de Koning L, 2007, EUR HEART J, V28, P850, DOI 10.1093/eurheartj/ehm026; Diaz-Apodaca BA, 2010, REV PANAM SALUD PUBL, V28, P174, DOI 10.1590/S1020-49892010000900007; Ennis S.R., 2011, C20108804 US CENS BU; Fisher-Hoch SP, 2012, PREV CHRONIC DIS, V9, DOI 10.5888/pcd9.110298; Fisher-Hoch SP, 2010, PREV CHRONIC DIS, V7; Gellad WF, 2007, J GEN INTERN MED, V22, P1572, DOI 10.1007/s11606-007-0385-z; Gregg EW, 2014, LANCET DIABETES ENDO, V2, P867, DOI 10.1016/S2213-8587(14)70161-5; HAFFNER SM, 1995, DIABETES, V44, P1386, DOI 10.2337/diabetes.44.12.1386; International Diabetes Federation, 2013, IDF DIAB ATL; Li Q, 2012, CLIN INVEST MED, V35, pL237; LILLIOJA S, 1993, NEW ENGL J MED, V329, P1988, DOI 10.1056/NEJM199312303292703; Lipscombe LL, 2014, LANCET DIABETES 0812; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Molarius A, 1999, INT J OBESITY, V23, P116, DOI 10.1038/sj.ijo.0800772; Pan American Health Organization, 2009, US MEX BORD AR, P1; Pan JJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021515; Pan JJ, 2015, WORLD J HEPATO UNPUB; Perreault L, 2012, LANCET, V379, P2243, DOI 10.1016/S0140-6736(12)60525-X; Qu HQ, 2012, DIABETES CARE, V35, P2591, DOI 10.2337/dc12-0636; Reininger BM, 2014, J IMMIGR MINOR HEALT, V16, P218, DOI 10.1007/s10903-012-9714-3; Reininger BM, 2010, HEALTH PROMOT PRACT, V11, P347, DOI 10.1177/1524839908321486; Selvin E, 2014, ANN INTERN MED, V160, P517, DOI 10.7326/M13-2411; Spranger J, 2003, DIABETES, V52, P812, DOI 10.2337/diabetes.52.3.812; TOMBAUGH TN, 1992, J AM GERIATR SOC, V40, P922, DOI 10.1111/j.1532-5415.1992.tb01992.x; United States Census Bureau, 2012, USA QUICKFACTS; van Dieren S, 2010, EUR J CARDIOV PREV R, V17, pS3, DOI 10.1097/01.hjr.0000368191.86614.5a; WARRAM JH, 1990, ANN INTERN MED, V113, P909, DOI 10.7326/0003-4819-113-12-909; Weston SR, 2005, HEPATOLOGY, V41, P372, DOI 10.1002/hep.20554; World Health Organization, 2011, WAIST CIRC WAIST HIP	36	51	51	3	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0133135	10.1371/journal.pone.0133135	http://dx.doi.org/10.1371/journal.pone.0133135			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN1RV	26186342	Green Published, Green Submitted, gold			2022-12-26	WOS:000358198700099
J	Gouveia-Figueira, S; Spath, J; Zivkovic, AM; Nording, ML				Gouveia-Figueira, Sandra; Spath, Jana; Zivkovic, Angela M.; Nording, Malin L.			Profiling the Oxylipin and Endocannabinoid Metabolome by UPLC-ESI-MS/MS in Human Plasma to Monitor Postprandial Inflammation	PLOS ONE			English	Article							C-REACTIVE PROTEIN; FATTY-ACID LEVELS; ARACHIDONIC-ACID; N-ACYLETHANOLAMINES; ANANDAMIDE; OBESE; OVERWEIGHT; MEDIATORS; MARKERS; ALPHA	Bioactive lipids, including oxylipins, endocannabinoids, and related compounds may function as specific biochemical markers of certain aspects of inflammation. However, the postprandial responsiveness of these compounds is largely unknown; therefore, changes in the circulating oxylipin and endocannabinoid metabolome in response to a challenge meal were investigated at six occasions in a subject who freely modified her usual diet. The dietary change, and especially the challenge meal itself, represented a modification of precursor fatty acid status, with expectedly subtle effects on bioactive lipid levels. To detect even the slightest alteration, highly sensitive ultra-performance liquid chromatography (UPLC) coupled to electrospray ionization (ESI) tandem mass spectrometry (MS/MS) methods for bioactive lipid profiling was employed. A previously validated UPLC-ESI-MS/MS method for profiling the endocannabinoid metabolome was used, while validation of an UPLC-ESI-MS/MS method for oxylipin analysis was performed with acceptable outcomes for a majority of the parameters according to the US Food and Drug Administration guidelines for linearity (0.9938 < R-2 < 0.9996), limit of detection (0.0005-2.1 pg on column), limit of quantification (0.0005-4.2 pg on column), inter-and intraday accuracy (85-115%) and precision (<5%), recovery (40-109%) and stability (40-105%). Forty-seven of fifty-two bioactive lipids were detected in plasma samples at fasting and in the postprandial state (0.5, 1, and 3 hours after the meal). Multivariate analysis showed a significant shift of bioactive lipid profiles in the postprandial state due to inclusion of dairy products in the diet, which was in line with univariate analysis revealing seven compounds (NAGly, 9-HODE, 13-oxo-ODE, 9(10)-EpOME, 12(13)-EpOME, 20-HETE, and 11,12-DHET) that were significantly different between background diets in the postprandial state (but not at fasting). The only change in baseline levels at fasting was displayed by TXB2. Furthermore, postprandial responsiveness was detected for seven compounds (POEA, SEA, 9(10)-DiHOME, 12(13)-DiHOME, 13-oxo-ODE, 9-HODE, and 13-HODE). Hence, the data confirm that the UPLC-ESI-MS/MS method performance was sufficient to detect i) a shift, in the current case most notably in the postprandial bioactive lipid metabolome, caused by changes in diet and ii) responsiveness to a challenge meal for a subset of the oxylipin and endocannabinoid metabolome. To summarize, we have shown proof-of-concept of our UPLC-ESI-MS/MS bioactive lipid protocols for the purpose of monitoring subtle shifts, and thereby useful to address lipid-mediated postprandial inflammation.	[Gouveia-Figueira, Sandra; Spath, Jana; Nording, Malin L.] Umea Univ, Dept Chem, Umea, Sweden; [Zivkovic, Angela M.] Univ Calif Davis, Dept Nutr, Davis, CA 95616 USA; [Zivkovic, Angela M.] Univ Calif Davis, Foods Hlth Inst, Davis, CA 95616 USA	Umea University; University of California System; University of California Davis; University of California System; University of California Davis	Nording, ML (corresponding author), Umea Univ, Dept Chem, Umea, Sweden.	malin.nording@chem.umu.se		Zivkovic, Angela/0000-0002-2828-7862; Nording, Malin/0000-0002-1732-8147	MLN The Vinnova grant [2010-02070]; Sweden's innovation agency Vinnova; MLN Formas grant (MLN) [2010-303]; Swedish Research Council Formas; AMZ University of California Discovery Program [09 GEB-02 NHB]; SG-F Postdoctoral Kempe foundation	MLN The Vinnova grant; Sweden's innovation agency Vinnova(Vinnova); MLN Formas grant (MLN); Swedish Research Council Formas(Swedish Research CouncilSwedish Research Council Formas); AMZ University of California Discovery Program; SG-F Postdoctoral Kempe foundation	This work was supported by MLN The Vinnova grant: 2010-02070, Sweden's innovation agency Vinnova, http://www.vinnova.se/en/; MLN Formas grant (MLN): 2010-303, The Swedish Research Council Formas, http://www.formas.se/en/; AMZ University of California Discovery Program 09 GEB-02 NHB; and SG-F Postdoctoral Kempe foundation grant http://www.kempe.com/index_english.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agostoni C, 1997, PROSTAG LEUKOTR ESS, V56, P219, DOI 10.1016/S0952-3278(97)90538-X; Anuurad E, 2009, ATHEROSCLEROSIS, V205, P290, DOI 10.1016/j.atherosclerosis.2008.11.028; Arya F, 2010, BRIT J NUTR, V104, P724, DOI 10.1017/S0007114510001042; Baer DJ, 2004, AM J CLIN NUTR, V79, P969; Balvers MGJ, 2012, METABOLOMICS, V8, P1130, DOI 10.1007/s11306-012-0421-9; Blackburn P, 2006, OBESITY, V14, P1747, DOI 10.1038/oby.2006.201; Blackburn R, 2001, ARTERIOSCL THROM VAS, V21, P1962, DOI 10.1161/hq1201.099433; Burdge GC, 2005, BRIT J NUTR, V93, P3, DOI 10.1079/BJN20041282; Bylesjo M, 2006, J CHEMOMETR, V20, P341, DOI 10.1002/cem.1006; Di Marzo V, 1998, BBA-LIPID LIPID MET, V1392, P153, DOI 10.1016/S0005-2760(98)00042-3; DIMARZO V, 1994, NATURE, V372, P686, DOI 10.1038/372686a0; Dumlao DS, 2011, BBA-MOL CELL BIOL L, V1811, P724, DOI 10.1016/j.bbalip.2011.06.005; Eriksson L, 2008, J CHEMOMETR, V22, P594, DOI 10.1002/cem.1187; Fowler CJ, 2012, TRENDS PHARMACOL SCI, V33, P468, DOI 10.1016/j.tips.2012.05.003; Fride E, 2005, EXP BIOL MED, V230, P225; Gachet MS, 2015, J CHROMATOGR B, V976, P6, DOI 10.1016/j.jchromb.2014.11.001; Gatta-Cherifi B, 2012, INT J OBESITY, V36, P880, DOI 10.1038/ijo.2011.165; Ghafouri N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027257; Gouveia-Figueira S, 2014, ANAL CHEM, V86, P1186, DOI 10.1021/ac403352e; Grapov D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048852; Joosten MM, 2010, NUTR METAB, V7, DOI 10.1186/1743-7075-7-49; Katcher HI, 2008, AM J CLIN NUTR, V87, P79, DOI 10.1093/ajcn/87.1.79; Liou YA, 2007, J NUTR, V137, P945, DOI 10.1093/jn/137.4.945; Maccarrone M, 2010, ANNU REV NUTR, V30, P423, DOI 10.1146/annurev.nutr.012809.104701; Manning PJ, 2008, OBESITY, V16, P2046, DOI 10.1038/oby.2008.334; Margioris AN, 2009, CURR OPIN CLIN NUTR, V12, P129, DOI 10.1097/MCO.0b013e3283232a11; Marowsky A, 2009, NEUROSCIENCE, V163, P646, DOI 10.1016/j.neuroscience.2009.06.033; Mas E, 2012, CLIN CHEM, V58, P1476, DOI 10.1373/clinchem.2012.190199; Masson CJ, 2011, J NUTR, V141, P816, DOI 10.3945/jn.110.136432; Meijerink J, 2013, BRIT J PHARMACOL, V169, P772, DOI 10.1111/bph.12030; Monteleone P, 2012, J CLIN ENDOCR METAB, V97, pE917, DOI 10.1210/jc.2011-3018; Moran LJ, 2007, J CLIN ENDOCR METAB, V92, P2944, DOI 10.1210/jc.2006-2336; Morisseau C, 2013, ANNU REV PHARMACOL, V53, P37, DOI 10.1146/annurev-pharmtox-011112-140244; Naughton SS, 2013, INT J ENDOCRINOL, V2013, DOI 10.1155/2013/361895; Neuhouser ML, 2012, J NUTR, V142, P369, DOI 10.3945/jn.111.149807; Nicholls SJ, 2006, J AM COLL CARDIOL, V48, P715, DOI 10.1016/j.jacc.2006.04.080; Nording ML, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076575; OLEFSKY JM, 1976, AM J CLIN NUTR, V29, P535, DOI 10.1093/ajcn/29.5.535; Payette C, 2009, METABOLISM, V58, P1593, DOI 10.1016/j.metabol.2009.05.011; Pellis L, 2012, METABOLOMICS, V8, P347, DOI 10.1007/s11306-011-0320-5; Pietraszek Anna, 2011, Rev Diabet Stud, V8, P477, DOI 10.1900/RDS.2011.8.477; Pintus S, 2013, BRIT J NUTR, V109, P1453, DOI 10.1017/S0007114512003224; Poppitt SD, 2008, NUTRITION, V24, P322, DOI 10.1016/j.nut.2007.12.012; Schuchardt JP, 2014, PROSTAG LEUKOTR ESS, V90, P27, DOI 10.1016/j.plefa.2013.12.008; Shearer GC, 2009, CURR ATHEROSCLER REP, V11, P403, DOI 10.1007/s11883-009-0061-3; Simmons DL, 2004, PHARMACOL REV, V56, P387, DOI 10.1124/pr.56.3.3; Sinclair AJ, 1996, J NUTR, V126, pS1110, DOI 10.1093/jn/126.suppl_4.1110S; Smilowitz JT, 2013, MOL NUTR FOOD RES, V57, P1319, DOI 10.1002/mnfr.201200808; Strassburg K, 2014, MOL NUTR FOOD RES, V58, P591, DOI 10.1002/mnfr.201300321; Strassburg K, 2012, ANAL BIOANAL CHEM, V404, P1413, DOI 10.1007/s00216-012-6226-x; Tulk HMF, 2009, METABOLISM, V58, P1709, DOI 10.1016/j.metabol.2009.05.031; Wang Y, 2014, J CHROMATOGR A, V1359, P60, DOI 10.1016/j.chroma.2014.07.006; Wong A, 2014, J LIPID RES, V55, P1902, DOI 10.1194/jlr.M048694; Yang J, 2012, FREE RADICAL BIO MED, V53, P160, DOI 10.1016/j.freeradbiomed.2012.05.001; Yang J, 2009, ANAL CHEM, V81, P8085, DOI 10.1021/ac901282n; Zhang MJ, 2012, ANNU REV NUTR, V32, P203, DOI 10.1146/annurev-nutr-071811-150726; Zivkovic AM, 2009, METABOLOMICS, V5, P209, DOI 10.1007/s11306-008-0136-0; Zoerner AA, 2011, BBA-MOL CELL BIOL L, V1811, P706, DOI 10.1016/j.bbalip.2011.08.004	58	44	44	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0132042	10.1371/journal.pone.0132042	http://dx.doi.org/10.1371/journal.pone.0132042			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RV	26186333	gold, Green Published, Green Submitted			2022-12-26	WOS:000358198700027
J	Guzman, CE; Bereza-Malcolm, LT; De Groef, B; Franks, AE				Guzman, Cesar E.; Bereza-Malcolm, Lara T.; De Groef, Bert; Franks, Ashley E.			Presence of Selected Methanogens, Fibrolytic Bacteria, and Proteobacteria in the Gastrointestinal Tract of Neonatal Dairy Calves from Birth to 72 Hours	PLOS ONE			English	Article							RUMEN; ESTABLISHMENT; COMMUNITY; NEWBORN; BORN; DNA	The microbial communities in the gastrointestinal tract of a young calf are essential for the anatomical and physiological development that permits a transition from milk to solid feed. Selected methanogens, fibrolytic bacteria, and proteobacteria were quantified in the rumen fluid and tissue, abomasum fluid, cecum fluid and tissue, and feces of Holstein bull calves on day 0 (0-20 mins after birth), day 1 (24 +/- 1 h after birth), day 2 (48 +/- 1 h after birth), and day 3 (72 +/- 1 h after birth). Methanogens, fibrolytic bacteria, and Geobacter spp. were found to be already present from birth, indicating that microbial colonization of the gastrointestinal tract occurred before or during delivery. The abundance of methanogens and Geobacter spp. differed between the days tested and between compartments of the digestive tract and feces, but such difference was not observed for fibrolytic bacteria. Our findings suggests that methanogens might have an alternative hydrogen provider such as Geobacter spp. during these early stages of postnatal development. In addition, fibrolytic bacteria were present in the rumen well before the availability of fibrous substrates, suggesting that they might use nutrients other than cellulose and hemicellose.	[Guzman, Cesar E.; Bereza-Malcolm, Lara T.; De Groef, Bert; Franks, Ashley E.] La Trobe Univ, Dept Physiol Anat & Microbiol, Melbourne, Vic, Australia	La Trobe University	Guzman, CE (corresponding author), La Trobe Univ, Dept Physiol Anat & Microbiol, Melbourne, Vic, Australia.	cerod12@outlook.com	Bereza-Malcolm, Lara/AAZ-5425-2020	De Groef, Bert/0000-0003-3191-852X; Franks, Ashley/0000-0003-1664-6060	Defence Science Institute, Defence Science and Technology Organisation, Office of Naval Research Global [N626909-13-1-N259]; Australian Research Council [LP140100459]	Defence Science Institute, Defence Science and Technology Organisation, Office of Naval Research Global; Australian Research Council(Australian Research Council)	LTBM and AEF, as part of Applied and Environmental Microbiology Laboratory at La Trobe University, receive support from the Defence Science Institute, Defence Science and Technology Organisation, Office of Naval Research Global (Award no. N626909-13-1-N259) and the Australian Research Council (Award no. LP140100459).	Aagaard K, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008599; Ardissone AN, 2014, PLOS ONE, V9; ASH RW, 1964, J PHYSIOL-LONDON, V172, P425, DOI 10.1113/jphysiol.1964.sp007430; Baldwin R L, 2004, J DAIRY SCI, V87, pE55, DOI [10.3168/jds.2012-5970, DOI 10.3168/JDS.S0022-0302(04)70061-2]; Denman SE, 2006, FEMS MICROBIOL ECOL, V58, P572, DOI 10.1111/j.1574-6941.2006.00190.x; Deppenmeier U, 2002, PROG NUCLEIC ACID RE, V71, P223, DOI 10.1016/S0079-6603(02)71045-3; Di Mauro A, 2013, ITAL J PEDIATR, V39, DOI 10.1186/1824-7288-39-15; DiGiulio DB, 2012, SEMIN FETAL NEONAT M, V17, P2, DOI 10.1016/j.siny.2011.10.001; Dominguez-Bello MG, 2010, P NATL ACAD SCI USA, V107, P11971, DOI 10.1073/pnas.1002601107; FONTY G, 1988, CAN J MICROBIOL, V34, P235, DOI 10.1139/m88-044; FONTY G, 1987, J GEN MICROBIOL, V133, P1835; Fonty G, 2007, APPL ENVIRON MICROB, V73, P6391, DOI 10.1128/AEM.00181-07; GILBERT WM, 1993, SEMIN PERINATOL, V17, P150; Guzman CE, 2015, ANIM SCI; Hammon HM, 2012, DOMEST ANIM ENDOCRIN, V43, P171, DOI 10.1016/j.domaniend.2012.02.005; Jami E, 2013, ISME J, V7, P1069, DOI 10.1038/ismej.2013.2; Janssen PH, 2008, APPL ENVIRON MICROB, V74, P3619, DOI 10.1128/AEM.02812-07; Jimenez E, 2005, CURR MICROBIOL, V51, P270, DOI 10.1007/s00284-005-0020-3; Jung S, 2011, APPL ENVIRON MICROB, V77, P564, DOI 10.1128/AEM.01392-10; Khafipour E, 2009, APPL ENVIRON MICROB, V75, P7115, DOI 10.1128/AEM.00739-09; Khan MA, 2011, J DAIRY SCI, V94, P1071, DOI 10.3168/jds.2010-3733; Krause DO, 2003, FEMS MICROBIOL REV, V27, P663, DOI 10.1016/S0168-6445(03)00072-X; LATEURROWET HJM, 1983, VET QUART, V5, P68, DOI 10.1080/01652176.1983.9693874; Leahy SC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008926; Malmuthuge N, 2014, APPL ENVIRON MICROB, V80, P2021, DOI 10.1128/AEM.03864-13; Malmuthuge N, 2013, J DAIRY SCI, V96, P3189, DOI 10.3168/jds.2012-6200; McBee R. H., 1971, A Rev Ecol Syst, V2, P165, DOI 10.1146/annurev.es.02.110171.001121; MINATO H, 1992, J GEN APPL MICROBIOL, V38, P447, DOI 10.2323/jgam.38.447; Moles L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066986; Morita M, 2011, MBIO, V2, DOI 10.1128/mBio.00159-11; MORVAN B, 1994, FEMS MICROBIOL LETT, V117, P249, DOI 10.1111/j.1574-6968.1994.tb06775.x; Rey M, 2014, J APPL MICROBIOL, V116, P245, DOI 10.1111/jam.12405; Rey M, 2012, J DAIRY SCI, V95, P1500, DOI 10.3168/jds.2011-4902; Schefe JH, 2006, J MOL MED, V84, P901, DOI 10.1007/s00109-006-0097-6; Skillman LC, 2004, ANAEROBE, V10, P277, DOI 10.1016/j.anaerobe.2004.05.003; St-Pierre B, 2013, MOL BIOL REP, V40, P369, DOI 10.1007/s11033-012-2070-5; Steel JH, 2005, PEDIATR RES, V57, P404, DOI 10.1203/01.PDR.0000153869.96337.90; Stevenson DM, 2007, APPL MICROBIOL BIOT, V75, P165, DOI 10.1007/s00253-006-0802-y; Summers ZM, 2010, SCIENCE, V330, P1413, DOI 10.1126/science.1196526; Xia Y, 2014, J APPL MICROBIOL, V116, P14, DOI 10.1111/jam.12356; Xu JL, 2013, MICROB ECOL, V66, P950, DOI 10.1007/s00248-013-0271-7; Yu ZT, 2004, BIOTECHNIQUES, V36, P808, DOI 10.2144/04365ST04	42	74	82	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0133048	10.1371/journal.pone.0133048	http://dx.doi.org/10.1371/journal.pone.0133048			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RV	26186002	Green Published, Green Submitted, gold			2022-12-26	WOS:000358198700089
J	Harmon, D; Lagi, M; de Aguiar, MAM; Chinellato, DD; Braha, D; Epstein, IR; Bar-Yam, Y				Harmon, Dion; Lagi, Marco; de Aguiar, Marcus A. M.; Chinellato, David D.; Braha, Dan; Epstein, Irving R.; Bar-Yam, Yaneer			Anticipating Economic Market Crises Using Measures of Collective Panic	PLOS ONE			English	Article							STOCK; DYNAMICS; BEHAVIOR; INDICATORS; ARBITRAGE; RISK	Predicting panic is of critical importance in many areas of human and animal behavior, notably in the context of economics. The recent financial crisis is a case in point. Panic may be due to a specific external threat or self-generated nervousness. Here we show that the recent economic crisis and earlier large single-day panics were preceded by extended periods of high levels of market mimicry-direct evidence of uncertainty and nervousness, and of the comparatively weak influence of external news. High levels of mimicry can be a quite general indicator of the potential for self-organized crises.	[Harmon, Dion; Lagi, Marco; de Aguiar, Marcus A. M.; Chinellato, David D.; Braha, Dan; Epstein, Irving R.; Bar-Yam, Yaneer] New England Complex Syst Inst, Cambridge, MA 02142 USA; [de Aguiar, Marcus A. M.; Chinellato, David D.] Univ Estadual Campinas, Campinas, SP, Brazil; [Braha, Dan] Univ Massachusetts, Dartmouth, MA USA; [Epstein, Irving R.] Brandeis Univ, Waltham, MA USA	Universidade Estadual de Campinas; University of Massachusetts System; University Massachusetts Dartmouth; Brandeis University	Braha, D (corresponding author), New England Complex Syst Inst, Cambridge, MA 02142 USA.	braha@necsi.edu	de Aguiar, Marcus A M/C-9137-2012; Chinellato, David D/D-3092-2012; de Aguiar, Marcus A. M./N-1377-2019	de Aguiar, Marcus A M/0000-0003-1379-7568; Chinellato, David D/0000-0002-9982-9577; 				Adrian T, 2009, AM ECON REV, V99, P600, DOI 10.1257/aer.99.2.600; Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; [Anonymous], 1988, EC EVOLVING COMPLEX; Bar-yam Y., 2019, DYNAMICS COMPLEX SYS; Bekaert G, 2000, REV FINANC STUD, V13, P1, DOI 10.1093/rfs/13.1.1; Berg A, 1999, J INT MONEY FINANC, V18, P561, DOI 10.1016/S0261-5606(99)00024-8; Bikhchandani S, 1998, J ECON PERSPECT, V12, P151, DOI 10.1257/jep.12.3.151; Bonanno G, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.046130; Bordo M., 2002, INT FINANC, V4, P139, DOI DOI 10.1111/1468-2362.00092; Borio C, 2002, PREPRINT; Braha D, 2002, IEEE T SEMICONDUCT M, V15, P91, DOI 10.1109/66.983448; Braha D, 2006, COMPLEXITY, V12, P59, DOI 10.1002/cplx.20156; Bree DS, 2010, PREPRINT; Bury T, 2014, PHYSICA A, V404, P79, DOI 10.1016/j.physa.2014.02.044; Calomiris C.W., 1990, FINANCIAL MARKETS FI, P109; CANNINGS C, 1975, ADV APPL PROBAB, V7, P264, DOI 10.2307/1426077; Caporale G.M., 2005, J EMPIR FINANC, V12, P476, DOI [DOI 10.1016/J.JEMPFIN.2004.02.005, 10.1016/j.jempfin.2004.02.005]; Carlson Mark A., 2007, FINANCE EC DISCUSSIO; CHAMBERLAIN G, 1983, ECONOMETRICA, V51, P1281, DOI 10.2307/1912275; Chinellato DD, 2015, J STAT PHYS, V159, P221, DOI 10.1007/s10955-015-1189-x; Chinellato DD, 2007, PREPRINT; Cho A, 2009, SCIENCE, V325, P408, DOI 10.1126/science.325_408; CHRISTIE AA, 1982, J FINANC ECON, V10, P407, DOI 10.1016/0304-405X(82)90018-6; Corsetti G, 1999, JPN WORLD ECON, V11, P305, DOI 10.1016/S0922-1425(99)00019-5; CUTLER DM, 1989, J PORTFOLIO MANAGE, V15, P4, DOI 10.3905/jpm.1989.409212; de Aguiar MAM, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.031901; DELONG JB, 1990, J FINANC, V45, P379, DOI 10.2307/2328662; DELONG JB, 1990, J POLIT ECON, V98, P703, DOI 10.1086/261703; DIAMOND DW, 1983, J POLIT ECON, V91, P401, DOI 10.1086/261155; Dow Jones Averages, DOW JON IND AV; Eichengreen B., 1995, ECON POLICY, V10, P251, DOI DOI 10.2307/1344591; Emmert-Streib F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012884; Ewens W. J., 1979, MATH POPULATION GENE; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; Feigenbaum JA, 1996, INT J MOD PHYS B, V10, P3737, DOI 10.1142/S021797929600204X; Forbes KJ, 2002, J FINANC, V57, P2223, DOI 10.1111/0022-1082.00494; Galbraith John Kenneth, 1954, THE GREAT CRASH 1929; Garas A, 2008, EUR PHYS J B, V63, P265, DOI 10.1140/epjb/e2008-00237-3; GLADSTEIN K, 1978, SIAM J APPL MATH, V34, P630, DOI 10.1137/0134050; GLAUBER RJ, 1963, J MATH PHYS, V4, P294, DOI 10.1063/1.1703954; Gopikrishnan P, 1998, EUR PHYS J B, V3, P139, DOI 10.1007/s100510050292; Grech D, 2004, PHYSICA A, V336, P133, DOI 10.1016/j.physa.2004.01.018; Guillaume D, 1997, FINANC STOCH, V1, P95, DOI [10.1007/s007800050018, DOI 10.1007/S007800050018]; Harmon D, 2011, PREPRINT; Harmon D, 2010, PREPRINT; Hill SA, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.046105; Hommes C, 2009, HANDB FINANC, P217, DOI 10.1016/B978-012374258-2.50008-7; Jorion P, 2006, VALUE RISK NEW BENCH; Kaminsky G, 1998, INT MONET FUND S PAP, V45, P1; KARDAR M, 1986, PHYS REV LETT, V56, P889, DOI 10.1103/PhysRevLett.56.889; Kardar M., 2007, STAT PHYS FIELDS; Kenett DY, 2012, INT J BIFURCAT CHAOS, V22, DOI 10.1142/S0218127412501817; Kenett DY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015032; Kindleberger C., 1978, MANIAS PANICS CRASHE; Kritzman M, 2011, J PORTFOLIO MANAGE, V37, P112, DOI 10.3905/jpm.2011.37.4.112; Lagi M, 2011, PREPRINT; LeBaron B, 1999, J ECON DYN CONTROL, V23, P1487, DOI 10.1016/S0165-1889(98)00081-5; Levy M., 2000, MICROSCOPIC SIMULATI; Longin F, 2001, J FINANC, V56, P649, DOI 10.1111/0022-1082.00340; Lux T, 1999, NATURE, V397, P498, DOI 10.1038/17290; Majdandzic A, 2014, NAT PHYS, V10, P34, DOI [10.1038/nphys2819, 10.1038/NPHYS2819]; MANN L, 1976, SOCIOMETRY, V39, P223, DOI 10.2307/2786515; Mantegna R. N., 2000, INTRO ECONOPHYSICS; Mantegna RN, 1999, EUR PHYS J B, V11, P193, DOI 10.1007/s100510050929; Mawson AR, 2005, PSYCHIATRY, V68, P95, DOI 10.1521/psyc.2005.68.2.95; Morris G., 2005, COMPLETE GUIDE MARKE; NELSON DB, 1991, ECONOMETRICA, V59, P347, DOI 10.2307/2938260; Onnela JP, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.056110; Preis T, 2010, PHILOS T R SOC A, V368, P5707, DOI 10.1098/rsta.2010.0284; Preis T, 2010, J STAT PHYS, V138, P431, DOI 10.1007/s10955-009-9914-y; Quarantelli E., 2001, INT ENCY SOCIAL BEHA, P11020, DOI 10.1016/B0-08-043076-7/01867-2; Rose AK, 2011, EUR ECON REV, V55, P309, DOI 10.1016/j.euroecorev.2010.12.006; ROSS SA, 1976, J ECON THEORY, V13, P341, DOI 10.1016/0022-0531(76)90046-6; Russell Investments, RUSS US EQ IND CONST; SCHARFSTEIN DS, 1990, AM ECON REV, V80, P465; Scheffer M, 2012, SCIENCE, V338, P344, DOI 10.1126/science.1225244; Scheffer M, 2009, NATURE, V461, P53, DOI 10.1038/nature08227; Schweitzer F, 2009, SCIENCE, V325, P422, DOI 10.1126/science.1173644; Shapira Y, 2011, AIP ADV, V1, DOI 10.1063/1.3598412; Smelser N. J., 1963, THEORY COLLECTIVE BE; Smith RD, 2009, J KOREAN PHYS SOC, V54, P2460, DOI 10.3938/jkps.54.2460; Sornette D, 1996, J PHYS I, V6, P167, DOI 10.1051/jp1:1996135; Sornette D, 2003, WHY STOCK MARKETS CRASH: CRITICAL EVENTS IN COMPLEX FINANCIAL SYSTEMS, P1; Sornette D., 2001, Quantitative Finance, V1, P452, DOI 10.1088/1469-7688/1/4/305; Sornette D, 1997, PHYSICA A, V245, P411, DOI 10.1016/S0378-4371(97)00318-X; Sornette D, 2002, SCI DISASTERS, P411; Sornette D, 2006, FRONTIERS COLL, P95; Vandewalle N, 2000, PREPRINT; WATTERSON G, 1961, ANN MATH STAT, V32, P716, DOI 10.1214/aoms/1177704967; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Wolfenstein M., 1957, DISASTER; Wu GJ, 2001, REV FINANC STUD, V14, P837, DOI 10.1093/rfs/14.3.837	94	27	27	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0131871	10.1371/journal.pone.0131871	http://dx.doi.org/10.1371/journal.pone.0131871			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN1RV	26185988	Green Published, Green Submitted, gold			2022-12-26	WOS:000358198700025
J	Kasoji, SK; Pattenden, SG; Malc, EP; Jayakody, CN; Tsuruta, JK; Mieczkowski, PA; Janzen, WP; Dayton, PA				Kasoji, Sandeep K.; Pattenden, Samantha G.; Malc, Ewa P.; Jayakody, Chatura N.; Tsuruta, James K.; Mieczkowski, Piotr A.; Janzen, William P.; Dayton, Paul A.			Cavitation Enhancing Nanodroplets Mediate Efficient DNA Fragmentation in a Bench Top Ultrasonic Water Bath	PLOS ONE			English	Article							LIBRARY CONSTRUCTION; PARTIAL DIGESTION; CONTRAST AGENTS; MICROBUBBLES; DESTRUCTION; SHEARING; IMPACT; PCR	A perfluorocarbon nanodroplet formulation is shown to be an effective cavitation enhancement agent, enabling rapid and consistent fragmentation of genomic DNA in a standard ultrasonic water bath. This nanodroplet-enhanced method produces genomic DNA libraries and next-generation sequencing results indistinguishable from DNA samples fragmented in dedicated commercial acoustic sonication equipment, and with higher throughput. This technique thus enables widespread access to fast bench-top genomic DNA fragmentation.	[Kasoji, Sandeep K.; Tsuruta, James K.; Dayton, Paul A.] Univ N Carolina, Joint Dept Biomed Engn, Chapel Hill, NC 27599 USA; [Kasoji, Sandeep K.; Tsuruta, James K.; Dayton, Paul A.] N Carolina State Univ, Raleigh, NC USA; [Pattenden, Samantha G.; Jayakody, Chatura N.; Janzen, William P.] Univ N Carolina, Ctr Integrat Chem Biol & Drug Discovery, Eshelman Sch Pharm, Chapel Hill, NC USA; [Malc, Ewa P.; Mieczkowski, Piotr A.] Univ N Carolina, Dept Genet High Throughput Sequencing Facil, Chapel Hill, NC USA; [Tsuruta, James K.] Univ N Carolina, Dept Pediat, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; North Carolina State University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Dayton, PA (corresponding author), Univ N Carolina, Joint Dept Biomed Engn, Chapel Hill, NC 27599 USA.	padayton@email.unc.edu		Kasoji, Sunny/0000-0002-4219-3424; Malc, Ewa/0000-0002-4596-1142; Mieczkowski, Piotr/0000-0003-2418-0096	National Institutes of Health [R21CA173124]; NATIONAL CANCER INSTITUTE [R21CA173124] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Support was provided by the National Institutes of Health R21CA173124. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON S, 1981, NUCLEIC ACIDS RES, V9, P3015, DOI 10.1093/nar/9.13.3015; Aparicio Oscar, 2004, Curr Protoc Cell Biol, VChapter 17, DOI 10.1002/0471143030.cb1707s23; Bortz PDS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026015; Brachmann CB, 1998, YEAST, V14, P115; Burger G, 2007, NAT PROTOC, V2, P603, DOI 10.1038/nprot.2007.59; Chomas JE, 2000, APPL PHYS LETT, V77, P1056, DOI 10.1063/1.1287519; Chomas JE, 2001, J BIOMED OPT, V6, P141, DOI 10.1117/1.1352752; Gingrich JC, 1996, BIOTECHNIQUES, V21, P99; Gonzalez-Garay ML, 2014, PERS MED, V11, P523, DOI 10.2217/PME.14.34; Hengen PN, 1997, TRENDS BIOCHEM SCI, V22, P273, DOI 10.1016/S0968-0004(97)01080-3; HOHEISEL JD, 1989, NUCLEIC ACIDS RES, V17, P9571, DOI 10.1093/nar/17.23.9571; Knierim E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028240; Laugharn JA, 2013, Method and system for acoustically treating material, Patent No. [US8459121 B2, 8459121]; Martin KH, 2013, WIRES NANOMED NANOBI, V5, P329, DOI 10.1002/wnan.1219; Morey M, 2013, MOL GENET METAB, V110, P3, DOI 10.1016/j.ymgme.2013.04.024; Oefner PJ, 1996, NUCLEIC ACIDS RES, V24, P3879, DOI 10.1093/nar/24.20.3879; OKPODU CM, 1994, BIOTECHNIQUES, V16, P154; Osoegawa K, 2001, GENOME RES, V11, P483, DOI 10.1101/gr.169601; Poptsova MS, 2014, SCI REP-UK, V4, DOI 10.1038/srep04532; Roe Bruce A, 2004, Methods Mol Biol, V255, P171; SEED B, 1982, GENE, V19, P201, DOI 10.1016/0378-1119(82)90007-5; Shah Y. T., 2012, CAVITATION REACTION; Sheeran PS, 2015, ULTRASOUND MED BIOL, V41, P814, DOI 10.1016/j.ultrasmedbio.2014.10.020; Sheeran PS, 2012, CURR PHARM DESIGN, V18, P2152; Sheeran PS, 2012, BIOMATERIALS, V33, P3262, DOI 10.1016/j.biomaterials.2012.01.021; Sheeran PS, 2011, ULTRASOUND MED BIOL, V37, P1518, DOI 10.1016/j.ultrasmedbio.2011.05.021; Shi WT, 2000, ULTRASOUND MED BIOL, V26, P1009, DOI 10.1016/S0301-5629(00)00223-4; Teytelman L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006700; Thomas F, 2014, CURR OPIN ONCOL, V26, P347, DOI 10.1097/CCO.0000000000000078; Thorstenson YR, 1998, GENOME RES, V8, P848, DOI 10.1101/gr.8.8.848; Wong KK, 1997, NUCLEIC ACIDS RES, V25, P4169, DOI 10.1093/nar/25.20.4169	31	27	27	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0133014	10.1371/journal.pone.0133014	http://dx.doi.org/10.1371/journal.pone.0133014			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RV	26186461	Green Published, gold, Green Submitted			2022-12-26	WOS:000358198700084
J	Metz, S; Ganter, C; Lorenzen, S; van Marwick, S; Holzapfel, K; Herrmann, K; Rummeny, EJ; Wester, HJ; Schwaiger, M; Nekolla, SG; Beer, AJ				Metz, Stephan; Ganter, Carl; Lorenzen, Sylvie; van Marwick, Sandra; Holzapfel, Konstantin; Herrmann, Ken; Rummeny, Ernst J.; Wester, Hans-Juergen; Schwaiger, Markus; Nekolla, Stephan G.; Beer, Ambros J.			Multiparametric MR and PET Imaging of Intratumoral Biological Heterogeneity in Patients with Metastatic Lung Cancer Using Voxel-by-Voxel Analysis	PLOS ONE			English	Article							DIFFUSION-WEIGHTED MRI; POSITRON-EMISSION-TOMOGRAPHY; ALPHA(V)BETA(3) EXPRESSION; GLUCOSE-METABOLISM; COEFFICIENT ADC; BODY; LESIONS; F-18-FDG; HYPOXIA; PET/MRI	Objectives Diffusion-weighted magnetic resonance imaging (DW-MRI) and imaging of glucose metabolism by positron emission tomography (FDG-PET) provide quantitative information on tissue characteristics. Combining the two methods might provide novel insights into tumor heterogeneity and biology. Here, we present a solution to analyze and visualize the relationship between the apparent diffusion coefficient (ADC) and glucose metabolism on a spatially resolved voxel-by-voxel basis using dedicated quantitative software. Materials and Methods In 12 patients with non small cell lung cancer (NSCLC), the primary tumor or metastases were examined with DW-MRI and PET using F-18-fluorodeoxyglucose (FDG). The ADC's from DW-MRI were correlated with standardized-uptake-values on a voxel-by-voxel basis using custom made software (Anima (MP)-P-3). For cluster analysis, we used prospectively defined thresholds for F-18-FDG and ADC to define tumor areas of different biological activity. Results Combined analysis and visualization of ADC maps and PET data was feasible in all patients. Spatial analysis showed relatively homogeneous ADC values over the entire tumor area, whereas FDG showed a decreasing uptake towards the tumor center. As expected, restricted water diffusivity was notable in areas with high glucose metabolism but was also found in areas with lower glucose metabolism. In detail, 72% of all voxels showed low ADC values (<1.5x10(-3) mm(2)/s) and high tracer uptake of F-18-FDG (SUV>3.6). However, 83% of the voxels with low FDG uptake also showed low ADC values, increasingly towards the tumor center. Conclusions Multiparametric analysis and visualization of DW-MRI and FDG-PET is feasible on a spatially resolved voxel-by-voxel respectively cluster basis using dedicated imaging software. Our preliminary data suggest that water diffusivity and glucose metabolism in metastatic NSCLC are not necessarily correlated in all tumor areas.	[Metz, Stephan; Ganter, Carl; Holzapfel, Konstantin; Rummeny, Ernst J.] Tech Univ Munich, Dept Radiol, D-80290 Munich, Germany; [Lorenzen, Sylvie] Tech Univ Munich, Dept Hematooncol, D-80290 Munich, Germany; [van Marwick, Sandra; Herrmann, Ken; Wester, Hans-Juergen; Schwaiger, Markus; Nekolla, Stephan G.; Beer, Ambros J.] Tech Univ Munich, Dept Nucl Med, D-80290 Munich, Germany; [Wester, Hans-Juergen] Tech Univ Munich, Inst Radiopharmaceut Chem, Garching, Germany	Technical University of Munich; Technical University of Munich; Technical University of Munich; University of Munich; Technical University of Munich	Metz, S (corresponding author), Tech Univ Munich, Dept Radiol, D-80290 Munich, Germany.	stephan.metz@tum.de	Nekolla, Stephan G/L-1857-2013; Herrmann, Ken/GOH-1465-2022; Ganter, Carl/U-6895-2017; Beer, Ambros J./AAA-5539-2022	Nekolla, Stephan G/0000-0002-8817-1482; Ganter, Carl/0000-0002-6735-7448; Beer, Ambros J./0000-0001-9042-7806; schwaiger, markus/0000-0002-2305-7144	German Research Foundation (DFG) within the SFB Initiative 824 (collaborative research center 824) "Imaging for Selection, Monitoring and Individualization of Cancer Therapies" [SFB 824]; German Research Foundation (DFG); Technische Universitat Munchen	German Research Foundation (DFG) within the SFB Initiative 824 (collaborative research center 824) "Imaging for Selection, Monitoring and Individualization of Cancer Therapies"; German Research Foundation (DFG)(German Research Foundation (DFG)); Technische Universitat Munchen	This work was supported by the German Research Foundation (DFG) within the SFB Initiative 824 (collaborative research center 824) "Imaging for Selection, Monitoring and Individualization of Cancer Therapies" (SFB 824, project C5), and by the German Research Foundation (DFG) and the Technische Universitat Munchen within the funding program Open Access Publishing. The funders played no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beer AJ, 2008, J NUCL MED, V49, P22, DOI 10.2967/jnumed.107.045864; Dewhirst MW, 2008, NAT REV CANCER, V8, P425, DOI 10.1038/nrc2397; HAMACHER K, 1986, J NUCL MED, V27, P235; Haubner R, 2004, BIOCONJUGATE CHEM, V15, P61, DOI 10.1021/bc034170n; Ho KC, 2009, EUR J NUCL MED MOL I, V36, P200, DOI 10.1007/s00259-008-0936-5; Judenhofer MS, 2008, NAT MED, V14, P459, DOI 10.1038/nm1700; Koh DM, 2007, AM J ROENTGENOL, V188, P1622, DOI 10.2214/AJR.06.1403; Kwee TC, 2010, J NUCL MED, V51, P1549, DOI 10.2967/jnumed.109.073908; Metz S, 2010, J NUCL MED, V51, P1691, DOI 10.2967/jnumed.110.077719; Padhani AR, 2010, RADIOLOGY, V256, P348, DOI 10.1148/radiol.10091760; Pichler BJ, 2010, J NUCL MED, V51, P333, DOI 10.2967/jnumed.109.061853; Rakheja R, 2013, AM J ROENTGENOL, V201, P1115, DOI 10.2214/AJR.13.11304; Ratib O, 2011, EUR J NUCL MED MOL I, V38, P992, DOI 10.1007/s00259-011-1790-4; Regier M, 2012, EUR J RADIOL, V81, P2913, DOI 10.1016/j.ejrad.2011.11.050; Rose CJ, 2009, MAGN RESON MED, V62, P488, DOI 10.1002/mrm.22003; Schmidt H, 2013, INVEST RADIOL, V48, P247, DOI 10.1097/RLI.0b013e31828d56a1; Sotak CH, 2004, NEUROCHEM INT, V45, P569, DOI 10.1016/j.neuint.2003.11.010; van Marwick S, 2011, RADIOLOGY S; Vaupel P, 2004, ONCOLOGIST, V9, P4, DOI 10.1634/theoncologist.9-90005-4; Wahl RL, 2009, J NUCL MED, V50, p122S, DOI 10.2967/jnumed.108.057307; Weber WA, 1999, J NUCL MED, V40, P1771; Weber WA, 2006, J CLIN ONCOL, V24, P3282, DOI 10.1200/JCO.2006.06.6068; Yu JX, 2014, ADV COND MATTER PHYS, V2014, DOI 10.1155/2014/364627	23	23	24	3	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0132386	10.1371/journal.pone.0132386	http://dx.doi.org/10.1371/journal.pone.0132386			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RV	26186719	Green Published, Green Submitted, gold			2022-12-26	WOS:000358198700040
J	Ho, TH; Nateras, RN; Yan, H; Park, JG; Jensen, S; Borges, C; Lee, JH; Champion, MD; Tibes, R; Bryce, AH; Carballido, EM; Todd, MA; Joseph, RW; Wong, WW; Parker, AS; Stanton, ML; Castle, EP				Ho, Thai H.; Nateras, Rafael Nunez; Yan, Huihuang; Park, Jin G.; Jensen, Sally; Borges, Chad; Lee, Jeong Heon; Champion, Mia D.; Tibes, Raoul; Bryce, Alan H.; Carballido, Estrella M.; Todd, Mark A.; Joseph, Richard W.; Wong, William W.; Parker, Alexander S.; Stanton, Melissa L.; Castle, Erik P.			A Multidisciplinary Biospecimen Bank of Renal Cell Carcinomas Compatible with Discovery Platforms at Mayo Clinic, Scottsdale, Arizona	PLOS ONE			English	Article							HUMAN SERUM-ALBUMIN; CHROMATIN IMMUNOPRECIPITATION; SULFENIC ACID; PLASMA-ALBUMIN; REDOX STATE; STORAGE; PATHOLOGY; CYSTEINYLATION; PROCUREMENT; EXPRESSION	To address the need to study frozen clinical specimens using next-generation RNA, DNA, chromatin immunoprecipitation (ChIP) sequencing and protein analyses, we developed a biobank work flow to prospectively collect biospecimens from patients with renal cell carcinoma (RCC). We describe our standard operating procedures and work flow to annotate pathologic results and clinical outcomes. We report quality control outcomes and nucleic acid yields of our RCC submissions (N=16) to The Cancer Genome Atlas (TCGA) project, as well as newer discovery platforms, by describing mass spectrometry analysis of albumin oxidation in plasma and 6 ChIP sequencing libraries generated from nephrectomy specimens after histone H3 lysine 36 trimethylation (H3K36me3) immunoprecipitation. From June 1, 2010, through January 1, 2013, we enrolled 328 patients with RCC. Our mean (SD) TCGA RNA integrity numbers (RINs) were 8.1 (0.8) for papillary RCC, with a 12.5% overall rate of sample disqualification for RIN <7. Banked plasma had significantly less albumin oxidation (by mass spectrometry analysis) than plasma kept at 25 degrees C (P<.001). For ChIP sequencing, the FastQC score for average read quality was at least 30 for 91% to 95% of paired-end reads. In parallel, we analyzed frozen tissue by RNA sequencing; after genome alignment, only 0.2% to 0.4% of total reads failed the default quality check steps of Bowtie2, which was comparable to the disqualification ratio (0.1%) of the 786-O RCC cell line that was prepared under optimal RNA isolation conditions. The overall correlation coefficients for gene expression between Mayo Clinic vs TCGA tissues ranged from 0.75 to 0.82. These data support the generation of high-quality nucleic acids for genomic analyses from banked RCC. Importantly, the protocol does not interfere with routine clinical care. Collections over defined time points during disease treatment further enhance collaborative efforts to integrate genomic information with outcomes.	[Ho, Thai H.; Tibes, Raoul; Bryce, Alan H.; Carballido, Estrella M.] Mayo Clin, Div Hematol & Oncol, Scottsdale, AZ 85259 USA; [Nateras, Rafael Nunez; Castle, Erik P.] Mayo Clin Hosp, Dept Urol, Phoenix, AZ USA; [Yan, Huihuang] Mayo Clin, Div Biomed Stat & Informat, Rochester, MN USA; [Park, Jin G.] Arizona State Univ, Biodesign Inst, Ctr Personalized Diagnost, Tempe, AZ USA; [Jensen, Sally; Borges, Chad] Arizona State Univ, Dept Chem & Biochem, Biodesign Inst, Ctr Personalized Diagnost, Tempe, AZ USA; [Lee, Jeong Heon] Mayo Clin, Dept Biochem & Mol Biol, Rochester, MN USA; [Champion, Mia D.] Mayo Clin, Div Biomed Stat & Informat, Scottsdale, AZ USA; [Todd, Mark A.] Mayo Clin, Div Anat Pathol, Scottsdale, AZ USA; [Joseph, Richard W.] Mayo Clin, Div Hematol & Oncol, Jacksonville, FL 32224 USA; [Wong, William W.] Mayo Clin, Dept Radiat Oncol, Scottsdale, AZ USA; [Parker, Alexander S.] Mayo Clin, Dept Hlth Sci Res, Jacksonville, FL 32224 USA; [Stanton, Melissa L.] Mayo Clin, Dept Lab Med Pathol, Scottsdale, AZ USA	Mayo Clinic; Mayo Clinic Phoenix; Mayo Clinic; Mayo Clinic Phoenix; Mayo Clinic; Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe; Mayo Clinic; Mayo Clinic; Mayo Clinic Phoenix; Mayo Clinic; Mayo Clinic Phoenix; Mayo Clinic; Mayo Clinic; Mayo Clinic Phoenix; Mayo Clinic; Mayo Clinic; Mayo Clinic Phoenix	Ho, TH (corresponding author), Mayo Clin, Div Hematol & Oncol, Scottsdale, AZ 85259 USA.	ho.thai@mayo.edu	Bryce, Alan/W-1765-2019; Tibes, Raoul/AAV-1683-2020	Bryce, Alan/0000-0002-0206-3895; Tibes, Raoul/0000-0002-1372-8733; Ho, Thai/0000-0003-0023-2939; Joseph, Richard/0000-0001-6102-4661	Mayo Clinic Center for Individualized Medicine Epigenomics Program; K12 grant from the National Institutes of Health [CA90628]; Career Development Award from the Fraternal Order of Eagles; Kathryn H. and Roger Penske Career Development Award; NATIONAL CANCER INSTITUTE [K12CA090628] Funding Source: NIH RePORTER	Mayo Clinic Center for Individualized Medicine Epigenomics Program; K12 grant from the National Institutes of Health; Career Development Award from the Fraternal Order of Eagles; Kathryn H. and Roger Penske Career Development Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	T.H.H. was supported by funding from the Mayo Clinic Center for Individualized Medicine Epigenomics Program; a K12 grant CA90628 from the National Institutes of Health; a Career Development Award from the Fraternal Order of Eagles; and a Kathryn H. and Roger Penske Career Development Award to Support Medical Research. H. Y., J.H.L., and M.D.C. were supported by funding from the Mayo Clinic Center for Individualized Medicine Epigenomics Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreasson A, 2013, BIOPRESERV BIOBANK, V11, P366, DOI 10.1089/bio.2013.0038; [Anonymous], 2013, NATURE, V499, P43, DOI [10.1038/nature12222, DOI 10.1038/NATURE12222, DOI 10.1038/nature12222]; Bar-Or D, 2005, PRENATAL DIAG, V25, P245, DOI 10.1002/pd.1122; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Blecher-Gonen R, 2013, NAT PROTOC, V8, P539, DOI 10.1038/nprot.2013.023; Borges CR, 2014, MOL CELL PROTEOMICS, V13, P1890, DOI 10.1074/mcp.M114.038455; Carmignani L, 2012, PATHOL ONCOL RES, V18, P663, DOI 10.1007/s12253-011-9492-6; Chantalat S, 2011, GENOME RES, V21, P1426, DOI 10.1101/gr.118091.110; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Choueiri TK, 2014, ANN ONCOL, V25, P2178, DOI 10.1093/annonc/mdu445; Dalgliesh GL, 2010, NATURE, V463, P360, DOI 10.1038/nature08672; Dillon SC, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-8-227; Edmunds JW, 2008, EMBO J, V27, P406, DOI 10.1038/sj.emboj.7601967; Esgueva R, 2012, DIAGN MOL PATHOL, V21, P61, DOI 10.1097/PDM.0b013e31823b6da6; Fanelli M, 2011, NAT PROTOC, V6, P1905, DOI 10.1038/nprot.2011.406; Fanelli M, 2010, P NATL ACAD SCI USA, V107, P21535, DOI 10.1073/pnas.1007647107; Hammerman PS, 2012, NATURE, V489, P519, DOI 10.1038/nature11404; Haring M, 2007, PLANT METHODS, V3, DOI 10.1186/1746-4811-3-11; Hedegaard J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098187; Ho TH, ONCOGENE HH IN PRESS, P1; Jones DP, 2000, FREE RADICAL BIO MED, V28, P625, DOI 10.1016/S0891-5849(99)00275-0; Kang Byunghak, 2013, Genomics & Informatics, V11, P211, DOI 10.5808/GI.2013.11.4.211; Kolasinska-Zwierz P, 2009, NAT GENET, V41, P376, DOI 10.1038/ng.322; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liu NW, 2013, CLIN CANCER RES, V19, P42, DOI 10.1158/1078-0432.CCR-12-2606; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Nagumo K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085216; Nakanishi T, 2003, KIDNEY INT, V63, P1137, DOI 10.1046/j.1523-1755.2003.00808.x; Nunez-Nateras R, 2014, UROL ONCOL, V32; Olson JE, 2014, MAYO CLIN PROC, V89, P276, DOI 10.1016/j.mayocp.2013.12.007; Olson JE, 2013, MAYO CLIN PROC, V88, P952, DOI 10.1016/j.mayocp.2013.06.006; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Regazzoni L, 2013, FREE RADICAL RES, V47, P172, DOI 10.3109/10715762.2012.756139; Rehder DS, 2010, BIOCHEMISTRY-US, V49, P7748, DOI 10.1021/bi1008694; Shabihkhani M, 2014, CLIN BIOCHEM, V47, P258, DOI 10.1016/j.clinbiochem.2014.01.002; Simon JM, 2014, GENOME RES, V24, P241, DOI 10.1101/gr.158253.113; Soejima A, 2004, BLOOD PURIFICAT, V22, P525, DOI 10.1159/000082524; Sun H, 2015, ANN SURG ONCOL; Turell L, 2009, BRAZ J MED BIOL RES, V42, P305, DOI 10.1590/S0100-879X2009000400001; Turell L, 2008, BIOCHEMISTRY-US, V47, P358, DOI 10.1021/bi701520y; Turell L, 2009, J CHROMATOGR B, V877, P3384, DOI 10.1016/j.jchromb.2009.03.035; Wu WQ, 2015, UROLOGY, V85, P299, DOI 10.1016/j.urology.2014.10.030; Yan HH, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-280; Zang CZ, 2009, BIOINFORMATICS, V25, P1952, DOI 10.1093/bioinformatics/btp340	45	7	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2015	10	7							e0132831	10.1371/journal.pone.0132831	http://dx.doi.org/10.1371/journal.pone.0132831			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RQ	26181416	Green Submitted, Green Published, gold			2022-12-26	WOS:000358198200038
J	Habka, D; Mann, D; Landes, R; Soto-Gutierrez, A				Habka, Dany; Mann, David; Landes, Ronald; Soto-Gutierrez, Alejandro			Future Economics of Liver Transplantation: A 20-Year Cost Modeling Forecast and the Prospect of Bioengineering Autologous Liver Grafts	PLOS ONE			English	Article							PLURIPOTENT STEM-CELLS; ORTHOTOPIC TRANSPLANTATION; RESOURCE UTILIZATION; HEPATITIS-C; DISEASE; HEPATOCYTES; REGENERATION; FIBROBLASTS; THERAPY; UPDATE	During the past 20 years liver transplantation has become the definitive treatment for most severe types of liver failure and hepatocellular carcinoma, in both children and adults. In the U.S., roughly 16,000 individuals are on the liver transplant waiting list. Only 38% of them will receive a transplant due to the organ shortage. This paper explores another option: bioengineering an autologous liver graft. We developed a 20-year model projecting future demand for liver transplants, along with costs based on current technology. We compared these cost projections against projected costs to bioengineer autologous liver grafts. The model was divided into: 1) the epidemiology model forecasting the number of wait-listed patients, operated patients and postoperative patients; and 2) the treatment model forecasting costs (pre-transplant-related costs; transplant (admission)-related costs; and 10-year post-transplant-related costs) during the simulation period. The patient population was categorized using the Model for End- Stage Liver Disease score. The number of patients on the waiting list was projected to increase 23% over 20 years while the weighted average treatment costs in the pre-liver transplantation phase were forecast to increase 83% in Year 20. Projected demand for livers will increase 10% in 10 years and 23% in 20 years. Total costs of liver transplantation are forecast to increase 33% in 10 years and 81% in 20 years. By comparison, the projected cost to bioengineer autologous liver grafts is $9.7M based on current catalog prices for iPS-derived liver cells. The model projects a persistent increase in need and cost of donor livers over the next 20 years that's constrained by a limited supply of donor livers. The number of patients who die while on the waiting list will reflect this ever-growing disparity. Currently, bioengineering autologous liver grafts is cost prohibitive. However, costs will decline rapidly with the introduction of new manufacturing strategies and economies of scale.	[Habka, Dany] Hlth Syst Reform, Beirut, Lebanon; [Mann, David] Cellular Dynam Int, Madison, WI USA; [Landes, Ronald] Solving Organ Shortage, Austin, TX 78701 USA; [Soto-Gutierrez, Alejandro] Univ Pittsburgh, Dept Pathol, Pittsburgh, PA USA; [Soto-Gutierrez, Alejandro] Univ Pittsburgh, Thomas E Starzl Transplantat Inst, Pittsburgh, PA USA; [Soto-Gutierrez, Alejandro] Univ Pittsburgh, McGowan Inst Regenerat Med, Pittsburgh, PA USA; [Soto-Gutierrez, Alejandro] SOS Whole Liver Res Community, Austin, TX USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Landes, R (corresponding author), Solving Organ Shortage, Austin, TX 78701 USA.	rgl@sosorgans.org; sotogutierrez@upmc.edu			Health Systems Reform; Cellular Dynamics International; National Institutes of Health [DK099257]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK099257] Funding Source: NIH RePORTER	Health Systems Reform; Cellular Dynamics International; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Dr. Dany Habka, a modeling and simulation expert with Health Systems Reform (www.healthsystemsreform.com), was engaged as a paid consultant by Solving Organ Shortage (www.solvingorganshortage.org) to develop the 20-year cost modeling forecast. Health Systems Reform provided support in the form of a salary for author Dany Habka, and Cellular Dynamics International (www.cellulardynamics.com) provided support in the form of a salary for author David A. Mann, but neither company had any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Alejandro Soto-Gutierrez also receives support (DK099257) from The National Institutes of Health. The specific roles of these authors are articulated in the 'author contributions' section.	Alqahtani SA, 2012, CURR OPIN GASTROEN, V28, P230, DOI 10.1097/MOG.0b013e3283527f16; Ammori JB, 2008, J AM COLL SURGEONS, V206, P89, DOI 10.1016/j.jamcollsurg.2007.06.292; [Anonymous], 2014, HARVONI LEDIPASVIR S; Axelrod DA, 2014, AM J TRANSPLANT, V14, P70, DOI 10.1111/ajt.12494; Baptista PM, 2011, HEPATOLOGY, V53, P604, DOI 10.1002/hep.24067; Bentley TS, 2011, ORGAN TISSUE TRANSPL, P2; BLOUIN A, 1977, J CELL BIOL, V72, P441, DOI 10.1083/jcb.72.2.441; Bredenkamp N, 2014, NAT CELL BIOL, V16, P902, DOI 10.1038/ncb3023; Buchanan P, 2009, LIVER TRANSPLANT, V15, P1270, DOI 10.1002/lt.21802; Busuttil RW, 2003, LIVER TRANSPLANT, V9, P651, DOI 10.1053/jlts.2003.50105; Ciria R, 2011, CURR OPIN ORGAN TRAN, V16, P489, DOI 10.1097/MOT.0b013e32834a94cf; Cooper DKC, 2013, J BIOMED RES, V27, P249, DOI 10.7555/JBR.27.20130063; Denniston MM, 2014, ANN INTERN MED, V160, P293, DOI 10.7326/M13-1133; Geissler EK, 2013, CURR OPIN ORGAN TRAN, V18, P408, DOI 10.1097/MOT.0b013e328363319d; Graham JA, 2014, J HEPATOL, V61, P418, DOI 10.1016/j.jhep.2014.04.019; Hayden EC, 2014, NATURE, V507, P294, DOI 10.1038/507294a; Hoofnagle JH, 2014, NEW ENGL J MED, V370, P1552, DOI 10.1056/NEJMe1401508; Hoyert Donna L, 2012, Natl Vital Stat Rep, V61, P1; Inc. GS, 2015, HARV LED SOF TABL OR; Jimenez-Romero C, 2014, WORLD J GASTROENTERO, V20, P10691, DOI 10.3748/wjg.v20.i31.10691; Longworth L, 2003, LIVER TRANSPLANT, V9, P1295, DOI 10.1016/j.lts.2003.09.012; Ma XC, 2013, STEM CELL TRANSL MED, V2, P409, DOI 10.5966/sctm.2012-0160; Menzin J, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-459; Nishikawa T, 2015, J CLIN INVEST, V125, P1533, DOI 10.1172/JCI73137; Ott HC, 2008, NAT MED, V14, P213, DOI 10.1038/nm1684; Ott HC, 2010, NAT MED, V16, P927, DOI 10.1038/nm.2193; Pawlotsky JM, 2015, GASTROENTEROLOGY, V148, P468, DOI 10.1053/j.gastro.2015.01.002; Petersen TH, 2010, SCIENCE, V329, P538, DOI 10.1126/science.1189345; Salvalaggio PR, 2011, LIVER TRANSPLANT, V17, P233, DOI 10.1002/lt.22230; Schnitzler MA, 2005, AM J TRANSPLANT, V5, P2289, DOI 10.1111/j.1600-6143.2005.01021.x; Schnitzler MA, 2001, AM J TRANSPLANT, V1, P360, DOI 10.1034/j.1600-6143.2001.10412.x; Showstack J, 1999, JAMA-J AM MED ASSOC, V281, P1381, DOI 10.1001/jama.281.15.1381; Si-Tayeb K, 2010, DEV CELL, V18, P175, DOI 10.1016/j.devcel.2010.01.011; Si-Tayeb K, 2010, HEPATOLOGY, V51, P297, DOI 10.1002/hep.23354; Sohlenius-Sternbeck AK, 2006, TOXICOL IN VITRO, V20, P1582, DOI 10.1016/j.tiv.2006.06.003; Soltys KA, 2010, J HEPATOL, V53, P769, DOI 10.1016/j.jhep.2010.05.010; Song JJ, 2013, NAT MED, V19, P646, DOI 10.1038/nm.3154; Song KH, 2012, NATURE, V485, P599, DOI 10.1038/nature11139; Soto-Gutierrez A, 2012, J CLIN INVEST, V122, P3817, DOI 10.1172/JCI61974; (SRTR) OPaTNOaSRoTR, 2014, OPTN SRTR 2012 ANN D, P1; Sullivan GJ, 2010, HEPATOLOGY, V51, P329, DOI 10.1002/hep.23335; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Torgerson D, 1999, BMJ-BRIT MED J, V318, P1413, DOI 10.1136/bmj.318.7195.1413; Ulvestad M, 2013, BIOCHEM PHARMACOL, V86, P691, DOI 10.1016/j.bcp.2013.06.029; Uygun BE, 2010, NAT MED, V16, P814, DOI 10.1038/nm.2170; Washburn WK, 2006, AM J TRANSPLANT, V6, P2449, DOI 10.1111/j.1600-6143.2006.01490.x; Wiesner R, 2003, GASTROENTEROLOGY, V124, P91, DOI 10.1053/gast.2003.50016; Wong RJ, 2015, GASTROENTEROLOGY, V148, P547, DOI 10.1053/j.gastro.2014.11.039; Yagi H, 2013, CELL TRANSPLANT, V22, P231, DOI 10.3727/096368912X654939; Yarbrough C, 2000, INT HUMAN GENOME SEQ; Yen EF, 2004, AM J TRANSPLANT, V4, P1703, DOI 10.1111/j.1600-6143.2004.00565.x; Zarrinpar A, 2013, NAT REV GASTRO HEPAT, V10, P434, DOI 10.1038/nrgastro.2013.88	52	44	47	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0131764	10.1371/journal.pone.0131764	http://dx.doi.org/10.1371/journal.pone.0131764			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26177505	Green Accepted, gold, Green Submitted, Green Published			2022-12-26	WOS:000358197600063
J	Hafren, L; Einarsdottir, E; Kentala, E; Hammaren-Malmi, S; Bhutta, MF; MacArthur, CJ; Wilmot, B; Casselbrant, M; Conley, YP; Weeks, DE; Mandel, EM; Vaarala, O; Kallio, A; Melin, M; Nieminen, JK; Leinonen, E; Kere, J; Mattila, PS				Hafren, Lena; Einarsdottir, Elisabet; Kentala, Erna; Hammaren-Malmi, Sari; Bhutta, Mahmood F.; MacArthur, Carol J.; Wilmot, Beth; Casselbrant, Margaretha; Conley, Yvette P.; Weeks, Daniel E.; Mandel, Ellen M.; Vaarala, Outi; Kallio, Anna; Melin, Merit; Nieminen, Janne K.; Leinonen, Eira; Kere, Juha; Mattila, Petri S.			Predisposition to Childhood Otitis Media and Genetic Polymorphisms within the Toll-Like Receptor 4 (TLR4) Locus	PLOS ONE			English	Article							SUSCEPTIBILITY LOCI; EFFUSION; ASSOCIATION; HERITABILITY; PATHOGENESIS; RESPONSES; CHILDREN; LINKAGE; EPIDEMIOLOGY; SYMPTOMS	Background Predisposition to childhood otitis media (OM) has a strong genetic component, with polymorphisms in innate immunity genes suspected to contribute to risk. Studies on several genes have been conducted, but most associations have failed to replicate in independent cohorts. Methods We investigated 53 gene polymorphisms in a Finnish cohort of 624 cases and 778 controls. A positive association signal was followed up in a tagging approach and tested in an independent Finnish cohort of 205 cases, in a British cohort of 1269 trios, as well as in two cohorts from the United States (US); one with 403 families and the other with 100 cases and 104 controls. Results In the initial Finnish cohort, the SNP rs5030717 in the TLR4 gene region showed significant association (OR 1.33, P=.003) to OM. Tagging SNP analysis of the gene found rs1329060 (OR 1.33, P=.002) and rs1329057 (OR 1.29, P=.003) also to be associated. In the more severe phenotype the association was stronger. This finding was supported by an independent Finnish case cohort, but the associations failed to replicate in the British and US cohorts. In studies on TLR4 signaling in 20 study subjects, the three-marker risk haplotype correlated with a decreased TNF alpha secretion in myeloid dendritic cells. Conclusions The TLR4 gene locus, regulating the innate immune response, influences the genetic predisposition to childhood OM in a subpopulation of patients. Environmental factors likely modulate the genetic components contributing to the risk of OM.	[Hafren, Lena; Kentala, Erna; Hammaren-Malmi, Sari; Mattila, Petri S.] Univ Helsinki, Cent Hosp, Dept Otorhinolaryngol, Helsinki, Finland; [Einarsdottir, Elisabet; Kere, Juha] Karolinska Inst, Ctr Innovat Med, Dept Biosci & Nutr, Huddinge, Sweden; [Bhutta, Mahmood F.] UCL Ear Inst, London, England; [MacArthur, Carol J.] Oregon Hlth & Sci Univ, Dept Otolaryngol Head & Neck Surg, Portland, OR 97201 USA; [Wilmot, Beth] Oregon Hlth & Sci Univ, Oregon Clin & Translat Res Inst, Portland, OR 97201 USA; [Wilmot, Beth] Oregon Hlth & Sci Univ, Div Bioinformat & Computat Biol, Portland, OR 97201 USA; [Casselbrant, Margaretha; Mandel, Ellen M.] Univ Pittsburgh, Sch Med, Dept Otolaryngol, Pittsburgh, PA USA; [Conley, Yvette P.] Univ Pittsburgh, Dept Nursing & Human Genet, Pittsburgh, PA USA; [Weeks, Daniel E.] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Human Genet, Pittsburgh, PA 15261 USA; [Vaarala, Outi] Univ Helsinki, Inst Clin Med, Helsinki, Finland; [Kallio, Anna; Melin, Merit; Nieminen, Janne K.] Natl Inst Hlth & Welf THL, Dept Vaccinat & Immune Protect, Helsinki, Finland; [Leinonen, Eira; Kere, Juha] Univ Helsinki, Mol Neurol Res Program, Helsinki, Finland; [Leinonen, Eira; Kere, Juha] Folkhalsan Inst Genet, Helsinki, Finland	University of Helsinki; Helsinki University Central Hospital; Karolinska Institutet; University of London; University College London; Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Helsinki; Finland National Institute for Health & Welfare; University of Helsinki	Hafren, L (corresponding author), Univ Helsinki, Cent Hosp, Dept Otorhinolaryngol, Helsinki, Finland.	lena.hafren@helsinki.fi; petri.mattila@helsinki.fi	Weeks, Daniel E/B-2995-2012; Kere, Juha/A-9179-2008; Kere, Juha/AAX-9117-2021	Weeks, Daniel E/0000-0001-9410-7228; Kere, Juha/0000-0003-1974-0271; Kere, Juha/0000-0003-1974-0271; Conley, Yvette/0000-0002-1784-6067; Bhutta, Mahmood/0000-0002-4688-1670; Leinonen, Eira/0000-0001-5278-5426; Nieminen, Janne/0000-0003-4089-163X; Einarsdottir, Elisabet/0000-0003-3101-2285; Hafren, Lena/0000-0002-4968-4357	Finska Lakaresallskapet; Helsinki University Central Hospital Research Funds; Paivikki and Sakari Sohlberg Foundation; Sigrid Juselius Foundation; Swedish Research Council Formas; Wellcome Trust; Oregon Clinical and Translational Research Institute; National Center for Advancing Translational Sciences [UL1TR000128]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000005] Funding Source: NIH RePORTER	Finska Lakaresallskapet; Helsinki University Central Hospital Research Funds; Paivikki and Sakari Sohlberg Foundation; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Swedish Research Council Formas(Swedish Research CouncilSwedish Research Council Formas); Wellcome Trust(Wellcome TrustEuropean Commission); Oregon Clinical and Translational Research Institute; National Center for Advancing Translational Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This study was supported by Finska Lakaresallskapet (http://fls.fi/sallskapet/ to LH), the Helsinki University Central Hospital Research Funds (http://www.hus.fi/tutkijalle/Sivut/HUSn-sisainenhankeohje.aspx to PM), the Paivikki and Sakari Sohlberg Foundation (http://www.pss-saatio.fi/english.htm to PM), the Sigrid Juselius Foundation (http://www.sigridjuselius.fi/foundation to JK), the Swedish Research Council Formas (http://www.formas.se/en/Financing/ to JK), the Wellcome Trust (http://www.wellcome.ac.uk/ to MB), the Oregon Clinical and Translational Research Institute (http://www.ohsu.edu/xd/research/centers-institutes/octri/ to CM), and the National Center for Advancing Translational Sciences, grant number UL1TR000128 (http://www.ncats.nih.gov/ to CM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen EK, 2013, JARO-J ASSOC RES OTO, V14, P791, DOI 10.1007/s10162-013-0411-2; Alles R, 2001, PEDIAT ALLERG IMM-UK, V12, P102, DOI 10.1046/j.0905-6157.2000.00008.x; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Beg AA, 2002, TRENDS IMMUNOL, V23, P509, DOI 10.1016/S1471-4906(02)02317-7; Beutler B, 2009, IMMUNOL REV, V227, P248, DOI 10.1111/j.1600-065X.2008.00733.x; Bhutta MF, 2014, AUDIOL NEURO-OTOL, V19, P210, DOI 10.1159/000358549; Casselbrant ML, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-85; Casselbrant ML, 1999, JAMA-J AM MED ASSOC, V282, P2125, DOI 10.1001/jama.282.22.2125; Chantzi FM, 2006, ALLERGY, V61, P332, DOI 10.1111/j.1398-9995.2006.00971.x; Chen WM, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-124; Daly KA, 2004, AM J HUM GENET, V75, P988, DOI 10.1086/426061; Daly KA, 2010, INT J PEDIATR OTORHI, V74, P231, DOI 10.1016/j.ijporl.2009.09.006; Darwiche SS, 2013, J TRAUMA ACUTE CARE, V74, P1454, DOI 10.1097/TA.0b013e3182905ed2; Deng MH, 2013, J IMMUNOL, V190, P5152, DOI 10.4049/jimmunol.1300496; Dudbridge F, 2008, HUM HERED, V66, P87, DOI 10.1159/000119108; Forrest ARR, 2014, NATURE, V507, P462, DOI 10.1038/nature13182; GOYCOOLEA MV, 1991, OTOLARYNG CLIN N AM, V24, P757; Hafren L, 2012, CURR ALLERGY ASTHM R, V12, P582, DOI 10.1007/s11882-012-0292-1; Hafren L, 2012, INT J PEDIATR OTORHI, V76, P41, DOI 10.1016/j.ijporl.2011.09.026; Hammad H, 2009, NAT MED, V15, P410, DOI 10.1038/nm.1946; Hammaren-Malmi S, 2005, ACTA OTO-LARYNGOL, V125, P1051, DOI 10.1080/00016480510038040; Kvestad E, 2004, TWIN RES, V7, P239, DOI 10.1375/twin.7.3.239; Leichtle A, 2011, CURR ALLERGY ASTHM R, V11, P78, DOI 10.1007/s11882-010-0158-3; Leichtle A, 2009, INNATE IMMUN-LONDON, V15, P205, DOI 10.1177/1753425909103170; MacArthur CJ, 2014, LARYNGOSCOPE, V124, P1229, DOI 10.1002/lary.24349; Malley R, 2003, P NATL ACAD SCI USA, V100, P1966, DOI 10.1073/pnas.0435928100; Millien VO, 2013, SCIENCE, V341, P792, DOI 10.1126/science.1240342; Mucha SM, 2003, CURR ALLERGY ASTHM R, V3, P232, DOI 10.1007/s11882-003-0045-2; Netea MG, 2012, NAT IMMUNOL, V13, P535, DOI 10.1038/ni.2284; Peltonen L, 1999, HUM MOL GENET, V8, P1913, DOI 10.1093/hmg/8.10.1913; Purcell S, 2003, BIOINFORMATICS, V19, P149, DOI 10.1093/bioinformatics/19.1.149; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rosenfeld RM, 2004, PEDIATRICS, V113, P1412, DOI 10.1542/peds.113.5.1412; Rovers M, 2002, AM J EPIDEMIOL, V155, P958, DOI 10.1093/aje/155.10.958; Rye MS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048215; Rye MS, 2012, LARYNGOSCOPE, V122, P665, DOI 10.1002/lary.22506; Sale M, 2008, ASSOCRESOTOLARYNGOL, V31; Sale MM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022297; TEELE DW, 1989, J INFECT DIS, V160, P83, DOI 10.1093/infdis/160.1.83; Trompette A, 2009, NATURE, V457, P585, DOI 10.1038/nature07548; Umapathy D, 2007, INT J PEDIATR OTORHI, V71, P705, DOI 10.1016/j.ijporl.2006.12.017; Yazji I, 2013, P NATL ACAD SCI USA, V110, P9451, DOI 10.1073/pnas.1219997110; Ziakas PD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081047	43	25	26	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0132551	10.1371/journal.pone.0132551	http://dx.doi.org/10.1371/journal.pone.0132551			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26177520	Green Published, Green Submitted, gold, Green Accepted			2022-12-26	WOS:000358197600123
J	Jia, L; Zhou, Z; Liang, H; Wu, J; Shi, P; Li, F; Wang, Z; Wang, C; Chen, W; Zhang, H; Wang, Y; Liu, R; Feng, J; Chen, C				Jia, L.; Zhou, Z.; Liang, H.; Wu, J.; Shi, P.; Li, F.; Wang, Z.; Wang, C.; Chen, W.; Zhang, H.; Wang, Y.; Liu, R.; Feng, J.; Chen, C.			KLF5 promotes breast cancer proliferation, migration and invasion in part by upregulating the transcription of TNFAIP2	ONCOGENE			English	Article							NECROSIS-FACTOR-ALPHA; PRIMARY RESPONSE GENE; KRUPPEL-LIKE FACTOR-5; CELL-PROLIFERATION; TUNNELING NANOTUBES; EPITHELIAL-CELLS; PROGNOSTIC-FACTOR; BINDING-PROTEIN; ANIMAL-CELLS; RHO-GTPASES	The Kruppel-like factor 5 (KLF5) transcription factor is highly expressed in high-grade and basal-like breast cancers. However, the mechanism by which KLF5 promotes cell migration and invasion is still not completely understood. In this study, we demonstrate that TNFAIP2, a tumor necrosis factor-alpha (TNF alpha)-induced gene, is a direct KLF5 target gene. The expression of TNFAIP2 is highly correlated with the expression of KLF5 in breast cancers. The manipulation of KLF5 expression positively alters TNFAIP2 expression levels. KLF5 directly binds to the TNFAIP2 gene promoter and activates its transcription. Functionally, KLF5 promotes cancer cell proliferation, migration and invasion in part through TNFAIP2. TNFAIP2 interacts with the two small GTPases Rac1 and Cdc42, thereby increasing their activities to change actin cytoskeleton and cell morphology. These findings collectively suggest that TNFAIP2 is a direct KLF5 target gene, and both KLF5 and TNFAIP2 promote breast cancer cell proliferation, migration and invasion through Rac1 and Cdc42.	[Jia, L.; Zhou, Z.; Liang, H.; Wu, J.; Shi, P.; Li, F.; Wang, Z.; Wang, C.; Zhang, H.; Liu, R.; Chen, C.] Chinese Acad Sci, Kunming Inst Zool, Chinese Acad Sci & Yunnan Prov, Key Lab Anim Models & Human Dis Mech, 32 Jiaochang East Rd, Kunming 650223, Yunnan, Peoples R China; [Jia, L.] Yuxi Normal Univ, Dept Biol, Yuxi, Peoples R China; [Jia, L.; Wu, J.; Wang, C.] Univ Chinese Acad Sci, Beijing, Peoples R China; [Wu, J.] Kunming Med Univ, Dept Biochem & Mol Biol, Kunming, Peoples R China; [Wang, C.] Kunming Med Univ, Dept Pathol, Affiliated Hosp 1, Kunming, Peoples R China; [Chen, W.; Wang, Y.] Kunming Med Univ, Canc Hosp, Kunming, Peoples R China; [Feng, J.] Southern Med Univ, Affiliated Fengxian Hosp, Dept Lab Med, Shanghai 201499, Peoples R China; [Feng, J.] Southern Med Univ, Affiliated Fengxian Hosp, Cent Lab, Shanghai 201499, Peoples R China	Chinese Academy of Sciences; Kunming Institute of Zoology; Yuxi Normal University; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Kunming Medical University; Kunming Medical University; Kunming Medical University; Southern Medical University - China; Southern Medical University - China	Chen, C (corresponding author), Chinese Acad Sci, Kunming Inst Zool, Chinese Acad Sci & Yunnan Prov, Key Lab Anim Models & Human Dis Mech, 32 Jiaochang East Rd, Kunming 650223, Yunnan, Peoples R China.; Feng, J (corresponding author), Southern Med Univ, Affiliated Fengxian Hosp, Dept Lab Med, Shanghai 201499, Peoples R China.; Feng, J (corresponding author), Southern Med Univ, Affiliated Fengxian Hosp, Cent Lab, Shanghai 201499, Peoples R China.	fengjing8801530@163.com; chenc@mail.kiz.ac.cn	Wang, Zehua/I-6452-2018	Wang, Zehua/0000-0002-0769-8865; wang, zhengbo/0000-0002-4717-5137	Strategic Priority Research Program of the Chinese Academy of Sciences, Stem Cell and Regenerative Medicine Research [XDA01040406]; National Natural Science Foundation of China [81120108019, 81325016, U1132605, 81322038, 81272930]; West Light Foundation of Chinese Academy of Sciences; Shanghai Health System outstanding academic leader training program [XBR2013114]	Strategic Priority Research Program of the Chinese Academy of Sciences, Stem Cell and Regenerative Medicine Research; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); West Light Foundation of Chinese Academy of Sciences(Chinese Academy of Sciences); Shanghai Health System outstanding academic leader training program	We thank Professor Jun Zhou at Nankai University for providing reagents and Professor Ping Wang from Tongji University for bioinformatics analysis. This study was supported by the Strategic Priority Research Program of the Chinese Academy of Sciences, Stem Cell and Regenerative Medicine Research (XDA01040406) and the National Natural Science Foundation of China (81120108019, 81325016, U1132605, 81322038 and 81272930) West Light Foundation of Chinese Academy of Sciences (to RL) and Shanghai Health System outstanding academic leader training program (XBR2013114 to JF).	Abounit S, 2012, J CELL SCI, V125, P1089, DOI 10.1242/jcs.083279; Aizawa K, 2004, J BIOL CHEM, V279, P70, DOI 10.1074/jbc.M306621200; Bafford R, 2006, SURGERY, V140, P289, DOI 10.1016/j.surg.2006.04.004; Bateman NW, 2004, J BIOL CHEM, V279, P12093, DOI 10.1074/jbc.M311532200; Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Chanchevalap S, 2006, NUCLEIC ACIDS RES, V34, P1216, DOI 10.1093/nar/gkl014; Chen C, 2002, ONCOGENE, V21, P6567, DOI 10.1038/sj.onc.1205817; Chen CS, 2007, INT J CANCER, V121, P80, DOI 10.1002/ijc.22653; Chen CH, 2006, INT J CANCER, V118, P1346, DOI 10.1002/ijc.21533; Chen CJ, 2012, PATHOL ONCOL RES, V18, P161, DOI 10.1007/s12253-011-9422-7; Chen CS, 2005, ONCOGENE, V24, P3319, DOI 10.1038/sj.onc.1208497; Chen LC, 2011, MODERN PATHOL, V24, P175, DOI 10.1038/modpathol.2010.193; Chevrier N, 2011, CELL, V147, P853, DOI 10.1016/j.cell.2011.10.022; Davis DM, 2008, NAT REV MOL CELL BIO, V9, P431, DOI 10.1038/nrm2399; Dent R, 2007, CLIN CANCER RES, V13, P4429, DOI 10.1158/1078-0432.CCR-06-3045; Dong JT, 2009, CELL MOL LIFE SCI, V66, P2691, DOI 10.1007/s00018-009-0045-z; Gerdes HH, 2007, FEBS LETT, V581, P2194, DOI 10.1016/j.febslet.2007.03.071; Haffty BG, 2006, J CLIN ONCOL, V24, P5652, DOI 10.1200/JCO.2006.06.5664; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Hase K, 2009, NAT CELL BIOL, V11, P1427, DOI 10.1038/ncb1990; He M, 2009, J BIOCHEM, V146, P683, DOI 10.1093/jb/mvp115; Ikeda M, 1998, J BIOL CHEM, V273, P814, DOI 10.1074/jbc.273.2.814; Kimura S, 2012, EXP CELL RES, V318, P1699, DOI 10.1016/j.yexcr.2012.05.013; Kojima S, 1997, J BIOCHEM, V121, P389; Liu R, 2011, MOL ENDOCRINOL, V25, P1137, DOI 10.1210/me.2010-0497; Ma Y, 2003, ONCOGENE, V22, P4924, DOI 10.1038/sj.onc.1206728; Maxmen A, 2012, NATURE, V485, pS50, DOI 10.1038/485S50a; McConnell BB, 2009, CANCER RES, V69, P4125, DOI 10.1158/0008-5472.CAN-08-4402; Mori A, 2009, MOL CANCER RES, V7, P1390, DOI 10.1158/1541-7786.MCR-08-0525; Ohno Hiroshi, 2010, Commun Integr Biol, V3, P231; Ohta Y, 1999, P NATL ACAD SCI USA, V96, P2122, DOI 10.1073/pnas.96.5.2122; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; SARMA V, 1992, J IMMUNOL, V148, P3302; Schiller C, 2013, J CELL SCI, V126, P767, DOI 10.1242/jcs.114033; Shi HP, 1999, NUCLEIC ACIDS RES, V27, P4807, DOI 10.1093/nar/27.24.4807; Shi XJ, 2012, CELL CYCLE, V11, P1554, DOI 10.4161/cc.19954; SOGAWA K, 1993, NUCLEIC ACIDS RES, V21, P1527, DOI 10.1093/nar/21.7.1527; Sur I, 2002, EUR J CELL BIOL, V81, P323, DOI 10.1078/0171-9335-00257; Suzuki T, 2009, J BIOL CHEM, V284, P9549, DOI 10.1074/jbc.M806230200; Takagi K, 2012, ENDOCR-RELAT CANCER, V19, P741, DOI 10.1530/ERC-12-0017; Tong D, 2006, CLIN CANCER RES, V12, P2442, DOI 10.1158/1078-0432.CCR-05-0964; Vega FM, 2008, FEBS LETT, V582, P2093, DOI 10.1016/j.febslet.2008.04.039; Wang C, 2015, ONCOTARGET; WOLF FW, 1994, J BIOL CHEM, V269, P3633; Xia HJ, 2013, J BIOL CHEM, V288, P26731, DOI 10.1074/jbc.M113.483958; Yang YZ, 2008, J BIOL CHEM, V283, P18812, DOI 10.1074/jbc.M801384200; Zhao D, 2012, CARCINOGENESIS, V33, P59, DOI 10.1093/carcin/bgr242; Zhao D, 2010, CANCER RES, V70, P4728, DOI 10.1158/0008-5472.CAN-10-0040; Zheng HQ, 2009, ONCOGENE, V28, P3702, DOI 10.1038/onc.2009.235; Zhu NX, 2006, J BIOL CHEM, V281, P14711, DOI 10.1074/jbc.M513810200	50	96	104	1	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 21	2016	35	16					2040	2051		10.1038/onc.2015.263	http://dx.doi.org/10.1038/onc.2015.263			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DJ9AH	26189798				2022-12-26	WOS:000374505600004
J	Deng, HY; Fung, G; Shi, JY; Xu, SW; Wang, C; Yin, MM; Hou, J; Zhang, JC; Jin, ZG; Luo, HL				Deng, Haoyu; Fung, Gabriel; Shi, Junyan; Xu, Suowen; Wang, Chen; Yin, Meimei; Hou, Jun; Zhang, Jingchun; Jin, Zheng-Gen; Luo, Honglin			Enhanced enteroviral infectivity via viral protease-mediated cleavage of Grb2-associated binder 1	FASEB JOURNAL			English	Article						coxsackievirus B3; viral protease 2A(pro); ERK1/2; signal transduction	GROWTH-FACTOR; COXSACKIEVIRUS; KINASE; GAB1; INHIBITION; RECEPTOR; ACTIVATION; APOPTOSIS; CYTOKINE; BINDING	Coxsackievirus B3 (CVB3), an important human causative pathogen for viral myocarditis, pancreatitis, and meningitis, has evolved different strategies to manipulate the host signaling machinery to ensure successful viral infection. We previously revealeda crucial role for the ERK1/2 signaling pathway in regulating viral infectivity. However, the detail mechanism remains largely unknown. Grb2-associated binder 1 (GAB1) is an important docking protein responsible for intracellular signaling assembly and transduction. In this study, we demonstrated that GAB1 was proteolytically cleaved after CVB3 infection at G175 and G436 by virus-encoded protease 2A(pro), independent of caspase activation. Knockdown of GAB1 resulted in a significant reduction of viral protein expression and virus titers. Moreover, we showed that virus-induced cleavage of GAB1 is beneficial to viral growth as the N-terminal proteolytic product of GAB1 (GAB1-N1-174) further enhances ERK1/2 activation and promotes viral replication. Our results collectively suggest that CVB3 targets host GAB1 to generate a GAB1-N1-174 fragment that enhances viral infectivity, at least in part, via activation of the ERK pathway. The findings in this study suggest a novel mechanism that CVB3 employs to subvert the host signaling and facilitate consequent viral replication.	[Deng, Haoyu; Fung, Gabriel; Shi, Junyan; Wang, Chen; Hou, Jun; Zhang, Jingchun; Luo, Honglin] St Pauls Hosp, Ctr Heart Lung Innovat, Vancouver, BC V6Z 1Y6, Canada; [Deng, Haoyu; Fung, Gabriel; Shi, Junyan; Wang, Chen; Hou, Jun; Zhang, Jingchun; Luo, Honglin] Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC V5Z 1M9, Canada; [Yin, Meimei; Jin, Zheng-Gen] Univ Rochester, Sch Med & Dent, Aab Cardiovasc Res Inst, Rochester, NY 14642 USA; [Xu, Suowen; Yin, Meimei; Jin, Zheng-Gen] Univ Rochester, Sch Med & Dent, Dept Med, Rochester, NY 14642 USA	St. Paul's Hospital; University of Saskatchewan; University of British Columbia; University of Rochester; University of Rochester	Luo, HL (corresponding author), St Pauls Hosp, Ctr Heart Lung Innovat, 1081 Burrard St, Vancouver, BC V6Z 1Y6, Canada.	zheng-gen_jin@urmc.rochester.edu; honglin.luo@hli.ubc.ca	Shi, Junyan/T-1777-2019; Yin, Meimei/I-8090-2016	Xu, Suowen/0000-0002-5488-5217	Canadian Institutes of Health Research [MOP-119274, CCI-125685]; U.S. National Institutes of Health National Heart, Lung, and Blood Institute [R01HL109502, R01HL114570]; American Diabetes Association [1-12-BS-92-R1]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL114570, R01HL109502] Funding Source: NIH RePORTER	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); U.S. National Institutes of Health National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Diabetes Association(American Diabetes Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by Canadian Institutes of Health Research Grants MOP-119274 and CCI-125685 to H.L., U.S. National Institutes of Health National Heart, Lung, and Blood Institute Grants R01HL109502 and R01HL114570 to Z.G.J., and American Diabetes Association Grant 1-12-BS-92-R1 to Z.G.J. The authors declare no conflicts of interest.	Cunnick JM, 2000, J BIOL CHEM, V275, P13842, DOI 10.1074/jbc.275.18.13842; Esfandiarei M, 2008, ANNU REV PATHOL-MECH, V3, P127, DOI 10.1146/annurev.pathmechdis.3.121806.151534; Eulenfeld R, 2009, J CELL SCI, V122, P55, DOI 10.1242/jcs.037226; Feng Q, 2014, J VIROL, V88, P3369, DOI 10.1128/JVI.02712-13; Fung G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079546; Gu HH, 2003, TRENDS CELL BIOL, V13, P122, DOI 10.1016/S0962-8924(03)00002-3; Itoh M, 2000, MOL CELL BIOL, V20, P3695, DOI 10.1128/MCB.20.10.3695-3704.2000; Jensen KJ, 2013, CELL HOST MICROBE, V13, P67, DOI 10.1016/j.chom.2012.11.009; Jones N, 1999, CURR BIOL, V9, P1057, DOI 10.1016/S0960-9822(99)80458-8; Kerekatte V, 1999, J VIROL, V73, P709, DOI 10.1128/JVI.73.1.709-717.1999; Kim SO, 2002, ENDOCRINOLOGY, V143, P4856, DOI 10.1210/en.2002-220565; Knowlton KU, 2008, CURR TOP MICROBIOL, V323, P315; Krebs JF, 1999, J CELL BIOL, V144, P915, DOI 10.1083/jcb.144.5.915; LAMPHEAR BJ, 1993, J BIOL CHEM, V268, P19200; Lim BK, 2013, J CLIN INVEST, V123, P5146, DOI 10.1172/JCI66271; Liu Y, 2002, FEBS LETT, V515, P1, DOI 10.1016/S0014-5793(02)02425-0; Luo HL, 2002, J VIROL, V76, P3365, DOI 10.1128/JVI.76.7.3365-3373.2002; Luo HH, 2010, CARDIOVASC RES, V85, P347, DOI 10.1093/cvr/cvp225; Marchant D, 2008, CURR TOP MICROBIOL, V323, P177; Maroun CR, 1999, MOL CELL BIOL, V19, P1784; Nakaoka Y, 2013, INT J INFLAMM, V2013, DOI 10.1155/2013/141068; Nishida K, 2003, CANCER SCI, V94, P1029, DOI 10.1111/j.1349-7006.2003.tb01396.x; Schroder WA, 2007, CELL SIGNAL, V19, P1279, DOI 10.1016/j.cellsig.2007.01.013; Shi J, 2014, CELL DEATH DIFFER, V21, P1432, DOI 10.1038/cdd.2014.58; Shi JY, 2013, AUTOPHAGY, V9, P1591, DOI 10.4161/auto.26059; Wang JP, 2010, J VIROL, V84, P254, DOI 10.1128/JVI.00631-09; Wang WY, 2015, INT J CARDIOL, V181, P180, DOI 10.1016/j.ijcard.2014.10.148; Weidner KM, 1996, NATURE, V384, P173, DOI 10.1038/384173a0; Wohrle FU, 2009, CELL COMMUN SIGNAL, V7, DOI 10.1186/1478-811X-7-22; Wong J, 2013, FASEB J, V27, P2777, DOI 10.1096/fj.12-226498; Wong J, 2012, CELL RES, V22, P360, DOI 10.1038/cr.2011.114; Yuan J, 2005, CELL DEATH DIFFER, V12, P1097, DOI 10.1038/sj.cdd.4401652	32	18	18	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2015	29	11					4523	4531		10.1096/fj.15-274829	http://dx.doi.org/10.1096/fj.15-274829			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CV8EZ	26183772	Green Published			2022-12-26	WOS:000364514700012
J	Sophocleous, A; Marino, S; Logan, JG; Mollat, P; Ralston, SH; Idris, AI				Sophocleous, Antonia; Marino, Silvia; Logan, John G.; Mollat, Patrick; Ralston, Stuart H.; Idris, Aymen I.			Bone Cell-autonomous Contribution of Type 2 Cannabinoid Receptor to Breast Cancer-induced Osteolysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FORMATION IN-VITRO; OSTEOCLAST FUNCTION; CB2; MASS; DIFFERENTIATION; INVOLVEMENT; OSTEOBLAST; STIMULATION; ACTIVATION; LIGANDS	The cannabinoid type 2 receptor (CB2) has previously been implicated as a regulator of tumor growth, bone remodeling, and bone pain. However, very little is known about the role of the skeletal CB2 receptor in the regulation of osteoblasts and osteoclasts changes associated with breast cancer. Here we found that the CB2-selective agonists HU308 and JWH133 reduced the viability of a variety of parental and bone-tropic human and mouse breast cancer cells at high micromolar concentrations. Under conditions in which these ligands are used at the nanomolar range, HU308 and JWH133 enhanced human and mouse breast cancer cell-induced osteoclastogenesis and exacerbated osteolysis, and these effects were attenuated in cultures obtained from CB2-deficient mice or in the presence of a CB2 receptor blocker. HU308 and JWH133 had no effects on osteoblast growth or differentiation in the presence of conditioned medium from breast cancer cells, but under these circumstances both agents enhanced parathyroid hormone-induced osteoblast differentiation and the ability to support osteoclast formation. Mechanistic studies in osteoclast precursors and osteoblasts showed that JWH133 and HU308 induced PI3K/AKT activity in a CB2-dependent manner, and these effects were enhanced in the presence of osteolytic and osteoblastic factors such as RANKL (receptor activator of NF kappa B ligand) and parathyroid hormone. When combined with published work, these findings suggest that breast cancer and bone cells exhibit differential responses to treatment with CB2 ligands depending upon cell type and concentration used. We, therefore, conclude that both CB2-selective activation and antagonism have potential efficacy in cancer-associated bone disease, but further studies are warranted and ongoing.	[Marino, Silvia; Idris, Aymen I.] Mellanby Ctr Bone Res, Dept Human Metab, Acad Unit Bone Biol, Sch Med, Sheffield S10 2RX, S Yorkshire, England; [Sophocleous, Antonia; Marino, Silvia; Logan, John G.; Idris, Aymen I.] Univ Edinburgh, Western Gen Hosp, Edinburgh Canc Res Ctr, Bone & Canc Grp, Edinburgh EH4 2XR, Midlothian, Scotland; [Sophocleous, Antonia; Logan, John G.; Ralston, Stuart H.] Univ Edinburgh, MRC Inst Genet & Mol Med, Ctr Genom & Expt Med, Rheumatol & Bone Dis Unit,Western Gen Hosp, Edinburgh EH4 2XU, Midlothian, Scotland; [Mollat, Patrick] Galapagos SASU, F-93230 Romainville, France	University of Edinburgh; University of Edinburgh; Galapagos NV	Idris, AI (corresponding author), Mellanby Ctr Bone Res, Dept Human Metab, Acad Unit Bone Biol, Sch Med, Beech Hill Rd, Sheffield S10 2RX, S Yorkshire, England.	aymen.idris@sheffield.ac.uk	Idris, Aymen I/AAX-1138-2020	Idris, Aymen I/0000-0003-4327-5306; Sophocleous, Antonia/0000-0003-0854-1429; Logan, John/0000-0003-2801-700X	European Calcified Tissue International Society/AMGEN (ECTS/AMGEN) fellowship; Arthritis Research UK [17713]; Versus Arthritis [17713] Funding Source: researchfish	European Calcified Tissue International Society/AMGEN (ECTS/AMGEN) fellowship; Arthritis Research UK(Versus Arthritis); Versus Arthritis(Versus Arthritis)	This work was supported in part by an European Calcified Tissue International Society/AMGEN (ECTS/AMGEN) fellowship grant (to A. I.) and a grant from the Arthritis Research UK (17713). Dr. A. I. Idris and Prof. S. H. Ralston are co-inventors on a patent claiming the use of cannabinoid receptor ligands as treatments for bone disease. Patrick Mollat is an employee of Galapagos SASU.	Aitken SJ, 2009, ARCH BIOCHEM BIOPHYS, V482, P96, DOI 10.1016/j.abb.2008.11.012; Bakker A., 2003, BONE RES PROTOCOLS, P183; Bhattacharjee R, 2009, BIOCHEM BIOPH RES CO, V382, P440, DOI 10.1016/j.bbrc.2009.03.044; Bifulco M, 2008, ENDOCR-RELAT CANCER, V15, P391, DOI 10.1677/ERC-07-0258; BOUABOULA M, 1995, BIOCHEM J, V312, P637, DOI 10.1042/bj3120637; Bouaboula M, 1996, EUR J BIOCHEM, V237, P704, DOI 10.1111/j.1432-1033.1996.0704p.x; Caffarel MM, 2008, ONCOGENE, V27, P5033, DOI 10.1038/onc.2008.145; Caffarel MM, 2012, CANCER TREAT REV, V38, P911, DOI 10.1016/j.ctrv.2012.06.005; Curto-Reyes V, 2010, BRIT J PHARMACOL, V160, P561, DOI 10.1111/j.1476-5381.2009.00629.x; Dhopeshwarkar A, 2014, MOL PHARMACOL, V86, P430, DOI 10.1124/mol.114.094649; Garret R., 2012, BONE RES PROTOCOLS, V816, P545; Grimaldi C, 2006, EXP CELL RES, V312, P363, DOI 10.1016/j.yexcr.2005.10.024; Guzman M, 2003, NAT REV CANCER, V3, P745, DOI 10.1038/nrc1188; Hart S, 2004, CANCER RES, V64, P1943, DOI 10.1158/0008-5472.CAN-03-3720; Idris AI, 2005, NAT MED, V11, P774, DOI 10.1038/nm1255; Idris AI, 2008, ENDOCRINOLOGY, V149, P5619, DOI 10.1210/en.2008-0150; Idris AI, 2008, CALCIFIED TISSUE INT, V82, P191, DOI 10.1007/s00223-008-9104-y; Idris AI, 2010, FASEB J, V24, P4545, DOI 10.1096/fj.10-164095; Idris AI, 2009, CELL METAB, V10, P139, DOI 10.1016/j.cmet.2009.07.006; Lozano-Ondoua AN, 2013, J BONE MINER RES, V28, P92, DOI 10.1002/jbmr.1732; Lozano-Ondoua AN, 2010, LIFE SCI, V86, P646, DOI 10.1016/j.lfs.2010.02.014; Lutz B, 2002, PROSTAG LEUKOTR ESS, V66, P123, DOI 10.1054/plef.2001.0342; Manera C, 2012, EUR J MED CHEM, V52, P284, DOI 10.1016/j.ejmech.2012.03.031; McKallip RJ, 2005, J IMMUNOL, V174, P3281, DOI 10.4049/jimmunol.174.6.3281; MUNSON AE, 1975, J NATL CANCER I, V55, P597, DOI 10.1093/jnci/55.3.597; Ofek O, 2006, P NATL ACAD SCI USA, V103, P696, DOI 10.1073/pnas.0504187103; Olea-Herrero N, 2009, BRIT J CANCER, V101, P940, DOI 10.1038/sj.bjc.6605248; Pertwee RG, 2002, PROSTAG LEUKOTR ESS, V66, P101, DOI 10.1054/plef.2001.0341; Ramer R, 2010, BIOCHEM PHARMACOL, V79, P955, DOI 10.1016/j.bcp.2009.11.007; Rhee MH, 1998, J NEUROCHEM, V71, P1525; Ross FP, 2006, ANN NY ACAD SCI, V1068, P110, DOI 10.1196/annals.1346.014; Sanchez MG, 2003, CELL SIGNAL, V15, P851, DOI 10.1016/S0898-6568(03)00036-6; Sarfaraz S, 2008, CANCER RES, V68, P339, DOI 10.1158/0008-5472.CAN-07-2785; Sophocleous A, 2014, CALCIFIED TISSUE INT, V94, P259, DOI 10.1007/s00223-013-9793-8; Sophocleous A, 2011, ENDOCRINOLOGY, V152, P2141, DOI 10.1210/en.2010-0930; Suda T, 1999, ENDOCR REV, V20, P345, DOI 10.1210/er.20.3.345; Tam J, 2006, MOL PHARMACOL, V70, P786, DOI 10.1124/mol.106.026435; Thomas RJ, 1999, ENDOCRINOLOGY, V140, P4451, DOI 10.1210/en.140.10.4451; Whyte LS, 2012, BRIT J PHARMACOL, V165, P2584, DOI 10.1111/j.1476-5381.2011.01519.x; Whyte LS, 2009, P NATL ACAD SCI USA, V106, P16511, DOI 10.1073/pnas.0902743106; Xian XS, 2010, J CELL BIOCHEM, V110, P321, DOI 10.1002/jcb.22540; Yamamoto T, 2007, BONE, V40, P354, DOI 10.1016/j.bone.2006.09.002; Zhu LX, 2000, J IMMUNOL, V165, P373, DOI 10.4049/jimmunol.165.1.373	43	26	26	2	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	2015	290	36					22049	22060		10.1074/jbc.M115.649608	http://dx.doi.org/10.1074/jbc.M115.649608			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CQ9XI	26195631	Green Published, hybrid			2022-12-26	WOS:000360968500024
J	Zheng, LJ; Farrell, DM; Fulton, RM; Bagg, EE; Salcedo, E; Manino, M; Britt, SG				Zheng, Lijun; Farrell, David M.; Fulton, Ruth M.; Bagg, Eve E.; Salcedo, Ernesto; Manino, Meridee; Britt, Steven G.			Analysis of Conserved Glutamate and Aspartate Residues in Drosophila Rhodopsin 1 and Their Influence on Spectral Tuning	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RETINYLIDENE SCHIFF-BASE; DOMINANT RETINITIS-PIGMENTOSA; SITE-DIRECTED MUTAGENESIS; VISUAL PIGMENTS; BOVINE RHODOPSIN; MOLECULAR-DYNAMICS; COUNTERION SWITCH; SQUID RHODOPSIN; INVERTEBRATE PHOTORECEPTORS; RETINAL CHROMOPHORE	The molecular mechanisms that regulate invertebrate visual pigment absorption are poorly understood. Studies of amphioxus G(o)-opsin have demonstrated that Glu-181 functions as the counterion in this pigment. This finding has led to the proposal that Glu-181 may function as the counterion in other invertebrate visual pigments as well. Here we describe a series of mutagenesis experiments to test this hypothesis and to also test whether other conserved acidic amino acids in Drosophila Rhodopsin 1 (Rh1) may serve as the counterion of this visual pigment. Of the 5 Glu and Asp residues replaced by Gln or Asn in our experiments, none of the mutant pigments shift the absorption of Rh1 by more than 6 nm. In combination with prior studies, these results suggest that the counterion in Drosophila Rh1 may not be located at Glu-181 as in amphioxus, or at Glu-113 as in bovine rhodopsin. Conversely, the extremely low steady state levels of the E194Q mutant pigment (bovine opsin site Glu-181), and the rhabdomere degeneration observed in flies expressing this mutant demonstrate that a negatively charged residue at this position is essential for normal rhodopsin function in vivo. This work also raises the possibility that another residue or physiologic anion may compensate for the missing counterion in the E194Q mutant.	[Zheng, Lijun; Fulton, Ruth M.; Bagg, Eve E.; Salcedo, Ernesto; Manino, Meridee; Britt, Steven G.] Univ Colorado, Sch Med, Dept Cell & Dev Biol, Aurora, CO 80045 USA; [Farrell, David M.] Univ Colorado, Sch Med, Dept Pharmacol, Aurora, CO 80045 USA; [Britt, Steven G.] Univ Colorado, Sch Med, Dept Ophthalmol, Aurora, CO 80045 USA; [Britt, Steven G.] Univ Colorado, Sch Med, Rocky Mt Lions Eye Inst, Aurora, CO 80045 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus	Britt, SG (corresponding author), Univ Colorado, Sch Med, Dept Cell & Dev Biol, Anschutz Med Campus, Aurora, CO 80045 USA.	steve.britt@ucdenver.edu	Britt, Steven/GVT-1340-2022	Britt, Steven/0000-0001-7656-7984	National Science Foundation [IOB-0449367]; National Eye Institute [R01-EY10759]; NATIONAL EYE INSTITUTE [R01EY010759] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by National Science Foundation Grant IOB-0449367 and National Eye Institute Grant R01-EY10759 (to S. G. B.). The authors declare that they have no conflicts of interest with the contents of this article.	Baudry J, 1997, J CHEM INF COMP SCI, V37, P1018, DOI 10.1021/ci9702398; Bennett-Lovsey RM, 2008, PROTEINS, V70, P611, DOI 10.1002/prot.21688; BUNGE S, 1993, GENOMICS, V17, P230, DOI 10.1006/geno.1993.1309; Chang HY, 2000, SCIENCE, V290, P1978, DOI 10.1126/science.290.5498.1978; Chou WH, 1999, DEVELOPMENT, V126, P607; COLLEY NJ, 1991, CELL, V67, P255, DOI 10.1016/0092-8674(91)90177-Z; COLLEY NJ, 1995, P NATL ACAD SCI USA, V92, P3070, DOI 10.1073/pnas.92.7.3070; Condon D, 2005, SCIENCE, V308, P95, DOI 10.1126/science.1107765; DECALUWE GLJ, 1995, BIOPHYS CHEM, V56, P79, DOI 10.1016/0301-4622(95)00018-S; DECOUET HG, 1987, EUR J CELL BIOL, V44, P50; DRYJA TP, 1991, P NATL ACAD SCI USA, V88, P9370, DOI 10.1073/pnas.88.20.9370; Erwin DH, 2002, DEVELOPMENT, V129, P3021; Fain GL, 2010, CURR BIOL, V20, pR114, DOI 10.1016/j.cub.2009.12.006; Fasick JI, 1998, BIOCHEMISTRY-US, V37, P433, DOI 10.1021/bi972500j; FEILER R, 1992, J NEUROSCI, V12, P3862; FEILER R, 1988, NATURE, V333, P737, DOI 10.1038/333737a0; Fisher CL, 1997, BIOTECHNIQUES, V23, P570, DOI 10.2144/97234bm01; Gille C, 2001, BIOINFORMATICS, V17, P377, DOI 10.1093/bioinformatics/17.4.377; GOMEZ MD, 1995, NEURON, V15, P607, DOI 10.1016/0896-6273(95)90149-3; GOMEZ MD, 1994, J GEN PHYSIOL, V103, P939, DOI 10.1085/jgp.103.6.939; Gomez MD, 2000, J NEUROSCI, V20, P5254, DOI 10.1523/JNEUROSCI.20-14-05254.2000; Hankins MW, 2008, TRENDS NEUROSCI, V31, P27, DOI 10.1016/j.tins.2007.11.002; Hardie RC, 2001, NATURE, V413, P186, DOI 10.1038/35093002; Hayashi S, 2000, J PHYS CHEM B, V104, P10678, DOI 10.1021/jp001508r; Hofmann KP, 2009, TRENDS BIOCHEM SCI, V34, P540, DOI 10.1016/j.tibs.2009.07.005; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; JANSSEN JJM, 1990, FEBS LETT, V260, P113, DOI 10.1016/0014-5793(90)80080-3; KARESS RE, 1984, CELL, V38, P135, DOI 10.1016/0092-8674(84)90534-8; Kelley LA, 2000, J MOL BIOL, V299, P499, DOI 10.1006/jmbi.2000.3741; KIRSCHFELD K, 1977, BIOPHYS STRUCT MECH, V3, P191, DOI 10.1007/BF00535818; Kochendoerfer GG, 1999, TRENDS BIOCHEM SCI, V24, P300, DOI 10.1016/S0968-0004(99)01432-2; KOUTALOS Y, 1989, BIOCHEMISTRY-US, V28, P2732, DOI 10.1021/bi00432a055; Kumar JP, 1995, DEVELOPMENT, V121, P4359; Kusnetzow AK, 2004, P NATL ACAD SCI USA, V101, P941, DOI 10.1073/pnas.0305206101; Lewis JW, 2004, BIOCHEMISTRY-US, V43, P12614, DOI 10.1021/bi049581l; Murakami M, 2008, NATURE, V453, P363, DOI 10.1038/nature06925; Murakami M, 2007, ACTA CRYSTALLOGR F, V63, P475, DOI 10.1107/S1744309107017423; Nagata T, 1998, BIOCHEMISTRY-US, V37, P17216, DOI 10.1021/bi9810149; Nagata T, 2002, J PHYS CHEM A, V106, P1969, DOI 10.1021/jp0124488; NAKAYAMA TA, 1991, J BIOL CHEM, V266, P4269; NATHANS J, 1990, BIOCHEMISTRY-US, V29, P937, DOI 10.1021/bi00456a013; Nathans J, 1999, NEURON, V24, P299, DOI 10.1016/S0896-6273(00)80845-4; NATHANS J, 1990, BIOCHEMISTRY-US, V29, P9746, DOI 10.1021/bi00493a034; Nickle B, 2007, CELL MOL LIFE SCI, V64, P2917, DOI 10.1007/s00018-007-7253-1; NINA M, 1995, BIOPHYS J, V68, P25, DOI 10.1016/S0006-3495(95)80184-0; Okada T, 2004, J MOL BIOL, V342, P571, DOI 10.1016/j.jmb.2004.07.044; OPRIAN DD, 1987, P NATL ACAD SCI USA, V84, P8874, DOI 10.1073/pnas.84.24.8874; OSTROY SE, 1978, J GEN PHYSIOL, V72, P717, DOI 10.1085/jgp.72.5.717; OTOUSA JE, 1985, CELL, V40, P839, DOI 10.1016/0092-8674(85)90343-5; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Porter ML, 2007, MOL BIOL EVOL, V24, P253, DOI 10.1093/molbev/msl152; Porter ML, 2012, P ROY SOC B-BIOL SCI, V279, P3, DOI 10.1098/rspb.2011.1819; Ramos LS, 2007, BIOCHEMISTRY-US, V46, P5330, DOI 10.1021/bi700138g; SAGA M, 1994, OPHTHALMIC GENET, V15, P61, DOI 10.3109/13816819409098865; SAKMAR TP, 1989, P NATL ACAD SCI USA, V86, P8309, DOI 10.1073/pnas.86.21.8309; Salcedo E, 1999, J NEUROSCI, V19, P10716, DOI 10.1523/JNEUROSCI.19-24-10716.1999; Salcedo E, 2003, J NEUROSCI, V23, P10873; Salcedo E, 2009, J BIOL CHEM, V284, P5717, DOI 10.1074/jbc.M807368200; Sekharan S, 2010, CHEM-EUR J, V16, P1744, DOI 10.1002/chem.200903194; Sekharan S, 2009, PHOTOCHEM PHOTOBIOL, V85, P517, DOI 10.1111/j.1751-1097.2008.00499.x; Shichida Y, 2009, PHILOS T R SOC B, V364, P2881, DOI 10.1098/rstb.2009.0051; Smith SO, 2010, ANNU REV BIOPHYS, V39, P309, DOI 10.1146/annurev-biophys-101209-104901; Tajkhorshid E, 1999, J PHYS CHEM B, V103, P5581, DOI 10.1021/jp983742b; Tajkhorshid E, 2000, BIOPHYS J, V78, P683, DOI 10.1016/S0006-3495(00)76626-4; Tajkhorshid E, 1997, J PHYS CHEM B, V101, P8021, DOI 10.1021/jp971283t; Takahashi Y, 2003, BIOCHEMISTRY-US, V42, P6025, DOI 10.1021/bi020629+; Terakita A, 2004, NAT STRUCT MOL BIOL, V11, P284, DOI 10.1038/nsmb731; Terakita A, 2000, P NATL ACAD SCI USA, V97, P14263, DOI 10.1073/pnas.260349597; To K, 2000, AM J OPHTHALMOL, V130, P790, DOI 10.1016/S0002-9394(00)00559-6; VANDERMEER JM, 1983, DEV BIOL, V95, P249, DOI 10.1016/0012-1606(83)90025-8; WANG ZY, 1993, BIOCHEMISTRY-US, V32, P2125, DOI 10.1021/bi00060a001; WEINER MP, 1994, GENE, V151, P119, DOI 10.1016/0378-1119(94)90641-6; Yamashita T, 2013, BIOCHEMISTRY-US, V52, P1192, DOI 10.1021/bi3016058; Yan ECY, 2003, P NATL ACAD SCI USA, V100, P9262, DOI 10.1073/pnas.1531970100; Yan ECY, 2002, BIOCHEMISTRY-US, V41, P3620, DOI 10.1021/bi0160011; Zhang L, 1996, PROTEINS, V24, P433, DOI 10.1002/(SICI)1097-0134(199604)24:4<433::AID-PROT3>3.0.CO;2-F; ZHUKOVSKY EA, 1989, SCIENCE, V246, P928, DOI 10.1126/science.2573154; ZUKER CS, 1985, CELL, V40, P851, DOI 10.1016/0092-8674(85)90344-7	79	7	7	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	2015	290	36					21951	21961		10.1074/jbc.M115.677765	http://dx.doi.org/10.1074/jbc.M115.677765			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CQ9XI	26195627	hybrid, Green Published			2022-12-26	WOS:000360968500016
J	Kegler, K; Spitzbarth, I; Imbschweiler, I; Wewetzer, K; Baumgartner, W; Seehusen, F				Kegler, Kristel; Spitzbarth, Ingo; Imbschweiler, Ilka; Wewetzer, Konstantin; Baumgaertner, Wolfgang; Seehusen, Frauke			Contribution of Schwann Cells to Remyelination in a Naturally Occurring Canine Model of CNS Neuroinflammation	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; NEUROTROPHIN RECEPTOR EXPRESSION; OLFACTORY ENSHEATHING CELLS; SPINAL-CORD; MULTIPLE-SCLEROSIS; NEURAL CREST; DISTEMPER VIRUS; GROWTH-FACTOR; GRANULOMATOUS MENINGOENCEPHALOMYELITIS; MONOCLONAL-ANTIBODIES	Gliogenesis under pathophysiological conditions is of particular clinical relevance since it may provide evidence for regeneration promoting cells recruitable for therapeutic purposes. There is evidence that neurotrophin receptor p75 (p75NTR)-expressing cells emerge in the lesioned CNS. However, the phenotype and identity of these cells, and signals triggering their in situ generation under normal conditions and certain pathological situations has remained enigmatic. In the present study, we used a spontaneous, idiopathic and inflammatory CNS condition in dogs with prominent lympho-histiocytic infiltration as a model to study the phenotype of Schwann cells and their relation to Schwann cell remyelination within the CNS. Furthermore, the phenotype of p75NTR-expressing cells within the injured CNS was compared to their counter-part in control sciatic nerve and after peripheral nerve injury. In addition, organotypic slice cultures were used to further elucidate the origin of p75NTR-positive cells. In cerebral and cerebellar white and grey matter lesions as well as in the brain stem, p75NTR-positive cells co-expressed the transcription factor Sox2, but not GAP-43, GFAP, Egr2/Krox20, periaxin and PDGFR-a. Interestingly, and contrary to the findings in control sciatic nerves, p75NTR-expressing cells only co-localized with Sox2 in degenerative neuropathy, thus suggesting that such cells might represent dedifferentiated Schwann cells both in the injured CNS and PNS. Moreover, effective Schwann cell remyelination represented by periaxin-and P0-positive mature myelinating Schwann cells, was strikingly associated with the presence of p75NTR/Sox2-expressing Schwann cells. Intriguingly, the emergence of dedifferentiated Schwann cells was not affected by astrocytes, and a macrophage-dominated inflammatory response provided an adequate environment for Schwann cells plasticity within the injured CNS. Furthermore, axonal damage was reduced in brain stem areas with p75(NTR)/Sox2-positive cells. This study provides novel insights into the involvement of Schwann cells in CNS remyelination under natural occurring CNS inflammation. Targeting p75(NTR)/Sox2-expressing Schwann cells to enhance their differentiation into competent remyelinating cells appears to be a promising therapeutic approach for inflammatory/demyelinating CNS diseases.	[Kegler, Kristel; Spitzbarth, Ingo; Imbschweiler, Ilka; Baumgaertner, Wolfgang; Seehusen, Frauke] Univ Vet Med, Dept Pathol, Hannover, Germany; [Kegler, Kristel; Spitzbarth, Ingo; Wewetzer, Konstantin; Baumgaertner, Wolfgang] Ctr Syst Neurosci, Hannover, Germany; [Wewetzer, Konstantin] Hannover Med Sch, Ctr Anat, Dept Funct & Appl Anat, Hannover, Germany	University of Veterinary Medicine Hannover, Foundation; Hannover Medical School	Baumgartner, W (corresponding author), Univ Vet Med, Dept Pathol, Hannover, Germany.	wolfgang.baumgaertner@tiho-hannover.de	Seehusen, Frauke/Q-8192-2018	Seehusen, Frauke/0000-0001-6701-7868	Deutscher Akademischer Austauschdienst (DAAD, Germany); German Research Foundation [FOR1103, BA815/10-2, BA815/9-1, WE1617/6-1, UL 421/12]	Deutscher Akademischer Austauschdienst (DAAD, Germany)(Deutscher Akademischer Austausch Dienst (DAAD)); German Research Foundation(German Research Foundation (DFG))	KK received financial support from Deutscher Akademischer Austauschdienst (DAAD, Germany). This study was in part supported by the German Research Foundation (FOR1103: grant BA815/10-2, BA815/9-1, WE1617/6-1 and UL 421/12). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], [No title captured]; ANTON ES, 1994, P NATL ACAD SCI USA, V91, P2795, DOI 10.1073/pnas.91.7.2795; Aranami Toshimasa, 2008, Allergol Int, V57, P115, DOI 10.2332/allergolint.R-07-159; ARCHELOS JJ, 1993, J NEUROSCI RES, V35, P46, DOI 10.1002/jnr.490350107; Arthur-Farraj PJ, 2012, NEURON, V75, P633, DOI 10.1016/j.neuron.2012.06.021; Barber RM, 2012, J VET INTERN MED, V26, P962, DOI 10.1111/j.1939-1676.2012.00954.x; Barnett MH, 2006, MULT SCLER, V12, P121, DOI 10.1191/135248506ms1304rr; BLAKEMORE WF, 1975, J NEUROCYTOL, V4, P745, DOI 10.1007/BF01181634; Blakemore WF, 2005, NEUROPATH APPL NEURO, V31, P1, DOI 10.1111/j.1365-2990.2005.00637.x; Buss A, 2007, BRAIN, V130, P940, DOI 10.1093/brain/awl374; Chang A, 2000, J NEUROSCI, V20, P6404, DOI 10.1523/JNEUROSCI.20-17-06404.2000; Cimadamore F, 2011, CELL STEM CELL, V8, P538, DOI 10.1016/j.stem.2011.03.011; Cotman CW, 2008, J ALZHEIMERS DIS, V15, P685; Crawford AH, 2013, J COMP PATHOL, V149, P242, DOI 10.1016/j.jcpa.2013.05.004; CURTIS R, 1992, J CELL BIOL, V116, P1455, DOI 10.1083/jcb.116.6.1455; Czasch S, 2006, NEUROBIOL AGING, V27, P293, DOI 10.1016/j.neurobiolaging.2005.02.017; Dowling P, 1999, NEUROLOGY, V53, P1676, DOI 10.1212/WNL.53.8.1676; Duncan ID, 1997, J ANAT, V190, P35, DOI 10.1046/j.1469-7580.1997.19010035.x; DUSART I, 1992, NEUROSCIENCE, V51, P137, DOI 10.1016/0306-4522(92)90478-K; Franklin R.J.M., 2013, MYELIN REPAIR NEUROP, P71, DOI 10.1007/978-1-4614-2218-1_4; FRANKLIN RJM, 1993, INT J DEV NEUROSCI, V11, P641, DOI 10.1016/0736-5748(93)90052-F; Franklin RJM, 2008, NAT REV NEUROSCI, V9, P839, DOI 10.1038/nrn2480; Franklin RJM, 2014, GLIA, V62, P1905, DOI 10.1002/glia.22622; Geuna Stefano, 2010, Italian Journal of Anatomy and Embryology, V115, P91; GILLESPIE CS, 1994, NEURON, V12, P497, DOI 10.1016/0896-6273(94)90208-9; Gilmore S. A., 1995, P829; Gudino-Cabrera G, 1999, J NEUROBIOL, V40, P458, DOI 10.1002/(SICI)1097-4695(19990915)40:4<458::AID-NEU4>3.0.CO;2-9; Gudino-Cabrera G, 2000, GLIA, V30, P49, DOI 10.1002/(SICI)1098-1136(200003)30:1<49::AID-GLIA6>3.0.CO;2-M; HARRISON BM, 1987, BRAIN RES, V409, P163, DOI 10.1016/0006-8993(87)90754-2; HARRISON BM, 1980, J NEUROL SCI, V46, P63, DOI 10.1016/0022-510X(80)90044-1; Hauser SL, 2006, NEURON, V52, P61, DOI 10.1016/j.neuron.2006.09.011; HEIMRICH B, 1993, HIPPOCAMPUS, V3, P11; Imbschweiler I, 2012, GLIA, V60, P358, DOI 10.1002/glia.22270; ITOYAMA Y, 1985, ACTA NEUROPATHOL, V65, P217, DOI 10.1007/BF00687001; ITOYAMA Y, 1983, ANN NEUROL, V14, P339, DOI 10.1002/ana.410140313; Iwashita Y, 2000, EXP NEUROL, V164, P292, DOI 10.1006/exnr.2000.7440; Iwashita Y, 2000, GLIA, V31, P232, DOI 10.1002/1098-1136(200009)31:3<232::AID-GLIA40>3.0.CO;2-8; Jeffery ND, 2005, J NEUROTRAUM, V22, P1282, DOI 10.1089/neu.2005.22.1282; Jessen KR, 2005, NAT REV NEUROSCI, V6, P671, DOI 10.1038/nrn1746; JESSEN KR, 1990, DEVELOPMENT, V109, P91; Jessen KR, 2008, GLIA, V56, P1552, DOI 10.1002/glia.20761; Joseph NM, 2004, DEVELOPMENT, V131, P5599, DOI 10.1242/dev.01429; Kegler K, 2014, J NEURAL TRANSM, V121, P569, DOI 10.1007/s00702-014-1163-9; Kioke T, 2014, HISTOCHEM CELL BIOL, V141, P301, DOI 10.1007/s00418-013-1158-x; Kipar A, 1998, VET PATHOL, V35, P43, DOI 10.1177/030098589803500104; Koeppen AH, 2004, J NEUROL SCI, V220, P115, DOI 10.1016/j.jns.2004.03.008; Lavdas AA, 2008, CURR MED CHEM, V15, P151; Le N, 2005, P NATL ACAD SCI USA, V102, P2596, DOI 10.1073/pnas.0407836102; Lee HJ, 2013, J NEUROSCI RES, V91, P196, DOI 10.1002/jnr.23151; Lutz AB, 2014, DEV CELL, V28, P7, DOI 10.1016/j.devcel.2013.12.002; Miron VE, 2014, J NEUROCHEM, V130, P165, DOI 10.1111/jnc.12705; Miron VE, 2013, NAT NEUROSCI, V16, P1211, DOI 10.1038/nn.3469; Nagoshi N, 2011, GLIA, V59, P771, DOI 10.1002/glia.21150; Omar M, 2011, CELL TISSUE RES, V344, P391, DOI 10.1007/s00441-011-1168-8; Orlando EA, 2008, NEUROPATH APPL NEURO, V34, P621, DOI 10.1111/j.1365-2990.2008.00958.x; Park ES, 2013, VET PATHOL, V50, P1127, DOI 10.1177/0300985813488957; Park ES, 2012, VET PATHOL, V49, P682, DOI 10.1177/0300985811429311; Parrinello S, 2010, CELL, V143, P145, DOI 10.1016/j.cell.2010.08.039; PERRY VH, 1995, EUR J NEUROSCI, V7, P271, DOI 10.1111/j.1460-9568.1995.tb01063.x; Petratos S, 2004, GLIA, V48, P64, DOI 10.1002/glia.20056; Poduslo JF, 1993, PERIPHERAL NEUROPATH, P282; Powers BE, 2013, P NATL ACAD SCI USA, V110, P4075, DOI 10.1073/pnas.1210293110; Richner M, 2014, MOL NEUROBIOL, V50, P945, DOI 10.1007/s12035-014-8706-9; Salzer JL, 2008, J CELL BIOL, V181, P575, DOI 10.1083/jcb.200804136; Scherer SS, 1995, DEVELOPMENT, V121, P4265; Schwab S, 2007, J COMP PATHOL, V136, P96, DOI 10.1016/j.jcpa.2006.11.006; Seehusen F, 2007, ACTA NEUROPATHOL, V114, P597, DOI 10.1007/s00401-007-0307-5; Seehusen F, 2010, BRAIN PATHOL, V20, P551, DOI 10.1111/j.1750-3639.2009.00332.x; Sim FJ, 2002, MOL CELL NEUROSCI, V20, P669, DOI 10.1006/mcne.2002.1145; Skripuletz T, 2013, BRAIN, V136, P147, DOI 10.1093/brain/aws262; Smith PM, 2002, EXP NEUROL, V176, P402, DOI 10.1006/exnr.2002.7936; SNYDER DH, 1975, J NEUROPATH EXP NEUR, V34, P209, DOI 10.1097/00005072-197505000-00001; Spitzbarth I, 2015, BRAIN RES, V1595, P29, DOI 10.1016/j.brainres.2014.11.027; Spitzbarth I, 2011, J NEUROPATH EXP NEUR, V70, P703, DOI 10.1097/NEN.0b013e3182270f8e; STEMPLE DL, 1991, NEUROSCI LETT, V124, P57, DOI 10.1016/0304-3940(91)90821-A; Talarico LR, 2010, J SMALL ANIM PRACT, V51, P138, DOI 10.1111/j.1748-5827.2009.00823.x; Techangamsuwan S, 2008, BRAIN RES, V1240, P31, DOI 10.1016/j.brainres.2008.08.092; TOPILKO P, 1994, NATURE, V371, P796, DOI 10.1038/371796a0; Ulrich R, 2014, GLIA, V62, P1559, DOI 10.1002/glia.22700; Wakamatsu Y, 2004, DEV DYNAM, V229, P74, DOI 10.1002/dvdy.10498; Weidner N, 1999, J COMP NEUROL, V413, P495, DOI 10.1002/(SICI)1096-9861(19991101)413:4<495::AID-CNE1>3.0.CO;2-Z; Wewetzer K, 1997, GLIA, V19, P213, DOI 10.1002/(SICI)1098-1136(199703)19:3<213::AID-GLIA4>3.0.CO;2-#; Wewetzer K, 2011, EXP NEUROL, V229, P80, DOI 10.1016/j.expneurol.2010.08.029; Woodhoo A, 2008, GLIA, V56, P1481, DOI 10.1002/glia.20723; Young KM, 2007, J NEUROSCI, V27, P5146, DOI 10.1523/JNEUROSCI.0654-07.2007; Zawadzka M, 2010, CELL STEM CELL, V6, P578, DOI 10.1016/j.stem.2010.04.002; Zujovic V, 2013, MYELIN REPAIR AND NE, P129; Zujovic V, 2007, NEUROSCIENTIST, V13, P383, DOI 10.1177/10738584070130041001	88	15	15	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0133916	10.1371/journal.pone.0133916	http://dx.doi.org/10.1371/journal.pone.0133916			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LZ	26196511	Green Published, gold, Green Submitted			2022-12-26	WOS:000358547600148
J	Tanaka, K; Ogata, K; Mukai, H; Yamawo, A; Tokuda, M				Tanaka, Koki; Ogata, Kanako; Mukai, Hiromi; Yamawo, Akira; Tokuda, Makoto			Adaptive Advantage of Myrmecochory in the Ant-Dispersed Herb Lamium amplexicaule (Lamiaceae): Predation Avoidance through the Deterrence of Post-Dispersal Seed Predators	PLOS ONE			English	Article							DIRECTED-DISPERSAL; DECIDUOUS FOREST; MATERNAL-CARE; BURROWER BUG; CONSEQUENCES; PLANT; MUTUALISM; FATE; RECRUITMENT; REDISPERSAL	Seed dispersal by ants (myrmecochory) is found worldwide, but the benefits that plants obtain from this mutualism remain uncertain. In the present study, we conducted laboratory experiments to demonstrate seed predator avoidance as a benefit of myrmecochory using the annual ant-dispersed herb Lamium amplexicaule, the disperser ant Tetramorium tsushimae, and the seed predatory burrower bug Adomerus rotundus. We compared the predation intensity of Lamium amplexicaule seeds by Adomerus rotundus under the presence or absence of Tetramorium tsushimae. Both the number of seeds sucked by Adomerus rotundus adults and the feeding duration of sucked seeds by nymphs were significantly reduced in the presence of ants. This effect was most likely due to the behavioral alteration of Adomerus rotundus in response to the ant presence, because ants seldom predated Adomerus rotundus during the experiment. Our results demonstrated that the presence of ants decreases post-dispersal seed predation, even when the ants do not bury the seeds. The present study thus suggests that the non-consumptive effects of ants on seed predators benefit myrmecochorous plants.	[Tanaka, Koki; Ogata, Kanako; Tokuda, Makoto] Saga Univ, Fac Agr, Saga 840, Japan; [Tanaka, Koki] Kagoshima Univ, United Grad Sch Agr Sci, Kagoshima 890, Japan; [Mukai, Hiromi] Forestry & Forest Prod Res Inst, Ibaraki, Japan; [Yamawo, Akira] Hirosaki Univ, Fac Agr & Life Sci, Hirosaki, Aomori, Japan	Saga University; Kagoshima University; Forestry & Forest Products Research Institute - Japan; Hirosaki University	Tanaka, K (corresponding author), Saga Univ, Fac Agr, Saga 840, Japan.	koukin817@gmail.com		Tokuda, Makoto/0000-0001-7162-0715	Sasakawa Scientific Research Grant; Grants-in-Aid for Scientific Research [15K18611] Funding Source: KAKEN	Sasakawa Scientific Research Grant; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was funded by Sasakawa Scientific Research Grant (http://www.jss.or.jp/ikusel/sasakawa/, KT, in data collection).	ABRAMS PA, 1995, AM NAT, V146, P112, DOI 10.1086/285789; Canner JE, 2012, ACTA OECOL, V40, P31, DOI 10.1016/j.actao.2012.02.004; Christian CE, 2001, NATURE, V413, P635, DOI 10.1038/35098093; Clinchy M, 2013, FUNCT ECOL, V27, P56, DOI 10.1111/1365-2435.12007; CULVER DC, 1980, AM J BOT, V67, P710, DOI 10.2307/2442664; Dangles O, 2009, Q REV BIOL, V84, P51, DOI 10.1086/596463; Depieri RA, 2011, NEOTROP ENTOMOL, V40, P197, DOI 10.1590/S1519-566X2011000200007; Do Bae S, 2014, J ASIA-PAC ENTOMOL, V17, P477, DOI 10.1016/j.aspen.2014.04.006; Fischer RC, 2008, OECOLOGIA, V155, P539, DOI 10.1007/s00442-007-0931-8; Freitas AVL, 1996, J ANIM ECOL, V65, P205, DOI 10.2307/5723; Gammans N, 2006, J CHEM ECOL, V32, P1935, DOI 10.1007/s10886-006-9119-7; GIBSON W, 1993, OIKOS, V67, P334, DOI 10.2307/3545480; Giladi I, 2006, OIKOS, V112, P481, DOI 10.1111/j.0030-1299.2006.14258.x; Gorb, 2003, SEED DISPERSAL ANTS; Gorb SN, 2000, ACTA OECOL, V21, P293, DOI 10.1016/S1146-609X(00)01081-X; Halpern SL, 2005, AM J BOT, V92, P205, DOI 10.3732/ajb.92.2.205; HANDEL SN, 1978, EVOLUTION, V32, P151, DOI 10.1111/j.1558-5646.1978.tb01105.x; HANDEL SN, 1990, SCI AM, V263, P76, DOI 10.1038/scientificamerican0890-76; HANZAWA FM, 1988, AM NAT, V131, P1, DOI 10.1086/284769; HEITHAUS ER, 1981, ECOLOGY, V62, P136, DOI 10.2307/1936677; HUGHES L, 1992, ECOLOGY, V73, P1285, DOI 10.2307/1940676; Inadomi K, 2014, CAN ENTOMOL, V146, P211, DOI 10.4039/tce.2013.69; Ishikawa T, 2012, FIELD GUIDE JAPANESE, P445; Japanese Ant Database Group, 2008, JAP ANT IM DAT; KJELLSSON G, 1991, OECOLOGIA, V88, P435, DOI 10.1007/BF00317590; Leal IR, 2015, BIOTROPICA, V47, P281, DOI 10.1111/btp.12213; Lengyel S, 2010, PERSPECT PLANT ECOL, V12, P43, DOI 10.1016/j.ppees.2009.08.001; Lobo D, 2011, NEOTROP ENTOMOL, V40, P440, DOI 10.1590/S1519-566X2011000400005; Lonnberg K, 2013, PLANT BIOLOGY, V15, P601, DOI 10.1111/j.1438-8677.2012.00676.x; Manzaneda AJ, 2005, ECOGRAPHY, V28, P583, DOI 10.1111/j.2005.0906-7590.04309.x; Manzaneda AJ, 2012, ECOGRAPHY, V35, P322, DOI 10.1111/j.1600-0587.2011.06923.x; Mukai H, 2012, ANIM BEHAV, V84, P1443, DOI 10.1016/j.anbehav.2012.09.012; Nakahira T, 2008, J INSECT BEHAV, V21, P306, DOI 10.1007/s10905-008-9129-0; Nakamura H., 2006, Journal of the Japanese Forest Society, V88, P141, DOI 10.4005/jjfs.88.141; Offenberg J, 2004, P ROY SOC B-BIOL SCI, V271, pS433, DOI 10.1098/rsbl.2004.0210; Ohnishi YK, 2013, PLANT ECOL, V214, P907, DOI 10.1007/s11258-013-0217-7; Ohnishi YK, 2011, POPUL ECOL, V53, P441, DOI 10.1007/s10144-010-0247-0; R Core Team, 2021, R LANGUAGE ENV STAT; Rudgers JA, 2003, OECOLOGIA, V135, P51, DOI 10.1007/s00442-002-1168-1; Ruhren S, 1996, AM J BOT, V83, P633, DOI 10.2307/2445923; Saska P, 2008, B ENTOMOL RES, V98, P169, DOI 10.1017/S0007485307005512; Satake Y, 1985, WILD FLOWERS JAPAN; Sernander R., 1906, KGL SVENSK VETENSK, V41, P1; Spiegel O, 2010, ECOLOGY, V91, P1538, DOI 10.1890/09-1166.1; TURNBULL CL, 1983, OECOLOGIA, V59, P360, DOI 10.1007/BF00378862; Van Mele P, 2009, PHYSIOL ENTOMOL, V34, P256, DOI 10.1111/j.1365-3032.2009.00685.x; Vaughton G, 1998, J ECOL, V86, P563, DOI 10.1046/j.1365-2745.1998.00279.x; Youngsteadt E, 2008, P NATL ACAD SCI USA, V105, P4571, DOI 10.1073/pnas.0708643105; Zuur Alain F., 2009, P1	49	9	9	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0133677	10.1371/journal.pone.0133677	http://dx.doi.org/10.1371/journal.pone.0133677			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LZ	26197397	Green Published, gold, Green Submitted			2022-12-26	WOS:000358547600133
J	Yuan, YH; Wen, Y; You, YG; Xing, Y; Li, HY; Weng, XM; Wu, N; Liu, S; Zhang, SS; Zhang, WH; Zhang, Y				Yuan, Youhua; Wen, Yan; You, Yuangang; Xing, Yan; Li, Huanying; Weng, Xiaoman; Wu, Nan; Liu, Shuang; Zhang, Shanshan; Zhang, Wenhong; Zhang, Ying			Characterization of Mycobacterium leprae Genotypes in China-Identification of a New Polymorphism C251T in the 16S rRNA Gene	PLOS ONE			English	Article							LEPROSY PATIENTS; LEPROMATOSIS; TRANSMISSION; EPIDEMIOLOGY; COUNTRIES; REVEALS; REGIONS; MEXICO	Leprosy continues to be prevalent in some mountainous regions of China, and genotypes of leprosy strains endemic to the country are not known. Mycobacterium lepromatosis is a new species that was discovered in Mexico in 2008, and it remains unclear whether this species exists in China. Here, we conducted PCR-restriction fragment length polymorphism (RFLP) analysis to classify genotypes of 85 DNA samples collected from patients from 18 different provinces. All 171 DNA samples from skin biopsies of leprosy patients were tested for the presence of Mycobacterium leprae and Mycobacterium lepromatosis by amplifying the 16S rRNA gene using nested PCR, followed by DNA sequencing. The new species M. lepromatosis was not found among the 171 specimens from leprosy patients in 22 provinces in China. However, we found three SNP genotypes among 85 leprosy patients. A mutation at C251T in the 16S rRNA gene was found in 76% of the strains. We also found that the strains that showed the 16S rRNA C251T mutation belonged to SNP type 3, whereas strains without the point mutation belonged to SNP type 1. The SNP type 3 leprosy strains were observed in patients from both the inner and coastal regions of China, but the SNP type 1 strains were focused only in the coastal region. This indicated that the SNP type 3 leprosy strains were more prevalent than the SNP type 1 strains in China. In addition, the 16S rRNA gene sequence mutation at C251T also indicated a difference in the geographical distribution of the strains. To our knowledge, this is the first report of a new polymorphism in 16S rRNA gene in M. leprae in China. Our findings shed light on the prevalent genotypes and provide insight about leprosy transmission that are important for leprosy control in China.	[Yuan, Youhua; Wu, Nan; Liu, Shuang; Zhang, Shanshan; Zhang, Wenhong; Zhang, Ying] Fudan Univ, Huashan Hosp, Shanghai Med Coll, Dept Infect Dis,Key Lab Med Virol, Shanghai 200433, Peoples R China; [Wen, Yan; You, Yuangang; Xing, Yan; Li, Huanying; Weng, Xiaoman] Capital Med Univ, Beijing Friendship Hosp, Beijing Trop Med Res Inst, Beijing, Peoples R China; [Zhang, Ying] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Mol Microbiol & Immunol, Baltimore, MD USA	Fudan University; Capital Medical University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Wen, Y (corresponding author), Capital Med Univ, Beijing Friendship Hosp, Beijing Trop Med Res Inst, Beijing, Peoples R China.	weny8@163.com; yzhang@jhsph.edu			Key Technologies Research and Development Program of China [2011ZX09102-008, 2013ZX10003008-003]; Shanghai Science and Technology Development Funds [13XD1401200]	Key Technologies Research and Development Program of China(National Key Technology R&D Program); Shanghai Science and Technology Development Funds	This work was supported by Key Technologies Research and Development Program of China (2011ZX09102-008, 2013ZX10003008-003) and Shanghai Science and Technology Development Funds (13XD1401200). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Britton WJ, 2004, LANCET, V363, P1209, DOI 10.1016/S0140-6736(04)15952-7; Fontes ANB, 2012, MEM I OSWALDO CRUZ, V107, P143, DOI 10.1590/S0074-02762012000900021; Fontes ANB, 2009, LEPROSY REV, V80, P302; Chae GT, 2002, LEPROSY REV, V73, P41; Clarridge JE, 2004, CLIN MICROBIOL REV, V17, P840, DOI 10.1128/CMR.17.4.840-862.2004; Han XY, 2008, AM J CLIN PATHOL, V130, P856, DOI 10.1309/AJCPP72FJZZRRVMM; Han XY, 2014, AM J CLIN PATHOL, V142, P524, DOI 10.1309/AJCP1GLCBE5CDZRM; Han XY, 2012, INT J DERMATOL, V51, P952, DOI 10.1111/j.1365-4632.2011.05414.x; Han XY, 2009, J BACTERIOL, V191, P6067, DOI 10.1128/JB.00762-09; Han XY, 2012, J DRUGS DERMATOL, V11, P168; Jessamine PG, 2012, J DRUGS DERMATOL, V11, P229; Lavania M, 2013, CLIN MICROBIOL INFEC, V19, P1058, DOI 10.1111/1469-0691.12125; Li Ming, 2013, Zhonghua Liu Xing Bing Xue Za Zhi, V34, P424; Matsuoka M, 2006, FEMS MICROBIOL LETT, V261, P150, DOI 10.1111/j.1574-6968.2006.00346.x; Matsuoka M, 2009, LEPROSY REV, V80, P322; Monot M, 2005, SCIENCE, V308, P1040, DOI 10.1126/science/1109759; Monot M, 2009, NAT GENET, V41, P1282, DOI 10.1038/ng.477; Phetsuksiri B, 2012, JPN J INFECT DIS, V65, P52; Sakamuri RM, 2009, J CLIN MICROBIOL, V47, P2844, DOI 10.1128/JCM.02021-08; Weng XM, 2007, J CLIN MICROBIOL, V45, P1728, DOI 10.1128/JCM.00018-07; Weng XM, 2013, INFECT GENET EVOL, V14, P361, DOI 10.1016/j.meegid.2012.12.009; Weng XM, 2011, INFECT GENET EVOL, V11, P363, DOI 10.1016/j.meegid.2010.11.014; Yu M., 2010, ZHONGHUA LIU XING BI, V31, P1155; Zhang Y, 2009, INT J TUBERC LUNG D, V13, P1320	24	6	6	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0133268	10.1371/journal.pone.0133268	http://dx.doi.org/10.1371/journal.pone.0133268			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LZ	26196543	Green Submitted, gold, Green Published			2022-12-26	WOS:000358547600078
J	Zhao, WJ; Song, Q; Zhang, ZJ; Mao, L; Zheng, WJ; Hu, X; Lian, HZ				Zhao, Wen-jie; Song, Qun; Zhang, Zi-jin; Mao, Li; Zheng, Wei-juan; Hu, Xin; Lian, Hong-zhen			The Kinetic Response of the Proteome in A549 Cells Exposed to ZnSO4 Stress	PLOS ONE			English	Article							EXOGENOUS ZINC; HEAVY-METALS; TRANSPORTERS; PROTEINS; METALLOTHIONEIN; HOMEOSTASIS; METABOLISM; TOXICITY; REVEALS; CYCLE	Zinc, an essential trace element, is involved in many important physiological processes. Cell responses to zinc stress show time-dependent effects besides concentration-dependence and tissue-specificity. Herein, we investigated the time-dependent differential expression of the proteome in A549 cells after administered with ZnSO4 for both 9 and 24 h using 2DE. 123 differentially expressed protein spots were detected, most of which were up-regulated by Zn2+ treatment. Interestingly, 49 proteins exhibited significant differential expression repeatedly during these two treatment periods, and moreover showed a conserved change with different ratios and four time-dependent expression patterns. Pattern 1 (up-regulated with rapid initial induction and subsequent repression) and pattern 4 (downregulated with steady repression) were the predominant expression patterns. The abundances of the proteins in patterns 1 and 4 after 24 h of zinc treatment are always lower than that after 9 h, indicating that exogenous zinc reduced the expression of proteins in cells after 24 h or longer. Importantly, these findings could also reflect the central challenge in detecting zinc homeostasis proteins by 2DE or other high throughput analytical methods resulting from slight variation in protein expression after certain durations of exogenous zinc treatment and/or low inherent protein content in cells. These time-dependent proteome expression patterns were further validated by measuring dynamic changes in protein content in cells and in expression of two proteins using the Bradford method and western blotting, respectively. The time-dependent changes in total zinc and free Zn2+ ion contents in cells were measured using ICP-MS and confocal microscopy, respectively. The kinetic process of zinc homeostasis regulated by muffling was further revealed. In addition, we identified 50 differentially expressed proteins which are predominantly involved in metabolic process, cellular process or developmental process, and function as binding, catalytic activity or structural molecule activity. This study further elucidates our understanding of dynamic nature of the cellular response to zinc stress and the mechanism of zinc homeostasis.	[Zhao, Wen-jie; Song, Qun; Zhang, Zi-jin; Hu, Xin; Lian, Hong-zhen] Nanjing Univ, Collaborat Innovat Ctr Chem Life Sci, Sch Chem & Chem Engn, State Key Lab Analyt Chem Life Sci, Nanjing 210008, Jiangsu, Peoples R China; [Zhao, Wen-jie; Song, Qun; Zhang, Zi-jin; Hu, Xin; Lian, Hong-zhen] Nanjing Univ, Ctr Mat Anal, Nanjing 210008, Jiangsu, Peoples R China; [Mao, Li] Nanjing Med Univ, Sch Publ Hlth, MOE Key Lab Modern Toxicol, Nanjing, Jiangsu, Peoples R China; [Zheng, Wei-juan] Nanjing Univ, Sch Life Sci, State Key Lab Pharmaceut Biotechnol, Nanjing 210008, Jiangsu, Peoples R China	Nanjing University; Nanjing University; Nanjing Medical University; Nanjing University	Lian, HZ (corresponding author), Nanjing Univ, Collaborat Innovat Ctr Chem Life Sci, Sch Chem & Chem Engn, State Key Lab Analyt Chem Life Sci, Nanjing 210008, Jiangsu, Peoples R China.	hzlian@nju.edu.cn	Hu, Xin/B-1792-2009	Hu, Xin/0000-0003-3400-554X	National Natural Science Foundation of China [21275069, 90913012]; National Basic Research Program of China (973 program) [2011CB911003]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (973 program)(National Basic Research Program of China)	This work was supported by the National Natural Science Foundation of China (21275069, 90913012), the National Basic Research Program of China (973 program, 2011CB911003). (http://www.nsfc.gov.cn/publish/portal0/default. htmhttp://www.973.gov.cn/AreaAppl. aspx).	Andrews GK, 2001, BIOMETALS, V14, P223, DOI 10.1023/A:1012932712483; Barkla BJ, 2014, J PROTEOMICS, V111, P128, DOI 10.1016/j.jprot.2014.03.006; Beyersmann D, 2001, BIOMETALS, V14, P331, DOI 10.1023/A:1012905406548; Bleackley MR, 2011, BIOMETALS, V24, P785, DOI 10.1007/s10534-011-9451-4; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Colvin RA, 2010, METALLOMICS, V2, P306, DOI 10.1039/b926662c; Costello LC, 2011, J BIOL INORG CHEM, V16, P3, DOI 10.1007/s00775-010-0736-9; Craddock TJA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033552; Dalton T, 1996, J NUTR, V126, P825, DOI 10.1093/jn/126.4.825; Dean KM, 2012, BBA-MOL CELL RES, V1823, P1406, DOI 10.1016/j.bbamcr.2012.04.001; Devergnas S, 2004, BIOCHEM PHARMACOL, V68, P699, DOI 10.1016/j.bcp.2004.05.024; Duce JA, 2010, CELL, V142, P857, DOI 10.1016/j.cell.2010.08.014; Eide DJ, 2006, BBA-MOL CELL RES, V1763, P711, DOI 10.1016/j.bbamcr.2006.03.005; Eide DJ, 2011, METALLOMICS, V3, P1124, DOI 10.1039/c1mt00064k; Gauci Victoria J, 2011, J Chem Biol, V4, P3, DOI 10.1007/s12154-010-0043-5; Gunther V, 2012, BBA-MOL CELL RES, V1823, P1416, DOI 10.1016/j.bbamcr.2012.01.005; Guerinot ML, 2000, BBA-BIOMEMBRANES, V1465, P190, DOI 10.1016/S0005-2736(00)00138-3; Haase H, 2007, BIOMETALS, V20, P579, DOI 10.1007/s10534-006-9029-8; Jean-Philippe J, 2013, INT J MOL SCI, V14, P18999, DOI 10.3390/ijms140918999; Kalin M, 2011, EUR UROL, V60, P1235, DOI 10.1016/j.eururo.2011.06.038; Kaler P, 2007, AM J PHYSIOL-RENAL, V292, pF217, DOI 10.1152/ajprenal.00014.2006; KIPRIJANOVSKA S, 2014, INT J PROTEOM, V2014, P1; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Langmade SJ, 2000, J BIOL CHEM, V275, P34803, DOI 10.1074/jbc.M007339200; Lichten LA, 2009, ANNU REV NUTR, V29, P153, DOI 10.1146/annurev-nutr-033009-083312; Liu YF, 2012, MED ONCOL, V29, P174, DOI 10.1007/s12032-010-9761-3; Luisi S, 2014, FASEB J, V28; Luque-Garcia JL, 2011, TRAC-TREND ANAL CHEM, V30, P703, DOI 10.1016/j.trac.2011.01.014; Ma YL, 2009, J PROTEOME RES, V8, P4525, DOI 10.1021/pr900365e; Maret W, 2013, METAL IONS LIFE SCI, V12, P479, DOI 10.1007/978-94-007-5561-1_14; Maret W, 2011, BIOMETALS, V24, P411, DOI 10.1007/s10534-010-9406-1; Miao X, 2013, FRONT MED-PRC, V7, P31, DOI 10.1007/s11684-013-0251-9; Mocchegiani Eugenio, 2006, Immun Ageing, V3, P6, DOI 10.1186/1742-4933-3-6; Mohammad MK, 2012, NUTR CLIN PRACT, V27, P305, DOI 10.1177/0884533612441470; Murakami M, 2008, CANCER SCI, V99, P1515, DOI 10.1111/j.1349-7006.2008.00854.x; Outten CE, 2001, SCIENCE, V292, P2488, DOI 10.1126/science.1060331; Padmini E, 2011, CELL STRESS CHAPERON, V16, P411, DOI 10.1007/s12192-011-0255-9; Palmiter RD, 2004, P NATL ACAD SCI USA, V101, P4918, DOI 10.1073/pnas.0401022101; Qian F, 2009, J AM CHEM SOC, V131, P1460, DOI 10.1021/ja806489y; Requejo R, 2005, PHYTOCHEMISTRY, V66, P1519, DOI 10.1016/j.phytochem.2005.05.003; Rink L., 2011, ZINC HUMAN HLTH; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; THOMAS RC, 1991, NATURE, V350, P564, DOI 10.1038/350564b0; Trepel J, 2010, NAT REV CANCER, V10, P537, DOI 10.1038/nrc2887; Ugarte M, 2014, METALLOMICS, V6, P189, DOI 10.1039/c3mt00291h; VALLEE BL, 1993, PHYSIOL REV, V73, P79, DOI 10.2466/pr0.1993.73.1.79; Wang YH, 2013, BIOL TRACE ELEM RES, V154, P418, DOI 10.1007/s12011-013-9737-1; Wu HF, 2011, MAR DRUGS, V9, P1566, DOI 10.3390/md9091566; Yamamoto K, 2005, J BACTERIOL, V187, P6333, DOI 10.1128/JB.187.18.6333-6340.2005; Yildirim V, 2011, PROTEOME SCI, V9, DOI 10.1186/1477-5956-9-12; Yuan N, 2012, BIOSCI BIOTECH BIOCH, V76, P2014, DOI 10.1271/bbb.120216; Zhang B, 2003, MOL CELL BIOL, V23, P8471, DOI 10.1128/MCB.23.23.8471-8485.2003; Zhao WJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105797; Zheng JL, 2014, FISH PHYSIOL BIOCHEM, V40, P1349, DOI 10.1007/s10695-014-9929-4	54	9	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0133451	10.1371/journal.pone.0133451	http://dx.doi.org/10.1371/journal.pone.0133451			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LZ	26196515	Green Published, Green Submitted, gold			2022-12-26	WOS:000358547600098
J	Bloch, N; Weiss, G; Szekely, S; Harel, D				Bloch, Naamah; Weiss, Guy; Szekely, Smadar; Harel, David			An Interactive Tool for Animating Biology, and Its Use in Spatial and Temporal Modeling of a Cancerous Tumor and Its Microenvironment	PLOS ONE			English	Article							REACTIVE ANIMATION; GROWTH; ANGIOGENESIS; SIMULATION; INVASION; HISTORY	The ability to visualize the ongoing events of a computational model of biology is critical, both in order to see the dynamics of the biological system in action and to enable interaction with the model from which one can observe the resulting behavior. To this end, we have built a new interactive animation tool, SimuLife, for visualizing reactive models of cellular biology. SimuLife is web- based, and is freely accessible at http://simulife.weizmann.ac.il/. We have used SimuLife to animate a model that describes the development of a cancerous tumor, based on the individual components of the system and its environment. This has helped in understanding the dynamics of the tumor and its surrounding blood vessels, and in verifying the behavior, fine-tuning the model accordingly, and learning in which way different factors affect the tumor.	[Bloch, Naamah; Weiss, Guy; Szekely, Smadar; Harel, David] Weizmann Inst Sci, Dept Comp Sci & Appl Math, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Bloch, N (corresponding author), Weizmann Inst Sci, Dept Comp Sci & Appl Math, IL-76100 Rehovot, Israel.	naamah.bloch@weizmann.ac.il			European Research Council (ERC) under the European Community's FP7 Programme [710932]; I- CORE program of the Israel Planning & Budgeting Committee; Israel Science Foundation	European Research Council (ERC) under the European Community's FP7 Programme; I- CORE program of the Israel Planning & Budgeting Committee; Israel Science Foundation(Israel Science Foundation)	The research was supported by an Advanced Research Grant from the European Research Council (ERC) under the European Community's FP7 Programme, number 710932. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Part of this research was supported by the I- CORE program of the Israel Planning & Budgeting Committee and the Israel Science Foundation.	Aebersold R, 2009, MOL ONCOL, V3, P9, DOI 10.1016/j.molonc.2008.11.003; Anderson ARA, 2008, NAT REV CANCER, V8, P227, DOI 10.1038/nrc2329; Anderson ARA, 2009, J MATH BIOL, V58, P579, DOI 10.1007/s00285-008-0210-2; Anderson ARA, 1998, B MATH BIOL, V60, P857, DOI 10.1006/bulm.1998.0042; Anderson ARA, 2005, MATH MED BIOL, V22, P163, DOI 10.1093/imammb/dqi005; Araujo RP, 2004, B MATH BIOL, V66, P1039, DOI 10.1016/j.bulm.2003.11.002; Avni R, 2011, NMR BIOMED, V24, P569, DOI 10.1002/nbm.1632; Chaplain MAJ, 2006, ANNU REV BIOMED ENG, V8, P233, DOI 10.1146/annurev.bioeng.8.061505.095807; Cobb K, 2007, MODELING CANC BIOL B; Efroni S, 2005, COMPUTER, V38, P38, DOI 10.1109/MC.2005.31; Efroni S, 2003, GENOME RES, V13, P2485, DOI 10.1101/gr.1215303; Fisher J, 2007, NAT BIOTECHNOL, V25, P1239, DOI 10.1038/nbt1356; Fisher J, 2011, COMMUN ACM, V54, P72, DOI 10.1145/2001269.2001289; FOLKMAN J, 1973, J EXP MED, V138, P745, DOI 10.1084/jem.138.4.745; FOLKMAN J, 1971, NEW ENGL J MED, V285, P1182; Folkman U, 2003, HOLLAND FREI CANC ME; Fukumura D, 2008, APMIS, V116, P695, DOI 10.1111/j.1600-0463.2008.01148.x; Gevertz JL, 2008, PHYS BIOL, V5, DOI 10.1088/1478-3975/5/3/036010; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; HAREL D, 1987, SCI COMPUT PROGRAM, V8, P231, DOI 10.1016/0167-6423(87)90035-9; Harel D, 2003, LECT NOTES COMPUT SC, V2852, P136; Harel D, 1997, EXECUTABLE OBJECT MO, V30; Harel D, 2003, EUROPEAN ASS THEORET, V81, P226; Harel D, 2008, LECT N BIOINFORMAT, V5054, P1, DOI 10.1007/978-3-540-68413-8_1; Hinow P, 2009, MATH BIOSCI ENG, V6, P521, DOI 10.3934/mbe.2009.6.521; Hoehme S, 2010, BIOINFORMATICS, V26, P2641, DOI 10.1093/bioinformatics/btq437; Iwasa JH, 2010, TRENDS CELL BIOL, V20, P699, DOI 10.1016/j.tcb.2010.08.005; Kam N, 2001, IEEE SYMPOSIA ON HUMAN-CENTRIC COMPUTING LANGUAGES AND ENVIRONMENTS, PROCEEDINGS, P15, DOI 10.1109/HCC.2001.995228; Kansal AR, 2000, J THEOR BIOL, V203, P367, DOI 10.1006/jtbi.2000.2000; Macklin P, 2009, J MATH BIOL, V58, P765, DOI 10.1007/s00285-008-0216-9; Mahoney AW, 2010, IEEE ACM T COMPUT BI; Markram H, 2006, NAT REV NEUROSCI, V7, P153, DOI 10.1038/nrn1848; McDougall SR, 2006, J THEOR BIOL, V241, P564, DOI 10.1016/j.jtbi.2005.12.022; MUTHUKKARUPPAN VR, 1982, J NATL CANCER I, V69, P699; Narang V., 2011, DEF SCI RES C EXP DS, P1; Quaranta V, 2005, CLIN CHIM ACTA, V357, P173, DOI 10.1016/j.cccn.2005.03.023; Qutub AA, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-13; Ribatti D, 2007, LEUKEMIA, V21, P44, DOI 10.1038/sj.leu.2404402; Setty Y, 2008, P NATL ACAD SCI USA, V105, P20374, DOI 10.1073/pnas.0808725105; Shirinifard A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007190; Swat MH, 2012, METHOD CELL BIOL, V110, P325, DOI 10.1016/B978-0-12-388403-9.00013-8; Swerdlin N, 2008, P IEEE, V96, P1421, DOI 10.1109/JPROC.2008.925435	42	6	6	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2015	10	7							e0133484	10.1371/journal.pone.0133484	http://dx.doi.org/10.1371/journal.pone.0133484			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LN	26191814	Green Published, gold, Green Submitted			2022-12-26	WOS:000358546400094
J	Chen, KC; Hsieh, YS; Tseng, YF; Shieh, MJ; Chen, JS; Lai, HS; Lee, JM				Chen, Ke-Cheng; Hsieh, Yi-Shan; Tseng, Ying-Fan; Shieh, Ming-Jium; Chen, Jin-Shing; Lai, Hong-Shiee; Lee, Jang-Ming			Pleural Photodynamic Therapy and Surgery in Lung Cancer and Thymoma Patients with Pleural Spread	PLOS ONE			English	Article							FORTHCOMING 7TH EDITION; TNM CLASSIFICATION; INVASIVE THYMOMA; STAGING PROJECT; REVISION; PROPOSALS; EFFUSION; DISSEMINATION; CHEMOTHERAPY; DESCRIPTORS	Pleural spread is difficult to treat in malignancies, especially in lung cancer and thymoma. Monotherapy with surgery fails to have a better survival benefit than palliative chemotherapy, the currently accepted treatment. Photodynamic therapy utilizes a photosensitizer to target the tumor site, and the tumor is exposed to light after performing a pleurectomy and tumor resection. However, the benefits of this procedure to lung cancer or thymoma patients are unknown. We retrospectively reviewed the clinical characteristics and treatment outcomes of patients with lung cancer or thymoma with pleural seeding who underwent pleural photodynamic therapy and surgery between 2005 and 2013. Eighteen patients enrolled in this study. The mean patient age was 52.9 +/- 12.2 years. Lung cancer was the inciting cancer of pleural dissemination in 10 patients (55.6%), and thymoma in 8 (44.4%). There was no procedure-related mortality. Using Kaplan-Meier survival analysis, the 3-year survival rate and the 5-year survival rate were 68.9% and 57.4%, respectively. We compared the PDT lung cancer patients with those receiving chemotherapy or target therapy (n = 51) and found that the PDT group had better survival than non-PDT patients (mean survival time: 39.0 versus 17.6 months; P = .047). With proper patient selection, radical surgical resection combined with intrapleural photodynamic therapy for pleural spread in patients with non-small cell lung cancer or thymoma is feasible and may provide a survival benefit.	[Chen, Ke-Cheng; Shieh, Ming-Jium] Natl Taiwan Univ, Inst Biomed Engn, Coll Med, Taipei 10764, Taiwan; [Chen, Ke-Cheng; Shieh, Ming-Jium] Natl Taiwan Univ, Coll Engn, Taipei, Taiwan; [Chen, Ke-Cheng; Tseng, Ying-Fan; Chen, Jin-Shing; Lai, Hong-Shiee; Lee, Jang-Ming] Natl Taiwan Univ Hosp, Dept Surg, Taipei 100, Taiwan; [Hsieh, Yi-Shan] Tao Yuan Gen Hosp, Minist Hlth & Welf, Dept Surg, Taoyuan, Taiwan; [Shieh, Ming-Jium] Natl Taiwan Univ Hosp, Dept Oncol, Taipei 100, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital	Lee, JM (corresponding author), Natl Taiwan Univ Hosp, Dept Surg, Taipei 100, Taiwan.	jangminglee@gmail.com		Lai, Hong-Shiee/0000-0002-7958-2183; LEE, JANG-MING/0000-0001-9727-227X; CHEN, JIN-SHING/0000-0001-5077-4483	National Science Council (NSC) [101-2314-B002-020-MY3]; National Health Research Institute [NHRI-EX102-10032BI]; Ministry of Health and Welfare [DOH101-TD-I-111-NSC003]; Excellent Translational Medicine Research Projects of National Taiwan University [102C101-51]; National Taiwan University Hospital of Republic of China [NTUH.102-S2140, NTUH 102-N2253, NTUH 104-M2914]	National Science Council (NSC)(Ministry of Science and Technology, Taiwan); National Health Research Institute(National Health Research Institutes - Taiwan); Ministry of Health and Welfare(Ministry of Health, Labour and Welfare, Japan); Excellent Translational Medicine Research Projects of National Taiwan University; National Taiwan University Hospital of Republic of China(National Taiwan University)	This study was supported by the National Science Council (NSC 101-2314-B002-020-MY3), National Health Research Institute (NHRI-EX102-10032BI), Ministry of Health and Welfare (DOH101-TD-I-111-NSC003), Excellent Translational Medicine Research Projects of National Taiwan University (102C101-51), and National Taiwan University Hospital (NTUH.102-S2140, NTUH 102-N2253, NTUH 104-M2914) of the Republic of China.	Dougherty TJ, 1998, JNCI-J NATL CANCER I, V90, P889, DOI 10.1093/jnci/90.12.889; Friedberg JS, 2012, ANN THORAC SURG, V93, P1658, DOI 10.1016/j.athoracsur.2012.02.009; Friedberg JS, 2004, J CLIN ONCOL, V22, P2192, DOI 10.1200/JCO.2004.07.097; Goldstraw Peter, 2007, J Thorac Oncol, V2, P706, DOI 10.1097/JTO.0b013e31812f3c1a; GOMER CJ, 1979, CANCER RES, V39, P146; Hahn SM, 1999, REV CONTEMP PHARMACO, V10, P69; ICHINOSE Y, 1993, J SURG ONCOL, V54, P180, DOI 10.1002/jso.2930540311; Ishikawa Y, 2009, ANN THORAC SURG, V88, P952, DOI 10.1016/j.athoracsur.2009.05.019; Liu TJ, 2014, ANN SURG ONCOL, V21, P322, DOI 10.1245/s10434-013-3228-7; Lucchi M, 2009, J THORAC CARDIOV SUR, V137, P1185, DOI 10.1016/j.jtcvs.2008.09.033; MARTINI N, 1975, CANCER, V35, P734, DOI 10.1002/1097-0142(197503)35:3<734::AID-CNCR2820350328>3.0.CO;2-N; Mordant P, 2011, EUR J CARDIO-THORAC, V40, P1444, DOI 10.1016/j.ejcts.2011.02.076; Mott FE, 2001, CHEST, V119, P317, DOI 10.1378/chest.119.1.317; Mountain CF, 1997, CHEST, V111, P1710, DOI 10.1378/chest.111.6.1710; Murakawa T, 2015, EUR J CARDIO-THORAC, V47, P567, DOI 10.1093/ejcts/ezu210; Postmus PE, 2007, J THORAC ONCOL, V2, P686, DOI 10.1097/JTO.0b013e31811f4703; Rami-Porta R, 2007, J THORAC ONCOL, V2, P593, DOI 10.1097/JTO.0b013e31807a2f81; REYES L, 1991, J THORAC CARDIOV SUR, V101, P946; Wang BY, 2011, J SURG RES, V169, pE1, DOI 10.1016/j.jss.2011.02.028; Werner-Wasik M, 2000, INT J RADIAT ONCOL, V48, P1475, DOI 10.1016/S0360-3016(00)00801-4; Yu L, 2013, ONCOTARGETS THER, V6, P517, DOI 10.2147/OTT.S41347	21	23	23	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2015	10	7							e0133230	10.1371/journal.pone.0133230	http://dx.doi.org/10.1371/journal.pone.0133230			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LN	26193470	Green Published, Green Submitted, gold			2022-12-26	WOS:000358546400067
J	de Visser, KL; Landman, GWD; Meyboom-de Jong, B; de Visser, W; te Meerman, GJ; Bilo, HJG				de Visser, Kees L.; Landman, Gijs W. D.; Meyboom-de Jong, Betty; de Visser, Wim; te Meerman, Gerard J.; Bilo, Henk J. G.			Familial Aggregation between the 14th and 21st Century and Type 2 Diabetes Risk in an Isolated Dutch Population	PLOS ONE			English	Article							MELLITUS; TWINS; CONCORDANCE; OBESITY	Introduction The development of type 2 diabetes results from an interaction of hereditary factors and environmental factors. This study aimed to investigate the contribution of interrelatedness to the risk of developing type 2 diabetes in an isolated Dutch population. Materials and Methods A genealogical database from inhabitants living on the former island Urk between the 14th and 21st century was constructed. In a case-control study, effects of interrelatedness and the risk of type 2 diabetes were estimated with Kinship Coefficients (KCs). Relative risks in first, second, and third degree relatives and spouses of inhabitants with type 2 diabetes were compared to matched controls. Results Patients with type 2 diabetes were more interrelated, expressed by a higher KC compared to controls (7.2 vs. 5.2, p=0.001). First, second and third degree relatives had an increased risk of developing type 2 diabetes. Second degree relatives had a similar risk, 1.7 (1.5-2.0) as third degree relatives, 1.8 (1.5-2.2). Spouses of patients with diabetes had a 3.4 (2.7-4.4) higher risk of developing type 2 diabetes. Conclusions Interrelatedness was higher among inhabitants with type 2 diabetes compared to controls. This differences extended beyond the nuclear family, thereby supporting the hypothesis that interrelatedness contributed to the development of type 2 diabetes on Urk. However, the size of this effect was small and the patterns of risk in first, second and third degree relatives suggested that factors other than interrelatedness were the main contributors to the development of type 2 diabetes on Urk.	[de Visser, Kees L.; Landman, Gijs W. D.; Meyboom-de Jong, Betty; Bilo, Henk J. G.] Isala, Ctr Diabet, NL-8025 BT Zwolle, Netherlands; [de Visser, Kees L.; Meyboom-de Jong, Betty] Univ Groningen, Univ Med Ctr Groningen, Dept Gen Practice, NL-9700 RB Groningen, Netherlands; [Landman, Gijs W. D.] Gelre Hosp, Dept Internal Med, NL-7334 DZ Apeldoorn, Netherlands; [Landman, Gijs W. D.] Langerhans Med Res Inst, Zwolle, Netherlands; [Bilo, Henk J. G.] Univ Groningen, Univ Med Ctr Groningen, Dept Internal Med, NL-9700 RB Groningen, Netherlands; [te Meerman, Gerard J.] Univ Groningen, Univ Med Ctr Groningen, Dept Genet, NL-9700 RB Groningen, Netherlands	University of Groningen; Gelre Hospitals; Langerhans Medical Research Group; University of Groningen; University of Groningen	Landman, GWD (corresponding author), Isala, Ctr Diabet, NL-8025 BT Zwolle, Netherlands.	g.w.d.landman@isala.nl	Landman, Gijs/AAJ-5540-2021	Landman, Gijs/0000-0002-6852-6450; Kleefstra, Nanne/0000-0003-1473-8519				Ahmad S, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003607; [Anonymous], 2002, THESIS U GRONINGEN G; [Anonymous], 1997, MATH STAT METHODS GE, P70; BARNETT AH, 1981, DIABETOLOGIA, V20, P87, DOI 10.1007/BF00262007; BOUCHARD C, 1990, NEW ENGL J MED, V322, P1477, DOI 10.1056/NEJM199005243222101; Di Castelnuovo A, 2009, AM J EPIDEMIOL, V169, P1, DOI 10.1093/aje/kwn234; Drong AW, 2012, CLIN PHARMACOL THER, V92, P707, DOI 10.1038/clpt.2012.149; Grant SFA, 2001, ARTHRITIS RHEUM-US, V44, P2247, DOI 10.1002/1529-0131(200110)44:10<2247::AID-ART387>3.0.CO;2-Y; HALES CN, 1992, DIABETOLOGIA, V35, P595, DOI 10.1007/BF00400248; HAMMAN RF, 1992, DIABETES METAB REV, V8, P287, DOI 10.1002/dmr.5610080402; Hermanides J, 2008, Ned Tijdschr Geneeskd, V152, P2415; Hopper JL, 1999, DIABETOLOGIA, V42, P125, DOI 10.1007/s001250051129; KAPRIO J, 1992, DIABETOLOGIA, V35, P1060, DOI 10.1007/BF02221682; Masel J, 2011, CURR BIOL, V21, pR837, DOI 10.1016/j.cub.2011.08.007; Medici F, 1999, DIABETOLOGIA, V42, P146, DOI 10.1007/s001250051132; Meigs JB, 2000, DIABETES, V49, P2201, DOI 10.2337/diabetes.49.12.2201; Poulsen P, 1999, DIABETOLOGIA, V42, P139, DOI 10.1007/s001250051131; Rathmann W, 2011, DIABETOLOGIA, V54, P2217, DOI 10.1007/s00125-011-2222-5; Scott RA, 2013, DIABETOLOGIA, V56, P60, DOI 10.1007/s00125-012-2715-x; Statistiek. CBvd, 1988, STAT BEST NED GEM 19; STUNKARD AJ, 1990, NEW ENGL J MED, V322, P1483, DOI 10.1056/NEJM199005243222102; Vaag AA, 2012, DIABETOLOGIA, V55, P2085, DOI 10.1007/s00125-012-2589-y; Vaag A, 2007, CURR OPIN CLIN NUTR, V10, P591, DOI 10.1097/MCO.0b013e3282ab9ea6; Voight BF, 2010, NAT GENET, V42, P579, DOI 10.1038/ng.609; Wang YC, 2011, LANCET, V378, P815, DOI 10.1016/S0140-6736(11)60814-3; Whitaker RC, 1997, NEW ENGL J MED, V337, P869, DOI 10.1056/NEJM199709253371301	26	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2015	10	7							e0132549	10.1371/journal.pone.0132549	http://dx.doi.org/10.1371/journal.pone.0132549			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LN	26193086	Green Published, gold, Green Submitted			2022-12-26	WOS:000358546400029
J	Fernandes, CAH; Cardoso, FF; Cavalcante, WGL; Soares, AM; Dal-Pai, M; Gallacci, M; Fontes, MRM				Fernandes, Carlos A. H.; Cardoso, Fabio Florena; Cavalcante, Walter G. L.; Soares, Andreimar M.; Dal-Pai, Maeli; Gallacci, Marcia; Fontes, Marcos R. M.			Structural Basis for the Inhibition of a Phospholipase A(2)-Like Toxin by Caffeic and Aristolochic Acids	PLOS ONE			English	Article							SNAKE-VENOM; BIOLOGICAL-ACTIVITIES; MYOTOXIC MECHANISM; A(2); LYS49; FLACOURTIACEAE; NEUTRALIZATION; IDENTIFICATION; PEPTIDES; SYSTEM	One of the main challenges in toxicology today is to develop therapeutic alternatives for the treatment of snake venom injuries that are not efficiently neutralized by conventional serum therapy. Venom phospholipases A(2) (PLA(2)s) and PLA(2)-like proteins play a fundamental role in skeletal muscle necrosis, which can result in permanent sequelae and disability. This leads to economic and social problems, especially in developing countries. In this work, we performed structural and functional studies with Piratoxin-I, a Lys49-PLA(2) from Bothropspirajai venom, complexed with two compounds present in several plants used in folk medicine against snakebites. These ligands partially neutralized the myotoxic activity of PrTX-I towards binding on the two independent sites of interaction between Lys49-PLA(2) and muscle membrane. Our results corroborate the previously proposed mechanism of action of PLA(2)s-like and provide insights for the design of structure-based inhibitors that could prevent the permanent injuries caused by these proteins in snakebite victims.	[Fernandes, Carlos A. H.; Cardoso, Fabio Florena; Cavalcante, Walter G. L.; Fontes, Marcos R. M.] Univ Estadual Paulista, UNESP, Inst Biociencias, Dept Fis & Biofis, Botucatu, SP, Brazil; [Fernandes, Carlos A. H.; Cardoso, Fabio Florena; Cavalcante, Walter G. L.; Fontes, Marcos R. M.] CNPq, Inst Nacl Ciencia Tecnol Toxinas, Sao Paulo, SP, Brazil; [Cardoso, Fabio Florena; Cavalcante, Walter G. L.; Gallacci, Marcia; Fontes, Marcos R. M.] Univ Estadual Paulista, UNESP, Inst Biociencias, Dept Farmacol, Botucatu, SP, Brazil; [Soares, Andreimar M.] Fundacao Oswaldo Cruz FIOCRUZ, Porto Velho, Rondonia, Brazil; [Soares, Andreimar M.] Univ Fed Rondonia, Ctr Estudos Biomol Aplicadas, Porto Velho, Rondonia, Brazil; [Dal-Pai, Maeli] Univ Estadual Paulista, UNESP, Inst Biociencias, Dept Morfol, Botucatu, SP, Brazil	Universidade Estadual Paulista; Universidade Estadual Paulista; Fundacao Oswaldo Cruz; Universidade Federal de Rondonia; Universidade Estadual Paulista	Fontes, MRM (corresponding author), Univ Estadual Paulista, UNESP, Inst Biociencias, Dept Fis & Biofis, Botucatu, SP, Brazil.	fontes@ibb.unesp.br	Soares, Andreimar M/K-5556-2014; Soares, Andrei/ABG-3545-2020; Cavalcante, Walter L G/B-1212-2013; Gallacci, Márcia/C-8479-2013; Soares, Andreimar/AAE-4657-2021; Fernandes, Carlos/AAY-6730-2020; Fontes, Marcos Roberto/B-1941-2009; Dal-Pai-Silva, Maeli/GLR-1413-2022; Cardoso, Fábio/G-2265-2016	Cavalcante, Walter L G/0000-0002-2354-636X; Gallacci, Márcia/0000-0001-6149-4030; Fernandes, Carlos/0000-0001-6515-6872; Fontes, Marcos Roberto/0000-0002-4634-6221; Cardoso, Fábio/0000-0003-2779-9564; Dal Pai, Maeli/0000-0001-7269-9197; Soares, Andreimar/0000-0003-1032-2188	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	Support was provided by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) to CAHF, FFC, WGLC, MDP, MRMF; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) to MDP, AMS, MRMF and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) to MRMF.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; AGORO JW, 1978, Patent No. 4124724; Araujo F.A.A., 2003, ANIMAIS PECONHENTOS, P6; Arni RK, 1996, TOXICON, V34, P827, DOI 10.1016/0041-0101(96)00036-0; Bahnson BJ, 2005, ARCH BIOCHEM BIOPHYS, V433, P96, DOI 10.1016/j.abb.2004.08.013; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bancroft JD, 1990, THEORY PRACTICE HIST; Bowman WC, 1980, TXB PHARM, P1711; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cavalcante WLG, 2007, J ETHNOPHARMACOL, V112, P490, DOI 10.1016/j.jep.2007.04.002; Chandra V, 2002, BIOCHEMISTRY-US, V41, P10914, DOI 10.1021/bi0258593; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chioato L, 2007, BBA-BIOMEMBRANES, V1768, P1247, DOI 10.1016/j.bbamem.2007.01.023; Cintra-Francischinelli M, 2008, PHYTOTHER RES, V22, P784, DOI 10.1002/ptr.2365; Correia-de-Sa P, 2013, TOXICON, V61, P16, DOI 10.1016/j.toxicon.2012.10.014; dos Santos JI, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028521; dos Santos JI, 2009, J STRUCT BIOL, V167, P106, DOI 10.1016/j.jsb.2009.04.003; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fernandes CAH, 2014, BBA-PROTEINS PROTEOM, V1844, P2265, DOI 10.1016/j.bbapap.2014.09.015; Fernandes CAH, 2013, BBA-PROTEINS PROTEOM, V1834, P2772, DOI 10.1016/j.bbapap.2013.10.009; Fernandes CAH, 2010, J STRUCT BIOL, V171, P31, DOI 10.1016/j.jsb.2010.03.019; Gallacci M, 2010, TOXICON, V55, P1, DOI 10.1016/j.toxicon.2009.10.025; Gutierrez JM, 2003, TOXICON, V42, P915, DOI 10.1016/j.toxicon.2003.11.005; GUTIERREZ JM, 1995, TOXICON, V33, P1405, DOI 10.1016/0041-0101(95)00085-Z; Gutierrez JM, 2006, PLOS MED, V3, P727, DOI 10.1371/journal.pmed.0030150; Harrison RA, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000569; HUANG MT, 1988, CANCER RES, V48, P5941; JOHNSON EK, 1994, COMP BIOCHEM PHYS C, V107, P359, DOI 10.1016/1367-8280(94)90062-0; Kasturiratne A, 2008, PLOS MED, V5, P1591, DOI 10.1371/journal.pmed.0050218; Laskowski RA, 2011, J CHEM INF MODEL, V51, P2778, DOI 10.1021/ci200227u; LOMONTE B, 1994, J BIOL CHEM, V269, P29867; Magro AJ, 2009, PROTEIN PEPTIDE LETT, V16, P852, DOI 10.2174/092986609788923301; MANCUSO LC, 1995, TOXICON, V33, P615, DOI 10.1016/0041-0101(95)00012-B; Marchi-Salvador DP, 2009, BBA-PROTEINS PROTEOM, V1794, P1583, DOI 10.1016/j.bbapap.2009.07.005; McPherson A., 2003, INTRO MACROMOLECULAR; Mebs D, 2006, TOXICON, V47, P797, DOI 10.1016/j.toxicon.2006.01.031; Ministerio da Saude (Brasil), 2001, FUNDACAO NACL SAUDE, V2nd; Montecucco C, 2008, CELL MOL LIFE SCI, V65, P2897, DOI 10.1007/s00018-008-8113-3; Mors WB, 2000, PHYTOCHEMISTRY, V55, P627, DOI 10.1016/S0031-9422(00)00229-6; Nunez CE, 2001, TOXICON, V39, P1587, DOI 10.1016/S0041-0101(01)00141-6; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Ownby CL, 1999, TOXICON, V37, P411, DOI 10.1016/S0041-0101(98)00188-3; RiceEvans CA, 1997, TRENDS PLANT SCI, V2, P152, DOI 10.1016/S1360-1385(97)01018-2; RODRIGUESSIMIONI L, 1983, NEUROSCIENCE, V10, P475, DOI 10.1016/0306-4522(83)90147-1; Salvador GHM, 2013, TOXICON, V72, P52, DOI 10.1016/j.toxicon.2013.06.013; Salvador GHM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060610; Samy RP, 2008, J ETHNOPHARMACOL, V115, P302, DOI 10.1016/j.jep.2007.10.006; Schaloske RH, 2006, BBA-MOL CELL BIOL L, V1761, P1246, DOI 10.1016/j.bbalip.2006.07.011; Shimabuku PS, 2011, ACTA CRYSTALLOGR F, V67, P249, DOI 10.1107/S1744309110051407; Soares AM, 2005, CURR MED CHEM, V12, P2625, DOI 10.2174/092986705774370655; Sousa LF, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002442; Ticli FK, 2005, TOXICON, V46, P318, DOI 10.1016/j.toxicon.2005.04.023; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; VISHWANATH BS, 1987, TOXICON, V25, P501; VISHWANATH BS, 1987, TOXICON, V25, P929, DOI 10.1016/0041-0101(87)90155-3; VISHWANATH BS, 1987, TOXICON, V25, P939, DOI 10.1016/0041-0101(87)90156-5; Ward RJ, 2002, BIOCHEM J, V362, P89, DOI 10.1042/0264-6021:3620089; Warrell DA, 2010, LANCET, V375, P77, DOI 10.1016/S0140-6736(09)61754-2; Xie YC, 2013, BIOORG MED CHEM LETT, V23, P3556, DOI 10.1016/j.bmcl.2013.04.033; Zhou X, 2008, BIOPHYS J, V95, P3366, DOI 10.1529/biophysj.107.117747	60	26	26	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2015	10	7							e0133370	10.1371/journal.pone.0133370	http://dx.doi.org/10.1371/journal.pone.0133370			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LN	26192963	Green Published, gold, Green Submitted			2022-12-26	WOS:000358546400076
J	Lovy, M; Skliba, J; Hrouzkova, E; Dvorakova, V; Nevo, E; Sumbera, R				Loevy, Matej; Skliba, Jan; Hrouzkova, Ema; Dvorakova, Veronika; Nevo, Eviatar; Sumbera, Radim			Habitat and Burrow System Characteristics of the Blind Mole Rat Spalax galili in an Area of Supposed Sympatric Speciation	PLOS ONE			English	Article							CRYPTOMYS-HOTTENTOTUS-HOTTENTOTUS; SUBTERRANEAN RODENT; REPRODUCTIVE-BEHAVIOR; SOIL TYPES; EHRENBERGI; ISRAEL; PATTERNS; BATHYERGIDAE; ARCHITECTURE; POPULATIONS	A costly search for food in subterranean rodents resulted in various adaptations improving their foraging success under given ecological conditions. In Spalax ehrenbergi superspecies, adaptations to local ecological conditions can promote speciation, which was recently supposed to occur even in sympatry at sites where two soil types of contrasting characteristics abut each other. Quantitative description of ecological conditions in such a site has been, nevertheless, missing. We measured characteristics of food supply and soil within 16 home ranges of blind mole rats Spalax galili in an area subdivided into two parts formed by basaltic soil and pale rendzina. We also mapped nine complete mole rat burrow systems to compare burrowing patterns between the soil types. Basaltic soil had a higher food supply and was harder than rendzina even under higher moisture content and lower bulk density. Population density of mole rats was five-times lower in rendzina, possibly due to the lower food supply and higher cover of Sarcopoterium shrubs which seem to be avoided by mole rats. A combination of food supply and soil parameters probably influences burrowing patterns resulting in shorter and more complex burrow systems in basaltic soil.	[Loevy, Matej; Skliba, Jan; Hrouzkova, Ema; Dvorakova, Veronika; Sumbera, Radim] Univ South Bohemia, Fac Sci, Dept Zool, Ceske Budejovice, Czech Republic; [Nevo, Eviatar] Univ Haifa, Inst Evolut, IL-31999 Haifa, Israel	University of South Bohemia Ceske Budejovice; University of Haifa	Lovy, M (corresponding author), Univ South Bohemia, Fac Sci, Dept Zool, Ceske Budejovice, Czech Republic.	mates.lovy@gmail.com	Šumbera, Radim/D-9072-2016; Lövy, Matěj/AGN-3116-2022	Šumbera, Radim/0000-0001-8658-9378; Lövy, Matěj/0000-0002-6451-2393; Hrouzkova, Ema/0000-0002-6289-7613; Skliba, Jan/0000-0002-0567-9302	Czech Science Foundation (GACR) [P506/11/1512, 14-31670P]; Ancell-Teicher Research Foundation of Genetics and Molecular Evolution	Czech Science Foundation (GACR)(Grant Agency of the Czech Republic); Ancell-Teicher Research Foundation of Genetics and Molecular Evolution	This study was supported by the Czech Science Foundation (GACR), projects P506/11/1512 (to RS) and 14-31670P (to ML) and by the Ancell-Teicher Research Foundation of Genetics and Molecular Evolution (to EN).	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Atlas of Israel, 1985, CART PHYS HUMAN GEOG; Auguie B, 2017, GRIDEXTRA MISCELLANE; Begall S., 2007, SUBTERRANEAN RODENTS; BLOCK A, 1990, PHYS REV A, V42, P1869, DOI 10.1103/PhysRevA.42.1869; Busch C, 2000, LIFE UNDERGROUND, P183; CAMERON GN, 1988, J MAMMAL, V69, P667, DOI 10.2307/1381621; DAFNI A, 1981, ANN MO BOT GARD, V68, P652, DOI 10.2307/2398893; Danin A, 2015, VEGETATION ISRAEL NE; Ebdon D., 1985, A PRACTICAL APPROACH, V2nd; Gazit I, 2000, CAN J ZOOL, V78, P570, DOI 10.1139/cjz-78-4-570; GRADSTEIN FM, 1994, J GEOPHYS RES-SOL EA, V99, P24051, DOI 10.1029/94JB01889; Grishkan I, 2008, EUR J SOIL BIOL, V44, P180, DOI 10.1016/j.ejsobi.2008.01.001; Hadid Y, 2013, P NATL ACAD SCI USA, V110, P2587, DOI 10.1073/pnas.1222588110; Henkin Z, 2007, RANGELAND ECOL MANAG, V60, P453, DOI 10.2111/1551-5028(2007)60[453:STAMOA]2.0.CO;2; HETH G, 1989, OECOLOGIA, V79, P496, DOI 10.1007/BF00378667; HETH G, 1989, J ZOOL, V217, P39, DOI 10.1111/j.1469-7998.1989.tb02473.x; Hillel D., 1998, ENV SOIL PHYS; Jarvis JUM, 1998, OECOLOGIA, V113, P290, DOI 10.1007/s004420050380; JARVIS JUM, 1973, J ZOOL, V171, P1; Karpien A, 1999, FRACLAC FOR IMAGEJ; Le Comber SC, 2002, CAN J ZOOL, V80, P436, DOI 10.1139/Z02-026; Levitte D, 2001, JERUSALEM; Lovy M, 2012, J ZOOL, V286, P145, DOI 10.1111/j.1469-7998.2011.00860.x; Luna F, 2006, CAN J ZOOL, V84, P661, DOI 10.1139/Z06-040; Mohammad AG, 2013, CATENA, V100, P10, DOI 10.1016/j.catena.2012.07.013; Nevo, 1999, MOSAIC EVOLUTION SUB; Nevo E., 1961, Mammalia Paris, V25, P127, DOI 10.1515/mamm.1961.25.2.127; NEVO E, 1982, EVOLUTION, V36, P1283, DOI 10.1111/j.1558-5646.1982.tb05497.x; NEVO E, 1994, P NATL ACAD SCI USA, V91, P8160, DOI 10.1073/pnas.91.17.8160; NEVO E, 1986, J GENET, V65, P65, DOI 10.1007/BF02923537; NEVO E., 2001, ADAPTIVE RAD BLIND S; PEARSON O. P., 1968, INV ZOOL CHILENAS, V13, P47; Polyakov A, 2004, P ROY SOC B-BIOL SCI, V271, pS156, DOI 10.1098/rsbl.2003.0112; RADO R, 1991, ANIM BEHAV, V42, P15, DOI 10.1016/S0003-3472(05)80601-3; REICHMAN OJ, 1982, ECOLOGY, V63, P687, DOI 10.2307/1936789; Romanach SS, 2005, J MAMMAL, V86, P750, DOI 10.1644/1545-1542(2005)086[0750:EOSSAA]2.0.CO;2; SAVIC IR, 1990, PROG CLIN BIOL RES, V335, P129; Shams I, 2005, COMP BIOCHEM PHYS A, V142, P376, DOI 10.1016/j.cbpa.2005.09.003; SHANAS U, 1995, J ZOOL, V237, P195, DOI 10.1111/j.1469-7998.1995.tb02758.x; Skliba J, 2011, ECOL RES, V26, P1081, DOI 10.1007/s11284-011-0860-1; Skliba J, 2010, ACTA THERIOL, V55, P271, DOI 10.4098/j.at.0001-7051.099.2009; SMITH CW, 1985, GEODERMA, V35, P47, DOI 10.1016/0016-7061(85)90055-2; SMITHGILL SJ, 1975, J MORPHOL, V146, P35, DOI 10.1002/jmor.1051460103; Spinks AC, 1999, J ZOOL, V249, P143; Spinks AC, 2000, OECOLOGIA, V125, P341, DOI 10.1007/s004420000460; Sumbera R, 2003, NATURWISSENSCHAFTEN, V90, P370, DOI 10.1007/s00114-003-0439-y; Sumbera R, 2008, J ZOOL, V274, P77, DOI 10.1111/j.1469-7998.2007.00359.x; Sumbera R, 2012, ACTA THERIOL, V57, P121, DOI 10.1007/s13364-011-0059-4; Ter Braak JFC, 2002, CANOCO REFERENCE MAN; Topachevskii VA, 1976, FAUNA USSR MAMMALS M; Verheye W., 2005, ENCY LIFE SUPPORT SY; Via S, 2001, TRENDS ECOL EVOL, V16, P381, DOI 10.1016/S0169-5347(01)02188-7; VLECK D, 1979, PHYSIOL ZOOL, V52, P122, DOI 10.1086/physzool.52.2.30152558; Weinstein Y, 2006, J PETROL, V47, P1017, DOI 10.1093/petrology/egl003; Zelova J, 2010, PHYSIOL BEHAV, V99, P54, DOI 10.1016/j.physbeh.2009.10.007; Zuri I, 1996, J ZOOL, V240, P123, DOI 10.1111/j.1469-7998.1996.tb05490.x; [No title captured]	58	33	35	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2015	10	7							e0133157	10.1371/journal.pone.0133157	http://dx.doi.org/10.1371/journal.pone.0133157			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LN	26192762	Green Published, gold, Green Submitted			2022-12-26	WOS:000358546400063
J	Osei-Owusu, P; Owens, EA; Jie, L; Reis, JS; Forrester, SJ; Kawai, T; Eguchi, S; Singh, H; Blumer, KJ				Osei-Owusu, Patrick; Owens, Elizabeth A.; Jie, Li; Reis, Janaina S.; Forrester, Steven J.; Kawai, Tatsuo; Eguchi, Satoru; Singh, Harpreet; Blumer, Kendall J.			Regulation of Renal Hemodynamics and Function by RGS2	PLOS ONE			English	Article							GTPASE-ACTIVATING PROTEINS; GLOMERULAR-FILTRATION-RATE; PRESSURE-NATRIURESIS; BLOOD-FLOW; ANGIOTENSIN-II; EXPRESSION; NA+; MECHANISMS; KIDNEYS; MICE	Regulator of G protein signaling 2 (RGS2) controls G protein coupled receptor (GPCR) signaling by acting as a GTPase-activating protein for heterotrimeric G proteins. Certain Rgs2 gene mutations have been linked to human hypertension. Renal RGS2 deficiency is sufficient to cause hypertension in mice; however, the pathological mechanisms are unknown. Here we determined how the loss of RGS2 affects renal function. We examined renal hemodynamics and tubular function by monitoring renal blood flow (RBF), glomerular filtration rate (GFR), epithelial sodium channel (ENaC) expression and localization, and pressure natriuresis in wild type (WT) and RGS2 null (RGS2-/-) mice. Pressure natriuresis was determined by stepwise increases in renal perfusion pressure (RPP) and blood flow, or by systemic blockade of nitric oxide synthase with L-NG-Nitroarginine methyl ester (L-NAME). Baseline GFR was markedly decreased in RGS2-/-mice compared to WT controls (5.0 +/- 0.8 vs. 2.5 +/- 0.1 mu l/min/g body weight, p<0.01). RBF was reduced (35.4 +/- 3.6 vs. 29.1 +/- 2.1 mu l/min/g body weight, p=0.08) while renal vascular resistance (RVR; 2.1 +/- 0.2 vs. 3.0 +/- 0.2 mmHg/mu l/min/g body weight, p<0.01) was elevated in RGS2-/-compared to WT mice. RGS2 deficiency caused decreased sensitivity and magnitude of changes in RVR and RBF after a step increase in RPP. The acute pressure-natriuresis curve was shifted rightward in RGS2-/-relative to WT mice. Sodium excretion rate following increased RPP by L-NAME was markedly decreased in RGS2-/-mice and accompanied by increased translocation of ENaC to the luminal wall. We conclude that RGS2 deficiency impairs renal function and autoregulation by increasing renal vascular resistance and reducing renal blood flow. These changes impair renal sodium handling by favoring sodium retention. The findings provide a new line of evidence for renal dysfunction as a primary cause of hypertension.	[Osei-Owusu, Patrick; Owens, Elizabeth A.; Jie, Li; Reis, Janaina S.; Singh, Harpreet] Drexel Univ, Coll Med, Dept Physiol & Pharmacol, Philadelphia, PA 19102 USA; [Forrester, Steven J.; Kawai, Tatsuo; Eguchi, Satoru] Temple Univ, Cardiovasc Res Ctr, Philadelphia, PA 19140 USA; [Forrester, Steven J.; Kawai, Tatsuo; Eguchi, Satoru] Temple Univ, Dept Physiol, Philadelphia, PA 19140 USA; [Blumer, Kendall J.] Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA	Drexel University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Washington University (WUSTL)	Osei-Owusu, P (corresponding author), Drexel Univ, Coll Med, Dept Physiol & Pharmacol, Philadelphia, PA 19102 USA.	patrick.osei-owusu@drexelmed.edu	Singh, Harpreet/M-9822-2019; Osei-Owusu, Patrick/AAH-9063-2019; Osei-Owusu, Patrick/L-9104-2018	Singh, Harpreet/0000-0002-6135-1897; 	NIH [HL075632, GM44592]; Washington University O'Brien Kidney Center; American Heart Association [13GRNT17060036]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL075632] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM044592] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Washington University O'Brien Kidney Center; American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by institutional support from the Drexel University College of Medicine to Patrick Osei-Owusu, grants to Kendall Blumer from the NIH (HL075632 and GM44592) and the Washington University O'Brien Kidney Center, and an American Heart Association grant (13GRNT17060036) to Satoru Eguchi. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amin MS, 2011, CAN J PHYSIOL PHARM, V89, P159, DOI 10.1139/Y11-005; Anantharam A, 2007, J GEN PHYSIOL, V130, P55, DOI 10.1085/jgp.200609716; Arendshorst WJ, 1999, J AM SOC NEPHROL, V10, pS149; Asico LD, 1998, J CLIN INVEST, V102, P493, DOI 10.1172/JCI3685; Berman DM, 1996, CELL, V86, P445, DOI 10.1016/S0092-8674(00)80117-8; BONVALET JP, 1977, J PHYSIOL-LONDON, V269, P627, DOI 10.1113/jphysiol.1977.sp011919; Brinks HL, 2010, BBA-MOL BASIS DIS, V1802, P1268, DOI 10.1016/j.bbadis.2010.01.005; CASELLAS D, 1993, AM J PHYSIOL, V264, pF315, DOI 10.1152/ajprenal.1993.264.2.F315; Chaston DJ, 2013, ARTERIOSCL THROM VAS, V33, P962, DOI 10.1161/ATVBAHA.112.300957; Cheng C, 1998, J BIOL CHEM, V273, P22693, DOI 10.1074/jbc.273.35.22693; Choi JY, 2007, EUR J PHARMACOL, V567, P19, DOI 10.1016/j.ejphar.2007.04.026; Cowley AW, 2006, NAT REV GENET, V7, P829, DOI 10.1038/nrg1967; COWLEY AW, 1992, PHYSIOL REV, V72, P231, DOI 10.1152/physrev.1992.72.1.231; Cupples WA, 2007, AM J PHYSIOL-RENAL, V292, pF1105, DOI 10.1152/ajprenal.00194.2006; EHMKE H, 1990, AM J PHYSIOL, V259, pF466, DOI 10.1152/ajprenal.1990.259.3.F466; Evans RG, 2004, J HYPERTENS, V22, P1439, DOI 10.1097/01.hjh.0000133744.85490.9d; Firsov D, 1998, EMBO J, V17, P344, DOI 10.1093/emboj/17.2.344; FLORIJN KW, 1994, KIDNEY INT, V46, P252, DOI 10.1038/ki.1994.267; Frindt G, 2007, AM J PHYSIOL-RENAL, V292, pF1190, DOI 10.1152/ajprenal.00399.2006; Grifoni SC, 2010, AM J PHYSIOL-RENAL, V298, pF285, DOI 10.1152/ajprenal.00496.2009; Gross V, 1997, HYPERTENSION, V29, P1252, DOI 10.1161/01.HYP.29.6.1252; Gurley SB, 2010, J AM SOC NEPHROL, V21, P1847, DOI 10.1681/ASN.2009121306; Guyenet PG, 2006, NAT REV NEUROSCI, V7, P335, DOI 10.1038/nrn1902; GUYTON AC, 1991, SCIENCE, V252, P1813, DOI 10.1126/science.2063193; GUYTON AC, 1989, AM J HYPERTENS, V2, P575, DOI 10.1093/ajh/2.7.575; Hahntow IN, 2009, AM J HYPERTENS, V22, P80, DOI 10.1038/ajh.2008.310; Hercule HC, 2007, EXP PHYSIOL, V92, P1014, DOI 10.1113/expphysiol.2007.038240; Heximer SP, 1999, J BIOL CHEM, V274, P34253, DOI 10.1074/jbc.274.48.34253; Heximer SP, 2004, METHOD ENZYMOL, V390, P65; Heximer SP, 2003, J CLIN INVEST, V111, P445, DOI 10.1172/JC1200315598; Hollinger S, 2002, PHARMACOL REV, V54, P527, DOI 10.1124/pr.54.3.527; Husted RF, 1996, AM J PHYSIOL-RENAL, V271, pF1029, DOI 10.1152/ajprenal.1996.271.5.F1029; Jang HS, 2014, BBA-MOL BASIS DIS, V1842, P1733, DOI 10.1016/j.bbadis.2014.06.022; Just A, 2003, AM J PHYSIOL-REG I, V285, pR619, DOI 10.1152/ajpregu.00766.2002; Kemp BA, 2014, CIRC RES, V115, P388, DOI 10.1161/CIRCRESAHA.115.304110; Kim SW, 2006, KIDNEY INT, V69, P89, DOI 10.1038/sj.ki.5000018; Kimura G, 1997, J HYPERTENS, V15, P1055, DOI 10.1097/00004872-199715100-00002; Lifton RP, 2001, CELL, V104, P545, DOI 10.1016/S0092-8674(01)00241-0; Mamenko M, 2012, J BIOL CHEM, V287, P660, DOI 10.1074/jbc.M111.298919; Mattson DL, 2005, AM J PHYSIOL-REG I, V289, pR991, DOI 10.1152/ajpregu.00207.2005; MIZELLE HL, 1989, AM J PHYSIOL, V257, pR1169, DOI 10.1152/ajpregu.1989.257.5.R1169; MORAN K, 1992, J UROLOGY, V148, P463, DOI 10.1016/S0022-5347(17)36629-6; Noonan WT, 2005, AM J PHYSIOL-REG I, V288, pR685, DOI 10.1152/ajpregu.00209.2004; Oliveira-dos-Santos AJ, 2000, P NATL ACAD SCI USA, V97, P12272, DOI 10.1073/pnas.220414397; Osei-Owusu P, 2012, J BIOL CHEM, V287, P12541, DOI 10.1074/jbc.M111.332130; Qi ZH, 2004, AM J PHYSIOL-RENAL, V286, pF590, DOI 10.1152/ajprenal.00324.2003; Ren YL, 2001, KIDNEY INT, V59, P222, DOI 10.1046/j.1523-1755.2001.00482.x; Riddle EL, 2006, HYPERTENSION, V47, P415, DOI 10.1161/01.HYP.0000200714.81990.61; ROMAN RJ, 1985, AM J PHYSIOL, V248, pF190, DOI 10.1152/ajprenal.1985.248.2.F190; Ross EM, 2000, ANNU REV BIOCHEM, V69, P795, DOI 10.1146/annurev.biochem.69.1.795; Singh H, 2012, MITOCHONDRION, V12, P230, DOI 10.1016/j.mito.2011.09.004; Snyder PM, 1998, J BIOL CHEM, V273, P681, DOI 10.1074/jbc.273.2.681; Sturgeon C, 1998, J APPL PHYSIOL, V84, P2154, DOI 10.1152/jappl.1998.84.6.2154; Vallon V, 2011, AM J PHYSIOL-RENAL, V301, pF463, DOI 10.1152/ajprenal.00236.2011; Watson N, 1996, NATURE, V383, P172, DOI 10.1038/383172a0; Wirth A, 2008, NAT MED, V14, P64, DOI 10.1038/nm1666; Worzfeld T, 2008, TRENDS PHARMACOL SCI, V29, P582, DOI 10.1016/j.tips.2008.08.002; Xie ZW, 2011, J BIOL CHEM, V286, P44646, DOI 10.1074/jbc.M111.265462; Yang J, 2005, J HYPERTENS, V23, P1497, DOI 10.1097/01.hjh.0000174606.41651.ae; Zhong JY, 2012, PEDIATR RES, V72, P241, DOI 10.1038/pr.2012.81; Zuber AM, 2007, J AM SOC NEPHROL, V18, P1672, DOI 10.1681/ASN.2007010032	61	14	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2015	10	7							e0132594	10.1371/journal.pone.0132594	http://dx.doi.org/10.1371/journal.pone.0132594			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LN	26193676	Green Published, gold, Green Submitted			2022-12-26	WOS:000358546400033
J	Pan, SM; Li, YK; Xu, ZQ; Chong, YW				Pan, Shaoming; Li, Yongkai; Xu, Zhengquan; Chong, Yanwen			Distributed Storage Algorithm for Geospatial Image Data Based on Data Access Patterns	PLOS ONE			English	Article								Declustering techniques are widely used in distributed environments to reduce query response time through parallel I/O by splitting large files into several small blocks and then distributing those blocks among multiple storage nodes. Unfortunately, however, many small geospatial image data files cannot be further split for distributed storage. In this paper, we propose a complete theoretical system for the distributed storage of small geospatial image data files based on mining the access patterns of geospatial image data using their historical access log information. First, an algorithm is developed to construct an access correlation matrix based on the analysis of the log information, which reveals the patterns of access to the geospatial image data. Then, a practical heuristic algorithm is developed to determine a reasonable solution based on the access correlation matrix. Finally, a number of comparative experiments are presented, demonstrating that our algorithm displays a higher total parallel access probability than those of other algorithms by approximately 10-15% and that the performance can be further improved by more than 20% by simultaneously applying a copy storage strategy. These experiments show that the algorithm can be applied in distributed environments to help realize parallel I/O and thereby improve system performance.	[Pan, Shaoming; Xu, Zhengquan; Chong, Yanwen] Wuhan Univ, State Key Lab Informat Engn Surveying Mapping & R, Wuhan, Hubei, Peoples R China; [Li, Yongkai] Wuhan Univ, Comp Sch, Wuhan, Hubei, Peoples R China; [Pan, Shaoming; Xu, Zhengquan] Collaborat Innovat Ctr Geospatial Technol, Wuhan, Hubei, Peoples R China	Wuhan University; Wuhan University	Xu, ZQ (corresponding author), Wuhan Univ, State Key Lab Informat Engn Surveying Mapping & R, Wuhan, Hubei, Peoples R China.	xuzq@whu.edu.cn			National Nature Science Foundation of China [41271398]; National Key Basic Research and Development Program of China [2011CB302306]; Fundamental Research Funds for the Central Universities [2042014kf0263, 2042014kf0242]; Fund of SAST [SAST201425]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Basic Research and Development Program of China(National Basic Research Program of China); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Fund of SAST	This research was sponsored by the National Nature Science Foundation of China (Project No. 41271398) (SMP), the National Key Basic Research and Development Program of China (Project No. 2011CB302306) (ZQX), the Fundamental Research Funds for the Central Universities (Project No. 2042014kf0263 (SMP), 2042014kf0242 (YWC)) and supported by the Fund of SAST (Project No. SAST201425) (YWC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barclay T, 2006, IEEE INTERNET COMPUT, V10, P16, DOI 10.1109/MIC.2006.95; Bell David G., 2007, 2007 IEEE Aerospace Conference, P1, DOI 10.1109/AERO.2007.352954; Boschetti L, 2008, INT J REMOTE SENS, V29, P3067, DOI 10.1080/01431160701733023; Carns P, 2009, INT PARALL DISTRIB P, P524, DOI 10.1079/9781845933975.0001; Cuthill E., 1969, P 24 NAT C ACM, P157, DOI DOI 10.1145/800195.805928; Dong B., 2010, P IEEE INT C SERV CO, DOI DOI 10.1109/SCC.2010.72; Dong B, 2012, J NETW COMPUT APPL, V35, P1847, DOI 10.1016/j.jnca.2012.07.009; Fisher D, 2007, IEEE T VIS COMPUT GR, V13, P1184, DOI 10.1109/TVCG.2007.70561; Fister I, 2015, APPL MATH COMPUT, V262, P178, DOI 10.1016/j.amc.2015.04.004; Garcia Martin R, 2013, INT J GEOGR INF SCI, V27, P614, DOI 10.1080/13658816.2012.721555; GHEMAWAT S, 2003, ACM SIGOPS OPERATING, V37, P29, DOI [10.1145/1165389.945450, DOI 10.1145/1165389.945450, 10.1145/945445.945450]; GIBBS NE, 1976, SIAM J NUMER ANAL, V13, P236, DOI 10.1137/0713023; Gibin M., 2008, APPL SPAT ANAL POLIC, V1, P85, DOI [10.1007/s12061-008-9005-5, DOI 10.1007/S12061-008-9005-5]; Giuliani G, 2012, COMPUT GEOSCI-UK, V47, P20, DOI 10.1016/j.cageo.2011.10.009; GRIFFIOEN J, 1994, PROCEEDINGS OF THE SUMMER 1994 USENIX CONFERENCE, P197; Hendricks J, 2006, 06104 CARN MELL U PA; Kroeger T. M., 1999, Proceedings of the Seventh Workshop on Hot Topics in Operating Systems, P14, DOI 10.1109/HOTOS.1999.798371; Lee DH, 2002, LECT NOTES COMPUT SC, V2457, P213; Li R, 2012, INT J GEOGR INF SCI, V26, P1831, DOI 10.1080/13658816.2012.659184; Liu XD, 2009, ENVIRON RES LETT, V4, DOI 10.1088/1748-9326/4/4/045203; Lu XF, 2011, SCI CHINA TECHNOL SC, V54, P3220, DOI 10.1007/s11431-011-4549-z; MCCULLOCH CM, 1985, IEEE T COMPUT, V34, P387, DOI 10.1109/TC.1985.5009393; Pan SM, 2013, PROCEEDINGS OF THE 2013 8TH INTERNATIONAL CONFERENCE ON COMPUTER SCIENCE & EDUCATION (ICCSE 2013), P1423; [潘少明 PAN Shaoming], 2009, [测绘学报, Acta Geodetica et Cartographica Sinica], V38, P236; Roselli D, 2000, USENIX ASSOCIATION PROCEEDINGS OF THE 2000 USENIX ANNUAL TECHNICAL CONFERENCE, P41; Samo R, 2015, 0201 U LJUBLJ U MAR; Sample JT, 2010, TILE-BASED GEOSPATIAL INFORMATION SYSTEMS: PRINCIPLES AND PRACTICES, P1, DOI 10.1007/978-1-4419-7631-4; Shafer J, 2010, INT SYM PERFORM ANAL, P122, DOI 10.1109/ISPASS.2010.5452045; Trujillo P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030546; Wang Hao, 2010, Geomatics and Information Science of Wuhan University, V35, P356; Weil S. A., 2007, P 2007 ACM PET DAT S; [颜安 YAN An], 2009, [地球信息科学, Geo-information Science], V11, P250; Yu Zhanwu, 2008, Geomatics and Information Science of Wuhan University, V33, P285; Zhu YF, 2006, CLUSTER COMPUT, V9, P433, DOI 10.1007/s10586-006-0011-6; Zukerman I, 1999, CISM COURSES LECT, P275	35	3	4	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2015	10	7							e0133029	10.1371/journal.pone.0133029	http://dx.doi.org/10.1371/journal.pone.0133029			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RQ	26181628	gold, Green Published, Green Submitted			2022-12-26	WOS:000358198200050
J	Zhuang, LL; Yuan, XY; Chen, Y; Xu, B; Yang, ZM; Huang, BR				Zhuang, Lili; Yuan, Xiuyun; Chen, Yu; Xu, Bin; Yang, Zhimin; Huang, Bingru			PpCBF3 from Cold-Tolerant Kentucky Bluegrass Involved in Freezing Tolerance Associated with Up-Regulation of Cold-Related Genes in Transgenic Arabidopsis thaliana	PLOS ONE			English	Article							BINDING TRANSCRIPTION FACTOR; CONFERS ELEVATED TOLERANCE; STRESS TOLERANCE; LOW-TEMPERATURE; HETEROLOGY EXPRESSION; FUNCTIONAL-ANALYSIS; COR15A GENE; DREB1A GENE; DROUGHT; DEHYDRATION	Dehydration-Responsive Element Binding proteins (DREB)/C-repeat (CRT) Binding Factors (CBF) have been identified as transcriptional activators during plant responses to cold stress. The objective of this study was to determine the physiological roles of a CBF gene isolated from a cold-tolerant perennial grass species, Kentucky bluegrass (Poa pratensis L.), which designated as PpCBF3, in regulating plant tolerance to freezing stress. Transient transformation of Arabidopsis thaliana mesophyll protoplast with PpCBF3-eGFP fused protein showed that PpCBF3 was localized to the nucleus. RT-PCR analysis showed that PpCBF3 was specifically induced by cold stress (4 degrees C) but not by drought stress [induced by 20% polyethylene glycol 6000 solution (PEG-6000)] or salt stress (150 mM NaCl). Transgenic Arabidopsis overexpressing PpCBF3 showed significant improvement in freezing (-20 degrees C) tolerance demonstrated by a lower percentage of chlorotic leaves, lower cellular electrolyte leakage (EL) and H2O2 and O-2(center dot-) content, and higher chlorophyll content and photochemical efficiency compared to the wild type. Relative mRNA expression level analysis by qRT-PCR indicated that the improved freezing tolerance of transgenic Arabidopsis plants overexpressing PpCBF3 was conferred by sustained activation of downstream cold responsive (COR) genes. Other interesting phenotypic changes in the PpCBF3-transgenic Arabidopsis plants included late flowering and slow growth or 'dwarfism', both of which are desirable phenotypic traits for perennial turfgrasses. Therefore, PpCBF3 has potential to be used in genetic engineering for improvement of turfgrass freezing tolerance and other desirable traits.	[Zhuang, Lili; Yuan, Xiuyun; Chen, Yu; Xu, Bin; Yang, Zhimin] Nanjing Agr Univ, Coll Agrograssland Sci, Nanjing, Jiangsu, Peoples R China; [Huang, Bingru] Rutgers State Univ, Dept Plant Biol & Pathol, New Brunswick, NJ 08901 USA	Nanjing Agricultural University; Rutgers State University New Brunswick	Yang, ZM (corresponding author), Nanjing Agr Univ, Coll Agrograssland Sci, Nanjing, Jiangsu, Peoples R China.	nauyzm@njau.edu.cn; huang@aesop.rutgers.edu						Agarwal PK, 2006, PLANT CELL REP, V25, P1263, DOI 10.1007/s00299-006-0204-8; ARNON DI, 1949, PLANT PHYSIOL, V24, P1, DOI 10.1104/pp.24.1.1; Artus NN, 1996, P NATL ACAD SCI USA, V93, P13404, DOI 10.1073/pnas.93.23.13404; ASADA K, 1992, PHYSIOL PLANTARUM, V85, P235, DOI 10.1111/j.1399-3054.1992.tb04728.x; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Dubouzet JG, 2003, PLANT J, V33, P751, DOI 10.1046/j.1365-313X.2003.01661.x; Earley KW, 2006, PLANT J, V45, P616, DOI 10.1111/j.1365-313X.2005.02617.x; Fowler S, 2002, PLANT CELL, V14, P1675, DOI 10.1105/tpc.003483; Fry J., 2004, APPL TURFGRASS SCI P; Gilmour SJ, 1998, PLANT J, V16, P433, DOI 10.1046/j.1365-313x.1998.00310.x; Haake V, 2002, PLANT PHYSIOL, V130, P639, DOI 10.1104/pp.006478; HAJELA RK, 1990, PLANT PHYSIOL, V93, P1246, DOI 10.1104/pp.93.3.1246; HOAGLAND D. R., 1950, Circular. California Agricultural Experiment Station, V347; Hsieh TH, 2002, PLANT PHYSIOL, V129, P1086, DOI 10.1104/pp.003442; Igarashi Y, 1997, PLANT MOL BIOL, V33, P857, DOI 10.1023/A:1005702408601; Ito Y, 2006, PLANT CELL PHYSIOL, V47, P141, DOI 10.1093/pcp/pci230; Jaglo-Ottosen KR, 1998, SCIENCE, V280, P104, DOI 10.1126/science.280.5360.104; James VA, 2008, TRANSGENIC RES, V17, P93, DOI 10.1007/s11248-007-9086-y; Kasuga M, 2004, PLANT CELL PHYSIOL, V45, P346, DOI 10.1093/pcp/pch037; Kasuga M, 1999, NAT BIOTECHNOL, V17, P287, DOI 10.1038/7036; Kidokoro S, 2015, PLANT J, V81, P505, DOI 10.1111/tpj.12746; Kourosh V, 2013, EXTREME TEMPERATURE, P169; Lata C, 2011, J EXP BOT, V62, P4731, DOI 10.1093/jxb/err210; Lee BH, 2002, PLANT CELL, V14, P1235, DOI 10.1105/tpc.010433; Li XL, 2014, PLANT CELL REP, V33, P767, DOI 10.1007/s00299-014-1602-y; Liu Q, 1998, PLANT CELL, V10, P1391, DOI 10.1105/tpc.10.8.1391; Magome H, 2004, PLANT J, V37, P720, DOI 10.1111/j.1365-313X.2003.01998.x; Marcum KB, 1998, CROP SCI, V38, P1214, DOI 10.2135/cropsci1998.0011183X003800050017x; Maruyama K, 2004, PLANT J, V38, P982, DOI 10.1111/j.1365-313X.2004.02100.x; Maruyama K, 2012, DNA RES, V19, P37, DOI 10.1093/dnares/dsr040; Mizoi J, 2012, BBA-GENE REGUL MECH, V1819, P86, DOI 10.1016/j.bbagrm.2011.08.004; Morran S, 2011, PLANT BIOTECHNOL J, V9, P230, DOI 10.1111/j.1467-7652.2010.00547.x; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Nilsen ET, 2004, ABIOTIC FACTORS; Pellegrineschi A, 2004, GENOME, V47, P493, DOI 10.1139/G03-140; Qin F, 2004, PLANT CELL PHYSIOL, V45, P1042, DOI 10.1093/pcp/pch118; Sakuma Y, 2002, BIOCHEM BIOPH RES CO, V290, P998, DOI 10.1006/bbrc.2001.6299; Sanghera GS, 2011, CURR GENOMICS, V12, P30, DOI 10.2174/138920211794520178; Shen YG, 2003, THEOR APPL GENET, V106, P923, DOI 10.1007/s00122-002-1131-x; Shinwari ZK, 1998, BIOCHEM BIOPH RES CO, V250, P161, DOI 10.1006/bbrc.1998.9267; Steponkus PL, 1998, P NATL ACAD SCI USA, V95, P14570, DOI 10.1073/pnas.95.24.14570; Stockinger EJ, 1997, P NATL ACAD SCI USA, V94, P1035, DOI 10.1073/pnas.94.3.1035; Taji T, 2002, PLANT J, V29, P417, DOI 10.1046/j.0960-7412.2001.01227.x; Tang MJ, 2005, PLANT PHYSIOL BIOCH, V43, P233, DOI 10.1016/j.plaphy.2005.01.015; Thomashow MF, 1998, PLANT PHYSIOL, V118, P1, DOI 10.1104/pp.118.1.1; Wang LH, 2015, MOL BIOL REP, V42, P937, DOI 10.1007/s11033-014-3831-0; Wanner LA, 1999, PLANT PHYSIOL, V120, P391, DOI 10.1104/pp.120.2.391; Wu FH, 2009, PLANT METHODS, V5, DOI 10.1186/1746-4811-5-16; Xiong YW, 2006, PLANTA, V224, P878, DOI 10.1007/s00425-006-0273-5; Xue GP, 2011, MOL PLANT, V4, P697, DOI 10.1093/mp/ssr013; Yang S, 2011, J PLANT PHYSIOL, V168, P1804, DOI 10.1016/j.jplph.2011.05.017; Zhang X, 2004, PLANT J, V39, P905, DOI 10.1111/j.1365-313X.2004.02176.x; Zhao H, 2008, MOL GENET GENOMICS, V279, P585, DOI 10.1007/s00438-008-0335-4	53	63	75	3	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0132928	10.1371/journal.pone.0132928	http://dx.doi.org/10.1371/journal.pone.0132928			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26177510	Green Submitted, Green Published, gold			2022-12-26	WOS:000358197600183
J	Satheesha, S; Manzella, G; Bovay, A; Casanova, EA; Bode, PK; Belle, R; Feuchtgruber, S; Jaaks, P; Dogan, N; Koscielniak, E; Schafer, BW				Satheesha, S.; Manzella, G.; Bovay, A.; Casanova, E. A.; Bode, P. K.; Belle, R.; Feuchtgruber, S.; Jaaks, P.; Dogan, N.; Koscielniak, E.; Schafer, B. W.			Targeting hedgehog signaling reduces self-renewal in embryonal rhabdomyosarcoma	ONCOGENE			English	Article							STEM-CELLS; TUMOR-CELL; PATHWAY; GROWTH; GLI; REQUIREMENT; EXPRESSION; MODEL; RAS	Current treatment regimens for rhabdomyosarcoma (RMS), the most common pediatric soft tissue cancer, rely on conventional chemotherapy, and although they show clinical benefit, there is a significant risk of adverse side effects and secondary tumors later in life. Therefore, identifying and targeting sub-populations with higher tumorigenic potential and self-renewing capacity would offer improved patient management strategies. Hedgehog signaling has been linked to the development of embryonal RMS (ERMS) through mouse genetics and rare human syndromes. However, activating mutations in this pathway in sporadic RMS are rare and therefore the contribution of hedgehog signaling to oncogenesis remains unclear. Here, we show by genetic loss-and gain-of-function experiments and the use of clinically relevant small molecule modulators that hedgehog signaling is important for controlling self-renewal of a subpopulation of RMS cells in vitro and tumor initiation in vivo. In addition, hedgehog activity altered chemoresistance, motility and differentiation status. The core stem cell gene NANOG was determined to be important for ERMS self-renewal, possibly acting downstream of hedgehog signaling. Crucially, evaluating the presence of a subpopulation of tumor-propagating cells in patient biopsies identified by GLI1 and NANOG expression had prognostic significance. Hence, this work identifies novel functional aspects of hedgehog signaling in ERMS, redefines the rationale for its targeting as means to control ERMS self-renewal and underscores the importance of studying functional tumor heterogeneity in pediatric cancers.	[Satheesha, S.; Manzella, G.; Bovay, A.; Casanova, E. A.; Bode, P. K.; Belle, R.; Jaaks, P.; Dogan, N.; Schafer, B. W.] Univ Childrens Hosp, Dept Oncol, Steinwiessstr 75, CH-8032 Zurich, Switzerland; [Satheesha, S.; Manzella, G.; Bovay, A.; Casanova, E. A.; Bode, P. K.; Belle, R.; Jaaks, P.; Dogan, N.; Schafer, B. W.] Univ Childrens Hosp, Childrens Res Ctr, Steinwiessstr 75, CH-8032 Zurich, Switzerland; [Bode, P. K.] Univ Zurich Hosp, Inst Surg Pathol, CH-8091 Zurich, Switzerland; [Feuchtgruber, S.; Koscielniak, E.] Klinikum Stuttgart, Olgahosp, Dept Oncol Hematol Immunol, Stuttgart, Germany	University Children's Hospital Zurich; University Children's Hospital Zurich; University of Zurich; University Zurich Hospital; General Hospital of N. Ionia Agia Olga; Klinikum Stuttgart	Schafer, BW (corresponding author), Univ Childrens Hosp, Dept Oncol, Steinwiessstr 75, CH-8032 Zurich, Switzerland.; Schafer, BW (corresponding author), Univ Childrens Hosp, Childrens Res Ctr, Steinwiessstr 75, CH-8032 Zurich, Switzerland.	Beat.Schaefer@kispi.uzh.ch		Bode, Peter/0000-0002-9633-4042; Schafer, Beat/0000-0001-5988-2915; Rappaz, Sampoorna/0000-0002-7330-7586; Bovay, Amandine/0000-0001-6947-9812	Swiss National Science Fund [31003A-138460]; Sciex [F-80016-02-01]; Cancer League Canton Zurich	Swiss National Science Fund(Swiss National Science Foundation (SNSF)); Sciex; Cancer League Canton Zurich	We highly appreciate St Jude's Children's Research Hospital for providing the ERMS PDX samples, Swiss Pediatric Oncology Group (SPOG) for providing ERMS patient tumor samples and the German Soft tissue sarcoma study group (CWS) for providing the TMA sections and performing the clinical data analysis. We are also grateful to Silvia Behnke (Sophistolab AG) and the technicians at the Institute of Surgical Pathology (University Hospital Zurich) for their excellent service. The work was supported by grants from Swiss National Science Fund (31003A-138460), Sciex (F-80016-02-01) and Cancer League Canton Zurich.	Amakye D, 2013, NAT MED, V19, P1410, DOI 10.1038/nm.3389; Annavarapu SR, 2013, LAB INVEST, V93, P1090, DOI 10.1038/labinvest.2013.97; Belyea Brian, 2012, Sarcoma, V2012, P406239, DOI 10.1155/2012/406239; Brack AS, 2008, CELL STEM CELL, V2, P50, DOI 10.1016/j.stem.2007.10.006; Buckingham M, 2007, ANNU REV CELL DEV BI, V23, P645, DOI 10.1146/annurev.cellbio.23.090506.123438; Chen EY, 2014, P NATL ACAD SCI USA, V111, P5349, DOI 10.1073/pnas.1317731111; Chen X, 2013, CANCER CELL, V24, P710, DOI 10.1016/j.ccr.2013.11.002; Ehnman M, 2013, CANCER RES, V73, P2139, DOI 10.1158/0008-5472.CAN-12-1646; Franken NAP, 2006, NAT PROTOC, V1, P2315, DOI 10.1038/nprot.2006.339; Gage PJ, 2005, INVEST OPHTH VIS SCI, V46, P4200, DOI 10.1167/iovs.05-0691; Hawkins DS, 2014, CURR OPIN PEDIATR, V26, P50, DOI 10.1097/MOP.0000000000000041; Hirotsu M, 2009, BRIT J CANCER, V101, P2030, DOI 10.1038/sj.bjc.6605407; Hui CC, 2011, ANNU REV CELL DEV BI, V27, P513, DOI 10.1146/annurev-cellbio-092910-154048; Ignatius MS, 2012, CANCER CELL, V21, P680, DOI 10.1016/j.ccr.2012.03.043; Kuang S, 2008, CELL STEM CELL, V2, P22, DOI 10.1016/j.stem.2007.12.012; Langenau DM, 2007, GENE DEV, V21, P1382, DOI 10.1101/gad.1545007; Liu P, 2010, DEV DYNAM, V239, P2161, DOI 10.1002/dvdy.22347; Mao J, 2006, CANCER RES, V66, P10171, DOI 10.1158/0008-5472.CAN-06-0657; Merchant AA, 2010, CLIN CANCER RES, V16, P3130, DOI 10.1158/1078-0432.CCR-09-2846; Nitzki F, 2011, ONCOGENE, V30, P4428, DOI 10.1038/onc.2011.157; Paulson V, 2011, GENE CHROMOSOME CANC, V50, P397, DOI 10.1002/gcc.20864; Po A, 2010, EMBO J, V29, P2646, DOI 10.1038/emboj.2010.131; Pressey JG, 2013, PEDIATR BLOOD CANCER, V60, P45, DOI 10.1002/pbc.24117; Pressey JG, 2011, PEDIATR BLOOD CANCER, V57, P930, DOI 10.1002/pbc.23174; Raimondi L, 2012, CELL DEATH DIFFER, V19, P871, DOI 10.1038/cdd.2011.171; Rajurkar M, 2014, ONCOGENE, V33, P5370, DOI 10.1038/onc.2013.480; Satheesha S, 2014, STEM CELLS CANC STEM, V11, P111; Shern JF, 2014, CANCER DISCOV, V4, P216, DOI 10.1158/2159-8290.CD-13-0639; Stecca B, 2007, P NATL ACAD SCI USA, V104, P5895, DOI 10.1073/pnas.0700776104; Stecca B, 2009, EMBO J, V28, P663, DOI 10.1038/emboj.2009.16; Theunissen TW, 2011, PHILOS T R SOC B, V366, P2222, DOI 10.1098/rstb.2011.0003; Vermeulen L, 2012, LANCET ONCOL, V13, pE83, DOI 10.1016/S1470-2045(11)70257-1; Vidal SJ, 2014, ONCOGENE, V33, P4451, DOI 10.1038/onc.2013.411; von Maltzahn J, 2012, TRENDS CELL BIOL, V22, P602, DOI 10.1016/j.tcb.2012.07.008; Voronova A, 2013, J BIOL CHEM, V288, P4389, DOI 10.1074/jbc.M112.400184; Wachtel M, 2006, J CLIN ONCOL, V24, P816, DOI 10.1200/JCO.2005.03.4934; Walter D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019506; Wang ML, 2013, ONCOTARGETS THER, V6, P1207, DOI 10.2147/OTT.S38114; Zbinden M, 2010, EMBO J, V29, P2659, DOI 10.1038/emboj.2010.137; Zibat A, 2010, ONCOGENE, V29, P6323, DOI 10.1038/onc.2010.368	40	37	37	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 21	2016	35	16					2020	2030		10.1038/onc.2015.267	http://dx.doi.org/10.1038/onc.2015.267			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DJ9AH	26189795	hybrid, Green Published			2022-12-26	WOS:000374505600002
J	Wotring, VE				Wotring, Virginia E.			Medication use by US crewmembers on the International Space Station	FASEB JOURNAL			English	Article						spaceflight; microgravity; pharmaceutical; astronaut; medicine	ASTRONAUTS; SLEEP; SPACEFLIGHT; HEADACHE; VIRUS	The environment on the International Space Station (ISS) includes a variety of potential physiologic stressors, including low gravity, elevated exposure to radiation, confined living and working quarters, a heavy workload, and high public visibility. This retrospective study examined medication use during long-duration spaceflights (>30 d). Medication records from 24 crewmembers on 20 missions longer than 30 d over a 10 yr period were examined for trends in usage rates, efficacy, and indication, as well as adverse event quality, frequency, and severity. Results were compared with those from crewmembers on shorter space shuttle missions (>16 d) and other reports of medication use by healthy adults. The most frequently used medications on the ISS were for sleep problems, pain, congestion, or allergy. Medication use during spaceflight missions was similar to that noted on the Space Shuttle and in adult ambulatory medicine, except that usage of sleep aids was about 10 times higher during spaceflight missions. There were also 2 apparent treatment failures in cases of skin rash, raising questions about the efficacy or suitability of the treatments used. Many spaceflight-related medication uses (at least 10%) were linked to extravehicular activities, exercise protocols, or equipment and operationally driven schedule changes. It seems likely that alterations in spaceflight mission operations (schedule-shifting and lighting) or hardware (extravehicular activity suits and exercise equipment) could reduce the need for a sizable fraction of medication uses.	[Wotring, Virginia E.] Univ Space Res Assoc, Div Space Life Sci, Houston, TX USA	Universities Space Research Association (USRA)	Wotring, VE (corresponding author), Baylor Coll Med, Ctr Space Med, 6500 Main St,Suite 910, Houston, TX 77030 USA.	virginia.wotring@bcm.edu		Wotring, Virginia/0000-0002-3391-3899	Human Research Program of the U.S. National Aeronautics and Space Administration (NASA)	Human Research Program of the U.S. National Aeronautics and Space Administration (NASA)	The author thanks the staff of the Johnson Space Center Lifetime Surveillance of Astronaut Health, especially J. Charvat, for supplying deidentified data for research purposes, P. Norsk for helpful discussions, J. Krauhs for manuscript editing, and K. So for library services. This study was funded by the Human Research Program of the U.S. National Aeronautics and Space Administration (NASA).	Barger LK, 2014, LANCET NEUROL, V13, P904, DOI 10.1016/S1474-4422(14)70122-X; BRUNNER LJ, 1995, J PHARMACOL EXP THER, V274, P345; Buckey JC, 2006, SPACE PHYSL; Castro VA, 2004, MICROB ECOL, V47, P119, DOI 10.1007/s00248-003-1030-y; Clement G, 2003, FUNDAMENTALS SPACE M; Crucian B., 2009, RISK CREW ADVERSE HL; Crucian B, 2013, J CLIN IMMUNOL, V33, P456, DOI 10.1007/s10875-012-9824-7; Crucian B, 2009, J LEUKOCYTE BIOL, V86, P1017, DOI 10.1189/jlb.0709500; Cucinotta FA, 2008, RADIAT RES, V170, P127, DOI 10.1667/RR1330.1; CZEISLER CA, 1991, EXP GERONTOL, V26, P217, DOI 10.1016/0531-5565(91)90014-D; DAVIS JR, 1988, AVIAT SPACE ENVIR MD, V59, P1185; DeMers G., 2009, ASSESSMENT HEADACHE; French DP, 2008, PHARM WORLD SCI, V30, P79, DOI 10.1007/s11096-007-9146-7; GRAYBIEL A, 1976, AVIAT SPACE ENVIR MD, V47, P873; Hargens AR, 2009, RESP PHYSIOL NEUROBI, V169, pS30, DOI 10.1016/j.resp.2009.07.005; Hargens AR, 1996, MED SCI SPORT EXER, V28, P977, DOI 10.1097/00005768-199608000-00007; Horn WG, 2003, AVIAT SPACE ENVIR MD, V74, P858; James J., 2011, 41 INT C ENV SYST; Jan MH, 2002, UNDERSEA HYPERBAR M, V29, P294; Kaufman DW, 2002, JAMA-J AM MED ASSOC, V287, P337, DOI 10.1001/jama.287.3.337; Kelly TH, 2005, J EXP ANAL BEHAV, V84, P227, DOI 10.1901/jeab.2005.77-04; Margel D, 2003, CHEST, V124, P1716, DOI 10.1378/chest.124.5.1716; Martelletti P, 2007, J HEADACHE PAIN, V8, P149, DOI 10.1007/s10194-007-0382-y; Mehta SK, 2004, J MED VIROL, V72, P174, DOI 10.1002/jmv.10555; Ortega H., 2019, PRINCIPLES CLIN MED, P221, DOI [10.1007/978-0-387-68164-1_10, DOI 10.1007/978-0-387-68164-1_10]; Pierson DL, 2005, BRAIN BEHAV IMMUN, V19, P235, DOI 10.1016/j.bbi.2004.08.001; Platts S., 2010, RISK CARDIAC RHYTHM; Putcha L, 1999, AVIAT SPACE ENVIR MD, V70, P705; Scheuring RA, 2009, AVIAT SPACE ENVIR MD, V80, P117, DOI 10.3357/ASEM.2270.2009; Steiner TJ, 2007, J HEADACHE PAIN, V8, pS3; Strauss S, 2005, AVIAT SPACE ENVIR MD, V76, P469; WING PC, 1991, ORTHOP CLIN N AM, V22, P255	32	44	47	3	29	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2015	29	11					4417	4423		10.1096/fj.14-264838	http://dx.doi.org/10.1096/fj.14-264838			7	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CV8EZ	26187345	Green Submitted			2022-12-26	WOS:000364514700003
J	Orogo, AM; Gonzalez, ER; Kubli, DA; Baptista, IL; Ong, SB; Prolla, TA; Sussman, MA; Murphy, AN; Gustafsson, AB				Orogo, Amabel M.; Gonzalez, Eileen R.; Kubli, Dieter A.; Baptista, Igor L.; Ong, Sang-Bing; Prolla, Tomas A.; Sussman, Mark A.; Murphy, Anne N.; Gustafsson, Asa B.			Accumulation of Mitochondrial DNA Mutations Disrupts Cardiac Progenitor Cell Function and Reduces Survival	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESENCHYMAL STEM-CELLS; ISCHEMIC CARDIOMYOPATHY; MYOCARDIAL-INFARCTION; ELECTRON-TRANSPORT; OXIDATIVE STRESS; RANDOMIZED-TRIAL; SKELETAL-MUSCLE; HEART-FAILURE; MUTATOR MICE; COMPLEX-III	Transfer of cardiac progenitor cells (CPCs) improves cardiac function in heart failure patients. However, CPC function is reduced with age, limiting their regenerative potential. Aging is associated with numerous changes in cells including accumulation of mitochondrial DNA (mtDNA) mutations, but it is unknown how this impacts CPC function. Here, we demonstrate that acquisition of mtDNA mutations disrupts mitochondrial function, enhances mitophagy, and reduces the replicative and regenerative capacities of the CPCs. We show that activation of differentiation in CPCs is associated with expansion of the mitochondrial network and increased mitochondrial oxidative phosphorylation. Interestingly, mutant CPCs are deficient in mitochondrial respiration and rely on glycolysis for energy. In response to differentiation, these cells fail to activate mitochondrial respiration. This inability to meet the increased energy demand leads to activation of cell death. These findings demonstrate the consequences of accumulating mtDNA mutations and the importance of mtDNA integrity in CPC homeostasis and regenerative potential.	[Orogo, Amabel M.; Gonzalez, Eileen R.; Kubli, Dieter A.; Baptista, Igor L.; Ong, Sang-Bing; Gustafsson, Asa B.] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA; [Murphy, Anne N.; Gustafsson, Asa B.] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [Sussman, Mark A.] San Diego State Univ, San Diego Heart Res Inst, San Diego, CA 92182 USA; [Prolla, Tomas A.] Univ Wisconsin, Dept Genet, Madison, WI 53706 USA; [Prolla, Tomas A.] Univ Wisconsin, Dept Med Genet, Madison, WI 53706 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; California State University System; San Diego State University; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Gustafsson, AB (corresponding author), Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, 9500 Gilman Dr MC 0758, La Jolla, CA 92093 USA.	asag@ucsd.edu	ONG, SANG-BING/B-7786-2014; Baptista, Igor Luchini/N-6442-2016; Baptista, Igor/ABC-1551-2021; Regan, Clinton/E-6250-2012; Murphy, Anne N/H-3217-2016; Sussman, Mark/H-2284-2014	ONG, SANG-BING/0000-0001-7421-2610; Baptista, Igor Luchini/0000-0001-5185-0185; Baptista, Igor/0000-0001-5185-0185; Murphy, Anne N/0000-0002-5222-9902; Sussman, Mark/0000-0002-0104-4799	Fondation Leducq Transatlantic Network; National Institutes of Health [R01HL087023, R01HL101217, P01HL085577]; National Research Service Award Predoctoral Fellowship [F31HL123309, R01HL067245, R37HL091102, R01HL105759, R01HL113656, R01HL113647, R01HL122525];  [T32GM007752]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL113647, R01HL122525, R01HL113656, R01HL101217, P01HL085577, R37HL091102, R01HL067245, R01HL087023, F31HL123309, R01HL105759] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007752] Funding Source: NIH RePORTER	Fondation Leducq Transatlantic Network(Leducq Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Research Service Award Predoctoral Fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Supported by an award from the Fondation Leducq Transatlantic Network.; This work was supported, in whole or in part, by National Institutes of Health Grants R01HL087023, R01HL101217, and P01HL085577 (to A. B. G.), Institutional Training Grant T32GM007752 (NIGMS; University of California San Diego Graduate Training Program in Cellular and Molecular Pharmacology) and National Research Service Award Predoctoral Fellowship F31HL123309 (to A. M. O.), and R01HL067245, R37HL091102, R01HL105759, R01HL113656, R01HL113647, and R01HL122525 (to M. A. S.). The authors declare that they have no conflicts of interest with the contents of this article.	Acin-Perez R, 2004, MOL CELL, V13, P805, DOI 10.1016/S1097-2765(04)00124-8; Ahlqvist KJ, 2012, CELL METAB, V15, P100, DOI 10.1016/j.cmet.2011.11.012; Andres AM, 2015, J MOL CELL CARDIOL, V78, P62, DOI 10.1016/j.yjmcc.2014.10.003; Atamna H, 2004, AGEING RES REV, V3, P303, DOI 10.1016/j.arr.2004.02.002; Bearzi C, 2007, P NATL ACAD SCI USA, V104, P14068, DOI 10.1073/pnas.0706760104; Beltrami AP, 2003, CELL, V114, P763, DOI 10.1016/S0092-8674(03)00687-1; Bolli R, 2011, LANCET, V378, P1847, DOI 10.1016/S0140-6736(11)61590-0; Bratic A, 2013, J CLIN INVEST, V123, P951, DOI 10.1172/JCI64125; Cesselli D, 2011, AM J PATHOL, V179, P349, DOI 10.1016/j.ajpath.2011.03.036; Chen CT, 2008, STEM CELLS, V26, P960, DOI 10.1634/stemcells.2007-0509; Chugh AR, 2012, CIRCULATION, V126, pS54, DOI 10.1161/CIRCULATIONAHA.112.092627; Chung Susan, 2007, Nat Clin Pract Cardiovasc Med, V4 Suppl 1, pS60, DOI 10.1038/ncpcardio0766; Chung S, 2010, J MOL CELL CARDIOL, V48, P725, DOI 10.1016/j.yjmcc.2009.12.014; CORRALDEBRINSKI M, 1992, NAT GENET, V2, P324, DOI 10.1038/ng1292-324; Dai DF, 2010, AGING CELL, V9, P536, DOI 10.1111/j.1474-9726.2010.00581.x; Dai DF, 2009, CIRCULATION, V119, P2789, DOI 10.1161/CIRCULATIONAHA.108.822403; De Angelis A, 2010, CIRCULATION, V121, P276, DOI 10.1161/CIRCULATIONAHA.109.895771; Ellison GM, 2013, CELL, V154, P827, DOI 10.1016/j.cell.2013.07.039; Fischer KM, 2009, CIRCULATION, V120, P2077, DOI 10.1161/CIRCULATIONAHA.109.884403; Fransioli J, 2008, STEM CELLS, V26, P1315, DOI 10.1634/stemcells.2007-0751; Frerichs FCP, 2002, NEW ENGL J MED, V347, P1895, DOI 10.1056/NEJM200212053472320; Gaspar JA, 2014, CIRC RES, V114, P1346, DOI 10.1161/CIRCRESAHA.113.302021; Goichberg P, 2013, CIRCULATION, V128, P2211, DOI 10.1161/CIRCULATIONAHA.113.004698; Hanna RA, 2012, J BIOL CHEM, V287, P19094, DOI 10.1074/jbc.M111.322933; Hare JM, 2012, JAMA-J AM MED ASSOC, V308, P2369, DOI 10.1001/jama.2012.25321; Hariharan N, 2015, J AM COLL CARDIOL, V65, P133, DOI 10.1016/j.jacc.2014.09.086; HATEFI Y, 1985, ANNU REV BIOCHEM, V54, P1015, DOI 10.1146/annurev.biochem.54.1.1015; Heldman AW, 2014, JAMA-J AM MED ASSOC, V311, P62, DOI 10.1001/jama.2013.282909; Huang CQ, 2010, CIRCULATION, V121, P675, DOI 10.1161/CIRCULATIONAHA.109.902221; Ide T, 2001, CIRC RES, V88, P529, DOI 10.1161/01.RES.88.5.529; Karantalis V, 2014, CIRC RES, V114, P1302, DOI 10.1161/CIRCRESAHA.114.303180; Kasahara A, 2014, TRENDS CELL BIOL, V24, P761, DOI 10.1016/j.tcb.2014.08.005; Kasahara A, 2013, SCIENCE, V342, P734, DOI 10.1126/science.1241359; Khaidakov M, 2003, MUTAT RES-FUND MOL M, V526, P1, DOI 10.1016/S0027-5107(03)00010-1; Kubli DA, 2013, J BIOL CHEM, V288, P915, DOI 10.1074/jbc.M112.411363; Kubli DA, 2012, CIRC RES, V111, P1208, DOI 10.1161/CIRCRESAHA.112.265819; Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125; Lebrecht D, 2007, CARDIOVASC TOXICOL, V7, P108, DOI 10.1007/s12012-007-0009-1; Leri A, 2011, CIRC RES, V109, P941, DOI 10.1161/CIRCRESAHA.111.243154; Li QH, 2011, BASIC RES CARDIOL, V106, P849, DOI 10.1007/s00395-011-0180-1; Linke A, 2005, P NATL ACAD SCI USA, V102, P8966, DOI 10.1073/pnas.0502678102; Luchessi AD, 2009, J CELL PHYSIOL, V218, P480, DOI 10.1002/jcp.21619; McKenzie M, 2006, J MOL BIOL, V361, P462, DOI 10.1016/j.jmb.2006.06.057; Mohsin S, 2013, CIRC RES, V113, P1169, DOI 10.1161/CIRCRESAHA.113.302302; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Norddahl GL, 2011, CELL STEM CELL, V8, P499, DOI 10.1016/j.stem.2011.03.009; Nunnari J, 2012, CELL, V148, P1145, DOI 10.1016/j.cell.2012.02.035; Rikka S, 2011, CELL DEATH DIFFER, V18, P721, DOI 10.1038/cdd.2010.146; Schagger H, 2004, J BIOL CHEM, V279, P36349, DOI 10.1074/jbc.M404033200; Senyo SE, 2013, NATURE, V493, P433, DOI 10.1038/nature11682; Shavlakadze T, 2010, BIOGERONTOLOGY, V11, P363, DOI 10.1007/s10522-009-9260-0; Shefer G, 2006, DEV BIOL, V294, P50, DOI 10.1016/j.ydbio.2006.02.022; Spitkovsky D, 2004, FASEB J, V18, P1300, DOI 10.1096/fj.03-0520fje; Torella D, 2004, CIRC RES, V94, P514, DOI 10.1161/01.RES.0000117306.10142.50; Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517; Twig G, 2008, EMBO J, V27, P433, DOI 10.1038/sj.emboj.7601963; van Berlo JH, 2014, NATURE, V509, P337, DOI 10.1038/nature13309; Wahlestedt M, 2014, STEM CELLS, V32, P1173, DOI 10.1002/stem.1630; Wanagat J, 2002, J MOL CELL CARDIOL, V34, P17, DOI 10.1006/jmcc.2001.1483; Wang W, 2010, STEM CELLS, V28, P2195, DOI 10.1002/stem.542; Xu XL, 2013, CELL METAB, V18, P325, DOI 10.1016/j.cmet.2013.06.005; Ye L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033407	62	20	20	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	2015	290	36					22061	22075		10.1074/jbc.M115.649657	http://dx.doi.org/10.1074/jbc.M115.649657			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CQ9XI	26183775	Green Published, hybrid			2022-12-26	WOS:000360968500025
J	Becker, AM; Callahan, DJ; Richner, JM; Choi, J; DiPersio, JF; Diamond, MS; Bhattacharya, D				Becker, Amy M.; Callahan, Derrick J.; Richner, Justin M.; Choi, Jaebok; DiPersio, John F.; Diamond, Michael S.; Bhattacharya, Deepta			GPR18 Controls Reconstitution of Mouse Small Intestine Intraepithelial Lymphocytes following Bone Marrow Transplantation	PLOS ONE			English	Article							VERSUS-HOST-DISEASE; T-CELL-RECEPTOR; HEMATOPOIETIC STEM-CELLS; RECENT THYMIC EMIGRANTS; B-CELL; LINEAGE SPECIFICATION; PROGENITORS; IDENTIFICATION; EXPRESSION; INTEGRINS	Specific G protein coupled receptors (GPRs) regulate the proper positioning, function, and development of immune lineage subsets. Here, we demonstrate that GPR18 regulates the reconstitution of intraepithelial lymphocytes (IELs) of the small intestine following bone marrow transplantation. Through analysis of transcriptional microarray data, we find that GPR18 is highly expressed in IELs, lymphoid progenitors, and mature follicular B cells. To establish the physiological role of this largely uncharacterized GPR, we generated Gpr18(-/-) mice. Despite high levels of GPR18 expression in specific hematopoietic progenitors, Gpr18(-/-) mice have no defects in lymphopoiesis or myelopoiesis. Moreover, antibody responses following immunization with hapten-protein conjugates or infection with West Nile virus are normal in Gpr18(-/-) mice. Steady-state numbers of IELs are also normal in Gpr18(-/-) mice. However, competitive bone marrow reconstitution experiments demonstrate that GPR18 is cell-intrinsically required for the optimal restoration of small intestine TCR gamma delta(+) and TCR alpha beta(+) CD8 alpha(+) IELs. In contrast, GPR18 is dispensable for the reconstitution of large intestine IELs. Moreover, Gpr18(-/-) bone marrow reconstitutes small intestine IELs similarly to controls in athymic recipients. Gpr18(-/-) chimeras show no changes in susceptibility to intestinal insults such as Citrobacter rodentium infections or graft versus host disease. These data reveal highly specific requirements for GPR18 in the development and reconstitution of thymus-derived intestinal IEL subsets in the steady-state and after bone marrow transplantation.	[Becker, Amy M.; Callahan, Derrick J.; Diamond, Michael S.; Bhattacharya, Deepta] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63130 USA; [Richner, Justin M.; Choi, Jaebok; DiPersio, John F.; Diamond, Michael S.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; [Richner, Justin M.; Diamond, Michael S.] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA; [Choi, Jaebok; DiPersio, John F.] Washington Univ, Sch Med, Div Oncol, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Bhattacharya, D (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63130 USA.	deeptab@wustl.edu	Diamond, Michael/AAH-1733-2019	Diamond, Michael/0000-0002-8791-3165; Richner, Justin/0000-0002-5344-118X; Choi, Jaebok/0000-0002-5590-087X	National Institutes of Health [P30AR48335, K01DK078318, T32CA009547, K01DK099395]; New York Stem Cell Foundation; NATIONAL CANCER INSTITUTE [T32CA009547] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR048335] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK078318, K01DK099395] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); New York Stem Cell Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The Transgenic, Microinjection, and Knockout core facility was supported in part by National Institutes of Health grant P30AR48335. D.B. is a New York Stem Cell Foundation-Robertson Investigator. This research was supported by The New York Stem Cell Foundation, National Institutes of Health grants K01DK078318 (D.B.), T32CA009547 (A.M.B.), and K01DK099395 (A.M.B.). The funders had no role in study design, data collection and	Andrew DP, 1996, EUR J IMMUNOL, V26, P897, DOI 10.1002/eji.1830260427; Bagriacik EU, 2000, IMMUNOL LETT, V75, P77, DOI 10.1016/S0165-2478(00)00275-3; BANDEIRA A, 1991, P NATL ACAD SCI USA, V88, P43, DOI 10.1073/pnas.88.1.43; BARTHOLD SW, 1976, LAB ANIM SCI, V26, P889; Becker AM, 2015, EXP HEMATOL, V43, P44, DOI 10.1016/j.exphem.2014.10.001; Becker AM, 2012, BLOOD, V119, P2003, DOI 10.1182/blood-2011-06-364976; Bell JJ, 2008, NATURE, V452, P764, DOI 10.1038/nature06840; BERLIN C, 1993, CELL, V74, P185, DOI 10.1016/0092-8674(93)90305-A; BOISMENU R, 1994, SCIENCE, V266, P1253, DOI 10.1126/science.7973709; Boyer SW, 2011, CELL STEM CELL, V9, P64, DOI 10.1016/j.stem.2011.04.021; Burstein SH, 2011, J CELL BIOCHEM, V112, P3227, DOI 10.1002/jcb.23245; Buza-Vidas N, 2011, BLOOD, V118, P1544, DOI 10.1182/blood-2010-10-316232; Campbell DJ, 2002, J EXP MED, V195, P135, DOI 10.1084/jem.20011502; CEPEK KL, 1994, NATURE, V372, P190, DOI 10.1038/372190a0; CEPEK KL, 1993, J IMMUNOL, V150, P3459; Chen YP, 2002, P NATL ACAD SCI USA, V99, P14338, DOI 10.1073/pnas.212290499; Chennupati V, 2010, J IMMUNOL, V185, P5160, DOI 10.4049/jimmunol.1001652; Choi J, 2010, BLOOD, V116, P129, DOI 10.1182/blood-2009-12-257253; Console-Bram L, 2014, BRIT J PHARMACOL, V171, P3908, DOI 10.1111/bph.12746; Ding L, 2013, NATURE, V495, P231, DOI 10.1038/nature11885; Drews J, 2000, SCIENCE, V287, P1960, DOI 10.1126/science.287.5460.1960; Eberl G, 2004, SCIENCE, V305, P248, DOI 10.1126/science.1096472; Ehrlich LIR, 2011, BLOOD, V117, P2618, DOI 10.1182/blood-2010-05-287102; FINDLY RC, 1993, EUR J IMMUNOL, V23, P2557, DOI 10.1002/eji.1830231027; FLANAGAN SP, 1966, GENET RES, V8, P295, DOI 10.1017/S0016672300010168; Gantz I, 1997, GENOMICS, V42, P462, DOI 10.1006/geno.1997.4752; GOODMAN T, 1988, NATURE, V333, P855, DOI 10.1038/333855a0; GOODMAN T, 1989, J EXP MED, V170, P1569, DOI 10.1084/jem.170.5.1569; Gray EE, 2013, NAT IMMUNOL, V14, P584, DOI 10.1038/ni.2585; Greenbaum A, 2013, NATURE, V495, P227, DOI 10.1038/nature11926; GUYGRAND D, 1991, J EXP MED, V173, P471, DOI 10.1084/jem.173.2.471; GUYGRAND D, 1974, EUR J IMMUNOL, V4, P435, DOI 10.1002/eji.1830040610; Higgins LM, 1999, INFECT IMMUN, V67, P3031, DOI 10.1128/IAI.67.6.3031-3039.1999; HOLZMANN B, 1989, CELL, V56, P37, DOI 10.1016/0092-8674(89)90981-1; Huleatt JW, 1996, IMMUNITY, V5, P263, DOI 10.1016/S1074-7613(00)80321-0; Inlay MA, 2009, GENE DEV, V23, P2376, DOI 10.1101/gad.1836009; Ismail AS, 2011, P NATL ACAD SCI USA, V108, P8743, DOI 10.1073/pnas.1019574108; Ismail AS, 2009, J IMMUNOL, V182, P3047, DOI 10.4049/jimmunol.0802705; JONES JM, 1971, RADIAT RES, V45, P577, DOI 10.2307/3573066; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Kohno M, 2006, BIOCHEM BIOPH RES CO, V347, P827, DOI 10.1016/j.bbrc.2006.06.175; Lai AY, 2009, BLOOD, V113, P5757, DOI 10.1182/blood-2009-01-201939; Lambolez F, 2006, NAT IMMUNOL, V7, P76, DOI 10.1038/ni1293; Lefrancois L, 2001, Curr Protoc Immunol, VChapter 3, DOI 10.1002/0471142735.im0319s17; Lepage AC, 1998, J IMMUNOL, V161, P4902; Lin TS, 1998, J CLIN INVEST, V101, P570, DOI 10.1172/JCI896; Lu VB, 2013, MOL PHARMACOL, V83, P267, DOI 10.1124/mol.112.081182; Luangsay S, 2003, GASTROENTEROLOGY, V125, P491, DOI 10.1016/S0016-5085(03)00903-X; Matsuoka Yumiko, 2009, Curr Protoc Microbiol, VChapter 15, DOI [10.1002/9780471729259.mc15g03s13, 10.1002/9780471729259.mc15g02s13]; McDonald BD, 2014, IMMUNITY, V41, P219, DOI 10.1016/j.immuni.2014.07.008; McHugh D, 2012, BRIT J PHARMACOL, V165, P2414, DOI 10.1111/j.1476-5381.2011.01497.x; McHugh D, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-44; MOMBAERTS P, 1992, NATURE, V360, P225, DOI 10.1038/360225a0; Mowat AM, 2014, NAT REV IMMUNOL, V14, P667, DOI 10.1038/nri3738; Narayan K, 2012, NAT IMMUNOL, V13, P511, DOI 10.1038/ni.2247; NOLAN GP, 1988, P NATL ACAD SCI USA, V85, P2603, DOI 10.1073/pnas.85.8.2603; Pereira JP, 2009, NATURE, V460, P1122, DOI 10.1038/nature08226; Purtha WE, 2011, J EXP MED, V208, P2599, DOI 10.1084/jem.20110740; Reis BS, 2013, NAT IMMUNOL, V14, P271, DOI 10.1038/ni.2518; Rettig MP, 2004, J IMMUNOL, V173, P3620, DOI 10.4049/jimmunol.173.6.3620; Roberts SJ, 1996, P NATL ACAD SCI USA, V93, P11774, DOI 10.1073/pnas.93.21.11774; Rumfelt LL, 2006, J EXP MED, V203, P675, DOI 10.1084/jem.20052444; Saito H, 1998, SCIENCE, V280, P275, DOI 10.1126/science.280.5361.275; Sakai T, 1997, GASTROENTEROLOGY, V113, P168, DOI 10.1016/S0016-5085(97)70092-1; SAKAI T, 1995, EUR J IMMUNOL, V25, P87, DOI 10.1002/eji.1830250117; Samuelson LC, 1996, MAMM GENOME, V7, P920, DOI 10.1007/s003359900272; Schlenner SM, 2010, IMMUNITY, V32, P426, DOI 10.1016/j.immuni.2010.03.005; Seita J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040321; Staton TL, 2004, J IMMUNOL, V172, P7282, DOI 10.4049/jimmunol.172.12.7282; Staton TL, 2006, NAT IMMUNOL, V7, P482, DOI 10.1038/ni1319; Stenstad H, 2007, P NATL ACAD SCI USA, V104, P10122, DOI 10.1073/pnas.0700269104; Sun CM, 2007, J EXP MED, V204, P1775, DOI 10.1084/jem.20070602; Takenouchi R, 2012, BIOCHEM BIOPH RES CO, V418, P366, DOI 10.1016/j.bbrc.2012.01.027; Tokoyoda K, 2004, IMMUNITY, V20, P707, DOI 10.1016/j.immuni.2004.05.001; TSUZUKI T, 1994, EUR J IMMUNOL, V24, P709, DOI 10.1002/eji.1830240333; Uehara S, 2002, J IMMUNOL, V168, P2811, DOI 10.4049/jimmunol.168.6.2811; Wagner N, 1996, NATURE, V382, P366, DOI 10.1038/382366a0; Wang XM, 2014, J EXP MED, V211, P2351, DOI 10.1084/jem.20140646; Wang YN, 2014, J EXP MED, V211, P841, DOI 10.1084/jem.20131821; Wurbel MA, 2007, J IMMUNOL, V178, P7598, DOI 10.4049/jimmunol.178.12.7598; Yin H, 2009, J BIOL CHEM, V284, P12328, DOI 10.1074/jbc.M806516200; Zhou S, 2008, INT IMMUNOL, V20, P385, DOI 10.1093/intimm/dxm153	83	19	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0133854	10.1371/journal.pone.0133854	http://dx.doi.org/10.1371/journal.pone.0133854			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LZ	26197390	Green Published, Green Submitted, gold			2022-12-26	WOS:000358547600143
J	Kern, A; Schnell, G; Bernard, Q; Boeuf, A; Jaulhac, B; Collin, E; Barthel, C; Ehret-Sabatier, L; Boulanger, N				Kern, Aurelie; Schnell, Gilles; Bernard, Quentin; Boeuf, Amandine; Jaulhac, Benoit; Collin, Elody; Barthel, Cathy; Ehret-Sabatier, Laurence; Boulanger, Nathalie			Heterogeneity of Borrelia burgdorferi Sensu Stricto Population and Its Involvement in Borrelia Pathogenicity: Study on Murine Model with Specific Emphasis on the Skin Interface	PLOS ONE			English	Article							EARLY LYME-DISEASE; PROTEOME ANALYSIS; HEMATOGENOUS DISSEMINATION; BACTERIAL-INFECTION; GENE-EXPRESSION; DEFENSE SYSTEM; IN-VITRO; HOST; MOUSE; PROTEINS	Lyme disease is a multisystemic disorder caused by B. burgdorferi sl. The molecular basis for specific organ involvement is poorly understood. The skin plays a central role in the development of Lyme disease as the entry site of B. burgdorferi in which specific clones are selected before dissemination. We compared the skin inflammatory response (antimicrobial peptides, cytokines and chemokines) elicited by spirochete populations recovered from patients presenting different clinical manifestations. Remarkably, these spirochete populations induced different inflammatory profiles in the skin of C3H/HeN mice. As spirochete population transmitted into the host skin is heterogeneous, we isolated one bacterial clone from a population recovered from a patient with neuroborreliosis and compared its virulence to the parental population. This clone elicited a strong cutaneous inflammatory response characterized by MCP-1, IL-6 and antimicrobial peptides induction. Mass spectrometry of this clone revealed 110 overexpressed proteins when compared with the parental population. We further focused on the expression of nine bacterial surface proteins. bb0347 coding for a protein that interacts with host fibronectin, allowing bacterial adhesion to vascular endothelium and extracellular matrix, was found to be induced in host skin with another gene bb0213 coding for a hypothetical protein. These findings demonstrate the heterogeneity of the B. burgdorferi ss population and the complexity of the interaction involved early in the skin.	[Kern, Aurelie; Bernard, Quentin; Jaulhac, Benoit; Collin, Elody; Barthel, Cathy; Boulanger, Nathalie] Univ Strasbourg, Fac Med & Pharmacie, EA7290 Virulence Bacterienne Precoce Grp Borrelio, Strasbourg, France; [Schnell, Gilles; Boeuf, Amandine; Ehret-Sabatier, Laurence] Univ Strasbourg, CNRS, Inst Pluridisciplinaire Hubert Curien, Lab Spectrometrie Masse BioOrgan,UMR7178, Strasbourg, France; [Kern, Aurelie] Tufts Med Ctr, Div Geog Med & Infect Dis, Boston, MA USA	UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute of Nuclear and Particle Physics (IN2P3); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Tufts Medical Center	Boulanger, N (corresponding author), Univ Strasbourg, Fac Med & Pharmacie, EA7290 Virulence Bacterienne Precoce Grp Borrelio, Strasbourg, France.	nboulanger@unistra.fr	Boulanger, Nathalie/ABF-1353-2020		Conseil Regional d'Alsace [2009.60.053, 2012.60.0033]; Direction Generale de l'Armement; Fulbright grant; Monahan grant	Conseil Regional d'Alsace(Region Grand-Est); Direction Generale de l'Armement; Fulbright grant; Monahan grant	Aurelie Kern was supported by a grant #2009.60.053 from the Conseil Regional d'Alsace and Direction Generale de l'Armement. Quentin Bernard is supported by a grant 2012.60.0033 from the Conseil Regional d'Alsace and Direction Generale de l'Armement. Nathalie Boulanger was supported by a Fulbright grant and a Monahan grant for her sabbatical.	Angel TE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013800; Antonara S, 2010, INFECT IMMUN, V78, P4723, DOI 10.1128/IAI.00464-10; Baranton Guy, 2009, V37, P1, DOI 10.1159/000213066; BARTHOLD SW, 1993, AM J PATHOL, V143, P959; Bernardi Q, 2014, J INVEST DERMATOL, V134, P1211, DOI 10.1038/jid.2014.36; Brisson D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022926; De Martino SJ, 2006, RES MICROBIOL, V157, P726, DOI 10.1016/j.resmic.2006.05.002; Ellis TC, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003567; Gallo RL, 2012, NAT REV IMMUNOL, V12, P503, DOI 10.1038/nri3228; Gaultney RA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075643; Gesslbauer B, 2012, PROTEOMICS, V12, P845, DOI 10.1002/pmic.201100211; Hodzic E, 2003, INFECT IMMUN, V71, P5042, DOI 10.1128/IAI.71.9.5042-5055.2003; Hodzic E, 2002, INFECT IMMUN, V70, P3382, DOI 10.1128/IAI.70.7.3382-3388.2002; Imai DM, 2011, VET PATHOL, V48, P1151, DOI 10.1177/0300985811398246; Jacobs JM, 2005, PROTEOMICS, V5, P1446, DOI 10.1002/pmic.200401052; Jones KL, 2006, J CLIN MICROBIOL, V44, P4407, DOI 10.1128/JCM.01077-06; Jungblut PR, 1999, ELECTROPHORESIS, V20, P3611, DOI 10.1002/(SICI)1522-2683(19991201)20:18&lt;3611::AID-ELPS3611&gt;3.0.CO;2-4; Kern A, 2011, VECTOR-BORNE ZOONOT, V11, P1343, DOI 10.1089/vbz.2010.0197; Lee YR, 2006, J GEN VIROL, V87, P3623, DOI 10.1099/vir.0.82093-0; Liveris D, 1996, J CLIN MICROBIOL, V34, P1306, DOI 10.1128/JCM.34.5.1306-1309.1996; Marchal C, 2011, INFECT IMMUN, V79, P774, DOI 10.1128/IAI.00482-10; Marchal CMP, 2009, J INVEST DERMATOL, V129, P2515, DOI 10.1038/jid.2009.73; Nestle FO, 2009, NAT REV IMMUNOL, V9, P679, DOI 10.1038/nri2622; Nizet V, 2001, NATURE, V414, P454, DOI 10.1038/35106587; Nowalk AJ, 2006, PROTEOMICS, V6, P2121, DOI 10.1002/pmic.200500187; Nowalk AJ, 2006, INFECT IMMUN, V74, P3864, DOI 10.1128/IAI.00189-06; Pal U, 2003, MICROBES INFECT, V5, P659, DOI 10.1016/S1286-4579(03)00097-2; Rego ROM, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0101009, DOI 10.1371/journal.pone.0101009]; Rohrl J, 2012, J IMMUNOL, V188, P4931, DOI 10.4049/jimmunol.1102442; Russell TM, 2013, MOL MICROBIOL, V90, P241, DOI 10.1111/mmi.12377; Schauber J, 2009, J ALLERGY CLIN IMMUN, V124, pR13, DOI 10.1016/j.jaci.2009.07.014; Schnell G, 2015, PROTEOMICS, V15, P1280, DOI 10.1002/pmic.201400177; Seinost G, 1999, INFECT IMMUN, V67, P3518, DOI 10.1128/IAI.67.7.3518-3524.1999; Seshu J, 2006, MOL MICROBIOL, V59, P1591, DOI 10.1111/j.1365-2958.2005.05042.x; Stanek G, 2012, LANCET, V379, P461, DOI 10.1016/S0140-6736(11)60103-7; Tilly K, 2007, INFECT IMMUN, V75, P1517, DOI 10.1128/IAI.01725-06; Wang G, 2001, INFECT IMMUN, V69, P4303, DOI 10.1128/IAI.69.7.4303-4312.2001; Woods A, 2008, INFECT IMMUN, V76, P1657, DOI 10.1128/IAI.00951-07; Wormser GP, 2008, J INFECT DIS, V198, P1358, DOI 10.1086/592279; Wormser GP, 1999, J INFECT DIS, V180, P720, DOI 10.1086/314922	40	15	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0133195	10.1371/journal.pone.0133195	http://dx.doi.org/10.1371/journal.pone.0133195			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LZ	26197047	Green Submitted, Green Published, gold			2022-12-26	WOS:000358547600071
J	Liu, ZY; Liu, XY; Yu, HY; Pei, JH; Zhang, YH; Gong, J; Pu, JL				Liu, Zhouying; Liu, Xiaoyan; Yu, Haiyun; Pei, Juanhui; Zhang, Yinhui; Gong, Jing; Pu, Jielin			Common Variants in TRDN and CALM1 Are Associated with Risk of Sudden Cardiac Death in Chronic Heart Failure Patients in Chinese Han Population	PLOS ONE			English	Article							VENTRICULAR-ARRHYTHMIAS; NOS1AP; MECHANISMS; TRIADIN; PROTEIN	Background Recent studies suggest that variants in two calcium handling genes (RyR2 and CASQ2) associated with sudden cardiac death (SCD) and non-sudden cardiac death (NSCD) in subjects with heart failure and coronary artery disease, respectively. The purpose of this study was to identify other calcium handling genes associated with SCD in the long-term of chronic heart failure (CHF) in Chinese Han population. Methods and Results We investigated 20 SNPs representing 10 genes that regulated calcium handling in 1429 patients with CHF, and the genetic association with SCD and all-cause death was analysed. During a median follow-up period of 63 months, 538 patients (37.65%) died from CHF, of whom 185 (34.38%) had SCD and the others were NSCD. SNPs that pass a P value cut-off of 0.0025 were considered as significant. We found that patients carrying the CC genotype of rs3814843 on CALM1 gene had greater risks of SCD (HR 5.542, 95% CI 2.054-14.948, P = .001) and all cause death (HR 3.484, 95% CI 1.651-7.350, P = .001). After adjusting for other risk factors, significant associations remained. Moreover, patients carrying G allele of rs361508 on TRDN gene also had increased risk of SCD. Conclusions Common variants in TRDN and CALM1 are associated with increased risk of SCD in patients with CHF. These findings provide further evidence for association of variants in calcium handling regulating proteins and SCD in chronic heart failure.	[Liu, Zhouying; Liu, Xiaoyan; Yu, Haiyun; Pei, Juanhui; Zhang, Yinhui; Gong, Jing; Pu, Jielin] Chinese Acad Med Sci, Fuwai Hosp, Natl Ctr Cardiovasc Dis, Physiol & Pathophysiol Lab,State Key Lab Cardiova, 167 Bei Li Shi Rd, Beijing 100037, Peoples R China; [Liu, Zhouying; Liu, Xiaoyan; Yu, Haiyun; Pei, Juanhui; Zhang, Yinhui; Gong, Jing; Pu, Jielin] Peking Union Med Coll, Beijing 100037, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Pu, JL (corresponding author), Chinese Acad Med Sci, Fuwai Hosp, Natl Ctr Cardiovasc Dis, Physiol & Pathophysiol Lab,State Key Lab Cardiova, 167 Bei Li Shi Rd, Beijing 100037, Peoples R China.; Pu, JL (corresponding author), Peking Union Med Coll, Beijing 100037, Peoples R China.	jielinpu@yahoo.com			National Basic Research Program of China (973 program) [2013CB531105]	National Basic Research Program of China (973 program)(National Basic Research Program of China)	This work was funded by National Basic Research Program of China (973 program projects, program number: 2013CB531105 to J. Pu).	Arking DE, 2006, NAT GENET, V38, P644, DOI 10.1038/ng1790; Bers DM, 2002, NATURE, V415, P198, DOI 10.1038/415198a; Darbar D, 2010, HEART FAIL REV, V15, P229, DOI 10.1007/s10741-008-9095-9; Fatkin Diane, 2007, Heart Lung Circ, V16, P19, DOI 10.1016/j.hlc.2006.10.018; Francia P, 2013, J INTERV CARD ELECTR, V38, P169, DOI 10.1007/s10840-013-9827-1; Jiang H, 2009, HEART, V95, P1727, DOI 10.1136/hrt.2008.150177; Kobayashi YM, 2000, J BIOL CHEM, V275, P17639, DOI 10.1074/jbc.M002091200; Liu XY, 2014, J CARD FAIL, V20, P244, DOI 10.1016/j.cardfail.2014.01.006; Marks AR, 2001, J MOL CELL CARDIOL, V33, P615, DOI 10.1006/jmcc.2000.1343; Mohler PJ, 2007, PHYSIOLOGY, V22, P342, DOI 10.1152/physiol.00018.2007; Narang R, 1996, EUR HEART J, V17, P1390; Nyegaard M, 2012, AM J HUM GENET, V91, P703, DOI 10.1016/j.ajhg.2012.08.015; Ran YQ, 2010, CLIN SCI, V119, P215, DOI 10.1042/CS20090656; Roux-Buisson N, 2012, HUM MOL GENET, V21, P2759, DOI 10.1093/hmg/dds104; Rubart M, 2005, J CLIN INVEST, V115, P2305, DOI 10.1172/JCI26381; VANDENPLAS S, 1984, J MED GENET, V21, P164, DOI 10.1136/jmg.21.3.164; Westaway SK, 2011, CIRC-CARDIOVASC GENE, V4, P397, DOI 10.1161/CIRCGENETICS.111.959916; Zipes DP, 2006, CIRCULATION, V114, pE385, DOI 10.1161/CIRCULATIONAHA.106.178233	18	16	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0132459	10.1371/journal.pone.0132459	http://dx.doi.org/10.1371/journal.pone.0132459			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LZ	26196381	Green Published, gold, Green Submitted			2022-12-26	WOS:000358547600037
J	Spaans, VM; Trietsch, MD; Peters, AAW; Osse, M; ter Haar, N; Fleuren, GJ; Jordanova, ES				Spaans, Vivian M.; Trietsch, Marjolijn D.; Peters, Alexander A. W.; Osse, Michelle; ter Haar, Natalja; Fleuren, Gert J.; Jordanova, Ekaterina S.			Precise Classification of Cervical Carcinomas Combined with Somatic Mutation Profiling Contributes to Predicting Disease Outcome	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; WNT/BETA-CATENIN; GENE-MUTATIONS; BETA-CATENIN; LUNG-CANCER; ADENOCARCINOMA; PATHWAY; INHIBITORS; BREAST; PI3K	Introduction Squamous cell carcinoma (SCC), adenocarcinoma (AC), and adenosquamous carcinoma (ASC) are the most common histological subtypes of cervical cancer. Differences in the somatic mutation profiles of these subtypes have been suggested. We investigated the prevalence of somatic hot-spot mutations in three well-defined cohorts of SCC, AC, and ASC and determined the additional value of mutation profiling in predicting disease outcome relative to well-established prognostic parameters. Materials and Methods Clinicopathological data were collected for 301 cervical tumors classified as SCC (n=166), AC (n=55), or ASC (n=80). Mass spectrometry was used to analyze 171 somatic hot-spot mutations in 13 relevant genes. Results In 103 (34%) tumors, 123 mutations were detected (36% in SCC, 38% in AC, and 28% in ASC), mostly in PIK3CA (20%) and KRAS (7%). PIK3CA mutations occurred more frequently in SCC than AC (25% vs. 11%, P=0.025), whereas KRAS mutations occurred more frequently in AC than SCC (24% vs. 3%, P<0.001) and ASC (24% vs. 3%, P<0.001). A positive mutation status correlated with worse disease-free survival (HR 1.57, P=0.043). In multivariate analysis, tumor diameter, parametrial infiltration, and lymph node metastasis, but not the presence of a somatic mutation, were independent predictors of survival. Conclusion Potentially targetable somatic mutations occurred in 34% of cervical tumors with different distributions among histological subtypes. Precise classification of cervical carcinomas in combination with mutation profiling is valuable for predicting disease outcome and may guide the development and selection of tumor-specific treatment approaches.	[Spaans, Vivian M.; Peters, Alexander A. W.] Leiden Univ, Med Ctr, Dept Gynecol & Obstet, Leiden, Netherlands; [Spaans, Vivian M.; Trietsch, Marjolijn D.; Osse, Michelle; ter Haar, Natalja; Fleuren, Gert J.; Jordanova, Ekaterina S.] Leiden Univ, Med Ctr, Dept Pathol, Leiden, Netherlands; [Jordanova, Ekaterina S.] Ctr Gynecol Oncol, Dept Gynecol & Obstet, Amsterdam, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Jordanova, ES (corresponding author), Leiden Univ, Med Ctr, Dept Pathol, Leiden, Netherlands.	E.S.Jordanova@lumc.nl		Jordanova, Ekaterina S./0000-0002-8121-1322				Arbyn M, 2011, ANN ONCOL, V22, P2675, DOI 10.1093/annonc/mdr015; Bamford S, 2004, BRIT J CANCER, V91, P355, DOI 10.1038/sj.bjc.6601894; Baselga J, 2009, J CLIN ONCOL, V27, P2630, DOI 10.1200/JCO.2008.18.8391; Baseman JG, 2005, J CLIN VIROL, V32, pS16, DOI 10.1016/j.jcv.2004.12.008; Bulk S, 2005, INT J CANCER, V113, P1005, DOI 10.1002/ijc.20678; Chen YW, 2012, J CELL PHYSIOL, V227, P2818, DOI 10.1002/jcp.23038; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; Cui B, 2009, INT J ONCOL, V34, P409, DOI 10.3892/ijo_00000164; de Jong AE, 2004, CLIN CANCER RES, V10, P972, DOI 10.1158/1078-0432.CCR-0956-3; de la Rochefordiere A, 2015, CLIN CANCER RES, V21, P2530, DOI 10.1158/1078-0432.CCR-14-2368; De Roock W, 2010, LANCET ONCOL, V11, P753, DOI 10.1016/S1470-2045(10)70130-3; Di Nicolantonio F, 2010, J CLIN INVEST, V120, P2858, DOI 10.1172/JCI37539; Dutton-Regester K, 2012, MOL CANCER THER, V11, P888, DOI 10.1158/1535-7163.MCT-11-0676; Engelman JA, 2008, NAT MED, V14, P1351, DOI 10.1038/nm.1890; Forouzanfar MH, 2011, LANCET, V378, P1461, DOI 10.1016/S0140-6736(11)61351-2; Fumagalli D, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-101; Galic V, 2012, GYNECOL ONCOL, V125, P287, DOI 10.1016/j.ygyno.2012.01.012; Gien LT, 2010, GYNECOL ONCOL, V116, P140, DOI 10.1016/j.ygyno.2009.09.040; Hennig G, 2010, CLIN CHEM, V56, P1845, DOI 10.1373/clinchem.2010.151233; Hudes G, 2007, NEW ENGL J MED, V356, P2271, DOI 10.1056/NEJMoa066838; Janne PA, 2013, LANCET ONCOL, V14, P38, DOI 10.1016/S1470-2045(12)70489-8; Janku F, 2013, CANCER RES, V73, P276, DOI 10.1158/0008-5472.CAN-12-1726; Janku F, 2012, J CLIN ONCOL, V30, P777, DOI 10.1200/JCO.2011.36.1196; Janku F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022769; Kloth JN, 2005, CARCINOGENESIS, V26, P1493, DOI 10.1093/carcin/bgi110; Konopka B, 2011, HUM PATHOL, V42, P1710, DOI 10.1016/j.humpath.2010.01.030; Kurman RJ, 2014, WHO CLASSIFICATION T, P169; Lee JY, 2014, INT J GYNECOL CANCER, V24, P289, DOI 10.1097/IGC.0000000000000063; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; MacConaill LE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007887; Miyake T, 2008, CANCER LETT, V261, P120, DOI 10.1016/j.canlet.2007.11.004; Motzer RJ, 2008, LANCET, V372, P449, DOI 10.1016/S0140-6736(08)61039-9; Nout RA, 2012, GYNECOL ONCOL, V126, P466, DOI 10.1016/j.ygyno.2012.05.012; Ogita S, 2011, TARGET ONCOL, V6, P103, DOI 10.1007/s11523-011-0176-7; Ojesina AI, 2014, NATURE, V506, P371, DOI 10.1038/nature12881; Oosterhuis JW, 2003, NAT REV CANCER, V3, P73, DOI 10.1038/nrc973; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Roberts PJ, 2013, J CLIN ONCOL, V31, P1112, DOI 10.1200/JCO.2012.43.0454; Rose PG, 2012, GYNECOL ONCOL, V125, P285, DOI 10.1016/j.ygyno.2012.03.010; Santarpia L, 2012, BREAST CANCER RES TR, V134, P333, DOI 10.1007/s10549-012-2035-3; Sherman ME, 2005, CANCER-AM CANCER SOC, V103, P1258, DOI 10.1002/cncr.20877; Shinohara A, 2001, GYNECOL ONCOL, V82, P450, DOI 10.1006/gyno.2001.6298; Spaans VM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093451; Stratton MR, 2009, NATURE, V458, P719, DOI 10.1038/nature07943; Tornesello ML, 2013, GYNECOL ONCOL, V128, P442, DOI 10.1016/j.ygyno.2012.11.017; Trietsch MD, 2014, GYNECOL ONCOL, V135, P149, DOI 10.1016/j.ygyno.2014.07.094; Ueda M, 2001, BRIT J CANCER, V85, P64, DOI 10.1054/bjoc.2001.1863; van Eijk R, 2013, EXP MOL PATHOL, V94, P121, DOI 10.1016/j.yexmp.2012.06.004; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Voronkov A, 2013, CURR PHARM DESIGN, V19, P634, DOI 10.2174/138161213804581837; Witzig TE, 2011, LEUKEMIA, V25, P341, DOI 10.1038/leu.2010.226; Wright AA, 2013, CANCER-AM CANCER SOC, V119, P3776, DOI 10.1002/cncr.28288; Zimmermann G, 2013, NATURE, V497, P638, DOI 10.1038/nature12205; zur Hausen H, 2002, NAT REV CANCER, V2, P342, DOI 10.1038/nrc798	55	35	35	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0133670	10.1371/journal.pone.0133670	http://dx.doi.org/10.1371/journal.pone.0133670			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LZ	26197069	Green Published, gold, Green Submitted			2022-12-26	WOS:000358547600131
J	Tan, XH; Gao, Y; Nan, YL; Zhang, JX; Di, CH; Wang, XB; Lian, FZ; Cao, YF; Hu, Y; Xu, LW; Ma, HY; Hong, Y; Liu, TJ; Wu, YY; Xu, XR; Yan, YT; Yang, L				Tan, Xiaohua; Gao, Yuan; Nan, Yulong; Zhang, Jinxia; Di, Chunhong; Wang, Xiaobo; Lian, Fuzhi; Cao, Yifei; Hu, Yu; Xu, Liangwen; Ma, Haiyan; Hong, Yu; Liu, Tingjie; Wu, Yinyin; Xu, Xianrong; Yan, Yutao; Yang, Lei			Cellular MicroRNA Let-7a Suppresses KSHV Replication through Targeting MAP4K4 Signaling Pathways	PLOS ONE			English	Article							SARCOMA-ASSOCIATED HERPESVIRUS; KAPOSI-SARCOMA; TUMOR-SUPPRESSOR; EXPRESSION; REACTIVATION; INFECTION; ESTABLISHMENT; INTERFERON; MODULATION; PREDICTION	Background Kaposi's sarcoma (KS)-associated herpesvirus (KSHV) is the etiologic agent of KS, the most common AIDS-related malignancy. The majority of KS tumor cells harbor latent KSHV virus but only a small percentage undergoes spontaneous lytic replication. Viral reactivation from latency is crucial for the pathogenesis and development of KS, but the cellular mechanisms underlying the switch between viral latency and replication are not well understood. Methods The level of let-7 miRNAs and MAP4K4 in KSHV infected 293T cells were quantified by real-time PCRs. Let-7 expression was silenced by the miRNA sponge technique. In let-7a transfected 293T cells, the expression of MAP4K4 was measured by real-time PCR and western blot. Luciferease expression was employed to examine the effect of let-7a on the 3'-untranslated region (UTR) of the MAP4K4 gene in 293T cells. Real-time PCR was used to quantify the KSHV copy numbers in BC-3 cells in which the expression of let-7a and/or MAP4K4 were altered. Finally, ERK, JNK and p38 protein production and their phosphorylation status were detected by western blots in let-7a or MAP4K4 transfected BCBL-1 cells. Results The expression of microRNA let-7 was dramatically decreased in KSHV infected 293T cells, but that of MAP4K4 was increased significantly. Let-7a is physically associated with and targets the MAP4K4 3'UTR, and inhibits MAP4K4 expression at both mRNA and protein levels. MAP4K4 stimulates KSHV reactivation from latency, whereas let-7a inhibits the function of MAP4K4 by reversing the function of MAP4K4 on JNK, phospho-JNK and phospho-ERK1/2 levels. Conclusion Our results establish that let-7a specifically suppresses MAP4K4 expression, and further inhibits KSHV reactivation by interfering with the function of MAP4K4 on the MAPK pathway, highlighting let-7a as a potential treatment for KS.	[Tan, Xiaohua; Gao, Yuan; Nan, Yulong; Zhang, Jinxia; Di, Chunhong; Wang, Xiaobo; Lian, Fuzhi; Cao, Yifei; Hu, Yu; Xu, Liangwen; Ma, Haiyan; Hong, Yu; Liu, Tingjie; Wu, Yinyin; Xu, Xianrong; Yan, Yutao; Yang, Lei] Hangzhou Normal Univ, Sch Med, Hangzhou, Zhejiang, Peoples R China	Hangzhou Normal University	Yang, L (corresponding author), Hangzhou Normal Univ, Sch Med, Hangzhou, Zhejiang, Peoples R China.	yanglei62@hznu.edu.cn	ma, haiyan/GWQ-7425-2022; Lian, Fuzhi/F-9083-2015	Lian, Fuzhi/0000-0002-0733-579X	Natural Science Foundation of China [81071636, 81161120420]; International Cooperation Project of Zhe-Jiang Province [2009C14014]; Natural Science Foundation of Zhejiang Province [LY12H16028]; Program for Zhejiang Leading Team of Science and Technology Innovation [2011R50021]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); International Cooperation Project of Zhe-Jiang Province; Natural Science Foundation of Zhejiang Province(Natural Science Foundation of Zhejiang Province); Program for Zhejiang Leading Team of Science and Technology Innovation	This work was supported by grants from the Natural Science Foundation of China (81071636, 81161120420), the International Cooperation Project of Zhe-Jiang Province (2009C14014), the Natural Science Foundation of Zhejiang Province (LY12H16028), and the Program for Zhejiang Leading Team of Science and Technology Innovation (2011R50021). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2001, CELL, V107, P823, DOI 10.1016/S0092-8674(01)00616-X; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Bajaj BG, 2006, VIROLOGY, V351, P18, DOI 10.1016/j.virol.2006.03.037; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bellare P, 2009, CELL HOST MICROBE, V6, P570, DOI 10.1016/j.chom.2009.11.008; Catrina AM, 2014, PATHOL ONCOL RES, V20, P153, DOI 10.1007/s12253-013-9678-1; CESARMAN E, 1995, NEW ENGL J MED, V332, P1186, DOI 10.1056/NEJM199505043321802; CHANG Y, 1994, SCIENCE, V266, P1865, DOI 10.1126/science.7997879; Cheng F, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000324; Christensen BC, 2009, CARCINOGENESIS, V30, P1003, DOI 10.1093/carcin/bgp099; Chugh PE, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003484; Cohen A, 2006, J GEN VIROL, V87, P795, DOI 10.1099/vir.0.81619-0; Dillon PJ, 2013, CELL HOST MICROBE, V13, P204, DOI 10.1016/j.chom.2012.12.005; DiMaio TA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002424; Dittmer DP, 2003, CANCER RES, V63, P2010; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Ford PW, 2006, J GEN VIROL, V87, P1139, DOI 10.1099/vir.0.81628-0; Fu M, 2014, GENE, V536, P272, DOI 10.1016/j.gene.2013.12.012; Greene Whitney, 2007, Cancer Treat Res, V133, P69; Gregory SM, 2009, P NATL ACAD SCI USA, V106, P11725, DOI 10.1073/pnas.0905316106; Grundhoff A, 2004, J CLIN INVEST, V113, P124, DOI 10.1172/JCI200417803; Haas DA, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003737; Hasan RN, 2008, CIRC RES, V102, P42, DOI 10.1161/CIRCRESAHA.107.155143; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Liang DG, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2011.00271; Lu CC, 2010, EMBO REP, V11, P784, DOI 10.1038/embor.2010.132; Maragkakis M, 2009, NUCLEIC ACIDS RES, V37, pW273, DOI 10.1093/nar/gkp292; Maragkakis M, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-295; O'Hara AJ, 2009, BLOOD, V113, P5938, DOI 10.1182/blood-2008-09-179168; Pan HY, 2006, J VIROL, V80, P5371, DOI 10.1128/JVI.02299-05; Pozharskaya VP, 2004, J GEN VIROL, V85, P2779, DOI 10.1099/vir.0.80214-0; Sharma-Walia N, 2005, J VIROL, V79, P10308, DOI 10.1128/JVI.79.16.10308-10329.2005; Slack F, 2009, CELL CYCLE, V8, P1823, DOI 10.4161/cc.8.12.8639; Tan XH, 2014, J CUTAN PATHOL, V41, P630, DOI 10.1111/cup.12332; Wang HW, 2004, NAT GENET, V36, P687, DOI 10.1038/ng1384; Wang JZ, 2005, J VIROL, V79, P2420, DOI 10.1128/JVI.79.4.2420-2431.2005; Xie JP, 2008, VIROLOGY, V371, P139, DOI 10.1016/j.virol.2007.09.040; Xie JP, 2005, J VIROL, V79, P15027, DOI 10.1128/JVI.79.24.15027-15037.2005; Yan Q, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055832; Ye FC, 2007, J VIROL, V81, P3980, DOI 10.1128/JVI.02089-06; Yu FQ, 2007, PLOS PATHOG, V3, DOI 10.1371/journal.ppat.0030044; Zhao G, 2013, MOL CANCER THER, V12, P83, DOI 10.1158/1535-7163.MCT-12-0534-T	42	15	16	3	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0132148	10.1371/journal.pone.0132148	http://dx.doi.org/10.1371/journal.pone.0132148			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LZ	26197270	gold, Green Submitted, Green Published			2022-12-26	WOS:000358547600022
J	Bai, YT; Xu, ZG; Lu, B; Sun, QH; Tang, WG; Liu, XB; Yang, WZ; Xu, XY; Liu, QY				Bai, Yuntao; Xu, Zhiguang; Lu, Bo; Sun, Qinghua; Tang, Wenge; Liu, Xiaobo; Yang, Weizhong; Xu, Xinyi; Liu, Qiyong			Effects of Climate and Rodent Factors on Hemorrhagic Fever with Renal Syndrome in Chongqing, China, 1997-2008	PLOS ONE			English	Article							REPUBLIC-OF-CHINA; HANTAVIRUS INFECTION; SYNDROME EPIDEMIC; TRANSMISSION; RESERVOIR; EUROPE; CITY; SURVEILLANCE; VARIABILITY; VARIABLES	China has the highest global incidence of hemorrhagic fever with renal syndrome (HFRS), constituting 90% of the cases in the world. Chongqing, located in the Three Gorges Reservoir Region, has been experiencing differences in the occurrence of HFRS from 1997 to 2008. The current study was designed to explore the effects of climate and rodent factors on the transmission of HFRS in Chongqing. Data on monthly HFRS cases, rodent strains, and climatic factors were collected from 1997 to 2008. Spatio-temporal analysis indicated that most HFRS cases were clustered in central Chongqing and that the incidence of HFRS decreased from 1997 to 2008. Poisson regression models showed that temperature (with lagged months of 0 and 5) and rainfall (with 2 lagged months) were key climatic factors contributing to the transmission of HFRS. A zero-inflated negative binomial model revealed that rodent density was also significantly associated with the occurrence of HFRS in the Changshou district. The monthly trend in HFRS incidence was positively associated with rodent density and rainfall and negatively associated with temperature. Possible mechanisms are proposed through which construction of the dam influenced the incidence of HFRS in Chongqing. The findings of this study may contribute to the development of early warning systems for the control and prevention of HFRS in the Three Gorges Reservoir Region.	[Bai, Yuntao; Sun, Qinghua] Ohio State Univ, Coll Publ Hlth, Div Environm Hlth Sci, Columbus, OH 43210 USA; [Xu, Zhiguang; Xu, Xinyi] Ohio State Univ, Dept Stat, Columbus, OH 43210 USA; [Lu, Bo] Ohio State Univ, Div Biostat, Coll Publ Hlth, Columbus, OH 43210 USA; [Tang, Wenge] Chongqing Ctr Dis Control & Prevent, Chongqing, Peoples R China; [Liu, Xiaobo; Yang, Weizhong; Liu, Qiyong] Chinese Ctr Dis Control & Prevent, Key Lab Surveillance & Early Warning Infect Dis, Beijing, Peoples R China; [Liu, Xiaobo; Liu, Qiyong] Chinese Ctr Dis Control & Prevent, Natl Inst Communicable Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Collaborat Innovat Ctr Diag & Treatment Infect Di, Beijing, Peoples R China	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Chinese Center for Disease Control & Prevention; Chinese Center for Disease Control & Prevention; National Institute for Communicable Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Collaborative Innovation Center for Diagnosis & Treatment of Infectious Diseases	Yang, WZ (corresponding author), Chinese Ctr Dis Control & Prevent, Key Lab Surveillance & Early Warning Infect Dis, Beijing, Peoples R China.	yangwz@chinacdc.cn; xinyi@stat.osu.edu; liuqiyong@icdc.cn	Bai, Yuntao/S-8408-2016; Yang, Wei/HIA-0360-2022		National Basic Research Program of China (973 Program) [2012CB955504]; Special Research Program for Health [200802019]; State Key Laboratory for Infectious Disease Prevention and Control [2014SKLID106]; Ohio State University Office of International Affairs Gateway Research Seed Grant; National Science Foundation [DMS-1209194]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); Special Research Program for Health; State Key Laboratory for Infectious Disease Prevention and Control; Ohio State University Office of International Affairs Gateway Research Seed Grant; National Science Foundation(National Science Foundation (NSF))	This study was supported in part by the National Basic Research Program of China (973 Program) (Grant No. 2012CB955504), the Special Research Program for Health (Grant No. 200802019), and the State Key Laboratory for Infectious Disease Prevention and Control (Grant No. 2014SKLID106) to Qiyong Liu; in part by the Ohio State University Office of International Affairs Gateway Research Seed Grant (2011) to Qinghua Sun; and in part by the National Science Foundation under award number DMS-1209194 to Xinyi Xu. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai YT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084326; Bi P, 2003, JAMA-J AM MED ASSOC, V289, P176, DOI 10.1001/jama.289.2.176-d; Bi P, 2002, INT J EPIDEMIOL, V31, P189, DOI 10.1093/ije/31.1.189; Bi ZQ, 2008, J INFECT DEV COUNTR, V2, P3; CHEN HX, 1994, CHINESE MED J-PEKING, V107, P107; CHEN HX, 1993, CHINESE MED J-PEKING, V106, P857; CLEMENT J, 1994, LANCET, V343, P114, DOI 10.1016/S0140-6736(94)90841-9; Cui F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067490; Fang LQ, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000789; Fang LQ, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-77; Guan P, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-109; Haredasht SA, 2013, INT J ENV RES PUB HE, V10, P499, DOI 10.3390/ijerph10020499; LEE HW, 1989, PROG MED VIROL, V36, P62; Lin H, 2013, INT J BIOMETEOROL; Liu XD, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-331; Michalski A, 2014, VECTOR-BORNE ZOONOT, V14, P514, DOI 10.1089/vbz.2013.1468; Papa A, 2006, EMERG INFECT DIS, V12, P1015, DOI 10.3201/eid1206.051564; Sleigh AC, 2001, LANCET, V357, P570, DOI 10.1016/S0140-6736(00)04072-1; Tersago K, 2009, EPIDEMIOL INFECT, V137, P250, DOI 10.1017/S0950268808000940; Tersago K, 2011, VECTOR-BORNE ZOONOT, V11, P715, DOI 10.1089/vbz.2010.0007; VERHAGEN R, 1986, ARCH VIROL, V91, P193, DOI 10.1007/BF01314280; Xiao H, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002615; Xiao H, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-305; Xiao H, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002260; Xu XB, 2011, SCI TOTAL ENVIRON, V409, P4656, DOI 10.1016/j.scitotenv.2011.08.004; Yan L, 2007, EMERG INFECT DIS, V13, P1301, DOI 10.3201/eid1309.061481; Zalesny G, 2014, PARASITE VECTOR, V7, DOI 10.1186/s13071-014-0457-y; Zhang Sheng, 2008, Huanjing Kexue, V29, P7; Zhang WY, 2010, ENVIRON HEALTH PERSP, V118, P915, DOI 10.1289/ehp.0901504; Zhang WY, 2009, AM J TROP MED HYG, V80, P678, DOI 10.4269/ajtmh.2009.80.678; Zhang YZ, 2010, EMERG INFECT DIS, V16, P1195, DOI 10.3201/eid1608.090470	31	9	11	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2015	10	7							e0133218	10.1371/journal.pone.0133218	http://dx.doi.org/10.1371/journal.pone.0133218			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LN	26193359	Green Submitted, Green Published, gold			2022-12-26	WOS:000358546400066
J	Frigerio, A; Wright, K; Wooderchak-Donahue, W; Tan, OT; Margraf, R; Stevenson, DA; Grimmer, JF; Bayrak-Toydemir, P				Frigerio, Alice; Wright, Karol; Wooderchak-Donahue, Whitney; Tan, Oon T.; Margraf, Rebecca; Stevenson, David A.; Grimmer, J. Fredrik; Bayrak-Toydemir, Pinar			Genetic Variants Associated with Port-Wine Stains	PLOS ONE			English	Article							MALFORMATION-ARTERIOVENOUS MALFORMATION; STURGE-WEBER SYNDROME; RASA1 MUTATIONS; BLOOD-VESSELS; CAPILLARY; GNAQ	Background Port-wine stains (PWS) are capillary malformations, typically located in the dermis of the head and neck, affecting 0.3% of the population. Current theories suggest that port-wine stains are caused by somatic mutations that disrupt vascular development. Objectives Understanding PWS genetic determinants could provide insight into new treatments. Methods Our study used a custom next generation sequencing (NGS) panel and digital polymerase chain reaction to investigate genetic variants in 12 individuals with isolated port-wine stains. Importantly, affected and healthy skin tissue from the same individual were compared. A subtractive correction method was developed to eliminate background noise from NGS data. This allowed the detection of a very low level of mosaicism. Results A novel somatic variant GNAQ, c.547C>G, p.Arg183Gly was found in one case with 4% allele frequency. The previously reported GNAQ c.548G>A, p.Arg183Gln was confirmed in 9 of 12 cases with an allele frequency ranging from 1.73 to 7.42%. Digital polymerase chain reaction confirmed novel variants detected by next generation sequencing. Two novel somatic variants were also found in RASA1, although neither was predicted to be deleterious. Conclusions This is the second largest study on isolated, non-syndromic PWS. Our data suggest that GNAQ is the main genetic determinant in this condition. Moreover, isolated port-wine stains are distinct from capillary malformations seen in RASA1 disorders, which will be helpful in clinical evaluation.	[Frigerio, Alice; Tan, Oon T.] Harvard Univ, Carolyn & Peter Lynch Ctr Laser & Reconstruct Sur, Div Facial Plast & Reconstruct Surg,Sch Med, Dept Otol & Laryngol,Massachusetts Eye & Ear Infi, Boston, MA 02115 USA; [Wright, Karol; Wooderchak-Donahue, Whitney; Margraf, Rebecca; Bayrak-Toydemir, Pinar] ARUP, Inst Clin & Expt Pathol, Salt Lake City, UT USA; [Wooderchak-Donahue, Whitney; Bayrak-Toydemir, Pinar] Univ Utah, Dept Pathol, Salt Lake City, UT USA; [Stevenson, David A.] Stanford Univ, Dept Pediat, Div Med Genet, Stanford, CA 94305 USA; [Grimmer, J. Fredrik] Univ Utah, Dept Surg, Div Otolaryngol, Salt Lake City, UT USA	Harvard University; Harvard Medical School; Utah System of Higher Education; University of Utah; Stanford University; Utah System of Higher Education; University of Utah	Frigerio, A (corresponding author), Harvard Univ, Carolyn & Peter Lynch Ctr Laser & Reconstruct Sur, Div Facial Plast & Reconstruct Surg,Sch Med, Dept Otol & Laryngol,Massachusetts Eye & Ear Infi, Boston, MA 02115 USA.	alice_frigerio@meei.harvard.edu			Lynch Foundation, Boston, MA	Lynch Foundation, Boston, MA	This work was supported by a grant awarded by the Lynch Foundation, Boston, MA, to Dr. Oon T. Tan.	Boon LM, 2005, CURR OPIN GENET DEV, V15, P265, DOI 10.1016/j.gde.2005.03.004; COLEMAN DE, 1994, SCIENCE, V265, P1405, DOI 10.1126/science.8073283; Desmet FO, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp215; Eerola I, 2003, AM J HUM GENET, V73, P1240, DOI 10.1086/379793; Frigerio A, 2014, LASER SURG MED, V46, P180, DOI 10.1002/lsm.22193; Frigerio A, 2012, CURR OPIN OTOLARYNGO, V20, P527, DOI 10.1097/MOO.0b013e3283587415; HAPPLE R, 1987, J AM ACAD DERMATOL, V16, P899, DOI 10.1016/S0190-9622(87)80249-9; JACOBS AH, 1976, PEDIATRICS, V58, P218; Lian CG, 2014, JAMA DERMATOL, V150, P1336, DOI 10.1001/jamadermatol.2014.1244; Margraf Rebecca L, 2011, J Biomol Tech, V22, P74; Margraf Rebecca L, 2010, J Biomol Tech, V21, P126; Nakashima M, 2014, J HUM GENET, V59, P691, DOI 10.1038/jhg.2014.95; Revencu N, 2013, HUM MUTAT, V34, P1632, DOI 10.1002/humu.22431; Sanchez-Carpintero I, 2004, J AM ACAD DERMATOL, V50, P608, DOI 10.1016/j.jaad.2003.04.002; Shirley MD, 2013, NEW ENGL J MED, V368, P1971, DOI 10.1056/NEJMoa1213507; SMOLLER BR, 1986, ARCH DERMATOL, V122, P177, DOI 10.1001/archderm.122.2.177; Tan WB, 2014, J AM ACAD DERMATOL, V71, P964, DOI 10.1016/j.jaad.2014.07.025; Troilius Rubin A, 2015, J COSMET LASERTHER, V20, P1; Waelchli R, 2014, BRIT J DERMATOL, V171, P861, DOI 10.1111/bjd.13203; Wooderchak-Donahue WL, 2012, BMC MED GENOMICS, V5, DOI 10.1186/1755-8794-5-50	20	26	27	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2015	10	7							e0133158	10.1371/journal.pone.0133158	http://dx.doi.org/10.1371/journal.pone.0133158			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LN	26192947	Green Published, Green Submitted, gold			2022-12-26	WOS:000358546400064
J	Renaud, S; Dufour, AB; Hardouin, EA; Ledevin, R; Auffray, JC				Renaud, Sabrina; Dufour, Anne-Beatrice; Hardouin, Emilie A.; Ledevin, Ronan; Auffray, Jean-Christophe			Once upon Multivariate Analyses: When They Tell Several Stories about Biological Evolution	PLOS ONE			English	Article							MOLAR SHAPE-ANALYSIS; HOUSE MOUSE; GEOMETRIC MORPHOMETRICS; LEAST RESISTANCE; MICE; DIVERGENCE; LINES; PATTERNS; RODENT; DIFFERENTIATION	Geometric morphometrics aims to characterize of the geometry of complex traits. It is therefore by essence multivariate. The most popular methods to investigate patterns of differentiation in this context are (1) the Principal Component Analysis (PCA), which is an eigenvalue decomposition of the total variance-covariance matrix among all specimens; (2) the Canonical Variate Analysis (CVA, a.k.a. linear discriminant analysis (LDA) for more than two groups), which aims at separating the groups by maximizing the between-group to withingroup variance ratio; (3) the between-group PCA (bgPCA) which investigates patterns of between-group variation, without standardizing by the within-group variance. Standardizing within-group variance, as performed in the CVA, distorts the relationships among groups, an effect that is particularly strong if the variance is similarly oriented in a comparable way in all groups. Such shared direction of main morphological variance may occur and have a biological meaning, for instance corresponding to the most frequent standing genetic variation in a population. Here we undertake a case study of the evolution of house mouse molar shape across various islands, based on the real dataset and simulations. We investigated how patterns of main variance influence the depiction of among-group differentiation according to the interpretation of the PCA, bgPCA and CVA. Without arguing about a method performing ` better' than another, it rather emerges that working on the total or between-group variance (PCA and bgPCA) will tend to put the focus on the role of direction of main variance as line of least resistance to evolution. Standardizing by the within-group variance (CVA), by dampening the expression of this line of least resistance, has the potential to reveal other relevant patterns of differentiation that may otherwise be blurred.	[Renaud, Sabrina; Dufour, Anne-Beatrice; Ledevin, Ronan] Univ Lyon 1, CNRS, UMR5558, Lab Biometrie & Biol Evolut, F-69622 Villeurbanne, France; [Hardouin, Emilie A.] Max Planck Inst Evolut Biol, D-24306 Plon, Germany; [Hardouin, Emilie A.] Bournemouth Univ, Fac Sci & Technol, Poole BH12 5BB, Dorset, England; [Auffray, Jean-Christophe] Univ Montpellier 2, CNRS, UMR 5554, Inst Sci Evolut Montpellier, Montpellier, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; VetAgro Sup; Max Planck Society; Bournemouth University; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier	Renaud, S (corresponding author), Univ Lyon 1, CNRS, UMR5558, Lab Biometrie & Biol Evolut, F-69622 Villeurbanne, France.	Sabrina.Renaud@univ-lyon1.fr	Dufour, Anne-Béatrice/I-9475-2016; Renaud, Sabrina/AAV-3141-2020; Auffray, Jean-Christophe/AAW-1052-2020; Auffray, jean-christophe/HCI-4881-2022; Auffray, Jean-Christophe/AAH-6131-2019; Renaud, Sabrina/D-4247-2009	Dufour, Anne-Béatrice/0000-0002-9339-4293; Renaud, Sabrina/0000-0002-8730-3113; Auffray, Jean-Christophe/0000-0002-5184-0507; Renaud, Sabrina/0000-0002-8730-3113	BIGTOOTH [ANR-11-BSV7-008]; Agence Nationale de la Recherche ECODEV [ANR-13-BSV7-005]; Agence Nationale de la Recherche	BIGTOOTH; Agence Nationale de la Recherche ECODEV(French National Research Agency (ANR)); Agence Nationale de la Recherche(French National Research Agency (ANR))	BIGTOOTH, grant ANR-11-BSV7-008 to SR, JCA and RL from the Agence Nationale de la Recherche ECODEV, grant ANR-13-BSV7-005 to SR, ABD and RL from the Agence Nationale de la Recherche.	Ackermann RR, 2004, P NATL ACAD SCI USA, V101, P17946, DOI 10.1073/pnas.0405919102; ADLER GH, 1994, Q REV BIOL, V69, P473, DOI 10.1086/418744; Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; Barton NH, 1996, PHILOS T R SOC B, V351, P785, DOI 10.1098/rstb.1996.0073; Begin M, 2003, EVOLUTION, V57, P1107; Berry RJ, 1996, PHILOS T R SOC B, V351, P753, DOI 10.1098/rstb.1996.0070; Boell L, 2013, EVOL DEV, V15, P197, DOI 10.1111/ede.12033; CAMPBELL NA, 1981, SYST ZOOL, V30, P268, DOI 10.2307/2413249; CHEVERUD JM, 1988, EVOLUTION, V42, P958, DOI 10.1111/j.1558-5646.1988.tb02514.x; Claude J, 2004, SYST BIOL, V53, P933, DOI 10.1080/10635150490889498; Cucchi T, 2008, J ARCHAEOL SCI, V35, P2953, DOI 10.1016/j.jas.2008.06.016; Cucchi T, 2006, HUMAN EVOLUTION, V21, P95, DOI DOI 10.1007/S11598-006-9011-Z; Cucchi T, 2014, EVOLUTION, V68, P2804, DOI 10.1111/evo.12476; Cucchi T, 2013, BIOL J LINN SOC, V108, P917, DOI 10.1111/bij.12004; Culhane AC, 2002, BIOINFORMATICS, V18, P1600, DOI 10.1093/bioinformatics/18.12.1600; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; DAVIS SJM, 1983, J ZOOL, V199, P521; Drake AG, 2010, AM NAT, V175, P289, DOI 10.1086/650372; Dray S, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i04; Fadda C, 2001, J ZOOL SYST EVOL RES, V39, P235, DOI 10.1046/j.1439-0469.2001.00169.x; Firmat C, 2012, BIOL J LINN SOC, V105, P369, DOI 10.1111/j.1095-8312.2011.01802.x; Fisher RA, 1936, ANN EUGENIC, V7, P179, DOI 10.1111/j.1469-1809.1936.tb02137.x; Gardner S, 2006, COMPUT STAT DATA AN, V50, P107, DOI 10.1016/j.csda.2004.07.020; GOWER JC, 1966, BIOMETRIKA, V53, P325, DOI 10.1093/biomet/53.3-4.325; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hallgrimsson B, 2006, EVOL DEV, V8, P61, DOI 10.1111/j.1525-142X.2006.05075.x; Hardouin EA, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-325; Helvaci Z, 2012, BIOL J LINN SOC, V107, P611, DOI 10.1111/j.1095-8312.2012.01952.x; Hunt G, 2007, EVOLUTION, V61, P1560, DOI 10.1111/j.1558-5646.2007.00129.x; Ihle S, 2006, MOL BIOL EVOL, V23, P790, DOI 10.1093/molbev/msj096; Jolliffe I.T., 2002, PRINCIPAL COMPONENT, V87, P513; Jones EP, 2011, J ZOOL, V283, P257, DOI 10.1111/j.1469-7998.2010.00767.x; Klingenberg CP, 2005, SYST BIOL, V54, P678, DOI 10.1080/10635150590947258; KUHL FP, 1982, COMPUT VISION GRAPH, V18, P236, DOI 10.1016/0146-664X(82)90034-X; Linnenbrink M, 2013, MOL ECOL, V22, P1904, DOI 10.1111/mec.12206; Marroig G, 2005, EVOLUTION, V59, P1128; Martinez-Abadias N, 2012, EVOLUTION, V66, P1010, DOI 10.1111/j.1558-5646.2011.01496.x; McGuigan K, 2005, AM NAT, V165, P32, DOI 10.1086/426600; Michaux J, 2007, J BIOGEOGR, V34, P1412, DOI 10.1111/j.1365-2699.2007.01701.x; Millien V, 2006, PLOS BIOL, V4, P1863, DOI 10.1371/journal.pbio.0040321; Mitteroecker P, 2011, EVOL BIOL, V38, P100, DOI 10.1007/s11692-011-9109-8; Mitteroecker P, 2009, EVOL BIOL, V36, P235, DOI 10.1007/s11692-009-9055-x; NACHMAN MW, 1994, GENETICS, V136, P1105; Oksanen J., 2020, VEGAN COMMUNITY ECOL; Paradis MR, 2013, EVOL DEV, V15, P268, DOI 10.1111/ede.12026; Peres-Neto PR, 2001, OECOLOGIA, V129, P169, DOI 10.1007/s004420100720; Pina M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091944; Polly PD, 2008, EVOL BIOL, V35, P83, DOI 10.1007/s11692-008-9020-0; PRAGER EM, 1993, BIOL J LINN SOC, V50, P85; R Core Team, 2021, R LANGUAGE ENV STAT; Rajabi-Maham H, 2008, MOL ECOL, V17, P627, DOI 10.1111/j.1365-294X.2007.03601.x; Rambaut A, 2009, FIGTREE VER 1 3 1; Renaud S, 2005, MAMM BIOL, V70, P157, DOI 10.1016/j.mambio.2004.10.004; Renaud S, 2013, J EVOLUTION IN PRESS; Renaud S, CAMBRIDGE S IN PRESS; Renaud S, 2007, ZOOL SCR, V36, P525, DOI 10.1111/j.1463-6409.2007.00297.x; Renaud S, 2006, EVOLUTION, V60, P1701; Renaud S, 2013, HYSTRIX, V24, P85, DOI 10.4404/hystrix-24.1-6296; Renaud S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018951; Rodrigues HG, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3504; ROHLF FJ, 1993, TRENDS ECOL EVOL, V8, P129, DOI 10.1016/0169-5347(93)90024-J; Schluter D, 1996, EVOLUTION, V50, P1766, DOI 10.1111/j.1558-5646.1996.tb03563.x; Searle JB, 2009, P ROY SOC B-BIOL SCI, V276, P201, DOI 10.1098/rspb.2008.0958; Siahsarvie R, 2012, BIOL J LINN SOC, V105, P635, DOI 10.1111/j.1095-8312.2011.01821.x; Staubach F, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002891; Suzuki H, 2013, HEREDITY, V111, P375, DOI 10.1038/hdy.2013.60; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Valenzuela-Lamas S, 2011, BIOL J LINN SOC, V102, P483, DOI 10.1111/j.1095-8312.2010.01603.x; Willmore KE, 2006, EVOL DEV, V8, P550, DOI 10.1111/j.1525-142X.2006.00127.x; Zelditch ML, 2004, EVOL DEV, V6, P194, DOI 10.1111/j.1525-142X.2004.04025.x	70	15	15	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2015	10	7							e0132801	10.1371/journal.pone.0132801	http://dx.doi.org/10.1371/journal.pone.0132801			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LN	26192946	Green Published, gold, Green Submitted			2022-12-26	WOS:000358546400040
J	Fallon, N; Li, XY; Stancak, A				Fallon, Nicholas; Li, Xiaoyun; Stancak, Andrej			Pain Catastrophising Affects Cortical Responses to Viewing Pain in Others	PLOS ONE			English	Article							RHEUMATOID-ARTHRITIS PAIN; EVENT-RELATED POTENTIALS; NEURAL RESPONSES; ACTIVITY INTOLERANCE; SOURCE LOCALIZATION; EMOTIONAL PICTURES; AROUSING PICTURES; BACK-PAIN; EMPATHY; BRAIN	Pain catastrophising is an exaggerated cognitive attitude implemented during pain or when thinking about pain. Catastrophising was previously associated with increased pain severity, emotional distress and disability in chronic pain patients, and is also a contributing factor in the development of neuropathic pain. To investigate the neural basis of how pain catastrophising affects pain observed in others, we acquired EEG data in groups of participants with high (High-Cat) or low (Low-Cat) pain catastrophising scores during viewing of pain scenes and graphically matched pictures not depicting imminent pain. The High-Cat group attributed greater pain to both pain and non-pain pictures. Source dipole analysis of even-trelated potentials during picture viewing revealed activations in the left (PHGL) and right (PHGR) paraphippocampal gyri, rostral anterior (rACC) and posterior cingulate (PCC) cortices. The late source activity (600-1100 ms) in PHGL and PCC was augmented in High-Cat, relative to Low-Cat, participants. Conversely, greater source activity was observed in the Low-Cat group during the mid-latency window (280-450 ms) in the rACC and PCC. Low-Cat subjects demonstrated a significantly stronger correlation between source activity in PCC and pain and arousal ratings in the long latency window, relative to high pain catastrophisers. Results suggest augmented activation of limbic cortex and higher order pain processing cortical regions during the late processing period in high pain catastrophisers viewing both types of pictures. This pattern of cortical activations is consistent with the distorted and magnified cognitive appraisal of pain threats in high pain catastrophisers. In contrast, high pain catastrophising individuals exhibit a diminished response during the midlatency period when attentional and top-down resources are ascribed to observed pain.	[Fallon, Nicholas; Li, Xiaoyun; Stancak, Andrej] Univ Liverpool, Inst Psychol Hlth & Soc, Dept Psychol Sci, Liverpool L69 3BX, Merseyside, England	University of Liverpool	Fallon, N (corresponding author), Univ Liverpool, Inst Psychol Hlth & Soc, Dept Psychol Sci, Liverpool L69 3BX, Merseyside, England.	nickfal@liverpool.ac.uk	Fallon, Nicvk/ABE-4809-2021					Akitsuki Y, 2009, NEUROIMAGE, V47, P722, DOI 10.1016/j.neuroimage.2009.04.091; [Anonymous], 2011, OXFORD HDB EVENT REL; BERG P, 1994, ELECTROEN CLIN NEURO, V90, P229, DOI 10.1016/0013-4694(94)90094-9; BRADLEY MM, 1994, J BEHAV THER EXP PSY, V25, P49, DOI 10.1016/0005-7916(94)90063-9; Cavanna AE, 2006, BRAIN, V129, P564, DOI 10.1093/brain/awl004; Chen CY, 2012, SOC NEUROSCI-UK, V7, P578, DOI 10.1080/17470919.2012.686924; Cheng YW, 2007, CURR BIOL, V17, P1708, DOI 10.1016/j.cub.2007.09.020; Crombez G, 2004, CLIN J PAIN, V20, P98, DOI 10.1097/00002508-200403000-00006; Davis M, 1980, JSAS CATALOG SELECTE, V10; DeCarlo LT, 1998, PSYCHOL METHODS, V3, P186, DOI 10.1037/1082-989X.3.2.186; Decety J, 2010, NEUROIMAGE, V50, P1676, DOI 10.1016/j.neuroimage.2010.01.025; Eccleston C, 1999, PSYCHOL BULL, V125, P356, DOI 10.1037/0033-2909.125.3.356; Edwards RR, 2004, PAIN, V111, P335, DOI 10.1016/j.pain.2004.07.012; Fallon N, 2015, J PAIN; Fan Y, 2008, NEUROPSYCHOLOGIA, V46, P160, DOI 10.1016/j.neuropsychologia.2007.07.023; Fan YT, 2014, SOC COGN AFFECT NEUR, V9, P1203, DOI 10.1093/scan/nst101; Foti D, 2008, J COGNITIVE NEUROSCI, V20, P977, DOI 10.1162/jocn.2008.20066; Foti D, 2009, PSYCHOPHYSIOLOGY, V46, P521, DOI 10.1111/j.1469-8986.2009.00796.x; Geisser ME, 2003, PAIN, V102, P243, DOI 10.1016/S0304-3959(02)00417-7; Glascher J, 2004, BMC NEUROSCI, V5, DOI 10.1186/1471-2202-5-45; Gracely RH, 2004, BRAIN, V127, P835, DOI 10.1093/brain/awh098; Gu XS, 2007, NEUROIMAGE, V36, P256, DOI 10.1016/j.neuroimage.2007.02.025; Gutschalk A, 2005, J NEUROSCI, V25, P5382, DOI 10.1523/JNEUROSCI.0347-05.2005; Hajcak G, 2008, EMOTION, V8, P250, DOI 10.1037/1528-3542.8.2.250; Hajcak G, 2007, BEHAV NEUROSCI, V121, P1156, DOI 10.1037/0735-7044.121.6.1156; Hajcak G, 2006, EMOTION, V6, P517, DOI 10.1037/1528-3542.6.3.517; Hajcak G, 2010, DEV NEUROPSYCHOL, V35, P129, DOI 10.1080/87565640903526504; Hamalainen JA, 2011, NEUROIMAGE, V54, P1910, DOI 10.1016/j.neuroimage.2010.10.016; Hoechstetter K., 2010, BESA RES TUTORIAL 4; Holmes AP, 1996, J CEREBR BLOOD F MET, V16, P7, DOI 10.1097/00004647-199601000-00002; Ibanez A, 2011, BRAIN RES, V1398, P72, DOI 10.1016/j.brainres.2011.05.014; Ikezawa S, 2014, SOC COGN AFFECT NEUR, V9, P1561, DOI 10.1093/scan/nst148; Jackson PL, 2006, NEUROPSYCHOLOGIA, V44, P752, DOI 10.1016/j.neuropsychologia.2005.07.015; Jackson PL, 2005, NEUROIMAGE, V24, P771, DOI 10.1016/j.neuroimage.2004.09.006; Jacobsen PB, 1996, J BEHAV MED, V19, P17, DOI 10.1007/BF01858172; KEEFE FJ, 1989, PAIN, V37, P51, DOI 10.1016/0304-3959(89)90152-8; Keefe FJ, 2000, PAIN, V87, P325, DOI 10.1016/S0304-3959(00)00296-7; Lamm C, 2011, NEUROIMAGE, V54, P2492, DOI 10.1016/j.neuroimage.2010.10.014; Lefebvre JC, 2002, CLIN J PAIN, V18, P56, DOI 10.1097/00002508-200201000-00009; Lehmann D., 1987, HDB ELECTROENCEPHALO, V1, P309; Leutgeb V, 2012, BIOL PSYCHOL, V90, P97, DOI 10.1016/j.biopsycho.2012.02.008; Leutgeb V, 2009, BIOL PSYCHOL, V82, P293, DOI 10.1016/j.biopsycho.2009.09.003; Li W, 2010, NEUROSCI LETT, V469, P328, DOI 10.1016/j.neulet.2009.12.021; Lin CS, 2013, J DENT RES, V92, P130, DOI 10.1177/0022034512467804; Linden DEJ, 2005, NEUROSCIENTIST, V11, P563, DOI 10.1177/1073858405280524; MacNamara A, 2009, NEUROPSYCHOLOGIA, V47, P2975, DOI 10.1016/j.neuropsychologia.2009.06.026; Maris E, 2007, J NEUROSCI METH, V164, P177, DOI 10.1016/j.jneumeth.2007.03.024; Martel MO, 2008, PAIN, V139, P562, DOI 10.1016/j.pain.2008.06.010; Martin A, 1999, HIPPOCAMPUS, V9, P62, DOI 10.1002/(SICI)1098-1063(1999)9:1<62::AID-HIPO7>3.0.CO;2-K; MCCARTHY G, 1981, SCIENCE, V211, P77, DOI 10.1126/science.7444452; Mella N, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00501; Muhlberger A, 2006, J ABNORM PSYCHOL, V115, P580, DOI 10.1037/0021-843X.115.3.580; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Olofsson JK, 2008, BIOL PSYCHOL, V77, P247, DOI 10.1016/j.biopsycho.2007.11.006; PASCUALMARQUI RD, 1994, INT J PSYCHOPHYSIOL, V18, P49, DOI 10.1016/0167-8760(84)90014-X; Pavlin DJ, 2005, CLIN J PAIN, V21, P83, DOI 10.1097/00002508-200501000-00010; Peters ML, 2005, PAIN, V113, P45, DOI 10.1016/j.pain.2004.09.033; Quartana PJ, 2009, EXPERT REV NEUROTHER, V9, P745, DOI 10.1586/ERN.09.34; Scharmuller W, 2011, BRAIN RES, V1397, P10, DOI 10.1016/j.brainres.2011.04.018; Schlereth T, 2003, NEUROIMAGE, V20, P441, DOI 10.1016/S1053-8119(03)00345-8; Seminowicz DA, 2006, PAIN, V120, P297, DOI 10.1016/j.pain.2005.11.008; Singer T, 2004, SCIENCE, V303, P1157, DOI 10.1126/science.1093535; Singer T, 2006, NATURE, V439, P466, DOI 10.1038/nature04271; Stancak A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019744; Sullivan MJL, 2006, PAIN, V122, P282, DOI 10.1016/j.pain.2006.02.001; Sullivan MJL, 2006, PAIN, V123, P37, DOI 10.1016/j.pain.2006.02.007; Sullivan M, 2009, PAIN, V143, P123, DOI 10.1016/j.pain.2009.02.011; Sullivan MJL, 2001, CLIN J PAIN, V17, P52, DOI 10.1097/00002508-200103000-00008; Sullivan MJL, 1995, PSYCHOL ASSESSMENT, V7, P524, DOI 10.1037/1040-3590.7.4.524; Sullivan MJL, 2004, PAIN, V107, P220, DOI 10.1016/j.pain.2003.11.003; Sullivan MJL, 2002, PAIN, V100, P47, DOI 10.1016/S0304-3959(02)00206-3; Sullivan MJL, 2001, PAIN, V91, P147, DOI 10.1016/S0304-3959(00)00430-9; Sullivan MJL, 1999, PAIN, V79, P155, DOI 10.1016/S0304-3959(98)00163-8; Swinkels-Meewisse IEJ, 2006, PAIN, V120, P36, DOI 10.1016/j.pain.2005.10.005; TARKKA IM, 1993, J CLIN NEUROPHYSIOL, V10, P513, DOI 10.1097/00004691-199310000-00009; Thibault P, 2008, PAIN, V139, P47, DOI 10.1016/j.pain.2008.02.029; Turner JA, 2002, PAIN, V98, P127, DOI 10.1016/S0304-3959(02)00045-3; Turner JA, 2001, CLIN J PAIN, V17, P65, DOI 10.1097/00002508-200103000-00009; Valentini E, 2012, NEUROIMAGE, V59, P1571, DOI 10.1016/j.neuroimage.2011.08.069; Valentini E, 2012, HUM BRAIN MAPP, V33, P2873, DOI 10.1002/hbm.21408; Van Damme S, 2004, PAIN, V107, P70, DOI 10.1016/j.pain.2003.09.023; Van Damme S, 2002, PAIN, V100, P111, DOI 10.1016/S0304-3959(02)00290-7; Vase L, 2012, EXP BRAIN RES, V218, P407, DOI 10.1007/s00221-012-3027-6; Vogt BA, 2005, NAT REV NEUROSCI, V6, P533, DOI 10.1038/nrn1704; Vogt BA, 2005, PROG BRAIN RES, V150, P205, DOI 10.1016/S0079-6123(05)50015-3; Weinberg A, 2010, EMOTION, V10, P767, DOI 10.1037/a0020242; Wideman TH, 2009, PAIN, V145, P45, DOI 10.1016/j.pain.2009.04.022	87	7	7	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0133504	10.1371/journal.pone.0133504	http://dx.doi.org/10.1371/journal.pone.0133504			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RV	26186545	Green Published, Green Submitted, gold			2022-12-26	WOS:000358198700149
J	Jeon, MJ; Kim, WG; Jang, EK; Choi, YM; Song, DE; Sung, TY; Yoon, JH; Chung, KW; Hong, SJ; Ryu, JS; Han, JM; Kim, TY; Shong, YK; Kim, WB				Jeon, Min Ji; Kim, Won Gu; Jang, Eun Kyung; Choi, Yun Mi; Song, Dong Eun; Sung, Tae-Yon; Yoon, Jong Ho; Chung, Ki-Wook; Hong, Suck Joon; Ryu, Jin-Sook; Han, Ji Min; Kim, Tae Yong; Shong, Young Kee; Kim, Won Bae			Sub-Classification of Lateral Cervical Lymph Node Metastasis in Papillary Thyroid Carcinoma by Pathologic Criteria	PLOS ONE			English	Article							DISTANT METASTASES; RADIOACTIVE IODINE; PROGNOSTIC-FACTORS; NECK DISSECTION; LUNG METASTASIS; TUMOR SIZE; CANCER; RISK; RECURRENCE; SURVIVAL	Background Lateral cervical lymph node (LCLN) metastasis, or pathologic N1b disease, is an important risk factor in papillary thyroid carcinoma (PTC). However, many patients have favorable prognosis even with pathologic N1b patients in clinical practice. The study aims to identify high-and intermediate-risk groups based on initial pathologic characteristics in these patients. Patients This study included 518 classical PTC patients confirmed as pathologic N1b at initial surgery between 2001 and 2010. All patients underwent a single fixed activity (5.6 GBq) of radioactive I-131 remnant ablation. Results Patients with a primary tumor larger than 4 cm, gross extrathyroidal extension, metastatic LN larger than 3 cm, or greater than 10 metastatic LCLN were classified as high-risk group. These comprehensive pathologic criteria were retrieved from cox proportional hazard models. Twenty two percent of patients (n = 113) were classified as high-risk and 78% (n = 405) as intermediate-risk group. Successful ablation was identified in only 32% of the patients in the high-risk group and 61% in the intermediate-risk group (p < 0.001). The difference between the two risk groups was independent to gender. There was a significant difference in disease-free survival between the high-and intermediate-risk N1b groups during 5.1 years of median follow-up (84% vs. 59%, p < 0.001). Distant metastasis was more prevalent in the high-risk group (20%) than in the intermediate-risk group (4%, p < 0.001). Conclusions The prognosis of PTC patients with LCLN metastasis varies depending on initial pathologic characteristics. We proposed the comprehensive pathologic criteria for sub-classification of N1b into high- and intermediate-risk groups and this sub-classification may permit personalized management of N1b PTC patients.	[Jeon, Min Ji; Kim, Won Gu; Jang, Eun Kyung; Choi, Yun Mi; Kim, Tae Yong; Shong, Young Kee; Kim, Won Bae] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Internal Med, Seoul, South Korea; [Song, Dong Eun] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Pathol, Seoul, South Korea; [Sung, Tae-Yon; Yoon, Jong Ho; Chung, Ki-Wook; Hong, Suck Joon] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Surg, Seoul, South Korea; [Ryu, Jin-Sook] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Nucl Med, Seoul, South Korea; [Han, Ji Min] Sungkyunkwan Univ, Sch Med, Dept Med, Samsung Changwon Hosp, Chang Won, South Korea	University of Ulsan; Asan Medical Center; University of Ulsan; Asan Medical Center; University of Ulsan; Asan Medical Center; University of Ulsan; Asan Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center	Kim, WG (corresponding author), Univ Ulsan, Coll Med, Asan Med Ctr, Dept Internal Med, Seoul, South Korea.	wongukim@amc.seoul.kr	Kim, Tae Yong/C-1272-2009; Kim, Won Gu/AAG-2096-2019	Kim, Tae Yong/0000-0003-4982-4441; Kim, Won Gu/0000-0002-8404-7759; Choi, Yun Mi/0000-0001-8209-874X; Shong, Young Kee/0000-0002-7911-9471; Kim, Won Bae/0000-0003-4544-1750; Jeon, Min Ji/0000-0002-1297-107X	Asan Institute for Life Sciences, Seoul, Korea [2015-582]	Asan Institute for Life Sciences, Seoul, Korea	This study was supported by a grant (2015-582) from the Asan Institute for Life Sciences, Seoul, Korea. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BYAR DP, 1979, EUR J CANCER, V15, P1033, DOI 10.1016/0014-2964(79)90291-3; CADY B, 1988, SURGERY, V104, P947; Chung JK, 2014, ENDOCRINOL METAB, V29, P233, DOI 10.3803/EnM.2014.29.3.233; Cooper DS, 2009, THYROID, V19, P1167, DOI 10.1089/thy.2009.0110; Davies L, 2006, JAMA-J AM MED ASSOC, V295, P2164, DOI 10.1001/jama.295.18.2164; de Meer SGA, 2012, WORLD J SURG, V36, P1262, DOI 10.1007/s00268-012-1427-1; Ferro DP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020706; Goffredo P, 2013, WORLD J SURG, V37, P1599, DOI 10.1007/s00268-013-2006-9; Greene FL, 2002, AJCC CANCER STAGING; Haymart MR, 2009, ONCOLOGIST, V14, P216, DOI 10.1634/theoncologist.2008-0194; Ibrahimpasic T, 2012, SURGERY, V152, P1096, DOI 10.1016/j.surg.2012.08.034; Ito Y, 2012, ENDOCR J, V59, P457, DOI 10.1507/endocrj.EJ12-0013; Ito Y, 2012, WORLD J SURG, V36, P1274, DOI 10.1007/s00268-012-1423-5; Ito Y, 2012, WORLD J SURG, V36, P593, DOI 10.1007/s00268-011-1391-1; Jeon MJ, 2014, CLIN ENDOCRINOL, V81, P593, DOI 10.1111/cen.12463; Jeon MJ, 2014, EUR J ENDOCRINOL, V170, P23, DOI 10.1530/EJE-13-0524; Jeon MJ, 2013, EUR J ENDOCRINOL, V168, P219, DOI 10.1530/EJE-12-0744; Kim SJ, 2014, ANNALS OF SURGICAL O; Kim SJ, 2014, ANN SURG ONCOL, V21, P1884, DOI 10.1245/s10434-014-3507-y; Kim TY, 2014, ENDOCRINOL METAB, V29, P217, DOI 10.3803/EnM.2014.29.3.217; Kim WG, 2011, ENDOCRINOL METAB, V26, P53, DOI 10.3803/EnM.2011.26.1.53; Leboulleux S, 2005, J CLIN ENDOCR METAB, V90, P5723, DOI 10.1210/jc.2005-0285; Lee YS, 2011, ANN SURG ONCOL, V18, P3486, DOI 10.1245/s10434-011-1763-7; Machens A, 2012, J CLIN ENDOCR METAB, V97, P4375, DOI 10.1210/jc.2012-1257; Metze K, 2011, J AM COLL SURGEONS, V212, P132, DOI 10.1016/j.jamcollsurg.2010.10.004; Nixon IJ, 2013, THYROID, V23, P683, DOI 10.1089/thy.2012.0307; Randolph GW, 2012, THYROID, V22, P1144, DOI 10.1089/thy.2012.0043; Reis-Alves SC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081048; Sabra M, 2014, THYROID; Schlumberger M, 2012, NEW ENGL J MED, V366, P1663, DOI 10.1056/NEJMoa1108586; Smith VA, 2012, J SURG ONCOL, V106, P357, DOI 10.1002/jso.23090; Verburg FA, 2013, J CLIN ENDOCR METAB, V98, P172, DOI 10.1210/jc.2012-2458; Wang LY, 2015, ANN SURG ONCOL, V22, P3530, DOI 10.1245/s10434-015-4398-2; Yim JH, 2011, J CLIN ENDOCR METAB, V96, P2049, DOI 10.1210/jc.2010-2298	34	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0133625	10.1371/journal.pone.0133625	http://dx.doi.org/10.1371/journal.pone.0133625			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RV	26186205	Green Published, Green Submitted, gold			2022-12-26	WOS:000358198700162
J	Kolahian, S; Sadri, H; Shahbazfar, AA; Amani, M; Mazadeh, A; Mirani, M				Kolahian, Saeed; Sadri, Hassan; Shahbazfar, Amir Ali; Amani, Morvarid; Mazadeh, Anis; Mirani, Mehdi			The Effects of Leucine, Zinc, and Chromium Supplements on Inflammatory Events of the Respiratory System in Type 2 Diabetic Rats	PLOS ONE			English	Article							ANTIOXIDANT PROPERTIES; RECEPTOR; EFFICACY; SAFETY; ULTRASTRUCTURE; INVOLVEMENT; MELLITUS; STRESS; CELLS; MODEL	Diabetes mellitus is a major cause of serious micro- and macrovascular diseases that affect nearly every system in the body, including the respiratory system. Non-enzymatic protein glycation due to hyperglycaemic stress has fundamental implications due to the large capillary network and amount of connective tissue in the lung. The current study was designed to determine whether leucine, zinc, and chromium supplementations influence the function and histological structure of the respiratory tract in a rat model of type 2 diabetes. Seventy-seven rats were divided into eleven groups, consisting of 7 animals each. One group served as negative control and insulin and glibenclamide were used as positive control drugs. Thus, eight groups received the nutritional supplements alone or in combination with each other. Nutritional supplements and glibenclamide were added to the drinking water and neutral protamine Hagedorn insulin was subcutaneously injected during the 4 weeks of treatment period. The induction of type 2 diabetes in the rats caused an infiltration of mononuclear cells and edema in the submucosa of the trachea and lung, severe fibrosis around the vessels and airways, and perivascular and peribronchial infiltration of inflammatory cells and fibrin. In the diabetic group, the total inflammation score and Reid index significantly increased. Diabetes induction significantly reduced the total antioxidant status and elevated the lipid peroxidation products in the serum, lung lavage and lung tissue of the diabetic animals. Treatment with nutritional supplements significantly decreased the histopathological changes and inflammatory indices in the diabetic animals. Supplementation of diabetic rats with leucine, zinc, and chromium, alone and in combination, significantly increased the total antioxidant status and lipid peroxidation level in the diabetic animals. The nutritional supplements improved the enzymatic antioxidant activity of catalase, glutathione peroxidase, myeloperoxidase, and superoxide dismutase in the diabetic rats. The present results demonstrate beneficial effects and amelioration of inflammation in the respiratory system of type 2 diabetic rats by leucine, zinc, and chromium supplements, probably due to their hypoglycaemic and antioxidant properties. Using safe and effective nutritional supplements, such as leucine, chromium and zinc, to replace proven conventional medical treatments may help to control diabetes and/or its complications.	[Kolahian, Saeed] Univ Tabriz, Fac Vet Med, Dept Basic Sci, Tabriz, Iran; [Sadri, Hassan] Univ Bonn, Inst Anim Sci, Physiol & Hyg Unit, Bonn, Germany; [Sadri, Hassan] Univ Tabriz, Dept Clin Sci, Fac Vet Med, Tabriz, Iran; [Shahbazfar, Amir Ali] Univ Tabriz, Dept Pathobiol, Fac Vet Med, Tabriz, Iran; [Amani, Morvarid; Mazadeh, Anis; Mirani, Mehdi] Univ Tabriz, Fac Vet Med, Tabriz, Iran	University of Tabriz; University of Bonn; University of Tabriz; University of Tabriz; University of Tabriz	Kolahian, S (corresponding author), Univ Tabriz, Fac Vet Med, Dept Basic Sci, Tabriz, Iran.	skolahian@tabrizu.ac.ir			Tuberculosis and Lung Research Center of Tabriz University of Medical Sciences; Research Council of University of Tabriz	Tuberculosis and Lung Research Center of Tabriz University of Medical Sciences; Research Council of University of Tabriz	This study was financially supported by the Tuberculosis and Lung Research Center of Tabriz University of Medical Sciences and the Research Council of University of Tabriz. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aebi H, 1984, Methods Enzymol, V105, P121; Ahmed R, 2005, MED J ISLAMIC WORLD, V15, P31; Bao SY, 2006, AM J PHYSIOL-LUNG C, V290, pL433, DOI 10.1152/ajplung.00341.2005; Bembde AS, 2012, INDIAN J HEMATOL BLO, V28, P105, DOI 10.1007/s12288-011-0116-9; Benzie IFF, 1996, ANAL BIOCHEM, V239, P70, DOI 10.1006/abio.1996.0292; BRADLEY PP, 1982, J INVEST DERMATOL, V78, P206, DOI 10.1111/1523-1747.ep12506462; Buege J A, 1978, Methods Enzymol, V52, P302; Ceglia L, 2006, ANN INTERN MED, V145, P665, DOI 10.7326/0003-4819-145-9-200611070-00009; Davis CM, 1997, BIOCHEMISTRY-US, V36, P4382, DOI 10.1021/bi963154t; Davis CM, 1997, INORG CHEM, V36, P5316, DOI 10.1021/ic970568h; Del Maestro R., 1985, CRC HDB METHODS OXYG, V1, P294; Flanagan AM, 2008, J NUTR BIOCHEM, V19, P505, DOI 10.1016/j.jnutbio.2007.06.005; FLOHE L, 1984, METHOD ENZYMOL, V105, P114; Gomez NN, 2006, NITRIC OXIDE-BIOL CH, V14, P30, DOI 10.1016/j.niox.2005.09.001; Hsia CCW, 2008, DIABETES CARE, V31, P828, DOI 10.2337/dc08-0103; Jakus V, 2004, PHYSIOL RES, V53, P131; Kahn SE, 1990, ELLENBERG RIFKINS DI, P436; KAKKAR P, 1984, INDIAN J BIOCHEM BIO, V21, P130; Kaparianos A, 2008, Chron Respir Dis, V5, P101, DOI 10.1177/1479972307086313; Kelleher SL, 2011, ADV NUTR, V2, P101, DOI 10.3945/an.110.000232; KIDA K, 1983, AM REV RESPIR DIS, V128, P125, DOI 10.1164/arrd.1983.128.1.125; Kodolova IM, 1982, ARKH PATOL, V44, P3840; Kuitert L M E, 2008, Chron Respir Dis, V5, P67, DOI 10.1177/1479972308091408; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Macotela Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021187; Murgia C, 2006, CURR DRUG TARGETS, V7, P607, DOI 10.2174/138945006776818683; NATHAN DM, 1993, NEW ENGL J MED, V328, P1676, DOI 10.1056/NEJM199306103282306; Onderci M, 2003, BIOL TRACE ELEM RES, V92, P139, DOI 10.1385/BTER:92:2:139; Oteiza Patricia I., 2005, Molecular Aspects of Medicine, V26, P245, DOI 10.1016/j.mam.2005.07.012; PLOPPER CG, 1978, LAB INVEST, V38, P143; PLOPPER CG, 1979, AM REV RESPIR DIS, V120, P1137; Rachdi L, 2012, DIABETES, V61, P409, DOI 10.2337/db11-0765; Reed MJ, 2000, METABOLISM, V49, P1390, DOI 10.1053/meta.2000.17721; Richter M, 2003, CHEST, V123, p446S, DOI 10.1378/chest.123.3_suppl.446S; Rosenstock J, 2008, DIABETES CARE, V31, P2177, DOI 10.2337/dc08-0315; Rosenstock J, 2008, DIABETES CARE, V31, P1723, DOI 10.2337/dc08-0159; Sahin K, 2011, BIOL TRACE ELEM RES, V143, P1018, DOI 10.1007/s12011-010-8905-9; Sahin N, 2003, ARCH ANIM NUTR, V57, P207, DOI 10.1080/0003942031000136639; SATOH K, 1978, CLIN CHIM ACTA, V90, P37; SINHA AK, 1972, ANAL BIOCHEM, V47, P389, DOI 10.1016/0003-2697(72)90132-7; Song MK, 2009, BRIT J PHARMACOL, V158, P442, DOI 10.1111/j.1476-5381.2009.00201.x; Swaminath G, 2003, J BIOL CHEM, V278, P352, DOI 10.1074/jbc.M206424200; Swaminath G, 2002, MOL PHARMACOL, V61, P65, DOI 10.1124/mol.61.1.65; Tang ZL, 2002, MOL CELL BIOCHEM, V234, P211, DOI 10.1023/A:1015930927407; Taniguchi CM, 2006, NAT REV MOL CELL BIO, V7, P85, DOI 10.1038/nrm1837; Teeter John G, 2008, Diabetes Care, V31, pe82, DOI 10.2337/dc08-1090; Varvarovska J, 2003, J DIABETES COMPLICAT, V17, P7, DOI 10.1016/S1056-8727(01)00228-8; VRACKO R, 1979, AM REV RESPIR DIS, V120, P973; White MF, 2002, AM J PHYSIOL-ENDOC M, V283, pE413, DOI 10.1152/ajpendo.00514.2001; Yang J, 2012, J BIOL CHEM, V287, P24795, DOI 10.1074/jbc.M112.344259; Yoshida T, 2007, PHYSIOL REV, V87, P1047, DOI 10.1152/physrev.00048.2006; Zemel MB, 2012, NUTRIENTS, V4, P529, DOI 10.3390/nu4060529; Zemel MB, 2010, AM J CLIN NUTR, V91, P16, DOI 10.3945/ajcn.2009.28468; Zivic Sasa, 2008, Med Pregl, V61, P458; Zou J, 2004, J BIOL CHEM, V279, P9818, DOI 10.1074/jbc.M309696200	55	11	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0133374	10.1371/journal.pone.0133374	http://dx.doi.org/10.1371/journal.pone.0133374			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RV	26185997	Green Submitted, Green Published, gold			2022-12-26	WOS:000358198700129
J	Labouba, I; Le Page, C; Communal, L; Kristessen, T; You, XT; Peant, B; Barres, V; Gannon, PO; Mes-Masson, AM; Saad, F				Labouba, Ingrid; Le Page, Cecile; Communal, Laudine; Kristessen, Torbjoern; You, Xiaotian; Peant, Benjamin; Barres, Veronique; Gannon, Philippe O.; Mes-Masson, Anne-Marie; Saad, Fred			Potential Cross-Talk between Alternative and Classical NF-kappa B Pathways in Prostate Cancer Tissues as Measured by a Multi-Staining Immunofluorescence Co-Localization Assay	PLOS ONE			English	Article							NUCLEAR-LOCALIZATION; TRANSCRIPTION FACTORS; PROGNOSTIC-SIGNIFICANCE; RELB; EXPRESSION; ACTIVATION; ALPHA; CARCINOGENESIS; APOPTOSIS; CELLS	Background While the classical NF-kappa B/p65 pathway is known to be involved in prostate cancer progression and is associated with poor patient outcome, the role of the NF-kappa B/RelB alternative protein is not well defined. Here we analyzed the activation of both NF-kappa B pathways in prostate cancer tissues and correlate this activation with clinical features of the disease. Methods A multiple immunofluorescence technique was employed to concomitantly and quantitatively visualize the nuclear localization of p65 and RelB in 200 paraffin embedded samples. Epithelia were defined using appropriate fluorochrome markers and the resulting immunofluorescent signals were quantified with an automated scoring system. Results The nuclear frequency of p65 was found to be significantly increased in tumor tissues as compared with normal adjacent tissue, whereas the frequency for RelB was decreased (p < 0.001, Wilcoxon test). As previously reported, p65 nuclear frequency was associated with a risk of biochemical recurrence. Although, RelB nuclear frequency alone did not predict recurrence, the presence of activated RelB reduced the risk of recurrence associated with the activation of p65. Conclusion For the first time p65/RelB co-distribution was assessed in prostate cancer tissues and suggested a negative crosstalk between the two NF-kappa B pathways in prostate cancer progression.	[Labouba, Ingrid; Le Page, Cecile; Communal, Laudine; You, Xiaotian; Peant, Benjamin; Barres, Veronique; Gannon, Philippe O.; Mes-Masson, Anne-Marie; Saad, Fred] CRCHUM, Inst Canc Montreal, Montreal, PQ, Canada; [Kristessen, Torbjoern] Visiopharm, Horsholm, Denmark; [Mes-Masson, Anne-Marie] Univ Montreal, Dept Med, Montreal, PQ H3C 3J7, Canada; [Saad, Fred] Univ Montreal, CHUM, Div Urol, Montreal, PQ H3C 3J7, Canada; [Saad, Fred] Univ Montreal, Dept Surg, Montreal, PQ H3C 3J7, Canada	Universite de Montreal; Universite de Montreal; Universite de Montreal; Universite de Montreal	Saad, F (corresponding author), CRCHUM, Inst Canc Montreal, 900 Rue St Denis, Montreal, PQ, Canada.	fred.saad.chum@ssss.gouv.qc.ca	Le Page, Cecile/B-3215-2010	Le Page, Cecile/0000-0002-8020-1544; Mes-Masson, Anne-Marie/0000-0002-6498-266X; Peant, Benjamin/0000-0001-5090-0558	Chair en Cancer de la prostate (Universite de montreal); CUOG award; Reseau de recheche en cancer	Chair en Cancer de la prostate (Universite de montreal); CUOG award; Reseau de recheche en cancer	Chair en Cancer de la prostate (Universite de montreal, http://www.recherche.umontreal.ca/en/research-at-udem/our-research-units/profile/unite/449/pid/15/) CUOG award (http://www.cuog.ca) Reseau de recheche en cancer (http://www.rrcancer.ca/fr/scientifique/biobanques/lister/2). Visiopharm' provided support in the form of a salary for author TK, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Annunziata CM, 2010, CANCER-AM CANCER SOC, V116, P3276, DOI 10.1002/cncr.25190; Beinke S, 2004, BIOCHEM J, V382, P393, DOI 10.1042/BJ20040544; Benedetti G, 2013, MOL PHARMACOL, V84, P128, DOI 10.1124/mol.112.084053; Campa VM, 2014, ONCOTARGET, V5, P8173, DOI 10.18632/oncotarget.2303; Demicco EG, 2005, MOL CELL BIOL, V25, P10136, DOI 10.1128/MCB.25.22.10136-10147.2005; Domingo-Domenech J, 2005, BRIT J CANCER, V93, P1285, DOI 10.1038/sj.bjc.6602851; Fournier G, 2004, ANN UROL, V38, P207, DOI 10.1016/j.anuro.2004.06.003; Fradet V, 2004, CLIN CANCER RES, V10, P8460, DOI 10.1158/1078-0432.CCR-04-0764; Gannon PO, 2013, EUR J CANCER, V49, P2441, DOI 10.1016/j.ejca.2013.02.026; Gilmore TD, 2006, ONCOGENE, V25, P6680, DOI 10.1038/sj.onc.1209954; Harris WP, 2009, NAT CLIN PRACT UROL, V6, P76, DOI 10.1038/ncpuro1296; Hatano K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031234; Hoesel B, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-86; Hoffmann A, 2006, ONCOGENE, V25, P6706, DOI 10.1038/sj.onc.1209933; Jacque E, 2005, P NATL ACAD SCI USA, V102, P14635, DOI 10.1073/pnas.0507342102; Jacque E, 2013, ONCOGENE, V32, P2661, DOI 10.1038/onc.2012.282; Koumakpayi IH, 2010, BRIT J CANCER, V102, P1163, DOI 10.1038/sj.bjc.6605571; Labouba I, 2014, CANCER CELL INT, V14, DOI 10.1186/1475-2867-14-67; Lawrence T, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001651; Le Page C, 2005, PROSTATE, V65, P130, DOI 10.1002/pros.20234; Lessard L, 2005, BRIT J CANCER, V93, P1019, DOI 10.1038/sj.bjc.6602796; Lessard L, 2003, BJU INT, V91, P417, DOI 10.1046/j.1464-410X.2003.04104.x; Lessard L, 2006, B CANCER, V93, P891; Lessard L, 2006, CLIN CANCER RES, V12, P5741, DOI 10.1158/1078-0432.CCR-06-0330; Li T, 2010, NAT IMMUNOL, V11, P799, DOI 10.1038/ni.1918; Li YW, 2006, CANCER RES, V66, P4816, DOI 10.1158/0008-5472.CAN-05-3752; Long RM, 2005, CLIN SCI, V108, P1, DOI 10.1042/CS20040241; McCall P, 2012, BRIT J CANCER, V107, P1554, DOI 10.1038/bjc.2012.372; NAGLE RB, 1991, AM J PATHOL, V138, P119; Nguyen DP, 2014, BJU INT, V114, P168, DOI [10.1111/bju.12488, 10.1111/j.1464-410X.2013.11397_10.x]; Perkins ND, 2012, NAT REV CANCER, V12, P121, DOI 10.1038/nrc3204; Qu Y, 2011, J CLIN PATHOL, V64, P695, DOI 10.1136/jclinpath-2011-200017; Robertson D, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-13; Rosa-Ribeiro R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097080; Ross JS, 2004, CLIN CANCER RES, V10, P2466, DOI 10.1158/1078-0432.CCR-0543-3; Sartor AO, 2008, UROLOGY, V72, P12, DOI 10.1016/j.urology.2008.10.004; Sethi G, 2008, EXP BIOL MED, V233, P21, DOI 10.3181/0707-MR-196; Shen MM, 2010, GENE DEV, V24, P1967, DOI 10.1101/gad.1965810; Shukla S, 2004, NEOPLASIA, V6, P390, DOI 10.1593/neo.04112; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Sun ZW, 2002, SHOCK, V18, P99, DOI 10.1097/00024382-200208000-00001; Tabruyn SP, 2007, CELL DEATH DIFFER, V14, P1393, DOI 10.1038/sj.cdd.4402156; Van der Kwast TH, 2013, NAT REV UROL, V10, P473, DOI 10.1038/nrurol.2013.112; Wang XB, 2007, NAT CELL BIOL, V9, P470, DOI 10.1038/ncb1559; Xu Y, 2012, J ENG FIBER FABR, V7, P7; Xu Y, 2008, MOL CANCER THER, V7, P2367, DOI 10.1158/1535-7163.MCT-08-0238; Xu Y, 2007, MOL CANCER THER, V6, P2048, DOI 10.1158/1535-7163.MCT-06-0700; Xu Y, 2010, MOL CANCER THER, V9, P803, DOI 10.1158/1535-7163.MCT-09-1001; Xu Y, 2009, CANCER RES, V69, P3267, DOI 10.1158/0008-5472.CAN-08-4635; Zhu HC, 2015, MOL MED REP, V11, P1167, DOI 10.3892/mmr.2014.2857; Zhu L, 2014, BIOMED REP, V2, P354, DOI 10.3892/br.2014.250	51	13	14	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0131024	10.1371/journal.pone.0131024	http://dx.doi.org/10.1371/journal.pone.0131024			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RV	26186215	gold, Green Submitted, Green Published			2022-12-26	WOS:000358198700010
J	Li, L; Gong, YX; Yin, H; Gong, DC				Li, Li; Gong, Yuxuan; Yin, Hao; Gong, Decai			Different Types of Peptide Detected by Mass Spectrometry among Fresh Silk and Archaeological Silk Remains for Distinguishing Modern Contamination	PLOS ONE			English	Article							FIBROIN; PROTEIN; DEGRADATION; PROTEOMICS; FIBERS	Archaeological silk provides abundant information for studying ancient technologies and cultures. However, due to the spontaneous degradation and the damages from burial conditions, most ancient silk fibers which suffered the damages for thousands of years were turned into invisible molecular residues. For the obtained rare samples, extra care needs to be taken to accurately identify the genuine archaeological silk remains from modern contaminations. Although mass spectrometry (MS) is a powerful tool for identifying and analyzing the ancient protein residues, the traditional approach could not directly determine the dating and contamination of each sample. In this paper, a series of samples with a broad range of ages were tested by MS to find an effective and innovative approach to determine whether modern contamination exists, in order to verify the authenticity and reliability of the ancient samples. The new findings highlighted that the detected peptide types of the fibroin light chain can indicate the degradation levels of silk samples and help to distinguish contamination from ancient silk remains.	[Li, Li; Gong, Yuxuan; Gong, Decai] Univ Sci & Technol China, Basic Res Ctr Heritage Conservat Sci, Dept Hist Sci & Sci Archaeol, Hefei 230026, Peoples R China; [Yin, Hao] Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Hefei 230026, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS	Gong, DC (corresponding author), Univ Sci & Technol China, Basic Res Ctr Heritage Conservat Sci, Dept Hist Sci & Sci Archaeol, Hefei 230026, Peoples R China.	gdclucky@ustc.edu.cn		Li, Li/0000-0001-5033-0911				Ajisawa A., 1998, J SERICULTURAL SCI J; [Anonymous], CURRENT PROTOCOLS PR; Arai T, 2004, J APPL POLYM SCI, V91, P2383, DOI 10.1002/app.13393; Brown KA, 2013, ANNU REV ANTHROPOL, V42, P159, DOI 10.1146/annurev-anthro-092412-155455; Buckley M, 2010, J ARCHAEOL SCI, V37, P13, DOI 10.1016/j.jas.2009.08.020; Calvert P, 1998, NATURE, V393, P309, DOI 10.1038/30610; Cappellini E, 2012, J PROTEOME RES, V11, P917, DOI 10.1021/pr200721u; Gong DC, 2013, POLYM DEGRAD STABIL, V98, P1780, DOI 10.1016/j.polymdegradstab.2013.05.011; Horan RL, 2005, BIOMATERIALS, V26, P3385, DOI 10.1016/j.biomaterials.2004.09.020; Keten S, 2010, NAT MATER, V9, P359, DOI [10.1038/nmat2704, 10.1038/NMAT2704]; Ki CS, 2009, MACROMOL RES, V17, P935, DOI 10.1007/BF03218639; Lu QA, 2011, BIOMACROMOLECULES, V12, P1080, DOI 10.1021/bm101422j; Matsumoto A, 2008, MACROMOL BIOSCI, V8, P1006, DOI 10.1002/mabi.200800020; Oonk S, 2012, ORG GEOCHEM, V50, P57, DOI 10.1016/j.orggeochem.2012.06.012; Scheibel T, 2005, CURR OPIN BIOTECH, V16, P427, DOI 10.1016/j.copbio.2005.05.005; Solazzo C, 2014, J ARCHAEOLOGICAL SCI; Solazzo C, 2012, PHOTOCHEM PHOTOBIOL, V88, P1217, DOI 10.1111/j.1751-1097.2012.01167.x; Solazzo C, 2011, ANTIQUITY, V85, P1418, DOI 10.1017/S0003598X00062141; Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013; Wadbua P, 2010, INT J BIOL MACROMOL, V46, P493, DOI 10.1016/j.ijbiomac.2010.03.007; Washburn MP, 2001, NAT BIOTECHNOL, V19, P242, DOI 10.1038/85686; Zhang XM, 2010, CHINESE J CHEM, V28, P656, DOI 10.1002/cjoc.201090128; Zhou CZ, 2001, PROTEINS, V44, P119, DOI 10.1002/prot.1078; Zhu Z, 2013, ARCHAEOMETRY	24	6	7	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0132827	10.1371/journal.pone.0132827	http://dx.doi.org/10.1371/journal.pone.0132827			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	CN1RV	26186676	Green Published, gold, Green Submitted			2022-12-26	WOS:000358198700063
J	Lou, YH; Hu, LX; Chen, LA; Sun, XY; Yang, Y; Liu, HM; Xu, QG				Lou, Yanhong; Hu, Longxing; Chen, Liang; Sun, Xiaoyan; Yang, Yong; Liu, Hongmei; Xu, Qingguo			Association Analysis of Simple Sequence Repeat (SSR) Markers with Agronomic Traits in Tall Fescue (Festuca arundinacea Schreb.)	PLOS ONE			English	Article							NORTH-AFRICAN VARIETIES; GENOME-WIDE ASSOCIATION; GENETIC DIVERSITY; CANDIDATE GENES; MOLECULAR DIVERSITY; FLOWERING-TIME; MAIZE; IDENTIFICATION; RESISTANCE; GERMPLASM	Tall fescue is widely used in temperate regions throughout the world as a dominant forage grass as well as a turfgrass, in pastoral and turf industry. However, the utilization of tall fescue was limited because of its leaf roughness, poor regeneration ability and poor stress resistance. New cultivars were desirable in modern pastoral industries exceed the potential of existing cultivars. Therefore, well understanding the agronomic traits and describing germplasms would help to overcome these constraints, and morphological evaluation of tall fescue germplasm is the key component in selecting rational parents for hybridization breeding. However, describing the morphological traits of tall fescue germplasm is costly and time-consuming. Fortunately, biotechnology approaches can supplement conventional breeding efforts for tall fescue improvement. Association mapping, as a powerful approach to identify association between agronomic traits and molecular markers has been widely used for enhancing the utilization, conservation and management of the tall fescue germplasms. Therefore, in the present research, 115 tall fescue accessions from different origins (25 accessions are cultivars; 31 accessions from America; 32 accessions from European; 7 accessions from Africa; 20 accessions from Asia), were evaluated for agronomic traits and genetic diversity with 90 simple sequence repeat (SSR) markers. The panel displayed significant variation in spike count per plant (SCP) and spike weight (SW). However, BCS performed the lowest CV among all the observed agronomic traits. Three subpopulations were identified within the collections but no obvious relative kinship (K) was found. The GLM model was used to describe the association between SSR and agronomic traits. Fifty-one SSR markers associated with agronomic traits were observed. Twelve single-associated markers were associated with PH; six single-associated markers were associated with BCS; eight single-associated markers were associated with SW; five single-associated markers were associated with SC; seven single-associated markers were associated with SCP; three single-associated markers were associated with SL. Especially, we observed that the genetic variation of SW was explained 11.6 % by M37 marker. It is interesting to observe that nine markers (M1, M2, M35, M54 marker was associated with both BCS and SC; M3, M4 markers were associated with BCS, SW, and SC; M19 marker was associated with both pH and PD, M40 marker was associated with both SCP and SW; and M193 marker was associated with both PH and SL) were associated with more than two agronomic traits. Notably, Branch count per spike (BCS) was explained by four markers (M1, M2, M3, and M4) exceeding 10 %. These identified marker alleles associated with agronomic traits could provide important information and markers for molecular-assisted breeding that facilitate the breeding process in tall fescue.	[Lou, Yanhong; Liu, Hongmei; Xu, Qingguo] Hunan Agr Univ, Coll Agron, Changsha 410128, Hunan, Peoples R China; [Lou, Yanhong; Hu, Longxing; Chen, Liang; Sun, Xiaoyan] Chinese Acad Sci, Wuhan Bot Garden, Key Lab Plant Germplasm Enhancement & Specialty A, Wuhan 430074, Hubei, Peoples R China; [Yang, Yong] Hunan Int Econ Univ, Golf Coll, Changsha 410205, Hunan, Peoples R China	Hunan Agricultural University; Chinese Academy of Sciences; Wuhan Botanical Garden, CAS	Xu, QG (corresponding author), Hunan Agr Univ, Coll Agron, Nongda Rd, Changsha 410128, Hunan, Peoples R China.	huxu0309@aliyun.com	Hu, Longxing/AAS-8287-2020; lou, yanhong/AAE-8504-2020		Research in crop genetics and breeding technology, Hunan Provincial Education Department [KC2011B023]	Research in crop genetics and breeding technology, Hunan Provincial Education Department	Research in crop genetics and breeding technology, Hunan Provincial Education Department, KC2011B023, Qingguo Xu. Research design.	Abdurakhmonov Ibrokhim Y, 2008, Int J Plant Genomics, V2008, P574927, DOI 10.1155/2008/574927; Ashfaq S, 2014, J BIOL AGR HEALTHCAR, V4, P10; BACON CW, 1995, J ANIM SCI, V73, P861; Bradbury P, 2011, CROP SCI, V51, P52, DOI 10.2135/cropsci2010.02.0064; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Breseghello F, 2006, GENETICS, V172, P1165, DOI 10.1534/genetics.105.044586; Buckler ES, 2002, CURR OPIN PLANT BIOL, V5, P107, DOI 10.1016/S1369-5266(02)00238-8; Buckner R.C., 1979, TALL FESCUE, V20, P1, DOI DOI 10.2134/AGRONMONOGR20.C1; BUGGE G, 1987, PLANT BREEDING, V98, P149, DOI 10.1111/j.1439-0523.1987.tb01108.x; Busti A, 2004, GENET RESOUR CROP EV, V51, P443, DOI 10.1023/B:GRES.0000023459.62679.e8; Casa AM, 2008, CROP SCI, V48, P30, DOI 10.2135/cropsci2007.02.0080; Chakanda R, 2013, GENET RESOUR CROP EV, V60, P1237, DOI 10.1007/s10722-012-9914-7; Chtourou-Ghorbel N, 2011, INT J AGRON, V2011, DOI 10.1155/2011/349240; Cross JW, 2013, HORTSCIENCE, V48, P1562, DOI 10.21273/HORTSCI.48.12.1562; Couto EGD, 2013, CIENC AGROTEC, V37, P25, DOI 10.1590/S1413-70542013000100003; Dutta P, 2013, UNIJ AGR RES, V1, P85, DOI DOI 10.13189/UJAR.2013.010308; Ebrahimiyan M, 2013, GRASS FORAGE SCI, V68, P59, DOI 10.1111/j.1365-2494.2012.00869.x; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Finger FL, 2010, GENET MOL RES, V9, P1852, DOI 10.4238/vol9-3gmr891; Flint-Garcia SA, 2005, PLANT J, V44, P1054, DOI 10.1111/j.1365-313X.2005.02591.x; Frankel OH, 1981, CONSERVATION EVOLUTI; Gonzalez-Martinez SC, 2006, GENETICS, V172, P1915, DOI 10.1534/genetics.105.047126; Gowda SJM, 2012, GENET RESOUR CROP EV, V59, P179, DOI 10.1007/s10722-011-9674-9; Han B, 2013, CURR OPIN PLANT BIOL, V16, P133, DOI 10.1016/j.pbi.2013.03.006; Hannaway D.B., 2005, TALL FESCUE ON LINE; Hey J, 2003, NAT REV GENET, V4, P535, DOI 10.1038/nrg1112; Hoagland D.R., 1950, 347 CAL AGR EXP STAT; HUMPHREYS MO, 1991, HEREDITY, V66, P437, DOI 10.1038/hdy.1991.53; Jha AB, 2013, GENET RESOUR CROP EV, V60, P747, DOI 10.1007/s10722-012-9871-1; Klepo T, 2013, SCI HORTIC-AMSTERDAM, V152, P92, DOI 10.1016/j.scienta.2012.12.010; Lee M, 1995, ADV AGRON, V55, P265, DOI 10.1016/S0065-2113(08)60542-8; Li HuiYing, 2010, Acta Prataculturae Sinica, V19, P208; Li XJ, 2012, CROP PASTURE SCI, V63, P303, DOI 10.1071/CP11302; Lou YH, 2015, HORTSCI IN PRESS FEB; Lu YL, 2012, MOL BREEDING, V30, P407, DOI 10.1007/s11032-011-9631-5; Majidi M. M., 2006, Pakistan Journal of Biological Sciences, V9, P1869, DOI 10.3923/pjbs.2006.1869.1876; Malosetti M, 2007, GENETICS, V175, P879, DOI 10.1534/genetics.105.054932; Matus IA, 2002, GENOME, V45, P1095, DOI 10.1139/G02-071; Niazkhani S.M., 2014, BASIC RES J AGR SCI, V3, P1; Pritchard JK, 2000, GENETICS, V155, P945; ROBSON MJ, 1968, J APPL ECOL, V5, P191, DOI 10.2307/2401283; ROBSON MJ, 1968, J APPL ECOL, V5, P179, DOI 10.2307/2401282; Roy JK, 2010, MOL BREEDING, V26, P243, DOI 10.1007/s11032-010-9402-8; Saha MC, 2006, THEOR APPL GENET, V113, P1449, DOI 10.1007/s00122-006-0391-2; Saha MC, 2005, THEOR APPL GENET, V110, P323, DOI 10.1007/s00122-004-1843-1; Salvi S, 2007, P NATL ACAD SCI USA, V104, P11376, DOI 10.1073/pnas.0704145104; SEAL AG, 1983, HEREDITY, V50, P225, DOI 10.1038/hdy.1983.26; Shi C, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-52; Shimelis H. A., 2006, South African Journal of Plant and Soil, V23, P305; Skot L, 2007, GENETICS, V177, P535, DOI 10.1534/genetics.107.071522; SMITH JSC, 1989, MAYDICA, V34, P151; SMITH SE, 1991, CROP SCI, V31, P1159, DOI 10.2135/cropsci1991.0011183X003100050016x; Soto-Cerda BJ, 2014, J INTEGR PLANT BIOL, V56, P75, DOI 10.1111/jipb.12118; Sun DF, 2011, EUPHYTICA, V178, P31, DOI 10.1007/s10681-010-0260-6; Sun XY, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0494-5; Sun XY, 2014, EUPHYTICA, V199, P247, DOI 10.1007/s10681-014-1122-4; Szalma SJ, 2005, THEOR APPL GENET, V110, P1324, DOI 10.1007/s00122-005-1973-0; Topal A, 2004, FIELD CROP RES, V87, P1, DOI 10.1016/j.fcr.2003.08.015; Xie Y., 2012, African Journal of Biotechnology, V11, P7659; Xu S, 2006, ENVIRON EXP BOT, V56, P274, DOI 10.1016/j.envexpbot.2005.03.002; Yu JM, 2006, CURR OPIN BIOTECH, V17, P155, DOI 10.1016/j.copbio.2006.02.003; Yu JM, 2006, NAT GENET, V38, P203, DOI 10.1038/ng1702; Zhang P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111508; Zhu CS, 2008, PLANT GENOME-US, V1, P5, DOI 10.3835/plantgenome2008.02.0089	64	13	17	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0133054	10.1371/journal.pone.0133054	http://dx.doi.org/10.1371/journal.pone.0133054			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RV	26186338	Green Published, gold, Green Submitted			2022-12-26	WOS:000358198700091
J	Rhee, H; Jang, KS; Shin, MJ; Lee, JW; Kim, IY; Song, SH; Lee, DW; Lee, SB; Kwak, IS; Seong, EY				Rhee, Harin; Jang, Keum Sook; Shin, Min Ji; Lee, Jang Won; Kim, Il Young; Song, Sang Heon; Lee, Dong Won; Lee, Soo Bong; Kwak, Ihm Soo; Seong, Eun Young			Use of Multifrequency Bioimpedance Analysis in Male Patients with Acute Kidney Injury Who Are Undergoing Continuous Veno-Venous Hemodiafiltration	PLOS ONE			English	Article							BIOELECTRICAL-IMPEDANCE ANALYSIS; CRITICALLY-ILL PATIENTS; RENAL REPLACEMENT THERAPY; BODY-COMPOSITION; FLUID OVERLOAD; PHASE-ANGLE; WHOLE-BODY; MORTALITY; HEMODIALYSIS; FAILURE	Introduction Fluid overload is a well-known predictor of mortality in patients with acute kidney injury (AKI). Multifrequency bioimpedance analysis (MF-BIA) is a promising tool for quantifying volume status. However, few studies have analyzed the effect of MF-BIA-defined volume status on the mortality of critically ill patients with AKI. This retrospective medical research study aimed to investigate this issue. Methods We retrospectively reviewed the medical records of patients with AKI who underwent continuous veno-venous hemodiafiltration (CVVHDF) from Jan. 2013 to Feb. 2014. Female patients were excluded to control for sex-based differences. Volume status was measured using MF-BIA (Inbody S20, Seoul, Korea) at the time of CVVHDF initiation, and volume parameters were adjusted with height squared (H-2). Binary logistic regression analyses were performed to test independent factors for prediction of in-hospital mortality. Results A total of 208 male patients were included in this study. The mean age was 65.19 +/- 12.90 years. During the mean ICU stay of 18.29 +/- 27.48 days, 40.4% of the patients died. The inhospital mortality rate increased with increasing total body water (TBW)/H-2 quartile. In the multivariable analyses, increased TBW/H-2 (OR 1.312(1.009-1.705), p=0.043) and having lower serum albumin (OR 0.564(0.346-0.919, p=0.022) were independently associated with higher in-hospital mortality. When the intracellular water (ICW)/H-2 or extracellular water (ECW)/H-2 was adjusted instead of the TBW/H-2, only excess ICW/H-2 was independently associated with increased mortality (OR 1.561(1.012-2.408, p=0.044). Conclusions MF-BIA-defined excess TBW/H-2 and ICW/H-2 are independently associated with higher in-hospital mortality in male patients with AKI undergoing CVVHDF.	[Rhee, Harin; Shin, Min Ji; Lee, Jang Won; Kim, Il Young; Song, Sang Heon; Lee, Dong Won; Lee, Soo Bong; Kwak, Ihm Soo; Seong, Eun Young] Pusan Natl Univ, Sch Med, Dept Internal Med, Busan, South Korea; [Rhee, Harin; Shin, Min Ji; Lee, Jang Won; Song, Sang Heon; Kwak, Ihm Soo; Seong, Eun Young] Pusan Natl Univ Hosp, Biomed Res Inst, Busan, South Korea; [Jang, Keum Sook] Pusan Natl Univ Hosp, Dept Nursing, Busan, South Korea	Pusan National University; Pusan National University; Pusan National University Hospital; Pusan National University; Pusan National University Hospital	Seong, EY (corresponding author), Pusan Natl Univ, Sch Med, Dept Internal Med, Busan, South Korea.	sey02200@paran.com	Kim, Il Young/ABG-2156-2021; Kim, Il Young/ABG-2153-2021	Kim, Il Young/0000-0002-1731-6357	Biomedical Institute of Pusan National University Hospital	Biomedical Institute of Pusan National University Hospital	This study was supported by the Biomedical Institute of Pusan National University Hospital.	Bagshaw SM, 2008, CRIT CARE, V12, DOI 10.1186/cc6948; Bellomo R, 2009, NEW ENGL J MED, V361, P1627, DOI 10.1056/NEJMoa0902413; Bellomo R, 2010, CONTRIB NEPHROL, V165, P299, DOI 10.1159/000313770; Buchholz Andrea C, 2004, Nutr Clin Pract, V19, P433, DOI 10.1177/0115426504019005433; Cerda J, 2010, BLOOD PURIFICAT, V29, P331, DOI 10.1159/000287776; Chamney PW, 2007, AM J CLIN NUTR, V85, P80, DOI 10.1093/ajcn/85.1.80; Chertow GM, 2005, J AM SOC NEPHROL, V16, P3365, DOI 10.1681/ASN.2004090740; CORNISH BH, 1993, PHYS MED BIOL, V38, P337, DOI 10.1088/0031-9155/38/3/001; Dabrowski W, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122193; Dabrowski W, 2014, CLIN NEPHROL, V82, P41, DOI 10.5414/CN108015; Davies SJ, 2014, KIDNEY INT, V86, P489, DOI 10.1038/ki.2014.207; Goovaerts HG, 1998, PHYSIOL MEAS, V19, P517, DOI 10.1088/0967-3334/19/4/006; Gupta D, 2004, AM J CLIN NUTR, V80, P1634, DOI 10.1093/ajcn/80.6.1634; Heering P, 1997, INTENS CARE MED, V23, P288, DOI 10.1007/s001340050330; Ismael S, 2014, CRIT CARE, V18, DOI 10.1186/cc13794; Jaeger JQ, 1999, J AM SOC NEPHROL, V10, P392; Kalantar-Zadeh K, 2003, AM J KIDNEY DIS, V42, P864, DOI 10.1016/j.ajkd.2003.07.016; Kalantari K, 2013, KIDNEY INT, V83, P1017, DOI 10.1038/ki.2012.424; Kaysen GA, 2005, AM J CLIN NUTR, V82, P988, DOI 10.1093/ajcn/82.5.988; Koh KH, 2011, PERITON DIALYSIS INT, V31, P574, DOI 10.3747/pdi.2009.00140; Kyle UG, 2004, CLIN NUTR, V23, P1430, DOI 10.1016/j.clnu.2004.09.012; Kyle UG, 2004, CLIN NUTR, V23, P1226, DOI 10.1016/j.clnu.2004.06.004; Kyle UG, 2002, J AM DIET ASSOC, V102, P944, DOI 10.1016/S0002-8223(02)90216-6; Kyle UG, 2006, NUTRITION, V22, P1103, DOI 10.1016/j.nut.2006.08.003; Mager JR, 2008, CLIN NUTR, V27, P832, DOI 10.1016/j.clnu.2008.06.007; Maioli M, 2014, J AM COLL CARDIOL, V63, P1387, DOI 10.1016/j.jacc.2014.01.025; Martin GS, 2003, NEW ENGL J MED, V348, P1546, DOI 10.1056/NEJMoa022139; Metnitz PGH, 2002, CRIT CARE MED, V30, P2051, DOI 10.1097/00003246-200209000-00016; Moissl U, 2013, CLIN J AM SOC NEPHRO, V8, P1575, DOI 10.2215/CJN.12411212; Nisula S, 2013, INTENS CARE MED, V39, P420, DOI 10.1007/s00134-012-2796-5; O'Lone EL, 2014, NEPHROL DIAL TRANSPL, V29, P1430, DOI 10.1093/ndt/gfu049; OTT M, 1995, J ACQ IMMUN DEF SYND, V9, P20; Palevsky PM, 2008, NEW ENGL J MED, V359, P7, DOI 10.1056/NEJMoa0802639; Peacock WF, 2010, CONTRIB NEPHROL, V165, P226, DOI 10.1159/000313762; Piccoli A, 2005, CONTRIB NEPHROL, V149, P150, DOI 10.1159/000085478; PICCOLI A, 1994, KIDNEY INT, V46, P534, DOI 10.1038/ki.1994.305; Ronco C, 2000, LANCET, V356, P26, DOI 10.1016/S0140-6736(00)02430-2; Ronco C, 2012, SEMIN NEPHROL, V32, P129, DOI 10.1016/j.semnephrol.2011.11.016; Schwenk A, 2000, AM J CLIN NUTR, V72, P496; Toso S, 2000, NUTRITION, V16, P120, DOI 10.1016/S0899-9007(99)00230-0; Uchino S, 2005, JAMA-J AM MED ASSOC, V294, P813, DOI 10.1001/jama.294.7.813; Uchino S, 2007, INTENS CARE MED, V33, P1563, DOI 10.1007/s00134-007-0754-4; Vaara ST, 2012, CRIT CARE, V16, DOI 10.1186/cc11158; Vesconi S, 2009, CRIT CARE, V13, DOI 10.1186/cc7784; Wizemann V, 2009, NEPHROL DIAL TRANSPL, V24, P1574, DOI 10.1093/ndt/gfn707	45	25	26	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0133199	10.1371/journal.pone.0133199	http://dx.doi.org/10.1371/journal.pone.0133199			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RV	26186370	gold, Green Submitted, Green Published			2022-12-26	WOS:000358198700107
J	Sbardella, D; Tundo, GR; Sciandra, F; Bozzi, M; Gioia, M; Ciaccio, C; Tarantino, U; Brancaccio, A; Coletta, M; Marini, S				Sbardella, Diego; Tundo, Grazia Raffaella; Sciandra, Francesca; Bozzi, Manuela; Gioia, Magda; Ciaccio, Chiara; Tarantino, Umberto; Brancaccio, Andrea; Coletta, Massimo; Marini, Stefano			Proteasome Activity Is Affected by Fluctuations in Insulin-Degrading Enzyme Distribution	PLOS ONE			English	Article							26S PROTEASOME; OXIDATIVE STRESS; OXIDIZED PROTEINS; UBIQUITIN SYSTEM; DEGRADATION; CELLS; SUBSTRATE; PEPTIDE; PATHWAY; ARCHITECTURE	Insulin-Degrading-Enzyme (IDE) is a Zn2+-dependent peptidase highly conserved throughout evolution and ubiquitously distributed in mammalian tissues wherein it displays a prevalent cytosolic localization. We have recently demonstrated a novel Heat Shock Protein-like behaviour of IDE and its association with the 26S proteasome. In the present study, we examine the mechanistic and molecular features of IDE-26S proteasome interaction in a cell experimental model, extending the investigation also to the effect of IDE on the enzymatic activities of the 26S proteasome. Further, kinetic investigations indicate that the 26S proteasome activity undergoes a functional modulation by IDE through an extra-catalytic mechanism. The IDE-26S proteasome interaction was analyzed during the Heat Shock Response and we report novel findings on IDE intracellular distribution that might be of critical relevance for cell metabolism.	[Sbardella, Diego; Tundo, Grazia Raffaella; Gioia, Magda; Ciaccio, Chiara; Tarantino, Umberto; Coletta, Massimo; Marini, Stefano] Univ Roma Tor Vergata, Dept Clin Sci & Translat Med, I-00133 Rome, Italy; [Sbardella, Diego; Tundo, Grazia Raffaella; Gioia, Magda; Ciaccio, Chiara; Tarantino, Umberto; Coletta, Massimo; Marini, Stefano] Univ Roma Tor Vergata, Ctr Space Biomed, I-00133 Rome, Italy; [Sciandra, Francesca; Brancaccio, Andrea] Univ Cattolica Sacro Cuore, Ist Chim Riconoscimento Mol CNR, I-00168 Rome, Italy; [Bozzi, Manuela] Univ Cattolica Sacro Cuore, Ist Biochim & Biochim Clin, I-00168 Rome, Italy; [Brancaccio, Andrea] Univ Walk, Sch Biochem, Bristol B58 1TD, Avon, England	University of Rome Tor Vergata; University of Rome Tor Vergata; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Consiglio Nazionale delle Ricerche (CNR); Istituto di Chimica del Riconoscimento Molecolare (ICRM-CNR); Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; University of Bristol	Marini, S (corresponding author), Univ Roma Tor Vergata, Dept Clin Sci & Translat Med, Via Montpellier 1, I-00133 Rome, Italy.	stefano.marini@uniroma2.it	Coletta, Massimiliano/GSN-5927-2022; Coletta, Massimo/N-9049-2015; Sciandra, Francesca/AAY-4650-2020; Sbardella, Diego/N-9187-2015; Marini, Stefano/B-1161-2012; Gioia, Magda/AAD-4781-2022; Sbardella, Diego/K-7519-2016; Brancaccio, Andrea/C-5876-2009; Gioia, Magda/ABF-8909-2020	Sciandra, Francesca/0000-0002-2123-1516; Marini, Stefano/0000-0003-1299-6696; Sbardella, Diego/0000-0002-9924-7761; Brancaccio, Andrea/0000-0003-4690-8826; COLETTA, Massimiliano/0000-0002-5489-9467; TUNDO, Grazia Raffaella/0000-0002-3866-3171; Gioia, Magda/0000-0003-0352-3547	Italian Ministry of the University and Research [MiUR FIRB RBNE03PX83]; Italian Space Agency (ASI SMEMCO) [DC-DTE-2011-033]	Italian Ministry of the University and Research(Ministry of Education, Universities and Research (MIUR)); Italian Space Agency (ASI SMEMCO)	The financial support is from the Italian Ministry of the University and Research (MiUR FIRB RBNE03PX83 to M.C.) and the Italian Space Agency (ASI SMEMCO n. DC-DTE-2011-033 to U.T.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baumeister W, 1998, CELL, V92, P367, DOI 10.1016/S0092-8674(00)80929-0; BENNETT RG, 1994, BIOCHEM BIOPH RES CO, V202, P1047, DOI 10.1006/bbrc.1994.2034; Bennett RG, 2000, ENDOCRINOLOGY, V141, P2508, DOI 10.1210/en.141.7.2508; Bennett RG, 2003, J ENDOCRINOL, V177, P399, DOI 10.1677/joe.0.1770399; Beuzelin C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067705; Bozidis Petros, 2007, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0327s37; Bulloj A, 2008, MOL NEURODEGENER, V3, DOI 10.1186/1750-1326-3-22; Ciaccio C, 2009, J MOL BIOL, V385, P1556, DOI 10.1016/j.jmb.2008.11.025; Ciechanover A, 1998, EMBO J, V17, P7151, DOI 10.1093/emboj/17.24.7151; Cuccioloni M, 2009, J MOL RECOGNIT, V22, P46, DOI 10.1002/jmr.929; Dahlmann B, 2000, J MOL BIOL, V303, P643, DOI 10.1006/jmbi.2000.4185; Davies KJA, 2001, BIOCHIMIE, V83, P301, DOI 10.1016/S0300-9084(01)01250-0; de Tullio MB, 2008, PRION, V2, P51, DOI 10.4161/pri.2.2.6710; Fernandez-Gamba A, 2009, CURR PHARM DESIGN, V15, P3644, DOI 10.2174/138161209789271799; Glebov K, 2011, J BIOL CHEM, V286, P22711, DOI 10.1074/jbc.C110.217893; Glickman MH, 2005, FEBS LETT, V579, P3214, DOI 10.1016/j.febslet.2005.04.048; Grasso G, 2008, BBA-PROTEINS PROTEOM, V1784, P1122, DOI 10.1016/j.bbapap.2008.04.011; Grasso G, 2011, CHEM-EUR J, V17, P2752, DOI 10.1002/chem.201002809; Grune T, 2011, FREE RADICAL BIO MED, V51, P1355, DOI 10.1016/j.freeradbiomed.2011.06.015; Hanna J, 2007, FEBS LETT, V581, P2854, DOI 10.1016/j.febslet.2007.03.053; Hanna J, 2007, CELL, V129, P747, DOI 10.1016/j.cell.2007.03.042; Hersh LB, 2006, CELL MOL LIFE SCI, V63, P2432, DOI 10.1007/s00018-006-6238-9; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Imai J, 2003, EMBO J, V22, P3557, DOI 10.1093/emboj/cdg349; Kaneko T, 2009, CELL, V137, P914, DOI 10.1016/j.cell.2009.05.008; KIRSCHNER RJ, 1983, J BIOL CHEM, V258, P967; Kisselev AF, 2005, METHOD ENZYMOL, V398, P364, DOI 10.1016/S0076-6879(05)98030-0; Kohler A, 2001, MOL CELL, V7, P1143, DOI 10.1016/S1097-2765(01)00274-X; Konstantinova IM, 2008, INT REV CEL MOL BIO, V267, P59, DOI 10.1016/S1937-6448(08)00602-3; Kurochkin IV, 1998, FEBS LETT, V427, P153, DOI 10.1016/S0014-5793(98)00422-0; Lander GC, 2012, NATURE, V482, P186, DOI 10.1038/nature10774; Lee SH, 2010, J BIOL CHEM, V285, P41280, DOI 10.1074/jbc.M110.182188; Maupin-Furlow JA, 2006, CURR TOP DEV BIOL, V75, P125, DOI 10.1016/S0070-2153(06)75005-0; Naujokat C, 2002, LAB INVEST, V82, P965, DOI 10.1097/01.LAB.0000022226.23741.37; Noinaj N, 2012, J BIOL CHEM, V287, P48, DOI 10.1074/jbc.M111.264614; Parmentier N, 2010, NAT IMMUNOL, V11, P449, DOI 10.1038/ni.1862; Pick E, 2013, FEBS LETT, V587, P389, DOI 10.1016/j.febslet.2013.01.014; Qiu WQ, 1998, J BIOL CHEM, V273, P32730, DOI 10.1074/jbc.273.49.32730; Radulescu RT, 2010, BIOCHEM BIOPH RES CO, V395, P196, DOI 10.1016/j.bbrc.2010.03.157; Ralat LA, 2011, J MOL BIOL, V406, P454, DOI 10.1016/j.jmb.2010.12.026; RAMACHANDRA KR, 2003, J BIOL CHEM, V278, P20915; Ravid T, 2008, NAT REV MOL CELL BIO, V9, P679, DOI 10.1038/nrm2468; Reinheckel T, 2000, ARCH BIOCHEM BIOPHYS, V377, P65, DOI 10.1006/abbi.2000.1717; Sbardella D, 2012, MOL ASPECTS MED, V33, P119, DOI 10.1016/j.mam.2011.10.015; Schwartz AL, 2009, ANNU REV PHARMACOL, V49, P73, DOI 10.1146/annurev.pharmtox.051208.165340; Seta KA, 1997, BIOCHEM BIOPH RES CO, V231, P167, DOI 10.1006/bbrc.1997.6066; Shringarpure R, 2003, J BIOL CHEM, V278, P311, DOI 10.1074/jbc.M206279200; Stadtmueller BM, 2011, MOL CELL, V41, P8, DOI 10.1016/j.molcel.2010.12.020; Tanaka Keiji, 2013, Keio Journal of Medicine, V62, P1, DOI 10.2302/kjm.2012-0006-RE; Taylor DM, 2005, CELL STRESS CHAPERON, V10, P230, DOI 10.1379/CSC-119R.1; Tomko RJ, 2013, ANNU REV BIOCHEM, V82, P415, DOI 10.1146/annurev-biochem-060410-150257; Tundo G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034376; Tundo GR, 2015, J BIOL INORG CHEM, V20, P101, DOI 10.1007/s00775-014-1217-3; Tundo GR, 2013, J BIOL CHEM, V288, P2281, DOI 10.1074/jbc.M112.393108; Vigneron N, 2012, CURR OPIN IMMUNOL, V24, P84, DOI 10.1016/j.coi.2011.12.002; Wang XR, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001232; Yfanti C, 2008, INT J MOL MED, V22, P421, DOI 10.3892/ijmm_00000038; Zhao J, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-4	58	23	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0132455	10.1371/journal.pone.0132455	http://dx.doi.org/10.1371/journal.pone.0132455			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RV	26186340	Green Published, gold, Green Submitted			2022-12-26	WOS:000358198700043
J	Yu, SJ; Reiner, D; Shen, H; Wu, KJ; Liu, QR; Wang, Y				Yu, Seong-Jin; Reiner, David; Shen, Hui; Wu, Kou-Jen; Liu, Qing-Rong; Wang, Yun			Time-Dependent Protection of CB2 Receptor Agonist in Stroke	PLOS ONE			English	Article							CANNABINOID RECEPTORS; CEREBRAL INFARCTION; MICROGLIAL CELLS; BINDING-SITES; BRAIN; ACTIVATION; RATS; LOCALIZATION; TRANSIENT; NEUROPROTECTION	Recent studies have indicated that type 2 cannabinoid receptor (CB2R) agonists reduce neurodegeneration after brain injury through anti-inflammatory activity. The purpose of this study was to examine the time-dependent interaction of CB2R and inflammation in stroke brain. Adult male rats were subjected to right middle cerebral artery occlusion (MCAo). CB2R mRNA expression was significantly elevated >20 fold on day 2, peaked >40-fold on day 5, and normalized on day 10 post-stroke. Inflammatory markers IBA1 and TLR4 were significantly upregulated 15 fold until day 5 after MCAo. Because of the delayed upregulation of CB2R and IBA1, we next treated animals daily with CB2R agonist AM1241 or anti-inflammatory PPAR-gamma agonist pioglitazone from 2 to 5 days after MCAo. Delayed treatment with pioglitazone significantly reduced abnormal neurological scores and body asymmetry as well as brain infarction in stroke animals. No behavioral improvement or reduction in brain infarction was found in animals receiving AM1241. Pioglitazone, but not AM1241, significantly reduced IBA1 expression in the stroke cortex, suggesting that delayed treatment with AM1241 failed to alter ischemia-mediated IBA-1 upregulation. In contrast, pretreatment with AM1241 significantly reduced brain infarction and neurological deficits. In conclusion, our data support a time-dependent neuroprotection of CB2 agonist in an animal model of stroke. Delayed post- treatment with PPAR-gamma agonist induced behavioral recovery and microglial suppression; early treatment with CB2R agonist suppressed neurodegeneration in stroke animals.	[Yu, Seong-Jin; Wu, Kou-Jen; Wang, Yun] Natl Hlth Res Inst, Ctr Neuropsychiat, Zhunan, Taiwan; [Reiner, David; Shen, Hui; Liu, Qing-Rong; Wang, Yun] Natl Inst Drug Abuse, Neural Protect & Regenerat Sect, NIH, Baltimore, MD USA	National Health Research Institutes - Taiwan; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); NIH National Institute on Drug Abuse (NIDA)	Wang, Y (corresponding author), Natl Hlth Res Inst, Ctr Neuropsychiat, Zhunan, Taiwan.	ywang@nhri.org.tw	Liu, Qing-Rong/A-3059-2012	Liu, Qing-Rong/0000-0001-8477-6452	Ministry of Science and Technology, Taiwan [MOST 03-2314-B-400-016-MY2]; National Institute on Drug Abuse, NIH, USA	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan); National Institute on Drug Abuse, NIH, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA))	Funding for this study was received from the Ministry of Science and Technology, Taiwan (MOST 03-2314-B-400-016-MY2) and from the National Institute on Drug Abuse, NIH, USA (intramural). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Assis LC, 2014, NEUROSCIENCE, V279, P220, DOI 10.1016/j.neuroscience.2014.08.043; BEDERSON JB, 1986, STROKE, V17, P472, DOI 10.1161/01.STR.17.3.472; Bingham B, 2007, BRIT J PHARMACOL, V151, P1061, DOI 10.1038/sj.bjp.0707303; BORLONGAN CV, 1995, J NEUROSCI, V15, P5372; Borlongan CV, 1998, NEUROREPORT, V9, P3615, DOI 10.1097/00001756-199811160-00012; Brusco A, 2008, ANN NY ACAD SCI, V1139, P450, DOI 10.1196/annals.1432.037; Capettini LSA, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/824093; Caso JR, 2007, CIRCULATION, V115, P1599, DOI 10.1161/CIRCULATIONAHA.106.603431; Chang CF, 2002, NEUROPHARMACOLOGY, V43, P418, DOI 10.1016/S0028-3908(02)00092-8; Contartese A, 2012, PHARMACOL RES, V66, P555, DOI 10.1016/j.phrs.2012.08.003; Elliott MB, 2011, J NEUROTRAUM, V28, P973, DOI 10.1089/neu.2010.1672; Fernandez-Lopez D, 2012, NEUROSCIENCE, V207, P307, DOI 10.1016/j.neuroscience.2012.01.008; Garcia-Ovejero D, 2009, NEUROBIOL DIS, V33, P57, DOI 10.1016/j.nbd.2008.09.015; Gatley SJ, 1996, EUR J PHARMACOL, V307, P331, DOI 10.1016/0014-2999(96)00279-8; Gong JP, 2006, BRAIN RES, V1071, P10, DOI 10.1016/j.brainres.2005.11.035; Hayakawa K, 2007, LIFE SCI, V80, P1466, DOI 10.1016/j.lfs.2007.01.014; Iyer SS, 2009, P NATL ACAD SCI USA, V106, P20388, DOI 10.1073/pnas.0908698106; Jin KL, 2000, ANN NEUROL, V48, P257, DOI 10.1002/1531-8249(200008)48:2<257::AID-ANA18>3.0.CO;2-P; Lehnardt S, 2003, P NATL ACAD SCI USA, V100, P8514, DOI 10.1073/pnas.1432609100; Liu HS, 2011, NEUROIMAGE, V56, P280, DOI 10.1016/j.neuroimage.2011.02.049; Luo Y, 2013, J CEREBR BLOOD F MET, V33, P300, DOI 10.1038/jcbfm.2012.172; Luo Y, 2009, ANN NEUROL, V65, P520, DOI 10.1002/ana.21592; LYNN AB, 1994, J PHARMACOL EXP THER, V268, P1612; Malan TP, 2001, PAIN, V93, P239, DOI 10.1016/S0304-3959(01)00321-9; Maresz K, 2005, J NEUROCHEM, V95, P437, DOI 10.1111/j.1471-4159.2005.03380.x; Muthian S, 2004, NEUROSCIENCE, V129, P743, DOI 10.1016/j.neuroscience.2004.08.044; Nagayama T, 1999, J NEUROSCI, V19, P2987; Nunez E, 2004, SYNAPSE, V53, P208, DOI 10.1002/syn.20050; Onaivi ES, 2006, ANN NY ACAD SCI, V1074, P514, DOI 10.1196/annals.1369.052; Palazuelos J, 2009, BRAIN, V132, P3152, DOI 10.1093/brain/awp239; Parmentier-Batteur S, 2002, J NEUROSCI, V22, P9771, DOI 10.1523/jneurosci.22-22-09771.2002; RinaldiCarmona M, 1996, LIFE SCI, V58, P1239, DOI 10.1016/0024-3205(96)00085-9; Shen H, 2010, J NEUROSCI METH, V186, P150, DOI 10.1016/j.jneumeth.2009.11.008; Sidney S, 2002, J CLIN PHARMACOL, V42, p64S, DOI 10.1002/j.1552-4604.2002.tb06005.x; Sundararajan S, 2005, NEUROSCIENCE, V130, P685, DOI 10.1016/j.neuroscience.2004.10.021; Ternianov A, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2010.09.012; Tumati S, 2012, J NEUROIMMUNOL, V244, P23, DOI 10.1016/j.jneuroim.2011.12.021; Wei Y, 2009, MOL VIS, V15, P1243; Wilkerson JL, 2012, BRAIN BEHAV, V2, P155, DOI 10.1002/brb3.44; Xi ZX, 2011, NAT NEUROSCI, V14, P1160, DOI 10.1038/nn.2874; Zarruk JG, 2012, STROKE, V43, P211, DOI 10.1161/STROKEAHA.111.631044; Zhang M, 2007, J CEREBR BLOOD F MET, V27, P1387, DOI 10.1038/sj.jcbfm.9600447; Zhang M, 2009, MICROVASC RES, V78, P86, DOI 10.1016/j.mvr.2009.03.005	43	42	45	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0132487	10.1371/journal.pone.0132487	http://dx.doi.org/10.1371/journal.pone.0132487			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RV	26186541	Green Submitted, Green Published, gold			2022-12-26	WOS:000358198700045
J	Zhou, GF; Zhang, QS; Zhang, XQ; Tan, C; Li, CD				Zhou, Gaofeng; Zhang, Qisen; Zhang, Xiao-qi; Tan, Cong; Li, Chengdao			Construction of High-Density Genetic Map in Barley through Restriction-Site Associated DNA Sequencing	PLOS ONE			English	Article							CONSENSUS MAP; DART MARKERS; QTL ANALYSIS; LOCI; SSR; DISCOVERY; TRAITS	Genetic maps in barley are usually constructed from a limited number of molecular markers such as SSR (simple sequence repeat) and DarT (diversity arrays technology). These markers must be first developed before being used for genotyping. Here, we introduce a new strategy based on sequencing progeny of a doubled haploid population from Baudin x AC Metcalfe to construct a genetic map in barley. About 13,547 polymorphic SNP tags with >93% calling rate were selected to construct the genetic map. A total of 12,998 SNP tags were anchored to seven linkage groups which spanned a cumulative 967.6 cM genetic distance. The high-density genetic map can be used for QTL mapping and the assembly of WGS and BAC contigs. The genetic map was evaluated for its effectiveness and efficiency in QTL mapping and candidate gene identification. A major QTL for plant height was mapped at 105.5 cM on chromosome 3H. This QTL with LOD value of 13.01 explained 44.5% of phenotypic variation. This strategy will enable rapid and efficient establishment of high-density genetic maps in other species.	[Zhou, Gaofeng; Li, Chengdao] Dept Agr & Food, S Perth, WA, Australia; [Zhang, Qisen; Li, Chengdao] Australian Export Grains Innovat Ctr, S Perth, WA, Australia; [Zhang, Xiao-qi; Tan, Cong; Li, Chengdao] Murdoch Univ, Western Australian State Agr Biotechnol Ctr, Murdoch, WA 6150, Australia	Government of Western Australia; Department of Agriculture & Food - Western Australia; Murdoch University	Li, CD (corresponding author), Dept Agr & Food, S Perth, WA, Australia.	c.li@murdoch.edu.au		tan, cong/0000-0003-0158-4442	Grains Research and Development Corporation (GRDC) of Australia [DAW00233]; Department of Agriculture and Food Western Australia; Western Australian State Agricultural Biotechnology Centre (SABC)	Grains Research and Development Corporation (GRDC) of Australia(Grains R&D Corp); Department of Agriculture and Food Western Australia; Western Australian State Agricultural Biotechnology Centre (SABC)	This work was supported by the fund from Grains Research and Development Corporation (GRDC) of Australia (DAW00233.), Department of Agriculture and Food Western Australia, and Western Australian State Agricultural Biotechnology Centre (SABC).	Baird NA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003376; Brenchley R, 2012, NATURE, V491, P705, DOI 10.1038/nature11650; Cakir M, 2011, CROP PASTURE SCI, V62, P152, DOI 10.1071/CP10154; Catchen JM, 2011, G3-GENES GENOM GENET, V1, P171, DOI 10.1534/g3.111.000240; Chutimanitsakun Y, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-4; Close TJ, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-582; Hearnden PR, 2007, THEOR APPL GENET, V115, P383, DOI 10.1007/s00122-007-0572-7; Huang XH, 2009, GENOME RES, V19, P1068, DOI 10.1101/gr.089516.108; Jia JZ, 2013, NATURE, V496, P91, DOI 10.1038/nature12028; Jia QJ, 2011, THEOR APPL GENET, V122, P1451, DOI 10.1007/s00122-011-1544-5; Li H, 2011, BIOINFORMATICS, V27, P2987, DOI 10.1093/bioinformatics/btr509; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Mascher M, 2013, PLANT J, V76, P718, DOI 10.1111/tpj.12319; Mayer KFX, 2012, NATURE, V491, P711, DOI 10.1038/nature11543; Poland JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032253; Van Ooijen J.W., 2004, MAPQTL 6 SOFTWARE MA; Varshney RK, 2007, THEOR APPL GENET, V114, P1091, DOI 10.1007/s00122-007-0503-7; Voorrips RE, 2002, J HERED, V93, P77, DOI 10.1093/jhered/93.1.77; Wenzl P, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-206; Wu YH, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000212; Yang HX, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0064799, 10.1371/journal.pone.0064058]; Zhang XQ, 2012, EUPHYTICA, V188, P103, DOI 10.1007/s10681-011-0576-x	22	21	23	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2015	10	7							e0133161	10.1371/journal.pone.0133161	http://dx.doi.org/10.1371/journal.pone.0133161			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RQ	26182149	gold, Green Published			2022-12-26	WOS:000358198200053
J	Bonura, C; Giuffre, M; Aleo, A; Fasciana, T; Di Bernardo, F; Stampone, T; Giammanco, A; Palma, DM; Mammina, C				Bonura, Celestino; Giuffre, Mario; Aleo, Aurora; Fasciana, Teresa; Di Bernardo, Francesca; Stampone, Tomaso; Giammanco, Anna; Palma, Daniela Maria; Mammina, Caterina		MDR-GN Working Grp	An Update of the Evolving Epidemic of bla(KPC) Carrying Klebsiella pneumoniae in Sicily, Italy, 2014: Emergence of Multiple Non-ST258 Clones	PLOS ONE			English	Article							INTENSIVE-CARE-UNIT; SEQUENCE TYPE 258; BETA-LACTAMASES; GENES; ENTEROBACTERIACEAE; RESISTANCE; HOSPITALS; COLISTIN; OUTBREAK; CARBAPENEMASES	Background In Italy, Klebsiella pneumoniae carbapenemase producing K. pneumoniae (KPC-Kp) strains are highly endemic and KPC producing CC258 is reported as the widely predominating clone. In Palermo, Italy, previous reports have confirmed this pattern. However, recent preliminary findings suggest that an epidemiological change is likely ongoing towards a polyclonal KPC-Kp spread. Here we present the results of molecular typing of 94 carbapenem non susceptible K. pneumoniae isolates detected during 2014 in the three different hospitals in Palermo, Italy. Methods and Results Ninety-four consecutive, non replicate carbapenem non susceptible isolates were identified in the three largest acute general hospitals in Palermo, Italy, in the six-month period March-August 2014. They were characterized by PCR for beta-lactam, aminoglycoside and plasmid mediated fluoroquinolone resistance genetic determinants. The mgrB gene of the colistin resistant isolates was amplified and sequenced. Clonality was assessed by pulsed field gel electrophoresis and multilocus sequence typing. Eight non-CC258 sequence types (STs) were identified accounting for 60% of isolates. In particular, ST307 and ST273 accounted for 29% and 18% of isolates. CC258 isolates were more frequently susceptible to gentamicin and non-CC258 isolates to amikacin. Colistin non susceptibility was found in 42% of isolates. Modifications of mgrB were found in 32 isolates. Conclusions Concurrent clonal expansion of some STs and lateral transmission of genetic resistance determinants are likely producing a thorough change of the KPC-Kp epidemiology in Palermo, Italy. In our setting mgrB inactivation proved to substantially contribute to colistin resistance. Our findings suggest the need to continuously monitor the KPC-Kp epidemiology and to assess by a nationwide survey the possible shifting towards a polyclonal epidemic.	[Bonura, Celestino; Giuffre, Mario; Aleo, Aurora; Fasciana, Teresa; Giammanco, Anna; Mammina, Caterina] Univ Palermo, Dept Sci Hlth Promot & Mother Child Care GD Aless, Palermo, Italy; [Di Bernardo, Francesca] ARNAS Civico Di Cristina & Benfratelli, Microbiol Lab, Palermo, Italy; [Stampone, Tomaso] Azienda Osped Osped Riuniti Villa Sofia V Cervell, Microbiol Lab, Palermo, Italy; [Giammanco, Anna] Azienda Osped Univ Paolo Giaccone, Microbiol Lab, Palermo, Italy; [Palma, Daniela Maria] ARNAS Civico Di Cristina & Benfratelli, Intens Care Unit 2, Palermo, Italy	University of Palermo; A.R.N.A.S. Ospedali Civico Di Cristina Benfratelli; University of Palermo; Policlinico Paolo Giaccone; A.R.N.A.S. Ospedali Civico Di Cristina Benfratelli	Mammina, C (corresponding author), Univ Palermo, Dept Sci Hlth Promot & Mother Child Care GD Aless, Palermo, Italy.	caterina.mammina@unipa.it	Giuffre, Mario/AAO-6913-2021; Mammina, Caterina/M-9339-2013; Giuffrè, Mario/J-7804-2016	Giuffre, Mario/0000-0001-9576-1635; Mammina, Caterina/0000-0003-2881-8018; Giuffrè, Mario/0000-0001-9576-1635; Geraci, Daniela Maria/0000-0002-4684-1273; SAPORITO, Laura/0000-0002-9756-0957				Ageevets VA, 2014, INT J ANTIMICROB AG, V44, P152, DOI 10.1016/j.ijantimicag.2014.05.004; Agodi A, 2011, J HOSP INFECT, V77, P279, DOI 10.1016/j.jhin.2010.10.007; Cannatelli A, 2014, ANTIMICROB AGENTS CH, V58, P5696, DOI 10.1128/AAC.03110-14; Castanheira M, 2013, MICROB DRUG RESIST, V19, P295, DOI 10.1089/mdr.2012.0238; Chen L, 2014, TRENDS MICROBIOL, V22, P686, DOI 10.1016/j.tim.2014.09.003; Dallenne C, 2010, J ANTIMICROB CHEMOTH, V65, P490, DOI 10.1093/jac/dkp498; EUCAST, 2013, BREAKPOINT TABLES FO; European Centre for Disease Prevention and Control, 2014, ANNUAL REPORT OF THE; Geraci DM, 2015, CLIN MICROBIOL INFEC, V21, pE15, DOI 10.1016/j.cmi.2014.08.022; Giani T, 2013, EURO SURVEILL, V18; Giani T, 2009, J CLIN MICROBIOL, V47, P3793, DOI 10.1128/JCM.01773-09; Giuffre M, 2013, J HOSP INFECT, V85, P233, DOI 10.1016/j.jhin.2013.08.004; Gomez-Simmonds A, 2015, J CLIN MICROBIOL; Habeeb MA, 2013, INT J ANTIMICROB AG, V41, P524, DOI 10.1016/j.ijantimicag.2013.02.017; Hu L, 2014, EPIDEMIOL INFECT, V142, P1972, DOI 10.1017/S0950268813002975; Mammina C, 2012, EUROSURVEILLANCE, V17; Mammina C, 2010, INT J ANTIMICROB AG, V36, P576, DOI 10.1016/j.ijantimicag.2010.08.004; Mammina C, 2010, J CLIN MICROBIOL, V48, P1506, DOI 10.1128/JCM.00315-10; Mezzatesta ML, 2011, CLIN MICROBIOL INFEC, V17, P1444, DOI 10.1111/j.1469-0691.2011.03572.x; Migliavacca R, 2015, 25TH EUROPEAN CONGRE; Monaco M, 2014, EURO SURVEILL, V19; Munoz-Price LS, 2013, LANCET INFECT DIS, V13, P785, DOI 10.1016/S1473-3099(13)70190-7; Poirel L, 2015, J ANTIMICROB CHEMOTH, V70, P75, DOI 10.1093/jac/dku323; Ruiz-Garbajosa P, 2013, J ANTIMICROB CHEMOTH, V68, P2487, DOI 10.1093/jac/dkt237; Tofteland S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059015; Tsakris A, 2010, J ANTIMICROB CHEMOTH, V65, P1664, DOI 10.1093/jac/dkq210; Woodford N, 2006, J ANTIMICROB CHEMOTH, V57, P154, DOI DOI 10.1093/jac/dki412	27	70	72	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0132936	10.1371/journal.pone.0132936	http://dx.doi.org/10.1371/journal.pone.0132936			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26177547	Green Published, Green Submitted, gold			2022-12-26	WOS:000358197600184
J	Thievessen, I; Fakhri, N; Steinwachs, J; Kraus, V; McIsaac, RS; Gao, L; Chen, BC; Baird, MA; Davidson, MW; Betzig, E; Oldenbourg, R; Waterman, CM; Fabry, B				Thievessen, Ingo; Fakhri, Nikta; Steinwachs, Julian; Kraus, Viola; McIsaac, R. Scott; Gao, Liang; Chen, Bi-Chang; Baird, Michelle A.; Davidson, Michael W.; Betzig, Eric; Oldenbourg, Rudolf; Waterman, Clare M.; Fabry, Ben			Vinculin is required for cell polarization, migration, and extracellular matrix remodeling in 3D collagen	FASEB JOURNAL			English	Article						3D cell migration; cell morphodynamics; traction force generation; integrin	ADHESION; TISSUE; MORPHOGENESIS; RECRUITMENT; MOVEMENT; SURVIVAL; INVASION; DEFECTS; TENSION	Vinculin is filamentous (F)-actin-binding protein enriched in integrin-based adhesions to the extracellular matrix (ECM). Whereas studies in 2-dimensional (2D) tissue culture models have suggested that vinculin negatively regulates cell migration by promoting cytoskeleton-ECM coupling to strengthen and stabilize adhesions, its role in regulating cell migration in more physiologic, 3-dimensional (3D) environments is unclear. To address the role of vinculin in 3D cell migration, we analyzed the morphodynamics, migration, and ECM remodeling of primary murine embryonic fibroblasts (MEFs) with cre/loxP-mediated vinculin gene disruption in 3D collagen I cultures. We found that vinculin promoted 3D cell migration by increasing directional persistence. Vinculin was necessary for persistent cell protrusion, cell elongation, and stable cell orientation in 3D collagen, but was dispensable for lamellipodia formation, suggesting that vinculin-mediated cell adhesion to the ECM is needed to convert actin-based cell protrusion into persistent cell shape change and migration. Consistent with this finding, vinculin was necessary for efficient traction force generation in 3D collagen without affecting myosin II activity and promoted 3D collagen fiber alignment and macroscopical gel contraction. Our results suggest that vinculin promotes directionally persistent cell migration and tension-dependent ECM remodeling in complex 3D environments by increasing cell-ECM adhesion and traction force generation.	[Thievessen, Ingo; Waterman, Clare M.] NHLBI, Lab Cell & Tissue Morphodynam, Cell Biol & Physiol Ctr, NIH, Bethesda, MD 20892 USA; [Thievessen, Ingo; Steinwachs, Julian; Kraus, Viola; Fabry, Ben] Univ Erlangen Nurnberg, Biophys Grp, Dept Phys, D-91054 Erlangen, Germany; [Thievessen, Ingo; Fakhri, Nikta; McIsaac, R. Scott; Gao, Liang; Chen, Bi-Chang; Baird, Michelle A.; Davidson, Michael W.; Betzig, Eric; Waterman, Clare M.] Marine Biol Lab, Physiol Course, Woods Hole, MA 02543 USA; [Oldenbourg, Rudolf] Marine Biol Lab, Cellular Dynam Program, Woods Hole, MA 02543 USA; [Fakhri, Nikta] Univ Gottingen, Phys Inst Biophys 3, D-37073 Gottingen, Germany; [Fakhri, Nikta] MIT, Dept Phys, Phys Living Syst, Cambridge, MA 02139 USA; [McIsaac, R. Scott] Princeton Univ, Lewis Sigler Inst Integrat Genom, Princeton, NJ 08544 USA; [McIsaac, R. Scott] Calif Life Co, San Francisco, CA USA; [Gao, Liang; Chen, Bi-Chang; Betzig, Eric] Howard Hughes Med Inst, Ashburn, VA USA; [Gao, Liang] SUNY Stony Brook, Dept Chem, Stony Brook, NY 11794 USA; [Chen, Bi-Chang] Acad Sinica, Res Ctr Appl Sci, Taipei 115, Taiwan; [Baird, Michelle A.; Davidson, Michael W.] Florida State Univ, Dept Biol Sci, Natl High Magnet Field Lab, Tallahassee, FL 32306 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); University of Erlangen Nuremberg; Marine Biological Laboratory - Woods Hole; Marine Biological Laboratory - Woods Hole; University of Gottingen; Massachusetts Institute of Technology (MIT); Princeton University; Howard Hughes Medical Institute; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Academia Sinica - Taiwan; State University System of Florida; Florida State University	Thievessen, I (corresponding author), Univ Erlangen Nurnberg, Biophys Grp, Dept Phys, Henkestr 91, D-91054 Erlangen, Germany.	ithievessen@biomed.uni-erlangen.de	Chen, Bi-Chang/F-3480-2014; Fabry, Ben/AAT-5717-2020; Fakhri, Nikta/B-4657-2008; Fabry, Ben/C-5496-2013	Chen, Bi-Chang/0000-0002-1876-7432; Fabry, Ben/0000-0003-1737-0465; Fakhri, Nikta/0000-0003-1261-7465; Fabry, Ben/0000-0003-1737-0465	NIH NHLBI Division of Intramural Research; Deutsche Forschungsgemeinschaft; Human Frontier Science Program Fellowship; U.S. National Science Foundation Graduate Research Fellowship Program; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL005104, ZIAHL005105] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB002583] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R13GM085967] Funding Source: NIH RePORTER	NIH NHLBI Division of Intramural Research; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Human Frontier Science Program Fellowship(Human Frontier Science Program); U.S. National Science Foundation Graduate Research Fellowship Program(National Science Foundation (NSF)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank the U.S. National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI) Flow Cytometry Core Facility, for fluorescence-activated cell sorting, Silvio Gutkind for adenovirus, and Robert Fischer for helpful discussion. This work was supported by the NIH NHLBI Division of Intramural Research (C.M.W. and I.T.), Deutsche Forschungsgemeinschaft (B.F., I.T., and J.S.), the Human Frontier Science Program Fellowship (N.F.), and the U.S. National Science Foundation Graduate Research Fellowship Program (R.S.M.).	Bays JL, 2014, J CELL BIOL, V205, P251, DOI 10.1083/jcb.201309092; Bradbury P, 2012, CELL ADHES MIGR, V6, P424, DOI 10.4161/cam.21559; Brindle NPJ, 1996, BIOCHEM J, V318, P753, DOI 10.1042/bj3180753; Carisey A, 2013, CURR BIOL, V23, P271, DOI 10.1016/j.cub.2013.01.009; Conklin MW, 2011, AM J PATHOL, V178, P1221, DOI 10.1016/j.ajpath.2010.11.076; Davidson LA, 2008, DEV DYNAM, V237, P2684, DOI 10.1002/dvdy.21600; DeMali KA, 2002, J CELL BIOL, V159, P881, DOI 10.1083/jcb.200206043; Dzamba BJ, 2009, DEV CELL, V16, P421, DOI 10.1016/j.devcel.2009.01.008; FERNANDEZ JLR, 1992, J CELL BIOL, V119, P427, DOI 10.1083/jcb.119.2.427; Fischer RS, 2009, CURR BIOL, V19, P260, DOI 10.1016/j.cub.2008.12.045; Friedl P, 2012, NAT REV MOL CELL BIO, V13, P743, DOI 10.1038/nrm3459; GEORGE EL, 1993, DEVELOPMENT, V119, P1079; Grashoff C, 2010, NATURE, V466, P263, DOI 10.1038/nature09198; Gupton SL, 2006, CELL, V125, P1361, DOI 10.1016/j.cell.2006.05.029; Haigo SL, 2011, SCIENCE, V331, P1071, DOI 10.1126/science.1199424; Humphries JD, 2007, J CELL BIOL, V179, P1043, DOI 10.1083/jcb.200703036; Huveneers S, 2012, J CELL BIOL, V196, P641, DOI 10.1083/jcb.201108120; Koch TM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033476; Kutys ML, 2014, NAT CELL BIOL, V16, P909, DOI 10.1038/ncb3026; Lammermann T, 2008, NATURE, V453, P51, DOI 10.1038/nature06887; Lang NR, 2015, ACTA BIOMATER, V13, P61, DOI 10.1016/j.actbio.2014.11.003; Lang NR, 2013, BIOPHYS J, V105, P1967, DOI 10.1016/j.bpj.2013.09.038; Legant WR, 2012, INTEGR BIOL-UK, V4, P1164, DOI 10.1039/c2ib20059g; Mierke CT, 2010, J BIOL CHEM, V285, P13121, DOI 10.1074/jbc.M109.087171; Mierke CT, 2011, J CELL SCI, V124, P369, DOI 10.1242/jcs.071985; OLDENBOURG R, 1995, J MICROSC-OXFORD, V180, P140, DOI 10.1111/j.1365-2818.1995.tb03669.x; Parsons JT, 2010, NAT REV MOL CELL BIO, V11, P633, DOI 10.1038/nrm2957; Peng XA, 2011, INT REV CEL MOL BIO, V287, P191, DOI 10.1016/B978-0-12-386043-9.00005-0; Petrie RJ, 2012, J CELL BIOL, V197, P439, DOI 10.1083/jcb.201201124; Planchon TA, 2011, NAT METHODS, V8, P417, DOI [10.1038/NMETH.1586, 10.1038/nmeth.1586]; Provenzano PP, 2008, BIOPHYS J, V95, P5374, DOI 10.1529/biophysj.108.133116; Rozario T, 2010, DEV BIOL, V341, P126, DOI 10.1016/j.ydbio.2009.10.026; Rubashkin MG, 2014, CANCER RES, V74, P4597, DOI 10.1158/0008-5472.CAN-13-3698; Shin W.D., 2010, LIVE CELL IMAGING LA, Vsecond; Smith ML, 2007, PLOS BIOL, V5, P2243, DOI 10.1371/journal.pbio.0050268; Subauste MC, 2005, J BIOL CHEM, V280, P5676, DOI 10.1074/jbc.M405561200; Subauste MC, 2004, J CELL BIOL, V165, P371, DOI 10.1083/jcb.200308011; Thievessen I, 2013, J CELL BIOL, V202, P163, DOI 10.1083/jcb.201303129; Wen Q, 2013, EXP CELL RES, V319, P2481, DOI 10.1016/j.yexcr.2013.05.017; Wolf K, 2013, J CELL BIOL, V201, P1069, DOI 10.1083/jcb.201210152; Xu WM, 1998, DEVELOPMENT, V125, P327	41	60	61	3	44	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2015	29	11					4555	4567		10.1096/fj.14-268235	http://dx.doi.org/10.1096/fj.14-268235			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CV8EZ	26195589	Green Published			2022-12-26	WOS:000364514700015
J	Camire, EJ; Grossman, JD; Thole, GJ; Fleischman, NM; Perlstein, DL				Camire, Eric J.; Grossman, John D.; Thole, Grace J.; Fleischman, Nicholas M.; Perlstein, Deborah L.			The Yeast Nbp35-Cfd1 Cytosolic Iron-Sulfur Cluster Scaffold Is an ATPase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CFD1-NBP35 COMPLEX; BACTERIAL APBC; PROTEIN; BINDING; MIND; MEMBRANE; REVEALS	Nbp35 and Cfd1 are prototypical members of the MRP/Nbp35 class of iron-sulfur (FeS) cluster scaffolds that function to assemble nascent FeS clusters for transfer to FeS-requiring enzymes. Both proteins contain a conserved NTPase domain that genetic studies have demonstrated is essential for their cluster assembly activity inside the cell. It was recently reported that these proteins possess no or very low nucleotide hydrolysis activity in vitro, and thus the role of the NTPase domain in cluster biogenesis has remained uncertain. We have reexamined the NTPase activity of Nbp35, Cfd1, and their complex. Using in vitro assays and site-directed mutagenesis, we demonstrate that the Nbp35 homodimer and the Nbp35-Cfd1 heterodimer are ATPases, whereas the Cfd1 homodimer exhibited no or very low ATPase activity. We ruled out the possibility that the observed ATP hydrolysis activity might result from a contaminating ATPase by showing that mutation of key active site residues reduced activity to background levels. Finally, we demonstrate that the fluorescent ATP analog 2'/3'-O-(N'-methylanthraniloyl)-ATP (mantATP) binds stoichiometrically to Nbp35 with a K-D = 15.6 mu M and that an Nbp35 mutant deficient in ATP hydrolysis activity also displays an increased K-D for mantATP. Together, our results demonstrate that the cytosolic iron-sulfur cluster assembly scaffold is an ATPase and pave the way for interrogating the role of nucleotide hydrolysis in cluster biogenesis by this large family of cluster scaffolding proteins found across all domains of life.	[Camire, Eric J.; Grossman, John D.; Thole, Grace J.; Fleischman, Nicholas M.; Perlstein, Deborah L.] Boston Univ, Dept Chem, Boston, MA 02114 USA	Boston University	Perlstein, DL (corresponding author), Boston Univ, Dept Chem, 590 Commonwealth Ave,Rm SCI299, Boston, MA 02114 USA.	dperl@bu.edu		Grossman, John/0000-0001-9586-0369; Perlstein, Deborah/0000-0002-7124-9896	Boston University; National Science Foundation [CHE1126545]	Boston University; National Science Foundation(National Science Foundation (NSF))	We thank Boston University for funding this work in the form of startup funds. We also thank Jin Gao, Mihayl Petkov, Tudor Gradinariu, Isaac Banda, and Harry Griffin for construction of clones and mutants and Xin Sun for development of the discontinuous ATPase assay and critical reading of the manuscript. The CD spectrometer was purchased under National Science Foundation Grant CHE1126545.	Bange G, 2013, NAT STRUCT MOL BIOL, V20, P776, DOI 10.1038/nsmb.2605; Boyd JM, 2008, BIOCHEMISTRY-US, V47, P8195, DOI 10.1021/bi800551y; Boyd JM, 2009, J BACTERIOL, V191, P1490, DOI 10.1128/JB.01469-08; Boyd JM, 2009, J BIOL CHEM, V284, P110, DOI 10.1074/jbc.M807003200; Fu HL, 2010, BIOCHEMISTRY-US, V49, P356, DOI 10.1021/bi901681v; Fuss JO, 2015, BBA-MOL CELL RES, V1853, P1253, DOI 10.1016/j.bbamcr.2015.01.018; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Hausmann A, 2005, P NATL ACAD SCI USA, V102, P3266, DOI 10.1073/pnas.0406447102; Leipe DD, 2002, J MOL BIOL, V317, P41, DOI 10.1006/jmbi.2001.5378; Leonard TA, 2005, EMBO J, V24, P270, DOI 10.1038/sj.emboj.7600530; Lutkenhaus J, 2012, TRENDS MICROBIOL, V20, P411, DOI 10.1016/j.tim.2012.05.002; Mateja A, 2009, NATURE, V461, P361, DOI 10.1038/nature08319; Netz DJA, 2007, NAT CHEM BIOL, V3, P278, DOI 10.1038/nchembio872; Netz DJA, 2012, J BIOL CHEM, V287, P12365, DOI 10.1074/jbc.M111.328914; Pallesen LJ, 2013, J BIOL CHEM, V288, P23358, DOI 10.1074/jbc.M113.486878; Paul VD, 2015, BBA-MOL CELL RES, V1853, P1528, DOI 10.1016/j.bbamcr.2014.12.018; Rome ME, 2013, P NATL ACAD SCI USA, V110, P7666, DOI 10.1073/pnas.1222054110; Roy A, 2003, EMBO J, V22, P4826, DOI 10.1093/emboj/cdg455; Schindelin N, 1997, NATURE, V387, P370, DOI 10.1038/387370a0; Schmid B, 2002, BIOCHEMISTRY-US, V41, P15557, DOI 10.1021/bi026642b; Schwenkert S, 2010, BIOCHEM J, V425, P207, DOI 10.1042/BJ20091290; Sheftel AD, 2009, MOL CELL BIOL, V29, P6059, DOI 10.1128/MCB.00817-09; Stehling O, 2008, MOL CELL BIOL, V28, P5517, DOI 10.1128/MCB.00545-08; Veatch JR, 2009, CELL, V137, P1247, DOI 10.1016/j.cell.2009.04.014; Vitale G, 1996, GENE, V178, P97, DOI 10.1016/0378-1119(96)00341-1; Wu W, 2011, MOL MICROBIOL, V79, P1515, DOI 10.1111/j.1365-2958.2010.07536.x; Zhou HJ, 2005, J BACTERIOL, V187, P629, DOI 10.1128/JB.187.2.629-638.2005; Zhou HJ, 2004, J BACTERIOL, V186, P1546, DOI 10.1128/JB.186.5.1546-1555.2004	28	17	17	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	2015	290	39					23793	23802		10.1074/jbc.M115.667022	http://dx.doi.org/10.1074/jbc.M115.667022			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CS1IF	26195633	Green Published, hybrid			2022-12-26	WOS:000361816500026
J	Allareddy, V; Rampa, S; Nalliah, RP; Martinez-Schlurmann, NI; Lidsky, KB; Allareddy, V; Rotta, AT				Allareddy, Veerajalandhar; Rampa, Sankeerth; Nalliah, Romesh P.; Martinez-Schlurmann, Natalia I.; Lidsky, Karen B.; Allareddy, Veerasathpurush; Rotta, Alexandre T.			Prevalence and Predictors of Gastrostomy Tube and Tracheostomy Placement in Anoxic/Hypoxic Ischemic Encephalopathic Survivors of In-Hospital Cardiopulmonary Resuscitation in the United States	PLOS ONE			English	Article							CARDIAC-ARREST; INSURANCE STATUS; MECHANICAL VENTILATION; COMATOSE SURVIVORS; CARE; OUTCOMES; MORTALITY; ILLNESS; END; EPIDEMIOLOGY	Introduction Current prevalence estimates of gastrostomy tube (GT)/tracheostomy placement in hospitalized patients with anoxic/hypoxic ischemic encephalopathic injury (AHIE) post cardiopulmonary resuscitation (CPR) are unknown. We sought, to estimate the prevalence of AHIE in hospitalized patients who had CPR and to identify patient/hospital level factors that predict the performance of GT/tracheostomy in those with AHIE. Methods We performed a retrospective analysis of the Nationwide Inpatient Sample (years 20042010). All patients who developed AHIE following CPR were included. In this cohort the odds of having GT and tracheostomy was computed by multivariable logistic regression analysis. Patient and hospital level factors were the independent variables. Results During the study period, a total of 686,578 CPR events occurred in hospitalized patients. Of these, 94,336 (13.7%) patients developed AHIE. In this AHIE cohort, 6.8% received GT and 8.3% tracheostomy. When compared to the 40-49 yrs age group, those aged >70 yrs were associated with lower odds for GT (OR = 0.65, 95% CI:0.53-0.80, p<0.0001). Those aged <18 years & those >60 years were associated with lower odds for having tracheostomy when compared to the 40-49 years group (p<0.0001). Each one unit increase in co-morbid burden was associated with higher odds for having GT (OR = 1.23, p<0.0001) or tracheostomy (OR = 1.17, p<0.0001). Blacks, Hispanics, Asians/Pacific Islanders, and other races were associated with higher odds for having GT or tracheostomy when compared to whites (p<0.05). Hospitals located in northeastern regions were associated with higher odds for performing GT (OR = 1.48, p<0.0001) or tracheostomy (OR = 1.63, p<0.0001) when compared to those in Western regions. Teaching hospitals (TH) were associated with higher odds for performing tracheostomy when compared to non-TH (OR = 1.36, 1.20-1.54, p<0.0001). Conclusions AHIE injury occurs in a significant number of in-hospital arrests requiring CPR. Certain predictors of GT/Tracheostomy placement are identified. Patients in teaching hospitals were more likely to receive tracheostomy than their counterparts.	[Allareddy, Veerajalandhar; Martinez-Schlurmann, Natalia I.; Lidsky, Karen B.; Rotta, Alexandre T.] Case Western Reserve Univ, UH Rainbow Babies & Childrens Hosp, Cleveland, OH 44106 USA; [Rampa, Sankeerth] Univ Nebraska, Hlth Serv & Res Dept, Omaha, NE 68182 USA; [Nalliah, Romesh P.] Univ Michigan, Coll Dent, Ann Arbor, MI 48109 USA; [Allareddy, Veerasathpurush] Univ Iowa, Sch Dent, Coll Dent & Dent Clin, Iowa City, IA USA	Case Western Reserve University; Case Western Reserve University Hospital; University Hospitals of Cleveland; Rainbow Babies & Children's Hospital; University of Nebraska System; University of Michigan System; University of Michigan; University of Iowa	Allareddy, V (corresponding author), Case Western Reserve Univ, UH Rainbow Babies & Childrens Hosp, Cleveland, OH 44106 USA.	Veerajalandhar.Allareddy@UHhospitals.org	Nalliah, Romesh/AAV-2016-2020	Nalliah, Romesh/0000-0002-6287-0656; Rotta, Alexandre/0000-0002-4406-2276				Abella BS, 2007, RESUSCITATION, V73, P54, DOI 10.1016/j.resuscitation.2006.10.027; Alosh H, 2009, SPINE, V34, P1956, DOI 10.1097/BRS.0b013e3181ab930e; Ayanian JZ, 2002, MILBANK Q, V80, P569, DOI 10.1111/1468-0009.00023; Barnato AE, 2007, J GEN INTERN MED, V22, P338, DOI 10.1007/s11606-006-0088-x; Barnato AE, 2009, J GEN INTERN MED, V24, P695, DOI 10.1007/s11606-009-0952-6; Diringer MN, 2001, CRIT CARE MED, V29, P1792, DOI 10.1097/00003246-200109000-00023; Edelson DP, 2008, ARCH INTERN MED, V168, P1063, DOI 10.1001/archinte.168.10.1063; EDGREN E, 1994, LANCET, V343, P1055, DOI 10.1016/S0140-6736(94)90179-1; Ehlenbach WJ, 2009, NEW ENGL J MED, V361, P22, DOI 10.1056/NEJMoa0810245; Field JM, 2010, CIRCULATION, V122, pS640, DOI 10.1161/CIRCULATIONAHA.110.970889; Fowler RA, 2010, AM J RESP CRIT CARE, V181, P1003, DOI 10.1164/rccm.200902-0281ST; GARRETT JM, 1993, J GEN INTERN MED, V8, P361, DOI 10.1007/BF02600073; Girotra S, 2013, CIRC-CARDIOVASC QUAL, V6, P42, DOI 10.1161/CIRCOUTCOMES.112.967968; Girotra S, 2012, NEW ENGL J MED, V367, P1912, DOI 10.1056/NEJMoa1109148; Goldberger ZD, 2012, LANCET, V380, P1473, DOI 10.1016/S0140-6736(12)60862-9; Healthcare Cost and Utilization Project (HCUP), 2004, HCUP NAT INP SAMPL N; Hunt EA, 2008, PEDIATRICS, V121, pE34, DOI 10.1542/peds.2007-0029; International Classification of Diseases, 9 REV CLIN MOD ICD 9; JENNETT B, 1975, LANCET, V1, P480; Kahn JM, 2015, CRIT CARE MED, V43, P282, DOI 10.1097/CCM.0000000000000710; Kazaure HS, 2013, RESUSCITATION, V84, P1255, DOI 10.1016/j.resuscitation.2013.02.021; Khuri SF, 2001, ANN SURG, V234, P370, DOI 10.1097/00000658-200109000-00011; Kokoska ER, 2007, J SURG RES, V137, P83, DOI 10.1016/j.jss.2006.06.020; LEVY DE, 1985, JAMA-J AM MED ASSOC, V253, P1420, DOI 10.1001/jama.253.10.1420; Lyon SM, 2011, AM J RESP CRIT CARE, V184, P809, DOI 10.1164/rccm.201101-0089OC; Matos RI, 2013, CIRCULATION, V127, P442, DOI 10.1161/CIRCULATIONAHA.112.125625; Mebane EW, 1999, J AM GERIATR SOC, V47, P579, DOI 10.1111/j.1532-5415.1999.tb02573.x; Merchant RM, 2011, CRIT CARE MED, V39, P2401, DOI 10.1097/CCM.0b013e3182257459; Muni S, 2011, CHEST, V139, P1025, DOI 10.1378/chest.10-3011; Nadkarni VM, 2006, JAMA-J AM MED ASSOC, V295, P50, DOI 10.1001/jama.295.1.50; Nelson JE, 2006, ARCH INTERN MED, V166, P1993, DOI 10.1001/archinte.166.18.1993; Nelson JE, 2010, AM J RESP CRIT CARE, V182, P446, DOI 10.1164/rccm.201002-0210CI; Patil SP, 2003, ARCH INTERN MED, V163, P1180, DOI 10.1001/archinte.163.10.1180; Peberdy MA, 2003, RESUSCITATION, V58, P297, DOI 10.1016/S0300-9572(03)00215-6; Periyakoil VS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122321; Reis AG, 2002, PEDIATRICS, V109, P200, DOI 10.1542/peds.109.2.200; Sandroni C, 2007, INTENS CARE MED, V33, P237, DOI 10.1007/s00134-006-0326-z; Scheinhorn DJ, 2007, CHEST, V131, P76, DOI 10.1378/chest.06-1079; Skinner J, 2003, NEW ENGL J MED, V349, P1350, DOI 10.1056/NEJMsa021569; Slonim AD, 1997, CRIT CARE MED, V25, P1951, DOI 10.1097/00003246-199712000-00008; Suominen P, 2000, RESUSCITATION, V45, P17, DOI 10.1016/S0300-9572(00)00167-2; Wijdicks EFM, 2006, NEUROLOGY, V67, P203, DOI 10.1212/01.wnl.0000227183.21314.cd; Zandbergen EGJ, 2006, NEUROLOGY, V66, P62, DOI 10.1212/01.wnl.0000191308.22233.88; Zilberberg MD, 2008, CRIT CARE MED, V36, P724, DOI 10.1097/CCM.0B013E31816536F7	44	6	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0132612	10.1371/journal.pone.0132612	http://dx.doi.org/10.1371/journal.pone.0132612			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LZ	26197229	Green Published, Green Submitted, gold			2022-12-26	WOS:000358547600042
J	Fellows, IE; Morris, M; Birnbaum, JK; Dombrowski, JC; Buskin, S; Bennett, A; Golden, MR				Fellows, Ian E.; Morris, Martina; Birnbaum, Jeanette K.; Dombrowski, Julia C.; Buskin, Susan; Bennett, Amy; Golden, Matthew R.			A New Method for Estimating the Number of Undiagnosed HIV Infected Based on HIV Testing History, with an Application to Men Who Have Sex with Men in Seattle/King County, WA	PLOS ONE			English	Article								We develop a new approach for estimating the undiagnosed fraction of HIV cases, the first step in the HIV Care Cascade. The goal is to address a critical blindspot in HIV prevention and treatment planning, with an approach that simplifies data requirements and can be implemented with open-source software. The primary data required is HIV testing history information on newly diagnosed cases. Two methods are presented and compared. The first is a general methodology based on simplified back-calculation that can be used to assess changes in the undiagnosed fraction over time. The second makes an assumption of constant incidence, allowing the estimate to be expressed as a simple closed formula calculation. We demonstrate the methods with an application to HIV diagnoses among men who have sex with men (MSM) from Seattle/King County. The estimates suggest that 6% of HIV-infected MSM in King County are undiagnosed, about one-third of the comparable national estimate. A sensitivity analysis on the key distributional assumption gives an upper bound of 11%. The undiagnosed fraction varies by race/ethnicity, with estimates of 4.9% among white, 8.6% of African American, and 9.3% of Hispanic HIV-infected MSM being undiagnosed.	[Fellows, Ian E.] Fellows Stat, San Diego, CA USA; [Morris, Martina] Univ Washington, Dept Sociol, Seattle, WA 98195 USA; [Morris, Martina] Univ Washington, Dept Stat, Seattle, WA 98195 USA; [Birnbaum, Jeanette K.] Univ Washington, Ctr AIDS Res, Seattle, WA 98195 USA; [Dombrowski, Julia C.; Golden, Matthew R.] Univ Washington, Sch Med, Div Allergy & Infect Dis, Seattle, WA 98195 USA; [Buskin, Susan; Bennett, Amy] Univ Washington, Sch Publ Hlth, Dept Epidemiol, Seattle, WA 98195 USA; [Buskin, Susan; Golden, Matthew R.] Publ Hlth Seattle King Cty, HIV AIDS Program, Seattle, WA USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Morris, M (corresponding author), Univ Washington, Dept Sociol, Seattle, WA 98195 USA.	morrism@uw.edu	Golden, Matthew/AAE-4314-2020		NIH [P30 AI027757]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD042828] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027757] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by NIH P30 AI027757.	[Anonymous], 2010, NAT HIV AIDS STRAT U; BROOKMEYER R, 1988, J AM STAT ASSOC, V83, P301, DOI 10.2307/2288844; Chen Mi, 2012, MMWR Suppl, V61, P57; Hall HI, 2008, JAMA-J AM MED ASSOC, V300, P520, DOI 10.1001/jama.300.5.520; Hall HI, 2013, JAMA INTERN MED, V173, P1337, DOI 10.1001/jamainternmed.2013.6841; [HIV/AIDS Epidemiology Unit PHSKC and the Infectious Disease and Reproductive Health Assessment Unit WSDoH Health PH-SKCaWSDo], 2013, HIV AIDS EP REP 2 HA; Lodwick R, 2011, AIDS, V25, P1017, DOI 10.1097/QAD.0b013e3283467087; LUI KJ, 1986, P NATL ACAD SCI USA, V83, P3051, DOI 10.1073/pnas.83.10.3051; Marzinke MA, 2013, CLIN INFECT DIS; Mugavero MJ, 2013, CLIN INFECT DIS; R Studio, 2014, SHIN WEB APPL FRAM; Sanchez TH, 2012, LACK AWARENESS HIV I, V2012; Skar H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060906; Smith A., 2010, Morbidity and Mortality Weekly Report, V59, P1201	14	8	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0129551	10.1371/journal.pone.0129551	http://dx.doi.org/10.1371/journal.pone.0129551			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LZ	26196132	Green Submitted, Green Published, gold			2022-12-26	WOS:000358547600005
J	Getty, CM; Dilger, RN				Getty, Caitlyn M.; Dilger, Ryan N.			Moderate Perinatal Choline Deficiency Elicits Altered Physiology and Metabolomic Profiles in the Piglet	PLOS ONE			English	Article							COGNITIVE FUNCTION; DIETARY CHOLINE; BRAIN GROWTH; PHOSPHATIDYLCHOLINE; SUPPLEMENTATION; PREGNANCY; CARNITINE; DEPLETION; SOWS; AGE	Few studies have evaluated the impact of dietary choline on the health and well-being of swine, and those pivotal papers were aimed at determining dietary requirements for sows and growing pigs. This is of importance as the piglet is becoming a widely accepted model for human infant nutrition, but little is known about the impacts of perinatal choline status on overall health and metabolism of the growing piglet. In the present study, sows were provided either a choline deficient (CD, 625 mg choline/kg dry matter) or choline sufficient (CS, 1306 mg choline/kg dry matter) diet for the last 65 d of gestation (prenatal intervention). Piglets were weaned from the sow 48 h after farrowing and provided either a CD (477 mg choline/kg dry matter) or CS (1528 mg choline/kg dry matter) milk replacer (postnatal intervention) for 29 +/- 2 d, resulting in a factorial arrangement of 4 treatment (prenatal/postnatal) groups: CS/CS, CS/CD, CD/CS, and CD/CD. Piglet growth was normal for artificially-reared piglets, and was not impacted by perinatal choline status. Piglets receiving the postnatal CD treatment had lower (P < 0.01) plasma choline and choline-containing phospholipid concentrations and higher (P < 0.05) liver enzyme (alkaline phosphatase and gamma-glutamyl transferase) values compared with piglets receiving the postnatal CS treatment. Hepatic lipid content of piglets receiving the postnatal CD treatment was higher (P < 0.01) compared with piglets receiving the postnatal CS treatment. Additionally, postnatally CD piglets had lower (P = 0.01) plasma cholesterol than postnatally CS piglets. Brain development was also impacted by perinatal choline status, with brains of piglets exposed to prenatal CD being smaller (P = 0.01) than those of prenatally CS piglets. These findings support the hypothesis that the piglet is a sensitive model for choline deficiency during the perinatal period. In the present study, piglets exhibited similarities in health markers and metabolomic profiles to rodents and humans when exposed to moderate choline deficiency.	[Getty, Caitlyn M.; Dilger, Ryan N.] Univ Illinois, Div Nutr Sci, Urbana, IL 61801 USA; [Getty, Caitlyn M.; Dilger, Ryan N.] Univ Illinois, Dept Anim Sci, Urbana, IL 61801 USA; [Getty, Caitlyn M.] Univ Illinois, Coll Vet Med, Urbana, IL 61801 USA; [Dilger, Ryan N.] Univ Illinois, Program Neurosci, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Dilger, RN (corresponding author), Univ Illinois, Div Nutr Sci, Urbana, IL 61801 USA.	rdilger2@illinois.edu		Dilger, Ryan/0000-0003-2538-2845	United States Department of Agriculture National Institute of Food and Agriculture, Hatch project [0224124]	United States Department of Agriculture National Institute of Food and Agriculture, Hatch project	This work was supported by the United States Department of Agriculture National Institute of Food and Agriculture, Hatch project 0224124. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boeke CE, 2013, AM J EPIDEMIOL, V177, P1338, DOI 10.1093/aje/kws395; CARTER AL, 1978, J NUTR, V108, P1748, DOI 10.1093/jn/108.11.1748; Cheatham CL, 2012, AM J CLIN NUTR, V96, P1465, DOI 10.3945/ajcn.112.037184; Conrad MS, 2012, DEV NEUROSCI-BASEL, V34, P291, DOI 10.1159/000339311; Conrad MS, 2012, PEDIATR RES, V71, P179, DOI 10.1038/pr.2011.21; CORREDOR C, 1967, BIOCHIM BIOPHYS ACTA, V144, P366, DOI 10.1016/0005-2760(67)90165-8; da Costa KA, 2011, AM J CLIN NUTR, V93, P968, DOI 10.3945/ajcn.110.011064; Dilger RN, 2010, BRAIN BEHAV IMMUN, V24, P1156, DOI 10.1016/j.bbi.2010.05.008; DOBBING J, 1979, EARLY HUM DEV, V3, P79, DOI 10.1016/0378-3782(79)90022-7; Donovan SM, 1997, J NUTR BIOCHEM, V8, P603, DOI 10.1016/S0955-2863(97)00115-0; Elmore MR, 2012, ANIM COGN; Evans AM, 2009, ANAL CHEM, V81, P6656, DOI 10.1021/ac901536h; Institute of Medicine aNAoSU, 1998, DIET REF INT FOL THI; Itagaki H, 2013, INT J CLIN EXP PATHO, V6, P2683; Jakob S, 1998, Z ERNAHRUNGSWISS, V37, P353, DOI 10.1007/s003940050036; Jensen LJ, 2007, FASEB J, V21, pA519; KORNEGAY ET, 1973, J ANIM SCI, V37, P506, DOI 10.2527/jas1973.372506x; Matrenza C, 2004, J PSYCHOPHARMACOL, V18, P21, DOI 10.1177/0269881104040215; MECK WH, 1989, BEHAV NEUROSCI, V103, P1234, DOI 10.1037/0735-7044.103.6.1234; Meck WH, 1997, NEUROREPORT, V8, P3045, DOI 10.1097/00001756-199709290-00009; Michel V, 2011, FOOD FUNCT, V2, P53, DOI 10.1039/c0fo00069h; MILLER ER, 1987, ANNU REV NUTR, V7, P361, DOI 10.1146/annurev.nu.07.070187.002045; Moughan P J, 1992, World Rev Nutr Diet, V67, P40; NRC, 2012, 2012 NUTR REQ SWIN; Ohta T, 2009, TOXICOL PATHOL, V37, P521, DOI 10.1177/0192623309336152; Pacelli C, 2010, J NUTR, V140, P1072, DOI 10.3945/jn.109.116673; [Pond WGaXGL Southern LaLL], 2001, OF PIGS AND PEOPL; Pyapali GK, 1998, J NEUROPHYSIOL, V79, P1790, DOI 10.1152/jn.1998.79.4.1790; Rytych JL, 2012, J NUTR, V142, P2050, DOI 10.3945/jn.112.165522; Sha W, 2010, FASEB J, V24, P2962, DOI 10.1096/fj.09-154054; STOCKLAND WL, 1974, J ANIM SCI, V39, P1113, DOI 10.2527/jas1974.3961113x; Wu GC, 2012, J APPL MATH, DOI 10.1155/2012/102850; Yan J, 2013, AM J CLIN NUTR, V98, P1459, DOI 10.3945/ajcn.113.066092; Yan J, 2012, AM J CLIN NUTR, V95, P1060, DOI 10.3945/ajcn.111.022772; ZEISEL SH, 1994, ANNU REV NUTR, V14, P269, DOI 10.1146/annurev.nu.14.070194.001413; ZEISEL SH, 1991, FASEB J, V5, P2093, DOI 10.1096/fasebj.5.7.2010061	36	11	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0133500	10.1371/journal.pone.0133500	http://dx.doi.org/10.1371/journal.pone.0133500			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LZ	26196148	Green Published, gold, Green Submitted			2022-12-26	WOS:000358547600105
J	Liang, MM; Adisetiyo, H; Liu, XQ; Liu, R; Gill, P; Roy-Burman, P; Jones, JO; Mulholland, DJ				Liang, Mengmeng; Adisetiyo, Helty; Liu, Xiuqing; Liu, Ren; Gill, Parkash; Roy-Burman, Pradip; Jones, Jeremy O.; Mulholland, David J.			Identification of Androgen Receptor Splice Variants in the Pten Deficient Murine Prostate Cancer Model	PLOS ONE			English	Article							TARGET GENES; CELL-LINES; RESISTANCE; GROWTH; ENZALUTAMIDE; PROGRESSION; THERAPY; AR-V7	Androgen receptor (AR) variants are associated with resistance to anti androgen therapy both in human prostate cancer cell lines and clinical samples. These observations support the hypothesis that AR isoform accumulation is a consequence of selective therapeutic pressure on the full length AR. The Pten deficient prostate cancer model proceeds with well-defined kinetics including progression to castration resistant prostate cancer (CRPC). While surgical castration and enzalutamide treatments yield an initial therapeutic response, Pten(-/-)epithelia continue to proliferate yielding locally invasive primary tumor pathology. That most epithelium remains AR positive, but ligand independent, suggests the presence of oncogenic AR variants. To address this hypothesis, we have used a panel of recently described Pten(-/-)tumor cell lines derived from both from hormone intact (E4, E8) and castrated Pten mutants (cE1, cE2) followed by RACE PCR to identify and characterize three novel truncated, amino terminus containing AR variants (mAR-Va, b, c). Variants appear not only conserved throughout progression but are correlated with nearly complete loss of full length AR (AR-FL) at castrate androgen levels. The overexpression of variants leads to enhanced transcriptional activity of AR while knock down studies show reduced transcriptional output. Collectively, the identification of truncated AR variants in the conditional PTEN deletion model supports a role for maintaining the CRPC phenotype and provides further therapeutic applications of this preclinical model.	[Liang, Mengmeng; Mulholland, David J.] Icahn Sch Med Mt Sinai, New York, NY 10029 USA; [Adisetiyo, Helty] Childrens Hosp Los Angeles, Los Angeles, CA 90027 USA; [Liu, Xiuqing] St Lukes Hosp, Internal Med Resident, Chesterfield, MO USA; [Liu, Ren; Gill, Parkash] Univ So Calif, Keck Sch Med, Dept Med, Los Angeles, CA 90033 USA; [Roy-Burman, Pradip] Univ So Calif, Dept Biochem & Mol Biol, Los Angeles, CA 90033 USA; [Jones, Jeremy O.] City Hope Natl Med Ctr, Beckman Res Inst, Duarte, CA 91010 USA	Icahn School of Medicine at Mount Sinai; Children's Hospital Los Angeles; Saint Luke's Hospital - Missouri; University of Southern California; University of Southern California; City of Hope; Beckman Research Institute of City of Hope	Jones, JO (corresponding author), City Hope Natl Med Ctr, Beckman Res Inst, Duarte, CA 91010 USA.	jjones@coh.org; david.mulholland@mssm.edu			NIH grant [RO1CA059705]; PCF Young Investigator Award; Icahn School of Medicine Cancer Research Funds; NATIONAL CANCER INSTITUTE [R01CA059705, R01CA197910] Funding Source: NIH RePORTER	NIH grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); PCF Young Investigator Award; Icahn School of Medicine Cancer Research Funds; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the NIH grant RO1CA059705 to PR, the PCF Young Investigator Award and Icahn School of Medicine Cancer Research Funds awarded to DJM.	Agoulnik IU, 2006, J CELL BIOCHEM, V99, P362, DOI 10.1002/jcb.20811; Antonarakis ES, 2014, NEW ENGL J MED, V371, P1028, DOI 10.1056/NEJMoa1315815; Bain DL, 2007, ANNU REV PHYSIOL, V69, P201, DOI 10.1146/annurev.physiol.69.031905.160308; Bolton EC, 2007, GENE DEV, V21, P2005, DOI 10.1101/gad.1564207; Carver BS, 2011, CANCER CELL, V19, P575, DOI 10.1016/j.ccr.2011.04.008; Chan SC, 2012, J BIOL CHEM, V287, P19736, DOI 10.1074/jbc.M112.352930; Dehm SM, 2008, CANCER RES, V68, P5469, DOI 10.1158/0008-5472.CAN-08-0594; Dehm SM, 2007, MOL ENDOCRINOL, V21, P2855, DOI 10.1210/me.2007-0223; Dehm SM, 2006, J CELL BIOCHEM, V99, P333, DOI 10.1002/jcb.20794; Dehm SM, 2011, ENDOCR-RELAT CANCER, V18, pR183, DOI 10.1530/ERC-11-0141; Feldman BJ, 2001, NAT REV CANCER, V1, P34, DOI 10.1038/35094009; Guo ZY, 2011, INT J BIOL SCI, V7, P815, DOI 10.7150/ijbs.7.815; Guo ZY, 2009, CANCER RES, V69, P2305, DOI 10.1158/0008-5472.CAN-08-3795; Haile S, 2011, CELL MOL LIFE SCI, V68, P3971, DOI 10.1007/s00018-011-0766-7; Hornberg E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019059; Hu R, 2011, PROSTATE, V71, P1656, DOI 10.1002/pros.21382; Hu R, 2009, CANCER RES, V69, P16, DOI 10.1158/0008-5472.CAN-08-2764; Jia SD, 2013, CANCER DISCOV, V3, P44, DOI 10.1158/2159-8290.CD-12-0262; Jiao J, 2007, CANCER RES, V67, P6083, DOI 10.1158/0008-5472.CAN-06-4202; Knudsen KE, 2011, EXPERT REV ENDOCRINO, V6, P483, DOI 10.1586/EEM.11.33; Lamont KR, 2011, MOL ENDOCRINOL, V25, P897, DOI 10.1210/me.2010-0469; Li YM, 2013, CANCER RES, V73, P483, DOI 10.1158/0008-5472.CAN-12-3630; Liao CP, 2010, CANCER RES, V70, P7294, DOI 10.1158/0008-5472.CAN-09-3982; Liao Chun-Peng, 2010, Hormones & Cancer, V1, P44, DOI 10.1007/s12672-009-0005-y; Libertini SJ, 2007, CANCER RES, V67, P9001, DOI 10.1158/0008-5472.CAN-07-1072; Marcias G, 2010, HUM MUTAT, V31, P74, DOI 10.1002/humu.21138; Mulholland DJ, 2012, CANCER RES, V72, P1878, DOI 10.1158/0008-5472.CAN-11-3132; Mulholland DJ, 2011, CANCER CELL, V19, P792, DOI 10.1016/j.ccr.2011.05.006; Pham LK, 2013, ENDOCR-RELAT CANCER, V20, P861, DOI 10.1530/ERC-13-0100; Qu YY, 2015, SCI REP-UK, V5, DOI 10.1038/srep07654; Ratajczak T, 2003, CURR TOP MED CHEM, V3, P1348, DOI 10.2174/1568026033451934; Shen MM, 2010, GENE DEV, V24, P1967, DOI 10.1101/gad.1965810; Sun SH, 2010, J CLIN INVEST, V120, P2715, DOI 10.1172/JCI41824; Wang SY, 2003, CANCER CELL, V4, P209, DOI 10.1016/S1535-6108(03)00215-0; Watson PA, 2010, P NATL ACAD SCI USA, V107, P16759, DOI 10.1073/pnas.1012443107; Yang X, 2011, J BIOL CHEM, V286, P36152, DOI 10.1074/jbc.M111.265124	36	8	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0131232	10.1371/journal.pone.0131232	http://dx.doi.org/10.1371/journal.pone.0131232			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LZ	26196517	Green Submitted, gold, Green Published			2022-12-26	WOS:000358547600008
J	Molinaro, R; Pecli, C; Guilherme, RF; Alves-Filho, JC; Cunha, FQ; Canetti, C; Kunkel, SL; Bozza, MT; Benjamim, CF				Molinaro, Raphael; Pecli, Cyntia; Guilherme, Rafael F.; Alves-Filho, Jose Carlos; Cunha, Fernando Q.; Canetti, Claudio; Kunkel, Steven L.; Bozza, Marcelo T.; Benjamim, Claudia F.			CCR4 Controls the Suppressive Effects of Regulatory T Cells on Early and Late Events during Severe Sepsis	PLOS ONE			English	Article							MURINE POLYMICROBIAL SEPSIS; CHEMOKINE RECEPTOR 4; NITRIC-OXIDE; NEUTROPHIL MIGRATION; SEPTIC SHOCK; PULMONARY-FIBROSIS; IMMUNE DYSFUNCTION; TUMOR-GROWTH; FAILURE; EXPRESSION	Sepsis is a deadly disease characterized by an overwhelming release of inflammatory mediators and the activation of different types of cells. This altered state of cell activation, termed leukocyte reprogramming, contributes to patient outcome. However, the understanding of the process underlying sepsis and the role of regulatory T cells (Tregs) in sepsis remains to be elucidated. In this study, we investigated the role of CCR4, the CCL17/CCL22 chemokine receptor, in the innate and acquired immune responses during severe sepsis and the role of Tregs in effecting the outcome. In contrast with wild-type (WT) mice subjected to cecal ligation and puncture (CLP) sepsis, CCR4-deficient (CCR4(-/-)) septic mice presented an increased survival rate, significant neutrophil migration toward the infection site, a low bacterial count in the peritoneum, and reduced lung inflammation and serum cytokine levels. Thus, a better early host response may favor an adequate long-term response. Consequently, the CCR4(-/-) septic mice were not susceptible to secondary fungal infection, in contrast with the WT septic mice. Furthermore, Tregs cells from the CCR4(-/-) septic mice showed reduced suppressive effects on neutrophil migration (both in vivo and in vitro), lymphocyte proliferation and ROS production from activated neutrophils, in contrast with what was observed for Tregs from the WT septic mice. These data show that CCR4 is involved in immunosuppression after severe sepsis and suggest that CCR4(+) Tregs negatively modulate the short and long-term immune responses.	[Molinaro, Raphael; Pecli, Cyntia; Guilherme, Rafael F.; Benjamim, Claudia F.] Univ Fed Rio de Janeiro, Inst Ciencias Biomed, BR-21941 Rio De Janeiro, RJ, Brazil; [Alves-Filho, Jose Carlos; Cunha, Fernando Q.] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Farmacol, Ribeirao Preto, SP, Brazil; [Canetti, Claudio] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, BR-21941 Rio De Janeiro, RJ, Brazil; [Kunkel, Steven L.] Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA; [Bozza, Marcelo T.] Univ Fed Rio de Janeiro, Inst Microbiol, Dept Imunol, BR-21941 Rio De Janeiro, RJ, Brazil	Universidade Federal do Rio de Janeiro; Universidade de Sao Paulo; Universidade Federal do Rio de Janeiro; University of Michigan System; University of Michigan; Universidade Federal do Rio de Janeiro	Benjamim, CF (corresponding author), Univ Fed Rio de Janeiro, Inst Ciencias Biomed, BR-21941 Rio De Janeiro, RJ, Brazil.	cbenjamim@icb.ufrj.br	Alves-Filho, Jose Carlos/B-5814-2008; Cunha, Fernando Q/M-3090-2014; Claudio, Canetti A/C-2774-2009; Benjamim, Claudia/T-5090-2019	Alves-Filho, Jose Carlos/0000-0002-9918-8714; Benjamim, Claudia/0000-0001-6247-9596; Pecli, Cyntia/0000-0003-0129-3514; Cunha, Fernando Queiroz/0000-0003-4755-1670; Bozza, Marcelo/0000-0003-3683-7550	Universal- CNPq; APQ1- FAPERJ; CAPES	Universal- CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); APQ1- FAPERJ(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	Funding provided by Universal- CNPq, APQ1- FAPERJ and Fellowship - CAPES.	Alves-Filho J. C., 2006, Endocrine Metabolic & Immune Disorders-Drug Targets, V6, P151; Annane D, 2009, CRIT CARE MED, V37, pS117, DOI 10.1097/CCM.0b013e318192078b; Baatar D, 2007, J IMMUNOL, V178, P4891, DOI 10.4049/jimmunol.178.8.4891; Belperio JA, 2004, J IMMUNOL, V173, P4692, DOI 10.4049/jimmunol.173.7.4692; Benjamim CF, 2003, AM J PATHOL, V163, P2605, DOI 10.1016/S0002-9440(10)63615-2; Benjamim CF, 2002, INFECT IMMUN, V70, P3602, DOI 10.1128/IAI.70.7.3602-3610.2002; Benjamim CF, 2000, J INFECT DIS, V182, P214, DOI 10.1086/315682; Benjamim CF, 2005, BLOOD, V105, P3588, DOI 10.1182/blood-2004-08-3251; BONE RC, 1992, CHEST, V101, P320, DOI 10.1378/chest.101.2.320; Bonecchi R, 1998, J EXP MED, V187, P129, DOI 10.1084/jem.187.1.129; Cavaillon JM, 2005, J ENDOTOXIN RES, V11, P311, DOI 10.1179/096805105X58733; Chvatchko Y, 2000, J EXP MED, V191, P1755, DOI 10.1084/jem.191.10.1755; Cuenca AG, 2010, BLOOD, V115, P4324, DOI 10.1182/blood-2010-03-271379; Curiel TJ, 2004, NAT MED, V10, P942, DOI 10.1038/nm1093; Doerschug KC, 2004, CRIT CARE MED, V32, P489, DOI 10.1097/01.CCM.0000109450.66450.23; Guilherme RF, 2013, AM J RESP CELL MOL, V49, P1029, DOI 10.1165/rcmb.2012-0462OC; HOYT DB, 1988, J SURG RES, V45, P342, DOI 10.1016/0022-4804(88)90129-1; Iellem A, 2001, J EXP MED, V194, P847, DOI 10.1084/jem.194.6.847; Inoue T, 2004, EUR RESPIR J, V24, P49, DOI 10.1183/09031936.04.00110203; Ishii M, 2008, EUR J IMMUNOL, V38, P2290, DOI 10.1002/eji.200838360; Jakubzick C, 2004, AM J PATHOL, V165, P1211, DOI 10.1016/S0002-9440(10)63381-0; Josefowicz SZ, 2012, NATURE, V482, P395, DOI 10.1038/nature10772; Katoh S, 2003, ALLERGY, V58, P518, DOI 10.1034/j.1398-9995.2003.00149.x; Kim SH, 2002, J CLIN INVEST, V110, P1675, DOI 10.1172/JCI200215547; Kingsley CI, 2002, J IMMUNOL, V168, P1080, DOI 10.4049/jimmunol.168.3.1080; Kox WJ, 2000, INTENS CARE MED, V26, pS124, DOI 10.1007/s001340051129; Landelle C, 2008, INFECT CONT HOSP EP, V29, P1054, DOI 10.1086/591859; Lee I, 2005, J EXP MED, V201, P1037, DOI 10.1084/jem.20041709; Lewkowicz P, 2006, J IMMUNOL, V177, P7155, DOI 10.4049/jimmunol.177.10.7155; LIN RY, 1993, CHEST, V104, P847, DOI 10.1378/chest.104.3.847; Margry B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088869; Monneret G, 2003, CRIT CARE MED, V31, P2068, DOI 10.1097/01.CCM.0000069345.78884.0F; Monneret G, 2008, MOL MED, V14, P64, DOI 10.2119/2007-00102.Monneret; Munford RS, 2001, AM J RESP CRIT CARE, V163, P316, DOI 10.1164/ajrccm.163.2.2007102; Nascimento DC, 2010, CRIT CARE MED, V38, P1718, DOI 10.1097/CCM.0b013e3181e78ad0; Neill DR, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002660; Ness TL, 2006, J IMMUNOL, V177, P7531, DOI 10.4049/jimmunol.177.11.7531; NISHIJIMA MK, 1986, CRIT CARE MED, V14, P87, DOI 10.1097/00003246-198602000-00002; Ocuin LM, 2011, J LEUKOCYTE BIOL, V89, P423, DOI 10.1189/jlb.0810479; Paula-Neto HA, 2011, SHOCK, V35, P17, DOI 10.1097/SHK.0b013e3181e37ea8; PERL TM, 1995, JAMA-J AM MED ASSOC, V274, P338, DOI 10.1001/jama.274.4.338; Quartin AA, 1997, JAMA-J AM MED ASSOC, V277, P1058, DOI 10.1001/jama.277.13.1058; Rios-Santos F, 2007, AM J RESP CRIT CARE, V175, P490, DOI 10.1164/rccm.200601-103OC; Rudensky AY, 2006, J EXP MED, V203, P489, DOI 10.1084/jem.20060214; Schlecker E, 2012, J IMMUNOL, V189, P5602, DOI 10.4049/jimmunol.1201018; Scumpia PO, 2007, BLOOD, V110, P3673, DOI 10.1182/blood-2007-04-087171; Scumpia PO, 2006, J IMMUNOL, V177, P7943, DOI 10.4049/jimmunol.177.11.7943; Souza DG, 2002, AM J PATHOL, V160, P1755, DOI 10.1016/S0002-9440(10)61122-4; Suratt BT, 2001, AM J PHYSIOL-LUNG C, V281, pL913, DOI 10.1152/ajplung.2001.281.4.L913; Tavares-Murta BM, 2002, CRIT CARE MED, V30, P1056, DOI 10.1097/00003246-200205000-00017; Torres-Duenas D, 2006, SHOCK, V25, P267, DOI 10.1097/01.shk.0000208804.34292.38; Traeger T, 2008, INFECT IMMUN, V76, P5285, DOI 10.1128/IAI.00310-08; Valenca SS, 2004, TOXICOL PATHOL, V32, P351, DOI 10.1080/01926230490431466; Venet F, 2004, CRIT CARE MED, V32, P2329, DOI 10.1097/01.CCM.0000145999.42971.4B; Walley ER, 1996, INFECT IMMUN, V64, P4733, DOI 10.1128/IAI.64.11.4733-4738.1996; Weighardt H, 2000, SURGERY, V127, P309, DOI 10.1067/msy.2000.104118; Wisnoski N, 2007, SHOCK, V27, P251, DOI 10.1097/01.shk.0000239780.33398.e4; Wysocka M, 2001, J IMMUNOL, V166, P7504, DOI 10.4049/jimmunol.166.12.7504; Yoneyama H, 1998, J CLIN INVEST, V102, P1933, DOI 10.1172/JCI4619; Yuan Q, 2007, J EXP MED, V204, P1327, DOI 10.1084/jem.20062076; ZHANG XK, 1993, J LEUKOCYTE BIOL, V54, P444, DOI 10.1002/jlb.54.5.444	61	23	23	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0133227	10.1371/journal.pone.0133227	http://dx.doi.org/10.1371/journal.pone.0133227			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LZ	26197455	Green Published, gold, Green Submitted			2022-12-26	WOS:000358547600074
J	Powell, JSV; Babbitt, KJ				Powell, Jessica S. Veysey; Babbitt, Kimberly J.			An Experimental Test of Buffer Utility as a Technique for Managing Pool-Breeding Amphibians	PLOS ONE			English	Article							SALAMANDERS AMBYSTOMA-MACULATUM; TERRESTRIAL HABITAT USE; FROG RANA-SYLVATICA; SPOTTED SALAMANDERS; WOOD FROG; POSTBREEDING EMIGRATION; FOREST MANAGEMENT; RETURN RATES; POND; CONSERVATION	Vegetated buffers are used extensively to manage wetland-dependent wildlife. Despite widespread application, buffer utility has not been experimentally validated for most species. To address this gap, we conducted a six-year, landscape-scale experiment, testing how buffers of different widths affect the demographic structure of two amphibian species at 11 ephemeral pools in a working forest of the northeastern U.S. We randomly assigned each pool to one of three treatments (i.e., reference, 100m buffer, 30m buffer) and clearcut to create buffers. We captured all spotted salamanders and wood frogs breeding in each pool and examined the impacts of treatment and hydroperiod on breeding-population abundance, sex ratio, and recapture rate. The negative effects of clearcutting tended to increase as forest-buffer width decreased and be strongest for salamanders and when other stressors were present (e.g., at short-hydroperiod pools). Recapture rates were reduced in the 30m, but not 100m, treatment. Throughout the experiment for frogs, and during the first year post-cut for salamanders, the predicted mean proportion of recaptured adults in the 30m treatment was only 62% and 40%, respectively, of that in the reference treatment. Frog sex ratio and abundance did not differ across treatments, but salamander sex ratios were increasingly male-biased in both cut treatments. By the final year, there were on average, only about 40% and 65% as many females predicted in the 100m and 30m treatments, respectively, compared to the first year. Breeding salamanders at short-hydroperiod pools were about 10% as abundant in the 100m versus reference treatment. Our study demonstrates that buffers partially mitigate the impacts of habitat disturbance on wetland-dependent amphibians, but buffer width and hydroperiod critically mediate that process. We provide the first experimental evidence showing that 30-m-wide buffers may be insufficient for maintaining resilient breeding populations of pool-dependent amphibians, at least during the first six years post-disturbance.	[Powell, Jessica S. Veysey; Babbitt, Kimberly J.] Univ New Hampshire, Dept Nat Resources & Environm, Durham, NH 03824 USA	University System Of New Hampshire; University of New Hampshire	Powell, JSV (corresponding author), Univ New Hampshire, Dept Nat Resources & Environm, Durham, NH 03824 USA.	jss4@unh.edu		Veysey Powell, Jessica/0000-0002-6706-9075	National Research Initiative of the USDA Cooperative State Research, Education, and Extension Service [2003-35101-12922, 2007-35101-18281]; Northeastern States Research Cooperative; Robert and Patricia Switzer Foundation; University of New Hampshire Graduate School; University of New Hampshire Cooperative Extension; New Hampshire Agricultural Experiment Station; USDA National Institute of Food and Agriculture McIntire-Stennis Project [0226124]	National Research Initiative of the USDA Cooperative State Research, Education, and Extension Service(United States Department of Agriculture (USDA)National Institute of Food and Agriculture); Northeastern States Research Cooperative; Robert and Patricia Switzer Foundation; University of New Hampshire Graduate School; University of New Hampshire Cooperative Extension; New Hampshire Agricultural Experiment Station; USDA National Institute of Food and Agriculture McIntire-Stennis Project	This work was supported by grants to KJB from the National Research Initiative of the USDA Cooperative State Research, Education, and Extension Service (http://www.csrees.usda.gov/funding/rfas/nri_rfa.html) grant numbers: 2003-35101-12922 and 2007-35101-18281; and the Northeastern States Research Cooperative (http://nsrcforest.org/). The project was also supported by fellowships to JSVP from the Robert and Patricia Switzer Foundation (http://www.switzernetwork.org/) the University of New Hampshire Graduate School (http://www.gradschool.unh.edu/), and the University of New Hampshire Cooperative Extension (http://extension.unh.edu/). Partial funding was provided by a grant to KJB from the New Hampshire Agricultural Experiment Station (http://www.colsa.unh.edu/aes). This is Scientific Contribution number: 2593. This work was also supported by the USDA National Institute of Food and Agriculture McIntire-Stennis Project, accession number: 0226124. These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler JH, 2007, VERMONT J ENV LAW, V56; [Anonymous], 2015, US DROUGHT MON; ARNOLD SJ, 1976, Z TIERPSYCHOL, V42, P247; Babbitt KJ, 2003, CAN J ZOOL, V81, P1539, DOI 10.1139/Z03-131; Bailey LL, 2004, ECOLOGY, V85, P2456, DOI 10.1890/03-0539; Baldwin RF, 2006, CAN J ZOOL, V84, P1604, DOI 10.1139/Z06-146; Baldwin RF, 2006, J HERPETOL, V40, P442, DOI 10.1670/0022-1511(2006)40[442:CPFASW]2.0.CO;2; Barber KN, 1997, GLCX1 NAT RES CAN CA; Bates D., 2011, PACKAGE LME4 LINEAR, V1; Bauer DM, 2010, ECOL APPL, V20, P798, DOI 10.1890/08-2209.1; BERVEN KA, 1981, EVOLUTION, V35, P707, DOI 10.1111/j.1558-5646.1981.tb04931.x; BERVEN KA, 1988, COPEIA, P605, DOI 10.2307/1445378; BERVEN KA, 1995, AUST J ECOL, V20, P385, DOI 10.1111/j.1442-9993.1995.tb00554.x; BERVEN KA, 1982, EVOLUTION, V36, P962, DOI 10.1111/j.1558-5646.1982.tb05466.x; BERVEN KA, 1990, EVOLUTION, V44, P2047, DOI 10.1111/j.1558-5646.1990.tb04310.x; BERVEN KA, 1990, ECOLOGY, V71, P1599, DOI 10.2307/1938295; Berven KA, 2009, COPEIA, P328, DOI 10.1643/CH-08-052; BLANCHARD FRANK N., 1933, COPEIA, V1933, P216, DOI 10.2307/1435562; Blaustein AR, 2002, ECOL LETT, V5, P597, DOI 10.1046/j.1461-0248.2002.00352.x; Broadmeadow S, 2004, HYDROL EARTH SYST SC, V8, P286, DOI 10.5194/hess-8-286-2004; Brodman R, 1996, COPEIA, P372, DOI 10.2307/1446853; BULL JJ, 1979, AM NAT, V114, P296, DOI 10.1086/283476; Calhoun A.J.K., 2002, FORESTRY HABITAT MAN; Caruso G, 2007, REG SCI URBAN ECON, V37, P542, DOI 10.1016/j.regsciurbeco.2007.01.005; CASTELLE AJ, 1994, J ENVIRON QUAL, V23, P878, DOI 10.2134/jeq1994.00472425002300050004x; Chase VP, 1997, BUFFERS WETLANDS SUR; Church DR, 2007, ECOLOGY, V88, P891, DOI 10.1890/06-0896; Cline BB, 2014, J APPL ECOL, V51, P319, DOI 10.1111/1365-2664.12197; Coster SS, 2013, THESIS U NEW HAMPSHI; Coster SS, HERPETOLOGI IN PRESS; Coster SS, 2015, MOL ECOL, V24, P742, DOI 10.1111/mec.13062; Cotton S, 2009, CONSERV BIOL, V23, P196, DOI 10.1111/j.1523-1739.2008.01053.x; Demaynadier PG, 1998, CONSERV BIOL, V12, P340, DOI 10.1046/j.1523-1739.1998.96412.x; Demaynadier Phillip G., 1995, Environmental Reviews, V3, P230, DOI 10.1139/a95-012; Dodd Jr C. K., 1994, MEASURING MONITORING, P125; Egan RS, 2004, WETLANDS, V24, P1, DOI 10.1672/0277-5212(2004)024[0001:WPAOBW]2.0.CO;2; ENGE KM, 1986, FOREST ECOL MANAG, V14, P177, DOI 10.1016/0378-1127(86)90116-7; Faccio SD, 2003, J HERPETOL, V37, P479, DOI 10.1670/155-02A; Ferner John W., 2010, P123; Finkler MS, 2013, COPEIA, P338, DOI 10.1643/CP-11-076; Finkler MS, 2003, COPEIA, P887, DOI 10.1643/h203-110.1; FLAGEOLE S, 1992, CAN J ZOOL, V70, P740, DOI 10.1139/z92-108; Freeman RC, 2012, WETLANDS, V32, P509, DOI 10.1007/s13157-012-0284-x; Freidenfelds NA, 2011, FOREST ECOL MANAG, V261, P2115, DOI 10.1016/j.foreco.2011.03.005; Gabrielsen CG, 2013, CONSERV GENET, V14, P1083, DOI 10.1007/s10592-013-0497-4; Gamble LR, 2006, WETLANDS, V26, P298, DOI 10.1672/0277-5212(2006)26[298:LORBZF]2.0.CO;2; Gervasi SS, 2008, FUNCT ECOL, V22, P100, DOI 10.1111/j.1365-2435.2007.01340.x; Goates MC, 2007, BIOL CONSERV, V138, P474, DOI 10.1016/j.biocon.2007.05.016; Graeter GJ, 2008, J WILDLIFE MANAGE, V72, P473, DOI 10.2193/2006-330; Grayson KL, 2012, FRONT ZOOL, V9, DOI 10.1186/1742-9994-9-24; Harper EB, 2008, CONSERV BIOL, V22, P1205, DOI 10.1111/j.1523-1739.2008.01015.x; Harper EB, 2007, OECOLOGIA, V153, P879, DOI 10.1007/s00442-007-0796-x; Harris RN, 2004, ECOLOGY, V85, P1585, DOI 10.1890/03-0492; Hector KL, 2012, J ANIM ECOL, V81, P583, DOI 10.1111/j.1365-2656.2011.01942.x; Heinen J. T., 2000, Journal of Environment & Development, V9, P45; Homan RN, 2007, J HERPETOL, V41, P401, DOI 10.1670/0022-1511(2007)41[401:CLHOTS]2.0.CO;2; Homan RN, 2003, J HERPETOL, V37, P617; HOWARD RD, 1985, EVOLUTION, V39, P260, DOI 10.1111/j.1558-5646.1985.tb05665.x; Husting E. L., 1965, Copeia, V1965, P352, DOI 10.2307/1440800; Johnston B, 2002, CAN J ZOOL, V80, P2170, DOI 10.1139/Z02-213; Kinkead KE, 2007, HERPETOLOGICA, V63, P151, DOI 10.1655/0018-0831(2007)63[151:ESSAAP]2.0.CO;2; Knapp SM, 2003, CONSERV BIOL, V17, P752, DOI 10.1046/j.1523-1739.2003.02061.x; Lee P, 2004, J ENVIRON MANAGE, V70, P165, DOI 10.1016/j.jenvman.2003.11.009; Lovell ST, 2006, AGR ECOSYST ENVIRON, V112, P249, DOI 10.1016/j.agee.2005.08.002; Madison DM, 1997, J HERPETOL, V31, P542, DOI 10.2307/1565607; Mangel M, 2005, AM NAT, V166, pE155, DOI 10.1086/444439; Marczak LB, 2010, ECOL APPL, V20, P126, DOI 10.1890/08-2064.1; Mayer PM, 2007, J ENVIRON QUAL, V36, P1172, DOI 10.2134/jeq2006.0462; McCarthy MA, 2004, J APPL ECOL, V41, P780, DOI 10.1111/j.0021-8901.2004.00919.x; McCarthy MA, 2009, J HERPETOL, V43, P394, DOI 10.1670/08-096R2.1; Miller A, 2001, THESIS N DAKOTA STAT; Montieth KE, 2006, J HERPETOL, V40, P195, DOI 10.1670/130-04A.1; Morey S, 2001, ECOLOGY, V82, P510, DOI 10.2307/2679876; Morrison C, 2003, J ANIM ECOL, V72, P270, DOI 10.1046/j.1365-2656.2003.00696.x; Parris KM, 2001, AMPHIBIA-REPTILIA, V22, P275, DOI 10.1163/156853801317050070; Parris MJ, 2005, AMPHIBIAN DECLINES: THE CONSERVATION STATUS OF UNITED STATES SPECIES, P526; Patrick DA, 2008, ECOLOGY, V89, P2563, DOI 10.1890/07-0906.1; Patrick DA, 2008, BIOL CONSERV, V141, P807, DOI 10.1016/j.biocon.2007.12.026; Pechmann J.H.K., 1989, Wetlands Ecology and Management, V1, P3; PECHMANN JHK, 1991, SCIENCE, V253, P892, DOI 10.1126/science.253.5022.892; Penman T. D., 2008, Endangered Species Research, V5, P45, DOI 10.3354/esr00111; Peterson CE, 2009, FOREST ECOL MANAG, V258, P409, DOI 10.1016/j.foreco.2008.12.029; Petranka JW, 2004, ECOL APPL, V14, P1065, DOI 10.1890/02-5394; Pinheiro J, 2001, MIXED EFFECTS MODELS; Popescu VD, 2012, FOREST ECOL MANAG, V270, P163, DOI 10.1016/j.foreco.2012.01.027; Popescu VD, 2011, ECOL APPL, V21, P1283, DOI 10.1890/10-0658.1; R Core Team, 2011, R LANG ENV STAT COMP; Regosin JV, 2005, J WILDLIFE MANAGE, V69, P1481, DOI 10.2193/0022-541X(2005)69[1481:VITHUB]2.0.CO;2; Regosin JV, 2004, COPEIA, P152, DOI 10.1643/CE-02-119R2; Regosin JV, 2003, CAN J ZOOL, V81, P596, DOI 10.1139/Z03-046; Regosin JV, 2003, J HERPETOL, V37, P390, DOI 10.1670/0022-1511(2003)037[0390:THUAWD]2.0.CO;2; Renken RB, 2004, CONSERV BIOL, V18, P174, DOI 10.1111/j.1523-1739.2004.00312.x; RIDEM Rhode Island Department of Environmental Management, 2010, RUL REG GOV ADM ENF; Riffell S, 2011, FOREST ECOL MANAG, V261, P878, DOI 10.1016/j.foreco.2010.12.021; Rittenhouse TAG, 2007, J HERPETOL, V41, P645, DOI 10.1670/07-015.1; Rittenhouse TAG, 2007, WETLANDS, V27, P153, DOI 10.1672/0277-5212(2007)27[153:DOAITH]2.0.CO;2; Rothermel BB, 2002, CONSERV BIOL, V16, P1324, DOI 10.1046/j.1523-1739.2002.01085.x; Rothermel BB, 2005, J HERPETOL, V39, P619, DOI 10.1670/251-04A.1; Savage WK, 2005, AMPHIBIAN DECLINES C, P621; Schulte LA, 2006, FOREST ECOL MANAG, V232, P1, DOI 10.1016/j.foreco.2006.05.009; Semlitsch RD, 2008, ECOL APPL, V18, P283, DOI 10.1890/07-0853.1; Semlitsch RD, 2008, J WILDLIFE MANAGE, V72, P260, DOI 10.2193/2007-082; Semlitsch RD, 2009, BIOSCIENCE, V59, P853, DOI 10.1525/bio.2009.59.10.7; SEMLITSCH RD, 1987, ECOLOGY, V68, P994, DOI 10.2307/1938370; SEMLITSCH RD, 1987, COPEIA, P61, DOI 10.2307/1446038; Semlitsch RD, 2000, J WILDLIFE MANAGE, V64, P615, DOI 10.2307/3802732; Semlitsch RD, 1998, CONSERV BIOL, V12, P1113, DOI 10.1046/j.1523-1739.1998.97274.x; Semlitsch RD, 2003, CONSERV BIOL, V17, P1219, DOI 10.1046/j.1523-1739.2003.02177.x; SEXTON OJ, 1990, COPEIA, P781, DOI 10.2307/1446443; Seymour RS, 2002, FOREST ECOL MANAG, V155, P357, DOI 10.1016/S0378-1127(01)00572-2; SHOOP CR, 1974, ECOLOGY, V55, P440, DOI 10.2307/1935233; Smith R., 2014, AMPHIBIAN CONSERVATI; SMITHGILL SJ, 1980, COPEIA, P723, DOI 10.2307/1444450; Stoffyn-Egli P, 2011, ENVIRON REV, V19, P479, DOI [10.1139/A11-019, 10.1139/a11-019]; Sztatecsny M, 2006, J ZOOL, V270, P517, DOI 10.1111/j.1469-7998.2006.00120.x; Tennessen JA, 2003, MOL ECOL, V12, P1567, DOI 10.1046/j.1365-294X.2003.01830.x; Thomas R., 2008, STATE WETLAND PROTEC; Tilghman JM, 2012, BIOL CONSERV, V152, P1, DOI 10.1016/j.biocon.2012.03.030; Todd BD, 2008, BIOL INVASIONS, V10, P539, DOI 10.1007/s10530-007-9150-9; Trenham PC, 2005, ECOL APPL, V15, P1158, DOI 10.1890/04-1150; Verrell PA, 1998, BEHAVIOUR, V135, P121, DOI 10.1163/156853998793066357; Veysey JS, 2011, LANDSCAPE ECOL, V26, P661, DOI 10.1007/s10980-011-9590-6; Veysey JS, 2009, BIOL CONSERV, V142, P2227, DOI 10.1016/j.biocon.2009.04.024; Veysey Powell JS, 2014, THESIS U NEW HAMPSHI; WILBUR HM, 1977, AM NAT, V111, P43, DOI 10.1086/283137; Willett TR, 2001, RESTOR ECOL, V9, P410, DOI 10.1046/j.1526-100X.2001.94010.x; Willson John D., 2010, P229; Windmiller Bryan, 2008, P41; WOODWARD BD, 1982, COPEIA, P157, DOI 10.2307/1444279	129	4	4	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0133642	10.1371/journal.pone.0133642	http://dx.doi.org/10.1371/journal.pone.0133642			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LZ	26196129	Green Published, gold, Green Submitted			2022-12-26	WOS:000358547600125
J	Craddock, TJA; Del Rosario, RR; Rice, M; Zysman, JP; Fletcher, MA; Klimas, NG; Broderick, G				Craddock, Travis J. A.; Del Rosario, Ryan R.; Rice, Mark; Zysman, Joel P.; Fletcher, Mary Ann; Klimas, Nancy G.; Broderick, Gordon			Achieving Remission in Gulf War Illness: A Simulation-Based Approach to Treatment Design	PLOS ONE			English	Article							PITUITARY-ADRENAL AXIS; GLUCOCORTICOID-RECEPTOR ANTAGONISTS; POSTTRAUMATIC-STRESS-DISORDER; IFN-GAMMA; MULTIPLE-SCLEROSIS; MUSCULOSKELETAL MANIFESTATIONS; ENDOCRINE DISORDERS; REGULATORY NETWORKS; ALZHEIMERS-DISEASE; ANTIBODIES	Gulf War Illness (GWI) is a chronic multi-symptom disorder affecting up to one-third of the 700,000 returning veterans of the 1991 Persian Gulf War and for which there is no known cure. GWI symptoms span several of the body's principal regulatory systems and include debilitating fatigue, severe musculoskeletal pain, cognitive and neurological problems. Using computational models, our group reported previously that GWI might be perpetuated at least in part by natural homeostatic regulation of the neuroendocrine-immune network. In this work, we attempt to harness these regulatory dynamics to identify treatment courses that might produce lasting remission. Towards this we apply a combinatorial optimization scheme to the Monte Carlo simulation of a discrete ternary logic model that represents combined hypothalamic-pituitary-adrenal (HPA), gonadal (HPG), and immune system regulation in males. In this work we found that no single intervention target allowed a robust return to normal homeostatic control. All combined interventions leading to a predicted remission involved an initial inhibition of Th1 inflammatory cytokines (Th1Cyt) followed by a subsequent inhibition of glucocorticoid receptor function (GR). These first two intervention events alone ended in stable and lasting return to the normal regulatory control in 40% of the simulated cases. Applying a second cycle of this combined treatment improved this predicted remission rate to 2 out of 3 simulated subjects (63%). These results suggest that in a complex illness such as GWI, a multi-tiered intervention strategy that formally accounts for regulatory dynamics may be required to reset neuroendocrine-immune homeostasis and support extended remission.	[Craddock, Travis J. A.; Del Rosario, Ryan R.; Rice, Mark; Fletcher, Mary Ann; Klimas, Nancy G.; Broderick, Gordon] Nova SE Univ, Inst Neuro Immune Med, Ft Lauderdale, FL 33314 USA; [Craddock, Travis J. A.; Broderick, Gordon] Nova SE Univ, Ctr Psychol Studies, Ft Lauderdale, FL 33314 USA; [Craddock, Travis J. A.] Nova SE Univ, Grad Sch Comp & Informat Sci, Ft Lauderdale, FL 33314 USA; [Craddock, Travis J. A.; Fletcher, Mary Ann; Klimas, Nancy G.; Broderick, Gordon] Nova SE Univ, Coll Osteopath Med, Ft Lauderdale, FL 33314 USA; [Zysman, Joel P.] Univ Miami, Ctr Computat Sci, Miami, FL USA; [Klimas, Nancy G.] Vet Affairs Med Ctr, Miami, FL 33125 USA; [Broderick, Gordon] Nova SE Univ, Coll Pharm, Ft Lauderdale, FL 33314 USA	Nova Southeastern University; Nova Southeastern University; Nova Southeastern University; Nova Southeastern University; University of Miami; US Department of Veterans Affairs; Veterans Health Administration (VHA); Nova Southeastern University	Craddock, TJA (corresponding author), Nova SE Univ, Inst Neuro Immune Med, Ft Lauderdale, FL 33314 USA.	tcraddock@nova.edu		Craddock, Travis/0000-0001-7244-6317	U.S. Department of Defense [W81XWH-10-1-0774, W81XWH-09-2-0071]; U.S. Department of Veterans Affairs	U.S. Department of Defense(United States Department of Defense); U.S. Department of Veterans Affairs(US Department of Veterans Affairs)	This work was funded under U.S. Department of Defense (CDMRP program cdmrp.army.mil) grant W81XWH-10-1-0774 (G. Broderick, PI) and grant W81XWH-09-2-0071 (N. Klimas, PI). Additional funding was received from the U.S. Department of Veterans Affairs (va.gov) (Merit Award, N. Klimas, PI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen JS, 2006, CLIN INFECT DIS, V43, P1, DOI 10.1086/504806; Amourette C, 2009, BEHAV BRAIN RES, V203, P207, DOI 10.1016/j.bbr.2009.05.002; Barbier L, 2009, BEHAV BRAIN RES, V197, P292, DOI 10.1016/j.bbr.2008.08.032; Ben-Zvi A, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000273; Bielekova B, 2010, NEUROLOGY, V74, pS31, DOI 10.1212/WNL.0b013e3181c97ed3; Boswell SB, 2014, CLIN IMAG, V38, P384, DOI 10.1016/j.clinimag.2014.02.014; Broderick G, 2013, BRAIN BEHAV IMMUN, V28, P159, DOI 10.1016/j.bbi.2012.11.007; Broderick G, 2011, BRAIN BEHAV IMMUN, V25, P302, DOI 10.1016/j.bbi.2010.10.011; Clark RD, 2008, CURR TOP MED CHEM, V8, P813, DOI 10.2174/156802608784535011; Craddock TJA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084839; Day J, 2006, J THEOR BIOL, V242, P237, DOI 10.1016/j.jtbi.2006.02.015; Dunn James P, 2004, Curr Opin Ophthalmol, V15, P293, DOI 10.1097/00055735-200408000-00003; Fritsch P, 2014, SYSTEMS BIOMED, V1, P0; Gaffen SL, 2004, CYTOKINE, V28, P109, DOI 10.1016/j.cyto.2004.06.010; Golier J, 2008, CONTROLLED TRIAL MIF; Golier J. A., 2012, DEPRESS RES TREAT, V2012, DOI DOI 10.1155/2012/393251; Golier JA, 2007, BIOL PSYCHIAT, V62, P1175, DOI 10.1016/j.biopsych.2007.04.027; Groeneweg FL, 2011, J ENDOCRINOL, V209, P153, DOI 10.1530/JOE-10-0472; Gupta S, 2007, THEOR BIOL MED MODEL, V4, DOI 10.1186/1742-4682-4-8; Harigai M, 2008, J IMMUNOL, V181, P2211, DOI 10.4049/jimmunol.181.3.2211; Healy DL, 2009, AUST PRESCR, V32, P152; Jacobs-Kosmin D, 2005, CURR OPIN RHEUMATOL, V17, P64, DOI 10.1097/01.bor.0000150950.43282.df; Kim SE, 2009, PHARMACOTHERAPY, V29, P227, DOI 10.1592/phco.29.2.227; Lamproglou I, 2009, BEHAV BRAIN RES, V197, P301, DOI 10.1016/j.bbr.2008.08.031; Lees JR, 2007, J CLIN INVEST, V117, P297, DOI 10.1172/JCI31254; Liscinsky M, 2012, FDA APPROVES KORLYM; Lupien SJ, 2009, NAT REV NEUROSCI, V10, P434, DOI 10.1038/nrn2639; Mendoza L, 2006, THEOR BIOL MED MODEL, V3, DOI 10.1186/1742-4682-3-13; Mikics E, 2004, PSYCHONEUROENDOCRINO, V29, P618, DOI 10.1016/S0306-4530(03)00090-8; Nicolson GL, 2000, CLIN PRACT ALTERN ME, V1, P92; Peeters BWMM, 2004, STRESS, V7, P233, DOI 10.1080/10253890400019672; Rankin J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030978; Rasmuson S, 2011, INT PSYCHOGERIATR, V23, P1386, DOI 10.1017/S1041610211000810; Research Advisory Committee on Gulf War Veterans' Illness (RAC-GWVI), 2008, GULF WAR ILLN HLTH G; Sigidin YA, 2001, SCAND J RHEUMATOL, V30, P203; Skowera A, 2004, J CLIN IMMUNOL, V24, P66, DOI 10.1023/B:JOCI.0000018065.64685.82; Skurkovich B, 2006, E SCHERING RES FDN W, V56, P1; Skurkovich S, 2001, MULT SCLER, V7, P277, DOI 10.1177/135245850100700502; Strittmatter M, 2005, SCHMERZ, V19, P109, DOI 10.1007/s00482-004-0330-6; Swanwick GRJ, 1998, AM J PSYCHIAT, V155, P286; Takemura S, 2001, J IMMUNOL, V167, P1072, DOI 10.4049/jimmunol.167.2.1072; Tennant F, 2013, PAIN THER, V2, P75, DOI 10.1007/s40122-013-0015-x; THOMAS R, 1991, J THEOR BIOL, V153, P1, DOI 10.1016/S0022-5193(05)80350-9; Vinther F, 2011, J MATH BIOL, V63, P663, DOI 10.1007/s00285-010-0384-2; Walker JJ, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001341; Walker JJ, 2010, P ROY SOC B-BIOL SCI, V277, P1627, DOI 10.1098/rspb.2009.2148; Weiner MW, 2011, MIL MED, V176, P896, DOI 10.7205/MILMED-D-10-00332; Whitley D, 2003, LECT NOTES COMPUT SC, V2724, P1469; Wilson CGM, 2011, CURR TOP MICROBIOL, V348, P25, DOI 10.1007/82_2010_93; Yeh S, 2008, J AUTOIMMUN, V31, P91, DOI 10.1016/j.jaut.2008.05.001; Zhang QW, 1999, CLIN DIAGN LAB IMMUN, V6, P6, DOI 10.1128/CDLI.6.1.6-13.1999	51	20	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2015	10	7							e0132774	10.1371/journal.pone.0132774	http://dx.doi.org/10.1371/journal.pone.0132774			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LN	26192591	Green Published, Green Submitted, gold			2022-12-26	WOS:000358546400038
J	Li, QW; Li, W; Wang, L; Wang, WD; Niu, SQ; Bi, XW; Wang, HY; Zhang, YJ				Li, Qiwen; Li, Wei; Wang, Liang; Wang, Weida; Niu, Shaoqing; Bi, Xiwen; Wang, Hanyu; Zhang, Yujing			Consolidation Radiotherapy in Stage IE- IIE, Non-Bulky Primary Gastric Diffuse Large B-Cell Lymphoma with Post-Chemotherapy Complete Remission	PLOS ONE			English	Article							NON-HODGKINS-LYMPHOMA; LOCALIZED AGGRESSIVE LYMPHOMA; INVOLVED-FIELD RADIOTHERAPY; CHOP PLUS RADIOTHERAPY; CLINICAL-FEATURES; ONCOLOGY-GROUP; CHEMOTHERAPY; SURGERY; TRIAL; EXPERIENCE	Background To investigate the effects of consolidation radiation in patients with stage IE-IIE, non-bulky primary gastric diffuse large B-cell lymphoma (DLBCL). Methods A cohort consisted of 71 consecutive patients with stage IE-IIE, non-bulky primary gastric DLBCL was retrospectively analyzed. All of them had been in complete remission after receiving at least four cycles of chemotherapy, containing rituximab or not. Consolidation radiation was delivered thereafter in 28 patients while other 43 received clinical observation only. Locoregional relapse-free survival (LRFS), disease-free survival (DFS), overall survival (OS) and distant metastasis-free survival (DMFS) were compared between patients with or without radiotherapy. Results The 10-year LRFS, DFS, OS and DMFS were 100% and 81.4%(p = 0.028), 91.7% and 77.1% (p = 0.14), 91.7% and 77.8% (p = 0.67), 91.7% and 78.0%(p = 0.42) for patients with or without radiotherapy. Conclusions Radiotherapy is associated with improved locoregional control of patients with early stage primary gastric DLBCL, who have achieved complete remission following at least four cycles of chemotherapy.	[Li, Qiwen; Wang, Hanyu; Zhang, Yujing] Sun Yat Sen Univ, Ctr Canc, Dept Radiat Oncol, State Key Lab Oncol South China, Guangzhou 510275, Guangdong, Peoples R China; [Li, Wei] Sun Yat Sen Univ, Ctr Canc, Dept Anesthesiol, State Key Lab Oncol South China, Guangzhou 510275, Guangdong, Peoples R China; [Wang, Liang; Wang, Weida] Sun Yat Sen Univ, Ctr Canc, Dept Hematol Oncol, State Key Lab Oncol South China, Guangzhou 510275, Guangdong, Peoples R China; [Niu, Shaoqing] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Radiat Oncol, Guangzhou 510275, Guangdong, Peoples R China; [Bi, Xiwen] Sun Yat Sen Univ, Ctr Canc, Dept Med Oncol, State Key Lab Oncol South China, Guangzhou 510275, Guangdong, Peoples R China	State Key Lab Oncology South China; Sun Yat Sen University; State Key Lab Oncology South China; Sun Yat Sen University; State Key Lab Oncology South China; Sun Yat Sen University; Sun Yat Sen University; State Key Lab Oncology South China; Sun Yat Sen University	Zhang, YJ (corresponding author), Sun Yat Sen Univ, Ctr Canc, Dept Radiat Oncol, State Key Lab Oncol South China, Guangzhou 510275, Guangdong, Peoples R China.	zhangyj@sysucc.org.cn	Wang, Weida/HGV-1933-2022					AMER MH, 1994, GASTROENTEROLOGY, V106, P846, DOI 10.1016/0016-5085(94)90742-0; Aviles A, 2004, ANN SURG, V240, P44, DOI 10.1097/01.sla.0000129354.31318.f1; Bonnet C, 2007, J CLIN ONCOL, V25, P787, DOI 10.1200/JCO.2006.07.0722; BROOKS JJ, 1983, CANCER, V51, P701, DOI 10.1002/1097-0142(19830215)51:4<701::AID-CNCR2820510425>3.0.CO;2-D; DAMORE F, 1994, J CLIN ONCOL, V12, P1673, DOI 10.1200/JCO.1994.12.8.1673; Ferreri AJM, 1999, LEUKEMIA LYMPHOMA, V33, P531, DOI 10.3109/10428199909058457; Fischbach W, 2011, Z GASTROENTEROL, V49, P430, DOI 10.1055/s-0029-1246012; Hans CP, 2004, BLOOD, V103, P275, DOI 10.1182/blood-2003-05-1545; HERRMANN R, 1980, CANCER, V46, P215, DOI 10.1002/1097-0142(19800701)46:1<215::AID-CNCR2820460136>3.0.CO;2-6; Horning SJ, 2004, J CLIN ONCOL, V22, P3032, DOI 10.1200/JCO.2004.06.088; Koch P, 2001, J CLIN ONCOL, V19, P3861, DOI 10.1200/JCO.2001.19.18.3861; Liu HT, 2000, AM J HEMATOL, V64, P175, DOI 10.1002/1096-8652(200007)64:3<175::AID-AJH6>3.3.CO;2-Z; Liu Hui, 2013, Zhonghua Wei Chang Wai Ke Za Zhi, V16, P36; Mafune K I, 2001, Gastric Cancer, V4, P137, DOI 10.1007/PL00011736; Martinelli G, 2009, LEUKEMIA LYMPHOMA, V50, P925, DOI 10.1080/10428190902912478; Mihaljevic B, 2006, MED ONCOL, V23, P225, DOI 10.1385/MO:23:2:225; Miller TP, 1998, NEW ENGL J MED, V339, P21, DOI 10.1056/NEJM199807023390104; Narita M, 1996, PATHOL INT, V46, P623, DOI 10.1111/j.1440-1827.1996.tb03664.x; Persky DO, 2008, J CLIN ONCOL, V26, P2258, DOI 10.1200/JCO.2007.13.6929; Pfreundschuh M, 2011, LANCET ONCOL, V12, P1013, DOI 10.1016/S1470-2045(11)70235-2; Phan Jack, 2010, J Clin Oncol, V28, P4170, DOI 10.1200/JCO.2009.27.3441; Reyes F, 2005, NEW ENGL J MED, V352, P1197, DOI 10.1056/NEJMoa042040; Sbitti Y, 2010, J HEMATOL ONCOL, V3, DOI 10.1186/1756-8722-3-23; Shenkier TN, 2002, J CLIN ONCOL, V20, P197, DOI 10.1200/JCO.20.1.197	24	4	5	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2015	10	7							e0133469	10.1371/journal.pone.0133469	http://dx.doi.org/10.1371/journal.pone.0133469			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LN	26193661	gold, Green Published, Green Submitted			2022-12-26	WOS:000358546400092
J	Adinan, J; Damian, DJ; Msuya, SE				Adinan, Juma; Damian, Damian J.; Msuya, Sia E.			Factors Associated with Testing and Prompt Use of Recommended Antimalarials following Malaria Diagnosis: A Secondary Analysis of 2011-12 Tanzania HIV and Malaria Indicator Survey Data	PLOS ONE			English	Article							CASE-MANAGEMENT; FEVER; FACILITIES; DISTRICTS; BEHAVIOR; CHILDREN; QUALITY	Introduction Malaria is still a public health problem in Sub-Saharan Africa. Malaria causes mortality mostly in children under-five years. Early detection and prompt treatment using recommended antimalarials is key to malaria control. However, in Tanzania, contrary to the national goals, a large proportion of children with fever taken to health facilities are not tested for malaria and those tested positive are not promptly treated using recommended antimalarials. The aim of this study was to determine factors associated with malaria testing and prompt use of recommended antimalarials among under-five children with fever in Tanzania. Methods This was a secondary analysis of Tanzania HIV and Malaria Indicator Survey (THMIS) data 2011-12 obtained from a national cross sectional survey. The analysis involved children aged 6-59 months whose mothers reported they had fever two weeks preceding the survey. Factors associated with testing and uses of recommended antimalarials were obtained using logistic regression. Results Of the 1675 under-five children with fever, 951 (56.8%) were taken to the health facilities. Of the 951 children, only 394 (41.48%) febrile children were tested for malaria. Of those tested, 291 (78.91%) were diagnosed with malaria. Of those diagnosed with malaria, only 124 (42.68%) children used recommended antimalarials within 1st 24 hours of diagnosis. In multivariate analysis, children taken to health centers (OR 1.79; 95%CI: 1.07-3.00) and to the hospitals (OR 3.4; 95%CI: 1.75-6.77) had higher odds of being tested compared to those taken to dispensary and other lower level health facilities. Children were more likely to use recommended antimalarial promptly if they had a caretaker with secondary or higher education (OR: 4.07; 95%CI: 0.61-2.68) or living in the rural area (OR: 3.21; 95%CI: 1.09-9.44) compared to those with an uneducated caretaker or from an urban area. Conclusion Training on malaria testing and treatment guidelines should be provided, and preventing stock outs of malaria testing kits and medications at dispensary level should be made available as it is the first point of health care for most Tanzanians. Reasons on why urban people are less likely to use recommended antimalarials need to be investigated and addressed for proper malaria management.	[Adinan, Juma; Damian, Damian J.; Msuya, Sia E.] Kilimanjaro Christian Med Univ Coll KCMU Co, Inst Publ Hlth, Dept Epidemiol & Biostat, Moshi, Tanzania; [Adinan, Juma; Damian, Damian J.; Msuya, Sia E.] Kilimanjaro Christian Med Univ Coll KCMU Co, Inst Publ Hlth, Dept Community Hlth, Moshi, Tanzania; [Adinan, Juma; Damian, Damian J.; Msuya, Sia E.] KCMC Hosp, Dept Community Hlth, Moshi, Tanzania; [Adinan, Juma] KCMC Hosp, Gen Teaching Coll, AMO, Moshi, Tanzania		Adinan, J (corresponding author), Kilimanjaro Christian Med Univ Coll KCMU Co, Inst Publ Hlth, Dept Epidemiol & Biostat, Moshi, Tanzania.	adinanjuma@gmail.com	Adinan, Juma/N-8259-2015	Adinan, Juma/0000-0002-7964-2879				[Anonymous], 2012, TANZANIA HIV AIDS MA; Bryce J, 2014, FULFILLING HLTH AGEN; Chanda-Kapata Pascalina, 2014, Asian Pacific Journal of Tropical Biomedicine, V4, P498, DOI 10.12980/APJTB.4.2014C153; Chandler CIR, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-53; Comoe CC, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-1089; Derua YA, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-78; Elmardi KA, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-128; Getahun A, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-320; Hetzel MW, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-317; Juma E, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-1; Kahabuka C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058789; Kyabayinze DJ, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-200; Leslie T, 2012, BMJ-BRIT MED J, V345, P5; Littrell M, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-327; Masanja IM, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-221; Ministry of Health and Social Welfare, 2007, UN REP TANZ MIN HLTH, P2007; Ministry of Health and Social Welfare, 2013, MIDT REV HLTH SECT S; Ministry of Health and Social Welfare (MoHSW), TANZ SERV AV READ AS; Ministry of Health and Social Welfare (Tanzania), 2011, NAT GUID DIAGN TREAT, V11; Mubi M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019753; Mukanga D, 2012, AM J TROP MED HYG, V87, P21, DOI 10.4269/ajtmh.2012.11-0816; Reyburn H, 2004, BMJ-BRIT MED J, V329, P1212, DOI 10.1136/bmj.38251.658229.55; Reyburn H, 2007, BMJ-BRIT MED J, V2007, DOI [10.1136/bmj.39073.496829, DOI 10.1136/BMJ.39073.496829]; Simba DO, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012104; Smith LA, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-333; Sserwanga A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016316; Thiam S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018419; WHO, WORLD MAL REP 2013; WHO, MAL UPD 2014; WHO, 2010, GUID TREATM MAL, V2nd	30	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0132964	10.1371/journal.pone.0132964	http://dx.doi.org/10.1371/journal.pone.0132964			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RV	26186547	gold, Green Published, Green Submitted			2022-12-26	WOS:000358198700077
J	Chang, YC; Wu, CC; Lin, CH; Wu, YW; Yang, YC; Chang, TJ; Jiang, YD; Chuang, LM				Chang, Yi-Cheng; Wu, Chau-Chung; Lin, Chih-Hung; Wu, Yen-Wen; Yang, Ying-Chieh; Chang, Tien-Jyun; Jiang, Yi-Der; Chuang, Lee-Ming			Early Myocardial Repolarization Heterogeneity Is Detected by Magnetocardiography in Diabetic Patients with Cardiovascular Risk Factors	PLOS ONE			English	Article							CORONARY-ARTERY-DISEASE; QT DISPERSION; METABOLIC SYNDROME; VENTRICULAR REPOLARIZATION; CARDIAC DEATH; ALL-CAUSE; DIAGNOSIS; INFARCTION; MORTALITY; INTERVAL	Multi-channel magnetocardiography (MCG) is a sensitive technique to map spatial ventricular repolarization with high resolution and reproducibility. Spatial ventricular repolarization heterogeneity measured by MCG has been shown to accurately detect and localize myocardial ischemia. Here, we explored whether these measurements correlated with cardiovascular risk factors in patients with type 2 diabetes. Two hundreds and seventy-seven type 2 diabetic patients without known coronary artery disease (CAD) and arrhythmia were recruited consecutively from the outpatient clinic of National Taiwan University Hospital. The spatially distributed QTc contour maps were constructed with 64-channel MCG using the superconducting quantum interference device (SQUID) system. Indices of myocardial repolarization heterogeneity including the smoothness index of QTc (SI-QTc) and QTc dispersion were derived and analyzed for association with conventional cardiovascular risk factors. SI-QTc correlated strongly with the QTc dispersion (r = 0.70, p < 0.0001). SI-QTc was significantly higher in patients with presence of metabolic syndrome in comparison to those without metabolic syndrome (8.56 vs. 7.96 ms, p = 0.02). In univariate correlation analyses, QTc dispersion was associated with smoking status (average 79.90, 83.83, 86.51, and 86.00 ms for never smokers, ex-smokers, current smokers reporting less than 10 cigarettes daily, and current smoker reporting more than 10 cigarettes daily, respectively, p = 0.03), body weight (r = 0.15, p = 0.01), and hemoglobin A1c (r = 0.12, p = 0.04). In step-wise multivariate regression analyses, QTc dispersion was associated with smoking (p = 0.02), body weight (p = 0.04), total cholesterol levels (p = 0.05), and possibly estimated glomerular filtration rate (p = 0.07). In summary, spatial heterogeneity of myocardial repolarization measured by MCG is positively associated cardiovascular risk factors including adiposity, smoking, and total cholesterol levels.	[Chang, Yi-Cheng] Natl Taiwan Univ, Grad Inst Med Genom & Prote, Taipei 10764, Taiwan; [Chang, Yi-Cheng; Yang, Ying-Chieh] Natl Taiwan Univ, Dept Internal Med, HsinChu Branch, Hsinchu, Taiwan; [Chang, Yi-Cheng; Wu, Chau-Chung; Wu, Yen-Wen; Chang, Tien-Jyun; Jiang, Yi-Der; Chuang, Lee-Ming] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan; [Chang, Yi-Cheng; Chang, Tien-Jyun; Jiang, Yi-Der; Chuang, Lee-Ming] Natl Taiwan Univ, Coll Med, Dept Med, Taipei 10764, Taiwan; [Wu, Chau-Chung] Natl Taiwan Univ, Coll Med, Dept Primary Care Med, Taipei 10764, Taiwan; [Lin, Chih-Hung] Taipei Med Univ Hosp, Dept Internal Med, Taipei, Taiwan; [Wu, Yen-Wen] Far Eastern Mem Hosp, Cardiovasc Med Ctr, Dept Nucl Med, New Taipei City, Taiwan; [Wu, Yen-Wen] Far Eastern Mem Hosp, Cardiovasc Med Ctr, Div Cardiol, New Taipei City, Taiwan; [Wu, Yen-Wen] Natl Taiwan Univ Hosp, Dept Nucl Med, Taipei, Taiwan; [Wu, Yen-Wen] Natl Yang Ming Univ, Sch Med, Taipei 112, Taiwan; [Chuang, Lee-Ming] Natl Taiwan Univ, Coll Publ Hlth, Inst Prevent Med, Taipei 10764, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University; Taipei Medical University; Taipei Medical University Hospital; Far Eastern Memorial Hospital; Far Eastern Memorial Hospital; National Taiwan University; National Taiwan University Hospital; National Yang Ming Chiao Tung University; National Taiwan University	Chuang, LM (corresponding author), Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan.	leeming@ntu.edu.tw	Chuang, Lee-Ming/AAF-3324-2019; Chang, Yi-cheng/O-1334-2018	Chang, Yi-cheng/0000-0002-8077-5011; CHUANG, LEE-MING/0000-0003-0978-2662; WU, YEN-WEN/0000-0003-1520-1166; CHANG, TIEN-JYUN/0000-0001-9437-5847; YANG, YING-CHIEH/0000-0003-1599-635X	National Science Council, Executive Yuan, Taipei, Taiwan [99-2314-B-002-141-MY3]; Diabetes Research Fund of the National Taiwan University Hospital, Taipei, Taiwan	National Science Council, Executive Yuan, Taipei, Taiwan(Ministry of Science and Technology, Taiwan); Diabetes Research Fund of the National Taiwan University Hospital, Taipei, Taiwan	This work was supported by National Science Council (99-2314-B-002-141-MY3), Executive Yuan, Taipei, Taiwan and the Diabetes Research Fund of the National Taiwan University Hospital, Taipei, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal R, 2012, ANN NONINVAS ELECTRO, V17, P291, DOI 10.1111/j.1542-474X.2012.00538.x; Antzelevitch C, 2006, J INTERN MED, V259, P48, DOI 10.1111/j.1365-2796.2005.01587.x; BARRY J, 1989, JAMA-J AM MED ASSOC, V261, P398, DOI 10.1001/jama.261.3.398; Bonow RO, 2011, BRAUNWALDS HEART DIS; Chen CA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086524; Coumel P, 1998, CIRCULATION, V97, P2491, DOI 10.1161/01.CIR.97.25.2491; Dilaveris P, 2001, AM HEART J, V142, P833, DOI 10.1067/mhj.2001.118737; Fenici R, 2005, EXPERT REV MOL DIAGN, V5, P291, DOI 10.1586/14737159.5.3.291; Girola A, 2001, OBES RES, V9, P71, DOI 10.1038/oby.2001.9; Grundy SM, 2005, CIRCULATION, V112, P2735, DOI 10.1161/CIRCULATIONAHA.105.169404; Gupta Anoop K, 2002, Indian Heart J, V54, P399; Haddock RE, 2011, J PHYSIOL-LONDON, V589, P3289, DOI 10.1113/jphysiol.2011.207944; Hailer B, 2004, Neurol Clin Neurophysiol, V2004, P82; International Diabetes Federation (IDF), IDF CONS WORLDW DEF; IOANNIDIS PJ, 1973, CARDIOLOGY, V58, P139, DOI 10.1159/000169628; Iribarren C, 2006, J AM COLL CARDIOL, V48, P1800, DOI 10.1016/j.jacc.2006.03.070; Kwon H, 2010, CIRC J, V74, P1424, DOI 10.1253/circj.CJ-09-0975; Kwong JSW, 2013, INT J CARDIOL, V167, P1835, DOI 10.1016/j.ijcard.2012.12.056; Levey AS, 2006, ANN INTERN MED, V145, P247, DOI 10.7326/0003-4819-145-4-200608150-00004; Liehr M, 2005, ANN BIOMED ENG, V33, P240, DOI 10.1007/s10439-005-8983-6; Lim HK, 2009, AM J CARDIOL, V103, P448, DOI 10.1016/j.amjcard.2008.10.013; Liu YB, 2003, CIRC RES, V92, P1145, DOI 10.1161/01.RES.0000072999.51484.92; Malik M, 2000, J CARDIOVASC ELECTR, V11, P835, DOI 10.1111/j.1540-8167.2000.tb00061.x; Malik M, 2000, J AM COLL CARDIOL, V36, P1749, DOI 10.1016/S0735-1097(00)00962-1; Marfella R, 2001, AM J CLIN NUTR, V73, P27; Marroquin OC, 2004, CIRCULATION, V109, P714, DOI 10.1161/01.CIR.0000115517.26897.A7; Mshui ME, 1999, P SOC EXP BIOL MED, V220, P133, DOI 10.1046/j.1525-1373.1999.d01-20.x; Naas AAO, 1998, BRIT MED J, V316, P745, DOI 10.1136/bmj.316.7133.745; Nam HK, 2003, CIRC J, V33, P58; Nenonen J, 1996, BIOMEDICAL LIFE PHYS; Oikarinen L, 1998, PACE, V21, P1934, DOI 10.1111/j.1540-8159.1998.tb00013.x; Okin PM, 2000, CIRCULATION, V101, P61, DOI 10.1161/01.CIR.101.1.61; Okin PM, 2004, DIABETES, V53, P434, DOI 10.2337/diabetes.53.2.434; Peng TI, 2010, ANN NY ACAD SCI, V1201, P183, DOI 10.1111/j.1749-6632.2010.05634.x; Sahu P, 2000, QJM-MON J ASSOC PHYS, V93, P425, DOI 10.1093/qjmed/93.7.425; Seyfeli E, 2006, INT J OBESITY, V30, P957, DOI 10.1038/sj.ijo.0803233; Soydinc S, 2006, ANN NONINVAS ELECTRO, V11, P313, DOI 10.1111/j.1542-474X.2006.00123.x; Stroink G, 1999, PACE, V22, P1718, DOI 10.1111/j.1540-8159.1999.tb00403.x; Tsukada K, 2000, INT J CARDIAC IMAG, V16, P55, DOI 10.1023/A:1006376326755; VANCAPELLE FJL, 1980, CIRC RES, V47, P454, DOI 10.1161/01.RES.47.3.454; VEMURI R, 1988, BIOCHIM BIOPHYS ACTA, V937, P258, DOI 10.1016/0005-2736(88)90248-9; Wu CC, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2433036; Wu YW, 2014, ACTA CARDIOL SIN, V30, P445; Wu YW, 2013, CIRC J, V77, P1783, DOI 10.1253/circj.CJ-12-1170; Zabel M, 1998, CIRCULATION, V97, P2543, DOI 10.1161/01.CIR.97.25.2543; Zabel M, 2001, J ELECTROCARDIOL, V34, P27, DOI 10.1054/jelc.2001.28822	46	3	4	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0133192	10.1371/journal.pone.0133192	http://dx.doi.org/10.1371/journal.pone.0133192			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RV	26185995	Green Published, Green Submitted, gold			2022-12-26	WOS:000358198700105
J	Sasada, T; Hinoi, T; Saito, Y; Adachi, T; Takakura, Y; Kawaguchi, Y; Sotomaru, Y; Sentani, K; Oue, N; Yasui, W; Ohdan, H				Sasada, Tatsunari; Hinoi, Takao; Saito, Yasufumi; Adachi, Tomohiro; Takakura, Yuji; Kawaguchi, Yasuo; Sotomaru, Yusuke; Sentani, Kazuhiro; Oue, Naohide; Yasui, Wataru; Ohdan, Hideki			Chlorinated Water Modulates the Development of Colorectal Tumors with Chromosomal Instability and Gut Microbiota in Apc-Deficient Mice	PLOS ONE			English	Article							MULTIPLE INTESTINAL NEOPLASIA; DRINKING-WATER; MICROSATELLITE INSTABILITY; COMMENSAL BACTERIA; REPEAT MARKERS; BY-PRODUCTS; CANCER; MUTATION; EXPRESSION; RECEPTOR	The gastrointestinal tract is continuously exposed to a variety of chemicals and commensal bacteria. Recent studies have shown that changes in gut microbial populations caused by chlorine or other chemicals in the drinking water influence the development of human colorectal cancer, although the mechanism of tumorigenesis in the gut epithelium is obfuscated by the diversity of microflora and complexity of the tumor microenvironment. In this regard, mouse models that recapitulate human colorectal cancer are an invaluable tool. In this study, we used two conditional adenomatous polyposis coli (Apc) knockout mouse models to investigate the effect of chlorinated water on tumorigenesis in the digestive tract. Mice with colon-specific carcinoma-caused by either chromosomal (CDX2P9.5-NLS Cre; Apc(+/flox), abbreviated to CPC;Apc) or microsatellite (CDX2P9.5-G19Cre;Apc(flox/flox) and CDX2P9.5-G22Cre;Apc(flox/flox)) instability, respectively-were administered chlorinated (10.0 mg/L chlorine) or tap (0.7 mg/L chlorine) water and evaluated for colon polyp formation. In CPC; Apc mice given chlorinated drinking water, tumors tended to develop in the colon, whereas in those that drank tap water, tumors were mostly observed in the small intestine. There was no difference in the rate of tumor formation of CDX2P9.5-G19Cre;Apc(flox/flox) and CDX2P9.5-G22Cre;Apc(flox/flox) mice consuming chlorinated as compared to tap water, suggesting that microsatellite instability in the Apc gene does not significantly affect tumorigenesis. Chlorinated water altered the enteric environment by reducing the fecal populations of the obligatory anaerobes Clostridium perfringens and C. difficile, as well as species belonging to the Atopobiumcluster, including Enterobacteriaceae and Staphylococcus sp., which was associated with colon tumorigenesis in CPC;Apcmice. These results suggest that differences in tumorigenesis among CPC; Apc mice consuming chlorinated versus tap water may be due to differences in gastrointestinal commensal populations.	[Sasada, Tatsunari; Hinoi, Takao; Saito, Yasufumi; Adachi, Tomohiro; Takakura, Yuji; Kawaguchi, Yasuo; Ohdan, Hideki] Hiroshima Univ, Inst Biomed & Hlth Sci, Appl Life Sci, Dept Gastroenterol & Transplant Surg, Hiroshima, Japan; [Sotomaru, Yusuke] Hiroshima Univ, Nat Sci Ctr Basic Res & Dev, Hiroshima, Japan; [Sentani, Kazuhiro; Oue, Naohide; Yasui, Wataru] Hiroshima Univ, Inst Biomed & Hlth Sci, Dept Mol Pathol, Hiroshima, Japan	Hiroshima University; Hiroshima University; Hiroshima University	Hinoi, T (corresponding author), Hiroshima Univ, Inst Biomed & Hlth Sci, Appl Life Sci, Dept Gastroenterol & Transplant Surg, Hiroshima, Japan.	thinoi@hiroshima-u.ac.jp	Sotomaru, Yusuke/G-5508-2019; Ohdan, Hideki/G-4719-2019; Hinoi, Takao/AAI-1443-2020	Ohdan, Hideki/0000-0002-9066-1288; Hinoi, Takao/0000-0003-0462-6177	JSPS [22390257]; Japanese Society of Gastroenterology; Japan Science and Technology Agency (JST) [AS231Z04862F]	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japanese Society of Gastroenterology(Japanese Society of Gastroenterology); Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST))	This work was supported by JSPS KAKENHI Grant-in-Aid for Scientific Research (B) (http://www.jsps.go.jp/j-grantsinaid/)(Grant Number 22390257) TH, and The Japanese Society of Gastroenterology (http://www.jsge.or.jp/english/english.html) Grant-in-Aid 2010 TH, and Japan Science and Technology Agency (JST) A-STEP (http://www.jst.go.jp/)(Grant Number AS231Z04862F) TH.	Akyol A, 2008, NAT METHODS, V5, P231, DOI 10.1038/NMETH.1182; Albuquerque C, 2010, GENE CHROMOSOME CANC, V49, P746, DOI 10.1002/gcc.20786; Arnold CN, 2005, CANCER-AM CANCER SOC, V104, P2035, DOI 10.1002/cncr.21462; Bacher JW, 2005, MOL CARCINOGEN, V44, P285, DOI 10.1002/mc.20146; Boland CR, 2010, GASTROENTEROLOGY, V138, P2073, DOI [10.1053/j.gastro.2009.12.064, 10.1053/j.gastro.2010.04.024]; Boorman GA, 1999, ENVIRON HEALTH PERSP, V107, P207, DOI 10.2307/3434484; CRUMP KS, 1982, ANNU REV PUBL HEALTH, V3, P339, DOI 10.1146/annurev.pu.03.050182.002011; Doyle TJ, 1997, AM J PUBLIC HEALTH, V87, P1168, DOI 10.2105/AJPH.87.7.1168; Edelmann W, 1996, CELL, V85, P1125, DOI 10.1016/S0092-8674(00)81312-4; Edelmann W, 1997, CELL, V91, P467, DOI 10.1016/S0092-8674(00)80433-X; Engle SJ, 2002, CANCER RES, V62, P6362; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; Grivennikov SI, 2012, NATURE, V491, P254, DOI 10.1038/nature11465; Hinoi T, 2007, CANCER RES, V67, P9721, DOI 10.1158/0008-5472.CAN-07-2735; HOMBERGER FR, 1993, LAB ANIM SCI, V43, P635; IONOV Y, 1993, NATURE, V363, P558, DOI 10.1038/363558a0; Jansen GJ, 1999, J MICROBIOL METH, V37, P215, DOI 10.1016/S0167-7012(99)00049-4; Jeon Min Kyung, 2013, World J Gastrointest Pathophysiol, V4, P94, DOI 10.4291/wjgp.v4.i4.94; Kabbarah O, 2003, MOL CARCINOGEN, V38, P155, DOI 10.1002/mc.10157; Kado S, 2001, CANCER RES, V61, P2395; Kanno T, 2009, BIOCHEM BIOPH RES CO, V381, P666, DOI 10.1016/j.bbrc.2009.02.109; Kinzler KW, 1996, CELL, V87, P159, DOI 10.1016/S0092-8674(00)81333-1; Koivusalo M, 1997, CANCER CAUSE CONTROL, V8, P192, DOI 10.1023/A:1018420229802; Lemercier C, 2015, CELL MOL LIFE SCI, V72, P2665, DOI 10.1007/s00018-015-1900-8; Louis P, 2014, NAT REV MICROBIOL, V12, P661, DOI 10.1038/nrmicro3344; Matsuda K, 2007, APPL ENVIRON MICROB, V73, P32, DOI 10.1128/AEM.01224-06; Matsuda K, 2009, APPL ENVIRON MICROB, V75, P1961, DOI 10.1128/AEM.01843-08; MOSER AR, 1990, SCIENCE, V247, P322, DOI 10.1126/science.2296722; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Nougayrede JP, 2006, SCIENCE, V313, P848, DOI 10.1126/science.1127059; Ohara T, 2010, HEPATO-GASTROENTEROL, V57, P1411; Ohtani N, 2015, SEMIN IMMUNOPATHOL, V37, P65, DOI 10.1007/s00281-014-0457-1; REITMAIR AH, 1995, NAT GENET, V11, P64, DOI 10.1038/ng0995-64; SAVAGE DC, 1977, ANNU REV MICROBIOL, V31, P107, DOI 10.1146/annurev.mi.31.100177.000543; Science NRCoNAo, 2011, GUIDE FOR THE CARE A; Shibata H, 1997, SCIENCE, V278, P120, DOI 10.1126/science.278.5335.120; Shoemaker AR, 1997, BBA-REV CANCER, V1332, pF25, DOI 10.1016/S0304-419X(96)00041-8; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; SU LK, 1992, SCIENCE, V256, P668, DOI 10.1126/science.1350108; Thorstensen L, 2005, NEOPLASIA, V7, P99, DOI 10.1593/neo.04448; Umar A, 2004, J NATL CANCER I, V96, P261, DOI 10.1093/jnci/djh034; Wang KP, 2014, IMMUNITY, V41, P1052, DOI 10.1016/j.immuni.2014.11.009; Wang XM, 2007, GASTROENTEROLOGY, V132, P551, DOI 10.1053/j.gastro.2006.11.040; Wang XM, 2015, GUT, V64, P459, DOI 10.1136/gutjnl-2014-307213; WHO, GUIDELINES FOR DRINK; Yang GZ, 2004, CANCER CELL, V6, P139, DOI 10.1016/j.ccr.2004.06.024; Yao Q, 2010, BIOCHEM BIOPH RES CO, V398, P413, DOI 10.1016/j.bbrc.2010.06.089; Yao X, 1999, P NATL ACAD SCI USA, V96, P6850, DOI 10.1073/pnas.96.12.6850	48	27	27	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0132435	10.1371/journal.pone.0132435	http://dx.doi.org/10.1371/journal.pone.0132435			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RV	26186212	Green Published, gold, Green Submitted			2022-12-26	WOS:000358198700042
J	Soares, LASS; Faria, D; Velez-Garcia, F; Vieira, EM; Talora, DC; Cazetta, E				Soares, Leiza Aparecida S. S.; Faria, Deborah; Velez-Garcia, Felipe; Vieira, Emerson M.; Talora, Daniela C.; Cazetta, Eliana			Implications of Habitat Loss on Seed Predation and Early Recruitment of a Keystone Palm in Anthropogenic Landscapes in the Brazilian Atlantic Rainforest	PLOS ONE			English	Article							EUTERPE-EDULIS; SOUTHERN BAHIA; FRAGMENTATION; DISPERSAL; GERMINATION; EXTINCTION; SURVIVAL; CONNECTIVITY; COVER; BIRDS	Habitat loss is the main driver of the loss of global biodiversity. Knowledge on this subject, however, is highly concentrated on species richness and composition patterns, with little discussion on the consequences of habitat loss for ecological interactions. Therefore, a systemic approach is necessary to maximize the success of conservation efforts by providing more realistic information about the effects of anthropogenic disturbances on natural environmental processes. We investigated the implications of habitat loss for the early recruitment of Euterpe edulis Martius, a keystone palm in the Brazilian Atlantic Forest, in nine sampling sites located in landscapes with different percentages of forest cover (9%-83%). We conducted a paired experiment using E. Edulis seeds set up in experimental stations composed of a vertebrate exclosure versus an open treatment. We used ANCOVA models with treatments as factors to assess the influence of habitat loss on the number of germinated seeds, predation by vertebrates and invertebrates, infestation by fungi, and number of seedlings established. Habitat loss did not affect the probability of transition from a dispersed to a germinated seed. However, when seeds were protected from vertebrate removal, seedling recruitment showed a positive relationship with the amount of forest cover. Seed infestation by fungi was not significant, and seed predation was the main factor limiting seed recruitment. The loss of forest cover antagonistically affected the patterns of seed predation by vertebrates and invertebrates; predation by invertebrates was higher in less forested areas, and predation by vertebrates was higher in forested areas. When seeds were exposed to the action of all biotic mortality factors, the number of recruited seedlings was very low and unrelated to habitat loss. This result indicates that the opposite effects of seed predation by vertebrates and invertebrates mask a differential response of E. edulis recruitment to habitat loss.	[Soares, Leiza Aparecida S. S.; Faria, Deborah; Velez-Garcia, Felipe; Talora, Daniela C.; Cazetta, Eliana] Univ Estadual Santa Cruz, Programa Posgrad Ecol & Conservacao Biodiversidad, Lab Ecol Aplicada Conservacao, Ilheus, Bahia, Brazil; [Vieira, Emerson M.] Univ Brasilia, Dept Ecol, Inst Ciencias Biol, Lab Ecol Vertebrados, Brasilia, DF, Brazil	Universidade Estadual de Santa Cruz; Universidade de Brasilia	Cazetta, E (corresponding author), Univ Estadual Santa Cruz, Programa Posgrad Ecol & Conservacao Biodiversidad, Lab Ecol Aplicada Conservacao, Ilheus, Bahia, Brazil.	eliana.cazetta@gmail.com	Faria, Deborah/F-2879-2010; Cazetta, Eliana/K-1880-2019; Cazetta, Eliana/F-3296-2010; Vieira, Emerson Monteiro/F-3562-2010; faria, deborah/ABC-2757-2021	Faria, Deborah/0000-0002-0375-2887; Cazetta, Eliana/0000-0002-2209-2554; Cazetta, Eliana/0000-0002-2209-2554; Vieira, Emerson Monteiro/0000-0003-3488-621X; faria, deborah/0000-0002-0375-2887	Brazilian Council of Science and Technology (CNPq) [Proc. 563216/2010-7]; Universidade Estadual de Santa Cruz [PROPP 00220.1100.1198]; FAPESB [BOL0303/2012, BOL08488/2012]; CNPq [307221/2012-1, 305981/2010-2]	Brazilian Council of Science and Technology (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Universidade Estadual de Santa Cruz; FAPESB(Fundacao de Amparo a Pesquisa do Estado da Bahia (FAPESB)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	The present study is a publication of REDE SISBIOTA, funded by the Brazilian Council of Science and Technology (CNPq Proc. 563216/2010-7) and with additional funding from Universidade Estadual de Santa Cruz (PROPP 00220.1100.1198). LSS and FVG received FAPESB fellowships (BOL0303/2012 and BOL08488/2012, respectively), and DF and EMV were granted CNPq fellowships ('Research Productivity' Grants 307221/2012-1 and 305981/2010-2, respectively). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, ATL REM FLOR MAT ATL; Antongiovanni M, 2005, BIOL CONSERV, V122, P441, DOI 10.1016/j.biocon.2004.09.005; Arroyo-Rodriguez V, 2014, AM J PRIMATOL, V76, P901, DOI 10.1002/ajp.22282; Arroyo-Rodriguez V, 2013, LANDSCAPE ECOL, V28, P1717, DOI 10.1007/s10980-013-9929-2; AUGUST PV, 1983, ECOLOGY, V64, P1495, DOI 10.2307/1937504; Bell T, 2006, ECOL LETT, V9, P569, DOI 10.1111/j.1461-0248.2006.00905.x; Bonte D, 2012, BIOL REV, V87, P290, DOI 10.1111/j.1469-185X.2011.00201.x; BOVI M. L. A., 1976, BRAGANTIA, V34, P29, DOI [10.1590/S0100-6762200600050000, DOI 10.1590/S0100-6762200600050000]; Bovi MLA, 1992, B TECNICO I AGRONOMI, V137, P1; Breitbach N, 2012, OECOLOGIA, V168, P425, DOI 10.1007/s00442-011-2090-1; Brook BW, 2008, TRENDS ECOL EVOL, V23, P453, DOI 10.1016/j.tree.2008.03.011; Calvi G. P., 2004, Revista Universidade Rural. Serie Ciencias da Vida, V24, P107; Cassano CR, 2012, BIOTROPICA, V44, P818, DOI 10.1111/j.1744-7429.2012.00870.x; Castellon TD, 2006, CONSERV BIOL, V20, P135, DOI 10.1111/j.1523-1739.2006.00332.x; Clark DL, 2003, AM J BOT, V90, P730, DOI 10.3732/ajb.90.5.730; Clark JS, 1999, AM J BOT, V86, P1, DOI 10.2307/2656950; Conte R, 2000, EUTERPE EDULIS MARTI, P106; Cordeiro NJ, 2003, P NATL ACAD SCI USA, V100, P14052, DOI 10.1073/pnas.2331023100; Cordeiro P.H.C., 2003, CORREDOR BIODIVERSID; Crowley BE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044538; da Silva JMC, 2000, NATURE, V404, P72, DOI 10.1038/35003563; Didham RK, 2014, PAC SCI, V68, P493, DOI 10.2984/68.4.4; Dobson A, 2006, ECOLOGY, V87, P1915, DOI 10.1890/0012-9658(2006)87[1915:HLTCAT]2.0.CO;2; Dracxler CM, 2011, BIOTROPICA, V43, P8, DOI 10.1111/j.1744-7429.2010.00723.x; Estavillo C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082369; Fadini RF, 2009, ACTA OECOL, V35, P188, DOI 10.1016/j.actao.2008.10.001; Fahrig L, 1997, J WILDLIFE MANAGE, V61, P603, DOI 10.2307/3802168; Fahrig L, 2002, ECOL APPL, V12, P346, DOI 10.1890/1051-0761(2002)012[0346:EOHFOT]2.0.CO;2; Faria D, 2009, FOREST ECOL MANAG, V257, P2226, DOI 10.1016/j.foreco.2009.02.032; Fleury M, 2004, ACTA OECOL, V26, P179, DOI 10.1016/j.actao.2004.04.003; Fleury Marina, 2014, PLoS ONE, V9, pe90060, DOI 10.1371/journal.pone.0090060; Fortuna MA, 2013, OIKOS, V122, P938, DOI 10.1111/j.1600-0706.2012.00042.x; Fragoso JMV, 2003, ECOLOGY, V84, P1998, DOI 10.1890/01-0621; Galetti M, 2006, BOT J LINN SOC, V151, P141, DOI 10.1111/j.1095-8339.2006.00529.x; Galetti M, 1998, J APPL ECOL, V35, P286, DOI 10.1046/j.1365-2664.1998.00294.x; Galetti M, 2013, SCIENCE, V340, P1086, DOI 10.1126/science.1233774; Garmendia A, 2013, J TROP ECOL, V29, P331, DOI 10.1017/S0266467413000370; Rigueira DMG, 2013, BIODIVERS CONSERV, V22, P3141, DOI 10.1007/s10531-013-0575-4; Grass I, 2014, OIKOS, V123, P575, DOI 10.1111/j.1600-0706.2013.00920.x; Howes A, 2014, IBIS, V156, P341, DOI 10.1111/ibi.12136; Janzen D. H., 1971, A Rev Ecol Syst, V2, P465, DOI 10.1146/annurev.es.02.110171.002341; JANZEN DH, 1974, NAT HIST, V83, P48; Kurten EL, 2013, BIOL CONSERV, V163, P22, DOI 10.1016/j.biocon.2013.04.025; Landau EC, 2003, CORREDOR BIODIVERSID, P54; Leite AD, 2012, J TROP ECOL, V28, P615, DOI 10.1017/S0266467412000594; Lima MM, 2014, FOREST ECOL MANAG, V312, P260, DOI 10.1016/j.foreco.2013.09.003; Martensen AC, 2008, BIOL CONSERV, V141, P2184, DOI 10.1016/j.biocon.2008.06.008; Martensen AC, 2012, CONSERV BIOL, V26, P1100, DOI 10.1111/j.1523-1739.2012.01940.x; Martins Cibele C., 2004, Hortic. Bras., V22, P271, DOI 10.1590/S0102-05362004000200021; Matos DMS, 1998, BIOTROPICA, V30, P595, DOI 10.1111/j.1744-7429.1998.tb00099.x; Molofskyr J, 2013, ECOLOGY, V74, P261; Moran C, 2014, CONSERV BIOL, V28, P551, DOI 10.1111/cobi.12236; Mortelliti A, 2010, DIVERS DISTRIB, V16, P941, DOI 10.1111/j.1472-4642.2010.00701.x; Muler AE, 2014, FOREST ECOL MANAG, V324, P117, DOI 10.1016/j.foreco.2013.09.001; MURCIA C, 1995, TRENDS ECOL EVOL, V10, P58, DOI 10.1016/S0169-5347(00)88977-6; Muscarella R, 2013, J ECOL, V101, P171, DOI 10.1111/1365-2745.12027; Nodari R. O., 1998, Revista Arvore, V22, P1; Nunez-Avila MC, 2013, J ECOL, V101, P1439, DOI 10.1111/1365-2745.12148; Orrock JL, 2006, J ECOL, V94, P838, DOI 10.1111/j.1365-2745.2006.01125.x; Paine CET, 2007, ECOLOGY, V88, P3076, DOI 10.1890/06-1835.1; Silva Maria das Graças C. Parada Costa, 2009, Braz. J. Bot., V32, P393, DOI 10.1590/S0100-84042009000200017; Pinto SRR, 2009, BRAZ J BIOL, V69, P763, DOI 10.1590/S1519-69842009000400003; Pizo MA, 2004, BIOTROPICA, V36, P417, DOI 10.1111/j.1744-7429.2004.tb00336.x; Pizo MA, 2001, ACTA OECOL, V22, P229, DOI 10.1016/S1146-609X(01)01108-0; Pizo MA, 2006, ACTA OECOL, V29, P311, DOI 10.1016/j.actao.2005.11.011; Rey PJ, 2002, FUNCT ECOL, V16, P773, DOI 10.1046/j.1365-2435.2002.00680.x; Rother DC, 2013, PERSPECT PLANT ECOL, V15, P86, DOI 10.1016/j.ppees.2012.12.004; Sambuichi RHR, 2003, THESIS U BRASILIA; Schroth G, 2011, BIODIVERS CONSERV, V20, P1635, DOI 10.1007/s10531-011-0052-x; SCHUPP EW, 1995, AM J BOT, V82, P399, DOI 10.2307/2445586; SHOEMAKER CA, 1990, HORTSCIENCE, V25, P762, DOI 10.21273/HORTSCI.25.7.762; Sikes RS, 2011, J MAMMAL, V92, P235, DOI 10.1644/10-MAMM-F-355.1; Silva Paulo D., 2007, Braz. J. Bot., V30, P553, DOI 10.1590/S0100-84042007000300019; Sodhi NS, 2010, BIOL CONSERV, V143, P2375, DOI 10.1016/j.biocon.2009.12.029; Spiesman BJ, 2013, ECOLOGY, V94, P2688, DOI 10.1890/13-0977.1; Steffler Carla Elisabete, 2008, Palms, V52, P133; Stephens EL, 2012, AM MIDL NAT, V167, P223, DOI 10.1674/0003-0031-167.2.223; Tabarelli M, 2010, CONSERV BIOL, V24, P1654, DOI 10.1111/j.1523-1739.2010.01529.x; Thomas WW, 1998, BIODIVERS CONSERV, V7, P311, DOI 10.1023/A:1008825627656; Trzcinski MK, 1999, ECOL APPL, V9, P586, DOI 10.1890/1051-0761(1999)009[0586:IEOFCA]2.0.CO;2; Valiente-Banuet A, 2015, FUNCT ECOL, V29, P299, DOI 10.1111/1365-2435.12356; Vieira EM, 2003, MAMMALIA, V67, P533; von Allmen C, 2004, J TROP ECOL, V20, P471, DOI 10.1017/S0266467404001348; Wenny DG, 2000, ECOL MONOGR, V70, P331, DOI 10.1890/0012-9615(2000)070[0331:SDSPAS]2.0.CO;2; Wright SJ, 2006, BIOTROPICA, V38, P287, DOI 10.1111/j.1744-7429.2006.00154.x; Wright SJ, 2001, BIOTROPICA, V33, P583, DOI 10.1111/j.1744-7429.2001.tb00217.x; Zuckerberg B, 2010, BIOL CONSERV, V143, P952, DOI 10.1016/j.biocon.2010.01.004	87	12	12	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0133540	10.1371/journal.pone.0133540	http://dx.doi.org/10.1371/journal.pone.0133540			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RV	26186339	Green Published, Green Submitted, gold			2022-12-26	WOS:000358198700155
J	Nata, T; Basheer, A; Cocchi, F; van Besien, R; Massoud, R; Jacobson, S; Azimi, N; Tagaya, Y				Nata, Toshie; Basheer, Asjad; Cocchi, Fiorenza; van Besien, Richard; Massoud, Raya; Jacobson, Steven; Azimi, Nazli; Tagaya, Yutaka			Targeting the Binding Interface on a Shared Receptor Subunit of a Cytokine Family Enables the Inhibition of Multiple Member Cytokines with Selectable Target Spectrum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED KILLER-CELLS; CELIAC-DISEASE; T-CELLS; RHEUMATOID-ARTHRITIS; NATURAL-KILLER; INTRAEPITHELIAL LYMPHOCYTES; LYMPHOID DEVELOPMENT; ULCERATIVE-COLITIS; TRANSGENIC MICE; BETA-CHAIN	The common gamma molecule (gamma c) is a shared signaling receptor subunit used by six gamma c-cytokines. These cytokines play crucial roles in the differentiation of the mature immune system and are involved in many human diseases. Moreover, recent studies suggest that multiple gamma c-cytokines are pathogenically involved in a single disease, thus making the shared gamma c-molecule a logical target for therapeutic intervention. However, the current therapeutic strategies seem to lack options to treat such cases, partly because of the lack of appropriate neutralizing antibodies recognizing the gamma c and, more importantly, because of the inherent and practical limitations in the use of monoclonal antibodies. By targeting the binding interface of the gamma c and cytokines, we successfully designed peptides that not only inhibit multiple gamma c-cytokines but with a selectable target spectrum. Notably, the lead peptide inhibited three gamma c-cytokines without affecting the other three or non-gamma c-cytokines. Biological and mutational analyses of our peptide provide new insights to our current understanding on the structural aspect of the binding of gamma c-cytokines the gamma c-molecule. Furthermore, we provide evidence that our peptide, when conjugated to polyethylene glycol to gain stability in vivo, efficiently blocks the action of one of the target cytokines in animal models. Collectively, our technology can be expanded to target various combinations of gamma c-cytokines and thereby will provide a novel strategy to the current anti-cytokine therapies against immune, inflammatory, and malignant diseases.	[Nata, Toshie; Cocchi, Fiorenza; van Besien, Richard; Tagaya, Yutaka] Univ Maryland, Sch Med, Inst Human Virol, Cell Biol Lab,Div Basic Sci, Baltimore, MD 21201 USA; [Basheer, Asjad; Azimi, Nazli] BIONIZ Inc, Irvine, CA 92618 USA; [Massoud, Raya; Jacobson, Steven] NINDS, Sect Neuroimmunol, NIH, Bethesda, MD 20890 USA	University System of Maryland; University of Maryland Baltimore; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Tagaya, Y (corresponding author), Univ Maryland, Sch Med, Inst Human Virol, Cell Biol Lab,Div Basic Sci, Baltimore, MD 21201 USA.	ytagaya@ihv.umaryland.edu		Van Besien, Richard/0000-0002-6967-0657; Tagaya, Yutaka/0000-0002-1342-9282	BIONIZ; Institute of Human Virology, University of Maryland School of Medicine; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS003040, ZIANS002817] Funding Source: NIH RePORTER	BIONIZ; Institute of Human Virology, University of Maryland School of Medicine; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported in part by research funding from BIONIZ (to T.N., F.C., and Y.T.) and in part by internal research funding from the Institute of Human Virology, University of Maryland School of Medicine. This work was authored, in whole or in part, by National Institutes of Health staff. A. B. is an employee of BIONIZ, Inc. N. A. is the founder of BIONIZ. BIONIZ holds the United States patent for the technology behind this work and the concept and peptides used in this paper. We also declare that these financial involvements of BIONIZ did not undermine the scientific objectivity and integrity of the presented work.	Amadi-Obi A, 2007, NAT MED, V13, P711, DOI 10.1038/nm1585; Antal Z, 2012, J IMMUNOL, V188, P5766, DOI 10.4049/jimmunol.1102930; Antony PA, 2006, J IMMUNOL, V176, P5255, DOI 10.4049/jimmunol.176.9.5255; Azimi N, 1999, J IMMUNOL, V163, P4064; Azimi N, 2001, P NATL ACAD SCI USA, V98, P14559, DOI 10.1073/pnas.251540598; BAMFORD RN, 1994, P NATL ACAD SCI USA, V91, P4940, DOI 10.1073/pnas.91.11.4940; BAZAN JF, 1992, SCIENCE, V257, P410, DOI 10.1126/science.1631562; Bhagat G, 2008, J CLIN INVEST, V118, P281, DOI 10.1172/JCI30989; Bodd M, 2010, MUCOSAL IMMUNOL, V3, P594, DOI 10.1038/mi.2010.36; Boulay JL, 2003, IMMUNITY, V19, P159, DOI 10.1016/S1074-7613(03)00211-5; Boyman O, 2012, TRANSPL P, V44, P1032, DOI 10.1016/j.transproceed.2012.01.093; Changelian PS, 2003, SCIENCE, V302, P875, DOI 10.1126/science.1087061; Chen J, 2008, BLOOD, V111, P5163, DOI 10.1182/blood-2007-09-113654; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Chtanova T, 2004, J IMMUNOL, V173, P68, DOI 10.4049/jimmunol.173.1.68; Costanzo A, 2010, J DERMATOL SCI, V60, P61, DOI 10.1016/j.jdermsci.2010.08.016; CRAIG DA, 1993, TRENDS PHARMACOL SCI, V14, P89, DOI 10.1016/0165-6147(93)90070-Z; Devkota S, 2012, NATURE, V487, P104, DOI 10.1038/nature11225; Fehniger TA, 2001, J EXP MED, V193, P219, DOI 10.1084/jem.193.2.219; Festen EAM, 2009, GUT, V58, P799, DOI 10.1136/gut.2008.166918; Garber K, 2011, NAT BIOTECHNOL, V29, P467, DOI 10.1038/nbt0611-467; Glas JN, 2009, AM J GASTROENTEROL, V104, P1737, DOI 10.1038/ajg.2009.163; GRABSTEIN KH, 1994, SCIENCE, V264, P965, DOI 10.1126/science.8178155; Hartgring SAY, 2006, ANN RHEUM DIS, V65, P69, DOI 10.1136/ard.2006.058479; Jabri B, 2000, GASTROENTEROLOGY, V118, P867, DOI 10.1016/S0016-5085(00)70173-9; Jiang JK, 2008, J MED CHEM, V51, P8012, DOI 10.1021/jm801142b; Ju W, 2011, BLOOD, V117, P1938, DOI 10.1182/blood-2010-09-305425; Kishimoto T, 2010, INT IMMUNOL, V22, P347, DOI 10.1093/intimm/dxq030; LaPorte SL, 2008, CELL, V132, P259, DOI 10.1016/j.cell.2007.12.030; Leonard WJ, 2005, NAT REV IMMUNOL, V5, P688, DOI 10.1038/nri1688; Li HM, 2010, J IMMUNOL, V185, P4095, DOI 10.4049/jimmunol.1000986; Liao W, 2013, IMMUNITY, V38, P13, DOI 10.1016/j.immuni.2013.01.004; Lundstrom W, 2012, SEMIN IMMUNOL, V24, P218, DOI 10.1016/j.smim.2012.02.005; MACCHI P, 1995, NATURE, V377, P65, DOI 10.1038/377065a0; Malek TR, 2002, IMMUNITY, V17, P167, DOI 10.1016/S1074-7613(02)00367-9; Marks-Konczalik J, 2000, P NATL ACAD SCI USA, V97, P11445, DOI 10.1073/pnas.200363097; Marquez A, 2009, AM J GASTROENTEROL, V104, P1968, DOI 10.1038/ajg.2009.224; Matsuura E, 2010, J NEUROIMMUNE PHARM, V5, P310, DOI 10.1007/s11481-010-9216-9; McInnes IB, 2005, NAT CLIN PRACT RHEUM, V1, P31, DOI 10.1038/ncprheum0020; Meresse B, 2004, IMMUNITY, V21, P357, DOI 10.1016/j.immuni.2004.06.020; Meresse B, 2006, J EXP MED, V203, P1343, DOI 10.1084/jem.20060028; Morrison KL, 2001, CURR OPIN CHEM BIOL, V5, P302, DOI 10.1016/S1367-5931(00)00206-4; Nicolaides NC, 1997, P NATL ACAD SCI USA, V94, P13175, DOI 10.1073/pnas.94.24.13175; NOGUCHI M, 1993, CELL, V73, P147, DOI 10.1016/0092-8674(93)90167-O; NOSAKA T, 1995, SCIENCE, V270, P800, DOI 10.1126/science.270.5237.800; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Nowak EC, 2009, J EXP MED, V206, P1653, DOI 10.1084/jem.20090246; Oh Chad K., 2011, Inflammation & Allergy Drug Targets, V10, P180; Ozaki K, 2002, J BIOL CHEM, V277, P29355, DOI 10.1074/jbc.R200003200; Ring AM, 2012, NAT IMMUNOL, V13, P1187, DOI 10.1038/ni.2449; Rochman Y, 2009, NAT REV IMMUNOL, V9, P480, DOI 10.1038/nri2580; RUSSELL SM, 1995, SCIENCE, V270, P797, DOI 10.1126/science.270.5237.797; Saikali P, 2010, J IMMUNOL, V185, P5693, DOI 10.4049/jimmunol.1002188; Sarra M, 2013, BIOFACTORS, V39, P368, DOI 10.1002/biof.1105; Sato N, 2011, BLOOD, V117, P4032, DOI 10.1182/blood-2010-09-307504; Shimbara A, 2000, J ALLERGY CLIN IMMUN, V105, P108, DOI 10.1016/S0091-6749(00)90185-4; Steinke JW, 2010, RECENT PATENTS INFLA, V4, P222, DOI 10.2174/187221310793564281; Steinke JW, 2003, J ALLERGY CLIN IMMUN, V111, P342, DOI 10.1067/mai.2003.67; Tagaya Y, 1996, EMBO J, V15, P4928, DOI 10.1002/j.1460-2075.1996.tb00873.x; Tagaya Y., 2013, U.S. Patent, Patent No. 08455449; Tang FM, 2009, J EXP MED, V206, P707, DOI 10.1084/jem.20071887; TENDLER CL, 1990, P NATL ACAD SCI USA, V87, P5218, DOI 10.1073/pnas.87.13.5218; VANDERHOEK JY, 1982, J BIOL CHEM, V257, P2191; Wang XQ, 2005, SCIENCE, V310, P1159, DOI 10.1126/science.1117893; West K, 2009, CURR OPIN INVEST DR, V10, P491; Yokoyama S, 2013, J CLIN IMMUNOL, V33, P586, DOI 10.1007/s10875-012-9849-y; Young DA, 2007, ARTHRITIS RHEUM, V56, P1152, DOI 10.1002/art.22452; Zambello R, 1997, BLOOD, V89, P201, DOI 10.1182/blood.V89.1.201.201_201_211	68	14	14	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	2015	290	37					22338	22351		10.1074/jbc.M115.661074	http://dx.doi.org/10.1074/jbc.M115.661074			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CR2PB	26183780	Green Published, hybrid			2022-12-26	WOS:000361171500003
J	Townsend, PD; Rodgers, TL; Glover, LC; Korhonen, HJ; Richards, SA; Colwell, LJ; Pohl, E; Wilson, MR; Hodgson, DRW; McLeish, TCB; Cann, MJ				Townsend, Philip D.; Rodgers, Thomas L.; Glover, Laura C.; Korhonen, Heidi J.; Richards, Shane A.; Colwell, Lucy J.; Pohl, Ehmke; Wilson, Mark R.; Hodgson, David R. W.; McLeish, Tom C. B.; Cann, Martin J.			The Role of Protein-Ligand Contacts in Allosteric Regulation of the Escherichia coli Catabolite Activator Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMP RECEPTOR PROTEIN; NORMAL-MODE ANALYSIS; CAP-DNA COMPLEX; DYNAMIC ALLOSTERY; EVOLUTIONARY CONSERVATION; CONFORMATIONAL CHANGE; VIBRATIONAL DYNAMICS; INTRINSIC DISORDER; CRYSTAL-STRUCTURE; PLAUSIBLE MODEL	Allostery is a fundamental process by which ligand binding to a protein alters its activity at a distant site. Both experimental and theoretical evidence demonstrate that allostery can be communicated through altered slow relaxation protein dynamics without conformational change. The catabolite activator protein (CAP) of Escherichia coli is an exemplar for the analysis of such entropically driven allostery. Negative allostery in CAP occurs between identical cAMP binding sites. Changes to the cAMP-binding pocket can therefore impact the allosteric properties of CAP. Here we demonstrate, through a combination of coarse-grained modeling, isothermal calorimetry, and structural analysis, that decreasing the affinity of CAP for cAMP enhances negative cooperativity through an entropic penalty for ligand binding. The use of variant cAMP ligands indicates the data are not explained by structural heterogeneity between protein mutants. We observe computationally that altered interaction strength between CAP and cAMP variously modifies the change in allosteric cooperativity due to second site CAP mutations. As the degree of correlated motion between the cAMP-contacting site and a second site on CAP increases, there is a tendency for computed double mutations at these sites to drive CAP toward noncooperativity. Naturally occurring pairs of covarying residues in CAP do not display this tendency, suggesting a selection pressure to fine tune allostery on changes to the CAP ligand-binding pocket without a drive to a noncooperative state. In general, we hypothesize an evolutionary selection pressure to retain slow relaxation dynamics-induced allostery in proteins in which evolution of the ligand-binding site is occurring.	[Townsend, Philip D.; Glover, Laura C.; Richards, Shane A.; Pohl, Ehmke; Cann, Martin J.] Univ Durham, Sch Biol & Biomed Sci, Durham DH1 3LE, England; [Townsend, Philip D.; Glover, Laura C.; Korhonen, Heidi J.; Pohl, Ehmke; Wilson, Mark R.; Hodgson, David R. W.; McLeish, Tom C. B.; Cann, Martin J.] Univ Durham, Biophys Sci Inst, Durham DH1 3LE, England; [Glover, Laura C.; Korhonen, Heidi J.; Pohl, Ehmke; Wilson, Mark R.; Hodgson, David R. W.; McLeish, Tom C. B.] Univ Durham, Dept Chem, Durham DH1 3LE, England; [McLeish, Tom C. B.] Univ Durham, Dept Phys, Durham DH1 3LE, England; [Rodgers, Thomas L.] Univ Manchester, Sch Chem Engn & Analyt Sci, Manchester M13 9PL, Lancs, England; [Korhonen, Heidi J.] Univ Turku, Dept Chem, Turku 20014, Finland; [Colwell, Lucy J.] Univ Cambridge, Dept Chem, Cambridge CB2 1EW, England	Durham University; Durham University; Durham University; Durham University; University of Manchester; University of Turku; University of Cambridge	Cann, MJ (corresponding author), Univ Durham, Sch Biol & Biomed Sci, S Rd, Durham DH1 3LE, England.	j.cann@durham.ac.uk	Rodgers, Thomas/K-5785-2019; Townsend, Phiip/J-3761-2018; Rodgers, Thomas L/G-9335-2013; Pohl, Ehmke/I-2408-2012; Cann, Martin/G-2864-2012; Wilson, Mark R/F-8670-2011; Hodgson, David/F-7174-2011	Rodgers, Thomas/0000-0002-4025-3753; Townsend, Phiip/0000-0001-9235-3492; Rodgers, Thomas L/0000-0002-4025-3753; Pohl, Ehmke/0000-0002-9949-4471; Cann, Martin/0000-0001-6305-8769; Wilson, Mark R/0000-0001-6413-2780; Hodgson, David/0000-0003-4517-9166; McLeish, Tom/0000-0002-2025-0299; Richards, Shane/0000-0002-9638-5827	EPSRC [EP/H051759/1]; BBSRC [BB/M007405/1] Funding Source: UKRI; EPSRC [EP/H028064/2, EP/H028064/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/M007405/1] Funding Source: researchfish; Engineering and Physical Sciences Research Council [EP/H051759/1, EP/H028064/1, EP/H028064/2] Funding Source: researchfish	EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported by EPSRC grant EP/H051759/1 (to T. C. B. M., M. J. C., E. P., and M. R. W.). The authors declare that they have no conflicts of interest with the contents of this article.	Bahar I, 1998, PHYS REV LETT, V80, P2733, DOI 10.1103/PhysRevLett.80.2733; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BELDUZ AO, 1993, NUCLEIC ACIDS RES, V21, P1827, DOI 10.1093/nar/21.8.1827; BROOKS B, 1983, P NATL ACAD SCI-BIOL, V80, P6571, DOI 10.1073/pnas.80.21.6571; Busby S, 1999, J MOL BIOL, V293, P199, DOI 10.1006/jmbi.1999.3161; Changeux JP, 2005, SCIENCE, V308, P1424, DOI 10.1126/science.1108595; COLOMBO MF, 1992, SCIENCE, V256, P655, DOI 10.1126/science.1585178; COOPER A, 1994, FEBS LETT, V348, P41, DOI 10.1016/0014-5793(94)00579-6; COOPER A, 1984, EUR BIOPHYS J BIOPHY, V11, P103, DOI 10.1007/BF00276625; Cui Q, 2008, PROTEIN SCI, V17, P1295, DOI 10.1110/ps.03259908; Delarue M, 2002, J MOL BIOL, V320, P1011, DOI 10.1016/S0022-2836(02)00562-4; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Garcia-Pino A, 2010, CELL, V142, P101, DOI 10.1016/j.cell.2010.05.039; Gekko K, 2004, BIOCHEMISTRY-US, V43, P3844, DOI 10.1021/bi036271e; GO N, 1983, P NATL ACAD SCI-BIOL, V80, P3696, DOI 10.1073/pnas.80.12.3696; Gorke B, 2008, NAT REV MICROBIOL, V6, P613, DOI 10.1038/nrmicro1932; Hawkins RJ, 2006, BIOPHYS J, V91, P2055, DOI 10.1529/biophysj.106.082180; Hawkins RJ, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.098104; Hawkins RJ, 2006, J R SOC INTERFACE, V3, P125, DOI 10.1098/rsif.2005.0068; Hilser VJ, 2012, ANNU REV BIOPHYS, V41, P585, DOI 10.1146/annurev-biophys-050511-102319; Hilser VJ, 2011, J BIOL CHEM, V286, P39675, DOI 10.1074/jbc.R111.278929; KOSHLAND DE, 1966, BIOCHEMISTRY-US, V5, P365, DOI 10.1021/bi00865a047; Leslie AGW, 2007, NATO SCI SER II-MATH, V245, P41, DOI 10.1007/978-1-4020-6316-9_4; Lin SH, 2002, BIOCHEMISTRY-US, V41, P11857, DOI 10.1021/bi026099z; Maguid S, 2008, GENE, V422, P7, DOI 10.1016/j.gene.2008.06.002; Maguid S, 2006, J MOL EVOL, V63, P448, DOI 10.1007/s00239-005-0209-x; Manley G, 2012, ARCH BIOCHEM BIOPHYS, V519, P223, DOI 10.1016/j.abb.2011.10.023; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McLeish TCB, 2013, PHYS BIOL, V10, DOI 10.1088/1478-3975/10/5/056004; Meigh L, 2013, ELIFE, V2, DOI 10.7554/eLife.01213; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; Motlagh HN, 2014, NATURE, V508, P331, DOI 10.1038/nature13001; Motlagh HN, 2012, P NATL ACAD SCI USA, V109, P4134, DOI 10.1073/pnas.1120519109; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nicolay S, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.078104; Passner JM, 1997, P NATL ACAD SCI USA, V94, P2843, DOI 10.1073/pnas.94.7.2843; Passner JM, 2000, J MOL BIOL, V304, P847, DOI 10.1006/jmbi.2000.4231; Petit CM, 2009, P NATL ACAD SCI USA, V106, P18249, DOI 10.1073/pnas.0904492106; Popovych N, 2006, NAT STRUCT MOL BIOL, V13, P831, DOI 10.1038/nsmb1132; Raimondi F, 2010, STRUCTURE, V18, P402, DOI 10.1016/j.str.2009.12.015; Reichheld SE, 2009, P NATL ACAD SCI USA, V106, P22263, DOI 10.1073/pnas.0911566106; Remmert M, 2012, NAT METHODS, V9, P173, DOI [10.1038/NMETH.1818, 10.1038/nmeth.1818]; Ringe D, 1986, Methods Enzymol, V131, P389; Rodgers TL, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001651; Rodgers TL, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-183; Schrank TP, 2009, P NATL ACAD SCI USA, V106, P16984, DOI 10.1073/pnas.0906510106; SCHULTZ SC, 1991, SCIENCE, V253, P1001, DOI 10.1126/science.1653449; Swain JF, 2006, CURR OPIN STRUC BIOL, V16, P102, DOI 10.1016/j.sbi.2006.01.003; Tama F, 2001, PROTEIN ENG, V14, P1, DOI 10.1093/protein/14.1.1; Tirion MM, 1996, PHYS REV LETT, V77, P1905, DOI 10.1103/PhysRevLett.77.1905; Toncrova H, 2010, BIOPHYS J, V98, P2317, DOI 10.1016/j.bpj.2010.01.039; Townsend Philip D, 2015, Biophys Rev, V7, P175, DOI 10.1007/s12551-015-0163-9; Tsai CJ, 2008, J MOL BIOL, V378, P1, DOI 10.1016/j.jmb.2008.02.034; Tzeng SR, 2012, NATURE, V488, P236, DOI 10.1038/nature11271; Tzeng SR, 2009, NATURE, V462, P368, DOI 10.1038/nature08560; Valadie H, 2003, J MOL BIOL, V332, P657, DOI 10.1016/S0022-2836(03)00851-9; Viappiani C, 2014, P NATL ACAD SCI USA, V111, P12758, DOI 10.1073/pnas.1413566111	57	22	22	0	30	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	2015	290	36					22225	22235		10.1074/jbc.M115.669267	http://dx.doi.org/10.1074/jbc.M115.669267			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CQ9XI	26187469	hybrid, Green Published, Green Accepted			2022-12-26	WOS:000360968500039
J	Carroll, P; Parish, T				Carroll, Paul; Parish, Tanya			Deletion of cyp125 Confers Increased Sensitivity to Azoles in Mycobacterium tuberculosis	PLOS ONE			English	Article							CYTOCHROME-P450; GENOME; MACROPHAGES; ANTIFUNGALS; SURVIVAL; REQUIREMENTS; ADAPTATION; RESISTANCE; VIRULENCE; GROWTH	Mycobacterium tuberculosis is able to utilize cholesterol as a carbon source, and this ability is linked to its virulence in macrophages and in the mouse model of infection. The M. tuberculosis cytochrome P450 Cyp125 plays a key role in cholesterol metabolism being involved in the first steps of its degradation. Cyp125 is a cholesterol hydroxylase which is essential for cholesterol catabolism in M. bovis BCG and some strains of M. tuberculosis. We generated an unmarked, in-frame deletion of Cyp125 in M. tuberculosis H37Rv. The deletion strain was able to grow as well as wild-type in medium containing glucose as the carbon source. The Cyp125 deletion strain was more sensitive to growth inhibition by clotrimazole consistent with the ability of Cyp125 to bind azoles with high affinity. The deletion strain showed no difference in sensitivity to nitric oxide or hydrogen peroxide and was not attenuated for growth inside THP-1 human macrophage-like cells. These data suggest that the attenuation of virulence seen in operon deletion strains is not linked to the lack of Cyp125 alone.	[Carroll, Paul; Parish, Tanya] Queen Mary Univ London, Ctr Infect Dis, Barts & London Sch Med & Dent, London, England; [Parish, Tanya] Infect Dis Res Inst, TB Discovery Res, Seattle, WA USA	University of London; Queen Mary University London	Parish, T (corresponding author), Queen Mary Univ London, Ctr Infect Dis, Barts & London Sch Med & Dent, London, England.	tanya.parish@idri.org			European Union Project [LSHP-CT-2005-018923]	European Union Project(European Commission)	This work was funded by the European Union Project LSHP-CT-2005-018923. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad Z, 2005, FEMS MICROBIOL LETT, V251, P19, DOI 10.1016/j.femsle.2005.07.022; Ahmad Z, 2006, FEMS MICROBIOL LETT, V258, P200, DOI 10.1111/j.1574-6968.2006.00224.x; Ahmad Z, 2006, FEMS MICROBIOL LETT, V261, P181, DOI 10.1111/j.1574-6968.2006.00350.x; Capyk JK, 2009, J BIOL CHEM, V284, P35534, DOI 10.1074/jbc.M109.072132; Chang JC, 2007, J INFECT DIS, V196, P788, DOI 10.1086/520089; Chang JC, 2009, J BACTERIOL, V191, P5232, DOI 10.1128/JB.00452-09; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Driscoll MD, 2010, J BIOL CHEM, V285, P38270, DOI 10.1074/jbc.M110.164293; Driscoll MD, 2011, BBA-PROTEINS PROTEOM, V1814, P76, DOI 10.1016/j.bbapap.2010.05.015; Giavini E, 2010, TOXICOL LETT, V198, P106, DOI 10.1016/j.toxlet.2010.07.005; Gomez-Valero L, 2007, GENOME RES, V17, P1178, DOI 10.1101/gr.6360207; Guardiola-Diaz HM, 2001, BIOCHEM PHARMACOL, V61, P1463, DOI 10.1016/S0006-2952(01)00571-8; Ioerger TR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075245; Ioerger TR, 2010, J BACTERIOL, V192, P3645, DOI 10.1128/JB.00166-10; KELLY SL, 2004, CYTOCHROME P450 STRU, P585; Lukey P T, 2001, Methods Mol Med, V54, P271, DOI 10.1385/1-59259-147-7:271; Lupetti A, 2002, TRENDS MOL MED, V8, P76, DOI 10.1016/S1471-4914(02)02280-3; Mahenthiralingam E, 1998, INFECT IMMUN, V66, P3626, DOI 10.1128/IAI.66.8.3626-3634.1998; McLean KJ, 2007, ARCH BIOCHEM BIOPHYS, V464, P228, DOI 10.1016/j.abb.2007.03.026; McLean KJ, 2009, J BIOL CHEM, V284, P35524, DOI 10.1074/jbc.M109.032706; McLean KJ, 2006, TRENDS MICROBIOL, V14, P220, DOI 10.1016/j.tim.2006.03.002; Milano A, 2009, TUBERCULOSIS, V89, P84, DOI 10.1016/j.tube.2008.08.003; Nelson DR, 1999, ARCH BIOCHEM BIOPHYS, V369, P1, DOI 10.1006/abbi.1999.1352; Ouellet H, 2010, MOL MICROBIOL, V77, P730, DOI 10.1111/j.1365-2958.2010.07243.x; Ouellet H, 2009, BIOCHEMISTRY-US, V48, P863, DOI 10.1021/bi801595t; Parish T, 2000, MICROBIOL-SGM, V146, P1969, DOI 10.1099/00221287-146-8-1969; Rengarajan J, 2005, P NATL ACAD SCI USA, V102, P8327, DOI 10.1073/pnas.0503272102; Rosloniec KZ, 2009, MOL MICROBIOL, V74, P1031, DOI 10.1111/j.1365-2958.2009.06915.x; Sassetti CM, 2003, P NATL ACAD SCI USA, V100, P12989, DOI 10.1073/pnas.2134250100; Schnappinger D, 2003, J EXP MED, V198, P693, DOI 10.1084/jem.20030846; TSUCHIYA S, 1980, INT J CANCER, V26, P171, DOI 10.1002/ijc.2910260208; Van der Geize R, 2007, P NATL ACAD SCI USA, V104, P1947, DOI 10.1073/pnas.0605728104; Vanden Bossche H, 1985, Curr Top Med Mycol, V1, P313; WHO, 2014, GLOB TUB REP 2014; Yam KC, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000344	35	9	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0133129	10.1371/journal.pone.0133129	http://dx.doi.org/10.1371/journal.pone.0133129			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LZ	26197389	gold, Green Published, Green Submitted			2022-12-26	WOS:000358547600063
J	Cho, EJ; Kim, MY; Lee, JH; Lee, IY; Lim, YL; Choi, DH; Kim, YJ; Yoon, JH; Baik, SK				Cho, Eun Ju; Kim, Moon Young; Lee, Jeong-Hoon; Lee, Il Young; Lim, Yoo Li; Choi, Dae Hee; Kim, Yoon Jun; Yoon, Jung-Hwan; Baik, Soon Koo			Diagnostic and Prognostic Values of Noninvasive Predictors of Portal Hypertension in Patients with Alcoholic Cirrhosis	PLOS ONE			English	Article							LIVER STIFFNESS MEASUREMENT; CHRONIC HEPATITIS-C; ESOPHAGEAL-VARICES; COMPENSATED CIRRHOSIS; SIGNIFICANT FIBROSIS; DISEASE; INDEX; DECOMPENSATION; MODEL; ELASTOGRAPHY	Portal hypertension is a direct consequence of hepatic fibrosis, and several hepatic fibrosis markers have been evaluated as a noninvasive alternative to the detection of portal hypertension and esophageal varices. In the present study, we compared the diagnostic and prognostic values of the noninvasive fibrosis markers in patients with alcoholic cirrhosis. A total of 219 consecutive alcoholic cirrhosis patients were included. Biochemical scores and liver stiffness (LS) were compared with hepatic venous pressure gradient (HVPG). For the detection of clinically significant portal hypertension (CSPH; HVPG >= 10 mmHg) in compensated patients, LS and LS-spleen diameter to platelet ratio score (LSPS) showed significantly better performance with area under the curves (AUCs) of 0.85 and 0.82, respectively, than aspartate aminotransferase-to-platelet ratio index, FIB-4, Forns' index, Lok index, (platelet count)(2)/[monocyte fraction (%) x segmented neutrophil fraction (%)], and platelet count-to-spleen diameter ratio (all P<0.001). However, for the detection of high-risk varices, none of the non-invasive tests showed reliable performance (AUCs of all investigated tests < 0.70). During a median follow-up period of 42.6 months, 46 patients with decompensated cirrhosis died. Lok index (hazard ratio [HR], 1.13; 95% confidence interval [CI], 1.05-1.22; P = 0.001) and FIB-4 (HR, 1.06; 95% CI, 1.01-1.10; P = 0.009) were independently associated with all-cause death in decompensated patients. Among the tested noninvasive markers, only Lok index significantly improved discrimination function of MELD score in predicting overall survival. In conclusion, LS and LSPS most accurately predict CSPH in patients with compensated alcoholic cirrhosis. In the prediction of overall survival in decompensated patients, however, Lok index is an independent prognostic factor and improves the predictive performance of MELD score.	[Cho, Eun Ju; Lee, Jeong-Hoon; Kim, Yoon Jun; Yoon, Jung-Hwan] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul, South Korea; [Cho, Eun Ju; Lee, Jeong-Hoon; Kim, Yoon Jun; Yoon, Jung-Hwan] Seoul Natl Univ, Coll Med, Liver Res Inst, Seoul, South Korea; [Kim, Moon Young; Lee, Il Young; Lim, Yoo Li; Baik, Soon Koo] Yonsei Univ, Coll Med, Dept Internal Med, Wonju, South Korea; [Choi, Dae Hee] Kangwon Natl Univ Hosp, Dept Internal Med, Chunchon, South Korea	Seoul National University (SNU); Seoul National University (SNU); Yonsei University; Yonsei University Health System; Kangwon National University; Kangwon National University Hospital	Yoon, JH (corresponding author), Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul, South Korea.	yoonjh@snu.ac.kr; baiksk@yonsei.ac.kr	Lee, Jeong-Hoon/Q-1055-2018	Lee, Jeong-Hoon/0000-0002-0315-2080; Kim, Yoon Jun/0000-0001-9141-7773; Yoon, Jung-Hwan/0000-0002-9128-3610; Cho, Eun Ju/0000-0002-2677-3189	National Research Foundation of Korea - Ministry of Education, Science and Technology [2010-000-7381]	National Research Foundation of Korea - Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of KoreaNational Research Foundation of Korea)	This research was supported by Basic Science Research Program through the National Research Foundation of Korea funded by the Ministry of Education, Science and Technology (2010-000-7381) (http://www.nrf.re.kr/nrf_eng_cms). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berzigotti A, 2013, GASTROENTEROLOGY, V144, P102, DOI 10.1053/j.gastro.2012.10.001; de Franchis R, 2010, J HEPATOL, V53, P762, DOI 10.1016/j.jhep.2010.06.004; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Fluss R, 2005, BIOMETRICAL J, V47, P458, DOI 10.1002/bimj.200410135; Forns X, 2002, HEPATOLOGY, V36, P986, DOI 10.1053/jhep.2002.36128; Garcia-Tsao G, 2007, HEPATOLOGY, V46, P922, DOI 10.1002/hep.21907; Gelsi E, 2011, ALCOHOL CLIN EXP RES, V35, P566, DOI 10.1111/j.1530-0277.2010.01374.x; Giannini E, 2003, GUT, V52, P1200, DOI 10.1136/gut.52.8.1200; Girard D E, 1987, Hematol Oncol Clin North Am, V1, P321; Kim BK, 2010, LIVER INT, V30, P1073, DOI 10.1111/j.1478-3231.2010.02269.x; Kim BK, 2010, AM J GASTROENTEROL, V105, P1382, DOI 10.1038/ajg.2009.750; Kim MY, 2012, HEPATOLOGY, V56, P1053, DOI 10.1002/hep.25752; Lee JH, 2009, J VIRAL HEPATITIS, V16, P444, DOI 10.1111/j.1365-2893.2009.01091.x; Lemoine M, 2008, ALIMENT PHARM THER, V28, P1102, DOI 10.1111/j.1365-2036.2008.03825.x; Lisotti A, 2014, HEPATOLOGY, V59, P643, DOI 10.1002/hep.26700; Lok ASF, 2005, HEPATOLOGY, V42, P282, DOI 10.1002/hep.20772; Moreau R, 2013, GASTROENTEROLOGY, V144, P1426, DOI 10.1053/j.gastro.2013.02.042; Nyblom H, 2004, ALCOHOL ALCOHOLISM, V39, P336, DOI 10.1093/alcalc/agh074; Pencina MJ, 2011, STAT MED, V30, P11, DOI 10.1002/sim.4085; Ripoll C, 2007, GASTROENTEROLOGY, V133, P481, DOI 10.1053/j.gastro.2007.05.024; Robic MA, 2011, J HEPATOL, V55, P1017, DOI 10.1016/j.jhep.2011.01.051; Saha P, 2010, BIOMETRICS, V66, P999, DOI 10.1111/j.1541-0420.2009.01375.x; Sandrin L, 2003, ULTRASOUND MED BIOL, V29, P1705, DOI 10.1016/j.ultrasmedbio.2003.07.001; Sebastiani G, 2010, J HEPATOL, V53, P630, DOI 10.1016/j.jhep.2010.04.019; Shah V, 1998, HEPATOLOGY, V27, P279, DOI 10.1002/hep.510270141; Singh S, 2013, CLIN GASTROENTEROL H, V11, P1573, DOI 10.1016/j.cgh.2013.07.034; Sterling RK, 2006, HEPATOLOGY, V43, P1317, DOI 10.1002/hep.21178; Thabut D, 2007, ALIMENT PHARM THER, V26, P359, DOI 10.1111/j.1365-2036.2007.03378.x; Thabut D, 2011, HEPATOLOGY, V53, P683, DOI 10.1002/hep.24129; Uno H, 2011, STAT MED, V30, P1105, DOI 10.1002/sim.4154; Vizzutti F, 2007, HEPATOLOGY, V45, P1290, DOI 10.1002/hep.21665; Wai CT, 2003, HEPATOLOGY, V38, P518, DOI 10.1053/jhep.2003.50346	32	33	34	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0133935	10.1371/journal.pone.0133935	http://dx.doi.org/10.1371/journal.pone.0133935			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LZ	26196942	Green Submitted, Green Published, gold			2022-12-26	WOS:000358547600150
J	Chowdhary, N; Selvaraj, A; KrishnaKumaar, L; Kumar, GR				Chowdhary, Nupoor; Selvaraj, Ashok; KrishnaKumaar, Lakshmi; Kumar, Gopal Ramesh			Genome Wide Re-Annotation of Caldicellulosiruptor saccharolyticus with New Insights into Genes Involved in Biomass Degradation and Hydrogen Production	PLOS ONE			English	Article							PROTEIN-FUNCTION; HYPOTHETICAL PROTEINS; ESCHERICHIA-COLI; PREDICTION; BACTERIUM; SEQUENCE; CLONING; PURIFICATION; DATABASE; WASTE	Caldicellulosiruptor saccharolyticus has proven itself to be an excellent candidate for biological hydrogen (H-2) production, but still it has major drawbacks like sensitivity to high osmotic pressure and low volumetric H-2 productivity, which should be considered before it can be used industrially. A whole genome re-annotation work has been carried out as an attempt to update the incomplete genome information that causes gap in the knowledge especially in the area of metabolic engineering, to improve the H-2 producing capabilities of C. saccharolyticus. Whole genome re-annotation was performed through manual means for 2,682 Coding Sequences (CDSs). Bioinformatics tools based on sequence similarity, motif search, phylogenetic analysis and fold recognition were employed for re-annotation. Our methodology could successfully add functions for 409 hypothetical proteins (HPs), 46 proteins previously annotated as putative and assigned more accurate functions for the known protein sequences. Homology based gene annotation has been used as a standard method for assigning function to novel proteins, but over the past few years many non-homology based methods such as genomic context approaches for protein function prediction have been developed. Using non-homology based functional prediction methods, we were able to assign cellular processes or physical complexes for 249 hypothetical sequences. Our re-annotation pipeline highlights the addition of 231 new CDSs generated from MicroScope Platform, to the original genome with functional prediction for 49 of them. The re-annotation of HPs and new CDSs is stored in the relational database that is available on the MicroScope web-based platform. In parallel, a comparative genome analyses were performed among the members of genus Caldicellulosiruptor to understand the function and evolutionary processes. Further, with results from integrated re-annotation studies (homology and genomic context approach), we strongly suggest that Csac_0437 and Csac_0424 encode for glycoside hydrolases (GH) and are proposed to be involved in the decomposition of recalcitrant plant polysaccharides. Similarly, HPs: Csac_0732, Csac_1862, Csac_1294 and Csac_0668 are suggested to play a significant role in biohydrogen production. Function prediction of these HPs by using our integrated approach will considerably enhance the interpretation of large-scale experiments targeting this industrially important organism.	[Chowdhary, Nupoor; Selvaraj, Ashok; KrishnaKumaar, Lakshmi; Kumar, Gopal Ramesh] Anna Univ, AU KBC Res Ctr, Chennai 600044, Tamil Nadu, India	Anna University; Anna University Chennai	Kumar, GR (corresponding author), Anna Univ, AU KBC Res Ctr, MIT Campus, Chennai 600044, Tamil Nadu, India.	grameshpub@au-kbc.org			Department of Science and Technology under "Women Scientists Scheme (WOS)-A" [SR/WOS-A/LS-362/2013]	Department of Science and Technology under "Women Scientists Scheme (WOS)-A"(Department of Science & Technology (India)Department of Science & Technology (DOST), Philippines)	Nupoor Chowdhary sincerely thanks Department of Science and Technology for financial assistance under "Women Scientists Scheme (WOS)-A" (File No.-SR/WOS-A/LS-362/2013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albertson GD, 1997, BBA-GENE STRUCT EXPR, V1354, P35, DOI 10.1016/S0167-4781(97)00123-1; Alikhan NF, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-402; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Benemann JR, 1997, INT J HYDROGEN ENERG, V22, P979, DOI 10.1016/S0360-3199(96)00189-9; Bielen Abraham A. M., 2013, Life-Basel, V3, P52, DOI 10.3390/life3010052; Blumer-Schuette SE, 2010, APPL ENVIRON MICROB, V76, P8084, DOI 10.1128/AEM.01400-10; Bocs S, 2003, NUCLEIC ACIDS RES, V31, P3723, DOI 10.1093/nar/gkg590; Chakrabarty AM, 1998, MOL MICROBIOL, V28, P875, DOI 10.1046/j.1365-2958.1998.00846.x; Cheng F, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00198; D'Afonseca V, 2012, OPEN ACCESS BIOINFOR, V4, P1, DOI DOI 10.2147/OAB.S25500; Das D, 2001, INT J HYDROGEN ENERG, V26, P13, DOI 10.1016/S0360-3199(00)00058-6; de Castro E, 2006, NUCLEIC ACIDS RES, V34, pW362, DOI 10.1093/nar/gkl124; de Vrije T, 2007, APPL MICROBIOL BIOT, V74, P1358, DOI 10.1007/s00253-006-0783-x; de Vrije T, 2009, BIOTECHNOL BIOFUELS, V2, DOI 10.1186/1754-6834-2-12; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Doerks T, 2004, NUCLEIC ACIDS RES, V32, P6321, DOI 10.1093/nar/gkh973; Doerks T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034302; Eng J, 2015, ROC ANAL WEB BASED C; Franceschini A, 2013, NUCLEIC ACIDS RES, V41, pD808, DOI 10.1093/nar/gks1094; Gil R, 2004, MICROBIOL MOL BIOL R, V68, P518, DOI 10.1128/MMBR.68.3.518-537.2004; Godzik A, 2005, STRUCTURAL BIOINFORM, V44, P525; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hallenbeck PC, 2009, TRENDS BIOTECHNOL, V27, P287, DOI 10.1016/j.tibtech.2009.02.004; HUDSON RC, 1991, BIOCHEM J, V273, P645, DOI 10.1042/bj2730645; Johnson DC, 2005, ANNU REV BIOCHEM, V74, P247, DOI 10.1146/annurev.biochem.74.082803.133518; Jones P, 2014, BIOINFORMATICS, V30, P1236, DOI 10.1093/bioinformatics/btu031; Kalia VC, 2003, TRENDS BIOTECHNOL, V21, P152, DOI 10.1016/S0167-7799(03)00028-3; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; LAMED R, 1988, ADV APPL MICROBIOL, V33, P1, DOI 10.1016/S0065-2164(08)70203-X; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee R. A., 2013, Animal Frontiers, V3, P6, DOI 10.2527/af.2013-0010; Liu DW, 2006, WATER RES, V40, P2230, DOI 10.1016/j.watres.2006.03.029; LOVE DR, 1987, BIO-TECHNOL, V5, P384, DOI 10.1038/nbt0487-384; Lubec G, 2005, PROG NEUROBIOL, V77, P90, DOI 10.1016/j.pneurobio.2005.10.001; LUTHI E, 1991, APPL ENVIRON MICROB, V57, P694; METZ CE, 1978, SEMIN NUCL MED, V8, P283, DOI 10.1016/S0001-2998(78)80014-2; Nandi R, 1998, CRIT REV MICROBIOL, V24, P61, DOI 10.1080/10408419891294181; Ofran Y, 2005, DRUG DISCOV TODAY, V10, P1475, DOI 10.1016/S1359-6446(05)03621-4; Ooi HS, 2009, NUCLEIC ACIDS RES, V37, pW435, DOI 10.1093/nar/gkp254; RAINEY FA, 1994, FEMS MICROBIOL LETT, V120, P263, DOI 10.1016/0378-1097(94)90481-2; Rajadurai CP, 2013, INDIAN J BIOTECHNOL, V12, P356; Rajadurai CP, 2011, CURR BIOINFORM, V6, P450; SCHMITZ O, 1995, EUR J BIOCHEM, V233, P266, DOI 10.1111/j.1432-1033.1995.266_1.x; SCHOFIELD LR, 1993, INT J BIOCHEM, V25, P609, DOI 10.1016/0020-711X(93)90670-A; Shahbaaz M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084263; SMITH ET, 1992, BIOCHEM J, V285, P181, DOI 10.1042/bj2850181; Swets JA, 2000, SCI AM, V283, P82, DOI 10.1038/scientificamerican1000-82; Tatusov RL, 2000, NUCLEIC ACIDS RES, V28, P33, DOI 10.1093/nar/28.1.33; THAUER RK, 1977, BACTERIOL REV, V41, P100, DOI 10.1128/MMBR.41.1.100-180.1977; Ueno Y, 1996, J FERMENT BIOENG, V82, P194, DOI 10.1016/0922-338X(96)85050-1; Vallenet D, 2013, NUCLEIC ACIDS RES, V41, pE636, DOI 10.1093/nar/gks1194; van de Werken HJG, 2008, APPL ENVIRON MICROB, V74, P6720, DOI 10.1128/AEM.00968-08; VanFossen AL, 2008, ANN NY ACAD SCI, V1125, P322, DOI 10.1196/annals.1419.017; VanFossen AL, 2011, BIOTECHNOL BIOENG, V108, P1559, DOI 10.1002/bit.23093; Whisstock JC, 2003, Q REV BIOPHYS, V36, P307, DOI 10.1017/S0033583503003901; Willquist K, 2010, MICROB CELL FACT, V9, DOI 10.1186/1475-2859-9-89; Xu P, 2004, NATURE, V431, P1107, DOI 10.1038/nature02977; Xu P, 2011, SCI REP-UK, V1, DOI 10.1038/srep00125; Yu NY, 2010, BIOINFORMATICS, V26, P1608, DOI 10.1093/bioinformatics/btq249; Zhou Y, 2007, NUCLEIC ACIDS RES, V35, pW678, DOI 10.1093/nar/gkm278	63	7	7	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0133183	10.1371/journal.pone.0133183	http://dx.doi.org/10.1371/journal.pone.0133183			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LZ	26196387	Green Published, Green Submitted, gold			2022-12-26	WOS:000358547600067
J	Rowe, W; Baker, KS; Verner-Jeffreys, D; Baker-Austin, C; Ryan, JJ; Maskell, D; Pearce, G				Rowe, Will; Baker, Kate S.; Verner-Jeffreys, David; Baker-Austin, Craig; Ryan, Jim J.; Maskell, Duncan; Pearce, Gareth			Search Engine for Antimicrobial Resistance: A Cloud Compatible Pipeline and Web Interface for Rapidly Detecting Antimicrobial Resistance Genes Directly from Sequence Data	PLOS ONE			English	Article							ANTIBIOTIC-RESISTANCE; IDENTIFICATION; METAGENOME; ALIGNMENT	Background Antimicrobial resistance remains a growing and significant concern in human and veterinary medicine. Current laboratory methods for the detection and surveillance of antimicrobial resistant bacteria are limited in their effectiveness and scope. With the rapidly developing field of whole genome sequencing beginning to be utilised in clinical practice, the ability to interrogate sequencing data quickly and easily for the presence of antimicrobial resistance genes will become increasingly important and useful for informing clinical decisions. Additionally, use of such tools will provide insight into the dynamics of antimicrobial resistance genes in metagenomic samples such as those used in environmental monitoring. Results Here we present the Search Engine for Antimicrobial Resistance (SEAR), a pipeline and web interface for detection of horizontally acquired antimicrobial resistance genes in raw sequencing data. The pipeline provides gene information, abundance estimation and the reconstructed sequence of antimicrobial resistance genes; it also provides web links to additional information on each gene. The pipeline utilises clustering and read mapping to annotate full-length genes relative to a user-defined database. It also uses local alignment of annotated genes to a range of online databases to provide additional information. We demonstrate SEAR's application in the detection and abundance estimation of antimicrobial resistance genes in two novel environmental metagenomes, 32 human faecal microbiome datasets and 126 clinical isolates of Shigella sonnei. Conclusions We have developed a pipeline that contributes to the improved capacity for antimicrobial resistance detection afforded by next generation sequencing technologies, allowing for rapid detection of antimicrobial resistance genes directly from sequencing data. SEAR uses raw sequencing data via an intuitive interface so can be run rapidly without requiring advanced bioinformatic skills or resources. Finally, we show that SEAR is effective in detecting antimicrobial resistance genes in metagenomic and isolate sequencing data from both environmental metagenomes and sequencing data from clinical isolates.	[Rowe, Will; Maskell, Duncan; Pearce, Gareth] Univ Cambridge, Dept Vet Med, Cambridge, England; [Baker, Kate S.] Wellcome Trust Sanger Inst, Cambridge, England; [Verner-Jeffreys, David; Baker-Austin, Craig] Ctr Environm Fisheries & Aquaculture Sci, Weymouth, MA USA; [Ryan, Jim J.] GlaxoSmithKline, Environm Hlth & Safety, Ware, Herts, England	University of Cambridge; Wellcome Trust Sanger Institute; GlaxoSmithKline	Rowe, W (corresponding author), Univ Cambridge, Dept Vet Med, Cambridge, England.	wpmr2@cam.ac.uk	Pearce, Gareth P/D-1044-2013; Baker, Kate/P-2087-2016	Baker, Kate/0000-0001-5850-1949; Rowe, Will/0000-0003-0384-4463; Pearce, Gareth/0000-0002-0656-6553	GlaxoSmithKline; Centre for Environment, Fisheries and Aquaculture Science; Biotechnology and Biological Sciences Research Council; Biotechnology and Biological Sciences Research Council [1075426] Funding Source: researchfish	GlaxoSmithKline(GlaxoSmithKline); Centre for Environment, Fisheries and Aquaculture Science; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This research was funded by GlaxoSmithKline, the Centre for Environment, Fisheries and Aquaculture Science and the Biotechnology and Biological Sciences Research Council under an industrial CASE studentship. The funder Centre for Environment, Fisheries and Aquaculture Science provided support in the form of salaries, research materials and facilities for authors DVJ and CBA, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funder GlaxoSmithKline provided support in the form of salaries for author JR, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of the authors are articulated in the 'author contributions' section.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Berendonk TU, 2015, NAT REV MICROBIOL, V13, P310, DOI 10.1038/nrmicro3439; CDC CfDCaP, 2013, ANT RES THREATS US; Diekema DJ, 2013, CLIN INFECT DIS, V56, P1614, DOI 10.1093/cid/cit038; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Espy MJ, 2006, CLIN MICROBIOL REV, V19, P165, DOI 10.1128/CMR.19.1.165-256.2006; Forslund K, 2013, GENOME RES, V23, P1163, DOI 10.1101/gr.155465.113; Gupta SK, 2014, ANTIMICROB AGENTS CH, V58, P212, DOI 10.1128/AAC.01310-13; Harrison EM, 2013, EMBO MOL MED, V5, P509, DOI 10.1002/emmm.201202413; Heiman KE, 2014, MMWR-MORBID MORTAL W, V63, P132; Holt KE, 2012, NAT GENET, V44, P1056, DOI 10.1038/ng.2369; Hu YF, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3151; Illumina, 2013, ILL MYSEQ BENCHT SEQ; Inouye M, 2014, GENOME MED, V6, DOI 10.1186/s13073-014-0090-6; Kidenya BR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057527; Koser CU, 2012, NEW ENGL J MED, V366, P2267, DOI 10.1056/NEJMoa1109910; Laxminarayan R, 2013, LANCET INFECT DIS, V13, P1057, DOI 10.1016/S1473-3099(13)70318-9; Lewin A, 2014, ENVIRON MICROBIOL, V16, P545, DOI 10.1111/1462-2920.12181; Li H, 2011, BIOINFORMATICS, V27, P2987, DOI 10.1093/bioinformatics/btr509; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liu B, 2009, NUCLEIC ACIDS RES, V37, pD443, DOI 10.1093/nar/gkn656; Mason OU, 2012, ISME J, V6, P1715, DOI 10.1038/ismej.2012.59; McArthur AG, 2013, ANTIMICROB AGENTS CH, V57, P3348, DOI 10.1128/AAC.00419-13; Miller RR, 2013, GENOME MED, V5, DOI 10.1186/gm485; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Naccache SN, 2014, GENOME RES, V24, P1180, DOI 10.1101/gr.171934.113; Oh S, 2013, ENVIRON MICROBIOL, V15, P2850, DOI 10.1111/1462-2920.12154; Port JA, 2014, ENVIRON HEALTH PERSP, V122, P222, DOI 10.1289/ehp.1307009; Rozen S, 1988, PRIMER3; Sack D.A., 2001, ANTIMICROBIAL RESIST; Tsafnat G, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar054; WHO, 2012, EVOLVING THREAT OF ANTIMICROBIAL RESISTANCE: OPTIONS FOR ACTION, P1; Zankari E, 2012, J ANTIMICROB CHEMOTH, V67, P2640, DOI 10.1093/jac/dks261	33	36	39	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0133492	10.1371/journal.pone.0133492	http://dx.doi.org/10.1371/journal.pone.0133492			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LZ	26197475	Green Published, gold, Green Submitted			2022-12-26	WOS:000358547600104
J	Moreira-Souza, ACA; Marinho, Y; Correa, G; Santoro, GF; Coutinho, CMLM; Vommaro, RC; Coutinho-Silva, R				Abreu Moreira-Souza, Aline Cristina; Marinho, Ygor; Correa, Gladys; Santoro, Giani Franca; Lara Melo Coutinho, Claudia Mara; Vommaro, Rossiane Claudia; Coutinho-Silva, Robson			Pyrimidinergic Receptor Activation Controls Toxoplasma gondii Infection in Macrophages	PLOS ONE			English	Article							MOLECULAR-MECHANISMS; SIGNALING CASCADES; IMMUNE-RESPONSE; HOST-CELLS; UTP; APOPTOSIS; INVASION; TRIGGERS; EGRESS; STORES	Infection by the protozoan parasite Toxoplasma gondii is highly prevalent worldwide and may have serious clinical manifestations in immunocompromised patients. T. gondii is an obligate intracellular parasite that infects almost any cell type in mammalian hosts, including immune cells. The immune cells express purinergic P2 receptors in their membrane subdivided into P2Y and P2X subfamilies - whose activation is important for infection control. Here, we examined the effect of treatment with UTP and UDP in mouse peritoneal macrophages infected with T. gondii tachyzoites. Treatment with these nucleotides reduced parasitic load by 90%, but did not increase the levels of the inflammatory mediators NO and ROS, nor did it modulate host cell death by apoptosis or necrosis. On the other hand, UTP and UDP treatments induced early egress of tachyzoites from infected macrophages, in a Ca2+-dependent manner, as shown by scanning electron microscopy analysis, and video-microscopy. In subsequent infections, prematurely egressed parasites had reduced infectivity, and could neither replicate nor inhibit the fusion of lysosomes to the parasitophorous vacuole. The use of selective agonists and antagonists of the receptor subtypes P2Y(2) and P2Y(4) and P2Y(6) showed that premature parasite egress may be mediated by the activation of these receptor subtypes. Our results suggest that the activity of P2Y host cell receptors controls T. gondii infection in macrophages, highlighting the importance of pyrimidinergic signaling for innate immune system response against infection. Finally the P2Y receptors should be considered as new target for the development of drugs against T. gondii infection.	[Abreu Moreira-Souza, Aline Cristina; Marinho, Ygor; Correa, Gladys; Santoro, Giani Franca; Coutinho-Silva, Robson] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Lab Imunofisiol, BR-21941902 Rio De Janeiro, RJ, Brazil; [Santoro, Giani Franca; Lara Melo Coutinho, Claudia Mara] Fiocruz MS, Inst Oswaldo Cruz, LITEB, BR-21040900 Rio De Janeiro, RJ, Brazil; [Lara Melo Coutinho, Claudia Mara] Univ Fed Fluminense, Inst Biol, BR-24020140 Niteroi, RJ, Brazil; [Abreu Moreira-Souza, Aline Cristina; Correa, Gladys; Vommaro, Rossiane Claudia] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Lab Ultraestrutura Celular Hertha Meyer, BR-21941902 Rio De Janeiro, RJ, Brazil; [Abreu Moreira-Souza, Aline Cristina; Marinho, Ygor; Correa, Gladys; Santoro, Giani Franca; Coutinho-Silva, Robson] Univ Fed Rio de Janeiro, Inst Nacl Ciencia & Tecnol Pesquisa Translac Saud, BR-21941902 Rio de Janeiro, RJ, Brazil	Universidade Federal do Rio de Janeiro; Fundacao Oswaldo Cruz; Universidade Federal Fluminense; Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro	Coutinho-Silva, R (corresponding author), Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Lab Imunofisiol, BR-21941902 Rio De Janeiro, RJ, Brazil.	rcsilva@biof.ufrj.br	vommaro, Rossiane/AAD-7193-2021; Coutinho-Silva, Robson/M-4690-2013	Coutinho-Silva, Robson/0000-0002-7318-0204; Moreira-Souza, Aline Cristina Abreu/0000-0002-9814-340X; Vommaro, Rossiane/0000-0003-4768-1555; Correa, Gladys/0000-0002-9707-7615	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico do Brasil (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Programa de Nucleos de Excelencia (PRONEX); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ); Instituto Nacional de Ciencia e Tecnologia para Pesquisa Translacional em Saude e Ambiente na Regiao Amazonica INPeTAm/UFRJ	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico do Brasil (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Programa de Nucleos de Excelencia (PRONEX)(Fundacao de Apoio a Pesquisa do Distrito Federal (FAPDF)Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Instituto Nacional de Ciencia e Tecnologia para Pesquisa Translacional em Saude e Ambiente na Regiao Amazonica INPeTAm/UFRJ	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico do Brasil (CNPq), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Programa de Nucleos de Excelencia (PRONEX), Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ), and Instituto Nacional de Ciencia e Tecnologia para Pesquisa Translacional em Saude e Ambiente na Regiao Amazonica INPeTAm/UFRJ.	Abbracchio MP, 2006, PHARMACOL REV, V58, P281, DOI 10.1124/pr.58.3.3; Akerman SE, 2005, J BIOL CHEM, V280, P564, DOI 10.1074/jbc.M406367200; Aliberti J, 2002, MOL IMMUNOL, V38, P891, DOI 10.1016/S0161-5890(02)00015-9; Bertaux L, 2008, PARASITE IMMUNOL, V30, P620, DOI 10.1111/j.1365-3024.2008.01064.x; Bierly AL, 2008, J IMMUNOL, V181, P8485, DOI 10.4049/jimmunol.181.12.8485; Billker O, 2009, CELL HOST MICROBE, V5, P612, DOI 10.1016/j.chom.2009.05.017; Bours MJL, 2006, PHARMACOL THERAPEUT, V112, P358, DOI 10.1016/j.pharmthera.2005.04.013; Caldas LA, 2007, VET PARASITOL, V147, P210, DOI 10.1016/j.vetpar.2007.05.012; Caldas LA, 2010, VET PARASITOL, V167, P8, DOI 10.1016/j.vetpar.2009.09.051; Correa G, 2010, MICROBES INFECT, V12, P497, DOI 10.1016/j.micinf.2010.03.004; Coutinho-Silva R, 2005, BIOCHEM PHARMACOL, V69, P641, DOI 10.1016/j.bcp.2004.11.012; Coutinho-Silva R, 2007, PURINERG SIGNAL, V3, P83, DOI 10.1007/s11302-006-9039-6; Coutinho-Silva R, 2009, PURINERG SIGNAL, V5, P197, DOI 10.1007/s11302-009-9130-x; D'Angelillo A, 2011, APOPTOSIS, V16, P551, DOI 10.1007/s10495-011-0586-0; Denkers EY, 2003, FEMS IMMUNOL MED MIC, V39, P193, DOI 10.1016/S0928-8244(03)00279-7; Denkers EY, 2003, CELL MICROBIOL, V5, P75, DOI 10.1046/j.1462-5822.2003.00258.x; Dubey JP, 1998, INT J PARASITOL, V28, P1019, DOI 10.1016/S0020-7519(98)00023-X; Flannagan RS, 2009, NAT REV MICROBIOL, V7, P355, DOI 10.1038/nrmicro2128; Ko HJ, 2008, BIOORGAN MED CHEM, V16, P6319, DOI 10.1016/j.bmc.2008.05.013; Kwok LY, 2004, MOL MICROBIOL, V51, P47, DOI 10.1046/j.1365-2958.2003.03823.x; Lavine MD, 2008, EUKARYOT CELL, V7, P131, DOI 10.1128/EC.00301-07; Lazarowski ER, 2001, NEWS PHYSIOL SCI, V16, P1; Lourido S, 2010, NATURE, V465, P359, DOI 10.1038/nature09022; Lovett JL, 2003, J CELL SCI, V116, P3009, DOI 10.1242/jcs.00596; Lovett JL, 2002, J BIOL CHEM, V277, P25870, DOI 10.1074/jbc.M202553200; Luder CGK, 2005, CURR TOP MICROBIOL, V289, P219; Magno RC, 2005, MICROSC RES TECHNIQ, V67, P45, DOI 10.1002/jemt.20182; Marques-da-Silva C, 2011, CELL MICROBIOL, V13, P1410, DOI 10.1111/j.1462-5822.2011.01630.x; Morandini Ana Carolina, 2014, Biomed J, V37, P169, DOI 10.4103/2319-4170.127803; Mordue DG, 1997, J IMMUNOL, V159, P4452; Moudy R, 2001, J BIOL CHEM, V276, P41492, DOI 10.1074/jbc.M106154200; Pifer R, 2011, TRENDS PARASITOL, V27, P388, DOI 10.1016/j.pt.2011.03.009; Ralevic V, 1998, PHARMACOL REV, V50, P413; Rossi L, 2007, BLOOD, V109, P533, DOI 10.1182/blood-2006-01-035634; Shainberg A, 2009, CAN J PHYSIOL PHARM, V87, P287, DOI 10.1139/Y09-010; Sibley LD, 2003, TRAFFIC, V4, P581, DOI 10.1034/j.1600-0854.2003.00117.x; Yamamoto JH, 2000, J INFECT DIS, V181, P2018, DOI 10.1086/315494; Zhang Z, 2011, J IMMUNOL, V186, P5376, DOI 10.4049/jimmunol.1002946	38	16	16	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2015	10	7							e0133502	10.1371/journal.pone.0133502	http://dx.doi.org/10.1371/journal.pone.0133502			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LN	26192447	gold, Green Published, Green Submitted			2022-12-26	WOS:000358546400097
J	Gardin, C; Ricci, S; Ferroni, L; Guazzo, R; Sbricoli, L; De Benedictis, G; Finotti, L; Isola, M; Bressan, E; Zavan, B				Gardin, Chiara; Ricci, Sara; Ferroni, Letizia; Guazzo, Riccardo; Sbricoli, Luca; De Benedictis, Giulia; Finotti, Luca; Isola, Maurizio; Bressan, Eriberto; Zavan, Barbara			Decellularization and Delipidation Protocols of Bovine Bone and Pericardium for Bone Grafting and Guided Bone Regeneration Procedures	PLOS ONE			English	Article							IN-VITRO; OSTEOBLAST DIFFERENTIATION; EXTRACELLULAR-MATRIX; TISSUE REGENERATION; SINUS AUGMENTATION; BARRIER MEMBRANES; FUTURE-DIRECTIONS; CRITICAL-SIZE; DEFECTS; COLLAGEN	The combination of bone grafting materials with guided bone regeneration (GBR) membranes seems to provide promising results to restore bone defects in dental clinical practice. In the first part of this work, a novel protocol for decellularization and delipidation of bovine bone, based on multiple steps of thermal shock, washes with detergent and dehydration with alcohol, is described. This protocol is more effective in removal of cellular materials, and shows superior biocompatibility compared to other three methods tested in this study. Furthermore, histological and morphological analyses confirm the maintenance of an intact bone extracellular matrix (ECM). In vitro and in vivo experiments evidence osteoinductive and osteoconductive properties of the produced scaffold, respectively. In the second part of this study, two methods of bovine pericardium decellularization are compared. The osmotic shock-based protocol gives better results in terms of removal of cell components, biocompatibility, maintenance of native ECM structure, and host tissue reaction, in respect to the freeze/thaw method. Overall, the results of this study demonstrate the characterization of a novel protocol for the decellularization of bovine bone to be used as bone graft, and the acquisition of a method to produce a pericardium membrane suitable for GBR applications.	[Gardin, Chiara; Ferroni, Letizia; Zavan, Barbara] Univ Padua, Dept Biomed Sci, Padua, Italy; [Ricci, Sara; Guazzo, Riccardo; Sbricoli, Luca; Bressan, Eriberto] Univ Padua, Dept Neurosci, Padua, Italy; [De Benedictis, Giulia; Finotti, Luca; Isola, Maurizio] Univ Padua, Dept Anim Med Prod & Hlth, Padua, Italy	University of Padua; University of Padua; University of Padua	Ferroni, L (corresponding author), Univ Padua, Dept Biomed Sci, Padua, Italy.	letizia.ferroni@unipd.it; barbara.zavan@unipd.it	De Benedictis, Giulia Maria/ABH-1546-2020; Sbricoli, Luca/AAX-2640-2020	De Benedictis, Giulia Maria/0000-0002-8422-6829; Sbricoli, Luca/0000-0003-2222-5764; Gardin, Chiara/0000-0003-3817-0032; Ferroni, Letizia/0000-0002-5457-0338	University of Padova (progetto di Ateneo) grant	University of Padova (progetto di Ateneo) grant	This research was supported by a University of Padova (progetto di Ateneo) grant to BZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrektsson T, 2001, EUR SPINE J, V10, pS96, DOI 10.1007/s005860100282; Aral A, 2008, CLIN ORAL IMPLAN RES, V19, P612, DOI 10.1111/j.1600-0501.2007.01518.x; ASHLEY F L, 1959, Plast Reconstr Surg Transplant Bull, V23, P526, DOI 10.1097/00006534-195905000-00006; Badylak SF, 2011, ANNU REV BIOMED ENG, V13, P27, DOI 10.1146/annurev-bioeng-071910-124743; Badylak SF, 2009, ACTA BIOMATER, V5, P1, DOI 10.1016/j.actbio.2008.09.013; Bai M, 2014, J PERIODONTAL RES, V49, P499, DOI 10.1111/jre.12129; Becker W, 1996, J PERIODONTOL, V67, P641, DOI 10.1902/jop.1996.67.7.641; Berardinelli P, 2013, CLIN ORAL INVEST, V17, P1661, DOI 10.1007/s00784-012-0857-3; Bressan E, 2011, POLYMERS-BASEL, V3, P509, DOI 10.3390/polym3010509; CHAPPARD D, 1993, BIOMATERIALS, V14, P507, DOI 10.1016/0142-9612(93)90238-W; Crapo PM, 2011, BIOMATERIALS, V32, P3233, DOI 10.1016/j.biomaterials.2011.01.057; Cucchi A, 2014, OPEN DENT J, V8, P194, DOI 10.2174/1874210601408010194; Cruz Gabriela Alessandra da, 2007, Braz. Dent. J., V18, P129, DOI 10.1590/S0103-64402007000200008; DENIZOT F, 1986, J IMMUNOL METHODS, V89, P271, DOI 10.1016/0022-1759(86)90368-6; Dimitriou R, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-66; Dong JM, 2013, J SURG RES, V183, P56, DOI 10.1016/j.jss.2012.11.047; Donos N, 2004, CLIN ORAL IMPLAN RES, V15, P101, DOI 10.1111/j.1600-0501.2004.00986.x; Donos N, 2002, CLIN ORAL IMPLAN RES, V13, P203, DOI 10.1034/j.1600-0501.2002.130211.x; Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3; Elsalanty ME, 2009, CRANIOMAX TRAUM REC, V2, P125, DOI 10.1055/s-0029-1215875; Ereno C, 2010, J BIOMED MATER RES A, V95A, P932, DOI 10.1002/jbm.a.32919; Estaca E, 2008, CLIN ORAL IMPLAN RES, V19, P1044, DOI 10.1111/j.1600-0501.2008.01557.x; FAGES J, 1994, BIOMATERIALS, V15, P650, DOI 10.1016/0142-9612(94)90162-7; FRANCESCHI RT, 1994, J BONE MINER RES, V9, P843; Frantz C, 2010, J CELL SCI, V123, P4195, DOI 10.1242/jcs.023820; Gardin C, 2012, STEM CELLS DEV, V21, P767, DOI 10.1089/scd.2011.0147; Gilbert TW, 2012, J CELL BIOCHEM, V113, P2217, DOI 10.1002/jcb.24130; Gilbert TW, 2006, BIOMATERIALS, V27, P3675, DOI 10.1016/j.biomaterials.2006.02.014; Guo TW, 2015, PHARMACOGN MAG, V11, P219, DOI 10.4103/0973-1296.149741; Hammerle CHF, 2003, PERIODONTOL 2000, V33, P36, DOI 10.1046/j.0906-6713.2003.03304.x; HAUSCHKA PV, 1989, PHYSIOL REV, V69, P990, DOI 10.1152/physrev.1989.69.3.990; Heinze J, 2004, ANN C INT ASS DENT R; Hirata HH, 2015, INJURY, V46, P1215, DOI 10.1016/j.injury.2015.03.039; Hsiong SX, 2006, PERIODONTOL 2000, V41, P109, DOI 10.1111/j.1600-0757.2006.00158.x; Jimbo R, 2012, INT J BIOMATER, V2012, DOI 10.1155/2012/279167; Kanczler JM, 2008, EUR CELLS MATER, V15, P100, DOI 10.22203/eCM.v015a08; Katz J, 2009, J BIOMATER APPL, V24, P159, DOI 10.1177/0885328208095174; Kern B, 2001, J BIOL CHEM, V276, P7101, DOI 10.1074/jbc.M006215200; Keskin D, 2007, MED PRIN PRACT, V16, P299, DOI 10.1159/000102153; Khan SN, 2005, J AM ACAD ORTHOP SUR, V13, P77, DOI 10.5435/00124635-200501000-00010; Kim JY, 2014, J ADV PROSTHODONT, V6, P539, DOI 10.4047/jap.2014.6.6.539; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Lai PH, 2006, TISSUE ENG, V12, P2499, DOI 10.1089/ten.2006.12.2499; Liu Jie, 2014, Open Dent J, V8, P56, DOI 10.2174/1874210601408010056; Liu WG, 2001, J CELL BIOL, V155, P157, DOI 10.1083/jcb.200105052; Mirsadraee S, 2007, J SURG RES, V143, P407, DOI 10.1016/j.jss.2007.01.026; Moreau MF, 2000, BIOMATERIALS, V21, P369, DOI 10.1016/S0142-9612(99)00193-3; Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/S0092-8674(01)00622-5; Oryan A, 2014, J ORTHOP SURG RES, V9, DOI 10.1186/1749-799X-9-18; Peng F, 2011, ACTA BIOMATER, V7, P2585, DOI 10.1016/j.actbio.2011.02.021; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Phillips JE, 2006, J CELL SCI, V119, P581, DOI 10.1242/jcs.02758; Rakhmatia YD, 2013, J PROSTHODONT RES, V57, P3, DOI 10.1016/j.jpor.2012.12.001; Salata LA, 2001, CLIN ORAL IMPLAN RES, V12, P62, DOI 10.1034/j.1600-0501.2001.012001062.x; Samouillan V, 1999, J BIOMED MATER RES, V46, P531, DOI 10.1002/(SICI)1097-4636(19990915)46:4<531::AID-JBM11>3.0.CO;2-2; SCANTLEBURY TV, 1993, J PERIODONTOL, V64, P1129, DOI 10.1902/jop.1993.64.11s.1129; Seibel MJ, 2000, OSTEOPOROSIS INT, V11, P18; SHAPOFF CA, 1980, J PERIODONTOL, V51, P625, DOI 10.1902/jop.1980.51.11.625; Silva-Correia J, 2013, ADV HEALTHC MATER, V2, P568, DOI 10.1002/adhm.201200256; Stapleton TW, 2008, TISSUE ENG PT A, V14, P505, DOI 10.1089/tea.2007.0233; Tadic D, 2004, BIOMATERIALS, V25, P987, DOI 10.1016/S0142-9612(03)00621-5; TERMINE JD, 1981, CELL, V26, P99, DOI 10.1016/0092-8674(81)90037-4; Thomaidis V, 2008, MED SCI MONITOR, V14, pBR67; Wang YB, 2013, MAT SCI ENG C-MATER, V33, P3489, DOI 10.1016/j.msec.2013.04.038; Zhang NL, 2014, CELL TISSUE BANK, V15, P357, DOI 10.1007/s10561-013-9391-z	65	62	62	3	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2015	10	7							e0132344	10.1371/journal.pone.0132344	http://dx.doi.org/10.1371/journal.pone.0132344			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LN	26191793	Green Submitted, Green Published, gold			2022-12-26	WOS:000358546400022
J	Fiset, C; Rioux, FM; Surette, ME; Fiset, S				Fiset, Catherine; Rioux, France M.; Surette, Marc E.; Fiset, Sylvain			Prenatal Iron Deficiency in Guinea Pigs Increases Locomotor Activity but Does Not Influence Learning and Memory	PLOS ONE			English	Article							ESSENTIAL FATTY-ACID; MORRIS WATER MAZE; BRAIN IRON; EICOSANOID METABOLISM; MONOAMINE METABOLISM; COGNITIVE DEFICITS; MATERNAL ANEMIA; SPATIAL MEMORY; MALE RATS; BEHAVIOR	The objective of the current study was to determine whether prenatal iron deficiency induced during gestation in guinea pigs affected locomotor activity and learning and memory processes in the progeny. Dams were fed either iron-deficient anemic or iron-sufficient diets throughout gestation and lactation. After weaning, all pups were fed an iron-sufficient diet. On postnatal day 24 and 40, the pups' locomotor activity was observed within an open-field test, and from postnatal day 25 to 40, their learning and memory processes were assessed within a Morris Water Maze. The behavioural and cognitive tests revealed that the iron deficient pup group had increased locomotor activity, but solely on postnatal day 40, and that there were no group differences in the Morris Water Maze. In the general discussion, we propose that prenatal iron deficiency induces an increase in nervousness due to anxiety in the progeny, which, in the current study, resulted in an increase of locomotor activity.	[Fiset, Catherine; Rioux, France M.] Univ Ottawa, Fac Sci Sante, Programme Nutr, Ottawa, ON, Canada; [Surette, Marc E.] Univ Moncton, Dept Chim & Biochim, Moncton, NB E1A 3E9, Canada; [Fiset, Sylvain] Univ Moncton, Secteur Sci Humaines, Edmundston, NB, Canada	University of Ottawa; University of Moncton; University of Moncton	Fiset, S (corresponding author), Univ Moncton, Secteur Sci Humaines, Campus Edmundston, Edmundston, NB, Canada.	sylvain.fiset@umoncton.ca	Fiset, Sylvain/J-5550-2019; Surette, Marc/AAW-1078-2021	Fiset, Sylvain/0000-0002-9173-8304; Fiset, Catherine/0000-0001-5593-4538	Canadian Institutes of Health Research [ME-298]; Corsortium National de Formation en Sante; Canada Research Chairs Program	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Corsortium National de Formation en Sante; Canada Research Chairs Program(Canada Research Chairs)	This study was supported by two research grants, one from the Canadian Institutes of Health Research (no. ME-298) [http://www.cihr-irsc.gc.ca] and another from the Corsortium National de Formation en Sante [http://cnfs.net/fr/]. M.E. Surette was also supported by the Canada Research Chairs Program [http://www.chairs-chaires.gc.ca].	[Anonymous], 2001, IRON DEFICIENCY ANAE; Baumgartner J, 2012, J NUTR, V142, P1472, DOI 10.3945/jn.111.156299; Baumgartner J, 2012, J NUTR, V142, P1463, DOI 10.3945/jn.111.156281; BHARGAVA M, 1991, J TROP PEDIATRICS, V37, P149, DOI 10.1093/tropej/37.4.149; Bourque SL, 2008, J NUTR, V138, P931, DOI 10.1093/jn/138.5.931; Briscoe TA, 2004, AM J OBSTET GYNECOL, V191, P847, DOI 10.1016/j.ajog.2004.01.050; Cesario J, 2014, PERSPECT PSYCHOL SCI, V9, P40, DOI 10.1177/1745691613513470; Chang SY, 2013, PEDIATRICS, V131, pE755, DOI 10.1542/peds.2011-3513; Daumas F, 1982, REV STAT APPL, V30, P23; deAndraca I, 1997, NUTR REV, V55, P125, DOI 10.1111/j.1753-4887.1997.tb06463.x; DOBBING J, 1970, BRAIN RES, V17, P115, DOI 10.1016/0006-8993(70)90311-2; Dringenberg HC, 2001, BEHAV BRAIN RES, V124, P97, DOI 10.1016/S0166-4328(01)00188-7; Erikson KM, 1997, J NUTR, V127, P2030, DOI 10.1093/jn/127.10.2030; Eseh R, 2005, BEHAV BRAIN RES, V164, P214, DOI 10.1016/j.bbr.2005.06.019; Felt BT, 2006, BEHAV BRAIN RES, V171, P261, DOI 10.1016/j.bbr.2006.04.001; Fu JY, 2012, BIOL TRACE ELEM RES, V149, P412, DOI 10.1007/s12011-012-9447-0; Gambling L, 2003, J NUTR, V133, p1554S, DOI 10.1093/jn/133.5.1554S; Girbovan C, 2009, NEUROBEHAVIOURAL PRO; Golub MS, 2006, AM J CLIN NUTR, V83, P647, DOI 10.1093/ajcn.83.3.647; Golub MS, 2006, NEUROTOXICOL TERATOL, V28, P3, DOI 10.1016/j.ntt.2005.10.005; Gould TD, 2009, NEUROMETHODS, V42, P1, DOI 10.1007/978-1-60761-303-9_1; Grantham-McGregor S, 2001, J NUTR, V131, p649S, DOI 10.1093/jn/131.2.649S; Graziano A, 2003, J NEUROSCI METH, V130, P33, DOI 10.1016/S0165-0270(03)00187-0; Harper LV, 1976, BIOL GUINEA PIG, P31, DOI DOI 10.1016/B978-0-12-730050-4.50010-7; Harvey L, 2014, BRAIN BEHAV IMMUN, V40, P27, DOI 10.1016/j.bbi.2014.06.005; Harvey L, 2014, BRAIN BEHAV IMMUN, V35, P144, DOI 10.1016/j.bbi.2013.09.009; Howell D.C., 2016, FUNDAMENTAL STAT BEH; IDJRADINATA P, 1993, LANCET, V341, P1, DOI 10.1016/0140-6736(93)92477-B; Jougleux JL, 2014, NUTR NEUROSCI, V17, P37, DOI 10.1179/1476830513Y.0000000067; Jougleux JL, 2011, J NUTR, V141, P1390, DOI 10.3945/jn.110.135715; Jougleux JL, 2014, NUTR NEUROSCI, DOI 10.1179.1476830514y.0000000140; Kwik-Uribe CL, 1999, NEUROTOXICOL TERATOL, V21, P661, DOI 10.1016/S0892-0362(99)00041-0; Kwik-Uribe CL, 2000, J NUTR, V130, P2040, DOI 10.1093/jn/130.8.2040; Leblanc CP, 2009, PROSTAG LEUKOTR ESS, V81, P1, DOI 10.1016/j.plefa.2009.05.023; LeBlanc CP, 2009, J NUTR, V139, P1653, DOI 10.3945/jn.109.106013; LIN JJ, 1968, PSYCHOL REP, V22, P431, DOI 10.2466/pr0.1968.22.2.431; LINDNER MD, 1992, BEHAV NEURAL BIOL, V58, P94, DOI 10.1016/0163-1047(92)90303-L; Lindner MD, 1997, NEUROBIOL LEARN MEM, V68, P203, DOI 10.1006/nlme.1997.3782; LINDNER MD, 1991, BEHAV BRAIN RES, V45, P45, DOI 10.1016/S0166-4328(05)80179-2; LOZOFF B, 1991, NEW ENGL J MED, V325, P687, DOI 10.1056/NEJM199109053251004; Lozoff B, 2000, PEDIATR RES, V48, P137, DOI 10.1203/00006450-200008000-00003; Lozoff B, 2007, FOOD NUTR BULL, V28, pS560, DOI 10.1177/15648265070284S409; Lozoff Betsy, 2006, Semin Pediatr Neurol, V13, P158, DOI 10.1016/j.spen.2006.08.004; MACDONALD VW, 1985, J LAB CLIN MED, V105, P11; McCann JC, 2007, AM J CLIN NUTR, V85, P931, DOI 10.1093/ajcn/85.4.931; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; MORRIS RGM, 1981, LEARN MOTIV, V12, P239, DOI 10.1016/0023-9690(81)90020-5; Nutrition SOLA Nutrition COA Agriculture BO Council NR, 1995, NUTR REQ LAB ANIM; Nyaradi A, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00097; Olfert ED, 1993, GUIDE CARE USE EXPT, V1; Park LM, 2013, THESIS U KANSAS; Pinero DJ, 2001, J NUTR, V131, P311, DOI 10.1093/jn/131.2.311; POLLITT E, 1993, ANNU REV NUTR, V13, P521, DOI 10.1146/annurev.nu.13.070193.002513; Rodriguez A, 2004, Proceedings of the Fourth IASTED International Conference on Visualization, Imaging, and Image Processing, P647; Roncagliolo M, 1998, AM J CLIN NUTR, V68, P683, DOI 10.1093/ajcn/68.3.683; Rood J.P., 1972, Animal Behav Monogr, V5, P1; Russell JF, 2013, NATURE, V496, P7, DOI 10.1038/496007a; Rytych JL, 2012, J NUTR, V142, P2050, DOI 10.3945/jn.112.165522; Savoie N, 2002, CAN J PUBLIC HEALTH, V93, P203, DOI 10.1007/BF03405001; SCHIML PA, 1990, J COMP PSYCHOL, V104, P283, DOI 10.1037/0735-7036.104.3.283; Shadish W. R., 2001, EXPT QUASIEXPERIMENT, V2nd; Simons DJ, 2014, PERSPECT PSYCHOL SCI, V9, P76, DOI 10.1177/1745691613514755; Singla PN, 1997, J TROP PEDIATRICS, V43, P89, DOI 10.1093/tropej/43.2.89; Spink AJ, 2001, PHYSIOL BEHAV, V73, P731, DOI 10.1016/S0031-9384(01)00530-3; Stover KR, 2012, P MEASURING BEHAV, P353; Tapiero H, 2001, BIOMED PHARMACOTHER, V55, P324, DOI 10.1016/S0753-3322(01)00067-1; Terry Jr AV, 2001, METH NE FRO NEUROSCI, P164; Tran TD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074876; TOBACH E, 1966, PSYCHOL REP, V18, P415, DOI 10.2466/pr0.1966.18.2.415; Unger EL, 2012, J NUTR, V142, P2040, DOI 10.3945/jn.112.162198; VAUGHN J, 1986, J NATL MED ASSOC, V78, P963; Vorhees CV, 2006, NAT PROTOC, V1, P848, DOI 10.1038/nprot.2006.116; Wachs TD, 2005, DEV PSYCHOBIOL, V46, P141, DOI 10.1002/dev.20049; WALSH RN, 1976, PSYCHOL BULL, V83, P482, DOI 10.1037/0033-2909.83.3.482; WILLIAMSON AM, 1980, PHYSIOL BEHAV, V24, P561, DOI 10.1016/0031-9384(80)90252-8; Wolfer DP, 1998, NEWS PHYSIOL SCI, V13, P118, DOI 10.1152/physiologyonline.1998.13.3.118; YEHUDA S, 1986, PHARMACOL BIOCHEM BE, V25, P141, DOI 10.1016/0091-3057(86)90244-3; Yong E, 2012, NATURE, V485, P298, DOI 10.1038/485298a; Zipser B, 2014, FRONT ZOOL, V11, DOI 10.1186/1742-9994-11-30	79	10	10	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0133168	10.1371/journal.pone.0133168	http://dx.doi.org/10.1371/journal.pone.0133168			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RV	26186713	gold, Green Submitted, Green Published			2022-12-26	WOS:000358198700104
J	Guillermet, E; Dicko, HM; Mai, LTP; N'Diaye, M; Hane, F; Ba, SO; Gomis, K; Tho, NTT; Lien, NTP; Than, PD; Van Dinh, T; Jaillard, P; Gessner, BD; Colombini, A				Guillermet, Elise; Dicko, Hamadou M.; Le Thi Phuong Mai; N'Diaye, Mamadou; Hane, Fatoumata; Ba, Seydina Ousmane; Gomis, Khadidjatou; Nguyen Thi Thi Tho; Nguyen Thi Phuong Lien; Phan Dang Than; Tran Van Dinh; Jaillard, Philippe; Gessner, Bradford D.; Colombini, Anais			Acceptability and Feasibility of Delivering Pentavalent Vaccines in a Compact, Prefilled, Autodisable Device in Vietnam and Senegal	PLOS ONE			English	Article							SAFETY; SERVICES; VACCINATIONS; IMMUNIZATION	Background Prefilled syringes are the standard in developed countries but logistic and financial barriers prevent their widespread use in developing countries. The current study evaluated use of a compact, prefilled, autodisable device (CPAD) to deliver pentavalent vaccine by field actors in Senegal and Vietnam. Methods We conducted a logistic, programmatic, and anthropological study that included a) interviews of immunization staff at different health system levels and parents attending immunization sessions; b) observation of immunization sessions including CPAD use on oranges; and c) document review. Results Respondents perceived that the CPAD would improve safety by being non-reusable and preventing needle and vaccine exposure during preparation. Preparation was considered simple and may reduce immunization time for staff and caretakers. CPAD impact on cold storage requirements depended on the current pentavalent vaccine being used; in both countries, CPAD would reduce the weight and volume of materials and safety boxes thereby potentially improving outreach strategies and waste disposal. CPAD also would reduce stock outages by bundling vaccine and syringes and reduce wastage by using a non-breakable plastic presentation. Respondents also cited potential challenges including ability to distinguish between CPAD and other pharmaceuticals delivered via a similar mechanism (such as contraceptives), safety, and concerns related to design and ease of administration (such as activation, ease of delivery, and needle diameter and length). Conclusions Compared to current pentavalent vaccine presentations in Vietnam and Senegal, CPAD technology will address some of the main barriers to vaccination, such as supply chain issues and safety concerns among health workers and families. Most of the challenges we identified can be addressed with health worker training, minor design modifications, and health messaging targeting parents and communities. Potentially the largest remaining barrier is the marginal increase in pentavalent cost - if any - from CPAD use, which we did not assess in our study.	[Guillermet, Elise; Dicko, Hamadou M.; Jaillard, Philippe; Gessner, Bradford D.; Colombini, Anais] AMP, Ferney Voltaire, France; [Le Thi Phuong Mai; Nguyen Thi Thi Tho; Nguyen Thi Phuong Lien; Phan Dang Than; Tran Van Dinh] Minist Hlth, Natl Inst Hyg & Epidemiol, Hanoi, Vietnam; [N'Diaye, Mamadou; Ba, Seydina Ousmane; Gomis, Khadidjatou] Minist Hlth, Dakar, Senegal; [Hane, Fatoumata] Univ Ziguinchor, Ziguinchor, Senegal	National Institute of Hygiene & Epidemiology (NIHE)	Gessner, BD (corresponding author), AMP, Ferney Voltaire, France.	bgessner@aamp.org	HANE, Fatoumata/GQA-9196-2022	Le, Mai/0000-0001-7581-4058; Tran, Van Dinh/0000-0001-7590-6518	Crucell	Crucell	This work was supported by Crucell. The funding source for this study had no role in the study design, data collection, data analysis, data interpretation, or writing of the article. The corresponding authors had full access to all data and had final responsibility for the decision to submit or publication.	American Academy of Pediatrics, 2012, REP COMM INF DIS; Bieslich B, 2000, SOC SCI MED, V50, P703, DOI 10.1016/S0277-9536(99)00322-6; Birungi H, 1998, SOC SCI MED, V47, P1455, DOI 10.1016/S0277-9536(98)00194-4; Centers for Disease Control and Prevention, 2012, APP D VACC ADM GUID; Clements CJ, 2004, VACCINE, V22, P2054, DOI 10.1016/j.vaccine.2004.01.008; D'Alois LA, 2004, IMPACT DELIVERY TECH; Diggle L, 2006, BMJ-BRIT MED J, V333, P571, DOI 10.1136/bmj.38906.704549.7C; Duong DV, 2004, SOC SCI MED, V59, P2585, DOI 10.1016/j.socscimed.2004.04.007; Feldman-Savelsberg P, 2000, MED ANTHROPOL Q, V14, P159, DOI 10.1525/maq.2000.14.2.159; Fleming J, 2003, INTRO TT UNIJECT MAT; Glenton C, 2013, TROP MED INT HEALTH, V18, P1002, DOI 10.1111/tmi.12126; Glenton C, 2011, TROP MED INT HEALTH, V16, P1044, DOI 10.1111/j.1365-3156.2011.02813.x; Kasi SG, 2013, PEDIAT INFECT DIS, V5, P181; Kotwal A, 2005, SOC SCI MED, V60, P1133, DOI 10.1016/j.socscimed.2004.06.044; Levine MM, 2011, VACCINE, V29, pD116, DOI 10.1016/j.vaccine.2011.11.090; Lippert WC, 2008, PEDIATRICS, V122, pE556, DOI 10.1542/peds.2008-0374; NICHTER M, 1995, SOC SCI MED, V41, P617, DOI 10.1016/0277-9536(95)00034-5; Pereira CC, 2010, EXPERT REV VACCINES, V9, P1343, DOI [10.1586/erv.10.129, 10.1586/ERV.10.129]; Quiroga R, 1998, Rev Panam Salud Publica, V4, P20; Reeler AV, 2000, B WORLD HEALTH ORGAN, V78, P135; Schaetti C, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-99; Scheifele DW, 2000, CAN J PUBLIC HEALTH, V91, P329, DOI 10.1007/BF03404801; Sepehri A, 2008, SOC SCI MED, V67, P1009, DOI 10.1016/j.socscimed.2008.06.005; STEINGLASS R, 1995, B WORLD HEALTH ORGAN, V73, P57; Streefland PH, 1999, B WORLD HEALTH ORGAN, V77, P722; Streefland PH, 2001, HEALTH POLICY, V55, P159, DOI 10.1016/S0168-8510(00)00132-9; Sutanto A, 1999, B WORLD HEALTH ORGAN, V77, P119; World Health Organization, COLD CHAIN LOG TOOLS	28	4	4	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0132292	10.1371/journal.pone.0132292	http://dx.doi.org/10.1371/journal.pone.0132292			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN1RV	26186456	Green Submitted, Green Published, gold			2022-12-26	WOS:000358198700036
J	Hancock, LG; Walker, SE; Perez-Huerta, A; Bowser, SS				Hancock, Leanne G.; Walker, Sally E.; Perez-Huerta, Alberto; Bowser, Samuel S.			Population Dynamics and Parasite Load of a Foraminifer on Its Antarctic Scallop Host with Their Carbonate Biomass Contributions	PLOS ONE			English	Article							GLOBAL OCEAN CARBONATE; MCMURDO SOUND; ADAMUSSIUM-COLBECKI; EXPLORERS COVE; SEA-ICE; BENTHIC FORAMINIFERA; ORGANIC-CARBON; FOOD WEBS; ROSS SEA; DIVERSITY	We studied the population dynamics and parasite load of the foraminifer Cibicides antarcticus on its host the Antarctic scallop Adamussium colbecki from three localities differing by sea ice cover within western McMurdo Sound, Ross Sea, Antarctica: Explorers Cove, Bay of Sails and Herbertson Glacier. We also estimated CaCO3 biomass and annual production for both species. Cibicides populations varied by locality, valve type, and depth. Explorers Cove with multiannual sea ice had larger populations than the two annual sea ice localities, likely related to differences in nutrients. Populations were higher on Adamussium top valves, a surface that is elevated above the sediment. Depth did not affect Cibicides distributions except at Bay of Sails. Cibicides parasite load (the number of complete boreholes in Adamussium valves) varied by locality between 2% and 50%. For most localities the parasite load was < 20%, contrary to a previous report that similar to 50% of Cibicides were parasitic. The highest and lowest parasite load occurred at annual sea ice localities, suggesting that sea ice condition is not important. Rather, the number of adults that are parasitic could account for these differences. Cibicides bioerosion traces were categorized into four ontogenetic stages, ranging from newly attached recruits to parasitic adults. These traces provide an excellent proxy for population structure, revealing that Explorers Cove had a younger population than Bay of Sails. Both species are important producers of CaCO3. Cibicides CaCO3 biomass averaged 47-73 kg ha(-1) and Adamussium averaged 4987-6806 kg ha(-1) by locality. Annual production rates were much higher. Moreover, Cibicides represents 1.0-2.3% of the total host-parasite CaCO3 biomass. Despite living in the coldest waters on Earth, these species can contribute a substantial amount of CaCO3 to the Ross Sea and need to be incorporated into food webs, ecosystem models, and carbonate budgets for Antarctica.	[Hancock, Leanne G.; Walker, Sally E.] Univ Georgia, Dept Geol, Athens, GA 30602 USA; [Perez-Huerta, Alberto] Univ Alabama, Dept Geol Sci, Tuscaloosa, AL USA; [Bowser, Samuel S.] New York State Dept Hlth, Wadsworth Ctr, Albany, NY USA	University System of Georgia; University of Georgia; University of Alabama System; University of Alabama Tuscaloosa; State University of New York (SUNY) System; Wadsworth Center	Walker, SE (corresponding author), Univ Georgia, Dept Geol, Athens, GA 30602 USA.	swalker@gly.uga.edu			NSF from Polar Programs Earth Sciences [ANT 0739512, ANT 0739583]; NSF from Office of Polar Programs (Biology) [PLR 0944646, PLR 0433575]; Directorate For Geosciences [0944646] Funding Source: National Science Foundation	NSF from Polar Programs Earth Sciences; NSF from Office of Polar Programs (Biology); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	NSF grants from Polar Programs Earth Sciences: ANT 0739512 and ANT 0739583. NSF grants from Office of Polar Programs (Biology): PLR 0944646 and PLR 0433575.	ALEXANDER SP, 1987, BIOL BULL, V173, P136, DOI 10.2307/1541868; ANDERSON JB, 1975, MAR GEOL, V19, P315, DOI 10.1016/0025-3227(75)90083-3; [Anonymous], 1995, OCEANOGR; Arrigo KR, 2014, ANNU REV MAR SCI, V6, P439, DOI 10.1146/annurev-marine-010213-135103; BARRY JP, 1988, POLAR BIOL, V8, P367, DOI 10.1007/BF00442028; Berkman P.A., 1990, P281; BERNHARD JM, 1987, J FORAMIN RES, V17, P286, DOI 10.2113/gsjfr.17.4.286; BERNHARD JM, 1989, LIMNOL OCEANOGR, V34, P1131, DOI 10.4319/lo.1989.34.6.1131; Beuck L, 2008, CURRENT DEVELOPMENTS IN BIOEROSION, P329, DOI 10.1007/978-3-540-77598-0_17; BOWSER SS, 1993, J EUKARYOT MICROBIOL, V40, P121, DOI 10.1111/j.1550-7408.1993.tb04891.x; Cerrano C, 2006, CHEM ECOL, V22, pS235; Chiantore M., 2000, P563; Chiantore MC, 2003, POLAR BIOL, V26, P416, DOI 10.1007/s00300-003-0491-2; Crawley M.J., 2005, STAT INTRO USING R, P1; CRENSHAW MA, 1972, BIOL BULL, V143, P506, DOI 10.2307/1540180; Culver SJ, 2003, T GEOBIOL, V20, P7; Dayton P.K., 1990, P631; Dayton PK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056939; DAYTON PK, 1986, POLAR BIOL, V6, P207, DOI 10.1007/BF00443397; DAYTON PK, 1969, SCIENCE, V163, P273, DOI 10.1126/science.163.3864.273; DAYTON PK, 1977, SCIENCE, V197, P55, DOI 10.1126/science.197.4298.55; DEAN WE, 1974, J SEDIMENT PETROL, V44, P242; DELACA TE, 1981, NATURE, V289, P287, DOI 10.1038/289287a0; DeLaca TE., 1985, ANTARCT J US, V20, P147; DUNBAR RB, 1989, MAR GEOL, V85, P155, DOI 10.1016/0025-3227(89)90152-7; Ebert D, 2001, ECOLOGY, V82, P3417; Fountain AG, 2006, J GLACIOL, V52, P451, DOI 10.3189/172756506781828511; Freiwald A, 1996, MAR MICROPALEONTOL, V28, P199, DOI 10.1016/0377-8398(96)00002-3; Gazdzicki Andrzej, 1996, Palaeontologia Polonica, V55, P147; GOODAY AJ, 1992, NATO ADV SCI I C-MAT, V360, P63; Gooday AJ, 1996, PROG OCEANOGR, V37, P117, DOI 10.1016/S0079-6611(96)00007-9; Hatcher MJ, 2012, FRONT ECOL ENVIRON, V10, P186, DOI 10.1890/110016; Hauck J, 2012, J MARINE SYST, V90, P77, DOI 10.1016/j.jmarsys.2011.09.005; Heilmayer O, 2003, J EXP MAR BIOL ECOL, V288, P239, DOI 10.1016/S0022-0981(03)00020-0; Hudson PJ, 2006, TRENDS ECOL EVOL, V21, P381, DOI 10.1016/j.tree.2006.04.007; Hunt GL, 2002, DEEP-SEA RES PT II, V49, P5821, DOI 10.1016/S0967-0645(02)00321-1; Huntley JW, 2007, J SHELLFISH RES, V26, P253, DOI 10.2983/0730-8000(2007)26[253:TEAMBF]2.0.CO;2; Kuris AM, 2008, NATURE, V454, P515, DOI 10.1038/nature06970; Lafferty KD, 2008, ECOL LETT, V11, P533, DOI 10.1111/j.1461-0248.2008.01174.x; Lafferty KD, 2006, P NATL ACAD SCI USA, V103, P11211, DOI 10.1073/pnas.0604755103; Langer MR, 2008, J EUKARYOT MICROBIOL, V55, P163, DOI 10.1111/j.1550-7408.2008.00321.x; Langer MR, 1997, J FORAMIN RES, V27, P271, DOI 10.2113/gsjfr.27.4.271; Lartaud F, 2010, J EXP MAR BIOL ECOL, V393, P158, DOI 10.1016/j.jembe.2010.07.016; LEVENTER A, 1987, MAR MICROPALEONTOL, V12, P49, DOI 10.1016/0377-8398(87)90013-2; Lipps J.H., 1983, Topics in Geobiology, V3, P331; Lizotte MP, 2001, AM ZOOL, V41, P57, DOI 10.1668/0003-1569(2001)041[0057:TCOSIA]2.0.CO;2; Mager SM, 2013, PROG PHYS GEOG, V37, P468, DOI 10.1177/0309133313479815; McClintock JB, 2010, ANTARCT SCI, V22, P173, DOI 10.1017/S0954102009990757; MILLIMAN JD, 1993, GLOBAL BIOGEOCHEM CY, V7, P927, DOI 10.1029/93GB02524; Mojtahid M, 2011, J EXP MAR BIOL ECOL, V399, P25, DOI 10.1016/j.jembe.2011.01.011; MULLINEAUX LS, 1984, POLAR BIOL, V3, P185, DOI 10.1007/BF00292622; Murray J, 2006, ECOLOGY AND APPLICATIONS OF BENTHIC FORAMINIFERA, P1; Norkko A, 2007, ECOLOGY, V88, P2810, DOI 10.1890/06-1396.1; Pawlowski J, 2002, POLAR BIOL, V25, P96, DOI 10.1007/s003000100317; Poulin R., 2007, EVOLUTIONARY ECOLOGY, P1; Pullan RL, 2012, PARASITOLOGY, V139, P1870, DOI 10.1017/S0031182012000698; Quaglio F, 2010, POL POLAR RES, V31, P291, DOI 10.2478/v10183.010.0006.0; R Core Team, 2012, R LANG ENV STAT COMP; Radford D, 2014, J FORAMIN RES, V44, P255, DOI 10.2113/gsjfr.44.3.255; Richardson-White S, 2011, PALAEOGEOGR PALAEOCL, V312, P305, DOI 10.1016/j.palaeo.2011.02.021; Schiaparelli S, 2006, DEEP-SEA RES PT II, V53, P912, DOI 10.1016/j.dsr2.2006.02.004; Schonfeld J, 2002, DEEP-SEA RES PT I, V49, P1853, DOI 10.1016/S0967-0637(02)00088-2; Schweizer M, 2012, J FORAMIN RES, V42, P340, DOI 10.2113/gsjfr.42.4.340; Schweizer M, 2009, J FORAMIN RES, V39, P300, DOI 10.2113/gsjfr.39.4.300; Sen Gupta BK, 2009, MODERN FORAMINIFERA, P3; Smith WO, 2007, PHILOS T R SOC B, V362, P95, DOI 10.1098/rstb.2006.1956; STOCKTON WL, 1984, MAR BIOL, V78, P171, DOI 10.1007/BF00394697; Suhr SB, 2008, MAR ECOL PROG SER, V371, P155, DOI 10.3354/meps07693; Thrush SF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011899; Walker SE, 2011, PALAEOGEOGR PALAEOCL, V312, P325, DOI 10.1016/j.palaeo.2011.04.028; Wisshak M, 2006, FACIES, V52, P1, DOI 10.1007/s10347-005-0033-1; Wolinska J, 2011, J PLANKTON RES, V33, P1284, DOI 10.1093/plankt/fbr016; ZUMWALT GS, 1980, J PALEONTOL, V54, P477	73	8	9	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0132534	10.1371/journal.pone.0132534	http://dx.doi.org/10.1371/journal.pone.0132534			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RV	26186724	Green Published, gold, Green Submitted			2022-12-26	WOS:000358198700048
J	Iwao, C; Shidoji, Y				Iwao, Chieko; Shidoji, Yoshihiro			Polyunsaturated Branched-Chain Fatty Acid Geranylgeranoic Acid Induces Unfolded Protein Response in Human Hepatoma Cells	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; 2ND PRIMARY TUMORS; AUTOPHAGIC RESPONSE; INDUCED APOPTOSIS; DOWN-REGULATION; ACTIVATION; PREVENTION; PALMITATE; INDUCTION; LINE	The acyclic diterpenoid acid geranylgeranoic acid (GGA) has been reported to induce autophagic cell death in several human hepatoma-derived cell lines; however, the molecular mechanism for this remains unknown. In the present study, several diterpenoids were examined for ability to induce XBP1 splicing and/or lipotoxicity for human hepatoma cell lines. Here we show that three groups of diterpenoids emerged: 1) GGA, 2,3-dihydro GGA and 9-cis retinoic acid induce cell death and XBP1 splicing; 2) all-trans retinoic acid induces XBP1 splicing but little cell death; and 3) phytanic acid, phytenic acid and geranylgeraniol induce neither cell death nor XBP1 splicing. GGA-induced ER stress/unfolded protein response (UPR) and its lipotoxicity were both blocked by co-treatment with oleic acid. The blocking activity of oleic acid for GGA-induced XBP1 splicing was not attenuated by methylation of oleic acid. These findings strongly suggest that GGA at micromolar concentrations induces the so-called lipid-induced ER stress response/UPR, which is oleate-suppressive, and shows its lipotoxicity in human hepatoma cells.	[Iwao, Chieko; Shidoji, Yoshihiro] Nagasaki Univ, Grad Sch Human Hlth Sci, Mol & Cellular Biol, Nagasaki 852, Japan	Nagasaki University	Shidoji, Y (corresponding author), Nagasaki Univ, Grad Sch Human Hlth Sci, Mol & Cellular Biol, Nagasaki 852, Japan.	shidoji@sun.ac.jp			University of Nagasaki [B-3]	University of Nagasaki	YS has received a research grant B-3 from the University of Nagasaki (URL:sun.ac.jp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Biden TJ, 2014, TRENDS ENDOCRIN MET, V25, P389, DOI 10.1016/j.tem.2014.02.003; Bosma M, 2014, BBA-MOL CELL BIOL L, V1841, P1648, DOI 10.1016/j.bbalip.2014.09.012; Brewer JW, 2000, P NATL ACAD SCI USA, V97, P12625, DOI 10.1073/pnas.220247197; Coto-Montes A, 2012, MOL CELL ENDOCRINOL, V361, P12, DOI 10.1016/j.mce.2012.04.009; Dhayal S, 2011, FEBS LETT, V585, P2243, DOI 10.1016/j.febslet.2011.05.045; Ding WX, 2008, AUTOPHAGY, V4, P141, DOI 10.4161/auto.5190; Honda M, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-191; Hosokawa N, 2009, MOL BIOL CELL, V20, P1981, DOI 10.1091/mbc.E08-12-1248; Jia W, 2011, J IMMUNOL, V186, P1564, DOI 10.4049/jimmunol.1001822; Karaskov E, 2006, ENDOCRINOLOGY, V147, P3398, DOI 10.1210/en.2005-1494; Kitai Y, 2013, GENES CELLS, V18, P798, DOI 10.1111/gtc.12074; Listenberger LL, 2003, P NATL ACAD SCI USA, V100, P3077, DOI 10.1073/pnas.0630588100; Malaviya R, 2014, TOXICOL APPL PHARM, V275, P145, DOI 10.1016/j.taap.2013.12.022; Margariti A, 2013, J BIOL CHEM, V288, P859, DOI 10.1074/jbc.M112.412783; Muto Y, 1999, NEW ENGL J MED, V340, P1046, DOI 10.1056/NEJM199904013401315; Muto Y, 1996, NEW ENGL J MED, V334, P1561, DOI 10.1056/NEJM199606133342402; NAKAMURA N, 1995, BIOCHEM BIOPH RES CO, V207, P382, DOI 10.1006/bbrc.1995.1199; Nakamura N, 1996, BIOCHEM BIOPH RES CO, V219, P100, DOI 10.1006/bbrc.1996.0188; Okamoto K, 2011, BIOCHEM J, V440, P63, DOI 10.1042/BJ20110610; Sheng R, 2012, AUTOPHAGY, V8, P310, DOI 10.4161/auto.18673; Shidoji Y, 2006, J CELL BIOCHEM, V97, P178, DOI 10.1002/jcb.20627; Shidoji Y, 2004, J LIPID RES, V45, P1092, DOI 10.1194/jlr.M300502-JLR200; Shidoji Y, 1997, BIOCHEM BIOPH RES CO, V230, P58, DOI 10.1006/bbrc.1996.5883; Shimonishi S, 2012, NUTR CANCER, V64, P473, DOI 10.1080/01635581.2012.655401; Shoulders MD, 2013, CELL REP, V3, P1279, DOI 10.1016/j.celrep.2013.03.024; Sommerweiss D, 2013, BIOCHEM BIOPH RES CO, V441, P770, DOI 10.1016/j.bbrc.2013.10.130; Volmer R, 2013, P NATL ACAD SCI USA, V110, P4628, DOI 10.1073/pnas.1217611110; Yang L, 2010, CELL METAB, V11, P467, DOI 10.1016/j.cmet.2010.04.005	28	7	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0132761	10.1371/journal.pone.0132761	http://dx.doi.org/10.1371/journal.pone.0132761			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RV	26186544	Green Submitted, Green Published, gold			2022-12-26	WOS:000358198700061
J	Legenzov, EA; Dirda, NDA; Hagen, BM; Kao, JPY				Legenzov, Eric A.; Dirda, Nathaniel D. A.; Hagen, Brian M.; Kao, Joseph P. Y.			Synthesis and Characterization of 8-O-Carboxymethylpyranine (CM-Pyranine) as a Bright, Violet-Emitting, Fluid-Phase Fluorescent Marker in Cell Biology	PLOS ONE			English	Article							INTRACELLULAR FATE; PRACTICAL ASPECTS; ENDOCYTOSIS; LIPOSOMES; TRANSPORTERS; MECHANISM; MIGRATION; PEPTIDES; BINDING; ACID	To avoid spectral interference with common fluorophores in multicolor fluorescence microscopy, a fluid-phase tracer with excitation and emission in the violet end of the visible spectrum is desirable. CM-pyranine is easily synthesized and purified. Its excitation and emission maxima at 401.5 nm and 428.5 nm, respectively, are well suited for excitation by 405-nm diode lasers now commonly available on laser-scanning microscopes. High fluorescence quantum efficiency (Q = 0.96) and strong light absorption (epsilon(405) > 25,000 M(-1)cm(-1)) together make CM-pyranine the brightest violet aqueous tracer. The fluorescence spectrum of CM-pyranine is invariant above pH 4, which makes it a good fluid-phase marker in all cellular compartments. CM-pyranine is very photostable, is retained for long periods by cells, does not self-quench, and has negligible excimer emission. The sum of its properties make CM-pyranine an ideal fluorescent tracer. The use of CM-pyranine as a fluid-phase marker is demonstrated by multicolor confocal microscopy of cells that are also labeled with lipid and nuclear markers that have green and red fluorescence emission, respectively.	[Kao, Joseph P. Y.] Univ Maryland, Ctr Biomed Engn & Technol, Sch Med, Baltimore, MD 21201 USA; Univ Maryland, Dept Physiol, Sch Med, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Kao, JPY (corresponding author), Univ Maryland, Ctr Biomed Engn & Technol, Sch Med, 111 South Penn St, Baltimore, MD 21201 USA.	jkao@umaryland.edu		Kao, Joseph/0000-0002-8875-2180	National Institutes of Health (U.S.) [GM056481]; University of Maryland Baltimore Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056481] Funding Source: NIH RePORTER	National Institutes of Health (U.S.)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Maryland Baltimore Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The work was supported by National Institutes of Health (U.S.) grant number GM056481 and the Nanobiology Fund of the University of Maryland Baltimore Foundation to JPYK.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; ARBELOA IL, 1981, J CHEM SOC FARAD T 2, V77, P1735, DOI 10.1039/f29817701735; BIRKS JB, 1976, J RES NBS A PHYS CH, V80, P389, DOI 10.6028/jres.080A.038; BIRKS JB, 1963, SPECTROCHIM ACTA, V19, P401, DOI 10.1016/0371-1951(63)80051-X; Borkowski M., REFRACTIVE INDEX SUL; Bradke TM, 2008, CELL ADHES MIGR, V2, P153, DOI 10.4161/cam.2.3.6484; Budo A, 1956, ACTA PHYS CHEM SZEGE, V2, P18; Burks SR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120982; Burks SR, 2009, BBA-BIOMEMBRANES, V1788, P2301, DOI 10.1016/j.bbamem.2009.08.007; Cabantous S, 2005, NAT BIOTECHNOL, V23, P102, DOI 10.1038/nbt1044; Casey JR, 2010, NAT REV MOL CELL BIO, V11, P50, DOI 10.1038/nrm2820; CHEN RF, 1988, ANAL BIOCHEM, V172, P61, DOI 10.1016/0003-2697(88)90412-5; Chia Pei Zhi Cheryl, 2013, Cells, V2, P105, DOI 10.3390/cells2010105; Clarke JDW, 1999, METH MOL B, V97, P319, DOI 10.1385/1-59259-270-8:319; DENHOLM EM, 1995, CYTOMETRY, V19, P366, DOI 10.1002/cyto.990190412; Esbjorner EK, 2007, BIOCHEMISTRY-US, V46, P13490, DOI 10.1021/bi701075y; Goppert-Mayer M., ELEMENTARAKTE ZWEI Q; Hagenbuch B, 2008, XENOBIOTICA, V38, P778, DOI [10.1080/00498250801986951, 10.1080/00498250801986951 ]; Haugland RP, 1992, United States patent US, Patent No. 005132432; Humphries WH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026626; JENSEN FC, 1964, P NATL ACAD SCI USA, V52, P53, DOI 10.1073/pnas.52.1.53; Kao JPY, 2010, METHOD CELL BIOL, V99, P113, DOI [10.1016/S0091-679X(10)99005-5, 10.1016/B978-0-12-374841-6.00005-0]; KAO JPY, 1994, METHOD CELL BIOL, V40, P155; KASHA M, 1950, DISCUSS FARADAY SOC, P14, DOI 10.1039/df9500900014; KELLER R, 1992, DEV DYNAM, V193, P199, DOI 10.1002/aja.1001930302; Klaassen CD, 2010, PHARMACOL REV, V62, P1, DOI 10.1124/pr.109.002014; LEE KD, 1992, BIOCHIM BIOPHYS ACTA, V1103, P185, DOI 10.1016/0005-2736(92)90086-2; LEYENDEKKERS JV, 1977, J CHEM ENG DATA, V22, P427, DOI 10.1021/je60075a019; McNeil P L, 2001, Curr Protoc Cell Biol, VChapter 20, DOI 10.1002/0471143030.cb2001s18; MELHUISH WH, 1961, J PHYS CHEM-US, V65, P229, DOI 10.1021/j100820a009; MURPHY RF, 1984, J CELL BIOL, V98, P1757, DOI 10.1083/jcb.98.5.1757; PLANK C, 1994, J BIOL CHEM, V269, P12918; PLANT AL, 1986, PHOTOCHEM PHOTOBIOL, V44, P453, DOI 10.1111/j.1751-1097.1986.tb04692.x; Rosen GM, 2005, ORG BIOMOL CHEM, V3, P645, DOI 10.1039/B415586F; SAVITZKY A, 1964, ANAL CHEM, V36, P1627, DOI 10.1021/ac60214a047; Sohn YS, 2012, HAEMATOL-HEMATOL J, V97, P670, DOI 10.3324/haematol.2011.054858; Sorkin A, 2002, NAT REV MOL CELL BIO, V3, P600, DOI 10.1038/nrm883; Srimaroeng C, 2008, XENOBIOTICA, V38, P889, DOI [10.1080/00498250801927435, 10.1080/00498250801927435 ]; STRAUBINGER RM, 1983, CELL, V32, P1069, DOI 10.1016/0092-8674(83)90291-X; STRAUBINGER RM, 1990, BIOCHEMISTRY-US, V29, P4929, DOI 10.1021/bi00472a025; WHITAKER JE, 1991, ANAL BIOCHEM, V198, P119, DOI 10.1016/0003-2697(91)90515-U; Wohlfarth C., 2008, LANDOLT HORNSTEIN GR, V47, P564; WOLFBEIS OS, 1983, FRESEN Z ANAL CHEM, V314, P119, DOI 10.1007/BF00482235; Wurth C, 2013, NAT PROTOC, V8, P1535, DOI 10.1038/nprot.2013.087; Xu C, 1996, P NATL ACAD SCI USA, V93, P10763, DOI 10.1073/pnas.93.20.10763; Zipfel WR, 2003, NAT BIOTECHNOL, V21, P1368, DOI 10.1038/nbt899	46	9	9	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0133518	10.1371/journal.pone.0133518	http://dx.doi.org/10.1371/journal.pone.0133518			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RV	26186650	Green Published, Green Submitted, gold			2022-12-26	WOS:000358198700151
J	Yang, SS; Jin, YL; He, Y; Jiang, CQ; Cheng, KK; Zhang, WS; Lam, TH				Yang, Shanshan; Jin, Yali; He, Yao; Jiang, Chaoqiang; Cheng, Kar Keung; Zhang, Weisen; Lam, Tai Hing			Childhood Passive Smoking Exposure and Age at Menarche in Chinese Women Who Had Never Smoked: The Guangzhou Biobank Cohort Study	PLOS ONE			English	Article							ENVIRONMENTAL TOBACCO-SMOKE; BREAST-CANCER; RISK-FACTORS; POPULATION; PREGNANCY; HORMONE; DISEASE; GROWTH; ADULTS; TIME	Objective We examined the associations between childhood passive smoking exposure and age at menarche in women who had never smoked in southern China. Methods Among 30,518 participants in Guangzhou Biobank Cohort Study (GBCS) from 2003-2008, 20,061 women who had never smoked and had complete outcome data were included. Childhood passive smoking exposure was defined as living with 1 or more smokers in the same household during childhood. Data on the number of smokers in the household and frequency of exposure (density and frequency) were also obtained. Age at menarche was measured as a continuous variable. Results 11,379 (56.7%) participants were exposed to passive smoking during childhood. Compared to those with no passive smoking exposure during childhood, those with exposure >= 5 days/week had menarche 0.19 year (95% confidence interval (CI): 0.13-0.25) earlier on average. Those exposed to more than two smokers had menarche 0.38 year earlier (95% CI: 0.290.47). Childhood exposure was associated with early age at menarche (<= 13 vs. >13 years), with an adjusted odds ratio of 1.34 (95% CI: 1.21-1.48) for high density, and 1.17 (95% CI: 1.09-1.26) for high frequency of exposure. Conclusion Childhood passive smoking exposure was associated with earlier age at menarche, with a dose-response relationship in Chinese women who had never smoked. If causal, the results support the promotion of smoking cessation in families with children, particularly young girls.	[Yang, Shanshan; He, Yao] Chinese Peoples Liberat Army Gen Hosp, Inst Geriatr, Beijing, Peoples R China; [Jin, Yali; Jiang, Chaoqiang; Zhang, Weisen] Guangzhou 12 Peoples Hosp, Guangzhou, Guangdong, Peoples R China; [Cheng, Kar Keung] Univ Birmingham, Publ Hlth Epidemiol & Biostat, Birmingham, W Midlands, England; [Lam, Tai Hing] Univ Hong Kong, Sch Publ Hlth, Hong Kong, Hong Kong, Peoples R China; [Yang, Shanshan] CDC, Jinan Mil Area, Jinan 250014, Shandong, Peoples R China; [He, Yao] Chinese Peoples Liberat Army Gen Hosp, Beijing Key Lab Aging & Geriatr, Beijing, Peoples R China; [He, Yao] Chinese Peoples Liberat Army Gen Hosp, State Key Lab Kidney Dis, Beijing, Peoples R China	Chinese People's Liberation Army General Hospital; University of Birmingham; University of Hong Kong; Chinese People's Liberation Army General Hospital; Chinese People's Liberation Army General Hospital	He, Y (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Inst Geriatr, Beijing, Peoples R China.	yhe301@x263.net; cqjiang@hkucc.hku.hk	Cheng, Kar/AAL-8899-2021; Lam, Tai Hing/C-4317-2009	Cheng, Kar/0000-0002-1516-1857; Lam, Tai Hing/0000-0002-2033-9971; He, Yao/0000-0001-6205-7895	Guangdong Natural Science Foundation of China, Guangdong, China [9451062001003477]; Guangzhou Science and Information Bureau, Guangzhou, China [2012J5100041]; National Natural Science Foundation of China [81373080]; Beijing Municipal Science and Technology Commission [Z121107001012070]; Chinese PLA General Hospital Doctor Innovation Foundation [13BCZ07]	Guangdong Natural Science Foundation of China, Guangdong, China; Guangzhou Science and Information Bureau, Guangzhou, China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Municipal Science and Technology Commission(Beijing Municipal Science & Technology Commission); Chinese PLA General Hospital Doctor Innovation Foundation	This study was supported by research grants from the Guangdong Natural Science Foundation of China, Guangdong, China (Grant number: 9451062001003477) - (http://www.nsfc.gov.cn/nsfc/cen/xmzn/2015xmzn/15/06.html), the Guangzhou Science and Information Bureau, Guangzhou, China (2012J5100041) - (http://www.gdstc.gov.cn/HTML/kjyw/tzgg/14067986446893065296778948092137.html), the National Natural Science Foundation of China (81373080) - (http://www.nsfc.gov.cn/), the Beijing Municipal Science and Technology Commission (Z121107001012070) -(http://www.bjkw.gov.cn/n8785584/index.html) and the Chinese PLA General Hospital Doctor Innovation Foundation (13BCZ07) (http://www.301hospital.com.cn/). The funders had roles in study design, data collection and analysis, decision to publish and preparation of the manuscript.	APTER D, 1983, J CLIN ENDOCR METAB, V57, P82, DOI 10.1210/jcem-57-1-82; Benedict MD, 2012, ENVIRON TOXICOL PHAR, V34, P761, DOI 10.1016/j.etap.2012.09.010; Chen CZ, 2005, ENVIRON HEALTH PERSP, V113, P412, DOI 10.1289/ehp.7436; Cho GJ, 2010, EUR J PEDIATR, V169, P89, DOI 10.1007/s00431-009-0993-1; Conway BN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030625; Dossus L, 2012, ANN EPIDEMIOL, V22, P723, DOI 10.1016/j.annepidem.2012.07.007; Dossus L, 2010, INT J CANCER, V127, P442, DOI 10.1002/ijc.25050; Ferris JS, 2010, PAEDIATR PERINAT EP, V24, P515, DOI 10.1111/j.1365-3016.2010.01154.x; Fried PA, 2001, NEUROTOXICOL TERATOL, V23, P431, DOI 10.1016/S0892-0362(01)00161-1; Guldbrandsen K, 2014, HUM REPROD, V29, P2058, DOI 10.1093/humrep/deu153; He CY, 2010, AM J EPIDEMIOL, V171, P334, DOI 10.1093/aje/kwp372; Heys M, 2011, J EPIDEMIOL COMMUN H, V65, P522, DOI 10.1136/jech.2009.099143; Iniguez C, 2012, J EPIDEMIOL COMMUN H, V66, P563, DOI 10.1136/jech.2010.116756; Jiang CQ, 2006, INT J EPIDEMIOL, V35, P844, DOI 10.1093/ije/dyl131; Lakshman R, 2009, J CLIN ENDOCR METAB, V94, P4953, DOI 10.1210/jc.2009-1789; Lewington S, 2014, INT J EPIDEMIOLOGY; Ong KK, 2006, MOL CELL ENDOCRINOL, V254, P8, DOI 10.1016/j.mce.2006.04.018; Parsa P, 2009, ASIAN PAC J CANCER P, V10, P545; Qiu CS, 2013, J CLIN ENDOCR METAB, V98, P1612, DOI 10.1210/jc.2012-2919; Reynolds P, 2004, J WOMENS HEALTH, V13, P778, DOI 10.1089/jwh.2004.13.778; Rigon F, 2010, J ADOLESCENT HEALTH, V46, P238, DOI 10.1016/j.jadohealth.2009.07.009; Rock V. J., 2007, Morbidity and Mortality Weekly Report, V56, P1157; So L L, 1992, Z Morphol Anthropol, V79, P21; Tamakoshi K, 2011, EUR J EPIDEMIOL, V26, P771, DOI 10.1007/s10654-011-9623-0; Terry MB, 2009, AM J EPIDEMIOL, V170, P72, DOI 10.1093/aje/kwp095; Towne B, 2005, AM J PHYS ANTHROPOL, V128, P210, DOI 10.1002/ajpa.20106; US Department of Health and Human Services, 2014, HLTH CONS SMOK 50 YE; Weghofer A, 2013, FERTIL STERIL, V100, P1039, DOI 10.1016/j.fertnstert.2013.05.042; Windham GC, 2004, AM J EPIDEMIOL, V159, P862, DOI 10.1093/aje/kwh117; Xu L, 2011, INT J CARDIOL, V148, P189, DOI 10.1016/j.ijcard.2009.11.001; Yang Gong-huan, 2005, Zhonghua Liu Xing Bing Xue Za Zhi, V26, P77; Yin P, 2007, LANCET, V370, P751, DOI 10.1016/S0140-6736(07)61378-6; ZACHARIAS L, 1969, NEW ENGL J MED, V280, P868, DOI 10.1056/NEJM196904172801606; Zou Zhi-yong, 2013, Zhonghua Yu Fang Yi Xue Za Zhi, V47, P726	34	20	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0130429	10.1371/journal.pone.0130429	http://dx.doi.org/10.1371/journal.pone.0130429			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN1RV	26186646	Green Published, Green Submitted, gold			2022-12-26	WOS:000358198700007
J	Miura, M; Ito, K; Hayashi, M; Nakajima, M; Tanaka, T; Ogura, S				Miura, Mai; Ito, Kensuke; Hayashi, Maiko; Nakajima, Motowo; Tanaka, Tohru; Ogura, Shun-ichiro			The Effect of 5-Aminolevulinic Acid on Cytochrome P450-Mediated Prodrug Activation	PLOS ONE			English	Article							HUMAN LIVER-MICROSOMES; ABC TRANSPORTER ABCG2; IN-VITRO; BILE-SALTS; EXPRESSION; CANCER; CYCLOPHOSPHAMIDE; 5-FLUOROURACIL; THERAPY; ROLES	Of late, numerous prodrugs are widely used for therapy. The hemeprotein cytochrome P450 (CYP) catalyzes the activation of prodrugs to form active metabolites. Therefore, the activation of CYP function might allow the use of lower doses of prodrugs and decrease toxicity. We hypothesized that the addition of 5-aminolevulinic acid (ALA), a precursor in the porphyrin biosynthetic pathway, enhances the synthesis of heme, leading to the up-regulation of CYP activity. To test this hypothesis, we treated a human gastric cancer cell line with ALA and determined the effect on CYP-dependent prodrug activation. For this purpose, we focused on the anticancer prodrug tegafur, which is converted to its active metabolite 5-fluorouracil (5-FU) mainly by CYP2A6. We show here that ALA increased CYP2A6-dependent tegafur activation, suggesting that ALA elevated CYP activity and potentiated the activation of the prodrug.	[Miura, Mai; Ito, Kensuke; Hayashi, Maiko; Ogura, Shun-ichiro] Tokyo Inst Technol, Grad Sch Biosci & Biotechnol, Midori Ku, Yokohama, Kanagawa 2268501, Japan; [Nakajima, Motowo; Tanaka, Tohru] SBI Pharmaceut CO LTD, Minato Ku, Tokyo 1066020, Japan	Tokyo Institute of Technology; SBI Pharmaceuticals	Ogura, S (corresponding author), Tokyo Inst Technol, Grad Sch Biosci & Biotechnol, Midori Ku, 4259 B47 Nagatsuta Cho, Yokohama, Kanagawa 2268501, Japan.	sogura@bio.titech.ac.jp			Ministry of Education, Culture, Sports, Science and Technology [26430141]; SBI Pharma CO., LTD.	Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); SBI Pharma CO., LTD.	The studies in the authors' laboratories were supported by the Grant-in-Aid for Scientific Research (C) (No. 26430141) from the Ministry of Education, Culture, Sports, Science and Technology. SBI Pharma CO., LTD., provided support in the form of salaries for authors MN and TT, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the author contributions section.	Bayeva M, 2013, CIRC RES, V113, P279, DOI 10.1161/CIRCRESAHA.113.301552; Chang TKH, 1997, CANCER RES, V57, P1946; GONZALEZ FJ, 1990, TRENDS GENET, V6, P182, DOI 10.1016/0168-9525(90)90174-5; Green RM, 2000, GENE, V241, P117, DOI 10.1016/S0378-1119(99)00460-6; Hagiya Y, 2013, PHOTODIAGN PHOTODYN, V10, P288, DOI 10.1016/j.pdpdt.2013.02.001; Hagiya Y, 2012, PHOTODIAGN PHOTODYN, V9, P204, DOI 10.1016/j.pdpdt.2011.12.004; Hagiya Yuichiro, 2008, J Exp Ther Oncol, V7, P153; Hagmann Wolfgang, 2010, Cancers (Basel), V3, P106, DOI 10.3390/cancers3010106; HENDRY GAF, 1980, J MED GENET, V17, P1, DOI 10.1136/jmg.17.1.1; Hirohashi T, 2000, J BIOL CHEM, V275, P2905, DOI 10.1074/jbc.275.4.2905; Hlavata I, 2012, MUTAGENESIS, V27, P187, DOI 10.1093/mutage/ger075; Ikeda K, 2000, CLIN CANCER RES, V6, P4409; Ishizuka M, 2011, INT IMMUNOPHARMACOL, V11, P358, DOI 10.1016/j.intimp.2010.11.029; Jounaidi Y, 2006, MOL CANCER THER, V5, P541, DOI 10.1158/1535-7163.MCT-05-0321; Komatsu T, 2000, DRUG METAB DISPOS, V28, P1457; Koskela S, 1999, BIOCHEM PHARMACOL, V57, P1407, DOI 10.1016/S0006-2952(99)00015-5; MORRISON GR, 1965, ANAL CHEM, V37, P1124, DOI 10.1021/ac60228a014; MOTOYAMA T, 1986, ACTA PATHOL JAPON, V36, P65; Ogura Shun-Ichiro, 2011, BMC Res Notes, V4, P66, DOI 10.1186/1756-0500-4-66; Pratt S, 2005, MOL CANCER THER, V4, P855, DOI 10.1158/1535-7163.MCT-04-0291; Rius M, 2003, HEPATOLOGY, V38, P374, DOI 10.1053/jhep.2003.50331; Robey RW, 2005, CANCER BIOL THER, V4, P187; Rodriguez-Antona C, 2006, ONCOGENE, V25, P1679, DOI 10.1038/sj.onc.1209377; SASSA S, 1988, SEMIN HEMATOL, V25, P312; Schwartz PS, 2003, CANCER GENE THER, V10, P571, DOI 10.1038/sj.cgt.7700601; Sugiyama Y, 2014, ONCOL REP, V31, P1282, DOI 10.3892/or.2013.2945; Tamura A, 2007, DRUG METAB PHARMACOK, V22, P428, DOI 10.2133/dmpk.22.428; Werck-Reichhart D, 2000, GENOME BIOL, V6, P1, DOI [10.1186/GB-2000-1-6-REVIEWS3003, DOI 10.1186/GB-2000-1-6-REVIEWS3003]; Zhou S, 2005, BLOOD, V105, P2571, DOI 10.1182/blood-2004-04-1566	29	16	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2015	10	7							e0131793	10.1371/journal.pone.0131793	http://dx.doi.org/10.1371/journal.pone.0131793			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RQ	26181717	Green Published, Green Submitted, gold			2022-12-26	WOS:000358198200011
J	Ortiz-Alvarez, R; de los Rios, A; Fernandez-Mendoza, F; Torralba-Burrial, A; Perez-Ortega, S				Ortiz-Alvarez, Ruediger; de los Rios, Asuncion; Fernandez-Mendoza, Fernando; Torralba-Burrial, Antonio; Perez-Ortega, Sergio			Ecological Specialization of Two Photobiont-Specific Maritime Cyanolichen Species of the Genus Lichina	PLOS ONE			English	Article							16S RIBOSOMAL-RNA; LICHEN CETRARIA-ACULEATA; CYANOBIONT SELECTIVITY; POPULATION-STRUCTURE; HOST SPECIALIZATION; SALINITY GRADIENT; GENETIC DIVERSITY; CANARY-ISLANDS; TRNL INTRON; CYANOBACTERIA	All fungi in the class Lichinomycetes are lichen-forming and exclusively associate with cyanobacteria. Two closely related maritime species of the genus Lichina (L. confinis and L. pygmaea) show similar distribution ranges in the Northeast Atlantic, commonly co-occurring at the same rocky shores but occupying different littoral zones. By means of 16S rRNA and phycocyanin operon markers we studied a) the phylogenetic relationships of cyanobionts associated with these species, b) the match of divergence times between both symbionts, and c) whether Lichina species differ in photobiont association and in how geography and ecology affect selectivity. The cyanobionts studied are closely related to both marine and freshwater strains of the genus Rivularia. We found evidence of a high specificity to particular cyanobiont lineages in both species: Lichina pygmaea and L. confinis incorporate specific lineages of Rivularia that do not overlap at the haplotype nor the OTU levels. Dating divergences of the fungal and cyanobacterial partners revealed an asynchronous origin of both lineages. Within each fungal species, selectivity varied across the studied area, influenced by environmental conditions (both atmospheric and marine), although patterns were highly correlated between both lichen taxa. Ecological speciation due to the differential association of photobionts to each littoral zone is suspected to have occurred in marine Lichina.	[Ortiz-Alvarez, Ruediger] Spanish Council Res CEAB CSIC, Integrat Freshwater Ecol Grp, Ctr Adv Studies Blanes, Blanes, Girona, Spain; [de los Rios, Asuncion; Perez-Ortega, Sergio] MNCN CSIC, Dept Biogeochem & Microbial Ecol, Madrid, Spain; [Fernandez-Mendoza, Fernando] Karl Franzens Univ Graz, Inst Bot, A-8010 Graz, Austria; [Torralba-Burrial, Antonio] Biosfera Consultoria Medioambiental, Oviedo 33012, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centre d'Estudis Avancats de Blanes (CEAB); Consejo Superior de Investigaciones Cientificas (CSIC); University of Graz	Perez-Ortega, S (corresponding author), MNCN CSIC, Dept Biogeochem & Microbial Ecol, Madrid, Spain.	s.perezortega@gmail.com	Torralba-Burrial, Antonio/C-3141-2008; Ortiz-Álvarez, Rüdiger/I-6365-2019; Pérez-Ortega, Sergio/G-1257-2016; de los Rios, Asuncion/L-3694-2014	Torralba-Burrial, Antonio/0000-0002-4957-2080; Ortiz-Álvarez, Rüdiger/0000-0002-8553-5420; Pérez-Ortega, Sergio/0000-0002-5411-3698; de los Rios, Asuncion/0000-0002-0266-3516	Spanish Ministry of Economy and Competitiveness [BES-2013-066105, CTM2012-38222-C02-02]; Microbial Ecology and Evolution Team, within the Integrative Freshwater Ecology Group; Biosfera Consultoria Medioambiental	Spanish Ministry of Economy and Competitiveness(Spanish Government); Microbial Ecology and Evolution Team, within the Integrative Freshwater Ecology Group; Biosfera Consultoria Medioambiental	Both ROA (BES-2013-066105) and SPO (CTM2012-38222-C02-02) were supported in the form of salary by grants from the Spanish Ministry of Economy and Competitiveness. The authors acknowledge the Microbial Ecology and Evolution Team, within the Integrative Freshwater Ecology Group for currently supporting ROA. Biosfera Consultoria Medioambiental provided support in the form of a salary for author ATB, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of all authors are articulated in the 'author contributions' section.	ADAMS DG, 2012, ECOLOGY CYANOBACTERI, V2, P593; Ahmadjian V, 1993, LICHEN SYMBIOSIS, P250; Bahl J, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1167; Barberan A, 2014, ECOL LETT; Bastian M, 2009, INT AAAI CONF WEBLOG; Beck A, 1998, NEW PHYTOL, V139, P709, DOI 10.1046/j.1469-8137.1998.00231.x; Beck A, 2002, NEW PHYTOL, V153, P317, DOI 10.1046/j.0028-646X.2001.00315.x; Beimforde C, 2014, MOL PHYLOGENET EVOL, V78, P386, DOI 10.1016/j.ympev.2014.04.024; Benton MJ, 2003, TRENDS ECOL EVOL, V18, P358, DOI 10.1016/S0169-5347(03)00093-4; Berrendero E, 2008, INT J SYST EVOL MICR, V58, P447, DOI 10.1099/ijs.0.65273-0; Bittencourt-Oliveira MD, 2001, J PHYCOL, V37, P810; Boto L, 2010, P ROY SOC B-BIOL SCI, V277, P819, DOI 10.1098/rspb.2009.1679; Budel B, 2000, ERGEBNISSE WELTWEITE, P209; Budel B, 2003, PALMARUM HORTUS FRAN, V7; Carine MA, 2010, J BIOGEOGR, V37, P77, DOI 10.1111/j.1365-2699.2009.02181.x; Casamayor EO, 2000, FEMS MICROBIOL ECOL, V34, P113, DOI 10.1016/S0168-6496(00)00079-9; Castillo RV, 2012, FUNGAL BIOL-UK, V116, P665, DOI 10.1016/j.funbio.2012.04.001; Chappuis E, 2014, ESTUAR COAST SHELF S, V147, P113, DOI 10.1016/j.ecss.2014.05.031; Clarke KR, 2001, MAR ECOL PROG SER, V216, P265, DOI 10.3354/meps216265; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Crump BC, 2009, P NATL ACAD SCI USA, V106, P21208, DOI 10.1073/pnas.0906149106; Cruz R, 2004, J EVOLUTION BIOL, V17, P288, DOI 10.1111/j.1420-9101.2003.00689.x; Cubero OF, 1999, PLANT SYST EVOL, V216, P243, DOI 10.1007/BF01084401; Dal-Forno M, 2013, FUNGAL BIOL-UK, V117, P584, DOI 10.1016/j.funbio.2013.05.006; Dale Virginia H., 2001, Ecological Indicators, V1, P3, DOI 10.1016/S1470-160X(01)00003-6; De Los Rios A, 2014, ANTARCT SCI, V26, P459, DOI 10.1017/S0954102014000194; Dominguez-Escobar J, 2011, FEMS MICROBIOL LETT, V316, P90, DOI 10.1111/j.1574-6968.2010.02195.x; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; Egea J. M., 1996, BOCCONEA, V6, P19; Elvebakk A, 2008, J PHYCOL, V44, P1049, DOI 10.1111/j.1529-8817.2008.00556.x; Estrada M, 2004, FEMS MICROBIOL ECOL, V49, P281, DOI 10.1016/j.femsec.2004.04.002; Fedrowitz K, 2012, ECOL EVOL, V2, P2291, DOI 10.1002/ece3.343; Fernandez Mendoza F, 2014, GENETIC DIVERSITY AN; Fernandez-Mendoza F, 2011, MOL ECOL, V20, P1208, DOI 10.1111/j.1365-294X.2010.04993.x; Fernandez-Mendoza F, 2013, MOL ECOL, V22, P1961, DOI 10.1111/mec.12210; Fletcher A, 1973, CAMBRIDGE JOURNALS O, V5, P368; Fletcher A, 1973, CAMBRIDGE JOURNALS O, V5, P401; FOX GE, 1992, INT J SYST BACTERIOL, V42, P166, DOI 10.1099/00207713-42-1-166; Friedl T, 2008, LICHEN BIOLOGY, 2ND EDITION, P9, DOI 10.1017/CBO9780511790478.003; Friedman J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053539; Fujisawa T, 2013, SYST BIOL, V62, P707, DOI 10.1093/sysbio/syt033; Garcia-Pichel F, 2013, SCIENCE, V340, P1574, DOI 10.1126/science.1236404; Goloboff PA, 2003, CLADISTICS, V19, P91, DOI 10.1016/S0748-3007(03)00017-3; Gorley C.K., 2006, GETTING STARTED PRIM; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Han D, 2009, CURR MICROBIOL, V58, P170, DOI 10.1007/s00284-008-9302-x; Henning C, 2014, FPC FLEXIBLE PROCEDU; Herrera-Campos MD, 2005, MYCOLOGIA, V97, P356; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Honegger R, 2012, THE MYCOTINA IX FUNG, P293; Hutsemekersa V, 2011, P NATL ACAD SCI USA, V108, P18989, DOI 10.1073/pnas.1109119108; Janse I, 2003, APPL ENVIRON MICROB, V69, P6634, DOI 10.1128/AEM.69.11.6634-6643.2003; JANSON S, 1993, NEW PHYTOL, V124, P149, DOI 10.1111/j.1469-8137.1993.tb03805.x; Juan C, 2000, TRENDS ECOL EVOL, V15, P104, DOI 10.1016/S0169-5347(99)01776-0; KAUFMAN L, 1990, FINDING GROUPS IN DA; Kny, 1874, DIE ENTWICKLUNG DES, P95; Kruse I, 2004, J SEA RES, V51, P53, DOI 10.1016/j.seares.2003.05.004; Lewis JR, 1964, THE ECOLOGY OF ROCKY; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lobban CS, 1994, SEAWEED ECOLOGY AND; Lorrain Smith A., 1921, LICHENS; Lucking R, 2009, AM J BOT, V96, P1409, DOI 10.3732/ajb.0800258; Lucking R, 2014, LICHENOLOGIST, V46, P261, DOI 10.1017/S0024282913000352; Miller KG, 2005, SCIENCE, V310, P1293, DOI 10.1126/science.1116412; MILLER M.A., 2010, 2010 GATEWAY COMPUTI; Monaghan MT, 2009, SYST BIOL, V58, P298, DOI 10.1093/sysbio/syp027; Moreno PP, 1991, TAXONOMIA CARACTERES, P1; Muggia L, 2014, ANN BOT-LONDON, V114, P463, DOI 10.1093/aob/mcu146; Myllys L, 2007, NEW PHYTOL, V173, P621, DOI 10.1111/j.1469-8137.2006.01944.x; NEILAN BA, 1995, APPL ENVIRON MICROB, V61, P3875, DOI 10.1128/AEM.61.11.3875-3883.1995; Neiva J, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-78; Nubel U, 1997, APPL ENVIRON MICROB, V63, P3327; O'Brien HE, 2005, EUR J PHYCOL, V40, P363, DOI 10.1080/09670260500342647; O'Brien HE, 2013, NEW PHYTOL, V198, P557, DOI 10.1111/nph.12165; Oksanen I, 2004, INT J SYST EVOL MICR, V54, P765, DOI 10.1099/ijs.0.02928-0; Olmanson LG, 2008, REMOTE SENS ENVIRON, V112, P4086, DOI 10.1016/j.rse.2007.12.013; Olsson S, 2012, CURR GENET, V58, P49, DOI 10.1007/s00294-011-0364-0; Otalora MAG, 2013, MICROB ECOL, V65, P517, DOI 10.1007/s00248-012-0136-5; Otalora MAG, 2010, MOL PHYLOGENET EVOL, V56, P1089, DOI 10.1016/j.ympev.2010.05.013; Paulsrud P, 2001, NEW PHYTOL, V152, P117, DOI 10.1046/j.0028-646x.2001.00234.x; Peksa O, 2011, MOL ECOL, V20, P3936, DOI 10.1111/j.1365-294X.2011.05168.x; Pons J, 2006, SYST BIOL, V55, P595, DOI 10.1080/10635150600852011; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Prieto M, 2013, PLOS ONE, V8; Quesada H, 2007, EVOLUTION, V61, P1600, DOI 10.1111/j.1558-5646.2007.00135.x; Rambold G, 1998, BRYOLOGIST, V101, P392; Reid NM, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-196; Rikkinen J, 2002, SCIENCE, V297, P357, DOI 10.1126/science.1072961; Rikkinen J, 2013, MYCOKEYS, P3, DOI 10.3897/mycokeys.6.3869; RIPPKA R., 1992, PASTEUR CULTURE COLL, V1; Robertson BR, 2001, INT J SYST EVOL MICR, V51, P861, DOI 10.1099/00207713-51-3-861; Schirrmeister BE, 2013, P NATL ACAD SCI USA, V110, P1791, DOI 10.1073/pnas.1209927110; Schluter D, 2009, SCIENCE, V323, P737, DOI 10.1126/science.1160006; Schneider S, 1999, GENETICS, V152, P1079; Schultz M, 2000, PLANT BIOLOGY, V2, P482, DOI 10.1055/s-2000-5951; Schultz M, 2003, LICHENOLOGIST, V35, P151, DOI 10.1016/S0024-2829(03)00019-7; Schultz M, 2009, BIBL LICHENOL, P315; Serusiaux E, 2011, J BIOGEOGR, V38, P1138, DOI 10.1111/j.1365-2699.2010.02469.x; Sihvonen LM, 2007, FEMS MICROBIOL ECOL, V61, P74, DOI 10.1111/j.1574-6941.2007.00321.x; Smith CW, 2009, THE LICHENS OF GREAT, P556; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Stenroos S, 2006, CLADISTICS, V22, P230, DOI 10.1111/j.1096-0031.2006.00101.x; Stolzer M, 2012, BIOINFORMATICS, V28, pI409, DOI 10.1093/bioinformatics/bts386; Summerfield TC, 2002, NEW PHYTOL, V155, P121, DOI 10.1046/j.1469-8137.2002.00431.x; TAJIMA F, 1983, GENETICS, V105, P437; Thompson JN, 1999, AM NAT, V153, pS1, DOI 10.1086/303208; Tronholm A, 2010, J PHYCOL, V46, P1075, DOI 10.1111/j.1529-8817.2010.00912.x; Tyberghein L, 2012, GLOBAL ECOL BIOGEOGR, V21, P272, DOI 10.1111/j.1466-8238.2011.00656.x; Villesen P, 2007, MOL ECOL NOTES, V7, P965, DOI 10.1111/j.1471-8286.2007.01821.x; Whitton B.A., 1987, CYANOBACTERIA A COMP, P513; Whitton BA, 2012, ECOLOGY CYANOBACTERI, VII, P1, DOI [10.1007/978-94-007-3855-3_1, DOI 10.1007/978-94-007-3855-3_1]; Whitton BA, 2012, ECOLOGY OF CYANOBACT; Wirtz N, 2003, NEW PHYTOL, V160, P177, DOI 10.1046/j.1469-8137.2003.00859.x; Yahr R, 2006, NEW PHYTOL, V171, P847, DOI 10.1111/j.1469-8137.2006.01792.x; Ye J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-134; Zahlbruckner A., 1926, DIE NATURLICHEN PFLA	116	23	24	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2015	10	7							e0132718	10.1371/journal.pone.0132718	http://dx.doi.org/10.1371/journal.pone.0132718			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RQ	26181436	Green Published, gold, Green Submitted			2022-12-26	WOS:000358198200029
J	Petti, CA; Stoddard, GJ; Sande, MA; Samore, MH; Simmon, KE; Hofmann, A				Petti, Cathy A.; Stoddard, Gregory J.; Sande, Merle A.; Samore, Matthew H.; Simmon, Keith E.; Hofmann, Aaron			The Suspected Infected Prosthetic Joint: Clinical Acumen and Added Value of Laboratory Investigations	PLOS ONE			English	Article							TOTAL HIP-ARTHROPLASTY; TOTAL KNEE ARTHROPLASTY; C-REACTIVE PROTEIN; REVISION HIP; DIAGNOSIS; MANAGEMENT; PCR; AMPLIFICATION; IMPACT; FLUID	Consensus definitions have emerged for the discrimination between infected and uninfected prosthetic joints but diagnostic uncertainty often occurs. We examined the accuracy of orthopaedic surgeons' assessments to diagnose the infected prosthetic hip or knee and elucidated the added value of laboratory parameters. A prospective cohort study of patients undergoing revision arthroplasty of hip or knee was conducted over a one-year period. Orthopaedic surgeons' determinations prior to arthroplasty were recorded. A reference diagnostic standard was determined retrospectively by independent review from 3 infectious diseases physicians. Patients were followed up to 12 months. For 198 patients enrolled, 228 surgical encounters (110 knee, 118 hip) were classified by independent reviewers as 176 uninfected and 52 infected. Orthopaedic surgeons' preoperative diagnoses of infection had high diagnostic accuracy (sensitivity 89%, specificity 99%, PPV 98%, NPV 97%). Addition of intraoperative findings and histopathology improved their diagnostic accuracy. Addition of culture and PCR results improved sensitivity of diagnostic determinations but not specificity. We provide evidence that clinical acumen has high diagnostic accuracy using routine preoperative parameters. Histopathology from intraoperative specimens would improve surgeons' diagnostic accuracy but culture and PCR from intraoperative specimens could create greater diagnostic uncertainty. This study is critical to further our understanding of the added value, if any, of laboratory testing to support clinical decision making for the suspected infected joint and allow us to identify diagnostic gaps for emerging technologies to fill that will improve our ability to diagnose the infected prosthetic joint.	[Petti, Cathy A.; Stoddard, Gregory J.; Sande, Merle A.; Samore, Matthew H.] Univ Utah Hosp & Clin, Dept Med, Salt Lake City, UT 84132 USA; [Simmon, Keith E.] Associated Reg & Univ Pathol Labs, Inst Clin & Expt Pathol, Salt Lake City, UT USA; [Hofmann, Aaron] Univ Utah Hosp & Clin, Dept Orthopaed Surg, Salt Lake City, UT USA	Utah System of Higher Education; University of Utah; University of Utah Hospital; Utah System of Higher Education; University of Utah; University of Utah Hospital	Petti, CA (corresponding author), Univ Utah Hosp & Clin, Dept Med, Salt Lake City, UT 84132 USA.	cpetti007@gmail.com			Atlantic Philanthropies; John A. Hartford Foundation; Association of Specialty Professors; Infectious Diseases Society of America	Atlantic Philanthropies; John A. Hartford Foundation; Association of Specialty Professors; Infectious Diseases Society of America	This study was partially funded by a competitive young investigator grant awarded to Dr. Petti by Atlantic Philanthropies, John A. Hartford Foundation, Association of Specialty Professors, and Infectious Diseases Society of America. The sponsors of the study had no role in the design and conduct of the study, in the collection, analysis, and interpretation of the data, or in the preparation, review, or approval of the manuscript.	Atkins BL, 1998, J CLIN MICROBIOL, V36, P2932, DOI 10.1128/JCM.36.10.2932-2939.1998; Austin MS, 2008, J ARTHROPLASTY, V23, P65, DOI 10.1016/j.arth.2007.09.005; Barrack RL, 2007, J ARTHROPLASTY, V22, P94, DOI 10.1016/j.arth.2007.03.029; Bauer TW, 2006, J BONE JOINT SURG AM, V88A, P869, DOI 10.2106/JBJS.E.01149; Bemer P, 2014, J CLIN MICROBIOL, V52, P3583, DOI 10.1128/JCM.01459-14; Berbari EF, 1998, CLIN INFECT DIS, V27, P1247, DOI 10.1086/514991; Berner ES, 2008, AM J MED, V121, P2, DOI 10.1016/j.amjmed.2008.01.001; Blom AW, 2003, J BONE JOINT SURG BR, V85B, P956, DOI 10.1302/0301-620X.85B7.14095; Bozic KJ, 2005, J BONE JOINT SURG AM, V87A, P1746, DOI 10.2106/JBJS.D.02937; Centers for disease control and prevention, NAT HOSP DISCH SURV; Croskerry P, 2008, AM J MED, V121, P24, DOI 10.1016/j.amjmed.2008.02.001; Deirmengian C, 2014, J BONE JOINT SURG AM, V96A, P1439, DOI 10.2106/JBJS.M.01316; Del Pozo JL, 2009, NEW ENGL J MED, V361, P787, DOI 10.1056/NEJMcp0905029; FEHRING TK, 1994, CLIN ORTHOP RELAT R, P229; Fenollar F, 2006, J CLIN MICROBIOL, V44, P1018, DOI 10.1128/JCM.44.3.1018-1028.2006; Fisman DN, 2001, CLIN INFECT DIS, V32, P419, DOI 10.1086/318502; Ghanem E, 2008, J BONE JOINT SURG AM, V90A, P1637, DOI 10.2106/JBJS.G.00470; Greenwood-Quaintance KE, 2014, J CLIN MICROBIOL, V52, P642, DOI 10.1128/JCM.03217-13; HALDANE JBS, 1956, ANN HUM GENET, V20, P309; Kurtz S, 2007, J BONE JOINT SURG AM, V89A, P780, DOI 10.2106/JBJS.F.00222; Lachiewicz PF, 1996, J BONE JOINT SURG AM, V78A, P749, DOI 10.2106/00004623-199605000-00015; Lonner JH, 1996, J BONE JOINT SURG AM, V78A, P1553, DOI 10.2106/00004623-199610000-00014; Osmon DR, 2013, CLIN INFECT DIS, V56, DOI [10.1093/cid/cis803, 10.1093/cid/cis966]; Parvizi J, 2011, CLIN ORTHOP RELAT R, V469, P3022, DOI 10.1007/s11999-011-1971-2; Peel TN, 2013, CLIN MICROBIOL INFEC, V19, P181, DOI 10.1111/j.1469-0691.2011.03758.x; Petti CA, 2007, CLIN INFECT DIS, V44, P1108, DOI 10.1086/512818; Ryu SY, 2014, DIAGN MICR INFEC DIS, V79, P448, DOI 10.1016/j.diagmicrobio.2014.03.021; Saleh K, 2002, J ORTHOP RES, V20, P506, DOI 10.1016/S0736-0266(01)00153-X; Saleh KJ, 2003, J BONE JOINT SURG AM, V85A, P18, DOI 10.2106/00004623-200300001-00005; SANZEN L, 1989, J BONE JOINT SURG BR, V71, P638, DOI 10.1302/0301-620X.71B4.2768312; SCULCO TP, 1995, ORTHOPEDICS, V18, P871; Segawa H, 1999, J BONE JOINT SURG AM, V81A, P1434, DOI 10.2106/00004623-199910000-00008; Selvin S., 2004, STAT ANAL EPIDEMIOLO; Spangehl MJ, 1999, J BONE JOINT SURG AM, V81A, P672, DOI 10.2106/00004623-199905000-00008; Trampuz A, 2007, NEW ENGL J MED, V357, P654, DOI 10.1056/NEJMoa061588; Virolainen P, 2002, Scand J Surg, V91, P178; Zimmerli W, 2004, NEW ENGL J MED, V351, P1645, DOI 10.1056/NEJMra040181; Zmistowski Benjamin, 2014, J Arthroplasty, V29, P77, DOI 10.1016/j.arth.2013.09.040	38	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2015	10	7							e0131609	10.1371/journal.pone.0131609	http://dx.doi.org/10.1371/journal.pone.0131609			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RQ	26181332	Green Published, Green Submitted, gold			2022-12-26	WOS:000358198200007
J	Pinskiy, V; Jones, J; Tolpygo, AS; Franciotti, N; Weber, K; Mitra, PP				Pinskiy, Vadim; Jones, Jamie; Tolpygo, Alexander S.; Franciotti, Neil; Weber, Kevin; Mitra, Partha P.			High-Throughput Method of Whole-Brain Sectioning, Using the Tape-Transfer Technique	PLOS ONE			English	Article							BONE	Cryostat sectioning is a popular but labor-intensive method for preparing histological brain sections. We have developed a modification of the commercially available CryoJane tape collection method that significantly improves the ease of collection and the final quality of the tissue sections. The key modification involves an array of UVLEDs to achieve uniform polymerization of the glass slide and robust adhesion between the section and slide. This report presents system components and detailed procedural steps, and provides examples of end results; that is, 20 mu m mouse brain sections that have been successfully processed for routine Nissl, myelin staining, DAB histochemistry, and fluorescence. The method is also suitable for larger brains, such as rat and monkey.	[Pinskiy, Vadim; Jones, Jamie; Tolpygo, Alexander S.; Franciotti, Neil; Weber, Kevin; Mitra, Partha P.] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Pinskiy, Vadim] SUNY Stony Brook, Dept Biomed Engn, Stony Brook, NY 11794 USA	Cold Spring Harbor Laboratory; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Pinskiy, V (corresponding author), Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA.	vpinskiy@gmail.com		Mitra, Partha/0000-0001-8818-6804	National Institutes of Health [RC1MH088659]; Office of NIH Director [R01MH087988]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH087988, RC1MH088659] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Office of NIH Director; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Support was provided by the Challenge Grant from the National Institutes of Health (RC1MH088659), PPM; Transformative Award from the Office of the NIH Director (R01MH087988), PPM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akins MR, 2006, J COMP NEUROL, V499, P979, DOI 10.1002/cne.21147; [Anonymous], CRYOJANE OP MAN; [Anonymous], 2007, MICR HM550 CRYOST MI; Gallyas F, 1979, Neurol Res, V1, P203; Jacquet R, 2005, ANAL BIOCHEM, V337, P22, DOI 10.1016/j.ab.2004.09.033; Jiang X, 2005, J HISTOCHEM CYTOCHEM, V53, P593, DOI 10.1369/jhc.4A6401.2005; Laux A, 2011, J COMP NEUROL, V519, P2390, DOI 10.1002/cne.22633; Peters Sr, 2010, PRACTICAL GUIDE TO FROZEN SECTION TECHNIQUE, P1, DOI 10.1007/978-1-4419-1234-3; Pinskiy V, 2013, J NEUROSCI METH, V218, P206, DOI 10.1016/j.jneumeth.2013.03.004; Reiner A, 2000, J NEUROSCI METH, V103, P23, DOI 10.1016/S0165-0270(00)00293-4; Salie R, 2008, CALCIFIED TISSUE INT, V83, P212, DOI 10.1007/s00223-008-9154-1	11	23	24	3	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2015	10	7							e0102363	10.1371/journal.pone.0102363	http://dx.doi.org/10.1371/journal.pone.0102363			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RQ	26181725	Green Accepted, gold, Green Published			2022-12-26	WOS:000358198200001
J	van Kampen, SC; Tursynbayeva, A; Koptleuova, A; Murzabekova, Z; Bigalieva, L; Aubakirova, M; Pak, S; van den Hof, S				van Kampen, Sanne Christine; Tursynbayeva, Aigul; Koptleuova, Aliya; Murzabekova, Zauresh; Bigalieva, Lyazzat; Aubakirova, Moldir; Pak, Svetlana; van den Hof, Susan			Effect of Introducing Xpert MTB/RIF to Test and Treat Individuals at Risk of Multidrug-Resistant Tuberculosis in Kazakhstan: A Prospective Cohort Study	PLOS ONE			English	Article							SURVEILLANCE	Background Xpert MTB/RIF (Xpert) was piloted in Kazakhstan to detect tuberculosis (TB) and rifampicin resistance (RR-) TB among individuals at risk of multidrug-resistant (MDR-) TB. This study assessed the performance of Xpert compared to conventional diagnostic methods, RR-TB case detection among various risk groups, treatment initiation and time to diagnosis and treatment. Methods Eligible individuals were tested with Xpert, smear microscopy, culture and drug-susceptibility testing (DST) at the national TB reference laboratory and three provincial laboratories. Data was collected prospectively from August 2012 to May 2013 from routine laboratory and treatment registers. Results A total of 5,611 Xpert tests were performed mostly targeting contacts of MDR-TB patients, 'other' presumptive MDR-TB patients, and retreatment cases (26%, 24% and 22%, respectively). Compared to phenotypic DST, the positive predictive value of Xpert to detect RR-TB was 93.1% and 96.4% and the negative predictive value was 94.6% and 92.7% using solid and liquid culture media, respectively. RR-TB detection was highest among (former) prisoners, retreatment cases, people living with HIV/AIDS (PLWHA), and TB patients with positive smears after intensive phase of treatment (59%, 58%, 54% and 53% among TB positives, respectively). 88.9% of RR-TB patients were registered to have started second-line TB treatment. Median time to diagnosis with Xpert was 0.0 days (IQR 0.0-1.0), time from diagnosis to start of first-line treatment 3.0 days (IQR 1.0-7.0), and to start of second-line treatment 7.0 days (IQR 4.0-16). Conclusions Compared to conventional culture and DST, Xpert had a shorter result turn-around-time and excellent concordance to detect RR-TB. Time from sputum collection to start of second-line treatment was reduced to one week. The yield of Xpert could be maximized by increasing referrals from penitentiary and HIV centers to TB centers.	[van Kampen, Sanne Christine; van den Hof, Susan] KNCV TB Fdn, Cent Off, The Hague, Netherlands; [Tursynbayeva, Aigul; Pak, Svetlana] KNCV TB Fdn, Cent Asia Off, Alma Ata, Kazakhstan; [Koptleuova, Aliya] Natl Ctr TB Control, Alma Ata, Kazakhstan; [Murzabekova, Zauresh] Akmola Reg TB Dispensary, Kokshetau, Kazakhstan; [Bigalieva, Lyazzat] East Kazakhstan Reg TB Dispensary, Oskemen, Kazakhstan; [Aubakirova, Moldir] Almaty City TB Dispensary, Alma Ata, Kazakhstan	KNCV Tuberculosis Foundation; KNCV Tuberculosis Foundation	van Kampen, SC (corresponding author), KNCV TB Fdn, Cent Off, The Hague, Netherlands.	sanne.vankampen@kncvtbc.org		van Kampen, Sanne/0000-0002-1519-5248	United States Agency for International Development under the USAID Tuberculosis CARE I [AID-OAA-A-10-000020]	United States Agency for International Development under the USAID Tuberculosis CARE I(United States Agency for International Development (USAID))	This study was funded by the United States Agency for International Development under the USAID Tuberculosis CARE I, Cooperative Agreement No. AID-OAA-A-10-000020. Funding was received by SK, AT, SP and SH. The funder was involved in conception of the study design and supervision of the project.	[Anonymous], 2010, MULTIDRUG EXTENSIVEL; Falzon D, 2013, LANCET INFECT DIS, V13, P690, DOI 10.1016/S1473-3099(13)70130-0; Klinkenberg E, 2012, INT J TUBERC LUNG D, V16, P615, DOI 10.5588/ijtld.11.0262; Medecins Sans Frontieres, 2011, 1 MSF GENEXPERT SUBG; Steingart KR, 2014, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD009593.pub2, 10.1002/14651858.CD009593.pub3]; TB CAREI, 2014, TB CARE 1 PROGR YEAR; TB CAREI, 2012, TB CARE 1 ANN REP YE; Theron G, 2014, LANCET, V383, P424, DOI 10.1016/S0140-6736(13)62073-5; USAID, TREATM TB MOV HOSP H; van den Hof S, 2013, INT J TUBERC LUNG D, V17, P526, DOI 10.5588/ijtld.12.0703; Van Kampen SC, 2014, PLOS ONE IN PRESS; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; WHO, 2011, POL STAT AUT REAL TI; World Health Organization, 2011, RAP IMPL XPERT MTB R; World Health Organization, 2014, XPERT MTB RIF IMPL M; World Health Organization, 2010, WHOHTMTB20109; World Health Organization, 2011, TUB COUNTR WORK SUMM; World Health Organization, 2011, WHO PROGRESS REPORT	18	19	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2015	10	7							e0132514	10.1371/journal.pone.0132514	http://dx.doi.org/10.1371/journal.pone.0132514			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RQ	26181578	gold, Green Published, Green Submitted			2022-12-26	WOS:000358198200020
J	Jaberzadeh, S; Bastani, A; Zoghi, M; Morgan, P; Fitzgerald, PB				Jaberzadeh, Shapour; Bastani, Andisheh; Zoghi, Maryam; Morgan, Prue; Fitzgerald, Paul B.			Anodal Transcranial Pulsed Current Stimulation: The Effects of Pulse Duration on Corticospinal Excitability	PLOS ONE			English	Article							MOTOR CORTICAL EXCITABILITY; MAGNETIC STIMULATION; ELECTRICAL-STIMULATION; TACS; PERCEPTION; MODULATION; SAFETY; CORTEX	The aim is to investigate the effects of pulse duration (PD) on the modulatory effects of transcranial pulsed current (tPCS) on corticospinal excitability (CSE). CSE of the dominant primary motor cortex (M1) of right first dorsal interosseous muscle was assessed by motor evoked potentials, before, immediately, 10, 20 and 30 minutes after application of five experimental conditions: 1) anodal transcranial direct current stimulation (a-tDCS), 2) a-tPCS with 125 ms pulse duartion (a-tPCS(PD = 125)), 3) a-tPCS with 250 ms pulse duration (a-tPCS(PD = 250)), 4) a-tPCS with 500 ms pulse duration (a-tPCS(PD = 500)) and 5) sham a-tPCS. The total charges were kept constant in all experimental conditions except sham condition. Post-hoc comparisons indicated that a-tPCS(PD = 500) produced larger CSE compared to a-tPCS(PD = 125) (P<0.0001), a-tPCS(PD = 250) (P = 0.009) and a-tDCS (P = 0.008). Also, there was no significant difference between a-tPCS(PD = 250) and a-tDCS on CSE changes (P>0.05). All conditions except a-tPCS(PD = 125) showed a significant difference to the sham group (P<0.006). All participants tolerated the applied currents. It could be concluded that a-tPCS with a PD of 500ms induces largest CSE changes, however further studies are required to identify optimal values.	[Jaberzadeh, Shapour; Bastani, Andisheh; Morgan, Prue] Monash Univ, Dept Physiotherapy, Sch Primary Hlth Care, Fac Med, Melbourne, Vic 3004, Australia; [Bastani, Andisheh; Zoghi, Maryam] Univ Melbourne, Royal Melbourne Hosp, Dept Med, Melbourne, Vic 3050, Australia; [Fitzgerald, Paul B.] Monash Univ, Cent Clin Sch & Alfred, Monash Alfred Psychiat Res Ctr, Melbourne, Vic 3004, Australia	Monash University; Royal Melbourne Hospital; University of Melbourne; Monash University	Jaberzadeh, S (corresponding author), Monash Univ, Dept Physiotherapy, Sch Primary Hlth Care, Fac Med, Melbourne, Vic 3004, Australia.	shapour.jaberzadeh@monash.edu	Fitzgerald, Paul B/A-1225-2008; , Zoghi/AAF-9536-2019	Fitzgerald, Paul B/0000-0003-4217-8096; , Zoghi/0000-0002-1819-6895	Monash University; Postgraduate Publication Award scheme	Monash University(Monash University); Postgraduate Publication Award scheme	This work was supported by the Monash University, Faculty Grant, Strategic Grant Scheme (SJ, MZ, PM, PBF) and Postgraduate Publication Award scheme (AB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antal A, 2008, BRAIN STIMUL, V1, P97, DOI 10.1016/j.brs.2007.10.001; Bastani A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047582; Bergmann TO, 2009, J NEUROPHYSIOL, V102, P2303, DOI 10.1152/jn.00437.2009; Brunoni AR, 2011, INT J NEUROPSYCHOPH, V14, P1133, DOI 10.1017/S1461145710001690; Dundas JE, 2007, CLIN NEUROPHYSIOL, V118, P1166, DOI 10.1016/j.clinph.2007.01.010; Durand S, 2002, J PHYSIOL-LONDON, V540, P261, DOI 10.1113/jphysiol.2001.013364; George MS, 2010, NEUROPSYCHOPHARMACOL, V35, P301, DOI 10.1038/npp.2009.87; Gilmore K L, 1983, Aust J Physiother, V29, P3, DOI 10.1016/S0004-9514(14)60659-0; Groppa S, 2010, NEUROSCIENCE, V166, P1219, DOI 10.1016/j.neuroscience.2010.01.019; Hallett M, 1996, ANN NEUROL, V40, P344, DOI 10.1002/ana.410400303; Jaberzadeh S, 2014, CLIN NEUROPHYSIOL, V125, P344, DOI 10.1016/j.clinph.2013.08.025; Kanai R, 2010, CLIN NEUROPHYSIOL, V121, P1551, DOI 10.1016/j.clinph.2010.03.022; Kanai R, 2008, CURR BIOL, V18, P1839, DOI 10.1016/j.cub.2008.10.027; Keel JC, 2001, CLIN NEUROPHYSIOL, V112, P720, DOI 10.1016/S1388-2457(00)00518-6; Kendall F., 2010, MUSCLES TESTING FUNC, V5th ed; Lakhanpal Rohit R, 2003, Curr Opin Ophthalmol, V14, P122, DOI 10.1097/00055735-200306000-00002; Nitsche MA, 2003, SUPPL CLIN NEUROPHYS, V56, P255; Nitsche MA, 2000, J PHYSIOL-LONDON, V527, P633, DOI 10.1111/j.1469-7793.2000.t01-1-00633.x; Nitsche MA, 2008, BRAIN STIMUL, V1, P206, DOI 10.1016/j.brs.2008.06.004; Noordzij M, 2010, NEPHROL DIAL TRANSPL, P732; Oh S.J., 2003, CLIN ELECTROMYOGRAPH, DOI [10.1046/j.1468-1331.2003.00654.x, DOI 10.1046/J.1468-1331.2003.00654.X]; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Pahn U, 2008, BRAIN STIMUL, V1, P386, DOI 10.1016/j.brs.2008.04.003; Paulus W, 2011, NEUROPSYCHOL REHABIL, V21, P602, DOI 10.1080/09602011.2011.557292; Pell GS, 2011, PROG NEUROBIOL, V93, P59, DOI 10.1016/j.pneurobio.2010.10.003; Perotto A., 2005, ANATOMICAL GUIDE ELE; Robertson V, 2006, ELECTROTHERAPY EXPLA, V4th; ROSSINI PM, 1994, ELECTROEN CLIN NEURO, V91, P79, DOI 10.1016/0013-4694(94)90029-9; Schwartz M. S., 2003, BIOFEEDBACK PRACTITI, V3rd; Turi Z, 2013, RESTOR NEUROL NEUROS, V31, P275, DOI 10.3233/RNN-120297; Wassermann E., 2008, OXFORD HDB TRANSCRAN; Zaghi S, 2010, NEUROSCI LETT, V479, P211, DOI 10.1016/j.neulet.2010.05.060	32	18	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0131779	10.1371/journal.pone.0131779	http://dx.doi.org/10.1371/journal.pone.0131779			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26177541	Green Submitted, gold, Green Published			2022-12-26	WOS:000358197600064
J	Samorodnitsky, D; Szyjka, C; Koudelka, GB				Samorodnitsky, Daniel; Szyjka, Courtney; Koudelka, Gerald B.			A Role for Autoinhibition in Preventing Dimerization of the Transcription Factor ETS1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-BINDING; STROMELYSIN-1 PROMOTER; UNSTRUCTURED REGION; IN-VIVO; DOMAIN; FAMILY; SITES; PU.1; PROTEINS; ENHANCER	ETS1 is the archetype of the ETS transcription factor (TF) family. ETS TFs share a DNA-binding domain, the ETS domain. All ETS TFs recognize a core GGA(A/T) binding site, and thus ETS TFs are found to redundantly regulate the same genes. However, each ETS TF has unique targets as well. One prevailing hypotheses explaining this duality is that protein-protein interactions, including homodimerization, allow each ETS TF to display distinct behavior. The behavior of ETS1 is further regulated by autoinhibition. Autoinhibition apparently modulates ETS1 DNA binding affinity, but the mechanism of this inhibition is not completely understood. We sought to characterize the relationship between DNA binding and ETS1 homodimer formation. We find that ETS1 interrogates DNA and forms dimers even when the DNA does not contain an ETS recognition sequence. Mutational studies also link nonspecific DNA backbone contacts with dimer formation, in addition to providing a new role for the recognition helix of ETS1 in maintaining the autoinhibited state. Finally, in showing that residues in the DNA recognition helix affect autoinhibition, we define a new function of ETS1 autoinhibition: maintenance of a monomeric state in the absence of DNA. The conservation of relevant amino acid residues across all ETS TFs indicates that the mechanisms of nonspecific DNA interrogation and protein oligomer formation elucidated here may be common to all ETS proteins that autoinhibit.	[Samorodnitsky, Daniel; Szyjka, Courtney; Koudelka, Gerald B.] SUNY Buffalo, Dept Biol Sci, Buffalo, NY 14260 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Koudelka, GB (corresponding author), SUNY Buffalo, Dept Biol Sci, 109 Cooke Hall,North Campus, Buffalo, NY 14260 USA.	koudelka@buffalo.edu	Koudelka, Gerald B./AAI-3738-2020	Koudelka, Gerald B./0000-0001-6280-0837; Szyjka, Courtney/0000-0001-9991-8038	College of Arts and Sciences, University at Buffalo	College of Arts and Sciences, University at Buffalo	This work was supported by funds from the College of Arts and Sciences, University at Buffalo (to G. B. K.). The authors declare that they have no conflicts of interest with the contents of this article.	Babayeva ND, 2010, CELL CYCLE, V9, P3054, DOI 10.4161/cc.9.14.12257; Baillat D, 2006, ONCOGENE, V25, P5764, DOI 10.1038/sj.onc.1209583; Baillat D, 2002, J BIOL CHEM, V277, P29386, DOI 10.1074/jbc.M200088200; Baillat D, 2009, BIOCHEM BIOPH RES CO, V378, P213, DOI 10.1016/j.bbrc.2008.11.035; Del S, 2014, J MOL BIOL, V426, P1390, DOI 10.1016/j.jmb.2013.11.031; Dittmer Jurgen, 2003, Mol Cancer, V2, P29, DOI 10.1186/1476-4598-2-29; Garvie CW, 2002, J BIOL CHEM, V277, P45529, DOI 10.1074/jbc.M206327200; Graves BJ, 1996, NATURE, V384, P322, DOI 10.1038/384322a0; Greenfield NJ, 2006, NAT PROTOC, V1, P2876, DOI 10.1038/nprot.2006.202; Gross P, 1998, BIOCHEMISTRY-US, V37, P5129, DOI 10.1021/bi972591k; Gu TL, 2000, MOL CELL BIOL, V20, P91, DOI 10.1128/MCB.20.1.91-103.2000; GUNTHER CV, 1994, MOL CELL BIOL, V14, P7569, DOI 10.1128/MCB.14.11.7569; Hellman LM, 2007, NAT PROTOC, V2, P1849, DOI 10.1038/nprot.2007.249; Hollenhorst PC, 2007, GENE DEV, V21, P1882, DOI 10.1101/gad.1561707; Hollenhorst PC, 2011, ANNU REV BIOCHEM, V80, P437, DOI 10.1146/annurev.biochem.79.081507.103945; Kim WY, 1999, EMBO J, V18, P1609, DOI 10.1093/emboj/18.6.1609; Lamber EP, 2008, EMBO J, V27, P2006, DOI 10.1038/emboj.2008.117; Lee GM, 2005, J BIOL CHEM, V280, P7088, DOI 10.1074/jbc.M410722200; Lee GM, 2008, J MOL BIOL, V382, P1014, DOI 10.1016/j.jmb.2008.07.064; Leprivier G, 2009, NUCLEIC ACIDS RES, V37, P4341, DOI 10.1093/nar/gkp307; Li RH, 1999, P NATL ACAD SCI USA, V96, P3876, DOI 10.1073/pnas.96.7.3876; Lionneton F, 2003, ONCOGENE, V22, P9156, DOI 10.1038/sj.onc.1207241; Maxam A M, 1980, Methods Enzymol, V65, P499; NYE JA, 1992, GENE DEV, V6, P975, DOI 10.1101/gad.6.6.975; PETERSEN JM, 1995, SCIENCE, V269, P1866, DOI 10.1126/science.7569926; Poon GMK, 2003, J MOL BIOL, V328, P805, DOI 10.1016/S0022-2836(03)00362-0; Poon GMK, 2012, J BIOL CHEM, V287, P18297, DOI 10.1074/jbc.M112.342345; Poon GMK, 2012, BIOCHEMISTRY-US, V51, P4096, DOI 10.1021/bi300331v; Pufall MA, 2005, SCIENCE, V309, P142, DOI 10.1126/science.1111915; Rao E, 1997, J BIOL CHEM, V272, P6722, DOI 10.1074/jbc.272.10.6722; Sharma S, 2014, NUCLEIC ACIDS RES, V42, P5543, DOI 10.1093/nar/gku211; Sharrocks AD, 2001, NAT REV MOL CELL BIO, V2, P827, DOI 10.1038/35099076; Wang H, 2002, J BIOL CHEM, V277, P2225, DOI 10.1074/jbc.M109430200; Wei GH, 2010, EMBO J, V29, P2147, DOI 10.1038/emboj.2010.106	34	5	5	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	2015	290	36					22101	22110		10.1074/jbc.M115.671339	http://dx.doi.org/10.1074/jbc.M115.671339			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CQ9XI	26195629	Green Published, hybrid			2022-12-26	WOS:000360968500028
J	Yin, H; Frontini, MJ; Arpino, JM; Nong, ZX; O'Neil, C; Xu, YW; Balint, B; Ward, AD; Chakrabarti, S; Ellis, CG; Gros, R; Pickering, JG				Yin, Hao; Frontini, Matthew J.; Arpino, John-Michael; Nong, Zengxuan; O'Neil, Caroline; Xu, Yiwen; Balint, Brittany; Ward, Aaron D.; Chakrabarti, Subrata; Ellis, Christopher G.; Gros, Robert; Pickering, J. Geoffrey			Fibroblast Growth Factor 9 Imparts Hierarchy and Vasoreactivity to the Microcirculation of Renal Tumors and Suppresses Metastases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMOOTH-MUSCLE-CELLS; PREMALIGNANT PROSTATE TUMORS; ANTIANGIOGENIC THERAPY; BLOOD-FLOW; VASCULAR NORMALIZATION; IN-VIVO; ANGIOGENESIS; FGF9; CANCER; MICE	Tumor vessel normalization has been proposed as a therapeutic paradigm. However, normal microvessels are hierarchical and vasoreactive with single file transit of red blood cells through capillaries. Such a network has not been identified in malignant tumors. We tested whether the chaotic tumor microcirculation could be reconfigured by the mesenchyme-selective growth factor, FGF9. Delivery of FGF9 to renal tumors in mice yielded microvessels that were covered by pericytes, smooth muscle cells, and a collagen-fortified basement membrane. This was associated with reduced pulmonary metastases. Intravital microvascular imaging revealed a haphazard web of channels in control tumors but a network of arterioles, bona fide capillaries, and venules in FGF9-expressing tumors. Moreover, whereas vasoreactivity was absent in control tumors, arterioles in FGF9-expressing tumors could constrict and dilate in response to adrenergic and nitric oxide releasing agents, respectively. These changes were accompanied by reduced hypoxia in the tumor core and reduced expression of the angiogenic factor VEGF-A. FGF9 was found to selectively amplify a population of PDGFR beta-positive stromal cells in the tumor and blocking PDGFR beta prevented microvascular differentiation by FGF9 and also worsened metastases. We conclude that harnessing local mesenchymal stromal cells with FGF9 can differentiate the tumor microvasculature to an extent not observed previously.	[Yin, Hao; Frontini, Matthew J.; Arpino, John-Michael; Nong, Zengxuan; O'Neil, Caroline; Xu, Yiwen; Balint, Brittany; Gros, Robert; Pickering, J. Geoffrey] Univ Western Ontario, Robarts Res Inst, London, ON N6A 5A5, Canada; [Frontini, Matthew J.; Pickering, J. Geoffrey] Univ Western Ontario, Dept Biochem, London, ON N6A 5A5, Canada; [Arpino, John-Michael; Xu, Yiwen; Balint, Brittany; Ward, Aaron D.; Ellis, Christopher G.; Pickering, J. Geoffrey] Univ Western Ontario, Dept Med Biophys, London, ON N6A 5A5, Canada; [Chakrabarti, Subrata] Univ Western Ontario, Dept Pathol, London, ON N6A 5A5, Canada; [Gros, Robert] Univ Western Ontario, Dept Physiol & Pharmacol, London, ON N6A 5A5, Canada; [Gros, Robert; Pickering, J. Geoffrey] Univ Western Ontario, Dept Med, London, ON N6A 5A5, Canada; [Pickering, J. Geoffrey] London Hlth Sci Ctr, London, ON N6A 5A5, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); London Health Sciences Centre	Pickering, JG (corresponding author), London Hlth Sci Ctr, 339 Windermere Rd, London, ON N6A 5A5, Canada.	gpickering@robarts.ca	Ward, Aaron/B-4950-2015; Pickering, J. Geoffrey/G-3341-2011; Gros, Robert/AAV-2237-2020; Gros, Robert/A-3010-2009; Ellis, Christopher G/AAV-2325-2020; Ellis, Christopher G/G-8649-2013	Pickering, J. Geoffrey/0000-0001-6474-3274; Gros, Robert/0000-0002-3667-8011; Gros, Robert/0000-0002-3667-8011; Ellis, Christopher G/0000-0002-7760-1846; Chakrabarti, Subrata/0000-0002-0208-1401; Balint, Brittany/0000-0002-7520-9509	Canadian Cancer Society [701080]; Canadian Institutes of Health Research [FRN-11715, FRN-126148]; Heart and Stroke Foundation of Canada (HSFC) [T7081]; University of Western Ontario (POEM); Canadian Institutes of Health Research Fellowship; New Investigator Award HSFC	Canadian Cancer Society(Canadian Cancer Society (CCS)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Canada (HSFC)(Heart & Stroke Foundation of Canada); University of Western Ontario (POEM); Canadian Institutes of Health Research Fellowship(Canadian Institutes of Health Research (CIHR)); New Investigator Award HSFC	This work was supported in part by Canadian Cancer Society Grant 701080, Canadian Institutes of Health Research Grants FRN-11715 and FRN-126148, Heart and Stroke Foundation of Canada (HSFC) Grant T7081, and the University of Western Ontario (POEM). J. G. P., M. J. F., and Z. N. hold a patent relating to FGF9 and vascular remodeling, assigned to the University of Western Ontario.; Supported by a Canadian Institutes of Health Research Fellowship.; Supported by a New Investigator Award HSFC.	Agrawal V, 2014, ONCOTARGET, V5, P2761, DOI 10.18632/oncotarget.1942; Andrae J, 2008, GENE DEV, V22, P1276, DOI 10.1101/gad.1653708; Baum O, 2013, AM J PHYSIOL-REG I, V304, pR1175, DOI 10.1152/ajpregu.00434.2012; Carmeliet P, 2011, NATURE, V473, P298, DOI 10.1038/nature10144; Chauhan VP, 2012, NAT NANOTECHNOL, V7, P383, DOI [10.1038/NNANO.2012.45, 10.1038/nnano.2012.45]; Chung AS, 2010, NAT REV CANCER, V10, P505, DOI 10.1038/nrc2868; Clifford PS, 2011, ADV PHYSIOL EDUC, V35, P5, DOI 10.1152/advan.00074.2010; Colvin JS, 2001, DEVELOPMENT, V128, P2095; Crisan M, 2008, CELL STEM CELL, V3, P301, DOI 10.1016/j.stem.2008.07.003; De Bock K, 2011, NAT REV CLIN ONCOL, V8, P393, DOI 10.1038/nrclinonc.2011.83; Ebos JML, 2011, NAT REV CLIN ONCOL, V8, P210, DOI 10.1038/nrclinonc.2011.21; Ebos JML, 2009, CANCER CELL, V15, P232, DOI 10.1016/j.ccr.2009.01.021; Emblem KE, 2013, NAT MED, V19, P1178, DOI 10.1038/nm.3289; Fera E, 2004, J BIOL CHEM, V279, P35573, DOI 10.1074/jbc.M400711200; FOLKMAN J, 1971, NEW ENGL J MED, V285, P1182; Frontini MJ, 2011, NAT BIOTECHNOL, V29, P421, DOI 10.1038/nbt.1845; Fukumura D, 2010, MICROCIRCULATION, V17, P206, DOI 10.1111/j.1549-8719.2010.00029.x; Gaengel K, 2009, ARTERIOSCL THROM VAS, V29, P630, DOI 10.1161/ATVBAHA.107.161521; Geske MJ, 2008, DEVELOPMENT, V135, P2959, DOI 10.1242/dev.020453; Goel S, 2011, PHYSIOL REV, V91, P1071, DOI 10.1152/physrev.00038.2010; Greenberg JI, 2008, NATURE, V456, P809, DOI 10.1038/nature07424; Helmlinger G, 1997, NAT MED, V3, P177, DOI 10.1038/nm0297-177; Jain RK, 2005, SCIENCE, V307, P58, DOI 10.1126/science.1104819; JAIN RK, 1988, CANCER RES, V48, P2641; Jin CL, 2004, CANCER RES, V64, P4555, DOI 10.1158/0008-5472.CAN-03-3752; KIM KJ, 1993, NATURE, V362, P841, DOI 10.1038/362841a0; Lavine KJ, 2006, GENE DEV, V20, P1651, DOI 10.1101/gad.1411406; LESS JR, 1991, CANCER RES, V51, P265; Lin YS, 2009, DEV BIOL, V329, P44, DOI 10.1016/j.ydbio.2009.02.011; Maes H, 2014, CANCER CELL, V26, P190, DOI 10.1016/j.ccr.2014.06.025; Mazzone M, 2009, CELL, V136, P839, DOI 10.1016/j.cell.2009.01.020; Nagy JA, 2009, BRIT J CANCER, V100, P865, DOI 10.1038/sj.bjc.6604929; Paez-Ribes M, 2009, CANCER CELL, V15, P220, DOI 10.1016/j.ccr.2009.01.027; Pena-LlopiS S, 2012, NAT GENET, V44, P751, DOI 10.1038/ng.2323; Pickering JG, 1997, ARTERIOSCL THROM VAS, V17, P475, DOI 10.1161/01.ATV.17.3.475; SALUP RR, 1985, J UROLOGY, V134, P1236, DOI 10.1016/S0022-5347(17)47702-0; Sato Y, 2013, NAT GENET, V45, P860, DOI 10.1038/ng.2699; Segal SS, 2005, MICROCIRCULATION, V12, P33, DOI 10.1080/10739680590895028; Small TW, 2006, CIRC RES, V99, P1338, DOI 10.1161/01.RES.0000252289.79841.d3; Tong RT, 2004, CANCER RES, V64, P3731, DOI 10.1158/0008-5472.CAN-04-0074; Vafaie F, 2014, AGING CELL, V13, P121, DOI 10.1111/acel.12155; Wang Q, 2011, INVEST OPHTH VIS SCI, V52, P6292, DOI 10.1167/iovs.10-6424; White AC, 2006, DEVELOPMENT, V133, P1507, DOI 10.1242/dev.02313; Wu XC, 2003, CANCER RES, V63, P4936; Xian XJ, 2006, J CLIN INVEST, V116, P642, DOI 10.1172/JCI25705; Yin H, 2012, J CELL SCI, V125, P5770, DOI 10.1242/jcs.110262; Yin YJ, 2013, CANCER RES, V73, P5730, DOI 10.1158/0008-5472.CAN-13-0495; Yuan F, 1996, P NATL ACAD SCI USA, V93, P14765, DOI 10.1073/pnas.93.25.14765; Zhang XQ, 2006, J BIOL CHEM, V281, P15694, DOI 10.1074/jbc.M601252200	49	11	12	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	2015	290	36					22127	22142		10.1074/jbc.M115.652222	http://dx.doi.org/10.1074/jbc.M115.652222			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CQ9XI	26183774	hybrid, Green Published			2022-12-26	WOS:000360968500030
J	Blanchet, MA; Lydersen, C; Ims, RA; Kovacs, KM				Blanchet, Marie-Anne; Lydersen, Christian; Ims, Rolf A.; Kovacs, Kit M.			Seasonal, Oceanographic and Atmospheric Drivers of Diving Behaviour in a Temperate Seal Species Living in the High Arctic	PLOS ONE			English	Article							SOUTHERN ELEPHANT SEALS; PRINCE-WILLIAM-SOUND; ADULT HARBOR SEALS; PHOCA-VITULINA; FORAGING BEHAVIOR; ATLANTIC WATER; POLAR COD; BOREOGADUS-SAIDA; KARLS FORLAND; BARENTS SEA	The harbour seal (Phoca vitulina) population in Svalbard marks the northernmost limit of the species' range. This small population experiences environmental extremes in sea and air temperatures, sea ice cover and also in light regime for this normally temperate species. This study deployed Conductivity Temperature Depth Satellite Relay Data Loggers (CTD-SRDLs) on 30 adult and juvenile harbour seals in 2009 and 2010 to study their foraging behaviour across multiple seasons. A total of 189,104 dives and 16,640 CTD casts (mean depth 72 m +/- 59) were recorded. Individuals dove to a mean depth of 41 m +/- 24 with a maximum dive depth range of 24 - 403 m. Dives lasted on average 204 sec +/- 120 with maximum durations ranging between 240 - 2,220 sec. Average daily depth and duration of dives, number of dives, time spent diving and dive time/surface time were influenced by date, while sex, age, sea-ice concentration and their interactions were not particularly influential. Dives were deeper (similar to 150 m), longer (similar to 480 sec), less numerous (similar to 250 dives/day) and more pelagic during the winter/early spring compared to the fall and animals spent proportionally less time at the bottom of their dives during the winter. Influxes of warm saline water, corresponding to Atlantic Water characteristics, were observed intermittently at depths similar to 100 m during both winters in this study. The seasonal changes in diving behaviour were linked to average weekly wind stresses from the north or north-east, which induced upwelling events onto the shelf through offshore Ekman transport. During these events the shelf became flooded with AW from the West Spitsbergen Current, which presumably brought Atlantic fish species close to shore and within the seals' foraging depth-range. Predicted increased in the influx of AW in this region are likely going to favour the growth and geographic expansion of this harbour seal population in the future.	[Blanchet, Marie-Anne; Lydersen, Christian; Kovacs, Kit M.] Norwegian Polar Res Inst, Fram Ctr, N-9296 Tromso, Norway; [Blanchet, Marie-Anne; Ims, Rolf A.] Arct Univ Norway, UiT, Dept Arct & Marine Biol, N-9037 Tromso, Norway	Norwegian Polar Institute; UiT The Arctic University of Tromso	Blanchet, MA (corresponding author), Norwegian Polar Res Inst, Fram Ctr, N-9296 Tromso, Norway.	blanchet@npolar.no			Norwegian Research Council [184644/S40]	Norwegian Research Council(Research Council of NorwayEuropean Commission)	This work was supported by Norwegian Research Council Grant no 184644/S40.	Alexeev V. A., 2013, CRYOSPHERE DISCUSS, V7, P245, DOI [DOI 10.5194/TCD-7-245-2013, 10.5194/tcd-7-245-2013]; Andersen SM, 2004, CAN J ZOOL, V82, P1230, DOI 10.1139/Z04-093; Arthun MT, 2012, J PHYS OCEANOGR, V25, P359; Baechler J, 2002, CAN J ZOOL, V80, P1569, DOI 10.1139/Z02-150; Bailleul F, 2008, J ANIM ECOL, V77, P948, DOI 10.1111/j.1365-2656.2008.01407.x; Bailleul F, 2007, PHILOS T R SOC B, V362, P2169, DOI 10.1098/rstb.2007.2109; Bennett KA, 2001, J EXP BIOL, V204, P649; Benoit D, 2010, POLAR BIOL, V33, P1505, DOI 10.1007/s00300-010-0840-x; Berge J, 2005, MAR ECOL PROG SER, V303, P167, DOI 10.3354/meps303167; Bigg MA, 1969, FISHERIES RES BOARD, V172; Biuw M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013816; Bjorge A, 2002, MAR MAMMAL SCI, V18, P963, DOI 10.1111/j.1748-7692.2002.tb01085.x; Bjorge A, 1995, DEV MAR BIO, V4, P211; Bjorge Arne, 2007, Aquatic Mammals, V33, P269, DOI 10.1578/AM.33.3.2007.269; Blanchet MA, 2014, AQUAT BIOL, V21, P167, DOI 10.3354/ab00580; Boehme L, 2009, OCEAN SCI, V5, P685, DOI 10.5194/os-5-685-2009; Bost CA, 2009, J MARINE SYST, V78, P363, DOI 10.1016/j.jmarsys.2008.11.022; Bowen WD, 1996, CAN J ZOOL, V74, P125, DOI 10.1139/z96-017; Bowen WD, 2002, MAR ECOL PROG SER, V244, P235, DOI 10.3354/meps244235; Burnham KP, 2002, MODEL SELECTION MULT, V2nd, DOI [DOI 10.1007/B97636, 10.1007/978-1-4757-2917-7, DOI 10.1007/978-1-4757-2917-7]; Charrassin JB, 2002, ECOL LETT, V5, P317, DOI 10.1046/j.1461-0248.2002.00341.x; Chen J., 2000, PARAMETRIC STAT CHAN, DOI 10.1007/978-1-4757-3131-6; Colominas R, 2012, THESIS U BERGEN NORW; Cotte C, 2011, LIMNOL OCEANOGR, V56, P219, DOI 10.4319/lo.2011.56.1.0219; Cottier FR, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL029948; de Bruyn PJN, 2009, MAR ECOL PROG SER, V394, P263, DOI 10.3354/meps08292; Eguchi T, 2005, MAR MAMMAL SCI, V21, P283, DOI 10.1111/j.1748-7692.2005.tb01228.x; Falk-Petersen S, 2015, POLAR BIOL, V38, P5, DOI 10.1007/s00300-014-1482-1; FALKPETERSEN IB, 1986, SARSIA, V71, P235, DOI 10.1080/00364827.1986.10419693; Floor J, 2006, THESIS U UTRECHT UTR; Freitas C, 2014, ARGOSFILTER R PACKAG; Freitas C, 2008, MAR MAMMAL SCI, V24, P315, DOI 10.1111/j.1748-7692.2007.00180.x; Frost KJ, 1999, MAR MAMMAL SCI, V15, P494, DOI 10.1111/j.1748-7692.1999.tb00815.x; Frost KJ, 2001, MAR MAMMAL SCI, V17, P813, DOI 10.1111/j.1748-7692.2001.tb01300.x; Gill AE, 1982, ATMOSPHERE OCEAN DYN; Gjertz I, 2001, POLAR BIOL, V24, P209, DOI 10.1007/s003000000197; Hamilton CD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086055; HARKONEN T, 1991, OPHELIA, V34, P191; Hastings KK, 2004, CAN J ZOOL, V82, P1755, DOI 10.1139/Z04-145; Hauksson Erlingur, 2010, NAMMCO Scientific Publications, V8, P227; Hijmans R, 2014, RASTER R PACKAGE VER; Hop H, 2013, MAR BIOL RES, V9, P878, DOI 10.1080/17451000.2013.775458; Jakobsson M, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL052219; Jessopp M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063720; Johnson D, 2013, CRAWL FIT CONTINUOUS; Jorgensen C, 2001, J EXP BIOL, V204, P3993; Kelley D., 2014, OCE ANAL OCEANOGRAPH; King JE., 1983, SEALS WORLD BRIT MUS; Koc N, 2002, POLAR RES, V21, P307, DOI 10.1111/j.1751-8369.2002.tb00085.x; Krafft BA, 2002, POLAR BIOL, V25, P230, DOI 10.1007/s00300-001-0330-2; Kuhn CE, 2011, MAR BIOL, V158, P649, DOI 10.1007/s00227-010-1589-z; Lance MM, 2012, MAR ECOL PROG SER, V464, P257, DOI 10.3354/meps09880; Lea MA, 2003, ICES J MAR SCI, V60, P990, DOI 10.1016/S1054-3139(03)00101-2; Lesage V, 1999, CAN J ZOOL, V77, P74, DOI 10.1139/cjz-77-1-74; Lind S, 2012, DEEP-SEA RES PT I, V62, P70, DOI 10.1016/j.dsr.2011.12.007; Lowther AD, 2014, ANTARCTIC SCI, V26, P1; Lowther AD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074348; Lydersen C, 2005, POLAR BIOL, V28, P156, DOI 10.1007/s00300-004-0656-7; Lydersen C, 2004, J MARINE SYST, V46, P99, DOI 10.1016/j.jmarsys.2003.11.019; Lydersen C, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2002GL015462; McDougall T, 2010, IOCCP REPORT; McIntyre T, 2013, POLAR BIOL, V36, P1693, DOI 10.1007/s00300-013-1384-7; Middlemas SJ, 2006, P ROY SOC B-BIOL SCI, V273, P193, DOI 10.1098/rspb.2005.3215; Mishin VL, 2001, MAMMALIA, V65, P295, DOI 10.1515/mamm.2001.65.3.295; Nilsen F, 2008, CONT SHELF RES, V28, P1838, DOI 10.1016/j.csr.2008.04.015; Nilsen JEO, 2006, PROG OCEANOGR, V70, P58, DOI 10.1016/j.pocean.2006.03.014; Nilssen Kjell Tormod, 2010, NAMMCO Scientific Publications, V8, P61; Nordli O, 2014, POLAR RES, V33, DOI 10.3402/polar.v33.21349; Nordstrom CA, 2013, DEEP-SEA RES PT II, V88-89, P78, DOI 10.1016/j.dsr2.2012.07.010; Olsen E, 2010, ICES J MAR SCI, V67, P87, DOI 10.1093/icesjms/fsp229; Owrid G, 2000, POLAR RES, V19, P155, DOI 10.1111/j.1751-8369.2000.tb00340.x; Pavlov AK, 2013, POLAR RES, V32, DOI 10.3402/polar.v32i0.11206; Peterson SH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039046; Photopoulou T, 2015, METHODS ECOL EVOL, V6, P278, DOI 10.1111/2041-210X.12328; Pierce G.J., 1990, P222; PIERCE GJ, 1990, J MAR BIOL ASSOC UK, V70, P829, DOI 10.1017/S0025315400059099; R Development Core Team, 2012, R LANG ENV STAT COMP; Renaud PE, 2012, POLAR BIOL, V35, P401, DOI 10.1007/s00300-011-1085-z; Ribic CA, 2008, DEEP-SEA RES PT II, V55, P485, DOI 10.1016/j.dsr2.2007.11.006; Roquet F, 2011, J ATMOS OCEAN TECH, V28, P787, DOI 10.1175/2010JTECHO801.1; Rosing-Asvid Aqqalu, 2010, NAMMCO Scientific Publications, V8, P161; Schlitzer R, 2002, COMPUT GEOSCI-UK, V28, P1211, DOI 10.1016/S0098-3004(02)00040-7; Simmons SE, 2007, MAR ECOL PROG SER, V346, P265, DOI 10.3354/meps07014; Stensholt BK, 2001, ICES J MAR SCI, V58, P770, DOI 10.1006/jmsc.2001.1067; THOMPSON PM, 1989, J APPL ECOL, V26, P521, DOI 10.2307/2404078; THOMPSON PM, 1990, J APPL ECOL, V27, P492, DOI 10.2307/2404296; THOMPSON PM, 1989, J ZOOL, V217, P281, DOI 10.1111/j.1469-7998.1989.tb02488.x; Tollit DJ, 1998, J ZOOL, V244, P209, DOI 10.1111/j.1469-7998.1998.tb00026.x; Tollit DJ, 1997, BEHAV ECOLOGY COMMON, P1; Troupin C, 2010, J GEOPHYS RES-OCEANS, V115, DOI 10.1029/2009JC005512; Tverberg V, 2014, J GEOPHYS RES-OCEANS, V119, P5945, DOI 10.1002/2014JC010013; Wienerroither Rupert, 2011, IMR-PINRO Joint Report Series, V1, P1; Willis KJ, 2008, POLAR BIOL, V31, P475, DOI 10.1007/s00300-007-0373-0; Wilson K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092838; Zyryanov Sergey V., 2010, NAMMCO Scientific Publications, V8, P37	95	14	14	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0132686	10.1371/journal.pone.0132686	http://dx.doi.org/10.1371/journal.pone.0132686			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LZ	26196289	Green Published, gold			2022-12-26	WOS:000358547600046
J	Cho, YH; Woo, HD; Jang, Y; Porter, V; Christensen, S; Hamilton, RF; Chung, HW				Cho, Yoon Hee; Woo, Hae Dong; Jang, Yoonhee; Porter, Virginia; Christensen, Sonja; Hamilton, Raymond F., Jr.; Chung, Hai Won			The Association of LINE-1 Hypomethylation with Age and Centromere Positive Micronuclei in Human Lymphocytes	PLOS ONE			English	Article							GENOMIC DNA METHYLATION; EPIGENETIC CHANGES; HEALTHY-SUBJECTS; BLADDER-CANCER; BLOOD; LEVEL; PREDICTORS; LEUKOCYTES; BIOMARKER; HISTORY	Global hypomethylation in white blood cell (WBC) DNA has recently been proposed as a potential biomarker for determining cancer risk through genomic instability. However, the amplitude of the changes associated with age and the impacts of environmental factors on DNA methylation are unclear. In this study, we investigated the association of genomic hypomethylation with age, cigarette use, drinking status and the presence of centromere positive micronuclei (MNC+)-a biomarker for age-dependent genomic instability. Genomic hypomethylation of the repetitive element LINE-1 was measured in WBC DNA from 32 healthy male volunteers using the pyrosequencing assay. We also measured MNC+ with the micronucleus-centromere assay using a pan-centromeric probe. Possibly due to the small sample size and resulting low statistical power, smoking and drinking status had no significant effect on LINE-1 hypomethylation or the occurrence of MNC+. Consequently, we did not include them in further analyses. In contrast, LINE-1 hypomethylation and age significantly predicted MNC+; therefore, we examined whether LINE-1 hypomethylation plays a role in MNC+ formation by age, since genomic hypomethylation is associated with genomic instability. However, LINE-1 hypomethylation did not significantly mediate the effect of age on MNC+. Our data indicate that the repetitive element LINE-1 is demethylated with age and increasing MNC+ frequency, but additional studies are needed to fully understand the relation between genomic DNA hypomethylation, age and genomic instability.	[Cho, Yoon Hee; Porter, Virginia; Christensen, Sonja; Hamilton, Raymond F., Jr.] Univ Montana, Ctr Environm Hlth Sci, Dept Biomed & Pharmaceut Sci, Missoula, MT 59812 USA; [Woo, Hae Dong] Natl Canc Ctr, Res Inst, Div Canc Epidemiol & Prevent, Mol Epidemiol Branch, Goyang Si, Gyeonggi Do, South Korea; [Jang, Yoonhee] Univ Montana, Dept Psychol, Missoula, MT 59812 USA; [Chung, Hai Won] Seoul Natl Univ, Sch Publ Hlth, Dept Mol Epidemiol, Seoul 151, South Korea	University of Montana System; University of Montana; National Cancer Center - Korea (NCC); University of Montana System; University of Montana; Seoul National University (SNU)	Cho, YH (corresponding author), Univ Montana, Ctr Environm Hlth Sci, Dept Biomed & Pharmaceut Sci, Missoula, MT 59812 USA.	yoonhee.cho@umontana.edu		Cho, Yoon Hee/0000-0002-4290-7140	National Institute of General Medical Sciences [P30GM103338]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM103338] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institute of General Medical Sciences (P30GM103338).	Baccarelli A, 2009, AM J RESP CRIT CARE, V179, P572, DOI 10.1164/rccm.200807-1097OC; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Bjornsson HT, 2008, JAMA-J AM MED ASSOC, V299, P2877, DOI 10.1001/jama.299.24.2877; Bollati V, 2007, CANCER RES, V67, P876, DOI 10.1158/0008-5472.CAN-06-2995; Bollati V, 2009, MECH AGEING DEV, V130, P234, DOI 10.1016/j.mad.2008.12.003; Bonassi S, 2001, ENVIRON MOL MUTAGEN, V37, P31; Castro R, 2003, CLIN CHEM, V49, P1292, DOI 10.1373/49.8.1292; Chalitchagorn K, 2004, ONCOGENE, V23, P8841, DOI 10.1038/sj.onc.1208137; Cho YH, 2009, MUTAT RES-GEN TOX EN, V680, P17, DOI 10.1016/j.mrgentox.2009.08.007; Christensen BC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000602; Cook T.C., 1979, QUASIEXPERIMENTATION; Dunn BK, 2003, ANN NY ACAD SCI, V983, P28, DOI 10.1111/j.1749-6632.2003.tb05960.x; Ehrlich M, 2002, ONCOGENE, V21, P5400, DOI 10.1038/sj.onc.1205651; El-Maarri O, 2007, HUM GENET, V122, P505, DOI 10.1007/s00439-007-0430-3; El-Maarri O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016252; Feinberg AP, 2004, SEMIN CANCER BIOL, V14, P427, DOI 10.1016/j.semcancer.2004.06.005; Feinberg AP, 2004, NAT REV CANCER, V4, P143, DOI 10.1038/nrc1279; Fenech M, 1997, ENVIRON MOL MUTAGEN, V30, P112, DOI 10.1002/(SICI)1098-2280(1997)30:2<112::AID-EM3>3.0.CO;2-P; Fenech M, 1999, MUTAT RES-FUND MOL M, V428, P271, DOI 10.1016/S1383-5742(99)00053-8; Figueiredo JC, 2009, CANCER EPIDEM BIOMAR, V18, P1041, DOI 10.1158/1055-9965.EPI-08-0926; Fuke C, 2004, ANN HUM GENET, V68, P196, DOI 10.1046/j.1529-8817.2004.00081.x; Gaudet F, 2003, SCIENCE, V300, P489, DOI 10.1126/science.1083558; Guz J, 2008, MUTAT RES-FUND MOL M, V640, P170, DOI 10.1016/j.mrfmmm.2007.12.013; Hamid A, 2009, FEBS J, V276, P2175, DOI 10.1111/j.1742-4658.2009.06959.x; Hayes AF., 2017, MEDIATION MODERATION, V2nd edn; HOALVANHELDEN EG, 1989, MUTAT RES, V219, P263, DOI 10.1016/0921-8734(89)90027-1; Hsiung DT, 2007, CANCER EPIDEM BIOMAR, V16, P108, DOI 10.1158/1055-9965.EPI-06-0636; Issa JP, 2003, CLIN IMMUNOL, V109, P103, DOI 10.1016/S1521-6616(03)00203-1; JAMES LR, 1984, J APPL PSYCHOL, V69, P307, DOI 10.1037/0021-9010.69.2.307; Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816; Jose P. E., 2013, DOING STAT MEDIATION; JUDD CM, 1981, EVALUATION REV, V5, P602, DOI 10.1177/0193841X8100500502; MacKinnon D.P., 2012, INTRO STAT MEDIATION; Moore LE, 2008, LANCET ONCOL, V9, P359, DOI 10.1016/S1470-2045(08)70038-X; Mortusewicz O, 2005, P NATL ACAD SCI USA, V102, P8905, DOI 10.1073/pnas.0501034102; Pavanello S, 2009, INT J CANCER, V125, P1692, DOI 10.1002/ijc.24492; Pisner R, 2009, EPIDEMIOLOGY, V20, pS84; Piyathilake C, 2011, CANCER EPIDEM BIOMAR, V20, P719, DOI 10.1158/1055-9965.EPI-11-0094; Ricceri F, 2014, SEASONALITY MODIFIES; Rusiecki JA, 2008, ENVIRON HEALTH PERSP, V116, P1547, DOI 10.1289/ehp.11338; Smith IM, 2007, INT J CANCER, V121, P1724, DOI 10.1002/ijc.22889; Thierens H, 1999, MUTAT RES-GEN TOX EN, V445, P105, DOI 10.1016/S1383-5718(99)00134-5; Thierens H, 2000, MUTAGENESIS, V15, P245, DOI 10.1093/mutage/15.3.245; Thompson RF, 2010, AGING CELL, V9, P506, DOI 10.1111/j.1474-9726.2010.00577.x; VIG BK, 1986, MUTAGENESIS, V1, P461, DOI 10.1093/mutage/1.6.461; Vral A, 1997, INT J RADIAT BIOL, V71, P61, DOI 10.1080/095530097144427; Wilhelm CS, 2010, CLIN CANCER RES, V16, P1682, DOI 10.1158/1078-0432.CCR-09-2983; WILSON V L, 1983, Science (Washington D C), V220, P1055, DOI 10.1126/science.6844925; WILSON VL, 1987, J BIOL CHEM, V262, P9948; Wu HC, 2012, CARCINOGENESIS, V33, P1946, DOI 10.1093/carcin/bgs201; Wu HC, 2011, EPIGENETICS-US, V6, P29, DOI 10.4161/epi.6.1.13393; Yang AS, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh032; Zhang FF, 2011, EPIGENETICS-US, V6, P623, DOI 10.4161/epi.6.5.15335; Zhang FF, 2011, EPIGENETICS-US, V6, P293, DOI 10.4161/epi.6.3.14378; Zhu ZZ, 2012, INT J EPIDEMIOL, V41, P126, DOI 10.1093/ije/dyq154	55	18	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0133909	10.1371/journal.pone.0133909	http://dx.doi.org/10.1371/journal.pone.0133909			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LZ	26196382	Green Published, gold, Green Submitted			2022-12-26	WOS:000358547600147
J	Hudson, RR				Hudson, Richard R.			A New Proof of the Expected Frequency Spectrum under the Standard Neutral Model	PLOS ONE			English	Article								The sample frequency spectrum is an informative and frequently employed approach for summarizing DNA variation data. Under the standard neutral model the expectation of the sample frequency spectrum has been derived by at least two distinct approaches. One relies on using results from diffusion approximations to the Wright-Fisher Model. The other is based on Polya urn models that correspond to the standard coalescent model. A new proof of the expected frequency spectrum is presented here. It is a proof by induction and does not require diffusion results and does not require the somewhat complex sums and combinatorics of the derivations based on urn models.	Univ Chicago, Dept Ecol & Evolut, Chicago, IL 60637 USA	University of Chicago	Hudson, RR (corresponding author), Univ Chicago, Dept Ecol & Evolut, 940 E 57Th St, Chicago, IL 60637 USA.	rr-hudson@uchicago.edu						Charlesworth B, 2010, ELEMENTS EVOLUTIONAR; Ewens W. J., 1979, MATH POPULATION GENE; FU YX, 1995, THEOR POPUL BIOL, V48, P172, DOI 10.1006/tpbi.1995.1025; FU YX, 1993, GENETICS, V133, P693; Griffiths R., 1998, COMMUN STAT STOCH MO, V14, P273, DOI [10.1080/15326349808807471, DOI 10.1080/15326349808807471]; TAJIMA F, 1989, GENETICS, V123, P585; Wakeley J., 2009, COALESCENT THEORY	7	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0118087	10.1371/journal.pone.0118087	http://dx.doi.org/10.1371/journal.pone.0118087			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LZ	26197064	Green Submitted, Green Published, gold			2022-12-26	WOS:000358547600001
J	Rossouw, TM; Feucht, UD; Melikian, G; van Dyk, G; Thomas, W; du Plessis, NM; Avenant, T				Rossouw, Theresa M.; Feucht, Ute D.; Melikian, George; van Dyk, Gisela; Thomas, Winifred; du Plessis, Nicolette M.; Avenant, Theunis			Factors Associated with the Development of Drug Resistance Mutations in HIV-1 Infected Children Failing Protease Inhibitor-Based Antiretroviral Therapy in South Africa	PLOS ONE			English	Article							HIV-INFECTED CHILDREN; THAN 2 YEARS; VIROLOGICAL RESPONSE; VIRAL LOAD; POPULATION PHARMACOKINETICS; ANTITUBERCULAR TREATMENT; DISEASE PROGRESSION; TREATMENT FAILURE; COMBINATION; RIFAMPICIN	Objective Limited data are available from the developing world on antiretroviral drug resistance in HIV-1 infected children failing protease inhibitor-based antiretroviral therapy, especially in the context of a high tuberculosis burden. We describe the proportion of children with drug resistance mutations after failed protease inhibitor-based antiretroviral therapy as well as associated factors. Methods Data from children initiated on protease inhibitor-based antiretroviral therapy with subsequent virological failure referred for genotypic drug resistance testing between 2008 and 2012 were retrospectively analysed. Frequencies of drug resistance mutations were determined and associations with these mutations identified through logistic regression analysis. Results The study included 65 young children (median age 16.8 months [IQR 7.8; 23.3]) with mostly advanced clinical disease (88.5% WHO stage 3 or 4 disease), severe malnutrition (median weight-for-age Z-score -2.4 [IQR -3.7;-1.5]; median height-for-age Z-score -3.1 [IQR -4.3;2.4]), high baseline HIV viral load (median 6.04 log(10), IQR 5.34; 6.47) and frequent tuberculosis co-infection (66%) at antiretroviral therapy initiation. Major protease inhibitor mutations were found in 49% of children and associated with low weight-for-age and height-for-age (p = 0.039; p = 0.05); longer duration of protease inhibitor regimens and virological failure (p = 0.001; p = 0.005); unsuppressed HIV viral load at 12 months of antiretroviral therapy (p = 0.001); tuberculosis treatment at antiretroviral therapy initiation (p = 0.048) and use of ritonavir as single protease inhibitor (p = 0.038). On multivariate analysis, cumulative months on protease inhibitor regimens and use of ritonavir as single protease inhibitor remained significant (p = 0.008; p = 0.033). Conclusion Major protease inhibitor resistance mutations were common in this study of HIV-1-infected children, with the timing of tuberculosis treatment and subsequent protease inhibitor dosing strategy proving to be important associated factors. There is an urgent need for safe, effective, and practicable HIV/tuberculosis co-treatment in young children and the optimal timing of treatment, optimal dosing of antiretroviral therapy, and alternative tuberculosis treatment strategies should be urgently addressed.	[Rossouw, Theresa M.; van Dyk, Gisela] Univ Pretoria, Fac Hlth Sci, Inst Cellular & Mol Med, Dept Immunol, ZA-0002 Pretoria, South Africa; [Feucht, Ute D.; Thomas, Winifred; du Plessis, Nicolette M.; Avenant, Theunis] Univ Pretoria, Kalafong Prov Tertiary Hosp, Dept Paediat, ZA-0002 Pretoria, South Africa; [Melikian, George] AIDS Healthcare Fdn, Los Angeles, CA USA	University of Pretoria; University of Pretoria	Rossouw, TM (corresponding author), Univ Pretoria, Fac Hlth Sci, Inst Cellular & Mol Med, Dept Immunol, ZA-0002 Pretoria, South Africa.	theresa.rossouw@up.ac.za	Feucht, Ute/AGE-5579-2022; Feucht, Ute/GQH-8596-2022	Feucht, Ute/0000-0002-6339-1040; Avenant, Theunis/0000-0003-2367-6479; Rossouw, Theresa/0000-0003-4066-922X	Delegation of the European Union [Sante 2007/147-790]; National Research Council of South Africa, Unlocking the Future [61509]	Delegation of the European Union; National Research Council of South Africa, Unlocking the Future	This research and selected researchers (TR and GVD) were partially funded by a grant from the Delegation of the European Union to South Africa: "Drug Resistance Surveillance and Treatment Monitoring Network for the Public Sector HIV Antiretroviral Treatment Programme in the Free State" - Sante 2007/147-790 - and National Research Council of South Africa, Unlocking the Future 61509. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams EJ, 1998, J INFECT DIS, V178, P101, DOI 10.1086/515596; Agwu A, 2008, AIDS PATIENT CARE ST, V22, P545, DOI 10.1089/apc.2007.0200; Ajose O, 2012, AIDS, V26, P929, DOI 10.1097/QAD.0b013e328351f5b2; [Anonymous], 2010, GUID MAN HIV CHILDR; Arrive E, 2007, INT J EPIDEMIOL, V36, P1009, DOI 10.1093/ije/dym104; Babiker A, 2011, LANCET INFECT DIS, V11, P273, DOI 10.1016/S1473-3099(10)70313-3; Baciewicz AM, 2008, AM J MED SCI, V335, P126, DOI 10.1097/MAJ.0b013e31814a586a; Bartlett JA, 2006, JAIDS-J ACQ IMM DEF, V41, P323; Centers for Disease Control and Prevention (CDC), 2000, MMWR Morb Mortal Wkly Rep, V49, P185; Chadwick EG, 2005, PEDIATR INFECT DIS J, V24, P793, DOI [10.1097/01.inf.0000111281.93658.df, 10.1097/01.inf.0000177281.93658.df]; Donegan KL, 2012, ANTIVIR THER, V17, P599, DOI 10.3851/IMP2015; Ebonyi Augustine O, 2015, Niger Med J, V56, P43, DOI 10.4103/0300-1652.149170; Elsherbiny D, 2010, EUR J CLIN PHARMACOL, V66, P1017, DOI 10.1007/s00228-010-0847-9; Feucht UD, 2014, PEDIATR INFECT DIS J, V33, pE53, DOI 10.1097/INF.0b013e31829f2694; Frohoff C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017273; Grabar S, 2000, AIDS, V14, P141, DOI 10.1097/00002030-200001280-00009; Gupta R, 2008, CLIN INFECT DIS, V47, P712, DOI 10.1086/590943; Heidari S, 2012, JAIDS-J ACQ IMM DEF, V59, P161, DOI 10.1097/QAI.0b013e3182427029; Heikens GT, 2008, LANCET, V371, P1305, DOI 10.1016/S0140-6736(08)60565-6; Jimenez JL, 2005, J ANTIMICROB CHEMOTH, V56, P1081, DOI 10.1093/jac/dki356; Kariminia A, 2014, JAIDS-J ACQ IMM DEF, V67, P71, DOI 10.1097/QAI.0000000000000227; Kerac M, 2007, MALAWI MED J, V19, P96; la Porte CJL, 2004, ANTIMICROB AGENTS CH, V48, P1553, DOI 10.1128/AAC.48.5.1553-1560.2004; Lathouwers E, 2011, ANTIVIR THER, V16, P99, DOI 10.3851/IMP1719; Le Moing V, 2002, AIDS, V16, P21, DOI 10.1097/00002030-200201040-00004; Lepri AC, 2001, AIDS, V15, P47, DOI 10.1097/00002030-200101050-00008; Maartens G, 2009, ANTIVIR THER, V14, P1039, DOI 10.3851/IMP1455; MacLeod IJ, 2010, J CLIN VIROL, V48, P162, DOI 10.1016/j.jcv.2010.03.017; Maiga AI, 2012, J ANTIMICROB CHEMOTH, V67, P2943, DOI [10.1093/jac/dks310, 10.1093]; Manasa J, 2012, AIDS RES HUM RETROV, V28, P558, DOI [10.1089/aid.2011.0284, 10.1089/AID.2011.0284]; McIlleron H, 2011, ANTIVIR THER, V16, P417, DOI 10.3851/IMP1757; Menson EN, 2006, BMJ-BRIT MED J, V332, P1183, DOI 10.1136/bmj.332.7551.1183; Molina JM, 2008, LANCET, V372, P646, DOI 10.1016/S0140-6736(08)61081-8; Moorthy A, 2011, CLIN INFECT DIS, V52, P514, DOI 10.1093/cid/ciq161; Moultrie H, 2015, J ANTIMICROB CHEMOTH, V70, P543, DOI 10.1093/jac/dku382; Musoke PM, 2010, BMC PEDIATR, V10, DOI 10.1186/1471-2431-10-56; Naidoo R, 2010, PEDIATR INFECT DIS J, V29, P511, DOI 10.1097/INF.0b013e3181d1e989; Niemi M, 2003, CLIN PHARMACOKINET, V42, P819, DOI 10.2165/00003088-200342090-00003; Orrell C, 2012, J INT AIDS SOC S4, V15, P18086; Oshikoya KA, 2010, EUR J CLIN PHARMACOL, V66, P1025, DOI 10.1007/s00228-010-0851-0; Palumbo P, 2009, 5 INT AIDS SOC C HIV; Palumbo P, 2010, NEW ENGL J MED, V363, P1510, DOI 10.1056/NEJMoa1000931; Paredes R, 2000, ARCH INTERN MED, V160, P1123, DOI 10.1001/archinte.160.8.1123; Peacock-Villada E, 2011, PEDIATRICS, V127, pE423, DOI 10.1542/peds.2009-2701; Pillay S, 2014, AIDS RES THER, V11, DOI 10.1186/1742-6405-11-3; Prendergast A, 2011, AIDS, V25, P951, DOI 10.1097/QAD.0b013e328345e56b; Prendergast AJ, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001273; Regazzi M, 2014, CLIN PHARMACOKINET, V53, P489, DOI 10.1007/s40262-014-0144-3; Reitz C, 2010, J INFECT DIS, V201, P1121, DOI 10.1086/651454; Ren Y, 2008, JAIDS-J ACQ IMM DEF, V47, P566, DOI 10.1097/QAI.0b013e3181642257; Riddick A, 2009, P 5 IAS C HIV PATH T; Riddler SA, 2008, NEW ENGL J MED, V358, P2095, DOI 10.1056/NEJMoa074609; Saez-Llorens X, 2003, PEDIATR INFECT DIS J, V22, P216, DOI 10.1097/00006454-200303000-00003; Scherpbier HJ, 2006, PEDIATRICS, V117, pE528, DOI 10.1542/peds.2005-1272; Schlaudecker EP, 2011, CURR OPIN INFECT DIS, V24, P496, DOI 10.1097/QCO.0b013e328349287d; Shearer WT, 1997, NEW ENGL J MED, V336, P1337, DOI 10.1056/NEJM199705083361901; Soeters HM, 2014, JAIDS-J ACQ IMM DEF, V67, P136, DOI 10.1097/QAI.0000000000000284; Sohn AH, 2010, CURR OPIN HIV AIDS, V5, P54, DOI 10.1097/COH.0b013e3283339bd8; Taylor BS, 2011, AIDS RES HUM RETROV, V27, P945, DOI 10.1089/aid.2010.0205; Trehan I, 2012, AIDS RES TREAT, V2012, DOI 10.1155/2012/790786; van Zyl GU, 2009, PEDIATR INFECT DIS J, V28, P1125, DOI 10.1097/INF.0b013e3181af829d; Vaz P, 2012, CLIN INFECT DIS, V54, pS369, DOI 10.1093/cid/cis006; Venturini E, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-S1-S5; Violari A, 2012, J INT AIDS SOC S4, V15, P18085; Violari A, 2008, NEW ENGL J MED, V359, P2233, DOI 10.1056/NEJMoa0800971; Violari A, 2012, NEW ENGL J MED, V366, P2380, DOI 10.1056/NEJMoa1113249; Wallis CL, 2009, PEDIATR INFECT DIS J, V28, P1123, DOI 10.1097/INF.0b013e3181af5a00; Weigel R, 2014, 20TH INTERNATIONAL A; WHO, 2013, CONSOLIDATED GUIDELI; World Health Organization, 2006, WHO MULT GROWTH REF; Xing H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062408; Zanoni BC, 2011, AIDS, V25, P49, DOI 10.1097/QAD.0b013e32833f9e04; Zhang C, 2012, ANTIVIR THER, V17, P25, DOI 10.3851/IMP1915	73	21	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0133452	10.1371/journal.pone.0133452	http://dx.doi.org/10.1371/journal.pone.0133452			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LZ	26196688	Green Submitted, gold, Green Published			2022-12-26	WOS:000358547600099
J	Milara, J; Morcillo, E; Monleon, D; Tenor, H; Cortijo, J				Milara, Javier; Morcillo, Esteban; Monleon, Daniel; Tenor, Herman; Cortijo, Julio			Roflumilast Prevents the Metabolic Effects of Bleomycin-Induced Fibrosis in a Murine Model	PLOS ONE			English	Article							IDIOPATHIC PULMONARY-FIBROSIS; INDUCED LUNG INJURY; PHOSPHODIESTERASE-4 INHIBITOR; N-OXIDE; PDE4 INHIBITORS; CIGARETTE-SMOKE; TETRAHYDROBIOPTERIN; DIFFERENTIATION; PENTOXIFYLLINE; EXPRESSION	Fibrotic remodeling is a process common to chronic lung diseases such as chronic obstructive pulmonary disease (COPD), pulmonary fibrosis, acute respiratory distress syndrome and asthma. Based on preclinical studies phosphodiesterase 4 (PDE4) inhibitors may exhibit beneficial anti-inflammatory and anti-remodeling properties for the treatment of these respiratory disorders. Effects of PDE4 inhibitors on changes in the lung metabolome in models of pulmonary fibrotic remodeling have not yet been explored. This work studies the effects of the PDE4 inhibitor roflumilast on changes in the lung metabolome in the common murine model of bleomycin-induced lung fibrosis by nuclear magnetic resonance (NMR) metabolic profiling of intact lung tissue. Metabolic profiling reveals strong differences between fibrotic and non-fibrotic tissue. These differences include increases in proline, glycine, lactate, taurine, phosphocholine and total glutathione and decreases in global fatty acids. In parallel, there was a loss in plasma BH4. This profile suggests that bleomycin produces alterations in the oxidative equilibrium, a strong inflammatory response and activation of the collagen synthesis among others. Roflumilast prevented most of these metabolic effects associated to pulmonary fibrosis suggesting a favorable anti-fibrotic profile.	[Milara, Javier; Cortijo, Julio] Univ Gen Hosp Consortium, Clin Res Unit, Valencia, Spain; [Milara, Javier; Morcillo, Esteban; Cortijo, Julio] Hlth Inst Carlos III, CIBERES, Valencia, Spain; [Milara, Javier; Cortijo, Julio] Res Fdn Gen Hosp Valencia, E-46104 Valencia, Spain; [Morcillo, Esteban; Tenor, Herman; Cortijo, Julio] Univ Valencia, Fac Med, Dept Pharmacol, Valencia, Spain; [Monleon, Daniel] Fdn Invest Hosp Clin Univ, INCLIVA, Valencia, Spain	CIBER - Centro de Investigacion Biomedica en Red; CIBERES; University of Valencia	Milara, J (corresponding author), Univ Gen Hosp Consortium, Clin Res Unit, Valencia, Spain.	xmilara@hotmail.com	Monleon, Daniel/A-5078-2010; Morcillo, Esteban/I-1552-2015; Monleon, Daniel/GNP-4083-2022	Monleon, Daniel/0000-0002-4803-1573; Morcillo, Esteban/0000-0003-4373-9457; Monleon, Daniel/0000-0002-4803-1573; MILARA, JAVIER/0000-0001-6033-4211	Spanish government grants [SAF2011-26443, SAF2012-31042, FIS CP11/00293, FIS PI14/01733]; centro de investigaciones biomedicas en red de enfermedades respiratorias (CIBERES) [CB06/06/0027]; fondos de la Generalitat Valenciana Prometeo [II/2013/014]	Spanish government grants; centro de investigaciones biomedicas en red de enfermedades respiratorias (CIBERES); fondos de la Generalitat Valenciana Prometeo	The study was supported by the Spanish government grants SAF2011-26443 (JC; http://www.idi.mineco.gob.es/stfls/MICINN/Ayudas/PN_2008_2011/LIA_Proyectos_I+D+I/FICHERO/Proyect_Invest_Fund_No_Orientada_2011/Anexo_40.1_P.R.Prov_Biomedicina_Presel.pdf), SAF2012-31042 (EM; https://sede.micinn.gob.es/stfls/eSede/Ficheros/2012/Anexo177saf_preselecc.pdf), FIS CP11/00293, FIS PI14/01733 (JM; http://gesdoc.isciii.es/?action=download&id=08/10/2014-fe2a818ac5) and centro de investigaciones biomedicas en red de enfermedades respiratorias (CIBERES; CB06/06/0027; http://www.ciberes.org/) as well as by fondos de la Generalitat Valenciana Prometeo II/2013/014 ( EM, JC, JM; http://www.cece.gva.es/poci/docs/2013/NUEVAS/RESOLUCIONES/PROMETEOII13_Resolucion_Concesion_c.pdf). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almudever P, 2013, THORAX, V68, P938, DOI 10.1136/thoraxjnl-2013-203408; Amara N, 2010, THORAX, V65, P733, DOI 10.1136/thx.2009.113456; ASHCROFT T, 1988, J CLIN PATHOL, V41, P467, DOI 10.1136/jcp.41.4.467; Benahmed MA, 2012, MAGN RESON MED, V68, P1026, DOI 10.1002/mrm.24110; Boorsma CE, 2014, PULM PHARMACOL THER, V29, P166, DOI 10.1016/j.pupt.2014.08.009; Conti M, 2003, J BIOL CHEM, V278, P5493, DOI 10.1074/jbc.R200029200; Cortijo J, 2009, BRIT J PHARMACOL, V156, P534, DOI 10.1111/j.1476-5381.2008.00041.x; Cortijo J, 2001, EUR RESPIR J, V17, P1228, DOI 10.1183/09031936.01.00049701; Dastidar SG, 2007, CURR OPIN INVEST DR, V8, P364; FDA, 2018, BIOANALYTICAL METHOD; Fiege B, 2004, MOL GENET METAB, V81, P45, DOI 10.1016/j.ymgme.2003.09.014; Foster MW, 2015, J PROTEOME RES, V14, P1238, DOI 10.1021/pr501149m; FUKUSHIMA T, 1980, ANAL BIOCHEM, V102, P176, DOI 10.1016/0003-2697(80)90336-X; Hatzelmann A, 2010, PULM PHARMACOL THER, V23, P235, DOI 10.1016/j.pupt.2010.03.011; Hecht SM, 2000, J NAT PROD, V63, P158, DOI 10.1021/np990549f; HORIUCHI H, 1995, EUR J PHARMACOL, V287, P27, DOI 10.1016/0014-2999(95)00468-7; King TE, 2011, LANCET, V378, P1949, DOI 10.1016/S0140-6736(11)60052-4; Kottmann RM, 2012, AM J RESP CRIT CARE, V186, P740, DOI 10.1164/rccm.201201-0084OC; Lauterbach R, 1999, EUR J PEDIATR, V158, P607, DOI 10.1007/s004310051158; Lee JS, 2011, AM J RESP CRIT CARE, V184, P1390, DOI 10.1164/rccm.201101-0138OC; Lipworth BJ, 2005, LANCET, V365, P167, DOI 10.1016/S0140-6736(05)17708-3; Liu RM, 2012, FREE RADICAL BIO MED, V53, P554, DOI 10.1016/j.freeradbiomed.2012.05.016; Lu YJ, 2010, AM J RESP CELL MOL, V42, P432, DOI 10.1165/rcmb.2009-0002OC; Marcinkiewicz J, 2000, IMMUNOPHARMACOLOGY, V49, P335, DOI 10.1016/S0162-3109(00)00249-6; Martinez-Granados B, 2011, INT J MOL MED, V27, P111, DOI 10.3892/ijmm.2010.563; Milara J, 2012, BRIT J PHARMACOL, V166, P2243, DOI 10.1111/j.1476-5381.2012.01929.x; Milara J, 2015, COPD, V12, P320, DOI 10.3109/15412555.2014.948995; Milara J, 2014, PULM PHARMACOL THER, V28, P138, DOI 10.1016/j.pupt.2014.02.001; Mouratis MA, 2011, CURR OPIN PULM MED, V17, P355, DOI 10.1097/MCP.0b013e328349ac2b; Nicholson JK, 2008, NATURE, V455, P1054, DOI 10.1038/4551054a; Nobakht BF, 2015, BIOMARKERS, V20, P5, DOI 10.3109/1354750X.2014.983167; Page CP, 2012, CURR OPIN PHARMACOL, V12, P275, DOI 10.1016/j.coph.2012.02.016; Peng RQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059348; Piotto M, 2005, J MAGN RESON, V173, P84, DOI 10.1016/j.jmr.2004.11.022; Sabatini F, 2010, PULM PHARMACOL THER, V23, P283, DOI 10.1016/j.pupt.2010.02.004; Sanz MJ, 2005, PHARMACOL THERAPEUT, V106, P269, DOI 10.1016/j.pharmthera.2004.12.001; Selige J, 2011, J CELL PHYSIOL, V226, P1970, DOI 10.1002/jcp.22529; Serrano-Mollar A, 2002, THORAX, V57, P629, DOI 10.1136/thorax.57.7.629; Vecchio D, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/745984; Wheelock CE, 2013, EUR RESPIR J, V42, P802, DOI 10.1183/09031936.00078812; Wuyts WA, 2013, EUR RESPIR J, V41, P1207, DOI 10.1183/09031936.00073012	41	11	12	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2015	10	7							e0133453	10.1371/journal.pone.0133453	http://dx.doi.org/10.1371/journal.pone.0133453			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LN	26192616	gold, Green Submitted, Green Published			2022-12-26	WOS:000358546400086
J	Aviziotis, IG; Kavousanakis, ME; Boudouvis, AG				Aviziotis, Ioannis G.; Kavousanakis, Michail E.; Boudouvis, Andreas G.			Effect of Intrinsic Noise on the Phenotype of Cell Populations Featuring Solution Multiplicity: An Artificial lac Operon Network Paradigm	PLOS ONE			English	Article							MONTE-CARLO-SIMULATION; POSITIVE-FEEDBACK LOOP; BISTABLE BEHAVIOR; ESCHERICHIA-COLI; GENETIC NETWORK; HETEROGENEITY; MODEL; EXPRESSION; DYNAMICS; GROWTH	Heterogeneity in cell populations originates from two fundamentally different sources: the uneven distribution of intracellular content during cell division, and the stochastic fluctuations of regulatory molecules existing in small amounts. Discrete stochastic models can incorporate both sources of cell heterogeneity with sufficient accuracy in the description of an isogenic cell population; however, they lack efficiency when a systems level analysis is required, due to substantial computational requirements. In this work, we study the effect of cell heterogeneity in the behaviour of isogenic cell populations carrying the genetic network of lac operon, which exhibits solution multiplicity over a wide range of extracellular conditions. For such systems, the strategy of performing solely direct temporal solutions is a prohibitive task, since a large ensemble of initial states needs to be tested in order to drive the system-through long time simulations-to possible co-existing steady state solutions. We implement a multiscale computational framework, the so-called "equation-free" methodology, which enables the performance of numerical tasks, such as the computation of coarse steady state solutions and coarse bifurcation analysis. Dynamically stable and unstable solutions are computed and the effect of intrinsic noise on the range of bistability is efficiently investigated. The results are compared with the homogeneous model, which neglects all sources of heterogeneity, with the deterministic cell population balance model, as well as with a stochastic model neglecting the heterogeneity originating from intrinsic noise effects. We show that when the effect of intrinsic source of heterogeneity is intensified, the bistability range shifts towards higher extracellular inducer concentration values.	[Aviziotis, Ioannis G.; Kavousanakis, Michail E.; Boudouvis, Andreas G.] Natl Tech Univ Athens, Sch Chem Engn, Athens, Greece	National Technical University of Athens	Kavousanakis, ME (corresponding author), Natl Tech Univ Athens, Sch Chem Engn, Athens, Greece.	mihkavus@chemeng.ntua.gr	Boudouvis, Andreas G/B-2307-2010; Kavousanakis, Mihalis/V-3519-2019; Kavousanakis, Michail/AAO-1292-2020; Kavousanakis, Michail/AAS-6198-2020	Boudouvis, Andreas G/0000-0001-6651-7318; Kavousanakis, Michail/0000-0001-6621-9249				Alberts B., 1994, MOL BIOL CELL; Aviziotis IG, 2015, J MATH BIOL, V70, P1457, DOI 10.1007/s00285-014-0799-2; Baek K, 2003, J MOL BIOL, V334, P363, DOI 10.1016/j.jmb.2003.09.037; Balaban NQ, 2004, SCIENCE, V305, P1622, DOI 10.1126/science.1099390; Beckwith JR, 1970, THE LACTOSE OPERON; BLOCK DE, 1990, BIOTECHNOL PROGR, V6, P504, DOI 10.1021/bp00006a015; Bruggeman FJ, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000506; CHUNG JD, 1995, BIOTECHNOL BIOENG, V47, P234, DOI 10.1002/bit.260470215; COHN M, 1959, J BACTERIOL, V78, P613, DOI 10.1128/JB.78.5.613-623.1959; Collins TJ, 2002, EMBO J, V21, P1616, DOI 10.1093/emboj/21.7.1616; das Neves RP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000560; DELBRUCK M, 1945, J BACTERIOL, V50, P131; Dien BS, 1994, THESIS U MINNESOTA M; Elgart V, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.041106; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; Gear CW, 2002, COMPUT CHEM ENG, V26, P941, DOI 10.1016/S0098-1354(02)00020-0; Gear CW., 2001, PROJECTIVE INTEGRATI, P2001; GILLESPIE DT, 1976, J COMPUT PHYS, V22, P403, DOI 10.1016/0021-9991(76)90041-3; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; GOEDDEL DV, 1977, P NATL ACAD SCI USA, V74, P3292, DOI 10.1073/pnas.74.8.3292; Gorochowski TE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042790; Hallen M, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002209; HATZIS C, 1995, BIOSYSTEMS, V36, P19, DOI 10.1016/0303-2647(95)01524-O; Hellweger FL, 2014, BMC SYST BIOL, V8, DOI 10.1186/1752-0509-8-18; Higham DJ, 2001, SIAM REV, V43, P525, DOI 10.1137/S0036144500378302; Johnston IG, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002416; Kavousanakis ME, 2009, CHEM ENG SCI, V64, P4247, DOI 10.1016/j.ces.2009.06.054; Keller H.B., 1977, APPL BIFURCATION THE; Kepler TB, 2001, BIOPHYS J, V81, P3116, DOI 10.1016/S0006-3495(01)75949-8; Kevrekidis IG, 2004, AICHE J, V50, P1346, DOI 10.1002/aic.10106; Kevrekidis IG, 2003, COMMUNICATIONS MATH, V1, P715, DOI DOI 10.4310/CMS.2003.V1.N4.A5; Maeda YT, 2006, J MOL BIOL, V359, P1107, DOI 10.1016/j.jmb.2006.03.064; Mantzaris NV, 2007, BIOPHYS J, V92, P4271, DOI 10.1529/biophysj.106.100271; Mantzaris NV, 2006, J THEOR BIOL, V241, P690, DOI 10.1016/j.jtbi.2006.01.005; Mantzaris NV, 2005, COMPUT CHEM ENG, V29, P897, DOI 10.1016/j.compchemeng.2004.09.012; Matsumoto Y, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/489265; Miller JH, 1978, THE OPERON; Murphy JT, 2011, P UND DYN BIOL SYST; Nevozhay D, 2009, P NATL ACAD SCI USA, V106, P5123, DOI 10.1073/pnas.0809901106; Paulsson J, 2004, NATURE, V427, P415, DOI 10.1038/nature02257; PTASHNE M, 1987, GENETIC SWITCH GENE; Ramkrishna D., 2000, POPULATION BALANCES; Roma DM, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.011902; Rubakhin SS, 2013, CURR OPIN BIOTECH, V24, P95, DOI 10.1016/j.copbio.2012.10.021; Santillan M, 2008, BIOPHYS J, V94, P2065, DOI 10.1529/biophysj.107.118026; Santillan M, 2004, BIOPHYS J, V86, P1282, DOI 10.1016/S0006-3495(04)74202-2; SHAH BH, 1976, MATH BIOSCI, V31, P1, DOI 10.1016/0025-5564(76)90037-7; Shu CC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079196; Shu CC, 2012, CHEM ENG SCI, V70, P188, DOI 10.1016/j.ces.2011.07.062; Siettos CI, 2003, AICHE J, V49, P1922, DOI 10.1002/aic.690490727; Smith M, 1998, CHEM ENG SCI, V53, P1777, DOI 10.1016/S0009-2509(98)00045-1; Stamatakis M, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-301; Stamatakis M, 2010, J THEOR BIOL, V266, P41, DOI 10.1016/j.jtbi.2010.06.002; Stamatakis M, 2009, BIOPHYS J, V96, P887, DOI 10.1016/j.bpj.2008.10.028; Stewart GR, 2003, NAT REV MICROBIOL, V1, P97, DOI 10.1038/nrmicro749; Tischler J, 2013, CURR OPIN BIOTECH, V24, P69, DOI 10.1016/j.copbio.2012.09.013; Toni T, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002960; VANKAMPEN NG, 1981, J STAT PHYS, V24, P175, DOI 10.1007/BF01007642; Warren L, 2006, P NATL ACAD SCI USA, V103, P17807, DOI 10.1073/pnas.0608512103; Weinberger LS, 2008, NAT GENET, V40, P466, DOI 10.1038/ng.116; Weinberger LS, 2007, PLOS BIOL, V5, P67, DOI 10.1371/journal.pbio.0050009; Weinberger LS, 2005, CELL, V122, P169, DOI 10.1016/j.cell.2005.06.006; Zechner C, 2012, P NATL ACAD SCI USA, V109, P8340, DOI 10.1073/pnas.1200161109; Zhang L, 2009, MATH COMPUT MODEL, V49, P307, DOI 10.1016/j.mcm.2008.05.011; Zou Y, 2010, J COMPUT PHYS, V229, P5299, DOI 10.1016/j.jcp.2010.03.007	65	2	2	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0132946	10.1371/journal.pone.0132946	http://dx.doi.org/10.1371/journal.pone.0132946			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RV	26185999	Green Published, gold, Green Submitted			2022-12-26	WOS:000358198700073
J	Greb-Markiewicz, B; Sadowska, D; Surgut, N; Godlewski, J; Zarebski, M; Ozyhar, A				Greb-Markiewicz, Beata; Sadowska, Daria; Surgut, Natalia; Godlewski, Jakub; Zarebski, Miroslaw; Ozyhar, Andrzej			Mapping of the Sequences Directing Localization of the Drosophila Germ Cell-Expressed Protein (GCE)	PLOS ONE			English	Article							METHOPRENE-TOLERANT MET; JUVENILE-HORMONE RECEPTOR; FTZ-F1 NUCLEAR RECEPTOR; BHLH-PAS; SUBCELLULAR-LOCALIZATION; INSECT METAMORPHOSIS; INTRINSIC DISORDER; TRANSCRIPTIONAL REGULATORS; PROGESTERONE-RECEPTOR; PHOSPHORYLATION SITES	Drosophila melanogaster germ cell-expressed protein (GCE) belongs to the family of bHLH-PAS transcription factors that are the regulators of gene expression networks that determine many physiological and developmental processes. GCE is a homolog of D. melanogaster methoprene tolerant protein (MET), a key mediator of anti-metamorphic signaling in insects and the putative juvenile hormone receptor. Recently, it has been shown that the functions of MET and GCE are only partially redundant and tissue specific. The ability of bHLH-PAS proteins to fulfill their function depends on proper intracellular trafficking, determined by specific sequences, i.e. the nuclear localization signal (NLS) and the nuclear export signal (NES). Nevertheless, until now no data has been published on the GCE intracellular shuttling and localization signals. We performed confocal microscopy analysis of the subcellular distribution of GCE fused with yellow fluorescent protein (YFP) and YFP-GCE derivatives which allowed us to characterize the details of the subcellular traffic of this protein. We demonstrate that GCE possess specific pattern of localization signals, only partially consistent with presented previously for MET. The presence of a strong NLS in the C-terminal part of GCE, seems to be unique and important feature of this protein. The intracellular localization of GCE appears to be determined by the NLSs localized in PAS-B domain and C-terminal fragment of GCE, and NESs localized in PAS-A, PAS-B domains and C-terminal fragment of GCE. NLSs activity can be modified by juvenile hormone (JH) and other partners, likely 14-3-3 proteins.	[Greb-Markiewicz, Beata; Sadowska, Daria; Surgut, Natalia; Ozyhar, Andrzej] Wroclaw Univ Technol, Fac Chem, Dept Biochem, PL-50370 Wroclaw, Poland; [Godlewski, Jakub] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Neurosurg,Harvard Inst Med, Boston, MA 02115 USA; [Zarebski, Miroslaw] Jagiellonian Univ, Fac Biochem Biophys & Biotechnol, Dept Cell Biophys, Krakow, Poland	Wroclaw University of Science & Technology; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Jagiellonian University	Greb-Markiewicz, B (corresponding author), Wroclaw Univ Technol, Fac Chem, Dept Biochem, PL-50370 Wroclaw, Poland.	beata.greb-markiewicz@pwr.edu.pl	Greb-Markiewicz, Beata/AAB-5246-2020; Godlewski, Jakub/U-4700-2019	Greb-Markiewicz, Beata/0000-0002-2831-439X; Godlewski, Jakub/0000-0003-2122-9798; OZYHAR, Andrzej/0000-0002-5874-784X	Polish Ministry of Science and High Education for the Faculty of Chemistry of Wroclaw University of Technology; Wroclaw Centre of Biotechnology, programme The Leading National Research Centre (KNOW)	Polish Ministry of Science and High Education for the Faculty of Chemistry of Wroclaw University of Technology; Wroclaw Centre of Biotechnology, programme The Leading National Research Centre (KNOW)	This work has been supported by a statutory activity subsidy from The Polish Ministry of Science and High Education for the Faculty of Chemistry of Wroclaw University of Technology. Publication supported by Wroclaw Centre of Biotechnology, programme The Leading National Research Centre (KNOW) for years 2014-2018.	Abdou MA, 2011, INSECT BIOCHEM MOLEC, V41, P938, DOI 10.1016/j.ibmb.2011.09.003; Ashok M, 1998, P NATL ACAD SCI USA, V95, P2761, DOI 10.1073/pnas.95.6.2761; Baumann A, 2010, GENETICS, V185, P1327, DOI 10.1534/genetics.110.116962; Baumann A, 2010, J INSECT PHYSIOL, V56, P1445, DOI 10.1016/j.jinsphys.2010.05.001; Bernardo Travis J., 2012, Insects, V3, P324, DOI 10.3390/insects3010324; Bernardo TJ, 2012, J BIOL CHEM, V287, P7821, DOI 10.1074/jbc.M111.327254; Bitra K, 2009, ARCH INSECT BIOCHEM, V70, P90, DOI 10.1002/arch.20281; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; Boonyaratanakornkit V, 2008, STEROIDS, V73, P922, DOI 10.1016/j.steroids.2008.01.010; Brameier M, 2007, BIOINFORMATICS, V23, P1159, DOI 10.1093/bioinformatics/btm066; Bustos DM, 2012, MOL BIOSYST, V8, P178, DOI 10.1039/c1mb05216k; Charles JP, 2011, P NATL ACAD SCI USA, V108, P21128, DOI 10.1073/pnas.1116123109; Darling DL, 2005, CURR TOP DEV BIOL, V68, P281, DOI 10.1016/S0070-2153(05)68010-6; Diella F, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-79; Dinkel H, 2012, NUCLEIC ACIDS RES, V40, pD242, DOI 10.1093/nar/gkr1064; Dougherty MK, 2004, J CELL SCI, V117, P1875, DOI 10.1242/jcs.01171; Dubrovsky EB, 2011, J BIOL CHEM, V286, P33689, DOI 10.1074/jbc.M111.273458; Dunker AK, 2002, BIOCHEMISTRY-US, V41, P6573, DOI 10.1021/bi012159+; Dunker AK, 2001, J MOL GRAPH MODEL, V19, P26, DOI 10.1016/S1093-3263(00)00138-8; Fu SC, 2013, NUCLEIC ACIDS RES, V41, pD338, DOI 10.1093/nar/gks936; Furness SGB, 2007, FEBS LETT, V581, P3616, DOI 10.1016/j.febslet.2007.04.011; Ganguly S, 2005, P NATL ACAD SCI USA, V102, P1222, DOI 10.1073/pnas.0406871102; Godlewski J, 2006, BIOCHEM BIOPH RES CO, V342, P1305, DOI 10.1016/j.bbrc.2006.02.097; Greb-Markiewicz B, 2011, MOL CELL ENDOCRINOL, V345, P16, DOI 10.1016/j.mce.2011.06.035; Guo EE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053256; He QY, 2014, J BIOL CHEM, V289, P27874, DOI 10.1074/jbc.M114.582825; Henrich VC, 2003, INSECT BIOCHEM MOLEC, V33, P1239, DOI 10.1016/j.ibmb.2003.08.002; Homma K, 2012, MOL BIOSYST, V8, P247, DOI 10.1039/c1mb05208j; Iakoucheva LM, 2004, NUCLEIC ACIDS RES, V32, P1037, DOI 10.1093/nar/gkh253; Iakoucheva LM, 2002, J MOL BIOL, V323, P573, DOI 10.1016/S0022-2836(02)00969-5; Jennings BH, 2011, MATER TODAY, V14, P190, DOI 10.1016/S1369-7021(11)70113-4; Jindra M, 2013, ANNU REV ENTOMOL, V58, P181, DOI 10.1146/annurev-ento-120811-153700; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Kayukawa T, 2012, P NATL ACAD SCI USA, V109, P11729, DOI 10.1073/pnas.1204951109; Kewley RJ, 2004, INT J BIOCHEM CELL B, V36, P189, DOI 10.1016/S1357-2725(03)00211-5; Ko JK, 2005, AM J PHYSIOL-CELL PH, V288, pC1273, DOI 10.1152/ajpcell.00517.2004; Konopova B, 2007, P NATL ACAD SCI USA, V104, P10488, DOI 10.1073/pnas.0703719104; la Cour T, 2004, PROTEIN ENG DES SEL, V17, P527, DOI 10.1093/protein/gzh062; Lange A, 2007, J BIOL CHEM, V282, P5101, DOI 10.1074/jbc.R600026200; Lee SH, 2003, ADV DRUG DELIVER REV, V55, P717, DOI 10.1016/S0169-409X(03)00052-8; Li, 1999, Genome Inform Ser Workshop Genome Inform, V10, P30; Li H, 2005, MOL PHARMACEUT, V2, P509, DOI 10.1021/mp0500418; Li M, 2011, P NATL ACAD SCI USA, V108, P638, DOI 10.1073/pnas.1013914108; Li XT, 2003, J BIOL CHEM, V278, P39261, DOI 10.1074/jbc.R300024200; Liu PC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019776; Liu W, 2013, BBA-GEN SUBJECTS, V1830, P5184, DOI 10.1016/j.bbagen.2013.06.037; Liu Y, 2009, DEVELOPMENT, V136, P2015, DOI 10.1242/dev.033712; Masters SC, 1999, BIOCHEMISTRY-US, V38, P5216, DOI 10.1021/bi982492m; Miura K, 2005, FEBS J, V272, P1169, DOI 10.1111/j.1742-4658.2005.04552.x; Moore AW, 2000, P NATL ACAD SCI USA, V97, P10436, DOI 10.1073/pnas.170301897; Muslin AJ, 2000, CELL SIGNAL, V12, P703, DOI 10.1016/S0898-6568(00)00131-5; Nakai K, 1999, TRENDS BIOCHEM SCI, V24, P34, DOI 10.1016/S0968-0004(98)01336-X; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; Obsilova V, 2014, PHYSIOL RES, V63, pS155, DOI 10.33549/physiolres.932659; Obsilova V, 2008, PHYSIOL RES, V57, pS11, DOI 10.33549/physiolres.931598; Rajagopalan S, 2008, NUCLEIC ACIDS RES, V36, P5983, DOI 10.1093/nar/gkn598; Riddiford LM, 1996, ARCH INSECT BIOCHEM, V32, P271, DOI 10.1002/(SICI)1520-6327(1996)32:3/4&lt;271::AID-ARCH2&gt;3.0.CO;2-W; Riddiford LM, 2012, GEN COMP ENDOCR, V179, P477, DOI 10.1016/j.ygcen.2012.06.001; Romero, 1997, Genome Inform Ser Workshop Genome Inform, V8, P110; Romero P, 2001, PROTEINS, V42, P38, DOI 10.1002/1097-0134(20010101)42:1<38::AID-PROT50>3.0.CO;2-3; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; Shin SW, 2012, P NATL ACAD SCI USA, V109, P16576, DOI 10.1073/pnas.1214209109; Sluchanko NN, 2012, FEBS LETT, V586, P4249, DOI 10.1016/j.febslet.2012.10.048; Sluchanko NN, 2012, BIOCHEMISTRY-US, V51, P6127, DOI 10.1021/bi300674e; Sorokin AV, 2007, BIOCHEMISTRY-MOSCOW+, V72, P1439, DOI 10.1134/S0006297907130032; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Truman JW, 1999, NATURE, V401, P447, DOI 10.1038/46737; Tzivion G, 2002, J BIOL CHEM, V277, P3061, DOI 10.1074/jbc.R100059200; Wang SL, 2007, J INSECT PHYSIOL, V53, P246, DOI 10.1016/j.jinsphys.2006.07.011; WILSON TG, 1986, DEV BIOL, V118, P190, DOI 10.1016/0012-1606(86)90087-4; Yaffe MB, 2002, FEBS LETT, V513, P53, DOI 10.1016/S0014-5793(01)03288-4; Zhang ZL, 2011, J BIOL CHEM, V286, P8437, DOI 10.1074/jbc.M110.191684	72	10	12	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0133307	10.1371/journal.pone.0133307	http://dx.doi.org/10.1371/journal.pone.0133307			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RV	26186223	Green Published, gold, Green Submitted			2022-12-26	WOS:000358198700122
J	Hola, E; Kosnar, J; Kucera, J				Hola, Eva; Kosnar, Jiri; Kucera, Jan			Comparison of Genetic Structure of Epixylic Liverwort Crossocalyx hellerianus between Central European and Fennoscandian Populations	PLOS ONE			English	Article							HEPATIC ANASTROPHYLLUM-HELLERIANUM; OLD-GROWTH FOREST; COMPUTER-PROGRAM; LINKAGE DISEQUILIBRIUM; HABITAT FRAGMENTATION; ASEXUAL REPRODUCTION; BRYOPHYTE; MOSS; DISPERSAL; DIVERSITY	Patterns of genetic variation and spatial genetic structure (SGS) were investigated in Cross-ocalyx hellerianus, a strictly epixylic dioicous liverwort (Scapaniaceae s.l., Marchantiophyta). Studied populations were located in Fennoscandia and Central Europe, with localities differing in availability of substrate and the population connectivity, and their populations consequently different in size, density, and prevailing reproductive mode. A set of nine polymorphic microsatellites was successfully developed and used. Identical individuals were only found within populations. Especially in large populations, the majority of the individuals were genetically unique. Resampled number of genotypes, mean number of observed alleles per locus after rarefaction, and Nei's gene diversity in large populations reached high values and ranged between 4.41-4.97, 3.13-4.45, and 0.94-0.99, respectively. On the contrary, the values in small populations were lower and ranged between 1.00-4.42, 1.00-2.73, and 0.00-0.95, respectively. As expected, large populations were found to be more genetically diverse than small populations but relatively big diversity of genotypes was also found in small populations. This indicated that even small populations are important sources of genetic variation in bryophytes and processes causing loss of genetic variation might be compensated by other sources of variability, of which somatic mutations might play an important role. The presence of SGS was discovered in all populations. Large populations possessed less SGS, with individuals showing a pronounced decrease in kinship over 50 cm of distance. Apparent SGS of small populations even at distances up to 16 meters suggests the aggregation of similar genotypes, caused predominantly by the deposition of asexually formed gemmae. Although no strong kinship was detectable at the distances over 16 meters in both small and large populations, identical genotypes were occasionally detected at longer distances (20-80 m), suggesting effective dispersal of asexual propagules.	[Hola, Eva; Kosnar, Jiri; Kucera, Jan] Univ South Bohemia, Fac Sci, Dept Bot, Ceske Budejovice, Czech Republic	University of South Bohemia Ceske Budejovice	Hola, E (corresponding author), Univ South Bohemia, Fac Sci, Dept Bot, Ceske Budejovice, Czech Republic.	eva.neurazy@gmail.com	Kucera, Jan/B-3633-2009	Kucera, Jan/0000-0002-0230-5997; Kosnar, Jiri/0000-0001-5128-593X; Hola, Eva/0000-0002-5123-251X	Grant Agency of the University of South Bohemia in Ceske Budejovice [138/2010/P]	Grant Agency of the University of South Bohemia in Ceske Budejovice	The research was financially supported by the Grant Agency of the University of South Bohemia in Ceske Budejovice No. 138/2010/P.	Agapow PM, 2001, MOL ECOL NOTES, V1, P101, DOI 10.1046/j.1471-8278.2000.00014.x; Andersson Kjell, 2002, Lindbergia, V27, P90; [Anonymous], 2009, SUOMEN UHANALAISET S; Arnaud-Haond S, 2007, MOL ECOL NOTES, V7, P15, DOI 10.1111/j.1471-8286.2006.01522.x; BACZKIEWICZ A, 2012, BIODIV RES CONSERV, V27, P3; Bengtsson BO, 2003, J EVOLUTION BIOL, V16, P189, DOI 10.1046/j.1420-9101.2003.00523.x; Bengtsson J, 2000, FOREST ECOL MANAG, V132, P39, DOI 10.1016/S0378-1127(00)00378-9; Bisang I, 2004, OIKOS, V104, P291, DOI 10.1111/j.0030-1299.2004.12853.x; BUSS LW, 1983, P NATL ACAD SCI-BIOL, V80, P1387, DOI 10.1073/pnas.80.5.1387; Crandall-Stotler B., 2009, Edinburgh Journal of Botany, V66, P155, DOI 10.1017/S0960428609005393; Dierssen K., 2001, BRYOPHYTORUM BIBLIOT, V56; Drag L, 2013, CONSERV GENET RESOUR, V5, P907, DOI 10.1007/s12686-013-9930-8; Eckert CG, 2001, EVOL ECOL, V15, P501, DOI 10.1023/A:1016005519651; ELLSTRAND NC, 1993, ANNU REV ECOL SYST, V24, P217, DOI 10.1146/annurev.es.24.110193.001245; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Gunnarsson U, 2005, BRYOLOGIST, V108, P194, DOI 10.1639/0007-2745(2005)108[0194:GSOTEP]2.0.CO;2; Hardy OJ, 2003, GENETICS, V163, P1467; Hardy OJ, 2002, MOL ECOL NOTES, V2, P618, DOI 10.1046/j.1471-8286.2002.00305.x; Hassel K, 2005, AM J BOT, V92, P1684, DOI 10.3732/ajb.92.10.1684; Hogberg N, 1999, MOL ECOL, V8, P703, DOI 10.1046/j.1365-294X.1999.00561.x; Hutsemekers V, 2013, AQUAT BOT, V108, P1, DOI 10.1016/j.aquabot.2013.02.001; Jansova I, 2006, PRESLIA, V78, P67; Jonsson BG, 2005, SILVA FENN, V39, P289, DOI 10.14214/sf.390; Jonsson M, 2003, J INSECT CONSERV, V7, P111, DOI 10.1023/A:1025552623766; Kalinowski ST, 2005, MOL ECOL NOTES, V5, P187, DOI 10.1111/j.1471-8286.2004.00845.x; Karlin EF, 2012, NEW PHYTOL, V193, P1088, DOI 10.1111/j.1469-8137.2011.03999.x; Koressaar T, 2007, BIOINFORMATICS, V23, P1289, DOI 10.1093/bioinformatics/btm091; Korpelainen H, 2013, PLANT BIOLOGY, V15, P514, DOI 10.1111/j.1438-8677.2012.00660.x; Korpelainen H, 2012, INT J PLANT SCI, V173, P1015, DOI 10.1086/667612; Korpelainen H, 2011, EVOL ECOL, V25, P45, DOI 10.1007/s10682-010-9378-1; Kucera J, 2012, PRESLIA, V84, P813; Laaka-Lindberg S, 2005, J BRYOL, V27, P119, DOI 10.1179/037366805X53031; Laaka-Lindberg S, 2006, J HATTORI BOT LAB, P311; Leonardia AAP, 2013, PLANT BIOLOGY, V15, P384, DOI 10.1111/j.1438-8677.2012.00640.x; Lienert Judit, 2004, Journal for Nature Conservation (Jena), V12, P53, DOI 10.1016/j.jnc.2003.07.002; Lockhart N., 2012, RARE THREATENED BRYO; LOISELLE BA, 1995, AM J BOT, V82, P1420, DOI 10.2307/2445869; Lynch M, 2010, TRENDS GENET, V26, P345, DOI 10.1016/j.tig.2010.05.003; Newton A.E., 1994, J HATTORI BOT LAB, V76, P127, DOI DOI 10.18968/JHBL.76.0_127; Nunome T, 2006, PLANT MOL BIOL REP, V24, P305, DOI 10.1007/BF02913457; Patino J, 2010, J BRYOL, V32, P220, DOI 10.1179/037366810X12735734836133; Paton J. A., 1999, LIVERWORT FLORA BRIT; Pohjamo M, 2004, PLANT ECOL, V173, P73, DOI 10.1023/B:VEGE.0000026330.62021.0a; Pohjamo M, 2004, PERSPECT PLANT ECOL, V6, P159; Pohjamo M, 2008, BIOL CONSERV, V141, P1204, DOI 10.1016/j.biocon.2008.02.016; Pohjamo M, 2006, EVOL ECOL, V20, P415, DOI 10.1007/s10682-006-0011-2; Prusa E., 1985, BOHMISCHEN MAHRISCHE; RENNER SS, 1995, AM J BOT, V82, P596, DOI 10.2307/2445418; Silvertown J, 2008, INT J PLANT SCI, V169, P157, DOI 10.1086/523357; Snall T, 2004, MOL ECOL, V13, P2109, DOI 10.1111/j.1365-294X.2004.02217.x; Soderstrom L, 1997, ADV BRYOLOG, V6, P205; SODERSTROM L, 1989, J BRYOL, V15, P793; Soderstrom L, 2010, PHYTOTAXA, V3, P47; Szovenyi P, 2009, HEREDITY, V103, P394, DOI 10.1038/hdy.2009.82; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; van Oppen Madeleine J.H., 2011, Diversity, V3, P405, DOI 10.3390/d3030405; van Zanten BO, 1981, ADV BRYOLOGY, V1, P479; van Zanten BO., 1978, J HATTORI BOT LAB, V44, P455, DOI DOI 10.1639/0007-2745(1997)100[380:OMDBIG]2.0.CO;2; Vekemans X, 2004, MOL ECOL, V13, P921, DOI 10.1046/j.1365-294X.2004.02076.x; Weismann A., 1892, KEIMPLASMA THEORIE V; Werner O, 2002, J BRYOL, V24, P127, DOI 10.1179/037366802125000980; Whitlock MC, 1999, HEREDITY, V82, P117, DOI 10.1038/sj.hdy.6884960; WYATT R, 1985, TAXON, V34, P420, DOI 10.2307/1221208; Young A, 1996, TRENDS ECOL EVOL, V11, P413, DOI 10.1016/0169-5347(96)10045-8; Zartman CE, 2006, MOL ECOL, V15, P2305, DOI 10.1111/j.1365-294X.2006.02929.x	65	7	7	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0133134	10.1371/journal.pone.0133134	http://dx.doi.org/10.1371/journal.pone.0133134			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RV	26186214	Green Published, gold, Green Submitted			2022-12-26	WOS:000358198700098
J	Kim, TH; Zhou, HJ				Kim, Tae Hyun; Zhou, Huaijun			Functional Analysis of Chicken IRF7 in Response to dsRNA Analog Poly(I:C) by Integrating Overexpression and Knockdown	PLOS ONE			English	Article							INTERFERON-STIMULATED GENES; REGULATORY FACTOR IRF; PATTERN-RECOGNITION RECEPTORS; AVIAN INFLUENZA-VIRUSES; TOLL-LIKE RECEPTORS; NF-KAPPA-B; RNA-SEQ; RIG-I; EXPRESSION ANALYSIS; TRANSCRIPTION FACTORS	In order to develop novel strategies to protect against increasingly virulent bird-linked pathogens, a better understanding of the avian antiviral response mechanism is essential. Type I interferons (IFNs) are recognized as the first line of defense in a host's antiviral response; and it has been suggested that IRF7, a member of the IFN regulatory factor (IRF) family, plays an important role in modulating the immune response to avian influenza virus infection in chickens. The objective of this study was to identify candidate genes and pathways associated with IRF7 regulation at the transcriptome level as a first step towards elucidating the underlying cellular mechanisms of IRF7 modulation in the chicken antiviral response. IRF7 overexpression and knockdown DF-1 cell lines were established and stimulated by various pathogen-associated molecular patterns. Significant IRF7 and type I IFN expression changes were observed in both the IRF7 overexpression cell line and the IRF7-knockdown cell line upon exposure to the double stranded RNA (dsRNA) analog poly(I:C). Using RNA-seq based transcriptome analysis, we identified potential novel genes that IRF7 may help regulate as part of the host immune response to dsRNA; potential biomarkers and therapeutic targets revealed as a result of this study warrant further investigation. Based on our results, we suggest that IRF7 may have conserved functional activity in the avian antiviral response, and plays a crucial role in type I IFN regulation.	[Kim, Tae Hyun; Zhou, Huaijun] Univ Calif Davis, Dept Anim Sci, Integrat Genet & Genom Grad Grp, Davis, CA 95616 USA	University of California System; University of California Davis	Zhou, HJ (corresponding author), Univ Calif Davis, Dept Anim Sci, Integrat Genet & Genom Grad Grp, Davis, CA 95616 USA.	hzhou@ucdavis.edu		Kim, Tae Hyun/0000-0002-4272-1530	California Agricultural Experimental Station; United States Department of Agriculture, National Institute of Food and Agriculture [NC1170, NRSP8, NE1334]	California Agricultural Experimental Station; United States Department of Agriculture, National Institute of Food and Agriculture(United States Department of Agriculture (USDA))	This work was supported by the California Agricultural Experimental Station (HZ), United States Department of Agriculture, National Institute of Food and Agriculture, Multistate Research Project NC1170, NRSP8, and NE1334 (HZ).	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Baril M, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003416; Bruns AM, 2014, MOL CELL, V55, P771, DOI 10.1016/j.molcel.2014.07.003; Castanier C, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-44; Chen G, 2009, ANNU REV PATHOL-MECH, V4, P365, DOI 10.1146/annurev.pathol.4.110807.092239; Chen S, 2013, VET RES, V44, DOI 10.1186/1297-9716-44-82; Ciraci C, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-545; Cormican P, 2009, DEV COMP IMMUNOL, V33, P967, DOI 10.1016/j.dci.2009.04.001; Cui J, 2010, CELL, V141, P483, DOI 10.1016/j.cell.2010.03.040; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Der SD, 1998, P NATL ACAD SCI USA, V95, P15623, DOI 10.1073/pnas.95.26.15623; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Erickson AK, 2008, CELL RES, V18, P433, DOI 10.1038/cr.2008.46; Esnault E, 2011, VIRUS RES, V159, P32, DOI 10.1016/j.virusres.2011.04.022; Feng ZQ, 2015, GENE, V561, P138, DOI 10.1016/j.gene.2015.02.025; Gitlin L, 2006, P NATL ACAD SCI USA, V103, P8459, DOI 10.1073/pnas.0603082103; Goossens KE, 2013, DEV COMP IMMUNOL, V41, P370, DOI 10.1016/j.dci.2013.05.020; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; GRANT CE, 1995, NUCLEIC ACIDS RES, V23, P2137, DOI 10.1093/nar/23.12.2137; Honda K, 2005, NATURE, V434, P772, DOI 10.1038/nature03464; Honda K, 2006, NAT REV IMMUNOL, V6, P644, DOI 10.1038/nri1900; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang YC, 2010, BMC IMMUNOL, V11, DOI 10.1186/1471-2172-11-40; Ivashkiv LB, 2014, NAT REV IMMUNOL, V14, P36, DOI 10.1038/nri3581; Karpala AJ, 2008, DEV COMP IMMUNOL, V32, P435, DOI 10.1016/j.dci.2007.08.004; Karpala AJ, 2011, J IMMUNOL, V186, P5397, DOI 10.4049/jimmunol.1003712; Kawai T, 2008, ANN NY ACAD SCI, V1143, P1, DOI 10.1196/annals.1443.020; Keestra AM, 2013, DEV COMP IMMUNOL, V41, P316, DOI 10.1016/j.dci.2013.04.009; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kong BW, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-571; Kuenzel S, 2010, J IMMUNOL, V184, P1990, DOI 10.4049/jimmunol.0900557; Lazear HM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003118; Lee CW, 2008, J VIROL METHODS, V153, P22, DOI 10.1016/j.jviromet.2008.06.019; Lee MS, 2013, NAT IMMUNOL, V14, P346, DOI 10.1038/ni.2535; Lian L, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-23; Liniger M, 2012, J VIROL, V86, P705, DOI 10.1128/JVI.00742-11; Liu AL, 2015, VIRUS GENES, V50, P189, DOI 10.1007/s11262-014-1151-z; Liu HC, 2003, CYTOGENET GENOME RES, V102, P304, DOI 10.1159/000075767; Loo YM, 2008, J VIROL, V82, P335, DOI 10.1128/JVI.01080-07; Magor KE, 2013, DEV COMP IMMUNOL, V41, P377, DOI 10.1016/j.dci.2013.04.010; Marcus PI, 2005, J VIROL, V79, P2880, DOI 10.1128/JVI.79.5.2880-2890.2005; Nehyba J, 2002, MOL CELL BIOL, V22, P3942, DOI 10.1128/MCB.22.11.3942-3957.2002; Ning S, 2011, GENES IMMUN, V12, P399, DOI 10.1038/gene.2011.21; Paladino P, 2006, J IMMUNOL, V177, P8008, DOI 10.4049/jimmunol.177.11.8008; Philbin VJ, 2005, IMMUNOLOGY, V114, P507, DOI 10.1111/j.1365-2567.2005.02125.x; Sadler AJ, 2008, NAT REV IMMUNOL, V8, P559, DOI 10.1038/nri2314; Sanada T, 2008, J BIOL CHEM, V283, P33858, DOI 10.1074/jbc.M806923200; Sato M, 2001, CYTOKINE GROWTH F R, V12, P133, DOI 10.1016/S1359-6101(00)00032-0; Satoh T, 2010, P NATL ACAD SCI USA, V107, P1512, DOI 10.1073/pnas.0912986107; Schmid S, 2010, J BIOL CHEM, V285, P42013, DOI 10.1074/jbc.M110.165936; Schmieder R, 2011, BIOINFORMATICS, V27, P863, DOI 10.1093/bioinformatics/btr026; Schneider WM, 2014, ANNU REV IMMUNOL, V32, P513, DOI 10.1146/annurev-immunol-032713-120231; Schoggins JW, 2011, CURR OPIN VIROL, V1, P519, DOI 10.1016/j.coviro.2011.10.008; Schoggins JW, 2011, NATURE, V472, P481, DOI 10.1038/nature09907; Staeheli P, 2001, J INTERF CYTOK RES, V21, P993, DOI 10.1089/107999001317205123; Stewart CR, 2013, DEV COMP IMMUNOL, V41, P463, DOI 10.1016/j.dci.2013.05.011; Tamura T, 2008, ANNU REV IMMUNOL, V26, P535, DOI 10.1146/annurev.immunol.26.021607.090400; Tong YZ, 2012, CELL RES, V22, P822, DOI 10.1038/cr.2012.53; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Wang J, 2013, J IMMUNOL, V191, P3393, DOI 10.4049/jimmunol.1300740; Wang XA, 2013, AM J PHYSIOL-ENDOC M, V305, pE485, DOI 10.1152/ajpendo.00505.2012; Wang Y, 2014, POULTRY SCI, V93, P485, DOI 10.3382/ps.2013-03557; Wang Y, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-278; Wang Y, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S10-S5; Wise TG, 2007, ANIM BIOTECHNOL, V18, P153, DOI 10.1080/10495390600867515	68	32	32	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0133450	10.1371/journal.pone.0133450	http://dx.doi.org/10.1371/journal.pone.0133450			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RV	26186542	gold, Green Published			2022-12-26	WOS:000358198700141
J	Liu, YQ; Wang, ZY; Su, JP; Liu, WW; Dhiloo, KH; Guo, YY				Liu, Yongqiang; Wang, Zhongyue; Su, Junping; Liu, Weiwei; Dhiloo, Khalid Hussain; Guo, Yuyuan			The Efficacy of Chinese Medicinal Herbs towards Grape Phylloxera (Daktulosphaira vitifoliae Fitch) (Hemiptera, Phylloxeridae)	PLOS ONE			English	Article							INSECT GROWTH-REGULATOR; HOMOPTERA; PESTICIDES; MANAGEMENT; MORTALITY; EXTRACTS; BIOTYPES; BIOLOGY; OIL	Bio-insecticidal effects of seven Chinese medicinal herbs on mortality, fecundity, developmental periods and life table parameters of the grape phylloxera were investigated. In an excised root bioassay experiment aqueous extracts from seven Chinese medicinal herbs increased grape phylloxera first instar mortality (26.00-38.50%) compared to other instars. The intrinsic rate of increase (r(m)), finite rate of increase (lambda), fecundity rate and net reproductive rate (R-0) were significantly reduced by A. bidentata, A. tataricus, O. basilicum, P. frutescensand N. cataria. In a glasshouse pot trial, eggs, nymphs, adults and total population were significantly reduced before population establishment compared to those after its population established, by A. bidentata, A. tataricus and O. basilicum. Overall, A. bidentata, A. tataricus and O. basilicum can be used to suppress all life-stages of grape phylloxera.	[Liu, Yongqiang; Wang, Zhongyue; Su, Junping; Liu, Weiwei; Dhiloo, Khalid Hussain; Guo, Yuyuan] Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing 100193, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS	Guo, YY (corresponding author), Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing 100193, Peoples R China.	yyguo@ippcaas.cn			National Technology System project for Grape Industry [nycytx-30]	National Technology System project for Grape Industry	The work was supported by the National Technology System project for Grape Industry (nycytx-30). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad N, 2012, CROP PROT, V38, P7, DOI 10.1016/j.cropro.2012.03.006; Athanassiou CG, 2005, J ECON ENTOMOL, V98, P1733, DOI 10.1603/0022-0493-98.5.1733; Benheim D, 2012, ANN APPL BIOL, V161, P91, DOI 10.1111/j.1744-7348.2012.00561.x; Bickerton MW, 2011, THESIS STATE U NEW J; BIRCH LC, 1948, J ANIM ECOL, V17, P15, DOI 10.2307/1605; CAHILL M, 1995, B ENTOMOL RES, V85, P181, DOI 10.1017/S0007485300034258; Charleston DS, 2004, THESIS, P1; Che PiLian, 2007, Journal of Shanghai Jiaotong University - Agricultural Science, V25, P587; Chokechaijaroenporn O, 1994, Phytomedicine, V1, P135, DOI 10.1016/S0944-7113(11)80031-0; DEBENEDICTIS JA, 1992, J ECON ENTOMOL, V85, P1527, DOI 10.1093/jee/85.4.1527; Dixon A.F.G., 1987, World Crop Pests, V2A, P269; Donald WL, 2000, THESIS; Dunstone RJ, 2003, AUST J GRAPE WINE R, V9, P107, DOI 10.1111/j.1755-0238.2003.tb00260.x; Forbes VE, 1999, ENVIRON TOXICOL CHEM, V18, P1544, DOI 10.1002/etc.5620180729; FUKAI S, 1993, FIELD CROP RES, V34, P247, DOI 10.1016/0378-4290(93)90117-6; GALET P, 1982, MALADIES PARASITES V, V2, P1059; GRANETT J, 1985, J ECON ENTOMOL, V78, P1463, DOI 10.1093/jee/78.6.1463; Granett J, 2001, ANNU REV ENTOMOL, V46, P387, DOI 10.1146/annurev.ento.46.1.387; Hao Hui-Ling, 2006, Acta Entomologica Sinica, V49, P533; Herbert KS, 2010, B ENTOMOL RES, V100, P671, DOI 10.1017/S0007485310000027; Herbert K, 2008, J ECON ENTOMOL, V101, P1934, DOI 10.1603/0022-0493-101.6.1934; Hummel JD, 2009, THESIS U ALBERTA CAN; Jeyabalan D, 2003, BIORESOURCE TECHNOL, V89, P185, DOI 10.1016/S0960-8524(03)00036-1; Kraiss H, 2008, PEST MANAG SCI, V64, P660, DOI 10.1002/ps.1541; Kumar P, 2011, IND CROP PROD, V34, P802, DOI 10.1016/j.indcrop.2011.02.019; Powell KS, 2013, ADV INSECT PHYSIOL, V45, P159, DOI 10.1016/B978-0-12-417165-7.00004-0; RANI PU, 1989, INSECT SCI APPL, V10, P327, DOI 10.1017/S1742758400003568; Ren Wei, 2007, Sichuan Journal of Zoology, V26, P635; Sisodia S., 2010, J AGR EXTENSION RURA, V2, P22, DOI DOI 10.5897/JAERD.9000005; Stark JD, 1997, ECOTOX ENVIRON SAFE, V37, P273, DOI 10.1006/eesa.1997.1552; STARK JD, 1995, J ECON ENTOMOL, V88, P1089, DOI 10.1093/jee/88.5.1089; Stark JD, 2007, J ECON ENTOMOL, V100, P1027, DOI 10.1603/0022-0493(2007)100[1027:IERMOP]2.0.CO;2; Tapondjou LA, 2002, J STORED PROD RES, V38, P395, DOI 10.1016/S0022-474X(01)00044-3; Walthall WK, 1997, ECOTOX ENVIRON SAFE, V37, P45, DOI 10.1006/eesa.1997.1521; Wang YX, 2009, THESIS NE NORMAL U J; WILLIAMS RN, 1988, ANN ENTOMOL SOC AM, V81, P1, DOI 10.1093/aesa/81.1.1; Worwood V. A., 1993, COMPLETE BOOK ESSENT; YANG RZ, 1988, ECON BOT, V42, P376, DOI 10.1007/BF02860162; ZHANG GZ, 2000, J QINGHAI U, V18, P3; Zhang HuaGe, 2009, Journal of Fruit Science, V26, P306; Zhong GH, 2001, J APPL ENTOMOL, V125, P563, DOI 10.1046/j.1439-0418.2001.00590.x; [No title captured]	42	1	1	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0128038	10.1371/journal.pone.0128038	http://dx.doi.org/10.1371/journal.pone.0128038			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RV	26186216	gold, Green Published, Green Submitted			2022-12-26	WOS:000358198700002
J	Silva, O; Crocetti, J; Humphries, LA; Burkhardt, JK; Miceli, MC				Silva, Oscar; Crocetti, Jillian; Humphries, Lisa A.; Burkhardt, Janis K.; Miceli, M. Carrie			Discs Large Homolog 1 Splice Variants Regulate p38-Dependent and -Independent Effector Functions in CD8+T Cells	PLOS ONE			English	Article							ALDRICH-SYNDROME PROTEIN; NF-KAPPA-B; LARGE TUMOR-SUPPRESSOR; T-CELLS; IMMUNOLOGICAL SYNAPSE; P38 ACTIVATION; ACTIN POLYMERIZATION; GENE-TRANSCRIPTION; RECEPTOR; DLGH1	Functionally diverse CD8+ T cells develop in response to antigenic stimulation with differing capacities to couple TCR engagement to downstream signals and functions. However, mechanisms of diversifying TCR signaling are largely uncharacterized. Here we identified two alternative splice variants of scaffold protein Dlg1, Dlg1AB and Dlg1B, that diversify signaling to regulate p38 -dependent and -independent effector functions in CD8+ T cells. Dlg1AB, but not Dlg1B associated with Lck, coupling TCR stimulation to p38 activation and proinflammatory cytokine production. Conversely, both Dlg1AB and Dlg1B mediated p38-independent degranulation. Degranulation depended on a Dlg1 fragment containing an intact Dlg1SH3-domain and required the SH3-ligand WASp. Further, Dlg1 controlled WASp activation by promoting TCR-triggered conformational opening of WASp. Collectively, our data support a model where Dlg1 regulates p38-dependent proinflammatory cytokine production and p38-independent cytotoxic granule release through the utilization of alternative splice variants, providing a mechanism whereby TCR engagement couples downstream signals to unique effector functions in CD8+ T cells.	[Silva, Oscar; Humphries, Lisa A.; Miceli, M. Carrie] Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA; [Crocetti, Jillian] Univ Calif Los Angeles, Mol Biol Interdept Program, Los Angeles, CA USA; [Burkhardt, Janis K.] Childrens Hosp Philadelphia, Dept Lab Med, Philadelphia, PA 19104 USA; [Burkhardt, Janis K.] Univ Penn, Philadelphia, PA 19104 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of Pennsylvania; Childrens Hospital of Philadelphia; University of Pennsylvania	Miceli, MC (corresponding author), Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA.	cmiceli@ucla.edu		Burkhardt, Janis/0000-0002-8176-1375	National Institutes of Health [R01-AI067253]; University of California, Los Angeles Microbial Pathogenesis Training Grant [T32-AI07323]; Arthritis Foundation Postdoctoral Fellowship; NATIONAL CANCER INSTITUTE [P01CA093615] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007323, R01AI067253] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of California, Los Angeles Microbial Pathogenesis Training Grant; Arthritis Foundation Postdoctoral Fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Work by M.C.M. was supported by National Institutes of Health grant R01-AI067253 and by a University of California, Los Angeles Microbial Pathogenesis Training Grant T32-AI07323 to O.S. and J.C., and an Arthritis Foundation Postdoctoral Fellowship to L.A.H. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi K, 2011, P NATL ACAD SCI USA, V108, P1549, DOI 10.1073/pnas.1017340108; Agnellini P, 2007, P NATL ACAD SCI USA, V104, P4565, DOI 10.1073/pnas.0610335104; Calvez R, 2011, HAEMATOL-HEMATOL J, V96, P1415, DOI 10.3324/haematol.2011.040204; Cavatorta AL, 2011, FEBS J, V278, P2596, DOI 10.1111/j.1742-4658.2011.08188.x; Crocetti J, 1950, J IMMUNOL, V193, P2651, DOI [10.4049/jimmunol.1401196, DOI 10.4049/JIMMUN0L.1401196]; Darrah PA, 2007, NAT MED, V13, P843, DOI 10.1038/nm1592; De Meester J, 2010, J LEUKOCYTE BIOL, V88, P1031, DOI 10.1189/jlb.0410197; Filipp D, 2003, J EXP MED, V197, P1221, DOI 10.1084/jem.20022112; Gmyrek GB, 2013, EUR J IMMUNOL, V43, P1185, DOI 10.1002/eji.201142362; Godreau D, 2003, J BIOL CHEM, V278, P47046, DOI 10.1074/jbc.M308463200; Hanada T, 1997, J BIOL CHEM, V272, P26899, DOI 10.1074/jbc.272.43.26899; Hanada T, 2000, J BIOL CHEM, V275, P28774, DOI 10.1074/jbc.M000715200; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; Huang CJ, 2006, J IMMUNOL, V176, P4173, DOI 10.4049/jimmunol.176.7.4173; Hufford MM, 2011, J EXP MED, V208, P167, DOI 10.1084/jem.20101850; Humphries LA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045276; Huse M, 2008, NAT IMMUNOL, V9, P1105, DOI 10.1038/ni.f.215; Jirmanova L, 2011, BLOOD, V118, P3280, DOI 10.1182/blood-2011-01-333039; Jirmanova L, 2009, BLOOD, V113, P2229, DOI 10.1182/blood-2008-04-153304; Kaminuma O, 2008, J IMMUNOL, V180, P319, DOI 10.4049/jimmunol.180.1.319; Kim TS, 2011, TRENDS IMMUNOL, V32, P225, DOI 10.1016/j.it.2011.02.006; Labno CM, 2003, CURR BIOL, V13, P1619, DOI 10.1016/j.cub.2003.08.005; Lasserre R, 2010, EMBO J, V29, P2301, DOI 10.1038/emboj.2010.127; Lopez-Santalla M, 2011, ARTHRITIS RHEUM-US, V63, P1833, DOI 10.1002/art.30375; Ludford-Menting MJ, 2005, IMMUNITY, V22, P737, DOI 10.1016/j.immuni.2005.04.009; Makedonas G, 2011, IMMUNOL REV, V239, P109, DOI 10.1111/j.1600-065X.2010.00968.x; Martinez NM, 2012, RNA, V18, P1029, DOI 10.1261/rna.032243.112; McLaughlin M, 2002, J BIOL CHEM, V277, P6406, DOI 10.1074/jbc.M108724200; Mittelstadt PR, 2009, J BIOL CHEM, V284, P15469, DOI 10.1074/jbc.M901004200; MOORE MW, 1988, CELL, V54, P777, DOI 10.1016/S0092-8674(88)91043-4; Morales-Tirado V, 2004, J IMMUNOL, V173, P726, DOI 10.4049/jimmunol.173.2.726; Nakagawa T, 2004, NEURON, V44, P453, DOI 10.1016/j.neuron.2004.10.012; Newell EW, 2012, IMMUNITY, V36, P142, DOI 10.1016/j.immuni.2012.01.002; Nikolov NP, 2010, BLOOD, V116, P740, DOI 10.1182/blood-2009-08-237560; O'Connell RM, 2009, P NATL ACAD SCI USA, V106, P7113, DOI 10.1073/pnas.0902636106; Padrick SB, 2008, MOL CELL, V32, P426, DOI 10.1016/j.molcel.2008.10.012; Palacios EH, 2004, ONCOGENE, V23, P7990, DOI 10.1038/sj.onc.1208074; Park SG, 2009, NAT IMMUNOL, V10, P158, DOI 10.1038/ni.1687; Rebeaud F, 2007, TRENDS IMMUNOL, V28, P196, DOI 10.1016/j.it.2007.03.004; Roberts S, 2007, EXP CELL RES, V313, P2521, DOI 10.1016/j.yexcr.2007.05.017; Round JL, 2005, J EXP MED, V201, P419, DOI 10.1084/jem.20041428; Round JL, 2007, NAT IMMUNOL, V8, P154, DOI 10.1038/ni1422; Salvador JM, 2005, NAT IMMUNOL, V6, P390, DOI 10.1038/ni1177; Schluter OM, 2006, NEURON, V51, P99, DOI 10.1016/j.neuron.2006.05.016; Seder RA, 2008, NAT REV IMMUNOL, V8, P247, DOI 10.1038/nri2274; Stephenson LM, 2007, MOL CELL BIOL, V27, P7574, DOI 10.1128/MCB.00439-07; Stinchcombe JC, 2007, ANNU REV CELL DEV BI, V23, P495, DOI 10.1146/annurev.cellbio.23.090506.123521; Trifari S, 2006, J IMMUNOL, V177, P7451, DOI 10.4049/jimmunol.177.10.7451; Valitutti S, 1996, J EXP MED, V183, P1917, DOI 10.1084/jem.183.4.1917; Xavier R, 2004, J CELL BIOL, V166, P173, DOI 10.1083/jcb.200309044; Yuan JD, 2008, P NATL ACAD SCI USA, V105, P20410, DOI 10.1073/pnas.0810114105; Zanin-Zhorov A, 2012, P NATL ACAD SCI USA, V109, P1625, DOI 10.1073/pnas.1110120109	52	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0133353	10.1371/journal.pone.0133353	http://dx.doi.org/10.1371/journal.pone.0133353			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RV	26186728	Green Published, Green Submitted, gold			2022-12-26	WOS:000358198700128
J	Stern, S; Agudelo-Toro, A; Rotem, A; Moses, E; Neef, A				Stern, Shani; Agudelo-Toro, Andres; Rotem, Assaf; Moses, Elisha; Neef, Andreas			Chronaxie Measurements in Patterned Neuronal Cultures from Rat Hippocampus	PLOS ONE			English	Article							DIRECT-CURRENT STIMULATION; CA1 PYRAMIDAL NEURONS; STRENGTH-DURATION RELATIONSHIP; ELECTRICAL-STIMULATION; DENDRITIC SPIKES; MAGNETIC STIMULATION; EXTRACELLULAR STIMULATION; PREFRONTAL CORTEX; ACTION-POTENTIALS; NERVOUS-SYSTEM	Excitation of neurons by an externally induced electric field is a long standing question that has recently attracted attention due to its relevance in novel clinical intervention systems for the brain. Here we use patterned quasi one-dimensional neuronal cultures from rat hippocampus, exploiting the alignment of axons along the linear patterned culture to separate the contribution of dendrites to the excitation of the neuron from that of axons. Network disconnection by channel blockers, along with rotation of the electric field direction, allows the derivation of strength-duration (SD) curves that characterize the statistical ensemble of a population of cells. SD curves with the electric field aligned either parallel or perpendicular to the axons yield the chronaxie and rheobase of axons and dendrites respectively, and these differ considerably. Dendritic chronaxie is measured to be about 1 ms, while that of axons is on the order of 0.1 ms. Axons are thus more excitable at short time scales, but at longer time scales dendrites are more easily excited. We complement these studies with experiments on fully connected cultures. An explanation for the chronaxie of dendrites is found in the numerical simulations of passive, realistically structured dendritic trees under external stimulation. The much shorter chronaxie of axons is not captured in the passive model and may be related to active processes. The lower rheobase of dendrites at longer durations can improve brain stimulation protocols, since in the brain dendrites are less specifically oriented than axonal bundles, and the requirement for precise directional stimulation may be circumvented by using longer duration fields.	[Stern, Shani; Moses, Elisha] Weizmann Inst Sci, Dept Phys Complex Syst, IL-76100 Rehovot, Israel; [Agudelo-Toro, Andres; Neef, Andreas] Max Planck Inst Dynam & Self Org, Dept Nonlinear Dynam, Gottingen, Germany; [Agudelo-Toro, Andres; Neef, Andreas] Bernstein Grp Biophys Neural Computat, Gottingen, Germany; [Rotem, Assaf] Harvard Univ, Dept Phys, Cambridge, MA 02138 USA; [Rotem, Assaf] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA	Weizmann Institute of Science; Max Planck Society; Harvard University; Harvard University	Moses, E (corresponding author), Weizmann Inst Sci, Dept Phys Complex Syst, IL-76100 Rehovot, Israel.	elisha.moses@weizmann.ac.il		Neef, Andreas/0000-0003-4445-7478; Stern, Shani/0000-0002-2644-7068	Minerva Foundation Israel; Ministry of Science and Technology Israel; Israel Science Foundation [1320/09]; Bi-National Science Foundation [2008331]; German Ministry for Education and Research through the Bernstein Focus Neurotechnology Gottingen [01GQ0811 01GQ0810]; Gottingen Graduate School for Neurosciences, Biophysics und Molecular Biosciences (DFG) [226/1]	Minerva Foundation Israel; Ministry of Science and Technology Israel(Ministry of Science, Technology and Space (MOST), Israel); Israel Science Foundation(Israel Science Foundation); Bi-National Science Foundation(US-Israel Binational Science Foundation); German Ministry for Education and Research through the Bernstein Focus Neurotechnology Gottingen; Gottingen Graduate School for Neurosciences, Biophysics und Molecular Biosciences (DFG)	This work was supported by the Minerva Foundation Israel to EM, the Ministry of Science and Technology Israel to SS, Israel Science Foundation to EM (1320/09), Bi-National Science Foundation to EM (2008331), German Ministry for Education and Research through the Bernstein Focus Neurotechnology Gottingen to AN (01GQ0811 01GQ0810), and by Gottingen Graduate School for Neurosciences, Biophysics und Molecular Biosciences to AN (DFG grant 226/1).	[Anonymous], 1901, ARCH ITAL BIOL; Boinagrov D, 2010, J NEUROPHYSIOL, V104, P2236, DOI 10.1152/jn.00343.2010; Bordey A, 1999, J NEUROPHYSIOL, V82, P3476, DOI 10.1152/jn.1999.82.6.3476; Braitenberg V, 1998, CORTEX STATISTICS AN; Breskin I, 2006, PHYSICAL REVIEW LETT, V97; Brunel N, 2007, BIOL CYBERN, V97, P341, DOI 10.1007/s00422-007-0189-6; CARTEE LA, 1992, IEEE T BIO-MED ENG, V39, P76, DOI 10.1109/10.108130; Downes JH, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002522; Feinerman O, 2005, J NEUROPHYSIOL, V94, P3406, DOI 10.1152/jn.00264.2005; Feinerman O, 2008, NAT PHYS, V4, P967, DOI 10.1038/nphys1099; Floel A, 2008, J COGNITIVE NEUROSCI, V20, P1415, DOI 10.1162/jocn.2008.20098; Fox PT, 2004, HUM BRAIN MAPP, V22, P1, DOI 10.1002/hbm.20006; Fregni F, 2005, EXP BRAIN RES, V166, P23, DOI 10.1007/s00221-005-2334-6; Gasparini S, 2004, J NEUROSCI, V24, P11046, DOI 10.1523/JNEUROSCI.2520-04.2004; Golding NL, 1999, J NEUROSCI, V19, P8789, DOI 10.1523/JNEUROSCI.19-20-08789.1999; Golding NL, 2002, NATURE, V418, P326, DOI 10.1038/nature00854; Golding NL, 1998, NEURON, V21, P1189, DOI 10.1016/S0896-6273(00)80635-2; GUSTAFSSON B, 1976, J PHYSIOL-LONDON, V258, P33, DOI 10.1113/jphysiol.1976.sp011405; Hallett M, 2007, NEURON, V55, P187, DOI 10.1016/j.neuron.2007.06.026; Harnett MT, 2012, NATURE, V491, P599, DOI 10.1038/nature11554; Higgs MH, 2011, J PHYSIOL-LONDON, V589, P5125, DOI 10.1113/jphysiol.2011.216721; Hill AV, 1936, PROC R SOC SER B-BIO, V119, P305, DOI 10.1098/rspb.1936.0012; Hines ML, 1997, NEURAL COMPUT, V9, P1179, DOI 10.1162/neco.1997.9.6.1179; Hoffman DA, 1997, NATURE, V390, P199, DOI 10.1038/36632; Hsu KH, 2000, IEEE T BIO-MED ENG, V47, P463, DOI 10.1109/10.828146; Iles JF, 2005, PROG BIOPHYS MOL BIO, V87, P17, DOI 10.1016/j.pbiomolbio.2004.06.002; Kamondi A, 1998, J NEUROSCI, V18, P3919; Kim S, 2012, NAT NEUROSCI, V15, P600, DOI [10.1038/nn.3060, 10.1038/nn.3173]; Kincses TZ, 2004, NEUROPSYCHOLOGIA, V42, P113, DOI 10.1016/S0028-3932(03)00124-6; Lapicque L., 1907, J PHYSIOL PATH GEN, V9, P620, DOI DOI 10.1007/S00422-007-0189-6; MCNEAL DR, 1976, IEEE T BIO-MED ENG, V23, P329, DOI 10.1109/TBME.1976.324593; NAGARAJAN SS, 1993, IEEE T BIO-MED ENG, V40, P1175, DOI 10.1109/10.245636; Nowak LG, 1998, EXP BRAIN RES, V118, P477, DOI 10.1007/s002210050304; Nowak LG, 1998, EXP BRAIN RES, V118, P489, DOI 10.1007/s002210050305; Pashut T, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002022; Peng YR, 2009, NEURON, V61, P71, DOI 10.1016/j.neuron.2008.11.015; Plonsey R, 2007, BIOELECTRICITY A QUA; Radman T, 2009, 31ST ANNUAL INTERNAT; Rahman A, 2013, J PHYSIOL-LONDON, V591, P2563, DOI 10.1113/jphysiol.2012.247171; RANCK JB, 1975, BRAIN RES, V98, P417, DOI 10.1016/0006-8993(75)90364-9; Rattay F, 1999, NEUROSCIENCE, V89, P335, DOI 10.1016/S0306-4522(98)00330-3; Rattay F, 2012, NEUROSCIENCE, V214, P1, DOI 10.1016/j.neuroscience.2012.04.004; RATTAY F, 1986, IEEE T BIO-MED ENG, V33, P974, DOI 10.1109/TBME.1986.325670; REILLY JP, 1989, MED BIOL ENG COMPUT, V27, P101, DOI 10.1007/BF02446217; Rotem A, 2008, BIOPHYS J, V94, P5065, DOI 10.1529/biophysj.107.125708; ROTH BJ, 1990, IEEE T BIO-MED ENG, V37, P588, DOI 10.1109/10.55662; SHINODA Y, 1979, EXP BRAIN RES, V34, P59; Soriano J, 2008, P NATL ACAD SCI USA, V105, P13758, DOI 10.1073/pnas.0707492105; Vetter P, 2001, J NEUROPHYSIOL, V85, P926, DOI 10.1152/jn.2001.85.2.926; Wagner T, 2009, CORTEX, V45, P1025, DOI 10.1016/j.cortex.2008.10.002; WARMAN EN, 1992, IEEE T BIO-MED ENG, V39, P1244, DOI 10.1109/10.184700; WEST DC, 1983, J PHYSIOL-LONDON, V337, P37, DOI 10.1113/jphysiol.1983.sp014610	52	17	19	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0132577	10.1371/journal.pone.0132577	http://dx.doi.org/10.1371/journal.pone.0132577			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RV	26186201	Green Submitted, Green Published, gold			2022-12-26	WOS:000358198700050
J	Borghans, L; Golsteyn, BHH; Zolitz, U				Borghans, Lex; Golsteyn, Bart H. H.; Zolitz, Ulf			School Quality and the Development of Cognitive Skills between Age Four and Six	PLOS ONE			English	Article							CHOICE; TECHNOLOGY	This paper studies the extent to which young children develop their cognitive ability in high and low quality schools. We use a representative panel data set containing cognitive test scores of 4-6 year olds in Dutch schools. School quality is measured by the school's average achievement test score at age 12. Our results indicate that children in high-quality schools develop their skills substantially faster than those in low-quality schools. The results remain robust to the inclusion of initial ability, parental background, and neighborhood controls. Moreover, using proximity to higher-achieving schools as an instrument for school choice corroborates the results. The robustness of the results points toward a causal interpretation, although it is not possible to erase all doubt about unobserved confounding factors.	[Borghans, Lex; Golsteyn, Bart H. H.; Zolitz, Ulf] Maastricht Univ, Dept Econ, Maastricht, Netherlands; [Borghans, Lex] Maastricht Univ, Res Ctr Educ & Lab Market ROA, Maastricht, Netherlands; [Golsteyn, Bart H. H.; Zolitz, Ulf] Maastricht Univ, Dept Econ, Maastricht, Netherlands; [Zolitz, Ulf] IZA, Bonn, Germany	Maastricht University; Maastricht University; Maastricht University; IZA Institute Labor Economics	Zolitz, U (corresponding author), IZA, Bonn, Germany.	zoelitz@iza.org		Golsteyn, Bart/0000-0002-2357-5857				Black SE, 1999, Q J ECON, V114, P577, DOI 10.1162/003355399556070; Blau David, 2006, HDB EC ED, V2, P1163, DOI [DOI 10.1016/S1574-0692(06)02020-4, DOI 10.3386/W10670]; Blomeyer D, 2009, J EUR ECON ASSOC, V7, P638, DOI 10.1162/JEEA.2009.7.2-3.638; Borghans L, 2015, BE J ECON ANAL POLI, V15, P85, DOI 10.1515/bejeap-2014-0032; Card D., 1995, MYTH MEASUREMENT NEW; CECI SJ, 1991, DEV PSYCHOL, V27, P703, DOI 10.1037/0012-1649.27.5.703; Chetty R, 2011, Q J ECON, V126, P1593, DOI 10.1093/qje/qjr041; Cullen JB, 2006, ECONOMETRICA, V74, P1191, DOI 10.1111/j.1468-0262.2006.00702.x; Cunha F, 2008, J HUM RESOUR, V43, P738; Cunha F, 2010, ECONOMETRICA, V78, P883, DOI 10.3982/ECTA6551; Downes TA, 2002, J URBAN ECON, V52, P1, DOI 10.1016/S0094-1190(02)00010-4; Hall J, 2009, OXFORD REV EDUC, V35, P331, DOI 10.1080/03054980902934613; Hastings JS, 2008, Q J ECON, V123, P1373, DOI 10.1162/qjec.2008.123.4.1373; Heckman J.J, 2000, RES ECON, V54, P3, DOI DOI 10.1006/REEC.1999.0225; Hoxby CM, 2002, J HUM RESOUR, V37, P846, DOI 10.2307/3069619; Knudsen EI, 2006, P NATL ACAD SCI USA, V103, P10155, DOI 10.1073/pnas.0600888103; Krueger AB, 1999, Q J ECON, V114, P497, DOI 10.1162/003355399556052; Peisner-Feinberg ES, 2001, CHILD DEV, V72, P1534, DOI 10.1111/1467-8624.00364; Shonkoff J. P., 2000, NEURONS NEIGHBORHOOD	19	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2015	10	7							e0129700	10.1371/journal.pone.0129700	http://dx.doi.org/10.1371/journal.pone.0129700			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN1RQ	26182123	gold, Green Accepted, Green Submitted, Green Published			2022-12-26	WOS:000358198200003
J	Moore, JH; Pinheiro, CCD; Zaenker, EI; Bolick, DT; Kolling, GL; van Opstal, E; Noronha, FJD; De Medeiros, PHQS; Rodriguez, RS; Lima, AA; Guerrant, RL; Warren, CA				Moore, John H.; Pinheiro, Caio C. D.; Zaenker, Edna I.; Bolick, David T.; Kolling, Glynis L.; van Opstal, Edward; Noronha, Francisco J. D.; De Medeiros, Pedro H. Q. S.; Rodriguez, Raphael S.; Lima, Aldo A.; Guerrant, Richard L.; Warren, Cirle A.			Defined Nutrient Diets Alter Susceptibility to Clostridium difficile Associated Disease in a Murine Model	PLOS ONE			English	Article							ANTIBIOTIC-ASSOCIATED DIARRHEA; COLONIZATION RESISTANCE; FECAL MICROBIOTA; TOXIN PRODUCTION; MOUSE MODEL; INFECTION; MALNUTRITION; MICE; EPIDEMIOLOGY; PATTERNS	Background Clostridium difficile is a major identifiable and treatable cause of antibiotic-associated diarrhea. Poor nutritional status contributes to mortality through weakened host defenses against various pathogens. The primary goal of this study was to assess the contribution of a reduced protein diet to the outcomes of C. difficile infection in a murine model. Methods C57BL/6 mice were fed a traditional house chow or a defined diet with either 20% protein or 2% protein and infected with C. difficile strain VPI10463. Animals were monitored for disease severity, clostridial shedding and fecal toxin levels. Select intestinal microbiota were measured in stool and C. difficilegrowth and toxin production were quantified ex vivoin intestinal contents from untreated or antibiotic-treated mice fed with the different diets. Results C. difficileinfected mice fed with defined diets, particularly (and unexpectedly) with protein deficient diet, had increased survival, decreased weight loss, and decreased overall disease severity. C. difficile shedding and toxin in the stool of the traditional diet group was increased compared with either defined diet 1 day post infection. Mice fed with traditional diet had an increased intestinal Firmicutes to Bacteroidetes ratio following antibiotic exposure compared with either a 2% or 20% protein defined nutrient diet. Ex vivo inoculation of cecal contents from antibiotic-treated mice showed decreased toxin production and C. difficile growth in both defined diets compared with a traditional diet. Conclusions Low protein diets, and defined nutrient diets in general, were found to be protective against CDI in mice. Associated diet-induced alterations in intestinal microbiota may influence colonization resistance and clostridial toxin production in a defined nutrient diet compared to a traditional diet, leading to increased survival. However, mechanisms which led to survival differences between 2% and 20% protein defined nutrient diets need to be further elucidated.	[Moore, John H.; Zaenker, Edna I.; Bolick, David T.; Kolling, Glynis L.; van Opstal, Edward; Guerrant, Richard L.; Warren, Cirle A.] Univ Virginia, Div Infect Dis & Int Hlth, Charlottesville, VA 22904 USA; [Pinheiro, Caio C. D.; Noronha, Francisco J. D.; De Medeiros, Pedro H. Q. S.; Rodriguez, Raphael S.; Lima, Aldo A.] Univ Fed Ceara, Inst Biomed, Fortaleza, Ceara, Brazil	University of Virginia; Universidade Federal do Ceara	Warren, CA (corresponding author), Univ Virginia, Div Infect Dis & Int Hlth, Charlottesville, VA 22904 USA.	ca6t@virginia.edu	Bolick, David/A-3467-2017; Lima, Aldo AM/D-8251-2018	Lima, Aldo AM/0000-0002-0299-1747; Pinheiro, Caio/0000-0003-1856-2442; van Opstal, Edward/0000-0002-2973-6308	NIH/NIAID [U01 AI075526]; Bill & Melinda Gates Foundation [APP16340]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI075526] Funding Source: NIH RePORTER	NIH/NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding was provided by NIH/NIAID U01 AI075526 and the Bill & Melinda Gates Foundation APP16340. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonopoulos DA, 2009, INFECT IMMUN, V77, P2367, DOI 10.1128/IAI.01520-08; Bartelt LA, 2013, J CLIN INVEST, V123, P2672, DOI 10.1172/JCI67294; Bartlett JG, 2002, NEW ENGL J MED, V346, P334, DOI 10.1056/NEJMcp011603; Baxter R, 2008, INFECT CONT HOSP EP, V29, P44, DOI 10.1086/524320; Belkaid Y, 2014, CELL, V157, P121, DOI 10.1016/j.cell.2014.03.011; Bolick DT, 2014, GUT MICROBES, V5, P618, DOI 10.4161/19490976.2014.969642; Bolick DT, 2013, J MED MICROBIOL, V62, P896, DOI 10.1099/jmm.0.046300-0; Bosscher D, 2009, J PHYSIOL PHARMACOL, V60, P5; Chen XH, 2008, GASTROENTEROLOGY, V135, P1984, DOI 10.1053/j.gastro.2008.09.002; Cohen SH, 2010, INFECT CONT HOSP EP, V31, P431, DOI 10.1086/651706; Costa LB, 2011, J PARASITOL, V97, P1113, DOI 10.1645/GE-2848.1; David LA, 2014, NATURE, V505, P559, DOI 10.1038/nature12820; Devkota S, 2012, NATURE, V487, P104, DOI 10.1038/nature11225; Gaskins HR, 2006, MICROBIAL ECOLOGY IN, V9; Gilca R, 2010, INFECT CONT HOSP EP, V31, P939, DOI 10.1086/655463; Gkouskou KK, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00028; Guerrant RL, 2008, NUTR REV, V66, P487, DOI 10.1111/j.1753-4887.2008.00082.x; HATHEWAY CL, 1990, CLIN MICROBIOL REV, V3, P66, DOI 10.1128/CMR.3.1.66-98.1990; Hopkins MJ, 2003, APPL ENVIRON MICROB, V69, P1920, DOI 10.1128/AEM.69.4.1920-1927.2003; Houser BA, 2010, FOODBORNE PATHOG DIS, V7, P719, DOI 10.1089/fpd.2009.0483; Hurley BW, 2002, ARCH INTERN MED, V162, P2177, DOI 10.1001/archinte.162.19.2177; Hussein H S, 1998, J Nutr, V128, p2803S, DOI 10.1093/jn/128.12.2803S; Ikeda D, 1998, ZBL BAKT-INT J MED M, V287, P375; Karlstrom O, 1998, CLIN INFECT DIS, V26, P141, DOI 10.1086/516277; KELLY CP, 1994, NEW ENGL J MED, V330, P257, DOI 10.1056/NEJM199401273300406; Lamouse-Smith ES, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027662; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Ling ZX, 2014, SCI REP-UK, V4, DOI 10.1038/srep07485; Mariat D, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-123; O'Connor JR, 2009, GASTROENTEROLOGY, V136, P1913, DOI 10.1053/j.gastro.2009.02.073; Panda S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095476; Pepin J, 2005, CLIN INFECT DIS, V41, P1254, DOI 10.1086/496986; Pultz NJ, 2005, ANTIMICROB AGENTS CH, V49, P3529, DOI 10.1128/AAC.49.8.3529-3532.2005; Samore MH, 1996, AM J MED, V100, P32, DOI 10.1016/S0002-9343(96)90008-X; Solomon K, 2013, THER ADV INFECT DIS, V1, P19, DOI 10.1177/2049936112472173; TEODOSIO NR, 1990, ARCH LATINOAM NUTR, V40, P533; VOLLAARD EJ, 1994, ANTIMICROB AGENTS CH, V38, P409, DOI 10.1128/AAC.38.3.409; Warren CA, 2013, ANTIMICROB AGENTS CH, V57, P689, DOI 10.1128/AAC.00877-12; Warren CA, 2012, ANTIMICROB AGENTS CH, V56, P4103, DOI 10.1128/AAC.00360-12; WILSON KH, 1993, CLIN INFECT DIS, V16, pS214, DOI 10.1093/clinids/16.Supplement_4.S214; Wu GD, 2011, SCIENCE, V334, P105, DOI 10.1126/science.1208344; Young VB, 2004, J CLIN MICROBIOL, V42, P1203, DOI 10.1128/JCM.42.3.1203-1206.2004	42	19	22	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2015	10	7							e0131829	10.1371/journal.pone.0131829	http://dx.doi.org/10.1371/journal.pone.0131829			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RQ	26181795	gold, Green Published, Green Submitted			2022-12-26	WOS:000358198200012
J	Yashin, DV; Ivanova, OK; Soshnikova, NV; Sheludchenkov, AA; Romanova, EA; Dukhanina, EA; Tonevitsky, AG; Gnuchev, NV; Gabibov, AG; Georgiev, GP; Sashchenko, LP				Yashin, Denis V.; Ivanova, Olga K.; Soshnikova, Natalia V.; Sheludchenkov, Anton A.; Romanova, Elena A.; Dukhanina, Elena A.; Tonevitsky, Alexander G.; Gnuchev, Nikolai V.; Gabibov, Alexander G.; Georgiev, Georgii P.; Sashchenko, Lidia P.			Tag7 (PGLYRP1) in Complex with Hsp70 Induces Alternative Cytotoxic Processes in Tumor Cells via TNFR1 Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						apoptosis; cell death; heat shock protein (HSP); RNA interference (RNAi); tumor necrosis factor (TNF); TNFR1; Tag7; Tag7-Hsp70 complex; necroptosis; Hsp70; TNFR1; cytotoxicity	PEPTIDOGLYCAN RECOGNITION PROTEIN; PROGRAMMED NECROSIS; KINASE RIP; DEATH; LYMPHOCYTES; DROSOPHILA; APOPTOSIS; PHOSPHORYLATION; NECROPTOSIS; MOLECULE	Background: A complex containing an innate immunity protein Tag7, and Hsp70 kills various cancer cells. Results: Tag7 and its complex with Hsp70 bind to the TNFR1 receptor, but only the Tag7-Hsp70 complex induces a cytotoxic effect via apoptosis and necroptosis. Conclusion: A new ligand has been found for the TNFR1 death receptor. Significance: Tag7 may be used as an inhibitor of the TNF--induced cytotoxicity. Tag7 (also known as peptidoglycan recognition protein PGRP-S, PGLYRP1), an innate immunity protein, interacts with Hsp70 to form a stable Tag7-Hsp70 complex with cytotoxic activity against some tumor cell lines. In this study, we have analyzed the programmed cell death mechanisms that are induced when cells interact with the Tag7-Hsp70 complex, which was previously shown to be released by human lymphocytes and is cytotoxic to cancer cells. We show that this complex induces both apoptotic and necroptotic processes in the cells. Apoptosis follows the classic caspase-8 and caspase-3 activation pathway. Inhibition of apoptosis leads to a switch to the RIP1-dependent necroptosis. Both of these cytotoxic processes are initiated by the involvement of TNFR1, a receptor for TNF-. Our results suggest that the Tag7-Hsp70 complex is a novel ligand for this receptor. One of its components, the innate immunity protein Tag7, can bind to the TNFR1 receptor, thereby inhibiting the cytotoxic actions of the Tag7-Hsp70 complex and TNF-, an acquired immunity cytokine.	[Yashin, Denis V.; Ivanova, Olga K.; Soshnikova, Natalia V.; Sheludchenkov, Anton A.; Romanova, Elena A.; Dukhanina, Elena A.; Gnuchev, Nikolai V.; Gabibov, Alexander G.; Georgiev, Georgii P.; Sashchenko, Lidia P.] Russian Acad Sci, Inst Gene Biol, Moscow 119334, Russia; [Dukhanina, Elena A.] RAS, Engelhardt Inst Mol Biol, Moscow 119334, Russia; [Tonevitsky, Alexander G.] PA Hertsen Moscow Res Oncol Inst, Moscow 125284, Russia; [Gabibov, Alexander G.] RAS, Shemyakin Ovchinnikov Inst Bioorgan Chem, Moscow 117997, Russia	Russian Academy of Sciences; Institute of Gene Biology (IGB) of Russian Academy of Sciences; Russian Academy of Sciences; Engelhardt Institute of Molecular Biology, RAS; Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Bioorganic Chemistry of the Russian Academy of Sciences	Sashchenko, LP (corresponding author), Russian Acad Sci, Inst Gene Biol, Vavilova 34-5, Moscow 119334, Russia.	sashchenko@genebiology.ru	Tonevitsky, Alexander/R-5596-2019	Tonevitsky, Alexander/0000-0002-7079-7145; Sheludchenkov, Anton/0000-0001-8636-649X	Russian Foundation for Basic Research, RAS program for Molecular and Cellular Biology, International Centre for Genetic Engineering and Biotechnology (ICGEB)	Russian Foundation for Basic Research, RAS program for Molecular and Cellular Biology, International Centre for Genetic Engineering and Biotechnology (ICGEB)	This work was supported by the Russian Foundation for Basic Research, RAS program for Molecular and Cellular Biology, International Centre for Genetic Engineering and Biotechnology (ICGEB). The authors declare that they have no conflicts of interest with the contents of this article.	Cho Y, 2009, CELL, V137, P1112, DOI 10.1016/j.cell.2009.05.037; Christofferson DE, 2010, CURR OPIN CELL BIOL, V22, P263, DOI 10.1016/j.ceb.2009.12.003; Corcione A, 1997, BLOOD, V90, P4493; Degterev A, 2005, NAT CHEM BIOL, V1, P112, DOI 10.1038/nchembio711; Degterev A, 2003, ONCOGENE, V22, P8543, DOI 10.1038/sj.onc.1207107; Dukhanina E A, 2007, Dokl Biol Sci, V414, P246, DOI 10.1134/S0012496607030222; Dziarski R, 2004, MOL IMMUNOL, V40, P877, DOI 10.1016/j.molimm.2003.10.011; Galluzzi L, 2011, INT REV CEL MOL BIO, V289, P1, DOI 10.1016/B978-0-12-386039-2.00001-8; Guan RJ, 2005, J MOL BIOL, V347, P683, DOI 10.1016/j.jmb.2005.01.070; Guan YJ, 2011, J IMMUNOL, V187, P1289, DOI 10.4049/jimmunol.1003399; Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710; Hoffmann JA, 2003, NATURE, V426, P33, DOI 10.1038/nature02021; Holler N, 2000, NAT IMMUNOL, V1, P489, DOI 10.1038/82732; Kang DW, 1998, P NATL ACAD SCI USA, V95, P10078, DOI 10.1073/pnas.95.17.10078; Kiselev SL, 1998, J BIOL CHEM, V273, P18633, DOI 10.1074/jbc.273.29.18633; Kohler M, 2008, ELECTROPHORESIS, V29, P4495, DOI 10.1002/elps.200800221; Kruglov AA, 2013, SCIENCE, V342, P1243, DOI 10.1126/science.1243364; Kustikova OS, 1996, GENETIKA+, V32, P621; Larin SS, 2004, J GENE MED, V6, P798, DOI 10.1002/jgm.560; Lejeune Ferdy J, 2006, Cancer Immun, V6, P6; Lemaitre B, 1996, CELL, V86, P973, DOI 10.1016/S0092-8674(00)80172-5; Lettre G, 2006, NAT REV MOL CELL BIO, V7, P97, DOI 10.1038/nrm1836; Lin Y, 1999, GENE DEV, V13, P2514, DOI 10.1101/gad.13.19.2514; MARGOLIS B, 1989, CELL, V57, P1101, DOI 10.1016/0092-8674(89)90047-0; MARSTERS SA, 1992, J BIOL CHEM, V267, P5747; Michel T, 2001, NATURE, V414, P756, DOI 10.1038/414756a; Oberst A, 2011, NATURE, V471, P363, DOI 10.1038/nature09852; Sashchenko LP, 2007, BLOOD, V110, P1997, DOI 10.1182/blood-2006-12-064444; Sashchenko LP, 2004, J BIOL CHEM, V279, P2117, DOI 10.1074/jbc.M307513200; Vanden Berghe T, 2014, NAT REV MOL CELL BIO, V15, P134, DOI 10.1038/nrm3737; Vandenabeele P, 2010, NAT REV MOL CELL BIO, V11, P700, DOI 10.1038/nrm2970; Vandenabeele P, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3115re4; VANHAESEBROECK B, 1991, CANCER RES, V51, P2469; Vanlangenakker N, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.111; Vanlangenakker N, 2011, CELL DEATH DIFFER, V18, P656, DOI 10.1038/cdd.2010.138	35	34	36	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	2015	290	35					21724	21731		10.1074/jbc.M115.639732	http://dx.doi.org/10.1074/jbc.M115.639732			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CQ5IS	26183779	Green Published, hybrid			2022-12-26	WOS:000360637600043
J	Bowers, JR; Kitchel, B; Driebe, EM; MacCannell, DR; Roe, C; Lemmer, D; de Man, T; Rasheed, JK; Engelthaler, DM; Keim, P; Limbago, BM				Bowers, Jolene R.; Kitchel, Brandon; Driebe, Elizabeth M.; MacCannell, Duncan R.; Roe, Chandler; Lemmer, Darrin; de Man, Tom; Rasheed, J. Kamile; Engelthaler, David M.; Keim, Paul; Limbago, Brandi M.			Genomic Analysis of the Emergence and Rapid Global Dissemination of the Clonal Group 258 Klebsiella pneumoniae Pandemic	PLOS ONE			English	Article							COMPLETE NUCLEOTIDE-SEQUENCE; STRAIN CAUSING OUTBREAKS; BETA-LACTAMASE; CARBAPENEM RESISTANCE; MULTIDRUG-RESISTANCE; EFFLUX PUMP; MARR FAMILY; 1ST REPORT; EPIDEMIOLOGY; PORIN	Multidrug-resistant Klebsiella pneumoniae producing the KPC carbapenemase have rapidly spread throughout the world, causing severe healthcare-associated infections with limited antimicrobial treatment options. Dissemination of KPC-producing K. pneumoniae is largely attributed to expansion of a single dominant strain, ST258. In this study, we explore phylogenetic relationships and evolution within ST258 and its clonal group, CG258, using whole genome sequence analysis of 167 isolates from 20 countries collected over 17 years. Our results show a common ST258 ancestor emerged from its diverse parental clonal group around 1995 and likely acquired bla(KPC) prior to dissemination. Over the past two decades, ST258 has remained highly clonal despite diversity in accessory elements and divergence in the capsule polysaccharide synthesis locus. Apart from the large recombination event that gave rise to ST258, few mutations set it apart from its clonal group. However, one mutation occurs in a global transcription regulator. Characterization of outer membrane protein sequences revealed a profile in ST258 that includes a truncated OmpK35 and modified OmpK37. Our work illuminates potential genomic contributors to the pathogenic success of ST258, helps us better understand the global dissemination of this strain, and identifies genetic markers unique to ST258.	[Bowers, Jolene R.; Driebe, Elizabeth M.; Roe, Chandler; Lemmer, Darrin; Engelthaler, David M.; Keim, Paul] Translat Genom Res Inst, Flagstaff, AZ 86001 USA; [Kitchel, Brandon; MacCannell, Duncan R.; de Man, Tom; Rasheed, J. Kamile; Limbago, Brandi M.] Ctr Dis Control & Prevent, Div Healthcare Qual Promot, Atlanta, GA USA	Translational Genomics Research Institute; Centers for Disease Control & Prevention - USA	Bowers, JR (corresponding author), Translat Genom Res Inst, Flagstaff, AZ 86001 USA.	jbowers@tgen.org	de Man, Tom/M-5453-2019	de Man, Tom/0000-0003-0511-5053; Lemmer, Darrin/0000-0003-2785-6928	National Institutes of Health [R01AI090782]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI090782] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by award number R01AI090782 from the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler A, 2014, DIAGN MICR INFEC DIS, V78, P12, DOI 10.1016/j.diagmicrobio.2013.10.003; Adler A, 2012, J CLIN MICROBIOL, V50, P3180, DOI 10.1128/JCM.00987-12; America TSfHEo, 2011, LARG VET HLTH ADM ST; Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; Bialek-Davenet S, 2015, J ANTIMICROB CHEMOTH, V70, P81, DOI 10.1093/jac/dku340; Bialek-Davenet S, 2014, EMERG INFECT DIS, V20, P1812, DOI 10.3201/eid2011.140206; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Brink AJ, 2012, J CLIN MICROBIOL, V50, P525, DOI 10.1128/JCM.05956-11; Brisse S, 2013, J CLIN MICROBIOL, V51, P4073, DOI 10.1128/JCM.01924-13; Carattoli A, 2014, ANTIMICROB AGENTS CH, V58, P3895, DOI 10.1128/AAC.02412-14; Centers for Disease Control and Prevention, 2013, ANT RES THREATS US; Chen Liang, 2014, Antimicrob Agents Chemother, V58, P2871, DOI 10.1128/AAC.00120-14; Chen L, 2014, MBIO, V5, DOI 10.1128/mBio.01355-14; Chen Luke F, 2012, Infect Drug Resist, V5, P133, DOI 10.2147/IDR.S26613; Chmelnitsky I, 2013, J ANTIMICROB CHEMOTH, V68, P74, DOI 10.1093/jac/dks370; Croucher NJ, 2014, MBIO, V5, DOI 10.1128/mBio.01550-14; Croucher NJ, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0202; Cuzon G, 2011, ANTIMICROB AGENTS CH, V55, P5370, DOI 10.1128/AAC.05202-11; De Majumdar S, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004627; Deleo FR, 2014, P NATL ACAD SCI USA, V111, P4988, DOI 10.1073/pnas.1321364111; Domenech-Sanchez A, 2003, ANTIMICROB AGENTS CH, V47, P3332, DOI 10.1128/AAC.47.10.3332-3335.2003; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Endimiani A, 2009, J ANTIMICROB CHEMOTH, V63, P427, DOI 10.1093/jac/dkn547; Frank CG, 2013, CELL MICROBIOL, V15, P1212, DOI 10.1111/cmi.12110; Frasson I, 2012, J CLIN MICROBIOL, V50, P3768, DOI 10.1128/JCM.01892-12; Gaiarsa S, 2015, ANTIMICROB AGENTS CH, V59, P389, DOI 10.1128/AAC.04224-14; Garcia-Fernandez A, 2012, ANTIMICROB AGENTS CH, V56, P2143, DOI 10.1128/AAC.05308-11; Garcia-Sureda L, 2011, ANTIMICROB AGENTS CH, V55, P4742, DOI 10.1128/AAC.00309-11; Giani T, 2009, J CLIN MICROBIOL, V47, P3793, DOI 10.1128/JCM.01773-09; Gomez SA, 2011, CLIN MICROBIOL INFEC, V17, P1520, DOI 10.1111/j.1469-0691.2011.03600.x; Grkovic S, 2002, MICROBIOL MOL BIOL R, V66, P671, DOI 10.1128/MMBR.66.4.671-701.2002; Grundmann H, 2010, EUROSURVEILLANCE, V15, P22; Hammerum AM, 2010, INT J ANTIMICROB AG, V35, P610, DOI 10.1016/j.ijantimicag.2010.01.024; Hansen LH, 2004, ANTIMICROB AGENTS CH, V48, P3332, DOI 10.1128/AAC.48.9.3332-3337.2004; Hao ZY, 2014, NAT CHEM BIOL, V10, P21, DOI [10.1038/NCHEMBIO.1380, 10.1038/nchembio.1380]; Holt K, 2013, SRST2 SHORT READ SEQ; Huntington P, 2011, AUSTR SOC MICR 2011; Jacob JT, 2013, MMWR-MORBID MORTAL W, P62; Jiang Y, 2010, ANTIMICROB AGENTS CH, V54, P3967, DOI 10.1128/AAC.00137-10; Kaczmarek FM, 2006, ANTIMICROB AGENTS CH, V50, P3396, DOI 10.1128/AAC.00285-06; Kitchel B, 2010, ANTIMICROB AGENTS CH, V54, P4201, DOI 10.1128/AAC.00008-10; Lascols C, 2013, ANTIMICROB AGENTS CH, V57, P130, DOI 10.1128/AAC.01686-12; Leavitt A, 2010, ANTIMICROB AGENTS CH, V54, P4493, DOI 10.1128/AAC.00175-10; Lery LMS, 2014, BMC BIOL, V12, DOI 10.1186/1741-7007-12-41; Letunic I, 2011, NUCLEIC ACIDS RES, V39, pW475, DOI [10.1093/nar/gkr931, 10.1093/nar/gkr201]; Li XZ, 2015, CLIN MICROBIOL REV, V28, P337, DOI 10.1128/CMR.00117-14; Lin J, 2002, MICROBES INFECT, V4, P325, DOI 10.1016/S1286-4579(02)01545-9; March C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056847; Mataseje LF, 2011, J ANTIMICROB CHEMOTH, V66, P1273, DOI 10.1093/jac/dkr092; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Munoz-Price LS, 2013, LANCET INFECT DIS, V13, P785, DOI 10.1016/S1473-3099(13)70190-7; Naas T, 2012, ANTIMICROB AGENTS CH, V56, P4753, DOI 10.1128/AAC.00334-12; Navon-Venezia S, 2009, ANTIMICROB AGENTS CH, V53, P818, DOI 10.1128/AAC.00987-08; Osterblad M, 2009, EURO SURVEILLANCE B, V14; Pan YJ, 2015, ANTIMICROB AGENTS CH, V59, P1038, DOI 10.1128/AAC.03560-14; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Patel G, 2008, INFECT CONT HOSP EP, V29, P1099, DOI 10.1086/592412; Pena I, 2014, INT J ANTIMICROB AG, V43, P460, DOI 10.1016/j.ijantimicag.2014.01.021; Perera IC, 2010, J MOL CELL BIOL, V2, P243, DOI 10.1093/jmcb/mjq021; Perez F, 2013, ANTIMICROB AGENTS CH, V57, P4602, DOI 10.1128/AAC.00725-13; Segura M, 2012, CAN J MICROBIOL, V58, P249, DOI [10.1139/w2012-003, 10.1139/W2012-003]; Smith SGJ, 2007, FEMS MICROBIOL LETT, V273, P1, DOI 10.1111/j.1574-6968.2007.00778.x; Snitkin ES, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004129; Almeida ACS, 2012, INT J ANTIMICROB AG, V40, P374, DOI 10.1016/j.ijantimicag.2012.05.022; Souli M, 2010, CLIN INFECT DIS, V50, P364, DOI 10.1086/649865; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tsai YK, 2011, ANTIMICROB AGENTS CH, V55, P1485, DOI 10.1128/AAC.01275-10; Veleba M, 2012, ANTIMICROB AGENTS CH, V56, P4450, DOI 10.1128/AAC.00456-12; Voulgari E, 2014, J ANTIMICROB CHEMOTH, V69, P2091, DOI 10.1093/jac/dku105; Wang XJ, 2015, INT J ANTIMICROB AG, V45, P635, DOI 10.1016/j.ijantimicag.2014.12.022; Wilkinson SP, 2006, CURR ISSUES MOL BIOL, V8, P51; Woodford N, 2004, ANTIMICROB AGENTS CH, V48, P4793, DOI 10.1128/AAC.48.12.4793-4799.2004; Woodford N, 2011, FEMS MICROBIOL REV, V35, P736, DOI 10.1111/j.1574-6976.2011.00268.x; Wyres KL, 2015, GENOME BIOL EVOL, V7, P1267, DOI 10.1093/gbe/evv062; Yigit H, 2001, ANTIMICROB AGENTS CH, V45, P1151, DOI 10.1128/AAC.45.4.1151-1161.2001; Zankari E, 2012, J ANTIMICROB CHEMOTH, V67, P2640, DOI 10.1093/jac/dks261; Zhong X, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115185	77	123	131	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0133727	10.1371/journal.pone.0133727	http://dx.doi.org/10.1371/journal.pone.0133727			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LZ	26196384	Green Published, Green Submitted, gold			2022-12-26	WOS:000358547600137
J	Dale, TP; de Castro, A; Kuiper, NJ; Parkinson, EK; Forsyth, NR				Dale, Tina P.; de Castro, Alice; Kuiper, Nicola J.; Parkinson, E. Kenneth; Forsyth, Nicholas R.			Immortalisation with hTERT Impacts on Sulphated Glycosaminoglycan Secretion and Immunophenotype in a Variable and Cell Specific Manner	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; HUMAN ARTICULAR CHONDROCYTES; MARROW STROMAL CELLS; DNA-DAMAGE-RESPONSE; TELOMERASE REVERSE-TRANSCRIPTASE; LIFE-SPAN; IN-VITRO; BETA-GALACTOSIDASE; GROWTH-FACTOR; OSTEOARTHRITIC CHONDROCYTES	Background Limited options for the treatment of cartilage damage have driven the development of tissue engineered or cell therapy alternatives reliant on ex vivo cell expansion. The study of chondrogenesis in primary cells is difficult due to progressive cellular aging and senescence. Immortalisation via the reintroduction of the catalytic component of telomerase, hTERT, could allow repeated, longitudinal studies to be performed while bypassing senescent phenotypes. Methods Three human cell types: bone marrow-derived stromal cells (BMA13), embryonic stem cell-derived (1C6) and chondrocytes (OK3) were transduced with hTERT (BMA13H, 1C6H and OK3H) and proliferation, surface marker expression and tri-lineage differentiation capacity determined. The sulphated glycosaminoglycan (sGAG) content of the monolayer and spent media was quantified in maintenance media (MM) and pro-chondrogenic media (PChM) and normalised to DNA. Results hTERT expression was confirmed in transduced cells with proliferation enhancement in 1C6H and OK3H cells but not BMA13H. All cells were negative for leukocyte markers (CD19, CD34, CD45) and CD73 positive. CD14 was expressed at low levels on OK3 and OK3H and HLA-DR on BMA13 (84.8%). CD90 was high for BMA13 (84.9%) and OK3 (97.3%) and moderate for 1C6 (56.7%), expression was reduced in BMA13H (33.7%) and 1C6H (1.6%). CD105 levels varied (BMA13 87.7%, 1C6 8.2%, OK3 43.3%) and underwent reduction in OK3H (25.1%). 1C6 and BMA13 demonstrated osteogenic and adipogenic differentiation but mineralised matrix and lipid accumulation appeared reduced post hTERT transduction. Chondrogenic differentiation resulted in increased monolayer-associated sGAG in all primary cells and 1C6H (p<0.001), and BMA13H (p<0.05). In contrast OK3H demonstrated reduced monolayer-associated sGAG in PChM (p<0.001). Media-associated sGAG accounted for >= 55% (PChM-1C6) and >= 74% (MM-1C6H). Conclusion In conclusion, hTERT transduction could, but did not always, prevent senescence and cell phenotype, including differentiation potential, was affected in a variable manner. As such, these cells are not a direct substitute for primary cells in cartilage regeneration research.	[Dale, Tina P.; Kuiper, Nicola J.; Forsyth, Nicholas R.] Keele Univ, Inst Sci & Technol Med, Stoke On Trent, Staffs, England; [de Castro, Alice; Parkinson, E. Kenneth] Queen Mary Univ London, Barts & London Sch Med & Dent, Res Ctr Clin & Diagnost Oral Sci, London, England	Keele University; University of London; Queen Mary University London	Forsyth, NR (corresponding author), Keele Univ, Inst Sci & Technol Med, Stoke On Trent, Staffs, England.	n.r.forsyth@keele.ac.uk	Dale, Tina/AAA-3560-2022; Dale, Tina Patricia/ABA-7020-2021	Dale, Tina/0000-0001-9461-8220; 	UK Engineering and Physical Sciences Research Council, Regenerative Medicine Doctoral Training Centre (Keele University) [EP/F500491/1]; UK Engineering and Physical Sciences Research Council, Regenerative Medicine Doctoral Training Centre (Loughborough University) [EP/F500491/1]; UK Engineering and Physical Sciences Research Council, Regenerative Medicine Doctoral Training Centre (University of Nottingham) [EP/F500491/1]; EPSRC [EP/H028277/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [1119373, EP/H028277/1] Funding Source: researchfish	UK Engineering and Physical Sciences Research Council, Regenerative Medicine Doctoral Training Centre (Keele University); UK Engineering and Physical Sciences Research Council, Regenerative Medicine Doctoral Training Centre (Loughborough University); UK Engineering and Physical Sciences Research Council, Regenerative Medicine Doctoral Training Centre (University of Nottingham); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	Funding was received from the UK Engineering and Physical Sciences Research Council as part of the Regenerative Medicine Doctoral Training Centre (Keele University, Loughborough University, The University of Nottingham (EP/F500491/1), http://www.dtcregenmed.com/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott RD, 2012, J ORTHOP RES, V30, P482, DOI 10.1002/jor.21534; Babur BK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058865; Banfi A, 2002, TISSUE ENG, V8, P901, DOI 10.1089/107632702320934001; Benz K, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-27; Bernstein P, 2010, OSTEOARTHR CARTILAGE, V18, P1596, DOI 10.1016/j.joca.2010.09.007; Bocelli-Tyndall C, 2010, ARTHRITIS RHEUM-US, V62, P3815, DOI 10.1002/art.27736; Bodnar AG, 1998, SCIENCE, V279, P349, DOI 10.1126/science.279.5349.349; Bocker W, 2008, J CELL MOL MED, V12, P1347, DOI [10.1111/j.1582-4934.2008.00299.x, 10.1111/j.1582-4934.2008.0299.x]; BRITTBERG M, 1994, NEW ENGL J MED, V331, P889, DOI 10.1056/NEJM199410063311401; Caron MMJ, 2012, OSTEOARTHR CARTILAGE, V20, P1170, DOI 10.1016/j.joca.2012.06.016; Chapman EJ, 2006, ONCOGENE, V25, P5037, DOI 10.1038/sj.onc.1209513; Counter CM, 1998, ONCOGENE, V16, P1217, DOI 10.1038/sj.onc.1201882; DESSAU W, 1981, J CELL BIOL, V90, P78, DOI 10.1083/jcb.90.1.78; Diaz-Romero J, 2005, J CELL PHYSIOL, V202, P731, DOI 10.1002/jcp.20164; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Ducrest AL, 2002, ONCOGENE, V21, P541, DOI 10.1038/sj.onc.1205081; FARNDALE RW, 1986, BIOCHIM BIOPHYS ACTA, V883, P173, DOI 10.1016/0304-4165(86)90306-5; Forsyth NR, 2008, REJUV RES, V11, P5, DOI 10.1089/rej.2007.0567; Forsyth NR, 2002, DIFFERENTIATION, V69, P188, DOI 10.1046/j.1432-0436.2002.690412.x; FRIEDENSTEIN AJ, 1974, TRANSPLANTATION, V17, P331, DOI 10.1097/00007890-197404000-00001; Fumagalli M, 2012, NAT CELL BIOL, V14, P355, DOI 10.1038/ncb2466; Goldring MB, 2012, THER ADV MUSCULOSKEL, V4, P269, DOI 10.1177/1759720X12448454; Goldring MB, 2004, METH MOLEC MED, V100, P23; Goldring MB, 2004, METH MOLEC MED, V100, P37; Graakjaer J, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-49; Hewitt G, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1708; Hunziker EB, 2002, OSTEOARTHR CARTILAGE, V10, P564, DOI 10.1053/joca.2002.0814; Hunziker EB, 2001, CLIN ORTHOP RELAT R, pS171; Kay A., 2010, THESIS; Kay Alasdair, 2011, Front Biosci (Elite Ed), V3, P1365; Kokenyesi R, 2000, ARCH BIOCHEM BIOPHYS, V383, P79, DOI 10.1006/abbi.2000.2044; Kolquist KA, 1998, NAT GENET, V19, P182, DOI 10.1038/554; Kuh SU, 2009, JOINT BONE SPINE, V76, P70, DOI 10.1016/j.jbspin.2008.02.021; Kuilman T, 2010, GENE DEV, V24, P2463, DOI 10.1101/gad.1971610; Lee AC, 1999, J BIOL CHEM, V274, P7936, DOI 10.1074/jbc.274.12.7936; Lee BY, 2006, AGING CELL, V5, P187, DOI 10.1111/j.1474-9726.2006.00199.x; Lee J, 2008, ONCOGENE, V27, P3754, DOI 10.1038/sj.onc.1211037; Loeser RF, 2000, ARTHRITIS RHEUM, V43, P2110, DOI 10.1002/1529-0131(200009)43:9<2110::AID-ANR23>3.0.CO;2-U; Maroudas A, 1998, ARCH BIOCHEM BIOPHYS, V350, P61, DOI 10.1006/abbi.1997.0492; Martin JA, 2003, J BONE JOINT SURG AM, V85A, P106, DOI 10.2106/00004623-200300002-00014; Martin JA, 2004, J GERONTOL A-BIOL, V59, P324; Martin JA, 2002, J GERONTOL A-BIOL, V57, pB48, DOI 10.1093/gerona/57.2.B48; Martin JA, 2001, J GERONTOL A-BIOL, V56, pB172, DOI 10.1093/gerona/56.4.B172; Mastrogiacomo M, 2001, OSTEOARTHR CARTILAGE, V9, pS36, DOI 10.1053/joca.2001.0442; Mihara K, 2003, BRIT J HAEMATOL, V120, P846, DOI 10.1046/j.1365-2141.2003.04217.x; Musina RA, 2007, B EXP BIOL MED+, V143, P127, DOI 10.1007/s10517-007-0032-z; Okamoto T, 2002, BIOCHEM BIOPH RES CO, V295, P354, DOI 10.1016/S0006-291X(02)00661-7; Parsch D, 2004, J MOL MED-JMM, V82, P49, DOI 10.1007/s00109-003-0506-z; Parsch D, 2002, ARTHRITIS RHEUM, V46, P2911, DOI 10.1002/art.10626; Peterson L, 2000, CLIN ORTHOP RELAT R, P212, DOI 10.1097/00003086-200005000-00020; Peterson L, 2010, AM J SPORT MED, V38, P1117, DOI 10.1177/0363546509357915; Piera-Velazquez S, 2002, ARTHRITIS RHEUM, V46, P683, DOI 10.1002/art.10116; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Serakinci N, 2008, BIOCHIMIE, V90, P33, DOI 10.1016/j.biochi.2007.09.005; Severino J, 2000, EXP CELL RES, V257, P162, DOI 10.1006/excr.2000.4875; Shahin K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023119; Shay JW, 2005, ANN NY ACAD SCI, V1057, P479, DOI 10.1196/annals.1356.037; Siddappa R, 2007, J ORTHOP RES, V25, P1029, DOI 10.1002/jor.20402; Simonsen JL, 2002, NAT BIOTECHNOL, V20, P592, DOI 10.1038/nbt0602-592; Sotiropoulou PA, 2006, STEM CELLS, V24, P462, DOI 10.1634/stemcells.2004-0331; Stewart MC, 2011, VET CLIN N AM-EQUINE, V27, P243, DOI 10.1016/j.cveq.2011.06.004; Stolzing A, 2008, MECH AGEING DEV, V129, P163, DOI 10.1016/j.mad.2007.12.002; Suram A, 2012, EMBO J, V31, P2839, DOI 10.1038/emboj.2012.132; Tang H, 2013, BIOCHEM BIOPH RES CO, V440, P502, DOI 10.1016/j.bbrc.2013.09.053; Tarte K, 2010, BLOOD, V115, P1549, DOI 10.1182/blood-2009-05-219907; Teng Y, 2014, BRAZ ARCH BIOL TECHN, V57, P37, DOI 10.1590/S1516-89132014000100006; Tew SR, 2008, METHODS, V45, P2, DOI 10.1016/j.ymeth.2008.01.006; Tew SR, 2005, OSTEOARTHR CARTILAGE, V13, P80, DOI 10.1016/j.joca.2004.10.011; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Untergasser G, 2003, EXP GERONTOL, V38, P1179, DOI 10.1016/j.exger.2003.08.008; Vaziri H, 1998, CURR BIOL, V8, P279, DOI 10.1016/S0960-9822(98)70109-5; von Zglinicki T, 2005, MECH AGEING DEV, V126, P111, DOI 10.1016/j.mad.2004.09.034; Wagner W, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002213; Wieland HA, 2005, NAT REV DRUG DISCOV, V4, P331, DOI 10.1038/nrd1693; Wimpenny I, 2010, TISSUE ENG PART C-ME, V16, P503, DOI [10.1089/ten.tec.2009.0128, 10.1089/ten.TEC.2009.0128]; Wolbank S, 2009, TISSUE ENG PT A, V15, P1843, DOI 10.1089/ten.tea.2008.0205; Zhu CH, 2007, AGING CELL, V6, P515, DOI 10.1111/j.1474-9726.2007.00306.x; Zimmermann S, 2003, LEUKEMIA, V17, P1146, DOI 10.1038/sj.leu.2402962	80	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0133745	10.1371/journal.pone.0133745	http://dx.doi.org/10.1371/journal.pone.0133745			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LZ	26196672	gold, Green Published, Green Submitted, Green Accepted			2022-12-26	WOS:000358547600139
J	Khan, SN; Shaeib, F; Najafi, T; Kavdia, M; Gonik, B; Saed, GM; Goud, PT; Abu-Soud, HM				Khan, Sana N.; Shaeib, Faten; Najafi, Tohid; Kavdia, Mahendra; Gonik, Bernard; Saed, Ghassan M.; Goud, Pravin T.; Abu-Soud, Husam M.			Diffused Intra-Oocyte Hydrogen Peroxide Activates Myeloperoxidase and Deteriorates Oocyte Quality	PLOS ONE			English	Article							FREE IRON RELEASE; II MOUSE OOCYTES; HYPOCHLOROUS ACID; OXIDATIVE STRESS; IN-VITRO; MAMMALIAN PEROXIDASES; SPINDLE STRUCTURE; FOLLICULAR-FLUID; HEME DESTRUCTION; PLASMA-MEMBRANE	Hydrogen peroxide (H2O2) is a relatively long-lived signaling molecule that plays an essential role in oocyte maturation, implantation, as well as early embryonic development. Exposure to relatively high levels of H2O2 functions efficiently to accelerate oocyte aging and deteriorate oocyte quality. However, little precise information exists regarding intra-oocyte H2O2 concentrations, and its diffusion to the oocyte milieu. In this work, we utilized an L-shaped amperometric integrated H2O2-selective probe to directly and quantitatively measure the real-time intra-oocyte H2O2 concentration. This investigation provides an exact measurement of H2O2 in situ by reducing the possible loss of H2O2 caused by diffusion or reactivity with other biological systems. This experiment suggests that the intra-oocyte H2O2 levels of oocytes obtained from young animals are reasonably high and remained constant during the procedure measurements. However, the intra-oocyte H2O2 concentration dropped significantly (40-50% reduction) in response to catalase pre-incubation, suggesting that the measurements are truly H2O2 based. To further confirm the extracellular diffusion of H2O2, oocytes were incubated with myeloperoxidase (MPO), and the diffused H2O2 triggered MPO chlorinating activity. Our results show that the generated hypochlorous acid (HOCl) facilitated the deterioration in oocyte quality, a process that could be prevented by pre-incubating the oocytes with melatonin, which was experimentally proven to be oxidized utilizing HPLC methods. This study is the first to demonstrate direct quantitative measurement of intracellular H2O2, and its extracellular diffusion and activation of MPO as well as its impact on oocyte quality. These results may help in designing more accurate treatment plans in assisted reproduction under inflammatory conditions.	[Khan, Sana N.; Shaeib, Faten; Najafi, Tohid; Gonik, Bernard; Saed, Ghassan M.; Abu-Soud, Husam M.] Wayne State Univ, Sch Med, CS Mott Ctr Human Growth & Dev, Dept Obstet & Gynecol, Detroit, MI 48202 USA; [Najafi, Tohid; Abu-Soud, Husam M.] Wayne State Univ, Sch Med, Dept Biochem & Mol Biol, Detroit, MI USA; [Kavdia, Mahendra] Wayne State Univ, Dept Biomed Engn, Detroit, MI USA; [Goud, Pravin T.] Univ Calif Davis, Dept Obstet & Gynecol, Div Reprod Endocrinol & Infertil, Sacramento, CA 95817 USA; [Goud, Pravin T.] Calif IVF Fertil Ctr, Davis, CA USA; [Goud, Pravin T.] Calif IVF Fertil Ctr, Sacramento, CA USA	Wayne State University; Wayne State University; Wayne State University; University of California System; University of California Davis	Abu-Soud, HM (corresponding author), Wayne State Univ, Sch Med, CS Mott Ctr Human Growth & Dev, Dept Obstet & Gynecol, Detroit, MI 48202 USA.	habusoud@med.wayne.edu			National Institute of Health [RO1 HL066367]; Children's Hospital of Michigan; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL066367] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Children's Hospital of Michigan; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the National Institute of Health RO1 HL066367, a grant from Children's Hospital of Michigan (H.M.A-S).	Abu-Soud HM, 2014, J INORG BIOCHEM, V140, P245, DOI 10.1016/j.jinorgbio.2014.06.018; Agarwal A, 2012, REPROD BIOL ENDOCRIN, V10, DOI 10.1186/1477-7827-10-49; ANDREWS PC, 1982, J BIOL CHEM, V257, P13240; Antunes F, 2001, FREE RADICAL BIO MED, V30, P1008, DOI 10.1016/S0891-5849(01)00493-2; Antunes F, 1996, FREE RADICAL BIO MED, V21, P917, DOI 10.1016/S0891-5849(96)00185-2; Antunes F, 2000, FEBS LETT, V475, P121, DOI 10.1016/S0014-5793(00)01638-0; Banerjee J, 2013, FERTIL STERIL, V100, P578, DOI 10.1016/j.fertnstert.2013.04.030; Banerjee J, 2012, J PINEAL RES, V53, P122, DOI 10.1111/j.1600-079X.2012.00977.x; Bienert GP, 2006, BBA-BIOMEMBRANES, V1758, P994, DOI 10.1016/j.bbamem.2006.02.015; Binder V, 2013, ARTERIOSCL THROM VAS, V33, P1020, DOI 10.1161/ATVBAHA.113.301235; Blair SA, 2013, J REPROD MED, V58, P107; Boveris A, 2002, METHOD ENZYMOL, V349, P280, DOI 10.1016/S0076-6879(02)49342-1; CHANCE B, 1979, PHYSIOL REV, V59, P527, DOI 10.1152/physrev.1979.59.3.527; Cheng WM, 2009, REPRODUCTION, V137, P633, DOI 10.1530/REP-08-0143; Choi WJ, 2007, FERTIL STERIL, V88, P1220, DOI 10.1016/j.fertnstert.2007.02.067; Cieutat AM, 1998, BLOOD, V91, P1044, DOI 10.1182/blood.V91.3.1044.1044_1044_1058; Conde A, 2010, INT J BIOCHEM CELL B, V42, P857, DOI 10.1016/j.biocel.2009.12.012; da Silva CM, 2014, BIOMEDICINE PHARMACO; Dalla Sega FV, 2014, BBA-MOL CELL RES, V1843, P806, DOI 10.1016/j.bbamcr.2014.01.011; Davies MJ, 2008, ANTIOXID REDOX SIGN, V10, P1199, DOI 10.1089/ars.2007.1927; de Matos DG, 2002, THERIOGENOLOGY, V57, P1443, DOI 10.1016/S0093-691X(02)00643-X; Fletcher NM, 2011, CANCER BIOMARK, V10, P267, DOI 10.3233/CBM-2012-0255; Galijasevic S, 2008, BIOCHEMISTRY-US, V47, P2668, DOI 10.1021/bi702016q; Goud AP, 2008, FREE RADICAL BIO MED, V44, P1295, DOI 10.1016/j.freeradbiomed.2007.11.014; Goud AP, 2005, REPROD BIOMED ONLINE, V11, P43, DOI 10.1016/S1472-6483(10)61297-7; Goud P, 1997, FERTIL STERIL, V67, P979, DOI 10.1016/S0015-0282(97)90147-3; Goud PT, 2008, FREE RADICAL BIO MED, V45, P453, DOI 10.1016/j.freeradbiomed.2008.04.035; Goud PT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098720; GUTTERIDGE JMC, 1992, FREE RADICAL BIO MED, V12, P93, DOI 10.1016/0891-5849(92)90062-L; Hampton MB, 1998, BLOOD, V92, P3007, DOI 10.1182/blood.V92.9.3007.421k47_3007_3017; Hennet ML, 2013, J ASSIST REPROD GEN, V30, P333, DOI 10.1007/s10815-012-9925-5; Henzler T, 2000, J EXP BOT, V51, P2053, DOI 10.1093/jexbot/51.353.2053; Jimenez-Jimenez F J, 1998, Rev Neurol, V26 Suppl 1, pS112; Klebanoff SJ, 2005, J LEUKOCYTE BIOL, V77, P598, DOI 10.1189/jlb.1204697; Kulagina NV, 2003, ANAL CHEM, V75, P4875, DOI 10.1021/ac034573g; Li LY, 2014, TRENDS BIOCHEM SCI, V39, P130, DOI 10.1016/j.tibs.2014.01.002; Maitra D, 2013, FREE RADICAL BIO MED, V63, P90, DOI 10.1016/j.freeradbiomed.2013.04.009; Maitra D, 2012, J PINEAL RES, V53, P198, DOI 10.1111/j.1600-079X.2012.00988.x; Maitra D, 2011, FREE RADICAL BIO MED, V51, P374, DOI 10.1016/j.freeradbiomed.2011.04.011; Makino N, 2004, BBA-GEN SUBJECTS, V1673, P149, DOI 10.1016/j.bbagen.2004.04.011; Malle E, 2007, BRIT J PHARMACOL, V152, P838, DOI 10.1038/sj.bjp.0707358; MILLS JL, 1988, NEW ENGL J MED, V318, P671, DOI 10.1056/NEJM198803173181104; Mueller S, 2000, FREE RADICAL BIO MED, V29, P410, DOI 10.1016/S0891-5849(00)00261-6; Navarro-Alarcon M, 2014, FOOD FUNCT, V5, P2806, DOI [10.1039/C4FO00317A, 10.1039/c4fo00317a]; Nicholls SJ, 2009, J LIPID RES, V50, pS346, DOI 10.1194/jlr.R800086-JLR200; OSHINO N, 1973, ARCH BIOCHEM BIOPHYS, V154, P117, DOI 10.1016/0003-9861(73)90040-4; PICK E, 1981, CELL IMMUNOL, V59, P301, DOI 10.1016/0008-8749(81)90411-1; Pogorelov AG, 2008, J MICROSC-OXFORD, V232, P36, DOI 10.1111/j.1365-2818.2008.02077.x; Presnell CE, 2013, CURR NEUROVASC RES, V10, P185; Proteasa G, 2007, BIOCHEMISTRY-US, V46, P398, DOI 10.1021/bi0609725; RAKITA RM, 1990, BIOCHEMISTRY-US, V29, P1075, DOI 10.1021/bi00456a033; Rambow J, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00199; Reiter RJ, 2014, PHYSIOLOGY, V29, P325, DOI 10.1152/physiol.00011.2014; Riley CF, 2007, ACTA OBSTET GYN SCAN, V86, P877, DOI 10.1080/00016340701417398; Saito H, 2002, GYNECOL OBSTET INVES, V53, P46, DOI 10.1159/000049424; Schallreuter KU, 1999, J INVEST DERM SYMP P, V4, P91, DOI 10.1038/sj.jidsp.5640189; Shaeib F, 2013, FREE RADICAL BIO MED, V58, P154, DOI 10.1016/j.freeradbiomed.2012.12.007; Singh AK, 2013, REPROD TOXICOL, V42, P116, DOI 10.1016/j.reprotox.2013.08.005; Sliskovic I, 2009, FREE RADICAL BIO MED, V47, P1005, DOI 10.1016/j.freeradbiomed.2009.07.007; Souza CEA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027641; Stone JR, 2006, ANTIOXID REDOX SIGN, V8, P243, DOI 10.1089/ars.2006.8.243; Tahboub YR, 2005, J BIOL CHEM, V280, P26129, DOI 10.1074/jbc.M503027200; Tripathi A, 2009, FREE RADICAL RES, V43, P287, DOI 10.1080/10715760802695985; Tsukaguchi H, 1998, J BIOL CHEM, V273, P24737, DOI 10.1074/jbc.273.38.24737; Ximenes VF, 2005, J BIOL CHEM, V280, P38160, DOI 10.1074/jbc.M506384200	65	15	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0132388	10.1371/journal.pone.0132388	http://dx.doi.org/10.1371/journal.pone.0132388			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LZ	26197395	Green Published, gold, Green Submitted			2022-12-26	WOS:000358547600033
J	Mouratis, MA; Magkrioti, C; Oikonomou, N; Katsifa, A; Prestwich, GD; Kaffe, E; Aidinis, V				Mouratis, Marios-Angelos; Magkrioti, Christiana; Oikonomou, Nikos; Katsifa, Aggeliki; Prestwich, Glenn D.; Kaffe, Eleanna; Aidinis, Vassilis			Autotaxin and Endotoxin-Induced Acute Lung Injury	PLOS ONE			English	Article							LYSOPHOSPHATIDIC ACID PRODUCTION; RESPIRATORY-DISTRESS-SYNDROME; LYSOPHOSPHOLIPASE-D ACTIVITY; PULMONARY-FIBROSIS; SURFACTANT DYSFUNCTION; LPA AXIS; EXPRESSION; INFLAMMATION; MICE; PATHOGENESIS	Acute Lung Injury (ALI) is a life-threatening, diffuse heterogeneous lung injury characterized by acute onset, pulmonary edema and respiratory failure. Lipopolysaccharide (LPS) is a common cause of both direct and indirect lung injury and when administered to a mouse induces a lung phenotype exhibiting some of the clinical characteristics of human ALI. Here, we report that LPS inhalation in mice results in increased bronchoalveolar lavage fluid (BALF) levels of Autotaxin (ATX, Enpp2), a lysophospholipase D largely responsible for the conversion of lysophosphatidylcholine (LPC) to lysophosphatidic acid (LPA) in biological fluids and chronically inflamed sites. In agreement, gradual increases were also detected in BALF LPA levels, following inflammation and pulmonary edema. However, genetic or pharmacologic targeting of ATX had minor effects in ALI severity, suggesting no major involvement of the ATX/LPA axis in acute inflammation. Moreover, systemic, chronic exposure to increased ATX/LPA levels was shown to predispose to and/or to promote acute inflammation and ALI unlike chronic inflammatory pathophysiological situations, further suggesting a differential involvement of the ATX/LPA axis in acute versus chronic pulmonary inflammation.	[Mouratis, Marios-Angelos; Magkrioti, Christiana; Oikonomou, Nikos; Katsifa, Aggeliki; Kaffe, Eleanna; Aidinis, Vassilis] Biomed Sci Res Ctr Alexander Fleming, Div Immunol, Athens, Greece; [Prestwich, Glenn D.] Univ Utah, Dept Med Chem, Salt Lake City, UT 84112 USA	Alexander Fleming Biomedical Sciences Research Center; Utah System of Higher Education; University of Utah	Aidinis, V (corresponding author), Biomed Sci Res Ctr Alexander Fleming, Div Immunol, Athens, Greece.	v.aidinis@fleming.gr	Aidinis, Vassilis/AAF-5380-2021	Aidinis, Vassilis/0000-0001-9531-7729	Hellenic Ministry for education and religion/General Secretariat of research and technology Aristia II of the National Strategic Reference Framework (NSRF) [INFLALIPID-3311, ATX-09SYN-11-679]; European Commission	Hellenic Ministry for education and religion/General Secretariat of research and technology Aristia II of the National Strategic Reference Framework (NSRF); European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was supported by the Hellenic Ministry for education and religion/General Secretariat of research and technology Aristia II (INFLALIPID-3311) and Synergasia 2009 (ATX-09SYN-11-679) grants, through the Operational Programs "Education and Lifelong Learning" and "Competitiveness and Entrepreneurship" (respectively) of the National Strategic Reference Framework (NSRF), co-funded by the European Commission (European Social Fund and European Regional Development Fund respectively) and National resources. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoki J, 2004, SEMIN CELL DEV BIOL, V15, P477, DOI 10.1016/j.semcdb.2004.05.001; Barbayianni E, 2015, PROG LIPID RES, V58, P76, DOI 10.1016/j.plipres.2015.02.001; Chen Hong, 2010, Expert Rev Respir Med, V4, P773, DOI 10.1586/ers.10.71; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; Emo J, 2012, J IMMUNOL, V188, P3784, DOI 10.4049/jimmunol.1102956; Fotopoulou S, 2010, DEV BIOL, V339, P451, DOI 10.1016/j.ydbio.2010.01.007; Ganguly K, 2007, PHYSIOL GENOMICS, V31, P410, DOI 10.1152/physiolgenomics.00260.2006; Huang LS, 2013, AM J RESP CELL MOL, V49, P912, DOI 10.1165/rcmb.2013-0070OC; Ingenito EP, 2001, AM J RESP CELL MOL, V25, P35, DOI 10.1165/ajrcmb.25.1.4021; Jiang GW, 2011, BIOORG MED CHEM LETT, V21, P5098, DOI 10.1016/j.bmcl.2011.03.068; Kennedy M, 1997, EXP LUNG RES, V23, P171, DOI 10.3109/01902149709087366; Knowlden S, 2014, J IMMUNOL, V192, P851, DOI 10.4049/jimmunol.1302831; Kotanidou A, 2006, VASC PHARMACOL, V45, P134, DOI 10.1016/j.vph.2006.06.016; Luquain C, 2003, TRENDS BIOCHEM SCI, V28, P377, DOI 10.1016/S0968-0004(03)00139-7; Magkrioti C., 2013, WORLD J RESPIROL, V3, P77, DOI [DOI 10.5320/WJR.V3.I3.77, 10.5320/wjr.v3.i3.77]; Matthay MA, 2012, J CLIN INVEST, V122, P2731, DOI 10.1172/JCI60331; Matute-Bello G, 2008, AM J PHYSIOL-LUNG C, V295, pL379, DOI 10.1152/ajplung.00010.2008; Matute-Bello G, 2011, AM J RESP CELL MOL, V44, P725, DOI 10.1165/rcmb.2009-0210ST; Mills GB, 2003, NAT REV CANCER, V3, P582, DOI 10.1038/nrc1143; Moolenaar WH, 2004, BIOESSAYS, V26, P870, DOI 10.1002/bies.20081; Nakanaga K, 2010, J BIOCHEM, V148, P13, DOI 10.1093/jb/mvq052; Nikitopoulou I, 2013, PLOS ONE IN PRESS; Nikitopoulou I, 2012, J EXP MED, V209, P923, DOI 10.1084/jem.20112012; Oikonomou N, 2010, AM THOR SOC INT C; Oikonomou N, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000108; Oikonomou N, 2012, AM J RESP CELL MOL, V47, P566, DOI 10.1165/rcmb.2012-0004OC; Pamuklar Z, 2009, J BIOL CHEM, V284, P7385, DOI 10.1074/jbc.M807820200; Park GY, 2013, AM J RESP CRIT CARE, DOI [10.1164/rccm.201306-1014OC, DOI 10.1164/RCCM.201306-10140C]; Perrakis A, 2014, J LIPID RES, V55, P1010, DOI 10.1194/jlr.R046391; Ranieri VM, 2012, JAMA-J AM MED ASSOC, V307, P2526, DOI 10.1001/jama.2012.5669; Ren YL, 2013, MICROVASC RES, V85, P59, DOI 10.1016/j.mvr.2012.10.004; Shea Barry S, 2012, Proc Am Thorac Soc, V9, P102, DOI 10.1513/pats.201201-005AW; Stefan C, 2005, TRENDS BIOCHEM SCI, V30, P542, DOI 10.1016/j.tibs.2005.08.005; Swaney JS, 2010, BRIT J PHARMACOL, V160, P1699, DOI 10.1111/j.1476-5381.2010.00828.x; Tager AM, 2008, NAT MED, V14, P45, DOI 10.1038/nm1685; Tager AM, 2012, AM J RESP CELL MOL, V47, P563, DOI 10.1165/rcmb.2012-0235ED; Umezu-Goto M, 2002, J CELL BIOL, V158, P227, DOI 10.1083/jcb.200204026; van Meeteren LA, 2007, PROG LIPID RES, V46, P145, DOI 10.1016/j.plipres.2007.02.001; Yanagida K, 2013, BBA-MOL CELL BIOL L, V1831, P33, DOI 10.1016/j.bbalip.2012.08.003; Yang Y, 1999, AM J RESP CELL MOL, V21, P216, DOI 10.1165/ajrcmb.21.2.3667; Yung YC, 2014, J LIPID RES, V55, P1192, DOI 10.1194/jlr.R046458; Zhao J, 2011, AM J PHYSIOL-LUNG C, V301, pL547, DOI 10.1152/ajplung.00058.2011; Zhao J, 2011, BIOCHEM J, V439, P45, DOI 10.1042/BJ20110274; Zhao YT, 2013, BBA-MOL CELL BIOL L, V1831, P86, DOI 10.1016/j.bbalip.2012.06.014	44	36	36	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0133619	10.1371/journal.pone.0133619	http://dx.doi.org/10.1371/journal.pone.0133619			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LZ	26196781	Green Published, Green Submitted, gold			2022-12-26	WOS:000358547600119
J	Peplonska, B; Bukowska, A; Sobala, W				Peplonska, Beata; Bukowska, Agnieszka; Sobala, Wojciech			Association of Rotating Night Shift Work with BMI and Abdominal Obesity among Nurses and Midwives	PLOS ONE			English	Article							BODY-MASS INDEX; METABOLIC SYNDROME; PHYSICAL-ACTIVITY; WEIGHT-GAIN; CHRONIC DISEASE; RISK-FACTORS; HEALTH; OVERWEIGHT; SLEEP; PREVALENCE	Background Mounting epidemiological evidence suggests that night shift work may contribute to the etiology of increased body weight. The present study aimed to examine association between rotating night shift work and body mass index (BMI), and abdominal adiposity respectively among nurses and midwives. Methods A cross-sectional study was conducted among 724 female nurses and midwives, aged 40-60 years (354 rotating night shift and 370 daytime workers) in Lod, Poland, between 2008 and 2011. Information about occupational history and potential confounders was collected during personal interviews. Anthropometric measurements of body weight, height, waist (WC) and hip (HC) circumference were made, and body mass index (BMI), waist to hip ratio (WHR) and waist to height ratio (WHtR) were calculated. GLM regression models and multinomial logit regression models were fitted to explore the association between night shift work and anthropometric parameters, with adjustment for age, body silhouette at age 20, current smoking status, packyears, marital status, and menopausal hormone therapy use. Results Cumulative night shift work showed significant associations with BMI, WC, HC and WHtR, with BMI increasing by 0.477 kg/m(2) per 1000 night duties and by 0.432 kg/m(2) per 10000 night shift hours, WC increasing respectively by 1.089 cm and 0.99 cm, and HC by 0.72 cm and WHtR by 0.007 cm for both metrics. Both current and cumulative night work was associated with obesity (BMI >= 30kg/m(2)), with OR=3.9 (95% CI: 1.5-9.9), in women reporting eight or more night shifts per month. Conclusion The results of the study support the previously reported relations between night shift work and development of obesity.	[Peplonska, Beata; Bukowska, Agnieszka; Sobala, Wojciech] Nofer Inst Occupat Med, Dept Environm Epidemiol, Lodz, Poland	Nofer Institute of Occupational Medicine	Peplonska, B (corresponding author), Nofer Inst Occupat Med, Dept Environm Epidemiol, Lodz, Poland.	beatap@imp.lodz.pl	Peplonska, Beata/AAO-1265-2020	Peplonska, Beata/0000-0003-3915-2872; Bukowska-Damska, Agnieszka/0000-0002-3223-6750	Norway Grants under the Polish-Norwegian Research Programme [PNRF - 243 - AI - 1/07, EOG 89/2013-clockshift]	Norway Grants under the Polish-Norwegian Research Programme	This project was supported by the Norway Grants, under the Polish-Norwegian Research Programme (Grant no. PNRF - 243 - AI - 1/07 and EOG 89/2013-clockshift) to BP.	Allen TD, 2006, AM BEHAV SCI, V49, P1204, DOI 10.1177/0002764206286386; Ashwell M, 2005, INT J FOOD SCI NUTR, V56, P303, DOI 10.1080/09637480500195066; Barbadoro P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063289; Barton J, 1995, WORK STRESS, V9, P109, DOI 10.1080/02678379508256545; Biggi N, 2008, CHRONOBIOL INT, V25, P443, DOI 10.1080/07420520802114193; Bolt HM, 2003, INT ARCH OCC ENV HEA, V76, P174, DOI 10.1017/s00420-002-0407-4; Borruel S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114112; Bushnell PT, 2010, IND HEALTH, V48, P395, DOI 10.2486/indhealth.MSSW-03; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; Elgar FJ, 2008, CAN J PUBLIC HEALTH, V99, P423, DOI 10.1007/BF03405254; Esquirol Y, 2009, CHRONOBIOL INT, V26, P544, DOI 10.1080/07420520902821176; FerroLuzzi A, 1995, WHO TECH REP SER, V854, P1; Garaulet M, 2010, INT J OBESITY, V34, P1667, DOI 10.1038/ijo.2010.118; Geliebter A, 2000, NUTRITION, V16, P27, DOI 10.1016/S0899-9007(99)00228-2; HAN TS, 1995, BRIT MED J, V311, P1401, DOI 10.1136/bmj.311.7017.1401; Kadane JB, 2004, J AM STAT ASSOC, V99, P279, DOI 10.1198/016214504000000269; Kalra SP, 1999, ENDOCR REV, V20, P68, DOI 10.1210/er.20.1.68; Kim MJ, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-1204; Kubo T, 2011, OCCUP ENVIRON MED, V68, P327, DOI 10.1136/oem.2009.054445; Lahmann PH, 2004, INT J CANCER, V111, P762, DOI 10.1002/ijc.20315; Lowden A, 2010, SCAND J WORK ENV HEA, V36, P150, DOI 10.5271/sjweh.2898; Macagnan J, 2012, CHRONOBIOL INT, V29, P336, DOI 10.3109/07420528.2011.653851; Manenschijn L, 2011, J CLIN ENDOCR METAB, V96, pE1862, DOI 10.1210/jc.2011-1551; Marqueze EC, 2012, WORK, V41, P2043, DOI 10.3233/WOR-2012-0429-2043; McElhone S, 1999, PUBLIC HEALTH NUTR, V2, P143, DOI 10.1017/S1368980099000191; Morikawa Y, 2008, J OCCUP HEALTH, V50, P270, DOI 10.1539/joh.L7116; Mudge Stephen M., 2008, P1; Nakamura K, 1997, OCCUP MED-OXFORD, V47, P142, DOI 10.1093/occmed/47.3.142; Niedhammer I, 1996, INT J OBESITY, V20, P625; Peplonska B, 2014, CHRONOBIOL INT, V31, P1152, DOI 10.3109/07420528.2014.957296; Peplonska B, 2014, INT J OCCUP MED ENV, V27, P693, DOI 10.2478/s13382-014-0298-0; Peplonska B, 2012, OCCUP ENVIRON MED, V69, P339, DOI 10.1136/oemed-2011-100273; Phipps AM, 2012, HANDBOOK OF ANTHROPO, P1703; Poulsen K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103425; Ramin C, 2015, OCCUP ENVIRON MED, V72, P100, DOI 10.1136/oemed-2014-102292; Roos E, 2013, ARCH ENVIRON OCCUP H, V68, P166, DOI 10.1080/19338244.2012.686931; Schneider HJ, 2010, J CLIN ENDOCR METAB, V95, P1777, DOI 10.1210/jc.2009-1584; Smith P, 2013, APPL NURS RES, V26, P24, DOI 10.1016/j.apnr.2012.10.001; Sookoian S, 2007, J INTERN MED, V261, P285, DOI 10.1111/j.1365-2796.2007.01766.x; Straif K, 2007, LANCET ONCOL, V8, P1065, DOI 10.1016/S1470-2045(07)70373-X; Stunkard AJ, 1983, GENETICS NEUROLOGICA, P115; Suwazono Y, 2008, OBESITY, V16, P1887, DOI 10.1038/oby.2008.298; Taheri S, 2004, PLOS MED, V1, P210, DOI 10.1371/journal.pmed.0010062; van Amelsvoort LGMP, 1999, INT J OBESITY, V23, P973, DOI 10.1038/sj.ijo.0801028; van Amelsvoort LGPM, 2004, J OCCUP ENVIRON MED, V46, P699, DOI 10.1097/01.jom.0000131794.83723.45; van Drongelen A, 2011, SCAND J WORK ENV HEA, V37, P263, DOI 10.5271/sjweh.3143; Wang XS, 2011, OCCUP MED-OXFORD, V61, P78, DOI 10.1093/occmed/kqr001; Watari M, 2006, PREV MED, V43, P107, DOI 10.1016/j.ypmed.2006.04.012; Wehrens SMT, 2010, J ENDOCRINOL, V206, P205, DOI 10.1677/JOE-10-0077; Zhao I, 2011, J OCCUP ENVIRON MED, V53, P153, DOI 10.1097/JOM.0b013e318205e1e8	51	94	98	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0133761	10.1371/journal.pone.0133761	http://dx.doi.org/10.1371/journal.pone.0133761			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN6LZ	26196859	Green Published, gold, Green Submitted			2022-12-26	WOS:000358547600140
J	Morgado, FN; Nascimento, MTC; Saraiva, EM; de Oliveira-Ribeiro, C; Madeira, MD; da Costa-Santos, M; Vasconcellos, ECF; Pimentel, MIF; Lyra, MR; Schubach, AD; Conceicao-Silva, F				Morgado, Fernanda Nazare; Nascimento, Michelle T. C.; Saraiva, Elvira M.; de Oliveira-Ribeiro, Carla; Madeira, Maria de Fatima; da Costa-Santos, Marcela; Vasconcellos, Erica C. F.; Pimentel, Maria Ines F.; Lyra, Marcelo Rosandiski; Schubach, Armando de Oliveira; Conceicao-Silva, Fatima			Are Neutrophil Extracellular Traps Playing a Role in the Parasite Control in Active American Tegumentary Leishmaniasis Lesions?	PLOS ONE			English	Article							SITU INFLAMMATORY REACTION; CUTANEOUS LEISHMANIASIS; ANTIMICROBIAL ACTIVITY; HUMAN MACROPHAGES; IMMUNE-RESPONSE; MAJOR INFECTION; HOST-CELLS; MAST-CELLS; IN-VIVO; AMAZONENSIS	Neutrophil extracellular traps (NETs) have been described as a network of extracellular fibers composed by DNA, histones and various proteins/enzymes. Studies have demonstrated that NETs could be responsible for the trapping and elimination of a variety of infectious agents. In order to verify the presence of NETs in American tegumentary leishmaniasis (ATL) and their relationship with the presence of amastigotes we evaluated active cutaneous lesions of 35 patients before treatment by the detection of parasites, neutrophils (neutrophil elastase) and histones through immunohistochemistry and confocal immunofluorescence. Intact neutrophils could be detected in all ATL lesions. NETs were present in 27 patients (median 1.1; range from 0.1 to 23.5/mm(2)) with lesion duration ranging from one to seven months. NETs were in close proximity with neutrophils (r = 0.586; p = 0.0001) and amastigotes (r = 0.710; p = 0.0001). Two patterns of NET formation were detected: small homogeneously distributed networks observed in all lesions; and large structures that could be visualized at a lower magnification in lesions presenting at least 20% of neutrophils. Lesions presenting the larger NET formation showed high parasite detection. A correlation between NET size and the number of intact amastigotes was observed (p=0.02). As we detected an association between NET and amastigotes, our results suggest that neutrophil migration and NET formation could be stimulated and maintained by stimuli derived from the parasite burden/parasite antigen in the extracellular environment. The observation of areas containing only antigens not intermingled with NETs (elastase and histone) suggests that the involvement of these structures in the control of parasite burden is a dynamic process in which the formation of NETs is exhausted with the destruction of the parasites. Since NETs were also associated with granulomas, this trapping would favor the activity of macrophages in order to control the parasite burden.	[Morgado, Fernanda Nazare; de Oliveira-Ribeiro, Carla; da Costa-Santos, Marcela; Conceicao-Silva, Fatima] Fiocruz MS, Inst Oswaldo Cruz, Lab Imunoparasitol, BR-21045900 Rio De Janeiro, Brazil; [Nascimento, Michelle T. C.; Saraiva, Elvira M.] Univ Fed Rio de Janeiro, Inst Microbiol Paulo de Goes, Dept Imunol, Rio De Janeiro, Brazil; [de Oliveira-Ribeiro, Carla; Madeira, Maria de Fatima; Vasconcellos, Erica C. F.; Pimentel, Maria Ines F.; Lyra, Marcelo Rosandiski; Schubach, Armando de Oliveira] Fiocruz MS, Inst Nacl Infectol Evandro Chagas INI, Lab Vigilancia Leishmanioses VigiLeish, BR-21045900 Rio De Janeiro, Brazil	Fundacao Oswaldo Cruz; Universidade Federal do Rio de Janeiro; Fundacao Oswaldo Cruz	Conceicao-Silva, F (corresponding author), Fiocruz MS, Inst Oswaldo Cruz, Lab Imunoparasitol, BR-21045900 Rio De Janeiro, Brazil.	fconcei@ioc.fiocruz.br	Saraiva, Elvira M/L-2864-2017; nascimento, Michelle Tanny Cunha/O-7844-2018; Morgado, Fernanda N/K-2527-2013; Morgado, Fernanda/AAV-4435-2021; Morgado, Fernanda/O-3577-2017	Saraiva, Elvira M/0000-0002-6388-5286; Morgado, Fernanda N/0000-0002-7188-251X; Morgado, Fernanda/0000-0002-7188-251X; Morgado, Fernanda/0000-0002-7188-251X	Instituto Oswaldo Cruz-IOC (POM); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico-CNPq [470886/2003-0, 471744/2012-3, 308236/2013-0]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico-CNPq-Proep [402557/2011-5]; Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro-FAPERJ [E26.111.717/2012, E-26/102.456/2012, E26/102.988/2012, E26/111.230/2014, E26/203638/2014, E-26/111.101/2014]; Coordenacao de Aperfeicomento de Pessoal de Nivel Superior-CAPES, Brazil [23038.005291/2011-61]; CNPq, Brazil; FAPERJ, Brazil; Instituto Nacional de Infectologia-INI (PA)-Fundacao Oswaldo Cruz-FIOCRUZ; Fundacao Nacional de Saude/Ministerio da Saude-FUNASA/MS	Instituto Oswaldo Cruz-IOC (POM); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico-CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico-CNPq-Proep(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro-FAPERJ(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Coordenacao de Aperfeicomento de Pessoal de Nivel Superior-CAPES, Brazil; CNPq, Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPERJ, Brazil(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Instituto Nacional de Infectologia-INI (PA)-Fundacao Oswaldo Cruz-FIOCRUZ; Fundacao Nacional de Saude/Ministerio da Saude-FUNASA/MS	This work was funded by Instituto Oswaldo Cruz-IOC (POM 2010-2011) and Instituto Nacional de Infectologia-INI (PA2010)- Fundacao Oswaldo Cruz-FIOCRUZ, Fundacao Nacional de Saude/Ministerio da Saude-FUNASA/MS, Conselho Nacional de Desenvolvimento Cientifico e Tecnologico-CNPq (470886/2003-0; 471744/2012-3; 308236/2013-0); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico-CNPq-Proep (402557/2011-5); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro-FAPERJ (E26.111.717/2012; E-26/102.456/2012, E26/102.988/2012, E26/111.230/2014, E26/203638/2014 and E-26/111.101/2014), and Coordenacao de Aperfeicomento de Pessoal de Nivel Superior-CAPES (23038.005291/2011-61), Brazil. AOS is the recipient of fellowships from CNPq and FAPERJ, Brazil. The funders had no role in study design data collection and analysis, decision to publish, or preparing the manuscript.	Abdallah DSA, 2012, INFECT IMMUN, V80, P768, DOI 10.1128/IAI.05730-11; Abi Abdallah Delbert S, 2012, Front Immunol, V3, P382, DOI 10.3389/fimmu.2012.00382; Afonso L, 2008, J LEUKOCYTE BIOL, V84, P389, DOI 10.1189/jlb.0108018; Baker VS, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-41; Bartneck M, 2010, NANO LETT, V10, P59, DOI 10.1021/nl902830x; Behrendt JH, 2010, VET IMMUNOL IMMUNOP, V133, P1, DOI 10.1016/j.vetimm.2009.06.012; Belkaid Y, 2000, J IMMUNOL, V165, P969, DOI 10.4049/jimmunol.165.2.969; Bogdan C, 2000, J EXP MED, V191, P2121, DOI 10.1084/jem.191.12.2121; Braian C, 2013, J INNATE IMMUN, V5, P591, DOI 10.1159/000348676; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; Brinkmann V, 2012, J CELL BIOL, V198, P773, DOI 10.1083/jcb.201203170; Bruns S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000873; Chow OA, 2010, CELL HOST MICROBE, V8, P445, DOI 10.1016/j.chom.2010.10.005; Fadok VA, 2001, J IMMUNOL, V166, P6847, DOI 10.4049/jimmunol.166.11.6847; Gabriel C, 2010, J IMMUNOL, V185, P4319, DOI 10.4049/jimmunol.1000893; Guimaraes-Costa Anderson B, 2012, J Parasitol Res, V2012, P929743, DOI 10.1155/2012/929743; Guimaraes-Costa AB, 2009, P NATL ACAD SCI USA, V106, P6748, DOI 10.1073/pnas.0900226106; Hespanhol RC, 2005, J HISTOCHEM CYTOCHEM, V53, P35, DOI 10.1369/jhc.4A6384.2005; Kahlenberg JM, 2013, J IMMUNOL, V190, P1217, DOI 10.4049/jimmunol.1202388; Laskay T, 2008, IMMUNOBIOLOGY, V213, P183, DOI 10.1016/j.imbio.2007.11.010; Lima GMAC, 1998, IMMUNOL LETT, V64, P145, DOI 10.1016/S0165-2478(98)00099-6; Lugo-Yarbuh Ana, 2003, Invest. clín, V44, P61; Madeira MF, 2006, T ROY SOC TROP MED H, V100, P442, DOI 10.1016/j.trstmh.2005.07.011; Marzochi M C, 1994, Cad Saude Publica, V10 Suppl 2, P359, DOI 10.1590/S0102-311X1994000800014; Menezes MJ, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-12; Morgado FN, 2008, BRIT J DERMATOL, V158, P50, DOI 10.1111/j.1365-2133.2007.08255.x; Morgado FN, 2010, PARASITE IMMUNOL, V32, P285, DOI 10.1111/j.1365-3024.2009.01188.x; Morgado FN, 2011, MED MYCOL, V49, P612, DOI 10.3109/13693786.2011.552532; Neeli I, 2008, J IMMUNOL, V180, P1895, DOI 10.4049/jimmunol.180.3.1895; Novais FO, 2009, J IMMUNOL, V183, P8088, DOI 10.4049/jimmunol.0803720; Peters NC, 2008, SCIENCE, V321, P970, DOI 10.1126/science.1159194; POMPEU ML, 1991, ACTA TROP, V48, P185, DOI 10.1016/0001-706X(91)90046-M; Quintella LP, 2009, REV I MED TROP, V51, P83, DOI 10.1590/S0036-46652009000200005; Ramos-Kichik V, 2009, TUBERCULOSIS, V89, P29, DOI 10.1016/j.tube.2008.09.009; Ribeiro-Gomes FL, 2004, J IMMUNOL, V172, P4454, DOI 10.4049/jimmunol.172.7.4454; Ribeiro-Gomes FL, 2007, J IMMUNOL, V179, P3988, DOI 10.4049/jimmunol.179.6.3988; Ribeiro-Gomes FL, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00059; Saitoh T, 2012, CELL HOST MICROBE, V12, P109, DOI 10.1016/j.chom.2012.05.015; Tacchini-Cottier F, 2000, J IMMUNOL, V165, P2628, DOI 10.4049/jimmunol.165.5.2628; Urban CF, 2006, CELL MICROBIOL, V8, P668, DOI 10.1111/j.1462-5822.2005.00659.x; van Zandbergen G, 2004, J IMMUNOL, V173, P6521, DOI 10.4049/jimmunol.173.11.6521; van Zandbergen G, 2002, INFECT IMMUN, V70, P4177, DOI 10.1128/IAI.70.8.4177-4184.2002; von Kockritz-Blickwede M, 2008, BLOOD, V111, P3070, DOI 10.1182/blood-2007-07-104018; Von Stebut E, 2007, EUR J DERMATOL, V17, P115, DOI 10.1684/ejd.2007.0122; Wang YM, 2009, J CELL BIOL, V184, P205, DOI 10.1083/jcb.200806072; Yipp BG, 2012, NAT MED, V18, P1386, DOI 10.1038/nm.2847; Yousefi S, 2008, NAT MED, V14, P949, DOI 10.1038/nm.1855	47	22	24	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2015	10	7							e0133063	10.1371/journal.pone.0133063	http://dx.doi.org/10.1371/journal.pone.0133063			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LN	26192752	gold, Green Submitted, Green Published			2022-12-26	WOS:000358546400051
J	Oguchi, M; Okajima, M; Tanaka, S; Koizumi, M; Kikusui, T; Ichihara, N; Kato, S; Kobayashi, K; Sakagami, M				Oguchi, Mineki; Okajima, Miku; Tanaka, Shingo; Koizumi, Masashi; Kikusui, Takefumi; Ichihara, Nobutsune; Kato, Shigeki; Kobayashi, Kazuto; Sakagami, Masamichi			Double Virus Vector Infection to the Prefrontal Network of the Macaque Brain	PLOS ONE			English	Article							RETROGRADE GENE-TRANSFER; TRANSDUCTION EFFICIENCY; CORTICAL CONNECTIONS; SUBSTANTIA-NIGRA; PATHWAY; CIRCUIT; DREADDS; CORTEX; KEY	To precisely understand how higher cognitive functions are implemented in the prefrontal network of the brain, optogenetic and pharmacogenetic methods to manipulate the signal transmission of a specific neural pathway are required. The application of these methods, however, has been mostly restricted to animals other than the primate, which is the best animal model to investigate higher cognitive functions. In this study, we used a double viral vector infection method in the prefrontal network of the macaque brain. This enabled us to express specific constructs into specific neurons that constitute a target pathway without use of germline genetic manipulation. The double-infection technique utilizes two different virus vectors in two monosynaptically connected areas. One is a vector which can locally infect cell bodies of projection neurons (local vector) and the other can retrogradely infect from axon terminals of the same projection neurons (retrograde vector). The retrograde vector incorporates the sequence which encodes Cre recombinase and the local vector incorporates the "Cre-On" FLEX double-floxed sequence in which a reporter protein (mCherry) was encoded. mCherry thus came to be expressed only in doubly infected projection neurons with these vectors. We applied this method to two macaque monkeys and targeted two different pathways in the prefrontal network: The pathway from the lateral prefrontal cortex to the caudate nucleus and the pathway from the lateral prefrontal cortex to the frontal eye field. As a result, mCherry-positive cells were observed in the lateral prefrontal cortex in all of the four injected hemispheres, indicating that the double virus vector transfection is workable in the prefrontal network of the macaque brain.	[Oguchi, Mineki; Tanaka, Shingo; Koizumi, Masashi; Sakagami, Masamichi] Tamagawa Univ, Brain Sci Inst, Machida, Tokyo, Japan; [Okajima, Miku] Univ Tokyo, Grad Sch Arts & Sci, Meguro, Tokyo, Japan; [Kikusui, Takefumi; Ichihara, Nobutsune] Azabu Univ, Sch Vet Med, Sagamihara, Kanagawa, Japan; [Kato, Shigeki; Kobayashi, Kazuto] Fukushima Med Univ, Inst Biomed Sci, Dept Mol Genet, Fukushima, Fukushima, Japan	University of Tokyo; Azabu University; Fukushima Medical University	Sakagami, M (corresponding author), Tamagawa Univ, Brain Sci Inst, Machida, Tokyo, Japan.	sakagami@lab.tamagawa.ac.jp	Kato, Shigeki/S-8016-2018	Kato, Shigeki/0000-0002-8792-7591	MEXT (Ministry of Education, Culture, Sports, Science and Technology) of Japan [4303]; AMED (Japan Agency for Medical Research and Development); JSPS KAKENHI from MEXT of Japan [23243071]; Grants-in-Aid for Scientific Research [23243071] Funding Source: KAKEN	MEXT (Ministry of Education, Culture, Sports, Science and Technology) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); AMED (Japan Agency for Medical Research and Development)(Japan Agency for Medical Research and Development (AMED)); JSPS KAKENHI from MEXT of Japan; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a Grant-in-Aid for Scientific Research on Innovative Areas (4303) from MEXT (Ministry of Education, Culture, Sports, Science and Technology) of Japan (http://decisions.naist.jp/index.html). This work was partially supported by a Grant-in-Aid for "Development of BMI Technologies for Clinical Application" carried out under the Strategic Research Program for Brain Sciences from AMED (Japan Agency for Medical Research and Development) and JSPS KAKENHI Grant Number 23243071 from MEXT of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander GM, 2009, NEURON, V63, P27, DOI 10.1016/j.neuron.2009.06.014; Armbruster BN, 2007, P NATL ACAD SCI USA, V104, P5163, DOI 10.1073/pnas.0700293104; Aschauer DF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076310; Becnel J, 2013, CELL REP, V4, P1049, DOI 10.1016/j.celrep.2013.08.003; Boender AJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095392; BRUCE CJ, 1985, J NEUROPHYSIOL, V54, P714, DOI 10.1152/jn.1985.54.3.714; Castle MJ, 2014, MOL THER, V22, P554, DOI 10.1038/mt.2013.237; Condy C, 2007, CEREB CORTEX, V17, P221, DOI 10.1093/cercor/bhj140; ElMallah MK, 2012, HUM GENE THER METHOD, V23, P148, DOI 10.1089/hgtb.2012.009; Fenno L, 2011, ANNU REV NEUROSCI, V34, P389, DOI 10.1146/annurev-neuro-061010-113817; Ferguson SM, 2013, J NEUROSCI, V33, P11668, DOI 10.1523/JNEUROSCI.4783-12.2013; Gerbella M, 2010, CEREB CORTEX, V20, P141, DOI 10.1093/cercor/bhp087; Haber SN, 2006, J NEUROSCI, V26, P8368, DOI 10.1523/JNEUROSCI.0271-06.2006; Hirano M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075896; Inoue K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039149; Kato S, 2014, J NEUROSCI METH, V227, P151, DOI 10.1016/j.jneumeth.2014.02.015; Kato S, 2011, J NEUROSCI, V31, P17169, DOI 10.1523/JNEUROSCI.4005-11.2011; Kato S, 2011, HUM GENE THER, V22, P197, DOI 10.1089/hum.2009.179; Kinoshita M, 2012, NATURE, V487, P235, DOI 10.1038/nature11206; Kobayashi S, 2007, EXP BRAIN RES, V176, P341, DOI 10.1007/s00221-006-0622-4; Mahler SV, 2014, NAT NEUROSCI, V17, P577, DOI 10.1038/nn.3664; Markakis EA, 2010, MOL THER, V18, P588, DOI 10.1038/mt.2009.286; Masamizu Y, 2011, NEUROSCIENCE, V193, P249, DOI 10.1016/j.neuroscience.2011.06.080; Meyer-Lindenberg A, 2002, NAT NEUROSCI, V5, P267, DOI 10.1038/nn804; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Ohayon S, 2013, J NEUROSCI, V33, P16684, DOI 10.1523/JNEUROSCI.2675-13.2013; Padmanabhan A, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00814; Pan XC, 2008, NAT NEUROSCI, V11, P703, DOI 10.1038/nn.2128; Pierrot-Deseilligny C, 2003, BRAIN, V126, P1460, DOI 10.1093/brain/awg148; Robbins TW, 2012, TRENDS COGN SCI, V16, P81, DOI 10.1016/j.tics.2011.11.009; Salegio EA, 2013, GENE THER, V20, P348, DOI 10.1038/gt.2012.27; San Sebastian W, 2013, GENE THER, V20, P1178, DOI 10.1038/gt.2013.48; SELEMON LD, 1985, J NEUROSCI, V5, P776; Sooksawate T, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00162; Stachniak TJ, 2014, NEURON, V82, P797, DOI 10.1016/j.neuron.2014.04.008; Stuber GD, 2013, PHARMACOL REV, V65, P156, DOI 10.1124/pr.111.005611; Urban DJ, 2015, ANNU REV PHARMACOL, V55, P399, DOI 10.1146/annurev-pharmtox-010814-124803; Williams DP, 1997, J PHARMACOL EXP THER, V283, P1375; YETERIAN EH, 1991, J COMP NEUROL, V312, P43, DOI 10.1002/cne.903120105; Yoon JH, 2013, BIOL PSYCHIAT, V74, P122, DOI 10.1016/j.biopsych.2012.11.018	40	27	27	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2015	10	7							e0132825	10.1371/journal.pone.0132825	http://dx.doi.org/10.1371/journal.pone.0132825			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LN	26193102	gold, Green Published, Green Submitted			2022-12-26	WOS:000358546400041
J	Christensen, J; Vonwil, D; Shastri, VP				Christensen, Jon; Vonwil, Daniel; Shastri, V. Prasad			Non-Invasive In Vivo Imaging and Quantification of Tumor Growth and Metastasis in Rats Using Cells Expressing Far-Red Fluorescence Protein	PLOS ONE			English	Article							HUMAN BREAST-CANCER; TUMORIGENICITY; PROGRESSION; COMPONENTS; MODELS; AGENTS	Non-invasive in vivo imaging is emerging as an important tool for basic and preclinical research. Near-infrared (NIR) fluorescence dyes and probes have been used for non-invasive optical imaging since in the NIR region absorption and auto fluorescence by body tissue is low, thus permitting for greater penetration depths and high signal to noise ratio. Currently, cell tracking systems rely on labeling cells prior to injection or administering probes targeting the cell population of choice right before imaging. These approaches do not enable imaging of tumor growth, as the cell label is diluted during cell division. In this study we have developed cell lines stably expressing the far-red fluorescence protein E2-Crimson, thus enabling continuous detection and quantification of tumor growth. In a xenograft rat model, we show that E2-Crimson expressing cells can be detected over a 5 week period using optical imaging. Fluorescence intensities correlated with tumor volume and weight and allowed for a reliable and robust quantification of the entire tumor compartment. Using a novel injection regime, the seeding of MDA-MB-231 breast cancer cells in the lungs in a rat model was established and verified.	[Christensen, Jon; Vonwil, Daniel; Shastri, V. Prasad] Univ Freiburg, Inst Macromol Chem, D-79104 Freiburg, Germany; [Christensen, Jon; Shastri, V. Prasad] Univ Freiburg, BIOSS Ctr Biol Signalling Studies, D-79104 Freiburg, Germany	University of Freiburg; University of Freiburg	Shastri, VP (corresponding author), Univ Freiburg, Inst Macromol Chem, D-79104 Freiburg, Germany.	prasad.shastri@gmail.com			Excellence Initiative of the German Federal Government (Centre for Biological Signalling Studies, BIOSS) [EXC 294]; Excellence Initiative of the German State Government (Centre for Biological Signalling Studies, BIOSS) [EXC 294]; 5th INTERREG Upper Rhine Program (Project: Nano@MATRIX)	Excellence Initiative of the German Federal Government (Centre for Biological Signalling Studies, BIOSS); Excellence Initiative of the German State Government (Centre for Biological Signalling Studies, BIOSS); 5th INTERREG Upper Rhine Program (Project: Nano@MATRIX)	This work was supported by the Excellence Initiative of the German Federal and State Governments (Grant EXC 294; Centre for Biological Signalling Studies, BIOSS) and by the 5th INTERREG Upper Rhine Program (Project: Nano@MATRIX). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bao BN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050860; Blouin S, 2005, CLIN EXP METASTAS, V22, P605, DOI 10.1007/s10585-006-9002-5; Boyd NF, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2942; Brekken RA, 2003, J CLIN INVEST, V111, P487, DOI 10.1172/JCI200316804; Contag CH, 1995, MOL MICROBIOL, V18, P593, DOI 10.1111/j.1365-2958.1995.mmi_18040593.x; Cui KM, 2008, LUMINESCENCE, V23, P292, DOI 10.1002/bio.1032; Direcks WGE, 2008, CANCER BIOL THER, V7, P532, DOI 10.4161/cbt.7.4.5481; Fournier LS, 2007, RADIOLOGY, V243, P105, DOI 10.1148/radiol.2431050658; Frangioni JV, 2003, CURR OPIN CHEM BIOL, V7, P626, DOI 10.1016/j.cbpa.2003.08.007; Histing T, 2011, BONE, V49, P591, DOI 10.1016/j.bone.2011.07.007; Iannaccone PM, 2009, DIS MODEL MECH, V2, P206, DOI 10.1242/dmm.002733; Kagadis GC, 2010, MED PHYS, V37, P6421, DOI 10.1118/1.3515456; Klerk CPW, 2007, BIOTECHNIQUES, V43, P7, DOI 10.2144/000112515; Leblond F, 2010, J PHOTOCH PHOTOBIO B, V98, P77, DOI 10.1016/j.jphotobiol.2009.11.007; Levin RA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097415; Lim Yong Taik, 2003, Mol Imaging, V2, P50, DOI 10.1162/153535003765276282; Mao Y, 2013, CANCER METAST REV, V32, P303, DOI 10.1007/s10555-012-9415-3; Mullen P, 1996, INT J CANCER, V67, P816, DOI 10.1002/(SICI)1097-0215(19960917)67:6<816::AID-IJC10>3.0.CO;2-#; Pierce MC, 2008, INT J CANCER, V123, P1979, DOI 10.1002/ijc.23858; PRICE JE, 1990, CANCER RES, V50, P717; Puissant A, 2014, CANCER CELL, V25, P226, DOI 10.1016/j.ccr.2014.01.022; Quail DF, 2013, NAT MED, V19, P1423, DOI 10.1038/nm.3394; Sato A, 2004, COMPARATIVE MED, V54, P631; Sharma V, 2009, BRIT J PHARMACOL, V157, P907, DOI 10.1111/j.1476-5381.2009.00267.x; Sim H, 2011, CANCER RES, V71, P686, DOI 10.1158/0008-5472.CAN-10-2666; Strack RL, 2008, NAT METHODS, V5, P955, DOI 10.1038/nmeth.1264; Strack RL, 2009, BIOCHEMISTRY-US, V48, P8279, DOI 10.1021/bi900870u; Swirski FK, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001075; TAKEUCHI J, 1976, CANCER RES, V36, P2133; TOMAYKO MM, 1989, CANCER CHEMOTH PHARM, V24, P148, DOI 10.1007/BF00300234; Vonwil D, 2014, MOL IMAGING BIOL, V16, P350, DOI 10.1007/s11307-013-0698-8; Weissleder R, 2003, NAT MED, V9, P123, DOI 10.1038/nm0103-123; Ying H, 2006, MOL CANCER THER, V5, P2158, DOI 10.1158/1535-7163.MCT-05-0440; Zhang YH, 2003, ONCOL REP, V10, P207	34	20	20	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0132725	10.1371/journal.pone.0132725	http://dx.doi.org/10.1371/journal.pone.0132725			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RV	26186005	Green Published, Green Submitted, gold			2022-12-26	WOS:000358198700057
J	He, CH; Kang, L; Miao, L; Li, Q; Liang, J; Li, XH; Wang, YP; Zhu, J				He, Chunhua; Kang, Leni; Miao, Lei; Li, Qi; Liang, Juan; Li, Xiaohong; Wang, Yanping; Zhu, Jun			Pneumonia Mortality among Children under 5 in China from 1996 to 2013: An Analysis from National Surveillance System	PLOS ONE			English	Article							CHILDHOOD PNEUMONIA; DEATHS	Objectives We investigated the mortality rate of pneumonia (PMR) among children under 5 and its time trend from 1996 to 2013 to determine the priorities for ending preventable deaths from pneumonia in children under 5, and share China's successful experience in reducing PMR with other developing countries. Methods We used data from China's Under 5 Child Mortality Surveillance System (U5CMSS) to calculate the PMR and the proportion of pneumonia deaths to total deaths of children under 5. The data were grouped by urban and rural areas with Cochran-Mantel-Haensel (CMH) test and Chi-square test to examine the differences of PMR and proportion. The time trend was tested by Cochran-Armitage trend test. Results The overall PMR of children under 5 was reduced by 85.5%(from 1053.2 to 153.2 per 100,000 live births) from 1996 to 2013, with the urban and rural areas reduced by 69.1% (from 188.4 to 58.2 per 100,000 live births) and 84.7%(from 1252.8 to 191.9 per 100,000 live births), respectively. The overall proportion of pneumonia deaths to total deaths was also declined from 23.4% in 1996 to 12.8% in 2013, with the rural areas decreased from 24.4% to 13.2% and the urban areas decreased from 11.1% to 9.7%. The PMRs in neonates (0-27 days), post-neonates (1-11 months), and childhood (12-59 months) were reduced by 80.7%, 77.4%, and 80.1%, respectively in rural areas, and 71.7%, 69.6%, and 39.0%, respectively in urban areas. During 1996-2013, the PMR in children under 5 years was 4.9 fold higher in rural areas relative to that in urban areas, with relative risk (RR) of 3.6 and 6.4 in neonates and 1- to 59-month-old children, respectively. Conclusions PMR in children under 5 significantly declined in China from 1996 to 2013, especially in rural areas. However, huge disparities still existed between rural and urban areas. Infants had the highest PMR, which indicated that interventions aiming at prevention and control of infant pneumonia should be the priority for further reducing PMR in China.	[He, Chunhua; Kang, Leni; Miao, Lei; Li, Qi; Liang, Juan; Li, Xiaohong; Wang, Yanping; Zhu, Jun] Sichuan Univ, Natl Off Maternal & Child Hlth Surveillance China, West China Univ 2, Chengdu 610064, Sichuan, Peoples R China	Sichuan University	Wang, YP (corresponding author), Sichuan Univ, Natl Off Maternal & Child Hlth Surveillance China, West China Univ 2, Chengdu 610064, Sichuan, Peoples R China.	yanpingwang0618@163.com; zzhj3121@163.com		Li, Xiaohong/0000-0003-0336-7302	Chinese National Key Technology Support Program [2013BAI04B02]	Chinese National Key Technology Support Program	This study is funded by Chinese National Key Technology Support Program (Grant No. 2013BAI04B02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agresti A., 1990, CATEGORICAL DATA ANA, pXV; Bhutta ZA, 2013, LANCET, V381, P1417, DOI 10.1016/S0140-6736(13)60648-0; Black RE, 2010, LANCET, V375, P1969, DOI 10.1016/S0140-6736(10)60549-1; Bryce J, 2005, LANCET, V365, P1147, DOI 10.1016/S0140-6736(05)71877-8; CEPSY China electricity council, 2013, CHIN EL POW STAT YB; DONG ZQ, 2000, CHIN J PEDIAT, V38, P597; Feng J, 2012, CHIN J EPIDEMIOL, V33, P558; Hajjeh R, 2012, EMERG INFECT DIS, V18, P1898, DOI 10.3201/eid1811.121217; Health EdoCJoR, 2008, CHIN J REPROD HLTH, V19, P280; Liang J, 2011, PAEDIATR PERINAT EP, V25, P593, DOI 10.1111/j.1365-3016.2011.01232.x; Liu L, 2012, LANCET, V379, P2151, DOI 10.1016/S0140-6736(12)60560-1; Liu Y, 1996, CHIN J PEDIAT, V34, P365; Ministry of Foreign Affairs of the People's Republic of China, CHIN PROGR MILL DEV; *NAT I POP RES TRA, 2005, BANGL DEM HLTH SURV; National Bureau of statistics of the People's Republic of China, 2014, CHIN STAT YB 2014; National Bureau of Statistics of the People's Republic of China, 1997, CHIN STAT YB 1997; National health and family planning commission in China, 2008, CHIN HLTH STAT YB; National Health and Family Planning Commission of China, 2013, CHIN HLTH STAT YB 20; Pediatric The 7th Conference of Chinese Academy of, 1978, 7 C CHIN AC PED, V11; Research Group of Pneumonia in MCH Model County, 1990, CHIN J EPIDEMIOL, V11, P257; Ruan RS., 2004, EPIDEMIOLOGY PRINCIP; Rudan I, 2008, LANCET, V372, P781, DOI 10.1016/S0140-6736(08)61167-8; Rudan I, 2013, J GLOB HEALTH, V3, DOI 10.7189/jogh.03.010401; *UNICEF, 2008, COUNTD 2015 TRACK PR; UNICEF, 2015, COMMITTING CHILD SUR; UNICEF W. H. O, 2006, PNEUM FORG KILL CHIL; WANG H, 2003, CHIN J MATERNAL CHIL, V18, P395; Wang YP, 2011, PUBLIC HEALTH, V125, P301, DOI 10.1016/j.puhe.2011.01.003; Wang YP, 2012, ARCH DIS CHILD-FETAL, V97, pF285, DOI 10.1136/archdischild-2011-300412; Williams BG, 2002, LANCET INFECT DIS, V2, P25, DOI 10.1016/S1473-3099(01)00170-0; World health organization, 2013, WORLD HLTH STAT 2013; World Health Organization and UNICEF, 2009, GLOB ACT PLAN PREV C; World Health Organization UNICEF, 2013, END PREV CHILD DEATH; World Health Organization [WHO], 1992, WORLD HLTH STAT ANN; ZHANG Y, 2003, CHINESE J CHILD HLTH, V11, P76; Zhang YF, 2007, CJCHC, V15, P519; Zhu FT, 1985, ZHU FT PRACTICE PEDI	38	23	26	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0133620	10.1371/journal.pone.0133620	http://dx.doi.org/10.1371/journal.pone.0133620			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RV	26186717	gold, Green Published, Green Submitted			2022-12-26	WOS:000358198700160
J	Kawakami, T; Nakamura, Y; Karibe, H				Kawakami, Tomomi; Nakamura, Yuko; Karibe, Hiroyuki			Cyclophosphamide-Induced Morphological Changes in Dental Root Development of ICR Mice	PLOS ONE			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; LONG-TERM SURVIVORS; CHILDHOOD-CANCER SURVIVOR; HIGH-DOSE CHEMOTHERAPY; TOTAL-BODY IRRADIATION; ORAL-HEALTH; CHILDREN; ABNORMALITIES; RISK; DENTITION	Background Survivors of childhood cancer are at risk of late dental development. Cyclophosphamide is one of the most commonly used chemotherapeutic agents against cancer in children. The aim of this study was to investigate the effects of cyclophosphamide on root formation in the molars of growing mice and to assess the morphological changes in these roots using three-dimensional structural images. Methods We treated 16 12-day-old ICR mice with cyclophosphamide (100 mg/kg, i.p.) and 16 control mice with saline. At 16, 20, 24, and 27 days of age, the mandibular left first molars were scanned using soft micro-computed tomography. After scanning, the structural indices were calculated using a three-dimensional image analysis system, and the images were subjected to three-dimensional reconstruction. The length and apical foramen area of all distal roots were assessed. Histological changes in the apical region were then assessed via hematoxylin and eosin staining. Results The mandibular molars of all experimental mice showed evidence of cytotoxic injury, which appeared in the form of anomalous root shapes. Although all roots developed further after cyclophosphamide injection, the three-dimensional structural images showed that the roots in the experimental group tended to develop more slowly and were shorter than those in the control group. At 27 days of age, the mean root length was shorter in the experimental group than in the control group. Conversely, the apical foramen of the roots in the experimental group tended to close faster than that of roots in the control group. In addition, hematoxylin and eosin staining of the distal roots in the experimental group showed increased dentin thickness in the apical region. Conclusion Our results suggest that cyclophosphamide can result in short root lengths and early apical foramen closure, eventually leading to V-shaped or thin roots.	[Kawakami, Tomomi; Nakamura, Yuko; Karibe, Hiroyuki] Nippon Dent Univ Tokyo, Sch Life Dent Tokyo, Dept Pediat Dent, Tokyo, Japan	Nippon Dental University	Kawakami, T (corresponding author), Nippon Dent Univ Tokyo, Sch Life Dent Tokyo, Dept Pediat Dent, Tokyo, Japan.	tomomi-k@tky.ndu.ac.jp	Karibe, Hiroyuki/AAV-4446-2020; Kawakami, Tomomi/AAV-9978-2020		Japan Society for the Promotion of Science, Tokyo, Japan [20592416, 23593048]	Japan Society for the Promotion of Science, Tokyo, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was supported by grants-in-Aid for Scientific Research (C) 20592416 and (C) 23593048 from the Japan Society for the Promotion of Science, Tokyo, Japan.	Anton E, 1996, INT J EXP PATHOL, V77, P83, DOI 10.1046/j.1365-2613.1996.00967.x; Bagattoni S, 2014, EUR J PAEDIATR DENT, V15, P45; DAHLLOF G, 1994, ORAL SURG ORAL MED O, V77, P56, DOI 10.1016/S0030-4220(06)80107-6; Dahllof G, 1998, ACTA ODONTOL SCAND, V56, P378, DOI 10.1080/000163598428365; de Jonge ME, 2005, CLIN PHARMACOKINET, V44, P1135, DOI 10.2165/00003088-200544110-00003; Dickerman JD, 2007, PEDIATRICS, V119, P554, DOI 10.1542/peds.2006-2826; Duggal MS, 2003, ORAL ONCOL, V39, P178, DOI 10.1016/S1368-8375(02)00089-1; Effinger KE, 2014, SUPPORT CARE CANCER, V22, P2009, DOI 10.1007/s00520-014-2260-x; Gawade PL, 2014, PEDIATR BLOOD CANCER, V61, P407, DOI 10.1002/pbc.24842; Goho Curt, 1993, Pediatric Dentistry, V15, P6; Holtta P, 2002, BONE MARROW TRANSPL, V29, P121, DOI 10.1038/sj.bmt.1703330; Hsieh SGS, 2011, CANCER-AM CANCER SOC, V117, P2219, DOI 10.1002/cncr.25704; Hutton A, 2010, INT J PAEDIATR DENT, V20, P15, DOI 10.1111/j.1365-263X.2009.00999.x; Ide Y, 2015, ORAL DIS, V21, P232, DOI 10.1111/odi.12253; Ishida Y, 2014, BRIT J HAEMATOL, V164, P101, DOI 10.1111/bjh.12602; Ishida Y, 2010, INT J HEMATOL, V92, P95, DOI 10.1007/s12185-010-0611-z; Kaste SC, 1997, LEUKEMIA, V11, P792, DOI 10.1038/sj.leu.2400670; Kaste SC, 2009, CANCER-AM CANCER SOC, V115, P5817, DOI 10.1002/cncr.24670; Kawakami T, 2014, ODONTOLOGY; Lopes NNF, 2006, J DENT CHILD, V73, P140; Maeda Miho, 2008, Journal of Nippon Medical School, V75, P320; Mertens AC, 2015, CANCER-AM CANCER SOC, V121, P1108, DOI 10.1002/cncr.29170; Minicucci EM, 2003, LEUKEMIA RES, V27, P45, DOI 10.1016/S0145-2126(02)00080-2; Mitomi T, 2014, ARCH ORAL BIOL, V59, P47, DOI 10.1016/j.archoralbio.2013.09.009; Nasman M, 1997, ACTA ODONTOL SCAND, V55, P186, DOI 10.3109/00016359709115414; Nasman M, 1996, ACTA ODONTOL SCAND, V54, P287, DOI 10.3109/00016359609003540; Nemeth O, 2013, PEDIATR HEMAT ONCOL, V30, P208, DOI 10.3109/08880018.2013.763391; PAJARI U, 1995, MED PEDIATR ONCOL, V24, P310, DOI 10.1002/mpo.2950240508; Pedersen LB, 2012, INT J PAEDIATR DENT, V22, P239, DOI 10.1111/j.1365-263X.2011.01199.x; PURDELLLEWIS DJ, 1988, COMMUNITY DENT ORAL, V16, P68, DOI 10.1111/j.1600-0528.1988.tb01845.x; Remmers D, 2006, Orthod Craniofac Res, V9, P206; ROSENBERG SW, 1987, CANCER-AM CANCER SOC, V59, P1640, DOI 10.1002/1097-0142(19870501)59:9<1640::AID-CNCR2820590920>3.0.CO;2-V; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; SONIS AL, 1990, CANCER, V66, P2645, DOI 10.1002/1097-0142(19901215)66:12<2645::AID-CNCR2820661230>3.0.CO;2-S; Ten Cate A R, 1996, Oral Dis, V2, P55; THOMAS HF, 1995, INT J DEV BIOL, V39, P231; Vasconcelos NPS, 2009, FORENSIC SCI INT, V184, P10, DOI 10.1016/j.forsciint.2008.11.009	37	12	13	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0133256	10.1371/journal.pone.0133256	http://dx.doi.org/10.1371/journal.pone.0133256			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RV	26186337	Green Published, gold, Green Submitted			2022-12-26	WOS:000358198700115
J	Kitagawa, H; Munekage, M; Matsumoto, T; Sadakane, C; Fukutake, M; Aoki, K; Watanabe, J; Maemura, K; Hattori, T; Kase, Y; Uezono, Y; Inui, A; Hanazaki, K				Kitagawa, Hiroyuki; Munekage, Masaya; Matsumoto, Takashi; Sadakane, Chiharu; Fukutake, Miwako; Aoki, Katsuyuki; Watanabe, Junko; Maemura, Kazuya; Hattori, Tomohisa; Kase, Yosio; Uezono, Yasuhito; Inui, Akio; Hanazaki, Kazuhiro			Pharmacokinetic Profiles of Active Ingredients and Its Metabolites Derived from Rikkunshito, a Ghrelin Enhancer, in Healthy Japanese Volunteers: A Cross-Over, Randomized Study	PLOS ONE			English	Article							CISPLATIN-INDUCED ANOREXIA; LICORICE-INDUCED PSEUDOALDOSTERONISM; 5-HT2C RECEPTOR; MEDICINE; DAIKENCHUTO; YOKUKANSAN; STOMACH; PEPTIDE; ACID; RATS	Background Rikkunshito, a traditional Japanese (Kampo) medicine, has been used to treat upper gastrointestinal disorders such as functional dyspepsia and gastroesophageal reflux. This study investigated the exposure and pharmacokinetics of the ingredients of rikkunshito in healthy volunteers. Methods and Results First, an exploratory nonrandomized, open-label, one-period, noncrossover study using four healthy Japanese volunteers to detect 32 typical ingredients of rikkunshito in plasma and urine. As a result, 18 or 21 of 32 ingredients was detected in plasma or urine samples after oral administration of rikkunshito (7.5 g/day). Furthermore, a randomized, open-label, three-arm, three-period, crossover study using 21 subjects was conducted to determine the amounts of exposure and pharmacokinetic parameters of nine ingredients derived from rikkunshito (atractylodin, atractylodin carboxylic acid, pachymic acid, 3,30,40,5,6,7,8-heptamethoxyflavone, naringenin, nobiletin, liquiritigenin, isoliquiritigenin, and 18 beta-glycyrrhetinic acid) after oral administration of rikkunshito at three different doses (2.5, 5.0, or 7.5 g/day) during each period. The pharmacokinetic profiles of the nine ingredients in plasma were characterized. The geometric means (95% confidence interval) for the Cmax of the ingredients at a dose of 7.5 g were 1570 (1210-2040), 14,300 (12,200-16,800), 91.0 (71.8-115), 105 (75.6-144), 1150 (802-1650), 35.9 (24.6-52.5), 800 (672-952), 42.8 (30.4-60.3), and 55,600 (39,600-78,100) pg/mL, respectively, and for the AUC(0-last) were 1760 (12902390), 12700 (11,100-14,600), 1210 (882-1650), 225 (157-322), 4630 (2930-7320), 35.7 (20.4-62.7), 4040 (3260-5010), 122 (88.2-168), and 832,000 (628,000-1,100,000) pg.h/mL respectively. Conclusions We identified the ingredients of rikkunshito that are absorbed in humans. Furthermore, we determined the pharmacokinetics of nine ingredients derived from rikkunshito. This information will be useful for elucidating the pharmacological effects of rikkunshito.	[Kitagawa, Hiroyuki; Munekage, Masaya; Hanazaki, Kazuhiro] Kochi Univ, Kochi Med Sch, Dept Surg, Kochi 780, Japan; [Matsumoto, Takashi; Sadakane, Chiharu; Fukutake, Miwako; Watanabe, Junko; Maemura, Kazuya; Hattori, Tomohisa; Kase, Yosio] Tsumura & Co, Kampo Sci Strategies Div, Tsumura Res Labs, Ibaraki, Japan; [Aoki, Katsuyuki] Tsumura & Co, Kampo Formulat Dev Ctr, Prod Div, Ibaraki, Japan; [Uezono, Yasuhito] Natl Canc Ctr, Res Inst, Div Canc Pathophysiol, Tokyo 104, Japan; [Inui, Akio] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Psychosomat Internal Med, Kagoshima 890, Japan	Kochi University; Tsumura & Company; Tsumura & Company; National Cancer Center - Japan; Kagoshima University	Matsumoto, T (corresponding author), Tsumura & Co, Kampo Sci Strategies Div, Tsumura Res Labs, Ibaraki, Japan.	matsumoto_takashi@mail.tsumura.co.jp			Tsumura Co.	Tsumura Co.(Tsumura & Company)	Tsumura & Co., provided support in the form of salaries for authors TM, CS, MF, KA, JW, KM, TH and YK. The specific roles of these authors are articulated in the 'author contributions' section. This study was funded by Tsumura & Co. Tsumura & Co. was responsible for the study design, and the collection, analysis and interpretation of data.	[Anonymous], 1995, DRUG INFORM J; Asakawa A, 2001, GASTROENTEROLOGY, V120, P337, DOI 10.1053/gast.2001.22158; CONN JW, 1968, J AMER MED ASSOC, V205, P492, DOI 10.1001/jama.205.7.492; Fujitsuka N, 2011, TRANSL PSYCHIAT, V1, DOI 10.1038/tp.2011.25; Fujitsuka N, 2009, BIOL PSYCHIAT, V65, P748, DOI 10.1016/j.biopsych.2008.10.031; Gardana C, 2007, BRIT J NUTR, V98, P165, DOI 10.1017/S0007114507699358; Hisada T., 2014, DIAGNOSIS TREATMENT, V102, P1577; Kanaze FI, 2007, EUR J CLIN NUTR, V61, P472, DOI 10.1038/sj.ejcn.1602543; Kanno H, 2015, J ETHNOPHARMACOL, V159, P122, DOI 10.1016/j.jep.2014.10.058; Kawakami Z, 2010, EUR J PHARMACOL, V626, P154, DOI 10.1016/j.ejphar.2009.09.046; Kojima M, 1999, NATURE, V402, P656, DOI 10.1038/45230; KRAHENBUHL S, 1994, J CLIN ENDOCR METAB, V78, P581, DOI 10.1210/jc.78.3.581; Kushida H, 2013, BIOMED CHROMATOGR, V27, P1647, DOI 10.1002/bmc.2974; Lee KK, 2013, J ETHNOPHARMACOL, V145, P286, DOI 10.1016/j.jep.2012.11.005; Makino T, 2014, BIOL PHARM BULL, V37, P898, DOI 10.1248/bpb.b13-00997; Mondal MS, 2005, REGUL PEPTIDES, V126, P55, DOI 10.1016/j.regpep.2004.08.038; Munekage M, 2011, DRUG METAB DISPOS, V39, P1784, DOI 10.1124/dmd.111.040097; Nahata M, 2013, PSYCHONEUROENDOCRINO, DOI S0306-4530(13)00109-1 PMID: 23583320; Nakazato M, 2001, NATURE, V409, P194, DOI 10.1038/35051587; Nishi A, 2012, NEUROSCIENCE, V207, P124, DOI 10.1016/j.neuroscience.2012.01.037; Sadakane C, 2011, BIOCHEM BIOPH RES CO, V412, P506, DOI 10.1016/j.bbrc.2011.08.002; Sakata Y, 2014, BMC GASTROENTEROL, V14, DOI 10.1186/1471-230X-14-116; Smith BP, 2000, PHARMACEUT RES, V17, P1278, DOI 10.1023/A:1026451721686; Suzuki H, 2014, NEUROGASTROENT MOTIL, V26, P950, DOI 10.1111/nmo.12348; Takeda H, 2008, GASTROENTEROLOGY, V134, P2004, DOI 10.1053/j.gastro.2008.02.078; Tokita Y., 2007, Inflammopharmacology, V15, P65, DOI 10.1007/s10787-006-1552-2; Tominaga K, 2014, J GASTROENTEROL, V49, P1392, DOI 10.1007/s00535-013-0896-9; Wren AM, 2000, ENDOCRINOLOGY, V141, P4325, DOI 10.1210/en.141.11.4325; Yakabi K, 2010, REGUL PEPTIDES, V161, P97, DOI 10.1016/j.regpep.2010.02.003; Youdim KA, 2003, J NEUROCHEM, V85, P180, DOI 10.1046/j.1471-4159.2003.01652.x	30	31	32	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0133159	10.1371/journal.pone.0133159	http://dx.doi.org/10.1371/journal.pone.0133159			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RV	26186592	Green Submitted, gold, Green Published			2022-12-26	WOS:000358198700102
J	Liao, HW; Hung, PH; Hsiao, CY; Liou, HH; Lin, HS; Huang, TH; Jou, IM; Tsai, KJ				Liao, Hung-Wei; Hung, Peir-Haur; Hsiao, Chih-Yen; Liou, Hung-Hsiang; Lin, Hsin-Shih; Huang, Tsang-Hai; Jou, I-Ming; Tsai, Kuen-Jer			Relationship between Fibroblast Growth Factor 23 and Biochemical and Bone Histomorphometric Alterations in a Chronic Kidney Disease Rat Model Undergoing Parathyroidectomy	PLOS ONE			English	Article							CIRCULATING LEVELS; GENE-EXPRESSION; ORAL PHOSPHATE; RENAL-FAILURE; MOUSE MODEL; IN-VIVO; HORMONE; FGF-23; FGF23; PHOSPHORUS	Background Phosphate burden in chronic kidney disease (CKD) leads to elevated serum fibroblast factor-23 (FGF-23) levels, secondary hyperparathyroidism and chronic kidney disease-mineral bone disorder (CKD-MBD). However dissociated hyperphosphatemia and low serum FGF-23 concentrations have been observed in experimentally parathyoridectomized rats. The relationships between serum mineral, hormone, and bone metabolism may be altered in the presence of CKD. The aim of our study was to investigate whether a consistent relationship existed between serum FGF-23 levels, specific serum biochemical markers, and histomorphometric parameters of bone metabolism in a parathyroidectomized CKD animal model. Results Sprague Dawley rats were divided into 3 groups: parathyroidectomy (PTX) and CKD (PTX+CKD, 9 rats), CKD without PTX (CKD, 9 rats), and neither PTX nor CKD (sham-operated control, 8 rats); CKD was induced by partial nephrectomy. At 8 weeks after partial nephrectomy, serum biomarkers were measured. Bone histomorphometries of the distal femoral metaphyseal bone were analyzed. The mean serum FGF-23 levels and mean bone formation rate were the highest in the CKD group and the lowest in the PTX+CKD group. Bone volume parameters increased significantly in the PTX+CKD group. Pearson's correlation revealed that serum FGF-23 levels associated with those of intact parathyroid hormone, phosphate, collagen type I C-telopeptide, and calcium. Univariate linear regression showed that serum FGF-23 values correlated with bone formation rate, bone volume, and osteoid parameters. Stepwise multivariate regression analysis revealed that circulating FGF-23 values were independently associated with bone volume and thickness (beta = -0.737; p < 0.001 and beta = -0.526; p = 0.006, respectively). Serum parathyroid hormone levels independently correlated with bone formation rate (beta = 0.714; p < 0.001) while collagen type I C-telopeptide levels correlated with osteoid parameter. Conclusion Serum FGF-23 levels independently correlated with bone volume parameters in rats with experimentally induced CKD.	[Liao, Hung-Wei] Jia Yi Clin, Taoyuan, Taiwan; [Hung, Peir-Haur; Hsiao, Chih-Yen] Chia Yi Christian Hosp, Ditmanson Med Fdn, Dept Internal Med, Chiayi, Taiwan; [Hung, Peir-Haur] Chia Nan Univ Pharm & Sci, Dept Appl Life Sci & Hlth, Tainan, Taiwan; [Liou, Hung-Hsiang] Hsin Jen Hosp, Dept Med, Div Nephrol, New Taipei City, Taiwan; [Lin, Hsin-Shih; Huang, Tsang-Hai] Natl Cheng Kung Univ, Inst Phys Educ Hlth & Leisure Studies, Tainan 70101, Taiwan; [Jou, I-Ming] Natl Cheng Kung Univ, Coll Med, Dept Orthoped, Tainan 70101, Taiwan; [Tsai, Kuen-Jer] Natl Cheng Kung Univ, Coll Med, Inst Clin Med, Tainan 70101, Taiwan; [Tsai, Kuen-Jer] Natl Cheng Kung Univ, Coll Med, Natl Cheng Kung Univ Hosp, Ctr Clin Med, Tainan 70101, Taiwan	Chia Nan University of Pharmacy & Science; National Cheng Kung University; National Cheng Kung University; National Cheng Kung University; National Cheng Kung University; National Cheng Kung University Hospital	Tsai, KJ (corresponding author), Natl Cheng Kung Univ, Coll Med, Inst Clin Med, Tainan 70101, Taiwan.	kjtsai@mail.ncku.edu.tw	Tsai, Kuen-Jer/B-9393-2009; Tsai, Kuen-Jer/AAZ-2714-2021	Tsai, Kuen-Jer/0000-0002-2170-9735; Tsai, Kuen-Jer/0000-0002-2170-9735; Liao, Hung-Wei/0000-0003-3090-1937	National Cheng Kung University Hospital [NCKUH-10408012]; National Cheng Kung University	National Cheng Kung University Hospital; National Cheng Kung University	This study was supported by National Cheng Kung University Hospital (NCKUH-10408012) and National Cheng Kung University.	Abdelhadi M, 1998, J CLIN ENDOCR METAB, V83, P3845, DOI 10.1210/jc.83.11.3845; Asci G, 2011, NEPHROL DIAL TRANSPL, V26, P1010, DOI 10.1093/ndt/gfq491; Bonewald LF, 2011, J BONE MINER RES, V26, P229, DOI 10.1002/jbmr.320; Danziger J, 2008, NEPHROL DIAL TRANSPL, V23, P2733, DOI 10.1093/ndt/gfn260; David V, 2013, ENDOCRINOLOGY, V154, P4469, DOI 10.1210/en.2013-1627; Desjardins L, 2012, OSTEOPOROSIS INT, V23, P2017, DOI 10.1007/s00198-011-1838-0; El-Abbadi MM, 2009, KIDNEY INT, V75, P1297, DOI 10.1038/ki.2009.83; Eriksen EF, 2010, REV ENDOCR METAB DIS, V11, P219, DOI 10.1007/s11154-010-9153-1; Evenepoel P, 2010, CLIN J AM SOC NEPHRO, V5, P1268, DOI 10.2215/CJN.08241109; Ferreira JC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079721; Fukagawa M, 2003, NEPHROL DIAL TRA S10, V17, P2; Glorieux FH, 2000, BONE, V26, P103, DOI 10.1016/S8756-3282(99)00257-4; Graciolli FG, 2009, NEPHROL DIAL TRANSPL, V24, P1416, DOI 10.1093/ndt/gfn686; Gutierrez O, 2005, J AM SOC NEPHROL, V16, P2205, DOI 10.1681/ASN.2005010052; HRUSKA KA, 1995, NEW ENGL J MED, V333, P166, DOI 10.1056/NEJM199507203330307; Jilka RL, 2007, BONE, V40, P1434, DOI 10.1016/j.bone.2007.03.017; Kawata T, 2007, J AM SOC NEPHROL, V18, P2683, DOI 10.1681/ASN.2006070783; Lane NE, 2013, J BONE MINER RES, V28, P2325, DOI 10.1002/jbmr.1985; Lavi-Moshayoff V, 2010, AM J PHYSIOL-RENAL, V299, pF882, DOI 10.1152/ajprenal.00360.2010; Li X, 2007, J BIOL CHEM, V282, P33086, DOI 10.1074/jbc.M705194200; Lopez I, 2011, KIDNEY INT, V80, P475, DOI 10.1038/ki.2011.107; Lu KC, 2012, CLIN ENDOCRINOL, V76, P634, DOI 10.1111/j.1365-2265.2011.04265.x; Mackenzie NCW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032177; Manghat P, 2010, OSTEOPOROSIS INT, V21, P1853, DOI 10.1007/s00198-009-1142-4; Martin KJ, 2007, J AM SOC NEPHROL, V18, P875, DOI 10.1681/ASN.2006070771; Mazzaferro S, 2000, NEPHROL DIAL TRANSPL, V15, P877, DOI 10.1093/ndt/15.6.877; Mittalhenkle A, 2004, AM J KIDNEY DIS, V44, P672, DOI 10.1053/j.ajkd.2004.07.001; Moe S, 2006, KIDNEY INT, V69, P1945, DOI 10.1038/sj.ki.5000414; Muras K, 2013, J CLIN ENDOCR METAB, V98, pE1901, DOI 10.1210/jc.2013-2418; Nishida Y, 2006, KIDNEY INT, V70, P2141, DOI 10.1038/sj.ki.5002000; Ott SM, 2008, CLIN J AM SOC NEPHRO, V3, pS151, DOI 10.2215/CJN.04301206; PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617; Pereira RC, 2009, BONE, V45, P1161, DOI 10.1016/j.bone.2009.08.008; PERETZ AM, 1992, J RHEUMATOL, V19, P411; Perwad F, 2007, AM J PHYSIOL-RENAL, V293, pF1577, DOI 10.1152/ajprenal.00463.2006; Razzaque MS, 2007, J ENDOCRINOL, V194, P1, DOI 10.1677/JOE-07-0095; Reyes-Garcia R, 2014, DIABETES CARE, V37, pE89, DOI 10.2337/dc13-2235; Rhee Y, 2011, BONE, V49, P636, DOI 10.1016/j.bone.2011.06.025; RODRIGUEZ M, 1991, KIDNEY INT, V40, P1063, DOI 10.1038/ki.1991.315; Rodriguez-Ortiz ME, 2012, J AM SOC NEPHROL, V23, P1190, DOI 10.1681/ASN.2011101006; Samadfam R, 2009, ENDOCRINOLOGY, V150, P4835, DOI 10.1210/en.2009-0472; Sato T, 2004, AM J KIDNEY DIS, V44, P481, DOI 10.1053/j.ajkd.2004.05.026; Seiler S, 2009, KIDNEY INT, V76, pS34, DOI 10.1038/ki.2009.405; Shalhoub V, 2011, CALCIFIED TISSUE INT, V89, P140, DOI 10.1007/s00223-011-9501-5; SHERRARD DJ, 1993, KIDNEY INT, V43, P436, DOI 10.1038/ki.1993.64; Shimada T, 2004, BIOCHEM BIOPH RES CO, V314, P409, DOI 10.1016/j.bbrc.2003.12.102; Stubbs JR, 2012, J BONE MINER RES, V27, P38, DOI 10.1002/jbmr.516; Vervloet MG, 2011, CLIN J AM SOC NEPHRO, V6, P383, DOI 10.2215/CJN.04730510; Wesseling-Perry K, 2012, CLIN J AM SOC NEPHRO, V7, P146, DOI 10.2215/CJN.05940611; Wesseling-Perry K, 2009, J CLIN ENDOCR METAB, V94, P511, DOI 10.1210/jc.2008-0326; West SL, 2010, BMC NEPHROL, V11, DOI 10.1186/1471-2369-11-17; Wheater G, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-201; Yajima A, 2010, J BONE MINER RES, V25, P2374, DOI 10.1002/jbmr.126; Yoda K, 2012, J CLIN ENDOCR METAB, V97, pE2036, DOI 10.1210/jc.2012-2024; Yoshiko Y, 2007, BONE, V40, P1565, DOI 10.1016/j.bone.2007.01.017	55	5	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0133278	10.1371/journal.pone.0133278	http://dx.doi.org/10.1371/journal.pone.0133278			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RV	26186634	Green Published, gold, Green Submitted			2022-12-26	WOS:000358198700119
J	Rasamiravaka, T; Vandeputte, OM; Pottier, L; Huet, J; Rabemanantsoa, C; Kiendrebeogo, M; Andriantsimahavandy, A; Rasamindrakotroka, A; Stevigny, C; Duez, P; El Jaziri, M				Rasamiravaka, Tsiry; Vandeputte, Olivier M.; Pottier, Laurent; Huet, Joelle; Rabemanantsoa, Christian; Kiendrebeogo, Martin; Andriantsimahavandy, Abel; Rasamindrakotroka, Andry; Stevigny, Caroline; Duez, Pierre; El Jaziri, Mondher			Pseudomonas aeruginosa Biofilm Formation and Persistence, along with the Production of Quorum Sensing-Dependent Virulence Factors, Are Disrupted by a Triterpenoid Coumarate Ester Isolated from Dalbergia trichocarpa, a Tropical Legume	PLOS ONE			English	Article							EXTRACELLULAR POLYMERIC SUBSTANCES; CAENORHABDITIS-ELEGANS; TWITCHING MOTILITY; SMALL RNAS; TRANSCRIPTIONAL REGULATION; ACYLHOMOSERINE LACTONES; BACTERIAL PATHOGENS; HOMOSERINE LACTONE; INFECTION MODEL; URSOLIC ACIDS	Recently, extracts of Dalbergia trichocarpabark have been shown to disrupt P. aeruginosa-PAO1 quorum sensing (QS) mechanisms, which are key regulators of virulence factor expression and implicated in biofilm formation. One of the active compounds has been isolated and identified as oleanolic aldehyde coumarate (OALC), a novel bioactive compound that inhibits the formation of P. aeruginosa PAO1 biofilm and its maintenance as well as the expression of the las and rhl QS systems. Consequently, the production of QS-controlled virulence factors including, rhamnolipids, pyocyanin, elastase and extracellular polysaccharides as well as twitching and swarming motilities is reduced. Native acylhomoserine lactones (AHLs) production is inhibited by OALC but exogenous supply of AHLs does not restore the production of virulence factors by OALC-treated cultures, indicating that OALC exerts its effect beyond AHLs synthesis in the QS pathways. Further experiments provided a significant inhibition of the global virulence factor activator gacA by OALC. OALC disorganizes established biofilm structure and improves the bactericidal activity of tobramycin against biofilm-encapsulated PAO1 cells. Finally, a significant reduction of Caenorhabditis elegans paralysis was recorded when the worms were infected with OALC-pre-treated P. aeruginosa. Taken together, these results show that triterpenoid coumarate esters are suitable chemical backbones to target P. aeruginosa virulence mechanisms.	[Rasamiravaka, Tsiry; Vandeputte, Olivier M.; Kiendrebeogo, Martin; El Jaziri, Mondher] Univ Libre Bruxelles, Lab Biotechnol Vegetale, Gosselies, Belgium; [Rasamiravaka, Tsiry; Andriantsimahavandy, Abel; Rasamindrakotroka, Andry] Univ Antananarivo, Fac Med, Lab Format & Rech Biol Med, Antananarivo, Madagascar; [Pottier, Laurent; Huet, Joelle; Stevigny, Caroline; Duez, Pierre] Univ Libre Bruxelles, Lab Pharmacognosie Bromatol & Nutr Humaine, Brussels, Belgium; [Rabemanantsoa, Christian] Inst Malgache Rech Appl, Lab Biodiversite & Biotechnol, Antananarivo, Madagascar; [Kiendrebeogo, Martin] Univ Ouagadougou, Lab Biochim & Chim Appl, Ouagadougou, Burkina Faso; [Duez, Pierre] Univ Mons, Serv Chim Therapeut & Pharmacognosie, B-7000 Mons, Belgium	Universite Libre de Bruxelles; University Antananarivo; Universite Libre de Bruxelles; University of Mons	El Jaziri, M (corresponding author), Univ Libre Bruxelles, Lab Biotechnol Vegetale, Gosselies, Belgium.	jaziri@ulb.ac.be	KIENDREBEOGO, Martin/F-5714-2011	Duez, Pierre/0000-0002-0484-1478	(Academie de Recherche et d'Enseignement Superieur-Commission de Cooperation au developpement) ARES-CCD; Universite Libre de Bruxelles Fonds Alice et David Van Buuren	(Academie de Recherche et d'Enseignement Superieur-Commission de Cooperation au developpement) ARES-CCD; Universite Libre de Bruxelles Fonds Alice et David Van Buuren	The study received funding from (Academie de Recherche et d'Enseignement Superieur-Commission de Cooperation au developpement) ARES-CCD "Projet PIC 2009-Madagascar" and from Universite Libre de Bruxelles Fonds Alice et David Van Buuren 2013-El Jaziri. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adonizio A, 2008, J MED MICROBIOL, V57, P809, DOI 10.1099/jmm.0.47802-0; Albus AM, 1997, J BACTERIOL, V179, P3928, DOI 10.1128/jb.179.12.3928-3935.1997; An SW, 2010, APPL ENVIRON MICROB, V76, P8160, DOI 10.1128/AEM.01233-10; Azam A. T. M. Z., 2013, Research Journal of Phytochemistry, V7, P1; Billings N, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003526; Blackledge MS, 2013, CURR OPIN PHARMACOL, V13, P699, DOI 10.1016/j.coph.2013.07.004; Bodini SF, 2009, LETT APPL MICROBIOL, V49, P551, DOI 10.1111/j.1472-765X.2009.02704.x; Brencic A, 2009, MOL MICROBIOL, V73, P434, DOI 10.1111/j.1365-2958.2009.06782.x; Brink M., 2008, DALBERGIA TRICHOCARP; Busetti A, 2015, MAR DRUGS, V13, P1, DOI 10.3390/md13010001; Byrd MS, 2011, INFECT IMMUN, V79, P3087, DOI 10.1128/IAI.00057-11; Cady NC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038492; Christensen LD, 2012, J ANTIMICROB CHEMOTH, V67, P1198, DOI 10.1093/jac/dks002; Chua SL, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5462; Colvin KM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001264; Darby C, 1999, P NATL ACAD SCI USA, V96, P15202, DOI 10.1073/pnas.96.26.15202; DARZINS A, 1993, J BACTERIOL, V175, P5934, DOI 10.1128/JB.175.18.5934-5944.1993; Das T, 2015, SCI REP-UK, V5, DOI 10.1038/srep08398; Davey ME, 2003, J BACTERIOL, V185, P1027, DOI 10.1128/JB.185.3.1027-1036.2003; de Kievit TR, 2009, ENVIRON MICROBIOL, V11, P279, DOI 10.1111/j.1462-2920.2008.01792.x; Deep Antariksh, 2011, J Lab Physicians, V3, P4, DOI 10.4103/0974-2727.78553; Defoirdt T, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000989; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; Franklin MJ, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00167; Gallagher LA, 2001, J BACTERIOL, V183, P6207, DOI 10.1128/JB.183.21.6207-6214.2001; Giannakaki Venetia, 2012, Recent Pat Antiinfect Drug Discov, V7, P182; Glessner A, 1999, J BACTERIOL, V181, P1623, DOI 10.1128/JB.181.5.1623-1629.1999; Gnoula C, 2007, TALANTA, V71, P1886, DOI 10.1016/j.talanta.2006.08.025; Gong AS, 2009, ENVIRON ENG SCI, V26, P1523, DOI 10.1089/ees.2008.0398; Gupta P, 2013, INDIAN J MED MICROBI, V31, P29, DOI 10.4103/0255-0857.108715; Hentzer M, 2002, MICROBIOL-SGM, V148, P87, DOI 10.1099/00221287-148-1-87; Hoge R., 2010, CURR RES TECHNOL ED, P383; Hope IA, 1999, C ELEGANS A PRACTICA; Hu JF, 2006, J NAT PROD, V69, P118, DOI 10.1021/np049600s; Imperi F, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00178; Irie Y, 2010, MOL MICROBIOL, V78, P158, DOI 10.1111/j.1365-2958.2010.07320.x; Ishida T, 2007, APPL ENVIRON MICROB, V73, P3183, DOI 10.1128/AEM.02233-06; Jackson KD, 2004, J BACTERIOL, V186, P4466, DOI 10.1128/JB.186.14.4466-4475.2004; Jacobs MA, 2003, P NATL ACAD SCI USA, V100, P14339, DOI 10.1073/pnas.2036282100; Jakobsen TH, 2012, ANTIMICROB AGENTS CH, V56, P2314, DOI 10.1128/AAC.05919-11; Jermain JD, 2009, J FORENSIC SCI, V54, P612, DOI 10.1111/j.1556-4029.2009.00999.x; Jimenez PN, 2012, MICROBIOL MOL BIOL R, V76, P46, DOI 10.1128/MMBR.05007-11; Kalia VC, 2011, CRIT REV MICROBIOL, V37, P121, DOI 10.3109/1040841X.2010.532479; Kay E, 2006, J BACTERIOL, V188, P6026, DOI 10.1128/JB.00409-06; Khalilzadeh P, 2010, CAN J MICROBIOL, V56, P317, DOI [10.1139/w10-013, 10.1139/W10-013]; Kim HS, 2015, SCI REP-UK, V5, DOI 10.1038/srep08656; Kiplimo JJ, 2011, AFR J PHARM PHARMACO, V5, P1150; Klausen M, 2003, MOL MICROBIOL, V50, P61, DOI 10.1046/j.1365-2958.2003.03677.x; Klausen M, 2003, MOL MICROBIOL, V48, P1511, DOI 10.1046/j.1365-2958.2003.03525.x; KNUTSON CA, 1968, ANAL BIOCHEM, V24, P470, DOI 10.1016/0003-2697(68)90154-1; Kohler T, 2000, J BACTERIOL, V182, P5990, DOI 10.1128/JB.182.21.5990-5996.2000; Kretzschmar U, 2008, ARCH MICROBIOL, V190, P151, DOI 10.1007/s00203-008-0381-7; Kuo YH, 1997, PHYTOCHEMISTRY, V46, P1135, DOI 10.1016/S0031-9422(97)00227-6; Kuo YH, 2002, J CHIN CHEM SOC-TAIP, V49, P269, DOI 10.1002/jccs.200200042; LaSarre B, 2013, MICROBIOL MOL BIOL R, V77, P73, DOI 10.1128/MMBR.00046-12; Latifi A, 1996, MOL MICROBIOL, V21, P1137, DOI 10.1046/j.1365-2958.1996.00063.x; Lewis K, 2013, NAT REV DRUG DISCOV, V12, P371, DOI 10.1038/nrd3975; Li YH, 2012, SENSORS-BASEL, V12, P2519, DOI 10.3390/s120302519; Livermore DM, 2012, INT J ANTIMICROB AG, V39, P283, DOI 10.1016/j.ijantimicag.2011.12.012; Ma L, 2006, J BACTERIOL, V188, P8213, DOI 10.1128/JB.01202-06; Ma LM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000354; Maatta KR, 2003, J AGR FOOD CHEM, V51, P6736, DOI 10.1021/jf0347517; Makemson J, 2006, LUMINESCENCE, V21, P1, DOI 10.1002/bio.873; McKnight SL, 2000, J BACTERIOL, V182, P2702, DOI 10.1128/JB.182.10.2702-2708.2000; Medina G, 2003, MICROBIOL-SGM, V149, P3073, DOI 10.1099/mic.0.26282-0; Mogayzel PJ, 2013, AM J RESP CRIT CARE, V187, P680, DOI 10.1164/rccm.201207-1160OE; Moreau-Marquis S, 2015, J ANTIMICROB CHEMOTH, V70, P160, DOI 10.1093/jac/dku357; Muh U, 2006, ANTIMICROB AGENTS CH, V50, P3674, DOI 10.1128/AAC.00665-06; Narayanan MC, 2007, NAT PROD RES, V21, P903, DOI 10.1080/14786410601130091; Nickzad A, 2014, LETT APPL MICROBIOL, V58, P447, DOI 10.1111/lam.12211; O'Toole GA, 2003, J BACTERIOL, V185, P2687, DOI 10.1128/JB.185.9.2687-2689.2003; O'Toole GA, 1998, MOL MICROBIOL, V30, P295, DOI 10.1046/j.1365-2958.1998.01062.x; Pamp SJ, 2007, J BACTERIOL, V189, P2531, DOI 10.1128/JB.01515-06; Papaioannou E, 2013, INT J MOL SCI, V14, P19309, DOI 10.3390/ijms140919309; Patriquin GM, 2008, J BACTERIOL, V190, P662, DOI 10.1128/JB.01473-07; Perez-Martinez I, 2011, ANTIMICROB AGENTS CH, V55, P3399, DOI 10.1128/AAC.01801-10; Pessi G, 2001, J BACTERIOL, V183, P6676, DOI 10.1128/JB.183.22.6676-6683.2001; Pinzon NM, 2009, APPL MICROBIOL BIOT, V82, P975, DOI 10.1007/s00253-009-1896-9; Rajaonson S, 2011, ENVIRON MICROBIOL, V13, P1236, DOI 10.1111/j.1462-2920.2011.02424.x; Rasamiravaka T, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/759348; Rasamiravaka T, 2013, MICROBIOL-SGM, V159, P924, DOI 10.1099/mic.0.064378-0; Rasmussen TB, 2005, J BACTERIOL, V187, P1799, DOI 10.1128/JB.187.5.1799-1814.2005; Ravindranath N, 2004, CHEM PHARM BULL, V52, P608, DOI 10.1248/cpb.52.608; Reardon S., 2014, NATURE, DOI [10.1038/nature.2014.15135, DOI 10.1038/NATURE.2014.15135.N, DOI 10.1038/NATURE.2014.15135]; Reimmann C, 1997, MOL MICROBIOL, V24, P309, DOI 10.1046/j.1365-2958.1997.3291701.x; Reis RS, 2011, BIORESOURCE TECHNOL, V102, P6377, DOI 10.1016/j.biortech.2011.03.074; Rutherford ST, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a012427; Sakuragi Y, 2007, J BACTERIOL, V189, P5383, DOI 10.1128/JB.00137-07; Sauer K, 2004, J BACTERIOL, V186, P7312, DOI 10.1128/JB.186.21.7312-7326.2004; Shrout JD, 2006, MOL MICROBIOL, V62, P1264, DOI 10.1111/j.1365-2958.2006.05421.x; SMITH AW, 1989, NUCLEIC ACIDS RES, V17, P10509, DOI 10.1093/nar/17.24.10509; Songsiang U, 2009, FITOTERAPIA, V80, P427, DOI 10.1016/j.fitote.2009.06.002; Stalikas CD, 2007, J SEP SCI, V30, P3268, DOI 10.1002/jssc.200700261; Takahashi H, 1999, PHYTOCHEMISTRY, V51, P543, DOI 10.1016/S0031-9422(99)00070-9; Tanachatchairatana T, 2008, CHEM PHARM BULL, V56, P194, DOI 10.1248/cpb.56.194; Tay SB, 2013, INT J MOL SCI, V14, P16570, DOI 10.3390/ijms140816570; Tolker-Nielsen T, 2014, APMIS, V122, P1, DOI 10.1111/apm.12335; Torino MI, 2001, J APPL MICROBIOL, V91, P846, DOI 10.1046/j.1365-2672.2001.01450.x; Tseng BS, 2013, ENVIRON MICROBIOL, V15, P2865, DOI 10.1111/1462-2920.12155; Vandeputte OM, 2011, MICROBIOL-SGM, V157, P2120, DOI 10.1099/mic.0.049338-0; Vandeputte OM, 2010, APPL ENVIRON MICROB, V76, P243, DOI 10.1128/AEM.01059-09; Ventre I, 2006, P NATL ACAD SCI USA, V103, P171, DOI 10.1073/pnas.0507407103; von Rosenvinge EC, 2013, PATHOG DIS, V67, P25, DOI 10.1111/2049-632X.12020; Wade DS, 2005, J BACTERIOL, V187, P4372, DOI 10.1128/JB.187.13.4372-4380.2005; Wagner VE, 2008, CLIN REV ALLERG IMMU, V35, P124, DOI 10.1007/s12016-008-8079-9; Wei Q, 2013, INT J MOL SCI, V14, P20983, DOI 10.3390/ijms141020983; WHO-World Health Organization, 2014, ANTIMICROBIAL RESIST; Williams P, 2009, CURR OPIN MICROBIOL, V12, P182, DOI 10.1016/j.mib.2009.01.005; Wolska KI, 2010, CENT EUR J BIOL, V5, P543, DOI 10.2478/s11535-010-0045-x; Yang L, 2011, ENVIRON MICROBIOL, V13, P1705, DOI 10.1111/j.1462-2920.2011.02503.x; Yang ZG, 2007, CHEM PHARM BULL, V55, P15, DOI 10.1248/cpb.55.15; ZHANG XG, 1995, J BIOL CHEM, V270, P11181, DOI 10.1074/jbc.270.19.11181; Zhou LM, 2013, BIOTECHNOL LETT, V35, P631, DOI 10.1007/s10529-012-1126-x	114	61	65	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0132791	10.1371/journal.pone.0132791	http://dx.doi.org/10.1371/journal.pone.0132791			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RV	26186595	Green Submitted, gold, Green Published			2022-12-26	WOS:000358198700062
J	Sandoval-Sierra, JV; Dieguez-Uribeondo, J				Sandoval-Sierra, Jose Vladimir; Dieguez-Uribeondo, Javier			A Comprehensive Protocol for Improving the Description of Saprolegniales (Oomycota): Two Practical Examples (Saprolegnia aenigmatica sp nov and Saprolegnia racemosa sp nov.)	PLOS ONE			English	Article							SPECIES DELIMITATION; DNA TAXONOMY; PARASITICA; IDENTIFICATION; STRAMINIPILA; DICLINA; AQUACULTURE; CHALLENGES; FUNGI; RIVER	The description, identification and classification of organisms are the pillar in biodiversity and evolutionary studies. The fungal-like organism Saprolegnia contains important animal pathogens. However, its taxonomy is weak, making it difficult to perform further studies. This problem mainly arises from the unavailability of suitable holotypes. We propose a standardized protocol for describing Saprolegnia spp. that includes good cultural practices and proper holotype preservation. In order to illustrate this new proposal, we describe two species, Saprolegnia aenigmatica sp. nov. and Saprolegnia racemosa sp. nov., based on the recently described molecular operational taxonomic units (MOTUs), phylogenetic relationships, and the analyses of morphological features. We show that they belong to two different MOTUs that are grouped into two sister clades. Morphologically, we find that S. racemosa exhibits a species-specific character, i.e., aggrupation of oogonia in racemes, while S. aenigmatica does not have any specific characters. Analyses of a combined set of characters, i.e., length and breadth of sporangia, length/breadth ratio (l/b) of oogonia, cyst and oospore diameter, and the number of oospores per oogomium, allow distinguishing these two species. To improve Saprolegnia taxonomy, we propose to incorporate into the protologue: (i) several isolates of the new species; (ii) the rDNA sequences to compare them to data-bases of Saprolegnia sequences of reference; (iii) a phylogenetic analysis to check relationships with other species; (iv) to preserve holotypes in absolute ethanol and to include lyophilized material from holotype; and (v) the ex-type as a pure culture from single-spore isolates stored in at least two different collections.	[Sandoval-Sierra, Jose Vladimir; Dieguez-Uribeondo, Javier] CSIC, Dept Micol, Real Jardin Bot, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Real Jardin Botanico de Madrid	Dieguez-Uribeondo, J (corresponding author), CSIC, Dept Micol, Real Jardin Bot, Madrid, Spain.	dieguez@rjb.csic.es	dieguez-uribeondo, javier/I-2178-2015; Sandoval, Vladimir/GYD-5018-2022; Diéguez-Uribeondo, Javier/ABF-1130-2021	dieguez-uribeondo, javier/0000-0002-4488-0658; Sandoval, Vladimir/0000-0003-2007-6582; Diéguez-Uribeondo, Javier/0000-0002-4488-0658	European Union [ITN-SAPRO-238550]; Ministerio de Economia y Competitividad [CGL2012-39357]; Foundation San Ignacio del Huinay, Endesa, Chile	European Union(European Commission); Ministerio de Economia y Competitividad(Spanish Government); Foundation San Ignacio del Huinay, Endesa, Chile	The funding or sources of support were grants of: (1) European Union (ITN-SAPRO-238550), (2) Ministerio de Economia y Competitividad (CGL2012-39357), which supported lab-bench expenses, experiments, and sampling, and (3) Foundation San Ignacio del Huinay, Endesa, Chile, which supported sampling expenses in the field station of San Ignacio del Huinay Chile. Moreover, Jose V. Sandoval-Sierra was supported by fellowships from ITN-SAPRO-238550 and Ministerio de Economia y Competitividad (CGL2012-39357). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beakes GW, 1994, SALMON SAPROLEGNIASI, P33; Benson D.A., 2014, NUCL ACIDS RES, V42, P32, DOI [DOI 10.1017/S1462399401002204, DOI 10.1093/nar/gkx1094]; BURR AW, 1994, PROTOPLASMA, V181, P142, DOI 10.1007/BF01666393; Chakrabarty P, 2010, ZOOTAXA, P67, DOI 10.11646/zootaxa.2632.1.4; Coker WC., 1923, SAPROLEGNIACEAE NOTE; Crous PW, 2004, STUD MYCOL, P19; Crous PW, 2002, MYCOL RES, V106, P1378, DOI 10.1017/S0953756202227136; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Day JG, 2010, TAXON, V59, P3, DOI 10.1002/tax.591001; Dieguez-Uribeondo J, 2007, FUNGAL GENET BIOL, V44, P585, DOI 10.1016/j.fgb.2007.02.010; Eissa AE, 2013, INT J VET SCI MED, V1, P7, DOI 10.1016/j.ijvsm.2013.04.001; ELLIOTT RUTH F., 1968, N Z J BOT, V6, P94; Federhen S, 2015, NUCLEIC ACIDS RES, V43, pD1086, DOI 10.1093/nar/gku1127; Fernandez-Beneitez MJ, 2008, FEMS MICROBIOL LETT, V279, P23, DOI 10.1111/j.1574-6968.2007.01002.x; Fontaneto D, 2014, INT REV HYDROBIOL, V99, P178, DOI 10.1002/iroh.201301719; Godfray HCJ, 2002, NATURE, V417, P17, DOI 10.1038/417017a; Goker M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006319; HATAI K, 1977, Fish Pathology, V12, P105; Inaba Shigeki, 2002, Mycoscience, V43, P73, DOI 10.1007/s102670200011; Johnson Jr TW, BIOL SYSTEMATICS SAP; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Leliaert F, 2014, EUR J PHYCOL, V49, P179, DOI 10.1080/09670262.2014.904524; Leliaert F, 2009, MOL PHYLOGENET EVOL, V53, P122, DOI 10.1016/j.ympev.2009.06.004; McNeill J, 2012, 18 INT BOT C MELB AU; MOLINA FI, 1995, ANTON LEEUW INT J G, V68, P65, DOI 10.1007/BF00873294; Mutanen M, 2015, MOL ECOL RESOUR, V15, P967, DOI 10.1111/1755-0998.12361; Paul B, 2004, FEMS MICROBIOL LETT, V237, P393, DOI 10.1016/j.femsle.2004.07.006; Perotti MG, 2013, AUSTRAL ECOL, V38, P672, DOI 10.1111/aec.12014; Pons J, 2006, SYST BIOL, V55, P595, DOI 10.1080/10635150600852011; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Redecker D, 2013, MYCORRHIZA, V23, P515, DOI 10.1007/s00572-013-0486-y; Rezinciuc S, 2014, FUNGAL BIOL-UK, V118, P591, DOI 10.1016/j.funbio.2013.11.011; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; SEYMOUR R. L., 1970, Nova Hedwigia, V19, P1; Silvestro D, 2012, ORG DIVERS EVOL, V12, P335, DOI 10.1007/s13127-011-0056-0; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Steciow MM, 2002, NEW ZEAL J BOT, V40, P679; Steciow MM, 2002, NEW ZEAL J BOT, V40, P473; Steciow MM, 2001, NEW ZEAL J BOT, V39, P483; Steciow M'OM, 2007, FEMS MICROBIOL LETT, V268, P225, DOI 10.1111/j.1574-6968.2006.00582.x; Steciow WM, 2003, FEMS MICROBIOL LETT, V219, P253, DOI 10.1016/S0378-1097(03)00024-7; van den Berg AH, 2013, FUNGAL BIOL REV, V27, P33, DOI 10.1016/j.fbr.2013.05.001; Van West Pieter, 2006, Mycologist, V20, P99, DOI 10.1016/j.mycol.2006.06.004; Venables WN., 2002, MODERN APPL STAT S 4; Sandoval-Sierra JV, 2014, AQUACULTURE, V434, P462, DOI 10.1016/j.aquaculture.2014.09.005; Sandoval-Sierra JV, 2014, FUNGAL BIOL-UK, V118, P559, DOI 10.1016/j.funbio.2013.10.005; White TJ., 1990, PCR PROTOCOLS GUIDE, P315; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Willoughby LG, 1998, NOVA HEDWIGIA, V66, P507	50	19	22	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0132999	10.1371/journal.pone.0132999	http://dx.doi.org/10.1371/journal.pone.0132999			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RV	26186364	Green Published, Green Submitted, gold			2022-12-26	WOS:000358198700083
J	Tanito, M; Kaidzu, S; Takai, Y; Ohira, A				Tanito, Masaki; Kaidzu, Sachiko; Takai, Yasuyuki; Ohira, Akihiro			Correlation between Systemic Oxidative Stress and Intraocular Pressure Level	PLOS ONE			English	Article							OPEN-ANGLE GLAUCOMA; REACTIVE OXYGEN METABOLITES; TRABECULAR MESHWORK CELLS; TOTAL ANTIOXIDANT STATUS; NORMAL-TENSION GLAUCOMA; D-ROMS TEST; AQUEOUS-HUMOR; PSEUDOEXFOLIATION SYNDROME; EXFOLIATION SYNDROME; SULFHYDRYL-GROUPS	Background The involvement of local and systemic oxidative stress in intraocular pressure (IOP) elevation and optic nerve damage has been hypothesized in the pathogenesis of glaucoma. We reported previously that the level of systemic antioxidative capacity is lower in patients with open-angle glaucoma than controls without glaucoma. Here, we assessed the correlation between IOP and systemic levels of prooxidants and antioxidants by analyzing the blood biochemistry in patients with glaucoma. Methods Peripheral blood samples were collected from Japanese patients with primary open-angle glaucoma (n = 206), exfoliation syndrome (n = 199), and controls (n = 126). Serum levels of lipid peroxides, ferric-reducing activity, and thiol antioxidant activity were measured by diacron reactive oxygen metabolite (dROM), biological antioxidant potential (BAP), and sulfhydryl (SH) tests, respectively, using a free radical analyzer. To test the possible effect of oxidative stress on IOP levels, the patients were classified into one of four groups (Q1, Q2, Q3, and Q4, with Q1 having the lowest IOP) based on the quartile value of IOP. For this classification, the known highest IOP value in both the right and left eyes was regarded as each subject's IOP. For comparisons among the IOP groups, the differences were calculated using one-way analysis of variance followed by post-hoc unpaired t-tests. To adjust for differences in demographic characteristic distributions, the dROM, BAP, and SH test values were compared among the IOP groups using multiple logistic regression analysis; the odds ratio (OR) of each variable was calculated with the Q1 group as the reference. Results The dROM and the SH levels did not differ significantly (p = 0.6704 and p = 0.6376, respectively) among the four IOP groups. The BAP levels differed significantly (p = 0.0115) among the four IOP groups; the value was significantly lower in the Q4 group (1,932 mu mol/L) compared with the Q1 (2,023 mu mol/L, p = 0.0042) and Q2 (2,003 mu mol/L, p = 0.0302) groups and significantly lower in the Q3 group (1,948 mu mol/L) than the Q1 (p = 0.0174) group. After adjustment for differences in various demographic characteristics, lower BAP values were significantly associated with the classification into higher IOP groups (Q3 group, p = 0.0261 and OR = 0.06/range; Q4 group, p = 0.0018 and OR = 0.04/range). The dROM and SH values did not reach significance in any comparisons. Conclusions Lower systemic antioxidant capacity measured by ferric-reducing activity is involved in the pathogenesis of open-angle glaucoma via its roles in IOP elevation.	[Tanito, Masaki] Matsue Red Cross Hosp, Div Ophthalmol, Matsue, Shimane, Japan; [Tanito, Masaki; Kaidzu, Sachiko; Takai, Yasuyuki; Ohira, Akihiro] Shimane Univ, Dept Ophthalmol, Fac Med, Izumo, Shimane, Japan	Shimane University	Tanito, M (corresponding author), Matsue Red Cross Hosp, Div Ophthalmol, Matsue, Shimane, Japan.	tanito-oph@umin.ac.jp	; ohira, akihiro/G-8352-2017	TAKAI, YASUYUKI/0000-0003-3881-3624; Kaidzu, Sachiko/0000-0002-3324-6678; ohira, akihiro/0000-0002-1307-5592	Imai Memorial Glaucoma Research Foundation; Suda Memorial Glaucoma Research Foundation	Imai Memorial Glaucoma Research Foundation; Suda Memorial Glaucoma Research Foundation	Research grants from the Imai Memorial Glaucoma Research Foundation and the Suda Memorial Glaucoma Research Foundation (MT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALVARADO JA, 1992, ARCH OPHTHALMOL-CHIC, V110, P1769, DOI 10.1001/archopht.1992.01080240109042; Beyazyildiz E, 2014, JPN J OPHTHALMOL, V58, P353, DOI 10.1007/s10384-014-0325-5; Carratelli M, 2001, INT J CLIN PHARM RES, V21, P79; Cornelli U, 2001, J NUTR, V131, P3208, DOI 10.1093/jn/131.12.3208; Cumurcu T, 2010, OPHTHALMIC RES, V43, P169, DOI 10.1159/000272019; Demirdogen BC, 2014, CLIN LAB, V60, P79, DOI 10.7754/Clin.Lab.2013.121229; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; Engin KN, 2010, MOL VIS, V16, P1260; Erdurmus M, 2011, CURR EYE RES, V36, P713, DOI 10.3109/02713683.2011.584370; Fatma N, 2009, FREE RADICAL RES, V43, P783, DOI 10.1080/10715760903062887; Foster A, 2005, EYE, V19, P1133, DOI 10.1038/sj.eye.6701973; Gherghel D, 2005, INVEST OPHTH VIS SCI, V46, P877, DOI 10.1167/iovs.04-0777; He Z, 2011, CLIN EXP OPTOM, V94, P133, DOI 10.1111/j.1444-0938.2010.00564.x; Himori N, 2013, J NEUROCHEM, V127, P669, DOI 10.1111/jnc.12325; Inomata Y, 2006, J NEUROCHEM, V98, P372, DOI 10.1111/j.1471-4159.2006.03871.x; Iwase A, 2006, OPHTHALMOLOGY, V113, P1354, DOI 10.1016/j.ophtha.2006.04.022; Izzotti A, 2006, MUTAT RES-REV MUTAT, V612, P105, DOI 10.1016/j.mrrev.2005.11.001; Izzotti A, 2003, AM J MED, V114, P638, DOI 10.1016/S0002-9343(03)00114-1; Izzotti A, 2011, PLOS ONE, V20, P14567, DOI DOI 10.1371/J0URNAL.P0NE.0014567; KAHN MG, 1983, INVEST OPHTH VIS SCI, V24, P1283; Kitaoka Y, 2011, ENDOCRINOLOGY, V152, P2775, DOI 10.1210/en.2011-0046; Koliakos GG, 2008, GRAEF ARCH CLIN EXP, V246, P1477, DOI 10.1007/s00417-008-0871-y; Kotani K, 2010, MED PRIN PRACT, V19, P496, DOI 10.1159/000320312; Lamoke F, 2012, FREE RADICAL BIO MED, V53, P577, DOI 10.1016/j.freeradbiomed.2012.04.010; Li L, 2009, EYE, V23, P1464, DOI 10.1038/eye.2008.281; Lopez-Riquelme N, 2015, INT OPHTHALMOL, V35, P527, DOI 10.1007/s10792-014-9979-8; Luna C, 2009, FOOD CHEM TOXICOL, V47, P198, DOI 10.1016/j.fct.2008.10.029; LUTJENDRECOLL E, 1986, EXP EYE RES, V42, P443, DOI 10.1016/0014-4835(86)90004-7; Majsterek I, 2011, EXP MOL PATHOL, V90, P231, DOI 10.1016/j.yexmp.2011.01.001; Martinovic J, 2009, INT J SPORTS MED, V30, P851, DOI 10.1055/s-0029-1238289; MICHELET F, 1995, CLIN CHEM, V41, P1509; Miyamoto N, 2011, INVEST OPHTH VIS SCI, V52, P1055, DOI 10.1167/iovs.10-5777; Munemasa Y, 2009, GENE THER, V16, P17, DOI 10.1038/gt.2008.126; Nakamura H, 2001, P NATL ACAD SCI USA, V98, P2688, DOI 10.1073/pnas.041624998; Nakayama Keisuke, 2007, Clin Exp Nephrol, V11, P218, DOI 10.1007/s10157-007-0486-3; Nucci C, 2013, MOL VIS, V19, P1841; Pasquini A, 2008, VET RES COMMUN, V32, P137, DOI 10.1007/s11259-007-9014-x; Sacca SC, 2005, ARCH OPHTHALMOL-CHIC, V123, P458, DOI 10.1001/archopht.123.4.458; Sacca SC, 2007, EXP EYE RES, V84, P389, DOI 10.1016/j.exer.2006.10.008; SEDLAK J, 1968, ANAL BIOCHEM, V25, P192, DOI 10.1016/0003-2697(68)90092-4; Shimano M, 2009, HEART RHYTHM, V6, P935, DOI 10.1016/j.hrthm.2009.03.012; Sorkhabi R, 2011, MOL VIS, V17, P41; Takai Y, 2012, INVEST OPHTH VIS SCI, V53, P241, DOI 10.1167/iovs.11-8434; Tanito M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049680; Tehrani S, 2015, CURR EYE RES, V40, P191, DOI 10.3109/02713683.2014.968935; Tezel G, 1998, INVEST OPHTH VIS SCI, V39, P2277; Vassalle C, 2008, CLIN BIOCHEM, V41, P1162, DOI 10.1016/j.clinbiochem.2008.07.005; Virgolici Bogdana, 2007, Rom J Intern Med, V45, P59; Wax MB, 1998, AM J OPHTHALMOL, V125, P145, DOI 10.1016/S0002-9394(99)80084-1; Weinreb RN, 2004, LANCET, V363, P1711, DOI 10.1016/S0140-6736(04)16257-0; Yagci R, 2008, EYE, V22, P128, DOI 10.1038/sj.eye.6702751; Yang JJ, 2001, INVEST OPHTH VIS SCI, V42, P1273; Yildirim O, 2005, EYE, V19, P580, DOI 10.1038/sj.eye.6701565; Yokoyama Y, 2014, BIOCHEM BIOPH RES CO, V451, P510, DOI 10.1016/j.bbrc.2014.08.009; Yuki K, 2013, CURR EYE RES, V38, P983, DOI 10.3109/02713683.2013.800889; Yuki K, 2010, ACTA OPHTHALMOL, V88, pe259, DOI 10.1111/j.1755-3768.2010.01997.x; Zhou LL, 1999, J CELL PHYSIOL, V180, P182, DOI 10.1002/(SICI)1097-4652(199908)180:2<182::AID-JCP6>3.0.CO;2-X	57	32	32	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0133582	10.1371/journal.pone.0133582	http://dx.doi.org/10.1371/journal.pone.0133582			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RV	26186651	Green Submitted, Green Published, gold			2022-12-26	WOS:000358198700159
J	Albertsen, M; Karst, SM; Ziegler, AS; Kirkegaard, RH; Nielsen, PH				Albertsen, Mads; Karst, Soren M.; Ziegler, Anja S.; Kirkegaard, Rasmus H.; Nielsen, Per H.			Back to Basics - The Influence of DNA Extraction and Primer Choice on Phylogenetic Analysis of Activated Sludge Communities	PLOS ONE			English	Article							BIOLOGICAL PHOSPHORUS REMOVAL; MICROBIAL COMMUNITIES; ENVIRONMENTAL DNA; WASTE-WATER; RNA; PURIFICATION; SEQUENCES; MODEL; BIAS	DNA extraction and primer choice have a large effect on the observed community structure in all microbial amplicon sequencing analyses. Although the biases are well known, no comprehensive analysis has been conducted in activated sludge communities. In this study we systematically explored the impact of a number of parameters on the observed microbial community: bead beating intensity, primer choice, extracellular DNA removal, and various PCR settings. In total, 176 samples were subjected to 16S rRNA amplicon sequencing, and selected samples were investigated through metagenomics and metatranscriptomics. Quantitative fluorescence in situ hybridization was used as a DNA extraction-independent method for qualitative comparison. In general, an effect on the observed community was found on all parameters tested, although bead beating and primer choice had the largest effect. The effect of bead beating intensity correlated with cell-wall strength as seen by a large increase in DNA from Gram-positive bacteria (up to 400%). However, significant differences were present at lower phylogenetic levels within the same phylum, suggesting that additional factors are at play. The best primer set based on in silico analysis was found to underestimate a number of important bacterial groups. For 16S rRNA gene analysis in activated sludge we recommend using the FastDNA SPIN Kit for Soil with four times the normal bead beating and V1-3 primers.	[Albertsen, Mads; Karst, Soren M.; Ziegler, Anja S.; Kirkegaard, Rasmus H.; Nielsen, Per H.] Aalborg Univ, Ctr Microbial Communities, Dept Chem & Biosci, Aalborg, Denmark	Aalborg University	Nielsen, PH (corresponding author), Aalborg Univ, Ctr Microbial Communities, Dept Chem & Biosci, Aalborg, Denmark.	phn@bio.aau.dk	Nielsen, Per Halkjær/T-6796-2018; Albertsen, Mads/T-7358-2018	Nielsen, Per Halkjær/0000-0002-6402-1877; Albertsen, Mads/0000-0002-6151-190X; Karst, Soren Michael/0000-0002-0233-160X; Kirkegaard, Rasmus Hansen/0000-0003-3349-3617	Innovation Fond Denmark (EcoDesign-MBR)	Innovation Fond Denmark (EcoDesign-MBR)	This study was funded by the Innovation Fond Denmark (EcoDesign-MBR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albertsen M, 2012, ISME J, V6, P1094, DOI 10.1038/ismej.2011.176; Allesen-Holm M, 2006, MOL MICROBIOL, V59, P1114, DOI 10.1111/j.1365-2958.2005.05008.x; Allison DG, 2003, BIOFOULING, V19, P139, DOI [10.1080/0892701031000072190, 10.1038/nrmicro2415]; [Anonymous], 2014, IMPLEMENTING REPROD; Bourrain M, 1999, CURR MICROBIOL, V38, P315, DOI 10.1007/PL00006809; Cai L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053649; Cangelosi GA, 2014, APPL ENVIRON MICROB, V80, P5884, DOI 10.1128/AEM.01763-14; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; de Vries A., 2013, GGDENDRO TOOLS EXTRA; Dominiak DM, 2011, ENVIRON MICROBIOL, V13, P710, DOI 10.1111/j.1462-2920.2010.02375.x; Dowle M., 2014, DATA TABLE EXTENSION; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; Gabor EM, 2003, FEMS MICROBIOL ECOL, V44, P153, DOI 10.1016/S0168-6496(02)00462-2; Guo F, 2013, APPL MICROBIOL BIOT, V97, P4607, DOI 10.1007/s00253-012-4244-4; Guo FD, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0071714, 10.1371/journal.pone.0076185]; Kennedy K, 2014, APPL ENVIRON MICROB, V80, P5717, DOI 10.1128/AEM.01451-14; Klindworth Anna, 2013, Nucleic Acids Res, V41, pe1, DOI 10.1093/nar/gks808; Kragelund C, 2011, FEMS MICROBIOL ECOL, V76, P451, DOI 10.1111/j.1574-6941.2011.01065.x; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Magoc T, 2011, BIOINFORMATICS, V27, P2957, DOI 10.1093/bioinformatics/btr507; McIlroy SJ, 2014, ISME J, V8, P613, DOI 10.1038/ismej.2013.162; McIlroy SJ, 2009, ANTON LEEUW INT J G, V96, P593, DOI 10.1007/s10482-009-9374-z; McIlroy SJ, 2015, MIDAS FIELD GUIDE MI; McLellan SL, 2010, ENVIRON MICROBIOL, V12, P378, DOI 10.1111/j.1462-2920.2009.02075.x; McMurdie PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061217; Morgan-Sagastume F, 2008, WATER RES, V42, P843, DOI 10.1016/j.watres.2007.08.026; Nielsen PH, 2012, CURR OPIN BIOTECH, V23, P452, DOI 10.1016/j.copbio.2011.11.027; Nielsen PH, 2010, WATER RES, V44, P5070, DOI 10.1016/j.watres.2010.07.036; Nocker A, 2006, J MICROBIOL METH, V67, P310, DOI 10.1016/j.mimet.2006.04.015; Oksanen J., 2020, VEGAN COMMUNITY ECOL; Pages H, 2014, BIOSTRINGS STRING OB; Prinja S, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0043093, 10.1371/journal.pone.0030362]; Purohit HJ, 2003, J MICROBIOL METH, V52, P315, DOI 10.1016/S0167-7012(02)00185-9; Quast Christian, 2013, Nucleic Acids Res, V41, pD590, DOI 10.1093/nar/gks1219; R Core Team, 2021, R LANGUAGE ENV STAT; Roh C, 2006, APPL BIOCHEM BIOTECH, V134, P97, DOI 10.1385/ABAB:134:2:97; Shan GB, 2008, J ENVIRON SCI-CHINA, V20, P80, DOI 10.1016/S1001-0742(08)60012-1; Sheik AR, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00047; Suzuki MT, 1996, APPL ENVIRON MICROB, V62, P625, DOI 10.1128/AEM.62.2.625-630.1996; Tchobanoglous G., 2014, WASTEWATER ENG TREAT, V5th; Vanysacker L, 2010, APPL MICROBIOL BIOT, V88, P299, DOI 10.1007/s00253-010-2770-5; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Ward DV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039315; Wickham H., 2015, DPLYR GRAMMAR DATA M; Wickham H, 2012, MAKE IT EASIER WORK; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wickham H, 2007, J STAT SOFTW, V21, P1; Yu ZT, 1999, CAN J MICROBIOL, V45, P269, DOI 10.1139/cjm-45-3-269	50	297	302	6	141	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2015	10	7							e0132783	10.1371/journal.pone.0132783	http://dx.doi.org/10.1371/journal.pone.0132783			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RQ	26182345	gold, Green Submitted, Green Published			2022-12-26	WOS:000358198200035
J	Song, SS; Liu, XH; Bai, XL; Jiang, YB; Zhang, XZ; Yu, CQ; Shao, XM				Song, Shanshan; Liu, Xuehua; Bai, Xueliang; Jiang, Yanbin; Zhang, Xianzhou; Yu, Chengqun; Shao, Xiaoming			Impacts of Environmental Heterogeneity on Moss Diversity and Distribution of Didymodon (Pottiaceae) in Tibet, China	PLOS ONE			English	Article							PREDICTING SPECIES DISTRIBUTIONS; DISTRIBUTION MODELS; AIR HUMIDITY; NORTH-AFRICA; BRYOPHYTE; INDICATORS; RICHNESS; SOUTHWEST; ECOSYSTEM; ACCURACY	Tibet makes up the majority of the Qinghai-Tibet Plateau, often referred to as the roof of the world. Its complex landforms, physiognomy, and climate create a special heterogeneous environment for mosses. Each moss species inhabits its own habitat and ecological niche. This, in combination with its sensitivity to environmental change, makes moss species distribution a useful indicator of vegetation alteration and climate change. This study aimed to characterize the diversity and distribution of Didymodon (Pottiaceae) in Tibet, and model the potential distribution of its species. A total of 221 sample plots, each with a size of 10 x 10 m and located at different altitudes, were investigated across all vegetation types. Of these, the 181 plots in which Didymodon species were found were used to conduct analyses and modeling. Three noteworthy results were obtained. First, a total of 22 species of Didymodon were identified. Among these, Didymodon rigidulusvar. subulatus had not previously been recorded in China, and Didymodon constrictusvar. constrictus was the dominant species. Second, analysis of the relationships between species distributions and environmental factors using canonical correspondence analysis revealed that vegetation cover and altitude were the main factors affecting the distribution of Didymodon in Tibet. Third, based on the environmental factors of bioclimate, topography and vegetation, the distribution of Didymodon was predicted throughout Tibet at a spatial resolution of 1 km, using the presence-only MaxEnt model. Climatic variables were the key factors in the model. We conclude that the environment plays a significant role in moss diversity and distribution. Based on our research findings, we recommend that future studies should focus on the impacts of climate change on the distribution and conservation of Didymodon.	[Song, Shanshan] China Agr Univ, Coll Biol Sci, Beijing 100094, Peoples R China; [Liu, Xuehua] Tsinghua Univ, Sch Environm, Beijing 100084, Peoples R China; [Bai, Xueliang] Inner Mongolia Univ, Coll Life Sci, Hohhot, Peoples R China; [Jiang, Yanbin] Huazhong Agr Univ, Coll Resources & Environm, Wuhan, Peoples R China; [Zhang, Xianzhou; Yu, Chengqun] Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, Beijing, Peoples R China; [Shao, Xiaoming] China Agr Univ, Coll Resources & Environm Sci, Beijing Key Lab Biodivers & Organ Farming, Beijing 100094, Peoples R China	China Agricultural University; Tsinghua University; Inner Mongolia University; Huazhong Agricultural University; Chinese Academy of Sciences; Institute of Geographic Sciences & Natural Resources Research, CAS; China Agricultural University	Liu, XH (corresponding author), Tsinghua Univ, Sch Environm, Beijing 100084, Peoples R China.	xuehua-hjx@tsinghua.edu.cn; shaoxm@cau.edu.cn	zhang, xian/GYA-0290-2022		grant entitled "Research and demonstration on key techniques of safety growing and efficient use of forage grass in the One River, Two Streams area" from the Tibet Autonomous Region [Z2013C02N02]	grant entitled "Research and demonstration on key techniques of safety growing and efficient use of forage grass in the One River, Two Streams area" from the Tibet Autonomous Region	This work was supported by the grant entitled "Research and demonstration on key techniques of safety growing and efficient use of forage grass in the One River, Two Streams area" from the Tibet Autonomous Region (NO: Z2013C02N02, URL: http://tibetsti.gov.cn/xzkjtportal/index.aspx). XS received the funding. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ah-Peng C, 2007, DIVERS DISTRIB, V13, P654, DOI 10.1111/j.1472-4642.2007.00393.x; Allouche O, 2006, J APPL ECOL, V43, P1223, DOI 10.1111/j.1365-2664.2006.01214.x; Baniya CB, 2010, MT RES DEV, V30, P275, DOI 10.1659/MRD-JOURNAL-D-09-00057.1; Belland RJ, 2005, CAN J BOT, V83, P243, DOI [10.1139/B04-172, 10.1139/b04-172]; Ceschin S, 2012, ECOL INDIC, V14, P74, DOI 10.1016/j.ecolind.2011.08.020; Cui XY, 2009, ECOL RES, V24, P645, DOI 10.1007/s11284-008-0535-8; del Hoyo LV, 2011, EUR J FOREST RES, V130, P983, DOI 10.1007/s10342-011-0488-2; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Ermakova EV, 2004, J RADIOANAL NUCL CH, V259, P51, DOI 10.1023/B:JRNC.0000015805.22707.a1; Fielding AH, 1997, ENVIRON CONSERV, V24, P38, DOI 10.1017/S0376892997000088; Frahm JP, 2007, GEFAHRST REINHALT L, V67, P269; Frego KA, 2007, FOREST ECOL MANAG, V242, P65, DOI 10.1016/j.foreco.2007.01.030; Gao QZ, 2010, QUATERN INT, V226, P143, DOI 10.1016/j.quaint.2009.10.035; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hutchinson M.F., 2004, ANUSPLIN VERSION 4 3; Imada Y, 2011, P ROY SOC B-BIOL SCI, V278, P3026, DOI 10.1098/rspb.2011.0134; Immerzeel W, 2008, AGR SYST, V96, P52, DOI 10.1016/j.agsy.2007.05.005; Ingerpuu N, 2001, BIODIVERS CONSERV, V10, P2153, DOI 10.1023/A:1013141609742; Jia Y., 2013, SPECIES CATALOGUE CH, V1; Jiang YB, 2011, POL J ECOL, V59, P317; Jiang YB, 2014, ECOL INDIC, V38, P72, DOI 10.1016/j.ecolind.2013.10.024; Jimenez JA, 2005, ANN MO BOT GARD, V92, P225; Jimenez JA, 2006, J HATTORI BOT LAB, P211; Jimenez JA, 2009, J BRYOL, V31, P49, DOI 10.1179/037366808X389342; Jimenez-Valverde A, 2012, GLOBAL ECOL BIOGEOGR, V21, P498, DOI 10.1111/j.1466-8238.2011.00683.x; Karger DN, 2012, ECOL INDIC, V20, P277, DOI 10.1016/j.ecolind.2012.02.026; Li Fen-Xia, 2006, Zhiwu Shengtai Xuebao, V30, P919; [李融 Li Rong], 2010, [干旱地区农业研究, Agricultural Research in the Arid Areas], V28, P228; Li XJ, 1985, MOSS FLORA OF TIBET; Loiselle BA, 2008, J BIOGEOGR, V35, P105, DOI 10.1111/j.1365-2699.2007.01779.x; Ochyra R, 2002, J BRYOL, V24, P33, DOI 10.1179/037366802125000331; Pearce J, 2000, ECOL MODEL, V133, P225, DOI 10.1016/S0304-3800(00)00322-7; Pearson RG, 2007, J BIOGEOGR, V34, P102, DOI 10.1111/j.1365-2699.2006.01594.x; Pesch R, 2006, ECOL INDIC, V6, P137, DOI 10.1016/j.ecolind.2005.08.018; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Piao SL, 2006, CLIMATIC CHANGE, V74, P253, DOI 10.1007/s10584-005-6339-8; Prates-Clark CD, 2008, ECOL MODEL, V211, P309, DOI 10.1016/j.ecolmodel.2007.09.024; Rapalee G, 2001, J GEOPHYS RES-ATMOS, V106, P33551, DOI 10.1029/2001JD000509; Ren DM, 2012, THESIS INNER MONGOLI; Shao JJ, 2012, 28 CHIN CHEM SOC C; Tian WL, 2011, THESIS SICHUAN NORMA; Turetsky MR, 2012, NEW PHYTOL, V196, P49, DOI 10.1111/j.1469-8137.2012.04254.x; Vanderpoorten A, 2006, BIODIVERS CONSERV, V15, P829, DOI 10.1007/s10531-004-1873-7; Weibull H, 2005, BIOL CONSERV, V122, P71, DOI 10.1016/j.biocon.2004.07.001; Werner O, 2005, SYST BOT, V30, P461, DOI 10.1600/0363644054782198; Werner O, 2009, PLANT BIOSYST, V143, pS136, DOI 10.1080/11263500903226965; Wu PC, 1998, BRYOPHYTES BIOL; Zander R.H., 1993, B BUFFALO SOC NATURA, V32, P1; Zhang JT, 2011, QUANTITATIVE ECOLOGY, V2	49	20	23	1	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2015	10	7							e0132346	10.1371/journal.pone.0132346	http://dx.doi.org/10.1371/journal.pone.0132346			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RQ	26181326	Green Published, Green Submitted, gold			2022-12-26	WOS:000358198200017
J	Khan, YA; Singh, BR; Ullah, R; Shoeb, M; Naqvi, AH; Abidi, SMA				Khan, Yasir Akhtar; Singh, Braj Raj; Ullah, Rizwan; Shoeb, Mohd; Naqvi, Alim H.; Abidi, Syed M. A.			Anthelmintic Effect of Biocompatible Zinc Oxide Nanoparticles (ZnO NPs) on Gigantocotyle explanatum, a Neglected Parasite of Indian Water Buffalo	PLOS ONE			English	Article							INDUCE OXIDATIVE STRESS; ANTIBACTERIAL ACTIVITY; ESCHERICHIA-COLI; CANCER-CELLS; SILVER NANOPARTICLES; SUPEROXIDE-DISMUTASE; TIO2 NANOPARTICLES; DNA-DAMAGE; MECHANISM; SIZE	Helminth parasites of veterinary importance cause huge revenue losses to agrarian economy worldwide. With the emergence of drug resistance against the current formulations, there is a need to focus on the alternative approaches in order to control this menace. In the present study, biocompatible zinc oxide nanoparticles (ZnO NPs) were used to see their in vitro effect on the biliary amphistomes, Gigantocotyle explanatum, infecting Bubalus bubalis because these nanoparticles are involved in generation of free radicals that induce oxidative stress, resulting in disruption of cellular machinery. The ZnO NPs were synthesized by using egg albumin as a biotemplate and subsequently characterized by Scanning Electron Microscopy (SEM), Transmission Electron Microscopy (TEM), X-ray Diffraction and Spectrophotometrical, which showed that ZnO NPs were highly purified wurtzite type polycrystals, with a mean size of 16.7 nm. When the parasites were treated with lower concentrations (0.004% and 0.008%) of the ZnO NPs, the worms mounted a protective response by stimulating the antioxidant system but the treatment of G. explanatum with 0.012% ZnO NPs produced significant inhibition of the antioxidant enzymes like superoxide dismutase (SOD) (p<0.05) and glutathione S-transferase (GST) (p<0.01), while the level of malondialdehyde (MDA), a lipid peroxidation marker, was significantly (p<0.01) elevated. SEM and histopathology revealed pronounced tegumental damage showing the disruption of surface papillae and the annulations, particularly in the posterior region near acetabulum. The under expression of a number of polypeptides, loss of worm motility in a time dependent manner, further reflect strong anthelmintic potential of ZnO NPs. It can be concluded that the anthelmintic effect might be due to the production of reactive oxygen species that target a variety of macromolecules such as nucleic acid, protein and lipids which are involved in different cellular processes.	[Khan, Yasir Akhtar; Ullah, Rizwan; Abidi, Syed M. A.] Aligarh Muslim Univ, Dept Zool, Sect Parasitol, Aligarh 202002, Uttar Pradesh, India; [Singh, Braj Raj; Shoeb, Mohd; Naqvi, Alim H.] Aligarh Muslim Univ, Dept Appl Phys, Ctr Excellence Mat Sci Nanomat, ZHCET, Aligarh 202002, Uttar Pradesh, India	Aligarh Muslim University; Aligarh Muslim University; Zakir Husain College Of Engineering & Technology	Abidi, SMA (corresponding author), Aligarh Muslim Univ, Dept Zool, Sect Parasitol, Aligarh 202002, Uttar Pradesh, India.	abbasabidi92@hotmail.com	Shoeb, Mohd/B-4206-2014	Shoeb, Mohd/0000-0003-0582-7034; Khan, Yasir Akhtar/0000-0001-9277-7164	University Grant Commission, New Delhi, under Maulana Azad National Fellowship [F117.1/201112/MANFMUSUTT1151]	University Grant Commission, New Delhi, under Maulana Azad National Fellowship	The authors received no specific funding for this project; however, YAK received a fellowship grant (F117.1/201112/MANFMUSUTT1151) from the University Grant Commission, New Delhi, under the scheme of Maulana Azad National Fellowship.	Abidi SMA, 2000, J HELMINTHOL, V74, P283; Ali M, 2014, PARASITOL RES, V113, P681, DOI 10.1007/s00436-013-3696-5; Allahverdiyev AM, 2011, FUTURE MICROBIOL, V6, P933, DOI [10.2217/FMB.11.78, 10.2217/fmb.11.78]; [Anonymous], 2011, ANN REPORT DEP ANIMA, P1; Antoine TE, 2012, ANTIVIR RES, V96, P363, DOI 10.1016/j.antiviral.2012.09.020; Armstrong RN, 1997, CHEM RES TOXICOL, V10, P2, DOI 10.1021/tx960072x; Buege J A, 1978, Methods Enzymol, V52, P302; Catherine EJ, 2007, TRENDS PARASITOL, V25, P28; Chitra K., 2013, International Food Research Journal, V20, P59; Chu XiuJuan, 2009, Modern Applied Science, V3, P177; Dwivedi S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111289; Emamifar A, 2010, INNOV FOOD SCI EMERG, V11, P742, DOI 10.1016/j.ifset.2010.06.003; Faisal M, 2011, J MATER SCI TECHNOL, V27, P594, DOI 10.1016/S1005-0302(11)60113-8; Giske CG, 2008, ANTIMICROB AGENTS CH, V52, P813, DOI 10.1128/AAC.01169-07; HABIG WH, 1974, J BIOL CHEM, V249, P7130; Hao LH, 2009, J ENVIRON SCI, V21, P1459, DOI 10.1016/S1001-0742(08)62440-7; Jin X, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106991; Jin X, 2013, ADV MATER, V25, P1342, DOI 10.1002/adma.201203849; Jin X, 2012, ADV MATER, V24, P5676, DOI 10.1002/adma.201201780; Kirthi AV, 2011, PARASITOL RES, V109, P461, DOI 10.1007/s00436-011-2277-8; Kumar A, 2011, FREE RADICAL BIO MED, V51, P1872, DOI 10.1016/j.freeradbiomed.2011.08.025; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Li XH, 2009, INT J FOOD SCI TECH, V44, P2161, DOI 10.1111/j.1365-2621.2009.02055.x; Li Y, 2012, ACS NANO, V6, P5164, DOI 10.1021/nn300934k; MARKLUND S, 1974, EUR J BIOCHEM, V47, P469; Marnett LJ, 2000, CARCINOGENESIS, V21, P361, DOI 10.1093/carcin/21.3.361; MCCORD JM, 1969, J BIOL CHEM, V244, P6049; Mishra A, 2011, APPL MICROBIOL BIOT, V92, P617, DOI 10.1007/s00253-011-3556-0; Mishra YK, 2012, J APPL PHYS, V112, DOI 10.1063/1.4752469; Mishra YK, 2011, ANTIVIR RES, V92, P305, DOI 10.1016/j.antiviral.2011.08.017; Morphew RM, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000937; Pal S, 2007, APPL ENVIRON MICROB, V73, P1712, DOI 10.1128/AEM.02218-06; Palanikumar L, 2013, APPL NANOSCI, V3, P441, DOI 10.1007/s13204-012-0141-5; Papavlassopoulos H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084983; Raghupathi KR, 2011, LANGMUIR, V27, P4020, DOI 10.1021/la104825u; Ramyadevi J, 2011, PARASITOL RES, V109, P1403, DOI 10.1007/s00436-011-2387-3; Sawai J, 1996, J CHEM ENG JPN, V29, P627, DOI 10.1252/jcej.29.627; Shoeb M, 2013, ADV NAT SCI-NANOSCI, V4, DOI 10.1088/2043-6262/4/3/035015; Singh BN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106937; Singh D., 2002, Journal of Veterinary Parasitology, V16, P115; Sondi I, 2004, J COLLOID INTERF SCI, V275, P177, DOI 10.1016/j.jcis.2004.02.012; SPECTOR T, 1978, ANAL BIOCHEM, V86, P142, DOI 10.1016/0003-2697(78)90327-5; Stadtman ER, 2000, ANN NY ACAD SCI, V899, P191; SWARUP D, 1987, INDIAN J ANIM SCI, V57, P252; Tansatit T, 2012, EXP PARASITOL, V131, P8, DOI 10.1016/j.exppara.2012.02.018; Thangaraj P, 2011, VACUUM, V86, P140, DOI 10.1016/j.vacuum.2011.05.001; Unfried K, 2007, NANOTOXICOLOGY, V1, P52, DOI 10.1080/00222930701314932; van Bladeren PJ, 2000, CHEM-BIOL INTERACT, V129, P61, DOI 10.1016/S0009-2797(00)00214-3; von Samson-Himmelstjerna G, 2005, VET PARASITOL, V132, P223, DOI 10.1016/j.vetpar.2005.07.014; Wahab R, 2007, MATER RES BULL, V42, P1640, DOI 10.1016/j.materresbull.2006.11.035; Wahab R, 2014, COLLOID SURFACE B, V123, P664, DOI 10.1016/j.colsurfb.2014.10.012; Wahab R, 2014, COLLOID SURFACE B, V117, P267, DOI 10.1016/j.colsurfb.2014.02.038; Wahab R, 2013, J BIOMED NANOTECHNOL, V9, P1181, DOI 10.1166/jbn.2013.1652; Wahab R, 2013, J BIOMED NANOTECHNOL, V9, P441, DOI 10.1166/jbn.2013.1593; Wahab R, 2012, J BIOMED NANOTECHNOL, V8, P424, DOI 10.1166/jbn.2012.1448; Wahab R, 2011, CHEM ENG J, V175, P450, DOI 10.1016/j.cej.2011.09.055; Wahab R, 2011, J BIOL INORG CHEM, V16, P431, DOI 10.1007/s00775-010-0740-0; Wahab R, 2010, MET MATER INT, V16, P767, DOI 10.1007/s12540-010-1011-x; Wahab R, 2010, APPL MICROBIOL BIOT, V87, P1917, DOI 10.1007/s00253-010-2692-2; Wahab R, 2009, SYNTHETIC MET, V159, P2443, DOI 10.1016/j.synthmet.2009.08.006; Wolstenholme AJ, 2004, TRENDS PARASITOL, V20, P469, DOI 10.1016/j.pt.2004.07.010; Yla-Herttuala S, 1999, ANN NY ACAD SCI, V874, P134, DOI 10.1111/j.1749-6632.1999.tb09231.x; Yu KN, 2013, TOXICOL IN VITRO, V27, P1187, DOI 10.1016/j.tiv.2013.02.010; Zak AK, 2011, INT J NANOMED, V6, P1399, DOI 10.2147/IJN.S19693; Zak AK, 2011, CERAM INT, V37, P393, DOI 10.1016/j.ceramint.2010.08.017	65	21	22	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0133086	10.1371/journal.pone.0133086	http://dx.doi.org/10.1371/journal.pone.0133086			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26177503	gold, Green Published, Green Submitted			2022-12-26	WOS:000358197600213
J	Galka, MM; Rajagopalan, N; Buhrow, LM; Nelson, KM; Switala, J; Cutler, AJ; Palmer, DRJ; Loewen, PC; Abrams, SR; Loewen, MC				Galka, Marek M.; Rajagopalan, Nandhakishore; Buhrow, Leann M.; Nelson, Ken M.; Switala, Jacek; Cutler, Adrian J.; Palmer, David R. J.; Loewen, Peter C.; Abrams, Suzanne R.; Loewen, Michele C.			Identification of Interactions between Abscisic Acid and Ribulose-1,5-Bisphosphate Carboxylase/Oxygenase	PLOS ONE			English	Article							RIBULOSE 1,5-BISPHOSPHATE CARBOXYLASE/OXYGENASE; COMPARTMENTAL DISTRIBUTION; MOLECULAR-STRUCTURE; PHOSPHATE-BINDING; CRYSTAL-STRUCTURE; RUBISCO ACTIVITY; INTACT LEAVES; LARGE SUBUNIT; ACTIVATION; SPINACH	Abscisic acid ((+)-ABA) is a phytohormone involved in the modulation of developmental processes and stress responses in plants. A chemical proteomics approach using an ABA mimetic probe was combined with in vitro assays, isothermal titration calorimetry (ITC), x-ray crystallography and in silico modelling to identify putative (+)-ABA binding-proteins in crude extracts of Arabidopsis thaliana. Ribulose-1,5-bisphosphate carboxylase/oxygenase (Rubisco) was identified as a putative ABA-binding protein. Radiolabelled-binding assays yielded a K-d of 47 nM for (+)-ABA binding to spinach Rubisco, which was validated by ITC, and found to be similar to reported and experimentally derived values for the native ribulose-1,5-bisphosphate (RuBP) substrate. Functionally, (+)-ABA caused only weak inhibition of Rubisco catalytic activity (K-i of 2.1 mM), but more potent inhibition of Rubisco activation (K-i of similar to 130 mu M). Comparative structural analysis of Rubisco in the presence of (+)-ABA with RuBP in the active site revealed only a putative low occupancy (+)-ABA binding site on the surface of the large subunit at a location distal from the active site. However, subtle distortions in electron density in the binding pocket and in silico docking support the possibility of a higher affinity (+)-ABA binding site in the RuBP binding pocket. Overall we conclude that (+)-ABA interacts with Rubisco. While the low occupancy (+)-ABA binding site and weak non-competitive inhibition of catalysis may not be relevant, the high affinity site may allow ABA to act as a negative effector of Rubisco activation.	[Galka, Marek M.; Rajagopalan, Nandhakishore; Buhrow, Leann M.; Nelson, Ken M.; Cutler, Adrian J.; Abrams, Suzanne R.; Loewen, Michele C.] Natl Res Council Canada, Saskatoon, SK, Canada; [Galka, Marek M.; Palmer, David R. J.; Abrams, Suzanne R.] Univ Saskatchewan, Dept Chem, Saskatoon, SK S7N 0W0, Canada; [Switala, Jacek; Loewen, Peter C.] Univ Manitoba, Dept Microbiol, Winnipeg, MB R3T 2N2, Canada; [Loewen, Michele C.] Univ Saskatchewan, Dept Biochem, Saskatoon, SK S7N 0W0, Canada	National Research Council Canada; University of Saskatchewan; University of Manitoba; University of Saskatchewan	Loewen, MC (corresponding author), Natl Res Council Canada, Saskatoon, SK, Canada.	michele.loewen@nrc.ca	Palmer, David R J/F-1934-2010	Palmer, David R J/0000-0001-9300-7460	Genome and Health Initiative, National Research Council of Canada [64-GH4P14]; Natural Sciences and Engineering Research Council of Canada [261683-2012, 9600-2012]; Canada Research Chair Program [950-214844]	Genome and Health Initiative, National Research Council of Canada; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canada Research Chair Program(Canada Research Chairs)	This work was funded by the Genome and Health Initiative, National Research Council of Canada #64-GH4P14 (http://www.nrc-cnrc.gc.ca/eng/index.html) to M.C.L and S.R.A., and Discovery Grants from the Natural Sciences and Engineering Research Council of Canada (http://www.nserc-crsng.gc.ca/index_eng.asp) to M.C.L (261683-2012) and P.C.L. (9600-2012), and by the Canada Research Chair Program (http://www.chairs-chaires.gc.ca/home-accueil-eng.aspx) to P.C.L (950-214844).	ABRAMS SR, 1989, PHYTOCHEMISTRY, V28, P2885, DOI 10.1016/0031-9422(89)80246-8; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Andersson I, 1996, J MOL BIOL, V259, P160, DOI 10.1006/jmbi.1996.0310; Andersson I, 2008, PLANT PHYSIOL BIOCH, V46, P275, DOI 10.1016/j.plaphy.2008.01.001; Andersson I, 2008, J EXP BOT, V59, P1555, DOI 10.1093/jxb/ern091; BADGER MR, 1981, BIOCHEMISTRY-US, V20, P2219, DOI 10.1021/bi00511a023; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Benson CL, 2015, PHYTOCHEMISTRY, V113, P96, DOI 10.1016/j.phytochem.2014.03.017; BRADFORD KJ, 1983, PLANT PHYSIOL, V72, P245, DOI 10.1104/pp.72.1.245; Bricogne G, 2009, BUSTER VERSION 2 8 0; Chattopadhyay A, 2011, PHYTOCHEMISTRY, V72, P1293, DOI 10.1016/j.phytochem.2011.01.024; Cutler SR, 2010, ANNU REV PLANT BIOL, V61, P651, DOI 10.1146/annurev-arplant-042809-112122; Desimone M, 1996, PLANT PHYSIOL, V111, P789, DOI 10.1104/pp.111.3.789; DIXON M, 1953, BIOCHEM J, V55, P170, DOI 10.1042/bj0550170; Dupeux F, 2011, EMBO J, V30, P4171, DOI 10.1038/emboj.2011.294; Eichelmann H, 2009, J EXP BOT, V60, P4077, DOI 10.1093/jxb/erp242; ELLIS RJ, 1979, TRENDS BIOCHEM SCI, V4, P241, DOI 10.1016/0968-0004(79)90212-3; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Feller U, 2008, J EXP BOT, V59, P1615, DOI 10.1093/jxb/erm242; Frank J, 1998, J CHEM SOC FARADAY T, V94, P2127, DOI 10.1039/a802124d; Fukayama H, 2010, PLANT PHYSIOL BIOCH, V48, P808, DOI 10.1016/j.plaphy.2010.08.002; Greene DN, 2007, BIOCHEM J, V404, P517, DOI 10.1042/BJ20070071; Ishida H, 1997, PLANT CELL PHYSIOL, V38, P471, DOI 10.1093/oxfordjournals.pcp.a029191; Jensen RG, 2000, P NATL ACAD SCI USA, V97, P12937, DOI 10.1073/pnas.97.24.12937; JORDAN DB, 1983, J BIOL CHEM, V258, P3752; Kharenko OA, 2013, J BIOCHEM, V154, P383, DOI 10.1093/jb/mvt067; Kharenko OA, 2011, BIOCHEM J, V437, P117, DOI 10.1042/BJ20101898; LAING WA, 1976, BIOCHEM J, V159, P563, DOI 10.1042/bj1590563; LAN Y, 1991, PLANT PHYSIOL, V95, P604, DOI 10.1104/pp.95.2.604; Leslie AGW, 2007, NATO SCI SER II-MATH, V245, P41, DOI 10.1007/978-1-4020-6316-9_4; Loewen PC, 2013, ACTA CRYSTALLOGR F, V69, P10, DOI 10.1107/S1744309112047549; LORIMER GH, 1980, BIOCHEMISTRY-US, V19, P5321, DOI 10.1021/bi00564a027; Marcus Y, 2005, J BACTERIOL, V187, P4222, DOI 10.1128/JB.187.12.4222-4228.2005; Matsumura H, 2012, J MOL BIOL, V422, P75, DOI 10.1016/j.jmb.2012.05.014; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Meyer S, 1999, PLANTA, V210, P126, DOI 10.1007/s004250050661; Miyakawa T, 2013, TRENDS PLANT SCI, V18, P259, DOI 10.1016/j.tplants.2012.11.002; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Nyangulu JM, 2006, ORG BIOMOL CHEM, V4, P1400, DOI 10.1039/b509193d; Nyangulu JM, 2005, J AM CHEM SOC, V127, P1662, DOI 10.1021/ja0429059; OHKUMA K, 1965, TETRAHEDRON LETT, P2529; Parry MAJ, 2002, ANN BOT-LONDON, V89, P833, DOI 10.1093/aob/mcf103; Parry MAJ, 2008, J EXP BOT, V59, P1569, DOI 10.1093/jxb/ern084; Parry MAJ, 2013, J EXP BOT, V64, P717, DOI 10.1093/jxb/ers336; Portis AR, 2008, J EXP BOT, V59, P1597, DOI 10.1093/jxb/erm240; Portis AR, 2007, PHOTOSYNTH RES, V94, P121, DOI 10.1007/s11120-007-9225-6; Potterton E, 2003, ACTA CRYSTALLOGR D, V59, P1131, DOI 10.1107/S0907444903008126; Rakwal R, 2004, MOL BIOL REP, V31, P217, DOI 10.1007/s11033-005-2710-0; SCHMALLE HW, 1977, ACTA CRYSTALLOGR B, V33, P2218, DOI 10.1107/S0567740877008036; Schrodinger L., 2020, PYMOL; SLOVIK S, 1992, PLANTA, V187, P37, DOI [10.1007/BF00201619, 10.1007/BF00201621]; SLOVIK S, 1992, PLANTA, V187, P26, DOI 10.1007/BF00201620; SWAMINATHAN P, 1976, ACTA CRYSTALLOGR B, V32, P2351, DOI 10.1107/S0567740876007747; Tabita FR, 2008, J EXP BOT, V59, P1515, DOI 10.1093/jxb/erm361; Taylor TC, 1997, BIOCHEMISTRY-US, V36, P4041, DOI 10.1021/bi962818w; Taylor TC, 1997, J MOL BIOL, V265, P432, DOI 10.1006/jmbi.1996.0738; VATER J, 1979, ARCH BIOCHEM BIOPHYS, V194, P190, DOI 10.1016/0003-9861(79)90609-X; Wang D, 2010, PHYSIOL PLANTARUM, V139, P55, DOI 10.1111/j.1399-3054.2009.01344.x; Wasilewska A, 2008, MOL PLANT, V1, P198, DOI 10.1093/mp/ssm022; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749	60	13	14	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0133033	10.1371/journal.pone.0133033	http://dx.doi.org/10.1371/journal.pone.0133033			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LZ	26197050	gold, Green Published, Green Submitted			2022-12-26	WOS:000358547600061
J	Janicki, AF; Frick, WF; Kilpatrick, AM; Parise, KL; Foster, JT; McCracken, GF				Janicki, Amanda F.; Frick, Winifred F.; Kilpatrick, A. Marm; Parise, Katy L.; Foster, Jeffrey T.; McCracken, Gary F.			Efficacy of Visual Surveys for White-Nose Syndrome at Bat Hibernacula	PLOS ONE			English	Article							PSEUDOGYMNOASCUS-DESTRUCTANS; GEOMYCES-DESTRUCTANS; SYNDROME FUNGUS; INFECTIOUS-DISEASE; EMERGING DISEASE; HIBERNATING BATS; NORTH-AMERICA; UNITED-STATES; PERSISTENCE; PHENOLOGY	White-Nose Syndrome (WNS) is an epizootic disease in hibernating bats caused by the fungus Pseudogymnoascus destructans. Surveillance for P. destructans at bat hibernacula consists primarily of visual surveys of bats, collection of potentially infected bats, and submission of these bats for laboratory testing. Cryptic infections (bats that are infected but display no visual signs of fungus) could lead to the mischaracterization of the infection status of a site and the inadvertent spread of P. destructans. We determined the efficacy of visual detection of P. destructans by examining visual signs and molecular detection of P. destructans on 928 bats of six species at 27 sites during surveys conducted from January through March in 2012-2014 in the southeastern USA on the leading edge of the disease invasion. Cryptic infections were widespread with 77% of bats that tested positive by qPCR showing no visible signs of infection. The probability of exhibiting visual signs of infection increased with sampling date and pathogen load, the latter of which was substantially higher in three species (Myotis lucifugus, M. septentrionalis, and Perimyotis subflavus). In addition, M. lucifugus was more likely to show visual signs of infection than other species given the same pathogen load. Nearly all infections were cryptic in three species (Eptesicus fuscus, M. grisescens, and M. sodalis), which had much lower fungal loads. The presence of M. lucifugus or M. septentrionalis at a site increased the probability that P. destructans was visually detected on bats. Our results suggest that cryptic infections of P. destructans are common in all bat species, and visible infections rarely occur in some species. However, due to very high infection prevalence and loads in some species, we estimate that visual surveys examining at least 17 individuals of M. lucifugus and M. septentrionalis, or 29 individuals of P. subflavus are still effective to determine whether a site has bats infected with P. destructans. In addition, because the probability of visually detecting the fungus was higher later in winter, surveys should be done as close to the end of the hibernation period as possible.	[Janicki, Amanda F.; McCracken, Gary F.] Univ Tennessee, Dept Ecol & Evolutionary Biol, Knoxville, TN 37996 USA; [Frick, Winifred F.; Kilpatrick, A. Marm] Univ Calif Santa Cruz, Dept Ecol & Evolutionary Biol, Santa Cruz, CA 95064 USA; [Parise, Katy L.; Foster, Jeffrey T.] No Arizona Univ, Ctr Microbial Genet & Genom, Flagstaff, AZ 86011 USA	University of Tennessee System; University of Tennessee Knoxville; University of California System; University of California Santa Cruz; Northern Arizona University	Janicki, AF (corresponding author), Univ Tennessee, Dept Ecol & Evolutionary Biol, Knoxville, TN 37996 USA.	ajanicki@vols.utk.edu	Frick, Winifred/ABA-3519-2020	Frick, Winifred/0000-0002-9469-1839; McCracken, Gary/0000-0002-2493-8103; Foster, Jeffrey/0000-0001-8235-8564	National Science Foundation Ecology of Infectious Diseases [DEB-1115895, DEB-1336290]; University of Tennessee Department of Ecology and Evolutionary Biology	National Science Foundation Ecology of Infectious Diseases(National Science Foundation (NSF)); University of Tennessee Department of Ecology and Evolutionary Biology	Funding was provided by the National Science Foundation Ecology of Infectious Diseases (DEB-1115895 and DEB-1336290) to WFF, AMK, JTF, and GFM; and the University of Tennessee Department of Ecology and Evolutionary Biology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blanchong JA, 2006, J WILDLIFE DIS, V42, P33, DOI 10.7589/0090-3558-42.1.33; Blehert DS, 2009, SCIENCE, V323, P227, DOI 10.1126/science.1163874; Canadian Wildlife Health Cooperative, 2015, NAT PLAN MAN WHIT NO; Coleman J, 2011, NATL PLAN ASSISTING; Cryan PM, 2013, J WILDLIFE DIS, V49, P398, DOI 10.7589/2012-04-121; Foley J, 2011, CONSERV BIOL, V25, P223, DOI 10.1111/j.1523-1739.2010.01638.x; Frank CL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113958; Frick WF, 2015, GLOBAL ECOL BIOGEOGR, V24, P741, DOI 10.1111/geb.12290; Frick WF, 2010, SCIENCE, V329, P679, DOI 10.1126/science.1188594; Hallam TG, 2011, CONSERV BIOL, V25, P189, DOI 10.1111/j.1523-1739.2010.01603.x; Hochachka WM, 2000, P NATL ACAD SCI USA, V97, P5303, DOI 10.1073/pnas.080551197; Hoyt JR, 2015, ECOHEALTH, V12, P330, DOI 10.1007/s10393-014-0981-4; Johnson JS, 2015, ECOL EVOL, V5, P2203, DOI 10.1002/ece3.1502; Langwig KE, 2015, EMERG INFECT DIS, V21, P1023, DOI 10.3201/eid2106.150123; Langwig KE, 2015, FRONT ECOL ENVIRON, V13, P195, DOI 10.1890/140241; Langwig KE, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.2335; Langwig KE, 2012, ECOL LETT, V15, P1050, DOI 10.1111/j.1461-0248.2012.01829.x; Leopardi S, 2015, CURR BIOL, V25, pR217, DOI 10.1016/j.cub.2015.01.047; Loeb S.C., 2015, SRS208; Lorch JM, 2015, J WILDLIFE DIS, V51, P36, DOI 10.7589/2014-05-134; Lorch JM, 2013, APPL ENVIRON MICROB, V79, P1293, DOI 10.1128/AEM.02939-12; Lorch JM, 2011, NATURE, V480, P376, DOI 10.1038/nature10590; Maher SP, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2301; Meteyer CU, 2009, J VET DIAGN INVEST, V21, P411, DOI 10.1177/104063870902100401; Minnis AM, 2013, FUNGAL BIOL-UK, V117, P638, DOI 10.1016/j.funbio.2013.07.001; Muller LK, 2013, MYCOLOGIA, V105, P253, DOI 10.3852/12-242; Norquay KJO, 2014, J ZOOL, V294, P85, DOI 10.1111/jzo.12155; O'Regan SM, 2015, ECOL APPL, V25, P621, DOI 10.1890/14-0417.1; Puechmaille SJ, 2011, TRENDS ECOL EVOL, V26, P570, DOI 10.1016/j.tree.2011.06.013; Puechmaille SJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019167; Reeder DM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038920; Reynolds HT, 2015, J WILDLIFE DIS, V51, P318, DOI 10.7589/2014-06-157; Sachanowicz K, 2014, CENT EUR J BIOL, V9, P437, DOI 10.2478/s11535-013-0280-z; Shelley V, 2013, J CAVE KARST STUD, V75, P1, DOI 10.4311/2011LSC0249; Shuey MM, 2014, APPL ENVIRON MICROB, V80, P1726, DOI 10.1128/AEM.02897-13; Sleeman JM, 2013, ECOHEALTH, V10, P335, DOI 10.1007/s10393-013-0880-0; Stallknecht DE, 2007, CURR TOP MICROBIOL, V315, P445; Thogmartin WE, 2013, BIOL CONSERV, V160, P162, DOI 10.1016/j.biocon.2013.01.010; Turner GG, 2014, J WILDLIFE DIS, V50, P566, DOI 10.7589/2014-03-058; U.S. Fish and Wildlife Service, 2015, WHIT NOS SYNDR MAP; Verant Michelle L., 2014, BMC Physiology, V14, P10, DOI 10.1186/s12899-014-0010-4; Warnecke L, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2013.0177; Warnecke L, 2012, P NATL ACAD SCI USA, V109, P6999, DOI 10.1073/pnas.1200374109; Wilder AP, 2011, BIOL LETTERS, V7, P950, DOI 10.1098/rsbl.2011.0355	44	28	28	1	77	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0133390	10.1371/journal.pone.0133390	http://dx.doi.org/10.1371/journal.pone.0133390			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LZ	26197236	Green Published, gold, Green Submitted			2022-12-26	WOS:000358547600092
J	Lai, YH; Tsao, Y; Chen, F				Lai, Ying-Hui; Tsao, Yu; Chen, Fei			Effects of Adaptation Rate and Noise Suppression on the Intelligibility of Compressed-Envelope Based Speech	PLOS ONE			English	Article							DYNAMIC-RANGE; SPECTRAL CHANNELS; BACKGROUND-NOISE; RELEASE TIME; COCHLEAR; RECOGNITION; REDUCTION; HEARING; NUMBER; ALGORITHMS	Temporal envelope is the primary acoustic cue used in most cochlear implant (CI) speech processors to elicit speech perception for patients fitted with CI devices. Envelope compression narrows down envelope dynamic range and accordingly degrades speech understanding abilities of CI users, especially under challenging listening conditions (e.g., in noise). A new adaptive envelope compression (AEC) strategy was proposed recently, which in contrast to the traditional static envelope compression, is effective at enhancing the modulation depth of envelope waveform by making best use of its dynamic range and thus improving the intelligibility of envelope-based speech. The present study further explored the effect of adaptation rate in envelope compression on the intelligibility of compressed-envelope based speech. Moreover, since noise reduction is another essential unit in modern CI systems, the compatibility of AEC and noise reduction was also investigated. In this study, listening experiments were carried out by presenting vocoded sentences to normal hearing listeners for recognition. Experimental results demonstrated that the adaptation rate in envelope compression had a notable effect on the speech intelligibility performance of the AEC strategy. By specifying a suitable adaptation rate, speech intelligibility could be enhanced significantly in noise compared to when using static envelope compression. Moreover, results confirmed that the AEC strategy was suitable for combining with noise reduction to improve the intelligibility of envelope-based speech in noise.	[Lai, Ying-Hui; Tsao, Yu] Acad Sinica, Res Ctr Informat Technol Innovat, Taipei 115, Taiwan; [Chen, Fei] South Univ Sci & Technol China, Dept Elect & Elect Engn, Shenzhen, Peoples R China	Academia Sinica - Taiwan; Southern University of Science & Technology	Tsao, Y (corresponding author), Acad Sinica, Res Ctr Informat Technol Innovat, Taipei 115, Taiwan.	yu.tsao@citi.sinica.edu.tw; fchen@sustc.edu.cn	Tsao, Yu/AAP-4779-2020; Chen, Fei/AAK-6755-2020; Chen, Fei/G-4674-2018	Tsao, Yu/0000-0001-6956-0418; Chen, Fei/0000-0002-6988-492X; Chen, Fei/0000-0002-6988-492X	Ministry of Science and Technology of Taiwan [MOST103-2221-E-001-003]	Ministry of Science and Technology of Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by the Ministry of Science and Technology of Taiwan under Project MOST103-2221-E-001-003.	Blamey Peter J, 2005, Trends Amplif, V9, P77, DOI 10.1177/108471380500900203; Buechner A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095542; Buechner A, 2010, OTOL NEUROTOL, V31, P1386, DOI 10.1097/MAO.0b013e3181f1cdc6; Chen F, 2014, EAR HEARING; Chen F, 2013, J SPEECH LANG HEAR R, V56, P1166, DOI 10.1044/1092-4388(2012/12-0255); Chung King, 2004, Trends Amplif, V8, P83, DOI 10.1177/108471380400800302; Dawson PW, 2011, EAR HEARING, V32, P382, DOI 10.1097/AUD.0b013e318201c200; Dawson PW, 2004, EAR HEARING, V25, P230, DOI 10.1097/01.AUD.0000130795.66185.28; Dorman MF, 1997, J ACOUST SOC AM, V102, P2993, DOI 10.1121/1.420354; Dorman MF, 1997, J ACOUST SOC AM, V102, P2403, DOI 10.1121/1.419603; Eddington DK, 1977, ANN OTOLOGY RHINOL 2, V87, P1; Fetterman BL, 2002, OTOLARYNG HEAD NECK, V126, P257, DOI 10.1067/mhn.2002.123044; Friesen LM, 2001, J ACOUST SOC AM, V110, P1150, DOI 10.1121/1.1381538; Fu QJ, 1998, J ACOUST SOC AM, V104, P3586, DOI 10.1121/1.423941; Gatehouse S, 2006, INT J AUDIOL, V45, P130, DOI 10.1080/14992020500429518; Goupell MJ, 2010, J ACOUST SOC AM, V127, P990, DOI 10.1121/1.3283014; Hamacher V, 1997, AM J OTOL, V18, pS46; Hansen M, 2002, EAR HEARING, V23, P369, DOI 10.1097/00003446-200208000-00012; Hersbach AA, 2013, J ACOUST SOC AM, V133, P2412, DOI 10.1121/1.4794391; Hersbach AA, 2012, EAR HEARING, V33, pE13, DOI 10.1097/AUD.0b013e31824b9e21; HOCHBERG I, 1992, EAR HEARING, V13, P263, DOI 10.1097/00003446-199208000-00008; Hu Y, 2003, IEEE T SPEECH AUDI P, V11, P334, DOI 10.1109/TSA.2003.814458; Hu Y, 2007, J ACOUST SOC AM, V122, P1777, DOI 10.1121/1.2766778; James CJ, 2002, EAR HEARING, V23, p49S, DOI 10.1097/00003446-200202001-00006; Jerlvall L, 1977, SCANDINAVIAN AUDIO S, P341; Kasturi K, 2007, EAR HEARING, V28, P402, DOI 10.1097/AUD.0b013e31804793c4; Khing PP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082263; Lai Y- H, 2014, 2014 INT S IN PRESS; Lai Y-H, 2013, INT J SPEECH LANGUAG, V1, P43; Lai YH, 2014, INTERSPEECH, P481; Lai YH, 2013, J AM ACAD AUDIOL, V24, P671, DOI 10.3766/jaaa.24.8.4; Loizou PC, 2005, J ACOUST SOC AM, V118, P2791, DOI 10.1121/1.2065847; Loizou PC, 2000, EAR HEARING, V21, P25, DOI 10.1097/00003446-200002000-00006; Muller-Deile J, 2008, Cochlear Implants Int, V9, P8, DOI 10.1179/cim.2008.9.1.8; NABELEK IV, 1977, AUDIOLOGY, V16, P73; National Institute on Deafness and other communication disorders N, 2013, NIH PUBL, V11-4798; Naylor G, 2009, J AM ACAD AUDIOL, V20, P161, DOI 10.3766/jaaa.20.3.2; Neuman AC, 1995, J ACOUST SOC AM, V98, P3182, DOI 10.1121/1.413807; Neuman AC, 1998, J ACOUST SOC AM, V103, P2273, DOI 10.1121/1.422745; NILSSON M, 1994, J ACOUST SOC AM, V95, P1085, DOI 10.1121/1.408469; Noel-Petroff N, 2013, AUDIOLOGY RES, V3, P9; Patrick James F, 2006, Trends Amplif, V10, P175, DOI 10.1177/1084713806296386; Scalart P, 1996, AC SPEECH SIGN PROC; SHANNON RV, 1995, SCIENCE, V270, P303, DOI 10.1126/science.270.5234.303; Souza Pamela E, 2002, Trends Amplif, V6, P131, DOI 10.1177/108471380200600402; Souza PE, 2006, J SPEECH LANG HEAR R, V49, P138, DOI 10.1044/1092-4388(2006/011); Spriet A, 2007, EAR HEARING, V28, P62, DOI 10.1097/01.aud.0000252470.54246.54; Stickney GS, 2004, J ACOUST SOC AM, V116, P1081, DOI 10.1121/1.1772399; van Hoesel R, 2005, EAR HEARING, V26, P381, DOI 10.1097/00003446-200508000-00002; VANHOESEL RJM, 1995, J ACOUST SOC AM, V97, P2498, DOI 10.1121/1.411970; Venema T, 2006, COMPRESSION CLIN; Wong LLN, 2007, EAR HEARING, V28, p70S, DOI 10.1097/AUD.0b013e31803154d0; Wouters J, 2001, EAR HEARING, V22, P420, DOI 10.1097/00003446-200110000-00006; Yang LP, 2005, J ACOUST SOC AM, V117, P1001, DOI 10.1121/1.1852873; Zeng Fan-Gang, 2004, Trends Amplif, V8, P1, DOI 10.1177/108471380400800102; ZENG FG, 1992, HEARING RES, V60, P231, DOI 10.1016/0378-5955(92)90024-H; Zeng FG, 2002, J ACOUST SOC AM, V111, P377, DOI 10.1121/1.1423926	57	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0133519	10.1371/journal.pone.0133519	http://dx.doi.org/10.1371/journal.pone.0133519			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LZ	26196508	Green Published, gold, Green Submitted			2022-12-26	WOS:000358547600108
J	Pica, A; Graziano, G				Pica, Andrea; Graziano, Giuseppe			On the Effect of Sodium Chloride and Sodium Sulfate on Cold Denaturation	PLOS ONE			English	Article							SCALED-PARTICLE THEORY; CONFORMATIONAL ENTROPY CHANGE; AQUEOUS-SOLUTIONS; HYDROPHOBIC HYDRATION; PROTEIN STABILITY; CRYSTAL-STRUCTURE; WATER-STRUCTURE; YEAST FRATAXIN; TEMPERATURE; DENSITY	Both sodium chloride and sodium sulfate are able to stabilize yeast frataxin, causing an overall increase of its thermodynamic stability curve, with a decrease in the cold denaturation temperature and an increase in the hot denaturation one. The influence of low concentrations of these two salts on yeast frataxin stability can be assessed by the application of a theoretical model based on scaled particle theory. First developed to figure out the mechanism underlying cold denaturation in water, this model is able to predict the stabilization of globular proteins provided by these two salts. The densities of the salt solutions and their temperature dependence play a fundamental role.	[Pica, Andrea] Univ Naples Federico II, Dipartimento Sci Chim, I-80126 Naples, Italy; [Pica, Andrea] CNR, Ist Biostrutture & Bioimmagini, I-80125 Naples, Italy; [Graziano, Giuseppe] Univ Sannio, Dipartimento Sci & Tecnol, I-82100 Benevento, Italy	University of Naples Federico II; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biostrutture e Bioimmagini (IBB-CNR); University of Sannio	Graziano, G (corresponding author), Univ Sannio, Dipartimento Sci & Tecnol, Via Port Arsa 11, I-82100 Benevento, Italy.	graziano@unisannio.it		Graziano, Giuseppe/0000-0001-6935-8172; PICA, Andrea/0000-0002-8736-8742				Adrover M, 2010, J AM CHEM SOC, V132, P16240, DOI 10.1021/ja1070174; Ashbaugh HS, 2007, J PHYS CHEM B, V111, P9330, DOI 10.1021/jp071969d; Ashbaugh HS, 2010, J CHEM PHYS, V132, DOI 10.1063/1.3366718; Ashbaugh HS, 2006, REV MOD PHYS, V78, P159, DOI 10.1103/RevModPhys.78.159; Baldwin RL, 1996, BIOPHYS J, V71, P2056, DOI 10.1016/S0006-3495(96)79404-3; Ball P, 2015, PHYS CHEM CHEM PHYS, V17, P8297, DOI 10.1039/c4cp04564e; Baxa MC, 2014, P NATL ACAD SCI USA, V111, P15396, DOI 10.1073/pnas.1407768111; Buchner GS, 2012, BIOCHEMISTRY-US, V51, P6496, DOI 10.1021/bi300916v; Chandler D, 2005, NATURE, V437, P640, DOI 10.1038/nature04162; Cho SJ, 2000, P NATL ACAD SCI USA, V97, P8932, DOI 10.1073/pnas.160270897; Collins KD, 1997, BIOPHYS J, V72, P65, DOI 10.1016/S0006-3495(97)78647-8; CONNAUGHTON LM, 1986, J SOLUTION CHEM, V15, P989, DOI 10.1007/BF00645194; DAquino JA, 1996, PROTEINS, V25, P143, DOI 10.1002/prot.1; Despretz M., 1840, ANN CHIM PHYS, V73, P296; Dhe-Paganon S, 2000, J BIOL CHEM, V275, P30753, DOI 10.1074/jbc.C000407200; DOIG AJ, 1995, PROTEIN SCI, V4, P2247, DOI 10.1002/pro.5560041101; Fitter J, 2003, BIOPHYS J, V84, P3924, DOI 10.1016/S0006-3495(03)75120-0; Garde S, 1996, PHYS REV LETT, V77, P4966, DOI 10.1103/PhysRevLett.77.4966; Graziano G, 2004, CHEM PHYS LETT, V396, P226, DOI 10.1016/j.cplett.2004.07.126; Graziano G, 2002, J PHYS CHEM B, V106, P7713, DOI 10.1021/jp014558k; Graziano G, 2001, J PHYS CHEM B, V105, P10367, DOI 10.1021/jp011382d; Graziano G, 2006, J PHYS CHEM B, V110, P11421, DOI 10.1021/jp0571269; Graziano G, 2014, PHYS CHEM CHEM PHYS, V16, P21755, DOI 10.1039/c4cp02729a; Graziano G, 2012, PHYS CHEM CHEM PHYS, V14, P2769, DOI 10.1039/c2cp23463g; Graziano G, 2011, PHYS CHEM CHEM PHYS, V13, P17689, DOI 10.1039/c1cp22176k; Graziano G, 2011, PHYS CHEM CHEM PHYS, V13, P12008, DOI 10.1039/c1cp20843h; Graziano G, 2010, PHYS CHEM CHEM PHYS, V12, P14245, DOI 10.1039/c0cp00945h; Graziano G, 2009, J PHYS CHEM B, V113, P11232, DOI 10.1021/jp9025738; Graziano G, 2008, J CHEM PHYS, V129, DOI 10.1063/1.2972979; Hofmeister F., 1888, ARCH EXP PATHOL PH, V24, P247, DOI [DOI 10.1007/BF01918191, 10.1007/BF01918191]; Hruby J, 2014, J PHYS CHEM LETT, V5, P425, DOI 10.1021/jz402571a; Karlberg T, 2006, STRUCTURE, V14, P1535, DOI 10.1016/j.str.2006.08.010; KAULGUD MV, 1995, J CHEM SOC FARADAY T, V91, P999, DOI 10.1039/ft9959100999; KAUZMANN W, 1959, ADV PROTEIN CHEM, V14, P1, DOI 10.1016/S0065-3233(08)60608-7; KELL GS, 1975, J CHEM ENG DATA, V20, P97, DOI 10.1021/je60064a005; LEBERMAN R, 1995, NATURE, V378, P364, DOI 10.1038/378364a0; LEE B, 1994, BIOPHYS CHEM, V51, P271, DOI 10.1016/0301-4622(94)00048-4; LEE B, 1985, BIOPOLYMERS, V24, P813, DOI 10.1002/bip.360240507; LEE B, 1971, J MOL BIOL, V55, P379, DOI 10.1016/0022-2836(71)90324-X; Luan BW, 2013, BIOCHEMISTRY-US, V52, P2402, DOI 10.1021/bi3016789; MARCUS Y, 1988, CHEM REV, V88, P1475, DOI 10.1021/cr00090a003; Martin SR, 2008, J AM CHEM SOC, V130, P9963, DOI 10.1021/ja803280e; Paschek D, 2004, J CHEM PHYS, V120, P6674, DOI 10.1063/1.1652015; Pastore A, 2007, J AM CHEM SOC, V129, P5374, DOI 10.1021/ja0714538; Pastore C, 2007, FEBS J, V274, P4199, DOI 10.1111/j.1742-4658.2007.05946.x; Pauling L, 1960, NATURE CHEM BOND, VThird, P644; PIEROTTI RA, 1976, CHEM REV, V76, P717, DOI 10.1021/cr60304a002; PRIVALOV PL, 1990, CRIT REV BIOCHEM MOL, V25, P281, DOI 10.3109/10409239009090612; Rees DC, 2001, PROTEIN SCI, V10, P1187, DOI 10.1110/ps.180101; Riess H., 1965, ADV CHEM PHYS, V9, P1, DOI DOI 10.1002/9780470143551.CHL; Sanfelice D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095801; Shah PP, 2008, J PHYS CHEM B, V112, P1049, DOI 10.1021/jp075783q; Sorenson JM, 2000, J CHEM PHYS, V113, P9149, DOI 10.1063/1.1319615; Tang KES, 2000, BIOPHYS J, V79, P2222, DOI 10.1016/S0006-3495(00)76470-8; Tran HT, 2006, BIOPHYS J, V91, P1868, DOI 10.1529/biophysj.106.086264; Waldron TT, 2005, J MOL BIOL, V346, P895, DOI 10.1016/j.jmb.2004.12.018; Yang C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6773; Zhang YJ, 2006, CURR OPIN CHEM BIOL, V10, P658, DOI 10.1016/j.cbpa.2006.09.020; Zhang YJ, 2010, ANNU REV PHYS CHEM, V61, P63, DOI 10.1146/annurev.physchem.59.032607.093635	59	3	3	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0133550	10.1371/journal.pone.0133550	http://dx.doi.org/10.1371/journal.pone.0133550			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LZ	26197394	Green Published, Green Submitted, gold			2022-12-26	WOS:000358547600113
J	Takami, H; Arai, W; Takemoto, K; Uchiyama, I; Taniguchi, T				Takami, Hideto; Arai, Wataru; Takemoto, Kazuhiro; Uchiyama, Ikuo; Taniguchi, Takeaki			Functional Classification of Uncultured "Candidatus Caldiarchaeum subterraneum" Using the Maple System	PLOS ONE			English	Article							ATP-DEPENDENT 6-PHOSPHOFRUCTOKINASE; CITRATE CLEAVAGE REACTION; NON-ALLOSTERIC ENZYME; SINGLE-CELL GENOMICS; SP. NOV.; NITROSOPUMILUS-MARITIMUS; GEN. NOV.; ARCHAEA; SEQUENCE; INSIGHTS	In this study, the metabolic and physiological potential evaluator system based on Kyoto Encyclopedia of Genes and Genomes (KEGG) functional modules was employed to establish a functional classification of archaeal species and to determine the comprehensive functions (functionome) of the previously uncultivated thermophile "Candidatus Caldiarchaeum subterraneum" (Ca. C. subterraneum). A phylogenetic analysis based on the concatenated sequences of proteins common among 142 archaea and 2 bacteria, and among 137 archaea and 13 unicellular eukaryotes suggested that Ca. C. subterraneum is closely related to thaumarchaeotic species. Consistent with the results of the phylogenetic analysis, clustering and principal component analyses based on the completion ratio patterns for all KEGG modules in 79 archaeal species suggested that the overall metabolic and physiological potential of Ca. C. subterraneum is similar to that of thaumarchaeotic species. However, Ca. C. subterraneum possessed almost no genes in the modules required for nitrification and the hydroxypropionate-hydroxybutyrate cycle for carbon fixation, unlike thaumarchaeotic species. However, it possessed all genes in the modules required for central carbohydrate metabolism, such as glycolysis, pyruvate oxidation, the tricarboxylic acid (TCA) cycle, and the glyoxylate cycle, as well as multiple sets of sugar and branched chain amino acid ABC transporters. These metabolic and physiological features appear to support the predominantly aerobic character of Ca. C. subterraneum, which lives in a subsurface thermophilic microbial mat community with a heterotrophic lifestyle.	[Takami, Hideto; Arai, Wataru] Japan Agcy Marine Earth Sci & Technol JAMSTEC, Yokohama Inst, Microbial Genome Res Grp, Yokohama, Kanagawa, Japan; [Takemoto, Kazuhiro] Kyushu Inst Technol, Dept Biosci & Bioinformat, Iizuka, Fukuoka, Japan; [Uchiyama, Ikuo] Natl Inst Nat Sci, Natl Inst Basic Biol, Lab Genome Informat, Okazaki, Aichi, Japan; [Taniguchi, Takeaki] Tokyo Inst Technol, Grad Sch Biosci & Biotechnol, Meguro Ku, Tokyo 152, Japan; [Taniguchi, Takeaki] Mitsubishi Res Inst Inc MRI, Adv Sci & Innovat Grp, Tokyo, Japan	Japan Agency for Marine-Earth Science & Technology (JAMSTEC); Kyushu Institute of Technology; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Tokyo Institute of Technology	Takami, H (corresponding author), Japan Agcy Marine Earth Sci & Technol JAMSTEC, Yokohama Inst, Microbial Genome Res Grp, Yokohama, Kanagawa, Japan.	takamih@jamstec.go.jp	Takami, Hideto/D-4200-2012; Takemoto, Kazuhiro/H-2915-2019	Takami, Hideto/0000-0003-3433-7018; Takemoto, Kazuhiro/0000-0002-6355-1366; Uchiyama, Ikuo/0000-0002-9197-5000	Ministry of Education, Culture, Sports, Science, and Technology of Japan [26550053, 20310124]; National Institute for Basic Biology (NIBB); Mitsubishi Research Institute Inc.	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); National Institute for Basic Biology (NIBB)(National Institutes of Natural Sciences (NINS) - Japan); Mitsubishi Research Institute Inc.	This research was supported in part by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan to H.T. (Nos. 26550053 and 20310124). This research was also supported in part by the collaborative research programs of the National Institute for Basic Biology (NIBB). Computational resources were provided partly by the Data Integration and Analysis Facility of NIBB. Mitsubishi Research Institute Inc. provided support in the form of salaries for T.T., but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author (T.T.) is articulated in the 'author contributions' section.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Aoshima M, 2004, MOL MICROBIOL, V52, P763, DOI 10.1111/j.1365-2958.2004.04010.x; Aoshima M, 2004, MOL MICROBIOL, V52, P751, DOI 10.1111/j.1365-2958.2004.04009.x; Baker BJ, 2010, P NATL ACAD SCI USA, V107, P8806, DOI 10.1073/pnas.0914470107; BARTOLUCCI S, 1987, J BIOL CHEM, V262, P7725; Berg IA, 2007, SCIENCE, V318, P1782, DOI 10.1126/science.1149976; Blainey PC, 2013, FEMS MICROBIOL REV, V37, P407, DOI 10.1111/1574-6976.12015; Blochl E, 1997, EXTREMOPHILES, V1, P14; Borrel G, 2013, GENOME ANNOUNCEMENTS, V1, DOI 10.1128/genomeA.00453-13; Borrel G, 2012, J BACTERIOL, V194, P6944, DOI 10.1128/JB.01867-12; Brasen C, 2014, MICROBIOL MOL BIOL R, V78, P89, DOI 10.1128/MMBR.00041-13; de la Torre JR, 2008, ENVIRON MICROBIOL, V10, P810, DOI 10.1111/j.1462-2920.2007.01506.x; DELONG EF, 1992, P NATL ACAD SCI USA, V89, P5685, DOI 10.1073/pnas.89.12.5685; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Elkins JG, 2008, P NATL ACAD SCI USA, V105, P8102, DOI 10.1073/pnas.0801980105; FUHRMAN JA, 1992, NATURE, V356, P148, DOI 10.1038/356148a0; Futterer O, 2004, P NATL ACAD SCI USA, V101, P9091, DOI 10.1073/pnas.0401356101; Ghai R, 2011, SCI REP-UK, V1, DOI 10.1038/srep00135; Hallam SJ, 2006, P NATL ACAD SCI USA, V103, P18296, DOI 10.1073/pnas.0608549103; Handelsman J, 2004, MICROBIOL MOL BIOL R, V68, P669, DOI 10.1128/MMBR.68.4.669-685.2004; Hansen T, 2001, ARCH MICROBIOL, V177, P62, DOI 10.1007/s00203-001-0359-1; Hansen T, 2000, ARCH MICROBIOL, V173, P103, DOI 10.1007/s002039900114; Hirayama H, 2005, EXTREMOPHILES, V9, P169, DOI 10.1007/s00792-005-0433-8; Huber R, 1998, INT J SYST BACTERIOL, V48, P31, DOI 10.1099/00207713-48-1-31; Hugenholtz P, 2008, NATURE, V455, P481, DOI 10.1038/455481a; Kanao T, 2001, EUR J BIOCHEM, V268, P1670, DOI 10.1046/j.1432-1033.2001.02034.x; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; KERSCHER L, 1981, EUR J BIOCHEM, V116, P587, DOI 10.1111/j.1432-1033.1981.tb05376.x; Konneke M, 2014, P NATL ACAD SCI USA, V111, P8239, DOI 10.1073/pnas.1402028111; KORNBERG HL, 1966, BIOCHEM J, V99, P1; Lindblad A, 1996, MOL MICROBIOL, V20, P559, DOI 10.1046/j.1365-2958.1996.5311054.x; Narasingarao P, 2012, ISME J, V6, P81, DOI 10.1038/ismej.2011.78; Nikitin Frederic, 2004, Genome Inform, V15, P266; Nishizawa M, 2013, GEOCHIM COSMOCHIM AC, V113, P152, DOI 10.1016/j.gca.2013.03.027; Nunoura T, 2005, ENVIRON MICROBIOL, V7, P1967, DOI 10.1111/j.1462-2920.2005.00881.x; Nunoura T, 2011, NUCLEIC ACIDS RES, V39, P3204, DOI 10.1093/nar/gkq1228; Offre P, 2013, ANNU REV MICROBIOL, V67, P437, DOI 10.1146/annurev-micro-092412-155614; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Otte J, 2015, APPL ENVIRON MICROB, V81, P1700, DOI 10.1128/AEM.03390-14; Overbeek R, 2005, NUCLEIC ACIDS RES, V33, P5691, DOI 10.1093/nar/gki866; Perevalova AA, 2010, INT J SYST EVOL MICR, V60, P2082, DOI 10.1099/ijs.0.019042-0; Qin W, 2014, P NATL ACAD SCI USA, V111, P12504, DOI 10.1073/pnas.1324115111; R Core Team, 2021, R LANGUAGE ENV STAT; Rinke C, 2013, NATURE, V499, P431, DOI 10.1038/nature12352; Ronimus RS, 2001, EXTREMOPHILES, V5, P357, DOI 10.1007/s007920100215; Sako Y, 1996, INT J SYST BACTERIOL, V46, P1070, DOI 10.1099/00207713-46-4-1070; Say RF, 2010, NATURE, V464, P1077, DOI 10.1038/nature08884; Spang A, 2012, ENVIRON MICROBIOL, V14, P3122, DOI 10.1111/j.1462-2920.2012.02893.x; Stepanauskas R, 2012, CURR OPIN MICROBIOL, V15, P613, DOI 10.1016/j.mib.2012.09.001; Takai K, 2002, APPL ENVIRON MICROB, V68, P3046, DOI 10.1128/AEM.68.6.3046-3054.2002; Takami H, 2014, ENCY METAGENOMICS, P525, DOI DOI 10.1007/978-1-4899-7478-5; Takami H, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-699; Takami H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030559; Takemoto K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025874; Talavera G, 2007, SYST BIOL, V56, P564, DOI 10.1080/10635150701472164; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tyson GW, 2004, NATURE, V428, P37, DOI 10.1038/nature02340; Uchiyama I, 2006, NUCLEIC ACIDS RES, V34, P647, DOI 10.1093/nar/gkj448; Uchiyama I, 2010, NUCLEIC ACIDS RES, V38, pD361, DOI 10.1093/nar/gkp948; Waino M, 2000, INT J SYST EVOL MICR, V50, P183, DOI 10.1099/00207713-50-1-183; Walker CB, 2010, P NATL ACAD SCI USA, V107, P8818, DOI 10.1073/pnas.0913533107; Waters E, 2003, P NATL ACAD SCI USA, V100, P12984, DOI 10.1073/pnas.1735403100; Xhang Q, 1996, J BIOCH, V120, P587; Xhen Yan, 2014, BIOCHIM BIOPHYS ACTA, V1844, P736, DOI [10.1016/j.bbapap.2014.01.015, DOI 10.1016/J.BBAPAP.2014.01.015]; Zou H, 2006, J COMPUT GRAPH STAT, V15, P265, DOI 10.1198/106186006X113430	65	12	12	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0132994	10.1371/journal.pone.0132994	http://dx.doi.org/10.1371/journal.pone.0132994			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LZ	26196861	Green Submitted, Green Published, gold			2022-12-26	WOS:000358547600060
J	Therit, B; Cheung, JK; Rood, JI; Melville, SB				Therit, Blair; Cheung, Jackie K.; Rood, Julian I.; Melville, Stephen B.			NanR, a Transcriptional Regulator That Binds to the Promoters of Genes Involved in Sialic Acid Metabolism in the Anaerobic Pathogen Clostridium perfringens	PLOS ONE			English	Article							ALPHA-TOXIN; EXPRESSION; PROTEIN; VIRULENCE; CLONING; CPE; SPORULATION; CATABOLISM; SIALIDASES; SEQUENCE	Among many other virulence factors, Clostridium perfringens produces three sialidases NanH, NanI and NanJ. NanH lacks a secretion signal peptide and is predicted to be an intracellular enzyme, while NanI and NanJ are secreted. Previously, we had identified part of an operon encoding NanE (epimerase) and NanA (sialic acid lyase) enzymes. Further analysis of the entire operon suggests that it encodes a complete pathway for the transport and metabolism of sialic acid along with a putative transcriptional regulator, NanR. The addition of 30 mM N-acetyl neuraminic acid (Neu5Ac) to a semi-defined medium significantly enhanced the growth yield of strain 13, suggesting that Neu5Ac can be used as a nutrient. C. perfringens strain 13 lacks a nanH gene, but has NanI- and NanJ-encoding genes. Analysis of nanI, nanJ, and nanInanJ mutants constructed by homologous recombination revealed that the expression of the major sialidase, NanI, was induced by the addition of Neu5Ac to the medium, and that in separate experiments, the same was true of a nanI-gusA transcriptional fusion. For the nanI and nanJ genes, primer extension identified three and two putative transcription start sites, respectively. Gel mobility shift assays using purified NanR and DNA from the promoter regions of the nanI and nanE genes showed high affinity, specific binding by NanR. We propose that NanR is a global regulator of sialic acid-associated genes and that it responds, in a positive feedback loop, to the concentration of sialic acid in the cell.	[Therit, Blair; Melville, Stephen B.] Virginia Tech, Dept Biol Sci, Blacksburg, VA 24061 USA; [Cheung, Jackie K.; Rood, Julian I.] Monash Univ, Dept Microbiol, Clayton, Vic 3168, Australia	Virginia Polytechnic Institute & State University; Monash University	Melville, SB (corresponding author), Virginia Tech, Dept Biol Sci, Blacksburg, VA 24061 USA.	melville@vt.edu	Rood, Julian I/A-4858-2008; Melville, Steve/D-4763-2016	Rood, Julian I/0000-0003-2126-7209; Melville, Steve/0000-0002-0116-4280	NRICGP/NIFA/USDA [200002621, 2003-35201-13580, 2004-04069]; Australian National Health and Medical Research Council [GNT1065985]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI109391] Funding Source: NIH RePORTER	NRICGP/NIFA/USDA; Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants 200002621, 2003-35201-13580 and 2004-04069 from NRICGP/NIFA/USDA (http://www.csrees.usda.gov/index.html) awarded to SBM and Project Grant GNT1065985 from the Australian National Health and Medical Research Council (http://www.nhmrc.gov.au/) awarded to JIR.	Abe K, 2010, BIOSCI BIOTECH BIOCH, V74, P1564, DOI 10.1271/bbb.100135; Afzal M, 2015, APPL ENVIRON MICROB, V81, P3121, DOI 10.1128/AEM.00499-15; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; AWAD MM, 1995, MOL MICROBIOL, V15, P191, DOI 10.1111/j.1365-2958.1995.tb02234.x; BANNAM TL, 1993, PLASMID, V29, P233, DOI 10.1006/plas.1993.1025; Boraston AB, 2007, BIOCHEMISTRY-US, V46, P11352, DOI 10.1021/bi701317g; Chiarezza M, 2009, INFECT IMMUN, V77, P4421, DOI 10.1128/IAI.00548-09; CORFIELD T, 1992, GLYCOBIOLOGY, V2, P509, DOI 10.1093/glycob/2.6.509; Fekete RA, 2003, BIOTECHNIQUES, V35, P90, DOI 10.2144/03351rr01; FRASER AG, 1978, J MED MICROBIOL, V11, P269, DOI 10.1099/00222615-11-3-269; GOLDNER SB, 1985, APPL ENVIRON MICROB, V50, P202, DOI 10.1128/AEM.50.2.202-206.1985; GRANT SGN, 1990, P NATL ACAD SCI USA, V87, P4645, DOI 10.1073/pnas.87.12.4645; HALDENWANG WG, 1995, MICROBIOL REV, V59, P1; Hartman AH, 2011, APPL ENVIRON MICROB, V77, P471, DOI 10.1128/AEM.01536-10; Hassan KA, 2015, RES MICROBIOL, V166, P255, DOI 10.1016/j.resmic.2014.10.003; Hiscox TJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073525; Hiscox TJ, 2011, INFECT IMMUN, V79, P2145, DOI 10.1128/IAI.00060-11; Hwang J, 2013, P NATL ACAD SCI USA, V110, pE2829, DOI 10.1073/pnas.1302859110; Kalivoda KA, 2013, J BACTERIOL, V195, P4689, DOI 10.1128/JB.00692-13; Kim BS, 2011, J BIOL CHEM, V286, P40889, DOI 10.1074/jbc.M111.300988; Li JH, 2014, APPL ENVIRON MICROB, V80, P1701, DOI 10.1128/AEM.03440-13; MAHONY DE, 1977, INFECT IMMUN, V15, P19, DOI 10.1128/IAI.15.1.19-25.1977; MELVILLE SB, 1994, INFECT IMMUN, V62, P5550, DOI 10.1128/IAI.62.12.5550-5558.1994; Myers GSA, 2006, GENOME RES, V16, P1031, DOI 10.1101/gr.5238106; Nees S, 1974, BEHRING I MITT, V55, P68; O'Brien DK, 2004, INFECT IMMUN, V72, P5204, DOI 10.1128/IAI.72.9.5204-5215.2004; Obana N, 2011, J BACTERIOL, V193, P4417, DOI 10.1128/JB.00262-11; Ohtani K, 2010, ANAEROBE, V16, P258, DOI 10.1016/j.anaerobe.2009.10.003; Ohtani K, 2009, J BACTERIOL, V191, P3919, DOI 10.1128/JB.01455-08; Olson ME, 2013, J BACTERIOL, V195, P1779, DOI 10.1128/JB.02294-12; ROGGENTIN P, 1995, BIOL CHEM H-S, V376, P569; Roggentin P, 1997, CLOSTRIDIA MOL BIOL, P423; ROOD JI, 1991, MICROBIOL REV, V55, P621, DOI 10.1128/MMBR.55.4.621-648.1991; Sambrock J, 1989, MOL CLONING LAB MANU, V1; SEBALD M, 1975, APPL MICROBIOL, V29, P1; Shimizu T, 2002, P NATL ACAD SCI USA, V99, P996, DOI 10.1073/pnas.022493799; Traving C, 1997, GLYCOCONJUGATE J, V14, P821, DOI 10.1023/A:1018585920853; TRAVING C, 1994, GLYCOCONJUGATE J, V11, P141, DOI 10.1007/BF00731154; Varga J, 2004, J BACTERIOL, V186, P5221, DOI 10.1128/JB.186.16.5221-5229.2004; Vimr Eric R, 2013, ISRN Microbiol, V2013, P816713, DOI 10.1155/2013/816713; Walters DM, 1999, J BACTERIOL, V181, P4526, DOI 10.1128/JB.181.15.4526-4532.1999; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9; Zhao YL, 1998, J BACTERIOL, V180, P136, DOI 10.1128/JB.180.1.136-142.1998	43	14	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0133217	10.1371/journal.pone.0133217	http://dx.doi.org/10.1371/journal.pone.0133217			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LZ	26197388	gold, Green Published, Green Submitted			2022-12-26	WOS:000358547600073
J	Zhang, F; Kwan, A; Xu, A; Suel, GM				Zhang, Fang; Kwan, Anna; Xu, Amy; Sueel, Guerol M.			A Synthetic Quorum Sensing System Reveals a Potential Private Benefit for Public Good Production in a Biofilm	PLOS ONE			English	Article							BACILLUS-SUBTILIS BIOFILMS; VIBRIO-CHOLERAE; PSEUDOMONAS-AERUGINOSA; TRANSCRIPTOME ANALYSIS; STAPHYLOCOCCUS-AUREUS; MATRIX; COOPERATION; GENES; PEPTIDE; MULTICELLULARITY	Bacteria predominantly reside in microbial communities known as biofilms, where cells are encapsulated and protected by the extracellular matrix (ECM). While all biofilm cells benefit from the ECM, only a subgroup of cells carries the burden of producing this public good. This dilemma provokes the question of how these cells balance the cost of ECM production. Here we show that ECM producing cells have a higher gene expression response to quorum sensing (QS) signals, which can lead to a private benefit. Specifically, we constructed a synthetic quorum-sensing system with designated "Sender" and "Receiver" cells in Bacillus subtilis. This synthetic QS system allowed us to uncouple and independently investigate ECM production and QS in both biofilms and single cells. Results revealed that ECM production directly enhances the response to QS signals, which may offset the cost of ECM production.	[Zhang, Fang; Kwan, Anna; Xu, Amy; Sueel, Guerol M.] Univ Calif San Diego, Div Biol Sci, Mol Biol Sect, San Diego, CA 92103 USA; [Zhang, Fang] Univ Texas Dallas, SW Med Ctr, Dallas, TX 75230 USA	University of California System; University of California San Diego; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Suel, GM (corresponding author), Univ Calif San Diego, Div Biol Sci, Mol Biol Sect, San Diego, CA 92103 USA.	gsuel@ucsd.edu			National Institutes of Health, National Institute of General Medical Sciences Grant [R01 GM088428]; National Science Foundation Grant [MCB-1450867]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088428] Funding Source: NIH RePORTER	National Institutes of Health, National Institute of General Medical Sciences Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Science Foundation Grant(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was funded by the National Institutes of Health, National Institute of General Medical Sciences Grant R01 GM088428 (http://www.nigms.nih.gov) and the National Science Foundation Grant MCB-1450867 (http://www.nsf.gov), both to GMS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Borenstein DB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063304; Branda SS, 2006, MOL MICROBIOL, V59, P1229, DOI 10.1111/j.1365-2958.2005.05020.x; Branda SS, 2005, TRENDS MICROBIOL, V13, P20, DOI 10.1016/j.tim.2004.11.006; Branda SS, 2001, P NATL ACAD SCI USA, V98, P11621, DOI 10.1073/pnas.191384198; Brockhurst MA, 2007, CURR BIOL, V17, P761, DOI 10.1016/j.cub.2007.02.057; Comella N, 2005, MOL MICROBIOL, V57, P1159, DOI 10.1111/j.1365-2958.2005.04749.x; Dandekar AA, 2012, SCIENCE, V338, P264, DOI 10.1126/science.1227289; Drescher K, 2014, CURR BIOL, V24, P50, DOI 10.1016/j.cub.2013.10.030; Flemming HC, 2010, NAT REV MICROBIOL, V8, P623, DOI 10.1038/nrmicro2415; Hammer BK, 2009, J BACTERIOL, V191, P169, DOI 10.1128/JB.01307-08; Hibbing ME, 2010, NAT REV MICROBIOL, V8, P15, DOI 10.1038/nrmicro2259; Irnov I, 2010, MOL MICROBIOL, V76, P559, DOI 10.1111/j.1365-2958.2010.07131.x; Jarmer H, 2002, FEMS MICROBIOL LETT, V206, P197, DOI 10.1016/S0378-1097(01)00525-0; Lopez D, 2009, FEMS MICROBIOL REV, V33, P152, DOI 10.1111/j.1574-6976.2008.00148.x; Lopez D, 2010, FEMS MICROBIOL REV, V34, P134, DOI 10.1111/j.1574-6976.2009.00199.x; Lopez D, 2009, GENE DEV, V23, P1631, DOI 10.1101/gad.1813709; Lopez D, 2009, P NATL ACAD SCI USA, V106, P280, DOI 10.1073/pnas.0810940106; MAGNUSON R, 1994, CELL, V77, P207, DOI 10.1016/0092-8674(94)90313-1; Middleton R, 2004, PLASMID, V51, P238, DOI 10.1016/j.plasmid.2004.01.006; Nadell CD, 2011, P NATL ACAD SCI USA, V108, P14181, DOI 10.1073/pnas.1111147108; Novick RP, 2008, ANNU REV GENET, V42, P541, DOI 10.1146/annurev.genet.42.110807.091640; NOVICK RP, 1995, MOL GEN GENET, V248, P446, DOI 10.1007/BF02191645; NOVICK RP, 1993, EMBO J, V12, P3967, DOI 10.1002/j.1460-2075.1993.tb06074.x; O'Toole G, 2000, ANNU REV MICROBIOL, V54, P49, DOI 10.1146/annurev.micro.54.1.49; Otto M, 1998, FEBS LETT, V424, P89, DOI 10.1016/S0014-5793(98)00145-8; Pottathil M, 2003, FRONT BIOSCI-LANDMRK, V8, pD32, DOI 10.2741/913; Rainey PB, 2003, NATURE, V425, P72, DOI 10.1038/nature01906; Romero D, 2014, J BACTERIOL, V196, P1505, DOI 10.1128/JB.01363-13; Romero D, 2010, P NATL ACAD SCI USA, V107, P2230, DOI 10.1073/pnas.0910560107; Rutherford ST, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a012427; Sakuragi Y, 2007, J BACTERIOL, V189, P5383, DOI 10.1128/JB.00137-07; Schluter J, 2015, ISME J, V9, P139, DOI 10.1038/ismej.2014.174; Schuster M, 2003, J BACTERIOL, V185, P2066, DOI 10.1128/JB.185.7.2066-2079.2003; Seminara A, 2012, P NATL ACAD SCI USA, V109, P1116, DOI 10.1073/pnas.1109261108; Seviour T, 2015, J BIOL CHEM, V290, P6457, DOI 10.1074/jbc.M114.613810; Shank EA, 2011, CURR OPIN MICROBIOL, V14, P741, DOI 10.1016/j.mib.2011.09.016; Solomon JM, 1996, GENE DEV, V10, P2014, DOI 10.1101/gad.10.16.2014; Suel GM, 2006, NATURE, V440, P545, DOI 10.1038/nature04588; van Gestel J, 2014, ISME J, V8, P2069, DOI 10.1038/ismej.2014.52; Vivant AL, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00160; Vlamakis H, 2008, GENE DEV, V22, P945, DOI 10.1101/gad.1645008; Waters CA, 2008, J BACTERIOL, V190, P2527, DOI 10.1128/JB.01756-07; Xavier JB, 2007, P NATL ACAD SCI USA, V104, P876, DOI 10.1073/pnas.0607651104; Zhang LS, 2002, J BIOL CHEM, V277, P34736, DOI 10.1074/jbc.M205367200; Zhao KL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101887	45	17	17	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0132948	10.1371/journal.pone.0132948	http://dx.doi.org/10.1371/journal.pone.0132948			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LZ	26196509	gold, Green Submitted, Green Published			2022-12-26	WOS:000358547600058
J	Zhang, Y; Li, JY; Wang, CS; Zhang, L				Zhang, Yuan; Li, Jingyun; Wang, Chengshuo; Zhang, Luo			Association between the Interaction of Key Genes Involved in Effector T-Cell Pathways and Susceptibility to Developallergic Rhinitis: A Population-Based Case-Control Association Study	PLOS ONE			English	Article							ALLERGIC RHINITIS; ARIA 2008; ASTHMA; POLYMORPHISMS; PREVALENCE; MECHANISMS; CYTOKINES; GENETICS; CHILDREN; DISEASES	Background Evidence suggests that interaction between key genes mediating signaling and transcriptional networks involving effector T-cell responses may influence an individual's susceptibility to develop allergic rhinitis(AR). Objective The aim of this study was to determine whether specific interactions between key genes involved in effector T-cell pathways are associated with an individual's susceptibility to develop AR in Han Chinese subjects. Method A cohort of 489 patients with AR and 421 healthy controls was enrolled from the Han Chinese population in Beijing, China. AR was established by questionnaire and clinical examination, and peripheral blood was drawn from all subjects for DNA extraction. A total of 96 single nucleotide polymorphisms (SNPs) in 26 reprehensive candidate genes involved in T helper 1 (Th1), Th2, Th17, Th9 and T regulatory cell pathways were selected from the International Haplotype Mappingdatabase for Han Chinese in Beijing (CHB) population, and Illumina Golden Gate assay was conducted for SNP genotyping. The PLINK software package was used to perform statistical analyses. Results Simple SNP-phenotype association analysis using logistic regression showed SNP rs8193036 in IL17A gene, rs2569254 in IL-12 and rs1898413 in ROR alpha were significantly associated with AR. Simple SNP-phenotype association analysis with genetic models demonstrated thatrs2569254 in IL-12, rs1031508 in STAT4, and rs3741809 in IL-26 were likely to be recessive, rs8193036 in IL17A allelic, rs897200 in STAT4 genotypic, and rs1898413 in ROR alpha dominant. Epistasis analyses exhibited that 83 SNPs in 23 genes were significantly interactive; of which 59 interactions/SNP pairs demonstrated OR values higher than 2 or lower than 0.5, and 12 interactions/SNP pairs OR values higher than 4 or lower than 0.25. STAT3, ROR alpha and IL-26, involved in Th17 pathway, were the most frequently interactive genes. Conclusion This study suggests that interactions between several SNPs in key genes involved in effector T-cell pathways are likely to influence an individual's susceptibility to develop AR.	[Zhang, Yuan; Wang, Chengshuo; Zhang, Luo] Capital Med Univ, Beijing TongRen Hosp, Dept Otolaryngol Head & Neck Surg, Beijing 100730, Peoples R China; [Zhang, Yuan; Li, Jingyun; Wang, Chengshuo; Zhang, Luo] Beijing Inst Otolaryngol, Beijing Key Lab Nasal Dis, Beijing 100005, Peoples R China; [Zhang, Yuan; Zhang, Luo] Capital Med Univ, Beijing TongRen Hosp, Dept Allergy, Beijing 100730, Peoples R China	Capital Medical University; Capital Medical University	Wang, CS (corresponding author), Capital Med Univ, Beijing TongRen Hosp, Dept Otolaryngol Head & Neck Surg, Beijing 100730, Peoples R China.	wangcs830@126.com; dr.luozhang@gmail.com		Zhang, Luo/0000-0002-0910-9884	Program for Changjiang Scholars and Innovative Research Team [IRT13082]; National Science Fund for the Major International Joint Research Program [81420108009]; National Natural Science Foundation of China [30973282, 81100706, 81441031, 81400447]; Beijing Natural Science Foundation [7131006]; 12th five year science and technology support program [2014BAI07B04]; Ministry of Health Foundation [201202005]; Capital Health Research and Development of Special [2011-1017-06]; Special Fund of Sanitation Elite Reconstruction of Beijing [2009-2-007]; Beijing Health Bureau Program for high level talents [2011-3-043]	Program for Changjiang Scholars and Innovative Research Team(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); National Science Fund for the Major International Joint Research Program; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation(Beijing Natural Science Foundation); 12th five year science and technology support program; Ministry of Health Foundation; Capital Health Research and Development of Special; Special Fund of Sanitation Elite Reconstruction of Beijing; Beijing Health Bureau Program for high level talents	This work was supported by the grants from the Program for Changjiang Scholars and Innovative Research Team (IRT13082), the National Science Fund for the Major International Joint Research Program (81420108009), National Natural Science Foundation of China (30973282, 81100706, 81441031 and 81400447), Beijing Natural Science Foundation (7131006), The 12th five year science and technology support program (2014BAI07B04), Ministry of Health Foundation (201202005), the Capital Health Research and Development of Special (2011-1017-06), the Special Fund of Sanitation Elite Reconstruction of Beijing (2009-2-007) and Beijing Health Bureau Program for high level talents (2011-3-043) to LZ, YZ and JYL.	Afzali B, 2010, CLIN EXP IMMUNOL, V159, P120, DOI 10.1111/j.1365-2249.2009.04038.x; Akdis CA, 2009, J ALLERGY CLIN IMMUN, V123, P735, DOI 10.1016/j.jaci.2009.02.030; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Barnes KC, 2000, J ALLERGY CLIN IMMUN, V106, pS192; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bateman ED, 2008, EUR RESPIR J, V31, P143, DOI 10.1183/09031936.00138707; Bousquet J, 2008, ALLERGY, V63, P8, DOI 10.1111/j.1398-9995.2007.01620.x; Carlborg O, 2004, NAT REV GENET, V5, P618, DOI 10.1038/nrg1407; Carlson CS, 2004, AM J HUM GENET, V74, P106, DOI 10.1086/381000; Chan IHS, 2006, J ALLERGY CLIN IMMUN, V117, P127, DOI 10.1016/j.jaci.2005.09.031; Chatila TA, 2008, J ALLERGY CLIN IMMUN, V121, P812, DOI 10.1016/j.jaci.2008.02.025; DREBORG S, 1993, ALLERGY, V48, P49, DOI 10.1111/j.1398-9995.1993.tb04756.x; Elyaman W, 2009, P NATL ACAD SCI USA, V106, P12885, DOI 10.1073/pnas.0812530106; Holloway JW, 2010, J ALLERGY CLIN IMMUN, V125, pS81, DOI 10.1016/j.jaci.2009.10.071; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Kabesch M, 2006, J ALLERGY CLIN IMMUN, V117, P269, DOI 10.1016/j.jaci.2005.10.024; Kay AB, 2001, NEW ENGL J MED, V344, P30, DOI 10.1056/NEJM200101043440106; Kim SH, 2009, ALLERGY, V64, P1221, DOI 10.1111/j.1398-9995.2009.01989.x; Liu X, 2004, J ALLERGY CLIN IMMUN, V113, P489, DOI 10.1016/j.jaci.2003.12.037; Liu Y, 2014, CLIN EXP ALLERGY; Mackay TFC, 2014, NAT REV GENET, V15, P22, DOI 10.1038/nrg3627; Melchiotti R, 2014, BMC MED GENET, V15, DOI 10.1186/1471-2350-15-73; MOSMANN TR, 1989, ANNU REV IMMUNOL, V7, P145, DOI 10.1146/annurev.immunol.7.1.145; Mullol J, 2008, J INVEST ALLERG CLIN, V18, P327; Orsmark-Pietras C, 2008, HUM MOL GENET, V17, P1673, DOI 10.1093/hmg/ddn058; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Stelmaszczyk-Emmel A, 2013, ADV EXP MED BIOL, V788, P321, DOI 10.1007/978-94-007-6627-3_43; Vercelli D, 2008, NAT REV IMMUNOL, V8, P169, DOI 10.1038/nri2257; Wang JY, 2009, ALLERGY, V64, P1056, DOI 10.1111/j.1398-9995.2009.01950.x; Wang M, 2012, HUM IMMUNOL, V73, P647, DOI 10.1016/j.humimm.2012.03.010; Wisniewski JA, 2011, ALLERGY ASTHMA PROC, V32, P83, DOI 10.2500/aap.2011.32.3428; Zhang L, 2009, INT ARCH ALLERGY IMM, V149, P47, DOI 10.1159/000176306; Zhang Y, 2014, ALLERGY ASTHMA IMMUN, V6, P105, DOI 10.4168/aair.2014.6.2.105; Zhang YJ, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0021342, 10.1371/journal.pone.0020596]	35	6	6	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0131248	10.1371/journal.pone.0131248	http://dx.doi.org/10.1371/journal.pone.0131248			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LZ	26196693	Green Published, gold, Green Submitted			2022-12-26	WOS:000358547600009
J	Van Den Berge, N; Vanhove, C; Descamps, B; Dauwe, I; van Mierlo, P; Vonck, K; Keereman, V; Raedt, R; Boon, P; Van Holen, R				Van Den Berge, Nathalie; Vanhove, Christian; Descamps, Benedicte; Dauwe, Ine; van Mierlo, Pieter; Vonck, Kristl; Keereman, Vincent; Raedt, Robrecht; Boon, Paul; Van Holen, Roel			Functional MRI during Hippocampal Deep Brain Stimulation in the Healthy Rat Brain	PLOS ONE			English	Article							INDEPENDENT COMPONENT ANALYSIS; ELECTRICAL-STIMULATION; PERFORANT PATHWAY; PARKINSON-DISEASE; BOLD RESPONSE; FMRI; EPILEPSY; CORTEX; SAFETY; SEIZURES	Deep Brain Stimulation (DBS) is a promising treatment for neurological and psychiatric disorders. The mechanism of action and the effects of electrical fields administered to the brain by means of an electrode remain to be elucidated. The effects of DBS have been investigated primarily by electrophysiological and neurochemical studies, which lack the ability to investigate DBS-related responses on a whole-brain scale. Visualization of whole-brain effects of DBS requires functional imaging techniques such as functional Magnetic Resonance Imaging (fMRI), which reflects changes in blood oxygen level dependent (BOLD) responses throughout the entire brain volume. In order to visualize BOLD responses induced by DBS, we have developed an MRI-compatible electrode and an acquisition protocol to perform DBS during BOLD fMRI. In this study, we investigate whether DBS during fMRI is valuable to study local and whole-brain effects of hippocampal DBS and to investigate the changes induced by different stimulation intensities. Seven rats were stereotactically implanted with a custom-made MRI-compatible DBS-electrode in the right hippocampus. High frequency Poisson distributed stimulation was applied using a block-design paradigm. Data were processed by means of Independent Component Analysis. Clusters were considered significant when p-values were <0.05 after correction for multiple comparisons. Our data indicate that real-time hippocampal DBS evokes a bilateral BOLD response in hippocampal and other mesolimbic structures, depending on the applied stimulation intensity. We conclude that simultaneous DBS and fMRI can be used to detect local and whole-brain responses to circuit activation with different stimulation intensities, making this technique potentially powerful for exploration of cerebral changes in response to DBS for both preclinical and clinical DBS.	[Van Den Berge, Nathalie; Vanhove, Christian; Descamps, Benedicte; van Mierlo, Pieter; Keereman, Vincent; Van Holen, Roel] Univ Ghent, iMinds Med IT Dept, Med Image & Signal Proc Grp, B-9000 Ghent, Belgium; [Dauwe, Ine; Vonck, Kristl; Raedt, Robrecht; Boon, Paul] Ghent Univ Hosp, Lab Clin & Expt Neurophysiol Neurobiol & Neuropsy, Ghent, Belgium	Ghent University; IMEC; Ghent University; Ghent University Hospital	Van Den Berge, N (corresponding author), Univ Ghent, iMinds Med IT Dept, Med Image & Signal Proc Grp, B-9000 Ghent, Belgium.	Nathalie.VanDenBerge@UGent.be	Vanhove, Christian/I-2095-2019	Vanhove, Christian/0000-0002-3988-5980; Boon, Paul/0000-0002-4180-8896; Van Den Berge, Nathalie/0000-0001-9384-1279; vonck, kristl/0000-0002-2671-2650; van Mierlo, Pieter/0000-0003-1650-5401; Keereman, Vincent/0000-0001-5833-5960; Raedt, Robrecht/0000-0002-8939-0169	iMinds; Research Foundation - Flanders, Belgium (FWO); GROUP-ID consortium of Ghent University; FWO; Special Research Fund from Ghent University; Ghent University Hospital; Ghent University	iMinds; Research Foundation - Flanders, Belgium (FWO)(FWO); GROUP-ID consortium of Ghent University; FWO(FWO); Special Research Fund from Ghent University; Ghent University Hospital(Ghent University); Ghent University(Ghent University)	This work is funded by iMinds and Ghent University. RVH is supported by the Research Foundation - Flanders, Belgium (FWO). CV is supported by the GROUP-ID consortium of Ghent University. PB is supported by grants from FWO, grants from the Special Research Fund from Ghent University, and by the Clinical Epilepsy Grant from Ghent University Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. FWO: http://www.fwo.be/en/, Special Research Fund: https://www.ugent.be/nl/onderzoek/financiering/bof	Akman T, 2011, TURK NEUROSURG, V21, P1; Alvarez-Salvado E, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0152; Angenstein F, 2013, NEUROIMAGE, V75, P213, DOI 10.1016/j.neuroimage.2013.03.007; Baker KB, 2005, J MAGN RESON IMAGING, V21, P72, DOI 10.1002/jmri.20224; Becerra L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025701; Boon P, 2007, EPILEPSIA, V48, P1551, DOI 10.1111/j.1528-1167.2007.01005.x; Boon P, 2009, NEUROTHERAPEUTICS, V6, P218, DOI 10.1016/j.nurt.2008.12.003; Bozzi Y, 2011, FRONT BEHAV NEUROSCI, V5, DOI 10.3389/fnbeh.2011.00045; Bronstein JM, 2011, ARCH NEUROL-CHICAGO, V68, P165, DOI 10.1001/archneurol.2010.260; BUCHHALTER JR, 1990, DEV BRAIN RES, V56, P211, DOI 10.1016/0165-3806(90)90084-C; Bunzeck N, 2012, HUM BRAIN MAPP, V33, P1309, DOI 10.1002/hbm.21288; Canals S, 2008, MAGN RESON IMAGING, V26, P978, DOI 10.1016/j.mri.2008.02.018; Canals S, 2009, CURR BIOL, V19, P398, DOI 10.1016/j.cub.2009.01.037; Carmichael DW, 2007, NEUROIMAGE, V37, P508, DOI 10.1016/j.neuroimage.2007.04.058; Ceballos-Baumann AO, 1999, ARCH NEUROL-CHICAGO, V56, P997, DOI 10.1001/archneur.56.8.997; Chao THH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097305; Cuellar-Herrera M, 2006, EPILEPSY RES, V72, P10, DOI 10.1016/j.eplepsyres.2006.07.002; Cukiert A, 2014, SEIZURE-EUR J EPILEP, V23, P6, DOI 10.1016/j.seizure.2013.08.005; Finelli DA, 2002, AM J NEURORADIOL, V23, P1795; Fisher R, 2010, EPILEPSIA, V51, P899, DOI 10.1111/j.1528-1167.2010.02536.x; Fisher RS, 2014, NAT REV NEUROL, V10, P261, DOI 10.1038/nrneurol.2014.59; Georgi JC, 2004, MAGNET RESON MED, V51, P380, DOI 10.1002/mrm.10699; Goodman JH, 2005, EPILEPSIA, V46, P1, DOI 10.1111/j.0013-9580.2005.03804.x; Haslinger B, 2003, NEUROIMAGE, V18, P517, DOI 10.1016/S1053-8119(02)00043-5; Helbing C, 2013, NEUROIMAGE, V64, P43, DOI 10.1016/j.neuroimage.2012.09.001; Hutchison RM, 2010, J NEUROPHYSIOL, V103, P3398, DOI 10.1152/jn.00141.2010; Jech R, 2003, MOVEMENT DISORD, V18, P461, DOI 10.1002/mds.10366; Jonckers E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018876; Klein J, 2011, J PSYCHIATR RES, V45, P927, DOI 10.1016/j.jpsychires.2010.12.008; Koob GF, 2010, NEUROPSYCHOPHARMACOL, V35, P217, DOI 10.1038/npp.2009.110; Krautwald K, 2013, NEUROIMAGE, V77, P14, DOI 10.1016/j.neuroimage.2013.03.046; Kwan P, 2000, NEW ENGL J MED, V342, P314, DOI 10.1056/NEJM200002033420503; Lai HY, 2014, NEUROIMAGE, V84, P11, DOI 10.1016/j.neuroimage.2013.08.026; Lauritzen M, 2005, NAT REV NEUROSCI, V6, P77, DOI 10.1038/nrn1589; LIEB JP, 1991, EPILEPSIA, V32, P822, DOI 10.1111/j.1528-1157.1991.tb05539.x; Liu H, P SPIE, V4319; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; Velasco AL, 2007, EPILEPSIA, V48, P1895, DOI 10.1111/j.1528-1167.2007.01181.x; McIntyre CC, 2004, CLIN NEUROPHYSIOL, V115, P1239, DOI 10.1016/j.clinph.2003.12.024; McKeown MJ, 2003, CURR OPIN NEUROBIOL, V13, P620, DOI 10.1016/j.conb.2003.09.012; Min HK, 2012, NEUROIMAGE, V63, P1408, DOI 10.1016/j.neuroimage.2012.08.006; Morrell M, 2006, CURR OPIN NEUROL, V19, P164, DOI 10.1097/01.wco.0000218233.60217.84; Okun MS, 2013, NEW ENGL J MED, V368, P483, DOI 10.1056/NEJMc1214078; Osorio I, 2005, ANN NEUROL, V57, P258, DOI 10.1002/ana.20377; Pawela CP, 2009, NEUROIMAGE, V46, P1137, DOI 10.1016/j.neuroimage.2009.03.004; Paxinos G., 2007, RAT BRAIN STEREOTACT; Pittau F, 2012, EPILEPSIA, V53, P1013, DOI 10.1111/j.1528-1167.2012.03464.x; Quigley MA, 2002, AM J NEURORADIOL, V23, P49; Rezai AR, 2004, INVEST RADIOL, V39, P300, DOI 10.1097/01.rli.0000124940.02340.ab; Shyu BC, 2004, MAGN RESON MED, V52, P47, DOI 10.1002/mrm.20111; Simeral JD, 1999, C P ISMRM, P1716; Spencer SS, 2002, EPILEPSIA, V43, P219, DOI 10.1046/j.1528-1157.2002.26901.x; Starr M.S., 1993, D1 D2 DOPAMINE RECEP, P235; Starr MS, 1996, SYNAPSE, V22, P159, DOI 10.1002/(SICI)1098-2396(199602)22:2<159::AID-SYN8>3.0.CO;2-C; Stefurak T, 2003, MOVEMENT DISORD, V18, P1508, DOI 10.1002/mds.10593; Tagliati M, 2009, NEUROIMAGE, V47, pT53, DOI 10.1016/j.neuroimage.2009.04.044; Tanabe J, 2002, NEUROIMAGE, V15, P902, DOI 10.1006/nimg.2002.1053; Theodore WH, 2007, ACTA NEUROCHIR SUPPL, V97, P261; Van Den Berge N, 2015, MOL IMAGING BIOL, V17, P373, DOI 10.1007/s11307-014-0801-9; Van Nieuwenhuyse B, 2015, BRAIN STIMUL, V8, P192, DOI 10.1016/j.brs.2014.11.016; Velasco F, 2001, STEREOT FUNCT NEUROS, V77, P223, DOI 10.1159/000064610; Vonck K, 2002, ANN NEUROL, V52, P556, DOI 10.1002/ana.10323; Vonck K, 2013, INT J NEURAL SYST, V23, DOI 10.1142/S0129065712500347; Weber R, 2006, NEUROIMAGE, V29, P1303, DOI 10.1016/j.neuroimage.2005.08.028; White AM, 2006, J NEUROSCI METH, V152, P255, DOI 10.1016/j.jneumeth.2005.09.014; Williams PA, 2009, J NEUROSCI, V29, P2103, DOI 10.1523/JNEUROSCI.0980-08.2009; Witter MP, 2007, PROG BRAIN RES, V163, P43, DOI 10.1016/S0079-6123(07)63003-9; Wyckhuys T, 2007, EPILEPSIA, V48, P1543, DOI 10.1111/j.1528-1167.2007.01038.x; Wyckhuys T, 2010, EPILEPSIA, V51, P2297, DOI 10.1111/j.1528-1167.2010.02750.x; Wyckhuys T, 2010, NEUROIMAGE, V52, P55, DOI 10.1016/j.neuroimage.2010.04.017; Yang PF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066821; Yelnik J, 2003, J NEUROSURG, V99, P89, DOI 10.3171/jns.2003.99.1.0089; Younce JR, 2014, JOVE-J VIS EXP, DOI 10.3791/51271; Zhao FQ, 2008, NEUROIMAGE, V39, P248, DOI 10.1016/j.neuroimage.2007.07.063; Zrinzo L, 2011, WORLD NEUROSURG, V76, P164, DOI 10.1016/j.wneu.2011.02.029	75	9	9	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2015	10	7							e0133245	10.1371/journal.pone.0133245	http://dx.doi.org/10.1371/journal.pone.0133245			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LN	26193653	Green Submitted, Green Published, gold			2022-12-26	WOS:000358546400068
J	Alajmi, F; Zeng, CS; Jerry, DR				Alajmi, Fahad; Zeng, Chaoshu; Jerry, Dean R.			Domestication as a Novel Approach for Improving the Cultivation of Calanoid Copepods: A Case Study with Parvocalanus crassirostris	PLOS ONE			English	Article							EGG-PRODUCTION RATES; ACARTIA-TONSA DANA; MARINE FISH; STOCKING DENSITY; CULTURE; FOOD; ZOOPLANKTON; PARAMETERS; LARVAE; ADULT	Calanoid copepods are an important food source for most fish larvae. Their role as a natural prey item means that it is important to develop culture technology for copepods to meet the requirements of larvae culture in aquaculture hatcheries. Copepods have been cultured successfully for some time; however, the implications of long-term cultivation or domestication on copepod life history traits have not yet been assessed. Therefore, the aim of this study was to determine if the domesticated and wild populations of Parvocalanus crassirostris are phenotypically or physiologically different. Wild-caught P. crassirostris were compared to a long-held domesticated strain (>2 years) for size of developmental stage, fecundity and lifespan of adult females, culture density, ingestion rates, faecal pellet production and fatty acid profiles. The domesticated strain was significantly different from the wild strain in size (eggs, nauplii, copepodites and adults were larger in the domesticated strain), egg production (112.3 +/- 1.8 eggs female(-1) vs. 64.6 +/- 3.3 eggs female(-1)) and adult female lifespan (8.8 +/- 0.1 days vs., 7.5 +/- 0.1 days). At 1, 3 and 5 adults mL(-1), the domesticated strain performed significantly better than the wild strain in egg production (4189.8 +/- 61.2, 11224.0 +/- 71.7 and 21860.6 +/- 103.6 eggs vs. 1319.5 +/- 54.3, 2374.5 +/- 80.9 and 4933.8 +/- 269.5 eggs, respectively) and mean daily mortality rate (5.6% across all densities vs. 22.9 +/- 1.6, 29.8 +/- 1.2 and 31.3 +/- 1.3%, respectively). The domesticated strain had significantly higher ingestion rates than the wild stain (888.4 +/- 9.9 ng Cl-1 and 775.3 +/- 11.2 ng Cl-1, respectively), while faecal pellet production was not significantly different between strains. Fatty acid profiles indicated higher levels (as % of total fatty acid) of long-chain polyunsaturated fatty acids in the domesticated strain (36.2 +/- 0.4%) than the wild strain (16.1 +/- 0.1%). Overall, this study found that the reproductive capacity and tolerance to the culture environment of the calanoid P. crassirostris have improved significantly due to domestication.	[Zeng, Chaoshu] James Cook Univ, Ctr Sustainable Trop Fisheries & Aquaculture, Townsville, Qld 4811, Australia; James Cook Univ, Marine & Trop Biol, Townsville, Qld 4811, Australia	James Cook University; James Cook University	Zeng, CS (corresponding author), James Cook Univ, Ctr Sustainable Trop Fisheries & Aquaculture, Townsville, Qld 4811, Australia.	Chaoshu.Zeng@jcu.edu.au	Zeng, Chaoshu/A-9758-2012; Jerry, Dean R/B-3053-2012	Jerry, Dean/0000-0003-3735-1798; Zeng, Chaoshu/0000-0001-9022-6588; Alajmi, Fahad/0000-0002-0235-8482	James Cook University Graduate Research Scheme	James Cook University Graduate Research Scheme	James Cook University Graduate Research Scheme (2014). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alajmi F, 2013, AQUACULTURE RES; Alajmi F, 2014, AQUACULTURE, V434, P201, DOI 10.1016/j.aquaculture.2014.08.029; Alajmi F, 2014, AQUACULTURE, V420, P18, DOI 10.1016/j.aquaculture.2013.10.031; Araki H, 2007, SCIENCE, V318, P100, DOI 10.1126/science.1145621; Boxshall GA, 2004, INTRO COPEPOD DIVERS, P966; Bradley CJ, 2013, J PLANKTON RES, V35, P49, DOI 10.1093/plankt/fbs088; BUSKEY EJ, 1993, B MAR SCI, V53, P29; Campbell RW, 2000, CAN J FISH AQUAT SCI, V57, P518, DOI 10.1139/cjfas-57-3-518; Camus T, 2009, AQUACULTURE, V287, P145, DOI 10.1016/j.aquaculture.2008.10.005; Coman GJ, 2013, AQUACULTURE, V400, P125, DOI 10.1016/j.aquaculture.2013.03.015; Conceicao LEC, 2010, AQUAC RES, V41, P613, DOI 10.1111/j.1365-2109.2009.02242.x; Doi M, 1997, HYDROBIOLOGIA, V358, P259, DOI 10.1023/A:1003193121532; DOYLE RW, 1983, AQUACULTURE, V33, P167, DOI 10.1016/0044-8486(83)90398-8; Drillet G, 2011, AQUACULTURE, V315, P155, DOI 10.1016/j.aquaculture.2011.02.027; Evjemo JO, 1997, HYDROBIOLOGIA, V358, P159, DOI 10.1023/A:1003196829109; Hamre K, 2013, REV AQUACULT, V5, pS26, DOI 10.1111/j.1753-5131.2012.01086.x; HUMES AG, 1994, HYDROBIOLOGIA, V293, P1, DOI 10.1007/BF00229916; Huskin I, 2000, J EXP MAR BIOL ECOL, V248, P239, DOI 10.1016/S0022-0981(00)00167-2; Jepsen PM, 2007, AQUAC RES, V38, P764, DOI 10.1111/j.1365-2109.2007.01730.x; Kline MD, 2015, AQUACULTURE, V435, P128, DOI 10.1016/j.aquaculture.2014.09.022; Kreibich T, 2008, HELGOLAND MAR RES, V62, P241, DOI 10.1007/s10152-008-0112-0; Liao IC, 2000, RECENT ADV MEDITERRA; MARIN V, 1986, MAR BIOL, V93, P49, DOI 10.1007/BF00428654; Mauchline J., 1998, ADV MAR BIOL, V33, P1, DOI DOI 10.1163/156854008784513492; Mayzaud P, 1998, J MARINE SYST, V15, P483, DOI 10.1016/S0924-7963(97)00039-0; McKinnon A. D., 1997, Hydrobiologia, V362, P145, DOI 10.1023/A:1003138718716; McKinnon AD, 1998, HYDROBIOLOGIA, V362, P127; MORRISON WR, 1964, J LIPID RES, V5, P600; Niehoff B, 2007, PROG OCEANOGR, V74, P1, DOI 10.1016/j.pocean.2006.05.005; OHNO A, 1988, AQUACULTURE, V70, P39, DOI 10.1016/0044-8486(88)90005-1; Parrish CC, 2012, J PLANKTON RES, V34, P356, DOI 10.1093/plankt/fbs003; PARRISH KK, 1978, MAR BIOL, V46, P65, DOI 10.1007/BF00393822; Payne MF, 2001, AQUACULTURE, V201, P329, DOI 10.1016/S0044-8486(01)00608-1; Payne MF, 2001, AQUACULTURE, V194, P137, DOI 10.1016/S0044-8486(00)00513-5; RONG W, 2002, CHINESE J OCEANOLOGY, V20, P348; Sargent J, 1999, AQUACULTURE, V179, P217, DOI 10.1016/S0044-8486(99)00191-X; Schipp GR, 1999, AQUACULTURE, V174, P81, DOI 10.1016/S0044-8486(98)00508-0; SMITH SL, 1990, MAR BIOL, V106, P59, DOI 10.1007/BF02114675; Stottrup J.G., 2003, LIVE FEEDS MARINE AQ; STOTTRUP JG, 1986, AQUACULTURE, V52, P87, DOI 10.1016/0044-8486(86)90028-1; Stottrup JG, 1997, AQUACULTURE, V155, P231, DOI 10.1016/S0044-8486(97)00120-8; Stottrup JG, 2006, MEM OCT S INT NUTR A; TISELIUS P, 1995, ICES J MAR SCI, V52, P369, DOI 10.1016/1054-3139(95)80052-2; van der Meeren T, 2008, AQUACULTURE, V274, P375, DOI 10.1016/j.aquaculture.2007.11.041; VanderLugt K, 2008, AQUACULTURE, V276, P69, DOI 10.1016/j.aquaculture.2008.01.041; Zuberi A, 2011, AQUACULTURE, V321, P267, DOI 10.1016/j.aquaculture.2011.09.006	46	20	23	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0133269	10.1371/journal.pone.0133269	http://dx.doi.org/10.1371/journal.pone.0133269			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RV	26186526	Green Published, gold, Green Submitted, Green Accepted			2022-12-26	WOS:000358198700117
J	da Rocha, PA; Ferrari, SF; Feijo, A; Gouveia, SF				da Rocha, Patricio Adriano; Ferrari, Stephen Francis; Feijo, Anderson; Gouveia, Sidney Feitosa			Zoogeography of South American Forest-Dwelling Bats: Disjunct Distributions or Sampling Deficiencies?	PLOS ONE			English	Article							CLIMATE-CHANGE; SPECIES DISTRIBUTION; DISTRIBUTION MODELS; ATLANTIC; BRAZIL; PREDICTION; DIVERSITY; AMAZON; SITE	Many forest-dwelling bats are purported to be widespread in South America, although records are scant from the vast diagonal belt of dry ecosystems that straddles the continent, implying possible sampling deficiencies. Here, we investigate this possibility in the case of four species of bat (Centronycteris maximiliani, Lampronycteris brachyotis, Peropteryx kappleri and Trinycteris nicefori), evaluating whether their disjunct present-day distributions reflect their true zoogeographic characteristics or the subsampling of intermediate zones. We use environmental niche modelling (ENM) in an ensemble approach, combining four different modeling techniques, and using niche descriptors based on climatic and remote sensing data, to estimate the potential distribution of the four species. The models indicate that all four species have disjunct distributions in the Amazon and Atlantic forest biomes. The one possible exception is P. kappleri, which the models indicated might potentially occur in humid forest enclaves in western Brazil and eastern Bolivia. The present-day distribution of the species may date back to the Plio-Pleistocene, when the forested biomes of South America were more extensive and connected. Further studies of different chiropteran lineages may provide additional insights into the historic processes of faunal interchange between the Amazon and Atlantic forest biomes.	[da Rocha, Patricio Adriano; Ferrari, Stephen Francis; Gouveia, Sidney Feitosa] Univ Fed Sergipe, Dept Ecol, BR-49100000 Sao Cristovao, Sergipe, Brazil; [Ferrari, Stephen Francis; Feijo, Anderson] Univ Fed Paraiba, Dept Systemat & Ecol, Grad Program Zool, BR-58059900 Joao Pessoa, Paraiba, Brazil	Universidade Federal de Sergipe; Universidade Federal da Paraiba	da Rocha, PA (corresponding author), Univ Fed Sergipe, Dept Ecol, BR-49100000 Sao Cristovao, Sergipe, Brazil.	parocha2@yahoo.com.br	Gouveia, Sidney F/G-6438-2013; Rocha, Patrício/B-3875-2013; Feijó, Anderson/F-4287-2018	Gouveia, Sidney F/0000-0003-4941-7440; Rocha, Patrício/0000-0003-1661-3779; Ferrari, Stephen/0000-0003-0566-0000	CNPq [16448/2013-5, 476528/2013-5, 503122/2010-6, 303994/2011-8, 483220/2013-2]; CAPES; FAPITEC [7733.UNI314.18598.04032013]	CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); FAPITEC(Fundacao de Amparo a Pesquisa do Estado do Sergipe (FAPITEC))	PAR was supported by a post-doctoral fellowship provided by CNPq (Process number 16448/2013-5) and AF by a graduate stipend provided by CAPES. SFG was supported by CNPq (476528/2013-5) and FAPITEC (7733.UNI314.18598.04032013) grants. SFF is supported by CNPq (503122/2010-6, 303994/2011-8 and 483220/2013-2).	Ab'Saber A.N, 1977, GEOMORFOLOGIA, V52, P1, DOI DOI 10.3897/ZOOKEYS.150.2109; Allouche O, 2006, J APPL ECOL, V43, P1223, DOI 10.1111/j.1365-2664.2006.01214.x; [Anonymous], 2011, ECOLOGICAL NICHES GE; Araujo MB, 2004, GLOBAL CHANGE BIOL, V10, P1618, DOI 10.1111/j.1365-2486.2004.00828.x; Araujo MB, 2007, TRENDS ECOL EVOL, V22, P42, DOI 10.1016/j.tree.2006.09.010; Auler AS, 2004, J QUATERNARY SCI, V19, P693, DOI 10.1002/jqs.876; Auler AS, 2001, QUATERNARY RES, V55, P159, DOI 10.1006/qres.2000.2213; Avise J. C., 2000, PHYLOGEOGRAPHY HIST; Batalha H, 2013, J ORNITHOL, V154, P41, DOI 10.1007/s10336-012-0866-7; Boakes EH, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000385; Busby JR, 1991, NATURE CONSERVATION, P64, DOI DOI 10.1046/J.1365-294X.2001.01244.X; Costa LP, 2003, J BIOGEOGR, V30, P71, DOI 10.1046/j.1365-2699.2003.00792.x; Davies BD, 2014, TRENDS ECOL IN PRESS; de Vivo M., 1997, AN 5 REUN ESP SBPC F, P60; Diniz JAF, 2010, INSECT CONSERV DIVER, V3, P213, DOI 10.1111/j.1752-4598.2010.00090.x; Diniz JAF, 2009, ECOGRAPHY, V32, P897, DOI 10.1111/j.1600-0587.2009.06196.x; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Farber O, 2003, ECOL MODEL, V160, P115, DOI 10.1016/S0304-3800(02)00327-7; Fielding AH, 1997, ENVIRON CONSERV, V24, P38, DOI 10.1017/S0376892997000088; Gardner AL, 2008, MAMMALS S AM, V1; Grenouillet G, 2011, ECOGRAPHY, V34, P9, DOI 10.1111/j.1600-0587.2010.06152.x; Guisan A, 2000, ECOL MODEL, V135, P147, DOI 10.1016/S0304-3800(00)00354-9; Haberle SG, 1999, QUATERNARY RES, V51, P27, DOI 10.1006/qres.1998.2020; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Liang S., 2012, GLOBAL LAND SURFACE, DOI [10.6050/glass863.3004.db, DOI 10.6050/GLASS863.3004.DB]; Lobo JM, 2008, GLOBAL ECOL BIOGEOGR, V17, P145, DOI 10.1111/j.1466-8238.2007.00358.x; Lomolino MV, 2004, FRONTIERS OF BIOGEOGRAPHY: NEW DIRECTIONS IN THE GEOGRAPHY OF NATURE, P1; Marmion M, 2009, DIVERS DISTRIB, V15, P59, DOI 10.1111/j.1472-4642.2008.00491.x; Martini AMZ, 2007, BIODIVERS CONSERV, V16, P3111, DOI 10.1007/s10531-007-9166-6; Nogueira MR, 2012, AM MUS NOVIT, P1; Peracchi Adriano, 1993, Revista Brasileira de Biologia, V53, P575; Peterson AT, 2008, ECOL MODEL, V213, P63, DOI 10.1016/j.ecolmodel.2007.11.008; Peterson AT, 2002, NATURE, V416, P626, DOI 10.1038/416626a; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Por FD, 1992, SOORETAMA ATLANTIC R; Porto, 2004, BREJOS ALTITUDE PERN, P285; RANGEL TFL, 2009, BIOENSEMBLES 1 0 SOF; REIS NR, 1983, REV ECOL, V38, P147; Ripley B. D., 1996, PATTERN RECOGNITION; Rocha PA, 2014, MASTOZOOL N IN PRESS; Santos AMM, 2007, J BIOGEOGR, V34, P437, DOI 10.1111/j.1365-2699.2006.01604.x; STOCKWELL DRB, 1992, MATH COMPUT SIMULAT, V33, P385, DOI 10.1016/0378-4754(92)90126-2; SWETS JA, 1988, SCIENCE, V240, P1285, DOI 10.1126/science.3287615; Tattoni C, 2012, ECOL MODEL, V245, P103, DOI 10.1016/j.ecolmodel.2012.03.020; Thuiller W, 2005, GLOBAL CHANGE BIOL, V11, P2234, DOI 10.1111/j.1365-2486.2005.001018.x; Thuiller W, 2005, P NATL ACAD SCI USA, V102, P8245, DOI 10.1073/pnas.0409902102; Van der Hammen T., 1974, J BIOGEOGR, V1, P3, DOI [10.2307/3038066, DOI 10.2307/3038066]; VUILLEUMIER SB, 1971, SCIENCE, V173, P771, DOI 10.1126/science.173.3999.771; Waltari E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000563; Xiao ZQ, 2014, IEEE T GEOSCI REMOTE, V52, P209, DOI 10.1109/TGRS.2013.2237780	50	7	8	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0133276	10.1371/journal.pone.0133276	http://dx.doi.org/10.1371/journal.pone.0133276			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RV	26186587	Green Published, gold			2022-12-26	WOS:000358198700118
J	Ma, ZX; Leng, YJ; Chen, GX; Zhou, PM; Ye, D; Chen, LQ				Ma, Zhao-Xia; Leng, Ya-Jun; Chen, Guang-Xia; Zhou, Peng-Min; Ye, De; Chen, Li-Qun			The THERMOSENSITIVE MALE STERILE 1 Interacts with the BiPs via DnaJ Domain and Stimulates Their ATPase Enzyme Activities in Arabidopsis	PLOS ONE			English	Article							UNFOLDED PROTEIN RESPONSE; RETICULUM STRESS-RESPONSE; HEAT-SHOCK-PROTEIN; ENDOPLASMIC-RETICULUM; TRANSCRIPTION FACTOR; ER STRESS; MOLECULAR CHAPERONES; TEMPERATURE STRESS; QUALITY-CONTROL; POLLEN	The Arabidopsis TMS1 encodes a heat shock protein identical to the Hsp40 protein AtERdj3A and plays important roles in the thermotolerance of pollen tubes and other plant tissues. Despite its importance to plant growth and reproduction, little has been known about its mechanisms underlying thermotolerance of plants. In this study, the relationship between TMS1 and the Hsp70 proteins, Binding Immunoglobulin Proteins (BiPs) was explored to understand the molecular mechanisms of TMS1 in thermotolerance of plants. The expression of TMS1 was induced not only by heat shock, but also by dithiothreitol (DTT) and L-azetidine-2-carboxylic acid (AZC), similarly to the three BiP genes, indicating that TMS1 may be involved in unfolded protein response (UPR). The firefly luciferase complementary imaging (LCI), GST pull-down and ATPase enzyme activity assays demonstrated that the DnaJ domain of TMS1 could interact with BiP1 and BiP3, and could stimulate their ATPase enzyme activities. In addition, the expression level of TMS1 was reduced in the bzip28 bzip60 double mutant. These results suggest that TMS1 may function at the downstream of bZIP28 and bZIP60 and be involved in termotolerance of plants, possibly by participating in refolding or degradation of unfolded and misfolded proteins through interaction with the BiPs.	[Ma, Zhao-Xia; Leng, Ya-Jun; Chen, Guang-Xia; Zhou, Peng-Min; Ye, De; Chen, Li-Qun] China Agr Univ, Coll Biol Sci, State Key Lab Plant Physiol & Biochem, Beijing 100094, Peoples R China; [Ye, De] Natl Ctr Plant Gene Res Beijing, Beijing, Peoples R China	China Agricultural University; Chinese Academy of Sciences	Ye, D (corresponding author), China Agr Univ, Coll Biol Sci, State Key Lab Plant Physiol & Biochem, Beijing 100094, Peoples R China.	yede@cau.edu.cn; chenliqun@cau.edu.cn			Natural Science Foundation of China (NSFC) [31470279, 31130007]; Ministry of Sciences and Technology [2013CB1945100]; Ministry of Education [B06003]	Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Ministry of Sciences and Technology; Ministry of Education	This work was supported by the research grants from the Natural Science Foundation of China (NSFC, project numbers: 31470279 and 31130007), the Ministry of Sciences and Technology (project number: 2013CB1945100) and the Ministry of Education (111 project numbered B06003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bilgin DD, 2003, DEV CELL, V4, P651, DOI 10.1016/S1534-5807(03)00125-4; Bukau B, 2006, CELL, V125, P443, DOI 10.1016/j.cell.2006.04.014; Chen HM, 2008, PLANT PHYSIOL, V146, P368, DOI 10.1104/pp.107.111740; Corsi AK, 1997, J CELL BIOL, V137, P1483, DOI 10.1083/jcb.137.7.1483; CYR DM, 1992, J BIOL CHEM, V267, P20927; Deng Y, 2013, INT J MOL SCI, V14, P8188, DOI 10.3390/ijms14048188; DUPUIS I, 1990, PLANT PHYSIOL, V94, P665, DOI 10.1104/pp.94.2.665; Ellgaard L, 2003, NAT REV MOL CELL BIO, V4, P181, DOI 10.1038/nrm1052; Endo M, 2009, PLANT CELL PHYSIOL, V50, P1911, DOI 10.1093/pcp/pcp135; Gao HB, 2008, P NATL ACAD SCI USA, V105, P16398, DOI 10.1073/pnas.0808463105; Heckman KL, 2007, NAT PROTOC, V2, P924, DOI 10.1038/nprot.2007.132; Hosoda A, 2003, J BIOL CHEM, V278, P2669, DOI 10.1074/jbc.M208346200; Howell SH, 2013, ANNU REV PLANT BIOL, V64, P477, DOI 10.1146/annurev-arplant-050312-120053; Hua DP, 2012, PLANT CELL, V24, P2546, DOI 10.1105/tpc.112.100107; Iwata Y, 2005, P NATL ACAD SCI USA, V102, P5280, DOI 10.1073/pnas.0408941102; Iwata Y, 2012, TRENDS PLANT SCI, V17, P720, DOI 10.1016/j.tplants.2012.06.014; Iwata Y, 2009, BIOSCI BIOTECH BIOCH, V73, P865, DOI 10.1271/bbb.80779; Iwata Y, 2008, PLANT CELL, V20, P3107, DOI 10.1105/tpc.108.061002; Kanapin A, 2003, GENOME RES, V13, P1335, DOI 10.1101/gr.978703; Koizumi N, 1996, PLANT CELL PHYSIOL, V37, P862, DOI 10.1093/oxfordjournals.pcp.a029023; Liu JX, 2007, PLANT CELL, V19, P4111, DOI 10.1105/tpc.106.050021; Liu JX, 2010, PLANT CELL, V22, P782, DOI 10.1105/tpc.109.072173; Maruyama D, 2014, PLANT CELL PHYSIOL, V55, P801, DOI 10.1093/pcp/pcu018; Maruyama D, 2010, P NATL ACAD SCI USA, V107, P1684, DOI 10.1073/pnas.0905795107; Mascarenhas JP, 1996, SEX PLANT REPROD, V9, P370, DOI 10.1007/BF02441959; Misselwitz B, 1998, MOL CELL, V2, P593, DOI 10.1016/S1097-2765(00)80158-6; Nekrasov V, 2009, EMBO J, V28, P3428, DOI 10.1038/emboj.2009.262; Nishikawa S, 2005, J BIOCHEM, V137, P551, DOI 10.1093/jb/mvi068; Noh SJ, 2003, GENE, V311, P81, DOI 10.1016/S0378-1119(03)00559-6; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; SCHOPER JB, 1987, PLANT PHYSIOL, V83, P121, DOI 10.1104/pp.83.1.121; Sugio A, 2009, PLANT CELL, V21, P642, DOI 10.1105/tpc.108.062596; Sun L, 2013, MOL PLANT, V6, P1605, DOI 10.1093/mp/sst059; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; XIAO CM, 1985, PLANT PHYSIOL, V78, P887, DOI 10.1104/pp.78.4.887; Yamamoto M, 2008, PLANT CELL PHYSIOL, V49, P1547, DOI 10.1093/pcp/pcn119; Yang KZ, 2009, PLANT J, V57, P870, DOI 10.1111/j.1365-313X.2008.03732.x; Young LW, 2004, J EXP BOT, V55, P485, DOI 10.1093/jxb/erh038	39	14	19	1	134	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0132500	10.1371/journal.pone.0132500	http://dx.doi.org/10.1371/journal.pone.0132500			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RV	26186593	Green Published, gold, Green Submitted			2022-12-26	WOS:000358198700046
J	Arevalo-Gardini, E; Canto, M; Alegre, J; Loli, O; Julca, A; Baligar, V				Arevalo-Gardini, Enrique; Canto, Manuel; Alegre, Julio; Loli, Oscar; Julca, Alberto; Baligar, Virupax			Changes in Soil Physical and Chemical Properties in Long Lerm Improved Natural and Traditional Agroforestry Management Systems of Cacao Genotypes in Peruvian Amazon	PLOS ONE			English	Article							LAND-CLEARING METHOD; ORGANIC-MATTER; FOREST SOILS; SHORT-TERM; FIRE; FERTILITY; IMPACT; CARBON; WATER; TREE	Growing cacao (Theobroma cacao L.) in an agroforestry system generates a productive use of the land, preserves the best conditions for physical, chemical and biological properties of tropical soils, and plays an important role in improving cacao production and fertility of degraded tropical soils. The aim of this study was to evaluate the impact of two long term agroforestry systems of cacao management on soil physical and chemical properties in an area originally inhabited by 30 years old native secondary forest (SF). The two agroforestry systems adapted were: improved natural agroforestry system (INAS) where trees without economic value were selectively removed to provide 50% shade and improved traditional agroforestry system (ITAS) where all native trees were cut and burnt in the location. For evaluation of the changes of soil physical and chemical properties with time due to the imposed cacao management systems, plots of 10 cacao genotypes (ICS95, UF613, CCN51, ICT1112, ICT1026, ICT2162, ICT2171, ICT2142, H35, U30) and one plot with a spontaneous hybrid were selected. Soil samples were taken at 0-20, 20-40 and 40-60 cm depths before the installation of the management systems (2004), and then followed at two years intervals. Bulk density, porosity, field capacity and wilting point varied significantly during the years of assessment in the different soil depths and under the systems assessed. Soil pH, CEC, exchangeable Mg and sum of the bases were higher in the INAS than the ITAS. In both systems, SOM, Ext. P, K and Fe, exch. K, Mg and Al+H decreased with years of cultivation; these changes were more evident in the 0-20 cm soil depth. Overall improvement of SOM and soil nutrient status was much higher in the ITAS than INAS. The levels of physical and chemical properties of soil under cacao genotypes showed a marked difference in both systems.	[Arevalo-Gardini, Enrique] ICT, Tarapoto, Peru; [Canto, Manuel; Alegre, Julio; Loli, Oscar; Julca, Alberto] UNALM, Lima, Peru; [Baligar, Virupax] USDA ARS, Beltsville Agr Res Ctr, Beltsville, MD 20705 USA	University Nacional Agraria La Molina; United States Department of Agriculture (USDA)	Arevalo-Gardini, E (corresponding author), ICT, Tarapoto, Peru.	enriquearevaloga@gmail.com	AREVALO-GARDINI, ENRIQUE/AAQ-8931-2020; Alegre, Julio/ABE-5452-2021		Instituto de Cultivos Tropicales (ICT); United States-Department of Agriculture-Agricultural Research Service (USDA-ARS); United States Embassy (INL) in Lima-Peru; ARS [ARS-0426238] Funding Source: Federal RePORTER	Instituto de Cultivos Tropicales (ICT); United States-Department of Agriculture-Agricultural Research Service (USDA-ARS)(United States Department of Agriculture (USDA)); United States Embassy (INL) in Lima-Peru; ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	This study was supported by Instituto de Cultivos Tropicales (ICT), United States-Department of Agriculture-Agricultural Research Service (USDA-ARS) and the United States Embassy (INL) in Lima-Peru.	Agoume V., 2009, Tropicultura, V27, P15; Alegre J, 2006, SISTEMAS AGROFLOREST, P27; ALEGRE JC, 1990, FIELD CROP RES, V24, P131, DOI 10.1016/0378-4290(90)90026-8; ALEGRE JC, 1988, SOIL SCI SOC AM J, V52, P1283, DOI 10.2136/sssaj1988.03615995005200050012x; ALEGRE JC, 1986, SOIL SCI SOC AM J, V50, P1379, DOI 10.2136/sssaj1986.03615995005000060002x; Alexis MA, 2007, BIOGEOCHEMISTRY, V82, P201, DOI 10.1007/s10533-006-9063-1; Alfaia SS, 2004, AGR ECOSYST ENVIRON, V102, P409, DOI 10.1016/j.agee.2003.08.011; Altieri M., 2011, EISA REV AGROECOLOGI, V27, P32; Altieri MA, 2004, MANEJO INTEGRADAO PL, V73, P8; Amusan A. A., 2006, Electronic Journal of Environmental, Agricultural and Food Chemistry, V5, P3; Anderson J. M., 1993, TROPICAL SOIL BIOL F; [Anonymous], 2012, REV CUBANA CIENCIA A; Are KS, 2009, SOIL TILL RES, V103, P4, DOI 10.1016/j.still.2008.08.011; Arevalo-Gardini E, 2004, CACAO MANEJO INTEGRA; Ayres E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005964; Azam M. G., 2008, Journal of Agronomy, V7, P56; Badia D, 2003, ARID LAND RES MANAG, V17, P23, DOI 10.1080/15324980301595; Barreto A. C., 2006, Caatinga, V19, P415; Bell MC, 2008, RENEW AGR FOOD SYST, V23, P70, DOI 10.1017/S1742170507001883; Boruvka L, 2005, J INORG BIOCHEM, V99, P1796, DOI 10.1016/j.jinorgbio.2005.06.028; Bot A., 2005, FAO SOILS B, V80, P71; Brye KR, 2006, ACTA OECOL, V30, P407, DOI 10.1016/j.actao.2006.06.001; Certini G, 2005, OECOLOGIA, V143, P1, DOI 10.1007/s00442-004-1788-8; Chepstow-Lusty A, 2000, AMBIO, V29, P322, DOI 10.1639/0044-7447(2000)029[0322:IALFTP]2.0.CO;2; Clark MS, 1998, AGRON J, V90, P662, DOI 10.2134/agronj1998.00021962009000050016x; Close DC, 2011, PLANT SOIL, V349, P203, DOI 10.1007/s11104-011-0862-3; Couto-Vazquez A, 2006, SCI TOTAL ENVIRON, V371, P353, DOI 10.1016/j.scitotenv.2006.08.016; Czimczik CI, 2005, EUR J SOIL SCI, V56, P417, DOI 10.1111/j.1365-2389.2004.00665.x; Dai ZH, 1998, WATER AIR SOIL POLL, V108, P377, DOI 10.1023/A:1005015526022; Danoff LE, 2007, MINERAL NUTR PLANT D; De Schrijver A, 2006, SCI TOTAL ENVIRON, V361, P189, DOI 10.1016/j.scitotenv.2005.06.015; Di Rienzo J., 2013, INFOSTAT VERSION 201; Dinesh R, 2010, GEODERMA, V158, P252, DOI 10.1016/j.geoderma.2010.04.034; DRINKWATER LE, 1995, ECOL APPL, V5, P1098, DOI 10.2307/2269357; Ekinci H., 2006, INT J AGRIC BIOL, V1, P102; Fageria NK, 2002, ADV AGRON, V77, P185, DOI 10.1016/S0065-2113(02)77015-6; FASSBENDER HW, 1998, SOILS TROPICAL FORES; Flores PS, 1998, GEOECOLOGIA DESARROL; Garcia-Marco S, 2008, SCI TOTAL ENVIRON, V407, P297, DOI 10.1016/j.scitotenv.2008.08.021; GIL J, 2010, ACTUALIZACION METODO, P327; Gomez-Rey MX, 2013, GEODERMA, V195, P155, DOI 10.1016/j.geoderma.2012.12.005; Granged AJP, 2011, GEODERMA, V167-68, P125, DOI 10.1016/j.geoderma.2011.09.011; Granged AJP, 2011, GEODERMA, V164, P85, DOI 10.1016/j.geoderma.2011.05.017; Gregory P.J., 2006, PLANT ROOTS GROWTH A; Havlin JL., 2005, SOIL FERTILITY FERTI, V7th; He J, 2011, SOIL TILL RES, V113, P48, DOI 10.1016/j.still.2011.01.005; Holdridge L.R., 1971, FOREST ENV TROPICAL; Igwe C. A., 2005, Tropical and Subtropical Agroecosystems, V5, P57; Jacobi J, 2014, AGROFOREST SYST, V88, P1117, DOI 10.1007/s10457-013-9643-8; Jobbagy EG, 2004, ECOLOGY, V85, P2380, DOI 10.1890/03-0245; Johnson DW, 2001, FOREST ECOL MANAG, V140, P227, DOI 10.1016/S0378-1127(00)00282-6; Jose S, 2009, AGROFOREST SYST, V76, P1, DOI 10.1007/s10457-009-9229-7; Julio A., 2012, LINEAR MIXED MODELS; Juo ASR, 1996, AGR ECOSYST ENVIRON, V58, P49, DOI 10.1016/0167-8809(95)00656-7; Lal R., 1998, METHODS ASSESSMENT S, P17; Lambers H., 2008, PLANT PHYSL ECOLOGY; Magdoff F, 1999, AGROECOLOGIA BASES C; McGrath DA, 2001, AGR ECOSYST ENVIRON, V83, P271, DOI 10.1016/S0167-8809(00)00176-6; Mendonca-Santos ML, 2006, SOIL BIODIVERSITY IN AMAZONIAN AND OTHER BRAZILIAN ECOSYSTEMS, P13, DOI 10.1079/9781845930325.0013; Moussa-Machraoui SB, 2010, SOIL TILL RES, V106, P247, DOI 10.1016/j.still.2009.10.009; Nair PKR, 2009, ENVIRON SCI POLICY, V12, P1099, DOI 10.1016/j.envsci.2009.01.010; NAMBIAR EKS, 1992, TREE PHYSIOL, V10, P297, DOI 10.1093/treephys/10.3.297; OEEE-MINAG, SER HIST PROD AGR CO; Olanrewaju O. D., 2008, Journal of Applied Biological Sciences, V2, P9; Ololade I. A., 2010, Modern Applied Science, V4, P35; Pardini G, 2004, SCI TOTAL ENVIRON, V328, P237, DOI 10.1016/j.scitotenv.2004.01.026; Perrin AS, 2014, AGR ECOSYST ENVIRON, V184, P101, DOI 10.1016/j.agee.2013.11.009; Phillips RP, 2008, SOIL SCI SOC AM J, V72, P453, DOI 10.2136/sssaj2006.0389; Phillips RP, 2006, ECOLOGY, V87, P1302, DOI 10.1890/0012-9658(2006)87[1302:TSAMAI]2.0.CO;2; Pinheiro JC, 2004, MIXED EFFECTS MODELS; Porebska G, 2008, SCI TOTAL ENVIRON, V399, P105, DOI 10.1016/j.scitotenv.2008.03.029; Radersma S, 2004, PLANT SOIL, V259, P209, DOI 10.1023/B:PLSO.0000020970.40167.40; Portella CMR, 2012, REV BRAS CIENC SOLO, V36, P1868, DOI 10.1590/S0100-06832012000600021; Reganold J. P., 1988, American Journal of Alternative Agriculture, V3, P144, DOI 10.1017/S0889189300002423; Rice RA, 2008, AGR ECOSYST ENVIRON, V128, P212, DOI 10.1016/j.agee.2008.06.007; Roscoe R, 2000, GEODERMA, V95, P141, DOI 10.1016/S0016-7061(99)00089-0; Russell AE, 2007, SOIL SCI SOC AM J, V71, P1389, DOI 10.2136/sssaj2006.0069; Saxton KE, 2006, SOIL SCI SOC AM J, V70, P1569, DOI 10.2136/sssaj2005.0117; Schroth G, 2015, MITIG ADAPT STRAT GL, V20, P1175, DOI 10.1007/s11027-013-9530-7; Seguel O, 2013, J SOIL SCI PLANT NUT, V13, P690, DOI [10.4067/S0718-95162013005000046, 10.4067/S0718-95162013005000055]; Sharma KL, 2009, COMMUN SOIL SCI PLAN, V40, P1436, DOI 10.1080/00103620902818096; Soil Survey Staff, 1994, KEYS SOIL TAX; Somarriba E, 2013, AGR ECOSYST ENVIRON, V173, P46, DOI 10.1016/j.agee.2013.04.013; Sumpam Tangjang, 2009, Research Journal of Soil Biology, V1, P1, DOI 10.3923/rjsb.2009.1.7; Theodoro VCA, 2003, REV BRAS CIENC SOLO, V27, P1039, DOI 10.1590/S0100-06832003000600008; Thomaz EL, 2014, CATENA, V122, P209, DOI 10.1016/j.catena.2014.06.016; Tolk J.A., 2003, PLANT AVAILABLE SOIL, P669, DOI [DOI 10.1081/E-EWS120010265, 10.1081/E-EWS120010265]; Venables W., 2014, INTRO R NOTES R PROG; Villegas R, 2008, THESIS CATIE TURRIAL; Wang QL, 2008, GEODERMA, V144, P502, DOI 10.1016/j.geoderma.2008.01.003; Watson RT, 2000, LAND USE LAND USE CH; Werner S., 1999, Management of secondary and logged-over forests in Indonesia. Selected proceedings of an international workshop, 17-19 November 1997, Bogor, Indonesia., P33; Willer H, 2004, WORLD ORGANIC AGR ST, P96; WOOD G. A. R., 2001, COCOA	94	25	26	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2015	10	7							e0132147	10.1371/journal.pone.0132147	http://dx.doi.org/10.1371/journal.pone.0132147			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RQ	26181053	Green Published, gold, Green Submitted			2022-12-26	WOS:000358198200016
J	Beksac, K; Beksac, M; Dalva, K; Karaagaoglu, E; Tirnaksiz, MB				Beksac, Kemal; Beksac, Meral; Dalva, Klara; Karaagaoglu, Ergun; Tirnaksiz, M. Bulent			Impact of "Killer Immunoglobulin-Like Receptor/Ligand" Genotypes on Outcome following Surgery among Patients with Colorectal Cancer: Activating KIRs Are Associated with Long-Term Disease Free Survival	PLOS ONE			English	Article							MHC CLASS-I; POLYMORPHISM; LIGANDS; GENES	Approximately 30% of patients with stage II/III colorectal cancer develop recurrence following surgery. How individual regulation of host mediated anti-tumor cytotoxicity is modified by the killer-cell immunoglobulin-like receptor (KIRs) genotype is essential for prediction of outcome. We analyzed the frequency of KIR and KIR ligand Human Leukocyte Antigen Class I genotypes, and their effects on recurrence and disease-free survival (DFS). Out of randomly selected 87 colorectal cancer patients who underwent R0 resection operations between 2005 and 2008, 29 patients whose cancers progressed within a median five-year follow-up period were compared with 58 patients with no recurrence within the same time period. Recurrent cases shared similar tumor stages with non-recurrent cases, but had different localizations. We used DNA isolated from pathological archival lymphoid and tumor tissues for KIR and KIR ligand (HLA-C, group C1, group C2, and HLA-A-Bw4) genotyping. Among cases with recurrence, KIR2DL1 (inhibitory KIR) and A-Bw4 (ligand for inhibitory KIR3DL1) were observed more frequently (p=0.017 and p=0.024); and KIR2DS2 and KIR2DS3 (both activating KIRs) were observed less frequently (p=0.005 and p=0.043). Similarly, in the non-recurrent group, inhibitory KIR-ligand combinations 2DL1-C2 and 2DL3-C1 were less frequent, while the activating combination 2DS2-C1 was more frequent. The lack of KIR2DL1, 2DL1-C2, and 2DL3-C1 improved disease-free survival (DFS) (100% vs. 62.3%, p=0.05; 93.8% vs. 60.0%, p=0.035; 73.6% vs. 55.9%, p=0.07). The presence of KIR2DS2, 2DS3, and 2DS2-C1 improved DFS (77.8% vs. 48.5%, p=0.01; 79.4% vs. 58.5%, p=0.003; 76.9% vs. 51.4%, p=0.023). KIR2DS3 reduced the risk of recurrence (HR=0.263, 95% CI =0.080-0.863, p=0.028). The number of activating KIRs are correlated strongly with DFS, none/one/two KIR : 54/77/98 months (p=0.004). In conclusion the inheritance of increasing numbers of activating KIRs and lack of inhibitory KIRs, independent of tumor localization or stage, is associated with long-term DFS.	[Beksac, Kemal; Tirnaksiz, M. Bulent] Hacettepe Univ, Dept Gen Surg, Ankara, Turkey; [Beksac, Meral; Dalva, Klara] Ankara Univ, Dept Hematol, TR-06100 Ankara, Turkey; [Karaagaoglu, Ergun] Hacettepe Univ, Dept Biostat, Ankara, Turkey	Hacettepe University; Ankara University; Hacettepe University	Beksac, K (corresponding author), Hacettepe Univ, Dept Gen Surg, Ankara, Turkey.	kemalbeksac@yahoo.com	Beksac, Kemal/AAI-6009-2020; dalva, klara/AAN-7704-2020	Beksac, Kemal/0000-0002-6339-505X; dalva, klara/0000-0001-6917-6870	Hacettepe University [GO 13/94]; Turkish Academy of Sciences	Hacettepe University(Hacettepe University); Turkish Academy of Sciences(Turkish Academy of Sciences)	This study was funded by research grants from Hacettepe University (GO 13/94) and Turkish Academy of Sciences (M. Beksac is a member of the Academy).	Al Omar S, 2010, HUM IMMUNOL, V71, P976, DOI 10.1016/j.humimm.2010.06.019; Babor F, 2014, BLOOD, V124, P2248, DOI 10.1182/blood-2014-05-572065; Beksac M, 2012, BONE MARROW RES, DOI 10.1155/2012/271695; Besson C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000406; Bonagura VR, 2010, HUM IMMUNOL, V71, P212, DOI 10.1016/j.humimm.2009.10.009; Carrington M, 2005, J EXP MED, V201, P1069, DOI 10.1084/jem.20042158; De Re V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084940; Disis ML, 2010, J CLIN ONCOL, V28, P4531, DOI 10.1200/JCO.2009.27.2146; Dorak M Tevfik, 2007, Methods Mol Med, V134, P123; Faure M, 2002, J IMMUNOL, V168, P6208, DOI 10.4049/jimmunol.168.12.6208; HALL WH, 1990, JAMA-J AM MED ASSOC, V264, P1444; Inoue M, 2012, ONCOIMMUNOLOGY, V1, P1104, DOI 10.4161/onci.21056; Lopez-Vazquez A, 2005, J INFECT DIS, V192, P162, DOI 10.1086/430351; Marisa L, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001453; Marsh SGE, 2003, HUM IMMUNOL, V64, P648, DOI 10.1016/S0198-8859(03)00067-3; Meguid RA, 2008, ANN SURG ONCOL, V15, P2388, DOI 10.1245/s10434-008-0015-y; Middleton D, 2007, TISSUE ANTIGENS, V69, P220, DOI 10.1111/j.1399-0039.2006.00792.x; Middleton D, 2010, IMMUNOLOGY, V129, P8, DOI 10.1111/j.1365-2567.2009.03208.x; Naumova E, 2005, CANCER IMMUNOL IMMUN, V54, P172, DOI 10.1007/s00262-004-0575-z; O'Connell JB, 2004, JNCI-J NATL CANCER I, V96, P1420, DOI 10.1093/jnci/djh275; Owen J. A., 2013, KUBY IMMUNOLOGY, P427; Pita-Fernandez S, 2014, ANN ONCOL; Salama P, 2008, ANZ J SURG, V78, P745, DOI 10.1111/j.1445-2197.2008.04642.x; Sandel MH, 2005, MOL IMMUNOL, V42, P541, DOI 10.1016/j.molimm.2004.07.039; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Singh K, 2013, NANOSCALE, V5, P2411, DOI 10.1039/c3nr33962a; Verheyden S, 2005, LEUKEMIA, V19, P1446, DOI 10.1038/sj.leu.2403839; Wisniewski A, 2012, HUM IMMUNOL, V73, P927, DOI 10.1016/j.humimm.2012.07.323; Yamazaki H, 2002, ONCOL REP, V9, P359	29	17	17	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2015	10	7							e0132526	10.1371/journal.pone.0132526	http://dx.doi.org/10.1371/journal.pone.0132526			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RQ	26181663	gold, Green Published, Green Submitted			2022-12-26	WOS:000358198200021
J	Meadows, SM; Cleaver, O				Meadows, Stryder M.; Cleaver, Ondine			Annexin A3 Regulates Early Blood Vessel Formation	PLOS ONE			English	Article							ENDOTHELIAL LINEAGE; EXPRESSION; XENOPUS; MORPHOGENESIS; CELLS; EXOCYTOSIS; CALPACTIN; RECEPTOR; FAMILY; MICE	Annexins are a large family of calcium binding proteins that associate with cell membrane phospholipids and are involved in various cellular processes including endocytosis, exocytosis and membrane-cytoskeletal organization. Despite studies on numerous Annexin proteins, the function of Annexin A3 (Anxa3) is largely unknown. Our studies identify Anxa3 as a unique marker of the endothelial and myeloid cell lineages of Xenopus laevis during development. Anxa3 transcripts are also detected in endothelial cells (ECs) of zebrafish and mouse embryos, suggesting an important evolutionary function during formation of blood vessels. Indeed, Anxa3 loss-of-function experiments in frog embryos reveal its critical role during the morphogenesis of early blood vessels, as angioblasts in MO injected embryos fail to form vascular cords. Furthermore, in vitro experiments in mammalian cells identify a role for Anxa3 in EC migration. Our results are the first to reveal an in vivo function for Anxa3 during vascular development and represent a previously unexplored aspect of annexin biology.	[Meadows, Stryder M.] Tulane Univ, Dept Cell & Mol Biol, New Orleans, LA 70118 USA; [Cleaver, Ondine] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA	Tulane University; University of Texas System; University of Texas Southwestern Medical Center Dallas	Meadows, SM (corresponding author), Tulane Univ, Dept Cell & Mol Biol, 2000 Percival Stern Hall,6400 Freret St, New Orleans, LA 70118 USA.	smeadows@tulane.edu		Cleaver, Ondine/0000-0003-2454-6641	American Heart Association [12POST11750032, 14BGIA18710018]; National Institutes of Health [NIH R01 HL113498, R01DK079862]; Cancer Prevention Research Institute of Texas [RP110405]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL113498] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK079862] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Prevention Research Institute of Texas; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	SMM was supported by the American Heart Association fellowship 12POST11750032 and currently by the American Heart Association award 14BGIA18710018 (www.heart.org). OC is supported by the National Institutes of Health grants: NIH R01 HL113498 and R01DK079862 (www.NIH.gov), and the Cancer Prevention Research Institute of Texas Award RP110405 (http://www.cprit.state.tx.us). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALI SM, 1989, NATURE, V340, P313, DOI 10.1038/340313a0; Baltzinger M, 1999, DEV DYNAM, V216, P420, DOI 10.1002/(SICI)1097-0177(199912)216:4/5<420::AID-DVDY10>3.0.CO;2-C; Bowes JB, 2010, NUCLEIC ACIDS RES, V38, pD607, DOI 10.1093/nar/gkp953; Brachvogel B, 2001, MECH DEVELOP, V109, P389, DOI 10.1016/S0925-4773(01)00532-9; Costa RMB, 2008, BLOOD, V112, P2287, DOI 10.1182/blood-2008-04-150268; Datta A, 2011, CURR BIOL, V21, pR126, DOI 10.1016/j.cub.2010.12.003; Devic E, 1996, MECH DEVELOP, V59, P129, DOI 10.1016/0925-4773(96)00585-0; Dreier R, 1998, HISTOCHEM CELL BIOL, V110, P137, DOI 10.1007/s004180050275; Farber SA, 2003, GENOME RES, V13, P1082, DOI 10.1101/gr.479603; FUTTER CE, 1993, J CELL BIOL, V120, P77, DOI 10.1083/jcb.120.1.77; Gerke V, 2005, NAT REV MOL CELL BIO, V6, P449, DOI 10.1038/nrm1661; Gerke V, 2002, PHYSIOL REV, V82, P331, DOI 10.1152/physrev.00030.2001; Gruenberg J, 2004, NAT REV MOL CELL BIO, V5, P317, DOI 10.1038/nrm1360; HARLAND RM, 1991, METHOD CELL BIOL, V36, P685; Hayes MJ, 2004, TRAFFIC, V5, P571, DOI 10.1111/j.1600-0854.2004.00210.x; Huang BH, 2011, BLOOD, V118, P2918, DOI 10.1182/blood-2011-03-341214; Kamal A, 1998, J CELL BIOL, V142, P937, DOI 10.1083/jcb.142.4.937; Kluger MS, 2013, ARTERIOSCL THROM VAS, V33, P489, DOI 10.1161/ATVBAHA.112.300893; Knop M, 2004, EMBO J, V23, P2982, DOI 10.1038/sj.emboj.7600319; Lee C., 2008, CSH PROTOC; Ling Q, 2004, J CLIN INVEST, V113, P38, DOI 10.1172/JCI200419684; Madureira PA, 2011, BLOOD, V118, P4789, DOI 10.1182/blood-2011-06-334672; Martin-Belmonte F, 2007, CELL, V128, P383, DOI 10.1016/j.cell.2006.11.051; Nieuwkoop PD, 1994, NORMAL TABLE XENOPUI; Park JE, 2005, BIOCHEM BIOPH RES CO, V337, P1283, DOI 10.1016/j.bbrc.2005.10.004; Pin AL, 2012, J BIOL CHEM, V287, P30541, DOI 10.1074/jbc.M112.393561; Salanga MC, 2010, DEV DYNAM, V239, P1178, DOI 10.1002/dvdy.22277; SARAFIAN T, 1991, J CELL BIOL, V114, P1135, DOI 10.1083/jcb.114.6.1135; SHALABY F, 1995, NATURE, V376, P62, DOI 10.1038/376062a0; Su SC, 2010, J BIOL CHEM, V285, DOI 10.1074/jbc.M110.157271; Uittenbogaard A, 2002, J BIOL CHEM, V277, P4925, DOI 10.1074/jbc.M109278200	31	18	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2015	10	7							e0132580	10.1371/journal.pone.0132580	http://dx.doi.org/10.1371/journal.pone.0132580			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RQ	26182056	Green Published, gold, Green Submitted			2022-12-26	WOS:000358198200023
J	Zhao, B; Li, CH; Liu, DR; Li, YC				Zhao, Bo; Li, Chenghao; Liu, Derong; Li, Yuanchun			Decentralized Sliding Mode Observer Based Dual Closed-Loop Fault Tolerant Control for Reconfigurable Manipulator against Actuator Failure	PLOS ONE			English	Article							FLIGHT CONTROL-SYSTEM; LITHIUM-ION BATTERY; ELECTRIC VEHICLES; DESIGN; ROBOTS; IDENTIFICATION; DIAGNOSIS	This paper considers a decentralized fault tolerant control (DFTC) scheme for reconfigurable manipulators. With the appearance of norm-bounded failure, a dual closed-loop trajectory tracking control algorithm is proposed on the basis of the Lyapunov stability theory. Characterized by the modularization property, the actuator failure is estimated by the proposed decentralized sliding mode observer (DSMO). Moreover, the actuator failure can be treated in view of the local joint information, so its control performance degradation is independent of other normal joints. In addition, the presented DFTC scheme is significantly simplified in terms of the structure of the controller due to its dual closed-loop architecture, and its feasibility is highly reflected in the control of reconfigurable manipulators. Finally, the effectiveness of the proposed DFTC scheme is demonstrated using simulations.	[Zhao, Bo; Li, Yuanchun] Changchun Univ Technol, Dept Control Engn, Changchun, Peoples R China; [Zhao, Bo; Liu, Derong] Chinese Acad Sci, Inst Automat, State Key Lab Management & Control Complex Syst, Beijing, Peoples R China; [Li, Chenghao] FAW Car Co Ltd, Prod Dev Dept, Changchun, Peoples R China	Changchun University of Technology; Chinese Academy of Sciences; Institute of Automation, CAS	Li, YC (corresponding author), Changchun Univ Technol, Dept Control Engn, Changchun, Peoples R China.	liyc@ccut.edu.cn	Liu, Derong/A-5304-2010; Li, Yuan/GXV-1310-2022	Liu, Derong/0000-0003-3715-4778; 	National Natural Science Foundation of China [61374051, 60974010]; Scientific and Technological Development Plan Project in Jilin Province of China [20150520112JH]; FAW Car Co., Ltd	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Scientific and Technological Development Plan Project in Jilin Province of China; FAW Car Co., Ltd	This work is supported by National Natural Science Foundation of China under grant nos. 61374051 and 60974010 and the Scientific and Technological Development Plan Project in Jilin Province of China under grant 20150520112JH. FAW Car Co., Ltd provided support in the form of salaries for author CL, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the "author contributions" section.	Abdi H, 2012, ROBOTICA, V30, P635, DOI 10.1017/S0263574711000671; Abdul S, 2008, IEEE INT CONF ROBOT, P3520, DOI 10.1109/ROBOT.2008.4543749; Abdul S, 2007, 2007 IEEE INTERNATIONAL CONFERENCE ON ROBOTICS AND BIOMIMETICS, VOLS 1-5, P1236, DOI 10.1109/ROBIO.2007.4522341; Aghili F, 2007, IEEE INT CONF ROBOT, P4077, DOI 10.1109/ROBOT.2007.364105; Ahmad S, 2013, MECHATRONICS, V23, P607, DOI 10.1016/j.mechatronics.2013.05.008; Du M, 2012, INT J ROBUST NONLIN, V22, P105, DOI 10.1002/rnc.1797; Gao Z, 2007, OPTIM CONTR APPL MET, V28, P143, DOI 10.1002/oca.786; HABIBI SR, 1995, IEEE INT CONF ROBOT, P2206, DOI 10.1109/ROBOT.1995.525589; Hassan M, 2007, MECH MACH THEORY, V42, P1401, DOI 10.1016/j.mechmachtheory.2006.10.001; He X, 2013, IEEE T IND INFORM, V9, P1670, DOI 10.1109/TII.2013.2251891; Hu QL, 2011, NONLINEAR DYNAM, V64, P13, DOI 10.1007/s11071-010-9842-z; Hu XS, 2011, J CENT SOUTH UNIV T, V18, P1525, DOI 10.1007/s11771-011-0869-1; Hu XS, 2013, SIMUL MODEL PRACT TH, V34, P1, DOI 10.1016/j.simpat.2013.01.001; Izumikawa Y, 2005, IEEE-ASME T MECH, V10, P391, DOI 10.1109/TMECH.2005.852442; Li Q, 2012, IND ROBOT, V39, P69, DOI 10.1108/01439911211192510; Liu M, 2013, AUTOMATICA, V49, P1242, DOI 10.1016/j.automatica.2013.01.030; Lu KF, 2013, IET CONTROL THEORY A, V7, P1529, DOI 10.1049/iet-cta.2012.1031; Muenchhof M, 2009, ANNU REV CONTROL, V33, P136, DOI 10.1016/j.arcontrol.2009.08.002; Paradis CJJ, 1997, ROBOT AUTON SYST, V21, P289, DOI [10.1016/S0921-8890(97)00081-X, DOI 10.1016/S0921-8890(97)00081-X]; Park S, 2013, J FRANKLIN I, V350, P2535, DOI 10.1016/j.jfranklin.2013.01.014; Seron MM, 2010, INT J CONTROL, V83, P2328, DOI 10.1080/00207179.2010.520032; Shen H, 2013, IET CONTROL THEORY A, V7, P1233, DOI 10.1049/iet-cta.2012.0822; Shen QK, 2012, IEEE T FUZZY SYST, V20, P652, DOI 10.1109/TFUZZ.2011.2181181; Sprowitz A, 2010, IEEE COMPUT INTELL M, V5, P20, DOI 10.1109/MCI.2010.937320; Staroswiecki M, 2012, IEEE T AUTOMAT CONTR, V57, P3181, DOI 10.1109/TAC.2012.2199179; Sun FC, 2011, ENERGY, V36, P3531, DOI 10.1016/j.energy.2011.03.059; Wang YQ, 2008, INT J CONTROL AUTOM, V6, P339; Xu YY, 2013, NONLINEAR DYNAM, V73, P2013, DOI 10.1007/s11071-013-0919-3; Yu X, 2012, IEEE T CONTR SYST T, V20, P871, DOI 10.1109/TCST.2011.2159606; Yuan J, 2011, IEEE T IND ELECTRON, V58, P4880, DOI 10.1109/TIE.2011.2116753; Yuan SA, 2011, INT J SYST SCI, V42, P2125, DOI 10.1080/00207721003770726; Zhang L, 2014, ENERGIES, V7, P3204, DOI 10.3390/en7053204; Zhao B, 2014, NONLINEAR DYNAM, V77, P859, DOI 10.1007/s11071-014-1347-8; Zhao B, 2013, MATH PROBL ENG, V2013, DOI 10.1155/2013/327916; Zhu MC, 2010, INT J ROBUST NONLIN, V20, P472, DOI 10.1002/rnc.1444	35	16	16	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2015	10	7							e0129315	10.1371/journal.pone.0129315	http://dx.doi.org/10.1371/journal.pone.0129315			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RQ	26181826	Green Submitted, gold, Green Published			2022-12-26	WOS:000358198200002
J	Fan, HY; Zhang, YL; Sun, HW; Liu, JY; Wang, Y; Wang, XB; Li, DW; Yu, JL; Han, CG				Fan, Huiyan; Zhang, Yongliang; Sun, Haiwen; Liu, Junying; Wang, Ying; Wang, Xianbing; Li, Dawei; Yu, Jialin; Han, Chenggui			Transcriptome Analysis of Beta macrocarpa and Identification of Differentially Expressed Transcripts in Response to Beet Necrotic Yellow Vein Virus Infection	PLOS ONE			English	Article							SUGAR-BEET; SSR-MARKERS; SILENCING-SUPPRESSION; GENE-EXPRESSION; RESISTANCE; RHIZOMANIA; DISEASE; PLANT; PATHOGENICITY; BREAKING	Background Rhizomania is one of the most devastating diseases of sugar beet. It is caused by Beet necrotic yellow vein virus (BNYVV) transmitted by the obligate root-infecting parasite Polymyxa betae. Beta macrocarpa, a wild beet species widely used as a systemic host in the laboratory, can be rub-inoculated with BNYVV to avoid variation associated with the presence of the vector P. betae. To better understand disease and resistance between beets and BNYVV, we characterized the transcriptome of B. macrocarpa and analyzed global gene expression of B. macrocarpa in response to BNYVV infection using the Illumina sequencing platform. Results The overall de novo assembly of cDNA sequence data generated 75,917 unigenes, with an average length of 1054 bp. Based on a BLASTX search (E-value <= 10(-5)) against the non-redundant (NR, NCBI) protein, Swiss-Prot, the Gene Ontology (GO), Clusters of Orthologous Groups of proteins (COG) and Kyoto Encyclopedia of Genes and Genomes (KEGG) databases, there were 39,372 unigenes annotated. In addition, 4,834 simple sequence repeats (SSRs) were also predicted, which could serve as a foundation for various applications in beet breeding. Furthermore, comparative analysis of the two transcriptomes revealed that 261 genes were differentially expressed in infected compared to control plants, including 128 up-and 133 down-regulated genes. GO analysis showed that the changes in the differently expressed genes were mainly enrichment in response to biotic stimulus and primary metabolic process. Conclusion Our results not only provide a rich genomic resource for beets, but also benefit research into the molecular mechanisms of beet-BNYVV interaction.	[Fan, Huiyan; Zhang, Yongliang; Sun, Haiwen; Liu, Junying; Wang, Ying; Wang, Xianbing; Li, Dawei; Yu, Jialin; Han, Chenggui] China Agr Univ, State Key Lab Agrobiotechnol, Beijing 100193, Peoples R China; [Fan, Huiyan; Zhang, Yongliang; Sun, Haiwen; Liu, Junying; Wang, Ying; Wang, Xianbing; Li, Dawei; Yu, Jialin; Han, Chenggui] China Agr Univ, Dept Plant Pathol, Beijing 100193, Peoples R China; [Fan, Huiyan] Zhejiang Chinese Med Univ, Coll Pharm, Hangzhou 310053, Zhejiang, Peoples R China	China Agricultural University; China Agricultural University; Zhejiang Chinese Medical University	Han, CG (corresponding author), China Agr Univ, State Key Lab Agrobiotechnol, Beijing 100193, Peoples R China.	hanchenggui@cau.edu.cn	Zhang, Yongliang/AAE-7639-2021; Wang, Xianbing/E-4831-2013; Li, Dawei/CAJ-5076-2022; Li, Dawei/I-8751-2016	Zhang, Yongliang/0000-0002-6790-1044; Li, Dawei/0000-0003-4133-1263; Liu, Jun-Ying/0000-0002-8388-1557; Wang, Xian-Bing/0000-0003-3082-2462	earmarked fund for China Agriculture Research System [CARS-210202]; Program for Changjiang Scholars and Innovative Research Team in University [IRT1042]	earmarked fund for China Agriculture Research System; Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT))	This work was supported in part by the earmarked fund for China Agriculture Research System (CARS-210202) and the Program for Changjiang Scholars and Innovative Research Team in University (IRT1042).	Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Biancardi E, 2002, EUPHYTICA, V127, P383, DOI 10.1023/A:1020310718166; Catoni M, 2009, MOL PLANT MICROBE IN, V22, P1504, DOI 10.1094/MPMI-22-12-1504; Chiba S, 2013, MOL PLANT MICROBE IN, V26, P168, DOI 10.1094/MPMI-06-12-0142-R; Chiba S, 2011, MOL PLANT MICROBE IN, V24, P207, DOI 10.1094/MPMI-10-10-0241; Cho HT, 2002, PLANT CELL, V14, P3237, DOI 10.1105/tpc.006437; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Culver JN, 2007, ANNU REV PHYTOPATHOL, V45, P221, DOI 10.1146/annurev.phyto.45.062806.094422; Cureton AN, 2002, MOL ECOL NOTES, V2, P402, DOI 10.1046/j.1471-8286.2002.00253.x; Dai SH, 2008, P NATL ACAD SCI USA, V105, P21012, DOI 10.1073/pnas.0810303105; Dardick C, 2007, MOL PLANT MICROBE IN, V20, P1004, DOI 10.1094/MPMI-20-8-1004; Dohm JC, 2012, PLANT J, V70, P528, DOI 10.1111/j.1365-313X.2011.04898.x; Eulgem T, 2007, CURR OPIN PLANT BIOL, V10, P366, DOI 10.1016/j.pbi.2007.04.020; Fan HY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085284; Fukazawa J, 2000, PLANT CELL, V12, P901, DOI 10.1105/tpc.12.6.901; Geyl L, 1995, PLANT PATHOL, V44, P819, DOI 10.1111/j.1365-3059.1995.tb02741.x; Gidner S, 2005, GENOME, V48, P279, DOI [10.1139/G04-108, 10.1139/g04-108]; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Gutterson N, 2004, CURR OPIN PLANT BIOL, V7, P465, DOI 10.1016/j.pbi.2004.04.007; Hanssen IM, 2011, PLANT PHYSIOL, V156, P301, DOI 10.1104/pp.111.173906; Heijbroek W, 1999, EUR J PLANT PATHOL, V105, P397, DOI 10.1023/A:1008705111232; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Itaya A, 2002, MOL PLANT MICROBE IN, V15, P990, DOI 10.1094/MPMI.2002.15.10.990; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Larson RL, 2008, PHYSIOL MOL PLANT P, V72, P62, DOI 10.1016/j.pmpp.2008.04.003; Laurent V, 2007, THEOR APPL GENET, V115, P793, DOI 10.1007/s00122-007-0609-y; Li JQ, 2010, EUPHYTICA, V175, P35, DOI 10.1007/s10681-010-0161-8; Liu HY, 2005, PLANT DIS, V89, P464, DOI 10.1094/PD-89-0464; Lu J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043447; McGrann GRD, 2009, MOL PLANT PATHOL, V10, P129, DOI 10.1111/j.1364-3703.2008.00514.x; Monteiro F., 2013, American Journal of Plant Sciences, V4, P21; Peltier C, 2011, TRANSGENIC RES, V20, P443, DOI 10.1007/s11248-010-9424-3; Rahim MD, 2007, J GEN VIROL, V88, P1611, DOI 10.1099/vir.0.82720-0; RICHARDS KE, 1992, ANNU REV PHYTOPATHOL, V30, P291, DOI 10.1146/annurev.py.30.090192.001451; Rush CM, 2003, ANNU REV PHYTOPATHOL, V41, P567, DOI 10.1146/annurev.phyto.41.052002.095705; Schmidlin L, 2008, MOL PLANT PATHOL, V9, P741, DOI 10.1111/J.1364-3703.2008.00498.X; Scholten OE, 2000, EUPHYTICA, V112, P219, DOI 10.1023/A:1003988003165; t Hoen PAC, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn705; Tamada T, 1999, PHYTOPATHOLOGY, V89, P1000, DOI 10.1094/PHYTO.1999.89.11.1000; Tatusov RL, 2001, NUCLEIC ACIDS RES, V29, P22, DOI 10.1093/nar/29.1.22; Thiel T, 2003, THEOR APPL GENET, V106, P411, DOI 10.1007/s00122-002-1031-0; Toth G, 2000, GENOME RES, V10, P967, DOI 10.1101/gr.10.7.967; Verma P, 2013, PLANT BIOTECHNOL J, V11, P894, DOI 10.1111/pbi.12082; Viard F, 2004, MOL ECOL, V13, P1357, DOI 10.1111/j.1365-294X.2004.02150.x; Wang SF, 2012, PLANT CELL REP, V31, P1437, DOI 10.1007/s00299-012-1259-3; Wang YN, 2011, STAT BIOPHARM RES, V3, P1, DOI 10.1198/sbr.2011.09051; Whitham SA, 2006, MOL PLANT MICROBE IN, V19, P1207, DOI 10.1094/MPMI-19-1207; Wilhelm BT, 2009, METHODS, V48, P249, DOI 10.1016/j.ymeth.2009.03.016; Xie FL, 2012, PLANTA, V236, P101, DOI 10.1007/s00425-012-1591-4; Zalapa JE, 2012, AM J BOT, V99, P193, DOI 10.3732/ajb.1100394; Zeng SH, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-94; Zhang LD, 2005, CHINESE SCI BULL, V50, P305, DOI 10.1360/982004-731; Zhang YQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045953	53	10	10	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0132277	10.1371/journal.pone.0132277	http://dx.doi.org/10.1371/journal.pone.0132277			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LZ	26196682	Green Published, Green Submitted, gold			2022-12-26	WOS:000358547600029
J	Nutsua, ME; Fischer, A; Nebel, A; Hofmann, S; Schreiber, S; Krawczak, M; Nothnagel, M				Nutsua, Marcel Elie; Fischer, Annegret; Nebel, Almut; Hofmann, Sylvia; Schreiber, Stefan; Krawczak, Michael; Nothnagel, Michael			Family-Based Benchmarking of Copy Number Variation Detection Software	PLOS ONE			English	Article							NUCLEOTIDE POLYMORPHISM ARRAYS; INTERNATIONAL HAPMAP PROJECT; GENOME-WIDE ASSOCIATION; HIDDEN-MARKOV MODEL; SNP GENOTYPING DATA; STRUCTURAL VARIATION; MISSING HERITABILITY; GENETIC-VARIATION; HAPLOTYPE MAP; SEQUENCE	The analysis of structural variants, in particular of copy-number variations (CNVs), has proven valuable in unraveling the genetic basis of human diseases. Hence, a large number of algorithms have been developed for the detection of CNVs in SNP array signal intensity data. Using the European and African HapMap trio data, we undertook a comparative evaluation of six commonly used CNV detection software tools, namely Affymetrix Power Tools (APT), QuantiSNP, PennCNV, GLAD, R-gada and VEGA, and assessed their level of pair-wise prediction concordance. The tool-specific CNV prediction accuracy was assessed in silico by way of intra-familial validation. Software tools differed greatly in terms of the number and length of the CNVs predicted as well as the number of markers included in a CNV. All software tools predicted substantially more deletions than duplications. Intra-familial validation revealed consistently low levels of prediction accuracy as measured by the proportion of validated CNVs (34-60%). Moreover, up to 20% of apparent family-based validations were found to be due to chance alone. Software using Hidden Markov models (HMM) showed a trend to predict fewer CNVs than segmentation-based algorithms albeit with greater validity. PennCNV yielded the highest prediction accuracy (60.9%). Finally, the pair-wise concordance of CNV prediction was found to vary widely with the software tools involved. We recommend HMM-based software, in particular PennCNV, rather than segmentation-based algorithms when validity is the primary concern of CNV detection. QuantiSNP may be used as an additional tool to detect sets of CNVs not detectable by the other tools. Our study also reemphasizes the need for laboratory-based validation, such as qPCR, of CNVs predicted in silico.	[Nutsua, Marcel Elie; Fischer, Annegret; Nebel, Almut; Hofmann, Sylvia; Schreiber, Stefan] Univ Kiel, Inst Clin Mol Biol, Kiel, Germany; [Krawczak, Michael; Nothnagel, Michael] Univ Kiel, Inst Med Informat & Stat, Kiel, Germany; [Nothnagel, Michael] Univ Cologne, Cologne Ctr Genom, D-50931 Cologne, Germany	University of Kiel; University of Kiel; University of Cologne	Nothnagel, M (corresponding author), Univ Kiel, Inst Med Informat & Stat, Kiel, Germany.	michael.nothnagel@uni-koeln.de	Nothnagel, Michael/L-7187-2019; Nothnagel, Michael/G-6545-2014; Krawczak, Michael/A-8964-2010; Hofmann, Sylvia/AAO-4802-2021; Nebel, Almut/E-4196-2010	Nothnagel, Michael/0000-0001-8305-7114; Krawczak, Michael/0000-0003-2603-1502; Hofmann, Dr. S./0000-0003-0621-9049	German Ministry of Education and Research (BMBF) through DFG Cluster of Excellence "Inflammation at Interfaces" [EXC 306]	German Ministry of Education and Research (BMBF) through DFG Cluster of Excellence "Inflammation at Interfaces"	This study was supported by the German Ministry of Education and Research (BMBF) through the DFG Cluster of Excellence EXC 306 "Inflammation at Interfaces". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Affymetrix Inc, 2012, AFFYMETRIX POWER TOO; Affymetrix Inc, 2011, AFF GEN WID HUM SNP; Ahn SM, 2009, GENOME RES, V19, P1622, DOI 10.1101/gr.092197.109; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Baross A, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-368; Bengtsson H, 2008, BIOINFORMATICS, V24, P759, DOI 10.1093/bioinformatics/btn016; Bengtsson H, 2009, BIOINFORMATICS, V25, P2149, DOI 10.1093/bioinformatics/btp371; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Bochukova EG, 2010, NATURE, V463, P666, DOI 10.1038/nature08689; Carter NP, 2007, NAT GENET, V39, pS16, DOI 10.1038/ng2028; Chen WT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023087; Coe BP, 2012, AM J MED GENET C, V160C, P118, DOI 10.1002/ajmg.c.31327; Coin LJM, 2012, BIOINFORMATICS, V28, pI370, DOI 10.1093/bioinformatics/bts379; Colella S, 2007, NUCLEIC ACIDS RES, V35, P2013, DOI 10.1093/nar/gkm076; Conrad DF, 2010, NATURE, V464, P704, DOI 10.1038/nature08516; Craddock N, 2010, NATURE, V464, P713, DOI 10.1038/nature08979; de Cid R, 2009, NAT GENET, V41, P211, DOI 10.1038/ng.313; Eckel-Passow JE, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-220; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Gunderson KL, 2005, NAT GENET, V37, P549, DOI 10.1038/ng1547; Hupe P, 2004, BIOINFORMATICS, V20, P3413, DOI 10.1093/bioinformatics/bth418; Ju YS, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq730; Kathiresan S, 2009, NAT GENET, V41, P334, DOI 10.1038/ng.327; Kato M, 2010, HUM MOL GENET, V19, P761, DOI 10.1093/hmg/ddp541; Kidd JM, 2008, NATURE, V453, P56, DOI 10.1038/nature06862; Kim JI, 2009, NATURE, V460, P1011, DOI 10.1038/nature08211; Korbel JO, 2007, SCIENCE, V318, P420, DOI 10.1126/science.1149504; Korn JM, 2008, NAT GENET, V40, P1253, DOI 10.1038/ng.237; LaFramboise T, 2009, NUCLEIC ACIDS RES, V37, P4181, DOI 10.1093/nar/gkp552; Levy Samuel, 2007, PLoS Biol, V5, pe254, DOI 10.1371/journal.pbio.0050254; Li J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007958; Locke DP, 2006, AM J HUM GENET, V79, P275, DOI 10.1086/505653; Maher B, 2008, NATURE, V456, P18, DOI 10.1038/456018a; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; McCarroll SA, 2008, NAT GENET, V40, P1166, DOI 10.1038/ng.238; McCarroll SA, 2008, NAT GENET, V40, P1107, DOI 10.1038/ng.215; McKernan KJ, 2009, GENOME RES, V19, P1527, DOI 10.1101/gr.091868.109; Mills RE, 2011, NATURE, V470, P59, DOI 10.1038/nature09708; Morganella S, 2010, BIOINFORMATICS, V26, P3020, DOI 10.1093/bioinformatics/btq586; Nannya Y, 2005, CANCER RES, V65, P6071, DOI 10.1158/0008-5472.CAN-05-0465; Pang AW, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-5-r52; Peiffer DA, 2006, GENOME RES, V16, P1136, DOI 10.1101/gr.5402306; Pinto D, 2011, NAT BIOTECHNOL, V29, P512, DOI 10.1038/nbt.1852; Pique-Regi R, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-380; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Scharpf RB, 2011, BIOSTATISTICS, V12, P33, DOI 10.1093/biostatistics/kxq043; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; Stefansson H, 2008, NATURE, V455, P232, DOI 10.1038/nature07229; Thorisson GA, 2005, GENOME RES, V15, P1592, DOI 10.1101/gr.4413105; Visscher PM, 2012, AM J HUM GENET, V90, P7, DOI 10.1016/j.ajhg.2011.11.029; Wang J, 2008, NATURE, V456, P60, DOI 10.1038/nature07484; Wang K, 2007, GENOME RES, V17, P1665, DOI 10.1101/gr.6861907; Winchester Laura, 2009, Briefings in Functional Genomics & Proteomics, V8, P353, DOI 10.1093/bfgp/elp017; Wong LP, 2013, AM J HUM GENET, V92, P52, DOI 10.1016/j.ajhg.2012.12.005; Zhang DD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014511; Zhao M, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-S11-S1; Zhao XJ, 2004, CANCER RES, V64, P3060, DOI 10.1158/0008-5472.CAN-03-3308	60	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0133465	10.1371/journal.pone.0133465	http://dx.doi.org/10.1371/journal.pone.0133465			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LZ	26197066	Green Submitted, Green Published, gold			2022-12-26	WOS:000358547600101
J	Barbet-Massin, C; Giuliano, S; Alletto, L; Dayde, J; Berger, M				Barbet-Massin, Claire; Giuliano, Simon; Alletto, Lionel; Dayde, Jean; Berger, Monique			Nitrogen Limitation Alters Biomass Production but Enhances Steviol Glycoside Concentration in Stevia rebaudiana Bertoni	PLOS ONE			English	Article							RESOURCE AVAILABILITY; SECONDARY METABOLITES; NUTRIENT AVAILABILITY; ACCUMULATION; BIOSYNTHESIS; LEAVES; PLANTS; LIGHT; GLYCOSYLTRANSFERASES; ALLOCATION	The need for medicinal and aromatic plants for industrial uses creates an opportunity for farmers to produce alternative crops. Stevia rebaudiana Bertoni, a perennial shrub originating from Paraguay, is of increasing interest as a source of zero-calorie natural sweeteners: the steviol glycosides (SVglys). The aim of this study was to investigate the relevance of nitrogen (N) supply for leaf yield and for SVgly concentrations in leaves, which are the two major components of S. rebaudiana productivity. In this regard, the relationship between leaf N concentration, CO2 assimilation, leaf production and SVgly accumulation was investigated. The experiments were conducted consecutively in growth-chamber (CC: controlled conditions), in greenhouse (SCC: semi-controlled conditions) and in field conditions (FC) on two genotypes. In CC and SCC, three levels of N fertilization were applied. Plants were grown on four locations in the FC experiment. Both N supply (CC and SCC) and location (FC) had a significant effect on N content in leaves. When light was not limiting (SCC and FC) N content in leaves was positively correlated with CO2 assimilation rate and biomass accumulation. Irrespective of the growth conditions, N content in leaves was negatively correlated with SVgly content. However, increased SVgly content was correlated with a decreased ratio of rebaudioside A over stevioside. The evidence that the increased SVgly accumulation compensates for the negative effect on biomass production suggests that adequate SVgly productivity per plant may be achieved with relatively low fertilization.	[Barbet-Massin, Claire; Dayde, Jean; Berger, Monique] Univ Toulouse, EI Purpan, INP, Dept Sci Agron & Agroalimentaires, F-31076 Toulouse, France; [Giuliano, Simon; Alletto, Lionel] Univ Toulouse, EI Purpan, INP, Dept Sci Agron & Agroalimentaires,AGIR UMR1248, Toulouse, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite de Toulouse; Institut National Polytechnique de Toulouse; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite de Toulouse; Institut National Polytechnique de Toulouse	Berger, M (corresponding author), Univ Toulouse, EI Purpan, INP, Dept Sci Agron & Agroalimentaires, 75 Voie TOEC,BP 57611, F-31076 Toulouse, France.	monique.berger@purpan.fr	Giuliano, Simon/B-4206-2015	Alletto, Lionel/0000-0003-0933-9476	Fonds Unique Interministeriel (STEVIANOV) [F11 07 018M]	Fonds Unique Interministeriel (STEVIANOV)	This work was supported by the Fonds Unique Interministeriel (STEVIANOV - F11 07 018M) (http://competitivite.gouv.fr/le-11e-appel-a-projets/lesresultats-du-11e-appel-a-projets-r-d-fui-784.html). Authors MB and SG received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALVES LM, 1979, PLANT CELL PHYSIOL, V20, P123; Andolfi L., 2006, Italian Journal of Agronomy, V1, P257; Baly ECC, 1935, PROC R SOC SER B-BIO, V117, P218, DOI 10.1098/rspb.1935.0026; Bondarev NI, 2003, BIOL PLANTARUM, V47, P261, DOI 10.1023/B:BIOP.0000022261.35259.4f; Brandle J, 1999, CAN J PLANT SCI, V79, P85, DOI 10.4141/P98-048; Brandle JE, 2007, PHYTOCHEMISTRY, V68, P1855, DOI 10.1016/j.phytochem.2007.02.010; Brandle JE, 1998, CAN J PLANT SCI, V78, P527, DOI 10.4141/P97-114; BRANDLE JE, 1992, CAN J PLANT SCI, V72, P1263, DOI 10.4141/cjps92-159; BRYANT JP, 1983, OIKOS, V40, P357, DOI 10.2307/3544308; Ceunen S, 2013, PLANT SCI, V198, P72, DOI 10.1016/j.plantsci.2012.10.003; COLEY PD, 1985, SCIENCE, V230, P895, DOI 10.1126/science.230.4728.895; Cordoba E, 2011, J EXP BOT, V62, P2023, DOI 10.1093/jxb/erq393; Cordoba E, 2009, J EXP BOT, V60, P2933, DOI 10.1093/jxb/erp190; Cronin G, 1996, OIKOS, V77, P93, DOI 10.2307/3545589; Hale BK, 2005, J CHEM ECOL, V31, P2601, DOI 10.1007/s10886-005-7616-8; Haukioja E, 1998, CHEMOECOLOGY, V8, P133, DOI 10.1007/s000490050018; HERMS DA, 1992, Q REV BIOL, V67, P283, DOI 10.1086/417659; Humphrey TV, 2006, PLANT MOL BIOL, V61, P47, DOI 10.1007/s11103-005-5966-9; Ibrahim MH, 2011, INT J MOL SCI, V12, P5238, DOI 10.3390/ijms12085238; Janawade A.D., 2012, KARNATAKA J AGR SCI, V25, P25, DOI DOI 10.2307/2399915; Jones P, 2001, PLANTA, V213, P164, DOI 10.1007/s004250000492; Kienle U, 2010, J VERBRAUCH LEBENSM, V5, P241, DOI 10.1007/s00003-010-0558-2; Kim KK, 1996, ARCH BIOCHEM BIOPHYS, V332, P223, DOI 10.1006/abbi.1996.0336; Koricheva J, 1998, OIKOS, V83, P212, DOI 10.2307/3546833; Kumar H, 2012, GENE, V492, P276, DOI 10.1016/j.gene.2011.10.015; Kumar R, 2013, ARCH AGRON SOIL SCI, V59, P963, DOI 10.1080/03650340.2012.699676; Lambers H., 2008, PLANT PHYSL ECOLOGY, p11Routl, DOI [DOI 10.1007/978-0-387-78341-3_2, 10.1007/978-0-387-78341-3_2]; Lobo FD, 2013, PHOTOSYNTHETICA, V51, P445, DOI 10.1007/s11099-013-0045-y; Massad TJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047554; Mohamed AAA, 2011, J PLANT PHYSIOL, V168, P1136, DOI 10.1016/j.jplph.2011.01.030; Izquierdo AM, 2011, ACTA PHYSIOL PLANT, V33, P2135, DOI 10.1007/s11738-011-0753-5; Muller V, 2013, J PLANT PHYSIOL, V170, P1165, DOI 10.1016/j.jplph.2013.03.010; Pal PK, 2013, J PLANT PHYSIOL, V170, P1526, DOI 10.1016/j.jplph.2013.06.017; Patil N. M., 2010, Recent Research in Science and Technology, V2, P42; R Core Team, 2021, R LANGUAGE ENV STAT; Rajasekaran T, 2007, J SCI FOOD AGR, V87, P420, DOI 10.1002/jsfa.2713; Richman A, 2005, PLANT J, V41, P56, DOI 10.1111/j.1365-313X.2004.02275.x; Richman AS, 1999, PLANT J, V19, P411, DOI 10.1046/j.1365-313X.1999.00531.x; Tavarini S, 2013, J SCI FOOD AGR, V93, P2121, DOI 10.1002/jsfa.6016; Totte N, 2000, TETRAHEDRON LETT, V41, P6407, DOI 10.1016/S0040-4039(00)01094-7; Tschoep H, 2009, PLANT CELL ENVIRON, V32, P300, DOI 10.1111/j.1365-3040.2008.01921.x; TUOMI J, 1984, OECOLOGIA, V61, P208, DOI 10.1007/BF00396762; Ward JL, 2011, P NATL ACAD SCI USA, V108, P10762, DOI 10.1073/pnas.1018875108; Yadav AK, 2011, CAN J PLANT SCI, V91, P1, DOI 10.4141/CJPS10086	44	34	37	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2015	10	7							e0133067	10.1371/journal.pone.0133067	http://dx.doi.org/10.1371/journal.pone.0133067			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LN	26192921	Green Published, Green Submitted, gold			2022-12-26	WOS:000358546400052
J	Bautista-Arredondo, S; Gonzalez, A; Servan-Mori, E; Beynon, F; Juarez-Figueroa, L; Conde-Glez, CJ; Gras, N; Sierra-Madero, J; Lopez-Ridaura, R; Volkow, P; Bertozzi, SM				Bautista-Arredondo, Sergio; Gonzalez, Andrea; Servan-Mori, Edson; Beynon, Fenella; Juarez-Figueroa, Luis; Conde-Glez, Carlos J.; Gras, Nathalie; Sierra-Madero, Juan; Lopez-Ridaura, Ruy; Volkow, Patricia; Bertozzi, Stefano M.			A Cross-Sectional Study of Prisoners in Mexico City Comparing Prevalence of Transmissible Infections and Chronic Diseases with That in the General Population	PLOS ONE			English	Article							RISK; HIV; INCARCERATION; INMATES; VIRUS	Objectives To describe patterns of transmissible infections, chronic illnesses, socio-demographic characteristics and risk behaviors in Mexico City prisons, including in comparison to the general population, to identify those currently needing healthcare and inform policy. Materials and Methods A cross-sectional study among 17,000 prisoners at 4 Mexico City prisons (June to December 2010). Participation was voluntary, confidential and based on informed consent. Participants were tested for HIV, Hepatitis B & C, syphilis, hypertension, obesity, and, if at risk, glucose and cholesterol. A subset completed a questionnaire on socio-demographic characteristics and risk behaviors. Positive results were delivered with counseling and treatment or referral. Results 76.8% (15,517/20,196) of men and 92.9% (1,779/1,914) of women participated. Complete data sets were available for 98.8%. The following prevalence data were established for transmissible infections: HIV 0.7%; syphilis: Anti-TP+/VDRL+2.0%; Hepatitis B: HBcAb 2.8%, HBsAg 0.15%; Anti-HCV 3.2%. Obesity: 9.5% men, 33.8% women. Compared with national age-and sex-matched data, the relative prevalence was greater for HIV and syphilis among women, HIV and Hepatitis C in men, and all infections in younger participants. Obesity prevalence was similar for women and lower among male participants. The prevalence of previously diagnosed diabetes and hypertension was lower. Questionnaire data (1,934 men, 520 women) demonstrated lower educational levels, increased smoking and substance use compared to national data. High levels of non-sterile tattooing, physical abuse and histories of sexual violence were found. Conclusion The study identified that health screening is acceptable to Mexico City prisoners and feasible on a large-scale. It demonstrated higher prevalence of HIV and other infections compared to national data, though low rates compared to international data. Individual participants benefited from earlier diagnosis, treatment and support. The data collected will also enable the formulation of improved policy for this vulnerable group.	[Bautista-Arredondo, Sergio; Servan-Mori, Edson; Beynon, Fenella; Juarez-Figueroa, Luis; Conde-Glez, Carlos J.; Lopez-Ridaura, Ruy] Natl Inst Publ Hlth, Cuernavaca, Morelos, Mexico; [Gonzalez, Andrea; Gras, Nathalie] Mexico Citys AIDS Program, Mexico City, DF, Mexico; [Sierra-Madero, Juan] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Mexico City, DF, Mexico; [Volkow, Patricia] Natl Inst Oncol, Mexico City, DF, Mexico; [Bertozzi, Stefano M.] Univ Calif Berkeley, Berkeley, CA 94720 USA	Instituto Nacional de Salud Publica; Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran - Mexico; University of California System; University of California Berkeley	Servan-Mori, E (corresponding author), Natl Inst Publ Hlth, Cuernavaca, Morelos, Mexico.	eservan@insp.mx	Sierra Madero, Juan/AAW-8825-2021; Bautista-Arredondo, Sergio/N-7305-2016; González Ríos, Andrea/HGU-7618-2022	Bautista-Arredondo, Sergio/0000-0001-8910-3011; Beynon, Fenella/0000-0002-4758-8847; Servan-Mori, Edson/0000-0001-9820-8325; Bertozzi, Stefano M/0000-0002-1723-7085	Ministry of Health of Mexico City [INSP-2010-340]	Ministry of Health of Mexico City	This work was supported by the Ministry of Health of Mexico City under contract INSP-2010-340.	Alvarado-Esquivel C, 2005, EPIDEMIOL INFECT, V133, P679, DOI 10.1017/S0950268805003961; American Diabetes Association, 2008, Diabetes Care, V31 Suppl 1, pS87, DOI 10.2337/dc08-S087; Bailey KV, 1995, B WORLD HEALTH ORGAN, V73, P673; Bautista-Arredondo S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072616; Binswanger IA, 2009, J EPIDEMIOL COMMUN H, V63, P912, DOI 10.1136/jech.2009.090662; Brown JL, 2013, CARIES RES, V47, P40, DOI 10.1159/000351827; Butler T, 2004, AUST NZ J PUBL HEAL, V28, P344, DOI 10.1111/j.1467-842X.2004.tb00442.x; Comision de Derechos Humanos del Distrito Federal, 2011, INF QUE PRES COM DER; Dolan K, 2007, LANCET INFECT DIS, V7, P32, DOI 10.1016/S1473-3099(06)70685-5; Dolan K, 2010, EUR J EPIDEMIOL, V25, P143, DOI 10.1007/s10654-009-9421-0; HERMAN WH, 1995, DIABETES CARE, V18, P382, DOI 10.2337/diacare.18.3.382; ICPS, 2004, PRIS HLTH PUBL HLTH; INEGI, 2010, MORT DAT 2010; Izazola Licea JA, 1998, ESTUDIOS CASO PRACTI; Johnson RC, 2009, J LAW ECON, V52, P251, DOI 10.1086/597102; Juarez-Figueroa L, 18 INT AIDS C JUL 18; Juarez-Figueroa L, 2011, 19 BIENN C INT SOC S; Jurado S, 1998, SALUD MENTAL, V21; Jurgens R, 2009, LANCET INFECT DIS, V9, P57, DOI 10.1016/S1473-3099(08)70305-0; Leddy Meaghan A, 2009, J Correct Health Care, V15, P318, DOI 10.1177/1078345809340426; Miranda AE, 2000, SEX TRANSM DIS, V27, P491, DOI 10.1097/00007435-200010000-00001; Nara K, 1998, IND HLTH, P1; Olaiz-Fernandez G, 2006, ENCUESTA NACL SALUD; Organizacion Panamericana de la Salud; Instituto Nacional de Salud Publica (MX), 2009, ENC GLOB TAB AD; Rojas R, 2010, SALUD PUBLICA MEXICO, V52, pS11, DOI 10.1590/s0036-36342010000700004; Salla F, 2009, HUMAN RIGHTS PRISON; Stata Corp. LP, 2011, STAT SE 12 1 WIND XP; Subsecretaria de Sistema Penitenciario G de DF2010, 2010, MOV DIAR POBL PEN; Thomas JC, 2008, J URBAN HEALTH, V85, P90, DOI 10.1007/s11524-007-9231-1; Vescio MF, 2008, J EPIDEMIOL COMMUN H, V62, P305, DOI 10.1136/jech.2006.051599; Villalpando S, 2010, SALUD PUBLICA MEXICO, V52, pS72; Weinbaum CA, 2005, AIDS, V19, pS41, DOI 10.1097/01.aids.0000192069.95819.aa; World Health Organization (WHO), 2007, HLTH PRIS WHO GUID E	33	35	35	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2015	10	7							e0131718	10.1371/journal.pone.0131718	http://dx.doi.org/10.1371/journal.pone.0131718			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN6LN	26192811	gold, Green Published, Green Submitted			2022-12-26	WOS:000358546400015
J	Kohyama-Koganeya, A; Kurosawa, M; Hirabayashi, Y				Kohyama-Koganeya, Ayako; Kurosawa, Mizuki; Hirabayashi, Yoshio			Differential Effects of Tissue-Specific Deletion of BOSS on Feeding Behaviors and Energy Metabolism	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTORS; DROSOPHILA; INSULIN; GPRC5B; BRIDE; HOMEOSTASIS; SECRETION; OBESITY; CELLS; CREB	Food intake and energy metabolism are tightly controlled to maintain stable energy homeostasis and healthy states. Thus, animals detect their stored energy levels, and based on this, they determine appropriate food intake and meal size. Drosophila melanogaster putative G protein-coupled receptor, Bride of sevenless (BOSS) is a highly evolutionarily conserved protein that responds to extracellular glucose levels in order to regulate energy homeostasis. To address how BOSS regulates energy homeostasis, we characterized a boss mutant by assessing its food intake and stored energy levels. Boss mutants exhibited increased food intake but decreased stored triacylglyceride levels. Using boss-GAL4 drivers, we found that boss is expressed in select tissues that are involved in nutrient sensing and food intake, in a subset of neurons in brain and chemosensory organs, in fat body, and in endocrine cells in gut (enteroendocrine cells). Flies with tissue-specific boss knockdowns in these tissues had abnormal stored energy levels and abnormal food intake. These results suggest that BOSS in either neurons or peripheral nutrient-sensing tissues affects energy homeostasis in ways that relate to the sensing of nutrients and regulation of food intake.	[Kohyama-Koganeya, Ayako; Kurosawa, Mizuki; Hirabayashi, Yoshio] RIKEN, Brain Sci Inst, Mol Membrane Neurosci, Wako, Saitama, Japan	RIKEN	Hirabayashi, Y (corresponding author), RIKEN, Brain Sci Inst, Mol Membrane Neurosci, Wako, Saitama, Japan.	hirabaya@riken.jp	香山, 綾子/ABF-4396-2021	香山, 綾子/0000-0002-7632-7953; Hirabayashi, Yoshio/0000-0002-5774-7354	RIKEN Brain Science Institute; General Research Grant from Nestle Nutrition Council, Japan	RIKEN Brain Science Institute; General Research Grant from Nestle Nutrition Council, Japan	This work was supported in part by grants from the RIKEN Brain Science Institute (to YH) and by 2010 General Research Grant from Nestle Nutrition Council, Japan (to AK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altarejos JY, 2011, NAT REV MOL CELL BIO, V12, P141, DOI 10.1038/nrm3072; Arrese EL, 2010, ANNU REV ENTOMOL, V55, P207, DOI 10.1146/annurev-ento-112408-085356; Audsley N, 2009, GEN COMP ENDOCR, V162, P93, DOI 10.1016/j.ygcen.2008.08.003; Badisco L, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00202; Billeter JC, 2009, NATURE, V461, P987, DOI 10.1038/nature08495; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Gronke S, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000857; HART AC, 1990, GENE DEV, V4, P1835, DOI 10.1101/gad.4.11.1835; Iijima K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008498; Jang HJ, 2007, P NATL ACAD SCI USA, V104, P15069, DOI 10.1073/pnas.0706890104; Janssen S, 2013, TRENDS ENDOCRIN MET, V24, P92, DOI 10.1016/j.tem.2012.11.006; Kannan K, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00288; Kim YJ, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003149; Kohyama-Koganeya A, 2008, P NATL ACAD SCI USA, V105, P15328, DOI 10.1073/pnas.0807833105; KRAMER H, 1991, NATURE, V352, P207, DOI 10.1038/352207a0; Li SZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076131; Melcher C, 2005, PLOS BIOL, V3, P1618, DOI 10.1371/journal.pbio.0030305; Metpally RPR, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-106; Morton GJ, 2014, NAT REV NEUROSCI, V15, P367, DOI 10.1038/nrn3745; Musselman LP, 2011, DIS MODEL MECH, V4, P842, DOI 10.1242/dmm.007948; Nassel DR, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00252; Okamoto N, 2013, GENE DEV, V27, P87, DOI 10.1101/gad.204479.112; Padmanabha D, 2014, TRENDS ENDOCRIN MET, V25, P518, DOI 10.1016/j.tem.2014.03.011; Park JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029022; Rajan A, 2012, CELL, V151, P123, DOI 10.1016/j.cell.2012.08.019; Rajan A, 2011, DEV CELL, V21, P29, DOI 10.1016/j.devcel.2011.06.034; Reiher W, 2011, J PROTEOME RES, V10, P1881, DOI 10.1021/pr101116g; Robbins MJ, 2000, GENOMICS, V67, P8, DOI 10.1006/geno.2000.6226; Sano T, 2011, BIOCHEM BIOPH RES CO, V412, P460, DOI 10.1016/j.bbrc.2011.07.118; Shiraiwa T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002191; Smith WW, 2014, PHYSIOL BEHAV, V136, P15, DOI 10.1016/j.physbeh.2014.01.017; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; Sunio A, 1999, MOL BIOL CELL, V10, P847, DOI 10.1091/mbc.10.4.847; Teleman AA, 2010, BIOCHEM J, V425, P13, DOI 10.1042/BJ20091181; Xu KY, 2008, CELL METAB, V8, P289, DOI 10.1016/j.cmet.2008.09.006	35	13	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2015	10	7							e0133083	10.1371/journal.pone.0133083	http://dx.doi.org/10.1371/journal.pone.0133083			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LN	26193363	gold, Green Submitted, Green Published			2022-12-26	WOS:000358546400054
J	Hou, JX; An, XP; Song, YX; Gao, TN; Lei, Y; Cao, BY				Hou, Jinxing; An, Xiaopeng; Song, Yuxuan; Gao, Teyang; Lei, Yingnan; Cao, Binyun			Two Mutations in the Caprine MTHFR 3 ' UTR Regulated by MicroRNAs Are Associated with Milk Production Traits	PLOS ONE			English	Article							BOVINE MAMMARY-GLAND; METHYLENETETRAHYDROFOLATE REDUCTASE; EXPRESSION; GENE; IDENTIFICATION; POLYMORPHISMS; LACTATION	Background 5,10-Methylenetetrahydrofolate reductase (MTHFR) plays a central role in folate metabolism by irreversibly converting 5,10-methylenetetrahydrofolate to 5-methylenetetrahydrofolate, a predominant circulating form of folate. Folate is reportedly important for milk protein synthesis, and MTHFR may be a key regulatory point of folate metabolism for milk protein synthesis in mammary epithelial cells. Prior to this study, polymorphisms of the MTHFR gene were not associated with milk production traits from a breeding perspective. Single nucleotide polymorphisms (SNPs) at microRNA (miRNA) binding sites (miR-SNPs) can affect gene expression. This study aimed to identify the effects of miR-SNPs (g.2244A>G and g.2264A>G) in the caprine MTHFR 3'UTR on the milk production traits of dairy goats. Results Guanzhong dairy (GD, n = 325) goats were used to detect SNPs in the caprine MTHFR 3'UTR by DNA sequencing. Two novel SNPs (g.2244A>G and g.2264A>G) were identified in the said region. The homozygous haplotype A-G of the SNPs g.2244A>G and g.2264A>G was significantly associated with milk yield and milk protein levels in GD goats (P<0.05). Functional assays indicated that the MTHFR 2244 A -> G substitution could increase the binding activity of hsa-miR-1266 with the MTHFR 3'UTR. The MTHFR 2264 A -> G substitution could decrease the binding activity of hsa-miR-616 with the MTHFR 3'UTR. In addition, we observed a significant increase in the MTHFR mRNA levels of homozygous haplotype A-G carriers relative to those of homozygous haplotype G-A carriers. These results indicated that both SNPs altered the MTHFR mRNA levels. These altered levels of MTHFR mRNA may account for the association of SNPs with milk production traits. Conclusions This study is the first to report that the g.2244A>G and g.2264A>G polymorphisms were associated with milk production traits in GD goats. Further investigations should explore the underlying miRNA-mediated mechanisms that are modified by the g.2244A>G and g.2264A>G SNPs. The current study evaluated these SNPs as potential genetic markers in goats, with potential applications in breeding programs.	[Hou, Jinxing; An, Xiaopeng; Song, Yuxuan; Gao, Teyang; Lei, Yingnan; Cao, Binyun] Northwest A&F Univ, Coll Anim Sci & Technol, Yangling 712100, Shaanxi, Peoples R China	Northwest A&F University - China	Cao, BY (corresponding author), Northwest A&F Univ, Coll Anim Sci & Technol, Yangling 712100, Shaanxi, Peoples R China.	caobinyun@126.com			National Support Program of China [2011BAD28B05-3]; national sparking plan project [2013GA850003]; Science and Technology Innovation Project of Shaanxi Province [2011KTCL02-09]; Northwest AF University [2013BSJJ003]; China Postdoctoral Science Foundation [2014M560808, 2014M552498]	National Support Program of China; national sparking plan project; Science and Technology Innovation Project of Shaanxi Province; Northwest AF University; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This study was supported by the National Support Program of China (2011BAD28B05-3), the national sparking plan project (2013GA850003), the Science and Technology Innovation Project of Shaanxi Province (2011KTCL02-09), the PhD Research Funding of Northwest A&F University (2013BSJJ003) and China Postdoctoral Science Foundation (2014M560808 and 2014M552498).	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Ardlie KG, 2002, NAT REV GENET, V3, P299, DOI 10.1038/nrg777; Bansal A, 2002, P NATL ACAD SCI USA, V99, P16871, DOI 10.1073/pnas.262671399; Bionaz M, 2008, J NUTR, V138, P1019, DOI 10.1093/jn/138.6.1019; Bionaz M, 2007, PHYSIOL GENOMICS, V29, P312, DOI 10.1152/physiolgenomics.00223.2006; BOTSTEIN D, 1980, AM J HUM GENET, V32, P314; Brodersen P, 2009, NAT REV MOL CELL BIO, V10, P141, DOI 10.1038/nrm2619; Clop A, 2006, NAT GENET, V38, P813, DOI 10.1038/ng1810; Dong Y, 2013, NAT BIOTECHNOL, V31, P135, DOI 10.1038/nbt.2478; Galio L, 2013, PHYSIOL GENOMICS, V45, P151, DOI 10.1152/physiolgenomics.00091.2012; Gao Q, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084355; Gaysina D, 2008, AM J MED GENET B, V147B, P699, DOI 10.1002/ajmg.b.30665; Goyette P, 1998, MAMM GENOME, V9, P652, DOI 10.1007/s003359900838; Huang T, 2011, J NUTR, V141, P654, DOI 10.3945/jn.110.134353; Ji ZB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049463; Lin XZ, 2013, GENE EXPRESSION, V16, P1, DOI 10.3727/105221613X13776146743262; Liu ME, 2013, ATHEROSCLEROSIS, V228, P161, DOI 10.1016/j.atherosclerosis.2013.01.036; Luo MF, 1989, ANIMAL HUSBANDRY VET, V1, P5; Menzies KK, 2009, FUNCT INTEGR GENOMIC, V9, P197, DOI 10.1007/s10142-008-0103-x; Nagaoka K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065127; Senhaji N, 2013, GENE, V521, P45, DOI 10.1016/j.gene.2013.02.046; Sun XH, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-194; Trott JF, 2014, ANIM GENET, V45, P74, DOI 10.1111/age.12100; Verbraak EJC, 2011, THERIOGENOLOGY, V75, P362, DOI 10.1016/j.theriogenology.2010.09.008; Wu C, 2013, NUTR METAB CARDIOVAS, V23, P693, DOI 10.1016/j.numecd.2012.02.009; Yamada K, 2001, P NATL ACAD SCI USA, V98, P14853, DOI 10.1073/pnas.261469998	26	21	23	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0133015	10.1371/journal.pone.0133015	http://dx.doi.org/10.1371/journal.pone.0133015			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RV	26186555	Green Published, gold, Green Submitted			2022-12-26	WOS:000358198700085
J	Song, ES; Ozbil, M; Zhang, TT; Sheetz, M; Lee, D; Tran, D; Li, S; Prabhakar, R; Hersh, LB; Rodgers, DW				Song, Eun Suk; Ozbil, Mehmet; Zhang, Tingting; Sheetz, Michael; Lee, David; Tran, Danny; Li, Sheng; Prabhakar, Rajeev; Hersh, Louis B.; Rodgers, David W.			An Extended Polyanion Activation Surface in Insulin Degrading Enzyme	PLOS ONE			English	Article							MASS-SPECTROMETRY; PROTEIN; EXCHANGE; RECOGNITION; SIMULATIONS; DEGRADATION; INSULYSIN; MODELS	Insulin degrading enzyme (IDE) is believed to be the major enzyme that metabolizes insulin and has been implicated in the degradation of a number of other bioactive peptides, including amyloid beta peptide (A beta), glucagon, amylin, and atrial natriuretic peptide. IDE is activated toward some substrates by both peptides and polyanions/anions, possibly representing an important control mechanism and a potential therapeutic target. A binding site for the polyanion ATP has previously been defined crystallographically, but mutagenesis studies suggest that other polyanion binding modes likely exist on the same extended surface that forms one wall of the substrate-binding chamber. Here we use a computational approach to define three potential ATP binding sites and mutagenesis and kinetic studies to confirm the relevance of these sites. Mutations were made at four positively charged residues (Arg 429, Arg 431, Arg 847, Lys 898) within the polyanion-binding region, converting them to polar or hydrophobic residues. We find that mutations in all three ATP binding sites strongly decrease the degree of activation by ATP and can lower basal activity and cooperativity. Computational analysis suggests conformational changes that result from polyanion binding as well as from mutating residues involved in polyanion binding. These findings indicate the presence of multiple polyanion binding modes and suggest the anion-binding surface plays an important conformational role in controlling IDE activity.	[Song, Eun Suk; Hersh, Louis B.] Univ Kentucky, Dept Mol & Cellular Biochem, Lexington, KY USA; [Song, Eun Suk; Hersh, Louis B.; Rodgers, David W.] Univ Kentucky, Struct Biol Ctr, Lexington, KY USA; [Ozbil, Mehmet; Zhang, Tingting; Prabhakar, Rajeev] Univ Miami, Dept Chem, Miami, FL 33124 USA; [Sheetz, Michael] Univ Kentucky, Ctr Computat Sci, Lexington, KY USA; [Lee, David; Tran, Danny; Li, Sheng] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA	University of Kentucky; University of Kentucky; University of Miami; University of Kentucky; University of California System; University of California San Diego	Prabhakar, R (corresponding author), Univ Miami, Dept Chem, Miami, FL 33124 USA.	rpr@miami.edu; lhersh@uky.edu; david.rodgers@uky.edu	Özbil, Mehmet/ABH-2905-2020; Ozbil, Mehmet/AAI-1882-2019	Özbil, Mehmet/0000-0002-1465-7674; Lee, David/0000-0001-7232-0968; Prabhakar, Rajeev/0000-0003-1137-1272	United States Department of Health and Human Services, National Institutes of Health [NS38041, DA02243, DA016176, GM110787, AI081982, GM020501, AI101436]; National Science Foundation [CHE1152846]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI101436, R01AI081982] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM110787] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R56NS038041, R01NS038041] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA002243, T32DA016176] Funding Source: NIH RePORTER; Direct For Mathematical & Physical Scien [1152846] Funding Source: National Science Foundation	United States Department of Health and Human Services, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This work was supported by United States Department of Health and Human Services, National Institutes of Health grants NS38041 (DWR); DA02243, DA016176, and GM110787 (LBH); and AI081982, GM020501, and AI101436 (SL). RP gratefully acknowledges support from the National Science Foundation (CHE1152846). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Daura X, 1999, PROTEINS, V34, P269, DOI 10.1002/(SICI)1097-0134(19990215)34:3<269::AID-PROT1>3.0.CO;2-3; de Tullio MB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059113; DUCKWORTH WC, 1994, J BIOL CHEM, V269, P24575; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Guo Q, 2010, J MOL BIOL, V395, P430, DOI 10.1016/j.jmb.2009.10.072; HAMEL FG, 1991, DIABETES, V40, P436, DOI 10.2337/diabetes.40.4.436; Hamuro Y, 2002, J MOL BIOL, V323, P871, DOI 10.1016/S0022-2836(02)01003-3; Hersh LB, 2006, CELL MOL LIFE SCI, V63, P2432, DOI 10.1007/s00018-006-6238-9; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; HOCKNEY RW, 1974, J COMPUT PHYS, V14, P148, DOI 10.1016/0021-9991(74)90010-2; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kim YG, 2013, NAT PROTOC, V8, P1730, DOI 10.1038/nprot.2013.104; Krieger E, 2002, BIOINFORMATICS, V18, P315, DOI 10.1093/bioinformatics/18.2.315; KUO WL, 1994, J BIOL CHEM, V269, P22599; Kurochkin IV, 1998, FEBS LETT, V427, P153, DOI 10.1016/S0014-5793(98)00422-0; Leissring MA, 2004, BIOCHEM J, V383, P439, DOI 10.1042/BJ20041081; Lindahl E, 2001, J MOL MODEL, V7, P306, DOI 10.1007/s008940100045; Manolopoulou M, 2009, J BIOL CHEM, V284, P14177, DOI 10.1074/jbc.M900068200; Marsh JJ, 2013, BIOCHEMISTRY-US, V52, P5491, DOI 10.1021/bi4007995; MIYAMOTO S, 1992, J COMPUT CHEM, V13, P952, DOI 10.1002/jcc.540130805; Noinaj N, 2012, J BIOL CHEM, V287, P48, DOI 10.1074/jbc.M111.264614; Noinaj N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020864; Oostenbrink C, 2004, J COMPUT CHEM, V25, P1656, DOI 10.1002/jcc.20090; Qiu WQ, 1998, J BIOL CHEM, V273, P32730, DOI 10.1074/jbc.273.49.32730; Rudovich N, 2009, J MOL MED, V87, P1145, DOI 10.1007/s00109-009-0540-6; Shen YQ, 2006, NATURE, V443, P870, DOI 10.1038/nature05143; Song ES, 2004, J BIOL CHEM, V279, P54216, DOI 10.1074/jbc.M411177200; Song ES, 2003, J BIOL CHEM, V278, P49789, DOI 10.1074/jbc.M308983200; Song ES, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046790; Song ES, 2011, J BIOL CHEM, V286, P13852, DOI 10.1074/jbc.M110.191668; Song ES, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009719; Sowole MA, 2014, ANAL CHEM, V86, P6715, DOI 10.1021/ac501849n; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Tundo GR, 2013, J BIOL CHEM, V288, P2281, DOI 10.1074/jbc.M112.393108; ZHANG ZQ, 1993, PROTEIN SCI, V2, P522	37	13	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0133114	10.1371/journal.pone.0133114	http://dx.doi.org/10.1371/journal.pone.0133114			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RV	26186535	gold, Green Published, Green Submitted			2022-12-26	WOS:000358198700093
J	Song, HD; Zhu, FQ				Song, Hyun Deok; Zhu, Fangqiang			Conformational Changes in Two Inter-Helical Loops of Mhp1 Membrane Transporter	PLOS ONE			English	Article							ALTERNATING-ACCESS MECHANISM; FREE-ENERGY CALCULATIONS; MOLECULAR-MECHANISM; BACTERIAL HOMOLOG; CRYSTAL-STRUCTURE; SODIUM SYMPORTER; OCCLUDED STATE; OUTWARD-OPEN; DYNAMICS; ION	Mhp1 is a bacterial secondary transporter with high-resolution crystal structures available for both the outward- and inward-facing conformations. Through molecular dynamics simulations of the ligand-free Mhp1 as well as analysis of its crystal structures, here we show that two inter-helical loops, respectively located at the extra-and intracellular ends of the "hash motif" in the protein, play important roles in the conformational transition. In the outward-and inward-facing states of the protein, the loops adopt different secondary structures, either wrapped to the end of an alpha-helix, or unwrapped to extended conformations. In equilibrium simulations of 100 ns with Mhp1 in explicit lipids and water, the loop conformations remain largely stable. In targeted molecular dynamics simulations with the protein structure driven from one state to the other, the loops exhibit resistance and only undergo abrupt changes when other parts of the protein already approach the target conformation. Free energy calculations on the isolated loops further confirm that the wrapping/unwrapping transitions are associated with substantial energetic barriers, and consist of multiple sequential steps involving the rotation of certain backbone torsion angles. Furthermore, in simulations with the loops driven from one state to the other, a large part of the protein follows the loops to the target conformation. Taken together, our simulations suggest that changes of the loop secondary structures would be among the slow degrees of freedom in the conformational transition of the entire protein. Incorporation of detailed loop structures into the reaction coordinate, therefore, should improve the convergence and relevance of the resulting conformational free energy.	[Song, Hyun Deok; Zhu, Fangqiang] Indiana Univ Purdue Univ, Dept Phys, Indianapolis, IN 46205 USA	Indiana University System; Indiana University-Purdue University Indianapolis	Zhu, FQ (corresponding author), Indiana Univ Purdue Univ, Dept Phys, Indianapolis, IN 46205 USA.	fzhu0@iupui.edu			Grants to Enhance Interdisciplinary Research and Education, Institute for Mathematical Modeling and Computational Science, School of Science, IUPUI; Release Time for Research, IUPUI	Grants to Enhance Interdisciplinary Research and Education, Institute for Mathematical Modeling and Computational Science, School of Science, IUPUI; Release Time for Research, IUPUI	This work was supported by the following: Grants to Enhance Interdisciplinary Research and Education, Institute for Mathematical Modeling and Computational Science, School of Science, IUPUI; and Release Time for Research, IUPUI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramson J, 2009, CURR OPIN STRUC BIOL, V19, P425, DOI 10.1016/j.sbi.2009.06.002; Adelman JL, 2011, BIOPHYS J, V101, P2399, DOI 10.1016/j.bpj.2011.09.061; Best RB, 2012, J CHEM THEORY COMPUT, V8, P3257, DOI 10.1021/ct300400x; Branduardi D, 2013, J CHEM THEORY COMPUT, V9, P4140, DOI 10.1021/ct400469w; Caplan DA, 2008, BIOPHYS J, V95, P4613, DOI 10.1529/biophysj.108.139741; Celik L, 2008, BIOPHYS J, V94, P1600, DOI 10.1529/biophysj.107.117580; Claxton DP, 2010, NAT STRUCT MOL BIOL, V17, P822, DOI 10.1038/nsmb.1854; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Faham S, 2008, SCIENCE, V321, P810, DOI 10.1126/science.1160406; FELLER SE, 1995, J CHEM PHYS, V103, P4613, DOI 10.1063/1.470648; Forrest LR, 2013, SCIENCE, V339, P399, DOI 10.1126/science.1228465; Forrest LR, 2011, BBA-BIOENERGETICS, V1807, P167, DOI 10.1016/j.bbabio.2010.10.014; Forrest LR, 2009, PHYSIOLOGY, V24, P377, DOI 10.1152/physiol.00030.2009; Fukunishi H, 2002, J CHEM PHYS, V116, P9058, DOI 10.1063/1.1472510; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Isralewitz B, 2001, CURR OPIN STRUC BIOL, V11, P224, DOI 10.1016/S0959-440X(00)00194-9; JARDETZK.O, 1966, NATURE, V211, P969, DOI 10.1038/211969a0; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Karney CFF, 2007, J MOL GRAPH MODEL, V25, P595, DOI 10.1016/j.jmgm.2006.04.002; Kazmier K, 2014, P NATL ACAD SCI USA, V111, P14752, DOI 10.1073/pnas.1410431111; Kazmier K, 2014, NAT STRUCT MOL BIOL, V21, P472, DOI 10.1038/nsmb.2816; Khavrutskii IV, 2006, J CHEM PHYS, V125, DOI 10.1063/1.2363379; Klauda JB, 2010, J PHYS CHEM B, V114, P7830, DOI 10.1021/jp101759q; Krishnamurthy H, 2012, NATURE, V481, P469, DOI 10.1038/nature10737; Krishnamurthy H, 2009, NATURE, V459, P347, DOI 10.1038/nature08143; Li J, 2013, P NATL ACAD SCI USA, V110, P7696, DOI 10.1073/pnas.1218986110; Li J, 2009, BIOPHYS J, V97, pL29, DOI 10.1016/j.bpj.2009.09.005; MacKerell AD, 2004, J AM CHEM SOC, V126, P698, DOI 10.1021/ja036959e; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Maragliano L, 2006, J CHEM PHYS, V125, DOI 10.1063/1.2212942; MIYAMOTO S, 1992, J COMPUT CHEM, V13, P952, DOI 10.1002/jcc.540130805; Moradi M, 2013, P NATL ACAD SCI USA, V110, P18916, DOI 10.1073/pnas.1313202110; Noskov SY, 2008, J MOL BIOL, V377, P804, DOI 10.1016/j.jmb.2008.01.015; Noskov SY, 2008, PROTEINS, V73, P851, DOI 10.1002/prot.22108; Ovchinnikov V, 2011, J CHEM PHYS, V134, DOI 10.1063/1.3544209; Perez C, 2012, NATURE, V490, P126, DOI 10.1038/nature11403; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Quick M, 2009, P NATL ACAD SCI USA, V106, P5563, DOI 10.1073/pnas.0811322106; Ressl S, 2009, NATURE, V458, P47, DOI 10.1038/nature07819; Rosta E, 2009, J COMPUT CHEM, V30, P1634, DOI 10.1002/jcc.21312; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Shi L, 2008, MOL CELL, V30, P667, DOI 10.1016/j.molcel.2008.05.008; Shi YG, 2013, ANNU REV BIOPHYS, V42, P51, DOI 10.1146/annurev-biophys-083012-130429; Shimamura T, 2010, SCIENCE, V328, P470, DOI 10.1126/science.1186303; Simmons KJ, 2014, EMBO J, V33, P1831, DOI 10.15252/embj.201387557; Song HD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068023; Suzuki S, 2006, J BACTERIOL, V188, P3329, DOI 10.1128/JB.188.9.3329-3336.2006; TANFORD C, 1983, P NATL ACAD SCI-BIOL, V80, P3701, DOI 10.1073/pnas.80.12.3701; Watanabe A, 2010, NATURE, V468, P988, DOI 10.1038/nature09580; Weinan E, 2002, PHYS REV B, V66, DOI 10.1103/PhysRevB.66.052301; Weyand S, 2008, SCIENCE, V322, P709, DOI [10.1126/science.1164440, 10.1126/science.1160058]; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; Zdravkovic I, 2012, BBA-BIOMEMBRANES, V1818, P337, DOI 10.1016/j.bbamem.2011.10.031; Zhao CF, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003296; Zhao CF, 2012, BIOPHYS J, V103, P878, DOI 10.1016/j.bpj.2012.07.044; Zhao YF, 2010, NATURE, V465, P188, DOI 10.1038/nature09057; Zhou Z, 2007, SCIENCE, V317, P1390, DOI 10.1126/science.1147614; Zhu FQ, 2012, J COMPUT CHEM, V33, P453, DOI 10.1002/jcc.21989; Zhu FQ, 2010, P NATL ACAD SCI USA, V107, P19814, DOI 10.1073/pnas.1009313107	59	6	6	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0133388	10.1371/journal.pone.0133388	http://dx.doi.org/10.1371/journal.pone.0133388			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RV	26186341	gold, Green Published, Green Submitted			2022-12-26	WOS:000358198700131
J	Stripp, ST; Lindenstrauss, U; Sawers, RG; Soboh, B				Stripp, Sven T.; Lindenstrauss, Ute; Sawers, R. Gary; Soboh, Basem			Identification of an Isothiocyanate on the HypEF Complex Suggests a Route for Efficient Cyanyl-Group Channeling during [NiFe]-Hydrogenase Cofactor Generation	PLOS ONE			English	Article							MATURATION PROTEINS HYPC; NIFE-HYDROGENASE; ACTIVE-SITE; CRYSTAL-STRUCTURES; ESCHERICHIA-COLI; INFRARED-SPECTRA; STRUCTURAL BASIS; ELECTRIC-FIELDS; MOLECULAR-BASIS; ISOMERIZATION	[NiFe]-hydrogenases catalyze uptake and evolution of H-2 in a wide range of microorganisms. The enzyme is characterized by an inorganic nickel/iron cofactor, the latter of which carries carbon monoxide and cyanide ligands. In vivo generation of these ligands requires a number of auxiliary proteins, the so-called Hyp family. Initially, HypF binds and activates the precursor metabolite carbamoyl phosphate. HypF catalyzes removal of phosphate and transfers the carbamate group to HypE. In an ATP-dependent condensation reaction, the C-terminal cysteinyl residue of HypE is modified to what has been interpreted as thiocyanate. This group is the direct precursor of the cyanide ligands of the [NiFe]-hydrogenase active site cofactor. We present a FT-IR analysis of HypE and HypF as isolated from E. coli. We follow the HypF-catalyzed cyanation of HypE in vitro and screen for the influence of carbamoyl phosphate and ATP. To elucidate on the differences between HypE and the HypEF complex, spectro-electrochemistry was used to map the vibrational Stark effect of naturally cyanated HypE. The IR signature of HypE could ultimately be assigned to isothiocyanate (-N=C=S) rather than thiocyanate (-S-C equivalent to N). This has important implications for cyanyl-group channeling during [NiFe]-hydrogenase cofactor generation.	[Stripp, Sven T.] Free Univ Berlin, Dept Phys, Berlin, Germany; [Lindenstrauss, Ute; Sawers, R. Gary; Soboh, Basem] Univ Halle Wittenberg, Inst Microbiol, D-06108 Halle, Germany	Free University of Berlin; Martin Luther University Halle Wittenberg	Stripp, ST (corresponding author), Free Univ Berlin, Dept Phys, Berlin, Germany.	sven.stripp@fu-berlin.de	Stripp, Sven Timo/O-9051-2019	Stripp, Sven Timo/0000-0002-8412-0258	Focus Area Nanoscale; EFRE; DFG [SA 494/3-2]	Focus Area Nanoscale; EFRE; DFG(German Research Foundation (DFG))	STS received funding from Focus Area Nanoscale (nanoscale.fu-berlin.de). RGS, BS, UL received funding from EFRE (foerderdatenbank.de) and DFG (Grant SA 494/3-2, dfg.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ataka K, 2013, BBA-BIOMEMBRANES, V1828, P2283, DOI 10.1016/j.bbamem.2013.04.026; Berggren G, 2013, NATURE, V499, P66, DOI 10.1038/nature12239; Blokesch M, 2004, EUR J BIOCHEM, V271, P3428, DOI 10.1111/j.1432-1033.2004.04280.x; Blokesch M, 2004, J MOL BIOL, V344, P155, DOI 10.1016/j.jmb.2004.09.040; Bockris JOM, 2002, INT J HYDROGEN ENERG, V27, P731, DOI 10.1016/S0360-3199(01)00154-9; Bock A, 2006, ADV MICROB PHYSIOL, V51, P1, DOI 10.1016/S0065-2911(06)51001-X; Boxall CR, 1973, J PHOTOCHEM, V1, P363; Brewer SH, 2003, J CHEM PHYS, V119, P851, DOI 10.1063/1.1578471; Bron M, 1999, ELECTROCHIM ACTA, V45, P1121, DOI 10.1016/S0013-4686(99)00302-3; Buckingham DA, 1970, INORG CHEM, V9, P655, DOI 10.1021/ic50085a044; BUCKINGHAM DA, 1994, COORDIN CHEM REV, V135, P587, DOI 10.1016/0010-8545(94)80078-2; Burstel I, 2012, J BIOL CHEM, V287, P38845, DOI 10.1074/jbc.M112.376947; Buhrke T, 2005, J BIOL CHEM, V280, P23791, DOI 10.1074/jbc.M503260200; BURMEISTER JL, 1968, COORDIN CHEM REV, V3, P225, DOI 10.1016/S0010-8545(00)80114-9; CALDOW GL, 1958, SPECTROCHIM ACTA, V13, P212, DOI 10.1016/0371-1951(58)80079-X; CLARK GR, 1970, INORG CHEM, V9, P2754; Colthup N.B., 1990, INTRO INFRARED RAMAN; Czech I, 2011, FEBS LETT, V585, P225, DOI 10.1016/j.febslet.2010.11.052; De Lacey AL, 2000, J AM CHEM SOC, V122, P11232, DOI 10.1021/ja002441o; Esselborn J, 2013, NAT CHEM BIOL, V9, P607, DOI [10.1038/NCHEMBIO.1311, 10.1038/nchembio.1311]; FORNES V, 1978, J CHEM PHYS, V68, P4667, DOI 10.1063/1.435576; Forzi L, 2007, BIOMETALS, V20, P565, DOI 10.1007/s10534-006-9048-5; Fritsch J, 2011, NATURE, V479, P249, DOI 10.1038/nature10505; GUTKNECHT J, 1982, BIOCHIM BIOPHYS ACTA, V685, P233, DOI 10.1016/0005-2736(82)90062-1; HAM NS, 1960, SPECTROCHIM ACTA, V16, P279, DOI 10.1016/0371-1951(60)80091-4; Hampp N, 2000, CHEM REV, V100, P1755, DOI 10.1021/cr980072x; HIRSCHMANN RP, 1965, SPECTROCHIM ACTA, V21, P2125, DOI 10.1016/0371-1951(65)80228-4; JACKSON WG, 1987, INORG CHEM, V26, P1286, DOI 10.1021/ic00255a019; KOPUT J, 1988, J MOL SPECTROSC, V127, P51, DOI 10.1016/0022-2852(88)90007-0; LAMBERT DK, 1984, SOLID STATE COMMUN, V51, P297, DOI 10.1016/0038-1098(84)90691-4; Li CL, 1999, STRUCTURE, V7, P1155, DOI 10.1016/S0969-2126(99)80182-8; LIEBER E, 1959, SPECTROCHIM ACTA, V13, P296, DOI 10.1016/0371-1951(59)80030-8; Lubitz W, 2014, CHEM REV, V114, P4081, DOI 10.1021/cr4005814; Ludwig M, 2009, J BIOL CHEM, V284, P2159, DOI 10.1074/jbc.M808488200; Maienschein-Cline MG, 2007, J PHYS CHEM A, V111, P10020, DOI 10.1021/jp0761158; Maroti G, 2010, INT J HYDROGEN ENERG, V35, P3358, DOI 10.1016/j.ijhydene.2009.10.059; Miles EW, 1999, J BIOL CHEM, V274, P12193, DOI 10.1074/jbc.274.18.12193; MIRABELLA FM, 1985, APPL SPECTROSC REV, V21, P45, DOI 10.1080/05704928508060428; Oh K-I, 2008, J CHEM PHYS, V128; OSAWA M, 1993, APPL SPECTROSC, V47, P1497, DOI 10.1366/0003702934067478; PALMER DA, 1978, INORG CHIM ACTA, V30, P83, DOI 10.1016/S0020-1693(00)89019-2; Park ES, 1999, J PHYS CHEM B, V103, P9813, DOI 10.1021/jp992329g; Paschos A, 2002, J BIOL CHEM, V277, P49945, DOI 10.1074/jbc.M204601200; Petkun S, 2011, STRUCTURE, V19, P1773, DOI 10.1016/j.str.2011.09.023; Pierik AJ, 1998, FEBS LETT, V438, P231, DOI 10.1016/S0014-5793(98)01306-4; Rangarajan ES, 2008, J BACTERIOL, V190, P1447, DOI 10.1128/JB.01610-07; Reissmann S, 2003, SCIENCE, V299, P1067, DOI 10.1126/science.1080972; Rotzinger FP, 2000, INORG CHEM, V39, P944, DOI 10.1021/ic990948y; Rotzinger FP, 2005, CHEM REV, V105, P2003, DOI 10.1021/cr030715v; Shafaat HS, 2013, BBA-BIOENERGETICS, V1827, P986, DOI 10.1016/j.bbabio.2013.01.015; Shepard EM, 2011, CURR OPIN CHEM BIOL, V15, P319, DOI 10.1016/j.cbpa.2011.02.012; Shomura Y, 2007, J MOL BIOL, V372, P1045, DOI 10.1016/j.jmb.2007.07.023; Shomura Y, 2012, J BIOL CHEM, V287, P28409, DOI 10.1074/jbc.M112.387134; Shomura Y, 2011, NATURE, V479, P253, DOI 10.1038/nature10504; SMITH PAS, 1960, J AM CHEM SOC, V82, P3076, DOI 10.1021/ja01497a025; Soboh B, 2013, ENCY INORGANIC BIOIN, P1; Soboh B, 2014, BIOCHEM J, V464, P169, DOI 10.1042/BJ20140485; Soboh B, 2012, FEBS LETT, V586, P3882, DOI 10.1016/j.febslet.2012.09.019; Stripp ST, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107488; Stripp ST, 2013, BIOCHEMISTRY-US, V52, P3289, DOI 10.1021/bi400302v; Stripp ST, 2009, DALTON T, P9960, DOI 10.1039/b916246a; Supuran CT, 2003, MED RES REV, V23, P146, DOI 10.1002/med.10025; Suydam IT, 2006, SCIENCE, V313, P200, DOI 10.1126/science.1127159; Suydam IT, 2003, BIOCHEMISTRY-US, V42, P12050, DOI 10.1021/bi0352926; Tominaga T, 2013, P NATL ACAD SCI USA, V110, P20485, DOI 10.1073/pnas.1313620110; Tominaga T, 2012, ACTA CRYSTALLOGR F, V68, P1153, DOI 10.1107/S1744309112036421; Vignais PM, 2004, CURR ISSUES MOL BIOL, V6, P159; Volbeda A, 2013, STRUCTURE, V21, P184, DOI 10.1016/j.str.2012.11.010; Volbeda A, 2012, P NATL ACAD SCI USA, V109, P5305, DOI 10.1073/pnas.1119806109; Watanabe S, 2007, MOL CELL, V27, P29, DOI 10.1016/j.molcel.2007.05.039; Watanabe S, 2012, STRUCTURE, V20, P2124, DOI 10.1016/j.str.2012.09.018; Watanabe S, 2012, BIOL CHEM, V393, P1089, DOI 10.1515/hsz-2012-0197; Wierzejewska M, 2003, J PHYS CHEM A, V107, P11209, DOI 10.1021/jp030971b; Winkler M, 2013, BBA-BIOENERGETICS, V1827, P974, DOI 10.1016/j.bbabio.2013.03.004	74	9	9	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0133118	10.1371/journal.pone.0133118	http://dx.doi.org/10.1371/journal.pone.0133118			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RV	26186649	Green Published, gold, Green Submitted			2022-12-26	WOS:000358198700095
J	Lu, L; Ku, KM; Palma-Salgado, SP; Storm, AP; Feng, H; Juvik, JA; Nguyen, TH				Lu, Lu; Ku, Kang-Mo; Palma-Salgado, Sindy Paola; Storm, Andrew Page; Feng, Hao; Juvik, John A.; Nguyen, Thanh H.			Influence of Epicuticular Physicochemical Properties on Porcine Rotavirus Adsorption to 24 Leafy Green Vegetables and Tomatoes	PLOS ONE			English	Article							NOROVIRUS DISEASE BURDEN; HEPATITIS-A-VIRUS; INACTIVATION KINETICS; SURFACE-ROUGHNESS; ENTERIC VIRUSES; ROMAINE LETTUCE; ORGANIC-MATTER; WATER; ATTACHMENT; FOOD	Foodborne diseases are a persistent problem in the United States and worldwide. Fresh produce, especially those used as raw foods like salad vegetables, can be contaminated, causing illness. In this study, we determined the number of rotaviruses adsorbed on produce surfaces using group A porcine rotaviruses and 24 cultivars of leafy vegetables and tomato fruits. We also characterized the physicochemical properties of each produce's outermost surface layer, known as the epicuticle. The number of rotaviruses found on produce surfaces varied among cultivars. Three-dimensional crystalline wax structures on the epicuticular surfaces were found to significantly contribute to the inhibition of viral adsorption to the produce surfaces (p = 0.01). We found significant negative correlations between the number of rotaviruses adsorbed on the epicuticular surfaces and the concentrations of alkanes, fatty acids, and total waxes on the epicuticular surfaces. Partial least square model fitting results suggest that alkanes, ketones, fatty acids, alcohols, contact angle and surface roughness together can explain 60% of the variation in viral adsorption. The results suggest that various fresh produce surface properties need to be collectively considered for efficient sanitation treatments. Up to 10.8% of the originally applied rotaviruses were found on the produce surfaces after three washing treatments, suggesting a potential public health concern regarding rotavirus contamination.	[Lu, Lu; Nguyen, Thanh H.] Univ Illinois, Dept Civil & Environm Engn, Urbana, IL 61801 USA; [Ku, Kang-Mo; Juvik, John A.] Univ Illinois, Dept Crop Sci, Urbana, IL USA; [Palma-Salgado, Sindy Paola; Feng, Hao] Univ Illinois, Dept Food Sci & Human Nutr, Urbana, IL USA; [Storm, Andrew Page] Univ Illinois, Dept Mol & Cellular Biol, Urbana, IL USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Nguyen, TH (corresponding author), Univ Illinois, Dept Civil & Environm Engn, Urbana, IL 61801 USA.	thn@illinois.edu	nguyen, thanh/G-1792-2017	, Hao/0000-0002-1703-2194; Ku, Kang Mo/0000-0002-8588-1163; nguyen, thanh/0000-0002-5461-5233	USDA National Institute of Food and Agriculture [ILLU-000-615]	USDA National Institute of Food and Agriculture(United States Department of Agriculture (USDA))	This work was supported by the USDA National Institute of Food and Agriculture grant ILLU-000-615 to THN, JAJ and HF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armah GE, 2010, LANCET, V376, P606, DOI 10.1016/S0140-6736(10)60889-6; Bargel H., 2004, EVOLUTION PLANT PHYS, P171, DOI DOI 10.1016/B978-012339552-8/50011-1; Barker SF, 2013, WATER RES, V47, P1421, DOI 10.1016/j.watres.2012.12.012; Berger CN, 2010, ENVIRON MICROBIOL, V12, P2385, DOI 10.1111/j.1462-2920.2010.02297.x; BOYCE RL, 1988, CAN J BOT, V66, P2599, DOI 10.1139/b88-353; Bozkurt H, 2015, INT J FOOD MICROBIOL, V193, P147, DOI 10.1016/j.ijfoodmicro.2014.10.015; Carter MJ, 2005, J APPL MICROBIOL, V98, P1354, DOI 10.1111/j.1365-2672.2005.02635.x; Cox I, 2013, DISCOVERING PARTIAL; D'Souza DH, 2006, INT J FOOD MICROBIOL, V108, P84, DOI 10.1016/j.ijfoodmicro.2005.10.024; Deboosere N, 2012, FOOD MICROBIOL, V32, P48, DOI 10.1016/j.fm.2012.04.007; Ensikat HJ, 2006, CHEM PHYS LIPIDS, V144, P45, DOI 10.1016/j.chemphyslip.2006.06.016; Eriksson L., 2006, MULTIMEGAVARIATE DAT; Esseili MA, 2012, APPL ENVIRON MICROB, V78, P6271, DOI 10.1128/AEM.01295-12; Esseili MA, 2012, APPL ENVIRON MICROB, V78, P786, DOI 10.1128/AEM.07081-11; Feikin DR, 2012, VACCINE, V30, pA52, DOI 10.1016/j.vaccine.2011.08.043; Fransisca L, 2012, J FOOD PROTECT, V75, P261, DOI 10.4315/0362-028X.JFP-11-279; Gniwotta F, 2005, PLANT PHYSIOL, V139, P519, DOI 10.1104/pp.104.053579; Gutierrez L, 2012, ENVIRON SCI TECHNOL, V46, P8705, DOI 10.1021/es301336u; Gutierrez L, 2010, ENVIRON SCI TECHNOL, V44, P4552, DOI 10.1021/es100120k; Gutierrez L, 2009, WATER RES, V43, P5198, DOI 10.1016/j.watres.2009.08.031; Hirneisen KA, 2013, PHYTOPATHOLOGY, V103, P389, DOI 10.1094/PHYTO-09-12-0231-FI; Jenks MA, 2010, HORTICULTURAL REV, P1; Jothikumar N, 2009, J VIROL METHODS, V155, P126, DOI 10.1016/j.jviromet.2008.09.025; Kiulia NM, 2010, J APPL MICROBIOL, V109, P818, DOI 10.1111/j.1365-2672.2010.04710.x; Koch K, 2008, SOFT MATTER, V4, P1943, DOI 10.1039/b804854a; Kosma DK, 2009, PLANT PHYSIOL, V151, P1918, DOI 10.1104/pp.109.141911; Kukavica-Ibrulj I, 2004, J APPL MICROBIOL, V97, P923, DOI 10.1111/j.1365-2672.2004.02366.x; Lou FF, 2011, APPL ENVIRON MICROB, V77, P8538, DOI 10.1128/AEM.06711-11; Madhi SA, 2010, NEW ENGL J MED, V362, P289, DOI 10.1056/NEJMoa0904797; Maffei M, 1996, BIOCHEM SYST ECOL, V24, P53, DOI 10.1016/0305-1978(95)00102-6; Maimon A, 2014, SCI TOTAL ENVIRON, V487, P20, DOI 10.1016/j.scitotenv.2014.03.133; Marshall GS, 2009, PEDIATR INFECT DIS J, V28, P355, DOI 10.1097/INF.0b013e318199494a; Mattioli MC, 2013, ENVIRON SCI TECHNOL, V47, P355, DOI 10.1021/es303878d; Mok HF, 2014, RISK ANAL, V34, P602, DOI 10.1111/risa.12178; Mok HF, 2014, WATER RES, V54, P347, DOI 10.1016/j.watres.2014.01.060; Painter JA, 2013, EMERG INFECT DIS, V19, P407, DOI 10.3201/eid1903.111866; Pathan AK, 2010, MATER TODAY, V12, P32, DOI 10.1016/S1369-7021(10)70143-7; Rhee Y, 1998, PLANT PHYSIOL, V116, P901, DOI 10.1104/pp.116.3.901; ROLSMA MD, 1994, J VIROL, V68, P258, DOI 10.1128/JVI.68.1.258-268.1994; Romero OC, 2011, ENVIRON SCI TECHNOL, V45, P10385, DOI 10.1021/es202067f; Romero-Maraccini OC, 2013, ENVIRON SCI TECHNOL, V47, P11004, DOI 10.1021/es402285u; Ruiz MC, 1996, J VIROL, V70, P4877, DOI 10.1128/JVI.70.8.4877-4883.1996; Scallan E, 2011, EMERG INFECT DIS, V17, P7, DOI 10.3201/eid1701.P11101; SCANION JT, 1985, J CHROMATOGR SCI, V23, P333, DOI 10.1093/chromsci/23.8.333; Seo PJ, 2011, PLANT CELL, V23, P1138, DOI 10.1105/tpc.111.083485; Symonds EM, 2014, WATER RES, V65, P257, DOI 10.1016/j.watres.2014.07.032; Trdan S., 2004, Acta Phytopathologica et Entomologica Hungarica, V39, P173, DOI 10.1556/APhyt.39.2004.1-3.17; U. S. Food and Drug Administration, 2004, PROD SAF PROD CONS 2; van Zyl WB, 2006, APPL ENVIRON MICROB, V72, P4554, DOI 10.1128/AEM.02119-05; Vega E, 2005, J FOOD PROTECT, V68, P2112, DOI 10.4315/0362-028X-68.10.2112; Vega E, 2008, J FOOD PROTECT, V71, P522, DOI 10.4315/0362-028X-71.3.522; Vogg G, 2004, J EXP BOT, V55, P1401, DOI 10.1093/jxb/erh149; Wang H, 2009, J FOOD SCI, V74, pE8, DOI 10.1111/j.1750-3841.2008.00998.x; Wei J, 2010, APPL ENVIRON MICROB, V76, P578, DOI 10.1128/AEM.02088-09; Wen M, 2009, J EXP BOT, V60, P1811, DOI 10.1093/jxb/erp061; Yuan Y., 2013, SURFACE SCI TECHNIQU, P3, DOI 10.1007/978-3-642-34243-1_1; Zaman K, 2010, LANCET, V376, P615, DOI 10.1016/S0140-6736(10)60755-6	57	21	21	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2015	10	7							e0132841	10.1371/journal.pone.0132841	http://dx.doi.org/10.1371/journal.pone.0132841			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RQ	26181904	Green Published, Green Submitted, gold			2022-12-26	WOS:000358198200042
J	Roy, D; Kumar, V; James, J; Shihabudeen, MS; Kulshrestha, S; Goel, V; Thirumurugan, K				Roy, Debasish; Kumar, Vinod; James, Joel; Shihabudeen, Mohamed Sham; Kulshrestha, Shweta; Goel, Varun; Thirumurugan, Kavitha			Evidence that Chemical Chaperone 4-Phenylbutyric Acid Binds to Human Serum Albumin at Fatty Acid Binding Sites	PLOS ONE			English	Article							MOLECULAR-DYNAMICS; ER STRESS; HEMOGLOBIN; QUERCETIN	Endoplasmic reticulum stress elicits unfolded protein response to counteract the accumulating unfolded protein load inside a cell. The chemical chaperone, 4-Phenylbutyric acid (4-PBA) is a FDA approved drug that alleviates endoplasmic reticulum stress by assisting protein folding. It is found efficacious to augment pathological conditions like type 2 diabetes, obesity and neurodegeneration. This study explores the binding nature of 4-PBA with human serum albumin (HSA) through spectroscopic and molecular dynamics approaches, and the results show that 4-PBA has high binding specificity to Sudlow Site II (Fatty acid binding site 3, subdomain IIIA). Ligand displacement studies, RMSD stabilization profiles and MM-PBSA binding free energy calculation confirm the same. The binding constant as calculated from fluorescence spectroscopic studies was found to be k(PBA) = 2.69 x 10(5) M-1. Like long chain fatty acids, 4-PBA induces conformational changes on HSA as shown by circular dichroism, and it elicits stable binding at Sudlow Site II (fatty acid binding site 3) by forming strong hydrogen bonding and a salt bridge between domain II and III of HSA. This minimizes the fluctuation of HSA backbone as shown by limited conformational space occupancy in the principal component analysis. The overall hydrophobicity of W214 pocket (located at subdomain IIA), increases upon occupancy of 4-PBA at any FA site. Descriptors of this pocket formed by residues from other subdomains largely play a role in compensating the dynamic movement of W214.	[Roy, Debasish; Kumar, Vinod; James, Joel; Shihabudeen, Mohamed Sham; Kulshrestha, Shweta; Goel, Varun; Thirumurugan, Kavitha] VIT Univ, Ctr Biomed Res, Sch BioSci & Technol, Div Biomed Sci,Struct Biol Lab 206, Vellore 632014, Tamil Nadu, India	Vellore Institute of Technology	Thirumurugan, K (corresponding author), VIT Univ, Ctr Biomed Res, Sch BioSci & Technol, Div Biomed Sci,Struct Biol Lab 206, Vellore 632014, Tamil Nadu, India.	m.kavitha@vit.ac.in	Thirumurugan, Kavitha/B-3282-2010; James, Joel/X-8792-2019	Thirumurugan, Kavitha/0000-0002-4673-4099; Haider Ali, Mohamed Sham Shihabudeen/0000-0002-2847-8140; Kulshrestha, Shweta/0000-0001-6232-8771; Roy, Debasish/0000-0001-7516-8615	VIT University	VIT University	We thank VIT University for supporting this work. We thank Bioinformatics Resources and Applications Facility (BRAF) supercomputing facility at C-DAC (Pune and Bangalore) for providing grid facilities to carry out this work. We thank Dr. Bhaskar Mohan Murari and Prof. G. Jayaraman, VIT University for facilitating the fluorescence and CD studies.	Back SH, 2012, ANNU REV BIOCHEM, V81, P767, DOI 10.1146/annurev-biochem-072909-095555; Bhattacharya AA, 2000, J BIOL CHEM, V275, P38731, DOI 10.1074/jbc.M005460200; BHATTACHARYYA J, 1994, BIOCHEM PHARMACOL, V47, P2049, DOI 10.1016/0006-2952(94)90080-9; Boden G, 2008, ENDOCRIN METAB CLIN, V37, P635, DOI 10.1016/j.ecl.2008.06.007; CARTER DC, 1994, ADV PROTEIN CHEM, V45, P153; Curry S, 1999, BBA-MOL CELL BIOL L, V1441, P131, DOI 10.1016/S1388-1981(99)00148-1; Curry S, 1998, NAT STRUCT BIOL, V5, P827, DOI 10.1038/1869; Guizado TRC, 2012, EUR BIOPHYS J BIOPHY, V41, P1033, DOI 10.1007/s00249-012-0860-2; Domonkos C, 2013, MOL PHARMACEUT, V10, P4706, DOI 10.1021/mp400531n; DOVER GJ, 1994, BLOOD, V84, P339; Dufour C, 2005, BBA-GEN SUBJECTS, V1721, P164, DOI 10.1016/j.bbagen.2004.10.013; Fanali G, 2012, MOL ASPECTS MED, V33, P209, DOI 10.1016/j.mam.2011.12.002; FEHSKE KJ, 1982, MOL PHARMACOL, V21, P387; Fujiwara SI, 2008, BIOPHYS J, V94, P95, DOI 10.1529/biophysj.107.111377; Fujiwara SI, 2006, PROTEINS, V64, P730, DOI 10.1002/prot.21053; Ghuman J, 2005, J MOL BIOL, V353, P38, DOI 10.1016/j.jmb.2005.07.075; Graciani FS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076849; He WY, 2006, J PHOTOCH PHOTOBIO A, V182, P158, DOI 10.1016/j.jphotochem.2006.02.004; HE XM, 1992, NATURE, V358, P209, DOI 10.1038/358209a0; Hess B, 2000, PHYS REV E, V62, P8438, DOI 10.1103/PhysRevE.62.8438; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Iranfar H, 2012, J PHYS CHEM B, V116, P1951, DOI 10.1021/jp210685q; KRAGHHANSEN U, 1990, DAN MED BULL, V37, P57; Lindholm D, 2006, CELL DEATH DIFFER, V13, P385, DOI 10.1038/sj.cdd.4401778; Maestri NE, 1996, NEW ENGL J MED, V335, P855, DOI 10.1056/NEJM199609193351204; Oltersdorf T, 2005, NATURE, V435, P677, DOI 10.1038/nature03579; Pongprayoon P, 2014, J MOL GRAPH MODEL, V54, P164, DOI 10.1016/j.jmgm.2014.10.007; Sengupta B, 2003, BIOPOLYMERS, V72, P427, DOI 10.1002/bip.10489; Sengupta B, 2002, BIOCHEM BIOPH RES CO, V299, P400, DOI 10.1016/S0006-291X(02)02667-0; Sousa da Silva Alan W, 2012, BMC Res Notes, V5, P367, DOI 10.1186/1756-0500-5-367; Spitaleri, 2015, COMPUT PHYS COMMUN, V186, P105, DOI [10.1016/j.cpc.2014.09.010, DOI 10.1016/J.CPC.2014.09.010]; Subramanyam R, 2009, J PHOTOCH PHOTOBIO B, V94, P8, DOI 10.1016/j.jphotobiol.2008.09.002; Thumser AEA, 1998, J LIPID RES, V39, P1033; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Yoshida H, 2007, FEBS J, V274, P630, DOI 10.1111/j.1742-4658.2007.05639.x; Zsila F, 2013, MOL PHARMACEUT, V10, P1668, DOI 10.1021/mp400027q	37	26	27	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2015	10	7							e0133012	10.1371/journal.pone.0133012	http://dx.doi.org/10.1371/journal.pone.0133012			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RQ	26181488	Green Published, gold, Green Submitted			2022-12-26	WOS:000358198200049
J	Borisova, AS; Isaksen, T; Dimarogona, M; Kognole, AA; Mathiesen, G; Varnai, A; Rohr, AK; Payne, CM; Sorlie, M; Sandgren, M; Eijsink, VGH				Borisova, Anna S.; Isaksen, Trine; Dimarogona, Maria; Kognole, Abhishek A.; Mathiesen, Geir; Varnai, Aniko; Rohr, Asmund K.; Payne, Christina M.; Sorlie, Morten; Sandgren, Mats; Eijsink, Vincent G. H.			Structural and Functional Characterization of a Lytic Polysaccharide Monooxygenase with Broad Substrate Specificity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELLO-OLIGOSACCHARIDES; CELLULOSE DEGRADATION; TRICHODERMA-REESEI; NEUROSPORA-CRASSA; ENZYMATIC-HYDROLYSIS; PICHIA-PASTORIS; BINDING; ENZYMES; PROTEINS; FAMILY	The recently discovered lytic polysaccharide monooxygenases (LPMOs) carry out oxidative cleavage of polysaccharides and are of major importance for efficient processing of biomass. NcLPMO9C from Neurospora crassa acts both on cellulose and on non-cellulose beta-glucans, including cellodextrins and xyloglucan. The crystal structure of the catalytic domain of NcLPMO9C revealed an extended, highly polar substrate-binding surface well suited to interact with a variety of sugar substrates. The ability of NcLPMO9C to act on soluble substrates was exploited to study enzyme-substrate interactions. EPR studies demonstrated that the Cu2+-center environment is altered upon substrate binding, whereas isothermal titration calorimetry studies revealed binding affinities in the low micromolar range for polymeric substrates that are due in part to the presence of a carbohydrate-binding module (CBM1). Importantly, the novel structure of NcLPMO9Cenabled a comparative study, revealing that the oxidative regioselectivity of LPMO9s (C1, C4, or both) correlates with distinct structural features of the copper coordination sphere. In strictly C1-oxidizing LPMO9s, access to the solvent-facing axial coordination position is restricted by a conserved tyrosine residue, whereas access to this same position seems unrestricted in C4-oxidizing LPMO9s. LPMO9s known to produce a mixture of C1- and C4- oxidized products show an intermediate situation.	Swedish Univ Agr Sci, Dept Chem & Biotechnol, SE-75007 Uppsala, Sweden; [Isaksen, Trine; Mathiesen, Geir; Varnai, Aniko; Sorlie, Morten; Eijsink, Vincent G. H.] Norwegian Univ Life Sci, Dept Chem Biotechnol & Food Sci, N-1432 As, Norway; [Rohr, Asmund K.] Univ Oslo, Dept Biosci, N-0316 Oslo, Norway; [Payne, Christina M.] Univ Kentucky, Dept Chem & Mat Engn, Lexington, KY 40506 USA	Swedish University of Agricultural Sciences; Norwegian University of Life Sciences; University of Oslo; University of Kentucky	Sandgren, M (corresponding author), Swedish Univ Agr Sci, Dept Chem & Biotechnol, SE-75007 Uppsala, Sweden.	mats.sandgren@slu.se; vincent.eijsink@nmbu.no	Payne, Christina/ABE-8330-2020; Kjendseth, Åsmund Røhr/O-2543-2016; Várnai, Anikó/Z-3190-2019; Payne, Christina M/C-7338-2011; Kognole, Abhishek A./AAB-5491-2019	Payne, Christina/0000-0001-5264-0964; Kjendseth, Åsmund Røhr/0000-0002-4956-4865; Várnai, Anikó/0000-0002-2796-514X; Payne, Christina M/0000-0001-5264-0964; Kognole, Abhishek A./0000-0002-6033-2344; Sandgren, Mats/0000-0002-2358-4534; Dimarogona, Maria/0000-0002-5663-1421; Borisova, Anna/0000-0002-3414-9888	National Science Foundation [ACI-1053575, TG-MCB090159]	National Science Foundation(National Science Foundation (NSF))	C. M. P. and A. A. K. thank the August T. Larsson Guest Researcher Programme at the Swedish University of Agricultural Sciences for the opportunity to work alongside the Sandgren and Stahlberg research groups. Computational time for this research was provided in part by the National Science Foundation through Extreme Science and Engineering Discovery Environment, which is supported by National Science Foundation Grant number ACI-1053575 under allocation number TG-MCB090159.	Aachmann FL, 2012, P NATL ACAD SCI USA, V109, P18779, DOI 10.1073/pnas.1208822109; Agger JW, 2014, P NATL ACAD SCI USA, V111, P6287, DOI 10.1073/pnas.1323629111; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Beeson WT, 2012, J AM CHEM SOC, V134, P890, DOI 10.1021/ja210657t; Cannella D, 2012, BIOTECHNOL BIOFUELS, V5, DOI 10.1186/1754-6834-5-26; Colussi F, 2015, J BIOL CHEM, V290, P2444, DOI 10.1074/jbc.M114.624163; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans PR, 2011, ACTA CRYSTALLOGR D, V67, P282, DOI 10.1107/S090744491003982X; Forsberg Z, 2014, P NATL ACAD SCI USA, V111, P8446, DOI 10.1073/pnas.1402771111; Forsberg Z, 2014, BIOCHEMISTRY-US, V53, P1647, DOI 10.1021/bi5000433; Forsberg Z, 2011, PROTEIN SCI, V20, P1479, DOI 10.1002/pro.689; Gasteiger E., 2005, PROTEOMICS PROTOC HD, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Gudmundsson M, 2014, J BIOL CHEM, V289, P18782, DOI 10.1074/jbc.M114.563494; Guo J, 2013, BIOMACROMOLECULES, V14, P1268, DOI 10.1021/bm300810t; Harris PV, 2010, BIOCHEMISTRY-US, V49, P3305, DOI 10.1021/bi100009p; Hemsworth GR, 2013, CURR OPIN STRUC BIOL, V23, P660, DOI 10.1016/j.sbi.2013.05.006; Hemsworth GR, 2013, J AM CHEM SOC, V135, P6069, DOI 10.1021/ja402106e; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Holt BTO, 2007, BIOCHEMISTRY-US, V46, P8816, DOI 10.1021/bi7007195; Horn SJ, 2012, BIOTECHNOL BIOFUELS, V5, DOI 10.1186/1754-6834-5-45; Isaksen T, 2014, J BIOL CHEM, V289, P2632, DOI 10.1074/jbc.M113.530196; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kim S, 2014, P NATL ACAD SCI USA, V111, P149, DOI 10.1073/pnas.1316609111; Kittl R, 2012, BIOTECHNOL BIOFUELS, V5, DOI 10.1186/1754-6834-5-79; Kjaergaard CH, 2014, P NATL ACAD SCI USA, V111, P8797, DOI 10.1073/pnas.1408115111; Kleywegt GJ, 1996, STRUCTURE, V4, P1395, DOI 10.1016/S0969-2126(96)00147-5; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Langston JA, 2011, APPL ENVIRON MICROB, V77, P7007, DOI 10.1128/AEM.05815-11; Levasseur A, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-41; Li X, 2012, STRUCTURE, V20, P1051, DOI 10.1016/j.str.2012.04.002; Liu YN, 1997, ANAL BIOCHEM, V250, P196, DOI 10.1006/abio.1997.2222; Loose JSM, 2014, FEBS LETT, V588, P3435, DOI 10.1016/j.febslet.2014.07.036; Mattinen ML, 1998, EUR J BIOCHEM, V256, P279, DOI 10.1046/j.1432-1327.1998.2560279.x; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Morgenstern I, 2014, BRIEF FUNCT GENOMICS, V13, P471, DOI 10.1093/bfgp/elu032; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Phillips CM, 2011, ACS CHEM BIOL, V6, P1399, DOI 10.1021/cb200351y; Quinlan RJ, 2011, P NATL ACAD SCI USA, V108, P15079, DOI 10.1073/pnas.1105776108; REINIKAINEN T, 1992, PROTEINS, V14, P475, DOI 10.1002/prot.340140408; Sorlie M, 2000, ANAL BIOCHEM, V287, P118, DOI 10.1006/abio.2000.4826; Stoll S, 2006, J MAGN RESON, V178, P42, DOI 10.1016/j.jmr.2005.08.013; Sygmund C, 2012, APPL ENVIRON MICROB, V78, P6161, DOI 10.1128/AEM.01503-12; Turnbull WB, 2003, J AM CHEM SOC, V125, P14859, DOI 10.1021/ja036166s; Vaaje-Kolstad G, 2010, SCIENCE, V330, P219, DOI 10.1126/science.1192231; Varnai A, 2014, MICROB CELL FACT, V13, DOI 10.1186/1475-2859-13-57; Vermaas JV, 2015, J PHYS CHEM B, V119, P6129, DOI 10.1021/acs.jpcb.5b00778; Vu VV, 2014, P NATL ACAD SCI USA, V111, P13822, DOI 10.1073/pnas.1408090111; Vu VV, 2014, J AM CHEM SOC, V136, P562, DOI 10.1021/ja409384b; Westereng B, 2013, J CHROMATOGR A, V1271, P144, DOI 10.1016/j.chroma.2012.11.048; Westereng B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027807; WISEMAN T, 1989, ANAL BIOCHEM, V179, P131, DOI 10.1016/0003-2697(89)90213-3; WOOD TM, 1988, METHOD ENZYMOL, V160, P19; Wu M, 2013, J BIOL CHEM, V288, P12828, DOI 10.1074/jbc.M113.459396; Zhang YHP, 2005, BIOMACROMOLECULES, V6, P1510, DOI 10.1021/bm049235j	57	123	130	3	83	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2015	290	38					22955	22969		10.1074/jbc.M115.660183	http://dx.doi.org/10.1074/jbc.M115.660183			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CR9OE	26178376	Green Published, hybrid			2022-12-26	WOS:000361685500009
J	D'Anna, C; Schmid, M; Bibbo, D; Bertollo, M; Comani, S; Conforto, S				D'Anna, Carmen; Schmid, Maurizio; Bibbo, Daniele; Bertollo, Maurizio; Comani, Silvia; Conforto, Silvia			The Effect of Continuous and Discretized Presentations of Concurrent Augmented Visual Biofeedback on Postural Control in Quiet Stance	PLOS ONE			English	Article							STANDING BALANCE; STROKE PATIENTS; HEALTHY-ADULTS; UPRIGHT STANCE; EXTERNAL-FOCUS; OLDER-ADULTS; FEEDBACK; SWAY; PRESSURE; YOUNG	The purpose of this study was to evaluate the effect of a continuous and a discretized Visual Biofeedback (VBF) on balance performance in upright stance. The coordinates of the Centre of Pressure (CoP), extracted from a force plate, were processed in real-time to implement the two VBFs, administered to two groups of 12 healthy participants. In the first group, a representation of the CoP was continuously shown, while in the second group, the discretized VBF was provided at an irregular frequency (that depended on the subject's performance) by displaying one out of a set of five different emoticons, each corresponding to a specific area covered by the current position of the CoP. In the first case, participants were asked to maintain a white spot within a given square area, whereas in the second case they were asked to keep the smiling emoticon on. Trials with no VBF were administered as control. The effect of the two VBFs on balance was studied through classical postural parameters and a subset of stabilogram diffusion coefficients. To quantify the amount of time spent in stable conditions, the percentage of time during which the CoP was inside the stability area was calculated. Both VBFs improved balance maintainance as compared to the absence of any VBF. As compared to the continuous VBF, in the discretized VBF a significant decrease of sway path, diffusion and Hurst coefficients was found. These results seem to indicate that a discretized VBF favours a more natural postural behaviour by promoting a natural intermittent postural control strategy.	[D'Anna, Carmen; Schmid, Maurizio; Bibbo, Daniele; Conforto, Silvia] Roma Tre Univ, Dept Engn, Rome, Italy; [Bertollo, Maurizio] Univ G DAnnunzio, Dept Basic & Appl Med Sci, Chieti, Italy; [Comani, Silvia] Univ G DAnnunzio, Dept Neurosci & Imaging, Chieti, Italy; [D'Anna, Carmen; Schmid, Maurizio; Bibbo, Daniele; Bertollo, Maurizio; Comani, Silvia; Conforto, Silvia] Univ G DAnnunzio, Behav Imaging & Neural Dynam Ctr BIND, Chieti, Italy	Roma Tre University; G d'Annunzio University of Chieti-Pescara; G d'Annunzio University of Chieti-Pescara; G d'Annunzio University of Chieti-Pescara	D'Anna, C (corresponding author), Roma Tre Univ, Dept Engn, Rome, Italy.	carmen.danna@uniroma3.it	D'Anna, Carmen/AAE-1667-2019; Schmid, Maurizio/E-5140-2010; D'Anna, Carolina/P-3831-2019; Bertollo, Maurizio/K-5469-2013	D'Anna, Carmen/0000-0003-3271-3075; Schmid, Maurizio/0000-0003-3380-6994; Bertollo, Maurizio/0000-0002-0972-9178; COMANI, Silvia/0000-0001-8100-457X; Bibbo, Daniele/0000-0003-1341-5427				Asai Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006169; Balasubramaniam R, 2002, TRENDS COGN SCI, V6, P531, DOI 10.1016/S1364-6613(02)02021-1; Bechly KE, 2013, GAIT POSTURE, V37, P391, DOI 10.1016/j.gaitpost.2012.08.007; Bibbo D, 2012, PROC SPIE, V8295, DOI 10.1117/12.910605; Borg G, 2001, INT J SPORT PSYCHOL, V32, P110; Bottaro A, 2008, HUM MOVEMENT SCI, V27, P473, DOI 10.1016/j.humov.2007.11.005; Caudron S, 2014, NEUROPHYSIOL CLIN, V44, P77, DOI 10.1016/j.neucli.2013.10.134; Cawsey RP, 2009, GAIT POSTURE, V29, P280, DOI 10.1016/j.gaitpost.2008.09.007; Chiari L, 2000, GAIT POSTURE, V12, P225, DOI 10.1016/S0966-6362(00)00086-2; COLLINS JJ, 1995, EXP BRAIN RES, V103, P151, DOI 10.1007/BF00241972; Conforto S, 2001, GAIT POSTURE, V14, P28, DOI 10.1016/S0966-6362(01)00112-6; D'Anna C, 2014, 13 MED C MED BIOL EN, P1755; Dault MC, 2003, HUM MOVEMENT SCI, V22, P221, DOI 10.1016/S0167-9457(03)00034-4; Davis JR, 2010, GAIT POSTURE, V31, P465, DOI 10.1016/j.gaitpost.2010.02.002; DIENER HC, 1988, PROG BRAIN RES, V76, P253; Dozza M, 2005, ARCH PHYS MED REHAB, V86, P1401, DOI 10.1016/j.apmr.2004.12.036; Gawthrop P, 2011, BIOL CYBERN, V104, P31, DOI 10.1007/s00422-010-0416-4; Geiger RA, 2001, PHYS THER, V81, P995, DOI 10.1093/ptj/81.4.995; Goffredo M, 2006, MED ENG PHYS, V28, P719, DOI 10.1016/j.medengphy.2005.10.007; Goldie PA, 1996, CLIN BIOMECH, V11, P333, DOI 10.1016/0268-0033(96)00014-9; Hagger MS, 2001, J SPORT SCI, V19, P711, DOI 10.1080/02640410152475847; Halicka Z, 2014, GAIT POSTURE, V39, P410, DOI 10.1016/j.gaitpost.2013.08.005; Ikegami T, 2012, J NEUROSCI, V32, P653, DOI 10.1523/JNEUROSCI.4230-11.2012; Insperger T, 2006, IEEE T CONTR SYST T, V14, P974, DOI 10.1109/TCST.2006.876938; Kamen G, 1998, GERONTOLOGY, V44, P40, DOI 10.1159/000021981; Kapteyn T S, 1983, Agressologie, V24, P321; Kiemel T, 2002, BIOL CYBERN, V87, P262, DOI 10.1007/s00422-002-0333-2; Kiemel T, 2008, J NEUROPHYSIOL, V100, P3394, DOI 10.1152/jn.01272.2007; Laurens J, 2010, GAIT POSTURE, V31, P37, DOI 10.1016/j.gaitpost.2009.08.241; Loram ID, 2011, J PHYSIOL-LONDON, V589, P307, DOI 10.1113/jphysiol.2010.194712; Murnaghan CD, 2014, J NEUROPHYSIOL, V111, P1920, DOI 10.1152/jn.00853.2012; Nichols DS, 1997, PHYS THER, V77, P553, DOI 10.1093/ptj/77.5.553; Paillex R, 2005, GAIT POSTURE, V21, P403, DOI 10.1016/j.gaitpost.2004.04.011; Peterka RJ, 1998, IDENTIFYING CONTROL, P73; Pollock AS, 2000, CLIN REHABIL, V14, P402, DOI 10.1191/0269215500cr342oa; POULTON EC, 1966, PSYCHOL BULL, V66, P1, DOI 10.1037/h0023427; Rougier P, 2004, GAIT POSTURE, V19, P154, DOI 10.1016/S0966-6362(03)00056-0; Sackley C M, 1991, Int Disabil Stud, V13, P1; SALMONI AW, 1984, PSYCHOL BULL, V95, P355, DOI 10.1037/0033-2909.95.3.355; Sayenko DG, 2012, GAIT POSTURE, V35, P339, DOI 10.1016/j.gaitpost.2011.10.005; Freitas SMSF, 2012, GAIT POSTURE, V35, P83, DOI 10.1016/j.gaitpost.2011.08.011; Schmid M, 2004, HUM MOVEMENT SCI, V23, P105, DOI 10.1016/j.humov.2004.06.001; Schmid M, 2002, MED ENG PHYS, V24, P623, DOI 10.1016/S1350-4533(02)00046-2; Schmid Maurizio, 2005, J Neuroeng Rehabil, V2, P29, DOI 10.1186/1743-0003-2-29; Schmidt R. A., 1991, TUTORIALS MOTOR NEUR; Severini G, 2012, J ELECTROMYOGR KINES, V22, P878, DOI 10.1016/j.jelekin.2012.04.010; Shea CH, 1999, HUM MOVEMENT SCI, V18, P553, DOI 10.1016/S0167-9457(99)00031-7; SHUMWAYCOOK A, 1988, ARCH PHYS MED REHAB, V69, P395; Sullivan EV, 2009, NEUROBIOL AGING, V30, P793, DOI 10.1016/j.neurobiolaging.2007.08.021; Tanaka Hideyuki, 2002, J Hum Ergol (Tokyo), V31, P1; Torricelli D, 2008, COMPUT METH PROG BIO, V92, P66, DOI 10.1016/j.cmpb.2008.06.008; van der Kooij H, 2007, J NEUROPHYSIOL, V98, P730, DOI 10.1152/jn.00457.2006; Vannozzi G, 2010, J ELECTROMYOGR KINES, V20, P767, DOI 10.1016/j.jelekin.2010.02.007; Vuillerme N, 2007, EXP BRAIN RES, V179, P409, DOI 10.1007/s00221-006-0800-4; Wade MG, 1997, PHYS THER, V77, P619, DOI 10.1093/ptj/77.6.619; Walker C, 2000, PHYS THER, V80, P886, DOI 10.1093/ptj/80.9.886; Walther JB, 2001, SOC SCI COMPUT REV, V19, P324, DOI 10.1177/089443930101900307; Wulf G, 2001, PSYCHON B REV, V8, P648, DOI 10.3758/BF03196201; Wulf G, 2001, RES Q EXERCISE SPORT, V72, P335, DOI 10.1080/02701367.2001.10608970; Wulf G, 2001, Q J EXP PSYCHOL-A, V54, P1143, DOI 10.1080/02724980143000118; Wulf G., 2013, INT REV SPORT EXERCI, V6, P77; Wulf G., 2010, EFFORTLESS ATTENTION, P75, DOI [10.7551/MITPRESS/9780262013840.003.0004, DOI 10.7551/MITPRESS/9780262013840.003.0004]	62	9	9	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0132711	10.1371/journal.pone.0132711	http://dx.doi.org/10.1371/journal.pone.0132711			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN6LZ	26196518	Green Published, gold, Green Submitted			2022-12-26	WOS:000358547600048
J	Seo, Y; Park, J; Kim, M; Lee, HK; Kim, JH; Jeong, JH; Namkung, W				Seo, Yohan; Park, Jinhong; Kim, Minseo; Lee, Ho K.; Kim, Jin-Hee; Jeong, Jin-Hyun; Namkung, Wan			Inhibition of ANO1/TMEM16A Chloride Channel by Idebenone and Its Cytotoxicity to Cancer Cell Lines	PLOS ONE			English	Article							CA2+-ACTIVATED CL-CHANNEL; CARCINOMA; TMEM16A; ANO1; MICONAZOLE; EXPRESSION; MIGRATION; PLUMBAGIN; PROGRESSION; METABOLISM	The expression levels of anoctamin 1 (ANO1, TMEM16A), a calcium-activated chloride channel (CaCC), are significantly increased in several tumors, and inhibition of ANO1 is known to reduce cell proliferation and migration. Here, we performed cell-based screening of a collection of natural products and drug-like compounds to identify inhibitors of ANO1. As a result of the screening, idebenone, miconazole and plumbagin were identified as novel ANO1 inhibitors. Electrophysiological studies showed that idebenone, a synthetic analog of coenzyme Q10, completely blocked ANO1 activity in FRT cells expressing ANO1 without any effect on intracellular calcium signaling and CFTR, a cAMP-regulated chloride channel. The CaCC activities in PC-3 and CFPAC-1 cells expressing abundant endogenous ANO1 were strongly blocked by idebenone. Idebenone inhibited cell proliferation and induced apoptosis in PC-3 and CFPAC-1 cells, but not in A549 cells, which do not express ANO1. These data suggest that idebenone, a novel ANO1 inhibitor, has potential for use in cancer therapy.	[Seo, Yohan; Park, Jinhong; Lee, Ho K.; Namkung, Wan] Yonsei Univ, Grad Sch, Dept Integrated OMICS Biomed Sci, Seoul 120749, South Korea; [Kim, Minseo; Kim, Jin-Hee; Jeong, Jin-Hyun; Namkung, Wan] Yonsei Univ, Yonsei Inst Pharmaceut Sci, Coll Pharm, Inchon 406840, South Korea	Yonsei University; Yonsei University	Namkung, W (corresponding author), Yonsei Univ, Grad Sch, Dept Integrated OMICS Biomed Sci, Seoul 120749, South Korea.	wnamkung@yonsei.ac.kr	서, 요한/AAZ-6433-2020; Kim, minseo/HHS-8532-2022	Seo, Yohan/0000-0002-9335-8604; Lee, Ho Kyun/0000-0003-1707-3217	Yonsei University Global Specialization Project; Grant of the Korea Healthcare technology RD Project; Ministry for Health & Welfare Affairs, Republic of Korea [HI08C2149]; Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology [NRF-2012R1A1A1040142]	Yonsei University Global Specialization Project; Grant of the Korea Healthcare technology RD Project; Ministry for Health & Welfare Affairs, Republic of Korea; Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology(National Research Foundation of Korea)	This work was funded by Yonsei University Global Specialization Project of 2014, a Grant of the Korea Healthcare technology R&D Project, Ministry for Health & Welfare Affairs, Republic of Korea (HI08C2149) and Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology [NRF-2012R1A1A1040142].	Ayoub C, 2010, BRIT J CANCER, V103, P715, DOI 10.1038/sj.bjc.6605823; BADER CR, 1982, J PHYSIOL-LONDON, V331, P253, DOI 10.1113/jphysiol.1982.sp014372; Berglund E, 2014, EXP CELL RES, V326, P315, DOI 10.1016/j.yexcr.2014.05.003; Bodmer M, 2009, EUR J CLIN PHARMACOL, V65, P493, DOI 10.1007/s00228-008-0596-1; Britschgi A, 2013, P NATL ACAD SCI USA, V110, pE1026, DOI 10.1073/pnas.1217072110; Buyse GM, 2011, NEUROMUSCULAR DISORD, V21, P396, DOI 10.1016/j.nmd.2011.02.016; Caputo A, 2008, SCIENCE, V322, P590, DOI 10.1126/science.1163518; Chen CA, 2009, PANCREATOLOGY, V9, P797, DOI 10.1159/000210028; De la Fuente R, 2008, MOL PHARMACOL, V73, P758, DOI 10.1124/mol.107.043208; Duran C, 2011, ACTA PHARMACOL SIN, V32, P685, DOI 10.1038/aps.2011.48; Duvvuri U, 2012, CANCER RES, V72, P3270, DOI 10.1158/0008-5472.CAN-12-0475-T; Eggermont Jan, 2004, Proc Am Thorac Soc, V1, P22, DOI 10.1513/pats.2306010; Galietta LJV, 2001, J BIOL CHEM, V276, P19723, DOI 10.1074/jbc.M101892200; Gutzmann H, 1998, J NEURAL TRANSM-SUPP, P301; Hartzell C, 2005, ANNU REV PHYSIOL, V67, P719, DOI 10.1146/annurev.physiol.67.032003.154341; Huang F, 2012, P NATL ACAD SCI USA, V109, P16354, DOI 10.1073/pnas.1214596109; Huang X, 2006, GENE CHROMOSOME CANC, V45, P1058, DOI 10.1002/gcc.20371; Ikejiri Y, 1996, NEUROLOGY, V47, P583, DOI 10.1212/WNL.47.2.583; Jacobsen KS, 2013, PFLUG ARCH EUR J PHY, V465, P1753, DOI 10.1007/s00424-013-1315-z; Jamal MS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087309; Kuo PL, 2006, MOL CANCER THER, V5, P3209, DOI 10.1158/1535-7163.MCT-06-0478; Li YD, 2014, MED ORAL PATOL ORAL, V19, pE313, DOI 10.4317/medoral.19076; Liu BY, 2010, J CLIN INVEST, V120, P1240, DOI 10.1172/JCI41084; Liu W, 2012, CANCER LETT, V326, P41, DOI 10.1016/j.canlet.2012.07.015; Mazzone A, 2012, BIOCHEM BIOPH RES CO, V427, P248, DOI 10.1016/j.bbrc.2012.09.022; Namkung W, 2011, J BIOL CHEM, V286, P2365, DOI 10.1074/jbc.M110.175109; Namkung W, 2010, FASEB J, V24, P4178, DOI 10.1096/fj.10-160648; Oh SJ, 2013, MOL PHARMACOL, V84, P726, DOI 10.1124/mol.113.087502; Park JY, 2014, CELL ONCOL, V37, P269, DOI 10.1007/s13402-014-0182-8; Parkinson MH, 2013, J NEUROCHEM, V126, P125, DOI 10.1111/jnc.12322; Pierard GE, 2012, EXPERT OPIN PHARMACO, V13, P1187, DOI 10.1517/14656566.2012.687047; Schroeder BC, 2008, CELL, V134, P1019, DOI 10.1016/j.cell.2008.09.003; Shi ZZ, 2013, CLIN CANCER RES, V19, P5867, DOI 10.1158/1078-0432.CCR-12-3753; Shih YW, 2009, HEPATOL RES, V39, P998, DOI 10.1111/j.1872-034X.2009.00540.x; Thal LJ, 2003, NEUROLOGY, V61, P1498, DOI 10.1212/01.WNL.0000096376.03678.C1; Verkman AS, 2009, NAT REV DRUG DISCOV, V8, P153, DOI 10.1038/nrd2780; Wan NK, 2011, FASEB J, V25, P4048, DOI 10.1096/fj.11-191627; West RB, 2004, AM J PATHOL, V165, P107, DOI 10.1016/S0002-9440(10)63279-8; Wu CH, 2002, TOXICOL APPL PHARM, V180, P22, DOI 10.1006/taap.2002.9352; Yang YD, 2008, NATURE, V455, P1210, DOI 10.1038/nature07313	40	48	52	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0133656	10.1371/journal.pone.0133656	http://dx.doi.org/10.1371/journal.pone.0133656			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LZ	26196390	gold, Green Published, Green Submitted			2022-12-26	WOS:000358547600127
J	Chang, HY; Sung, YH; Wang, SM; Lung, HL; Chang, JH; Hsu, CH; Jim, WT; Lee, CH; Hung, HF				Chang, Hung-Yang; Sung, Yi-Hsiang; Wang, Shwu-Meei; Lung, Hou-Ling; Chang, Jui-Hsing; Hsu, Chyong-Hsin; Jim, Wai-Tim; Lee, Ching-Hsiao; Hung, Hsiao-Fang			Short- and Long-Term Outcomes in Very Low Birth Weight Infants with Admission Hypothermia	PLOS ONE			English	Article							BODY-TEMPERATURE; VLBW INFANTS; BORN; ENVIRONMENT; MORTALITY; DELIVERY; WRAP	Background Neonatal hypothermia remains a common problem and is related to elevated morbidities and mortality. However, the long-term neurodevelopmental effects of admission hypothermia are still unknown. This study attempted to determine the short-term and long-term consequences of admission hypothermia in VLBW preterm infants. Study Design This retrospective study measured the incidence and compared the outcomes of admission hypothermia in very low birth weight (VLBW) preterm infants in a tertiary-level neonatal intensive care unit. Infants were divided into the following groups: normothermia (36.5-37.5 degrees C), mild hypothermia (36.0-36.4 degrees C), moderate hypothermia (32.0-35.9 degrees C), and severe hypothermia (< 32 degrees C). We compared the distribution, demographic variables, short-term outcomes, and neurodevelopmental outcomes at 24 months of corrected age among groups. Results We studied 341 infants: 79 with normothermia, 100 with mild hypothermia, 162 with moderate hypothermia, and 0 with severe hypothermia. Patients in the moderate hypothermia group had significantly lower gestational ages (28.1 wk vs. 29.7 wk, P < .02) and smaller birth weight (1004 g vs. 1187 g, P < .001) compared to patients in the normothermia group. Compared to normothermic infants, moderately hypothermic infants had significantly higher incidences of 1-min Apgar score < 7 (63.6% vs. 31.6%, P < .001), respiratory distress syndrome (RDS) (58.0% vs. 39.2%, P = .006), and mortality (18.5% vs. 5.1%, P = .005). Moderate hypothermia did not affect neurodevelopmental outcomes at 2 years' corrected age. Mild hypothermia had no effect on short-term or long-term outcomes. Conclusions Admission hypothermia was common in VLBW infants and correlated inversely with birth weight and gestational age. Although moderate hypothermia was associated with higher RDS and mortality rates, it may play a limited role among multifactorial causes of neurodevelopmental impairment.	[Chang, Hung-Yang; Sung, Yi-Hsiang; Lung, Hou-Ling] MacKay Mem Hosp, Dept Pediat, Hsinchu Branch, Hsinchu, Taiwan; [Chang, Hung-Yang; Lee, Ching-Hsiao; Hung, Hsiao-Fang] Jen Teh Jr Coll Med Nursing & Management, Dept Med Technol, Miaoli, Taiwan; [Wang, Shwu-Meei; Chang, Jui-Hsing; Hsu, Chyong-Hsin; Jim, Wai-Tim] MacKay Childrens Hosp, Dept Pediat, Taipei, Taiwan	Mackay Memorial Hospital	Wang, SM (corresponding author), MacKay Childrens Hosp, Dept Pediat, Taipei, Taiwan.	smwang65@gmail.com						Aylott Marion, 2006, Paediatr Nurs, V18, P38; Bartels DB, 2005, ARCH DIS CHILD-FETAL, V90, pF53, DOI 10.1136/adc.2004.053892; BERTEROTTIERE D, 1990, J DEV PHYSIOL, V13, P303; Bhatt DR, 2007, J PERINATOL, V27, pS45, DOI 10.1038/sj.jp.7211842; Billimoria Z, 2013, J PERINAT MED, V41, P455, DOI 10.1515/jpm-2012-0259; Bissinger Robin L, 2010, Adv Neonatal Care, V10, P230, DOI 10.1097/ANC.0b013e3181f0ae63; Boo NY, 2013, J TROP PEDIATRICS, V59, P447, DOI 10.1093/tropej/fmt051; de Almeida MFB, 2014, J PEDIATR-US, V164, P271, DOI 10.1016/j.jpeds.2013.09.049; Bredemeyer S, 2005, J ADV NURS, V52, P482, DOI 10.1111/j.1365-2648.2005.03616.x; Chitty H, 2013, SEMIN FETAL NEONAT M, V18, P362, DOI 10.1016/j.siny.2013.08.002; Costeloe K, 2000, PEDIATRICS, V106, P659, DOI 10.1542/peds.106.4.659; DAGA AS, 1991, J TROP PEDIATRICS, V37, P53, DOI 10.1093/tropej/37.2.53; Fransson AL, 2005, ARCH DIS CHILD-FETAL, V90, pF500, DOI 10.1136/adc.2004.066589; GANDY GM, 1964, J CLIN INVEST, V43, P751, DOI 10.1172/JCI104959; HAMMARLUND K, 1982, ACTA PAEDIATR SCAND, V71, P191, DOI 10.1111/j.1651-2227.1982.tb09398.x; HERTING E, 1992, BIOL NEONATE, V61, P26; Kattwinkel J, 2010, CIRCULATION, V122, pS909, DOI 10.1161/CIRCULATIONAHA.110.971119; Laptook AR, 2007, PEDIATRICS, V119, pE643, DOI 10.1542/peds.2006-0943; MANN TP, 1957, LANCET, V1, P229; Mathur NB, 2005, J TROP PEDIATRICS, V51, P341, DOI 10.1093/tropej/fmi049; McCall EM, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004210.pub4; Miller SS, 2011, J PERINATOL, V31, pS49, DOI 10.1038/jp.2010.177; Mitchell Ann, 2002, Adv Neonatal Care, V2, P316, DOI 10.1053/adnc.2002.36831; Pinheiro JMB, 2014, PEDIATRICS, V133, pE218, DOI 10.1542/peds.2013-1293; POMERANC.JJ, 1974, PEDIATR RES, V8, P449; Reilly MC, 2015, J PEDIATR-US, V166, P262, DOI 10.1016/j.jpeds.2014.09.068; Russo A, 2014, PEDIATRICS, V133, pE1055, DOI 10.1542/peds.2013-2544; Smith J, 2013, NEONATAL NETW, V32, P235, DOI [10.1891/0730-0832.32.4.235, 10.1891/0730-0832.32.1.16]; Takayama JI, 2000, CLIN PEDIATR, V39, P503, DOI 10.1177/000992280003900901; van der Spek RDG, 2009, ACTA PAEDIATR, V98, P282, DOI 10.1111/j.1651-2227.2008.01063.x; World Health Organization, 1997, THERM PROT NEWB PRAC	31	49	56	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2015	10	7							e0131976	10.1371/journal.pone.0131976	http://dx.doi.org/10.1371/journal.pone.0131976			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LN	26193370	Green Published, gold, Green Submitted			2022-12-26	WOS:000358546400018
J	Eisenstein, SA; Gredysa, DM; Antenor-Dorsey, JA; Green, L; Arbelaez, AM; Koller, JM; Black, KJ; Perlmutter, JS; Moerlein, SM; Hershey, T				Eisenstein, Sarah A.; Gredysa, Danuta M.; Antenor-Dorsey, Jo Ann; Green, Leonard; Arbelaez, Ana Maria; Koller, Jonathan M.; Black, Kevin J.; Perlmutter, Joel S.; Moerlein, Stephen M.; Hershey, Tamara			Insulin, Central Dopamine D2 Receptors, and Monetary Reward Discounting in Obesity	PLOS ONE			English	Article							HUMAN BRAIN; FOOD-INTAKE; INTRAVENTRICULAR INSULIN; SUBJECTIVE VALUE; BINDING; FUTURE; AVAILABILITY; IMPULSIVITY; DELAY; SENSITIVITY	Animal research finds that insulin regulates dopamine signaling and reward behavior, but similar research in humans is lacking. We investigated whether individual differences in body mass index, percent body fat, pancreatic beta-cell function, and dopamine D2 receptor binding were related to reward discounting in obese and non-obese adult men and women. Obese (n = 27; body mass index>30) and non-obese (n = 20; body mass index<30) adults were assessed for percent body fat with dual-energy X-ray absorptiometry and for beta-cell function using disposition index. Choice of larger, but delayed or less certain, monetary rewards relative to immediate, certain smaller monetary rewards was measured using delayed and probabilistic reward discounting tasks. Positron emission tomography using a non-displaceable D2-specific radioligand, [C-11](N-methyl) benperidol quantified striatal D2 receptor binding. Groups differed in body mass index, percent body fat, and disposition index, but not in striatal D2 receptor specific binding or reward discounting. Higher percent body fat in non-obese women related to preference for a smaller, certain reward over a larger, less likely one (greater probabilistic discounting). Lower beta-cell function in the total sample and lower insulin sensitivity in obese related to stronger preference for an immediate and smaller monetary reward over delayed receipt of a larger one (greater delay discounting). In obese adults, higher striatal D2 receptor binding related to greater delay discounting. Interestingly, striatal D2 receptor binding was not significantly related to body mass index, percent body fat, or beta-cell function in either group. Our findings indicate that individual differences in percent body fat, beta-cell function, and striatal D2 receptor binding may each contribute to altered reward discounting behavior in non-obese and obese individuals. These results raise interesting questions about whether and how striatal D2 receptor binding and metabolic factors, including beta-cell function, interact to affect reward discounting in humans.	[Eisenstein, Sarah A.; Antenor-Dorsey, Jo Ann; Koller, Jonathan M.; Black, Kevin J.; Hershey, Tamara] Washington Univ, Dept Psychiat, St Louis, MO 63130 USA; [Eisenstein, Sarah A.; Black, Kevin J.; Perlmutter, Joel S.; Moerlein, Stephen M.; Hershey, Tamara] Washington Univ, Dept Radiol, St Louis, MO USA; [Gredysa, Danuta M.; Green, Leonard] Washington Univ, Dept Psychol, St Louis, MO USA; [Arbelaez, Ana Maria] Washington Univ, Dept Pediat, St Louis, MO USA; [Black, Kevin J.] Washington Univ, Dept Neurol, St Louis, MO USA; [Black, Kevin J.; Perlmutter, Joel S.] Washington Univ, Dept Anat & Neurobiol, St Louis, MO USA; [Perlmutter, Joel S.] Washington Univ, Programs Phys Therapy & Occupat Therapy, St Louis, MO USA; [Moerlein, Stephen M.] Washington Univ, Biochem & Mol Biophys Dept, St Louis, MO USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Hershey, T (corresponding author), Washington Univ, Dept Psychiat, St Louis, MO 63130 USA.	tammy@npg.wustl.edu	Black, Kevin John/B-8272-2008	Black, Kevin John/0000-0002-6921-9567; Hershey, Tamara/0000-0001-7549-0698	National Institutes of Health [R01 DK085575, T32DA007261, T32DA007313, K24 MH087913, R21 MH098670, P60 DK20579]; Clinical and Translational Science Award [UL1 TR000448]; Barnes Jewish Hospital Foundation (Elliot Stein Family Fund); McDonnell Center for Higher Brain Function; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000448] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020579, P30DK056341, P60DK020579, R01DK085575] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH098670, K24MH087913] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS075321] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [T32DA007261, T32DA007313] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Clinical and Translational Science Award; Barnes Jewish Hospital Foundation (Elliot Stein Family Fund); McDonnell Center for Higher Brain Function; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by the National Institutes of Health (R01 DK085575 (TH), T32DA007261 (SAE), T32DA007313 (DMG, JAD); K24 MH087913 (KJB), R21 MH098670 (KJB), P60 DK20579), Clinical and Translational Science Award (UL1 TR000448), Barnes Jewish Hospital Foundation (Elliot Stein Family Fund, JSP), and the McDonnell Center for Higher Brain Function (JSP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam TC, 2015, PEDIATR OBES, V10, P30, DOI 10.1111/j.2047-6310.2013.00210.x; Air EL, 2002, PHARMACOL BIOCHEM BE, V72, P423, DOI 10.1016/S0091-3057(01)00780-8; Antenor-Dorsey JAV, 2008, NUCL MED BIOL, V35, P335, DOI 10.1016/j.nucmedbio.2007.12.004; Anthony K, 2006, DIABETES, V55, P2986, DOI 10.2337/db06-0376; Antonelli F, 2014, HUM BRAIN MAPP, V35, P2499, DOI 10.1002/hbm.22344; Arrondo G, 2015, EUR NEUROPSYCHOPHARM, V25, P817, DOI 10.1016/j.euroneuro.2015.02.011; Babbs RK, 2013, PHYSIOL BEHAV, V121, P103, DOI 10.1016/j.physbeh.2013.03.025; Ballard K, 2009, NEUROIMAGE, V45, P143, DOI 10.1016/j.neuroimage.2008.11.004; Ballard ME, 2015, INT J NEUROPSYCHOPH, V18, DOI 10.1093/ijnp/pyu119; Bechara A, 1999, J NEUROSCI, V19, P5473; Breda E, 2001, DIABETES, V50, P150, DOI 10.2337/diabetes.50.1.150; Brogan A, 2011, J PSYCHOSOM RES, V70, P189, DOI 10.1016/j.jpsychores.2010.07.012; Burger Kyle S, 2011, Curr Drug Abuse Rev, V4, P182; Cardinal RN, 2006, NEURAL NETWORKS, V19, P1277, DOI 10.1016/j.neunet.2006.03.004; Carr KD, 2000, BRAIN RES, V863, P160, DOI 10.1016/S0006-8993(00)02143-0; Christensen J, 1998, J EXP ANAL BEHAV, V69, P123, DOI 10.1901/jeab.1998.69-123; Cohen J.E., 1988, STAT POWER ANAL BEHA; Cropley VL, 2008, SYNAPSE, V62, P399, DOI 10.1002/syn.20506; Dalla Man C, 2002, IEEE T BIO-MED ENG, V49, P419, DOI 10.1109/10.995680; Davis C, 2004, OBES RES, V12, P929, DOI 10.1038/oby.2004.113; Davis C, 2013, PHYSIOL BEHAV, V118, P63, DOI 10.1016/j.physbeh.2013.05.014; Davis C, 2010, APPETITE, V54, P208, DOI 10.1016/j.appet.2009.11.002; de Weijer BA, 2011, EJNMMI RES, V1, DOI 10.1186/2191-219X-1-37; de Wit H, 2002, NEUROPSYCHOPHARMACOL, V27, P813, DOI 10.1016/S0893-133X(02)00343-3; Despres JP, 2006, NATURE, V444, P881, DOI 10.1038/nature05488; DEWEY SL, 1993, SYNAPSE, V13, P350, DOI 10.1002/syn.890130407; Dunn JP, 2012, DIABETES CARE, V35, P1105, DOI 10.2337/dc11-2250; Eisenstein SA, 2015, SCI REP IN PRESS; Eisenstein SA, 2013, SYNAPSE, V67, P748, DOI 10.1002/syn.21680; Eisenstein SA, 2012, SYNAPSE, V66, P770, DOI 10.1002/syn.21566; Elias Merrill F, 2005, Neurobiol Aging, V26 Suppl 1, P11, DOI 10.1016/j.neurobiolaging.2005.08.019; Elsinga PH, 2006, CURR MED CHEM, V13, P2139, DOI 10.2174/092986706777935258; Epstein LH, 2014, OBESITY, V22, P1394, DOI 10.1002/oby.20661; Figlewicz DP, 2006, PHYSIOL BEHAV, V89, P611, DOI 10.1016/j.physbeh.2006.07.023; Figlewicz DP, 2003, BRAIN RES, V964, P107, DOI 10.1016/S0006-8993(02)04087-8; Figlewicz DP, 2004, BEHAV NEUROSCI, V118, P479, DOI 10.1037/0735-7044.118.3.479; First M.B., 2016, STRUCTURED CLIN INTE; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Freeman TP, 2013, DRUG ALCOHOL DEPEN, V130, P109, DOI 10.1016/j.drugalcdep.2012.10.016; Green L, 1999, J EXP PSYCHOL LEARN, V25, P418, DOI 10.1037/0278-7393.25.2.418; Green L, 1999, BEHAV PROCESS, V46, P89, DOI 10.1016/S0376-6357(99)00021-2; Green L, 2004, PSYCHOL BULL, V130, P769, DOI 10.1037/0033-2909.130.5.769; Green L, 2013, J EXP ANAL BEHAV, V99, P3, DOI 10.1002/jeab.1; Guo J, 2014, MOL PSYCHIATR, V19, P1078, DOI 10.1038/mp.2014.102; Guo JF, 2006, PSYCHOL MED, V36, P547, DOI 10.1017/S0033291705006732; Hallschmid M, 2012, DIABETES, V61, P782, DOI 10.2337/db11-1390; Haltia LT, 2007, SYNAPSE, V61, P748, DOI 10.1002/syn.20418; Hamidovic A, 2008, J CLIN PSYCHOPHARM, V28, P45, DOI 10.1097/jcp.0b013e3181602fab; Heni M, 2012, DIABETOLOGIA, V55, P1773, DOI 10.1007/s00125-012-2528-y; Hershey T, 2003, J NEUROL NEUROSUR PS, V74, P844, DOI 10.1136/jnnp.74.7.844; Hind K, 2011, EUR J CLIN NUTR, V65, P140, DOI 10.1038/ejcn.2010.190; Jacobs E, 2011, J NEUROSCI, V31, P5286, DOI 10.1523/JNEUROSCI.6394-10.2011; Jastreboff AM, 2013, DIABETES CARE, V36, P394, DOI 10.2337/dc12-1112; Jauch-Chara K, 2012, DIABETES, V61, P2261, DOI 10.2337/db12-0025; Joutsa J, 2015, TRANSL PSYCHIAT, V5, DOI 10.1038/tp.2014.133; Kable JW, 2007, NAT NEUROSCI, V10, P1625, DOI 10.1038/nn2007; Karimi M, 2011, MOVEMENT DISORD, V26, P100, DOI 10.1002/mds.23401; Karlsson HK, 2015, J NEUROSCI, V35, P3959, DOI 10.1523/JNEUROSCI.4744-14.2015; Kessler RM, 2014, SYNAPSE, V68, P317, DOI 10.1002/syn.21738; Kleinridders A, 2015, P NATL ACAD SCI USA, V112, P3463, DOI 10.1073/pnas.1500877112; Kroemer NB, 2013, HUM BRAIN MAPP, V34, P2367, DOI 10.1002/hbm.22071; Kullmann S, 2013, NEUROENDOCRINOLOGY, V97, P176, DOI 10.1159/000341406; Leroi I, 2013, J NEUROPSYCHOL, V7, P306, DOI 10.1111/jnp.12026; MacKillop J, 2013, J EXP ANAL BEHAV, V99, P14, DOI 10.1002/jeab.4; Manwaring JL, 2011, PSYCHOL REC, V61, P561, DOI 10.1007/BF03395777; Marco-Pallares J, 2010, BRAIN RES, V1320, P123, DOI 10.1016/j.brainres.2010.01.025; Matsuda M, 1999, DIABETES CARE, V22, P1462, DOI 10.2337/diacare.22.9.1462; Mebel DM, 2012, EUR J NEUROSCI, V36, P2336, DOI 10.1111/j.1460-9568.2012.08168.x; Michaelides M, 2012, NEUROIMAGE, V59, P1508, DOI 10.1016/j.neuroimage.2011.08.028; Moerlein SM, 2010, EUR J NUCL MED MOL I, V37, pS366; Moerlein SM, 2004, RADIOCHIM ACTA, V92, P333, DOI 10.1524/ract.92.4.333.35584; Moerlein SM, 1997, J CEREBR BLOOD F MET, V17, P833, DOI 10.1097/00004647-199708000-00002; Myerson J, 2003, J ECON PSYCHOL, V24, P619, DOI 10.1016/S0167-4870(03)00005-9; Myerson J, 2001, J EXP ANAL BEHAV, V76, P235, DOI 10.1901/jeab.2001.76-235; Onoda K, 2011, EXP BRAIN RES, V212, P593, DOI 10.1007/s00221-011-2771-3; Peters J, 2009, J NEUROSCI, V29, P15727, DOI 10.1523/JNEUROSCI.3489-09.2009; Pietras CJ, 2003, PSYCHOPHARMACOLOGY, V170, P390, DOI 10.1007/s00213-003-1547-2; Pine A, 2010, J NEUROSCI, V30, P8888, DOI 10.1523/JNEUROSCI.6028-09.2010; Pohjalainen T, 1998, MOL PSYCHIATR, V3, P256, DOI 10.1038/sj.mp.4000350; Reimers S, 2009, PERS INDIV DIFFER, V47, P973, DOI 10.1016/j.paid.2009.07.026; Russo SJ, 2007, NAT NEUROSCI, V10, P93, DOI 10.1038/nn1812; Sipols AJ, 2000, PEPTIDES, V21, P1361, DOI 10.1016/S0196-9781(00)00279-5; Smith CT, 2014, J NEUROSCI, V34, P5468, DOI 10.1523/JNEUROSCI.0014-14.2014; Soper DS, 2015, EFFECT SIZE CALCULAT; Tanaka SC, 2004, NAT NEUROSCI, V7, P887, DOI 10.1038/nn1279; Volkow ND, 2008, NEUROIMAGE, V42, P1537, DOI 10.1016/j.neuroimage.2008.06.002; Wang GJ, 2012, MOL PSYCHIATR, V17, P918, DOI 10.1038/mp.2011.86; Wang GJ, 2001, LANCET, V357, P354, DOI 10.1016/S0140-6736(00)03643-6; Wechsler D., 2011, WASI 2 WECHSLER ABBR; Wechsler H, 2001, PSYCHOL ADDICT BEHAV, V15, P287, DOI 10.1037/0893-164X.15.4.287; Weiss R, 2004, NEW ENGL J MED, V350, P2362, DOI 10.1056/NEJMoa031049; Weller RE, 2008, APPETITE, V51, P563, DOI 10.1016/j.appet.2008.04.010; Wittmann M, 2007, EXP BRAIN RES, V179, P643, DOI 10.1007/s00221-006-0822-y	93	42	42	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2015	10	7							e0133621	10.1371/journal.pone.0133621	http://dx.doi.org/10.1371/journal.pone.0133621			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN6LN	26192187	gold, Green Published			2022-12-26	WOS:000358546400107
J	Kupers, LK; L'Abee, C; Bocca, G; Stolk, RP; Sauer, PJJ; Corpeleijn, E				Kupers, Leanne K.; L'Abee, Carianne; Bocca, Gianni; Stolk, Ronald P.; Sauer, Pieter J. J.; Corpeleijn, Eva			Determinants of Weight Gain during the First Two Years of Life-The GECKO Drenthe Birth Cohort	PLOS ONE			English	Article							BODY-MASS INDEX; EARLY-CHILDHOOD; INFANT GROWTH; POSTNATAL-GROWTH; MATERNAL SMOKING; ADULT DISEASE; RISK-FACTORS; FOLLOW-UP; OBESITY; CHILDREN	Objectives To explain weight gain patterns in the first two years of life, we compared the predictive values of potential risk factors individually and within four different domains: prenatal, nutrition, lifestyle and socioeconomic factors. Methods In a Dutch population-based birth cohort, length and weight were measured in 2475 infants at 1, 6, 12 and 24 months. Factors that might influence weight gain (e.g. birth weight, parental BMI, breastfeeding, hours of sleep and maternal education) were retrieved from health care files and parental questionnaires. Factors were compared with linear regression to best explain differences in weight gain, defined as changes in Z-score of weight-for-age and weight-for-length over 1- 6, 6-12 and 12-24 months. In a two-step approach, factors were first studied individually for their association with growth velocity, followed by a comparison of the explained variance of the four domains. Results Birth weight and type of feeding were most importantly related to weight gain in the first six months. Breastfeeding versus formula feeding showed distinct growth patterns in the first six months, but not thereafter. From six months onwards, the ability to explain differences in weight gain decreased substantially (from R-total(2) = 38.7% to R-total(2)<7%). Conclusion Birth weight and breast feeding were most important to explain early weight gain, especially in the first six months of life. After the first six months of life other yet undetermined factors start to play a role.	[Kupers, Leanne K.; L'Abee, Carianne; Stolk, Ronald P.; Corpeleijn, Eva] Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, Groningen, Netherlands; [L'Abee, Carianne; Bocca, Gianni; Sauer, Pieter J. J.] Univ Groningen, Univ Med Ctr Groningen, Beatrix Childrens Hosp, Dept Pediat, Groningen, Netherlands	University of Groningen; University of Groningen	Kupers, LK (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, Groningen, Netherlands.	l.k.kupers@umcg.nl		Kupers, Leanne/0000-0001-9850-5215; Corpeleijn, Eva/0000-0002-2974-3305; Stolk, Ronald/0000-0002-0518-1205	Hutchison Whampoa Ltd.; University Medical Center Groningen	Hutchison Whampoa Ltd.; University Medical Center Groningen	The GECKO Drenthe is supported by an unlimited grant from Hutchison Whampoa Ltd. and by the University Medical Center Groningen. The study sponsors had no involvement in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baird J, 2005, BMJ-BRIT MED J, V331, P929, DOI 10.1136/bmj.38586.411273.E0; Baker JL, 2004, AM J CLIN NUTR, V80, P1579, DOI 10.1093/ajcn/80.6.1579; Barker DJP, 2007, J INTERN MED, V261, P412, DOI 10.1111/j.1365-2796.2007.01809.x; Barker DJP, 2002, INT J EPIDEMIOL, V31, P1235, DOI 10.1093/ije/31.6.1235; Bocca G, 2014, CLIN NUTR, V33, P1095, DOI 10.1016/j.clnu.2013.12.002; Brisbois TD, 2012, OBES REV, V13, P347, DOI 10.1111/j.1467-789X.2011.00965.x; Claris O, 2010, SEMIN PERINATOL, V34, P207, DOI 10.1053/j.semperi.2010.02.005; Danielsson P, 2012, ARCH PEDIAT ADOL MED, V166, P1103, DOI 10.1001/2013.jamapediatrics.319; de Hoog MLA, 2011, BRIT J NUTR, V106, P1592, DOI 10.1017/S0007114511002327; Dietz WH, 1998, PEDIATRICS, V101, P518; Druet C, 2012, PAEDIATR PERINAT EP, V26, P19, DOI 10.1111/j.1365-3016.2011.01213.x; DutchGrowthFoundation, 2001, GROWTH ANAL, V3.5; Fredriks AM, 2000, PEDIATR RES, V47, P316, DOI 10.1203/00006450-200003000-00006; Gaillard R, 2014, MATERNAL PARITY FETA; Griffiths LJ, 2009, ARCH DIS CHILD, V94, P577, DOI 10.1136/adc.2008.137554; Gunnarsdottir I, 2010, PUBLIC HEALTH NUTR, V13, P201, DOI 10.1017/S1368980009005874; Heerman WJ, 2014, ACAD PEDIATR, V14, P463, DOI 10.1016/j.acap.2014.05.005; Heude B, 2005, INT J OBESITY, V29, P1222, DOI 10.1038/sj.ijo.0802920; Hindmarsh PC, 2008, PEDIATR RES, V63, P99, DOI 10.1203/PDR.0b013e31815b8e8f; Horta BL, 2007, EVIDENCE LONG TERM E; Karaolis-Danckert N, 2008, AM J CLIN NUTR, V87, P1356, DOI 10.1093/ajcn/87.5.1356; Knight B, 2007, DIABETES CARE, V30, P777, DOI 10.2337/dc06-1849; L'Abee C, 2008, INT J EPIDEMIOL, V37, P486, DOI 10.1093/ije/dym218; Lalonde M, 1974, NEW PERSPECTIVE HLTH; Li N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077809; Monteiro POA, 2005, OBES REV, V6, P143, DOI 10.1111/j.1467-789X.2005.00183.x; Ong KKL, 2002, PEDIATR RES, V52, P863, DOI 10.1203/00006450-200212000-00009; Regnault N, 2010, AM J CLIN NUTR, V92, P594, DOI 10.3945/ajcn.2010.29292; Robinson S, 2012, NARRATIVE LIT REV DE; Sijtsma A, 2014, EUR J PEDIAT; StatisticsNetherlands S, 2014, GEB NAAR DIV KENM; StatisticsNetherlands S, 2015, BEV GEB 1989 2013; StatisticsNetherlands S, 2014, PER ZUIG ZWANG EEN E; Touwslager RNH, 2011, J PEDIATR-US, V158, P566, DOI 10.1016/j.jpeds.2010.10.005; Vielwerth SE, 2007, EARLY HUM DEV, V83, P491, DOI 10.1016/j.earlhumdev.2006.09.010; Wabitsch M, 2000, EUR J PEDIATR, V159, pS8, DOI 10.1007/PL00014368; WHITEHEAD RG, 1995, PEDIATR RES, V37, P239, DOI 10.1203/00006450-199502000-00019; Willers SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039517	38	19	19	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2015	10	7							e0133326	10.1371/journal.pone.0133326	http://dx.doi.org/10.1371/journal.pone.0133326			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LN	26192417	Green Published, Green Submitted, gold			2022-12-26	WOS:000358546400073
J	Tsakraklides, V; Brevnova, E; Stephanopoulos, G; Shaw, AJ				Tsakraklides, Vasiliki; Brevnova, Elena; Stephanopoulos, Gregory; Shaw, A. Joe			Improved Gene Targeting through Cell Cycle Synchronization	PLOS ONE			English	Article							DEOXYRIBONUCLEIC-ACID SYNTHESIS; YARROWIA-LIPOLYTICA STRAINS; STRAND BREAK REPAIR; AGROBACTERIUM T-DNA; HUMAN SOMATIC-CELLS; SACCHAROMYCES-CEREVISIAE; HOMOLOGOUS RECOMBINATION; KLUYVEROMYCES-LACTIS; YEAST; INTEGRATION	Gene targeting is a challenge in organisms where non-homologous end-joining is the predominant form of recombination. We show that cell division cycle synchronization can be applied to significantly increase the rate of homologous recombination during transformation. Using hydroxyurea-mediated cell cycle arrest, we obtained improved gene targeting rates in Yarrowia lipolytica, Arxula adeninivorans, Saccharomyces cerevisiae, Kluyveromyces lactis and Pichia pastoris demonstrating the broad applicability of the method. Hydroxyurea treatment enriches for S-phase cells that are active in homologous recombination and enables previously unattainable genomic modifications.	[Tsakraklides, Vasiliki; Brevnova, Elena] Total New Energies, Emeryville, CA 94608 USA; [Stephanopoulos, Gregory; Shaw, A. Joe] Novogy Inc, Cambridge, MA USA; [Stephanopoulos, Gregory] MIT, Dept Chem Engn, Cambridge, MA 02139 USA	Total SA; Massachusetts Institute of Technology (MIT)	Tsakraklides, V (corresponding author), Total New Energies, Emeryville, CA 94608 USA.	vtsakraklides@novogyinc.com		Tsakraklides, Vasiliki/0000-0003-1998-1075	Total New Energies; Novogy Inc.	Total New Energies(Total SA); Novogy Inc.	The author(s) received no specific funding for this work. VT and EB are employed by Total New Energies. JS is employed by Novogy Inc. A patent application relating to the method described in the submitted manuscript was filed with the USPTO (PCT/US14/036905) on 5/6/2014. Total New Energies and Novogy Inc. provided support in the form of salaries for authors (VT, EB, JS), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Banat BMA, 2010, YEAST, V27, P29, DOI 10.1002/yea.1729; Amberg DC, 2006, COLD SPRING HARBOR P, V2006, DOI [10.1101/pdb.prot4174, DOI 10.1101/PDB.PR0T4174]; Amon A, 2002, METHOD ENZYMOL, V351, P457; Aylon Y, 2005, CELL CYCLE, V4, P259; Barnes G, 1997, P NATL ACAD SCI USA, V94, P867, DOI 10.1073/pnas.94.3.867; BAUDIN A, 1993, NUCLEIC ACIDS RES, V21, P3329, DOI 10.1093/nar/21.14.3329; Beckerich J M, 1998, Int Microbiol, V1, P123; Bertolini LR, 2009, MOL BIOTECHNOL, V41, P106, DOI 10.1007/s12033-008-9098-8; BUBECK P, 1993, NUCLEIC ACIDS RES, V21, P3601, DOI 10.1093/nar/21.15.3601; Chapman JR, 2012, MOL CELL, V47, P497, DOI 10.1016/j.molcel.2012.07.029; de Boer P, 2010, FUNGAL GENET BIOL, V47, P839, DOI 10.1016/j.fgb.2010.07.008; DORFMAN BZ, 1969, GENETICS, V61, P377; Dudasova Z, 2004, FEMS MICROBIOL REV, V28, P581, DOI 10.1016/j.femsre.2004.06.001; Dujon B, 2004, NATURE, V430, P35, DOI 10.1038/nature02579; Fattah FJ, 2008, P NATL ACAD SCI USA, V105, P8703, DOI 10.1073/pnas.0712060105; Fisher R. A, 1925, STAT METHODS RES WOR, V1, DOI DOI 10.1111/J.2397-2335.1926.TB01837.X; Galli A, 1996, MUTAT RES-FUND MOL M, V354, P69, DOI 10.1016/0027-5107(96)00037-1; Goins CL, 2006, FUNGAL GENET BIOL, V43, P531, DOI 10.1016/j.fgb.2006.02.007; Goswami RS, 2012, METHODS MOL BIOL, V835, P255, DOI 10.1007/978-1-61779-501-5_16; Herrero AB, 1999, MICROBIOL-SGM, V145, P2727, DOI 10.1099/00221287-145-10-2727; Iiizumi S, 2008, NUCLEIC ACIDS RES, V36, P6333, DOI 10.1093/nar/gkn649; Jia Q., 2012, J BOT, V2012, P1, DOI [10.1155/2012/989272, DOI 10.1155/2012/989272]; Karanam K, 2012, MOL CELL, V47, P320, DOI 10.1016/j.molcel.2012.05.052; Klinner U, 2004, FEMS MICROBIOL REV, V28, P201, DOI 10.1016/j.femsre.2003.10.002; Kooistra R, 2004, YEAST, V21, P781, DOI 10.1002/yea.1131; Kretzschmar A, 2013, CURR GENET, V59, P63, DOI 10.1007/s00294-013-0389-7; Kuijpers NGA, 2013, FEMS YEAST RES, V13, P769, DOI 10.1111/1567-1364.12087; Kunze G, 2014, BIOTECHNOL BIOFUELS, V7, DOI 10.1186/1754-6834-7-66; MA H, 1987, GENE, V58, P201, DOI 10.1016/0378-1119(87)90376-3; Maassen N, 2008, FEMS YEAST RES, V8, P735, DOI 10.1111/j.1567-1364.2008.00383.x; Manthey Glenn M, 2004, Methods Mol Biol, V262, P157; Manukyan A, 2011, METHODS MOL BIOL, V761, P173, DOI 10.1007/978-1-61779-182-6_12; Mathiasen DP, 2014, FEMS MICROBIOL REV, V38, P172, DOI 10.1111/1574-6976.12066; Naatsaari L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039720; Nakazawa T, 2011, FUNGAL GENET BIOL, V48, P939, DOI 10.1016/j.fgb.2011.06.003; Nicaud JM, 2012, YEAST, V29, P409, DOI 10.1002/yea.2921; Ninomiya Y, 2004, P NATL ACAD SCI USA, V101, P12248, DOI 10.1073/pnas.0402780101; Nishizawa-Yokoi A, 2012, NEW PHYTOL, V196, P1048, DOI 10.1111/j.1469-8137.2012.04350.x; ORRWEAVER TL, 1981, P NATL ACAD SCI-BIOL, V78, P6354, DOI 10.1073/pnas.78.10.6354; Poggeler S, 2006, GENE, V378, P1, DOI 10.1016/j.gene.2006.03.020; RODRIGUEZ C, 1990, EXP MYCOL, V14, P310, DOI 10.1016/0147-5975(90)90054-W; ROSENKRANZ HS, 1965, BIOCHIM BIOPHYS ACTA, V95, P181, DOI 10.1016/0005-2787(65)90225-X; Sabirova JS, 2011, MICROB BIOTECHNOL, V4, P47, DOI 10.1111/j.1751-7915.2010.00187.x; SINCLAIR WK, 1965, SCIENCE, V150, P1729, DOI 10.1126/science.150.3704.1729; SLATER ML, 1973, J BACTERIOL, V113, P263, DOI 10.1128/JB.113.1.263-270.1973; Tanaka S, 2010, BIOCHEM BIOPH RES CO, V396, P289, DOI 10.1016/j.bbrc.2010.04.082; Ueno K, 2007, EUKARYOT CELL, V6, P1239, DOI 10.1128/EC.00414-06; Ushimaru T, 2010, MOL GENET GENOMICS, V284, P357, DOI 10.1007/s00438-010-0572-1; van Attikum H, 2001, EMBO J, V20, P6550, DOI 10.1093/emboj/20.22.6550; van Attikum H, 2003, NUCLEIC ACIDS RES, V31, P826, DOI 10.1093/nar/gkg183; Verbeke J, 2013, BIOTECHNOL LETT, V35, P571, DOI 10.1007/s10529-012-1107-0; Zhang XJ, 2012, J IND MICROBIOL BIOT, V39, P917, DOI 10.1007/s10295-012-1097-x; ZONNEVELD BJM, 1995, YEAST, V11, P823, DOI 10.1002/yea.320110904	53	41	43	2	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2015	10	7							e0133434	10.1371/journal.pone.0133434	http://dx.doi.org/10.1371/journal.pone.0133434			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LN	26192309	Green Published, Green Submitted, gold			2022-12-26	WOS:000358546400084
J	Alberti, L; Losi, L; Leyvraz, S; Benhattar, J				Alberti, Loredana; Losi, Lorena; Leyvraz, Serge; Benhattar, Jean			Different Effects of BORIS/CTCFL on Stemness Gene Expression, Sphere Formation and Cell Survival in Epithelial Cancer Stem Cells	PLOS ONE			English	Article							TESTIS ANTIGEN BORIS; TUMOR-INITIATING CELLS; HEPATOCELLULAR-CARCINOMA; INDUCED APOPTOSIS; IMPRINTED SITES; SIDE POPULATION; IN-VITRO; TELOMERASE; IDENTIFICATION; CTCF	Cancer stem cells are cancer cells characterized by stem cell properties and represent a small population of tumor cells that drives tumor development, progression, metastasis and drug resistance. To date, the molecular mechanisms that generate and regulate cancer stem cells are not well defined. BORIS (Brother of Regulator of Imprinted Sites) or CTCFL (CTCF-like) is a DNA-binding protein that is expressed in normal tissues only in germ cells and is re-activated in tumors. Recent evidences have highlighted the correlation of BORIS/CTCFL expression with poor overall survival of different cancer patients. We have previously shown an association of BORIS-expressing cells with stemness gene expression in embryonic cancer cells. Here, we studied the role of BORIS in epithelial tumor cells. Using BORIS-molecular beacon that was already validated, we were able to show the presence of BORIS mRNA in cancer stem cell-enriched populations (side population and spheres) of cervical, colon and breast tumor cells. BORIS silencing studies showed a decrease of sphere formation capacity in breast and colon tumor cells. Importantly, BORIS-silencing led to down-regulation of hTERT, stem cell (NANOG, OCT4, SOX2 and BMI1) and cancer stem cell markers (ABCG2, CD44 and ALDH1) genes. Conversely, BORIS-induction led to up-regulation of the same genes. These phenotypes were observed in cervical, colon and invasive breast tumor cells. However, a completely different behavior was observed in the non-invasive breast tumor cells (MCF7). Indeed, these cells acquired an epithelial mesenchymal transition phenotype after BORIS silencing. Our results demonstrate that BORIS is associated with cancer stem cell-enriched populations of several epithelial tumor cells and the different phenotypes depend on the origin of tumor cells.	[Alberti, Loredana; Benhattar, Jean] Univ Lausanne Hosp, Inst Pathol, Lausanne, Switzerland; [Losi, Lorena] Univ Modena & Reggio Emilia, Dept Life Sci, Modena, Italy; [Leyvraz, Serge] Univ Lausanne Hosp, Dept Oncol, Lausanne, Switzerland; [Benhattar, Jean] Biopath Lab, Lausanne, Switzerland	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Universita di Modena e Reggio Emilia; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Benhattar, J (corresponding author), Univ Lausanne Hosp, Inst Pathol, Lausanne, Switzerland.	jean.benhattar@gmail.com	Losi, Lorena/B-2583-2012	Losi, Lorena/0000-0002-8483-3936	Swiss National Science Foundation [31003A-113505]; Emma Muschamp Foundation	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Emma Muschamp Foundation	Financial support was given by the Swiss National Science Foundation (31003A-113505) and Emma Muschamp Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. One of the authors (JB) is employed by a molecular pathology laboratory (Biopath Lab). Biopath Lab provided support in the form of salaries, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Alberti L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109921; Bollmann FM, 2008, BIOESSAYS, V30, P728, DOI 10.1002/bies.20793; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Charafe-Jauffret E, 2009, CANCER RES, V69, P1302, DOI 10.1158/0008-5472.CAN-08-2741; Cheema Z, 2014, PROSTATE, V74, P164, DOI 10.1002/pros.22738; Chen KF, 2013, GENET TEST MOL BIOMA, V17, P160, DOI 10.1089/gtmb.2012.0242; Chiba T, 2006, HEPATOLOGY, V44, P240, DOI 10.1002/hep.21227; Dalerba P, 2007, P NATL ACAD SCI USA, V104, P10158, DOI 10.1073/pnas.0703478104; Dalerba P, 2007, ANNU REV MED, V58, P267, DOI 10.1146/annurev.med.58.062105.204854; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; Dougherty CJ, 2008, BIOCHEM BIOPH RES CO, V370, P109, DOI 10.1016/j.bbrc.2008.03.040; Dudognon C, 2004, ONCOGENE, V23, P7469, DOI 10.1038/sj.onc.1208029; Gaykalova D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040389; Ginestier C, 2007, CELL STEM CELL, V1, P555, DOI 10.1016/j.stem.2007.08.014; Hirschmann-Jax C, 2004, P NATL ACAD SCI USA, V101, P14228, DOI 10.1073/pnas.0400067101; Jordan CT, 2006, NEW ENGL J MED, V355, P1253, DOI 10.1056/NEJMra061808; Kang HJ, 2004, J NEUROSCI, V24, P1280, DOI 10.1523/JNEUROSCI.4082-03.2004; Katayama R, 2009, CANCER SCI, V100, P2060, DOI 10.1111/j.1349-7006.2009.01288.x; Kondo T, 2004, P NATL ACAD SCI USA, V101, P781, DOI 10.1073/pnas.0307618100; Lee J, 2006, CANCER CELL, V9, P391, DOI 10.1016/j.ccr.2006.03.030; Li CW, 2007, CANCER RES, V67, P1030, DOI 10.1158/0008-5472.CAN-06-2030; Liu Z, 2013, ONCOGENE, V32, P4203, DOI 10.1038/onc.2012.441; Loukinov DI, 2002, P NATL ACAD SCI USA, V99, P6806, DOI 10.1073/pnas.092123699; Luiten RM, 2003, BLOOD, V101, P4512, DOI 10.1182/blood-2002-07-2018; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Meerbrey KL, 2011, P NATL ACAD SCI USA, V108, P3665, DOI 10.1073/pnas.1019736108; Muller T, 2002, EXP CELL RES, V280, P119, DOI 10.1006/excr.2002.5630; Okabayashi K, 2012, CANCER SCI, V103, P1617, DOI 10.1111/j.1349-7006.2012.02355.x; Park JI, 2009, NATURE, V460, P66, DOI 10.1038/nature08137; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; PUCK TT, 1956, J EXP MED, V103, P653, DOI 10.1084/jem.103.5.653; Pugacheva EM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013872; Renaud S, 2007, NUCLEIC ACIDS RES, V35, P7372, DOI 10.1093/nar/gkm896; Renaud S, 2011, NUCLEIC ACIDS RES, V39, P862, DOI 10.1093/nar/gkq827; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Rosa-Garrido M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039371; Sargent D, 2009, J CLIN ONCOL, V27, P872, DOI 10.1200/JCO.2008.19.5362; Satelli A, 2011, CELL MOL LIFE SCI, V68, P3033, DOI 10.1007/s00018-011-0735-1; Schatton T, 2009, BIOESSAYS, V31, P1038, DOI 10.1002/bies.200900058; Sheridan C, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1610; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Stewart SA, 2002, P NATL ACAD SCI USA, V99, P12606, DOI 10.1073/pnas.182407599; Tiffen JC, 2013, INT J CANCER, V133, P1603, DOI 10.1002/ijc.28184; Woloszynska-Read A, 2011, CLIN CANCER RES, V17, P2170, DOI 10.1158/1078-0432.CCR-10-2315; Zhang S, 2008, CANCER RES, V68, P4311, DOI 10.1158/0008-5472.CAN-08-0364; Zhou BBS, 2009, NAT REV DRUG DISCOV, V8, P806, DOI 10.1038/nrd2137	48	23	24	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0132977	10.1371/journal.pone.0132977	http://dx.doi.org/10.1371/journal.pone.0132977			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RV	26185996	Green Submitted, gold, Green Published			2022-12-26	WOS:000358198700081
J	Chang, CY; Lin, CY; Chen, LC; Sun, CH; Li, TY; Tsai, TH; Chang, ST; Wu, YT				Chang, Chih-Ya; Lin, Ching-Yueh; Chen, Liang-Cheng; Sun, Chia-Hung; Li, Tsung-Ying; Tsai, Tung-Han; Chang, Shin-Tsu; Wu, Yung-Tsan			The Predictor of Mortality within Six-Months in Patients with Spontaneous Cerebellar Hemorrhage: A Retrospective Study	PLOS ONE			English	Article							SPONTANEOUS INTRACEREBRAL HEMORRHAGE; PROGNOSTIC-FACTORS; MANAGEMENT; DEATH	Background and Purpose The mortality rate of cerebellar hemorrhage (CH) is generally higher than other types of intracranial hemorrhage. Recently, the increased survey rate of CH has come from improved clinical imaging and earlier surgical intervention. Hence, the predictors of intermittent-(1 to 6 months) and long-term (>6months) mortality are clinically practical use for educational and therapeutic decisions. Unfortunately, the factors predictive mortality within six-month had not yet been systematically investigated. Methods Seventy-two patients with acute spontaneous CH were retrospectively analyzed. The patients were divided into the six-month mortality group (n = 21, died within 6 months after CH onset) and survival group (n = 51, survived beyond 6 months). The independent predictors of six-month mortality were investigated by multivariate Cox proportional hazards regression. Results The radiological brainstem compression (hazard ratios = 23.5; p < 0.001) was independent predictor of mortality within six-month after CH onset. The median onset time of six-month mortality was 5 days in patients with brainstem compression (p < 0.001) and the hazard ratios for the onset time was 13.1 compared with those without brainstem compression (95% CI, 4.7 to 36.3, p < 0.001). Conclusions We report the first study that radiological brainstem compression predicted the mortality within six-month after onset of CH. Patients with radiological brainstem compression were about 23 times more likely to die within 6 months after CH than those without radiological brainstem compression.	[Chang, Chih-Ya; Lin, Ching-Yueh; Chen, Liang-Cheng; Sun, Chia-Hung; Li, Tsung-Ying; Wu, Yung-Tsan] Triserv Gen Hosp, Dept Phys Med & Rehabil, 325,Sec 2, Taipei, Taiwan; [Chang, Chih-Ya; Lin, Ching-Yueh; Chen, Liang-Cheng; Sun, Chia-Hung; Li, Tsung-Ying; Chang, Shin-Tsu; Wu, Yung-Tsan] Natl Def Med Ctr, Dept Phys Med & Rehabil, Sch Med, Taipei, Taiwan; [Tsai, Tung-Han] Natl Def Med Ctr, Triserv Gen Hosp, Dept Neurosurg, Taipei, Taiwan; [Chang, Shin-Tsu] Taichung Vet Gen Hosp, Dept Rehabil, Taichung, Taiwan	Tri-Service General Hospital; National Defense Medical Center; National Defense Medical Center; Tri-Service General Hospital; Taichung Veterans General Hospital	Wu, YT (corresponding author), Triserv Gen Hosp, Dept Phys Med & Rehabil, 325,Sec 2, Taipei, Taiwan.	crwu98@gmail.com	Li, Tsung-Ying/AAJ-2359-2020; Chang, Shin-Tsu/AAF-8506-2020; chihya, Chang/AAI-6537-2021	Chang, Shin-Tsu/0000-0003-4005-2094				Chobanian AV., 2003, HYPERTENSION, V42, P1206, DOI [10.1161/01.HYP.0000107251, DOI 10.1161/01.HYP.9.2_PT_2.II36, DOI 10.1161/01.HYP.0000107251.49515.C2]; Da Pian R, 1984, Neurol Res, V6, P145; Dammann P, 2011, NEUROSURG REV, V34, P77, DOI 10.1007/s10143-010-0279-0; DAVERAT P, 1991, STROKE, V22, P1, DOI 10.1161/01.STR.22.1.1; Dolderer S, 2004, EUR NEUROL, V52, P112, DOI 10.1159/000080268; Garibi J, 2002, BRIT J NEUROSURG, V16, P355, DOI 10.1080/0268869021000007579; Hardemark HG, 1999, CEREBROVASC DIS, V9, P10, DOI 10.1159/000015890; Hemphill JC, 2009, NEUROLOGY, V73, P1088, DOI 10.1212/WNL.0b013e3181b8b332; Inagawa T, 2000, J NEUROSURG, V93, P967, DOI 10.3171/jns.2000.93.6.0967; Kirollos RW, 2001, NEUROSURGERY, V49, P1378, DOI 10.1097/00006123-200112000-00015; Morgenstern LB, 2010, STROKE, V41, P2108, DOI 10.1161/STR.0b013e3181ec611b; Nilsson OG, 2002, J NEUROSURG, V97, P531, DOI 10.3171/jns.2002.97.3.0531; Pong V, 2012, CEREBELLUM, V11, P939, DOI 10.1007/s12311-012-0371-9; Rajajee Venkatakrishna, 2004, J Stroke Cerebrovasc Dis, V13, P47, DOI 10.1016/j.jstrokecerebrovasdis.2004.01.002; Saloheimo P, 2006, STROKE, V37, P487, DOI 10.1161/01.STR.0000198868.78546.fc; Salvati M, 2001, SURG NEUROL, V55, P156, DOI 10.1016/S0090-3019(01)00347-0; Schwarz S, 2000, NEUROLOGY, V54, P354, DOI 10.1212/WNL.54.2.354; St Louis EK, 1998, NEUROLOGY, V51, P1364, DOI 10.1212/WNL.51.5.1364; St Louis EK, 2000, CAN J NEUROL SCI, V27, P32; Vermeer SE, 2002, NEUROLOGY, V59, P205, DOI 10.1212/WNL.59.2.205; Wu YT, 2013, CEREBELLUM, V12, P165, DOI 10.1007/s12311-012-0410-6; Wu YT, 2012, CEREBELLUM, V11, P543, DOI 10.1007/s12311-011-0317-7; Zia E, 2009, STROKE, V40, P3567, DOI 10.1161/STROKEAHA.109.556324	23	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0132975	10.1371/journal.pone.0132975	http://dx.doi.org/10.1371/journal.pone.0132975			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RV	26186721	Green Published, gold, Green Submitted			2022-12-26	WOS:000358198700080
J	Li, JT; Zhong, BY; Xu, HH; Qiao, SY; Wang, G; Huang, J; Fan, HZ; Zhao, HC				Li, Jing-Tao; Zhong, Bao-Yuan; Xu, Hui-Hui; Qiao, Sheng-Yan; Wang, Gui; Huang, Jing; Fan, Hui-Zhen; Zhao, Hong-Chuan			Associations between NBS1 Polymorphisms and Colorectal Cancer in Chinese Population	PLOS ONE			English	Article							NIJMEGEN-BREAKAGE-SYNDROME; DOUBLE-STRAND BREAKS; SINGLE-NUCLEOTIDE POLYMORPHISMS; DNA-REPAIR GENES; LUNG-CANCER; RISK; SURVIVAL; DAMAGE; RADIOTHERAPY; RECURRENCE	As the central protein of the double strand breaks (DSB)-induced DNA repair pathway, NBS1 participates in detecting the DSBs and plays an essential role in maintaining genomic stability. Single nucleotide polymorphisms (SNPs) in NBS1 gene were commonly tested that associated with the susceptibility to multiple cancers, but the results remained controversial. Thus, we conducted two independent hospital-based case-control studies comprising 1,072 colorectal cancer patients and 1,263 controls to evaluate the association between four NBS1 SNPs and colorectal cancer risk. The result showed that rs2735383C/G polymorphism in the 3'-untranslated region (UTR) of NBS1 was significantly associated with risk of colorectal cancer using logistic regression (P<10(-4)). Furthermore, we observed that rs2735383CC genotype was associated with substantially increased risk of colorectal cancer (odds ratio=1.55, 95% confidence interval=1.27-1.94), compared with the rs2735383GC+GG genotypes. Further functional experiments demonstrated that the rs2735383C allele in the NBS1 disrupted the binding affinity of has-miR-509-5p to the NBS1 3'-UTR in colorectal cancer cells, affecting the NBS1 transcriptional activity and expression level. In conclusion, current evidence suggests that the rs2735383C/G polymorphism might contribute to the risk for colorectal cancer.	[Li, Jing-Tao; Zhao, Hong-Chuan] China Japan Friendship Hosp, Dept Gastroenterol, Beijing, Peoples R China; [Zhong, Bao-Yuan] First Affiliated Hosp, Gannan Med Coll, Dept Gen Surg, Ganzhou, Peoples R China; [Xu, Hui-Hui; Qiao, Sheng-Yan; Wang, Gui; Huang, Jing] China Japan Friendship Hosp, Inst Clin Med, Beijing, Peoples R China; [Fan, Hui-Zhen] Peoples Hosp Yichun City, Dept Gastroenterol, Yichun, Peoples R China	China-Japan Friendship Hospital; Gannan Medical University; China-Japan Friendship Hospital	Fan, HZ (corresponding author), Peoples Hosp Yichun City, Dept Gastroenterol, Yichun, Peoples R China.	fhz9205@163.com; zhaohongchuan2000@163.com			National High Technology Research and Development Program of China (863 Program) [2014AA020801]; International Science & Technology Cooperation Program of China [2013DFA31510]; Research Fund of Beijing Municipal Science & Technology Commission [Z111107067311021]; National Natural Science Foundation of China [81360606]	National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); International Science & Technology Cooperation Program of China; Research Fund of Beijing Municipal Science & Technology Commission; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Dr. Hong-Chuan Zhao received funds from the National High Technology Research and Development Program of China (863 Program) (No. 2014AA020801), International Science & Technology Cooperation Program of China (No. 2013DFA31510) and the Research Fund of Beijing Municipal Science & Technology Commission (No. Z111107067311021); Dr. Hui-Zhen Fan was supported by the National Natural Science Foundation of China (No. 81360606). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernstein C, 2002, MUTAT RES-REV MUTAT, V511, P145, DOI 10.1016/S1383-5742(02)00009-1; Canbay E, 2011, CURR MED RES OPIN, V27, P1295, DOI 10.1185/03007995.2011.573544; Celeste A, 2002, SCIENCE, V296, P922, DOI 10.1126/science.1069398; Choudhury A, 2008, BMC MED GENET, V9, DOI 10.1186/1471-2350-9-69; Du HN, 2014, SCI REP-UK, V4, DOI 10.1038/srep06700; Fan Li-hui, 2010, Zhonghua Liu Xing Bing Xue Za Zhi, V31, P213; Forsti A, 2004, ONCOL REP, V11, P917; Gao P, 2013, MUTAGENESIS, V28, P683, DOI 10.1093/mutage/get048; Han JL, 2009, BREAST CANCER RES TR, V115, P613, DOI 10.1007/s10549-008-0089-z; Hoeijmakers JHJ, 2001, NATURE, V411, P366, DOI 10.1038/35077232; Hu YD, 2011, GENE DEV, V25, P685, DOI 10.1101/gad.2011011; Iijima K, 2004, CHROMOSOMA, V113, P53, DOI 10.1007/s00412-004-0298-0; Jelonek K, 2010, J APPL GENET, V51, P343, DOI 10.1007/BF03208865; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Khanna KK, 2001, NAT GENET, V27, P247, DOI 10.1038/85798; Kobayashi J, 2004, J RADIAT RES, V45, P473, DOI 10.1269/jrr.45.473; Lee JH, 2003, MOL CANCER RES, V1, P674; Li N, 2014, CARCINOGENESIS, V35, P2687, DOI 10.1093/carcin/bgu201; Li W, 2014, GASTROENTEROLOGY, V146, P1714, DOI 10.1053/j.gastro.2014.03.002; Lins S, 2009, GENE, V447, P12, DOI 10.1016/j.gene.2009.07.013; Lu JC, 2006, CARCINOGENESIS, V27, P2209, DOI 10.1093/carcin/bgl077; Mahaney BL, 2009, BIOCHEM J, V417, P639, DOI 10.1042/BJ20080413; Moghimi-Dehkordi B, 2012, WORLD J GASTRO ONCOL, V4, P71, DOI 10.4251/wjgo.v4.i4.71; Mohideen AMSH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113513; Rollinson S, 2006, LEUKEMIA LYMPHOMA, V47, P2567, DOI 10.1080/10428190600909743; Ryk C, 2006, LUNG CANCER, V54, P285, DOI 10.1016/j.lungcan.2006.08.004; Silva J, 2012, DNA CELL BIOL, V31, P1182, DOI 10.1089/dna.2011.1562; Smolinska K, 2010, ARCH MED SCI, V6, P605, DOI 10.5114/aoms.2010.14475; Stavridi ES, 2005, NAT CELL BIOL, V7, P648, DOI 10.1038/ncb0705-648; Teo MTW, 2012, CARCINOGENESIS, V33, P581, DOI 10.1093/carcin/bgr300; Tseng SF, 2005, J BIOL CHEM, V280, P39594, DOI 10.1074/jbc.M508425200; Vrieling A, 2010, AM J CLIN NUTR, V92, P471, DOI [10.3945/ajcn.2010.29005, 10.3945/ajcn.2009.29005]; Wang Y, 2000, GENE DEV, V14, P927; Williams RS, 2009, CELL, V139, P87, DOI 10.1016/j.cell.2009.07.033; Xing DY, 2003, ONCOL REP, V10, P1615; Yang L, 2012, CARCINOGENESIS, V33, P338, DOI 10.1093/carcin/bgr272; Yang TT, 2014, CANCER CAUSE CONTROL, V25, P11, DOI 10.1007/s10552-013-0303-0; Yao F, 2013, TUMOR BIOL, V34, P1255, DOI 10.1007/s13277-013-0668-4; Zhang GF, 2013, TUMOR BIOL, V34, P2753, DOI 10.1007/s13277-013-0830-z; Zhao S, 2002, NUCLEIC ACIDS RES, V30, P4815, DOI 10.1093/nar/gkf612; Zheng J, 2013, CANCER RES, V73, P5151, DOI 10.1158/0008-5472.CAN-13-0395; Zheng J, 2011, MOL CARCINOGEN, V50, P689, DOI 10.1002/mc.20803	42	6	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0132332	10.1371/journal.pone.0132332	http://dx.doi.org/10.1371/journal.pone.0132332			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RV	26186548	gold, Green Submitted, Green Published			2022-12-26	WOS:000358198700037
J	Pidoux, G; Gerbaud, P; Guibourdenche, J; Therond, P; Ferreira, F; Simasotchi, C; Evain-Brion, D; Gil, S				Pidoux, Guillaume; Gerbaud, Pascale; Guibourdenche, Jean; Therond, Patrice; Ferreira, Fatima; Simasotchi, Christelle; Evain-Brion, Daniele; Gil, Sophie			Formaldehyde Crosses the Human Placenta and Affects Human Trophoblast Differentiation and Hormonal Functions	PLOS ONE			English	Article							IN-VITRO DIFFERENTIATION; AMINO-ACID TRANSPORTERS; CELL-FUSION; ENVELOPE GLYCOPROTEIN; OXIDATIVE STRESS; PLASMA-MEMBRANE; GENE-EXPRESSION; HERV-W; RECEPTOR; MODULATION	The chorionic villus of the human placenta is the source of specific endocrine functions and nutrient exchanges. These activities are ensured by the syncytiotrophobast (ST), which bathes in maternal blood. The ST arises and regenerates throughout pregnancy by fusion of underlying cytotrophoblasts (CT). Any anomaly of ST formation or regeneration can affect pregnancy outcome and fetal growth. Because of its direct interaction with maternal blood, the ST is sensitive to drugs, pollutants and xenohormones. Ex vivo assays of perfused cotyledon show that formaldehyde, a common pollutant present in furniture, paint and plastics, can accumulate in the human placenta and cross to the fetal compartment. By means of RT-qPCR, immunoblot and immunocytochemistry experiments, we demonstrate in vitro that formaldehyde exerts endocrine toxicity on human trophoblasts, including a decrease in the production of protein hormones of pregnancy. In addition, formaldehyde exposure triggered human trophoblast fusion by upregulating syncitin-1 receptor expression (ASC-type amino-acid transporter 2: ASCT2). Moreover, we show that formaldehyde-exposed trophoblasts present an altered redox status associated with oxidative stress, and an increase in ASCT2 expression intended to compensate for this stress. Finally, we demonstrate that the adverse effects of formaldehyde on trophoblast differentiation and fusion are reversed by Nacetyl-L-cysteine (Nac), an antioxidant.	[Pidoux, Guillaume; Gerbaud, Pascale; Guibourdenche, Jean; Ferreira, Fatima; Evain-Brion, Daniele; Gil, Sophie] INSERM, U1139, Paris, France; [Pidoux, Guillaume; Gerbaud, Pascale; Guibourdenche, Jean; Ferreira, Fatima; Evain-Brion, Daniele; Gil, Sophie] Univ Paris 05, Paris, France; [Therond, Patrice] Univ Paris Sud, UFR Pharmacie, EA4529, Chatenay Malabry, France; [Therond, Patrice] Hop Bicetre, AP HP, Serv Biochim, F-94275 Le Kremlin Bicetre, France; [Guibourdenche, Jean; Simasotchi, Christelle; Evain-Brion, Daniele; Gil, Sophie] PremUp, Paris, France; [Pidoux, Guillaume; Simasotchi, Christelle; Gil, Sophie] Univ Paris Sud, Fac Pharm, Chatenay Malabry, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Saclay	Pidoux, G (corresponding author), INSERM, U1139, Paris, France.	guillaume.pidoux@inserm.fr	GIL, Sophie/ABB-1071-2020; Pidoux, Guillaume/O-1292-2018	Pidoux, Guillaume/0000-0002-5074-429X; Gerbaud, Pascale/0000-0001-5579-1979; /0000-0001-5197-7434	Inserm; program "Domaines d'Interet Majeur Sante, Environnement, Toxicologie" of Region Ile de France; Caisse d'Assurance Maladie des Professions Liberales Province	Inserm(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); program "Domaines d'Interet Majeur Sante, Environnement, Toxicologie" of Region Ile de France(Region Ile-de-France); Caisse d'Assurance Maladie des Professions Liberales Province	This work was supported Inserm and by a fellowship from the program "Domaines d'Interet Majeur Sante, Environnement, Toxicologie" of Region Ile de France (to GP) and Caisse d'Assurance Maladie des Professions Liberales Province (tools).	Alsat E, 1996, J CELL PHYSIOL, V168, P346, DOI 10.1002/(SICI)1097-4652(199608)168:2<346::AID-JCP13>3.0.CO;2-1; ALSAT E, 1993, J CELL PHYSIOL, V154, P122, DOI 10.1002/jcp.1041540115; Alsat E, 1997, AM J OBSTET GYNECOL, V177, P1526, DOI 10.1016/S0002-9378(97)70103-0; APLIN JD, 1991, J CELL SCI, V99, P681; Attia D, 2016, TOXICOL IND HEALTH, V32, P1097, DOI 10.1177/0748233714547152; Benirschke KKP, 2000, PATHOLOGY OF THE HUM; Bjerregaard B, 2006, CELL MOL LIFE SCI, V63, P1906, DOI 10.1007/s00018-006-6201-9; Blaise S, 2003, P NATL ACAD SCI USA, V100, P13013, DOI 10.1073/pnas.2132646100; Blond JL, 2000, J VIROL, V74, P3321, DOI 10.1128/JVI.74.7.3321-3329.2000; Cariappa R, 2003, PLACENTA, V24, P713, DOI 10.1016/S0143-4004(03)00085-7; Challier J C, 1985, Contrib Gynecol Obstet, V13, P32; Chang C, 2004, BIOL REPROD, V71, P1956, DOI 10.1095/biolreprod.104.033340; Collins JJ, 2001, REGUL TOXICOL PHARM, V34, P17, DOI 10.1006/rtph.2001.1486; Cronier L, 2002, MOL HUM REPROD, V8, P1005, DOI 10.1093/molehr/8.11.1005; Dang CV, 2010, CANCER RES, V70, P859, DOI 10.1158/0008-5472.CAN-09-3556; Duong A, 2011, MUTAT RES-REV MUTAT, V728, P118, DOI 10.1016/j.mrrev.2011.07.003; EATON B, 1993, HUMAN PLACENTA, P471; Esnault C, 2008, P NATL ACAD SCI USA, V105, P17532, DOI 10.1073/pnas.0807413105; Fournier T, 2015, PLACENTA, V36, pS60, DOI 10.1016/j.placenta.2015.02.002; Frendo JL, 2003, MOL CELL BIOL, V23, P3566, DOI 10.1128/MCB.23.10.3566-3574.2003; Frendo JL, 2001, ENDOCRINOLOGY, V142, P3638, DOI 10.1210/en.142.8.3638; Frendo JL, 2000, PLACENTA, V21, P773, DOI 10.1053/plac.2000.0575; FURESZ TC, 1993, AM J PHYSIOL, V265, pC212, DOI 10.1152/ajpcell.1993.265.1.C212; Gerbaud P, 2015, PLACENTA, V36, pS35, DOI 10.1016/j.placenta.2014.12.015; Gerbaud P, 2011, ENDOCRINOLOGY, V152, P5017, DOI 10.1210/en.2011-1193; Gorrini C, 2013, NAT REV DRUG DISCOV, V12, P931, DOI 10.1038/nrd4002; Heazell AEP, 2009, REPROD BIOMED ONLINE, V18, P111, DOI 10.1016/S1472-6483(10)60432-4; HECK HD, 1985, AM IND HYG ASSOC J, V46, P1, DOI 10.1080/15298668591394275; HOELTZLI SD, 1989, AM J PHYSIOL, V256, pC630, DOI 10.1152/ajpcell.1989.256.3.C630; Honkisz E, 2012, REPROD TOXICOL, V34, P385, DOI 10.1016/j.reprotox.2012.05.094; Huang FM, 2005, J BIOMED MATER RES B, V74B, P768, DOI 10.1002/jbm.b.30283; Hutson JR, 2011, J POPUL THER CLIN PH, V18, pE533; IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, 2006, IARC Monogr Eval Carcinog Risks Hum, V88, P1; Inoue Y, 1999, J BIOL CHEM, V274, P27002, DOI 10.1074/jbc.274.38.27002; Jansson T, 2001, PEDIATR RES, V49, P141, DOI 10.1203/00006450-200102000-00003; JEAVONS CM, 1984, ALCOHOL CLIN EXP RES, V8, P352, DOI 10.1111/j.1530-0277.1984.tb05679.x; JOHN EM, 1994, EPIDEMIOLOGY, V5, P147, DOI 10.1097/00001648-199403000-00004; JOHNSON LW, 1988, AM J PHYSIOL, V254, pC773, DOI 10.1152/ajpcell.1988.254.6.C773; Katakura Y, 1990, Sangyo Igaku, V32, P42; Katakura Y, 1991, Sangyo Igaku, V33, P264; KATAKURA Y, 1993, BRIT J IND MED, V50, P176; Keryer G, 1998, J CELL SCI, V111, P995; KLIMAN HJ, 1986, ENDOCRINOLOGY, V118, P1567, DOI 10.1210/endo-118-4-1567; Lavillette D, 2002, J VIROL, V76, P6442, DOI 10.1128/JVI.76.13.6442-6452.2002; Levovich I, 2008, CANCER CHEMOTH PHARM, V62, P471, DOI 10.1007/s00280-007-0627-0; Lino-dos-Santos-Franco A, 2011, TOXICOL LETT, V207, P278, DOI 10.1016/j.toxlet.2011.09.026; Longtine MS, 2012, PLACENTA, V33, P971, DOI 10.1016/j.placenta.2012.09.013; Malassine A, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-6; Malassine A, 2011, ADV EXP MED BIOL, V714, P103, DOI 10.1007/978-94-007-0782-5_4; MARKS TA, 1980, TERATOLOGY, V22, P51, DOI 10.1002/tera.1420220108; Mohammadi S, 2014, ELECTRONIC PHYSICIAN, V6, P939, DOI 10.14661/2014.939-943; Monfared AL, 2014, TOXICOL IND HEALTH, V30, P174, DOI 10.1177/0748233712452603; Myatt L, 2002, ENDOCRINE, V19, P103, DOI 10.1385/ENDO:19:1:103; Neuberger A., 1981, COMP BIOCHEM, V19A, P257; Newbern D, 2011, CURR OPIN ENDOCRINOL, V18, P409, DOI 10.1097/MED.0b013e32834c800d; Ogren Linda, 1994, P875; Perot P, 2011, CELL FUSIONS: REGULATION AND CONTROL, P63, DOI 10.1007/978-90-481-9772-9_4; Pidoux G, 2004, PLACENTA, V25, pS79, DOI 10.1016/j.placenta.2004.01.007; Pidoux G, 2004, PLACENTA, V25, P469, DOI 10.1016/j.placenta.2003.10.016; Pidoux G, 2007, J CELL PHYSIOL, V212, P26, DOI 10.1002/jcp.20995; Pidoux G, 2014, J CELL SCI, V127, P4172, DOI 10.1242/jcs.149609; Pidoux G, 2010, AM J PHYSIOL-CELL PH, V298, pC1517, DOI 10.1152/ajpcell.00484.2008; Potgens AJG, 2004, HUM REPROD UPDATE, V10, P487, DOI 10.1093/humupd/dmh039; SCHMON B, 1991, J CLIN ENDOCR METAB, V73, P888, DOI 10.1210/jcem-73-4-888; SCHNEIDE.H, 1972, AM J OBSTET GYNECOL, V114, P822, DOI 10.1016/0002-9378(72)90909-X; Shi YQ, 2014, TOXICOL IND HEALTH, V30, P901, DOI 10.1177/0748233712466129; SOMMERFELT MA, 1990, VIROLOGY, V176, P58, DOI 10.1016/0042-6822(90)90230-O; SOMMERFELT MA, 1990, J VIROL, V64, P6214, DOI 10.1128/JVI.64.12.6214-6220.1990; Speit G, 2014, MUTAT RES-FUND MOL M, V760, P48, DOI 10.1016/j.mrfmmm.2013.11.007; Switala J, 2002, ARCH BIOCHEM BIOPHYS, V401, P145, DOI 10.1016/S0003-9861(02)00049-8; Takamiya M, 2007, REPROD TOXICOL, V24, P265, DOI 10.1016/j.reprotox.2007.07.003; TASKINEN H, 1994, J OCCUP ENVIRON MED, V36, P311, DOI 10.1097/00043764-199403000-00008; Taskinen HK, 1999, AM J IND MED, V36, P206, DOI 10.1002/(SICI)1097-0274(199907)36:1&lt;206::AID-AJIM29&gt;3.0.CO;2-D; Teng S, 2001, CHEM-BIOL INTERACT, V130, P285, DOI 10.1016/S0009-2797(00)00272-6; Thrasher JD, 2001, ARCH ENVIRON HEALTH, V56, P300, DOI 10.1080/00039890109604460; Vargas A, 2009, J MOL BIOL, V392, P301, DOI 10.1016/j.jmb.2009.07.025; Wang JB, 2010, CANCER CELL, V18, P207, DOI 10.1016/j.ccr.2010.08.009; WILBOURN J, 1995, SCAND J WORK ENV HEA, V21, P229, DOI 10.5271/sjweh.1368; Zeller J, 2012, ARCH TOXICOL, V86, P1465, DOI 10.1007/s00204-012-0830-6; Zhang YC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074974	80	21	22	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0133506	10.1371/journal.pone.0133506	http://dx.doi.org/10.1371/journal.pone.0133506			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RV	26186596	Green Published, gold, Green Submitted			2022-12-26	WOS:000358198700150
J	Williams, J; Scarborough, P; Townsend, N; Matthews, A; Burgoine, T; Mumtaz, L; Rayner, M				Williams, Julianne; Scarborough, Peter; Townsend, Nick; Matthews, Anne; Burgoine, Thomas; Mumtaz, Lorraine; Rayner, Mike			Associations between Food Outlets around Schools and BMI among Primary Students in England: A Cross-Classified Multi-Level Analysis	PLOS ONE			English	Article							DIETARY BEHAVIORS; PHYSICAL-ACTIVITY; CHILDHOOD OVERWEIGHT; US CHILDREN; OBESITY; ENVIRONMENT; NEIGHBORHOOD; RESTAURANTS; ADOLESCENTS; WEIGHT	Introduction Researchers and policy-makers are interested in the influence that food retailing around schools may have on child obesity risk. Most previous research comes from North America, uses data aggregated at the school-level and focuses on associations between fast food outlets and school obesity rates. This study examines associations between food retailing and BMI among a large sample of primary school students in Berkshire, England. By controlling for individual, school and home characteristics and stratifying results across the primary school years, we aimed to identify if the food environment around schools had an effect on BMI, independent of socio-economic variables. Methods We measured the densities of fast food outlets and food stores found within schoolchildren's home and school environments using Geographic Information Systems (GIS) and data from local councils. We linked these data to measures from the 2010/11 National Child Measurement Programme and used a cross-classified multi-level approach to examine associations between food retailing and BMI z-scores. Analyses were stratified among Reception (aged 4-5) and Year 6 (aged 10-11) students to measure associations across the primary school years. Results Our multilevel model had three levels to account for individual (n = 16,956), home neighbourhood (n = 664) and school (n = 268) factors. After controlling for confounders, there were no significant associations between retailing near schools and student BMI, but significant positive associations between fast food outlets in home neighbourhood and BMI z-scores. Year 6 students living in areas with the highest density of fast food outlets had an average BMI z-score that was 0.12 (95% CI:0.04, 0.20) higher than those living in areas with none. Discussion We found little evidence to suggest that food retailing around schools influences student BMI. There is some evidence to suggest that fast food outlet densities in a child's home neighbourhood may have an effect on BMI, particularly among girls, but more research is needed to inform effective policies targeting the effects of the retail environment on child obesity.	[Williams, Julianne; Scarborough, Peter; Townsend, Nick; Matthews, Anne; Mumtaz, Lorraine; Rayner, Mike] Univ Oxford, British Heart Fdn, Ctr Populat Approaches Noncommunicable Dis Preven, Nuffield Dept Populat Hlth, Oxford OX3 7LF, England; [Burgoine, Thomas] Univ Cambridge, Sch Clin Med, MRC, UKCRC Ctr Diet & Act Res CEDAR,Inst Metab Sci,Epi, Cambridge CB2 0QQ, England	University of Oxford; University of Cambridge	Williams, J (corresponding author), Univ Oxford, British Heart Fdn, Ctr Populat Approaches Noncommunicable Dis Preven, Nuffield Dept Populat Hlth, Old Rd Campus, Oxford OX3 7LF, England.	julianne.williams@dph.ox.ac.uk	Scarborough, Peter/ABD-6111-2021	Scarborough, Peter/0000-0002-2378-2944; Townsend, Nick/0000-0001-9890-0901	British Heart Foundation [006/P&C/CORE/2013/OXFSTATS, 021/P&C/Core/2010/HPRG]; National Health Services Berkshire project grant; Cancer Research UK; Economic and Social Research Council; Medical Research Council; National Institute for Health Research; Wellcome Trust under the UK Clinical Research Collaboration; ESRC [ES/G007462/1] Funding Source: UKRI; MRC [MR/K023187/1] Funding Source: UKRI; Economic and Social Research Council [ES/G007462/1] Funding Source: researchfish; Medical Research Council [MR/K023187/1] Funding Source: researchfish	British Heart Foundation(British Heart Foundation); National Health Services Berkshire project grant; Cancer Research UK(Cancer Research UK); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research(National Institute for Health Research (NIHR)); Wellcome Trust under the UK Clinical Research Collaboration(Wellcome Trust); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was undertaken in part by the British Heart Foundation Centre on Population Approaches for Non-Communicable Disease Prevention, a World Health Organization Collaborating Centre and by the Centre for Diet and Activity Research (CEDAR), a UK Clinical Research Collaboration (UKCRC) Public Health Research Centre of Excellence. Funding from the British Heart Foundation (006/P&C/CORE/2013/OXFSTATS, 021/P&C/Core/2010/HPRG), National Health Services Berkshire project grant, Cancer Research UK, Economic and Social Research Council, Medical Research Council, the National Institute for Health Research, and the Wellcome Trust, under the auspices of the UK Clinical Research Collaboration, is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Academy of Royal Medical Colleges, 2013, MEAS MED PROF PRESCR; [Anonymous], 2013, CHILDREN YOUNG PEOPL; [Anonymous], BEG GUID UK GEOGR; Austin SB, 2005, AM J PUBLIC HEALTH, V95, P1575, DOI 10.2105/AJPH.2004.056341; Burgoine T, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g1464; Burgoine T, 2010, APPETITE, V55, P522, DOI 10.1016/j.appet.2010.08.020; Caspi CE, 2012, HEALTH PLACE, V18, P1172, DOI 10.1016/j.healthplace.2012.05.006; Cavill N, 2013, HLTH PEOPLE HLTH PLA; Cetateanu A, 2014, HEALTH PLACE, V27, P68, DOI 10.1016/j.healthplace.2014.01.007; Charreire H, 2014, HEALTH PLACE, V25, P1, DOI [10.1016/j.healthplace.2013.09.017, 10.1010/j.healthplace.2013.09.017]; Chiang PH, 2011, PUBLIC HEALTH NUTR, V14, P1601, DOI 10.1017/S1368980011001042; Cole TJ, 2007, BMJ-BRIT MED J, V335, P194, DOI 10.1136/bmj.39238.399444.55; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; Crawford PB, 2011, PREV CHRONIC DIS, V8; Cummins S, 2006, INT J EPIDEMIOL, V35, P100, DOI 10.1093/ije/dyi276; Cummins S, 2007, INT J EPIDEMIOL, V36, P355, DOI 10.1093/ije/dym033; Cummins S, 2009, PREV MED, V49, P527, DOI 10.1016/j.ypmed.2009.10.007; Currie J, 2010, AM ECON J-ECON POLIC, V2, P32, DOI 10.1257/pol.2.3.32; Day PL, 2011, AM J PREV MED, V40, P113, DOI 10.1016/j.amepre.2010.10.018; Department for Education, 2011, SCH CENS ENGL; Diller PA, 2011, J LAW MED ETHICS, V39, P89, DOI 10.1111/j.1748-720X.2011.00575.x; Drewnowski A, 2004, AM J PREV MED, V27, P154, DOI 10.1016/j.amepre.2004.06.011; Drewnowski A, 2013, NUTR J, V12, DOI 10.1186/1475-2891-12-59; Egger G, 1997, BRIT MED J, V315, P477, DOI 10.1136/bmj.315.7106.477; Ellaway A, 2012, HEALTH PLACE, V18, P1335, DOI 10.1016/j.healthplace.2012.06.001; Evans CEL, 2009, J HUM NUTR DIET, V22, P89, DOI 10.1111/j.1365-277X.2008.00941.x; Feng J, 2010, HEALTH PLACE, V16, P175, DOI 10.1016/j.healthplace.2009.09.008; Fleischhacker SE, 2011, OBES REV, V12, pe460, DOI 10.1111/j.1467-789X.2010.00715.x; Forsyth A, 2012, HEALTH PLACE, V18, P1261, DOI 10.1016/j.healthplace.2012.09.005; Gebremariam MK, 2012, SCAND J PUBLIC HEALT, V40, P491, DOI 10.1177/1403494812454948; Gilliland JA, 2012, CAN J PUBLIC HEALTH, V103, pS15, DOI 10.1007/BF03403830; Grier S, 2013, J PUBLIC POLICY MARK, V32, P116, DOI 10.1509/jppm.11.158; Harrison F, 2014, INT J HEALTH GEOGR, V13, DOI 10.1186/1476-072X-13-5; Harrison F, 2011, SOC SCI MED, V72, P1411, DOI 10.1016/j.socscimed.2011.02.023; Harrison F, 2011, HEALTH PLACE, V17, P710, DOI 10.1016/j.healthplace.2011.01.009; He MZ, 2012, INT J ENV RES PUB HE, V9, P1458, DOI 10.3390/ijerph9041458; Health and Social Care Information Centre, 2013, NAT CHILD MEAS PROGR; Holsten JE, 2009, PUBLIC HEALTH NUTR, V12, P397, DOI 10.1017/S1368980008002267; Jaime PC, 2009, PREV MED, V48, P45, DOI 10.1016/j.ypmed.2008.10.018; Katz DL, 2008, INT J OBESITY, V32, P1780, DOI 10.1038/ijo.2008.158; Kestens Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041418; Khambalia AZ, 2012, OBES REV, V13, P214, DOI 10.1111/j.1467-789X.2011.00947.x; Kubik MY, 2003, AM J PUBLIC HEALTH, V93, P1168, DOI 10.2105/AJPH.93.7.1168; Lake AA, 2010, HEALTH PLACE, V16, P666, DOI 10.1016/j.healthplace.2010.02.004; Larson N, 2009, ANN BEHAV MED, V38, pS56, DOI 10.1007/s12160-009-9120-9; Lytle LA, 2009, AM J PREV MED, V36, pS134, DOI 10.1016/j.amepre.2009.01.018; Maffeis C, 2001, HORM RES, V55, P42, DOI 10.1159/000063462; Matthews A, 2011, FOOD PURCHASES CONSU; Matthews SA, 2012, AM J PREV MED, V42, P516, DOI 10.1016/j.amepre.2012.02.004; McKinnon RA, 2009, AM J PREV MED, V36, pS124, DOI 10.1016/j.amepre.2009.01.012; Mhurchu CN, 2013, OBES REV, V14, P108, DOI 10.1111/obr.12080; Mitchell C, 2011, OBES REV, V12, P660, DOI 10.1111/j.1467-789X.2011.00872.x; Moudon AV, 2013, PUBLIC HEALTH NUTR, V16, P1238, DOI 10.1017/S1368980013000773; Neckerman KM, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g1817; Neckerman KM, 2010, AM J PREV MED, V39, P195, DOI 10.1016/j.amepre.2010.05.004; Nestle M, 2010, AM J PREV MED, V39, P280, DOI 10.1016/j.amepre.2010.06.001; Nixon H, 2011, J AGRIC FOOD SYST CO, V2, P181, DOI 10.5304/jafscd.2011.021.007; Oakes JM, 2009, AM J PREV MED, V36, pS177, DOI 10.1016/j.amepre.2009.01.015; Office for National Statistics, 2014, RUR URB CLASS; Oude Luttikhuis H, 2009, COCHRANE DB SYST REV, V3, P1, DOI DOI 10.1002/14651858.CD001872.PUB2; Park S, 2013, J ADOLESCENT HEALTH, V53, P655, DOI 10.1016/j.jadohealth.2013.06.002; Poti JM, 2014, J ACAD NUTR DIET, V114, P908, DOI 10.1016/j.jand.2013.08.012; Public Health England, 2013, NAT CHILD MEAS PROGR; Public Health England, 2013, OB ENV REG GROWTH FA; Rossen LM, 2013, J URBAN HEALTH, V90, P653, DOI 10.1007/s11524-012-9785-4; Rossen LM, 2012, HEALTH PLACE, V18, P956, DOI 10.1016/j.healthplace.2012.06.012; Rutter H, 2012, INT J PUBLIC HEALTH, P1; Sanchez BN, 2012, AM J EPIDEMIOL, V175, P1284, DOI 10.1093/aje/kwr454; Schabas L, 2014, NUTR BULL, V39, P99, DOI 10.1111/nbu.12074; Sinclair S, 2008, SCH FRINGE WHAT PUPI; Smith D, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-70; Story M, 2006, FUTURE CHILD, V16, P109, DOI 10.1353/foc.2006.0007; Story M, 1999, INT J OBESITY, V23, pS43, DOI 10.1038/sj.ijo.0800859; Swinburn BA, 2011, LANCET, V378, P804, DOI 10.1016/S0140-6736(11)60813-1; The London Food Board Chartered Institute of Environmental Health, 2012, TAK TOOLK TOOLS INT; Timperio A, 2008, PREV MED, V46, P331, DOI 10.1016/j.ypmed.2007.11.011; Townsend N, 2012, INT J OBESITY, V36, P45, DOI 10.1038/ijo.2011.191; United Kingdom Government, 2014, TYP SCH; [United Kingdom Government Department for Communities and Local Government], 2010, CHILD WELLB IND; van der Horst K, 2008, AM J PREV MED, V35, P217, DOI 10.1016/j.amepre.2008.05.022; Waters E, 2011, COCHRANE COLLABORATI, V12, P1; Williams J, 2014, OBES REV, V15, P359, DOI 10.1111/obr.12142; Wooten H, 2012, ZONING LICENSING REG, P65; Zenk SN, 2011, HEALTH PLACE, V17, P1150, DOI 10.1016/j.healthplace.2011.05.001	84	19	19	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0132930	10.1371/journal.pone.0132930	http://dx.doi.org/10.1371/journal.pone.0132930			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN1RV	26186610	Green Published, Green Submitted, gold			2022-12-26	WOS:000358198700070
J	Zhang, ML; Sun, T; Jian, CS; Lei, L; Han, PD; Lv, QL; Yang, R; Zhou, XH; Xu, JJ; Hu, YC; Men, YF; Huang, YU; Zhang, CM; Zhu, XJ; Wang, XH; Cheng, HP; Xiong, JW				Zhang, Meiling; Sun, Tao; Jian, Chongshu; Lei, Lei; Han, Peidong; Lv, Quanlong; Yang, Ran; Zhou, Xiaohai; Xu, Jiejia; Hu, Yingchun; Men, Yongfan; Huang, Yanyi; Zhang, Chuanmao; Zhu, Xiaojun; Wang, Xianhua; Cheng, Heping; Xiong, Jing-Wei			Remodeling of Mitochondrial Flashes in Muscular Development and Dystrophy in Zebrafish	PLOS ONE			English	Article							FISH ORYZIAS-LATIPES; SUPEROXIDE FLASHES; PERMEABILITY TRANSITION; MOUSE; PROLIFERATION; INHIBITION; APOPTOSIS; ELEMENT	Mitochondrial flash (mitoflash) is a highly-conserved, universal, and physiological mitochondrial activity in isolated mitochondria, intact cells, and live organisms. Here we investigated developmental and disease-related remodeling of mitoflash activity in zebrafish skeletal muscles. In transgenic zebrafish expressing the mitoflash reporter cpYFP, in vivo imaging revealed that mitoflash frequency and unitary properties underwent multiphasic and muscle type-specific changes, accompanying mitochondrial morphogenesis from 2 to 14 dpf. In particular, short (S)-type mitoflashes predominated in early muscle formation, then S-, transitory (T)- and regular (R)-type mitoflashes coexisted during muscle maturation, followed by a switch to R-type mitoflashes in mature skeletal muscles. In early development of muscular dystrophy, we found accelerated S-to R-type mitoflash transition and reduced mitochondrial NAD(P)H amidst a remarkable cell-to-cell heterogeneity. This study not only unravels a profound functional and morphological remodeling of mitochondria in developing and diseased skeletal muscles, but also underscores mitoflashes as a useful reporter of mitochondrial function in milieu of live animals under physiological and pathophysiological conditions.	[Zhang, Meiling; Sun, Tao; Jian, Chongshu; Lei, Lei; Han, Peidong; Yang, Ran; Zhou, Xiaohai; Xu, Jiejia; Zhu, Xiaojun; Wang, Xianhua; Cheng, Heping; Xiong, Jing-Wei] Peking Univ, Inst Mol Med, Beijing Key Lab Cardiometabol Mol Med, Beijing 100871, Peoples R China; [Sun, Tao; Jian, Chongshu; Han, Peidong; Lv, Quanlong; Xu, Jiejia; Zhang, Chuanmao; Wang, Xianhua; Cheng, Heping] Peking Univ, State Key Lab Biomembrane & Membrane Biotechnol, Beijing 100871, Peoples R China; [Cheng, Heping] Peking Univ, Peking Tsinghua Ctr Life Sci, Beijing 100871, Peoples R China; [Hu, Yingchun; Men, Yongfan; Zhang, Chuanmao] Peking Univ, Coll Life Sci, Beijing 100871, Peoples R China; [Men, Yongfan; Huang, Yanyi] Peking Univ, Biodynam Opt Imaging Ctr, Beijing 100871, Peoples R China; [Huang, Yanyi] Peking Univ, Coll Engn, Beijing 100871, Peoples R China	Peking University; Peking University; Peking University; Peking University; Peking University; Peking University	Cheng, HP (corresponding author), Peking Univ, Inst Mol Med, Beijing Key Lab Cardiometabol Mol Med, Beijing 100871, Peoples R China.	chengp@pku.edu.cn; jingwei_xiong@pku.edu.cn	cheng, heping/A-7299-2011; Lu, Quanlong/M-4436-2015; Heping, Cheng/AAE-2680-2019; Hu, Ying/GQZ-8100-2022; Men, Yongfan/AAU-5701-2020	Lu, Quanlong/0000-0002-4261-5121; Heping, Cheng/0000-0002-9604-6702; Men, Yongfan/0000-0001-8265-1787; Xu, Jiejia/0000-0003-3885-3546	National Basic Research Program of China [2013CB531200, 2012CB944501, 2010CB529503]; National Natural Science Foundation of China [31430059, 81470399, 31221002, 31271549, 81270164]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Basic Research Program of China (2013CB531200, 2012CB944501, and 2010CB529503), and the National Natural Science Foundation of China (31430059, 81470399, 31221002, 31271549, and 81270164).	Bassett DI, 2003, DEVELOPMENT, V130, P5851, DOI 10.1242/dev.00799; Breckwoldt M, 2014, NAT MED, V20, P559, DOI 10.1038/nm.3520; De Palma C, 2010, CELL DEATH DIFFER, V17, P1684, DOI 10.1038/cdd.2010.48; Dickey AS, 2011, J NEUROSCI, V31, P15716, DOI 10.1523/JNEUROSCI.3159-11.2011; Douglas DS, 2009, NEUROCHEM RES, V34, P124, DOI 10.1007/s11064-008-9719-4; Fang HQ, 2011, CELL RES, V21, P1295, DOI 10.1038/cr.2011.81; Granato M, 1996, DEVELOPMENT, V123, P399; Hom JR, 2011, DEV CELL, V21, P469, DOI 10.1016/j.devcel.2011.08.008; Hou TT, 2014, J PHYSIOL-LONDON, V592, P3703, DOI 10.1113/jphysiol.2014.275735; Hou Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076721; Hou Y, 2012, STEM CELLS, V30, P2535, DOI 10.1002/stem.1213; Irwin WA, 2003, NAT GENET, V35, P367, DOI 10.1038/ng1270; Kawakami K, 2004, GENE, V338, P93, DOI 10.1016/j.gene.2004.05.013; Kawakami K, 2004, GENETICS, V166, P895, DOI 10.1534/genetics.166.2.895; Kirchmaier BC, 2012, DEV BIOL, V363, P438, DOI 10.1016/j.ydbio.2012.01.015; Li KT, 2012, BIOPHYS J, V102, P1011, DOI 10.1016/j.bpj.2012.01.044; Lobbardi R, 2011, DEVELOPMENT, V138, P1783, DOI 10.1242/dev.059121; Millay DP, 2008, NAT MED, V14, P442, DOI 10.1038/nm1736; Mishra P, 2014, NAT REV MOL CELL BIO, V15, P634, DOI 10.1038/nrm3877; Palma E, 2009, HUM MOL GENET, V18, P2024, DOI 10.1093/hmg/ddp126; Pouvreau S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013035; Reutenauer J, 2008, BRIT J PHARMACOL, V155, P574, DOI 10.1038/bjp.2008.285; Schwarzlander M, 2012, TRENDS CELL BIOL, V22, P503, DOI 10.1016/j.tcb.2012.07.007; Schwarzlander M, 2011, BIOCHEM J, V437, P381, DOI 10.1042/BJ20110883; Shen EZ, 2014, NATURE, V508, P128, DOI 10.1038/nature13012; Stellabotte F, 2007, DEV DYNAM, V236, P2432, DOI 10.1002/dvdy.21253; Telfer WR, 2010, HUM MOL GENET, V19, P2433, DOI 10.1093/hmg/ddq126; Tidball JG, 2007, J APPL PHYSIOL, V102, P1677, DOI 10.1152/japplphysiol.01145.2006; Wang W, 2008, CELL, V134, P279, DOI 10.1016/j.cell.2008.06.017; Wang XH, 2012, J MOL CELL CARDIOL, V52, P940, DOI 10.1016/j.yjmcc.2012.02.007; Wang X, 2013, J CELL SCI, V126, P1381, DOI 10.1242/jcs.116996; Wei L, 2012, J GEN PHYSIOL, V139, P425, DOI 10.1085/jgp.201210790; Wei L, 2011, FASEB J, V25, P3068, DOI 10.1096/fj.11-187252; Xu SH, 2014, DEV CELL, V31, P48, DOI 10.1016/j.devcel.2014.08.002; Zhang X, 2013, LIFE SCI, V93, P178, DOI 10.1016/j.lfs.2013.06.012	35	20	21	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0132567	10.1371/journal.pone.0132567	http://dx.doi.org/10.1371/journal.pone.0132567			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RV	26186000	Green Published, gold, Green Submitted			2022-12-26	WOS:000358198700049
J	Ero-Tolliver, IA; Hudson, BG; Bhave, G				Ero-Tolliver, Isi A.; Hudson, Billy G.; Bhave, Gautam			The Ancient Immunoglobulin Domains of Peroxidasin Are Required to Form Sulfilimine Cross-links in Collagen IV	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						basement membrane; extracellular matrix; myeloperoxidase; peroxidase; protein cross-linking; collagen IV; peroxidasin; sulfilimine bond	BASEMENT-MEMBRANE; EXTRACELLULAR-MATRIX; MYELOPEROXIDASE; EVOLUTION; BINDING; PROTEIN; BONDS	Background: Because peroxidasin generates HOBr to form sulfilimine cross-links in collagen IV, any peroxidase producing HOBr may cross-link collagen IV. Results: Among animal peroxidases, only peroxidasin efficiently cross-linked collagen IV requiring its catalytic and immunoglobulin domains. Conclusion: Peroxidasin uniquely reacts HOBr with collagen IV to catalyze sulfilimine bond formation. Significance: Insight into how peroxidasin cross-links collagen IV is critical to understand basement membrane function. The collagen IV sulfilimine cross-link and its catalyzing enzyme, peroxidasin, represent a dyad critical for tissue development, which is conserved throughout the animal kingdom. Peroxidasin forms novel sulfilimine bonds between opposing methionine and hydroxylysine residues to structurally reinforce the collagen IV scaffold, a function critical for basement membrane and tissue integrity. However, the molecular mechanism underlying cross-link formation remains unclear. In this work, we demonstrate that the catalytic domain of peroxidasin and its immunoglobulin (Ig) domains are required for efficient sulfilimine bond formation. Thus, these molecular features underlie the evolutionarily conserved function of peroxidasin in tissue development and integrity and distinguish peroxidasin from other peroxidases, such as myeloperoxidase (MPO) and eosinophil peroxidase (EPO).	[Ero-Tolliver, Isi A.; Hudson, Billy G.; Bhave, Gautam] Vanderbilt Univ, Med Ctr, Div Nephrol & Hypertens, Nashville, TN 37232 USA; [Ero-Tolliver, Isi A.; Hudson, Billy G.; Bhave, Gautam] Vanderbilt Univ, Med Ctr, Dept Med, Nashville, TN 37232 USA; [Ero-Tolliver, Isi A.; Hudson, Billy G.; Bhave, Gautam] Vanderbilt Univ, Med Ctr, Ctr Matrix Biol, Nashville, TN 37232 USA; [Hudson, Billy G.] Vanderbilt Univ, Med Ctr, Dept Biochem, Nashville, TN 37232 USA; [Hudson, Billy G.] Vanderbilt Univ, Med Ctr, Dept Pathol Microbiol & Immunol, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University	Bhave, G (corresponding author), S-3223 Med Ctr North,1161 21st Ave South, Nashville, TN 37232 USA.	gautam.bhave@vanderbilt.edu	Ero-Tolliver, Isi/AAD-6038-2019; Regan, Clinton/E-6250-2012	Hudson, Billy/0000-0002-5420-4100	National Institutes of Health [R01 DK18381, R01 DK 18381-38S1, K08 DK 097306]; Burroughs-Wellcome Fund Career Award for Medical Scientists [13030995]; Vanderbilt University Division of Nephrology Hypertension; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK097306, R01DK018381] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs-Wellcome Fund Career Award for Medical Scientists(Burroughs Wellcome Fund); Vanderbilt University Division of Nephrology Hypertension; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 DK18381 (to B. G. H.), R01 DK 18381-38S1 (to I. A. E-T.), and K08 DK 097306 (to G. B.) and a Burroughs-Wellcome Fund Career Award for Medical Scientists (13030995) and developmental funds from the Vanderbilt University Division of Nephrology & Hypertension (to G. B.). The authors declare that they have no conflicts of interest with the contents of this article.	Baldus S, 2001, J CLIN INVEST, V108, P1759; Bhave G, 2002, NEURON, V35, P721, DOI 10.1016/S0896-6273(02)00802-4; Bhave G, 2012, NAT CHEM BIOL, V8, P784, DOI [10.1038/NCHEMBIO.1038, 10.1038/nchembio.1038]; BORK P, 1994, J MOL BIOL, V242, P309, DOI 10.1006/jmbi.1994.1582; Brondijk THC, 2010, BLOOD, V115, P1364, DOI 10.1182/blood-2009-10-246322; Buljan M, 2009, BIOCHEM SOC T, V37, P751, DOI 10.1042/BST0370751; Fidler AL, 2014, P NATL ACAD SCI USA, V111, P331, DOI 10.1073/pnas.1318499111; Gotenstein JR, 2010, DEVELOPMENT, V137, P3603, DOI 10.1242/dev.049189; Horii K, 2006, BLOOD, V108, P936, DOI 10.1182/blood-2006-01-010215; Khoshnoodi J, 2008, MICROSC RES TECHNIQ, V71, P357, DOI 10.1002/jemt.20564; Kiselyov VV, 1997, J BIOL CHEM, V272, P10125; Kubala L, 2013, BBA-GEN SUBJECTS, V1830, P4524, DOI 10.1016/j.bbagen.2013.05.024; Leitinger B, 2011, ANNU REV CELL DEV BI, V27, P265, DOI 10.1146/annurev-cellbio-092910-154013; McCall AS, 2014, CELL, V157, P1380, DOI 10.1016/j.cell.2014.05.009; NELSON RE, 1994, EMBO J, V13, P3438, DOI 10.1002/j.1460-2075.1994.tb06649.x; Obinger C, 2006, ARCH BIOCHEM BIOPHYS, V445, P197, DOI 10.1016/j.abb.2005.10.015; Peterfi Z, 2009, AM J PATHOL, V175, P725, DOI 10.2353/ajpath.2009.080693; Rees MD, 2010, MATRIX BIOL, V29, P63, DOI 10.1016/j.matbio.2009.09.005; Senthilmohan R, 2006, ARCH BIOCHEM BIOPHYS, V445, P235, DOI 10.1016/j.abb.2005.07.005; Smith DK, 1997, J MOL BIOL, V274, P530, DOI 10.1006/jmbi.1997.1432; Soudi M, 2015, J BIOL CHEM, V290, P10876, DOI 10.1074/jbc.M114.632273; Vanacore R, 2009, SCIENCE, V325, P1230, DOI 10.1126/science.1176811; WEBER S, 1984, EUR J BIOCHEM, V139, P401, DOI 10.1111/j.1432-1033.1984.tb08019.x; WEBER S, 1988, EUR J BIOCHEM, V175, P229, DOI 10.1111/j.1432-1033.1988.tb14188.x; WEISS SJ, 1989, NEW ENGL J MED, V320, P365; WEISS SJ, 1986, SCIENCE, V234, P200, DOI 10.1126/science.3018933; Zamocky M, 2008, PROTEINS, V72, P589, DOI 10.1002/prot.21950	27	24	25	2	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	2015	290	35					21741	21748		10.1074/jbc.M115.673996	http://dx.doi.org/10.1074/jbc.M115.673996			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CQ5IS	26178375	Green Published, hybrid			2022-12-26	WOS:000360637600045
J	Liu, J; Kim, KH; Morales, MJ; Heximer, SP; Hui, CC; Backx, PH				Liu, Jie; Kim, Kyoung-Han; Morales, Michael J.; Heximer, Scott P.; Hui, Chi-chung; Backx, Peter H.			Kv4.3-Encoded Fast Transient Outward Current Is Presented in Kv4.2 Knockout Mouse Cardiomyocytes	PLOS ONE			English	Article							K+ CURRENTS; POTASSIUM CHANNEL; MESSENGER-RNA; GENE-EXPRESSION; DOWN-REGULATION; BETA-SUBUNIT; CANINE; HEART; REPOLARIZATION; HETEROGENEITY	Gradients of the fast transient outward K+ current (I-to,I- f) contribute to heterogeneity of ventricular repolarization in a number of species. Cardiac I-to,I- f levels and gradients change notably with heart disease. Human cardiac I-to,I- f appears to be encoded by the Kv4.3 pore-forming alpha-subunit plus the auxiliary KChIP2 beta-subunit while mouse cardiac I-to,I- f requires Kv4.2 and Kv4.3 alpha-subunits plus KChIP2. Regional differences in cardiac I-to,I- f are associated with expression differences in Kv4.2 and KChIP2. Although I-to,I- f was reported to be absent in mouse ventricular cardiomyocytes lacking the Kv4.2 gene (Kv4.2-/-) when short depolarizing voltage pulses were used to activate voltage-gated K+ currents, in the present study, we showed that the use of long depolarization steps revealed a heteropodatoxin-sensitive I-to,I- f (at similar to 40% of the wild-type levels). Immunohistological studies further demonstrated membrane expression of Kv4.3 in Kv4.2-/- cardiomyocytes. Transmural I-to,I- f gradients across the left ventricular wall were reduced by similar to 3.5-fold in Kv4.2-/- heart, compared to wild-type. The I-to,I- f gradient in Kv4.2-/- hearts was associated with gradients in KChIP2 mRNA expression while in wild-type there was also a gradient in Kv4.2 expression. In conclusion, we found that Kv4.3-based I-to,I- f exists in the absence of Kv4.2, although with a reduced transmural gradient. Kv4.2-/- mice may be a useful animal model for studying Kv4.3-based I-to,I- f as observed in humans.	[Liu, Jie; Kim, Kyoung-Han; Heximer, Scott P.; Backx, Peter H.] Univ Toronto, Dept Physiol, Toronto, ON, Canada; [Liu, Jie; Kim, Kyoung-Han; Heximer, Scott P.; Backx, Peter H.] Univ Toronto, Dept Med, Toronto, ON, Canada; [Liu, Jie; Kim, Kyoung-Han; Backx, Peter H.] Univ Hlth Network, Div Cardiol, Toronto, ON, Canada; [Kim, Kyoung-Han; Hui, Chi-chung] Hosp Sick Children, Program Dev & Stem Cell Biol, Toronto, ON M5G 1X8, Canada; [Morales, Michael J.] SUNY Buffalo, Dept Physiol & Biophys, Buffalo, NY 14260 USA; [Hui, Chi-chung] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada	University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; University of Toronto	Hui, CC (corresponding author), Hosp Sick Children, Program Dev & Stem Cell Biol, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	cchui@sickkids.ca; p.backx@utoronto.ca	Kim, Kyoung-Han/AAZ-4908-2021	Kim, Kyoung-Han/0000-0002-0433-656X	Canadian Institutes for Health Research [MOP 119339]	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR))	PHB received a grant (MOP 119339) from the Canadian Institutes for Health Research.	Bertaso F, 2002, BASIC RES CARDIOL, V97, P424, DOI 10.1007/s00395-002-0377-4; Calloe K, 2009, CARDIOVASC RES, V81, P686, DOI 10.1093/cvr/cvn339; Chen XX, 2006, J NEUROSCI, V26, P12143, DOI 10.1523/JNEUROSCI.2667-06.2006; Cordeiro JM, 2004, AM J PHYSIOL-HEART C, V286, pH1471, DOI 10.1152/ajpheart.00748.2003; Crank J, 1975, MATH DIFFUSION, V2nd; DELBALZO U, 1992, CIRCULATION, V85, P1464, DOI 10.1161/01.CIR.85.4.1464; Deschenes I, 2002, CIRCULATION, V106, P423, DOI 10.1161/01.CIR.0000025417.65658.B6; Dilks D, 1999, J NEUROPHYSIOL, V81, P1974, DOI 10.1152/jn.1999.81.4.1974; Dixon JE, 1996, CIRC RES, V79, P659, DOI 10.1161/01.RES.79.4.659; El-Haou S, 2009, CIRC RES, V104, P758, DOI 10.1161/CIRCRESAHA.108.191007; Faivre JF, 1999, CARDIOVASC RES, V41, P188, DOI 10.1016/S0008-6363(98)00215-6; Fedida D, 1996, J PHYSIOL-LONDON, V494, P377, DOI 10.1113/jphysiol.1996.sp021499; Fick A, 1855, PHILOS MAG, P10; Fiset C'L, 2006, CIRC RES, V98, P1237, DOI 10.1161/01.RES.0000225859.82676.ba; Glover DM JW, 2005, MODELING METHODS FOR; Grubb S, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00118; Guo WN, 2005, CIRC RES, V97, P1342, DOI 10.1161/01.RES.0000196559.63223.aa; Guo WN, 2002, J BIOL CHEM, V277, P26436, DOI 10.1074/jbc.M201431200; Guo WN, 2002, CIRC RES, V90, P586, DOI 10.1161/01.RES.0000012664.05949.E0; Holzem KM, 2012, EUROPACE, V14, pV50, DOI 10.1093/europace/eus275; Kaab S, 1998, CIRCULATION, V98, P1383, DOI 10.1161/01.CIR.98.14.1383; Kaprielian R, 2002, AM J PHYSIOL-HEART C, V283, pH1157, DOI 10.1152/ajpheart.00518.2001; Kassiri Z, 2002, CIRC RES, V90, P578, DOI 10.1161/01.RES.0000012223.86441.A1; Kim KH, 2008, J PHARMACOL EXP THER, V324, P160, DOI 10.1124/jpet.107.125773; Liu J, 2011, BASIC RES CARDIOL, V106, P189, DOI 10.1007/s00395-010-0134-z; MATSUBARA H, 1993, J CLIN INVEST, V92, P1659, DOI 10.1172/JCI116751; Menegola M, 2006, J NEUROSCI, V26, P12137, DOI 10.1523/JNEUROSCI.2783-06.2006; NABAUER M, 1993, CIRC RES, V73, P386, DOI 10.1161/01.RES.73.2.386; Niwa N, 2008, J MOL CELL CARDIOL, V44, P95, DOI 10.1016/j.yjmcc.2007.10.007; Niwa N, 2010, J MOL CELL CARDIOL, V48, P12, DOI 10.1016/j.yjmcc.2009.07.013; Patberg KW, 2003, CIRC RES, V93, P472, DOI 10.1161/01.RES.0000088785.24381.2F; Patel SP, 2004, J PHYSIOL-LONDON, V557, P19, DOI 10.1113/jphysiol.2003.058172; Perrin MJ, 2014, CIRC-CARDIOVASC GENE, V7, P782, DOI 10.1161/CIRCGENETICS.114.000623; Petersen KR, 1999, PFLUG ARCH EUR J PHY, V437, P381, DOI 10.1007/s004240050792; Rosati B, 2003, J PHYSIOL-LONDON, V548, P815, DOI 10.1113/jphysiol.2002.033704; Rosati B, 2001, J PHYSIOL-LONDON, V533, P119, DOI 10.1111/j.1469-7793.2001.0119b.x; Sah R, 2003, J PHYSIOL-LONDON, V546, P5, DOI 10.1113/jphysiol.2002.026468; Sah R, 2001, J PHYSIOL-LONDON, V533, P201, DOI 10.1111/j.1469-7793.2001.0201b.x; Teutsch C, 2007, CARDIOVASC RES, V73, P739, DOI 10.1016/j.cardiores.2006.11.034; Wickenden AD, 1997, J PHYSIOL-LONDON, V504, P271, DOI 10.1111/j.1469-7793.1997.271be.x; Yan GX, 1996, CIRCULATION, V93, P372, DOI 10.1161/01.CIR.93.2.372; Zhang M, 2001, CIRC RES, V88, P1012, DOI 10.1161/hh1001.090839; Zhang SS, 2011, P NATL ACAD SCI USA, V108, P13576, DOI 10.1073/pnas.1106911108; Zhou J, 2003, AM J PHYSIOL-HEART C, V284, pH491, DOI 10.1152/ajpheart.00576.2002; Zhu XR, 1999, RECEPTOR CHANNEL, V6, P387; Zicha S, 2004, J PHYSIOL-LONDON, V561, P735, DOI 10.1113/jphysiol.2004.075861	46	12	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0133274	10.1371/journal.pone.0133274	http://dx.doi.org/10.1371/journal.pone.0133274			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LZ	26196737	Green Submitted, Green Published, gold			2022-12-26	WOS:000358547600079
J	Qi, WH; Jiang, XM; Du, LM; Xiao, GS; Hu, TZ; Yue, BS; Quan, QM				Qi, Wen-Hua; Jiang, Xue-Mei; Du, Lian-Ming; Xiao, Guo-Sheng; Hu, Ting-Zhang; Yue, Bi-Song; Quan, Qiu-Mei			Genome-Wide Survey and Analysis of Microsatellite Sequences in Bovid Species	PLOS ONE			English	Article							GC CONTENT; SECONDARY STRUCTURES; REPEATS; DNA; IDENTIFICATION; CONSERVATION; EXPRESSION; MUTATIONS; DIVERSITY; PATTERNS	Microsatellites or simple sequence repeats (SSRs) have become the most popular source of genetic markers, which are ubiquitously distributed in many eukaryotic and prokaryotic genomes. This is the first study examining and comparing SSRs in completely sequenced genomes of the Bovidae. We analyzed and compared the number of SSRs, relative abundance, relative density, guanine-cytosine (GC) content and proportion of SSRs in six taxonomically different bovid species: Bos taurus, Bubalus bubalis, Bos mutus, Ovis aries, Capra hircus, and Pantholops hodgsonii. Our analysis revealed that, based on our search criteria, the total number of perfect SSRs found ranged from 663,079 to 806,907 and covered from 0.44% to 0.48% of the bovid genomes. Relative abundance and density of SSRs in these Bovinae genomes were non-significantly correlated with genome size (Pearson, r < 0.420, p > 0.05). Perfect mononucleotide SSRs were the most abundant, followed by the pattern: perfect di- > tri- > penta- > tetra- > hexanucleotide SSRs. Generally, the number of SSRs, relative abundance, and relative density of SSRs decreased as the motif repeat length increased in each species of Bovidae. The most GC-content was in trinucleotide SSRs and the least was in the mononucleotide SSRs in the six bovid genomes. The GC-contents of tri- and pentanucleotide SSRs showed a great deal of similarity among different chromosomes of B. taurus, O. aries, and C. hircus. SSR number of all chromosomes in the B. taurus, O. aries, and C. hircus is closely positively correlated with chromosome sequence size (Pearson, r > 0.980, p < 0.01) and significantly negatively correlated with GC-content (Pearson, r < -0.638, p < 0.01). Relative abundance and density of SSRs in all chromosomes of the three species were significantly negatively correlated with GC-content (Pearson, r <-0.333, P< 0.05) but not significantly correlated with chromosome sequence size (Pearson, r< -0.185, P > 0.05). Relative abundances of the same nucleotide SSR type showed great similarity among different chromosomes of B. taurus, O. aries, and C. hircus.	[Qi, Wen-Hua; Xiao, Guo-Sheng; Hu, Ting-Zhang] Chongqing Three Gorges Univ, Coll Life Sci & Engn, Chongqing, Peoples R China; [Jiang, Xue-Mei] Chongqing Three Gorges Univ, Coll Environm & Chem Engn, Chongqing 404100, Peoples R China; [Du, Lian-Ming; Yue, Bi-Song] Sichuan Univ, Coll Life Sci, Minist Educ, Key Lab Bioresources & Ecoenvironm, Chengdu 610064, Peoples R China; [Quan, Qiu-Mei] China West Normal Univ, Sch Life Sci, Nanchong 637009, Peoples R China	Chongqing Three Gorges University; Chongqing Three Gorges University; Sichuan University; China West Normal University	Qi, WH (corresponding author), Chongqing Three Gorges Univ, Coll Life Sci & Engn, Chongqing, Peoples R China.	wenhuaqi357@163.com			Scientific and Technological Research Program of Chongqing Municipal Education Commission [KJ1401004]; Chongqing Three Gorges University [13QN12, 201403068, 12RC03]	Scientific and Technological Research Program of Chongqing Municipal Education Commission; Chongqing Three Gorges University	This work was supported by the Scientific and Technological Research Program of Chongqing Municipal Education Commission (No. KJ1401004) and Wanzhou District (No. 201403068), Talent Introduction Project (No. 12RC03) and Youth Project (No. 13QN12) of Chongqing Three Gorges University.	Alam CM, 2014, INFECT GENET EVOL, V21, P287, DOI 10.1016/j.meegid.2013.11.018; Bachmann L, 2004, J ZOOL SYST EVOL RES, V42, P215, DOI 10.1111/j.1439-0469.2004.00275.x; Bachtrog D, 1999, MOL BIOL EVOL, V16, P602, DOI 10.1093/oxfordjournals.molbev.a026142; BECKMANN JS, 1992, GENOMICS, V12, P627, DOI 10.1016/0888-7543(92)90285-Z; Castagnone-Sereno P, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-598; Chambers GK, 2000, COMP BIOCHEM PHYS B, V126, P455, DOI 10.1016/S0305-0491(00)00233-9; Coenye T, 2005, DNA RES, V12, P221, DOI 10.1093/dnares/dsi009; Dieringer D, 2003, GENOME RES, V13, P2242, DOI 10.1101/gr.1416703; Du LM, 2013, J HERED, V104, P154, DOI 10.1093/jhered/ess082; Ellegren H, 2004, NAT REV GENET, V5, P435, DOI 10.1038/nrg1348; ESTOUP A, 1993, NUCLEIC ACIDS RES, V21, P1427, DOI 10.1093/nar/21.6.1427; Glenn TC, 1996, MOL BIOL EVOL, V13, P1151, DOI 10.1093/oxfordjournals.molbev.a025678; Griffiths A, 2006, J VIROL, V80, P6568, DOI 10.1128/JVI.00155-06; Grimwood J, 2001, INFECT IMMUN, V69, P2383, DOI 10.1128/IAI.69.4.2383-2389.2001; Hagerman PJ, 2004, MENT RETARD DEV D R, V10, P25, DOI 10.1002/mrdd.20005; Hefferon TW, 2004, P NATL ACAD SCI USA, V101, P3504, DOI 10.1073/pnas.0400182101; Hiratani I, 2004, P NATL ACAD SCI USA, V101, P16861, DOI 10.1073/pnas.0406687101; Hong CP, 2007, MOL CELLS, V23, P349; Jarne P, 1996, TRENDS ECOL EVOL, V11, P424, DOI 10.1016/0169-5347(96)10049-5; Jarne P, 1998, MOL BIOL EVOL, V15, P28, DOI 10.1093/oxfordjournals.molbev.a025844; Jayashree B., 2006, In Silico Biology, V6, P607; JURKA J, 1995, J MOL EVOL, V40, P120, DOI 10.1007/BF00167107; Karaoglu H, 2005, MOL BIOL EVOL, V22, P639, DOI [10.1093/molbev/mis057, 10.1093/molbev/msi057]; Kashi Y, 2006, TRENDS GENET, V22, P253, DOI 10.1016/j.tig.2006.03.005; Katti MV, 2001, MOL BIOL EVOL, V18, P1161, DOI 10.1093/oxfordjournals.molbev.a003903; Khrustalev VV, 2009, COMPUT BIOL CHEM, V33, P295, DOI 10.1016/j.compbiolchem.2009.06.005; Kim TS, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-31; Korpelainen H, 2007, BIOTECHNIQUES, V42, P479, DOI 10.2144/000112415; Kumpatla SP, 2005, GENOME, V48, P985, DOI 10.1139/G05-060; Lawson MJ, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-2-r14; Li CY, 2009, INTERDISCIP SCI, V1, P141, DOI 10.1007/s12539-009-0014-5; Li YC, 2004, MOL BIOL EVOL, V21, P991, DOI 10.1093/molbev/msh073; Moore H, 1999, P NATL ACAD SCI USA, V96, P1504, DOI 10.1073/pnas.96.4.1504; Morgante M, 2002, NAT GENET, V30, P194, DOI 10.1038/ng822; Mrazek J, 2007, P NATL ACAD SCI USA, V104, P8472, DOI 10.1073/pnas.0702412104; Ouyang QJ, 2012, GENE, V499, P37, DOI 10.1016/j.gene.2012.02.049; Prasad MD, 2005, GENETICS, V169, P197, DOI 10.1534/genetics.104.031005; Qian J, 2013, GENE, V512, P331, DOI 10.1016/j.gene.2012.09.127; Ren LC, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-3-r35; Rocha EPC, 2002, NUCLEIC ACIDS RES, V30, P2031, DOI 10.1093/nar/30.9.2031; Schlotterer C, 2004, NAT REV GENET, V5, P63, DOI 10.1038/nrg1249; Selkoe KA, 2006, ECOL LETT, V9, P615, DOI 10.1111/j.1461-0248.2006.00889.x; Sharma PC, 2007, TRENDS BIOTECHNOL; Sharma RK, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-53; Sherman SL, 2000, AM J MED GENET, V97, P189, DOI 10.1002/1096-8628(200023)97:3<189::AID-AJMG1036>3.0.CO;2-J; Subramanian S, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-2-r13; TAUTZ D, 1984, NUCLEIC ACIDS RES, V12, P4127, DOI 10.1093/nar/12.10.4127; Toth G, 2000, GENOME RES, V10, P967, DOI 10.1101/gr.10.7.967; Vinogradov AE, 2003, NUCLEIC ACIDS RES, V31, P1838, DOI 10.1093/nar/gkg296; Vinogradov AE, 2001, MOL BIOL EVOL, V18, P2195, DOI 10.1093/oxfordjournals.molbev.a003766; Wang Y, 2014, BIOMED RES INT; Winnepenninckx B, 2007, AM J HUM GENET, V80, P221, DOI 10.1086/510800; Zhao XY, 2011, GENE, V488, P52, DOI 10.1016/j.gene.2011.08.016	53	28	31	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0133667	10.1371/journal.pone.0133667	http://dx.doi.org/10.1371/journal.pone.0133667			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LZ	26196922	Green Published, gold, Green Submitted			2022-12-26	WOS:000358547600130
J	Wang, X; Zhang, B; Zhang, KB; Zhou, JX; Ahmad, B				Wang, Xiao; Zhang, Bo; Zhang, Kebin; Zhou, Jinxing; Ahmad, Bilal			The Spatial Pattern and Interactions of Woody Plants on the Temperate Savanna of Inner Mongolia, China: The Effects of Alternating Seasonal Grazing-Mowing Regimes	PLOS ONE			English	Article							HORQIN SANDY LAND; SHRUB ENCROACHMENT; ULMUS-PUMILA; CARAGANA-MICROPHYLLA; GRASSLAND DEGRADATION; PROPERTY-RIGHTS; ECOSYSTEM; CLIMATE; FACILITATION; RESTORATION	Ulmus pumila tree-dominated temperate savanna, which is distributed widely throughout the forest-steppe ecotone on the Mongolian Plateau, is a relatively stable woody-herbaceous complex ecosystem in northern China. Relatively more attention has been paid to the degradation of typical steppe areas, whereas less focus has been placed on the succession of this typical temperate savanna under the present management regime. In this study, we established 3 sample plots 100 mx100m in size along a gradient of fixed distances from one herder's stationary site and then surveyed all the woody plants in these plots. A spatial point pattern analysis was employed to clarify the spatial distribution and interaction of these woody plants. The results indicated that old U. pumila trees (DBH >= 20 cm) showed a random distribution and that medium U. pumila trees (5 cm <= DBH < 20 cm) showed an aggregated distribution at a smaller scale and a random distribution at a larger scale; few or no juvenile trees (DBH < 5 cm) were present, and seedlings (without DBH) formed aggregations in all 3 plots. These findings can be explained by an alternate seasonal grazing-mowing regime (exclosure in summer, mowing in autumn and grazing in winter and spring); the shrubs in all 3 plots exist along a grazing gradient that harbors xerophytic and mesophytic shrubs. Of these shrubs, xerophytic shrubs show significant aggregation at a smaller scale (0-5.5 m), whereas mesophytic shrubs show significant aggregation at a larger scale (0-25 m), which may be the result of the dual effects of grazing pressure and climate change. Medium trees and seedlings significantly facilitate the distributions of xerophytic shrubs and compete significantly with mesophytic shrubs due to differences in water use strategies. We conclude that the implementation of an alternative grazing-mowing regime results in xerophytic shrub encroachment or existence, breaking the chain of normal succession in a U. pumila tree community in this typical temperate savanna ecosystem. This might eventually result in the degradation of the original tree-dominated savanna to a xerophytic shrub-dominated savanna.	[Wang, Xiao; Zhang, Bo; Zhang, Kebin; Zhou, Jinxing; Ahmad, Bilal] Beijing Forestry Univ, Soil & Water Conservat, Beijing, Peoples R China	Beijing Forestry University	Zhang, KB (corresponding author), Beijing Forestry Univ, Soil & Water Conservat, Beijing, Peoples R China.	ctccd@126.com; zjx9277@126.com	Jinxing, Zhou/I-6015-2017	Jinxing, Zhou/0000-0003-2182-9849	"948" Project of State Forestry Administration P.R. China [2015-4-27]; International S&T Cooperation Program of China [2015DFR31130]; National Natural Science Foundation of China [41271033, 41471029, 41371500]	"948" Project of State Forestry Administration P.R. China; International S&T Cooperation Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by grants from "948" Project of State Forestry Administration P.R. China (2015-4-27), International S&T Cooperation Program of China (2015DFR31130), and the National Natural Science Foundation of China (41271033; 41471029; 41371500). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1983, TEMPERATE DESERTS SE; [Anonymous], WOODY PLANTS AGROECO; Barnes PW, 1999, J VEG SCI, V10, P525, DOI 10.2307/3237187; Bossdorf O, 2000, J VEG SCI, V11, P253, DOI 10.2307/3236804; Brooker RW, 2008, J ECOL, V96, P18, DOI 10.1111/j.1365-2745.2007.01295.x; Cabral AC, 2003, J VEG SCI, V14, P145, DOI 10.1111/j.1654-1103.2003.tb02139.x; Callaway R. M., 2007, POSITIVE INTERACTION; Calvo L, 2005, PLANT ECOL, V180, P175, DOI 10.1007/s11258-005-0200-z; Ci Longjun YX, 2010, DESERTIFICATION ITS; Cipriotti PA, 2012, APPL VEG SCI, V15, P35, DOI 10.1111/j.1654-109X.2011.01138.x; Collins SL, 1998, SCIENCE, V280, P745, DOI 10.1126/science.280.5364.745; Condit R, 2000, SCIENCE, V288, P1414, DOI 10.1126/science.288.5470.1414; D'Odorico P, 2012, ECOHYDROLOGY, V5, P520, DOI 10.1002/eco.259; D'Odorico P, 2010, ECOSPHERE, V1, DOI 10.1890/ES10-00073.1; DALE MRT, 1999, ECOLOGY, V0088, P00366; Davies KW, 2012, RANGELAND ECOL MANAG, V65, P268, DOI 10.2111/REM-D-11-00146.1; Dormann CF, 2002, PLANT BIOLOGY, V4, P647, DOI 10.1055/s-2002-35437; Druckenbrod DL, 2005, J VEG SCI, V16, P37, DOI 10.1111/j.1654-1103.2005.tb02336.x; Dunn C. P., 2000, ELMS BREEDING CONSER; Fang J., 2011, ATLAS WOODY PLANTS C, V1; Flores J, 2003, J VEG SCI, V14, P911, DOI 10.1111/j.1654-1103.2003.tb02225.x; GARNER W, 1989, J ARID ENVIRON, V16, P257, DOI 10.1016/S0140-1963(18)30941-8; Gomez-Aparicio L, 2004, ECOL APPL, V14, P1128, DOI 10.1890/03-5084; Gordon I.J., 2008, ECOLOGY BROWSING GRA; Grace J., 2012, PERSPECTIVES PLANT C; Greig-Smith P., 1983, QUANTITATIVE PLANT E; Guo K, 2003, ACTA ECOLOGICA SINIC, V24, P2024; Gutterman Y, 2001, REGENERATION PLANTS; HALL LM, 1992, J RANGE MANAGE, V45, P503, DOI 10.2307/4002912; He FL, 1997, J VEG SCI, V8, P105, DOI 10.2307/3237248; Hilbig W., 1995, VEGETATION MONGOLIA; Ho P, 2001, J DEV STUD, V37, P99, DOI 10.1080/00220380412331321991; Illian J, 2008, STAT ANAL MODELLING; Jackson RB, 2002, NATURE, V418, P623, DOI 10.1038/nature00910; Jiang DM, 2014, J ARID LAND, V6, P343, DOI 10.1007/s40333-013-0204-9; Jiuru X, 2001, J BEIJING FORESTRY U, V23, P75; Kirilyuk V.E., 2012, EURASIAN STEPPES ECO; Li A, 2012, LANDSCAPE ECOL, V27, P969, DOI 10.1007/s10980-012-9751-2; Li WJ, 2007, J ENVIRON MANAGE, V85, P461, DOI 10.1016/j.jenvman.2006.10.010; Li XY, 2013, AGR FOREST METEOROL, V171, P20, DOI 10.1016/j.agrformet.2012.11.001; Li XR, 2001, J ARID ENVIRON, V47, P271, DOI 10.1006/jare.2000.0707; Li YL, 2013, ECOL ENG, V53, P299, DOI 10.1016/j.ecoleng.2012.12.061; Liu Gui-feng, 2011, Yingyong Shengtai Xuebao, V22, P9; Liu L, 2013, CHINESE GEOGR SCI, V23, P321, DOI 10.1007/s11769-013-0607-8; Maestre FT, 2011, SOIL BIOL BIOCHEM, V43, P1746, DOI 10.1016/j.soilbio.2011.04.023; Maestre FT, 2009, ECOL LETT, V12, P930, DOI 10.1111/j.1461-0248.2009.01352.x; Manly BFL., 2007, RESOURCE SELECTION A; Nathan R, 2006, SCIENCE, V313, P786, DOI 10.1126/science.1124975; Padilla FM, 2006, FRONT ECOL ENVIRON, V4, P196, DOI 10.1890/1540-9295(2006)004[0196:TRONPI]2.0.CO;2; Peng HY, 2013, CATENA, V109, P39, DOI 10.1016/j.catena.2013.05.008; Pontes LD, 2012, ACTA OECOL, V45, P25, DOI 10.1016/j.actao.2012.08.006; Quero JL, 2013, ECOSYSTEMS, V16, P1248, DOI 10.1007/s10021-013-9683-y; Ratajczak Z, 2012, ECOLOGY, V93, P697, DOI 10.1890/11-1199.1; Roy J, 2012, EXPLOITATION ENV HET; Schurr FM, 2004, PLANT ECOL, V173, P271, DOI 10.1023/B:VEGE.0000029335.13948.87; Schwinning S, 2013, FUNCT ECOL, V27, P886, DOI 10.1111/1365-2435.12115; Shao C, 2012, J ARID ENVIRON, V82, P1, DOI 10.1016/j.jaridenv.2012.02.019; Shi L, 2004, ANN BOT-LONDON, V94, P553, DOI 10.1093/aob/mch174; Smit C, 2011, J VEG SCI, V22, P377, DOI 10.1111/j.1654-1103.2011.01264.x; Spencer DF, 2014, WEED RES, V54, P140, DOI 10.1111/wre.12058; Squires VR, 2009, RANGELAND DEGRATION; Stoyan D, 2000, SCAND J STAT, V27, P641, DOI 10.1111/1467-9469.00213; Stoyan D., 1994, FRACTALS RANDOM SHAP; Su H, 2014, TREES-STRUCT FUNCT, V28, P41, DOI 10.1007/s00468-013-0928-3; Su YZ, 2003, ECOL ENG, V20, P223, DOI 10.1016/S0925-8574(03)00042-9; Thwaites R, 1998, SOC NATUR RESOUR, V11, P319, DOI 10.1080/08941929809381085; Tong C, 2004, J ARID ENVIRON, V59, P133, DOI 10.1016/j.jaridenv.2004.01.004; Vallentine, 2000, GRAZING MANAGEMENT; Van Auken OW, 2000, ANNU REV ECOL SYST, V31, P197, DOI 10.1146/annurev.ecolsys.31.1.197; [王雪 WANG Xue], 2011, [干旱区研究, Arid Zone Research], V28, P542; WANG Y, 2013, PLOS ONE, V2013; WATT TA, 1988, VEGETATIO, V78, P91, DOI 10.1007/BF00045643; Wesche K, 2011, FLORA, V206, P91, DOI 10.1016/j.flora.2010.01.012; Wiegand T, 2004, OIKOS, V104, P209, DOI 10.1111/j.0030-1299.2004.12497.x; Wiegand T., 2013, HDB SPATIAL POINT PA; Williams DM, 2002, GREAT WALLS ENV IDEN; WU B, 2013, PLOS ONE, V8; Wu Z.Y., 2013, FLORA CHINA; Xie YN, 2008, NOMAD PEOPLES, V12, P35, DOI 10.3167/np.2008.120203; Yang HJ, 2012, ECOL LETT, V15, P619, DOI 10.1111/j.1461-0248.2012.01778.x; Yang HX, 2014, APPL VEG SCI, V17, P338, DOI 10.1111/avsc.12062; Yu P, 2005, RESTORING DEGRADED E; Zhang Jian, 2007, Yingyong Shengtai Xuebao, V18, P1681; Zhang MA, 2007, ECOL ECON, V62, P19, DOI 10.1016/j.ecolecon.2006.11.005; Zhang TH, 2006, PEDOSPHERE, V16, P319, DOI 10.1016/S1002-0160(06)60058-1; Zhang X.S, 2007, VEGETATION MAP CHINA, P296; Zheng YR, 2006, J ARID ENVIRON, V64, P523, DOI 10.1016/j.jaridenv.2005.06.007; Zida D, 2009, AFR J ECOL, V47, P97, DOI 10.1111/j.1365-2028.2008.01011.x; Zou CB, 2005, OECOLOGIA, V145, P32, DOI 10.1007/s00442-005-0110-8	89	8	10	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0133277	10.1371/journal.pone.0133277	http://dx.doi.org/10.1371/journal.pone.0133277			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LZ	26196956	Green Submitted, gold, Green Published			2022-12-26	WOS:000358547600080
J	Furmston, T; Morton, AJ; Hailes, S				Furmston, Thomas; Morton, A. Jennifer; Hailes, Stephen			A Significance Test for Inferring Affiliation Networks from Spatio-Temporal Data	PLOS ONE			English	Article							NEURONAL CEROID-LIPOFUSCINOSIS; BEHAVIOR; COHESION	Scientists have long been interested in studying social structures within groups of gregarious animals. However, obtaining evidence about interactions between members of a group is difficult. Recent technologies, such as Global Positioning System technology, have made it possible to obtain a vast wealth of animal movement data, but inferring the underlying ( latent) social structure of the group from such data remains an important open problem. While intuitively appealing measures of social interaction exist in the literature, they typically lack formal statistical grounding. In this article, we provide a statistical approach to the problem of inferring the social structure of a group from the movement patterns of its members. By constructing an appropriate null model, we are able to construct a significance test to detect meaningful affiliations between members of the group. We demonstrate our method on large-scale real-world data sets of positional data of flocks of Merino sheep, Ovis aries.	[Furmston, Thomas; Hailes, Stephen] UCL, Dept Comp Sci, London, England; [Morton, A. Jennifer] Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge, England	University of London; University College London; University of Cambridge	Furmston, T (corresponding author), UCL, Dept Comp Sci, London, England.	T.Furmston@cs.ucl.ac.uk	Morton, Jenny/AAT-8642-2020	Morton, Jenny/0000-0003-0181-6346	CHDI Foundation, Inc.	CHDI Foundation, Inc.	This work was supported by a grant to AJM from CHDI Foundation, Inc. (http://www.highqfoundation.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, BAYESIAN REASONING M; [Anonymous], 2010, MATLAB VERS 7 10 0 R; Aplin LM, 2013, ECOL LETT, V16, P1365, DOI 10.1111/ele.12181; CAIRNS SJ, 1987, ANIM BEHAV, V35, P1454, DOI 10.1016/S0003-3472(87)80018-0; Croft DP, 2004, P ROY SOC B-BIOL SCI, V271, pS516, DOI 10.1098/rsbl.2004.0206; Delcourt J, 2009, BEHAV RES METHODS, V41, P228, DOI 10.3758/BRM.41.1.228; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; Farine DR, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2013.0578; Foster EA, 2012, ANIM BEHAV, V83, P731, DOI 10.1016/j.anbehav.2011.12.021; FRUCHTERMAN TMJ, 1991, SOFTWARE PRACT EXPER, V21, P1129, DOI 10.1002/spe.4380211102; Frugier T, 2008, NEUROBIOL DIS, V29, P306, DOI 10.1016/j.nbd.2007.09.006; Haddadi H, 2011, BEHAV ECOL SOCIOBIOL, V65, P1659, DOI 10.1007/s00265-011-1193-3; Hagberg A.A., 2008, 7 PYTH SCI C SCIPY20, P11; Jolly RD, 2002, NEW ZEAL VET J, V50, P199, DOI 10.1080/00480169.2002.36311; Krause J, 2009, BEHAV ECOLOGY SOCIOB; Miller NY, 2008, BEHAV BRAIN RES, V193, P148, DOI 10.1016/j.bbr.2008.05.004; Nagy M, 2010, NATURE, V464, P890, DOI 10.1038/nature08891; Psorakis I, 2012, J R SOC INTERFACE, V9, P3055, DOI 10.1098/rsif.2012.0223; Read T., 1988, GOODNESS OF FIT STAT; Sriperumbudur BK, 2010, J MACH LEARN RES, V11, P1517; Sueur C, 2011, AM J PRIMATOL, V73, P703, DOI 10.1002/ajp.20915; Wey T, 2008, ANIM BEHAV, V75, P333, DOI 10.1016/j.anbehav.2007.06.020; Whitehead H, 1999, ADV STUD BEHAV, V28, P33, DOI 10.1016/S0065-3454(08)60215-6; Willis CKR, 2004, ANIM BEHAV, V68, P495, DOI 10.1016/j.anbehav.2003.08.028; Yasuda T, 2005, ZOOL SCI, V22, P547, DOI 10.2108/zsj.22.547	25	2	2	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2015	10	7							e0132417	10.1371/journal.pone.0132417	http://dx.doi.org/10.1371/journal.pone.0132417			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LN	26192280	gold, Green Submitted, Green Published			2022-12-26	WOS:000358546400024
J	Guan, HJ; Chow, KM; Song, E; Verma, N; Despa, F; Hersh, LB				Guan, Hanjun; Chow, K. Martin; Song, Eunsuk; Verma, Nirmal; Despa, Florin; Hersh, Louis B.			The Mitochondrial Peptidase Pitrilysin Degrades Islet Amyloid Polypeptide in Beta-Cells	PLOS ONE			English	Article							A-BETA; DIABETES-MELLITUS; TYPE-2; DEGRADATION; DYSFUNCTION; APOPTOSIS; OLIGOMERS; HUMANS; AMYLIN; ACCUMULATION	Amyloid formation and mitochondrial dysfunction are characteristics of type 2 diabetes. The major peptide constituent of the amyloid deposits in type 2 diabetes is islet amyloid polypeptide (IAPP). In this study, we found that pitrilysin, a zinc metallopeptidase of the inverzincin family, degrades monomeric, but not oligomeric, islet amyloid polypeptide in vitro. In insulinoma cells when pitrilysin expression was decreased to 5% of normal levels, there was a 60% increase in islet amyloid polypeptide-induced apoptosis. In contrast, overexpression of pitrilysin protects insulinoma cells from human islet amyloid polypeptide-induced apoptosis. Since pitrilysin is a mitochondrial protein, we used immunofluorescence staining of pancreases from human IAPP transgenic mice and Western blot analysis of IAPP in isolated mitochondria from insulinoma cells to provide evidence for a putative intramitochondrial pool of IAPP. These results suggest that pitrilysin regulates islet amyloid polypeptide in beta cells and suggest the presence of an intramitochondrial pool of islet amyloid polypeptide involved in beta-cell apoptosis.	[Guan, Hanjun; Chow, K. Martin; Song, Eunsuk; Hersh, Louis B.] Univ Kentucky, Dept Mol & Cellular Biochem, Lexington, KY 40536 USA; [Verma, Nirmal; Despa, Florin] Univ Kentucky, Dept Mol & Biomed Pharmacol, Lexington, KY 40536 USA	University of Kentucky; University of Kentucky	Guan, HJ (corresponding author), Univ Kentucky, Dept Mol & Cellular Biochem, Biomed Biol Sci Res Bldg, Lexington, KY 40536 USA.	hguan2@uky.edu	Verma, Nirmal/O-4255-2019	verma, nirmal/0000-0002-9218-2475	National Institutes on Drug Abuse [RO1DA02243]; National Institutes of General Medical Sciences [P2ORR020171]; National Institutes Heart Lung and Blood [R01-HL118474]; National Science Foundation [CBET 1133339]; NATIONAL CANCER INSTITUTE [P30CA177558] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL118474] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA002243] Funding Source: NIH RePORTER	National Institutes on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); National Institutes of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institutes Heart Lung and Blood; National Science Foundation(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was funded by National Institutes on Drug Abuse (http://www.drugabuse.gov/; grant RO1DA02243; LBH), National Institutes of General Medical Sciences (http://www.nigms.nih.gov; grant P2ORR020171; LBH), National Institutes Heart Lung and Blood (http://www.nhlbi.nih.gov; grant R01-HL118474; FD), and National Science Foundation (http://www.nsf.gov; grant CBET 1133339; FD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Bennett RG, 2003, DIABETES, V52, P2315, DOI 10.2337/diabetes.52.9.2315; Bennett RG, 2000, J BIOL CHEM, V275, P36621, DOI 10.1074/jbc.M006170200; Bhushan S, 2006, BIOL CHEM, V387, P1087, DOI 10.1515/BC.2006.134; Butler AE, 2003, DIABETES, V52, P102, DOI 10.2337/diabetes.52.1.102; Caspersen C, 2005, FASEB J, V19, P2040, DOI 10.1096/fj.05-3735fje; Chow KM, 2009, BIOCHEMISTRY-US, V48, P2868, DOI 10.1021/bi8016125; Despa S, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.001015; Despa S, 2012, CIRC RES, V110, P598, DOI [10.1161/CIRCRESAHA.111.258285, 10.1161/circresaha.111.258285]; Falkevall A, 2006, J BIOL CHEM, V281, P29096, DOI 10.1074/jbc.M602532200; FOLK JE, 1963, J BIOL CHEM, V238, P3884; Glaser E, 2010, BBA-BIOENERGETICS, V1797, P1076, DOI 10.1016/j.bbabio.2009.12.016; Gotz J, 2009, CELL MOL LIFE SCI, V66, P1321, DOI 10.1007/s00018-009-9070-1; Guan H, 2012, DIABETOLOGIA, V55, P2989, DOI 10.1007/s00125-012-2678-y; Guan HJ, 2010, CEREB CORTEX, V20, P2684, DOI 10.1093/cercor/bhq016; Gurlo T, 2010, AM J PATHOL, V176, P861, DOI 10.2353/ajpath.2010.090532; Haataja L, 2008, ENDOCR REV, V29, P303, DOI 10.1210/er.2007-0037; Hohmeier HE, 2000, DIABETES, V49, P424, DOI 10.2337/diabetes.49.3.424; Huang CJ, 2007, AM J PHYSIOL-ENDOC M, V293, pE1656, DOI 10.1152/ajpendo.00318.2007; Huang CJ, 2007, DIABETES, V56, P2016, DOI 10.2337/db07-0197; Janson J, 1996, P NATL ACAD SCI USA, V93, P7283, DOI 10.1073/pnas.93.14.7283; JOHNSON KH, 1992, LAB INVEST, V66, P522; Kahn SE, 1999, DIABETES, V48, P241, DOI 10.2337/diabetes.48.2.241; Khemtemourian L, 2008, EXP DIABETES RES, DOI 10.1155/2008/421287; Law E, 2010, DIABETOLOGIA, V53, P1415, DOI 10.1007/s00125-010-1717-9; Leissring MA, 2003, J BIOL CHEM, V278, P37314, DOI 10.1074/jbc.M305627200; Li XL, 2011, INT J BIOCHEM CELL B, V43, P525, DOI 10.1016/j.biocel.2010.12.008; Lin CY, 2007, DIABETES, V56, P1324, DOI 10.2337/db06-1579; Lustbader JW, 2004, SCIENCE, V304, P448, DOI 10.1126/science.1091230; Magzoub M, 2012, FASEB J, V26, P1228, DOI 10.1096/fj.11-194613; Manczak M, 2006, HUM MOL GENET, V15, P1437, DOI 10.1093/hmg/ddl066; Mao PZ, 2011, BBA-MOL BASIS DIS, V1812, P1359, DOI 10.1016/j.bbadis.2011.08.005; Miller BC, 2003, P NATL ACAD SCI USA, V100, P6221, DOI 10.1073/pnas.1031520100; Mzhavia N, 1999, DNA CELL BIOL, V18, P369, DOI 10.1089/104454999315268; Patti ME, 2010, ENDOCR REV, V31, P364, DOI 10.1210/er.2009-0027; Petersen CAH, 2008, P NATL ACAD SCI USA, V105, P13145, DOI 10.1073/pnas.0806192105; Safavi A, 1996, BIOCHEMISTRY-US, V35, P14318, DOI 10.1021/bi960582q; SANKE T, 1988, J BIOL CHEM, V263, P17243; Szabadkai G, 2009, APOPTOSIS, V14, P1405, DOI 10.1007/s10495-009-0363-5; Trikha S, 2011, J BIOL CHEM, V286, P36086, DOI 10.1074/jbc.M111.240762; Wang CH, 2010, ANN NY ACAD SCI, V1201, P157, DOI 10.1111/j.1749-6632.2010.05625.x; Wieckowski MR, 2009, NAT PROTOC, V4, P1582, DOI 10.1038/nprot.2009.151; Zraika S, 2010, DIABETOLOGIA, V53, P1046, DOI 10.1007/s00125-010-1671-6	43	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2015	10	7							e0133263	10.1371/journal.pone.0133263	http://dx.doi.org/10.1371/journal.pone.0133263			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LN	26191799	Green Published, gold, Green Submitted			2022-12-26	WOS:000358546400070
J	Takano, Y; Kasai, K; Takagishi, Y; Kikumori, T; Imai, T; Murata, Y; Hayashi, Y				Takano, Yuko; Kasai, Kenji; Takagishi, Yoshiko; Kikumori, Toyone; Imai, Tsuneo; Murata, Yoshiharu; Hayashi, Yoshitaka			Pancreatic Neuroendocrine Tumors in Mice Deficient in Proglucagon-Derived Peptides	PLOS ONE			English	Article							ALPHA-CELL HYPERPLASIA; ANGIOPOIETIN-LIKE PROTEIN; GLUCAGON RECEPTOR; TRANSCRIPTIONAL REGULATION; G(S)ALPHA DEFICIENCY; BETA-CELLS; LIVER; ABSENCE; HYPERGLUCAGONEMIA; PROLIFERATION	Animal models with defective glucagon action show hyperplasia of islet alpha-cells, however, the regulatory mechanisms underlying the proliferation of islet endocrine cells remain largely to be elucidated. The Gcg(gfp/gfp) mice, which are homozygous for glucagon/green fluorescent protein knock-in allele (GCGKO), lack all proglucagon-derived peptides including glucagon and GLP-1. The present study was aimed to characterize pancreatic neuroendocrine tumors (panNETs), which develop in the GCGKO mice. At 15 months of age, macroscopic GFP-positive tumors were identified in the pancreas of all the GCGKO mice, but not in that of the control heterozygous mice. The tumor manifested several features that were consistent with pancreatic neuroendocrine tumors (panNETs), such as organoid structures with trabecular and cribriform patterns, and the expression of chromogranin A and synaptophysin. Dissemination of GFP-positive cells was observed in the liver and lungs in 100% and 95%, respectively, of 15-month-old GCGKO mice. To elucidate the regulatory mechanism for tumor growth, PanNET grafts were transplanted into subrenal capsules in GCGKO and control mice. Ki-67 positive cells were identified in panNET grafts transplanted to GCGKO mice 1 month after transplantation, but not in those to control mice. These results suggest that humoral factors or conditions specific to GCGKO mice, are involved in the proliferation of panNETs. Taken together, GCGKO mice are novel animal model for studying the development, pathogenesis, and metastasis panNETs.	[Takano, Yuko; Takagishi, Yoshiko; Murata, Yoshiharu; Hayashi, Yoshitaka] Nagoya Univ, Environm Med Res Inst, Dept Genet, Nagoya, Aichi 4648601, Japan; [Takano, Yuko; Kikumori, Toyone; Imai, Tsuneo] Nagoya Univ, Grad Sch Med, Dept Transplantat & Endocrine Surg, Nagoya, Aichi 4668550, Japan; [Kasai, Kenji] Aichi Med Univ, Dept Pathol, Nagakute, Aichi 4801195, Japan; [Imai, Tsuneo] Aichi Med Univ, Dept Breast & Endocrine Surg, Nagakute, Aichi 4801195, Japan	Nagoya University; Nagoya University; Aichi Medical University; Aichi Medical University	Hayashi, Y (corresponding author), Nagoya Univ, Environm Med Res Inst, Dept Genet, Nagoya, Aichi 4648601, Japan.	hayashiy@riem.nagoya-u.ac.jp	Kikumori, Toyone/M-4905-2014; Kasai, Kenji/K-6382-2019; Hayashi, Yoshitaka/I-6168-2014	Kikumori, Toyone/0000-0003-3203-3766; Hayashi, Yoshitaka/0000-0002-7557-4303	Japan Society for the Promotion of Science [24659451, 15K15356]; Ministry of Education, Culture, Sports, Science and Technology [25122708, 15H04681]; SOYU medical foundation; Grants-in-Aid for Scientific Research [15K15356] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); SOYU medical foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Japan Society for the Promotion of Science (https://www.jsps.go.jp/english/index.html, Grant #24659451 and #15K15356), Ministry of Education, Culture, Sports, Science and Technology (http://www.mext.go.jp/english/, Grant #25122708 and #15H04681), and SOYU medical foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali S, 2011, J CLIN INVEST, V121, P1917, DOI 10.1172/JCI43615; Baggio LL, 2007, GASTROENTEROLOGY, V132, P2131, DOI 10.1053/j.gastro.2007.03.054; Bramswig NC, 2011, DIABETES OBES METAB, V13, P13, DOI 10.1111/j.1463-1326.2011.01440.x; Campbell JE, 2013, CELL METAB, V17, P819, DOI 10.1016/j.cmet.2013.04.008; Chen M, 2005, J CLIN INVEST, V115, P3217, DOI 10.1172/JCI24196; Chen M, 2011, ENDOCRINOLOGY, V152, P3343, DOI 10.1210/en.2011-0012; El Ouaamari A, 2013, CELL REP, V3, P401, DOI 10.1016/j.celrep.2013.01.007; Fu ZY, 2013, BIOCHEM BIOPH RES CO, V430, P1126, DOI 10.1016/j.bbrc.2012.12.025; Fukami A, 2013, DIABETES, V62, P510, DOI 10.2337/db12-0294; Furuta M, 1997, P NATL ACAD SCI USA, V94, P6646, DOI 10.1073/pnas.94.13.6646; Futaki S, 2003, J BIOL CHEM, V278, P50691, DOI 10.1074/jbc.M304985200; Gelling RW, 2003, P NATL ACAD SCI USA, V100, P1438, DOI 10.1073/pnas.0237106100; Gromada J, 2007, ENDOCR REV, V28, P84, DOI 10.1210/er.2006-0007; Habener JF, 2005, ENDOCRINOLOGY, V146, P1025, DOI 10.1210/en.2004-1576; Habener JF, 2013, TRENDS ENDOCRIN MET, V24, P153, DOI 10.1016/j.tem.2012.10.009; Hang Y, 2011, TRENDS ENDOCRIN MET, V22, P364, DOI 10.1016/j.tem.2011.05.003; Hayashi Y, 2011, DIABETES OBES METAB, V13, P151, DOI 10.1111/j.1463-1326.2011.01456.x; Hayashi Y, 2009, MOL ENDOCRINOL, V23, P1990, DOI 10.1210/me.2009-0296; Henopp T, 2009, J CLIN ENDOCR METAB, V94, P213, DOI 10.1210/jc.2008-1300; Imai J, 2008, SCIENCE, V322, P1250, DOI 10.1126/science.1163971; Kieffer TJ, 1999, ENDOCR REV, V20, P876, DOI 10.1210/er.20.6.876; Klimstra DS., 2010, WHO CLASSIFICATION T, P322; Kloppel G, 2011, ENDOCR-RELAT CANCER, V18, pS1, DOI 10.1530/ERC-11-0013; Longuet C, 2013, DIABETES, V62, P1196, DOI 10.2337/db11-1605; Quagliarini F, 2012, P NATL ACAD SCI USA, V109, P19751, DOI 10.1073/pnas.1217552109; Ren G, 2012, AM J PHYSIOL-ENDOC M, V303, pE334, DOI 10.1152/ajpendo.00084.2012; Unger RH, 2012, J CLIN INVEST, V122, P4, DOI 10.1172/JCI60016; Xie T, 2010, J ENDOCRINOL, V206, P261, DOI 10.1677/JOE-10-0030; Yi P, 2013, CELL, V153, P747, DOI 10.1016/j.cell.2013.04.008; Yu R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021255; Yu R, 2008, PANCREAS, V36, P428, DOI 10.1097/MPA.0b013e31815ceb23; Yu R, 2014, J CLIN ENDOCR METAB, V99, P748, DOI 10.1210/jc.2013-2952; Zhou CQ, 2009, PANCREAS, V38, P941, DOI 10.1097/MPA.0b013e3181b2bb03	33	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2015	10	7							e0133812	10.1371/journal.pone.0133812	http://dx.doi.org/10.1371/journal.pone.0133812			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LN	26192435	Green Submitted, gold, Green Published			2022-12-26	WOS:000358546400121
J	Chen, FY; Bo, J; Ma, XW; Dong, LX; Shan, ZG; Cui, Q; Chen, HY; Wang, KJ				Chen, Fangyi; Bo, Jun; Ma, Xiaowan; Dong, Lixia; Shan, Zhongguo; Cui, Qian; Chen, Huiyun; Wang, Kejian			A New Membrane Lipid Raft Gene SpFLT-1 Facilitating the Endocytosis of Vibrio alginolyticus in the Crab Scylla paramamosain	PLOS ONE			English	Article							MOLECULAR-CLONING; ANTIMICROBIAL ACTIVITY; BACTERIAL INVASION; ANCHORED PROTEINS; TETANUS TOXIN; CLATHRIN; FLOTILLIN-1; CELLS; MICRODOMAINS; EXPRESSION	Pathogens can enter their host cells by way of endocytosis in which the membrane lipid raft gene flotillins are probably involved in the invasion process and this is an important way to cause infection. In this study, a new gene SpFLT-1 was identified in Scylla paramamosain, which shared high identity with the flotillin-1 of other species. The SpFLT-1 gene was widely distributed in tissues and showed the highest level of mRNA transcripts in the hemocytes. This gene might be a maternal gene based on the evident results that it was highly expressed in maternal ovaries and in the early developmental stages of the zygote and early embryo stage whereas it gradually decreased in zoea 1. SpFLT-1 positively responded to the challenge of Vibrio alginolyticus with a significantly increased level of mRNA expression in the hemocytes and gills at 3 hours post infection (hpi). The SpFLT-1 protein was detected densely in the same fraction layer where the Vibrio protein was most present in the hemocytes and gills at 3 hpi. Furthermore, it was found that the expression of SpFLT-1 decreased to the base level following disappearance of the Vibrio protein at 6 hpi in the gills. Silencing SpFLT-1 inhibited the endocytosis rate of V. alginolyticus but overexpression of the gene could facilitate bacterial entry into the epithelioma papulosum cyprinid cells. Our study indicated that SpFLT-1 may act as a key protein involved in the process of bacterial infection and this sheds light on clarifying the pathogenesis of pathogens infecting S. paramamosain.	[Chen, Fangyi; Bo, Jun; Ma, Xiaowan; Dong, Lixia; Shan, Zhongguo; Cui, Qian; Chen, Huiyun; Wang, Kejian] Xiamen Univ, Coll Ocean & Earth Sci, State Key Lab Marine Environm Sci, Xiamen, Fujian, Peoples R China; [Chen, Fangyi; Ma, Xiaowan; Dong, Lixia; Shan, Zhongguo; Cui, Qian; Chen, Huiyun; Wang, Kejian] Xiamen Univ, Fujian Collaborat Innovat Ctr Exploitat & Utiliza, Xiamen, Fujian, Peoples R China; [Chen, Fangyi; Ma, Xiaowan; Dong, Lixia; Shan, Zhongguo; Cui, Qian; Chen, Huiyun; Wang, Kejian] Xiamen Univ, Fujian Engn Lab Marine Bioprod & Technol, Xiamen, Fujian, Peoples R China	Xiamen University; Xiamen University; Xiamen University	Wang, KJ (corresponding author), Xiamen Univ, Coll Ocean & Earth Sci, State Key Lab Marine Environm Sci, Xiamen, Fujian, Peoples R China.	wkjian@xmu.edu.cn	Wang, KJ/G-4609-2010; Bo, Jun/ABG-7639-2020	Bo, Jun/0000-0002-8726-1654	National Natural Science Foundation of China (NSFC) [U1205123]; National Key Technology Support Program of China [2013BAD10B03-2]; 55th China Postdoctoral Science Foundation [2014M550354]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); National Key Technology Support Program of China(National Key Technology R&D Program); 55th China Postdoctoral Science Foundation	This study was supported by a grant (U1205123) from the National Natural Science Foundation of China (NSFC), a grant (2013BAD10B03-2) from National Key Technology Support Program of China and a grant (2014M550354) from the 55th China Postdoctoral Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrami L, 2003, J CELL BIOL, V160, P321, DOI 10.1083/jcb.200211018; Ait-Slimane T, 2009, MOL BIOL CELL, V20, P3792, DOI 10.1091/mbc.E09-04-0275; Amaddii M, 2012, J BIOL CHEM, V287, P7265, DOI 10.1074/jbc.M111.287599; Babuke T, 2009, CELL SIGNAL, V21, P1287, DOI 10.1016/j.cellsig.2009.03.012; Campbell P A, 2001, Curr Protoc Immunol, VChapter 14, DOI 10.1002/0471142735.im1406s12; Carcea I, 2010, J NEUROSCI, V30, P15317, DOI 10.1523/JNEUROSCI.1821-10.2010; Chen FY, 2010, FISH SHELLFISH IMMUN, V28, P167, DOI 10.1016/j.fsi.2009.10.017; Cossart P, 2004, SCIENCE, V304, P242, DOI 10.1126/science.1090124; de Gassart A, 2003, BLOOD, V102, P4336, DOI 10.1182/blood-2003-03-0871; Deinhardt K, 2006, J CELL BIOL, V174, P459, DOI 10.1083/jcb.200508170; Dermine JF, 2001, J BIOL CHEM, V276, P18507, DOI 10.1074/jbc.M101113200; Ding J, 2013, AQUAC RES, P1; Ding J, 2013, GENOME, V56, P273, DOI 10.1139/gen-2013-0002; Duncan MJ, 2004, J BIOL CHEM, V279, P18944, DOI 10.1074/jbc.M400769200; Eto DS, 2008, CELL MICROBIOL, V10, P2553, DOI 10.1111/j.1462-5822.2008.01229.x; Frick M, 2007, CURR BIOL, V17, P1151, DOI 10.1016/j.cub.2007.05.078; Gagescu R, 2000, MOL BIOL CELL, V11, P2775, DOI 10.1091/mbc.11.8.2775; Galbiati F, 1998, GENE, V210, P229, DOI 10.1016/S0378-1119(98)00064-X; Ge LA, 2011, P NATL ACAD SCI USA, V108, P551, DOI 10.1073/pnas.1014434108; Girardot N, 2003, NEUROPATH APPL NEURO, V29, P451, DOI 10.1046/j.1365-2990.2003.00479.x; Gkantiragas I, 2001, MOL BIOL CELL, V12, P1819, DOI 10.1091/mbc.12.6.1819; Glebov OO, 2006, NAT CELL BIOL, V8, P46, DOI 10.1038/ncb1342; Gomez V, 2010, J BIOL CHEM, V285, P20683, DOI 10.1074/jbc.M110.130591; Herreros J, 2001, MOL BIOL CELL, V12, P2947, DOI 10.1091/mbc.12.10.2947; Imjongjirak C, 2007, MOL IMMUNOL, V44, P3195, DOI 10.1016/j.molimm.2007.01.028; Imjongjirak C, 2009, MOL BIOL REP, V36, P841, DOI 10.1007/s11033-008-9253-0; Jacobowitz DM, 2004, NEUROTOX RES, V6, P245, DOI 10.1007/BF03033435; Kazlauskaite J, 2005, BIOCHEM SOC SYMP, V72, P211, DOI 10.1042/bss0720211; Korhonen JT, 2012, INFECT IMMUN, V80, P1072, DOI 10.1128/IAI.05528-11; Kumari S, 2010, CELL RES, V20, P256, DOI 10.1038/cr.2010.19; Lang DM, 1998, J NEUROBIOL, V37, P502, DOI 10.1002/(SICI)1097-4695(199812)37:4<502::AID-NEU2>3.0.CO;2-S; Langui D, 2004, AM J PATHOL, V165, P1465, DOI 10.1016/S0002-9440(10)63405-0; Lee SY, 2002, FISH SHELLFISH IMMUN, V12, P421, DOI 10.1006/fsim.2002.0420; Liu HP, 2010, DEV COMP IMMUNOL, V34, P741, DOI 10.1016/j.dci.2010.02.005; Liu HP, 2010, FISH SHELLFISH IMMUN, V28, P862, DOI 10.1016/j.fsi.2010.02.008; Liu J, 2005, J BIOL CHEM, V280, P1432, DOI 10.1074/jbc.M409740200; Liu PS, 2004, J BIOL CHEM, V279, P3787, DOI 10.1074/jbc.M311945200; Ludwig A, 2010, J CELL BIOL, V191, P771, DOI 10.1083/jcb.201005140; Macdonald JL, 2005, J LIPID RES, V46, P1061, DOI 10.1194/jlr.D400041-JLR200; Moreno-Ruiz E, 2009, CELL MICROBIOL, V11, P1179, DOI 10.1111/j.1462-5822.2009.01319.x; Morrow IC, 2002, J BIOL CHEM, V277, P48834, DOI 10.1074/jbc.M209082200; Moura T, 2011, MAR BIOL, V158, P401, DOI 10.1007/s00227-010-1568-4; Munderloh C, 2009, J NEUROSCI, V29, P6607, DOI 10.1523/JNEUROSCI.0870-09.2009; Nestorov P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056049; Neumann-Giesen C, 2004, BIOCHEM J, V378, P509, DOI 10.1042/BJ20031100; Neumann-Giesen C, 2007, J CELL SCI, V120, P395, DOI 10.1242/jcs.03336; Peng H, 2012, PROTEIN EXPRES PURIF, V82, P37, DOI 10.1016/j.pep.2011.11.008; Pust S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008844; Qu HD, 2013, BIOSCI BIOTECH BIOCH, V77, P103, DOI 10.1271/bbb.120600; Riento K, 2009, J CELL SCI, V122, P912, DOI 10.1242/jcs.039024; Roy CR, 2003, NAT CELL BIOL, V5, P16, DOI 10.1038/ncb0103-16; Samuel BU, 2001, J BIOL CHEM, V276, P29319, DOI 10.1074/jbc.M101268200; Santamaria A, 2003, AM J PATHOL, V162, P897, DOI 10.1016/S0002-9440(10)63885-0; Saslowsky DE, 2010, J CLIN INVEST, V120, P4399, DOI 10.1172/JCI42958; Solis GP, 2007, BIOCHEM J, V403, P313, DOI 10.1042/BJ20061686; Stuermer CAO, 2004, FASEB J, V18, P1731, DOI 10.1096/fj.04-2150fje; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Swain P, 2009, FISH SHELLFISH IMMUN, V27, P89, DOI 10.1016/j.fsi.2009.04.008; Tomasovic A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029739; Veiga E, 2005, NAT CELL BIOL, V7, P894, DOI 10.1038/ncb1292; Veiga E, 2007, CELL HOST MICROBE, V2, P340, DOI 10.1016/j.chom.2007.10.001; Volonte D, 1999, J BIOL CHEM, V274, P12702, DOI 10.1074/jbc.274.18.12702; von Philipsborn AC, 2005, J COMP NEUROL, V482, P257, DOI 10.1002/cne.20423; Xu WF, 2011, DEV COMP IMMUNOL, V35, P1076, DOI 10.1016/j.dci.2011.03.028	64	4	4	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0133443	10.1371/journal.pone.0133443	http://dx.doi.org/10.1371/journal.pone.0133443			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RV	26186350	Green Published, gold, Green Submitted			2022-12-26	WOS:000358198700139
J	Cheng, CM; Nair, ADS; Jaworski, DC; Ganta, RR				Cheng, Chuanmin; Nair, Arathy D. S.; Jaworski, Deborah C.; Ganta, Roman R.			Mutations in Ehrlichia chaffeensis Causing Polar Effects in Gene Expression and Differential Host Specificities	PLOS ONE			English	Article							INFECTION; TRANSPOSON; TRANSMISSION; MUTAGENESIS; MUTANTS; BLOOD; LIVE	Ehrlichia chaffeensis, a tick-borne rickettsial, is responsible for human monocytic ehrlichiosis. In this study, we assessed E. chaffeensis insertion mutations impacting the transcription of genes near the insertion sites. We presented evidence that the mutations within the E. chaffeensis genome at four genomic locations cause polar effects in altering gene expressions. We also reported mutations causing attenuated growth in deer (the pathogen's reservoir host) and in dog (an incidental host), but not in its tick vector, Amblyomma americanum. This is the first study documenting insertion mutations in E. chaffeensis that cause polar effects in altering gene expression from the genes located upstream and downstream to insertion sites and the differential requirements of functionally active genes of the pathogen for its persistence in vertebrate and tick hosts. This study is important in furthering our knowledge on E. chaffeensis pathogenesis.	[Cheng, Chuanmin; Nair, Arathy D. S.; Jaworski, Deborah C.; Ganta, Roman R.] Kansas State Univ, Coll Vet Med, Dept Diagnost Med Pathobiol, Ctr Excellence Vector Borne Dis, Manhattan, KS 66506 USA; [Jaworski, Deborah C.] Oklahoma State Univ, Noble Res Ctr, Dept Entomol & Plant Pathol, Stillwater, OK 74074 USA	Kansas State University; Oklahoma State University System; Oklahoma State University - Stillwater	Ganta, RR (corresponding author), Kansas State Univ, Coll Vet Med, Dept Diagnost Med Pathobiol, Ctr Excellence Vector Borne Dis, Manhattan, KS 66506 USA.	rganta@vet.ksu.edu			National Institutes of Health [AI070908]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI070908, R01AI070908] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	AI070908 (http://projectreporter.nih.gov/project_info_description.cfm?aid=8704697&icde=23195389), National Institutes of Health, RRG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Breitschwerdt EB, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-298; Cartman ST, 2010, APPL ENVIRON MICROB, V76, P1103, DOI 10.1128/AEM.02525-09; Cheng CM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003171; Cheng Chuanmin, 2008, Curr Protoc Microbiol, VChapter 3, DOI 10.1002/9780471729259.mc03a01s9; Conway T, 2014, MBIO, V5, DOI 10.1128/mBio.01442-14; Crosby FL, 2015, APPL ENVIRON MICROB, V81, P2206, DOI 10.1128/AEM.03241-14; Cuccui J, 2007, INFECT IMMUN, V75, P1186, DOI 10.1128/IAI.01240-06; Davidson WR, 2001, J WILDLIFE DIS, V37, P538, DOI 10.7589/0090-3558-37.3.538; DAWSON JE, 1991, J CLIN MICROBIOL, V29, P2741, DOI 10.1128/JCM.29.12.2741-2745.1991; Dugan VG, 2000, J CLIN MICROBIOL, V38, P448; DUMLER JS, 1993, CLIN INFECT DIS, V17, P903, DOI 10.1093/clinids/17.5.903; Felsheim RF, 2006, BMC BIOTECHNOL, V6, DOI 10.1186/1472-6750-6-42; Hackett PB, 2010, MOL THER, V18, P674, DOI 10.1038/mt.2010.2; Hammac GK, 2013, VACCINE, V31, P3617, DOI 10.1016/j.vaccine.2013.04.069; Karim S, 2012, J MED ENTOMOL, V49, P547, DOI 10.1603/ME11214; Kawano M, 2005, NUCLEIC ACIDS RES, V33, P6268, DOI 10.1093/nar/gki928; Kawula TH, 2004, APPL ENVIRON MICROB, V70, P6901, DOI 10.1128/AEM.70.11.6901-6904.2004; Kocan A, 2000, EMERG INFECT DIS, V6, P477, DOI 10.3201/eid0605.000505; McBride JW, 2011, EXPERT REV MOL MED, V13, DOI 10.1017/S1462399410001730; McQuiston JH, 2000, TRANSFUSION, V40, P274, DOI 10.1046/j.1537-2995.2000.40030274.x; Nair ADS, 2015, INFECT IMMUN, V83, P2827, DOI 10.1128/IAI.00487-15; Nair ADS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109056; Paddock CD, 2003, CLIN MICROBIOL REV, V16, P37, DOI 10.1128/CMR.16.1.37-64.2003; Park KT, 2011, VACCINE, V29, P4709, DOI 10.1016/j.vaccine.2011.04.090; PATRICK CD, 1975, J MED ENTOMOL, V12, P389, DOI 10.1093/jmedent/12.3.389; Qin AP, 2004, APPL ENVIRON MICROB, V70, P2816, DOI 10.1128/AEM.70.5.2816-2822.2004; Sachdev SH, 2014, TRANSPL INFECT DIS, V16, P119, DOI 10.1111/tid.12172; SAMBROOK J, 2000, MOL CLONING LAB MANU; Sirigireddy KR, 2005, J MOL DIAGN, V7, P308, DOI 10.1016/S1525-1578(10)60559-4; Walker DH, 1996, EMERG INFECT DIS, V2, P18, DOI 10.3201/eid0201.960102; Yabsley MJ, 2010, VET PARASITOL, V167, P136, DOI 10.1016/j.vetpar.2009.09.015; Zhang T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062454	32	17	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0132657	10.1371/journal.pone.0132657	http://dx.doi.org/10.1371/journal.pone.0132657			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RV	26186429	Green Published, gold, Green Submitted			2022-12-26	WOS:000358198700052
J	Nicolini, D; Mocchegiani, F; Palmonella, G; Coletta, M; Brugia, M; Montalti, R; Fava, G; Taccaliti, A; Risaliti, A; Vivarelli, M				Nicolini, Daniele; Mocchegiani, Federico; Palmonella, Gioia; Coletta, Martina; Brugia, Marina; Montalti, Roberto; Fava, Giammarco; Taccaliti, Augusto; Risaliti, Andrea; Vivarelli, Marco			Postoperative Insulin-Like Growth Factor 1 Levels Reflect the Graft's Function and Predict Survival after Liver Transplantation	PLOS ONE			English	Article							SINGLE-CENTER EXPERIENCE; I IGF-I; INDOCYANINE GREEN; BINDING-PROTEINS; CIRRHOSIS; SERUM; HORMONE; DYSFUNCTION; IGFBP-3; MORTALITY	Background The reduction of insulin-like growth factor 1 (IGF-1) plasma levels is associated with the degree of liver dysfunction and mortality in cirrhotic patients. However, little research is available on the recovery of the IGF-1 level and its prognostic role after liver transplantation (LT). Methods From April 2010 to May 2011, 31 patients were prospectively enrolled (25/6 M/F; mean age +/- SEM: 55.2 +/- 1.4 years), and IGF-1 serum levels were assessed preoperatively and at 15, 30, 90, 180 and 365 days after transplantation. The influence of the donor and recipient characteristics (age, use of extended criteria donor grafts, D-MELD and incidence of early allograft dysfunction) on hormonal concentration was analyzed. The prognostic role of IGF-1 level on patient survival and its correlation with routine liver function tests were also investigated. Results All patients showed low preoperative IGF-1 levels (mean +/- SEM: 29.5 +/- 2.1), and on postoperative day 15, a significant increase in the IGF-1 plasma level was observed (102.7 +/- 11.7 ng/ml; p<0.0001). During the first year after LT, the IGF-1 concentration remained significantly lower in recipients transplanted with older donors (>65 years) or extended criteria donor grafts. An inverse correlation between IGF-1 and bilirubin serum levels at day 15 (r = -0.3924, p = 0.0320) and 30 (r = -0.3894, p = 0.0368) was found. After multivariate analysis, early (within 15 days) IGF-1 normalization [Exp(b) = 3.913; p = 0.0484] was the only prognostic factor associated with an increased 3-year survival rate. Conclusion IGF-1 postoperative levels are correlated with the graft's quality and reflect liver function. Early IGF-1 recovery is associated with a higher 3-year survival rate after LT.	[Nicolini, Daniele; Mocchegiani, Federico; Coletta, Martina; Montalti, Roberto; Vivarelli, Marco] Polytech Univ Marche, Dept Gastroenterol & Transplantat, Div Hepatobiliary & Transplant Surg, Ancona, Italy; [Palmonella, Gioia; Taccaliti, Augusto] Polytech Univ Marche, Dept Clin & Mol Sci, Div Endocrinol, Ancona, Italy; [Brugia, Marina] AOU Osped Riuniti, Dept Serv, Div Lab Med, Ancona, Italy; [Fava, Giammarco] AOU Osped Riuniti, Dept Gastroenterol & Transplantat, Div Gastroenterol, Ancona, Italy; [Risaliti, Andrea] Univ Udine, Dept Med & Biol Sci, Div Liver & Kidney Transplant Surg, I-33100 Udine, Italy	Marche Polytechnic University; University of Udine	Mocchegiani, F (corresponding author), Polytech Univ Marche, Dept Gastroenterol & Transplantat, Div Hepatobiliary & Transplant Surg, Ancona, Italy.	federicomocchegiani@hotmail.com	Montalti, Roberto/AAF-5627-2019; NICOLINI, DANIELE/AAD-8241-2020; Palmonella, Gioia/K-3253-2018; Nicolini, Daniele/AAK-3717-2020	NICOLINI, DANIELE/0000-0002-5477-3346; Palmonella, Gioia/0000-0002-2983-8208; MOCCHEGIANI, FEDERICO/0000-0002-8833-5360; Fava, Giammarco/0000-0001-6757-1420; VIVARELLI, MARCO/0000-0003-0500-9461; Montalti, Roberto/0000-0002-3915-3851				Assy N, 2008, J HEPATOL, V49, P34, DOI 10.1016/j.jhep.2008.02.013; Barthel E, 2012, CLIN TRANSPLANT, V26, pE38, DOI 10.1111/j.1399-0012.2011.01516.x; Barshes NR, 2007, AM J TRANSPLANT, V7, P1265, DOI 10.1111/j.1600-6143.2007.01758.x; Baruch Y, 2000, J HEPATOL, V32, P505, DOI 10.1016/S0168-8278(00)80403-1; Bassanello M, 2004, LIVER TRANSPLANT, V10, P692, DOI 10.1002/lt.20111; Bonefeld K, 2011, LIVER INT, V31, P911, DOI 10.1111/j.1478-3231.2010.02428.x; Caregaro L, 1997, NUTRITION, V13, P185; Castro GRA, 2013, ANN TRANSPL, V18, P57, DOI 10.12659/AOT.883819; DAUGHADAY WH, 1989, ENDOCR REV, V10, P68, DOI 10.1210/edrv-10-1-68; De Palo EF, 2001, CLIN CHIM ACTA, V310, P31, DOI 10.1016/S0009-8981(01)00511-3; Dehghani SM, 2012, EXP CLIN TRANSPLANT, V10, P252, DOI 10.6002/ect.2011.0095; Donaghy AJ, 2002, J HEPATOL, V36, P751, DOI 10.1016/S0168-8278(02)00049-1; Elmlinger MW, 2004, CLIN CHEM LAB MED, V42, P654, DOI 10.1515/CCLM.2004.112; Escorsell A, 2012, TRANSPL P, V44, P1539, DOI 10.1016/j.transproceed.2012.05.023; Feng S, 2006, AM J TRANSPLANT, V6, P783, DOI 10.1111/j.1600-6143.2006.01242.x; Gruttadauria S, 2008, LIVER TRANSPLANT, V14, P220, DOI 10.1002/lt.21359; Halldorson JB, 2009, AM J TRANSPLANT, V9, P318, DOI 10.1111/j.1600-6143.2008.02491.x; Holt R I, 1998, Pediatr Transplant, V2, P76; Imber CJ, 2002, TRANSPLANTATION, V73, P701, DOI 10.1097/00007890-200203150-00008; Infante D, 1998, PEDIATR SURG INT, V13, P323, DOI 10.1007/s003830050330; Markmann JF, 2003, J AM COLL SURGEONS, V196, P566, DOI 10.1016/S1072-7515(02)01907-5; MOLLER S, 1995, J CLIN ENDOCR METAB, V80, P1148, DOI 10.1210/jc.80.4.1148; Monbaliu D, 2005, TRANSPLANT P, V37, P413, DOI 10.1016/j.transproceed.2004.12.103; Nikolic JA, 2000, CLIN CHIM ACTA, V294, P169, DOI 10.1016/S0009-8981(99)00254-5; O'Connor KG, 1998, J GERONTOL A-BIOL, V53, pM176, DOI 10.1093/gerona/53A.3.M176; Olthoff KM, 2010, LIVER TRANSPLANT, V16, P943, DOI 10.1002/lt.22091; RUSSELL WE, 1985, AM J PHYSIOL, V248, pE618, DOI 10.1152/ajpendo.1985.248.5.E618; Salso A, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/240873; Schalch DS, 1998, METABOLISM, V47, P200, DOI 10.1016/S0026-0495(98)90221-9; Seehofer Daniel, 2002, Ann Transplant, V7, P32; Shaked A, 1997, CLIN CHEM, V43, P1539; Shen XY, 1998, J CLIN ENDOCR METAB, V83, P2532, DOI 10.1210/jc.83.7.2532; Siemens Healthcare Diagnostics Inc, 2013, IMM 2000 GROWTH HORM; Silva MA, 2008, TRANSPLANTATION, V85, P718, DOI 10.1097/TP.0b013e3181663366; Stockmann M, 2009, HEPATO-GASTROENTEROL, V56, P734; Sutton ME, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110642; Uemura T, 2007, LIVER TRANSPLANT, V13, P227, DOI 10.1002/lt.20992; Volzke H, 2009, EUR J ENDOCRINOL, V161, P705, DOI 10.1530/EJE-09-0374; Weber MM, 2002, HORM RES, V57, P105, DOI 10.1159/000057960; Wu YL, 2004, WORLD J GASTROENTERO, V10, P2740, DOI 10.3748/wjg.v10.i18.2740; Zietz B, 2003, EUR J GASTROEN HEPAT, V15, P495, DOI 10.1097/01.meg.0000059115.41030.e0	41	5	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0133153	10.1371/journal.pone.0133153	http://dx.doi.org/10.1371/journal.pone.0133153			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RV	26186540	Green Published, gold, Green Submitted			2022-12-26	WOS:000358198700101
J	Zhu, ZB; Zhu, JZ; Zhao, XR; Yang, K; Lu, L; Zhang, FR; Shen, WF; Zhang, RY				Zhu, Zhengbin; Zhu, Jinzhou; Zhao, Xiaoran; Yang, Ke; Lu, Lin; Zhang, Fengru; Shen, Weifeng; Zhang, Ruiyan			All-Trans Retinoic Acid Ameliorates Myocardial Ischemia/Reperfusion Injury by Reducing Cardiomyocyte Apoptosis	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; REPERFUSION INJURY; EXPRESSION; MECHANISM; ISCHEMIA; INHIBITION; RECEPTORS; PATHWAYS; ADAM10; RAGE	Myocardial ischemia/reperfusion (I/R) injury interferes with the restoration of blood flow to ischemic myocardium. Oxidative stress-elicited apoptosis has been reported to contribute to I/R injury. All-trans retinoic acid (ATRA) has anti-apoptotic activity as previously reported. Here, we investigated the effects and the mechanism of action of ATRA on myocardial I/R injury both in vivo and in vitro. In vivo, ATRA reduced the size of the infarcted area (17.81 +/- 1.05% vs. 24.41 +/- 1.03%, P<0.05) and rescued cardiac function loss (ejection fraction 46.42 +/- 6.76% vs. 37.18 +/- 4.63%, P<0.05) after I/R injury. Flow-cytometric analysis and TUNEL assay demonstrated that the protective role of ATRA on myocardial I/R injury was related to its anti-apoptotic effects. The anti-apoptotic effects of ATRA were associated with partial inhibition of reactive oxygen species (ROS) production and significantly less phosphorylation of mitogen-activated protein kinases (MAPKs) including p38, JNK, and ERK. Western blot analysis also revealed that ATRA pre-treatment increased a disintegrin and metalloproteinase domain-containing protein 10 (ADAM10) expression (0.65 +/- 0.20 vs. 0.41 +/- 0.02 in vivo) and reduced the level of receptor for advanced glycation end-products (RAGE) (0.38 +/- 0.17 vs. 0.52 +/- 0.11 in vivo). Concomitantly, the protective role of ATRA on I/R injury was not observed in RAGE-KO mice. The current results indicated that ATRA could prevent myocardial injury and reduced cardiomyocyte apoptosis after I/R effectively. One possible mechanism underlying these effects is that ATRA could increase ADAM10 expression and thus cleave RAGE, which is the main receptor up-stream of MAPKs in myocardial I/R injury, resulting in the down-regulation of MAPK signaling and protective role on myocardial I/R injury.	[Zhu, Zhengbin; Zhu, Jinzhou; Zhao, Xiaoran; Lu, Lin; Zhang, Fengru; Shen, Weifeng; Zhang, Ruiyan] Shanghai Jiao Tong Univ, Sch Med, Rui Jin Hosp, Dept Cardiol, Shanghai 200025, Peoples R China; [Zhu, Zhengbin; Zhu, Jinzhou; Zhao, Xiaoran; Yang, Ke; Lu, Lin; Shen, Weifeng; Zhang, Ruiyan] Shanghai Jiao Tong Univ, Sch Med, Inst Cardiovasc Dis, Shanghai 200025, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University	Zhang, RY (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Rui Jin Hosp, Dept Cardiol, Shanghai 200025, Peoples R China.	rjzhangruiyan@yahoo.cn	Zhang, Ruiyan/HHC-5329-2022	Yang, Ke/0000-0002-1870-1134	National Natural Science Foundation of China [81000050, 81300178, 81370401]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundation of China (grants 81000050, 81300178 and 81370401).	Amann PM, 2011, CURR MED CHEM, V18, P1405; Armstrong SC, 2004, CARDIOVASC RES, V61, P427, DOI 10.1016/j.cardiores.2003.09.031; Baines CP, 2011, J CARDIOVASC PHARM T, V16, P239, DOI 10.1177/1074248411407769; Bucciarelli LG, 2006, CIRCULATION, V113, P1226, DOI 10.1161/CIRCULATIONAHA.105.575993; Celay J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062771; Cicconi S, 2003, J CELL PHYSIOL, V195, P27, DOI 10.1002/jcp.10219; Clanachan AS, 2003, TRANSPLANTATION, V75, P173, DOI 10.1097/01.TP.0000040429.40245.3A; Gao F, 2002, CARDIOVASC RES, V53, P414, DOI 10.1016/S0008-6363(01)00488-6; Johnson GL, 2002, SCIENCE, V298, P1911, DOI 10.1126/science.1072682; Komori R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061938; Li CY, 2002, AM J PHYSIOL-CELL PH, V282, pC227, DOI 10.1152/ajpcell.00112.2001; Liu ZW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040943; MANGELSDORF DJ, 1995, CELL, V83, P841, DOI 10.1016/0092-8674(95)90200-7; O'Gara PT, 2013, J AM COLL CARDIOL, V61, pE78, DOI [10.1016/j.jacc.2012.11.019, 10.1161/CIR.0b013e3182742cf6]; Rao JH, 2010, BIOL PHARM BULL, V33, P869, DOI 10.1248/bpb.33.869; Raucci A, 2008, FASEB J, V22, P3716, DOI 10.1096/fj.08-109033; Reffelmann T, 2006, BASIC RES CARDIOL, V101, P359, DOI 10.1007/s00395-006-0615-2; Ren X, 2007, J NUTR BIOCHEM, V18, P832, DOI 10.1016/j.jnutbio.2006.12.023; Sanz Miguel A, 2006, Hematology Am Soc Hematol Educ Program, P147; Sanz-Rosa D, 2012, ANN NY ACAD SCI, V1254, P90, DOI 10.1111/j.1749-6632.2012.06501.x; Shang LS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010092; Tippmann F, 2009, FASEB J, V23, P1643, DOI 10.1096/fj.08-121392; Tsai FM, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-15; Ueki S, 2008, J IMMUNOL, V181, P7689, DOI 10.4049/jimmunol.181.11.7689; Vanden Hoek TL, 2003, AM J PHYSIOL-HEART C, V284, pH141, DOI 10.1152/ajpheart.00132.2002; Vinten-Johansen J, 2004, CARDIOVASC RES, V61, P481, DOI 10.1016/j.cardiores.2003.10.011; Woo AYH, 2005, CARDIOVASC RES, V65, P244, DOI 10.1016/j.cardiores.2004.09.027; Yan SF, 2010, CIRC RES, V106, P842, DOI 10.1161/CIRCRESAHA.109.212217; Yellon DM, 2007, NEW ENGL J MED, V357, P1121, DOI 10.1056/NEJMra071667; Zhao ZQ, 2004, CURR OPIN PHARMACOL, V4, P159, DOI 10.1016/j.coph.2003.10.010; Zhu HL, 2011, EXP MOL MED, V43, P437, DOI 10.3858/emm.2011.43.8.049	31	26	31	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0133414	10.1371/journal.pone.0133414	http://dx.doi.org/10.1371/journal.pone.0133414			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RV	26186635	Green Published, Green Submitted, gold			2022-12-26	WOS:000358198700135
J	Pauletti, RB; Stynen, APR; Mol, JPD; Dorneles, EMS; Alves, TM; Souto, MDM; Minharro, S; Heinemann, MB; Lage, AP				Pauletti, Rebeca Barbosa; Reinato Stynen, Ana Paula; da Silva Mol, Juliana Pinto; Seles Dorneles, Elaine Maria; Alves, Telma Maria; Moura Souto, Monalisa de Sousa; Minharro, Silvia; Heinemann, Marcos Bryan; Lage, Andrey Pereira			Reduced Susceptibility to Rifampicin and Resistance to Multiple Antimicrobial Agents among Brucella abortus Isolates from Cattle in Brazil	PLOS ONE			English	Article							ANTIBIOTIC SUSCEPTIBILITY; MELITENSIS; QUINOLONES; ASSAY; PCR	This study aimed to determine the susceptibility profile of Brazilian Brucella abortus isolates from cattle to eight antimicrobial agents that are recommended for the treatment of human brucellosis and to correlate the susceptibility patterns with origin, biotype and MLVA16-genotype of the strains. Screening of 147 B. abortus strains showed 100% sensitivity to doxycycline and ofloxacin, one (0.68%) strain resistant to ciprofloxacin, two strains (1.36%) resistant to streptomycin, two strains (1.36%) resistant to trimethoprim-sulfamethoxazole and five strains (3.40%) resistant to gentamicin. For rifampicin, three strains (2.04%) were resistant and 54 strains (36.73%) showed reduced sensitivity. Two strains were considered multidrug resistant. In conclusion, the majority of B. abortus strains isolated from cattle in Brazil were sensitive to the antimicrobials commonly used for the treatment of human brucellosis; however, a considerable proportion of strains showed reduced susceptibility to rifampicin and two strains were considered multidrug resistant. Moreover, there was no correlation among the drug susceptibility pattern, origin, biotype and MLVA16-genotypes of these strains.	[Pauletti, Rebeca Barbosa; Reinato Stynen, Ana Paula; da Silva Mol, Juliana Pinto; Seles Dorneles, Elaine Maria; Alves, Telma Maria; Moura Souto, Monalisa de Sousa; Lage, Andrey Pereira] Univ Fed Minas Gerais, Escola Vet, Belo Horizonte, MG, Brazil; [Minharro, Silvia] Univ Fed Tocantins, Escola Med Vet & Zootecnia, Araguaina, Tocantins, Brazil; [Heinemann, Marcos Bryan] Univ Sao Paulo, Fac Med Vet & Zootecnia, Sao Paulo, Brazil	Universidade Federal de Minas Gerais; Universidade Federal do Tocantins (UFT); Universidade de Sao Paulo	Lage, AP (corresponding author), Univ Fed Minas Gerais, Escola Vet, Belo Horizonte, MG, Brazil.	alage@vet.ufmg.br	Minharro, Silvia SM/K-9933-2015; Dorneles, Elaine/V-2816-2019; Heinemann, Marcos Bryan/AAI-9390-2020; Dorneles, Elaine/J-1115-2016; Heinemann, Marcos B/G-2780-2015	Dorneles, Elaine/0000-0002-2753-1296; Heinemann, Marcos Bryan/0000-0001-6444-9788; Heinemann, Marcos B/0000-0001-6444-9788; Mol, Juliana/0000-0002-6946-8213; Minharro, Silvia/0000-0001-5844-5326	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico-CNPq; Fundacao de Amparo a Pesquisa do Estado de Minas Gerais-Fapemig; Fundacao de Estudo e Pesquisa em Medicina Veterinaria e Zootecnia-FEP-MVZ; Coordenacao de Aperfeicoamento do Pessoal de Ensino Superior-Capes	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico-CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais-Fapemig(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Fundacao de Estudo e Pesquisa em Medicina Veterinaria e Zootecnia-FEP-MVZ; Coordenacao de Aperfeicoamento do Pessoal de Ensino Superior-Capes(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This study was supported by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico-CNPq, Fundacao de Amparo a Pesquisa do Estado de Minas Gerais-Fapemig and Fundacao de Estudo e Pesquisa em Medicina Veterinaria e Zootecnia-FEP-MVZ. RBP and MSMS are indebted with Coordenacao de Aperfeicoamento do Pessoal de Ensino Superior-Capes for their fellowships. APRS, JPSM, EMSD and APL had fellowships from CNPq.	Abdel-Maksoud M, 2012, ANN CLIN MICROB ANTI, V11, DOI 10.1186/1476-0711-11-24; Ariza J, 2007, PLOS MED, V4, P1872, DOI 10.1371/journal.pmed.0040317; BAILY GG, 1992, J TROP MED HYG, V95, P271; Bayram Y, 2011, INT J MED SCI, V8, P198, DOI 10.7150/ijms.8.198; Berkelman RL, 2003, CLIN INFECT DIS, V37, P407, DOI 10.1086/375595; Braibant M, 2002, ANTIMICROB AGENTS CH, V46, P3050, DOI 10.1128/AAC.46.9.3050-3053.2002; BRICKER BJ, 1994, J CLIN MICROBIOL, V32, P2660, DOI 10.1128/JCM.32.11.2660-2666.1994; CLSI, 2014, METH ANT DIL DISK SU; CLSI, 2007, M100S17 CLSI; Corbel M.J., 2006, BRUCELLOSIS HUMANS A; GARCIARODRIGUEZ JA, 1991, ANTIMICROB AGENTS CH, V35, P756, DOI 10.1128/AAC.35.4.756; Jiang H, 2010, T ROY SOC TROP MED H, V104, P796, DOI 10.1016/j.trstmh.2010.08.002; Kocagoz S, 2002, CLIN MICROBIOL INFEC, V8, P240, DOI 10.1046/j.1469-0691.2002.00416.x; Le Fleche P, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-9; Lopez-Goni I, 2008, J CLIN MICROBIOL, V46, P3484, DOI 10.1128/JCM.00837-08; Lopez-Merino A, 2004, SCAND J INFECT DIS, V36, P636, DOI 10.1080/00365540410020767; Magiorakos AP, 2012, CLIN MICROBIOL INFEC, V18, P268, DOI 10.1111/j.1469-0691.2011.03570.x; Marianelli C, 2004, J CLIN MICROBIOL, V42, P5439, DOI 10.1128/JCM.42.12.5439-5443.2004; Marianelli C, 2007, J CLIN MICROBIOL, V45, P2923, DOI 10.1128/JCM.00822-07; Maves RC, 2011, ANTIMICROB AGENTS CH, V55, P1279, DOI 10.1128/AAC.00979-10; Memish Z, 2000, J INFECTION, V40, P59, DOI 10.1053/jinf.1999.0586; Minharro S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081152; Pappas G, 2005, NEW ENGL J MED, V352, P2325, DOI 10.1056/NEJMra050570; Poester FP, 2002, VET MICROBIOL, V90, P55, DOI 10.1016/S0378-1135(02)00245-6; Radostits O., 2007, VET MED TXB DIS CATT, V10; Ramos TRR, 2008, BRAZ J INFECT DIS, V12, P133, DOI 10.1590/S1413-86702008000200007; Skalsky K, 2008, BMJ-BRIT MED J, V336, P701, DOI 10.1136/bmj.39497.500903.25; Souza A P, 1977, Rev Saude Publica, V11, P238; Turkmani Aun, 2006, Ann Clin Microbiol Antimicrob, V5, P24, DOI 10.1186/1476-0711-5-24; Van Bambeke F, 2003, J ANTIMICROB CHEMOTH, V51, P1055, DOI 10.1093/jac/dkg224; Verger JM, 1988, TECHNIQUES BRUCELLOS	31	14	16	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2015	10	7							e0132532	10.1371/journal.pone.0132532	http://dx.doi.org/10.1371/journal.pone.0132532			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RQ	26181775	gold, Green Submitted, Green Published			2022-12-26	WOS:000358198200022
J	Takahara, B; Takahashi, KH				Takahara, Baku; Takahashi, Kazuo H.			Genome-Wide Association Study on Male Genital Shape and Size in Drosophila melanogaster	PLOS ONE			English	Article							MALE FERTILIZATION SUCCESS; GENETIC ARCHITECTURE; SEXUAL SELECTION; MATING-BEHAVIOR; MORPHOLOGY; SIMULANS; PHOSPHODIESTERASES; DIFFERENCE; EVOLUTION; TRAITS	Male genital morphology of animals with internal fertilization and promiscuous mating systems have been one of the most diverse and rapidly evolving morphological traits. The male genital morphology in general is known to have low phenotypic and genetic variations, but the genetic basis of the male genital variation remains unclear. Drosophila melanogaster and its closely related species are morphologically very similar, but the shapes of the posterior lobe, a cuticular projection on the male genital arch are distinct from each other, representing a model system for studying the genetic basis of male genital morphology. In this study, we used highly inbred whole genome sequenced strains of D. melanogaster to perform genome wide association analysis on posterior lobe morphology. We quantified the outline shape of posterior lobes with Fourier coefficients obtained from elliptic Fourier analysis and performed principal component analysis, and posterior lobe size. The first and second principal components (PC1 and PC2) explained approximately 88% of the total variation of the posterior lobe shape. We then examined the association between the principal component scores and posterior lobe size and 1902142 single nucleotide polymorphisms (SNPs). As a result, we obtained 15, 14 and 15 SNPs for PC1, PC2 and posterior lobe size with P-values smaller than 10-5. Based on the location of the SNPs, 13, 13 and six protein coding genes were identified as potential candidates for PC1, PC2 and posterior lobe size, respectively. In addition to the previous findings showing that the intraspecific posterior shape variation are regulated by multiple QTL with strong effects, the present study suggests that the intraspecific variation may be under polygenic regulation with a number of loci with small effects. Further studies are required for investigating whether these candidate genes are responsible for the intraspecific posterior lobe shape variation.	[Takahara, Baku] Okayama Univ, Fac Agr, Kita Ku, Okayama 7008530, Japan; [Takahashi, Kazuo H.] Okayama Univ, Grad Sch Environm Sci, Kita Ku, Okayama 7008530, Japan	Okayama University; Okayama University	Takahashi, KH (corresponding author), Okayama Univ, Grad Sch Environm Sci, Kita Ku, Tsushima Naka 1-1-1, Okayama 7008530, Japan.	kaz_tak@cc.okayama-u.ac.jp		Takahashi, Kazuo/0000-0002-1353-4971	 [25440212]		This study was supported by Grant-in-Aid for Scientific Research (C) (25440212).	Arnqvist G, 1998, ACTA ZOOL ACAD SCI H, V44, P73; Arnqvist G, 1999, EVOLUTION, V53, P147, DOI [10.2307/2640927, 10.1111/j.1558-5646.1999.tb05340.x]; Arnqvist G, 1998, GENET RES, V71, P193, DOI 10.1017/S0016672398003279; Ashburner M., 2004, DROSOPHILA LAB HDB; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bonhomme V, 2014, J STAT SOFTW, V56, P1; Chatterjee SS, 2011, DEVELOPMENT, V138, P1099, DOI 10.1242/dev.055731; Danielsson I, 1999, BEHAV ECOL SOCIOBIOL, V46, P149, DOI 10.1007/s002650050604; Day JP, 2005, BIOCHEM J, V388, P333, DOI 10.1042/BJ20050057; Eberhard W.G., 1985, SEXUAL SELECTION ANI; Eberhard WG, 2001, EVOLUTION, V55, P93, DOI 10.1111/j.0014-3820.2001.tb01275.x; Fry AJ, 2004, HEREDITY, V93, P379, DOI 10.1038/sj.hdy.6800514; Hosken DJ, 2004, TRENDS ECOL EVOL, V19, P87, DOI 10.1016/j.tree.2003.11.012; House CM, 2003, P ROY SOC B-BIOL SCI, V270, P447, DOI 10.1098/rspb.2002.2266; Inagaki S, 2005, GENES CELLS, V10, P1163, DOI 10.1111/j.1365-2443.2005.00910.x; Jagadeeshan S, 2006, J EVOLUTION BIOL, V19, P1058, DOI 10.1111/j.1420-9101.2006.01099.x; Kamimura Y, 2011, ENTOMOL SCI, V14, P399, DOI 10.1111/j.1479-8298.2011.00467.x; Khazaeli AA, 2010, EVOLUTION, V64, P3409, DOI 10.1111/j.1558-5646.2010.01139.x; Kleppisch Thomas, 2009, V191, P71, DOI 10.1007/978-3-540-68964-5_5; KUHL FP, 1982, COMPUT VISION GRAPH, V18, P236, DOI 10.1016/0146-664X(82)90034-X; LeVasseur-Viens H, 2015, EVOLUTION; Liu J, 1996, GENETICS, V142, P1129; Macdonald SJ, 1999, GENETICS, V153, P1683; Mackay TFC, 2012, NATURE, V482, P173, DOI 10.1038/nature10811; Masly JP, 2014, EVOLUTION, V68, P2401, DOI 10.1111/evo.12436; Masly JP, 2011, GENETICS, V189, P357, DOI 10.1534/genetics.111.130815; McNeil CL, 2011, G3-GENES GENOM GENET, V1, P343, DOI 10.1534/g3.111.000661; Morton DB, 2010, GENETICS, V186, P159, DOI 10.1534/genetics.110.118018; Morton DB, 2002, ADV INSECT PHYSIOL, V29, P1, DOI 10.1016/S0065-2806(02)29001-3; Otronen M, 1998, BEHAV ECOL SOCIOBIOL, V42, P185, DOI 10.1007/s002650050430; Rasband W., 2006, IMAGEJ; Shingleton AW, 2009, P ROY SOC B-BIOL SCI, V276, P2625, DOI 10.1098/rspb.2008.1796; Tanaka KM, 2015, GENETICS, V200, P357, DOI 10.1534/genetics.114.174045; Turner MJ, 2005, PHYSIOL GENOMICS, V22, P76, DOI 10.1152/physiolgenomics.00243.2004; Zeng ZB, 2000, GENETICS, V154, P299	35	19	20	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2015	10	7							e0132846	10.1371/journal.pone.0132846	http://dx.doi.org/10.1371/journal.pone.0132846			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RQ	26182199	Green Published, Green Submitted, gold			2022-12-26	WOS:000358198200043
J	Papadakis, G; Skandalis, N; Dimopoulou, A; Glynos, P; Gizeli, E				Papadakis, George; Skandalis, Nicholas; Dimopoulou, Anastasia; Glynos, Paraskevas; Gizeli, Electra			Bacteria Murmur: Application of an Acoustic Biosensor for Plant Pathogen Detection	PLOS ONE			English	Article							SYRINGAE PV. TOMATO; XANTHOMONAS-CAMPESTRIS; MULTIPLEX PCR; DNA; MICROFLUIDICS; MICHIGANENSIS; VESICATORIA; ASSAY	A multi-targeting protocol for the detection of three of the most important bacterial phytopathogens, based on their scientific and economic importance, was developed using an acoustic biosensor (the Quartz Crystal Microbalance) for DNA detection. Acoustic detection was based on a novel approach where DNA amplicons were monitored and discriminated based on their length rather than mass. Experiments were performed during real time monitoring of analyte binding and in a direct manner, i.e. without the use of labels for enhancing signal transduction. The proposed protocol improves time processing by circumventing gel electrophoresis and can be incorporated as a routine detection method in a diagnostic lab or an automated lab-on-a-chip system for plant pathogen diagnostics.	[Papadakis, George; Gizeli, Electra] Inst Mol Biol & Biotechnol, Iraklion, Greece; [Skandalis, Nicholas; Dimopoulou, Anastasia; Glynos, Paraskevas] Benaki Phytopathol Inst, Athens, Greece; [Gizeli, Electra] Univ Crete, Dept Biol, Vassilika Vouton, Heraklion Crete, Greece	University of Crete	Gizeli, E (corresponding author), Inst Mol Biol & Biotechnol, Iraklion, Greece.	gizeli@imbb.forth.gr	Papadakis, George/V-9612-2019	Papadakis, George/0000-0001-5964-6568; Skandalis, Nicholas/0000-0002-4236-8909	European Regional Development Funds; Greek National Funds on "Competitiveness and Enterpreneurship"; European Commision [317742, 316223]	European Regional Development Funds(European Commission); Greek National Funds on "Competitiveness and Enterpreneurship"; European Commision	The European Regional Development Funds and Greek National Funds on "Competitiveness and Enterpreneurship" are acknowledged through SYNERGASIA 2011. This work was also supported by the European Commision through Framework Package 7-Information and Communication Technologies (FP7-ICT, Grant agreement No 317742) and Framework Package 7 Research Potential (REGPOT, Grant agreement No 316223). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berg T, 2006, LETT APPL MICROBIOL, V42, P624, DOI 10.1111/j.1472-765X.2006.01887.x; Campbell C. K., 1998, SURFACE ACOUSTIC WAV; Chen Y, 2010, J MICROBIOL BIOTECHN, V20, P193, DOI 10.4014/jmb.0906.06019; Cho YK, 2004, J COLLOID INTERF SCI, V278, P44, DOI 10.1016/j.jcis.2004.05.008; Cuppels DA, 2006, PLANT DIS, V90, P451, DOI 10.1094/PD-90-0451; EPPO, 2012, EUR MED PLANT PROT O; Gizeli E., 2002, BIOMOLECULAR SENSORS; Goto Mikihiro, 2010, 2010 International Ultrasonics Symposium, P736, DOI 10.1109/ULTSYM.2010.0189; Hauben L, 1997, INT J SYST BACTERIOL, V47, P328, DOI 10.1099/00207713-47-2-328; HAYWARD AC, 1991, ANNU REV PHYTOPATHOL, V29, P65, DOI 10.1146/annurev.py.29.090191.000433; Jones JB., 1991, COMPENDIUM TOMATO DI; KING EO, 1954, J LAB CLIN MED, V44, P301; KLEMENT Z, 1964, PHYTOPATHOLOGY, V54, P474; Koo C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082704; Landgraf A, 2006, MOL PLANT PATHOL, V7, P355, DOI 10.1111/j.1364-3703.2006.00343.x; Lapage SP, 1970, METHODS MICROBIOLOGY; Lee W, 2013, ANALYST, V138, P2558, DOI 10.1039/c3an00182b; Mansfield J, 2012, MOL PLANT PATHOL, V13, P614, DOI 10.1111/j.1364-3703.2012.00804.x; Marttila AT, 2000, FEBS LETT, V467, P31, DOI 10.1016/S0014-5793(00)01119-4; Matatagui D, 2013, SENSOR ACTUAT B-CHEM, V185, P218, DOI 10.1016/j.snb.2013.04.118; Mitsakakis K, 2008, J MICROELECTROMECH S, V17, P1010, DOI 10.1109/JMEMS.2008.927173; Mitsakakis K, 2011, BIOSENS BIOELECTRON, V26, P4579, DOI 10.1016/j.bios.2011.05.030; MURRAY MG, 1980, NUCLEIC ACIDS RES, V8, P4321, DOI 10.1093/nar/8.19.4321; Obradovic A, 2004, EUR J PLANT PATHOL, V110, P285, DOI 10.1023/B:EJPP.0000019797.27952.1d; Ozdemir Z, 2009, J PLANT PATHOL, V91, P495; Palacio-Bielsa A, 2009, J PLANT PATHOL, V91, P249; Papadakis G, 2013, SCI REP-UK, V3, DOI 10.1038/srep02033; Papadakis G, 2014, ANAL METHODS-UK, V6, P363, DOI 10.1039/c3ay41143e; Pastrik KH, 2000, EUR J PLANT PATHOL, V106, P155, DOI 10.1023/A:1008736017029; Peterson AW, 2001, NUCLEIC ACIDS RES, V29, P5163, DOI 10.1093/nar/29.24.5163; Seal SE, 1999, PLANT PATHOL, V48, P115, DOI 10.1046/j.1365-3059.1999.00322.x; Skandalis N., 2012, Hellenic Plant Protection Journal, V5, P31; Tampakaki AP, 2010, ANNU REV PHYTOPATHOL, V48, P347, DOI 10.1146/annurev-phyto-073009-114407; Tsortos A, 2008, BIOPHYS J, V94, P2706, DOI 10.1529/biophysj.107.119271; Tsortos A, 2008, BIOSENS BIOELECTRON, V24, P836, DOI 10.1016/j.bios.2008.07.006; VAUTERIN L, 1995, INT J SYST BACTERIOL, V45, P472, DOI 10.1099/00207713-45-3-472; Xu GL, 2015, CHEM COMMUN, V51, P2589, DOI 10.1039/c4cc08389j; Young J. M., 1996, Review of Plant Pathology, V75, P721	38	15	15	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0132773	10.1371/journal.pone.0132773	http://dx.doi.org/10.1371/journal.pone.0132773			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26177507	Green Submitted, Green Published, gold			2022-12-26	WOS:000358197600153
J	Carvalho, S; Catarino, TA; Dias, AM; Kato, M; Almeida, A; Hessling, B; Figueiredo, J; Gartner, F; Sanches, JM; Ruppert, T; Miyoshi, E; Pierce, M; Carneiro, F; Kolarich, D; Seruca, R; Yamaguchi, Y; Taniguchi, N; Reis, CA; Pinho, SS				Carvalho, S.; Catarino, T. A.; Dias, A. M.; Kato, M.; Almeida, A.; Hessling, B.; Figueiredo, J.; Gaertner, F.; Sanches, J. M.; Ruppert, T.; Miyoshi, E.; Pierce, M.; Carneiro, F.; Kolarich, D.; Seruca, R.; Yamaguchi, Y.; Taniguchi, N.; Reis, C. A.; Pinho, S. S.			Preventing E-cadherin aberrant N-glycosylation at Asn-554 improves its critical function in gastric cancer	ONCOGENE			English	Article							CELL-CELL ADHESION; GLYCOMICS EXPERIMENT; ORAL-CANCER; IN-SITU; TOOL; GLYCOPROTEINS; ORGANIZATION; ANNOTATION; PROTEINS; FEATURES	E-cadherin is a central molecule in the process of gastric carcinogenesis and its posttranslational modifications by N-glycosylation have been described to induce a deleterious effect on cell adhesion associated with tumor cell invasion. However, the role that site-specific glycosylation of E-cadherin has in its defective function in gastric cancer cells needs to be determined. Using transgenic mice models and human clinical samples, we demonstrated that N-acetylglucosaminyltransferase V (GnT-V)-mediated glycosylation causes an abnormal pattern of E-cadherin expression in the gastric mucosa. In vitro models further indicated that, among the four potential N-glycosylation sites of E-cadherin, Asn-554 is the key site that is selectively modified with beta 1,6 GlcNAc-branched N-glycans catalyzed by GnT-V. This aberrant glycan modification on this specific asparagine site of E-cadherin was demonstrated to affect its critical functions in gastric cancer cells by affecting E-cadherin cellular localization, cis-dimer formation, molecular assembly and stability of the adherens junctions and cell-cell aggregation, which was further observed in human gastric carcinomas. Interestingly, manipulating this site-specific glycosylation, by preventing Asn-554 from receiving the deleterious branched structures, either by a mutation or by silencing GnT-V, resulted in a protective effect on E-cadherin, precluding its functional dysregulation and contributing to tumor suppression.	[Carvalho, S.; Catarino, T. A.; Dias, A. M.; Figueiredo, J.; Gaertner, F.; Carneiro, F.; Seruca, R.; Reis, C. A.; Pinho, S. S.] Univ Porto, Inst Res & Innovat Hlth, Rua Campo Alegre 823, P-4100 Oporto, Portugal; [Carvalho, S.; Catarino, T. A.; Dias, A. M.; Figueiredo, J.; Gaertner, F.; Carneiro, F.; Seruca, R.; Reis, C. A.; Pinho, S. S.] Univ Porto IPATIMUP, Inst Mol Pathol & Immunol, Oporto, Portugal; [Carvalho, S.; Dias, A. M.; Gaertner, F.; Reis, C. A.; Pinho, S. S.] Univ Porto, Inst Biomed Sci Abel Salazar ICBAS, Rua Campo Alegre 823, P-4100 Oporto, Portugal; [Kato, M.; Yamaguchi, Y.; Taniguchi, N.] RIKEN Global Res Cluster, Syst Glycobiol Res Grp, RIKEN Max Planck Joint Res Ctr, Wako, Saitama, Japan; [Almeida, A.; Kolarich, D.] Max Planck Inst Colloids & Interfaces, Dept Biomol Syst, Potsdam, Germany; [Almeida, A.] Free Univ Berlin, Inst Chem & Biochem, Berlin, Germany; [Hessling, B.; Ruppert, T.] Heidelberg Univ, Ctr Mol Biol, Heidelberg, Germany; [Sanches, J. M.] Univ Lisbon, Inst Super Tecn, LARSyS, Inst Syst & Robot ISR IST, P-1699 Lisbon, Portugal; [Miyoshi, E.] Osaka Univ, Mol Biochem & Clin Invest, Grad Sch Med, Osaka, Japan; [Pierce, M.] Univ Georgia, Complex Carbohydrate Res Ctr, Dept Biochem & Mol Biol, 220 Riverbend Rd, Athens, GA 30602 USA; [Carneiro, F.; Seruca, R.; Reis, C. A.] Univ Porto, Med Fac, Rua Campo Alegre 823, P-4100 Oporto, Portugal; [Carneiro, F.] Hosp Sao Joao, Dept Pathol, Oporto, Portugal	Universidade do Porto; i3S - Instituto de Investigacao e Inovacao em Saude, Universidade do Porto; Universidade do Porto; Universidade do Porto; RIKEN; Max Planck Society; Free University of Berlin; Ruprecht Karls University Heidelberg; Universidade de Lisboa; Instituto Superior Tecnico; Osaka University; University System of Georgia; University of Georgia; Universidade do Porto; Sao Joao Hospital	Pinho, SS (corresponding author), Univ Porto, Inst Mol Pathol & Immunol, Glycobiol Canc Grp, Rua Doutor Roberto Frias, P-4200465 Oporto, Portugal.	salomep@ipatimup.pt	REIS, Celso A/B-9969-2008; Carvalho, Sandra S/K-1724-2016; Carneiro, Fatima/AAV-8677-2021; Kolarich, Daniel/B-6893-2012; Carvalho, Sandra/ABA-8715-2020; Figueiredo, Joana/J-7305-2013; Kolarich, Daniel/AAJ-3550-2020; Yamaguchi, Yoshiki/N-5246-2015; Taniguchi, Naoyuki/I-4182-2014; Sanches, Joao/ABG-2684-2021; Carneiro, Fatima/J-6432-2013; Sanches, Joao Miguel/C-1947-2013; Ruppert, Thomas/AAC-2467-2021; Dias, Ana/AAE-8828-2020; Taniguchi, Naoyuki/A-7086-2016; Gartner, Maria de Fatima/A-3530-2010; Pinho, Salome/F-1764-2011; Araujo Catarino, Telmo/L-2012-2013	REIS, Celso A/0000-0002-0286-6639; Carvalho, Sandra S/0000-0003-3647-3582; Carneiro, Fatima/0000-0002-1964-1006; Kolarich, Daniel/0000-0002-8452-1350; Carvalho, Sandra/0000-0003-3647-3582; Figueiredo, Joana/0000-0002-1590-1974; Kolarich, Daniel/0000-0002-8452-1350; Yamaguchi, Yoshiki/0000-0003-0100-5439; Taniguchi, Naoyuki/0000-0001-5889-5968; Sanches, Joao/0000-0001-9089-2740; Carneiro, Fatima/0000-0002-1964-1006; Sanches, Joao Miguel/0000-0001-9089-2740; Ruppert, Thomas/0000-0001-9152-2266; Gartner, Maria de Fatima/0000-0002-5302-0086; Dias, Ana/0000-0003-0060-2872; Seruca, Raquel/0000-0002-8851-4166; Pinho, Salome/0000-0002-3484-5162; Araujo Catarino, Telmo/0000-0002-2498-9648	FCT, the Portuguese Foundation for Science and Technology; FEDER funds through the Operational Programme for Competitiveness Factors-COMPETE-; National Funds through the FCT-Foundation for Science and Technology [PTDC/CVT/111358/2009, EXPL/BIM-MEC/0149/2012, PTDC/BBB-EBI/0786/2012]; FCT [SFRH/BD/77386/2011, SFRH/BI/52380/2013, SFRH/BPD/63094/2009]; Luso-American Foundation (FLAD) [SFRH/BD/77386/2011, SFRH/BI/52380/2013, SFRH/BPD/63094/2009]; Max Planck Society; European Union [PCIG09-GA-2011-293847, 316929]; NATIONAL CANCER INSTITUTE [U01CA128454] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103490] Funding Source: NIH RePORTER; Fundação para a Ciência e a Tecnologia [PTDC/CVT/111358/2009, UID/EEA/50009/2013, PTDC/BBB-EBI/0786/2012, EXPL/BIM-MEC/0149/2012] Funding Source: FCT	FCT, the Portuguese Foundation for Science and Technology(Portuguese Foundation for Science and Technology); FEDER funds through the Operational Programme for Competitiveness Factors-COMPETE-; National Funds through the FCT-Foundation for Science and Technology; FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); Luso-American Foundation (FLAD); Max Planck Society(Max Planck SocietyFoundation CELLEX); European Union(European Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Fundação para a Ciência e a Tecnologia	IPATIMUP integrates the I3S Research Unit, which is partially supported by FCT, the Portuguese Foundation for Science and Technology. This work is funded by FEDER funds through the Operational Programme for Competitiveness Factors-COMPETE- and National Funds through the FCT-Foundation for Science and Technology, under the projects: PTDC/CVT/111358/2009; EXPL/BIM-MEC/0149/2012; and PTDC/BBB-EBI/0786/2012. SC (SFRH/BD/77386/2011), AMD (SFRH/BI/52380/2013) BiotechHealth Doctoral Programme, and SSP (SFRH/BPD/63094/2009) thank FCT and the Luso-American Foundation (FLAD) for funding. JMS acknowledges FCT (UID/EEA/50009/2013). DK acknowledges support by the Max Planck Society and European Union (Seventh Framework Programme 'Glycoproteomics', grant number PCIG09-GA-2011-293847. CAR and DK acknowledge GastricGlycoExplorer project, grant number 316929). We thank Ola Soderberg and Gaelle Cane (Department of Genetics and Pathology, University of Uppsala, Uppsala, Sweden) for providing the Streptavidin PLA probe and to Marcia Pereira and Sara Campos for the support in PLA technique and statistical analyses.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; BAUSE E, 1983, BIOCHEM J, V209, P331, DOI 10.1042/bj2090331; Ceroni A, 2008, J PROTEOME RES, V7, P1650, DOI 10.1021/pr7008252; CHOU PY, 1979, BIOPHYS J, V26, P367, DOI 10.1016/S0006-3495(79)85259-5; Cooper CA, 2001, PROTEOMICS, V1, P340, DOI 10.1002/1615-9861(200102)1:2<340::AID-PROT340>3.0.CO;2-B; Davis MA, 2003, J CELL BIOL, V163, P525, DOI 10.1083/jcb.200307111; Deshpande N, 2010, J PROTEOME RES, V9, P1063, DOI 10.1021/pr900956x; GAVEL Y, 1990, PROTEIN ENG, V3, P433, DOI 10.1093/protein/3.5.433; Gu JG, 2012, GLYCOCONJUGATE J, V29, P599, DOI 10.1007/s10719-012-9386-1; Gu J, 2009, J PROTEOME RES, V8, P431, DOI 10.1021/pr800674g; Guilford P, 1999, MOL MED TODAY, V5, P172, DOI 10.1016/S1357-4310(99)01461-6; Guo HB, 2009, J BIOL CHEM, V284, P34986, DOI 10.1074/jbc.M109.060806; Hirohashi S, 2003, CANCER SCI, V94, P575, DOI 10.1111/j.1349-7006.2003.tb01485.x; Jensen PH, 2012, NAT PROTOC, V7, P1299, DOI 10.1038/nprot.2012.063; Jones J, 2005, BIOCHIM BIOPHYS ACTA, V1726, P121; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kitada T, 2001, J BIOL CHEM, V276, P475, DOI 10.1074/jbc.M006689200; Kolarich D, 2013, MOL CELL PROTEOMICS, V12, P991, DOI 10.1074/mcp.O112.026492; Langer MD, 2012, J CELL SCI, V125, P2478, DOI 10.1242/jcs.101147; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LEWIS JE, 1994, J CELL SCI, V107, P3615; Liwosz A, 2006, J BIOL CHEM, V281, P23138, DOI 10.1074/jbc.M512621200; Lommel M, 2013, P NATL ACAD SCI USA, V110, P21024, DOI 10.1073/pnas.1316753110; de-Freitas JCM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081579; Nelson WJ, 2008, BIOCHEM SOC T, V36, P149, DOI 10.1042/BST0360149; Nita-Lazar M, 2009, CANCER RES, V69, P5673, DOI 10.1158/0008-5472.CAN-08-4512; ODA T, 1994, P NATL ACAD SCI USA, V91, P1858, DOI 10.1073/pnas.91.5.1858; Paredes J, 2012, BBA-REV CANCER, V1826, P297, DOI 10.1016/j.bbcan.2012.05.002; Pertz O, 1999, EMBO J, V18, P1738, DOI 10.1093/emboj/18.7.1738; Pinho SS, 2013, TRENDS MOL MED, V19, P664, DOI [10.1016/j.molmed.2013, 10.1016/j.molmed.2013.07.003]; Pinho SS, 2013, BBA-GEN SUBJECTS, V1830, P2690, DOI 10.1016/j.bbagen.2012.10.021; Pinho SS, 2011, CELL MOL LIFE SCI, V68, P1011, DOI 10.1007/s00018-010-0595-0; Pinho SS, 2009, HUM MOL GENET, V18, P2599, DOI 10.1093/hmg/ddp194; Pinho SS, 2009, BIOCHEM BIOPH RES CO, V379, P1091, DOI 10.1016/j.bbrc.2009.01.024; Pruitt KD, 2012, NUCLEIC ACIDS RES, V40, pD130, DOI 10.1093/nar/gkr1079; Przybylo Malgorzata, 2002, Cancer Cell Int, V2, P6, DOI 10.1186/1475-2867-2-6; Rose PW, 2013, NUCLEIC ACIDS RES, V41, pD475, DOI 10.1093/nar/gks1200; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sanches JM, 2015, EUR J HUM GENET, V23, P1072, DOI 10.1038/ejhg.2014.240; Sato Y, 2009, J BIOL CHEM, V284, P11873, DOI 10.1074/jbc.M807660200; SHAPIRO L, 1995, NATURE, V374, P327, DOI 10.1038/374327a0; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; TAKEICHI M, 1977, J CELL BIOL, V75, P464, DOI 10.1083/jcb.75.2.464; Thaysen-Andersen M, 2012, GLYCOBIOLOGY, V22, P1440, DOI 10.1093/glycob/cws110; van Roy F, 2008, CELL MOL LIFE SCI, V65, P3756, DOI 10.1007/s00018-008-8281-1; Varelas X, 2014, GLYCOBIOLOGY, V24, P579, DOI 10.1093/glycob/cwu031; Vester-Christensen MB, 2013, P NATL ACAD SCI USA, V110, P21018, DOI 10.1073/pnas.1313446110; Yap AS, 1998, J CELL BIOL, V141, P779, DOI 10.1083/jcb.141.3.779; York WS, 2014, GLYCOBIOLOGY, V24, P402, DOI 10.1093/glycob/cwu018; Yoshimura M, 1996, J BIOL CHEM, V271, P13811, DOI 10.1074/jbc.271.23.13811; Zhou F, 2008, GLYCOCONJUGATE J, V25, P727, DOI 10.1007/s10719-008-9133-9	51	73	73	0	29	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 31	2016	35	13					1619	1631		10.1038/onc.2015.225	http://dx.doi.org/10.1038/onc.2015.225			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DH8RP	26189796	Bronze, Green Accepted, Green Submitted			2022-12-26	WOS:000373064200002
J	Tam, MF; Tam, TCS; Simplaceanu, V; Ho, NT; Zou, M; Ho, C				Tam, Ming F.; Tam, Tsuey Chyi S.; Simplaceanu, Virgil; Ho, Nancy T.; Zou, Ming; Ho, Chien			Sickle Cell Hemoglobin with Mutation at His-50 Has Improved Solubility	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						hemoglobin; mutant; nuclear magnetic resonance (NMR); oxygen binding; protein stability; Csat; autoxidation; sickle cell	NUCLEAR-MAGNETIC-RESONANCE; REFINED CRYSTAL-STRUCTURE; EXCHANGEABLE PROTON NMR; NORMAL HUMAN ADULT; DEOXYHEMOGLOBIN-S; AMINO-ACID; RECOMBINANT HEMOGLOBINS; ACCEPTOR POCKET; HYDROGEN-BOND; BETA 88	Background: Deoxy sickle cell hemoglobin (Hb S) tetramers polymerize in solution via lateral and axial contacts among neighbors. Results: His-50 Gln mutation can, whereas His-20 Gln mutation cannot, improve the solubility of Hb S. Conclusion: (2)His-50 interacts with the (S)(1) CD corner, whereas (2)His-20 has minimal interaction with (S)(1)Glu-22. Significance: (2)His-50 contributes significantly to the polymerization of the Hb S tetramers. The unliganded tetrameric Hb S has axial and lateral contacts with neighbors and can polymerize in solution. Novel recombinants of Hb S with single amino acid substitutions at the putative axial (recombinant Hb (rHb) (E6V/H20R) and rHb (E6V/H20Q)) or lateral (rHb (E6V/H50Q)) or double amino acid substitutions at both the putative axial and lateral (rHb (E6V/H20R/H50Q) and rHb (E6V/H20Q/H50Q)) contact sites were expressed in Escherichia coli and purified for structural and functional studies. The H-1 NMR spectra of the CO and deoxy forms of these mutants indicate that substitutions at either His-20 or His-50 do not change the subunit interfaces or the heme pockets of the proteins. The double mutants show only slight structural alteration in the -heme pockets. All mutants have similar cooperativity (n(50)), alkaline Bohr effect, and autoxidation rate as Hb S. The oxygen binding affinity (P-50) of the single mutants is comparable with that of Hb S. The double mutants bind oxygen with slightly higher affinity than Hb S under the acidic conditions. In high salt, rHb (E6V/H20R) is the only mutant that has a shorter delay time of polymerization and forms polymers more readily than Hb S with a dextran-Csat value of 1.86 +/- 0.20 g/dl. Hb S, rHb (E6V/H20Q), rHb (E6V/H50Q), rHb (E6V/H20R/H50Q), and rHb (E6V/H20Q/H50Q) have dextran-Csat values of 2.95 +/- 0.10, 3.04 +/- 0.17, 11.78 +/- 0.59, 7.11 +/- 0.66, and 10.89 +/- 0.83 g/dl, respectively. rHb (E6V/H20Q/H50Q) is even more stable than Hb S under elevated temperature (60 degrees C).	[Tam, Ming F.; Tam, Tsuey Chyi S.; Simplaceanu, Virgil; Ho, Nancy T.; Zou, Ming; Ho, Chien] Carnegie Mellon Univ, Dept Biol Sci, Pittsburgh, PA 15213 USA	Carnegie Mellon University	Ho, C (corresponding author), Carnegie Mellon Univ, Dept Biol Sci, 4400 Fifth Ave, Pittsburgh, PA 15213 USA.	chienho@andrew.cmu.edu	Regan, Clinton/E-6250-2012; Ho, Chien/O-6112-2016	Ho, Chien/0000-0002-4094-9232	National Institutes of Health [R01GM084614]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084614] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01GM084614. The authors declare that they have no conflicts of interest with the contents of this article.	ACHARYA AS, 1985, BIOCHEMISTRY-US, V24, P4885, DOI 10.1021/bi00339a024; ADACHI K, 1993, J BIOL CHEM, V268, P21650; ADACHI K, 1987, J BIOL CHEM, V262, P12920; ADACHI K, 1979, J BIOL CHEM, V254, P7765; Adachi K, 1996, J BIOL CHEM, V271, P24557, DOI 10.1074/jbc.271.40.24557; ADACHI K, 1994, J BIOL CHEM, V269, P9562; ADACHI K, 1994, J BIOL CHEM, V269, P31563; ADACHI K, 1994, J BIOL CHEM, V269, P17477; Adachi K, 2008, BIOCHEMISTRY-US, V47, P5441, DOI 10.1021/bi800149u; Adachi K, 2009, ARCH BIOCHEM BIOPHYS, V481, P137, DOI 10.1016/j.abb.2008.11.006; Banerjee S, 2007, PROTEIN J, V26, P445, DOI 10.1007/s10930-007-9084-1; BAUDINCHICH V, 1990, P NATL ACAD SCI USA, V87, P1845, DOI 10.1073/pnas.87.5.1845; BENSINGER TA, 1974, ARCH INTERN MED, V133, P624, DOI 10.1001/archinte.133.4.624; Bookchin RM, 1999, J BIOL CHEM, V274, P6689, DOI 10.1074/jbc.274.10.6689; Cao ZQ, 1997, J MOL BIOL, V265, P580, DOI 10.1006/jmbi.1996.0749; Chang CK, 2002, BIOCHEMISTRY-US, V41, P5644, DOI 10.1021/bi011919d; DALVIT C, 1985, BIOCHEMISTRY-US, V24, P3398, DOI 10.1021/bi00335a003; Dickerson R E., 1983, HEMOGLOBIN STRUCTURE, P19; DYKES GW, 1979, J MOL BIOL, V130, P451, DOI 10.1016/0022-2836(79)90434-0; EATON WA, 1987, BLOOD, V70, P1245; Fang TY, 2000, BIOCHEMISTRY-US, V39, P13708, DOI 10.1021/bi001115i; FUNG LWM, 1975, BIOCHEMISTRY-US, V14, P2526, DOI 10.1021/bi00682a036; Harrington DJ, 1997, J MOL BIOL, V272, P398, DOI 10.1006/jmbi.1997.1253; HAYASHI A, 1973, BIOCHIM BIOPHYS ACTA, V310, P309, DOI 10.1016/0005-2795(73)90110-4; HIMANEN JP, 1995, J BIOL CHEM, V270, P13885, DOI 10.1074/jbc.270.23.13885; Himanen JP, 1997, BLOOD, V89, P4196, DOI 10.1182/blood.V89.11.4196; Ho C, 1996, J MOL BIOL, V263, P475, DOI 10.1006/jmbi.1996.0590; HO C, 1992, ADV PROTEIN CHEM, V43, P153, DOI 10.1016/S0065-3233(08)60555-0; HOFRICHTER J, 1974, P NATL ACAD SCI USA, V71, P4864, DOI 10.1073/pnas.71.12.4864; INGRAM VM, 1959, BIOCHIM BIOPHYS ACTA, V36, P402, DOI 10.1016/0006-3002(59)90183-0; ISHIMORI K, 1992, BIOCHEMISTRY-US, V31, P3256, DOI 10.1021/bi00127a030; KOWALCZYKOWSKI S, 1977, J MOL BIOL, V115, P201, DOI 10.1016/0022-2836(77)90097-3; LAMAR GN, 1980, BIOCHEM BIOPH RES CO, V96, P1172, DOI 10.1016/0006-291X(80)90075-3; LINDSTROM TR, 1972, P NATL ACAD SCI USA, V69, P1707, DOI 10.1073/pnas.69.7.1707; LINDSTROM TR, 1972, BIOCHEMISTRY-US, V11, P1677, DOI 10.1021/bi00759a023; LOOKER D, 1994, METHOD ENZYMOL, V231, P364; MCCUNE SL, 1994, P NATL ACAD SCI USA, V91, P9852, DOI 10.1073/pnas.91.21.9852; NAGEL RL, 1979, P NATL ACAD SCI USA, V76, P670, DOI 10.1073/pnas.76.2.670; PADLAN EA, 1985, J BIOL CHEM, V260, P8272; PADLAN EA, 1985, J BIOL CHEM, V260, P8280; Patskovska LN, 2005, ACTA CRYSTALLOGR D, V61, P566, DOI 10.1107/S0907444905004622; PERUTZ MF, 1950, NATURE, V166, P677, DOI 10.1038/166677a0; PLATEAU P, 1982, J AM CHEM SOC, V104, P7310, DOI 10.1021/ja00389a067; Reddy LR, 1996, J BIOL CHEM, V271, P24564, DOI 10.1074/jbc.271.40.24564; Reiter CD, 2002, NAT MED, V8, P1383, DOI 10.1038/nm799; RHODA MD, 1984, BIOCHIM BIOPHYS ACTA, V786, P62, DOI 10.1016/0167-4838(84)90154-7; RUSSU IM, 1987, BIOCHIM BIOPHYS ACTA, V914, P40, DOI 10.1016/0167-4838(87)90159-2; RUSSU IM, 1980, P NATL ACAD SCI-BIOL, V77, P6577, DOI 10.1073/pnas.77.11.6577; SHEN TJ, 1993, P NATL ACAD SCI USA, V90, P8108, DOI 10.1073/pnas.90.17.8108; Simplaceanu V, 2000, BIOPHYS J, V79, P1146, DOI 10.1016/S0006-3495(00)76368-5; Sivaram MVS, 2001, J BIOL CHEM, V276, P18209, DOI 10.1074/jbc.M101788200; Srinivasulu S, 2007, PROTEIN J, V26, P523, DOI 10.1007/s10930-007-9089-9; Srinivasulu S, 2006, PROTEIN J, V25, P503, DOI 10.1007/s10930-006-9034-3; TAKAHASHI S, 1980, BIOCHEMISTRY-US, V19, P5196, DOI 10.1021/bi00564a007; Tam MF, 2005, BIOCHEMISTRY-US, V44, P12188, DOI 10.1021/bi050300z; Tam MF, 2013, J BIOL CHEM, V288, P25512, DOI 10.1074/jbc.M113.474841; WATOWICH SJ, 1989, J MOL BIOL, V209, P821, DOI 10.1016/0022-2836(89)90610-4; WELLEMS TE, 1979, J MOL BIOL, V135, P651, DOI 10.1016/0022-2836(79)90170-0; WELLEMS TE, 1981, J MOL BIOL, V153, P1011, DOI 10.1016/0022-2836(81)90464-2; Williams TN, 2006, CURR OPIN MICROBIOL, V9, P388, DOI 10.1016/j.mib.2006.06.009; WISHNER BC, 1975, J MOL BIOL, V98, P179, DOI 10.1016/S0022-2836(75)80108-2; WYMAN J, 1964, ADV PROTEIN CHEM, V19, P223, DOI 10.1016/S0065-3233(08)60190-4; Yuan Y, 2015, CHEM REV, V115, P1702, DOI 10.1021/cr500495x	63	5	5	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	2015	290	35					21762	21772		10.1074/jbc.M115.658054	http://dx.doi.org/10.1074/jbc.M115.658054			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CQ5IS	26187468	Green Published, hybrid			2022-12-26	WOS:000360637600047
J	Abdalla, FC; Domingues, CED				Abdalla, Fabio Camargo; da Costa Domingues, Caio Eduardo			Hepato-Nephrocitic System: A Novel Model of Biomarkers for Analysis of the Ecology of Stress in Environmental Biomonitoring	PLOS ONE			English	Article							FAT-BODY; PERICARDIAL CELLS; PROTEIN; BOMBUS; HYMENOPTERA; DROSOPHILA; DECLINE	Bombus presents a serious global decline of populations and even loss of species. This phenomenon is complex and multifactorial: environmental degradation due to increasing cultivation and grazing areas, indiscriminate use of agrochemicals, and a plethora of xeno-biotics daily discharged in the environment. We proposed that bees have an integrated cell system, which ensures protection against chemical stressors up to a certain limit. Therefore, this hypothesis was tested, exposing workers of Bombus morio to cadmium, a harmful trace metal nowadays widespread in our society. The workers were kept in BOD (26 degrees C, RH 70%, in the dark), fed ad libitum, and divided into a control group (n = 20) and an experimental group (n = 20). For the first group, we offered 2 mL of distilled water; for the experimental groups, 2mL of cadmium at 1 ppb. In relation to the control group, exposed bees showed that their fat body and hemocytes responded in synchronization with pericardial cells in a topographical and temporal cascade of events, where the fat body is the first barrier against xenobiotics, followed by pericardial cells. The immune cells participate throughout the process. To this system, we proposed the name of hepato-nephrocitic system (HNS), which may explain many phenomena that remain unclear in similar research with Apis mellifera and other species of bees, as shown in this paper. The bee's HNS is a system of highly responsive cells to toxicants, considered a novel parameter for the study of the ecology of stress applied in environmental management.	[Abdalla, Fabio Camargo; da Costa Domingues, Caio Eduardo] Univ Fed Sao Carlos, Dept Biol, Lab Struct & Funct Biol, Sorocaba, SP, Brazil	Universidade Federal de Sao Carlos	Abdalla, FC (corresponding author), Univ Fed Sao Carlos, Dept Biol, Lab Struct & Funct Biol, Sorocaba, SP, Brazil.	fabdalla@ufscar.br	Abdalla, Fabio Camargo/W-4022-2019; Domingues, Caio Eduardo C/V-4142-2017; Abdalla, Fábio C/F-2390-2012	Abdalla, Fabio Camargo/0000-0002-1180-8211; Domingues, Caio Eduardo C/0000-0001-8575-2735; 	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [11/17840-6, 14/04697-9]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was funded by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP: 11/17840-6, 14/04697-9), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq).	Abdalla FC, 2014, REV BRAS ENTOMOL, V58, P343, DOI 10.1590/S0085-56262014000400003; Abdalla FC, 2014, ECOTOX 2014, V8, P44; Babthan NMG, 1972, Z ZELLFORSCH MIKR AN, V124, P433; Baranski M, 2014, BRIT J NUTR, V112, P794, DOI 10.1017/S0007114514001366; BEHAN M, 1978, CELL TISSUE RES, V186, P499, DOI 10.1007/BF00224938; Biesmeijer JC, 2006, SCIENCE, V313, P351, DOI 10.1126/science.1127863; Cameron SA, 2011, P NATL ACAD SCI USA, V108, P662, DOI 10.1073/pnas.1014743108; Chapman RF, 2012, INSECT STRUCTURE FUN; Cruz-Landim C, 2009, ABELHAS MORTOLOGIA F; Cruz-Landim C, 2000, MORTE CELULAR PROGRA; da Cruz Landin C., 1985, Revista Brasileira de Biologia, V45, P221; Das D, 2008, CELL TISSUE RES, V331, P565, DOI 10.1007/s00441-007-0518-z; de Olliveira Vagner Tadeu Paes, 2003, Biociencias (Porto Alegre), V11, P195; Dean R.L., 1985, P155; ENGELMANN F, 1971, ARCH BIOCHEM BIOPHYS, V145, P439, DOI 10.1016/S0003-9861(71)80003-6; FIFE HG, 1987, INSECT BIOCHEM, V17, P829, DOI 10.1016/0020-1790(87)90017-5; Grixti JC, 2009, BIOL CONSERV, V142, P75, DOI 10.1016/j.biocon.2008.09.027; Keeley L.L., 1985, P211; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; LOCKE M, 1969, Tissue and Cell, V1, P103, DOI 10.1016/S0040-8166(69)80009-1; LOCKE M, 1966, NATURE, V210, P552, DOI 10.1038/210552a0; Locke M., 1984, P151; Lycett GJ, 2006, INSECT MOL BIOL, V15, P321, DOI 10.1111/j.1365-2583.2006.00647.x; Martins AC, 2010, J INSECT CONSERV, V14, P207, DOI 10.1007/s10841-009-9237-y; MILLS RP, 1965, Q J MICROSC SCI, V106, P261; MUNN EA, 1969, J INSECT PHYSIOL, V15, P1601, DOI 10.1016/0022-1910(69)90180-2; MUNN EA, 1967, BIOCHEM J, V102, pP5; Poiani SB, 2007, MICRON, V38, P766, DOI 10.1016/j.micron.2006.11.008; Pywell RF, 2006, BIOL CONSERV, V129, P192, DOI 10.1016/j.biocon.2005.10.034; Roma GC, 2010, MICRON, V41, P395, DOI 10.1016/j.micron.2009.12.007; ROSELL RC, 1995, INT J INSECT MORPHOL, V24, P413, DOI 10.1016/0020-7322(95)00008-R; SHIGEMATSU H, 1958, NATURE, V182, P880, DOI 10.1038/182880b0; Silva-Zacarin E.C.M., 2012, CURRENT MICROSCOPY C, P696; Snodgrass R.E., 1956, ANATOMY HONEY BEE; TADKOWSKI TM, 1979, J MORPHOL, V159, P185, DOI 10.1002/jmor.1051590203; Tonolli PN, 2011, ANN ENTOMOL SOC AM, V104, P761, DOI 10.1603/AN10143; Viviani VR, 2008, PHOTOCH PHOTOBIO SCI, V7, P448, DOI 10.1039/b718016k; Wigglesworth VB, 1942, J EXP BIOL, V19, P56; Wyatt G.R., 1980, P201	39	11	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0132349	10.1371/journal.pone.0132349	http://dx.doi.org/10.1371/journal.pone.0132349			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LZ	26197058	Green Published, gold			2022-12-26	WOS:000358547600031
J	Conover, MM; Funk, MJ; Kinlaw, AC; Borawski, KM; Wu, JM				Conover, Mitchell M.; Funk, Michele Jonsson; Kinlaw, Alan C.; Borawski, Kristy M.; Wu, Jennifer M.			Trends and Patterns of Urodynamic Studies in US Males, 2000-2012	PLOS ONE			English	Article								Objective To evaluate trends in urodynamic procedures in the U.S. males from 2000-2012 and determine if a 2010 decline in reimbursement was associated with decreased utilization. Subjects and methods We analyzed 2000-2012 administrative healthcare claims from Truven Health's Marketscan Database and evaluated males >= 18 years of age. We identified cystometrograms and any concurrent procedures using procedure billing codes. Covariates included age, year of cystometrogram, region and associated diagnosis codes. We estimated standardized cystometrogram utilization rates per 10,000 person-years (PY). We used age, region, and calendar year adjusted Poisson regression models to estimate the independent effect of calendar year and region. Results During 127,558,186 PY of observation, we identified 153,168 cystometrograms for an overall utilization rate of 12.0 per 10,000 PY (95% CI 11.9-12.1). Cystometrogram utilization increased with age, peaking at age 85 with a rate of 77.7 per 10,000 PY (95% CI 74.7-80.7). Adjusted cystometrogram utilization rate ratios show that compared to a referent of 2000-2004, utilization was significantly higher in each year 2005 to 2011 among all patients and in 2012 among patients >= 65. Standardized utilization rates peaked in 2008 at 12.4 per 10,000 PY (95% CI 12.2-12.6), remained elevated until 2010, then decreased slightly in 2011 and substantially in 2012 to 8.5 per 10,000 PY (95% CI 8.4-8.7). Conclusions Utilization of urodynamic procedures increased until 2010 and decreased thereafter. Utilization was greatest among men older than 65.	[Conover, Mitchell M.; Funk, Michele Jonsson; Kinlaw, Alan C.] Univ N Carolina, Gillings Sch Global Publ Hlth, Dept Epidemiol, Chapel Hill, NC 27599 USA; [Borawski, Kristy M.] Univ N Carolina, Dept Urol, Chapel Hill, NC USA; [Wu, Jennifer M.] Univ N Carolina, Dept Obstet & Gynecol, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Conover, MM (corresponding author), Univ N Carolina, Gillings Sch Global Publ Hlth, Dept Epidemiol, Chapel Hill, NC 27599 USA.	mconover@email.unc.edu	Funk, Michele Jonsson/F-6885-2011; Wu, Jennifer/GRX-1831-2022	Funk, Michele Jonsson/0000-0002-3756-7540; Conover, Mitchell/0000-0001-5682-3688; Wu, Jennifer/0000-0002-4477-3932; Wu, Jennifer/0000-0002-3171-1054; Kinlaw, Alan/0000-0002-4279-8685	Amgen; Eunice Kennedy Shriver National Institute of Child Health & Human Development [K23HD068404]; Agency for Healthcare Research and Quality [K02HS017950]; Department of Epidemiology; UNC Gillings School of Global Public Health; Cecil G. Sheps Center for Health Services Research; CER Strategic Initiative of UNC's Clinical Translational Science Award [UL1TR001111]; UNC School of Medicine; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [K02HS017950] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K23HD068404] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001111] Funding Source: NIH RePORTER	Amgen(Amgen); Eunice Kennedy Shriver National Institute of Child Health & Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); Department of Epidemiology; UNC Gillings School of Global Public Health; Cecil G. Sheps Center for Health Services Research; CER Strategic Initiative of UNC's Clinical Translational Science Award; UNC School of Medicine; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This study was funded by Amgen (MC, pharmacoepidemiology fellowship recipient; www.amgen.com); the Eunice Kennedy Shriver National Institute of Child Health & Human Development (JMW salary paid by K23HD068404; http://www.nichd.nih.gov/); Agency for Healthcare Research and Quality (MJF salary paid by K02HS017950; http://www.ahrq.gov/); The Department of Epidemiology, UNC Gillings School of Global Public Health (http://sph.unc.edu/epid); the Cecil G. Sheps Center for Health Services Research http://www.shepscenter.unc.edu/); the CER Strategic Initiative of UNC's Clinical Translational Science Award (MJF salary paid by UL1TR001111, http://tracs.unc.edu/), and the UNC School of Medicine (https://www.med.unc.edu/). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH or the Agency for Healthcare Research and Quality. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Urological Association Education and Research, 2010, GUID MAN BEN PROST H; [Anonymous], 2003, GUID MAN BEN PROST H; [Anonymous], 2015, MARKETSCAN COMM CLAI; [Anonymous], 2012, MARKETSCAN CCAE MDCR, V2011; Clement Keiran D, 2014, COCHRANE COLLABORATI, P1; Danielson E, WHITE PAPER HLTH RES; DeNavas-Walt C, 2013, US CENSUS BUREAU CUR; Medicare Program, 2009, FED REGISTER, V74, P62017; Medicare Program, 2010, FED REGISTER, V75, P26360; Medicare Program, 2008, FED REGISTER, V73, P69944; Painter R, 2009, UROL TIMES       DEC, P30; Reynolds WS, 2013, J UROLOGY, V189, P1791, DOI 10.1016/j.juro.2012.11.066; Rosier PFWM, 2010, NEUROUROL URODYNAM, V29, P146, DOI 10.1002/nau.20763; Rothman KJ, 2008, MODERN EPIDEMIOLOGY, P121; Schafer W, 2002, NEUROUROL URODYNAM, V21, P261, DOI 10.1002/nau.10066; U.S. Census Bureau, 2011, CURR POP SURV ANN SO; Winters JC, 2012, J UROLOGY, V188, P2464, DOI 10.1016/j.juro.2012.09.081	17	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0133657	10.1371/journal.pone.0133657	http://dx.doi.org/10.1371/journal.pone.0133657			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LZ	26196514	Green Published, gold, Green Submitted			2022-12-26	WOS:000358547600128
J	Danoff, EJ; Fleming, KG				Danoff, Emily J.; Fleming, Karen G.			Aqueous, Unfolded OmpA Forms Amyloid-Like Fibrils upon Self-Association	PLOS ONE			English	Article							BARREL MEMBRANE-PROTEIN; IN-VITRO; BETA-BARREL; ALPHA-SYNUCLEIN; THIOFLAVINE-T; DISEASE; AGGREGATION; DOMAIN	Unfolded outer membrane beta-barrel proteins have been shown to self-associate in the absence of lipid bilayers. We previously investigated the formation of high molecular weight species by OmpA, with both the transmembrane domain alone and the full-length protein, and discovered that the oligomeric form contains non-native beta-sheet structure. We have further probed the conformation of self-associated OmpA by monitoring binding to Thioflavin T, a dye that is known to bind the cross-beta a structure inherent in amyloid fibrils, and by observing the species by electron microscopy. The significant increase in fluorescence indicative of Thioflavin T binding and the appearance of fibrillar species by electron microscopy verify that the protein forms amyloid-like fibril structures upon oligomerization. These results are also consistent with our previous kinetic analysis of OmpA self-association that revealed a nucleated growth polymerization mechanism, which is frequently observed in amyloid formation. The discovery of OmpA's ability to form amyloid-like fibrils provides a new model protein with which to study fibrillization, and implicates periplasmic chaperone proteins as capable of inhibiting fibril formation.	[Danoff, Emily J.; Fleming, Karen G.] Johns Hopkins Univ, TC Jenkins Dept Biophys, Baltimore, MD 21218 USA	Johns Hopkins University	Fleming, KG (corresponding author), Johns Hopkins Univ, TC Jenkins Dept Biophys, Baltimore, MD 21218 USA.	karen.fleming@jhu.edu			National Science Foundation (NSF) [MCB 0919868, MCB 1412108]; National Institutes of Health (NIH) [R01 GM079440, T32 GM008403]; NSF graduate research fellowship [DGE-0707427]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079440, T32GM008403] Funding Source: NIH RePORTER; Div Of Molecular and Cellular Bioscience [1412108] Funding Source: National Science Foundation	National Science Foundation (NSF)(National Science Foundation (NSF)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF graduate research fellowship(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by grants from the National Science Foundation (NSF) (MCB 0919868 and MCB 1412108) and the National Institutes of Health (NIH) (R01 GM079440 and T32 GM008403). EJD is a recipient of an NSF graduate research fellowship (DGE-0707427). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson VL, 2010, P NATL ACAD SCI USA, V107, P18850, DOI 10.1073/pnas.1012336107; Biancalana M, 2010, BBA-PROTEINS PROTEOM, V1804, P1405, DOI 10.1016/j.bbapap.2010.04.001; Chapman MR, 2002, SCIENCE, V295, P851, DOI 10.1126/science.1067484; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Conway KA, 2000, BIOCHEMISTRY-US, V39, P2552, DOI 10.1021/bi991447r; Danoff EJ, 2011, BIOPHYS CHEM, V159, P194, DOI 10.1016/j.bpc.2011.06.013; Denoncin K, 2012, PROTEOMICS, V12, P1391, DOI 10.1002/pmic.201100633; Kayed R, 2004, J BIOL CHEM, V279, P46363, DOI 10.1074/jbc.C400260200; Khan MA, 2007, BIOCHEMISTRY-US, V46, P4565, DOI 10.1021/bi602526k; Lashuel HA, 2003, J MOL BIOL, V332, P795, DOI 10.1016/S0022-2836(03)00927-6; LEVINE H, 1993, PROTEIN SCI, V2, P404, DOI 10.1002/pro.5560020312; McMorran LM, 2014, ARCH BIOCHEM BIOPHYS, V564, P265, DOI 10.1016/j.abb.2014.02.011; NAIKI H, 1989, ANAL BIOCHEM, V177, P244, DOI 10.1016/0003-2697(89)90046-8; Nilsson MR, 2004, METHODS, V34, P151, DOI 10.1016/j.ymeth.2004.03.012; Pautsch A, 2000, J MOL BIOL, V298, P273, DOI 10.1006/jmbi.2000.3671; Qiang W, 2012, P NATL ACAD SCI USA, V109, P4443, DOI 10.1073/pnas.1111305109; Serpell LC, 2000, J MOL BIOL, V300, P1033, DOI 10.1006/jmbi.2000.3908; Shin TM, 2008, MOL NEURODEGENER, V3, DOI 10.1186/1750-1326-3-16; SURREY T, 1995, J BIOL CHEM, V270, P28199; Tan AE, 2010, MACROMOL BIOSCI, V10, P763, DOI 10.1002/mabi.200900479; Ulmschneider MB, 2005, PROTEINS, V59, P252, DOI 10.1002/prot.20334; VASSAR PS, 1959, ARCH PATHOL, V68, P487; Walsh DM, 1999, J BIOL CHEM, V274, P25945, DOI 10.1074/jbc.274.36.25945; West MW, 1999, P NATL ACAD SCI USA, V96, P11211, DOI 10.1073/pnas.96.20.11211; Wimley WC, 2003, CURR OPIN STRUC BIOL, V13, P404, DOI 10.1016/S0959-440X(03)00099-X; WOODY RW, 1995, METHOD ENZYMOL, V246, P34	26	25	26	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0132301	10.1371/journal.pone.0132301	http://dx.doi.org/10.1371/journal.pone.0132301			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LZ	26196893	Green Submitted, gold, Green Published			2022-12-26	WOS:000358547600030
J	Sheahan, TD; Copits, BA; Golden, JP; Gereau, RW				Sheahan, Tayler D.; Copits, Bryan A.; Golden, Judith P.; Gereau, Robert W.			Voluntary Exercise Training: Analysis of Mice in Uninjured, Inflammatory, and Nerve-Injured Pain States	PLOS ONE			English	Article							PERIPHERAL NEUROPATHIC PAIN; STRESS-INDUCED ANALGESIA; QUALITY-OF-LIFE; PHYSICAL-EXERCISE; HSP72 EXPRESSION; BETA-ENDORPHIN; MUSCLE ATROPHY; RATS; INTENSITY; SKIN	Both clinical and animal studies suggest that exercise may be an effective way to manage inflammatory and neuropathic pain conditions. However, existing animal studies commonly use forced exercise paradigms that incorporate varying degrees of stress, which itself can elicit analgesia, and thus may complicate the interpretation of the effects of exercise on pain. We investigated the analgesic potential of voluntary wheel running in the formalin model of acute inflammatory pain and the spared nerve injury model of neuropathic pain in mice. In uninjured, adult C57BL/6J mice, 1 to 4 weeks of exercise training did not alter nociceptive thresholds, lumbar dorsal root ganglia neuronal excitability, or hindpaw intraepidermal innervation. Further, exercise training failed to attenuate formalin-induced spontaneous pain. Lastly, 2 weeks of exercise training was ineffective in reversing spared nerve injury-induced mechanical hypersensitivity or in improving muscle wasting or hindpaw denervation. These findings indicate that in contrast to rodent forced exercise paradigms, short durations of voluntary wheel running do not improve pain-like symptoms in mouse models of acute inflammation and peripheral nerve injury.	[Sheahan, Tayler D.; Copits, Bryan A.; Golden, Judith P.; Gereau, Robert W.] Washington Univ, Pain Ctr, St Louis, MO 63130 USA; [Sheahan, Tayler D.; Copits, Bryan A.; Golden, Judith P.; Gereau, Robert W.] Washington Univ, Sch Med, Dept Anesthesiol, St Louis, MO 63110 USA; [Sheahan, Tayler D.; Gereau, Robert W.] Washington Univ, Sch Med, Washington Univ Program Neurosci, St Louis, MO USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Gereau, RW (corresponding author), Washington Univ, Pain Ctr, St Louis, MO 63130 USA.	gereaur@wustl.edu		Sheahan, Tayler/0000-0002-5015-0600; Golden, Judith/0000-0002-5168-8525	National Institutes of Neurological Disorders and Stroke [R01 NS48602]; Washington University in St. Louis W.M. Keck Fellowship in Molecular Medicine; National Institutes of General Medical Sciences [TR32 GM108539]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM108539] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS048602] Funding Source: NIH RePORTER	National Institutes of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Washington University in St. Louis W.M. Keck Fellowship in Molecular Medicine; National Institutes of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	RWG was supported by National Institutes of Neurological Disorders and Stroke R01 NS48602 (nih.gov). BAC was supported by Washington University in St. Louis W.M. Keck Fellowship in Molecular Medicine (http://www.wmkeck.org) and National Institutes of General Medical Sciences TR32 GM108539 (nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or in preparation of the manuscript.	Almeida C, 2015, PAIN, V156, P504, DOI 10.1097/01.j.pain.0000460339.23976.12; Armada-da-Silva PAS, 2013, INT REV NEUROBIOL, V109, P125, DOI 10.1016/B978-0-12-420045-6.00006-7; Baldo G, 2013, J INHERIT METAB DIS, V36, P499, DOI 10.1007/s10545-012-9530-x; Belter JG, 2004, J APPL PHYSIOL, V96, P1270, DOI 10.1152/japplphysiol.00838.2003; Bement MKH, 2005, ARCH PHYS MED REHAB, V86, P1736, DOI 10.1016/j.apmr.2005.03.029; BENRATH J, 1995, NEUROSCI LETT, V200, P17, DOI 10.1016/0304-3940(95)12062-9; Binder E, 2004, BEHAV BRAIN RES, V155, P197, DOI 10.1016/j.bbr.2004.04.017; Bobinski F, 2011, NEUROSCIENCE, V194, P337, DOI 10.1016/j.neuroscience.2011.07.075; Boeltz T, 2013, J NEUROPHYSIOL, V109, P2645, DOI 10.1152/jn.00946.2012; Bonaldo P, 2013, DIS MODEL MECH, V6, P25, DOI 10.1242/dmm.010389; Boucher TJ, 2000, SCIENCE, V290, P124, DOI 10.1126/science.290.5489.124; Brenner DS, 2015, JOVE-J VIS EXP, DOI 10.3791/52640; Brenner DS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039765; Butler RK, 2009, PROG NEUROBIOL, V88, P184, DOI 10.1016/j.pneurobio.2009.04.003; CAGGIULA AR, 1995, PSYCHOPHARMACOLOGY, V122, P301, DOI 10.1007/BF02246552; CARMODY J, 1987, NEUROSCI LETT, V74, P358, DOI 10.1016/0304-3940(87)90324-7; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; Chen YW, 2013, ANESTH ANALG, V116, P482, DOI 10.1213/ANE.0b013e318274e4a0; Chiang HY, 1998, EXP NEUROL, V154, P137, DOI 10.1006/exnr.1998.6896; Cobianchi S, 2010, NEUROSCIENCE, V168, P273, DOI 10.1016/j.neuroscience.2010.03.035; Cobianchi S, 2013, EXP NEUROL, V240, P157, DOI 10.1016/j.expneurol.2012.11.023; Courneya KS, 2013, JNCI-J NATL CANCER I, V105, P1821, DOI 10.1093/jnci/djt297; Daenen L, 2015, CLIN J PAIN, V31, P108, DOI 10.1097/AJP.0000000000000099; Decosterd I, 2000, PAIN, V87, P149, DOI 10.1016/S0304-3959(00)00276-1; Decosterd I, 2002, PAIN, V96, P269, DOI 10.1016/S0304-3959(01)00456-0; Detloff MR, 2014, EXP NEUROL, V255, P38, DOI 10.1016/j.expneurol.2014.02.013; Dixit S, 2014, QUAL LIFE RES, V23, P1629, DOI 10.1007/s11136-013-0602-7; Djouhri L, 2006, J NEUROSCI, V26, P1281, DOI 10.1523/JNEUROSCI.3388-05.2006; Dobson JL, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00102; Draxler P, 2014, J NEUROSCI, V34, P12015, DOI 10.1523/JNEUROSCI.2157-14.2014; Dubreucq S, 2011, HIPPOCAMPUS, V21, P239, DOI 10.1002/hipo.20778; Duman CH, 2008, BRAIN RES, V1199, P148, DOI 10.1016/j.brainres.2007.12.047; Duraku LS, 2012, MOL PAIN, V8, DOI 10.1186/1744-8069-8-61; Gereau RW, 2014, J PAIN, V15, P1203, DOI 10.1016/j.jpain.2014.09.004; Geva N, 2013, PAIN, V154, P2317, DOI 10.1016/j.pain.2013.06.031; Grace PM, 2014, J PAIN, V15, P121, DOI 10.1016/j.jpain.2013.10.001; Groover AL, 2013, PAIN, V154, P2658, DOI 10.1016/j.pain.2013.07.052; HARGREAVES K, 1988, PAIN, V32, P77, DOI 10.1016/0304-3959(88)90026-7; Hawkley LC, 2012, HORM BEHAV, V62, P314, DOI 10.1016/j.yhbeh.2012.05.011; HOFFMANN P, 1990, REGUL PEPTIDES, V28, P233, DOI 10.1016/0167-0115(90)90021-N; Hurkmans E, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006853.pub2; Ilha J, 2008, NEUROREHAB NEURAL RE, V22, P355, DOI 10.1177/1545968307313502; Inst Med, 2011, RELIEVING PAIN IN AMERICA: A BLUEPRINT FOR TRANSFORMING PREVENTION, CARE, EDUCATION, AND RESEARCH, P1; Ke Z, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016643; Klusakova I, 2009, ANN ANAT, V191, P248, DOI 10.1016/j.aanat.2009.02.007; Koltyn KF, 2000, SPORTS MED, V29, P85, DOI 10.2165/00007256-200029020-00002; Korb A, 2010, NEUROCHEM RES, V35, P380, DOI 10.1007/s11064-009-0066-x; Kuphal KE, 2007, J PAIN, V8, P989, DOI 10.1016/j.jpain.2007.08.001; Lame IE, 2005, EUR J PAIN, V9, P15, DOI 10.1016/j.ejpain.2004.02.006; Leasure JL, 2008, NEUROSCIENCE, V156, P456, DOI 10.1016/j.neuroscience.2008.07.041; Li YB, 1997, EXP NEUROL, V147, P452, DOI 10.1006/exnr.1997.6624; Mathes WF, 2006, PHARMACOL BIOCHEM BE, V83, P578, DOI 10.1016/j.pbb.2006.03.020; Michaelis M, 2000, J NEUROSCI, V20, P2742; Moraska A, 2000, AM J PHYSIOL-REG I, V279, pR1321, DOI 10.1152/ajpregu.2000.279.4.R1321; Noble EG, 1999, J APPL PHYSIOL, V86, P1696, DOI 10.1152/jappl.1999.86.5.1696; Ploughman M, 2007, BRAIN RES, V1150, P207, DOI 10.1016/j.brainres.2007.02.065; Ren Ke, 1999, ILAR J, V40, P111; Rubinstein M, 1996, P NATL ACAD SCI USA, V93, P3995, DOI 10.1073/pnas.93.9.3995; Salam JN, 2009, BEHAV BRAIN RES, V197, P31, DOI 10.1016/j.bbr.2008.07.036; Sciolino NR, 2012, NEUROSCI BIOBEHAV R, V36, P1965, DOI 10.1016/j.neubiorev.2012.06.005; Sharma NK, 2010, PHYS THER, V90, P714, DOI 10.2522/ptj.20090168; Shen J, 2013, PAIN MED, V14, P516, DOI 10.1111/pme.12057; SHYU BC, 1982, LIFE SCI, V30, P833; Sluka KA, 2013, J APPL PHYSIOL, V114, P725, DOI 10.1152/japplphysiol.01317.2012; Stagg NJ, 2011, ANESTHESIOLOGY, V114, P940, DOI 10.1097/ALN.0b013e318210f880; TAKAHASHI K, 1993, J INVEST DERMATOL, V101, P646, DOI 10.1111/1523-1747.ep12371670; Tesarz J, 2012, PAIN, V153, P1253, DOI 10.1016/j.pain.2012.03.005; Urban R, 2011, PAIN, V152, P990, DOI 10.1016/j.pain.2010.12.003; van der Heijden MMP, 2013, DIABETOLOGIA, V56, P1210, DOI 10.1007/s00125-013-2871-7; Wright A, 2001, CLIN J PAIN, V17, P33, DOI 10.1097/00002508-200103000-00006; Xu QH, 2011, CURR OPIN ANESTHESIO, V24, P400, DOI 10.1097/ACO.0b013e32834871df; Zhao L, 2012, NEURAL REGEN RES, V7, P2507, DOI 10.3969/j.issn.1673-5374.2012.32.004	72	26	28	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0133191	10.1371/journal.pone.0133191	http://dx.doi.org/10.1371/journal.pone.0133191			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LZ	26196858	Green Published, gold, Green Submitted			2022-12-26	WOS:000358547600070
J	Ball, RL; Knapp, CM; Whitehead, KA				Ball, Rebecca L.; Knapp, Christopher M.; Whitehead, Kathryn A.			Lipidoid Nanoparticles for siRNA Delivery to the Intestinal Epithelium: In Vitro Investigations in a Caco-2 Model	PLOS ONE			English	Article							TNF-ALPHA-SIRNA; FUNCTIONAL DIVERSITY; CELL-LINE; DRUG; MECHANISMS; PERMEABILITY; INFLAMMATION; ABSORPTION; EXPRESSION; GENETICS	Short interfering ribonucleic acid (siRNA) therapeutics show promise for the treatment of intestinal diseases by specifically suppressing the expression of disease relevant proteins. Recently, a class of lipid-like materials termed "lipidoids" have been shown to potently deliver siRNA to the liver and immune cells. Here, we seek to establish the utility of lipidoid nanoparticles (LNPs) in the context of siRNA delivery to the intestinal epithelium. Initial studies demonstrated that the siRNA-loaded LNPs mediated potent, dose dependent, and durable gene silencing in Caco-2 intestinal epithelial cells, with a single 10 nM dose depressing GAPDH mRNA expression for one week. Transfection with siRNA-loaded LNPs did not induce significant cytotoxicity in Caco-2 cells or alter intestinal barrier function. Protein silencing was confirmed by Western blotting, with the lowest levels of GAPDH protein expression observed five days post-transfection. Together, these data underscore the potential of LNPs for the treatment of intestinal disorders.	[Ball, Rebecca L.; Knapp, Christopher M.; Whitehead, Kathryn A.] Carnegie Mellon Univ, Dept Chem Engn, Pittsburgh, PA 15213 USA; [Whitehead, Kathryn A.] Carnegie Mellon Univ, Dept Biomed Engn, Pittsburgh, PA 15213 USA	Carnegie Mellon University; Carnegie Mellon University	Whitehead, KA (corresponding author), Carnegie Mellon Univ, Dept Chem Engn, Pittsburgh, PA 15213 USA.	kawhite@cmu.edu	Whitehead, Kathryn/ABF-3857-2020	Whitehead, Kathryn/0000-0002-0100-7824	Center for Nucleic Acids Science and Technology	Center for Nucleic Acids Science and Technology	This work was funded by the Center for Nucleic Acids Science and Technology (http://www.cmu.edu/cnast/). This is an internal grant and no grant # was provided. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akinc A, 2008, NAT BIOTECHNOL, V26, P561, DOI 10.1038/nbt1402; Benson K, 2013, FLUIDS BARRIERS CNS, V10, DOI 10.1186/2045-8118-10-5; Blair SA, 2006, LAB INVEST, V86, P191, DOI 10.1038/labinvest.3700373; Burnett JC, 2012, CHEM BIOL, V19, P60, DOI 10.1016/j.chembiol.2011.12.008; Camilleri M, 2012, AM J PHYSIOL-GASTR L, V303, pG775, DOI 10.1152/ajpgi.00155.2012; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; Collnot EM, 2012, J CONTROL RELEASE, V161, P235, DOI 10.1016/j.jconrel.2012.01.028; CREAMER B, 1961, GUT, V2, P110, DOI 10.1136/gut.2.2.110; Fearon ER, 2011, ANNU REV PATHOL-MECH, V6, P479, DOI 10.1146/annurev-pathol-011110-130235; Franch HA, 2001, J BIOL CHEM, V276, P19126, DOI 10.1074/jbc.M101777200; GOTTLIEB TA, 1993, J CELL BIOL, V120, P695, DOI 10.1083/jcb.120.3.695; Guo JF, 2013, INT J PHARMACEUT, V447, P150, DOI 10.1016/j.ijpharm.2013.02.050; He CL, 2012, ADV HEALTHC MATER, V1, P48, DOI 10.1002/adhm.201100008; He CB, 2013, BIOMATERIALS, V34, P2843, DOI 10.1016/j.biomaterials.2013.01.033; He F, 2012, CYTOKINE, V59, P264, DOI 10.1016/j.cyto.2012.04.008; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Khor B, 2011, NATURE, V474, P307, DOI 10.1038/nature10209; Kriegel C, 2011, J CONTROL RELEASE, V150, P77, DOI 10.1016/j.jconrel.2010.10.002; Lautenschlager C, 2014, ADV DRUG DELIVER REV, V71, P58, DOI 10.1016/j.addr.2013.10.001; Lv HT, 2006, J CONTROL RELEASE, V114, P100, DOI 10.1016/j.jconrel.2006.04.014; Mahon KP, 2010, BIOCONJUGATE CHEM, V21, P1448, DOI 10.1021/bc100041r; Maloy KJ, 2011, NATURE, V474, P298, DOI 10.1038/nature10208; Mladenovska K, 2007, INT J PHARMACEUT, V342, P124, DOI 10.1016/j.ijpharm.2007.05.028; Nielsen OH, 2011, J INTERN MED, V270, P15, DOI 10.1111/j.1365-2796.2011.02344.x; Nielsen OH, 2013, NEW ENGL J MED, V369, P754, DOI 10.1056/NEJMct1209614; PINTO M, 1983, BIOL CELL, V47, P323; Ponder Alexis, 2013, Clin Epidemiol, V5, P237, DOI 10.2147/CLEP.S33961; Press B, 2008, CURR DRUG METAB, V9, P893, DOI 10.2174/138920008786485119; Reineke JJ, 2013, P NATL ACAD SCI USA, V110, P13803, DOI 10.1073/pnas.1305882110; Sambuy Y, 2005, CELL BIOL TOXICOL, V21, P1, DOI 10.1007/s10565-005-0085-6; SERAFINI EP, 1981, GUT, V22, P648, DOI 10.1136/gut.22.8.648; Shen L, 2011, ANNU REV PHYSIOL, V73, P283, DOI 10.1146/annurev-physiol-012110-142150; Siegwart DJ, 2011, P NATL ACAD SCI USA, V108, P12996, DOI 10.1073/pnas.1106379108; Sirover MA, 1999, BBA-PROTEIN STRUCT M, V1432, P159, DOI 10.1016/S0167-4838(99)00119-3; Sirover MA, 2011, BBA-GEN SUBJECTS, V1810, P741, DOI 10.1016/j.bbagen.2011.05.010; Suzuki M., 2014, PLOS ONE, V9; Tahara K, 2011, BIOMATERIALS, V32, P870, DOI 10.1016/j.biomaterials.2010.09.034; Talaei F, 2013, EUR J PHARM SCI, V49, P712, DOI 10.1016/j.ejps.2013.04.031; Varkouhi AK, 2011, J CONTROL RELEASE, V151, P220, DOI 10.1016/j.jconrel.2010.11.004; Verma UN, 2003, CLIN CANCER RES, V9, P1291; Walsh CL, 2013, BIOCONJUGATE CHEM, V24, P36, DOI 10.1021/bc300346h; Whitehead K, 2008, PHARM RES-DORDR, V25, P1782, DOI 10.1007/s11095-007-9488-9; Whitehead KA, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5277; Whitehead KA, 2012, ACS NANO, V6, P6922, DOI 10.1021/nn301922x; Whitehead KA, 2009, NAT REV DRUG DISCOV, V8, P129, DOI 10.1038/nrd2742; Wilson DS, 2010, NAT MATER, V9, P923, DOI [10.1038/NMAT2859, 10.1038/nmat2859]; Yonchevai K, 2008, J MICROENCAPSUL, V25, P82, DOI [10.1080/02652040701776083, 10.1080/02652040701776083 ]; Zhang YD, 2013, MATH PROBL ENG, V2013, DOI 10.1155/2013/705238	48	28	28	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2015	10	7							e0133154	10.1371/journal.pone.0133154	http://dx.doi.org/10.1371/journal.pone.0133154			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LN	26192592	gold, Green Submitted, Green Published			2022-12-26	WOS:000358546400062
J	Chang, SH; Fang, KC; Zhang, KL; Wang, J				Chang, Suhua; Fang, Kechi; Zhang, Kunlin; Wang, Jing			Network-Based Analysis of Schizophrenia Genome-Wide Association Data to Detect the Joint Functional Association Signals	PLOS ONE			English	Article							UBIQUITIN-PROTEASOME SYSTEM; VARIANTS CONFERRING RISK; COMMON VARIANTS; BIPOLAR DISORDER; PATHWAY ANALYSIS; HAN CHINESE; GENETIC ASSOCIATION; SUSCEPTIBILITY; METAANALYSIS; PROVIDE	Schizophrenia is a common psychiatric disorder with high heritability and complex genetic architecture. Genome-wide association studies (GWAS) have identified several significant loci associated with schizophrenia. However, the explained heritability is still low. Growing evidence has shown schizophrenia is attributable to multiple genes with moderate effects. In-depth mining and integration of GWAS data is urgently expected to uncover disease-related gene combination patterns. Network-based analysis is a promising strategy to better interpret GWAS to identify disease-related network modules. We performed a network-based analysis on three independent schizophrenia GWASs by using a refined analysis framework, which included a more accurate gene P-value calculation, dynamic network module searching algorithm and detailed functional analysis for the obtained modules genes. The result generated 79 modules including 238 genes, which form a highly connected subnetwork with more statistical significance than expected by chance. The result validated several reported disease genes, such as MAD1L1, MCC, SDCCAG8, VAT1L, MAPK14, MYH9 and FXYD6, and also obtained several novel candidate genes and gene-gene interactions. Pathway enrichment analysis of the module genes suggested they were enriched in several neural and immune system related pathways/GO terms, such as neurotrophin signaling pathway, synaptosome, regulation of protein ubiquitination, and antigen processing and presentation. Further crosstalk analysis revealed these pathways/GO terms were cooperated with each other, and identified several important genes, which might play vital roles to connect these functions. Our network-based analysis of schizophrenia GWASs will facilitate the understanding of genetic mechanisms of schizophrenia.	[Chang, Suhua; Fang, Kechi; Zhang, Kunlin; Wang, Jing] Chinese Acad Sci, Inst Psychol, Key Lab Mental Hlth, Beijing 100101, Peoples R China	Chinese Academy of Sciences; Institute of Psychology, CAS	Wang, J (corresponding author), Chinese Acad Sci, Inst Psychol, Key Lab Mental Hlth, Beijing 100101, Peoples R China.	wangjing@psych.ac.cn	Chang, Suhua/AGZ-1921-2022		National Natural Science Foundation of China [NSFC] [31401139]; Strategic Priority Research Program (B) of Chinese Academy of Sciences [XDB02030002]; State Administration of Foreign Experts Affairs of Chinese Academy of Sciences (CAS/SAFEA) International Partnership Program for Creative Research Teams [Y2CX131003]	National Natural Science Foundation of China [NSFC](National Natural Science Foundation of China (NSFC)); Strategic Priority Research Program (B) of Chinese Academy of Sciences; State Administration of Foreign Experts Affairs of Chinese Academy of Sciences (CAS/SAFEA) International Partnership Program for Creative Research Teams	This work was supported by the National Natural Science Foundation of China [NSFC, Grant No. 31401139], Strategic Priority Research Program (B) of the Chinese Academy of Sciences (Grant No. XDB02030002) and State Administration of Foreign Experts Affairs of Chinese Academy of Sciences (CAS/SAFEA) International Partnership Program for Creative Research Teams (Grant No. Y2CX131003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen NC, 2008, NAT GENET, V40, P827, DOI 10.1038/ng.171; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Amagane H, 2010, SCHIZOPHR RES, V118, P106, DOI 10.1016/j.schres.2010.01.023; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Baranzini SE, 2013, AM J HUM GENET, V92, P854, DOI 10.1016/j.ajhg.2013.04.019; Basler M, 2013, CURR OPIN IMMUNOL, V25, P74, DOI 10.1016/j.coi.2012.11.004; Bergen SE, 2012, MOL PSYCHIATR, V17, P880, DOI 10.1038/mp.2012.73; Bousman CA, 2010, AM J MED GENET B, V153B, P494, DOI 10.1002/ajmg.b.31006; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Chang SH, 2013, BIOL PSYCHIAT, V74, P727, DOI 10.1016/j.biopsych.2013.04.016; Choudhury K, 2007, AM J HUM GENET, V80, P664, DOI 10.1086/513475; Chung JY, 2007, ADV EXP MED BIOL, V597, P93; DELAROSA EJ, 1994, NEUROSCIENCE, V58, P347, DOI 10.1016/0306-4522(94)90041-8; Efron B, 2010, J AM STAT ASSOC, V105, P1042, DOI 10.1198/jasa.2010.tm09129; Eleftherohorinou H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008068; Flicek P, 2013, NUCLEIC ACIDS RES, V41, pD48, DOI 10.1093/nar/gks1236; Frankle W. Gordon, 2003, Neuron, V39, P205, DOI 10.1016/S0896-6273(03)00423-9; Gilman SR, 2012, NAT NEUROSCI, V15, P1723, DOI 10.1038/nn.3261; Gray KA, 2013, NUCLEIC ACIDS RES, V41, pD545, DOI 10.1093/nar/gks1066; He KJ, 2014, PROG NEURO-PSYCHOPH, V51, P34, DOI 10.1016/j.pnpbp.2013.12.004; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Huang J, 2010, AM J PSYCHIAT, V167, P1254, DOI 10.1176/appi.ajp.2010.09091335; Ideker Trey, 2002, Bioinformatics, V18 Suppl 1, pS233; INTERNATIONAL S, 2009, NATURE, V460, P748, DOI DOI 10.1038/NATURE08185; Jia PL, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-S6-S15; Jia PL, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002587; Jia PL, 2011, BIOINFORMATICS, V27, P95, DOI 10.1093/bioinformatics/btq615; Jia PL, 2010, SCHIZOPHR RES, V122, P38, DOI 10.1016/j.schres.2010.07.001; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Khvotchev M, 2010, BIOL PSYCHIAT, V67, P197, DOI 10.1016/j.biopsych.2009.12.007; Kondo K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070964; Lage K, 2007, NAT BIOTECHNOL, V25, P309, DOI 10.1038/nbt1295; Lam YA, 2000, P NATL ACAD SCI USA, V97, P9902, DOI 10.1073/pnas.170173897; Lecker SH, 2006, J AM SOC NEPHROL, V17, P1807, DOI 10.1681/ASN.2006010083; Li MX, 2011, AM J HUM GENET, V88, P283, DOI 10.1016/j.ajhg.2011.01.019; Liu JZ, 2010, AM J HUM GENET, V87, P139, DOI 10.1016/j.ajhg.2010.06.009; Liu YL, 2008, BIOL PSYCHIAT, V64, P789, DOI 10.1016/j.biopsych.2008.04.035; Luo X, 2013, SCHIZOPHRENIA BULLET, DOI [10.1093/schbultsbt066, DOI 10.1093/SCHBULTSBT066]; Manolio TA, 2010, NEW ENGL J MED, V363, P166, DOI 10.1056/NEJMra0905980; McGrath J, 2008, EPIDEMIOL REV, V30, P67, DOI 10.1093/epirev/mxn001; Moskvina V, 2009, MOL PSYCHIATR, V14, P252, DOI 10.1038/mp.2008.133; O'Dushlaine C, 2011, MOL PSYCHIATR, V16, P286, DOI 10.1038/mp.2010.7; Olsen L, 2008, BMC MED GENET, V9, DOI 10.1186/1471-2350-9-39; Opal SM, 2005, INFECT IMMUN, V73, P5101, DOI 10.1128/IAI.73.8.5101-5105.2005; Pedroso I, 2012, BIOL PSYCHIAT, V72, P311, DOI 10.1016/j.biopsych.2011.12.031; Prabhu S, 2012, GENOME RES, V22, P2230, DOI 10.1101/gr.137885.112; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Ripke S, 2014, NATURE, V511, P421, DOI 10.1038/nature13595; Ripke S, 2013, NAT GENET, V45, P1150, DOI 10.1038/ng.2742; Ripke S, 2011, NAT GENET, V43, P969, DOI 10.1038/ng.940; Rossin EJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001273; Rubio MD, 2013, NEUROPSYCHOPHARMACOL, V38, P1910, DOI 10.1038/npp.2013.84; Shi JX, 2009, NATURE, V460, P753, DOI 10.1038/nature08192; Shi YY, 2011, NAT GENET, V43, P1224, DOI 10.1038/ng.980; Shimura H, 2001, SCIENCE, V293, P263, DOI 10.1126/science.1060627; Smoller JW, 2013, LANCET, V381, P1371, DOI 10.1016/S0140-6736(12)62129-1; Stefansson H, 2009, NATURE, V460, P744, DOI 10.1038/nature08186; Sullivan PF, 2003, ARCH GEN PSYCHIAT, V60, P1187, DOI 10.1001/archpsyc.60.12.1187; Tandon R, 2008, SCHIZOPHR RES, V102, P1, DOI 10.1016/j.schres.2008.04.011; Wang K, 2010, NAT REV GENET, V11, P843, DOI 10.1038/nrg2884; Wang K, 2009, AM J HUM GENET, V84, P399, DOI 10.1016/j.ajhg.2009.01.026; Wang KS, 2010, SCHIZOPHR RES, V124, P192, DOI 10.1016/j.schres.2010.09.002; Yu H, 2014, J PSYCHIATR RES, V50, P73, DOI 10.1016/j.jpsychires.2013.11.014; Yue WH, 2011, NAT GENET, V43, P1228, DOI 10.1038/ng.979; Zhang KL, 2011, CHINESE SCI BULL, V56, P3398, DOI 10.1007/s11434-011-4742-2	68	27	27	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2015	10	7							e0133404	10.1371/journal.pone.0133404	http://dx.doi.org/10.1371/journal.pone.0133404			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LN	26193471	Green Published, Green Submitted, gold			2022-12-26	WOS:000358546400079
J	Kerstjens, JM; Nijhuis, A; Hulzebos, CV; van Imhoff, DE; van Wassenaer-Leemhuis, AG; van Haastert, IC; Lopriore, E; Katgert, T; Swarte, RM; van Lingen, RA; Mulder, TL; Laarman, CR; Steiner, K; Dijk, PH				Kerstjens, Jorien M.; Nijhuis, Ard; Hulzebos, Christian V.; van Imhoff, Deirdre E.; van Wassenaer-Leemhuis, Aleid G.; van Haastert, Ingrid C.; Lopriore, Enrico; Katgert, Titia; Swarte, Renate M.; van Lingen, Richard A.; Mulder, Twan L.; Laarman, Celeste R.; Steiner, Katerina; Dijk, Peter H.			The Ages and Stages Questionnaire and Neurodevelopmental Impairment in Two-Year-Old Preterm-Born Children	PLOS ONE			English	Article							BIRTH-WEIGHT INFANTS; RANDOMIZED CONTROLLED-TRIAL; BAYLEY-III SCALE; DEVELOPMENTAL DELAY; FOLLOW-UP; SURVEILLANCE; PREMATURE; VALIDITY; OUTCOMES; 2ND	Objective To test the ability of the Ages and Stages Questionnaire, Third Edition (ASQ3) to help identify or exclude neurodevelopmental impairment (NDI) in very preterm-born children at the corrected age of two. Methods We studied the test results of 224 children, born at <32 postmenstrual weeks, who had scores on ASQ3 and Bayley Scales of Infant and Toddler Development, Third Edition (BSIDIII) and neurological examination at 22-26 months' corrected age. We defined NDI as a score of <70 on the cognitive-or motor composite scale of BSIDIII, or impairment on neurological examination or audiovisual screening. We compared NDI with abnormal ASQ3 scores, i.e., < -2SDs on any domain, and with ASQ3 total scores. To correct for possible overestimation of BSIDIII, we also analyzed the adjusted BSIDIII thresholds for NDI, i.e., scores < 80 and <85. Results We found 61 (27%) children with abnormal ASQ3 scores, and 10 (4.5%) children who had NDI with original BSIDIII thresholds (<70). Twelve children had NDI at BSIDIII thresholds at <80, and 15 had <85. None of the 163 (73%) children who passed ASQ3 had NDI. The sensitivity of ASQ3 to detect NDI was excellent (100%), its specificity was acceptable (76%), and its negative predictive value (NPV) was 100%. Sensitivity and NPV remained high with the adjusted BSIDIII thresholds. Conclusion The Ages and Stages Questionnaire is a simple, valid and cost-effective screening tool to help identify and exclude NDI in very preterm-born children at the corrected age of two years.	[Kerstjens, Jorien M.; Nijhuis, Ard; Hulzebos, Christian V.; van Imhoff, Deirdre E.; Dijk, Peter H.] Univ Groningen, Univ Med Ctr Groningen, Beatrix Childrens Hosp, Dept Pediat,Div Neonatol, Groningen, Netherlands; [van Wassenaer-Leemhuis, Aleid G.] Univ Amsterdam, Acad Med Ctr, Emma Childrens Hosp, Dept Neonatol, NL-1105 AZ Amsterdam, Netherlands; [van Haastert, Ingrid C.] Univ Med Ctr Utrecht, Wilhelmina Childrens Hosp, Dept Neonatol, Utrecht, Netherlands; [Lopriore, Enrico] Leiden Univ, Med Ctr, Dept Pediat, Div Neonatol, Leiden, Netherlands; [Katgert, Titia] Maxima Med Ctr, Dept Med Psychol, Veldhoven, Netherlands; [Swarte, Renate M.] Erasmus MC Sophia, Dept Neonatol, Rotterdam, Netherlands; [van Lingen, Richard A.] Isala, Princess Amalia Dept Pediat, Dept Neonatol, Zwolle, Netherlands; [Mulder, Twan L.] Maastricht Univ, Med Ctr, GROW Sch Oncol & Dev Biol, Dept Pediat, Maastricht, Netherlands; [Laarman, Celeste R.] Vrije Univ Amsterdam, Med Ctr, Dept Pediat, Div Neonatol, Amsterdam, Netherlands; [Steiner, Katerina] Radboud Univ Nijmegen, Med Ctr Nijmegen, Dept Pediat, Div Neonatol, NL-6525 ED Nijmegen, Netherlands	University of Groningen; Emma Children's Hospital; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; Utrecht University; Utrecht University Medical Center; Wilhelmina Kinderziekenhuis; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Maxima Medical Center; Erasmus University Rotterdam; Erasmus MC; Maastricht University; Vrije Universiteit Amsterdam; Radboud University Nijmegen	Dijk, PH (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Beatrix Childrens Hosp, Dept Pediat,Div Neonatol, Groningen, Netherlands.	p.h.dijk@umcg.nl	Lopriore, Enrico/ABE-3576-2021; Mulder, Antonius/AAJ-5935-2021; Hulzebos, Christian Victor/AAY-6803-2021; Steiner, K./L-4672-2015	Lopriore, Enrico/0000-0002-3513-5066; Mulder, Antonius/0000-0001-8625-4359; Hulzebos, Christian Victor/0000-0002-8159-7501; 	Netherlands Organization for Health Research and Development (ZonMw) Cost-Effectiveness Program [94507407]	Netherlands Organization for Health Research and Development (ZonMw) Cost-Effectiveness Program	This work was funded by The Netherlands Organization for Health Research and Development (ZonMw) Cost-Effectiveness Program: 94507407. The authors received no other specific funding for this work.	Acton BV, 2011, PEDIATRICS, V128, pE794, DOI 10.1542/peds.2011-0331; Adams-Chapman I, 2013, J PEDIATR-US, V163, P961, DOI 10.1016/j.jpeds.2013.04.034; Anderson PJ, 2010, ARCH PEDIAT ADOL MED, V164, P352, DOI 10.1001/archpediatrics.2010.20; [Anonymous], 2006, BAYLEY SCALES INFANT; [Anonymous], BAYLEY SCALES INFANT; Bayley N, 1993, BAYLEY SCALES INFANT; Cans C, 2000, DEV MED CHILD NEUROL, V42, P816, DOI 10.1111/j.1469-8749.2000.tb00695.x; Duby JC, 2006, PEDIATRICS, V118, P405, DOI 10.1542/peds.2006-1231; Flamant C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020004; Glascoe FP, 2005, MENT RETARD DEV D R, V11, P173, DOI 10.1002/mrdd.20068; Gollenberg AL, 2010, CHILD CARE HLTH DEV, V36, P485, DOI 10.1111/j.1365-2214.2009.01041.x; Harcourt Assessment Inc, 2007, 2 HARC ASS INC; Hulzebos CV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099466; Jary S, 2011, J PEDIATR-US, V159, P211, DOI 10.1016/j.jpeds.2011.01.037; Johnson S, 2014, PEDIATR RES, V75, P670, DOI 10.1038/pr.2014.10; KLOOSTERMAN GJ, 1970, INT J GYNECOL OBSTET, V8, P895, DOI DOI 10.1002/J.1879-3479.1970.TB00313.X; Limbos MM, 2011, J DEV BEHAV PEDIATR, V32, P499, DOI 10.1097/DBP.0b013e31822552e9; Moore T, 2012, J PEDIATR-US, V160, P553, DOI 10.1016/j.jpeds.2011.09.047; Morris C, 2004, DEV MED CHILD NEUROL, V46, P60, DOI 10.1017/S0012162204000118; Msall ME, 2010, J PEDIATR-US, V157, P863, DOI 10.1016/j.jpeds.2010.09.022; Nordhov SM, 2012, PEDIATRICS, V129, pE9, DOI 10.1542/peds.2011-0248; Nordhov SM, 2010, PEDIATRICS, V126, pE1088, DOI 10.1542/peds.2010-0778; Schonhaut L, 2013, PEDIATRICS, V131, pE1468, DOI 10.1542/peds.2012-3313; Silveira RC, 2012, ARCH PEDIAT ADOLESC, V24, P1; Skellern CY, 2001, J PAEDIATR CHILD H, V37, P125, DOI 10.1046/j.1440-1754.2001.00604.x; Squire J, 2009, ASQ 3 USER S GUIDE; Stark AR, 2013, J PEDIAT; Touwen BCL, 1984, NEUROLOGISCHE ONTWIK; van Imhoff DE, 2011, EARLY HUM DEV, V87, P521, DOI 10.1016/j.earlhumdev.2011.04.004; van Wyk L, 2012, AM J OBSTET GYNECOL, V206, DOI [10.1016/j.ajog.2012.02.003, DOI 10.1016/J.AJOG.2012.02.003]; Vandborg PK, 2012, PEDIATRICS, V130, P61, DOI 10.1542/peds.2011-2760; Woodward BJ, 2011, J PERINATOL, V31, P641, DOI 10.1038/jp.2011.1	32	23	23	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2015	10	7							e0133087	10.1371/journal.pone.0133087	http://dx.doi.org/10.1371/journal.pone.0133087			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LN	26193474	Green Published, Green Submitted, gold			2022-12-26	WOS:000358546400055
J	Liu, X; Ma, XR; Lei, ZG; Feng, H; Wang, SSS; Cen, X; Gao, SY; Jiang, YP; Jiang, J; Chen, QM; Tang, YJ; Tang, YL; Liang, XH				Liu, Xin; Ma, Xiangrui; Lei, Zhengge; Feng, Hao; Wang, Shasha; Cen, Xiao; Gao, Shiyu; Jiang, Yaping; Jiang, Jian; Chen, Qianming; Tang, Yajie; Tang, Yaling; Liang, Xinhua			Chronic Inflammation-Related HPV: A Driving Force Speeds Oropharyngeal Carcinogenesis	PLOS ONE			English	Article							IMMATURE MYELOID CELLS; HUMAN-PAPILLOMAVIRUS INFECTION; COLONY-STIMULATING FACTOR; NF-KAPPA-B; TNF-ALPHA; TGF-BETA; CANCER; ASSOCIATION; CARCINOMA; SURVIVAL	Oropharyngeal squamous cell carcinoma (OPSCC) has been known to be a highly aggressive disease associated with human papilloma virus (HPV) infection. To investigate the relationship between HPV and chronic inflammation in oropharyngeal carcinogenesis, we collected 140 oral mucous fresh specimens including 50 OPSCC patients, 50 cancer in situ, 30 precancerous lesions, and 10 normal oral mucous. Our data demonstrated that there was a significantly higher proportion of severe chronic inflammation in dysplastic epithelia in comparison with that in normal tissues (P<0.001). The positive rate of HPV 16 was parallel with the chronic inflammation degrees from mild to severe inflammation (P<0.05). The positive rate of HPV 16 was progressively improved with the malignant progression of oral mucous (P<0.05). In addition, CD11b+ LIN-HLA-DR-CD33+ MDSCs were a critical cell population that mediates inflammation response and immune suppression in HPV-positive OPSCC. These indicated that persistent chronic inflammation-related HPV infection might drive oropharyngeal carcinogenesis and MDSCs might pay an important role during this process. Thus, a combination of HPV infection and inflammation expression might become a helpful biomedical marker to predict oropharyngeal carcinogenesis.	[Liu, Xin; Ma, Xiangrui; Lei, Zhengge; Feng, Hao; Wang, Shasha; Cen, Xiao; Gao, Shiyu; Jiang, Yaping; Jiang, Jian; Chen, Qianming; Tang, Yaling; Liang, Xinhua] Sichuan Univ, West China Hosp Stomatol, State Key Lab Oral Dis, Chengdu 610064, Peoples R China; [Tang, Yajie] Hubei Univ Technol, Key Lab Fermentat Engn, Minist Educ, Wuhan, Peoples R China; [Tang, Yaling] Sichuan Univ, West China Hosp Stomatol, Dept Oral Pathol, Chengdu 610064, Peoples R China; [Liang, Xinhua] Sichuan Univ, West China Hosp Stomatol, Dept Oral & Maxillofacial Surg, Chengdu 610064, Peoples R China	Sichuan University; Hubei University of Technology; Sichuan University; Sichuan University	Tang, YL (corresponding author), Sichuan Univ, West China Hosp Stomatol, State Key Lab Oral Dis, Chengdu 610064, Peoples R China.	tangyaling@scu.edu.cn; lxh88866@scu.edu.cn	Tang, Ya-Jie/M-2538-2016; ma, xiangrui xiangrui/GSN-6533-2022	ma, xiangrui xiangrui/0000-0003-2756-8774; Cen, Xiao/0000-0002-3959-1608	National Natural Science Foundation of China [81361120399, 81321002, 81272961, 81372891]; State Key Laboratory of Oral Diseases Special Funded Projects [SKLOD201512]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Key Laboratory of Oral Diseases Special Funded Projects	This work was supported by National Natural Science Foundation of China grants (Nos. 81361120399, 81321002, 81272961, and 81372891) and by State Key Laboratory of Oral Diseases Special Funded Projects (SKLOD201512).	Almand B, 2001, J IMMUNOL, V166, P678, DOI 10.4049/jimmunol.166.1.678; Ang KK, 2010, NEW ENGL J MED, V363, P24, DOI 10.1056/NEJMoa0912217; Balkwill F, 2001, LANCET, V357, P539, DOI 10.1016/S0140-6736(00)04046-0; Bronte V, 1999, J IMMUNOL, V162, P5728; Bronte V, 2001, J IMMUNOTHER, V24, P431, DOI 10.1097/00002371-200111000-00001; Bunt SK, 2009, J LEUKOCYTE BIOL, V85, P996, DOI 10.1189/jlb.0708446; Castle PE, 2001, CANCER EPIDEM BIOMAR, V10, P1021; Chen WJ, 2010, J MOL CELL BIOL, V2, P30, DOI 10.1093/jmcb/mjp004; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; De Cecco L, 2015, ONCOTARGET; Derynck R, 2001, NAT GENET, V29, P117, DOI 10.1038/ng1001-117; Dunn GP, 2004, IMMUNITY, V21, P137, DOI 10.1016/j.immuni.2004.07.017; Dunn GP, 2002, NAT IMMUNOL, V3, P991, DOI 10.1038/ni1102-991; Farhan-Alanie OM, 2015, BRIT J ORAL MAX SURG, V53, P126, DOI 10.1016/j.bjoms.2014.10.007; Gabrilovich DI, 1996, NAT MED, V2, P1096, DOI 10.1038/nm1096-1096; Gabrilovich DI, 2001, J IMMUNOL, V166, P5398, DOI 10.4049/jimmunol.166.9.5398; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Han Y W, 2014, Adv Dent Res, V26, P47, DOI 10.1177/0022034514528334; Hawes SE, 2002, J NATL CANCER I, V94, P1592; Hormia M, 2005, J PERIODONTOL, V76, P358, DOI 10.1902/jop.2005.76.3.358; Huh WK, 2009, OBSTET GYNECOL, V114, P139, DOI 10.1097/AOG.0b013e3181ab6878; Hussain SP, 2003, NAT REV CANCER, V3, P276, DOI 10.1038/nrc1046; Jin L, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-80; Jones KB, 2013, INT J ORAL SCI, V5, P121, DOI 10.1038/ijos.2013.46; Kusmartsev S, 2002, CANCER IMMUNOL IMMUN, V51, P293, DOI 10.1007/s00262-002-0280-8; Li W, 2003, INT J CANCER, V106, P553, DOI 10.1002/ijc.11261; Li Y, 2015, INT J ORAL SCI, V7, P161, DOI 10.1038/ijos.2015.5; Li YX, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118391; Liang XH, 2011, ORAL ONCOL, V47, P92, DOI 10.1016/j.oraloncology.2010.11.014; Lin RH, 2015, ONCOTARGET, V6, P2856, DOI 10.18632/oncotarget.3091; Lindel K, 2001, CANCER-AM CANCER SOC, V92, P805, DOI 10.1002/1097-0142(20010815)92:4<805::AID-CNCR1386>3.0.CO;2-9; Luo JL, 2004, CANCER CELL, V6, P297, DOI 10.1016/j.ccr.2004.08.012; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Melani C, 2003, BLOOD, V102, P2138, DOI 10.1182/blood-2003-01-0190; Mellin H, 2002, INT J CANCER, V102, P152, DOI 10.1002/ijc.10669; Mroz EA, 2011, J CLIN ONCOL, V29, P4222, DOI 10.1200/JCO.2011.37.8893; Pasparakis M, 2009, NAT REV IMMUNOL, V9, P778, DOI 10.1038/nri2655; Rubin DT, 2013, CLIN GASTROENTEROL H, V11, P1601, DOI 10.1016/j.cgh.2013.06.023; Samoff E, 2005, AM J EPIDEMIOL, V162, P668, DOI 10.1093/aje/kwi262; Schafer G, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-185; Schwartz SR, 2001, OTOLARYNG HEAD NECK, V125, P1, DOI 10.1067/mhn.2001.116979; Schwebke JR, 1997, GENITOURIN MED, V73, P383; Scott ME, 2009, INT J CANCER, V124, P1379, DOI 10.1002/ijc.24117; Serafini P, 2004, CANCER IMMUNOL IMMUN, V53, P64, DOI 10.1007/s00262-003-0443-2; Singh PK, 2015, CANCER BIOMARK, V15, P125, DOI 10.3233/CBM-140444; Sinha P, 2005, J IMMUNOL, V174, P636, DOI 10.4049/jimmunol.174.2.636; Song XP, 2005, J IMMUNOL, V175, P8200, DOI 10.4049/jimmunol.175.12.8200; Sotlar K, 2004, J CLIN MICROBIOL, V42, P3176, DOI 10.1128/JCM.42.7.3176-3184.2004; Tezal M, 2012, ARCH OTOLARYNGOL, V138, P669, DOI 10.1001/archoto.2012.873; Thamphiwatana S, 2014, P NATL ACAD SCI USA, V111, P17600, DOI 10.1073/pnas.1418230111; Warif NMA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127155; Williams D A, 2001, J Natl Cancer Inst Monogr, P26; Woodford D, 2014, J CLIN CELL IMMUNOL, V5; Yilmaz Ozlem, 2008, Microbiology (Reading), V154, P2897, DOI 10.1099/mic.0.2008/021220-0; Young MRI, 1997, INT J CANCER, V74, P69, DOI 10.1002/(SICI)1097-0215(19970220)74:1<69::AID-IJC12>3.0.CO;2-D	55	10	11	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2015	10	7							e0133681	10.1371/journal.pone.0133681	http://dx.doi.org/10.1371/journal.pone.0133681			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LN	26193368	Green Submitted, Green Published, gold			2022-12-26	WOS:000358546400114
J	Sankar, S; Upadhyay, M; Ramamurthy, M; Vadivel, K; Sagadevan, K; Nandagopal, B; Vivekanandan, P; Sridharan, G				Sankar, Sathish; Upadhyay, Mohita; Ramamurthy, Mageshbabu; Vadivel, Kumaran; Sagadevan, Kalaiselvan; Nandagopal, Balaji; Vivekanandan, Perumal; Sridharan, Gopalan			Novel Insights on Hantavirus Evolution: The Dichotomy in Evolutionary Pressures Acting on Different Hantavirus Segments	PLOS ONE			English	Article							DINUCLEOTIDE FREQUENCIES; NUCLEOCAPSID PROTEIN; MOLECULAR EVOLUTION; PUUMALA HANTAVIRUS; EFFECTIVE NUMBER; VIRUS EVOLUTION; DNA METHYLATION; RNA VIRUSES; CODON USAGE; CPG	Background Hantaviruses are important emerging zoonotic pathogens. The current understanding of hantavirus evolution is complicated by the lack of consensus on co-divergence of hantaviruses with their animal hosts. In addition, hantaviruses have long-term associations with their reservoir hosts. Analyzing the relative abundance of dinucleotides may shed new light on hantavirus evolution. We studied the relative abundance of dinucleotides and the evolutionary pressures shaping different hantavirus segments. Methods A total of 118 sequences were analyzed; this includes 51 sequences of the S segment, 43 sequences of the M segment and 23 sequences of the L segment. The relative abundance of dinucleotides, effective codon number (ENC), codon usage biases were analyzed. Standard methods were used to investigate the relative roles of mutational pressure and translational selection on the three hantavirus segments. Results All three segments of hantaviruses are CpG depleted. Mutational pressure is the predominant evolutionary force leading to CpG depletion among hantaviruses. Interestingly, the S segment of hantaviruses is GpU depleted and in contrast to CpG depletion, the depletion of GpU dinucleotides from the S segment is driven by translational selection. Our findings also suggest that mutational pressure is the primary evolutionary pressure acting on the S and the M segments of hantaviruses. While translational selection plays a key role in shaping the evolution of the L segment. Our findings highlight how different evolutionary pressures may contribute disproportionally to the evolution of the three hantavirus segments. These findings provide new insights on the current understanding of hantavirus evolution. Conclusions There is a dichotomy among evolutionary pressures shaping a) the relative abundance of different dinucleotides in hantavirus genomes b) the evolution of the three hantavirus segments.	[Sankar, Sathish; Ramamurthy, Mageshbabu; Vadivel, Kumaran; Sagadevan, Kalaiselvan; Nandagopal, Balaji; Sridharan, Gopalan] Sri Narayani Hosp & Res Ctr, Sri Sakthi Amma Inst Biomed Res, Vellore 632055, Tamil Nadu, India; [Upadhyay, Mohita; Vivekanandan, Perumal] Indian Inst Technol, Kusuma Sch Biol Sci, New Delhi 110016, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Delhi	Vivekanandan, P (corresponding author), Indian Inst Technol, Kusuma Sch Biol Sci, New Delhi 110016, India.	vperumal@bioschool.iitd.ac.in	Sankar, Sathish/E-8348-2011	Sankar, Sathish/0000-0002-9389-5231	Division of Biomedical Research of Sri Narayani Hospital and Research Center	Division of Biomedical Research of Sri Narayani Hospital and Research Center	This work was supported by the Division of Biomedical Research of Sri Narayani Hospital and Research Center.	Arai S, 2012, VIROLOGY, V424, P99, DOI 10.1016/j.virol.2011.11.013; Atkinson NJ, 2014, NUCLEIC ACIDS RES, V42, P4527, DOI 10.1093/nar/gku075; Belalov IS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056642; Bennett SN, 2014, TRENDS MICROBIOL, V22, P473, DOI 10.1016/j.tim.2014.04.008; BEUTLER E, 1989, P NATL ACAD SCI USA, V86, P192, DOI 10.1073/pnas.86.1.192; BIRD AP, 1980, NUCLEIC ACIDS RES, V8, P1499, DOI 10.1093/nar/8.7.1499; Cheng XF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074109; Chinnery HR, 2012, AM J PATHOL, V180, P209, DOI 10.1016/j.ajpath.2011.09.041; Duret L, 2000, MOL BIOL EVOL, V17, P1620, DOI 10.1093/oxfordjournals.molbev.a026261; Escutenaire S, 2001, VIRUS RES, V74, P1, DOI 10.1016/S0168-1702(00)00224-0; Fuglsang A, 2004, BIOCHEM BIOPH RES CO, V317, P957, DOI 10.1016/j.bbrc.2004.03.138; Goodenbour JM, 2006, NUCLEIC ACIDS RES, V34, P6137, DOI 10.1093/nar/gkl725; GRIOT C, 1993, ANNU REV MICROBIOL, V47, P117, DOI 10.1146/annurev.mi.47.100193.001001; Gu SH, 2013, INFECT GENET EVOL, V20, P118, DOI 10.1016/j.meegid.2013.08.016; Guo WP, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003159; Hendrich B, 2003, TRENDS GENET, V19, P269, DOI 10.1016/S0168-9525(03)00080-5; Hoelzer K, 2008, NUCLEIC ACIDS RES, V36, P2825, DOI 10.1093/nar/gkn121; Hughes AL, 2000, MOL BIOL EVOL, V17, P1558, DOI 10.1093/oxfordjournals.molbev.a026254; Jackson AP, 2004, MOL BIOL EVOL, V21, P45, DOI 10.1093/molbev/msg232; Jenkins GM, 2003, VIRUS RES, V92, P1, DOI 10.1016/S0168-1702(02)00309-X; JONAS E, 1985, P NATL ACAD SCI USA, V82, P5413, DOI 10.1073/pnas.82.16.5413; Jonsson CB, 2010, CLIN MICROBIOL REV, V23, P412, DOI 10.1128/CMR.00062-09; Kang HJ, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-373; Kang HJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006149; Kaukinen P, 2005, ARCH VIROL, V150, P1693, DOI 10.1007/s00705-005-0555-4; Lednicky JA, 2003, ARCH PATHOL LAB MED, V127, P30; Lee BH, 2003, VIRUS RES, V98, P83, DOI 10.1016/j.virusres.2003.09.001; Lobo FP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006282; Mancini D, 1997, AM J HUM GENET, V61, P80, DOI 10.1086/513898; Nemirov K, 2003, J VIROL, V77, P8793, DOI 10.1128/JVI.77.16.8793-8800.2003; Nikaido M, 2001, J MOL EVOL, V53, P508, DOI 10.1007/s002390010241; Plyusnin A, 2001, CURR TOP MICROBIOL, V256, P47; Plyusnin A, 1996, J GEN VIROL, V77, P2677, DOI 10.1099/0022-1317-77-11-2677; Ramsden C, 2009, MOL BIOL EVOL, V26, P143, DOI 10.1093/molbev/msn234; Ramsden C, 2008, MOL BIOL EVOL, V25, P1488, DOI 10.1093/molbev/msn093; Sanjuan R, 2010, J VIROL, V84, P9733, DOI 10.1128/JVI.00694-10; SCHORDERET DF, 1992, P NATL ACAD SCI USA, V89, P957, DOI 10.1073/pnas.89.3.957; Shackelton LA, 2006, J MOL EVOL, V62, P551, DOI 10.1007/s00239-005-0221-1; Shioiri C, 2001, J MOL EVOL, V53, P364, DOI 10.1007/s002390010226; Simmonds P, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-610; Souza WM, 2014, INFECT GENET EVOL, V21, P198, DOI 10.1016/j.meegid.2013.11.015; Upadhyay M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111793; Upadhyay M, 2013, J VIROL, V87, P13816, DOI 10.1128/JVI.02515-13; WRIGHT F, 1990, GENE, V87, P23, DOI 10.1016/0378-1119(90)90491-9; Zhang YZ, 2010, EMERG INFECT DIS, V16, P1195, DOI 10.3201/eid1608.090470	45	2	2	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2015	10	7							e0133407	10.1371/journal.pone.0133407	http://dx.doi.org/10.1371/journal.pone.0133407			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LN	26193652	Green Submitted, Green Published, gold			2022-12-26	WOS:000358546400080
J	Abrantes, P; Santos, MM; Sousa, I; Xavier, JM; Francisco, V; Krug, T; Sobral, J; Matos, M; Martins, M; Jacinto, A; Coiteiro, D; Oliveira, SA				Abrantes, Patricia; Santos, Maria M.; Sousa, Ines; Xavier, Joana M.; Francisco, Vania; Krug, Tiago; Sobral, Joao; Matos, Mafalda; Martins, Madalena; Jacinto, Antonio; Coiteiro, Domingos; Oliveira, Sofia A.			Genetic Variants Underlying Risk of Intracranial Aneurysms: Insights from a GWAS in Portugal	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; ISOLATED BLOOD-VESSELS; POTENTIAL CANDIDATE; IDENTIFIES 3; COMPLEX; DISEASE; LOCI; AMERICANS; PACKAGE	Subarachnoid hemorrhage (SAH) is a life-threatening event that most frequently leads to severe disability and death. Its most frequent cause is the rupture of a saccular intracranial aneurysm (IA), which is a blood vessel dilation caused by disease or weakening of the vessel wall. Although the genetic contribution to IA is well established, to date no single gene has been unequivocally identified as responsible for IA formation or rupture. We aimed to identify IA susceptibility genes in the Portuguese population through a pool-based multi-stage genome-wide association study. Replicate pools were allelotyped in triplicate in a discovery dataset (100 IA cases and 92 gender-matched controls) using the Affymetrix Human SNP Array 6.0. Top SNPs (absolute value of the relative allele score difference between cases and controls vertical bar RAS(diff)vertical bar >= 13.0%) were selected for technical validation by individual genotyping in the discovery dataset. From the 101 SNPs successfully genotyped, 99 SNPs were nominally associated with IA. Replication of technically validated SNPs was conducted in an independent replication dataset (100 Portuguese IA cases and 407 controls). rs4667622 (between UBR3 and MYO3B), rs6599001 (between SCN11A and WDR48), rs3932338 (214 kilobases downstream of PRDM9), and rs10943471 (96 kilobases upstream of HTR1B) were associated with IA (unadjusted allelic chi-square tests) in the datasets tested (discovery: 6.84E-04 <= P <= 1.92E-02, replication: 2.66E-04 <= P <= 2.28E-02, and combined datasets: 6.05E-05 <= P <= 5.50E-04). Additionally, we confirmed the known association with IA of rs1333040 at the 9p21.3 genomic region, thus validating our dataset. These novel findings in the Portuguese population warrant further replication in additional independent studies, and provide additional candidates to more comprehensively understand IA etiopathogenesis.	[Abrantes, Patricia; Sousa, Ines; Xavier, Joana M.; Francisco, Vania; Krug, Tiago; Sobral, Joao; Matos, Mafalda; Martins, Madalena; Oliveira, Sofia A.] Univ Lisbon, Fac Med, Inst Mol Med, P-1699 Lisbon, Portugal; [Abrantes, Patricia; Sousa, Ines; Xavier, Joana M.; Francisco, Vania; Krug, Tiago; Sobral, Joao; Matos, Mafalda; Martins, Madalena; Oliveira, Sofia A.] Inst Gulbenkian Ciencias, Oeiras, Portugal; [Santos, Maria M.; Coiteiro, Domingos] Hosp Santa Maria, Serv Neurocirurgia, Lisbon, Portugal; [Jacinto, Antonio] Univ Nova Lisboa, Fac Ciencias Med, Ctr Estudos Doencas Cron CEDOC, P-1200 Lisbon, Portugal	Universidade de Lisboa; Instituto Gulbenkian de Ciencia; Universidade de Lisboa; Hospital Santa Maria; Universidade Nova de Lisboa	Oliveira, SA (corresponding author), Univ Lisbon, Fac Med, Inst Mol Med, P-1699 Lisbon, Portugal.	aaoliveira@medicina.ulisboa.pt	Sobral, João/M-5195-2015; Jacinto, Antonio/F-5729-2013; Abrantes, Patrícia/G-2649-2019; Xavier, Joana M./I-4676-2014	Sobral, João/0000-0002-7161-0661; Jacinto, Antonio/0000-0002-4193-6089; Xavier, Joana M./0000-0002-0702-6700; Abrantes, Patricia/0000-0002-7484-2441; Martins, Madalena/0000-0001-8360-6806	Fundacao para a Ciencia e Tecnologia (FCT-Portugal) [PTDC/SAU-GMG/101537/2008, PTDC/IIM-GES/5015/2012, CMUP-ERI/TPE/0028/2013, SFRH/BPD/35737/2007, SFRH/BPD/70008/2010, SFRH/BD/43895/2008]; Fundacao para a Ciencia e Tecnologia (FCT-Portugal) (Ciencia and Investigator-FCT); Fundação para a Ciência e a Tecnologia [PTDC/IIM-GES/5015/2012, PTDC/SAU-GMG/101537/2008, CMUP-ERI/TPE/0028/2013] Funding Source: FCT	Fundacao para a Ciencia e Tecnologia (FCT-Portugal)(Portuguese Foundation for Science and Technology); Fundacao para a Ciencia e Tecnologia (FCT-Portugal) (Ciencia and Investigator-FCT); Fundação para a Ciência e a Tecnologia	This work was supported by the Fundacao para a Ciencia e Tecnologia (FCT-Portugal) through several grants (PTDC/SAU-GMG/101537/2008, PTDC/IIM-GES/5015/2012 and CMUP-ERI/TPE/0028/2013), fellowships and research contracts (SFRH/BPD/35737/2007 to PA, SFRH/BPD/70008/2010 to IS, SFRH/BD/43895/2008 to JMX, and Ciencia and Investigator-FCT contracts to SAO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham R, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-44; Akiyama K, 2010, J HUM GENET, V55, P656, DOI 10.1038/jhg.2010.82; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bellenguez C, 2012, NAT GENET, V44, P328, DOI 10.1038/ng.1081; Belz MM, 2003, KIDNEY INT, V63, P1824, DOI 10.1046/j.1523-1755.2003.00918.x; Bermingham ML, 2014, HEREDITY, V112, P543, DOI 10.1038/hdy.2013.137; Bilguvar K, 2008, NAT GENET, V40, P1472, DOI 10.1038/ng.240; Bosse Y, 2009, HUM GENET, V125, P305, DOI 10.1007/s00439-009-0626-9; Bostrom MA, 2010, HUM GENET, V128, P195, DOI 10.1007/s00439-010-0842-3; Castro-Giner F, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-128; Comabella M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003490; Davis OSP, 2009, BIOINFORMATICS, V25, P281, DOI 10.1093/bioinformatics/btn587; Dose AC, 2002, GENOMICS, V79, P621, DOI 10.1006/geno.2002.6749; Edwards SL, 2013, AM J HUM GENET, V93, P779, DOI 10.1016/j.ajhg.2013.10.012; Foroud T, 2014, STROKE, V45, P3194, DOI 10.1161/STROKEAHA.114.006096; Foroud T, 2012, STROKE, V43, P2846, DOI 10.1161/STROKEAHA.112.656397; Gangula NR, 2013, J BIOL CHEM, V288, P34545, DOI 10.1074/jbc.M113.503383; Gonzalez JR, 2007, BIOINFORMATICS, V23, P644, DOI 10.1093/bioinformatics/btm025; Hashikata H, 2010, STROKE, V41, P1138, DOI 10.1161/STROKEAHA.109.576694; Hussin J, 2013, GENOME RES, V23, P419, DOI 10.1101/gr.144188.112; Inagawa T, 2001, STROKE, V32, P1499, DOI 10.1161/01.STR.32.7.1499; Johnson AD, 2008, BIOINFORMATICS, V24, P2938, DOI 10.1093/bioinformatics/btn564; Juvela S, 2003, STROKE, V34, P1852, DOI 10.1161/01.STR.0000080380.56799.DD; KAUMANN AJ, 1993, CARDIOVASC RES, V27, P2094, DOI 10.1093/cvr/27.12.2094; Kerns SL, 2013, J UROLOGY, V190, P102, DOI 10.1016/j.juro.2013.01.096; Kurki MI, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004134; Leung H. K., 2011, Hong Kong Medical Journal, V17, P151; Low SK, 2012, HUM MOL GENET, V21, P2102, DOI 10.1093/hmg/dds020; Macgregor S, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkm1060; Macgregor S, 2007, EUR J HUM GENET, V15, P501, DOI 10.1038/sj.ejhg.5201768; Matarin M, 2007, LANCET NEUROL, V6, P414, DOI 10.1016/S1474-4422(07)70081-9; Molyneux A, 2002, LANCET, V360, P1267, DOI 10.1016/S0140-6736(02)11314-6; Pearson JV, 2007, AM J HUM GENET, V80, P126, DOI 10.1086/510686; Price AL, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0030236; Razzaque Z, 2002, BRIT J CLIN PHARMACO, V53, P266, DOI 10.1046/j.0306-5251.2001.01536.x; Rinkel GJE, 1998, STROKE, V29, P251, DOI 10.1161/01.STR.29.1.251; Ruigrok YM, 2010, GENOME MED, V2, DOI 10.1186/gm182; Saunders EJ, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004129; Schwartz JJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5370; Seshadri S, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-S1-S15; Steer S, 2007, GENES IMMUN, V8, P57, DOI 10.1038/sj.gene.6364359; van den Broek RWM, 2002, CEPHALALGIA, V22, P83, DOI 10.1046/j.1468-2982.2002.00295.x; Verheggen R, 1996, BRIT J PHARMACOL, V117, P283, DOI 10.1111/j.1476-5381.1996.tb15188.x; Vlak MHM, 2012, J NEUROL, V259, P1298, DOI 10.1007/s00415-011-6341-1; Wiebers D, 2003, LANCET, V362, P103, DOI 10.1016/S0140-6736(03)13860-3; Woodward EL, 2014, BRIT J HAEMATOL, V166, P947, DOI 10.1111/bjh.12914; Xavier JM, 2015, ANN RHEUM DIS, V74, P618, DOI 10.1136/annrheumdis-2013-204475; Yasuno K, 2010, NAT GENET, V42, P420, DOI 10.1038/ng.563; Zeller T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010693	49	15	16	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0133422	10.1371/journal.pone.0133422	http://dx.doi.org/10.1371/journal.pone.0133422			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RV	26186006	Green Submitted, gold, Green Published			2022-12-26	WOS:000358198700137
J	Perez-Jorge, S; Pereira, T; Corne, C; Wijtten, Z; Omar, M; Katello, J; Kinyua, M; Oro, D; Louzao, M				Perez-Jorge, Sergi; Pereira, Thalia; Corne, Chloe; Wijtten, Zeno; Omar, Mohamed; Katello, Jillo; Kinyua, Mark; Oro, Daniel; Louzao, Maite			Can Static Habitat Protection Encompass Critical Areas for Highly Mobile Marine Top Predators? Insights from Coastal East Africa	PLOS ONE			English	Article							BOTTLE-NOSED DOLPHINS; MANAGEMENT; CONSERVATION; PATTERNS; ENVIRONMENT; PREFERENCE; FISHERIES; MODELS; SHIFTS; CORAL	Along the East African coast, marine top predators are facing an increasing number of anthropogenic threats which requires the implementation of effective and urgent conservation measures to protect essential habitats. Understanding the role that habitat features play on the marine top predator' distribution and abundance is a crucial step to evaluate the suitability of an existing Marine Protected Area (MPA), originally designated for the protection of coral reefs. We developed species distribution models (SDM) on the IUCN data deficient Indo-Pacific bottlenose dolphin (Tursiops aduncus) in southern Kenya. We followed a comprehensive ecological modelling approach to study the environmental factors influencing the occurrence and abundance of dolphins while developing SDMs. Through the combination of ensemble prediction maps, we defined recurrent, occasional and unfavourable habitats for the species. Our results showed the influence of dynamic and static predictors on the dolphins' spatial ecology: dolphins may select shallow areas (5-30 m), close to the reefs (<500 m) and oceanic fronts (<10 km) and adjacent to the 100m isobath (<5 km). We also predicted a significantly higher occurrence and abundance of dolphins within the MPA. Recurrent and occasional habitats were identified on large percentages on the existing MPA (47% and 57% using presence-absence and abundance models respectively). However, the MPA does not adequately encompass all occasional and recurrent areas and within this context, we propose to extend the MPA to incorporate all of them which are likely key habitats for the highly mobile species. The results from this study provide two key conservation and management tools: (i) an integrative habitat modelling approach to predict key marine habitats, and (ii) the first study evaluating the effectiveness of an existing MPA for marine mammals in the Western Indian Ocean.	[Perez-Jorge, Sergi; Pereira, Thalia; Corne, Chloe; Wijtten, Zeno] Global Vision Int Kenya GVI, Shimoni 80409, Kenya; [Perez-Jorge, Sergi; Oro, Daniel] CSIC, UIB, IMEDEA, Populat Ecol Grp, Esporles 07190, Balearic Island, Spain; [Omar, Mohamed; Katello, Jillo; Kinyua, Mark] Kenya Wildlife Serv, Ukunda 80400, Kenya; [Louzao, Maite] AZTI Fdn, Pasaia, Spain; [Louzao, Maite] IEO, Ctr Oceanog Xixon, E-33212 Gijon Xixon, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Mediterraneo de Estudios Avanzados (IMEDEA); Universitat de les Illes Balears; AZTI	Perez-Jorge, S (corresponding author), Global Vision Int Kenya GVI, POB 10, Shimoni 80409, Kenya.	sergiperezjorge@gmail.com	Jorge, Sergi Pérez/H-4865-2019; Louzao, Maite/N-5379-2014; Oro, Daniel/H-4208-2012	Jorge, Sergi Pérez/0000-0002-4843-0443; Oro, Daniel/0000-0003-4782-3007; Louzao, Maite/0000-0002-9997-5144	Spanish Ministry of Science and Innovation [JCI-2010-07639]; Ramon y Cajal postdoctoral contract [RYC-2012-09897]; Spanish Ministry of Economy [CGL2013-42203-R]	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Ramon y Cajal postdoctoral contract(Spanish Government); Spanish Ministry of Economy(Spanish Government)	ML was funded by a Juan de la Cierva postdoctoral contract (JCI-2010-07639, Spanish Ministry of Science and Innovation - http://www.idi.mineco.gob.es/) and a Ramon y Cajal postdoctoral contract (RYC-2012-09897). Funds were partially provided by a grant from the Spanish Ministry of Economy - http://www.idi.mineco.gob.es/(CGL2013-42203-R). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amir OA, 2005, ESTUAR COAST SHELF S, V63, P429, DOI 10.1016/j.ecss.2004.12.006; Araujo MB, 2005, GLOBAL ECOL BIOGEOGR, V14, P529, DOI 10.1111/j.1466-822x.2005.00182.x; Araujo MB, 2007, TRENDS ECOL EVOL, V22, P42, DOI 10.1016/j.tree.2006.09.010; Barton K., 2013, MUMLN MULTIMODEL INF; Bejder L, 2006, CONSERV BIOL, V20, P1791, DOI 10.1111/j.1523-1739.2006.00540.x; Bjornstad O. N., 2013, NCF SPATIAL NONPARAM; Bjornstad ON, 1999, TRENDS ECOL EVOL, V14, P427, DOI 10.1016/S0169-5347(99)01677-8; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Canadas A., 2006, Journal of Cetacean Research and Management, V8, P13; Canadas A, 2005, AQUAT CONSERV, V15, P495, DOI 10.1002/aqc.689; Castilla JC, 1998, ECOL APPL, V8, pS124, DOI 10.1890/1051-0761(1998)8[S124:SBFICO]2.0.CO;2; Cerchio S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086464; Christiansen Fredrik, 2010, Endangered Species Research, V11, P91, DOI 10.3354/esr00265; Cinner JE, 2015, GLOBAL ENVIRON CHANG, V30, P133, DOI 10.1016/j.gloenvcha.2014.10.003; Cockcroft V.G., 1990, P295; Crossman ND, 2008, DIVERS DISTRIB, V14, P213, DOI 10.1111/j.1472-4642.2007.00436.x; Elith J, 2009, ECOGRAPHY, V32, P66, DOI 10.1111/j.1600-0587.2008.05505.x; ESRI, 2011, ARCDESKTOP REL 10; Fauchald P, 2003, ECOLOGY, V84, P282, DOI 10.1890/0012-9658(2003)084[0282:UFPTIT]2.0.CO;2; Ferguson MC, 2006, ECOL MODEL, V193, P645, DOI 10.1016/j.ecolmodel.2005.10.034; Francis J, 2002, AMBIO, V31, P503, DOI 10.1639/0044-7447(2002)031[0503:MPAITE]2.0.CO;2; Gallus Anja, 2012, Endangered Species Research, V18, P265, DOI 10.3354/esr00448; Game ET, 2008, CONSERV BIOL, V22, P1619, DOI 10.1111/j.1523-1739.2008.01037.x; Game ET, 2009, TRENDS ECOL EVOL, V24, P360, DOI 10.1016/j.tree.2009.01.011; Gell F. R., 2002, FISHERY EFFECTS MARI, DOI 10.1016/s1386-5056(02)00038-2; Gormley AM, 2012, J APPL ECOL, V49, P474, DOI 10.1111/j.1365-2664.2012.02121.x; Halpern BS, 2003, ECOL APPL, V13, pS117; Hammond PS, 2012, TURSIOPS ADUNCUS IUC; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; Harwood J, 2001, J MAMMAL, V82, P630, DOI 10.1644/1545-1542(2001)082<0630:MMATEI>2.0.CO;2; Hooker SK, 2004, BIOSCIENCE, V54, P27, DOI 10.1641/0006-3568(2004)054[0027:MRAATF]2.0.CO;2; HURLBERT SH, 1984, ECOL MONOGR, V54, P187, DOI 10.2307/1942661; Hyrenbach KD, 2000, AQUAT CONSERV, V10, P437, DOI 10.1002/1099-0755(200011/12)10:6<437::AID-AQC425>3.3.CO;2-H; IUCN, 2004, MAN MAR PROT AR TOOL; Kelleher G., 1999, GUIDELINES MARINE PR; Kenya Wildlife Service, 2011, KIS MPUNG MAR CONS A; Lennon JJ, 2000, ECOGRAPHY, V23, P101, DOI 10.1034/j.1600-0587.2000.230111.x; Louzao M, 2009, MAR ECOL PROG SER, V391, P183, DOI 10.3354/meps08124; Louzao M, 2013, ECOGRAPHY, V36, P57, DOI 10.1111/j.1600-0587.2012.07587.x; Louzao M, 2011, J APPL ECOL, V48, P121, DOI 10.1111/j.1365-2664.2010.01910.x; Mannocci L, 2014, ECOGRAPHY, V37, P261, DOI 10.1111/j.1600-0587.2013.00317.x; Marmion M, 2009, DIVERS DISTRIB, V15, P59, DOI 10.1111/j.1472-4642.2008.00491.x; McClanahan TR, 2006, AQUAT CONSERV, V16, P147, DOI 10.1002/aqc.715; McClanahan TR, 2001, CORAL REEFS, V19, P380, DOI 10.1007/s003380000133; McClanahan TR, 1999, BIOL CONSERV, V89, P161, DOI 10.1016/S0006-3207(98)00123-2; Meyler S, 2012, W INDIAN OCEAN J MAR, V10, P201; Moore JE, 2013, MAR MAMMAL SCI, V29, P446, DOI 10.1111/j.1748-7692.2012.00586.x; MORAN PAP, 1950, BIOMETRIKA, V37, P17, DOI 10.1093/biomet/37.1-2.17; Pirotta E, 2011, MAR ECOL PROG SER, V436, P257, DOI 10.3354/meps09236; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Ready J, 2010, ECOL MODEL, V221, P467, DOI 10.1016/j.ecolmodel.2009.10.025; Reeves RR., 2000, VALUE SANCTUARIES PA, P50; Roberts CM, 2002, SCIENCE, V295, P1280, DOI 10.1126/science.1067728; Rocliffe S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103000; Silva MA, 2012, AQUAT CONSERV, V22, P122, DOI 10.1002/aqc.1243; Spyrakos E, 2011, HYDROBIOLOGIA, V670, P87, DOI 10.1007/s10750-011-0722-4; SWETS JA, 1988, SCIENCE, V240, P1285, DOI 10.1126/science.3287615; UN CBD, 2010, COP 10 DEC X 2 STRAT; Venables WN., 2002, MODERN APPL STAT S 4; VERON JEN, 1995, CORALS SPACE TIME BI; Wilson B, 1997, J APPL ECOL, V34, P1365, DOI 10.2307/2405254; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279; Worm B, 2005, SCIENCE, V309, P1365, DOI 10.1126/science.1113399; [No title captured]	65	30	30	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0133265	10.1371/journal.pone.0133265	http://dx.doi.org/10.1371/journal.pone.0133265			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RV	26186438	Green Published, gold, Green Submitted			2022-12-26	WOS:000358198700116
J	Ursu, RG; Onofriescu, M; Luca, A; Prisecariu, LJ; Salceanu, SO; Nemescu, D; Iancu, LS				Ursu, Ramona Gabriela; Onofriescu, Mircea; Luca, Alexandru; Prisecariu, Liviu Jany; Salceanu, Silvia Olivia; Nemescu, Dragos; Iancu, Luminita Smaranda			The Need for Cervical Cancer Control in HIV-Positive and HIV-Negative Women from Romania by Primary Prevention and by Early Detection Using Clinically Validated HPV/DNA Tests	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS; HPV INFECTION; VIRUS	Background In Romania, a country with no organized national surveillance program regarding cervical cancer, the early diagnosis of HPV (Human Papilloma Virus) infections is a major requirement, especially in HIV-infected women. The objective of this study was to determine the HPV prevalence and type distribution in young HIV-positive women and to assess the difference in the risk factors for developing cervical cancer compared to those of HIV-negative women. Method We conducted one cross-sectional cohort study from June 2013-September 2014, including 1,032 women: 992 HIV-women who were 36.5 years old (limits: 17 ->divided by 84) and 40 HIV + women who were 22.9 years old (limits: 17 divided by 30) with iatrogenic HIV infected. We detected HPV types with the Linear Array HPV Genotyping test (Roche, Romania). Results DNA/HPV was detected in 18/40 (45%) of the HIV+ patients and in 350/992 (35.2%) of the HIV-patients (OR = 1.5, 95%CI 0.76 divided by 2.96). After age adjustment, the overall HPV prevalence was 51.6% in HIV+ versus 63.2% in HIV-women aged under 25, and 22.2% in HPV+ versus 47.2% in HIV-women aged 25-34. We detect HIV being a risk factor for acquiring multiple HPV type infections (OR = 2.30, 95% CI 0.88 divided by 5.97). The eight most common HPV types (high-risk, and low-risk) for women below age 30, HIV+/-were: HPV 16, 18, 31, 51, 58, 68, and 6 and 82 respectively. To assess the risk factors of HIV-positive women for acquiring HPV infection, we analyzed the CD4/mu L, ARN/HIV copies/mu L, the age group, the number of sexual partners, smoking, and the type of HPV infection (single versus multiple infections). We found that the number of sexual partners and smoking are statistically significant risk factors. Conclusion Even though there are no significant differences regarding the prevalence of HPV infection in HIV + versus HIV - patients, multiple infections were more frequent in the first group. In our study group young HIV-infected patients under HAART therapy, high number of sexual partners (more than 3) and smoking were detected to be risk factors. Future organized screening for HPV infection using sensitive and specific methods are necessary at the national level in Romania.	[Ursu, Ramona Gabriela; Iancu, Luminita Smaranda] Univ Med & Pharm Gr T Popa, Dept Microbiol, Iasi, Romania; [Onofriescu, Mircea; Nemescu, Dragos] Univ Med & Pharm Gr T Popa, Dept Obstet & Gynecol, Iasi, Romania; [Onofriescu, Mircea; Luca, Alexandru; Nemescu, Dragos] Cuza Voda Obstet & Gynecol Hosp, Iasi, Romania; [Prisecariu, Liviu Jany] Infect Dis St Parascheva Clin Univ Hosp Iasi, Iasi, Romania; [Salceanu, Silvia Olivia] Clin Hosp Cai Ferate Iasi, Iasi, Romania	Grigore T Popa University of Medicine & Pharmacy; Grigore T Popa University of Medicine & Pharmacy	Ursu, RG (corresponding author), Univ Med & Pharm Gr T Popa, Dept Microbiol, Iasi, Romania.	ramonagabrielaursu@yahoo.com	Ursu, Ramona Gabriela/U-6053-2017; Iancu, Luminita-Smaranda/U-4331-2017; Iancu, Luminita Smaranda C./C-8864-2015; Onofriescu, Mircea/Y-5702-2018; Nemescu, Dragos/AAC-7813-2019	Iancu, Luminita-Smaranda/0000-0002-2592-3982; Iancu, Luminita Smaranda C./0000-0002-2592-3982; Nemescu, Dragos/0000-0003-2345-1077; Ursu, Ramona Gabriela/0000-0002-1811-7923	European Social Fund, Human Resources Development Operational Programme [POSDRU/159/1.5/136893]	European Social Fund, Human Resources Development Operational Programme	This paper was published under the frame of European Social Fund, Human Resources Development Operational Programme 2007-2013, project no. POSDRU/159/1.5/136893.	[Anonymous], 2013, ANN EPIDEMIOLOGICAL; Castellsague X, 2008, GYNECOL ONCOL, V110, pS4, DOI 10.1016/j.ygyno.2008.07.045; Clifford GM, 2006, AIDS, V20, P2337, DOI 10.1097/01.aids.0000253361.63578.14; Dames DN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085429; De Vuyst H, 2012, BRIT J CANCER, V107, P1624, DOI 10.1038/bjc.2012.441; Denny LA, 2012, VACCINE, V30, pF168, DOI 10.1016/j.vaccine.2012.06.045; Desruisseau Andrew J, 2009, Infect Dis Obstet Gynecol, V2009, P810596, DOI 10.1155/2009/810596; Ezechi OC, 2014, VIROL J, V11, DOI 10.1186/1743-422X-11-5; Ferlay J, 2013, GLOBOCAN 2012 V1 0 C; Firnhaber C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053494; Heard I, 2013, BJOG-INT J OBSTET GY, V120, P41, DOI 10.1111/1471-0528.12015; Kojic EM, 2014, CLIN INFECT DIS, V59, P127, DOI 10.1093/cid/ciu238; Stuardo V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047755; Ursu RG, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-558; Vaccarella S, 2013, INFECT AGENTS CANCER, V8, DOI 10.1186/1750-9378-8-50; Walboomers JMM, 1999, J PATHOL, V189, P12, DOI 10.1002/(SICI)1096-9896(199909)189:1&lt;12::AID-PATH431&gt;3.0.CO;2-F; World Health Organization, 2013, KEY FACTS HIV EP ROM	17	11	12	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0132271	10.1371/journal.pone.0132271	http://dx.doi.org/10.1371/journal.pone.0132271			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RV	26186361	Green Published, gold, Green Submitted			2022-12-26	WOS:000358198700035
J	Glynn, JR; Guerra-Assuncao, JA; Houben, RMGJ; Sichali, L; Mzembe, T; Mwaungulu, LK; Mwaungulu, JN; McNerney, R; Khan, P; Parkhill, J; Crampin, AC; Clark, TG				Glynn, Judith R.; Guerra-Assuncao, Jose Afonso; Houben, Rein M. G. J.; Sichali, Lifted; Mzembe, Themba; Mwaungulu, Lorrain K.; Mwaungulu, J. Nimrod; McNerney, Ruth; Khan, Palwasha; Parkhill, Julian; Crampin, Amelia C.; Clark, Taane G.			Whole Genome Sequencing Shows a Low Proportion of Tuberculosis Disease Is Attributable to Known Close Contacts in Rural Malawi	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; TRANSMISSION; HOUSEHOLDS; COMMUNITY; UK	Background The proportion of tuberculosis attributable to transmission from close contacts is not well known. Comparison of the genome of strains from index patients and prior contacts allows transmission to be confirmed or excluded. Methods In Karonga District, Malawi, all tuberculosis patients are asked about prior contact with others with tuberculosis. All available strains from culture-positive patients were sequenced. Up to 10 single nucleotide polymorphisms between index patients and their prior contacts were allowed for confirmation, and >= 100 for exclusion. The population attributable fraction was estimated from the proportion of confirmed transmissions and the proportion of patients with contacts. Results From 1997-2010 there were 1907 new culture-confirmed tuberculosis patients, of whom 32% reported at least one family contact and an additional 11% had at least one other contact; 60% of contacts had smear-positive disease. Among case-contact pairs with sequences available, transmission was confirmed from 38% (62/163) smear-positive prior contacts and 0/17 smear-negative prior contacts. Confirmed transmission was more common in those related to the prior contact (42.4%, 56/132) than in non-relatives (19.4%, 6/31, p = 0.02), and in those with more intense contact, to younger index cases, and in more recent years. The proportion of tuberculosis attributable to known contacts was estimated to be 9.4% overall. Conclusions In this population known contacts only explained a small proportion of tuberculosis cases. Even those with a prior family contact with smear positive tuberculosis were more likely to have acquired their infection elsewhere.	[Glynn, Judith R.; Guerra-Assuncao, Jose Afonso; Houben, Rein M. G. J.; Khan, Palwasha; Crampin, Amelia C.; Clark, Taane G.] London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, London WC1, England; [Sichali, Lifted; Mzembe, Themba; Mwaungulu, Lorrain K.; Mwaungulu, J. Nimrod; Crampin, Amelia C.] Karonga Prevent Study, Chilumba, Malawi; [McNerney, Ruth; Clark, Taane G.] London Sch Hyg & Trop Med, Fac Infect & Trop Dis, London WC1, England; [Parkhill, Julian] Wellcome Trust Sanger Inst, Hinxton, England	University of London; London School of Hygiene & Tropical Medicine; Malawi Epidemiology and Intervention Research Unit; University of London; London School of Hygiene & Tropical Medicine; Wellcome Trust Sanger Institute	Glynn, JR (corresponding author), London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, London WC1, England.	Judith.glynn@lshtm.ac.uk	Clark, Taane G./AAM-2570-2020; khan, Palwasha/GRS-4835-2022; Parkhill, Julian/G-4703-2011; Guerra-Assuncao, Jose Afonso/F-3887-2011	Clark, Taane G./0000-0001-8985-9265; Parkhill, Julian/0000-0002-7069-5958; Crampin, Amelia/0000-0002-1513-4330; Khan, Palwasha Yousafzai/0000-0002-0873-8355; Guerra-Assuncao, Jose Afonso/0000-0001-6593-403X	Wellcome Trust [096249/Z/11/B]	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by The Wellcome Trust grant number 096249/Z/11/B (PI JG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson LF, 2014, LANCET INFECT DIS, V14, P406, DOI 10.1016/S1473-3099(14)70022-2; Behr MA, 1998, AM J RESP CRIT CARE, V158, P465, DOI 10.1164/ajrccm.158.2.9801062; Bennett DE, 2002, EMERG INFECT DIS, V8, P1224; Bryant JM, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-110; Coll F, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0164-0; Coll F, 2012, BIOINFORMATICS, V28, P2991, DOI 10.1093/bioinformatics/bts544; Crampin AC, 2006, EMERG INFECT DIS, V12, P729; Crampin AC, 2004, INT J TUBERC LUNG D, V8, P194; Demay C, 2012, INFECT GENET EVOL, V12, P755, DOI 10.1016/j.meegid.2012.02.004; Fox GJ, 2013, EUR RESPIR J, V41, P140, DOI 10.1183/09031936.00070812; Guerra-Assuncao JA, 2015, ELIFE, V4, DOI 10.7554/eLife.05166; Guerra-Assuncao JA, 2014, J INFECT DIS JIU, P574; Lonnroth K, 2013, INT J TUBERC LUNG D, V17, P289, DOI 10.5588/ijtld.12.0797; Mallard K, 2010, J CLIN MICROBIOL, V48, P4512, DOI 10.1128/JCM.01683-10; Marais BJ, 2009, J CLIN MICROBIOL, V47, P1338, DOI 10.1128/JCM.02490-08; Mboma SM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058192; NARAIN R, 1966, B WORLD HEALTH ORGAN, V34, P639; Schaaf HS, 2003, INT J TUBERC LUNG D, V7, P426; Sloot R, 2014, AM J RESP CRIT CARE, V190, P1044, DOI 10.1164/rccm.201406-1159OC; Verver S, 2004, LANCET, V363, P212, DOI 10.1016/S0140-6736(03)15332-9; Walker TM, 2014, LANCET RESP MED, V2, P285, DOI 10.1016/S2213-2600(14)70027-X; Walker TM, 2013, LANCET INFECT DIS, V13, P137, DOI 10.1016/S1473-3099(12)70277-3; World Health Organization, 2013, SYST SCREEN ACT TUB; Zachariah R, 2011, INT J TUBERC LUNG D, V15, P933, DOI 10.5588/ijtld.10.0666	24	70	70	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2015	10	7							e0132840	10.1371/journal.pone.0132840	http://dx.doi.org/10.1371/journal.pone.0132840			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RQ	26181760	Green Accepted, Green Published, gold, Green Submitted			2022-12-26	WOS:000358198200041
J	Tsai, LCL; Xie, L; Dore, K; Xie, L; Del Rio, JC; King, CC; Martinez-Ariza, G; Hulme, C; Malinow, R; Bourne, PE; Newton, AC				Tsai, Li-Chun Lisa; Xie, Lei; Dore, Kim; Xie, Li; Del Rio, Jason C.; King, Charles C.; Martinez-Ariza, Guillermo; Hulme, Christopher; Malinow, Roberto; Bourne, Philip E.; Newton, Alexandra C.			Zeta Inhibitory Peptide Disrupts Electrostatic Interactions That Maintain Atypical Protein Kinase C in Its Active Conformation on the Scaffold p62	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMPA RECEPTOR TRAFFICKING; PKC-ZETA; SPATIOTEMPORAL DYNAMICS; SYNAPTIC PLASTICITY; DOMAIN; TRANSLOCATION; DOCKING; BINDING; ALPHA; PHOSPHORYLATION	Atypical protein kinase C (aPKC) enzymes signal on protein scaffolds, yet how they are maintained in an active conformation on scaffolds is unclear. A myristoylated peptide based on the autoinhibitory pseudosubstrate fragment of the atypical PKC zeta, zeta inhibitory peptide (ZIP), has been extensively used to inhibit aPKC activity; however, we have previously shown that ZIP does not inhibit the catalytic activity of aPKC isozymes in cells (Wu-Zhang, A. X., Schramm, C. L., Nabavi, S., Malinow, R., and Newton, A. C. (2012) J. Biol. Chem. 287, 12879-12885). Here we sought to identify a bona fide target of ZIP and, in so doing, unveiled a novel mechanism by which aPKCs are maintained in an active conformation on a protein scaffold. Specifically, we used protein-protein interaction network analysis, structural modeling, and protein-protein docking to predict that ZIP binds an acidic surface on the Phox and Bem1 (PB1) domain of p62, an interaction validated by peptide array analysis. Using a genetically encoded reporter for PKC activity fused to the p62 scaffold, we show that ZIP inhibits the activity of wild-type aPKC, but not a construct lacking the pseudosubstrate. These data support a model in which the pseudosubstrate of aPKCs is tethered to the acidic surface on p62, locking aPKC in an open, signaling-competent conformation. ZIP competes for binding to the acidic surface, resulting in displacement of the pseudosubstrate of aPKC and re-engagement in the substrate-binding cavity. This study not only identifies a cellular target for ZIP, but also unveils a novel mechanism by which scaffolded aPKC is maintained in an active conformation.	[Tsai, Li-Chun Lisa; Del Rio, Jason C.; Newton, Alexandra C.] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [Dore, Kim; Malinow, Roberto] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; [Xie, Li] Univ Calif San Diego, Skaggs Sch Pharm, La Jolla, CA 92093 USA; [King, Charles C.] Univ Calif San Diego, Pediat Diabet Res Ctr, La Jolla, CA 92093 USA; [Xie, Lei] CUNY, Hunter Coll, Dept Comp Sci, New York, NY 10065 USA; [Martinez-Ariza, Guillermo; Hulme, Christopher] Univ Arizona, Coll Pharm, Dept Pharmacol & Toxicol, Tucson, AZ 85721 USA; [Bourne, Philip E.] NIH, Off Director, Bethesda, MD 20892 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; City University of New York (CUNY) System; Hunter College (CUNY); University of Arizona; National Institutes of Health (NIH) - USA	Newton, AC (corresponding author), Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA.	anewton@ucsd.edu	Dore, Kim/AAN-1470-2021; Bourne, Philip/ABG-8967-2021; Regan, Clinton/E-6250-2012	Dore, Kim/0000-0001-6263-367X; Bourne, Philip/0000-0002-7618-7292; Del Rio, Jason/0000-0001-8540-2065; Martinez-Ariza, Guillermo/0000-0003-2002-3958	National Institutes of Health [P01 DK54441]; University of California San Diego through Training Program in Diabetes Research from the National Institute of Diabetes and Digestive and kidney Diseases [5T32DK007494]; University of California San Diego Graduate Training Program in Cellular and Molecular Pharmacology from the National Institute of General Medical Sciences [T32GM007752]; NATIONAL LIBRARY OF MEDICINE [ZIALM000928] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of California San Diego through Training Program in Diabetes Research from the National Institute of Diabetes and Digestive and kidney Diseases; University of California San Diego Graduate Training Program in Cellular and Molecular Pharmacology from the National Institute of General Medical Sciences; NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This work was supported by National Institutes of Health Grant P01 DK54441 (to A. C. N.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported in part by the University of California San Diego through Training Program in Diabetes Research 5T32DK007494 from the National Institute of Diabetes and Digestive and kidney Diseases.; Supported in part by the University of California San Diego Graduate Training Program in Cellular and Molecular Pharmacology through Training Grant T32GM007752 from the National Institute of General Medical Sciences.	Antal CE, 2015, CELL REP, V12, P1252, DOI 10.1016/j.celrep.2015.07.039; Antal CE, 2013, MOL CELL PROTEOMICS, V12, P3498, DOI 10.1074/mcp.R113.029819; Babu JR, 2008, J NEUROCHEM, V106, P107, DOI 10.1111/j.1471-4159.2008.05340.x; Bandyopadhyay G, 2002, J CLIN ENDOCR METAB, V87, P716, DOI 10.1210/jc.87.2.716; Becker W, 2004, MICROSC RES TECHNIQ, V63, P58, DOI 10.1002/jemt.10421; Cariou B, 2004, FRONT BIOSCI-LANDMRK, V9, P1626, DOI 10.2741/1228; Chen R, 2003, PROTEINS, V52, P80, DOI 10.1002/prot.10389; Erdogan E, 2006, J BIOL CHEM, V281, P28450, DOI 10.1074/jbc.M606054200; Evans JH, 2006, MOL BIOL CELL, V17, P56, DOI 10.1091/mbc.e05-06-0499; Gallegos LL, 2006, J BIOL CHEM, V281, P30947, DOI 10.1074/jbc.M603741200; Gallegos LL, 2011, METHODS MOL BIOL, V756, P295, DOI 10.1007/978-1-61779-160-4_17; GOODE NT, 1994, FEBS LETT, V340, P145, DOI 10.1016/0014-5793(94)80190-8; Gray JJ, 2003, J MOL BIOL, V331, P281, DOI 10.1016/S0022-2836(03)00670-3; Graybill C, 2012, J BIOL CHEM, V287, P21003, DOI 10.1074/jbc.M112.360495; Hirano Y, 2004, J BIOL CHEM, V279, P31883, DOI 10.1074/jbc.M403092200; Imamura T, 2003, MOL CELL BIOL, V23, P4892, DOI 10.1128/MCB.23.14.4892-4900.2003; ISHIHARA H, 1989, BIOCHEM BIOPH RES CO, V159, P871, DOI 10.1016/0006-291X(89)92189-X; Jiang JX, 2009, HIPPOCAMPUS, V19, P392, DOI 10.1002/hipo.20528; KAZANIETZ MG, 1994, J BIOL CHEM, V269, P11590; Kim J, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002510; Kunkel MT, 2005, J BIOL CHEM, V280, P5581, DOI 10.1074/jbc.M411534200; Kusne Y, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005196; Lakowicz J.R., 2006, PRINCIPLES FLUORESCE; Lamark T, 2003, J BIOL CHEM, V278, P34568, DOI 10.1074/jbc.M303221200; Langeberg LK, 2015, NAT REV MOL CELL BIO, V16, P232, DOI 10.1038/nrm3966; Lee AM, 2013, NATURE, V493, P416, DOI 10.1038/nature11803; Ling DSF, 2002, NAT NEUROSCI, V5, P295, DOI 10.1038/nn829; Lopez-Garcia LA, 2011, CHEM BIOL, V18, P1463, DOI 10.1016/j.chembiol.2011.08.010; Lu RF, 2015, MOL BIOL CELL, V26, P1523, DOI 10.1091/mbc.E14-12-1613; Macindoe G, 2010, NUCLEIC ACIDS RES, V38, pW445, DOI 10.1093/nar/gkq311; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; Migues PV, 2010, NAT NEUROSCI, V13, P630, DOI 10.1038/nn.2531; NAKANISHI H, 1993, J BIOL CHEM, V268, P13; Nalefski EA, 2001, BIOCHEMISTRY-US, V40, P13216, DOI 10.1021/bi010761u; Newton AC, 2010, AM J PHYSIOL-ENDOC M, V298, pE395, DOI 10.1152/ajpendo.00477.2009; ORR JW, 1992, J BIOL CHEM, V267, P15263; Parker PJ, 2014, BIOCHEM PHARMACOL, V88, P1, DOI 10.1016/j.bcp.2013.10.023; Parker PJ, 2004, J CELL SCI, V117, P131, DOI 10.1242/jcs.00982; Pastalkova E, 2006, SCIENCE, V313, P1141, DOI 10.1126/science.1128657; Pu YM, 2006, J BIOL CHEM, V281, P33773, DOI 10.1074/jbc.M606560200; Ren J, 2014, SCI CHINA LIFE SCI, V57, P69, DOI 10.1007/s11427-013-4592-z; Ron D, 1999, FASEB J, V13, P1658, DOI 10.1096/fasebj.13.13.1658; Rosse C, 2010, NAT REV MOL CELL BIO, V11, P103, DOI 10.1038/nrm2847; Sanchez-Bautista S, 2006, J MOL BIOL, V362, P901, DOI 10.1016/j.jmb.2006.07.093; SCOTT JD, 1986, P NATL ACAD SCI USA, V83, P1613, DOI 10.1073/pnas.83.6.1613; Seibenhener ML, 2007, FEBS LETT, V581, P175, DOI 10.1016/j.febslet.2006.12.027; Serrano P, 2008, PLOS BIOL, V6, P2698, DOI 10.1371/journal.pbio.0060318; Shema R, 2007, SCIENCE, V317, P951, DOI 10.1126/science.1144334; Sumimoto Hideki, 2007, Sci STKE, V2007, pre6, DOI 10.1126/stke.4012007re6; Trujillo JI, 2009, BIOORG MED CHEM LETT, V19, P908, DOI 10.1016/j.bmcl.2008.11.105; Viger ML, 2014, ACS NANO, V8, P4815, DOI 10.1021/nn500702g; Violin JD, 2003, J CELL BIOL, V161, P899, DOI 10.1083/jcb.200302125; Volk LJ, 2013, NATURE, V493, P420, DOI 10.1038/nature11802; Wu-Zhang AX, 2013, BIOCHEM J, V452, P195, DOI 10.1042/BJ20130220; Wu-Zhang AX, 2012, J BIOL CHEM, V287, P12879, DOI 10.1074/jbc.M112.357244; Xu D, 2012, PROTEINS, V80, P1715, DOI 10.1002/prot.24065	56	26	27	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	2015	290	36					21845	21856		10.1074/jbc.M115.676221	http://dx.doi.org/10.1074/jbc.M115.676221			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CQ9XI	26187466	Green Published, hybrid			2022-12-26	WOS:000360968500007
J	Chen, WN; Han, C; Zhang, JQ; Song, K; Wang, Y; Wu, T				Chen, Weina; Han, Chang; Zhang, Jinqiang; Song, Kyoungsub; Wang, Ying; Wu, Tong			miR-150 Deficiency Protects against FAS-Induced Acute Liver Injury in Mice through Regulation of AKT	PLOS ONE			English	Article							HEPATIC STELLATE CELLS; FACTOR C-MYB; HEPATOCYTE APOPTOSIS; MEDIATED APOPTOSIS; SIGNALING PATHWAY; DOWN-REGULATION; IMMUNE-SYSTEM; MICRORNA; RECEPTOR; ACTIVATION	Although miR-150 is implicated in the regulation of immune cell differentiation and activation, it remains unknown whether miR-150 is involved in liver biology and disease. This study was performed to explore the potential role of miR-150 in LPS/D-GalN and Fas-induced liver injuries by using wild type and miR-150 knockout (KO) mice. Whereas knockout of miR-150 did not significantly alter LPS/D-GalN-induced animal death and liver injury, it protected against Fas-induced liver injury and mortality. The Jo2-induced increase in serum transaminases, apoptotic hepatocytes, PARP cleavage, as well as caspase-3/7, caspase-8, and caspase-9 activities were significantly attenuated in miR-150 KO mice. The liver tissues from Jo2-treated miR-150 KO mice expressed higher levels of Akt1, Akt2, total Akt, as well as p-Akt (Ser473) compared to the wild type livers. Pretreatment with the Akt inhibitor V reversed Jo2-induced liver injury in miR-150 KO mice. The primary hepatocytes isolated from miR-150 KO mice also showed protection against Fas-induced apoptosis in vitro (characterized by less prominent PARP cleavage, less nuclear fragmentation and less caspase activation) in comparison to hepatocytes from wild type mice. Luciferase reporter assays in hepatocytes transfected with the Akt1 or Akt2 3'-UTR reporter constructs (with or without mutation of miR-150 binding site) established Akt1 and Akt2 as direct targets of miR-150. Tail vein injection of lentiviral particles containing pre-miR-150 enhanced Jo2-induced liver injury in miR-150 KO mice. These findings demonstrate that miR-150 deficiency prevents Fas-induced hepatocyte apoptosis and liver injury through regulation of the Akt pathway.	[Chen, Weina; Han, Chang; Zhang, Jinqiang; Song, Kyoungsub; Wang, Ying; Wu, Tong] Tulane Univ, Sch Med, Dept Pathol & Lab Med, New Orleans, LA 70118 USA; [Wang, Ying] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Gastroenterol & Internal Med, Wuhan 430074, Peoples R China	Tulane University; Huazhong University of Science & Technology	Wu, T (corresponding author), Tulane Univ, Sch Med, Dept Pathol & Lab Med, 1430 Tulane Ave SL-79, New Orleans, LA 70118 USA.	twu@tulane.edu			National Institutes of Health [CA106280, CA102325, CA134568, DK077776]; NATIONAL CANCER INSTITUTE [R01CA106280, R01CA102325, R01CA134568] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK077776, R01DK077776] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health grants CA106280, CA102325, CA134568, and DK077776 (to T.W.).	Bezman NA, 2011, J EXP MED, V208, P2717, DOI 10.1084/jem.20111386; Dillon RL, 2010, CANCER RES, V70, P4260, DOI 10.1158/0008-5472.CAN-10-0266; Farhana L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061015; Feldstein AE, 2003, GASTROENTEROLOGY, V125, P437, DOI 10.1016/S0016-5085(03)00907-7; Gonzalez E, 2009, CELL CYCLE, V8, P2502, DOI 10.4161/cc.8.16.9335; Guicciardi ME, 2005, GUT, V54, P1024, DOI 10.1136/gut.2004.053850; Han C, 2010, HEPATOLOGY, V52, P644, DOI 10.1002/hep.23703; Hanada M, 2004, BBA-PROTEINS PROTEOM, V1697, P3, DOI 10.1016/j.bbapap.2003.11.009; Hatano E, 2001, AM J PHYSIOL-GASTR L, V281, pG1357, DOI 10.1152/ajpgi.2001.281.6.G1357; Honda N, 2013, AM J PATHOL, V182, P206, DOI 10.1016/j.ajpath.2012.09.023; Jirillo E, 2002, J ENDOTOXIN RES, V8, P319, DOI 10.1179/096805102125000641; Jones RG, 2002, J EXP MED, V196, P335, DOI 10.1084/jem.20020307; Kondo T, 1997, NAT MED, V3, P409, DOI 10.1038/nm0497-409; Krammer PH, 2000, NATURE, V407, P789, DOI 10.1038/35037728; Lavrik IN, 2012, CELL DEATH DIFFER, V19, P36, DOI 10.1038/cdd.2011.155; LEHMANN V, 1987, J EXP MED, V165, P657, DOI 10.1084/jem.165.3.657; Li GY, 2009, HEPATOLOGY, V50, P834, DOI 10.1002/hep.23052; Li PF, 2010, J BIOL CHEM, V285, P22713, DOI 10.1074/jbc.M110.105692; Liu DY, 2004, J BIOL CHEM, V279, P48434, DOI 10.1074/jbc.M407190200; Lu J, 2008, DEV CELL, V14, P843, DOI 10.1016/j.devcel.2008.03.012; LUSTER MI, 1994, HEPATOLOGY, V19, P480; Malhi H, 2006, HEPATOLOGY, V43, pS31, DOI 10.1002/hep.21062; Minana JB, 2002, HEPATOLOGY, V35, P1205, DOI 10.1053/jhep.2002.32969; Miranda KC, 2006, CELL, V126, P1203, DOI 10.1016/j.cell.2006.07.031; Miyoshi H, 1999, GASTROENTEROLOGY, V117, P669, DOI 10.1016/S0016-5085(99)70461-0; Morris VA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075815; Moumen A, 2007, HEPATOLOGY, V45, P1210, DOI 10.1002/hep.21604; Mraz M, 2014, BLOOD, V124, P84, DOI 10.1182/blood-2013-09-527234; Nicholson KM, 2002, CELL SIGNAL, V14, P381, DOI 10.1016/S0898-6568(01)00271-6; Parasuraman S, 2010, J PHARMACOL PHARMACO, V1, P87, DOI 10.4103/0976-500X.72350; Peter ME, 2007, CELL, V129, P447, DOI 10.1016/j.cell.2007.04.031; Pianko S, 2001, J VIRAL HEPATITIS, V8, P406, DOI 10.1046/j.1365-2893.2001.00316.x; Roderburg C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054612; Rolland-Turner M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054135; Salehi S, 2013, AM J TRANSPLANT, V13, P1282, DOI 10.1111/ajt.12183; Schmidt WM, 2009, BIOCHEM BIOPH RES CO, V380, P437, DOI 10.1016/j.bbrc.2008.12.190; Schultze Simon M., 2011, Archives of Physiology and Biochemistry, V117, P70, DOI 10.3109/13813455.2010.539236; Schulze-Bergkamen H, 2004, HEPATOLOGY, V39, P645, DOI 10.1002/hep.20138; Sharma AD, 2011, HEPATOLOGY, V53, P1651, DOI 10.1002/hep.24243; Shen J, 2013, CANCER EPIDEM BIOMAR, V22, P2364, DOI 10.1158/1055-9965.EPI-13-0237; Srivastava SK, 2011, CARCINOGENESIS, V32, P1832, DOI 10.1093/carcin/bgr223; Strasser A, 2009, IMMUNITY, V30, P180, DOI 10.1016/j.immuni.2009.01.001; Tano N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023114; Tsitsiou E, 2009, CURR OPIN PHARMACOL, V9, P514, DOI 10.1016/j.coph.2009.05.003; Valva P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053519; Vasilatou D, 2010, EUR J HAEMATOL, V84, P1, DOI 10.1111/j.1600-0609.2009.01348.x; Vasilescu C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007405; Venugopal SK, 2010, AM J PHYSIOL-GASTR L, V298, pG101, DOI 10.1152/ajpgi.00220.2009; Wang CM, 2015, HEPATOLOGY, V61, P200, DOI 10.1002/hep.27396; Wang Q, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036818; Wang SL, 2015, ONCOL REP, V33, P819, DOI 10.3892/or.2014.3641; Xiao CC, 2007, CELL, V131, P146, DOI 10.1016/j.cell.2007.07.021; Yeh YY, 2015, BLOOD, V125, P3297, DOI 10.1182/blood-2014-12-618470; Yue JM, 2010, MAMM GENOME, V21, P88, DOI 10.1007/s00335-009-9240-3; Zhang J, 2012, INT J ONCOL, V40, P747, DOI 10.3892/ijo.2011.1242; Zhang YJ, 2010, MOL CELL, V39, P133, DOI 10.1016/j.molcel.2010.06.010; Zheng JJ, 2013, INT J MOL MED, V32, P17, DOI 10.3892/ijmm.2013.1356; Zhou BY, 2007, P NATL ACAD SCI USA, V104, P7080, DOI 10.1073/pnas.0702409104	58	15	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0132734	10.1371/journal.pone.0132734	http://dx.doi.org/10.1371/journal.pone.0132734			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LZ	26196694	Green Published, Green Submitted, gold			2022-12-26	WOS:000358547600049
J	Matteau, D; Baby, V; Pelletier, S; Rodrigue, S				Matteau, Dominick; Baby, Vincent; Pelletier, Stephane; Rodrigue, Sebastien			A Small-Volume, Low-Cost, and Versatile Continuous Culture Device	PLOS ONE			English	Article							SYSTEMS BIOLOGY; EVOLUTION; SURFACES; GROWTH; CHEMOSTAT; BACTERIA	Background Continuous culture devices can be used for various purposes such as establishing reproducible growth conditions or maintaining cell populations under a constant environment for long periods. However, commercially available instruments are expensive, were not designed to handle small volumes in the milliliter range, and can lack the flexibility required for the diverse experimental needs found in several laboratories. Methodology/Principal Findings We developed a versatile continuous culture system and provide detailed instructions as well as a graphical user interface software for potential users to assemble and operate their own instrument. Three culture chambers can be controlled simultaneously with the proposed configuration, and all components are readily available from various sources. We demonstrate that our continuous culture device can be used under different modes, and can easily be programmed to behave either as a turbidostat or chemostat. Addition of fresh medium to the culture vessel can be controlled by a real-time feedback loop or simply calibrated to deliver a defined volume. Furthermore, the selected light-emitting diode and photodetector enable the use of phenol red as a pH indicator, which can be used to indirectly monitor the bulk metabolic activity of a cell population rather than the turbidity. Conclusions/Significance This affordable and customizable system will constitute a useful tool in many areas of biology such as microbial ecology as well as systems and synthetic biology.	[Matteau, Dominick; Baby, Vincent; Rodrigue, Sebastien] Univ Sherbrooke, Dept Biol, Sherbrooke, PQ J1K 2R1, Canada; [Pelletier, Stephane] Univ Sherbrooke, Dept Phys, Sherbrooke, PQ J1K 2R1, Canada	University of Sherbrooke; University of Sherbrooke	Rodrigue, S (corresponding author), Univ Sherbrooke, Dept Biol, Sherbrooke, PQ J1K 2R1, Canada.	sebastien.rodrigue@usherbrooke.ca			Fonds de recherche du Quebec - Nature et technologies (FRQNT) [144858]; Natural Sciences and Engineering Research Council of Canada (NSERC) [386393]	Fonds de recherche du Quebec - Nature et technologies (FRQNT); Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by grant 144858 from the Fonds de recherche du Quebec - Nature et technologies (FRQNT; www.frqnt.gouv.qc.ca) and grant 386393 from the Natural Sciences and Engineering Research Council of Canada (NSERC; www.nserc-crsng.gc.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baby V, 2013, GENOME ANNOUNCEMENTS, V1, DOI 10.1128/genomeA.00879-13; Banerjee I, 2011, ADV MATER, V23, P690, DOI 10.1002/adma.201001215; Bijmans MFM, 2010, BIOTECHNOL PROGR, V26, P1029, DOI 10.1002/btpr.400; Bull AT, 2010, J IND MICROBIOL BIOT, V37, P993, DOI 10.1007/s10295-010-0816-4; Chuang HY, 2010, ANNU REV CELL DEV BI, V26, P721, DOI 10.1146/annurev-cellbio-100109-104122; Clyde WA, 1985, MYCOPLASMA PATHOGENI, V6, P391; de Crecy E, 2007, APPL MICROBIOL BIOT, V77, P489, DOI 10.1007/s00253-007-1168-5; Epstein AK, 2012, P NATL ACAD SCI USA, V109, P13182, DOI 10.1073/pnas.1201973109; Esvelt KM, 2011, NATURE, V472, P499, DOI 10.1038/nature09929; Gilbert A, 2009, BIOTECHNOL BIOENG, V103, P500, DOI 10.1002/bit.22272; Grenier F, 2014, GENOME ANNOUNCEMENTS, V2, DOI 10.1128/genomeA.01038-14; Hoskisson PA, 2005, MICROBIOL-SGM, V151, P3153, DOI 10.1099/mic.0.27924-0; Lee KS, 2011, LAB CHIP, V11, P1730, DOI 10.1039/c1lc20019d; MARKX GH, 1991, J GEN MICROBIOL, V137, P735, DOI 10.1099/00221287-137-4-735; MARTIN GA, 1976, ARCH MICROBIOL, V107, P41, DOI 10.1007/BF00427865; MCCOY RE, 1984, INT J SYST BACTERIOL, V34, P11, DOI 10.1099/00207713-34-1-11; Miller AW, 2013, JOVE-J VIS EXP, DOI 10.3791/50262; Moffitt JR, 2012, LAB CHIP, V12, P1487, DOI 10.1039/c2lc00009a; MONOD J, 1949, ANNU REV MICROBIOL, V3, P371, DOI 10.1146/annurev.mi.03.100149.002103; MONOD J, 1950, ANN I PASTEUR PARIS, V79, P390; NOVICK A, 1950, SCIENCE, V112, P715, DOI 10.1126/science.112.2920.715; Park KD, 1998, BIOMATERIALS, V19, P851, DOI 10.1016/S0142-9612(97)00245-7; Piper MDW, 2002, J BIOL CHEM, V277, P37001, DOI 10.1074/jbc.M204490200; STEMKE GW, 1982, J CLIN MICROBIOL, V16, P959, DOI 10.1128/JCM.16.5.959-961.1982; Takahashi CN, 2015, ACS SYNTH BIOL, V4, P32, DOI 10.1021/sb500165g; Toda K, 2003, J GEN APPL MICROBIOL, V49, P219, DOI 10.2323/jgam.49.219; Tomson K, 2006, J MICROBIOL METH, V64, P380, DOI 10.1016/j.mimet.2005.05.014; Toprak E, 2013, NAT PROTOC, V8, P555, DOI [10.1038/nprot.2013.021, 10.1038/nprot.nprot.2013.021]; Winder CL, 2011, METHOD ENZYMOL, V500, P261, DOI 10.1016/B978-0-12-385118-5.00014-1; Zhang ZY, 2006, LAB CHIP, V6, P906, DOI 10.1039/b518396k	30	19	21	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0133384	10.1371/journal.pone.0133384	http://dx.doi.org/10.1371/journal.pone.0133384			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LZ	26197065	Green Published, Green Submitted, gold			2022-12-26	WOS:000358547600091
J	Matuszek, MA; Anton, A; Thillainathan, S; Armstrong, NJ				Matuszek, Maria A.; Anton, Angelyn; Thillainathan, Sobana; Armstrong, Nicola J.			Increased Insulin following an Oral Glucose Load, Genetic Variation near the Melatonin Receptor MTNR1B, but No Biochemical Evidence of Endothelial Dysfunction in Young Asian Men and Women	PLOS ONE			English	Article							FASTING PLASMA-GLUCOSE; TYPE-2 DIABETES RISK; METABOLIC SYNDROME; MENSTRUAL-CYCLE; SEX-DIFFERENCES; ADIPOSE-TISSUE; VARIANTS; RESISTANCE; ASSOCIATION; SENSITIVITY	Aim To identify biochemical and genetic variation relating to increased risk of developing type 2 diabetes mellitus and cardiovascular disease in young, lean male and female adults of different ethnicities. Method Fasting blood and urine and non-fasting blood following oral glucose intake were analysed in 90 Caucasians, South Asians and South East/East Asians. Results There were no differences in age, birthweight, blood pressure, body mass index, percent body fat, total energy, percentage of macronutrient intake, microalbumin, leptin, cortisol, adrenocorticotropic hormone, nitric oxide metabolites, C-reactive protein, homocysteine, tumor necrosis factor-alpha, interleukin-6, von Willebrand factor, vascular cell adhesion molecule-1, plasminogen activator inhibitor-1, and tissue plasminogen activator. Fasting total cholesterol (P =.000), triglycerides (P = .050), low density lipoprotein (P = .009) and non-fasting blood glucose (15 min) (P = .024) were elevated in South Asians compared with Caucasians, but there was no significant difference in glucose area under curve (AUC). Non-fasting insulin in South Asians (15-120 min), in South East/East Asians (60-120 min), and insulin AUC in South Asians and South East/East Asians, were elevated compared with Caucasians (P <= 0.006). The molar ratio of C-peptide AUC/Insulin AUC (P = .045) and adiponectin (P = .037) were lower in South Asians compared with Caucasians. A significant difference in allele frequency distributions in Caucasians and South Asians was found for rs2166706 (P = 0.022) and rs10830963 (P = 0.009), which are both near the melatonin receptor MTNR1B. Conclusions Elevated non-fasting insulin exists in young South Asians of normal fasting glucose and insulin. Hepatic clearance of insulin may be reduced in South Asians. No current biochemical evidence exists of endothelial dysfunction at this stage of development. MTNR1B signalling may be a useful therapeutic target in Asian populations in the prevention of type 2 diabetes mellitus.	[Matuszek, Maria A.; Anton, Angelyn; Thillainathan, Sobana] Univ New S Wales, Sch Med Sci, Sydney, NSW, Australia; [Armstrong, Nicola J.] Murdoch Univ, Math & Stat, Perth, WA, Australia	University of New South Wales Sydney; Murdoch University	Matuszek, MA (corresponding author), Univ New S Wales, Sch Med Sci, Sydney, NSW, Australia.	m.matuszek@unsw.edu.au	Armstrong, Nicola J./AAF-3045-2021	Armstrong, Nicola J./0000-0002-4477-293X	University of New South Wales Faculty Grant Project [PS12293]	University of New South Wales Faculty Grant Project	The author MAM received a University of New South Wales Faculty Grant Project PS12293. The funding committee had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abate N, 2004, J CLIN ENDOCR METAB, V89, P2750, DOI 10.1210/jc.2003-031843; Abate N, 2001, J DIABETES COMPLICAT, V15, P320, DOI 10.1016/S1056-8727(01)00161-1; Avogaro A, 2005, CLIN CHIM ACTA, V360, P9, DOI 10.1016/j.cccn.2005.04.020; Balletshofer BM, 2000, CIRCULATION, V101, P1780, DOI 10.1161/01.CIR.101.15.1780; Barker A, 2011, DIABETES, V60, P1805, DOI 10.2337/db10-1575; Bingley CA, 2008, HORM METAB RES, V40, P901, DOI 10.1055/s-0028-1082081; Bodhini D, 2007, METABOLISM, V56, P1174, DOI 10.1016/j.metabol.2007.04.012; Bonnefond A, 2012, NAT GENET, V44, P297, DOI 10.1038/ng.1053; Brunner H, 2005, J HYPERTENS, V23, P233, DOI 10.1097/00004872-200502000-00001; Carulli L, 2005, ALIMENT PHARM THERAP, V22, P16, DOI 10.1111/j.1365-2036.2005.02588.x; Chambers JC, 2009, DIABETES, V58, P2703, DOI 10.2337/db08-1805; Chew GT, 2006, MED J AUSTRALIA, V185, P445, DOI 10.5694/j.1326-5377.2006.tb00644.x; Chowdhury TA, 2003, BRIT MED J, V327, P1059, DOI 10.1136/bmj.327.7423.1059; Considine RV, 1996, NEW ENGL J MED, V334, P292, DOI 10.1056/NEJM199602013340503; Dickinson S, 2002, J NUTR, V132, P2574, DOI 10.1093/jn/132.9.2574; DIMSDALE JE, 1991, CIRCULATION, V83, P36; Donahue RP, 2007, DIABETES CARE, V30, P354, DOI 10.2337/dc06-1772; Dupuis J, 2010, NAT GENET, V42, P105, DOI 10.1038/ng.520; DURNIN JVGA, 1974, BRIT J NUTR, V32, P77, DOI 10.1079/BJN19740060; Elbein Steven C, 2009, J Diabetes Sci Technol, V3, P685; Endemann DH, 2004, J AM SOC NEPHROL, V15, P1983, DOI 10.1097/01.ASN.0000132474.50966.DA; Faerch K, 2010, DIABETOLOGIA, V53, P858, DOI 10.1007/s00125-010-1673-4; Faerch K, 2013, DIABETES CARE, V36, P3691, DOI 10.2337/dc13-0592; Feldstein CA, 2002, J HUM HYPERTENS, V16, pS48, DOI 10.1038/sj.jhh.1001342; Frayling TM, 2007, DIABETIC MED, V24, P696, DOI 10.1111/j.1464-5491.2007.02172.x; Gordon BA, 2009, DIABETES RES CLIN PR, V83, P157, DOI 10.1016/j.diabres.2008.11.024; Grundy SM, 2005, CIRCULATION, V112, P2735, DOI 10.1161/CIRCULATIONAHA.105.169404; Harder T, 2007, AM J EPIDEMIOL, V165, P849, DOI 10.1093/aje/kwk071; Hong KW, 2009, DIABETES RES CLIN PR, V84, P117, DOI 10.1016/j.diabres.2009.02.019; Humphries SE, 2006, J MOL MED, V84, P1005, DOI 10.1007/s00109-006-0108-7; Kalsbeek A, 2014, MOL METAB, V3, P372, DOI 10.1016/j.molmet.2014.03.002; Karamitri A, 2013, MOL ENDOCRINOL, V27, P1217, DOI 10.1210/me.2013-1101; Ko GTC, 2001, BRIT J NUTR, V85, P239, DOI 10.1079/BJN2000251; Kuriyan R, 1998, INDIAN J MED RES, V107, P37; Kurose T, 2011, J DIABETES INVEST, V2, P176, DOI 10.1111/j.2040-1124.2011.00105.x; Langenberg C, 2009, DIABETOLOGIA, V52, P1537, DOI 10.1007/s00125-009-1392-x; Lara-Castro C, 2007, CURR OPIN LIPIDOL, V18, P263, DOI 10.1097/MOL.0b013e32814a645f; Lardone PJ, 2014, CURR PHARM DESIGN, V20, P4841; Liao SY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040113; Liew CF, 2003, INT J OBESITY, V27, P784, DOI 10.1038/sj.ijo.0802307; Liu C, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-59; Liu PH, 2009, J CLIN ENDOCR METAB, V94, P3575, DOI 10.1210/jc.2009-0609; Lopez LM, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006133.pub2; Luo YY, 2009, DIABETES RES CLIN PR, V85, P139, DOI 10.1016/j.diabres.2009.04.024; Lyssenko V, 2009, NAT GENET, V41, P82, DOI 10.1038/ng.288; Marchetti P, 2012, ISLETS, V4, P323, DOI 10.4161/isl.22282; Marques RG, 2004, PANCREAS, V29, P231, DOI 10.1097/00006676-200410000-00009; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; McMullan CJ, 2013, JAMA-J AM MED ASSOC, V309, P1388, DOI 10.1001/jama.2013.2710; Meier JJ, 2007, AM J PHYSIOL-ENDOC M, V293, pE849, DOI 10.1152/ajpendo.00289.2007; Misra A, 2009, BRIT J NUTR, V101, P465, DOI 10.1017/S0007114508073649; Mohan V, 2007, INDIAN J MED RES, V125, P217; Mora MEV, 2003, J AM COLL NUTR, V22, P487, DOI 10.1080/07315724.2003.10719326; Mussig K, 2010, ANN MED, V42, P387, DOI 10.3109/07853890.2010.502125; Nagorny C, 2012, CURR DIABETES REP, V12, P667, DOI 10.1007/s11892-012-0327-y; Okamoto K, 2010, AM J HUM GENET, V86, P54, DOI 10.1016/j.ajhg.2009.12.009; Pedersen BK, 2006, SCAND J MED SCI SPOR, V16, P3, DOI 10.1111/j.1600-0838.2006.00520.x; Peschke E, 2012, J PINEAL RES, V52, P389, DOI 10.1111/j.1600-079X.2011.00951.x; Prokopenko I, 2009, NAT GENET, V41, P77, DOI 10.1038/ng.290; Pulido JME, 1999, ARCH MED RES, V30, P19, DOI 10.1016/S0188-0128(98)00008-6; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Qi L, 2008, CURR MOL MED, V8, P519, DOI 10.2174/156652408785747915; Radha V, 2007, INDIAN J MED RES, V125, P259; Rattarasarn C, 2006, ACTA PHYSIOL, V186, P87, DOI 10.1111/j.1748-1716.2005.01521.x; Rees SD, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-83; Ronn T, 2009, DIABETOLOGIA, V52, P830, DOI 10.1007/s00125-009-1297-8; Sanghera DK, 2008, BMC MED GENET, V9, DOI 10.1186/1471-2350-9-59; Sanghera DK, 2010, METABOLISM, V59, P492, DOI 10.1016/j.metabol.2009.07.043; She MH, 2014, EUR J PHARMACOL, V744, P220, DOI 10.1016/j.ejphar.2014.08.012; SHUSTER LT, 1988, DIABETES, V37, P200, DOI 10.2337/diabetes.37.2.200; Sigal RJ, 2007, ANN INTERN MED, V147, P357, DOI 10.7326/0003-4819-147-6-200709180-00005; Sigal RJ, 2006, DIABETES CARE, V29, P1433, DOI 10.2337/dc06-9910; Sluijs I, 2010, DIABETES CARE, V33, P43, DOI 10.2337/dc09-1321; Sparso T, 2009, DIABETES, V58, P1450, DOI 10.2337/db08-1660; Srinivasan V, 2013, RECENT PATENTS ENDOC, V7, P11, DOI 10.2174/187221413804660953; Staiger H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003962; Taddei S, 1996, CIRCULATION, V94, P1298, DOI 10.1161/01.CIR.94.6.1298; Takeuchi F, 2010, DIABETOLOGIA, V53, P299, DOI 10.1007/s00125-009-1595-1; Tan JT, 2010, J CLIN ENDOCR METAB, V95, P390, DOI 10.1210/jc.2009-0688; Thorand B, 2007, DIABETES CARE, V30, P854, DOI 10.2337/dc06-1693; Tosini G, 2014, BIOESSAYS, V36, P778, DOI 10.1002/bies.201400017; TOTH EL, 1987, J CLIN ENDOCR METAB, V64, P74, DOI 10.1210/jcem-64-1-74; Tuomilehto J, 2003, DIABETES CARE, V26, P1770; Twigg SM, 2007, MED J AUSTRALIA, V186, P461, DOI 10.5694/j.1326-5377.2007.tb00998.x; VALDES CT, 1991, J CLIN ENDOCR METAB, V72, P642, DOI 10.1210/jcem-72-3-642; Wahlqvist ML, 2001, ASIA PAC J CLIN NUTR, V10, P90, DOI 10.1111/j.1440-6047.2001.00228.x; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; Yajnik CS, 2009, DIABETOLOGIA, V52, P247, DOI 10.1007/s00125-008-1186-6; Zhou DZ, 2009, J HUM GENET, V54, P433, DOI 10.1038/jhg.2009.54; Zimmet P, 2005, J ATHEROSCLER THROMB, V12, P295, DOI 10.5551/jat.12.295; Zizek B, 2001, J INTERN MED, V249, P189, DOI 10.1046/j.1365-2796.2001.00794.x	91	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0133611	10.1371/journal.pone.0133611	http://dx.doi.org/10.1371/journal.pone.0133611			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LZ	26196519	Green Published, gold, Green Submitted			2022-12-26	WOS:000358547600118
J	Romer, JD; Gitelman, AI; Clements, S; Schreck, CB				Romer, Jeremy D.; Gitelman, Alix I.; Clements, Shaun; Schreck, Carl B.			Designing a Monitoring Program to Estimate Estuarine Survival of Anadromous Salmon Smolts: Simulating the Effect of Sample Design on Inference	PLOS ONE			English	Article							PACIFIC SALMON; COLUMBIA RIVER; JUVENILE SALMONIDS; BRITISH-COLUMBIA; STEELHEAD SMOLTS; CHINOOK SALMON; CONSERVATION; MIGRATION; BEHAVIOR; OREGON	A number of researchers have attempted to estimate salmonid smolt survival during outmigration through an estuary. However, it is currently unclear how the design of such studies influences the accuracy and precision of survival estimates. In this simulation study we consider four patterns of smolt survival probability in the estuary, and test the performance of several different sampling strategies for estimating estuarine survival assuming perfect detection. The four survival probability patterns each incorporate a systematic component (constant, linearly increasing, increasing and then decreasing, and two pulses) and a random component to reflect daily fluctuations in survival probability. Generally, spreading sampling effort (tagging) across the season resulted in more accurate estimates of survival. All sampling designs in this simulation tended to under-estimate the variation in the survival estimates because seasonal and daily variation in survival probability are not incorporated in the estimation procedure. This under-estimation results in poorer performance of estimates from larger samples. Thus, tagging more fish may not result in better estimates of survival if important components of variation are not accounted for. The results of our simulation incorporate survival probabilities and run distribution data from previous studies to help illustrate the tradeoffs among sampling strategies in terms of the number of tags needed and distribution of tagging effort. This information will assist researchers in developing improved monitoring programs and encourage discussion regarding issues that should be addressed prior to implementation of any telemetry-based monitoring plan. We believe implementation of an effective estuary survival monitoring program will strengthen the robustness of life cycle models used in recovery plans by providing missing data on where and how much mortality occurs in the riverine and estuarine portions of smolt migration. These data could result in better informed management decisions and assist in guidance for more effective estuarine restoration projects.	[Romer, Jeremy D.; Clements, Shaun] Oregon Dept Fish & Wildlife Fish Res, Corvallis, OR USA; [Gitelman, Alix I.] Oregon State Univ, Dept Stat, Corvallis, OR 97331 USA; [Schreck, Carl B.] Oregon State Univ, United States Geol Survey, Oregon Cooperat Fish & Wildlife Res Unit, Corvallis, OR 97331 USA	Oregon State University; Oregon State University; United States Department of the Interior; United States Geological Survey	Romer, JD (corresponding author), Oregon Dept Fish & Wildlife Fish Res, Corvallis, OR USA.	Jeremy.Romer2@oregonstate.edu		Romer, Jeremy/0000-0001-8107-2134				Adrean L, 2013, AVIAN PREDATION PROG; Allendorf FW, 1997, CONSERV BIOL, V11, P140, DOI 10.1046/j.1523-1739.1997.95248.x; American Banker, 2002, WASHINGTON COMPREHEN, V5, P1; [Anonymous], 1998, OREGON PLAN SALMON W; Brosnan IG, 2014, MAR ECOL PROG SER, V496, P181, DOI 10.3354/meps10550; Brown E, 2011, OPSWODFW201109; Brown LD, 2001, STAT SCI, V16, P101, DOI 10.1214/ss/1009213286; Buchanan RA, 2013, N AM J FISH MANAGE, V33, P216, DOI 10.1080/02755947.2012.728178; Clemens BJ, 2009, T AM FISH SOC, V138, P169, DOI 10.1577/T07-090.1; Clements S, 2012, AQUACULTURE, V362, P148, DOI 10.1016/j.aquaculture.2011.11.029; Drenner SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031311; Harnish RA, 2012, T AM FISH SOC, V141, P507, DOI 10.1080/00028487.2012.670576; JACOBS S, 2000, OPSWODFW20003; Johnson SL, 2010, N AM J FISH MANAGE, V30, P55, DOI 10.1577/M08-224.1; Lichatowich J.A., 1999, SALMON RIVERS HIST P; MEFFE GK, 1992, CONSERV BIOL, V6, P350, DOI 10.1046/j.1523-1739.1992.06030350.x; Melnychuk MC, 2007, HYDROBIOLOGIA, V582, P55, DOI 10.1007/s10750-006-0541-1; Moore ME, 2010, T AM FISH SOC, V139, P49, DOI 10.1577/T09-012.1; NEHLSEN W, 1991, FISHERIES, V16, P4, DOI 10.1577/1548-8446(1991)016&lt;0004:PSATCS&gt;2.0.CO;2; Romer JD, 2013, ENVIRON BIOL FISH, V96, P849, DOI 10.1007/s10641-012-0080-8; Slaney TL, 1996, FISHERIES, V21, P20, DOI 10.1577/1548-8446(1996)021<0020:SOASAT>2.0.CO;2; Suring E., 2012, OPSWODFW20122; Suring E, 2009, OPSWODFW20091; United States Fish and Wildlife Service (USFWS) and National Marine Fisheries Service (NMFS), 1976, LOW SNAK RIV COMP PL; Waples RS, 2008, EVOL APPL, V1, P183, DOI 10.1111/j.1752-4571.2008.00035.x; Washington Department of Fish and Wildlife, 2008, 21 CENT SALM STEELH; Welch DW, 2011, P NATL ACAD SCI USA, V108, P8708, DOI 10.1073/pnas.1014044108; Williams JG, 2005, EFFECTS FEDERAL COLU, P63; [No title captured]	29	1	1	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0132912	10.1371/journal.pone.0132912	http://dx.doi.org/10.1371/journal.pone.0132912			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LZ	26196283	gold, Green Published, Green Submitted			2022-12-26	WOS:000358547600056
J	Han, J; Bao, GS; Zhang, DQ; Gao, PC; Wu, TJ; Craig, P; Giraudoux, P; Chen, X; Xin, Q; He, LL; Chen, G; Jing, T				Han, Jian; Bao, Genshu; Zhang, Duoqiang; Gao, Pengcheng; Wu, Tinjun; Craig, Philip; Giraudoux, Patrick; Chen, Xiao; Xin, Qi; He, Lili; Chen, Gen; Jing, Tao			A Newly Discovered Epidemic Area of Echinococcus multilocularis in West Gansu Province in China	PLOS ONE			English	Article							HUMAN ALVEOLAR ECHINOCOCCOSIS; AUTONOMOUS REGION; TRANSMISSION; IDENTIFICATION; COMMUNITIES; NORTHWEST; LANDSCAPE; HOST	Alveolar echinococcosis (AE) is a lethal parasitic disease. In Gansu Province of China, all AE cases reported in literature were from Zhang and Min Counties, the southern part of the province. Here, we report the discovery of nine AE cases and one cystic echinococcosis (CE) case from Nanfeng Town of Minle County, in the middle of Hexi Corridor in west Gansu Province. The diagnosis of these cases were confirmed by serology, histopathology, computed tomography, B-ultrasound, immunohistochemistry method, DNA polymerase chain reaction and sequencing analysis. Because eight of nine AE cases came from First Zhanglianzhuang (FZLZ) village, we conducted preliminary epidemiological analyses of 730 persons on domestic water, community and ecology such as 356 dogs' faeces of FZLZ, in comparison with those of other five villages surrounding FZLZ. Our studies indicate that Nanfeng Town of Minle County is a newly discovered focus of AE in China as a CE and AE co-epidemic area. Further research of Echinococcus multilocularis transmission pattern in the area should be carried for prevention of this parasitic disease.	[Han, Jian; Bao, Genshu; Xin, Qi; He, Lili; Chen, Gen; Jing, Tao] Lanzhou Univ, Dept Pathogen Biol, Sch Basic Med Sci, Lanzhou 730000, Peoples R China; [Han, Jian; Jing, Tao] Lanzhou Univ, Res Inst Biomed Nanotechnol, Sch Basic Med Sci, Lanzhou 730000, Peoples R China; [Zhang, Duoqiang] Ningxia Peoples Hosp, Dept Hepatobiliary Surg, Yinchuan, Peoples R China; [Gao, Pengcheng] Zhangye Peoples Hosp, Dept Gen Surg, Zhangye, Peoples R China; [Wu, Tinjun] Ctr Dis Control Minle Cty, Minle, Peoples R China; [Craig, Philip] Univ Salford, Sch Environm & Life Sci, Cestode Zoonoses Res Grp, Manchester, Lancs, England; [Giraudoux, Patrick] Univ Franche Comte, Chrono Environm Lab, F-25030 Besancon, France; [Chen, Xiao] Lanzhou Univ, Hosp 2, Dept Gen Surg, Lanzhou 730000, Peoples R China	Lanzhou University; Lanzhou University; University of Manchester; University of Salford; Universite de Franche-Comte; Lanzhou University	Jing, T (corresponding author), Lanzhou Univ, Dept Pathogen Biol, Sch Basic Med Sci, Lanzhou 730000, Peoples R China.	jtao@lzu.edu.cn	EHEDE, Ecosystem health GDRI/G-1677-2016; Giraudoux, Patrick/B-9274-2011	Giraudoux, Patrick/0000-0003-2376-0136; Chen, Gen/0000-0002-5780-0901	Fundamental Research Funds for the Central Universities [lzujbky-2014-m02]	Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This study was supported by the Fundamental Research Funds for the Central Universities, Grant number: lzujbky-2014-m02, JH.	Beiromvand M, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002313; Craig P, 2003, CURR OPIN INFECT DIS, V16, P437, DOI 10.1097/00001432-200310000-00010; Craig PS, 2006, PARASITOL INT, V55, pS221, DOI 10.1016/j.parint.2005.11.034; CRAIG PS, 1992, LANCET, V340, P826, DOI 10.1016/0140-6736(92)92693-A; Craig PS, 2000, ACTA TROP, V77, P167, DOI 10.1016/S0001-706X(00)00134-0; Eckert J, 2000, INT J PARASITOL, V30, P1283, DOI 10.1016/S0020-7519(00)00130-2; Giraudoux P, 2003, PARASITOLOGY, V127, pS121, DOI 10.1017/S0031182003003512; Ito A, 1996, J HELMINTHOL, V70, P355, DOI 10.1017/S0022149X00015662; Jiang CP, 2002, CHINESE MED J-PEKING, V115, P1244; JIANG CP, 1981, CHINESE MED J-PEKING, V94, P771; Kern P, 2010, CURR OPIN INFECT DIS, V23, P505, DOI 10.1097/QCO.0b013e32833d7516; Li TY, 2008, T ROY SOC TROP MED H, V102, P585, DOI 10.1016/j.trstmh.2008.02.019; Li TY, 2010, ACTA TROP, V113, P248, DOI 10.1016/j.actatropica.2009.11.006; Li TY, 2005, EMERG INFECT DIS, V11, P1866, DOI 10.3201/eid1112.050079; Liccioli S, 2013, PARASITOL INT, V62, P355, DOI 10.1016/j.parint.2013.03.007; McManus DP, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-196; McManus DP, 2003, LANCET, V362, P1295, DOI 10.1016/S0140-6736(03)14573-4; Moro P, 2009, INT J INFECT DIS, V13, P125, DOI 10.1016/j.ijid.2008.03.037; Moss JE, 2013, PARASITOLOGY, V140, P1685, DOI 10.1017/S0031182013001200; Schneider R, 2008, INT J PARASITOL, V38, P1065, DOI 10.1016/j.ijpara.2007.11.008; Tanner F, 2006, SCHWEIZ ARCH TIERH, V148, P501, DOI 10.1024/0036-7281.148.9.501; Tappe D, 2010, ACTA TROP, V115, P167, DOI 10.1016/j.actatropica.2010.03.001; Vuitton DA, 2003, PARASITOLOGY, V127, pS87, DOI 10.1017/S0031182003004153; Wang CM, 2009, J WILDLIFE DIS, V45, P288, DOI 10.7589/0090-3558-45.2.288; Wang ZH, 2008, ECOHEALTH, V5, P115, DOI 10.1007/s10393-008-0174-0; World Health Organization, 1991, BAS LAB METH MED PAR; Yang YR, 2008, T ROY SOC TROP MED H, V102, P319, DOI 10.1016/j.trstmh.2008.01.007; Zhang WB, 2015, ACTA TROP, V141, P235, DOI 10.1016/j.actatropica.2014.03.014; Zhao Z-Y., 2010, ENDEMIC DIS B, V25, P27; Zhou HX, 2000, ANN TROP MED PARASIT, V94, P715, DOI 10.1080/00034983.2000.11813595	30	16	18	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0132731	10.1371/journal.pone.0132731	http://dx.doi.org/10.1371/journal.pone.0132731			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RV	26186219	Green Submitted, Green Published, gold			2022-12-26	WOS:000358198700058
J	Ivarsson, M; Peckmann, J; Tehler, A; Broman, C; Bach, W; Behrens, K; Reitner, J; Bottcher, ME; Ivarsson, LN				Ivarsson, Magnus; Peckmann, Joern; Tehler, Anders; Broman, Curt; Bach, Wolfgang; Behrens, Katharina; Reitner, Joachim; Boettcher, Michael E.; Ivarsson, Lena Norback			Zygomycetes in Vesicular Basanites from Vesteris Seamount, Greenland Basin - A New Type of Cryptoendolithic Fungi	PLOS ONE			English	Article							LIFE; DIVERSITY; OXIDATION; METALS; BASALT; ROCKS; GLASS	Fungi have been recognized as a frequent colonizer of subseafloor basalt but a substantial understanding of their abundance, diversity and ecological role in this environment is still lacking. Here we report fossilized cryptoendolithic fungal communities represented by mainly Zygomycetes and minor Ascomycetes in vesicles of dredged volcanic rocks (basanites) from the Vesteris Seamount in the Greenland Basin. Zygomycetes had not been reported from subseafloor basalt previously. Different stages in zygospore formation are documented in the studied samples, representing a reproduction cycle. Spore structures of both Zygomycetes and Ascomycetes are mineralized by romanechite-like Mn oxide phases, indicating an involvement in Mn(II) oxidation to form Mn(III, VI) oxides. Zygospores still exhibit a core of carbonaceous matter due to their resistance to degradation. The fungi are closely associated with fossiliferous marine sediments that have been introduced into the vesicles. At the contact to sediment infillings, fungi produced haustoria that penetrated and scavenged on the remains of fragmented marine organisms. It is most likely that such marine debris is the main carbon source for fungi in shallow volcanic rocks, which favored the establishment of vital colonies.	[Ivarsson, Magnus] Swedish Museum Nat Hist, Dept Palaeobiol, S-10405 Stockholm, Sweden; [Ivarsson, Magnus] Swedish Museum Nat Hist, Ctr Earth Evolut NordCEE, S-10405 Stockholm, Sweden; [Peckmann, Joern] Univ Vienna, Ctr Earth Sci, Dept Geodynam & Sedimentol, Vienna, Austria; [Tehler, Anders] Swedish Museum Nat Hist, Dept Bot, S-10405 Stockholm, Sweden; [Broman, Curt] Stockholm Univ, Dept Geol Sci, S-10691 Stockholm, Sweden; [Bach, Wolfgang; Behrens, Katharina] Univ Bremen, MARUM Ctr Marine Environm Sci, D-28359 Bremen, Germany; [Reitner, Joachim] Univ Gottingen, Geosci Ctr, Geobiol Grp, D-37073 Gottingen, Germany; [Boettcher, Michael E.] Leibniz Inst Balt Sea Res IOW, Dept Marine Geol, Geochem & Isotope Biogeochem Grp, Warnemunde, Germany; [Ivarsson, Lena Norback] Sodertorn Univ, Sch Nat Sci, Technol & Environm Studies, Stockholm, Sweden	Swedish Museum of Natural History; Swedish Museum of Natural History; University of Vienna; Swedish Museum of Natural History; Stockholm University; University of Bremen; University of Gottingen; Leibniz Institut fur Ostseeforschung Warnemunde; Sodertorn University	Ivarsson, M (corresponding author), Swedish Museum Nat Hist, Dept Palaeobiol, S-10405 Stockholm, Sweden.	Magnus.ivarsson@nrm.se	Bach, Wolfgang/D-3713-2017	Bach, Wolfgang/0000-0002-3099-7142; Bottcher, Michael Ernst/0000-0002-8877-0303; Peckmann, Jorn/0000-0002-8572-0060	Swedish Research Council [2012-4364]; Deutsche Forschungsgemeinschaft [BO 1583/3, PE 847/3, RE 665/25, 1144]; Danish National Research Foundation [DNRF53]	Swedish Research Council(Swedish Research CouncilEuropean Commission); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Danish National Research Foundation(Danmarks Grundforskningsfond)	This work was funded by the Swedish Research Council (Contract No. 2012-4364), the Deutsche Forschungsgemeinschaft through project BO 1583/3, PE 847/3, RE 665/25 within priority program 1144 'From Mantle to Ocean: Energy-, Material-and Lifecycles at Spreading Axes', and the Danish National Research Foundation (DNRF53).	Bengtson S, 2014, GEOBIOLOGY, V12, P489, DOI 10.1111/gbi.12100; BENNY GL, 1992, MYCOLOGIA, V84, P615, DOI 10.2307/3760372; CANFIELD DE, 1989, GEOCHIM COSMOCHIM AC, V53, P619, DOI 10.1016/0016-7037(89)90005-7; CLINE JD, 1969, LIMNOL OCEANOGR, V14, P454, DOI 10.4319/lo.1969.14.3.0454; Dellwig O, 2002, CHEM GEOL, V182, P423, DOI 10.1016/S0009-2541(01)00335-7; Downs R. T., 2006, 19 GEN M INT MIN ASS, pO03; Edwards KJ, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00008; Eickmann B, 2009, PALAEOGEOGR PALAEOCL, V283, P120, DOI 10.1016/j.palaeo.2009.09.006; Fisk M, 2013, GEOSPHERE, V9, P317, DOI 10.1130/GES00827.1; FOSSING H, 1989, BIOGEOCHEMISTRY, V8, P205; Francis CA, 2002, APPL ENVIRON MICROB, V68, P874, DOI 10.1128/AEM.68.2.874-880.2002; Gadd GM, 2007, MYCOL RES, V111, P3, DOI 10.1016/j.mycres.2006.12.001; Glass NL, 2006, MYCOTA 1 GROWTH DIFF; HAASE KM, 1994, J PETROL, V35, P295, DOI 10.1093/petrology/35.2.295; Hansel CM, 2012, P NATL ACAD SCI USA, V109, P12621, DOI 10.1073/pnas.1203885109; Henrich R., 1992, Facies, V27, P71, DOI 10.1007/BF02536805; Hibbett DS, 2007, MYCOL RES, V111, P509, DOI 10.1016/j.mycres.2007.03.004; Ivarsson M, 2012, BIOGEOSCIENCES, V9, P3625, DOI 10.5194/bg-9-3625-2012; Ivarsson M, 2013, GEO-MAR LETT, V33, P233, DOI 10.1007/s00367-013-0321-7; Ivarsson M, 2012, GEOLOGY, V40, P163, DOI 10.1130/G32590.1; James TY, 2006, NATURE, V443, P818, DOI 10.1038/nature05110; LAMPILA LE, 1985, MYCOPATHOLOGIA, V90, P65, DOI 10.1007/BF00436853; Le Maitre R. W., 1989, CLASSIFICATION IGNEO; Leipe T, 2013, CHEM ERDE-GEOCHEM, V73, P249, DOI 10.1016/j.chemer.2013.06.005; Lever MA, 2013, SCIENCE, V339, P1305, DOI 10.1126/science.1229240; Lysnes K, 2004, FEMS MICROBIOL ECOL, V50, P213, DOI 10.1016/j.femsec.2004.06.014; Mason OU, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015399; Mertz D. F., 1995, Journal of Geodynamics, V19, P79, DOI 10.1016/0264-3707(94)E0001-B; Orcutt BN, 2011, ISME J, V5, P692, DOI 10.1038/ismej.2010.157; Peckmann J, 2008, GEOBIOLOGY, V6, P125, DOI 10.1111/j.1472-4669.2007.00131.x; Reitner J., 2006, FUNGI BIOGEOCHEMICAL, P377, DOI DOI 10.1017/CBO9780511550522.017; Santelli CM, 2008, NATURE, V453, P653, DOI 10.1038/nature06899; Schulz HN, 2001, ANNU REV MICROBIOL, V55, P105, DOI 10.1146/annurev.micro.55.1.105; Schumann G, 2004, GEOMICROBIOL J, V21, P241, DOI 10.1080/01490450490438748; Staudigel H, 2008, EARTH-SCI REV, V89, P156, DOI 10.1016/j.earscirev.2008.04.005; Thiede J., 1991, Berichte zur Polarforschung, V80, P1; Thorseth IH, 2001, EARTH PLANET SC LETT, V194, P31, DOI 10.1016/S0012-821X(01)00537-4; Webster J., 2007, INTRO FUNGI, V3rd; ZAMARRENO I, 1989, AM MINERAL, V74, P1054	39	12	13	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2015	10	7							e0133368	10.1371/journal.pone.0133368	http://dx.doi.org/10.1371/journal.pone.0133368			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RQ	26181773	gold, Green Published			2022-12-26	WOS:000358198200062
J	Volkers, RJM; Snoek, LB; Ruijssenaars, HJ; de Winde, JH				Volkers, Rita J. M.; Snoek, L. Basten; Ruijssenaars, Harald J.; de Winde, Johannes H.			Dynamic Response of Pseudomonas putida S12 to Sudden Addition of Toluene and the Potential Role of the Solvent Tolerance Gene trgI	PLOS ONE			English	Article							ORGANIC-SOLVENTS; MOLECULAR CHARACTERIZATION; TRANSCRIPTIONAL REGULATOR; ESCHERICHIA-COLI; FATTY-ACID; BACTERIA; STRESS; METABOLISM; AERUGINOSA; EFFLUX	Pseudomonas putida S12 is exceptionally tolerant to various organic solvents. To obtain further insight into this bacterium's primary defence mechanisms towards these potentially harmful substances, we studied its genome wide transcriptional response to sudden addition of toluene. Global gene expression profiles were monitored for 30 minutes after toluene addition. During toluene exposure, high oxygen-affinity cytochrome c oxidase is specifically expressed to provide for an adequate proton gradient supporting solvent efflux mechanisms. Concomitantly, the glyoxylate bypass route was up-regulated, to repair an apparent toluene stress-induced redox imbalance. A knock-out mutant of trgI, a recently identified toluene-repressed gene, was investigated in order to identify TrgI function. Remarkably, upon addition of toluene the number of differentially expressed genes initially was much lower in the trgI-mutant than in the wild-type strain. This suggested that after deletion of trgI cells were better prepared for sudden organic solvent stress. Before, as well as after, addition of toluene many genes of highly diverse functions were differentially expressed in trgI-mutant cells as compared to wild-type cells. This led to the hypothesis that TrgI may not only be involved in the modulation of solvent-elicited responses but in addition may affect basal expression levels of large groups of genes.	[Volkers, Rita J. M.; Snoek, L. Basten] Wageningen Univ, Lab Nematol Plant Sci, NL-6700 AP Wageningen, Netherlands; [Ruijssenaars, Harald J.] Corbion, Gorinchem, Netherlands; [de Winde, Johannes H.] Delft Univ Technol, Fac Sci Appl, Dept Biotechnol, Delft, Netherlands; [Volkers, Rita J. M.; Ruijssenaars, Harald J.; de Winde, Johannes H.] Kluyver Ctr Genom Ind Fermentat, Delft, Netherlands	Wageningen University & Research; Delft University of Technology	de Winde, JH (corresponding author), Leiden Univ, Fac Sci, Inst Biol, Leiden, Netherlands.	j.h.de.winde@science.leidenuniv.nl	de Winde, J.H./AAC-5520-2021; Snoek, Basten L/E-4713-2014	de Winde, J.H./0000-0002-7999-9317; Snoek, Basten L/0000-0001-5321-2996	Kluyver Centre for Genomics of Industrial Fermentation; Netherlands Genomics Initiative (NGI); Corbion	Kluyver Centre for Genomics of Industrial Fermentation; Netherlands Genomics Initiative (NGI); Corbion	This research was funded by the Kluyver Centre for Genomics of Industrial Fermentation (www.kluyvercentre.nl), which is supported by the Netherlands Genomics Initiative (NGI) (www.genomics.nl). Corbion provided support in the form of a salary for author HJR, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	[Anonymous], 1982, MOL CLONING LAB MANU; Arai H, 2014, J BACTERIOL, V196, P4206, DOI 10.1128/JB.02176-14; Berg JM, 2002, BIOCHEMISTRY-US, V5th; Bernal P, 2007, ENVIRON MICROBIOL, V9, P1658, DOI 10.1111/j.1462-2920.2007.01283.x; Collet JF, 2002, MOL MICROBIOL, V44, P1, DOI 10.1046/j.1365-2958.2002.02851.x; Cray JA, 2015, CURR OPIN BIOTECH, V33, P228, DOI 10.1016/j.copbio.2015.02.010; Cray JA, 2013, ENVIRON MICROBIOL, V15, P287, DOI 10.1111/1462-2920.12018; del Castillo T, 2007, J BACTERIOL, V189, P5142, DOI 10.1128/JB.00203-07; DIRUSSO CC, 1992, J BIOL CHEM, V267, P8685; Fonseca P, 2014, INT J BIOL MACROMOL, V71, P14, DOI 10.1016/j.ijbiomac.2014.04.014; Frunzke J, 2008, MOL MICROBIOL, V67, P305, DOI 10.1111/j.1365-2958.2007.06020.x; Hall DR, 1999, EMBO J, V18, P1435, DOI 10.1093/emboj/18.6.1435; Hallsworth JE, 2003, APPL ENVIRON MICROB, V69, P7032, DOI 10.1128/AEM.69.12.7032-7034.2003; HARTMANS S, 1989, APPL ENVIRON MICROB, V55, P2850, DOI 10.1128/AEM.55.11.2850-2855.1989; He MX, 2012, BIOTECHNOL BIOFUELS, V5, DOI 10.1186/1754-6834-5-75; Heipieper HJ, 2007, APPL MICROBIOL BIOT, V74, P961, DOI 10.1007/s00253-006-0833-4; INOUE A, 1989, NATURE, V338, P264, DOI 10.1038/338264a0; Isken S, 1999, APPL ENVIRON MICROB, V65, P2631; Isken S, 1998, EXTREMOPHILES, V2, P229, DOI 10.1007/s007920050065; Kazakov AE, 2009, J BACTERIOL, V191, P52, DOI 10.1128/JB.01175-08; Kieboom J, 1998, J BACTERIOL, V180, P6769, DOI 10.1128/JB.180.24.6769-6772.1998; Kieboom J, 1998, J BIOL CHEM, V273, P85, DOI 10.1074/jbc.273.1.85; Kieboom J, 2001, MICROBIOL-SGM, V147, P43, DOI 10.1099/00221287-147-1-43; Kuepper J, 2015, J BIOTECHNOL, V200, P17, DOI 10.1016/j.jbiotec.2015.02.027; Lauchnor EG, 2011, BIOTECHNOL BIOENG, V108, P750, DOI 10.1002/bit.22999; MERCENIER A, 1980, J BACTERIOL, V144, P159, DOI 10.1128/JB.144.1.159-163.1980; Muller EEL, 2011, ENVIRON MICROBIOL, V13, P2518, DOI 10.1111/j.1462-2920.2011.02524.x; Ramos JL, 2002, ANNU REV MICROBIOL, V56, P743, DOI 10.1146/annurev.micro.56.012302.161038; Ramos JL, 2015, FEMS MICROBIOL REV; Rhee HJ, 2007, J CELL MOL MED, V11, P685, DOI 10.1111/j.1582-4934.2007.00077.x; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; SUNNARBORG A, 1990, J BACTERIOL, V172, P2642, DOI 10.1128/jb.172.5.2642-2649.1990; Swanson BL, 2000, MOL MICROBIOL, V37, P561, DOI 10.1046/j.1365-2958.2000.02012.x; Tatusov RL, 1997, SCIENCE, V278, P631, DOI 10.1126/science.278.5338.631; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Trautwein K, 2008, APPL ENVIRON MICROB, V74, P2267, DOI 10.1128/AEM.02381-07; Volkers RJM, 2006, ENVIRON MICROBIOL, V8, P1674, DOI 10.1111/j.1462-2920.2006.01056.x; Volkers RJM, 2010, ENV MICROBIOL REP, V2, P456, DOI 10.1111/j.1758-2229.2010.00172.x; Volkers RJM, 2009, EXTREMOPHILES, V13, P283, DOI 10.1007/s00792-008-0216-0; Zhang YM, 2008, NAT REV MICROBIOL, V6, P222, DOI 10.1038/nrmicro1839	40	11	12	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2015	10	7							e0132416	10.1371/journal.pone.0132416	http://dx.doi.org/10.1371/journal.pone.0132416			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RQ	26181384	Green Published, gold, Green Submitted			2022-12-26	WOS:000358198200018
J	Tashima, R; Nishimura, R; Osako, T; Nishiyama, Y; Okumura, Y; Nakano, M; Fujisue, M; Toyozumi, Y; Arima, N				Tashima, Rumiko; Nishimura, Reiki; Osako, Tomofumi; Nishiyama, Yasuyuki; Okumura, Yasuhiro; Nakano, Masahiro; Fujisue, Mamiko; Toyozumi, Yasuo; Arima, Nobuyuki			Evaluation of an Optimal Cut-Off Point for the Ki-67 Index as a Prognostic Factor in Primary Breast Cancer: A Retrospective Study	PLOS ONE			English	Article							CHEMOTHERAPY; PREDICTOR; WOMEN; KI67; RECURRENCE; EXPRESSION; FEATURES; MARKERS; HER2; P53	The Ki-67 index is an important biomarker for indicating the proliferation of cancer cells and is considered to be an effective prognostic factor for breast cancer. However, a standard cut-off point for the Ki-67 index has not yet been established. Therefore, the aim of this retrospective study was to determine an optimal cut-off point in order to establish it as a more accurate prognostic factor. Immunohistochemical analysis of the Ki-67 index was performed on 4329 patients with primary breast cancer from August 1987 to March 2012. Out of this sample, there were 3186 consecutive cases from September 1997 with simultaneous evaluations of ER, PgR and HER2 status. Cox's proportional hazard model was used to perform univariate and multivariate analyses of the factors related to OS. The hazard ratios (HR) and the p values were then compared to determine the optimal cut-off point for the Ki-67 index. The median Ki-67 index value was 20.5% (mean value 26.2%). The univariate analysis revealed that there was a statistically significant negative correlation with DFS and OS and the multivariate analysis revealed that the Ki-67 index value was a significant factor for DFS and OS. The top seven cut-off points were then carefully chosen based on the results of the univariate analysis using the lowest p-values and the highest HR as the main selection criteria. The multivariate analysis of the factors for OS showed that the cut-off point of 20% had the highest HR in all of the cases. However, the cutoff point of 20% was only a significant factor for OS in the Luminal/HER2-subtype. There was no correlation between the Ki-67 index value and OS in any of the other subtypes. These data indicate that the optimal cut-off point of 20% is the most effective prognostic factor for Luminal/HER2-breast cancer.	[Tashima, Rumiko] Kumamoto City Hosp, Surg, Kumamoto, Japan; [Nishimura, Reiki; Osako, Tomofumi; Nishiyama, Yasuyuki; Nakano, Masahiro; Fujisue, Mamiko] Kumamoto City Hosp, Breast & Endocrine Surg, Kumamoto, Japan; [Okumura, Yasuhiro; Toyozumi, Yasuo; Arima, Nobuyuki] Kumamoto City Hosp, Pathol, Kumamoto, Japan		Nishimura, R (corresponding author), Kumamoto City Hosp, Breast & Endocrine Surg, Kumamoto, Japan.	j_nishimura2002@yahoo.co.jp						Aleskandarany MA, 2010, INT J CANCER, V126, P1761, DOI 10.1002/ijc.24860; Arima N, 2013, CANC RES S, V15, P24; Cheang MCU, 2009, JNCI-J NATL CANCER I, V101, P736, DOI 10.1093/jnci/djp082; Dai HY, 2005, CANCER RES, V65, P4059, DOI 10.1158/0008-5472.CAN-04-3953; de Azambuja E, 2007, BRIT J CANCER, V96, P1504, DOI 10.1038/sj.bjc.6603756; Denkert C, 2013, ANN ONCOL, P1; Dowsett M, 2011, JNCI-J NATL CANCER I, V103, P1; Fasching PA, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-486; Finek J, 2007, ANTICANCER RES, V27, P1893; Goldhirsch A, 2013, ANN ONCOL, V24, P2206, DOI 10.1093/annonc/mdt303; Goldhirsch A, 2011, ANN ONCOL, V23, P2997; Gong P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054912; HARRELL FE, 1982, JAMA-J AM MED ASSOC, V247, P2543, DOI 10.1001/jama.247.18.2543; Harris L, 2007, J CLIN ONCOL, V25, P5287, DOI 10.1200/JCO.2007.14.2364; Honma N, 2013, BREAST CANC, V12; Kai Kazuharu, 2006, Int J Clin Oncol, V11, P426, DOI 10.1007/s10147-006-0601-6; Kikuchi S, 2013, ANTICANCER RES, V33, P3891; Nishimura R, 2013, ONCOLOGY-BASEL, V85, P100, DOI 10.1159/000353099; Nishimura R, 2011, WORLD J SURG ONCOL, V9, DOI 10.1186/1477-7819-9-131; Nishimura R, 2010, EXP THER MED, V1, P747, DOI 10.3892/etm.2010.133; Nishimura R, 2010, BREAST CANCER-TOKYO, V17, P269, DOI 10.1007/s12282-009-0161-5; Penault-Llorca F, 2009, J CLIN ONCOL, V27, P2809, DOI 10.1200/JCO.2008.18.2808; Reyal F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055901; Ruiz C, 2006, INT J CANCER, V118, P2190, DOI 10.1002/ijc.21581; Senkus E, 2013, ANN ONCOL, V24, P7, DOI 10.1093/annonc/mdt284; Taktak AFG, 2008, COMPUT BIOL MED, V38, P785, DOI 10.1016/j.compbiomed.2008.04.005; Viale G, 2008, J CLIN ONCOL, V26, P5569, DOI 10.1200/JCO.2008.17.0829; Wirapati P, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2124	28	44	47	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0119565	10.1371/journal.pone.0119565	http://dx.doi.org/10.1371/journal.pone.0119565			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26177501	Green Published, gold, Green Submitted			2022-12-26	WOS:000358197600003
J	Sorensen, TH; Cruys-Bagger, N; Borch, K; Westh, P				Sorensen, Trine Holst; Cruys-Bagger, Nicolaj; Borch, Kim; Westh, Peter			Free Energy Diagram for the Heterogeneous Enzymatic Hydrolysis of Glycosidic Bonds in Cellulose	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-PROTEIN ASSOCIATION; TRICHODERMA-REESEI; CELLOBIOHYDROLASE-I; TRANSITION-STATE; MICROCRYSTALLINE CELLULOSE; PROCESSIVE CELLULASES; TRANSLATIONAL ENTROPY; INSOLUBLE CELLULOSE; SUBSTRATE AFFINITY; ENZYMES	Kinetic and thermodynamic data have been analyzed according to transition state theory and a simplified reaction scheme for the enzymatic hydrolysis of insoluble cellulose. For the cellobiohydrolase Cel7A from Hypocrea jecorina (Trichoderma reesei), we were able to measure or collect relevant values for all stable and activated complexes defined by the reaction scheme and hence propose a free energy diagram for the full heterogeneous process. For other Cel7A enzymes, including variants with and without carbohydrate binding module (CBM), we obtained activation parameters for the association and dissociation of the enzyme-substrate complex. The results showed that the kinetics of enzyme-substrate association (i.e. formation of the Michaelis complex) was almost entirely entropy-controlled and that the activation entropy corresponded approximately to the loss of translational and rotational degrees of freedom of the dissolved enzyme. This implied that the transition state occurred early in the path where the enzyme has lost these degrees of freedom but not yet established extensive contact interactions in the binding tunnel. For dissociation, a similar analysis suggested that the transition state was late in the path where most enzyme-substrate contacts were broken. Activation enthalpies revealed that the rate of dissociation was far more temperature-sensitive than the rates of both association and the inner catalytic cycle. Comparisons of one-and two-domain variants showed that the CBM had no influence on the transition state for association but increased the free energy barrier for dissociation. Hence, the CBM appeared to promote the stability of the complex by delaying dissociation rather than accelerating association.	[Sorensen, Trine Holst; Cruys-Bagger, Nicolaj; Westh, Peter] Roskilde Univ, NSM, Res Unit Funct Biomat, DK-4000 Roskilde, Denmark; [Borch, Kim] Novozymes AS, DK-2880 Bagsvaerd, Denmark	Roskilde University; Novozymes	Westh, P (corresponding author), Roskilde Univ, NSM, Res Unit Funct Biomat, 1 Univ Svej,Bldg 28, DK-4000 Roskilde, Denmark.	pwesth@ruc.dk	Westh, Peter/AAR-9731-2021	Westh, Peter/0000-0002-6185-0637; Sorensen, Trine Holst/0000-0002-2045-7580	Danish Council for Strategic Research, Program Commission on Sustainable Energy and Environment [2104-07-0028, 11-116772]; Carlsberg Foundation [2013-01-0208]	Danish Council for Strategic Research, Program Commission on Sustainable Energy and Environment; Carlsberg Foundation(Carlsberg Foundation)	This work was supported by Danish Council for Strategic Research, Program Commission on Sustainable Energy and Environment Grants 2104-07-0028 and 11-116772 (to P. W.) and by Carlsberg Foundation Grant 2013-01-0208 (to P. W.). Novozymes is a major enzyme-producing company.	Adney WS, 2009, CELLULOSE, V16, P699, DOI 10.1007/s10570-009-9305-1; Alasepp K, 2014, LANGMUIR, V30, P7134, DOI 10.1021/la500161e; Alsallaq R, 2007, BIOPHYS J, V92, P1486, DOI 10.1529/biophysj.106.096024; Amzel LM, 1997, PROTEINS, V28, P144; Anslyn E. V., 2004, MODERN PHYS ORGANIC; Barnett CB, 2011, J AM CHEM SOC, V133, P19474, DOI 10.1021/ja206842j; Barnett CB, 2010, J AM CHEM SOC, V132, P12800, DOI 10.1021/ja103766w; Beckham GT, 2011, J PHYS CHEM B, V115, P4118, DOI 10.1021/jp1106394; Bu LT, 2011, J BIOL CHEM, V286, P18161, DOI 10.1074/jbc.M110.212076; Colussi F, 2015, J BIOL CHEM, V290, P2444, DOI 10.1074/jbc.M114.624163; Cruys-Bagger N, 2013, BIOCHEMISTRY-US, V52, P8938, DOI 10.1021/bi401210n; Cruys-Bagger N, 2013, FEBS J, V280, P3952, DOI 10.1111/febs.12397; Cruys-Bagger N, 2012, BIOTECHNOL BIOENG, V109, P3199, DOI 10.1002/bit.24593; Cruys-Bagger N, 2012, J BIOL CHEM, V287, P18451, DOI 10.1074/jbc.M111.334946; Davidson EA, 2006, NATURE, V440, P165, DOI 10.1038/nature04514; Divne C, 1998, J MOL BIOL, V275, P309, DOI 10.1006/jmbi.1997.1437; Fox JM, 2012, BIOCHEMISTRY-US, V51, P442, DOI 10.1021/bi2011543; Gelb MH, 2000, BBA-MOL CELL BIOL L, V1488, P20, DOI 10.1016/S1388-1981(00)00106-2; German DP, 2012, GLOBAL CHANGE BIOL, V18, P1468, DOI 10.1111/j.1365-2486.2011.02615.x; Gilson MK, 1997, BIOPHYS J, V72, P1047, DOI 10.1016/S0006-3495(97)78756-3; Horn SJ, 2012, METHOD ENZYMOL, V510, P69, DOI 10.1016/B978-0-12-415931-0.00005-7; Igarashi K, 2006, FEBS J, V273, P2869, DOI 10.1111/j.1742-4658.2006.05299.x; Igarashi K, 2011, SCIENCE, V333, P1279, DOI 10.1126/science.1208386; Igarashi K, 2009, J BIOL CHEM, V284, P36186, DOI 10.1074/jbc.M109.034611; Illanes A., 2013, PROBLEM SOLVING ENZY; Jalak J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108181; Jalak J, 2012, J BIOL CHEM, V287, P28802, DOI 10.1074/jbc.M112.381624; Jalak J, 2010, BIOTECHNOL BIOENG, V106, P871, DOI 10.1002/bit.22779; Jeoh T, 2008, BIOTECHNOL BIOFUELS, V1, DOI 10.1186/1754-6834-1-10; Johnson K. A., 1992, ENZYMES, V20, P1, DOI DOI 10.1016/S1874-6047(08)60019-0; Kari J, 2014, J BIOL CHEM, V289, DOI 10.1074/jbc.M114.604264; Kipper K, 2005, BIOCHEM J, V385, P527, DOI 10.1042/BJ20041144; Kirk O, 2002, CURR OPIN BIOTECH, V13, P345, DOI 10.1016/S0958-1669(02)00328-2; Knott BC, 2014, J AM CHEM SOC, V136, P8810, DOI 10.1021/ja504074g; Knott BC, 2014, J AM CHEM SOC, V136, P321, DOI 10.1021/ja410291u; Kostylev M, 2014, BIOTECHNOL BIOENG, V111, P664, DOI 10.1002/bit.25139; Kurasin M, 2011, J BIOL CHEM, V286, P169, DOI 10.1074/jbc.M110.161059; Laidler K J, 1979, Methods Enzymol, V63, P234; Li JH, 2010, J PHYS CHEM B, V114, P15261, DOI 10.1021/jp1064177; Lonhienne T, 2000, BBA-PROTEIN STRUCT M, V1543, P1, DOI 10.1016/S0167-4838(00)00210-7; Marx JC, 2007, MAR BIOTECHNOL, V9, P293, DOI 10.1007/s10126-006-6103-8; Maurer SA, 2012, IND ENG CHEM RES, V51, P11389, DOI 10.1021/ie3008538; Medve J, 1998, BIOTECHNOL BIOENG, V59, P621, DOI 10.1002/(SICI)1097-0290(19980905)59:5&lt;621::AID-BIT13&gt;3.0.CO;2-C; Medve J, 1997, APPL BIOCHEM BIOTECH, V66, P39, DOI 10.1007/BF02788806; MURPHY KP, 1994, PROTEINS, V18, P63, DOI 10.1002/prot.340180108; Murphy L, 2010, ENZYME MICROB TECH, V46, P141, DOI 10.1016/j.enzmictec.2009.09.009; Nakamura A, 2014, J AM CHEM SOC, V136, P4584, DOI 10.1021/ja4119994; PAGE MI, 1971, P NATL ACAD SCI USA, V68, P1678, DOI 10.1073/pnas.68.8.1678; Palonen H, 1999, APPL ENVIRON MICROB, V65, P5229; Payne CM, 2013, P NATL ACAD SCI USA, V110, P14646, DOI 10.1073/pnas.1309106110; Praestgaard E, 2011, FEBS J, V278, P1547, DOI 10.1111/j.1742-4658.2011.08078.x; Pu JZ, 2006, CHEM REV, V106, P3140, DOI 10.1021/cr050308e; Shang BZ, 2013, J BIOL CHEM, V288, P29081, DOI 10.1074/jbc.M113.497412; SINNOTT ML, 1990, CHEM REV, V90, P1171, DOI 10.1021/cr00105a006; Sorensen TH, 2015, J BIOL CHEM, V290, P22193, DOI 10.1074/jbc.M115.658930; STAHLBERG J, 1991, BIO-TECHNOL, V9, P286, DOI 10.1038/nbt0391-286; Tailford LE, 2008, NAT CHEM BIOL, V4, P306, DOI 10.1038/nchembio.81; Tamura A, 1997, J MOL BIOL, V273, P1048, DOI 10.1006/jmbi.1997.1368; Taylor CB, 2013, J PHYS CHEM B, V117, P4924, DOI 10.1021/jp401410h; Tewari YB, 2008, J CHEM THERMODYN, V40, P1517, DOI 10.1016/j.jct.2008.05.015; Vijayakumar M, 1998, J MOL BIOL, V278, P1015, DOI 10.1006/jmbi.1998.1747; Vocadlo DJ, 2008, CURR OPIN CHEM BIOL, V12, P539, DOI 10.1016/j.cbpa.2008.05.010; von Ossowski I, 2003, J MOL BIOL, V333, P817, DOI 10.1016/S0022-2836(03)00881-7; WEBER JP, 1980, J BIOL CHEM, V255, P9030; Wicki J, 2007, J AM CHEM SOC, V129, P4530, DOI 10.1021/ja0707254; Wilson DB, 2012, APPL MICROBIOL BIOT, V93, P497, DOI 10.1007/s00253-011-3701-9; Wilson DB, 2009, CURR OPIN BIOTECH, V20, P295, DOI 10.1016/j.copbio.2009.05.007; Withers SG, 2001, CARBOHYD POLYM, V44, P325, DOI 10.1016/S0144-8617(00)00249-6; YAMAMOTO K, 1974, J BIOCHEM-TOKYO, V76, P385, DOI 10.1093/oxfordjournals.jbchem.a130580; Yan SH, 2011, J PHYS CHEM B, V115, P4982, DOI 10.1021/jp200384m; Zakariassen H, 2010, CARBOHYD POLYM, V81, P14, DOI 10.1016/j.carbpol.2010.01.048	71	24	24	2	35	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	2015	290	36					22203	22211		10.1074/jbc.M115.659656	http://dx.doi.org/10.1074/jbc.M115.659656			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CQ9XI	26183776	hybrid, Green Published			2022-12-26	WOS:000360968500037
J	Zuo, RJ; Gu, XW; Qi, QR; Wang, TS; Zhao, XY; Liu, JL; Yang, ZM				Zuo, Ru-Juan; Gu, Xiao-Wei; Qi, Qian-Rong; Wang, Tong-Song; Zhao, Xu-Yu; Liu, Ji-Long; Yang, Zeng-Ming			Warburg-like Glycolysis and Lactate Shuttle in Mouse Decidua during Early Pregnancy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						carbohydrate metabolism; glycolysis; pregnancy; reproduction; Warburg effect; Warburg-like glycolysis; lactate flux; decidualization; Hif1; progesterone	PYRUVATE-KINASE M2; GLUCOSE TRANSPORTERS; HUMAN ENDOMETRIUM; RECEPTOR-ALPHA; EXPRESSION; UTERUS; DECIDUALIZATION; PROGESTERONE; METABOLISM; ESTROGEN	Background: Carbohydrate metabolism during decidualization is unknown. Results: Decidual cells undergo glycolysis upon progesterone signals, and the undifferentiated stromal cells consume lactate for proliferation. Inhibition of glycolysis or lactate flux could compromise decidual development. Conclusion: Warburg-like glycolysis and lactate communication play critical roles during decidualization. Significance: Our study will be valuable for understanding the mechanism underlying decidualization. Decidualization is an essential process of maternal endometrial stromal cells to support pregnancy. Although it is known that enhanced glucose influx is critical for decidualization, the underlying mechanism in regulating glucose metabolism in decidua remains insufficiently understood. Here, we demonstrate that aerobic glycolysis-related genes and factors are all substantially induced during decidualization, indicating the existence of Warburg-like glycolysis in decidua. In vitro, progesterone activates hypoxia-inducible factor 1 (Hif1) and c-Myc through Pi3k-Akt signaling pathway to maintain aerobic glycolysis in decidualizing cells. Knocking down of pyruvate kinase M2 (Pkm2) attenuates the induction of decidual marker gene. Decidual formation in vivo is also impaired by glycolysis inhibitor 3-bromopyruvate. Besides, lactate exporter monocarboxylate transporter 4 (Mct4) is induced in newly formed decidual cells, whereas lactate importer Mct1 and proliferation marker Ki-67 are complementarily located in the surrounding undifferentiated cells, which are supposed to consume lactate for proliferation. Hif1 activation is required for lactate-dependent proliferation of the undifferentiated cells. Inhibition of lactate flux leads to compromised decidualization and decelerated lactate-dependent proliferation. In summary, we reveal that Warburg-like glycolysis and local lactate shuttle are activated in decidua and play important roles for supporting early pregnancy.	[Zuo, Ru-Juan; Liu, Ji-Long; Yang, Zeng-Ming] South China Agr Univ, Coll Vet Med, Guangzhou 510642, Guangdong, Peoples R China; [Gu, Xiao-Wei; Qi, Qian-Rong; Wang, Tong-Song; Zhao, Xu-Yu] Shantou Univ, Dept Biol, Shantou 515063, Peoples R China	South China Agricultural University; Shantou University	Yang, ZM (corresponding author), South China Agr Univ, Coll Vet Med, Guangzhou 510642, Guangdong, Peoples R China.	zmyang@scau.edu.cn	Qi, Qian-Rong/AAV-7553-2020	Qi, Qian-Rong/0000-0003-0276-7187; Liu, Ji-Long/0000-0002-6948-2576; Zuo, Rujuan/0000-0003-3060-2179; Yang, Zeng-Ming/0000-0001-6775-0082	National Basic Research Program of China [2011CB944402, 2013CB910803]; National Natural Science Foundation of China [31271602, 31471397, 31272263]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Basic Research Program of China Grants 2011CB944402 and 2013CB910803) and National Natural Science Foundation of China (Grants 31271602, 31471397 and 31272263). The authors declare that they have no conflicts of interest with the contents of this article.	Bombail V, 2010, J CLIN ENDOCR METAB, V95, pE224, DOI 10.1210/jc.2010-0154; Cardaci S, 2012, CANCER RES, V72, P4526, DOI 10.1158/0008-5472.CAN-12-1741; Cha JY, 2012, NAT MED, V18, P1754, DOI 10.1038/nm.3012; Christofk HR, 2008, NATURE, V452, P230, DOI 10.1038/nature06734; Christofk HR, 2008, NATURE, V452, P181, DOI 10.1038/nature06667; Daikoku T, 2003, J BIOL CHEM, V278, P7683, DOI 10.1074/jbc.M211390200; Das A, 2009, P NATL ACAD SCI USA, V106, P12542, DOI 10.1073/pnas.0901647106; David CJ, 2010, NATURE, V463, P364, DOI 10.1038/nature08697; Del Prete E, 2004, PHYSIOL BEHAV, V80, P489, DOI 10.1016/j.physbeh.2003.10.007; Doherty JR, 2013, J CLIN INVEST, V123, P3685, DOI 10.1172/JCI69741; Frolova A, 2009, ENDOCRINOLOGY, V150, P1512, DOI 10.1210/en.2008-1081; Frolova AI, 2011, MOL ENDOCRINOL, V25, P1444, DOI 10.1210/me.2011-0026; Frolova AI, 2011, REPRODUCTION, V142, P211, DOI 10.1530/REP-11-0114; Frolova AI, 2011, ENDOCRINOLOGY, V152, P2123, DOI 10.1210/en.2010-1266; Gatenby RA, 2004, NAT REV CANCER, V4, P891, DOI 10.1038/nrc1478; HACKL H, 1973, ACTA OBSTET GYN SCAN, V52, P135, DOI 10.3109/00016347309158301; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hirschhaeuser F, 2011, CANCER RES, V71, P6921, DOI 10.1158/0008-5472.CAN-11-1457; Hitosugi T, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000431; Jansen S, 2008, BIOL REPROD, V79, P84, DOI 10.1095/biolreprod.107.066811; Jiang P, 2011, NAT CELL BIOL, V13, P310, DOI 10.1038/ncb2172; Kaplon J, 2013, NATURE, V498, P109, DOI 10.1038/nature12154; Kim JY, 2009, J CLIN ENDOCR METAB, V94, P1416, DOI 10.1210/jc.2008-1612; Kim ST, 2009, BIOL REPROD, V81, P188, DOI 10.1095/biolreprod.108.072629; Kommagani R, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003900; Lei W, 2012, J BIOL CHEM, V287, P15174, DOI 10.1074/jbc.M111.308023; Li QX, 2011, SCIENCE, V331, P912, DOI 10.1126/science.1197454; Lu HS, 2002, J BIOL CHEM, V277, P23111, DOI 10.1074/jbc.M202487200; Mathupala SP, 2009, SEMIN CANCER BIOL, V19, P17, DOI 10.1016/j.semcancer.2008.11.006; MURDOCH RN, 1987, TERATOLOGY, V35, P169, DOI 10.1002/tera.1420350202; RODESCH F, 1992, OBSTET GYNECOL, V80, P283; Salama SA, 2014, J CLIN ENDOCR METAB, V99, P3790, DOI 10.1210/jc.2013-2639; Semenza GL, 2010, CURR OPIN GENET DEV, V20, P51, DOI 10.1016/j.gde.2009.10.009; Sonveaux P, 2008, J CLIN INVEST, V118, P3930, DOI 10.1172/JCI36843; SURAN MAH, 1971, ACTA ENDOCRINOL-COP, V68, P805, DOI 10.1530/acta.0.0680805; Ullah MS, 2006, J BIOL CHEM, V281, P9030, DOI 10.1074/jbc.M511397200; Vegran F, 2011, CANCER RES, V71, P2550, DOI 10.1158/0008-5472.CAN-10-2828; von Wolff M, 2003, J CLIN ENDOCR METAB, V88, P3885, DOI 10.1210/jc.2002-021890; Wang HB, 2006, NAT REV GENET, V7, P185, DOI 10.1038/nrg1808; Wang HJ, 2014, P NATL ACAD SCI USA, V111, P279, DOI 10.1073/pnas.1311249111; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309	41	67	69	2	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	2015	290	35					21280	21291		10.1074/jbc.M115.656629	http://dx.doi.org/10.1074/jbc.M115.656629			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CQ5IS	26178372	Green Published, hybrid			2022-12-26	WOS:000360637600008
J	Cai, XB; Hu, X; Tan, XJ; Cheng, WJ; Wang, QJ; Chen, XF; Guan, YH; Chen, C; Jing, XB				Cai, Xianbin; Hu, Xi; Tan, Xiaojun; Cheng, Weijie; Wang, Qinjia; Chen, Xiaofeng; Guan, Yinghong; Chen, Chong; Jing, Xubin			Metformin Induced AMPK Activation, G0/G1 Phase Cell Cycle Arrest and the Inhibition of Growth of Esophageal Squamous Cell Carcinomas In Vitro and In Vivo	PLOS ONE			English	Article							PROTEIN-KINASE; CANCER-CELLS; PROLIFERATION; CISPLATIN; ANGIOGENESIS; INDUCTION; APOPTOSIS; PROSTATE; LIVER	Esophageal squamous cell carcinomas (ESCC) have become a severe threat to health and the current treatments for ESCC are frequently not effective. Recent epidemiological studies suggest that the anti-hyperglycemic agent metformin may reduce the risk of developing cancer, including ESCC, among diabetic patients. However, the antitumor effects of metformin on ESCC and the mechanisms underlying its cell cycle regulation remain elusive. The findings reported herein show that the anti-proliferative action of metformin on ESCC cell lines is partially mediated by AMPK. Moreover, we observed that metformin induced G0/G1 phase arrest accompanied by the up-regulation of p21(CIP1) and p27(KIP1). In vivo experiments further showed that metformin inhibited tumor growth in a ESCC xenograft model. Most importantly, the up-regulation of AMPK, p53, p21(CIP1), p27(KIP1) and the down-regulation of cyclinD1 are involved in the anti-tumor action of metformin in vivo. In conclusion, metformin inhibits the growth of ESCC cells both in cell cultures and in an animal model. AMPK, p53, p21(CIP1), p27(KIP1) and cyclinD1 are involved in the inhibition of tumor growth that is induced by metformin and cell cycle arrest in ESCC. These findings indicate that metformin has the potential for use in the treatment of ESCC.	[Cai, Xianbin; Hu, Xi; Cheng, Weijie; Wang, Qinjia; Chen, Xiaofeng; Guan, Yinghong; Chen, Chong; Jing, Xubin] Shantou Univ, Affiliated Hosp 1, Coll Med, Dept Gastroenterol, Shantou 515031, Guangdong, Peoples R China; [Tan, Xiaojun] Chancheng Dist Cent Hosp, Dept Internal Med, Foshan 528031, Guangdong, Peoples R China	Shantou University	Jing, XB (corresponding author), Shantou Univ, Affiliated Hosp 1, Coll Med, Dept Gastroenterol, Shantou 515031, Guangdong, Peoples R China.	xbjing@stu.edu.cn	tan, xiao/GZL-0264-2022		National Natural Science Foundation of China [81172263]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Natural Science Foundation of China (81172263).	BALDIN V, 1993, GENE DEV, V7, P812, DOI 10.1101/gad.7.5.812; Baron JA, 2011, CANCER CAUSE CONTROL, V12, P875; Ben Sahra I, 2011, CANCER RES, V71, P4366, DOI 10.1158/0008-5472.CAN-10-1769; Bhalla K, 2012, CANCER PREV RES, V5, P544, DOI 10.1158/1940-6207.CAPR-11-0228; Chen HP, 2013, GUT, V62, P606, DOI 10.1136/gutjnl-2011-301708; Deng XK, 2014, J MED FOOD, V17, P787, DOI 10.1089/jmf.2013.2886; Foretz M, 2010, J CLIN INVEST, V120, P2355, DOI 10.1172/JCI40671; Gartel AL, 2002, MOL CANCER THER, V1, P639; Hirst J, 2011, ANN SURG ONCOL, V18, P1766, DOI 10.1245/s10434-010-1508-z; Hung CM, 2012, J AGR FOOD CHEM, V60, P8427, DOI 10.1021/jf302754w; Jones RG, 2005, MOL CELL, V18, P283, DOI 10.1016/j.molcel.2005.03.027; Kato K, 2012, MOL CANCER THER, V11, P549, DOI 10.1158/1535-7163.MCT-11-0594; Kim HJ, 2010, J AGR FOOD CHEM, V58, P8643, DOI 10.1021/jf101510z; Kobayashi M, 2013, INT J ONCOL, V42, P517, DOI 10.3892/ijo.2012.1722; Komninou D, 2003, EXP BIOL MED, V228, P396, DOI 10.1177/153537020322800410; Lee MS, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-20; Luo H, 2012, FOOD CHEM, V130, P321, DOI 10.1016/j.foodchem.2011.07.045; Luo ZJ, 2010, FUTURE ONCOL, V6, P457, DOI 10.2217/FON.09.174; Memmott RM, 2011, CANCER PREV RES, V3, P1066; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Qu Z, 2012, HEPATOL RES, V42, P922, DOI 10.1111/j.1872-034X.2012.01007.x; Rattan R, 2011, NEOPLASIA, V13, P483, DOI 10.1593/neo.11148; Ravi R, 2000, GENE DEV, V14, P34; Schneider MB, 2001, GASTROENTEROLOGY, V120, P1263, DOI 10.1053/gast.2001.23258; Shi P, 2010, J CELL MOL MED, V14, P1777, DOI 10.1111/j.1582-4934.2009.00795.x; Song HY, 2014, EXP THER MED, V8, P1484, DOI 10.3892/etm.2014.1972; Towler MC, 2007, CIRC RES, V100, P328, DOI 10.1161/01.RES.0000256090.42690.05; TOYOSHIMA H, 1994, CELL, V78, P67, DOI 10.1016/0092-8674(94)90573-8; Vermeulen K, 2003, CELL PROLIFERAT, V36, P165, DOI 10.1046/j.1365-2184.2003.00267.x; Wu H, 2014, PAK J PHARM SCI, V27, P1661; Xavier DO, 2010, BIOMED PHARMACOTHER, V64, P220, DOI 10.1016/j.biopha.2009.08.004; Xiao H, 2010, CARDIOVASC RES, V87, P504, DOI 10.1093/cvr/cvq066; Yu L, 2014, CANCER LETT, V355, P34, DOI 10.1016/j.canlet.2014.09.020; Zakikhani M, 2008, CANCER PREV RES, V1, P369, DOI 10.1158/1940-6207.CAPR-08-0081; Zhuang Yongxian, 2008, J Mol Signal, V3, P18, DOI 10.1186/1750-2187-3-18; Zu XY, 2013, MOLECULES, V18, P1704, DOI 10.3390/molecules18021704	36	64	70	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0133349	10.1371/journal.pone.0133349	http://dx.doi.org/10.1371/journal.pone.0133349			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LZ	26196392	Green Published, gold, Green Submitted			2022-12-26	WOS:000358547600087
J	Cheong, HT; Chow, WZ; Takebe, Y; Chook, JB; Chan, KG; Al-Darraji, HAA; Koh, C; Kamarulzaman, A; Tee, KK				Cheong, Hui Ting; Chow, Wei Zhen; Takebe, Yutaka; Chook, Jack Bee; Chan, Kok Gan; Al-Darraji, Haider Abdulrazzaq Abed; Koh, Clayton; Kamarulzaman, Adeeba; Tee, Kok Keng			Genetic Characterization of a Novel HIV-1 Circulating Recombinant Form (CRF74_01B) Identified among Intravenous Drug Users in Malaysia: Recombination History and Phylogenetic Linkage with Previously Defined Recombinant Lineages	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1	In many parts of Southeast Asia, the HIV-1 epidemic has been driven by the sharing of needles and equipment among intravenous drug users (IDUs). Over the last few decades, many studies have proven time and again that the diversity of HIV-1 epidemics can often be linked to the route of infection transmission. That said, the diversity and complexity of HIV-1 molecular epidemics in the region have been increasing at an alarming rate, due in part to the high tendency of the viral RNA to recombine. This scenario was exemplified by the discovery of numerous circulating recombinant forms (CRFs), especially in Thailand and Malaysia. In this study, we characterized a novel CRF designated CRF74_01B, which was identified in six epidemiologically unlinked IDUs in Kuala Lumpur, Malaysia. The near-full length genomes were composed of CRF01_AE and subtype B', with eight breakpoints dispersed in the gag-pol and nef regions. Remarkably, this CRF shared four and two recombination hotspots with the previously described CRF33_01B and the less prevalent CRF53_01B, respectively. Genealogy-based Bayesian phylogenetic analysis of CRF74_01B genomic regions showed that it is closely related to both CRF33_01B and CRF53_01B. This observation suggests that CRF74_01B was probably a direct descendent from specific lineages of CRF33_01B, CRF53_01B and subtype B' that could have emerged in the mid-1990s. Additionally, it illustrated the active recombination processes between prevalent HIV-1 subtypes and recombinants in Malaysia. In summary, we report a novel HIV-1 genotype designated CRF74_01B among IDUs in Kuala Lumpur, Malaysia. The characterization of the novel CRF74_01B is of considerable significance towards the understanding of the genetic diversity and population dynamics of HIV-1 circulating in the region.	[Cheong, Hui Ting; Chow, Wei Zhen; Takebe, Yutaka; Chook, Jack Bee; Al-Darraji, Haider Abdulrazzaq Abed; Koh, Clayton; Kamarulzaman, Adeeba; Tee, Kok Keng] Univ Malaya, Fac Med, Ctr Excellence Res AIDS CERiA, Dept Med, Kuala Lumpur, Malaysia; [Takebe, Yutaka] Natl Inst Infect Dis, AIDS Res Ctr, Shinjuku Ku, Tokyo 1628640, Japan; [Takebe, Yutaka] Yokohama City Univ, Sch Med, Yokohama, Kanagawa 232, Japan; [Chan, Kok Gan] Univ Malaya, Fac Sci, Inst Biol Sci, Div Genet & Mol Biol, Kuala Lumpur, Malaysia	Universiti Malaya; National Institute of Infectious Diseases (NIID); Yokohama City University; Universiti Malaya	Tee, KK (corresponding author), Univ Malaya, Fac Med, Ctr Excellence Res AIDS CERiA, Dept Med, Kuala Lumpur, Malaysia.	k2tee@um.edu.my	Chan, Kok Gan/B-8347-2010; Al-Darraji, Haider Abdulrazzaq Abed/B-7978-2012; KAMARULZAMAN, ADEEBA/B-5216-2010; Tee, Kok Keng/A-8148-2008	Chan, Kok Gan/0000-0002-1883-1115; Al-Darraji, Haider Abdulrazzaq Abed/0000-0003-2576-3218; Tee, Kok Keng/0000-0002-7923-5448	Ministry of Education, Malaysia: High Impact Research [H-500001-00-A000012-000001]	Ministry of Education, Malaysia: High Impact Research	The work was supported by grants from the Ministry of Education, Malaysia: High Impact Research H-500001-00-A000012-000001 to KKT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abecasis AB, 2007, J VIROL, V81, P8543, DOI 10.1128/JVI.00463-07; Chen JHK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012198; Cheong HT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111236; Chow WZ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085250; Chow WZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062560; Chow WZ, 2012, J VIROL, V86, P11398, DOI 10.1128/JVI.01932-12; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Frost SDW, 2015, EPIDEMICS-NETH, V10, P88, DOI 10.1016/j.epidem.2014.09.001; Hemelaar J, 2011, AIDS, V25, P679, DOI 10.1097/QAD.0b013e328342ff93; Kijak GH, 2013, J VIROL, V87, P7265, DOI 10.1128/JVI.03070-12; Lemey P, 2006, AIDS REV, V8, P125; Li Y, 2010, JAIDS-J ACQ IMM DEF, V54, P129, DOI 10.1097/QAI.0b013e3181d82ce5; Liu YJ, 2012, AIDS RES HUM RETROV, V28, P1357, DOI 10.1089/aid.2011.0376; Lole KS, 1999, J VIROL, V73, P152, DOI 10.1128/JVI.73.1.152-160.1999; McCutchan FE, 2002, AIDS RES HUM RETROV, V18, P1135, DOI 10.1089/088922202320567879; Ng KT, 2012, J VIROL, V86, P11405, DOI 10.1128/JVI.01949-12; Robertson DL, 2000, SCIENCE, V288, P55, DOI 10.1126/science.288.5463.55d; SALMINEN MO, 1995, AIDS RES HUM RETROV, V11, P1423, DOI 10.1089/aid.1995.11.1423; Swofford DL., 2003, PAUP PHYLOGENETIC AN; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tee KK, 2006, JAIDS-J ACQ IMM DEF, V43, P523; Tee KK, 2009, VIROLOGY, V387, P229, DOI 10.1016/j.virol.2009.02.020	22	12	13	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0133883	10.1371/journal.pone.0133883	http://dx.doi.org/10.1371/journal.pone.0133883			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LZ	26196131	gold, Green Submitted, Green Published			2022-12-26	WOS:000358547600145
J	Ehler, M; Dobrosotskaya, J; Cunningham, D; Wong, WT; Chew, EY; Czaja, W; Bonner, RF				Ehler, Martin; Dobrosotskaya, Julia; Cunningham, Denise; Wong, Wai T.; Chew, Emily Y.; Czaja, Wojtek; Bonner, Robert F.			Modeling Photo-Bleaching Kinetics to Create High Resolution Maps of Rod Rhodopsin in the Human Retina	PLOS ONE			English	Article							FUNDUS AUTOFLUORESCENCE; DARK-ADAPTATION; MACULAR PIGMENT; GEOGRAPHIC ATROPHY; BLOOD-VESSELS; IMAGES; SEGMENTATION; RECOVERY; DENSITY; LIGHT	We introduce and describe a novel non-invasive in-vivo method for mapping local rod rhodopsin distribution in the human retina over a 30-degree field. Our approach is based on analyzing the brightening of detected lipofuscin autofluorescence within small pixel clusters in registered imaging sequences taken with a commercial 488nm confocal scanning laser ophthalmoscope (cSLO) over a 1 minute period. We modeled the kinetics of rhodopsin bleaching by applying variational optimization techniques from applied mathematics. The physical model and the numerical analysis with its implementation are outlined in detail. This new technique enables the creation of spatial maps of the retinal rhodopsin and retinal pigment epithelium (RPE) bisretinoid distribution with an approximate to 50 mu m resolution.	[Ehler, Martin] Univ Vienna, Fac Math, Vienna, Austria; [Dobrosotskaya, Julia] Case Western Reserve Univ, Dept Math Appl Math & Stat, Cleveland, OH 44106 USA; [Cunningham, Denise] NEI, Off Clin Director, NIH, Bethesda, MD 20892 USA; [Wong, Wai T.] NEI, Unit Neuron Glia Interact, NIH, Bethesda, MD 20892 USA; [Chew, Emily Y.] NEI, Div Epidemiol & Clin Applicat, NIH, Bethesda, MD 20892 USA; [Czaja, Wojtek] Univ Maryland, Dept Math, College Pk, MD 20742 USA; [Bonner, Robert F.] NICHHD, Sect Med Biophys, NIH, Bethesda, MD 20892 USA	University of Vienna; Case Western Reserve University; National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); University System of Maryland; University of Maryland College Park; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Ehler, M (corresponding author), Univ Vienna, Fac Math, Vienna, Austria.	martin.ehler@univie.ac.at	Wong, Wai/B-6118-2017; Bonner, Robert/GQO-9087-2022	Wong, Wai/0000-0003-0681-4016; 	National Institute of Child Health and Human Development/National Institutes of Health; Research Career Transition Awards Program of National Institutes of Health; German Science Foundation [EH 405/1-1/575910]; National Science Foundation [CBET 0854233]; Defense Threat Reduction Agency [HDTRA 1-13-1-0015]; Vienna Science and Technology Fund [VRG12-009]; NATIONAL EYE INSTITUTE [ZIAEY000489, ZIAEY000485] Funding Source: NIH RePORTER	National Institute of Child Health and Human Development/National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Research Career Transition Awards Program of National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); German Science Foundation(German Research Foundation (DFG)); National Science Foundation(National Science Foundation (NSF)); Defense Threat Reduction Agency(United States Department of DefenseDefense Threat Reduction Agency); Vienna Science and Technology Fund; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This material is based upon work supported in part by intramural research funds from the National Institute of Child Health and Human Development/National Institutes of Health, the Research Career Transition Awards Program of the National Institutes of Health and the German Science Foundation under Grant EH 405/1-1/575910, the National Science Foundation under Grant CBET 0854233, the Defense Threat Reduction Agency under Grant HDTRA 1-13-1-0015, and the Vienna Science and Technology Fund under Grant VRG12-009. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALPERN M, 1974, J PHYSIOL-LONDON, V237, P341, DOI 10.1113/jphysiol.1974.sp010485; ALPERN M, 1971, J PHYSIOL-LONDON, V217, P447, DOI 10.1113/jphysiol.1971.sp009580; Bedggood P, 2012, INVEST OPHTH VIS SCI, V53, P3673, DOI 10.1167/iovs.11-8796; Benedetto J. J., 2013, INT J GEOMATHEMATICS, V4, P137, DOI DOI 10.1007/S13137-013-0052-Y; Bernstein PS, 2010, VISION RES, V50, P716, DOI 10.1016/j.visres.2009.10.014; Bertalmio M, 2003, IEEE T IMAGE PROCESS, V12, P882, DOI 10.1109/TIP.2003.815261; BIRD AEC, 1995, SURV OPHTHALMOL, V39, P367, DOI 10.1016/S0039-6257(05)80092-X; Bone RA, 2007, VISION RES, V47, P3259, DOI 10.1016/j.visres.2007.09.002; Burns ME, 2009, BIOPHYS J, V97, P1538, DOI 10.1016/j.bpj.2009.06.037; Cai JF, 2008, APPL COMPUT HARMON A, V24, P131, DOI 10.1016/j.acha.2007.10.002; Cameron AM, 2008, J PHYSIOL-LONDON, V586, P5419, DOI 10.1113/jphysiol.2008.160028; Chan TF, 2002, SIAM J APPL MATH, V62, P1019, DOI 10.1137/S0036139900368844; Chan TF, 2006, J MATH IMAGING VIS, V25, P107, DOI 10.1007/s10851-006-5257-3; Cunningham D, 2007, J OPHTHALMIC PHOTO S, V29, P93; Curcio CA, 2001, EYE, V15, P376, DOI 10.1038/eye.2001.140; CURCIO CA, 1993, INVEST OPHTH VIS SCI, V34, P3278; CURCIO CA, 1990, J COMP NEUROL, V292, P497, DOI 10.1002/cne.902920402; Czaja W, 2013, IEEE T PATTERN ANAL, V35, P1274, DOI 10.1109/TPAMI.2012.270; Delori FC, 2006, J OPT SOC AM A, V23, P521, DOI 10.1364/JOSAA.23.000521; Delori FC, 2001, J OPT SOC AM A, V18, P1212, DOI 10.1364/JOSAA.18.001212; Dobrosotskaya J, 2010, IFMBE PROC, V32, P361, DOI 10.1007/978-3-642-14998-6_92; Dobrosotskaya J, 2011, SPIE MED IMAGING, V7962; Dobrosotskaya JA, 2008, IEEE T IMAGE PROCESS, V17, P657, DOI 10.1109/TIP.2008.919367; Ehler M., 2011, IEEE INT C COMP ADV, P93; Ehler M, 2011, SPIE MED IMAGING, V7963; Ehler M, 2010, IFMBE PROC, V32, P344, DOI 10.1007/978-3-642-14998-6_88; Elad M, 2005, APPL COMPUT HARMON A, V19, P340, DOI 10.1016/j.acha.2005.03.005; Fawzi AA, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3640813; FEENEYBURNS L, 1987, INVEST OPHTH VIS SCI, V28, P1138; Fornasier M, 2006, J MATH IMAGING VIS, V24, P359, DOI 10.1007/s10851-006-4242-1; Fornasier M, 2009, ADV COMPUT MATH, V31, P157, DOI 10.1007/s10444-008-9103-6; Galic I, 2008, J MATH IMAGING VIS, V31, P255, DOI 10.1007/s10851-008-0087-0; Gang L, 2002, IEEE T BIO-MED ENG, V49, P168, DOI 10.1109/10.979356; GLOSTER J, 1964, Br J Ophthalmol, V48, P260, DOI 10.1136/bjo.48.5.260; Gross OG, 2012, IN PRESS BIOPHYSICAL; Grossauer H, 2003, LECT NOTES COMPUT SC, V2695, P225; Holz FG, 1999, GRAEF ARCH CLIN EXP, V237, P145, DOI 10.1007/s004170050209; Holz FG, 2007, AM J OPHTHALMOL, V143, P463, DOI 10.1016/j.ajo.2006.11.041; Hoover A, 2000, IEEE T MED IMAGING, V19, P203, DOI 10.1109/42.845178; Kainerstorfer JM, 2011, BIOMED OPT EXPRESS, V2, P1040, DOI 10.1364/BOE.2.001040; Kainerstorfer JM, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3470094; Kainerstorfer JM, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3463010; Krause M, 2012, TECHNICAL REPORT, P320; Lamb TD, 2004, PROG RETIN EYE RES, V23, P307, DOI 10.1016/j.preteyeres.2004.03.001; Lamb TD, 2006, INVEST OPHTH VIS SCI, V47, P5138, DOI 10.1167/iovs.06-0849; LeVeque RJ, 2007, OTHER TITL APPL MATH, V98, P1, DOI 10.1137/1.9780898717839; Lowell J, 2004, IEEE T MED IMAGING, V23, P1196, DOI 10.1109/TMI.2004.830524; Lyubarsky AL, 2004, VISION RES, V44, P3235, DOI 10.1016/j.visres.2004.09.019; Mahroo OAR, 2004, J PHYSIOL-LONDON, V554, P417, DOI 10.1113/jphysiol.2003.051250; Mendonca AM, 2006, IEEE T MED IMAGING, V25, P1200, DOI 10.1109/TMI.2006.879955; Meyers Sanford M, 2004, Trans Am Ophthalmol Soc, V102, P83; Morgan JIW, 2013, INVEST OPHTH VIS SCI, V54, P2048, DOI 10.1167/iovs.12-11089; Morgan JW, 2009, INVEST OPHTHALMOL VI, V50; Naarendorp F, 2010, J NEUROSCI, V30, P12495, DOI 10.1523/JNEUROSCI.2186-10.2010; Ricci E, 2007, IEEE T MED IMAGING, V26, P1357, DOI 10.1109/TMI.2007.898551; RIPPS H, 1969, J PHYSIOL-LONDON, V200, P151, DOI 10.1113/jphysiol.1969.sp008686; RUDIN LI, 1992, PHYSICA D, V60, P259, DOI 10.1016/0167-2789(92)90242-F; RUSHTON WAH, 1968, VISION RES, V8, P617, DOI 10.1016/0042-6989(68)90040-0; RUSHTON WAH, 1972, VISION RES, V12, P1073, DOI 10.1016/0042-6989(72)90098-3; Sandberg MA, 1996, INVEST OPHTH VIS SCI, V37, P1693; Soares JVB, 2006, IEEE T MED IMAGING, V25, P1214, DOI 10.1109/TMI.2006.879967; Sparrow JR, 2010, INVEST OPHTH VIS SCI, V51, P4351, DOI 10.1167/iovs.10-5852; Teschke G, 2007, INVERSE PROBL, V23, P1851, DOI 10.1088/0266-5611/23/5/005; Theelen T, 2008, EXP EYE RES, V86, P296, DOI 10.1016/j.exer.2007.10.022; Thomas MM, 1999, J PHYSIOL-LONDON, V518, P479, DOI 10.1111/j.1469-7793.1999.0479p.x; Tornow RP, 1998, ACTA ANAT, V162, P163; Vermeer KA, 2004, COMPUT BIOL MED, V34, P209, DOI 10.1016/S0010-4825(03)00055-6; Wang L, 2007, IEEE T MED IMAGING, V26, P137, DOI 10.1109/TMI.2006.889732; Weickert J, 2006, VISUALIZATION AND PROCESSING OF TENSOR FIELDS, P315, DOI 10.1007/3-540-31272-2_19	69	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0131881	10.1371/journal.pone.0131881	http://dx.doi.org/10.1371/journal.pone.0131881			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LZ	26196397	gold, Green Published, Green Submitted			2022-12-26	WOS:000358547600017
J	Kita, Y; Yoshida, K; Tokuoka, SM; Hamano, F; Yamazaki, M; Sakimura, K; Kano, M; Shimizu, T				Kita, Yoshihiro; Yoshida, Kenij; Tokuoka, Suzumi M.; Hamano, Fumie; Yamazaki, Maya; Sakimura, Kenji; Kano, Masanobu; Shimizu, Takao			Fever Is Mediated by Conversion of Endocannabinoid 2-Arachidonoylglycerol to Prostaglandin E-2	PLOS ONE			English	Article							CYTOSOLIC PHOSPHOLIPASE A(2); BRAIN ENDOTHELIAL-CELLS; FEBRILE RESPONSE; HUMAN-PLATELETS; RECEPTORS; LIPASE; LIPOPOLYSACCHARIDE; SUPPRESSION; HYDROLYSIS; MICE	Fever is a common response to inflammation and infection. The mechanism involves prostaglandin E-2 (PGE(2))-EP3 receptor signaling in the hypothalamus, which raises the set point of hypothalamic thermostat for body temperature, but the lipid metabolic pathway for pyretic PGE(2) production remains unknown. To reveal the molecular basis of fever initiation, we examined lipopolysaccharides (LPS)-induced fever model in monoacylglycerol lipase (MGL)-deficient (Mgll(-/-)) mice, CB1 receptor-MGL compound-deficient (Cnr1(-/-)Mgll(-/-)) mice, cytosolic phospholipase A(2)alpha (cPLA(2)alpha)-deficient (Pla2g4a(-/-)) mice, and diacylglycerol lipase alpha (DGL alpha)-deficient (Dagla(-/-)) mice. Febrile reactions were abolished in Mgll(-/-) and Cnr1(-/-)Mgll(-/-) mice, whereas Cnr1(-/-)Mgll(+/+), Pla2g4a(-/-) and Dagla(-/-) mice responded normally, demonstrating that MGL is a critical enzyme for fever, which functions independently of endocannabinoid signals. Intracerebroventricular administration of PGE(2) caused fever similarly in Mgll(-/-) and wild-type control mice, suggesting a lack of pyretic PGE(2) production in Mgll(-/-) hypothalamus, which was confirmed by lipidomics analysis. Normal blood cytokine responses after LPS administration suggested that MGL-deficiency does not affect pyretic cytokine productions. Diurnal body temperature profiles were normal in Mgll(-/-) mice, demonstrating that MGL is unrelated to physiological thermoregulation. In conclusion, MGL-dependent hydrolysis of endocannabinoid 2-arachidonoylglycerol is necessary for pyretic PGE(2) production in the hypothalamus.	[Kita, Yoshihiro; Yoshida, Kenij; Tokuoka, Suzumi M.; Hamano, Fumie; Shimizu, Takao] Univ Tokyo, Grad Sch Med, Dept Lipid, Bunkyo Ku, Tokyo, Japan; [Kita, Yoshihiro; Hamano, Fumie] Univ Tokyo, Grad Sch Med, Life Sci Core Facil, Bunkyo Ku, Tokyo, Japan; [Yamazaki, Maya; Sakimura, Kenji] Niigata Univ, Brain Res Inst, Dept Cellular Neurobiol, Niigata, Niigata, Japan; [Kano, Masanobu] Univ Tokyo, Grad Sch Med, Dept Neurophysiol, Bunkyo Ku, Tokyo, Japan; [Shimizu, Takao] Natl Ctr Global Hlth & Med, Res Inst, Dept Lipid Signaling, Shinjuku Ku, Tokyo, Japan	University of Tokyo; University of Tokyo; Niigata University; University of Tokyo; National Center for Global Health & Medicine - Japan	Kita, Y (corresponding author), Univ Tokyo, Grad Sch Med, Dept Lipid, Bunkyo Ku, Tokyo, Japan.	kita@m.u-tokyo.ac.jp	Shimizu, Takao/AAV-7052-2021; Yamazaki, Maya/C-6952-2012	Kano, Masanobu/0000-0002-0725-3292	MEXT KAKENHI [23790356, 25116707, 21220006, 25000015, 24229003]; Tokyo Society of Medical Sciences, Japan; Takeda Science Foundation; Ono Pharmaceutical Co., LTD. (Osaka, Japan); Shimadzu Corp. (Kyoto, Japan)	MEXT KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Tokyo Society of Medical Sciences, Japan; Takeda Science Foundation(Takeda Science Foundation (TSF)); Ono Pharmaceutical Co., LTD. (Osaka, Japan); Shimadzu Corp. (Kyoto, Japan)	This work was supported by MEXT KAKENHI Grant Numbers 23790356, 25116707 (to Y.K.), 21220006, 25000015 (to M.K.), and 24229003 (to T.S.), a grant from the Tokyo Society of Medical Sciences, Japan (to Y.K.), and Takeda Science Foundation (to T.S.). Department of Lipidomics, Graduate School of Medicine, The University of Tokyo, is funded in part by Ono Pharmaceutical Co., LTD. (Osaka, Japan) and Shimadzu Corp. (Kyoto, Japan). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BELL RL, 1979, P NATL ACAD SCI USA, V76, P3238, DOI 10.1073/pnas.76.7.3238; Cabanac M, 2006, J APPL PHYSIOL, V100, P1338, DOI 10.1152/japplphysiol.01021.2005; Engblom D, 2003, NAT NEUROSCI, V6, P1137, DOI 10.1038/nn1137; Engstrom L, 2012, ENDOCRINOLOGY, V153, P4849, DOI 10.1210/en.2012-1375; Hanada R, 2009, NATURE, V462, P505, DOI 10.1038/nature08596; Kawai T, 2011, IMMUNITY, V34, P637, DOI 10.1016/j.immuni.2011.05.006; Kita Y, 2005, ANAL BIOCHEM, V342, P134, DOI 10.1016/j.ab.2005.03.048; Kluger MJ, 1998, ANN NY ACAD SCI, V856, P224, DOI 10.1111/j.1749-6632.1998.tb08329.x; Lazarus M, 2007, NAT NEUROSCI, V10, P1131, DOI 10.1038/nn1949; Li S, 1999, BRAIN RES, V825, P86, DOI 10.1016/S0006-8993(99)01225-1; Li ZH, 2006, AM J PHYSIOL-REG I, V290, pR1262, DOI 10.1152/ajpregu.00724.2005; Lovegrove BG, 2009, J COMP PHYSIOL B, V179, P451, DOI 10.1007/s00360-008-0329-x; Netea MG, 2000, CLIN INFECT DIS, V31, pS178, DOI 10.1086/317513; Nomura DK, 2011, SCIENCE, V334, P809, DOI 10.1126/science.1209200; Plaisance KI, 2000, CLIN INFECT DIS, V31, pS219, DOI 10.1086/317518; PRESCOTT SM, 1983, J BIOL CHEM, V258, P764; Ridder DA, 2011, J EXP MED, V208, P2615, DOI 10.1084/jem.20110398; Savinainen JR, 2012, ACTA PHYSIOL, V204, P267, DOI 10.1111/j.1748-1716.2011.02280.x; Schlosburg JE, 2010, NAT NEUROSCI, V13, P1113, DOI 10.1038/nn.2616; Shimizu T, 2006, IUBMB LIFE, V58, P328, DOI 10.1080/15216540600702289; Steiner AA, 2006, PLOS BIOL, V4, P1517, DOI 10.1371/journal.pbio.0040284; Sugimoto Y, 2007, J BIOL CHEM, V282, P11613, DOI 10.1074/jbc.R600038200; Tanimura A, 2012, P NATL ACAD SCI USA, V109, P12195, DOI 10.1073/pnas.1204404109; Tanimura A, 2010, NEURON, V65, P320, DOI 10.1016/j.neuron.2010.01.021; Uchigashima M, 2011, J NEUROSCI, V31, P7700, DOI 10.1523/JNEUROSCI.5665-10.2011; Uozumi N, 1997, NATURE, V390, P618, DOI 10.1038/37622; Ushikubi F, 1998, NATURE, V395, P281, DOI 10.1038/26233	27	23	24	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0133663	10.1371/journal.pone.0133663	http://dx.doi.org/10.1371/journal.pone.0133663			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LZ	26196692	gold, Green Submitted, Green Published			2022-12-26	WOS:000358547600129
J	Shemesh, N; Alvarez, GA; Frydman, L				Shemesh, Noam; Alvarez, Gonzalo A.; Frydman, Lucio			Size Distribution Imaging by Non-Uniform Oscillating-Gradient Spin Echo (NOGSE) MRI	PLOS ONE			English	Article							AXON DIAMETER DISTRIBUTION; DIFFUSION; NMR; MATTER; LENGTH; BRAIN; ARCHITECTURE; ANISOTROPY; SYSTEMS; DENSITY	Objects making up complex porous systems in Nature usually span a range of sizes. These size distributions play fundamental roles in defining the physicochemical, biophysical and physiological properties of a wide variety of systems - ranging from advanced catalytic materials to Central Nervous System diseases. Accurate and noninvasive measurements of size distributions in opaque, three-dimensional objects, have thus remained long-standing and important challenges. Herein we describe how a recently introduced diffusion-based magnetic resonance methodology, Non-Uniform-Oscillating-Gradient-Spin-Echo (NOGSE), can determine such distributions noninvasively. The method relies on its ability to probe confining lengths with a (length) 6 parametric sensitivity, in a constant-time, constant-number-of-gradients fashion; combined, these attributes provide sufficient sensitivity for characterizing the underlying distributions in mu m-scaled cellular systems. Theoretical derivations and simulations are presented to verify NOGSE's ability to faithfully reconstruct size distributions through suitable modeling of their distribution parameters. Experiments in yeast cell suspensions - where the ground truth can be determined from ancillary microscopy - corroborate these trends experimentally. Finally, by appending to the NOGSE protocol an imaging acquisition, novel MRI maps of cellular size distributions were collected from a mouse brain. The ensuing micro-architectural contrasts successfully delineated distinctive hallmark anatomical sub-structures, in both white matter and gray matter tissues, in a non-invasive manner. Such findings highlight NOGSE's potential for characterizing aberrations in cellular size distributions upon disease, or during normal processes such as development.	[Shemesh, Noam; Alvarez, Gonzalo A.; Frydman, Lucio] Weizmann Inst Sci, Dept Chem Phys, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Frydman, L (corresponding author), Weizmann Inst Sci, Dept Chem Phys, IL-76100 Rehovot, Israel.	lucio.frydman@weizmann.ac.il	Shemesh, Noam/GPK-7972-2022; Alvarez, Gonzalo A/B-2329-2010	Alvarez, Gonzalo A/0000-0002-7328-357X; Shemesh, Noam/0000-0001-6681-5876	Israel Science Foundation [ISF 1142/13]; Helen and Martin Kimmel Award for Innovative Investigation; Perlman Family Foundation; Weizmann Institute; European Commission under the Marie Curie Intra-European Fellowship for Career Development [PIEF-GA-2012-328605]	Israel Science Foundation(Israel Science Foundation); Helen and Martin Kimmel Award for Innovative Investigation; Perlman Family Foundation; Weizmann Institute; European Commission under the Marie Curie Intra-European Fellowship for Career Development	This work was supported by the Israel Science Foundation grant ISF 1142/13, Helen and Martin Kimmel Award for Innovative Investigation, and Perlman Family Foundation. NS acknowledges a Dean's Fellowship of the Weizmann Institute; GAA acknowledges the support of the European Commission under the Marie Curie Intra-European Fellowship for Career Development Grant No. PIEF-GA-2012-328605. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABOITIZ F, 1992, BRAIN RES, V598, P143, DOI 10.1016/0006-8993(92)90178-C; Aggarwal M, 2012, MAGN RESON MED, V67, P98, DOI 10.1002/mrm.22981; Alexander DC, 2010, NEUROIMAGE, V52, P1374, DOI 10.1016/j.neuroimage.2010.05.043; Altamura C, 2007, CEREB CORTEX, V17, P1394, DOI 10.1093/cercor/bhl051; Alvarez GA, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.080404; Ambrosone L, 2004, J PHYS CHEM B, V108, P18472, DOI 10.1021/jp046480o; Assaf Y, 2005, NEUROIMAGE, V27, P48, DOI 10.1016/j.neuroimage.2005.03.042; Assaf Y, 2008, MAGN RESON MED, V59, P1347, DOI 10.1002/mrm.21577; Barazany D, 2009, BRAIN, V132, P1210, DOI 10.1093/brain/awp042; Beaulieu C, 2002, NMR BIOMED, V15, P435, DOI 10.1002/nbm.782; Budde MD, 2010, P NATL ACAD SCI USA, V107, P14472, DOI 10.1073/pnas.1004841107; CALLAGHAN PT, 1991, NATURE, V351, P467, DOI 10.1038/351467a0; CALLAGHAN PT, 1995, J MAGN RESON SER A, V117, P118, DOI 10.1006/jmra.1995.9959; Caminiti R, 2013, J NEUROSCI, V33, P14501, DOI 10.1523/JNEUROSCI.0761-13.2013; Caminiti R, 2009, P NATL ACAD SCI USA, V106, P19551, DOI 10.1073/pnas.0907655106; CORY DG, 1990, MAGNET RESON MED, V14, P435, DOI 10.1002/mrm.1910140303; Cruz L, 2004, P NATL ACAD SCI USA, V101, P15846, DOI 10.1073/pnas.0407002101; CULLHEIM S, 1978, NEUROSCI LETT, V8, P17, DOI 10.1016/0304-3940(78)90090-3; DeLuca GC, 2004, BRAIN, V127, P1009, DOI 10.1093/brain/awh118; Drobnjak I, 2010, J MAGN RESON, V206, P41, DOI 10.1016/j.jmr.2010.05.017; Evangelou N, 2001, BRAIN, V124, P1813, DOI 10.1093/brain/124.9.1813; Gore JC, 2010, NMR BIOMED, V23, P745, DOI 10.1002/nbm.1531; Hagemann G, 2003, NEUROSCIENCE, V117, P991, DOI 10.1016/S0306-4522(02)00959-4; Innocenti GM, 2011, PROG BRAIN RES, V189, P65, DOI 10.1016/B978-0-444-53884-0.00018-X; Innocenti GM, 2013, CORTEX IN PRESS; JohansenBerg H, 2009, DIFFUSION MRI: FROM QUANTITATIVE MEASUREMENT TO IN VIVO NEUROANATOMY, P1; Kang SH, 2013, NAT NEUROSCI, V16, P571, DOI 10.1038/nn.3357; KLAUDER JR, 1962, PHYS REV, V125, P912, DOI 10.1103/PhysRev.125.912; Latt J, 2007, IEEE T MED IMAGING, V26, P1437, DOI 10.1109/TMI.2007.907278; Lai WS, 2006, P NATL ACAD SCI USA, V103, P16906, DOI 10.1073/pnas.0604994103; Lasic S, 2006, J MAGN RESON, V182, P208, DOI 10.1016/j.jmr.2006.06.030; LAWSON SN, 1979, J NEUROCYTOL, V8, P275, DOI 10.1007/BF01236123; Le Bihan D, 2003, NAT REV NEUROSCI, V4, P469, DOI 10.1038/nrn1119; Lovas G, 2000, BRAIN, V123, P308, DOI 10.1093/brain/123.2.308; Mitchell S, 2012, NAT CHEM, V4, P825, DOI [10.1038/NCHEM.1403, 10.1038/nchem.1403]; MOSELEY ME, 1990, MAGN RESON MED, V14, P330, DOI 10.1002/mrm.1910140218; Ozarslan E, 2011, NEW J PHYS, V13, DOI 10.1088/1367-2630/13/1/015010; Ong HH, 2008, NEUROIMAGE, V40, P1619, DOI 10.1016/j.neuroimage.2008.01.017; Pajevic S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054095; Panagiotaki E, 2012, NEUROIMAGE, V59, P2241, DOI 10.1016/j.neuroimage.2011.09.081; Park Y, 2010, P NATL ACAD SCI USA, V107, P6731, DOI 10.1073/pnas.0909533107; Perge JA, 2012, J NEUROSCI, V32, P626, DOI 10.1523/JNEUROSCI.4254-11.2012; Shemesh N, 2013, J MAGN RESON, V237, P49, DOI 10.1016/j.jmr.2013.09.009; Shemesh N, 2012, MAGN RESON MED, V68, P794, DOI 10.1002/mrm.23300; Shemesh N, 2012, NMR BIOMED, V25, P236, DOI 10.1002/nbm.1737; Shemesh N, 2011, J AM CHEM SOC, V133, P6028, DOI 10.1021/ja200303h; Shemesh N, 2011, MAGN RESON MED, V65, P1216, DOI 10.1002/mrm.22738; Shemesh N, 2010, J CHEM PHYS, V132, DOI 10.1063/1.3285299; Siow B, 2012, J MAGN RESON, V214, P51, DOI 10.1016/j.jmr.2011.10.004; Smith PES, 2012, P NATL ACAD SCI USA, V109, P5958, DOI 10.1073/pnas.1120704109; Stepanyants A, 2002, NEURON, V34, P275, DOI 10.1016/S0896-6273(02)00652-9; Stepisnik J, 1999, PHYSICA B, V270, P110, DOI 10.1016/S0921-4526(99)00160-X; STEPISNIK J, 1993, PHYSICA B, V183, P343, DOI 10.1016/0921-4526(93)90124-O; Stepisnik J, 2006, J MAGN RESON, V182, P195, DOI 10.1016/j.jmr.2006.06.023; Tzur A, 2009, SCIENCE, V325, P167, DOI 10.1126/science.1174294; Uhrig GS, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.100504	56	27	27	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0133201	10.1371/journal.pone.0133201	http://dx.doi.org/10.1371/journal.pone.0133201			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LZ	26197220	Green Submitted, gold, Green Published			2022-12-26	WOS:000358547600072
J	Spampinato, SF; Obermeier, B; Cotleur, A; Love, A; Takeshita, Y; Sano, Y; Kanda, T; Ransohoff, RM				Spampinato, Simona F.; Obermeier, Birgit; Cotleur, Anne; Love, Anna; Takeshita, Yukio; Sano, Yasuteru; Kanda, Takashi; Ransohoff, Richard M.			Sphingosine 1 Phosphate at the Blood Brain Barrier: Can the Modulation of S1P Receptor 1 Influence the Response of Endothelial Cells and Astrocytes to Inflammatory Stimuli?	PLOS ONE			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; CENTRAL-NERVOUS-SYSTEM; MULTIPLE-SCLEROSIS PATHOGENESIS; GM-CSF; SPHINGOSINE-1-PHOSPHATE RECEPTOR-2; 1-PHOSPHATE RECEPTOR-1; REACTIVE ASTROCYTES; LYMPHOCYTE EGRESS; GROWTH-FACTOR; IN-VIVO	The ability of the Blood Brain Barrier (BBB) to maintain proper barrier functions, keeping an optimal environment for central nervous system (CNS) activity and regulating leukocytes' access, can be affected in CNS diseases. Endothelial cells and astrocytes are the principal BBB cellular constituents and their interaction is essential to maintain its function. Both endothelial cells and astrocytes express the receptors for the bioactive sphingolipid S1P. Fingolimod, an immune modulatory drug whose structure is similar to S1P, has been approved for treatment in multiple sclerosis (MS): fingolimod reduces the rate of MS relapses by preventing leukocyte egress from the lymph nodes. Here, we examined the ability of S1P and fingolimod to act on the BBB, using an in vitro co-culture model that allowed us to investigate the effects of S1P on endothelial cells, astrocytes, and interactions between the two. Acting selectively on endothelial cells, S1P receptor signaling reduced cell death induced by inflammatory cytokines. When acting on astrocytes, fingolimod treatment induced the release of a factor, granulocyte macrophage colony-stimulating factor (GM-CSF) that reduced the effects of cytokines on endothelium. In an in vitro BBB model incorporating shear stress, S1P receptor modulation reduced leukocyte migration across the endothelial barrier, indicating a novel mechanism that might contribute to fingolimod efficacy in MS treatment.	[Spampinato, Simona F.; Obermeier, Birgit; Cotleur, Anne; Love, Anna; Takeshita, Yukio; Ransohoff, Richard M.] Cleveland Clin, Dept Neurosci, Lerner Res Inst, Neuroinflammat Res Ctr, Cleveland, OH 44106 USA; [Sano, Yasuteru; Kanda, Takashi] Yamaguchi Univ, Grad Sch Med, Dept Neurol & Clin Neurosci, Ube, Yamaguchi 755, Japan	Cleveland Clinic Foundation; Yamaguchi University	Ransohoff, RM (corresponding author), Biogen, Neuroimmunol Res, Cambridge, MA 02142 USA.	richard.ransohoff@biogen.com	Spampinato, Simona Federica/AAJ-8087-2020; Love, Anna/GWN-0733-2022	Spampinato, Simona Federica/0000-0001-7564-1986; Love, Anna/0000-0001-5657-2858	Novartis funding [CFTY7220DUSNC10T]	Novartis funding	The study was supported by Novartis funding #CFTY7220DUSNC10T. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABBASI T, 2013, HDB EXP PHARM, V216, P201, DOI DOI 10.1007/978-3-7091-1511-4_; Abbott NJ, 2006, NAT REV NEUROSCI, V7, P41, DOI 10.1038/nrn1824; Alvarez JI, 2013, GLIA, V61, P1939, DOI 10.1002/glia.22575; Bazzoni G, 2004, PHYSIOL REV, V84, P869, DOI 10.1152/physrev.00035.2003; Bigaud M, 2014, BBA-MOL CELL BIOL L, V1841, P745, DOI 10.1016/j.bbalip.2013.11.001; Brana C, 2014, NEUROPATH APPL NEURO, V40, P564, DOI 10.1111/nan.12048; Brinkmann V, 2002, J BIOL CHEM, V277, P21453, DOI 10.1074/jbc.C200176200; Brinkmann V, 2004, AM J TRANSPLANT, V4, P1019, DOI 10.1111/j.1600-6143.2004.00476.x; Brinkmann V, 2010, NAT REV DRUG DISCOV, V9, P883, DOI 10.1038/nrd3248; Choi JW, 2011, P NATL ACAD SCI USA, V108, P751, DOI 10.1073/pnas.1014154108; Codarri L, 2011, NAT IMMUNOL, V12, P560, DOI 10.1038/ni.2027; Cohen JA, 2011, ANN NEUROL, V69, P759, DOI 10.1002/ana.22426; Colombo E, 2014, ANN NEUROL, V76, P325, DOI 10.1002/ana.24217; COOMBER BL, 1986, ANAT REC, V215, P256, DOI 10.1002/ar.1092150308; Cruz-Orengo L, 2014, J CLIN INVEST, V124, P2571, DOI 10.1172/JCI73408; Du J, 2012, PATHOL RES PRACT, V208, P82, DOI 10.1016/j.prp.2011.11.008; Engelhardt B, 2012, TRENDS IMMUNOL, V33, P579, DOI 10.1016/j.it.2012.07.004; Fischer I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023905; Foster CA, 2009, BRAIN PATHOL, V19, P254, DOI 10.1111/j.1750-3639.2008.00182.x; Fujino M, 2003, J PHARMACOL EXP THER, V305, P70, DOI 10.1124/jpet.102.045658; Furukawa A, 2007, MOL CELL BIOCHEM, V305, P27, DOI 10.1007/s11010-007-9524-4; Gaengel K, 2012, DEV CELL, V23, P587, DOI 10.1016/j.devcel.2012.08.005; Galicia-Rosas G, 2012, J IMMUNOL, V189, P3700, DOI 10.4049/jimmunol.1102261; Garcia JGN, 2001, J CLIN INVEST, V108, P689, DOI 10.1172/JCI12450; Haruki H, 2013, J NEUROL SCI, V331, P136, DOI 10.1016/j.jns.2013.05.035; HLA T, 1990, J BIOL CHEM, V265, P9308; Kimura A, 2007, STEM CELLS, V25, P115, DOI 10.1634/stemcells.2006-0223; Kono M, 2004, J BIOL CHEM, V279, P29367, DOI 10.1074/jbc.M403937200; Kooij G, 2011, BRAIN, V134, P555, DOI 10.1093/brain/awq330; Lassmann H, 2012, NAT REV NEUROL, V8, P647, DOI 10.1038/nrneurol.2012.168; Lee MJ, 1999, CELL, V99, P301, DOI 10.1016/S0092-8674(00)81661-X; Maceyka M, 2012, TRENDS CELL BIOL, V22, P50, DOI 10.1016/j.tcb.2011.09.003; Mahad D, 2006, BRAIN, V129, P212, DOI 10.1093/brain/awh655; McGeachy MJ, 2011, NAT IMMUNOL, V12, P521, DOI 10.1038/ni.2044; McVerry BJ, 2004, J CELL BIOCHEM, V92, P1075, DOI 10.1002/jcb.20088; Mizee MR, 2014, ACTA NEUROPATHOL, V128, P691, DOI 10.1007/s00401-014-1335-6; Mortha A, 2014, SCIENCE, V343, P1477, DOI 10.1126/science.1249288; Mullershausen F, 2009, NAT CHEM BIOL, V5, P428, DOI 10.1038/nchembio.173; Murata N, 2000, BIOCHEM J, V352, P809, DOI 10.1042/0264-6021:3520809; Nair A, 2008, CELL MOL LIFE SCI, V65, P2702, DOI 10.1007/s00018-008-8059-5; Nishihara H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121488; Obermeier B, 2013, NAT MED, V19, P1584, DOI 10.1038/nm.3407; Oo ML, 2007, J BIOL CHEM, V282, P9082, DOI 10.1074/jbc.M610318200; Pebay A, 2001, EUR J NEUROSCI, V13, P2067, DOI 10.1046/j.0953-816x.2001.01585.x; Prager B, 2015, TRENDS MOL MED, V21, P354, DOI 10.1016/j.molmed.2015.03.006; Quancard J, 2012, CHEM BIOL, V19, P1142, DOI 10.1016/j.chembiol.2012.07.016; Ransohoff RM, 2012, NAT REV IMMUNOL, V12, P623, DOI 10.1038/nri3265; Rosen H, 2014, CURR TOP MICROBIOL, V378, P1, DOI 10.1007/978-3-319-05879-5_1; Rutherford C, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.455; Sanchez T, 2007, ARTERIOSCL THROM VAS, V27, P1312, DOI 10.1161/ATVBAHA.107.143735; Sanna MG, 2006, NAT CHEM BIOL, V2, P434, DOI 10.1038/nchembio804; Sano Y, 2010, J CELL PHYSIOL, V225, P519, DOI 10.1002/jcp.22232; Sato K, 1999, MOL BRAIN RES, V74, P182, DOI 10.1016/S0169-328X(99)00279-X; Schabitz WR, 2008, J CEREBR BLOOD F MET, V28, P29, DOI 10.1038/sj.jcbfm.9600496; Singleton PA, 2005, FASEB J, V19, P1646, DOI 10.1096/fj.05-3928com; Takeshita Y, 2014, J NEUROSCI METH, V232, P165, DOI 10.1016/j.jneumeth.2014.05.013; Teitelbaum D, 1996, J NEUROIMMUNOL, V64, P209, DOI 10.1016/0165-5728(95)00180-8; Tisato V., 2013, MEDIAT INFLAMM, V2013, DOI DOI 10.1155/2013/561689; van Doorn R, 2012, ACTA NEUROPATHOL, V124, P397, DOI 10.1007/s00401-012-1014-4; Van Doorn R, 2010, GLIA, V58, P1465, DOI 10.1002/glia.21021; Webb M, 2004, J NEUROIMMUNOL, V153, P108, DOI 10.1016/j.jneuroim.2004.04.015; YEDNOCK TA, 1992, NATURE, V356, P63, DOI 10.1038/356063a0; Zhan YF, 2012, MOL IMMUNOL, V52, P30, DOI 10.1016/j.molimm.2012.04.009; Zhang WL, 2013, PROSTAG OTH LIPID M, V106, P62, DOI 10.1016/j.prostaglandins.2013.06.001	64	52	53	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0133392	10.1371/journal.pone.0133392	http://dx.doi.org/10.1371/journal.pone.0133392			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LZ	26197437	gold, Green Published, Green Submitted			2022-12-26	WOS:000358547600093
J	Sun, PF; Sun, CK; Li, WQ; Wang, P				Sun, Pengfei; Sun, Changku; Li, Wenqiang; Wang, Peng			A New Pose Estimation Algorithm Using a Perspective-Ray-Based Scaled Orthographic Projection with Iteration	PLOS ONE			English	Article							ACCURATE; OBJECT; MODEL	Pose estimation aims at measuring the position and orientation of a calibrated camera using known image features. The pinhole model is the dominant camera model in this field. However, the imaging precision of this model is not accurate enough for an advanced pose estimation algorithm. In this paper, a new camera model, called incident ray tracking model, is introduced. More importantly, an advanced pose estimation algorithm based on the perspective ray in the new camera model, is proposed. The perspective ray, determined by two positioning points, is an abstract mathematical equivalent of the incident ray. In the proposed pose estimation algorithm, called perspective-ray-based scaled orthographic projection with iteration (PRSOI), an approximate ray-based projection is calculated by a linear system and refined by iteration. Experiments on the PRSOI have been conducted, and the results demonstrate that it is of high accuracy in the six degrees of freedom (DOF) motion. And it outperforms three other state-of-the-art algorithms in terms of accuracy during the contrast experiment.	[Sun, Pengfei; Sun, Changku; Li, Wenqiang; Wang, Peng] Tianjin Univ, State Key Lab Precis Measuring Technol & Instrume, Tianjin 300072, Peoples R China; [Li, Wenqiang; Wang, Peng] Luoyang Inst Electroopt Equipment, Sci & Technol Electroopt Control Lab, Luoyang, Peoples R China	Tianjin University	Wang, P (corresponding author), Tianjin Univ, State Key Lab Precis Measuring Technol & Instrume, Tianjin 300072, Peoples R China.	wang_peng@tju.edu.cn	SUN, CHANG/GXM-3680-2022		National Natural Science Foundation of China [51375339]; Aviation Science Foundation of China [20135148004]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Aviation Science Foundation of China	This work is supported by the National Natural Science Foundation of China (No. 51375339), http://www.nsfc.gov.cn/. This work is also supported by the Aviation Science Foundation of China (No. 20135148004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bertok K, 2011, ROBUST HEAD POSE ESI; Borui Li, 2012, 2012 Third International Conference on Intelligent Control and Information Processing (ICICIP 2012), P1, DOI 10.1109/ICICIP.2012.6391480; Bujnak M., 2008, 2008 IEEE C COMPUTER, P1; David P, 2004, INT J COMPUT VISION, V59, P259, DOI 10.1023/B:VISI.0000025800.10423.1f; DEMENTHON DF, 1992, LECT NOTES COMPUT SC, V588, P335, DOI 10.1007/BF01450852; Gramegna T, 2004, ROBOT AUTON SYST, V48, P145, DOI 10.1016/j.robot.2004.05.001; Grossberg MD, 2005, INT J COMPUT VISION, V61, P119, DOI 10.1023/B:VISI.0000043754.56350.10; Grossberg MD, 2001, EIGHTH IEEE INTERNATIONAL CONFERENCE ON COMPUTER VISION, VOL II, PROCEEDINGS, P108, DOI 10.1109/ICCV.2001.937611; Guo Y, 2012, I C CONT AUTOMAT ROB, P1413, DOI 10.1109/ICARCV.2012.6485396; He M., 2011, INT J DIGIT CONTENT, V5, P153; Hesch JA, 2011, IEEE I CONF COMP VIS, P383, DOI 10.1109/ICCV.2011.6126266; Hu ZY, 2002, IEEE T PATTERN ANAL, V24, P550, DOI 10.1109/34.993561; Kim W.W., 2011, 2011 8 INT C INF COM, P1; Klein George, 2007, P1; Kuang Y, 2013, POSE ESTIMATION UNKN, P529; Lepetit Vincent, 2005, Foundations and Trends in Computer Graphics and Vision, V1, P1, DOI 10.1561/0600000001; Lepetit V, 2009, INT J COMPUT VISION, V81, P155, DOI 10.1007/s11263-008-0152-6; Li L, 2013, OPTIK, V124, P1116, DOI 10.1016/j.ijleo.2012.03.018; Li SQ, 2012, IEEE T PATTERN ANAL, V34, P1444, DOI 10.1109/TPAMI.2012.41; Lin PD, 2006, J DYN SYST-T ASME, V128, P548, DOI 10.1115/1.2192824; Lin PD, 2006, OPTIK, V117, P329, DOI 10.1016/j.ijleo.2005.10.004; Liu ML, 1999, PATTERN RECOGN LETT, V20, P69, DOI 10.1016/S0167-8655(98)00128-7; Lu CP, 2000, IEEE T PATTERN ANAL, V22, P610, DOI 10.1109/34.862199; MARQUARDT DW, 1963, J SOC IND APPL MATH, V11, P431, DOI 10.1137/0111030; Martinez C, 2013, ROBOT AUTON SYST, V61, P876, DOI 10.1016/j.robot.2013.02.006; Martins P, 2008, IMAGE ANAL RECOGNITI; Park JS, 2013, 2013 13TH INTERNATIONAL CONFERENCE ON CONTROL, AUTOMATION AND SYSTEMS (ICCAS 2013), P386, DOI 10.1109/ICCAS.2013.6703930; Sturm P, 2010, FOUND TRENDS COMPUT, V6, P1, DOI 10.1561/0600000023; Taketomi T, 2014, COMPUT GRAPH-UK, V44, P11, DOI 10.1016/j.cag.2014.07.003; Wu Ping, 2014, MMSP 2014 IEEE 16 IN, P1; Xu GL, 2013, CHINESE J AERONAUT, V26, P1498, DOI 10.1016/j.cja.2013.07.049; Zheng YQ, 2013, IEICE T INF SYST, VE96D, P1525, DOI 10.1587/transinf.E96.D.1525	32	7	9	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0134029	10.1371/journal.pone.0134029	http://dx.doi.org/10.1371/journal.pone.0134029			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LZ	26197272	Green Published, gold, Green Submitted			2022-12-26	WOS:000358547600152
J	Skinner, C; Patfield, S; Hernlem, BJ; He, XH				Skinner, Craig; Patfield, Stephanie; Hernlem, Bradley J.; He, Xiaohua			New Stx2e Monoclonal Antibodies for Immunological Detection and Distinction of Stx2 Subtypes	PLOS ONE			English	Article							SHIGA TOXIN 2; NEUTRALIZATION; PURIFICATION; VARIANTS; SUBUNIT; PIGS	Background Stx2e is a primary virulence factor in STEC strains that cause edema disease in neonatal piglets. Though Stx2a and Stx2e are similar, many antibody-based Stx detection kits are designed to detect Stx2a and do not recognize the Stx2e subtype. Methods and Findings Four monoclonal antibodies against Stx2e were developed and characterized. Two of these mAbs recognize the B subunit of Stx2e, Stx2f, and to a lesser extent, Stx2b, Stx2c, and Stx2d. The other two mAbs recognize the A subunit of Stx2e, and cross-react with all Stx2 subtypes except Stx2f. The most sensitive sandwich ELISA using these mAbs has a limit of detection for Stx2e of 11.8 pg/mL. The ability of the neutralizing antibody Stx2e-2 to block Stx2e-receptor binding in Vero cells was visualized using immunofluorescence. Combinations of these and previously developed mAbs permit ELISA-based differentiation between closely related Stx2a, Stx2c, and Stx2d (using mAbs Stx2-5/2-1, Stx2-5/2e-2, and Stx2e-3/2e-2, respectively). Conclusions The sensitive immunoassays developed in this study should augment our capacity to detect Stx2e in porcine environments and biological samples. Moreover, immunoassays that can distinguish between the closely related Stx2a, Stx2c, and Stx2d subtypes can be useful in quickly analyzing Stx subtypes in samples containing more than one strain of STEC.	[Skinner, Craig; Patfield, Stephanie; Hernlem, Bradley J.; He, Xiaohua] USDA ARS, Western Reg Res Ctr, Albany, CA 94710 USA	United States Department of Agriculture (USDA)	He, XH (corresponding author), USDA ARS, Western Reg Res Ctr, 800 Buchanan St, Albany, CA 94710 USA.	xiaohua.he@ars.usda.gov			United States Department of Agriculture-Agricultural Research Service (USDA-ARS) National Program Current Research Information System (CRIS) [5325-42000-048-00D, NP108]	United States Department of Agriculture-Agricultural Research Service (USDA-ARS) National Program Current Research Information System (CRIS)	This study was funded by the United States Department of Agriculture-Agricultural Research Service (USDA-ARS) National Program NP108 Current Research Information System (CRIS) project 5325-42000-048-00D. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beddoe T, 2010, TRENDS BIOCHEM SCI, V35, P411, DOI 10.1016/j.tibs.2010.02.003; Beutin L, 2008, APPL ENVIRON MICROB, V74, P4806, DOI 10.1128/AEM.00623-08; DEGRANDIS S, 1989, J BIOL CHEM, V264, P12520; ENDO Y, 1988, EUR J BIOCHEM, V171, P45, DOI 10.1111/j.1432-1033.1988.tb13756.x; Fagerquist CK, 2015, J AM SOC MASS SPECTR, V26, P788, DOI 10.1007/s13361-015-1076-3; Gallegos KM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030368; Gupta P, 2010, PROTEIN PEPTIDE LETT, V17, P774, DOI 10.2174/092986610791190291; He X, 2012, J IMMUNOLOGICAL METH; He XH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076368; He XH, 2012, TOXINS, V4, P487, DOI 10.3390/toxins4070487; He XH, 2011, APPL ENVIRON MICROB, V77, P3558, DOI 10.1128/AEM.02205-10; Lienemann T, 2011, CURR MICROBIOL, V62, P1239, DOI 10.1007/s00284-010-9832-x; Lo AWH, 2014, J BIOL CHEM, V289, P25374, DOI 10.1074/jbc.M114.566257; Moxley RA, 2000, VET CLIN N AM-FOOD A, V16, P175, DOI 10.1016/S0749-0720(15)30142-0; Muthing J, 2012, GLYCOBIOLOGY, V22, P849, DOI 10.1093/glycob/cws009; Muthing J, 2009, THROMB HAEMOSTASIS, V101, P252, DOI 10.1160/TH08-05-0317; Parma YR, 2011, TOXICON, V58, P380, DOI 10.1016/j.toxicon.2011.07.009; Paton AW, 2000, NAT MED, V6, P265, DOI 10.1038/73111; Paton AW, 2001, INFECT IMMUN, V69, P1967, DOI 10.1128/IAI.69.3.1967-1970.2001; Rasooly R, 2012, FEMS IMMUNOL MED MIC, V64, P169, DOI 10.1111/j.1574-695X.2011.00874.x; Rocha LB, 2012, TOXINS, V4, P729, DOI 10.3390/toxins4090729; SAMUEL JE, 1990, INFECT IMMUN, V58, P611, DOI 10.1128/IAI.58.3.611-618.1990; SCHMITT CK, 1991, INFECT IMMUN, V59, P1065, DOI 10.1128/IAI.59.3.1065-1073.1991; Silva CJ, 2014, ANAL CHEM, V86, P4698, DOI 10.1021/ac402930r; Skinner C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099854; Skinner C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076563; Sonntag AK, 2005, APPL ENVIRON MICROB, V71, P8855, DOI 10.1128/AEM.71.12.8855-8863.2005; Willford J, 2009, J FOOD PROTECT, V72, P741, DOI 10.4315/0362-028X-72.4.741	28	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2015	10	7							e0132419	10.1371/journal.pone.0132419	http://dx.doi.org/10.1371/journal.pone.0132419			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LN	26192407	Green Submitted, Green Published, gold			2022-12-26	WOS:000358546400025
J	Budge, GE; Pietravalle, S; Brown, M; Laurenson, L; Jones, B; Tomkies, V; Delaplane, KS				Budge, Giles E.; Pietravalle, Stephane; Brown, Mike; Laurenson, Lynn; Jones, Ben; Tomkies, Victoria; Delaplane, Keith S.			Pathogens as Predictors of Honey Bee Colony Strength in England and Wales	PLOS ONE			English	Article							NATIONAL-SURVEY; VARROA MITES; VIRUS; LOSSES	Inspectors with the UK National Bee Unit were asked for 2007-2008 to target problem apiaries in England and Wales for pathogen screening and colony strength measures. Healthy colonies were included in the sampling to provide a continuum of health conditions. A total of 406 adult bee samples was screened and yielded 7 viral, 1 bacterial, and 2 micro-sporidial pathogens and 1 ectoparasite (Acarapis woodi). In addition, 108 samples of brood were screened and yielded 4 honey bee viruses. Virus prevalence varied from common (deformed wing virus, black queen cell virus) to complete absence (Israeli acute paralysis virus). When colonies were forced into one of two classes, strong or weak, the weak colonies contained more pathogens in adult bees. Among observed pathogens, only deformed wing virus was able to predict colony strength. The effect was negative such that colonies testing positive for deformed wing virus were likely to have fewer combs of bees or brood. This study constitutes the first record for Nosema ceranae in Great Britain. These results contribute to the growing body of evidence linking pathogens to poor honey bee health.	[Budge, Giles E.; Pietravalle, Stephane; Brown, Mike; Laurenson, Lynn; Jones, Ben; Tomkies, Victoria] Food & Environm Res Agcy, York YO41 1LZ, N Yorkshire, England; [Delaplane, Keith S.] Univ Georgia, Dept Entomol, Athens, GA 30602 USA	Food & Environment Research Agency; University System of Georgia; University of Georgia	Delaplane, KS (corresponding author), Univ Georgia, Dept Entomol, Athens, GA 30602 USA.	ksd@uga.edu	Delaplane, Keith/AAN-5197-2021	Delaplane, Keith/0000-0001-9323-441X	DEFRA; BBSRC; US [BB/I025220/1]; BBSRC [BB/I025220/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/I025220/1] Funding Source: researchfish	DEFRA(Department for Environment, Food & Rural Affairs (DEFRA)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); US; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded jointly between a grant from DEFRA and a BBSRC Partnering award with the US between GEB and KSD (BB/I025220/1).	Bacandritsos N, 2010, J INVERTEBR PATHOL, V105, P335, DOI 10.1016/j.jip.2010.08.004; Budge GE, 2010, J INVERTEBR PATHOL, V105, P164, DOI 10.1016/j.jip.2010.06.004; Cornman RS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043562; Cox-Foster DL, 2007, SCIENCE, V318, P283, DOI 10.1126/science.1146498; Dainat B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032151; Delaplane KS, 2012, J APIC RES, V51; Dietemann V, 2012, J APICULT RES, V51, P125, DOI 10.3896/IBRA.1.51.1.15; Domingo E, 1997, ANNU REV MICROBIOL, V51, P151, DOI 10.1146/annurev.micro.51.1.151; Dussaubat C, 2013, VET MICROBIOL, V162, P670, DOI 10.1016/j.vetmic.2012.09.012; Evison SEF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030641; Genersch E, 2010, APIDOLOGIE, V41, P332, DOI 10.1051/apido/2010014; GOODMAN RA, 2002, FIELD EPIDEMIOLOGY, P3; Guzman-Novoa E, 2010, APIDOLOGIE, V41, P443, DOI 10.1051/apido/2009076; Higes M, 2008, ENVIRON MICROBIOL, V10, P2659, DOI 10.1111/j.1462-2920.2008.01687.x; Higes M, 2010, ENV MICROBIOL REP, V2, P243, DOI 10.1111/j.1758-2229.2009.00099.x; Hooper T, 1997, GUIDE BEES HONEY; Kajobe R, 2010, J INVERTEBR PATHOL, V104, P153, DOI 10.1016/j.jip.2010.02.007; Koepsell T. D, 2003, EPIDEMIOLOGIC METHOD; Le Conte Y, 2010, APIDOLOGIE, V41, P353, DOI 10.1051/apido/2010017; Lee KV, 2015, APIDOLOGIE, V46, P292, DOI 10.1007/s13592-015-0356-z; Martin SJ, 2012, SCIENCE, V336, P1304, DOI 10.1126/science.1220941; Nazzi F, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002735; Neumann P, 2010, J APICULT RES, V49, P1, DOI 10.3896/IBRA.1.49.1.01; Ravoet J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072443; Shen MQ, 2005, VIROLOGY, V342, P141, DOI 10.1016/j.virol.2005.07.012; Sumpter DJT, 2004, J ANIM ECOL, V73, P51, DOI 10.1111/j.1365-2656.2004.00776.x; van der Zee R, 2012, J APICULT RES, V51, P91, DOI 10.3896/IBRA.1.51.1.12; Vanbergen AJ, 2013, FRONT ECOL ENVIRON, V11, P251, DOI 10.1890/120126; Vanengelsdorp D, 2012, J APICULT RES, V51, P115, DOI 10.3896/IBRA.1.51.1.14; vanEngelsdorp D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006481; Ward L, 2007, APIDOLOGIE, V38, P181, DOI 10.1051/apido:2006072; Wilkins S, 2007, PEST MANAG SCI, V63, P1062, DOI 10.1002/ps.1461	32	34	35	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0133228	10.1371/journal.pone.0133228	http://dx.doi.org/10.1371/journal.pone.0133228			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RV	26186735	gold, Green Published			2022-12-26	WOS:000358198700112
J	Janssen, PA; Mitton, C; Aghajanian, J				Janssen, Patricia A.; Mitton, Craig; Aghajanian, Jaafar			Costs of Planned Home vs. Hospital Birth in British Columbia Attended by Registered Midwives and Physicians	PLOS ONE			English	Article							LOW-RISK; MIDWIFERY; EXPERIENCES	Background Home birth is available to women in Canada who meet eligibility requirements for low risk status after assessment by regulated midwives. While UK researchers have reported lower costs associated with planned home birth, there have been no published studies of the costs of home versus hospital birth in Canada. Methods Costs for all women planning home birth with a regulated midwife in British Columbia, Canada were compared with those of all women who met eligibility requirements for home birth and were planning to deliver in hospital with a registered midwife, and with a sample of women of similar low risk status planning birth in the hospital with a physician. We calculated costs of physician service billings, midwifery fees, hospital in-patient costs, pharmaceuticals, home birth supplies, and transport. We compared costs among study groups using the Kruskall Wallis test for independent groups. Results In the first 28 days postpartum, we report a $2,338 average savings per birth among women planning home birth compared to hospital birth with a midwife and $2,541 compared to hospital birth planned with a physician. In longer term outcomes, similar reductions were observed, with cost savings per birth at $1,683 compared to the planned hospital birth with a midwife, and $1,100 compared to the physician group during the first eight weeks postpartum. During the first year of life, costs for infants of mothers planning home birth were reduced overall. Cost savings compared to planned hospital births with a midwife were $810 and with a physician $1,146. Costs were similarly reduced when findings were stratified by parity. Conclusions Planned home birth in British Columbia with a registered midwife compared to planned hospital birth is less expensive for our health care system up to 8 weeks postpartum and to one year of age for the infant.	[Janssen, Patricia A.; Mitton, Craig] Univ British Columbia, Sch Populat & Publ Hlth, Vancouver, BC V5Z 1M9, Canada; [Janssen, Patricia A.] Child & Family Res Inst, Vancouver, BC, Canada; [Mitton, Craig] Ctr Clin Epidemiol & Evaluat, Vancouver, BC, Canada; [Aghajanian, Jaafar] BC Ctr Epidemiol & Int Ophthalmol, Vancouver, BC, Canada	University of British Columbia; Child & Family Research Institute	Janssen, PA (corresponding author), Univ British Columbia, Sch Populat & Publ Hlth, Vancouver, BC V5Z 1M9, Canada.	patti.janssen@ubc.ca	Janssen, Patricia/B-1036-2018	Janssen, Patricia/0000-0002-4178-1195	Canadian Institutes of Health Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This study was funded by the Canadian Institutes of Health Research. The agency does not issue grant numbers. The URL is http://www.cihr-irsc.gc.ca/e/193.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson RE, 1999, J NURSE-MIDWIFERY, V44, P30, DOI 10.1016/S0091-2182(98)00072-X; [Anonymous], 2009, BC AMB SERV DAT EXTR; [Anonymous], 2009, PHARMANET; [Anonymous], 2008, DISCH ABSTRACT DAT H; [Anonymous], 2008, CONS FIL MSP REG PRE; BC Go, 2012, PAYM SCH MIDW SERV 2; British Columbia Perinatal Health Program, 2008, MIDW BRIT COL; Brocklehurst P, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d7400; Canadian Institutes of Health Research, 2006, GIV BRITH CAN COSTS; College of Midwives in Ontario, 2011, FACTS HOM BIRTH ONT; CUNNINGHAM JD, 1993, SOC SCI MED, V36, P475, DOI 10.1016/0277-9536(93)90409-W; de Jonge A, 2009, BJOG-INT J OBSTET GY, V116, P1177, DOI 10.1111/j.1471-0528.2009.02175.x; Health Management Associates, 2007, MIDW LIC DISC PROGR; Henderson J, 2008, BIRTH-ISS PERINAT C, V35, P136, DOI 10.1111/j.1523-536X.2008.00227.x; Hendrix MJC, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-211; Hutton EK, 2009, BIRTH-ISS PERINAT C, V36, P180, DOI 10.1111/j.1523-536X.2009.00322.x; Janssen PA, 2006, J MIDWIFERY WOM HEAL, V51, P91, DOI 10.1016/j.jmwh.2005.10.012; Janssen PA, 2002, CAN MED ASSOC J, V166, P315; Janssen PA, 2009, BIRTH-ISS PERINAT C, V36, P297, DOI 10.1111/j.1523-536X.2009.00357.x; Janssen PA, 2009, CAN MED ASSOC J, V181, P377, DOI 10.1503/cmaj.081869; Lindgren H, 2006, MIDWIFERY, V22, P15, DOI 10.1016/j.midw.2005.04.002; Longworth L, 2001, HEALTH SOC CARE COMM, V9, P404, DOI 10.1046/j.1365-2524.2001.00319.x; Medical Services Plan (MSP), 2008, MED SERVICES PLAN MS; Neuhaus W, 2002, J Obstet Gynaecol, V22, P143; Ogden J., 1997, BRIT J MIDWIFERY, V5, P208, DOI [https://doi.org/10.12968/bjom.1997.5.4.208, DOI 10.12968/BJOM.1997.5.4.208]; Reinharz D, 2000, CAN J PUBLIC HEALTH, V91, pI12, DOI 10.1007/BF03404261; Schroeder E, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e2292; Sjoblom I, 2006, MIDWIFERY, V22, P348, DOI 10.1016/j.midw.2005.11.004; University of Manitoba-Manitoba Centre for Health Policy, 2012, CONC CALC HOSP COSTS	29	19	19	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0133524	10.1371/journal.pone.0133524	http://dx.doi.org/10.1371/journal.pone.0133524			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN1RV	26186720	Green Published, Green Submitted, gold			2022-12-26	WOS:000358198700152
J	Listowski, MA; Leluk, J; Kraszewski, S; Sikorski, AF				Listowski, Marcin A.; Leluk, Jacek; Kraszewski, Sebastian; Sikorski, Aleksander F.			Cholesterol Interaction with the MAGUK Protein Family Member, MPP1, via CRAC and CRAC-Like Motifs: An In Silico Docking Analysis	PLOS ONE			English	Article							H-RAS; PLASMA-MEMBRANE; IDENTIFICATION; BINDING; PALMITOYLATION; RECEPTOR; ORGANIZATION; RECOGNITION; ALGORITHM; SEQUENCE	Cholesterol is essential for the proper organization of the biological membrane. Therefore, predicting which proteins can bind cholesterol is important in understanding how proteins participate in lateral membrane organization. In this study, a simple bioinformatics approach was used to establish whether MPP1, a member of the MAGUK protein family, is capable of binding cholesterol. Modelled and experimentally-validated fragment structures were mined from online resources and searched for CRAC and CRAC-like motifs. Several of these motifs were found in the primary structure of MPP1, and these were structurally visualized to see whether they localized to the protein surface. Since all of the CRAC and CRAC-like motifs were found at the surface of MPP1 domains, in silico docking experiments were performed to assess the possibility of interaction between CRAC motifs and cholesterol. The results obtained show that MPP1 can bind cholesterol via CRAC and CRAC-like motifs with moderate to high affinity (K-I in the nano-to micro-molar range). It was also found that palmitoylation-mimicking mutations (C/F or C/M) did not affect the affinity of MPP1 towards cholesterol. Data presented here may help to understand at least one of the molecular mechanisms via which MPP1 affects lateral organization of the membrane.	[Listowski, Marcin A.; Sikorski, Aleksander F.] Univ Wroclaw, Fac Biotechnol, Dept Cytobiochem, PL-50138 Wroclaw, Poland; [Leluk, Jacek; Sikorski, Aleksander F.] Univ Zielona Gora, Dept Mol Biol, Zielona Gora, Poland; [Kraszewski, Sebastian] Wroclaw Univ Technol, Dept Biomed Engn, PL-50370 Wroclaw, Poland	University of Wroclaw; University of Zielona Gora; Wroclaw University of Science & Technology	Sikorski, AF (corresponding author), Univ Wroclaw, Fac Biotechnol, Dept Cytobiochem, PL-50138 Wroclaw, Poland.	afsbc@ibmb.uni.wroc.pl	Sikorski, Aleksander F/C-3361-2009; Kraszewski, Sebastian/ABA-9541-2021; Sikorski, Aleksander/HGD-5159-2022	Kraszewski, Sebastian/0000-0003-3244-7694; Sikorski, Aleksander F./0000-0003-3779-8266	NCN (NCN = Narodowe Centrum Nauki (National Centre for Research)); Department of Biotechnology, University of Wroclaw, Poland [DEC-2012/05/B/NZ/01638]; Wroclaw Center of Biotechnology Program, The Leading National Research Center (KNOW)	NCN (NCN = Narodowe Centrum Nauki (National Centre for Research)); Department of Biotechnology, University of Wroclaw, Poland; Wroclaw Center of Biotechnology Program, The Leading National Research Center (KNOW)	This work was supported by NCN (NCN = Narodowe Centrum Nauki (National Centre for Research)); and Grant DEC-2012/05/B/NZ/01638 and faculty grant of Department of Biotechnology, University of Wroclaw, Poland. Publication cost was supported by Wroclaw Center of Biotechnology Program, The Leading National Research Center (KNOW) for years 2014-2018.	Anderson JM, 1996, CURR BIOL, V6, P382, DOI 10.1016/S0960-9822(02)00501-8; Baier CJ, 2011, SCI REP-UK, V1, DOI 10.1038/srep00069; Barylko B, 2009, J BIOL CHEM, V284, P9994, DOI 10.1074/jbc.M900724200; Biernatowska A, 2013, BBA-MOL CELL RES, V1833, P1876, DOI 10.1016/j.bbamcr.2013.03.009; Boesze-Battaglia K, 2009, J BIOL CHEM, V284, P10650, DOI 10.1074/jbc.M809094200; Brannigan G, 2008, P NATL ACAD SCI USA, V105, P14418, DOI 10.1073/pnas.0803029105; Costantini S, 2008, BIOINFORMATION, V3, P137, DOI 10.6026/97320630003137; Dimitratos SD, 1999, BIOESSAYS, V21, P912, DOI 10.1002/(SICI)1521-1878(199911)21:11<912::AID-BIES3>3.0.CO;2-Z; Eggeling C, 2009, NATURE, V457, P1159, DOI 10.1038/nature07596; EISENBERG D, 1982, FARADAY SYMP CHEM S, P109, DOI 10.1039/fs9821700109; Epand RF, 2006, BIOCHEMISTRY-US, V45, P6105, DOI 10.1021/bi060245+; Epand RM, 2006, PROG LIPID RES, V45, P279, DOI 10.1016/j.plipres.2006.02.001; Funke L, 2005, ANNU REV BIOCHEM, V74, P219, DOI 10.1146/annurev.biochem.74.082803.133339; Hamouda AK, 2006, BIOCHEMISTRY-US, V45, P976, DOI 10.1021/bi051978h; HEMMING NJ, 1995, J BIOL CHEM, V270, P5360, DOI 10.1074/jbc.270.10.5360; Jayasinghe S, 2001, J MOL BIOL, V312, P927, DOI 10.1006/jmbi.2001.5008; Kusunoki H, 2007, BIOCHEM BIOPH RES CO, V359, P972, DOI 10.1016/j.bbrc.2007.05.215; Kusunoki H, 2006, PROTEINS, V64, P804, DOI 10.1002/prot.21028; Lach A, 2012, J BIOL CHEM, V287, P18974, DOI 10.1074/jbc.M111.332981; Li H, 1998, ENDOCRINOLOGY, V139, P4991, DOI 10.1210/en.139.12.4991; Liao ZH, 2003, AIDS RES HUM RETROV, V19, P675, DOI 10.1089/088922203322280900; MADDON PJ, 1986, CELL, V47, P333, DOI 10.1016/0092-8674(86)90590-8; Manes S, 2000, EMBO REP, V1, P190, DOI 10.1093/embo-reports/kvd025; Munoz-Barroso I, 1999, J VIROL, V73, P6089; Niv H, 2002, J CELL BIOL, V157, P865, DOI 10.1083/jcb.200202009; Oddi S, 2011, J NEUROCHEM, V116, P858, DOI 10.1111/j.1471-4159.2010.07041.x; Palmer M, 2004, FEMS MICROBIOL LETT, V238, P281, DOI 10.1016/j.femsle.2004.07.059; Picazo-Juarez G, 2011, J BIOL CHEM, V286, P24966, DOI 10.1074/jbc.M111.237537; Rosnizeck IC, 2010, ANGEW CHEM INT EDIT, V49, P3830, DOI 10.1002/anie.200907002; Roy A, 2012, NUCLEIC ACIDS RES, V40, pW471, DOI 10.1093/nar/gks372; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Roy S, 1999, NAT CELL BIOL, V1, P98, DOI 10.1038/10067; RUFF P, 1991, P NATL ACAD SCI USA, V88, P6595, DOI 10.1073/pnas.88.15.6595; Seo PS, 2009, EXP BIOL MED, V234, P255, DOI 10.3181/0809-RM-275; Sheng R, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2221; Swarthout JT, 2005, J BIOL CHEM, V280, P31141, DOI 10.1074/jbc.M504113200; Vishwanathan SA, 2008, BIOCHEMISTRY-US, V47, P11869, DOI 10.1021/bi8014828; Wilkins MR, 1999, METH MOL B, V112, P531; Wimley WC, 1996, P NATL ACAD SCI USA, V93, P2985, DOI 10.1073/pnas.93.7.2985; Xavier R, 1998, IMMUNITY, V8, P723, DOI 10.1016/S1074-7613(00)80577-4; Yang GH, 2014, BBA-BIOMEMBRANES, V1838, P2588, DOI 10.1016/j.bbamem.2014.06.018; Yang W, 2010, MOL CELL PROTEOMICS, V9, P54, DOI 10.1074/mcp.M800448-MCP200; Zhang Y, 2005, NUCLEIC ACIDS RES, V33, P2302, DOI 10.1093/nar/gki524; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40; Zhou QJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4552	45	16	16	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0133141	10.1371/journal.pone.0133141	http://dx.doi.org/10.1371/journal.pone.0133141			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RV	26186446	Green Published, gold			2022-12-26	WOS:000358198700100
J	Qiao, M; Sun, JW; Liu, N; Sun, TJ; Liu, G; Han, SF; Hou, CY; Wang, DM				Qiao, Mei; Sun, Jiawei; Liu, Na; Sun, Tianjie; Liu, Gang; Han, Shengfang; Hou, Chunyan; Wang, Dongmei			Changes of Nitric Oxide and Its Relationship with H2O2 and Ca2+ in Defense Interactions between Wheat and Puccinia Triticina	PLOS ONE			English	Article							HYDROGEN-PEROXIDE; CELL-DEATH; PATHOGEN DEFENSE; PROTEIN-KINASES; CALCIUM; ARABIDOPSIS; CHANNELS; INCREASE; NO; INVOLVEMENT	In this research, the wheat cultivar 'Lovrin 10' and Puccinia triticina races 165 and 260 were used to constitute compatible and incompatible combinations to investigate the relationship between NO and H2O2 and between NO and calcium (Ca2+) signaling in the cell defense process by pharmacological means. The specific fluorescent probe DAF-FM DA was coupled with confocal laser scanning microscopy and used to label intracellular nitric oxide (NO) and monitoring the real-time NO dynamics during the processes of wheat defense response triggered by P. triticina infection. The results showed that at 4 h after inoculation, weak green fluorescence was observed in the stomatal guard cells at the P. triticina infection site in the incompatible combination, which indicates a small amount of NO production. Twelve hours after inoculation, the fluorescence of NO in-cell adjacent to the stomata gradually intensified, and the NO fluorescent area also expanded continuously; the green fluorescence primarily occurred in the cells undergoing a hypersensitive response (HR) at 24-72 h after inoculation. For the compatible combination, however, a small amount of green fluorescence was observed in stomata where the pathogenic contact occurred at 4 h after inoculation, and fluorescence was not observed thereafter. Injections of the NO scavenger c-PTIO prior to inoculation postponed the onset of NO production to 48 h after inoculation and suppressed HR advancement. The injection of imidazole, a NADPH oxidase inhibitor, or EGTA, an extracellular calcium chelator, in the leaves prior to inoculation, delayed the onset of NO production in the incompatible combination and suppressed HR advancement. Combined with our previous results, it could be concluded that, Ca2+ and hydrogen peroxide (H2O2) are involved in upstream of NO production to induce the HR cell death during P. triticina infection, and Ca2+, NO and H2O2 are jointly involved in the signal transduction process of HR in the interaction system.	[Qiao, Mei; Sun, Jiawei; Liu, Na; Sun, Tianjie; Liu, Gang; Han, Shengfang; Hou, Chunyan; Wang, Dongmei] Agr Univ Hebei, Coll Life Sci, Baoding, Hebei Province, Peoples R China	Hebei Agricultural University	Wang, DM (corresponding author), Agr Univ Hebei, Coll Life Sci, Baoding, Hebei Province, Peoples R China.	dongmeiwang63@126.com	Sun, Tianjie/AAC-8087-2020		National Natural Science Foundation of China [31171472]; Doctoral Program of Higher Education Research Fund [20111302130001]; Key Basic Research Program of Hebei on Basic Research for Application [12967149D]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Doctoral Program of Higher Education Research Fund; Key Basic Research Program of Hebei on Basic Research for Application	This work was supported by the National Natural Science Foundation of China (no. 31171472), the Doctoral Program of Higher Education Research Fund (no. 20111302130001) and the Key Basic Research Program of Hebei on Basic Research for Application (no. 12967149D).	Ali R, 2007, PLANT CELL, V19, P1081, DOI 10.1105/tpc.106.045096; Bei Z, 2010, ACTA AGRON SIN, V36, P833; Blume B, 2000, PLANT CELL, V12, P1425, DOI 10.1105/tpc.12.8.1425; [陈晓波 Chen Xiaobo], 2002, [植物生理与分子生物学学报, Journal of Plant Physiology and Molecular Biology], V28, P344; Chen YH, 2011, SCI AGR SIN, V44, P2061; Cheval C, 2013, BBA-MOL CELL RES, V1833, P1766, DOI 10.1016/j.bbamcr.2013.01.031; de Pinto MC, 2006, PLANT J, V48, P784, DOI 10.1111/j.1365-313X.2006.02919.x; DEAN JV, 1986, PLANT PHYSIOL, V82, P718, DOI 10.1104/pp.82.3.718; Delledonne M, 2005, CURR OPIN PLANT BIOL, V8, P390, DOI 10.1016/j.pbi.2005.05.002; Delledonne M, 2001, P NATL ACAD SCI USA, V98, P13454, DOI 10.1073/pnas.231178298; DENG EX, 1992, PLANT PHYSL COMM, V28, P296; Dong XN, 2001, CURR OPIN PLANT BIOL, V4, P309, DOI 10.1016/S1369-5266(00)00178-3; Feilner T, 2005, MOL CELL PROTEOMICS, V4, P1558, DOI 10.1074/mcp.M500007-MCP200; Furch ACU, 2009, PLANT CELL, V21, P2118, DOI 10.1105/tpc.108.063107; Garcia-Mata C, 2003, P NATL ACAD SCI USA, V100, P11116, DOI 10.1073/pnas.1434381100; Grant M, 2000, PLANT J, V23, P441, DOI 10.1046/j.1365-313x.2000.00804.x; [关春蕾 Guan Chunlei], 2006, [河北农业大学学报, Journal of Agricultural University of Hebei], V29, P4; Hai-bo W, 2010, NO HORTICULTURE, V22, P189; Heo WD, 1999, P NATL ACAD SCI USA, V96, P766, DOI 10.1073/pnas.96.2.766; Hong JK, 2008, J EXP BOT, V59, P147, DOI 10.1093/jxb/erm244; [侯春燕 HOU Chunyan], 2007, [华北农学报, Acta Agriculturae Boreali-Sinica], V22, P145; Imbaby IA, 2014, SCI WORLD J, DOI 10.1155/2014/574285; Jasid S, 2006, PLANT PHYSIOL, V142, P1246, DOI 10.1104/pp.106.086918; Jeandroz S, 2013, PLANT PHYSIOL, V163, P459, DOI 10.1104/pp.113.220624; KLEPPER L, 1979, ATMOS ENVIRON, V13, P537, DOI 10.1016/0004-6981(79)90148-3; Kudla J, 2010, PLANT CELL, V22, P541, DOI 10.1105/tpc.109.072686; Kuta D. D., 2004, African Journal of Biotechnology, V3, P76; Lam E, 2004, NAT REV MOL CELL BIO, V5, P305, DOI 10.1038/nrm1358; Lamattina L, 2003, ANNU REV PLANT BIOL, V54, P109, DOI 10.1146/annurev.arplant.54.031902.134752; Lamotte O, 2006, FREE RADICAL BIO MED, V40, P1369, DOI 10.1016/j.freeradbiomed.2005.12.006; Lecourieux D, 2002, PLANT CELL, V14, P2627, DOI 10.1105/tpc.005579; Li AL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028810; Lin AH, 2012, PLANT PHYSIOL, V158, P451, DOI 10.1104/pp.111.184531; Liu Gang, 2005, Shi Yan Sheng Wu Xue Bao, V38, P331; Liu G, 2010, PHYSIOL MOL PLANT P, V74, P267, DOI 10.1016/j.pmpp.2010.04.002; Liu Gang, 2007, Fen Zi Xi Bao Sheng Wu Xue Bao, V40, P205; Lu Dong, 2005, Zhiwu Shengli yu Fenzi Shengwuxue Xuebao, V31, P62; Lum HK, 2002, NITRIC OXIDE-BIOL CH, V6, P205, DOI 10.1006/niox.2001.0395; Ma W, 2007, CELL MICROBIOL, V9, P2571, DOI 10.1111/j.1462-5822.2007.01031.x; Ma W, 2011, NEW PHYTOL, V190, P566, DOI 10.1111/j.1469-8137.2010.03577.x; Ma Y, 2013, PLANT PHYSIOL, V163, P1459, DOI 10.1104/pp.113.226068; Neill SJ, 2003, NEW PHYTOL, V159, P11, DOI 10.1046/j.1469-8137.2003.00804.x; Neill SJ, 2002, J EXP BOT, V53, P1237, DOI 10.1093/jexbot/53.372.1237; Ninnemann H, 1996, PHOTOCHEM PHOTOBIOL, V64, P393, DOI 10.1111/j.1751-1097.1996.tb02477.x; Qi Yan, 2008, Fen Zi Xi Bao Sheng Wu Xue Bao, V41, P245; [乔妹 Qiao Mei], 2015, [植物学报, Chinese Bulletin of Botany], V50, P1; Ren LiMei, 2010, Scientia Agricultura Sinica, V43, P1577; Ribeiro EA, 1999, FEBS LETT, V445, P283, DOI 10.1016/S0014-5793(99)00138-6; ROHRINGER R, 1977, PHYTOPATHOLOGY, V67, P808, DOI 10.1094/Phyto-67-808; She XP, 2004, ACTA BOT SIN, V46, P1292; Shi FM, 2008, BMB REP, V41, P79, DOI 10.5483/BMBRep.2008.41.1.079; Sridharamurthy M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113643; Torres MA, 2006, PLANT PHYSIOL, V141, P373, DOI 10.1104/pp.106.079467; Vandelle E, 2006, MOL PLANT MICROBE IN, V19, P429, DOI 10.1094/MPMI-19-0429; Wendehenne D, 2001, TRENDS PLANT SCI, V6, P177, DOI 10.1016/S1360-1385(01)01893-3; Yamasaki H, 1999, TRENDS PLANT SCI, V4, P128, DOI 10.1016/S1360-1385(99)01393-X; Zago E, 2006, PLANT PHYSIOL, V141, P404, DOI 10.1104/pp.106.078444; [赵晓刚 Zhao Xiaogang], 2004, [植物学通报, Chinese Bulletin of Botany], V21, P44; 刘新, 2003, [自然科学进展, Progress in Natural Science], V13, P355; 刘国华, 2009, [自然科学进展, Progress in Natural Science], V19, P841	60	16	21	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0132265	10.1371/journal.pone.0132265	http://dx.doi.org/10.1371/journal.pone.0132265			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RV	26185989	Green Published, gold, Green Submitted			2022-12-26	WOS:000358198700033
J	Liu, W; Sigdel, KR; Wang, Y; Su, Q; Huang, Y; Zhang, YL; Chen, J; Duan, LH; Shi, GX				Liu, Wen; Sigdel, Keshav Raj; Wang, Ying; Su, Qun; Huang, Yan; Zhang, Yan Lin; Chen, Jie; Duan, Lihua; Shi, Guixiu			High Level Serum Procalcitonin Associated Gouty Arthritis Susceptibility: From a Southern Chinese Han Population	PLOS ONE			English	Article							BACTERIAL-INFECTION; RHEUMATOID-ARTHRITIS; SEPTIC ARTHRITIS; ACTIVITY SCORE; INFLAMMATORY MARKERS; DIAGNOSTIC-VALUE; DISEASE; DIFFERENTIATION; METAANALYSIS; PREVALENCE	Objectives To study the serum Procalcitonin (PCT) level in inflammatory arthritis including gouty arthritis (GA), Rheumatoid arthritis (RA), and ankylosing spondylitis (AS) without any evidence of infection were evaluated the possible discriminative role of PCT in gouty arthritis susceptibility in southern Chinese Han Population. Material and Methods From Feb, 2012 to Feb, 2015, 51 patients with GA, 37 patients with RA, 41 patients with AS and 33 healthy control were enrolled in this study with no evidence of infections. The serum level of PCT (normal range < 0.05 ng/ml) was measured by electrochemiluminescence immunoassay (ECLIA). Disease activity was determined by scores of VAS (4.07 +/- 1.15), DAS28 (4.97 +/- 1.12), and ASDAS (2.97 +/- 0.81) in GA, RA and AS groups respectively. Other laboratory parameters such as, serum creatinine (CRE), erythrocyte sedimentation rate (ESR), C-reactive protein (CRP), uric acid (UA) and white blood cells (WBC) were extracted from medical record system. Results Serum PCT level was predominantly higher in gouty arthritis than in RA and AS patients, especially in the GA patients with tophi. PCT was significantly positively correlated with VAS, CRP and ESR in gouty arthritis and CRP in AS. PCT also had positive correlationship with ESR, DAS28 and ASDAS in RA and AS patients respectively, but significant differences were not observed. Conclusions These data suggested that PCT is not solely a biomarker for infection, but also an indicator in inflammatory arthritis, especially in gouty arthritis.	[Liu, Wen; Wang, Ying; Su, Qun; Huang, Yan; Duan, Lihua; Shi, Guixiu] Xiamen Univ, Affiliated Hosp 1, Dept Rheumatol & Clin Immunol, Xiamen, Fujian, Peoples R China; [Sigdel, Keshav Raj; Zhang, Yan Lin] Xiamen Univ, Affiliated Hosp 1, Dept Nephrol, Xiamen, Fujian, Peoples R China; [Chen, Jie] Xiamen Univ, Coll Med, Dept Immunol, Xiamen, Fujian, Peoples R China	Xiamen University; Xiamen University; Xiamen University	Duan, LH (corresponding author), Xiamen Univ, Affiliated Hosp 1, Dept Rheumatol & Clin Immunol, Xiamen, Fujian, Peoples R China.	lh-duan@163.com; gshi@xmu.edu.cn		shi, guixiu/0000-0003-4044-3394	National Natural Science Foundation of China [81302564, 81471534, 81301786]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work is supported by the National Natural Science Foundation of China (81302564 to Lihua Duan, 81471534 to Guixiu Shi, 81301786 to Jie Chen).	Aletaha D, 2005, ARTHRITIS RES THER, V7, pR796, DOI 10.1186/ar1740; Badulescu M, 2014, MED-SURG J, V118, P942; Becker KL, 2004, J CLIN ENDOCR METAB, V89, P1512, DOI 10.1210/jc.2002-021444; Chen DY, 2009, ANN RHEUM DIS, V68, P1074, DOI 10.1136/ard.2008.098335; Dalbeth N, 2014, J RHEUMATOL, V41, P558, DOI 10.3899/jrheum.131244; Delevaux I, 2003, ANN RHEUM DIS, V62, P337, DOI 10.1136/ard.62.4.337; Eberhard OK, 1997, ARTHRITIS RHEUM, V40, P1250, DOI 10.1002/1529-0131(199707)40:7<1250::AID-ART9>3.0.CO;2-A; Fernandez-Espartero C, 2014, ANN RHEUM DIS, V73, P1350, DOI 10.1136/annrheumdis-2012-202976; Heegaard C, 2013, CLIN RHEUMATOL, V32, P1493, DOI 10.1007/s10067-013-2300-9; Hugle T, 2008, CLIN EXP RHEUMATOL, V26, P453; Kettelhack C, 2000, CRIT CARE MED, V28, P1040, DOI 10.1097/00003246-200004000-00021; Khanna D, 2012, ARTHRIT CARE RES, V64, P1447, DOI 10.1002/acr.21773; Lawrence RC, 2008, ARTHRITIS RHEUM, V58, P26, DOI 10.1002/art.23176; Limper M, 2012, J RHEUMATOL, V39, P1914, DOI 10.3899/jrheum.120586; Liote F, 2006, RHEUM DIS CLIN N AM, V32, P295, DOI 10.1016/j.rdc.2006.03.001; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Martinot M, 2005, CLIN EXP RHEUMATOL, V23, P303; Maruna P, 2000, PHYSIOL RES, V49, pS57; Meisner M, 2001, EUR J ANAESTH, V18, P79, DOI 10.1046/j.0265-0215.2000.00783.x; Okada Y, 2004, J INFECTION, V48, P199, DOI 10.1016/j.jinf.2003.08.002; Ottaviani S, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4303; Ozmen M, 2014, INT J RHEUMATIC DIS; Petrilli V, 2007, JOINT BONE SPINE, V74, P571, DOI 10.1016/j.jbspin.2007.04.004; Richette P, 2010, LANCET, V375, P318, DOI 10.1016/S0140-6736(09)60883-7; Saeed K, 2014, EXPERT REV MOL DIAGN, V14, P47, DOI 10.1586/14737159.2014.864238; Sato H, 2012, J RHEUMATOL, V39, P1517, DOI 10.3899/jrheum.111601; Schneider HG, 2007, PATHOLOGY, V39, P383, DOI 10.1080/00313020701444564; Schuetz P, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-107; Shah K, 2007, J EMERG MED, V32, P23, DOI 10.1016/j.jemermed.2006.07.019; Shaikh MM, 2014, RHEUMATOLOGY OXFORD; Simon L, 2004, CLIN INFECT DIS, V39, P206, DOI 10.1086/421997; Soderquist B, 1998, SCAND J INFECT DIS, V30, P591, DOI 10.1080/00365549850161151; Talebi-Taher M, 2013, RHEUMATOL INT, V33, P319, DOI 10.1007/s00296-012-2363-y; V N Panicker, 2014, Open Orthop J, V8, P482, DOI 10.2174/1874325001408010482; Wacker C, 2013, LANCET INFECT DIS, V13, P426, DOI 10.1016/S1473-3099(12)70323-7; Wang CG, 2014, EXP THER MED, V8, P1075, DOI 10.3892/etm.2014.1870; Weng CT, 2009, CLIN EXP RHEUMATOL, V27, P902; Zeng QY, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2368; Zhu YY, 2011, ARTHRITIS RHEUM-US, V63, P3136, DOI 10.1002/art.30520	39	12	16	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2015	10	7							e0132855	10.1371/journal.pone.0132855	http://dx.doi.org/10.1371/journal.pone.0132855			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RQ	26182343	Green Published, Green Submitted, gold			2022-12-26	WOS:000358198200044
J	Morgado-Santos, M; Pereira, HM; Vicente, L; Collares-Pereira, MJ				Morgado-Santos, Miguel; Pereira, Henrique Miguel; Vicente, Lus; Collares-Pereira, Maria Joao			Mate Choice Drives Evolutionary Stability in a Hybrid Complex	PLOS ONE			English	Article							REPRODUCTIVE STRATEGIES; SEXUAL SELECTION; PLOIDY LEVEL; GENOME SIZE; SPECIATION; HYBRIDIZATION; POPULATIONS; MALES; FROGS; REINFORCEMENT	Previous studies have shown that assortative mating acts as a driver of speciation by countering hybridization between two populations of the same species (pre-zygotic isolation) or through mate choice among the hybrids (hybrid speciation). In both speciation types, assortative mating promotes speciation over a transient hybridization stage. We studied mate choice in a hybrid vertebrate complex, the allopolyploid fish Squalius alburnoides. This complex is composed by several genomotypes connected by an intricate reproductive dynamics. We developed a model that predicts the hybrid complex can persist when females exhibit particular mate choice patterns. Our model is able to reproduce the diversity of population dynamic outcomes found in nature, namely the dominance of the triploids and the dominance of the tetraploids, depending on female mate choice patterns and frequency of the parental species. Experimental mate choice trials showed that females exhibit the preferences predicted by the model. Thus, despite the known role of assortative mating in driving speciation, our findings suggest that certain mate choice patterns can instead hinder speciation and support the persistence of hybrids over time without speciation or extinction.	[Morgado-Santos, Miguel; Pereira, Henrique Miguel; Collares-Pereira, Maria Joao] Univ Lisbon, Fac Ciencias, CE3C Ctr Ecol Evolut & Environm Changes, P-1749016 Lisbon, Portugal; [Morgado-Santos, Miguel; Vicente, Lus] Univ Lisbon, Fac Ciencias, Ctr Estudos Ambiente & Mar, Dept Biol Anim, P-1749016 Lisbon, Portugal; [Pereira, Henrique Miguel] IDiv German Ctr Integrat Biodivers Res, Leipzig, Germany; [Vicente, Lus] Univ Lisbon, CFCUL Ctr Filosofia Ciencias, Fac Ciencias, P-1749016 Lisbon, Portugal	Universidade de Lisboa; Universidade de Lisboa; Universidade de Lisboa	Morgado-Santos, M (corresponding author), Univ Lisbon, Fac Ciencias, CE3C Ctr Ecol Evolut & Environm Changes, P-1749016 Lisbon, Portugal.	mfsantos@fc.ul.pt	Pereira, Henrique/B-3975-2009; VICENTE, LIERN/B-6112-2008; Vicente, Luis/A-7443-2013; Collares-Pereira, Maria/M-6246-2013	Pereira, Henrique/0000-0003-1043-1675; VICENTE, LIERN/0000-0001-5883-9640; Vicente, Luis/0000-0002-3383-5480; Collares-Pereira, Maria/0000-0002-8081-9539	Centro de Biologia Ambiental [PEstOE/BIA/UI0329/2014]; Portuguese Fundacao para a Ciencia e Tecnologia [SFRH/BD/65154/2009]	Centro de Biologia Ambiental; Portuguese Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission)	This work was supported by Centro de Biologia Ambiental (www.cba.pt, PEstOE/BIA/UI0329/2014) and the Portuguese Fundacao para a Ciencia e Tecnologia (www.fct.pt, PhD grant SFRH/BD/65154/2009 awarded to M.M.-S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABT G, 1993, BEHAV ECOL SOCIOBIOL, V32, P221; Alves MJ, 2001, GENETICA, V111, P375, DOI 10.1023/A:1013783029921; [Anonymous], 2012, ANIM BEHAV, V83, P301, DOI 10.1016/j.anbehav.2011.10.031; Bank C, 2012, EVOLUTION, V66, P229, DOI 10.1111/j.1558-5646.2011.01423.x; Brown JL, 1997, BEHAV ECOL, V8, P60, DOI 10.1093/beheco/8.1.60; BUTLIN R, 1987, TRENDS ECOL EVOL, V2, P8, DOI 10.1016/0169-5347(87)90193-5; Cabral M.J., 2005, LIVRO VERMELHO VERTE; Christiansen DG, 2005, EVOLUTION, V59, P1348; Christiansen DG, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-135; Christiansen DG, 2009, EVOLUTION, V63, P1754, DOI 10.1111/j.1558-5646.2009.00673.x; Collares-Pereira MJ, 2013, CYTOGENET GENOME RES, V140, P97, DOI 10.1159/000351729; Coyne J.A., 2004, SPECIATION; Cunha C, 2009, J EVOLUTION BIOL, V22, P718, DOI 10.1111/j.1420-9101.2009.01695.x; Cunha C, 2008, PHILOS T R SOC B, V363, P2921, DOI 10.1098/rstb.2008.0048; Darwin C., 1871, P423; Dawley R. M, 1989, EVOLUTION ECOLOGY UN; Dobzhansky T, 1940, AM NAT, V74, P312, DOI 10.1086/280899; Evans BJ, 2004, MOL PHYLOGENET EVOL, V33, P197, DOI 10.1016/j.ympev.2004.04.018; GROSS MR, 1991, PHILOS T R SOC B, V332, P59, DOI 10.1098/rstb.1991.0033; Janko K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045384; Jennions MD, 2000, BIOL REV, V75, P21, DOI 10.1017/S0006323199005423; Jiang YX, 2013, AM NAT, V181, pE125, DOI 10.1086/670160; Kirkpatrick M, 2001, P ROY SOC B-BIOL SCI, V268, P1259, DOI 10.1098/rspb.2000.1427; KNOPPIEN P, 1985, BIOL REV, V60, P81, DOI 10.1111/j.1469-185X.1985.tb00418.x; Kokko H, 2005, EVOL ECOL, V19, P123, DOI 10.1007/s10682-004-7919-1; Lamatsch DK, 2000, CYTOMETRY, V39, P91, DOI 10.1002/(SICI)1097-0320(20000201)39:2<91::AID-CYTO1>3.0.CO;2-4; Lamatsch DK, 2009, LOST SEX: THE EVOLUTIONARY BIOLOGY OF PARTHENOGENESIS, P399, DOI 10.1007/978-90-481-2770-2_19; Maan ME, 2011, ECOL LETT, V14, P591, DOI 10.1111/j.1461-0248.2011.01606.x; Mallet J, 2007, NATURE, V446, P279, DOI 10.1038/nature05706; Mavarez J, 2006, NATURE, V441, P868, DOI 10.1038/nature04738; Melo MC, 2009, EVOLUTION, V63, P1660, DOI 10.1111/j.1558-5646.2009.00633.x; Meyer A, 2006, MOL ECOL, V15, P721, DOI 10.1111/j.1365-294X.2006.02810.x; Morgado-Santos M, 2010, J FISH BIOL, V76, P1228, DOI 10.1111/j.1095-8649.2010.02591.x; Neaves WB, 2011, TRENDS GENET, V27, P81, DOI 10.1016/j.tig.2010.12.002; Nolte AW, 2007, TIG, V26, P54; Petrie M, 1998, P NATL ACAD SCI USA, V95, P9390, DOI 10.1073/pnas.95.16.9390; Pruvost NBM, 2015, J EVOLUTION BIOL, V28, P189, DOI 10.1111/jeb.12556; R Core Team, 2012, R LANG ENV STAT COMP; Saitoh K, 2010, MOL PHYLOGENET EVOL, V56, P1001, DOI 10.1016/j.ympev.2010.04.021; SCHLUPP I, 1994, SCIENCE, V263, P373, DOI 10.1126/science.8278809; Sinervo B, 1996, NATURE, V380, P240, DOI 10.1038/380240a0; Sousa-Santos C, 2005, DNA SEQUENCE, V16, P462, DOI 10.1080/10425170500356065; Sousa-Santos C., 2007, THESIS LISBON U; StatSoft Inc, 2013, EL STAT TXB; van Doorn GS, 2009, SCIENCE, V326, P1704, DOI 10.1126/science.1181661; Willis PM, 2011, BEHAV ECOL, V22, P1234, DOI 10.1093/beheco/arr119	46	7	7	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2015	10	7							e0132760	10.1371/journal.pone.0132760	http://dx.doi.org/10.1371/journal.pone.0132760			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RQ	26181664	Green Published, gold			2022-12-26	WOS:000358198200031
J	Rueda-Cediel, P; Anderson, KE; Regan, TJ; Franklin, J; Regan, HM				Rueda-Cediel, Pamela; Anderson, Kurt E.; Regan, Tracey J.; Franklin, Janet; Regan, Helen M.			Combined Influences of Model Choice, Data Quality, and Data Quantity When Estimating Population Trends	PLOS ONE			English	Article							ENDANGERED SPECIES ACT; VIABILITY ANALYSIS; OBSERVATION ERROR; EXTINCTION MODELS; RISK; DYNAMICS; RECOVERY; GROWTH; VARIABILITY; ASSESSMENTS	Estimating and projecting population trends using population viability analysis (PVA) are central to identifying species at risk of extinction and for informing conservation management strategies. Models for PVA generally fall within two categories, scalar (count-based) or matrix (demographic). Model structure, process error, measurement error, and time series length all have known impacts in population risk assessments, but their combined impact has not been thoroughly investigated. We tested the ability of scalar and matrix PVA models to predict percent decline over a ten-year interval, selected to coincide with the IUCN Red List criterion A. 3, using data simulated for a hypothetical, short-lived organism with a simple life-history and for a threatened snail, Tasmaphena lamproides. PVA performance was assessed across different time series lengths, population growth rates, and levels of process and measurement error. We found that the magnitude of effects of measurement error, process error, and time series length, and interactions between these, depended on context. We found that high process and measurement error reduced the reliability of both models in predicted percent decline. Both sources of error contributed strongly to biased predictions, with process error tending to contribute to the spread of predictions more than measurement error. Increasing time series length improved precision and reduced bias of predicted population trends, but gains substantially diminished for time series lengths greater than 10-15 years. The simple parameterization scheme we employed contributed strongly to bias in matrix model predictions when both process and measurement error were high, causing scalar models to exhibit similar or greater precision and lower bias than matrix models. Our study provides evidence that, for short-lived species with structured but simple life histories, short time series and simple models can be sufficient for reasonably reliable conservation decision-making, and may be preferable for population projections when unbiased estimates of vital rates cannot be obtained.	[Rueda-Cediel, Pamela; Anderson, Kurt E.; Regan, Helen M.] Univ Calif Riverside, Dept Biol, Riverside, CA 92521 USA; [Regan, Tracey J.] Arthur Rylah Inst Environm Res, Heidelberg, Vic, Australia; [Regan, Tracey J.] Univ Melbourne, Sch Biosci, Parkville, Vic 3052, Australia; [Franklin, Janet] Arizona State Univ, Sch Geog Sci & Urban Planning, Tempe, AZ 85287 USA	University of California System; University of California Riverside; Arthur Rylah Institute for Environmental Research (ARI); University of Melbourne; Arizona State University; Arizona State University-Tempe	Anderson, KE (corresponding author), Univ Calif Riverside, Dept Biol, Riverside, CA 92521 USA.	kurt.anderson@ucr.edu	Anderson, Kurt E/A-1339-2013		National Science Foundation [DEB-0824708, EF-1065753]; California Landscape Conservation Cooperative [5288768]	National Science Foundation(National Science Foundation (NSF)); California Landscape Conservation Cooperative	This research was supported by the National Science Foundation (www.nsf.gov; DEB-0824708, and EF-1065753) and the California Landscape Conservation Cooperative (californialcc.org; 5288768) through grants to HMR, JF and KEA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akcakaya HR, 1999, APPL POPULAR ECOLOGY; Andelman SJ, 2004, ACTA OECOL, V26, P75, DOI 10.1016/j.actao.2004.04.005; Baxter PWJ, 2005, ECOL APPL, V15, P1331, DOI 10.1890/02-5382; Beissinger SR, 2002, POPULATION VIABILITY ANALYSIS, P5; Beissinger SR, 1998, J WILDLIFE MANAGE, V62, P821, DOI 10.2307/3802534; Boor GKH, 2014, CONSERV BIOL, V28, P33, DOI 10.1111/cobi.12155; BURGMAN MA, 1988, BIOL CONSERV, V43, P9, DOI 10.1016/0006-3207(88)90075-4; BURGMAN MA, 1993, RISK ASSESMENT CONSE; Coulson T, 2001, TRENDS ECOL EVOL, V16, P219, DOI 10.1016/S0169-5347(01)02137-1; De Valpine P, 2002, ECOL MONOGR, V72, P57, DOI 10.1890/0012-9615(2002)072[0057:FPMIPN]2.0.CO;2; Dennis B, 2010, ECOLOGY, V91, P610, DOI 10.1890/08-1095.1; DOAK D, 1994, ECOL APPL, V4, P446, DOI 10.2307/1941949; Drake JM, 2004, ECOL LETT, V7, P26, DOI 10.1046/j.1461-0248.2003.00546.x; Dunham AE, 2006, CONSERV BIOL, V20, P1499, DOI 10.1111/j.1523-1739.2006.00474.x; Fieberg J, 2000, ECOLOGY, V81, P2040; Holmes EE, 2001, P NATL ACAD SCI USA, V98, P5072, DOI 10.1073/pnas.081055898; Holmes EE, 2007, ECOL LETT, V10, P1182, DOI 10.1111/j.1461-0248.2007.01105.x; Hovestadt T, 2008, BIODIVERS CONSERV, V17, P3417, DOI 10.1007/s10531-008-9426-0; Humbert JY, 2009, OIKOS, V118, P1940, DOI 10.1111/j.1600-0706.2009.17839.x; IUCN Standards and Petitions Subcommittee, 2014, GUID IUCN RED LIST C; Lande R., 2003, OXFORD SERIES ECOLOG; LEWONTIN RC, 1969, P NATL ACAD SCI USA, V62, P1056, DOI 10.1073/pnas.62.4.1056; Linden A, 2009, OIKOS, V118, P675, DOI 10.1111/j.1600-0706.2008.17250.x; MARTIN TE, 1992, ECOLOGY, V73, P579, DOI 10.2307/1940764; McCarthy MA, 2003, CONSERV BIOL, V17, P982, DOI 10.1046/j.1523-1739.2003.01570.x; Meir E, 2000, CONSERV BIOL, V14, P148, DOI 10.1046/j.1523-1739.2000.98502.x; Morris W. F., 2002, QUANTITATIVE CONSERV; Morris WF, 2002, ECOL APPL, V12, P708, DOI 10.2307/3060981; Oli MK, 2003, AM NAT, V161, P422, DOI 10.1086/367591; Regan HM, 2010, ECOLOGY, V91, P1114, DOI 10.1890/09-0287.1; Regan HM, 2003, HUM ECOL RISK ASSESS, V9, P889, DOI 10.1080/713610015; Regan TJ, 2001, ECOL MODEL, V139, P253, DOI 10.1016/S0304-3800(01)00240-X; Regan TJ, 2013, CONSERV BIOL, V27, P821, DOI 10.1111/cobi.12055; Shaffer M, 2002, POPULATION VIABILITY ANALYSIS, P123; SHAFFER ML, 1990, CONSERV BIOL, V4, P39, DOI 10.1111/j.1523-1739.1990.tb00265.x; Stover JP, 2012, THEOR ECOL-NETH, V5, P297, DOI 10.1007/s12080-011-0129-x; The Mathworks Inc, 2007, MATLAB VER 7 14 0; TULJAPURKAR SD, 1980, THEOR POPUL BIOL, V18, P314, DOI 10.1016/0040-5809(80)90057-X; White GC, 1999, BIRD STUDY, V46, P120, DOI 10.1080/00063659909477239; Wilson HB, 2011, CONSERV BIOL, V25, P747, DOI 10.1111/j.1523-1739.2011.01671.x; Zeigler SL, 2013, CONSERV BIOL, V27, P1265, DOI 10.1111/cobi.12130	41	16	16	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0132255	10.1371/journal.pone.0132255	http://dx.doi.org/10.1371/journal.pone.0132255			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26177511	Green Published, gold			2022-12-26	WOS:000358197600093
J	Chadwick, JA; Hauck, JS; Lowe, J; Shaw, JJ; Guttridge, DC; Gomez-Sanchez, CE; Gomez-Sanchez, EP; Rafael-Fortney, JA				Chadwick, Jessica A.; Hauck, J. Spencer; Lowe, Jeovanna; Shaw, Jeremiah J.; Guttridge, Denis C.; Gomez-Sanchez, Celso E.; Gomez-Sanchez, Elise P.; Rafael-Fortney, Jill A.			Mineralocorticoid receptors are present in skeletal muscle and represent a potential therapeutic target	FASEB JOURNAL			English	Article						aldosterone; gene expression microarray; muscular dystrophy; spironolactone; steroid hormone receptors	DUCHENNE MUSCULAR-DYSTROPHY; CONVERTING-ENZYME-INHIBITORS; GENE-EXPRESSION; MONOCLONAL-ANTIBODIES; HEART-FAILURE; TNF-ALPHA; IN-VIVO; C-FOS; ALDOSTERONE; MOUSE	Early treatment with heart failure drugs lisinopril and spironolactone improves skeletal muscle pathology in Duchenne muscular dystrophy (DMD) mouse models. The angiotensin converting enzyme inhibitor lisinopril and mineralocorticoid receptor (MR) antagonist spironolactone indirectly and directly target MR. The presence and function of MR in skeletal muscle have not been explored. MR mRNA and protein are present in all tested skeletal muscles from both wild-typemice and DMD mouse models. MR expression is cell autonomous in both undifferentiated myoblasts and differentiated myotubes from mouse and human skeletal muscle cultures. To test for MR function in skeletal muscle, global gene expression analysis was conducted on human myotubes treated with MR agonist (aldosterone; EC50 1.3 nM) or antagonist (spironolactone; IC50 1.6 nM), and 53 gene expression differences were identified. Five differences were conserved in quadriceps muscles from dystrophic mice treated with spironolactone plus lisinopril (IC50 0.1 nM) compared with untreated controls. Genes down-regulated morethan 2-fold by MR antagonism included FOS, ANKRD1, and GADD45B, with known roles in skeletal muscle, in addition to NPR3 and SERPINA3, bona fide targets of MR in other tissues. MR is a novel drug target in skeletal muscle and use of clinically safe antagonists may be beneficial for muscle diseases.	[Chadwick, Jessica A.; Hauck, J. Spencer; Lowe, Jeovanna; Shaw, Jeremiah J.; Rafael-Fortney, Jill A.] Ohio State Univ, Coll Med, Dept Mol & Cellular Biochem, Columbus, OH 43210 USA; [Chadwick, Jessica A.; Hauck, J. Spencer; Lowe, Jeovanna; Shaw, Jeremiah J.; Rafael-Fortney, Jill A.] Ohio State Univ, Coll Med, Dept Physiol & Cell Biol, Columbus, OH 43210 USA; [Guttridge, Denis C.] Ohio State Univ, Coll Med, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43210 USA; [Gomez-Sanchez, Celso E.] Univ Mississippi, Med Ctr, Dept Internal Med, Jackson, MS 39216 USA; [Gomez-Sanchez, Elise P.] Univ Mississippi, Med Ctr, Dept Pharmacol & Toxicol, Jackson, MS 39216 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University of Mississippi; University of Mississippi Medical Center; University of Mississippi; University of Mississippi Medical Center	Rafael-Fortney, JA (corresponding author), Ohio State Univ, Coll Med, Dept Physiol & Cell Biol, 410 Hamilton Hall,1645 Neil Ave, Columbus, OH 43210 USA.	rafael-fortney.1@osu.edu		Guttridge, Denis/0000-0002-7276-6609; Hauck, J. Spencer/0000-0003-1722-8709	U.S. National Institutes of Health [R01 NS082868, R01 HL116533, T32 NS077984]; Department of Defense [MD120063]; Center for Muscle Health and Neuromuscular Disorders at The Ohio State University (OSU); Center for Muscle Health and Neuromuscular Disorders at Nationwide Children's Hospital; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL116533] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS082868, T32NS077984] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); Center for Muscle Health and Neuromuscular Disorders at The Ohio State University (OSU); Center for Muscle Health and Neuromuscular Disorders at Nationwide Children's Hospital; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the U.S. National Institutes of Health [R01 NS082868 and R01 HL116533 (to J.R.F.), and T32 NS077984 (to J.A.C.)], Department of Defense [MD120063 (to J.R.F.)], and the Center for Muscle Health and Neuromuscular Disorders at The Ohio State University (OSU) and Nationwide Children's Hospital. The authors thank The Ohio State Microarray Core, and in particular S. Warner, for microarray processing and analysis; Pfizer for supplying eplerenone under their Compound Transfer Program; K. J. Ladner (OSU) for RNA preparation for mouse microarray; A. Wodarcyk (OSU) for technical assistance in mouse maintenance, dissections, and genotyping; and S. Swager (OSU) for assistance with confocal imaging.	Anand-Srivastava MB, 2005, PEPTIDES, V26, P1044, DOI 10.1016/j.peptides.2004.09.023; Angelini Corrado, 2012, Acta Myol, V31, P9; ARRIZA JL, 1987, SCIENCE, V237, P268, DOI 10.1126/science.3037703; Bakay M, 2002, NEUROMUSCULAR DISORD, V12, pS125, DOI 10.1016/S0960-8966(02)00093-7; Baker PE, 2006, NEUROGENETICS, V7, P81, DOI 10.1007/s10048-006-0031-7; Bauer R, 2009, EUR J HEART FAIL, V11, P463, DOI 10.1093/eurjhf/hfp028; Bledsoe RK, 2005, J BIOL CHEM, V280, P31283, DOI 10.1074/jbc.M504098200; BULFIELD G, 1984, P NATL ACAD SCI-BIOL, V81, P1189, DOI 10.1073/pnas.81.4.1189; Burniston JG, 2005, J MOL CELL CARDIOL, V39, P395, DOI 10.1016/j.yjmcc.2005.04.001; Casey WM, 2008, BIOMARKERS, V13, P364, DOI [10.1080/13547500801903545, 10.1080/13547500801903545 ]; Caughey GH, 2011, ADV EXP MED BIOL, V716, P212, DOI 10.1007/978-1-4419-9533-9_12; Chitnis AS, 2012, J COMP EFFECT RES, V1, P195, DOI [10.2217/CER.12.5, 10.2217/cer.12.5]; Clyne CD, 2009, MOL CELL ENDOCRINOL, V302, P81, DOI 10.1016/j.mce.2008.11.030; Deconinck AE, 1997, CELL, V90, P717, DOI 10.1016/S0092-8674(00)80532-2; Delyani JA, 2001, CARDIOVASC DRUG REV, V19, P185; DESILVA S, 1987, ARCH NEUROL-CHICAGO, V44, P818, DOI 10.1001/archneur.1987.00520200022012; Duboc D, 2005, J AM COLL CARDIOL, V45, P855, DOI 10.1016/j.jacc.2004.09.078; El Haddad M, 2012, J CELL SCI, V125, P6147, DOI 10.1242/jcs.115220; Emery AEH, 2002, LANCET, V359, P687, DOI 10.1016/S0140-6736(02)07815-7; EVANS RM, 1988, SCIENCE, V240, P889, DOI 10.1126/science.3283939; Garriz JMR, 2009, ENDOCRINOLOGY, V150, P1294, DOI 10.1210/en.2008-1036; Gomez-Sanchez CE, 2006, ENDOCRINOLOGY, V147, P1343, DOI 10.1210/en.2005-0860; Gomez-Sanchez CE, 2011, STEROIDS, V76, P1541, DOI 10.1016/j.steroids.2011.09.004; Gomez-Sanchez EP, 2009, J HISTOCHEM CYTOCHEM, V57, P633, DOI 10.1369/jhc.2009.953059; Gomez-Sanchez EP, 2004, CURR OPIN NEPHROL HY, V13, P191, DOI 10.1097/00041552-200403000-00007; Hawkins UA, 2012, CURR HYPERTENS REP, V14, P573, DOI 10.1007/s11906-012-0297-0; Jaisser F., 2010, U.S. Patent Application, Patent No. 20110257140; Janssen PML, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088360; Kim JH, 2014, HEPATOLOGY, V59, P695, DOI 10.1002/hep.26683; Kojic S, 2011, CRIT REV CL LAB SCI, V48, P269, DOI 10.3109/10408363.2011.643857; Lannan EA, 2012, ENDOCRINOLOGY, V153, P3701, DOI 10.1210/en.2012-1020; Lastra G, 2008, AM J PHYSIOL-ENDOC M, V295, pE110, DOI 10.1152/ajpendo.00258.2007; Latouche C, 2010, ENDOCRINOLOGY, V151, P4467, DOI 10.1210/en.2010-0237; Laure L, 2009, FEBS J, V276, P669, DOI 10.1111/j.1742-4658.2008.06814.x; LOCASCIO V, 1995, CALCIFIED TISSUE INT, V56, P109, DOI 10.1007/BF00296340; Lother A, 2015, ANNU REV PHARMACOL, V55, P289, DOI 10.1146/annurev-pharmtox-010814-124302; Lowe J., 2015, J NEUROMUSC IN PRESS; Mendell JR, 2012, ANN NEUROL, V71, P304, DOI 10.1002/ana.23528; Messaoudi S, 2012, MOL CELL ENDOCRINOL, V350, P266, DOI 10.1016/j.mce.2011.06.038; Nakada C, 2003, LAB INVEST, V83, P711, DOI 10.1097/01.LAB.0000067484.35298.1A; Odermatt A, 2012, MOL CELL ENDOCRINOL, V350, P168, DOI 10.1016/j.mce.2011.07.020; OKAZAKI K, 1995, EMBO J, V14, P5048, DOI 10.1002/j.1460-2075.1995.tb00187.x; Rafael-Fortney JA, 2011, CIRCULATION, V124, P582, DOI 10.1161/CIRCULATIONAHA.111.031716; Raman SV, 2015, LANCET NEUROL, V14, P153, DOI 10.1016/S1474-4422(14)70318-7; Rogerson FM, 2004, CLIN EXP PHARMACOL P, V31, P704, DOI 10.1111/j.1440-1681.2004.04079.x; RUBIN H, 1990, J BIOL CHEM, V265, P1199; SICINSKI P, 1989, SCIENCE, V244, P1578, DOI 10.1126/science.2662404; Stewart CEH, 2004, J CELL PHYSIOL, V198, P237, DOI 10.1002/jcp.10387; Takekawa M, 1998, CELL, V95, P521, DOI 10.1016/S0092-8674(00)81619-0; Tamargo J, 2014, SEMIN NEPHROL, V34, P285, DOI 10.1016/j.semnephrol.2014.04.005; Ueda K, 2014, BIOCHEM BIOPH RES CO, V445, P132, DOI 10.1016/j.bbrc.2014.01.125; Vasques GA, 2014, HORM RES PAEDIAT, V82, P222, DOI 10.1159/000365049; Viengchareun Say, 2007, Nucl Recept Signal, V5, pe012, DOI 10.1621/nrs.05012; WEINBERGER C, 1987, CLIN PHYSIOL BIOCH, V5, P179; Yang J, 2009, J MOL ENDOCRINOL, V43, P53, DOI 10.1677/JME-09-0031; Young MJ, 2012, MOL CELL ENDOCRINOL, V350, P248, DOI 10.1016/j.mce.2011.09.008; Zennaro MC, 2001, MOL ENDOCRINOL, V15, P1586, DOI 10.1210/me.15.9.1586; Zhou L, 2008, J NEUROL SCI, V264, P106, DOI 10.1016/j.jns.2007.08.029	58	32	33	0	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2015	29	11					4544	4554		10.1096/fj.15-276782	http://dx.doi.org/10.1096/fj.15-276782			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CV8EZ	26178166	Green Published			2022-12-26	WOS:000364514700014
J	Patel, VA; Massenburg, D; Vujicic, S; Feng, LF; Tang, MY; Litbarg, N; Antoni, A; Rauch, J; Lieberthal, W; Levine, JS				Patel, Vimal A.; Massenburg, Donald; Vujicic, Snezana; Feng, Lanfei; Tang, Meiyi; Litbarg, Natalia; Antoni, Angelika; Rauch, Joyce; Lieberthal, Wilfred; Levine, Jerrold S.			Apoptotic Cells Activate AMP-activated Protein Kinase (AMPK) and Inhibit Epithelial Cell Growth without Change in Intracellular Energy Stores	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNALING EVENTS; PHOSPHATIDYLINOSITOL 3-KINASE; IMMUNE-RESPONSE; NECROTIC CELLS; AKT; PATHWAY; PHOSPHORYLATION; RECOGNITION; BETA; MECHANISMS	Apoptosis plays an indispensable role in the maintenance and development of tissues. We have shown that receptor-mediated recognition of apoptotic target cells by viable kidney proximal tubular epithelial cells (PTECs) inhibits the proliferation and survival of PTECs. Here, we examined the effect of apoptotic targets on PTEC cell growth (cell size during G1 phase of the cell cycle). Using a cell culture model, we show that apoptotic cells potently activate AMP-activated protein kinase (AMPK), a highly sensitive sensor of intracellular energy stores. AMPK activation leads to decreased activity of its downstream target, ribosomal protein p70 S6 kinase (p70S6K), and concomitant inhibition of cell growth. Importantly, these events occur without detectable change in intracellular levels of AMP, ADP, or ATP. Inhibition of AMPK, either pharmacologically by compound C or molecularly by shRNA, diminishes the effects of apoptotic targets and largely restores p70S6K activity and cell size to normal levels. Apoptotic targets also inhibit Akt, a second signaling pathway regulating cell growth. Expression of a constitutively active Akt construct partially relieved cell growth inhibition but was less effective than inhibition of AMPK. Inhibition of cell growth by apoptotic targets is dependent on physical interaction between apoptotic targets and PTECs but independent of phagocytosis. We conclude that receptor-mediated recognition of apoptotic targets mimics the effects of intracellular energy depletion, activating AMPK and inhibiting cell growth. By acting as sentinels of environmental change, apoptotic death may enable nearby viable cells, especially nonmigratory epithelial cells, to monitor and adapt to local stresses.	Univ Illinois, Nephrol Sect, Chicago, IL 60612 USA; [Patel, Vimal A.; Massenburg, Donald; Vujicic, Snezana; Feng, Lanfei; Litbarg, Natalia; Levine, Jerrold S.] Univ Illinois, Dept Med, Chicago, IL 60612 USA; [Levine, Jerrold S.] Univ Illinois, Dept Microbiol & Immunol, Chicago, IL 60612 USA; [Patel, Vimal A.; Massenburg, Donald; Vujicic, Snezana; Feng, Lanfei; Litbarg, Natalia; Levine, Jerrold S.] Jesse Brown Vet Affairs Hosp, Dept Med, Nephrol Sect, Chicago, IL 60612 USA; [Tang, Meiyi; Lieberthal, Wilfred] SUNY Stony Brook, Med Ctr, Dept Med, Nephrol Sect, Stony Brook, NY 11794 USA; [Tang, Meiyi; Lieberthal, Wilfred] Northport Vet Affairs Hosp, Northport, NY 11768 USA; [Antoni, Angelika] Kutztown Univ Penn, Dept Biol, Kutztown, PA 19530 USA; [Rauch, Joyce] McGill Univ, Ctr Hlth, Res Inst, Div Rheumatol,Dept Med, Montreal, PQ H4A 3J1, Canada	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; US Department of Veterans Affairs; Veterans Health Administration (VHA); Jesse Brown VA Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Pennsylvania State System of Higher Education (PASSHE); Kutztown University - Pennsylvania; McGill University	Levine, JS (corresponding author), Univ Illinois, Dept Med, Nephrol Sect, 840 South Wood St,MC-793, Chicago, IL 60612 USA.	jslevine@uic.edu			National Institutes of Health from NCRR [S10RR024516]; Section of Nephrology, University of Illinois at Chicago; Canadian Institutes of Health Research [MOP-67101, MOP-97916]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR024516] Funding Source: NIH RePORTER	National Institutes of Health from NCRR; Section of Nephrology, University of Illinois at Chicago; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported, in whole or in part, by National Institutes of Health Grant S10RR024516 from NCRR (for purchase of the 5500 QTRAP LC/MS/MS system). This work was also supported by institutional funds from Dr. Jose A. Arruda and the Section of Nephrology, University of Illinois at Chicago (to J. S. L. and N. L.), and Operating Grants MOP-67101 and MOP-97916 from the Canadian Institutes of Health Research (to J. R.). The authors declare that they have no conflicts of interest with the contents of this article.	Alexander A, 2010, P NATL ACAD SCI USA, V107, P4153, DOI 10.1073/pnas.0913860107; Anderson KA, 2008, CELL METAB, V7, P377, DOI 10.1016/j.cmet.2008.02.011; Ariel A, 2006, NAT IMMUNOL, V7, P1209, DOI 10.1038/ni1392; Birge RB, 2008, CELL DEATH DIFFER, V15, P1096, DOI 10.1038/cdd.2008.58; Cai SL, 2006, J CELL BIOL, V173, P279, DOI 10.1083/jcb.200507119; Chen P, 2009, PHARM RES-DORDR, V26, P1504, DOI 10.1007/s11095-009-9863-9; Corradetti MN, 2004, GENE DEV, V18, P1533, DOI 10.1101/gad.1199104; Cvetanovic M, 2004, J IMMUNOL, V172, P880, DOI 10.4049/jimmunol.172.2.880; Cvetanovic M, 2006, J BIOL CHEM, V281, P20055, DOI 10.1074/jbc.M603920200; Dan HC, 2002, J BIOL CHEM, V277, P35364, DOI 10.1074/jbc.M205838200; Djouder N, 2010, EMBO J, V29, P469, DOI 10.1038/emboj.2009.339; Dowling RJO, 2010, SCIENCE, V328, P1172, DOI 10.1126/science.1187532; Esmann L, 2010, J IMMUNOL, V184, P391, DOI 10.4049/jimmunol.0900564; Eves EM, 1998, MOL CELL BIOL, V18, P2143, DOI 10.1128/MCB.18.4.2143; Fadok VA, 1998, J CLIN INVEST, V101, P890, DOI 10.1172/JCI1112; Feng ZH, 2005, P NATL ACAD SCI USA, V102, P8204, DOI 10.1073/pnas.0502857102; Fogarty S, 2010, BIOCHEM J, V426, P109, DOI 10.1042/BJ20091372; Gaidhu MP, 2006, J BIOL CHEM, V281, P25956, DOI 10.1074/jbc.M602992200; Gwinn DM, 2008, MOL CELL, V30, P214, DOI 10.1016/j.molcel.2008.03.003; Hardie DG, 2012, NAT REV MOL CELL BIO, V13, P251, DOI 10.1038/nrm3311; Hawley SA, 2005, CELL METAB, V2, P9, DOI 10.1016/j.cmet.2005.05.009; Hess KL, 1997, EXP CELL RES, V236, P404, DOI 10.1006/excr.1997.3745; Hochreiter-Hufford A, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a008748; Inoki K, 2002, NAT CELL BIOL, V4, P648, DOI 10.1038/ncb839; JAT PS, 1991, P NATL ACAD SCI USA, V88, P5096, DOI 10.1073/pnas.88.12.5096; Kennedy SG, 1997, GENE DEV, V11, P701, DOI 10.1101/gad.11.6.701; King TD, 2006, BIOCHEM PHARMACOL, V71, P1637, DOI 10.1016/j.bcp.2006.03.005; Li F, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000634; Lieberthal W, 2012, AM J PHYSIOL-RENAL, V303, pF1, DOI 10.1152/ajprenal.00014.2012; Lieberthal W, 2011, AM J PHYSIOL-RENAL, V301, pF1177, DOI 10.1152/ajprenal.00034.2011; Lucas M, 2003, J IMMUNOL, V171, P2610, DOI 10.4049/jimmunol.171.5.2610; Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672; Magnuson B, 2012, BIOCHEM J, V441, P1, DOI 10.1042/BJ20110892; Oakhill JS, 2011, SCIENCE, V332, P1433, DOI 10.1126/science.1200094; Obeid M, 2007, NAT MED, V13, P54, DOI 10.1038/nm1523; Patel VA, 2006, J BIOL CHEM, V281, P4663, DOI 10.1074/jbc.M508342200; Patel VA, 2012, J BIOL CHEM, V287, P13761, DOI 10.1074/jbc.M112.350843; Patel VA, 2010, J BIOL CHEM, V285, P1829, DOI 10.1074/jbc.M109.018440; Patel VA, 2009, AUTOIMMUNITY, V42, P317, DOI 10.1080/08916930902832124; Peter C, 2010, APOPTOSIS, V15, P1007, DOI 10.1007/s10495-010-0472-1; Rabinowitz JD, 2007, ANAL CHEM, V79, P6167, DOI 10.1021/ac070470c; Racioppi L, 2012, J BIOL CHEM, V287, P31658, DOI 10.1074/jbc.R112.356485; Reddy SM, 2002, J IMMUNOL, V169, P702, DOI 10.4049/jimmunol.169.2.702; Rothlin CV, 2007, CELL, V131, P1124, DOI 10.1016/j.cell.2007.10.034; Sancak Y, 2007, MOL CELL, V25, P903, DOI 10.1016/j.molcel.2007.03.003; Schwab JM, 2007, NATURE, V447, P869, DOI 10.1038/nature05877; Shaw RJ, 2004, P NATL ACAD SCI USA, V101, P3329, DOI 10.1073/pnas.0308061100; Sinha D, 2005, AM J PHYSIOL-RENAL, V288, pF703, DOI 10.1152/ajprenal.00189.2004; Steinberg GR, 2009, PHYSIOL REV, V89, P1025, DOI 10.1152/physrev.00011.2008; Vander Haar E, 2007, NAT CELL BIOL, V9, P316, DOI 10.1038/ncb1547; Voll RE, 1997, NATURE, V390, P350, DOI 10.1038/37022; Wallach D, 2014, NAT REV IMMUNOL, V14, P51, DOI 10.1038/nri3561; Wayman GA, 1997, J BIOL CHEM, V272, P16073, DOI 10.1074/jbc.272.26.16073; Woods A, 2005, CELL METAB, V2, P21, DOI 10.1016/j.cmet.2005.06.005; Zernecke A, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000610; Zmijewski JW, 2010, J BIOL CHEM, V285, P33154, DOI 10.1074/jbc.M110.143685	56	15	16	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	2015	290	37					22352	22369		10.1074/jbc.M115.667345	http://dx.doi.org/10.1074/jbc.M115.667345			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CR2PB	26183782	hybrid, Green Published, Green Submitted			2022-12-26	WOS:000361171500004
J	Yang, XX; Yao, H; Chen, YL; Sun, L; Li, Y; Ma, XZ; Duan, SZ; Li, XJ; Xiang, R; Han, JH; Duan, YJ				Yang, Xiaoxiao; Yao, Hui; Chen, Yuanli; Sun, Lei; Li, Yan; Ma, Xingzhe; Duan, Shengzhong; Li, Xiaoju; Xiang, Rong; Han, Jihong; Duan, Yajun			Inhibition of Glutathione Production Induces Macrophage CD36 Expression and Enhances Cellular-oxidized Low Density Lipoprotein (oxLDL) Uptake	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							E-DEFICIENT MICE; MONOCYTE-DERIVED MACROPHAGES; B SCAVENGER RECEPTOR; VITAMIN-E; PPAR-GAMMA; MYOCARDIAL-INFARCTION; CARDIOVASCULAR EVENTS; MODIFIER SUBUNIT; OXIDATIVE STRESS; GENE-EXPRESSION	The glutathione (GSH)-dependent antioxidant system has been demonstrated to inhibit atherosclerosis. Macrophage CD36 uptakes oxidized low density lipoprotein (oxLDL) thereby facilitating foam cell formation and development of atherosclerosis. It remains unknown if GSH can influence macrophage CD36 expression and cellular oxLDL uptake directly. Herein we report that treatment of macrophages with L-buthionine-S, R-sulfoximine (BSO) decreased cellular GSH production and ratios of GSH to glutathione disulfide (GSH/GSSG) while increasing production of reactive oxygen species. Associated with decreased GSH levels, macrophage CD36 expression was increased, which resulted in enhanced cellular oxLDL uptake. In contrast, N-acetyl cysteine and antioxidant enzyme (catalase or superoxide dismutase) blocked BSO-induced CD36 expression as well as oxLDL uptake. In vivo, administration of mice with BSO increased CD36 expression in peritoneal macrophages and kidneys. BSO had no effect on CD36 mRNA expression and promoter activity but still induced CD36 protein expression in macrophages lacking peroxisome proliferator-activated receptor gamma expression, suggesting it induced CD36 expression at the translational level. Indeed, we determined that BSO enhanced CD36 translational efficiency. Taken together, our study demonstrates that cellular GSH levels and GSH/GSSG status can regulate macrophage CD36 expression and cellular oxLDL uptake and demonstrate an important anti-atherogenic function of the GSH-dependent antioxidant system by providing a novel molecular mechanism.	[Yang, Xiaoxiao; Yao, Hui; Chen, Yuanli; Xiang, Rong; Han, Jihong; Duan, Yajun] Nankai Univ, State Key Lab Med Chem Biol, Tianjin 300071, Peoples R China; [Yang, Xiaoxiao; Yao, Hui; Sun, Lei; Li, Yan; Ma, Xingzhe; Li, Xiaoju; Duan, Yajun] Nankai Univ, Coll Life Sci, Tianjin 300071, Peoples R China; [Chen, Yuanli; Xiang, Rong] Nankai Univ, Coll Med, Tianjin 300071, Peoples R China; [Chen, Yuanli; Han, Jihong] Nankai Univ, Collaborat Innovat Ctr Biotherapy, Tianjin 300071, Peoples R China; [Duan, Shengzhong] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Nutr Sci, Shanghai 200031, Peoples R China	Nankai University; Nankai University; Nankai University; Nankai University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Han, JH (corresponding author), Nankai Univ, Coll Life Sci, 94 Weijin Rd, Tianjin 300071, Peoples R China.	jihonghan2008@nankai.edu.cn; yajunduan@nankai.edu.cn			National Science Foundation of China (NSFC) [81272460, 81473204, 31400694]; Tianjin Municipal Science and Technology Commission of China [14JCY-BJC25100, 13JCYBJC24600]; Nankai University	National Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Tianjin Municipal Science and Technology Commission of China; Nankai University	This work was supported by National Science Foundation of China (NSFC) Grants 81272460 and 81473204 (to J. H.) and 31400694 (to Y. C.), Tianjin Municipal Science and Technology Commission of China Grants 14JCY-BJC25100 (to Y. D.) and 13JCYBJC24600 (to X. L.), respectively, and the Ph.D. Candidate Research Innovation Fund of Nankai University (to X. Y.). The authors declare that they have no conflicts of interest with the contents of this article.	Aranda A, 2013, TOXICOL IN VITRO, V27, P954, DOI 10.1016/j.tiv.2013.01.016; Aviram M, 1999, ANTIOXID REDOX SIGN, V1, P585, DOI 10.1089/ars.1999.1.4-585; Babaev VR, 2011, FREE RADICAL BIO MED, V50, P27, DOI 10.1016/j.freeradbiomed.2010.10.702; Babaev VR, 2010, ARTERIOSCL THROM VAS, V30, P1751, DOI 10.1161/ATVBAHA.110.209502; Babaev VR, 2005, ARTERIOSCL THROM VAS, V25, P1647, DOI 10.1161/01.ATV.0000173413.31789.1a; Blankenberg S, 2003, NEW ENGL J MED, V349, P1605, DOI 10.1056/NEJMoa030535; Callegari A, 2011, ARTERIOSCL THROM VAS, V31, P2473, DOI 10.1161/ATVBAHA.111.229765; Chen L, 2010, LAB INVEST, V90, P762, DOI 10.1038/labinvest.2010.36; Chen Y, 2005, J BIOL CHEM, V280, P33766, DOI 10.1074/jbc.M504604200; Chen YL, 2012, J BIOL CHEM, V287, P43340, DOI 10.1074/jbc.M112.403394; Cook NR, 2007, ARCH INTERN MED, V167, P1610, DOI 10.1001/archinte.167.15.1610; David A, 2012, J CELL BIOL, V197, P45, DOI 10.1083/jcb.201112145; Devaraj S, 2001, J LIPID RES, V42, P521; ENDEMANN G, 1993, J BIOL CHEM, V268, P11811; Febbraio M, 2000, J CLIN INVEST, V105, P1049, DOI 10.1172/JCI9259; Goodman CA, 2011, FASEB J, V25, P1028, DOI 10.1096/fj.10-168799; Griffin E, 2001, NAT MED, V7, P840, DOI 10.1038/89969; GRIFFITH OW, 1985, P NATL ACAD SCI USA, V82, P4668, DOI 10.1073/pnas.82.14.4668; GRIFFITH OW, 1979, J BIOL CHEM, V254, P7558; Han JH, 1997, J BIOL CHEM, V272, P21654, DOI 10.1074/jbc.272.34.21654; Kersten S, 2000, NATURE, V405, P421, DOI 10.1038/35013000; Koide S, 2003, J AM COLL CARDIOL, V41, P539, DOI 10.1016/S0735-1097(02)02866-8; Kotla S, 2014, FREE RADICAL BIO MED, V76, P147, DOI 10.1016/j.freeradbiomed.2014.08.007; Lee JG, 2008, CELL SIGNAL, V20, P2266, DOI 10.1016/j.cellsig.2008.08.022; Lewis P, 2007, CIRCULATION, V115, P2178, DOI 10.1161/CIRCULATIONAHA.106.664250; MACH M, 1986, J BIOL CHEM, V261, P1697; MEISTER A, 1983, ANNU REV BIOCHEM, V52, P711, DOI 10.1146/annurev.bi.52.070183.003431; Nagy L, 1998, CELL, V93, P229, DOI 10.1016/S0092-8674(00)81574-3; Nakamura S, 2002, CIRCULATION, V105, P2968, DOI 10.1161/01.CIR.0000019739.66514.1E; NICHOLSON AC, 1995, ARTERIOSCL THROM VAS, V15, P269, DOI 10.1161/01.ATV.15.2.269; Nikulina MA, 2000, CYTOKINE, V12, P1391, DOI 10.1006/cyto.2000.0712; NOZAKI S, 1995, J CLIN INVEST, V96, P1859, DOI 10.1172/JCI118231; Qiao M, 2007, ARTERIOSCL THROM VAS, V27, P1375, DOI 10.1161/ATVBAHA.107.142109; Qiao M, 2009, ARTERIOSCL THROM VAS, V29, P1779, DOI 10.1161/ATVBAHA.109.191759; Rahaman SO, 2006, CELL METAB, V4, P211, DOI 10.1016/j.cmet.2006.06.007; Rahman I, 2006, NAT PROTOC, V1, P3159, DOI 10.1038/nprot.2006.378; Ricciarelli R, 2000, CIRCULATION, V102, P82, DOI 10.1161/01.CIR.102.1.82; Rosenblat M, 1998, FREE RADICAL BIO MED, V24, P305, DOI 10.1016/S0891-5849(97)00231-1; Schmidt EK, 2009, NAT METHODS, V6, P275, DOI [10.1038/NMETH.1314, 10.1038/nmeth.1314]; Schwenke DC, 1998, CIRC RES, V83, P366, DOI 10.1161/01.RES.83.4.366; Sesso HD, 2008, JAMA-J AM MED ASSOC, V300, P2123, DOI 10.1001/jama.2008.600; Silverstein Roy L, 2010, Trans Am Clin Climatol Assoc, V121, P206; Sun L, 2003, J LIPID RES, V44, P1877, DOI 10.1194/jlr.M300084-JLR200; Thomas SR, 2001, ARTERIOSCL THROM VAS, V21, P585, DOI 10.1161/01.ATV.21.4.585; Tontonoz P, 1998, CELL, V93, P241, DOI 10.1016/S0092-8674(00)81575-5; Torzewski M, 2007, ARTERIOSCL THROM VAS, V27, P850, DOI 10.1161/01.ATV.0000258809.47285.07; Wang C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103071; Wang C, 2014, BIOCHEM BIOPH RES CO, V447, P57, DOI 10.1016/j.bbrc.2014.03.103; Zhang BT, 2013, MOL CELL BIOL, V33, P4919, DOI 10.1128/MCB.00787-13; Zhang H, 2014, FREE RADICAL BIO MED, V69, P219, DOI 10.1016/j.freeradbiomed.2014.01.025	50	41	41	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	2015	290	36					21788	21799		10.1074/jbc.M115.654582	http://dx.doi.org/10.1074/jbc.M115.654582			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CQ9XI	26187465	Green Published, hybrid			2022-12-26	WOS:000360968500002
J	Orsenigo, S; Abeli, T; Rossi, G; Bonasoni, P; Pasquaretta, C; Gandini, M; Mondoni, A				Orsenigo, Simone; Abeli, Thomas; Rossi, Graziano; Bonasoni, Paolo; Pasquaretta, Cristian; Gandini, Maurizia; Mondoni, Andrea			Effects of Autumn and Spring Heat Waves on Seed Germination of High Mountain Plants	PLOS ONE			English	Article							CLIMATE EXTREMES; ELEVATED CO2; GROWTH; TOLERANCE; RESPONSES; TEMPERATURE; VEGETATION; EUROPE; ESTABLISHMENT; REPRODUCTION	Alpine plants are considered to be particularly vulnerable to climate change and related extreme episodes, such as heat waves. Despite growing interest in the impact of heat waves on alpine plants, knowledge about their effects on regeneration is still fragmentary. Recruitment from seeds will be crucial for the successful migration and survival of these species and will play a key role in their future adaptation to climate change. In this study, we assessed the impacts of heat waves on the seed germination of 53 high mountain plants from the Northern Apennines ( Italy). The seeds were exposed to laboratory simulations of three seasonal temperature treatments, derived from real data recorded at a meteorological station near the species growing site, which included two heat wave episodes that occurred both in spring 2003 and in autumn 2011. Moreover, to consider the effect of increasing drought conditions related to heat waves, seed germination was also investigated under four different water potentials. In the absence of heat waves, seed germination mainly occurred in spring, after seeds had experienced autumn and winter seasons. However, heat waves resulted in a significant increase of spring germination in c. 30% of the species and elicited autumn germination in 50%. When heat waves were coupled with drought, seed germination decreased in all species, but did not stop completely. Our results suggest that in the future, heat waves will affect the germination phenology of alpine plants, especially conditionally dormant and strictly cold-adapted chorotypes, by shifting the emergence time from spring to autumn and by increasing the proportion of emerged seedlings. The detrimental effects of heat waves on recruitment success is less likely to be due to the inhibition of seed germination per se, but rather due to seedling survival in seasons, and temperature and water conditions that they are not used to experiencing. Changes in the proportion and timing of emergence suggest that there may be major implications for future plant population size and structure.	[Orsenigo, Simone; Abeli, Thomas; Rossi, Graziano; Mondoni, Andrea] Univ Pavia, Dept Earth & Environm Sci, I-27100 Pavia, Italy; [Bonasoni, Paolo] Inst Atmospher Sci & Climate, Bologna, Italy; [Pasquaretta, Cristian] CNRS, Inst Pluridisciplinaire Hubert Curien, Strasbourg, France; [Gandini, Maurizia] MUSE Sci Museum, Trento, Italy	University of Pavia; Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienze dell'Atmosfera e del Clima (ISAC-CNR); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Orsenigo, S (corresponding author), Univ Milan, Dept Agr & Environm Sci Prod Landscape Agroenergy, Milan, Italy.	simone.orsenigo@unipv.it	Pasquaretta, Cristian/AAA-3364-2021; Rossi, Graziano/P-3353-2015; Orsenigo, Simone/E-5961-2017; Bonasoni, Paolo/C-6338-2015	Pasquaretta, Cristian/0000-0001-8308-9968; Rossi, Graziano/0000-0002-5102-5019; Orsenigo, Simone/0000-0003-0348-9115; Bonasoni, Paolo/0000-0002-8812-5291; MONDONI, ANDREA/0000-0002-4605-6304; Abeli, Thomas/0000-0003-3096-2035	Ministry of Education, University and Research (MIUR); Provincia Autonoma di Trento, through the program "People" (Marie Curie Action - COFUND) within European Union's Seventh Framework Programme (FP7)	Ministry of Education, University and Research (MIUR)(Ministry of Education, Universities and Research (MIUR)); Provincia Autonoma di Trento, through the program "People" (Marie Curie Action - COFUND) within European Union's Seventh Framework Programme (FP7)	This work was carried out in the framework of SHARE project (Ev-K2-CNR, Bergamo), of the Italian Project of National Interest NextData, supported by the Ministry of Education, University and Research (MIUR), and of the project CLIMBIVEG, funded by the Provincia Autonoma di Trento, through the program "People" (Marie Curie Action - COFUND) within European Union's Seventh Framework Programme (FP7).	Abeli T, 2014, AGROCHIMICA, V58, P128; Abeli T, 2012, NORD J BOT, V30, P109, DOI 10.1111/j.1756-1051.2011.01303.x; ALESSANDRINI A., 2003, FLORA ALTITUDINE APP; Andrello M, 2012, BIOL CONSERV, V147, P99, DOI 10.1016/j.biocon.2011.12.012; [Anonymous], 2014, R LANG ENV STAT COMP; ARPA, 2010, ATL IDR EM ROM 1961; Ballester J, 2010, CLIM DYNAM, V35, P1191, DOI 10.1007/s00382-009-0641-5; Baskin CC, 2014, SEEDS: ECOLOGY, BIOGEOGRAPHY, AND EVOLUTION OF DORMANCY AND GERMINATION, 2ND EDITION, P1, DOI 10.1016/B978-0-12-416677-6.00001-9; Bauweraerts I, 2014, PLANT ECOL, V215, P733, DOI 10.1007/s11258-014-0352-9; Bokhorst S, 2011, GLOBAL CHANGE BIOL, V17, P2817, DOI 10.1111/j.1365-2486.2011.02424.x; Buchner O, 2003, ARCT ANTARCT ALP RES, V35, P411, DOI 10.1657/1523-0430(2003)035[0411:VOHTIA]2.0.CO;2; Christensen JH, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P847; Ciais P, 2005, NATURE, V437, P529, DOI 10.1038/nature03972; Conti F., 2005, ANNOTATED CHECKLIST, V4, P227; De Boeck HJ, 2011, NEW PHYTOL, V189, P806, DOI 10.1111/j.1469-8137.2010.03515.x; De Boeck HJ, 2010, GLOBAL CHANGE BIOL, V16, P1992, DOI 10.1111/j.1365-2486.2009.02049.x; Easterling DR, 2000, SCIENCE, V289, P2068, DOI 10.1126/science.289.5487.2068; Elguindi N, 2013, CLIMATIC CHANGE, V117, P415, DOI 10.1007/s10584-012-0528-z; Erlat E, 2013, INT J CLIMATOL, V33, P1898, DOI 10.1002/joc.3556; EVANS CE, 1990, NEW PHYTOL, V115, P539, DOI 10.1111/j.1469-8137.1990.tb00482.x; Gerdol R, 2008, NEW PHYTOL, V179, P142, DOI 10.1111/j.1469-8137.2008.02429.x; Gerdol R, 2013, J VEG SCI, V24, P569, DOI 10.1111/j.1654-1103.2012.01472.x; Gill EC, 2013, J GEOPHYS RES-ATMOS, V118, P8297, DOI 10.1002/jgrd.50635; Gottfried M, 2012, NAT CLIM CHANGE, V2, P111, DOI [10.1038/nclimate1329, 10.1038/NCLIMATE1329]; Graae BJ, 2009, POLAR BIOL, V32, P1117, DOI 10.1007/s00300-009-0608-3; Hamilton EW, 2008, J INTEGR PLANT BIOL, V50, P1375, DOI 10.1111/j.1744-7909.2008.00747.x; Hay F.R., 2003, SEED CONSERVATION TU, P97; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; Hoyle GL, 2013, GLOBAL CHANGE BIOL, V19, P1549, DOI 10.1111/gcb.12135; IPCC (Intergovernmental Panel on Climate Change), 2013, CLIMATE CHANGE 2013; Korner C, 2003, ALPINE PLANT LIFE FU, DOI DOI 10.1007/978-3-030-59538-8; Larcher W, 2010, FLORA, V205, P3, DOI 10.1016/j.flora.2008.12.005; Marcante S, 2014, PLANT ECOL, V215, P747, DOI 10.1007/s11258-014-0361-8; Marcante S, 2012, J VEG SCI, V23, P858, DOI 10.1111/j.1654-1103.2012.01411.x; MICHEL BE, 1973, PLANT PHYSIOL, V51, P914, DOI 10.1104/pp.51.5.914; Milbau A, 2009, ANN BOT-LONDON, V104, P287, DOI 10.1093/aob/mcp117; Mondoni A, 2015, ANN BOT LON IN PRESS; Mondoni A, 2012, ANN BOT-LONDON, V110, P155, DOI 10.1093/aob/mcs097; Niu SL, 2014, ENVIRON EXP BOT, V98, P13, DOI 10.1016/j.envexpbot.2013.10.004; Nogues-Bravo D, 2007, GLOBAL ENVIRON CHANG, V17, P420, DOI 10.1016/j.gloenvcha.2006.11.007; Ooi MKJ, 2012, PLANT SOIL, V353, P289, DOI 10.1007/s11104-011-1032-3; Orlowsky B, 2012, CLIMATIC CHANGE, V110, P669, DOI 10.1007/s10584-011-0122-9; Orsenigo S, 2014, PLANT ECOL, V215, P677, DOI 10.1007/s11258-014-0363-6; Parolo G, 2008, BASIC APPL ECOL, V9, P100, DOI 10.1016/j.baae.2007.01.005; Passalacqua NG, 2015, J BIOGEOGR, V42, P611, DOI 10.1111/jbi.12473; Pauli H, 2012, SCIENCE, V336, P353, DOI 10.1126/science.1219033; Penuelas J, 2007, GLOBAL CHANGE BIOL, V13, P2563, DOI 10.1111/j.1365-2486.2007.01464.x; Peruzzi L., 2010, INFORM BOT ITALIANO, V42, P151; Probert R. J., 2000, Seeds: the ecology of regeneration in plant communities, P261, DOI 10.1079/9780851994321.0261; Schaberg PG, 2008, GLOBAL CHANGE BIOL, V14, P1282, DOI 10.1111/j.1365-2486.2008.01577.x; Schwienbacher E, 2011, FLORA, V206, P845, DOI 10.1016/j.flora.2011.05.001; Seneviratne SI, 2010, EARTH-SCI REV, V99, P125, DOI 10.1016/j.earscirev.2010.02.004; Shaver GR, 1997, PLANT FUNCTIONAL TYP, P153; Sherry RA, 2007, P NATL ACAD SCI USA, V104, P198, DOI 10.1073/pnas.0605642104; Shevtsova A, 2009, GLOBAL CHANGE BIOL, V15, P2662, DOI 10.1111/j.1365-2486.2009.01947.x; Smith MD, 2011, J ECOL, V99, P656, DOI 10.1111/j.1365-2745.2011.01798.x; Stanisci A, 2016, PLANT BIOSYST, V150, P227, DOI 10.1080/11263504.2014.968232; Tank AMGK, 2003, J CLIMATE, V16, P3665, DOI [10.1175/1520-0442(2003)016<3665:TIIODT>2.0.CO;2, 10.1175/1520-0442(2003)016&lt;3665:TIIODT&gt;2.0.CO;2]; Theurillat JP, 2001, CLIMATIC CHANGE, V50, P77, DOI 10.1023/A:1010632015572; Tomaselli M., 1994, FITOSOCIOLOGIA, V26, P35; Trenberth KE, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL022760; Valt M, 2010, COLD REG SCI TECHNOL, V64, P146, DOI 10.1016/j.coldregions.2010.08.008; Walck JL, 2011, GLOBAL CHANGE BIOL, V17, P2145, DOI 10.1111/j.1365-2486.2010.02368.x; Walker MD, 2006, P NATL ACAD SCI USA, V103, P1342, DOI 10.1073/pnas.0503198103; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a	65	28	32	3	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0133626	10.1371/journal.pone.0133626	http://dx.doi.org/10.1371/journal.pone.0133626			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LZ	26197387	Green Published, Green Submitted, gold			2022-12-26	WOS:000358547600122
J	Roman, E; Alonso-Monge, R; Miranda, A; Pla, J				Roman, Elvira; Alonso-Monge, Rebeca; Miranda, Alberto; Pla, Jesus			The Mkk2 MAPKK Regulates Cell Wall Biogenesis in Cooperation with the Cek1-Pathway in Candida albicans	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; GLOBAL TRANSCRIPTIONAL RESPONSE; OXIDATIVE-STRESS-RESPONSE; SACCHAROMYCES-CEREVISIAE; CHLAMYDOSPORE FORMATION; HYPHAL FORMATION; GENE-EXPRESSION; YEAST; PATHWAY; VIRULENCE	The cell wall integrity pathway (CWI) plays an important role in the biogenesis of the cell wall in Candida albicans and other fungi. In the present work, the C. albicans MKK2 gene that encodes the putative MAPKK of this pathway was deleted in different backgrounds and the phenotypes of the resultant mutants were characterised. We show here that Mkk2 mediates the phosphorylation of the Mkc1 MAPK in response to cell wall assembly interfering agents such as zymolyase or tunicamycin and also to oxidative stress. Remarkably, mkk2 and mkc1 mutants display related but distinguishable-cell wall associated phenotypes and differ in the pattern of MAPK phosphorylation under different stress conditions. mkk2 and mkc1 mutants display an altered expression of GSC1, CEK1 and CRH11 genes at different temperatures. Combined deletion of MKK2 with HST7 supports a cooperative role for the Cek1-mediated and CWI pathways in regulating cell wall architecture under vegetative growth. However, and in contrast to Mkc1, Mkk2 does not seem to play a role in the virulence of C. albicans in the mouse systemic model or the Galleria mellonella model of infection.	[Roman, Elvira; Alonso-Monge, Rebeca; Miranda, Alberto; Pla, Jesus] Univ Complutense Madrid, Fac Farm, Dept Microbiol 2, E-28040 Madrid, Spain	Complutense University of Madrid	Pla, J (corresponding author), Univ Complutense Madrid, Fac Farm, Dept Microbiol 2, Plaza Ramon y Cajal S-N, E-28040 Madrid, Spain.	jpla@ucm.es	Alonso, Rebeca/H-8841-2015; Román, Elvira/H-8894-2015; Pla, Jesús/ABG-9609-2020; Pla, Jesús/G-8238-2015; GONZALEZ, ELVIRA ROMAN/U-3576-2019	Román, Elvira/0000-0002-7335-7292; Pla, Jesús/0000-0003-0897-1963; GONZALEZ, ELVIRA ROMAN/0000-0002-7335-7292; Alonso Monge, Rebeca/0000-0001-8390-917X; Miranda-Bedate, Alberto/0000-0003-2623-2857	 [BIO2012-31839];  [PIM2010EPA-00658];  [S2010-BMD2414]	; ; 	Work in the authors' laboratory is supported by Grants BIO2012-31839, PIM2010EPA-00658 and S2010-BMD2414. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso-Monge R, 1999, J BACTERIOL, V181, P3058, DOI 10.1128/JB.181.10.3058-3068.1999; Alonso-Monge R, 2003, EUKARYOT CELL, V2, P351, DOI 10.1128/EC.2.2.351-361.2003; Alonso-Monge R, 2009, EVOLUTIONARY BIOL BA, P105; Arana DM, 2007, CELL MICROBIOL, V9, P1647, DOI 10.1111/j.1462-5822.2007.00898.x; Arana DM, 2005, MICROBIOL-SGM, V151, P1033, DOI 10.1099/mic.0.27723-0; Arvanitis M, 2013, BBA-MOL BASIS DIS, V1832, P1378, DOI 10.1016/j.bbadis.2013.03.008; Brand A, 2004, EUKARYOT CELL, V3, P900, DOI 10.1128/EC.3.4.900-909.2004; Brennan M, 2002, FEMS IMMUNOL MED MIC, V34, P153, DOI 10.1111/j.1574-695X.2002.tb00617.x; Chauhan N, 2003, EUKARYOT CELL, V2, P1018, DOI 10.1128/EC.2.5.1018-1024.2003; Cheetham J, 2007, MOL BIOL CELL, V18, P4603, DOI 10.1091/mbc.E07-06-0581; Cotter G, 2000, FEMS IMMUNOL MED MIC, V27, P163, DOI 10.1111/j.1574-695X.2000.tb01427.x; Diez-Orejas R, 1997, INFECT IMMUN, V65, P833; Eisman B, 2006, EUKARYOT CELL, V5, P347, DOI 10.1128/EC.5.2.347-358.2006; Enjalbert B, 2006, MOL BIOL CELL, V17, P1018, DOI 10.1091/mbc.E05-06-0501; FONZI WA, 1993, GENETICS, V134, P717; Galan-Diez M, 2010, INFECT IMMUN, V78, P1426, DOI 10.1128/IAI.00989-09; Gantner BN, 2005, EMBO J, V24, P1277, DOI 10.1038/sj.emboj.7600594; Garcia R, 2004, J BIOL CHEM, V279, P15183, DOI 10.1074/jbc.M312954200; Heilmann CJ, 2013, EUKARYOT CELL, V12, P254, DOI 10.1128/EC.00278-12; de Dios CH, 2013, FUNGAL GENET BIOL, V50, P21, DOI 10.1016/j.fgb.2012.11.001; IRIE K, 1993, MOL CELL BIOL, V13, P3076, DOI 10.1128/MCB.13.5.3076; Jendretzki A, 2011, EUR J CELL BIOL, V90, P740, DOI 10.1016/j.ejcb.2011.04.006; Jimenez-Sanchez M, 2007, J BIOL CHEM, V282, P31174, DOI 10.1074/jbc.M706270200; Kamada Y, 1996, J BIOL CHEM, V271, P9193, DOI 10.1074/jbc.271.16.9193; Kohler JR, 1996, P NATL ACAD SCI USA, V93, P13223, DOI 10.1073/pnas.93.23.13223; Kumamoto CA, 2005, P NATL ACAD SCI USA, V102, P5576, DOI 10.1073/pnas.0407097102; LaFayette SL, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001069; Lay J, 1998, INFECT IMMUN, V66, P5301, DOI 10.1128/IAI.66.11.5301-5306.1998; Leach MD, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003069; Leberer E, 1996, P NATL ACAD SCI USA, V93, P13217, DOI 10.1073/pnas.93.23.13217; Lee BN, 1999, P NATL ACAD SCI USA, V96, P12679, DOI 10.1073/pnas.96.22.12679; Li DM, 2009, FUNGAL GENET BIOL, V46, P731, DOI 10.1016/j.fgb.2009.06.008; LIU HP, 1994, SCIENCE, V266, P1723, DOI 10.1126/science.7992058; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Madhani HD, 1997, SCIENCE, V275, P1314, DOI 10.1126/science.275.5304.1314; Martin H, 2000, J BIOL CHEM, V275, P1511, DOI 10.1074/jbc.275.2.1511; MAZUR P, 1995, MOL CELL BIOL, V15, P5671; Mio T, 1997, J BACTERIOL, V179, P4096, DOI 10.1128/jb.179.13.4096-4105.1997; Monge RA, 2006, MICROBIOL-SGM, V152, P905, DOI 10.1099/mic.0.28616-0; Munro CA, 2007, MOL MICROBIOL, V63, P1399, DOI 10.1111/j.1365-2958.2007.05588.x; Naglik JR, 2011, MICROBES INFECT, V13, P963, DOI 10.1016/j.micinf.2011.06.009; Navarro-Garcia F, 2005, MICROBIOL-SGM, V151, P2737, DOI 10.1099/mic.0.28038-0; Navarro-Garcia F, 1998, MICROBIOL-UK, V144, P411, DOI 10.1099/00221287-144-2-411; NAVARROGARCIA F, 1995, MOL CELL BIOL, V15, P2197; Ohkuni K, 2003, GENETICS, V165, P517; Pardini G, 2006, J BIOL CHEM, V281, P40399, DOI 10.1074/jbc.M606361200; Park YN, 2013, EUKARYOT CELL, V12, P1120, DOI 10.1128/EC.00112-13; Park YN, 2005, EUKARYOT CELL, V4, P1328, DOI 10.1128/EC.4.8.1328-1342.2005; Popolo L, 2001, MED MYCOL, V39, P111, DOI 10.1080/744118881; Ramirez-Zavala B, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003696; Reuss O, 2004, GENE, V341, P119, DOI 10.1016/j.gene.2004.06.021; Roman E, 2005, MOL CELL BIOL, V25, P10611, DOI 10.1128/MCB.25.23.10611-10627.2005; Roman E, 2009, FEMS YEAST RES, V9, P942, DOI 10.1111/j.1567-1364.2009.00545.x; Roman E, 2009, EUKARYOT CELL, V8, P1235, DOI 10.1128/EC.00081-09; RONCERO C, 1985, J BACTERIOL, V163, P1180, DOI 10.1128/JB.163.3.1180-1185.1985; Sahni N, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000363; Saito H, 2013, MICROB PATHOGENESIS, V56, P16, DOI 10.1016/j.micpath.2013.01.002; SanJose C, 1996, J BACTERIOL, V178, P5850, DOI 10.1128/jb.178.19.5850-5852.1996; Singh SD, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000532; Smith DA, 2004, MOL BIOL CELL, V15, P4179, DOI 10.1091/mbc.E04-03-0181; SOLER M, 1995, MOL MICROBIOL, V17, P833, DOI 10.1111/j.1365-2958.1995.mmi_17050833.x; Urrialde V, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00118; Wheeler RT, 2006, PLOS PATHOG, V2, P328, DOI 10.1371/journal.ppat.0020035; Wheeler RT, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000227; WHITEWAY M, 1992, P NATL ACAD SCI USA, V89, P9410, DOI 10.1073/pnas.89.20.9410; Zhu WD, 2010, CELL MICROBIOL, V12, P273, DOI 10.1111/j.1462-5822.2009.01412.x	66	23	23	3	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0133476	10.1371/journal.pone.0133476	http://dx.doi.org/10.1371/journal.pone.0133476			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LZ	26197240	Green Published, Green Accepted, Green Submitted, gold			2022-12-26	WOS:000358547600102
J	Sousa, L; Garcia, IJP; Costa, TGF; Silva, LND; Reno, CO; Oliveira, ES; Tilelli, CQ; Santos, LL; Cortes, VF; Santos, HL; Barbosa, LA				Sousa, Leilismara; Garcia, Israel J. P.; Costa, Tamara G. F.; Silva, Lilian N. D.; Reno, Cristiane O.; Oliveira, Eneida S.; Tilelli, Cristiane Q.; Santos, Luciana L.; Cortes, Vanessa F.; Santos, Herica L.; Barbosa, Leandro A.			Effects of Iron Overload on the Activity of Na, K-ATPase and Lipid Profile of the Human Erythrocyte Membrane	PLOS ONE			English	Article							HFE GENE-MUTATIONS; RED-BLOOD-CELLS; P-TYPE ATPASES; SODIUM-POTASSIUM PUMP; HEREDITARY HEMOCHROMATOSIS; ION-TRANSPORT; MOLECULAR ACTIVITY; BRAZILIAN PATIENTS; CRYSTAL-STRUCTURE; NA,K-ATPASE	Iron is an essential chemical element for human life. However, in some pathological conditions, such as hereditary hemochromatosis type 1 (HH1), iron overload induces the production of reactive oxygen species that may lead to lipid peroxidation and a change in the plasma-membrane lipid profile. In this study, we investigated whether iron overload interferes with the Na, K-ATPase activity of the plasma membrane by studying erythrocytes that were obtained from the whole blood of patients suffering from iron overload. Additionally, we treated erythrocytes of normal subjects with 0.8 mM H2O2 and 1 mu M FeCl3 for 24 h. We then analyzed the lipid profile, lipid peroxidation and Na, K-ATPase activity of plasma membranes derived from these cells. Iron overload was more frequent in men (87.5%) than in women and was associated with an increase (446%) in lipid peroxidation, as indicated by the amount of the thiobarbituric acid reactive substances (TBARS) and an increase (327%) in the Na, K-ATPase activity in the plasma membrane of erythrocytes. Erythrocytes treated with 1 mu M FeCl3 for 24 h showed an increase (132%) in the Na, K-ATPase activity but no change in the TBARS levels. Iron treatment also decreased the cholesterol and phospholipid content of the erythrocyte membranes and similar decreases were observed in iron overload patients. In contrast, erythrocytes treated with 0.8 mM H2O2 for 24 h showed no change in the measured parameters. These results indicate that erythrocytes from patients with iron overload exhibit higher Na, K-ATPase activity compared with normal subjects and that this effect is specifically associated with altered iron levels.	[Sousa, Leilismara; Garcia, Israel J. P.; Costa, Tamara G. F.; Silva, Lilian N. D.; Reno, Cristiane O.; Cortes, Vanessa F.; Santos, Herica L.; Barbosa, Leandro A.] Univ Fed Sao Joao Rei, Lab Bioquim Celular, BR-35501296 Divinopolis, Brazil; [Tilelli, Cristiane Q.] Univ Fed Sao Joao Rei, Lab Estudos Neurociencias Epilepsias & Comorbidad, BR-35501296 Divinopolis, Brazil; [Oliveira, Eneida S.; Santos, Luciana L.] Univ Fed Sao Joao Rei, Lab Biol Mol, BR-35501296 Divinopolis, Brazil		Barbosa, LA (corresponding author), Univ Fed Sao Joao Rei, Lab Bioquim Celular, Campus Ctr Oeste Dona Lindu, BR-35501296 Divinopolis, Brazil.	leaugust@yahoo.com.br	Sousa, Leilismara/AAS-3853-2021; Cortes, Vanessa Faria/GWC-0392-2022; Garcia, Israel J. P./M-9539-2015; Barbosa, Leandro/K-1008-2013; Santos, Luciana L/C-9688-2013	Sousa, Leilismara/0000-0002-8598-973X; Garcia, Israel J. P./0000-0002-4972-6561; Barbosa, Leandro/0000-0002-4631-0130; Santos, Luciana L/0000-0001-6186-4062; Fernandes Costa, Tamara Gabriela/0000-0003-0806-540X; Cortes, Vanessa Faria/0000-0002-6464-7634; Tilelli, Cristiane/0000-0002-9489-7933	FAPEMIG (Fundacao de Amparo a Pesquisa do Estado de Minas Gerais); CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior); CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico)	FAPEMIG (Fundacao de Amparo a Pesquisa do Estado de Minas Gerais)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by FAPEMIG (Fundacao de Amparo a Pesquisa do Estado de Minas Gerais), CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior) and CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico).	Adams PC, 2015, INT J LAB HEMATOL, V37, P25, DOI 10.1111/ijlh.12347; Adams PC, 1997, HEPATOLOGY, V25, P162, DOI 10.1002/hep.510250130; ADAMS PE, 1995, J CHEM EDUC, V72, P649, DOI 10.1021/ed072p649; Almeida AM, 2006, AN ACAD BRAS CIENC, V78, P505, DOI 10.1590/S0001-37652006000300010; Apell HJ, 2004, BIOELECTROCHEMISTRY, V63, P149, DOI 10.1016/j.bioelechem.2003.09.021; Beutler E., 2006, WILLIAMS HEMATOLOGY; Bittencourt PL, 2009, CLINICS, V64, P837, DOI 10.1590/S1807-59322009000900003; Bogdanova A, 2009, ACTA PHYSIOL, V195, P305, DOI 10.1111/j.1748-1716.2008.01934.x; Brissot Pierre, 2006, Hematology Am Soc Hematol Educ Program, P36; BRITTON RS, 1990, HEPATOLOGY, V11, P93, DOI 10.1002/hep.1840110116; BRUGNARA C, 1989, ANN NY ACAD SCI, V565, P96; Buege J A, 1978, Methods Enzymol, V52, P302; Bueno Simone, 2006, Rev. Bras. Hematol. Hemoter., V28, P293, DOI 10.1590/S1516-84842006000400015; Calado RT, 2000, BRAZ J MED BIOL RES, V33, P301, DOI 10.1590/S0100-879X2000000300007; Cançado Rodolfo D., 2007, Rev. Bras. Hematol. Hemoter., V29, P351, DOI 10.1590/S1516-84842007000400007; Cançado Rodolfo Delfini, 2006, Sao Paulo Med. J., V124, P55; Cançado Rodolfo Delfini, 2010, Rev. Bras. Hematol. Hemoter., V32, P469, DOI 10.1590/S1516-84842010000600011; CHEN PS, 1956, ANAL CHEM, V28, P1756, DOI 10.1021/ac60119a033; CLARET M, 1978, J PHYSIOL-LONDON, V274, P247, DOI 10.1113/jphysiol.1978.sp012145; Cluitmans JCA, 2012, BLOOD TRANSFUS-ITALY, V10, pS12, DOI 10.2450/2012.004S; Cornelius F, 2015, BBA-BIOMEMBRANES, V1848, P1729, DOI 10.1016/j.bbamem.2015.03.012; CORNELIUS F, 1995, BBA-BIOMEMBRANES, V1235, P205, DOI 10.1016/0005-2736(95)80006-2; Cornelius F, 2001, BIOCHEMISTRY-US, V40, P8842, DOI 10.1021/bi010541g; Delaunay J, 2007, BLOOD REV, V21, P1, DOI 10.1016/j.blre.2006.03.005; Dhar-Chowdhury P, 2007, CELL MOL LIFE SCI, V64, P3069, DOI 10.1007/s00018-007-7332-3; Else PL, 1999, J COMP PHYSIOL B, V169, P296, DOI 10.1007/s003600050224; Esmann M, 2006, CHEM PHYS LIPIDS, V141, P94, DOI 10.1016/j.chemphyslip.2006.02.018; Fiske CH, 1925, J BIOL CHEM, V66, P375; FORBUSH B, 1978, BIOCHEMISTRY-US, V17, P3667, DOI 10.1021/bi00610a037; Gallagher PG, 2013, CURR OPIN HEMATOL, V20, P201, DOI 10.1097/MOH.0b013e32835f6870; Garty H, 2006, ANNU REV PHYSIOL, V68, P431, DOI 10.1146/annurev.physiol.68.040104.131852; Geering K, 2001, J BIOENERG BIOMEMBR, V33, P425, DOI 10.1023/A:1010623724749; Goldshleger R, 1997, P NATL ACAD SCI USA, V94, P9596, DOI 10.1073/pnas.94.18.9596; Goldshleger R, 1999, J BIOL CHEM, V274, P16213, DOI 10.1074/jbc.274.23.16213; Haro KJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048841; HIGGINS ET, 1987, PSYCHOL REV, V94, P319, DOI 10.1037/0033-295X.94.3.319; Hoffman JF, 2002, P NATL ACAD SCI USA, V99, P14572, DOI 10.1073/pnas.222539999; Hollan S, 1996, HAEMATOLOGIA, V27, P109; Kaplan JH, 2002, ANNU REV BIOCHEM, V71, P511, DOI 10.1146/annurev.biochem.71.102201.141218; Kelley M, 2014, CAN J GASTROENTEROL, V28, P198, DOI 10.1155/2014/468521; KUMAR V., 2005, PATOLOGIA BASES PATO; Leao GDR, 2010, JOURNAL OF MEDICINE, V1, P453; Md AWY, 2006, AM J MED, V119, P391, DOI 10.1016/j.amjmed.2005.10.041; Mendanha SA, 2012, BRAZ J MED BIOL RES, V45, P473, DOI 10.1590/S0100-879X2012007500050; Morth JP, 2007, NATURE, V450, P1043, DOI 10.1038/nature06419; Motta VT, 2009, BIOQUIMICA CLINICA P; Moura E, 1998, BLOOD, V92, P2511, DOI 10.1182/blood.V92.7.2511.2511_2511_2519; Ogawa H, 2002, P NATL ACAD SCI USA, V99, P15977, DOI 10.1073/pnas.202622299; Ogawa H, 2009, P NATL ACAD SCI USA, V106, P13742, DOI 10.1073/pnas.0907054106; Oliveira TM, 2006, BRAZ J MED BIOL RES, V39, P1575, DOI 10.1590/S0100-879X2006005000041; Oliveira VC, 2009, GENET MOL RES, V8, P794, DOI 10.4238/vol8-3gmr562; Palmgren MG, 2011, ANNU REV BIOPHYS, V40, P243, DOI 10.1146/annurev.biophys.093008.131331; Pietrangelo A, 2004, NEW ENGL J MED, V350, P2383, DOI 10.1056/NEJMra031573; Pietrangelo A, 2010, GASTROENTEROLOGY, V139, P393, DOI 10.1053/j.gastro.2010.06.013; Pretorius E, 2014, INTEGR BIOL-UK, V6, P486, DOI 10.1039/c4ib00025k; Pretorius E, 2014, LANCET, V383, P722, DOI 10.1016/S0140-6736(13)61208-8; Pretorius E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085271; Pretorius E, 2013, CARDIOVASC DIABETOL, V12, DOI 10.1186/1475-2840-12-63; Rega A., 1979, CATION FLUX BIOMEMBR, P67; Rodrigo R, 2007, MOL CELL BIOCHEM, V303, P73, DOI 10.1007/s11010-007-9457-y; ROSE HG, 1965, J LIPID RES, V6, P428; Santos HD, 2005, COLLOID SURFACE B, V41, P239, DOI 10.1016/j.colsurfb.2004.12.013; Santos PCJL, 2011, BLOOD CELL MOL DIS, V46, P302, DOI 10.1016/j.bcmd.2011.02.008; Santos Paulo C. J. L., 2009, Rev. Bras. Hematol. Hemoter., V31, P192; Santos RD, 2006, COMP BIOCHEM PHYS C, V142, P309, DOI 10.1016/j.cbpc.2005.11.003; SARKADI B, 1991, BIOCHIM BIOPHYS ACTA, V1071, P407, DOI 10.1016/0304-4157(91)90005-H; Suhail Mohd, 2010, J Clin Med Res, V2, P1, DOI 10.4021/jocmr2010.02.263w; Turi JL, 2008, BIOMETALS, V21, P571, DOI 10.1007/s10534-008-9143-x; Vokurkova M, 2005, LIFE SCI, V77, P1452, DOI 10.1016/j.lfs.2005.03.014; WHITTAM R, 1965, BIOCHEM J, V97, P214, DOI 10.1042/bj0970214; Yin W, 2003, J MEMBRANE BIOL, V193, P177, DOI 10.1007/s00232-003-2016-x; YOUNG IS, 1994, FREE RADICAL BIO MED, V16, P393, DOI 10.1016/0891-5849(94)90041-8; Zhou XM, 2003, AM J PHYSIOL-CELL PH, V285, pC319, DOI 10.1152/ajpcell.00536.2002	74	20	20	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0132852	10.1371/journal.pone.0132852	http://dx.doi.org/10.1371/journal.pone.0132852			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LZ	26197432	Green Published, gold, Green Submitted			2022-12-26	WOS:000358547600053
J	Wang, RR; Ding, YY; Bai, HL; Duan, S; Ye, RH; Yang, YC; Wang, JB; Tang, RH; Gao, MY; Ha, N				Wang, Rongrong; Ding, Yingying; Bai, Hongling; Duan, Song; Ye, Runhua; Yang, Yuecheng; Wang, Jibao; Tang, Renhai; Gao, Meiyang; Ha, Na			Illicit Heroin and Methamphetamine Use among Methadone Maintenance Treatment Patients in Dehong Prefecture of Yunnan Province, China	PLOS ONE			English	Article							DRUG-USE; TREATMENT PROGRAM; HIV EPIDEMIC; REDUCTION	Objective Methadone maintenance treatment (MMT) was introduced to China in 2004 to reduce the harm of injecting drug users (IDUs). However, little is known about continued drug use, especially methamphetamine (MAMP), among MMT patients. Methods A survey was conducted among patients attending five major MMT clinics in Dehong Prefecture in 2014 to investigate the heroin and MAMP use and their associated risk factors. Participants were administered with face-to-face interviews, and urine tests for morphine and MAMP. Results A total of 2,121 were eligible and participated in the study. Among them, 220 (10.4%) were only positive for morphine, 12.9% were only positive for MAMP, and 196 (9.2%) were positive for both morphine and MAMP. Compared with neither use of heroin nor MAMP during MMT, heroin use (not using MAMP) was associated with ethnicity, shorter duration of MMT, lower dose of methadone, and having had no more than two sex partners in the past year; MAMP use (not using heroin) was associated with ethnicity, longer duration of MMT, higher dose of methadone and being aged <30 years (vs. >= 50 years); use of both heroin and MAMP was associated with being Dai minority (vs. Han), a marital status of divorced or widowed, having used drugs for >= 10 years and shorter duration of MMT. Conclusion These findings indicate the complexity in the treatment of heroin users and underscore the importance in prescribing appropriate methadone dosages in order to reduce both heroin and MAMP use.	[Wang, Rongrong; Ding, Yingying; Bai, Hongling; Gao, Meiyang; Ha, Na] Fudan Univ, Sch Publ Hlth, Dept Epidemiol, Shanghai 200433, Peoples R China; [Wang, Rongrong; Ding, Yingying; Bai, Hongling; Gao, Meiyang; Ha, Na] Fudan Univ, Key Lab Publ Hlth Safety, Minist Educ, Shanghai 200433, Peoples R China; [Wang, Rongrong; Ding, Yingying; Bai, Hongling; Gao, Meiyang; Ha, Na] Fudan Univ, Collaborat Innovat Ctr Social Risks Governance Hl, Shanghai 200433, Peoples R China; [Wang, Rongrong] Natl Hlth & Family Planning Commiss, Dept Dis Control & Prevent, Beijing, Peoples R China; [Duan, Song; Ye, Runhua; Yang, Yuecheng; Wang, Jibao; Tang, Renhai] Dehong Prefecture Ctr Dis Control & Prevent, Mangshi, Yunnan, Peoples R China	Fudan University; Fudan University; Fudan University	Ha, N (corresponding author), Fudan Univ, Sch Publ Hlth, Dept Epidemiol, Shanghai 200433, Peoples R China.	nhe@shmu.edu.cn	ding, yy/HHS-9589-2022		China National Major AIDS Research Project [2012ZX10001001-004]; Shanghai Municipal Health Bureau [XBR2011043, KBF201232]; Junior Faculty Award of Fudan University [JJF201016]	China National Major AIDS Research Project; Shanghai Municipal Health Bureau; Junior Faculty Award of Fudan University	This study was supported by China National Major AIDS Research Project (grant no. 2012ZX10001001-004 to Na He) and Shanghai Municipal Health Bureau (grant no. XBR2011043 to Na He; KBF201232 to Yingying Ding) and the Junior Faculty Award of Fudan University (grant no. JJF201016 to Yingying Ding).	Bao YP, 2015, ADDICTION, V110, P11, DOI 10.1111/add.12770; Baumeister M, 2014, SUBST ABUSE TREAT PR, V9, DOI 10.1186/1747-597X-9-46; Cao XB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082476; [常亚萍 Chang Yaping], 2011, [中国药物依赖性杂志, Chinese Journal of Drug Dependence], V20, P37; Chen W, 2013, HARM REDUCT J, V10, DOI 10.1186/1477-7517-10-23; China Ministry of Health World Health Organization (WHO), 2012, 2011 EST HIV AIDS EP; China National Narcotics Control Commission (CNNCC), 2012, 2012 ANN REP DRUG CO; China National Narcotics Control Commission (CNNCC), 2013, 2013 ANN REP DRUG CO; Chu TX, 2005, CELL RES, V15, P865, DOI 10.1038/sj.cr.7290360; Ding Ying-ying, 2012, Fudan Xuebao (Yixueban), V39, P551, DOI 10.3969/j.issn.1672-8467.2012.06.001; Ding YY, 2013, AIDS BEHAV, V17, P2439, DOI 10.1007/s10461-012-0380-1; Faggiano F., 2003, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD002208; Fareed A, 2009, J ADDICT DIS, V28, P399, DOI 10.1080/10550880903183042; Gossop M, 2001, DRUG ALCOHOL DEPEN, V62, P255, DOI 10.1016/S0376-8716(00)00211-8; Hittner JB, 2012, ADDICT BEHAV, V37, P790, DOI 10.1016/j.addbeh.2012.02.018; Jia MH, 2010, JAIDS-J ACQ IMM DEF, V53, pS34, DOI 10.1097/QAI.0b013e3181c7d6ff; Kamal F, 2007, Ir Med J, V100, P393; Ko NY, 2012, J STUD ALCOHOL DRUGS, V73, P469, DOI 10.15288/jsad.2012.73.469; Li L, 2011, DRUG ALCOHOL DEPEN, V116, P246, DOI 10.1016/j.drugalcdep.2010.12.007; Li L, 2012, ADDICT BEHAV, V37, P264, DOI 10.1016/j.addbeh.2011.11.004; Liu En-wu, 2008, Zhonghua Yufang Yixue Zazhi, V42, P875; Palha AP, 2002, J SEX MARITAL THER, V28, P427, DOI 10.1080/00926230290001547; Pang L, 2007, AIDS, V21, pS103, DOI 10.1097/01.aids.0000304704.71917.64; Shariatirad S, 2013, INT J DRUG POLICY, V24, P636, DOI [10.1016/j.drugpo.2013.04.003, 10.1016/j.drugpo.2013.05.003]; Sullivan SG, 2007, INT J DRUG POLICY, V18, P118, DOI 10.1016/j.drugpo.2006.11.014; Sullivan SG, 2014, J SUBST ABUSE TREAT, V47, P86, DOI 10.1016/j.jsat.2013.12.004; Sun HM, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-005997; Trujillo KA, 2011, PHARMACOL BIOCHEM BE, V99, P451, DOI 10.1016/j.pbb.2011.04.014; Wang L, 2015, ADDICTION, V110, P20, DOI 10.1111/add.12779; Yin WY, 2010, INT J EPIDEMIOL, V39, pII29, DOI 10.1093/ije/dyq210	30	22	26	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0133431	10.1371/journal.pone.0133431	http://dx.doi.org/10.1371/journal.pone.0133431			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LZ	26196394	gold, Green Published, Green Submitted			2022-12-26	WOS:000358547600097
J	Castillo, A; Rodriguez-Suarez, C; Martin, AC; Piston, F				Castillo, Almudena; Rodriguez-Suarez, Cristina; Martin, Azahara C.; Piston, Fernando			Contribution of Chromosomes 1H(ch)S and 6H(ch)S to Fertility Restoration in the Wheat msH1 CMS System under Different Environmental Conditions	PLOS ONE			English	Article							CYTOPLASMIC MALE-STERILITY	Exploiting hybrid wheat heterosis has been long pursued to increase crop yield, stability and uniformity. Cytoplasmic male sterility (CMS) systems based in the nuclear-cytoplasmic incompatible interactions are a classic way for hybrid seed production, but to date, no definitive system is available in wheat. The msH1 CMS system results from the incompatibility between the nuclear genome of wheat and the cytoplasmic genome of the wild barley Hordeum chilense. Fertility restoration of the CMS phenotype was first associated with the disomic addition of the short arm of chromosome 6H from H. chilense. In further studies it was observed that chromosome arm 1H(ch)S was also implicated, and the combination of genes in both chromosome arms restored fertility more efficiently. In this work we aim to dissect the effect of each chromosome in fertility restoration when combined in different genomic backgrounds and under different environmental conditions. We propose a model to explain how restoration behaves in the msH1 system and generate valuable information necessary to develop an efficient system for hybrid wheat production.	[Castillo, Almudena; Rodriguez-Suarez, Cristina; Piston, Fernando] CSIC, Inst Agricultura Sostenible, Dept Mejora Genet Vegetal, Cordoba, Spain; [Martin, Azahara C.] John Innes Ctr, Crop Genet, Norwich, Norfolk, England	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Agricultura Sostenible (IAS); UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center	Piston, F (corresponding author), CSIC, Inst Agricultura Sostenible, Dept Mejora Genet Vegetal, Cordoba, Spain.	fpiston@ias.csic.es	Piston, Fernando/AAD-6975-2020; Martin, Azahara C./AAH-8797-2019; Rodríguez-Suárez, Cristina/M-2304-2014	Martin, Azahara C./0000-0002-6087-7491; Rodríguez-Suárez, Cristina/0000-0002-5409-1839	Spanish Ministerio de Economia y Competitividad (MINECO) [AGL2013-43329-R, AGL2011-22596]; Ramon y Cajal research contract from MINECO [RYC-2010-07345]	Spanish Ministerio de Economia y Competitividad (MINECO); Ramon y Cajal research contract from MINECO	This work was supported by the Spanish Ministerio de Economia y Competitividad (MINECO, AGL2013-43329-R, and AGL2011-22596). FP is supported by a Ramon y Cajal research contract from the MINECO (RYC-2010-07345). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atienza SG, 2007, J AGR FOOD CHEM, V55, P4244, DOI 10.1021/jf070342p; Atienza SG, 2004, PLANT BREEDING, V123, P303, DOI 10.1111/j.1439-0523.2004.00918.x; Castillo A, 2014, J EXP BOT, V65, P6667, DOI 10.1093/jxb/eru388; Chen LT, 2014, ANNU REV PLANT BIOL, V65, P579, DOI 10.1146/annurev-arplant-050213-040119; Coors JG, 1999, GENETICS AND EXPLOITATION OF HETEROSIS IN CROPS, P225; De Storme N, 2014, PLANT CELL ENVIRON, V37, P1, DOI 10.1111/pce.12142; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; Kaul M. L. H., 1988, MALE STERILITY HIGHE, P97, DOI [10.1007/978-3-642-83139-3, DOI 10.1007/978-3-642-83139-3]; Lenth RV, 2014, LSMEANS LEAST SQUARE; Martin A, 1996, DEV PLANT BREED, V5, P57; Martin A, 1998, TRITICEAE III, P377; Martin AC, 2008, AUST J AGR RES, V59, P206, DOI 10.1071/AR07239; Martin AC, 2010, THEOR APPL GENET, V121, P1093, DOI 10.1007/s00122-010-1374-x; Martin AC, 2009, MOL BREEDING, V24, P397, DOI 10.1007/s11032-009-9301-z; R Core Team, 2012, R LANG ENV STAT COMP; Schnable PS, 1998, TRENDS PLANT SCI, V3, P175, DOI 10.1016/S1360-1385(98)01235-7; Song XY, 2014, EUPHYTICA, V196, P129, DOI 10.1007/s10681-013-1020-1; Song XY, 2013, EUPHYTICA, V192, P393, DOI 10.1007/s10681-013-0871-9; TRACY WF, 1991, J HERED, V82, P343, DOI 10.1093/oxfordjournals.jhered.a111096; VONBOTHMER R, 1986, PLANT SYST EVOL, V153, P49, DOI 10.1007/BF00989417; WELSH JR, 1971, CROP SCI, V11, P864, DOI 10.2135/cropsci1971.0011183X001100060029x; Whitford R, 2013, J EXP BOT, V64, P5411, DOI 10.1093/jxb/ert333	22	10	10	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2015	10	7							e0121479	10.1371/journal.pone.0121479	http://dx.doi.org/10.1371/journal.pone.0121479			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LN	26192191	Green Published, gold, Green Submitted			2022-12-26	WOS:000358546400001
J	Klemm, M; Schweitzer, D; Peters, S; Sauer, L; Hammer, M; Haueisen, J				Klemm, Matthias; Schweitzer, Dietrich; Peters, Sven; Sauer, Lydia; Hammer, Martin; Haueisen, Jens			FLIMX: A Software Package to Determine and Analyze the Fluorescence Lifetime in Time-Resolved Fluorescence Data from the Human Eye	PLOS ONE			English	Article							IMAGING OPHTHALMOSCOPY; DECAY CURVES; AUTOFLUORESCENCE; FUNDUS; DECONVOLUTION	Fluorescence lifetime imaging ophthalmoscopy (FLIO) is a new technique for measuring the in vivo autofluorescence intensity decays generated by endogenous fluorophores in the ocular fundus. Here, we present a software package called FLIM eXplorer (FLIMX) for analyzing FLIO data. Specifically, we introduce a new adaptive binning approach as an optimal tradeoff between the spatial resolution and the number of photons required per pixel. We also expand existing decay models (multi-exponential, stretched exponential, spectral global analysis, incomplete decay) to account for the layered structure of the eye and present a method to correct for the influence of the crystalline lens fluorescence on the retina fluorescence. Subsequently, the Holm-Bonferroni method is applied to FLIO measurements to allow for group comparisons between patients and controls on the basis of fluorescence lifetime parameters. The performance of the new approaches was evaluated in five experiments. Specifically, we evaluated static and adaptive binning in a diabetes mellitus patient, we compared the different decay models in a healthy volunteer and performed a group comparison between diabetes patients and controls. An overview of the visualization capabilities and a comparison of static and adaptive binning is shown for a patient with macular hole. FLIMX's applicability to fluorescence lifetime imaging microscopy is shown in the ganglion cell layer of a porcine retina sample, obtained by a laser scanning microscope using two-photon excitation.	[Klemm, Matthias; Haueisen, Jens] Tech Univ Ilmenau, Inst Biomed Engn & Informat, D-98694 Ilmenau, Germany; [Schweitzer, Dietrich; Peters, Sven; Sauer, Lydia; Hammer, Martin] Univ Hosp Jena, Expt Ophthalmol, D-07740 Jena, Germany	Technische Universitat Ilmenau; Friedrich Schiller University of Jena	Klemm, M (corresponding author), Tech Univ Ilmenau, Inst Biomed Engn & Informat, POB 100565, D-98694 Ilmenau, Germany.	matthias.klemm@tu-ilmenau.de	; Haueisen, Jens/B-7183-2011	Klemm, Matthias/0000-0002-2418-0259; Haueisen, Jens/0000-0003-3871-2890	German Federal Ministry of Education and Research [03IPT605A]; German Research Council [DFG HA 2899/19-1]; German Research Foundation; Open Access Publication Fund of the Technische Universitat Ilmenau	German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); German Research Council(German Research Foundation (DFG)); German Research Foundation(German Research Foundation (DFG)); Open Access Publication Fund of the Technische Universitat Ilmenau	The authors gratefully acknowledge funding from the German Federal Ministry of Education and Research (Grant No. 03IPT605A; http://www.unternehmen-region.de) and the German Research Council (DFG HA 2899/19-1; www.dfg.de). We acknowledge support for the Article Processing Charge by the German Research Foundation and the Open Access Publication Fund of the Technische Universitat Ilmenau. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1991, Ophthalmology, V98, P786; Becker W, 2012, J MICROSC-OXFORD, V247, P119, DOI 10.1111/j.1365-2818.2012.03618.x; Becker W, 2005, ADV TIME CORRELATED; Becker W., 2012, BH TCPSC HDB; Berendschot TTJM, 2003, PROG RETIN EYE RES, V22, P171, DOI 10.1016/S1350-9462(02)00060-5; Clerc M, 2002, IEEE T EVOLUT COMPUT, V6, P58, DOI 10.1109/4235.985692; DILLON J, 1990, PHOTOCHEM PHOTOBIOL, V51, P465, DOI 10.1111/j.1751-1097.1990.tb01738.x; Dysli C, 2014, INVEST OPHTH VIS SCI, V55, P2106, DOI 10.1167/iovs.13-13627; Enderlein J, 1997, OPT COMMUN, V134, P371, DOI 10.1016/S0030-4018(96)00384-7; Goss DA, 2001, INTRO OPTICS EYE; Hammer M, 2008, GRAEF ARCH CLIN EXP, V246, P105, DOI 10.1007/s00417-007-0639-9; Hollander M., 2014, NONPARAMETRIC STAT M, V3rd ed.; HOLM S, 1979, SCAND J STAT, V6, P65; Institute ANS, 2007, Z1361 ANSI; Jentsch S, 2015, ACTA OPHTHALMOL, V93, pE241, DOI 10.1111/aos.12609; Kennedy J., 1995, P ICNN 95 INT C NEUR, P1942; Klemm M, 2013, CURR EYE RES, V38, P793, DOI 10.3109/02713683.2013.779723; KOLLNER M, 1992, CHEM PHYS LETT, V200, P199, DOI 10.1016/0009-2614(92)87068-Z; Lakowicz J.R., 2006, PRINCIPLES FLUORESCE; Laptenok S, 2007, J STAT SOFTW, V18; Lee KCB, 2001, BIOPHYS J, V81, P1265, DOI 10.1016/S0006-3495(01)75784-0; Leung RWK, 2011, BIOMED OPT EXPRESS, V2, P2517, DOI 10.1364/BOE.2.002517; Luchowski R, 2010, APPL SPECTROSC, V64, P918, DOI 10.1366/000370210792081000; Marcu L, 2012, ANN BIOMED ENG, V40, P304, DOI 10.1007/s10439-011-0495-y; MARQUARDT DW, 1963, J SOC IND APPL MATH, V11, P431, DOI 10.1137/0111030; NELDER JA, 1965, COMPUT J, V7, P308, DOI 10.1093/comjnl/7.4.308; Neyman J, 1928, BIOMETRIKA, V20A, P263, DOI 10.2307/2332112; OCONNOR DV, 1979, J PHYS CHEM-US, V83, P1333, DOI 10.1021/j100473a019; PAU H, 1993, GRAEF ARCH CLIN EXP, V231, P656, DOI 10.1007/BF00921961; Peters S, 2011, PROC SPIE, V8086, DOI 10.1117/12.889807; Ramm L, 2014, GRAEF ARCH CLIN EXP, V252, P2025, DOI 10.1007/s00417-014-2813-1; Rechenberg I., 1973, EVOLUTIONSSTRATEGIE; Schmitz-Valckenberg S, 2008, RETINA-J RET VIT DIS, V28, P385, DOI 10.1097/IAE.0b013e318164a907; Schweitzer D, 2007, MICROSC RES TECHNIQ, V70, P410, DOI 10.1002/jemt.20427; Schweitzer D, 2004, J BIOMED OPT, V9, P1214, DOI 10.1117/1.1806833; Schweitzer D, 2009, OPHTHALMOLOGE, V106, P714, DOI 10.1007/s00347-009-1975-4; Schweitzer D, 2009, CLIN BIOMEDICAL SPEC, V7368, DOI [10.1364/ECS0.200977368_04, DOI 10.1364/ECSO.200977368_04]; Schweitzer D, 2015, J BIOMED OPT, V20, DOI 10.1117/1.JBO.20.6.061106; Schweitzer D, 2012, INVEST OPHTH VIS SCI, V53, P3376, DOI 10.1167/iovs.11-8970; Schweitzer D, 2010, ESSENT OPHTHALMOL, P107, DOI 10.1007/978-3-540-85540-8_10; Storn R, 1997, J GLOBAL OPTIM, V11, P341, DOI 10.1023/A:1008202821328; Turton DA, 2003, ANAL CHEM, V75, P4182, DOI 10.1021/ac034325k; WARE WR, 1973, J PHYS CHEM-US, V77, P2038, DOI 10.1021/j100636a003; Warren SC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070687	44	33	34	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2015	10	7							e0131640	10.1371/journal.pone.0131640	http://dx.doi.org/10.1371/journal.pone.0131640			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LN	26192624	Green Submitted, gold, Green Published			2022-12-26	WOS:000358546400014
J	Lu, WW; Ding, WX; Zhang, JH; Zhang, HJ; Luo, JF; Bolan, N				Lu, Weiwei; Ding, Weixin; Zhang, Junhua; Zhang, Huanjun; Luo, Jiafa; Bolan, Nanthi			Nitrogen Amendment Stimulated Decomposition of Maize Straw-Derived Biochar in a Sandy Loam Soil: A Short-Term Study	PLOS ONE			English	Article							MICROBIAL COMMUNITY; ORGANIC-MATTER; LITTER DECOMPOSITION; ENZYME-ACTIVITY; BLACK CARBON; PINE FOREST; BIOMASS; MINERALIZATION; GRASSLAND; RESPONSES	This study examined the effect of nitrogen (N) on biochar stability in relation to soil microbial community as well as biochar labile components using delta C-13 stable isotope technology. A sandy loam soil under a long-term rotation of C-3 crops was amended with biochar produced from maize (a C(4)plant) straw in absence (BC0) and presence (BCN) of N and monitored for dynamics of carbon dioxide (CO2) flux, phospholipid fatty acids (PLFAs) profile and dissolved organic carbon (DOC) content. N amendment significantly increased the decomposition of biochar during the first 5 days of incubation (P < 0.05), and the proportions of decomposed biochar carbon (C) were 2.30% and 3.28% in BC0 and BCN treatments, respectively, during 30 days of incubation. The magnitude of decomposed biochar C was significantly (P < 0.05) higher than DOC in biochar (1.75%) and part of relatively recalcitrant biochar C was mineralized in both treatments. N amendment increased soil PLFAs concentration at the beginning of incubation, indicating that microorganisms were N-limited in test soil. Furthermore, N amendment significantly (P < 0.05) increased the proportion of grampositive (G(+)) bacteria and decreased that of fungi, while no noticeable changes were observed for gram-negative (G(-)) bacteria and actinobacteria at the early stage of incubation. Our results indicated that N amendment promoted more efficiently the proliferation of G(+) bacteria and accelerated the decomposition of relatively recalcitrant biochar C, which in turn reduced the stability of maize straw-derived biochar in test soil.	[Lu, Weiwei; Ding, Weixin; Zhang, Junhua; Zhang, Huanjun] Chinese Acad Sci, Inst Soil Sci, State Key Lab Soil & Sustainable Agr, Nanjing, Jiangsu, Peoples R China; [Luo, Jiafa] AgResearch, Land & Environm, Hamilton, New Zealand; [Bolan, Nanthi] Univ S Australia, Ctr Environm Risk Assessment & Remediat, Adelaide, SA 5001, Australia	Chinese Academy of Sciences; Institute of Soil Science, CAS; AgResearch - New Zealand; University of South Australia	Ding, WX (corresponding author), Chinese Acad Sci, Inst Soil Sci, State Key Lab Soil & Sustainable Agr, Nanjing, Jiangsu, Peoples R China.	wxding@issas.ac.cn	SPRP, XDB150200/N-7373-2016; Bolan, Nanthi Sirangie/E-8535-2011	Bolan, Nanthi Sirangie/0000-0003-2056-1692; lu, weiwei/0000-0003-1361-686X; Luo, Jiafa/0000-0001-6198-6887	Chinese Academy of Sciences [XDB15020101]; Postdoctoral Science Foundation of China [2013M531411]; Postdoctoral Scientific Funding of Jiangsu province [1301060C]; AgResearch	Chinese Academy of Sciences(Chinese Academy of Sciences); Postdoctoral Science Foundation of China(China Postdoctoral Science Foundation); Postdoctoral Scientific Funding of Jiangsu province; AgResearch	This study was funded by the Chinese Academy of Sciences (http://www.cas.cn/), the Postdoctoral Science Foundation of China (http://res.chinapostdoctor.org.cn/BshWeb/index.shtml) and the Postdoctoral Scientific Funding of Jiangsu province (http://bsh.jshrss.gov.cn/), under the contract numbers of XDB15020101, 2013M531411 and 1301060C, respectively. The first supported author WXD, the two postdoctoral fundings supported author WWL. AgResearch (http://www.agresearch.co.nz/) provided support in the form of a salary for JFL. The funders did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Ai C, 2015, BIOL FERT SOILS, V51, P465, DOI 10.1007/s00374-015-0994-3; Ameloot N, 2013, EUR J SOIL SCI, V64, P379, DOI 10.1111/ejss.12064; Amelung W, 2008, ADV AGRON, V100, P155, DOI 10.1016/S0065-2113(08)00606-8; Ascough PL, 2010, ISOT ENVIRON HEALT S, V46, P64, DOI 10.1080/10256010903388436; BALDOCK JA, 1992, BIOGEOCHEMISTRY, V16, P1, DOI 10.1007/BF02402261; Baldock JA, 2002, ORG GEOCHEM, V33, P1093, DOI 10.1016/S0146-6380(02)00062-1; Balesdent J., 1996, Mass spectrometry of soils., P83; Biasi C, 2005, RAPID COMMUN MASS SP, V19, P1401, DOI 10.1002/rcm.1911; Billings SA, 2008, GLOBAL CHANGE BIOL, V14, P1025, DOI 10.1111/j.1365-2486.2008.01562.x; Bird JA, 2011, SOIL BIOL BIOCHEM, V43, P718, DOI 10.1016/j.soilbio.2010.08.010; Blagodatskaya EV, 2009, EUR J SOIL SCI, V60, P186, DOI 10.1111/j.1365-2389.2008.01103.x; Brant JB, 2006, SOIL BIOL BIOCHEM, V38, P2219, DOI 10.1016/j.soilbio.2006.01.022; Bruun S, 2008, ORG GEOCHEM, V39, P839, DOI 10.1016/j.orggeochem.2008.04.020; Butler JL, 2003, APPL ENVIRON MICROB, V69, P6793, DOI 10.1128/AEM.69.11.6793-6800.2003; Cai YJ, 2013, ATMOS ENVIRON, V65, P112, DOI 10.1016/j.atmosenv.2012.10.038; Carreiro MM, 2000, ECOLOGY, V81, P2359, DOI 10.1890/0012-9658(2000)081[2359:MESELD]2.0.CO;2; Chapman SK, 2007, PLANT SOIL, V299, P153, DOI 10.1007/s11104-007-9372-8; Cheng W. X., 2005, Roots and soil management: interactions between roots and the soil, P119; Chenu C, 2006, EUR J SOIL SCI, V57, P596, DOI 10.1111/j.1365-2389.2006.00834.x; Chodak M, 2003, BIOL FERT SOILS, V39, P123, DOI 10.1007/s00374-003-0688-0; Compton JE, 2004, FOREST ECOL MANAG, V196, P143, DOI 10.1016/j.foreco.2004.03.017; Cross A, 2011, SOIL BIOL BIOCHEM, V43, P2127, DOI 10.1016/j.soilbio.2011.06.016; de Vries FT, 2007, SOIL BIOL BIOCHEM, V39, P1620, DOI 10.1016/j.soilbio.2007.01.013; Demoling F, 2008, SOIL BIOL BIOCHEM, V40, P370, DOI 10.1016/j.soilbio.2007.08.019; Denef K, 2009, SOIL BIOL BIOCHEM, V41, P144, DOI 10.1016/j.soilbio.2008.10.008; Ding WX, 2010, GEODERMA, V155, P381, DOI 10.1016/j.geoderma.2009.12.023; Farrell M, 2013, SCI TOTAL ENVIRON, V465, P288, DOI 10.1016/j.scitotenv.2013.03.090; Frey SD, 2004, FOREST ECOL MANAG, V196, P159, DOI 10.1016/j.foreco.2004.03.018; Glaser B, 2002, BIOL FERT SOILS, V35, P219, DOI 10.1007/s00374-002-0466-4; Graber ER, 2010, PLANT SOIL, V337, P481, DOI 10.1007/s11104-010-0544-6; Gul S, 2015, AGR ECOSYST ENVIRON, V206, P46, DOI 10.1016/j.agee.2015.03.015; HACKETT WF, 1977, APPL ENVIRON MICROB, V33, P43, DOI 10.1128/AEM.33.1.43-51.1977; Hilscher A, 2011, SOIL BIOL BIOCHEM, V43, P261, DOI 10.1016/j.soilbio.2010.10.007; Jeffery S, 2011, AGR ECOSYST ENVIRON, V144, P175, DOI 10.1016/j.agee.2011.08.015; Keeler BL, 2009, ECOSYSTEMS, V12, P1, DOI 10.1007/s10021-008-9199-z; Kramer MG, 2012, GLOBAL CHANGE BIOL, V18, P2594, DOI 10.1111/j.1365-2486.2012.02681.x; Kuehn KA, 2000, LIMNOL OCEANOGR, V45, P862, DOI 10.4319/lo.2000.45.4.0862; Kuzyakov Y, 2004, PLANT SOIL, V263, P85, DOI 10.1023/B:PLSO.0000047728.61591.fd; Lehmann J, 2007, FRONT ECOL ENVIRON, V5, P381, DOI 10.1890/1540-9295(2007)5[381:BITB]2.0.CO;2; Li LJ, 2010, BIOL FERT SOILS, V46, P653, DOI 10.1007/s00374-010-0463-y; Lu R, 2000, METHODS SOIL AGROCHE; Luo Y, 2011, SOIL BIOL BIOCHEM, V43, P2304, DOI 10.1016/j.soilbio.2011.07.020; McMahon SK, 2005, SOIL SCI SOC AM J, V69, P1238, DOI 10.2136/sssaj2004.0289; Michelsen A, 2004, SOIL BIOL BIOCHEM, V36, P1707, DOI 10.1016/j.soilbio.2004.04.028; Midwood AJ, 1998, SOIL BIOL BIOCHEM, V30, P1301, DOI 10.1016/S0038-0717(98)00030-3; Min K, 2011, SOIL BIOL BIOCHEM, V43, P2461, DOI 10.1016/j.soilbio.2011.08.019; Nguyen BT, 2009, ORG GEOCHEM, V40, P846, DOI 10.1016/j.orggeochem.2009.05.004; Novak JM, 2009, SOIL SCI, V174, P105, DOI 10.1097/SS.0b013e3181981d9a; Potthoff M, 2005, SOIL BIOL BIOCHEM, V37, P1259, DOI 10.1016/j.soilbio.2004.11.022; Rinnan R, 2007, GLOBAL CHANGE BIOL, V13, P28, DOI 10.1111/j.1365-2486.2006.01263.x; Santos F, 2012, SOIL BIOL BIOCHEM, V51, P115, DOI 10.1016/j.soilbio.2012.04.005; Schulz H, 2012, J PLANT NUTR SOIL SC, V175, P410, DOI 10.1002/jpln.201100143; Smith JL, 2010, SOIL BIOL BIOCHEM, V42, P2345, DOI 10.1016/j.soilbio.2010.09.013; SOLUM MS, 1989, ENERG FUEL, V3, P187, DOI 10.1021/ef00014a012; Spokas KA, 2010, CARBON MANAG, V1, P289, DOI 10.4155/CMT.10.32; Spring S, 2000, FEMS MICROBIOL REV, V24, P573, DOI 10.1016/S0168-6445(00)00046-2; Steinbeiss S, 2009, SOIL BIOL BIOCHEM, V41, P1301, DOI 10.1016/j.soilbio.2009.03.016; Thirukkumaran CM, 2000, SOIL BIOL BIOCHEM, V32, P59, DOI 10.1016/S0038-0717(99)00129-7; Treseder KK, 2011, ECOL LETT, V14, P933, DOI 10.1111/j.1461-0248.2011.01650.x; Tscherko D, 2004, SOIL BIOL BIOCHEM, V36, P1685, DOI 10.1016/j.soilbio.2004.07.004; Uchimiya M, 2013, J ANAL APPL PYROL, V104, P84, DOI 10.1016/j.jaap.2013.09.003; USDA (United States Department of Agriculture), 1994, KEYS SOIL TAX; Vanotti MB, 1996, SOIL ORGANIC MATTER, P105; Watzinger A, 2014, EUR J SOIL SCI, V65, P40, DOI 10.1111/ejss.12100; Xie ZB, 2013, PLANT SOIL, V370, P527, DOI 10.1007/s11104-013-1636-x; Zhang HJ, 2013, SOIL BIOL BIOCHEM, V57, P228, DOI 10.1016/j.soilbio.2012.08.024; Zimmerman AR, 2013, BIOCHAR AND SOIL BIOTA, P1; Zimmerman AR, 2010, ENVIRON SCI TECHNOL, V44, P1295, DOI 10.1021/es903140c	68	11	12	2	90	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2015	10	7							e0133131	10.1371/journal.pone.0133131	http://dx.doi.org/10.1371/journal.pone.0133131			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LN	26192282	Green Published, Green Submitted, Green Accepted, gold			2022-12-26	WOS:000358546400060
J	Tan, WK; Lim, TK; Loh, CS; Kumar, P; Lin, QS				Tan, Wee-Kee; Lim, Teck-Kwang; Loh, Chiang-Shiong; Kumar, Prakash; Lin, Qingsong			Proteomic Characterisation of the Salt Gland-Enriched Tissues of the Mangrove Tree Species Avicennia officinalis	PLOS ONE			English	Article							CHLORIS-GAYANA KUNTH; HEAT-SHOCK PROTEINS; SECRETE NA+; PLANT; LOCALIZATION; TOLERANCE; MEMBRANE; ABILITY; ATPASE; LEAVES	Plant salt glands are nature's desalination devices that harbour potentially useful information pertaining to salt and water transport during secretion. As part of the program toward deciphering secretion mechanisms in salt glands, we used shotgun proteomics to compare the protein profiles of salt gland-enriched (isolated epidermal peels) and salt gland-deprived (mesophyll) tissues of the mangrove species Avicennia officinalis. The purpose of the work is to identify proteins that are present in the salt gland-enriched tissues. An average of 2189 and 977 proteins were identified from the epidermal peel and mesophyll tissues, respectively. Among these, 2188 proteins were identified in salt gland-enriched tissues and a total of 1032 selected proteins were categorized by Gene Ontology (GO) analysis. This paper reports for the first time the proteomic analysis of salt gland-enriched tissues of a mangrove tree species. Candidate proteins that may play a role in the desalination process of the mangrove salt glands and their potential localization were identified. Information obtained from this study paves the way for future proteomic research aiming at elucidating the molecular mechanism underlying secretion in plant salt glands. The data have been deposited to the ProteomeXchange with identifier PXD000771.	[Tan, Wee-Kee; Lim, Teck-Kwang; Loh, Chiang-Shiong; Kumar, Prakash; Lin, Qingsong] Natl Univ Singapore, Dept Biol Sci, Singapore 117543, Singapore; [Tan, Wee-Kee; Loh, Chiang-Shiong; Lin, Qingsong] Natl Univ Singapore, NUS Environm Res Inst, Singapore 117411, Singapore	National University of Singapore; National University of Singapore	Lin, QS (corresponding author), Natl Univ Singapore, Dept Biol Sci, 14 Sci Dr 4, Singapore 117543, Singapore.	dbslinqs@nus.edu.sg	Kumar, Prakash P/A-6236-2009	Kumar, Prakash P/0000-0002-0963-1664; TAN, WEE KEE/0000-0001-5770-068X	Singapore National Research Foundation; NRF-EWI-IRIS [2P 10004/81, R-706-000010-272, R-706-000-040-279]; National University of Singapore [R-154-000-505-651]; Water Industry Programme Office of the PUB	Singapore National Research Foundation(National Research Foundation, Singapore); NRF-EWI-IRIS; National University of Singapore(National University of Singapore); Water Industry Programme Office of the PUB	This work was supported by research grants from Singapore National Research Foundation [under its Environmental & Water Technologies Strategic Research Programme administered by the Environment] & Water Industry Programme Office of the PUB, NRF-EWI-IRIS (2P 10004/81) (R-706-000010-272) and (R-706-000-040-279) and the National University of Singapore (R-154-000-505-651). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdallah Cosette, 2012, Int J Plant Genomics, V2012, P494572, DOI 10.1155/2012/494572; [Anonymous], 2009, CHECKLIST TOTAL VASC; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Balsamo RA, 1996, PLANT CELL REP, V15, P418, DOI 10.1007/BF00232067; BALSAMO RA, 1995, INT J PLANT SCI, V156, P658, DOI 10.1086/297288; Ben Hassine A, 2009, ANN BOT-LONDON, V104, P925, DOI 10.1093/aob/mcp174; BHATTI AS, 1993, ENVIRON EXP BOT, V33, P259, DOI 10.1016/0098-8472(93)90071-M; Chen JA, 2010, TREE PHYSIOL, V30, P1570, DOI 10.1093/treephys/tpq086; Delahunty C, 2001, PROTEOMICS SHOTGUN A; DSCHIDA WJ, 1992, ANN BOT-LONDON, V70, P501, DOI 10.1093/oxfordjournals.aob.a088510; FARADAY CD, 1986, J EXP BOT, V37, P482, DOI 10.1093/jxb/37.4.482; Flowers TJ, 2010, FUNCT PLANT BIOL, V37, P604, DOI 10.1071/FP09269; Geiser L, 2011, METHODS MOL BIOL, V681, P459, DOI 10.1007/978-1-60761-913-0_27; HILL AE, 1973, J MEMBRANE BIOL, V12, P129, DOI 10.1007/BF01869995; HILL AE, 1973, INT REV CYTOL, V35, P299, DOI 10.1016/S0074-7696(08)60357-5; Jyothi-Prakash PA, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0291-6; Kobayashi H, 2008, SOIL SCI PLANT NUTR, V54, P393, DOI 10.1111/j.1747-0765.2008.00246.x; Kobayashi H, 2007, SOIL SCI PLANT NUTR, V53, P764, DOI 10.1111/j.1747-0765.2007.00192.x; Krishnamurthy P, 2014, PROTEOMICS, V14, P2545, DOI 10.1002/pmic.201300527; Krishnamurthy P, 2014, PLANT CELL ENVIRON, V37, P1656, DOI 10.1111/pce.12272; KYLIN A, 1970, PLANT PHYSIOL, V45, P169, DOI 10.1104/pp.45.2.169; Labidi N, 2010, ACTA BIOL HUNG, V61, P299, DOI 10.1556/ABiol.61.2010.3.6; Ma HY, 2011, SCI CHINA LIFE SCI, V54, P282, DOI 10.1007/s11427-011-4145-2; Morgany, 1999, GUIDE MANGROVES SING; Naidoo Y, 1999, S AFR J BOT, V65, P370, DOI 10.1016/S0254-6299(15)31024-3; Polidoro BA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010095; Pont F, 2010, PROTEOMICS, V10, P1091, DOI 10.1002/pmic.200900667; Sadowski PG, 2006, NAT PROTOC, V1, P1778, DOI 10.1038/nprot.2006.254; Tada Y, 2009, PLANT CELL PHYSIOL, V50, P439, DOI 10.1093/pcp/pcp002; Tan WK, 2013, PLANT CELL ENVIRON, V36, P1410, DOI 10.1111/pce.12068; Tan WK, 2010, PLANT METHODS, V6, DOI 10.1186/1746-4811-6-24; Thomson W. W., 1988, Solute transport in plant cells and tissues., P498; Tomlinson P.B., 2016, BOT MANGROVES, DOI [10.1017/CBO9781139946575, DOI 10.1017/CBO9781139946575]; Tyerman SD, 2013, PLANT CELL ENVIRON, V36, P1407, DOI 10.1111/pce.12110; VASSILYEV AE, 1990, J EXP BOT, V41, P41, DOI 10.1093/jxb/41.1.41; VIERLING E, 1991, ANNU REV PLANT PHYS, V42, P579, DOI 10.1146/annurev.pp.42.060191.003051; Vizcaino JA, 2013, NUCLEIC ACIDS RES, V41, pD1063, DOI 10.1093/nar/gks1262; Wang LX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083141; Wang WX, 2004, TRENDS PLANT SCI, V9, P244, DOI 10.1016/j.tplants.2004.03.006; Zhang H, 2012, J PROTEOME RES, V11, P49, DOI 10.1021/pr200861w; Zhu Z, 2012, TREE PHYSIOL, V32, P1378, DOI 10.1093/treephys/tps097	41	7	8	5	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2015	10	7							e0133386	10.1371/journal.pone.0133386	http://dx.doi.org/10.1371/journal.pone.0133386			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LN	26193361	Green Submitted, gold, Green Published			2022-12-26	WOS:000358546400078
J	Depiereux, S; De Meulder, B; Bareke, E; Berger, F; Le Gac, F; Depiereux, E; Kestemont, P				Depiereux, Sophie; De Meulder, Bertrand; Bareke, Eric; Berger, Fabrice; Le Gac, Florence; Depiereux, Eric; Kestemont, Patrick			Adaptation of a Bioinformatics Microarray Analysis Workflow for a Toxicogenomic Study in Rainbow Trout	PLOS ONE			English	Article							GENE-EXPRESSION PROFILES; FALSE DISCOVERY RATE; MOLECULAR RESPONSES; SEX-DIFFERENTIATION; ONCORHYNCHUS-MYKISS; POWERFUL APPROACH; T-TEST; FISH; IDENTIFICATION; ONTOLOGY	Sex steroids play a key role in triggering sex differentiation in fish, the use of exogenous hormone treatment leading to partial or complete sex reversal. This phenomenon has attracted attention since the discovery that even low environmental doses of exogenous steroids can adversely affect gonad morphology (ovotestis development) and induce reproductive failure. Modern genomic-based technologies have enhanced opportunities to find out mechanisms of actions (MOA) and identify biomarkers related to the toxic action of a compound. However, high throughput data interpretation relies on statistical analysis, species genomic resources, and bioinformatics tools. The goals of this study are to improve the knowledge of feminisation in fish, by the analysis of molecular responses in the gonads of rainbow trout fry after chronic exposure to several doses (0.01, 0.1, 1 and 10 mu g/L) of ethynylestradiol (EE2) and to offer target genes as potential biomarkers of ovotestis development. We successfully adapted a bioinformatics microarray analysis workflow elaborated on human data to a toxicogenomic study using rainbow trout, a fish species lacking accurate functional annotation and genomic resources. The workflow allowed to obtain lists of genes supposed to be enriched in true positive differentially expressed genes (DEGs), which were subjected to over-representation analysis methods (ORA). Several pathways and ontologies, mostly related to cell division and metabolism, sexual reproduction and steroid production, were found significantly enriched in our analyses. Moreover, two sets of potential ovotestis biomarkers were selected using several criteria. The first group displayed specific potential biomarkers belonging to pathways/ontologies highlighted in the experiment. Among them, the early ovarian differentiation gene foxl2a was overexpressed. The second group, which was highly sensitive but not specific, included the DEGs presenting the highest fold change and lowest p-value of the statistical workflow output. The methodology can be generalized to other (non-model) species and various types of microarray platforms.	[Depiereux, Sophie; Kestemont, Patrick] Univ Namur, Lab Ecophysiol & Ecotoxicol, Unit Res Environm & Evolutionary Biol URBE NARILI, Namur, Belgium; [De Meulder, Bertrand; Bareke, Eric; Berger, Fabrice; Depiereux, Eric] Univ Namur, Unit Res Mol Biol URBM NARILIS, Namur, Belgium; [Le Gac, Florence] INRA, LPGP, UPR1037, F-35042 Rennes, France; [Bareke, Eric] Univ Montreal, St Justine UHC Res Ctr, Montreal, PQ H3T 1C5, Canada	University of Namur; University of Namur; INRAE; Universite de Montreal	Depiereux, S (corresponding author), Univ Namur, Lab Ecophysiol & Ecotoxicol, Unit Res Environm & Evolutionary Biol URBE NARILI, Namur, Belgium.	sophie.depiereux@unamur.be		Bareke, Eric/0000-0003-3928-7160	'Fond de la recherche scientifique' (FNRS)	'Fond de la recherche scientifique' (FNRS)(Fonds de la Recherche Scientifique - FNRS)	SD was funded by a grant from the 'Fond de la recherche scientifique' (FNRS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agilent Technologies, ON COL MICR BAS GEN, P92; Al-Shahrour F, 2004, BIOINFORMATICS, V20, P578, DOI 10.1093/bioinformatics/btg455; Ankley GT, 2009, AQUAT TOXICOL, V92, P168, DOI 10.1016/j.aquatox.2009.01.013; Apweiler R, 2013, NUCLEIC ACIDS RES, V41, pD43, DOI 10.1093/nar/gks1068; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Baldi P, 2001, BIOINFORMATICS, V17, P509, DOI 10.1093/bioinformatics/17.6.509; Baron D, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-357; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berger F, 2008, CENT EUR J BIOL, V3, P327, DOI 10.2478/s11535-008-0030-9; Berger F, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-510; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Cope LM, 2004, BIOINFORMATICS, V20, P323, DOI 10.1093/bioinformatics/btg410; Currie RA, 2005, REPROD TOXICOL, V20, P433, DOI 10.1016/j.reprotox.2005.03.014; Dagnelie P., 2013, STAT THEORIQUE APPL, V3e; Dahlquist KD, 2002, NAT GENET, V31, P19, DOI 10.1038/ng0502-19; De Hertogh B, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-17; De Meulder B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086699; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Denslow ND, 2007, MOL BIOSYST, V3, P172, DOI 10.1039/b612802p; Depiereux S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098531; Devlin RH, 2002, AQUACULTURE, V208, P191, DOI 10.1016/S0044-8486(02)00057-1; Dietrich DR, 2009, HISTOLOGICAL ANAL EN; Dudoit S, 2002, STAT SINICA, V12, P111; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Fertuck KC, 2003, PHYSIOL GENOMICS, V15, P127, DOI 10.1152/physiolgenomics.00058.2003; Filby AL, 2007, AQUAT TOXICOL, V81, P219, DOI 10.1016/j.aquatox.2006.12.003; Flicek P, 2012, NUCLEIC ACIDS RES, V2012, P40; Foster D L., 1994, PHYSL REPROD, V2; Handley-Goldstone HM, 2005, TOXICOL SCI, V85, P683, DOI 10.1093/toxsci/kfi116; Harris CA, 2011, ENVIRON HEALTH PERSP, V119, P306, DOI 10.1289/ehp.1002555; Helaers Raphael, 2011, BMC Res Notes, V4, P452, DOI 10.1186/1756-0500-4-452; Hirakawa I, 2012, CHEMOSPHERE, V87, P668, DOI 10.1016/j.chemosphere.2011.12.047; Hoffmann JL, 2006, AQUAT TOXICOL, V79, P233, DOI 10.1016/j.aquatox.2006.06.009; Hook SE, 2006, AQUAT TOXICOL, V77, P372, DOI 10.1016/j.aquatox.2006.01.007; Hosack DA, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r70; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Irizarry RA, 2006, BIOINFORMATICS, V22, P789, DOI 10.1093/bioinformatics/btk046; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jobling S, 1996, ENVIRON TOXICOL CHEM, V15, P194, DOI [10.1002/etc.5620150218, 10.1897/1551-5028(1996)015&lt;0194:IOTGIR&gt;2.3.CO;2]; Jobling S, 1998, ENVIRON SCI TECHNOL, V32, P2498, DOI 10.1021/es9710870; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Konishi T, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-S2-S6; Koskinen H, 2004, BIOCHEM BIOPH RES CO, V320, P745, DOI 10.1016/j.bbrc.2004.06.024; Larkin P, 2003, ECOTOXICOLOGY, V12, P463, DOI 10.1023/B:ECTX.0000003031.05390.b5; Larkin P, 2002, ENV HLTH PERSPECT, V111, P839; Legler J, 2002, SCI TOTAL ENVIRON, V293, P69, DOI 10.1016/S0048-9697(01)01146-9; Martyniuk CJ, 2007, AQUAT TOXICOL, V84, P38, DOI 10.1016/j.aquatox.2007.05.012; Moens LN, 2006, TOXICOL SCI, V93, P298, DOI 10.1093/toxsci/kfl057; Moggs JG, 2005, TOXICOLOGY, V213, P177, DOI 10.1016/j.tox.2005.05.020; Nadzialek S, 2011, ARCH ENVIRON CON TOX, V60, P471, DOI 10.1007/s00244-010-9548-8; Nguyen C., 2010, NANOSCIENCE NANOBIOT, P911; Opgen-Rhein R, 2007, STAT APPL GENET MOL, V6, DOI 10.2202/1544-6115.1252; Owens JW, 2002, CRIT REV TOXICOL, V32, P445, DOI 10.1080/20024091064291; Pierre M, 2011, J PROTEOM BIOINFORM, V04, P36; Pierre M, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-176; Purdom C.E., 1994, Chemistry and Ecology, V8, P275, DOI 10.1080/02757549408038554; Rao YL, 2008, STAT APPL GENET MOL, V7, DOI 10.2202/1544-6115.1287; Reiner A, 2003, BIOINFORMATICS, V19, P368, DOI 10.1093/bioinformatics/btf877; Rolland AD, 2010, TRANSCRIPTOME WIDE P; Routledge EJ, 1998, ENVIRON SCI TECHNOL, V32, P1559, DOI 10.1021/es970796a; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Schmittgen TD, 2000, ANAL BIOCHEM, V285, P194, DOI 10.1006/abio.2000.4753; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Sturn A, 2002, BIOINFORMATICS, V18, P207, DOI 10.1093/bioinformatics/18.1.207; Tilton SC, 2006, TOXICOL SCI, V90, P61, DOI 10.1093/toxsci/kfi341; van Aerle R, 2001, ENVIRON TOXICOL CHEM, V20, P2841, DOI 10.1002/etc.5620201225; Vizziano D, 2007, DEV DYNAM, V236, P2198, DOI 10.1002/dvdy.21212; Vizziano-Cantonnet D, 2008, J MOL ENDOCRINOL, V41, P277, DOI 10.1677/JME-08-0039; Wang RL, 2008, ENVIRON TOXICOL CHEM, V27, P664, DOI 10.1897/07-192.1; Wang RL, 2010, AQUAT TOXICOL, V98, P230, DOI 10.1016/j.aquatox.2010.02.021; Yano A, 2012, CURR BIOL; Zahurak M, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-142; Zeeberg BR, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-4-r28	73	5	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0128598	10.1371/journal.pone.0128598	http://dx.doi.org/10.1371/journal.pone.0128598			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RV	26186543	Green Published, Green Submitted, gold			2022-12-26	WOS:000358198700005
J	Eom, BW; Joo, J; Kim, S; Shin, A; Yang, HR; Park, J; Choi, IJ; Kim, YW; Kim, J; Nam, BH				Eom, Bang Wool; Joo, Jungnam; Kim, Sohee; Shin, Aesun; Yang, Hye-Ryung; Park, Junghyun; Choi, Il Ju; Kim, Young-Woo; Kim, Jeongseon; Nam, Byung-Ho			Prediction Model for Gastric Cancer Incidence in Korean Population	PLOS ONE			English	Article							BODY-MASS INDEX; AMERICAN JOINT COMMITTEE; PHYSICAL-ACTIVITY; SOCIOECONOMIC-STATUS; RISK; ADENOCARCINOMA; COHORT; ALCOHOL; STOMACH; VALIDATION	Background Predicting high risk groups for gastric cancer and motivating these groups to receive regular checkups is required for the early detection of gastric cancer. The aim of this study is was to develop a prediction model for gastric cancer incidence based on a large population-based cohort in Korea. Method Based on the National Health Insurance Corporation data, we analyzed 10 major risk factors for gastric cancer. The Cox proportional hazards model was used to develop gender specific prediction models for gastric cancer development, and the performance of the developed model in terms of discrimination and calibration was also validated using an independent cohort. Discrimination ability was evaluated using Harrell's C-statistics, and the calibration was evaluated using a calibration plot and slope. Results During a median of 11.4 years of follow-up, 19,465 (1.4%) and 5,579 (0.7%) newly developed gastric cancer cases were observed among 1,372,424 men and 804,077 women, respectively. The prediction models included age, BMI, family history, meal regularity, salt preference, alcohol consumption, smoking and physical activity for men, and age, BMI, family history, salt preference, alcohol consumption, and smoking for women. This prediction model showed good accuracy and predictability in both the developing and validation cohorts (C-statistics: 0.764 for men, 0.706 for women). Conclusions In this study, a prediction model for gastric cancer incidence was developed that displayed a good performance.	[Eom, Bang Wool; Choi, Il Ju; Kim, Young-Woo] Natl Canc Ctr, Res Inst & Hosp, Gastr Canc Branch, Goyang Si, South Korea; [Joo, Jungnam; Kim, Sohee; Yang, Hye-Ryung; Park, Junghyun; Nam, Byung-Ho] Natl Canc Ctr, Res Inst & Hosp, Div Canc Epidemiol & Prevent, Biometr Res Branch, Goyang Si, South Korea; [Shin, Aesun; Kim, Jeongseon] Natl Canc Ctr, Res Inst & Hosp, Div Canc Epidemiol & Prevent, Mol Epidemiol Branch, Goyang Si, South Korea	National Cancer Center - Korea (NCC); National Cancer Center - Korea (NCC); National Cancer Center - Korea (NCC)	Nam, BH (corresponding author), Natl Canc Ctr, Res Inst & Hosp, Div Canc Epidemiol & Prevent, Biometr Res Branch, Goyang Si, South Korea.	byunghonam@ncc.re.kr	Eom, Bang Wool/K-4412-2016; KIM, JEONGSEON/AAA-4643-2022; Shin, Aesun/E-9145-2014	Eom, Bang Wool/0000-0002-0332-2051; Shin, Aesun/0000-0002-6426-1969; Kim, Sohee/0000-0003-4660-6043; Kim, Young-Woo/0000-0002-1559-9672	National Cancer Center of Korea [NCC-1110310]	National Cancer Center of Korea	This work was supported by a grant from the National Cancer Center of Korea (No. NCC-1110310).	Ahn HS, 2010, CANCER-AM CANCER SOC, V116, P5592, DOI 10.1002/cncr.25550; Bae JM, 2008, GASTRIC CANCER, V11, P23, DOI 10.1007/s10120-007-0447-2; Bang YJ, 2010, LANCET, V376, P1302; Bang YJ, 2012, LANCET, V379, P315, DOI 10.1016/S0140-6736(11)61873-4; Bertuccio P, 2009, INT J CANCER, V125, P666, DOI 10.1002/ijc.24290; BROWN LM, 1994, CANCER CAUSE CONTROL, V5, P333, DOI 10.1007/BF01804984; Carolyn JA, 2008, BEST PRACTICES QUANT; D'Agostino RB, 2004, HANDB STAT, V23, P1; Fernandez E, 1999, AM J CLIN NUTR, V70, P85; Gammon MD, 1997, J NATL CANCER I, V89, P1277, DOI 10.1093/jnci/89.17.1277; Gonzalez CA, 2006, JNCI-J NATL CANCER I, V98, P345, DOI 10.1093/jnci/djj071; HARRELL FE, 1982, JAMA-J AM MED ASSOC, V247, P2543, DOI 10.1001/jama.247.18.2543; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; International Agency for Research on Cancer, 2004, IARC MONOGR EVAL CAR, V83, P1; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jung H, 2011, CANCER-AM CANCER SOC, V117, P2371, DOI 10.1002/cncr.25778; Jung KW, 2012, CANCER RES TREAT, V44, P11, DOI 10.4143/crt.2012.44.1.11; Kim J, 2010, AM J CLIN NUTR, V91, P1289, DOI 10.3945/ajcn.2009.28732; Kim Y, 2011, ASIAN PAC J CANCER P, V12, P725; Larsson SC, 2006, J NATL CANCER I, V98, P1078, DOI 10.1093/jnci/djj301; Lee DS, 2009, CANCER NURS, V32, P135, DOI 10.1097/NCC.0b013e3181982c2e; Lee Hyuk-Joon, 2002, Gastric Cancer, V5, P177, DOI 10.1007/s101200200031; Lee K, 2010, PUBLIC HEALTH, V124, P698, DOI 10.1016/j.puhe.2010.07.004; Lee KJ, 2006, INT J CANCER, V118, P2315, DOI 10.1002/ijc.21664; Levi Z, 2013, CANCER-AM CANCER SOC, V119, P4086, DOI 10.1002/cncr.28241; Lin XJ, 2014, JPN J CLIN ONCOL, V44, P783, DOI 10.1093/jjco/hyu082; Lindblad M, 2005, CANCER CAUSE CONTROL, V16, P285, DOI 10.1007/s10552-004-3485-7; Lindblad M, 2004, CANCER EPIDEM BIOMAR, V13, P2203; Mayne ST, 2001, CANCER EPIDEM BIOMAR, V10, P1055; McMichael AJ, 2008, PUBLIC HEALTH NUTR, V11, P762, DOI 10.1017/S1368980008002358; Merry AHH, 2007, GUT, V56, P1503, DOI 10.1136/gut.2006.116665; Miyamoto A, 2007, PREV MED, V44, P12, DOI 10.1016/j.ypmed.2006.07.016; Mouw T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003639; Nam SY, 2009, EUR J GASTROEN HEPAT, V21, P855, DOI 10.1097/MEG.0b013e328318ed42; Ngoan LT, 2002, BRIT J CANCER, V87, P37, DOI 10.1038/sj.bjc.6600415; Park S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054823; Pencina MJ, 2004, STAT MED, V23, P2109, DOI 10.1002/sim.1802; Royston P, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-33; Shin CM., 2010, J CLIN GASTROENTEROL, V44, pe34, DOI [DOI 10.1097/MCG.0B013E3181A159C4, 10.1097/MCG.0b013e3181a159c4]; Sjodahl K, 2008, CANCER EPIDEM BIOMAR, V17, P135, DOI 10.1158/1055-9965.EPI-07-0704; Tramacere I, 2012, ANN ONCOL, V23, P28, DOI 10.1093/annonc/mdr135; Tsubono Y, 2001, NEW ENGL J MED, V344, P632, DOI 10.1056/NEJM200103013440903; Vainio H, 2002, EUR J CANCER PREV, V11, pS94; van Houwelingen HC, 2000, STAT MED, V19, P3401, DOI 10.1002/1097-0258(20001230)19:24<3401::AID-SIM554>3.0.CO;2-2; Yaghoobi M, 2010, BRIT J CANCER, V102, P237, DOI 10.1038/sj.bjc.6605380	45	20	21	3	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0132613	10.1371/journal.pone.0132613	http://dx.doi.org/10.1371/journal.pone.0132613			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RV	26186332	Green Published, Green Submitted, gold			2022-12-26	WOS:000358198700051
J	Hu, GP; Zhou, YM; Wu, YK; Yu, Y; Liang, WQ; Ran, PX				Hu, Guoping; Zhou, Yumin; Wu, Yankui; Yu, Yan; Liang, Weiqiang; Ran, Pixin			The Pneumonia Severity Index as a Predictor of In-Hospital Mortality in Acute Exacerbation of Chronic Obstructive Pulmonary Disease	PLOS ONE			English	Article							COPD EXACERBATION; RISK; DYSPNEA; SCORE; COMORBIDITIES; VALIDATION; ADMISSION; SURVIVAL; AUDIT	Objective To determine whether the pneumonia severity index (PSI) can predict in-hospital mortality for AECOPD patients and compare its usefulness with the CURB65 and BAP65 indexes to predict mortality. Methods Demographics, clinical signs and symptoms, comorbidities, and laboratory and radiographic findings of hospitalized AECOPD patients were obtained. Univariate and multiple logistic regression analyses were used to identify the risk factors for in-hospital mortality. The PSI, CURB65 and BAP65 scores were calculated. Receiver operating characteristic (ROC) curve analysis was used to identify the PSI, CURB65 and BAP65 scores that could discriminate between non-survivors and survivors. To control for the confounding factor of invasive mechanical ventilation (IMV) regarding the mortality of AECOPD, subgroup analysis was performed when excluded patients who had met the criteria of IMV but who had not received the cure of IMV according to their wishes. Results During the in-hospital period, 73 patients died and 679 patients recovered. Age, PaO2<60 mmHg, pH < 7.35, PaCO2 >= 50 mmHg, nursing home residency, congestive heart failure, liver disease, sodium<130 mmol/L, lower FEV1% and altered mental status were risk factors for in-hospital mortality. The areas under the ROC curves (AUCs) of the PSI for death were 0.847 (95% CI: 0.799-0.895). The cut-off value was 116.5 with a sensitivity of 82.2% and a specificity of 77.6%. However, the AUCs of the CURB65 and BAP65 for death were only 0.744 (95% CI: 0.680-0.809) and 0.665 (95% CI: 0.594-0.736), respectively. Subgroup analysis also showed that the PSI score could predict the mortality of AECOPD patients with an AUC = 0.857 (95% CI: 0.802-0.913), with exclusion of the patients who met the criteria of IMV but who did not receive the cure of IMV. Conclusion The PSI score may be used to predict in-hospital mortality for hospitalized AECOPD patients, with a prognostic capacity superior to CURB65 and BAP65.	[Hu, Guoping; Yu, Yan; Liang, Weiqiang] Guangzhou Med Univ, Affiliated Hosp 3, Dept Resp Med, Guangzhou, Guangdong, Peoples R China; [Zhou, Yumin; Ran, Pixin] Guangzhou Med Univ, Affiliated Hosp 1, Guangzhou Inst Resp Dis, State Key Lab Resp Dis, Guangzhou, Guangdong, Peoples R China; [Wu, Yankui] Peoples Hosp Guangxi Zhuang Autonomous Reg, Dept Resp Dis, Nanning, Guangxi Zhuang, Peoples R China	Guangzhou Medical University; Guangzhou Medical University; State Key Laboratory of Respiratory Disease	Ran, PX (corresponding author), Guangzhou Med Univ, Affiliated Hosp 1, Guangzhou Inst Resp Dis, State Key Lab Resp Dis, Guangzhou, Guangdong, Peoples R China.	pxran@gzhmc.edu.cn			Guangzhou municipal health bureau scientific research fund [201102A213176]	Guangzhou municipal health bureau scientific research fund	This work was funded by the Guangzhou municipal health bureau scientific research fund (201102A213176) (URL: http://kjgl.gzmed.gov.cn/stmsres/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almagro P, 2014, CHEST, V145, P972, DOI 10.1378/chest.13-1328; Almagro P, 2012, CHEST, V142, P1126, DOI 10.1378/chest.11-2413; Asiimwe AC, 2011, LUNG, V189, P225, DOI 10.1007/s00408-011-9298-z; Bartziokas K, 2014, EUR RESPIR J, V43, P43, DOI 10.1183/09031936.00209212; Celli BR, 2008, RESP MED, V102, pS27, DOI 10.1016/S0954-6111(08)70005-2; Celli BR, 2004, NEW ENGL J MED, V350, P1005, DOI 10.1056/NEJMoa021322; Chalmers JD, 2010, THORAX, V65, P878, DOI 10.1136/thx.2009.133280; Chang CL, 2007, INTERN MED J, V37, P236, DOI 10.1111/j.1445-5994.2006.01283.x; Chang CL, 2011, RESPIROLOGY, V16, P146, DOI 10.1111/j.1440-1843.2010.01866.x; Divo M, 2012, AM J RESP CRIT CARE, V186, P155, DOI 10.1164/rccm.201201-0034OC; Edwards L, 2011, RESPIROLOGY, V16, P625, DOI 10.1111/j.1440-1843.2011.01926.x; Esteban C, 2011, RESP MED, V105, P1662, DOI 10.1016/j.rmed.2011.05.005; Fabbri LM, 2008, EUR RESPIR J, V31, P204, DOI 10.1183/09031936.00114307; Fine MJ, 1997, NEW ENGL J MED, V336, P243, DOI 10.1056/NEJM199701233360402; Francis RFMT, 1998, INTRO MED STAT; Fruchter O, 2015, AM J MED SCI, V349, P29, DOI 10.1097/MAJ.0000000000000332; FUSO L, 1995, AM J MED, V98, P272, DOI 10.1016/S0002-9343(99)80374-X; Garcia-Rio F, 2012, CHEST, V142, P338, DOI 10.1378/chest.11-2014; Groenewegen KH, 2003, CHEST, V124, P459, DOI 10.1378/chest.124.2.459; Gunen H, 2005, EUR RESPIR J, V26, P234, DOI 10.1183/09031936.05.00024804; Hoiseth AD, 2011, THORAX, V66, P775, DOI 10.1136/thx.2010.153122; Soler-Cataluna JJ, 2009, RESP MED, V103, P692, DOI 10.1016/j.rmed.2008.12.005; Ko FWS, 2011, RESP MED, V105, P266, DOI 10.1016/j.rmed.2010.06.022; Loke YK, 2010, THORAX, V65, P884, DOI 10.1136/thx.2009.134072; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Madkour AM, 2013, EGYPT J CHEST DIS TU, V62, P393, DOI 10.1016/j.ejcdt.2013.07.003; Miravitlles M, 2011, RESP MED, V105, P740, DOI 10.1016/j.rmed.2010.12.020; Murphy SA, 2010, RESP MED, V104, P1668, DOI 10.1016/j.rmed.2010.04.025; Murray CJL, 1997, LANCET, V349, P1269, DOI 10.1016/S0140-6736(96)07493-4; Puhan MA, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-002152; Rabe KF, 2007, AM J RESP CRIT CARE, V176, P532, DOI 10.1164/rccm.200703-456SO; Roberts CM, 2002, THORAX, V57, P137, DOI 10.1136/thorax.57.2.137; Roche N, 2008, EUR RESPIR J, V32, P953, DOI 10.1183/09031936.00129507; Ruiz-Gonzalez A, 2008, RESPIROLOGY, V13, P1028, DOI 10.1111/j.1440-1843.2008.01403.x; Shorr AF, 2011, CHEST, V140, P1177, DOI 10.1378/chest.10-3035; Singanayagam Aran, 2013, Ann Am Thorac Soc, V10, P81, DOI 10.1513/AnnalsATS.201208-043OC; Slenter RHJ, 2013, RESPIRATION, V85, P15, DOI 10.1159/000342036; Steer J, 2012, THORAX, V67, P117, DOI 10.1136/thoraxjnl-2011-200332; Steer J, 2012, THORAX, V67, P970, DOI 10.1136/thoraxjnl-2012-202103; Sundh J, 2012, PRIM CARE RESP J, V21, P295, DOI 10.4104/pcrj.2012.00054; Tabak YP, 2009, ARCH INTERN MED, V169, P1595, DOI 10.1001/archinternmed.2009.270; Tofan Fatmeh, 2012, Pneumologia, V61, P160	42	14	17	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0133160	10.1371/journal.pone.0133160	http://dx.doi.org/10.1371/journal.pone.0133160			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RV	26186637	gold, Green Submitted, Green Published			2022-12-26	WOS:000358198700103
J	Kiware, SS; Corliss, G; Merrill, S; Lwetoijera, DW; Devine, G; Majambere, S; Killeen, GF				Kiware, Samson S.; Corliss, George; Merrill, Stephen; Lwetoijera, Dickson W.; Devine, Gregor; Majambere, Silas; Killeen, Gerry F.			Predicting Scenarios for Successful Autodissemination of Pyriproxyfen by Malaria Vectors from Their Resting Sites to Aquatic Habitats; Description and Simulation Analysis of a Field-Parameterizable Model	PLOS ONE			English	Article							INSECTICIDE-TREATED NETS; ANOPHELES-GAMBIAE; BED NETS; OVIPOSITION BEHAVIOR; TRANSMISSION; MOSQUITOS; IMPACT; INDOOR; PREVENTION; ARABIENSIS	Background Large-cage experiments indicate pyriproxifen (PPF) can be transferred from resting sites to aquatic habitats by Anopheles arabiensis - malaria vector mosquitoes to inhibit emergence of their own offspring. PPF coverage is amplified twice: (1) partial coverage of resting sites with PPF contamination results in far higher contamination coverage of adult mosquitoes because they are mobile and use numerous resting sites per gonotrophic cycle, and (2) even greater contamination coverage of aquatic habitats results from accumulation of PPF from multiple oviposition events. Methods and Findings Deterministic mathematical models are described that use only field-measurable input parameters and capture the biological processes that mediate PPF autodissemination. Recent successes in large cages can be rationalized, and the plausibility of success under full field conditions can be evaluated a priori. The model also defines measurable properties of PPF delivery prototypes that may be optimized under controlled experimental conditions to maximize chances of success in full field trials. The most obvious flaw in this model is the endogenous relationship that inevitably occurs between the larval habitat coverage and the measured rate of oviposition into those habitats if the target mosquito species is used to mediate PPF transfer. However, this inconsistency also illustrates the potential advantages of using a different, non-target mosquito species for contamination at selected resting sites that shares the same aquatic habitats as the primary target. For autodissemination interventions to eliminate malaria transmission or vector populations during the dry season window of opportunity will require comprehensive contamination of the most challenging subset of aquatic habitats (C-lx) that persist or retain PPF activity (U-x) for only one week (C-lx -> 1, where U-x = 7 days). To achieve >99% contamination coverage of these habitats will necessitate values for the product of the proportional coverage of the ovipositing mosquito population with PPF contamination (C-M) by the ovitrap-detectable rates of oviposition by wild mosquitoes into this subset of habitats (m(lx,z,d)), divided by the titre of contaminated mosquitoes required to render them unproductive (T-lx,T-z,T-d), that approximately approach unity (C(M)m(lx,z,d)/T-lx,T-z,T-d -> 1). Conclusions The simple multiplicative relationship between C-M and m(lx,z,d)/T-lx,T-z,T-d, and the simple exponential decay effect they have upon uncontaminated aquatic habitats, allows application of this model by theoreticians and field biologists alike.	[Kiware, Samson S.; Lwetoijera, Dickson W.; Majambere, Silas; Killeen, Gerry F.] Ifakara Hlth Inst, Environm Hlth & Ecol Sci Themat Grp, Ifakara, Tanzania; [Kiware, Samson S.; Corliss, George; Merrill, Stephen] Marquette Univ, Dept Math Stat & Comp Sci, Milwaukee, WI 53201 USA; [Devine, Gregor] QIMR Berghofer Med Res Inst, Brisbane, Qld, Australia; [Lwetoijera, Dickson W.; Majambere, Silas; Killeen, Gerry F.] Univ Liverpool Liverpool Sch Trop Med, Vector Biol Dept, Liverpool L3 5QA, Merseyside, England	Ifakara Health Institute; Marquette University; QIMR Berghofer Medical Research Institute; Liverpool School of Tropical Medicine	Kiware, SS (corresponding author), Ifakara Hlth Inst, Environm Hlth & Ecol Sci Themat Grp, POB 53, Ifakara, Tanzania.	skiware@ihi.or.tz	Devine, Gregor J/H-1141-2014	Devine, Gregor J/0000-0001-6312-0390; Kiware, Samson/0000-0001-7252-520X	Bill & Melinda Gates Foundation [OPP52644]	Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR)	The funds for this study was received from the Bill & Melinda Gates Foundation, http://www.gatesfoundation.org/, award number OPP52644 awarded to GD and SM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abad-Franch F, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003702; Achee NL, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-164; Alonso PL, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000406; [Anonymous], 1998, COCHRANE DB SYST REV; Bayoh MN, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-62; Brady OJ, 2015, INT HEALTH, V7, P121, DOI 10.1093/inthealth/ihv010; Briet OJT, 2002, MED VET ENTOMOL, V16, P22, DOI 10.1046/j.0269-283x.2002.00335.x; Butail S, 2012, J R SOC INTERFACE, V9, P2624, DOI 10.1098/rsif.2012.0150; Caputo B, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001793; Chen H, 2006, AM J TROP MED HYG, V75, P246, DOI 10.4269/ajtmh.2006.75.246; Clements A, 1995, AM J TROP MED HYG, V52, P579; Cohen JM, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-213; Derua YA, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-188; Devine GJ, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-142; Devine GJ, 2009, P NATL ACAD SCI USA, V106, P11530, DOI 10.1073/pnas.0901369106; Dhadialla TS, 1998, ANNU REV ENTOMOL, V43, P545, DOI 10.1146/annurev.ento.43.1.545; Dugassa S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068948; Dugassa S, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-374; Durnez L, 2013, ANOPHELES MOSQUITOES - NEW INSIGHTS INTO MALARIA VECTORS, P671, DOI 10.5772/55925; Ferguson HM, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000303; Fillinger U, 2004, TROP MED INT HEALTH, V9, P1274, DOI 10.1111/j.1365-3156.2004.01335.x; Fillinger Ulrike, 2011, Malar J, V10, P353, DOI 10.1186/1475-2875-10-353; Gillies M, 1968, THE ANOPHELINAE OF A, P54; Govella NJ, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-124; Govella NJ, 2010, AM J TROP MED HYG, V82, P415, DOI 10.4269/ajtmh.2010.09-0579; Hagler JR, 2001, ANNU REV ENTOMOL, V46, P511, DOI 10.1146/annurev.ento.46.1.511; Hardy AJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081931; Harris C., 2011, Parasites and Vectors, V4; Hawley WA, 2003, AM J TROP MED HYG, V68, P121, DOI 10.4269/ajtmh.2003.68.121; Holstein M., 1954, BIOLOGY OF ANOPHELES; Jawara M, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-156; Killeen GF, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-338; Killeen GF, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-330; Killeen GF, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-146; Killeen GF, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-172; Killeen GF, 2013, AM J TROP MED HYG, V88, P809, DOI 10.4269/ajtmh.13-0065; Killeen GF, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-207; Killeen GF, 2003, LANCET INFECT DIS, V3, P297, DOI 10.1016/S1473-3099(03)00611-X; Killeen GF, 2002, LANCET INFECT DIS, V2, P618, DOI 10.1016/S1473-3099(02)00397-3; Kimani EW, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-63; Kitau J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031481; Kiware SS, 2012, BIOL LETTERS, V8, P874, DOI 10.1098/rsbl.2012.0352; Kiware SS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037661; Le Menach A, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-23; Lwetoijera DW, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-331; Macintyre K, 2003, INT J EPIDEMIOL, V32, P157, DOI 10.1093/ije/dyg019; Mbare O, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-94; Midega JT, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1672; Muller GC, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-210; MULLA MS, 1989, J AM MOSQUITO CONTR, V5, P15; Mutuku FM, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-356; Mwangangi JM, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-114; Mwangangi JM, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-13; Okumu FO, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-46; Okumu FO, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-17; Okumu FO, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011573; Okumu FO, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008951; Perkins TA, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003327; Pluess B, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006657.pub2; Rowland M, 2001, LANCET, V357, P1837, DOI 10.1016/S0140-6736(00)04955-2; Russell TL, 2011, P ROY SOC B-BIOL SCI, V278, P3142, DOI 10.1098/rspb.2011.0153; Russell TL, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-80; Service MW, 1997, J MED ENTOMOL, V34, P579, DOI 10.1093/jmedent/34.6.579; Sihuincha M, 2005, J MED ENTOMOL, V42, P620, DOI 10.1603/0022-2585(2005)042[0620:PUOPFC]2.0.CO;2; Silver J. B, 2008, MOSQUITO ECOLOGY FIE; Smith DL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071247; Smith DL, 2004, PLOS BIOL, V2, P1957, DOI 10.1371/journal.pbio.0020368; Spitzen J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062995; Thomas CJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068679; White MT, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-153; WHO, 2013, LARVAL SOURCE MANAGE	71	5	5	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0131835	10.1371/journal.pone.0131835	http://dx.doi.org/10.1371/journal.pone.0131835			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RV	26186730	Green Published, gold, Green Accepted			2022-12-26	WOS:000358198700024
J	Lee, S; Eguchi, A; Tsuzuki, S; Matsumura, S; Inoue, K; Iwanaga, T; Masuda, D; Yamashita, S; Fushiki, T				Lee, Shinhye; Eguchi, Ai; Tsuzuki, Satoshi; Matsumura, Shigenobu; Inoue, Kazuo; Iwanaga, Toshihiko; Masuda, Daisaku; Yamashita, Shizuya; Fushiki, Tohru			Expression of CD36 by Olfactory Receptor Cells and Its Abundance on the Epithelial Surface in Mice	PLOS ONE			English	Article							FATTY-ACID; PROTEINS; FAMILY; PREFERENCE; OXIDATION; NEURONS; MUSCLE; SNMP-1	CD36 is a transmembrane protein that is involved in the recognition of certain amphiphilic molecules such as polar lipids in various tissues and body fluids. So far, CD36 homologues in insects have been demonstrated to be present on the surface of olfactory dendrites and to participate in the perception of exogenous compounds. However, little is known about the relationship between CD36 and mammalian olfaction. Indeed, the detection of only CD36 mRNA in the mouse olfactory epithelium has been reported to date. In the present study, to provide potential pieces of evidence for the involvement of CD36 in mammalian olfactory perception, we extensively investigated the localisation of this protein in the mouse olfactory mucosa. In situ hybridisation analysis using antisense oligonucleotides to CD36 mRNA detected aggregated signals within the deeper epithelial layer of olfactory mucosa. The mRNA signals were also detected consistently in the superficial layer of the olfactory epithelium, which is occupied by supporting cells. Immunostaining with an anti-CD36 polyclonal antibody revealed that CD36 localises in the somata and dendrites of distinct olfactory receptor cells and that it occurs abundantly on the olfactory epithelial surface. However, immunoreactive CD36 was rarely detectable in the nerve bundles running in the lamina propria of olfactory mucosa, the axons forming the olfactory nerve layer in the outermost layer of the bulb and axon terminals in the glomeruli. We also obtained electron microscopic evidence for the association of CD36 protein with olfactory cilia. Altogether, we suggest that CD36 plays a role in the mammalian olfaction. In addition, signals for CD36 protein were also detected on or around the microvilli of olfactory supporting cells and the cilia of nasal respiratory epithelium, suggesting a role for this protein other than olfaction in the nasal cavity.	[Lee, Shinhye; Eguchi, Ai; Tsuzuki, Satoshi; Matsumura, Shigenobu; Inoue, Kazuo; Fushiki, Tohru] Kyoto Univ, Grad Sch Agr, Div Food Sci & Biotechnol, Nutr Chem Lab, Kyoto, Japan; [Iwanaga, Toshihiko] Hokkaido Univ, Grad Sch Med, Lab Histol & Cytol, Sapporo, Hokkaido, Japan; [Masuda, Daisaku] Osaka Univ, Grad Sch Med, Dept Cardiovasc Med, Suita, Osaka, Japan; [Yamashita, Shizuya] Osaka Univ, Grad Sch Med, Dept Community Med, Suita, Osaka, Japan	Kyoto University; Hokkaido University; Osaka University; Osaka University	Tsuzuki, S (corresponding author), Kyoto Univ, Grad Sch Agr, Div Food Sci & Biotechnol, Nutr Chem Lab, Kyoto, Japan.	tkmone@kais.kyoto-u.ac.jp	Matsumura, Shigenobu/Z-2088-2019	Tsuzuki, Satoshi/0000-0003-4385-0075; Masuda, Daisaku/0000-0002-0954-4042	JSPS KAKENHI [25292071]; Science and technology research promotion program for agriculture, forestry, fisheries and food industry	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Science and technology research promotion program for agriculture, forestry, fisheries and food industry	This work was supported by a JSPS KAKENHI Grant (B), Grant number 25292071, http://www.jsps.go.jp/english/e-grants/; and The Science and technology research promotion program for agriculture, forestry, fisheries and food industry, grant number not assigned, http://www.s.affrc.go.jp/docs/research_fund/2014/sinki_koubo_2014.htm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdoul-Azize S, 2014, BIOCHIMIE, V96, P8, DOI 10.1016/j.biochi.2013.06.005; Alkhatatbeh MJ, 2011, J THROMB HAEMOST, V9, P844, DOI 10.1111/j.1538-7836.2011.04220.x; Barnea G, 2004, SCIENCE, V304, P1468, DOI 10.1126/science.1096146; Benton R, 2007, NATURE, V450, P289, DOI 10.1038/nature06328; Coburn CT, 2000, J BIOL CHEM, V275, P32523, DOI 10.1074/jbc.M003826200; ENDEMANN G, 1993, J BIOL CHEM, V268, P11811; Febbraio M, 1999, J BIOL CHEM, V274, P19055, DOI 10.1074/jbc.274.27.19055; Forstner M, 2008, CHEM SENSES, V33, P291, DOI 10.1093/chemse/bjm087; Fujitani M, 2014, BIOSCI BIOTECH BIOCH, V78, P1871, DOI 10.1080/09168451.2014.940835; Fukuwatari T, 1997, FEBS LETT, V414, P461, DOI 10.1016/S0014-5793(97)01055-7; Glezer I, 2009, J COMP NEUROL, V517, P906, DOI 10.1002/cne.22185; Ibrahimi A, 1999, J BIOL CHEM, V274, P26761, DOI 10.1074/jbc.274.38.26761; Jin X, 2008, P NATL ACAD SCI USA, V105, P10996, DOI 10.1073/pnas.0803309105; Laugerette F, 2005, J CLIN INVEST, V115, P3177, DOI 10.1172/JCI25299; Martin C, 2011, PHYSIOL BEHAV, V105, P36, DOI 10.1016/j.physbeh.2011.02.029; Miller YI, 2011, CIRC RES, V108, P235, DOI 10.1161/CIRCRESAHA.110.223875; Mochida S, 2010, J BIOCHEM, V148, P721, DOI 10.1093/jb/mvq108; Moore KJ, 2002, J BIOL CHEM, V277, P47373, DOI 10.1074/jbc.M208788200; Pepino MY, 2014, ANNU REV NUTR, V34, P281, DOI 10.1146/annurev-nutr-071812-161220; Podrez EA, 2002, J BIOL CHEM, V277, P38503, DOI 10.1074/jbc.M203318200; Rogers ME, 1997, J BIOL CHEM, V272, P14792, DOI 10.1074/jbc.272.23.14792; Rogers ME, 2001, J NEUROBIOL, V49, P47, DOI 10.1002/neu.1065; Schwartz GJ, 2008, CELL METAB, V8, P281, DOI 10.1016/j.cmet.2008.08.005; Strotmann J, 2004, J NEUROSCI, V24, P7754, DOI 10.1523/JNEUROSCI.2588-04.2004; Strotmann J, 2011, HISTOCHEM CELL BIOL, V136, P357, DOI 10.1007/s00418-011-0850-y; Yoon HY, 2005, CELL, V123, P669, DOI 10.1016/j.cell.2005.08.039	26	19	20	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0133412	10.1371/journal.pone.0133412	http://dx.doi.org/10.1371/journal.pone.0133412			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RV	26186589	Green Submitted, Green Published, gold			2022-12-26	WOS:000358198700134
J	Rajapakse, NW; Karim, F; Evans, RG; Kaye, DM; Head, GA				Rajapakse, Niwanthi W.; Karim, Florian; Evans, Roger G.; Kaye, David M.; Head, Geoffrey A.			Augmented Endothelial-Specific L-Arginine Transport Blunts the Contribution of the Sympathetic Nervous System to Obesity Induced Hypertension in Mice	PLOS ONE			English	Article							NITRIC-OXIDE PRODUCTION; HIGH BLOOD-PRESSURE; MENTAL STRESS; ZUCKER RATS; RESPONSES; ANGIOTENSIN; DYSFUNCTION; INHIBITION; ACTIVATION; SYNTHASE	Augmenting endothelial specific transport of the nitric oxide precursor L-arginine via cationic amino acid transporter-1 (CAT1) can prevent obesity related hypertension. We tested the hypotheses that CAT1 overexpression prevents obesity-induced hypertension by buffering the influence of the sympathetic nervous system (SNS) on the maintenance of arterial pressure and by buffering pressor responses to stress. Wild type (WT; n=13) and CAT1 overexpressing mice (CAT+; n=13) were fed a normal or a high fat diet for 20 weeks. Mice fed a high fat diet were returned to the control diet before experiments commenced. Baseline mean arterial pressure (MAP) and effects of restraint-, shaker-and almond feeding-stress and ganglionic blockade (pentolinium; 5 mg/kg; i.p.) on MAP were determined in conscious mice. Fat feeding increased body weight to a similar extent in WT and CAT+ but MAP was greater only in WT compared to appropriate controls (by 29%). The depressor response to pentolinium was 65% greater in obese WT than lean WT (P < 0.001), but was similar in obese and lean CAT+ (P = 0.65). In lean WT and CAT+, pressor responses to shaker and feeding stress, but not restraint stress, were less in the latter genotype compared to the former (P <= 0.001). Pressor responses to shaker and feeding stress were less in obese WT than lean WT (P <= 0.001), but similar in obese and lean CAT+. The increase in MAP in response to restraint stress was less in obese WT (22 +/- 2%), but greater in obese CAT+ (37 +/- 2%), when compared to respective lean WT (31 +/- 3%) and lean CAT+ controls (27 +/- 2%; P <= 0.02). We conclude that CAT1 overexpression prevents obesity-induced hypertension by reducing the influence of the SNS on the maintenance of arterial pressure but not by buffering pressor responses to stress.	[Rajapakse, Niwanthi W.; Karim, Florian; Kaye, David M.; Head, Geoffrey A.] Baker IDI Heart & Diabet Inst, Melbourne, Vic, Australia; [Rajapakse, Niwanthi W.; Evans, Roger G.] Monash Univ, Dept Physiol, Melbourne, Vic 3168, Australia	Baker Heart and Diabetes Institute; Monash University	Rajapakse, NW (corresponding author), Baker IDI Heart & Diabet Inst, Melbourne, Vic, Australia.	niwanthi.rajapakse@bakeridi.edu.au	Head, Geoffrey A./B-2177-2010; Kaye, David/AAF-1202-2021; Evans, Roger/N-8580-2019	Head, Geoffrey A./0000-0002-7623-137X; Evans, Roger/0000-0002-9241-0757; Kaye, David/0000-0003-4058-0372; Rajapakse, Niwanthi/0000-0001-9777-1087	National Heart Foundation [PF09M4668]; National Health and Medical Research Council; Victorian Government's Operational Infrastructure Support Program	National Heart Foundation(National Heart Foundation of Australia); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Victorian Government's Operational Infrastructure Support Program	NR was a recipient of a National Heart Foundation post-doctoral fellowship (PF09M4668) for part of this study. The present study was supported by a National Health and Medical Research Council Program Grant to DK, and also in part by the Victorian Government's Operational Infrastructure Support Program. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armitage JA, 2012, HYPERTENSION, V60, P163, DOI 10.1161/HYPERTENSIONAHA.111.190413; Bayraktar H. Ozyurt, 2013, Autonomic & Autacoid Pharmacology, V33, P7, DOI 10.1111/aap.12004; Bjorntorp P, 2001, Obes Rev, V2, P73, DOI 10.1046/j.1467-789x.2001.00027.x; Butz GM, 2001, PHYSIOL GENOMICS, V5, P89, DOI 10.1152/physiolgenomics.2001.5.2.89; Cardillo C, 1998, J AM COLL CARDIOL, V32, P1207, DOI 10.1016/S0735-1097(98)00391-X; Chin-Dusting JPF, 2007, PHARMACOL THERAPEUT, V116, P428, DOI 10.1016/j.pharmthera.2007.08.001; D'Angelo G, 2006, HYPERTENSION, V48, P1109, DOI 10.1161/01.HYP.0000247306.53547.d4; da Silva AA, 2009, CURR HYPERTENS REP, V11, P206, DOI 10.1007/s11906-009-0036-3; Davern PJ, 2014, J HYPERTENS, V32, P352, DOI 10.1097/HJH.0000000000000015; Davern PJ, 2010, AM J HYPERTENS, V23, P838, DOI 10.1038/ajh.2010.69; Durand S, 2005, J PHYSIOL-LONDON, V562, P629, DOI 10.1113/jphysiol.2004.075747; Hall JE, 2010, J BIOL CHEM, V285, P17271, DOI 10.1074/jbc.R110.113175; Head GA, 2014, CURR HYPERTENS REP, V16, DOI 10.1007/s11906-014-0466-4; Jackson K, 2007, AM J HYPERTENS, V20, P893, DOI 10.1016/j.amjhyper.2007.02.010; KASSAB S, 1995, HYPERTENSION, V25, P893, DOI 10.1161/01.HYP.25.4.893; Kuniyoshi FHS, 2003, OBES RES, V11, P1411, DOI 10.1038/oby.2003.190; Mayorov DN, 2007, NEUROSCI LETT, V424, P89, DOI 10.1016/j.neulet.2007.07.007; PACAK K, 1995, ENDOCRINOLOGY, V136, P4360, DOI 10.1210/en.136.10.4360; Palma-Rigo K, 2011, J HYPERTENS, V29, P2156, DOI 10.1097/HJH.0b013e32834bbb6b; Rajapakse NW, 2014, ACTA PHYSIOL, V212, P39, DOI 10.1111/apha.12344; Rajapakse NW, 2014, CLIN EXP PHARMACOL P, V41, P1031, DOI 10.1111/1440-1681.12279; Rajapakse NW, 2013, CURR OPIN NEPHROL HY, V22, P45, DOI 10.1097/MNH.0b013e32835a6ff7; Rajapakse NW, 2009, CLIN EXP PHARMACOL P, V36, P249, DOI 10.1111/j.1440-1681.2008.05123.x; Rajapakse NW, 2005, AM J PHYSIOL-REG I, V289, pR745, DOI 10.1152/ajpregu.00477.2004; Ramchandra R, 2014, AM J PHYSIOL-REG I, V307, pR271, DOI 10.1152/ajpregu.00057.2014; Sadler CJ, 2004, BRAIN RES, V1016, P222, DOI 10.1016/j.brainres.2004.05.007; Schmidt FP, 2013, EUR HEART J, V34, P3508, DOI 10.1093/eurheartj/eht269; Skarphedinsson JO, 1997, J PHYSIOL-LONDON, V501, P671, DOI 10.1111/j.1469-7793.1997.671bm.x; Tabara Y, 2008, HYPERTENS RES, V31, P1219, DOI 10.1291/hypres.31.1219; Wofford MR, 2001, AM J HYPERTENS, V14, P694, DOI 10.1016/S0895-7061(01)01293-6; Yang ZY, 2007, CIRCULATION, V115, P1269, DOI 10.1161/CIRCULATIONAHA.106.665836	31	3	3	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0131424	10.1371/journal.pone.0131424	http://dx.doi.org/10.1371/journal.pone.0131424			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RV	26186712	Green Published, Green Submitted, gold			2022-12-26	WOS:000358198700016
J	Vinay, M; Franche, N; Gregori, G; Fantino, JR; Pouillot, F; Ansaldi, M				Vinay, Manon; Franche, Nathalie; Gregori, Gerald; Fantino, Jean-Raphael; Pouillot, Flavie; Ansaldi, Mireille			Phage-Based Fluorescent Biosensor Prototypes to Specifically Detect Enteric Bacteria Such as E. coli and Salmonella enterica Typhimurium	PLOS ONE			English	Article							ESCHERICHIA-COLI; CHROMOSOMAL GENES; MYCOBACTERIUM-TUBERCULOSIS; REPORTER PHAGE; FLOW-CYTOMETRY; WATER; SUSCEPTIBILITY; GFP; BACTERIOPHAGES; CONSTRUCTION	Water safety is a major concern for public health and for natural environment preservation. We propose to use bacteriophages to develop biosensor tools able to detect human and animal pathogens present in water. For this purpose, we take advantage of the highly discriminating properties of the bacteriophages, which specifically infect their bacterial hosts. The challenge is to use a fluorescent reporter protein that will be synthesized, and thus detected, only once the specific recognition step between a genetically modified temperate bacteriophage and its bacterial host has occurred. To ensure the accuracy and the execution speed of our system, we developed a test that does not require bacterial growth, since a simple 1-hour infection step is required. To ensure a high sensitivity of our tool and in order to detect up to a single bacterium, fluorescence is measured using a portable flow cytometer, also allowing on-site detection. In this study, we have constructed and characterized several "phagosensor" prototypes using the HK620 bacteriophage and its host Escherichia coli TD2158 and we successfully adapted this method to Salmonella detection. We show that the method is fast, robust and sensitive, allowing the detection of as few as 10 bacteria per ml with no concentration nor enrichment step. Moreover, the test is functional in sea water and allows the detection of alive bacteria. Further development will aim to develop phagosensors adapted on demand to the detection of any human or animal pathogen that may be present in water.	[Vinay, Manon; Franche, Nathalie; Fantino, Jean-Raphael; Ansaldi, Mireille] Aix Marseille Univ, CNRS, Chim Bacterienne Lab, UMR7283, Marseille, France; [Gregori, Gerald] Aix Marseille Univ, Univ Sud Toulon Var, CNRS, IRD,Mediterranean Inst Oceanol,UM110, Marseille, France; [Pouillot, Flavie] Pherecydes Pharma, Romainville, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Aix-Marseille Universite	Ansaldi, M (corresponding author), Aix Marseille Univ, CNRS, Chim Bacterienne Lab, UMR7283, Marseille, France.	mireille.ansaldi@imm.cnrs.fr	Grégori, Gérald J/D-8657-2013	Grégori, Gérald J/0000-0003-1645-9468; ANSALDI, Mireille/0000-0002-2878-0702	Centre National pour la Recherche Scientifique (CNRS); Agence Nationale pour la Recherche (ANR) [ECOTECH 11ECOT00902]; joint Pherecydes Pharma - Provence Alpes Cote d'Azur (PACA) region fellowship; Pherecydes-Pharma	Centre National pour la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Agence Nationale pour la Recherche (ANR)(French National Research Agency (ANR)); joint Pherecydes Pharma - Provence Alpes Cote d'Azur (PACA) region fellowship(Region Provence-Alpes-Cote d'Azur); Pherecydes-Pharma	This work was supported by the Centre National pour la Recherche Scientifique (CNRS), Agence Nationale pour la Recherche (ANR) grant ECOTECH 11ECOT00902 and a joint Pherecydes Pharma - Provence Alpes Cote d'Azur (PACA) region fellowship to MV. The funder Pherecydes-Pharma provided support in the form of a salary for author FP, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of all authors are articulated in the 'author contributions' section.	ALDEA M, 1989, EMBO J, V8, P3923, DOI 10.1002/j.1460-2075.1989.tb08573.x; [Anonymous], 2006, OFFICIAL J EUROPEA L, V64, P37; Barbesti S, 2005, CYTOM PART B-CLIN CY, V68B, P43, DOI 10.1002/cyto.b.20068; Battaglioli EJ, 2011, APPL ENVIRON MICROB, V77, P6630, DOI 10.1128/AEM.05307-11; Clark AJ, 2001, J MOL BIOL, V311, P657, DOI 10.1006/jmbi.2001.4868; Cormack BP, 1996, GENE, V173, P33, DOI 10.1016/0378-1119(95)00685-0; D'Herelle F, 2007, RES MICROBIOL, V158, P553, DOI 10.1016/j.resmic.2007.07.005; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Denes T, 2014, CURR OPIN BIOTECH, V26, P45, DOI 10.1016/j.copbio.2013.09.001; Derbise A, 2003, FEMS IMMUNOL MED MIC, V38, P113, DOI 10.1016/S0928-8244(03)00181-0; Derda R, 2013, ANAL CHEM, V85, P7213, DOI 10.1021/ac400961b; Dhillon TS, 1998, FEMS MICROBIOL LETT, V161, P129, DOI 10.1111/j.1574-6968.1998.tb12938.x; Edgar R, 2006, P NATL ACAD SCI USA, V103, P4841, DOI 10.1073/pnas.0601211103; Efstratiou MA, 2009, MAR POLLUT BULL, V58, P1039, DOI 10.1016/j.marpolbul.2009.02.007; Foladori P, 2010, WATER RES, V44, P3807, DOI 10.1016/j.watres.2010.04.027; Funatsu T, 2002, MICROBIOL IMMUNOL, V46, P365, DOI 10.1111/j.1348-0421.2002.tb02708.x; Goodridge L, 1999, APPL ENVIRON MICROB, V65, P1397; Goodridge L., 2003, SIM NEWS, V53, P254; Haq IU, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-9; Husseiny MI, 2005, INFECT IMMUN, V73, P1598, DOI 10.1128/IAI.73.3.1598-1605.2005; Jain P, 2012, J CLIN MICROBIOL, V50, P1362, DOI 10.1128/JCM.06192-11; Jia B, 2010, BIOTECHNOL LETT, V32, P521, DOI 10.1007/s10529-009-0189-9; Katashkina JI, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-34; Lee JW, 2013, INT J NANOMED, V8, P3917, DOI 10.2147/IJN.S51894; Lesic B, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-20; Loessner MJ, 1997, APPL ENVIRON MICROB, V63, P2961, DOI 10.1128/AEM.63.8.2961-2965.1997; Mansilha CR, 2010, MAR POLLUT BULL, V60, P819, DOI 10.1016/j.marpolbul.2010.01.013; Mosier-Boss PA, 2003, APPL SPECTROSC, V57, P1138, DOI 10.1366/00037020360696008; Namura M, 2008, BIOTECHNOL PROGR, V24, P481, DOI 10.1021/bp070326c; Panis G, 2010, VIROLOGY, V404, P41, DOI 10.1016/j.virol.2010.04.027; Parks DR, 2006, CYTOM PART A, V69A, P541, DOI 10.1002/cyto.a.20258; Piuri M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004870; POND K, 2005, WATER RECREATION DIS; Schmelcher Mathias, 2014, Bacteriophage, V4, pe28137; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schofield DA, 2012, APPL ENVIRON MICROB, V78, P3592, DOI 10.1128/AEM.00252-12; Singh A, 2013, SENSORS-BASEL, V13, P1763, DOI 10.3390/s130201763; Steen HB, 2004, CYTOM PART A, V57A, P94, DOI 10.1002/cyto.a.10115; Tanji Y, 2004, J BIOTECHNOL, V114, P11, DOI 10.1016/j.jbiotec.2004.05.011; Twort FW, 1915, LANCET, V2, P1241, DOI 10.1016/s0140-6736(01)20383-3; Ul Haq I, 2012, MICROB ECOL, V63, P954, DOI 10.1007/s00248-011-9944-2; Waddell TE, 2000, FEMS MICROBIOL LETT, V182, P285, DOI 10.1016/S0378-1097(99)00603-5; Willford John D, 2011, Bacteriophage, V1, P101; Winfield MD, 2003, APPL ENVIRON MICROB, V69, P3687, DOI 10.1128/AEM.69.7.3687-3694.2003; Yamamoto S, 2009, GENE, V438, P57, DOI 10.1016/j.gene.2009.02.015; Zaslaver A, 2006, NAT METHODS, V3, P623, DOI 10.1038/NMETH895	46	42	42	2	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0131466	10.1371/journal.pone.0131466	http://dx.doi.org/10.1371/journal.pone.0131466			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RV	26186207	Green Published, gold, Green Submitted			2022-12-26	WOS:000358198700018
J	Zheng, ZQ; Yan, DS; Chen, XY; Huang, H; Chen, K; Li, GJ; Zhou, LL; Zheng, DD; Tu, LL; Dong, XD				Zheng, Zhiqiang; Yan, Dongsheng; Chen, Xiaoyan; Huang, He; Chen, Ke; Li, Guangjing; Zhou, Linglin; Zheng, Dandan; Tu, Lili; Dong, Xiang Da			MicroRNA-206: Effective Inhibition of Gastric Cancer Progression through the c-Met Pathway	PLOS ONE			English	Article							DOWN-REGULATION; OVEREXPRESSION; PROLIFERATION; METASTASIS; CARCINOMA	MicroRNAs are endogenous short chain nucleotide RNAs that regulate gene function by direct binding of target mRNAs. In this study, we investigated the effects of microRNA-206 (miR-206) on the development of gastric cancer. miR-206 was first confirmed to be downregulated in gastric cancer specimens. Conversely, upregulation of c-Met was confirmed in tissue samples of human gastric cancer, with its level inversely correlated with miR-206 expression. Introduction of miR-206 inhibited cellular proliferation by inducing G1 cell cycle arrest, as well as migration and invasion. Moreover, important proliferation and/or migration related molecules such as c-Met, CDK4, p-Rb, p-Akt and p-ERK were confirmed to be downregulated by Western blot analysis. Targeting of c-Met also directly affected AGS cell proliferation, migration and invasion. In vivo, miR-206 expressing tumor cells also displayed growth delay in comparison to unaffected tumor cells. Our results demonstrated that miR-206 suppressed c-Met expression in gastric cancer and could function as a potent tumor suppressor in c-Met overexpressing tumors. Inhibition of miR-206 function could contribute to aberrant cell proliferation and migration, leading to gastric cancer development.	[Zheng, Zhiqiang; Yan, Dongsheng; Chen, Xiaoyan; Huang, He; Chen, Ke; Li, Guangjing; Zhou, Linglin; Zheng, Dandan; Tu, Lili] Wenzhou Med Univ, Wenzhou, Zhejiang, Peoples R China; [Zheng, Zhiqiang; Huang, He; Chen, Ke] Wenzhou Med Univ, Affiliated Hosp 2, Wenzhou, Zhejiang, Peoples R China; [Yan, Dongsheng; Chen, Xiaoyan; Li, Guangjing; Zhou, Linglin; Zheng, Dandan; Tu, Lili] Wenzhou Med Univ, Hosp Eye, Sch Ophthalmol & Optometry, Wenzhou, Zhejiang, Peoples R China; [Yan, Dongsheng; Chen, Xiaoyan; Li, Guangjing; Zhou, Linglin; Zheng, Dandan; Tu, Lili] Minist Hlth, State Key Lab Cultivat Base, Wenzhou, Zhejiang, Peoples R China; [Yan, Dongsheng; Chen, Xiaoyan; Li, Guangjing; Zhou, Linglin; Zheng, Dandan; Tu, Lili] Minist Hlth, Key Lab Vis Sci, Zhejiang Prov Key Lab Ophthalmol & Optometry, Wenzhou, Zhejiang, Peoples R China; [Dong, Xiang Da] Columbia Univ, Stamford Hosp Affiliate, Dept Surg, Stamford, CT USA	Wenzhou Medical University; Wenzhou Medical University; Wenzhou Medical University; Columbia University; Stamford Hospital	Tu, LL (corresponding author), Wenzhou Med Univ, Wenzhou, Zhejiang, Peoples R China.	tulili@mail.eye.ac.cn; xddong@hotmail.com	chen, xia/GXM-5435-2022; Yan, Dongsheng/B-1861-2018; chen, xi/GXH-3653-2022; chen, xia/GYR-3948-2022	Yan, Dongsheng/0000-0003-0551-2219; 	National Natural Science Foundation of China Grant [81100671]; Zhejiang Provincial Natural Science Foundation of China Grant [Y2110609]; Wenzhou Science & Technology Bureau Grant [Y20080096]	National Natural Science Foundation of China Grant(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Natural Science Foundation of China Grant; Wenzhou Science & Technology Bureau Grant	This work was supported, in part, by the National Natural Science Foundation of China Grant 81100671 (DY), Zhejiang Provincial Natural Science Foundation of China Grant Y2110609 (DY), and Wenzhou Science & Technology Bureau Grant Y20080096 (DY). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Birchmeier C, 2003, NAT REV MOL CELL BIO, V4, P915, DOI 10.1038/nrm1261; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Gommans Willemijn M, 2012, Methods Mol Biol, V822, P1, DOI 10.1007/978-1-61779-427-8_1; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; He XP, 2012, FEBS J, V279, P4201, DOI 10.1111/febs.12013; Huang TJ, 2001, ACTA ONCOL, V40, P638; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; NAITO S, 1986, CANCER RES, V46, P4109; Oh HK, 2011, CLIN CANCER RES, V17, P2657, DOI 10.1158/1078-0432.CCR-10-3152; Parasramka MA, 2012, CLIN EPIGENETICS, V4, DOI 10.1186/1868-7083-4-16; Peng Z, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0092924, 10.1371/journal.pone.0084502, 10.1371/journal.pone.0085663]; Ren J, 2014, CELL BIOSCI, V4, DOI 10.1186/2045-3701-4-26; Shrestha S, 2014, CANCER MED-US, V3, P878, DOI 10.1002/cam4.246; Sotoudeh K, 2012, DIAGN PATHOL, V7, DOI 10.1186/1746-1596-7-57; Ueda T, 2010, LANCET ONCOL, V11, P136, DOI 10.1016/S1470-2045(09)70343-2; Xu XH, 2013, ONCOL LETT, V6, P631, DOI 10.3892/ol.2013.1428; Yan D, 2009, J BIOL CHEM, V284, P29596, DOI 10.1074/jbc.M109.020511; Yan DS, 2009, INVEST OPHTH VIS SCI, V50, P1559, DOI 10.1167/iovs.08-2681; Zeng ZY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073278; Zhang L, 2013, CANCER LETT, V332, P94, DOI 10.1016/j.canlet.2013.01.023	21	24	27	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0128751	10.1371/journal.pone.0128751	http://dx.doi.org/10.1371/journal.pone.0128751			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RV	26186594	Green Submitted, Green Published, gold			2022-12-26	WOS:000358198700006
J	Politikos, I; Kim, HT; Nikiforow, S; Li, LQ; Brown, J; Antin, JH; Cutler, C; Ballen, K; Ritz, J; Boussiotis, VA				Politikos, Ioannis; Kim, Haesook T.; Nikiforow, Sarah; Li, Lequn; Brown, Julia; Antin, Joseph H.; Cutler, Corey; Ballen, Karen; Ritz, Jerome; Boussiotis, Vassiliki A.			IL-7 and SCF Levels Inversely Correlate with T Cell Reconstitution and Clinical Outcomes after Cord Blood Transplantation in Adults	PLOS ONE			English	Article							VERSUS-HOST-DISEASE; BONE-MARROW-TRANSPLANTATION; RECENT THYMIC EMIGRANTS; IMMUNE RECONSTITUTION; IN-VIVO; PLASMA-LEVELS; STEM-CELLS; ACUTE GVHD; INTERLEUKIN-7; RECOVERY	Recovery of thymopoiesis is critical for immune reconstitution after HSCT. IL-7 and SCF are two major thymotropic cytokines. We investigated whether the kinetics of circulating levels of these cytokines might provide insight into the prolonged immunodeficiency after double umbilical cord blood transplantation (dUCBT) in adults. We examined plasma levels of IL-7 and SCF, T-cell receptor rearrangement excision circle (TREC) levels and T cell subsets in 60 adult patients undergoing dUCBT. Median levels of IL-7 increased by more than 3-fold at 4 weeks and remained elevated through 100 days after dUCBT. SCF showed a less than 2-fold increase and more protracted elevation than IL-7. IL-7 levels inversely correlated with the reconstitution of various T cell subsets but not with TRECs. SCF levels inversely correlated with reconstitution of CD4(+)T cells, especially the naive CD4(+)CD45RA(+) subset, and with TRECs suggesting that SCF but not IL-7 had an effect on thymic regeneration. In Cox models, elevated levels of IL-7 and SCF were associated with higher non-relapse mortality (p = 0.03 and p = 0.01) and worse overall survival (p = 0.002 and p = 0.001). Elevated IL-7 but not SCF was also associated with development of GvHD (p = 0.03). Thus, IL-7 and SCF are elevated for a prolonged period after dUCBT and persistently high levels of these cytokines may correlate with worse clinical outcomes.	[Politikos, Ioannis; Li, Lequn; Brown, Julia; Boussiotis, Vassiliki A.] Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA 02215 USA; [Politikos, Ioannis; Li, Lequn; Brown, Julia; Boussiotis, Vassiliki A.] Beth Israel Deaconess Med Ctr, Div Hematol Oncol, Boston, MA 02215 USA; [Kim, Haesook T.] Dana Farber Canc Inst, Dept Computat Biol, Boston, MA 02115 USA; [Nikiforow, Sarah; Antin, Joseph H.; Cutler, Corey; Ritz, Jerome] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Ballen, Karen] Massachusetts Gen Hosp, Bone Marrow Transplantat Unit, Boston, MA 02114 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Massachusetts General Hospital	Boussiotis, VA (corresponding author), Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA 02215 USA.	vboussio@bidmc.harvard.edu	Ritz, Jerome/C-7929-2009	Ritz, Jerome/0000-0001-5526-4669	National Institutes of Health [A1098129, CA183605, CA142106, CA183559, CA183560]; Leukemia and Lymphoma grant [TRP 6222-11]; HHV6 Foundation Pilot Grant; NATIONAL CANCER INSTITUTE [P01CA142106, R01CA183605, R01CA183559, R01CA183560] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia and Lymphoma grant; HHV6 Foundation Pilot Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Institutes of Health Grants A1098129 (V.A.B.), CA183605 (V.A.B.), CA142106 (J.R.), CA183559 (J.R.) and CA183560 (J.R.); the Leukemia and Lymphoma grant TRP 6222-11 (V.A.B.); and the HHV6 Foundation Pilot Grant (V.A.B.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alpdogan O, 2001, BLOOD, V98, P2256, DOI 10.1182/blood.V98.7.2256; Arora M, 2007, BIOL BLOOD MARROW TR, V13, P1145, DOI 10.1016/j.bbmt.2007.06.004; Ballen K, 2012, BIOL BLOOD MARROW TR, V18, P1851, DOI 10.1016/j.bbmt.2012.06.016; Ballen KK, 2007, BIOL BLOOD MARROW TR, V13, P82, DOI 10.1016/j.bbmt.2006.08.041; Barker JN, 2005, BLOOD, V105, P1343, DOI 10.1182/blood-2004-07-2717; Bolotin E, 1996, BLOOD, V88, P1887; Bolotin E, 1999, BONE MARROW TRANSPL, V23, P783, DOI 10.1038/sj.bmt.1701655; Broers AEC, 2003, BLOOD, V102, P1534, DOI 10.1182/blood-2002-11-3349; Broudy VC, 1997, BLOOD, V90, P1345, DOI 10.1182/blood.V90.4.1345.1345_1345_1364; Brown JA, 2010, BLOOD, V115, P4111, DOI 10.1182/blood-2009-09-244145; Chung B, 2008, BIOL BLOOD MARROW TR, V14, P16, DOI 10.1016/j.bbmt.2007.07.015; Chung B, 2007, BLOOD, V110, P2803, DOI 10.1182/blood-2006-11-055673; Chung B, 2011, BIOL BLOOD MARROW TR, V17, P48, DOI 10.1016/j.bbmt.2010.07.027; Clave E, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00054; Cutler C, 2011, BONE MARROW TRANSPL, V46, P659, DOI 10.1038/bmt.2010.192; Cutler C, 2013, BLOOD, V122, P3074, DOI 10.1182/blood-2013-05-503177; De Bock M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055876; Dean RM, 2008, J CLIN ONCOL, V26, P5735, DOI 10.1200/JCO.2008.17.1314; DECASTRO CM, 1994, EXP HEMATOL, V22, P1025; Douek DC, 1998, NATURE, V396, P690, DOI 10.1038/25374; Fry TJ, 2001, BLOOD, V97, P2983, DOI 10.1182/blood.V97.10.2983; Fry TJ, 2005, J IMMUNOL, V174, P6571, DOI 10.4049/jimmunol.174.11.6571; Fry TJ, 2001, BLOOD, V97, P1525, DOI 10.1182/blood.V97.6.1525; Fry TJ, 2001, TRENDS IMMUNOL, V22, P564, DOI 10.1016/S1471-4906(01)02028-2; GODFREY DI, 1992, J IMMUNOL, V149, P2281; Gray R, 1988, ANN STAT, V16, P1140; Jacobson CA, 2012, BIOL BLOOD MARROW TR, V18, P565, DOI 10.1016/j.bbmt.2011.08.018; Kanda J, 2012, BIOL BLOOD MARROW TR, V18, P1664, DOI 10.1016/j.bbmt.2012.06.005; Kielsen K, 2015, SCAND J IMMUNOL, V81, P72, DOI 10.1111/sji.12244; Kim HT, 2015, BIOL BLOOD MARROW TR; Komanduri KV, 2007, BLOOD, V110, P4543, DOI 10.1182/blood-2007-05-092130; Krenger W, 2011, BLOOD, V117, P6768, DOI 10.1182/blood-2011-02-334623; Krenger W, 2008, SEMIN IMMUNOPATHOL, V30, P439, DOI 10.1007/s00281-008-0131-6; LEVY RB, 1995, J IMMUNOL, V154, P106; Mackall CL, 2001, BLOOD, V97, P1491, DOI 10.1182/blood.V97.5.1491; Mackall CL, 2011, NAT REV IMMUNOL, V11, P330, DOI 10.1038/nri2970; Massa S, 2006, EUR J IMMUNOL, V36, P526, DOI 10.1002/eji.200535760; Milano F, 2013, BIOL BLOOD MARROW TR, V19, P847, DOI 10.1016/j.bbmt.2013.04.006; MORRISSEY PJ, 1994, CELL IMMUNOL, V157, P118, DOI 10.1006/cimm.1994.1210; Murray R, 1989, Int Immunol, V1, P526, DOI 10.1093/intimm/1.5.526; Narimatsu H, 2008, BLOOD, V112, P2579, DOI 10.1182/blood-2007-11-118893; Newell LF, 2013, BONE MARROW TRANSPL, V48, P1285, DOI 10.1038/bmt.2013.48; Okamoto Y, 2002, BLOOD, V99, P2851, DOI 10.1182/blood.V99.8.2851; Perales MA, 2012, BLOOD, V120, P4882, DOI 10.1182/blood-2012-06-437236; Plum J, 1996, BLOOD, V88, P4239; Politikos I, 2014, BLOOD, V124, P3201, DOI 10.1182/blood-2014-07-589176; Ponce DM, 2013, BIOL BLOOD MARROW TR, V19, P904, DOI 10.1016/j.bbmt.2013.02.008; PRENTICE RL, 1978, BIOMETRICS, V34, P541, DOI 10.2307/2530374; RODEWALD HR, 1995, IMMUNITY, V3, P313, DOI 10.1016/1074-7613(95)90116-7; Sairafi D, 2012, CLIN IMMUNOL, V142, P343, DOI 10.1016/j.clim.2011.12.001; Sinha ML, 2002, BLOOD, V100, P2642, DOI 10.1182/blood-2002-04-1082; Sportes C, 2008, J EXP MED, V205, P1701, DOI 10.1084/jem.20071681; TESTA U, 1994, BLOOD, V84, P3532; Thiant S, 2011, BONE MARROW TRANSPL, V46, P1374, DOI 10.1038/bmt.2010.300; Thiant S, 2010, BONE MARROW TRANSPL, V45, P1546, DOI 10.1038/bmt.2010.13; Uhlin M, 2012, STEM CELLS DEV, V21, P1409, DOI 10.1089/scd.2011.0310; Williams KA, 2007, SEMIN IMMUNOL, V19, P318, DOI 10.1016/j.smim.2007.10.004; Wils EJ, 2011, HAEMATOL-HEMATOL J, V96, P1846, DOI 10.3324/haematol.2011.047696; Wils EJ, 2011, J IMMUNOL, V187, P2974, DOI 10.4049/jimmunol.1004209; Zhang LQ, 1999, J EXP MED, V190, P725, DOI 10.1084/jem.190.5.725	60	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0132564	10.1371/journal.pone.0132564	http://dx.doi.org/10.1371/journal.pone.0132564			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26177551	Green Published, Green Submitted, gold			2022-12-26	WOS:000358197600124
J	Emerenini, BO; Hense, BA; Kuttler, C; Eberl, HJ				Emerenini, Blessing O.; Hense, Burkhard A.; Kuttler, Christina; Eberl, Hermann J.			A Mathematical Model of Quorum Sensing Induced Biofilm Detachment	PLOS ONE			English	Article							PLANKTONIC-CELL YIELD; PSEUDOMONAS-AERUGINOSA; GENE-EXPRESSION; DIFFUSION; AUTOINDUCER; MECHANISMS; DISPERSAL; COMMUNICATION; BIOSYNTHESIS; ANTIBIOTICS	Background Cell dispersal (or detachment) is part of the developmental cycle of microbial biofilms. It can be externally or internally induced, and manifests itself in discrete sloughing events, whereby many cells disperse in an instance, or in continuous slower dispersal of single cells. One suggested trigger of cell dispersal is quorum sensing, a cell-cell communication mechanism used to coordinate gene expression and behavior in groups based on population densities. Method To better understand the interplay of colony growth and cell dispersal, we develop a dynamic, spatially extended mathematical model that includes biofilm growth, production of quorum sensing molecules, cell dispersal triggered by quorum sensing molecules, and reattachment of cells. This is a highly nonlinear system of diffusion-reaction equations that we study in computer simulations. Results Our results show that quorum sensing induced cell dispersal can be an efficient mechanism for bacteria to control the size of a biofilm colony, and at the same time enhance its downstream colonization potential. In fact we find that over the lifetime of a biofilm colony the majority of cells produced are lost into the aqueous phase, supporting the notion of biofilms as cell nurseries. We find that a single quorum sensing based mechanism can explain both, discrete dispersal events and continuous shedding of cells from a colony. Moreover, quorum sensing induced cell dispersal affects the structure and architecture of the biofilm, for example it might lead to the formation of hollow inner regions in a biofilm colony.	[Emerenini, Blessing O.; Eberl, Hermann J.] Univ Guelph, Dept Math & Stat, Guelph, ON N1G 2W1, Canada; [Hense, Burkhard A.] Helmholtz Zentrum Munchen, Inst Computat Biol, Neuherberg, Germany; [Kuttler, Christina] Tech Univ Munich, Zentrum Math, Neuherberg, Germany	University of Guelph; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich	Emerenini, BO (corresponding author), Univ Guelph, Dept Math & Stat, Guelph, ON N1G 2W1, Canada.	buzor@uoguelph.ca		Eberl, Hermann/0000-0001-5558-0872; Emerenini, Blessing/0000-0001-9178-2738	Natural Sciences and Engineering Research Council, Discovery Grants; OMAFRA - UofG Partnership	Natural Sciences and Engineering Research Council, Discovery Grants; OMAFRA - UofG Partnership	This work was supported by Natural Sciences and Engineering Research Council, Discovery Grants (http:///www.nserc.ca) and OMAFRA - UofG Partnership (http://www.uoguelph.ca/omafra_partnership/hqp/en/index.asp).	Abbas F, 2012, MATH BIOSC ENG, V9; ADAR YY, 1992, J BACTERIOL, V174, P7138, DOI 10.1128/jb.174.22.7138-7143.1992; ADAR YY, 1993, J BIOLUM CHEMILUM, V8, P261, DOI 10.1002/bio.1170080506; Anguige K, 2005, J MATH BIOL, V51, P557, DOI 10.1007/s00285-005-0316-8; Annous Bassam A, 2009, J Food Sci, V74, pR24, DOI 10.1111/j.1750-3841.2008.01022.x; Barraud N, 2006, J BACTERIOL, V188, P7344, DOI 10.1128/JB.00779-06; Baty AM, 2000, APPL ENVIRON MICROB, V66, P3574, DOI 10.1128/AEM.66.8.3574-3585.2000; Beech WB, 2004, CURR OPIN BIOTECH, V15, P181, DOI 10.1016/j.copbio.2004.05.001; Beenken KE, 2003, INFECT IMMUN, V71, P4206, DOI 10.1128/IAI.71.7.4206-4211.2003; Ben Jacob E, 2004, TRENDS MICROBIOL, V12, P366, DOI 10.1016/j.tim.2004.06.006; Bester E, 2005, APPL ENVIRON MICROB, V71, P7792, DOI 10.1128/AEM.71.12.7792-7798.2005; Bester E, 2009, CAN J MICROBIOL, V55, P1195, DOI 10.1139/W09-075; Boles BR, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000052; Boles BR, 2005, MOL MICROBIOL, V57, P1210, DOI 10.1111/j.1365-2958.2005.04743.x; Bollinger N, 2001, J BACTERIOL, V183, P1990, DOI 10.1128/JB.183.6.1990-1996.2001; BOYD A, 1994, APPL ENVIRON MICROB, V60, P2355, DOI 10.1128/AEM.60.7.2355-2359.1994; Bruchmann J, 2013, ENVIRON SCI POLLUT R, V20, P3539, DOI 10.1007/s11356-013-1521-4; Chambless JD, 2006, APPL ENVIRON MICROB, V72, P2005, DOI 10.1128/AEM.72.3.2005-2013.2006; Chmielewski R A N, 2003, Compr Rev Food Sci Food Saf, V2, P22, DOI 10.1111/j.1541-4337.2003.tb00012.x; Chopp DL, 2007, TOP BIOMED ENG, P1, DOI 10.1007/978-0-387-68413-0_1; D'Acunto B, J MATH BIOSCIENCE, V259, P20; D'Argenio DA, 2002, J BACTERIOL, V184, P6481, DOI 10.1128/JB.184.23.6481-6489.2002; Davey ME, 2003, J BACTERIOL, V185, P1027, DOI 10.1128/JB.185.3.1027-1036.2003; Davies DG, 2009, J BACTERIOL, V191, P1393, DOI 10.1128/JB.01214-08; De Monte S, 2007, P NATL ACAD SCI USA, V104, P18377, DOI 10.1073/pnas.0706089104; Dockery J, 2002, SIAM J APPL MATH, V62, P853, DOI 10.1137/S0036139900371709; Dockery JD, 2001, B MATH BIOL, V63, P95, DOI 10.1006/bulm.2000.0205; Donlan RM, 2001, EMERG INFECT DIS, V7, P277, DOI 10.3201/eid0702.010226; Duddu R, 2009, BIOTECHNOL BIOENG, V103, P92, DOI 10.1002/bit.22233; Eberl H.J., 2002, RIMS KOKYUROKO, V1258, P49; Eberl H. J., 2007, ELECTRON J DIFFER EQ, V15, P77; Eberl HJ, 2008, J THEOR BIOL, V253, P788, DOI 10.1016/j.jtbi.2008.04.013; Eberl HJ., 2001, J THEORETICAL MED, V3, P161, DOI [10.1080/10273660108833072, DOI 10.1080/10273660108833072]; Efendiev MA, 2009, COMMUN PUR APPL ANAL, V8, P509, DOI 10.3934/cpaa.2009.8.509; Fekete A, 2010, FEMS MICROBIOL ECOL, V72, P22, DOI 10.1111/j.1574-6941.2009.00828.x; Fratamico PM, 2009, WOODHEAD PUBL FOOD S, P1; Frederick M.R., 2010, CAN APPL MATH Q, V18, P267; Frederick MR, 2011, THEOR BIOL MED MODEL, V8, DOI 10.1186/1742-4682-8-8; Gilbert KB, 2009, MOL MICROBIOL, V73, P1072, DOI 10.1111/j.1365-2958.2009.06832.x; Hense BA, 2007, NAT REV MICROBIOL, V5, P230, DOI 10.1038/nrmicro1600; Hense BA, 2012, SENSORS-BASEL, V12, P4156, DOI 10.3390/s120404156; Hunt SM, 2004, APPL ENVIRON MICROB, V70, P7418, DOI 10.1128/AEM.70.12.7418-7425.2004; Hunt SM, 2003, MICROBIOL-SGM, V149, P1155, DOI 10.1099/mic.0.26134-0; KAPLAN HB, 1985, J BACTERIOL, V163, P1210, DOI 10.1128/JB.163.3.1210-1214.1985; Kaplan JB, 2010, J DENT RES, V89, P205, DOI 10.1177/0022034509359403; Khassehkhan H, 2009, LECT NOTES COMPUT SC, V5544, P735, DOI 10.1007/978-3-642-01970-8_73; Kirov SM, 2005, MICROBIOL-SGM, V151, P3452, DOI 10.1099/mic.0.28295-0; Kreft JU, 1998, MICROBIOL-UK, V144, P3275, DOI 10.1099/00221287-144-12-3275; Kreft JU, 2001, MICROBIOL-SGM, V147, P2897, DOI 10.1099/00221287-147-11-2897; Krol E, 2004, MOL GENET GENOMICS, V272, P1, DOI 10.1007/s00438-004-1030-8; Kuttler C, 2008, J THEOR BIOL, V251, P167, DOI 10.1016/j.jtbi.2007.11.015; Langebrake JB, 2014, J THEOR BIOL, V363, P53, DOI 10.1016/j.jtbi.2014.07.033; Liang W, 2008, FEBS LETT, V582, P3744, DOI 10.1016/j.febslet.2008.10.008; Ma LM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000354; Marsh Philip D, 2006, BMC Oral Health, V6 Suppl 1, pS14, DOI 10.1186/1472-6831-6-S1-S14; Mellbye B, 2014, J BACTERIOL, V196, P1155, DOI 10.1128/JB.01223-13; Morgenroth E, 2000, WATER RES, V34, P417, DOI 10.1016/S0043-1354(99)00157-8; Muller J, 2006, J MATH BIOL, V53, P672, DOI 10.1007/s00285-006-0024-z; Muhammad N, 2011, MATH BIOSCI, V233, P1, DOI 10.1016/j.mbs.2011.05.006; Muhammad N, 2010, LECT NOTES COMPUT SC, V5976, P180, DOI 10.1007/978-3-642-12659-8_14; Nadell CD, 2009, FEMS MICROBIOL REV, V33, P206, DOI 10.1111/j.1574-6976.2008.00150.x; Parsek MR, 2003, ANNU REV MICROBIOL, V57, P677, DOI 10.1146/annurev.micro.57.030502.090720; Periasamy S, 2012, P NATL ACAD SCI USA, V109, P1281, DOI 10.1073/pnas.1115006109; Picioreanu C, 2001, BIOTECHNOL BIOENG, V72, P205; PICIOREANU C, 2001, J BIOTECHNOLOGY BIOE, V58, P101; Pizarro GE, 2005, J COMPUT CIVIL ENG, V19, P258, DOI 10.1061/(ASCE)0887-3801(2005)19:3(258); Rice SA, 2005, J BACTERIOL, V187, P3477, DOI 10.1128/JB.187.10.3477-3485.2005; SAAD Y, 2003, ITERATIVE METHODS SP, V2nd; Sawyer LK, 1998, WATER SCI TECHNOL, V37, P211, DOI 10.1016/S0273-1223(98)00108-5; Schuster M, 2003, J BACTERIOL, V185, P2066, DOI 10.1128/JB.185.7.2066-2079.2003; Scutera S, 2014, EXPERT OPIN DRUG DIS, V9, P353, DOI 10.1517/17460441.2014.894974; Slater H, 2003, MOL MICROBIOL, V47, P303, DOI 10.1046/j.1365-2958.2003.03295.x; Smoller J., 2012, SHOCK WAVES REACTION, V258; Solano C, 2014, CURR OPIN MICROBIOL, V18, P96, DOI 10.1016/j.mib.2014.02.008; Stewart PS, 2003, J BACTERIOL, V185, P1485, DOI 10.1128/JB.185.5.1485-1491.2003; Sudarsan R, 2015, ARXIV150107221V1PHYS; Suppiger A, 2013, VIRULENCE, V4, P400, DOI 10.4161/viru.25338; Tatek YB, 2006, PHYSICA A, V362, P382, DOI 10.1016/j.physa.2005.08.011; Thomas MS, 2012, TOPICS ECOLOGICAL EN, P265; Van Houdt R, 2010, J APPL MICROBIOL, V109, P1117, DOI 10.1111/j.1365-2672.2010.04756.x; Vaughan BL, 2010, B MATH BIOL, V72, P1143, DOI 10.1007/s11538-009-9485-8; Vuong C, 2000, J INFECT DIS, V182, P1688, DOI 10.1086/317606; Wanner O, 1996, BIOTECHNOL BIOENG, V49, P172; WANNER O, 1986, BIOTECHNOL BIOENG, V28, P314, DOI 10.1002/bit.260280304; Wanner O, 2006, 18 IWA; Ward J., 2008, CONTROL BIOFILM INFE, P79; Ward JP, 2001, IMA J MATH APPL MED, V18, P263; Webb J. S., 2007, BOOK CHAPTER BIOFILM; Willcox MDP, 2008, MICROBIOL-SGM, V154, P2184, DOI 10.1099/mic.0.2008/019281-0; Wilson S, 2004, APPL ENVIRON MICROB, V70, P5847, DOI 10.1128/AEM.70.10.5847-5852.2004; Xavier JB, 2005, MICROBIOL-SGM, V151, P3817, DOI 10.1099/mic.0.28165-0; Xavier JD, 2005, BIOTECHNOL BIOENG, V91, P651, DOI 10.1002/bit.20544; Yarwood JM, 2004, J BACTERIOL, V186, P1838, DOI 10.1128/JB.186.6.1838-1850.2004; Zhang W., 2011, CHARACTERIZATION PAS	94	50	51	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0132385	10.1371/journal.pone.0132385	http://dx.doi.org/10.1371/journal.pone.0132385			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LZ	26197231	Green Published, Green Submitted, gold			2022-12-26	WOS:000358547600032
J	Lella, LK; Sales, VL; Goldsmith, Y; Chan, J; Iskandir, M; Gulkarov, I; Tortolani, A; Brener, SJ; Sacchi, TJ; Heitner, JF				Lella, Leela K.; Sales, Virna L.; Goldsmith, Yulia; Chan, Jacqueline; Iskandir, Marina; Gulkarov, Iosif; Tortolani, Anthony; Brener, Sorin J.; Sacchi, Terrence J.; Heitner, John F.			Reduced Right Ventricular Function Predicts Long-Term Cardiac Re-Hospitalization after Cardiac Surgery	PLOS ONE			English	Article							ARTERY-BYPASS-SURGERY; LOW EJECTION FRACTION; CARDIOPULMONARY BYPASS; NONCARDIAC SURGERY; OFF-PUMP; DYSFUNCTION; SURVIVAL; GUIDELINES; MORTALITY; FAILURE	Background The significance of right ventricular ejection fraction (RVEF), independent of left ventricular ejection fraction (LVEF), following isolated coronary artery bypass grafting (CABG) and valve procedures remains unknown. The aim of this study is to examine the significance of abnormal RVEF by cardiac magnetic resonance (CMR), independent of LVEF in predicting outcomes of patients undergoing isolated CABG and valve surgery. Methods From 2007 to 2009, 109 consecutive patients (mean age, 66 years; 38% female) were referred for pre-operative CMR. Abnormal RVEF and LVEF were considered <35% and <45%, respectively. Elective primary procedures include CABG (56%) and valve (44%). Thirty-day outcomes were perioperative complications, length of stay, cardiac re-hospitalizations and early mortaility; long-term (> 30 days) outcomes included, cardiac re-hospitalization, worsening congestive heart failure and mortality. Mean clinical follow up was 14 months. Findings Forty-eight patients had reduced RVEF (mean 25%) and 61 patients had normal RVEF (mean 50%) (p<0.001). Fifty-four patients had reduced LVEF (mean 30%) and 55 patients had normal LVEF (mean 59%) (p<0.001). Patients with reduced RVEF had a higher incidence of long-term cardiac re-hospitalization vs. patients with normal RVEF (31% vs. 13%, p<0.05). Abnormal RVEF was a predictor for long-term cardiac re-hospitalization (HR 3.01 [CI 1.5-7.9], p<0.03). Reduced LVEF did not influence long-term cardiac re-hospitalization. Conclusion Abnormal RVEF is a stronger predictor for long-term cardiac re-hospitalization than abnormal LVEF in patients undergoing isolated CABG and valve procedures.	[Lella, Leela K.; Sales, Virna L.; Goldsmith, Yulia; Chan, Jacqueline; Iskandir, Marina; Brener, Sorin J.; Sacchi, Terrence J.; Heitner, John F.] New York Methodist Hosp, Div Cardiol, Brooklyn, NY 11215 USA; [Gulkarov, Iosif; Tortolani, Anthony] New York Methodist Hosp, Dept Cardiothorac Surg, Brooklyn, NY 11215 USA	NewYork-Presbyterian Brooklyn Methodist Hospital; NewYork-Presbyterian Hospital; NewYork-Presbyterian Brooklyn Methodist Hospital; NewYork-Presbyterian Hospital	Heitner, JF (corresponding author), New York Methodist Hosp, Div Cardiol, Brooklyn, NY 11215 USA.	jfh9003@nyp.org						Adhyapak Srilakshmi M, 2010, Prev Cardiol, V13, P72, DOI 10.1111/j.1751-7141.2009.00053.x; Bonow RO, 2011, NEW ENGL J MED, V364, P1617, DOI 10.1056/NEJMoa1100358; Bove T, 2014, EUR J CARDIO-THORAC, V45, pE6, DOI 10.1093/ejcts/ezt505; Cuspidi C, 2014, J CARDIOVASC MED HAG; Davidson MJ, 2008, CIRCULATION, V117, P2181, DOI 10.1161/CIRCULATIONAHA.108.767723; de Groote P, 1998, J AM COLL CARDIOL, V32, P948, DOI 10.1016/S0735-1097(98)00337-4; Denault AY, 2010, SEMIN CARDIOTHORAC V, V14, P165, DOI 10.1177/1089253210376673; Dupuis JY, 2001, ANESTHESIOLOGY, V94, P194, DOI 10.1097/00000542-200102000-00006; Filsoufi F, 2007, ANN THORAC SURG, V84, P808, DOI 10.1016/j.athoracsur.2007.04.117; Fleisher LA, 2007, CIRCULATION, V116, pE418, DOI 10.1161/CIRCULATIONAHA.107.185699; Greil GF, 2008, HEART, V94, P803, DOI 10.1136/hrt.2005.079111; Hillis GS, 2006, CIRCULATION, V114, pI414, DOI 10.1161/CIRCULATIONAHA.105.000661; Hochman JS, 1999, NEW ENGL J MED, V341, P625, DOI 10.1056/NEJM199908263410901; Joshi SB, 2010, CARDIOVASC REVASCULA, V11, P98, DOI 10.1016/j.carrev.2009.04.002; Kjaergaard J, 2006, EUR J ECHOCARDIOGR, V7, P430, DOI 10.1016/j.euje.2005.10.009; Maslow AD, 2002, ANESTH ANALG, V95, P1507, DOI 10.1097/00000539-200212000-00009; McCarthy Patrick M, 2010, Curr Treat Options Cardiovasc Med, V12, P587, DOI 10.1007/s11936-010-0098-1; McCarthy PM, 2004, J THORAC CARDIOV SUR, V127, P674, DOI 10.1016/j.jtcvs.2003.11.019; Messika-Zeitoun D, 2004, J THORAC CARDIOV SUR, V128, P296, DOI 10.1016/j.jtcvs.2004.01.035; Nardi P, 2009, ANN THORAC SURG, V87, P1401, DOI 10.1016/j.athoracsur.2009.02.062; PASSAMANI E, 1985, NEW ENGL J MED, V312, P1665, DOI 10.1056/NEJM198506273122603; Pegg TJ, 2008, CIRCULATION, V117, P2202, DOI 10.1161/CIRCULATIONAHA.107.735621; Poldermans D, 2009, EUR HEART J, V30, P2769, DOI 10.1093/eurheartj/ehp337; RAPER R, 1987, WORLD J SURG, V11, P154, DOI 10.1007/BF01656397; Reichert C L, 1992, J Cardiothorac Vasc Anesth, V6, P429, DOI 10.1016/1053-0770(92)90008-U; SIBBALD WJ, 1983, CRIT CARE MED, V11, P339, DOI 10.1097/00003246-198305000-00004; Siddiqui MMA, 2012, HEART SURG FORUM, V15, pE185, DOI 10.1532/HSF98.20111142; STEIN KL, 1990, CRIT CARE MED, V18, P1197, DOI 10.1097/00003246-199011000-00001; van Wolferen SA, 2007, EUR HEART J, V28, P1250, DOI 10.1093/eurheartj/ehl477; Velazquez EJ, 2011, NEW ENGL J MED, V364, P1607, DOI 10.1056/NEJMoa1100356; Yoo JS, 2013, INT J CARDIOL, V168, P5316, DOI 10.1016/j.ijcard.2013.08.009; Zhao XQ, 2003, J CARDIOTHOR VASC AN, V17, P193, DOI 10.1053/jcan.2003.46	32	23	23	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0132808	10.1371/journal.pone.0132808	http://dx.doi.org/10.1371/journal.pone.0132808			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LZ	26197273	Green Submitted, Green Published, gold			2022-12-26	WOS:000358547600052
J	Mahmoud-Awny, M; Attia, AS; Abd-Ellah, MF; El-Abhar, HS				Mahmoud-Awny, Magdy; Attia, Ahmed S.; Abd-Ellah, Mohamed F.; El-Abhar, Hanan Salah			Mangiferin Mitigates Gastric Ulcer in Ischemia/Reperfused Rats: Involvement of PPAR-gamma, NF-kappa B and Nrf2/HO-1 Signaling Pathways	PLOS ONE			English	Article							ACTIVATED RECEPTOR-GAMMA; ISCHEMIA-REPERFUSION INJURY; INDICA L. EXTRACT; HEME OXYGENASE-1; CARBON-MONOXIDE; NITRIC-OXIDE; ANTIOXIDANT RESPONSE; EXPRESSION; DAMAGE; STRESS	Mangiferin (MF), a xanthonoid from Mangifera indica, has been proved to have antisecretory and antioxidant gastroprotective effects against different gastric ulcer models; however, its molecular mechanism has not been previously elucidated. Therefore, the aim of this study was to test its modulatory effect on several signaling pathways using the ischemia/ reperfusion model for the first time. Animals were treated with MF, omeprazole (OMP), and the vehicle. The mechanistic studies revealed that MF mediated its gastroprotective effect partly via inducing the expression of Nrf2, HO-1 and PPAR-gamma along with downregulating that of NF-kappa B. Surprisingly, the effect of MF, especially the high dose, exceeded that mediated by OMP except for Nrf2. The molecular results were reflected on the biomarkers measured, where the antioxidant effect of MF was manifested by increasing total antioxidant capacity and glutathione, besides normalizing malondialdehyde level. Additionally, MF decreased the I/R-induced nitric oxide elevation, an effect that was better than that of OMP. In the serum, MF, dose dependently, enhanced endothelial nitric oxide synthase, while reduced the inducible isoform. Regarding the anti-inflammatory effect of MF, it reduced serum level of IL-1 beta and sE-selectin, effects that were mirrored on the tissue level of myeloperoxidase, the neutrophil infiltration marker. In addition, MF possessed an antiapoptotic character evidenced by elevating Bcl-2 level and reducing that of caspase-3 in a dose related order. As a conclusion, the intimated gastroprotective mechanisms of MF are mediated, partially, by modulation of oxidative stress, inflammation and apoptosis possibly via the Nrf2/HO-1, PPAR-gamma/NF-kappa B signaling pathways.	[Mahmoud-Awny, Magdy] October Univ, Dept Pharmacol & Toxicol, Cairo, Egypt; [Attia, Ahmed S.] Cairo Univ, Dept Microbiol & Immunologyol, Cairo, Egypt; [Abd-Ellah, Mohamed F.] El Azhar Univ, Dept Pharmacol & Toxicol, Cairo, Egypt; [El-Abhar, Hanan Salah] Cairo Univ, Dept Pharmacol & Toxicol, Cairo, Egypt	Egyptian Knowledge Bank (EKB); October 6 University (O6U); Egyptian Knowledge Bank (EKB); Cairo University; Egyptian Knowledge Bank (EKB); Al Azhar University; Egyptian Knowledge Bank (EKB); Cairo University	El-Abhar, HS (corresponding author), Cairo Univ, Dept Pharmacol & Toxicol, Cairo, Egypt.	Hanabhar@yahoo.com	El-Abhar, Hanan/L-2289-2019; Attia, Ahmed S./F-6875-2011	El-Abhar, Hanan/0000-0001-8819-9891; Attia, Ahmed S./0000-0003-0491-1007				Abdallah DM, 2009, EUR J PHARMACOL, V603, P93, DOI 10.1016/j.ejphar.2008.11.057; AHMED AE, 1991, J BIOCHEM TOXICOL, V6, P115, DOI 10.1002/jbt.2570060205; ANDERSON ME, 1983, P NATL ACAD SCI-BIOL, V80, P707, DOI 10.1073/pnas.80.3.707; Benzie IFF, 1996, ANAL BIOCHEM, V239, P70, DOI 10.1006/abio.1996.0292; Biswas K, 2003, J BIOL CHEM, V278, P10993, DOI 10.1074/jbc.M210328200; BRADLEY PP, 1982, J INVEST DERMATOL, V78, P206, DOI 10.1111/1523-1747.ep12506462; Carvalho ACS, 2007, PLANTA MED, V73, P1372, DOI 10.1055/s-2007-990231; Chamoun F, 2000, FRONT BIOSCI, V5, pE103, DOI 10.2741/chamoun; Das J, 2012, TOXICOL APPL PHARM, V260, P35, DOI 10.1016/j.taap.2012.01.015; Dou W, 2014, INT IMMUNOPHARMACOL, V23, P170, DOI 10.1016/j.intimp.2014.08.025; El-Abhar HS, 2003, J ETHNOPHARMACOL, V84, P251, DOI 10.1016/S0378-8741(02)00324-0; Flogel U, 1999, J MOL CELL CARDIOL, V31, P827, DOI 10.1006/jmcc.1998.0921; Franklin CC, 2009, MOL ASPECTS MED, V30, P86, DOI 10.1016/j.mam.2008.08.009; Ghosal S, 1996, INDIAN J CHEM B, V35, P561; Ghosh M, 2012, FREE RADICAL RES, V46, P116, DOI 10.3109/10715762.2011.644240; Giakoustidis AE, 2008, FREE RADICAL RES, V42, P180, DOI 10.1080/10715760701840039; Gilberto L, 2006, PHARMACOLOGY, V3, P712; Glantzounis GK, 2005, LIVER TRANSPLANT, V11, P1031, DOI 10.1002/lt.20504; Gong X, 2013, J NUTR BIOCHEM, V24, P1173, DOI 10.1016/j.jnutbio.2012.09.003; Handa O, 2006, INFLAMM RES, V55, P476, DOI 10.1007/s00011-006-6056-4; He CH, 2001, J BIOL CHEM, V276, P20858, DOI 10.1074/jbc.M101198200; Idriss NK, 2008, J AM COLL CARDIOL, V52, P971, DOI 10.1016/j.jacc.2008.06.019; Itoh K, 2004, FREE RADICAL BIO MED, V36, P1208, DOI 10.1016/j.freeradbiomed.2004.02.075; Jangra A, 2014, EUR J PHARMACOL, V740, P337, DOI 10.1016/j.ejphar.2014.07.031; Kaspar JW, 2009, FREE RADICAL BIO MED, V47, P1304, DOI 10.1016/j.freeradbiomed.2009.07.035; Konturek PC, 2003, EUR J PHARMACOL, V472, P213, DOI 10.1016/S0014-2999(03)01932-0; Kotani T, 2007, LIFE SCI, V80, P1984, DOI 10.1016/j.lfs.2007.02.041; Leiro J, 2004, INT IMMUNOPHARMACOL, V4, P763, DOI 10.1016/j.intimp.2004.03.002; Liu GH, 2008, BBA-MOL CELL RES, V1783, P713, DOI 10.1016/j.bbamcr.2008.01.002; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Marquez L, 2010, WORLD J GASTROENTERO, V16, P4922, DOI 10.3748/wjg.v16.i39.4922; Matsuyama M, 2005, TRANSPL P, V37, P1684, DOI 10.1016/j.transproceed.2005.02.068; Miranda KM, 2001, NITRIC OXIDE-BIOL CH, V5, P62, DOI 10.1006/niox.2000.0319; Nakajima A, 2001, GASTROENTEROLOGY, V120, P460, DOI 10.1053/gast.2001.21191; Nakao A, 2003, AM J PATHOL, V163, P1587, DOI 10.1016/S0002-9440(10)63515-8; Nguyen T, 2000, J BIOL CHEM, V275, P15466, DOI 10.1074/jbc.M000361200; Nishida K, 1998, NITRIC OXIDE-BIOL CH, V2, P215, DOI 10.1006/niox.1998.0178; Otterbein LE, 2000, NAT MED, V6, P422, DOI 10.1038/74680; Pae HO, 2008, RECENT PATENTS INFLA, V2, P159, DOI 10.2174/187221308786241929; Pan H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114186; Qiao WL, 2011, WORLD J GASTROENTERO, V17, P1718, DOI 10.3748/wjg.v17.i13.1718; Rajendran P, 2008, NAT PROD RES, V22, P672, DOI 10.1080/14786410701824973; Ricote M, 1998, NATURE, V391, P79, DOI 10.1038/34178; Ryter SW, 2005, ANTIOXID REDOX SIGN, V7, P80, DOI 10.1089/ars.2005.7.80; Sanchez GM, 2003, PHYTOTHER RES, V17, P197, DOI 10.1002/ptr.921; Sarkar A, 2004, J BIOL CHEM, V279, P33768, DOI 10.1074/jbc.M403424200; SATO N, 1995, SCAND J GASTROENTERO, V30, P14, DOI 10.3109/00365529509107756; Sener-Muratoglu G, 2001, DIGEST DIS SCI, V46, P318, DOI 10.1023/A:1005652815921; Serracino-Inglott F, 2001, AM J SURG, V181, P160, DOI 10.1016/S0002-9610(00)00573-0; STOCKER R, 1987, SCIENCE, V235, P1043, DOI 10.1126/science.3029864; Surh YJ, 2008, PLANTA MED, V74, P1526, DOI 10.1055/s-0028-1088302; Takahashi T, 2009, J CLIN BIOCHEM NUTR, V44, P28, DOI 10.3164/jcbn.08-210-HO; Tanaka J, 2001, EUR J PHARMACOL, V424, P69, DOI 10.1016/S0014-2999(01)01119-0; UCHIYAMA M, 1978, ANAL BIOCHEM, V86, P271, DOI 10.1016/0003-2697(78)90342-1; Vieira AB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071759; Villegas I, 2004, EUR J PHARMACOL, V505, P195, DOI 10.1016/j.ejphar.2004.10.020; Villeneuve NF, 2010, ANTIOXID REDOX SIGN, V13, P1699, DOI 10.1089/ars.2010.3211; Wada K, 2004, AM J PHYSIOL-GASTR L, V287, pG452, DOI 10.1152/ajpgi.00523.2003; Wang B, 2014, INT IMMUNOPHARMACOL, V23, P170; Wood JG, 1996, AM J PHYSIOL, V271, P27; Wu JS, 2009, J CELL PHYSIOL, V220, P58, DOI 10.1002/jcp.21730; Zhao XR, 2015, CNS NEUROSCI THER, V21, P357, DOI 10.1111/cns.12350	62	52	53	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0132497	10.1371/journal.pone.0132497	http://dx.doi.org/10.1371/journal.pone.0132497			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LZ	26196679	Green Published, Green Submitted, gold			2022-12-26	WOS:000358547600039
J	Martinez, E; Ros, M; Bonilla, MA; Dirzo, R				Martinez, Eliana; Roes, Matthias; Argenis Bonilla, Maria; Dirzo, Rodolfo			Habitat Heterogeneity Affects Plant and Arthropod Species Diversity and Turnover in Traditional Cornfields	PLOS ONE			English	Article							BIOLOGICAL-CONTROL; BETA-DIVERSITY; LANDSCAPE COMPLEXITY; WEED COMMUNITIES; NATURAL ENEMIES; CEREAL FIELDS; AFFECTS ALPHA; CROP PEST; CONSERVATION; BIODIVERSITY	The expansion of the agricultural frontier by the clearing of remnant forests has led to human-dominated landscape mosaics. Previous studies have evaluated the effect of these landscape mosaics on arthropod diversity at local spatial scales in temperate and tropical regions, but little is known about fragmentation effects in crop systems, such as the complex tropical traditional crop systems that maintain a high diversity of weeds and arthropods in low-Andean regions. To understand the factors that influence patterns of diversity in human-dominated landscapes, we investigate the effect of land use types on plant and arthropod diversity in traditionally managed cornfields, via surveys of plants and arthropods in twelve traditional cornfields in the Colombian Andes. We estimated alpha and beta diversity to analyze changes in diversity related to land uses within a radius of 100 m to 1 km around each cornfield. We observed that forests influenced alpha diversity of plants, but not of arthropods. Agricultural lands had a positive relationship with plants and herbivores, but a negative relationship with predators. Pastures positively influenced the diversity of plants and arthropods. In addition, forest cover seemed to influence changes in plant species composition and species turnover of herbivore communities among cornfields. The dominant plant species varied among fields, resulting in high differentiation of plant communities. Predator communities also exhibited high turnover among cornfields, but differences in composition arose mainly among rare species. The crop system evaluated in this study represents a widespread situation in the tropics, therefore, our results can be of broad significance. Our findings suggest that traditional agriculture may not homogenize biological communities, but instead could maintain the regional pool of species through high beta diversity.	[Martinez, Eliana] Univ Nacl Colombia, Fac Ciencias Agr, Escuela Posgrad, Bogota, Colombia; [Roes, Matthias] Inst Ecol AC, Red Ecoetol, Xalapa, Veracruz, Mexico; [Roes, Matthias] Inst Politecn Nacl, Ctr Interdisciplinario Invest Desarrollo Integral, Oaxaca, Mexico; [Argenis Bonilla, Maria] Univ Nacl Colombia, Fac Ciencias, Dept Biol, Bogota, Colombia; [Dirzo, Rodolfo] Stanford Univ, Dept Biol, Palo Alto, CA 94304 USA	Universidad Nacional de Colombia; Instituto de Ecologia - Mexico; Instituto Politecnico Nacional - Mexico; Universidad Nacional de Colombia; Stanford University	Martinez, E (corresponding author), Univ Nacl Colombia, Fac Ciencias Agr, Escuela Posgrad, Bogota, Colombia.	emartinezpa@unal.edu.co	Rös, Matthias/AAS-5755-2021	Rös, Matthias/0000-0002-5722-6321; Martinez Pachon, Eliana/0000-0002-5144-132X	Departamento Administrativo de Ciencia, Tecnologia e Innovacion (COLCIENCIAS); Stanford University via Dirzo Lab operational budget; Research Group Biologia de Organismos Tropicales, Universidad Nacional de Colombia	Departamento Administrativo de Ciencia, Tecnologia e Innovacion (COLCIENCIAS)(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias); Stanford University via Dirzo Lab operational budget; Research Group Biologia de Organismos Tropicales, Universidad Nacional de Colombia	Funding for this research was provided by Departamento Administrativo de Ciencia, Tecnologia e Innovacion (COLCIENCIAS) through its Creditos Condonables para estudios de Doctorado Nacionales program - 2010 (granted to EM). Additional funding for field work was obtained from Stanford University via Dirzo Lab operational budget, and the Research Group Biologia de Organismos Tropicales, Universidad Nacional de Colombia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altieri MA, 1991, REV CLADES, P1; Armengot L, 2012, APPL VEG SCI, V15, P571, DOI 10.1111/j.1654-109X.2012.01190.x; Arroyo-Rodriguez V, 2013, J ECOL, V101, P1449, DOI 10.1111/1365-2745.12153; Callaway RM, 1997, ECOLOGY, V78, P1958, DOI 10.1890/0012-9658(1997)078[1958:CAFASA]2.0.CO;2; Chao A, 2012, ECOLOGY, V93, P2533, DOI 10.1890/11-1952.1; Chaplin-Kramer R, 2011, ECOL LETT, V14, P922, DOI 10.1111/j.1461-0248.2011.01642.x; Chen Xiao, 2003, REGRESSION STATA; Clough Y, 2005, J BIOGEOGR, V32, P2007, DOI 10.1111/j.1365-2699.2005.01367.x; Clough Y, 2007, J APPL ECOL, V44, P22, DOI 10.1111/j.1365-2664.2006.01239.x; Clough Y, 2007, J APPL ECOL, V44, P804, DOI 10.1111/j.1365-2664.2007.01294.x; Clough Y, 2009, BIOL CONSERV, V142, P1032, DOI 10.1016/j.biocon.2008.12.027; Colwell R, 2009, STAT ESTIMATION SPEC; Crawley M. J, 2002, STAT COMPUTING INTRO; de Souza Mendonça Jr. Milton, 2007, Bol. Soc. Argent. Bot., V42, P347; Drapela T, 2008, ECOGRAPHY, V31, P254, DOI 10.1111/j.0906-7590.2008.5250.x; ESRI, 1999, ARC VIEW 3 2 GIS; Fahrig L, 2015, AGR ECOSYST ENVIRON, V200, P219, DOI 10.1016/j.agee.2014.11.018; Fahrig L, 2011, ECOL LETT, V14, P101, DOI 10.1111/j.1461-0248.2010.01559.x; Fereres A, 2000, VIRUS RES, V71, P221, DOI 10.1016/S0168-1702(00)00200-8; FERNANDES GW, 1988, OECOLOGIA, V76, P161, DOI 10.1007/BF00379948; Fernandez M., 2006, U NACL COLOMBIA, V1, DOI [10.1017/CBO9781107415324.004, DOI 10.1017/CBO9781107415324.004]; Fiedler AK, 2008, BIOL CONTROL, V45, P254, DOI 10.1016/j.biocontrol.2007.12.009; Franke AC, 2009, WEED RES, V49, P131, DOI 10.1111/j.1365-3180.2009.00692.x; Gardiner MM, 2009, ECOL APPL, V19, P143, DOI 10.1890/07-1265.1; GRAU HR, 2008, ECOL SOC, V0013; Gurr GM, 2003, BASIC APPL ECOL, V4, P107, DOI 10.1078/1439-1791-00122; Holzschuh A, 2007, J APPL ECOL, V44, P41, DOI 10.1111/j.1365-2664.2006.01259.x; Holzschuh A, 2008, OIKOS, V117, P354, DOI 10.1111/j.2007.0030-1299.16303.x; Isaacs R, 2009, FRONT ECOL ENVIRON, V7, P196, DOI 10.1890/080035; Jimenez-Valverde A, 2010, INSECT CONSERV DIVER, V3, P51, DOI 10.1111/j.1752-4598.2009.00067.x; Jocque R, 2007, SPIDER FAMILIES WORL; Jost L, 2006, OIKOS, V113, P363, DOI 10.1111/j.2006.0030-1299.14714.x; Jost L, 2007, ECOLOGY, V88, P2427, DOI 10.1890/06-1736.1; Kahane R, 2013, AGRON SUSTAIN DEV, V33, P671, DOI 10.1007/s13593-013-0147-8; Kaston BJ, 1978, PICTURED KEY NATURE; Klein AM, 2006, J ANIM ECOL, V75, P315, DOI 10.1111/j.1365-2656.2006.01042.x; Langebank C, 1996, HIST COLOMBIA ESTABL; Lavandero B, 2006, BASIC APPL ECOL, V7, P236, DOI 10.1016/j.baae.2005.09.004; Lee JC, 2008, J ANIM ECOL, V77, P565, DOI 10.1111/j.1365-2656.2008.01355.x; Letourneau DK, 2012, J APPL ECOL, V49, P1405, DOI 10.1111/1365-2664.12001; Lewinsohn TM, 2008, ECOL LETT, V11, P398, DOI 10.1111/j.1461-0248.2008.01155.x; Limberger R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044555; Limberger R, 2012, OECOLOGIA, V168, P785, DOI 10.1007/s00442-011-2140-8; Navas ML, 2012, WEED RES, V52, P479, DOI 10.1111/j.1365-3180.2012.00941.x; Oyarzun PJ, 2013, ECOL FOOD NUTR, V52, P515, DOI 10.1080/03670244.2013.769099; PAOLETTI MG, 1992, AGR ECOSYST ENVIRON, V40, P3, DOI 10.1016/0167-8809(92)90080-U; PIMENTEL D, 1987, BIOMASS, V14, P15, DOI 10.1016/0144-4565(87)90020-5; Pluess T, 2010, AGR ECOSYST ENVIRON, V137, P68, DOI 10.1016/j.agee.2009.12.020; Poggio SL, 2010, BIOL CONSERV, V143, P2477, DOI 10.1016/j.biocon.2010.06.014; Price P.W., 2011, INSECT ECOLOGY BEHAV; R Core Team, 2018, R LANG ENV STAT COMP; Risch S.J., 1987, P217; Riveros P, 2013, THESIS PONTIFICIA U; Roschewitz I, 2005, J APPL ECOL, V42, P873, DOI 10.1111/j.1365-2664.2005.01072.x; Rusch A, 2013, J APPL ECOL, V50, P345, DOI 10.1111/1365-2664.12055; Samu F, 2002, J ARACHNOL, V30, P389, DOI 10.1636/0161-8202(2002)030[0389:OTNOAS]2.0.CO;2; Schmidt MH, 2008, J BIOGEOGR, V35, P157, DOI 10.1111/j.1365-2699.2007.01774.x; Schmidt MH, 2005, J APPL ECOL, V42, P281, DOI 10.1111/j.1365-2664.2005.01014.x; Schmidt MH, 2005, J BIOGEOGR, V32, P467, DOI 10.1111/j.1365-2699.2004.01244.x; Settle WH, 1996, ECOLOGY, V77, P1975, DOI 10.2307/2265694; Sieving KE, 1996, AUK, V113, P944, DOI 10.2307/4088877; Sobek S, 2009, ECOL ENTOMOL, V34, P772, DOI 10.1111/j.1365-2311.2009.01132.x; Taylor KE, 2001, J GEOPHYS RES-ATMOS, V106, P7183, DOI 10.1029/2000JD900719; Triplehorn C., 2005, BORRER DELONGS INTRO, V7; Tscharntke T, 2012, BIOL REV, V87, P661, DOI 10.1111/j.1469-185X.2011.00216.x; Tylianakis JM, 2006, J BIOGEOGR, V33, P1295, DOI 10.1111/j.1365-2699.2006.01493.x; Tylianakis JM, 2004, ECOLOGY, V85, P658, DOI 10.1890/03-0222; Western AW, 2002, ANNU REV EARTH PL SC, V30, P149, DOI 10.1146/annurev.earth.30.091201.140434; Wharton R. A., 1997, MANUAL NEW WORLD GEN; Wyckhuys KAG, 2007, INT J PEST MANAGE, V53, P89, DOI 10.1080/09670870701245207; Zuckerberg B, 2012, J WILDLIFE MANAGE, V76, P1072, DOI 10.1002/jwmg.326	71	8	9	1	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0128950	10.1371/journal.pone.0128950	http://dx.doi.org/10.1371/journal.pone.0128950			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LZ	26197473	Green Submitted, Green Published, gold			2022-12-26	WOS:000358547600004
J	Wirshing, HH; Baker, AC				Wirshing, Herman H.; Baker, Andrew C.			Molecular and Morphological Species Boundaries in the Gorgonian Octocoral Genus Pterogorgia (Octocorallia: Gorgoniidae)	PLOS ONE			English	Article							PHYLOGENETIC ANALYSIS; SECONDARY STRUCTURES; DNA-SEQUENCES; CNIDARIA; CORAL; MITOCHONDRIAL; ANTHOZOA; FAMILY; ALCYONACEA; EVOLUTION	Most gorgonian octocoral species are described using diagnostic characteristics of their sclerites (microscopic skeletal components). Species in the genus Pterogorgia, however, are separated primarily by differences in their calyx and branch morphology. Specimens of a morphologically unusual Pterogorgia collected from Saba Bank in the NE Caribbean Sea were found with calyx morphology similar to P. citrina and branch morphology similar to P. guadalupensis. In order to test morphological species boundaries, and the validity of calyx and branch morphology as systematic characters, a phylogenetic analysis was undertaken utilizing partial gene fragments of three mitochondrial (mtMutS, cytochrome b, and igr4; 726bp total) and two nuclear (ITS2, 166bp; and SRP54 intron, 143bp) loci. The datasets for nuclear and mitochondrial loci contained few phylogenetically informative sites, and tree topologies did not resolve any of the morphological species as monophyletic groups. Instead, the mitochondrial loci and SRP54 each recovered two clades but were slightly incongruent, with a few individuals of P. guadalupensis represented in both clades with SRP54. A concatenated dataset of these loci grouped all P. anceps and P. guadalupensis in a clade, and P. citrina and the Pterogorgia sp. from Saba Bank in a sister clade, but with minimal variation/resolution within each clade. However, in common with other octocoral taxa, the limited genetic variation may not have been able to resolve whether branch variation represents intraspecific variation or separate species. Therefore, these results suggest that there are at least two phylogenetic lineages of Pterogorgia at the species level, and the atypical Pterogorgia sp. may represent an unusual morphotype of P. citrina, possibly endemic to Saba Bank. Branch morphology does not appear to be a reliable morphological character to differentiate Pterogorgia species (e.g., branches "flat" or "3-4 edges" in P. guadalupensis and P. anceps, respectively), and a re-evaluation of species-level characters (e.g., sclerites) is needed.	[Wirshing, Herman H.; Baker, Andrew C.] Univ Miami, Rosenstiel Sch Marine & Atmospher Sci, Dept Marine Biol & Ecol, Miami, FL 33149 USA	University of Miami	Wirshing, HH (corresponding author), Smithsonian Inst, Natl Museum Nat Hist, Dept Invertebrate Zool, Washington, DC 20560 USA.	wirshingh@si.edu		Baker, Andrew/0000-0002-7866-2587; Wirshing, Herman H./0000-0003-4926-4237	U.S. National Science Foundation [OCE-0527184]; Rowlands Graduate Fellowship, University of Miami; Knight Graduate Fellowship, University of Miami	U.S. National Science Foundation(National Science Foundation (NSF)); Rowlands Graduate Fellowship, University of Miami; Knight Graduate Fellowship, University of Miami	This work was supported by the U.S. National Science Foundation OCE-0527184 to ACB and Rowlands and Knight Graduate Fellowships, University of Miami to HHW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar C, 2007, MOL PHYLOGENET EVOL, V43, P774, DOI 10.1016/j.ympev.2006.11.005; [Anonymous], 1961, SHALLOW WATER OCTOCO; BAYER F M, 1981, Proceedings of the Biological Society of Washington, V94, P902; Bayer F.M., 1956, TREATISE INVERTEBR F, P167; BAYER FREDERICK M., 1951, JOUR WASHINGTON ACAD SCI, V41, P91; Bilewitch JP, 2014, MOL PHYLOGENET EVOL, V73, P106, DOI 10.1016/j.ympev.2014.01.023; Bilewitch JP, 2010, P BIOL SOC WASH, V123, P93, DOI 10.2988/09-22.1; Cairns S., 1977, GUIDE COMMONER SHALL; Concepcion GT, 2008, CORAL REEFS, V27, P323, DOI 10.1007/s00338-007-0323-x; Concepcion GT, 2010, MAR ECOL PROG SER, V401, P113, DOI 10.3354/meps08364; Drummond AJ, 2008, GENEIOUS V4 8 5; Duenas LF, 2014, MOL PHYLOGENET EVOL, V74, P15, DOI 10.1016/j.ympev.2014.01.031; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Etnoyer PJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010668; Frade PR, 2010, MOL PHYLOGENET EVOL, V57, P1072, DOI 10.1016/j.ympev.2010.09.010; France SC, 2002, HYDROBIOLOGIA, V471, P149, DOI 10.1023/A:1016517724749; France SC, 2007, B MAR SCI, V81, P323; France Scott C., 2001, Bulletin of the Biological Society of Washington, P110; Franzosa EA, 2007, TREEROT VERSION 3; GOLDBERG WM, 1973, B MAR SCI, V23, P465; Grajales A, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-90; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Gutierrez-Rodriguez C, 2009, MOL PHYLOGENET EVOL, V50, P1, DOI 10.1016/j.ympev.2008.09.019; Hoeksema BW, 2011, MAR ECOL-EVOL PERSP, V32, P135, DOI 10.1111/j.1439-0485.2011.00434.x; Hoetjes PC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010769; Jaap WC, 1984, US FISH WILDL SER, VFWS/OBS-82/08; Jarman SN, 2002, MAR BIOTECHNOL, V4, P347, DOI 10.1007/s10126-002-0029-6; Kim E, 2004, HYDROBIOLOGIA, V530, P423, DOI 10.1007/s10750-004-2646-8; LASKER HR, 1983, MAR ECOL PROG SER, V13, P21, DOI 10.3354/meps013021; LEWIS JC, 1991, BIOL BULL, V181, P275, DOI 10.2307/1542099; McFadden CS, 2006, MOL PHYLOGENET EVOL, V41, P513, DOI 10.1016/j.ympev.2006.06.010; McFadden CS, 2013, ZOOKEYS, P59, DOI 10.3897/zookeys.346.6270; McFadden CS, 2012, INVERTEBR SYST, V26, P331, DOI 10.1071/IS12035; McFadden CS, 2011, MOL ECOL RESOUR, V11, P19, DOI 10.1111/j.1755-0998.2010.02875.x; McFadden CS, 2010, INTEGR COMP BIOL, V50, P389, DOI 10.1093/icb/icq056; McFadden CS, 2004, MOL ECOL, V13, P1495, DOI 10.1111/j.1365-294X.2004.02167.x; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Prada C, 2013, P NATL ACAD SCI USA, V110, P3961, DOI 10.1073/pnas.1208931110; Prada C, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-47; Quattrini AM, 2014, DEEP-SEA RES PT II, V99, P92, DOI 10.1016/j.dsr2.2013.05.027; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Sanchez JA, 2003, MOL PHYLOGENET EVOL, V29, P31, DOI 10.1016/S1055-7903(03)00090-3; Sanchez JA, 2003, MAR BIOL, V142, P975, DOI 10.1007/s00227-003-1018-7; Sanchez JA, 1997, B MAR SCI, V61, P453; Seehausen O, 2004, TRENDS ECOL EVOL, V19, P198, DOI 10.1016/j.tree.2004.01.003; Shearer TL, 2002, MOL ECOL, V11, P2475, DOI 10.1046/j.1365-294X.2002.01652.x; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Thornhill DJ, 2007, MOL ECOL, V16, P5326, DOI 10.1111/j.1365-294X.2007.03576.x; TINDALL KR, 1988, BIOCHEMISTRY-US, V27, P6008, DOI 10.1021/bi00416a027; van der Ham JL, 2009, MAR GENOM, V2, P183, DOI 10.1016/j.margen.2009.10.002; van Oppen MJH, 2001, MOL BIOL EVOL, V18, P1315, DOI 10.1093/oxfordjournals.molbev.a003916; Varon A, 2010, CLADISTICS, V26, P72, DOI 10.1111/j.1096-0031.2009.00282.x; Veron J.E.N., 2000, CORALS WORLD, V1-3; Vollmer SV, 2004, MOL ECOL, V13, P2763, DOI 10.1111/j.1365-294X.2004.02265.x; Wareham VE, 2007, CONSERVATION AND ADAPTIVE MANAGEMENT OF SEAMOUNT AND DEEP-SEA CORAL ECOSYSTEMS, P289; Wirshing HH, 2005, MAR BIOL, V147, P497, DOI 10.1007/s00227-005-1592-y; [No title captured]	57	10	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0133517	10.1371/journal.pone.0133517	http://dx.doi.org/10.1371/journal.pone.0133517			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LZ	26196389	gold, Green Submitted, Green Published			2022-12-26	WOS:000358547600107
J	Hung, GY; Horng, JL; Yen, HJ; Lee, CY; Lee, YS				Hung, Giun-Yi; Horng, Jiun-Lin; Yen, Hsiu-Ju; Lee, Chih-Ying; Lee, Yu-Sheng			Geographic Variation in Cancer Incidence among Children and Adolescents in Taiwan (1995-2009)	PLOS ONE			English	Article							TRAFFIC AIR-POLLUTION; CHILDHOOD LEUKEMIA; EXPOSURE; ASSOCIATION; TRENDS; RISK	Background Evidence from our recent study suggested that the overall trend for cancer incidence in children and adolescents has been increasing in Taiwan. Methods To analyze geographic variations in this trend, cancer frequencies and incidence rates of disease groups were quantified according to geographic areas among 12,633 patients aged <20 years during 1995-2009 by using the population-based Taiwan Cancer Registry. Three geographic levels were defined, namely county or city, region (Northern, Central, Southern, and Eastern Taiwan), and local administrative area (special municipality, provincial city, county-administered city, township, and aboriginal area). Results Of the regions, Northern Taiwan had the highest incidence rate at 139.6 per million person-years, followed by Central (132.8), Southern (131.8), and Eastern (128.4) Taiwan. Significantly higher standardized rate ratios (SRRs) were observed in Northern Taiwan (SRR = 1.06, 95% confidence interval [CI] = 1.02-1.10) and at the township level (SRR = 1.07, 95% CI = 1.03-1.11). Of the cities or counties, New Taipei City yielded the highest SRR (1.08), followed by Taipei City (SRR = 1.07). A comparison of the rates in the four regions and the remainder of Taiwan according to cancer type revealed that only the rate of neuroblastomas in Eastern Taiwan was significantly low. Trend analysis showed that the most significant increase in incidence rate was observed at the township level, with an annual percent change of 1.8% during the 15-year study period. Conclusions The high rate of childhood cancer in Northern Taiwan and at the township level deserves further attention. The potential impacts of environmental factors on the upward trend of childhood cancer incidence rate in townships warrant further investigation.	[Hung, Giun-Yi; Yen, Hsiu-Ju; Lee, Chih-Ying] Taipei Vet Gen Hosp, Div Pediat Hematol & Oncol, Taipei, Taiwan; [Hung, Giun-Yi; Yen, Hsiu-Ju; Lee, Chih-Ying; Lee, Yu-Sheng] Taipei Vet Gen Hosp, Dept Pediat, Taipei, Taiwan; [Hung, Giun-Yi; Yen, Hsiu-Ju; Lee, Chih-Ying; Lee, Yu-Sheng] Natl Yang Ming Univ, Sch Med, Dept Pediat, Taipei 112, Taiwan; [Hung, Giun-Yi] Natl Taiwan Normal Univ, Dept Life Sci, Taipei, Taiwan; [Horng, Jiun-Lin] Taipei Med Univ, Coll Med, Sch Med, Dept Anat & Cell Biol, Taipei, Taiwan; [Lee, Yu-Sheng] Natl Yang Ming Univ, Sch Med, Inst Publ Hlth, Taipei 112, Taiwan	Taipei Veterans General Hospital; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; National Taiwan Normal University; Taipei Medical University; National Yang Ming Chiao Tung University	Hung, GY (corresponding author), Taipei Vet Gen Hosp, Div Pediat Hematol & Oncol, Taipei, Taiwan.	gyhung@vghtpe.gov.tw			Ministry of Science and Technology, Taiwan (MOST) [103-2311-B-038-002]	Ministry of Science and Technology, Taiwan (MOST)(Ministry of Science and Technology, Taiwan)	This study was supported by the grants designated to Jiun-Lin Horng, PhD from the Ministry of Science and Technology, Taiwan (MOST 103-2311-B-038-002, http://www.most.gov.tw/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander FE, 1997, BRIT J CANCER, V75, P457, DOI 10.1038/bjc.1997.77; [Anonymous], 1995, TAIW CANC REG ANN RE; [Anonymous], TAIW GEOGR NAM INF S; [Anonymous], 1999, CANC INCIDENCE SURVI; [Anonymous], NUMB FOR SPOUS COUNT; [Anonymous], POP DENS TOT AR COUN; Boyle P, 1991, CANC REGISTRATION PR, V95; Buka I, 2007, PEDIATR CLIN N AM, V54, P177, DOI 10.1016/j.pcl.2006.11.010; Chen CL, 2010, ENVIRON RES, V110, P455, DOI 10.1016/j.envres.2009.08.010; Chen CL, 2010, CANCER EPIDEM BIOMAR, V19, P101, DOI 10.1158/1055-9965.EPI-09-0333; Chen CL, 2004, JAMA-J AM MED ASSOC, V292, P2984, DOI 10.1001/jama.292.24.2984; Chen YM, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-247; Cheng TM, 2003, HEALTH AFFAIR, V22, P61, DOI 10.1377/hlthaff.22.3.61; Chiang CJ, 2015, JPN J CLIN ONCOL, V45, P291, DOI 10.1093/jjco/hyu211; Chiang CJ, 2010, JPN J CLIN ONCOL, V40, P897, DOI 10.1093/jjco/hyq057; Curado MP, 2007, CANC INCIDENCE 5 CON, VIx, p[160, 961]; Engel A, 2008, J ENVIRON HEALTH, V71, P12; Francis SS, 2012, CHEM-BIOL INTERACT, V196, P102, DOI 10.1016/j.cbi.2011.02.019; Hung GY, 2014, CANCER-AM CANCER SOC, V120, P3545, DOI 10.1002/cncr.28903; Kim HJ, 2000, STAT MED, V19, P335, DOI 10.1002/(SICI)1097-0258(20000215)19:3<335::AID-SIM336>3.0.CO;2-Z; KINLEN LJ, 1990, LANCET, V336, P577, DOI 10.1016/0140-6736(90)93389-7; Li CY, 2012, SCI TOTAL ENVIRON, V435, P472, DOI 10.1016/j.scitotenv.2012.06.078; Li CY, 1998, INT J EPIDEMIOL, V27, P587, DOI 10.1093/ije/27.4.587; Linet MS, 2003, PEDIATRICS, V112, P218; Monthly Bulletin of Interior Statistics, MONTHL B INT STAT; National Cancer Institute, 2013, JOINP REGR PROGR VER; Steinmaus C, 2004, ENVIRON HEALTH PERSP, V112, P766, DOI 10.1289/ehp.6592; Steliarova-Foucher E, 2005, CANCER-AM CANCER SOC, V103, P1457, DOI 10.1002/cncr.20910; Stiller CA, 2004, ONCOGENE, V23, P6429, DOI 10.1038/sj.onc.1207717; Tseng CH, 2005, J ENVIRON SCI HEAL C, V23, P55, DOI 10.1081/GNC-200051860; Wang HK, 2010, J HAZARD MATER, V179, P1115, DOI 10.1016/j.jhazmat.2010.03.122; Weng HH, 2008, INHAL TOXICOL, V20, P31, DOI [10.1080/08958370701758734, 10.1080/08958370701758734 ]; Weng HH, 2008, J TOXICOL ENV HEAL A, V71, P434, DOI 10.1080/15287390701839042; Weng HH, 2009, J TOXICOL ENV HEAL A, V72, P83, DOI 10.1080/15287390802477338	34	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2015	10	7							e0133051	10.1371/journal.pone.0133051	http://dx.doi.org/10.1371/journal.pone.0133051			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LN	26192415	gold, Green Submitted, Green Published			2022-12-26	WOS:000358546400049
J	Ayllon, N; Naranjo, V; Hajdusek, O; Villar, M; Galindo, RC; Kocan, KM; Alberdi, P; Sima, R; Cabezas-Cruz, A; Ruckert, C; Bell-Sakyi, L; Kazimirova, M; Havlikova, S; Klempa, B; Kopacek, P; de la Fuente, J				Ayllon, Nieves; Naranjo, Victoria; Hajdusek, Ondrej; Villar, Margarita; Galindo, Ruth C.; Kocan, Katherine M.; Alberdi, Pilar; Sima, Radek; Cabezas-Cruz, Alejandro; Rueckert, Claudia; Bell-Sakyi, Lesley; Kazimirova, Myria; Havlikova, Sabna; Klempa, Boris; Kopacek, Petr; de la Fuente, Jose			Nuclease Tudor-SN Is Involved in Tick dsRNA-Mediated RNA Interference and Feeding but Not in Defense against Flaviviral or Anaplasma phagocytophilum Rickettsial Infection	PLOS ONE			English	Article							QUANTITATIVE PROTEOMICS; GENE-EXPRESSION; CELL-LINES; MACHINERY; INSIGHTS; ACCURATE; DISEASE; BINDING; GROWTH	Tudor staphylococcal nuclease (Tudor-SN) and Argonaute (Ago) are conserved components of the basic RNA interference (RNAi) machinery with a variety of functions including immune response and gene regulation. The RNAi machinery has been characterized in tick vectors of human and animal diseases but information is not available on the role of Tudor-SN in tick RNAi and other cellular processes. Our hypothesis is that tick Tudor-SN is part of the RNAi machinery and may be involved in innate immune response and other cellular processes. To address this hypothesis, Ixodes scapularis and I. ricinus ticks and/or cell lines were used to annotate and characterize the role of Tudor-SN in dsRNA-mediated RNAi, immune response to infection with the rickettsia Anaplasma phagocytophilum and the flaviviruses TBEV or LGTV and tick feeding. The results showed that Tudor-SN is conserved in ticks and involved in dsRNA-mediated RNAi and tick feeding but not in defense against infection with the examined viral and rickettsial pathogens. The effect of Tudor-SN gene knockdown on tick feeding could be due to down-regulation of genes that are required for protein processing and blood digestion through a mechanism that may involve selective degradation of dsRNAs enriched in G:U pairs that form as a result of adenosine-to-inosine RNA editing. These results demonstrated that Tudor-SN plays a role in tick RNAi pathway and feeding but no strong evidence for a role in innate immune responses to pathogen infection was found.	[Ayllon, Nieves; Naranjo, Victoria; Villar, Margarita; Galindo, Ruth C.; Alberdi, Pilar; Cabezas-Cruz, Alejandro; de la Fuente, Jose] CSIC UCLM JCCM, Inst Invest Recursos Cineget IREC, SaBio, Ciudad Real 13005, Spain; [Naranjo, Victoria; Galindo, Ruth C.; Kocan, Katherine M.; de la Fuente, Jose] Oklahoma State Univ, Ctr Vet Hlth Sci, Dept Vet Pathobiol, Stillwater, OK 74078 USA; [Hajdusek, Ondrej; Sima, Radek; Kopacek, Petr] Acad Sci Czech Republ, Inst Parasitol, Ctr Biol, CR-37005 Ceske Budejovice, Czech Republic; [Cabezas-Cruz, Alejandro] Univ Lille Nord France, CNRS, Inst Pasteur Lille, CIIL,INSERM U1019,UMR 8204, Lille, France; [Rueckert, Claudia; Bell-Sakyi, Lesley] Pirbright Inst, Woking GU24 0NF, Surrey, England; [Kazimirova, Myria] Slovak Acad Sci, Inst Zool, Bratislava 84506, Slovakia; [Havlikova, Sabna; Klempa, Boris] Slovak Acad Sci, Inst Virol, Bratislava 84505, Slovakia	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigacion en Recursos Cinegeticos (IREC); Universidad de Castilla-La Mancha; Oklahoma State University System; Oklahoma State University - Stillwater; Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Pirbright Institute; Slovak Academy of Sciences; Slovak Academy of Sciences	de la Fuente, J (corresponding author), CSIC UCLM JCCM, Inst Invest Recursos Cineget IREC, SaBio, Ronda Toledo S-N, Ciudad Real 13005, Spain.	jose_delafuente@yahoo.com	Hajdusek, Ondrej/G-7911-2014; Alberdi, Pilar/K-7788-2014; Klempa, Boris/N-3096-2019; Villar-Rayo, Marga M/J-4155-2012; Šíma, Radek/E-6658-2012; Kopacek, Petr/G-8414-2014; Cabezas-Cruz, Alejandro/P-2755-2017; Kazimirova, Maria/U-8222-2017; Klempa, Boris/J-8876-2012	Alberdi, Pilar/0000-0002-6999-9735; Klempa, Boris/0000-0002-6931-1224; Villar-Rayo, Marga M/0000-0003-4172-9079; Kopacek, Petr/0000-0003-2412-5724; Cabezas-Cruz, Alejandro/0000-0002-8660-730X; Kazimirova, Maria/0000-0001-6904-8342; Klempa, Boris/0000-0002-6931-1224; Ruckert, Claudia/0000-0003-3732-6752	European Union [278976, 316304]; Ministerio de Educacion y Ciencia, Spain; European Social Fund; Junta de Comunidades de Castilla-La Mancha (Program FSE), Spain; project Postdok_BIOGLOBE [CZ.1.07/2.3.00/30.0032]; GA CR [13-12816P]; Grant Agency of the Czech Republic [3-27630P]; United Kingdom Biotechnology and Biological Sciences Research Council's National Capability Grant;  [BFU2011-23896]; BBSRC [BBS/E/I/00001741] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/I/00001741] Funding Source: researchfish	European Union(European Commission); Ministerio de Educacion y Ciencia, Spain(Spanish Government); European Social Fund(European Social Fund (ESF)); Junta de Comunidades de Castilla-La Mancha (Program FSE), Spain(Junta de Comunidades de Castilla-La Mancha); project Postdok_BIOGLOBE; GA CR(Grant Agency of the Czech Republic); Grant Agency of the Czech Republic(Grant Agency of the Czech Republic); United Kingdom Biotechnology and Biological Sciences Research Council's National Capability Grant(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); ; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This research was supported by grants BFU2011-23896 and the European Union FP7 ANTIGONE project number 278976 (JdlF). NA was funded by Ministerio de Educacion y Ciencia, Spain. VN was funded by the European Social Fund and the Junta de Comunidades de Castilla-La Mancha (Program FSE 2007-2013), Spain. RS was supported by the project Postdok_BIOGLOBE (CZ.1.07/2.3.00/30.0032) and by the Grant 13-12816P (GA CR). OH was supported by the Grant Agency of the Czech Republic grant no. 13-27630P and European Union FP7 MODBIOLIN project number 316304. CR and LBS were supported by the United Kingdom Biotechnology and Biological Sciences Research Council's National Capability Grant to the Pirbright Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achazi K, 2012, ANTIVIR RES, V93, P94, DOI 10.1016/j.antiviral.2011.10.023; Aljamali MN, 2002, EXP APPL ACAROL, V28, P89, DOI 10.1023/A:1025346131903; Alsford S, 2010, MOL BIOCHEM PARASIT, V174, P70, DOI 10.1016/j.molbiopara.2010.06.006; Anisimova M, 2006, SYST BIOL, V55, P539, DOI 10.1080/10635150600755453; Aung KM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028407; Ayllon N, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005120; Ayllon N, 2013, INFECT IMMUN, V81, P2415, DOI 10.1128/IAI.00194-13; Barnard AC, 2012, GENES-BASEL, V3, P702, DOI 10.3390/genes3040702; Barry G, 2013, EXP APPL ACAROL, V59, P319, DOI 10.1007/s10493-012-9598-x; Bell-Sakyi L, 2004, J COMP PATHOL, V130, P285, DOI 10.1016/j.jcpa.2003.12.002; Bell-Sakyi L, 2007, TRENDS PARASITOL, V23, P450, DOI 10.1016/j.pt.2007.07.009; Beugnet F, 2009, VET PARASITOL, V163, P298, DOI 10.1016/j.vetpar.2009.03.028; Bonzon-Kulichenko E, 2011, J PROTEOMICS, V75, P561, DOI 10.1016/j.jprot.2011.08.022; Chevenet F, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-439; Contreras M, 2014, MOL ECOL RESOUR, V14, P1095, DOI 10.1111/1755-0998.12298; de la Fuente J, 2005, CELL MICROBIOL, V7, P549, DOI 10.1111/j.1462-5822.2004.00485.x; de la Fuente J, 2008, FRONT BIOSCI-LANDMRK, V13, P6938, DOI 10.2741/3200; de la Fuente J, 2007, TRENDS PARASITOL, V23, P427, DOI 10.1016/j.pt.2007.07.002; Donald Claire L, 2012, Insects, V3, P511, DOI 10.3390/insects3020511; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Frey NFD, 2010, PLANT CELL, V22, P1575, DOI 10.1105/tpc.109.070680; Friberg A, 2009, J MOL BIOL, V387, P921, DOI 10.1016/j.jmb.2009.02.018; Garcia S, 2005, J VIROL, V79, P8942, DOI 10.1128/JVI.79.14.8942-8947.2005; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Havlikova S, 2013, VACCINE, V31, P1582, DOI 10.1016/j.vaccine.2013.01.017; Jorge I, 2009, MOL CELL PROTEOMICS, V8, P1130, DOI 10.1074/mcp.M800260-MCP200; Joshua-Tor L, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003772; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kocan KM, 2011, JOVE-J VIS EXP, DOI 10.3791/2474; Kocan KM, 2012, TICKS TICK-BORNE DIS, V3, P147, DOI 10.1016/j.ttbdis.2012.01.004; Kurscheid S, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-26; Li CL, 2008, NUCLEIC ACIDS RES, V36, P3579, DOI 10.1093/nar/gkn236; Li X, 2014, WIRES RNA, V5, P111, DOI 10.1002/wrna.1201; Liu QH, 2010, ANNU REV BIOCHEM, V79, P295, DOI 10.1146/annurev.biochem.052208.151733; Martinez-Bartolome S, 2008, MOL CELL PROTEOMICS, V7, P1135, DOI 10.1074/mcp.M700239-MCP200; Munderloh UG, 1999, J CLIN MICROBIOL, V37, P2518, DOI 10.1128/JCM.37.8.2518-2524.1999; Navarro P, 2014, J PROTEOME RES, V13, P1234, DOI 10.1021/pr4006958; Navarro P, 2009, J PROTEOME RES, V8, P1792, DOI 10.1021/pr800362h; Nicolas FE, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003089; Nishikura K, 2006, NAT REV MOL CELL BIO, V7, P919, DOI 10.1038/nrm2061; Phetrungnapha A, 2011, FISH SHELLFISH IMMUN, V31, P373, DOI 10.1016/j.fsi.2011.05.026; Popara M, 2013, VACCINE, V31, P4728, DOI 10.1016/j.vaccine.2013.08.031; Scadden ADJ, 2008, BIOCHEM SOC T, V36, P534, DOI 10.1042/BST0360534; Schnettler E, 2014, NUCLEIC ACIDS RES, V42, P9436, DOI 10.1093/nar/gku657; Sojka D, 2013, TRENDS PARASITOL, V29, P276, DOI 10.1016/j.pt.2013.04.002; Sprong H, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-77; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Tuckow AP, 2015, INSECT MOL BIOL, V24, P454, DOI 10.1111/imb.12172; Wang LK, 2010, BIOINFORMATICS, V26, P136, DOI 10.1093/bioinformatics/btp612; Weissbach R, 2012, RNA, V18, P462, DOI 10.1261/rna.027656.111; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/NMETH.1322, 10.1038/nmeth.1322]	51	10	10	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0133038	10.1371/journal.pone.0133038	http://dx.doi.org/10.1371/journal.pone.0133038			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RV	26186700	Green Published, Green Submitted, gold			2022-12-26	WOS:000358198700087
J	Chung, J; Ou, XZ; Kulkarni, RP; Yang, CH				Chung, Jaebum; Ou, Xiaoze; Kulkarni, Rajan P.; Yang, Changhuei			Counting White Blood Cells from a Blood Smear Using Fourier Ptychographic Microscopy	PLOS ONE			English	Article							HEART-DISEASE; MORTALITY; CORONARY; FLOW	White blood cell (WBC) count is a valuable metric for assisting with diagnosis or prognosis of various diseases such as coronary heart disease, type 2 diabetes, or infection. Counting WBCs can be done either manually or automatically. Automatic methods are capable of counting a large number of cells to give a statistically more accurate reading of the WBC count of a sample, but the specialized equipment tends to be expensive. Manual methods are inexpensive since they only involve a conventional light microscope setup. However, it is more laborious and error-prone because the small field-of-view (FOV) of the microscope necessitates mechanical scanning of a specimen for counting an adequate number of WBCs. Here, we investigate the use of Fourier ptychographic microscopy (FPM) to bypass these issues of the manual methods. With a 2x objective, FPM can provide a FOV of 120 mm(2) with enhanced resolution comparable to that of a 20x objective, which is adequate for non-differentially counting WBCs in just one FOV. A specialist was able to count the WBCs in FPM images with 100% accuracy compared to the count as determined from conventional microscope images. An automatic counting algorithm was also developed to identify WBCs from FPM's captured images with 95% accuracy, paving the way for a cost-effective WBC counting setup with the advantages of both the automatic and manual counting methods.	[Chung, Jaebum; Ou, Xiaoze; Yang, Changhuei] CALTECH, Dept Elect Engn, Pasadena, CA 91125 USA; [Kulkarni, Rajan P.] Univ Calif Los Angeles, Div Dermatol, Los Angeles, CA 90024 USA; [Yang, Changhuei] CALTECH, Dept Bioengn, Pasadena, CA 91125 USA	California Institute of Technology; University of California System; University of California Los Angeles; California Institute of Technology	Chung, J (corresponding author), CALTECH, Dept Elect Engn, Pasadena, CA 91125 USA.	jchung@caltech.edu		Chung, Jaebum/0000-0003-3932-8428	NIH [1DP2OD007307]; Caltech Innovation Initiative (CI2) Program; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD007307] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Caltech Innovation Initiative (CI2) Program; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by NIH grant 1DP2OD007307; 2014 Caltech Innovation Initiative (CI2) Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barron HV, 2000, CIRCULATION, V102, P2329, DOI 10.1161/01.CIR.102.19.2329; Bellwood B, 2013, VET TECHNICIANS HDB; Breslauer DN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006320; Brown DW, 2001, J CLIN EPIDEMIOL, V54, P316, DOI 10.1016/S0895-4356(00)00296-1; Fritsma GA, 2008, HEMATOLOGY CLIN PRIN; Ghaznavi F, 2013, ANNU REV PATHOL-MECH, V8, P331, DOI 10.1146/annurev-pathol-011811-120902; GRIMM RH, 1985, JAMA-J AM MED ASSOC, V254, P1932, DOI 10.1001/jama.254.14.1932; Horstmeyer R, 2014, OPT EXPRESS, V22, P338, DOI 10.1364/OE.22.000338; Huh D, 2005, PHYSIOL MEAS, V26, pR73, DOI 10.1088/0967-3334/26/3/R02; JAFFE DM, 1991, PEDIATRICS, V87, P670; KANNEL WB, 1992, JAMA-J AM MED ASSOC, V267, P1253, DOI 10.1001/jama.267.9.1253; Kessel R. G., 1998, BASIC MED HISTOLOGY; Mandel L., 1995, OPTICAL COHERENCE QU; Ou XZ, 2015, OPT EXPRESS, V23, P3472, DOI 10.1364/OE.23.003472; Ou XZ, 2014, OPT EXPRESS, V22, P4960, DOI 10.1364/OE.22.004960; Shapiro HM, 2003, PRACTICAL FLOW CYTOM; Tong PC, 2004, DIABETES CARE, V27, P216, DOI 10.2337/diacare.27.1.216; Turgeon M.L., 2005, CLIN HEMATOLOGY THEO; Twig G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047183; Vozarova B, 2002, DIABETES, V51, P455, DOI 10.2337/diabetes.51.2.455; YARNELL JWG, 1991, CIRCULATION, V83, P836, DOI 10.1161/01.CIR.83.3.836; Zheng GA, 2013, NAT PHOTONICS, V7, P739, DOI [10.1038/NPHOTON.2013.187, 10.1038/nphoton.2013.187]; Zuba-Surma EK, 2007, FOLIA HISTOCHEM CYTO, V45, P279	23	48	64	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0133489	10.1371/journal.pone.0133489	http://dx.doi.org/10.1371/journal.pone.0133489			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RV	26186353	Green Published, gold, Green Accepted			2022-12-26	WOS:000358198700147
J	Lewis, KL; Han, PKJ; Hooker, GW; Klein, WMP; Biesecker, LG; Biesecker, BB				Lewis, Katie L.; Han, Paul K. J.; Hooker, Gillian W.; Klein, William M. P.; Biesecker, Leslie G.; Biesecker, Barbara B.			Characterizing Participants in the ClinSeq Genome Sequencing Cohort as Early Adopters of a New Health Technology	PLOS ONE			English	Article							PERSONAL GENOMICS; RISK; INTENTIONS; PSYCHOLOGY; AMBIGUITY; OPTIMISM	Genome sequencing is a novel clinical tool that has the potential to identify genetic origins of disease. However, the complexities of this new technology are significant and little is known about its integration into clinical care, and its potential adoption by patients. Expectations of its promise for personalized medicine are high and it is important to properly match expectations to the realities of the test. The NIH ClinSeq cohort study pilots the integration of genome sequencing into clinical research and care to assess the technical, medical and socio-behavioral aspects of implementing this technology. Over 950 adults ages 45-65 have been enrolled and clinically phenotyped. As an initial study, we describe the personality traits of ClinSeq participants, and explore how these traits compare to those that characterize early adopters of other new technologies. Our analysis was conducted on responses from 630 members of the cohort who completed a baseline survey on health cognitions, affect, health-related behaviors and personality traits, prior to receipt of any genome sequencing results. The majority of participants were white (90.5%), had at least a college degree (86.5%), and had at least one biological child (74.6%). Members of this ClinSeq sample were found to be high in dispositional optimism and resilience. Their high SES paralleled that of other early adopters of new technology. These attributes may contribute to participants' expectations for favorable outcomes and willingness to take higher risks when compared to the general population. These characteristics may distinguish those who are most likely to pursue genome sequencing and be indicative of their psychological resources to manage returned results.	[Lewis, Katie L.; Biesecker, Leslie G.; Biesecker, Barbara B.] NHGRI, Med Genom & Metab Genet Branch, Bethesda, MD 20892 USA; [Han, Paul K. J.] Ctr Outcomes Res & Evaluat, Maine Med Ctr Res Inst, Scarborough, ME USA; [Hooker, Gillian W.; Biesecker, Barbara B.] NHGRI, Social & Behav Res Branch, Bethesda, MD 20892 USA; [Hooker, Gillian W.] NextGxDx, Franklin, TN USA; [Klein, William M. P.] NCI, Div Canc Control & Populat Sci, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Maine Medical Center; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Lewis, KL (corresponding author), NHGRI, Med Genom & Metab Genet Branch, Bethesda, MD 20892 USA.	lewiskatie@mail.nih.gov	Biesecker, Leslie/AAG-2526-2021	Han, Paul/0000-0003-0165-1940; Biesecker, Barbara/0000-0001-9665-8963	Intramural Research Program of the National Human Genome Research Institute, National Institutes of Health; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG200317, ZIAHG200387] Funding Source: NIH RePORTER	Intramural Research Program of the National Human Genome Research Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This study was funded by the Intramural Research Program of the National Human Genome Research Institute, National Institutes of Health. NextGxDx provided support in the form of salary for one author (GWH) during the time that this manuscript was prepared, but did not have any additional role in the study design, data collection and analysis, decision to publish or preparation of the manuscript. The specific roles of that author are articulated in the 'author contributions' section.	Achat H, 2000, ANN BEHAV MED, V22, P127, DOI 10.1007/BF02895776; Armstrong K, 2005, JAMA-J AM MED ASSOC, V293, P1729, DOI 10.1001/jama.293.14.1729; Aspinwall LG, 2008, CANCER EPIDEM BIOMAR, V17, P1510, DOI 10.1158/1055-9965.EPI-08-0010; Biesecker LG, 2014, NEW ENGL J MED, V370, P2418, DOI 10.1056/NEJMra1312543; Biesecker LG, 2013, GENOME RES, V23, P1051, DOI 10.1101/gr.157826.113; Biesecker LG, 2009, GENOME RES, V19, P1665, DOI 10.1101/gr.092841.109; Bloss CS, 2011, NEW ENGL J MED, V364, P524, DOI 10.1056/NEJMoa1011893; Bloss CS, 2010, GENET MED, V12, P556, DOI 10.1097/GIM.0b013e3181eb51c6; Bollinger JM, 2012, GENET MED, V14, P451, DOI 10.1038/gim.2011.66; Carere DA, 2014, GENOME MED, V6, DOI 10.1186/s13073-014-0096-0; Chapman BP, 2010, AM J EPIDEMIOL, V171, P83, DOI 10.1093/aje/kwp323; Costa PT, NEO PERSONALITY INVE; ELLSBERG D, 1961, Q J ECON, V75, P643, DOI 10.2307/1884324; Facio FM, 2013, EUR J HUM GENET, V21, P261, DOI 10.1038/ejhg.2012.179; Facio FM, 2011, EUR J HUM GENET, V19, P1213, DOI 10.1038/ejhg.2011.123; Feero WG, 2013, JAMA-J AM MED ASSOC, V309, P1235, DOI 10.1001/jama.2013.113; Ferrer RA, COGN EMOT IN PRESS; Fredrickson BL, 2001, AM PSYCHOL, V56, P218, DOI 10.1037/0003-066X.56.3.218; Furnham A., 2013, PSYCHOLOGY, V4, P717, DOI [10.4236/psych.2013.49102, DOI 10.4236/PSYCH.2013.49102]; Gelade GA, 2002, GENET SOC GEN PSYCH, V128, P213; GELLER G, 1993, MED CARE, V31, P989, DOI 10.1097/00005650-199311000-00002; Georgsdottir A. S., 2004, CREATIVITY INNOVATIO, V13, P166, DOI DOI 10.1111/J.0963-1690.2004.00306.X; Gollust SE, 2012, PUBLIC HEALTH GENOM, V15, P22, DOI 10.1159/000327296; Gray SW, 2014, GENET MED, V16, P727, DOI 10.1038/gim.2014.26; Han PKJ, 2011, MED DECIS MAKING, V31, P828, DOI 10.1177/0272989X11393976; Heshka JT, 2008, GENET MED, V10, P19, DOI 10.1097/GIM.0b013e31815f524f; Hopwood CJ, 2007, J STUD ALCOHOL DRUGS, V68, P455, DOI 10.15288/jsad.2007.68.455; John O.P., 1999, HDB PERSONALITY THEO, VVolume 2, P102; Kaphingst KA, 2012, CLIN GENET, V82, P408, DOI 10.1111/j.1399-0004.2012.01909.x; Kirkpatrick B, 2013, J GENET COUNS, V22, P407, DOI 10.1007/s10897-013-9572-8; Klein WMP, 2015, PERS SOC PSYCHOL REV, V19, P77, DOI 10.1177/1088868314539852; Marcati A, 2008, RES POLICY, V37, P1579, DOI 10.1016/j.respol.2008.06.004; McBride CM, 2010, ANNU REV PUBL HEALTH, V31, P89, DOI 10.1146/annurev.publhealth.012809.103532; McGowan ML, 2010, NEW GENET SOC, V29, P261, DOI 10.1080/14636778.2010.507485; Michie S, 2001, J MED GENET, V38, P519, DOI 10.1136/jmg.38.8.519; Munafo MR, 2007, NICOTINE TOB RES, V9, P405, DOI 10.1080/14622200701188851; Presidential Commission for the Study of Bioethical Issues, ANT COMM ETH MAN INC; Rogers EM, 1962, DIFFUSION INNOVATION; SCHEIER MF, 1994, J PERS SOC PSYCHOL, V67, P1063, DOI 10.1037/0022-3514.67.6.1063; SCHEIER MF, 1987, J PERS, V55, P169, DOI 10.1111/j.1467-6494.1987.tb00434.x; Srivastava S, 2008, J PERS SOC PSCYHOL, V84, P1041; Taber JM, HLTH PSYCHO IN PRESS; Taber JM, ANN BEHAV M IN PRESS; Wagnild GM., THE RESILIENCE SCALE; Wright MF, 2014, GENET MED, V16, P442, DOI 10.1038/gim.2013.170; Zhao H, 2006, J APPL PSYCHOL, V91, P259, DOI 10.1037/0021-9010.91.2.259	46	36	36	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0132690	10.1371/journal.pone.0132690	http://dx.doi.org/10.1371/journal.pone.0132690			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RV	26186621	Green Published, gold, Green Submitted			2022-12-26	WOS:000358198700055
J	Meiyazhagan, G; Raju, R; Winfred, SB; Mannivanan, B; Bhoopalan, H; Shankar, V; Sekar, S; Venkatachalam, DP; Pitani, R; Nagendrababu, V; Thaiman, M; Devivanayagam, K; Jayaraman, J; Ragavachary, R; Venkatraman, G				Meiyazhagan, Gowri; Raju, Rajesh; Winfred, Sofi Beaula; Mannivanan, Bhavani; Bhoopalan, Hemadev; Shankar, Venkatesh; Sekar, Sathiya; Venkatachalam, Deepa Parvathi; Pitani, Ravishankar; Nagendrababu, Venkateshbabu; Thaiman, Malini; Devivanayagam, Kandaswamy; Jayaraman, Jeyakanthan; Ragavachary, Raghunathan; Venkatraman, Ganesh			Bioactivity Studies of beta-Lactam Derived Polycyclic Fused Pyrroli-Dine/Pyrrolizidine Derivatives in Dentistry: In Vitro, In Vivo and In Silico Studies	PLOS ONE			English	Article							ENTEROCOCCUS-FAECALIS; ENDODONTIC TREATMENT; CALCIUM HYDROXIDE; INHIBITORS; MECHANISM; ANTIBIOTICS; PENICILLINS; POTENT	The antibacterial activity of beta-lactam derived polycyclic fused pyrrolidine/pyrrolizidine derivatives synthesized by 1, 3-dipolar cycloaddition reaction was evaluated against microbes involved in dental infection. Fifteen compounds were screened; among them compound 3 showed efficient antibacterial activity in an ex vivo dentinal tubule model and in vivo mice infectious model. In silico docking studies showed greater affinity to penicillin binding protein. Cell damage was observed under Scanning Electron Microscopy (SEM) which was further proved by Confocal Laser Scanning Microscope (CLSM) and quantified using Flow Cytometry by PI up-take. Compound 3 treated E. faecalis showed ROS generation and loss of membrane integrity was quantified by flow cytometry. Compound 3 was also found to be active against resistant E. faecalis strains isolated from failed root canal treatment cases. Further, compound 3 was found to be hemocompatible, not cytotoxic to normal mammalian NIH 3T3 cells and non mutagenic. It was concluded that beta-lactam compound 3 exhibited promising antibacterial activity against E. faecalis involved in root canal infections and the mechanism of action was deciphered. The results of this research can be further implicated in the development of potent antibacterial medicaments with applications in dentistry.	[Meiyazhagan, Gowri; Winfred, Sofi Beaula; Mannivanan, Bhavani; Bhoopalan, Hemadev; Venkatachalam, Deepa Parvathi; Venkatraman, Ganesh] Sri Ramachandra Univ, Dept Human Genet, Madras, Tamil Nadu, India; [Raju, Rajesh; Ragavachary, Raghunathan] Univ Madras, Dept Organ Chem, Madras, Tamil Nadu, India; [Shankar, Venkatesh; Jayaraman, Jeyakanthan] Alagappa Univ, Dept Bioinformat, Karaikkudi, Tamil Nadu, India; [Sekar, Sathiya] Sri Ramachandra Univ, Ctr Toxicol & Dev Res, Madras, Tamil Nadu, India; [Pitani, Ravishankar] Sri Ramachandra Univ, Dept Community Med, Madras, Tamil Nadu, India; [Nagendrababu, Venkateshbabu; Devivanayagam, Kandaswamy] Sri Ramachandra Univ, Dept Conservat Dent & Endodont, Madras, Tamil Nadu, India; [Thaiman, Malini] Sri Ramachandra Univ, Cent Res Facil, Madras, Tamil Nadu, India	Sri Ramachandra Institute of Higher Education & Research; University of Madras; Alagappa University; Sri Ramachandra Institute of Higher Education & Research; Sri Ramachandra Institute of Higher Education & Research; Sri Ramachandra Institute of Higher Education & Research; Sri Ramachandra Institute of Higher Education & Research	Ragavachary, R (corresponding author), Univ Madras, Dept Organ Chem, Guindy Campus, Madras, Tamil Nadu, India.	ragharaghunathan@yahoo.com; ganeshv@sriramachandra.edu.in	Venkatraman, Ganesh/AAB-1467-2020; Parvathi, Venkatachalam Deepa/AAX-7300-2020; Sekar, Sathiya/AAN-7175-2020	Venkatraman, Ganesh/0000-0003-0179-9785; Parvathi, Venkatachalam Deepa/0000-0002-5177-8862; Raju, Rajesh/0000-0003-3724-3148	Department of Biotechnology, Ministry of Science & Technology, Government of India [BT/PR13246/27/GBD/230/2009]	Department of Biotechnology, Ministry of Science & Technology, Government of India(Department of Biotechnology (DBT) India)	This work was supported by the Department of Biotechnology, Ministry of Science & Technology, Government of India (BT/PR13246/27/GBD/230/2009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akinlaja OA, 1998, NIG Q J HOSP MED, V8, P148; ALCAIDE B, 1992, J ORG CHEM, V57, P5921, DOI 10.1021/jo00048a027; Alcaide B, 2000, J ORG CHEM, V65, P3453, DOI 10.1021/jo991984h; Alder J, 2003, ANTIMICROB AGENTS CH, V47, P3561, DOI 10.1128/AAC.47.11.3561-3566.2003; Andiappan M, 2013, PROG BIOMATER, V2, DOI 10.1186/2194-0517-2-6; [Anonymous], 2014, LIGPREP VERS 3 0; Arumugam N, 2011, EUR J MED CHEM, V46, P600, DOI 10.1016/j.ejmech.2010.11.039; Arumugam N, 2010, BIOORG MED CHEM LETT, V20, P3698, DOI 10.1016/j.bmcl.2010.04.084; Ballal V, 2007, AUST DENT J, V52, P257; Borthwick AD, 1998, BIOORG MED CHEM LETT, V8, P365, DOI 10.1016/S0960-894X(98)00032-8; CIMARUSTI CM, 1984, MED RES REV, V4, P1, DOI 10.1002/med.2610040103; Curson I, 1966, Br Dent J, V121, P381; Dwyer DJ, 2014, P NATL ACAD SCI USA, V111, pE2100, DOI 10.1073/pnas.1401876111; Estrela C, 1999, J ENDODONT, V25, P416, DOI 10.1016/S0099-2399(99)80269-6; Evans M, 2002, INT ENDOD J, V35, P221, DOI 10.1046/j.1365-2591.2002.00504.x; FARR SB, 1991, MICROBIOL REV, V55, P561, DOI 10.1128/MMBR.55.4.561-585.1991; Fenech M, 2007, NAT PROTOC, V2, P1084, DOI 10.1038/nprot.2007.77; Flavia A, 2012, BMC COMPLEM ALTERN M, V12, P203, DOI [10.1186/1472-6882-12-203, DOI 10.1186/1472-6882-12-203]; Gentry-Weeks C, 2003, INFECT IMMUN, V71, P1434, DOI 10.1128/IAI.71.3.1434-1441.2003; GRIEVE AR, 1973, BRIT DENT J, V134, P188, DOI 10.1038/sj.bdj.4802977; Halve AK, 2007, BIOORG MED CHEM LETT, V17, P341, DOI 10.1016/j.bmcl.2006.10.064; HAN WT, 1995, BIOORGAN MED CHEM, V3, P1123, DOI 10.1016/0968-0896(95)00101-L; Kavindra VS, 2012, ANTIMICROB AGENTS CH, V56, P3457, DOI [10.1128/AAC.06102-11, DOI 10.1128/AAC.06102-11]; Kishen A, 2008, J ENDODONT, V34, P1515, DOI 10.1016/j.joen.2008.08.035; LLC S, 2014, PRIME VERSION 35; Macheboeuf P, 2006, FEMS MICROBIOL REV, V30, P673, DOI 10.1111/j.1574-6976.2006.00024.x; Maurya IK, 2011, PEPTIDES, V32, P1732, DOI 10.1016/j.peptides.2011.06.003; Mims C, 2001, MIMS PATHOGENESIS IN, P474; MOORHEAD PS, 1960, EXP CELL RES, V20, P613, DOI 10.1016/0014-4827(60)90138-5; Muthumanickkam A, 2013, IRAN POLYM J, V22, P143, DOI 10.1007/s13726-012-0113-3; Nagarajan S, 2012, TETRAHEDRON, V68, P3037, DOI 10.1016/j.tet.2012.02.017; Nair PNR, 2005, ORAL SURG ORAL MED O, V99, P231, DOI 10.1016/j.tripleo.2004.10.005; Prasanna MS, 2011, ACTA CRYSTALLOGR E, VE 67; Rajesh R, 2014, TETRAHEDRON LETT, V55, P699, DOI 10.1016/j.tetlet.2013.11.117; Rajesh R, 2013, EUR J ORG CHEM, V2013, P2597, DOI 10.1002/ejoc.201201471; Rosenblum SB, 1998, J MED CHEM, V41, P973, DOI 10.1021/jm970701f; Sarah S, 2011, J MOL BIOL, V405, P173, DOI [10.1016/j.jmb.2010.10.024, DOI 10.1016/J.JMB.2010.10.024]; SARIKA P, 2011, ANTIMICROB AGENTS CH, V55, P2178; SHAYMAA EE, 2012, J BIOMED RES, V26, P193, DOI DOI 10.7555/JBR.26.20110136; Singh GS, 2004, MINI-REV MED CHEM, V4, P69, DOI 10.2174/1389557043487501; Sundqvist G, 1998, ORAL SURG ORAL MED O, V85, P86, DOI 10.1016/S1079-2104(98)90404-8; TIPPER DJ, 1965, P NATL ACAD SCI USA, V54, P1133, DOI 10.1073/pnas.54.4.1133; TOMASZ A, 1979, ANNU REV MICROBIOL, V33, P113, DOI 10.1146/annurev.mi.33.100179.000553; Vales G, 2013, NANOTOXICOLOGY, V7, P462, DOI 10.3109/17435390.2012.689882; Vivek R, 2009, J SCI RES, V2, P45; Warshaviak DT, 2014, J CHEM INF MODEL, V54, P1941, DOI 10.1021/ci500175r; Wojnicz D, 2012, UROL RES, V40, P683, DOI 10.1007/s00240-012-0499-6; Yamada M, 2007, ANTIMICROB AGENTS CH, V51, P3902, DOI 10.1128/AAC.00743-07; Zapata RO, 2008, J ENDODONT, V34, P1198, DOI 10.1016/j.joen.2008.07.001; Zehnder M, 2006, J ENDODONT, V32, P389, DOI 10.1016/j.joen.2005.09.014; Zhu K, 2014, J CHEM INF MODEL, V54, P1932, DOI 10.1021/ci500118s	51	4	4	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0131433	10.1371/journal.pone.0131433	http://dx.doi.org/10.1371/journal.pone.0131433			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RV	26185985	gold, Green Published, Green Submitted			2022-12-26	WOS:000358198700017
J	Herzeel, C; Costanza, P; Decap, D; Fostier, J; Reumers, J				Herzeel, Charlotte; Costanza, Pascal; Decap, Dries; Fostier, Jan; Reumers, Joke			elPrep: High-Performance Preparation of Sequence Alignment/Map Files for Variant Calling	PLOS ONE			English	Article							SECONDARY ANALYSIS; WHOLE-GENOME	elPrep is a high-performance tool for preparing sequence alignment/map files for variant calling in sequencing pipelines. It can be used as a replacement for SAMtools and Picard for preparation steps such as filtering, sorting, marking duplicates, reordering contigs, and so on, while producing identical results. What sets elPrep apart is its software architecture that allows executing preparation pipelines by making only a single pass through the data, no matter how many preparation steps are used in the pipeline. elPrep is designed as a multithreaded application that runs entirely in memory, avoids repeated file I/O, and merges the computation of several preparation steps to significantly speed up the execution time. For example, for a preparation pipeline of five steps on a whole-exome BAM file (NA12878), we reduce the execution time from about 1: 40 hours, when using a combination of SAMtools and Picard, to about 15 minutes when using elPrep, while utilising the same server resources, here 48 threads and 23GB of RAM. For the same pipeline on whole-genome data (NA12878), elPrep reduces the runtime from 24 hours to less than 5 hours. As a typical clinical study may contain sequencing data for hundreds of patients, elPrep can remove several hundreds of hours of computing time, and thus substantially reduce analysis time and cost.	[Herzeel, Charlotte] IMEC, Leuven, Belgium; [Costanza, Pascal] Intel Corp, Leuven, Belgium; [Decap, Dries; Fostier, Jan] Univ Ghent, Dept Informat Technol, iMinds, B-9000 Ghent, Belgium; [Reumers, Joke] Janssen Pharmaceut NV, Janssen Res & Dev, Div, Beerse, Belgium; [Herzeel, Charlotte; Costanza, Pascal; Decap, Dries; Fostier, Jan; Reumers, Joke] ExaSci Life Lab, Leuven, Belgium	IMEC; Intel Corporation; Ghent University; IMEC; Johnson & Johnson; Janssen Pharmaceuticals	Herzeel, C (corresponding author), IMEC, Leuven, Belgium.	Charlotte.Herzeel@imec.be	Fostier, Jan/A-8275-2012	Fostier, Jan/0000-0002-9994-8269; Herzeel, Charlotte/0000-0002-9319-9885; Reumers, Joke/0000-0001-5434-6515	Intel; Janssen Pharmaceutica; Institute for the Promotion of Innovation through Science and Technology in Flanders (IWT) [130406]	Intel(Intel Corporation); Janssen Pharmaceutica(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Institute for the Promotion of Innovation through Science and Technology in Flanders (IWT)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT))	This work is funded by Intel, Janssen Pharmaceutica, and by the Institute for the Promotion of Innovation through Science and Technology in Flanders (IWT): IWT O&O Project 130406. Charlotte Herzeel is an employee of IMEC vzw, Belgium; Pascal Costanza is an employee of Intel Corporation NV/SA, Belgium; Dries Decap and Jan Fostier are employees of iMinds vzw, Ghent, Belgium; Joke Reumers is an employee of Janssen Pharmaceutica NV/SA, Belgium. All authors are also affiliated with ExaScience Life Lab which is a consortium of companies and universities. These companies provided support in the form of salaries for these authors but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of each author is articulated in the "author contributions" section.	[Anonymous], 2012, EMBNET J, DOI DOI 10.14806/EJ.17.B.286; Blumofe RD, 1999, J ACM, V46, P720, DOI 10.1145/324133.324234; Cochrane G, 2012, GIGASCIENCE, V1, DOI 10.1186/2047-217X-1-2; Decap D, 2015, BIOINFORMATICS, V31, P2482, DOI 10.1093/bioinformatics/btv179; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Faust GG, 2014, BIOINFORMATICS, V30, P2503, DOI 10.1093/bioinformatics/btu314; Fritz MHY, 2011, GENOME RES, V21, P734, DOI 10.1101/gr.114819.110; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Luo RB, 2014, PEERJ, V2, DOI 10.7717/peerj.421; Raczy C, 2013, BIOINFORMATICS, V29, P2041, DOI 10.1093/bioinformatics/btt314; Van der Auwera Geraldine A, 2013, Curr Protoc Bioinformatics, V43, DOI [10.1002/0471250953.bi1201s43, 10.1002/0471250953.bi1110s43]; Tarasov A, 2012, SAMBAMBA; The SAM/BAM Format Specification Working Group, 2015, SEQ AL MAP FORM SPEC; Tischler G, 2014, SOURCE CODE BIOL MED, V9, DOI 10.1186/1751-0473-9-13; Van der Auwera G, 2013, COLLECTED FAQS BAM F; Wing MK, 2010, BAMUTIL OVERVIEW	16	17	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2015	10	7							e0132868	10.1371/journal.pone.0132868	http://dx.doi.org/10.1371/journal.pone.0132868			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RQ	26182406	Green Published, Green Submitted, gold			2022-12-26	WOS:000358198200045
J	Cho, MC; Cho, SY; Yoon, CY; Lee, SB; Kwak, C; Kim, HH; Jeong, H				Cho, Min Chul; Cho, Sung Yong; Yoon, Cheol Yong; Lee, Seung Bae; Kwak, Cheol; Kim, Hyeon Hoe; Jeong, Hyeon			EphA2 Is a Potential Player of Malignant Cellular Behavior in Non-Metastatic Renal Cell Carcinoma Cells but Not in Metastatic Renal Cell Carcinoma Cells	PLOS ONE			English	Article							FOCAL ADHESION KINASE; RECEPTOR TYROSINE KINASE; PROSTATE-CANCER; OVEREXPRESSION; ADENOCARCINOMA; EXPRESSION; SURVIVAL; INVASION; DISEASE; TARGET	Objectives To investigate the role of EphA2 in malignant cellular behavior in renal cell carcinoma (RCC) cells and whether FAK/RhoA signaling can act as downstream effectors of EphA2 on RCC cells. Methods Expression of EphA2 protein in non-metastatic RCC (Caki-2 and A498), metastatic RCC cells (Caki-1 and ACHN), HEK-293 cells and prostate cancer cells (PC-3 and DU-145; positive controls of EphA2 expression) was evaluated by Western blot. Changes in mRNA or protein expression of EphA2, FAK or membrane-bound RhoA following EphA2, FAK or RhoA small interfering RNA (siRNA) transfection were determined by reverse transcription polymerase chain reaction or Western blot. The effect of siRNA treatment on cellular viability, apoptosis and invasion was analyzed by cell counting kit-8, Annexin-V and modified Matrigel-Boyden assays, respectively. Results In all RCC cell lines, the expression of EphA2 protein was detectable at variable levels; however, in HEK-293 cells, EphA2 expression was very low. Treatment with EphA2 siRNA significantly reduced the expression of EphA2 mRNA and protein in all RCC cell lines. For non-metastatic RCC cells (Caki-2 and A498) but not metastatic RCC cells (Caki-1 and ACHN), cellular viability, invasiveness, resistance to apoptosis, expression of membrane-bound RhoA protein and FAK phosphorylation were significantly decreased in EphA2 siRNA-treated cells compared to the control. In non-metastatic RCC cells, FAK siRNA significantly attenuated the invasiveness, resistance to apoptosis, as well as expression of membrane-bound RhoA protein without changing protein expression of EphA2. RhoA siRNA significantly decreased the malignant cellular behavior and expression of membrane-bound RhoA protein without changing EphA2 protein expression or FAK phosphorylation. Conclusions Our data provide the first functional evidence that the EphA2/FAK/RhoA signaling pathway plays a critical role in the malignant cellular behavior of RCC and appears to be functional particularly in the early stage of malignant progression of non-metastatic RCC.	[Cho, Min Chul] Dongguk Univ, Coll Med, Dept Urol, Seoul, South Korea; [Cho, Sung Yong; Lee, Seung Bae; Jeong, Hyeon] SMG SNU Boramae Med Ctr, Dept Urol, Seoul, South Korea; [Yoon, Cheol Yong] Korea Univ, Dept Urol, Guro Hosp, Seoul, South Korea; [Kwak, Cheol; Kim, Hyeon Hoe] Seoul Natl Univ, Coll Med, Dept Urol, Seoul, South Korea	Dongguk University; Seoul National University (SNU); Seoul National University Hospital; Korea University; Korea University Medicine (KU Medicine); Seoul National University (SNU)	Jeong, H (corresponding author), SMG SNU Boramae Med Ctr, Dept Urol, Seoul, South Korea.	drjh@brm.co.kr	CHO, MIN CHUL/R-7835-2019		Seoul National University Hospital (SNUH) Research Fund [04-2009-042-0]	Seoul National University Hospital (SNUH) Research Fund	This study was supported by grant no. 04-2009-042-0 from the Seoul National University Hospital (SNUH) Research Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of our manuscript.	Brantley-Sieders D, 2004, CURR PHARM DESIGN, V10, P3431, DOI 10.2174/1381612043383160; Brantley-Sieders DM, 2008, J CLIN INVEST, V118, P64, DOI 10.1172/JCI33154; Carles-Kinch K, 2002, CANCER RES, V62, P2840; Castano J, 2008, HISTOL HISTOPATHOL, V23, P1011, DOI 10.14670/HH-23.1011; Chan PC, 2002, J BIOL CHEM, V277, P50373, DOI 10.1074/jbc.M204691200; Cindolo L, 2005, CANCER-AM CANCER SOC, V104, P1362, DOI 10.1002/cncr.21331; Coppin C, 2011, BJU INT, V108, P1556, DOI 10.1111/j.1464-410X.2011.10629.x; Duxbury MS, 2004, ONCOGENE, V23, P1448, DOI 10.1038/sj.onc.1207247; Frisch SM, 1996, J CELL BIOL, V134, P793, DOI 10.1083/jcb.134.3.793; Herrem CJ, 2005, CLIN CANCER RES, V11, P226; Ireton RC, 2005, CURR CANCER DRUG TAR, V5, P149, DOI 10.2174/1568009053765780; Jenq WM, 1996, CONNECT TISSUE RES, V34, P161, DOI 10.3109/03008209609000696; Jones J, 2007, J CELL MOL MED, V11, P826, DOI 10.1111/j.1582-4934.2007.00071.x; Parri M, 2007, J BIOL CHEM, V282, P19619, DOI 10.1074/jbc.M701319200; Parri M, 2009, CANCER RES, V69, P2072, DOI 10.1158/0008-5472.CAN-08-1845; Pasquale EB, 2008, CELL, V133, P38, DOI 10.1016/j.cell.2008.03.011; Rini BI, 2009, LANCET, V373, P1119, DOI 10.1016/S0140-6736(09)60229-4; Schwock J, 2010, EXPERT OPIN THER TAR, V14, P77, DOI 10.1517/14728220903460340; Taddei ML, 2009, AM J PATHOL, V174, P1492, DOI 10.2353/ajpath.2009.080473; Vega FM, 2008, FEBS LETT, V582, P2093, DOI 10.1016/j.febslet.2008.04.039; Walker-Daniels J, 1999, PROSTATE, V41, P275, DOI 10.1002/(SICI)1097-0045(19991201)41:4<275::AID-PROS8>3.0.CO;2-T; Zhao J, 2009, CANCER METAST REV, V28, P35, DOI 10.1007/s10555-008-9165-4; Zhou ZM, 2008, SURG NEUROL, V70, P562, DOI 10.1016/j.surneu.2008.04.031	23	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0130975	10.1371/journal.pone.0130975	http://dx.doi.org/10.1371/journal.pone.0130975			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26177500	gold, Green Published			2022-12-26	WOS:000358197600033
J	Neiva, J; Assis, J; Coelho, NC; Fernandes, F; Pearson, GA; Serrao, EA				Neiva, Joao; Assis, Jorge; Coelho, Nelson C.; Fernandes, Francisco; Pearson, Gareth A.; Serrao, Ester A.			Genes Left Behind: Climate Change Threatens Cryptic Genetic Diversity in the Canopy-Forming Seaweed Bifurcaria bifurcata	PLOS ONE			English	Article							SPECIES DISTRIBUTION MODELS; RANGE SHIFTS; PSEUDO-ABSENCES; REAR EDGE; SEA-ICE; MARINE; RESPONSES; BIODIVERSITY; SOFTWARE; REFUGIA	The global redistribution of biodiversity will intensify in the coming decades of climate change, making projections of species range shifts and of associated genetic losses important components of conservation planning. Highly-structured marine species, notably brown seaweeds, often harbor unique genetic variation at warmer low-latitude rear edges and thus are of particular concern. Here, a combination of Ecological Niche Models (ENMs) and molecular data is used to forecast the potential near-future impacts of climate change for a warm-temperate, canopy forming seaweed, Bifurcaria bifurcata. ENMs for B. bifurcata were developed using marine and terrestrial climatic variables, and its range projected for 2040-50 and 2090-2100 under two greenhouse emission scenarios. Geographical patterns of genetic diversity were assessed by screening 18 populations spawning the entire distribution for two organelle genes and 6 microsatellite markers. The southern limit of B. bifurcata was predicted to shift northwards to central Morocco by the mid-century. By 2090-2100, depending on the emission scenario, it could either retreat further north to western Iberia or be relocated back to Western Sahara. At the opposing margin, B. bifurcata was predicted to expand its range to Scotland or even Norway. Microsatellite diversity and endemism were highest in Morocco, where a unique and very restricted lineage was also identified. Our results imply that B. bifurcata will maintain a relatively broad latitudinal distribution. Although its persistence is not threatened, the predicted extirpation of a unique southern lineage or even the entire Moroccan diversity hotspot will erase a rich evolutionary legacy and shrink global diversity to current (low) European levels. NW Africa and similarly understudied southern regions should receive added attention if expected range changes and diversity loss of warm-temperate species is not to occur unnoticed.	[Neiva, Joao; Assis, Jorge; Coelho, Nelson C.; Fernandes, Francisco; Pearson, Gareth A.; Serrao, Ester A.] Univ Algarve, Ctr Ciencias Mar, Faro, Portugal	Universidade do Algarve	Neiva, J (corresponding author), Univ Algarve, Ctr Ciencias Mar, Faro, Portugal.	jmneiva@ualg.pt	Serrao, Ester A/C-6686-2012; Assis, Jorge/AAC-6524-2019; Assis, Jorge/G-9688-2012; Neiva, Joao/AAP-6267-2020; Neiva, João/M-3818-2013; Pearson, Gareth/J-3911-2013	Serrao, Ester A/0000-0003-1316-658X; Assis, Jorge/0000-0002-6624-4820; Assis, Jorge/0000-0002-6624-4820; Neiva, Joao/0000-0002-5927-4570; Neiva, João/0000-0002-5927-4570; Pearson, Gareth/0000-0002-0768-464X; Coelho, Nelson/0000-0002-8331-5889	Portuguese FCT (Fundacao para a Ciencia e a Tecnologia) [PTDC/AAC-CLI/109108/2008, EXPL/BIA-BIC/1471/2012, EXCL/AAG-GLO/0661/2012];  [SFRH/BPD/88935/2012]; Fundação para a Ciência e a Tecnologia [PTDC/AAC-CLI/109108/2008, EXPL/BIA-BIC/1471/2012] Funding Source: FCT	Portuguese FCT (Fundacao para a Ciencia e a Tecnologia)(Portuguese Foundation for Science and Technology); ; Fundação para a Ciência e a Tecnologia	This work was funded by Portuguese FCT (Fundacao para a Ciencia e a Tecnologia) through projects EDGES (PTDC/AAC-CLI/109108/2008), ReUp (EXPL/BIA-BIC/1471/2012) and EXTANT (EXCL/AAG-GLO/0661/2012) and a postdoctoral fellowship to JN (SFRH/BPD/88935/2012).	Allouche O, 2006, J APPL ECOL, V43, P1223, DOI 10.1111/j.1365-2664.2006.01214.x; Alsos IG, 2012, P ROY SOC B-BIOL SCI, V279, P2042, DOI 10.1098/rspb.2011.2363; Araujo MB, 2005, GLOBAL ECOL BIOGEOGR, V14, P529, DOI 10.1111/j.1466-822x.2005.00182.x; Araujo MB, 2007, TRENDS ECOL EVOL, V22, P42, DOI 10.1016/j.tree.2006.09.010; Araujo MB, 2011, ECOL LETT, V14, P484, DOI 10.1111/j.1461-0248.2011.01610.x; Assis J, 2014, MOL ECOL, V23, P2797, DOI 10.1111/mec.12772; Assis J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068646; Balint M, 2011, NAT CLIM CHANGE, V1, P313, DOI 10.1038/NCLIMATE1191; Barbet-Massin M, 2012, METHODS ECOL EVOL, V3, P327, DOI 10.1111/j.2041-210X.2011.00172.x; Barton ED, 2013, PROG OCEANOGR, V116, P167, DOI 10.1016/j.pocean.2013.07.007; Bartsch I, 2012, SEAWEED BIOL, P383, DOI DOI 10.1007/978-3-642-28451-9_18; Bates AE, 2014, GLOBAL ENVIRON CHANG, V26, P27, DOI 10.1016/j.gloenvcha.2014.03.009; Bellard C, 2012, ECOL LETT, V15, P365, DOI 10.1111/j.1461-0248.2011.01736.x; Benhissoune S, 2002, BOT MAR, V45, P217, DOI 10.1515/BOT.2002.021; Bennett KD, 2008, QUATERNARY SCI REV, V27, P2449, DOI 10.1016/j.quascirev.2008.08.019; Berge J, 2005, MAR ECOL PROG SER, V303, P167, DOI 10.3354/meps303167; Burrows MT, 2011, SCIENCE, V334, P652, DOI 10.1126/science.1210288; Calenge C, 2008, ECOLOGY, V89, P555, DOI 10.1890/06-1750.1; Chefaoui RM, 2008, ECOL MODEL, V210, P478, DOI 10.1016/j.ecolmodel.2007.08.010; Chen IC, 2011, SCIENCE, V333, P1024, DOI 10.1126/science.1206432; Crawford NG, 2010, MOL ECOL RESOUR, V10, P556, DOI 10.1111/j.1755-0998.2009.02801.x; D'Amen M, 2013, GLOBAL ECOL BIOGEOGR, V22, P93, DOI 10.1111/j.1466-8238.2012.00774.x; Dalen L, 2007, P NATL ACAD SCI USA, V104, P6726, DOI 10.1073/pnas.0701341104; de Valera M., 1962, P R IR ACAD B, V62B, P77; De'ath G, 2007, ECOLOGY, V88, P243, DOI 10.1890/0012-9658(2007)88[243:BTFEMA]2.0.CO;2; Dee DP, 2011, Q J ROY METEOR SOC, V137, P553, DOI 10.1002/qj.828; Diffenbaugh NS, 2013, SCIENCE, V341, P486, DOI 10.1126/science.1237123; Donlon CJ, 2012, REMOTE SENS ENVIRON, V116, P140, DOI 10.1016/j.rse.2010.10.017; Duarte L, 2013, ACTA OECOL, V51, P1, DOI 10.1016/j.actao.2013.05.002; Dudgeon S, 2001, FUNCT ECOL, V15, P595, DOI 10.1046/j.0269-8463.2001.00559.x; Elith J, 2008, J ANIM ECOL, V77, P802, DOI 10.1111/j.1365-2656.2008.01390.x; Elith J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI 10.1146/annurev.ecolsys.110308.120159; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Faircloth BC, 2008, MOL ECOL RESOUR, V8, P92, DOI 10.1111/j.1471-8286.2007.01884.x; Fraser CI, 2009, P NATL ACAD SCI USA, V106, P3249, DOI 10.1073/pnas.0810635106; FRIEDMAN JH, 1991, ANN STAT, V19, P1, DOI 10.1214/aos/1176347963; Gallardo GT, 2000, FLORA PHYCOLOGICA IB, V1, P91; Gomez A, 2007, PHYLOGEOGRAPHY OF SOUTHERN EUROPEAN REFUGIA, P155, DOI 10.1007/1-4020-4904-8_5; Hampe A, 2005, ECOL LETT, V8, P461, DOI 10.1111/j.1461-0248.2005.00739.x; Hardy F.D., 2003, CHECK LIST ATLAS SEA; Harley CDG, 2006, ECOL LETT, V9, P228, DOI 10.1111/j.1461-0248.2005.00871.x; Helmuth B, 2002, SCIENCE, V298, P1015, DOI 10.1126/science.1076814; Helmuth B, 2006, ECOL MONOGR, V76, P461, DOI 10.1890/0012-9615(2006)076[0461:MPOTSI]2.0.CO;2; Helmuth B, 2006, ANNU REV ECOL EVOL S, V37, P373, DOI 10.1146/annurev.ecolsys.37.091305.110149; Hughes AR, 2008, ECOL LETT, V11, P609, DOI 10.1111/j.1461-0248.2008.01179.x; Jost L, 2008, MOL ECOL, V17, P4015, DOI 10.1111/j.1365-294X.2008.03887.x; Jueterbock A, 2013, ECOL EVOL, V3, P1356, DOI 10.1002/ece3.541; Jump AS, 2009, TRENDS PLANT SCI, V14, P51, DOI 10.1016/j.tplants.2008.10.002; Le Corguille G, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-253; Lee YK, 1999, EUR J PHYCOL, V34, P205, DOI 10.1080/09670269910001736262; LESICA P, 1995, CONSERV BIOL, V9, P753, DOI 10.1046/j.1523-1739.1995.09040753.x; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lima FP, 2007, GLOBAL CHANGE BIOL, V13, P2592, DOI 10.1111/j.1365-2486.2007.01451.x; Lima FP, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1713; Luning K, 1990, SEAWEEDS THEIR ENV B; McGregor HV, 2007, SCIENCE, V315, P637, DOI 10.1126/science.1134839; Mieszkowska N, 2006, HYDROBIOLOGIA, V555, P241, DOI 10.1007/s10750-005-1120-6; Mieszkowska N, 2005, MARINE BIOL ASS OCCA, V20; Mieszkowska N., 2010, 9212010 CCW; Montecinos A, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-97; Moss RH, 2010, NATURE, V463, P747, DOI 10.1038/nature08823; Mota CF, 2015, FUNCT ECOL, V29, P640, DOI 10.1111/1365-2435.12373; Motomura T, 2010, J PLANT RES, V123, P185, DOI 10.1007/s10265-010-0313-x; NEI M, 1983, J MOL EVOL, V19, P153, DOI 10.1007/BF02300753; Neiva J, 2014, J BIOGEOGR, V41, P1137, DOI 10.1111/jbi.12278; Neiva J, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-78; Neiva J, 2012, J BIOGEOGR, V39, P1167, DOI 10.1111/j.1365-2699.2011.02670.x; New M, 2002, CLIMATE RES, V21, P1, DOI 10.3354/cr021001; Nicastro KR, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-6; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Pauls SU, 2013, MOL ECOL, V22, P925, DOI 10.1111/mec.12152; Perry AL, 2005, SCIENCE, V308, P1912, DOI 10.1126/science.1111322; Petit RJ, 2003, SCIENCE, V300, P1563, DOI 10.1126/science.1083264; Pfenninger M, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-224; Phillips NE, 2005, PHYCOL RES, V53, P1; Pitt NR, 2010, MAR FRESHWATER RES, V61, P963, DOI 10.1071/MF09225; Poloczanska ES, 2013, NAT CLIM CHANGE, V3, P919, DOI [10.1038/nclimate1958, 10.1038/NCLIMATE1958]; Provan J., 2013, FRONT BIOGEOGR, V5, P60, DOI [10.21425/F5FBG14732, DOI 10.21425/F55114732]; Provan J, 2012, P ROY SOC B-BIOL SCI, V279, P39, DOI 10.1098/rspb.2011.0536; Ramstein G, 2007, CLIMATE DISCUSSIONS, V3, P197, DOI DOI 10.5194/CPD-3-197-2007; Riegl B, 2003, INT J EARTH SCI, V92, P520, DOI 10.1007/s00531-003-0328-9; Rubidge EM, 2012, NAT CLIM CHANGE, V2, P285, DOI 10.1038/NCLIMATE1415; SERRAO EA, 1997, PHYCOLOGIA S, V36, P101; Silberfeld T, 2010, MOL PHYLOGENET EVOL, V56, P659, DOI 10.1016/j.ympev.2010.04.020; SOUTHWARD AJ, 1995, J THERM BIOL, V20, P127, DOI 10.1016/0306-4565(94)00043-I; Stewart JR, 2010, P ROY SOC B-BIOL SCI, V277, P661, DOI 10.1098/rspb.2009.1272; Sunday JM, 2012, NAT CLIM CHANGE, V2, P686, DOI 10.1038/NCLIMATE1539; Takezaki N, 2010, MOL BIOL EVOL, V27, P747, DOI 10.1093/molbev/msp312; Tomanek L, 2010, J EXP BIOL, V213, P971, DOI 10.1242/jeb.038034; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Wernberg T, 2011, CURR BIOL, V21, P1828, DOI 10.1016/j.cub.2011.09.028; Wethey DS, 2008, HYDROBIOLOGIA, V606, P139, DOI 10.1007/s10750-008-9338-8; Wethey DS, 2011, J EXP MAR BIOL ECOL, V400, P132, DOI 10.1016/j.jembe.2011.02.008; Willis KJ, 2010, SYST BIODIVERS, V8, P3, DOI 10.1080/14772000903495833	95	47	47	0	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0131530	10.1371/journal.pone.0131530	http://dx.doi.org/10.1371/journal.pone.0131530			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26177545	Green Submitted, Green Published, gold			2022-12-26	WOS:000358197600049
J	Denicol, AC; Leao, BCS; Dobbs, KB; Mingoti, GZ; Hansen, PJ				Denicol, Anna C.; Leao, Beatriz C. S.; Dobbs, Kyle B.; Mingoti, Gisele Z.; Hansen, Peter J.			Influence of Sex on Basal and Dickkopf-1 Regulated Gene Expression in the Bovine Morula	PLOS ONE			English	Article							MOUSE PREIMPLANTATION DEVELOPMENT; COLONY-STIMULATING FACTOR-2; EMBRYONIC GENOME ACTIVATION; MESSENGER-RNA EXPRESSION; INNER CELL-MASS; IN-VITRO; STEM-CELLS; HEAT-SHOCK; MOLECULAR-MECHANISMS; CULTURE-CONDITIONS	Sex affects function of the developing mammalian embryo as early as the preimplantation period. There were two goals of the current objective. The first was to determine the degree and nature of differences in gene expression between female and male embryos in the cow at the morula stage of development. The second objective was to determine whether DKK1, a molecule known to alter differentiation of the blastocyst, would affect gene expression differently for female and male morulae. In Experiment 1, female and male embryos were treated with DKK1 at Day 5 after insemination. Morulae were harvested 24 h after treatment, pooled in groups of 20 for microarray analysis and RNA subjected to analysis of gene expression by microarray hybridization. There were 662 differentially expressed genes between females and males and 128 of these genes had a fold change >= 1.5 between the two sexes. Of the genes upregulated in females, 49.5% were located in the X chromosome. Functional analysis predicted that cell survival was greater in female embryos. Experiment 2 involved a similar design except that transcripts for 12 genes previously reported to be affected by sex, DKK1 or the interaction were quantified by quantitative polymerase chain reaction. Expression of all genes tested that were affected by sex in experiment 1 was affected in a similar manner in Experiment 2. In contrast, effects of DKK1 on gene expression were largely not repeatable in Experiment 2. The exception was for the Hippo signaling gene AMOT, which was inhibited by DKK1. In Experiment 3, embryos produced by fertilization with unsorted sperm were treated with DKK1 at Day 5 and abundance of transcripts for CDX2, GATA6, and NANOG determined at Days 5, 6 and 7 after insemination. There was no effect of DKK1 on expression of any of the three genes. In conclusion, female and male bovine embryos have a different pattern of gene expression as early as the morula stage, and this is due to a large extent to expression of genes in the X chromosomes in females. Differential gene expression between female and male embryos is likely the basis for increased resistance to cell death signals in female embryos and disparity in responses of female and male embryos to changes in the maternal environment.	[Denicol, Anna C.; Dobbs, Kyle B.; Hansen, Peter J.] Univ Florida, Dept Anim Sci, DH Barron Reprod & Perinatal Biol Res Program, Gainesville, FL 32611 USA; [Denicol, Anna C.; Dobbs, Kyle B.; Hansen, Peter J.] Univ Florida, Genet Inst, Gainesville, FL USA; [Leao, Beatriz C. S.; Mingoti, Gisele Z.] UNESP, Sch Vet Med, Reprod Physiol Lab, Aracatuba, SP, Brazil	State University System of Florida; University of Florida; State University System of Florida; University of Florida; Universidade Estadual Paulista	Hansen, PJ (corresponding author), Univ Florida, Dept Anim Sci, DH Barron Reprod & Perinatal Biol Res Program, Gainesville, FL 32611 USA.	pjhansen@ufl.edu	Hansen, Peter/AAI-4693-2021; Leao, Beatriz/GRJ-5642-2022; Mingoti, Gisele Zoccal/D-6902-2012; Caetano da Silva Leao, Beatriz/N-9242-2016	Hansen, Peter/0000-0003-3061-9333; Mingoti, Gisele Zoccal/0000-0002-3059-4458; Caetano da Silva Leao, Beatriz/0000-0003-2737-5614	National Institutes of Health and Agriculture and Food Research Initiative Competitive Grant from the USDA National Institute of Food and Agriculture [R03 HD080855, 2011-67015-30688]; CAPES/PDSE (Coordination for the Improvement of Higher Level Personnel, Brazil) scholarship; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R03HD080855] Funding Source: NIH RePORTER	National Institutes of Health and Agriculture and Food Research Initiative Competitive Grant from the USDA National Institute of Food and Agriculture; CAPES/PDSE (Coordination for the Improvement of Higher Level Personnel, Brazil) scholarship; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	Research was supported by Grant R03 HD080855 from the National Institutes of Health and Agriculture and Food Research Initiative Competitive Grant no. 2011-67015-30688 from the USDA National Institute of Food and Agriculture. BCSL was supported by a CAPES/PDSE (Coordination for the Improvement of Higher Level Personnel, Brazil) scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Naib A, 2011, J REPROD IMMUNOL, V91, P31, DOI 10.1016/j.jri.2011.05.005; Bermejo-Alvarez P, 2008, PHYSIOL GENOMICS, V32, P264, DOI 10.1152/physiolgenomics.00234.2007; Bermejo-Alvarez P, 2011, REPRODUCTION, V141, P801, DOI 10.1530/REP-11-0006; Bermejo-Alvarez P, 2010, P NATL ACAD SCI USA, V107, P3394, DOI 10.1073/pnas.0913843107; Bermejo-Alvarez P, 2012, STEM CELLS DEV, V21, P1215, DOI 10.1089/scd.2011.0685; Block J, 2003, J ANIM SCI, V81, P1590; Bonilla AQS, 2011, GROWTH HORM IGF RES, V21, P107, DOI 10.1016/j.ghir.2011.03.003; Bromfield JJ, 2014, P NATL ACAD SCI USA, V111, P2200, DOI 10.1073/pnas.1305609111; Carvajal-Rodriguez A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024700; Cerri RLA, 2012, J DAIRY SCI, V95, P5657, DOI 10.3168/jds.2011-5114; Chitwood JL, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-350; De La Fuente R, 1999, BIOL REPROD, V60, P769, DOI 10.1095/biolreprod60.3.769; Denicol AC, 2014, FASEB J, V28, P3975, DOI 10.1096/fj.14-253112; Dobbs KB, 2014, BIOL REPROD, V91, DOI 10.1095/biolreprod.114.121087; Dobbs KB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066230; Fields SD, 2011, THERIOGENOLOGY, V75, P1466, DOI 10.1016/j.theriogenology.2010.12.007; Gad A, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.112.099697; Galve-Roperh I, 2013, PROG LIPID RES, V52, P633, DOI 10.1016/j.plipres.2013.05.004; Gardner DK, 2010, MOL HUM REPROD, V16, P539, DOI 10.1093/molehr/gaq042; Gebert C, 2009, GENOMICS, V94, P63, DOI 10.1016/j.ygeno.2009.03.004; Goossens K, 2005, BMC DEV BIOL, V5, DOI 10.1186/1471-213X-5-27; Guo WJ, 2013, EXP CELL RES, V319, P2801, DOI 10.1016/j.yexcr.2013.09.006; Gutierrez-Adan A, 2000, MOL REPROD DEV, V55, P146, DOI 10.1002/(SICI)1098-2795(200002)55:2&lt;146::AID-MRD3&gt;3.0.CO;2-F; GutierrezAdan A, 1996, THERIOGENOLOGY, V46, P515, DOI 10.1016/0093-691X(96)00173-2; Hendricks KEM, 2009, J REPROD DEVELOP, V55, P69, DOI 10.1262/jrd.20097; Hershey GKK, 2003, J ALLERGY CLIN IMMUN, V111, P677, DOI 10.1067/mai.2003.1333; Hirate Y, 2013, CURR BIOL, V23, P1181, DOI 10.1016/j.cub.2013.05.014; Ideta A, 2010, ANIM REPROD SCI, V117, P18, DOI 10.1016/j.anireprosci.2009.04.004; Jiang SX, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000641; Killick R, 2014, MOL PSYCHIATR, V19, P88, DOI 10.1038/mp.2012.163; Kimura K, 2005, MOL REPROD DEV, V72, P201, DOI 10.1002/mrd.20342; Kobayashi S, 2006, CURR BIOL, V16, P166, DOI 10.1016/j.cub.2005.11.071; Kuijk EW, 2008, DEV DYNAM, V237, P918, DOI 10.1002/dvdy.21480; Kuijk EW, 2012, DEVELOPMENT, V139, P871, DOI 10.1242/dev.071688; Kwong WY, 2000, DEVELOPMENT, V127, P4195; Laguna-Barraza R, 2013, REPROD FERT DEVELOP, V25, P38, DOI 10.1071/RD12262; Larson MA, 2001, P NATL ACAD SCI USA, V98, P9677, DOI 10.1073/pnas.171305398; LARSON RC, 1992, MOL REPROD DEV, V33, P432, DOI 10.1002/mrd.1080330409; Lim KT, 2013, THERIOGENOLOGY, V79, P284, DOI 10.1016/j.theriogenology.2012.08.018; Liu WS, 2009, CYTOGENET GENOME RES, V126, P318, DOI 10.1159/000266168; Loureiro B, 2007, REPRODUCTION, V133, P1129, DOI 10.1530/REP-06-0307; Loureiro B, 2011, REPRODUCTION, V141, P617, DOI 10.1530/REP-10-0511; Loureiro B, 2009, ENDOCRINOLOGY, V150, P5046, DOI 10.1210/en.2009-0481; Lowe R, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1506-4; Maekawa M, 2007, DEVELOPMENT, V134, P2751, DOI 10.1242/dev.003756; Meazza R, 2011, J BIOMED BIOTECHNOL, P1, DOI 10.1155/2011/861920; Morris Samantha A, 2012, Results Probl Cell Differ, V55, P203, DOI 10.1007/978-3-642-30406-4_11; Morton KM, 2007, MOL REPROD DEV, V74, P931, DOI 10.1002/mrd.20573; Nishioka N, 2009, DEV CELL, V16, P398, DOI 10.1016/j.devcel.2009.02.003; Nones J, 2010, CELL BIOL INT, V34, P399, DOI 10.1042/CBI20090036; Oh HA, 2013, MOL HUM REPROD, V19, P93, DOI 10.1093/molehr/gas049; Oliveira CS, 2013, REPRODUCTION, V145, P9, DOI 10.1530/REP-11-0343; Ozawa M, 2012, THERIOGENOLOGY, V78, P1243, DOI 10.1016/j.theriogenology.2012.05.020; Ozawa M, 2011, FERTIL STERIL, V95, P799, DOI 10.1016/j.fertnstert.2010.10.006; Peippo JP, 2002, MOL HUM REPROD, V8, P923, DOI 10.1093/molehr/8.10.923; Perez-Crespo M, 2005, MOL REPROD DEV, V72, P502, DOI 10.1002/mrd.20366; Pestova TV, 2001, P NATL ACAD SCI USA, V98, P7029, DOI 10.1073/pnas.111145798; Rosenfeld CS, 2004, BIOL REPROD, V71, P1063, DOI 10.1095/biolreprod.104.030890; Rosner A, 2007, CURR MED CHEM, V14, P2517, DOI 10.2174/092986707782023677; Sakatani M, 2012, J DAIRY SCI, V95, P3080, DOI 10.3168/jds.2011-4986; Shpargel KB, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002964; Sinclair KD, 2007, P NATL ACAD SCI USA, V104, P19351, DOI 10.1073/pnas.0707258104; Sturmey RG, 2010, MOL REPROD DEV, V77, P285, DOI 10.1002/mrd.21145; TIFFIN GJ, 1991, J REPROD FERTIL, V93, P125; Watkins AJ, 2008, BIOL REPROD, V78, P299, DOI 10.1095/biolreprod.107.064220; Watkins AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028745; Watkins AJ, 2010, BRIT J NUTR, V103, P1762, DOI 10.1017/S0007114509993783; YANG BK, 1993, THERIOGENOLOGY, V40, P521, DOI 10.1016/0093-691X(93)90405-T	68	17	17	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0133587	10.1371/journal.pone.0133587	http://dx.doi.org/10.1371/journal.pone.0133587			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LZ	26196299	gold, Green Published, Green Submitted			2022-12-26	WOS:000358547600116
J	Motsa, SS; Makukula, ZG; Shateyi, S				Motsa, S. S.; Makukula, Z. G.; Shateyi, S.			Numerical Investigation of the Effect of Unsteadiness on Three-Dimensional Flow of an Oldroyb-B Fluid	PLOS ONE			English	Article							HELICAL FLOWS	A spectral relaxation method used with bivariate Lagrange interpolation is used to find numerical solutions for the unsteady three-dimensional flow problem of an Oldroyd-B fluid with variable thermal conductivity and heat generation. The problem is governed by a set of three highly coupled nonlinear partial differential equations. The method, originally used for solutions of systems of ordinary differential equations is extended to solutions of systems of nonlinear partial differential equations. The modified approach involves seeking solutions that are expressed as bivariate Lagrange interpolating polynomials and applying pseudospectral collocation in both independent variables of the governing PDEs. Numerical simulations were carried out to generate results for some of the important flow properties such as the local skin friction and the heat transfer rate. Numerical analysis of the error and convergence properties of the method are also discussed. One of the benefits of the proposed method is that it is computationally fast and gives very accurate results after only a few iterations using very few grid points in the numerical discretization process.	[Motsa, S. S.; Makukula, Z. G.] Univ KwaZulu Natal, ZA-3209 Pietermaritzburg, South Africa; [Shateyi, S.] Univ Venda, Dept Math & Appl Math, ZA-0950 Thohoyandou, South Africa	University of Kwazulu Natal; University of Venda	Motsa, SS (corresponding author), Univ KwaZulu Natal, Private Bag X01, ZA-3209 Pietermaritzburg, South Africa.	sandilemotsa@gmail.com	Shateyi, Stanford/G-3172-2016					Ariel PD, 2003, Z ANGEW MATH MECH, V83, P844, DOI 10.1002/zamm.200310052; CANUTO C, 1988, SPECTRAL METHODS IN; Fetecau C, 2008, APPL MATH COMPUT, V205, P497, DOI 10.1016/j.amc.2008.08.017; Hayat T, 2013, APPL MATH MECH-ENGL, V34, P489, DOI 10.1007/s10483-013-1685-9; Hayat T, 2011, ARAB J SCI ENG, V36, P1113, DOI 10.1007/s13369-011-0066-4; Hayat T, 2004, INT J ENG SCI, V42, P65, DOI 10.1016/S0020-7225(03)00277-5; Hayat T, 2014, J HYDROL HYDROMECH, V62, P117, DOI 10.2478/johh-2014-0016; Khan WA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105107; Liu YQ, 2011, COMPUT MATH APPL, V61, P443, DOI 10.1016/j.camwa.2010.11.021; Motsa SS, 2014, SCI WORLD J; Nadeem S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069811; Pires M., 2011, PARABOLIC PROBLEMS P, V80, P21; Qi HT, 2009, NONLINEAR ANAL-REAL, V10, P2700, DOI 10.1016/j.nonrwa.2008.07.008; Rubbab Q, 2009, J PRIME RES MATH, V5, P139; Sajid M, 2014, J EGYPTIAN IN PRESS; Shehzad SA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078240; Takhar HS, 2001, ACTA MECH, V146, P59, DOI 10.1007/BF01178795; Tong DK, 2009, J NON-NEWTON FLUID, V156, P75, DOI 10.1016/j.jnnfm.2008.07.004; Trefethen L. N., 2000, NUMERICAL LINEAR ALG	19	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0133507	10.1371/journal.pone.0133507	http://dx.doi.org/10.1371/journal.pone.0133507			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LZ	26196291	Green Submitted, Green Published, gold			2022-12-26	WOS:000358547600106
J	Zhang, F; Liu, M; Huang, H				Zhang, Fan; Liu, Ming; Huang, He			Investigation of Timing to Switch Control Mode in Powered Knee Prostheses during Task Transitions	PLOS ONE			English	Article							MECHANICAL WORK; VOLITIONAL CONTROL; RECOGNITION; MOMENTUM; AMPUTEE; DESIGN; FALLS; COST	Current powered prosthetic legs require switching control modes according to the task the user is performing (e.g. level-ground walking, stair climbing, walking on slopes, etc.). To allow prosthesis users safely and seamlessly transition between tasks, it is critical to determine when to switch the prosthesis control mode during task transitions. Our previous study defined critical timings for different types of task transitions in ambulation; however, it is unknown whether it is the unique timing that allows safe and seamless transitions. The goals of this study were to (1) systematically investigate the effects of mode switch timing on the prosthesis user's performance in task transitions, and (2) identify appropriate timing to switch the prosthesis control mode so that the users can seamlessly transition between different locomotion tasks. Five able-bodied (AB) and two transfemoral (TF) amputee subjects were tested as they wore a powered knee prosthesis. The prosthesis control mode was switched manually at various times while the subjects performed different types of task transitions. The subjects' task transition performances were evaluated by their walking balance and success in performing seamless task transitions. The results demonstrated that there existed a time window within which switching the prosthesis control mode neither interrupted the subjects' task transitions nor disturbed their walking balance. Therefore, the results suggested the control mode switching of a lower limb prosthesis can be triggered within an appropriate time window instead of a specific timing or an individual phase. In addition, a generalized criterion to determine the appropriate mode switch timing was proposed. The outcomes of this study could provide important guidance for future designs of neurally controlled powered knee prostheses that are safe and reliable to use.	[Zhang, Fan] N Carolina State Univ, Joint Dept Biomed Engn, Raleigh, NC 27695 USA; Univ N Carolina, Raleigh, NC USA	University of North Carolina; North Carolina State University; University of North Carolina	Zhang, F (corresponding author), N Carolina State Univ, Joint Dept Biomed Engn, Raleigh, NC 27695 USA.	fzhang9@ncsu.edu		Huang, He/0000-0001-5581-1423	National Science Foundation (NSF) [1406750, 1361549]; National Institute on Disability and Rehabilitation Research (NIDRR) [H133G130308]; Direct For Computer & Info Scie & Enginr [1406750] Funding Source: National Science Foundation	National Science Foundation (NSF)(National Science Foundation (NSF)); National Institute on Disability and Rehabilitation Research (NIDRR); Direct For Computer & Info Scie & Enginr(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE))	This work was funded by National Science Foundation (NSF) #1406750, to HH; National Science Foundation (NSF) #1361549, to HH; National Institute on Disability and Rehabilitation Research (NIDRR) # H133G130308, to HH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Au S, 2008, NEURAL NETWORKS, V21, P654, DOI 10.1016/j.neunet.2008.03.006; Detrembleur C, 2003, GAIT POSTURE, V18, P47, DOI 10.1016/S0966-6362(02)00193-5; Donelan JM, 2002, J EXP BIOL, V205, P3717; Du L, 2012, IEEE T BIO-MED ENG, V59, P2716, DOI 10.1109/TBME.2012.2208641; Ha KH, 2011, IEEE T BIO-MED ENG, V58, P144, DOI 10.1109/TBME.2010.2070840; HANAVAN E P Jr, 1964, AMRL TR, P1; Hargrove LJ, 2013, NEW ENGL J MED, V369, P1237, DOI 10.1056/NEJMoa1300126; Hargrove LJ, 2011, JAMA-J AM MED ASSOC, V305, P1542, DOI 10.1001/jama.2011.465; Herr H, 2008, J EXP BIOL, V211, P467, DOI 10.1242/jeb.008573; Huang H, 2011, IEEE T BIO-MED ENG, V58, P2867, DOI 10.1109/TBME.2011.2161671; Huang H, 2009, IEEE T BIO-MED ENG, V56, P65, DOI 10.1109/TBME.2008.2003293; Industry IOBO, 1998, MAN 3C 100 OTT BOCK; iWalk, BIOM ANKL SYST; Kaya BK, 1998, J GERONTOL A-BIOL, V53, pM126, DOI 10.1093/gerona/53A.2.M126; Liu M, 2016, IEEE T NEUR SYS REH, V24, P434, DOI 10.1109/TNSRE.2015.2420539; Liu M, 2014, J INTELL ROBOT SYST, V76, P461, DOI 10.1007/s10846-013-9979-3; Seroussi RE, 1996, ARCH PHYS MED REHAB, V77, P1209, DOI 10.1016/S0003-9993(96)90151-3; SHELDON JH, 1960, BRIT MED J, V2, P1685, DOI 10.1136/bmj.2.5214.1685; Sup F., 2009, THESIS VANDERBILT U; Sup F, 2008, INT J ROBOT RES, V27, P263, DOI 10.1177/0278364907084588; Varol HA, 2010, IEEE T BIO-MED ENG, V57, P542, DOI 10.1109/TBME.2009.2034734; WILD D, 1981, RHEUMATOL REHABIL, V20, P153, DOI 10.1093/rheumatology/20.3.153; Zhang F, 2014, JOVE-J VIS EXP, DOI 10.3791/51059; Zhang F, 2015, IEEE T NEUR SYS REH, V23, P64, DOI 10.1109/TNSRE.2014.2327230; Zhang F, 2013, IEEE J BIOMED HEALTH, V17, P907, DOI 10.1109/JBHI.2012.2236563	25	13	13	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0133965	10.1371/journal.pone.0133965	http://dx.doi.org/10.1371/journal.pone.0133965			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LZ	26197084	Green Submitted, Green Published, gold			2022-12-26	WOS:000358547600151
J	Wang, JL; Wang, GD; Khan, MF				Wang, Jianling; Wang, Gangduo; Khan, M. Firoze			Disorder of G2-M Checkpoint Control in Aniline-Induced Cell Proliferation in Rat Spleen	PLOS ONE			English	Article							OXIDATIVE STRESS; DNA-DAMAGE; CANCER; ACTIVATION; SPLENOTOXICITY; HYDROCHLORIDE; INDUCTION; MICRORNAS; TOXICITY; SARCOMAS	Aniline, a toxic aromatic amine, is known to cause hemopoietic toxicity both in humans and animals. Aniline exposure also leads to toxic response in spleen which is characterized by splenomegaly, hyperplasia, fibrosis and the eventual formation of tumors on chronic in vivo exposure. Previously, we have shown that aniline exposure leads to iron overload, oxidative DNA damage, and increased cell proliferation, which could eventually contribute to a tumorigenic response in the spleen. Despite our demonstration that cell proliferation was associated with deregulation of G1 phase cyclins and increased expression of G1 phase cyclin-dependent kinases (CDKs), molecular mechanisms, especially the regulation of G2 phase and contribution of epigenetic mechanisms in aniline-induced splenic cellular proliferation remain largely unclear. This study therefore, mainly focused on the regulation of G2 phase in an animal model preceding a tumorigenic response. Male Sprague-Dawley rats were given aniline ( 0.5 mmol/kg/day) in drinking water or drinking water only ( controls) for 30 days, and expression of G2 phase cyclins, CDK1, CDK inhibitors and miRNAs were measured in the spleen. Aniline treatment resulted in significant increases in cell cycle regulatory proteins, including cyclins A, B and CDK1, particularly phosphor-CDK1, and decreases in CDK inhibitors p21 and p27, which could promote the splenocytes to go through G2/M transition. Our data also showed upregulation of tumor markers Trx-1 and Ref-1 in rats treated with aniline. More importantly, we observed lower expression of miRNAs including Let-7a, miR-15b, miR24, miR-100 and miR-125, and greater expression of CDK inhibitor regulatory miRNAs such as miR-181a, miR-221 and miR-222 in the spleens of aniline-treated animals. Our findings suggest that significant increases in the expression of cyclins, CDK1 and aberrant regulation of miRNAs could lead to an accelerated G2/M transition of the splenocytes, and potentially to a tumorigenic response on chronic aniline exposure.	[Wang, Jianling; Wang, Gangduo; Khan, M. Firoze] Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA	University of Texas System; University of Texas Medical Branch Galveston	Khan, MF (corresponding author), Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA.	mfkhan@utmb.edu			National Institute of Environmental Health Sciences (NIEHS), NIH [ES06476]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R29ES006476, R01ES006476] Funding Source: NIH RePORTER	National Institute of Environmental Health Sciences (NIEHS), NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by Grant ES06476 from the National Institute of Environmental Health Sciences (NIEHS), NIH. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abukhdeir Abde M., 2008, Expert Reviews in Molecular Medicine, V10, P1, DOI 10.1017/S1462399408000744; Bapat A, 2009, ANTIOXID REDOX SIGN, V11, P651, DOI [10.1089/ars.2008.2218, 10.1089/ARS.2008.2218]; BUS JS, 1987, FOOD CHEM TOXICOL, V25, P619, DOI 10.1016/0278-6915(87)90024-X; Chiu J, 2012, TRENDS CELL BIOL, V22, P592, DOI 10.1016/j.tcb.2012.08.002; Chulu Julius L C, 2009, Recent Pat Biotechnol, V3, P1; Di Girolamo F, 2009, ECOTOX ENVIRON SAFE, V72, P1601, DOI 10.1016/j.ecoenv.2008.09.006; Di Leva G, 2014, ANNU REV PATHOL-MECH, V9, P287, DOI 10.1146/annurev-pathol-012513-104715; Emmendoerffer A, 2000, TOXICOL LETT, V112, P185, DOI 10.1016/S0378-4274(99)00285-4; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; GOODMAN DG, 1984, JNCI-J NATL CANCER I, V73, P265; Henkler Frank, 2010, Cancers (Basel), V2, P376, DOI 10.3390/cancers2020376; Hillman GG, 2011, FREE RADICAL BIO MED, V51, P289, DOI 10.1016/j.freeradbiomed.2011.04.039; Iliakis G, 2003, ONCOGENE, V22, P5834, DOI 10.1038/sj.onc.1206682; Jansson MD, 2012, MOL ONCOL, V6, P590, DOI 10.1016/j.molonc.2012.09.006; Bueno MJ, 2011, BBA-MOL BASIS DIS, V1812, P592, DOI 10.1016/j.bbadis.2011.02.002; Kakehashi Anna, 2013, Cancers (Basel), V5, P1332, DOI 10.3390/cancers5041332; Khan MF, 2006, TOXICOL APPL PHARM, V210, P86, DOI 10.1016/j.taap.2005.08.006; Khan MF, 1999, TOXICOL SCI, V48, P134, DOI 10.1093/toxsci/48.1.134; Khan MF, 2003, J TOXICOL ENV HEAL A, V66, P93, DOI 10.1080/15287390390155778; Khan MF, 1999, J TOXICOL ENV HEAL A, V57, P173, DOI 10.1080/009841099157746; KHAN MF, 1993, ARCH ENVIRON CON TOX, V24, P368, DOI 10.1007/BF01128736; Khan MF, 1997, FUND APPL TOXICOL, V35, P22, DOI 10.1006/faat.1996.2259; Klaunig JE, 2004, ANNU REV PHARMACOL, V44, P239, DOI 10.1146/annurev.pharmtox.44.101802.121851; Lobrich M, 2007, NAT REV CANCER, V7, P861, DOI 10.1038/nrc2248; Ma HX, 2013, TOXICOL APPL PHARM, V267, P276, DOI 10.1016/j.taap.2013.01.005; Ma HX, 2011, TOXICOL APPL PHARM, V251, P1, DOI 10.1016/j.taap.2010.12.001; Ma HX, 2008, TOXICOL APPL PHARM, V233, P247, DOI 10.1016/j.taap.2008.08.010; Malumbres M, 2009, NAT REV CANCER, V9, P153, DOI 10.1038/nrc2602; Poirier MC, 2012, DISCOV MED, V14, P283; Powis G, 2007, CURR OPIN PHARMACOL, V7, P392, DOI 10.1016/j.coph.2007.04.003; Saeidnia S, 2013, TOXICOL APPL PHARM, V273, P442, DOI 10.1016/j.taap.2013.09.031; Sankpal UT, 2012, TUMOR BIOL, V33, P1265, DOI 10.1007/s13277-012-0413-4; Stark GR, 2006, MOL BIOTECHNOL, V32, P227, DOI 10.1385/MB:32:3:227; Takizawa CG, 2000, CURR OPIN CELL BIOL, V12, P658, DOI 10.1016/S0955-0674(00)00149-6; Wang JL, 2008, TOXICOL APPL PHARM, V230, P227, DOI 10.1016/j.taap.2008.02.022; Wang JL, 2011, TOXICOL APPL PHARM, V250, P213, DOI 10.1016/j.taap.2010.10.026; Wang JL, 2010, FREE RADICAL BIO MED, V48, P513, DOI 10.1016/j.freeradbiomed.2009.11.027; Wang JL, 2005, TOXICOL APPL PHARM, V203, P36, DOI 10.1016/j.taap.2004.07.012; WEINBERGER MA, 1985, JNCI-J NATL CANCER I, V75, P681; Williams GM, 2002, TOXICOL PATHOL, V30, P41, DOI 10.1080/01926230252824699; Wolgemuth DJ, 2013, INT J DEV BIOL, V57, P159, DOI 10.1387/ijdb.130047av	41	5	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2015	10	7							e0131457	10.1371/journal.pone.0131457	http://dx.doi.org/10.1371/journal.pone.0131457			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LN	26192324	Green Submitted, gold, Green Published			2022-12-26	WOS:000358546400012
J	Andersson, DP; Ekstrom, U; Lehtihet, M				Andersson, Daniel Peter; Ekstrom, Urban; Lehtihet, Mikael			Rigiscan Evaluation of Men with Diabetes Mellitus and Erectile Dysfunction and Correlation with Diabetes Duration, Age, BMI, Lipids and HbA1c	PLOS ONE			English	Article							COMPLICATIONS; PREVALENCE; SYMPTOMS	Objective This study aimed to investigate differences between patients with type 1 and type 2 diabetes mellitus with erectile dysfunction (ED) evaluated with Rigiscan and if there were a correlation to age, duration of diabetes, BMI, sex hormones, lipids and HbA1c. Research design and methods: A retrospective study on patients with type 1 diabetes (n=15), type 2 diabetes (n=17) and a control group (n=31) that underwent Rigiscan examination for ED. Age, BMI, blood pressure, sex hormones, lipids and HbA1c were recorded and analyzed between groups. Results Diabetes duration and HbA1C did not correlate with Rigiscan outcome. Rigiscan measures did not differ between patients with type 1 diabetes and control subjects besides from fewer erectile episodes (p<0.01) and lower tumescence activity units in base (p<0.05). By contrast, patients with type 2 diabetes differed significantly with respect to RigiScan parameters both in comparison with the type 1 diabetic patients and the control group. BMI had a strong correlation to number of erectile episodes, duration of erection, duration of erection >60 % and rigidity activated unit (RAU) in tip and base. Age and HDL-cholesterol had a significant correlation with number of erectile episodes during night (p<0.05). Conclusion Our results indicate that erectile dysfunction in men with diabetes differ between type 1 and type 2 diabetes patients. Neither diabetes duration nor HbA1C correlated to grade of erectile dysfunction among patients with diabetes. Increased BMI might be an explanation to the increased rate of erectile dysfunction seen in patients with type 2 diabetes.	[Andersson, Daniel Peter; Lehtihet, Mikael] Karolinska Univ Hosp, Dept Med, Huddinge, Sweden; [Andersson, Daniel Peter; Ekstrom, Urban; Lehtihet, Mikael] Karolinska Inst, Huddinge, Sweden; [Ekstrom, Urban; Lehtihet, Mikael] Karolinska Univ Hosp, Dept Med, Huddinge, Sweden; [Ekstrom, Urban; Lehtihet, Mikael] Karolinska Univ Hosp, Ctr Androl & Sexual Med, Huddinge, Sweden	Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital	Andersson, DP (corresponding author), Karolinska Univ Hosp, Dept Med, Huddinge, Sweden.	daniel.p.andersson@ki.se	Andersson, Daniel/AAY-6362-2021; Andersson, Daniel Peter/AAN-8648-2020	Andersson, Daniel Peter/0000-0003-4655-4837	Stockholm County Council	Stockholm County Council(Stockholm County Council)	DPA was supported by the Stockholm County Council (combined clinical residency and PhD training program). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bancroft J, 1996, DIABETIC MED, V13, P84, DOI 10.1002/(SICI)1096-9136(199601)13:1<84::AID-DIA16>3.3.CO;2-1; Dale AC, 2008, BRIT MED J, V337, DOI 10.1136/bmj.39582.447998.BE; Elhanbly S, 2004, J ANDROL, V25, P991; Gokkaya SC, 2008, SCAND J UROL NEPHROL, V42, P437, DOI 10.1080/00365590801950279; Jacobson AM, 2013, DIABETES CARE, V36, P3131, DOI 10.2337/dc12-2109; Jannini EA, 2009, J SEX MED, V6, P1820, DOI 10.1111/j.1743-6109.2009.01343.x; Jerums G, 2015, J HUM HYPERTENS, V29, P473, DOI 10.1038/jhh.2014.117; Knopfholz J, 2014, CHOLESTEROL, DOI 10.1155/2014/261878; MCCULLOCH DK, 1980, DIABETOLOGIA, V18, P279; Orchard TJ, 2015, JAMA-J AM MED ASSOC, V313, P45, DOI 10.1001/jama.2014.16107; Rowland DL, 2012, J SEX MARITAL THER, V38, P115, DOI 10.1080/0092623X.2011.569640; SCHIAVI RC, 1993, DIABETOLOGIA, V36, P745, DOI 10.1007/BF00401146; Schouten BWV, 2010, J SEX MED, V7, P2547, DOI 10.1111/j.1743-6109.2010.01849.x; Shabsigh R, 1998, UROLOGY, V52, P848, DOI 10.1016/S0090-4295(98)00292-1; Sohn M H, 1993, Int J Impot Res, V5, P59; Van Den Eeden SK, 2009, DIABETES CARE, V32, P664, DOI 10.2337/dc07-2375; Zimmern P, 1999, PROG UROL, V9, P37	17	15	19	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0133121	10.1371/journal.pone.0133121	http://dx.doi.org/10.1371/journal.pone.0133121			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RV	26186716	Green Submitted, Green Published, gold			2022-12-26	WOS:000358198700096
J	Bizzarro, T; Martini, M; Marrocco, C; D'Amato, D; Traini, E; Lombardi, CP; Pontecorvi, A; Fadda, G; Larocca, LM; Rossi, ED				Bizzarro, Tommaso; Martini, Maurizio; Marrocco, Carla; D'Amato, Donato; Traini, Emanuela; Lombardi, Celestino Pio; Pontecorvi, Alfredo; Fadda, Guido; Larocca, Luigi Maria; Rossi, Esther Diana			The Role of CD56 in Thyroid Fine Needle Aspiration Cytology: A Pilot Study Performed on Liquid Based Cytology	PLOS ONE			English	Article							FOLLICULAR-PATTERNED LESIONS; UNDETERMINED SIGNIFICANCE; HISTOLOGICAL CONTROL; DOWN-REGULATION; CYTOKERATIN 19; CARCINOMA; EXPRESSION; DIAGNOSIS; NODULES; BIOPSIES	Background Fine needle aspiration Cytology (FNAC) fulfills a reliable role in the evaluation of thyroid lesions. Although the majority of nodules are quite easily diagnosed as benign or malignant, 30% of them represent an indeterminate category whereby the application of ancillary techniques (i.e. immunocytochemistry-ICC and molecular testing) has been encouraged. The search for a specific immunomarker of malignancy sheds light on a huge number of ICC stains although none of them attempt to yield 100% conclusive results. Our aim was to define in a pilot study on thyroid FNAC whether CD56 might be a valid marker also in comparison with HBME-1 and Galectin-3. Materials and Methods Inasmuch as this is the largest pilot study using only liquid based cytology (LBC), we selected all the cases only in the categories of benign nodules (BN) and positive for malignancy (PM) for validation purposes. Eighty-five consecutive (including 50 PM and 35 BN) out of 950 thyroid FNACs had surgical follow-up. The ICC panel (HBME-1, Galectin-3 and CD56) was carried out on LBC and histology. Results All BNs and PMs were histological confirmed. CD56 was negative in 96% of the PM while 68.5% of the BNs showed cytoplasmic positivity for this marker, with an overall high sensitivity (96%) but lower specificity (69%). In specific, our 96% of the PMs did not show any follicular cell with CD56 expression. Different ICC combinations were evaluated showing that the panel made up of CD56 plus HBME-1 and Galectin-3 had the highest sensitivity (98%) and specificity (86%). Conclusions Our pilot study suggests that CD56 may be a good marker for ruling out PTC and its variants. The low specificity suggests that an immunopanel including also HBME-1 and Galectin- 3 could obtain the highest diagnostic accuracy in thyroid lesions. Our results suggest that CD56 may be a feasible additional marker for identifying malignancies also in the FNs and SMs.	[Bizzarro, Tommaso; Martini, Maurizio; Marrocco, Carla; D'Amato, Donato; Fadda, Guido; Larocca, Luigi Maria; Rossi, Esther Diana] Univ Cattolica Sacro Cuore, Agostino Gemelli Sch Med, Div Anat Pathol & Histol, Rome, Italy; [Traini, Emanuela; Lombardi, Celestino Pio] Univ Cattolica Sacro Cuore, Agostino Gemelli Sch Med, Div Endocrine Surg, Rome, Italy; [Pontecorvi, Alfredo] Univ Cattolica Sacro Cuore, Agostino Gemelli Sch Med, Div Endocrinol, Rome, Italy	Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli	Rossi, ED (corresponding author), Univ Cattolica Sacro Cuore, Agostino Gemelli Sch Med, Div Anat Pathol & Histol, Rome, Italy.	esther.rossi@rm.unicatt.it	FADDA, Guido/AAR-3196-2021; Larocca, Luigi Maria/M-9590-2019; Martini, Maurizio/AAB-1564-2019; Rossi, esther/R-8601-2017; Fadda, Guido/AAY-5511-2020; Larocca, Luigi M/A-1577-2008; fadda, guido/AAQ-5754-2021	Larocca, Luigi Maria/0000-0003-1739-4758; Martini, Maurizio/0000-0002-6260-6310; Larocca, Luigi M/0000-0003-1739-4758; fadda, guido/0000-0001-9736-0544; Traini, Emanuela/0000-0002-6387-6558; Rossi, Esther/0000-0003-3819-4229				Abd El Atti RM, 2012, J EGYPT NATL CANCER, V24, P175, DOI 10.1016/j.jnci.2012.10.002; Alexander EK, 2012, NEW ENGL J MED, V367, P705, DOI 10.1056/NEJMoa1203208; American Joint Commission on Cancer (AJCC), 2013, AM JOINT COMM CANC A; Baloch ZW, 2002, AM J CLIN PATHOL, V117, P143; Baloch ZW, 2002, DIAGN CYTOPATHOL, V26, P41, DOI 10.1002/dc.10043; Bartolazzi A, 2008, LANCET ONCOL, V9, P543, DOI 10.1016/S1470-2045(08)70132-3; British Thyroid Association Guidelines for the Management of Thyroid Cancer, 2007, FIN NEEDL ASP, P10; Cibas ES, 2001, AM J CLIN PATHOL, V32, P658; Cochand-Priollet B, 2003, CYTOPATHOLOGY, V14, P343, DOI 10.1046/j.0956-5507.2003.00098.x; Cochand-Priollet B, 2011, THYROID, V21, P1067, DOI 10.1089/thy.2011.0014; Cooper DS, 2009, THYROID, V19, P1167, DOI 10.1089/thy.2009.0110; Rodrigues HGC, 2012, ENDOCR J, V59, P417; D Rossi E, 2006, HISTOPATHOLOGY, V48, P795, DOI 10.1111/j.1365-2559.2006.02428.x; Dabbs DJ, 1997, DIAGN CYTOPATHOL, V17, P388, DOI 10.1002/(SICI)1097-0339(199711)17:5<388::AID-DC14>3.0.CO;2-J; El Demellawy D, 2009, PATHOL RES PRACT, V205, P303, DOI 10.1016/j.prp.2008.11.011; Fada G, 2010, PATHOLOGICA, V102, P405; Fadda G, 2011, ACTA CYTOL, V55, P389, DOI 10.1159/000329029; Fadda G, 2011, EUR J ENDOCRINOL, V165, P447, DOI 10.1530/EJE-11-0181; Faquin WC, 2010, DIAGN CYTOPATHOL, V38, P731, DOI 10.1002/dc.21292; Herrmann ME, 2002, ARCH PATHOL LAB MED, V126, P710; Kim JH, 2012, HUM PATHOL, V43, P1221, DOI 10.1016/j.humpath.2011.09.008; Lobo C, 2011, ACTA CYTOL, V55, P499, DOI 10.1159/000333234; Mokhtari M, 2013, J RES MED SCI, V18, P1046; Nardi F, 2014, J ENDOCRINOL INVEST, V37, DOI 10.1007/s40618-014-0062-0; Nasr MR, 2006, MODERN PATHOL, V19, P1631, DOI 10.1038/modpathol.3800705; Nechifor-Boila A, 2013, PATHOL RES PRACT, V209, P585, DOI 10.1016/j.prp.2013.06.012; Nikiforov YE, 2009, J CLIN ENDOCR METAB, V94, P2092, DOI 10.1210/jc.2009-0247; Ohori NP, 2010, CANCER CYTOPATHOL, V118, P17, DOI 10.1002/cncy.20063; Ozolins A, 2012, MEDICINA-LITHUANIA, V48, P507; Park WY, 2009, BASIC APPL PATHOLOGY, V2, P63; Pazaitou-Panayiotou K, 2010, J ONCOL, V2010, DOI 10.1155/2010/963926; Poller DN, 2000, CANCER CYTOPATHOL, V90, P239, DOI 10.1002/1097-0142(20000825)90:4<239::AID-CNCR7>3.0.CO;2-S; Pusztaszeri MP, 2014, CANCER CYTOPATHOL, V122, P666, DOI 10.1002/cncy.21441; Pusztaszeri MP, 2014, CANCER CYTOPATHOL, V122, P596, DOI 10.1002/cncy.21437; Ravetto C, 2000, CANCER CYTOPATHOL, V90, P357, DOI 10.1002/1097-0142(20001225)90:6<357::AID-CNCR6>3.0.CO;2-4; Rossi ED, 2005, CANCER CYTOPATHOL, V105, P87, DOI 10.1002/cncr.21026; Rossi ED, 2013, EUR J ENDOCRINOL, V168, P853, DOI 10.1530/EJE-13-0023; Scarpino S, 2007, J PATHOL, V212, P411, DOI 10.1002/path.2183; Schmitt AC, 2010, CANCER CYTOPATHOL, V118, P196, DOI 10.1002/cncy.20082; Walts AE, 2014, DIAGN CYTOPATHOL, V42, P18, DOI 10.1002/dc.23019; ZEROMSKI J, 1992, CLIN EXP IMMUNOL, V89, P474	41	12	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0132939	10.1371/journal.pone.0132939	http://dx.doi.org/10.1371/journal.pone.0132939			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RV	26186733	Green Published, gold, Green Submitted			2022-12-26	WOS:000358198700072
J	Cunha, CW; Taylor, KE; Pritchard, SM; Delboy, MG; Sari, TK; Aguilar, HC; Mossman, KL; Nicola, AV				Cunha, Cristina W.; Taylor, Kathryne E.; Pritchard, Suzanne M.; Delboy, Mark G.; Sari, Tri Komala; Aguilar, Hector C.; Mossman, Karen L.; Nicola, Anthony V.			Widely Used Herpes Simplex Virus 1 ICP0 Deletion Mutant Strain dl1403 and Its Derivative Viruses Do Not Express Glycoprotein C Due to a Secondary Mutation in the gC Gene	PLOS ONE			English	Article							REGULATORY PROTEIN ICP0; IMMEDIATE EARLY GENE-1; HEPARAN-SULFATE; INFECTED-CELLS; IN-VIVO; COMPLEMENT COMPONENT; CLINICAL ISOLATE; GENOME SEQUENCE; TYPE-1 VIRIONS; TEGUMENT ICP0	Herpes simplex virus 1 (HSV-1) ICP0 is a multi-functional phosphoprotein expressed with immediate early kinetics. An ICP0 deletion mutant, HSV-1 dl1403, has been widely used to study the roles of ICP0 in the HSV-1 replication cycle including gene expression, latency, entry and assembly. We show that HSV-1 dl1403 virions lack detectable levels of envelope protein gC, and that gC is not synthesized in infected cells. Sequencing of the gC gene from HSV-1 dl1403 revealed a single amino acid deletion that results in a frameshift mutation. The HSV-1 dl1403 gC gene is predicted to encode a polypeptide consisting of the original 62 N-terminal amino acids of the gC protein followed by 112 irrelevant, non-gC residues. The mutation was also present in a rescuant virus and in two dl1403-derived viruses, D8 and FXE, but absent from the parental 17+, suggesting that the mutation was introduced during the construction of the dl1403 virus, and not as a result of passage in culture.	[Cunha, Cristina W.; Pritchard, Suzanne M.; Sari, Tri Komala; Aguilar, Hector C.; Nicola, Anthony V.] Washington State Univ, Coll Vet Med, Dept Vet Microbiol & Pathol, Pullman, WA 99164 USA; [Taylor, Kathryne E.; Mossman, Karen L.] McMaster Univ, McMaster Immunol Res Ctr, Inst Infect Dis Res, Dept Pathol & Mol Med, Hamilton, ON, Canada; [Delboy, Mark G.] Virginia Commonwealth Univ, Sch Med, Dept Microbiol & Immunol, Richmond, VA USA; [Aguilar, Hector C.; Nicola, Anthony V.] Washington State Univ, Paul G Allen Sch Global Anim Hlth, Pullman, WA 99164 USA	Washington State University; McMaster University; Virginia Commonwealth University; Washington State University	Mossman, KL (corresponding author), McMaster Univ, McMaster Immunol Res Ctr, Inst Infect Dis Res, Dept Pathol & Mol Med, Hamilton, ON, Canada.	mossk@mcmaster.ca; nicola@vetmed.wsu.edu	Cunha, Cristina/AAC-6120-2021; Aguilar, Hector/AAD-6663-2022; Taylor, Kathryne/AAD-4025-2019; Cunha, Cristina/V-7622-2019	Cunha, Cristina/0000-0002-8168-5448; Komala Sari, Tri/0000-0002-7801-474X	National Institutes of Health [AI113619]; Marvel Shields Autzen Foundation; Canadian Institutes for Health Research [MOP-57669]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R03AI113619, R01AI109022] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008336] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Marvel Shields Autzen Foundation; Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health AI113619 to AVN and a grant from the Marvel Shields Autzen Foundation to AVN. This work was also supported by Canadian Institutes for Health Research MOP-57669 to KLM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrow E, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-177; BROWN SM, 1973, J GEN VIROL, V18, P329, DOI 10.1099/0022-1317-18-3-329; CAI WH, 1993, J VIROL, V67, P7501, DOI 10.1128/JVI.67.12.7501-7512.1993; CAI WZ, 1992, J VIROL, V66, P2904, DOI 10.1128/JVI.66.5.2904-2915.1992; CAI WZ, 1991, J VIROL, V65, P4078, DOI 10.1128/JVI.65.8.4078-4090.1991; CLEMENTS GB, 1989, J GEN VIROL, V70, P2501, DOI 10.1099/0022-1317-70-9-2501; Delboy MG, 2008, J VIROL, V82, P3381, DOI 10.1128/JVI.02296-07; Delboy MG, 2011, J VIROL, V85, P5910, DOI 10.1128/JVI.00267-11; Delboy MG, 2010, J VIROL, V84, P1637, DOI 10.1128/JVI.02041-09; DELUCA N, 1982, VIROLOGY, V122, P411, DOI 10.1016/0042-6822(82)90240-9; Dollery SJ, 2011, J VIROL, V85, P9964, DOI 10.1128/JVI.05291-11; Dollery SJ, 2010, J VIROL, V84, P3759, DOI 10.1128/JVI.02573-09; Drolet BS, 2004, CURR EYE RES, V29, P181, DOI 10.1080/02713680490504542; EISENBERG RJ, 1987, MICROB PATHOGENESIS, V3, P423, DOI 10.1016/0882-4010(87)90012-X; EISENBERG RJ, 1985, J VIROL, V53, P634, DOI 10.1128/JVI.53.2.634-644.1985; Everett RD, 2004, J VIROL, V78, P9599, DOI 10.1128/JVI.78.18.9599-9604.2004; EVERETT RD, 1989, J GEN VIROL, V70, P1185, DOI 10.1099/0022-1317-70-5-1185; Everett RD, 2000, BIOESSAYS, V22, P761, DOI 10.1002/1521-1878(200008)22:8<761::AID-BIES10>3.0.CO;2-A; FENG Y, 1992, J VIROL, V66, P2709, DOI 10.1128/JVI.66.5.2709-2716.1992; Friedman Harvey M, 2003, Trans Am Clin Climatol Assoc, V114, P103; FRIEDMAN HM, 1984, NATURE, V309, P633, DOI 10.1038/309633a0; Grant K, 2012, J VIROL, V86, P4029, DOI 10.1128/JVI.06962-11; Gu HD, 2009, J VIROL, V83, P181, DOI 10.1128/JVI.01940-08; Gu HD, 2005, P NATL ACAD SCI USA, V102, P7571, DOI 10.1073/pnas.0502658102; Hagglund R, 2004, J VIROL, V78, P2169, DOI 10.1128/JVI.78.5.2169-2178.2004; Halford WP, 2001, J VIROL, V75, P3240, DOI 10.1128/JVI.75.7.3240-3249.2001; HARRIS RA, 1989, J VIROL, V63, P3513, DOI 10.1128/JVI.63.8.3513-3515.1989; Haugo AC, 2011, J VIROL, V85, P7203, DOI 10.1128/JVI.00262-11; HEINE JW, 1974, J VIROL, V14, P640, DOI 10.1128/JVI.14.3.640-651.1974; HEROLD BC, 1994, J GEN VIROL, V75, P1211, DOI 10.1099/0022-1317-75-6-1211; Herold BC, 1996, J VIROL, V70, P3461, DOI 10.1128/JVI.70.6.3461-3469.1996; HEROLD BC, 1991, J VIROL, V65, P1090, DOI 10.1128/JVI.65.3.1090-1098.1991; Kawaguchi Y, 1997, J VIROL, V71, P1019, DOI 10.1128/JVI.71.2.1019-1024.1997; Kawaguchi Y, 1997, J VIROL, V71, P7328, DOI 10.1128/JVI.71.10.7328-7336.1997; Kawaguchi Y, 2001, P NATL ACAD SCI USA, V98, P1877, DOI 10.1073/pnas.041592598; Kyratsous CA, 2009, J VIROL, V83, P10637, DOI 10.1128/JVI.01144-09; LEIB DA, 1989, J VIROL, V63, P759, DOI 10.1128/JVI.63.2.759-768.1989; Liang Y, 2006, J VIROL, V80, P3349, DOI 10.1128/JVI.80.7.3349-3359.2006; Liang Y, 2005, P NATL ACAD SCI USA, V102, P5838, DOI 10.1073/pnas.0501253102; Lilley CE, 2010, EMBO J, V29, P943, DOI 10.1038/emboj.2009.400; Liu MY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010975; LIU Y, 1993, ARCH VIROL, V129, P105, DOI 10.1007/BF01316888; Lomonte P, 2004, J VIROL, V78, P6744, DOI 10.1128/JVI.78.13.6744-6757.2004; Loret S, 2008, J VIROL, V82, P8605, DOI 10.1128/JVI.00904-08; Loret S, 2012, J GEN VIROL, V93, P624, DOI 10.1099/vir.0.039776-0; Lubinski JM, 2002, J VIROL, V76, P9232, DOI 10.1128/JVI.76.18.9232-9241.2002; Lubinski JM, 1998, J VIROL, V72, P8257, DOI 10.1128/JVI.72.10.8257-8263.1998; Macdonald SJ, 2012, J VIROL, V86, P9540, DOI 10.1128/JVI.01469-12; Macdonald SJ, 2012, J VIROL, V86, P6371, DOI 10.1128/JVI.00646-12; Maringer K, 2010, J VIROL, V84, P4682, DOI 10.1128/JVI.00126-10; Minagawa H, 1997, MICROBIOL IMMUNOL, V41, P545, DOI 10.1111/j.1348-0421.1997.tb01890.x; Morency E, 2007, J CELL BIOL, V177, P757, DOI 10.1083/jcb.200612107; Mossman KL, 2000, J VIROL, V74, P2052, DOI 10.1128/JVI.74.4.2052-2056.2000; Nagel CH, 2011, J VIROL, V85, P7644, DOI 10.1128/JVI.02207-10; Negatsch A, 2011, J GEN VIROL, V92, P167, DOI 10.1099/vir.0.026484-0; Nicola AV, 2004, J VIROL, V78, P7508, DOI 10.1128/JVI.78.14.7508-7517.2004; Paladino P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010428; Pritchard SM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070889; Radtke K, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000991; Reston CAP, 2007, J VIROL, V81, P11781, DOI 10.1128/JVI.01234-07; Roller DG, 2008, VIROLOGY, V382, P207, DOI 10.1016/j.virol.2008.09.015; RUSSELL J, 1987, J GEN VIROL, V68, P3009, DOI 10.1099/0022-1317-68-12-3009; RUYECHAN WT, 1979, J VIROL, V29, P677, DOI 10.1128/JVI.29.2.677-697.1979; SACKS WR, 1987, J VIROL, V61, P829, DOI 10.1128/JVI.61.3.829-839.1987; SAKAI Y, 1994, OPHTHALMOLOGICA, V208, P157, DOI 10.1159/000310474; SHIEH MT, 1992, J CELL BIOL, V116, P1273, DOI 10.1083/jcb.116.5.1273; Shukla D, 2001, J CLIN INVEST, V108, P503, DOI 10.1172/JCI13799; STOW ND, 1986, J GEN VIROL, V67, P2571, DOI 10.1099/0022-1317-67-12-2571; SUNSTRUM JC, 1988, VIRUS RES, V11, P17, DOI 10.1016/0168-1702(88)90064-0; Szpara ML, 2014, GENOME ANNOUNCEMENTS, V2; Taylor KE, 2014, J VIROL, V88, P8091, DOI 10.1128/JVI.00944-14; Thompson RL, 2006, J VIROL, V80, P10919, DOI 10.1128/JVI.01253-06; Van Sant C, 1999, P NATL ACAD SCI USA, V96, P8184, DOI 10.1073/pnas.96.14.8184; Warner MS, 1998, VIROLOGY, V246, P179, DOI 10.1006/viro.1998.9218; WUDUNN D, 1989, J VIROL, V63, P52, DOI 10.1128/JVI.63.1.52-58.1989; Yu XA, 2010, BIOCHIMIE, V92, P1024, DOI 10.1016/j.biochi.2010.04.025; ZEZULAK KM, 1984, J VIROL, V49, P741, DOI 10.1128/JVI.49.3.741-747.1984	77	5	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0131129	10.1371/journal.pone.0131129	http://dx.doi.org/10.1371/journal.pone.0131129			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RV	26186447	Green Published, Green Submitted, gold			2022-12-26	WOS:000358198700012
J	Hanschen, FS; Yim, B; Winkelmann, T; Smalla, K; Schreiner, M				Hanschen, Franziska S.; Yim, Bunlong; Winkelmann, Traud; Smalla, Kornelia; Schreiner, Monika			Degradation of Biofumigant Isothiocyanates and Allyl Glucosinolate in Soil and Their Effects on the Microbial Community Composition	PLOS ONE			English	Article							ENHANCED BIODEGRADATION; BENZYL ISOTHIOCYANATE; RHIZOSPHERE; PRODUCTS; DECOMPOSITION; NITRILES; SINIGRIN; KINETICS; SPROUTS; RADISH	Brassicales species rich in glucosinolates are used for biofumigation, a process based on releasing enzymatically toxic isothiocyanates into the soil. These hydrolysis products are volatile and often reactive compounds. Moreover, glucosinolates can be degraded also without the presence of the hydrolytic enzyme myrosinase which might contribute to bioactive effects. Thus, in the present study the stability of Brassicaceae plant-derived and pure glucosinolates hydrolysis products was studied using three different soils ( model biofumigation). In addition, the degradation of pure 2-propenyl glucosinolate was investigated with special regard to the formation of volatile breakdown products. Finally, the influence of pure glucosinolate degradation on the bacterial community composition was evaluated using denaturing gradient gel electrophoresis of 16S rRNA gene amplified from total community DNA. The model biofumigation study revealed that the structure of the hydrolysis products had a significant impact on their stability in the soil but not the soil type. Following the degradation of pure 2-propenyl glucosinolate in the soils, the nitrile as well as the isothiocyanate can be the main degradation products, depending on the soil type. Furthermore, the degradation was shown to be both chemically as well as biologically mediated as autoclaving reduced degradation. The nitrile was the major product of the chemical degradation and its formation increased with iron content of the soil. Additionally, the bacterial community composition was significantly affected by adding pure 2-propenyl glucosinolate, the effect being more pronounced than in treatments with myrosinase added to the glucosinolate. Therefore, glucosinolates can have a greater effect on soil bacterial community composition than their hydrolysis products.	[Hanschen, Franziska S.; Schreiner, Monika] Leibniz Inst Vegetable & Ornamental Crops Grossbe, Dept Qual, D-14979 Grossbeeren, Germany; [Yim, Bunlong; Winkelmann, Traud] Leibniz Univ Hannover, Inst Hort Prod Syst, Sect Woody Plant & Propagat Physiol, D-30419 Hannover, Germany; [Yim, Bunlong; Smalla, Kornelia] Fed Res Ctr Cultivated Plants JKI, Inst Epidemiol & Pathogen Diagnost, Julius Kuhn Inst, D-38104 Braunschweig, Germany	Leibniz Institut fur Gemuse- und Zierpflanzenbau (IGZ); Leibniz University Hannover; Julius Kuhn-Institut	Hanschen, FS (corresponding author), Leibniz Inst Vegetable & Ornamental Crops Grossbe, Dept Qual, Theodor Echtermeyer Weg 1, D-14979 Grossbeeren, Germany.	hanschen@igzev.de	Hanschen, Franziska/AAO-2855-2020; Smalla, Kornelia/H-4002-2011	Winkelmann, Traud/0000-0002-2509-1418; Hanschen, Franziska/0000-0003-0949-6228; Schreiner, Monika/0000-0002-5629-4429	Bundesanstalt fur Landwirtschaft und Ernahrung Geschaftsstelle Bundesprogramm Okologischer Landbau und andere Formen nachhaltiger Landwirtschaft (BOLN) [2811NA065]	Bundesanstalt fur Landwirtschaft und Ernahrung Geschaftsstelle Bundesprogramm Okologischer Landbau und andere Formen nachhaltiger Landwirtschaft (BOLN)	The work was part of a project funded by the Bundesanstalt fur Landwirtschaft und Ernahrung Geschaftsstelle Bundesprogramm Okologischer Landbau und andere Formen nachhaltiger Landwirtschaft (BOLN), grant number FKZ: 2811NA065 (http://www.bundesprogramm-oekolandbau.de/).	Agerbirk N, 2012, PHYTOCHEMISTRY, V77, P16, DOI 10.1016/j.phytochem.2012.02.005; Aissani N, 2013, J AGR FOOD CHEM, V61, P4723, DOI 10.1021/jf4008949; [Anonymous], 1991, VDLUFA METHODENBUCH, VI, P1; Araujo JF, 2012, MICROB ECOL, V64, P760, DOI 10.1007/s00248-012-0057-3; Badri DV, 2009, PLANT CELL ENVIRON, V32, P666, DOI [10.1111/j.1365-3040.2009.01926.x, 10.1111/j.1365-3040.2008.01926.x]; Bangarwa SK, 2011, WEED SCI, V59, P247, DOI 10.1614/WS-D-10-00137.1; Bellostas N, 2007, J SCI FOOD AGR, V87, P1586, DOI 10.1002/jsfa.2896; Bending GD, 2000, SOIL BIOL BIOCHEM, V32, P1261, DOI 10.1016/S0038-0717(00)00043-2; BOREK V, 1995, J AGR FOOD CHEM, V43, P1935, DOI 10.1021/jf00055a033; BOREK V, 1994, J AGR FOOD CHEM, V42, P1030, DOI 10.1021/jf00040a037; Bressan M, 2009, ISME J, V3, P1243, DOI 10.1038/ismej.2009.68; Ding GC, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00290; Dungan RS, 2003, WATER AIR SOIL POLL, V142, P299, DOI 10.1023/A:1022092907878; Fahey JW, 2002, P NATL ACAD SCI USA, V99, P7610, DOI 10.1073/pnas.112203099; Gabler FM, 2006, PLANT DIS, V90, P1019, DOI 10.1094/PD-90-1019; Gimsing AL, 2006, SOIL BIOL BIOCHEM, V38, P2255, DOI 10.1016/j.soilbio.2006.01.024; Gimsing AL, 2009, ENVIRON TOXICOL CHEM, V28, P1178, DOI 10.1897/08-516.1; Gimsing AL, 2007, ENVIRON SCI TECHNOL, V41, P4271, DOI 10.1021/es061987t; Gimsing AL, 2007, APPL CLAY SCI, V35, P212, DOI 10.1016/j.clay.2006.08.008; Gimsing AL, 2006, ENVIRON TOXICOL CHEM, V25, P2038, DOI 10.1897/05-610R.1; Gimsing AL, 2009, PHYTOCHEM REV, V8, P299, DOI 10.1007/s11101-008-9105-5; Grosch R, 2010, BERICHTE J KUHN I, V155, P36; Hallmann J, 2009, CHANCEN GRENZEN BIOF; Hanschen FS, 2014, ANGEW CHEM INT EDIT, V53, P11430, DOI 10.1002/anie.201402639; Hanschen FS, 2012, J AGR FOOD CHEM, V60, P7735, DOI 10.1021/jf301718g; Hanschen FS, 2012, J AGR FOOD CHEM, V60, P2231, DOI 10.1021/jf204830p; Heuer H, 2001, ENVIRONMENTAL MOLECULAR MICROBIOLOGY : PROTOCOLS AND APPLICATIONS, P177; Heuer H, 1997, APPL ENVIRON MICROB, V63, P3233, DOI 10.1128/AEM.63.8.3233-3241.1997; Hu P, 2015, FRONT MICROBIOL, V5; Ignatieff V, 1941, SOIL SCI, V51, P249, DOI 10.1097/00010694-194104000-00001; KJAER A, 1963, ACTA CHEM SCAND, V17, P2143; KOSEMURA S, 1993, TETRAHEDRON LETT, V34, P481, DOI 10.1016/0040-4039(93)85107-8; Kropfa S, 2004, J MICROBIOL METH, V57, P187, DOI 10.1016/j.mimet.2004.01.002; Matsuoka H, 1997, BIOSCI BIOTECH BIOCH, V61, P2109, DOI 10.1271/bbb.61.2109; Matthiessen JN, 2006, CRIT REV PLANT SCI, V25, P235, DOI 10.1080/07352680600611543; Montaut S, 2010, PHYTOCHEMISTRY, V71, P6, DOI 10.1016/j.phytochem.2009.09.021; Morra MJ, 2002, SOIL BIOL BIOCHEM, V34, P1683, DOI 10.1016/S0038-0717(02)00153-0; Mullaney JA, 2013, J AGR FOOD CHEM, V61, P3039, DOI 10.1021/jf305442j; Omirou M, 2013, EUR J SOIL BIOL, V56, P49, DOI 10.1016/j.ejsobi.2013.01.005; Omirou M, 2011, MICROB ECOL, V61, P201, DOI 10.1007/s00248-010-9740-4; Rumberger A, 2003, SOIL BIOL BIOCHEM, V35, P445, DOI 10.1016/S0038-0717(02)00296-1; Sarwar M, 1998, PLANT SOIL, V201, P103, DOI 10.1023/A:1004381129991; Schreiter S, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00144; Smalla K, 2001, APPL ENVIRON MICROB, V67, P4742, DOI 10.1128/AEM.67.10.4742-4751.2001; Smetanska I, 2006, THESIS TU BERLIN BER; Song D, 2013, J AGR FOOD CHEM, V61, P5097, DOI 10.1021/jf400355d; SPENCER GF, 1980, J SCI FOOD AGR, V31, P359, DOI 10.1002/jsfa.2740310406; van Loon LC, 2007, EUR J PLANT PATHOL, V119, P243, DOI 10.1007/s10658-007-9165-1; Warton B, 2003, SOIL BIOL BIOCHEM, V35, P1123, DOI 10.1016/S0038-0717(03)00164-0; Weinert N, 2009, APPL ENVIRON MICROB, V75, P3859, DOI 10.1128/AEM.00414-09; Wiesner M, 2013, INT J MOL SCI, V14, P14996, DOI 10.3390/ijms140714996; Wittstock U., 2010, Arabidopsis Book, V8, pe0134, DOI 10.1199/tab.0134; Witzel K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071877; Wu H, 2011, CROP PROT, V30, P33, DOI 10.1016/j.cropro.2010.09.004; Yim B, 2013, PLANT SOIL, V366, P617, DOI 10.1007/s11104-012-1454-6; YOUNGS CG, 1967, CAN J CHEMISTRY, V45, P1801, DOI 10.1139/v67-289	56	40	42	4	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0132931	10.1371/journal.pone.0132931	http://dx.doi.org/10.1371/journal.pone.0132931			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RV	26186695	Green Submitted, Green Published, gold			2022-12-26	WOS:000358198700071
J	Huang, CC; Kuo, KK; Cheng, TC; Chuang, CH; Kao, CH; Hsieh, YC; Cheng, KH; Wang, JY; Cheng, CM; Chen, CS; Cheng, TL				Huang, Chien-Chiao; Kuo, Kung-Kai; Cheng, Ta-Chun; Chuang, Chih-Hung; Kao, Chien-Han; Hsieh, Yuan-Chin; Cheng, Kuang-Hung; Wang, Jaw-Yuan; Cheng, Chiu-Min; Chen, Chien-Shu; Cheng, Tian-Lu			Development of Membrane-Bound GM-CSF and IL-18 as an Effective Tumor Vaccine	PLOS ONE			English	Article							COLONY-STIMULATING FACTOR; GAMMA-INDUCING FACTOR; ANTITUMOR IMMUNITY; CANCER-IMMUNOTHERAPY; CELL VACCINES; ACTIVATION; INTERLEUKIN-12; MICROENVIRONMENT; PROLIFERATION; INFLAMMATION	The development of effective adjuvant is the key factor to boost the immunogenicity of tumor cells as a tumor vaccine. In this study, we expressed membrane-bound granulocyte-macrophage colony-stimulating factor (GM-CSF) and interleukin-18 (IL-18) as adjuvants in tumor cells to stimulate immune response. B7 transmembrane domain fused GM-CSF and IL-18 was successfully expressed in the cell membrane and stimulated mouse splenocyte proliferation. Co-expression of GM-CSF and IL-18 reduced tumorigenesis (P<0.05) and enhanced tumor protective efficacy (P<0.05) significantly in comparison with GM-CSF alone. These results indicated that the combination of GM-CSF andIL-18 will enhance the immunogenicity of a cell-based anti-tumor vaccine. This membrane-bound approach can be applied to other cytokines for the development of novel vaccine strategies.	[Huang, Chien-Chiao; Cheng, Ta-Chun; Chuang, Chih-Hung; Kao, Chien-Han; Cheng, Tian-Lu] Kaohsiung Med Univ, Dept Biomed Sci & Environm Biol, Kaohsiung, Taiwan; [Kuo, Kung-Kai] Kaohsiung Med Univ Hosp, Dept Surg, Kaohsiung, Taiwan; [Huang, Chien-Chiao; Hsieh, Yuan-Chin; Wang, Jaw-Yuan; Cheng, Tian-Lu] Kaohsiung Med Univ, Coll Med, Grad Inst Med, Kaohsiung, Taiwan; [Cheng, Ta-Chun] Taipei Med Univ, Grad Inst Pharmacognosy, Taipei, Taiwan; [Chuang, Chih-Hung; Cheng, Tian-Lu] Kaohsiung Med Univ, Ctr Biomarkers & Biotech Drugs, Kaohsiung, Taiwan; [Cheng, Kuang-Hung; Cheng, Tian-Lu] Natl Sun Yat Sen Univ, Inst Biomed Sci, Kaohsiung 80424, Taiwan; [Wang, Jaw-Yuan] Kaohsiung Med Univ, Coll Med, Fac Med, Dept Surg, Kaohsiung, Taiwan; [Cheng, Chiu-Min] Natl Kaohsiung Marine Univ, Dept Aquaculture, Kaohsiung, Taiwan; [Chen, Chien-Shu] China Med Univ, Sch Pharm, Taichung, Taiwan	Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Taipei Medical University; Kaohsiung Medical University; National Sun Yat Sen University; Kaohsiung Medical University; National Kaohsiung University of Science & Technology; China Medical University Taiwan	Chen, CS (corresponding author), China Med Univ, Sch Pharm, Taichung, Taiwan.	cschen7@mail.cmu.edu.tw; tlcheng@kmu.edu.tw	Jaw-Yuan, Wang/AFS-8845-2022	Jaw-Yuan, Wang/0000-0002-7705-2621; Hsieh, Yuan Chin/0000-0003-4005-5340; Cheng, Tian-Lu/0000-0002-7263-2766	Ministry of Science and Technology, Taipei, Taiwan [MOST 104-2325-B-037-007, MOST 104-2325-B-037-005, MOST 104-2325-B-041-001]; Grant of Biosignature in Colorectal Cancers, Academia Sinica, Taiwan; Kaohsiung Medical University [KMU-TP103C00, KMU-TP103H00, KMU-DT103005]	Ministry of Science and Technology, Taipei, Taiwan; Grant of Biosignature in Colorectal Cancers, Academia Sinica, Taiwan; Kaohsiung Medical University	This work was supported by grants from the National Research Program for Biopharmaceuticals, Ministry of Science and Technology, Taipei, Taiwan (MOST 104-2325-B-037-007, MOST 104-2325-B-037-005, MOST 104-2325-B-041-001), the Grant of Biosignature in Colorectal Cancers, Academia Sinica, Taiwan. This study is also supported partially by Kaohsiung Medical University "Aim for the Top 500 Universities grant, grant No. KMU-TP103C00, KMU-TP103H00, and KMU-DT103005."	Aldrich JF, 2010, CLIN DEV IMMUNOL, DOI 10.1155/2010/697158; Bozeman EN, 2013, VACCINE, V31, P2449, DOI 10.1016/j.vaccine.2013.03.028; BURGESS AW, 1977, J BIOL CHEM, V252, P1998; Campbell IK, 1997, ANN RHEUM DIS, V56, P364, DOI 10.1136/ard.56.6.364; Cook AD, 2004, J IMMUNOL, V173, P4643, DOI 10.4049/jimmunol.173.7.4643; Copier J, 2006, INT REV IMMUNOL, V25, P297, DOI 10.1080/08830180600992472; Dao T, 1996, CELL IMMUNOL, V173, P230, DOI 10.1006/cimm.1996.0272; DRANOFF G, 1993, P NATL ACAD SCI USA, V90, P3539, DOI 10.1073/pnas.90.8.3539; Dunussi-Joannopoulos K, 1998, BLOOD, V91, P222, DOI 10.1182/blood.V91.1.222.222_222_230; Faries MB, 2009, CLIN CANCER RES, V15, P7029, DOI 10.1158/1078-0432.CCR-09-1540; Gajewski TF, 2012, MOL ONCOL, V6, P242, DOI 10.1016/j.molonc.2012.01.002; Gerritsen WR, 2009, GEN CANC S P AM SOC; Gupta R, 2010, DISCOV MED, V10, P52; Hamilton JA, 2008, NAT REV IMMUNOL, V8, P533, DOI 10.1038/nri2356; HAZENBERG BPC, 1989, BLOOD, V74, P2769, DOI 10.1182/blood.V74.8.2769.2769; He H, 2012, INT J MOL MED, V30, P599, DOI 10.3892/ijmm.2012.1027; Higano CSF, 2009, GEN CANC S P AM SOC; Iwai Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002404; Jaffee EM, 2001, J CLIN ONCOL, V19, P145, DOI 10.1200/JCO.2001.19.1.145; Keenan BP, 2012, SEMIN ONCOL, V39, P276, DOI 10.1053/j.seminoncol.2012.02.007; Kim Young Sang, 2009, Immune Netw, V9, P158, DOI 10.4110/in.2009.9.5.158; Kohno K, 1997, J IMMUNOL, V158, P1541; Le DT, 2010, CANCER J, V16, P304, DOI 10.1097/PPO.0b013e3181eb33d7; Liao KW, 2001, BIOTECHNOL BIOENG, V73, P313, DOI 10.1002/bit.1064; Lutz E, 2011, ANN SURG, V253, P328, DOI 10.1097/SLA.0b013e3181fd271c; Marshall DJ, 2006, VACCINE, V24, P244, DOI 10.1016/j.vaccine.2005.07.087; Ostrand-Rosenberg S, 2008, CURR OPIN GENET DEV, V18, P11, DOI 10.1016/j.gde.2007.12.007; Pan WY, 2012, MOL THER, V20, P927, DOI 10.1038/mt.2012.10; Sankar S, 2013, ASIAN PAC J CANCER P, V14, P4041, DOI 10.7314/APJCP.2013.14.7.4041; Srivatsan S, 2013, HUMAN VACCINES IMMUN, V10; TAHARA H, 1994, CANCER RES, V54, P182; Tian HW, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-48; Tomura M, 1998, J IMMUNOL, V160, P4738; Tse BWC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024241; Tsutsui H, 1996, J IMMUNOL, V157, P3967; van den Boorn JG, 2013, IMMUNITY, V39, P27, DOI 10.1016/j.immuni.2013.07.011; van Nieuwenhuijze A, 2013, MOL IMMUNOL, V56, P675, DOI 10.1016/j.molimm.2013.05.002; Zhang XJ, 2012, J UROLOGY, V187, P1071, DOI 10.1016/j.juro.2011.10.126	38	2	3	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0133470	10.1371/journal.pone.0133470	http://dx.doi.org/10.1371/journal.pone.0133470			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RV	26186692	Green Published, Green Submitted, gold			2022-12-26	WOS:000358198700143
J	Khandkar, C; Harrington, Z; Jelfs, PJ; Sintchenko, V; Dobler, CC				Khandkar, Chinmay; Harrington, Zinta; Jelfs, Peter J.; Sintchenko, Vitali; Dobler, Claudia C.			Epidemiology of Peripheral Lymph Node Tuberculosis and Genotyping of M. tuberculosis Strains: A Case-Control Study	PLOS ONE			English	Article							EXTRA-PULMONARY TUBERCULOSIS; EXTRAPULMONARY TUBERCULOSIS; MYCOBACTERIUM-TUBERCULOSIS; SEX-DIFFERENCES; MIRU-VNTRPLUS; DISEASE; LYMPHADENITIS; DIAGNOSIS; LINEAGES; RISK	Background This study examined potential risk factors of lymph node tuberculosis (LNTB), including phylogenetic lineages of Mycobacterium tuberculosis (MTB), in comparison to pulmonary tuberculosis (PTB) in a setting with an ethnically diverse population. Methods We conducted a case-control study at a major tuberculosis clinic in Sydney, Australia, which included all patients with peripheral LNTB seen at the clinic between 2000 and 2012. Controls were randomly selected patients with PTB seen at the same clinic during the study period. Epidemiological data were extracted from the hospital electronic database and medical records. Associations between LNTB and age, sex, ethnicity, comorbidities and phylogenetic lineages of MTB in comparison to PTB were examined using logistic regression in univariate and multivariate analyses. Results There were 212 cases with LNTB and 424 randomly selected controls with PTB. Among patients with LNTB, 74% were female and the mean age (standard deviation, SD) was 42 (16) years. Among patients with PTB, 43% were female and the mean age was 44 (22) years. Females, 45 to 64-year-olds and Southern Asians had an increased risk for LNTB (OR 3.13, 95% CI 2.10-4.67; OR 2.50, 95% CI 1.29-4.84; OR 3.95, 95% CI 1.54-10.12 respectively). Patients with diabetes were at a higher risk of PTB (OR 0.40, 95% CI 0.19-0.83 for LNTB). A subset analysis showed that patients infected with the East African Indian strain of MTB were more likely to develop LNTB (OR 10.07, 95% CI 2.37-42.77). Conclusions An increased risk for LNTB (but still lower rates than for PTB) was found among females, people aged 45 to 64 years and people born in Southern Asia. An increased risk for PTB was found among patients with diabetes. The East African Indian strain of MTB was significantly associated with a higher likelihood of LNTB compared to other MTB strains.	[Khandkar, Chinmay; Harrington, Zinta; Dobler, Claudia C.] Univ New S Wales, South Western Sydney Clin Sch, Sydney, NSW, Australia; [Jelfs, Peter J.; Sintchenko, Vitali] Westmead Hosp, NSW Mycobacterium Reference Lab, Ctr Infect Dis & Microbiol Lab Serv, Inst Clin Pathol & Med Res, Sydney, NSW, Australia; [Sintchenko, Vitali] Univ Sydney, Marie Bashir Inst Infect Dis & Biosecur, Sydney, NSW 2006, Australia	University of New South Wales Sydney; University of Sydney; University of Sydney	Khandkar, C (corresponding author), Univ New S Wales, South Western Sydney Clin Sch, Sydney, NSW, Australia.	chinmay.khandkar@gmail.com		Dobler, Claudia/0000-0002-5460-0189; Sintchenko, Vitali/0000-0002-9261-3650				Al-Otaibi F, 2010, INDIAN J PATHOL MICR, V53, P227, DOI 10.4103/0377-4929.64327; Allix-Beguec C, 2008, J CLIN MICROBIOL, V46, P2692, DOI 10.1128/JCM.00540-08; [Anonymous], 2003, KEKKAKU TUBERCULOSIS, V78, P717; BAREJA C, 2011, COMMUNICABLE DIS INT, V38, P356; Chan-Yeung M, 2002, INT J TUBERC LUNG D, V6, P11; CHEN YM, 1992, TUBERCLE LUNG DIS, V73, P368, DOI 10.1016/0962-8479(92)90042-I; Click ES, 2012, CLIN INFECT DIS, V54, P211, DOI 10.1093/cid/cir788; Dale JW, 2005, J MED MICROBIOL, V54, P575, DOI 10.1099/jmm.0.45959-0; Fader T, 2010, INT J INFECT DIS, V14, pE102, DOI 10.1016/j.ijid.2009.03.023; Fanning A, 1999, CAN MED ASSOC J, V160, P1597; FARER LS, 1979, AM J EPIDEMIOL, V109, P205, DOI 10.1093/oxfordjournals.aje.a112675; Firdessa R, 2013, EMERG INFECT DIS, V19, P460, DOI 10.3201/eid1903.120256; Geldmacher H, 2002, CHEST, V121, P1177, DOI 10.1378/chest.121.4.1177; Golden MP, 2005, AM FAM PHYSICIAN, V72, P1751; HOPEWELL P C, 1991, Kekkaku, V66, P433; Khan AH, 2010, PHARM PRACTICE, V1, P7; Lari N, 2009, CLIN MICROBIOL INFEC, V15, P538, DOI 10.1111/j.1469-0691.2009.02712.x; Leeds IL, 2012, CLIN INFECT DIS, V55, P75, DOI 10.1093/cid/cis303; Leung CC, 2008, AM J EPIDEMIOL, V167, P1486, DOI 10.1093/aje/kwn075; Lin JN, 2009, INT J TUBERC LUNG D, V13, P620; Lowbridge Chris, 2013, N S W Public Health Bull, V24, P3, DOI 10.1071/NB12115; MOUDGIL H, 1994, RESP MED, V88, P507, DOI 10.1016/S0954-6111(05)80332-4; NSW Ministry of Health, 2012, COMMUNICABLE DIS INT, V36, P286; Ong A, 2004, CLIN INFECT DIS, V38, P25, DOI 10.1086/380448; PANG SC, 1992, TUBERCLE LUNG DIS, V73, P362, DOI 10.1016/0962-8479(92)90041-H; Pareek M, 2013, THORAX, V68, P221, DOI 10.1136/thoraxjnl-2012-201824; Peto HM, 2009, CLIN INFECT DIS, V49, P1350, DOI 10.1086/605559; Polesky A, 2005, MEDICINE, V84, P350, DOI 10.1097/01.md.0000189090.52626.7a; Sankar MM, 2013, TUBERCULOSIS, V93, P75, DOI 10.1016/j.tube.2012.10.005; Sharma SK, 2004, INDIAN J MED RES, V120, P316; Sreeramareddy CT, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-8; Supply P, 2006, J CLIN MICROBIOL, V44, P4498, DOI 10.1128/JCM.01392-06; Temple SEL, 2008, CELL IMMUNOL, V251, P69, DOI 10.1016/j.cellimm.2008.04.013; Torgersen J, 2006, CLIN INFECT DIS, V42, P1375, DOI 10.1086/503421; United Nations Statisical Division, 2003, COMP MACR GEOGR CONT; Watkins RE, 2006, EPIDEMIOL INFECT, V134, P333, DOI 10.1017/S0950268805005042; Weniger T, 2010, NUCLEIC ACIDS RES, V38, pW326, DOI 10.1093/nar/gkq351; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; Young F, 2012, J EPIDEMIOL COMMUN H, V66, P519, DOI 10.1136/jech.2010.114595; Zumla A, 2013, NEW ENGL J MED, V368, P745, DOI 10.1056/NEJMra1200894	40	7	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0132400	10.1371/journal.pone.0132400	http://dx.doi.org/10.1371/journal.pone.0132400			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26177546	Green Submitted, gold, Green Published			2022-12-26	WOS:000358197600109
J	Pagano, S; Gaertner, H; Cerini, F; Mannic, T; Satta, N; Teixeira, PC; Cutler, P; Mach, F; Vuilleumier, N; Hartley, O				Pagano, Sabrina; Gaertner, Hubert; Cerini, Fabrice; Mannic, Tiphaine; Satta, Nathalie; Teixeira, Priscila Camillo; Cutler, Paul; Mach, Francois; Vuilleumier, Nicolas; Hartley, Oliver			The Human Autoantibody Response to Apolipoprotein A-I Is Focused on the C-Terminal Helix: A New Rationale for Diagnosis and Treatment of Cardiovascular Disease?	PLOS ONE			English	Article							SOLID-PHASE SYNTHESIS; A-1 AUTOANTIBODIES; RHEUMATOID-ARTHRITIS; IGG; ANTIBODIES; RISK; CHOLESTEROL; EVENTS	Background Cardiovascular disease (CVD) is the leading cause of death worldwide and new approaches for both diagnosis and treatment are required. Autoantibodies directed against apolipoprotein A-I (ApoA-I) represent promising biomarkers for use in risk stratification of CVD and may also play a direct role in pathogenesis. Methodology To characterize the anti-ApoA-I autoantibody response, we measured the immunoreactivity to engineered peptides corresponding to the different alpha-helical regions of ApoA-I, using plasma from acute chest pain cohort patients known to be positive for anti-ApoA-I autoantibodies. Principal Findings Our results indicate that the anti-ApoA-I autoantibody response is strongly biased towards the C-terminal alpha-helix of the protein, with an optimized mimetic peptide corresponding to this part of the protein recapitulating the diagnostic accuracy for an acute ischemic coronary etiology (non-ST segment elevation myocardial infarction and unstable angina) obtainable using intact endogenous ApoA-I in immunoassay. Furthermore, the optimized mimetic peptide strongly inhibits the pathology-associated capacity of anti-ApoA-I antibodies to elicit proinflammatory cytokine release from cultured human macrophages. Conclusions In addition to providing a rationale for the development of new approaches for the diagnosis and therapy of CVD, our observations may contribute to the elucidation of how anti-ApoA-I autoantibodies are elicited in individuals without autoimmune disease.	[Pagano, Sabrina; Mannic, Tiphaine; Satta, Nathalie; Vuilleumier, Nicolas] Univ Geneva, Dept Human Prot Sci, Fac Med, Geneva, Switzerland; [Pagano, Sabrina; Mannic, Tiphaine; Satta, Nathalie; Vuilleumier, Nicolas] Univ Hosp Geneva, Dept Genet & Lab Med, Div Lab Med, Geneva, Switzerland; [Gaertner, Hubert; Cerini, Fabrice; Hartley, Oliver] Univ Geneva, Dept Pathol & Immunol, Fac Med, Geneva, Switzerland; [Teixeira, Priscila Camillo; Cutler, Paul] F Hoffmann La Roche, Pharmaceut Sci Pharma Res & Early Dev, Basel, Switzerland; [Mach, Francois] Univ Geneva, Div Cardiol, Fdn Med Res, Geneva, Switzerland	University of Geneva; University of Geneva; University of Geneva; Roche Holding; University of Geneva	Vuilleumier, N (corresponding author), Univ Geneva, Dept Human Prot Sci, Fac Med, Geneva, Switzerland.	Nicolas.Vuilleumier@hcuge.ch; Oliver.Hartley@unige.ch		, Nicolas/0000-0002-1122-438X; Camillo Teixeira, Priscila/0000-0002-9698-4563	Swiss National Science Foundation [310030_140736]; Leenaards Foundation [3698]; deReuters foundation [566]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Leenaards Foundation; deReuters foundation	This work was supported by Swiss National Science Foundation Grants #310030_140736 to NV, by grants from the Leenaards Foundation no. 3698 to NV and OH, and from the deReuters foundation no. 566 to NV. These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. F. Hoffmann-La Roche played an indirect role in the form of salaries for authors PC and PT, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Ajees AA, 2006, P NATL ACAD SCI USA, V103, P2126, DOI 10.1073/pnas.0506877103; Ames PRJ, 2010, LUPUS, V19, P711, DOI 10.1177/0961203309357765; Antman EM, 2000, JAMA-J AM MED ASSOC, V284, P835, DOI 10.1001/jama.284.7.835; Batuca JR, 2007, ANN NY ACAD SCI, V1108, P137, DOI 10.1196/annals.1422.016; Bloedon LT, 2008, J LIPID RES, V49, P1344, DOI 10.1194/jlr.P800003-JLR200; Cunningham MW, 2012, CURR OPIN RHEUMATOL, V24, P408, DOI 10.1097/BOR.0b013e32835461d3; Davidson WS, 2007, J BIOL CHEM, V282, P22249, DOI 10.1074/jbc.R700014200; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Dinu AR, 1998, LUPUS, V7, P355, DOI 10.1191/096120398678920262; Eyre H, 2004, CIRCULATION, V109, P3244, DOI 10.1161/01.CIR.0000133321.00456.00; Finckh A, 2012, ARTHRIT CARE RES, V64, P817, DOI 10.1002/acr.21631; Hafiane A, 2014, CURR OPIN ENDOCRINOL, V21, P134, DOI 10.1097/MED.0000000000000049; Henchey LK, 2008, CURR OPIN CHEM BIOL, V12, P692, DOI 10.1016/j.cbpa.2008.08.019; KATES SA, 1993, TETRAHEDRON LETT, V34, P1549, DOI 10.1016/0040-4039(93)85003-F; Keller PF, 2012, J INTERN MED, V271, P451, DOI 10.1111/j.1365-2796.2011.02479.x; Krauel K, 2011, BLOOD, V117, P1370, DOI 10.1182/blood-2010-08-301424; Libby P, 2011, NATURE, V473, P317, DOI 10.1038/nature10146; McManus DD, 2011, AM J MED, V124, P40, DOI 10.1016/j.amjmed.2010.07.023; Montecucco F, 2011, EUR HEART J, V32, P412, DOI 10.1093/eurheartj/ehq521; Naghavi M, 2006, AM J CARDIOL, V98, p2H, DOI 10.1016/j.amjcard.2006.03.002; Navab M, 2011, NAT REV CARDIOL, V8, P222, DOI 10.1038/nrcardio.2010.222; Pagano S, 2012, J INTERN MED, V272, P344, DOI 10.1111/j.1365-2796.2012.02530.x; Patgiri A, 2010, NAT PROTOC, V5, P1857, DOI 10.1038/nprot.2010.146; Rossier MF, 2012, ENDOCRINOLOGY, V153, P1269, DOI 10.1210/en.2011-1835; Roux-Lombard P, 2013, CLIN REV ALLERG IMMU, V44, P84, DOI 10.1007/s12016-010-8233-z; Srivastava R, 2011, ARTHRITIS RHEUM-US, V63, P201, DOI 10.1002/art.27764; Taylor JW, 2002, BIOPOLYMERS, V66, P49, DOI 10.1002/bip.10203; Teixeira PC, 2014, J BIOL CHEM, V289, P28249, DOI 10.1074/jbc.M114.589002; Thygesen K, 2012, EUR HEART J, V33, P2551, DOI 10.1093/eurheartj/ehs184; Vuilleumier N, 2010, SCAND J RHEUMATOL, V39, P447, DOI 10.3109/03009741003742755; Vuilleumier N, 2013, SWISS MED WKLY, V143, DOI 10.4414/smw.2013.13781; Vuilleumier N, 2013, THROMB HAEMOSTASIS, V109, P706, DOI 10.1160/TH12-10-0714; Vuilleumier N, 2010, ARTHRITIS RHEUM-US, V62, P2640, DOI 10.1002/art.27546; Vuilleumier N, 2010, EUR HEART J, V31, P815, DOI 10.1093/eurheartj/ehq055; Watson CE, 2011, J LIPID RES, V52, P361, DOI 10.1194/jlr.M011098; Wick PA, 2013, J PERIODONTAL RES, V48, P350, DOI 10.1111/jre.12014; Yuki N, 2001, Lancet Infect Dis, V1, P29	37	20	20	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0132780	10.1371/journal.pone.0132780	http://dx.doi.org/10.1371/journal.pone.0132780			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26177543	gold, Green Submitted, Green Published			2022-12-26	WOS:000358197600154
J	Vesk, PA; Robinson, D; van der Ree, R; Wilson, CM; Saywell, S; McCarthy, MA				Vesk, Peter A.; Robinson, Doug; van der Ree, Rodney; Wilson, Caroline M.; Saywell, Shirley; McCarthy, Michael A.			Demographic Effects of Habitat Restoration for the Grey-Crowned Babbler Pomatostomus temporalis, in Victoria, Australia	PLOS ONE			English	Article							AGRI-ENVIRONMENT SCHEME; WOODLAND BIRDS; POPULATION-STRUCTURE; FARMLAND BIRDS; REVEGETATION; BIODIVERSITY; VEGETATION; LANDSCAPE; ATTRIBUTES; MANAGEMENT	Background Considerable resources are spent on habitat restoration across the globe to counter the impacts of habitat loss and degradation on wildlife populations. But, because of time and resourcing constraints on many conservation programs, the effectiveness of these habitat restoration programs in achieving their long-termgoals of improving the population viability of particular wildlife species is rarely assessed and many restoration programs cannot demonstrate their effectiveness. Without such demonstration, and in particular demonstrating the causal relationships between habitat restoration actions and demographic responses of the target species, investments in restoration to achieve population outcomes are of uncertain value. Approach Here, we describe an approach that builds on population data collected for a threatened Australian bird - the Grey-crowned Babbler Pomatostomus temporalis - to evaluate how effectively targeted habitat restoration work improves its viability. We built upon an extensive historical survey by conducting surveys 13 years later at 117 sites stratified by presence/absence of restoration works and by detection or not of birds in the first survey. Our performance metric was the number of individuals in a social group, which is both a measure of local abundance and directly related to breeding success. We employed an occupancy model to estimate the response of Grey-crowned Babbler social group size to the effects of time, restoration works, local habitat as measured by the density of large trees, and distance to the nearest other known group of babblers. Results and implications Babbler group size decreased over the survey period at sites without restoration works, but restoration works were effective in stemming declines where they were done. Restoration was responsible for a difference of about one bird per group of 3-5 individuals; this is an important effect on the reproductive success of the social group. Effectiveness of restoration works targeted at the Grey-crowned Babbler was only demonstrable by sampling through time and including control sites without restoration works. This work demonstrates that while calls for better monitoring of restoration are valid, scope exists to recover a signal of effectiveness from opportunistic retrospective analyses.	[Vesk, Peter A.; McCarthy, Michael A.] Univ Melbourne, Sch Biosci, Australian Res Council Ctr Excellence Environm De, Parkville, Vic 3052, Australia; [Robinson, Doug] Trust Nat, Melbourne, Vic, Australia; [van der Ree, Rodney; Wilson, Caroline M.] Univ Melbourne, Sch Biosci, Australian Res Ctr Urban Ecol, Parkville, Vic 3052, Australia; [Saywell, Shirley] Friends Grey Crowned Babbler, Euroa, Vic, Australia	University of Melbourne; University of Melbourne	Vesk, PA (corresponding author), Univ Melbourne, Sch Biosci, Australian Res Council Ctr Excellence Environm De, Parkville, Vic 3052, Australia.	pvesk@unimelb.edu.au	Vesk, Peter/AAG-9970-2020; McCarthy, Michael/O-5655-2014	Vesk, Peter/0000-0003-2008-7062; McCarthy, Michael/0000-0003-1039-7980	Norman Wettenhall Foundation; Goulburn Broken Catchment Management Authority; Baker Foundation; Australian Centre of Excellence in Environmental Decisions from the Australian Research Council; Australian Research Council	Norman Wettenhall Foundation; Goulburn Broken Catchment Management Authority; Baker Foundation; Australian Centre of Excellence in Environmental Decisions from the Australian Research Council(Australian Research Council); Australian Research Council(Australian Research Council)	The authors acknowledge funding from The Norman Wettenhall Foundation (http://nwf.org.au/), the Goulburn Broken Catchment Management Authority (http://www.gbcma.vic.gov.au/), The Baker Foundation and the Australian Centre of Excellence in Environmental Decisions (http://ceed.edu.au/) from the Australian Research Council (http://www.arc.gov.au/). MAM was supported by an Australian Research Council Future Fellowship (http://www.arc.gov.au/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	*ANAO, 1997, 36199697 ANAO; Ausden M, 2002, BIOL CONSERV, V106, P279, DOI 10.1016/S0006-3207(01)00254-3; Australian National Audit Office (ANAO), 2008, 21200708 ANAO; Barrett GW, 2008, WILDLIFE RES, V35, P19, DOI 10.1071/WR07100; Barrett G.W., 2003, NEW ATLAS AUSTR BIRD; Bennett A. F, 2003, LINKAGES LANDSCAPE R, DOI DOI 10.2305/IUCN.CH.2004.FR.1.EN; Bennett AF, 2011, EMU, V111, pI, DOI 10.1071/MUv111n1_ED; Bernhardt ES, 2005, SCIENCE, V308, P636, DOI 10.1126/science.1109769; Blackmore CJ, 2007, J ZOOL, V273, P326, DOI 10.1111/j.1469-7998.2007.00332.x; Blakers M., 1984, ATLAS AUSTR BIRDS; Brooks SP, 1998, J COMPUT GRAPH STAT, V7, P434, DOI 10.2307/1390675; Brown J.L., 1981, P244; BROWN JL, 1978, BEHAV ECOL SOCIOBIOL, V4, P43, DOI 10.1007/BF00302560; BROWN JL, 1983, BEHAV ECOL SOCIOBIOL, V13, P115, DOI 10.1007/BF00293801; BROWN JL, 1977, CONDOR, V79, P312, DOI 10.2307/1368008; Cale P., 1999, THESIS U NEW ENGLAND; Cale PG, 2003, BIOL CONSERV, V109, P237, DOI 10.1016/S0006-3207(02)00152-0; Chandler RB, 2011, ECOLOGY, V92, P1429, DOI 10.1890/10-2433.1; Cristofoli S, 2010, ECOL INDIC, V10, P773, DOI 10.1016/j.ecolind.2009.11.013; Cunningham RB, 2008, CONSERV BIOL, V22, P742, DOI 10.1111/j.1523-1739.2008.00924.x; Davidson I, 1992, COMMUNICATION; DOW DD, 1984, EMU, V84, P193, DOI 10.1071/MU9840193; Duncan DH, 2013, ECOL APPL, V23, P1277, DOI 10.1890/12-1670.1; Emison W., 1987, ATLAS VICTORIAN BIRD; Ford HA, 2011, EMU, V111, P1, DOI 10.1071/MU09115; Gelman A, 2008, ANN APPL STAT, V2, P1360, DOI 10.1214/08-AOAS191; Grice P, 2004, IBIS, V146, P239, DOI 10.1111/j.1474-919X.2004.00359.x; Hajkowicz S, 2009, LAND USE POLICY, V26, P471, DOI 10.1016/j.landusepol.2008.06.004; Hanski I, 2000, NATURE, V404, P755, DOI 10.1038/35008063; Higgins P.J., 2002, HDB AUSTR NZ ANTARCT; Hobbs Richard J., 2003, Ecological Management & Restoration, V4, pS2, DOI 10.1046/j.1442-8903.4.s.10.x; Kery M, 2009, J APPL ECOL, V46, P1163, DOI 10.1111/j.1365-2664.2009.01724.x; KING BR, 1980, EMU, V80, P59, DOI 10.1071/MU9800059; Kleijn D, 2003, J APPL ECOL, V40, P947, DOI 10.1111/j.1365-2664.2003.00868.x; Lindenmayer DB, 2010, BIOL CONSERV, V143, P289, DOI 10.1016/j.biocon.2009.10.010; Lindenmayer D, 2012, BIOL CONSERV, V152, P62, DOI 10.1016/j.biocon.2012.02.026; Lindenmayer DB, 2012, AUSTRAL ECOL, V37, P285, DOI 10.1111/j.1442-9993.2011.02314.x; Munro Nicola T., 2007, Ecological Management & Restoration, V8, P199, DOI 10.1111/j.1442-8903.2007.00368.x; Patten MA, 1997, RESTOR ECOL, V5, P156, DOI 10.1046/j.1526-100X.1997.09718.x; Peach WJ, 2001, BIOL CONSERV, V101, P361, DOI 10.1016/S0006-3207(01)00083-0; Plummer M., 2003, P 3 INT WORKSH DISTR; PULLIAM HR, 1991, AM NAT, V137, pS50, DOI 10.1086/285139; Robinson D, 2008, STATE AUSTR BIRDS 20, P37; Robinson D, 1996, WINGSPAN S, V10, P16; ROBINSON D, 1994, RES PLAN THREATENED; Robinson Doug, 2006, Ecological Management & Restoration, V7, P93, DOI 10.1111/j.1442-8903.2006.00263.x; Robinson D, 2012, BIODIVERSITY MONITORING IN AUSTRALIA, P141; Royle J. A., 2008, HIERARCHICAL MODELIN; Royle JA, 2006, J AGR BIOL ENVIR ST, V11, P249, DOI 10.1198/108571106X129153; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Saunders DA, 1995, CONSERVING BIODIVERSITY: THREATS AND SOLUTIONS, P104; Selwood K, 2009, OECOLOGIA, V159, P435, DOI 10.1007/s00442-008-1221-9; Su Y.-S., 2009, R PACKAGE R2JAGS PAC; van der Ree R, 2003, J ZOOL, V259, P327, DOI 10.1017/S0952836902003229; van der Ree R, 2008, EFFECTS TRAFFIC OCCU; VANHORNE B, 1983, J WILDLIFE MANAGE, V47, P893; Vesk PA, 2006, AGR ECOSYST ENVIRON, V112, P356, DOI 10.1016/j.agee.2005.08.038; Vesk PA, 2008, BIOL CONSERV, V141, P174, DOI 10.1016/j.biocon.2007.09.010; Walker KJ, 2004, BIOL CONSERV, V119, P1, DOI 10.1016/j.biocon.2003.10.020; Yen JDL, 2011, ECOGRAPHY, V34, P946, DOI 10.1111/j.1600-0587.2011.06651.x	60	7	7	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0130153	10.1371/journal.pone.0130153	http://dx.doi.org/10.1371/journal.pone.0130153			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26177497	Green Published, gold			2022-12-26	WOS:000358197600018
J	Kang, CH; Goodman, CA; Hornberger, TA; Ji, LL				Kang, Chounghun; Goodman, Craig A.; Hornberger, Troy A.; Ji, Li Li			PGC-1 alpha overexpression by in vivo transfection attenuates mitochondrial deterioration of skeletal muscle caused by immobilization	FASEB JOURNAL			English	Article						atrophy; inflammation; oxidative stress	UBIQUITIN LIGASE; COACTIVATOR PGC-1; OXIDATIVE STRESS; BED-REST; ATROPHY; EXPRESSION; DISUSE; BIOGENESIS; PROTEIN; EXERCISE	Prolonged immobilization (IM) causes skeletal muscle atrophy characterized by mitochondrial deterioration and proteolysis. Muscle remobilization (RM) increases reactive oxygen species generation, proinflammatory cytokine expression, and oxidative stress, preventing muscle from quick recovery. Thus, we hypothesized that overexpression of peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PGC-1 alpha) via in vivo transfection would promote mitochondrial biogenesis and antioxidant defense, thus ameliorating the aforementioned deteriorations in a mouse model with 14-d IM followed by 5-d RM. PGC-1 alpha transfection in tibialis anterior muscle resulted in a 7.2-and 4-fold increase in PGC-1 alpha content in cytosol and nucleus, respectively. Mitochondrial biogenic (cytochrome c, mitochondrial transcription factor A), morphologic (mitochondrial density, mDNA/nDNA ratio), and functional (cytochrome c oxidase activity, ATP synthesis rate) markers, as well as fiber cross-sectional area, significantly increased in IM-RM muscle by PGC-1 alpha overexpression. These effects were accompanied by an 18% decrease in H2O2, 30% decrease in nuclear factor-kB-DNA binding, and 25% reduction of IL-1 beta and-6 production in IM-RMmuscle. There was a 34% increase in superoxide dismutase-2 activity, along with a 3.5-fold increase in NAD-dependent deacetylase sirtuin-3 expression caused by enhanced PGC-1 alpha-estrogen-related receptor a binding. Our findings highlighted the importance of PGC-1 alpha in protecting muscle from metabolic and redox disturbances caused by IM.	[Kang, Chounghun; Ji, Li Li] Univ Minnesota Twin Cities, Sch Kinesiol, Lab Physiol Hyg & Exercise Sci, Minneapolis, MN USA; [Goodman, Craig A.; Hornberger, Troy A.] Univ Wisconsin, Sch Vet Med, Dept Comparat Biosci, Madison, WI 53706 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Wisconsin System; University of Wisconsin Madison	Ji, LL (corresponding author), Lab Physiol Hyg & Exercise Sci, 1900 Univ Ave, Minneapolis, MN 55455 USA.	llji@umn.edu	Goodman, Craig/H-8085-2019	Goodman, Craig/0000-0002-5874-7743	Wisconsin Alumni Research Foundation; University of Minnesota Office of Vice-President for Research; U.S. National Institutes of Health, National Institute of Arthritis and Musculoskeletal and Skin Diseases [AR057347]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR057347] Funding Source: NIH RePORTER	Wisconsin Alumni Research Foundation; University of Minnesota Office of Vice-President for Research; U.S. National Institutes of Health, National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This project was supported in part by grants from the Wisconsin Alumni Research Foundation and the University of Minnesota Office of Vice-President for Research (to L.L.J.), and a U.S. National Institutes of Health, National Institute of Arthritis and Musculoskeletal and Skin Diseases Grant AR057347 (to T.A.H.). The authors declare no conflicts of interest.	Ahn BH, 2008, P NATL ACAD SCI USA, V105, P14447, DOI 10.1073/pnas.0803790105; Alvarez-Guardia D, 2010, CARDIOVASC RES, V87, P449, DOI 10.1093/cvr/cvq080; Baar K, 2002, FASEB J, V16, P1879, DOI 10.1096/fj.02-0367com; Bodine SC, 2001, SCIENCE, V294, P1704, DOI 10.1126/science.1065874; Caron AZ, 2009, J APPL PHYSIOL, V106, P2049, DOI 10.1152/japplphysiol.91505.2008; Chen YH, 2011, EMBO REP, V12, P534, DOI 10.1038/embor.2011.65; Clarke BA, 2007, CELL METAB, V6, P376, DOI 10.1016/j.cmet.2007.09.009; Falk DJ, 2006, J APPL PHYSIOL, V101, P1017, DOI 10.1152/japplphysiol.00104.2006; Gomes MD, 2001, P NATL ACAD SCI USA, V98, P14440, DOI 10.1073/pnas.251541198; Guttridge DC, 2000, SCIENCE, V289, P2363, DOI 10.1126/science.289.5488.2363; Handschin C, 2007, J CLIN INVEST, V117, P3463, DOI 10.1172/JCI31785; Handschin C, 2007, J BIOL CHEM, V282, P30014, DOI 10.1074/jbc.M704817200; Irrcher I, 2003, AM J PHYSIOL-CELL PH, V284, pC1669, DOI 10.1152/ajpcell.00409.2002; Jackman RW, 2004, AM J PHYSIOL-CELL PH, V287, pC834, DOI 10.1152/ajpcell.00579.2003; Kandarian SC, 2006, MUSCLE NERVE, V33, P155, DOI 10.1002/mus.20442; Kang C, 2013, J APPL PHYSIOL, V115, P1618, DOI 10.1152/japplphysiol.01354.2012; Kedar V, 2004, P NATL ACAD SCI USA, V101, P18135, DOI 10.1073/pnas.0404341102; KONDO H, 1993, AM J PHYSIOL, V265, pE839, DOI 10.1152/ajpendo.1993.265.6.E839; Kong XX, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011707; Krawiec BJ, 2005, AM J PHYSIOL-ENDOC M, V289, pE969, DOI 10.1152/ajpendo.00126.2005; LEBLANC AD, 1992, J APPL PHYSIOL, V73, P2172, DOI 10.1152/jappl.1992.73.5.2172; Leick L, 2010, EXP GERONTOL, V45, P336, DOI 10.1016/j.exger.2010.01.011; Leick L, 2009, AM J PHYSIOL-ENDOC M, V297, pE92, DOI 10.1152/ajpendo.00076.2009; Li HH, 2004, J CLIN INVEST, V114, P1058, DOI 10.1172/JCl200422220; Li H, 2008, J MOL MED, V86, P1113, DOI 10.1007/s00109-008-0373-8; Li YP, 2000, AM J PHYSIOL-REG I, V279, pR1165, DOI 10.1152/ajpregu.2000.279.4.R1165; Liu J, 2014, FREE RADICAL BIO MED, V69, P116, DOI 10.1016/j.freeradbiomed.2014.01.003; Lombard DB, 2007, MOL CELL BIOL, V27, P8807, DOI 10.1128/MCB.01636-07; Powers SK, 2007, J APPL PHYSIOL, V102, P2389, DOI 10.1152/japplphysiol.01202.2006; Powers SK, 2012, AM J PHYSIOL-ENDOC M, V303, pE31, DOI 10.1152/ajpendo.00609.2011; Sacheck JM, 2007, FASEB J, V21, P140, DOI 10.1096/fj.06-6604com; Sandri M, 2008, PHYSIOLOGY, V23, P160, DOI 10.1152/physiol.00041.2007; Sandri M, 2006, P NATL ACAD SCI USA, V103, P16260, DOI 10.1073/pnas.0607795103; Scarpulla RC, 2008, PHYSIOL REV, V88, P611, DOI 10.1152/physrev.00025.2007; Schreiber SN, 2004, P NATL ACAD SCI USA, V101, P6472, DOI 10.1073/pnas.0308686101; St-Pierre J, 2003, J BIOL CHEM, V278, P26597, DOI 10.1074/jbc.M301850200; St-Pierre J, 2006, CELL, V127, P397, DOI 10.1016/j.cell.2006.09.024; Stevenson EJ, 2003, J PHYSIOL-LONDON, V551, P33, DOI 10.1113/jphysiol.2003.044701; STUART CA, 1988, METABOLISM, V37, P802, DOI 10.1016/0026-0495(88)90018-2; THOMASON DB, 1990, J APPL PHYSIOL, V68, P1, DOI 10.1152/jappl.1990.68.1.1; Timmons JA, 2006, GENOMICS, V87, P165, DOI 10.1016/j.ygeno.2005.09.007; Tintignac LA, 2005, J BIOL CHEM, V280, P2847, DOI 10.1074/jbc.M411346200; Tisdale MJ, 1997, J NATL CANCER I, V89, P1763, DOI 10.1093/jnci/89.23.1763; Valle I, 2005, CARDIOVASC RES, V66, P562, DOI 10.1016/j.cardiores.2005.01.026; Wenz T, 2009, P NATL ACAD SCI USA, V106, P20405, DOI 10.1073/pnas.0911570106; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X	46	51	55	1	12	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2015	29	10					4092	4106		10.1096/fj.14-266619	http://dx.doi.org/10.1096/fj.14-266619			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CR5FY	26178167	Green Published			2022-12-26	WOS:000361367300002
J	Annandale, E; Hammarstrom, A				Annandale, Ellen; Hammarstrom, Anne			Gender Inequality in the Couple Relationship and Leisure-Based Physical Exercise	PLOS ONE			English	Article							HEALTH; TIME; WOMEN; MEN; HOUSEWORK; EQUALITY; WORK; CONVERGENCE; DIVISION; QUALITY	Aims To analyse whether gender inequality in the couple relationship was related to leisure-based physical activity, after controlling for earlier physical activity and confounders. Methods Data drawn from the Northern Swedish Cohort of all pupils in their final year of compulsory schooling in a town in the North of Sweden. The sample consisted of 772 respondents (n = 381 men, n = 391 women) in the 26-year follow-up (in 2007, aged 42) who were either married or cohabiting. Ordinal regression, for men and women separately, was used to assess the association between gender inequality (measured as self-perceived equality in the couple relationship using dummy variables) and a measure of exercise frequency, controlling for prior exercise frequency, socioeconomic status, the presence of children in the home, and longer than usual hours in paid work. Results The perception of greater gender equality in the couple relationship was associated with higher levels of physical activity for both men and women. This remained significant when the other variables were controlled for. Amongst men the confidence intervals were high. Conclusions The results point to the potential of perceived gender equality in the couple relationship to counteract the general time poverty and household burden that often arises from the combination of paid work and responsibility for children and the home, especially for women. The high confidence intervals among men indicate the need for more research within the field with larger samples.	[Annandale, Ellen] Univ York, Dept Sociol, York YO10 5DD, N Yorkshire, England; [Hammarstrom, Anne] Umea Univ, Unit Social Med, Dept Publ Hlth & Clin Med, Umea, Sweden	University of York - UK; Umea University	Annandale, E (corresponding author), Univ York, Dept Sociol, York YO10 5DD, N Yorkshire, England.	ellen.annandale@york.ac.uk		Hammarstrom, Anne/0000-0002-4095-7961	Swedish Council for Working Life and Social Research [Dnr 2007-2073]; Swedish Research Council Formas [Dnr 259-2012-37]	Swedish Council for Working Life and Social Research(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte)); Swedish Research Council Formas(Swedish Research CouncilSwedish Research Council Formas)	Financial support was provided by the Swedish Council for Working Life and Social Research, grant number: Dnr 2007-2073 and by the Swedish Research Council Formas: Dnr 259-2012-37. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, FOLKHALSORAPPORT2014; Backhans MC, 2007, SOC SCI MED, V64, P1892, DOI 10.1016/j.socscimed.2007.01.016; Bellows-Riecken KH, 2008, PREV MED, V46, P99, DOI 10.1016/j.ypmed.2007.08.003; Bianchi SM, 2010, J MARRIAGE FAM, V72, P705, DOI 10.1111/j.1741-3737.2010.00726.x; Biblarz TJ, 2010, J MARRIAGE FAM, V72, P480, DOI 10.1111/j.1741-3737.2010.00714.x; Bird C, 2008, GENDER AND HLTH, P256; Bittman M, 2000, SOC FORCES, V79, P165, DOI 10.2307/2675568; Bittman M, 2003, AM J SOCIOL, V109, P186, DOI 10.1086/378341; Brown H, 2011, SOC SCI MED, V73, P383, DOI 10.1016/j.socscimed.2011.06.001; Carr D, 2010, J MARRIAGE FAM, V72, P743, DOI 10.1111/j.1741-3737.2010.00728.x; Cockerham WC, 2005, J HEALTH SOC BEHAV, V46, P51, DOI 10.1177/002214650504600105; Connell R, 2012, SOC SCI MED, V74, P1675, DOI 10.1016/j.socscimed.2011.06.006; Davis SN, 2013, J FAM THEOR REV, V5, P63, DOI 10.1111/jftr.12004; European Commission, 2014, SPEC EUR 414 SPORT P, P135; Evertsson M, 2007, EUR SOCIOL REV, V23, P455, DOI 10.1093/esr/jcm018; Ferree MM, 2010, J MARRIAGE FAM, V72, P420, DOI 10.1111/j.1741-3737.2010.00711.x; Grzywacz JG, 2000, J MARRIAGE FAM, V62, P336, DOI 10.1111/j.1741-3737.2000.00336.x; Hallerod B, 2007, MODERN COUPLES SHARING MONEY, SHARING LIFE, P143; Harryson L, 2013, EQUAL SHARE THATS MY; Harryson L, 2012, J EPIDEMIOL COMMUN H, V66, P271, DOI 10.1136/jech.2010.109231; Lewis MA, 2006, SOC SCI MED, V62, P1369, DOI 10.1016/j.socscimed.2005.08.006; Markula P, 2011, WOMEN EXERCISE BODY, P320; Mattingly MJ, 2003, SOC FORCES, V81, P999, DOI 10.1353/sof.2003.0036; Moss N, 2009, SOC SCI MED, V54, P649; National Centre for Health Research, 2009, HLTH SURV ENGL, V1; Nomaguchi KM, 2004, J MARRIAGE FAM, V66, P413, DOI 10.1111/j.1741-3737.2004.00029.x; Nordenmark M, 2003, EUR J WOMENS STUD, V10, P181, DOI 10.1177/1350506803010002004; Payne S, 2006, HLTH MEN WOMEN, P229; Ridgeway CL, 2004, GENDER SOC, V18, P510, DOI 10.1177/0891243204265269; Roos E, 2007, PUBLIC HEALTH NUTR, V10, P222, DOI 10.1017/S1368980007248487; Sayer LC, 2005, SOC FORCES, V84, P285, DOI 10.1353/sof.2005.0126; Solomon SE, 2005, SEX ROLES, V52, P561, DOI 10.1007/s11199-005-3725-7; Statistics Sweden, 2014, MEN WOM SWED 2014; Such E, 2008, LEISURE STUD, V25, P185; Umberson D, 2006, J HEALTH SOC BEHAV, V47, P1, DOI 10.1177/002214650604700101; Van de Velde S, 2013, SOCIOL HEALTH ILL, V35, P682, DOI 10.1111/j.1467-9566.2012.01521.x; West C, 1987, GENDER SOC, V1, P125, DOI 10.1177/0891243287001002002	37	4	4	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0133348	10.1371/journal.pone.0133348	http://dx.doi.org/10.1371/journal.pone.0133348			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN6LZ	26196280	Green Published, gold, Green Submitted			2022-12-26	WOS:000358547600086
J	Deguen, S; Petit, C; Delbarre, A; Kihal, W; Padilla, C; Benmarhnia, T; Lapostolle, A; Chauvin, P; Zmirou-Navier, D				Deguen, Severine; Petit, Claire; Delbarre, Angelique; Kihal, Wahida; Padilla, Cindy; Benmarhnia, Tarik; Lapostolle, Annabelle; Chauvin, Pierre; Zmirou-Navier, Denis			Neighbourhood Characteristics and Long-Term Air Pollution Levels Modify the Association between the Short-Term Nitrogen Dioxide Concentrations and All-Cause Mortality in Paris	PLOS ONE			English	Article							CASE-CROSSOVER ANALYSES; SOCIAL INEQUALITIES; PARTICULATE MATTER; TIME-SERIES; SOCIOECONOMIC-STATUS; HEALTH; EXPOSURE; DESIGN; SUSCEPTIBILITY; TEMPERATURE	Background While a great number of papers have been published on the short-term effects of air pollution on mortality, few have tried to assess whether this association varies according to the neighbourhood socioeconomic level and long-term ambient air concentrations measured at the place of residence. We explored the effect modification of 1) socioeconomic status, 2) long-term NO2 ambient air concentrations, and 3) both combined, on the association between short-term exposure to NO2 and all-cause mortality in Paris (France). Methods A time-stratified case-crossover analysis was performed to evaluate the effect of short-term NO2 variations on mortality, based on 79,107 deaths having occurred among subjects aged over 35 years, from 2004 to 2009, in the city of Paris. Simple and double interactions were statistically tested in order to analyse effect modification by neighbourhood characteristics on the association between mortality and short-term NO2 exposure. The data was estimated at the census block scale (n=866). Results The mean of the NO2 concentrations during the five days prior to deaths were associated with an increased risk of all-cause mortality: overall Excess Risk (ER) was 0.94% (95% CI=[0.08;1.80]. A higher risk was revealed for subjects living in the most deprived census blocks in comparison with higher socioeconomic level areas (ER=3.14% (95% CI=[1.4-14.90], p<0.001). Among these deprived census blocks, excess risk was even higher where long-term average NO2 concentrations were above 55.8 mu g/m(3) (the top tercile of distribution): ER=4.84%(95% CI=[1.56;8.24], p for interaction= 0.02). Conclusion Our results show that people living in census blocks characterized by low socioeconomic status are more vulnerable to air pollution episodes. There is also an indication that people living in these disadvantaged census blocks might experience even higher risk following short-term air pollution episodes, when they are also chronically exposed to higher NO2 levels.	[Deguen, Severine; Petit, Claire; Delbarre, Angelique; Kihal, Wahida; Padilla, Cindy; Benmarhnia, Tarik; Zmirou-Navier, Denis] EHESP Sch Publ Hlth, Rennes, France; [Deguen, Severine; Petit, Claire; Kihal, Wahida; Padilla, Cindy; Benmarhnia, Tarik; Zmirou-Navier, Denis] INSERM U1085 IRSET, Rennes, France; [Lapostolle, Annabelle; Chauvin, Pierre] INSERM U707, Res Grp Social Determinants Hlth & Healthcare, Paris, France; [Zmirou-Navier, Denis] Lorraine Univ, Sch Med, Vandoeuvre Les Nancy, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Franche-Comte; Universite de Lorraine	Deguen, S (corresponding author), EHESP Sch Publ Hlth, Rennes, France.	severine.deguen@ehesp.fr	Chauvin, Pierre/S-2981-2019; deguen, Severine/K-4958-2015; Chauvin, Pierre/G-1095-2015; Zmirou, Denis/J-9433-2015	Chauvin, Pierre/0000-0002-9183-6406; Chauvin, Pierre/0000-0002-9183-6406; PADILLA, Cindy.M/0000-0001-6673-7847	ANR [2010-PRSP-002-01]	ANR(French National Research Agency (ANR))	Support for this study was provided by the LERES laboratory at EHESP, which provided the weather variables. Nitrogen concentrations were modelled at census block level by the Paris region air surveillance network AirParif, as part of a research project on environment and social health disparities (ANR grant 2010-PRSP-002-01).	Adamkiewicz G, 2011, AM J PUBLIC HEALTH, V101, pS238, DOI 10.2105/AJPH.2011.300119; Anderson H R, 2003, Eur Respir J Suppl, V40, p39s; Bateson TF, 2004, EPIDEMIOLOGY, V15, P143, DOI 10.1097/01.ede.0000112210.68754.fa; Bateson TF, 2001, EPIDEMIOLOGY, V12, P654, DOI 10.1097/00001648-200111000-00013; Bell ML, 2013, AM J EPIDEMIOL, V178, P865, DOI 10.1093/aje/kwt090; Breitner S, 2014, SCI TOTAL ENVIRON, V485, P49, DOI 10.1016/j.scitotenv.2014.03.048; Brochu PJ, 2011, AM J PUBLIC HEALTH, V101, pS224, DOI 10.2105/AJPH.2011.300232; Chardon B, 2008, REV EPIDEMIOL SANTE, V56, P31, DOI 10.1016/j.respe.2007.11.002; Chen Bingheng, 2008, Environmental Health and Preventive Medicine, V13, P94, DOI 10.1007/s12199-007-0018-5; Chiusolo M, 2011, ENVIRON HEALTH PERSP, V119, P1233, DOI 10.1289/ehp.1002904; Clarisse B, 2007, EUR J EPIDEMIOL, V22, P203, DOI 10.1007/s10654-007-9109-2; Danet S, 1999, Circulation, V100, pE1; Deguen S, 2010, EUR J PUBLIC HEALTH, V20, P27, DOI 10.1093/eurpub/ckp220; Deschenes O., 18345 NBER; ERS (European Respiratory Society), AIR QUAL HLTH; Filleul L, 2004, J OCCUP ENVIRON MED, V46, P1115, DOI 10.1097/01.jom.0000144998.82543.9d; Forastiere F, 2007, AM J IND MED, V50, P208, DOI 10.1002/ajim.20368; Goldberg MS, 2011, ENVIRON RES, V111, P853, DOI 10.1016/j.envres.2011.05.022; Hajat S, 2005, EPIDEMIOLOGY, V16, P613, DOI 10.1097/01.ede.0000164559.41092.2a; Hoibian S, 2012, S3916 CRED, pS3916; Janes H, 2005, EPIDEMIOLOGY, V16, P717, DOI 10.1097/01.ede.0000181315.18836.9d; Jerrett M, 2004, J EPIDEMIOL COMMUN H, V58, P31, DOI 10.1136/jech.58.1.31; Kloog I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034664; Krieger N, 2003, J EPIDEMIOL COMMUN H, V57, P186, DOI 10.1136/jech.57.3.186; Kruize H, 2007, ENVIRON MANAGE, V40, P578, DOI 10.1007/s00267-005-0378-9; Lalloue B, 2013, INT J EQUITY HEALTH, V12, DOI 10.1186/1475-9276-12-21; Lepeule J, 2006, ENVIRON HEALTH PERSP, V114, P242, DOI 10.1289/ehp.8311; MACLURE M, 1991, AM J EPIDEMIOL, V133, P144, DOI 10.1093/oxfordjournals.aje.a115853; Marmot M, 2005, LANCET, V365, P1099, DOI 10.1016/S0140-6736(05)74234-3; McLeod H., 2000, REG ENV CHANG, V1, P18; Mesle F, 1996, HIST METHOD, V29, P72, DOI 10.1080/01615440.1996.10112731; Montero JC, 2012, SCI TOTAL ENVIRON, V414, P73, DOI 10.1016/j.scitotenv.2011.10.009; Niedhammer I, 2008, SOC SCI MED, V67, P1870, DOI 10.1016/j.socscimed.2008.09.007; Ou CQ, 2008, ENVIRON RES, V107, P237, DOI 10.1016/j.envres.2008.02.002; Padilla CM, 2014, ENVIRON RES, V34, P315; Ren C, 2008, ENVIRON HEALTH-GLOB, V7, DOI 10.1186/1476-069X-7-56; Samoli E, 2006, EUR RESPIR J, V27, P1129, DOI 10.1183/09031936.06.00143905; Samoli E, 2008, ENVIRON HEALTH PERSP, V116, P1480, DOI 10.1289/ehp.11345; Schwartz J, 2001, EPIDEMIOLOGY, V12, P55, DOI 10.1097/00001648-200101000-00010; Sun QH, 2010, CIRCULATION, V121, P2755, DOI 10.1161/CIRCULATIONAHA.109.893461; Vardoulakis S, 2003, ATMOS ENVIRON, V37, P155, DOI 10.1016/S1352-2310(02)00857-9; Wojtyniak B, 2001, EPIDEMIOLOGY, V12, pS64; Wong CM, 2008, ENVIRON HEALTH PERSP, V116, P1189, DOI 10.1289/ehp.10850; Zanobetti A, 2004, CIRCULATION, V110, P2184, DOI 10.1161/01.CIR.0000143831.33243.D8; Zanobetti A, 2002, EPIDEMIOLOGY, V13, P87, DOI 10.1097/00001648-200201000-00014; Zanobetti A, 2000, J OCCUP ENVIRON MED, V42, P469, DOI 10.1097/00043764-200005000-00002; Zeka A, 2006, AM J EPIDEMIOL, V163, P849, DOI 10.1093/aje/kwj116	47	36	36	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0131463	10.1371/journal.pone.0131463	http://dx.doi.org/10.1371/journal.pone.0131463			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LZ	26197409	Green Published, gold			2022-12-26	WOS:000358547600013
J	Gesualdo, F; Stilo, G; D'Ambrosio, A; Carloni, E; Pandolfi, E; Velardi, P; Fiocchi, A; Tozzi, AE				Gesualdo, Francesco; Stilo, Giovanni; D'Ambrosio, Angelo; Carloni, Emanuela; Pandolfi, Elisabetta; Velardi, Paola; Fiocchi, Alessandro; Tozzi, Alberto E.			Can Twitter Be a Source of Information on Allergy? Correlation of Pollen Counts with Tweets Reporting Symptoms of Allergic Rhinoconjunctivitis and Names of Antihistamine Drugs	PLOS ONE			English	Article							INTERNET; MEDIA	Pollen forecasts are in use everywhere to inform therapeutic decisions for patients with allergic rhinoconjunctivitis (ARC). We exploited data derived from Twitter in order to identify tweets reporting a combination of symptoms consistent with a case definition of ARC and those reporting the name of an antihistamine drug. In order to increase the sensitivity of the system, we applied an algorithm aimed at automatically identifying jargon expressions related to medical terms. We compared weekly Twitter trends with National Allergy Bureau weekly pollen counts derived from US stations, and found a high correlation of the sum of the total pollen counts from each stations with tweets reporting ARC symptoms (Pearson's correlation coefficient: 0.95) and with tweets reporting antihistamine drug names (Pearson's correlation coefficient: 0.93). Longitude and latitude of the pollen stations affected the strength of the correlation. Twitter and other social networks may play a role in allergic disease surveillance and in signaling drug consumptions trends.	[Gesualdo, Francesco; D'Ambrosio, Angelo; Carloni, Emanuela; Pandolfi, Elisabetta; Fiocchi, Alessandro; Tozzi, Alberto E.] Bambino Gesu Childrens Hosp IRCCS, Multifactorial Dis & Complex Phenotype Res Area, Rome, Italy; [Stilo, Giovanni; Velardi, Paola] Univ Roma La Sapienza, Dept Informat, I-00185 Rome, Italy	IRCCS Bambino Gesu; Sapienza University Rome	Gesualdo, F (corresponding author), Bambino Gesu Childrens Hosp IRCCS, Multifactorial Dis & Complex Phenotype Res Area, Rome, Italy.	f.gesualdo@gmail.com	Fiocchi, Alessandro/K-9235-2016; Gesualdo, Francesco/H-9221-2012; D'Ambrosio, Angelo/Y-1798-2018; Carloni, Emanuela/AAB-5959-2020; Tozzi, Alberto Eugenio/F-9494-2012; Stilo, Giovanni/AAE-5484-2020; Pandolfi, Elisabetta/K-5173-2016	Fiocchi, Alessandro/0000-0002-2549-0523; Gesualdo, Francesco/0000-0002-9087-4398; D'Ambrosio, Angelo/0000-0002-2045-5155; Tozzi, Alberto Eugenio/0000-0002-6884-984X; Velardi, Paola/0000-0003-0884-1499; Pandolfi, Elisabetta/0000-0003-2424-2736; Carloni, Emanuela/0000-0002-3486-4507				Baptist AP, 2011, J ASTHMA, V48, P824, DOI 10.3109/02770903.2011.608460; Bauchau V, 2005, ALLERGY, V60, P350, DOI 10.1111/j.1398-9995.2005.00751.x; Bousquet J, 2014, EUR RESPIR J, V44, P304, DOI 10.1183/09031936.00014614; Chew C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014118; Eberth JM, 2014, J ADOLESCENT HEALTH, V54, P289, DOI 10.1016/j.jadohealth.2013.09.005; Freifeld CC, 2008, J AM MED INFORM ASSN, V15, P150, DOI 10.1197/jamia.M2544; Freifeld CC, 2014, DRUG SAFETY, V37, P343, DOI 10.1007/s40264-014-0155-x; Gesualdo F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082489; Ginsberg J, 2009, NATURE, V457, P1012, DOI 10.1038/nature07634; Imonikhe R, 2011, EYE, V25, P1663, DOI 10.1038/eye.2011.249; Keith PK, 2012, ALLERGY ASTHMA CL IM, V8, DOI 10.1186/1710-1492-8-7; Maurer M, 2007, ALLERGY, V62, P1057, DOI 10.1111/j.1398-9995.2007.01367.x; McIver DJ, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003581; Milinovich GJ, 2014, LANCET INFECT DIS, V14, P160, DOI 10.1016/S1473-3099(13)70244-5; Signorini A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019467; Simmering JE, 2014, RES SOCIAL ADM PHARM; Velardi P, 2014, ARTIF INTELL MED, V61, P153, DOI 10.1016/j.artmed.2014.01.002; Zuckerman O, 2014, ANN ALLERGY ASTHMA I	18	16	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0133706	10.1371/journal.pone.0133706	http://dx.doi.org/10.1371/journal.pone.0133706			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LZ	26197474	gold, Green Submitted, Green Published			2022-12-26	WOS:000358547600134
J	Horowitz-Kraus, T; Toro-Serey, C; DiFrancesco, M				Horowitz-Kraus, Tzipi; Toro-Serey, Claudio; DiFrancesco, Mark			Increased Resting-State Functional Connectivity in the Cingulo-Opercular Cognitive-Control Network after Intervention in Children with Reading Difficulties	PLOS ONE			English	Article							ERROR-DETECTION MECHANISM; VISUAL-SPATIAL ATTENTION; SMALL-WORLD NETWORKS; EXECUTIVE FUNCTIONS; DEVELOPMENTAL DYSLEXIA; WORKING-MEMORY; TERM-MEMORY; BRAIN; FMRI; DEFICITS	Dyslexia, or reading difficulty, is characterized by slow, inaccurate reading accompanied by executive dysfunction. Reading training using the Reading Acceleration Program improves reading and executive functions in both children with dyslexia and typical readers. This improvement is associated with increased activation in and functional connectivity between the anterior cingulate cortex, part of the cingulo-opercular cognitive-control network, and the fusiform gyrus during a reading task after training. The objective of the current study was to determine whether the training also has an effect on functional connectivity of the cingulo-opercular and fronto-parietal cognitive-control networks during rest in children with dyslexia and typical readers. Fifteen children with reading difficulty and 17 typical readers (8-12 years old) were included in the study. Reading and executive functions behavioral measures and resting-state functional magnetic resonance imaging data were collected before and after reading training. Imaging data were analyzed using a graphical network-modeling tool. Both reading groups had increased reading and executive-functions scores after training, with greater gains among the dyslexia group. Training may have less effect on cognitive control in typical readers and a more direct effect on the visual area, as previously reported. Statistical analysis revealed that compared to typical readers, children with reading difficulty had significantly greater functional connectivity in the cingulo-opercular network after training, which may demonstrate the importance of cognitive control during reading in this population. These results support previous findings of increased error-monitoring activation after reading training in children with dyslexia and confirm greater gains with training in this group.	[Horowitz-Kraus, Tzipi; DiFrancesco, Mark] Cincinnati Childrens Hosp Med Ctr, Pediat Neuroimaging Res Consortium, Cincinnati, OH 45229 USA; [Horowitz-Kraus, Tzipi; Toro-Serey, Claudio] Cincinnati Childrens Hosp Med Ctr, Reading & Literacy Discovery Ctr, Cincinnati, OH 45229 USA	Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center	Horowitz-Kraus, T (corresponding author), Cincinnati Childrens Hosp Med Ctr, Pediat Neuroimaging Res Consortium, Cincinnati, OH 45229 USA.	Tzipi.Horowitz-Kraus@cchmc.org	DiFrancesco, Mark William/AAE-6138-2020	DiFrancesco, Mark William/0000-0001-8002-0332; Toro-Serey, Claudio/0000-0002-5273-2276	Fulbright Foundation; US-Israel Binational Science Foundation [2009053]	Fulbright Foundation; US-Israel Binational Science Foundation(US-Israel Binational Science Foundation)	The study was supported by the Fulbright Foundation and the US-Israel Binational Science Foundation number 2009053.	Altemeier LE, 2008, J CLIN EXP NEUROPSYC, V30, P588, DOI 10.1080/13803390701562818; Baria AT, 2011, J NEUROSCI, V31, P7910, DOI 10.1523/JNEUROSCI.1296-11.2011; Behzadi Y, 2007, NEUROIMAGE, V37, P90, DOI 10.1016/j.neuroimage.2007.04.042; Breznitz Z, 2003, BRAIN LANG, V85, P486, DOI 10.1016/S0093-934X(03)00071-3; BREZNITZ Z, 1992, J EDUC PSYCHOL, V84, P193, DOI 10.1037/0022-0663.84.2.193; Breznitz Z, 1997, J EDUC PSYCHOL, V89, P103, DOI 10.1037/0022-0663.89.1.103; Breznitz Z, 1997, J EDUC PSYCHOL, V89, P289, DOI 10.1037/0022-0663.89.2.289; Breznitz Z., 2006, FLUENCY READING SYNC; Breznitz Z., 2010, READING ACCELERATION; Breznitz Z, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2488; Brosnan M, 2002, NEUROPSYCHOLOGIA, V40, P2144, DOI 10.1016/S0028-3932(02)00046-5; Brown L., 1997, TEST NONVERBAL INTEL; Byars AW, 2002, J CHILD NEUROL, V17, P885, DOI 10.1177/08830738020170122201; Conners C.K., 1989, CONNERS RATING SCALE; de Jong PF, 1998, J EXP CHILD PSYCHOL, V70, P75, DOI 10.1006/jecp.1998.2451; Dellis D. C., 2001, DELIS KAPLAN EXECUTI; Dosenbach NUF, 2008, TRENDS COGN SCI, V12, P99, DOI 10.1016/j.tics.2008.01.001; Dosenbach NUF, 2010, SCIENCE, V329, P1358, DOI 10.1126/science.1194144; Facoetti A, 2000, CORTEX, V36, P109, DOI 10.1016/S0010-9452(08)70840-2; Facoetti A, 2000, EXP BRAIN RES, V132, P531, DOI 10.1007/s002219900330; Fair D. A., 2012, COGNITIVE NEUROSCIEN, P291; Fair DA, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000381; Gabrieli JDE, 2012, CURR BIOL, V22, pR298, DOI 10.1016/j.cub.2012.03.041; Gooch D, 2011, J CHILD PSYCHOL PSYC, V52, P195, DOI 10.1111/j.1469-7610.2010.02312.x; Gordon EM, 2016, CEREB CORTEX, V26, P288, DOI 10.1093/cercor/bhu239; Gratton C, 2015, NETWORK PROPERTIES A; Helland T, 2000, CHILD NEUROPSYCHOL, V6, P37, DOI 10.1076/0929-7049(200003)6:1;1-B;FT037; Hoeft F, 2007, BEHAV NEUROSCI, V121, P602, DOI 10.1037/0735-7044.121.3.602; Horowitz-Kraus T, 2015, INCREASED FUNCTIONAL; Horowitz-Kraus T, 2014, INCREASED FUNCTIONAL; Horowitz-Kraus T., 2010, LESS IS MORE ABILITY; Horowitz-Kraus T, 2008, CLIN NEUROPHYSIOL, V119, P2238, DOI 10.1016/j.clinph.2008.06.009; Horowitz-Kraus T, 2015, ANN DYSLEXIA, V65, P1, DOI 10.1007/s11881-015-0096-9; Horowitz-Kraus T, 2014, BRAIN BEHAV, V4, P886, DOI 10.1002/brb3.281; Horowitz-Kraus T, 2014, ANN DYSLEXIA, V64, P183, DOI 10.1007/s11881-014-0093-4; Horowitz-Kraus T, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00447; Horowitz-Kraus T, 2014, J LEARN DISABIL-US, V47, P208, DOI 10.1177/0022219412453084; Horowitz-Kraus T, 2014, BRAIN RES, V1544, P1, DOI 10.1016/j.brainres.2013.11.027; Horowitz-Kraus T, 2011, INT J DISABIL DEV ED, V58, P33, DOI 10.1080/1034912X.2011.548466; Horowitz-Kraus T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007141; Houde O, 2010, DEVELOPMENTAL SCI, V13, P876, DOI 10.1111/j.1467-7687.2009.00938.x; Ihnen SKZ, 2015, CEREB CORTEX, V25, P1198, DOI 10.1093/cercor/bht313; Korinth S. P., 2009, EJ SAFR IN C HAIF IS; Koyama MS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055454; Latora V, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.198701; Leikin M, 2001, GENET SOC GEN PSYCH, V127, P193; Liao W, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008525; Maldjian JA, 2004, NEUROIMAGE, V21, P450, DOI 10.1016/j.neuroimage.2003.09.032; Manly T, 1999, TEST EVERYDAY ATTENT; Masur D, 2013, NEUROLOGY, V81, P1572, DOI 10.1212/WNL.0b013e3182a9f3ca; McCandliss BD, 2003, MENT RETARD DEV D R, V9, P196, DOI 10.1002/mrdd.10080; Menghini D, 2010, DYSLEXIA, V16, P213, DOI 10.1002/dys.410; Neta M, 2014, NEUROIMAGE, V99, P59, DOI 10.1016/j.neuroimage.2014.05.053; Niedo J, 2014, LEARN DISABILITY Q, V37, P100, DOI 10.1177/0731948713507263; Nyhus E, 2009, BRAIN COGNITION, V71, P437, DOI 10.1016/j.bandc.2009.03.005; Power JD, 2015, NEUROIMAGE, V105, P536, DOI 10.1016/j.neuroimage.2014.10.044; Power JD, 2011, NEURON, V72, P665, DOI 10.1016/j.neuron.2011.09.006; Reiter A, 2005, DYSLEXIA, V11, P116, DOI 10.1002/dys.289; Shaywitz SE, 2008, DEV PSYCHOPATHOL, V20, P1329, DOI 10.1017/S0954579408000631; Snellings P, 2009, J LEARN DISABIL-US, V42, P291, DOI 10.1177/0022219408331038; Supekar K, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000100; Swanson E, 2011, J LEARN DISABIL-US, V44, P258, DOI 10.1177/0022219410378444; Sylvester CM, 2012, TRENDS NEUROSCI, V35, P527, DOI 10.1016/j.tins.2012.04.012; Szaflarski JP, 2006, ANN NEUROL, V59, P796, DOI 10.1002/ana.20817; Thevenaz P, 1998, IEEE T IMAGE PROCESS, V7, P27, DOI 10.1109/83.650848; Tiffin-Richards MC, 2008, J NEURAL TRANSM, V115, P227, DOI 10.1007/s00702-007-0816-3; Torgesen J.K., 1999, TOWRE TEST WORD READ; Torgesen J.K., 1999, COMPREHENSIVE TEST P; Vogel AC, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00088; Vogel AC, 2012, CEREB CORTEX, V22, P537, DOI 10.1093/cercor/bhr100; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Wechsler D., 1999, WECHSLER INTELLIGENC, V1; Whitfield-Gabrieli S, 2012, BRAIN CONNECT, V2, P125, DOI 10.1089/brain.2012.0073	73	46	46	1	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0133762	10.1371/journal.pone.0133762	http://dx.doi.org/10.1371/journal.pone.0133762			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN6LZ	26197049	Green Published, gold, Green Submitted			2022-12-26	WOS:000358547600141
J	Huber, S; Huettner, JP; Hacker, K; Bernhardt, G; Konig, J; Buschauer, A				Huber, Stefan; Huettner, Johannes Philip; Hacker, Kristina; Bernhardt, Guenther; Koenig, Joerg; Buschauer, Armin			Esters of Bendamustine Are by Far More Potent Cytotoxic Agents than the Parent Compound against Human Sarcoma and Carcinoma Cells	PLOS ONE			English	Article							CHRONIC LYMPHOCYTIC-LEUKEMIA; ORGANIC CATION TRANSPORTERS; RANDOMIZED PHASE-III; MYELOMA CELLS; IN-VITRO; MELPHALAN; RITUXIMAB; PROFILE; ANIONS; DETERMINANTS	The alkylating agent bendamustine is approved for the treatment of hematopoietic malignancies such as non-Hodgkin lymphoma, chronic lymphocytic leukemia and multiple myeloma. As preliminary data on recently disclosed bendamustine esters suggested increased cytotoxicity, we investigated representative derivatives in more detail. Especially basic esters, which are positively charged under physiological conditions, were in the crystal violet and the MTT assay up to approximately 100 times more effective than bendamustine, paralleled by a higher fraction of early apoptotic cancer cells and increased expression of p53. Analytical studies performed with bendamustine and representative esters revealed pronounced cellular accumulation of the derivatives compared to the parent compound. In particular, the pyrrolidinoethyl ester showed a high enrichment in tumor cells and inhibition of OCT1-and OCT3-mediated transport processes, suggesting organic cation transporters to be involved. However, this hypothesis was not supported by the differential expression of OCT1 (SLC22A1) and OCT3 (SLC22A3), comparing a panel of human cancer cells. Bendamustine esters proved to be considerably more potent cytotoxic agents than the parent compound against a broad panel of human cancer cell types, including hematologic and solid malignancies (e.g. malignant melanoma, colorectal carcinoma and lung cancer), which are resistant to bendamustine. Interestingly, spontaneously immortalized human keratinocytes, as a model of "normal" cells, were by far less sensitive than tumor cells against the most potent bendamustine esters.	[Huber, Stefan; Bernhardt, Guenther; Buschauer, Armin] Univ Regensburg, Inst Pharm, Pharmaceut & Med Chem 2, D-93053 Regensburg, Germany; [Huettner, Johannes Philip] Univ Regensburg, Inst Pharm, Pharmacol & Toxicol, D-93053 Regensburg, Germany; [Hacker, Kristina; Koenig, Joerg] Univ Erlangen Nurnberg, Inst Expt & Clin Pharmacol & Toxicol, D-91054 Erlangen, Germany	University of Regensburg; University of Regensburg; University of Erlangen Nuremberg	Buschauer, A (corresponding author), Univ Regensburg, Inst Pharm, Pharmaceut & Med Chem 2, D-93053 Regensburg, Germany.	armin.buschauer@chemie.uni-regensburg.de		Koenig, Joerg/0000-0001-7016-5482	Arevipharma (Radebeul, Germany); DFG	Arevipharma (Radebeul, Germany); DFG(German Research Foundation (DFG))	This study was sponsored in part by Arevipharma (Radebeul, Germany), and supported within the DFG funding program Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachmakov L, 2008, DIABETES, V57, P1463, DOI 10.2337/db07-1515; Bakale RP, 2014, Patent, Patent No. [WO2014075035A1, 2014075035]; BERNHARDT G, 1992, J CANCER RES CLIN, V118, P35, DOI 10.1007/BF01192309; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; Cheson BD, 2010, CL LYMPH MYELOM LEUK, V10, P452, DOI 10.3816/CLML.2010.n.079; Cheson BD, 2009, J CLIN ONCOL, V27, P1492, DOI 10.1200/JCO.2008.18.7252; Ciarimboli G, 2005, AM J PATHOL, V167, P1477, DOI 10.1016/S0002-9440(10)61234-5; Ciarimboli G, 2004, J CELL PHYSIOL, V201, P420, DOI 10.1002/jcp.20081; Cives M, 2013, CELL SIGNAL, V25, P1108, DOI 10.1016/j.cellsig.2013.01.020; Colledge J, 2010, Patent, Patent No. [WO2010063476, 2010063476]; Colledge J, 2010, Patent, Patent No. [WO2010063493, 2010063493, WO2010063493A1]; DOBRETSOV GE, 1985, BIOFIZIKA+, V30, P833; Eichbaum MHR, 2007, ANTI-CANCER DRUG, V18, P963; Friedberg JW, 2011, BLOOD, V117, P2807, DOI 10.1182/blood-2010-11-314708; Gaul L, 2008, J CANCER RES CLIN, V134, P245, DOI 10.1007/s00432-007-0278-x; Gil L, 2014, MED ONCOL, V31, DOI 10.1007/s12032-014-0944-1; Gupta S, 2012, J PHARMACOL EXP THER, V341, P16, DOI 10.1124/jpet.111.190561; Gust R, 1997, MONATSH CHEM, V128, P291, DOI 10.1007/BF00807895; Hallek M, 2013, HEMATOL-AM SOC HEMAT, P138, DOI 10.1182/asheducation-2013.1.138; Hiraoka N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090675; Huber S, 2015, J PHARMACEUT BIOMED, V104, P137, DOI 10.1016/j.jpba.2014.11.038; Kahl BS, 2010, CANCER-AM CANCER SOC, V116, P106, DOI 10.1002/cncr.24714; Kalaycio M, 2009, CANCER-AM CANCER SOC, V115, P473, DOI 10.1002/cncr.24057; Knauf WU, 2012, BRIT J HAEMATOL, V159, P67, DOI 10.1111/bjh.12000; Konig J, 2013, PHARMACOL REV, V65, P944, DOI 10.1124/pr.113.007518; Koepsell H, 2013, MOL ASPECTS MED, V34, P413, DOI 10.1016/j.mam.2012.10.010; Labell RY, 2010, Patent, Patent No. [WO2010126676, 2010126676]; Lammers PE, 2014, J THORAC ONCOL, V9, P559, DOI 10.1097/JTO.0000000000000079; Lentzsch S, 2014, BLOOD, V123, P948, DOI 10.1182/blood-2013-12-539817; Leoni LM, 2008, CLIN CANCER RES, V14, P309, DOI 10.1158/1078-0432.CCR-07-1061; Leoni LM, 2011, SEMIN HEMATOL, V48, pS4, DOI 10.1053/j.seminhematol.2011.03.002; Ludwig H, 2014, BLOOD, V123, P985, DOI 10.1182/blood-2013-08-521468; Massmann V, 2014, PFLUG ARCH EUR J PHY, V466, P517, DOI 10.1007/s00424-013-1335-8; MONKS A, 1991, J NATL CANCER I, V83, P757, DOI 10.1093/jnci/83.11.757; More SS, 2010, MOL CANCER THER, V9, P1058, DOI 10.1158/1535-7163.MCT-09-1084; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Owen JS, 2010, CANCER CHEMOTH PHARM, V66, P1039, DOI 10.1007/s00280-010-1254-8; OZEGOWSKI W, 1963, J PRAKT CHEM, V20, P178, DOI 10.1002/prac.19630200310; Ozegowski W., 1971, ZBL PHARM, V110, P1013; Pencheva I, 2008, J PHARMACEUT BIOMED, V48, P1143, DOI 10.1016/j.jpba.2008.09.001; PIETRUCK F, 1995, KIDNEY INT, V47, P1647, DOI 10.1038/ki.1995.229; Ponisch W, 2014, J CANCER RES CLIN, V140, P1947, DOI 10.1007/s00432-014-1737-9; Ponisch W, 2006, J CANCER RES CLIN, V132, P205, DOI 10.1007/s00432-005-0074-4; Preiss S, 2011, THESIS CHARITE UNIVE; REILE H, 1990, ANAL BIOCHEM, V187, P262, DOI 10.1016/0003-2697(90)90454-H; ROHLICEK V, 1994, RENAL PHYSIOL BIOCH, V17, P57; Rummel MJ, 2005, J CLIN ONCOL, V23, P3383, DOI 10.1200/JCO.2005.08.100; Rummel MJ, 2002, SEMIN ONCOL, V29, P12, DOI 10.1053/sonc.2002.34873; Schickaneder H, 2013, Patent, Patent No. [EP2656843, 2656843]; Scutaru AM, 2010, BIOCONJUGATE CHEM, V21, P1728, DOI 10.1021/bc900453f; Seithel A, 2007, DRUG METAB DISPOS, V35, P779, DOI 10.1124/dmd.106.014407; Shnitsar V, 2009, CANCER RES, V69, P1494, DOI 10.1158/0008-5472.CAN-08-2483; Solbach TF, 2011, J CARDIOVASC PHARM, V58, P409, DOI 10.1097/FJC.0b013e3182270783; Surget S, 2014, LEUKEMIA LYMPHOMA, V55, P2165, DOI 10.3109/10428194.2013.871277; Tageja N, 2010, CANCER CHEMOTH PHARM, V66, P413, DOI 10.1007/s00280-010-1317-x; Ullrich KJ, 1996, PFLUG ARCH EUR J PHY, V432, P471, DOI 10.1007/s004240050159; WERNER W, 1991, PHARMAZIE, V46, P113; White DL, 2006, BLOOD, V108, P697, DOI 10.1182/blood-2005-11-4687; Yokoo S, 2008, DRUG METAB DISPOS, V36, P2299, DOI 10.1124/dmd.108.023168; Zhang L, 1998, J PHARMACOL EXP THER, V286, P354; Zhang SZ, 2006, CANCER RES, V66, P8847, DOI 10.1158/0008-5472.CAN-06-0769	61	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0133743	10.1371/journal.pone.0133743	http://dx.doi.org/10.1371/journal.pone.0133743			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LZ	26196503	Green Published, gold, Green Submitted			2022-12-26	WOS:000358547600138
J	Tafreshi, M; Zwickel, N; Gorrell, RJ; Kwok, T				Tafreshi, Mona; Zwickel, Nicolas; Gorrell, Rebecca Jane; Kwok, Terry			Preservation of Helicobacter pylori CagA Translocation and Host Cell Proinflammatory Responses in the Face of CagL Hypervariability at Amino Acid Residues 58/59	PLOS ONE			English	Article							IV SECRETION; PROTEIN; SYSTEM; TRANSFORMATION; EXPRESSION	Carriage of the CagA oncoprotein by the human gastric cancer-associated pathogen Helicobacter pylori is significantly associated with this typically benign chronic infection advancing to a potentially fatal outcome. However it remains to be elucidated why only a small subset of individuals infected with H. pylori CagA-positive strains develops gastric cancer. H. pylori translocates CagA into host cells using a type IV secretion apparatus that interacts with host integrin receptors via a three-amino-acid-residue RGD motif on the H. pylori protein CagL. The RGD motif of CagL also plays a major role in the induction of proinflammatory responses. Upstream of this motif is a conserved glycine flanked by four hypervariable amino acid residues (residues 58, 59, 61 and 62). Certain amino acid polymorphisms at 58 and 59 are significantly prevalent in strains from gastric cancer patients in particular geographic regions; Y58E59 is seen in Taiwan and D58K59 in India. In light of the seemingly contradictory findings of recent CagL mutagenesis studies, we have examined the contribution of sequence promiscuity specifically at CagL residues 58 and 59 to CagA translocation and H. pylori-mediated proinflammatory responses of gastric epithelial cells. Using isogenic mutants of H. pylori strains P12 and 26695 with amino acid substitutions at CagL residues 58 and 59, we determined that carriage of the polymorphisms Y58E59, D58K59, D58E59, N58E59 or N58K59 did not significantly alter the capacity of H. pylori to translocate CagA into, or induce IL-8 secretion in, host cells. Our findings, together with other recently published data, suggest that the variation at CagL residues 58 and 59 does not influence type IV secretion system function in isolation, but rather may work in concert with particular polymorphisms elsewhere in CagL to modulate disease progression.	[Tafreshi, Mona; Zwickel, Nicolas; Gorrell, Rebecca Jane; Kwok, Terry] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic, Australia; [Gorrell, Rebecca Jane; Kwok, Terry] Monash Univ, Dept Microbiol, Clayton, Vic 3168, Australia	Monash University; Monash University	Kwok, T (corresponding author), Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic, Australia.	terry.kwok@monash.edu	Gorrell, Rebecca/H-5259-2019	Gorrell, Rebecca/0000-0003-0728-3325; Kwok, Terry/0000-0002-5905-3233	National Health and Medical Research Council Australia project grant [545983]; Monash University Research Accelerator Program Award	National Health and Medical Research Council Australia project grant(National Health and Medical Research Council (NHMRC) of Australia); Monash University Research Accelerator Program Award	TK was supported by National Health and Medical Research Council Australia project grant 545983, and the Monash University Research Accelerator Program Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barden S, 2014, ACTA CRYSTALLOGR D, V70, P1391, DOI 10.1107/S1399004714003150; Barden S, 2013, STRUCTURE, V21, P1931, DOI 10.1016/j.str.2013.08.018; BARRANCO SC, 1983, CANCER RES, V43, P1703; Censini S, 1996, P NATL ACAD SCI USA, V93, P14648, DOI 10.1073/pnas.93.25.14648; Gorrell RJ, 2013, CELL MICROBIOL, V15, P554, DOI 10.1111/cmi.12055; Gorrell RJ, 2005, FEMS IMMUNOL MED MIC, V44, P213, DOI 10.1016/j.femsim.2004.10.019; HAAS R, 1993, MOL MICROBIOL, V8, P753, DOI 10.1111/j.1365-2958.1993.tb01618.x; Kwok T, 2002, INFECT IMMUN, V70, P2108, DOI 10.1128/IAI.70.4.2108-2120.2002; Kwok T, 2007, NATURE, V449, P862, DOI 10.1038/nature06187; McWilliam H, 2013, NUCLEIC ACIDS RES, V41, pW597, DOI 10.1093/nar/gkt376; Rizzato C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029605; Saha A, 2010, GASTROENTEROLOGY, V139, P239, DOI 10.1053/j.gastro.2010.03.036; Saha A, 2010, GUT, V59, P874, DOI 10.1136/gut.2009.194795; Tegtmeyer N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097782; Tegtmeyer N, 2010, J BIOL CHEM, V285, P23513, DOI 10.1074/jbc.M109.096214; Tomb JF, 1997, NATURE, V388, P539, DOI 10.1038/41483; Wiedemann T, 2012, GUT, V61, P986, DOI 10.1136/gutjnl-2011-300525; Yeh YC, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0101912, DOI 10.1371/JOURNAL.PONE.0101912]; Yeh YC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072735; Yeh YC, 2011, MOL CARCINOGEN, V50, P751, DOI 10.1002/mc.20753	20	11	11	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0133531	10.1371/journal.pone.0133531	http://dx.doi.org/10.1371/journal.pone.0133531			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LZ	26196862	Green Submitted, Green Published, gold			2022-12-26	WOS:000358547600110
J	Thomsen, SB; Gjesing, AP; Rathcke, CN; Ekstrom, CT; Eiberg, H; Hansen, T; Pedersen, O; Vestergaard, H				Thomsen, Stine B.; Gjesing, Anette P.; Rathcke, Camilla N.; Ekstrom, Claus T.; Eiberg, Hans; Hansen, Torben; Pedersen, Oluf; Vestergaard, Henrik			Associations of the Inflammatory Marker YKL-40 with Measures of Obesity and Dyslipidaemia in Individuals at High Risk of Type 2 Diabetes	PLOS ONE			English	Article							BETA-CELL FUNCTION; CHITINASE 3-LIKE 1; SERUM YKL-40; ENDOTHELIAL DYSFUNCTION; INSULIN SENSITIVITY; PROMOTER REGION; PLASMA YKL-40; CHI3L1; BIOMARKER; DISEASE	Introduction Circulating levels of the inflammatory marker YKL-40 are elevated in cardiovascular disease and obesity-related type 2 diabetes (T2D), and serum YKL-40 levels are related to elements of dyslipidaemia. Objective We aimed to investigate the associations between serum YKL-40 and obesity-related traits in a Danish sample of non-diabetic relatives to T2D patients and, furthermore, to estimate the heritability of YKL-40. Research Design and Methods 324 non-diabetic individuals with family relation to a T2D patient were included in the study. The participants underwent oral-and intravenous glucose tolerance tests for estimation of glucose tolerance and surrogate measures of insulin sensitivity. Anthropometric measures were retrieved and biochemical measures of the plasma lipid profile and serum YKL-40 levels were obtained. Association-analyses between serum YKL-40 and obesity-related traits and estimates of the narrow sense heritability of YKL-40 were based on a polygenic variance component model. Results Fasting serum levels of YKL-40 were positively associated with waist-hip-ratio (p<0.001) and fasting plasma triglyceride levels (p<0.001). None of the insulin sensitivity indexes were significantly associated with YKL-40. According to the AE model, the familiality-estimate h(2) of YKL-40 was 0.45 (SE 0.13). When the ACE-model was applied, the heritability-estimate h(2) of YKL-40 did not reach statistical significance. Conclusions Our results suggest a role of serum YKL-40 in obesity-related low grade inflammation, but do not indicate that YKL-40 is directly involved in the development of T2D.	[Thomsen, Stine B.; Gjesing, Anette P.; Hansen, Torben; Pedersen, Oluf; Vestergaard, Henrik] Univ Copenhagen, Fac Hlth & Med Sci, Novo Nordisk Fdn Ctr Basic Metab Res, Sect Metab Genet, Copenhagen, Denmark; [Rathcke, Camilla N.] Copenhagen Univ Hosp, Dept Med, Ctr Endocrinol & Metab, Herlev, Denmark; [Ekstrom, Claus T.] Univ Copenhagen, Fac Hlth & Med Sci, Dept Publ Hlth, Biostat, Copenhagen, Denmark; [Eiberg, Hans] Univ Copenhagen, Fac Hlth & Med Sci, Dept Cellular & Mol Med, Copenhagen, Denmark; [Hansen, Torben] Univ Southern Denmark, Sect Mol Diabet & Metab, Inst Clin Res, Odense, Denmark; [Hansen, Torben] Univ Southern Denmark, Inst Mol Med, Fac Hlth Sci, Odense, Denmark; [Pedersen, Oluf] Univ Copenhagen, Fac Hlth & Med Sci, Inst Biomed Sci, Copenhagen, Denmark; [Pedersen, Oluf] Univ Aarhus, Fac Hlth Sci, Aarhus, Denmark	Novo Nordisk Foundation; University of Copenhagen; University of Copenhagen; University of Copenhagen; University of Copenhagen; University of Southern Denmark; University of Southern Denmark; University of Copenhagen; Aarhus University	Thomsen, SB (corresponding author), Univ Copenhagen, Fac Hlth & Med Sci, Novo Nordisk Fdn Ctr Basic Metab Res, Sect Metab Genet, Copenhagen, Denmark.	sbt@dadlnet.dk	Gjesing, Anette/ACC-7521-2022; Pedersen, Oluf/AAG-8015-2020; Pedersen, Oluf/Z-1731-2019	Gjesing, Anette/0000-0003-4580-1576; Pedersen, Oluf/0000-0002-3321-3972; Ekstrom, Claus Thorn/0000-0003-1191-373X; Vestergaard, Henrik/0000-0003-3090-269X	Novo Nordisk Foundation; Research Foundation of Copenhagen University Hospital Herlev; Jacobsen Foundation; A.P. Moeller and wife Chastine McKinney Moeller Foundation; Novo Nordisk Fonden [NNF11OC1014593] Funding Source: researchfish	Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Research Foundation of Copenhagen University Hospital Herlev; Jacobsen Foundation; A.P. Moeller and wife Chastine McKinney Moeller Foundation; Novo Nordisk Fonden(Novo Nordisk Foundation)	The study was supported by grants from The Novo Nordisk Foundation, The Research Foundation of Copenhagen University Hospital Herlev, The Jacobsen Foundation and The A.P. Moeller and wife Chastine McKinney Moeller Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul-Ghani MA, 2008, AM J PHYSIOL-ENDOC M, V295, pE401, DOI 10.1152/ajpendo.00674.2007; Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; Almasy L, 1998, AM J HUM GENET, V62, P1198, DOI 10.1086/301844; ANDERSEN L, 1993, CLIN CHEM, V39, P578; Boden G, 2011, CURR OPIN ENDOCRINOL, V18, P139, DOI 10.1097/MED.0b013e3283444b09; Brix JM, 2011, EUR J CLIN INVEST, V41, P589, DOI 10.1111/j.1365-2362.2010.02446.x; Catalan V, 2011, J CLIN ENDOCR METAB, V96, P200, DOI 10.1210/jc.2010-0994; Gjesing AP, 2012, DIABETOLOGIA, V55, P1338, DOI 10.1007/s00125-012-2484-6; Gjesing AP, 2014, DIABETOLOGIA, V57, P1173, DOI 10.1007/s00125-014-3207-y; Hajer GR, 2008, EUR HEART J, V29, P2959, DOI 10.1093/eurheartj/ehn387; Hansen T, 2001, DIABETOLOGIA, V44, P1330, DOI 10.1007/s001250100651; Hansen T, 2007, DIABETES CARE, V30, P257, DOI 10.2337/dc06-1240; Hempen M, 2009, OBES SURG, V19, P1557, DOI 10.1007/s11695-009-9917-4; Johansen JS, 2006, CANCER EPIDEM BIOMAR, V15, P194, DOI 10.1158/1055-9965.EPI-05-0011; Kjaergaard AD, 2013, J MED GENET, V50, P831, DOI 10.1136/jmedgenet-2013-101908; Kjaergaard AD, 2010, ANN NEUROL, V68, P672, DOI 10.1002/ana.22220; Kolb H, 2005, DIABETOLOGIA, V48, P1038, DOI 10.1007/s00125-005-1764-9; Kruit A, 2007, RESP MED, V101, P1563, DOI 10.1016/j.rmed.2006.12.006; Kucur M, 2007, CORONARY ARTERY DIS, V18, P391, DOI 10.1097/MCA.0b013e328241d991; Letuve S, 2008, J IMMUNOL, V181, P5167, DOI 10.4049/jimmunol.181.7.5167; Maury E, 2010, MOL CELL ENDOCRINOL, V314, P1, DOI 10.1016/j.mce.2009.07.031; Michelsen AE, 2010, ATHEROSCLEROSIS, V211, P589, DOI 10.1016/j.atherosclerosis.2010.02.035; Mygind ND, 2011, INFLAMM RES, V60, P281, DOI 10.1007/s00011-010-0266-5; Nielsen AR, 2008, DIABETES, V57, P3078, DOI 10.2337/db08-0182; Nielsen KR, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3391; Ober C, 2008, NEW ENGL J MED, V358, P1682, DOI 10.1056/NEJMoa0708801; PACINI G, 1986, COMPUT METH PROG BIO, V23, P113, DOI 10.1016/0169-2607(86)90106-9; Pickup JC, 2004, DIABETES CARE, V27, P813, DOI 10.2337/diacare.27.3.813; Rathcke CN, 2006, INFLAMM RES, V55, P221, DOI 10.1007/s00011-006-0076-y; Rathcke CN, 2009, CARDIOVASC DIABETOL, V8, DOI 10.1186/1475-2840-8-61; Rathcke CN, 2009, DIABETES CARE, V32, P323, DOI 10.2337/dc08-1144; Rathcke CN, 2006, INFLAMM RES, V55, P53, DOI 10.1007/s00011-005-0010-8; Rehli M, 1997, GENOMICS, V43, P221, DOI 10.1006/geno.1997.4778; Rondbjerg AK, 2011, CARDIOVASC DIABETOL, V10, DOI 10.1186/1475-2840-10-54; Shao R, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00122; Shu CJ, 2012, SEMIN IMMUNOL, V24, P436, DOI 10.1016/j.smim.2012.12.001; Sohn MH, 2009, AM J RESP CRIT CARE, V179, P449, DOI 10.1164/rccm.200809-1422OC; Thomsen SB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047094; Tuomi T, 2014, LANCET, V383, P1084, DOI 10.1016/S0140-6736(13)62219-9; Wang YZ, 2008, SCAND CARDIOVASC J, V42, P295, DOI 10.1080/14017430802220567; World Health Organization, 1999, WHO DIAGN CLASS DI 1; Zhao XZ, 2007, AM J HUM GENET, V80, P12, DOI 10.1086/510438; Zhao YF, 2006, INT J BIOCHEM CELL B, V38, P804, DOI 10.1016/j.biocel.2005.11.008; Zheng JL, 2011, CYTOKINE, V54, P51, DOI 10.1016/j.cyto.2010.12.018	44	12	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0133672	10.1371/journal.pone.0133672	http://dx.doi.org/10.1371/journal.pone.0133672			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LZ	26197239	Green Submitted, gold, Green Published			2022-12-26	WOS:000358547600132
J	Wang, R; Ma, JQ; Niu, G; Zheng, J; Liu, Z; Du, YH; Yu, BL; Yang, J				Wang, Rong; Ma, Jiaqi; Niu, Gang; Zheng, Jie; Liu, Zhe; Du, Yonghao; Yu, Bolang; Yang, Jian			Differentiation between Solitary Cerebral Metastasis and Astrocytoma on the Basis of Subventricular Zone Involvement on Magnetic Resonance Imaging	PLOS ONE			English	Article							NERVOUS-SYSTEM TUMORS; HIGH-GRADE GLIOMA; GLIOBLASTOMA-MULTIFORME; BRAIN-TUMORS; STEM-CELLS; VOLUMETRIC ASSESSMENT; SUBEPENDYMAL PLATE; ANGIOGENESIS; SURVIVAL; MRI	Purpose To determine the relationship between the subventricular zone (SVZ) and astrocytoma based on magnetic resonance imaging (MRI) and whether SVZ involvement can be used to distinguish solitary cerebral metastases (SCMs) from astrocytomas. Methods This retrospective study involved 154 patients with solitary low-grade astrocytoma (LGA), high-grade astrocytoma (HGA), and SCM, who underwent T1-weighted imaging (T1WI), Gd-DTPA-enhanced T1WI, and T2-weighted imaging (T2WI) or fluid-attenuated inversion recovery (FLAIR) T2WI. The spatial relationship between the tumor and SVZ was classified as "involvement" or "segregation" on contrast-enhanced T1WI for enhanced tumors and T2WI/FLAIR T2WI for non-enhanced tumors. Patient-based SVZ-contact rates were compared between the LGA, HGA, and SCM groups. The frequencies of involvement of various lateral ventricle regions by astrocytoma were compared. The correlation between SVZ involvement and tumor necrosis was analyzed. Results Patient-based SVZ-contact rates in SCM, LGA, and HGA were 24.1%, 68.8%, and 85.4%, respectively. Univariate analysis showed that the SVZ-contact rate was significantly different between SCM and astrocytoma (24.1% vs. 75.2% P < 0.001), also between LGA and HGA (68.1% vs. 85.4% P=0.037). After the tumor volume was adjusted as a covariate, SVZ-contact rates still differed between SCMs and astrocytomas (Odds ratio [OR]: 4.58, 95% Confidence interval [CI]: 1.65 to 12.8, P=0.004). Tumor volume differed between LGA and HGA (P < 0.001), and influenced the association between SVZ involvement and astrocytoma grade (P = 0.05). Among the lateral ventricle regions, the frontal horn was the most frequently involved by astrocytomas. SVZ-contact rates were higher in necrosis group compared with non-necrosis groups (83.9% vs. 50.0%, P < 0.001) among astrocytoma patients. Necrosis positively correlated with SVZ involvement in astrocytomas (r(s) = 0.342, P < 0.001), but did not correlate with SVZ involvement in SCMs (P = 0.193). Conclusions Compared to SCMs, solitary cerebral astrocytomas exhibited spatial proximity to the SVZ, which might distinguish the supratentorial astrocytomas from SCMs.	[Wang, Rong; Ma, Jiaqi; Niu, Gang; Liu, Zhe; Du, Yonghao; Yu, Bolang; Yang, Jian] Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Radiol, Xian 710049, Shaanxi, Peoples R China; [Zheng, Jie] Xi An Jiao Tong Univ, Affiliated Hosp 1, Clin Res Ctr, Xian 710049, Shaanxi, Peoples R China	Xi'an Jiaotong University; Xi'an Jiaotong University	Yang, J (corresponding author), Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Radiol, Xian 710049, Shaanxi, Peoples R China.	cjr.yangjian@vip.163.com		ZHENG, JIE/0000-0003-4958-2091	National Natural Science Foundation of China [30970797, 81201134]; New Century Excellent Talent Support Plan from Ministry of Education of China [NCET-11-0438]; Fund for National Clinical Key Specialty from Ministry of Health of China	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); New Century Excellent Talent Support Plan from Ministry of Education of China; Fund for National Clinical Key Specialty from Ministry of Health of China	This work was supported by the grant from National Natural Science Foundation of China (No. 30970797 to JY, 81201134 to RW), the 2011 New Century Excellent Talent Support Plan from Ministry of Education of China (NCET-11-0438) and the Fund for the National Clinical Key Specialty from the Ministry of Health of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bao SD, 2006, CANCER RES, V66, P7843, DOI 10.1158/0008-5472.CAN-06-1010; Barami K, 2009, J CLIN NEUROSCI, V16, P195, DOI 10.1016/j.jocn.2008.03.006; Blanchet L, 2011, AM J NEURORADIOL, V32, P67, DOI 10.3174/ajnr.A2269; Boxerman JL, 2006, AM J NEURORADIOL, V27, P859; Chen LD, 2013, INT J RADIAT ONCOL, V86, P616, DOI 10.1016/j.ijrobp.2013.02.014; Cherubini A, 2010, NEUROSCI LETT, V469, P214, DOI 10.1016/j.neulet.2009.11.077; Goebell E, 2006, RADIOLOGY, V239, P217, DOI 10.1148/radiol.2383050059; Hakyemez B, 2010, CLIN RADIOL, V65, P15, DOI 10.1016/j.crad.2009.09.005; HOPEWELL JW, 1975, J PATHOL, V117, P101, DOI 10.1002/path.1711170208; Hwang TL, 1996, CANCER, V77, P1551; Jafri NF, 2013, NEURO-ONCOLOGY, V15, P91, DOI 10.1093/neuonc/nos268; Jamshidi N, 2014, RADIOLOGY, V270, P212, DOI 10.1148/radiol.13130078; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; LANTOS PL, 1976, EXPERIENTIA, V32, P1467, DOI 10.1007/BF01937439; Larjavaara S, 2007, NEURO-ONCOLOGY, V9, P319, DOI 10.1215/15228517-2007-016; Law M, 2002, RADIOLOGY, V222, P715, DOI 10.1148/radiol.2223010558; Lee EJ, 2013, CLIN RADIOL, V68, pE689, DOI 10.1016/j.crad.2013.06.021; Maher Elizabeth A, 2009, Cancer Res, V69, P6015, DOI 10.1158/0008-5472.CAN-08-4347; Marsh JC, 2011, INT J RAD ONCOL BIOL; Mendez O, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-133; Nimsky C, 2004, NEUROSURGERY, V55, P358, DOI 10.1227/01.NEU.0000129694.64671.91; Ostrom QT, 2013, NEURO-ONCOLOGY, V15, P1, DOI 10.1093/neuonc/not151; Quinones-Hinojosa A, 2006, J COMP NEUROL, V494, P415, DOI 10.1002/cne.20798; Quinones-Hinojosa A, 2007, EXP NEUROL, V205, P313, DOI 10.1016/j.expneurol.2007.03.016; Rebetz J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001936; Rhoton AL, 2002, NEUROSURGERY, V51, pS207, DOI 10.1227/01.NEU.0000028161.91504.4F; Rong Y, 2006, J NEUROPATH EXP NEUR, V65, P529, DOI 10.1097/00005072-200606000-00001; Sakariassen PO, 2006, P NATL ACAD SCI USA, V103, P16466, DOI 10.1073/pnas.0607668103; Schellinger PD, 1999, J NEURO-ONCOL, V44, P275, DOI 10.1023/A:1006308808769; SIMPSON JR, 1993, INT J RADIAT ONCOL, V26, P239, DOI 10.1016/0360-3016(93)90203-8; Singh SK, 2004, ONCOGENE, V23, P7267, DOI 10.1038/sj.onc.1207946; Singh SK, 2003, CANCER RES, V63, P5821; Talos IF, 2007, ACAD RADIOL, V14, P431, DOI 10.1016/j.acra.2007.01.033; Tsuchiya K, 2005, BRIT J RADIOL, V78, P533, DOI 10.1259/bjr/68749637; Vergani F, 2011, NEUROSURGERY, V68, P1293, DOI 10.1227/NEU.0b013e31820b522a; Vescovi AL, 2006, NAT REV CANCER, V6, P425, DOI 10.1038/nrc1889; VICK NA, 1977, ACTA NEUROPATHOL, V40, P63, DOI 10.1007/BF00688574; Zhong H, 1999, CANCER RES, V59, P5830; Zhu Y, 2005, CANCER CELL, V8, P119, DOI 10.1016/j.ccr.2005.07.004	39	4	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0133480	10.1371/journal.pone.0133480	http://dx.doi.org/10.1371/journal.pone.0133480			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LZ	26197398	gold, Green Submitted, Green Published			2022-12-26	WOS:000358547600103
J	Chong, YH; Pankhurst, MW; McLennan, IS				Chong, Yih Harng; Pankhurst, Michael W.; McLennan, Ian S.			The Daily Profiles of Circulating AMH and INSL3 in Men are Distinct from the Other Testicular Hormones, Inhibin B and Testosterone	PLOS ONE			English	Article							ANTI-MULLERIAN HORMONE; INSULIN-LIKE FACTOR-3; ANTIMULLERIAN HORMONE; IMMUNOREACTIVE INHIBIN; LUTEINIZING-HORMONE; CIRCADIAN-RHYTHM; SERUM-LEVELS; HUMAN BLOOD; YOUNG MEN; GONADOTROPINS	The testes secrete four hormones (anti-Mullerian hormone, insulin-like peptide 3, Inhibin B and testosterone) from two endocrine cell types. It is unknown whether anti-Mullerian hormone and insulin-like peptide 3 levels have a diurnal variation, and if so, whether they covary during the day with testosterone and InhB. Sera were obtained from 13 men at 00:00, 06:00, 09:00, 12:00, 14:00, 17:00 and 19:00 hours and the levels of their testicular hormones measured by ELISA. A second cohort of 20 men was similarly examined with blood drawn at 19:00 and the following 06:00. Anti-Mullerian hormone levels exhibited a subtle diurnal pattern with a 19:00 peak that was 4.9% higher on average than the 06:00 nadir (p = 0.004). The decrease in anti-Mullerian hormone coincided with a rise in testosterone and InhB, but there was no association between the person-to-person variation in the diurnal patterns of anti-Mullerian hormone and testosterone or Inhibin B. Insulin-like peptide 3 had no diurnal pattern, with only minor sporadic variation between time points being observed in some men. In conclusion, the diurnal and sporadic variation of each testicular hormone is distinct, indicating that the major regulation is at the level of the hormone rather than at the endocrine cell type. Consequently, the balance of the hormones being released by the testes has complex variation during the day. The physiological significance of this will vary depending on which combinations of testicular hormones that the target cells respond to.	[Chong, Yih Harng; Pankhurst, Michael W.; McLennan, Ian S.] Univ Otago, Otago Sch Med Sci, Dept Anat, Dunedin, New Zealand; [Chong, Yih Harng] Univ Otago, Dunedin Sch Med, Dept Med, Dunedin, New Zealand; [McLennan, Ian S.] Univ Otago, Brain Hlth Res Ctr, Dunedin, New Zealand	University of Otago; University of Otago; University of Otago	McLennan, IS (corresponding author), Univ Otago, Otago Sch Med Sci, Dept Anat, Dunedin, New Zealand.	ian.mclennan@otago.ac.nz	Pankhurst, Michael/F-2585-2017	Pankhurst, Michael/0000-0002-0976-5742	Ministry of Business, Innovation and Employment, New Zealand; Frances Cotter PhD Scholarship (Dunedin School of Medicine, University of Otago)	Ministry of Business, Innovation and Employment, New Zealand(New Zealand Ministry of Business, Innovation and Employment (MBIE)); Frances Cotter PhD Scholarship (Dunedin School of Medicine, University of Otago)	This study was funded by the Ministry of Business, Innovation and Employment, New Zealand. YHC was a recipient of the Frances Cotter PhD Scholarship (Dunedin School of Medicine, University of Otago). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anand-Ivell R, 2006, INT J ANDROL, V29, P618, DOI 10.1111/j.1365-2605.2006.00714.x; Appt SE, 2012, MENOPAUSE, V19, P1353, DOI 10.1097/gme.0b013e31825b4fe2; Axelsson J, 2005, J CLIN ENDOCR METAB, V90, P4530, DOI 10.1210/jc.2005-0520; Bay K, 2005, J CLIN ENDOCR METAB, V90, P3410, DOI 10.1210/jc.2004-2257; Brambilla DJ, 2009, J CLIN ENDOCR METAB, V94, P907, DOI 10.1210/jc.2008-1902; Bungum L, 2011, HUM REPROD, V26, P678, DOI 10.1093/humrep/deq380; Carlsen E, 1999, J CLIN ENDOCR METAB, V84, P1664, DOI 10.1210/jc.84.5.1664; Chong YH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070967; CHRISTENSEN RB, 1994, J ANDROL, V15, P125; de Kretser DM, 2000, MOL CELL ENDOCRINOL, V161, P43, DOI 10.1016/S0303-7207(99)00222-1; Dennis NA, 2013, J ENDOCRINOL, V219, P13, DOI 10.1530/JOE-13-0125; Diver MJ, 2003, CLIN ENDOCRINOL, V58, P710, DOI 10.1046/j.1365-2265.2003.01772.x; Eldar-Geva T, 2010, EUR J ENDOCRINOL, V162, P177, DOI 10.1530/EJE-09-0366; ELDER PA, 1985, J STEROID BIOCHEM, V22, P635, DOI 10.1016/0022-4731(85)90217-1; Ferlin A, 2013, NAT REV ENDOCRINOL, V9, P548, DOI 10.1038/nrendo.2013.135; Griesinger G, 2012, J CLIN ENDOCR METAB, V97, P2160, DOI 10.1210/jc.2012-1070; Ivell R, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.113.108969; Ivell R, 2009, HUM REPROD UPDATE, V15, P463, DOI 10.1093/humupd/dmp011; Klerman EB, 2002, J BIOL RHYTHM, V17, P181, DOI 10.1177/074873002129002474; Lehtihet M, 2012, ANDROLOGIA, V44, P405, DOI 10.1111/j.1439-0272.2012.01296.x; Luboshitzky R, 1999, J ANDROL, V20, P731; Nicks Kristy M, 2010, Curr Osteoporos Rep, V8, P60, DOI 10.1007/s11914-010-0014-3; Pankhurst MW, 2014, FERTIL STERIL, V101, P846, DOI 10.1016/j.fertnstert.2013.12.009; Pankhurst MW, 2013, AM J PHYSIOL-ENDOC M, V305, pE1241, DOI 10.1152/ajpendo.00395.2013; Roney JR, 2007, HORM BEHAV, V52, P326, DOI 10.1016/j.yhbeh.2007.05.008; Stewart J, 2013, BIRTH DEFECTS RES B, V98, P104, DOI 10.1002/bdrb.21049; TENOVER JS, 1991, J GERONTOL, V46, pM181, DOI 10.1093/geronj/46.5.M181; Trumble BC, 2013, EVOL HUM BEHAV, V34, P350, DOI 10.1016/j.evolhumbehav.2013.06.002; VELDHUIS JD, 1987, J CLIN ENDOCR METAB, V65, P929, DOI 10.1210/jcem-65-5-929; Veldhuis JD, 2010, EUR J ENDOCRINOL, V162, P787, DOI 10.1530/EJE-09-1085; VIGIER B, 1983, J REPROD FERTIL, V69, P207; WINTERS SJ, 1990, J CLIN ENDOCR METAB, V70, P548, DOI 10.1210/jcem-70-2-548; YAMAGUCHI M, 1991, J CLIN ENDOCR METAB, V72, P554, DOI 10.1210/jcem-72-3-554; Young J, 1999, J CLIN ENDOCR METAB, V84, P2696, DOI 10.1210/jc.84.8.2696	34	18	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2015	10	7							e0133637	10.1371/journal.pone.0133637	http://dx.doi.org/10.1371/journal.pone.0133637			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LN	26192622	gold, Green Published, Green Submitted			2022-12-26	WOS:000358546400110
J	Gonzalez-Morales, N; Mendoza-Ortiz, MA; Blowes, LM; Missirlis, F; Riesgo-Escovar, JR				Gonzalez-Morales, Nicanor; Angel Mendoza-Ortiz, Miguel; Blowes, Liisa M.; Missirlis, Fanis; Riesgo-Escovar, Juan R.			Ferritin Is Required in Multiple Tissues during Drosophila melanogaster Development	PLOS ONE			English	Article							IRON-METABOLISM; MULTICOPPER OXIDASE-1; H-FERRITIN; MALVOLIO; HOMOLOG; OVEREXPRESSION; PROTEINS; STORAGE; CHAIN; ACCUMULATION	In Drosophila melanogaster, iron is stored in the cellular endomembrane system inside a protein cage formed by 24 ferritin subunits of two types (Fer1HCH and Fer2LCH) in a 1: 1 stoichiometry. In larvae, ferritin accumulates in the midgut, hemolymph, garland, pericardial cells and in the nervous system. Here we present analyses of embryonic phenotypes for mutations in Fer1HCH, Fer2LCH and in both genes simultaneously. Mutations in either gene or deletion of both genes results in a similar set of cuticular embryonic phenotypes, ranging from non-deposition of cuticle to defects associated with germ band retraction, dorsal closure and head involution. A fraction of ferritin mutants have embryonic nervous systems with ventral nerve cord disruptions, misguided axonal projections and brain malformations. Ferritin mutants die with ectopic apoptotic events. Furthermore, we show that ferritin maternal contribution, which varies reflecting the mother's iron stores, is used in early development. We also evaluated phenotypes arising from the blockage of COPII transport from the endoplasmic reticulum to the Golgi apparatus, feeding the secretory pathway, plus analysis of ectopically expressed and fluorescently marked Fer1HCH and Fer2LCH. Overall, our results are consistent with insect ferritin combining three functions: iron storage, intercellular iron transport, and protection from iron-induced oxidative stress. These functions are required in multiple tissues during Drosophila embryonic development.	[Gonzalez-Morales, Nicanor; Angel Mendoza-Ortiz, Miguel; Blowes, Liisa M.; Missirlis, Fanis; Riesgo-Escovar, Juan R.] Univ Nacl Autonoma Mexico, Inst Neurobiol, Dept Neurobiol Desarrollo & Neurofisiol, Queretaro 76230, Mexico	Universidad Nacional Autonoma de Mexico	Riesgo-Escovar, JR (corresponding author), Univ Nacl Autonoma Mexico, Inst Neurobiol, Dept Neurobiol Desarrollo & Neurofisiol, Campus UNAM Juriquilla, Queretaro 76230, Mexico.	juanriesgo@prodigy.net.mx	Missirlis, Fanis/C-1137-2011	Missirlis, Fanis/0000-0003-0467-8444; Gonzalez-Morales, Nicanor/0000-0003-1305-8992; Blowes, Liisa/0000-0002-9614-9074	Consejo Nacional de Ciencia y Tecnologia (CONACYT) [164428, 177962]; Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT) [IN203110]; Universidad Nacional Autonoma de Mexico laboratory	Consejo Nacional de Ciencia y Tecnologia (CONACYT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT)(Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT)); Universidad Nacional Autonoma de Mexico laboratory	Miguel Angel Mendoza-Ortiz is a PhD student in the Programa de Doctorado en Ciencias Biologicas, Universidad Nacional Autonoma de Mexico (UNAM), and received a PhD fellowship from Consejo Nacional de Ciencia y Tecnologia (CONACYT) [164428]. This work was supported by Consejo Nacional de Ciencia y Tecnologia (CONACYT) [177962 to J.R.R.E.], Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT) [IN203110 to J.R.R.E], and Universidad Nacional Autonoma de Mexico laboratory budget to J.R.R.E. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams EW, 2005, DEVELOPMENT, V132, P2743, DOI 10.1242/dev.01863; Bettedi L, 2011, J EXP BIOL, V214, P971, DOI 10.1242/jeb.051664; Biffar L, 2014, DEV BIOL, V388, P103, DOI 10.1016/j.ydbio.2014.01.028; Boone JQ, 2008, DEV NEUROBIOL, V68, P1185, DOI 10.1002/dneu.20648; D'Souza J, 1999, J EXP BIOL, V202, P1909; De Domenico I, 2008, NAT REV MOL CELL BIO, V9, P72, DOI 10.1038/nrm2295; Denton D, 2008, METHOD ENZYMOL, V446, P17, DOI 10.1016/S0076-6879(08)01602-9; Dixon SJ, 2012, CELL, V149, P1060, DOI 10.1016/j.cell.2012.03.042; dos Santos G, 2015, NUCLEIC ACIDS RES, V43, pD690, DOI 10.1093/nar/gku1099; Evans IR, 2011, CURR BIOL, V21, pR173, DOI 10.1016/j.cub.2011.01.061; Fisher J, 2007, AM J PHYSIOL-CELL PH, V293, pC641, DOI 10.1152/ajpcell.00599.2006; Folwell JL, 2006, J EXP BIOL, V209, P1988, DOI 10.1242/jeb.02193; Galay RL, 2013, J EXP BIOL, V216, P1905, DOI 10.1242/jeb.081240; Gambis A, 2011, DEV BIOL, V351, P128, DOI 10.1016/j.ydbio.2010.12.040; Georgieva T, 2002, INSECT BIOCHEM MOLEC, V32, P295, DOI 10.1016/S0965-1748(01)00090-X; Georgieva T, 1999, P NATL ACAD SCI USA, V96, P2716, DOI 10.1073/pnas.96.6.2716; Gunshin H, 1997, NATURE, V388, P482, DOI 10.1038/41343; Gutierrez L, 2013, METALLOMICS, V5, P997, DOI 10.1039/c3mt00118k; Gutierrez L, 2010, FEBS LETT, V584, P2942, DOI 10.1016/j.febslet.2010.05.029; Hajdusek O, 2009, P NATL ACAD SCI USA, V106, P1033, DOI 10.1073/pnas.0807961106; Hamburger AE, 2005, J MOL BIOL, V349, P558, DOI 10.1016/j.jmb.2005.03.074; Harrison PM, 1996, BBA-BIOENERGETICS, V1275, P161, DOI 10.1016/0005-2728(96)00022-9; Hentze MW, 2004, CELL, V117, P285, DOI 10.1016/S0092-8674(04)00343-5; Kell DB, 2014, METALLOMICS, V6, P748, DOI 10.1039/c3mt00347g; Kelso RJ, 2004, NUCLEIC ACIDS RES, V32, pD418, DOI 10.1093/nar/gkh014; Kohwi M, 2013, CELL, V152, P97, DOI 10.1016/j.cell.2012.11.049; Kosmidis S, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00066; Kosmidis S, 2011, NEUROBIOL DIS, V43, P213, DOI 10.1016/j.nbd.2011.03.013; Kumar S, 2011, BIOINFORMATICS, V27, P3319, DOI 10.1093/bioinformatics/btr567; Lang ML, 2012, P NATL ACAD SCI USA, V109, P13337, DOI 10.1073/pnas.1208703109; Li JY, 2009, DEV CELL, V16, P35, DOI 10.1016/j.devcel.2008.12.002; Lind MI, 2006, J BIOL CHEM, V281, P18707, DOI 10.1074/jbc.M603354200; Mandilaras K, 2013, NUTRIENTS, V5, P1622, DOI 10.3390/nu5051622; Mandilaras K, 2012, METALLOMICS, V4, P928, DOI 10.1039/c2mt20065a; Mehta A, 2009, BIOCHIMIE, V91, P1331, DOI 10.1016/j.biochi.2009.05.003; Metzendorf C, 2009, BIOCHEM J, V421, P463, DOI 10.1042/BJ20082231; Meyron-Holtz EG, 2011, J NEURAL TRANSM, V118, P337, DOI 10.1007/s00702-011-0582-0; Missirlis F, 2006, P NATL ACAD SCI USA, V103, P5893, DOI 10.1073/pnas.0601471103; Missirlis F, 2003, J BIOL CHEM, V278, P47365, DOI 10.1074/jbc.M307700200; Missirlis F, 2003, BIOL CHEM, V384, P463, DOI 10.1515/BC.2003.052; Missirlis F, 2007, GENETICS, V177, P89, DOI 10.1534/genetics.107.075150; Na JB, 2013, J AM SOC NEPHROL, V24, P161, DOI 10.1681/ASN.2012121227; Nichol H, 2002, ANNU REV ENTOMOL, V47, P535, DOI 10.1146/annurev.ento.47.091201.145237; NUSSLEINVOLHARD C, 1980, NATURE, V287, P795, DOI 10.1038/287795a0; Pantopoulos K, 2004, ANN NY ACAD SCI, V1012, P1, DOI 10.1196/annals.1306.001; Pantopoulos K, 2012, BIOCHEMISTRY-US, V51, P5705, DOI 10.1021/bi300752r; Peng ZY, 2015, INSECT BIOCHEM MOLEC, V59, P58, DOI 10.1016/j.ibmb.2015.02.005; Pham CG, 2004, CELL, V119, P529, DOI 10.1016/j.cell.2004.10.017; Piccinelli P, 2007, RNA, V13, P952, DOI 10.1261/rna.464807; RODRIGUES V, 1995, EMBO J, V14, P3007, DOI 10.1002/j.1460-2075.1995.tb07303.x; Rouault TA, 2006, NAT CHEM BIOL, V2, P406, DOI 10.1038/nchembio807; SANTAMBROGIO P, 1993, J BIOL CHEM, V268, P12744; Sheftel AD, 2012, BBA-GEN SUBJECTS, V1820, P161, DOI 10.1016/j.bbagen.2011.08.002; Spradling AC, 1999, GENETICS, V153, P135; Tang XN, 2013, FASEB J, V27, P288, DOI 10.1096/fj.12-213595; Tennessen JM, 2014, G3-GENES GENOM GENET, V4, P839, DOI 10.1534/g3.114.010652; Thompson K, 2003, J NEUROSCI RES, V71, P46, DOI 10.1002/jnr.10463; Todorich B, 2008, J NEUROCHEM, V107, P1495, DOI 10.1111/j.1471-4159.2008.05678.x; Uhrigshardt H, 2013, J BIOL INORG CHEM, V18, P441, DOI 10.1007/s00775-013-0988-2; Wu ZH, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2010.06.018; XU T, 1993, DEVELOPMENT, V117, P1223; Zhou GL, 2007, J INSECT PHYSIOL, V53, P1169, DOI 10.1016/j.jinsphys.2007.06.009	62	33	33	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2015	10	7							e0133499	10.1371/journal.pone.0133499	http://dx.doi.org/10.1371/journal.pone.0133499			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LN	26192321	Green Published, gold, Green Submitted			2022-12-26	WOS:000358546400096
J	Khan, AU; Mikut, R; Reischl, M				Khan, Arif ul Maula; Mikut, Ralf; Reischl, Markus			A Benchmark Data Set to Evaluate the Illumination Robustness of Image Processing Algorithms for Object Segmentation and Classification	PLOS ONE			English	Article							VISION	Developers of image processing routines rely on benchmark data sets to give qualitative comparisons of new image analysis algorithms and pipelines. Such data sets need to include artifacts in order to occlude and distort the required information to be extracted from an image. Robustness, the quality of an algorithm related to the amount of distortion is often important. However, using available benchmark data sets an evaluation of illumination robustness is difficult or even not possible due to missing ground truth data about object margins and classes and missing information about the distortion. We present a new framework for robustness evaluation. The key aspect is an image benchmark containing 9 object classes and the required ground truth for segmentation and classification. Varying levels of shading and background noise are integrated to distort the data set. To quantify the illumination robustness, we provide measures for image quality, segmentation and classification success and robustness. We set a high value on giving users easy access to the new benchmark, therefore, all routines are provided within a software package, but can as well easily be replaced to emphasize other aspects.	[Khan, Arif ul Maula; Mikut, Ralf; Reischl, Markus] Karlsruhe Inst Technol, Inst Appl Comp Sci, Image & Data Anal Grp, D-76021 Karlsruhe, Baden Wuerttemb, Germany	Helmholtz Association; Karlsruhe Institute of Technology	Reischl, M (corresponding author), Karlsruhe Inst Technol, Inst Appl Comp Sci, Image & Data Anal Grp, D-76021 Karlsruhe, Baden Wuerttemb, Germany.	markus.reischl@kit.edu	Reischl, Markus/H-6970-2013; Mikut, Ralf/A-5949-2013	Reischl, Markus/0000-0002-7780-6374; Mikut, Ralf/0000-0001-9100-5496	German Academic Exchange Service (DAAD); BioInterfaces International Graduate School (BIF-IGS) in KIT; Helmholtz Association	German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); BioInterfaces International Graduate School (BIF-IGS) in KIT; Helmholtz Association(Helmholtz Association)	The first author has received funding from German Academic Exchange Service (DAAD: https://www.daad.de/de/). The role of DAAD is to provide research opportunities for international students in Germany. The authors also acknowledge BioInterfaces International Graduate School (BIF-IGS) in KIT and Helmholtz Association for supporting this research work.	Anderson E., 1935, B AM IRIS SOC, V59, P2; Bock R, 2009, DATA ANAL TECHNIQUES; Boehme HJ, 1999, GESTURE BASED COMMUN; Brosnan T, 2004, J FOOD ENG, V61, P3, DOI 10.1016/S0260-8774(03)00183-3; Caselles V, 1997, INT J COMPUT VISION, V22, P61, DOI 10.1023/A:1007979827043; Deng J, 2009, PROC CVPR IEEE, P248, DOI 10.1109/CVPRW.2009.5206848; Du CJ, 2004, TRENDS FOOD SCI TECH, V15, P230, DOI 10.1016/j.tifs.2003.10.006; Forina M., 1991, PARVUS EXTENDIBLE PA; Ge F, 2007, J ELECTRON IMAGING, V16, DOI 10.1117/1.2762250; Gelasca ED, 2008, IEEE IMAGE PROC, P1816, DOI 10.1109/ICIP.2008.4712130; Guthaus MR, 2001, WWC-4: IEEE INTERNATIONAL WORKSHOP ON WORKLOAD CHARACTERIZATION, P3, DOI 10.1109/WWC.2001.990739; Escalante HJ, 2010, COMPUT VIS IMAGE UND, V114, P419, DOI 10.1016/j.cviu.2009.03.008; Kavoussanos M, 1998, INT J ADV MANUF TECH, V14, P358, DOI 10.1007/BF01178915; Lieschke GJ, 2007, NAT REV GENET, V8, P353, DOI 10.1038/nrg2091; Malamas EN, 2003, IMAGE VISION COMPUT, V21, P171, DOI 10.1016/S0262-8856(02)00152-X; Nickel K, 2007, IMAGE VISION COMPUT, V25, P1875, DOI 10.1016/j.imavis.2005.12.020; NUSSLEINVOLHARD C, 1980, NATURE, V287, P795, DOI 10.1038/287795a0; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Patil G, 2013, INT J ADV RES COMPUT, V3, P196; Ruusuvuori P., 2008, P 16 EUR SIGN PROC C; Sobel I, 1968, A3 3 ISOTORPIC GRADI; Stallkamp J, 2011, 2011 INTERNATIONAL JOINT CONFERENCE ON NEURAL NETWORKS (IJCNN), P1453, DOI 10.1109/IJCNN.2011.6033395; Stegmaier J., 2012, BIOMED TECH, V57, P458; Stegmaier J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090036; Wang W H, 2006, Conf Proc IEEE Eng Med Biol Soc, V2006, P2219; Zhang Wen, 2004, J Biol, V3, P21, DOI 10.1186/jbiol16	27	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2015	10	7							e0131098	10.1371/journal.pone.0131098	http://dx.doi.org/10.1371/journal.pone.0131098			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LN	26191792	Green Published, Green Submitted, gold			2022-12-26	WOS:000358546400010
J	Bargagna-Mohan, P; Lei, L; Thompson, A; Shaw, C; Kasahara, K; Inagaki, M; Mohan, R				Bargagna-Mohan, Paola; Lei, Ling; Thompson, Alexis; Shaw, Camille; Kasahara, Kousuke; Inagaki, Masaki; Mohan, Royce			Vimentin Phosphorylation Underlies Myofibroblast Sensitivity to Withaferin A In Vitro and during Corneal Fibrosis	PLOS ONE			English	Article							INTERMEDIATE-FILAMENT PROTEIN; UBIQUITIN-PROTEASOME PATHWAY; LIVING CELLS; KINASE; ADHESION; FIBROBLASTS; ACTIVATION; BHK-21-CELLS; MECHANISMS; DEFICIENT	Vimentin is a newly recognized target for corneal fibrosis. Using primary rabbit corneal fibroblasts and myofibroblasts we show that myofibroblasts, unlike fibroblasts, display impaired cell spreading and cell polarization, which is associated with increased levels of soluble serine-38 phosphorylated vimentin (pSer38Vim). This pSer38Vim isoform is inefficiently incorporated into growing vimentin intermediate filaments (IFs) of myofibroblasts during cell spreading, and as a result, myofibroblasts maintain higher soluble pSer38Vim levels compared to fibroblasts. Moreover, the soluble vimentin-targeting small molecule and fibrotic inhibitor withaferin A (WFA) causes a potent blockade of cell spreading selectively in myofibroblasts by targeting soluble pSer38Vim for hyperphosphorylation. WFA treatment does not induce vimentin hyperphosphorylation in fibroblasts. This hyperphosphorylated pSer38Vim species in WFA-treated myofibroblasts becomes complexed with adaptor protein filamin A (FlnA), and these complexes appear as short squiggles when displaced from focal adhesions. The extracellular-signal regulated kinase (ERK) is also phosphorylated (pERK) in response to WFA, but surprisingly, pERK does not enter the nucleus but remains bound to pSer38Vim in cytoplasmic complexes. Using a model of corneal alkali injury, we show that fibrotic corneas of wild type mice possess high levels of pERK, whereas injured corneas of vimentin-deficient (Vim KO) mice that heal with reduced fibrosis have highly reduced pERK expression. Finally, WFA treatment causes a decrease in pERK and pSer38Vim expression in healing corneas of wild type mice. Taken together, these findings identify a hereto-unappreciated role for pSer38Vim as an important determinant of myofibroblast sensitivity to WFA.	[Bargagna-Mohan, Paola; Lei, Ling; Thompson, Alexis; Shaw, Camille; Mohan, Royce] Univ Connecticut, Ctr Hlth, Dept Neurosci, Farmington, CT 06030 USA; [Kasahara, Kousuke; Inagaki, Masaki] Aichi Canc Ctr, Res Inst, Div Biochem, Nagoya, Aichi 464, Japan	University of Connecticut; Aichi Cancer Center	Mohan, R (corresponding author), Univ Connecticut, Ctr Hlth, Dept Neurosci, Farmington, CT 06030 USA.	mohan@uchc.edu	Inagaki, Masaki/B-9920-2016		National Eye Institute [EY016782]; National Institutes of Health [EY016782]; University of Connecticut Foundation, John A. and Linda Florence Solomon Endowed Chair funds; NATIONAL EYE INSTITUTE [R01EY016782] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [25460089] Funding Source: KAKEN	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Connecticut Foundation, John A. and Linda Florence Solomon Endowed Chair funds; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the National Eye Institute, National Institutes of Health grant EY016782 (https://www.nei.nih.gov/), and the University of Connecticut Foundation (www.foundation.uconn.edu/), John A. and Linda Florence Solomon Endowed Chair funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bargagna-Mohan P, 2007, CHEM BIOL, V14, P623, DOI 10.1016/j.chembiol.2007.04.010; Bargagna-Mohan P, 2006, INVEST OPHTH VIS SCI, V47, P4138, DOI 10.1167/iovs.05-1452; Bargagna-Mohan P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063881; Bargagna-Mohan P, 2012, J BIOL CHEM, V287, P989, DOI 10.1074/jbc.M111.297150; Baum M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5494; Bhattacharya R, 2009, J CELL SCI, V122, P1390, DOI 10.1242/jcs.043042; Chou YH, 1996, J CELL SCI, V109, P817; Chou YH, 2007, EXP CELL RES, V313, P2236, DOI 10.1016/j.yexcr.2007.04.008; Eckes B, 1998, J CELL SCI, V111, P1897; Eckes B, 2000, J CELL SCI, V113, P2455; Eriksson JE, 2004, J CELL SCI, V117, P919, DOI 10.1242/jcs.00906; Gladilin E, 2014, J BIOMECH, V47, P2598, DOI 10.1016/j.jbiomech.2014.05.020; Goto H, 1998, J BIOL CHEM, V273, P11728, DOI 10.1074/jbc.273.19.11728; Gregor M, 2014, FASEB J, V28, P715, DOI 10.1096/fj.13-231829; Grin B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039065; Havel LS, 2014, ONCOGENE; Helfand BT, 2011, MOL BIOL CELL, V22, P1274, DOI 10.1091/mbc.E10-08-0699; Helfand BT, 2004, J CELL SCI, V117, P133, DOI 10.1242/jcs.00936; Hinz B, 2012, AM J PATHOL, V180, P1340, DOI 10.1016/j.ajpath.2012.02.004; Hyder C, 2014, THESIS ABO AKAD U; Izawa I, 2006, CANCER SCI, V97, P167, DOI 10.1111/j.1349-7006.2006.00161.x; Jester JV, 2002, EXP EYE RES, V75, P645, DOI 10.1006/exer.2002.2066; Jester JV, 1999, PROG RETIN EYE RES, V18, P311, DOI 10.1016/S1350-9462(98)00021-4; Johnson CP, 2007, SCIENCE, V317, P663, DOI 10.1126/science.1139857; Johnston JA, 1998, J CELL BIOL, V143, P1883, DOI 10.1083/jcb.143.7.1883; Kim H, 2010, AM J PHYSIOL-CELL PH, V298, pC221, DOI 10.1152/ajpcell.00323.2009; Kim KB, 2013, NAT PROD REP, V30, P600, DOI 10.1039/c3np20126k; Lahat G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010105; Li QF, 2006, J BIOL CHEM, V281, P34716, DOI 10.1074/jbc.M607715200; Lynch CD, 2013, MOL BIOL CELL, V24, P21, DOI 10.1091/mbc.E12-05-0377; Mahammad S, 2013, J CLIN INVEST, V123, P1964, DOI 10.1172/JCI66387; Masur SK, 1999, INVEST OPHTH VIS SCI, V40, P904; Mendez MG, 2010, FASEB J, V24, P1838, DOI 10.1096/fj.09-151639; Menko AS, 2014, MOL BIOL CELL, V25, P776, DOI 10.1091/mbc.E12-12-0900; Middeldorp J, 2009, FASEB J, V23, P2710, DOI 10.1096/fj.08-127696; Mohan Royce, 2004, Angiogenesis, V7, P115, DOI 10.1007/s10456-004-1026-3; Nakazawa T, 2007, INVEST OPHTH VIS SCI, V48, P2760, DOI 10.1167/iovs.06-1398; Perlson E, 2005, NEURON, V45, P715, DOI 10.1016/j.neuron.2005.01.023; Perlson E, 2006, J MOL BIOL, V364, P938, DOI 10.1016/j.jmb.2006.09.056; Prager-Khoutorsky M, 2011, NAT CELL BIOL, V13, P1457, DOI 10.1038/ncb2370; Prahlad V, 1998, J CELL BIOL, V143, P159, DOI 10.1083/jcb.143.1.159; RonnovJessen L, 1996, J CELL BIOL, V134, P67, DOI 10.1083/jcb.134.1.67; Satelli A, 2011, CELL MOL LIFE SCI, V68, P3033, DOI 10.1007/s00018-011-0735-1; Scott MGH, 2006, MOL CELL BIOL, V26, P3432, DOI 10.1128/MCB.26.9.3432-3445.2006; Sihag RK, 2007, EXP CELL RES, V313, P2098, DOI 10.1016/j.yexcr.2007.04.010; Snider NT, 2014, NAT REV MOL CELL BIO, V15, P163, DOI 10.1038/nrm3753; SOELLNER P, 1985, P NATL ACAD SCI USA, V82, P7929, DOI 10.1073/pnas.82.23.7929; Stramer BM, 2001, INVEST OPHTH VIS SCI, V42, P1698; Takai Y, 1996, J CELL BIOL, V133, P141, DOI 10.1083/jcb.133.1.141; Thaiparambil JT, 2011, INT J CANCER, V129, P2744, DOI 10.1002/ijc.25938; Toda M, 2012, J BIOL CHEM, V287, P24516, DOI 10.1074/jbc.M111.319624; Tojkander S, 2012, J CELL SCI, V125, P1855, DOI 10.1242/jcs.098087; Tomasek JJ, 2002, NAT REV MOL CELL BIO, V3, P349, DOI 10.1038/nrm809; VIKSTROM KL, 1989, P NATL ACAD SCI USA, V86, P549, DOI 10.1073/pnas.86.2.549; WESTMAYS JA, 1995, P NATL ACAD SCI USA, V92, P6768, DOI 10.1073/pnas.92.15.6768; Wong VW, 2012, NAT MED, V18, P148, DOI 10.1038/nm.2574	56	18	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0133399	10.1371/journal.pone.0133399	http://dx.doi.org/10.1371/journal.pone.0133399			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RV	26186445	gold, Green Published, Green Submitted			2022-12-26	WOS:000358198700132
J	Hitier, M; Hamon, M; Denise, P; Lacoudre, J; Thenint, MA; Mallet, JF; Moreau, S; Quarck, G				Hitier, Martin; Hamon, Michele; Denise, Pierre; Lacoudre, Julien; Thenint, Marie-Aude; Mallet, Jean-Francois; Moreau, Sylvain; Quarck, Gaelle			Lateral Semicircular Canal Asymmetry in Idiopathic Scoliosis: An Early Link between Biomechanical, Hormonal and Neurosensory Theories?	PLOS ONE			English	Article							REFERENT BONE TURNOVER; OTIC CAPSULE; VESTIBULAR NUCLEI; CRITICAL PERIOD; HORSERADISH-PEROXIDASE; AFFERENT-PROJECTIONS; VERTEBRAL ROTATION; ADOLESCENT GIRLS; EARLY EXPERIENCE; NEURON ACTIVITY	Introduction Despite its high incidence and severe morbidity, the physiopathogenesis of adolescent idiopathic scoliosis (AIS) is still unknown. Here, we looked for early anomalies in AIS which are likely to be the cause of spinal deformity and could also be targeted by early treatments. We focused on the vestibular system, which is suspected of acting in AIS pathogenesis and which exhibits an end organ with size and shape fixed before birth. We hypothesize that, in adolescents with idiopathic scoliosis, vestibular morphological anomalies were already present at birth and could possibly have caused other abnormalities. Materials and Methods The vestibular organ of 18 adolescents with AIS and 9 controls were evaluated with MRI in a prospective case controlled study. We studied lateral semicircular canal orientation and the three semicircular canal positions relative to the midline. Lateral semicircular canal function was also evaluated by vestibulonystagmography after bithermal caloric stimulation. Results The left lateral semicircular canal was more vertical and further from the midline in AIS (p = 0.01) and these two parameters were highly correlated (r = -0.6; p = 0.02). These morphological anomalies were associated with functional anomalies in AIS (lower excitability, higher canal paresis), but were not significantly different from controls (p>0.05). Conclusion Adolescents with idiopathic scoliosis exhibit morphological vestibular asymmetry, probably determined well before birth. Since the vestibular system influences the vestibulospinal pathway, the hypothalamus, and the cerebellum, this indicates that the vestibular system is a possible cause of later morphological, hormonal and neurosensory anomalies observed in AIS. Moreover, the simple lateral SCC MRI measurement demonstrated here could be used for early detection of AIS, selection of children for close follow-up, and initiation of preventive treatment before spinal deformity occurs.	[Hitier, Martin; Lacoudre, Julien; Moreau, Sylvain] CHU Caen, Dept Otolaryngol Head & Neck Surg, F-14000 Caen, France; [Hitier, Martin; Moreau, Sylvain] UNICAEN, Dept Anat, F-14032 Caen, France; [Hitier, Martin] Univ Otago, Sch Med Sci, Dept Pharmacol & Toxicol, Dunedin, New Zealand; [Hitier, Martin] Univ Otago, Brain Hlth Res Ctr, Dunedin, New Zealand; [Hitier, Martin; Denise, Pierre; Quarck, Gaelle] INSERM, U COMETE 1075, F-14032 Caen, France; [Hamon, Michele; Thenint, Marie-Aude] CHU Caen, Dept Neuroradiol, F-14000 Caen, France; [Mallet, Jean-Francois] CHU Caen, Dept Paediat Surg, F-14000 Caen, France	CHU de Caen NORMANDIE; Universite de Caen Normandie; Universite de Caen Normandie; University of Otago; University of Otago; Institut National de la Sante et de la Recherche Medicale (Inserm); CHU de Caen NORMANDIE; Universite de Caen Normandie; CHU de Caen NORMANDIE; Universite de Caen Normandie	Hitier, M (corresponding author), CHU Caen, Dept Otolaryngol Head & Neck Surg, F-14000 Caen, France.	mart1_hit@yahoo.fr	Denise, Pierre/E-2174-2011; Quarck, Gaelle/O-1247-2015	Denise, Pierre/0000-0002-9049-7692; Hitier, Martin/0000-0002-1323-133X	Marie Curie International Research Staff Exchange Scheme Fellowship within the 7th European Community Framework Program [918980]; Emergence Program Basse-Normandie Region [11P03919/11P03921]	Marie Curie International Research Staff Exchange Scheme Fellowship within the 7th European Community Framework Program; Emergence Program Basse-Normandie Region(Region Normandie)	This research was supported by a Marie Curie International Research Staff Exchange Scheme Fellowship within the 7th European Community Framework Program #918980, and Emergence Program (No 11P03919/11P03921) Basse-Normandie Region. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altaf F, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2508; Angelaki DE, 2010, CEREBELLUM, V9, P174, DOI 10.1007/s12311-009-0147-z; Asher MA, 2006, SCOLIOSIS SPINAL DIS, V1, DOI 10.1186/1748-7161-1-2; Assaiante C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040646; Bast TH, 1930, OSSIFICATION OF THE; Bast TH, 1949, THE TEMPORAL BONE AN; Best C, 2014, BRAIN STRUCT FUNCT, V219, P2141, DOI 10.1007/s00429-013-0628-1; BLANKS RHI, 1983, EXP BRAIN RES, V52, P293; Bouret SG, 2004, SCIENCE, V304, P108, DOI 10.1126/science.1095004; British Society of Audiology, 2010, RECOMMENDED PROCEDUR; BRODAL A, 1985, EXP BRAIN RES, V58, P62; Burwell RG, 2006, STUD HEALTH TECHNOL, V123, P72; Burwell RG, 2006, ST HEAL T, V123, P57; Burwell RG, 2006, ST HEAL T, V123, P66; Burwell RG, 2009, STUD HEALTH TECHNOL, V135, P3; Burwell RG, 2009, SCOLIOSIS SPINAL DIS, V4, DOI 10.1186/1748-7161-4-24; BYL NN, 1993, J ORTHOP RES, V11, P215, DOI 10.1002/jor.1100110209; CARLETON SC, 1984, BRAIN RES, V294, P281, DOI 10.1016/0006-8993(84)91040-0; Cheng JC, 2001, SPINE, V26, pC1; Cheng JCY, 1999, SPINE, V24, P1218, DOI 10.1097/00007632-199906150-00008; Cheng JCY, 2000, J BONE MINER RES, V15, P1587, DOI 10.1359/jbmr.2000.15.8.1587; Cheng JCY, 1997, SPINE, V22, P1716, DOI 10.1097/00007632-199708010-00006; Chettier R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117708; Cook JS, 2010, J APPL PHYSIOL, V109, P1697, DOI 10.1152/japplphysiol.00698.2010; Cox PG, 2007, J MORPHOL, V268, P878, DOI 10.1002/jmor.10559; Curthoys IS, 2012, LARYNGOSCOPE, V122, P1342, DOI 10.1002/lary.23258; Curthoys IS, 2000, CURR OPIN NEUROL, V13, P27, DOI 10.1097/00019052-200002000-00006; Dahm MC, 2009, ACTA OTO-LARYNGOL, V113, P4; Dalleau G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036755; DE GEORGE FRANCES V., 1967, J MED GENET, V4, P251, DOI 10.1136/jmg.4.4.251; Denise P, 2009, Aviakosm Ekolog Med, V43, P36; DEWAELE C, 1989, EXP BRAIN RES, V77, P166, DOI 10.1007/BF00250579; Dieterich M, 2003, CEREB CORTEX, V13, P994, DOI 10.1093/cercor/13.9.994; Eugene D, 2009, ANN NY ACAD SCI, V1164, P180, DOI 10.1111/j.1749-6632.2008.03727.x; Fraschini F, 1999, BIOL SIGNAL RECEPT, V8, P111; Frisch T, 1998, BONE, V22, P677, DOI 10.1016/S8756-3282(98)00050-7; Frisch T, 2000, ANN OTO RHINOL LARYN, V109, P33, DOI 10.1177/000348940010900106; Frisch T, 2015, ACTA OTO-LARYNGOL, V135, P771, DOI 10.3109/00016489.2015.1035400; GEISSELE AE, 1991, SPINE, V16, P761; Girardo M, 2011, EUR SPINE J, V20, P68, DOI 10.1007/s00586-011-1750-5; Goldberg C J, 1993, Eur Spine J, V2, P29, DOI 10.1007/BF00301052; HALLPIKE C S, 1956, J Laryngol Otol, V70, P15, DOI 10.1017/S0022215100052610; Hensch TK, 2005, CURR TOP DEV BIOL, V69, P215, DOI 10.1016/S0070-2153(05)69008-4; HOAGLIN DC, 1987, J AM STAT ASSOC, V82, P1147, DOI 10.1080/01621459.1987.10478551; Hublin JJ, 1996, NATURE, V381, P224, DOI 10.1038/381224a0; Jansen M, 1912, BRIT MED J, V1912, P1372; Janssen MMA, 2011, SPINE, V36, pE486, DOI 10.1097/BRS.0b013e3181f468cc; Jeffery N, 2004, J ANAT, V204, P71, DOI 10.1111/j.1469-7580.2004.00250.x; JONGKEES L B, 1962, Pract Otorhinolaryngol (Basel), V24, P65; KANE WJ, 1977, CLIN ORTHOP RELAT R, P43; KATAFUCHI T, 1987, BRAIN RES, V400, P62, DOI 10.1016/0006-8993(87)90653-6; Keuroghlian AS, 2007, PROG NEUROBIOL, V82, P109, DOI 10.1016/j.pneurobio.2007.03.005; KORTE GE, 1979, J COMP NEUROL, V184, P265, DOI 10.1002/cne.901840204; KOTCHABHAKDI N, 1978, EXP BRAIN RES, V31, P591; Kou I, 2013, NAT GENET, V45, P676, DOI 10.1038/ng.2639; Kouwenhoven JWM, 2007, SPINE, V32, P2545, DOI 10.1097/BRS.0b013e318158cd86; Kouwenhoven JWM, 2006, SPINE, V31, P1467, DOI 10.1097/01.brs.0000219938.14686.b3; Kouwenhoven JWM, 2008, SPINE, V33, P2898, DOI 10.1097/BRS.0b013e3181891751; Lambert FM, 2009, J NEUROSCI, V29, P12477, DOI 10.1523/JNEUROSCI.2583-09.2009; Liu TM, 2008, J MAGN RESON IMAGING, V27, P732, DOI 10.1002/jmri.21321; Londono D, 2014, J MED GENET, V51, P401, DOI 10.1136/jmedgenet-2013-102067; Lowe TG, 2000, J BONE JOINT SURG AM, V82A, P1157, DOI 10.2106/00004623-200008000-00014; Mazzucchelli C, 1996, MOL BRAIN RES, V39, P117, DOI 10.1016/0169-328X(96)00017-4; Mercer JG, 1996, FEBS LETT, V387, P113, DOI 10.1016/0014-5793(96)00473-5; Miyake A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072802; Moorman SJ, 2002, DEV DYNAM, V223, P285, DOI 10.1002/dvdy.10052; Moreau A, 2004, SPINE, V29, P1772, DOI 10.1097/01.BRS.0000134567.52303.1A; Naganuma H, 2003, ANN OTO RHINOL LARYN, V112, P419, DOI 10.1177/000348940311200506; Nemzek WR, 1996, AM J NEURORADIOL, V17, P1467; NORMELLI H, 1985, SPINE, V10, P590, DOI 10.1097/00007632-198507000-00015; Pietkiewicz P, 2012, INT J OCCUP MED ENV, V25, P59, DOI [10.2478/s13382-012-0002-1, 10.2478/S13382-012-0002-1]; Podda MV, 2003, NEUROSCI LETT, V341, P209, DOI 10.1016/S0304-3940(03)00209-X; Qiu Y, 2007, SPINE, V32, P2703, DOI 10.1097/BRS.0b013e31815a59e5; Reamy BV, 2001, AM FAM PHYSICIAN, V64, P111; Richards BS, 2003, SPINE, V28, P1148, DOI 10.1097/00007632-200306010-00012; Risold PY, 1997, BRAIN RES REV, V24, P197, DOI 10.1016/S0165-0173(97)00007-6; Sato T, 1902, VERGLEICHENDE UNTERS; Schlosser TPC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097461; Sharma S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7452; Shi L, 2009, AM J NEURORADIOL, V30, P1302, DOI 10.3174/ajnr.A1577; Shi L, 2006, LECT NOTES COMPUT SC, V4190, P175; Shi L, 2013, SPINE J, V13, P1904, DOI 10.1016/j.spinee.2013.06.045; Shi L, 2011, NEUROIMAGE, V54, pS180, DOI 10.1016/j.neuroimage.2010.04.002; Simoneau M, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-68; Simoneau M, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-102; SIMONS DJ, 1987, NATURE, V326, P694, DOI 10.1038/326694a0; SMITH PF, 1989, BRAIN RES REV, V14, P155, DOI 10.1016/0165-0173(89)90013-1; Sorensen M S, 1992, Acta Otolaryngol Suppl, V496, P1; SORENSEN MS, 1990, ACTA OTO-LARYNGOL, V110, P217, DOI 10.3109/00016489009122540; Spoor F, 2002, PORTRAIT ARTIST CHIL, V22, P287; Spoor F, 2002, THE BONY LABYRINTH O, P215; Stankovic KM, 2010, HEARING RES, V265, P83, DOI 10.1016/j.heares.2010.02.006; Takahashi Y, 2011, NAT GENET, V43, P1237, DOI 10.1038/ng.974; Vignaux G, 2013, J BONE MINER RES, V28, P2136, DOI 10.1002/jbmr.1940; WALBERG F, 1988, BRAIN RES, V449, P47, DOI 10.1016/0006-8993(88)91022-0; Wallace MT, 2007, J NEUROPHYSIOL, V97, P921, DOI 10.1152/jn.00497.2006; Wang DF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083767; Wang DF, 2012, NEUROIMAGE, V59, P935, DOI 10.1016/j.neuroimage.2011.07.097; Wang WJ, 2011, J PEDIATR ORTHOPED, V31, pS14, DOI 10.1097/BPO.0b013e3181f73c12; Weinstein SL, 2008, LANCET, V371, P1527, DOI 10.1016/S0140-6736(08)60658-3; Wiener-Vacher SR, 1998, J PEDIATR-US, V132, P1028, DOI 10.1016/S0022-3476(98)70403-2; WORTHINGTON V, 1993, J MANIP PHYSIOL THER, V16, P169; Yates BJ, 2005, J VESTIBUL RES-EQUIL, V15, P119; YATES BJ, 1992, BRAIN RES REV, V17, P51, DOI 10.1016/0165-0173(92)90006-8; Yates BJ, 1996, ANN NY ACAD SCI, V781, P458, DOI 10.1111/j.1749-6632.1996.tb15720.x; Zhou SC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059929	107	17	20	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0131120	10.1371/journal.pone.0131120	http://dx.doi.org/10.1371/journal.pone.0131120			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RV	26186348	gold, Green Published, Green Submitted			2022-12-26	WOS:000358198700011
J	Miao, W; Man, FY; Wu, SQ; Lv, B; Wang, ZC; Xian, JF; Sabel, BA; He, HG; Jiao, YH				Miao, Wen; Man, Fengyuan; Wu, Shaoqin; Lv, Bin; Wang, Zhenchang; Xian, Junfang; Sabel, Bernhard A.; He, Huiguang; Jiao, Yonghong			Brain Abnormalities in Congenital Fibrosis of the Extraocular Muscles Type 1: A Multimodal MRI Imaging Study	PLOS ONE			English	Article							VOXEL-BASED MORPHOMETRY; EXTERNAL OPHTHALMOPLEGIA; ORBITOFRONTAL CORTEX; DYSINNERVATION; INNERVATION; HOMOGENEITY; MUTATIONS; KIF21A	Purpose To explore the possible brain structural and functional alterations in congenital fibrosis of extraocular muscles type 1 (CFEOM1) patients using multimodal MRI imaging. Methods T1-weighted, diffusion tensor images and functional MRI data were obtained from 9 KIF21A positive patients and 19 age-and gender-matched healthy controls. Voxel based morphometry and tract based spatial statistics were applied to the T1-weighted and diffusion tensor images, respectively. Amplitude of low frequency fluctuations and regional homogeneity were used to process the functional MRI data. We then compared these multimodal characteristics between CFEOM1 patients and healthy controls. Results Compared with healthy controls, CFEOM1 patients demonstrated increased grey matter volume in bilateral frontal orbital cortex and in the right temporal pole. No diffusion indices changes were detected, indicating unaffected white matter microstructure. In addition, from resting state functional MRI data, trend of amplitude of low-frequency fluctuations increases were noted in the right inferior parietal lobe and in the right frontal cortex, and a trend of ReHo increase (p<0.001 uncorrected) in the left precentral gyrus, left orbital frontal cortex, temporal pole and cingulate gyrus. Conclusions CFEOM1 patients had structural and functional changes in grey matter, but the white matter was unaffected. These alterations in the brain may be due to the abnormality of extraocular muscles and their innervating nerves. Future studies should consider the possible correlations between brain morphological/functional findings and clinical data, especially pertaining to eye movements, to obtain more precise answers about the role of brain area changes and their functional consequence in CFEOM1.	[Miao, Wen; Sabel, Bernhard A.; He, Huiguang] Chinese Acad Sci, Inst Automat, State Key Lab Management & Control Complex Syst, Beijing, Peoples R China; [Man, Fengyuan; Xian, Junfang] Capital Med Univ, Beijing Tongren Hosp, Dept Radiol, Beijing, Peoples R China; [Sabel, Bernhard A.; Jiao, Yonghong] Capital Med Univ, Beijing Tongren Hosp, Beijing Tongren Eye Ctr, Beijing Ophthalmol & Visual Sci Key Lab, Beijing, Peoples R China; [Wu, Shaoqin] Capital Med Univ, Beijing Anzhen Hosp, Dept Radiol, Beijing, Peoples R China; [Lv, Bin] China Acad Telecommun Res, Minist Ind & Informat Technol, Beijing, Peoples R China; [Wang, Zhenchang] Capital Med Univ, Beijing Friendship Hosp, Beijing, Peoples R China; [Sabel, Bernhard A.] Univ Magdeburg, Fac Med, Inst Med Psychol, Magdeburg, Germany	Chinese Academy of Sciences; Institute of Automation, CAS; Capital Medical University; Capital Medical University; Capital Medical University; Capital Medical University; Otto von Guericke University	He, HG (corresponding author), Chinese Acad Sci, Inst Automat, State Key Lab Management & Control Complex Syst, Beijing, Peoples R China.	huiguang.he@ia.ac.cn; yhjiao2001@aliyun.com	He, Huiguang/AAD-7643-2020; yongbei, Zhu/L-7015-2016	He, Huiguang/0000-0002-0684-1711; 	National Natural Science Foundation of China [81070762, 61271151, 81401397, 61201066]; 863 Project [2013AA013803]; Beijing Natural Science Foundation [7152039]; Chinese Academy of Sciences; Beijing Tongren Hospital	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 863 Project(National High Technology Research and Development Program of China); Beijing Natural Science Foundation(Beijing Natural Science Foundation); Chinese Academy of Sciences(Chinese Academy of Sciences); Beijing Tongren Hospital	This work was partly supported by the National Natural Science Foundation of China (81070762, 61271151, 81401397 and 61201066), 863 Project (2013AA013803) and Beijing Natural Science Foundation (7152039). Prof. Sabel was partly supported by Chinese Academy of Sciences Senior Visiting Professorships Programs and by the "Hai-ju" by Beijing Overseas Talents Program at Beijing Tongren Hospital. The funding organizations had no role in design or conduct of this research.	Andersson J. L., 2007, TR07JA2 FMRIB AN GRO; Andrews CV, 1993, GENEREVIEWS; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Assaf AA, 2011, EYE, V25, P1251, DOI 10.1038/eye.2011.38; Barnes GR, 2010, INVEST OPHTH VIS SCI, V51, P1432, DOI 10.1167/iovs.09-3931; BASSER PJ, 1994, BIOPHYS J, V66, P259, DOI 10.1016/S0006-3495(94)80775-1; Basser PJ, 1996, J MAGN RESON SER B, V111, P209, DOI [10.1006/jmrb.1996.0086, 10.1016/j.jmr.2011.09.022]; Behrens TEJ, 2003, MAGN RESON MED, V50, P1077, DOI 10.1002/mrm.10609; Brodsky MC, 1998, OPHTHALMOLOGY, V105, P717, DOI 10.1016/S0161-6420(98)94029-5; Cavada C, 2000, CEREB CORTEX, V10, P205, DOI 10.1093/cercor/10.3.205; Cheng L, 2014, NEURON, V82, P334, DOI 10.1016/j.neuron.2014.02.038; Demer JL, 2005, INVEST OPHTH VIS SCI, V46, P530, DOI 10.1167/iovs.04-1125; Desai J, 2012, GENE EXPR PATTERNS, V12, P180, DOI 10.1016/j.gep.2012.03.003; Di Paola M, 2010, NEUROLOGY, V74, P1136, DOI 10.1212/WNL.0b013e3181d7d8cb; Engle EC, 2006, PEDIATR RES, V59, P343, DOI 10.1203/01.pdr.0000200797.91630.08; ENGLE EC, 1995, AM J HUM GENET, V57, P1086; Engle EC, 1997, ANN NEUROL, V41, P314, DOI 10.1002/ana.410410306; Engle EC, 2002, ANN NY ACAD SCI, V956, P55, DOI 10.1111/j.1749-6632.2002.tb02808.x; Flaherty MP, 2001, OPHTHALMOLOGY, V108, P1313, DOI 10.1016/S0161-6420(01)00582-6; Haier Richard J, 2009, BMC Res Notes, V2, P174, DOI 10.1186/1756-0500-2-174; Heidary Gena, 2008, Semin Ophthalmol, V23, P3, DOI 10.1080/08820530701745181; Hornberger M, 2011, BRAIN, V134, P2502, DOI 10.1093/brain/awr173; Huppi PS, 2006, SEMIN FETAL NEONAT M, V11, P489, DOI 10.1016/j.siny.2006.07.006; Li W, 2015, RESTOR NEUROL NEUROS; Lin XM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043373; Liu YO, 2011, J NEUROL SCI, V304, P127, DOI 10.1016/j.jns.2011.01.023; Liu YX, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0063447, 10.1371/journal.pone.0076105]; Miao W, 2013, AM J NEURORADIOL, V34, P1264, DOI 10.3174/ajnr.A3370; Muller-Vahl KR, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-47; Munoz DP, 2004, NAT REV NEUROSCI, V5, P218, DOI 10.1038/nrn1345; NAKAMURA K, 1994, J NEUROPHYSIOL, V71, P1206, DOI 10.1152/jn.1994.71.3.1206; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Pascual B, 2015, CEREB CORTEX, V25, P680, DOI 10.1093/cercor/bht260; Reck AC, 1998, BRIT J OPHTHALMOL, V82, P676, DOI 10.1136/bjo.82.6.676; Scheuerecker J, 2010, J PSYCHIATR NEUROSCI, V35, P311, DOI 10.1503/jpn.090076; Shi XFF, 2012, RESTOR NEUROL NEUROS, V30, P445, DOI 10.3233/RNN-2012-129000; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Smith SM, 2009, NEUROIMAGE, V44, P83, DOI 10.1016/j.neuroimage.2008.03.061; Song XW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025031; Tiab Leila, 2004, Ophthalmic Genet, V25, P241, DOI 10.1080/13816810490902828; Traboulsi EI, 2007, J AAPOS, V11, P215, DOI 10.1016/j.jaapos.2007.04.007; Wang ZQ, 2011, HUM BRAIN MAPP, V32, P1720, DOI 10.1002/hbm.21140; Zang YF, 2004, NEUROIMAGE, V22, P394, DOI 10.1016/j.neuroimage.2003.12.030; Zang YF, 2007, BRAIN DEV-JPN, V29, P83, DOI 10.1016/j.braindev.2006.07.002; Zhang YY, 2001, IEEE T MED IMAGING, V20, P45, DOI 10.1109/42.906424	46	3	4	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0133473	10.1371/journal.pone.0133473	http://dx.doi.org/10.1371/journal.pone.0133473			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RV	26186732	Green Published, gold, Green Submitted			2022-12-26	WOS:000358198700144
J	Li, WH; Qiu, Y; Zhang, HQ; Tian, XX; Fang, WG				Li, Wei-Hua; Qiu, Ying; Zhang, Hong-Quan; Tian, Xin-Xia; Fang, Wei-Gang			P2Y2 Receptor and EGFR Cooperate to Promote Prostate Cancer Cell Invasion via ERK1/2 Pathway	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; EXTRACELLULAR ATP; INTERLEUKIN-8; METASTASIS; EXPRESSION; P2Y(2); PHOSPHORYLATION; IDENTIFICATION; SITES	As one member of G protein-coupled P2Y receptors, P2Y2 receptor can be equally activated by extracellular ATP and UTP. Our previous studies have proved that activation of P2Y2 receptor by extracellular ATP could promote prostate cancer cell invasion and metastasis in vitro and in vivo via regulating the expressions of some epithelial-mesenchymal transition/invasion-related genes (including IL-8, E-cadherin, Snail and Claudin-1), and the most significant change in expression of IL-8 was observed after P2Y2 receptor activation. However, the signaling pathway downstream of P2Y2 receptor and the role of IL-8 in P2Y2-mediated prostate cancer cell invasion remain unclear. Here, we found that extracellular ATP/UTP induced activation of EGFR and ERK1/2. After knockdown of P2Y2 receptor, the ATP -stimulated phosphorylation of EGFR and ERK1/2 was significantly suppressed. Further experiments showed that inactivation of EGFR and ERK1/2 attenuated ATP-induced invasion and migration, and suppressed ATP-mediated IL-8 production. In addition, knockdown of IL-8 inhibited ATP-mediated invasion and migration of prostate cancer cells. These findings suggest that P2Y2 receptor and EGFR cooperate to upregulate IL-8 production via ERK1/2 pathway, thereby promoting prostate cancer cell invasion and migration. Thus blocking of the P2Y2-EGFR-ERK1/2 pathway may provide effective therapeutic interventions for prostate cancer.	[Li, Wei-Hua; Qiu, Ying; Zhang, Hong-Quan; Tian, Xin-Xia; Fang, Wei-Gang] Peking Univ, Hlth Sci Ctr, Key Lab Carcinogenesis & Translat Res, Minist Educ, Beijing 100191, Peoples R China; [Li, Wei-Hua; Qiu, Ying; Tian, Xin-Xia; Fang, Wei-Gang] Peking Univ, Hlth Sci Ctr, Dept Pathol, Beijing 100191, Peoples R China; [Zhang, Hong-Quan] Peking Univ, Hlth Sci Ctr, Dept Anat Histol & Embryol, Beijing 100191, Peoples R China	Peking University; Peking University; Peking University	Tian, XX (corresponding author), Peking Univ, Hlth Sci Ctr, Key Lab Carcinogenesis & Translat Res, Minist Educ, Beijing 100191, Peoples R China.	tianxinxia@163.com; wgfang@bjmu.edu.cn			National Natural Science Foundation of China [81321003]; Ministry of Science and Technology of China [2010CB529402]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China)	This work was supported by grants to WGF from National Natural Science Foundation of China (81321003) and 973 Program (2010CB529402) from the Ministry of Science and Technology of China.	ALBINI A, 1987, CANCER RES, V47, P3239; Araki S, 2007, CANCER RES, V67, P6854, DOI 10.1158/0008-5472.CAN-07-1162; Bagchi S, 2005, J BIOL CHEM, V280, P39050, DOI 10.1074/jbc.M504819200; Bertagnolo V, 2007, CARCINOGENESIS, V28, P1638, DOI 10.1093/carcin/bgm078; Burnstock G, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2009.11; Burnstock G, 2011, BJU INT, V107, P192, DOI 10.1111/j.1464-410X.2010.09926.x; Buzzi N, 2009, BBA-GEN SUBJECTS, V1790, P1651, DOI 10.1016/j.bbagen.2009.10.005; Cathomas R, 2012, CLIN CANCER RES, V18, P6049, DOI 10.1158/1078-0432.CCR-12-2219; Chen L, 2004, CANCER LETT, V215, P239, DOI 10.1016/j.canlet.2004.05.023; De Luca A, 2008, J CELL PHYSIOL, V214, P559, DOI 10.1002/jcp.21260; FANG WG, 1992, J CLIN INVEST, V89, P191, DOI 10.1172/JCI115562; Green AR, 1997, INT J CANCER, V72, P937; Gupta GP, 2006, CELL, V127, P679, DOI 10.1016/j.cell.2006.11.001; Inoue K, 2000, CLIN CANCER RES, V6, P2104; Johnson GL, 2002, SCIENCE, V298, P1911, DOI 10.1126/science.1072682; Kinkade CW, 2008, J CLIN INVEST, V118, P3051, DOI 10.1172/JCI34764; Lehrer S, 2004, TECHNOL CANCER RES T, V3, P411, DOI 10.1177/153303460400300501; Li WH, 2013, BRIT J CANCER, V109, P1666, DOI 10.1038/bjc.2013.484; Liu J, 2004, J BIOL CHEM, V279, P8212, DOI 10.1074/jbc.M312230200; Liu YX, 2001, CHINESE MED J-PEKING, V114, P35; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MATSUSHIMA K, 1992, CHEM IMMUNOL, V51, P236; Molliver DC, 2002, EUR J NEUROSCI, V16, P1850, DOI 10.1046/j.1460-9568.2002.02253.x; Norambuena A, 2010, J BIOL CHEM, V285, DOI 10.1074/jbc.M109.081166; Pellegatti P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002599; Prevarskaya N, 2011, NAT REV CANCER, V11, P609, DOI 10.1038/nrc3105; Ratchford AM, 2010, J BIOL CHEM, V285, P7545, DOI 10.1074/jbc.M109.078170; Roberts PJ, 2007, ONCOGENE, V26, P3291, DOI 10.1038/sj.onc.1210422; Schlomm T, 2007, CLIN CANCER RES, V13, P6579, DOI 10.1158/1078-0432.CCR-07-1257; Bilbao PS, 2010, ARCH BIOCHEM BIOPHYS, V494, P7, DOI 10.1016/j.abb.2009.11.002; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Turner T, 1996, CLIN EXP METASTAS, V14, P409, DOI 10.1007/BF00123400; VELU TJ, 1987, SCIENCE, V238, P1408, DOI 10.1126/science.3500513; Yokdang N, 2011, BRIT J CANCER, V104, P1628, DOI 10.1038/bjc.2011.134; Zhang Y, 2010, CANCER LETT, V293, P189, DOI 10.1016/j.canlet.2010.01.010	35	27	30	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2015	10	7							e0133165	10.1371/journal.pone.0133165	http://dx.doi.org/10.1371/journal.pone.0133165			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RQ	26182292	Green Published, gold, Green Submitted			2022-12-26	WOS:000358198200054
J	Cerrato, CP; Pirisinu, M; Vlachos, EN; Langel, U				Cerrato, Carmine Pasquale; Pirisinu, Marco; Vlachos, Efstathios Nikolaos; Langel, Ulo			Novel cell-penetrating peptide targeting mitochondria	FASEB JOURNAL			English	Article						mitochondrial targeting; ROS reduction; mitochondrial membrane potential; antioxidant activity	HUMAN IMMUNODEFICIENCY VIRUS; ANTIOXIDANTS; PROTEIN; SUPEROXIDE; ANALOGS; GLUTATHIONE; PREDICTION; MEMBRANES; DELIVERY; BILAYERS	Cell-penetrating peptides (CPPs) are short, nontoxic peptides with cationic and/or amphipathic properties able to cross the cellular membrane. CPPs are used for the delivery of awide variety of cargoes, such as proteins, oligonucleotides, and therapeuticmolecules. The aim of the present study was to synthesize unusually small novel CPPs targeting mitochondria based on the Szeto-Schiller peptide (SS-31) to influence intramitochondrial processes and to improve the biologic effects. All the peptides used were synthesized manually using 9-fluorenylmethyloxycarbonyl chemistry. In the first part of the study, HeLa 705, U87, and bEnd. 3 cells were used as in vitro delivery model. Cells were incubated for 24 h at 37 degrees C and 5% CO2 with different concentrations of our peptides. Cell proliferation assay was performed to evaluate cell viability. Biologic effects such as mitochondrial membrane potential and antioxidant activity were evaluated. H2O2 was used as positive control. Uptake studies were performed using peptides conjugated with 5(6)-carboxyfluorescein (FAM). Fluorescent microscopy was used to determine presence and localization of peptides into the cells. Isolated mitochondria from pretreated cells and mitochondria treated after isolation were used to confirmthe targeting ability of the peptide. Uptake of FAM alone was used as negative control. Microscopy studies confirmed the ability of peptides to penetrate cell. Localization analysis showed increase in uptake by35% compared with SS-31. Mitochondrial CPP 1 (mtCPP-1) had no effect on mitochondrial membrane potential and prevented reactive oxygen species formation in bEnd. 3 cells by 2-fold compared with SS-31. No cytotoxicity was observed even at high concentration (100 mu M). These data suggest that mtCPP-1 is a mitochondrial CPP and protect mitochondria from oxidative damage due to its own antioxidant activities.	[Cerrato, Carmine Pasquale; Pirisinu, Marco; Vlachos, Efstathios Nikolaos; Langel, Ulo] Stockholm Univ, Dept Neurochem, SE-10691 Stockholm, Sweden; [Pirisinu, Marco] Univ Sassari, Dept Clin & Expt Med, I-07100 Sassari, Italy	Stockholm University; University of Sassari	Cerrato, CP (corresponding author), Stockholm Univ, Dept Neurochem, Svante Arrhenius Vag 16B, SE-10691 Stockholm, Sweden.	carmine@neurochem.su.se	Cerrato, Carmine Pasquale/Y-5180-2019; Pirisinu, Marco/AAR-5399-2021; Langel, Ulo/K-9773-2018	Cerrato, Carmine Pasquale/0000-0001-7769-6905; Pirisinu, Marco/0000-0002-7834-4386; Langel, Ulo/0000-0001-6107-0844				Cartier R, 2002, GENE THER, V9, P157, DOI 10.1038/sj.gt.3301635; Chen H, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S4-S14; CHOU PY, 1974, BIOCHEMISTRY-US, V13, P222, DOI 10.1021/bi00699a002; Dai Dao-Fu, 2014, Longev Healthspan, V3, P6, DOI 10.1186/2046-2395-3-6; DEROSSI D, 1994, J BIOL CHEM, V269, P10444; Doughan AK, 2007, ANTIOXID REDOX SIGN, V9, P1825, DOI 10.1089/ars.2007.1693; FAWELL S, 1994, P NATL ACAD SCI USA, V91, P664, DOI 10.1073/pnas.91.2.664; FRANKEL AD, 1988, CELL, V55, P1189, DOI 10.1016/0092-8674(88)90263-2; Gauuan PJF, 2002, BIOORGAN MED CHEM, V10, P3013, DOI 10.1016/S0968-0896(02)00153-0; GREEN M, 1988, CELL, V55, P1179, DOI 10.1016/0092-8674(88)90262-0; Horobin RW, 2007, J CONTROL RELEASE, V121, P125, DOI 10.1016/j.jconrel.2007.05.040; Kaminaga Y, 2003, FEBS LETT, V555, P311, DOI 10.1016/S0014-5793(03)01265-1; Mahon KP, 2007, CHEM BIOL, V14, P923, DOI 10.1016/j.chembiol.2007.07.011; Miller ER, 2005, ANN INTERN MED, V142, P37, DOI 10.7326/0003-4819-142-1-200501040-00110; PICHORNER H, 1995, ARCH BIOCHEM BIOPHYS, V323, P429, DOI 10.1006/abbi.1995.0064; Rosania GR, 2003, CURR TOP MED CHEM, V3, P659, DOI 10.2174/1568026033452410; Ross MF, 2004, BIOCHEM SOC T, V32, P1072, DOI 10.1042/BST0321072; Ross MF, 2004, BIOCHEM J, V383, P457, DOI 10.1042/BJ20041095; Rothbard JB, 2004, J AM CHEM SOC, V126, P9506, DOI 10.1021/ja0482536; Roy A, 2008, MOL PHARMACOL, V74, P1292, DOI 10.1124/mol.108.050161; Schiller PW, 2000, EUR J MED CHEM, V35, P895, DOI 10.1016/S0223-5234(00)01171-5; Soomets Ursel, 2005, V298, P241; Steinhubl SR, 2008, AM J CARDIOL, V101, p14D, DOI 10.1016/j.amjcard.2008.02.003; Szeto HH, 2006, AAPS J, V8, pE521, DOI 10.1208/aapsj080362; Szeto HH, 2006, AAPS J, V8, pE277, DOI 10.1007/BF02854898; Terrone D, 2003, BIOCHEMISTRY-US, V42, P13787, DOI 10.1021/bi035293y; Tieu K, 2003, IUBMB LIFE, V55, P329, DOI 10.1080/1521654032000114320; Wender PA, 2000, P NATL ACAD SCI USA, V97, P13003, DOI 10.1073/pnas.97.24.13003; Zhao KS, 2004, J BIOL CHEM, V279, P34682, DOI 10.1074/jbc.M402999200	29	72	72	2	84	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2015	29	11					4589	4599		10.1096/fj.14-269225	http://dx.doi.org/10.1096/fj.14-269225			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CV8EZ	26195590				2022-12-26	WOS:000364514700018
J	Oh, SK; Shin, JO; Baek, JI; Lee, J; Bae, JW; Ankamerddy, H; Kim, MJ; Huh, TL; Ryoo, ZY; Kim, UK; Bok, J; Lee, KY				Oh, Se-Kyung; Shin, Jeong-Oh; Baek, Jeong-In; Lee, Jinwook; Bae, Jae Woong; Ankamerddy, Harinarayana; Kim, Myoung-Jin; Huh, Tae-Lin; Ryoo, Zae-Young; Kim, Un-Kyung; Bok, Jinwoong; Lee, Kyu-Yup			Pannexin 3 is required for normal progression of skeletal development in vertebrates	FASEB JOURNAL			English	Article						chondrocytes; osteoblasts; differentiation; mineralization	GAP-JUNCTION PROTEINS; INTRAMEMBRANOUS BONE; CARTILAGE; DIFFERENTIATION; ZEBRAFISH; FAMILY; CELLS; CALCIFICATION; OSSIFICATION; OSTEOBLASTS	The vertebrate skeletal system has various functions, including support, movement, protection, and the production of blood cells. The development of cartilage and bones, the core components of the skeletal system, is mediated by systematic inter- and intracellular communication among multiple signaling pathways in differentiating progenitors and the surrounding tissues. Recently, Pannexin (Panx) 3 has been shown to play important roles in bone development in vitro by mediating multiple signaling pathways, although its roles in vivo have not been explored. In this study, we generated and analyzed Panx3 knockout mice and examined the skeletal phenotypes of panx3 morphant zebrafish. Panx3(-/-) embryos exhibited delays in hypertrophic chondrocyte differentiation and osteoblast differentiation as well as the initiation of mineralization, resulting in shortened long bones in adulthood. The abnormal progression of hypertrophic chondrogenesis appeared to be associated with the sustained proliferation of chondrocytes, which resulted from increased intracellular cAMP levels. Similarly, osteoblast differentiation and mineralization were delayed in panx3 morphant zebrafish. Taken together, our results provide evidence of the crucial roles of Panx3 in vertebrate skeletal development in vivo.	[Oh, Se-Kyung; Lee, Jinwook; Kim, Un-Kyung] Kyungpook Natl Univ, Coll Nat Sci, Dept Biol, Daegu, South Korea; [Oh, Se-Kyung; Lee, Jinwook; Kim, Un-Kyung] Kyungpook Natl Univ, Creat BioRes Grp, Sch Life Sci, PLUS Project BrainKorea21, Daegu, South Korea; [Kim, Myoung-Jin; Huh, Tae-Lin; Ryoo, Zae-Young] Kyungpook Natl Univ, Sch Life Sci & Biotechnol, Daegu, South Korea; [Lee, Kyu-Yup] Kyungpook Natl Univ, Coll Med, Dept Otorhinolaryngol Head & Neck Surg, Daegu 702721, South Korea; [Shin, Jeong-Oh; Bae, Jae Woong; Ankamerddy, Harinarayana; Bok, Jinwoong] Yonsei Univ, Coll Med, Dept Anat, PLUS Project Med Sci BrainKorea21, Seoul 120752, South Korea; [Baek, Jeong-In] Univ Penn, Dept Med, Philadelphia, PA 19104 USA	Kyungpook National University; Kyungpook National University; Kyungpook National University; Kyungpook National University; Yonsei University; Yonsei University Health System; University of Pennsylvania	Bok, J (corresponding author), Yonsei Univ, Coll Med, Dept Anat, Seoul 120752, South Korea.	bokj@yuhs.ac; kylee@knu.ac.kr	RYOO, ZAEYOUNG/AAQ-1573-2020; Bok, Jinwoong/M-2834-2019; Ankamreddy, Harinarayana/AFQ-5718-2022	Bok, Jinwoong/0000-0003-1958-1872; Ankamreddy, Harinarayana/0000-0002-2859-087X	Basic Science Research Program through the National Research Foundation of Korea - Ministry of Science, Information and Communications Technology and Future Planning [2013R1A2A2A01067405]; Bio and Medical Technology Development Program of the National Research Foundation of Korea - Ministry of Science, Information and Communications Technology and Future Planning [2014M3A9D5073865]; Korea Health Technology Research and Development Project through the Korea Health Industry Development Institute - Ministry of Health and Welfare, Republic of Korea [HI14C0384]	Basic Science Research Program through the National Research Foundation of Korea - Ministry of Science, Information and Communications Technology and Future Planning; Bio and Medical Technology Development Program of the National Research Foundation of Korea - Ministry of Science, Information and Communications Technology and Future Planning; Korea Health Technology Research and Development Project through the Korea Health Industry Development Institute - Ministry of Health and Welfare, Republic of Korea	The authors thank Byeonghyeon Lee and Tae-Jun Kwon for technical assistance and the Korea Zebrafish Resource Bank for providing the zebrafish lines. This research was supported by the Basic Science Research Program through the National Research Foundation of Korea, funded by the Ministry of Science, Information and Communications Technology and Future Planning (2013R1A2A2A01067405; to K.-Y.L.), the Bio and Medical Technology Development Program of the National Research Foundation of Korea, funded by the Ministry of Science, Information and Communications Technology and Future Planning (2014M3A9D5073865; to J.B. and U.-K.K.), and the Korea Health Technology Research and Development Project through the Korea Health Industry Development Institute, funded by the Ministry of Health and Welfare, Republic of Korea (HI14C0384; to K.-Y.L.).	ANDERSON HC, 1967, J CELL BIOL, V35, P81, DOI 10.1083/jcb.35.1.81; Bar-Shavit Z, 2007, J CELL BIOCHEM, V102, P1130, DOI 10.1002/jcb.21553; Baranova A, 2004, GENOMICS, V83, P706, DOI 10.1016/j.ygeno.2003.09.025; Barbe MT, 2006, PHYSIOLOGY, V21, P103, DOI 10.1152/physiol.00048.2005; BERNARD GW, 1969, AM J ANAT, V125, P271, DOI 10.1002/aja.1001250303; Bond SR, 2011, J BONE MINER RES, V26, P2911, DOI 10.1002/jbmr.509; BONUCCI E, 1967, J ULTRA MOL STRUCT R, V20, P33, DOI 10.1016/S0022-5320(67)80034-0; Bruzzone R, 2003, P NATL ACAD SCI USA, V100, P13644, DOI 10.1073/pnas.2233464100; Chaible LM, 2011, TOXICOL PATHOL, V39, P1046, DOI 10.1177/0192623311422075; Franz-Odendaal TA, 2011, FRONT BIOSCI-LANDMRK, V16, P2734, DOI 10.2741/3882; Golub EE, 2009, BBA-GEN SUBJECTS, V1790, P1592, DOI 10.1016/j.bbagen.2009.09.006; Hall BK, 1995, INT J DEV BIOL, V39, P881; Hauptmann G, 2000, METH MOL B, V137, P139; Ishikawa M, 2014, J BIOL CHEM, V289, P2839, DOI 10.1074/jbc.M113.523241; Ishikawa M, 2011, J CELL BIOL, V193, P1257, DOI 10.1083/jcb.201101050; Iwamoto T, 2010, J BIOL CHEM, V285, P18948, DOI 10.1074/jbc.M110.127027; Karsenty G, 2002, DEV CELL, V2, P389, DOI 10.1016/S1534-5807(02)00157-0; Kim YI, 2013, MOL CELLS, V36, P145, DOI 10.1007/s10059-013-0117-7; Lakso M, 1996, P NATL ACAD SCI USA, V93, P5860, DOI 10.1073/pnas.93.12.5860; Lecanda F, 2000, J CELL BIOL, V151, P931, DOI 10.1083/jcb.151.4.931; Lefebvre V, 2010, CURR TOP DEV BIOL, V90, P291, DOI 10.1016/S0070-2153(10)90008-2; Mackie EJ, 2008, INT J BIOCHEM CELL B, V40, P46, DOI 10.1016/j.biocel.2007.06.009; Maes C, 2002, MECH DEVELOP, V111, P61, DOI 10.1016/S0925-4773(01)00601-3; Marie PJ, 2008, ARCH BIOCHEM BIOPHYS, V473, P98, DOI 10.1016/j.abb.2008.02.030; Opperman LA, 2000, DEV DYNAM, V219, P472, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1073>3.0.CO;2-F; Penuela S, 2007, J CELL SCI, V120, P3772, DOI 10.1242/jcs.009514; Penuela S, 2014, J INVEST DERMATOL, V134, P2026, DOI 10.1038/jid.2014.86; Penuela S, 2009, MOL BIOL CELL, V20, P4313, DOI 10.1091/mbc.E09-01-0067; RUANGVORAVAT CP, 1992, DEV DYNAM, V194, P261, DOI 10.1002/aja.1001940403; THISSE C, 1993, DEVELOPMENT, V119, P1203; Thouverey C, 2011, J PROTEOMICS, V74, P1123, DOI 10.1016/j.jprot.2011.04.005; Thouverey C, 2009, J CELL BIOCHEM, V106, P127, DOI 10.1002/jcb.21992; Walker MB, 2007, BIOTECH HISTOCHEM, V82, P23, DOI 10.1080/10520290701333558; Wuelling M, 2010, PEDIATR NEPHROL, V25, P625, DOI 10.1007/s00467-009-1368-6; Xiao Z, 2007, J CELL PHYSIOL, V210, P325, DOI 10.1002/jcp.20826; Zhang ML, 2008, BONE, V43, P511, DOI 10.1016/j.bone.2008.04.021; Zhou XY, 2012, INT J BIOL SCI, V8, P778, DOI 10.7150/ijbs.4538	37	20	20	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2015	29	11					4473	4484		10.1096/fj.15-273722	http://dx.doi.org/10.1096/fj.15-273722			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CV8EZ	26183770				2022-12-26	WOS:000364514700008
J	Kloverpris, S; Mikkelsen, JH; Pedersen, JH; Jepsen, MR; Laursen, LS; Petersen, SV; Oxvig, C				Kloverpris, Soren; Mikkelsen, Jakob H.; Pedersen, Josefine H.; Jepsen, Malene R.; Laursen, Lisbeth S.; Petersen, Steen V.; Oxvig, Claus			Stanniocalcin-1 Potently Inhibits the Proteolytic Activity of the Metalloproteinase Pregnancy-associated Plasma Protein-A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAJOR BASIC-PROTEIN; PAPP-A; MOLECULAR-CLONING; STC1 EXPRESSION; GROWTH; INSULIN; IGF; CALCIUM; IDENTIFICATION; REGULATOR	Stanniocalcin-1 (STC1) is a disulfide-bound homodimeric glycoprotein, first identified as a hypocalcemic hormone important for maintaining calcium homeostasis in teleost fish. STC1 was later found to be widely expressed in mammals, although it is not believed to function in systemic calcium regulation in these species. Several physiological functions of STC1 have been reported, although many molecular details are still lacking. We here demonstrate that STC1 is an inhibitor of the metzincin metalloproteinase, pregnancy-associated plasma protein-A (PAPP-A), which modulates insulin-like growth factor (IGF) signaling through proteolytic cleavage of IGF-binding proteins (IGFBPs). STC1 potently (K-i = 68 pM) inhibits PAPP-A cleavage of IGFBP-4, and we show in a cell-based assay that STC1 effectively antagonizes PAPP-A-mediated type 1 IGF receptor (IGF1R) phosphorylation. It has recently been found that the homologous STC2 inhibits PAPP-A proteolytic activity, and that this depends on the formation of a covalent complex between the inhibitor and the proteinase, mediated by Cys-120 of STC2. We find that STC1 is unable to bind covalently to PAPP-A, in agreement with the absence of a corresponding cysteine residue. It rather binds to PAPP-A with high affinity(K-D = 75 pM). We further demonstrate that both STC1 and STC2 show inhibitory activity toward PAPP-A2, but not selected serine proteinases and metalloproteinases. We therefore conclude that the STCs are proteinase inhibitors, probably restricted in specificity to the pappalysin family of metzincin metalloproteinases. Ourdata are the first to identify STC1 as a proteinase inhibitor, suggesting a previously unrecognized function of STC1 in the IGF system.	[Kloverpris, Soren; Mikkelsen, Jakob H.; Pedersen, Josefine H.; Jepsen, Malene R.; Laursen, Lisbeth S.; Oxvig, Claus] Aarhus Univ, Dept Mol Biol & Genet, DK-8000 Aarhus, Denmark; [Petersen, Steen V.] Aarhus Univ, Dept Biomed, DK-8000 Aarhus, Denmark	Aarhus University; Aarhus University	Oxvig, C (corresponding author), Aarhus Univ, Dept Mol Biol & Genet, DK-8000 Aarhus, Denmark.	co@mbg.au.dk		Mikkelsen, Jakob Hauge/0000-0002-2914-3297; Vang Petersen, Steen/0000-0002-9338-911X; Jepsen, Malene/0000-0003-1959-5019; Laursen, Lisbeth Schmidt/0000-0002-8676-5869; Oxvig, Claus/0000-0002-4715-9719	Lundbeck Foundation; Novo Nordisk Foundation; Danish Council for Independent Research; Novo Nordisk Fonden [NNF14OC0010497] Funding Source: researchfish	Lundbeck Foundation(Lundbeckfonden); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Danish Council for Independent Research(Det Frie Forskningsrad (DFF)); Novo Nordisk Fonden(Novo Nordisk Foundation)	This work was supported by grants from the Lundbeck Foundation, the Novo Nordisk Foundation, and the Danish Council for Independent Research. The authors declare that they have no conflicts of interest with the contents of this article.	Becker MA, 2015, MOL CANCER THER, V14, P973, DOI 10.1158/1535-7163.MCT-14-0880; Boldt HB, 2001, BIOCHEM J, V358, P359, DOI 10.1042/0264-6021:3580359; Brew K, 2010, BBA-MOL CELL RES, V1803, P55, DOI 10.1016/j.bbamcr.2010.01.003; Chang ACM, 2005, MOL CELL BIOL, V25, P10604, DOI 10.1128/MCB.25.23.10604-10610.2005; Chang ACM, 1998, MOL CELL ENDOCRINOL, V141, P95, DOI 10.1016/S0303-7207(98)00097-5; CHANG ACM, 1995, MOL CELL ENDOCRINOL, V112, P241, DOI 10.1016/0303-7207(95)03601-3; Chang ACM, 2008, ENDOCRINOLOGY, V149, P2403, DOI 10.1210/en.2007-1219; Chang ACM, 2015, CLIN EXP METASTAS, V32, P15, DOI 10.1007/s10585-014-9687-9; Conover CA, 2004, DEVELOPMENT, V131, P1187, DOI 10.1242/dev.00997; Dai W, 2014, CELL DEATH DIFFER, V21, P568, DOI 10.1038/cdd.2013.177; DiMattia GE, 1998, MOL CELL ENDOCRINOL, V146, P137, DOI 10.1016/S0303-7207(98)00163-4; Forbes Briony E, 2012, Front Endocrinol (Lausanne), V3, P38, DOI 10.3389/fendo.2012.00038; Gagliardi AD, 2005, AM J PHYSIOL-ENDOC M, V288, pE92, DOI 10.1152/ajpendo.00268.2004; Godiksen S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077146; Gyrup C, 2007, CLIN CHEM, V53, P947, DOI 10.1373/clinchem.2006.080614; Gyrup C, 2007, BIOCHEMISTRY-US, V46, P1972, DOI 10.1021/bi062229i; Hulova I, 1999, BIOCHEM BIOPH RES CO, V257, P295, DOI 10.1006/bbrc.1999.0466; Hwang PP, 2013, PFLUG ARCH EUR J PHY, V465, P1233, DOI 10.1007/s00424-013-1269-1; Ishibashi K, 1998, BIOCHEM BIOPH RES CO, V250, P252, DOI 10.1006/bbrc.1998.9300; Jepsen MR, 2015, J BIOL CHEM, V290, P3430, DOI 10.1074/jbc.M114.611665; Kjaer-Sorensen K, 2013, J BIOL CHEM, V288, P9982, DOI 10.1074/jbc.M112.426304; Laursen LS, 2007, MOL ENDOCRINOL, V21, P1246, DOI 10.1210/me.2006-0522; Laursen LS, 2001, FEBS LETT, V504, P36, DOI 10.1016/S0014-5793(01)02760-0; Lawrence JB, 1999, P NATL ACAD SCI USA, V96, P3149, DOI 10.1073/pnas.96.6.3149; Lin CH, 2014, ENDOCRINOLOGY, V155, P56, DOI 10.1210/en.2013-1608; Loddo M, 2014, J PATHOL, V233, P344, DOI 10.1002/path.4393; Madsen KL, 1998, AM J PHYSIOL-GASTR L, V274, pG96, DOI 10.1152/ajpgi.1998.274.1.G96; Mikkelsen JH, 2014, ONCOTARGET, V5, P1014, DOI 10.18632/oncotarget.1629; Monget P, 2003, BIOL REPROD, V68, P77, DOI 10.1095/biolreprod.102.007609; Moore EE, 1999, HORM METAB RES, V31, P406, DOI 10.1055/s-2007-978764; Olsen HS, 1996, P NATL ACAD SCI USA, V93, P1792, DOI 10.1073/pnas.93.5.1792; Overgaard MT, 2000, J BIOL CHEM, V275, P31128, DOI 10.1074/jbc.M001384200; Overgaard MT, 1999, BIOL REPROD, V61, P1083, DOI 10.1095/biolreprod61.4.1083; Overgaard MT, 2001, J BIOL CHEM, V276, P21849, DOI 10.1074/jbc.M102191200; OXVIG C, 1994, BBA-GEN SUBJECTS, V1201, P415, DOI 10.1016/0304-4165(94)90071-X; Oxvig C, 2015, J CELL COMMUN SIGNAL, V9, P177, DOI 10.1007/s12079-015-0259-9; Pena C, 2013, CANCER RES, V73, P1287, DOI 10.1158/0008-5472.CAN-12-1875; Pollak M, 2012, NAT REV CANCER, V12, P159, DOI 10.1038/nrc3215; Qin QP, 1997, CLIN CHEM, V43, P2323; Roch GJ, 2011, GENOME BIOL EVOL, V3, P284, DOI 10.1093/gbe/evr020; Serlachius M, 2004, EXP CELL RES, V296, P256, DOI 10.1016/j.yexcr.2004.02.016; Sheikh-Hamad D, 2003, AM J PHYSIOL-HEART C, V285, pH442, DOI 10.1152/ajpheart.01071.2002; Stewart CEH, 1996, PHYSIOL REV, V76, P1005, DOI 10.1152/physrev.1996.76.4.1005; Trindade DM, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-57; Tseng DY, 2009, AM J PHYSIOL-REG I, V296, pR549, DOI 10.1152/ajpregu.90742.2008; Varghese R, 1998, ENDOCRINOLOGY, V139, P4714, DOI 10.1210/en.139.11.4714; Varghese R, 2002, ENDOCRINOLOGY, V143, P868, DOI 10.1210/en.143.3.868; WAGNER GF, 1986, GEN COMP ENDOCR, V63, P481, DOI 10.1016/0016-6480(86)90149-8; Wagner GF, 1997, J BONE MINER RES, V12, P165, DOI 10.1359/jbmr.1997.12.2.165; Wagner GF, 2006, J EXP ZOOL PART A, V305A, P769, DOI 10.1002/jez.a.313; Welcsh PL, 2002, P NATL ACAD SCI USA, V99, P7560, DOI 10.1073/pnas.062181799; Wu SF, 2006, J BIOL CHEM, V281, P5120, DOI 10.1074/jbc.M506667200; Yeung BHY, 2012, MOL CELL ENDOCRINOL, V349, P272, DOI 10.1016/j.mce.2011.11.007; Zhang JL, 1998, PROTEIN EXPRES PURIF, V12, P390, DOI 10.1006/prep.1997.0857	54	52	53	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	2015	290	36					21915	21924		10.1074/jbc.M115.650143	http://dx.doi.org/10.1074/jbc.M115.650143			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CQ9XI	26195635	Green Published, hybrid			2022-12-26	WOS:000360968500013
J	Yang, H; Liu, S; He, WT; Zhao, J; Jiang, LL; Hu, HY				Yang, Hui; Liu, Shuai; He, Wen-Tian; Zhao, Jian; Jiang, Lei-Lei; Hu, Hong-Yu			Aggregation of Polyglutamine-expanded Ataxin 7 Protein Specifically Sequesters Ubiquitin-specific Protease 22 and Deteriorates Its Deubiquitinating Function in the Spt-Ada-Gcn5-Acetyltransferase (SAGA) Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEURONAL INTRANUCLEAR INCLUSIONS; HISTONE ACETYLTRANSFERASE ACTIVITY; DOMINANT CEREBELLAR-ATAXIA; STEM-CELL MARKER; TRANSCRIPTIONAL ACTIVATION; SPINOCEREBELLAR ATAXIA-7; RETINAL DEGENERATION; MACULAR DYSTROPHY; 26S PROTEASOME; SCA7	Human ataxin 7 (Atx7) is a component of the deubiquitination module (DUBm) in the Spt-Ada-Gcn5-acetyltransferase (SAGA) complex for transcriptional regulation, and expansion of its polyglutamine (polyQ) tract leads to spinocerebellar ataxia type 7. However, how polyQ expansion of Atx7 affects DUBm function remains elusive. We investigated the effects of polyQ-expanded Atx7 on ubiquitin-specific protease (USP22), an interacting partner of Atx7 functioning in deubiquitination of histone H2B. The results showed that the inclusions or aggregates formed by polyQ-expanded Atx7 specifically sequester USP22 through their interactions mediated by the N-terminal zinc finger domain of Atx7. The mutation of the zinc finger domain in Atx7 that disrupts its interaction with USP22 dramatically abolishes sequestration of USP22. Moreover, polyQ expansion of Atx7 decreases the deubiquitinating activity of USP22 and, consequently, increases the level of monoubiquitinated H2B. Therefore, we propose that polyQ-expanded Atx7 forms insoluble aggregates that sequester USP22 into a catalytically inactive state, and then the impaired DUBm loses the function to deubiquitinate monoubiquitinated histone H2B or H2A. This may result in dysfunction of the SAGA complex and transcriptional dysregulation in spinocerebellar ataxia type 7 disease.	[Yang, Hui; Liu, Shuai; He, Wen-Tian; Zhao, Jian; Jiang, Lei-Lei; Hu, Hong-Yu] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, State Key Lab Mol Biol, Shanghai 200031, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Hu, HY (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, State Key Lab Mol Biol, 320 Yue Yang Rd, Shanghai 200031, Peoples R China.	hyhu@sibcb.ac.cn	Hu, Hong-Yu/AAQ-2633-2020	Liu, Shuai/0000-0002-6069-4900	National Basic Research Program of China [2012CB911003]; National Natural Science Foundation of China [31270773, 31200570, 31470758]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Basic Research Program of China Grant 2012CB911003 and National Natural Science Foundation of China Grants 31270773, 31200570, and 31470758. The authors declare that they have no conflicts of interest with the contents of this article.	Ansorge O, 2004, ANN NEUROL, V56, P448, DOI 10.1002/ana.20230; Baker SP, 2007, ONCOGENE, V26, P5329, DOI 10.1038/sj.onc.1210603; Bao WJ, 2006, PROTEIN EXPRES PURIF, V47, P599, DOI 10.1016/j.pep.2005.11.021; Blum ES, 2013, TRENDS CELL BIOL, V23, P168, DOI 10.1016/j.tcb.2012.11.003; Bonnet J, 2010, EMBO REP, V11, P612, DOI 10.1038/embor.2010.98; Borodovsky A, 2001, EMBO J, V20, P5187, DOI 10.1093/emboj/20.18.5187; Chai YH, 1999, HUM MOL GENET, V8, P673, DOI 10.1093/hmg/8.4.673; Chai YH, 2001, J BIOL CHEM, V276, P44889, DOI 10.1074/jbc.M106575200; Choi YJ, 2012, MOL CELL NEUROSCI, V49, P127, DOI 10.1016/j.mcn.2011.11.003; Chou AH, 2010, NEUROCHEM INT, V56, P329, DOI 10.1016/j.neuint.2009.11.003; Damrath E, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002920; David G, 1998, HUM MOL GENET, V7, P165, DOI 10.1093/hmg/7.2.165; David G, 1997, NAT GENET, V17, P65, DOI 10.1038/ng0997-65; Einum DD, 2001, NEUROGENETICS, V3, P83, DOI 10.1007/s100480000100; ENEVOLDSON TP, 1994, BRAIN, V117, P445, DOI 10.1093/brain/117.3.445; Friedman MJ, 2007, NAT NEUROSCI, V10, P1519, DOI 10.1038/nn2011; Fujita K, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2828; Gao YG, 2014, STRUCTURE, V22, P378, DOI 10.1016/j.str.2013.12.005; Helmlinger D, 2006, PLOS BIOL, V4, P432, DOI 10.1371/journal.pbio.0040067; Helmlinger D, 2004, HUM MOL GENET, V13, P1257, DOI 10.1093/hmg/ddh139; Helmlinger D, 2006, TRENDS GENET, V22, P562, DOI 10.1016/j.tig.2006.07.010; Henry KW, 2003, GENE DEV, V17, P2648, DOI 10.1101/gad.1144003; Holmberg M, 1998, HUM MOL GENET, V7, P913, DOI 10.1093/hmg/7.5.913; Holmes WM, 2014, CRIT REV BIOCHEM MOL, V49, P294, DOI 10.3109/10409238.2014.914151; Hsu TC, 2014, HUM MOL GENET, V23, P6878, DOI 10.1093/hmg/ddu410; Janer A, 2010, HUM MOL GENET, V19, P181, DOI 10.1093/hmg/ddp478; Jiang YJ, 2013, FEBS LETT, V587, P2905, DOI 10.1016/j.febslet.2013.07.021; Jiang YJ, 2011, J BIOL CHEM, V286, P25236, DOI 10.1074/jbc.M110.216333; Johnsen SA, 2012, FEBS LETT, V586, P1592, DOI 10.1016/j.febslet.2012.04.002; Kayatekin C, 2014, P NATL ACAD SCI USA, V111, P12085, DOI 10.1073/pnas.1412504111; Lan XJ, 2015, MOL CELL BIOL, V35, P1777, DOI 10.1128/MCB.01454-14; Lang G, 2011, MOL CELL BIOL, V31, P3734, DOI 10.1128/MCB.05231-11; Latouche M, 2007, J NEUROSCI, V27, P2483, DOI 10.1523/JNEUROSCI.5453-06.2007; Lebre AS, 2001, HUM MOL GENET, V10, P1201, DOI 10.1093/hmg/10.11.1201; Lin ZH, 2012, MOL CELL, V46, P484, DOI 10.1016/j.molcel.2012.03.024; McCampbell A, 2000, HUM MOL GENET, V9, P2197, DOI 10.1093/hmg/9.14.2197; McCullough SD, 2012, P NATL ACAD SCI USA, V109, P21319, DOI 10.1073/pnas.1218331110; McMahon SJ, 2005, P NATL ACAD SCI USA, V102, P8478, DOI 10.1073/pnas.0503493102; Mohan RD, 2014, GENE DEV, V28, P259, DOI 10.1101/gad.225151.113; Nagy Z, 2007, ONCOGENE, V26, P5341, DOI 10.1038/sj.onc.1210604; Olzscha H, 2011, CELL, V144, P67, DOI 10.1016/j.cell.2010.11.050; Orr HT, 2007, ANNU REV NEUROSCI, V30, P575, DOI 10.1146/annurev.neuro.29.051605.113042; Palhan VB, 2005, P NATL ACAD SCI USA, V102, P8472, DOI 10.1073/pnas.0503505102; Park SH, 2013, CELL, V154, P134, DOI 10.1016/j.cell.2013.06.003; Perez MK, 1998, J CELL BIOL, V143, P1457, DOI 10.1083/jcb.143.6.1457; Rantanen K, 2013, J CELL SCI, V126, P1144, DOI 10.1242/jcs.115667; Reyes-Turcu FE, 2006, CELL, V124, P1197, DOI 10.1016/j.cell.2006.02.038; Rodriguez-Navarro S, 2009, EMBO REP, V10, P843, DOI 10.1038/embor.2009.168; Schmidt T, 2002, ANN NEUROL, V51, P302, DOI 10.1002/ana.10101; Takahashi J, 2002, BRAIN, V125, P1534, DOI 10.1093/brain/awf154; Verma R, 2002, SCIENCE, V298, P611, DOI 10.1126/science.1075898; Weake VM, 2008, MOL CELL, V29, P653, DOI 10.1016/j.molcel.2008.02.014; Xie YY, 2010, FASEB J, V24, P196, DOI 10.1096/fj.09-133082; Yang H, 2014, SCI REP-UK, V4, DOI 10.1038/srep06410; Yu A, 2014, P NATL ACAD SCI USA, V111, pE1481, DOI 10.1073/pnas.1321811111; Zhang XY, 2008, CELL CYCLE, V7, P1522, DOI 10.4161/cc.7.11.5962; Zhang XY, 2008, MOL CELL, V29, P102, DOI 10.1016/j.molcel.2007.12.015; Zhao XH, 2012, J BIOL CHEM, V287, P23346, DOI 10.1074/jbc.M111.287748; Zhao Y, 2008, MOL CELL, V29, P92, DOI 10.1016/j.molcel.2007.12.011; Zoghbi HY, 2000, ANNU REV NEUROSCI, V23, P217, DOI 10.1146/annurev.neuro.23.1.217	60	24	25	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	2015	290	36					21996	22004		10.1074/jbc.M114.631663	http://dx.doi.org/10.1074/jbc.M114.631663			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CQ9XI	26195632	Green Published, hybrid			2022-12-26	WOS:000360968500020
J	Gao, JJ; Wang, Q; Dong, C; Chen, SQ; Qi, Y; Liu, YH				Gao, Juanjuan; Wang, Qi; Dong, Cheng; Chen, Siqi; Qi, Yu; Liu, Yuhe			Whole Exome Sequencing Identified MCM2 as a Novel Causative Gene for Autosomal Dominant Nonsyndromic Deafness in a Chinese Family	PLOS ONE			English	Article							HEARING-LOSS; INDUCED APOPTOSIS; DNA-REPLICATION; HAIR-CELLS; MUTATION; LOCALIZATION; EXPRESSION; COMPLEX; INNER; OVEREXPRESSION	We report the genetic analysis of autosomal dominant, nonsyndromic, progressive sensorineural hearing loss in a Chinese family. Using whole exome sequencing, we identified a missense variant (c.130C>T, p.R44C) in the MCM2 gene, which has a pro-apoptosis effect and is involved in the initiation of eukaryotic genome replication. This missense variant is very likely to be the disease causing variant. It segregated with hearing loss in this pedigree, and was not found in the dbSNP database or databases of genomes and SNP in the Chinese population, in 76 patients with sporadic hearing loss, or in 145 normal individuals. We performed western blot and immunofluorescence to test the MCM2 protein expression in the cochlea of rats and guinea pigs, demonstrating that MCM2 was widely expressed in the cochlea and was also surprisingly expressed in the cytoplasm of terminally differentiated hair cells. We then transiently expressed the variant MCM2 cDNA in HEK293 cells, and found that these cells displayed a slight increase in apoptosis without any changes in proliferation or cell cycle, supporting the view that this variant is pathogenic. In summary, we have identified MCM2 as a novel gene responsible for nonsyndromic hearing loss of autosomal dominant inheritance in a Chinese family.	[Gao, Juanjuan; Wang, Qi; Dong, Cheng; Chen, Siqi; Liu, Yuhe] Peking Univ, Hosp 1, Dept Otolaryngol Head & Neck Surg, Beijing 100871, Peoples R China; [Qi, Yu] Peking Univ, Hosp 1, Dept Cent Lab, Beijing 100871, Peoples R China	Peking University; Peking University	Liu, YH (corresponding author), Peking Univ, Hosp 1, Dept Otolaryngol Head & Neck Surg, Beijing 100871, Peoples R China.	liuyuhefeng@163.com	gao, juan/GXV-1381-2022		National Natural Science Foundation of China [81271083, 81470691]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This project was funded by National Natural Science Foundation of China under the grant 81271083 and 81470691. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040129; Asan, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-9-r95; Bayazit YA, 2006, ORL-J OTO-RHIN-LARYN, V68, P57, DOI 10.1159/000091090; Bell SD, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012807; Bochman ML, 2008, MOL CELL, V31, P287, DOI 10.1016/j.molcel.2008.05.020; Burke TW, 2001, J BIOL CHEM, V276, P15397, DOI 10.1074/jbc.M011556200; de Beeck KO, 2011, HEARING RES, V281, P18, DOI 10.1016/j.heares.2011.07.002; Forsburg SL, 2004, MICROBIOL MOL BIOL R, V68, P109, DOI 10.1128/MMBR.68.1.109-131.2004; Frolenkov GI, 2004, NAT REV GENET, V5, P489, DOI 10.1038/nrg1377; Gao J, 2013, CLIN GENET, V83, P477, DOI 10.1111/cge.12006; Hasegawa M, 2009, LEUKEMIA RES, V33, P1100, DOI 10.1016/j.leukres.2008.10.025; Hildebrand MS, 2007, AM J MED GENET A, V143A, P1599, DOI 10.1002/ajmg.a.31860; Hilgert N, 2009, CURR MOL MED, V9, P546, DOI 10.2174/156652409788488775; Holland L, 2002, EUR J BIOCHEM, V269, P5192, DOI 10.1046/j.1432-1033.2002.03224.x; Ishimi Y, 1998, J BIOL CHEM, V273, P8369, DOI 10.1074/jbc.273.14.8369; Kuhlenbaumer G, 2011, HUM MUTAT, V32, P144, DOI 10.1002/humu.21400; Lallemend F, 2005, CURR PHARM DESIGN, V11, P2257, DOI 10.2174/1381612054367346; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Liu HZ, 2014, J NEUROSCI, V34, P11085, DOI 10.1523/JNEUROSCI.1690-14.2014; Pacek M, 2006, MOL CELL, V21, P581, DOI 10.1016/j.molcel.2006.01.030; PREZANT TR, 1993, NAT GENET, V4, P289, DOI 10.1038/ng0793-289; Ramnath N, 2001, J CLIN ONCOL, V19, P4259, DOI 10.1200/JCO.2001.19.22.4259; Riera A, 2013, CELL CYCLE, V12, P2155, DOI 10.4161/cc.25336; Robertson NG, 2003, J MED GENET, V40, P479, DOI 10.1136/jmg.40.7.479; Sanders SS, 2011, CLIN GENET, V79, P132, DOI 10.1111/j.1399-0004.2010.01585.x; Smith RJ., 1993, GENEREVIEWS; Stelma F, 2014, J LARYNGOL OTOL, V128, P13, DOI 10.1017/S0022215113003265; Suzuki S, 2012, EXP MOL PATHOL, V92, P160, DOI 10.1016/j.yexmp.2011.11.003; Tsuji T, 2006, MOL BIOL CELL, V17, P4459, DOI 10.1091/mbc.E06-03-0241; Tsuruga H, 1997, BIOCHEM BIOPH RES CO, V236, P118, DOI 10.1006/bbrc.1997.6865; Van De Water TR, 2004, OTOL NEUROTOL, V25, P627, DOI 10.1097/00129492-200407000-00035; Walsh T, 2010, AM J HUM GENET, V87, P101, DOI 10.1016/j.ajhg.2010.05.011; Yan D, 2013, P NATL ACAD SCI USA, V110, P2228, DOI 10.1073/pnas.1222285110; Zhao H, 2004, AM J HUM GENET, V74, P139, DOI 10.1086/381133; Zhao YL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069549	35	16	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0133522	10.1371/journal.pone.0133522	http://dx.doi.org/10.1371/journal.pone.0133522			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LZ	26196677	Green Published, gold, Green Submitted			2022-12-26	WOS:000358547600109
J	Huang, YJ; Wu, JY; Wang, P; Lin, YQ; Fu, C; Deng, ZH; Wang, QN; Li, QW; Chen, RK; Zhang, MQ				Huang, Yongji; Wu, Jiayun; Wang, Ping; Lin, Yanquan; Fu, Cheng; Deng, Zuhu; Wang, Qinnan; Li, Qiwei; Chen, Rukai; Zhang, Muqing			Characterization of Chromosome Inheritance of the Intergeneric BC2 and BC3 Progeny between Saccharum spp. and Erianthus arundinaceus	PLOS ONE			English	Article							HALF-TETRAD ANALYSIS; SEXUAL POLYPLOIDIZATION; MEIOTIC STABILITY; SUGARCANE; RELATIVES; HYBRIDS; ANDROPOGONEAE; INTROGRESSION; TRANSMISSION; RESISTANCE	Erianthus arundinaceus (E. arundinaceus) has many desirable agronomic traits for sugarcane improvement, such as high biomass, vigor, rationing ability, tolerance to drought, and water logging, as well as resistance to pests and disease. To investigate the introgression of the E. arundinaceus genome into sugarcane in the higher generations, intergeneric BC2 and BC3 progeny generated between Saccharum spp. and E. arundinaceus were studied using the genomic in situ hybridization (GISH) technique. The results showed that the BC2 and BC3 generations resulted from n + n chromosome transmission. Furthermore, chromosome translocation occurred at terminal fragments from the E. arundinaceus chromosome in some progeny of Saccharum spp. and E. arundinaceus. Notably, the translocated chromosomes could be stably transmitted to their progeny. This study illustrates the characterization of chromosome inheritance of the intergeneric BC2 and BC3 progeny between Saccharum spp. and E. arundinaceus. This work could provide more useful molecular cytogenetic information for the germplasm resources of E. arundinaceus, and may promote further understanding of the germplasm resources of E. arundinaceus for sugarcane breeders to accelerate its progress in sugarcane commercial breeding.	[Huang, Yongji; Wang, Ping; Lin, Yanquan; Deng, Zuhu; Chen, Rukai] Fujian Agr & Forestry Univ, Minist Agr, Key Lab Sugarcane Biol & Genet Breeding, Fuzhou, Peoples R China; [Wu, Jiayun; Fu, Cheng; Wang, Qinnan; Li, Qiwei] Guangzhou Sugarcane Ind Res Inst, Guangdong Key Lab Sugarcane Improvement & Biorefi, Guangzhou, Guangdong, Peoples R China; [Deng, Zuhu; Zhang, Muqing] Guangxi Collaborat Ctr Sugarcane & Cane Sugar Ind, Guangxi, Peoples R China	Fujian Agriculture & Forestry University; Ministry of Agriculture & Rural Affairs; Guangdong Academy of Sciences; Institute of Nanfan & Seed Industry, Guangdong Academy of Sciences	Deng, ZH (corresponding author), Fujian Agr & Forestry Univ, Minist Agr, Key Lab Sugarcane Biol & Genet Breeding, Fuzhou, Peoples R China.	dengzuhu@163.com		zhang, muqing/0000-0003-3138-3422	National Natural Science Foundation of China [31401440]; earmarked fund for the Modern Agriculture Technology of China [CARS-20-1-5]; Guangxi Natural Science Foundation [2014GXNSFFA118002]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); earmarked fund for the Modern Agriculture Technology of China; Guangxi Natural Science Foundation(National Natural Science Foundation of Guangxi Province)	This work was funded by National Natural Science Foundation of China (31401440, http://www.nsfc.gov.cn/), the earmarked fund for the Modern Agriculture Technology of China (CARS-20-1-5). This project is also supported by Guangxi Natural Science Foundation (2014GXNSFFA118002, http://gxnsf.gxsti.net/stms/login.jsp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleza P, 2010, PLANT CELL REP, V29, P1023, DOI 10.1007/s00299-010-0888-7; Alix K, 1999, THEOR APPL GENET, V99, P962, DOI 10.1007/s001220051403; Alix K, 1998, GENOME, V41, P854, DOI 10.1139/gen-41-6-854; Amalraj VA, 2006, GENET RESOUR CROP EV, V53, P35, DOI 10.1007/s10722-004-0581-1; An DG, 2013, CHROMOSOME RES, V21, P419, DOI 10.1007/s10577-013-9366-8; Barba-Gonzalez R, 2004, THEOR APPL GENET, V109, P1125, DOI 10.1007/s00122-004-1739-0; BREMER G, 1961, EUPHYTICA, V10, P121, DOI 10.1007/BF00037206; BURNER DM, 1991, EUPHYTICA, V54, P125, DOI 10.1007/BF00145639; BURNER DM, 1993, CROP SCI, V33, P600, DOI 10.2135/cropsci1993.0011183X003300030036x; Cai Q, 2005, PLANT SCI, V169, P976, DOI 10.1016/j.plantsci.2005.07.002; Cuenca J, 2011, HEREDITY, V107, P462, DOI 10.1038/hdy.2011.33; Cuenca J, 2013, ANN BOT-LONDON, V111, P731, DOI 10.1093/aob/mct032; De Storme N, 2013, NEW PHYTOL, V198, P670, DOI 10.1111/nph.12184; Deng ZH, 2010, AGR SCI CHINA, V9, P1271, DOI 10.1016/S1671-2927(09)60216-9; DHONT A, 1995, THEOR APPL GENET, V91, P320, DOI 10.1007/BF00220894; DHONT A, 1996, MOL GEN GENET, V250, P405, DOI DOI 10.1007/BF02174028; Harper J, 2011, ANN BOT-LONDON, V107, P1313, DOI 10.1093/aob/mcr083; Hermann SR, 2012, EUPHYTICA, V187, P359, DOI 10.1007/s10681-012-0698-9; Lavia GI, 2011, ANN BOT-LONDON, V108, P103, DOI 10.1093/aob/mcr108; Irvine JE, 1999, THEOR APPL GENET, V98, P186, DOI 10.1007/s001220051057; JACKSON P, 2011, WILD CROP RELATIVES, P97, DOI DOI 10.1007/978-3-642-21102-7_5; Jannoo N, 2007, PLANT J, V50, P574, DOI 10.1111/j.1365-313X.2007.03082.x; Jansky SH, 2006, GENET RESOUR CROP EV, V53, P669, DOI 10.1007/s10722-004-2949-7; Kynast RG, 2001, PLANT PHYSIOL, V125, P1216, DOI 10.1104/pp.125.3.1216; Lam E, 2009, GCB BIOENERGY, V1, P251, DOI 10.1111/j.1757-1707.2009.01016.x; Lim KB, 2004, BREEDING SCI, V54, P13, DOI 10.1270/jsbbs.54.13; LU YH, 1994, EUPHYTICA, V78, P7; Manzanero S, 2002, CHROMOSOMA, V111, P228, DOI 10.1007/s00412-002-0211-7; Markova M, 2007, CHROMOSOME RES, V15, P1051, DOI 10.1007/s10577-007-1180-8; Mason AS, 2015, TRENDS GENET, V31, P5, DOI 10.1016/j.tig.2014.09.011; Mestiri I, 2010, NEW PHYTOL, V186, P86, DOI 10.1111/j.1469-8137.2010.03186.x; Nair NV, 1999, GENET RESOUR CROP EV, V46, P73, DOI 10.1023/A:1008696808645; Park TH, 2007, GENETICS, V176, P85, DOI 10.1534/genetics.107.070870; Piperidis G, 2000, GENOME, V43, P1033, DOI 10.1139/gen-43-6-1033; Piperidis G, 2010, MOL GENET GENOMICS, V284, P65, DOI 10.1007/s00438-010-0546-3; Piperidis N, 2013, INT SUGAR J, P1; Piperidis N, 2010, GENOME, V53, P331, DOI [10.1139/G10-010, 10.1139/g10-010]; Ram B, 2001, EUPHYTICA, V122, P145, DOI 10.1023/A:1012626805467; Ramanna MS, 2003, EUPHYTICA, V133, P3, DOI 10.1023/A:1025600824483; Roach BT, 1972, P INT SOC SUGAR CANE, V14, P206; Rott P, 1997, PHYTOPATHOLOGY, V87, P1202, DOI 10.1094/PHYTO.1997.87.12.1202; SOBRAL BWS, 1994, THEOR APPL GENET, V87, P843, DOI 10.1007/BF00221137; Ssebuliba RN, 2008, EUPHYTICA, V164, P53, DOI 10.1007/s10681-007-9637-6; Su YC, 2013, PLANT CELL REP, V32, P1503, DOI 10.1007/s00299-013-1463-9; Su YC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084426; Wu JY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110390; Zhang HK, 2013, P NATL ACAD SCI USA, V110, P19466, DOI 10.1073/pnas.1319598110; Zhang P, 2008, GENETICS, V179, P1169, DOI 10.1534/genetics.108.089599	48	18	22	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0133722	10.1371/journal.pone.0133722	http://dx.doi.org/10.1371/journal.pone.0133722			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LZ	26196281	Green Submitted, Green Published, gold			2022-12-26	WOS:000358547600136
J	Mayaka, TB; Kamla, AT; Self-Sullivan, C				Mayaka, Theodore B.; Kamla, Aristide Takoukam; Self-Sullivan, Caryn			Using Pooled Local Expert Opinions (PLEO) to Discern Patterns in Sightings of Live and Dead Manatees (Trichechus senegalensis, Link 1785) in Lower Sanaga Basin, Cameroon	PLOS ONE			English	Article							TRADITIONAL ECOLOGICAL KNOWLEDGE; WEST-INDIAN MANATEE; BIODIVERSITY CONSERVATION; INDIGENOUS KNOWLEDGE; FLORIDA MANATEE; AFRICAN MANATEE; BIAS REDUCTION; DROWNED CAYES; HABITAT USE; MARINE	We aimed at unveiling patterns in live and dead manatee sightings in the Lower Sanaga Basin, Cameroon. For this purpose, the expert opinions of 133 local fishers were collected during in-person interviews, distilled using categorical data analysis, and checked against scientific literature. The five main results are as follows: manatees were sighted averagely once a week in lakes, rivers, and the coast & estuaries, mostly in group sizes of 2-3; the odds of sighting live manatees (respectively dead manatees) decreased (respectively increased) from inland lakes to estuaries and the coast, via rivers; manatee carcasses were reported in all habitats, albeit more frequently in rivers; a distribution map based on fishers' reports show two manatee concentration areas: Lake Ossa and the Malimba-Mbiako section of River Sanaga; the number of manatees was perceived as increasing despite incidental and directed catches. Thus, our findings corroborate earlier assessments of the Lower Sanaga Basin as being a major manatee conservation area. Additionally, from these results and the literature, we identified three hypotheses about local manatee persistence: deep pools such as lakes offer year round sanctuaries, not just dry-season refugia; seasonality of specific habitat variables determine manatee occurrence patterns; and local variability in habitat encroachment mediate the meta-population dynamics of manatee in the Lower Sanaga Basin. Finally, we examine the implications for data requirements in light of the small ecological scale at which the surveyed fishers ply their trade. Thus, consonant with the Malawi principles for the ecosystem approach to management (www.cbd.int/ecosystem), we recommend collecting data preferably at landscape scale, through a participatory monitoring program that fully integrates scientific and traditional knowledge systems. This program should include, amongst others, a standardised necropsy protocol for collecting mortality and biological data together with sonar and radio-telemetry technology to discern manatee use and movements between critical habitat components.	[Mayaka, Theodore B.; Kamla, Aristide Takoukam] Univ Dschang, Dept Anim Biol, Dschang, West Region, Cameroon; [Self-Sullivan, Caryn] Nova SE Univ, Oceanog Ctr, Dania, FL 33004 USA	Nova Southeastern University	Mayaka, TB (corresponding author), Univ Dschang, Dept Anim Biol, Dschang, West Region, Cameroon.	theodoremayaka@yahoo.com						Agresti A., 2013, CATEGORICAL DATA ANA, V3rd ed.; [Anonymous], 2008, DRAFT ACTION PLAN CO; Aswani S, 2004, ENVIRON CONSERV, V31, P69, DOI 10.1017/S037689290400116X; Auil NE, 1998, BZE92G31 UNDP GEF CO; Auil NE, 2004, THESIS TEXAM A M U; Bacchus Marie-Lys C., 2009, Aquatic Mammals, V35, P62, DOI 10.1578/AM.35.1.2009.62; Barlas ME, 2011, 40181AG037 USFWS; BECK CA, 1991, MAR POLLUT BULL, V22, P508, DOI 10.1016/0025-326X(91)90406-I; Berkes F, 2000, ECOL APPL, V10, P1251, DOI 10.1890/1051-0761(2000)010[1251:ROTEKA]2.0.CO;2; BIRD A., 1998, PHILOS SCI; Bonde R.K., 1983, MANUAL PROCEDURES SA; Bonde R.K., 2004, ECOHEALTH, V1, P255, DOI [10.1007/s10393-004-0095-5.2, DOI 10.1007/S10393-004-0095-5.2]; Carney J, 2014, GEOFORUM, V53, P126, DOI 10.1016/j.geoforum.2014.02.013; Christensen R, 1990, LOG LINEAR MODELS LO, V2nd; Cochran W.G, 1971, SAMPLING TECHNIQUES; Courbis Sarah S., 2003, Aquatic Mammals, V29, P104, DOI 10.1578/016754203101023942; Deutsch CJ, 2003, WILDLIFE MONOGR, P1; Deutsch CJ, 2010, 2010 IUCN RED LIST T; DEWALT BR, 1994, HUM ORGAN, V53, P123, DOI 10.17730/humo.53.2.ku60563817m03n73; Dodman T., 2008, CONSERVATION STRATEG; Drew JA, 2005, CONSERV BIOL, V19, P1286, DOI 10.1111/j.1523-1739.2005.00158.x; Drew JA, 2006, ECOL SOC, V11; Evans PGH, 2004, MAMMAL REV, V34, P131, DOI 10.1046/j.0305-1838.2003.00027.x; Fazey I, 2006, ENVIRON CONSERV, V33, P1, DOI 10.1017/S037689290600275X; Feka Njisuh Z., 2011, International Journal of Biodiversity Science Ecosystem Services & Management, V7, P217, DOI 10.1080/21513732.2011.634436; Field SA, 2005, J WILDLIFE MANAGE, V69, P473, DOI 10.2193/0022-541X(2005)069[0473:OAOMEU]2.0.CO;2; FIRTH D, 1993, BIOMETRIKA, V80, P27, DOI 10.2307/2336755; Flewelling LJ, 2005, NATURE, V435, P755, DOI 10.1038/nature435755a; Fraser DJ, 2006, ECOL SOC, V11; GADGIL M, 1993, AMBIO, V22, P151; Gagnon CA, 2009, ECOL SOC, V14; Gannon JG, 2007, MAR MAMMAL SCI, V23, P133, DOI 10.1111/j.1748-7692.2006.00096.x; Gonzalez-Socoloske Daniel, 2009, Endangered Species Research, V8, P249, DOI 10.3354/esr00232; Gorzelany J, 2003, 874 MOT MAR LAB; Gray JS, 1997, BIODIVERS CONSERV, V6, P153, DOI 10.1023/A:1018335901847; Grigione MM, 1996, AFR J ECOL, V34, P189; HALLEGRAEFF GM, 1993, PHYCOLOGIA, V32, P79, DOI 10.2216/i0031-8884-32-2-79.1; IRVINE AB, 1983, BIOL CONSERV, V25, P315; Jimenez I, 2002, ORYX, V36, P272, DOI 10.1017/S0030605302000492; Kosmidis I, 2011, BIOMETRIKA, V98, P755, DOI 10.1093/biomet/asr026; Kouadio A., 2004, THESIS U KENT; LaCommare KS, 2012, BIOL CONSERV, V152, P169, DOI 10.1016/j.biocon.2012.02.021; LaCommare Katherine S., 2008, Aquatic Mammals, V34, P35, DOI 10.1578/AM.34.1.2008.35; Lefebvre Lynn W., 2001, P425; Legg CJ, 2006, J ENVIRON MANAGE, V78, P194, DOI 10.1016/j.jenvman.2005.04.016; Lewison RL, 2004, TRENDS ECOL EVOL, V19, P598, DOI 10.1016/j.tree.2004.09.004; Lightsey JD, 2006, J ZOO WILDLIFE MED, V37, P262, DOI 10.1638/04-095.1; Marsh H., 1994, Aquatic Mammals, V20, P155; Marsh H., 2012, ECOLOGY CONSERVATION, DOI [10.1017/CBO9781139013277, DOI 10.1017/CBO9781139013277]; Mayaka TB, 2012, TROPICAL CONSERVATIO, V6, P521; Miksis-Olds JL, 2011, MAR MAMMAL SCI, V27, P130, DOI 10.1111/j.1748-7692.2010.00381.x; Moore JE, 2010, BIOL CONSERV, V143, P795, DOI 10.1016/j.biocon.2009.12.023; Nataly Castelblanco-Martinez Delma, 2012, Endangered Species Research, V18, P129, DOI 10.3354/esr00439; Castelblanco-Martinez DN, 2012, ESTUAR COAST, V35, P60, DOI 10.1007/s12237-011-9420-8; Castelblanco-Martinez DN, 2009, ORYX, V43, P235, DOI 10.1017/S0030605307000944; NISHIWAKI M, 1982, RECENT SURVEY DISTRI, V34, P137; Nishiwaki M, 1984, ACTA ZOOL FENN, V20, P155; Ortiz RM, 1998, PHYSIOL ZOOL, V71, P449, DOI 10.1086/515427; Osterblom H, 2010, MAR POLICY, V34, P1290, DOI 10.1016/j.marpol.2010.05.007; PACKARD JM, 1986, COAST MANAGE, V14, P279, DOI 10.1080/08920758609362007; Powell J, 2010, IUCN 2010 IUCN RED L; Powell J, 1985, MANATEES GAMBIA RIVE; POWELL JA, 1978, J MAMMAL, V59, P442, DOI 10.2307/1379938; Powell JA, 1996, DISTRIBUTION BIOL W; Quintana-Rizzo E, 2008, REGIONAL MANATEE PLA; *R DEV COR TEAM, 2007, LANG ENV STAT COMP; RATHBUN GB, 1983, BIOL CONSERV, V26, P301, DOI 10.1016/0006-3207(83)90094-0; Raymond CM, 2010, J ENVIRON MANAGE, V91, P1766, DOI 10.1016/j.jenvman.2010.03.023; Reynolds J. E., 1991, MANATEES AND DUGONGS; REYNOLDS JE, 1995, BIOL CONSERV, V71, P193, DOI 10.1016/0006-3207(94)00046-S; Rist L, 2010, ECOL SOC, V15; Rodas-Trejo J, 2008, TROP CONSERV SCI, V1, P321, DOI 10.1177/194008290800100403; Self-Sullivan C, 2008, THESIS TEXAS A M U; Self-Sullivan Caryn, 2003, Aquatic Mammals, V29, P342, DOI 10.1578/01675420360736514; Semeyn DJ, 2011, J COAST CONSERV, V15, P573, DOI 10.1007/s11852-011-0146-3; Shackeroff J.M., 2007, CONSERV SOC, V5, P343; Silva MA, 2001, MAR MAMMAL SCI, V17, P418, DOI 10.1111/j.1748-7692.2001.tb01285.x; Sinclair ARE, 2006, WILDLIFE ECOLOGY CON; Snedecor GW, 1980, STAT METHODS, V7th; Stith BM, 2006, REV SYNTHESIS MANATE; van der Hoeven Christiaan A., 2004, Journal for Nature Conservation (Jena), V12, P193, DOI 10.1016/j.jnc.2004.06.003; White PCL, 2005, J APPL ECOL, V42, P421, DOI 10.1111/j.1365-2664.2005.01032.x; Yoccoz NG, 2001, TRENDS ECOL EVOL, V16, P446, DOI 10.1016/S0169-5347(01)02205-4	83	4	4	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0128579	10.1371/journal.pone.0128579	http://dx.doi.org/10.1371/journal.pone.0128579			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN6LZ	26197396	Green Submitted, gold, Green Published			2022-12-26	WOS:000358547600003
J	Tasca, F; Farias, D; Castro, C; Acuna-Rougier, C; Antiochia, R				Tasca, Federico; Farias, Diego; Castro, Carmen; Acuna-Rougier, Cristina; Antiochia, Riccarda			Bilirubin Oxidase from Myrothecium verrucaria Physically Absorbed on Graphite Electrodes. Insights into the Alternative Resting Form and the Sources of Activity Loss	PLOS ONE			English	Article							ELECTROCATALYTIC REDUCTION; MULTICOPPER OXIDASES; HYDROGEN-PEROXIDE; COPPER CENTERS; O-2; LACCASE; OXYGEN; H2O; CHALLENGES; KINETICS	The oxygen reduction reaction is one of the most important chemical processes in energy converting systems and living organisms. Mediator-less, direct electro-catalytic reduction of oxygen to water was achieved on spectrographite electrodes modified by physical adsorption of bilirubin oxidases from Myrothecium verrucaria. The existence of an alternative resting form of the enzyme is validated. The effect on the catalytic cycle of temperature, pH and the presence of halogens in the buffer was investigated. Previous results on the electrochemistry of bilirubin oxidase and on the impact of the presence of halogens are reviewed and reinterpreted.	[Tasca, Federico; Castro, Carmen; Acuna-Rougier, Cristina] Univ Santiago Chile, Fac Quim & Biol, Dept Quim Mat, Santiago, RM, Chile; [Farias, Diego] Univ Tecnol Metropolitana, Fac Ciencias Nat Matemat & Medioambiente, Santiago, RM, Chile; [Antiochia, Riccarda] Univ Roma La Sapienza, Dept Chem & Drug Technol, I-00185 Rome, Italy	Universidad de Santiago de Chile; Universidad Tecnologica Metropolitana; Sapienza University Rome	Tasca, F (corresponding author), Univ Santiago Chile, Fac Quim & Biol, Dept Quim Mat, Santiago, RM, Chile.	federico.tasca@usach.cl	Tasca, Federico/J-4134-2015	Tasca, Federico/0000-0002-4111-4624; ANTIOCHIA, RICCARDA/0000-0001-8990-8506	Fondo Nacional de Desarrollo Cientifico y Tecnologico (Fondecyt) [1130167]; Direccion de Investigacion Cientifica y Tecnologica (Dicyt) [021342TG_DAS]; Center for the Development of Nanoscience and Nanotechnology (CEDENNA); MECESUP project [USA1298]	Fondo Nacional de Desarrollo Cientifico y Tecnologico (Fondecyt)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Direccion de Investigacion Cientifica y Tecnologica (Dicyt); Center for the Development of Nanoscience and Nanotechnology (CEDENNA)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT PIA/BASAL); MECESUP project	This work was supported by Fondo Nacional de Desarrollo Cientifico y Tecnologico (Fondecyt) Project No 1130167 (http://www.conicyt.cl/fondecyt/) and Direccion de Investigacion Cientifica y Tecnologica (Dicyt) Project No 021342TG_DAS (http://dicyt.usach.cl/). The Center for the Development of Nanoscience and Nanotechnology (CEDENNA) is also acknowledged for financial support. C. A. thanks MECESUP project USA1298 (http://www.mecesup.cl/) for financing her post-doc.	Armaroli N, 2007, ANGEW CHEM INT EDIT, V46, P52, DOI 10.1002/anie.200602373; Balzani V., 2001, ELECT TRANSFER CHEM; Bard A. J., 2007, ENCY ELECTROCHEMISTR; Blanford CF, 2008, FARADAY DISCUSS, V140, P319, DOI 10.1039/b808939f; Cadet M, 2013, CHEMPHYSCHEM, V14, P2097, DOI 10.1002/cphc.201300027; Christenson A, 2006, BBA-BIOENERGETICS, V1757, P1634, DOI 10.1016/j.bbabio.2006.08.008; DOUMAS BT, 1987, CLIN CHEM, V33, P1349; Frasconi M, 2010, ELECTROCHIM ACTA, V56, P817, DOI 10.1016/j.electacta.2010.09.056; Gewirth AA, 2010, INORG CHEM, V49, P3557, DOI 10.1021/ic9022486; GRAY HB, 2001, ELECT TRANSFER CHEM; Kjaergaard CH, 2012, J AM CHEM SOC, V134, P5548, DOI 10.1021/ja211872j; Ludwig R, 2010, CHEMPHYSCHEM, V11, P2674, DOI 10.1002/cphc.201000216; Mano N, 2003, J AM CHEM SOC, V125, P15290, DOI 10.1021/ja038285d; Mano N, 2003, J ELECTROCHEM SOC, V150, pA1136, DOI 10.1149/1.1592519; Mano N, 2002, J AM CHEM SOC, V124, P6480, DOI 10.1021/ja025874v; Mano N, 2002, J PHYS CHEM B, V106, P8842, DOI 10.1021/jp025955d; Mano N, 2013, BIOSENS BIOELECTRON, V50, P478, DOI 10.1016/j.bios.2013.07.014; McCrory CCL, 2007, J PHYS CHEM A, V111, P12641, DOI 10.1021/jp076106z; MESSERSCHMIDT A, 1992, J MOL BIOL, V224, P179, DOI 10.1016/0022-2836(92)90583-6; Milton RD, 2014, CHEM COMMUN, V50, P94, DOI 10.1039/c3cc47689h; MURAO S, 1981, AGR BIOL CHEM TOKYO, V45, P2383, DOI 10.1080/00021369.1981.10864896; PETERSEN LC, 1978, BIOCHIM BIOPHYS ACTA, V526, P85, DOI 10.1016/0005-2744(78)90292-9; Ramirez P, 2008, BBA-BIOENERGETICS, V1777, P1364, DOI 10.1016/j.bbabio.2008.06.010; Shleev S, 2004, ELECTROCHEM COMMUN, V6, P934, DOI 10.1016/j.elecom.2004.07.008; Solomon EI, 2008, DALTON T, P3921, DOI 10.1039/b800799c; Solomon EI, 2011, FARADAY DISCUSS, V148, P11, DOI 10.1039/c005500j; Stone JR, 2006, ANTIOXID REDOX SIGN, V8, P243, DOI 10.1089/ars.2006.8.243; Vaz-Dominguez C, 2008, BIOSENS BIOELECTRON, V24, P531, DOI 10.1016/j.bios.2008.05.002; Zaitseva I, 1996, J BIOL INORG CHEM, V1, P15, DOI 10.1007/s007750050018	29	24	25	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0132181	10.1371/journal.pone.0132181	http://dx.doi.org/10.1371/journal.pone.0132181			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LZ	26196288	gold, Green Published, Green Submitted			2022-12-26	WOS:000358547600026
J	Dang, MT; Wehrli, S; Dang, CV; Curran, T				Dang, Mai T.; Wehrli, Suzanne; Dang, Chi V.; Curran, Tom			The Ketogenic Diet Does Not Affect Growth of Hedgehog Pathway Medulloblastoma in Mice	PLOS ONE			English	Article							GLUTAMINE-METABOLISM; XENOGRAFT MODEL; CACHEXIA MODEL; CANCER CELLS; TUMOR-GROWTH; WEIGHT-LOSS; CARBOHYDRATE; CHILDREN; BRAIN; INHIBITOR	The altered metabolism of cancer cells has long been viewed as a potential target for therapeutic intervention. In particular, brain tumors often display heightened glycolysis, even in the presence of oxygen. A subset of medulloblastoma, the most prevalent malignant brain tumor in children, arises as a consequence of activating mutations in the Hedgehog (HH) pathway, which has been shown to promote aerobic glycolysis. Therefore, we hypothesized that a low carbohydrate, high fat ketogenic diet would suppress tumor growth in a genetically engineered mouse model of medulloblastoma. However, we found that the ketogenic diet did not slow the growth of spontaneous tumors or allograft flank tumors, and it did not exhibit synergy with a small molecule inhibitor of Smoothened. Serum insulin was significantly reduced in mice fed the ketogenic diet, but no alteration in PI3 kinase activity was observed. These findings indicate that while the ketogenic diet may be effective in inhibiting growth of other tumor types, it does not slow the growth of HH-medulloblastoma in mice.	[Dang, Mai T.; Wehrli, Suzanne; Curran, Tom] Childrens Hosp Philadelphia, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Dang, Chi V.] Univ Penn, Abramson Canc Ctr, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine	Curran, T (corresponding author), Childrens Hosp Philadelphia, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA.	currant@email.chop.edu	Curran, Tom/F-5234-2018; Dang, Chi/Y-3375-2019; Curran, Tom/D-7515-2011; Curran, Thomas/AAE-7631-2019	Curran, Tom/0000-0003-1444-7551; Curran, Thomas/0000-0003-1444-7551; Dang, Chi/0000-0002-4031-2522	National Institutes of Health [T32NS007413, R25NS065745]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS007413, R25NS065745] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Funded by National Institutes of Health T32NS007413 and R25NS065745. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelwahab MG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036197; Akyuz C, 2008, J NEURO-ONCOL, V90, P99, DOI 10.1007/s11060-008-9638-x; Allen BG, 2013, CLIN CANCER RES, V19, P3905, DOI 10.1158/1078-0432.CCR-12-0287; Ashley DM, 2012, J CLIN ONCOL, V30, P3181, DOI 10.1200/JCO.2010.34.4341; BECK SA, 1989, BRIT J CANCER, V59, P677, DOI 10.1038/bjc.1989.140; Bhatia B, 2012, ACTA NEUROPATHOL, V123, P587, DOI 10.1007/s00401-012-0968-6; Borghjid S, 2012, NUTR METAB, V9, DOI 10.1186/1743-7075-9-69; Caso J, 2013, PROSTATE, V73, P449, DOI 10.1002/pros.22586; Champ CE, 2014, J NEURO-ONCOL, V117, P125, DOI 10.1007/s11060-014-1362-0; DeBerardinis RJ, 2007, P NATL ACAD SCI USA, V104, P19345, DOI 10.1073/pnas.0709747104; Dowling RJO, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-33; Dutton SBB, 2011, EPILEPSIA, V52, P2050, DOI 10.1111/j.1528-1167.2011.03211.x; Gajjar A, 2013, CLIN CANCER RES, V19, P6305, DOI 10.1158/1078-0432.CCR-13-1425; Gao P, 2009, NATURE, V458, P762, DOI 10.1038/nature07823; Gershon TR, 2013, CANCER METAB, V1, DOI 10.1186/2049-3002-1-2; Hahn H, 2000, J BIOL CHEM, V275, P28341, DOI 10.1074/jbc.C000352200; Jain M, 2012, SCIENCE, V336, P1040, DOI 10.1126/science.1218595; Jones DTW, 2012, NATURE, V488, P100, DOI 10.1038/nature11284; Kalaany NY, 2009, NATURE, V458, P725, DOI 10.1038/nature07782; Manninen AH, 2006, NUTR METAB, V3, DOI 10.1186/1743-7075-3-9; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Mavropoulos JC, 2009, CANCER PREV RES, V2, P557, DOI 10.1158/1940-6207.CAPR-08-0188; Northcott PA, 2011, J CLIN ONCOL, V29, P1408, DOI 10.1200/JCO.2009.27.4324; Otto C, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-122; Pomeroy SL, 2002, NATURE, V415, P436, DOI 10.1038/415436a; Ramanan M, 2012, J CLIN NEUROSCI, V19, P1387, DOI 10.1016/j.jocn.2012.01.028; Robinson G, 2012, NATURE, V488, P43, DOI 10.1038/nature11213; Romer JT, 2004, CANCER CELL, V6, P229, DOI 10.1016/j.ccr.2004.08.019; Rudin CM, 2009, NEW ENGL J MED, V361, P1173, DOI 10.1056/NEJMoa0902903; Shim H, 1997, P NATL ACAD SCI USA, V94, P6658, DOI 10.1073/pnas.94.13.6658; Shukla SK, 2014, CANCER METAB, V2, DOI 10.1186/2049-3002-2-18; SOKOLOFF L, 1973, ANNU REV MED, V24, P271, DOI 10.1146/annurev.me.24.020173.001415; Taylor RE, 2005, EUR J CANCER, V41, P727, DOI 10.1016/j.ejca.2004.12.017; Teperino R, 2012, CELL, V151, P414, DOI 10.1016/j.cell.2012.09.021; TISDALE MJ, 1987, BRIT J CANCER, V56, P39, DOI 10.1038/bjc.1987.149; Tran Hien, 2003, Sci STKE, V2003, pRE5, DOI 10.1126/stke.2003.172.re5; Van der Auwera Ingrid, 2005, Nutr Metab (Lond), V2, P28, DOI 10.1186/1743-7075-2-28; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Wetmore C, 2001, CANCER RES, V61, P513; Yauch RL, 2009, SCIENCE, V326, P572, DOI 10.1126/science.1179386; Zeltzer PM, 1999, J CLIN ONCOL, V17, P832, DOI 10.1200/JCO.1999.17.3.832; Zhou WH, 2007, NUTR METAB, V4, DOI 10.1186/1743-7075-4-5	42	19	19	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2015	10	7							e0133633	10.1371/journal.pone.0133633	http://dx.doi.org/10.1371/journal.pone.0133633			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LN	26192445	Green Published, gold, Green Submitted			2022-12-26	WOS:000358546400109
J	Fochi, MML; Baring, S; Spegiorin, LCJF; Vaz-Oliani, DCM; Galao, EA; Oliani, AH; de Mattos, LC; de Mattos, CCB				Lemos Fochi, Mariana Machado; Baring, Sabrina; Junqueira Franco Spegiorin, Ligia Cosentino; Mos Vaz-Oliani, Denise Cristina; Galao, Eloisa Aparecida; Oliani, Antonio Helio; de Mattos, Luiz Carlos; Brandao de Mattos, Cinara Cassia			Prematurity and Low Birth Weight did not Correlate with Anti-Toxoplasma gondii Maternal Serum Profiles - a Brazilian Report	PLOS ONE			English	Article							CONGENITAL TOXOPLASMOSIS; PREGNANT-WOMEN; SAO-PAULO; RISK-FACTORS; OCULAR TOXOPLASMOSIS; INFECTION; STATE; HIV; ASSOCIATION; ANTIBODIES	Gestational Toxoplasma gondii infection is considered a major risk factor for miscarriage, prematurity and low birth weight in animals. However, studies focusing on this topic in humans are scarce. The objective of this study is to determine whether anti-Toxoplasma gondii maternal serum profiles correlate prematurity and low birth weight in humans. The study examined 213 pregnant women seen at the High-Risk Pregnancy Hospital de Base, Sao Jose do Rio Preto, Sao Paulo, Brazil. All serological profiles (IgM-/IgG+; IgM-/IgG-; IgM +/IgG+) were determined by ELISA commercial kits. Maternal age, gestational age and weight of the newborn at birth were collected and recorded in the Statement of Live Birth. Prematurity was defined as gestational age <37 weeks and low birth weight <= 2499 grams. The t-test was used to compare values (p < 0.05). The mean maternal age was 27.6 +/- 6.6 years. Overall, 56.3% (120/213) of the women studied were IgM-/IgG+, 36.2% (77/213) were IgM-/IgG-and 7.5% (16/213) were IgM+/IgG+. The average age of the women with serological profile IgM+/IgG+ (22.3 +/- 3.9 years) was different from women with the profile IgM-/IgG+ (27.9 +/- 6.7 years, p = 0.0011) and IgM-/IgG-(27.9 +/- 6.4 years, p = 0.0012). There was no statistically significant difference between the different serological profiles in relation to prematurity (p = 0.6742) and low birth weight (p = 0.7186). The results showed that prematurity and low birth weight did not correlate with anti-Toxoplasma gondii maternal serum profiles.	[Lemos Fochi, Mariana Machado; de Mattos, Luiz Carlos; Brandao de Mattos, Cinara Cassia] Fac Med Sao Jose do Rio Preto FAMERP, Dept Mol Biol, Immunogenet Lab, Sao Jose Do Rio Preto, SP, Brazil; [Baring, Sabrina; Junqueira Franco Spegiorin, Ligia Cosentino; Mos Vaz-Oliani, Denise Cristina; Galao, Eloisa Aparecida] Fundacao Fac Reg Med Sao Jose do Rio Preto HB FUN, Hosp Base, Obstet & Gynecol Serv, Sao Jose Do Rio Preto, SP, Brazil; [Junqueira Franco Spegiorin, Ligia Cosentino; Mos Vaz-Oliani, Denise Cristina; Galao, Eloisa Aparecida; Oliani, Antonio Helio] Fac Med Sao Jose do Rio Preto FAMERP, Dept Gynecol & Obstet, Sao Jose Do Rio Preto, SP, Brazil; [Junqueira Franco Spegiorin, Ligia Cosentino; Mos Vaz-Oliani, Denise Cristina; Galao, Eloisa Aparecida; Oliani, Antonio Helio] Hosp Crianca & Maternidade Sao Jose do Rio Preto, Sao Jose Do Rio Preto, SP, Brazil; [Lemos Fochi, Mariana Machado; Junqueira Franco Spegiorin, Ligia Cosentino; de Mattos, Luiz Carlos; Brandao de Mattos, Cinara Cassia] Fac Med Sao Jose do Rio Preto FAMERP, FAMERP Toxoplasma Res Grp, Sao Jose Do Rio Preto, SP, Brazil	Universidade de Sao Paulo; Faculdade de Medicina de Sao Jose do Rio Preto (FAMERP); Universidade de Sao Paulo; Faculdade de Medicina de Sao Jose do Rio Preto (FAMERP); Universidade de Sao Paulo; Faculdade de Medicina de Sao Jose do Rio Preto (FAMERP)	de Mattos, CCB (corresponding author), Fac Med Sao Jose do Rio Preto FAMERP, Dept Mol Biol, Immunogenet Lab, Sao Jose Do Rio Preto, SP, Brazil.	cinara.brandao@famerp.br	DE MATTOS, LUIZ CARLOS/F-6739-2010; de Mattos, Luiz Carlos/P-4005-2019; OLIANI, ANTONIO/O-1673-2019; de Mattos, Luiz Carlos/P-3574-2019; BRANDÃO, CINARA/B-3650-2008	DE MATTOS, LUIZ CARLOS/0000-0002-8572-8177; de Mattos, Luiz Carlos/0000-0002-8572-8177; BRANDÃO, CINARA/0000-0002-4836-3113; Spegiorin, Ligia Cosentino Junqueira Franco/0000-0003-4405-8098; Oliani, Antonio Helio/0000-0003-1242-4364	Scientific Initiation Scholarship from the Brazilian Ministry of Science Technology and Inovation - PIBIC - CNPq (The National Council for Scientific and Technological Development); Brazilian Ministry of Education CAPES PhD Scholarship; Institutional Scientific Initiation Scholarship BIC FAMERP; Institutional Research Grant BAP-FAMERP; Sao Paulo Research Foundation FAPESP [2013/03269-0]; FAPESP [2009/17540-2]	Scientific Initiation Scholarship from the Brazilian Ministry of Science Technology and Inovation - PIBIC - CNPq (The National Council for Scientific and Technological Development); Brazilian Ministry of Education CAPES PhD Scholarship; Institutional Scientific Initiation Scholarship BIC FAMERP; Institutional Research Grant BAP-FAMERP; Sao Paulo Research Foundation FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by a Scientific Initiation Scholarship from the Brazilian Ministry of Science Technology and Inovation - PIBIC - CNPq (The National Council for Scientific and Technological Development) to MMLF; a Brazilian Ministry of Education CAPES PhD Scholarship to CCBM; an Institutional Scientific Initiation Scholarship BIC FAMERP to MMLF; an Institutional Research Grant BAP-FAMERP to LCM, DCMVO, and LCJFS; and Sao Paulo Research Foundation FAPESP #2013/03269-0 to CCBM and FAPESP #2009/17540-2 to LCM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Carneiro ACAV, 2013, J CLIN MICROBIOL, V51, P901, DOI 10.1128/JCM.02502-12; [Anonymous], 1977, Acta Obstet Gynecol Scand, V56, P247; Asilsoy S, 2008, J TROP PEDIATRICS, V54, P129, DOI 10.1093/tropej/fmm069; Avelino MM, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-33; Bortoletti Filho Joao, 2013, Interdiscip Perspect Infect Dis, V2013, P370769, DOI 10.1155/2013/370769; da Fonseca CRB, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-255; de Mattos CDB, 2011, SAO PAULO MED J, V129, P261; Bichara CNC, 2012, REV SOC BRAS MED TRO, V45, P122, DOI 10.1590/S0037-86822012000100024; Carruthers VB, 2002, ACTA TROP, V81, P111, DOI 10.1016/S0001-706X(01)00201-7; Collantes-Fernandez E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032123; Nascimento LFC, 2014, REV BRAS GINECOL OBS, V36, P303, DOI 10.1590/SO100-720320140005012; De Carolis S, 2012, LUPUS, V21, P773, DOI 10.1177/0961203312447866; de Inagaki AD M, REV SOC BRAS MED TRO, V42, P532; de Jong EP, 2013, ARCH DIS CHILDHOOD-E, V98, P93, DOI 10.1136/archdischild-2012-303327; de Romanelli RM C, 2014, REV MED MINAS GERIAS, V24, P202; de Souza-e-Silva CH, 2013, PEDIATR INFECT DIS J, V32, P13, DOI 10.1097/INF.0b013e3182703460; de Toxoplasmose RB, 2010, SCI MED, P5; Deorari AK, 2000, J TROP PEDIATRICS, V46, P155, DOI 10.1093/tropej/46.3.155; Di Mario S, 2009, DATABASE SYST REV; Dias RCF, REV I MED TROPICAL S, V53, P185; Goncalves MAD, 2010, BRAZ J INFECT DIS, V14, P601, DOI 10.1590/S1413-86702010000600009; Dubey JP, 2012, PARASITOLOGY, V139, P1375, DOI 10.1017/S0031182012000765; Porto AMF, 2008, REV ASSOC MED BRAS, V54, P242, DOI 10.1590/S0104-42302008000300018; Ferezin RI, 2013, REV BRAS GINECOL OBS, V35, P66, DOI 10.1590/S0100-72032013000200005; Fernandez-Sabe N, 2012, CLIN INFECT DIS, V54, P355, DOI 10.1093/cid/cir806; Ferreira AIC, 2014, EPIDEMIOL INFECT, V142, P142, DOI 10.1017/S0950268813000526; Filisetti Denis, 2004, Ann Ist Super Sanita, V40, P71; Fricker-Hidalgo H, 2013, J CLIN MICROBIOL, V51, P2103, DOI 10.1128/JCM.00169-13; Furtado JM, 2012, REV OCULAR TOXOPLASM; Furtado JM, 2012, SURV OPHTHALMOL, V57, P149, DOI 10.1016/j.survophthal.2011.07.002; GARCIA AGP, 1983, J TROP PEDIATRICS, V29, P95, DOI 10.1093/tropej/29.2.95; Gonzalez-Padilla M, 2013, INT J INFECT DIS, V17, pE681, DOI 10.1016/j.ijid.2013.01.021; Herrmann DC, 2014, INT J MED MICROBIOL, V304, P911, DOI 10.1016/j.ijmm.2014.06.008; Hotez PJ, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003012; House PK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023277; Inacio P, 2007, TOXOPLASMOSE GESTANT, P57; Kiatchoosakun Pakaphan, 2012, Journal of the Medical Association of Thailand, V95, P52; Leal MD, 2012, REPROD HEALTH, V9, DOI 10.1186/1742-4755-9-15; Lima RRCM, 2011, ENS CIENC, V15, P53; Lopes AP, 2014, PARASITOLOGY, V141, P1699, DOI 10.1017/S0031182014001413; Machala L, 2013, INT J INFECT DIS, V17, pE892, DOI 10.1016/j.ijid.2013.03.017; Mandelbrot L., 2014, EMC GINECOLOGIA OBST, V50, P1; Martins LM, 2015, J IMMUNOL METHODS, V417, P97, DOI 10.1016/j.jim.2014.12.012; McLeod R., 2014, CURR PEDIAT REP, V2, P166; McLeod R, 2012, CLIN INFECT DIS, V54, P1595, DOI 10.1093/cid/cis258; Moraes Maria Sílvia de, 2004, Rev. Bras. Saude Mater. Infant., V4, P375, DOI 10.1590/S1519-38292004000400006; Munoz-Zanzi CA, 2010, EMERG INFECT DIS, V16, P1591, DOI 10.3201/eid1610.091674; Mussi-Pinhata MM, 2012, CURR WOMENS HEALTH R, V8, P158, DOI 10.2174/157340412800194902; Pappas G, 2009, INT J PARASITOL, V39, P1385, DOI 10.1016/j.ijpara.2009.04.003; Pardini L, 2014, PARASITOL INT, V63, P470, DOI 10.1016/j.parint.2013.10.011; Pessanha Tatiana Melino, 2011, Rev. paul. pediatr., V29, P341; Pinto FS, REV SOC BRASILEIRA M, V46, P196; Pleyer U, 2014, OPHTHALMIC RES, V52, P116, DOI 10.1159/000363141; Porto LC, 2012, INT J INFECT DIS, V16, pE480, DOI 10.1016/j.ijid.2012.01.016; Robert-Gangneux F, 2012, CLIN MICROBIOL REV, V25, P264, DOI 10.1128/CMR.05013-11; Rodrigues ACF, 2011, J VENOM ANIM TOXINS, V17, P184, DOI 10.1590/S1678-91992011000200009; Rodrigues IMX, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-349; Sagel U, 2013, J BACTERIOLOGY PARAS, V01; Said RN, 2011, J TROP PEDIATRICS, V57, P333, DOI 10.1093/tropej/fmq097; Segundo GRS, 2004, J TROP PEDIATRICS, V50, P50, DOI 10.1093/tropej/50.1.50; Silva LA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090237; Stillwaggon E, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001333; Sullivan WJ, 2012, FEMS MICROBIOL REV, V36, P717, DOI 10.1111/j.1574-6976.2011.00305.x; Ursini T, 2013, INT J INFECT DIS, V17, pE280, DOI 10.1016/j.ijid.2012.11.031; Vaz S., 2011, FIELD ACTIONS SCI RE; Wallon M, 2013, CLIN INFECT DIS, V56, P1223, DOI 10.1093/cid/cit032; Wallon M, 2014, PEDIATRICS, V133, pE601, DOI 10.1542/peds.2013-2153; Watts P, 2013, J AAPOS, V17, P70, DOI 10.1016/j.jaapos.2012.07.012	68	10	10	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2015	10	7							e0132719	10.1371/journal.pone.0132719	http://dx.doi.org/10.1371/journal.pone.0132719			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LN	26192182	Green Published, gold, Green Submitted			2022-12-26	WOS:000358546400035
J	Lench, AM; Robson, E; Jones, RSG				Lench, Alex M.; Robson, Emma; Jones, Roland S. G.			Differential Effects of D-Cycloserine and ACBC at NMDA Receptors in the Rat Entorhinal Cortex Are Related to Efficacy at the Co-Agonist Binding Site	PLOS ONE			English	Article							PRESYNAPTIC NMDA; COGNITIVE IMPAIRMENT; GLUTAMATE RELEASE; ANTICONVULSANT ACTIVITY; SOMATOSENSORY CORTEX; ANTIEPILEPTIC DRUGS; SYNAPTIC INHIBITION; ALZHEIMERS-DISEASE; DECLARATIVE MEMORY; TONIC FACILITATION	Partial agonists at the NMDA receptor co-agonist binding site may have potential therapeutic efficacy in a number of cognitive and neurological conditions. The entorhinal cortex is a key brain area in spatial memory and cognitive processing. At synapses in the entorhinal cortex, NMDA receptors not only mediate postsynaptic excitation but are expressed in presynaptic terminals where they tonically facilitate glutamate release. In a previous study we showed that the co-agonist binding site of the presynaptic NMDA receptor is endogenously and tonically activated by D-serine released from astrocytes. In this study we determined the effects of two co-agonist site partial agonists on both presynaptic and postsynaptic NMDA receptors in layer II of the entorhinal cortex. The high efficacy partial agonist, D-cycloserine, decreased the decay time of postsynaptic NMDA receptor mediated currents evoked by electrical stimulation, but had no effect on amplitude or other kinetic parameters. In contrast, a lower efficacy partial agonist, 1-aminocyclobutane-1-carboxylic acid, decreased decay time to a greater extent than D-cycloserine, and also reduced the peak amplitude of the evoked NMDA receptor mediated postsynaptic responses. Presynaptic NMDA receptors, (monitored indirectly by effects on the frequency of AMPA receptor mediated spontaneous excitatory currents) were unaffected by D-cycloserine, but were reduced in effectiveness by 1-aminocyclobutane-1-carboxylic acid. We discuss these results in the context of the effect of endogenous regulation of the NMDA receptor co-agonist site on receptor gating and the potential therapeutic implications for cognitive disorders.	[Lench, Alex M.; Robson, Emma; Jones, Roland S. G.] Univ Bath, Dept Pharm & Pharmacol, Bath BA2 7AY, Avon, England	University of Bath	Jones, RSG (corresponding author), Univ Bath, Dept Pharm & Pharmacol, Bath BA2 7AY, Avon, England.	r.s.g.jones@bath.ac.uk	Jones, Roland/K-1539-2016	Jones, Roland/0000-0002-3072-7505; Robson, Emma/0000-0001-5136-6158	Medical Research Council; Biological Sciences Research Council	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The Medical Research Council provided a studentship and materials for Alex Lench. The Biotechnology and Biological Sciences Research Council Provided a studentship for Emma Robson. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahnaou A, 2014, NEUROPHARMACOLOGY, V86, P362, DOI 10.1016/j.neuropharm.2014.08.015; Bender VA, 2006, J NEUROSCI, V26, P4166, DOI 10.1523/JNEUROSCI.0176-06.2006; Berretta N, 1996, NEUROSCIENCE, V75, P339, DOI 10.1016/0306-4522(96)00301-6; Bora E, 2015, PSYCHOL MED, V45, P1, DOI 10.1017/S0033291714001263; Bortolato B, 2014, CNS NEUROL DISORD-DR, V13, P1804; Brainin M, 2015, EUR J NEUROL, V22, P229, DOI 10.1111/ene.12626; Brasier DJ, 2008, J NEUROSCI, V28, P2199, DOI 10.1523/JNEUROSCI.3915-07.2008; Chamberlain SEL, 2008, NEURAL PLASTICITY; CLEMENTS JD, 1992, SCIENCE, V258, P1498, DOI 10.1126/science.1359647; Collingridge GL, 2013, NEUROPHARMACOLOGY, V64, P13, DOI 10.1016/j.neuropharm.2012.06.051; Coutureau E, 2009, PROG NEURO-PSYCHOPH, V33, P753, DOI 10.1016/j.pnpbp.2009.03.038; Cunningham MO, 2006, J NEUROSCI, V26, P2767, DOI 10.1523/JNEUROSCI.5054-05.2006; De Sarro G, 2000, EPILEPSY RES, V40, P109, DOI 10.1016/S0920-1211(00)00113-3; Dravid SM, 2010, J NEUROSCI, V30, P2741, DOI 10.1523/JNEUROSCI.5390-09.2010; Eichenbaum H, 2001, BEHAV BRAIN RES, V127, P199, DOI 10.1016/S0166-4328(01)00365-5; Feld GB, 2013, NEUROPSYCHOPHARMACOL, V38, P2688, DOI 10.1038/npp.2013.179; FLOOD JF, 1992, EUR J PHARMACOL, V221, P249, DOI 10.1016/0014-2999(92)90709-D; Ghasemi M, 2011, EPILEPSY BEHAV, V22, P617, DOI 10.1016/j.yebeh.2011.07.024; GOFF DC, 1995, AM J PSYCHIAT, V152, P1213; Greenhill SD, 2010, NEUROSCIENCE, V167, P456, DOI 10.1016/j.neuroscience.2010.02.021; Harrison PJ, 2003, LANCET, V361, P417, DOI 10.1016/S0140-6736(03)12379-3; Hashimoto K, 2014, EXPERT OPIN THER TAR, V18, P1049, DOI 10.1517/14728222.2014.934225; Hashimoto K, 2013, EUR ARCH PSY CLIN N, V263, P367, DOI 10.1007/s00406-013-0399-y; Igarashi KM, 2014, NATURE, V510, P143, DOI 10.1038/nature13162; Inanobe A, 2005, NEURON, V47, P71, DOI 10.1016/j.neuron.2005.05.022; JAVITT DC, 1991, AM J PSYCHIAT, V148, P1301; JONES RSG, 1988, J NEUROPHYSIOL, V59, P1476, DOI 10.1152/jn.1988.59.5.1476; Jones RSG, 2005, J PHYSIOL-LONDON, V562, P107, DOI 10.1113/jphysiol.2004.076133; Jourdain P, 2007, NAT NEUROSCI, V10, P331, DOI 10.1038/nn1849; Klatte K, 2013, J NEUROSCI, V33, P13066, DOI 10.1523/JNEUROSCI.5423-12.2013; KRYSTAL JH, 1994, ARCH GEN PSYCHIAT, V51, P199, DOI 10.1001/archpsyc.1994.03950030035004; Kussius CL, 2009, NAT NEUROSCI, V12, P1114, DOI 10.1038/nn.2361; Le Bail M, 2015, P NATL ACAD SCI USA, V112, pE204, DOI 10.1073/pnas.1416668112; Ledgerwood L, 2003, BEHAV NEUROSCI, V117, P341, DOI 10.1037/0735-7044.117.2.341; Lehrner J, 2015, INT PSYCHOGERIATR, V27, P357, DOI 10.1017/S1041610214002245; Lench AM, 2014, NEUROPHARMACOLOGY, V83, P118, DOI 10.1016/j.neuropharm.2014.04.004; LESTER RAJ, 1990, NATURE, V346, P565, DOI 10.1038/346565a0; LESTER RAJ, 1992, J NEUROSCI, V12, P635; Li YH, 2007, J NEUROPHYSIOL, V97, P817, DOI 10.1152/jn.00980.2006; Menlove L, 2015, SEIZURE-EUR J EPILEP, V25, P126, DOI 10.1016/j.seizure.2014.10.002; Middleton S, 2008, P NATL ACAD SCI USA, V105, P18572, DOI 10.1073/pnas.0809302105; Moskal JR, 2014, EXPERT OPIN INV DRUG, V23, P243, DOI 10.1517/13543784.2014.852536; Myers KM, 2012, BIOL PSYCHIAT, V71, P947, DOI 10.1016/j.biopsych.2012.02.030; Nave AM, 2012, J CLIN PSYCHIAT, V73, P1179, DOI 10.4088/JCP.11m07564; Norberg MM, 2008, BIOL PSYCHIAT, V63, P1118, DOI 10.1016/j.biopsych.2008.01.012; Paganelli MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080953; Papouin T, 2012, CELL, V150, P633, DOI 10.1016/j.cell.2012.06.029; Parsons CG, 2013, NEUROTOX RES, V24, P358, DOI 10.1007/s12640-013-9398-z; Popescu GK, 2012, J PHYSIOL-LONDON, V590, P73, DOI 10.1113/jphysiol.2011.223750; PRIESTLEY T, 1994, MOL PHARMACOL, V46, P1191; QUARTERMAIN D, 1994, EUR J PHARMACOL, V257, P7, DOI 10.1016/0014-2999(94)90687-4; Rodrigues H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093519; Roopun AK, 2008, SCHIZOPHRENIA BULL, V34, P962, DOI 10.1093/schbul/sbn059; Samson RD, 2005, J NEUROSCI, V25, P1847, DOI 10.1523/JNEUROSCI.3713-04.2005; Schorge S, 2005, J PHYSIOL-LONDON, V569, P395, DOI 10.1113/jphysiol.2005.095349; Schwartz TL, 2012, CURR PHARM DESIGN, V18, P1580, DOI 10.2174/138161212799958594; Sheinin A, 2001, NEUROPHARMACOLOGY, V41, P151, DOI 10.1016/S0028-3908(01)00073-9; SINGER W, 1995, ANNU REV NEUROSCI, V18, P555, DOI 10.1146/annurev.neuro.18.1.555; Sjostrom PJ, 2003, NEURON, V39, P641, DOI 10.1016/S0896-6273(03)00476-8; Squire LR, 2004, ANNU REV NEUROSCI, V27, P279, DOI 10.1146/annurev.neuro.27.070203.144130; Tallon-Baudry C, 1998, J NEUROSCI, V18, P4244; TIITINEN H, 1993, NATURE, V364, P59, DOI 10.1038/364059a0; vanBerckel BNM, 1996, BIOL PSYCHIAT, V40, P1298, DOI 10.1016/S0006-3223(96)00311-3; Vinther-Jensen T, 2014, ORPHANET J RARE DIS, V9, DOI 10.1186/s13023-014-0114-8; Weickert CS, 2013, MOL PSYCHIATR, V18, P1185, DOI 10.1038/mp.2012.137; Witter MP, 2006, TRENDS NEUROSCI, V29, P671, DOI 10.1016/j.tins.2006.10.003; Wlaz P, 2011, PHARMACOL REP, V63, P1231; Woodhall G, 2001, J NEUROPHYSIOL, V86, P1644, DOI 10.1152/jn.2001.86.4.1644; Woodhall GL, 2005, HIPPOCAMPUS, V15, P232, DOI 10.1002/hipo.20047; Yang J, 2006, J NEUROSCI, V26, P406, DOI 10.1523/JNEUROSCI.4413-05.2006; Yang J, 2008, J PHYSIOL-LONDON, V586, P4905, DOI 10.1113/jphysiol.2008.157974	71	8	8	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2015	10	7							e0133548	10.1371/journal.pone.0133548	http://dx.doi.org/10.1371/journal.pone.0133548			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LN	26193112	Green Published, Green Submitted, gold			2022-12-26	WOS:000358546400101
J	Chung, HJ; Pellegrini, KL; Chung, J; Wanigasuriya, K; Jayawardene, I; Lee, K; Lee, H; Vaidya, VS; Weissleder, R				Chung, Hyun Jung; Pellegrini, Kathryn L.; Chung, Jaehoon; Wanigasuriya, Kamani; Jayawardene, Innocent; Lee, Kyungheon; Lee, Hakho; Vaidya, Vishal S.; Weissleder, Ralph			Nanoparticle Detection of Urinary Markers for Point-of-Care Diagnosis of Kidney Injury	PLOS ONE			English	Article							BIOMARKERS; CELLS	The high incidence of acute and chronic kidney injury due to various environmental factors such as heavy metals or chemicals has been a major problem in developing countries. However, the diagnosis of kidney injury in these areas can be more challenging due to the lack of highly sensitive and specific techniques that can be applied in point-of-care settings. To address this, we have developed a technique called 'micro-urine nanoparticle detection (mu UNPD)', that allows the detection of trace amounts of molecular markers in urine. Specifically, this technique utilizes an automated on-chip assay followed by detection with a hand-held device for the read-out. Using the mu UNPD technology, the kidney injury markers KIM-1 and Cystatin C were detected down to concentrations of 0.1 ng/ml and 20 ng/ml respectively, which meets the cut-off range required to identify patients with acute or chronic kidney injury. Thus, we show that the mu UNPD technology enables point of care and non-invasive detection of kidney injury, and has potential for applications in diagnosing kidney injury with high sensitivity in resource-limited settings.	[Chung, Hyun Jung; Chung, Jaehoon; Lee, Kyungheon; Lee, Hakho; Weissleder, Ralph] Massachusetts Gen Hosp, Ctr Syst Biol, Boston, MA 02114 USA; [Pellegrini, Kathryn L.; Vaidya, Vishal S.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Renal Div,Dept Med, Boston, MA 02115 USA; [Wanigasuriya, Kamani] Univ Sri Jayewardenepura, Fac Med Sci, Dept Med, Nugegoda, Sri Lanka; [Jayawardene, Innocent] Harvard Univ, Sch Med, Brigham & Womens Hosp, Channing Lab,Dept Med, Boston, MA 02115 USA; [Jayawardene, Innocent] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; [Vaidya, Vishal S.] Harvard Univ, Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02115 USA; [Weissleder, Ralph] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital; Harvard Medical School; University Sri Jayewardenepura; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard Medical School	Weissleder, R (corresponding author), Massachusetts Gen Hosp, Ctr Syst Biol, 185 Cambridge St,CPZN 5206, Boston, MA 02114 USA.	rweissleder@mgh.harvard.edu	Chung, Hyun Jung/J-3205-2014	/0000-0003-0828-4143; Pellegrini, Kathryn/0000-0002-5089-5477	National Institute of Health [HHSN268201000044C, U54 CA151884]; National Institute of Environmental Health Sciences [ES017543]; NATIONAL CANCER INSTITUTE [U54CA151884] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL113156] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB010011] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R56ES017543, R01ES017543] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	The work in the Weissleder laboratory was funded in parts by National Institute of Health grants HHSN268201000044C and U54 CA151884. The research in Vaidya laboratory was supported by Outstanding New Environmental Scientist Award (ES017543) from the National Institute of Environmental Health Sciences.	Bonventre JV, 2010, NAT BIOTECHNOL, V28, P436, DOI 10.1038/nbt0510-436; Bonventre JV, 2009, NEPHROL DIAL TRANSPL, V24, P3265, DOI 10.1093/ndt/gfp010; Chung HJ, 2013, NAT NANOTECHNOL, V8, P369, DOI [10.1038/nnano.2013.70, 10.1038/NNANO.2013.70]; Chung HJ, 2011, ACS NANO, V5, P8834, DOI 10.1021/nn2029692; Coca SG, 2008, KIDNEY INT, V73, P1008, DOI 10.1038/sj.ki.5002729; Coca SG, 2012, KIDNEY INT, V81, P442, DOI 10.1038/ki.2011.379; Devaraj NK, 2009, ANGEW CHEM INT EDIT, V48, P7013, DOI 10.1002/anie.200903233; Ferguson MA, 2012, CLIN CHEM, V58, P680, DOI 10.1373/clinchem.2011.167494; Ghazani AA, 2014, NANOMED-NANOTECHNOL, V10, P661, DOI 10.1016/j.nano.2013.10.008; Gupta BK, 2012, SMALL, V8, P3028, DOI 10.1002/smll.201200909; Haun JB, 2010, NAT NANOTECHNOL, V5, P660, DOI [10.1038/NNANO.2010.148, 10.1038/nnano.2010.148]; Iqbal MCM, 2014, SCIENCE, V344, P981, DOI 10.1126/science.344.6187.981-b; Koyner JL, 2008, KIDNEY INT, V74, P1059, DOI 10.1038/ki.2008.341; Lee H, 2008, NAT MED, V14, P869, DOI 10.1038/nm.1711; Li Z, 2011, SMALL, V7, P3193, DOI 10.1002/smll.201100959; Shao HL, 2012, NAT MED, V18, P1835, DOI 10.1038/nm.2994; Vaidya VS, 2008, ANNU REV PHARMACOL, V48, P463, DOI 10.1146/annurev.pharmtox.48.113006.094615; Vaidya VS, 2010, NAT BIOTECHNOL, V28, P478, DOI 10.1038/nbt.1623; Vaidya VS, 2009, KIDNEY INT, V76, P108, DOI 10.1038/ki.2009.96; Vaidya VS, 2008, CTS-CLIN TRANSL SCI, V1, P200, DOI 10.1111/j.1752-8062.2008.00053.x; Vanmassenhove J, 2013, NEPHROL DIAL TRANSPL, V28, P254, DOI 10.1093/ndt/gfs380; Wald R, 2009, JAMA-J AM MED ASSOC, V302, P1179, DOI 10.1001/jama.2009.1322; Yaqub F, 2014, LANCET, V383, P1794, DOI 10.1016/S0140-6736(14)60867-9	23	25	25	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0133417	10.1371/journal.pone.0133417	http://dx.doi.org/10.1371/journal.pone.0133417			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RV	26186708	gold, Green Published, Green Submitted			2022-12-26	WOS:000358198700136
J	Colombo, MC; Giverso, C; Faggiano, E; Boffano, C; Acerbi, F; Ciarletta, P				Colombo, Maria Cristina; Giverso, Chiara; Faggiano, Elena; Boffano, Carlo; Acerbi, Francesco; Ciarletta, Pasquale			Towards the Personalized Treatment of Glioblastoma: Integrating Patient-Specific Clinical Data in a Continuous Mechanical Model	PLOS ONE			English	Article							SOLID TUMOR-GROWTH; MATHEMATICAL-MODEL; BRAIN-TUMORS; GLIOMA GROWTH; GUIDED SURGERY; PHASE-III; DIFFUSION; RESECTION; EXTENT; MRI	Glioblastoma multiforme (GBM) is the most aggressive and malignant among brain tumors. In addition to uncontrolled proliferation and genetic instability, GBM is characterized by a diffuse infiltration, developing long protrusions that penetrate deeply along the fibers of the white matter. These features, combined with the underestimation of the invading GBM area by available imaging techniques, make a definitive treatment of GBM particularly difficult. A multidisciplinary approach combining mathematical, clinical and radiological data has the potential to foster our understanding of GBM evolution in every single patient throughout his/her oncological history, in order to target therapeutic weapons in a patient-specific manner. In this work, we propose a continuous mechanical model and we perform numerical simulations of GBM invasion combining the main mechano-biological characteristics of GBM with the micro-structural information extracted from radiological images, i.e. by elaborating patient-specific Diffusion Tensor Imaging (DTI) data. The numerical simulations highlight the influence of the different biological parameters on tumor progression and they demonstrate the fundamental importance of including anisotropic and heterogeneous patient-specific DTI data in order to obtain a more accurate prediction of GBM evolution. The results of the proposed mathematical model have the potential to provide a relevant benefit for clinicians involved in the treatment of this particularly aggressive disease and, more importantly, they might drive progress towards improving tumor control and patient's prognosis.	[Colombo, Maria Cristina; Giverso, Chiara; Faggiano, Elena] Politecn Milan, MOX Dept Math, I-20133 Milan, Italy; [Colombo, Maria Cristina; Giverso, Chiara] Fdn CEN, I-20133 Milan, Italy; [Faggiano, Elena] Politecn Milan, Labs Dept Chem Mat & Chem Engn, I-20133 Milan, Italy; [Boffano, Carlo] Fdn IRCCS Ist Neurol Carlo Besta, Neuroradiol, I-20133 Milan, Italy; [Acerbi, Francesco] Fdn IRCCS Ist Neurol Carlo Besta, Dept Neurosurg, I-20133 Milan, Italy; [Ciarletta, Pasquale] Univ Paris 06, Sorbonne Univ, CNRS, Inst Jean Rond Alembert,UMR 7190, F-75005 Paris, France	Polytechnic University of Milan; Polytechnic University of Milan; IRCCS Istituto Neurologico Besta; IRCCS Istituto Neurologico Besta; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); UDICE-French Research Universities; Sorbonne Universite	Ciarletta, P (corresponding author), Univ Paris 06, Sorbonne Univ, CNRS, Inst Jean Rond Alembert,UMR 7190, F-75005 Paris, France.	pasquale.ciarletta@upmc.fr	Ciarletta, Pasquale/L-2052-2015; Acerbi, Francesco/K-6810-2016	Ciarletta, Pasquale/0000-0002-1011-5587; Acerbi, Francesco/0000-0002-4063-3924; Faggiano, Elena/0000-0001-5027-3910	"Start-up Packages and PhD Program" project - Regione Lombardia through the "Fondo per lo sviluppo e la coesione"; Progetto Giovani GNFM - National Group of Mathematical Physics (GNFM-INdAM)	"Start-up Packages and PhD Program" project - Regione Lombardia through the "Fondo per lo sviluppo e la coesione"; Progetto Giovani GNFM - National Group of Mathematical Physics (GNFM-INdAM)	This work was partially supported by the "Start-up Packages and PhD Program" project, co-funded by Regione Lombardia through the "Fondo per lo sviluppo e la coesione 2007-2013 -formerly FAS", and by the "Progetto Giovani GNFM 2014," funded by the National Group of Mathematical Physics (GNFM-INdAM).	Acerbi F, 2014, NEUROSURG FOCUS, V36, DOI 10.3171/2013.11.FOCUS13487; Acerbi F, 2013, ACTA NEUROCHIR, V155, P1277, DOI 10.1007/s00701-013-1734-9; Ambrosi D, 2002, MATH MOD METH APPL S, V12, P737, DOI 10.1142/S0218202502001878; Ambrosi D, 2002, INT J ENG SCI, V40, P1297, DOI 10.1016/S0020-7225(02)00014-9; Antiga L, 2008, MED BIOL ENG COMPUT, V46, P1097, DOI 10.1007/s11517-008-0420-1; Araujo RP, 2004, B MATH BIOL, V66, P1039, DOI 10.1016/j.bulm.2003.11.002; Arbit E, 1994, INTRACRANIAL PRESSUR, P609; Artzi M, 2015, J NEURO-ONCOL, V121, P349, DOI 10.1007/s11060-014-1639-3; Barazzuol L, 2010, J THEOR BIOL, V262, P553, DOI 10.1016/j.jtbi.2009.10.021; Bondiau PY, 2008, PHYS MED BIOL, V53, P879, DOI 10.1088/0031-9155/53/4/004; Boucher Y, 1997, BRIT J CANCER, V75, P829, DOI 10.1038/bjc.1997.148; Bowen RM., 1976, CONTINUUM PHYS, V3; Bruehlmeier M, 2003, J NUCL MED, V44, P1210; Burgess PK, 1997, J NEUROPATH EXP NEUR, V56, P704; Byrne H, 2003, MATH MED BIOL, V20, P341; Byrne HM, 2006, PHILOS T R SOC A, V364, P1563, DOI 10.1098/rsta.2006.1786; Byrne HM, 2003, APPL MATH LETT, V16, P567, DOI 10.1016/S0893-9659(03)00038-7; Chang LC, 2005, MAGN RESON MED, V53, P1088, DOI 10.1002/mrm.20426; Chatelain C, 2011, NEW J PHYS, V13, DOI 10.1088/1367-2630/13/11/115013; Chen LL, 2010, PHYS MED BIOL, V55, P329, DOI 10.1088/0031-9155/55/2/001; Cheng G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004632; Clatz O, 2005, IEEE T MED IMAGING, V24, P1334, DOI 10.1109/TMI.2005.857217; Corwin D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079115; CRANK J, 1947, P CAMB PHILOS SOC, V43, P50, DOI 10.1007/BF02127704; Cristini V, 2009, J MATH BIOL, V58, P723, DOI 10.1007/s00285-008-0215-x; Deisboeck TS, 2001, CELL PROLIFERAT, V34, P115, DOI 10.1046/j.1365-2184.2001.00202.x; DOI M, 1992, J PHYS II, V2, P1631, DOI 10.1051/jp2:1992225; Dolecek TA, 2012, NEURO-ONCOLOGY, V14, pv1, DOI 10.1093/neuonc/nos218; Engwer C, 2014, J MATH BIOL, P09; FORD RM, 1991, B MATH BIOL, V53, P721; Frieboes HB, 2007, NEUROIMAGE, V37, pS59, DOI 10.1016/j.neuroimage.2007.03.008; Friedl P, 2011, CELL, V147, P992, DOI 10.1016/j.cell.2011.11.016; Harpold HLP, 2007, J NEUROPATH EXP NEUR, V66, P1, DOI 10.1097/nen.0b013e31802d9000; Hatzikirou H, 2005, MATH MOD METH APPL S, V15, P1779, DOI 10.1142/S0218202505000960; Hillen T, 2009, J MATH BIOL, V58, P183, DOI 10.1007/s00285-008-0201-3; Hogea C, 2008, J MATH BIOL, V56, P793, DOI 10.1007/s00285-007-0139-x; Jain RK, 2007, NAT REV NEUROSCI, V8, P610, DOI 10.1038/nrn2175; Jain RK, 2014, ANNU REV BIOMED ENG, V16, P321, DOI 10.1146/annurev-bioeng-071813-105259; Jbabdi S, 2005, MAGN RESON MED, V54, P616, DOI 10.1002/mrm.20625; JELLINGER K, 1978, ACTA NEUROCHIR, V42, P5, DOI 10.1007/BF01406628; Jiang Y, 2005, BIOPHYS J, V89, P3884, DOI 10.1529/biophysj.105.060640; Jung SC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069323; Kansal AR, 2000, J THEOR BIOL, V203, P367, DOI 10.1006/jtbi.2000.2000; Kaufman LJ, 2005, BIOPHYS J, V89, P635, DOI 10.1529/biophysj.105.061994; KELLER EF, 1971, J THEOR BIOL, V30, P225, DOI 10.1016/0022-5193(71)90050-6; Kiran KL, 2009, CAN J CHEM ENG, V87, P732, DOI 10.1002/cjce.20204; Lacroix M, 2001, J NEUROSURG, V95, P190, DOI 10.3171/jns.2001.95.2.0190; Leemans A, 2009, MAGN RESON MED, V61, P1336, DOI 10.1002/mrm.21890; Logg A, 2012, AUTOMATED SOLUTION D, V84, P141; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Martinez-Gonzalez A, 2012, B MATH BIOL, V74, P2875, DOI 10.1007/s11538-012-9786-1; McAuliffe MJ, 2001, COMP MED SY, P381; McGirt MJ, 2009, J NEUROSURG, V110, P156, DOI 10.3171/2008.4.17536; Moreira J, 2002, ADV COMPLEX SYST, V5, P247, DOI [10.1142/s0219525902000572, DOI 10.1142/S0219525902000572]; Neal ML, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0051951; Okegawa T, 2004, ACTA BIOCHIM POL, V51, P445; Painter KJ, 2013, J THEOR BIOL, V323, P25, DOI 10.1016/j.jtbi.2013.01.014; Painter KJ, 2009, B MATH BIOL, V71, P1117, DOI 10.1007/s11538-009-9396-8; Pieper S, 2004, IEEE INT S BIOMED IM, V26, P632, DOI DOI 10.1109/ISBI.2004.1398617; PIERPAOLI C, 2010, ISMRM P, V18, P1597; POHL KM, 2004, BIOM IM NAN MACR 200, P81; Porter KR, 2010, NEURO-ONCOLOGY, V12, P520, DOI 10.1093/neuonc/nop066; Provenzale JM, 2006, RADIOLOGY, V239, P632, DOI 10.1148/radiol.2393042031; Rohde GK, 2004, MAGN RESON MED, V51, P103, DOI 10.1002/mrm.10677; Roose T, 2007, SIAM REV, V49, P179, DOI 10.1137/S0036144504446291; Sander LM, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.051901; Schuetz TA, 2014, COMPUT MATH METHOD M, V2014, DOI 10.1155/2014/437094; Senft C, 2011, LANCET ONCOL, V12, P997, DOI 10.1016/S1470-2045(11)70196-6; Shieh AC, 2011, ANN BIOMED ENG, V39, P1379, DOI 10.1007/s10439-011-0252-2; Si H, 2006, WEIERSTRASS INSTITUT; Stummer W, 2006, LANCET ONCOL, V7, P392, DOI 10.1016/S1470-2045(06)70665-9; Stupp R, 2009, LANCET ONCOL, V10, P459, DOI 10.1016/S1470-2045(09)70025-7; Suarez C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039616; SWABB EA, 1974, CANCER RES, V34, P2814; Swanson KR, 2008, BRIT J CANCER, V98, P113, DOI 10.1038/sj.bjc.6604125; Swanson KR, 2000, CELL PROLIFERAT, V33, P317, DOI 10.1046/j.1365-2184.2000.00177.x; Swanson KR, 2003, J NEUROL SCI, V216, P1, DOI 10.1016/j.jns.2003.06.001; Swanson KR, 2003, MATH COMPUT MODEL, V37, P1177, DOI 10.1016/S0895-7177(03)00129-8; Swanson KR, 2002, ACTA BIOTHEOR, V50, P223, DOI 10.1023/A:1022644031905; Tanaka ML, 2009, CELL PROLIFERAT, V42, P637, DOI 10.1111/j.1365-2184.2009.00631.x; Toma A, 2013, CURR MED IMAGING, V9, P145, DOI 10.2174/1573405611309020010; Tonn Jorg-Christian, 2008, Clin Neurosurg, V55, P20; Tournier JD, 2011, MAGN RESON MED, V65, P1532, DOI 10.1002/mrm.22924; TRACQUI P, 1995, CELL PROLIFERAT, V28, P17, DOI 10.1111/j.1365-2184.1995.tb00036.x; Tracqui P, 1995, ACTA BIOTHEOR, V43, P443, DOI 10.1007/BF00713564; Walker L, 2011, NEUROIMAGE, V54, P1168, DOI 10.1016/j.neuroimage.2010.08.048; Wise SM, 2008, J THEOR BIOL, V253, P524, DOI 10.1016/j.jtbi.2008.03.027; Woodward DE, 1996, CELL PROLIFERAT, V29, P269, DOI 10.1111/j.1365-2184.1996.tb01580.x; Wu M, 2008, LECT NOTES COMPUT SC, V5242, P321, DOI 10.1007/978-3-540-85990-1_39; Yankeelov TE, 2010, INTEGR BIOL-UK, V2, P338, DOI 10.1039/b921497f; Zhang JY, 2007, MAGN RESON MED, V58, P454, DOI 10.1002/mrm.21371	91	31	31	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0132887	10.1371/journal.pone.0132887	http://dx.doi.org/10.1371/journal.pone.0132887			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RV	26186462	Green Published, gold			2022-12-26	WOS:000358198700068
J	Cooksey, R; Husain, MJ; Brophy, S; Davies, H; Rahman, MA; Atkinson, MD; Phillips, CJ; Siebert, S				Cooksey, Roxanne; Husain, Muhammad J.; Brophy, Sinead; Davies, Helen; Rahman, Muhammad A.; Atkinson, Mark D.; Phillips, Ceri J.; Siebert, Stefan			The Cost of Ankylosing Spondylitis in the UK Using Linked Routine and Patient-Reported Survey Data	PLOS ONE			English	Article							3 EUROPEAN COUNTRIES; HEALTH-CARE COSTS; QUALITY-OF-LIFE; RHEUMATOID-ARTHRITIS; PSORIATIC-ARTHRITIS; WORK PRODUCTIVITY; QUESTIONNAIRE; PERSPECTIVE; VALIDITY; ILLNESS	Background Ankylosing spondylitis (AS) is a chronic inflammatory arthritis which typically begins in early adulthood and impacts on healthcare resource utilisation and the ability to work. Previous studies examining the cost of AS have relied on patient-reported questionnaires based on recall. This study uses a combination of patient-reported and linked-routine data to examine the cost of AS in Wales, UK. Methods Participants in an existing AS cohort study (n = 570) completed questionnaires regarding work status, out-of-pocket expenses, visits to health professionals and disease severity. Participants gave consent for their data to be linked to routine primary and secondary care clinical datasets. Health resource costs were calculated using a bottom-up micro-costing approach. Human capital costs methods were used to estimate work productivity loss costs, particularly relating to work and early retirement. Regression analyses were used to account for age, gender, disease activity. Results The total cost of AS in the UK is estimated at 19016 pound per patient per year, calculated to include GP attendance, administration costs and hospital costs derived from routine data records, plus patient-reported non-NHS costs, out-of-pocket AS-related expenses, early retirement, absenteeism, presenteeism and unpaid assistance costs. The majority of the cost (>80%) was as a result of work-related costs. Conclusion The major cost of AS is as a result of loss of working hours, early retirement and unpaid carer's time. Therefore, much of AS costs are hidden and not easy to quantify. Functional impairment is the main factor associated with increased cost of AS. Interventions which keep people in work to retirement age and reduce functional impairment would have the greatest impact on reducing costs of AS. The combination of patient-reported and linked routine data significantly enhanced the health economic analysis and this methodology that can be applied to other chronic conditions.	[Cooksey, Roxanne; Brophy, Sinead; Davies, Helen; Rahman, Muhammad A.; Atkinson, Mark D.] Swansea Univ, Coll Med, Swansea, W Glam, Wales; [Husain, Muhammad J.] Keele Univ, Keele Management Sch, Newcastle Upon Tyne, Tyne & Wear, England; [Phillips, Ceri J.] Swansea Univ, Coll Human & Hlth Sci, Swansea, W Glam, Wales; [Siebert, Stefan] Univ Glasgow, Inst Infect Immun & Inflammat, Glasgow, Lanark, Scotland	Swansea University; Keele University; Swansea University; University of Glasgow	Cooksey, R (corresponding author), Swansea Univ, Coll Med, Swansea, W Glam, Wales.	r.cooksey@swansea.ac.uk	Atkinson, Mark D/K-1813-2013; Rahman, Muhammad Azizur/GLR-8606-2022	Atkinson, Mark D/0000-0003-4237-3588; Rahman, Muhammad Azizur/0000-0002-0805-7461; Phillips, Ceri/0000-0003-1076-9289; Cooksey, Roxanne/0000-0002-6763-9373; Siebert, Stefan/0000-0002-1802-7311; Brophy, Sinead/0000-0001-7417-2858; Husain, Muhammad Jami/0000-0001-6049-0505	Medical Research Council; National Institute for Social care and Health Research (NISCHR) as part of their Patient Research Cohort Initiative [G0800583]; I-CRP award from Pfizer; Medical Research Council [G0800583, MR/K006525/1] Funding Source: researchfish; MRC [MR/K006525/1, G0800583] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Social care and Health Research (NISCHR) as part of their Patient Research Cohort Initiative; I-CRP award from Pfizer; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The PAS cohort was funded by the Medical Research Council and the National Institute for Social care and Health Research (NISCHR) as part of their Patient Research Cohort Initiative (grant number: G0800583) (SB & SS). The health economics component was funded by an I-CRP award from Pfizer (SS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ara RM, 2008, RHEUMATOLOGY, V47, P68, DOI 10.1093/rheumatology/kem296; Atkinson MD, 2010, BMC MUSCULOSKEL DIS, V11, DOI 10.1186/1471-2474-11-197; Bakland G, 2011, J RHEUMATOL, V38, P479, DOI 10.3899/jrheum.100686; Boonen A, 2003, ANN RHEUM DIS, V62, P741, DOI 10.1136/ard.62.8.741; Boonen A, 2003, ANN RHEUM DIS, V62, P732, DOI 10.1136/ard.62.8.732; Boonen A, 2002, ANN RHEUM DIS, V61, P429, DOI 10.1136/ard.61.5.429; Boonen A, 2010, ANN RHEUM DIS, V69, P1123, DOI 10.1136/ard.2009.116764; CALIN A, 1994, J RHEUMATOL, V21, P2281; Coons SJ, 2009, VALUE HEALTH, V12, P419, DOI 10.1111/j.1524-4733.2008.00470.x; Curtis L., 2010, UNIT COSTS HLTH SOCI; Ford DV, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-157; GARRETT S, 1994, J RHEUMATOL, V21, P2286; Hamilton L, 2011, RHEUMATOLOGY, V50, P1991, DOI 10.1093/rheumatology/ker013; Healey EL, 2011, SCAND J RHEUMATOL, V40, P34, DOI 10.3109/03009742.2010.487838; Hodgson TA, 1982, MILBANK MEM FUND Q, V6, P429; Hulsemann JL, 2005, ANN RHEUM DIS, V64, P1456, DOI 10.1136/ard.2004.031880; Husain MJ, 2012, BMC MED INFORM DECIS, V12, DOI 10.1186/1472-6947-12-24; Huscher D, 2006, ANN RHEUM DIS, V65, P1175, DOI 10.1136/ard.2005.046367; Kobelt G, 2006, J RHEUMATOL, V33, P289; Kobelt G, 2008, VALUE HEALTH, V11, P408, DOI 10.1111/j.1524-4733.2007.00252.x; Lerner D, 2002, J CLIN EPIDEMIOL, V55, P197, DOI 10.1016/S0895-4356(01)00424-3; Lerner D, 2001, MED CARE, V39, P72, DOI 10.1097/00005650-200101000-00009; Lyons RA, 2009, BMC MED INFORM DECIS, V9, DOI 10.1186/1472-6947-9-3; Merkesdal S, 2005, ARTHRIT RHEUM-ARTHR, V53, P234, DOI 10.1002/art.21080; NWIS, 2010, PRESCR COST AN WAL 2; Pincus T, 2001, BRIT J CLIN PSYCHOL, V40, P143, DOI 10.1348/014466501163599; Poole CD, 2010, RHEUMATOLOGY, V49, P1949, DOI 10.1093/rheumatology/keq182; Rafia R, 2012, CLIN EXP RHEUMATOL, V30, P246; Reilly MC, 2010, RHEUMATOLOGY, V49, P812, DOI 10.1093/rheumatology/kep457; REILLY MC, 1993, PHARMACOECONOMICS, V4, P353, DOI 10.2165/00019053-199304050-00006; RICE DP, 1967, AM J PUBLIC HEALTH N, V57, P424, DOI 10.2105/AJPH.57.3.424; Singh JA, 2009, RHEUMATOLOGY, V48, P272, DOI 10.1093/rheumatology/ken472; Strombeck B, 2010, J RHEUMATOL, V37, P2348, DOI 10.3899/jrheum.100099; Verstappen SMM, 2007, ANN RHEUM DIS, V66, P727, DOI 10.1136/ard.2006.061283; Verstappen SMM, 2005, ANN RHEUM DIS, V64, P1754, DOI 10.1136/ard.2004.033977; Zhu TY, 2008, RHEUMATOLOGY, V47, P1422, DOI 10.1093/rheumatology/ken287; 1990, HLTH POLICY, V16, P199	37	31	31	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0126105	10.1371/journal.pone.0126105	http://dx.doi.org/10.1371/journal.pone.0126105			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RV	26185984	Green Published, Green Accepted, gold, Green Submitted			2022-12-26	WOS:000358198700001
J	Howie, RN; Borke, JL; Kurago, Z; Daoudi, A; Cray, J; Zakhary, IE; Brown, TL; Raley, JN; Tran, LT; Messer, R; Medani, F; Elsalanty, ME				Howie, R. Nicole; Borke, James L.; Kurago, Zoya; Daoudi, Asma; Cray, James; Zakhary, Ibrahim E.; Brown, Tara L.; Raley, J. Nathan; Tran, Loan T.; Messer, Regina; Medani, Fardous; Elsalanty, Mohammed E.			A Model for Osteonecrosis of the Jaw with Zoledronate Treatment following Repeated Major Trauma	PLOS ONE			English	Article							BISPHOSPHONATE-RELATED OSTEONECROSIS; INDUCE OSTEONECROSIS; RAT MODEL; PERIAPICAL DISEASE; ANIMAL-MODEL; BONE; ACID; CANCER; MICE; HISTOMORPHOMETRY	This study aims to develop a reproducible rat model for post-traumatic bisphosphonate-related osteonecrosis of the jaw (BRONJ). In our previous studies using dental extraction as an inducing factor, only 30% - 60% of zoledronate-treated animals fulfilled the definition of clinical BRONJ. We modified the zoledronate regimen and introduced repeated surgical extraction to illicit quantifiable BRONJ in all animals. Eighty retired-breeder female Sprague-Dawley rats were divided between the treatment (IV zoledronate; 80 mu g/kg/week for 13 weeks) and control (saline) groups. On week 13, the left mandibular first molar was surgically extracted, followed by the second molar a week later. Animals were euthanized at 1-week, 2-weeks, and 8-weeks following extraction. The occurrence and severity of BRONJ were scored in each animal based on gross and MicroCT analysis. Parameters of bone formation and osteoclast functions at the extraction site were compared between groups. All zoledronate-treated animals developed a severe case of BRONJ that fulfilled the clinical definition of the condition in humans. Osteoclast attachment continued to be defective eight weeks after stopping the treatment. There were no signs of kidney or liver toxicity. Our data confirmed that repeated surgical extraction (major trauma) by itself consistently precipitated massive bone necrosis in ZA-treated animals, eliminating the need to induce pre-existing infection or comorbidity. These results will be the basis for further studies examining the in-vivo pathogenesis and prevention of BRONJ.	[Howie, R. Nicole; Kurago, Zoya; Brown, Tara L.; Raley, J. Nathan; Tran, Loan T.; Messer, Regina; Medani, Fardous; Elsalanty, Mohammed E.] Georgia Regents Univ, Coll Dent Med, Augusta, GA 30912 USA; [Borke, James L.] Western Univ Hlth Sci, Coll Dent Med, Pomona, CA USA; [Daoudi, Asma] Georgia Regents Univ, Coll Sci & Math, Augusta, GA USA; [Cray, James] Med Univ S Carolina, Coll Dent Med, Charleston, SC 29425 USA; [Zakhary, Ibrahim E.] Univ Detroit Mercy, Sch Dent, Detroit, MI 48221 USA	University System of Georgia; Augusta University; Western University of Health Sciences; University System of Georgia; Augusta University; Medical University of South Carolina; University of Detroit Mercy	Elsalanty, ME (corresponding author), Georgia Regents Univ, Coll Dent Med, Augusta, GA 30912 USA.	melsalanty@gru.edu			National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) [1P01AG036675]; National Institute of Dental and Craniofacial Research (NIDCR) [1R15DE025134-01]; Georgia Regents University Extramural Success Award (ESA); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R15DE025134] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG036675] Funding Source: NIH RePORTER	National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); National Institute of Dental and Craniofacial Research (NIDCR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); Georgia Regents University Extramural Success Award (ESA); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was supported by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) 1P01AG036675, The National Institute of Dental and Craniofacial Research (NIDCR) 1R15DE025134-01, and a Georgia Regents University Extramural Success Award (ESA).	Abtahi J, 2013, INT J ORAL MAX SURG, V42, P632, DOI 10.1016/j.ijom.2013.02.007; Abtahi J, 2013, J DENT RES, V92, P279, DOI 10.1177/0022034512472335; Abtahi J, 2012, J ORAL PATHOL MED, V41, P494, DOI 10.1111/j.1600-0714.2011.01125.x; Aghaloo TL, 2014, J BONE MINER RES, V29, P843, DOI 10.1002/jbmr.2097; Aghaloo TL, 2014, J ORAL MAXIL SURG, V72, P702, DOI 10.1016/j.joms.2013.09.008; Aghaloo TL, 2011, J BONE MINER RES, V26, P1871, DOI 10.1002/jbmr.379; Aguirre JI, 2012, J BONE MINER RES, V27, P2130, DOI 10.1002/jbmr.1669; Ali-Erdem M, 2011, MED ORAL PATOL ORAL, V16, pC879, DOI 10.4317/medoral.17150; Allen MR, 2011, OSTEOPOROSIS INT, V22, P693, DOI 10.1007/s00198-010-1268-4; Allen MR, 2011, ODONTOLOGY, V99, P8, DOI 10.1007/s10266-010-0153-0; Bamias A, 2005, J CLIN ONCOL, V23, P8580, DOI 10.1200/JCO.2005.02.8670; Biasotto M, 2010, J ORAL PATHOL MED, V39, P390, DOI 10.1111/j.1600-0714.2009.00878.x; Black DM, 2007, NEW ENGL J MED, V356, P1809, DOI 10.1056/NEJMoa067312; Boabaid F, 2004, J PERIODONTOL, V75, P1247, DOI 10.1902/jop.2004.75.9.1247; Cankaya AB, 2011, INT J MED SCI, V8, P667, DOI 10.7150/ijms.8.667; Dempster DW, 2013, J BONE MINER RES, V28, P1, DOI 10.1002/jbmr.1805; Doggrell SA, 2009, EXPERT REV ANTICANC, V9, P1211, DOI [10.1586/era.09.95, 10.1586/ERA.09.95]; ENGBAEK K, 1979, J CLIN PATHOL, V32, P187, DOI 10.1136/jcp.32.2.187; Ersan N, 2014, DENTOMAXILLOFAC RAD, V43, DOI 10.1259/dmfr.20130144; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Gabriel P, 2008, AM SOC HEM 50 ANN M; Guevarra CS, 2013, J ORAL IMPLANTOL; Herberg S, 2013, TISSUE ENG A; Jabbour Z, 2014, ORAL ONCOL, V50, P485, DOI 10.1016/j.oraloncology.2014.02.013; Kang B, 2013, J BONE MINER RES, V28, P1631, DOI 10.1002/jbmr.1894; Khan AA, 2015, J BONE MINER RES, V30, P3, DOI 10.1002/jbmr.2405; Kikuiri T, 2010, J BONE MINER RES, V25, P1668, DOI 10.1002/jbmr.37; Kozloff KM, 2010, J BONE MINER RES, V25, P1748, DOI 10.1002/jbmr.66; Landesberg R, 2011, ANN NY ACAD SCI, V1218, P62, DOI 10.1111/j.1749-6632.2010.05835.x; Leu CT, 2006, BONE, V38, P628, DOI 10.1016/j.bone.2005.07.023; Marino KL, 2012, J ORAL IMPLANTOL, V38, P511, DOI 10.1563/AAID-JOI-D-11-00057; Neto NC, 2013, INT J EXP PATHOL, V94, P65, DOI 10.1111/iep.12007; Palaska PK, 2009, ONCOLOGIST; Pautke C, 2012, BONE, V51, P592, DOI 10.1016/j.bone.2012.04.020; Reid IR, 2012, NAT REV RHEUMATOL, V8, P90, DOI 10.1038/nrrheum.2011.181; Reid IR, 2002, NEW ENGL J MED, V346, P653, DOI 10.1056/NEJMoa011807; Ruggiero S, 2014, MED RELATED OSTEONEC; Ruggiero SL, 2009, AUST ENDOD J, V35, P119, DOI 10.1111/j.1747-4477.2009.00213.x; Sonis ST, 2009, ORAL ONCOL, V45, P164, DOI 10.1016/j.oraloncology.2008.04.013; VIGNERY A, 1980, ANAT REC, V196, P191, DOI 10.1002/ar.1091960210; Weiss HM, 2008, DRUG METAB DISPOS, V36, P2043, DOI 10.1124/dmd.108.021071; Xue DT, 2014, J ORTHOP SURG RES, V9, DOI 10.1186/1749-799X-9-45	42	23	23	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0132520	10.1371/journal.pone.0132520	http://dx.doi.org/10.1371/journal.pone.0132520			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RV	26186665	gold, Green Published, Green Submitted			2022-12-26	WOS:000358198700047
J	Mazaheri, M; Moosavi-Movahedi, AA; Saboury, AA; Khodagholi, F; Shaerzadeh, F; Sheibani, N				Mazaheri, Mansooreh; Moosavi-Movahedi, Ali Akbar; Saboury, Ali Akbar; Khodagholi, Fariba; Shaerzadeh, Fatemeh; Sheibani, Nader			Curcumin Protects beta-Lactoglobulin Fibril Formation and Fibril-Induced Neurotoxicity in PC12Cells	PLOS ONE			English	Article							DISULFIDE BOND FORMATION; AFLATOXIN M-1; CHEESE PRODUCTION; TOXICITY; BINDING; CYTOTOXICITY; AGGREGATION; STABILITY; STORAGE; DAMAGE	In this study the beta-lactoglobulin fibrillation, in the presence or absence of lead ions, aflatoxin M1 and curcumin, was evaluated using ThT fluorescence, Circular dichroism spectroscopy and atomic force microscopy. To investigate the toxicity of the different form of beta-Lg fibrils, in the presence or absence of above toxins and curcumin, we monitored changes in the level of reactive oxygen species and morphology of the differentiated neuron-like PC12 cells. The cell viability, cell body area, average neurite length, neurite width, number of primary neurites, percent of bipolar cells and node/primary neurite ratios were used to assess the growth and complexity of PC12 cells exposed to different form of beta-Lg fibrils. Incubation of beta-Lg with curcumin resulted in a significant decrease in ROS levels even in the presence of lead ions and aflatoxin M1. The beta-Lg fibrils formed in the presence of lead ions and aflatoxin M1 attenuated the growth and complexity of PC12 cells compared with other form of beta-Lg fibrils. However, the adverse effects of these toxins and protein fibrils were negated in the presence of curcumin. Furthermore, the antioxidant and inhibitory effects of curcumin protected PC12 cells against fibril neurotoxicity and enhanced their survival. Thus, curcumin may provide a protective effect toward beta-Lg, and perhaps other protein, fibrils mediated neurotoxicity.	[Mazaheri, Mansooreh; Moosavi-Movahedi, Ali Akbar; Saboury, Ali Akbar] Univ Tehran, Inst Biochem & Biophys, Tehran, Iran; [Mazaheri, Mansooreh] Standard Res Inst, Food Dept, Karaj, Iran; [Moosavi-Movahedi, Ali Akbar; Saboury, Ali Akbar] Univ Tehran, Ctr Excellence Biothermodynam, Tehran, Iran; [Khodagholi, Fariba; Shaerzadeh, Fatemeh] Shahid Beheshti Univ Med Sci, Neuro Biol Res Ctr, Tehran, Iran; [Sheibani, Nader] Univ Wisconsin, Sch Med & Publ Hlth, Dept Ophthalmol, Madison, WI USA; [Sheibani, Nader] Univ Wisconsin, Sch Med & Publ Hlth, Dept Visual Sci, Madison, WI USA	University of Tehran; University of Tehran; Shahid Beheshti University Medical Sciences; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Moosavi-Movahedi, AA (corresponding author), Univ Tehran, Inst Biochem & Biophys, Tehran, Iran.	moosavi@ut.ac.ir	Saboury, Ali Akbar/L-6136-2019; Mazaheri, Mansooreh/H-1464-2011; Sheibani, Nader/AAG-2379-2020; Mazaheri, Mansooreh/ABB-3490-2020; Khodagholi, Fariba/AAZ-4436-2020; Shaerzadeh, Fatemeh/L-4425-2017	Sheibani, Nader/0000-0003-2723-9217; Saboury, Ali Akbar/0000-0003-0604-9465; Khodagholi, Fariba/0000-0002-4911-4530; Moosavi-Movahedi, Ali Akbar/0000-0002-1707-8432; Shaerzadeh, Fatemeh/0000-0002-3342-4139; Mazaheri, Mansooreh/0000-0001-8568-6694	NATIONAL EYE INSTITUTE [R24EY022883] Funding Source: NIH RePORTER; NEI NIH HHS [R24 EY022883] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Akkermans C, 2008, BIOMACROMOLECULES, V9, P1474, DOI 10.1021/bm7014224; Barzegar A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026012; Brownlow S, 1997, STRUCTURE, V5, P481, DOI 10.1016/S0969-2126(97)00205-0; Bryant CM, 1998, TRENDS FOOD SCI TECH, V9, P143, DOI 10.1016/S0924-2244(98)00031-4; Cattaneo TMP, 2013, FOOD CONTROL, V32, P77, DOI 10.1016/j.foodcont.2012.11.007; Caughey B, 2003, ANNU REV NEUROSCI, V26, P267, DOI 10.1146/annurev.neuro.26.010302.081142; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Cornelis R, 2005, HDB ELEMENTAL SPECIA; Daniel S, 2004, J INORG BIOCHEM, V98, P266, DOI 10.1016/j.jinorgbio.2003.10.014; Deveci O, 2007, FOOD CONTROL, V18, P1103, DOI 10.1016/j.foodcont.2006.07.012; Divsalar A, 2005, FEBS J, V272, P340; Dobson CM, 2004, SEMIN CELL DEV BIOL, V15, P3, DOI 10.1016/j.semcdb.2003.12.008; DUFOUR E, 1992, J PROTEIN CHEM, V11, P645, DOI 10.1007/BF01024965; Fox PF, 2003, ADV DAIRY CHEM 1 PRO, P9; Gotz J, 2006, MED J AUSTRALIA, V185, P381, DOI 10.5694/j.1326-5377.2006.tb00615.x; Govaris A, 2001, FOOD ADDIT CONTAM A, V18, P437, DOI 10.1080/02652030010022700; Gupta SC, 2011, NAT PROD REP, V28, P1937, DOI 10.1039/c1np00051a; Huang WH, 2014, RSC ADV, V4, P52088, DOI 10.1039/c4ra09193k; Hudson SA, 2009, FEBS J, V276, P5960, DOI 10.1111/j.1742-4658.2009.07307.x; Iyer HV, 1996, J COLLOID INTERF SCI, V177, P391, DOI 10.1006/jcis.1996.0049; Jiang T, 2012, RSC ADV, V2, P9106, DOI 10.1039/c2ra21453a; Kachooei E, 2014, J BIOCHEM, V155, P361, DOI 10.1093/jb/mvu012; Kachooei E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041344; Kamkar A, 2008, FOOD CHEM TOXICOL, V46, P2236, DOI 10.1016/j.fct.2008.02.028; Kaufmann WE, 2000, CEREB CORTEX, V10, P981, DOI 10.1093/cercor/10.10.981; Klafki HW, 2006, BRAIN, V129, P2840, DOI 10.1093/brain/awl280; Knobloch M, 2008, MOL NEUROBIOL, V37, P73, DOI 10.1007/s12035-008-8018-z; Kontopidis G, 2004, J DAIRY SCI, V87, P785, DOI 10.3168/jds.S0022-0302(04)73222-1; Kroes-Nijboer A, 2012, FOOD FUNCT, V3, P221, DOI 10.1039/c1fo10163c; Kroes-Nijboer A, 2011, LANGMUIR, V27, P5753, DOI 10.1021/la104797u; Kroes-Nijboer A, 2009, FOOD BIOPHYS, V4, P59, DOI 10.1007/s11483-009-9101-3; Kunwar A, 2006, BBA-GEN SUBJECTS, V1760, P1513, DOI 10.1016/j.bbagen.2006.06.012; Liu XY, 2010, NEUROCHEM INT, V57, P588, DOI 10.1016/j.neuint.2010.07.007; Manetta AC, 2009, FOOD CHEM, V113, P595, DOI 10.1016/j.foodchem.2008.07.091; Oruc HH, 2006, FOOD ADDIT CONTAM A, V23, P190, DOI 10.1080/02652030500389048; Patrick L, 2006, ALTERN MED REV, V11, P114; Picciano AL, 2013, BIOPHYS CHEM, V184, P62, DOI 10.1016/j.bpc.2013.09.004; PIKE CJ, 1991, EUR J PHARM-MOLEC PH, V207, P367, DOI 10.1016/0922-4106(91)90014-9; POLLACK SJ, 1995, NEUROSCI LETT, V184, P113, DOI 10.1016/0304-3940(94)11182-I; Rader AJ, 2002, P NATL ACAD SCI USA, V99, P3540, DOI 10.1073/pnas.062492699; Rehder DS, 2010, BIOCHEMISTRY-US, V49, P7748, DOI 10.1021/bi1008694; Relkin P, 1998, INT J BIOL MACROMOL, V22, P59, DOI 10.1016/S0141-8130(97)00089-5; Remondetto GE, 2003, BIOPOLYMERS, V69, P461, DOI 10.1002/bip.10423; Sardar S, 2014, INT J BIOL MACROMOL, V69, P137, DOI 10.1016/j.ijbiomac.2014.05.006; Schleeger M, 2013, POLYMER, V54, P2473, DOI 10.1016/j.polymer.2013.02.029; Scrocchi LA, 2003, DIABETOLOGIA, V46, pA49; Selkoe DJ, 2003, NATURE, V426, P900, DOI 10.1038/nature02264; Shoval H, 2008, BBA-PROTEINS PROTEOM, V1784, P1570, DOI 10.1016/j.bbapap.2008.08.007; Sneharani AH, 2010, J AGR FOOD CHEM, V58, P11130, DOI 10.1021/jf102826q; Visschers RW, 2005, BIOTECHNOL ADV, V23, P75, DOI 10.1016/j.biotechadv.2004.09.005; Zako T, 2009, BIOPHYS J, V96, P3331, DOI 10.1016/j.bpj.2008.12.3957; Zhang C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012529	52	13	16	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0133206	10.1371/journal.pone.0133206	http://dx.doi.org/10.1371/journal.pone.0133206			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RV	26186474	Green Submitted, Green Published, gold			2022-12-26	WOS:000358198700108
J	Yu, Q; Vegh, V; Liu, FW; Turner, I				Yu, Qiang; Vegh, Viktor; Liu, Fawang; Turner, Ian			A Variable Order Fractional Differential-Based Texture Enhancement Algorithm with Application in Medical Imaging	PLOS ONE			English	Article							DIFFUSION EQUATION; NUMERICAL-METHODS; DIGITAL IMAGE; SPACE; APPROXIMATION; ENTROPY	Texture enhancement is one of the most important techniques in digital image processing and plays an essential role in medical imaging since textures discriminate information. Most image texture enhancement techniques use classical integral order differential mask operators or fractional differential mask operators using fixed fractional order. These masks can produce excessive enhancement of low spatial frequency content, insufficient enhancement of large spatial frequency content, and retention of high spatial frequency noise. To improve upon existing approaches of texture enhancement, we derive an improved Variable Order Fractional Centered Difference (VOFCD) scheme which dynamically adjusts the fractional differential order instead of fixing it. The new VOFCD technique is based on the second order Riesz fractional differential operator using a Lagrange 3-point interpolation formula, for both grey scale and colour image enhancement. We then use this method to enhance photographs and a set of medical images related to patients with stroke and Parkinson's disease. The experiments show that our improved fractional differential mask has a higher signal to noise ratio value than the other fractional differential mask operators. Based on the corresponding quantitative analysis we conclude that the new method offers a superior texture enhancement over existing methods.	[Yu, Qiang; Liu, Fawang; Turner, Ian] Queensland Univ Technol, Sch Math Sci, Brisbane, Qld 4001, Australia; [Vegh, Viktor] Univ Queensland, Ctr Adv Imaging, Brisbane, Qld, Australia	Queensland University of Technology (QUT); University of Queensland	Yu, Q (corresponding author), Univ Queensland, Ctr Adv Imaging, Brisbane, Qld, Australia.	qiang.yu@cai.uq.edu.au	Yu, Qiang/A-2275-2014; Liu, Fawang/G-3456-2010	Yu, Qiang/0000-0002-2664-8310; Liu, Fawang/0000-0003-1034-2349; Turner, Ian/0000-0003-2794-3968; Vegh, Viktor/0000-0002-4310-1421	Queensland University of Technology Write Up Scholarship	Queensland University of Technology Write Up Scholarship	This work was supported by Queensland University of Technology Write Up Scholarship (QY). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chappard D, 2003, BIOMATERIALS, V24, P1399, DOI 10.1016/S0142-9612(02)00524-0; Chen DL, 2012, SIGNAL IMAGE VIDEO P, V6, P503, DOI 10.1007/s11760-012-0334-0; Chen DL, 2011, IEEE T CIRCUITS-II, V58, P758, DOI 10.1109/TCSII.2011.2168022; Do MN, 2005, IEEE T IMAGE PROCESS, V14, P2091, DOI 10.1109/TIP.2005.859376; Fazel S. A. A., 2011, Proceedings of the 2011 International Conference on Digital Image Computing: Techniques and Applications (DICTA 2011), P308, DOI 10.1109/DICTA.2011.58; Gao C, 2011, J COMPUT INF SYST, V7, P257; Gao CB, 2011, IET IMAGE PROCESS, V5, P261, DOI 10.1049/iet-ipr.2009.0409; Gao CB, 2012, MATH PROBL ENG, V2012, DOI 10.1155/2012/325785; Garg V, 2012, INT J ADV COMPUT SC, V3, P130; Gilboa G, 2002, IEEE T IMAGE PROCESS, V11, P689, DOI 10.1109/TIP.2002.800883; Gonzalez R. C., 2008, DIGITAL IMAGE PROCES; Gorenflo R., 1998, FRACT CALC APPL ANAL, V1, P167; GROENEWALD AM, 1993, PATTERN RECOGN LETT, V14, P567, DOI 10.1016/0167-8655(93)90107-O; Huang Guo, 2012, Journal of Shenyang University of Technology, V34, P446; Kumar R, 2005, INT J MACH TOOL MANU, V45, P228, DOI 10.1016/j.ijmachtools.2004.07.001; LeBihan D, 1995, NMR BIOMED, V8, P375, DOI 10.1002/nbm.1940080711; Liu F, 2007, APPL MATH COMPUT, V191, P12, DOI 10.1016/j.amc.2006.08.162; Liu F, 2004, J COMPUT APPL MATH, V166, P209, DOI 10.1016/j.cam.2003.09.028; Mathieu B, 2003, SIGNAL PROCESS, V83, P2421, DOI 10.1016/S0165-1684(03)00194-4; Ortigueira M. D., 2006, INT J MATH MATH SCI, V2006, DOI [DOI 10.1155/IJMMS/2006/48391, 10.1155/IJMMS/2006/48391]; Pal SK, 2005, PATTERN RECOGN LETT, V26, P2509, DOI 10.1016/j.patrec.2005.05.007; Panda CS, 2009, INT J IMAGE PROCESS, V3, P105; Pesquet-Popescu B, 2002, IEEE SIGNAL PROC MAG, V19, P48, DOI 10.1109/MSP.2002.1028352; Podlubny I., 1999, FRACTIONAL DIFFERENT; Pu YF, 2010, IEEE T IMAGE PROCESS, V19, P491, DOI 10.1109/TIP.2009.2035980; Pu YF, 2008, SCI CHINA SER F, V51, P1319, DOI 10.1007/s11432-008-0098-x; Roop JP, 2006, J COMPUT APPL MATH, V193, P243, DOI 10.1016/j.cam.2005.06.005; Sejdic E, 2011, SIGNAL PROCESS, V91, P1351, DOI 10.1016/j.sigpro.2010.10.008; SHANNON CE, 1948, BELL SYST TECH J, V27, P623, DOI 10.1002/j.1538-7305.1948.tb00917.x; Shuja SZ, 2001, COMPUT METHOD APPL M, V190, P3623, DOI 10.1016/S0045-7825(00)00291-7; Trampel R, 2002, MAGNET RESON MED, V48, P543, DOI 10.1002/mrm.10228; WESZKA JS, 1979, IEEE T SYST MAN CYB, V9, P38; Yang QQ, 2011, SIAM J SCI COMPUT, V33, P1159, DOI 10.1137/100800634; Yu Q, 2014, J COMPUT APPL MATH, V255, P635, DOI 10.1016/j.cam.2013.06.027; Yu Q, 2012, APPL MATH COMPUT, V219, P4082, DOI 10.1016/j.amc.2012.10.056; Yu Q, 2013, ANZIAM J, V54, pC590; Yu Q., 2013, THESIS QUEENSLAND U; Yu Q, 2011, ANZIAM J, V52, pC18; Yu Q, 2013, PHILOS T R SOC A, V371, DOI 10.1098/rsta.2012.0150; Zhang H, 2010, APPL MATH COMPUT, V217, P2534, DOI 10.1016/j.amc.2010.07.066; Zhang Y., 2010, J COMPUT INFORM SYST, V6, P3191; Zhuang P, 2009, SIAM J NUMER ANAL, V47, P1760, DOI 10.1137/080730597; Zhuang P, 2008, SIAM J NUMER ANAL, V46, P1079, DOI 10.1137/060673114	43	18	18	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0132952	10.1371/journal.pone.0132952	http://dx.doi.org/10.1371/journal.pone.0132952			35	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RV	26186221	Green Published, gold, Green Submitted			2022-12-26	WOS:000358198700074
J	Korkola, JE; Collisson, EA; Heiser, L; Oates, C; Bayani, N; Itani, S; Esch, A; Thompson, W; Griffith, OL; Wang, NJ; Kuo, WL; Cooper, B; Billig, J; Ziyad, S; Hung, JL; Jakkula, L; Feiler, H; Lu, YL; Mills, GB; Spellman, PT; Tomlin, C; Mukherjee, S; Gray, JW				Korkola, James E.; Collisson, Eric A.; Heiser, Laura; Oates, Chris; Bayani, Nora; Itani, Sleiman; Esch, Amanda; Thompson, Wallace; Griffith, Obi L.; Wang, Nicholas J.; Kuo, Wen-Lin; Cooper, Brian; Billig, Jessica; Ziyad, Safiyyah; Hung, Jenny L.; Jakkula, Lakshmi; Feiler, Heidi; Lu, Yiling; Mills, Gordon B.; Spellman, Paul T.; Tomlin, Claire; Mukherjee, Sach; Gray, Joe W.			Decoupling of the PI3K Pathway via Mutation Necessitates Combinatorial Treatment in HER2+Breast Cancer	PLOS ONE			English	Article							METASTATIC BREAST-CANCER; KINASE INHIBITOR; CELL-LINES; TRASTUZUMAB; LAPATINIB; THERAPY; CHEMOTHERAPY; ACTIVATION; RESISTANCE; PIK3CA	We report here on experimental and theoretical efforts to determine how best to combine drugs that inhibit HER2 and AKT in HER2+ breast cancers. We accomplished this by measuring cellular and molecular responses to lapatinib and the AKT inhibitors (AKT(i)) GSK690693 and GSK2141795 in a panel of 22 HER2+ breast cancer cell lines carrying wild type or mutant PIK3CA. We observed that combinations of lapatinib plus AKTi were synergistic in HER2(+)/PIK3CA(mut) cell lines but not in HER2(+)/PIK3CA(wt)cell lines. We measured changes in phospho-protein levels in 15 cell lines after treatment with lapatinib, AKT(i) or lapatinib + AKT(i) to shed light on the underlying signaling dynamics. This revealed that pS6RP levels were less well attenuated by lapatinib in HER2(+)/PIK3CA(mut)cells compared to HER2(+)/PIK3CA(wt)cells and that lapatinib + AKT(i) reduced p-S6RP levels to those achieved in HER2(+)/PIK3CA(wt) cells with lapatinib alone. We also found that that compensatory upregulation of p-HER3 and p-HER2 is blunted in PIK3CA(mut) cells following lapatinib + AKT(i)-treatment. Responses of HER2(+) SKBR3 cells transfected with lentiviruses carrying control or PIK3CAmut sequences were similar to those observed in HER2(+)/PIK3CA(mut) cell lines but not in HER2(+)/PIK3CA(wt)cell lines. We used a nonlinear ordinary differential equation model to support the idea that PIK3CA mutations act as downstream activators of AKT that blunt lapatinib inhibition of downstream AKT signaling and that the effects of PIK3CA mutations can be countered by combining lapatinib with an AKT(i). This combination does not confer substantial benefit beyond lapatinib in HER2(+)/PIK3CA(wt) cells.	[Korkola, James E.; Heiser, Laura; Esch, Amanda; Thompson, Wallace; Wang, Nicholas J.; Feiler, Heidi; Spellman, Paul T.; Gray, Joe W.] Oregon Hlth & Sci Univ, Dept Biomed Engn, Portland, OR 97239 USA; [Bayani, Nora; Griffith, Obi L.; Kuo, Wen-Lin; Cooper, Brian; Billig, Jessica; Ziyad, Safiyyah; Hung, Jenny L.; Jakkula, Lakshmi; Feiler, Heidi] Lawrence Berkeley Natl Labs, Div Life Sci, Berkeley, CA USA; [Collisson, Eric A.] Univ Calif San Francisco, Div Heme Onc, San Francisco, CA 94143 USA; [Oates, Chris; Mukherjee, Sach] Netherlands Canc Inst, Div Biochem, Amsterdam, Netherlands; [Oates, Chris] Univ Warwick, Ctr Complex Sci, Coventry CV4 7AL, W Midlands, England; [Itani, Sleiman; Tomlin, Claire] Univ Calif Berkeley, Dept Elect Engn & Comp Sci, Berkeley, CA 94720 USA; [Lu, Yiling; Mills, Gordon B.] Univ Texas Houston, MD Anderson Canc Ctr, Dept Syst Biol, Houston, TX 77030 USA	Oregon Health & Science University; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California San Francisco; Netherlands Cancer Institute; University of Warwick; University of California System; University of California Berkeley; University of Texas System; University of Texas Health Science Center Houston; UTMD Anderson Cancer Center	Gray, JW (corresponding author), Oregon Hlth & Sci Univ, Dept Biomed Engn, Portland, OR 97239 USA.	grayjo@ohsu.edu	Gray, Joe/AAX-9549-2020; Griffith, Obi/P-1286-2014	, James/0000-0002-0030-6216; Griffith, Obi/0000-0002-0843-4271	National Institutes of Health, National Cancer Institute [U54 CA 112970, U24 CA 126477, U01 CA164720]; OHSU Knight Cancer Institute [5P30CA069533-16]; Susan G. Komen Foundation [SAC110012]; Prospect Creek Foundation; NATIONAL CANCER INSTITUTE [U01CA195469, P30CA069533, U01CA164720, U54CA112970, P30CA016672, U24CA126477] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM107615] Funding Source: NIH RePORTER	National Institutes of Health, National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); OHSU Knight Cancer Institute; Susan G. Komen Foundation(Susan G. Komen Breast Cancer Foundation); Prospect Creek Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health, National Cancer Institute grants U54 CA 112970, the U24 CA 126477, the U01 CA164720, by the OHSU Knight Cancer Institute 5P30CA069533-16, by the Susan G. Komen Foundation SAC110012 and by the Prospect Creek Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Lazikani B, 2012, NAT BIOTECHNOL, V30, P679, DOI 10.1038/nbt.2284; Amin DN, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000389; BAND V, 1990, CANCER RES, V50, P7351; Berns K, 2007, CANCER CELL, V12, P395, DOI 10.1016/j.ccr.2007.08.030; Blackwell KL, 2010, J CLIN ONCOL, V28, P1124, DOI 10.1200/JCO.2008.21.4437; Chakrabarty A, 2010, ONCOGENE, V29, P5193, DOI 10.1038/onc.2010.257; Chandarlapaty S, 2011, CANCER CELL, V19, P58, DOI 10.1016/j.ccr.2010.10.031; Dave B, 2011, J CLIN ONCOL, V29, P166, DOI 10.1200/JCO.2009.27.7814; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Esteva FJ, 2010, AM J PATHOL, V177, P1647, DOI 10.2353/ajpath.2010.090885; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Geyer CE, 2006, NEW ENGL J MED, V355, P2733, DOI 10.1056/NEJMoa064320; Gould CM, 2011, J BIOL CHEM, V286, P28922, DOI 10.1074/jbc.M111.272526; Gymnopoulos M, 2007, P NATL ACAD SCI USA, V104, P5569, DOI 10.1073/pnas.0701005104; Heiser LM, 2011, P NATL ACAD SCI US; Holbro T, 2003, P NATL ACAD SCI USA, V100, P8933, DOI 10.1073/pnas.1537685100; Johnston S, 2009, J CLIN ONCOL, V27, P5538, DOI 10.1200/JCO.2009.23.3734; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Kuo WL, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-77; Lee JJ, 2007, J BIOPHARM STAT, V17, P461, DOI 10.1080/10543400701199593; Lee-Hoeflich ST, 2008, CANCER RES, V68, P5878, DOI 10.1158/0008-5472.CAN-08-0380; Mirzoeva OK, 2009, CANCER RES, V69, P565, DOI 10.1158/0008-5472.CAN-08-3389; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Park JW, 2008, CLIN BREAST CANCER, V8, P392, DOI 10.3816/CBC.2008.n.047; Piccart-Gebhart MJ, 2005, NEW ENGL J MED, V353, P1659, DOI 10.1056/NEJMoa052306; Pritchard JR, 2012, DRUG RESIST UPDATE, V15, P249, DOI 10.1016/j.drup.2012.10.003; Razis E, 2011, BREAST CANCER RES TR, V128, P447, DOI 10.1007/s10549-011-1572-5; Rhodes N, 2008, CANCER RES, V68, P2366, DOI 10.1158/0008-5472.CAN-07-5783; Scaltriti M, 2009, ONCOGENE, V28, P803, DOI 10.1038/onc.2008.432; Sergina NV, 2007, NATURE, V445, P437, DOI 10.1038/nature05474; She QB, 2003, CLIN CANCER RES, V9, P4340; Slamon DJ, 2001, NEW ENGL J MED, V344, P783, DOI 10.1056/NEJM200103153441101; Stemke-Hale K, 2008, CANCER RES, V68, P6084, DOI 10.1158/0008-5472.CAN-07-6854; Tibes R, 2006, MOL CANCER THER, V5, P2512, DOI 10.1158/1535-7163.MCT-06-0334; Wang LP, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-248; Winter GE, 2012, NAT CHEM BIOL, V8, P905, DOI [10.1038/nchembio.1085, 10.1038/NCHEMBIO.1085]	36	16	16	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2015	10	7							e0133219	10.1371/journal.pone.0133219	http://dx.doi.org/10.1371/journal.pone.0133219			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RQ	26181325	Green Published, Green Submitted, gold			2022-12-26	WOS:000358198200057
J	Zhao, MZ; Lei, CN; Yang, YD; Bu, XL; Ma, HL; Gong, H; Liu, J; Fang, XD; Hu, ZY; Fang, QJ				Zhao, Minzhi; Lei, Chunni; Yang, Yadong; Bu, Xiangli; Ma, Huailei; Gong, He; Liu, Juan; Fang, Xiangdong; Hu, Zhiyuan; Fang, Qiaojun			Abraxane, the Nanoparticle Formulation of Paclitaxel Can Induce Drug Resistance by Up-Regulation of P-gp	PLOS ONE			English	Article							ALBUMIN-BOUND PACLITAXEL; MULTIDRUG-RESISTANCE; CANCER-CELLS; RNA-SEQ; CREMOPHOR-FREE; GENE; GLYCOPROTEIN; ADHESION; ABI-007; PHARMACOKINETICS	P-glycoprotein (P-gp) can actively pump paclitaxel (PTX) out of cells and induces drug resistance. Abraxane, a nanoparticle (NP) formulation of PTX, has multiple clinical advantages over the single molecule form. However, it is still unclear whether Abraxane overcomes the common small molecule drug resistance problem mediated by P-gp. Here we were able to establish an Abraxane-resistant cell line from the lung adenocarcinoma cell line A549. We compared the transcriptome of A549/Abr resistant cell line to that of its parental cell line using RNA-Seq technology. Several pathways were found to be up or down regulated. Specifically, the most significantly up-regulated gene was ABCB1, which translates into P-glycoprotein. We verified the overexpression of P-glycoprotein and confirmed its function by reversing the drug resistance with P-gp inhibitor Verapamil. The results suggest that efflux pathway plays an important role in the Abraxane-resistant cell line we established. However, the relevance of this P-gp mediated Abraxane resistance in tumors of lung cancer patients remains unknown.	[Zhao, Minzhi; Lei, Chunni; Bu, Xiangli; Ma, Huailei; Gong, He; Liu, Juan; Hu, Zhiyuan; Fang, Qiaojun] Chinese Acad Sci, Natl Ctr Nanosci & Technol, CAS Key Lab Biol Effects Nanomat & Nanosafety, Beijing 100190, Peoples R China; [Yang, Yadong; Fang, Xiangdong] Chinese Acad Sci, CAS Key Lab Genome Sci & Informat, Beijing Inst Genom, Beijing 100101, Peoples R China; [Hu, Zhiyuan] Beijing Proteome Res Ctr, Beijing Inst Radiat Med, Beijing 102206, Peoples R China	Chinese Academy of Sciences; National Center for Nanoscience & Technology - China; Chinese Academy of Sciences; Beijing Institute of Genomics, CAS	Fang, XD (corresponding author), Chinese Acad Sci, CAS Key Lab Genome Sci & Informat, Beijing Inst Genom, Beijing 100101, Peoples R China.	fangxd@big.ac.cn; huzy@nanoctr.cn; fangqj@nanoctr.cn		Liu, Juan/0000-0003-1399-6719; Leggas, Markos/0000-0003-4314-4533	National Natural Science Foundation of China [31270875, 31470049]; Chinese Academy of Science [YZ201217, Y4362911ZX]; International S&T Cooperation Program of China [2010DFB33880]; State Key Development Program for Basic Research of China [2011CB915502]; "Strategic Priority Research Program" of Chinese Academy of Sciences; Stem Cell and Regenerative Medicine Research [XDA01040405]; National Programs for High Technology Research and Development (863 Project) [2012AA022502]; National "Twelfth Five-Year" Plan for Science & Technology Support [2013BAI01B09]; Shanghai Leading Academic Discipline Project [B502]; Shanghai Key Laboratory Project [08DZ2230500]; Science and Technology Commission of Shanghai Municipality Project [11nm0507000]; Scientific Research Foundation for Returned Overseas Chinese Scholars, State Education Ministry	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Science(Chinese Academy of Sciences); International S&T Cooperation Program of China; State Key Development Program for Basic Research of China(State Key Development Program for Basic Research of China); "Strategic Priority Research Program" of Chinese Academy of Sciences(Chinese Academy of Sciences); Stem Cell and Regenerative Medicine Research; National Programs for High Technology Research and Development (863 Project); National "Twelfth Five-Year" Plan for Science & Technology Support; Shanghai Leading Academic Discipline Project(Shanghai Leading Academic Discipline Project); Shanghai Key Laboratory Project; Science and Technology Commission of Shanghai Municipality Project(Science & Technology Commission of Shanghai Municipality (STCSM)); Scientific Research Foundation for Returned Overseas Chinese Scholars, State Education Ministry(Scientific Research Foundation for the Returned Overseas Chinese Scholars)	The authors acknowledge funding from the National Natural Science Foundation of China (31270875, 31470049), Chinese Academy of Science (YZ201217, Y4362911ZX), the International S&T Cooperation Program of China (2010DFB33880), the State Key Development Program for Basic Research of China grant (2011CB915502), the "Strategic Priority Research Program" of the Chinese Academy of Sciences, Stem Cell and Regenerative Medicine Research (XDA01040405 to X.F.), National Programs for High Technology Research and Development (863 Projects, 2012AA022502 to X.F.), National "Twelfth Five-Year" Plan for Science & Technology Support (2013BAI01B09 to X.F.), Shanghai Leading Academic Discipline Project (B502), Shanghai Key Laboratory Project (08DZ2230500), Science and Technology Commission of Shanghai Municipality Project (11nm0507000), and the Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry.	Aller SG, 2009, SCIENCE, V323, P1718, DOI 10.1126/science.1168750; Ambudkar SV, 1999, ANNU REV PHARMACOL, V39, P361, DOI 10.1146/annurev.pharmtox.39.1.361; Armstrong SR, 2012, J OVARIAN RES, V5, DOI 10.1186/1757-2215-5-40; Chauhan VP, 2012, NAT NANOTECHNOL, V7, P383, DOI [10.1038/NNANO.2012.45, 10.1038/nnano.2012.45]; CHEN CJ, 1986, CELL, V47, P381, DOI 10.1016/0092-8674(86)90595-7; Chen X, 2012, NANOSCALE RES LETT, V7, P1, DOI 10.1186/1556-276X-7-598; Cukierman E, 2010, BIOCHEM PHARMACOL, V80, P762, DOI 10.1016/j.bcp.2010.04.020; Damiano JS, 1999, BLOOD, V93, P1658, DOI 10.1182/blood.V93.5.1658; Desai N, 2006, CLIN CANCER RES, V12, P1317, DOI 10.1158/1078-0432.CCR-05-1634; Desai N, 2007, NAB TECHNOLOGY DRUG, V2008, P37; Dong XW, 2009, CANCER RES, V69, P3918, DOI 10.1158/0008-5472.CAN-08-2747; Dumontet C, 1996, CANCER RES, V56, P1091; Fan JT, 2010, BIOORGAN MED CHEM, V18, P8226, DOI 10.1016/j.bmc.2010.10.019; Gardner ER, 2008, J CHROMATOGR B, V862, P213, DOI 10.1016/j.jchromb.2007.12.013; Gottesman MM, 2002, NAT REV CANCER, V2, P48, DOI 10.1038/nrc706; Grantab R, 2006, CANCER RES, V66, P1033, DOI 10.1158/0008-5472.CAN-05-3077; Hung TH, 2014, ONCOTARGET, V5, P12273, DOI 10.18632/oncotarget.2631; Hutter G, 2001, PROTEOMICS, V1, P1233; Johnstone RW, 2000, TRENDS BIOCHEM SCI, V25, P1, DOI 10.1016/S0968-0004(99)01493-0; Jordan MA, 2004, NAT REV CANCER, V4, P253, DOI 10.1038/nrc1317; Ke WF, 2011, MED ONCOL, V28, pS135, DOI 10.1007/s12032-010-9747-1; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Liu JH, 2012, BIOMATERIALS, V33, P6155, DOI 10.1016/j.biomaterials.2012.05.035; Liu Y, 2012, NANOTECHNOLOGY, V23, DOI 10.1088/0957-4484/23/38/385302; Ma Ping, 2013, J Nanomed Nanotechnol, V4, P1000164; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; MATSUMURA Y, 1986, CANCER RES, V46, P6387; Matsumura Y, 2009, CANCER SCI, V100, P572, DOI 10.1111/j.1349-7006.2009.01103.x; McGrail DJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep09529; Metzinger DS, 2006, CANCER LETT, V236, P302, DOI 10.1016/j.canlet.2005.05.016; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Mungrue IN, 2009, J IMMUNOL, V182, P466, DOI 10.4049/jimmunol.182.1.466; Nyman DW, 2005, J CLIN ONCOL, V23, P7785, DOI 10.1200/JCO.2004.00.6148; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Pahor M, 1996, LANCET, V348, P493, DOI 10.1016/S0140-6736(96)04277-8; Pahor M, 1996, AM J HYPERTENS, V9, P695, DOI 10.1016/0895-7061(96)00186-0; PANDA D, 1994, P NATL ACAD SCI USA, V91, P11358, DOI 10.1073/pnas.91.24.11358; Riganti C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060975; Sahay G, 2010, J CONTROL RELEASE, V145, P182, DOI 10.1016/j.jconrel.2010.01.036; Shain KH, 2001, MOL CANCER THER, V1, P69; Sparreboom A, 2005, CLIN CANCER RES, V11, P4136, DOI 10.1158/1078-0432.CCR-04-2291; Stordal B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040717; TANG C, 1994, LEUKEMIA, V8, P1960; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Tredan O, 2007, J NATL CANCER I, V99, P1441, DOI 10.1093/jnci/djm135; van Vlerken Lilian E, 2006, Expert Opin Drug Deliv, V3, P205, DOI 10.1517/17425247.3.2.205; Vara D, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.141; Wang J, 2013, NUCLEIC ACIDS RES, V41, pW77, DOI 10.1093/nar/gkt439; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wei CM, 2007, NANOMED-NANOTECHNOL, V3, P322, DOI 10.1016/j.nano.2007.10.005; Yang YD, 2013, GENOMICS, V102, P431, DOI 10.1016/j.ygeno.2013.09.005; Zhang F, 2009, J PROTEOME RES, V8, P5041, DOI 10.1021/pr900461c; Zhang LB, 2013, CLIN CANCER RES, V19, P5972, DOI 10.1158/1078-0432.CCR-13-1485; Zhao XF, 2014, J EXP CLIN CANC RES, V33, DOI 10.1186/1756-9966-33-3	54	66	77	2	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2015	10	7							e0131429	10.1371/journal.pone.0131429	http://dx.doi.org/10.1371/journal.pone.0131429			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RQ	26182353	Green Published, gold, Green Submitted			2022-12-26	WOS:000358198200005
J	Johnson, V; Xiang, MQ; Chen, Z; Junge, HJ				Johnson, Verity; Xiang, Mengqing; Chen, Zhe; Junge, Harald J.			Neurite Mistargeting and Inverse Order of Intraretinal Vascular Plexus Formation Precede Subretinal Vascularization in Vldlr Mutant Mice	PLOS ONE			English	Article							RETINAL ANGIOMATOUS PROLIFERATION; DENSITY LIPOPROTEIN RECEPTOR; HORIZONTAL CELLS; MOUSE RETINA; MACULAR DEGENERATION; OUTER RETINA; SYNAPSE FORMATION; KNOCKOUT MICE; NEOVASCULARIZATION; AGE	In the retina blood vessels are required to support a high metabolic rate, however, uncontrolled vascular growth can lead to impaired vision and blindness. Subretinal vascularization (SRV), one type of pathological vessel growth, occurs in retinal angiomatous proliferation and proliferative macular telangiectasia. In these diseases SRV originates from blood vessels within the retina. We use mice with a targeted disruption in the Vldl-receptor (Vldlr) gene as a model to study SRV with retinal origin. We find that Vldlr mRNA is strongly expressed in the neuroretina, and we observe both vascular and neuronal phenotypes in Vldlr(-/-)mice. Unexpectedly, horizontal cell (HC) neurites are mistargeted prior to SRV in this model, and the majority of vascular lesions are associated with mistargeted neurites. In Foxn4(-/-)mice, which lack HCs and display reduced amacrine cell (AC) numbers, we find severe defects in intraretinal capillary development. However, SRV is not suppressed in Foxn4(-/-); Vldlr(-/-)mice, which reveals that mistargeted HC neurites are not required for vascular lesion formation. In the absence of VLDLR, the intraretinal capillary plexuses form in an inverse order compared to normal development, and subsequent to this early defect, vascular proliferation is increased. We conclude that SRV in the Vldlr(-/-)model is associated with mistargeted neurites and that SRV is preceded by altered retinal vascular development.	[Johnson, Verity; Chen, Zhe; Junge, Harald J.] Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA; [Xiang, Mengqing] Rutgers State Univ, Robert Wood Johnson Med Sch, Ctr Adv Biotechnol & Med, Piscataway, NJ 08901 USA; [Xiang, Mengqing] Rutgers State Univ, Robert Wood Johnson Med Sch, Dept Pediat, Piscataway, NJ 08901 USA; [Xiang, Mengqing] Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou 510060, Guangdong, Peoples R China	University of Colorado System; University of Colorado Boulder; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; Sun Yat Sen University	Junge, HJ (corresponding author), Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA.	harald.junge@colorado.edu	Chen, Zhe/AAI-3485-2020	JUNGE, HARALD/0000-0003-2458-6010; CHEN, ZHE/0000-0003-0683-9491	National Eye Institute [1R01EY024261-01, R01EY020849]; Boettcher Foundation Webb-Waring Biomedical Research Award; Gordon Stone Fellowship; Linda Crnik Institute sponsored Dean's research grant; NATIONAL EYE INSTITUTE [R01EY024261, R01EY020849] Funding Source: NIH RePORTER	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Boettcher Foundation Webb-Waring Biomedical Research Award; Gordon Stone Fellowship; Linda Crnik Institute sponsored Dean's research grant; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by National Eye Institute, 1R01EY024261-01 to HJ, Boettcher Foundation Webb-Waring Biomedical Research Award to HJ, Linda Crnik Institute sponsored Dean's research grant to VJ, Gordon Stone Fellowship to VJ, and National Eye Institute R01EY020849 to MX. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams RH, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001875; Alves CH, 2013, HUM MOL GENET, V22, P35, DOI 10.1093/hmg/dds398; Bayley PR, 2007, J COMP NEUROL, V500, P286, DOI 10.1002/cne.21188; Cai X, 2014, BIOMATERIALS, V35, P249, DOI 10.1016/j.biomaterials.2013.10.022; Chen Y, 2007, J BIOL CHEM, V282, P34420, DOI 10.1074/jbc.M611289200; Chen Y, 2009, MICROVASC RES, V78, P119, DOI 10.1016/j.mvr.2009.02.005; Claes E, 2004, INVEST OPHTH VIS SCI, V45, P2039, DOI 10.1167/iovs.03-0741; Dick O, 2003, NEURON, V37, P775, DOI 10.1016/S0896-6273(03)00086-2; Donovan SL, 2004, VISION RES, V44, P3323, DOI 10.1016/j.visres.2004.08.007; Dorrell MI, 2006, PROG RETIN EYE RES, V25, P277, DOI 10.1016/j.preteyeres.2006.01.001; Dorrell MI, 2009, J CLIN INVEST, V119, P611, DOI 10.1172/JCI35977; FRYKMAN PK, 1995, P NATL ACAD SCI USA, V92, P8453, DOI 10.1073/pnas.92.18.8453; Haeseleer F, 2004, NAT NEUROSCI, V7, P1079, DOI 10.1038/nn1320; Haines JL, 2006, INVEST OPHTH VIS SCI, V47, P329, DOI 10.1167/iovs.05-0116; Heckenlively JR, 2003, RETINA-J RET VIT DIS, V23, P518, DOI 10.1097/00006982-200308000-00012; Hippenmeyer S, 2014, ADV EXP MED BIOL, V800, P1, DOI 10.1007/978-94-007-7687-6_1; Hu WZ, 2008, INVEST OPHTH VIS SCI, V49, P407, DOI 10.1167/iovs.07-0870; Hua J, 2011, INVEST OPHTH VIS SCI, V52, P2809, DOI 10.1167/iovs.10-6496; Itzkovitz S, 2011, NAT METHODS, V8, pS12, DOI [10.1038/NMETH.1573, 10.1038/nmeth.1573]; Ivanova E, 2014, INVEST OPHTH VIS SCI, V55, P78, DOI 10.1167/iovs.13-13196; Jiang AH, 2009, INVEST OPHTH VIS SCI, V50, P844, DOI 10.1167/iovs.08-2447; Junge HJ, 2009, CELL, V139, P299, DOI 10.1016/j.cell.2009.07.048; Kunzevitzky NJ, 2011, MOL CELL NEUROSCI, V46, P731, DOI 10.1016/j.mcn.2011.02.004; Kyosseva SV, 2013, EXP EYE RES, V116, P63, DOI 10.1016/j.exer.2013.08.003; Larrivee B, 2009, CIRC RES, V104, P428, DOI 10.1161/CIRCRESAHA.108.188144; Li C, 2007, ARCH OPHTHALMOL-CHIC, V125, P795, DOI 10.1001/archopht.125.6.795; Li SG, 2004, NEURON, V43, P795, DOI 10.1016/j.neuron.2004.08.041; Luo L, 2013, ELIFE, V2, DOI 10.7554/eLife.00324; Mansergh F, 2005, HUM MOL GENET, V14, P3035, DOI 10.1093/hmg/ddi336; Marticorena J, 2011, CURR DRUG TARGETS, V12, P199, DOI 10.2174/138945011794182683; Matsuoka RL, 2012, J NEUROSCI, V32, P6859, DOI 10.1523/JNEUROSCI.0267-12.2012; Michalakis S, 2013, CELL MOL LIFE SCI, V70, P1831, DOI 10.1007/s00018-012-1230-z; Mukouyama Y, 2002, CELL, V109, P693, DOI 10.1016/S0092-8674(02)00757-2; Paes KT, 2011, INVEST OPHTH VIS SCI, V52, P6452, DOI 10.1167/iovs.10-7146; Park B, 2011, J NEUROSCI, V31, P17230, DOI 10.1523/JNEUROSCI.4430-11.2011; Poche RA, 2009, DEVELOPMENT, V136, P2141, DOI 10.1242/dev.033175; Rice DS, 2001, NEURON, V31, P929, DOI 10.1016/S0896-6273(01)00436-6; Richard M, 2006, HUM MOL GENET, V15, pR235, DOI 10.1093/hmg/ddl195; Samuel MA, 2014, NAT NEUROSCI, V17, P1190, DOI 10.1038/nn.3772; Samuel MA, 2011, J NEUROSCI, V31, P16033, DOI 10.1523/JNEUROSCI.3580-11.2011; Sapieha P, 2012, BLOOD, V120, P2182, DOI 10.1182/blood-2012-04-396846; Schafer NF, 2009, INVEST OPHTH VIS SCI, V50, P906, DOI 10.1167/iovs.08-1731; Sonntag S, 2012, J NEUROSCI, V32, P10713, DOI 10.1523/JNEUROSCI.0442-12.2012; Takahashi Sadao, 2004, J Atheroscler Thromb, V11, P200; Terzibasi E, 2009, NEUROBIOL AGING, V30, P819, DOI 10.1016/j.neurobiolaging.2007.08.017; Thoreson WB, 2012, PROG RETIN EYE RES, V31, P407, DOI 10.1016/j.preteyeres.2012.04.003; Trotter JH, 2011, J NEUROSCI, V31, P14413, DOI 10.1523/JNEUROSCI.3135-11.2011; Tuo JS, 2007, INVEST OPHTH VIS SCI, V48, P3827, DOI 10.1167/iovs.07-0051; Wang YS, 2012, CELL, V151, P1332, DOI 10.1016/j.cell.2012.10.042; Westenskow PD, 2013, J CLIN INVEST, V123, P4900, DOI 10.1172/JCI70230; Xia CH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075186; Xia CH, 2011, INVEST OPHTH VIS SCI, V52, P6572, DOI 10.1167/iovs.10-7082; Xiang MQ, 2013, SCI CHINA LIFE SCI, V56, P985, DOI 10.1007/s11427-013-4543-8; Yannuzzi LA, 2001, RETINA-J RET VIT DIS, V21, P416, DOI 10.1097/00006982-200110000-00003; Zhang J, 2013, SYNAPSE, V67, P515, DOI 10.1002/syn.21674; Zhou XH, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0016733, 10.1371/journal.pone.0017812]; Zhou YD, 2011, EXP EYE RES, V93, P636, DOI 10.1016/j.exer.2011.07.017	57	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0132013	10.1371/journal.pone.0132013	http://dx.doi.org/10.1371/journal.pone.0132013			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26177550	gold, Green Published, Green Submitted			2022-12-26	WOS:000358197600079
J	Duan, JL; Hu, HH; Wang, G; Arao, T				Duan, Jiali; Hu, Huanhuan; Wang, Guan; Arao, Takashi			Study on Current Levels of Physical Activity and Sedentary Behavior among Middle School Students in Beijing, China	PLOS ONE			English	Article							BLOOD-PRESSURE; METABOLIC SYNDROME; SCREEN-TIME; ADOLESCENTS; CHILDREN; INACTIVITY; OBESITY; NUTRITION; OVERWEIGHT; HEALTH	Introduction This study aimed to determine current levels of physical activity and sedentary behavior in middle school students on the basis of grade, sex, student attitudes toward physical education, and residence location. Methods In 2013, a cross-sectional study of 1793 students aged 12 to 15 years was conducted across eight middle schools in Beijing, China. Four schools were selected from an urban district and another four schools were from a suburban district. Physical activity and sedentary behavior data were collected using the commonly used school-based Chinese version of the China Health and Nutrition Survey. Results The mean age of sampled students was 13.3 +/- 1.0 years; 51.5% were boys. Approximately 76.6% of students reported having three 45-minute physical education classes every week. A total of 35.6% students spent >= 1 h/day performing moderate to vigorous physical activity (MVPA) during school, and 34.9% spent >= 1 h/day in MVPA outside school time. Approximately half (49.7%) of the students engaged in reading, writing, or drawing for >= 2 h/day, and 42.9% reported screen time for >= 2 h/day. Although boys spent more time engaged in physical activity than girls did, they also spent more time exhibiting sedentary behavior. Each 10-unit increase in attitudes toward physical education was associated with an increased odds of 1.15 (95% CI: 1.09-1.20) for spending more than 1 h/day on MVPA. Students in suburban schools reported engaging in physical activity less when compared with those in urban schools. Conclusion The majority of our students did not meet the current physical activity recommendations, and about half of the students spent excessive time engaging in sedentary behaviors. Findings from this study highlight a positive association between student attitudes toward physical education and physical activity. Studies are needed to further explore the role of student attitudes toward physical education in promoting physical activity among Chinese students.	[Duan, Jiali; Wang, Guan] Beijing Ctr Dis Control & Prevent, Inst Sch Hlth, Beijing, Peoples R China; [Hu, Huanhuan] Waseda Univ, Sch Sport Sci, Lab Exercise Epidemiol, Saitama, Japan; [Arao, Takashi] Waseda Univ, Fac Sport Sci, Lab Exercise Epidemiol, Saitama, Japan	Waseda University; Waseda University	Hu, HH (corresponding author), Waseda Univ, Sch Sport Sci, Lab Exercise Epidemiol, Saitama, Japan.	hu.huanhuan@yahoo.com	Duan, Jiaobo/AAA-8651-2019		GCOE in Waseda University	GCOE in Waseda University	This research was supported by grant of GCOE in Waseda University (http://www.sport-sciences-gcoe-waseda.jp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsworth BE, 2011, MED SCI SPORT EXER, V43, P1575, DOI 10.1249/MSS.0b013e31821ece12; Albarwani S, 2009, METAB SYNDR RELAT D, V7, P369, DOI 10.1089/met.2008.0052; Bucksch J, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-351; Cao H, 2011, PREV MED, V53, P316, DOI 10.1016/j.ypmed.2011.09.002; Chen CM, 2008, OBES REV, V9, P14, DOI 10.1111/j.1467-789X.2007.00433.x; Chen Y, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-744; Cothran DJ, 1998, J TEACH PHYS EDUC, V17, P307, DOI 10.1123/jtpe.17.3.307; Cui ZH, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-93; Ding HY, 2014, QUEST, V66, P117, DOI 10.1080/00336297.2013.821415; Ennis, 2003, STUDENT LEARNING PHY, P207; Gordon-Larsen P, 2000, PEDIATRICS, V105, DOI 10.1542/peds.105.6.e83; Hallal PC, 2012, LANCET, V380, P247, DOI 10.1016/S0140-6736(12)60646-1; Hobbs M, 2015, BRIT J SPORT MED, V49, P1179, DOI 10.1136/bjsports-2014-093754; Hu HH, 2014, ADV PHYS ED, V4, P181, DOI DOI 10.4236/APE.2014.44022; Jiang XX, 2014, J EPIDEMIOL, V24, P397, DOI 10.2188/jea.JE20140006; Kristjansdottir G, 2001, ACTA PAEDIATR, V90, P429, DOI 10.1111/j.1651-2227.2001.tb00445.x; Lam JWK, 2010, PREV MED, V51, P96, DOI 10.1016/j.ypmed.2010.04.017; Leary SD, 2008, HYPERTENSION, V51, P92, DOI 10.1161/HYPERTENSIONAHA.107.099051; Leatherdale ST, 2008, INT J PEDIATR OBES, V3, P93, DOI 10.1080/17477160701830879; LeBlanc AGW, 2010, PEDIATR EXERC SCI, V22, P523, DOI 10.1123/pes.22.4.523; Lees C, 2013, PREV CHRONIC DIS, V10, DOI 10.5888/pcd10.130010; Li M, 2007, J ADOLESCENT HEALTH, V41, P99, DOI 10.1016/j.jadohealth.2007.02.005; Liang YJ, 2011, BLOOD PRESSURE, V20, P45, DOI 10.3109/08037051.2010.524085; Liu JH, 2008, J RURAL HEALTH, V24, P407, DOI 10.1111/j.1748-0361.2008.00188.x; Liu WJ, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-780; Lutfiyya MN, 2007, OBESITY, V15, P2348, DOI 10.1038/oby.2007.278; Martinez-Gomez D, 2011, ARCH DIS CHILD, V96, P240, DOI 10.1136/adc.2010.187161; PORTMAN PA, 1995, J TEACH PHYS EDUC, V14, P445, DOI 10.1123/jtpe.14.4.445; Rey-Lopez JP, 2008, NUTR METAB CARDIOVAS, V18, P242, DOI 10.1016/j.numecd.2007.07.008; Sallis JF, 2000, MED SCI SPORT EXER, V32, P963, DOI 10.1097/00005768-200009000-00012; Schmitz KH, 2002, PREV MED, V34, P266, DOI 10.1006/pmed.2001.0982; Shi ZM, 2006, PREV MED, V43, P218, DOI 10.1016/j.ypmed.2006.04.017; Sigmundova D, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-731; Silva K, 2014, INT J PUBLIC HEALTH, V59, P77, DOI 10.1007/s00038-013-0464-3; Springer AE, 2009, PREV CHRONIC DIS, V6; Steinberger J, 2009, CIRCULATION, V119, P628, DOI 10.1161/CIRCULATIONAHA.108.191394; Tandon PS, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-88; Tian BenChun, 2007, International Electronic Journal of Health Education, V10, P35; Tremblay MS, 2011, APPL PHYSIOL NUTR ME, V36, P65, DOI 10.1139/H11-013; Tudor-Locke C, 2003, INT J OBESITY, V27, P1093, DOI 10.1038/sj.ijo.0802377; Van der Horst K, 2007, MED SCI SPORT EXER, V39, P1241, DOI 10.1249/mss.0b013e318059bf35; Wang CKJ, 2010, INT J SPORT EXERC PS, V8, P284, DOI 10.1080/1612197X.2010.9671954; Welk GJ, 1999, QUEST, V51, P5, DOI 10.1080/00336297.1999.10484297; Wu Tsu-Yin, 2006, J Sch Nurs, V22, P25, DOI 10.1177/10598405060220010501; Zhang YX, 2013, ANN HUM BIOL, V40, P88, DOI 10.3109/03014460.2012.740073	45	34	38	4	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2015	10	7							e0133544	10.1371/journal.pone.0133544	http://dx.doi.org/10.1371/journal.pone.0133544			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RQ	25664813	Green Published, gold, Green Submitted			2022-12-26	WOS:000358198200066
J	Duan, JB; Fu, JF; Gao, HJ; Chen, CS; Fu, JF; Shi, X; Liu, XF				Duan, Jiaobo; Fu, Jufang; Gao, Hongjie; Chen, Changsheng; Fu, Jianfang; Shi, Xin; Liu, Xufeng			Factor Analysis of the Caregiver Quality of Life Index-Cancer (CQOLC) Scale for Chinese Cancer Caregivers: A Preliminary Reliability and Validity Study of the CQOLC-Chinese Version	PLOS ONE			English	Article							FAMILY CAREGIVER; SURVIVORS; HOME	The English version of the Caregiver Quality of Life Index-Cancer (CQOLC) was translated into simplified Chinese (CQOLC-C), following cultural translation, back-translation and pretest steps. Three hundred and sixty one cancer caregivers participated in this study. Cronbach's alpha was used to assess CQOLC-C reliability. Exploratory factor analyses (EFA) was used to generate two models of the measure's factor structure, and confirmatory factor analyses (CFA) were used to test each model, such that the best model to explain the latent structure of the CQOLC-C was identified. EFA using different factor extraction methods yielded two models including four and eight factors. According to the CFA results, model 2 was better fit for the original study data, based on the RMSEA criterion [ 0.058(90% CI = 0.051-0.065)],X-2 (531) = 853.92, p < 0.0001; CFI (0.96), NNFI (0.96), IFI (0.97), and NFI (0.92). We also examined the effect of removing three items on the CQOLC-C factor structure and discuss the resulting differences from other versions. These results indicate that the CQOLC-C's factor structure does not fully fit the original theorized model. This study provides preliminary support for further use of the CQOLC-C. However, the present work provides only partial support for the relevance and construct validity of the scale for Chinese caregivers.	[Duan, Jiaobo; Liu, Xufeng] Fourth Mil Med Univ, Sch Psychol, Xian 710032, Shaanxi, Peoples R China; [Fu, Jufang] Fourth Mil Med Univ, Infect Control Ctr, Xijing Hosp, Xian 710032, Shaanxi, Peoples R China; [Gao, Hongjie] Fourth Mil Med Univ, Sch Prevent Med, Dept Hlth Serv, Xian 710032, Shaanxi, Peoples R China; [Chen, Changsheng] Fourth Mil Med Univ, Sch Prevent Med, Dept Stat, Xian 710032, Shaanxi, Peoples R China; [Fu, Jianfang] Fourth Mil Med Univ, Xijing Hosp, Dept Endocrinol, Xian 710032, Shaanxi, Peoples R China; [Shi, Xin] Fourth Mil Med Univ, Sch Pharm, Xian 710032, Shaanxi, Peoples R China	Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University	Liu, XF (corresponding author), Fourth Mil Med Univ, Sch Psychol, Xian 710032, Shaanxi, Peoples R China.	lllfmmu@fmmu.edu.cn	Duan, Jiaobo/AAA-8651-2019		Fourth Military Medical University Scientific Research Projects	Fourth Military Medical University Scientific Research Projects	This study received external funding from the Fourth Military Medical University Scientific Research Projects. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACWF (All Chinese Women's Federation), 2008, NAT RUR LEFT BEH CHI; Bektas HA, 2009, J CLIN NURS, V18, P3003, DOI 10.1111/j.1365-2702.2009.02915.x; Bergelt C, 2008, QUAL LIFE RES, V17, P653, DOI 10.1007/s11136-008-9349-y; Cella D F, 1996, Oncology (Williston Park), V10, P233; Chen WQ, 2011, CANC FAR US CHINESE; Cong HW, 2007, MEASUREMENTS APPL QU, DOI [10.1093/jxb/erm028, DOI 10.1093/JXB/ERM028]; Ferrell B, 1991, Hosp J, V7, P9; Ferrell B R, 1995, Oncol Nurs Forum, V22, P1211; Ferrell BR, 1995, QUAL LIFE RES, V4, P523, DOI 10.1007/BF00634747; Fu YD, 2012, XUE SHU YUE KAN, V5, P9; Given BA, 2001, CA-CANCER J CLIN, V51, P213, DOI 10.3322/canjclin.51.4.213; Haley William E, 2003, J Palliat Med, V6, P215; HINDS C, 1985, J ADV NURS, V10, P575, DOI 10.1111/j.1365-2648.1985.tb00550.x; Hodges LJ, 2005, SOC SCI MED, V60, P1, DOI 10.1016/j.socscimed.2004.04.018; Huang LL, 2012, EC RES GUIDE, V21, P238; John F, 2003, J PAIN SYMPTOM MANAG, V26, P922; Kim Y, 2008, CANCER-AM CANCER SOC, V112, P2556, DOI 10.1002/cncr.23449; Lafaye A, 2013, QUAL LIFE RES, V22, P119, DOI 10.1007/s11136-012-0113-y; Li DH, 2012, LIAONING DA XUE XUE, P22; Lu QQ, 2010, SIXIANG ZHENG ZHI GO, P10; McMillan S C, 1994, Oncol Nurs Forum, V21, P1189; National Office of Aging Beijing, 2010, URB RUR AG PEOPL STA; Otis WB, 2010, 16 INT C CANC NURS U, P1; Ozer ZC, 2009, QUAL LIFE RES, V18, P913, DOI 10.1007/s11136-009-9503-1; Panke JT, 2004, OXFORD TXB PALLIATIV; Pitceathly C, 2003, EUR J CANCER, V39, P1517, DOI 10.1016/S0959-8049(03)00309-5; Rhee YS, 2005, QUAL LIFE RES, V14, P899, DOI 10.1007/s11136-004-1264-2; Schreiber JB, 2006, J EDUC RES, V99, P323, DOI 10.3200/JOER.99.6.323-338; Shultz K. S., 2004, MEASUREMENT THEORY A; Su CT, 2002, AM J OCCUP THER, V56, P581, DOI 10.5014/ajot.56.5.581; Tang WR, 2009, CANCER NURS, V32, P220, DOI 10.1097/NCC.0b013e31819b5ae8; Weitzner M A, 1997, Cancer Pract, V5, P25; Weitzner MA, 1999, QUAL LIFE RES, V8, P55, DOI 10.1023/A:1026407010614; Weitzner MA, 1999, J PAIN SYMPTOM MANAG, V17, P418, DOI 10.1016/S0885-3924(99)00014-7; Weitzner MA, 1999, J PALLIAT CARE, V15, P13, DOI 10.1177/082585979901500203; Xia Q, 2012, ZHONGGUO JIA TING JI, V2, P13	36	34	38	4	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2015	10	2							e0116438	10.1371/journal.pone.0116438	http://dx.doi.org/10.1371/journal.pone.0116438			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CA7UO	25664813	gold, Green Published, Green Submitted			2022-12-26	WOS:000349123100009
